#4##2##1##(2008-10#1)(2008-12#1)
#ENTITYSTARTX00026##4##1##(2010-7#2)(2012-3#2)
$1 million##3##2##(1992-8#1)(1995-12#2)
$1##17##1##(1991-1#1)(1991-12#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-5#2)(2008-10#1)(2008-5#1)
$10##3##1##(1991-3#1)(1994-2#1)(2008-10#1)
$100##4##1##(1994-2#1)(1996-5#1)(1997-1#1)(2008-10#1)
$120##3##1##(1995-6#2)(1996-5#1)
$125##3##1##(1995-6#1)(1996-5#2)
$15##2##1##(1992-1#1)(1993-5#1)
$16##3##1##(1993-3#1)(1995-12#1)(1995-6#1)
$2##7##1##(1992-11#1)(1993-1#1)(1994-1#2)(1994-2#2)(2008-10#1)
$25##2##1##(1991-12#1)(1996-5#1)
$267##2##1##(1995-6#2)
$3 billion##2##2##(1991-1#1)(2008-5#1)
$3##8##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-2#1)(1997-3#1)(2008-5#1)
$30 million##2##2##(1995-6#1)(1997-1#1)
$35##2##1##(1991-9#1)(1997-2#1)
$4##3##1##(1992-3#1)(1994-1#1)(1994-2#1)
$49##2##1##(1990-11#1)(1990-8#1)
$5 million##2##2##(1991-1#1)(1995-12#1)
$5##5##1##(1991-1#1)(1995-1#1)(1995-12#2)(2008-11#1)
$50##4##1##(1990-2#1)(1990-8#1)(1993-5#1)(1995-12#1)
$500 million##3##2##(1994-9#2)(2008-10#1)
$500##4##1##(1991-3#1)(1994-9#2)(2008-10#1)
$592##2##1##(1995-2#1)(2008-7#1)
$6 billion in##2##3##(1996-3#1)(2013-8#1)
$6##3##1##(1992-1#1)(1996-3#1)(2013-8#1)
$60##2##1##(1995-6#2)
$7##2##1##(1994-2#1)(2008-5#1)
$90##3##1##(1990-11#1)(1994-2#1)(1995-12#1)
% (n =##2##3##(2008-10#1)(2012-3#1)
% H(2)SO(4)##2##2##(2008-3#1)(2013-1#1)
% Nb##2##2##(2008-2#2)
% RSD##2##2##(2008-10#2)
% and##7##2##(1997-8#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-1#1)
% for##4##2##(2008-10#1)(2008-8#1)(2012-12#2)
% had##3##2##(2011-2#1)(2012-12#2)
% in case of the##2##5##(2008-10#2)
% in##4##2##(2008-10#3)(2008-8#1)
% of NiS##2##3##(2008-10#2)
% of cases##3##3##(1997-8#2)(2012-12#1)
% of the children##3##4##(2012-12#3)
% of the cohort were##2##5##(2012-12#2)
% of the participants##2##4##(2011-2#2)
% of the##25##3##(2008-1#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-12#13)
% of##43##2##(1995-11#1)(1996-3#1)(1997-8#3)(2008-1#1)(2008-10#5)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#1)(2011-1#2)(2011-2#9)(2012-12#17)
% on##2##2##(2010-7#1)(2012-12#1)
% potassium##2##2##(2008-10#2)
% was##4##2##(2008-11#1)(2013-1#3)
% water##2##2##(2008-5#2)
% were##2##2##(2012-12#2)
% when##3##2##(1997-8#2)(2008-1#1)
%##162##1##(1991-5#1)(1992-11#1)(1993-2#4)(1994-5#2)(1995-11#1)(1996-3#1)(1997-8#12)(2008-1#2)(2008-10#39)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#5)(2008-8#7)(2008-9#1)(2009-1#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#22)(2012-12#35)(2012-3#2)(2013-1#9)
%) Li(2)CO(3) and##2##3##(2008-10#2)
%) and##9##2##(1997-3#1)(1997-8#1)(2012-12#7)
%) in##2##2##(2011-2#1)(2012-12#1)
%) of##2##2##(2008-10#1)(2012-12#1)
%) or##3##2##(1997-8#1)(2012-12#2)
%) were##2##2##(2008-10#2)
%) with##2##2##(2008-8#1)(2012-12#1)
%)##74##1##(1993-2#2)(1993-8#1)(1997-3#1)(1997-8#8)(2008-1#2)(2008-10#10)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#6)(2012-12#38)(2012-2#1)(2013-1#2)
%Ca##2##1##(2008-10#2)
%K##3##1##(2008-10#3)
%Mg##2##1##(2008-10#2)
%R##3##1##(2008-10#3)
%RDBP##2##1##(2012-2#2)
&amp##242##1##(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-4#3)(1993-1#1)(1993-12#2)(1993-3#5)(1993-8#5)(1994-12#1)(1994-3#2)(1994-5#11)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#47)(2008-12#8)(2008-5#7)(2008-6#5)(2008-7#37)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-6#6)(2010-7#4)(2010-8#2)(2011-2#14)(2012-12#1)(2012-2#26)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#13)(2013-8#1)
&gt##499##1##(1992-12#2)(1992-9#2)(1993-1#2)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#13)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#8)(1994-6#1)(1994-8#3)(1995-11#6)(1995-12#9)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#10)(1996-12#9)(1996-2#3)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#7)(1997-4#1)(1997-5#4)(1997-6#1)(1997-8#8)(1997-9#1)(2007-12#1)(2008-1#5)(2008-10#190)(2008-11#28)(2008-12#8)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#17)(2008-6#1)(2008-7#17)(2008-8#9)(2008-9#7)(2009-3#1)(2009-6#1)(2009-8#4)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#3)(2010-7#2)(2010-8#1)(2011-2#22)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#14)(2012-5#3)(2013-1#17)(2013-8#7)
&lt##1100##1##(1991-12#2)(1992-11#4)(1992-12#9)(1992-9#4)(1993-1#7)(1993-11#7)(1993-12#3)(1993-2#7)(1993-3#4)(1993-8#1)(1994-11#7)(1994-12#17)(1994-2#2)(1994-3#22)(1994-5#6)(1994-8#7)(1995-12#9)(1995-2#2)(1995-3#5)(1995-6#2)(1995-8#11)(1996-1#1)(1996-11#2)(1996-12#20)(1996-2#4)(1996-3#5)(1996-6#4)(1996-8#2)(1997-1#10)(1997-3#3)(1997-4#3)(1997-5#5)(1997-6#1)(1997-8#7)(2006-6#1)(2007-11#13)(2007-12#1)(2008-1#5)(2008-10#359)(2008-11#37)(2008-12#21)(2008-2#1)(2008-3#40)(2008-5#15)(2008-7#27)(2008-8#6)(2008-9#23)(2009-1#3)(2009-11#3)(2009-12#4)(2009-3#2)(2009-5#7)(2009-6#8)(2009-8#8)(2009-9#4)(2010-1#7)(2010-11#5)(2010-12#8)(2010-2#9)(2010-3#2)(2010-4#22)(2010-6#4)(2010-7#6)(2010-8#11)(2011-2#51)(2011-3#28)(2012-12#3)(2012-2#16)(2012-3#40)(2012-5#2)(2013-1#55)(2013-8#38)
&quot##1708##1##(1990-11#9)(1990-12#4)(1990-2#5)(1990-3#5)(1990-5#5)(1990-6#7)(1990-8#7)(1990-9#9)(1991-1#4)(1991-11#5)(1991-12#17)(1991-2#8)(1991-3#25)(1991-6#2)(1991-7#1)(1991-8#12)(1991-9#6)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#22)(1992-3#17)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#9)(1993-11#7)(1993-12#20)(1993-2#27)(1993-3#15)(1993-5#3)(1993-6#3)(1993-8#4)(1993-9#2)(1994-1#19)(1994-11#5)(1994-12#17)(1994-2#29)(1994-3#13)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#12)(1995-11#1)(1995-12#7)(1995-2#21)(1995-3#26)(1995-5#14)(1995-6#19)(1996-1#10)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#10)(1996-5#4)(1996-6#4)(1996-9#5)(1997-1#12)(1997-2#15)(1997-3#19)(1997-4#6)(1997-5#5)(1997-6#4)(1997-7#5)(1997-8#3)(2008-1#18)(2008-10#187)(2008-11#81)(2008-12#38)(2008-3#4)(2008-4#33)(2008-5#18)(2008-6#12)(2008-7#22)(2008-8#86)(2008-9#48)(2009-1#2)(2009-10#32)(2009-11#4)(2009-12#3)(2009-3#8)(2009-4#11)(2009-5#19)(2009-6#9)(2009-7#9)(2009-8#8)(2009-9#21)(2010-1#11)(2010-11#4)(2010-12#21)(2010-4#17)(2010-5#8)(2010-6#17)(2010-7#12)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#122)(2011-3#6)(2011-7#1)(2012-12#7)(2012-2#57)(2012-3#35)(2012-4#1)(2013-1#60)(2013-7#4)(2013-8#45)
'##10##1##(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#1)
'90s##5##1##(1992-1#1)(1992-3#1)(1993-1#1)(1994-3#2)
'Acala 44'##2##2##(2008-10#2)
'B'##3##1##(1997-6#3)
'Burley 21' transgenic lines##3##4##(2008-10#3)
'Burley 21'##7##2##(2008-10#7)
'CI##2##1##(2008-10#2)
'Candidatus Phytoplasma mali'##2##3##(2008-10#2)
'Candidatus##3##1##(2008-10#3)
'Canthatch' nullisomic 7D##2##3##(2008-10#2)
'Canthatch'##5##1##(2008-10#5)
'Caring encounters from the perspective of##3##6##(2010-10#3)
'Chardonnay' and 'Riesling'##2##3##(2008-10#2)
'Chardonnay'##4##1##(2008-10#4)
'Chinese Spring'##5##2##(2008-10#5)
'Colorado'##2##1##(1990-11#2)
'Dehalococcoides' spp##2##2##(2011-1#2)
'Denver'##3##1##(1990-11#3)
'Discovery'##2##1##(2008-10#2)
'Eltan'##2##1##(2008-10#2)
'Fiesta'##2##1##(2008-10#2)
'Florunner'##3##1##(2008-10#3)
'Gala' apple seedlings##2##3##(2008-10#2)
'Gala' apple##3##2##(2008-10#3)
'Golden Delicious' x##2##3##(2008-10#2)
'Golden Delicious'##4##2##(2008-10#4)
'Healthy Islands'##2##2##(2008-1#2)
'J##4##1##(2008-10#4)
'Jerseyglo'##2##1##(2008-10#2)
'K-326' F(1) hybrid##2##3##(2008-10#2)
'K-326'##4##1##(2008-10#4)
'Katahdin'##2##1##(2008-10#2)
'Lalbahadur'##2##1##(2008-10#2)
'Lepidium' isolates##2##2##(2008-10#2)
'Loring'##2##1##(2008-10#2)
'Minneola'##3##1##(2008-10#3)
'Murcott'##2##1##(2008-10#2)
'NK-184mm-O'##3##1##(2012-3#3)
'NK-310mm-O'##2##1##(2012-3#2)
'Norin 4'##2##2##(2008-10#2)
'Nova'##4##1##(2008-10#4)
'Oketsu'##14##1##(2008-10#14)
'Okrun'##3##1##(2008-10#3)
'Orlando'##3##1##(2008-10#3)
'Otachibana'##3##1##(2008-10#3)
'Pavon 76' was##2##3##(2008-10#2)
'Pavon 76'##5##2##(2008-10#5)
'PhysioDirect'##2##1##(2011-2#2)
'Pito'##3##1##(2008-10#3)
'Ranger Russet'##2##2##(2008-10#2)
'Redhaven'##2##1##(2008-10#2)
'Riesling'##3##1##(2008-10#3)
'Seri 82' inoculated with##2##4##(2008-10#2)
'Seri 82'##4##2##(2008-10#4)
'Shafir'##3##1##(2008-10#3)
'Shepody'##2##1##(2008-10#2)
'Sumner'##3##1##(2008-10#3)
'Sunburst'##2##1##(2008-10#2)
'Thatcher'##4##1##(2008-10#4)
'Thlaspi'##3##1##(2008-10#3)
'Variegata'##3##1##(2008-10#3)
'What##2##1##(2008-11#1)(2008-12#1)
'Wichita'##2##1##(2008-10#2)
'a##2##1##(1995-2#1)(1997-8#1)
'acceptable'##2##1##(1996-12#1)(2009-8#1)
'active oxygen' in##2##3##(2008-10#2)
'active oxygen'##5##2##(2008-10#5)
'active##6##1##(2008-10#5)(2008-5#1)
'acute-phase' response##2##2##(1991-12#2)
'anthropogenic'##2##1##(2008-10#2)
'as##2##1##(2008-10#2)
'biological'##2##1##(2008-11#1)(2010-5#1)
'clean'##2##1##(1993-9#1)(2008-11#1)
'communication'##2##1##(2013-8#2)
'concentration polarization'##2##2##(2008-9#2)
'differentiation of##2##2##(2013-8#2)
'direct'##2##1##(2008-10#1)(2011-2#1)
'equal importance'##2##2##(2010-3#2)
'gassy'##2##1##(1997-8#2)
'global'##2##1##(2009-10#1)(2011-2#1)
'glucose sensors'##2##2##(1994-2#2)
'glucose##3##1##(1994-2#3)
'good'##2##1##(2008-3#1)(2013-1#1)
'health promotion in##3##3##(2008-11#3)
'health##6##1##(2008-11#6)
'high##2##1##(1993-3#1)(2008-5#1)
'hot##3##1##(2008-11#1)(2008-9#1)(2011-1#1)
'in vivo'##2##2##(1997-1#2)
'in##3##1##(1997-1#2)(2008-10#1)
'incorrect' and 'unsocial'##3##3##(2008-11#3)
'incorrect' and##4##2##(2008-11#4)
'inguinal' glands##2##2##(2008-7#2)
'internal##2##1##(2008-5#2)
'learning##2##1##(2008-11#1)(2009-10#1)
'low##2##1##(2008-11#1)(2008-5#1)
'man in the barrel' syndrome##2##5##(2008-7#2)
'natural##3##1##(1994-12#1)(2008-11#1)(2010-2#1)
'natural'##4##1##(2008-10#1)(2008-5#3)
'non-Oketsu'##2##1##(2008-10#2)
'normal'##3##1##(1990-5#1)(2008-8#1)(2008-9#1)
'nuez de##2##2##(2008-5#2)
'occupational##2##1##(2010-9#2)
'off campus'##2##2##(2008-11#2)
'off##4##1##(2008-10#2)(2008-11#2)
'off'##3##1##(2008-7#3)
'omic##4##1##(2012-12#4)
'optimal'##2##1##(2008-10#1)(2008-11#1)
'outlier'##2##1##(2012-5#2)
'overload phenomenon'##2##2##(2008-7#2)
'pseudodipeptides'##2##1##(2008-5#2)
'recovery' period##2##2##(1994-2#2)
'recovery'##3##1##(1994-2#3)
'rescue' therapy constitutes an encouraging##2##5##(2010-12#2)
'rescue'##6##1##(2010-12#6)
's##5##1##(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
'secondary##2##1##(1994-6#1)(2008-10#1)
'shear sensitivity'##3##2##(2008-11#3)
'social brain'##2##2##(2008-11#2)
'social##3##1##(2008-11#2)(2012-2#1)
'social'##4##1##(2008-11#4)
'support##2##1##(2008-11#1)(2010-10#1)
't##2##1##(1992-10#1)(2012-3#1)
'taque'##2##1##(2008-5#2)
'time release'##2##2##(2008-5#2)
'time##3##1##(1992-9#1)(2008-5#2)
'toxic second messengers'##2##3##(2008-5#2)
'toxic##3##1##(2008-5#3)
'treating different diseases by the same method'##3##7##(2013-8#3)
'treating different diseases by the same##4##6##(2013-8#4)
'true'##3##1##(1994-8#1)(2008-7#1)(2008-9#1)
'unmodifiable'##2##1##(2008-1#2)
'unsafe'##2##1##(1996-9#2)
'unsocial'##4##1##(2008-11#4)
'urgent'##5##1##(1994-3#5)
'what we##2##2##(2010-10#2)
'what##3##1##(2008-12#1)(2010-10#2)
'young' and##2##2##(2007-12#1)(2008-5#1)
( WAF-1 )##3##3##(2008-8#3)
( [Formula##2##2##(2008-10#2)
( alpha = 0##2##4##(2008-10#2)
( approximately 0##3##3##(2008-10#2)(2010-4#1)
( approximately 1##7##3##(2008-10#4)(2008-11#1)(2008-9#2)
( approximately 10##2##3##(2008-10#1)(2008-6#1)
( approximately 2##2##3##(2008-10#1)(2008-11#1)
( approximately 4##2##3##(2008-10#2)
( approximately 60##3##3##(2008-10#2)(2008-11#1)
( approximately##51##2##(1997-9#1)(2008-10#38)(2008-11#5)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#1)
( p &lt##3##3##(2008-11#3)
(##96##1##(1992-2#1)(1997-9#1)(2008-10#57)(2008-11#14)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2013-1#8)
(#70)##2##1##(2011-7#2)
(%##9##1##(1994-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2012-2#1)
(%)##13##1##(2008-10#12)(2010-5#1)
(%R##4##1##(2008-10#4)
(&gt##109##1##(1992-12#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-3#2)(1997-9#1)(2007-11#1)(2008-10#55)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#3)(2011-7#1)(2012-2#2)(2013-1#6)(2013-8#2)
(&lt##126##1##(1990-8#1)(1992-9#2)(1993-8#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-11#2)(2008-10#53)(2008-11#6)(2008-12#2)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#4)
(&quot##54##1##(1990-11#1)(1991-5#1)(1991-9#1)(1993-12#3)(1993-8#1)(1994-1#1)(1994-8#3)(1995-3#1)(1995-6#1)(1996-1#2)(1996-5#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#2)
('difficulty##2##1##(2011-2#2)
((52)Cr ) to##2##3##(2008-10#2)
((64)Zn+(66)Zn)/(68)Zn##2##1##(2008-10#2)
((66)Zn )##2##2##(2008-10#2)
()##10##1##(2008-10#1)(2008-11#9)
(+ )##3##2##(2008-10#3)
(+ 9##2##2##(1991-11#2)
(+ =##2##2##(2008-12#2)
(+##9##1##(1991-11#2)(2008-10#3)(2008-11#1)(2008-12#2)(2011-2#1)
(+)##10##1##(1990-5#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#1)
(+)-##2##1##(1992-12#1)(2008-8#1)
(+)-catechin acts as##2##3##(2008-10#2)
(+)-catechin and##2##2##(1993-8#1)(2008-11#1)
(+)-catechin##6##1##(1993-8#1)(2008-10#4)(2008-11#1)
(+)gauche##2##1##(1992-12#2)
(+/-##7##1##(1990-8#2)(1996-2#1)(1997-1#2)(2008-10#1)(2011-2#1)
(+/-)##2##1##(2008-11#2)
(+/-)-synephrine##2##1##(2008-10#2)
(+/-0##11##1##(2007-8#2)(2008-10#7)(2008-5#2)
(+/-1##4##1##(2008-10#4)
(+/-3##2##1##(2008-10#2)
(+/-SD)##3##1##(1994-12#2)(2008-3#1)
(+0##7##1##(1996-5#3)(2008-10#4)
(+1 to##2##2##(1990-5#1)(2012-5#1)
(+1##3##1##(1990-5#1)(2012-5#1)(2012-6#1)
(-)##17##1##(1990-5#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-7#1)(2011-2#2)(2013-8#2)
(-)-4-nitrophenyl-beta-d-glucopyranoside##2##1##(2008-10#2)
(-)-carvone##2##1##(2008-11#2)
(-)-epicatechin gallate##2##2##(2008-10#1)(2008-11#1)
(-)-epicatechin##8##1##(1993-8#1)(2008-10#6)(2008-11#1)
(-)-epigallocatechin gallate##3##2##(2008-11#3)
(-)-epigallocatechin##5##1##(2008-10#1)(2008-11#4)
(-0##4##1##(1990-5#2)(2008-10#1)(2009-7#1)
(-1##6##1##(2008-10#2)(2008-3#1)(2013-8#3)
(-1)##3##1##(2007-11#2)(2008-10#1)
(-2##5##1##(2008-10#1)(2008-3#1)(2010-10#1)(2010-4#1)(2013-8#1)
(-2-1##3##1##(2008-10#3)
(-3##2##1##(2013-1#2)
(-4##3##1##(1997-2#1)(2008-7#1)(2013-8#1)
(-5##3##1##(2008-10#1)(2008-9#1)(2013-8#1)
(-59##2##1##(2008-10#2)
(-7##2##1##(2008-10#1)(2008-4#1)
(-85 degrees##2##2##(2008-11#2)
(0 &lt##2##2##(2008-11#2)
(0 =##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
(0 degrees##2##2##(2008-10#2)
(0 to 3##2##3##(2008-10#1)(2011-2#1)
(0 to##7##2##(2008-10#6)(2011-2#1)
(0 tumors/10 injections)##2##3##(2013-1#2)
(0 vs##2##2##(2013-1#2)
(0##599##1##(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#12)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-3#2)(1992-4#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#1)(1993-3#3)(1993-6#8)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#7)(1995-11#2)(1995-12#1)(1995-3#3)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#3)(1996-2#14)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#16)(1997-4#6)(2006-6#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#285)(2008-11#20)(2008-12#11)(2008-2#4)(2008-3#9)(2008-5#8)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#7)(2009-1#1)(2009-11#3)(2009-12#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#3)(2011-2#18)(2011-3#4)(2012-12#2)(2012-2#6)(2012-3#9)(2012-4#1)(2013-1#16)(2013-8#4)
(0%##2##1##(2010-4#1)(2010-7#1)
(0%) in##3##2##(1993-1#2)(2011-2#1)
(0)##2##1##(2008-10#2)
(0-0##2##1##(2011-2#2)
(0-1##7##1##(1996-12#1)(1997-8#2)(2008-10#4)
(0-1)##2##1##(2008-10#1)(2013-1#1)
(0-3##2##1##(1992-12#1)(2008-3#1)
(0P was##3##2##(2010-12#3)
(1 -##5##2##(2008-10#5)
(1 0 0)##2##3##(2008-3#2)
(1 and##5##2##(1993-12#2)(1995-12#1)(2008-10#2)
(1 case)##6##2##(1990-6#1)(1997-6#1)(2007-8#1)(2008-11#3)
(1 cm##2##2##(2008-10#2)
(1 group)##2##2##(2008-12#2)
(1 mM)##5##2##(1990-2#2)(1993-8#1)(1995-11#1)(1996-2#1)
(1 mg L(-1)##2##3##(2008-12#2)
(1 mg##4##2##(2008-12#2)(2010-6#1)(2011-2#1)
(1 mg/kg i##3##3##(1991-2#1)(1992-3#1)(1996-2#1)
(1 mg/kg##5##2##(1991-2#1)(1992-3#1)(1993-6#1)(1996-2#1)(2008-10#1)
(1 microM)##8##2##(1991-6#1)(1995-11#2)(1996-2#1)(1997-1#1)(1997-4#3)
(1 mm##2##2##(2008-10#2)
(1 mol l(-1))##2##3##(2008-10#2)
(1 muM) showed##2##3##(2008-11#2)
(1 muM)##4##2##(2008-10#1)(2008-11#3)
(1 nM)##3##2##(1997-1#1)(2008-11#2)
(1 ng/ml)##2##2##(1990-5#1)(1993-12#1)
(1 of##2##2##(1996-3#2)
(1 to##8##2##(1990-6#1)(1991-5#1)(2008-10#5)(2008-6#1)
(1 week)##2##2##(1991-9#1)(2008-7#1)
(1 x 10(8) CFU/ml) were##2##5##(2008-10#2)
(1 x##7##2##(2008-10#6)(2008-7#1)
(1##437##1##(1990-11#1)(1990-12#3)(1990-2#6)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#3)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#7)(1993-6#2)(1993-8#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#6)(1994-9#1)(1995-11#7)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#2)(1997-1#4)(1997-2#4)(1997-4#3)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#173)(2008-11#24)(2008-12#14)(2008-2#4)(2008-3#14)(2008-5#2)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#22)(2011-3#1)(2011-7#2)(2012-12#2)(2012-2#4)(2012-3#10)(2013-1#14)(2013-8#6)
(1%##3##1##(1993-11#1)(2008-10#2)
(1%) did##2##2##(2008-5#1)(2008-9#1)
(1%)##13##1##(1997-3#2)(2008-10#3)(2008-5#3)(2008-7#1)(2008-9#1)(2010-8#2)(2013-1#1)
(1) a##3##2##(1997-3#1)(2011-2#1)(2013-8#1)
(1) access##2##2##(1993-12#1)(2009-6#1)
(1) and (2)##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
(1) and AA560##2##3##(1990-11#2)
(1) and##17##2##(1990-11#4)(1992-3#1)(2008-10#4)(2008-11#4)(2010-6#1)(2012-2#1)(2013-1#2)
(1) by##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
(1) from##2##2##(2008-10#1)(2008-11#1)
(1) greater##2##2##(1990-11#1)(1993-12#1)
(1) have##2##2##(2010-9#1)(2012-2#1)
(1) how##2##2##(2008-4#2)
(1) is##2##2##(2008-10#1)(2008-12#1)
(1) no##2##2##(1990-5#1)(2013-1#1)
(1) one##2##2##(2008-5#1)(2008-7#1)
(1) that the##4##3##(1990-6#1)(1991-2#2)(1993-12#1)
(1) that##5##2##(1990-6#1)(1991-2#2)(1993-12#1)(2009-11#1)
(1) the##30##2##(1990-11#1)(1993-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-12#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)
(1) to describe##2##3##(1992-12#1)(2013-1#1)
(1) to evaluate the##2##4##(1994-1#1)(2013-1#1)
(1) to evaluate##3##3##(1993-12#1)(1994-1#1)(2013-1#1)
(1) to##12##2##(1992-12#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-2#1)(2009-1#1)(2010-8#1)(2013-1#3)
(1) with##3##2##(1996-5#3)
(1)##275##1##(1990-11#7)(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#8)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#7)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#6)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(2007-12#3)(2008-10#48)(2008-11#21)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#5)(2008-7#10)(2008-9#5)(2009-1#1)(2009-11#1)(2009-6#4)(2009-7#4)(2009-8#3)(2010-1#1)(2010-12#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#18)(2013-8#4)
(1)D at##4##2##(2008-10#4)
(1)D##10##1##(2008-10#10)
(1)E(1/2) = -0##4##3##(2009-9#4)
(1)H NMR spectra##4##3##(2008-10#3)(2008-9#1)
(1)H NMR##13##2##(1996-5#1)(2008-10#8)(2008-7#1)(2008-9#1)(2011-2#2)
(1)H and (13)C NMR analyses of this##2##7##(2008-10#2)
(1)H and (13)C NMR##5##4##(2008-10#3)(2013-1#2)
(1)H##28##1##(1996-5#3)(2008-10#15)(2008-7#1)(2008-9#1)(2009-7#2)(2011-2#2)(2012-2#2)(2013-1#2)
(1)H-NMR spectra##2##2##(2008-10#2)
(1)H-NMR##4##1##(2008-10#3)(2008-11#1)
(1-100##2##1##(1997-4#1)(2008-10#1)
(1-106) months (p = 0##2##5##(1997-5#2)
(1-2##5##1##(1993-6#1)(2008-10#2)(2008-11#1)(2010-1#1)
(1-3##2##1##(1992-6#1)(1995-6#1)
(1-3)##4##1##(1997-3#1)(2008-12#1)(2010-12#2)
(1-4##2##1##(1996-2#1)(2008-12#1)
(1-4)##2##1##(1993-8#1)(2008-10#1)
(1-5##2##1##(1995-2#1)(1997-1#1)
(1-5%)##2##1##(2008-5#2)
(1-50##2##1##(1994-8#1)(2008-10#1)
(1/10##2##1##(2008-10#1)(2008-11#1)
(1/2) years##2##2##(2008-1#2)
(1/2)##3##1##(2008-1#2)(2008-3#1)
(10 and##2##2##(2010-5#1)(2010-6#1)
(10 mM)##3##2##(1990-2#1)(2008-11#2)
(10 male##2##2##(2011-2#1)(2012-3#1)
(10 mg l(-1))##6##3##(2008-10#6)
(10 mg##7##2##(2008-10#7)
(10 mg)##2##2##(1990-12#1)(1990-6#1)
(10 mg/kg##5##2##(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)
(10 mg/kg)##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
(10 microM) and##3##3##(1993-8#1)(1995-11#1)(1997-2#1)
(10 microM)##9##2##(1993-8#1)(1995-11#1)(1996-2#4)(1997-1#1)(1997-2#2)
(10 micrograms)##2##2##(1993-6#1)(1996-2#1)
(10 micrograms/ml)##4##2##(1993-12#2)(1994-3#2)
(10 muM)##2##2##(2008-10#2)
(10 mul)##3##2##(2008-10#3)
(10 mumol/L)##2##2##(2008-8#2)
(10 nM)##2##2##(1994-8#1)(1995-11#1)
(10 patients##2##2##(1991-8#1)(2008-1#1)
(10 per##3##2##(2008-10#3)
(10 to##5##2##(1995-12#1)(2007-11#1)(2008-10#1)(2012-3#2)
(10 x##2##2##(1992-2#1)(2013-1#1)
(10##156##1##(1990-12#4)(1990-2#1)(1990-6#2)(1991-8#2)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#9)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-8#1)(1997-9#1)(2007-11#2)(2008-1#4)(2008-10#41)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-7#1)(2009-8#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#4)
(10%##4##1##(2008-10#2)(2008-7#1)(2011-3#1)
(10%) were##3##2##(1995-8#1)(2008-10#1)(2008-7#1)
(10%)##16##1##(1992-1#1)(1993-8#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#5)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)
(10(-10) to 10(-7) M)##2##4##(1997-4#2)
(10(-10)##3##1##(1996-2#1)(1997-4#2)
(10(-2) mol##2##2##(2008-10#2)
(10(-2)##4##1##(2008-10#4)
(10(-4) M)##2##2##(1991-5#2)
(10(-5) M)##3##2##(1991-5#1)(1994-2#1)(2008-11#1)
(10(-6) to##2##2##(2008-10#2)
(10(-6)##5##1##(1994-2#1)(1995-12#1)(1997-4#1)(2008-10#2)
(10(-7) M)##3##2##(1994-11#1)(1997-4#2)
(10(-7)##4##1##(1994-11#1)(1997-4#3)
(10(-7)M)##2##1##(1994-11#2)
(10(-8)##3##1##(1996-2#2)(1997-4#1)
(10(3)##2##1##(2008-10#1)(2012-2#1)
(10(5)##2##1##(1992-3#1)(2008-10#1)
(10(6)##4##1##(1993-8#1)(2008-10#1)(2008-11#2)
(10(7)##3##1##(2008-10#1)(2008-9#1)(2013-1#1)
(10) and##3##2##(1992-12#1)(1996-5#1)(2011-2#1)
(10)##7##1##(1992-12#1)(1994-3#1)(1996-5#2)(2010-12#1)(2011-2#2)
(10-20##2##1##(2008-10#1)(2011-1#1)
(10-20%)##2##1##(2008-10#2)
(10-fold)##2##1##(1996-2#1)(2007-12#1)
(100 Hz)##2##2##(1996-12#1)(2010-1#1)
(100 mg l(-1)##2##3##(2008-10#2)
(100 mg/kg body##2##3##(2008-10#1)(2013-1#1)
(100 mg/kg##4##2##(2008-10#1)(2010-1#1)(2012-2#1)(2013-1#1)
(100 microM) or methylene blue (2##2##6##(1993-8#2)
(100 microM) or##3##3##(1993-8#3)
(100 microM)##6##2##(1993-8#4)(1996-2#1)(1997-2#1)
(100 ml##3##2##(2008-10#2)(2008-11#1)
(100 mul) was##2##3##(2008-10#2)
(100 mul)##4##2##(2008-10#4)
(100 nM)##3##2##(1991-5#1)(1991-6#1)(1997-1#1)
(100 to##3##2##(2008-10#3)
(100##59##1##(1991-5#1)(1991-6#3)(1993-8#4)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#23)(2008-11#5)(2008-7#1)(2009-3#2)(2009-5#1)(2010-1#2)(2011-2#4)(2011-3#4)(2012-2#1)(2013-1#1)
(100% in young cirrhotics vs##2##5##(2012-3#2)
(100%##3##1##(1996-8#1)(2012-3#2)
(100%) with##2##2##(1993-6#1)(2008-7#1)
(100%)##13##1##(1993-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#2)
(101##2##1##(2011-2#1)(2013-1#1)
(103)Rh##2##1##(2008-10#2)
(109##4##1##(1994-2#1)(2011-1#1)(2012-2#2)
(109)Ag##2##1##(2008-10#2)
(10mM) and##2##2##(1993-3#2)
(10mM)##4##1##(1993-3#4)
(10mm##2##1##(2008-10#1)(2008-11#1)
(10mugL(-1)##2##1##(2008-10#2)
(10mul)##2##1##(2008-10#2)
(10sigma)##3##1##(2008-10#3)
(11 cases)##3##2##(1990-12#1)(1994-8#1)(2008-7#1)
(11##32##1##(1990-12#2)(1992-9#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-5#2)(1996-12#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
(11%)##9##1##(1990-6#1)(1996-11#1)(1996-9#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
(11)##4##1##(1990-3#1)(1996-5#2)(2011-2#1)
(110 degrees##2##2##(2008-10#2)
(110##10##1##(1995-12#1)(2008-10#7)(2010-1#1)(2011-2#1)
(112)Cd##2##1##(2008-10#2)
(115##2##1##(2008-12#2)
(117 +/-##2##2##(1994-2#1)(2011-3#1)
(12 to##2##2##(1996-11#1)(2008-10#1)
(12##52##1##(1990-6#1)(1990-7#1)(1990-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
(12%)##5##1##(1996-12#1)(1997-3#2)(1997-8#1)(2008-12#1)
(12)##5##1##(1992-12#1)(1996-5#1)(2007-12#1)(2011-2#2)
(120 kV) &gt##3##3##(1997-8#3)
(120 kV)##4##2##(1997-8#4)
(120##11##1##(1990-12#1)(1990-7#1)(1995-8#1)(1997-8#4)(2008-10#2)(2008-11#2)
(122##3##1##(1991-8#1)(2008-10#1)(2013-1#1)
(123##2##1##(2008-10#1)(2011-2#1)
(125##2##1##(1994-8#1)(1997-4#1)
(13 to##3##2##(1993-9#1)(1996-12#1)(2008-10#1)
(13##45##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-9#1)(2010-1#1)(2011-1#3)(2011-2#4)(2012-3#2)(2013-1#1)
(13%)##9##1##(1994-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
(13)##7##1##(1996-5#1)(2008-12#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-9#2)
(13)C NMR spectral##2##3##(2008-10#2)
(13)C NMR spectroscopy##6##3##(2008-10#5)(2013-1#1)
(13)C NMR##21##2##(1996-5#1)(2008-10#16)(2011-2#1)(2013-1#3)
(13)C at##2##2##(2008-4#2)
(13)C##31##1##(1996-5#3)(2008-10#16)(2008-4#3)(2008-7#1)(2009-7#2)(2010-3#2)(2011-2#1)(2013-1#3)
(13)C-CPMAS##2##1##(2008-10#2)
(13)C-depleted leaf litter##2##3##(2010-3#2)
(13)C-labeled##3##1##(2008-10#1)(2008-7#1)(2012-2#1)
(135##2##1##(1996-1#1)(2008-5#1)
(137 kV) &gt##2##3##(1997-8#2)
(137 kV)##3##2##(1997-8#3)
(137)Ba##5##1##(2010-8#5)
(14 cases)##2##2##(1990-2#1)(1994-8#1)
(14##29##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-8#1)(1996-8#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2011-2#3)(2013-8#1)
(14%) patients##2##2##(2008-7#1)(2011-2#1)
(14%)##16##1##(1991-6#2)(1992-3#1)(1993-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-7#1)(2011-2#3)(2012-3#1)
(14)##4##1##(1996-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
(14)C-labeled##3##1##(2008-10#2)(2008-7#1)
(14)CO(2)##2##1##(2008-10#2)
(140##2##1##(2008-10#2)
(141##3##1##(2008-11#1)(2008-6#1)(2011-1#1)
(145##2##1##(2008-10#1)(2008-11#1)
(149##2##1##(1994-2#1)(1994-3#1)
(15 cm##2##2##(2008-10#2)
(15 mg/kg##2##2##(1992-8#1)(1993-11#1)
(15##48##1##(1990-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#2)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-7#4)(2009-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
(15%##4##1##(2008-10#3)(2010-4#1)
(15%)##7##1##(1991-3#1)(1992-12#2)(1996-12#1)(1996-9#1)(2008-1#1)(2011-2#1)
(15) and##2##2##(1997-5#1)(2011-3#1)
(15)##4##1##(1997-5#1)(2008-8#1)(2010-7#1)(2011-3#1)
(15)N##4##1##(1996-5#1)(2008-4#1)(2009-7#2)
(15)N-labeled nucleosides##2##2##(2008-4#2)
(15)N-labeled##3##1##(2008-4#2)(2012-2#1)
(150##11##1##(1990-6#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#1)(2011-2#1)
(1500 mg l(-1) level)##2##4##(2008-10#2)
(1500##3##1##(2008-10#2)(2009-6#1)
(15C5)##2##1##(2008-10#2)
(16 mM)##2##2##(1996-2#1)(2008-11#1)
(16##42##1##(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1994-5#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
(16%) of the##2##3##(1994-1#1)(2008-10#1)
(16%)##11##1##(1990-9#1)(1992-5#1)(1994-1#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#2)
(16)##5##1##(1992-12#1)(1993-1#1)(2008-10#1)(2008-8#1)(2011-3#1)
(160##4##1##(1991-6#1)(1997-4#1)(2011-2#1)(2013-1#1)
(17 mm)##2##2##(2012-2#2)
(17##23##1##(1990-2#1)(1991-3#1)(1992-9#1)(1994-6#1)(1995-11#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#4)
(17%)##12##1##(1990-3#1)(1991-12#1)(1996-6#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
(17)##2##1##(2008-10#1)(2008-8#1)
(171##3##1##(2008-10#1)(2009-12#1)(2013-8#1)
(18 children)##2##2##(2008-1#1)(2013-1#1)
(18 kDa)##3##2##(2012-2#3)
(18##39##1##(1991-6#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-12#1)(1997-7#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
(18%) were##2##2##(1996-12#1)(2010-4#1)
(18%)##13##1##(1990-9#1)(1992-5#1)(1994-12#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#2)(2010-4#1)(2011-2#3)(2012-3#1)
(18)##2##1##(1990-12#1)(2008-11#1)
(18)F##2##1##(2010-6#2)
(18)F-FB-PEG(3)-RGD-BBN##3##1##(2010-6#3)
(18)F-SKI249380##2##1##(2013-1#2)
(18)F-SKI249380-containing##3##1##(2013-1#3)
(180##3##1##(2008-10#1)(2008-7#1)(2010-6#1)
(186)Os and (188)Os##3##3##(2008-10#3)
(187)Os##3##1##(2008-10#3)
(18C6)##5##1##(2008-10#5)
(19##24##1##(1990-3#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
(19%##2##1##(2008-7#1)(2011-2#1)
(19%) and##2##2##(1991-6#1)(2012-2#1)
(19%)##13##1##(1991-5#1)(1991-6#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
(19)##2##1##(1996-5#1)(2012-2#1)
(19)F NMR T(1)##2##3##(2008-10#1)(2008-7#1)
(19)F NMR##4##2##(1996-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
(19)F nuclear magnetic resonance##2##4##(2008-10#2)
(19)F##6##1##(1996-5#1)(2008-10#3)(2008-7#1)(2012-3#1)
(1938)##3##1##(2007-12#2)(2008-11#1)
(1959)##3##1##(2008-10#2)(2011-2#1)
(1961)##2##1##(2008-10#2)
(1974)##2##1##(2008-10#1)(2008-7#1)
(1978)##3##1##(1992-1#1)(1993-8#1)(2008-9#1)
(1979)##4##1##(1992-1#1)(1993-12#1)(2008-10#2)
(1980)##4##1##(1991-12#1)(1991-2#1)(1994-5#1)(2009-10#1)
(1983##2##1##(2008-11#2)
(1983)##5##1##(1991-9#1)(1992-1#2)(1997-8#1)(2008-11#1)
(1984)##4##1##(1991-5#1)(1993-6#1)(1993-8#1)(1995-6#1)
(1985)##8##1##(1990-2#1)(1990-7#1)(1991-9#1)(1993-12#1)(2008-10#2)(2008-12#1)(2008-5#1)
(1986##2##1##(1994-2#1)(2008-11#1)
(1986) and##2##2##(1992-1#1)(2011-2#1)
(1986)##10##1##(1991-5#1)(1992-1#3)(1993-8#2)(2007-12#1)(2008-10#1)(2009-10#1)(2011-2#1)
(1987)##5##1##(1990-10#1)(1991-5#1)(1994-12#1)(1994-3#1)(2008-10#1)
(1988##3##1##(2008-10#2)(2013-1#1)
(1988) J##3##2##(1990-5#1)(1991-3#1)(1992-4#1)
(1988)##7##1##(1990-5#1)(1991-3#1)(1992-4#2)(1993-9#1)(1994-5#1)(1997-8#1)
(1989)##5##1##(1990-5#1)(1991-12#1)(1991-9#2)(1992-1#1)
(1990##6##1##(1991-9#1)(1994-9#1)(1995-3#2)(1996-11#1)(2008-10#1)
(1990) Biochemistry 29##2##3##(1992-3#1)(1992-4#1)
(1990) Biochemistry##3##2##(1992-3#1)(1992-4#1)(1995-6#1)
(1990) FEBS Lett##2##3##(1991-7#1)(1997-8#1)
(1990)##18##1##(1990-5#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-4#3)(1993-12#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-1#1)(1997-8#1)(2009-10#1)
(1991##4##1##(1992-3#1)(1997-2#1)(2008-11#1)(2009-10#1)
(1991) Biochemistry 30##3##3##(1992-4#1)(1992-8#1)(1993-8#1)
(1991) J##4##2##(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)
(1991)##17##1##(1991-6#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#4)(1994-3#1)(1994-5#1)
(1992##2##1##(2008-10#1)(2009-10#1)
(1992) Biochemistry 31##4##3##(1993-8#1)(1994-5#2)(1995-6#1)
(1992) J##4##2##(1992-8#1)(1993-8#1)(1995-12#1)(1995-6#1)
(1992)##25##1##(1992-8#1)(1993-12#4)(1993-3#2)(1993-8#3)(1994-5#3)(1995-12#1)(1995-6#3)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#2)
(1993##3##1##(1994-9#1)(2008-10#1)(2013-1#1)
(1993) Development##2##2##(1995-6#2)
(1993) Proc##2##2##(1995-6#2)
(1993)##22##1##(1993-12#3)(1993-3#1)(1993-9#1)(1994-5#1)(1995-6#5)(1995-8#2)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)
(1994 to 2004)##2##3##(2008-10#2)
(1994##3##1##(2008-10#3)
(1994) J##2##2##(1994-5#1)(1995-6#1)
(1994)##9##1##(1994-5#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
(1995)##5##1##(1995-12#1)(1995-6#1)(2008-10#2)(2012-2#1)
(1996)##11##1##(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-6#1)(2012-2#1)
(1996)]##3##1##(2008-2#2)(2008-3#1)
(1997)##6##1##(2008-10#4)(2008-2#1)(2010-7#1)
(1997)]##4##1##(2007-12#1)(2008-2#2)(2008-6#1)
(1998) (in press)]##2##3##(2008-10#2)
(1998)##12##1##(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#2)(2013-1#1)
(1999)##5##1##(2008-10#3)(2008-12#1)(2008-7#1)
(1999)] presented##2##2##(2008-3#2)
(1999)]##5##1##(2008-3#5)
(1R##3##1##(1996-5#1)(2008-10#2)
(1S##9##1##(1996-5#6)(2008-10#3)
(1a##2##1##(1996-5#1)(2008-10#1)
(1a)##3##1##(1992-12#1)(2008-11#1)(2009-9#1)
(1b)##3##1##(1992-10#1)(1992-12#1)(2008-10#1)
(2 S##2##2##(2008-10#2)
(2 and 3)##3##3##(2008-10#3)
(2 cases)##3##2##(1990-12#1)(2007-8#1)(2008-11#1)
(2 h at##2##3##(2008-10#1)(2011-2#1)
(2 mg/kg)##4##2##(1993-3#3)(2010-6#1)
(2 nM)##2##2##(1997-4#2)
(2 to 5##2##3##(1991-5#1)(2008-10#1)
(2 to##10##2##(1991-5#1)(1993-1#1)(2008-10#6)(2011-2#1)(2012-3#1)
(2 with##3##2##(1994-12#1)(1997-6#1)(2012-3#1)
(2 x##3##2##(2008-10#2)(2008-11#1)
(2##278##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#4)(1991-3#3)(1991-5#2)(1991-7#1)(1993-1#3)(1993-12#1)(1993-3#3)(1993-8#3)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-8#2)(1996-12#1)(1996-2#4)(1996-3#2)(1997-1#1)(1997-2#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#116)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#1)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2010-11#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#17)(2012-12#2)(2012-2#3)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#6)
(2%##6##1##(2008-10#2)(2011-2#2)(2011-3#1)(2013-1#1)
(2%) and##2##2##(1990-3#1)(2008-5#1)
(2%)##12##1##(1990-3#2)(1990-9#1)(2007-12#1)(2008-10#3)(2008-5#1)(2011-2#2)(2013-1#2)
(2'F-ANA)##3##1##(2008-4#3)
(2) = 0##3##3##(2008-10#2)(2013-8#1)
(2) =##5##2##(2008-10#2)(2008-9#2)(2013-8#1)
(2) The##4##2##(1992-12#1)(1995-9#1)(2008-11#1)(2011-2#1)
(2) To##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
(2) What are the##2##4##(1996-1#1)(1996-3#1)
(2) What##3##2##(1996-1#1)(1996-3#1)(2012-12#1)
(2) a##7##2##(1994-3#1)(1997-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
(2) and##5##2##(1990-11#1)(2008-10#3)(2008-11#1)
(2) are##2##2##(2008-10#1)(2010-9#1)
(2) how##2##2##(1993-3#1)(2008-4#1)
(2) in##2##2##(1995-11#1)(1996-5#1)
(2) no##2##2##(1992-2#1)(2013-1#1)
(2) over##2##2##(2008-10#1)(2008-11#1)
(2) sample##2##2##(2008-10#1)(2013-1#1)
(2) that##6##2##(1991-2#2)(1993-12#1)(1996-12#1)(2009-11#1)(2009-7#1)
(2) the##31##2##(1991-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
(2) their##3##2##(1990-11#1)(2007-12#1)(2008-10#1)
(2) there##2##2##(1994-8#1)(2008-5#1)
(2) to##10##2##(1992-12#1)(1993-12#1)(1994-1#1)(1995-12#1)(2008-2#1)(2008-4#1)(2009-1#1)(2010-8#1)(2013-1#2)
(2) two##2##2##(2008-5#1)(2012-3#1)
(2) use of##2##3##(1992-3#1)(1993-12#1)
(2) use##3##2##(1992-3#1)(1993-12#1)(2008-7#1)
(2) using##2##2##(2008-11#1)(2011-2#1)
(2) was##3##2##(1992-3#1)(2008-10#1)(2012-3#1)
(2)##261##1##(1990-11#5)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-9#1)(1993-1#1)(1993-12#7)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#5)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(2007-12#3)(2008-10#50)(2008-11#22)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#5)(2008-7#9)(2008-9#7)(2009-1#1)(2009-11#1)(2009-6#4)(2009-7#4)(2009-8#3)(2010-1#1)(2010-12#2)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#17)(2013-8#5)
(2))##2##1##(2008-10#2)
(2)D values##2##2##(2008-10#2)
(2)D##7##1##(2008-10#7)
(2)E(1/2) = -0##4##3##(2009-9#4)
(2)E(1/2) =##5##2##(2009-9#5)
(2)F(2) population##2##2##(2008-9#2)
(2)F(2)##3##1##(2008-9#3)
(2) = 0##2##1##(2012-5#2)
(2+)##2##1##(2008-10#2)
(2-##2##1##(1995-11#1)(1997-2#1)
(2-10##2##1##(2012-2#1)(2013-7#1)
(2-3##3##1##(2008-10#1)(2008-12#1)(2013-8#1)
(2-3)##2##1##(2008-12#1)(2008-8#1)
(2-6##2##1##(1994-12#1)(1995-11#1)
(2-9)##2##1##(2008-10#1)(2013-7#1)
(2-D##2##1##(2008-4#1)(2009-12#1)
(2-D)##4##1##(1993-3#1)(1993-9#1)(2008-10#1)(2008-11#1)
(2-ethylhexyl##3##1##(2008-5#3)
(20 mM)##3##2##(1990-2#1)(1995-8#1)(2008-11#1)
(20 mg/kg##3##2##(1996-2#1)(2012-2#1)(2013-1#1)
(20 mg/kg)##5##2##(1993-3#1)(1995-2#1)(2012-2#3)
(20 to##4##2##(1990-5#1)(2008-10#2)(2008-12#1)
(20##75##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#4)(1997-8#1)(2008-1#4)(2008-10#29)(2008-11#5)(2008-12#2)(2008-9#1)(2010-4#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
(20%##8##1##(1993-11#1)(1996-2#1)(2008-10#4)(2013-8#2)
(20%) and##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
(20%) were##2##2##(1990-3#1)(2008-9#1)
(20%)##15##1##(1990-3#1)(1992-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#2)(2008-10#3)(2008-9#1)(2011-2#2)(2013-8#1)
(20)##2##1##(1990-8#1)(2008-11#1)
(20-fold)##2##1##(2008-10#1)(2008-8#1)
(200 mg##3##2##(2008-10#1)(2013-1#2)
(200 mg/kg##2##2##(1991-5#1)(1997-2#1)
(200 to##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
(200##21##1##(1991-5#1)(1992-2#1)(1993-8#2)(1994-11#1)(1994-8#1)(1996-1#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#3)
(2000##2##1##(2008-11#1)(2011-3#1)
(2000)##8##1##(2008-10#7)(2010-1#1)
(2000)]##2##1##(2007-11#1)(2008-3#1)
(2001)##6##1##(2008-10#5)(2008-12#1)
(2001)]##4##1##(2008-3#4)
(2002 to##2##2##(2008-10#2)
(2002)##2##1##(2008-10#1)(2008-12#1)
(2003)##7##1##(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2013-1#1)(2013-8#1)
(2004)##6##1##(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2013-1#1)
(2005)##6##1##(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2012-3#1)
(2006)##4##1##(2008-12#1)(2010-10#1)(2010-12#1)(2010-7#1)
(2007)##2##1##(2008-11#1)(2008-12#1)
(2008) provides##2##2##(2009-12#1)(2013-8#1)
(2008)##6##1##(2009-12#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-8#2)
(2009##3##1##(2009-12#3)
(2009)##6##1##(2009-6#1)(2010-5#1)(2010-7#1)(2012-3#3)
(2011)##7##1##(2011-2#4)(2012-3#3)
(2012)##2##1##(2013-1#2)
(203)Tl##2##1##(2008-10#2)
(206)Pb and##2##2##(2008-10#2)
(20mlg(-1) sample)##2##2##(2008-10#2)
(21 and##2##2##(2008-10#1)(2012-3#1)
(21 of##2##2##(2008-10#1)(2011-2#1)
(21##27##1##(1990-11#1)(1990-5#1)(1991-5#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
(21%)##8##1##(1993-11#1)(1996-12#1)(1996-6#1)(2008-1#2)(2008-10#2)(2013-1#1)
(21)##2##1##(2008-10#1)(2011-2#1)
(213##3##1##(1992-2#1)(2008-10#1)(2011-3#1)
(22##25##1##(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
(22%##2##1##(2008-8#1)(2013-1#1)
(22%) were##2##2##(1996-12#1)(2008-10#1)
(22%)##8##1##(1990-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#3)(2011-1#1)
(220##2##1##(2008-10#2)
(226##2##1##(2008-10#1)(2013-1#1)
(23 and##2##2##(1992-12#1)(2012-3#1)
(23##20##1##(1990-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-12#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-5#4)(2012-3#2)(2013-1#2)(2013-8#1)
(23%##2##1##(2008-10#1)(2008-11#1)
(23%)##8##1##(1994-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
(23)##2##1##(1996-5#1)(2008-10#1)
(23)Na MRI##2##2##(2012-2#2)
(23-25 months old)##2##3##(2008-7#2)
(234)Th ingrowth##2##2##(2008-10#2)
(234)Th##4##1##(2008-10#4)
(234)U/(238)U activity##3##2##(2008-10#3)
(239##2##1##(2008-10#1)(2011-1#1)
(24 h)##2##2##(2008-10#1)(2008-12#1)
(24##27##1##(1990-2#1)(1991-12#1)(1993-1#1)(1994-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
(24%##4##1##(1992-12#1)(1992-5#1)(2008-8#1)(2013-1#1)
(24%)##7##1##(1991-6#2)(1991-8#1)(1997-8#1)(2008-7#1)(2013-1#2)
(240##3##1##(1994-5#1)(2008-10#2)
(244##2##1##(2008-1#1)(2011-3#1)
(245##2##1##(2010-8#1)(2012-3#1)
(25 and 50##2##3##(1996-2#1)(2008-12#1)
(25 and##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
(25 cm x 4##2##4##(2008-10#1)(2009-8#1)
(25 degrees C##3##3##(1992-9#1)(2008-10#1)(2010-4#1)
(25 degrees##4##2##(1992-9#1)(2008-10#2)(2010-4#1)
(25 mg/kg##2##2##(1992-3#1)(1997-2#1)
(25 to##3##2##(2008-10#2)(2012-3#1)
(25##54##1##(1990-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#15)(2008-11#4)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
(25%##5##1##(1995-6#1)(2008-10#3)(2011-2#1)
(25%) and##2##2##(2008-1#1)(2011-2#1)
(25%) patients##2##2##(1992-12#1)(2012-2#1)
(25%)##10##1##(1992-12#2)(1997-2#1)(2008-1#1)(2008-10#2)(2011-2#2)(2012-2#1)(2013-7#1)
(25(OH)D)##2##1##(2011-1#2)
(25)##2##1##(1996-5#1)(2008-7#1)
(25-45##2##1##(1996-12#1)(2008-5#1)
(25-fold)##2##1##(1995-11#1)(2008-10#1)
(250 +/-##2##2##(1994-3#1)(1996-2#1)
(250 x##2##2##(2008-10#1)(2008-12#1)
(250##18##1##(1994-11#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)
(250mmx4##2##1##(2008-10#2)
(25mugL(-1)##2##1##(2008-10#2)
(26 of##2##2##(2009-9#1)(2013-1#1)
(26##30##1##(1990-11#1)(1990-12#1)(1990-8#1)(1992-12#1)(1993-2#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2009-8#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
(26%##2##1##(1992-5#1)(2008-10#1)
(26%)##5##1##(1997-3#1)(2008-10#2)(2011-2#1)(2012-3#1)
(27##25##1##(1991-2#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-3#1)(1997-8#2)(2008-1#1)(2008-10#5)(2009-10#1)(2010-11#2)(2010-7#1)(2010-8#2)(2012-2#3)(2013-1#1)(2013-8#2)
(27%) of##2##2##(1990-3#1)(1997-8#1)
(27%)##8##1##(1990-3#1)(1994-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
(27)Al NMR and Raman spectra##2##5##(2008-10#2)
(27)Al NMR and Raman##3##4##(2008-10#3)
(27)Al NMR##4##2##(2008-10#4)
(270##2##1##(1993-8#1)(1995-12#1)
(271##2##1##(1992-3#1)(2013-1#1)
(28##17##1##(1990-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
(28%) of##2##2##(2008-10#2)
(28%)##11##1##(1991-6#1)(1992-5#1)(1993-1#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
(28-32##2##1##(1993-8#1)(2010-1#1)
(29##20##1##(1993-1#1)(1994-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
(29%) of##2##2##(1990-8#1)(1996-3#1)
(29%) were##2##2##(1991-9#1)(1996-12#1)
(29%)##13##1##(1990-8#1)(1991-9#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-3#1)(2011-2#1)(2012-3#2)
(293##2##1##(1996-2#1)(2008-10#1)
(295##2##1##(1993-2#1)(2011-2#1)
(2D-MS)##3##1##(2008-11#3)
(2F10##2##1##(1995-2#2)
(2R##3##1##(1996-5#3)
(2S##4##1##(1996-5#3)(2008-11#1)
(2b)##2##1##(1992-10#1)(2008-10#1)
(2f) signal was generated from absorption by##2##7##(2008-2#1)(2008-3#1)
(2min##2##1##(2008-10#2)
(2n = 16+X)##2##3##(2008-12#2)
(2n = 2x = 24)##3##5##(2009-12#3)
(2n =##10##2##(2008-10#2)(2008-12#3)(2009-12#5)
(2n##11##1##(2008-10#2)(2008-12#3)(2009-10#1)(2009-12#5)
(2nd##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
(2sigma##2##1##(2008-10#2)
(3 S/N)##2##2##(2008-10#2)
(3 alpha##2##2##(1990-11#2)
(3 and##2##2##(2008-10#1)(2013-1#1)
(3 beta##2##2##(2008-11#2)
(3 microM)##7##2##(1995-11#1)(1997-4#3)(2013-1#3)
(3 months)##2##2##(2008-10#1)(2008-12#1)
(3 s) of##2##3##(2008-10#2)
(3 s)##4##2##(2008-10#4)
(3 to##7##2##(1995-3#1)(2008-10#6)
(3##163##1##(1990-11#4)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-1#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#3)(1997-8#3)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#66)(2008-11#7)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-9#3)(2011-1#2)(2011-2#9)(2011-3#2)(2012-2#5)(2012-3#3)(2013-1#9)(2013-8#2)
(3%##2##1##(2011-2#1)(2013-1#1)
(3%) and##2##2##(2008-10#1)(2013-1#1)
(3%)##9##1##(1990-12#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-8#1)(2013-1#1)
(3) The##4##2##(1995-9#1)(2008-11#1)(2010-6#1)(2013-8#1)
(3) To##2##2##(2008-11#1)(2011-1#1)
(3) a##2##2##(2007-12#1)(2013-1#1)
(3) and##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2013-1#1)
(3) from##2##2##(2008-10#1)(2008-11#1)
(3) have been##2##3##(2008-10#1)(2011-2#1)
(3) no##2##2##(2008-10#1)(2008-5#1)
(3) that##3##2##(1993-12#1)(1996-12#1)(2008-10#1)
(3) the &quot##2##3##(2008-4#1)(2013-1#1)
(3) the presence##2##3##(2008-11#1)(2009-6#1)
(3) the##17##2##(1993-8#1)(1994-3#1)(1995-9#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-6#1)(2013-1#1)
(3) to##5##2##(1992-12#1)(1995-12#1)(2008-2#1)(2008-4#1)(2009-1#1)
(3) was##2##2##(2008-11#1)(2012-3#1)
(3)##174##1##(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#1)(1993-12#5)(1993-3#3)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-2#3)(1997-3#3)(1997-7#1)(2007-12#3)(2008-10#26)(2008-11#16)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#5)(2008-7#4)(2008-9#4)(2009-1#1)(2009-6#4)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#16)(2013-8#3)
(3-5##4##1##(2008-10#2)(2008-12#1)(2011-2#1)
(3-D)##10##1##(2008-11#2)(2008-3#3)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
(30 degrees##2##2##(1996-2#1)(2008-10#1)
(30 mg/kg##2##2##(1992-3#1)(2008-7#1)
(30 mg/kg)##4##2##(1992-8#1)(1993-3#2)(2008-11#1)
(30 microM)##3##2##(1993-6#1)(1996-2#2)
(30 mul)##2##2##(2008-10#2)
(30 nM)##2##2##(1994-8#1)(2008-11#1)
(30 nmol)##2##2##(1997-4#2)
(30 to##2##2##(2008-10#1)(2011-2#1)
(30##60##1##(1990-12#1)(1990-2#1)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-2#1)(1997-4#2)(2008-10#18)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
(30%##2##1##(1991-3#1)(2008-10#1)
(30%) and##5##2##(1996-9#1)(2008-10#1)(2011-2#1)(2013-1#2)
(30%)##18##1##(1992-12#1)(1992-5#1)(1996-11#1)(1996-12#1)(1996-9#3)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
(30)##2##1##(1994-1#1)(2007-11#1)
(30-40##3##1##(1990-5#1)(2008-3#1)(2013-1#1)
(300##11##1##(1992-6#1)(1993-2#1)(1994-9#1)(2008-10#5)(2011-2#2)(2012-2#1)
(300-400##2##1##(1993-9#1)(1994-8#1)
(31 of##2##2##(1990-8#1)(1997-8#1)
(31##19##1##(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#3)
(31%) of##2##2##(1990-12#1)(2012-3#1)
(31%)##13##1##(1990-12#2)(1991-6#1)(1992-3#1)(1995-8#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
(31)##2##1##(1994-1#1)(2012-2#1)
(31)P NMR spectroscopy##2##3##(2008-10#1)(2008-11#1)
(31)P NMR##4##2##(2008-10#3)(2008-11#1)
(31)P and##2##2##(2008-10#1)(2012-2#1)
(31)P##8##1##(2008-10#5)(2008-11#1)(2010-8#1)(2012-2#1)
(32 and##3##2##(1996-3#1)(2008-7#1)(2012-2#1)
(32##13##1##(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
(32%##3##1##(1996-3#1)(2008-10#1)(2011-2#1)
(32%)##13##1##(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
(33##25##1##(1991-12#2)(1993-1#1)(1994-8#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
(33%##2##1##(2008-5#1)(2013-8#1)
(33%) had##2##2##(2008-12#1)(2008-7#1)
(33%)##8##1##(1996-8#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)
(34##16##1##(1990-2#1)(1991-6#1)(1993-3#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
(34%##3##1##(1990-12#1)(2009-3#1)(2012-3#1)
(34%)##7##1##(1991-12#2)(1991-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
(340##2##1##(1996-9#1)(2008-10#1)
(35##14##1##(1991-11#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#2)(2013-8#1)
(35%)##11##1##(1994-9#1)(1996-9#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
(350##2##1##(2008-10#1)(2009-10#1)
(353##2##1##(1997-2#1)(2008-10#1)
(36##13##1##(1991-7#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-7#1)(2013-1#1)
(36%##2##1##(1993-8#1)(1996-3#1)
(36%)##3##1##(1990-2#1)(1997-3#1)(2013-8#1)
(37 degrees##2##2##(1996-12#1)(2008-12#1)
(37##24##1##(1990-9#1)(1994-6#1)(1996-12#2)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-9#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
(37%)##6##1##(1991-6#1)(1995-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
(37)##2##1##(2008-12#1)(2010-2#1)
(38##17##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-9#1)(1994-12#1)(1997-8#1)(2008-1#1)(2008-5#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
(38%##3##1##(1991-8#1)(1994-5#1)(2008-10#1)
(38%)##5##1##(2009-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
(38)##2##1##(2013-1#2)
(39##9##1##(1990-11#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
(39%) and##2##2##(2008-5#1)(2011-2#1)
(39%)##7##1##(1992-3#1)(1994-1#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
(394##2##1##(1991-11#1)(2011-1#1)
(3D)##15##1##(1995-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#2)(2009-11#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#1)(2012-4#1)
(3PP##2##1##(2008-11#2)
(3R##2##1##(2008-10#2)
(3S/N)##4##1##(2008-10#4)
(3a)##2##1##(2008-10#1)(2009-9#1)
(3b)##2##1##(1992-10#1)(2008-10#1)
(3s)##6##1##(2008-10#6)
(3sigma criterion)##2##2##(2008-10#2)
(3sigma of##2##2##(2008-10#2)
(3sigma##10##1##(2008-10#10)
(3sigma(b)/S)##2##1##(2008-10#2)
(3sigma) and the relative standard##2##5##(2008-10#2)
(3sigma) and the##3##3##(2008-10#3)
(3sigma) and##7##2##(2008-10#7)
(3sigma) are##3##2##(2008-10#3)
(3sigma) for##3##2##(2008-10#3)
(3sigma) in the##2##3##(2008-10#2)
(3sigma) in##4##2##(2008-10#4)
(3sigma) is##3##2##(2008-10#3)
(3sigma) of 0##10##3##(2008-10#10)
(3sigma) of 1##3##3##(2008-10#3)
(3sigma) of##20##2##(2008-10#20)
(3sigma) was 0##6##3##(2008-10#6)
(3sigma) was##8##2##(2008-10#8)
(3sigma) were##7##2##(2008-10#7)
(3sigma)##66##1##(2008-10#66)
(4 cases)##2##2##(1990-12#1)(1996-6#1)
(4 degrees C for##2##4##(2008-10#1)(2008-11#1)
(4 degrees C##3##3##(2008-10#2)(2008-11#1)
(4 degrees##4##2##(2008-10#3)(2008-11#1)
(4 mg/kg##4##2##(1992-3#3)(2008-10#1)
(4 to##2##2##(1994-12#1)(2008-10#1)
(4 x##3##2##(1993-9#1)(1995-8#1)(2008-10#1)
(4##133##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#4)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#3)(1993-1#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#34)(2008-11#4)(2008-12#4)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#11)(2013-3#1)(2013-8#4)
(4%##4##1##(1991-12#1)(1993-11#1)(2008-10#1)(2013-8#1)
(4%)##7##1##(1994-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
(4'##2##1##(1991-3#2)
(4) and##2##2##(2008-10#1)(2008-7#1)
(4) management##2##2##(1993-3#1)(1997-3#1)
(4) or##2##2##(1990-3#1)(1992-9#1)
(4) the##11##2##(1991-2#1)(1993-8#1)(1995-9#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
(4) using##2##2##(1995-5#1)(2009-6#1)
(4)##95##1##(1990-3#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#2)(1996-3#1)(1996-5#2)(1997-2#3)(1997-3#2)(2007-12#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#3)(2009-6#3)(2009-8#2)(2010-12#1)(2010-6#2)(2010-9#1)(2011-2#6)(2011-3#1)(2012-3#1)(2013-1#11)(2013-8#1)
(4-307) versus##2##2##(1997-5#2)
(4-6 months old)##2##3##(2008-7#2)
(4-6##6##1##(1994-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-12#1)
(4-6) and##2##2##(2008-7#1)(2010-12#1)
(4-6)##3##1##(2008-7#1)(2010-12#1)(2013-1#1)
(4-8##2##1##(1993-11#1)(2008-7#1)
(4-9)##2##1##(2008-10#2)
(4-AP)##3##1##(1990-12#1)(2008-10#1)(2008-9#1)
(4-VP)##3##1##(2008-10#3)
(4-hydroxyphenyl)##2##1##(2008-10#2)
(4-sulphophenylazo-)1-naphthylamine##2##1##(2008-10#2)
(4/12)##2##1##(1991-2#1)(2011-2#1)
(40##29##1##(1990-12#1)(1992-12#2)(1993-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#3)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
(40%) and##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
(40%) had##2##2##(1994-6#1)(1996-11#1)
(40%) of##2##2##(1993-11#1)(2008-12#1)
(40%)##19##1##(1992-12#1)(1993-11#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
(400##9##1##(1991-11#1)(1992-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#2)
(4000##2##1##(1993-6#1)(1993-9#1)
(41##9##1##(1990-2#1)(1991-12#1)(1995-8#2)(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#1)
(41%)##6##1##(1991-8#1)(1993-12#1)(1996-6#1)(2011-2#3)
(42 cases)##2##2##(1991-2#1)(1994-1#1)
(42##13##1##(1990-5#1)(1991-2#1)(1992-9#1)(1994-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
(42%##2##1##(1993-2#1)(2011-2#1)
(42%) were##2##2##(2011-2#1)(2012-12#1)
(42%)##8##1##(1990-5#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
(420 mug##2##2##(2008-10#2)
(43##10##1##(1997-7#1)(2008-11#3)(2008-12#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-12#1)
(43%##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
(43%) and##2##2##(2008-7#1)(2011-2#1)
(43%) were##2##2##(1990-6#1)(2008-7#1)
(43%)##10##1##(1990-6#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-7#4)(2008-9#1)(2011-2#1)
(44##11##1##(1990-8#1)(1991-8#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#2)(2012-3#1)
(44%)##10##1##(1990-6#1)(1993-8#1)(1996-11#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#2)(2013-1#2)
(45 or 90 sec)##2##4##(2008-5#2)
(45##19##1##(1990-8#1)(1996-6#1)(2008-10#3)(2008-5#4)(2008-9#1)(2009-10#2)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)
(45%)##6##1##(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
(46##17##1##(1990-2#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
(46%##2##1##(1991-7#1)(2008-3#1)
(46%)##7##1##(1997-2#1)(2008-1#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
(47##6##1##(1993-2#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-3#1)
(47%)##6##1##(1994-1#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-3#1)
(48 h)##3##2##(1996-5#1)(2008-10#1)(2013-8#1)
(48##17##1##(1993-8#1)(1996-5#1)(1996-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
(48%)##7##1##(1990-6#1)(1990-8#1)(1992-12#1)(2008-10#1)(2008-7#2)(2011-2#1)
(49##8##1##(1990-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
(49%##2##1##(2008-3#1)(2010-1#1)
(49%) were##2##2##(1997-8#1)(2010-11#1)
(49%)##4##1##(1997-8#1)(2009-4#1)(2009-5#1)(2010-11#1)
(4m##2##1##(2008-10#1)(2009-12#1)
(5 IU)##2##2##(2008-5#2)
(5 and 10 mg/kg i##2##5##(1996-2#2)
(5 and 10##5##3##(1996-2#2)(2008-10#2)(2013-1#1)
(5 and##6##2##(1996-2#2)(2008-10#3)(2013-1#1)
(5 cases)##2##2##(1990-6#1)(1994-8#1)
(5 mM)##2##2##(1995-6#1)(1996-2#1)
(5 mg/kg##2##2##(1996-2#1)(1997-2#1)
(5 mg/kg/day)##2##2##(1994-2#1)(2012-2#1)
(5 mg/ml)##2##2##(2012-3#2)
(5 microM)##3##2##(1990-10#1)(1996-2#1)(1997-1#1)
(5 nM)##3##2##(1992-8#1)(1994-11#1)(1994-2#1)
(5 of##3##2##(1992-4#1)(2010-12#2)
(5 or##2##2##(2008-10#2)
(5 per##2##2##(1997-3#1)(2013-1#1)
(5 to##7##2##(1990-2#1)(2008-10#5)(2012-3#1)
(5 x##2##2##(2008-10#1)(2008-3#1)
(5##153##1##(1990-10#1)(1990-11#5)(1990-2#2)(1990-6#2)(1990-8#1)(1991-6#1)(1991-7#1)(1992-4#1)(1992-8#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#2)(1995-11#2)(1995-6#1)(1996-11#3)(1996-2#5)(1997-1#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#65)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-2#4)(2012-2#5)(2012-3#7)(2013-1#5)
(5%##6##1##(1993-8#1)(1995-8#1)(2008-10#3)(2008-9#1)
(5%) as##2##2##(1993-11#1)(2008-10#1)
(5%) had##2##2##(1996-9#1)(2012-3#1)
(5%)##15##1##(1993-11#1)(1994-12#1)(1995-11#1)(1996-9#3)(2008-10#2)(2010-7#1)(2011-2#5)(2012-3#1)
(5'GAATUC3')##2##1##(1992-3#2)
(5) the##5##2##(1991-3#1)(1993-8#1)(2007-12#1)(2008-5#1)(2013-1#1)
(5)##53##1##(1991-3#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-5#2)(1997-2#3)(1997-3#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-6#2)(2009-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#8)
(5-15##2##1##(1991-6#1)(2008-10#1)
(5-30##3##1##(1990-8#1)(1997-2#1)(2008-10#1)
(5-7##3##1##(1997-8#2)(2006-6#1)
(5-Br-PADAP)##8##1##(2008-10#8)
(5-HT)##10##1##(1992-1#1)(1993-3#1)(1994-2#2)(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
(5-nitro-1##2##1##(2008-11#2)
(50 mg##3##2##(1995-8#1)(2008-10#2)
(50 micrograms)##2##2##(1995-12#1)(1996-1#1)
(50 muM##2##2##(2008-10#2)
(50 ppm##2##2##(2008-10#2)
(50##51##1##(1990-3#1)(1990-6#1)(1991-6#1)(1992-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-4#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#2)(2008-4#1)(2009-12#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
(50% effective##4##2##(2008-10#3)(2011-3#1)
(50% of##4##2##(1990-12#1)(1993-2#1)(2008-10#1)(2008-11#1)
(50%##11##1##(1990-12#1)(1993-2#1)(1993-6#1)(1995-11#1)(2008-10#5)(2008-11#1)(2011-3#1)
(50%) and##4##2##(1990-5#1)(1996-8#1)(2008-10#1)(2008-7#1)
(50%) in##2##2##(1990-2#1)(1994-2#1)
(50%) of##2##2##(1991-3#1)(2007-11#1)
(50%) patients##3##2##(2012-3#1)(2013-1#2)
(50%)##26##1##(1990-2#1)(1990-5#1)(1991-3#2)(1994-12#1)(1994-2#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#3)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
(50-100##3##1##(1997-1#1)(2008-10#1)(2011-1#1)
(50/50)##2##1##(2008-10#2)
(500 and 1000##2##3##(1995-12#1)(2012-2#1)
(500 mg l(-1))##2##3##(2008-10#2)
(500 mg##3##2##(2008-10#3)
(500##13##1##(1992-8#2)(1994-11#1)(1995-12#1)(2008-10#6)(2008-3#1)(2010-7#1)(2012-2#1)
(51##8##1##(1993-1#1)(1993-2#1)(1994-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
(51%##3##1##(1996-1#1)(2008-10#1)(2008-11#1)
(51%)##4##1##(1992-3#1)(1995-12#1)(1996-2#1)(2013-1#1)
(52##12##1##(1990-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(52% female)##2##2##(2010-10#1)(2010-7#1)
(52% reduction) in the IDDS group (P = 0##2##9##(2008-7#2)
(52%##5##1##(1995-6#1)(2008-7#2)(2010-10#1)(2010-7#1)
(52%)##5##1##(1991-11#1)(1994-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
(53##12##1##(1991-3#1)(2008-10#5)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
(53%)##10##1##(1997-6#1)(2008-10#2)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
(537 nm) and##2##3##(2008-10#1)(2008-9#1)
(54##11##1##(1991-3#1)(1993-8#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2013-1#1)
(54%##3##1##(2009-7#1)(2011-2#1)(2012-3#1)
(54%)##4##1##(1997-3#1)(2008-1#1)(2011-1#2)
(55##12##1##(1992-2#1)(1994-2#1)(1997-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
(55%)##8##1##(1990-3#1)(1992-12#1)(1996-9#2)(2008-10#1)(2008-11#1)(2011-2#2)
(56##11##1##(1993-11#1)(1997-3#1)(2008-10#4)(2011-2#2)(2012-12#1)(2012-3#2)
(56%##3##1##(2008-11#1)(2010-1#1)(2013-8#1)
(56%)##4##1##(1994-12#1)(1996-11#1)(2011-2#1)(2012-12#1)
(57##10##1##(1992-9#1)(2008-10#2)(2008-12#2)(2008-8#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
(57%##3##1##(2008-10#1)(2010-4#1)(2012-2#1)
(57%) of the##2##3##(2008-7#1)(2013-1#1)
(57%) of##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
(57%)##5##1##(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
(570##2##1##(1990-12#1)(2008-10#1)
(58##8##1##(1991-11#1)(1992-9#1)(2008-1#1)(2008-10#2)(2009-5#1)(2009-6#1)(2011-2#1)
(58%) and##2##2##(1996-6#1)(2012-12#1)
(58%)##10##1##(1992-1#1)(1994-1#2)(1996-6#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-12#2)(2013-1#1)
(580##2##1##(2008-10#2)
(59##8##1##(1990-5#1)(1993-2#1)(1997-3#1)(2008-10#2)(2010-8#1)(2011-2#1)(2012-3#1)
(59%)##5##1##(1991-8#1)(2008-1#1)(2011-2#2)(2013-1#1)
(5HT)##2##1##(1996-12#1)(2008-11#1)
(5mg/ml)##3##1##(2012-3#3)
(5th)##2##1##(1991-2#1)(1992-6#1)
(6 and##2##2##(1997-8#1)(2008-10#1)
(6 cM)##2##2##(2008-10#2)
(6 to##2##2##(2008-10#2)
(6##93##1##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-8#3)(2008-1#1)(2008-10#30)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-7#1)(2010-1#1)(2010-3#1)(2011-2#11)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#3)
(6%##2##1##(1992-9#1)(2008-10#1)
(6%)##15##1##(1991-3#1)(1993-8#1)(1995-11#1)(1997-3#1)(2008-10#5)(2008-12#1)(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
(6) and##6##2##(1991-5#1)(2008-10#3)(2008-11#2)
(6)##33##1##(1991-5#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-9#1)(1996-5#2)(1997-2#1)(1997-3#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#4)(2011-3#1)(2013-1#5)
(6-8)##2##1##(1996-5#1)(2008-10#1)
(6/7)##2##1##(1994-3#1)(2012-3#1)
(60 and##2##2##(2008-10#2)
(60 min)##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
(60##27##1##(1990-12#1)(1991-11#1)(1993-6#1)(1994-6#1)(1996-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-7#1)(2009-11#1)(2010-1#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
(60%) had##2##2##(1990-3#1)(1996-11#1)
(60%) of##2##2##(2008-5#1)(2011-2#1)
(60%) patients##2##2##(2008-10#1)(2008-7#1)
(60%)##17##1##(1990-12#1)(1990-3#1)(1996-11#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
(60)Co##2##1##(2008-11#1)(2008-9#1)
(60-70%)##2##1##(1997-2#1)(2008-10#1)
(600##6##1##(2008-10#4)(2011-1#1)(2011-2#1)
(61##11##1##(1992-9#1)(1993-2#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#2)
(61%) had##2##2##(1992-3#1)(2012-3#1)
(61%)##6##1##(1990-3#1)(1991-2#1)(1992-3#1)(2008-10#1)(2009-8#1)(2012-3#1)
(62##12##1##(1991-3#1)(1993-2#1)(1994-5#1)(1996-11#1)(1996-3#1)(2008-10#5)(2008-7#1)(2010-11#1)
(62%) and##3##2##(2008-10#1)(2013-1#1)(2013-7#1)
(62%) of##3##2##(1990-8#1)(1994-1#1)(2008-7#1)
(62%)##10##1##(1990-8#1)(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
(620 nm)##2##2##(2008-10#2)
(620##3##1##(2008-10#3)
(63##7##1##(1991-12#1)(1991-8#1)(1994-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
(63%) and##2##2##(1995-11#1)(2012-2#1)
(63%)##9##1##(1995-11#2)(1996-8#1)(1997-8#3)(2008-10#1)(2010-8#1)(2012-2#1)
(63)Cu##2##1##(2008-10#2)
(63)Ni ionization source##2##3##(2008-10#2)
(63)Ni##3##1##(2008-10#3)
(64##5##1##(1996-11#1)(2008-10#1)(2008-11#2)(2013-8#1)
(64%)##4##1##(1990-6#1)(2008-10#2)(2010-4#1)
(64)Cu##2##1##(2010-6#2)
(64)Cu-NOTA-RGD-BBN and (68)Ga-NOTA-RGD-BBN##2##3##(2010-6#2)
(64)Cu-NOTA-RGD-BBN##3##1##(2010-6#3)
(65##10##1##(1991-12#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)
(65%##2##1##(1995-5#1)(2013-1#1)
(65%) and##2##2##(1997-3#1)(2008-9#1)
(65%) of##2##2##(1996-11#1)(2011-1#1)
(65%)##14##1##(1990-3#1)(1992-3#1)(1996-11#1)(1997-3#2)(1997-6#1)(2008-1#3)(2008-10#1)(2008-7#1)(2008-9#2)(2011-1#1)
(65)Cu##2##1##(2008-10#2)
(65+35##2##1##(2008-10#2)
(66 Gy)##2##2##(1990-6#1)(1993-8#1)
(66 to##2##2##(2008-10#2)
(66##16##1##(1990-6#1)(1991-11#1)(1992-9#1)(1993-8#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
(66%)##9##1##(1990-12#1)(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
(660##2##1##(2008-10#2)
(67##12##1##(1990-2#1)(1993-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
(67%)##2##1##(1990-2#1)(2008-1#1)
(68##9##1##(1991-10#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2009-5#1)(2012-3#1)
(68%)##5##1##(1991-6#1)(1994-8#1)(1996-2#1)(2008-8#1)(2012-2#1)
(68)Ga-NOTA-RGD-BBN##4##1##(2010-6#4)
(68)Zn##2##1##(2008-10#2)
(69##7##1##(2008-10#2)(2008-12#1)(2010-6#1)(2013-1#1)(2013-8#2)
(69%)##5##1##(1996-3#1)(2008-7#1)(2008-9#2)(2013-1#1)
(6PGD)##2##1##(2010-12#2)
(6a)##2##1##(1991-5#1)(2009-9#1)
(7 patients)##2##2##(1990-8#1)(2011-2#1)
(7##81##1##(1990-2#2)(1990-3#2)(1990-8#2)(1991-11#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-4#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(2008-10#23)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-2#4)(2012-3#3)(2013-1#5)
(7%##2##1##(1991-6#1)(2008-10#1)
(7%)##8##1##(1991-2#1)(1993-8#1)(1996-11#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-7#1)(2013-8#1)
(7)##20##1##(1994-1#1)(1994-5#1)(1996-5#2)(1997-3#2)(1997-5#2)(2008-10#2)(2008-11#2)(2009-6#1)(2010-12#1)(2011-2#2)(2011-3#2)(2013-1#2)
(7-8##2##1##(1994-12#1)(2013-8#1)
(70##16##1##(1995-12#2)(2008-10#7)(2008-7#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
(70%) patients##2##2##(1992-5#1)(2011-2#1)
(70%)##18##1##(1990-3#1)(1991-2#1)(1992-5#1)(1993-2#1)(1994-12#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
(71##7##1##(1992-9#1)(1997-8#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
(71%) and##2##2##(2010-3#1)(2012-3#1)
(71%) of the##2##3##(1997-3#1)(2008-1#1)
(71%)##8##1##(1994-1#2)(1997-3#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-3#2)
(72 h)##2##2##(1990-2#1)(1993-12#1)
(72##15##1##(1990-2#1)(1991-9#1)(1993-12#1)(1995-11#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#2)
(72% of##3##2##(1991-12#1)(1996-12#1)(2011-2#1)
(72%##4##1##(1991-12#1)(1996-12#1)(2011-2#1)(2013-1#1)
(72%)##8##1##(1994-1#1)(1994-12#1)(2008-7#2)(2012-3#2)(2013-1#2)
(73##13##1##(1990-3#1)(1996-11#1)(2008-10#2)(2008-11#2)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-7#2)
(73%##2##1##(1994-3#1)(2008-10#1)
(73%)##3##1##(2008-9#1)(2011-2#2)
(74##10##1##(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#3)(2012-12#2)(2013-1#1)
(74%)##7##1##(1990-3#1)(1990-9#1)(1992-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2012-3#1)
(75 to##2##2##(2008-10#2)
(75##21##1##(1990-12#1)(2008-1#1)(2008-10#7)(2008-5#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-3#3)(2013-1#1)
(75%##5##1##(1996-1#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
(75%) and##2##2##(1997-3#1)(2008-7#1)
(75%) of the##2##3##(1991-12#1)(2011-2#1)
(75%) of##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
(75%)##14##1##(1991-12#1)(1992-12#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-11#1)(2011-2#3)
(75)Se##2##1##(2008-10#2)
(750##2##1##(1990-12#1)(2008-2#1)
(76##11##1##(1990-8#1)(1991-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(76%##2##1##(1993-9#1)(2008-12#1)
(76%)##5##1##(1997-3#1)(2008-10#2)(2011-2#2)
(77##4##1##(1997-8#1)(2008-11#1)(2011-10#1)(2012-3#1)
(77%)##7##1##(1997-3#1)(2008-10#4)(2011-2#2)
(78##14##1##(1991-12#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-2#3)(2013-1#1)
(78%)##6##1##(1990-12#1)(1996-1#1)(1997-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
(780##2##1##(2008-10#2)
(79##9##1##(1993-12#1)(1993-2#1)(1993-8#1)(1995-1#1)(1996-6#1)(2008-1#1)(2011-2#2)(2013-1#1)
(79%)##4##1##(1991-5#1)(1993-8#1)(2008-7#2)
(79)Se is##2##2##(2008-10#2)
(8 cases)##2##2##(2008-11#2)
(8 to##2##2##(2008-10#1)(2008-5#1)
(8 x##2##2##(1993-9#1)(2008-10#1)
(8##61##1##(1990-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-5#2)(2008-9#3)(2009-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#3)(2013-1#3)
(8%)##6##1##(1991-6#1)(2008-1#1)(2008-10#4)
(8)##17##1##(1990-5#1)(1992-12#1)(1992-9#1)(1994-11#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#3)(2008-8#1)(2010-12#1)(2011-2#2)(2011-3#2)
(8-HQ)##2##1##(2008-10#2)
(80 mg/day)##2##2##(2012-3#2)
(80##20##1##(1990-11#1)(1992-5#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-8#1)
(80%##4##1##(2008-10#3)(2013-1#1)
(80%) of##2##2##(1995-2#1)(1997-9#1)
(80%)##11##1##(1991-6#1)(1995-2#1)(1997-9#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-3#3)(2013-8#1)
(800##2##1##(1996-6#1)(2008-11#1)
(81##3##1##(2008-10#1)(2010-1#1)(2012-12#1)
(81%)##3##1##(1990-5#1)(1991-6#1)(2011-2#1)
(82 to##2##2##(2008-10#2)
(82##7##1##(2008-10#3)(2008-9#1)(2011-2#2)(2012-12#1)
(82%)##7##1##(1992-2#2)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
(824##2##1##(2008-10#1)(2011-1#1)
(83##4##1##(1994-12#1)(1995-9#1)(2008-12#1)(2011-2#1)
(83%##2##1##(1994-12#1)(2013-1#1)
(83%)##6##1##(1992-12#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
(84##7##1##(1991-11#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
(84%)##5##1##(1990-9#1)(1991-3#1)(1992-12#1)(2008-8#1)(2012-3#1)
(85##9##1##(1993-11#1)(1995-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2011-2#1)
(85% of##2##2##(1991-9#1)(2011-3#1)
(85%##4##1##(1991-9#1)(1995-12#1)(2008-10#1)(2011-3#1)
(85%)##5##1##(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)
(86##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
(86%)##6##1##(1993-3#1)(1997-8#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
(87##12##1##(1991-11#1)(1996-2#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
(87%##3##1##(1992-3#1)(1995-12#1)(2013-1#1)
(87%)##7##1##(1991-3#1)(2008-10#2)(2008-9#1)(2012-3#1)(2013-7#2)
(88##8##1##(1991-11#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#2)
(88%##2##1##(1991-6#1)(2008-8#1)
(88%)##5##1##(1992-12#1)(1993-12#1)(2008-1#1)(2011-1#1)(2012-2#1)
(89##7##1##(1993-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
(89%)##4##1##(1996-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
(9 men and##2##3##(2013-1#2)
(9 patients)##3##2##(1990-12#1)(2007-11#1)(2011-2#1)
(9 subjects)##2##2##(1994-12#1)(2011-3#1)
(9##67##1##(1990-12#3)(1990-3#1)(1990-9#1)(1992-5#1)(1994-12#3)(1994-2#1)(1995-12#2)(1996-12#1)(2007-11#1)(2008-10#24)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-6#1)(2011-2#10)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#6)
(9%) had##3##2##(1994-6#1)(2008-10#1)(2011-2#1)
(9%) of the##2##3##(1996-9#1)(2011-2#1)
(9%) patients##2##2##(1997-3#1)(2008-10#1)
(9%)##13##1##(1994-6#1)(1996-11#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2010-11#2)(2011-2#2)
(9)##6##1##(1990-12#1)(2008-8#1)(2010-12#1)(2011-2#2)(2011-3#1)
(90 degrees##2##2##(1991-2#1)(2008-10#1)
(90##19##1##(1991-2#1)(1996-2#1)(2008-10#11)(2008-11#2)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
(90%##2##1##(2008-10#1)(2013-1#1)
(90%)##8##1##(1992-1#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)
(91##12##1##(1994-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#3)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
(91%)##6##1##(1991-3#1)(2008-1#1)(2008-10#2)(2011-1#1)(2011-2#1)
(92##7##1##(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#3)
(92%##2##1##(1991-2#1)(1994-12#1)
(92%) were##2##2##(1995-12#1)(2008-10#1)
(92%)##4##1##(1995-12#1)(2008-10#2)(2011-2#1)
(93##12##1##(1990-6#1)(1991-8#1)(1993-8#1)(1994-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-1#1)(2012-3#3)
(93%)##2##1##(2008-10#1)(2012-3#1)
(94##5##1##(1996-3#1)(2008-10#2)(2010-8#1)(2012-12#1)
(94%##2##1##(2008-10#1)(2008-3#1)
(94%)##2##1##(1994-12#1)(1995-3#1)
(95##12##1##(1991-8#1)(1996-1#3)(2008-10#3)(2010-6#1)(2012-3#2)(2013-1#1)(2013-8#1)
(95% C##14##2##(1990-6#7)(1994-12#7)
(95% CI 0##3##3##(2013-1#3)
(95% CI 1##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
(95% CI 2##2##3##(2013-1#2)
(95% CI =##3##3##(2009-9#1)(2011-2#2)
(95% CI##39##2##(1992-2#1)(1993-2#1)(2008-10#4)(2008-11#5)(2008-12#4)(2009-9#1)(2010-9#1)(2011-2#6)(2012-3#6)(2013-1#10)
(95% confidence interval##5##3##(1991-11#2)(2008-11#1)(2011-2#1)(2013-1#1)
(95% confidence level)##2##3##(2008-10#2)
(95% confidence limits 0##2##4##(2013-1#2)
(95% confidence limits##4##3##(1990-6#1)(1997-3#1)(2013-1#2)
(95% confidence##14##2##(1990-6#1)(1991-11#2)(1991-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#4)(2013-8#1)
(95%##73##1##(1990-12#1)(1990-6#8)(1991-11#2)(1991-5#1)(1992-2#1)(1993-2#1)(1994-12#7)(1997-3#1)(2008-10#8)(2008-11#6)(2008-12#4)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#8)(2012-3#6)(2013-1#15)(2013-8#1)
(95%)##10##1##(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#2)
(96##4##1##(1997-3#1)(2008-11#1)(2008-12#2)
(96%)##13##1##(1990-3#1)(1991-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(2008-10#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
(97%##2##1##(2008-10#1)(2008-4#1)
(97%)##4##1##(1994-1#1)(2007-12#1)(2008-10#1)(2008-8#1)
(98##13##1##(1990-12#1)(1994-2#1)(2008-1#1)(2008-10#6)(2008-7#1)(2012-12#1)(2012-2#2)
(98%##3##1##(2008-10#1)(2009-3#1)(2013-1#1)
(98%) and##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
(98%)##9##1##(1991-1#1)(1994-9#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
(99##10##1##(2008-10#8)(2008-9#1)(2012-12#1)
(99%)##3##1##(1993-6#1)(2008-10#2)
(= 1##2##2##(1994-11#1)(1995-2#1)
(=##5##1##(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
(A beta##3##2##(1994-11#1)(1996-2#2)
(A beta)##2##2##(1995-12#1)(1996-2#1)
(A through##2##2##(2008-10#1)(2012-2#1)
(A##33##1##(1990-5#1)(1992-3#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-2#3)(2008-10#13)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-2#1)
(A) and##2##2##(1997-7#1)(2011-2#1)
(A) or##2##2##(1992-12#1)(1994-5#1)
(A)##23##1##(1991-12#1)(1992-12#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-9#2)(2010-4#3)(2011-2#3)
(A)(+)##3##1##(2008-8#2)(2008-9#1)
(A1##2##1##(2008-10#2)
(A5005##2##1##(2008-10#2)
(A549)##2##1##(1994-11#1)(2008-11#1)
(AA and##2##2##(2008-10#1)(2008-8#1)
(AA##3##1##(1992-12#1)(2008-10#1)(2008-8#1)
(AA) is##4##2##(2008-10#3)(2008-5#1)
(AA)##26##1##(1992-12#2)(1993-3#1)(1993-8#1)(1997-2#1)(2008-10#18)(2008-11#2)(2008-5#1)
(AAA)##4##1##(2009-7#1)(2010-12#1)(2010-7#1)(2013-1#1)
(AAC)(n) repeats##2##2##(2008-10#2)
(AAC)(n)##4##1##(2008-10#4)
(AAP)##2##1##(2008-10#2)
(AAPCC)##4##1##(1991-3#1)(1993-3#3)
(AAPH)##2##1##(1991-1#1)(2008-10#1)
(AAS##3##1##(2008-10#3)
(AAS) method##2##2##(2008-10#2)
(AAS)##20##1##(1996-3#1)(2008-10#19)
(AB)##5##1##(2008-10#4)(2009-4#1)
(ABC)##3##1##(1993-12#1)(1994-3#1)(2009-8#1)
(ABSTRACT TRUNCATED AT 250 WORDS)##69##5##(1990-12#3)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-3#4)(1991-8#2)(1992-1#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#6)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#9)(1994-3#1)(1994-5#15)(1994-8#3)(1995-3#3)(1995-5#1)(1996-2#3)
(ABSTRACT TRUNCATED AT 400 WORDS)##18##5##(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)
(ABSTRACT TRUNCATED AT##87##3##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-3#4)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#8)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#10)(1994-3#2)(1994-5#16)(1994-8#4)(1995-3#3)(1995-5#1)(1996-2#3)
(AC##3##1##(2008-10#3)
(AC)##8##1##(1994-12#1)(2008-10#7)
(ACA)##2##1##(2011-2#1)(2013-8#1)
(ACC) is##2##2##(2008-10#1)(2013-8#1)
(ACC)##8##1##(1991-11#1)(1993-6#1)(2008-10#3)(2009-6#1)(2011-10#1)(2013-8#1)
(ACD)##2##1##(2008-5#1)(2011-2#1)
(ACE)##6##1##(1993-12#1)(2008-1#1)(2008-6#1)(2008-7#2)(2010-10#1)
(ACETBC)##2##1##(1997-7#2)
(ACG)##2##1##(1995-2#1)(2008-10#1)
(ACP) were##2##2##(1991-11#1)(2013-8#1)
(ACP)##4##1##(1991-11#1)(1992-4#1)(1993-12#1)(2013-8#1)
(ACS) and##2##2##(1997-1#1)(2008-10#1)
(ACS)##7##1##(1997-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-4#1)(2012-2#1)
(ACT)##3##1##(1991-1#1)(2008-10#1)(2011-2#1)
(ACTH)##6##1##(1992-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(2011-1#1)(2011-2#1)
(AChE) activity##3##2##(2008-11#3)
(AChE)##9##1##(1990-5#1)(1994-5#1)(2008-10#2)(2008-11#3)(2009-8#1)(2011-3#1)
(AD) duration##2##2##(1992-12#1)(1994-2#1)
(AD) is##3##2##(2008-7#2)(2011-2#1)
(AD)##30##1##(1991-1#1)(1992-12#2)(1994-2#1)(1995-12#1)(1995-8#1)(1996-2#2)(1997-2#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#7)(2009-10#1)(2011-2#2)(2011-3#1)(2012-3#1)
(ADA)##13##1##(1994-1#2)(1995-12#4)(1995-6#2)(1996-1#1)(1996-5#1)(2008-10#2)(2008-3#1)
(ADC)##5##1##(1992-12#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-4#1)
(ADH)##3##1##(1997-8#1)(2008-10#1)(2008-11#1)
(ADHD)##6##1##(1996-6#1)(2008-2#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
(ADL)##5##1##(1995-2#1)(2008-7#2)(2011-2#1)(2012-2#1)
(ADM)##3##1##(1992-3#1)(1993-12#1)(2013-1#1)
(ADR) and##2##2##(1997-7#1)(2011-3#1)
(ADR)##7##1##(1990-2#1)(1993-12#1)(1997-7#1)(2008-10#2)(2011-2#1)(2011-3#1)
(ADS)##3##1##(2008-10#2)(2009-10#1)
(ADT)##2##1##(1994-2#1)(2012-2#1)
(ADX)##2##1##(1994-2#1)(2008-11#1)
(AE)##3##1##(2008-9#1)(2010-8#1)(2011-2#1)
(AED)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
(AF)##5##1##(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
(AFC)##4##1##(1993-8#1)(2008-10#2)(2011-2#1)
(AFLP)##41##1##(2008-10#41)
(AFM)##20##1##(2008-10#14)(2008-11#1)(2008-4#1)(2008-7#2)(2009-7#1)(2013-8#1)
(AFP)##4##1##(1990-9#1)(2008-10#1)(2008-8#1)(2011-1#1)
(AFS)##7##1##(1996-12#1)(2008-10#6)
(AG##2##1##(2008-10#1)(2011-2#1)
(AG)##5##1##(2008-10#4)(2012-3#1)
(AG)-5##2##1##(2008-10#2)
(AG-1-ID)##2##1##(2008-10#2)
(AGT)##2##1##(1993-11#1)(2008-5#1)
(AH)##6##1##(1993-8#2)(1995-1#1)(2009-7#1)(2010-3#1)(2011-2#1)
(AH8##4##1##(2010-5#4)
(AHA)##3##1##(1991-12#1)(2008-3#1)(2008-5#1)
(AI)##4##1##(2008-10#3)(2013-1#1)
(AIBN)##2##1##(2008-12#1)(2009-10#1)
(AICAR)##2##1##(1994-8#1)(2009-12#1)
(AIS)##2##1##(2008-10#1)(2010-7#1)
(AL)##2##1##(2008-10#1)(2011-2#1)
(ALA)##3##1##(1992-3#1)(2008-1#1)(2008-6#1)
(ALL)##6##1##(1991-8#1)(2008-12#1)(2010-11#1)(2010-6#1)(2011-2#2)
(ALP)##11##1##(2008-10#3)(2008-11#4)(2011-1#2)(2012-3#1)(2013-1#1)
(ALS)##5##1##(2008-10#2)(2008-4#1)(2008-7#1)(2009-9#1)
(ALT)##8##1##(2008-10#3)(2008-11#1)(2009-8#1)(2012-3#2)(2013-8#1)
(AM##2##1##(2006-6#1)(2008-11#1)
(AM)##2##1##(1994-2#1)(2008-11#1)
(AM1)##4##1##(2008-10#3)(2008-11#1)
(AMD) and##2##2##(2011-2#2)
(AMD)##11##1##(2008-10#2)(2011-2#7)(2011-7#1)(2013-1#1)
(AMI)##12##1##(1990-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-6#1)(2010-11#1)(2010-12#1)
(AML)##9##1##(2008-10#1)(2008-4#1)(2010-1#1)(2011-2#4)(2012-12#1)(2013-1#1)
(AMOVA)##5##1##(2008-10#5)
(AMP)##3##1##(2008-10#1)(2011-2#2)
(AMPA)##2##1##(1995-11#1)(1995-2#1)
(AMT)##3##1##(2008-10#1)(2009-11#1)(2011-2#1)
(ANG##2##1##(1991-5#1)(1994-8#1)
(ANN) model##5##2##(2008-10#5)
(ANN)##24##1##(2008-10#21)(2010-8#2)(2013-1#1)
(ANNs) are##4##2##(2008-10#4)
(ANNs)##13##1##(2008-10#13)
(ANOVA and##2##2##(1990-9#1)(2013-1#1)
(ANOVA p &lt##2##3##(2008-7#2)
(ANOVA##5##1##(1990-9#1)(2008-10#1)(2008-7#2)(2013-1#1)
(ANOVA)##13##1##(1994-2#1)(1995-2#1)(2008-10#7)(2009-1#1)(2009-2#1)(2012-2#1)(2013-1#1)
(ANS)##4##1##(1991-9#1)(2008-10#1)(2009-11#1)(2013-8#1)
(AOA)##2##1##(1991-12#1)(2008-7#1)
(AOD)##3##1##(2012-12#2)(2012-3#1)
(AOP)##2##1##(2008-10#2)
(AOR =##3##2##(2011-2#1)(2013-1#2)
(AOT)##2##1##(2008-10#1)(2013-1#1)
(AOTF)##2##1##(2008-10#2)
(AP) is##3##2##(2009-8#1)(2013-1#2)
(AP)##14##1##(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2009-8#2)(2012-3#1)(2013-1#2)
(APC) and##2##2##(1997-2#1)(2008-11#1)
(APC)##3##1##(1997-2#1)(2008-11#1)(2013-1#1)
(APD)##4##1##(2010-12#1)(2010-2#1)(2011-10#1)(2013-8#1)
(APDC)##11##1##(2008-10#11)
(APM)##2##1##(2008-10#1)(2008-3#1)
(APP) is##2##2##(1992-12#1)(1996-12#1)
(APP)##9##1##(1992-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#2)(2008-10#2)(2008-11#1)
(APS)##4##1##(2008-10#2)(2008-8#1)(2009-8#1)
(APTES)##2##1##(2008-10#2)
(AQ) modified##2##2##(2008-10#2)
(AQ)##3##1##(2008-10#3)
(AR) and##3##2##(2008-7#1)(2012-12#1)(2013-8#1)
(AR)##10##1##(1990-11#2)(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
(ARDS)##6##1##(1993-2#1)(1997-1#2)(2010-5#2)(2012-3#1)
(ARF)##3##1##(1992-12#1)(2008-11#1)(2012-3#1)
(ARI)##2##1##(1997-3#1)(2008-10#1)
(ARM)##2##1##(2011-2#2)
(ARMD) and##2##2##(2011-2#2)
(ARS) in##2##2##(1996-2#1)(2008-10#1)
(ARS)##7##1##(1996-2#1)(2008-10#4)(2008-3#1)(2008-8#1)
(ART)##3##1##(1992-2#1)(2011-2#2)
(AS) and##2##2##(2008-12#1)(2013-8#1)
(AS)##7##1##(2008-10#2)(2008-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
(ASA)##7##1##(1997-3#1)(1997-6#1)(2008-10#5)
(ASC)##2##1##(2008-11#1)(2009-3#1)
(ASD) may##2##2##(2010-7#1)(2012-3#1)
(ASD)##6##1##(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)
(ASE)##5##1##(2008-10#3)(2008-3#1)(2012-2#1)
(ASN)##2##1##(2008-10#1)(2013-1#1)
(ASR)##2##1##(1992-2#1)(1996-5#1)
(AST)##5##1##(1994-5#1)(1997-3#1)(2008-10#2)(2009-8#1)
(ASTM##3##1##(2008-10#3)
(ASV)##6##1##(2008-10#5)(2010-7#1)
(AT)##5##1##(1995-6#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
(ATCC##12##1##(1993-8#1)(2008-10#2)(2008-12#2)(2008-8#1)(2011-2#2)(2013-1#4)
(ATP##2##1##(1992-3#1)(2008-10#1)
(ATP)##3##1##(1990-5#1)(1997-6#1)(2008-10#1)
(ATR)##3##1##(2008-10#3)
(ATR-FTIR)##6##1##(2008-10#5)(2008-5#1)
(AUC##2##1##(2008-10#1)(2012-4#1)
(AUROC = 71##2##3##(2008-3#2)
(AUROC =##3##2##(2008-3#3)
(AV)##2##1##(1997-6#1)(2011-3#1)
(AVF)##4##1##(1996-9#2)(2008-7#2)
(AVM)##8##1##(1996-6#1)(2008-7#6)(2013-1#1)
(AVP)##4##1##(1990-5#1)(2008-11#1)(2008-4#1)(2008-8#1)
(AVS)##2##1##(2008-10#2)
(AW##2##1##(1994-8#1)(2012-9#1)
(AZ)##2##1##(2008-10#2)
(AZA)##2##1##(2010-12#1)(2011-2#1)
(AZT)##3##1##(1993-8#1)(2008-10#1)(2011-3#1)
(Ab)##8##1##(1993-12#1)(2008-10#2)(2008-11#5)
(Abernathy##2##1##(2010-8#2)
(AcNPV)##6##1##(1994-11#1)(1997-3#1)(2008-11#2)(2008-7#1)(2008-8#1)
(AcP)##2##1##(2008-10#2)
(Acari##2##1##(1996-12#1)(2007-12#1)
(Acariformes##2##1##(2007-12#2)
(AdSV)##3##1##(2008-10#3)
(Aedes albopictusC6/36)##2##2##(2008-7#2)
(Affi-Gel##2##1##(2008-4#1)(2008-7#1)
(Ag##3##1##(2008-10#3)
(Ag)##5##1##(1990-8#1)(1991-5#1)(1993-1#1)(2008-10#2)
(Ag/AgCl)##3##1##(2008-10#3)
(AgMNPV)##2##1##(2008-11#2)
(Agaricus bisporus)##4##2##(2008-10#4)
(Agavacea)##2##1##(2009-8#2)
(Ah) receptor##3##2##(1993-12#1)(1995-11#1)(2008-11#1)
(Al##4##1##(2008-10#4)
(Al)##6##1##(1996-2#1)(2008-10#2)(2009-6#1)(2009-8#1)(2013-8#1)
(Alb##2##1##(2008-7#2)
(Alizarin Red S)##2##3##(2008-10#2)
(Allium cepa##2##2##(2008-10#2)
(Allium##4##1##(2008-10#4)
(Amberlite##3##1##(2008-10#3)
(American Psychiatric##2##2##(2008-8#1)(2011-2#1)
(American##4##1##(1996-1#1)(2008-8#2)(2011-2#1)
(Amersham Biosciences##2##2##(2008-11#2)
(Anal##2##1##(2008-10#2)
(Andean##3##1##(2008-10#3)
(Apis mellifera)##2##2##(2012-2#1)(2013-1#1)
(Apis##3##1##(2012-2#2)(2013-1#1)
(ApoAI)##2##1##(1993-12#2)
(April and May)##2##3##(2008-10#2)
(April##6##1##(2008-10#3)(2008-4#1)(2013-1#2)
(Arachis hypogaea)##5##2##(2008-10#5)
(Arachis##6##1##(2008-10#6)
(Arachnida##2##1##(2007-12#2)
(Araneae##2##1##(2007-12#1)(2008-9#1)
(Arbutus##2##1##(2008-10#2)
(Arg)##2##1##(2008-10#1)(2008-11#1)
(As##7##1##(2008-10#7)
(As(2)O(3))##2##1##(2008-8#2)
(As(III)##4##1##(2008-10#4)
(As(III))##5##1##(2008-10#5)
(As(V)##2##1##(2008-10#2)
(As(V))##5##1##(2008-10#5)
(As)##8##1##(2008-10#7)(2013-1#1)
(AsA)##4##1##(2008-10#3)(2008-11#1)
(Atr)##2##1##(2008-10#1)(2008-8#1)
(Atra-PBP1)##2##1##(2009-7#2)
(Au##4##1##(2008-10#4)
(Australia)##5##1##(2008-10#3)(2008-11#1)(2008-9#1)
(Avena sativa)##3##2##(2008-10#3)
(Avena##5##1##(2008-10#5)
(AxB(I))##2##1##(2008-10#2)
(B --&gt##2##2##(2011-3#2)
(B = 0##6##3##(1992-9#1)(2010-4#5)
(B =##8##2##(1992-9#1)(2008-3#1)(2010-4#6)
(B##24##1##(1992-9#1)(2008-10#12)(2008-3#1)(2008-5#1)(2010-4#6)(2011-1#1)(2011-3#2)
(B) and##4##2##(2008-10#2)(2008-11#2)
(B)##18##1##(1992-12#1)(1993-8#1)(1994-5#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#3)(2011-2#1)
(B-type)##2##1##(1991-5#2)
(B1 and B2) were##2##4##(2008-11#2)
(B1 and B2)##3##3##(2008-10#1)(2008-11#2)
(B1##4##1##(2008-10#1)(2008-11#3)
(B18C6) and##2##2##(2008-10#2)
(B18C6)##3##1##(2008-10#3)
(BA)##6##1##(1995-11#1)(2008-10#3)(2008-11#1)(2008-7#1)
(BAC)##8##1##(1997-8#1)(2008-10#2)(2008-8#3)(2009-10#1)(2010-10#1)
(BAE) is##2##2##(2010-12#1)(2012-3#1)
(BAL) fluid##2##2##(2008-10#1)(2008-12#1)
(BAL)##5##1##(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
(BAT)##3##1##(2012-2#1)(2012-3#1)(2013-1#1)
(BB)##2##1##(2008-10#1)(2011-2#1)
(BBA)##2##1##(2008-11#2)
(BBO)##2##1##(2008-2#1)(2008-3#1)
(BC##3##1##(2008-10#2)(2013-1#1)
(BC)##4##1##(2008-10#3)(2013-1#1)
(BCA)##3##1##(2008-10#3)
(BCC)##6##1##(1996-1#1)(1997-3#2)(2008-9#1)(2012-3#2)
(BCF)##2##1##(2008-12#2)
(BCG)##3##1##(1997-2#1)(2008-10#1)(2011-2#1)
(BCT)##2##1##(1994-12#1)(2008-6#1)
(BCVA)##4##1##(2011-2#3)(2013-1#1)
(BDD) electrode##3##2##(2008-10#3)
(BDD)##6##1##(2008-10#5)(2012-12#1)
(BDL)##2##1##(2009-8#1)(2013-8#1)
(BDNF) is##2##2##(2009-8#1)(2013-8#1)
(BDNF)##11##1##(1996-12#1)(1997-2#2)(2008-11#1)(2008-7#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-8#2)
(BE)##4##1##(2008-10#2)(2010-12#1)(2013-8#1)
(BET)##2##1##(2009-11#1)(2012-12#1)
(BEVS)##2##1##(2008-11#1)(2008-7#1)
(BF##2##1##(2008-5#1)(2012-2#1)
(BF)##2##1##(2009-12#1)(2013-1#1)
(BG)##3##1##(2008-10#3)
(BGE)##3##1##(2008-10#3)
(BGMV) is##2##2##(2008-10#2)
(BGMV)##3##1##(2008-10#3)
(BHA) and##3##2##(2008-10#3)
(BHA)##4##1##(2008-10#4)
(BHT)##5##1##(1994-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
(BHV-1)##2##1##(1995-9#1)(2008-11#1)
(BI) was##2##2##(2008-10#2)
(BI)##6##1##(2008-10#4)(2011-2#1)(2012-3#1)
(BII) phobia##2##2##(2012-2#1)(2013-1#1)
(BIRADS##2##1##(2011-2#2)
(BL)##2##1##(2009-8#1)(2011-2#1)
(BLM)##2##1##(1990-12#1)(2008-10#1)
(BLS)##4##1##(2008-10#4)
(BMDBM)##2##1##(2008-5#2)
(BMI##3##1##(1997-8#1)(2008-10#1)(2012-12#1)
(BMI)##19##1##(1991-11#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-1#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
(BML)##2##1##(1996-11#1)(2012-3#1)
(BMP-2)##2##1##(2011-2#1)(2012-3#1)
(BMV)##2##1##(2008-10#2)
(BN)##2##1##(2008-10#2)
(BOD)##3##1##(2008-10#3)
(BOLD)##2##1##(2008-11#1)(2009-9#1)
(BOX)##2##1##(2009-6#2)
(BP##2##1##(2008-10#1)(2008-7#1)
(BP) and##4##2##(2008-10#1)(2008-11#2)(2013-8#1)
(BP) for##2##2##(2008-10#1)(2010-8#1)
(BP) is##2##2##(2008-10#1)(2008-8#1)
(BP)##15##1##(2008-1#1)(2008-10#4)(2008-11#3)(2008-8#1)(2010-4#3)(2010-7#1)(2010-8#1)(2013-8#1)
(BPA) was##2##2##(2008-10#1)(2010-8#1)
(BPA)##6##1##(2008-10#3)(2009-8#1)(2010-8#1)(2010-9#1)
(BPD)##3##1##(2008-4#1)(2009-9#1)(2010-5#1)
(BR)##7##1##(1990-5#1)(2008-10#4)(2008-9#1)(2009-8#1)
(BRONJ)##2##1##(2012-12#2)
(BS)##3##1##(2008-10#2)(2013-1#1)
(BSA##2##1##(2008-10#1)(2011-2#1)
(BSA) and##5##2##(2008-10#4)(2008-7#1)
(BSA) in##4##2##(2008-10#2)(2008-11#2)
(BSA)##36##1##(1995-12#1)(2008-10#27)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
(BSE)##2##1##(1994-6#1)(2011-2#1)
(BSTFA)##2##1##(2008-10#1)(2008-5#1)
(BT)##4##1##(2008-10#1)(2011-2#3)
(BTEX) compounds##2##2##(2008-10#2)
(BTEX)##3##1##(2008-10#2)(2008-11#1)
(BTH) significantly##2##2##(2008-10#2)
(BTH)##5##1##(2008-10#5)
(BV)##2##1##(2008-10#1)(2008-11#1)
(BW)##4##1##(1994-8#1)(2008-10#2)(2010-7#1)
(BWYV)##2##1##(2008-10#2)
(BYDV-PAV)##2##1##(2008-10#2)
(BYMV)##2##1##(2008-10#2)
(BZ)##3##1##(1996-12#2)(2008-10#1)
(Bacillus subtilis)##3##2##(2008-10#2)(2008-5#1)
(Bacillus##9##1##(2008-10#6)(2008-11#1)(2008-5#2)
(Bcl-2##2##1##(2011-2#1)(2012-2#1)
(Bemisia tabaci##2##2##(2008-10#2)
(Bemisia tabaci)##2##2##(2008-10#2)
(Bemisia##4##1##(2008-10#4)
(Beta vulgaris L##2##3##(2012-3#2)
(Beta vulgaris)##2##2##(2008-10#2)
(Beta##4##1##(2008-10#2)(2012-3#2)
(Bio-Rad Laboratories##2##2##(2008-10#2)
(Biol##2##1##(2008-11#1)(2010-3#1)
(Blumeria graminis f##4##3##(2008-10#4)
(BmNPV)##3##1##(1997-3#1)(2008-11#2)
(Bmax =##2##2##(1995-11#1)(1995-12#1)
(Bmax##3##1##(1990-11#1)(1995-11#1)(1995-12#1)
(Br-PADAP)##2##1##(2008-10#2)
(Brassica napus) in##2##3##(2008-10#2)
(Brassica napus)##3##2##(2008-10#3)
(Brassica##9##1##(2008-10#5)(2008-12#1)(2011-1#3)
(Brazil)##4##1##(2008-10#2)(2008-5#1)(2010-8#1)
(BrdU)##3##1##(1995-12#1)(2008-11#1)(2008-9#1)
(Brethaire##6##1##(1992-2#6)
(British##3##1##(2008-10#2)(2008-12#1)
(C and##2##2##(2008-10#2)
(C##43##1##(1990-6#2)(1992-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#2)
(C(18)##2##1##(2008-10#2)
(C(18))##3##1##(2008-10#3)
(C(L))##2##1##(2008-10#2)
(C(max))##2##1##(2008-11#1)(2008-12#1)
(C) and##3##2##(1994-3#1)(2008-10#2)
(C)##18##1##(1990-5#1)(1993-8#1)(1994-3#1)(2008-10#9)(2008-11#3)(2008-4#1)(2010-4#1)(2013-8#1)
(C-6)##2##1##(2008-10#2)
(C-ADR)##7##1##(2012-12#7)
(C1##3##1##(1994-5#1)(2008-12#2)
(C14##2##1##(2008-10#1)(2011-1#1)
(C16##5##1##(2008-10#2)(2008-8#1)(2011-1#2)
(C18##8##1##(1996-6#2)(2008-10#4)(2008-11#2)
(C18)##3##1##(2008-10#2)(2012-2#1)
(C20##2##1##(2008-10#2)
(C70)(2)-p-tert-butylcalix[6]arene##2##1##(2008-10#2)
(CA##5##1##(1994-12#1)(2008-10#4)
(CA) and##2##2##(2008-10#1)(2012-12#1)
(CA)##21##1##(1992-6#1)(1994-2#1)(1995-11#1)(2008-10#12)(2009-3#1)(2009-7#1)(2011-2#3)(2012-12#1)
(CAA)##4##1##(2007-8#1)(2008-10#2)(2008-11#1)
(CAB##3##1##(1995-2#3)
(CABG)##4##1##(1994-12#1)(2008-12#1)(2011-2#1)(2013-1#1)
(CAC-TDI)##2##1##(2008-10#2)
(CAD)##6##1##(1994-5#1)(1997-8#1)(2008-10#1)(2009-10#1)(2012-2#1)(2013-8#1)
(CAF) was##2##2##(2008-5#1)(2012-3#1)
(CAF)##3##1##(1997-7#1)(2008-5#1)(2012-3#1)
(CAH)##3##1##(2008-4#1)(2010-2#1)(2012-3#1)
(CAL)##2##1##(2008-10#1)(2008-11#1)
(CALUX##3##1##(2008-10#3)
(CALUX) bioassay##2##2##(2008-10#2)
(CALUX)##3##1##(2008-10#3)
(CAM)##3##1##(2008-10#2)(2008-8#1)
(CAP)##2##1##(2008-10#1)(2010-5#1)
(CAR)##2##1##(2008-11#1)(2013-1#1)
(CAR/PDMS)##3##1##(2008-10#2)(2009-8#1)
(CARS) of O(2) and##2##4##(2008-3#2)
(CARS)##5##1##(2008-2#1)(2008-3#4)
(CART)##2##1##(2008-10#1)(2008-7#1)
(CAS No##3##2##(2008-9#3)
(CAS RN##5##2##(2008-5#5)
(CAS##8##1##(2008-5#5)(2008-9#3)
(CAS)##7##1##(2008-10#2)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
(CASY)##2##1##(2008-11#2)
(CAT) and##2##2##(2008-10#2)
(CAT)##13##1##(1992-6#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-5#1)
(CAs)##3##1##(2008-10#1)(2008-11#1)(2010-1#1)
(CB)##5##1##(1994-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2009-12#1)
(CBB)##4##1##(2008-10#3)(2011-2#1)
(CBC)##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
(CBCT)##2##1##(2013-1#2)
(CBD)##2##1##(2008-7#1)(2009-9#1)
(CBP)##4##1##(1995-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
(CBP2)##2##1##(1997-7#2)
(CBS##2##1##(1996-6#1)(2008-7#1)
(CBS)##5##1##(1993-8#1)(2008-10#2)(2011-2#2)
(CBs)##4##1##(2008-10#4)
(CC)##6##1##(1991-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-1#1)
(CCA)##2##1##(2010-1#1)(2011-2#1)
(CCD)##8##1##(1991-2#1)(2008-1#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-1#1)
(CCF)##2##1##(1996-6#1)(1997-3#1)
(CCK)##6##1##(1992-8#1)(1993-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-7#1)
(CCMV)##2##1##(2008-10#2)
(CCT)##2##1##(1994-1#1)(2013-1#1)
(CCTS-NMDG)##2##1##(2008-10#2)
(CD) and the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
(CD) and##5##2##(2008-10#3)(2008-7#1)(2011-2#1)
(CD) is a##2##3##(2012-2#1)(2013-8#1)
(CD) is##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
(CD) of##2##2##(2008-10#1)(2008-4#1)
(CD)##32##1##(1990-5#1)(1990-9#1)(1994-5#1)(1995-2#1)(2008-10#16)(2008-4#2)(2008-7#2)(2009-12#1)(2010-12#2)(2011-2#2)(2012-2#2)(2013-8#1)
(CD-R)##2##1##(2008-10#1)(2008-3#1)
(CD11b/CD18)##2##1##(1994-5#1)(2008-11#1)
(CD86)##2##1##(1995-12#1)(2008-11#1)
(CDC##2##1##(2011-2#1)(2012-12#1)
(CDC)##14##1##(1995-12#3)(1995-6#3)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2011-2#1)
(CDR)##2##1##(2008-4#1)(2008-7#1)
(CDV)##2##1##(2008-12#1)(2012-3#1)
(CDs)##5##1##(2008-10#4)(2009-8#1)
(CE) and##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
(CE) is##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
(CE)##43##1##(1997-2#1)(2008-10#33)(2008-4#1)(2008-5#3)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
(CE-UV)##2##1##(2008-10#2)
(CEA)##6##1##(1990-5#1)(1992-6#1)(2008-10#1)(2008-11#2)(2008-8#1)
(CEC) and##2##2##(2008-10#1)(2010-1#1)
(CEC)##4##1##(2008-10#3)(2010-1#1)
(CEF)##4##1##(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
(CELISA) for the detection of antibodies##2##6##(1990-12#2)
(CEUS)##6##1##(2010-12#3)(2012-2#3)
(CF) and flow-injection (FI)##2##4##(2008-10#2)
(CF) and##3##2##(2008-10#2)(2011-3#1)
(CF) in##2##2##(2008-10#1)(2012-3#1)
(CF)##17##1##(1994-2#1)(1997-1#2)(2008-10#8)(2008-5#1)(2009-11#1)(2009-8#1)(2011-3#2)(2012-3#1)
(CFA)##6##1##(2008-10#3)(2008-11#1)(2008-4#1)(2012-2#1)
(CFC) propellants##4##2##(1992-3#2)(1996-1#2)
(CFC)##7##1##(1992-3#2)(1996-1#3)(1996-2#1)(2008-8#1)
(CFCs)##4##1##(1996-1#3)(1996-2#1)
(CFU-GEMM)##2##1##(2008-11#1)(2008-7#1)
(CFU-GM and BFU-E)##2##3##(2008-11#1)(2008-8#1)
(CGE)##2##1##(2008-10#1)(2010-4#1)
(CGH)##4##1##(2008-12#1)(2008-9#1)(2012-3#2)
(CH)##2##1##(2008-10#1)(2012-2#1)
(CHA)##3##1##(1997-2#1)(2008-10#1)(2009-7#1)
(CHB)##2##1##(2009-8#1)(2013-1#1)
(CHD)##7##1##(2008-10#1)(2008-11#1)(2008-6#1)(2010-10#1)(2010-9#1)(2012-2#2)
(CHO##3##1##(2008-11#3)
(CHO) cell line##5##3##(2008-11#5)
(CHO) cell##8##2##(2008-11#6)(2008-7#2)
(CHO) cells producing##2##3##(2008-11#1)(2008-7#1)
(CHO) cells##24##2##(1992-10#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#15)(2008-7#3)
(CHO)##39##1##(1991-6#1)(1992-10#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#25)(2008-7#5)(2013-1#1)(2013-8#1)
(CHX) and##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
(CHX)##6##1##(2008-11#2)(2011-3#1)(2012-3#1)(2013-1#2)
(CI##5##1##(2008-10#1)(2008-11#2)(2012-3#2)
(CI)##13##1##(2008-10#2)(2008-11#1)(2008-8#2)(2009-8#1)(2011-2#5)(2012-12#1)(2012-3#1)
(CID)##3##1##(2008-10#2)(2008-8#1)
(CIM)##2##1##(2012-3#2)
(CIN)##3##1##(1991-2#1)(2010-10#1)(2011-2#1)
(CIP)##2##1##(2011-2#1)(2012-3#1)
(CIS)##2##1##(1994-1#1)(2008-10#1)
(CIs)##2##1##(2008-8#1)(2012-2#1)
(CK##2##1##(2008-9#1)(2013-1#1)
(CL) emission##2##2##(2008-10#2)
(CL) method is proposed for the##4##6##(2008-10#4)
(CL) method is##5##3##(2008-10#5)
(CL) method##12##2##(2008-10#12)
(CL) system is proposed##2##4##(2008-10#2)
(CL) system##8##2##(2008-10#8)
(CL)##68##1##(1991-2#1)(2008-10#61)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2013-8#1)
(CLB)##3##1##(2008-10#3)
(CLD)##3##1##(2008-10#3)
(CLL)##5##1##(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#1)
(CLM)##2##1##(2008-10#1)(2012-3#1)
(CLS)##10##1##(2008-10#9)(2012-3#1)
(CLSM)##3##1##(2008-8#1)(2008-9#1)(2010-8#1)
(CM)##4##1##(2008-10#2)(2008-8#1)(2011-2#1)
(CM-dextran)##2##1##(2008-10#2)
(CMC)##12##1##(2008-10#9)(2008-9#1)(2009-3#1)(2011-2#1)
(CME)##7##1##(2008-1#1)(2008-10#6)
(CMF##2##1##(1990-6#1)(1992-12#1)
(CMI 80 &gt##2##3##(2008-5#2)
(CMI##3##1##(2008-5#3)
(CMI)##4##1##(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
(CML)##5##1##(1990-2#1)(2009-7#2)(2010-11#1)(2011-2#1)
(CMM)##2##1##(2008-7#1)(2012-3#1)
(CMS)##3##1##(2008-10#2)(2008-9#1)
(CMT)##2##1##(1997-3#1)(2011-2#1)
(CMV) promoter##3##2##(1995-12#1)(2008-11#2)
(CMV)##21##1##(1995-12#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-8#3)(2008-9#1)(2012-12#1)(2012-2#1)
(CN IX)##2##2##(2011-2#2)
(CN##5##1##(2008-9#1)(2011-2#4)
(CN)##7##1##(1994-12#1)(2008-10#5)(2008-11#1)
(CNP)##3##1##(1994-11#1)(1994-8#1)(2009-5#1)
(CNS)##27##1##(1991-12#2)(1991-2#1)(1994-2#1)(1996-12#3)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
(CO##3##1##(1991-2#1)(1992-1#1)(1996-12#1)
(CO(2)##2##1##(2008-10#1)(2010-7#1)
(CO)##6##1##(1990-5#1)(1995-2#1)(1996-12#2)(2008-10#1)(2013-1#1)
(COD)##6##1##(2008-10#5)(2008-12#1)
(COOH)##3##1##(2008-10#2)(2011-2#1)
(COPE)##2##1##(1997-4#1)(2008-11#1)
(COX)##3##1##(2008-12#1)(2009-8#1)(2012-2#1)
(COX-2)##3##1##(2011-2#1)(2013-8#2)
(CP) and##6##2##(2008-10#5)(2012-2#1)
(CP) of##3##2##(2008-10#3)
(CP)##46##1##(1994-12#1)(1995-6#1)(2008-10#38)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
(CPA)##6##1##(1993-1#1)(1993-3#1)(1994-6#1)(1997-7#1)(2011-2#1)(2012-3#1)
(CPB)##7##1##(1995-12#1)(2008-10#4)(2012-2#1)(2013-8#1)
(CPC) and##2##2##(2008-10#2)
(CPC)##9##1##(2008-10#8)(2013-8#1)
(CPE) has been##2##3##(2008-10#2)
(CPE) in##2##2##(2008-10#1)(2008-11#1)
(CPE) was##2##2##(2008-10#1)(2011-3#1)
(CPE)##17##1##(2008-10#13)(2008-11#2)(2011-2#1)(2011-3#1)
(CPEs)##2##1##(2008-10#2)
(CPI)##4##1##(1993-3#1)(2008-10#3)
(CPL)##2##1##(2008-10#1)(2008-11#1)
(CPM)##2##1##(2008-11#1)(2008-7#1)
(CPP)##4##1##(1993-6#1)(1994-2#1)(2008-10#1)(2012-2#1)
(CPS)##4##1##(1990-7#2)(2008-10#1)(2008-4#1)
(CPT)##2##1##(1994-8#1)(2008-10#1)
(CPs)##5##1##(2008-10#4)(2012-8#1)
(CQI)##6##1##(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1997-2#1)
(CR) and##2##2##(1991-2#1)(1997-7#1)
(CR)##12##1##(1991-2#1)(1993-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-7#1)(2012-8#1)
(CRC)##6##1##(2008-10#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
(CRE)##6##1##(1993-3#1)(1994-11#1)(1996-2#1)(1997-2#2)(2013-1#1)
(CREB)##5##1##(1996-12#2)(2008-7#1)(2009-3#1)(2012-3#1)
(CRF) is##2##2##(1997-4#1)(2008-1#1)
(CRF)##11##1##(1990-12#1)(1996-12#1)(1997-4#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2011-2#1)
(CRM##4##1##(2008-10#4)
(CRM)##4##1##(2008-10#4)
(CRMs)##9##1##(2008-10#9)
(CRP##2##1##(1990-2#1)(2008-10#1)
(CRS)##4##1##(1991-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
(CRT)##4##1##(2008-10#1)(2010-6#1)(2011-2#2)
(CS) and##2##2##(2008-10#1)(2008-7#1)
(CS) was##2##2##(2008-5#1)(2011-2#1)
(CS)##12##1##(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
(CSA)##3##1##(2008-10#2)(2010-12#1)
(CSD)##2##1##(2008-10#2)
(CSF) was##2##2##(1990-2#1)(2008-9#1)
(CSF)##24##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#2)(1994-8#1)(1996-12#1)(2008-12#1)(2008-7#4)(2008-9#1)(2009-11#1)(2011-2#5)(2012-3#2)(2013-1#1)
(CSIC)##2##1##(2008-10#2)
(CSP)##6##1##(2007-12#1)(2008-10#4)(2011-2#1)
(CSQ)##2##1##(1990-2#1)(2008-12#1)
(CSS)##2##1##(2008-10#1)(2010-6#1)
(CT##2##1##(2008-10#1)(2010-3#1)
(CT(4##2##1##(2008-5#2)
(CT) and magnetic resonance##3##4##(2011-2#2)(2013-7#1)
(CT) and##8##2##(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#3)(2013-7#1)
(CT) scan and##2##3##(2008-7#1)(2013-8#1)
(CT) scan showed##3##3##(2008-7#2)(2010-1#1)
(CT) scan##13##2##(1996-9#1)(2008-12#1)(2008-7#5)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
(CT)##56##1##(1991-3#1)(1994-2#1)(1996-9#1)(2008-10#1)(2008-12#4)(2008-7#10)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#2)(2010-7#1)(2011-2#8)(2011-3#1)(2012-2#10)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
(CTA) and##2##2##(2008-10#1)(2008-12#1)
(CTA)##5##1##(2008-10#3)(2008-12#2)
(CTAB)##15##1##(2008-10#13)(2008-11#2)
(CTC)##7##1##(1997-8#2)(2008-1#1)(2008-10#3)(2008-8#1)
(CTL)##6##1##(1995-12#1)(2008-11#3)(2011-2#1)(2013-1#1)
(CTS)##4##1##(2008-10#1)(2008-9#2)(2010-8#1)
(CUSUM)##2##1##(2008-10#2)
(CV &lt##2##2##(2008-10#2)
(CV##7##1##(2008-10#7)
(CV) of##3##2##(2008-10#2)(2008-8#1)
(CV) was##3##2##(1990-12#1)(2008-10#2)
(CV)##32##1##(1990-12#1)(1993-2#1)(2008-10#29)(2008-8#1)
(CVAAS)##8##1##(2008-10#8)
(CVD)##11##1##(2008-2#1)(2008-6#1)(2010-12#3)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
(CVS = 0##2##3##(2012-2#2)
(CVS)##2##1##(2008-4#1)(2012-2#1)
(CVs)##2##1##(2008-10#1)(2008-9#1)
(CW/TPR##2##1##(2008-10#2)
(CYC)##2##1##(2010-12#1)(2013-1#1)
(CYP)##2##1##(2008-12#1)(2011-1#1)
(Ca##6##1##(1992-9#1)(2008-10#5)
(CaCl(2))##2##1##(2008-10#1)(2009-7#1)
(CaM)##3##1##(1994-3#1)(2008-8#2)
(CaMKII)##4##1##(1997-2#1)(2008-8#1)(2009-7#1)(2012-2#1)
(Cajanus cajan##2##2##(2008-10#1)(2010-10#1)
(Cajanus cajan)##2##2##(2008-10#1)(2010-10#1)
(Cajanus##4##1##(2008-10#2)(2010-10#2)
(California##4##1##(1991-2#1)(1992-2#1)(1995-8#1)(2008-10#1)
(Canada)##2##1##(2012-3#1)(2013-1#1)
(Candida##5##1##(2008-10#3)(2008-5#1)(2013-8#1)
(Canis##2##1##(1996-12#2)
(Capsicum annuum##2##2##(2008-10#2)
(Capsicum annuum) plants##2##3##(2008-10#2)
(Capsicum annuum)##4##2##(2008-10#4)
(Capsicum##6##1##(2008-10#6)
(Carassius auratus##3##2##(2008-5#2)(2008-8#1)
(Carassius auratus)##2##2##(2008-6#2)
(Carassius##5##1##(2008-5#2)(2008-6#2)(2008-8#1)
(Cardiidae)##2##1##(2008-5#2)
(Catharanthus roseus)##2##2##(2008-10#2)
(Cd(2+)) and##2##2##(2008-10#2)
(Cd(2+))##5##1##(2008-10#5)
(Cd) and##3##2##(2008-10#3)
(Cd)##7##1##(2008-10#6)(2008-7#1)
(Ce##2##1##(2008-10#1)(2008-3#1)
(Ce)##2##1##(2011-2#1)(2012-2#1)
(ChAT)##3##1##(1991-9#1)(1993-3#1)(2011-2#1)
(Chelex 100##2##2##(2008-10#2)
(Chelex##3##1##(2008-10#3)
(China)##3##1##(2008-10#1)(2013-8#2)
(Chinese##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
(Chiralpak IA)##2##2##(2008-10#2)
(Chiralpak##4##1##(2008-10#4)
(Chrysanthemum coronarium)##2##2##(2008-10#2)
(Chrysanthemum##4##1##(2008-10#4)
(Citrus reticulata)##2##2##(2008-10#2)
(Citrus sinensis) and##2##3##(2008-10#2)
(Citrus sinensis)##4##2##(2008-10#4)
(Citrus##10##1##(2008-10#10)
(ClYVV)##2##1##(2008-10#2)
(Class III evidence)##2##3##(2012-3#2)
(Class##3##1##(2008-7#1)(2012-3#2)
(Clayton##2##1##(2008-10#2)
(Clinical##2##1##(1994-12#1)(1994-2#1)
(Co##3##1##(2008-10#2)(2008-8#1)
(Co)##4##1##(2008-10#4)
(Coal##2##1##(2008-10#2)
(Coffea arabica)##2##2##(2008-10#2)
(Coleoptera##12##1##(2007-12#2)(2008-12#2)(2008-6#1)(2008-7#3)(2013-8#4)
(Collembola)##2##1##(2008-8#2)
(Compound##7##1##(1994-8#7)
(ConA)##3##1##(1995-12#2)(2008-10#1)
(Copepoda##2##1##(2008-12#1)(2008-5#1)
(Coturnix##4##1##(2008-12#2)(2008-6#2)
(Cr##4##1##(2008-10#3)(2008-12#1)
(Cr(2)O(7)(2-))##2##1##(2008-10#2)
(Cr2) for##2##2##(2008-10#2)
(Cr2)##3##1##(2008-10#3)
(Cronartium ribicola)##2##2##(2008-10#2)
(Crustacea##4##1##(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
(Cs##3##1##(2008-10#3)
(CsA)##6##1##(1991-9#1)(1994-3#1)(1994-8#1)(2008-6#1)(2011-3#1)(2013-1#1)
(Ct)##3##1##(1990-5#1)(1996-3#1)(2008-10#1)
(Cu##8##1##(1993-2#2)(1995-6#1)(2008-10#5)
(Cu(2)O)##2##1##(2008-10#1)(2008-2#1)
(Cu)##7##1##(2008-10#4)(2010-5#1)(2012-2#1)(2013-8#1)
(CuHCF)##2##1##(2008-10#2)
(Cucumis##8##1##(2008-10#8)
(Cucurbita pepo)##3##2##(2008-10#3)
(Cucurbita##4##1##(2008-10#4)
(Cyanex##2##1##(2008-10#2)
(Cyclamen##2##1##(2008-10#2)
(CymMV) and##3##2##(2008-10#3)
(Cys) or##2##2##(2008-10#2)
(Cys)##5##1##(2008-10#5)
(Cyt##2##1##(2008-10#1)(2009-10#1)
(Czech##2##1##(1994-12#1)(2011-2#1)
(D##14##1##(1993-12#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-9#1)
(D) and##3##2##(2008-10#3)
(D) is##3##2##(1991-9#1)(2008-10#2)
(D) to##2##2##(1991-9#1)(2008-10#1)
(D)##18##1##(1991-9#5)(2008-10#13)
(D4T)##2##1##(1991-3#1)(2008-7#1)
(DA) and##4##2##(1992-1#1)(1994-2#1)(1996-2#1)(2008-10#1)
(DA)##22##1##(1992-1#1)(1993-6#1)(1994-2#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#11)(2009-7#1)(2011-1#1)(2013-7#1)
(DAB)##6##1##(1992-3#1)(2008-10#5)
(DAD)##6##1##(2008-10#5)(2011-2#1)
(DAI)##4##1##(2008-10#3)(2011-3#1)
(DAPG)##4##1##(2008-10#4)
(DAPI)##3##1##(2008-10#2)(2008-9#1)
(DAS)##2##1##(2008-10#1)(2008-12#1)
(DASH)##2##1##(2008-9#2)
(DAT)##6##1##(1996-11#1)(1996-12#3)(2008-6#1)(2012-2#1)
(DB18C6)##3##1##(2008-10#3)
(DBBP)##4##1##(2008-10#4)
(DBH)##3##1##(1995-12#1)(1997-3#1)(2013-1#1)
(DBP) as##2##2##(2008-10#2)
(DBP)##10##1##(1992-12#1)(2008-10#8)(2013-8#1)
(DBS(-))##2##1##(2008-10#2)
(DBS)##4##1##(2008-10#2)(2010-12#1)(2012-3#1)
(DBT)##2##1##(2008-10#1)(2008-11#1)
(DC##2##1##(2013-8#2)
(DC) and##2##2##(2008-10#1)(2013-1#1)
(DC)##10##1##(2008-10#4)(2008-11#3)(2008-8#1)(2012-2#1)(2013-1#1)
(DCE)##4##1##(1996-5#1)(2008-10#2)(2010-12#1)
(DCF)##3##1##(2008-10#2)(2008-11#1)
(DCG)##2##1##(1997-1#1)(2008-3#1)
(DCM)##2##1##(2008-10#1)(2011-2#1)
(DD)##4##1##(1994-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
(DDD)##2##1##(2008-11#1)(2012-12#1)
(DDH)##2##1##(2008-10#1)(2013-7#1)
(DDQ)##2##1##(2008-10#2)
(DDS)##2##1##(2010-10#1)(2011-2#1)
(DDTP)##3##1##(2008-10#3)
(DDVP)##2##1##(2008-10#2)
(DE)##2##1##(2008-10#2)
(DE3) cells##3##2##(1994-5#2)(2010-6#1)
(DE3)##6##1##(1994-5#2)(1995-12#1)(2009-3#1)(2010-6#1)(2011-2#1)
(DEHP)##3##1##(2008-10#3)
(DEP)##3##1##(2008-10#2)(2010-5#1)
(DFG)##2##1##(2008-3#1)(2012-2#1)
(DFO) and##3##2##(2008-10#2)(2012-2#1)
(DGT)##3##1##(2008-10#3)
(DH) population##5##2##(2008-10#3)(2008-9#2)
(DHA) in##2##2##(1994-8#1)(2010-1#1)
(DHA)##4##1##(1994-8#1)(2008-11#1)(2008-3#1)(2010-1#1)
(DHI)##2##1##(2008-10#1)(2008-5#1)
(DHS)##2##1##(1997-1#1)(2013-1#1)
(DI)##5##1##(1997-8#1)(2008-10#3)(2008-3#1)
(DIC)##3##1##(2008-10#1)(2009-12#1)(2010-3#1)
(DISC)##3##1##(2008-11#2)(2012-2#1)
(DIT)##2##1##(1992-2#1)(2008-10#1)
(DIV)##2##1##(2008-10#1)(2011-2#1)
(DL)##8##1##(2008-10#8)
(DLBCL)##3##1##(2009-8#3)
(DM##2##1##(2011-2#1)(2012-3#1)
(DM)##10##1##(2008-10#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
(DMA) and##3##2##(2008-10#3)
(DMA) were##3##2##(2008-10#3)
(DMA)##17##1##(1995-11#1)(2008-10#16)
(DME)##4##1##(2008-1#1)(2008-10#1)(2011-2#1)(2011-7#1)
(DMEM)##3##1##(2008-11#1)(2013-1#2)
(DMF) and##5##2##(2008-10#5)
(DMF)##7##1##(2008-10#7)
(DMG)##3##1##(2008-10#3)
(DMIs)##3##1##(2008-10#3)
(DMN)##3##1##(2008-9#1)(2012-3#1)(2013-8#1)
(DMPD)##2##1##(2008-10#2)
(DMPO)##2##1##(1993-6#1)(2008-5#1)
(DMPP)##2##1##(1994-5#1)(1995-11#1)
(DMSA)##4##1##(1992-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
(DMSO) and##2##2##(2008-10#2)
(DMSO)##10##1##(1994-5#1)(1994-8#1)(2008-10#8)
(DMT)##2##1##(1992-3#1)(2008-10#1)
(DNA##8##1##(1992-8#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-8#1)
(DNA)##2##1##(2008-10#2)
(DNP)##2##1##(2008-10#1)(2009-5#1)
(DNT)##2##1##(2008-10#1)(2008-7#1)
(DO)##11##1##(2008-10#6)(2008-11#3)(2008-12#1)(2010-4#1)
(DOC)##2##1##(2008-10#1)(2008-4#1)
(DOE)##5##1##(1994-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
(DOG) and##2##2##(1997-1#1)(2008-8#1)
(DOLT-3)##2##1##(2008-10#2)
(DON and##2##2##(2008-10#2)
(DON##3##1##(2008-10#3)
(DON)##10##1##(2008-10#9)(2013-1#1)
(DOP) as plasticizer##2##3##(2008-10#2)
(DOP)##11##1##(2008-10#10)(2008-2#1)
(DOS) and##2##2##(2008-10#2)
(DOS)##8##1##(2008-10#7)(2012-2#1)
(DOT)##8##1##(1996-11#1)(1996-3#6)(2013-8#1)
(DP)##4##1##(2008-10#2)(2008-2#1)(2009-10#1)
(DPA)##9##1##(2008-10#6)(2008-8#1)(2010-7#1)(2011-2#1)
(DPCSV)##3##1##(2008-10#3)
(DPH)##2##1##(1991-5#1)(2008-10#1)
(DPI)##7##1##(1994-6#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-5#1)
(DPP)##10##1##(2008-10#10)
(DPPC)##4##1##(1991-5#1)(2008-10#3)
(DPPH)##6##1##(2008-10#4)(2008-11#1)(2013-1#1)
(DPTH-gel)##2##1##(2008-10#2)
(DPV) and##3##2##(2008-10#3)
(DPV)##16##1##(2008-10#16)
(DQDC)##2##1##(2008-10#2)
(DR)##2##1##(1996-12#1)(2008-1#1)
(DRE)##2##1##(1994-12#1)(2008-7#1)
(DRG)##7##1##(1991-3#1)(1992-12#1)(1995-2#1)(1997-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
(DRIFT)##3##1##(2008-10#3)
(DRIFTS)##2##1##(2008-10#2)
(DS)##10##1##(1991-1#1)(1996-2#1)(2008-10#4)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
(DSA) of##2##2##(1993-8#1)(2008-11#1)
(DSA)##4##1##(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
(DSO)##2##1##(2008-10#1)(2011-2#1)
(DSP)##4##1##(2008-10#2)(2008-7#1)(2010-6#1)
(DSTD)##4##1##(2008-10#4)
(DT##2##1##(1996-12#2)
(DT)##5##1##(1995-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
(DTA)##2##1##(2008-10#2)
(DTAODC)##2##1##(2008-10#2)
(DTDC) and##2##2##(2008-10#2)
(DTODC)##2##1##(2008-10#2)
(DTs)##2##1##(2011-1#1)(2012-2#1)
(DUM) neurones##2##2##(1994-2#2)
(DW)##3##1##(2008-10#1)(2012-5#1)(2013-1#1)
(DX +##2##2##(2008-10#2)
(DX##3##1##(2008-10#3)
(DX)##2##1##(1990-2#1)(2008-10#1)
(Daucus carota L##2##3##(1994-11#1)(2008-9#1)
(Daucus carota)##3##2##(2008-10#3)
(Daucus##5##1##(1994-11#1)(2008-10#3)(2008-9#1)
(Day##2##1##(2008-11#2)
(De##3##1##(2008-10#2)(2011-2#1)
(Decapoda##2##1##(2007-12#2)
(December##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
(DeltaG degrees##2##2##(2008-10#2)
(Department of Health 1999)##2##4##(2008-11#2)
(Department of Health##4##3##(2008-11#4)
(Diptera##15##1##(2007-12#7)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#3)(2013-8#1)
(Dns-Thr)##2##1##(2008-10#2)
(Dogfish##2##1##(2008-10#2)
(Dysmicoccus spp##3##2##(2008-10#3)
(Dz)##2##1##(2008-10#2)
(E =##2##2##(2009-9#2)
(E and##2##2##(1990-5#1)(1994-11#1)
(E sigma##2##2##(1990-12#1)(1993-12#1)
(E##26##1##(1990-12#1)(1990-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-8#2)(2008-10#13)(2009-7#2)(2009-9#2)(2010-10#1)(2010-5#1)
(E) and##3##2##(1995-6#1)(2008-10#2)
(E)##18##1##(1992-12#1)(1993-6#1)(1995-11#1)(1995-6#1)(2008-10#11)(2008-7#1)(2012-4#1)(2013-1#1)
(E-102)##2##1##(2008-10#2)
(E1 and##2##2##(2008-10#2)
(E1##4##1##(1997-1#1)(2008-10#3)
(E1)##3##1##(1992-9#1)(2008-10#1)(2008-11#1)
(E2)##9##1##(1990-11#1)(1993-1#1)(1995-12#1)(2008-10#2)(2008-11#2)(2010-5#1)(2011-2#1)
(E3)##2##1##(2008-10#1)(2008-11#1)
(E=0##2##1##(2008-10#2)
(EA)##4##1##(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)
(EAA)##3##1##(1994-11#1)(2008-10#1)(2008-11#1)
(EAFD)##3##1##(2008-10#3)
(EASE)##2##1##(2008-11#2)
(EB)##5##1##(2008-10#3)(2008-3#1)(2008-9#1)
(EBV)##10##1##(1993-8#1)(1995-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-9#3)(2010-6#1)(2011-2#1)
(EC 1##11##2##(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#3)(2008-10#4)(2008-8#1)
(EC 2##4##2##(1992-6#1)(1993-12#1)(2008-6#1)(2011-1#1)
(EC 3##17##2##(1990-2#4)(1990-5#2)(1991-12#2)(1994-11#1)(1995-6#1)(1995-8#1)(1996-8#1)(2008-10#4)(2008-9#1)
(EC##40##1##(1990-2#4)(1990-5#2)(1990-7#1)(1991-12#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#2)(1995-2#1)(1995-6#1)(1995-8#4)(1996-8#1)(2008-10#13)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)
(EC(50) values)##2##2##(2008-10#2)
(EC(50)##4##1##(2008-10#4)
(EC(50)) for##2##2##(2008-10#2)
(EC(50))##4##1##(2008-10#4)
(EC) and##2##2##(2008-7#1)(2009-10#1)
(EC) techniques##2##2##(2008-10#1)(2008-5#1)
(EC) was##2##2##(2008-10#2)
(EC)##18##1##(1990-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-4#1)(2013-1#1)(2013-8#2)
(EC50 0##2##2##(1995-11#1)(1997-1#1)
(EC50 =##4##2##(1994-11#1)(1995-11#3)
(EC50##14##1##(1994-11#3)(1995-11#4)(1995-2#5)(1997-1#2)
(ECD) of the##2##3##(1995-11#1)(1995-12#1)
(ECD) of##3##2##(1995-11#1)(1995-12#1)(2008-11#1)
(ECD)##8##1##(1995-11#1)(1995-12#1)(2008-10#5)(2008-11#1)
(ECG)##6##1##(2008-12#1)(2008-3#1)(2010-1#2)(2010-8#1)(2012-12#1)
(ECL) behavior of##2##3##(2008-10#2)
(ECL)##12##1##(2008-10#9)(2010-7#1)(2012-2#2)
(ECV)##2##1##(1993-12#1)(2008-11#1)
(ECoG)##2##1##(2008-11#2)
(ED) at##2##2##(2008-11#1)(2010-8#1)
(ED)##17##1##(1993-3#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-6#2)(2010-10#1)(2010-8#1)(2011-2#2)(2011-9#1)(2012-2#2)(2013-1#1)
(ED50 =##2##2##(1994-3#2)
(EDA)##2##1##(2008-10#2)
(EDNRB)##2##1##(1994-12#2)
(EDTA) and##3##2##(2008-10#2)(2008-5#1)
(EDTA)##14##1##(1994-5#1)(2008-10#9)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
(EDX)##4##1##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
(EDXRF) and##2##2##(2008-10#2)
(EDXRF)##4##1##(2008-10#4)
(EE)##3##1##(2009-11#1)(2013-8#2)
(EEG) and##2##2##(2008-11#1)(2008-4#1)
(EEG)##13##1##(1993-6#1)(2008-11#1)(2008-4#2)(2008-7#4)(2009-8#3)(2010-7#1)(2010-8#1)
(EEM)##2##1##(2008-10#2)
(EF) of##2##2##(2008-10#2)
(EF)##7##1##(2008-10#6)(2013-1#1)
(EF-1alpha)##3##1##(2008-10#3)
(EG)##3##1##(2008-10#3)
(EGF) receptors##2##2##(1992-7#1)(1993-3#1)
(EGF)##12##1##(1990-12#2)(1991-12#1)(1992-7#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
(EGFP)##3##1##(2008-11#2)(2013-8#1)
(EGTA)##2##1##(2008-10#1)(2008-5#1)
(EHMC)##3##1##(2008-10#2)(2008-5#1)
(EHR)##3##1##(2008-7#1)(2010-8#1)(2012-2#1)
(EI)##4##1##(2008-10#3)(2013-1#1)
(EIA)##4##1##(1990-12#1)(1993-11#1)(2008-10#1)(2012-3#1)
(EIS)##7##1##(2008-10#6)(2008-11#1)
(EKFA)##2##1##(2008-10#2)
(ELISA)##41##1##(1990-2#1)(1994-3#2)(1995-11#2)(1996-9#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-4#2)(2011-2#2)(2011-3#1)
(EM) and##2##2##(2008-10#1)(2008-9#1)
(EM)##5##1##(2008-10#1)(2008-9#2)(2012-2#1)(2013-1#1)
(EMF) on##2##2##(2011-2#2)
(EMF)##3##1##(2008-10#1)(2011-2#2)
(EMG)##8##1##(1990-9#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
(EMS)##2##1##(1996-3#1)(2013-1#1)
(ENOX2)##2##1##(2009-9#2)
(EOX)##2##1##(2008-10#2)
(EP) was##2##2##(2008-10#2)
(EP)##4##1##(2008-10#4)
(EPA##2##1##(2008-10#2)
(EPA) and##3##2##(2008-11#1)(2008-9#1)(2010-1#1)
(EPA)##7##1##(1992-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-1#1)
(EPO)##6##1##(2008-1#1)(2008-11#3)(2008-12#1)(2008-8#1)
(EPS I)##2##2##(2008-10#2)
(EPS)##3##1##(2008-10#1)(2011-2#2)
(ER) and##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
(ER)##28##1##(1990-11#1)(1990-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-6#1)(1994-12#2)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#4)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
(ER+)##2##1##(1992-4#1)(2011-1#1)
(ERAS)##2##1##(2013-1#1)(2013-8#1)
(ERE)##2##1##(1992-6#1)(1995-11#1)
(ERG)##2##1##(2008-10#1)(2009-12#1)
(ERK##2##1##(1996-2#1)(2011-2#1)
(ERK)##4##1##(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
(ERP)##2##1##(2008-11#1)(2013-8#1)
(ERT) for the##3##3##(2008-10#1)(2012-12#2)
(ES)##17##1##(1992-12#1)(1994-5#1)(1997-8#1)(2008-11#6)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
(ESC)##4##1##(2008-10#1)(2008-11#2)(2011-2#1)
(ESI)##4##1##(2008-10#3)(2011-2#1)
(ESI-MS)##6##1##(2008-10#4)(2008-5#1)(2011-1#1)
(ESR)##7##1##(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#2)
(ESS)##6##1##(2008-8#2)(2008-9#3)(2012-3#1)
(EST)##7##1##(1995-9#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)
(ESWL)##2##1##(1990-11#1)(1994-5#1)
(ET) is##2##2##(2008-7#1)(2012-3#1)
(ET)##9##1##(1995-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#1)
(ET-1)##5##1##(1991-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)
(ETAAS) determination of##3##3##(2008-10#3)
(ETAAS) is##6##2##(2008-10#6)
(ETAAS) method##3##2##(2008-10#3)
(ETAAS)##39##1##(2008-10#39)
(ETH##2##1##(2008-10#2)
(EU)##4##1##(1996-1#1)(2008-10#2)(2013-8#1)
(EUS)##4##1##(2008-2#1)(2010-12#1)(2013-1#2)
(EV71)##2##1##(2008-12#1)(2011-3#1)
(EVA)##2##1##(2008-10#2)
(EXAFS)##3##1##(2008-10#1)(2008-9#1)(2010-11#1)
(Eastern##2##1##(2011-2#1)(2013-8#1)
(Eating##2##1##(2011-2#1)(2013-1#1)
(Eds##3##1##(2008-12#3)
(Endo)##2##1##(1992-3#2)
(Endoloop)##3##1##(1995-1#3)
(England)##2##1##(2009-6#1)(2012-12#1)
(English##2##1##(2008-10#1)(2012-12#1)
(Epo)##4##1##(2008-11#4)
(Erwinia##2##1##(2008-10#2)
(Erwinia)##2##1##(1993-3#1)(2008-10#1)
(Escherichia##2##1##(2009-8#1)(2012-2#1)
(Eth)##3##1##(2008-1#1)(2008-10#2)
(Eu##2##1##(2008-10#1)(2008-11#1)
(European##2##1##(2008-11#1)(2012-3#1)
(Exam##3##1##(2012-2#3)
(Experiment 1)##2##2##(2013-1#2)
(Experiment 2)##2##2##(2013-1#2)
(Experiment##6##1##(2008-5#1)(2009-10#1)(2013-1#4)
(Experiments##2##1##(2008-5#1)(2011-1#1)
(F = 3##2##3##(2009-11#2)
(F = 4##2##3##(1990-2#1)(2010-9#1)
(F =##8##2##(1990-2#2)(2008-11#1)(2008-5#1)(2009-11#2)(2010-9#2)
(F##16##1##(1990-2#2)(2008-10#7)(2008-11#2)(2008-5#1)(2009-11#2)(2010-9#2)
(F(ST)##2##1##(2008-10#1)(2012-3#1)
(F) to##2##2##(2008-10#1)(2010-4#1)
(F)##3##1##(2008-10#2)(2010-4#1)
(F-actin)##3##1##(1994-6#1)(2008-11#1)(2011-2#1)
(F1 and F3)##2##3##(2008-11#1)(2009-2#1)
(F1##4##1##(2008-10#2)(2008-11#1)(2009-2#1)
(F1)##2##1##(2008-12#1)(2009-2#1)
(F2##2##1##(2008-10#1)(2008-12#1)
(FA) and##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
(FA)##16##1##(1992-2#1)(1993-6#1)(1997-3#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
(FAAS) after##2##2##(2008-10#2)
(FAAS) and##7##2##(2008-10#7)
(FAAS) at##2##2##(2008-10#2)
(FAAS)##56##1##(2008-10#56)
(FACE)##4##1##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
(FAD)##2##1##(1992-12#1)(2008-10#1)
(FAME)##5##1##(2008-10#4)(2009-3#1)
(FAP)##3##1##(2008-10#1)(2009-12#2)
(FC))##2##1##(2008-11#2)
(FCM)##3##1##(2008-10#1)(2009-6#1)(2010-1#1)
(FCPBSQ)##2##1##(2008-10#2)
(FCS)##3##1##(2008-11#2)(2008-7#1)
(FD)##2##1##(2008-7#2)
(FDG)##2##1##(2008-1#1)(2011-2#1)
(FET)##2##1##(2008-10#2)
(FF)##3##1##(1996-12#1)(2010-1#1)(2013-8#1)
(FFA)##2##1##(2008-10#2)
(FFE)##2##1##(2008-4#1)(2008-5#1)
(FFS)##10##1##(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-2#5)
(FGF)##2##1##(1994-11#1)(2008-11#1)
(FHB)##14##1##(2008-10#12)(2011-10#1)(2012-3#1)
(FHP)##2##1##(2009-7#1)(2010-9#1)
(FI) analysis##7##2##(2008-10#7)
(FI) method was developed##2##4##(2008-10#2)
(FI) method##9##2##(2008-10#9)
(FI) system##16##2##(2008-10#16)
(FI)##68##1##(2008-10#68)
(FI-CV-AAS)##2##1##(2008-10#2)
(FI-ICP-MS)##2##1##(2008-10#2)
(FIA) method was##2##3##(2008-10#2)
(FIA) method##3##2##(2008-10#3)
(FIA)##54##1##(2008-10#53)(2008-11#1)
(FID)##5##1##(2008-10#5)
(FIP)##2##1##(2008-10#2)
(FITC)##3##1##(2008-10#2)(2008-4#1)
(FL)##5##1##(2008-10#3)(2010-11#2)
(FLC)##2##1##(2008-3#1)(2012-3#1)
(FM)##5##1##(2008-10#2)(2009-11#1)(2010-12#1)(2012-2#1)
(FMLP)##2##1##(1993-6#1)(2006-6#1)
(FMOC)##3##1##(2008-10#3)
(FMS)##2##1##(2011-2#2)
(FN)##7##1##(1990-8#1)(1993-12#1)(1994-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-5#1)
(FN=31)##2##1##(2008-12#2)
(FNAB)##5##1##(1997-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
(FNAC)##3##1##(1990-6#1)(2008-7#1)(2012-12#1)
(FOC##3##1##(2008-10#3)
(FP)##4##1##(1996-1#1)(1996-2#2)(2008-9#1)
(FPCA)##2##1##(2008-10#1)(2010-7#1)
(FPP)##2##1##(1990-2#1)(1993-9#1)
(FR)##3##1##(2008-1#1)(2008-10#1)(2013-8#1)
(FRET)##7##1##(2008-10#3)(2008-4#2)(2008-9#1)(2010-12#1)
(FS)##3##1##(2008-10#2)(2011-2#1)
(FSM)##3##1##(2008-1#3)
(FSS)##2##1##(2012-3#2)
(FT)##3##1##(1991-11#1)(2012-12#1)(2013-1#1)
(FT-IR)##10##1##(1997-2#1)(2008-10#8)(2013-1#1)
(FT-Raman)##3##1##(2008-10#3)
(FTIR) spectroscopy##6##2##(2008-10#4)(2008-5#1)(2008-8#1)
(FTIR)##24##1##(2008-10#21)(2008-3#1)(2008-5#1)(2008-8#1)
(FTLE##4##1##(2008-10#4)
(FVC)##4##1##(1997-3#1)(2008-1#1)(2011-2#1)(2012-2#1)
(FY)##3##1##(1992-12#1)(1993-12#1)(2012-2#1)
(Fabricius)##2##1##(2007-12#1)(2008-6#1)
(Family##2##1##(2008-10#1)(2013-1#1)
(Fasciola hepatica)##2##2##(2008-12#2)
(Fe##3##1##(2008-10#2)(2010-11#1)
(Fe)##4##1##(1996-2#1)(2008-10#3)
(Fe- and Mn-TCPP(g)s)##2##3##(2008-10#2)
(Fe- and##3##2##(2008-10#3)
(Felis##3##1##(1996-12#3)
(Ficedula##2##1##(2008-8#1)(2008-9#1)
(Fig##8##1##(1994-3#3)(2008-10#2)(2008-9#3)
(Figure 1)##2##2##(1995-3#1)(2012-3#1)
(First##2##1##(2011-3#1)(2013-1#1)
(France) and##2##2##(2008-10#1)(2008-5#1)
(France)##9##1##(1990-8#1)(2008-10#7)(2008-5#1)
(Friedman test##2##2##(2010-9#2)
(Fuhrmann##2##1##(2011-2#2)
(Fusarium##6##1##(2008-10#6)
(G protein)##2##2##(1993-6#1)(1993-8#1)
(G##10##1##(1993-6#1)(1993-8#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)
(G(ST) = 0##7##3##(2008-10#7)
(G(ST))##3##1##(2008-10#3)
(G)##10##1##(2008-10#4)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-10#1)
(G1##2##1##(2008-10#1)(2008-11#1)
(G418)##2##1##(1993-2#1)(2008-11#1)
(G6PD)##2##1##(1991-6#1)(2007-12#1)
(GA) to##2##2##(2008-3#1)(2008-9#1)
(GA)##14##1##(2008-10#9)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)
(GAC)##2##1##(1992-5#1)(2013-1#1)
(GAD67##2##1##(1996-12#1)(2013-8#1)
(GAP)##2##1##(1995-11#1)(2013-1#1)
(GAPDH)##3##1##(1992-6#1)(1993-6#1)(1994-5#1)
(GAS)##2##1##(2008-11#1)(2008-8#1)
(GAU)##2##1##(2008-7#2)
(GBP)##2##1##(1992-6#1)(2008-10#1)
(GBW##5##1##(2008-10#5)
(GC##5##1##(2008-10#4)(2008-11#1)
(GC) analysis##2##2##(2008-10#2)
(GC) and##2##2##(1997-1#1)(2008-10#1)
(GC)##42##1##(1990-9#1)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#34)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
(GC-ECD)##4##1##(2008-10#4)
(GC-MS) in##3##2##(2008-10#3)
(GC-MS)##24##1##(1990-5#1)(1997-1#1)(2008-10#21)(2008-5#1)
(GC/MS)##6##1##(1995-11#1)(2008-10#5)
(GC/MS/MS)##2##1##(2008-10#2)
(GCS)##5##1##(1991-2#1)(2011-2#2)(2013-1#2)
(GCV)##2##1##(2008-10#1)(2013-2#1)
(GCs)##2##1##(2008-11#1)(2012-2#1)
(GD)##5##1##(2008-10#4)(2010-2#1)
(GDC)##4##1##(1995-11#1)(1996-9#1)(1997-6#1)(2008-7#1)
(GE##2##1##(1990-2#1)(2010-3#1)
(GEP)##3##1##(2008-10#1)(2009-8#1)(2010-1#1)
(GFAAS) and##2##2##(2008-10#2)
(GFAAS)##29##1##(2008-10#29)
(GFAP) and##2##2##(1997-3#1)(2011-2#1)
(GFAP)##5##1##(1990-7#1)(1997-2#1)(1997-3#1)(2008-11#1)(2011-2#1)
(GFP##2##1##(2008-11#2)
(GGGTCAT)n##2##1##(1993-12#2)
(GGT)##2##1##(2006-6#1)(2009-6#1)
(GI)##7##1##(1991-2#1)(1994-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#1)
(GIST)##2##1##(2009-7#1)(2012-3#1)
(GL)##5##1##(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)
(GLP-1)##3##1##(1995-8#1)(1996-2#1)(2012-3#1)
(GLRaV-5)##2##1##(2008-10#2)
(GLS)##5##1##(2008-10#5)
(GLUT4)##3##1##(1994-11#2)(2008-11#1)
(GM)##4##1##(2008-11#1)(2008-8#1)(2009-7#1)(2012-4#1)
(GO) and##2##2##(1997-7#1)(2008-9#1)
(GO) terms##2##2##(2010-4#1)(2010-5#1)
(GO)##9##1##(1997-7#1)(2008-10#1)(2008-9#2)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
(GP) and##2##2##(1995-3#1)(2011-2#1)
(GP)##3##1##(1993-3#1)(1995-3#1)(2011-2#1)
(GPC)##4##1##(2008-10#1)(2008-12#2)(2010-2#1)
(GPI)##6##1##(1990-8#1)(1995-3#1)(1996-3#1)(1997-6#1)(2008-9#1)(2012-2#1)
(GPIIb-IIIa)##2##1##(2006-6#2)
(GPS)##2##1##(2008-10#1)(2011-2#1)
(GPT)##2##1##(2008-11#2)
(GPX)##2##1##(2008-10#1)(2010-5#1)
(GR)##4##1##(1994-2#1)(2008-11#1)(2010-2#1)(2011-2#1)
(GS##2##1##(1993-12#1)(2011-2#1)
(GS) in the##2##3##(2008-11#1)(2010-8#1)
(GS) was##2##2##(2008-7#1)(2010-11#1)
(GS)##8##1##(2008-10#2)(2008-11#2)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)
(GSC)##2##1##(2008-10#1)(2011-2#1)
(GSM)##2##1##(2008-9#1)(2009-6#1)
(GSSG)##3##1##(2008-10#2)(2008-11#1)
(GST)##6##1##(1990-2#1)(1993-2#1)(1994-2#1)(2010-5#1)(2011-10#1)(2012-3#1)
(GT)##3##1##(2006-6#1)(2008-5#2)
(GTC)##2##1##(1997-8#2)
(GTCGAC)##2##1##(1991-9#2)
(GTP gamma S##2##3##(1991-6#1)(1992-8#1)
(GTP gamma S)##3##3##(1993-8#1)(1994-3#1)(1995-8#1)
(GTP gamma##5##2##(1991-6#1)(1992-8#1)(1993-8#1)(1994-3#1)(1995-8#1)
(GUS) activity##3##2##(2008-10#3)
(GUS)##7##1##(2008-10#7)
(GV)##2##1##(2008-9#1)(2013-1#1)
(Gallus##3##1##(2008-12#2)(2008-5#1)
(Gd and Tb) separation##2##4##(2008-10#2)
(Gd)##3##1##(1997-8#2)(2012-2#1)
(GenBank accession number##2##3##(2008-10#1)(2008-9#1)
(GenBank accession##3##2##(2008-10#2)(2008-9#1)
(General##2##1##(2008-3#1)(2011-3#1)
(Germany)##3##1##(2008-10#1)(2008-11#2)
(Globodera rostochiensis and G##3##4##(2008-10#3)
(Glx)3##2##1##(1992-12#2)
(Glycine Max)##2##2##(2010-11#2)
(Glycine max)##8##2##(2008-10#7)(2008-11#1)
(Glycine##11##1##(1990-5#1)(2008-10#7)(2008-11#1)(2010-11#2)
(GnRH) in##2##2##(1992-6#1)(2009-6#1)
(GnRH)##7##1##(1992-6#1)(1994-2#1)(1994-8#2)(1995-11#1)(1996-2#1)(2009-6#1)
(Gossypium##5##1##(1993-3#1)(2008-10#3)(2008-9#1)
(Gr##5##1##(2008-10#5)
(Grade##2##1##(2008-10#1)(2009-12#1)
(Green##2##1##(2008-11#1)(2012-2#1)
(Group I##3##2##(1992-11#1)(2008-10#1)(2012-2#1)
(Group##11##1##(1990-5#1)(1992-11#2)(2008-10#1)(2010-12#3)(2010-7#3)(2012-2#1)
(Gs##2##1##(1994-2#1)(1995-6#1)
(H = 0##2##3##(2008-10#2)
(H =##3##2##(1995-2#1)(2008-10#2)
(H##9##1##(1991-2#1)(1995-2#1)(2008-10#6)(2011-2#1)
(H(+)##2##1##(2008-10#2)
(H(+)-ISE)##2##1##(2008-10#2)
(H(0)##2##1##(2008-10#2)
(H(T) = 0##2##3##(2008-10#2)
(H(o)##2##1##(2008-10#2)
(H)##13##1##(1993-12#1)(1995-6#1)(2008-10#11)
(H-7)##4##1##(1993-8#1)(1995-8#1)(1996-12#1)(1997-1#1)
(H-H)##2##1##(2008-12#1)(2010-4#1)
(H1N1) 2009##5##2##(2011-2#4)(2013-1#1)
(H1N1)##10##1##(1990-5#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
(HA) and##4##2##(2008-10#3)(2008-9#1)
(HA) are##2##2##(2008-10#1)(2013-8#1)
(HA) is##3##2##(2009-7#1)(2010-8#1)(2011-2#1)
(HA)##27##1##(1990-5#1)(1993-12#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
(HAA)##2##1##(1997-2#1)(2008-10#1)
(HAD)##2##1##(2008-10#1)(2011-1#1)
(HAI-RTP)##2##1##(2008-10#2)
(HAP)##2##1##(2008-10#1)(2012-2#1)
(HAV)##4##1##(2007-12#1)(2008-7#1)(2009-5#1)(2010-8#1)
(HB)##3##1##(2008-10#1)(2008-8#2)
(HBD-2 and IL-6) and##2##4##(2011-3#2)
(HBS)##3##1##(2008-10#2)(2010-5#1)
(HBV)##20##1##(1990-8#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#4)(2012-3#1)(2013-1#4)(2013-8#1)
(HBr)##2##1##(1996-12#1)(2008-10#1)
(HBsAg)##9##1##(1994-11#2)(1995-2#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
(HC) of##2##2##(2008-10#2)
(HC)##10##1##(2008-10#6)(2008-11#2)(2012-3#1)(2013-8#1)
(HC-Pro) of##2##2##(2008-10#2)
(HC-Pro)##3##1##(2008-10#3)
(HCA)##2##1##(2009-8#1)(2013-1#1)
(HCB)##3##1##(2008-10#2)(2008-11#1)
(HCC)##15##1##(1993-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#2)(2010-12#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
(HCFA)##17##1##(1992-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#4)(1997-2#5)(1997-3#1)
(HCQ)##2##1##(2012-3#2)
(HCT)##3##1##(2008-10#1)(2008-8#1)(2010-11#1)
(HCV)##16##1##(2008-1#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#2)(2011-2#1)(2013-1#6)(2013-8#1)
(HCl or##2##2##(2008-10#2)
(HCl##6##1##(1991-5#1)(2008-10#4)(2008-3#1)
(HCl)##6##1##(1996-12#1)(2008-10#5)
(HD##2##1##(2008-10#1)(2011-2#1)
(HD)##9##1##(1996-8#1)(2008-1#1)(2008-10#2)(2008-9#1)(2011-10#1)(2011-2#2)(2011-8#1)
(HDC)##3##1##(1997-1#1)(2008-10#1)(2008-11#1)
(HDL)##8##1##(1993-6#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-6#2)(2010-4#1)(2011-1#1)
(HDPE)##2##1##(2008-10#1)(2009-3#1)
(HDR)##2##1##(2009-11#1)(2013-1#1)
(HEBB)##2##1##(2008-11#2)
(HEI)##3##1##(2008-11#1)(2011-2#1)(2012-3#1)
(HEK293) were##2##2##(2008-11#2)
(HEK293)##3##1##(2008-11#3)
(HEL)##3##1##(1990-2#1)(2008-10#1)(2008-11#1)
(HF)##8##1##(1996-12#1)(2008-10#4)(2011-2#1)(2013-8#2)
(HFA)##2##1##(1996-2#1)(2008-10#1)
(HFS)##2##1##(2008-12#1)(2008-7#1)
(HG) or##2##2##(2008-10#1)(2011-2#1)
(HG) were##2##2##(2008-10#2)
(HG)##13##1##(2008-10#11)(2008-11#1)(2011-2#1)
(HG-AFS)##5##1##(2008-10#5)
(HGAAS)##5##1##(2008-10#5)
(HGAFS)##4##1##(2008-10#4)
(HI)##3##1##(1996-12#1)(2008-3#1)(2008-5#1)
(HIV)##26##1##(1990-2#1)(1990-6#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
(HIV-1)##10##1##(1992-12#1)(1995-2#1)(2008-11#1)(2008-2#4)(2009-8#1)(2010-11#1)(2011-2#1)
(HL)##5##1##(1990-12#1)(1991-2#2)(1992-12#1)(2008-10#1)
(HLA)##5##1##(1990-12#1)(2008-10#4)
(HLB)##2##1##(2008-10#2)
(HM)##6##1##(1990-6#1)(2008-10#4)(2008-9#1)
(HMB)##2##1##(2008-10#1)(2008-5#1)
(HMC-1)##2##1##(2011-2#2)
(HMDE)##14##1##(2008-10#14)
(HMF)##3##1##(2008-10#1)(2008-11#1)(2011-1#1)
(HMG)##3##1##(1990-3#1)(1995-8#1)(1997-6#1)
(HMM)##3##1##(1996-12#1)(1997-2#1)(2009-7#1)
(HMOs) have##2##2##(1991-3#1)(1993-3#1)
(HMOs)##9##1##(1991-1#1)(1991-3#3)(1993-3#2)(1994-1#1)(1994-3#1)(1996-3#1)
(HMP)##2##1##(1993-3#1)(2008-10#1)
(HMX)##4##1##(2008-10#4)
(HN) gene##2##2##(2008-11#1)(2008-9#1)
(HN)##3##1##(2008-11#1)(2008-9#2)
(HNO(3)) and##3##2##(2008-10#3)
(HNSCC)##2##1##(1997-7#1)(2013-8#1)
(HO##2##1##(1995-2#1)(2008-5#1)
(HO)##4##1##(1991-6#1)(1994-5#1)(1994-8#1)(2012-2#1)
(HOMA-IR)##5##1##(2010-4#1)(2011-1#2)(2012-3#1)(2013-8#1)
(HP) and##2##2##(1991-5#1)(1996-12#1)
(HP)##5##1##(1991-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
(HP-beta-CD)##2##1##(2008-10#2)
(HPA) axis##4##2##(1994-2#1)(1996-12#1)(2008-11#1)(2013-1#1)
(HPA)##5##1##(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
(HPB)##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
(HPI)##2##1##(1992-12#1)(2008-7#1)
(HPLC) and##8##2##(2008-10#6)(2008-12#1)(2009-8#1)
(HPLC) method for##2##3##(2008-10#1)(2008-5#1)
(HPLC) method is described for the##2##6##(2008-10#2)
(HPLC) method##10##2##(2008-10#9)(2008-5#1)
(HPLC)##89##1##(1992-11#1)(1995-3#1)(1997-2#1)(2008-10#75)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)
(HPLC-ICPMS)##2##1##(2008-10#2)
(HPSAM) for##3##2##(2008-10#3)
(HPSAM)##11##1##(2008-10#11)
(HPTP)##2##1##(1996-12#2)
(HPV)##5##1##(1992-3#1)(1994-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
(HQ)##2##1##(2008-10#2)
(HR##4##1##(1995-6#1)(1996-5#1)(2008-10#1)(2013-1#1)
(HR) and##6##2##(1992-12#1)(2011-2#1)(2013-1#1)(2013-8#3)
(HR) on##2##2##(2008-10#2)
(HR)##30##1##(1992-12#1)(2008-10#15)(2008-11#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#5)
(HRQOL)##2##1##(2008-7#1)(2011-2#1)
(HRV) in##2##2##(2008-12#1)(2013-8#1)
(HRV)##7##1##(2008-12#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#2)
(HS) and##3##2##(2008-10#3)
(HS)##12##1##(1996-2#1)(2008-10#11)
(HS-SPME)##5##1##(2008-10#5)
(HSA) and##5##2##(2008-10#5)
(HSA) was##3##2##(2008-10#3)
(HSA)##20##1##(1997-2#1)(1997-6#1)(2008-10#17)(2011-2#1)
(HSC)##3##1##(1991-2#1)(2008-10#1)(2008-11#1)
(HSCT)##2##1##(2010-11#1)(2012-12#1)
(HSDB)##2##1##(1995-11#2)
(HSG)##2##1##(1993-1#1)(2011-2#1)
(HSGC)##2##1##(2008-10#2)
(HSP70)##4##1##(1993-9#1)(2008-10#1)(2008-7#1)(2010-5#1)
(HSV)##3##1##(1996-12#1)(2008-11#1)(2008-6#1)
(HT)##4##1##(2008-11#1)(2008-8#2)(2013-8#1)
(HTLV-I)##2##1##(2008-11#1)(2008-4#1)
(HTS)##3##1##(2008-10#1)(2012-2#1)(2013-8#1)
(HU)##4##1##(1994-11#1)(1997-8#1)(2008-10#1)(2012-3#1)
(HUVEC)##9##1##(1994-8#1)(1997-1#1)(2008-11#1)(2008-8#2)(2008-9#2)(2010-3#1)(2012-2#1)
(HV)##3##1##(2008-10#1)(2010-6#1)(2011-2#1)
(HX)##3##1##(1990-5#1)(2008-10#1)(2008-11#1)
(Hb) was##3##2##(1990-2#1)(1991-2#1)(1995-11#1)
(Hb)##11##1##(1990-2#1)(1990-8#1)(1991-2#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-8#1)
(Health##2##1##(1991-2#1)(1995-12#1)
(Helianthus annuus L##2##3##(2008-10#2)
(Helianthus annuus)##3##2##(2008-10#3)
(Helianthus##7##1##(2008-10#5)(2008-8#2)
(Hemiptera##6##1##(2007-12#1)(2008-12#1)(2008-7#2)(2013-8#2)
(Hexapeptide##2##1##(1992-12#2)
(Hg##4##1##(2008-10#4)
(Hg)##3##1##(2006-6#1)(2008-10#1)(2008-7#1)
(Hi)##2##1##(2008-5#2)
(High Fivetrade mark)##2##3##(2008-11#1)(2008-7#1)
(High Fivetrade##3##2##(2008-11#1)(2008-7#2)
(High##7##1##(1990-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)
(His)##2##1##(1994-11#1)(2008-10#1)
(Ho)##2##1##(2008-5#1)(2013-8#1)
(Homoptera##3##1##(2007-12#1)(2008-12#1)(2008-9#1)
(Hordeum vulgare)##2##2##(2008-10#2)
(Hordeum##7##1##(1995-6#1)(2008-10#4)(2008-11#1)(2008-9#1)
(HpD)##3##1##(1990-6#1)(2008-7#1)(2008-9#1)
(Hs = 0##4##3##(2008-10#4)
(Hx)##3##1##(2008-10#3)
(Hymenoptera##6##1##(1992-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
(I and II)##5##3##(2007-12#1)(2008-10#3)(2011-2#1)
(I##15##1##(2007-12#1)(2008-10#13)(2011-2#1)
(I(d))##2##1##(2008-10#2)
(I) and##10##2##(1991-5#2)(2008-10#7)(2009-3#1)
(I) as an##2##3##(2008-10#2)
(I) as electroactive material##2##4##(2008-10#2)
(I) as##6##2##(2008-10#6)
(I) was##4##2##(1994-12#1)(2008-10#3)
(I) with##4##2##(2008-10#4)
(I)##63##1##(1991-2#2)(1991-5#7)(1992-8#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-5#1)(2008-10#39)(2008-8#3)(2009-3#1)(2010-11#6)
(I-IV)##2##1##(2008-10#1)(2010-4#1)
(I-V)##3##1##(2008-10#2)(2010-7#1)
(I/R)##2##1##(2010-1#1)(2010-5#1)
(IA)##2##1##(2010-3#1)(2011-2#1)
(IAA) and##2##2##(1994-12#1)(2008-12#1)
(IAA) in##2##2##(2008-10#1)(2008-9#1)
(IAA)##9##1##(1994-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)
(IB-DCTFM)##2##1##(2010-8#2)
(IBD)##6##1##(2008-11#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
(IBS) is a##2##3##(2013-1#2)
(IBS)##3##1##(2013-1#3)
(IC _ 50##4##3##(2008-5#4)
(IC##5##1##(2008-10#1)(2008-5#4)
(IC(50)##3##1##(2008-5#1)(2008-8#1)(2008-9#1)
(IC)##16##1##(2008-10#15)(2011-2#1)
(IC-RT-PCR)##2##1##(2008-10#2)
(IC50 = 1 nM)##2##4##(1995-8#2)
(IC50 = 3##2##3##(1995-8#1)(1997-4#1)
(IC50 =##9##2##(1993-8#1)(1994-8#1)(1995-8#5)(1996-2#1)(1997-4#1)
(IC50##30##1##(1992-12#1)(1992-6#1)(1993-8#1)(1994-11#3)(1994-8#1)(1995-2#4)(1995-8#5)(1996-2#1)(1997-4#1)(2008-5#10)(2009-9#2)
(ICA)##9##1##(1994-12#2)(1997-3#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
(ICAM-1) on##2##2##(1995-2#1)(2009-10#1)
(ICAM-1)##3##1##(1995-2#1)(2009-10#1)(2010-1#1)
(ICC)##4##1##(2010-12#2)(2011-2#1)(2013-1#1)
(ICD-10##3##1##(2012-12#3)
(ICF)##4##1##(2008-3#2)(2011-2#1)(2012-12#1)
(ICH)##3##1##(2008-12#1)(2011-2#1)(2012-3#1)
(ICP)##9##1##(1992-3#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-7#3)(2010-5#1)(2011-2#1)
(ICP-AES and##2##2##(2008-10#2)
(ICP-AES) and##3##2##(2008-10#3)
(ICP-AES) method##2##2##(2008-10#2)
(ICP-AES) was##2##2##(2008-10#2)
(ICP-AES)##29##1##(2008-10#29)
(ICP-MS) and##3##2##(2008-10#3)
(ICP-MS) was##2##2##(2008-10#2)
(ICP-MS)##37##1##(2008-10#37)
(ICP-OES) after##3##2##(2008-10#2)(2011-2#1)
(ICP-OES)##18##1##(2008-10#17)(2011-2#1)
(ICP-TOFMS)##2##1##(2008-10#2)
(ICR)##2##1##(2008-10#1)(2013-1#1)
(ICSI)##3##1##(1996-9#1)(2012-3#2)
(ICU)##4##1##(1992-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
(ICUs)##3##1##(1991-2#1)(2011-2#1)(2013-1#1)
(ICs)##2##1##(2008-10#1)(2008-8#1)
(ID)##6##1##(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2012-2#1)
(IDA)##3##1##(2008-10#3)
(IDH)##2##1##(2008-9#1)(2012-5#1)
(IDHR)##2##1##(2008-10#2)
(IE) and##2##2##(2011-2#1)(2013-1#1)
(IE)##5##1##(1995-12#1)(2006-6#1)(2011-2#2)(2013-1#1)
(IEC)##4##1##(2008-10#2)(2008-12#1)(2011-2#1)
(IEG)##2##1##(2008-11#2)
(IES)##2##1##(2008-1#1)(2012-3#1)
(IFA)##3##1##(1995-12#1)(2008-12#1)(2008-9#1)
(IFN)##5##1##(1992-2#1)(1993-2#1)(2008-11#1)(2008-5#1)(2009-8#1)
(IFN-alpha)##3##1##(1994-3#1)(2009-5#1)(2009-7#1)
(IFN-gamma)##5##1##(1996-12#1)(2008-11#3)(2008-7#1)
(IGBP)##2##1##(1996-12#2)
(IGF-I) and transferrin##2##3##(2008-11#2)
(IGF-I) and##4##2##(2008-11#3)(2008-9#1)
(IGF-I)##12##1##(1991-12#1)(1995-11#1)(1995-12#1)(1997-1#1)(2008-11#4)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
(IGS)##7##1##(2008-10#7)
(IHA)##2##1##(2008-7#1)(2008-9#1)
(IHC) for##2##2##(2008-10#1)(2011-2#1)
(IHC)##4##1##(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)
(II &gt##2##2##(2012-3#2)
(II##6##1##(1991-5#1)(2008-10#2)(2012-3#3)
(II) and mercury (II)##3##4##(2008-10#3)
(II) and##10##2##(2008-10#10)
(II) complex formation with two poly(acrylic acids) of high molecular weight (Mw=2##2##12##(2008-10#2)
(II) complex##3##2##(2008-10#3)
(II) from##3##2##(2008-10#3)
(II) in the##2##3##(2008-10#2)
(II) in##7##2##(2008-10#7)
(II) ion##4##2##(2008-10#4)
(II) ion-selective##2##2##(2008-10#2)
(II) ions##4##2##(2008-10#4)
(II) or##2##2##(2008-10#2)
(II) selective membrane##2##3##(2008-10#2)
(II) were##3##2##(2008-10#3)
(II) with##6##2##(2008-10#6)
(II)##81##1##(1991-5#1)(1993-8#1)(1996-12#1)(2008-10#73)(2008-7#2)(2008-8#1)(2009-9#1)(2012-3#1)
(II)]##2##1##(1990-3#1)(1994-6#1)
(III and IV)##2##3##(2008-10#1)(2011-2#1)
(III) and thallium##3##3##(2008-10#3)
(III) and##13##2##(2008-10#13)
(III) are##3##2##(2008-10#3)
(III) can be##2##3##(2008-10#2)
(III) in##4##2##(2008-10#4)
(III) is##5##2##(2008-10#5)
(III)##67##1##(2008-10#66)(2008-8#1)
(IL-1 beta##2##2##(1993-8#1)(1996-12#1)
(IL-1 beta)##3##2##(1995-12#1)(1996-12#2)
(IL-1##8##1##(1993-8#1)(1995-12#1)(1996-12#4)(1996-2#1)(2008-8#1)
(IL-1)##4##1##(1990-12#1)(1990-5#1)(1995-2#1)(1995-6#1)
(IL-10)##2##1##(1993-8#1)(2009-12#1)
(IL-12)##3##1##(2008-11#3)
(IL-2) and##3##2##(1994-11#1)(2008-11#1)(2008-5#1)
(IL-2)##10##1##(1991-6#1)(1994-11#1)(1994-5#1)(1995-12#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)
(IL-5)##2##1##(1992-3#1)(1995-6#1)
(IL-6)##11##1##(1990-5#1)(1994-3#1)(1995-12#2)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-3#1)
(IL-8) and##2##2##(2009-12#1)(2013-1#1)
(IL-8)##6##1##(1994-11#1)(1994-5#1)(2008-10#1)(2009-10#1)(2009-12#1)(2013-1#1)
(IL-9)##3##1##(2008-4#1)(2011-2#2)
(ILI)##4##1##(2008-10#3)(2011-9#1)
(ILS)##4##1##(2008-10#3)(2008-3#1)
(IM)##6##1##(2008-10#2)(2010-11#1)(2010-4#1)(2011-1#1)(2012-3#1)
(IMAC)##3##1##(1997-2#1)(2011-2#1)(2012-3#1)
(IMRT)##3##1##(2008-2#1)(2011-2#1)(2013-1#1)
(IMS)##11##1##(2008-10#8)(2008-5#1)(2010-9#1)(2012-2#1)
(IMSC)##2##1##(2008-7#2)
(IN)##4##1##(2008-10#3)(2011-3#1)
(INH)##4##1##(1997-2#1)(2008-1#1)(2008-10#2)
(IO)##2##1##(2008-10#2)
(IOP)##5##1##(2008-2#1)(2011-2#3)(2013-1#1)
(IP)##2##1##(2008-7#1)(2012-3#1)
(IP-RPHPLC)##2##1##(2008-10#2)
(IPD)##2##1##(2008-10#1)(2008-7#1)
(IPL)##2##1##(2008-11#1)(2010-6#1)
(IPS)##2##1##(2008-10#1)(2013-1#1)
(IPTG)##3##1##(1993-8#1)(2008-11#1)(2010-6#1)
(IR)##18##1##(1990-5#1)(1995-8#1)(1997-4#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
(IRES)##3##1##(1997-8#1)(2008-10#1)(2008-11#1)
(IRI)##3##1##(1991-2#1)(1994-12#1)(2012-3#1)
(IS)##11##1##(1990-6#1)(1995-12#1)(2008-10#7)(2012-3#1)(2012-5#1)
(ISE) array##2##2##(2008-10#2)
(ISE)##16##1##(1991-2#1)(2008-10#15)
(ISR)##7##1##(2008-10#6)(2011-2#1)
(IT)##2##1##(2008-10#1)(2008-9#1)
(ITS 1-5##2##2##(2008-10#2)
(ITS##3##1##(2008-10#3)
(ITS) of ribosomal##2##3##(2008-10#1)(2008-8#1)
(ITS) of##3##2##(2008-10#2)(2008-8#1)
(ITS)##41##1##(2008-10#38)(2008-11#1)(2008-8#1)(2008-9#1)
(ITS1 and ITS2) and##2##4##(2008-10#1)(2008-12#1)
(ITS1 and ITS2)##3##3##(2008-10#2)(2008-12#1)
(ITS1##7##1##(2008-10#5)(2008-12#1)(2012-2#1)
(ITS1-5##2##1##(2008-10#2)
(ITT) is##2##2##(2008-10#1)(2012-3#1)
(IV) and##3##2##(2008-10#3)
(IV) in the presence of##2##5##(2008-10#2)
(IV) in the##3##3##(2008-10#3)
(IV) in##4##2##(2008-10#4)
(IV) with##2##2##(2008-10#2)
(IV)##29##1##(1990-12#3)(1990-5#1)(1993-1#1)(1994-12#2)(2008-10#21)(2012-12#1)
(IVC)##3##1##(2008-7#1)(2011-2#1)(2013-1#1)
(IVS-2-654 C--&gt##4##2##(2008-8#4)
(Ig)##4##1##(1996-12#1)(2008-10#1)(2008-11#1)(2013-7#1)
(IgA)##5##1##(2008-10#2)(2008-11#1)(2010-4#1)(2013-8#1)
(IgG##3##1##(1991-2#1)(2008-10#2)
(IgG)##5##1##(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)
(IgM)##2##1##(1994-3#1)(2008-7#1)
(Insecta##6##1##(2007-12#1)(2008-12#2)(2008-7#2)(2008-8#1)
(International##4##1##(1991-12#1)(1992-12#1)(2008-10#2)
(Ipomoea batatas)##3##2##(2008-10#3)
(Ipomoea##4##1##(2008-10#4)
(Isoptera##2##1##(2007-12#1)(2013-8#1)
(Italian##3##1##(1992-2#1)(2008-10#1)(2011-10#1)
(Italy) and##2##2##(1990-8#1)(2008-10#1)
(Italy)##10##1##(1990-8#1)(1991-2#1)(1993-2#1)(1994-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
(IκB##2##1##(2012-2#1)(2012-3#1)
(J##9##1##(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#6)
(J2)##5##1##(2008-10#5)
(JH)##5##1##(1991-6#1)(1992-6#1)(1995-11#1)(2012-2#2)
(JNK##2##1##(2009-6#1)(2011-2#1)
(Japan)##4##1##(1996-6#1)(1996-9#1)(2008-11#1)(2008-2#1)
(Japanese##4##1##(2008-10#2)(2013-1#2)
(Java##2##1##(1996-9#1)(2008-10#1)
(Johnson and##2##2##(1990-10#1)(2008-10#1)
(July and August)##2##3##(2008-10#2)
(K(+))##3##1##(2008-10#2)(2010-7#1)
(K(D##3##1##(2008-10#3)
(K(MLA))##4##1##(2008-10#4)
(K(a))##2##1##(2008-10#2)
(K(app))##2##1##(2008-10#1)(2008-8#1)
(K(ex##2##1##(2008-10#2)
(K(ex))##7##1##(2008-10#7)
(K(p)) of##2##2##(2008-10#2)
(K) and##3##2##(1995-8#1)(2008-10#2)
(K)##9##1##(1995-8#1)(2008-10#8)
(K+)##2##1##(1994-3#1)(2008-7#1)
(KCl)##2##1##(2008-10#2)
(KD##2##1##(1993-6#1)(1994-2#1)
(KD)##3##1##(1990-8#1)(2011-2#1)(2012-2#1)
(KE)##2##1##(2008-12#1)(2013-1#1)
(KF)##4##1##(1996-5#1)(2008-10#3)
(KI)##3##1##(2008-10#3)
(KIE)##2##1##(1995-6#1)(2009-6#1)
(KOH)##3##1##(2008-10#3)
(KP)##2##1##(2009-6#1)(2010-8#1)
(KS)##4##1##(1991-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
(KSA)##3##1##(2008-7#1)(2013-1#2)
(KT) is##2##2##(2008-11#1)(2013-1#1)
(KT)##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
(KTP)##4##1##(2008-10#1)(2008-3#3)
(KTZ##3##1##(2008-5#3)
(KTpClPB) as##2##2##(2008-10#2)
(KTpClPB)##4##1##(2008-10#4)
(Kampo)##2##1##(2008-10#2)
(Kd =##11##2##(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#3)
(Kd##14##1##(1990-11#2)(1990-12#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#3)
(Kd)##2##1##(1990-11#1)(1993-6#1)
(Kelex-100)##2##1##(2008-10#2)
(Ki =##6##2##(1991-5#2)(1994-8#1)(1995-8#2)(1996-2#1)
(Ki##9##1##(1991-5#3)(1994-6#2)(1994-8#1)(1995-8#2)(1996-2#1)
(Ki)##2##1##(2008-7#1)(2009-3#1)
(Km =##2##2##(1990-11#1)(1996-12#1)
(Km##4##1##(1990-11#1)(1992-3#1)(1995-6#1)(1996-12#1)
(Kmy1##3##1##(1997-8#3)
(L##14##1##(2008-10#6)(2008-11#1)(2008-12#4)(2010-8#1)(2011-2#1)(2012-2#1)
(L(1))##2##1##(2008-10#2)
(L(2))##3##1##(2008-10#2)(2008-5#1)
(L) and##3##2##(2008-10#3)
(L)##21##1##(1993-12#1)(1995-2#1)(1995-6#1)(2008-10#13)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
(L1)##2##1##(1995-2#1)(2008-10#1)
(LA##2##1##(1995-12#1)(2009-8#1)
(LA)##6##1##(2008-10#3)(2013-1#3)
(LAD)##3##1##(2013-1#3)
(LAV)##4##1##(2008-10#4)
(LAVH)##3##1##(1994-2#1)(1995-1#1)(1995-3#1)
(LB)##10##1##(2008-10#6)(2008-11#2)(2008-8#1)(2009-6#1)
(LC)##24##1##(1996-12#1)(2008-10#21)(2008-4#1)(2011-2#1)
(LC-ESI-MS)##2##1##(2008-10#2)
(LC-MS/MS)##4##1##(2008-10#3)(2011-3#1)
(LCA)##2##1##(2008-11#1)(2010-10#1)
(LCM)##4##1##(2008-11#2)(2009-8#1)(2010-12#1)
(LCR)##3##1##(2008-10#1)(2008-8#2)
(LCs)##4##1##(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#1)
(LD)##13##1##(1994-8#1)(2008-10#4)(2008-12#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-5#1)(2012-5#1)
(LD50##2##1##(2008-10#1)(2008-11#1)
(LDA)##8##1##(2008-10#8)
(LDH)##11##1##(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(2008-10#2)(2008-11#3)(2010-4#1)(2011-2#1)
(LDL)##23##1##(1991-5#2)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-6#1)(1995-8#3)(1996-2#1)(2008-10#3)(2008-3#1)(2008-6#4)(2008-9#1)(2010-12#1)(2011-1#1)
(LDLR)##3##1##(1995-2#1)(2012-2#1)(2013-1#1)
(LDR)##4##1##(2008-10#2)(2008-7#1)(2013-1#1)
(LE)##4##1##(1995-8#1)(2008-10#2)(2013-1#1)
(LEA3 and LEA14)##2##3##(2008-10#2)
(LED) and##3##2##(2008-10#3)
(LED) as##3##2##(2008-10#3)
(LED)##10##1##(2008-10#9)(2008-11#1)
(LF)##3##1##(2008-10#1)(2008-4#1)(2013-8#1)
(LFD)##2##1##(2008-10#2)
(LFP) and##2##2##(1990-5#1)(2008-11#1)
(LFP)##3##1##(1990-5#1)(2008-11#2)
(LG)##3##1##(2007-12#1)(2008-10#1)(2008-5#1)
(LH) and##2##2##(2008-4#1)(2010-3#1)
(LH)##6##1##(1996-2#1)(2008-4#1)(2009-10#1)(2010-3#1)(2011-1#1)(2013-8#1)
(LI)##2##1##(2008-10#1)(2008-4#1)
(LIBS)##4##1##(2008-10#4)
(LIF) is##2##2##(2008-10#1)(2008-11#1)
(LIF)##15##1##(1991-12#1)(1995-11#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)
(LLETZ) as##2##2##(1994-2#1)(2012-3#1)
(LLME)##2##1##(2008-10#1)(2008-11#1)
(LLNA)##3##1##(2008-10#2)(2008-5#1)
(LM) and##2##2##(1990-6#1)(2008-10#1)
(LM)##4##1##(1990-6#1)(2008-10#1)(2011-1#1)(2011-2#1)
(LMS)##3##1##(2008-10#2)(2012-2#1)
(LN)##2##1##(1995-1#1)(2008-10#1)
(LNT) model##3##2##(2008-7#1)(2013-1#2)
(LNT)##8##1##(2008-12#1)(2008-7#3)(2008-9#2)(2013-1#2)
(LOD##4##1##(2008-10#4)
(LOD) and##8##2##(2008-10#8)
(LOD) of##11##2##(2008-10#11)
(LOD) were##3##2##(2008-10#3)
(LOD)##54##1##(2008-10#53)(2010-5#1)
(LODs) of##2##2##(2008-10#2)
(LODs)##9##1##(2008-10#9)
(LOH)##3##1##(2011-2#1)(2012-3#2)
(LOQ) and##2##2##(2008-10#2)
(LOQ) is##2##2##(2008-10#2)
(LOQ) were##3##2##(2008-10#3)
(LOQ)##16##1##(2008-10#16)
(LOS)##6##1##(1991-12#1)(1993-12#3)(1994-3#1)(1995-12#1)
(LOV)##3##1##(2008-10#2)(2011-1#1)
(LOX)##2##1##(2008-6#1)(2011-10#1)
(LP)##9##1##(1994-5#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2011-2#1)
(LPA)##2##1##(2011-2#1)(2013-1#1)
(LPG)##3##1##(2008-10#3)
(LPP)##2##1##(1994-8#1)(2008-5#1)
(LPS##2##1##(1995-12#2)
(LPS)##9##1##(1994-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)
(LRR)##3##1##(2008-8#1)(2009-6#1)(2009-8#1)
(LRS)##2##1##(2008-9#1)(2011-2#1)
(LS##2##1##(2008-10#2)
(LS) method##2##2##(2008-10#2)
(LS)##5##1##(1993-12#1)(2008-10#2)(2008-11#1)(2012-3#1)
(LSC)##3##1##(2008-9#2)(2013-1#1)
(LSCSV)##2##1##(2008-10#2)
(LSD)##2##1##(2008-10#2)
(LT)##4##1##(1995-2#1)(2008-11#1)(2011-3#1)(2013-1#1)
(LTP) in the##3##3##(1990-5#1)(2008-7#2)
(LTP)##12##1##(1990-5#1)(1993-12#2)(1995-12#2)(1995-2#1)(1997-2#1)(2008-11#1)(2008-7#4)
(LTR##2##1##(1991-2#1)(2008-9#1)
(LV)##5##1##(1991-3#1)(2008-10#1)(2011-2#2)(2012-2#1)
(LVS)##2##1##(1990-11#1)(2012-2#1)
(La(3+)##2##1##(2008-10#2)
(Lamiales##2##1##(2013-8#2)
(Laureth 4)##2##2##(2008-5#2)
(Lee et al##2##3##(1994-8#1)(2008-7#1)
(Lee##3##1##(1994-8#1)(2008-10#1)(2008-7#1)
(Leguminosae)##2##1##(2008-10#1)(2008-11#1)
(Lemna pausicostata L##2##3##(2008-10#2)
(Lens##2##1##(2008-10#2)
(Lepidoptera##7##1##(1990-8#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
(Leptosphaeria maculans)##2##2##(2008-10#2)
(Leu)##2##1##(2008-8#2)
(Lewisites)##2##1##(2008-11#2)
(Li##2##1##(2008-10#2)
(Li(0##4##1##(2008-10#4)
(Linn)##2##1##(2008-10#1)(2008-12#1)
(Lolium perenne)##5##2##(2008-10#5)
(Lolium##6##1##(2008-10#6)
(Low##2##1##(2008-3#1)(2012-7#1)
(Lycopersicon esculentum)##9##2##(2008-10#9)
(Lycopersicon##10##1##(2008-10#10)
(M (age) =##2##3##(2009-7#1)(2010-7#1)
(M =##3##2##(2008-12#1)(2009-7#1)(2012-3#1)
(M##22##1##(1991-2#1)(1992-6#1)(1993-2#1)(1994-5#1)(2008-10#7)(2008-11#3)(2008-12#1)(2009-7#2)(2010-1#1)(2010-7#1)(2011-2#2)(2012-3#1)
(M(1) =##2##2##(2008-12#2)
(M(1)##3##1##(2008-10#1)(2008-12#2)
(M(2+))##2##1##(2008-10#2)
(M(r)##3##1##(1994-11#2)(1996-6#1)
(M)##9##1##(1990-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-12#1)
(M=mol dm(-3))##2##2##(2008-10#2)
(MA) and##2##2##(1996-12#1)(2008-12#1)
(MA)##13##1##(1994-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-12#1)(2009-7#1)(2013-1#2)(2013-8#1)
(MAA)##4##1##(1994-11#1)(2008-10#3)
(MAC)##2##1##(2008-10#1)(2012-3#1)
(MAE) for##3##2##(2008-10#2)(2008-11#1)
(MAE)##6##1##(2008-10#5)(2008-11#1)
(MALDI-TOF MS)##2##2##(2008-10#1)(2008-11#1)
(MAP) kinase##3##2##(1996-2#2)(2008-7#1)
(MAP)##13##1##(1993-8#1)(1995-8#1)(1996-12#1)(1996-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
(MAPK)##10##1##(1995-2#2)(1996-2#1)(2008-10#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
(MAR)##3##1##(1992-10#1)(2008-10#1)(2008-8#1)
(MAT)##2##1##(1992-6#1)(2008-10#1)
(MAb)##7##1##(1996-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)
(MB) and##3##2##(2008-10#3)
(MB) in##3##2##(2008-10#3)
(MB)##19##1##(1996-2#1)(2008-10#18)
(MBC)##2##1##(1991-5#1)(2008-10#1)
(MBP)##8##1##(1992-9#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#3)(2008-8#1)
(MBT)##2##1##(2008-10#1)(2008-11#1)
(MC)##6##1##(2008-10#2)(2008-11#3)(2011-2#1)
(MCA)##4##1##(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
(MCF7)##2##1##(1995-6#1)(2011-2#1)
(MCFA)##3##1##(2008-10#2)(2011-1#1)
(MCFIA)##2##1##(2008-10#2)
(MCH)##2##1##(1995-12#1)(2008-7#1)
(MCL)##5##1##(2008-10#1)(2008-9#2)(2009-1#1)(2009-8#1)
(MCP-1)##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
(MCR)##2##1##(1990-11#1)(2008-11#1)
(MCR-ALS)##2##1##(2008-10#2)
(MCS)##4##1##(1993-12#1)(2008-11#1)(2010-3#1)(2011-2#1)
(MCTSI)##2##1##(2009-8#2)
(MCs) are##2##2##(2008-11#1)(2012-12#1)
(MCs)##4##1##(1992-6#1)(2008-11#1)(2010-5#1)(2012-12#1)
(MD) simulation##2##2##(1992-9#1)(2012-2#1)
(MD)##11##1##(1992-9#1)(1996-12#1)(1996-5#1)(2008-10#5)(2008-5#1)(2012-2#2)
(MDA-MB-231)##2##1##(2012-2#1)(2013-1#1)
(MDCT)##5##1##(2008-12#1)(2011-2#3)(2012-2#1)
(MDD)##5##1##(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#2)
(MDI) aerosols##2##2##(1992-3#2)
(MDI)##13##1##(1992-3#5)(1996-1#2)(1996-2#2)(1997-1#1)(1997-2#2)(2012-4#1)
(MDL)##7##1##(1996-2#1)(2008-10#6)
(MDP)##2##1##(2008-10#1)(2008-11#1)
(MDR)##6##1##(1993-3#1)(2008-11#1)(2010-2#1)(2011-2#2)(2013-8#1)
(MDS##3##1##(2008-11#1)(2008-7#1)(2009-11#1)
(MDS)##8##1##(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)(2011-2#1)
(MEDPAR)##4##1##(1992-12#1)(1993-12#2)(1995-2#1)
(MEG)##2##1##(1996-2#1)(2008-10#1)
(MEI)##2##1##(1992-2#1)(1994-1#1)
(MEK)##2##1##(1995-2#1)(2008-10#1)
(MEP)##3##1##(2008-11#1)(2008-7#1)(2011-2#1)
(MF)##3##1##(2008-10#1)(2010-9#1)(2013-1#1)
(MFA)##2##1##(2008-10#1)(2009-3#1)
(MFC)##2##1##(2008-5#1)(2010-9#1)
(MFS)##7##1##(1994-1#3)(1994-12#1)(1995-12#1)(1996-3#1)(2008-10#1)
(MG)##10##1##(1996-2#1)(2007-12#1)(2008-10#7)(2008-11#1)
(MHC) class I##4##3##(1995-12#1)(1995-2#1)(1997-9#1)(2008-1#1)
(MHC)##8##1##(1990-5#1)(1995-12#1)(1995-2#1)(1997-9#3)(2008-1#1)(2008-9#1)
(MHO)##2##1##(2013-1#2)
(MHPG)##2##1##(1993-1#1)(2008-10#1)
(MI) and##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
(MI)##9##1##(2008-10#2)(2008-11#1)(2009-5#1)(2010-1#1)(2013-1#1)(2013-8#3)
(MIBK)##4##1##(2008-10#4)
(MIC =##2##2##(2008-12#2)
(MIC##6##1##(2008-10#1)(2008-12#3)(2008-5#1)(2012-3#1)
(MIC)##10##1##(2008-5#3)(2008-7#1)(2009-6#1)(2010-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
(MIF)##2##1##(2008-10#1)(2009-6#1)
(MIP)##4##1##(1995-11#1)(2008-10#3)
(MK-801)##2##1##(1996-12#1)(2012-2#1)
(ML)##2##1##(2008-9#1)(2013-8#1)
(MLD)##2##1##(1997-3#1)(2008-10#1)
(MLPNN)##2##1##(2010-8#2)
(MLR)##7##1##(2008-10#7)
(MM)##7##1##(1990-12#1)(2008-10#4)(2010-12#1)(2012-12#1)
(MMA)##11##1##(1995-11#2)(2008-10#7)(2008-12#1)(2010-8#1)
(MMC)##6##1##(1992-12#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-11#2)
(MMD##2##1##(1994-12#1)(1995-3#1)
(MMD)##4##1##(1993-2#1)(1995-3#1)(2008-10#1)(2013-1#1)
(MMP)##2##1##(2011-2#1)(2013-8#1)
(MMP-2)##4##1##(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#1)
(MMSE)##5##1##(2008-7#5)
(MNC)##2##1##(2008-5#1)(2010-6#1)
(MNCs)##4##1##(2008-11#3)(2008-9#1)
(MO)##6##1##(1995-12#1)(2008-10#2)(2008-3#2)(2013-8#1)
(MOF)##4##1##(1992-5#1)(1997-1#1)(2008-10#1)(2009-7#1)
(MP) and##2##2##(2008-10#1)(2008-9#1)
(MP)##7##1##(2008-10#4)(2008-9#3)
(MPA)##6##1##(1993-1#2)(1995-11#1)(2008-10#3)
(MPC) of the##2##3##(1996-2#1)(2008-10#1)
(MPC)##4##1##(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#1)
(MPCs)##2##1##(2008-11#1)(2011-2#1)
(MPD)##2##1##(2012-2#2)
(MPLS)##2##1##(2008-10#2)
(MPM)##5##1##(2008-10#5)
(MPOA)##2##1##(1992-12#1)(1994-2#1)
(MPP+)##5##1##(1990-5#2)(1990-7#1)(1995-11#1)(1996-12#1)
(MPS)##2##1##(2008-10#2)
(MPTP)##5##1##(1990-7#1)(1995-11#1)(1996-12#1)(2008-7#1)(2012-2#1)
(MR) findings of##2##3##(2011-2#1)(2012-2#1)
(MR)##14##1##(1990-11#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-2#1)(2008-10#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#2)
(MRA)##4##1##(2008-10#2)(2008-12#1)(2008-7#1)
(MRI) of##4##2##(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
(MRI)##47##1##(1992-3#1)(1995-5#1)(1996-11#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#7)(2008-9#2)(2009-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-9#3)(2011-2#2)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
(MRP)##3##1##(2008-11#2)(2010-1#1)
(MS##3##1##(2008-10#2)(2008-11#1)
(MS) as##2##2##(2008-10#1)(2008-4#1)
(MS) medium##2##2##(2008-10#1)(2008-8#1)
(MS)##27##1##(1995-12#2)(1996-12#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#2)(2010-2#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)
(MSA)##2##1##(2008-11#1)(2012-3#1)
(MSC)##3##1##(2008-10#2)(2012-12#1)
(MSFA)##4##1##(2008-10#4)
(MSFIA)##5##1##(2008-10#5)
(MSM)##6##1##(2008-10#1)(2008-3#1)(2009-5#3)(2011-2#1)
(MSP)##2##1##(2008-10#1)(2008-8#1)
(MT) and##3##2##(1990-5#1)(2008-10#2)
(MT) in##2##2##(2008-11#1)(2013-7#1)
(MT) isoforms##2##2##(2008-10#2)
(MT)##20##1##(1990-5#1)(1993-12#1)(1994-11#1)(2008-10#13)(2008-11#2)(2013-1#1)(2013-7#1)
(MTB)##3##1##(2008-10#3)
(MTEC1)##2##1##(2008-8#2)
(MTS)##2##1##(1994-12#1)(2007-9#1)
(MTSC4)##2##1##(2008-8#2)
(MTT##2##1##(2008-11#2)
(MTT)##2##1##(2008-11#1)(2012-3#1)
(MTs)##7##1##(2008-10#2)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-7#1)
(MV)##3##1##(2008-10#1)(2012-2#1)(2013-8#1)
(MVC)##3##1##(2008-10#1)(2010-6#1)(2013-8#1)
(MVD)##3##1##(2010-12#1)(2011-2#2)
(MW approximately##2##2##(1992-12#2)
(MW##8##1##(1992-12#2)(2008-10#3)(2008-11#2)(2008-5#1)
(MW) and##2##2##(2008-10#1)(2011-2#1)
(MW) irradiation##2##2##(2008-10#2)
(MW)##9##1##(2008-10#7)(2011-2#1)(2013-8#1)
(MW=348)##2##1##(2008-10#2)
(MY(2-)+H(2)Y(2-))##2##1##(2008-10#2)
(Macaca fascicularis)##2##2##(1994-3#1)(2012-2#1)
(Macaca##3##1##(1994-3#1)(1997-2#1)(2012-2#1)
(Mallophaga)##2##1##(2007-12#1)(2011-2#1)
(Malpighiales##2##1##(2013-8#2)
(Malus domestica)##3##2##(2008-10#2)(2009-8#1)
(Malus##6##1##(2008-10#3)(2008-9#2)(2009-8#1)
(Malvales##2##1##(2013-8#2)
(Mangifera indica)##2##2##(2008-10#2)
(Maryland##2##1##(2008-10#2)
(May and##2##2##(2008-10#1)(2013-8#1)
(Mb)##6##1##(1994-5#1)(2008-10#3)(2009-10#1)(2010-4#1)
(MbSA and##3##2##(2011-2#3)
(MeHg)##2##1##(2008-10#1)(2008-7#1)
(MeOH)##6##1##(2008-10#4)(2008-11#1)(2008-12#1)
(MeSH)##2##1##(1992-12#1)(2008-6#1)
(Medicago sativa) plants##2##3##(2008-10#2)
(Medicago sativa)##4##2##(2008-10#4)
(Medicago##7##1##(2008-10#4)(2008-11#2)(2012-3#1)
(Medical##2##1##(1991-2#1)(2008-9#1)
(Medicare##4##1##(1992-2#1)(1994-1#1)(1994-12#1)(1996-2#1)
(Meloidogyne incognita)##3##2##(2008-10#3)
(Meloidogyne##4##1##(2008-10#4)
(Merck##3##1##(2008-10#2)(2008-5#1)
(Met352----Arg)##3##1##(1990-8#3)
(Metavir##2##1##(2013-1#2)
(Method##3##1##(2008-10#3)
(Microsporidia##2##1##(2011-2#2)
(Mn##2##1##(2008-10#2)
(Mn)##5##1##(2008-10#5)
(Mollusca##2##1##(2008-11#1)(2008-7#1)
(Mr##7##1##(1990-5#4)(1991-5#1)(1992-3#2)
(Multi-TCCCN)##2##1##(2008-10#2)
(Musa##2##1##(2008-1#1)(2008-10#1)
(Myrmicinae)##2##1##(2007-12#2)
(Mytilus##2##1##(1995-8#1)(2008-10#1)
(Myzus persicae)##4##2##(2008-10#3)(2012-2#1)
(N = 20)##2##3##(2008-10#2)
(N = 9)##2##3##(1994-8#1)(1995-5#1)
(N =##41##2##(1994-11#1)(1994-8#1)(1995-5#2)(1996-2#3)(2008-1#1)(2008-10#9)(2008-12#1)(2008-9#1)(2009-4#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
(N##49##1##(1991-12#1)(1994-11#1)(1994-8#1)(1995-5#2)(1995-8#1)(1996-2#4)(2008-1#1)(2008-10#12)(2008-12#1)(2008-9#3)(2009-4#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
(N(2)##2##1##(2008-10#2)
(N) and##2##2##(2008-10#1)(2012-5#1)
(N)##18##1##(1990-6#1)(2008-10#9)(2008-2#1)(2011-2#1)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#2)(2013-8#1)
(N-acetyl-5-methoxytryptamine)##2##1##(1990-5#1)(1995-11#1)
(N5) haploinsufficient] mice (drinking water studies)##2##6##(2008-9#2)
(N5) haploinsufficient] mice##3##3##(2008-9#3)
(N=10)##2##1##(2008-10#1)(2009-10#1)
(N=11)##3##1##(2008-10#3)
(N=76)##2##1##(2008-12#1)(2008-4#1)
(NA) and##4##2##(2008-10#3)(2011-1#1)
(NA) is a##2##3##(2008-10#1)(2010-11#1)
(NA)##14##1##(2008-10#8)(2008-11#3)(2008-9#1)(2010-11#1)(2011-1#1)
(NAA##2##1##(2008-12#1)(2013-1#1)
(NAA)##4##1##(2008-10#3)(2008-12#1)
(NAC) and##2##2##(1996-5#1)(2008-10#1)
(NAC)##6##1##(1996-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
(NAD(+))##2##1##(2008-10#1)(2008-11#1)
(NAD)##2##1##(2008-10#1)(2008-7#1)
(NADH)##6##1##(2008-10#3)(2008-11#1)(2011-2#1)(2013-1#1)
(NAS)##4##1##(1993-6#1)(2008-9#1)(2009-10#1)(2011-2#1)
(NAT)##4##1##(1994-2#1)(1995-11#1)(2011-2#2)
(NAT2)##3##1##(1993-3#2)(1995-9#1)
(NB)##5##1##(1991-9#1)(2008-10#3)(2013-8#1)
(NB1-RGB)##2##1##(2008-11#2)
(NBD-PE)##2##1##(2008-10#1)(2008-7#1)
(NBM)##4##1##(1991-12#1)(1993-3#1)(2008-8#1)(2008-9#1)
(NBS SRM 85b)##2##3##(2008-10#2)
(NBS SRM##3##2##(2008-10#3)
(NBS) and##2##2##(2008-10#1)(2008-8#1)
(NBS)##10##1##(1992-6#1)(1995-2#1)(2008-10#6)(2008-8#1)(2010-10#1)
(NC)##6##1##(2008-10#4)(2008-11#1)(2009-7#1)
(NCCLS)##2##1##(2008-5#2)
(NCI)##5##1##(1997-1#1)(1997-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
(NCR)##2##1##(2008-4#1)(2008-9#1)
(NCT)##2##1##(2008-10#1)(2013-1#1)
(ND)##3##1##(1995-2#1)(2008-10#2)
(NDV)##3##1##(2008-11#1)(2008-5#1)(2013-8#1)
(NE)##7##1##(1993-3#1)(1996-12#1)(2008-10#3)(2008-7#1)(2011-2#1)
(NED)##4##1##(2008-10#3)(2013-1#1)
(NEM)##3##1##(1990-2#1)(1995-8#1)(2008-11#1)
(NER)##3##1##(2008-11#3)
(NF)##3##1##(1996-3#1)(1997-2#1)(2008-12#1)
(NF-κB)##4##1##(2012-2#1)(2012-3#2)(2013-1#1)
(NFP)##2##1##(2008-10#1)(2008-11#1)
(NGF) and##2##2##(1991-12#1)(2008-11#1)
(NGF)##14##1##(1991-12#2)(1996-12#2)(1996-2#1)(1997-2#1)(2008-11#5)(2008-5#1)(2010-8#2)
(NH(4))(2)CO(3)##2##1##(2008-10#2)
(NH(4))(2)SO(4)##8##1##(2008-10#7)(2008-8#1)
(NHL)##3##1##(1990-12#1)(2013-1#2)
(NHS)##6##1##(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
(NI)##3##1##(1993-2#1)(2011-2#1)(2013-8#1)
(NICE)##3##1##(2012-12#1)(2012-3#1)(2013-8#1)
(NIES No##2##2##(2008-10#2)
(NIES##3##1##(2008-10#3)
(NIF)##2##1##(2008-10#1)(2008-3#1)
(NIH##2##1##(1993-8#1)(1997-1#1)
(NIR) spectroscopy##5##2##(2008-10#5)
(NIR)##17##1##(2008-10#15)(2010-1#1)(2012-2#1)
(NIST SRM##4##2##(2008-10#4)
(NIST##10##1##(2008-10#10)
(NIST) and##2##2##(2008-10#2)
(NIST)##3##1##(2008-10#3)
(NKK CRM No##3##3##(2008-10#3)
(NL)##2##1##(2008-7#1)(2008-8#1)
(NLM)##4##1##(1991-2#1)(1992-1#1)(1994-12#1)(1995-11#1)
(NM)##2##1##(1995-5#1)(2010-12#1)
(NMDA)##11##1##(1992-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#2)(2008-11#1)(2008-8#1)(2012-2#1)
(NMDAR)##2##1##(2009-7#1)(2012-2#1)
(NMF)##2##1##(2008-10#2)
(NMR)##13##1##(1992-4#1)(1993-3#1)(1996-2#1)(2008-10#5)(2008-12#2)(2008-4#1)(2009-11#1)(2010-8#1)
(NN)##4##1##(1996-2#1)(2008-10#2)(2010-8#1)
(NNK)##2##1##(1990-6#1)(1993-11#1)
(NO##3##1##(2008-10#3)
(NO(2) 0##2##2##(2008-10#2)
(NO2 +##2##2##(1996-12#2)
(NOE)##2##1##(1993-8#1)(2008-11#1)
(NOR)##6##1##(2008-10#4)(2008-12#1)(2013-8#1)
(NP)##5##1##(2008-10#2)(2008-8#1)(2010-1#1)(2013-8#1)
(NPC) is##2##2##(1990-8#1)(2011-2#1)
(NPC)##6##1##(1990-8#1)(2008-9#1)(2011-2#3)(2013-1#1)
(NPCs)##3##1##(2008-7#1)(2011-2#1)(2013-7#1)
(NPD)##2##1##(2008-12#1)(2008-9#1)
(NPOE)##6##1##(2008-10#6)
(NPRS)##2##1##(2008-12#2)
(NQS)##3##1##(2008-10#3)
(NR)##7##1##(1993-6#1)(2008-10#4)(2008-11#1)(2008-12#1)
(NS)##5##1##(2008-10#3)(2009-1#1)(2012-2#1)
(NSAID)##3##1##(2008-10#1)(2008-11#1)(2012-3#1)
(NSAIDs)##7##1##(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-1#1)(2012-2#1)
(NSC)##3##1##(2009-10#1)(2011-2#1)(2012-5#1)
(NSCLC)##7##1##(1993-2#1)(2008-10#1)(2008-11#3)(2013-1#1)(2013-8#1)
(NSS)##2##1##(2008-10#1)(2008-9#1)
(NSTEMI)##3##1##(2011-2#2)(2012-3#1)
(NSs)##3##1##(2008-10#3)
(NT##2##1##(1994-8#1)(2008-10#1)
(NT) and##2##2##(1996-2#1)(2008-9#1)
(NT)##6##1##(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
(NTA)##2##1##(2008-10#2)
(NTP)##2##1##(2008-11#1)(2010-8#1)
(NTS) of##3##2##(1997-2#2)(2008-8#1)
(NTS)##4##1##(1997-2#2)(2008-10#1)(2008-8#1)
(NYHA##3##1##(1991-6#2)(2008-10#1)
(Na##3##1##(2008-10#3)
(Na)##2##1##(1995-8#2)
(NaCl##2##1##(2008-10#1)(2008-7#1)
(NaCl)##3##1##(1990-5#1)(2008-10#1)(2008-8#1)
(NaNO(3)##3##1##(2008-10#3)
(NaNO(3))##2##1##(2008-10#2)
(NaTPB) as anion##2##3##(2008-10#2)
(NaTPB) as##5##2##(2008-10#5)
(NaTPB)##7##1##(2008-10#7)
(National Association##2##2##(1991-3#1)(1992-2#1)
(National Institute##2##2##(2008-10#1)(2013-8#1)
(National##6##1##(1990-12#1)(1991-3#1)(1992-2#1)(2008-10#1)(2008-5#1)(2013-8#1)
(Nc)##2##1##(2008-10#2)
(Nei's coefficient of gene differentiation [G(ST)] = 0##2##8##(2008-10#2)
(Nematoda##3##1##(2008-10#1)(2008-12#1)(2011-2#1)
(Ni)##8##1##(2008-10#8)
(NiHCF)##3##1##(2008-10#3)
(Nicotiana tabacum cv##2##3##(2008-10#1)(2008-9#1)
(Nicotiana tabacum##4##2##(2008-10#3)(2008-9#1)
(Nicotiana##6##1##(2008-10#5)(2008-9#1)
(Nit) mutants##2##2##(2008-10#2)
(Nm##3##1##(2008-10#3)
(No##3##1##(2008-12#2)(2010-3#1)
(North##5##1##(1991-8#2)(2008-10#3)
(Northern##2##1##(1995-11#1)(2008-7#1)
(O##5##1##(1991-11#1)(2008-10#3)(2008-11#1)
(O)##3##1##(2008-10#2)(2013-1#1)
(O2##2##1##(1995-6#1)(2008-5#1)
(O2)##3##1##(2009-10#1)(2011-1#1)(2013-8#1)
(OA)##7##1##(1992-3#1)(1993-8#1)(1994-11#1)(2010-11#1)(2013-1#3)
(OBP)##2##1##(2008-10#1)(2008-8#1)
(OCD) is##2##2##(2008-11#1)(2013-1#1)
(OCD)##3##1##(2008-11#1)(2013-1#2)
(OCT) is an##2##3##(2011-2#1)(2011-7#1)
(OCT)##13##1##(2008-5#1)(2011-2#2)(2011-7#8)(2013-1#2)
(OD)##3##1##(2010-10#1)(2011-2#1)(2012-2#1)
(ODN)##3##1##(2008-10#2)(2011-2#1)
(ODS)##3##1##(2008-10#3)
(OF)##2##1##(2008-10#1)(2008-3#1)
(OFLX)##2##1##(2008-10#2)
(OH)##9##1##(2008-10#1)(2012-3#8)
(OH-NA)##3##1##(2008-10#3)
(OM)##4##1##(2008-10#1)(2009-7#1)(2012-4#1)(2013-8#1)
(OMC)##2##1##(1995-12#1)(2008-5#1)
(OMT)##2##1##(2008-10#1)(2013-1#1)
(OP) pesticides##2##2##(2010-5#1)(2013-1#1)
(OP)##8##1##(2008-10#4)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
(OPA) in##2##2##(2008-10#1)(2008-2#1)
(OPA)##7##1##(2008-10#6)(2008-2#1)
(OPA-NAC)##2##1##(2008-10#2)
(OPC)##2##1##(2008-5#1)(2010-10#1)
(OPD)##2##1##(2008-10#2)
(OPSS-PEG-NHS)##2##1##(2008-10#2)
(OR 1##2##2##(2012-12#1)(2012-2#1)
(OR 2##2##2##(2011-2#2)
(OR 4##2##2##(2012-12#1)(2013-1#1)
(OR = 0##5##3##(1994-12#1)(2010-11#4)
(OR = 1##9##3##(1994-12#5)(2010-11#3)(2010-12#1)
(OR = 2##3##3##(1993-12#1)(1994-12#1)(2010-10#1)
(OR =##20##2##(1993-12#3)(1994-12#7)(2008-10#1)(2010-10#1)(2010-11#7)(2010-12#1)
(OR##30##1##(1993-12#3)(1994-12#7)(2008-10#1)(2010-10#1)(2010-11#7)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)
(OR) for##2##2##(2012-3#1)(2013-1#1)
(OR) were##2##2##(2011-2#1)(2012-12#1)
(OR)##10##1##(2008-10#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
(OR=1##2##1##(2008-10#1)(2008-11#1)
(OR=2##3##1##(2012-12#3)
(ORF##7##1##(2008-10#7)
(ORF)##23##1##(1990-11#1)(1991-9#1)(1992-3#1)(1993-12#4)(1993-6#1)(1994-12#1)(1995-8#1)(1996-8#1)(1997-7#2)(2008-10#5)(2008-8#3)(2008-9#1)(2010-5#1)
(ORF1)##2##1##(2008-8#1)(2008-9#1)
(ORSV)##3##1##(2008-10#3)
(OR = 0##3##1##(2011-2#3)
(OR = 3##2##1##(2011-2#2)
(OS) and##2##2##(2008-10#1)(2010-10#1)
(OS)##6##1##(1991-8#1)(1993-1#1)(2008-10#2)(2010-10#1)(2011-2#1)
(OSCE)##5##1##(2008-11#5)
(OT)##3##1##(1996-12#1)(2008-10#1)(2010-12#1)
(OTC)##6##1##(2008-10#4)(2009-8#1)(2012-7#1)
(OVA)##3##1##(1993-12#1)(2008-10#1)(2008-11#1)
(OWG)##2##1##(2008-10#2)
(Oncorhynchus##4##1##(1993-3#1)(1995-11#1)(2008-5#1)(2008-6#1)
(One-way parametric ANOVA##3##3##(2008-10#3)
(Onrigin™)##2##1##(2010-11#2)
(Orthoptera##2##1##(2008-12#1)(2013-8#1)
(Oryza sativa L##10##3##(1994-11#1)(2008-10#2)(2008-9#7)
(Oryza sativa##13##2##(1994-11#1)(2008-10#2)(2008-9#8)(2009-10#2)
(Oryza sativa)##4##2##(2008-10#3)(2009-10#1)
(Oryza##19##1##(1994-11#1)(1996-12#1)(2008-10#5)(2008-9#8)(2009-10#4)
(Ox)##2##1##(1993-6#1)(2008-10#1)
(Ox-LDL)##2##1##(1990-8#2)
(OxLDL)##2##1##(1995-2#1)(2013-7#1)
(Oxine)##2##1##(2008-10#2)
(P &gt##20##2##(1994-12#1)(1996-12#1)(2008-10#11)(2008-7#1)(2008-9#2)(2011-3#1)(2012-2#2)(2013-8#1)
(P &lt##265##2##(1992-11#1)(1992-12#5)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#5)(1993-8#1)(1994-12#6)(1994-3#5)(1994-5#1)(1994-8#5)(1995-12#7)(1995-8#2)(1996-12#14)(1996-6#4)(1997-1#1)(1997-3#1)(1997-8#4)(2006-6#1)(2008-10#85)(2008-11#3)(2008-3#4)(2008-5#6)(2008-7#8)(2008-8#1)(2008-9#6)(2009-11#3)(2009-3#1)(2010-1#2)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#10)(2011-3#13)(2012-2#7)(2012-3#22)(2013-1#12)(2013-8#2)
(P = 0##117##3##(1991-12#2)(1992-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(2008-10#55)(2008-3#3)(2008-5#4)(2008-7#11)(2008-8#3)(2010-1#2)(2011-2#9)(2012-2#1)(2012-3#4)(2013-1#12)(2013-8#2)
(P =##127##2##(1991-12#2)(1992-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(2008-10#55)(2008-3#3)(2008-5#4)(2008-7#11)(2008-8#4)(2009-1#1)(2010-1#2)(2010-4#1)(2010-8#1)(2011-2#10)(2012-2#1)(2012-3#8)(2013-1#13)(2013-8#2)
(P less than 0##13##4##(1990-11#2)(1990-8#1)(1991-12#1)(1991-9#7)(1992-3#2)
(P ≤ 0##2##3##(2012-3#2)
(P ≤##3##2##(2010-12#1)(2012-3#2)
(P##455##1##(1990-11#2)(1990-8#1)(1991-12#3)(1991-9#7)(1992-11#1)(1992-12#6)(1992-3#2)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#5)(1993-8#1)(1994-12#8)(1994-2#1)(1994-3#7)(1994-5#1)(1994-8#5)(1995-12#8)(1995-8#2)(1996-12#15)(1996-3#2)(1996-6#5)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#4)(2006-6#1)(2008-10#170)(2008-11#3)(2008-3#7)(2008-5#11)(2008-7#21)(2008-8#5)(2008-9#8)(2009-1#1)(2009-11#3)(2009-3#1)(2010-1#4)(2010-12#2)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-10#1)(2011-2#22)(2011-3#14)(2012-2#10)(2012-3#32)(2013-1#26)(2013-8#5)
(P&gt##10##1##(2008-10#1)(2008-12#3)(2008-7#2)(2008-9#1)(2009-3#2)(2013-8#1)
(P&lt##65##1##(1997-8#1)(2008-10#11)(2008-12#1)(2008-5#6)(2008-7#18)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#6)(2010-2#3)(2010-4#4)(2012-2#3)(2012-3#3)(2013-1#4)
(P(1))##3##1##(2008-10#3)
(P(2))##3##1##(2008-10#3)
(P) and##2##2##(2008-10#1)(2011-1#1)
(P) in##2##2##(2008-10#2)
(P) with##2##2##(1995-6#1)(2008-10#1)
(P)##23##1##(1993-8#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-12#1)(2008-10#10)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-8#1)
(P-450(11 beta)##2##2##(1990-5#2)
(P-gp)##2##1##(2008-7#1)(2011-3#1)
(P1)##4##1##(1990-11#1)(1997-8#1)(2008-10#1)(2012-3#1)
(P2##3##1##(1993-1#2)(2012-3#1)
(P450##2##1##(1992-8#1)(1993-8#1)
(P450s)##2##1##(2008-9#1)(2009-8#1)
(P= 0##2##2##(1997-7#1)(2012-3#1)
(P=0##27##1##(2006-6#1)(2008-10#10)(2008-11#1)(2008-12#8)(2008-7#4)(2008-8#1)(2012-2#1)(2013-8#1)
(PA =##3##2##(2008-12#3)
(PA##4##1##(2008-10#1)(2008-12#3)
(PA) is##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
(PA) or##2##2##(1991-5#1)(2008-8#1)
(PA)##18##1##(1991-5#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-8#2)(2009-3#1)(2012-2#2)(2013-1#1)
(PAA)##5##1##(2008-10#5)
(PAC)##2##1##(1997-8#1)(2008-10#1)
(PAD) and##2##2##(2008-10#2)
(PAD)##7##1##(1991-7#1)(2008-10#4)(2008-8#1)(2012-2#1)
(PAF)##3##1##(1991-5#1)(2009-3#1)(2013-1#1)
(PAGE)##5##1##(1990-11#1)(1995-12#1)(2008-5#2)(2010-3#1)
(PAH) in##4##2##(2008-10#3)(2010-10#1)
(PAH)##17##1##(1994-5#1)(1995-11#1)(2008-10#7)(2008-11#1)(2009-10#1)(2010-10#5)(2011-1#1)
(PAI)##2##1##(1995-2#1)(2008-10#1)
(PAL)##3##1##(2008-10#2)(2008-4#1)
(PAM)##5##1##(1993-8#1)(1996-3#1)(2008-10#1)(2008-9#1)(2012-12#1)
(PAN) and##2##2##(2008-10#2)
(PAN) in##2##2##(2008-10#2)
(PAN)##15##1##(2008-10#14)(2009-6#1)
(PANDAS)##2##1##(2011-2#2)
(PANI)##2##1##(2008-10#2)
(PAP) is##2##2##(2008-12#1)(2010-7#1)
(PAP)##9##1##(1990-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2009-1#1)(2010-7#1)
(PAR) and##4##2##(2008-10#4)
(PAR) chelates##2##2##(2008-10#2)
(PAR)##16##1##(2008-10#15)(2008-7#1)
(PARAFAC) and##2##2##(2008-10#2)
(PARAFAC)##6##1##(2008-10#6)
(PAS)##4##1##(1994-2#1)(1996-1#1)(1996-5#1)(2009-7#1)
(PB and CuHCF##2##3##(2008-10#2)
(PB##3##1##(2008-10#3)
(PB) and##2##2##(2008-10#2)
(PB)##11##1##(2008-10#9)(2008-4#1)(2008-5#1)
(PBD)##2##1##(1992-12#1)(2008-10#1)
(PBDEs) in##3##2##(2008-10#3)
(PBDEs)##4##1##(2008-10#4)
(PBL) and##3##2##(1995-12#1)(2008-7#1)(2013-8#1)
(PBL)##13##1##(1995-12#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
(PBMC)##7##1##(2008-10#1)(2008-11#2)(2008-7#2)(2011-2#1)(2011-3#1)
(PBN)##3##1##(1993-6#1)(2008-5#1)(2009-10#1)
(PBS##2##1##(2008-10#1)(2011-3#1)
(PBS)##7##1##(1990-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-3#1)
(PC##3##1##(2008-10#3)
(PC) and##4##2##(1995-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
(PC) is##2##2##(2008-10#1)(2008-7#1)
(PC) were##2##2##(2008-10#1)(2009-8#1)
(PC)##20##1##(1991-5#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
(PC1)##2##1##(2008-10#2)
(PC12)##4##1##(1992-12#1)(1994-11#1)(1995-12#1)(2013-8#1)
(PCA) is a##3##3##(2008-10#1)(2010-7#1)(2011-1#1)
(PCA) with##2##2##(2008-10#1)(2012-3#1)
(PCA)##43##1##(1995-11#1)(1997-6#1)(2008-10#37)(2008-7#1)(2010-7#1)(2011-1#1)(2012-3#1)
(PCB)##2##1##(2008-10#1)(2012-2#1)
(PCD)##3##1##(2008-11#1)(2009-8#2)
(PCDD/Fs)##2##1##(2008-10#2)
(PCE) and##2##2##(1993-8#1)(2008-10#1)
(PCI)##3##1##(2008-11#1)(2011-2#1)(2013-8#1)
(PCL)##3##1##(2008-10#1)(2009-7#1)(2013-1#1)
(PCOS)##9##1##(2008-4#9)
(PCP)##9##1##(1991-1#2)(2007-12#1)(2008-10#4)(2008-8#1)(2009-3#1)
(PCR##2##1##(1997-8#1)(2009-8#1)
(PCR) and##14##2##(2008-10#12)(2010-6#1)(2011-2#1)
(PCR) in##4##2##(1994-1#1)(2008-10#3)
(PCR) using degenerate oligonucleotides##2##4##(1993-8#1)(1996-8#1)
(PCR) using##7##2##(1993-8#1)(1996-12#1)(1996-8#1)(2008-10#3)(2011-2#1)
(PCR) were##2##2##(2008-10#2)
(PCR) with##3##2##(2008-10#3)
(PCR)##120##1##(1991-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1995-12#1)(1996-12#3)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#92)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#3)
(PCR-RFLP) and##2##2##(2008-10#2)
(PCR-RFLP)##5##1##(1997-8#1)(2008-10#4)
(PCS)##3##1##(1995-5#1)(2013-1#2)
(PCT)##4##1##(2008-10#1)(2008-5#2)(2010-2#1)
(PCs) of the##2##3##(1994-2#1)(2008-10#1)
(PCs)##7##1##(1994-2#1)(2008-10#4)(2008-11#1)(2010-9#1)
(PD) and##4##2##(2008-10#1)(2008-12#1)(2008-6#1)(2013-1#1)
(PD) is a##5##3##(2008-12#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
(PD) is an##3##3##(2008-10#1)(2008-7#2)
(PD) is##11##2##(2008-10#1)(2008-12#1)(2008-7#5)(2008-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
(PD) patients##5##2##(2008-7#4)(2011-2#1)
(PD)##51##1##(1990-2#1)(2008-10#7)(2008-12#3)(2008-6#1)(2008-7#23)(2008-8#1)(2010-12#2)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
(PDA) for##2##2##(2008-10#2)
(PDA)##11##1##(2008-10#8)(2008-12#1)(2012-12#1)(2012-2#1)
(PDAs)##2##1##(2008-12#1)(2012-2#1)
(PDB)##2##1##(2008-10#1)(2011-3#1)
(PDC)##2##1##(2008-10#2)
(PDE)##2##1##(2008-6#1)(2008-8#1)
(PDGFRA)##2##1##(2013-1#1)(2013-8#1)
(PDI)##2##1##(2008-3#1)(2013-1#1)
(PDL)##6##1##(1995-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2013-1#1)
(PDMS) microfluidic##3##2##(2008-10#3)
(PDMS)##8##1##(1990-8#1)(2008-10#6)(2008-5#1)
(PDMS/DVB##2##1##(2008-10#2)
(PDS)##8##1##(1992-1#1)(1995-2#1)(2008-10#3)(2008-9#1)(2011-1#1)(2011-2#1)
(PDT)##8##1##(1994-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-8#2)
(PDV)##3##1##(1993-12#1)(2008-10#2)
(PE) and##2##2##(1995-8#1)(2011-2#1)
(PE)##9##1##(1995-8#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#2)
(PED)##2##1##(2008-10#1)(2011-2#1)
(PEG##6##1##(2008-10#1)(2008-12#4)(2008-5#1)
(PEG)##13##1##(1990-12#1)(2008-10#6)(2008-12#2)(2008-7#2)(2012-3#1)(2013-1#1)
(PEI) as##2##2##(1992-9#1)(2008-10#1)
(PEI)##8##1##(1992-11#1)(1992-9#1)(2008-10#5)(2008-11#1)
(PEO)##3##1##(2008-10#3)
(PEP)##2##1##(1997-3#1)(2009-12#1)
(PES)##2##1##(1996-1#1)(2008-10#1)
(PET##2##1##(2011-3#1)(2013-8#1)
(PET)##12##1##(1990-8#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2011-2#2)
(PET/CT)##3##1##(2009-2#1)(2012-12#1)(2013-1#1)
(PEX)##2##1##(2011-2#2)
(PF)##2##1##(2008-10#1)(2011-2#1)
(PFA)##2##1##(1996-2#1)(2008-10#1)
(PFBBr)##2##1##(2008-10#2)
(PFC)##12##1##(1993-12#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-4#2)(2013-8#2)
(PFD)##2##1##(1993-12#1)(2010-10#1)
(PFS)##4##1##(1991-8#1)(2008-10#2)(2008-11#1)
(PFT)##2##1##(1995-2#1)(2012-2#1)
(PG) and##4##2##(1994-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
(PG)##17##1##(1990-2#1)(1994-8#1)(2008-10#8)(2008-11#1)(2008-8#1)(2012-2#2)(2013-1#2)(2013-8#1)
(PGA)##2##1##(2009-8#1)(2011-2#1)
(PGE)##4##1##(2008-11#2)(2008-8#1)(2011-3#1)
(PGE2)##5##1##(1990-11#1)(1993-12#1)(1997-1#1)(1997-2#1)(2007-11#1)
(PGP)##2##1##(1997-3#1)(2008-5#1)
(PGs)##6##1##(1990-2#1)(2008-10#2)(2008-11#2)(2011-10#1)
(PH)##9##1##(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-7#1)(2010-10#2)(2011-1#1)
(PHA)##2##1##(2011-2#1)(2013-1#1)
(PHB)##2##1##(2008-10#1)(2008-7#1)
(PHL)##2##1##(2008-11#1)(2012-12#1)
(PHT)##2##1##(1995-10#1)(2009-8#1)
(PI is from##2##3##(2008-9#2)
(PI##12##1##(1993-8#1)(1994-11#2)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)
(PI) and##5##2##(1996-6#1)(2008-10#1)(2008-9#1)(2009-6#1)(2013-1#1)
(PI)##18##1##(1992-12#1)(1993-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(2008-10#3)(2008-4#1)(2008-9#3)(2009-6#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
(PIBs)##2##1##(2008-11#2)
(PICs)##2##1##(2008-8#1)(2011-2#1)
(PIH)##2##1##(1994-3#1)(2012-2#1)
(PIP)##2##1##(2008-8#1)(2008-9#1)
(PIPDMAHA)##2##1##(2008-10#2)
(PIXE)##2##1##(2008-10#2)
(PK##2##1##(1990-5#1)(2011-2#1)
(PK)##9##1##(1993-2#2)(1993-9#1)(1994-11#1)(1997-6#1)(2008-7#1)(2011-2#2)(2013-1#1)
(PKA) and##2##2##(1995-2#1)(2008-10#1)
(PKA)##7##1##(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-10#1)(2009-7#1)
(PKC##3##1##(1993-12#1)(1993-8#1)(1994-5#1)
(PKC)##28##1##(1990-5#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
(PL)##5##1##(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
(PLGA)##3##1##(2008-11#1)(2009-7#2)
(PLL)##6##1##(1991-5#1)(2008-10#4)(2012-5#1)
(PLS) and##8##2##(2008-10#8)
(PLS) calibration approach##2##3##(2008-10#2)
(PLS) calibration##7##2##(2008-10#7)
(PLS) model##3##2##(2008-10#3)
(PLS) multivariate calibration##4##3##(2008-10#4)
(PLS) regression##7##2##(2008-10#7)
(PLS) was developed##2##3##(2008-10#2)
(PLS) was##4##2##(2008-10#3)(2008-5#1)
(PLS)##57##1##(1994-12#1)(2008-10#53)(2008-5#2)(2009-10#1)
(PLS-1 and PLS-2)##2##3##(2008-10#2)
(PLS-1##3##1##(2008-10#3)
(PLS-1) and##3##2##(2008-10#3)
(PLS-1)##6##1##(2008-10#6)
(PLSR)##2##1##(2008-10#2)
(PM)##10##1##(1994-12#1)(2008-10#3)(2008-11#1)(2008-7#3)(2009-7#1)(2013-1#1)
(PMA) and##3##2##(1993-6#1)(1994-3#1)(2008-11#1)
(PMA) or##2##2##(1991-5#1)(2008-11#1)
(PMA)##16##1##(1991-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#2)(1997-1#1)(2006-6#1)(2008-11#4)
(PMC)##2##1##(1992-3#1)(2008-5#1)
(PME)##2##1##(2008-10#1)(2008-8#1)
(PMMA)##5##1##(2008-10#3)(2008-5#1)(2010-4#1)
(PMN)##3##1##(1991-2#1)(2008-10#2)
(PMNL)##2##1##(2006-6#2)
(PMNs) in##2##2##(2008-12#2)
(PMNs)##5##1##(1995-6#1)(2008-10#1)(2008-12#2)(2009-10#1)
(PMS)##2##1##(2008-10#1)(2008-11#1)
(PMT)##3##1##(2008-10#2)(2008-5#1)
(PN)##4##1##(2008-10#3)(2008-11#1)
(PNMT)##2##1##(1997-3#1)(2013-1#1)
(PNS)##2##1##(1996-12#1)(2011-2#1)
(PO)##4##1##(1993-8#1)(2008-10#2)(2011-10#1)
(PO-CL)##2##1##(2008-10#2)
(POA)##2##1##(1991-12#1)(2008-8#1)
(POI)##2##1##(2008-10#1)(2010-4#1)
(POMC)##4##1##(1995-12#1)(1996-12#1)(2008-4#1)(2009-8#1)
(PONPE 5##2##2##(2008-10#2)
(POR)##2##1##(1993-1#1)(2009-9#1)
(PP) and spleen (SPL)##2##4##(2008-11#2)
(PP) and##3##2##(2008-11#2)(2008-5#1)
(PP)##10##1##(1991-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2009-8#1)(2011-1#1)(2013-1#1)
(PPA)##3##1##(1990-9#1)(1996-2#1)(2008-10#1)
(PPC)##3##1##(2008-10#2)(2008-7#1)
(PPD) as##2##2##(2008-10#1)(2008-5#1)
(PPD)##8##1##(1996-12#2)(1997-2#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-1#2)
(PPE)##6##1##(1991-3#1)(1991-9#1)(1996-12#2)(2008-5#2)
(PPG)##3##1##(2008-12#2)(2008-9#1)
(PPI)##5##1##(1993-3#1)(2008-11#2)(2008-8#1)(2011-2#1)
(PPL)##2##1##(1996-3#1)(2013-1#1)
(PPO)##9##1##(1992-2#1)(2008-10#8)
(PPR)##2##1##(1995-12#1)(2011-2#1)
(PPS)##17##1##(1991-2#1)(1992-1#1)(1992-12#6)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1996-3#1)(2008-7#1)
(PPT)##3##1##(2008-10#1)(2009-5#1)(2010-12#1)
(PPV) isolates##2##2##(2008-10#2)
(PPV)##5##1##(1995-3#1)(2008-10#4)
(PPY)##3##1##(1997-6#1)(2008-10#2)
(PR) in##2##2##(2008-10#2)
(PR) proteins##3##2##(2008-10#3)
(PR)##17##1##(1991-2#1)(1991-8#1)(1995-11#1)(1997-7#1)(2008-10#11)(2010-1#1)(2013-8#1)
(PRC)##2##1##(2008-12#1)(2010-12#1)
(PRE)##2##1##(2012-3#1)(2013-1#1)
(PRL)##3##1##(1994-3#1)(2008-10#1)(2011-2#1)
(PRO)##3##1##(1995-12#1)(1996-2#1)(2008-10#1)
(PRO-C3 and P4NP7S)##2##3##(2013-8#2)
(PS##3##1##(1995-12#1)(2008-10#1)(2008-7#1)
(PS) and##3##2##(1995-12#1)(2008-10#1)(2008-5#1)
(PS)##14##1##(1993-11#1)(1995-12#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
(PSA##2##1##(2010-11#2)
(PSA) and##2##2##(2010-12#1)(2010-8#1)
(PSA) was##2##2##(1990-9#1)(2008-10#1)
(PSA)##11##1##(1990-9#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
(PSD) of##2##2##(2008-3#1)(2010-8#1)
(PSD)##7##1##(1996-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)
(PSG)##2##1##(1990-5#1)(2012-3#1)
(PSI)##2##1##(2008-8#1)(2010-12#1)
(PSS)##4##1##(2008-10#3)(2010-1#1)
(PST)##2##1##(2008-10#1)(2008-9#1)
(PSV)##4##1##(2008-10#3)(2013-8#1)
(PT) and##2##2##(1995-11#1)(2013-1#1)
(PT)##5##1##(1995-11#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
(PTA)##4##1##(1995-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
(PTFE) turnings##3##2##(2008-10#3)
(PTFE)##10##1##(2008-10#9)(2008-3#1)
(PTH) and##2##2##(1994-11#1)(2008-1#1)
(PTH)##7##1##(1990-11#1)(1991-12#1)(1994-11#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-12#1)
(PTM)##3##1##(2008-8#1)(2009-6#1)(2009-7#1)
(PTO)##2##1##(1993-1#1)(2008-5#1)
(PTP)##3##1##(1994-6#1)(1997-8#1)(2008-7#1)
(PTSD##2##1##(2009-11#2)
(PTSD)##9##1##(1991-2#1)(2008-10#1)(2008-6#1)(2009-11#1)(2010-10#1)(2012-12#3)(2013-8#1)
(PTTH)##2##1##(1995-11#2)
(PTV)##2##1##(2008-11#1)(2008-7#1)
(PTX)##3##1##(2008-4#1)(2008-8#1)(2008-9#1)
(PUF)##7##1##(2008-10#5)(2008-11#2)
(PUFA)##2##1##(2008-7#1)(2012-12#1)
(PUV)##2##1##(2008-10#2)
(PV)##6##1##(2008-10#3)(2008-11#1)(2011-2#2)
(PVA##2##1##(2008-10#2)
(PVA)##9##1##(2008-10#6)(2008-12#1)(2008-9#1)(2012-3#1)
(PVC##3##1##(2008-10#3)
(PVC) matrix##5##2##(2008-10#5)
(PVC) membrane electrode##4##3##(2008-10#4)
(PVC) membrane##10##2##(2008-10#10)
(PVC) membranes##6##2##(2008-10#6)
(PVC)##31##1##(2008-10#31)
(PVM)##2##1##(2012-2#1)(2013-8#1)
(PVP)##3##1##(2008-10#2)(2008-5#1)
(PVY##4##1##(2008-10#4)
(PWB)##2##1##(2008-10#1)(2010-8#1)
(Panax quinquefolius)##4##2##(2008-10#4)
(Panthera pardus)##2##2##(1996-12#2)
(Panthera##5##1##(1996-12#5)
(Park##2##1##(2011-2#1)(2013-8#1)
(Part##5##1##(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2011-2#1)
(Parus##3##1##(2008-5#3)
(Pb##3##1##(2008-10#3)
(Pb(2+)) and##3##2##(2008-10#3)
(Pb(2+))##5##1##(2008-10#5)
(Pb)##9##1##(2008-10#9)
(Pdx)##2##1##(1994-5#2)
(Pearson r = -0##2##4##(2011-3#2)
(Pearson r = 0##2##4##(2011-3#2)
(Pearson r =##4##3##(2011-3#4)
(Pearson's##2##1##(1991-8#1)(2008-10#1)
(Ped##2##1##(2008-5#2)
(Pemulen##2##1##(2008-5#2)
(Persea americana)##4##2##(2008-10#4)
(Phase##2##1##(2008-10#2)
(Phaseolus vulgaris L##3##3##(2008-12#2)(2013-8#1)
(Phaseolus vulgaris##4##2##(2008-10#1)(2008-12#2)(2013-8#1)
(Phaseolus vulgaris) in##2##3##(2008-10#2)
(Phaseolus vulgaris)##16##2##(2008-10#16)
(Phaseolus##22##1##(2008-10#18)(2008-12#2)(2008-3#1)(2013-8#1)
(Phe##2##1##(2008-10#1)(2008-9#1)
(Phytophthora##3##1##(2008-10#3)
(Pi) and##2##2##(1990-5#1)(2010-8#1)
(Picea##4##1##(2008-10#3)(2012-2#1)
(Pima S-7 x NemX)##2##4##(2008-10#2)
(Pinus monticola)##4##2##(2008-10#4)
(Pinus strobus)##2##2##(2008-10#2)
(Pinus##13##1##(2008-10#13)
(Poecilia reticulata)##3##2##(2008-8#3)
(Pol III##2##2##(1992-3#2)
(Poland)##2##1##(1994-12#2)
(Portugal)##2##1##(1994-5#1)(2008-10#1)
(Pr)##3##1##(2007-12#1)(2008-10#1)(2012-2#1)
(PrEP) in preventing##2##3##(2012-2#1)(2013-1#1)
(Prajer##2##1##(2008-12#2)
(PreOp##2##1##(2011-2#2)
(Principal##2##1##(2008-10#2)
(Pro)2##2##1##(1992-12#2)
(Prunus##6##1##(2008-10#6)
(Pseudomonas##2##1##(2008-10#1)(2011-2#1)
(Pt##3##1##(2008-10#1)(2008-11#2)
(Ptr##2##1##(2008-10#2)
(Public Law##10##2##(1991-1#1)(1991-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1994-3#3)
(Pusa hispida)##2##2##(2008-10#2)
(P &lt##3##1##(2013-1#2)(2013-3#1)
(P &lt##18##1##(2011-2#1)(2013-1#17)
(P = 0##4##1##(2010-10#1)(2012-2#2)(2013-1#1)
(Q(o)I)##2##1##(2008-10#2)
(Q)##5##1##(1997-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-8#1)
(QA)##7##1##(1994-2#2)(1995-3#3)(1996-2#2)
(QAAMS)##2##1##(2008-6#2)
(QC)##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
(QCM)##13##1##(2008-10#13)
(QD)##2##1##(2008-7#1)(2013-1#1)
(QM)##2##1##(2008-10#1)(2009-8#1)
(QPCR)##2##1##(2008-10#1)(2012-2#1)
(QS)##3##1##(2008-10#1)(2009-6#1)(2013-1#1)
(QSAR)##2##1##(2008-10#1)(2009-3#1)
(QSR International##2##2##(2011-1#2)
(QTL) analysis##3##2##(2008-10#2)(2012-3#1)
(QTL) mapping##2##2##(2008-10#1)(2012-3#1)
(QTL)##36##1##(2008-10#31)(2008-8#1)(2012-3#3)(2013-8#1)
(QTLs)##8##1##(2008-10#3)(2008-8#3)(2008-9#1)(2009-10#1)
(Qa-2(a)##2##1##(2008-5#2)
(QoL)##5##1##(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
(Quercus##4##1##(2008-10#2)(2012-5#1)(2012-7#1)
(R = -0##2##3##(2008-10#1)(2008-12#1)
(R = 0##5##3##(2008-10#4)(2008-9#1)
(R =##7##2##(2008-10#5)(2008-12#1)(2008-9#1)
(R##174##1##(1992-11#1)(1993-6#2)(2008-10#165)(2008-12#2)(2008-8#1)(2008-9#1)(2012-3#1)(2012-5#1)
(R&amp##3##1##(2008-5#1)(2008-8#1)(2010-12#1)
(R(2) &gt##2##2##(2008-10#2)
(R(2) = 0##17##3##(2008-10#17)
(R(2)##23##1##(2008-10#20)(2008-5#2)(2008-7#1)
(R(2)&gt##3##1##(2008-10#3)
(R(2))##4##1##(2008-10#4)
(R(2)=0##11##1##(2008-10#10)(2008-11#1)
(R(f) 0##3##2##(2008-10#3)
(R(f) value of 0##2##4##(2008-10#2)
(R(f)##5##1##(2008-10#5)
(R) for##2##2##(2008-10#2)
(R) were##2##2##(2008-10#2)
(R)##25##1##(1990-5#1)(1994-8#1)(2008-1#2)(2008-10#16)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
(R2 = 0##2##3##(1990-4#1)(1992-12#1)
(R2 =##3##2##(1990-4#1)(1992-12#1)(1995-2#1)
(R2##4##1##(1990-4#1)(1992-12#1)(1995-2#1)(2013-1#1)
(R338W)##2##1##(1995-8#2)
(R68A##2##1##(1995-6#2)
(R=-0##3##1##(2008-7#3)
(R=0##13##1##(2008-10#11)(2008-12#1)(2013-1#1)
(RA##2##1##(1993-2#1)(1995-6#1)
(RA) in##2##2##(1995-9#1)(2012-3#1)
(RA)##20##1##(1990-6#1)(1994-11#1)(1995-9#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
(RAFT)##3##1##(2008-12#2)(2009-10#1)
(RAG-1)##2##1##(1991-9#1)(1994-11#1)
(RAM)##2##1##(2008-10#1)(2012-2#1)
(RAW 264##2##2##(2011-2#1)(2012-12#1)
(RB)##10##1##(1995-11#1)(2008-10#8)(2013-1#1)
(RBC)##3##1##(2008-10#1)(2010-8#1)(2013-1#1)
(RC)##3##1##(2008-10#1)(2008-12#1)(2008-8#1)
(RCA)##2##1##(2008-11#1)(2013-2#1)
(RCCs)##2##1##(2010-8#1)(2012-3#1)
(RCT)##5##1##(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#2)
(RDX) using##2##2##(2008-10#2)
(RDX)##9##1##(2008-10#8)(2008-3#1)
(RE)##5##1##(2008-10#5)
(REE)##7##1##(2008-10#6)(2012-2#1)
(REM)##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
(REMS)##2##1##(2012-3#1)(2013-1#1)
(RER)##3##1##(1992-12#1)(2008-10#1)(2013-8#1)
(REV)##2##1##(2008-5#1)(2013-8#1)
(RF)##6##1##(1992-4#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
(RFLP)##36##1##(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#31)(2008-9#1)(2012-3#1)
(RFS)##4##1##(2011-2#1)(2012-2#2)(2012-3#1)
(RGD)##3##1##(2008-11#1)(2008-7#1)(2010-12#1)
(RH)##21##1##(1996-12#1)(2008-10#19)(2008-8#1)
(RI)##9##1##(1991-7#1)(1994-8#1)(1996-6#1)(2008-10#4)(2008-12#1)(2013-8#1)
(RIA)##3##1##(1990-11#1)(2008-12#1)(2008-8#1)
(RIANA)##2##1##(2008-10#2)
(RICH)##2##1##(2011-2#2)
(RIP)##2##1##(2008-10#2)
(RIWs)##2##1##(1991-12#2)
(RIfS)##2##1##(2008-10#2)
(RL)##2##1##(2008-10#1)(2008-11#1)
(RLS) signals##2##2##(2008-10#2)
(RLS)##11##1##(1997-4#1)(2008-10#9)(2012-3#1)
(RM)##7##1##(1991-7#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-8#1)(2013-1#1)
(RMS)##2##1##(2008-10#1)(2010-9#1)
(RMSD)##2##1##(2008-10#1)(2008-8#1)
(RN)##2##1##(2008-11#1)(2010-2#1)
(RNA)##2##1##(2008-10#1)(2013-8#1)
(RNase##2##1##(1992-4#1)(2008-10#1)
(ROH)##2##1##(2008-10#2)
(ROS 17/2##2##2##(1990-11#1)(1991-3#1)
(ROS##3##1##(1990-11#1)(1991-3#1)(2009-8#1)
(ROS) and##3##2##(2010-5#1)(2012-2#1)(2012-3#1)
(ROS) generation##2##2##(2012-2#2)
(ROS)##31##1##(1994-5#1)(1994-6#1)(2008-10#6)(2008-11#5)(2008-5#1)(2008-9#1)(2009-8#5)(2010-1#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-2#3)(2012-3#1)(2012-6#1)
(RP)##9##1##(1995-3#1)(2008-10#2)(2008-11#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)
(RP-HPLC)##9##1##(2008-10#9)
(RPA)##2##1##(2008-10#2)
(RQA)##2##1##(2008-11#2)
(RR)##5##1##(1992-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
(RR=1##2##1##(2008-8#2)
(RS)##5##1##(2008-10#2)(2008-11#2)(2008-8#1)
(RS4(XL))##3##1##(2010-8#3)
(RSD approximately##3##2##(2008-10#3)
(RSD for##2##2##(2008-10#2)
(RSD less than##2##3##(2008-10#2)
(RSD values lower than 4##2##5##(2008-10#2)
(RSD##21##1##(2008-10#21)
(RSD&lt##2##1##(2008-10#2)
(RSD) for##5##2##(2008-10#4)(2008-5#1)
(RSD) of##6##2##(2008-10#6)
(RSD)##27##1##(2008-10#25)(2008-5#1)(2009-8#1)
(RSF)##2##1##(2008-10#1)(2008-8#1)
(RSP)##3##1##(2008-10#1)(2008-3#1)(2010-9#1)
(RT) is##3##2##(1990-11#1)(2008-11#1)(2013-1#1)
(RT)##15##1##(1990-11#1)(1991-9#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#2)(2013-1#2)
(RTIs)##2##1##(2008-10#1)(2011-2#1)
(RTK)##2##1##(1991-5#1)(1995-8#1)
(RTKs)##3##1##(1993-8#1)(2009-8#1)(2009-9#1)
(RTP) and##2##2##(2008-10#2)
(RTP)##11##1##(1993-9#1)(2008-10#10)
(RTS)##2##1##(2008-10#1)(2011-2#1)
(RVR)##2##1##(2008-3#1)(2013-1#1)
(RXR)##2##1##(1995-8#2)
(Rana##6##1##(1991-5#2)(1996-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
(Rchb##2##1##(2008-11#2)
(Rdc1##2##1##(2008-10#2)
(Reference##2##1##(2008-10#1)(2008-11#1)
(Region##3##1##(1997-2#3)
(Rep)##3##1##(2008-10#3)
(Resource Utilization##2##2##(1994-12#2)
(Rh##2##1##(2008-10#2)
(Rio##3##1##(2008-10#2)(2008-8#1)
(Rocc)##2##1##(2008-1#2)
(Rosa##2##1##(2008-10#2)
(Rp-cAMPS)##2##1##(1993-6#1)(1995-11#1)
(Ru##2##1##(2008-10#2)
(Ru-red)##2##1##(2008-10#2)
(Rubisco)##3##1##(1993-12#2)(2009-10#1)
(S and##2##2##(1995-3#1)(2008-10#1)
(S##39##1##(1991-2#1)(1991-3#2)(1992-3#3)(1994-5#1)(1995-3#1)(2008-10#24)(2008-12#1)(2008-7#1)(2010-10#1)(2010-2#1)(2012-3#3)
(S)##11##1##(1993-8#1)(2008-10#6)(2008-8#2)(2013-1#1)(2013-8#1)
(S)-1##2##1##(1993-1#2)
(S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG)##2##2##(1995-12#2)
(S-type)##2##1##(1995-8#1)(2008-10#1)
(S/N =##2##2##(2008-10#2)
(S/N##4##1##(2008-10#4)
(S/N=2)##3##1##(2008-10#3)
(S/N=3) and the##2##3##(2008-10#2)
(S/N=3) and##4##2##(2008-10#4)
(S/N=3) are##4##2##(2008-10#4)
(S/N=3) for##4##2##(2008-10#4)
(S/N=3) is##3##2##(2008-10#3)
(S/N=3) of 0##3##3##(2008-10#3)
(S/N=3) of##11##2##(2008-10#11)
(S/N=3) was 0##4##3##(2008-10#4)
(S/N=3) was##7##2##(2008-10#7)
(S/N=3) were##2##2##(2008-10#2)
(S/N=3)##53##1##(2008-10#52)(2008-11#1)
(S/N=4)##2##1##(2008-10#2)
(S1)##2##1##(1992-3#1)(1994-5#1)
(S=+/-0##2##1##(2008-10#2)
(SA) and##4##2##(2008-10#2)(2009-8#1)(2013-1#1)
(SA) in the##2##3##(1995-12#1)(2008-10#1)
(SA) in##4##2##(1995-12#1)(2008-10#2)(2009-8#1)
(SA)##22##1##(1993-6#1)(1995-11#1)(1995-12#1)(2008-10#13)(2008-12#1)(2009-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
(SAA)##2##1##(2008-10#1)(2009-10#1)
(SADIE)##4##1##(2008-10#4)
(SAH)##9##1##(2008-7#5)(2009-7#1)(2012-3#2)(2013-8#1)
(SAM) and##2##2##(1995-11#1)(2008-10#1)
(SAM) as##2##2##(2008-8#1)(2013-8#1)
(SAM)##15##1##(1995-11#1)(2008-10#10)(2008-8#1)(2009-8#2)(2013-8#1)
(SAMs)##4##1##(2008-10#4)
(SAP)##3##1##(2013-1#2)(2013-8#1)
(SAR) in##2##2##(2008-10#1)(2008-8#1)
(SAR) is##2##2##(2008-10#1)(2013-1#1)
(SAR)##9##1##(2008-10#5)(2008-8#2)(2011-10#1)(2013-1#1)
(SAS)##2##1##(2008-7#1)(2009-8#1)
(SAW)##6##1##(2007-12#1)(2008-10#5)
(SAX)##2##1##(2008-10#2)
(SB)##3##1##(1997-8#1)(2008-10#1)(2008-11#1)
(SBE)##3##1##(2008-9#2)(2010-12#1)
(SBP)##5##1##(1992-12#1)(2009-8#1)(2010-4#1)(2013-8#2)
(SC) and##3##2##(2008-10#3)
(SC)##17##1##(2008-10#7)(2008-11#1)(2008-5#7)(2011-2#1)(2013-1#1)
(SCA)##4##1##(2008-7#1)(2010-1#1)(2011-2#1)(2013-7#1)
(SCC)##2##1##(2012-3#2)
(SCE)##5##1##(1990-6#1)(2008-10#3)(2008-11#1)
(SCF)##2##1##(2008-7#1)(2011-2#1)
(SCG)##3##1##(1994-8#1)(2008-10#2)
(SCI)##4##1##(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
(SCIT) and##2##2##(2011-2#2)
(SCMV)##3##1##(2008-10#2)(2008-9#1)
(SCO)##2##1##(2008-10#2)
(SCR) and##2##2##(2011-2#2)
(SD +/-##4##2##(1990-11#4)
(SD##11##1##(1990-11#4)(2008-10#1)(2008-12#3)(2010-3#2)(2012-4#1)
(SD) rats##3##2##(1996-12#1)(2008-10#1)(2012-3#1)
(SD)##12##1##(1990-2#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2011-1#1)(2012-3#1)(2012-5#1)(2013-1#3)
(SD-OCT)##3##1##(2011-7#3)
(SDS) and##5##2##(2008-10#5)
(SDS) in##3##2##(2008-10#3)
(SDS) medium##2##2##(2008-10#2)
(SDS) solutions##2##2##(2008-10#2)
(SDS)##40##1##(1990-11#1)(2008-10#31)(2008-4#1)(2008-5#2)(2011-1#3)(2012-2#2)
(SE##5##1##(1996-12#4)(2008-7#1)
(SE) and##2##2##(2008-3#1)(2009-8#1)
(SE)##5##1##(1997-8#1)(2008-10#2)(2008-3#1)(2009-8#1)
(SEA)##2##1##(1993-6#1)(2011-2#1)
(SEAP)##5##1##(2008-11#3)(2008-7#1)(2011-2#1)
(SEM 2##2##2##(1992-6#2)
(SEM##4##1##(1992-6#3)(2008-11#1)
(SEM) equipped with an##2##4##(2008-10#1)(2008-11#1)
(SEM) showed##2##2##(2008-10#1)(2013-1#1)
(SEM) was##2##2##(2008-10#1)(2008-5#1)
(SEM)##39##1##(1992-2#1)(1996-3#1)(2008-10#18)(2008-11#2)(2008-5#3)(2008-7#2)(2009-11#1)(2009-3#1)(2009-7#3)(2010-12#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
(SEM-EDXS)##2##1##(2008-10#2)
(SEP)##5##1##(2008-10#4)(2009-3#1)
(SERS)##6##1##(2008-10#6)
(SES)##4##1##(2008-11#1)(2010-11#1)(2011-1#1)(2012-2#1)
(SF-36)##2##1##(2008-10#1)(2012-12#1)
(SF-CO(2))##3##1##(2008-10#3)
(SFA)##8##1##(2008-10#5)(2008-11#1)(2008-3#1)(2013-8#1)
(SFM)##3##1##(2008-11#2)(2008-7#1)
(SFO)##2##1##(1994-2#1)(2013-1#1)
(SFS)##2##1##(2008-10#2)
(SFT)##2##1##(2012-2#1)(2013-1#1)
(SFV)##2##1##(2008-11#2)
(SG##2##1##(1993-12#1)(2008-6#1)
(SG)##2##1##(2008-10#2)
(SH)##2##1##(2007-12#1)(2008-10#1)
(SHLI)##2##1##(2011-2#2)
(SHM)##2##1##(2008-8#1)(2011-2#1)
(SHR)##2##1##(1994-2#1)(1994-8#1)
(SI##3##1##(2008-10#3)
(SI) on##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
(SI)##16##1##(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)
(SIA) and##4##2##(2008-10#4)
(SIA) technique was##3##3##(2008-10#3)
(SIA) technique##4##2##(2008-10#4)
(SIA)##35##1##(2008-10#35)
(SIDS)##6##1##(1991-11#3)(1993-12#1)(2008-1#2)
(SIL)##2##1##(1994-12#1)(2012-12#1)
(SIM)##10##1##(2008-10#9)(2008-5#1)
(SIMCA)##5##1##(2008-10#5)
(SIP)##2##1##(1993-6#1)(2011-2#1)
(SIR)##2##1##(2008-10#1)(2008-9#1)
(SIT)##3##1##(2008-10#1)(2011-2#2)
(SL) to##2##2##(2008-11#2)
(SLDA)##2##1##(2008-10#2)
(SLE)##11##1##(1990-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-2#2)(2012-12#1)(2013-1#2)
(SLI)##3##1##(2008-11#1)(2009-8#1)(2011-1#1)
(SLIT)##2##1##(2011-2#2)
(SLM)##7##1##(2008-10#5)(2008-3#1)(2009-7#1)
(SLS)##5##1##(2008-10#4)(2008-5#1)
(SLT)##2##1##(2011-2#1)(2012-2#1)
(SM)##5##1##(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#2)
(SMA)##4##1##(1994-2#1)(1994-8#1)(2008-9#1)(2009-7#1)
(SMC)##2##1##(1994-11#1)(2008-10#1)
(SMD)##3##1##(2008-10#1)(2009-7#1)(2013-8#1)
(SMR)##2##1##(1995-2#1)(2008-3#1)
(SMS)##2##1##(1991-2#1)(1997-3#1)
(SMT)##2##1##(2013-1#2)
(SN)##3##1##(1994-2#1)(2008-10#1)(2012-2#1)
(SNC)##2##1##(1996-12#1)(2008-10#1)
(SNK)##2##1##(2008-10#2)
(SNP)##10##1##(2008-10#2)(2008-11#2)(2009-7#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
(SNc)##2##1##(2008-12#1)(2008-7#1)
(SO)##3##1##(1990-8#1)(2008-10#1)(2008-11#1)
(SOD1)##2##1##(1996-5#1)(2008-4#1)
(SOM)##2##1##(1992-1#1)(2013-8#1)
(SOS)##2##1##(2008-10#2)
(SP)##10##1##(1997-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#2)(2010-6#1)
(SPA)##5##1##(2008-10#1)(2008-4#2)(2008-9#1)(2012-12#1)
(SPAN)##3##1##(1995-12#1)(2008-10#2)
(SPC)##4##1##(1995-2#1)(1996-1#1)(2008-10#2)
(SPD)##3##1##(2008-1#1)(2008-5#1)(2008-7#1)
(SPE) and##5##2##(2008-10#4)(2008-11#1)
(SPE) with##2##2##(2008-10#2)
(SPE)##50##1##(1997-2#1)(2008-10#48)(2008-11#1)
(SPF) of##3##2##(2008-5#3)
(SPF)##9##1##(1993-1#1)(2008-5#8)
(SPFMV)##2##1##(2008-10#2)
(SPL)##5##1##(1996-2#1)(2008-11#2)(2008-8#1)(2011-1#1)
(SPM)##2##1##(2008-10#2)
(SPME) and##3##2##(2008-10#3)
(SPME)##28##1##(2008-10#26)(2009-8#1)(2012-12#1)
(SPR) and##2##2##(2008-10#2)
(SPR)##19##1##(1995-2#1)(2008-10#15)(2008-11#1)(2008-4#1)(2008-9#1)
(SPS) and##2##2##(2008-12#1)(2011-2#1)
(SPS)##5##1##(2008-10#2)(2008-12#2)(2011-2#1)
(SPT)##3##1##(2008-10#2)(2012-3#1)
(SR) in##2##2##(1995-6#1)(2013-8#1)
(SR)##11##1##(1994-8#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#2)(2013-8#1)
(SRBC)##7##1##(2008-10#5)(2008-4#1)(2008-7#1)
(SRI)##2##1##(2008-10#1)(2009-8#1)
(SRM##5##1##(2008-10#5)
(SRR)##2##1##(2013-1#1)(2013-8#1)
(SS##2##1##(2008-10#1)(2011-2#1)
(SS) and##2##2##(1993-8#1)(2011-2#1)
(SS)##10##1##(1993-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2009-1#1)(2010-5#1)(2011-2#2)(2013-8#1)
(SS-ETAAS)##2##1##(2008-10#2)
(SSA)##5##1##(2008-10#3)(2009-12#1)(2013-1#1)
(SSB)##4##1##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
(SSC)##2##1##(2008-10#1)(2012-2#1)
(SSCP)##5##1##(2008-10#3)(2008-12#1)(2008-8#1)
(SSE)##4##1##(2008-10#1)(2013-1#2)(2013-8#1)
(SSEA-1)##2##1##(2008-11#2)
(SSH)##3##1##(2008-10#1)(2010-4#1)(2012-12#1)
(SSP)##4##1##(1991-3#1)(1993-1#1)(2010-2#1)(2011-2#1)
(SSR) markers##6##2##(2008-10#4)(2008-9#2)
(SSR)##10##1##(2008-10#8)(2008-9#2)
(SSRs)##3##1##(1996-8#1)(2008-10#2)
(SSc)##3##1##(2008-10#1)(2010-10#1)(2011-2#1)
(ST##3##1##(2010-7#2)(2013-1#1)
(ST)##3##1##(1993-12#1)(1994-2#1)(2008-10#1)
(STA)##2##1##(2008-10#2)
(STB)##3##1##(2008-10#3)
(STI)##2##1##(2008-12#1)(2011-2#1)
(STLR)##2##1##(2008-11#2)
(STM) and##2##2##(2008-8#1)(2010-9#1)
(STM)##4##1##(2008-10#1)(2008-8#1)(2010-7#1)(2010-9#1)
(STP)##2##1##(1994-11#1)(1995-12#1)
(STR) and##2##2##(2008-10#1)(2008-7#1)
(STR) profiling##2##2##(1995-11#1)(2008-12#1)
(STR)##9##1##(1995-11#2)(2008-10#1)(2008-12#5)(2008-7#1)
(STS)##7##1##(1996-12#2)(1997-8#1)(2008-10#2)(2008-11#1)(2013-8#1)
(STZ##2##1##(2011-3#1)(2012-3#1)
(STZ)##3##1##(2008-10#1)(2010-11#1)(2011-3#1)
(SUS)##2##1##(2012-3#1)(2013-1#1)
(SUVs) of 1##2##3##(2008-10#2)
(SVD)##2##1##(1990-8#1)(2011-2#1)
(SVM)##2##1##(2010-8#2)
(SVV)##2##1##(2008-10#1)(2013-1#1)
(SW##4##1##(2008-10#3)(2008-11#1)
(SW)##7##1##(2008-10#6)(2011-2#1)
(SWATLD)##3##1##(2008-10#3)
(SWV)##11##1##(2008-10#11)
(SYSV)##2##1##(2008-10#2)
(Saccharomyces cerevisiae)##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
(Salmo##3##1##(1992-9#1)(1995-11#1)(2008-10#1)
(Sb(V))##2##1##(2008-10#2)
(Schrank)##2##1##(2007-12#1)(2013-8#1)
(Science##2##1##(1994-12#1)(2010-10#1)
(Se(IV))##4##1##(2008-10#4)
(Se(VI))##3##1##(2008-10#3)
(Se)##5##1##(2008-10#4)(2012-2#1)
(SeCys(2))##2##1##(2008-10#2)
(SeMet)##4##1##(2008-10#4)
(Sephadex QAE A-25) previously loaded with the fluorogenic reagent##2##9##(2008-10#2)
(Sephadex##3##1##(2008-10#3)
(Si)##5##1##(2008-10#4)(2008-9#1)
(SiO(-)NH(4)(+))##2##1##(2008-10#2)
(Sigma)##2##1##(2008-10#1)(2008-11#1)
(Siluriformes##2##1##(2008-12#1)(2008-9#1)
(SjAb)##3##1##(2008-10#3)
(Sma##3##1##(1992-6#2)(1992-8#1)
(Snodgraft)##2##1##(2008-10#2)
(Snyder et al##2##3##(2008-11#2)
(Solanaceae)##2##1##(2008-11#1)(2009-8#1)
(Solanum tuberosum L##2##3##(2008-10#2)
(Solanum tuberosum)##3##2##(2008-10#3)
(Solanum##7##1##(2008-10#6)(2008-12#1)
(Southern Italy)##2##2##(1994-2#1)(2010-4#1)
(Southern##4##1##(1994-2#1)(2008-10#2)(2010-4#1)
(Spain)##18##1##(1996-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2011-2#1)
(Spinacia oleracea)##3##2##(2008-10#3)
(Spodoptera frugiperda)##2##2##(2008-10#1)(2008-9#1)
(Squamata##2##1##(2008-7#1)(2013-1#1)
(St##2##1##(2008-3#1)(2008-7#1)
(Stenotaphrum secundatum)##2##2##(2008-10#2)
(Sternorrhyncha##2##1##(2007-12#2)
(Sweden)##2##1##(2008-3#1)(2008-5#1)
(T =##3##2##(2008-10#1)(2008-2#1)(2010-9#1)
(T##10##1##(1992-8#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-7#1)(2010-9#1)(2012-3#1)
(T(1))##2##1##(2008-10#1)(2010-4#1)
(T(3))##2##1##(2008-10#1)(2008-11#1)
(T(50))##3##1##(2008-10#3)
(T(max))##2##1##(2008-10#1)(2008-11#1)
(T) and lymph node##2##4##(1990-6#1)(1995-1#1)
(T) and##5##2##(1990-11#1)(1990-6#1)(1995-1#1)(1996-2#1)(2008-10#1)
(T) is##2##2##(2008-10#1)(2013-8#1)
(T)##14##1##(1990-11#1)(1990-6#1)(1995-1#1)(1995-2#1)(1996-2#1)(2008-10#6)(2008-3#1)(2008-8#1)(2013-8#1)
(T1##3##1##(2008-10#1)(2009-10#1)(2011-2#1)
(T1)##9##1##(1991-5#1)(1996-12#2)(2008-10#2)(2008-12#2)(2011-2#1)(2013-1#1)
(T2##2##1##(2009-10#1)(2011-2#1)
(T2)##5##1##(1996-12#2)(2008-10#1)(2008-12#1)(2013-1#1)
(T2DM)##2##1##(2010-10#1)(2013-1#1)
(T3)##9##1##(1992-5#1)(1993-8#1)(1994-11#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)
(T4) and##2##2##(2008-12#1)(2008-7#1)
(T4)##5##1##(2008-12#1)(2008-6#2)(2008-7#2)
(TA)##9##1##(1997-8#4)(2008-10#3)(2013-1#2)
(TAC)##4##1##(2008-10#4)
(TAM)##7##1##(1993-1#2)(1997-7#2)(2008-10#2)(2008-12#1)
(TAN)##3##1##(2008-10#3)
(TAT)##6##1##(1991-3#1)(2008-11#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#1)
(TB##2##1##(2008-10#2)
(TB)##15##1##(1996-3#4)(2008-10#2)(2009-12#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
(TBA)##3##1##(2008-10#3)
(TBAB) and##3##2##(1995-12#1)(2008-10#2)
(TBARS)##3##1##(1993-2#1)(2008-10#1)(2012-5#1)
(TBHQ)##3##1##(2008-10#3)
(TBI)##5##1##(1995-3#1)(2008-10#1)(2009-10#1)(2010-9#1)(2013-1#1)
(TBII)##2##1##(1991-5#1)(1995-12#1)
(TBP)##13##1##(1993-2#3)(1993-8#1)(1993-9#1)(2008-10#8)
(TBZ)##2##1##(2008-10#1)(2011-10#1)
(TC) and##2##2##(1992-10#1)(2009-5#1)
(TC)##6##1##(1992-10#1)(2008-10#3)(2009-5#1)(2011-2#1)
(TC)(n) repeats##2##2##(2008-10#2)
(TC)(n)##4##1##(2008-10#4)
(TCA)##6##1##(2008-10#4)(2010-1#1)(2010-12#1)
(TCC) of the##2##3##(2008-10#2)
(TCC)##7##1##(1992-12#1)(1993-11#1)(1993-6#1)(1997-7#1)(2008-10#2)(2012-3#1)
(TCD)##2##1##(1996-2#1)(1996-6#1)
(TCDD) was##2##2##(2008-10#1)(2008-11#1)
(TCDD)##11##1##(1992-12#1)(1994-5#1)(1995-11#1)(2008-10#7)(2008-11#1)
(TCE)##7##1##(2008-10#6)(2010-4#1)
(TCM)##3##1##(2008-10#1)(2009-6#1)(2012-2#1)
(TCMTB)##2##1##(2008-10#2)
(TCP)##3##1##(1994-2#1)(2008-10#1)(2009-8#1)
(TCPP)##2##1##(2008-10#2)
(TCR)##7##1##(1994-3#1)(2008-11#4)(2008-4#1)(2008-9#1)
(TCs)##2##1##(1992-6#1)(2008-10#1)
(TD)##4##1##(2008-10#1)(2009-8#1)(2010-12#1)(2012-12#1)
(TDAR)##6##1##(2008-10#6)
(TDF)##2##1##(2009-10#1)(2013-1#1)
(TE##2##1##(2008-10#2)
(TE)##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
(TEA)##9##1##(2008-10#7)(2008-5#1)(2008-8#1)
(TEA)(+)##2##1##(2008-10#2)
(TEHP)##3##1##(2008-10#3)
(TEM)##14##1##(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#3)(2011-2#2)
(TEP)##4##1##(2008-10#4)
(TEQ)##5##1##(2008-10#5)
(TER)##3##1##(2008-10#1)(2008-11#2)
(TES)##3##1##(1996-2#1)(2008-3#1)(2009-10#1)
(TEWL) and##4##2##(2008-5#4)
(TEWL)##6##1##(2008-5#6)
(TFA)##4##1##(2008-10#2)(2008-7#1)(2013-1#1)
(TFs)##3##1##(2010-7#2)(2012-2#1)
(TG) and##2##2##(2008-10#2)
(TG)##8##1##(2008-10#6)(2012-12#1)(2013-8#1)
(TG-DTG)##2##1##(2008-10#2)
(TGF-beta##3##1##(1991-12#1)(1995-2#2)
(TGF-beta) on##2##2##(2008-11#1)(2008-12#1)
(TGF-beta)##8##1##(1990-2#1)(1995-2#1)(2008-1#1)(2008-11#4)(2008-12#1)
(TH)##7##1##(1990-7#1)(1996-12#2)(1997-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
(THD)##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
(THF)##4##1##(1992-10#1)(1996-5#1)(2008-10#2)
(TI)##2##1##(2008-10#2)
(TIC)##2##1##(2008-10#2)
(TIP)##2##1##(2008-10#1)(2011-2#1)
(TIRF)##2##1##(2008-10#2)
(TJ) permeability##2##2##(2008-11#2)
(TJ)##5##1##(2008-11#2)(2009-10#1)(2012-2#2)
(TL)##4##1##(1995-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
(TLC)##5##1##(2008-10#3)(2008-12#1)(2008-4#1)
(TLS)##5##1##(2008-10#3)(2008-7#2)
(TMA) in##2##2##(1995-11#1)(2008-10#1)
(TMA)##9##1##(1995-11#1)(2008-10#8)
(TMAO)##3##1##(2008-10#3)
(TMD)##2##1##(2012-3#1)(2013-1#1)
(TMV)##5##1##(2008-10#5)
(TN)##2##1##(2008-10#1)(2011-2#1)
(TNB)##2##1##(2008-10#2)
(TNF##3##1##(1995-12#1)(1995-2#1)(2012-3#1)
(TNF) is an##2##3##(1992-7#1)(2008-9#1)
(TNF)##19##1##(1990-5#1)(1992-12#1)(1992-7#1)(1994-8#1)(1996-2#2)(1997-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#3)(2012-3#2)
(TNF-alpha) and##2##2##(2008-10#1)(2008-11#1)
(TNF-alpha)##14##1##(1992-8#1)(1995-12#2)(1995-9#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-9#1)(2010-7#1)(2012-2#1)
(TNF-α)##3##1##(2010-12#1)(2012-3#2)
(TNP)##2##1##(2008-10#2)
(TNT) using##2##2##(2008-10#2)
(TNT)##16##1##(2008-10#12)(2008-11#3)(2008-3#1)
(TNT-H)(-)##3##1##(2008-10#3)
(TOA)##2##1##(2008-10#1)(2008-3#1)
(TOM)##3##1##(2008-4#2)(2012-2#1)
(TOP)##2##1##(2008-10#1)(2008-11#1)
(TP)##3##1##(2008-10#2)(2009-8#1)
(TPA)##10##1##(1990-12#1)(1990-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-9#1)
(TPB)##3##1##(2008-10#2)(2011-1#1)
(TPE)##2##1##(2011-2#2)
(TPF)##3##1##(2008-10#1)(2008-3#1)(2010-12#1)
(TPL)##2##1##(1997-8#1)(2010-1#1)
(TPO)##3##1##(2008-8#2)(2011-1#1)
(TPP)##3##1##(2008-10#3)
(TR =##2##2##(1997-8#2)
(TR##3##1##(1997-8#3)
(TRA)##3##1##(2011-1#1)(2011-2#2)
(TRE)##3##1##(1993-3#1)(1993-8#1)(1995-8#1)
(TRH)##5##1##(1992-6#1)(1996-12#1)(2008-10#1)(2008-4#1)(2013-7#1)
(TRIS) buffer##2##2##(2008-10#2)
(TRIS)##3##1##(2008-10#3)
(TRSV)##2##1##(2008-10#2)
(TRUS)##2##1##(1997-8#1)(2011-2#1)
(TS)##5##1##(2008-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
(TS/pH##2##1##(2008-11#2)
(TSA)##4##1##(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)
(TSC)##2##1##(1992-1#1)(1993-12#1)
(TSH##3##1##(2012-12#1)(2012-3#2)
(TSH)##6##1##(1991-5#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
(TSK)##3##1##(1997-8#2)(2008-10#1)
(TSPO) (18 kDa)##2##3##(2012-2#2)
(TSPO) (18##3##2##(2012-2#3)
(TSPO) in##4##2##(2012-2#4)
(TSPO)##16##1##(2012-2#16)
(TSWV) is##2##2##(2008-10#2)
(TSWV) was##2##2##(2008-10#2)
(TSWV)##20##1##(2008-10#20)
(TT##2##1##(1992-6#1)(2008-10#1)
(TTF)##2##1##(1996-5#1)(2008-8#1)
(TTM)##4##1##(2008-12#1)(2010-12#1)(2010-2#1)(2013-1#1)
(TTR)##2##1##(1992-8#1)(2008-12#1)
(TU)##2##1##(2008-9#1)(2013-8#1)
(TUNEL)##4##1##(2008-8#3)(2008-9#1)
(TXRF)##2##1##(2008-10#2)
(TYLCV)-Sr by TYLCV-Is##2##3##(2008-10#2)
(Takayasu's disease)##2##2##(2012-3#2)
(TaqMan)##5##1##(2008-10#5)
(Tb)##2##1##(2008-8#1)(2012-2#1)
(Teleostei##6##1##(2008-5#1)(2008-7#3)(2010-8#2)
(Tg)##2##1##(1991-6#1)(2013-1#1)
(Th)##2##1##(1995-12#1)(2008-11#1)
(Th1)##3##1##(2008-10#1)(2008-11#2)
(The##7##1##(1996-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)
(Thevetia##2##1##(2008-12#2)
(TiO(2)##2##1##(2008-10#2)
(Tiron)##2##1##(2008-10#2)
(Tomato##2##1##(2008-10#2)
(Topo##4##1##(1994-8#4)
(Toxic##2##1##(1992-1#1)(2008-10#1)
(Trace Elements in##2##3##(2008-10#2)
(Trace##3##1##(2008-10#3)
(Trichoplusia##2##1##(2008-7#1)(2008-9#1)
(Tridacnidae)##2##1##(2008-5#2)
(Triticum aestivum)##13##2##(2008-10#10)(2008-11#1)(2008-12#1)(2008-9#1)
(Triticum turgidum##2##2##(2008-10#1)(2012-3#1)
(Triticum##23##1##(2008-10#16)(2008-11#2)(2008-12#2)(2008-9#1)(2012-3#2)
(Triton X-114) after centrifugation##2##4##(2008-10#2)
(Triton##3##1##(2008-10#3)
(Trx)##2##1##(1991-6#2)
(TuMV)##5##1##(2008-10#5)
(Tyr) and##2##2##(2008-10#1)(2013-1#1)
(Tyr)##3##1##(2008-10#2)(2013-1#1)
(U##5##1##(1996-12#1)(2008-10#3)(2010-8#1)
(U)##3##1##(2008-10#2)(2008-11#1)
(U-shaped)##2##1##(2008-7#2)
(UC)##6##1##(2008-9#1)(2009-12#1)(2010-12#2)(2011-2#2)
(UER)##2##1##(2008-5#1)(2011-2#1)
(UI)##2##1##(1991-2#1)(2010-10#1)
(UK)##5##1##(1995-3#1)(2008-10#1)(2008-11#2)(2008-12#1)
(UKCC##2##1##(2008-11#2)
(UN)##2##1##(1996-1#1)(2008-10#1)
(UOx)##2##1##(2008-10#2)
(UPDRS)##2##1##(2008-7#2)
(US##5##1##(1992-12#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
(US) examination##2##2##(2011-2#1)(2013-8#1)
(US) findings##2##2##(2011-2#1)(2012-2#1)
(US)##12##1##(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#4)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
(US-1##3##1##(2008-10#3)
(US-8##4##1##(2008-10#4)
(USA)##4##1##(2008-10#2)(2008-7#1)(2010-12#1)
(USC)##2##1##(1992-12#1)(2010-12#1)
(USN)##2##1##(2008-10#2)
(UTI)##4##1##(1994-3#1)(2008-7#1)(2011-2#2)
(UTR) of the##2##3##(1993-12#1)(2008-10#1)
(UTR)##5##1##(1993-12#1)(1997-7#1)(2008-10#3)
(UV) irradiation##2##2##(2008-10#1)(2012-2#1)
(UV)##13##1##(1991-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
(UV-Vis)##2##1##(2008-10#2)
(UV-vis)##4##1##(2008-10#3)(2009-11#1)
(UVB)##3##1##(2008-11#2)(2008-5#1)
(Uni-TCCCN) and##2##2##(2008-10#2)
(United States##2##2##(2008-8#1)(2013-8#1)
(United States) and##2##3##(2008-10#2)
(United States)##3##2##(1995-3#1)(2008-10#2)
(United##6##1##(1995-3#1)(2008-10#2)(2008-8#1)(2013-1#1)(2013-8#1)
(University of##2##2##(1990-2#1)(1992-12#1)
(V##7##1##(2008-10#6)(2008-8#1)
(V) to##2##2##(1991-5#1)(2008-10#1)
(V) were##2##2##(2008-10#2)
(V)##17##1##(1991-5#1)(2008-10#14)(2008-4#1)(2011-2#1)
(V-ATPase##2##1##(2008-11#2)
(V/V)##2##1##(2008-10#1)(2008-5#1)
(V106-P322)##4##1##(2008-8#4)
(VA)##7##1##(1993-12#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
(VAM)##2##1##(2008-10#1)(2008-9#1)
(VAP)##2##1##(1995-5#1)(2010-7#1)
(VAS)##3##1##(2008-7#1)(2012-12#1)(2013-1#1)
(VB)##3##1##(2008-10#2)(2013-1#1)
(VC)##4##1##(2008-10#1)(2009-1#1)(2011-2#1)(2012-2#1)
(VCG) diversity##2##2##(2008-10#2)
(VCG)##9##1##(2008-10#8)(2010-8#1)
(VDR)##4##1##(1995-2#1)(1995-8#1)(2012-12#1)(2013-1#1)
(VDRE)##2##1##(1995-8#1)(2012-12#1)
(VI) and##3##2##(2008-10#3)
(VI) by##2##2##(2008-10#2)
(VI) in##6##2##(2008-10#6)
(VI) species##2##2##(2008-10#2)
(VI) with##5##2##(2008-10#5)
(VI)##38##1##(1993-3#1)(2008-10#37)
(VII) and p-cresol (VIII)##2##4##(1991-5#2)
(VII)##5##1##(1991-5#2)(2008-10#3)
(VIII)##3##1##(1991-5#2)(2008-10#1)
(VIP)##6##1##(1990-5#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-11#1)(2011-2#1)
(VLDL)##6##1##(1991-12#1)(1995-6#1)(2008-10#2)(2008-6#1)(2011-1#1)
(VOCs) in##2##2##(2008-10#2)
(VOCs)##6##1##(2008-10#6)
(VP)##2##1##(2008-5#1)(2008-7#1)
(VPA)##6##1##(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
(VPD) of##3##2##(2008-10#3)
(VPD)##4##1##(2008-10#4)
(VR)##3##1##(1992-3#1)(1994-12#1)(2009-11#1)
(VR1)##2##1##(2008-11#2)
(VS)##2##1##(2008-11#1)(2011-2#1)
(VSMC)##3##1##(1993-2#1)(2008-1#1)(2008-9#1)
(Vicia##4##1##(2008-10#3)(2009-8#1)
(Vigna##3##1##(2008-10#1)(2008-12#2)
(Vitex agnus castus)##2##3##(2008-12#2)
(Vitis vinifera)##2##2##(2008-10#2)
(Vitis##5##1##(2008-10#5)
(W) interface##2##2##(2008-10#2)
(W)##4##1##(2008-10#3)(2008-9#1)
(W370)##2##1##(2008-10#2)
(WA)##3##1##(2008-10#3)
(WB##2##1##(1993-11#1)(2008-10#1)
(WB)##4##1##(1993-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
(WD)##3##1##(2008-10#2)(2010-12#1)
(WDM)##2##1##(2008-2#1)(2008-3#1)
(WG##2##1##(2008-10#1)(2008-11#1)
(WHO)##14##1##(1994-9#1)(1995-3#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
(WM) diode-laser##2##2##(2008-3#2)
(WM)##5##1##(1994-8#2)(2008-3#2)(2013-1#1)
(WMS)##2##1##(2008-3#1)(2008-7#1)
(WRAP)##2##1##(2008-11#2)
(WT) and##4##2##(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
(WT)##16##1##(1991-10#1)(1995-6#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
(Waters)##2##1##(1997-2#1)(2008-10#1)
(Wld(S))##3##1##(1997-3#3)
(X##9##1##(2008-10#7)(2008-7#1)(2008-9#1)
(X) in##2##2##(2008-10#2)
(X)##4##1##(2008-10#4)
(X-ray##2##1##(2008-10#1)(2010-4#1)
(XO)##6##1##(2008-10#5)(2008-11#1)
(XPS)##6##1##(2008-10#6)
(XRD) and scanning##2##3##(2008-10#2)
(XRD) and##8##2##(2008-10#8)
(XRD)##19##1##(2008-10#16)(2009-11#1)(2009-7#1)(2010-4#1)
(Xanthomonas##3##1##(2008-10#3)
(Y =##3##2##(2008-10#3)
(Y)##5##1##(2008-10#4)(2012-2#1)
(YGG)##2##1##(2008-10#1)(2008-6#1)
(Yang##2##1##(1994-5#2)
(Yb##2##1##(2008-2#1)(2008-3#1)
(Yb) and##2##2##(1997-8#2)
(Z##4##1##(2008-10#3)(2008-12#1)
(Z)-3-hexen-1-ol##2##1##(2008-10#2)
(Zea mays L##8##3##(2008-10#3)(2008-12#1)(2008-9#1)(2012-3#3)
(Zea mays##9##2##(2008-10#3)(2008-12#1)(2008-9#1)(2009-10#1)(2012-3#3)
(Zea mays)##7##2##(2008-10#6)(2012-2#1)
(Zea##16##1##(2008-10#9)(2008-12#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#3)
(Zip)##2##1##(2008-10#1)(2012-2#1)
(Zn##5##1##(1993-12#1)(2008-10#4)
(Zn)##4##1##(2008-10#3)(2012-2#1)
([Ca(2+)](i))##4##1##(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)
([Ca2+]i)##7##1##(1990-5#1)(1992-6#2)(1994-11#1)(1994-6#1)(1995-11#1)(1997-1#1)
([Formula##2##1##(2008-8#2)
(a &quot##2##2##(2013-1#2)
(a benzimidazole) and vinclozolin (a dicarboximide) (S(T)S(V))##2##7##(2008-10#2)
(a calcium channel##2##3##(1995-12#1)(2008-10#1)
(a measure of##2##3##(2008-10#2)
(a measure##3##2##(2008-10#3)
(a mixture of##2##3##(2008-10#1)(2012-3#1)
(a relatively##2##2##(1991-12#1)(2010-1#1)
(a representative of subgroup##2##4##(2008-10#2)
(a##130##1##(1990-5#1)(1991-1#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1996-1#1)(1996-2#3)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#43)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#8)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#3)(2013-1#4)
(a) What##2##2##(2008-12#1)(2009-5#1)
(a) a##6##2##(1991-1#1)(1992-1#1)(1994-1#3)(2008-10#1)
(a) all##2##2##(2007-12#1)(2011-2#1)
(a) in##3##2##(1991-12#1)(1993-12#1)(2008-11#1)
(a) no##2##2##(1990-6#1)(2008-2#1)
(a) reduction##2##2##(1997-2#1)(2008-11#1)
(a) the##10##2##(1994-6#1)(1996-12#1)(2008-10#4)(2008-4#2)(2012-2#1)(2013-8#1)
(a)##91##1##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#4)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-8#3)(2007-12#1)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#7)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-2#3)(2013-1#2)(2013-8#2)
(aFGF)##3##1##(1990-8#1)(1991-12#1)(1997-7#1)
(aOR 2##2##2##(2008-11#2)
(aOR##3##1##(2008-11#3)
(aa) changes##2##2##(1993-12#1)(1993-6#1)
(aa) protein##3##2##(1993-12#1)(1993-9#1)(1997-7#1)
(aa) sequence of##3##3##(1991-6#1)(1993-12#1)(1993-6#1)
(aa) sequence##5##2##(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#2)
(aa)##36##1##(1990-11#2)(1990-5#1)(1991-6#2)(1991-9#1)(1993-12#7)(1993-2#4)(1993-6#8)(1993-9#2)(1994-8#1)(1995-12#1)(1996-6#1)(1997-7#3)(2008-10#2)(2010-5#1)
(about 4##3##2##(1990-11#1)(1995-6#1)(2008-7#1)
(about a##2##2##(2009-1#1)(2009-5#1)
(about##25##1##(1990-11#1)(1994-5#1)(1995-12#2)(1995-6#2)(2007-12#1)(2008-10#11)(2008-7#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
(above##4##1##(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)
(absolute##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
(absolute)##2##1##(2008-10#1)(2008-3#1)
(absorbance##2##1##(2008-10#2)
(absorption##3##1##(2008-10#3)
(accuracy##4##1##(2008-10#4)
(acetic acid)##2##2##(2008-10#1)(2008-7#1)
(acetic##4##1##(2008-10#3)(2008-7#1)
(acetic-acetate)##2##1##(2008-10#2)
(acetone##2##1##(2008-10#1)(2008-5#1)
(acting as##2##2##(2008-10#2)
(activation of##2##2##(1993-12#2)
(active##4##1##(2008-10#3)(2013-1#1)
(activity##2##1##(1994-12#2)
(actual##3##1##(2008-3#1)(2013-1#2)
(acute##7##1##(1992-3#1)(1995-11#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
(adding##2##1##(1995-2#1)(2008-10#1)
(adhesive knobs)##2##2##(2008-10#2)
(adhesive networks)##2##2##(2008-10#2)
(adhesive##4##1##(2008-10#4)
(adjusted OR 0##3##3##(2008-10#3)
(adjusted OR 1##3##3##(2008-10#2)(2011-2#1)
(adjusted OR##7##2##(2008-10#6)(2011-2#1)
(adjusted r(2) = 0##2##4##(2008-10#2)
(adjusted r(2)##3##2##(2008-10#3)
(adjusted to pH##4##3##(2008-10#4)
(adjusted##18##1##(1993-3#1)(2008-10#15)(2011-2#1)(2013-1#1)
(adsorption)##2##1##(2008-10#2)
(adult##3##1##(2007-11#1)(2008-10#1)(2010-8#1)
(adult)##3##1##(1995-8#1)(2008-12#2)
(after oxidation##2##2##(2008-10#2)
(after##10##1##(1995-3#1)(2008-10#5)(2008-5#2)(2008-8#1)(2011-3#1)
(against amino acid sequence##2##4##(1996-12#2)
(age &gt##2##2##(2008-11#1)(2012-3#1)
(age range##2##2##(1995-12#1)(1997-3#1)
(age##23##1##(1991-8#1)(1995-12#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2009-9#1)(2010-1#1)(2011-2#5)(2012-2#1)(2012-3#4)(2013-1#1)
(age- and##2##2##(2008-7#1)(2013-1#1)
(aged##12##1##(2008-11#2)(2008-5#1)(2008-9#2)(2010-8#1)(2011-1#1)(2013-1#4)(2013-8#1)
(aggrecan)##2##1##(1991-5#1)(1993-2#1)
(air##2##1##(2008-11#1)(2008-7#1)
(albumin##2##1##(2008-10#1)(2008-11#1)
(alfalfa##2##1##(2008-10#1)(2008-5#1)
(all p &gt##2##3##(2011-2#1)(2013-8#1)
(all p values &lt##2##4##(2008-3#2)
(all p##4##2##(2008-3#2)(2011-2#1)(2013-8#1)
(all##18##1##(1991-2#2)(1992-4#3)(1997-8#1)(2008-10#3)(2008-3#2)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
(allele##3##1##(1993-3#1)(1993-6#1)(2008-12#1)
(alpha##15##1##(1990-4#1)(1990-8#1)(1992-10#1)(1993-12#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-11#2)(2008-10#5)
(alpha&lt##2##1##(2009-2#2)
(alpha) and##3##2##(1991-5#1)(2008-10#2)
(alpha) of##2##2##(2008-10#1)(2008-11#1)
(alpha)##8##1##(1991-5#1)(2008-10#5)(2008-11#2)
(alpha=0##3##1##(2008-10#2)(2008-7#1)
(also known as##5##3##(1994-11#1)(1996-2#1)(2008-10#2)(2008-5#1)
(also##10##1##(1993-11#1)(1994-11#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)
(alt)##6##1##(2008-9#6)
(although##4##1##(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
(ambient##2##1##(2008-10#1)(2008-5#1)
(amino acids##3##2##(1995-11#1)(1995-12#1)(2008-8#1)
(amino##4##1##(1991-5#1)(1995-11#1)(1995-12#1)(2008-8#1)
(ammonium##5##1##(2008-10#5)
(among##4##1##(1991-12#1)(1996-12#1)(2008-8#2)
(amount of##2##2##(2008-10#2)
(an 1##3##2##(2008-11#3)
(an index of##2##3##(1993-8#1)(2008-6#1)
(an##21##1##(1993-8#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#6)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
(analyte##2##1##(2008-10#2)
(anamorph Phoma##2##2##(2008-10#2)
(anamorph##14##1##(2008-10#13)(2010-3#1)
(and a##2##2##(2008-11#1)(2009-6#1)
(and also##2##2##(2008-10#1)(2008-7#1)
(and hence##3##2##(1992-6#1)(1993-12#1)(2010-7#1)
(and increase##2##2##(2008-3#1)(2008-9#1)
(and not##2##2##(2008-10#1)(2009-4#1)
(and other##3##2##(1995-2#1)(2008-9#1)(2013-1#1)
(and potentially##2##2##(2008-3#1)(2011-2#1)
(and sometimes##2##2##(2008-11#1)(2011-2#1)
(and the##4##2##(2008-8#2)(2011-2#1)(2012-3#1)
(and their##3##2##(2008-10#2)(2008-12#1)
(and thereby##3##2##(2008-10#1)(2008-8#2)
(and therefore the##2##3##(2008-5#2)
(and thus##2##2##(2008-10#1)(2008-7#1)
(and##67##1##(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#1)
(and/or##3##1##(1994-6#1)(1997-5#1)(2008-10#1)
(animal##2##1##(2008-10#2)
(another##2##1##(2008-10#1)(2008-7#1)
(anterolateral approach##2##2##(2011-2#2)
(antioxidant##2##1##(2008-10#1)(2012-6#1)
(aorta##2##1##(2013-8#2)
(aortic arch##2##2##(1997-8#2)
(apical##2##1##(2012-2#1)(2013-8#1)
(apparent##4##1##(1994-8#3)(2008-10#1)
(approx##2##1##(1994-2#1)(1994-8#1)
(approximately##32##1##(1990-12#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-3#1)(1995-11#4)(1995-2#2)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
(area under##2##2##(2008-3#1)(2010-8#1)
(area##4##1##(2008-3#1)(2008-8#1)(2010-8#1)(2013-8#1)
(areas##3##1##(1994-3#1)(2013-1#1)(2013-8#1)
(around##3##1##(1993-11#1)(1993-3#1)(2008-10#1)
(arsenite##2##1##(2008-10#2)
(as a result of##2##4##(2008-10#1)(2010-6#1)
(as a##10##2##(2008-10#7)(2008-9#2)(2010-6#1)
(as an##2##2##(2008-10#1)(2008-8#1)
(as assessed##2##2##(1990-8#1)(2010-12#1)
(as compared with##2##3##(2008-10#1)(2011-2#1)
(as in##3##2##(2008-10#3)
(as measured by a##2##4##(2008-3#1)(2013-1#1)
(as measured by##9##3##(1991-9#1)(1995-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2013-1#1)
(as opposed to##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)
(as the##2##2##(2008-10#1)(2011-2#1)
(as well as##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
(as##76##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-9#1)(1993-1#1)(1995-1#1)(1996-3#1)(2008-10#39)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#4)(2013-8#1)
(ascorbic acid##2##2##(2008-10#2)
(ascorbic acid)##2##2##(1993-12#1)(2008-10#1)
(ascorbic##4##1##(1993-12#1)(2008-10#3)
(aspartate##2##1##(1990-7#1)(1995-6#1)
(assessed##4##1##(2008-10#4)
(associated with##2##2##(2013-1#1)(2013-8#1)
(assuming##2##1##(1993-1#1)(2009-10#1)
(at &gt##2##2##(1995-8#1)(1997-1#1)
(at 0##2##2##(2008-10#2)
(at 1##3##2##(2008-10#2)(2008-11#1)
(at 10##3##2##(1992-12#1)(2008-10#2)
(at 20##2##2##(2008-10#2)
(at 2400 degrees C)##2##4##(2008-10#2)
(at 25 degrees C)##2##4##(2008-10#2)
(at 37 degrees##2##3##(1992-3#1)(2008-11#1)
(at 50 mug l(-1))##2##4##(2008-10#2)
(at 95%##3##2##(2008-10#3)
(at a##4##2##(1997-8#1)(2008-10#2)(2008-12#1)
(at least in the##2##4##(2011-2#1)(2012-2#1)
(at least##9##2##(1991-5#1)(2008-10#3)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)
(at pH##3##2##(2008-10#3)
(at the##5##2##(1992-4#1)(2008-10#3)(2008-11#1)
(at##70##1##(1990-5#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1994-2#1)(1995-8#1)(1997-1#2)(1997-8#1)(2008-10#46)(2008-11#4)(2008-12#1)(2008-3#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#2)(2012-7#1)(2013-8#1)
(atmospheric##2##1##(2008-11#1)(2008-3#1)
(atomic##2##1##(1994-3#1)(2008-11#1)
(atrazine)##2##1##(2008-10#2)
(average age of##2##3##(2010-9#2)
(average age##8##2##(1993-11#2)(2008-7#1)(2010-1#1)(2010-3#1)(2010-9#2)(2011-2#1)
(average kappa = 0##2##4##(1997-8#2)
(average##28##1##(1991-2#1)(1993-11#2)(1996-9#1)(1997-8#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#3)(2011-3#1)(2012-3#1)(2012-4#1)(2013-1#2)
(axis##2##1##(2008-10#2)
(b##2##1##(2010-12#1)(2010-7#1)
(b) How##2##2##(2009-5#1)(2010-12#1)
(b) The##2##2##(2008-5#1)(2008-7#1)
(b) a##4##2##(1991-1#1)(1994-1#3)
(b) the##14##2##(1992-1#1)(1994-6#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
(b) to##2##2##(1991-12#1)(2013-1#1)
(b)##83##1##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#4)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-8#3)(2007-12#1)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#7)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#2)(2013-8#2)
(bFGF)##6##1##(1991-12#1)(1992-3#1)(1994-11#1)(1995-12#2)(2008-11#1)
(bacterial##3##1##(1990-12#1)(1997-2#1)(2008-10#1)
(basal##3##1##(1994-3#1)(2009-10#1)(2012-2#1)
(base##4##1##(1993-9#1)(2008-10#2)(2008-5#1)
(based on the##3##3##(1990-8#1)(2008-10#1)(2010-11#1)
(based on visual##2##3##(2008-10#2)
(based on##16##2##(1990-8#1)(1993-11#1)(2008-10#10)(2008-3#1)(2010-11#1)(2011-2#1)(2011-3#1)
(baseline)##2##1##(2012-3#1)(2013-1#1)
(bean and##2##2##(2008-10#2)
(because the##2##2##(2008-11#1)(2008-8#1)
(because##4##1##(1993-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
(before the past 12 months)##2##5##(2009-5#2)
(before the##3##2##(2009-5#2)(2012-3#1)
(before##14##1##(1995-2#1)(1996-11#2)(2008-10#3)(2008-5#1)(2009-5#2)(2009-6#1)(2011-2#2)(2011-3#1)(2012-3#1)
(beliefs)##2##1##(2008-12#1)(2010-11#1)
(below##2##1##(1996-8#1)(2008-10#1)
(benzene##2##1##(2008-10#2)
(besides##3##1##(2008-10#3)
(best##2##1##(2010-10#1)(2011-2#1)
(beta -##2##2##(2008-11#2)
(beta = -0##5##3##(2010-2#2)(2010-4#3)
(beta = 0##7##3##(2010-2#2)(2010-4#4)(2011-2#1)
(beta =##12##2##(2010-2#4)(2010-4#7)(2011-2#1)
(beta b = 0##2##4##(1997-1#2)
(beta b =##5##3##(1997-1#5)
(beta b##7##2##(1997-1#7)
(beta##28##1##(1990-5#1)(1991-10#2)(1991-5#1)(1993-6#1)(1993-9#1)(1997-1#7)(1997-3#1)(2008-11#2)(2010-2#4)(2010-4#7)(2011-2#1)
(beta)##2##1##(1993-8#1)(2008-12#1)
(beta-1##3##1##(2008-10#3)
(beta-CD) and##5##2##(2008-10#5)
(beta-CD)##17##1##(2008-10#17)
(beta-NAD(+))##2##1##(2008-10#2)
(beta-carboline-3-carboxylate##2##1##(1995-11#2)
(beta-cyclodextrin##2##1##(2008-10#1)(2008-11#1)
(beta=##3##1##(2008-4#3)
(better than##2##2##(2008-10#1)(2010-1#1)
(better##3##1##(2008-10#1)(2008-11#1)(2010-1#1)
(between 0##2##2##(2008-10#2)
(between environments)##2##2##(2008-8#2)
(between##16##1##(1996-12#1)(2008-10#9)(2008-4#2)(2008-8#2)(2010-6#1)(2011-3#1)
(bin##2##1##(2008-10#2)
(biological##3##1##(2008-10#1)(2010-10#1)(2010-12#1)
(biomass##2##1##(2008-11#1)(2008-7#1)
(blank##2##1##(2008-10#2)
(bleaches)##2##1##(2008-10#2)
(blood##3##1##(2008-10#1)(2008-5#1)(2013-8#1)
(body mass index##2##3##(2009-7#1)(2012-12#1)
(body mass##4##2##(2008-9#1)(2009-7#1)(2012-12#1)(2013-8#1)
(body temperature##2##2##(2008-7#2)
(body##7##1##(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-12#1)(2013-8#1)
(bone##2##1##(2008-11#1)(2008-9#1)
(both p &lt##2##3##(2013-1#2)
(both##37##1##(1991-12#1)(1995-11#1)(1995-3#1)(1995-8#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#9)
(bound##2##1##(2008-10#1)(2012-12#1)
(bp)##6##1##(1993-3#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
(broccoli##2##1##(2008-10#2)
(but not the##3##3##(1994-8#1)(2008-9#1)(2010-7#1)
(but not##22##2##(1991-12#1)(1991-2#1)(1991-9#1)(1994-2#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-8#2)(2008-9#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-6#1)(2013-1#1)
(but##28##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-8#4)(2008-9#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-6#1)(2013-1#1)
(butylated##2##1##(1996-2#2)
(by about 50%)##2##3##(2009-8#2)
(by about##4##2##(2009-8#4)
(by adding##2##2##(2008-10#2)
(by comparison with##2##3##(2008-10#2)
(by comparison##3##2##(2008-10#2)(2008-7#1)
(by the##2##2##(2008-10#2)
(by using##3##2##(2008-10#1)(2011-2#2)
(by##32##1##(1993-1#1)(1993-3#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#4)(2011-2#2)(2013-1#1)(2013-8#1)
(c##14##1##(1993-2#1)(1995-2#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-8#7)(2011-1#1)
(c(L)=1##2##1##(2008-10#2)
(c) 1997 John Wiley &amp##36##5##(2008-7#36)
(c) the##10##2##(1990-5#1)(1992-1#1)(1994-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-2#1)
(c)##126##1##(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#4)(2008-11#39)(2008-12#2)(2008-2#1)(2008-4#4)(2008-7#40)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#2)
(cAMP)##7##1##(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#2)
(cDNA)##5##1##(1993-6#1)(2008-10#3)(2008-9#1)
(cGMP)##2##1##(1995-2#1)(1995-8#1)
(cM) of the##2##3##(1993-12#1)(2008-10#1)
(cM)##9##1##(1993-12#1)(2008-10#8)
(ca##19##1##(1993-8#1)(2008-10#14)(2008-5#2)(2009-4#1)(2009-6#1)
(cadmium##3##1##(2008-10#2)(2008-11#1)
(calcium##2##1##(1993-2#1)(2008-10#1)
(calculated as##2##2##(2008-10#2)
(calculated##4##1##(1991-6#1)(2008-10#3)
(called##5##1##(1992-4#2)(2008-12#1)(2008-8#1)(2012-2#1)
(calpain##2##1##(1994-5#1)(2013-1#1)
(carbaryl)##2##1##(2008-10#2)
(carbendazim##2##1##(2008-10#2)
(carbon##2##1##(2008-10#2)
(caregiver##2##1##(2010-11#1)(2011-2#1)
(carotid intima-media thickness##2##3##(2008-11#2)
(carries Bs1 + Bs2 + Bs3)##2##6##(2008-10#2)
(carries Bs1 + Bs2)##2##4##(2008-10#2)
(carries Bs1 + Bs3)##2##4##(2008-10#2)
(carries Bs1 +##6##3##(2008-10#6)
(carries Bs1)##2##2##(2008-10#2)
(carries Bs2)##2##2##(2008-10#2)
(carries##13##1##(2008-10#13)
(carrying##3##1##(2008-10#3)
(causal agent of##2##3##(2008-10#2)
(causal agent##3##2##(2008-10#3)
(caused by Phialophora gregata)##2##4##(2008-10#2)
(caused by the##2##3##(1993-6#1)(2008-10#1)
(caused by##14##2##(1993-6#1)(2008-10#13)
(causing##5##1##(2007-12#1)(2008-10#4)
(cava and champagne)##2##3##(2008-10#2)
(cell##5##1##(2008-10#1)(2008-11#3)(2012-4#1)
(cellular##2##1##(1990-12#1)(2011-2#1)
(central##4##1##(1994-12#1)(2008-10#3)
(cf##2##1##(1992-12#1)(2008-10#1)
(changes in##3##2##(1994-6#1)(2013-8#2)
(channel##2##1##(2008-10#1)(2008-7#1)
(characterized by##2##2##(2008-10#1)(2009-12#1)
(charge##2##1##(2008-10#1)(2008-4#1)
(chemical##2##1##(2008-10#2)
(chi 2 =##2##3##(1997-8#2)
(chi(2) = 0##2##3##(2008-10#2)
(chi(2)##3##1##(2008-10#2)(2010-2#1)
(chi2 =##4##2##(2009-6#2)(2011-2#2)
(children with##2##2##(1995-3#1)(2013-1#1)
(children##5##1##(1992-3#1)(1995-3#1)(2009-9#1)(2013-1#2)
(chimaera monstrosa)##2##2##(1991-6#2)
(chl)##2##1##(1990-5#1)(2008-9#1)
(chloride##3##1##(2008-10#3)
(chloroform##2##1##(2008-10#2)
(choice##2##1##(2008-10#2)
(cholesterol##3##1##(1992-12#1)(2008-4#1)(2013-1#1)
(chromosome##3##1##(2008-10#1)(2008-12#1)(2009-10#1)
(chromosomes##2##1##(2008-10#2)
(chronic##3##1##(1992-3#1)(2008-10#1)(2008-5#1)
(cisplatin) and##2##2##(1993-8#1)(2008-11#1)
(class III activity)##2##3##(1992-3#2)
(class##6##1##(1992-3#3)(2008-10#3)
(clinical##5##1##(1994-12#1)(1995-5#1)(1997-8#1)(2010-5#1)(2012-2#1)
(close to##3##2##(1990-5#2)(2008-10#1)
(cloud##2##1##(2008-10#1)(2008-3#1)
(coding##2##1##(2008-4#1)(2008-9#1)
(coefficient of variation##2##3##(2008-10#2)
(coefficients of variation##2##3##(2008-10#2)
(cold##3##1##(1991-5#1)(2008-10#2)
(collagen##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
(colonization)##2##1##(2008-10#1)(2008-5#1)
(combined effect of Thompson disc grades##2##6##(2011-2#2)
(combined##5##1##(1994-2#1)(2010-7#1)(2011-2#2)(2013-1#1)
(commercial##4##1##(2008-10#3)(2008-8#1)
(common##4##1##(2008-10#2)(2010-8#1)(2011-2#1)
(commonly##2##1##(2008-10#2)
(community health information##6##3##(1996-1#6)
(compared to##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
(compared##4##1##(2008-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
(comparing##3##1##(2010-7#1)(2012-9#2)
(competitive##2##1##(2008-10#1)(2009-7#1)
(complete##2##1##(1997-3#1)(2012-12#1)
(composed##2##1##(2008-12#1)(2011-2#1)
(concentration of##2##2##(2008-10#2)
(concentration##6##1##(2008-10#3)(2008-6#2)(2011-10#1)
(concentrations##3##1##(2008-10#2)(2008-11#1)
(constant##4##1##(2008-10#2)(2008-5#1)(2011-2#1)
(containing##9##1##(1992-6#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
(continuous)##2##1##(2008-9#1)(2009-12#1)
(control group)##3##2##(2008-11#1)(2008-5#1)(2009-1#1)
(control##14##1##(1990-6#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2012-9#1)(2013-1#1)(2013-8#2)
(control)##11##1##(1994-5#1)(2008-10#1)(2008-12#3)(2009-6#1)(2011-2#2)(2013-1#3)
(controls)##2##1##(1991-7#1)(2011-2#1)
(conventional##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
(corrected##2##1##(2008-10#1)(2011-2#1)
(correlation coefficient##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
(correlation coefficients##4##2##(2008-10#3)(2013-8#1)
(correlation##8##1##(1990-12#1)(2008-10#5)(2011-2#1)(2013-8#1)
(corresponding to 0##2##3##(2008-10#1)(2010-4#1)
(corresponding to##7##2##(1991-5#1)(1994-5#1)(2008-10#4)(2010-4#1)
(craniopharyngioma##2##1##(2012-3#2)
(cross-validation R(2)=0##4##2##(2009-7#4)
(currently##2##1##(2010-1#2)
(cut-off##2##1##(2008-10#2)
(cv##14##1##(2008-10#13)(2008-8#1)
(cw) laser##3##2##(2008-2#2)(2008-3#1)
(d##2##1##(1995-6#1)(2011-2#1)
(d) the##3##2##(1992-1#1)(2008-4#1)(2012-2#1)
(d)##25##1##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1996-12#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2009-6#1)(2009-9#1)(2010-7#1)(2012-2#2)
(d=##2##1##(2008-4#2)
(dA-dT)##2##1##(1994-8#2)
(data##6##1##(1992-2#4)(1993-2#1)(2008-10#1)
(days##5##1##(1994-3#2)(1995-11#2)(2013-8#1)
(de##2##1##(1997-1#1)(2013-8#1)
(deep##2##1##(2008-11#1)(2011-2#1)
(defined as the##2##3##(2008-10#2)
(defined as##6##2##(1990-5#1)(2008-10#3)(2008-7#1)(2008-9#1)
(defined based on##2##3##(2008-10#2)
(defined##10##1##(1990-5#1)(2008-10#6)(2008-7#1)(2008-9#1)(2012-12#1)
(delta##5##1##(1990-9#1)(1991-4#1)(1993-8#1)(1994-5#1)(1994-8#1)
(delta(13)C(vsPDB) approximately from##2##3##(2010-3#2)
(delta(13)C(vsPDB) approximately##3##2##(2010-3#3)
(delta)##2##1##(2008-10#2)
(denoted as##2##2##(2008-10#1)(2012-2#1)
(denoted##6##1##(1997-8#1)(2008-10#4)(2012-2#1)
(dependence of##2##2##(2008-10#2)
(dependence##3##1##(2008-10#2)(2008-7#1)
(depending on the##3##3##(2008-10#2)(2009-4#1)
(depending on##4##2##(2008-10#2)(2009-4#1)(2010-10#1)
(depending##5##1##(2008-10#2)(2009-4#1)(2010-10#1)(2010-4#1)
(derived from##4##2##(2008-10#4)
(described##2##1##(2008-10#1)(2008-11#1)
(designated as##3##2##(2008-9#1)(2009-2#1)(2012-3#1)
(designated##14##1##(1995-2#1)(1996-12#1)(1997-1#1)(1997-9#2)(2008-10#5)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)
(detection at##3##2##(2008-10#2)(2012-2#1)
(detection limit 0##3##3##(1992-11#1)(2008-10#2)
(detection limit approximately 0##2##4##(2008-10#2)
(detection limit##10##2##(1992-11#1)(2008-10#9)
(detection limits##2##2##(2008-10#2)
(detection of the##2##3##(2008-10#2)
(detection of##3##2##(2008-10#3)
(detection##18##1##(1992-11#1)(2008-10#16)(2012-2#1)
(determined##3##1##(2008-10#1)(2008-8#1)(2011-2#1)
(diabetes##2##1##(2010-6#1)(2011-2#1)
(diameter##6##1##(1990-11#1)(2008-10#1)(2008-2#1)(2008-8#2)(2011-2#1)
(dibutyl##2##1##(2008-10#2)
(diet##2##1##(1996-11#1)(2008-10#1)
(diethylenetriamine and##2##2##(2008-10#2)
(diethylenetriamine##3##1##(2008-10#3)
(difference##2##1##(2008-11#1)(2013-1#1)
(different##3##1##(2008-10#1)(2008-7#2)
(dimethyl##2##1##(2008-10#1)(2011-1#1)
(dimethylsulfoxide (DMSO)##2##2##(1994-5#1)(2008-10#1)
(direct##5##1##(2008-10#4)(2008-11#1)
(direct)##2##1##(2008-4#1)(2008-7#1)
(discrete##2##1##(2008-10#1)(2011-2#1)
(disease severity##2##2##(2008-10#2)
(disease##4##1##(2008-10#3)(2011-2#1)
(dishabituation)##3##1##(1994-3#1)(2008-6#2)
(dithizone)##2##1##(2008-10#2)
(dominant##2##1##(2008-10#1)(2008-9#1)
(dopamine##4##1##(1996-2#2)(2008-10#1)(2013-7#1)
(dorsal##3##1##(1993-6#1)(2008-11#1)(2010-8#1)
(dose optimization points##2##3##(2009-2#2)
(dose##3##1##(2009-2#2)(2009-7#1)
(dot-blot##3##1##(1990-8#3)
(double##3##1##(1995-11#1)(2008-10#1)(2008-11#1)
(down to##3##2##(2008-10#2)(2008-3#1)
(driven by##2##2##(2008-9#2)
(drug##2##1##(1992-9#1)(2008-10#1)
(dry##8##1##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)
(ds) DNA##2##2##(2008-10#2)
(ds) RNA##2##2##(2008-10#2)
(ds)##6##1##(2008-10#6)
(dsDNA)##5##1##(1995-2#1)(2008-10#4)
(due to##5##2##(1994-8#1)(1996-3#2)(2008-10#1)(2008-9#1)
(during##3##1##(2008-10#2)(2010-6#1)
(dw)##2##1##(2008-11#2)
(dynamic)##2##1##(2008-10#1)(2013-1#1)
(e##298##1##(1990-11#1)(1990-9#1)(1991-6#1)(1991-8#2)(1992-3#4)(1992-9#2)(1994-1#2)(1994-8#2)(1995-12#1)(1995-2#2)(1995-5#2)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#8)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#3)(2008-1#1)(2008-10#72)(2008-11#27)(2008-12#5)(2008-3#15)(2008-4#12)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#20)(2008-9#7)(2009-10#4)(2009-11#1)(2009-4#3)(2009-6#1)(2009-7#4)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#15)(2012-2#9)(2012-3#3)(2013-1#15)(2013-8#6)
(e) the##4##2##(1996-12#1)(2007-12#1)(2008-11#1)(2012-2#1)
(e)##13##1##(1992-1#1)(1992-2#1)(1996-12#2)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#2)
(eNOS)##2##1##(2009-10#1)(2010-4#1)
(early##5##1##(2008-10#3)(2011-2#1)(2013-1#1)
(eat##3##1##(2011-2#3)
(effective##3##1##(1997-4#1)(2008-11#1)(2012-2#1)
(eg##15##1##(2007-12#2)(2008-10#2)(2008-11#4)(2010-1#2)(2010-7#1)(2010-8#1)(2011-2#3)
(eight##3##1##(2008-10#3)
(either##8##1##(1993-2#1)(1994-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#1)
(electrical##2##1##(2008-10#2)
(elevated##2##1##(2010-3#1)(2011-2#1)
(elite##2##1##(2009-7#2)
(em##4##1##(2008-10#4)
(emotional##2##1##(2008-11#1)(2008-5#1)
(encoding##6##1##(1993-12#2)(1993-9#2)(2008-10#1)(2011-1#1)
(endoPG) and##2##2##(2008-10#2)
(energy##2##1##(2008-10#1)(2013-8#1)
(epithelial##2##1##(2008-7#1)(2013-8#1)
(epsilon) of##2##2##(2008-10#2)
(epsilon)##4##1##(2008-10#4)
(epsilon=7##2##1##(2008-10#2)
(equilibrium##2##1##(2008-10#2)
(equipped with##2##2##(2008-10#2)
(equivalent to##5##2##(2008-5#1)(2008-9#4)
(equivalent##6##1##(2008-12#1)(2008-5#1)(2008-9#4)
(error##2##1##(2008-10#2)
(especially in##3##2##(1993-1#1)(2008-10#1)(2011-2#1)
(especially the##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
(especially with##2##2##(1997-5#1)(2011-2#1)
(especially##19##1##(1991-11#1)(1993-1#1)(1997-5#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-3#1)
(estimated by##3##2##(2008-9#1)(2009-8#2)
(estimated##4##1##(2008-10#1)(2008-9#1)(2009-8#2)
(ethanol##2##1##(2008-10#2)
(ethanol) and##2##2##(2008-9#1)(2009-7#1)
(ethanol)##3##1##(2008-10#1)(2008-9#1)(2009-7#1)
(ethylene##3##1##(2008-10#3)
(evaluated##2##1##(2008-10#1)(2008-5#1)
(even if##2##2##(2008-8#2)
(even##8##1##(1995-11#1)(2008-10#3)(2008-8#3)(2008-9#1)
(every##3##1##(1997-8#1)(2008-5#1)(2008-9#1)
(ex##3##1##(2008-10#2)(2011-2#1)
(except for##9##2##(1990-11#1)(1992-5#1)(1995-5#1)(2008-10#5)(2010-12#1)
(except##18##1##(1990-11#1)(1992-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-5#1)
(excitation at##2##2##(2008-10#2)
(excitation wavelength##2##2##(2008-10#2)
(excitation##4##1##(2008-10#4)
(excluding the##2##2##(1991-7#1)(2013-8#1)
(excluding##6##1##(1991-7#1)(2008-11#3)(2008-3#1)(2013-8#1)
(executive##2##1##(1993-2#1)(2012-2#1)
(experimental group)##2##2##(2008-11#1)(2008-5#1)
(experimental##4##1##(2008-11#1)(2008-5#1)(2008-9#2)
(expressed as##6##2##(1996-12#1)(2008-10#5)
(expressed sequence##2##2##(2008-10#1)(2008-9#1)
(expressed##11##1##(1993-1#1)(1996-12#1)(2008-10#7)(2008-3#1)(2008-9#1)
(extraction in##2##2##(2008-10#2)
(extraction step##3##2##(2008-10#3)
(extraction##7##1##(2008-10#7)
(f##2##1##(2008-10#1)(2008-9#1)
(f)##5##1##(1996-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
(fMLP)##2##1##(1995-6#1)(1996-2#1)
(fMRI)##9##1##(2008-11#5)(2009-9#2)(2010-7#1)(2013-8#1)
(fa/fa) rats##2##2##(1994-11#1)(1996-12#1)
(fa/fa)##5##1##(1994-11#1)(1996-12#4)
(family##4##1##(2008-10#2)(2008-7#1)(2009-5#1)
(fatty acid##3##2##(1996-3#1)(1997-2#1)(2008-5#1)
(feed##2##1##(2008-10#1)(2008-7#1)
(females)##4##1##(1994-2#2)(2008-10#1)(2008-8#1)
(ferbam)##3##1##(2008-10#3)
(fever##2##1##(1992-2#1)(2009-10#1)
(fg##2##1##(2008-10#2)
(field)##2##1##(2008-10#2)
(final concentration##3##2##(2008-5#1)(2008-7#2)
(final concentration) in 0##2##4##(2008-10#2)
(final##8##1##(1990-11#1)(2008-10#3)(2008-5#1)(2008-7#2)(2011-2#1)
(first##9##1##(1990-11#1)(1994-12#1)(2008-10#6)(2009-9#1)
(five cases)##2##2##(2008-5#1)(2008-7#1)
(five##10##1##(1995-5#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
(flattened##2##1##(1993-1#1)(1995-6#1)
(flow injection##3##2##(2008-10#3)
(flow rate of##2##3##(2008-10#2)
(flow rate##4##2##(2008-10#4)
(flow##11##1##(1993-6#1)(2008-10#8)(2008-7#1)(2008-9#1)
(focal##3##1##(2008-10#1)(2012-2#1)(2013-1#1)
(follow-up##2##1##(2012-12#1)(2012-2#1)
(food##2##1##(1993-12#1)(2008-11#1)
(for 1##3##2##(2008-10#3)
(for 2##2##2##(2008-10#2)
(for 45 min)##2##3##(2008-11#2)
(for a##4##2##(2008-10#3)(2008-3#1)
(for ages##2##2##(1996-1#2)
(for both##4##2##(1995-9#1)(2008-10#1)(2008-3#2)
(for example##4##2##(2008-10#1)(2008-11#1)(2012-3#2)
(for movement##2##2##(1991-5#2)
(for subsequent##2##2##(2008-9#1)(2012-12#1)
(for the assay of##2##4##(2008-10#2)
(for the##10##2##(1996-3#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
(for##89##1##(1991-5#2)(1993-6#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-3#1)(2008-10#50)(2008-11#6)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-9#4)(2010-1#1)(2010-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#3)
(form##2##1##(1997-1#2)
(formaldehyde##2##1##(2008-10#2)
(formerly called##2##2##(1991-12#1)(2008-10#1)
(formerly known as##2##3##(2008-4#1)(2011-2#1)
(formerly##14##1##(1991-1#1)(1991-12#1)(1992-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
(four isolates)##2##2##(2008-10#2)
(four##12##1##(1990-3#1)(1990-6#1)(1992-3#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
(fourth##2##1##(2008-10#1)(2011-2#1)
(fragment##3##1##(1995-6#1)(1997-6#2)
(free of##2##2##(1993-8#1)(2011-2#1)
(free or bound##2##3##(2008-10#2)
(free##8##1##(1993-8#1)(2008-10#6)(2011-2#1)
(frequency##3##1##(2008-10#2)(2010-8#1)
(fresh##4##1##(1995-8#1)(2008-9#1)(2009-6#1)(2010-4#1)
(from 0##6##2##(1996-2#3)(2008-10#3)
(from 1 to##3##3##(2008-8#1)(2013-1#2)
(from 1##6##2##(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
(from 2##2##2##(1991-8#1)(2008-10#1)
(from 3##2##2##(2008-1#1)(2011-2#1)
(from 92##2##2##(2012-3#1)(2013-1#1)
(from method##2##2##(2008-10#2)
(from the##6##2##(1991-3#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
(from two countries)##3##3##(2013-8#3)
(from##81##1##(1990-3#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-6#1)(1994-5#1)(1996-12#1)(1996-2#3)(1997-3#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#5)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#7)
(fused##2##1##(2008-10#1)(2008-4#1)
(g l(-1) of##2##3##(2008-10#2)
(g l(-1)##3##2##(2008-10#3)
(gamma##2##1##(1993-8#1)(2008-10#1)
(gamma-aminobutyric##2##1##(1992-3#1)(1995-11#1)
(gas##2##1##(1990-8#1)(2011-2#1)
(gene##2##1##(2008-10#1)(2009-10#1)
(gene)##4##1##(2008-10#1)(2008-8#3)
(general##2##1##(1995-9#1)(2008-10#1)
(generally##6##1##(2008-10#4)(2008-5#1)(2008-8#1)
(generation##2##1##(1996-5#1)(2012-3#1)
(genetic##2##1##(2008-11#2)
(genotype##4##1##(2008-10#4)
(genus Begomovirus##2##2##(2008-10#2)
(genus##5##1##(2008-10#5)
(geographic##2##1##(1991-6#1)(2009-3#1)
(germinal##2##1##(2007-12#1)(2013-8#1)
(gfg)##2##1##(1994-11#2)
(giant-cell arteritis)##2##2##(2012-3#2)
(given##2##1##(2008-10#1)(2008-11#1)
(glial##2##1##(2008-7#2)
(global##2##1##(2008-11#1)(2013-1#1)
(glucose##3##1##(2008-10#2)(2008-11#1)
(grade##7##1##(1997-3#2)(2008-10#2)(2008-12#2)(2011-2#1)
(graphite##4##1##(2008-10#4)
(grass##2##1##(2008-11#1)(2013-1#1)
(gray##2##1##(2008-10#1)(2008-3#1)
(greater than 0##2##3##(2008-10#1)(2008-11#1)
(greater than or equal to##3##5##(1990-12#2)(1990-6#1)
(greater than##16##2##(1990-12#3)(1990-3#1)(1990-6#1)(1991-3#1)(1992-4#1)(1992-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-9#2)
(green##2##1##(2008-11#1)(2008-8#1)
(green)##2##1##(2008-10#2)
(ground##2##1##(2008-10#2)
(group 1)##4##2##(2008-10#1)(2008-11#1)(2009-6#1)(2012-4#1)
(group 2)##4##2##(2008-10#1)(2008-11#1)(2009-6#1)(2012-4#1)
(group 3)##3##2##(2008-12#1)(2009-6#1)(2012-4#1)
(group A) and##2##3##(1990-6#1)(2008-5#1)
(group A)##3##2##(1990-6#1)(1996-6#1)(2008-5#1)
(group B)##3##2##(1990-6#1)(1996-6#1)(2008-5#1)
(group I)##2##2##(1991-3#1)(2008-10#1)
(group II)##2##2##(1991-3#1)(2008-10#1)
(group##29##1##(1990-6#2)(1991-3#2)(1996-1#2)(1996-3#2)(1996-6#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#2)(2009-6#3)(2011-2#2)(2012-4#3)
(growth##4##1##(2008-10#2)(2008-11#1)(2011-2#1)
(hESC)##2##1##(2008-11#2)
(hFIXR338A)##2##1##(2008-9#2)
(hIL-6)##4##1##(2008-11#2)(2008-8#2)
(hMSCs)##3##1##(2008-11#2)(2010-8#1)
(hTR)##2##1##(1991-6#1)(2008-9#1)
(habitat##2##1##(2008-11#1)(2012-3#1)
(hair##2##1##(2008-10#2)
(half-life##2##1##(2008-10#2)
(hard)##2##1##(2008-10#1)(2008-9#1)
(hardness##2##1##(2008-5#1)(2009-7#1)
(harsh##2##1##(2009-9#2)
(hcp)##2##1##(2009-7#2)
(head##2##1##(2008-10#1)(2008-5#1)
(health)##4##1##(1997-6#4)
(heart##2##1##(2008-11#1)(2009-8#1)
(heat##3##1##(2008-7#1)(2010-4#1)(2011-2#1)
(height##2##1##(2008-10#1)(2012-3#1)
(hence the##2##2##(2008-6#1)(2008-8#1)
(hereditary##2##1##(2008-7#1)(2011-2#1)
(heritability##2##1##(2008-10#2)
(high performance liquid chromatography##2##4##(2008-10#1)(2008-5#1)
(high##15##1##(1991-3#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
(higher##4##1##(2008-10#3)(2012-6#1)
(highest##2##1##(2008-10#1)(2013-8#1)
(highest)##2##1##(2008-10#1)(2013-8#1)
(highly##2##1##(2008-10#2)
(home##2##1##(1997-4#1)(2009-3#1)
(homocysteine##2##1##(2008-10#2)
(hospital##2##1##(1990-3#1)(1993-12#1)
(host##3##1##(2008-10#1)(2008-2#1)(2008-9#1)
(hs-CRP)##4##1##(2011-2#2)(2012-5#1)(2013-1#1)
(http##15##1##(2008-10#3)(2008-11#3)(2008-7#2)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#3)(2011-3#1)
(human##15##1##(1991-9#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-2#1)(1997-9#1)(2008-10#3)(2008-11#5)
(human) and##2##2##(1994-3#2)
(hydride##2##1##(2008-10#2)
(hydrochloric acid)##2##2##(2008-10#2)
(hydrochloric##3##1##(2008-10#3)
(hydrodynamic diameter##2##2##(2008-10#2)
(i##318##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#7)(1992-8#1)(1993-12#2)(1993-3#2)(1994-11#1)(1994-2#6)(1994-3#2)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#8)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#3)(2007-12#1)(2008-1#3)(2008-10#107)(2008-11#19)(2008-12#3)(2008-3#4)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#14)(2008-9#16)(2009-10#4)(2009-4#1)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#3)(2011-2#15)(2012-12#5)(2012-2#8)(2012-3#1)(2012-9#2)(2013-1#6)(2013-8#3)
(i) The##5##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
(i) a##5##2##(2008-10#4)(2013-1#1)
(i) an##2##2##(2008-10#2)
(i) both##2##2##(1995-2#1)(2008-8#1)
(i) in##5##2##(1994-3#1)(1995-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
(i) the transfer##2##3##(2008-10#1)(2008-9#1)
(i) the two##2##3##(2008-8#1)(2012-5#1)
(i) the##34##2##(1994-8#1)(1995-11#1)(1995-12#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#5)(2010-10#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#3)
(i) to##4##2##(2008-10#3)(2011-2#1)
(i) whether##2##2##(1992-9#1)(2008-11#1)
(i)##165##1##(1990-11#1)(1990-5#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-3#2)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-6#2)(1996-6#1)(2006-6#1)(2007-12#1)(2008-10#75)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#6)(2008-8#14)(2008-9#11)(2009-12#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-5#1)(2013-1#6)(2013-8#1)
(iNOS)##6##1##(1996-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)
(identified##2##1##(2008-10#2)
(ie##9##1##(1992-6#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-1#1)(2012-12#1)(2012-3#1)
(if the##2##2##(2008-3#2)
(if##5##1##(1990-12#2)(2008-3#2)(2008-5#1)
(ii) A##3##2##(1994-5#1)(2008-8#2)
(ii) The##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
(ii) a##5##2##(1994-5#1)(2008-10#3)(2012-5#1)
(ii) for##2##2##(1994-3#1)(1995-12#1)
(ii) identify and##2##3##(2008-10#1)(2011-2#1)
(ii) identify##4##2##(2008-10#3)(2011-2#1)
(ii) in##2##2##(1995-2#1)(2008-8#1)
(ii) its##2##2##(2008-5#1)(2013-1#1)
(ii) placing##2##2##(2008-10#1)(2008-3#1)
(ii) sensitivity##2##2##(2008-10#1)(2008-8#1)
(ii) the use of##3##4##(2008-10#2)(2012-2#1)
(ii) the##34##2##(1993-8#2)(1994-8#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2012-2#1)(2013-1#2)
(ii) to##4##2##(2008-10#3)(2011-2#1)
(ii) with##2##2##(2007-12#1)(2008-10#1)
(ii)##164##1##(1990-11#1)(1990-5#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-3#2)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-6#2)(1996-6#1)(2006-6#1)(2007-12#1)(2008-10#75)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#6)(2008-8#15)(2008-9#10)(2009-12#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-5#1)(2013-1#5)(2013-8#1)
(iii) The##3##2##(1994-5#1)(2008-10#1)(2008-9#1)
(iii) a##5##2##(2008-10#4)(2010-5#1)
(iii) in##3##2##(1996-6#1)(2008-8#2)
(iii) on##2##2##(2008-10#1)(2008-9#1)
(iii) the##14##2##(1993-8#1)(2008-10#4)(2008-11#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#1)(2013-1#1)
(iii)##94##1##(1993-8#1)(1994-3#2)(1994-5#2)(1995-2#2)(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#47)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#10)(2008-9#6)(2009-7#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
(immobilised##3##1##(1990-12#1)(2008-10#2)
(immobilized##2##1##(2008-10#2)
(immune##2##1##(2010-3#2)
(implying involvement of##2##3##(2006-6#2)
(in 0##3##2##(2008-10#3)
(in 10(-3)%)##2##2##(2008-10#2)
(in Pascals)##2##2##(2008-5#2)
(in a##4##2##(2008-10#2)(2008-4#1)(2008-6#1)
(in addition to##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
(in comparison##2##2##(2008-10#1)(2008-8#1)
(in particular##4##2##(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
(in press)]##3##2##(1994-5#1)(2008-10#2)
(in terms of##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
(in the case of##4##4##(2008-10#1)(2008-11#1)(2008-7#2)
(in the form of##5##4##(2008-10#4)(2010-4#1)
(in the range of##2##4##(2008-10#1)(2008-11#1)
(in the range##3##3##(2008-10#2)(2008-11#1)
(in the##25##2##(1992-12#1)(1994-2#1)(1994-6#1)(1996-9#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-7#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-3#1)(2013-8#2)
(in vitro##3##2##(2008-10#2)(2008-11#1)
(in vitro)##2##2##(2008-10#2)
(in vivo##2##2##(2008-10#2)
(in which the##2##3##(2008-4#1)(2013-1#1)
(in which##6##2##(2008-4#1)(2008-9#2)(2012-12#2)(2013-1#1)
(in##122##1##(1991-2#2)(1991-3#3)(1991-6#1)(1991-8#1)(1992-12#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-5#1)(1996-9#1)(1997-2#2)(2008-10#48)(2008-11#6)(2008-12#3)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-6#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#3)
(incidence##3##1##(1997-3#1)(2008-10#1)(2008-9#1)
(including TASER devices)##2##3##(2010-1#2)
(including a##3##2##(2007-12#1)(2008-10#2)
(including the##2##2##(2010-12#1)(2011-2#1)
(including##52##1##(1991-12#1)(1992-1#1)(1994-12#3)(1994-8#2)(1996-12#1)(1997-3#2)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#5)(2013-1#5)
(incorporating##2##1##(1994-5#1)(2008-10#1)
(increase or decrease)##2##3##(2008-10#2)
(increase##3##1##(2008-10#2)(2009-9#1)
(increased##4##1##(1995-11#1)(2010-12#1)(2013-8#2)
(index##2##1##(2008-10#2)
(indigenous##2##1##(2008-10#2)
(indirect##2##1##(2008-10#1)(2008-11#1)
(individuals##2##1##(1992-2#1)(2009-7#1)
(induced by##2##2##(1995-8#2)
(inducing##2##1##(2008-10#1)(2008-12#1)
(information##3##1##(1993-2#2)(2008-9#1)
(inhibitor##2##1##(1997-2#1)(2008-10#1)
(initial##3##1##(2008-10#1)(2008-7#1)(2012-2#1)
(injection##2##1##(2008-10#1)(2008-7#1)
(instantaneous value##2##2##(2008-10#2)
(insulin##3##1##(1994-3#1)(2008-11#2)
(internal standard)##2##2##(2008-10#1)(2011-3#1)
(internal##7##1##(1996-5#1)(2008-10#4)(2008-8#1)(2011-3#1)
(intervention##2##1##(2008-8#1)(2010-10#1)
(intraoperative##2##1##(2007-8#2)
(introduced##2##1##(2008-8#2)
(inverse)##4##1##(2008-7#4)
(involving both the##2##3##(2011-2#2)
(involving##3##1##(2008-10#1)(2011-2#2)
(ion exchanger##2##2##(2008-10#2)
(ion-exchanger)##2##1##(2008-10#2)
(ionic##3##1##(2008-10#3)
(isoenzyme##2##1##(2008-5#2)
(isolate from##2##2##(2008-10#2)
(isolate##5##1##(1997-3#1)(2008-10#3)(2008-5#1)
(isolated##3##1##(1994-8#1)(2008-10#1)(2008-11#1)
(its##2##1##(1995-6#1)(2008-10#1)
(iv) a##2##2##(2008-10#1)(2008-7#1)
(iv) the##7##2##(1993-8#1)(2008-11#1)(2008-8#3)(2008-9#1)(2009-7#1)
(iv)##37##1##(1993-8#1)(1995-2#1)(1996-6#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-7#1)(2011-1#1)(2013-1#1)
(japonica)##2##1##(2008-8#1)(2009-10#1)
(k##2##1##(2008-10#1)(2011-2#1)
(k(373K) =##2##2##(1996-5#2)
(k(a))##2##1##(2008-11#1)(2008-12#1)
(k)##5##1##(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
(k=3)##2##1##(2008-10#1)(2008-12#1)
(kappa = 0##4##3##(1997-8#2)(2008-11#2)
(kappa)##2##1##(1993-1#1)(2008-10#1)
(kb)##5##1##(1997-9#1)(2008-10#3)(2011-2#1)
(kcat/Km =##4##2##(1991-9#1)(1995-6#3)
(kidney##2##1##(2008-9#1)(2009-8#1)
(known as##2##2##(2008-5#1)(2011-2#1)
(known##3##1##(2008-5#1)(2008-9#1)(2011-2#1)
(labeling)##2##1##(2008-4#1)(2008-6#1)
(labelled##2##1##(1993-9#1)(2008-10#1)
(laboratory##2##1##(1992-12#1)(2008-10#1)
(lacking##3##1##(2008-10#2)(2008-9#1)
(lake##2##1##(2008-10#2)
(lambda &gt##2##2##(1996-5#1)(2008-11#1)
(lambda##5##1##(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
(lambda')(-5##2##1##(2008-2#2)
(lambda(ex)##2##1##(2008-10#2)
(lambda(ex)=480 nm##2##2##(2008-10#2)
(lambda(max)##2##1##(2008-10#2)
(lambda(max)=460 nm)##2##2##(2008-10#2)
(largest##2##1##(2008-10#2)
(laser##2##1##(2008-10#1)(2012-3#1)
(late##12##1##(1991-6#1)(1997-3#1)(2008-10#5)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
(latent##3##1##(2008-10#3)
(lead##2##1##(2008-10#2)
(leaf##6##1##(2008-10#5)(2008-12#1)
(left masseter muscle)##2##3##(2008-10#2)
(left or##2##2##(1993-11#1)(2008-10#1)
(left##6##1##(1993-11#1)(2008-10#3)(2008-5#1)(2012-3#1)
(left)##3##1##(1996-2#1)(1997-3#1)(2011-2#1)
(length and##2##2##(2007-11#1)(2008-10#1)
(length##4##1##(2007-11#1)(2008-10#2)(2013-1#1)
(less than 0##5##3##(1990-2#1)(1990-5#1)(1997-2#1)(2008-10#1)(2008-12#1)
(less than 2##3##3##(1990-12#1)(1991-6#1)(2008-10#1)
(less than 30##2##3##(1990-12#1)(2013-1#1)
(less than##25##2##(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-6#2)(1997-2#2)(1997-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
(less##27##1##(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-6#2)(1997-2#2)(1997-9#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2013-1#1)
(lettuce##2##1##(2008-10#1)(2008-11#1)
(lichenase)##2##1##(1991-5#2)
(lidar)##2##1##(2008-10#1)(2008-2#1)
(light intensity##2##2##(1994-8#1)(2008-10#1)
(light##7##1##(1994-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
(like##2##1##(2008-9#1)(2009-6#1)
(limit of##2##2##(2008-10#2)
(limits##2##1##(2008-1#1)(2008-10#1)
(limonene##2##1##(2008-11#1)(2008-5#1)
(lindane)##2##1##(2008-11#1)(2010-6#1)
(linear range 10(-5)-10(-2) mol l(-1) detection limit##2##7##(2008-10#2)
(linear range##5##2##(2008-10#5)
(linear sweep##2##2##(2008-10#2)
(linear transfer function)##2##3##(2008-10#2)
(linear##11##1##(2008-10#9)(2008-3#2)
(literature##2##1##(2011-2#1)(2012-3#1)
(litter##2##1##(1994-8#1)(2008-11#1)
(live##2##1##(2008-8#1)(2011-2#1)
(liver##4##1##(1990-11#1)(2008-10#1)(2008-12#1)(2008-5#1)
(local##2##1##(2008-10#1)(2013-1#1)
(located##2##1##(1997-3#1)(2008-10#1)
(log 3##2##2##(2008-10#2)
(log K##3##2##(2008-10#3)
(log##18##1##(1990-6#1)(1996-2#1)(2008-10#16)
(log-rank test##5##2##(1997-7#4)(2011-2#1)
(logK(ex)=-6##2##1##(2008-10#2)
(logic##4##1##(2008-10#4)
(long axis view) (p##2##4##(2008-10#2)
(long##4##1##(2008-10#3)(2008-4#1)
(loss of##4##2##(1995-12#1)(2008-5#1)(2008-8#1)(2009-9#1)
(loss##7##1##(1995-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)
(low temperature##2##2##(2008-10#2)
(low##13##1##(1992-3#1)(1994-3#1)(1994-6#1)(1995-3#1)(2008-10#6)(2011-2#2)(2012-3#1)
(lower limit 95% CI##2##4##(2008-12#2)
(lower limit##3##2##(2008-10#1)(2008-12#2)
(lower##7##1##(2008-10#3)(2008-12#2)(2010-11#1)(2010-4#1)
(lux) genes##2##2##(2007-12#1)(2011-1#1)
(lux)##3##1##(2007-12#1)(2008-10#1)(2011-1#1)
(lymph##2##1##(2008-11#1)(2012-12#1)
(m##3##1##(1994-11#1)(2008-10#2)
(m)##6##1##(2008-10#2)(2008-8#1)(2013-1#3)
(m/m)##4##1##(2008-10#4)
(m/v)##7##1##(2008-10#7)
(mAb)##8##1##(1996-12#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
(mAbs##2##1##(1996-12#2)
(mRNA)##3##1##(1994-8#1)(2012-12#1)(2013-1#1)
(macro##2##1##(1996-3#1)(2008-10#1)
(macrocycle##2##1##(2008-10#2)
(main##2##1##(2008-10#2)
(mainly##16##1##(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)
(major and minor##2##3##(1993-12#1)(2008-10#1)
(major##4##1##(1993-12#1)(2008-10#3)
(making##2##1##(1992-6#1)(2010-10#1)
(malachite##2##1##(2008-8#1)(2010-5#1)
(male##6##1##(2008-11#3)(2008-5#1)(2008-8#1)(2009-7#1)
(male/female##2##1##(2011-2#2)
(malondialdehyde)##2##1##(1996-2#1)(2008-10#1)
(marked by##2##2##(2009-12#2)
(mass##5##1##(1996-2#1)(2008-10#4)
(maternal##3##1##(2008-10#2)(2012-3#1)
(matrix)##2##1##(2008-10#1)(2012-2#1)
(maximal at lambda ex =##2##5##(1994-5#2)
(maximal diameter##3##2##(1997-3#3)
(maximal##8##1##(1991-6#1)(1994-2#1)(1994-5#2)(1997-3#3)(2008-11#1)
(maximum of##2##2##(2008-10#2)
(maximum##11##1##(1994-11#1)(1995-8#1)(1996-1#1)(1996-11#1)(2008-10#4)(2008-11#1)(2012-5#1)(2013-1#1)
(mean +/- S##3##3##(1992-11#1)(1994-3#1)(1995-8#1)
(mean +/- SD##2##3##(2009-7#1)(2011-3#1)
(mean +/-##8##2##(1992-11#1)(1993-1#1)(1994-3#1)(1995-8#1)(2008-7#1)(2009-7#1)(2011-3#1)(2013-8#1)
(mean 2##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
(mean 21##2##2##(2008-10#1)(2008-7#1)
(mean 3##6##2##(1996-11#1)(1997-3#1)(2008-7#1)(2013-1#3)
(mean 4##2##2##(1994-12#1)(2013-1#1)
(mean 5##2##2##(1996-11#1)(2008-10#1)
(mean =##5##2##(1992-9#1)(2008-10#3)(2011-2#1)
(mean age##18##2##(1993-1#1)(2008-12#2)(2008-7#4)(2008-9#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-9#1)(2011-2#3)(2013-1#2)
(mean ages##2##2##(2008-1#2)
(mean body mass##3##3##(2007-12#2)(2013-1#1)
(mean change##2##2##(2008-8#2)
(mean difference##5##2##(2010-4#4)(2013-1#1)
(mean disease##3##2##(2008-10#3)
(mean follow-up##2##2##(1994-3#1)(2008-7#1)
(mean length##3##2##(2009-1#3)
(mean ± SD##4##3##(2013-1#2)(2013-8#2)
(mean ±##5##2##(2013-1#3)(2013-8#2)
(mean##124##1##(1990-6#2)(1991-11#2)(1991-5#1)(1992-11#1)(1992-9#2)(1993-1#2)(1993-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-5#1)(1995-8#1)(1996-11#2)(1997-3#3)(1997-8#1)(1997-9#2)(2007-12#2)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-5#6)(2008-7#13)(2008-8#2)(2008-9#9)(2009-1#3)(2009-3#2)(2009-7#2)(2010-1#2)(2010-4#4)(2010-8#2)(2010-9#1)(2011-2#9)(2011-3#1)(2012-3#2)(2013-1#15)(2013-8#3)
(measured as##5##2##(1992-9#1)(2008-5#1)(2008-9#3)
(measured by##2##2##(1995-11#1)(2009-9#1)
(measured in a previous study)##2##5##(2008-9#2)
(measured in a##3##3##(2008-3#1)(2008-9#2)
(measured##13##1##(1991-11#1)(1992-9#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#5)(2009-9#1)(2013-1#1)
(median 20) years##2##3##(1997-3#2)
(median age##2##2##(2011-2#2)
(median##25##1##(1991-2#2)(1991-5#1)(1992-12#1)(1994-12#1)(1995-8#3)(1996-8#1)(1997-3#6)(1997-4#3)(2008-10#1)(2008-5#1)(2011-2#4)(2013-8#1)
(median)##2##1##(2010-4#2)
(medical and##2##2##(2013-1#2)
(melatonin##2##1##(1995-12#1)(1996-2#1)
(membrane##2##1##(2008-7#1)(2009-3#1)
(men##3##1##(1997-8#1)(2008-11#2)
(metal##6##1##(2008-10#6)
(methanol in DMDTPA)##2##3##(2008-10#2)
(methanol##6##1##(2008-10#5)(2008-11#1)
(method##9##1##(2008-10#9)
(methyl##8##1##(1992-12#2)(1995-11#1)(1995-8#1)(2008-10#4)
(mg l(-1)) of##3##3##(2008-11#3)
(mg l(-1))##4##2##(2008-10#1)(2008-11#3)
(mg##6##1##(2008-10#3)(2008-11#3)
(mg/m2)##2##1##(2011-3#2)
(mg/mL)##2##1##(2008-10#1)(2013-1#1)
(miRNAs) are##2##2##(2010-7#1)(2013-1#1)
(miRNAs)##8##1##(2008-10#1)(2010-1#1)(2010-7#1)(2011-2#3)(2013-1#2)
(mild##4##1##(1990-5#1)(1990-6#1)(2010-8#1)(2013-1#1)
(milk##2##1##(2008-10#1)(2011-2#1)
(min##2##1##(1992-9#2)
(minimally invasive##2##2##(1993-3#1)(2011-2#1)
(minimum inhibitory##2##2##(2008-5#1)(2012-3#1)
(minimum##5##1##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
(minutes)##4##1##(2008-11#2)(2008-3#1)(2013-8#1)
(mixed##2##1##(2008-7#1)(2012-3#1)
(ml##3##1##(2008-10#3)
(mm(2))##3##1##(2008-10#1)(2011-2#1)(2012-3#1)
(mmol##2##1##(2008-10#2)
(model##2##1##(2008-10#1)(2008-8#1)
(modified##7##1##(1992-5#1)(1993-9#1)(1997-5#1)(2008-10#3)(2008-8#1)
(moisture index##2##2##(2008-10#2)
(moisture##4##1##(2008-10#3)(2008-5#1)
(mol##6##1##(2008-10#6)
(mol/L)(-1)##2##1##(2008-8#2)
(molar##3##1##(2008-10#2)(2008-7#1)
(molecular##3##1##(1990-5#1)(2008-10#2)
(monitored##2##1##(2008-10#2)
(more than##9##2##(1991-11#1)(1996-12#2)(1996-2#1)(2008-10#5)
(more##14##1##(1991-11#1)(1996-12#2)(1996-2#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
(mostly##9##1##(1990-6#1)(1992-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2013-8#1)
(mu) and##2##2##(2008-11#1)(2010-4#1)
(mu)##3##1##(2008-11#2)(2010-4#1)
(mu=0##2##1##(2008-10#2)
(muTAS)##4##1##(2008-10#4)
(mug l(-1))##2##2##(2008-10#2)
(mug ml(-1))##2##2##(2008-10#2)
(mug##7##1##(2008-10#7)
(mull(-1)) for##2##2##(2008-10#2)
(multidrug##2##1##(2008-11#1)(2011-2#1)
(multiple##3##1##(1991-6#1)(1995-9#1)(2011-2#1)
(multiplex##2##1##(2012-12#1)(2013-8#1)
(mumol##2##1##(2008-10#2)
(murine##2##1##(2008-11#1)(2009-12#1)
(muscle)##3##1##(1994-11#1)(2010-9#1)(2013-8#1)
(muscularis propria)##2##2##(2011-2#1)(2013-1#1)
(n = 1##2##3##(2008-10#1)(2009-7#1)
(n = 1) and##3##4##(1994-3#1)(1996-11#1)(2011-2#1)
(n = 1)##17##3##(1994-3#7)(1996-11#3)(2011-2#2)(2012-12#4)(2012-3#1)
(n = 10) and##2##4##(2008-10#1)(2013-1#1)
(n = 10) for##2##4##(2008-10#2)
(n = 10) were##2##4##(2008-10#2)
(n = 10)##16##3##(1993-6#1)(1995-2#1)(2008-10#11)(2008-9#1)(2011-2#1)(2013-1#1)
(n = 11)##4##3##(1995-5#3)(1996-3#1)
(n = 12##2##3##(2010-9#1)(2011-2#1)
(n = 12)##12##3##(1991-5#1)(1993-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#1)(2012-3#2)
(n = 120)##2##3##(2009-8#1)(2012-3#1)
(n = 127)##3##3##(1992-9#1)(2010-10#2)
(n = 13##2##3##(1992-6#1)(2010-8#1)
(n = 13)##2##3##(2008-10#1)(2013-8#1)
(n = 14)##2##3##(2013-8#2)
(n = 141)##2##3##(1996-8#1)(1997-8#1)
(n = 15)##3##3##(1997-3#1)(2008-10#2)
(n = 17)##2##3##(1993-1#1)(2012-3#1)
(n = 18)##6##3##(1992-1#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
(n = 19)##3##3##(1990-9#1)(1993-6#1)(2008-10#1)
(n = 2##4##3##(1996-11#2)(2012-2#1)(2013-1#1)
(n = 2)##4##3##(2008-11#1)(2010-6#1)(2012-3#2)
(n = 20)##9##3##(1993-1#1)(1993-3#2)(1997-8#1)(2008-10#1)(2013-1#4)
(n = 21)##3##3##(2008-11#1)(2008-12#1)(2013-8#1)
(n = 22)##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
(n = 23)##2##3##(2008-12#1)(2013-8#1)
(n = 24)##4##3##(1990-5#1)(2008-7#1)(2012-3#2)
(n = 26)##2##3##(2008-10#1)(2010-8#1)
(n = 27##2##3##(2008-5#1)(2012-2#1)
(n = 27)##3##3##(1990-8#1)(2008-10#1)(2013-1#1)
(n = 28)##2##3##(1992-1#1)(2008-8#1)
(n = 29)##2##3##(2008-10#1)(2013-8#1)
(n = 3) was##2##4##(2008-10#1)(2008-9#1)
(n = 3)##12##3##(1990-8#1)(1993-8#1)(1994-6#2)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
(n = 30)##8##3##(1990-8#1)(1993-1#1)(2009-1#1)(2009-9#1)(2012-3#1)(2013-8#3)
(n = 32)##2##3##(2008-12#1)(2010-4#1)
(n = 33)##2##3##(2012-3#1)(2013-1#1)
(n = 39)##2##3##(2012-3#2)
(n = 4##2##3##(1994-3#1)(1997-1#1)
(n = 4) and##2##4##(1995-2#1)(2008-5#1)
(n = 4)##11##3##(1990-5#4)(1994-6#2)(1995-2#1)(2008-11#1)(2008-5#1)(2011-2#2)
(n = 40)##2##3##(2013-1#2)
(n = 41) to Borderline##2##5##(2011-2#2)
(n = 42)##3##3##(2008-3#1)(2009-1#1)(2012-2#1)
(n = 48)##2##3##(2008-11#1)(2008-7#1)
(n = 5) &lt##2##4##(2008-10#2)
(n = 5)##13##3##(1994-11#1)(1994-3#2)(1995-2#1)(1996-12#2)(2008-10#7)
(n = 50)##5##3##(1990-8#2)(2008-10#2)(2008-12#1)
(n = 51)##2##3##(1993-1#1)(2010-8#1)
(n = 521)##4##3##(1991-8#4)
(n = 57)##4##3##(1993-1#1)(1997-8#1)(2008-9#1)(2012-3#1)
(n = 6##3##3##(1995-2#1)(1996-11#1)(2008-10#1)
(n = 6)##7##3##(1991-5#1)(1993-6#1)(1993-8#1)(1997-8#2)(2010-6#2)
(n = 60)##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
(n = 64)##2##3##(1993-1#1)(2010-8#1)
(n = 7##3##3##(2008-12#3)
(n = 7)##2##3##(2008-8#1)(2012-3#1)
(n = 8##2##3##(1996-11#1)(2011-2#1)
(n = 8)##10##3##(1990-5#2)(1993-6#1)(1994-5#1)(1997-1#1)(2008-10#2)(2010-7#1)(2012-3#1)(2013-1#1)
(n = 9##2##3##(2011-2#2)
(n = 9)##7##3##(1990-12#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
(n =##311##2##(1990-12#1)(1990-5#7)(1990-8#5)(1990-9#1)(1991-2#2)(1991-5#2)(1991-8#5)(1992-1#4)(1992-6#1)(1992-9#2)(1993-1#8)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#4)(1994-11#1)(1994-2#2)(1994-3#11)(1994-5#3)(1994-6#4)(1995-12#3)(1995-2#6)(1995-5#3)(1995-8#1)(1996-11#7)(1996-12#3)(1996-3#1)(1996-8#3)(1997-1#2)(1997-3#2)(1997-8#6)(2008-10#47)(2008-11#10)(2008-12#9)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#6)(2009-1#2)(2009-7#4)(2009-8#1)(2009-9#3)(2010-10#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#4)(2011-2#21)(2012-12#5)(2012-2#6)(2012-3#27)(2013-1#15)(2013-8#9)
(n and m values)##2##4##(2008-10#2)
(n##330##1##(1990-12#1)(1990-5#7)(1990-8#5)(1990-9#1)(1991-2#2)(1991-5#2)(1991-8#5)(1992-1#4)(1992-6#1)(1992-9#2)(1993-1#8)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#4)(1994-11#1)(1994-2#2)(1994-3#11)(1994-5#4)(1994-6#4)(1995-12#3)(1995-2#6)(1995-5#3)(1995-8#1)(1996-11#7)(1996-12#3)(1996-3#1)(1996-8#3)(1997-1#2)(1997-3#2)(1997-8#6)(2008-10#57)(2008-11#10)(2008-12#9)(2008-3#5)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#6)(2009-1#2)(2009-7#4)(2009-8#1)(2009-9#3)(2010-10#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#5)(2011-2#23)(2012-12#5)(2012-2#6)(2012-3#27)(2013-1#18)(2013-8#9)
(n) and##3##2##(1996-12#1)(2008-10#1)(2009-12#1)
(n) at##2##2##(2008-10#1)(2008-8#1)
(n)##11##1##(1994-5#1)(1996-12#1)(2008-10#5)(2008-8#1)(2009-12#2)(2011-2#1)
(n)Bu-P2DA##2##1##(2012-12#2)
(n=##8##1##(2008-10#2)(2010-5#1)(2012-3#2)(2013-1#3)
(n=1##2##1##(2008-11#1)(2012-12#1)
(n=1) and##2##2##(2008-10#1)(2008-5#1)
(n=1)##10##1##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2011-2#3)
(n=10) and##4##2##(2008-10#4)
(n=10) at the##2##3##(2008-10#2)
(n=10) at##3##2##(2008-10#3)
(n=10) for##3##2##(2008-10#3)
(n=10) was##6##2##(2008-10#6)
(n=10) were##2##2##(2008-10#2)
(n=10)##47##1##(2008-10#44)(2012-2#1)(2013-1#2)
(n=11) is 1##2##3##(2008-10#2)
(n=11) was##3##2##(2008-10#3)
(n=11)##20##1##(2008-10#18)(2008-12#1)(2011-2#1)
(n=12) and##2##2##(2008-10#1)(2008-11#1)
(n=12) for##2##2##(2008-10#2)
(n=12)##10##1##(2008-10#8)(2008-11#2)
(n=12)] and the##2##3##(2008-10#2)
(n=13)##4##1##(2008-10#1)(2011-2#3)
(n=15)##5##1##(2008-10#4)(2013-1#1)
(n=16)##5##1##(2008-10#1)(2008-12#2)(2012-12#1)(2013-1#1)
(n=2)##6##1##(2008-5#1)(2011-2#4)(2012-12#1)
(n=20##6##1##(2008-10#3)(2011-2#3)
(n=20)##5##1##(2008-10#3)(2008-12#1)(2008-9#1)
(n=21##2##1##(2008-10#2)
(n=21)##2##1##(2008-11#1)(2008-12#1)
(n=24)##2##1##(2008-12#1)(2009-7#1)
(n=25##2##1##(2008-10#1)(2008-4#1)
(n=25)##3##1##(2008-11#2)(2012-12#1)
(n=26)##4##1##(2012-2#2)(2013-1#2)
(n=3##3##1##(2008-10#2)(2008-6#1)
(n=3) and##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
(n=3)##14##1##(2008-10#10)(2011-2#2)(2011-3#1)(2012-12#1)
(n=30) for##2##2##(2010-7#2)
(n=30)##4##1##(2008-7#1)(2010-7#2)(2013-1#1)
(n=32)##2##1##(2008-12#2)
(n=35)##2##1##(2010-6#1)(2011-2#1)
(n=4##2##1##(2008-10#2)
(n=4) for##2##2##(2008-10#2)
(n=4)##14##1##(2008-10#11)(2008-12#3)
(n=44)##2##1##(2008-12#1)(2013-1#1)
(n=5##2##1##(2008-10#2)
(n=5) at##2##2##(2008-10#2)
(n=5) for a##2##3##(2008-10#2)
(n=5) for##9##2##(2008-10#9)
(n=5) of 2##2##3##(2008-10#2)
(n=5) of##5##2##(2008-10#5)
(n=5) was##3##2##(2008-10#3)
(n=5)##44##1##(2008-10#40)(2008-11#1)(2008-12#1)(2011-2#2)
(n=50##2##1##(2008-10#1)(2008-4#1)
(n=6) was##3##2##(2008-10#3)
(n=6)##14##1##(2008-10#12)(2008-11#1)(2011-2#1)
(n=7) for 0##2##3##(2008-10#2)
(n=7) for##4##2##(2008-10#4)
(n=7)##21##1##(2008-10#21)
(n=8##2##1##(2008-10#2)
(n=8) for##2##2##(2008-10#2)
(n=8)##18##1##(2008-10#15)(2008-11#1)(2008-12#1)(2013-1#1)
(n=9##4##1##(2008-10#4)
(n=9) and##3##2##(2008-10#2)(2011-2#1)
(n=9)##15##1##(1995-11#1)(2007-12#1)(2008-10#8)(2011-2#3)(2011-3#1)(2013-1#1)
(n=number of possible salt bridges)##2##5##(2008-10#2)
(n=number of##3##2##(2008-10#3)
(named &quot##4##2##(2008-6#2)(2012-2#2)
(named##8##1##(1994-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2010-12#1)(2012-2#2)
(namely##12##1##(2008-10#11)(2011-2#1)
(naphazoline##2##1##(2008-10#2)
(natural##3##1##(2008-10#1)(2008-11#1)(2008-8#1)
(near##5##1##(1996-2#1)(2007-12#2)(2008-10#1)(2010-5#1)
(nebulizer##3##1##(1995-3#2)(2008-10#1)
(negative##4##1##(1996-1#1)(2008-10#2)(2008-11#1)
(neo)##2##1##(1997-8#1)(2008-11#1)
(neocuproine##2##1##(2008-10#2)
(nest##2##1##(2008-8#2)
(neutral##3##1##(1991-7#1)(1994-5#1)(2011-2#1)
(new##3##1##(1991-3#1)(2008-5#1)(2012-3#1)
(new)##2##1##(1993-6#1)(2008-10#1)
(ng l(-1))##2##2##(2008-10#2)
(ng ml(-1))##2##2##(2008-10#2)
(ng##7##1##(2008-10#7)
(ng/ml)##2##1##(2008-10#2)
(nidus##2##1##(1995-11#1)(2008-7#1)
(nine out of 20)##2##4##(2008-5#2)
(nine##8##1##(1994-3#1)(2008-10#1)(2008-5#2)(2008-7#3)(2011-10#1)
(nit) mutant of##2##3##(2008-10#2)
(nit) mutants##3##2##(2008-10#3)
(nit)##8##1##(2008-10#8)
(nitrate##2##1##(2008-11#1)(2010-4#1)
(nitric and##2##2##(2008-10#2)
(no symptoms##2##2##(2008-10#2)
(no##29##1##(1990-11#1)(1990-6#2)(1991-12#1)(1992-4#1)(1995-3#1)(2008-10#13)(2008-12#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-8#1)(2013-1#3)(2013-8#2)
(normal less than##2##3##(2012-3#2)
(normal range##2##2##(1994-11#2)
(normal##9##1##(1994-11#2)(1997-3#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-8#1)
(normalized##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
(northeast##2##1##(1996-12#1)(2008-10#1)
(northern##3##1##(2008-10#2)(2008-4#1)
(not statistically##2##2##(1994-8#1)(2013-1#1)
(not##18##1##(1994-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
(now##2##1##(2008-10#1)(2008-11#1)
(ns =##2##2##(1993-6#2)
(nt) and##5##2##(1993-12#1)(1993-2#2)(2008-8#2)
(nt) differences##2##2##(1991-6#1)(1993-6#1)
(nt) sequence##9##2##(1990-11#1)(1991-6#1)(1993-12#5)(1997-7#1)(2008-10#1)
(nt)##28##1##(1990-11#1)(1991-6#2)(1991-9#1)(1993-12#8)(1993-2#3)(1993-3#1)(1993-6#5)(1997-7#1)(2008-10#4)(2008-8#2)
(nu(0) =##2##2##(2008-3#2)
(nuclear##3##1##(2008-9#1)(2009-8#1)(2013-1#1)
(nucleotides##3##1##(1995-6#1)(2008-10#2)
(number of##13##2##(1990-5#1)(1992-2#1)(2008-10#8)(2008-9#2)(2009-8#1)
(number per##2##2##(2008-10#1)(2008-5#1)
(number##15##1##(1990-5#1)(1992-2#1)(2008-10#9)(2008-5#1)(2008-9#2)(2009-8#1)
(n = 7)##2##1##(2011-2#2)
(o##4##1##(1991-5#1)(2008-10#3)
(o-NPOE)##7##1##(2008-10#7)
(o-hydroxyphenyl)##2##1##(2008-10#2)
(o/w) emulsions##2##2##(2008-5#2)
(o/w)##3##1##(2008-11#1)(2008-5#2)
(oak)##2##1##(2008-10#1)(2008-8#1)
(odds ratio 0##2##3##(2010-6#1)(2012-3#1)
(odds ratio [OR]##2##3##(2010-10#1)(2011-2#1)
(odds ratio##12##2##(1994-3#2)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-8#1)
(odds##13##1##(1994-3#2)(2009-5#1)(2010-10#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-8#1)
(of##11##1##(1990-6#1)(1995-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)
(off New Zealand)##2##3##(2011-2#2)
(often##3##1##(2008-10#1)(2008-9#1)(2009-5#1)
(oil##2##1##(2008-10#2)
(oil)##3##1##(2008-10#2)(2008-5#1)
(on a scale of 0 to##2##6##(2010-6#1)(2010-8#1)
(on a##4##2##(2008-4#1)(2010-12#1)(2010-6#1)(2010-8#1)
(on the##4##2##(1993-3#1)(1995-3#1)(2008-8#1)(2013-7#1)
(on##15##1##(1993-3#1)(1994-1#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-7#1)
(one isolate)##2##2##(2008-10#2)
(one of the##2##3##(2008-10#1)(2008-9#1)
(one of##4##2##(2008-10#3)(2008-9#1)
(one##24##1##(1990-5#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-3#1)(2008-10#13)(2008-11#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#2)
(one-step##2##1##(2008-10#1)(2008-11#1)
(onion)##2##1##(1993-12#1)(2008-10#1)
(only##8##1##(1993-12#1)(2008-1#2)(2008-10#3)(2008-7#2)
(open##2##1##(2008-10#2)
(or &quot##2##2##(2008-4#1)(2008-8#1)
(or more)##2##2##(2008-8#1)(2012-2#1)
(or oxygen)##2##2##(1993-8#1)(2008-10#1)
(or the##3##2##(1990-5#1)(2008-10#1)(2008-2#1)
(or##101##1##(1990-2#1)(1990-5#2)(1991-11#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(2008-10#39)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)
(oral##2##1##(1990-12#1)(2008-11#1)
(out of##6##2##(2008-10#6)
(over##10##1##(1994-12#1)(1994-9#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
(overall##4##1##(1992-6#1)(2008-10#2)(2013-8#1)
(overall)##2##1##(2008-10#1)(2010-12#1)
(oxidative##2##1##(2008-10#1)(2009-6#1)
(p &gt##13##2##(1993-3#1)(2008-10#1)(2008-12#3)(2009-6#1)(2010-11#1)(2010-7#2)(2011-2#2)(2013-8#2)
(p &lt##165##2##(1991-12#2)(1992-12#1)(1993-1#1)(1993-11#6)(1993-2#1)(1993-3#3)(1994-11#6)(1994-3#7)(1995-12#1)(1995-3#4)(1996-11#2)(1996-8#2)(1997-1#3)(1997-4#3)(1997-5#1)(1997-8#2)(2008-10#8)(2008-11#11)(2008-12#11)(2008-3#6)(2008-5#2)(2008-9#7)(2009-1#2)(2009-12#3)(2009-5#6)(2009-6#5)(2009-8#1)(2009-9#1)(2010-1#3)(2010-12#5)(2010-4#2)(2010-6#2)(2010-7#3)(2010-8#1)(2011-2#10)(2012-3#1)(2013-1#11)(2013-8#19)
(p = 0##92##3##(1991-3#1)(1991-8#1)(1993-1#5)(1993-11#3)(1995-3#1)(1996-2#1)(1997-5#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#7)(2010-6#3)(2010-9#3)(2011-2#31)(2012-3#2)(2013-1#5)(2013-8#4)
(p =##104##2##(1991-3#1)(1991-8#1)(1993-1#5)(1993-11#3)(1993-2#1)(1994-12#2)(1995-3#1)(1996-2#1)(1997-5#2)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#4)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#7)(2010-10#2)(2010-6#3)(2010-9#3)(2011-2#32)(2012-3#2)(2013-1#5)(2013-8#6)
(p less than 0##30##4##(1990-12#2)(1990-2#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#4)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#2)(1994-1#4)(1994-3#1)(1995-1#1)
(p ・・0##6##2##(2011-2#6)
(p##330##1##(1990-12#2)(1990-2#2)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#2)(1991-8#3)(1991-9#4)(1992-12#2)(1992-2#2)(1992-3#3)(1993-1#8)(1993-11#9)(1993-2#2)(1993-3#4)(1994-1#4)(1994-11#6)(1994-12#2)(1994-3#8)(1995-1#1)(1995-12#1)(1995-3#5)(1996-11#2)(1996-2#1)(1996-8#2)(1997-1#3)(1997-4#3)(1997-5#3)(1997-8#2)(2008-1#2)(2008-10#21)(2008-11#15)(2008-12#18)(2008-3#10)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#14)(2009-1#2)(2009-12#3)(2009-5#6)(2009-6#6)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#5)(2010-4#2)(2010-6#5)(2010-7#5)(2010-8#1)(2010-9#3)(2011-2#51)(2012-3#3)(2013-1#16)(2013-8#27)
(p&gt##16##1##(2008-12#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#8)
(p&lt##103##1##(1994-12#2)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#8)(2008-4#3)(2008-5#2)(2008-8#1)(2009-2#2)(2010-12#6)(2010-4#2)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#14)(2012-12#3)(2012-2#2)(2013-1#32)
(p-benzoquinone##2##1##(2008-10#2)
(p53) that##2##2##(2008-10#1)(2008-7#1)
(p75)##2##1##(1995-2#1)(1996-12#1)
(p=0##48##1##(2008-10#17)(2008-11#5)(2008-5#1)(2008-7#10)(2011-1#4)(2011-2#3)(2012-3#2)(2013-1#6)
(pH 1##6##2##(2008-10#6)
(pH 10##5##2##(1994-8#1)(2008-10#4)
(pH 2##11##2##(1994-8#1)(2008-10#10)
(pH 3##10##2##(2008-10#9)(2008-9#1)
(pH 4##19##2##(1990-9#1)(2008-10#17)(2008-3#1)
(pH 5##9##2##(2008-10#9)
(pH 5)##2##2##(2008-10#2)
(pH 6##15##2##(2008-10#15)
(pH 6)##2##2##(2008-10#2)
(pH 7##30##2##(1990-2#1)(1992-10#1)(1994-3#1)(2008-10#26)(2013-1#1)
(pH 7)##6##2##(2008-10#4)(2010-7#2)
(pH 8##10##2##(2008-10#9)(2008-11#1)
(pH 9##7##2##(2008-10#7)
(pH = 5##2##3##(2008-5#2)
(pH =##3##2##(2008-10#1)(2008-5#2)
(pH and##2##2##(2008-10#2)
(pH##167##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-10#1)(1994-3#1)(1994-8#2)(2008-10#150)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-7#2)(2013-1#1)
(pH&gt##2##1##(2008-10#2)
(pH&lt##4##1##(2008-10#4)
(pH)##3##1##(2008-10#3)
(pH=3##3##1##(2008-10#3)
(pH=5##2##1##(2008-10#2)
(pI 5##4##2##(1992-3#4)
(pI##6##1##(1992-3#4)(1995-6#1)(2008-10#1)
(pIC50##2##1##(1994-11#2)
(pIND9)##2##1##(2008-10#2)
(pK(a)) of##3##2##(2008-10#3)
(pMHC##2##1##(2013-8#2)
(pO(2)) in the##2##3##(2008-11#2)
(pTRKH1##2##1##(1993-12#2)
(packed##3##1##(2008-10#3)
(pain##3##1##(1992-12#1)(2008-7#1)(2010-11#1)
(paper##2##1##(2008-10#1)(2008-4#1)
(partial least-squares##2##2##(2008-10#2)
(partial##5##1##(2008-10#3)(2008-11#1)(2011-2#1)
(partially resistant)##2##2##(2008-10#2)
(partially##3##1##(2008-10#2)(2009-4#1)
(particularly in##3##2##(2008-4#1)(2008-6#1)(2012-12#1)
(particularly##9##1##(1991-2#1)(1996-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2012-12#1)(2013-1#1)
(parts in##2##2##(2008-3#2)
(parts per billion by##2##4##(2008-10#1)(2008-3#1)
(parts##4##1##(2008-10#1)(2008-3#3)
(paste##2##1##(2008-10#2)
(pathologic##2##1##(1991-2#1)(2012-3#1)
(patients whose height##2##3##(2011-1#2)
(patients##7##1##(1995-5#3)(2007-8#1)(2009-9#1)(2011-1#2)
(pcbAB##2##1##(2011-1#2)
(peak at -1##2##3##(2008-10#2)
(peak height)##3##2##(2008-10#3)
(peak##8##1##(2008-10#8)
(pedicle##2##1##(2008-8#1)(2012-12#1)
(per##6##1##(1994-12#1)(2008-10#3)(2012-5#1)(2013-8#1)
(percent##3##1##(2008-10#3)
(percentage##3##1##(2008-10#3)
(peritoneal##2##1##(1992-5#1)(2012-3#1)
(pesta)##2##1##(2008-10#2)
(pharaonis hRblue)##2##2##(1994-5#2)
(pharaonis##3##1##(1994-5#3)
(phase I##3##2##(2008-8#2)(2011-2#1)
(phase##10##1##(1991-3#2)(2008-11#1)(2008-3#1)(2008-8#4)(2010-12#1)(2011-2#1)
(phases##3##1##(2008-10#1)(2009-12#2)
(phenotype class##3##2##(2008-10#3)
(phi = 0##2##3##(1991-11#1)(2008-2#1)
(phi(STAT) =##2##2##(2008-10#2)
(phosphate##2##1##(1997-2#1)(2013-1#1)
(physical##5##1##(1996-8#1)(2008-10#1)(2009-7#1)(2012-3#1)(2013-1#1)
(physiological##4##1##(1996-2#1)(2008-10#2)(2013-8#1)
(pi)##2##1##(2008-10#1)(2008-8#1)
(plant##7##1##(1991-7#1)(2008-10#5)(2008-11#1)
(plasma##3##1##(2008-10#2)(2009-8#1)
(plasmodiophorids)##2##1##(2012-2#2)
(poly##2##1##(2008-10#2)
(poly)ammonium##2##1##(2008-10#2)
(population##6##1##(1996-11#3)(2008-10#1)(2008-7#1)(2008-8#1)
(position##3##1##(1992-9#1)(2008-10#2)
(positive control##3##2##(2008-10#2)(2013-1#1)
(positive##10##1##(1990-12#1)(1990-2#1)(1990-6#1)(1995-11#1)(2008-10#3)(2008-11#1)(2010-4#1)(2013-1#1)
(possibly##2##1##(1992-6#1)(1993-1#1)
(potassium##4##1##(2008-10#4)
(potential##2##1##(2008-10#1)(2009-6#1)
(ppb) were##2##2##(2008-10#1)(2008-3#1)
(ppb)##4##1##(2008-10#2)(2008-3#2)
(ppm)##2##1##(2008-10#1)(2008-3#1)
(pre-test N = 70 and post-test N =##2##8##(1994-1#2)
(precision##3##1##(2008-10#3)
(preconcentration factor##2##2##(2008-10#2)
(preconcentration##3##1##(2008-10#3)
(predicted##2##1##(2008-10#1)(2008-5#1)
(predominantly##2##1##(1995-9#1)(1996-12#1)
(prepared##2##1##(2008-10#2)
(presence of##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
(presenting##2##1##(1996-9#1)(2013-7#1)
(presumably##2##1##(1991-11#1)(2008-8#1)
(previously##2##1##(2008-10#2)
(primarily##2##1##(2008-10#2)
(primary##8##1##(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#2)
(prior to##2##2##(2008-10#1)(2013-1#1)
(private versus##2##2##(2008-10#1)(2008-12#1)
(private##3##1##(1997-5#1)(2008-10#1)(2008-12#1)
(procedure##2##1##(2008-10#2)
(product concentration##2##2##(1996-12#1)(2013-1#1)
(programmed cell death)##3##3##(1993-2#1)(1994-11#1)(1995-8#1)
(proportion of##5##2##(2008-10#4)(2008-8#1)
(protein##3##1##(1993-8#2)(2008-10#1)
(proximal##3##1##(1995-10#1)(2008-7#1)(2009-8#1)
(ps &lt##3##2##(2010-2#3)
(pth)##2##1##(2008-10#2)
(pure##4##1##(2008-10#3)(2013-8#1)
(putative##2##1##(2008-10#2)
(putative)##2##1##(2008-10#1)(2011-1#1)
(p &lt##3##1##(2013-8#3)
(p = 0##17##1##(2012-5#6)(2013-8#11)
(p = 0##2##1##(2012-2#2)
(p &lt##5##1##(2011-2#1)(2012-2#1)(2013-1#3)
(p = 0##4##1##(2011-2#2)(2012-2#2)
(q##2##1##(2008-10#1)(2008-11#1)
(qPCR)##3##1##(2009-6#2)(2013-8#1)
(quality of##3##2##(1993-2#1)(2008-11#1)(2008-7#1)
(r = -##2##3##(2010-9#1)(2012-3#1)
(r = -0##33##3##(1991-2#1)(1992-9#1)(1993-2#5)(1995-11#3)(1995-8#2)(2008-1#4)(2008-10#7)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)
(r = 0##60##3##(1990-2#1)(1991-12#1)(1991-2#2)(1992-12#1)(1993-2#1)(1994-12#1)(1995-11#2)(1995-5#1)(1995-8#3)(1996-2#1)(2008-10#20)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#7)(2011-2#5)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#1)
(r =##97##2##(1990-2#1)(1991-12#1)(1991-2#3)(1992-12#1)(1992-9#1)(1993-2#6)(1994-12#1)(1995-11#5)(1995-5#1)(1995-8#5)(1996-2#1)(2008-1#4)(2008-10#27)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#8)(2010-6#1)(2010-9#2)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#1)
(r##107##1##(1990-2#1)(1991-12#1)(1991-2#3)(1992-12#1)(1992-9#1)(1993-2#6)(1994-12#1)(1995-11#5)(1995-3#1)(1995-5#1)(1995-8#5)(1996-2#1)(2008-1#4)(2008-10#33)(2008-11#4)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#8)(2010-6#1)(2010-9#2)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#1)
(r&gt##9##1##(2008-10#9)
(r(2) &gt##2##2##(2008-10#1)(2009-8#1)
(r(2) = 0##20##3##(2008-10#16)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
(r(2)##23##1##(2008-10#17)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)
(r(2)&gt##2##1##(2008-10#1)(2008-11#1)
(r(2)) of##2##2##(2008-10#2)
(r(2))##3##1##(2008-10#3)
(r(2)=0##14##1##(2008-10#14)
(r) and R##3##3##(2008-10#3)
(r) and##5##2##(2008-10#5)
(r) protein##2##2##(1991-6#1)(2008-11#1)
(r)##19##1##(1991-6#1)(1993-8#1)(2008-10#13)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
(r))##2##1##(2008-10#1)(2008-11#1)
(r2 = 0##2##3##(1995-11#1)(1997-2#1)
(r=-0##2##1##(2011-1#1)(2013-1#1)
(r=0##41##1##(2008-10#37)(2008-7#1)(2011-1#3)
(rDNA) and the##2##3##(2008-10#2)
(rDNA)##7##1##(2008-10#5)(2008-8#1)(2008-9#1)
(rFIA)##2##1##(2008-10#2)
(rIL-2)##2##1##(1990-12#1)(1991-8#1)
(rTMS)##6##1##(2008-12#1)(2010-5#1)(2010-7#2)(2011-2#2)
(race##8##1##(2008-10#8)
(races##2##1##(2008-10#2)
(radiation##2##1##(1997-4#1)(2008-11#1)
(radical##2##1##(2008-10#1)(2010-11#1)
(random##3##1##(2008-10#1)(2008-8#1)(2013-8#1)
(range 0##3##2##(1990-6#1)(1993-11#1)(2008-12#1)
(range 3##2##2##(2008-6#1)(2008-8#1)
(range 4##2##2##(2008-8#1)(2012-3#1)
(range 5##2##2##(2008-10#2)
(range from##2##2##(2008-10#2)
(range##103##1##(1990-11#1)(1990-12#5)(1990-6#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#4)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#2)(1994-8#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-6#1)(2008-1#2)(2008-10#7)(2008-12#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#9)(2009-3#3)(2009-8#4)(2010-1#1)(2010-12#2)(2010-3#2)(2010-6#1)(2011-2#9)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#8)
(range)##3##1##(1992-3#1)(1993-12#1)(2013-1#1)
(ranged from##2##2##(2008-10#1)(2009-8#1)
(ranging from 0##3##3##(2008-10#2)(2013-1#1)
(ranging from 30 to##4##4##(2008-10#4)
(ranging from 5##3##3##(1991-2#1)(1994-5#1)(2008-10#1)
(ranging from##13##2##(1991-2#1)(1994-5#1)(2008-10#9)(2013-1#2)
(rat##4##1##(1994-8#1)(1996-12#1)(2008-10#2)
(rat) nM for the##2##4##(1994-3#2)
(rat)##4##1##(1993-12#1)(1994-3#2)(2008-10#1)
(rate##2##1##(1991-11#1)(2008-9#1)
(rather than##5##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
(raw##4##1##(2008-10#4)
(real##2##1##(2008-10#2)
(recommended##7##1##(2008-10#7)
(recoveries##7##1##(2008-10#7)
(recovery##3##1##(1992-11#1)(2008-10#2)
(reduced##3##1##(1996-2#1)(2008-10#2)
(ref##7##1##(1990-5#2)(1991-2#1)(1993-9#2)(1995-8#2)
(reference##4##1##(1993-3#1)(1996-12#1)(2008-10#1)(2012-2#1)
(referred to as##4##3##(2007-12#1)(2008-10#1)(2008-9#2)
(referred to here as##2##4##(2008-3#1)(2008-4#1)
(referred to##7##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#2)
(referred##8##1##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)
(reflux##2##1##(1996-5#1)(2011-3#1)
(refs##3##1##(1990-5#3)
(reinforced)##2##1##(2008-11#1)(2008-7#1)
(relative decrease##2##2##(1991-8#2)
(relative humidity##2##2##(2008-10#2)
(relative increase##2##2##(1991-8#2)
(relative mobility##2##2##(1991-12#2)
(relative risk##2##2##(1991-2#1)(1997-3#1)
(relative standard deviation (R##3##4##(2008-10#3)
(relative standard deviation##8##3##(2008-10#8)
(relative standard deviation)##4##3##(2008-10#3)(2008-12#1)
(relative standard##13##2##(2008-10#12)(2008-12#1)
(relative to the##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
(relative to##8##2##(1993-12#1)(1994-3#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-2#1)
(relative##40##1##(1990-2#1)(1991-12#2)(1991-2#1)(1991-8#4)(1993-12#1)(1994-3#1)(1997-1#1)(1997-3#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#1)(2012-2#1)(2013-1#1)
(relatively##2##1##(2008-11#2)
(rep-PCR)##11##1##(2008-10#11)
(repeatability##2##1##(2008-10#2)
(repeatability)##3##1##(2008-10#2)(2009-1#1)
(representing##3##1##(1990-12#1)(2008-8#1)(2012-12#1)
(reproducibility##2##1##(2008-10#2)
(requiring##2##1##(1994-3#1)(2010-8#1)
(residue##2##1##(1997-8#1)(2008-7#1)
(residues##14##1##(1993-8#1)(1995-6#3)(1997-3#3)(1997-9#1)(2008-9#4)(2009-7#1)(2012-2#1)
(resistant to##6##2##(2008-10#5)(2011-3#1)
(resistant##7##1##(2008-10#6)(2011-3#1)
(resistant) and##3##2##(2008-10#3)
(resistant) were inoculated##2##3##(2008-10#2)
(resistant)##7##1##(2008-10#7)
(respectively##2##1##(2008-10#1)(2012-3#1)
(response rate##8##2##(1991-8#1)(2008-10#2)(2008-11#1)(2011-2#3)(2013-1#1)
(response##9##1##(1991-8#1)(2008-10#2)(2008-11#1)(2009-4#1)(2011-2#3)(2013-1#1)
(rest##3##1##(1991-8#2)(2010-12#1)
(resulting in an increase in##2##5##(1993-3#1)(2007-12#1)
(retention time##2##2##(2008-10#2)
(retention##3##1##(1994-2#1)(2008-10#2)
(reversal of##2##2##(1991-8#1)(2008-8#1)
(reverse##3##1##(2008-10#1)(2008-7#1)(2011-3#1)
(rhizosphere##2##1##(2008-10#2)
(rho)##2##1##(2008-10#2)
(rice##2##1##(1997-4#1)(2008-10#1)
(rice)##2##1##(2008-10#1)(2008-9#1)
(right##5##1##(1991-5#1)(1995-8#1)(2007-11#1)(2008-5#1)(2010-8#1)
(river##5##1##(2008-10#5)
(route##2##1##(2008-3#2)
(rutile)##2##1##(2008-10#1)(2008-5#1)
(r = 0##8##1##(2012-4#3)(2012-5#3)(2013-1#2)
(s##3##1##(1996-2#1)(2011-2#1)(2011-3#1)
(s(r)=0##2##1##(2008-10#2)
(s)##3##1##(1994-12#1)(2008-12#2)
(s/n=3)##3##1##(2008-10#3)
(sRBC)##2##1##(1993-12#1)(2008-10#1)
(salicylic acid##2##2##(2008-10#2)
(salicylic##3##1##(2008-10#3)
(saline##2##1##(1994-2#1)(2008-10#1)
(salt##3##1##(2008-9#3)
(sample and##3##2##(2008-10#3)
(sample of##2##2##(2009-12#2)
(sample pH##2##2##(2008-10#2)
(sample volume##2##2##(2008-10#2)
(sample##12##1##(2008-10#10)(2009-12#2)
(samples)##2##1##(2008-10#2)
(sampling##2##1##(2008-10#2)
(saturated##4##1##(2008-10#4)
(scFv)##6##1##(2008-10#4)(2008-8#1)(2009-9#1)
(scFvs)##4##1##(2008-10#3)(2008-4#1)
(screening)##2##1##(1993-2#1)(2008-10#1)
(sea##2##1##(2008-10#2)
(second##2##1##(1994-12#1)(2008-10#1)
(secondary##4##1##(1990-6#1)(1995-5#1)(1997-8#1)(2008-10#1)
(see RFN##3##2##(1996-5#2)(1997-2#1)
(see##10##1##(1994-5#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(2008-9#1)(2010-7#1)(2013-8#2)
(selective##2##1##(1993-12#1)(2008-7#1)
(sensitivity 60##2##2##(1997-8#2)
(sensitivity 77##2##2##(1997-8#1)(2011-1#1)
(sensitivity##13##1##(1992-3#3)(1997-8#3)(2008-10#2)(2011-1#4)(2011-2#1)
(sensitized with##2##2##(1990-12#2)
(sensu##2##1##(2008-10#1)(2008-6#1)
(serotonin##2##1##(1990-5#1)(2012-3#1)
(serotype##3##1##(2008-7#2)(2010-7#1)
(serovar##2##1##(2012-2#2)
(serum and##2##2##(2008-10#2)
(serum) and##2##2##(2008-10#2)
(serum)##3##1##(2008-10#3)
(seven##4##1##(2008-10#2)(2008-6#1)(2008-8#1)
(severe##2##1##(1990-5#1)(2008-10#1)
(sex##3##1##(1993-2#1)(2008-10#1)(2008-8#1)
(short stature##2##2##(2008-7#1)(2013-1#1)
(short##6##1##(1990-3#1)(1997-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
(sigmoid##3##1##(2008-10#1)(2010-8#2)
(signal to noise ratio=2) and the linearity is maintained in the concentration range 0##2##14##(2008-10#2)
(signal to noise##4##3##(2008-10#4)
(signal##7##1##(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#4)
(signal-to-noise ratio##5##2##(2008-10#3)(2008-3#2)
(signal-to-noise ratio=3)##2##2##(2008-10#2)
(signal-to-noise##8##1##(2008-10#6)(2008-3#2)
(signaling##2##1##(2012-2#1)(2013-8#1)
(significant##2##1##(2008-10#1)(2008-12#1)
(since##2##1##(1990-8#1)(2008-6#1)
(single##7##1##(1991-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-10#1)(2013-8#1)
(six##7##1##(1997-4#1)(2008-10#3)(2008-5#1)(2011-2#2)
(size##2##1##(2008-10#1)(2008-3#1)
(skin##4##1##(2007-8#1)(2008-5#2)(2012-3#1)
(slope##3##1##(2008-10#3)
(small##6##1##(2008-10#3)(2008-8#1)(2011-2#1)(2012-9#1)
(social##2##1##(1995-5#1)(2008-11#1)
(sodium salt of##2##3##(2008-10#2)
(sodium##10##1##(2008-10#8)(2008-11#2)
(soft##2##1##(1995-3#1)(2008-10#1)
(soil##2##1##(2008-10#2)
(solid phase##2##2##(2008-10#2)
(solid##4##1##(1994-12#1)(2008-10#3)
(some##2##1##(2008-8#1)(2009-10#1)
(space##2##1##(2008-10#1)(2008-8#1)
(spatial##2##1##(1993-3#1)(2008-8#1)
(special##2##1##(2008-10#1)(2008-4#1)
(species##4##1##(2008-10#2)(2008-8#2)
(specific##2##1##(2008-10#2)
(specifically##2##1##(1996-1#1)(2011-2#1)
(spike##2##1##(2008-10#1)(2009-8#1)
(spores per##2##2##(2008-10#2)
(spray##2##1##(2008-10#2)
(spring##5##1##(2008-10#3)(2008-5#1)(2008-8#1)
(ss) and##2##2##(2008-10#2)
(ssDNA)##7##1##(1991-5#1)(1995-2#1)(2008-10#4)(2012-3#1)
(stage 1)##2##2##(2008-10#1)(2008-11#1)
(stage##10##1##(1991-3#1)(1991-7#1)(2008-10#3)(2008-11#2)(2011-2#2)(2012-2#1)
(stages##2##1##(2008-10#2)
(standard deviation##3##2##(2008-10#1)(2008-9#1)(2010-3#1)
(standard##8##1##(2008-10#2)(2008-5#2)(2008-9#1)(2009-9#1)(2010-3#1)(2012-3#1)
(static)##2##1##(2008-3#1)(2013-1#1)
(statistical significance at##2##3##(1995-8#2)
(steady##2##1##(1995-3#1)(2012-2#1)
(strain 7)##2##2##(2008-5#2)
(strain rate##2##2##(2012-2#2)
(strain##12##1##(1997-3#1)(2008-10#5)(2008-5#3)(2011-2#1)(2012-2#2)
(strains##5##1##(2008-10#4)(2008-5#1)
(strong##5##1##(1997-5#1)(2008-10#3)(2008-11#1)
(strongly##2##1##(2008-11#1)(2009-8#1)
(structured##2##1##(2010-8#2)
(study##4##1##(2008-10#1)(2011-1#1)(2013-1#2)
(subfascial)##2##1##(1990-12#2)
(subfrontal approach) versus##2##3##(2011-2#2)
(subgroup II)##4##2##(2008-10#4)
(subgroup##7##1##(2008-10#7)
(substance##2##1##(2008-11#1)(2012-3#1)
(substrate##4##1##(2010-11#4)
(such as a##2##3##(2007-12#1)(2008-8#1)
(such as the##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
(such as those##2##3##(1996-12#1)(2010-1#1)
(such as##38##2##(1995-2#1)(1996-12#3)(1997-2#3)(2007-12#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-10#1)(2010-1#2)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
(sudden##2##1##(1995-12#1)(2011-2#1)
(supplement)##5##1##(1996-12#2)(1996-2#1)(1996-6#2)
(suppressor of##2##2##(1997-8#1)(2009-6#1)
(survival)##2##1##(1995-2#1)(2009-6#1)
(susceptible##5##1##(2008-10#5)
(susceptible) and##3##2##(2008-10#2)(2011-2#1)
(susceptible) were##2##2##(2008-10#2)
(susceptible) x##2##2##(2008-10#2)
(susceptible)##11##1##(2008-10#10)(2011-2#1)
(syn##6##1##(2008-10#5)(2008-11#1)
(synonym##2##1##(2008-10#2)
(systemic##2##1##(1995-5#1)(2011-2#1)
(systole##2##1##(2008-10#2)
(t = 2##3##3##(1990-12#3)
(t =##5##2##(1990-12#3)(1993-2#1)(2013-8#1)
(t##9##1##(1990-12#3)(1993-2#1)(2008-10#4)(2013-8#1)
(t(1/2)##2##1##(1995-8#1)(2008-10#1)
(t(m))##2##1##(2008-10#2)
(t(max))##2##1##(2008-12#1)(2010-8#1)
(t)##4##1##(1995-2#1)(2008-10#2)(2008-9#1)
(t-PA)##4##1##(1994-3#1)(1995-8#1)(2008-11#2)
(t1/2 =##7##2##(1992-8#5)(1993-1#1)(1996-1#1)
(t1/2##10##1##(1992-8#5)(1993-1#1)(1995-8#3)(1996-1#1)
(t=-3##2##1##(2008-11#1)(2010-6#1)
(t=-4##3##1##(2010-6#3)
(t=4##3##1##(2008-11#2)(2010-6#1)
(tPA) were##2##2##(2008-10#1)(2008-11#1)
(tPA)##6##1##(1992-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-3#1)
(tR =##2##2##(1997-2#2)
(tablets and##4##2##(2008-10#4)
(tablets)##4##1##(2008-10#4)
(taken as##3##2##(2008-10#2)(2009-8#1)
(tea##2##1##(2008-10#2)
(teleomorph##12##1##(2008-10#12)
(temperature##6##1##(1996-12#1)(2008-10#4)(2008-12#1)
(ten##2##1##(2008-10#1)(2011-2#1)
(tentatively##2##1##(1993-11#1)(2008-10#1)
(termed##2##1##(2008-10#1)(2008-4#1)
(tetracycline##2##1##(2008-10#2)
(that activates##2##2##(2010-10#2)
(that is##4##2##(1992-9#1)(2008-10#3)
(that##10##1##(1991-3#1)(1992-9#1)(2008-10#4)(2010-10#2)(2013-1#2)
(the &quot##6##2##(1997-3#1)(2008-10#1)(2008-8#4)
(the Michaelis constant##3##3##(2008-10#3)
(the among-group component of##2##4##(2008-8#2)
(the causative agent of##2##4##(2011-2#2)
(the length##2##2##(2011-3#1)(2012-3#1)
(the most##2##2##(2008-10#1)(2008-8#1)
(the number of##3##3##(2008-10#3)
(the##160##1##(1990-10#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-7#2)(2007-12#2)(2008-10#47)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#18)(2008-9#5)(2009-12#1)(2009-8#4)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
(theta =##2##2##(2008-10#2)
(theta##3##1##(2008-10#2)(2008-11#1)
(third##2##1##(2008-10#1)(2008-7#1)
(though##3##1##(1993-3#1)(2008-10#1)(2009-9#1)
(three##8##1##(1996-9#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-5#1)
(three)##2##1##(1996-12#2)
(through##3##1##(2008-9#1)(2011-2#1)(2013-1#1)
(time from##3##2##(1990-12#2)(2008-10#1)
(time peak##2##2##(2008-7#2)
(time##12##1##(1990-12#2)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#2)(2010-8#1)(2011-2#1)
(to approx##2##2##(1994-8#2)
(to the##2##2##(2008-10#1)(2012-2#1)
(to##18##1##(1994-8#2)(1995-6#2)(1997-1#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#1)(2012-2#1)
(tobacco)##2##1##(2008-10#2)
(toluene)##2##1##(2008-10#2)
(too##2##1##(2008-8#2)
(total dose##2##2##(1991-11#1)(1992-12#1)
(total##15##1##(1991-11#1)(1991-12#1)(1992-12#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-7#2)(2009-1#1)(2010-8#1)(2013-1#1)
(transmission##2##1##(2008-10#2)
(treated with##2##2##(2008-12#1)(2011-2#1)
(treatment)##2##1##(2008-4#1)(2013-1#1)
(tsp)##6##1##(1993-12#3)(1993-6#1)(1993-9#1)(1995-11#1)
(twice##2##1##(2008-12#1)(2011-3#1)
(two cases)##2##2##(2008-5#2)
(two patients)##2##2##(1997-4#1)(2008-7#1)
(two##24##1##(1990-5#1)(1996-12#1)(1997-4#1)(1997-5#1)(2008-10#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
(type I and type II)##2##5##(1995-11#1)(2011-2#1)
(type I and##3##3##(1995-11#1)(2008-11#1)(2011-2#1)
(type I##5##2##(1995-11#1)(1996-2#1)(2008-11#1)(2011-2#2)
(type I) and##2##3##(2008-10#2)
(type II##4##2##(1996-2#1)(2008-10#1)(2010-8#1)(2011-2#1)
(type II)##3##2##(2008-10#3)
(type##23##1##(1990-5#3)(1993-2#1)(1993-8#1)(1995-11#1)(1995-6#1)(1996-2#2)(2008-10#7)(2008-11#2)(2010-8#1)(2011-2#4)
(typical##4##1##(2008-10#3)(2012-4#1)
(typically##6##1##(2007-12#1)(2008-10#5)
(u-PA)##2##1##(1994-3#1)(2008-11#1)
(uPA)##2##1##(1992-6#1)(2008-11#1)
(un)said about AIDS in##2##4##(2012-3#2)
(under##3##1##(1995-2#1)(2008-10#1)(2008-3#1)
(untreated)##2##1##(1996-8#1)(2008-8#1)
(up to 1##6##3##(1992-3#1)(1997-4#1)(2008-10#3)(2013-8#1)
(up to 12##2##3##(1994-11#1)(2008-10#1)
(up to 3##2##3##(1993-6#1)(2008-10#1)
(up to 4##2##3##(1995-5#1)(2008-10#1)
(up to 48##2##3##(2008-10#2)
(up to about##2##3##(2009-8#2)
(up to##47##2##(1990-10#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-10#20)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-8#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
(urban##3##1##(1991-1#1)(2008-10#2)
(urine##3##1##(2008-10#3)
(urine)##2##1##(2008-10#2)
(used as##3##2##(2008-10#3)
(used for##2##2##(2008-10#2)
(used##7##1##(1990-12#1)(1994-8#1)(2008-10#5)
(using a##2##2##(1992-9#1)(2010-9#1)
(using the##2##2##(1991-12#2)
(using##15##1##(1991-12#2)(1992-9#1)(2008-10#8)(2008-11#1)(2010-8#1)(2010-9#1)(2012-2#1)
(usually a##2##2##(1992-5#1)(2008-8#1)
(usually##5##1##(1992-5#1)(1997-6#1)(2008-5#1)(2008-8#1)(2008-9#1)
(v)##12##1##(1995-2#1)(2008-10#8)(2008-5#1)(2008-9#2)
(v/v) FBS##2##2##(2008-11#2)
(v/v) HNO(3)##6##2##(2008-10#6)
(v/v) acetic acid##3##3##(2008-10#3)
(v/v) acetonitrile as##2##3##(2008-10#2)
(v/v) acetonitrile##3##2##(2008-10#3)
(v/v) and##2##2##(2008-10#1)(2013-1#1)
(v/v) concentrated hydrofluoric acid##2##4##(2008-10#2)
(v/v) content of methanol for##3##5##(2008-10#3)
(v/v) ethanol##4##2##(2008-10#4)
(v/v) in the##3##3##(2008-10#3)
(v/v) in##4##2##(2008-10#4)
(v/v) methanol##7##2##(2008-10#6)(2008-7#1)
(v/v) nitric acid##5##3##(2008-10#5)
(v/v) non-aqueous content##2##3##(2008-10#2)
(v/v) of##7##2##(2008-10#7)
(v/v) raw milk##2##3##(2008-10#2)
(v/v)##83##1##(2008-10#77)(2008-11#3)(2008-7#1)(2009-8#1)(2013-1#1)
(v/v)) as##2##2##(2008-10#2)
(v/v))##12##1##(2008-10#12)
(vWF)##2##1##(1993-3#1)(2008-12#1)
(values##4##1##(2008-10#3)(2013-1#1)
(vanillin and##2##2##(2008-10#1)(2011-2#1)
(varepsilon=4##2##1##(2008-10#2)
(variation##2##1##(2008-10#2)
(varphi##2##1##(2008-10#1)(2008-11#1)
(varying##2##1##(1993-6#1)(2008-10#1)
(vascular##2##1##(2008-10#1)(2010-6#1)
(verapamil or##2##2##(1995-11#1)(2008-7#1)
(version##2##1##(2008-10#1)(2008-9#1)
(versus Ag/AgCl reference electrode) detection potential (E(det)) for##2##8##(2008-10#2)
(versus Ag/AgCl reference electrode) oxidation potential (E(oxd)) for 70ms oxidation time (t(oxd)) and 250mV (versus Ag/AgCl reference electrode) reduction potentail (E(red)) for 400ms reactivation time (t(red))##2##26##(2008-10#2)
(versus Ag/AgCl reference electrode)##6##4##(2008-10#6)
(versus Ag/AgCl##9##2##(2008-10#9)
(versus Ag/AgCl)##13##2##(2008-10#13)
(versus SCE)##9##2##(2008-10#9)
(versus##41##1##(2007-12#1)(2008-10#38)(2009-8#2)
(very##3##1##(2012-2#3)
(vi)##4##1##(1995-2#1)(2008-10#2)(2008-9#1)
(via##5##1##(1990-2#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-12#1)
(viable##2##1##(2008-11#2)
(view##2##1##(2012-2#2)
(vii)##2##1##(2008-10#1)(2008-9#1)
(vitamin C##2##2##(2008-10#2)
(vitamin##10##1##(1992-9#2)(2008-10#4)(2008-5#1)(2009-7#1)(2011-1#2)
(viz##7##1##(2008-10#6)(2013-8#1)
(vol/vol)##7##1##(1995-2#1)(2008-10#6)
(volume##3##1##(2008-11#1)(2008-5#1)(2008-7#1)
(vs##27##1##(2008-10#24)(2012-3#3)
(w##2##1##(1991-5#1)(2008-10#1)
(w)##4##1##(2008-10#2)(2010-4#1)(2012-2#1)
(w/v) Ni##2##2##(2008-10#2)
(w/v) in##2##2##(2008-10#2)
(w/v)##22##1##(2008-10#19)(2008-11#2)(2013-1#1)
(w/w) and##5##2##(2008-10#5)
(w/w) by##2##2##(2008-10#2)
(w/w) of PVC##2##3##(2008-10#2)
(w/w) of the##2##3##(2008-10#2)
(w/w) of##9##2##(2008-10#9)
(w/w) was##3##2##(2008-10#2)(2008-5#1)
(w/w) were found##2##3##(2008-10#2)
(w/w)##48##1##(1997-2#1)(2008-10#39)(2008-12#1)(2008-5#3)(2011-2#3)(2012-2#1)
(water##7##1##(1990-6#1)(2008-10#5)(2008-5#1)
(water)##2##1##(2008-10#1)(2008-7#1)
(we call##2##2##(2011-3#1)(2013-8#1)
(week##2##1##(2008-3#2)
(wet##3##1##(1990-5#1)(1994-5#1)(2010-8#1)
(what##2##1##(1992-9#1)(2008-10#1)
(when##5##1##(1992-3#1)(1993-12#1)(2008-2#1)(2008-3#2)
(where##7##1##(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)
(whether##2##1##(2008-11#1)(2012-3#1)
(which are##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
(which constitute the major##2##4##(1997-8#2)
(which exhibits##2##2##(2008-10#2)
(which inhibits##2##2##(2008-10#2)
(which is##5##2##(1994-11#1)(2008-10#4)
(which secrete##5##2##(2008-1#5)
(which was##2##2##(2008-10#1)(2008-9#1)
(which##48##1##(1991-3#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-8#2)(2008-1#5)(2008-10#16)(2008-11#2)(2008-3#2)(2008-6#4)(2008-8#2)(2008-9#2)(2010-10#2)(2011-2#1)(2012-3#1)(2013-1#1)
(who##5##1##(2008-11#1)(2008-4#2)(2009-7#2)
(whole milk powder##2##3##(2008-10#2)
(whole milk##3##2##(2008-10#3)
(winter##2##1##(2008-10#2)
(with a##7##2##(1991-11#1)(1993-3#1)(2008-10#3)(2009-7#1)(2011-2#1)
(with an##2##2##(2008-10#2)
(with and##2##2##(1997-5#1)(2008-10#1)
(with dynamics described by##2##4##(2008-8#2)
(with high##2##2##(1993-8#1)(2013-8#1)
(with no##2##2##(2008-10#2)
(with or without##2##3##(1992-12#1)(1995-3#1)
(with slope of##2##3##(2008-10#2)
(with the##10##2##(1994-5#1)(2007-12#1)(2008-10#5)(2008-9#2)(2011-2#1)
(with##69##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-5#2)(2007-12#1)(2008-10#31)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-7#2)(2011-2#5)(2013-8#3)
(within 1##2##2##(2007-11#1)(2008-12#1)
(within##19##1##(1990-8#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#10)(2008-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
(within-day##2##1##(1992-11#1)(2008-10#1)
(without the##2##2##(2008-10#1)(2008-11#1)
(without##16##1##(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
(working volume##2##2##(2008-11#2)
(working##6##1##(1993-3#1)(2008-10#1)(2008-11#3)(2008-9#1)
(wpi)##2##1##(2008-12#1)(2009-8#1)
(wt)##2##1##(1997-7#1)(2008-10#1)
(www##8##1##(2008-12#3)(2010-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
(x##2##1##(1992-11#1)(2008-3#1)
(x)##3##1##(1994-8#1)(2008-10#1)(2008-9#1)
(y =##2##2##(1994-8#1)(2008-10#1)
(young##2##1##(1995-3#1)(2008-7#1)
(zero##5##1##(1991-5#1)(2008-10#4)
(zeta)##2##1##(1991-5#1)(1994-8#1)
(~0##2##1##(2007-12#1)(2008-3#1)
(±1##4##1##(2010-10#4)
(±3##3##1##(2010-10#3)
(ΔE=3##2##1##(2013-1#2)
(α=0##7##1##(2013-1#7)
(β = 0##3##3##(2011-2#3)
(β##4##1##(2011-2#3)(2013-1#1)
(μ=0##2##1##(2010-10#2)
(π(i) = 0##2##3##(2012-3#2)
(∼50%##2##1##(2013-1#1)(2013-8#1)
) &lt##4##2##(2008-10#4)
) 1##2##2##(1991-2#1)(2008-10#1)
) 30 min prior to MCAO significantly##2##7##(2011-2#2)
) Bail##3##2##(2008-10#3)
) Baill##2##2##(2008-8#2)
) Sesquipedalis subspecies##2##3##(2008-12#2)
) The##3##2##(1994-5#1)(2008-10#2)
) administration of##3##3##(1994-8#1)(1996-2#2)
) and a##2##3##(1997-2#1)(1997-4#1)
) and its##2##3##(2008-10#2)
) and relative##2##3##(2008-10#2)
) and the##5##3##(1992-2#1)(1996-2#1)(2008-10#2)(2009-6#1)
) and was##2##3##(2008-11#1)(2008-9#1)
) and##59##2##(1990-5#1)(1991-5#1)(1992-2#1)(1992-3#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1997-2#1)(1997-4#1)(2008-10#22)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-4#1)(2012-7#2)(2013-1#2)(2013-8#2)
) are discussed##2##3##(2008-11#1)(2009-3#1)
) are##8##2##(1996-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-3#1)(2011-2#1)
) as a model##2##4##(2008-8#1)(2009-6#1)
) as a##4##3##(1992-12#2)(2008-8#1)(2009-6#1)
) as##6##2##(1992-12#2)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)
) at##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
) better than##2##3##(2008-10#2)
) but##3##2##(1996-2#2)(2008-10#1)
) by the##2##3##(2008-10#2)
) by##5##2##(2008-10#4)(2008-9#1)
) caused##2##2##(1996-2#1)(2008-10#1)
) column with methanol##2##4##(2008-10#2)
) column##3##2##(2008-10#2)(2008-4#1)
) cultivars##4##2##(2008-10#1)(2008-12#2)(2008-9#1)
) for 11##2##3##(2008-10#2)
) for the##8##3##(2008-10#6)(2008-12#2)
) for##22##2##(1997-2#1)(2008-10#18)(2008-12#2)(2011-2#1)
) from##5##2##(1997-1#1)(2008-10#2)(2013-1#1)(2013-8#1)
) has been##2##3##(1990-9#1)(2008-10#1)
) has##4##2##(1990-6#1)(1990-9#1)(2008-10#1)(2008-9#1)
) in the range 0##2##5##(2008-10#2)
) in the##3##3##(1991-9#1)(2008-10#2)
) in##14##2##(1991-9#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-6#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-8#1)(2012-7#1)
) injection of##4##3##(1994-2#1)(1994-5#1)(1996-12#1)(1996-2#1)
) is 4##3##3##(2008-10#3)
) is a##2##3##(2010-6#1)(2011-1#1)
) is##7##2##(2008-10#3)(2010-1#1)(2010-6#1)(2011-1#1)(2012-3#1)
) less than 1%##2##4##(2008-10#2)
) obtained for##2##3##(2008-10#2)
) of 0##3##3##(2008-10#3)
) of 3##5##3##(2008-10#5)
) of As at##2##4##(2008-10#2)
) of the proposed##2##4##(2008-10#2)
) of the##9##3##(2008-10#9)
) of##34##2##(2008-10#33)(2013-1#1)
) on the##2##3##(2008-12#2)
) on##3##2##(1995-12#1)(2008-12#2)
) or##9##2##(1991-2#1)(1992-3#2)(1993-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
) plants##3##2##(2008-10#1)(2008-12#2)
) production##2##2##(1997-3#1)(2008-10#1)
) that##3##2##(2008-3#2)(2009-8#1)
) to##8##2##(1990-7#1)(2008-10#5)(2008-11#2)
) using##2##2##(2008-5#1)(2008-9#1)
) values for##2##3##(2008-10#2)
) values were##2##3##(2008-10#2)
) values##7##2##(2008-10#7)
) was 0##2##3##(2008-10#2)
) was 1##6##3##(2008-10#6)
) was found to be##2##5##(1991-5#1)(2008-10#1)
) was found to##3##4##(1991-5#1)(2008-10#1)(2008-12#1)
) was found##4##3##(1991-5#1)(2008-10#2)(2008-12#1)
) was used##2##3##(2008-5#1)(2012-3#1)
) was##30##2##(1991-5#2)(2008-10#21)(2008-12#1)(2008-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
) were##17##2##(1992-3#2)(1993-3#1)(1996-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-9#1)
) where##2##2##(2008-10#2)
) with##7##2##(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-5#1)
)##611##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#4)(1991-7#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#9)(1992-8#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#3)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#4)(1996-2#19)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#5)(1997-8#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#277)(2008-11#24)(2008-12#24)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#7)(2008-8#20)(2008-9#18)(2009-1#1)(2009-10#2)(2009-3#1)(2009-6#5)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#23)(2011-7#2)(2012-12#1)(2012-2#8)(2012-3#12)(2012-4#2)(2012-7#4)(2012-8#1)(2013-1#9)(2013-8#12)
)&lt##2##1##(2008-10#2)
))##5##1##(2008-10#2)(2008-11#1)(2008-8#1)(2010-8#1)
)=-1##2##1##(2008-10#2)
)]##3##1##(2011-2#2)(2011-3#1)
)s bases##3##2##(2008-10#3)
* Influence of the##2##4##(2008-5#2)
* s(-1)##4##2##(2008-8#2)(2008-9#2)
*##25##1##(1997-8#4)(2008-11#3)(2008-5#4)(2008-8#6)(2008-9#4)(2012-2#4)
*) and##3##2##(2008-10#1)(2010-4#2)
*)##11##1##(2008-10#1)(2010-4#10)
+ 0##5##2##(2008-10#3)(2008-12#2)
+ 1##9##2##(1990-12#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-9#1)
+ 1)##2##2##(2007-12#1)(2008-10#1)
+ 2##4##2##(1990-12#1)(2008-3#1)(2008-7#2)
+ 2]##3##2##(1996-5#2)(2010-4#1)
+ 3##3##2##(2008-10#1)(2008-3#2)
+ 4##3##2##(1990-12#1)(2008-10#2)
+ Bs3) and##2##3##(2008-10#2)
+ Bs3) than on##2##4##(2008-10#2)
+ Bs3)##5##2##(2008-10#5)
+ CO2)##3##2##(1996-12#3)
+ Cu(II)##3##2##(2008-10#3)
+ FeSO(4)##3##2##(2008-11#3)
+ M##2##2##(1996-3#1)(2008-10#1)
+ NH(4)NO(3)##5##2##(2008-10#5)
+ PCB##2##2##(2008-10#2)
+ VI)##4##2##(2008-10#4)
+ cells)##2##2##(1996-12#1)(1996-2#1)
+ direct##2##2##(2008-10#2)
+ glyceraldehyde 3-phosphate) to be quantified as##2##7##(2008-7#2)
+ leaf mold##4##3##(2008-12#4)
+ mancozeb)##2##2##(2008-10#2)
+##215##1##(1990-11#1)(1990-12#5)(1990-5#2)(1990-8#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-2#7)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#5)(1994-6#1)(1995-12#1)(1996-12#6)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#3)(1997-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#75)(2008-11#5)(2008-12#14)(2008-3#10)(2008-5#7)(2008-7#10)(2008-8#16)(2008-9#2)(2009-3#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#3)
+) and##3##2##(2008-10#2)(2008-5#1)
+) were##2##2##(2008-10#1)(2009-11#1)
+)##20##1##(1996-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2009-11#1)(2009-8#2)(2010-1#1)
+))##4##1##(2008-10#4)
+/+ mice##2##2##(1993-3#1)(1997-8#1)
+/+##4##1##(1993-3#1)(1997-8#1)(2008-12#1)(2012-3#1)
+/- 0##222##2##(1990-12#1)(1990-2#8)(1990-5#4)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#3)(1992-10#1)(1992-11#4)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#8)(1993-11#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#8)(1994-3#2)(1994-5#7)(1994-6#3)(1994-8#3)(1995-11#3)(1995-12#1)(1996-12#4)(1996-2#9)(1996-3#2)(1997-1#2)(2008-1#2)(2008-10#25)(2008-11#11)(2008-12#15)(2008-2#1)(2008-3#1)(2008-5#9)(2008-7#4)(2008-8#3)(2009-11#6)(2009-8#2)(2009-9#1)(2010-1#8)(2010-4#5)(2010-6#1)(2010-8#2)(2011-2#12)(2011-3#6)(2012-3#5)(2013-1#12)
+/- 1 to##2##3##(1990-3#1)(2008-1#1)
+/- 1##72##2##(1990-3#1)(1990-8#2)(1991-11#3)(1991-5#1)(1992-10#3)(1992-12#1)(1992-2#5)(1993-11#1)(1993-2#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#2)(1996-12#2)(1997-8#1)(2008-1#4)(2008-10#7)(2008-12#7)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#3)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#6)(2012-3#3)(2013-1#2)
+/- 1%##2##2##(1994-2#1)(2008-10#1)
+/- 10##14##2##(1992-10#1)(1994-11#3)(1995-12#1)(1997-3#1)(2008-10#1)(2009-8#1)(2010-7#2)(2011-2#2)(2012-3#1)(2013-8#1)
+/- 10%##2##2##(1994-2#1)(1997-7#1)
+/- 11 vs##2##3##(1992-11#1)(2009-8#1)
+/- 11##9##2##(1992-11#1)(1994-2#1)(2008-10#3)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
+/- 12 mmHg##2##3##(2008-10#2)
+/- 12##12##2##(1990-8#1)(1991-6#1)(1997-3#1)(2008-10#3)(2008-3#2)(2009-1#1)(2010-4#1)(2011-2#1)(2013-8#1)
+/- 13 years##2##3##(1995-10#1)(2011-2#1)
+/- 13##7##2##(1991-6#1)(1994-6#1)(1995-10#1)(1995-8#1)(1996-2#1)(2008-10#1)(2011-2#1)
+/- 14 mmHg##2##3##(1991-6#2)
+/- 14##8##2##(1990-12#1)(1990-8#1)(1991-6#3)(2008-10#2)(2010-7#1)
+/- 15##6##2##(1994-2#1)(1995-8#1)(2008-1#1)(2011-2#2)(2013-1#1)
+/- 15% of##2##3##(1991-11#1)(1994-2#1)
+/- 16##3##2##(1991-6#1)(1993-3#1)(2012-3#1)
+/- 17##3##2##(1991-6#1)(2008-10#1)(2011-2#1)
+/- 18##5##2##(1990-5#1)(1992-11#1)(1993-11#1)(2010-6#1)(2011-2#1)
+/- 19##3##2##(2008-1#1)(2008-8#1)(2011-2#1)
+/- 2 degrees C##2##4##(2008-10#1)(2008-12#1)
+/- 2 for##2##3##(1994-5#1)(2010-1#1)
+/- 2##48##2##(1990-2#2)(1990-8#1)(1991-5#1)(1992-10#1)(1992-11#2)(1992-2#5)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1997-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#1)(2009-1#1)(2010-1#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-7#1)
+/- 2%##4##2##(1993-8#1)(1996-2#1)(1997-1#1)(2009-8#1)
+/- 20##4##2##(2008-10#2)(2008-12#1)(2008-2#1)
+/- 22##5##2##(1996-3#2)(2008-10#1)(2011-2#2)
+/- 23%##2##2##(1991-11#1)(2008-10#1)
+/- 25%##2##2##(1991-11#1)(2008-12#1)
+/- 26##2##2##(2008-10#1)(2011-3#1)
+/- 3 and##2##3##(1997-1#1)(2008-10#1)
+/- 3 mm##2##3##(2008-12#1)(2010-7#1)
+/- 3##46##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-8#2)(1997-1#2)(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#2)(2010-4#3)(2010-7#2)(2010-8#1)(2011-2#2)(2011-3#2)(2012-3#1)
+/- 33##4##2##(1994-12#1)(1994-3#1)(1994-8#1)(2008-10#1)
+/- 34##3##2##(1994-12#1)(1995-11#1)(2011-2#1)
+/- 4##15##2##(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-8#1)(1996-2#1)(2008-11#2)(2008-12#2)(2010-1#2)(2012-3#1)(2013-7#1)
+/- 4% of##2##3##(1995-12#2)
+/- 4%##5##2##(1991-6#1)(1994-8#1)(1995-12#2)(2008-10#1)
+/- 40##4##2##(1990-12#1)(2008-10#1)(2011-2#2)
+/- 42##2##2##(1994-3#1)(1996-12#1)
+/- 5##26##2##(1992-10#1)(1992-11#1)(1993-8#2)(1994-12#3)(1994-2#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-8#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-2#1)
+/- 5% with##2##3##(1993-8#2)
+/- 5%##5##2##(1993-8#2)(1995-12#1)(1997-1#1)(2008-12#1)
+/- 50##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
+/- 6##13##2##(1990-5#1)(1992-12#1)(1994-2#1)(1995-8#1)(1996-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)(2011-3#1)
+/- 6%##5##2##(1990-5#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#1)
+/- 6%)##2##2##(1994-11#1)(2008-11#1)
+/- 7##10##2##(1993-3#1)(1993-8#1)(1994-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2010-1#1)(2011-2#1)(2011-3#2)
+/- 7%##5##2##(1990-5#1)(1991-5#1)(1992-11#2)(1994-8#1)
+/- 8##6##2##(1994-2#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
+/- 8%##4##2##(1991-5#1)(2008-10#2)(2011-2#1)
+/- 9##12##2##(1991-6#1)(1992-12#1)(1993-8#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-3#1)(2009-1#1)(2012-3#2)
+/- 90##2##2##(1990-12#1)(2011-2#1)
+/- S##6##2##(1992-11#1)(1994-3#2)(1995-8#1)(1997-1#1)(1997-3#1)
+/- SD##6##2##(1993-3#1)(2008-11#1)(2009-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
+/- SD)##3##2##(1991-12#1)(1992-6#1)(1993-1#1)
+/- SE##2##2##(2008-10#1)(2008-12#1)
+/- SE)##2##2##(1990-5#2)
+/- standard##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
+/-##720##1##(1990-11#4)(1990-12#5)(1990-2#11)(1990-3#2)(1990-5#15)(1990-8#6)(1991-11#11)(1991-12#3)(1991-5#7)(1991-6#14)(1991-8#1)(1992-10#8)(1992-11#13)(1992-12#3)(1992-2#11)(1992-3#1)(1992-6#2)(1992-9#2)(1993-1#9)(1993-11#7)(1993-2#6)(1993-3#4)(1993-6#1)(1993-8#14)(1994-11#14)(1994-12#19)(1994-2#14)(1994-3#12)(1994-5#8)(1994-6#4)(1994-8#12)(1995-10#1)(1995-11#7)(1995-12#14)(1995-3#1)(1995-8#10)(1996-1#5)(1996-12#8)(1996-2#17)(1996-3#10)(1996-8#1)(1997-1#8)(1997-3#6)(1997-7#2)(1997-8#4)(2008-1#14)(2008-10#91)(2008-11#22)(2008-12#39)(2008-2#2)(2008-3#9)(2008-5#13)(2008-7#7)(2008-8#7)(2008-9#1)(2009-1#3)(2009-11#6)(2009-7#1)(2009-8#12)(2009-9#1)(2010-1#18)(2010-4#10)(2010-6#3)(2010-7#9)(2010-8#5)(2011-2#48)(2011-3#20)(2012-2#1)(2012-3#18)(2013-1#18)(2013-7#2)(2013-8#3)
+/-0##26##1##(2008-10#20)(2008-8#5)(2008-9#1)
+/-1##8##1##(2008-10#8)
+/-1%##2##1##(2008-10#2)
+/-10%##5##1##(2008-10#3)(2008-3#2)
+/-2##7##1##(2008-10#7)
+/-20% for##2##2##(2008-10#2)
+/-20%##4##1##(2008-10#4)
+/-3##3##1##(2008-10#2)(2008-8#1)
+/-3%##3##1##(2008-10#3)
+/-5##3##1##(2008-10#1)(2008-8#2)
+/-s##2##1##(2010-8#2)
+0##33##1##(2008-10#33)
+1##9##1##(1990-5#1)(1992-3#1)(2008-10#5)(2008-5#1)(2010-8#1)
+10 dB##2##2##(2008-9#2)
+10##4##1##(1993-8#2)(2008-9#2)
+13##4##1##(1990-5#2)(2008-10#1)(2009-9#1)
+180##2##1##(2008-10#1)(2008-9#1)
+2##3##1##(2008-10#3)
+20##2##1##(1995-2#1)(1997-2#1)
+2000V##2##1##(2008-10#2)
+4 degrees C##2##3##(2008-10#1)(2008-11#1)
+5##5##1##(2008-10#1)(2008-9#2)(2011-2#2)
+61 G/A polymorphism and glioma risk in a Chinese Han population##2##11##(2011-2#2)
+61 G/A polymorphism##3##3##(2011-2#3)
+61##4##1##(2011-2#4)
- 0##9##2##(1993-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#2)(2012-3#1)
- 1 patient##2##3##(2013-1#2)
- 1##17##2##(1993-8#1)(1997-8#1)(2008-10#2)(2010-7#1)(2011-2#10)(2013-1#2)
- 10##2##2##(2013-1#2)
- 2##3##2##(1993-2#1)(2012-3#1)(2013-1#1)
- 3##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
- 4##5##2##(1994-5#1)(2008-11#2)(2012-3#1)(2013-1#1)
- 45##2##2##(2008-11#1)(2011-2#1)
- 5##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
- 6##5##2##(1990-12#1)(1993-2#1)(2008-11#1)(2012-3#1)(2013-1#1)
- 8##4##2##(1993-2#1)(2008-11#1)(2012-3#1)(2013-1#1)
- A comment##3##3##(2013-8#3)
- A reply##2##3##(2013-8#2)
- A##18##2##(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2013-8#6)
- An ex vivo study##2##5##(2013-1#2)
- An##5##2##(2007-12#1)(2008-12#2)(2013-1#2)
- Is##2##2##(2008-11#1)(2011-2#1)
- The study##2##3##(2008-11#2)
- The##8##2##(2007-8#1)(2008-11#5)(2008-12#1)(2009-9#1)
- We##2##2##(2008-11#2)
- a case report##2##4##(2010-7#1)(2012-12#1)
- a case##3##3##(2008-11#1)(2010-7#1)(2012-12#1)
- a new##3##3##(2008-2#1)(2008-8#1)(2013-8#1)
- a review##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
- a##37##2##(2008-10#5)(2008-11#11)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-10#3)(2010-12#1)(2010-7#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#1)
- an overview##2##3##(2009-10#1)(2011-1#1)
- an unusual##2##3##(2009-9#1)(2012-12#1)
- an##8##2##(2008-10#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
- and##5##2##(1990-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
- are##4##2##(2008-11#2)(2008-7#1)(2013-1#1)
- as well as##2##4##(2008-10#1)(2008-9#1)
- as##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
- associated##2##2##(2008-11#1)(2012-12#1)
- at least##3##3##(1996-3#1)(2008-11#1)(2013-8#1)
- drug##2##2##(2008-11#2)
- for##5##2##(1991-3#1)(2008-11#3)(2010-10#1)
- from##3##2##(2008-10#1)(2012-9#1)(2013-1#1)
- group##2##2##(2008-11#1)(2013-1#1)
- has##2##2##(2007-8#1)(2008-10#1)
- hereditary##2##2##(2009-12#1)(2013-8#1)
- i##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
- in##4##2##(1996-3#1)(2011-2#3)
- induced##2##2##(1991-5#1)(2008-1#1)
- is there a##3##4##(2008-11#3)
- is##6##2##(2008-11#3)(2008-7#2)(2010-10#1)
- kappa##2##2##(1990-5#1)(2007-11#1)
- new##2##2##(2008-11#1)(2012-3#1)
- one##3##2##(2008-11#1)(2008-5#1)(2010-10#1)
- that##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
- the##15##2##(1996-3#1)(2008-11#4)(2008-5#4)(2008-7#3)(2009-10#1)(2012-2#1)(2013-1#1)
- to##2##2##(2008-7#1)(2013-1#1)
- using##2##2##(2008-10#2)
- was##6##2##(2008-11#4)(2008-5#1)(2013-1#1)
- whether##2##2##(2008-11#1)(2009-11#1)
- which##2##2##(1991-3#1)(2008-11#1)
- with the##3##3##(2008-10#2)(2008-11#1)
- with##4##2##(2008-10#2)(2008-11#2)
-##527##1##(1990-12#3)(1990-5#1)(1990-9#1)(1991-3#2)(1991-5#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-2#4)(1993-8#4)(1994-5#1)(1995-2#2)(1995-6#1)(1996-3#6)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#8)(2007-11#4)(2007-12#4)(2007-8#5)(2008-1#2)(2008-10#62)(2008-11#143)(2008-12#16)(2008-2#1)(2008-3#3)(2008-5#16)(2008-6#4)(2008-7#21)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#7)(2010-1#1)(2010-10#13)(2010-11#2)(2010-12#5)(2010-4#4)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#6)(2011-10#2)(2011-2#27)(2011-3#4)(2011-7#1)(2012-12#9)(2012-2#15)(2012-3#15)(2012-9#2)(2013-1#39)(2013-7#1)(2013-8#16)
-) and##2##2##(2008-5#2)
-)##6##1##(1995-6#1)(2008-12#1)(2008-5#3)(2013-8#1)
--##10##1##(1991-9#1)(1993-3#1)(1994-8#1)(1994-9#2)(2008-2#1)(2008-3#3)(2012-12#1)
--&gt##26##1##(1992-8#1)(1995-6#3)(1996-2#2)(1997-1#1)(2008-10#2)(2008-3#5)(2008-7#3)(2011-2#2)(2011-3#7)
--Ksiaz##2##1##(2009-5#2)
-/+ 0##7##2##(2008-11#4)(2008-5#3)
-/+##12##1##(2008-11#9)(2008-5#3)
-0##213##1##(1990-5#1)(1991-2#2)(1992-9#1)(1993-2#5)(1995-11#3)(1995-8#2)(1996-2#1)(2007-12#1)(2008-1#4)(2008-10#133)(2008-11#2)(2008-12#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#9)(2010-2#2)(2010-4#11)(2010-6#1)(2011-2#3)(2011-3#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#5)
-1 and##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
-1 kPa##2##2##(2008-10#2)
-1##64##1##(1991-11#1)(1991-6#1)(1992-12#1)(1993-8#1)(1996-2#1)(2008-10#41)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#2)(2012-9#1)(2013-1#1)(2013-8#3)
-10 kPa##3##2##(2008-10#3)
-10##12##1##(1991-9#1)(1993-1#1)(2008-10#7)(2008-4#1)(2008-5#1)(2012-2#1)
-100 mV##2##2##(2008-10#2)
-100##5##1##(1995-6#3)(2008-10#2)
-1035 to +24##2##3##(1995-6#2)
-1035 to##3##2##(1995-6#3)
-11##4##1##(1994-3#1)(2008-10#2)(2008-8#1)
-12##2##1##(2008-10#2)
-140 x 10(3)##3##3##(2008-10#3)
-146##2##1##(1991-5#2)
-15##3##1##(1994-5#1)(2010-4#1)(2011-2#1)
-18##8##1##(1992-10#1)(1992-12#1)(1993-8#2)(1994-5#1)(2008-10#1)(2010-1#1)(2010-3#1)
-19##2##1##(2010-1#1)(2011-2#1)
-2##20##1##(1991-11#1)(1991-6#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
-2-2 IIIB##2##2##(2008-10#2)
-2-2 IV##2##2##(2008-10#2)
-2-2 LP##2##2##(2008-10#2)
-2-2##6##1##(2008-10#6)
-2-3##2##1##(2008-10#2)
-20 and##2##2##(2008-10#2)
-20 degrees C for##2##4##(2008-10#1)(2008-11#1)
-20 degrees C##6##3##(1992-9#1)(2008-10#3)(2008-11#2)
-20##13##1##(1990-5#1)(1992-9#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#1)
-200 mV##3##2##(2008-10#3)
-200##4##1##(2008-10#4)
-200mV##3##1##(2008-10#3)
-25%##3##1##(2008-11#3)
-2548 G/A##3##2##(2008-10#3)
-2548##4##1##(2008-10#4)
-3 degrees C##2##3##(2008-10#2)
-3 in##2##2##(2008-9#2)
-3##17##1##(1995-2#2)(2008-10#9)(2008-9#4)(2009-5#1)(2011-2#1)
-3)##2##1##(2008-9#1)(2012-2#1)
-300 mV (versus##2##3##(2008-10#2)
-300 mV##3##2##(2008-10#3)
-300##4##1##(2008-10#3)(2011-2#1)
-330 x 10(3) Pa##2##4##(2008-10#2)
-344##2##1##(2008-9#2)
-35##2##1##(1991-9#1)(2010-3#1)
-374##2##1##(2008-9#2)
-38##2##1##(1992-3#1)(2010-3#1)
-4##13##1##(1991-11#1)(1993-8#2)(1995-2#3)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)
-40 kPa##3##2##(2008-10#3)
-40##7##1##(1992-8#1)(1995-6#1)(1996-6#1)(2008-10#3)(2008-8#1)
-414##2##1##(2008-9#2)
-42##2##1##(2008-10#1)(2010-3#1)
-43##2##1##(2010-3#1)(2012-9#1)
-48##2##1##(1992-10#1)(2008-10#1)
-484##2##1##(2008-9#2)
-5 and##2##2##(2008-10#2)
-5 degrees C##4##3##(2008-10#4)
-5##14##1##(1995-2#2)(2008-10#11)(2011-1#1)
-50 mV versus##2##3##(2008-10#2)
-50 mV##3##2##(2008-10#3)
-50##4##1##(2008-10#4)
-50%##2##1##(2008-11#2)
-540##2##1##(2008-9#2)
-55##3##1##(1992-10#1)(2008-10#2)
-56##3##1##(2008-10#3)
-57##2##1##(2008-10#2)
-58##3##1##(2008-10#3)
-580##2##1##(2008-9#2)
-6 and -7##2##3##(2011-2#2)
-6##12##1##(1990-5#1)(1991-6#1)(1993-8#1)(2008-10#2)(2008-4#3)(2009-5#1)(2010-1#1)(2011-2#2)
-60##2##1##(2008-3#1)(2012-12#1)
-7 x 10(3)##3##3##(2008-10#3)
-7##14##1##(1992-9#1)(2008-10#8)(2008-4#1)(2010-1#1)(2011-2#3)
-70##2##1##(1992-3#1)(2008-3#1)
-78 degrees##6##2##(1992-4#1)(1996-5#5)
-8##5##1##(1991-6#1)(2008-10#2)(2008-4#1)(2010-4#1)
-80##4##1##(1996-5#1)(2008-10#1)(2008-8#2)
-9 and##2##2##(2008-4#2)
-9##4##1##(1991-5#1)(2008-4#2)(2013-7#1)
-93 to -100##2##3##(1995-6#2)
-95##2##1##(2011-2#1)(2012-12#1)
-B and##2##2##(1996-6#1)(2013-1#1)
-B##6##1##(1996-6#1)(1997-4#1)(2008-10#3)(2013-1#1)
-C##3##1##(1995-6#1)(1996-6#1)(2008-8#1)
-DPD level##2##2##(2008-10#2)
-DPD##3##1##(2008-10#3)
-DQ##2##1##(1997-8#1)(1997-9#1)
-G##2##1##(1997-8#1)(2008-10#1)
-H##2##1##(1992-8#1)(1997-3#1)
-I##2##1##(2008-10#1)(2008-11#1)
-M##2##1##(1992-8#1)(1995-6#1)
-The##2##1##(2008-10#1)(2008-11#1)
-YY##2##1##(1997-3#2)
-chiro-inositol##6##1##(2008-11#6)
-dependent##3##1##(1995-10#1)(1995-11#1)(2008-5#1)
-expressing##2##1##(1995-11#1)(2013-1#1)
-lactate##2##1##(2008-11#1)(2011-2#1)
-lysine/alginate (APA)##2##2##(2008-11#2)
-merging zone##2##2##(2008-10#2)
-omics##3##1##(2011-2#1)(2012-3#2)
-pinitol##2##1##(2008-11#2)
-specific##3##1##(2008-10#1)(2012-5#2)
-test##4##1##(2008-10#1)(2008-11#3)
-tryptophan##2##1##(2008-11#2)
/##18##1##(1996-3#1)(1997-6#3)(2008-10#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-10#1)(2010-7#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
//dx##5##1##(2013-8#5)
//fbpe/img/rmc/v141n3/art19-a##2##1##(2013-8#2)
//www##23##1##(2008-10#4)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#8)
/= 0##26##2##(2008-10#25)(2008-9#1)
/= 25%)##2##2##(2008-10#2)
/= 3##2##2##(2008-10#1)(2008-7#1)
/= 70% (range##2##3##(2008-12#2)
/= phi &lt##2##3##(2008-3#2)
/= phi(min)##2##2##(2008-3#2)
/=##58##1##(2008-10#39)(2008-12#4)(2008-3#6)(2008-6#1)(2008-7#6)(2008-9#1)(2010-3#1)
/=0##13##1##(2008-10#11)(2008-3#1)(2008-9#1)
/=1##9##1##(2008-10#7)(2008-3#1)(2008-8#1)
/=10 000##2##2##(2008-10#1)(2008-11#1)
/=10##5##1##(2008-10#4)(2008-11#1)
/=120##3##1##(2008-10#1)(2008-3#1)(2008-9#1)
/=18##3##1##(2008-10#2)(2008-11#1)
/=2##3##1##(2008-10#3)
/=2% for##2##2##(2008-10#2)
/=2%##3##1##(2008-10#3)
/=3##8##1##(2008-10#6)(2008-12#2)
/=4##7##1##(2008-10#6)(2010-4#1)
/=5##3##1##(2008-10#3)
/=50 mug l(-1) As##3##4##(2008-10#3)
/=50##4##1##(2008-10#4)
/=50%##2##1##(2008-10#2)
/=7##2##1##(2008-10#2)
/=90%##2##1##(2008-10#2)
/=95%##2##1##(2008-10#2)
/=I&lt##2##1##(2008-10#2)
/=I/molkg(-1)&lt##3##1##(2008-10#3)
/=x(2pr)&lt##2##1##(2008-10#2)
/font&gt##2##1##(2010-11#2)
/kg##2##1##(2011-2#2)
/ml##4##1##(2008-10#4)
0 &lt##3##2##(2008-3#2)(2013-1#1)
0 (0##3##2##(2008-10#3)
0 (1##2##2##(1993-12#1)(2012-3#1)
0 (C##2##2##(2008-7#1)(2013-1#1)
0 +/- 0##5##3##(1990-5#2)(1991-5#1)(1993-8#1)(2010-8#1)
0 +/- 1##4##3##(1991-5#1)(1992-2#1)(1994-2#1)(2009-8#1)
0 +/- 3##2##3##(2010-1#1)(2010-7#1)
0 +/- 5##2##3##(1994-2#1)(2008-11#1)
0 +/-##22##2##(1990-5#2)(1991-5#2)(1992-2#1)(1993-3#2)(1993-8#1)(1994-2#2)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#3)
0 -##3##2##(2008-11#1)(2010-4#1)(2011-2#1)
0 =##5##2##(2008-10#1)(2008-11#1)(2013-1#3)
0 A##5##2##(1992-11#1)(2008-8#4)
0 M HCl##3##3##(2008-10#3)
0 M acid##2##3##(2008-10#2)
0 M##13##2##(2008-10#12)(2009-10#1)
0 MPa##5##2##(2008-10#4)(2009-7#1)
0 Primary Scale##2##3##(2008-10#2)
0 V vs##2##3##(2008-10#2)
0 V##13##2##(2008-10#13)
0 V)##2##2##(2008-10#2)
0 and 0##14##3##(1990-6#1)(1993-3#1)(2008-10#12)
0 and 1##6##3##(1991-5#1)(1997-8#1)(2008-10#3)(2008-12#1)
0 and 10##6##3##(1991-10#1)(1994-11#1)(1997-2#1)(2008-10#3)
0 and 12##2##3##(2008-10#2)
0 and 2##8##3##(1995-8#1)(2008-10#4)(2008-11#2)(2011-2#1)
0 and 3##6##3##(1996-12#1)(2008-10#5)
0 and 4##9##3##(1996-12#1)(2008-10#8)
0 and 5##6##3##(2008-10#6)
0 and 6##5##3##(1996-12#1)(2008-10#4)
0 and 7##5##3##(1990-8#1)(2008-10#4)
0 and 98##2##3##(2008-10#2)
0 and 99##2##3##(2008-10#2)
0 and a detection limit of 3##2##7##(2008-10#2)
0 and a##4##3##(1995-12#1)(2008-10#2)(2010-3#1)
0 and analysis time was##2##5##(2008-10#2)
0 and at##3##3##(2008-10#3)
0 and in##2##3##(2008-10#2)
0 and then##2##3##(2008-10#2)
0 and##127##2##(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#3)(1997-2#1)(1997-8#1)(2008-10#98)(2008-11#3)(2008-12#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
0 approximately##2##2##(2008-10#2)
0 as the##3##3##(2008-10#2)(2008-11#1)
0 as##4##2##(1994-3#1)(2008-10#2)(2008-11#1)
0 at##3##2##(2008-10#3)
0 billion##2##2##(1992-2#1)(1994-1#1)
0 by##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
0 cM)##2##2##(2008-10#2)
0 cells##2##2##(2008-11#2)
0 cm##5##2##(2008-10#2)(2009-2#1)(2012-12#1)(2013-1#1)
0 compared with pH##2##4##(2008-10#2)
0 containing##4##2##(2008-10#4)
0 degrees C##14##3##(1991-5#1)(1993-8#1)(2008-10#11)(2008-7#1)
0 degrees C)##3##3##(2008-10#3)
0 degrees##20##2##(1991-5#1)(1993-8#1)(2008-10#14)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)
0 diethanolamine-typed dendrimer##2##3##(2008-10#2)
0 for Cu##2##3##(2008-10#2)
0 for both##2##3##(1991-9#1)(2008-10#1)
0 for the##3##3##(1993-8#2)(2008-10#1)
0 for##16##2##(1991-9#1)(1993-8#2)(1994-6#1)(2008-10#11)(2008-3#1)
0 g l(-1) of fraction##2##5##(2008-11#2)
0 g l(-1)##3##3##(2008-10#1)(2008-11#2)
0 g of##7##3##(2008-10#7)
0 g##14##2##(2008-10#12)(2008-11#2)
0 h##3##2##(1995-12#2)(2008-11#1)
0 if##3##2##(2008-10#3)
0 in presence of##3##4##(2008-10#3)
0 in the##3##3##(1994-5#1)(1995-2#1)(2008-10#1)
0 in##12##2##(1990-12#2)(1994-5#1)(1995-2#1)(1995-5#1)(2008-10#6)(2012-2#1)
0 is##6##2##(1994-2#1)(1995-5#1)(2008-10#1)(2008-4#1)(2012-2#2)
0 kDa##2##2##(2008-10#2)
0 kb in##2##3##(1990-2#1)(1997-2#1)
0 kb##11##2##(1990-2#2)(1993-6#1)(1996-2#1)(1997-2#3)(2008-10#1)(2008-8#3)
0 kcal/mol##2##2##(1993-8#2)
0 kg##2##2##(2008-10#1)(2012-3#1)
0 kg/ha##2##2##(2011-1#2)
0 l and##2##3##(2008-10#2)
0 l##4##2##(2008-10#4)
0 lyso-PC##4##2##(2008-8#4)
0 lyso-PC/DPPS molar##2##3##(2008-8#2)
0 m##5##2##(2008-10#4)(2008-8#1)
0 mL##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
0 mM##11##2##(1997-2#1)(2008-10#8)(2009-6#1)(2011-2#1)
0 mM)##3##2##(2009-6#1)(2011-2#2)
0 mV##5##2##(1993-8#1)(2008-10#4)
0 mV/decade##2##2##(2008-10#2)
0 mg L(-1) 2##2##4##(2008-12#2)
0 mg L(-1) BAP##2##4##(2008-12#2)
0 mg L(-1)##5##3##(2008-10#1)(2008-12#4)
0 mg and##2##3##(1993-2#1)(2008-10#1)
0 mg l(-1) for##2##4##(2008-10#2)
0 mg l(-1) of##3##4##(2008-10#3)
0 mg l(-1) with a##2##5##(2008-10#2)
0 mg l(-1)##16##3##(2008-10#16)
0 mg mL(-1)##4##3##(2008-5#4)
0 mg##30##2##(1993-2#1)(2008-10#20)(2008-12#4)(2008-5#4)(2012-2#1)
0 mg/L 6-BA and 0##2##5##(2008-8#2)
0 mg/L##4##2##(2008-10#1)(2008-8#3)
0 mg/L)##2##2##(2013-1#2)
0 mg/kg##8##2##(1991-10#1)(2008-10#1)(2008-11#4)(2008-7#2)
0 mg/kg)##2##2##(1991-10#1)(1996-2#1)
0 mg/ml##2##2##(2008-11#2)
0 mgl(-1)##4##2##(2008-10#4)
0 microM##3##2##(1990-10#1)(1993-8#1)(1995-6#1)
0 microM)##2##2##(1992-3#1)(2008-8#1)
0 microW/cm(2) UVA##2##3##(2008-11#2)
0 microW/cm(2)##4##2##(2008-11#4)
0 microg l(-1)##2##3##(2008-10#2)
0 microg ml(-1)##3##3##(2008-10#3)
0 microg##9##2##(2008-10#9)
0 microg/l for##2##3##(2008-10#2)
0 microg/l##3##2##(2008-10#3)
0 microgml(-1)##2##2##(2008-10#2)
0 microm##3##2##(1996-12#2)(2008-10#1)
0 micromol L(-1)##2##3##(2008-10#2)
0 micromol##3##2##(2008-10#3)
0 min for##2##3##(2008-10#2)
0 min region on the linkage map (supplement)##2##8##(1996-12#1)(1996-6#1)
0 min region on the linkage map##4##7##(1996-12#2)(1996-6#2)
0 min region on the##5##5##(1996-12#3)(1996-6#2)
0 min region##6##3##(1996-12#4)(1996-6#2)
0 min##13##2##(1996-12#4)(1996-6#2)(2008-1#1)(2008-10#5)(2013-1#1)
0 ml min(-1) for##3##4##(2008-10#3)
0 ml min(-1)##15##3##(2008-10#15)
0 ml min(-1))##2##3##(2008-10#2)
0 ml of sample volume)##2##5##(2008-10#2)
0 ml of##5##3##(2008-10#5)
0 ml##27##2##(1993-3#1)(2008-10#26)
0 mlmin(-1)##3##2##(2008-10#3)
0 mm##9##2##(2008-10#3)(2008-7#2)(2009-11#1)(2009-2#1)(2010-8#2)
0 mm)##2##2##(2008-9#1)(2012-2#1)
0 mmHg##2##2##(2008-11#2)
0 mmol l(-1)##2##3##(2008-10#2)
0 mmol##3##2##(2008-10#2)(2008-9#1)
0 mmol/kg##2##2##(1992-12#2)
0 mol dm(-3)##4##3##(2008-10#4)
0 mol dm(-3))##4##3##(2008-10#4)
0 mol l(-1) HCl##2##4##(2008-10#2)
0 mol l(-1) NaOH##2##4##(2008-10#2)
0 mol l(-1)##8##3##(2008-10#8)
0 mol l(-1))##2##3##(2008-10#2)
0 mol##20##2##(2008-10#20)
0 muM (R=0##2##3##(2008-10#2)
0 muM##4##2##(2008-10#4)
0 mug As l(-1)##2##4##(2008-10#2)
0 mug Cd l(-1)##2##4##(2008-10#2)
0 mug Mo l(-1)##2##4##(2008-10#2)
0 mug Mo##3##3##(2008-10#3)
0 mug g(-1)##2##3##(2008-10#2)
0 mug l(-1)##16##3##(2008-10#16)
0 mug ml(-1) cobalt##2##4##(2008-10#2)
0 mug ml(-1) for both##2##5##(2008-10#2)
0 mug ml(-1) for calf thymus DNA##2##7##(2008-10#2)
0 mug ml(-1) for fish sperm DNA##2##7##(2008-10#2)
0 mug ml(-1) for yeast RNA##2##6##(2008-10#2)
0 mug ml(-1) for##18##4##(2008-10#18)
0 mug ml(-1) of##5##4##(2008-10#5)
0 mug ml(-1)##38##3##(2008-10#37)(2008-11#1)
0 mug ml(-1))##2##3##(2008-10#2)
0 mug of cobalt##2##4##(2008-10#2)
0 mug of##6##3##(2008-10#6)
0 mug##80##2##(2008-10#78)(2008-11#1)(2008-5#1)
0 mug/l##2##2##(2008-10#2)
0 mug/ml##3##2##(2008-10#3)
0 mugl(-1) for##2##3##(2008-10#2)
0 mum##6##2##(1992-2#1)(2008-3#2)(2008-5#1)(2008-8#2)
0 mumol of##2##3##(2008-10#2)
0 ng for##4##3##(2008-10#4)
0 ng ml(-1) and##2##4##(2008-10#2)
0 ng ml(-1) for##5##4##(2008-10#5)
0 ng ml(-1) vanadium##2##4##(2008-10#2)
0 ng ml(-1) was##2##4##(2008-10#2)
0 ng ml(-1)##24##3##(2008-10#24)
0 ng##39##2##(2008-10#38)(2010-5#1)
0 ngcm(-3))##2##2##(2008-10#2)
0 nm##7##2##(2008-10#7)
0 of##4##2##(1990-6#1)(2008-10#3)
0 on##3##2##(1991-3#1)(2008-10#2)
0 or 2##4##3##(2008-10#4)
0 or##9##2##(1994-11#1)(2008-10#8)
0 per##2##2##(2008-11#1)(2008-7#1)
0 percent##2##2##(1991-1#1)(2008-8#1)
0 pg for##2##3##(2008-10#2)
0 pg##3##2##(2008-10#3)
0 pg)##2##2##(2008-10#2)
0 phosphate buffer##2##3##(2008-10#2)
0 ppb for##2##3##(2008-10#2)
0 ppb##5##2##(2008-10#5)
0 ppm with##2##3##(2008-10#2)
0 ppm##6##2##(2008-10#6)
0 pyrrolidine-phosphoric acid buffer solution##2##5##(2008-10#2)
0 pyrrolidine-phosphoric acid buffer##3##4##(2008-10#3)
0 to 0##7##3##(2008-10#4)(2008-11#1)(2008-8#1)(2010-4#1)
0 to 1##7##3##(2008-10#7)
0 to 10##6##3##(2008-10#2)(2008-5#1)(2008-7#2)(2009-11#1)
0 to 100##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
0 to 12##2##3##(2008-10#2)
0 to 16##3##3##(2008-10#3)
0 to 2##4##3##(1996-2#1)(2008-10#1)(2010-8#1)(2012-12#1)
0 to 20##2##3##(2008-10#1)(2013-1#1)
0 to 25%##2##3##(2008-10#2)
0 to 3##6##3##(1994-3#1)(1995-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
0 to 30##7##3##(1990-12#1)(2008-10#5)(2013-1#1)
0 to 35##2##3##(2008-10#2)
0 to 4##3##3##(2008-11#1)(2009-2#1)(2010-7#1)
0 to 5##3##3##(2008-10#3)
0 to 6##2##3##(2008-10#2)
0 to 65##2##3##(1991-11#1)(2008-3#1)
0 to 7##6##3##(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
0 to 72##2##3##(2008-10#1)(2010-8#1)
0 to 8##2##3##(2008-10#2)
0 to 9##2##3##(2008-10#1)(2013-8#1)
0 to##145##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-1#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#88)(2008-11#6)(2008-3#5)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#3)(2011-2#2)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#1)
0 vs##6##2##(2008-7#1)(2009-8#1)(2011-2#3)(2013-8#1)
0 was##7##2##(1992-3#1)(2008-10#5)(2011-3#1)
0 were##2##2##(2008-11#2)
0 when the flow rate##2##5##(2008-10#2)
0 when##3##2##(2008-10#2)(2008-3#1)
0 with a fast response time of approximately##2##8##(2008-10#2)
0 with a##4##3##(2008-10#4)
0 with##11##2##(2008-10#10)(2008-5#1)
0 x 10(-1) mol 1(-1) and##2##6##(2008-10#2)
0 x 10(-1) mol##3##4##(2008-10#3)
0 x 10(-1)##4##3##(2008-10#4)
0 x 10(-1)M##4##3##(2008-10#4)
0 x 10(-10)##3##3##(1994-5#1)(2008-10#1)(2008-3#1)
0 x 10(-2)##2##3##(2008-10#2)
0 x 10(-2)-2##2##3##(2008-10#2)
0 x 10(-3) mol l(-1)##2##5##(2008-10#2)
0 x 10(-3)##3##3##(2008-10#3)
0 x 10(-3)-1##2##3##(2008-10#2)
0 x 10(-4) mol l(-1)##2##5##(2008-10#2)
0 x 10(-4)##3##3##(2008-10#3)
0 x 10(-5) M##2##4##(2008-10#2)
0 x 10(-5) to 1##2##5##(2008-10#2)
0 x 10(-5) to##3##4##(2008-10#3)
0 x 10(-5)##6##3##(2008-10#6)
0 x 10(-5)M##4##3##(2008-10#4)
0 x 10(-6) and 1##2##5##(2008-10#2)
0 x 10(-6) and##3##4##(2008-10#3)
0 x 10(-6) mol l(-1)##2##5##(2008-10#2)
0 x 10(-6) mol##3##4##(2008-10#3)
0 x 10(-6)##9##3##(1990-8#1)(2008-10#8)
0 x 10(-6)mol##2##3##(2008-10#2)
0 x 10(-7) mol l(-1) concentration range##2##7##(2008-10#2)
0 x 10(-7) mol l(-1) for##2##6##(2008-10#2)
0 x 10(-7) mol l(-1)##6##5##(2008-10#6)
0 x 10(-7) mol##7##4##(2008-10#7)
0 x 10(-7) to 1##4##5##(2008-10#4)
0 x 10(-7) to##7##4##(2008-10#6)(2008-3#1)
0 x 10(-7)##15##3##(2008-10#14)(2008-3#1)
0 x 10(-7)M##2##3##(2008-10#2)
0 x 10(-7)mol L(-1) and##2##5##(2008-10#2)
0 x 10(-8) g ml(-1)##2##5##(2008-10#2)
0 x 10(-8) to##2##4##(2008-10#2)
0 x 10(-8)##5##3##(2008-10#5)
0 x 10(-9)##3##3##(2008-10#3)
0 x 10(-9)M##2##3##(2008-10#2)
0 x 10(4)##2##3##(2008-10#2)
0 x 10(5)##2##3##(2008-10#1)(2008-9#1)
0 x 105 cells mL-1##2##5##(2008-11#2)
0 x 109/l with a median of##2##7##(2008-10#2)
0 x 109/l##3##3##(2008-10#3)
0 x##102##2##(1990-8#1)(1994-5#1)(2008-10#93)(2008-11#3)(2008-3#2)(2008-9#1)(2009-6#1)
0 years##5##2##(1990-9#1)(1992-9#1)(2008-11#1)(2008-7#1)(2009-8#1)
0 years)##4##2##(2008-7#1)(2009-7#1)(2012-12#1)(2013-8#1)
0 ±##3##2##(2010-11#1)(2011-2#1)(2012-3#1)
0##8044##1##(1990-10#3)(1990-11#5)(1990-12#16)(1990-2#27)(1990-3#5)(1990-4#2)(1990-5#16)(1990-6#14)(1990-8#12)(1990-9#3)(1991-1#1)(1991-10#7)(1991-11#26)(1991-12#18)(1991-2#16)(1991-3#9)(1991-5#14)(1991-6#5)(1991-7#5)(1991-8#11)(1991-9#20)(1992-10#5)(1992-11#16)(1992-12#33)(1992-2#10)(1992-3#18)(1992-4#4)(1992-6#9)(1992-7#2)(1992-8#1)(1992-9#11)(1993-1#40)(1993-11#15)(1993-12#12)(1993-2#24)(1993-3#17)(1993-6#12)(1993-8#43)(1993-9#2)(1994-1#5)(1994-11#19)(1994-12#44)(1994-2#15)(1994-3#29)(1994-5#34)(1994-6#12)(1994-8#34)(1994-9#1)(1995-1#2)(1995-11#17)(1995-12#25)(1995-2#10)(1995-3#12)(1995-5#8)(1995-6#8)(1995-8#22)(1996-1#3)(1996-11#2)(1996-12#41)(1996-2#32)(1996-3#12)(1996-5#2)(1996-6#10)(1996-8#7)(1997-1#10)(1997-2#22)(1997-3#4)(1997-4#8)(1997-5#3)(1997-7#4)(1997-8#24)(2006-6#2)(2007-11#1)(2007-12#9)(2007-8#3)(2008-1#11)(2008-10#4733)(2008-11#271)(2008-12#119)(2008-2#23)(2008-3#118)(2008-4#3)(2008-5#137)(2008-6#12)(2008-7#143)(2008-8#85)(2008-9#107)(2009-1#4)(2009-10#8)(2009-11#21)(2009-12#4)(2009-2#9)(2009-3#17)(2009-5#3)(2009-6#13)(2009-7#10)(2009-8#20)(2009-9#5)(2010-1#33)(2010-10#7)(2010-11#27)(2010-12#24)(2010-2#20)(2010-3#8)(2010-4#52)(2010-5#5)(2010-6#30)(2010-7#19)(2010-8#28)(2010-9#14)(2011-1#20)(2011-2#267)(2011-3#54)(2012-12#18)(2012-2#82)(2012-3#99)(2012-7#1)(2012-8#1)(2013-1#253)(2013-8#101)
0% (P &lt##2##3##(2008-11#1)(2013-1#1)
0% (n=10)##3##2##(2008-10#3)
0% (v/v)##2##2##(2008-10#2)
0% and 0##2##3##(2008-10#2)
0% and the##2##3##(2008-10#2)
0% and##20##2##(1992-6#1)(2008-10#11)(2008-11#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-3#1)(2012-2#1)
0% arginine##4##2##(2011-2#4)
0% at the##3##3##(2008-10#3)
0% at##4##2##(1995-12#1)(2008-10#3)
0% by##2##2##(2008-10#1)(2012-2#1)
0% for a##2##3##(2008-10#2)
0% for all##2##3##(2008-10#2)
0% for the##3##3##(1997-2#1)(1997-7#1)(2008-10#1)
0% for##21##2##(1997-2#1)(1997-7#1)(2008-10#17)(2012-12#1)(2012-3#1)
0% in##10##2##(1990-9#1)(1994-8#1)(1995-1#1)(2008-10#4)(2008-11#1)(2012-3#1)(2013-8#1)
0% increase##2##2##(2013-1#2)
0% knew##2##2##(2008-11#2)
0% of the##2##3##(2008-10#1)(2008-5#1)
0% of##11##2##(1991-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
0% relative standard deviation (R##2##5##(2008-10#2)
0% to##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
0% v/v##3##2##(2008-10#3)
0% vs##4##2##(1990-3#1)(1994-2#1)(2011-2#1)(2013-8#1)
0% were obtained for##2##4##(2008-10#2)
0% were obtained##4##3##(2008-10#4)
0% were##5##2##(2008-10#5)
0% with##2##2##(2008-10#2)
0%##230##1##(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-6#3)(1992-6#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#146)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#8)(2013-1#5)(2013-8#4)
0%) and is##2##3##(2008-10#1)(2008-6#1)
0%) and##4##2##(2008-10#2)(2008-6#1)(2008-9#1)
0%) had##3##2##(1994-12#1)(1996-6#1)(2012-3#1)
0%) in##2##2##(1993-1#1)(2013-8#1)
0%) of##3##2##(2008-10#2)(2008-11#1)
0%) on##2##2##(2012-3#2)
0%) people##2##2##(2008-11#2)
0%) were##3##2##(1997-7#1)(2008-10#1)(2012-3#1)
0%)##55##1##(1990-6#1)(1990-8#1)(1993-1#1)(1993-8#1)(1994-12#2)(1996-6#1)(1997-7#1)(1997-8#1)(2008-10#18)(2008-11#5)(2008-5#1)(2008-6#1)(2008-9#6)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#10)(2013-8#2)
0&lt##4##1##(2008-10#4)
0(2##4##1##(1996-5#3)(2008-10#1)
0) and BALB/cByJ (mean##2##4##(2008-5#2)
0) and##25##2##(1991-11#1)(1991-12#1)(1994-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#3)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
0) containing##3##2##(2008-10#3)
0) could detect fsDNA over the range of##2##8##(2008-10#2)
0) for##2##2##(2008-10#2)
0) g/L and 0##2##4##(2008-8#2)
0) in the##3##3##(1994-12#1)(2008-10#2)
0) in##8##2##(1994-12#1)(1997-8#1)(2008-10#6)
0) is##2##2##(2008-10#1)(2008-11#1)
0) or##2##2##(2008-10#1)(2008-3#1)
0) to##2##2##(2008-3#1)(2011-1#1)
0) transitions##2##2##(2008-3#2)
0) was##2##2##(2008-10#1)(2008-11#1)
0) were##3##2##(2008-10#2)(2012-3#1)
0) when##2##2##(2008-10#1)(2008-6#1)
0) with##2##2##(2008-10#2)
0)##144##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-11#2)(1994-12#2)(1994-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#77)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#11)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-3#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
0))##3##1##(2008-10#2)(2012-3#1)
0)/I(294##3##1##(2008-10#3)
0)G(0##3##1##(2008-5#3)
0)R(1##3##1##(2008-5#3)
0+ to##2##2##(2008-10#1)(2010-8#1)
0+##4##1##(2008-10#3)(2010-8#1)
0+/-0##20##1##(2008-10#19)(2008-7#1)
0+/-1##7##1##(2008-10#7)
0- and##3##2##(1993-8#1)(2008-10#2)
0- to##4##2##(2008-10#3)(2012-3#1)
0-##10##1##(1990-12#1)(1993-8#1)(2008-10#6)(2008-11#1)(2012-3#1)
0-0##7##1##(2008-10#6)(2008-2#1)
0-1##8##1##(2008-10#6)(2011-2#1)(2012-12#1)
0-10 min##2##2##(1994-12#1)(1995-11#1)
0-10##22##1##(1994-12#1)(1995-11#1)(2008-10#15)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
0-100##7##1##(2008-10#6)(2008-9#1)
0-11##3##1##(2008-10#3)
0-12##7##1##(2008-10#6)(2012-3#1)
0-13##2##1##(2008-10#2)
0-14##3##1##(1994-12#1)(1997-3#1)(2012-3#1)
0-15##3##1##(1994-6#1)(2008-10#1)(2008-3#1)
0-150##3##1##(2008-10#3)
0-18##2##1##(2008-10#1)(2013-1#1)
0-2##14##1##(1990-2#1)(2008-10#12)(2012-12#1)
0-20##5##1##(2008-10#4)(2013-8#1)
0-200##3##1##(2008-10#3)
0-25##3##1##(2008-10#3)
0-3##13##1##(1990-8#1)(1993-8#1)(2008-10#7)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
0-30##4##1##(2008-10#3)(2012-3#1)
0-300##2##1##(2008-10#2)
0-3R)##2##1##(2013-8#2)
0-4##9##1##(1991-3#1)(1993-8#1)(2008-10#5)(2008-5#1)(2012-3#1)
0-40##7##1##(1996-12#3)(2008-10#4)
0-5##19##1##(1991-11#1)(2008-10#10)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
0-6##17##1##(2006-6#1)(2008-10#15)(2010-4#1)
0-60##4##1##(2008-10#3)(2008-8#1)
0-7##21##1##(1991-5#1)(2008-10#19)(2008-11#1)
0-74##2##1##(1992-2#1)(2008-10#1)
0-8##21##1##(1990-5#1)(1994-12#1)(2008-10#18)(2012-3#1)
0-9##10##1##(2008-10#8)(2008-6#1)(2008-7#1)
00 (+/-0##2##2##(2008-10#2)
00 (95% CI##2##3##(2008-12#2)
00 +/-##2##2##(2011-3#2)
00 M##2##2##(2008-10#2)
00 U##2##2##(2008-10#1)(2010-10#1)
00 and 3##3##3##(2008-10#3)
00 and##7##2##(2008-10#5)(2012-12#2)
00 degrees##2##2##(2008-10#1)(2013-1#1)
00 g##2##2##(2008-10#2)
00 hours##2##2##(2008-5#1)(2012-12#1)
00 mg l(-1)##2##3##(2008-10#2)
00 mg##3##2##(2008-10#3)
00 micrometer##2##2##(2013-1#2)
00 ml of##2##3##(2008-10#2)
00 ml##4##2##(2008-10#4)
00 mol l(-1) NaCl were##2##5##(2008-10#2)
00 mol l(-1) NaCl##3##4##(2008-10#3)
00 mol l(-1)##4##3##(2008-10#4)
00 mug l(-1)##2##3##(2008-10#2)
00 mug ml(-1) for##3##4##(2008-10#3)
00 mug ml(-1) of##3##4##(2008-10#3)
00 mug ml(-1)##12##3##(2008-10#12)
00 mug##14##2##(2008-10#14)
00 p##2##2##(1990-2#1)(1992-12#1)
00 phosphate buffer##2##3##(2008-10#2)
00 to 0##5##3##(2008-10#5)
00 to 22##2##3##(2012-12#2)
00 to 3##2##3##(2008-10#2)
00 to##17##2##(1992-12#1)(1994-2#1)(2008-10#9)(2012-12#5)(2013-1#1)
00 x 10(-2)) and (5##2##5##(2008-10#2)
00 x 10(-2))M in##2##4##(2008-10#2)
00 x##5##2##(2008-10#5)
00##124##1##(1990-2#1)(1991-5#1)(1991-6#1)(1992-12#2)(1993-12#1)(1994-11#1)(1994-2#1)(1995-6#1)(2008-10#81)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#3)(2009-12#1)(2010-10#2)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#10)(2013-1#4)(2013-8#1)
00%##4##1##(2008-10#2)(2008-11#1)(2012-12#1)
00)##9##1##(1995-3#2)(1997-3#1)(2008-10#2)(2008-12#1)(2011-2#2)(2012-3#1)
00+/-0##3##1##(2008-10#2)(2008-11#1)
00-50##4##1##(2008-10#4)
000 (DARPP-32)##2##2##(1991-10#2)
000 Da##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
000 Da)##3##2##(2008-10#2)(2008-5#1)
000 J2##2##2##(2008-10#2)
000 Medicare##2##2##(1993-12#1)(1994-3#1)
000 U##2##2##(2011-1#1)(2011-2#1)
000 and 2##3##3##(2008-9#3)
000 and##16##2##(1990-5#1)(1992-7#1)(1993-3#1)(1993-8#1)(1995-8#1)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#3)(2012-2#1)
000 are##2##2##(1997-6#1)(2008-10#1)
000 at##3##2##(1996-2#1)(1997-6#1)(2008-3#1)
000 award##2##2##(1995-6#2)
000 births##2##2##(1995-2#1)(2012-12#1)
000 by the year 2000##2##5##(1997-6#2)
000 by the##3##3##(1990-12#1)(1997-6#2)
000 cases of##2##3##(1995-12#1)(2012-12#1)
000 cases##5##2##(1992-9#1)(1995-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
000 cells##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
000 children##6##2##(1990-2#1)(1997-6#2)(2008-1#1)(2008-11#1)(2008-6#1)
000 chlamydospores g(1) of soil##2##5##(2008-10#2)
000 chlamydospores per gram of soil)##2##6##(2008-10#2)
000 chlamydospores per gram of##3##5##(2008-10#3)
000 chlamydospores##5##2##(2008-10#5)
000 clones were##2##3##(2008-8#1)(2010-10#1)
000 clones##3##2##(2008-8#1)(2010-10#1)(2011-1#1)
000 consecutive##2##2##(1994-3#1)(2012-2#1)
000 copies##2##2##(1996-12#1)(2009-8#1)
000 deaths##2##2##(1997-2#1)(2012-2#1)
000 epinephrine##3##2##(1993-1#3)
000 expressed sequence tags##2##4##(2008-8#1)(2010-10#1)
000 females##2##2##(1991-6#1)(1997-4#1)
000 for the##4##3##(1995-2#1)(1997-4#3)
000 for##8##2##(1995-2#1)(1996-5#2)(1997-4#3)(2008-1#1)(2012-12#1)
000 in##7##2##(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(2007-12#1)(2008-11#1)
000 individuals##5##2##(1992-9#1)(1996-3#1)(2008-10#2)(2008-8#1)
000 infectious units/cell##2##3##(2008-11#2)
000 inhabitants##5##2##(1990-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
000 km##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
000 live births##4##3##(1991-11#1)(2013-1#3)
000 m##2##2##(2008-10#1)(2008-3#1)
000 mg/L dichloroacetic acid for 26 weeks with additional groups of 10 males and 10 females exposed for 41 weeks##2##20##(2008-9#2)
000 mg/L dichloroacetic acid for##3##5##(2008-9#3)
000 mg/L for##2##3##(2008-9#2)
000 mg/L males and females##2##5##(2008-9#2)
000 mg/L##11##2##(2008-9#11)
000 microg ml(-1) from##2##4##(2008-10#2)
000 microg##3##2##(2008-10#2)(2010-5#1)
000 mug##2##2##(2008-10#2)
000 ng##2##2##(2008-10#2)
000 of##3##2##(1997-2#1)(2011-2#1)(2012-2#1)
000 or##2##2##(2008-10#1)(2008-11#1)
000 orphans##2##2##(1990-12#1)(1997-6#1)
000 patients##2##2##(2012-2#1)(2013-1#1)
000 people in##2##3##(2008-10#1)(2012-3#1)
000 people were##3##3##(1992-9#1)(1996-6#2)
000 people##13##2##(1990-2#1)(1990-6#1)(1992-9#1)(1996-6#3)(1997-6#1)(2008-10#2)(2008-7#1)(2010-7#1)(2012-3#1)(2013-8#1)
000 per year##2##3##(1992-1#1)(1995-6#1)
000 per##3##2##(1992-1#1)(1995-6#1)(2008-10#1)
000 persons had##2##3##(1994-9#2)
000 persons##5##2##(1991-6#1)(1993-1#1)(1994-9#2)(1996-6#1)
000 plates##2##2##(2008-10#2)
000 ppm of##3##3##(2008-10#3)
000 single##2##2##(1993-6#1)(2012-3#1)
000 spores##2##2##(2008-10#1)(2010-5#1)
000 substrate##3##2##(1990-10#3)
000 times that of##2##4##(2008-10#2)
000 times##8##2##(1995-11#1)(2008-10#6)(2012-12#1)
000 to##14##2##(1991-9#1)(1992-9#2)(1995-6#3)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#2)
000 with##2##2##(1990-5#1)(2011-2#1)
000 years ago##2##3##(1994-3#1)(2012-3#1)
000 years##6##2##(1994-3#3)(2010-5#1)(2012-3#1)(2013-8#1)
000 zoospores per##2##3##(2008-10#2)
000##414##1##(1990-10#6)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#4)(1990-9#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#3)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#6)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#3)(1994-2#5)(1994-3#6)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#8)(1995-2#4)(1995-6#9)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#7)(1996-6#4)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#5)(1997-6#10)(1997-7#1)(1997-9#1)(2007-12#3)(2008-1#2)(2008-10#93)(2008-11#19)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#19)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#1)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#15)(2012-12#13)(2012-2#10)(2012-3#4)(2013-1#9)(2013-8#8)
000) in##2##2##(1994-9#1)(2008-7#1)
000) is##2##2##(1990-5#2)
000) over##2##2##(2009-8#2)
000) was##4##2##(1992-3#1)(1994-12#1)(2008-10#1)(2008-5#1)
000)##33##1##(1990-5#4)(1991-12#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#1)(2009-8#3)(2010-10#2)(2011-2#5)(2012-2#1)
000+/-2000##2##1##(2008-10#2)
000-10##2##1##(1996-6#1)(2008-1#1)
000-4##2##1##(2008-11#2)
000-50 000##2##2##(2008-10#1)(2013-1#1)
000-bp##2##1##(2008-10#1)(2010-5#1)
000-fold##3##1##(1992-6#1)(2008-10#1)(2008-4#1)
000-grain weight##2##2##(2008-10#1)(2008-9#1)
000/QALY##2##1##(2009-8#2)
000/year)##2##1##(1997-3#2)
00001) and##2##2##(1993-2#1)(2010-2#1)
00001)##3##1##(1993-2#1)(2010-2#2)
000061##2##1##(2011-2#2)
0001 for##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
0001##35##1##(1992-12#3)(1994-12#2)(1995-8#2)(1996-3#4)(2008-10#15)(2008-11#1)(2010-1#1)(2010-8#4)(2012-3#1)(2013-1#2)
0001) and##9##2##(1993-2#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#3)
0001) between##2##2##(2008-10#2)
0001) by##2##2##(2008-10#2)
0001) compared with##2##3##(2008-10#2)
0001) enhanced##2##2##(2008-10#2)
0001) in##3##2##(1997-1#1)(2008-12#1)(2013-1#1)
0001) lower##2##2##(2008-5#1)(2012-3#1)
0001) more##2##2##(2008-9#1)(2010-8#1)
0001) than##3##2##(2008-10#1)(2009-1#1)(2010-1#1)
0001) were##2##2##(2008-5#1)(2013-1#1)
0001)##118##1##(1990-4#1)(1991-12#1)(1992-12#2)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-1#1)(2008-10#31)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#6)(2008-7#2)(2008-9#2)(2009-1#1)(2010-1#2)(2010-11#7)(2010-12#2)(2010-2#1)(2010-4#7)(2010-8#4)(2011-2#8)(2012-12#1)(2012-3#2)(2013-1#18)(2013-8#3)
000107##2##1##(2008-9#2)
0002)##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
000308##3##1##(2008-9#3)
0005##6##1##(1996-3#1)(2008-10#1)(2008-9#1)(2010-4#2)(2012-3#1)
0005) and##2##2##(2008-10#1)(2012-3#1)
0005)##10##1##(1994-3#1)(1996-11#1)(2008-10#3)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
000567 and 0##2##3##(2011-2#2)
0006##2##1##(2008-10#2)
0007##4##1##(2008-10#1)(2008-5#1)(2010-4#2)
0007)##2##1##(2008-10#1)(2011-2#1)
0008)##2##1##(1993-11#1)(2008-7#1)
000mgkg(-1) dry weight##2##3##(2008-10#2)
000mgkg(-1)##3##1##(2008-10#3)
001 &amp##3##2##(2010-6#3)
001 M##2##2##(1990-3#1)(2008-10#1)
001 and 0##3##3##(2008-10#3)
001 and##6##2##(1994-12#1)(2008-10#4)(2013-8#1)
001 for the##2##3##(1994-12#1)(2010-12#1)
001 for##7##2##(1990-12#1)(1992-11#2)(1994-12#1)(2008-10#1)(2008-12#1)(2010-12#1)
001 in the##2##3##(2008-10#2)
001 mg (1##2##3##(1994-12#2)
001 mg##3##2##(1994-12#2)(2008-10#1)
001 to 0##2##3##(2008-10#2)
001 vs##4##2##(1990-2#1)(1997-8#1)(2013-8#2)
001##81##1##(1990-12#1)(1990-2#1)(1990-3#1)(1992-11#2)(1993-12#1)(1994-11#2)(1994-12#5)(1997-4#1)(1997-8#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-6#3)(2011-2#1)(2012-2#3)(2012-3#2)(2012-5#7)(2013-8#11)
001% and##2##2##(2008-10#1)(2010-1#1)
001%##6##1##(1990-2#1)(2008-10#3)(2010-1#1)(2013-1#1)
001) and a##2##3##(1994-3#1)(2008-11#1)
001) and decreased##2##3##(2008-3#1)(2013-3#1)
001) and the##4##3##(1997-4#1)(2008-10#1)(2010-9#1)(2012-5#1)
001) and was##2##3##(2008-10#1)(2008-4#1)
001) and##43##2##(1990-3#1)(1991-9#3)(1992-9#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#2)(2010-6#2)(2010-9#1)(2011-2#1)(2012-3#3)(2012-5#1)(2013-1#7)(2013-3#1)(2013-8#1)
001) as##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
001) at##2##2##(2008-10#1)(2013-8#1)
001) between##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
001) but not##2##3##(1991-2#1)(2012-5#1)
001) but##7##2##(1991-2#1)(1995-8#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-5#1)
001) by##4##2##(1994-8#1)(1996-6#1)(2011-3#2)
001) compared to##5##3##(1993-1#1)(1994-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
001) higher##2##2##(2008-10#1)(2008-11#1)
001) in##4##2##(1993-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
001) of##3##2##(2008-10#2)(2012-3#1)
001) positive##2##2##(2008-10#2)
001) than##6##2##(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#3)
001) to##2##2##(2008-10#1)(2012-3#1)
001) was found in the##2##5##(2008-11#1)(2008-5#1)
001) was found##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
001) was##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
001) were##2##2##(2008-10#1)(2013-1#1)
001) with##2##2##(1992-12#1)(2013-1#1)
001)##289##1##(1990-12#1)(1990-2#2)(1990-3#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#6)(1992-12#3)(1992-9#2)(1993-1#3)(1993-2#6)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-8#1)(1995-12#3)(1995-8#3)(1996-12#2)(1996-6#1)(1997-4#3)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#47)(2008-11#8)(2008-12#4)(2008-3#11)(2008-4#3)(2008-5#6)(2008-7#13)(2008-8#2)(2008-9#5)(2009-11#2)(2009-12#1)(2009-3#6)(2009-5#3)(2009-8#1)(2010-12#7)(2010-2#2)(2010-4#3)(2010-6#7)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#12)(2011-3#3)(2012-2#2)(2012-3#22)(2012-5#2)(2013-1#41)(2013-3#1)(2013-8#9)
001)]##2##1##(2008-10#2)
001-0##6##1##(1993-11#1)(2008-10#5)
001-1##3##1##(2008-10#2)(2012-2#1)
0012##2##1##(2008-10#2)
0015)##2##1##(1993-12#1)(1997-5#1)
0015-0##2##1##(2008-10#1)(2010-4#1)
0019##2##1##(2008-10#1)(2009-7#1)
002 and 0##2##3##(2008-10#2)
002 mg (2##2##3##(1994-12#2)
002 mg##3##2##(1994-12#2)(2008-10#1)
002 mug ml(-1)##2##3##(2008-10#2)
002 mug##3##2##(2008-10#3)
002##19##1##(1993-2#1)(1994-12#2)(1994-2#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)
002%##2##1##(2008-10#1)(2010-1#1)
002) and##5##2##(1994-11#1)(2008-10#1)(2008-7#1)(2013-1#2)
002) was##2##2##(2008-10#1)(2009-3#1)
002)##26##1##(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-11#2)(2008-10#4)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
002-0##4##1##(2008-10#4)
0024)##2##1##(2008-5#1)(2013-8#1)
002]##2##1##(2013-1#1)(2013-8#1)
002mm)##2##1##(2008-10#2)
003##13##1##(1990-8#1)(1991-9#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-10#5)(2010-1#1)(2011-2#1)
003) and##2##2##(2007-8#1)(2010-9#1)
003) with##2##2##(2008-10#1)(2013-8#1)
003)##15##1##(1993-1#1)(1993-11#2)(2007-8#1)(2008-10#2)(2008-7#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-8#1)
004 and##2##2##(2008-8#1)(2013-8#1)
004 mg l(-1)##3##3##(2008-10#3)
004 to 0##3##3##(2008-10#2)(2013-1#1)
004##20##1##(2008-10#13)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
004% and##2##2##(2008-10#1)(2010-1#1)
004) and##2##2##(2011-2#1)(2012-12#1)
004)##14##1##(1994-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
0042##2##1##(2008-10#2)
0044##2##1##(2008-10#2)
0044)##2##1##(2008-10#2)
0044s##2##1##(2008-10#2)
0048##2##1##(2008-10#1)(2010-4#1)
005 M##3##2##(2008-10#3)
005 and 0##2##3##(2008-10#2)
005 and##7##2##(2008-10#5)(2008-3#1)(2008-7#1)
005 at##3##2##(2008-10#1)(2012-2#2)
005 mg##2##2##(1994-12#2)
005 mug l(-1)##2##3##(2008-10#2)
005 mug##3##2##(2008-10#3)
005 to 0##2##3##(2008-10#1)(2009-8#1)
005##30##1##(1993-8#2)(1994-12#2)(2008-10#18)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-1#1)(2012-2#2)(2012-3#1)
005%##4##1##(2008-10#4)
005) and##3##2##(1991-11#1)(1994-11#1)(2010-1#1)
005)##15##1##(1991-11#1)(1994-11#1)(1994-3#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#1)(2013-1#3)(2013-8#1)
005-0##5##1##(2008-10#3)(2008-5#1)(2011-2#1)
0050molL(-1)##2##1##(2008-10#2)
0051##2##1##(2010-4#1)(2011-2#1)
006 and 0##3##3##(2008-10#3)
006 and##5##2##(1991-12#1)(2008-10#3)(2013-1#1)
006##9##1##(1991-12#1)(1995-6#1)(2008-10#6)(2013-1#1)
006) in##2##2##(1992-9#1)(1993-11#1)
006)##9##1##(1992-9#1)(1993-11#1)(2008-10#1)(2010-4#1)(2011-2#2)(2012-5#1)(2013-8#2)
007 mol/l##2##2##(2008-10#2)
007 s##2##2##(2008-10#1)(2010-1#1)
007 vs 0##2##3##(2010-1#2)
007##15##1##(2008-10#10)(2008-11#1)(2008-2#1)(2010-1#3)
007%##2##1##(2008-10#1)(2011-2#1)
007)##13##1##(2008-11#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
0079 g of Al##2##4##(2008-10#2)
008##12##1##(1993-6#1)(2008-10#6)(2008-11#3)(2010-1#1)(2011-3#1)
008)##12##1##(1991-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(2006-6#1)(2008-10#3)(2008-7#1)(2011-2#2)(2013-1#1)
0082##4##1##(2008-10#3)(2010-4#1)
0083##3##1##(2008-10#2)(2008-5#1)
009 and##2##2##(2008-10#2)
009 mg l(-1)##2##3##(2008-10#2)
009 mg##3##2##(2008-10#3)
009##11##1##(2008-10#9)(2008-3#1)(2011-2#1)
009%##2##1##(2008-10#2)
009)##5##1##(1996-2#1)(2010-4#1)(2011-2#2)(2012-2#1)
0099)##2##1##(2008-10#2)
00V##3##1##(2008-10#3)
00h##2##1##(2012-12#2)
00mgl(-1)##2##1##(2008-10#2)
00x10(-9)##2##1##(2008-10#2)
00x10(-9)-1##2##1##(2008-10#2)
01 &lt##2##2##(1997-1#1)(2008-9#1)
01 (substrate##2##2##(2010-11#2)
01 +/-##2##2##(1992-12#1)(2008-1#1)
01 M sodium##3##3##(1990-3#1)(1992-3#1)(2008-10#1)
01 M##13##2##(1990-3#1)(1992-3#1)(2008-10#11)
01 M)##2##2##(2008-10#2)
01 Ogawa Biotype##2##3##(2012-3#2)
01 and 0##5##3##(1996-2#1)(2008-10#3)(2013-8#1)
01 and 1##2##3##(2008-10#2)
01 and r =##2##4##(1991-2#2)
01 and##16##2##(1991-2#2)(1996-2#1)(2008-10#9)(2008-11#1)(2009-5#1)(2013-1#1)(2013-8#1)
01 for 0##2##3##(2008-10#2)
01 for##3##2##(2008-10#2)(2008-12#1)
01 g##3##2##(2008-10#3)
01 in##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
01 mM##5##2##(2008-10#5)
01 mg l(-1)##6##3##(2008-10#6)
01 microg##2##2##(2008-10#2)
01 mol l(-1)##6##3##(2008-10#6)
01 mug ml(-1) of##2##4##(2008-10#2)
01 mug ml(-1)##8##3##(2008-10#8)
01 mug##9##2##(2008-10#9)
01 ng ml(-1)##3##3##(2008-10#3)
01 ng##5##2##(2008-10#5)
01 ppm##2##2##(2008-10#2)
01 ppm)##2##2##(2008-10#2)
01 respectively##2##2##(2008-5#1)(2012-2#1)
01 to 0##6##3##(1994-8#1)(2008-10#4)(2008-11#1)
01 to##10##2##(1994-8#1)(2008-10#7)(2008-11#1)(2009-7#1)
01 vs##3##2##(1994-2#1)(1994-5#1)(2013-1#1)
01 x 10(-5))-(1##2##3##(2008-10#2)
01 x##3##2##(2008-10#2)(2008-11#1)
01##168##1##(1990-3#1)(1991-2#4)(1992-12#2)(1992-3#1)(1993-6#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#3)(1996-2#1)(1997-1#2)(1997-4#1)(2008-1#1)(2008-10#96)(2008-11#5)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#5)
01% of the##2##3##(1991-6#1)(1992-11#1)
01% of##3##2##(1991-6#1)(1992-11#1)(1994-6#1)
01%##15##1##(1991-6#1)(1992-11#1)(1994-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
01%)##5##1##(1990-2#1)(1994-5#1)(2008-10#2)(2008-12#1)
01) after##2##2##(2008-9#1)(2013-1#1)
01) and##13##2##(1995-12#1)(1996-12#1)(2008-10#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#2)
01) as##2##2##(2009-6#1)(2012-2#1)
01) but not##2##3##(2008-10#1)(2012-5#1)
01) but##4##2##(1991-9#1)(1995-3#1)(2008-10#1)(2012-5#1)
01) compared to normal##2##4##(2009-1#2)
01) compared##3##2##(2008-5#1)(2009-1#2)
01) for##3##2##(1990-11#1)(2008-10#2)
01) in a dose-dependent fashion##2##5##(1992-12#2)
01) in##9##2##(1992-12#3)(1997-8#1)(2008-10#2)(2010-9#1)(2013-1#2)
01) increased##2##2##(1993-1#1)(2008-12#1)
01) than##3##2##(1992-3#1)(2008-5#1)(2013-1#1)
01) was found between##3##4##(1996-12#1)(2008-10#1)(2013-1#1)
01) with##4##2##(2008-10#3)(2010-9#1)
01)##208##1##(1990-11#2)(1991-11#1)(1991-12#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#4)(1992-3#2)(1993-1#3)(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#5)(1995-12#5)(1995-3#1)(1995-8#3)(1996-1#1)(1996-12#4)(1996-8#2)(1997-1#2)(1997-8#3)(2007-8#1)(2008-10#42)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#9)(2009-1#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#3)(2011-2#13)(2011-3#9)(2012-2#5)(2012-3#4)(2012-5#3)(2013-1#24)(2013-8#7)
01-0##11##1##(1990-6#1)(1991-9#1)(1995-8#1)(1996-2#2)(2008-10#6)
01-1##5##1##(2008-10#4)(2012-2#1)
01-2##5##1##(2008-10#3)(2011-2#1)(2011-3#1)
01-50##2##1##(2008-10#2)
01-7##2##1##(2008-10#2)
010 M##2##2##(2008-10#2)
010 mM##2##2##(2008-10#2)
010 mug##2##2##(2008-10#2)
010##10##1##(2008-10#7)(2008-11#2)(2013-1#1)
010molL(-1) KCl##2##2##(2008-10#2)
010molL(-1)##3##1##(2008-10#3)
011##6##1##(2008-10#5)(2011-2#1)
011)##3##1##(2010-4#1)(2010-6#1)(2011-2#1)
012 and 0##2##3##(2008-10#2)
012 and##3##2##(2008-10#3)
012 mg##2##2##(2008-10#1)(2008-5#1)
012##11##1##(1990-6#1)(2008-10#8)(2008-11#1)(2008-5#1)
012)##4##1##(2008-10#1)(2008-8#1)(2010-4#1)(2011-1#1)
0125##2##1##(1997-2#1)(2008-10#1)
013##7##1##(1997-8#1)(2008-10#3)(2009-7#1)(2011-2#1)(2012-2#1)
013)##5##1##(2008-10#1)(2009-11#1)(2010-6#1)(2012-3#1)(2013-8#1)
014##9##1##(1993-8#1)(2008-10#5)(2008-3#1)(2009-7#1)(2011-2#1)
014)##2##1##(2008-11#1)(2011-2#1)
015 M of##2##3##(2008-10#2)
015 mug##2##2##(2008-10#2)
015##10##1##(2008-10#7)(2008-11#1)(2008-5#1)(2011-2#1)
015%##4##1##(2008-10#2)(2013-1#2)
015)##4##1##(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
0158##2##1##(2008-10#2)
016##4##1##(1993-1#1)(2008-10#3)
016)##7##1##(2010-9#1)(2011-2#3)(2012-5#2)(2013-1#1)
017##5##1##(1992-3#1)(2008-10#3)(2008-3#1)
018##4##1##(1992-4#1)(2008-10#1)(2011-2#1)(2011-3#1)
019##2##1##(2008-11#1)(2008-3#1)
019)##2##1##(2008-10#1)(2012-3#1)
01M##7##1##(2008-10#7)
01]##5##1##(2008-7#1)(2008-8#1)(2013-8#3)
01molL(-1)##2##1##(2008-10#2)
02 +/- 0##3##3##(1996-12#1)(2008-5#1)(2010-4#1)
02 +/-##5##2##(1996-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-3#1)
02 M##5##2##(1992-10#3)(2008-10#2)
02 OSM##2##2##(1991-11#2)
02 V##2##2##(2008-10#1)(2008-8#1)
02 and 0##5##3##(2008-10#5)
02 and P &lt##2##4##(1994-12#1)(1994-3#1)
02 and##15##2##(1994-12#1)(1994-3#1)(2008-10#12)(2011-3#1)
02 mM##2##2##(1994-5#1)(2008-11#1)
02 mg l(-1)##2##3##(2008-10#2)
02 mg##3##2##(2008-10#3)
02 mol l(-1)##3##3##(2008-10#3)
02 mol##5##2##(2008-10#5)
02 mug g(-1)##2##3##(2008-10#2)
02 mug ml(-1)##5##3##(2008-10#5)
02 mug##8##2##(2008-10#8)
02 ng ml(-1)##6##3##(2008-10#6)
02 ng##8##2##(1996-2#1)(2008-10#7)
02 to 0##2##3##(2008-10#2)
02 to##3##2##(2008-10#3)
02 years##2##2##(2008-9#1)(2013-8#1)
02##103##1##(1991-11#2)(1991-3#1)(1992-10#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#63)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#2)
02% sodium##3##2##(1991-3#1)(2008-10#2)
02% thiourea##3##2##(2008-10#3)
02%##18##1##(1991-3#1)(1994-8#1)(2008-10#14)(2008-5#1)(2012-2#1)
02%)##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
02) and##6##2##(2008-10#4)(2011-2#1)(2013-8#1)
02) in##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
02) were##3##2##(1991-8#1)(2011-2#2)
02)##36##1##(1991-8#2)(1993-1#1)(1993-11#1)(1994-1#2)(1994-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-9#1)(2011-2#5)(2012-5#1)(2013-1#5)(2013-8#1)
02-0##7##1##(2008-10#7)
02-1##4##1##(1994-12#1)(2008-10#3)
02-2##6##1##(2008-10#5)(2008-12#1)
02-3##6##1##(2008-10#6)
02-4##2##1##(2008-10#2)
02-6##2##1##(2008-10#1)(2011-2#1)
020##5##1##(1992-3#1)(1992-4#1)(2008-10#1)(2008-11#1)(2010-8#1)
020-0##3##1##(2008-10#3)
021 and 0##4##3##(2008-10#4)
021 and##5##2##(2008-10#4)(2011-1#1)
021##7##1##(2008-10#6)(2011-1#1)
021)##3##1##(1993-11#1)(2008-10#1)(2010-1#1)
022##4##1##(1993-8#1)(2008-10#3)
022)##5##1##(2008-10#1)(2008-7#1)(2011-2#2)(2012-2#1)
023 to 0##2##3##(2008-10#2)
023##8##1##(1991-9#1)(1996-1#1)(2008-10#4)(2008-11#1)(2011-2#1)
023) and##2##2##(2008-12#1)(2008-7#1)
023)##5##1##(2008-10#2)(2008-12#1)(2008-7#2)
024 and##2##2##(2008-10#2)
024##7##1##(2008-10#4)(2008-7#1)(2011-2#1)(2012-3#1)
024)##2##1##(1997-5#1)(2008-10#1)
02428##2##1##(2008-9#2)
0248##2##1##(2008-11#2)
025 M##3##2##(1997-2#1)(2008-10#2)
025 and 0##4##3##(2008-10#4)
025 and##5##2##(2008-10#5)
025 mug ml(-1)##2##3##(2008-10#2)
025##16##1##(1994-12#1)(1997-2#1)(2008-10#13)(2008-9#1)
025-0##2##1##(2008-10#2)
026##4##1##(1994-5#1)(2008-10#3)
026)##3##1##(2008-10#1)(2013-1#2)
0260 and##2##2##(2008-10#2)
0261##2##1##(2008-10#2)
027##4##1##(2011-2#3)(2013-8#1)
028 and 0##2##3##(2008-10#1)(2008-11#1)
028 mug ml(-1)##2##3##(2008-10#2)
028 mug##3##2##(2008-10#3)
028##10##1##(1995-8#1)(2008-10#6)(2008-11#2)(2009-11#1)
028)##6##1##(2008-10#1)(2008-9#1)(2010-1#1)(2011-2#3)
029##3##1##(2008-10#1)(2008-11#2)
02moll(-1)##2##1##(2008-10#2)
02mugg(-1)##2##1##(2008-10#2)
02mugl(-1)##3##1##(2008-10#3)
02mugml(-1)##2##1##(2008-10#2)
03 and 0##2##3##(2008-10#2)
03 and 1##2##3##(2008-10#2)
03 and##8##2##(2008-10#8)
03 in##3##2##(2008-10#2)(2010-12#1)
03 mM)##2##2##(1997-2#1)(2008-10#1)
03 mV##2##2##(2008-10#2)
03 mg##3##2##(2008-10#3)
03 mmol##2##2##(2008-10#2)
03 mug ml(-1)##3##3##(2008-10#3)
03 mug##6##2##(2008-10#6)
03 pmole/mg protein) over that of control##2##7##(2008-11#2)
03 to 0##2##3##(2008-10#2)
03 to##7##2##(1994-6#1)(2008-10#6)
03 ± 0##2##3##(2010-10#1)(2010-9#1)
03##93##1##(1991-3#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-2#2)(2008-10#60)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#3)
03% and##2##2##(2008-3#1)(2012-2#1)
03% for##2##2##(2008-10#2)
03% of##2##2##(1990-11#1)(2012-12#1)
03%##14##1##(1990-11#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2011-3#1)(2012-12#1)(2012-2#1)
03%)##4##1##(1990-3#1)(2008-10#2)(2008-2#1)
03) and##5##2##(1991-12#1)(1991-8#1)(2008-7#1)(2010-4#1)(2011-2#1)
03)##33##1##(1991-12#1)(1991-8#1)(1993-1#1)(1993-2#1)(2006-6#1)(2008-10#7)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-4#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
03+/-0##2##1##(2008-10#2)
03-0##6##1##(2008-10#6)
03-1##2##1##(2008-10#2)
03-2##2##1##(2009-6#1)(2013-8#1)
030##3##1##(2008-10#1)(2009-4#1)(2011-2#1)
031##2##1##(1993-8#1)(2013-1#1)
031)##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
032##4##1##(2008-10#3)(2008-9#1)
033##3##1##(2008-10#3)
034##3##1##(1994-12#1)(2008-4#1)(2011-2#1)
035##4##1##(2008-10#3)(2008-5#1)
035)##3##1##(2010-1#1)(2013-1#1)(2013-8#1)
038)##2##1##(2013-1#2)
039##3##1##(2008-10#2)(2008-11#1)
039)##3##1##(1997-7#1)(2008-11#1)(2011-2#1)
04 +/-##2##2##(2008-1#1)(2011-2#1)
04 M##3##2##(2008-10#3)
04 and 0##3##3##(2008-10#1)(2008-9#2)
04 and##7##2##(2008-10#5)(2008-9#2)
04 in##2##2##(2008-10#1)(2010-4#1)
04 mol/l##2##2##(2008-10#1)(2008-11#1)
04 mug ml(-1)##5##3##(2008-10#5)
04 mug##6##2##(2008-10#6)
04 ng ml(-1)##2##3##(2008-10#2)
04 to 0##4##3##(2008-10#3)(2008-9#1)
04 to 1##2##3##(2008-10#2)
04 to##7##2##(2008-10#5)(2008-8#1)(2008-9#1)
04 x 10(6)##2##3##(2008-11#2)
04 x##3##2##(2008-10#1)(2008-11#2)
04##69##1##(1993-2#1)(1993-6#1)(1994-5#1)(2008-1#1)(2008-10#41)(2008-11#5)(2008-3#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
04% w/w (C(4##3##3##(2008-5#3)
04%##13##1##(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#3)(2012-2#2)
04) and##4##2##(2008-10#2)(2011-3#1)(2013-1#1)
04) was##2##2##(1997-8#1)(2012-3#1)
04)##20##1##(1991-11#1)(1994-3#1)(1997-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-1#3)
04))##3##1##(2008-5#3)
04+/-0##2##1##(2008-10#2)
04-0##9##1##(2008-10#8)(2008-11#1)
04-1##3##1##(2008-10#3)
04-10##2##1##(2008-10#2)
04-2##2##1##(2008-10#2)
040##5##1##(2008-10#4)(2008-11#1)
041##4##1##(1993-1#1)(1994-6#1)(2008-10#1)(2011-2#1)
042##7##1##(1990-2#1)(1991-5#1)(1993-8#1)(2008-10#2)(2011-1#1)(2011-2#1)
043##4##1##(2008-10#3)(2011-2#1)
043)##2##1##(2008-8#1)(2010-1#1)
044##7##1##(1997-8#2)(2008-10#5)
045)##3##1##(2008-7#1)(2009-8#1)(2011-2#1)
046 and 0##2##3##(2008-10#2)
046 and##3##2##(2008-10#3)
046##5##1##(2008-10#3)(2008-9#1)(2013-1#1)
046)##2##1##(1993-2#1)(2008-12#1)
047##4##1##(1990-2#1)(2008-10#3)
047)##5##1##(2008-11#2)(2009-8#1)(2010-4#1)(2011-2#1)
048##5##1##(2008-10#3)(2008-3#1)(2013-8#1)
048)##3##1##(2008-12#1)(2011-2#1)(2012-3#1)
049##2##1##(2008-10#1)(2011-2#1)
04mugg(-1)##2##1##(2008-10#2)
05 M citrate buffer##2##4##(2008-10#2)
05 M phosphate buffer (pH 2##2##6##(2008-10#2)
05 M phosphate buffer##3##4##(2008-10#3)
05 M potassium phosphate buffer (pH 7##2##7##(2008-10#2)
05 M##18##2##(2008-10#18)
05 V##2##2##(2008-10#2)
05 and 0##10##3##(2008-10#10)
05 and 2##2##3##(2008-10#2)
05 and##22##2##(1991-2#1)(2008-10#17)(2008-11#1)(2009-6#1)(2012-2#2)
05 for##2##2##(1994-3#1)(2008-10#1)
05 g##2##2##(2008-10#1)(2008-3#1)
05 in##2##2##(1994-12#1)(2011-2#1)
05 mL##2##2##(2011-2#2)
05 mM##3##2##(1994-11#1)(2008-10#2)
05 mg l(-1)##2##3##(2008-10#2)
05 mg##3##2##(2008-10#2)(2008-12#1)
05 microg l(-1)##3##3##(2008-10#3)
05 ml##3##2##(1993-3#1)(1994-8#1)(2008-10#1)
05 mol kg(-1) potassium hydrogen phthalate##2##6##(2008-10#2)
05 mol l(-1)##9##3##(2008-10#9)
05 mol##12##2##(1990-10#1)(2008-10#11)
05 muM##2##2##(2008-10#1)(2008-11#1)
05 mug l(-1)##2##3##(2008-10#2)
05 mug ml(-1) and##2##4##(2008-10#2)
05 mug ml(-1)##4##3##(2008-10#4)
05 mug##8##2##(2008-10#8)
05 ng ml(-1)##2##3##(2008-10#2)
05 ng##3##2##(2008-10#3)
05 or P &lt##2##4##(2011-3#2)
05 or##3##2##(2008-10#1)(2011-3#2)
05 pmole/mg protein)##2##3##(2008-11#2)
05 ppm##3##2##(2008-10#3)
05 to 0##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
05 to 2##2##3##(2008-10#2)
05 to 3##4##3##(2008-10#3)(2013-1#1)
05 to##14##2##(2008-10#10)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
05 was considered##2##3##(2011-2#1)(2013-1#1)
05 x##2##2##(2008-10#1)(2008-7#1)
05 years for##2##3##(2013-1#2)
05##210##1##(1990-10#1)(1990-12#1)(1991-2#2)(1992-2#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-2#3)(1997-1#1)(2008-10#121)(2008-11#9)(2008-12#4)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#12)(2011-3#8)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#9)(2013-8#1)
05% NaF for 3 min##2##5##(2013-1#2)
05% NaF##3##2##(2013-1#3)
05% Trypsin-EDTA##2##2##(2008-8#2)
05% m/v##2##2##(2008-10#2)
05% of the##2##3##(1991-6#1)(2012-12#1)
05% w/w##2##2##(2008-5#1)(2008-7#1)
05%##29##1##(1990-6#1)(1991-6#1)(1992-6#1)(2008-10#14)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
05) and higher##2##3##(2008-7#1)(2010-4#1)
05) and##26##2##(1990-2#1)(1991-8#1)(1994-12#2)(1994-8#1)(1995-3#1)(1996-12#2)(2008-4#2)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#2)
05) at##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
05) between 3##2##3##(2008-5#2)
05) between the##4##3##(1994-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
05) between##7##2##(1994-12#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
05) but##2##2##(2008-7#1)(2013-1#1)
05) by the rate of##2##5##(2010-11#2)
05) by##3##2##(2008-10#1)(2010-11#2)
05) compared to##3##3##(1993-1#1)(2010-4#1)(2012-3#1)
05) compared##4##2##(1993-1#1)(2008-10#1)(2010-4#1)(2012-3#1)
05) correlations between##2##3##(2008-10#2)
05) differences##4##2##(2008-10#3)(2012-12#1)
05) differentiated##2##2##(2008-10#2)
05) effect##2##2##(2008-12#2)
05) from the##4##3##(2008-10#4)
05) from##5##2##(1994-3#1)(2008-10#4)
05) greater than##2##3##(2008-10#2)
05) greater##5##2##(1996-8#1)(2008-10#3)(2013-1#1)
05) had##2##2##(1991-12#1)(2011-2#1)
05) higher in##2##3##(2008-10#1)(2013-1#1)
05) higher than##2##3##(1993-3#1)(2008-12#1)
05) higher##4##2##(1993-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
05) in the SER##2##4##(2011-2#2)
05) in the##3##3##(2011-2#3)
05) in##19##2##(1990-8#1)(1992-12#1)(1994-8#1)(1995-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#2)
05) increase in##2##3##(2012-2#2)
05) increased the##2##3##(2008-10#1)(2013-1#1)
05) increased##5##2##(2008-10#2)(2008-11#1)(2010-4#1)(2013-1#1)
05) inhibitory effect##2##3##(2008-10#1)(2010-4#1)
05) levels##2##2##(2013-1#1)(2013-8#1)
05) lower in##2##3##(2008-10#2)
05) lower##4##2##(2008-10#3)(2010-7#1)
05) more##2##2##(2008-10#1)(2013-1#1)
05) of##2##2##(2008-7#1)(2013-1#1)
05) reduced##3##2##(2008-10#3)
05) suppressed##2##2##(2008-10#1)(2008-11#1)
05) than in##2##3##(2008-10#1)(2013-1#1)
05) than the##2##3##(2008-10#1)(2008-7#1)
05) than those of##2##4##(2008-10#1)(2011-2#1)
05) than those##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
05) than##8##2##(1994-12#1)(2008-10#3)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
05) the##2##2##(2013-1#2)
05) to##3##2##(1990-12#1)(2008-12#1)(2013-1#1)
05) were found##2##3##(2008-10#2)
05) were observed##3##3##(2008-5#1)(2013-1#2)
05) were##7##2##(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#3)
05) when##2##2##(2008-12#1)(2010-9#1)
05) with##3##2##(2008-10#2)(2013-1#1)
05) within groups##2##3##(1996-6#2)
05)##445##1##(1990-12#3)(1990-2#2)(1990-8#1)(1991-12#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#8)(1994-2#1)(1994-3#5)(1994-8#2)(1995-12#2)(1995-3#4)(1995-8#1)(1996-12#9)(1996-6#3)(1996-8#1)(1997-1#2)(1997-8#2)(2008-1#4)(2008-10#89)(2008-11#12)(2008-12#24)(2008-3#1)(2008-4#2)(2008-5#9)(2008-7#28)(2008-8#1)(2008-9#9)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#5)(2009-8#2)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#3)(2010-4#12)(2010-6#3)(2010-7#10)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#34)(2011-3#5)(2012-12#4)(2012-2#7)(2012-3#10)(2013-1#56)(2013-8#24)
05))##2##1##(2008-11#1)(2008-5#1)
05+/-0##2##1##(2008-10#1)(2008-11#1)
05-0##14##1##(1990-2#1)(1994-8#1)(1997-4#1)(2008-10#7)(2008-3#1)(2010-4#2)(2013-1#1)
05-1##9##1##(2008-10#9)
05-2##6##1##(1994-12#1)(2008-10#5)
05-3##2##1##(2008-10#2)
05-4##2##1##(2008-10#2)
05-5##4##1##(2008-10#4)
05-6##3##1##(2008-10#3)
05-7##3##1##(2008-10#3)
05-8##2##1##(2008-10#2)
050##7##1##(1993-2#1)(2008-10#2)(2009-8#1)(2011-2#1)(2011-7#1)(2013-8#1)
051 to##2##2##(2008-11#1)(2011-2#1)
051##3##1##(2008-11#1)(2011-2#2)
052##3##1##(1994-12#1)(2008-10#1)(2011-2#1)
053##3##1##(2008-10#2)(2008-3#1)
054##2##1##(2008-10#2)
055##3##1##(2008-10#3)
056##2##1##(2008-10#2)
057##2##1##(1991-5#1)(2008-11#1)
059##2##1##(2008-10#1)(2012-12#1)
05M phosphate buffer##2##3##(2008-10#2)
05M##10##1##(2008-10#10)
05V##2##1##(2008-10#2)
05mM##2##1##(2008-10#2)
05molL(-1)##5##1##(2008-10#5)
05muM##2##1##(2008-10#2)
05mugl(-1)##2##1##(2008-10#2)
05mugml(-1)##2##1##(2008-10#2)
05ngml(-1)##2##1##(2008-10#2)
06 +/- 0##3##3##(1991-11#1)(1997-1#1)(2008-12#1)
06 +/-##5##2##(1991-11#1)(1997-1#1)(2008-12#1)(2012-3#1)(2013-1#1)
06 V##2##2##(2008-10#2)
06 and 0##2##3##(2008-10#1)(2011-2#1)
06 and##6##2##(2008-10#4)(2011-2#2)
06 in##2##2##(1994-11#1)(2008-10#1)
06 mM##2##2##(1994-3#2)
06 microM##2##2##(1993-8#1)(2008-10#1)
06 mug l(-1) for##2##4##(2008-10#2)
06 mug l(-1)##4##3##(2008-10#4)
06 mug ml(-1)##2##3##(2008-10#2)
06 mug##6##2##(2008-10#6)
06 mum and##2##3##(2008-3#2)
06 mum##3##2##(2008-2#1)(2008-3#2)
06 ng ml(-1)##2##3##(2008-10#2)
06 ng##4##2##(1996-2#1)(2008-10#3)
06 to 0##2##3##(2008-10#1)(2013-1#1)
06 to##5##2##(2008-10#4)(2013-1#1)
06 x##2##2##(2008-10#2)
06##76##1##(1990-12#1)(1991-11#1)(1993-8#2)(1994-11#1)(1994-3#3)(1996-2#1)(1997-1#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
06%##6##1##(1992-11#1)(2008-10#4)(2012-3#1)
06)##14##1##(1991-11#2)(1992-11#1)(1993-11#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-7#2)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#1)
06+/-0##2##1##(2008-10#2)
06-0##2##1##(2008-10#2)
060##3##1##(1991-9#1)(1992-8#1)(2011-2#1)
0600 PST##3##2##(2008-10#3)
0600 to##3##2##(2008-10#3)
0600##6##1##(2008-10#6)
061##2##1##(2008-10#2)
062 bp##2##2##(1997-8#2)
062##3##1##(1992-12#1)(1997-8#2)
062)##2##1##(2008-10#1)(2008-5#1)
063##2##1##(1992-5#1)(2008-10#1)
064 mum##2##2##(2008-2#1)(2008-3#1)
064##5##1##(2008-10#2)(2008-2#1)(2008-3#2)
064-mum##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
065##4##1##(2008-10#3)(2008-11#1)
066##3##1##(1990-2#1)(2008-10#1)(2008-12#1)
067##3##1##(2008-10#2)(2008-2#1)
067)##2##1##(2008-1#1)(2008-10#1)
069##2##1##(2011-2#1)(2013-1#1)
06mugl(-1)##2##1##(2008-10#2)
07 and 0##4##3##(2008-10#3)(2008-3#1)
07 and##5##2##(2008-10#4)(2008-3#1)
07 microg##2##2##(2008-10#2)
07 mol l(-1) ammonium sulfate##2##5##(2008-10#2)
07 to 0##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
07 to##5##2##(2008-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
07##43##1##(1994-5#1)(1995-6#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-3#2)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
07%##4##1##(2008-10#2)(2008-5#1)(2009-8#1)
07%)##4##1##(2008-12#3)(2009-8#1)
07)##6##1##(1997-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
07-0##3##1##(2008-10#3)
070##2##1##(1997-4#1)(2008-10#1)
071##2##1##(1994-12#1)(1997-2#1)
072##4##1##(1990-2#1)(2008-10#2)(2011-3#1)
073##3##1##(2008-10#2)(2008-11#1)
074)##2##1##(1994-3#1)(2008-10#1)
074-microm##2##1##(2008-3#2)
075##6##1##(1990-5#1)(2008-10#4)(2012-2#1)
076##3##1##(1990-2#1)(1991-11#2)
076)##2##1##(2008-10#1)(2008-9#1)
078##5##1##(1993-8#1)(1996-8#1)(2008-10#3)
079)##3##1##(1997-7#1)(2008-10#1)(2008-11#1)
0795##2##1##(2008-2#2)
07mgL(-1)##2##1##(2008-10#2)
07mugml(-1)##2##1##(2008-10#2)
08 and 0##7##3##(1993-8#1)(1994-8#1)(2008-10#4)(2010-11#1)
08 and##11##2##(1992-9#1)(1993-8#1)(1994-8#1)(2008-10#7)(2010-11#1)
08 for the##2##3##(1994-11#1)(2009-1#1)
08 for##4##2##(1994-11#1)(2009-1#3)
08 mM##2##2##(2008-10#2)
08 mg##2##2##(2008-10#2)
08 mg/kg##2##2##(2008-10#1)(2012-3#1)
08 microg##2##2##(2008-9#2)
08 mug ml(-1)##2##3##(2008-10#2)
08 mug##3##2##(2008-10#3)
08 ppb##2##2##(2008-10#2)
08 to 0##5##3##(2008-10#5)
08 to##6##2##(2008-10#6)
08##70##1##(1991-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-2#2)(2008-10#41)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#3)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-3#1)
08%##3##1##(1993-11#1)(2008-10#1)(2009-8#1)
08%)##2##1##(2008-10#1)(2012-2#1)
08)##5##1##(2008-10#2)(2008-12#1)(2008-4#1)(2011-2#1)
08+/-0##2##1##(1997-4#1)(2008-10#1)
08-0##4##1##(2008-10#4)
08-1##2##1##(1994-3#1)(2008-10#1)
08-10##2##1##(2008-10#2)
08-2##2##1##(2008-10#1)(2011-2#1)
08-4##2##1##(2008-10#2)
080##3##1##(2008-10#2)(2008-11#1)
0800##4##1##(2008-10#4)
081##4##1##(1990-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
083##4##1##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
085##2##1##(1996-5#1)(2011-2#1)
086##3##1##(1994-1#1)(2008-10#1)(2011-2#1)
087##4##1##(1993-8#1)(2008-10#2)(2008-11#1)
088##3##1##(2008-10#2)(2011-2#1)
09 and 0##3##3##(2008-10#3)
09 and##6##2##(2008-10#5)(2012-3#1)
09 to##3##2##(1992-3#1)(2008-10#1)(2012-2#1)
09##35##1##(1990-6#1)(1992-3#1)(1993-8#1)(1994-5#1)(2008-10#24)(2008-12#1)(2008-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
09%##4##1##(2008-10#2)(2012-12#1)(2013-1#1)
09%)##5##1##(2008-10#1)(2008-5#1)(2011-2#3)
09)##4##1##(1996-6#1)(2008-12#1)(2008-7#2)
0900##2##1##(2008-10#2)
092##2##1##(2008-10#2)
095##3##1##(1992-10#1)(2008-10#2)
097##3##1##(2008-10#2)(2011-2#1)
0975##2##1##(2008-5#2)
098##5##1##(2008-10#3)(2010-10#1)(2012-3#1)
09mgkg(-1)##2##1##(2008-10#2)
0D##2##1##(2008-6#1)(2010-5#1)
0M##5##1##(2008-10#5)
0V versus Ag/AgCl##2##3##(2008-10#2)
0V##7##1##(2008-10#7)
0]octenes##3##1##(1996-5#3)
0anteiso##2##1##(2011-1#2)
0g##2##1##(2008-10#2)
0mL of##2##2##(2008-10#2)
0mLmin(-1)##5##1##(2008-10#5)
0mM##6##1##(2008-10#4)(2011-2#2)
0mg##4##1##(2008-10#4)
0mg/L##2##1##(2008-10#2)
0mgL(-1)##3##1##(2008-10#3)
0mgkg(-1)##2##1##(2008-10#2)
0mgl(-1) for a##2##3##(2008-10#2)
0mgl(-1)##8##1##(2008-10#8)
0min of##2##2##(2008-10#2)
0min##4##1##(2008-10#4)
0ml of 2M##2##3##(2008-10#2)
0ml of##4##2##(2008-10#4)
0ml##8##1##(2008-10#8)
0mlmin(-1) and##2##2##(2008-10#2)
0mlmin(-1)##5##1##(2008-10#5)
0mm##2##1##(2008-10#2)
0mmolL(-1))##2##1##(2008-10#2)
0mmolkg(-1))##2##1##(2008-10#2)
0mmoll(-1)##2##1##(2008-10#2)
0molL(-1)##4##1##(2008-10#4)
0moll(-1)##3##1##(2008-10#3)
0muM##2##1##(2008-10#2)
0mug##2##1##(2008-10#2)
0mug/mL##2##1##(2008-10#2)
0mug/ml##2##1##(2008-10#2)
0mugL(-1) of As(III)##2##3##(2008-10#2)
0mugg(-1)##4##1##(2008-10#4)
0mugl(-1) Cd)##2##2##(2008-10#2)
0mugl(-1) of##3##2##(2008-10#3)
0mugl(-1)##17##1##(2008-10#17)
0mugml(-1) for##3##2##(2008-10#3)
0mugml(-1)##15##1##(2008-10#15)
0mul of##2##2##(2008-10#2)
0mumol/L##3##1##(2008-10#3)
0ngl(-1)##3##1##(2008-10#3)
0ngmL(-1) for##3##2##(2008-10#3)
0ngml(-1) for##2##2##(2008-10#2)
0ngml(-1) with a limit of##2##5##(2008-10#2)
0ngml(-1)##12##1##(2008-10#12)
0nm##3##1##(2008-10#3)
0ppm##2##1##(2008-10#2)
0wt##3##1##(2008-10#1)(2013-1#2)
0x10##3##1##(2008-10#3)
0x10(-1) M with##2##3##(2008-10#2)
0x10(-1) M##4##2##(2008-10#4)
0x10(-1)##8##1##(2008-10#8)
0x10(-1)) with a##2##3##(2008-10#2)
0x10(-1)-1##3##1##(2008-10#3)
0x10(-1)M (detection limit##2##3##(2008-10#2)
0x10(-1)M and##2##2##(2008-10#2)
0x10(-1)M with a slope##2##4##(2008-10#2)
0x10(-1)M##6##1##(2008-10#6)
0x10(-1)moll(-1)##2##1##(2008-10#2)
0x10(-10)##4##1##(2008-10#4)
0x10(-10)-1##2##1##(2008-10#2)
0x10(-11)##5##1##(2008-10#5)
0x10(-2) M for##2##3##(2008-10#2)
0x10(-2) M##6##2##(2008-10#6)
0x10(-2) mol l(-1) Hepes buffer at pH 8##2##8##(2008-10#2)
0x10(-2) mol l(-1)##5##3##(2008-10#5)
0x10(-2)##11##1##(2008-10#11)
0x10(-2)-1##2##1##(2008-10#2)
0x10(-2)-7##2##1##(2008-10#2)
0x10(-2)M##2##1##(2008-10#2)
0x10(-2)moll(-1)##3##1##(2008-10#3)
0x10(-3) M##4##2##(2008-10#4)
0x10(-3) and##3##2##(2008-10#3)
0x10(-3) mol l(-1)##5##3##(2008-10#5)
0x10(-3) to##3##2##(2008-10#3)
0x10(-3)##15##1##(2008-10#15)
0x10(-3)% (m/v)##2##2##(2008-10#2)
0x10(-3)M##4##1##(2008-10#4)
0x10(-3)molL(-1) with a##2##3##(2008-10#2)
0x10(-3)molL(-1)##4##1##(2008-10#4)
0x10(-3)moll(-1) with a detection limit of##2##6##(2008-10#2)
0x10(-3)moll(-1)##3##1##(2008-10#3)
0x10(-4) M for##2##3##(2008-10#2)
0x10(-4) M##7##2##(2008-10#7)
0x10(-4) M)##2##2##(2008-10#2)
0x10(-4) mol l(-1) with##2##4##(2008-10#2)
0x10(-4) mol l(-1)##8##3##(2008-10#8)
0x10(-4) mol##9##2##(2008-10#9)
0x10(-4)##24##1##(2008-10#24)
0x10(-4)M##4##1##(2008-10#4)
0x10(-4)moll(-1)##5##1##(2008-10#5)
0x10(-5) M with a detection limit of##2##7##(2008-10#2)
0x10(-5) M##15##2##(2008-10#15)
0x10(-5) and 1##2##3##(2008-10#2)
0x10(-5) and##4##2##(2008-10#4)
0x10(-5) mol l(-1) with##2##4##(2008-10#2)
0x10(-5) mol l(-1)##11##3##(2008-10#11)
0x10(-5) mol##12##2##(2008-10#12)
0x10(-5) to 1##6##3##(2008-10#6)
0x10(-5) to 2##2##3##(2008-10#2)
0x10(-5) to##10##2##(2008-10#10)
0x10(-5)##43##1##(2008-10#43)
0x10(-5)-2##2##1##(2008-10#2)
0x10(-5)M##5##1##(2008-10#5)
0x10(-5)molL(-1) for##2##2##(2008-10#2)
0x10(-5)molL(-1)##4##1##(2008-10#4)
0x10(-5)moll(-1)##2##1##(2008-10#2)
0x10(-6) M##11##2##(2008-10#11)
0x10(-6) M)##2##2##(2008-10#2)
0x10(-6) and 1##2##3##(2008-10#2)
0x10(-6) and##4##2##(2008-10#4)
0x10(-6) mol l(-1)##12##3##(2008-10#12)
0x10(-6) to 1##6##3##(2008-10#6)
0x10(-6) to 2##3##3##(2008-10#3)
0x10(-6) to##12##2##(2008-10#12)
0x10(-6)##42##1##(2008-10#42)
0x10(-6)-1##7##1##(2008-10#7)
0x10(-6)-2##2##1##(2008-10#2)
0x10(-6)-3##2##1##(2008-10#2)
0x10(-6)gml(-1)##3##1##(2008-10#3)
0x10(-6)mol/l##3##1##(2008-10#3)
0x10(-6)molL(-1)##3##1##(2008-10#3)
0x10(-6)moll(-1)##4##1##(2008-10#4)
0x10(-7) M for##2##3##(2008-10#2)
0x10(-7) M##12##2##(2008-10#12)
0x10(-7) M)##2##2##(2008-10#2)
0x10(-7) and 1##3##3##(2008-10#3)
0x10(-7) and##4##2##(2008-10#4)
0x10(-7) mol l(-1)##11##3##(2008-10#11)
0x10(-7) mol##13##2##(2008-10#13)
0x10(-7) mol/l##2##2##(2008-10#2)
0x10(-7) to 1##4##3##(2008-10#4)
0x10(-7) to 2##3##3##(2008-10#3)
0x10(-7) to##8##2##(2008-10#8)
0x10(-7)##45##1##(2008-10#45)
0x10(-7)-1##8##1##(2008-10#8)
0x10(-7)-2##2##1##(2008-10#2)
0x10(-7)M##6##1##(2008-10#6)
0x10(-7)mol/l##3##1##(2008-10#3)
0x10(-7)moll(-1)##3##1##(2008-10#3)
0x10(-8) M##3##2##(2008-10#3)
0x10(-8) gml(-1)##2##2##(2008-10#2)
0x10(-8) mol l(-1) and the##2##5##(2008-10#2)
0x10(-8) mol l(-1)##7##3##(2008-10#7)
0x10(-8) to 1##4##3##(2008-10#4)
0x10(-8) to 2##2##3##(2008-10#2)
0x10(-8) to##7##2##(2008-10#7)
0x10(-8)##20##1##(2008-10#20)
0x10(-8)-2##2##1##(2008-10#2)
0x10(-8)-3##2##1##(2008-10#2)
0x10(-8)M with a 0##2##4##(2008-10#2)
0x10(-8)M##5##1##(2008-10#5)
0x10(-9) M##5##2##(2008-10#5)
0x10(-9) mol l(-1)##2##3##(2008-10#2)
0x10(-9) to 2##2##3##(2008-10#2)
0x10(-9) to 4##2##3##(2008-10#2)
0x10(-9) to##8##2##(2008-10#8)
0x10(-9)##16##1##(2008-10#16)
0x10(-9)-1##2##1##(2008-10#2)
0x10(-9)M##2##1##(2008-10#2)
0x10(3)##2##1##(2008-10#2)
0x10(4) l mol(-1) cm(-1)##2##4##(2008-10#2)
0x10(4)##3##1##(2008-10#3)
0zeta##2##1##(2008-10#2)
0 μM##2##1##(2013-8#2)
1 %##7##2##(1997-8#1)(2008-11#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-12#1)
1 %) and##2##3##(1997-8#1)(2012-12#1)
1 %)##4##2##(1997-8#1)(2012-12#3)
1 &amp##2##2##(2008-11#1)(2008-9#1)
1 (+/-0##2##2##(2007-8#1)(2008-10#1)
1 (0##2##2##(2008-10#1)(2011-2#1)
1 (1##2##2##(1990-5#1)(2008-10#1)
1 (10##2##2##(1996-3#1)(2010-6#1)
1 (2##3##2##(1991-3#3)
1 (IL-1)##2##2##(1990-12#1)(1995-2#1)
1 (IL1) and tumour necrosis factor (TNF)##2##7##(1996-2#2)
1 (ITS1)##4##2##(2008-10#4)
1 (P##2##2##(1993-2#1)(2008-10#1)
1 (Th1)##2##2##(2008-10#1)(2008-11#1)
1 (codon##3##2##(2008-11#3)
1 (v/v)##2##2##(2008-10#2)
1 (v/v))##2##2##(2008-10#2)
1 +##2##2##(1990-12#1)(2008-7#1)
1 +/- 0##7##3##(1993-2#1)(1994-3#1)(1994-8#1)(2008-12#2)(2012-3#1)(2013-1#1)
1 +/- 1##3##3##(1991-11#1)(1992-10#1)(1993-2#1)
1 +/- 5##2##3##(2008-8#1)(2010-1#1)
1 +/- 7##2##3##(1996-3#1)(2011-3#1)
1 +/- 8##2##3##(1996-3#1)(2008-10#1)
1 +/-##21##2##(1991-11#1)(1992-10#1)(1993-2#2)(1994-3#2)(1994-8#1)(1996-3#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2010-1#1)(2011-3#1)(2012-3#1)(2013-1#1)
1 -##7##2##(1995-2#2)(1997-4#1)(2008-10#1)(2008-11#2)(2010-7#1)
1 =##5##2##(1990-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
1 CFU/g##2##2##(2012-2#2)
1 GHz##2##2##(2007-12#1)(2008-6#1)
1 Gy##3##2##(2013-1#1)(2013-8#2)
1 Hz##2##2##(2008-10#1)(2013-8#1)
1 In##2##2##(2009-8#2)
1 January 1991##3##3##(1992-9#2)(1997-8#1)
1 January 2000##2##3##(1996-1#1)(2012-12#1)
1 January##8##2##(1990-12#1)(1992-9#2)(1996-1#3)(1997-8#1)(2012-12#1)
1 M (H##2##3##(2008-10#2)
1 M H(2)SO(4)##2##3##(2008-10#2)
1 M HCl##3##3##(2008-10#3)
1 M HF medium##2##4##(2008-10#2)
1 M HNO(3) and##2##4##(2008-10#2)
1 M HNO(3)##7##3##(2008-10#7)
1 M KCl##3##3##(1993-8#2)(2008-10#1)
1 M NaCl##5##3##(1990-8#1)(1992-3#1)(1993-3#1)(2008-10#2)
1 M NaClO(4)##2##3##(2008-10#2)
1 M NaNO(3) solution##2##4##(2008-10#2)
1 M NaOH##3##3##(1995-6#1)(2008-10#2)
1 M hydrochloric acid solution##2##5##(2008-10#2)
1 M hydrochloric acid##4##4##(2008-10#4)
1 M ionic strength##2##4##(2008-10#2)
1 M nitric acid##2##4##(2008-10#2)
1 M sodium##2##3##(2008-10#2)
1 M##70##2##(1990-2#1)(1990-8#1)(1992-3#2)(1993-3#2)(1993-8#2)(1994-2#1)(1994-8#1)(1995-6#2)(1997-2#1)(2008-10#57)
1 M)##2##2##(1993-3#1)(2008-10#1)
1 MHz##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
1 MPa##2##2##(2008-10#2)
1 Mb##2##2##(1995-8#1)(1996-8#1)
1 R and NuMA##2##4##(2010-5#2)
1 R##7##2##(2010-5#7)
1 S##3##2##(1997-8#2)(2010-6#1)
1 V vs##2##3##(2008-10#2)
1 V##8##2##(1996-5#1)(2008-10#7)
1 actin##2##2##(1991-5#1)(1992-3#1)
1 activity##3##2##(1991-12#2)(2012-12#1)
1 added##2##2##(1993-3#1)(2008-9#1)
1 after##4##2##(1991-3#2)(1992-3#1)(1995-12#1)
1 alpha##2##2##(1990-5#1)(2008-3#1)
1 ammonia and estimated spectrophotometrically with pyrimidine-2-thiol##2##7##(2008-10#2)
1 and 0##16##3##(1994-8#1)(2008-10#14)(2008-12#1)
1 and 1##25##3##(1992-9#1)(1994-6#1)(1996-12#1)(2008-10#21)(2009-10#1)
1 and 10##6##3##(1995-12#1)(2008-10#4)(2011-1#1)
1 and 100##2##3##(2008-10#2)
1 and 13##2##3##(1994-2#1)(2008-10#1)
1 and 17##2##3##(2008-12#1)(2010-11#1)
1 and 2 and the##3##5##(1997-1#1)(2008-10#1)(2008-8#1)
1 and 2 and##4##4##(1997-1#1)(2008-10#2)(2008-8#1)
1 and 2 of##4##4##(2008-10#4)
1 and 2 orders of magnitude##2##6##(2008-10#1)(2008-3#1)
1 and 2 t##2##4##(2008-12#2)
1 and 2 were##7##4##(1994-2#1)(2008-10#3)(2008-11#3)
1 and 2##60##3##(1990-11#1)(1994-11#1)(1994-2#3)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#27)(2008-11#9)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
1 and 2) in##2##4##(2011-2#1)(2012-12#1)
1 and 2)##5##3##(1994-2#1)(1995-3#1)(2008-10#1)(2011-2#1)(2012-12#1)
1 and 2A##5##3##(1991-5#1)(1992-8#1)(1994-11#2)(2008-10#1)
1 and 3 in##4##4##(2008-10#1)(2012-3#3)
1 and 3##21##3##(1993-12#1)(1994-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
1 and 4##11##3##(1993-6#1)(1994-8#1)(1997-2#1)(2008-10#6)(2008-7#2)
1 and 5##7##3##(1990-9#1)(1991-9#1)(2008-10#5)
1 and 6##4##3##(1991-2#1)(2008-10#2)(2012-2#1)
1 and 7##3##3##(2008-10#2)(2013-1#1)
1 and 8 and##3##4##(2008-10#3)
1 and 8##8##3##(2008-10#8)
1 and MAX##3##3##(1995-6#3)
1 and the##8##3##(1995-3#1)(1995-8#1)(2008-10#4)(2008-6#1)(2012-12#1)
1 and type##9##3##(1993-2#3)(1997-3#1)(2008-10#2)(2011-2#1)(2012-4#2)
1 and##283##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-2#6)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-10#149)(2008-11#12)(2008-12#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#6)(2012-4#2)(2013-1#4)(2013-8#2)
1 approximately##3##2##(2008-10#2)(2008-11#1)
1 are##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
1 at saturation by S1##2##5##(1992-3#2)
1 at the##3##3##(2008-10#2)(2011-1#1)
1 at##10##2##(1992-3#3)(2008-10#4)(2008-9#1)(2010-5#1)(2011-1#1)
1 based##2##2##(2008-10#2)
1 binds##2##2##(1994-5#1)(2008-12#1)
1 but##2##2##(2008-10#2)
1 cM##4##2##(1997-2#1)(2008-10#1)(2008-9#2)
1 cM)##2##2##(2008-10#2)
1 case developed##2##3##(2013-1#2)
1 case of##9##3##(1994-1#1)(1994-12#4)(2010-6#1)(2012-3#3)
1 case##18##2##(1990-12#1)(1990-6#1)(1991-3#1)(1994-1#1)(1994-12#4)(1996-6#1)(2008-11#1)(2010-6#1)(2012-3#3)(2013-1#4)
1 cells are##2##3##(2007-12#1)(2008-11#1)
1 cells transfected with##2##4##(1995-12#1)(2008-11#1)
1 cells##15##2##(1995-12#2)(2007-12#2)(2008-11#10)(2008-7#1)
1 centimorgans (cM)##2##3##(2008-10#2)
1 chain##3##2##(1992-2#2)(1994-12#1)
1 cm and##2##3##(1997-4#1)(2008-10#1)
1 cm##10##2##(1993-3#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#4)(2009-2#1)(2013-1#1)
1 cm(-1))##2##2##(2007-12#1)(2008-3#1)
1 cm(3)##2##2##(2008-10#2)
1 complex was formed##2##4##(1995-11#1)(2008-10#1)
1 complex was##3##3##(1995-11#2)(2008-10#1)
1 complex with##2##3##(2008-10#2)
1 complex##12##2##(1995-11#3)(2008-10#9)
1 complexes were determined at 25 degrees C##2##8##(2008-10#2)
1 complexes were determined##5##4##(2008-10#5)
1 complexes with the alkali metal##2##6##(2008-10#2)
1 complexes with the##3##4##(2008-10#3)
1 complexes##13##2##(2008-10#13)
1 cultivars##2##2##(2008-10#1)(2008-12#1)
1 dB##2##2##(2008-2#1)(2008-3#1)
1 dS m(-1)) and##2##4##(2008-10#2)
1 dS m(-1))##4##3##(2008-10#4)
1 day after##4##3##(1991-2#1)(1992-6#1)(2008-10#2)
1 day before##2##3##(2008-10#2)
1 day prior to##2##4##(2008-10#2)
1 day##19##2##(1991-2#1)(1992-6#1)(1996-12#2)(1997-3#1)(2008-10#11)(2008-11#3)
1 days##4##2##(1992-12#1)(1996-3#1)(2008-12#2)
1 degrees C and ionic strength##2##6##(2008-10#2)
1 degrees C and##3##4##(2008-10#2)(2008-3#1)
1 degrees C##11##3##(2008-10#10)(2008-3#1)
1 degrees##13##2##(1995-5#1)(2008-10#10)(2008-3#2)
1 diabetes in##2##3##(1994-12#1)(2008-11#1)
1 diabetes mellitus##6##3##(1991-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#2)
1 diabetes##25##2##(1991-12#1)(1994-12#2)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-5#2)(2010-9#2)(2011-1#3)(2012-3#1)(2012-4#2)
1 diabetic patients##4##3##(2010-10#1)(2010-12#1)(2012-4#2)
1 established by spectrophotometry##2##4##(2008-10#2)
1 female##2##2##(1992-9#1)(2012-3#1)
1 fg of##2##3##(2008-10#2)
1 fg##3##2##(2008-10#3)
1 for 18##2##3##(1995-2#1)(2008-10#1)
1 for AP and AP's cover)##2##6##(2012-3#2)
1 for AP and##3##4##(2012-3#3)
1 for##13##2##(1995-2#1)(2008-10#7)(2008-11#1)(2012-3#4)
1 from##6##2##(1993-6#1)(2008-10#5)
1 g Amberlite##2##3##(2008-10#2)
1 g L(-1)##2##3##(2008-11#2)
1 g l(-1)##2##3##(2008-11#2)
1 g of##2##3##(2008-10#2)
1 g##16##2##(1996-11#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-7#1)(2013-1#1)
1 gene##3##2##(1996-2#2)(2008-8#1)
1 gene/4##2##2##(1997-6#1)(1997-8#1)
1 h after the##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
1 h after##7##3##(1991-2#1)(1992-12#1)(1994-2#1)(1995-8#1)(2008-10#2)(2008-11#1)
1 h at##2##3##(2008-10#1)(2008-6#1)
1 h before##2##3##(1991-2#1)(2008-7#1)
1 h of handcycling exercise##2##5##(2013-1#2)
1 h of##8##3##(1992-8#1)(1993-3#1)(1995-8#1)(1997-2#1)(2008-10#2)(2013-1#2)
1 h##49##2##(1990-12#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-2#2)(1994-5#1)(1995-3#1)(1995-8#2)(1996-2#2)(1997-2#1)(2008-10#16)(2008-11#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#4)
1 h)##2##2##(1993-12#1)(2013-8#1)
1 had only##2##3##(1990-2#1)(2010-1#1)
1 had##3##2##(1990-2#1)(2008-11#1)(2010-1#1)
1 host-guest complex with##2##4##(2008-10#2)
1 hour after##2##3##(1993-11#1)(2008-7#1)
1 hour##7##2##(1993-11#1)(1993-6#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-7#1)(2010-7#1)
1 hr after##3##3##(2008-11#2)(2008-6#1)
1 hr##4##2##(2008-11#2)(2008-6#2)
1 in 10##3##3##(1996-1#1)(2008-11#1)(2012-12#1)
1 in 100##2##3##(2008-11#1)(2008-5#1)
1 in frontal cortex##2##4##(1996-2#2)
1 in the mixed sample##2##5##(2008-10#2)
1 in the##14##3##(1993-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-1#1)(2008-10#7)(2008-11#1)(2013-1#1)
1 in##50##2##(1991-2#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#4)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#3)
1 inclusion complex with##2##4##(2008-10#2)
1 inclusion complex##3##3##(2008-10#3)
1 is a##3##3##(1994-5#1)(2008-11#2)
1 is##10##2##(1994-5#1)(1996-12#1)(2008-10#2)(2008-11#3)(2009-10#1)(2012-3#1)(2013-1#1)
1 isolate##4##2##(2008-10#4)
1 kDa##3##2##(1990-5#1)(2008-11#2)
1 kb DNA##2##3##(1997-8#2)
1 kb by Northern blotting##2##5##(1996-6#2)
1 kb fragment##2##3##(1995-9#2)
1 kb region##2##3##(2008-11#1)(2008-12#1)
1 kb##13##2##(1991-9#1)(1995-9#2)(1996-6#2)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)
1 kg##2##2##(2008-4#1)(2012-3#1)
1 km##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
1 l min(-1)##2##3##(2008-10#2)
1 l##5##2##(2008-10#3)(2008-11#2)
1 m of##2##3##(2008-10#2)
1 m##11##2##(2008-10#9)(2008-3#1)(2011-2#1)
1 m(2)##3##2##(2008-10#3)
1 m/sec(2)##2##2##(2008-11#2)
1 mM Ca2+##3##3##(1990-5#1)(1990-8#2)
1 mM sodium##2##3##(2008-10#1)(2008-11#1)
1 mM##35##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-3#1)(1992-3#1)(1992-7#1)(1993-6#1)(1993-8#1)(1995-8#1)(1997-1#3)(1997-2#1)(2008-10#14)(2008-11#5)(2008-7#1)(2011-2#1)
1 mM) and##2##3##(1990-5#1)(1996-2#1)
1 mM)##7##2##(1990-5#1)(1992-3#1)(1993-8#1)(1996-2#2)(1997-2#2)
1 mV per decade##2##4##(2008-10#2)
1 mV##5##2##(2008-10#3)(2008-7#1)(2009-9#1)
1 macrophage-like cells##2##3##(1996-12#2)
1 maternal-to-paternal genome ratio##2##4##(2009-12#2)
1 mediates##3##2##(1993-3#2)(2013-8#1)
1 mg l(-1) and##2##4##(2008-10#2)
1 mg l(-1) for##2##4##(2008-10#2)
1 mg l(-1)##11##3##(2008-10#10)(2008-11#1)
1 mg of##2##3##(1994-3#1)(2008-10#1)
1 mg##21##2##(1994-3#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-5#1)
1 mg/kg BW)##2##3##(2012-3#2)
1 mg/kg i##3##3##(1993-6#1)(1996-2#2)
1 mg/kg##9##2##(1993-6#1)(1996-2#2)(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#2)(2013-8#1)
1 mg/liter##2##2##(2008-10#2)
1 microM ICI D1694##2##4##(1994-8#2)
1 microM and##2##3##(1990-8#1)(1992-3#1)
1 microM extracellular calcium##2##4##(1991-12#2)
1 microM##25##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-2#2)(1994-5#1)(1994-8#3)(1995-11#2)(1995-2#3)(1997-4#1)(2008-11#1)
1 microM) did not##2##4##(1995-8#1)(1997-4#1)
1 microM)##7##2##(1992-6#1)(1994-8#1)(1995-8#2)(1997-4#3)
1 microcarriers##4##2##(2008-11#4)
1 microg l(-1)##2##3##(2008-10#2)
1 microg ml(-1) of##2##4##(2008-10#1)(2008-11#1)
1 microg##10##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
1 microm##2##2##(2008-3#2)
1 microns)##2##2##(1994-12#1)(1997-1#1)
1 million in##2##3##(1991-12#1)(1992-6#1)
1 million##7##2##(1990-11#1)(1991-12#2)(1992-6#1)(1995-12#1)(2010-11#1)(2012-3#1)
1 min region on the linkage map##2##7##(1996-12#2)
1 min region on the##3##5##(1996-12#3)
1 min##26##2##(1996-12#3)(1996-2#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2011-2#2)
1 minute##3##2##(2011-2#2)(2012-3#1)
1 mixture of##7##3##(2008-10#4)(2008-11#1)(2010-3#1)(2010-7#1)
1 ml min(-1)##9##3##(2008-10#9)
1 ml of 1##2##4##(2008-10#2)
1 ml of a##2##4##(2008-10#2)
1 ml of methanol##2##4##(2008-10#2)
1 ml of##19##3##(1990-2#1)(1992-3#1)(1993-3#1)(1994-5#1)(2008-10#13)(2008-11#1)(2008-12#1)
1 ml##32##2##(1990-2#1)(1992-3#1)(1993-3#1)(1994-5#1)(1996-12#1)(2008-10#24)(2008-11#2)(2008-12#1)
1 ml/min##4##2##(1997-2#2)(2008-10#1)(2012-2#1)
1 mm day(-1)##2##3##(2008-10#2)
1 mm trench##2##3##(1991-2#2)
1 mm##22##2##(1991-2#2)(1991-6#1)(1994-2#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-4#1)(2011-3#1)(2013-1#1)
1 mm)##2##2##(2008-11#2)
1 mmol g(-1)##2##3##(2008-10#1)(2008-5#1)
1 mmol l(-1)##2##3##(2008-10#2)
1 mmol##6##2##(1997-8#1)(2008-10#4)(2008-5#1)
1 mol L(-1)##2##3##(2008-10#2)
1 mol dm(-3)##7##3##(2008-10#7)
1 mol l(-1) HCl##5##4##(2008-10#5)
1 mol l(-1) of##2##4##(2008-10#2)
1 mol l(-1) phosphate buffer (pH 7##2##7##(2008-10#2)
1 mol l(-1)##29##3##(2008-10#29)
1 mol of tightly bound##2##5##(1990-10#1)(1994-5#1)
1 mol of zinc per subunit##2##6##(1994-5#2)
1 mol of##8##3##(1990-10#1)(1990-2#1)(1991-5#3)(1994-5#3)
1 mol##51##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-5#3)(1994-5#3)(2008-10#40)(2008-9#1)(2010-4#1)
1 mol(-1) cm(-1)##2##3##(2008-10#2)
1 mol(-1)##3##2##(2008-10#3)
1 mol/L##2##2##(2008-10#2)
1 moll(-1)##2##2##(2008-10#2)
1 month after##8##3##(2008-10#5)(2008-7#1)(2011-2#1)(2013-8#1)
1 month following##2##3##(2008-10#1)(2010-6#1)
1 month of##5##3##(1991-12#1)(2008-10#3)(2008-7#1)
1 month to##2##3##(2011-2#2)
1 month##35##2##(1990-6#1)(1991-12#1)(1995-2#2)(2008-10#18)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-8#1)
1 month)##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
1 morbidity##2##2##(1992-5#1)(2008-10#1)
1 ms##3##2##(1991-2#1)(1997-8#1)(2008-3#1)
1 mu g ml(-1)##2##4##(2008-11#2)
1 mu##3##2##(2007-12#1)(2008-11#2)
1 muM for##3##3##(2008-10#3)
1 muM##11##2##(2008-10#9)(2008-11#2)
1 mug l(-1) for##3##4##(2008-10#3)
1 mug l(-1)##13##3##(2008-10#13)
1 mug ml(-1) and##2##4##(2008-10#2)
1 mug ml(-1) of##3##4##(2008-10#3)
1 mug ml(-1)##10##3##(2008-10#10)
1 mug##35##2##(2008-10#35)
1 mug/ml##7##2##(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#1)
1 mugml(-1)##2##2##(2008-10#2)
1 mul##3##2##(2008-10#3)
1 mum##7##2##(1992-2#2)(2008-10#2)(2008-3#2)(2008-6#1)
1 mumol l(-1)##2##3##(2008-10#2)
1 mumol##3##2##(2008-10#3)
1 mumol/L)##3##2##(2008-8#3)
1 mumol/l##2##2##(1994-6#2)
1 nM##7##2##(1994-8#1)(1995-11#1)(1995-2#1)(2008-11#4)
1 nM)##3##2##(1995-2#1)(1995-8#2)
1 ng in##2##3##(2008-10#1)(2012-3#1)
1 ng ml(-1) for##2##4##(2008-10#2)
1 ng ml(-1)##10##3##(2008-10#10)
1 ng of##4##3##(2008-10#4)
1 ng##25##2##(1997-2#1)(2008-10#22)(2008-12#1)(2012-3#1)
1 ng/L##3##2##(2008-10#3)
1 ng/ml of##2##3##(1995-11#1)(2008-11#1)
1 ng/ml##6##2##(1995-11#1)(2008-10#4)(2008-11#1)
1 nm##2##2##(2008-2#1)(2009-7#1)
1 nmol##4##2##(1997-2#3)(2008-10#1)
1 of Fusarium##2##3##(2008-10#2)
1 of the##2##3##(2008-10#1)(2010-4#1)
1 of##21##2##(1990-5#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-2#3)(2013-8#1)
1 on##6##2##(1990-2#1)(1990-5#2)(2008-10#2)(2012-2#1)
1 or 1 mT)##2##4##(2011-2#2)
1 or 2##5##3##(1990-11#1)(1992-10#1)(1995-11#1)(2008-10#1)(2008-5#1)
1 or 5##2##3##(1995-12#1)(2008-11#1)
1 or more##2##3##(2012-12#1)(2013-8#1)
1 or##19##2##(1990-11#1)(1992-10#1)(1993-6#1)(1995-11#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#3)(2012-12#1)(2013-8#1)
1 order of magnitude larger than that for spheres with##2##10##(2008-3#2)
1 order of magnitude##4##4##(1992-3#1)(2008-3#3)
1 out of##3##3##(2008-7#1)(2009-5#2)
1 part##3##2##(1990-2#1)(2008-3#2)
1 patient with##3##3##(1994-3#1)(2008-7#2)
1 patient##15##2##(1990-3#1)(1990-6#1)(1992-1#1)(1994-12#3)(1994-3#1)(2007-11#1)(2008-7#2)(2010-7#1)(2011-2#1)(2013-1#3)
1 patients##2##2##(2008-11#1)(2008-7#1)
1 per##5##2##(1996-8#1)(2008-10#2)(2013-1#2)
1 percent of##3##3##(1993-3#1)(1994-12#1)(2013-1#1)
1 percent##4##2##(1993-3#2)(1994-12#1)(2013-1#1)
1 pg##5##2##(1996-12#1)(2008-10#4)
1 pmol for##4##3##(2008-10#4)
1 ppb (1##2##3##(2008-10#1)(2008-3#1)
1 ppb##6##2##(2008-10#4)(2008-3#2)
1 ppm for##3##3##(2008-10#3)
1 ppm##12##2##(2008-10#11)(2008-3#1)
1 ps##2##2##(2007-12#1)(2008-3#1)
1 rather than##2##3##(2008-10#1)(2008-11#1)
1 ratio and##2##3##(2008-10#2)
1 ratio in##2##3##(2008-10#1)(2008-8#1)
1 ratio of##5##3##(2008-10#5)
1 ratio##21##2##(1997-8#1)(2008-10#19)(2008-8#1)
1 ratios in##2##3##(2008-10#2)
1 receptor##7##2##(1992-3#1)(1994-11#1)(1995-11#2)(1995-2#1)(2008-9#1)(2012-2#1)
1 region of##3##3##(2008-10#3)
1 region##7##2##(1992-10#1)(1995-6#1)(2008-10#5)
1 responses##2##2##(1995-11#1)(2008-10#1)
1 s##2##2##(2008-10#1)(2008-6#1)
1 s)##2##2##(2008-10#1)(2009-8#1)
1 showed##2##2##(1991-3#1)(2008-11#1)
1 software##2##2##(2012-3#2)
1 starting molar percentage of##2##5##(2008-10#2)
1 stoichiometry of##2##3##(2008-10#2)
1 stoichiometry##8##2##(1991-3#1)(1992-3#1)(2008-10#6)
1 strains from##2##3##(2008-10#2)
1 strains##4##2##(2008-10#4)
1 subunit##2##2##(1992-2#1)(1996-2#1)
1 through 6##2##3##(2008-10#1)(2011-2#1)
1 times##2##2##(1997-8#1)(2008-10#1)
1 to 0##4##3##(2008-10#3)(2008-3#1)
1 to 1##10##3##(1993-9#1)(2008-10#6)(2008-11#3)
1 to 10 muM##3##4##(2008-10#3)
1 to 10 mug a##2##5##(2008-10#2)
1 to 10##12##3##(1995-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-8#1)(2013-1#2)
1 to 100##5##3##(1992-7#1)(2008-10#2)(2008-11#1)(2008-6#1)
1 to 12##4##3##(2008-10#3)(2008-2#1)
1 to 13##3##3##(2008-10#3)
1 to 14##2##3##(2008-10#1)(2008-7#1)
1 to 2 h##2##4##(2008-10#2)
1 to 2##13##3##(2008-1#1)(2008-10#7)(2008-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
1 to 28##2##3##(1997-3#1)(2008-10#1)
1 to 3##6##3##(1993-6#1)(1997-3#1)(2008-10#2)(2009-5#1)(2011-1#1)
1 to 4 weeks##2##4##(2008-10#1)(2008-11#1)
1 to 4##12##3##(1991-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#2)(2013-1#1)
1 to 5##10##3##(2008-10#8)(2008-3#1)(2012-3#1)
1 to 6##4##3##(2008-10#3)(2013-1#1)
1 to 7##3##3##(2008-10#3)
1 to 8##4##3##(1993-8#1)(2008-10#2)(2010-4#1)
1 to 9##4##3##(2008-10#3)(2008-6#1)
1 to##144##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-5#1)(1997-3#4)(1997-4#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#84)(2008-11#9)(2008-2#1)(2008-3#3)(2008-6#3)(2008-7#2)(2008-8#3)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
1 type##2##2##(1994-5#1)(2008-12#1)
1 v/v)##2##2##(1995-11#1)(2008-10#1)
1 vs##4##2##(1993-2#2)(1994-2#1)(2009-8#1)
1 was used##2##3##(2008-11#2)
1 was##21##2##(1990-3#2)(1992-3#3)(1993-8#2)(1995-6#1)(1997-8#1)(2008-10#4)(2008-11#4)(2008-7#1)(2011-1#1)(2011-3#1)(2013-8#1)
1 week after##5##3##(1996-12#2)(2008-10#2)(2008-11#1)
1 week in the##3##4##(2008-10#1)(2008-11#2)
1 week later##6##3##(1997-8#1)(2008-10#2)(2008-11#2)(2010-12#1)
1 week of##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
1 week##34##2##(1994-12#1)(1995-12#1)(1996-12#2)(1997-6#1)(1997-8#1)(2008-10#13)(2008-11#6)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#2)
1 were##10##2##(1993-3#1)(1994-12#1)(1995-6#1)(2008-10#3)(2008-9#1)(2013-8#3)
1 where##2##2##(1997-8#1)(2008-10#1)
1 which##2##2##(1992-7#1)(1995-8#1)
1 with eight##2##3##(1992-12#1)(1997-8#1)
1 with the##3##3##(2008-10#2)(2008-9#1)
1 with##15##2##(1990-2#1)(1992-12#1)(1994-3#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)
1 x 10(-10)##2##3##(1991-5#1)(2008-2#1)
1 x 10(-12)##2##3##(1991-5#1)(2008-8#1)
1 x 10(-3)##3##3##(2008-2#2)(2008-3#1)
1 x 10(-4) mg##2##4##(2008-10#2)
1 x 10(-4)##4##3##(2008-10#3)(2008-3#1)
1 x 10(-5)##3##3##(1994-5#1)(2008-10#2)
1 x 10(-6)##2##3##(2008-10#1)(2008-5#1)
1 x 10(-8) M##2##4##(2008-10#2)
1 x 10(-8)##3##3##(2008-10#3)
1 x 10(5)##4##3##(2008-10#4)
1 x 10(6)##6##3##(1991-12#1)(2008-10#4)(2008-11#1)
1 x 10(7)##4##3##(2008-10#4)
1 x##54##2##(1991-12#1)(1991-5#2)(1994-5#1)(2008-10#37)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#2)(2009-6#1)(2010-6#1)(2011-2#1)
1 year after the##3##4##(1994-3#1)(2011-2#1)(2013-1#1)
1 year after##8##3##(1994-12#1)(1994-3#1)(2008-10#1)(2011-2#4)(2013-1#1)
1 year and##3##3##(1991-2#1)(2008-11#1)(2013-1#1)
1 year of##2##3##(1995-8#1)(2013-1#1)
1 year to##2##3##(1995-3#1)(2008-10#1)
1 year##45##2##(1990-12#1)(1991-2#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(2008-10#12)(2008-11#2)(2008-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
1 years (range##2##3##(2009-3#1)(2012-12#1)
1 years##7##2##(1991-8#1)(1997-7#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)
1 years)##3##2##(2011-2#2)(2013-8#1)
1 yr##2##2##(2008-8#1)(2008-9#1)
1 ±##4##2##(2012-3#1)(2013-1#3)
1 μg/kg##2##2##(2013-8#2)
1##6188##1##(1990-10#3)(1990-11#13)(1990-12#16)(1990-2#32)(1990-3#5)(1990-5#31)(1990-6#13)(1990-7#2)(1990-8#20)(1990-9#8)(1991-1#3)(1991-10#2)(1991-11#15)(1991-12#18)(1991-2#18)(1991-3#20)(1991-5#33)(1991-6#10)(1991-8#5)(1991-9#12)(1992-1#8)(1992-10#13)(1992-11#1)(1992-12#16)(1992-2#17)(1992-3#32)(1992-4#8)(1992-5#5)(1992-6#17)(1992-7#5)(1992-8#8)(1992-9#7)(1993-1#10)(1993-11#3)(1993-12#19)(1993-2#19)(1993-3#25)(1993-6#24)(1993-8#54)(1993-9#6)(1994-1#3)(1994-11#30)(1994-12#36)(1994-2#23)(1994-3#27)(1994-5#33)(1994-6#8)(1994-8#33)(1994-9#2)(1995-1#4)(1995-11#39)(1995-12#24)(1995-2#43)(1995-3#10)(1995-5#3)(1995-6#22)(1995-8#30)(1995-9#2)(1996-1#9)(1996-11#16)(1996-12#46)(1996-2#30)(1996-3#11)(1996-5#45)(1996-6#20)(1996-8#7)(1996-9#1)(1997-1#25)(1997-2#33)(1997-3#22)(1997-4#13)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#54)(1997-9#2)(2006-5#2)(2007-11#7)(2007-12#22)(2007-8#3)(2008-1#11)(2008-10#3018)(2008-11#297)(2008-12#100)(2008-2#38)(2008-3#123)(2008-4#11)(2008-5#66)(2008-6#17)(2008-7#66)(2008-8#90)(2008-9#78)(2009-1#8)(2009-10#13)(2009-11#7)(2009-12#7)(2009-2#3)(2009-3#8)(2009-4#1)(2009-5#7)(2009-6#10)(2009-7#12)(2009-8#30)(2009-9#4)(2010-1#6)(2010-10#14)(2010-11#12)(2010-12#18)(2010-3#10)(2010-4#19)(2010-5#24)(2010-6#22)(2010-7#12)(2010-8#8)(2010-9#10)(2011-1#22)(2011-10#1)(2011-2#202)(2011-3#17)(2012-12#56)(2012-2#72)(2012-3#111)(2012-4#6)(2012-5#1)(2013-1#129)(2013-7#2)(2013-8#63)
1% (P &lt##2##3##(2008-9#1)(2013-1#1)
1% (P##3##2##(1996-3#1)(2008-9#1)(2013-1#1)
1% (m/v)##2##2##(2008-10#2)
1% (v/v)##4##2##(2008-10#4)
1% (w/v)##4##2##(2008-10#2)(2008-11#2)
1% NaCl##2##2##(2008-10#2)
1% R##2##2##(2008-10#2)
1% SDS##2##2##(1990-2#1)(2012-2#1)
1% Triton X-100##3##3##(2008-10#2)(2008-8#1)
1% and 2##2##3##(1996-3#1)(2008-10#1)
1% and 81##2##3##(1997-4#1)(2013-1#1)
1% and a##2##3##(2008-10#2)
1% and an##2##3##(2008-10#2)
1% and##26##2##(1991-6#1)(1993-8#1)(1996-3#1)(1997-4#1)(2008-10#14)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
1% as##2##2##(1994-12#1)(2010-3#1)
1% at a##2##3##(2008-10#2)
1% at the 0##2##4##(2008-10#2)
1% at the##3##3##(2008-10#3)
1% at##10##2##(2008-10#9)(2008-3#1)
1% cream##5##2##(1990-9#1)(2008-5#4)
1% for 1##2##3##(2008-10#2)
1% for peak##3##3##(2008-10#3)
1% for##23##2##(1990-2#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2012-3#3)
1% formic acid in##2##4##(2008-10#1)(2011-3#1)
1% had no droplet and##2##5##(2008-12#2)
1% had##3##2##(2008-12#2)(2010-1#1)
1% in the##3##3##(2008-10#3)
1% in young and adult cirrhotics respectively)##2##7##(2012-3#2)
1% in##11##2##(2008-1#1)(2008-10#6)(2008-11#1)(2012-3#3)
1% ketoconazole##2##2##(2008-5#2)
1% methanol##2##2##(2008-10#1)(2008-8#1)
1% nitric##2##2##(2008-10#2)
1% of all##2##3##(1996-12#1)(2013-7#1)
1% of the children with##2##5##(2008-11#2)
1% of the population##2##4##(2008-10#1)(2010-7#1)
1% of the total##2##4##(2008-10#2)
1% of the##13##3##(1993-12#1)(1995-2#1)(1996-11#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-7#1)
1% of##32##2##(1990-6#1)(1991-12#1)(1991-6#1)(1993-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-11#2)(1996-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
1% on##2##2##(2008-9#1)(2010-1#1)
1% per##2##2##(2008-10#2)
1% piroctone olamine##2##3##(2008-5#2)
1% sodium##2##2##(2008-10#1)(2013-1#1)
1% to##5##2##(1993-8#1)(1994-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
1% vs##3##2##(2008-9#1)(2009-12#1)(2012-3#1)
1% w/w##2##2##(2008-10#1)(2008-5#1)
1% was##5##2##(2008-10#5)
1% were##6##2##(1990-12#1)(1990-6#2)(2008-10#2)(2013-1#1)
1% zinc pyrithione##2##3##(2008-5#2)
1%##368##1##(1990-12#2)(1990-2#4)(1990-6#4)(1990-9#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-12#3)(1995-2#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#183)(2008-11#16)(2008-12#5)(2008-3#6)(2008-5#19)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#8)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-1#4)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#4)(2012-2#4)(2012-3#12)(2013-1#14)(2013-7#2)(2013-8#1)
1%) and the##2##3##(2008-10#1)(2008-5#1)
1%) and##8##2##(1992-9#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
1%) had##2##2##(2008-10#1)(2013-8#1)
1%) in##5##2##(1993-1#1)(1996-11#1)(2008-1#1)(2008-10#2)
1%) of##2##2##(2010-8#1)(2013-1#1)
1%) patients##2##2##(2010-8#1)(2012-3#1)
1%) reported##3##2##(2011-2#1)(2013-1#2)
1%) was##2##2##(2008-11#1)(2011-2#1)
1%) were##2##2##(2008-10#1)(2008-11#1)
1%) when##2##2##(1994-12#1)(2008-11#1)
1%)##81##1##(1992-2#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-11#3)(1996-12#1)(2008-1#3)(2008-10#17)(2008-11#9)(2008-12#2)(2008-3#2)(2008-5#8)(2010-12#1)(2010-8#2)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#5)(2013-8#4)
1&lt##4##1##(2008-10#4)
1&quot##3##1##(2008-11#1)(2009-9#1)(2013-8#1)
1'##2##1##(2008-10#1)(2008-11#1)
1'-[(1##2##1##(2008-10#2)
1'-bi-2-naphthol dibenzoate##2##2##(2008-10#2)
1'-dioctadecyl-3##2##1##(1997-3#2)
1'-thiocarbonyldiimidazole##2##1##(2008-10#2)
1(-1) and a##2##3##(2008-10#2)
1(-1) and##3##2##(2008-10#3)
1(-1) with##3##2##(2008-10#3)
1(-1)##18##1##(1991-12#1)(2008-10#17)
1) The##2##2##(1991-2#1)(1992-2#1)
1) a##3##2##(1990-2#1)(2008-11#1)(2008-7#1)
1) and##19##2##(1992-3#1)(1994-3#1)(1995-2#1)(1996-11#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#2)
1) at##2##2##(2008-10#1)(2012-3#1)
1) for##2##2##(2008-10#2)
1) from##2##2##(1994-8#1)(2008-9#1)
1) in##4##2##(1996-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
1) is##5##2##(1990-2#1)(1992-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
1) of##4##2##(2008-10#2)(2008-3#2)
1) patient##2##2##(2011-2#2)
1) the##4##2##(1991-3#1)(1995-11#1)(1995-6#1)(2008-6#1)
1) to##5##2##(2008-10#4)(2008-3#1)
1) values = 0##2##4##(2008-9#2)
1) was##6##2##(2008-10#4)(2008-11#1)(2011-2#1)
1) were##3##2##(1997-8#1)(2008-10#2)
1) when the##3##3##(1991-11#1)(1993-6#1)(1995-12#1)
1) μm##2##2##(2010-10#2)
1)##236##1##(1990-12#2)(1990-2#5)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#2)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#9)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#65)(2008-11#21)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#7)(2009-6#1)(2009-7#1)(2010-10#5)(2010-4#3)(2011-2#8)(2011-9#1)(2012-12#4)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#5)(2013-8#3)
1)%##2##1##(2008-10#1)(2008-3#1)
1)(T )=10##2##2##(2008-10#2)
1)(T##5##1##(2008-10#5)
1+##2##1##(1993-8#1)(2010-8#1)
1+/-0##14##1##(2008-10#12)(2008-7#1)(2008-9#1)
1+2##2##1##(2008-10#2)
1- and 2-naphthol##3##3##(2008-10#3)
1- and##12##2##(1991-6#1)(1994-11#2)(1996-12#2)(1996-2#1)(2008-10#6)
1- to 2-days-old quail chicks (Coturnix japonica)##2##7##(2008-6#2)
1- to##4##2##(1990-9#1)(2008-10#1)(2008-6#2)
1-##19##1##(1990-9#1)(1991-6#1)(1994-11#2)(1996-12#2)(1996-2#1)(2008-10#7)(2008-3#2)(2008-6#2)(2012-3#1)
1-(1##2##1##(1996-5#1)(2008-5#1)
1-(2##2##1##(2008-10#2)
1-(2-pyridylazo) 2-naphtol (PAN) impregnated Ambersorb 563 resin##2##7##(2008-10#2)
1-(2-pyridylazo)-2-naphthol (PAN)##5##2##(2008-10#5)
1-(2-pyridylazo)-2-naphthol##13##1##(2008-10#13)
1-(2-thiasolylazo)-2-naphthol##3##1##(2008-10#3)
1-(2-thiazolylazo)-2-naphthol##2##1##(2008-10#2)
1-(3##3##1##(2008-10#3)
1-(5-bromo-2-pyridylazo)-2-naphthol-6-sulphonic acid##2##2##(2008-10#2)
1-0##21##1##(1990-5#1)(1992-6#1)(2008-10#14)(2008-11#2)(2008-2#1)(2011-2#1)(2012-2#1)
1-1##16##1##(1997-4#1)(2008-10#11)(2008-11#1)(2008-2#1)(2009-6#1)(2013-1#1)
1-10 mM)##2##2##(1995-11#2)
1-10 mugml(-1)##2##2##(2008-10#2)
1-10 mumol##2##2##(2008-10#2)
1-10 ng ml(-1)##2##3##(2008-10#2)
1-10##23##1##(1991-11#1)(1993-6#1)(1994-12#1)(1995-11#2)(1996-12#1)(1996-2#1)(2008-10#13)(2009-12#1)(2012-2#1)(2012-3#1)
1-10)##2##1##(1994-12#1)(2008-10#1)
1-100 mug ml(-1)##2##3##(2008-10#2)
1-100 nM)##2##2##(1993-3#1)(1997-4#1)
1-100##11##1##(1993-3#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-10#6)(2008-11#1)
1-1000 ng ml(-1)##2##3##(2008-10#2)
1-1000##4##1##(1992-6#1)(2008-10#3)
1-102##2##1##(1992-4#1)(2008-10#1)
1-11##2##1##(1995-11#1)(1997-3#1)
1-12##10##1##(1994-11#5)(2008-10#5)
1-12)##2##1##(1990-6#1)(2008-10#1)
1-14##3##1##(1992-3#1)(1996-12#1)(2008-7#1)
1-15##6##1##(1991-3#1)(2008-10#4)(2013-1#1)
1-17##2##1##(2008-10#1)(2013-1#1)
1-2 cm##2##2##(1992-9#1)(2008-1#1)
1-2 days##2##2##(1991-3#1)(2008-8#1)
1-2##38##1##(1990-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-7#1)(2008-8#3)(2010-6#1)(2012-12#1)(2013-1#1)
1-2% of##3##2##(1990-6#1)(1996-11#1)(2013-8#1)
1-2%##6##1##(1990-6#1)(1996-11#1)(2008-10#3)(2013-8#1)
1-2)##2##1##(1991-6#1)(2008-10#1)
1-2-(thiazolylazo)-2-naphthol##2##1##(2008-10#2)
1-2-3##2##1##(1992-12#1)(2008-10#1)
1-20 mug##2##2##(2008-10#2)
1-20##10##1##(2008-10#6)(2008-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
1-25##3##1##(1991-11#1)(2008-10#1)(2008-11#1)
1-29##2##1##(1992-3#1)(1992-9#1)
1-2min##2##1##(2008-10#2)
1-3##32##1##(1990-8#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-6#1)(1996-12#2)(1996-2#1)(1997-3#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-8#2)(2011-2#1)(2011-3#1)
1-3%##2##1##(2008-10#2)
1-30 mug ml(-1)##2##3##(2008-10#2)
1-30##5##1##(2008-10#5)
1-34##2##1##(1991-6#1)(1994-11#1)
1-4##20##1##(1991-2#1)(1994-12#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-5#1)(2009-6#1)(2009-8#1)(2013-1#4)
1-4%##3##1##(2008-10#1)(2008-2#1)(2011-3#1)
1-40 OH##5##2##(1992-9#5)
1-40##14##1##(1992-9#5)(1994-11#5)(2008-10#4)
1-400##2##1##(2008-10#2)
1-43##2##1##(1997-4#1)(1997-7#1)
1-5 mug ml(-1)##2##3##(2008-10#2)
1-5##24##1##(1990-2#2)(1994-6#1)(1995-12#1)(1995-3#1)(2008-10#15)(2008-12#1)(2008-3#1)(2009-10#1)(2011-3#1)
1-5% of the##2##3##(1997-4#1)(2008-7#1)
1-5% of##3##2##(1997-4#1)(2008-7#1)(2009-8#1)
1-5%##8##1##(1997-4#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-8#1)
1-5)##2##1##(1990-12#1)(2009-10#1)
1-50##7##1##(1996-12#3)(2008-10#2)(2008-3#1)(2010-8#1)
1-6##9##1##(1996-12#1)(2008-10#4)(2008-7#1)(2010-7#1)(2011-2#2)
1-7##4##1##(2008-10#3)(2008-11#1)
1-8##6##1##(1992-12#1)(2008-10#3)(2008-6#1)(2008-8#1)
1-9##6##1##(1992-12#1)(1995-12#2)(2008-5#1)(2010-11#1)(2013-1#1)
1-IB##3##1##(2008-10#3)
1-MT and MTH-trp##3##3##(2008-11#3)
1-MeTIQ##4##1##(1994-2#4)
1-N-way##3##1##(2008-3#3)
1-NO(2) naphthalene##2##2##(2008-11#2)
1-O-hexadecyl molecular species of##2##4##(1991-5#2)
1-O-hexadecyl-2-O-methylglycerol##2##1##(2008-11#2)
1-[G'(1)]##3##1##(1996-5#3)
1-[G'(1)]-1-[G'(4)]##4##1##(1996-5#4)
1-[G'(4)]##2##1##(1996-5#2)
1-[pyridyl-(2)-azo]-naphthol-(2)##2##1##(2008-10#2)
1-acylindazol-3-ols as##2##2##(2008-10#2)
1-alpha##5##1##(1995-9#2)(2008-10#2)(2013-1#1)
1-aminocyclopropane-1-carboxylic acid##2##2##(1995-2#1)(2011-10#1)
1-chloronaphthalene (CN)##2##2##(2008-10#2)
1-cm##3##1##(1992-11#1)(2008-10#1)(2008-5#1)
1-day##3##1##(2008-10#2)(2010-6#1)
1-decyl-3-methylimidazolium bromide##2##2##(2008-10#2)
1-deoxy##3##1##(1992-12#3)
1-dichloro-2##2##1##(2008-10#2)
1-diphenyl-2-picrylhydrazyl radical##2##2##(2008-11#1)(2008-5#1)
1-diphenyl-2-picrylhydrazyl##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
1-dopa##3##1##(2008-7#3)
1-ethyl-3-methylimidazolium##2##1##(2008-10#2)
1-fold##4##1##(1994-8#1)(2008-10#1)(2009-3#1)(2010-5#1)
1-h Post##3##2##(2013-1#3)
1-h##5##1##(2008-10#1)(2008-3#1)(2013-1#3)
1-hour##3##1##(2010-7#1)(2013-1#2)
1-kHz##4##1##(2007-11#1)(2008-3#3)
1-kb##3##1##(1991-6#1)(2008-10#2)
1-m(2)##2##1##(2008-10#2)
1-methyl##2##1##(1994-2#1)(2008-10#1)
1-methyl-1##2##1##(1990-7#1)(1994-2#1)
1-methyl-4-phenyl-1##5##1##(1990-7#1)(1995-11#1)(1996-12#1)(2008-7#2)
1-methyl-4-phenylpyridinium (MPP+)##4##2##(1990-5#2)(1990-7#1)(1996-12#1)
1-methyl-4-phenylpyridinium##6##1##(1990-5#2)(1990-7#1)(1995-11#2)(1996-12#1)
1-methyladenosine##6##1##(1992-3#5)(1997-2#1)
1-microm wavelength##3##2##(2008-2#2)(2008-3#1)
1-mm##5##1##(1994-2#1)(2008-10#3)(2008-3#1)
1-month period##2##2##(2008-10#2)
1-month##4##1##(2008-10#4)
1-ms##2##1##(2008-3#2)
1-naphthalenacetamide in##2##2##(2008-10#2)
1-naphthalenacetamide##3##1##(2008-10#3)
1-naphthol and##2##2##(2008-11#2)
1-naphthol##3##1##(2008-10#1)(2008-11#2)
1-naphthyl##2##1##(2008-10#1)(2008-5#1)
1-naphthylamine##2##1##(2008-10#2)
1-nitroso-2-naphthol##6##1##(2008-10#6)
1-nm linewidth and a##2##4##(2008-2#1)(2008-3#1)
1-nm##3##1##(2008-2#1)(2008-3#2)
1-octanol##2##1##(2008-10#2)
1-q13##2##1##(1997-8#2)
1-s##2##1##(2008-3#2)
1-specific##2##1##(2008-5#1)(2012-2#1)
1-tris(N-ethyl-N-phenylamino-carboxylmethoxymethyl) propane##2##2##(2008-10#2)
1-year follow-up##5##2##(2008-10#1)(2008-4#1)(2012-3#1)(2012-5#1)(2013-8#1)
1-year followup##2##2##(1991-1#1)(2010-8#1)
1-year prospective cohort study##2##4##(2013-1#2)
1-year##18##1##(1991-1#1)(1991-2#2)(1991-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
1-year-old##7##1##(1997-8#1)(2008-10#4)(2012-3#1)(2012-8#1)
1-yr##3##1##(2008-8#2)(2010-10#1)
1/1##3##1##(2008-10#2)(2013-1#1)
1/10##4##1##(1990-12#1)(1990-6#1)(1995-11#1)(2008-10#1)
1/100##3##1##(2008-10#1)(2008-5#1)(2013-1#1)
1/1000##2##1##(1990-2#1)(1990-3#1)
1/2 years##5##2##(1990-6#4)(1992-1#1)
1/2##12##1##(1990-6#4)(1992-1#1)(1994-2#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
1/3 of the##2##3##(1991-6#1)(1991-9#1)
1/3##6##1##(1990-9#1)(1991-12#2)(1991-6#1)(1991-9#1)(2008-5#1)
1/4##2##1##(2008-11#1)(2010-11#1)
1/n##3##1##(2008-10#3)
1/n=0##2##1##(2008-10#2)
10 % of##2##3##(1997-8#1)(2012-12#1)
10 %##3##2##(1997-8#1)(2008-10#1)(2012-12#1)
10 (95%##2##2##(2008-11#1)(2013-1#1)
10 +/-##3##2##(1994-5#1)(1995-12#1)(2010-7#1)
10 000##4##2##(2008-10#2)(2013-8#2)
10 =##4##2##(2008-10#1)(2008-7#1)(2013-1#2)
10 A##3##2##(1992-11#1)(2008-10#1)(2008-3#1)
10 Commandments##4##2##(2008-12#4)
10 HIV##2##2##(2013-8#2)
10 M##7##2##(1990-5#1)(2008-10#6)
10 MPa##2##2##(2008-10#1)(2008-5#1)
10 OSM to##2##3##(1991-11#2)
10 OSM##3##2##(1991-11#3)
10 Pa##3##2##(2008-11#3)
10 QTLs##2##2##(2008-10#1)(2008-8#1)
10 V##2##2##(2008-10#2)
10 accessions##2##2##(2008-10#2)
10 and 0##4##3##(2008-10#3)(2008-5#1)
10 and 100##3##3##(1992-3#1)(2008-10#2)
10 and 1000 µg/L##2##3##(2013-1#2)
10 and 11##3##3##(1994-12#2)(2008-8#1)
10 and 12##6##3##(1996-12#5)(2008-10#1)
10 and 13##3##3##(2008-10#2)(2008-12#1)
10 and 15##2##3##(1994-8#1)(2008-10#1)
10 and 16##2##3##(2008-10#1)(2008-11#1)
10 and 18##2##3##(2008-10#1)(2012-3#1)
10 and 20##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
10 and 20%##2##3##(2008-10#1)(2008-11#1)
10 and 30##4##3##(1991-2#1)(1995-8#1)(2008-11#1)(2012-3#1)
10 and 50##3##3##(2008-10#3)
10 and about##2##3##(1996-12#1)(2008-10#1)
10 and in##2##3##(2008-10#1)(2008-5#1)
10 and##75##2##(1991-2#1)(1992-12#1)(1992-3#1)(1994-12#2)(1994-8#1)(1995-8#1)(1996-12#7)(1997-2#1)(1997-9#1)(2008-10#41)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#2)
10 as##3##2##(1996-5#1)(2008-10#2)
10 at##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
10 cases and##2##3##(2008-7#1)(2011-2#1)
10 cases##7##2##(1990-2#1)(1991-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)
10 cm##7##2##(1997-8#1)(2008-10#2)(2008-8#1)(2013-1#2)(2013-8#1)
10 commandments##2##2##(2008-12#2)
10 commonly##2##2##(2008-10#1)(2011-1#1)
10 consecutive##4##2##(2008-10#3)(2013-8#1)
10 copies of##2##3##(1997-2#1)(2013-1#1)
10 days after##3##3##(2008-10#3)
10 days and##3##3##(1992-12#1)(2011-2#1)(2013-1#1)
10 days apart##2##3##(2008-10#2)
10 days later##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
10 days of##3##3##(1992-12#2)(2008-10#1)
10 days##38##2##(1992-12#4)(1995-11#1)(1995-2#1)(1995-3#1)(1997-3#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
10 days)##2##2##(2009-10#1)(2011-1#1)
10 degrees C##9##3##(2008-10#7)(2008-11#1)(2010-4#1)
10 degrees##11##2##(2008-10#7)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#1)
10 determinations of##3##3##(2008-10#3)
10 different##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)
10 elements##2##2##(2008-10#2)
10 female Tg##3##3##(2008-9#3)
10 female##4##2##(2008-9#4)
10 fg##2##2##(2008-10#2)
10 fmol##3##2##(1997-2#3)
10 fold higher##2##3##(1994-11#1)(2008-11#1)
10 fold##3##2##(1991-5#1)(1994-11#1)(2008-11#1)
10 for the##2##3##(2008-10#2)
10 for##8##2##(1990-5#2)(2008-10#5)(2008-11#1)
10 g##2##2##(2008-10#2)
10 g)##2##2##(1994-11#1)(2008-10#1)
10 genes##3##2##(1996-2#1)(2008-11#2)
10 h in##2##3##(2008-10#2)
10 h was##2##3##(2008-10#2)
10 h##16##2##(1992-8#1)(1994-5#2)(2008-10#9)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
10 h(-1) with##2##3##(2008-10#2)
10 had##2##2##(1990-3#1)(1995-12#1)
10 hospitals##2##2##(1994-3#2)
10 impacted##2##2##(2008-7#2)
10 in##5##2##(1992-3#1)(2008-10#3)(2013-1#1)
10 injections##2##2##(2008-10#2)
10 isolates were##2##3##(2008-10#1)(2008-9#1)
10 isolates##6##2##(2008-10#4)(2008-5#1)(2008-9#1)
10 kDa##2##2##(1992-10#1)(2011-2#1)
10 kb##4##2##(1993-2#1)(1996-6#1)(1997-2#1)(2008-10#1)
10 km##2##2##(1990-11#1)(2008-8#1)
10 m##6##2##(2007-12#1)(2008-10#4)(2008-3#1)
10 mM K+##2##3##(1997-1#1)(2008-11#1)
10 mM and##2##3##(1992-7#1)(2008-10#1)
10 mM sodium##2##3##(2008-10#1)(2008-11#1)
10 mM##25##2##(1992-7#2)(1993-3#1)(1995-11#2)(1995-8#1)(1997-1#2)(2008-10#13)(2008-11#3)(2008-6#1)
10 mV##4##2##(2008-10#4)
10 male##5##2##(1990-2#1)(2008-12#1)(2008-9#3)
10 measurements of 0##2##4##(2008-10#2)
10 mg l(-1)##7##3##(2008-10#7)
10 mg##19##2##(1993-1#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
10 mg/kg##4##2##(1993-3#1)(1996-2#2)(1997-2#1)
10 mg/kg/day##3##2##(1992-11#2)(1995-8#1)
10 microM and##2##3##(1994-5#1)(1996-2#1)
10 microM##7##2##(1991-5#2)(1994-5#1)(1995-11#1)(1995-2#1)(1996-2#2)
10 microM) and##2##3##(1995-11#1)(1996-2#1)
10 microM)##5##2##(1990-2#1)(1991-6#2)(1995-11#1)(1996-2#1)
10 microg l(-1)##3##3##(2008-10#3)
10 microg##5##2##(2008-10#5)
10 micrograms##4##2##(1990-2#1)(1993-6#1)(1996-2#2)
10 micrograms/ml##4##2##(1990-2#1)(1994-11#3)
10 microm##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)
10 micromol##2##2##(2008-10#2)
10 microns##2##2##(1995-3#1)(1997-1#1)
10 min after##2##3##(1993-1#1)(1997-2#1)
10 min and##2##3##(2008-10#1)(2013-1#1)
10 min for##2##3##(2008-10#1)(2008-3#1)
10 min in a##2##4##(1990-12#1)(2008-10#1)
10 min in##3##3##(1990-12#1)(1993-1#1)(2008-10#1)
10 min incubation##2##3##(1992-3#1)(2008-10#1)
10 min of##3##3##(1991-12#1)(1996-12#1)(2008-10#1)
10 min per sample##2##4##(2008-10#2)
10 min sampling##2##3##(2008-10#2)
10 min static##2##3##(2008-10#2)
10 min##54##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#2)(1993-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(2006-6#1)(2008-10#28)(2008-11#5)(2008-3#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
10 min)##3##2##(1991-6#1)(1997-2#1)(2008-10#1)
10 minutes after##2##3##(1992-1#1)(2012-3#1)
10 minutes at##2##3##(2008-11#1)(2012-2#1)
10 minutes of##3##3##(2010-1#1)(2011-1#1)(2013-1#1)
10 minutes##10##2##(1991-1#1)(1992-1#1)(2008-11#1)(2010-1#2)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
10 ml of 0##2##4##(1995-3#1)(2008-10#1)
10 ml of 1%##2##4##(2008-10#2)
10 ml of sample##3##4##(2008-10#3)
10 ml of##17##3##(1995-3#1)(2008-10#16)
10 ml sample##4##3##(2008-10#4)
10 ml##27##2##(1995-3#1)(2008-10#26)
10 mm in##5##3##(1990-2#2)(2008-10#3)
10 mm##15##2##(1990-2#2)(1991-12#1)(1995-2#2)(1997-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
10 mm)##3##2##(2010-12#1)(2011-7#1)(2013-1#1)
10 mmol/l##4##2##(1991-11#1)(1991-6#1)(1992-12#1)(2010-4#1)
10 mol l(-1) Tris-SO(4) buffer##2##5##(2008-10#2)
10 mol l(-1)##4##3##(2008-10#4)
10 moles of##2##3##(2008-10#2)
10 months after surgery##2##4##(2011-2#2)
10 months after##7##3##(1991-6#1)(1991-8#1)(2008-10#1)(2008-7#1)(2011-2#3)
10 months later##3##3##(2008-7#2)(2009-1#1)
10 months of##2##3##(2008-10#1)(2008-9#1)
10 months##23##2##(1991-6#1)(1991-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-7#3)(2008-9#2)(2009-1#1)(2010-1#1)(2010-2#1)(2011-2#3)(2013-1#1)(2013-8#1)
10 ms)##2##2##(1996-5#1)(2008-6#1)
10 muM cytokinin##2##3##(2008-7#2)
10 muM##12##2##(2008-10#7)(2008-11#2)(2008-7#3)
10 mug l(-1) and##2##4##(2008-10#2)
10 mug l(-1)##6##3##(2008-10#6)
10 mug l(-1))##2##3##(2008-10#2)
10 mug ml(-1)##4##3##(2008-10#3)(2008-11#1)
10 mug##20##2##(2008-10#19)(2008-11#1)
10 mug/kg##2##2##(2008-10#1)(2008-11#1)
10 mug/ml##3##2##(2008-10#3)
10 mul of##3##3##(2008-10#3)
10 mul##6##2##(2008-10#6)
10 mumol##2##2##(2008-10#2)
10 nM T4 at##2##4##(2008-6#2)
10 nM T4##3##3##(2008-6#3)
10 nM hormone##2##3##(1995-12#2)
10 nM##10##2##(1992-6#1)(1994-11#1)(1995-12#3)(2008-10#1)(2008-11#1)(2008-6#3)
10 nM)##2##2##(1993-6#1)(2008-6#1)
10 newborns delivered by##2##4##(2009-8#2)
10 ng ml(-1) level##2##4##(2008-10#2)
10 ng ml(-1)##6##3##(2008-10#6)
10 ng##14##2##(2008-10#14)
10 ng/ml##5##2##(1994-11#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-6#1)
10 ngml(-1)##2##2##(2008-10#2)
10 nm filaments##3##3##(2008-8#3)
10 nm##7##2##(2007-12#1)(2008-10#1)(2008-8#4)(2009-5#1)
10 normal##2##2##(2008-10#1)(2008-9#1)
10 of 13##2##3##(2008-10#1)(2008-12#1)
10 of the##6##3##(1995-8#1)(1996-8#1)(2008-10#4)
10 of##12##2##(1995-8#1)(1996-1#1)(1996-8#1)(2008-10#7)(2008-12#1)(2013-1#1)
10 or##5##2##(1994-12#1)(2008-10#3)(2008-12#1)
10 out of 18##2##4##(2008-10#2)
10 out of##4##3##(1995-8#1)(2008-10#2)(2013-1#1)
10 parallel##2##2##(2008-10#2)
10 parathyroid adenomas and##2##4##(2008-5#2)
10 parts##2##2##(1990-2#1)(2007-12#1)
10 patients treated##2##3##(2008-7#1)(2008-8#1)
10 patients were##2##3##(2011-2#1)(2012-3#1)
10 patients with##3##3##(1996-2#1)(2008-5#1)(2010-12#1)
10 patients##20##2##(1990-12#1)(1990-6#1)(1991-3#1)(1993-1#1)(1995-11#1)(1996-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
10 percent##5##2##(1991-11#1)(1992-3#1)(1994-1#1)(1995-6#2)
10 pg of##2##3##(2008-10#2)
10 pg##8##2##(2008-10#6)(2008-11#1)(2011-3#1)
10 ppb##3##2##(2008-10#3)
10 ppm##4##2##(2008-10#3)(2010-1#1)
10 rats##2##2##(1993-3#2)
10 replicate determinations of##4##4##(2008-10#4)
10 replicate determinations##8##3##(2008-10#8)
10 replicate injections##2##3##(2008-10#2)
10 replicate##10##2##(2008-10#10)
10 replicates##3##2##(2008-10#3)
10 s and can be used for at least##3##9##(2008-10#3)
10 s and##7##3##(2008-10#7)
10 s##14##2##(1997-2#1)(2008-10#12)(2008-3#1)
10 samples per hour##2##4##(2008-10#2)
10 samples per##3##3##(2008-10#3)
10 samples##6##2##(1992-3#1)(2008-10#4)(2013-1#1)
10 seconds##2##2##(1990-2#1)(2013-1#1)
10 times higher than##2##4##(2012-3#1)(2013-8#1)
10 times higher##3##3##(1995-11#1)(2012-3#1)(2013-8#1)
10 times lower##2##3##(2008-11#1)(2008-7#1)
10 times that##2##3##(1994-11#1)(2008-7#1)
10 times##15##2##(1994-11#1)(1995-11#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-7#2)(2008-8#1)(2012-3#1)(2013-8#1)
10 to 0##3##3##(2008-10#2)(2012-2#1)
10 to 1##3##3##(2008-10#2)(2008-8#1)
10 to 10##2##3##(2008-10#2)
10 to 100##2##3##(2008-10#2)
10 to 12##3##3##(2008-10#2)(2008-2#1)
10 to 14 days##2##4##(2008-10#2)
10 to 14##4##3##(2008-10#2)(2013-1#2)
10 to 15##3##3##(1991-8#1)(2008-10#1)(2008-7#1)
10 to 20##2##3##(2008-10#2)
10 to 30##7##3##(1994-11#1)(2008-10#4)(2008-2#1)(2009-7#1)
10 to 5##3##3##(2008-10#3)
10 to##64##2##(1991-5#1)(1991-8#1)(1993-3#1)(1994-11#1)(1994-3#1)(2008-10#47)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
10 w/w% Ag-zeolite##2##3##(2008-5#2)
10 was##5##2##(1996-5#1)(2008-10#3)(2008-7#1)
10 weeks after##2##3##(2008-10#1)(2008-11#1)
10 weeks##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
10 were##7##2##(1993-1#1)(1996-5#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
10 when##2##2##(2008-10#2)
10 with a##2##3##(2008-10#2)
10 with##3##2##(1996-1#1)(2008-10#2)
10 women and##2##3##(1991-8#1)(2008-10#1)
10 women##4##2##(1991-8#1)(1995-1#1)(2008-10#1)(2011-2#1)
10 x 10##2##3##(1993-9#1)(2008-10#1)
10 x##4##2##(1993-9#1)(2008-10#2)(2008-8#1)
10 year##3##2##(1993-1#1)(2008-11#1)(2008-5#1)
10 years after##5##3##(1997-8#1)(2010-3#1)(2013-1#3)
10 years ago##2##3##(2010-7#1)(2012-3#1)
10 years and##3##3##(2008-10#2)(2009-3#1)
10 years are##2##3##(1997-3#1)(2008-11#1)
10 years in prison##2##4##(1996-5#2)
10 years in##3##3##(1996-5#3)
10 years it##2##3##(1995-9#1)(2009-1#1)
10 years of age and##2##5##(2008-12#1)(2012-12#1)
10 years of age##4##4##(2008-10#1)(2008-12#1)(2012-12#2)
10 years of##8##3##(1997-5#1)(2008-10#2)(2008-12#1)(2010-3#1)(2011-2#1)(2012-12#2)
10 years period##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
10 years to##2##3##(1990-2#1)(2012-3#1)
10 years##71##2##(1990-2#1)(1991-6#1)(1991-7#1)(1992-3#2)(1992-5#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#4)(2013-8#2)
10 young##2##2##(1995-8#1)(2011-2#1)
10 yr##3##2##(2008-9#1)(2009-10#1)(2010-4#1)
10##1712##1##(1990-11#4)(1990-12#5)(1990-2#13)(1990-3#1)(1990-5#6)(1990-6#4)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#6)(1991-12#4)(1991-2#3)(1991-3#4)(1991-5#7)(1991-6#10)(1991-7#2)(1991-8#5)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#12)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#10)(1993-12#3)(1993-2#3)(1993-3#8)(1993-6#3)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#11)(1994-12#6)(1994-2#5)(1994-3#5)(1994-5#5)(1994-6#2)(1994-8#10)(1995-1#2)(1995-10#1)(1995-11#9)(1995-12#13)(1995-2#8)(1995-3#5)(1995-6#5)(1995-8#13)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#10)(1996-2#12)(1996-3#3)(1996-5#12)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#8)(1997-2#14)(1997-3#7)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#7)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-1#3)(2008-10#759)(2008-11#95)(2008-12#36)(2008-2#7)(2008-3#26)(2008-5#41)(2008-6#9)(2008-7#43)(2008-8#23)(2008-9#38)(2009-1#3)(2009-10#3)(2009-11#2)(2009-12#9)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#5)(2010-1#9)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#5)(2010-9#4)(2011-1#9)(2011-10#2)(2011-2#59)(2011-3#7)(2011-7#1)(2012-12#9)(2012-2#16)(2012-3#22)(2013-1#55)(2013-8#18)
10% (v/v)##2##2##(2008-10#1)(2008-11#1)
10% Genapol X-080##2##3##(2008-10#2)
10% HCl##3##2##(2008-10#3)
10% after##2##2##(2008-10#2)
10% and 20%##2##3##(2008-11#1)(2010-4#1)
10% and##14##2##(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)
10% at the##3##3##(1991-6#1)(2008-10#2)
10% fetal bovine serum (FBS)##2##5##(1995-3#1)(2008-11#1)
10% fetal bovine serum##3##4##(1995-3#1)(2008-11#2)
10% for##5##2##(2008-1#1)(2008-10#3)(2008-5#1)
10% from##2##2##(2008-10#1)(2012-2#1)
10% in##6##2##(1990-6#1)(1993-9#1)(2008-10#2)(2008-7#1)(2011-2#1)
10% of all##2##3##(1991-11#1)(2008-10#1)
10% of cases##2##3##(2010-12#1)(2011-2#1)
10% of patients##3##3##(1996-11#1)(2008-7#1)(2009-12#1)
10% of the total##2##4##(2008-10#1)(2008-7#1)
10% of the##22##3##(1990-2#1)(1991-8#1)(1992-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
10% of total##2##3##(2008-9#1)(2010-11#1)
10% of##56##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-11#2)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#3)(2010-11#2)(2010-12#1)(2011-2#4)(2012-3#1)
10% or##2##2##(2008-3#1)(2012-3#1)
10% oxygen##2##2##(2008-10#1)(2008-11#1)
10% sucrose##2##2##(1993-6#1)(2008-10#1)
10% w/v##2##2##(2008-10#2)
10% was##2##2##(2008-10#2)
10% were##6##2##(1990-12#1)(2008-10#4)(2010-11#1)
10% with##2##2##(1991-5#1)(2008-10#1)
10%##235##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1996-11#4)(1996-12#4)(1996-3#1)(1997-3#2)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#100)(2008-11#19)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#4)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#4)(2010-6#2)(2010-8#2)(2011-2#10)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
10%) and##5##2##(2008-10#4)(2012-3#1)
10%)##16##1##(2008-10#12)(2008-12#1)(2008-9#1)(2012-3#2)
10(-1) M##3##2##(2008-10#3)
10(-1) M)##2##2##(2008-10#2)
10(-1) mol l(-1)##2##3##(2008-10#2)
10(-1) mol##6##2##(2008-10#6)
10(-1)##14##1##(2008-10#14)
10(-1)M with a##2##3##(2008-10#2)
10(-1)M##6##1##(2008-10#6)
10(-10) M##9##2##(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-3#1)(1997-4#2)(2008-10#2)
10(-10) and##4##2##(1995-11#1)(2008-10#2)(2008-3#1)
10(-10)##21##1##(1991-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#3)(1996-3#1)(1997-4#2)(2008-10#8)(2008-2#1)(2008-3#2)
10(-11) M##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
10(-11)##9##1##(1995-11#1)(1996-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)
10(-12) to##2##2##(2008-10#2)
10(-12)##5##1##(1991-5#1)(1997-4#1)(2008-10#2)(2008-8#1)
10(-13)##4##1##(1990-12#1)(2008-3#2)(2010-4#1)
10(-14) M to##2##3##(1997-4#2)
10(-14) M##3##2##(1997-4#3)
10(-14)##5##1##(1997-4#3)(2008-3#1)(2008-5#1)
10(-15)##2##1##(1997-4#1)(2008-10#1)
10(-16)##3##1##(2008-3#2)(2008-5#1)
10(-2) M##4##2##(2008-10#4)
10(-2) mol##3##2##(2008-10#3)
10(-2) mul##4##2##(2008-11#4)
10(-2)##16##1##(2008-10#8)(2008-11#4)(2008-3#1)(2009-6#1)(2011-2#2)
10(-20)##2##1##(2008-10#1)(2008-3#1)
10(-3) M##6##2##(2008-10#6)
10(-3) and 10(-2) mul ml(-1) concentrations of TE were used for 48 h to##2##14##(2008-11#2)
10(-3) and 10(-2) mul ml(-1) concentrations##3##6##(2008-11#3)
10(-3) and##5##2##(2008-10#1)(2008-11#3)(2008-3#1)
10(-3) mol l(-1)##5##3##(2008-10#5)
10(-3) to##5##2##(2008-10#5)
10(-3)##40##1##(1990-8#1)(1994-5#1)(1995-11#1)(2007-12#1)(2008-10#24)(2008-11#3)(2008-2#2)(2008-3#5)(2008-7#2)
10(-4) M##8##2##(1994-8#1)(2008-10#6)(2008-11#1)
10(-4) mol l(-1)##5##3##(2008-10#5)
10(-4) mol##6##2##(2008-10#6)
10(-4) to 10(-2) M##2##4##(2008-10#2)
10(-4) to##6##2##(2008-10#6)
10(-4)##49##1##(1990-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#28)(2008-11#6)(2008-2#1)(2008-3#8)(2010-12#1)(2011-2#1)
10(-4)-1##2##1##(2008-10#2)
10(-5) M in##2##3##(2008-10#2)
10(-5) M of##2##3##(1997-4#2)
10(-5) M##21##2##(1990-11#1)(1992-6#2)(1994-11#1)(1994-5#2)(1997-4#2)(2008-10#13)
10(-5) M)##2##2##(1994-2#1)(1997-4#1)
10(-5) and##2##2##(2008-10#2)
10(-5) mol l(-1)##4##3##(2008-10#4)
10(-5) mol##5##2##(2008-10#5)
10(-5) mol/l##2##2##(2011-2#2)
10(-5) s-1##2##2##(1991-5#2)
10(-5) to##11##2##(2008-10#11)
10(-5)##58##1##(1990-11#1)(1990-8#1)(1991-5#3)(1992-6#2)(1994-11#1)(1994-2#1)(1994-5#2)(1997-4#3)(2008-10#36)(2008-11#2)(2008-2#1)(2008-3#1)(2010-1#1)(2010-4#1)(2011-2#2)
10(-5))##2##1##(2008-3#1)(2011-2#1)
10(-5)-10(-2) M##2##2##(2008-10#2)
10(-5)-10(-2)##4##1##(2008-10#4)
10(-5)-10(-4) M##2##2##(1990-7#1)(2008-10#1)
10(-5)M##7##1##(1995-8#1)(2008-10#6)
10(-6) M or##2##3##(1994-5#1)(1997-4#1)
10(-6) M##14##2##(1991-5#3)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-2#3)(1997-4#1)(2008-10#2)(2008-11#1)
10(-6) M)##3##2##(1991-5#1)(1997-4#1)(2008-10#1)
10(-6) and 1##6##3##(1995-11#2)(2008-10#4)
10(-6) and##9##2##(1995-11#2)(2008-10#7)
10(-6) cells day(-1)##2##3##(2008-11#2)
10(-6) mol l(-1)##6##3##(2008-10#6)
10(-6) mol##8##2##(2008-10#8)
10(-6) to##7##2##(2008-10#7)
10(-6)##57##1##(1990-11#1)(1990-8#2)(1991-5#4)(1992-3#2)(1994-3#1)(1994-5#1)(1995-11#3)(1996-12#1)(1996-2#3)(1997-4#2)(1997-8#1)(2008-10#28)(2008-11#4)(2008-3#3)(2008-5#1)
10(-6)-10(-2) mol l(-1)##2##3##(2008-10#2)
10(-6)-10(-2)##3##1##(2008-10#3)
10(-6)-10(-3) M##2##2##(2008-10#2)
10(-6)-10(-3)##3##1##(2008-10#3)
10(-6)M##6##1##(2008-10#6)
10(-7) M in##2##3##(1990-11#1)(2008-10#1)
10(-7) M##18##2##(1990-10#1)(1990-11#2)(1990-5#4)(1991-5#1)(1995-11#1)(2008-10#8)(2008-11#1)
10(-7) M)##5##2##(1990-5#1)(1994-2#1)(1996-2#1)(1997-4#2)
10(-7) and##2##2##(1990-11#1)(2008-10#1)
10(-7) mol dm(-3)##2##3##(2008-10#2)
10(-7) mol l(-1)##8##3##(2008-10#8)
10(-7) mol##13##2##(2008-10#13)
10(-7)##55##1##(1990-10#1)(1990-11#3)(1990-5#5)(1990-8#1)(1991-5#1)(1994-2#1)(1995-11#1)(1996-2#1)(1997-4#2)(2008-10#33)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
10(-7)M##5##1##(1993-6#1)(2008-10#4)
10(-8) M of somatostatin released##2##5##(1997-4#2)
10(-8) M##13##2##(1990-5#1)(1991-5#1)(1994-8#1)(1997-4#2)(2008-10#8)
10(-8) M)##2##2##(1996-2#1)(2008-10#1)
10(-8) to##6##2##(2008-10#6)
10(-8)##33##1##(1990-5#1)(1991-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-4#2)(2008-10#22)(2008-3#3)(2009-6#1)
10(-8)moll(-1)##2##1##(2008-10#2)
10(-9) M##14##2##(1990-11#1)(1991-5#1)(1994-3#1)(1995-11#1)(1997-4#3)(2008-10#7)
10(-9) and##6##2##(1995-11#1)(2008-10#5)
10(-9) mol##2##2##(2008-10#2)
10(-9)##34##1##(1990-11#1)(1990-8#1)(1991-5#1)(1994-3#1)(1995-11#3)(1996-2#1)(1997-4#3)(2008-10#17)(2008-3#2)(2008-8#1)(2010-1#1)(2011-2#2)
10(-9)M##3##1##(2008-10#3)
10(10)##5##1##(1994-8#1)(2008-10#1)(2008-11#2)(2008-3#1)
10(10))##2##1##(2008-3#1)(2008-7#1)
10(11)##4##1##(2008-8#3)(2010-1#1)
10(12)##4##1##(2008-3#2)(2008-7#1)(2008-9#1)
10(2) to##2##2##(2008-10#1)(2009-7#1)
10(2)##9##1##(1995-2#1)(2008-10#4)(2009-6#1)(2009-7#1)(2012-2#1)(2013-8#1)
10(3) and##3##2##(2008-10#2)(2008-3#1)
10(3) cells##3##2##(1991-11#1)(2008-10#2)
10(3) to##4##2##(2008-10#4)
10(3)##41##1##(1991-11#2)(1995-12#1)(1995-2#1)(1996-12#4)(1996-5#1)(2008-10#25)(2008-11#1)(2008-3#3)(2008-5#1)(2009-7#1)(2013-8#1)
10(4) CFU per##2##3##(2008-10#2)
10(4) CFU/cm(2)##2##2##(2008-10#2)
10(4) CFU/g of##2##3##(2008-10#2)
10(4) cells##2##2##(2008-10#1)(2008-11#1)
10(4) to 10(5)##2##3##(2008-10#2)
10(4) to 10(6)##2##3##(1995-2#1)(2008-10#1)
10(4) to##5##2##(1995-2#1)(2008-10#4)
10(4)##50##1##(1993-1#1)(1993-8#1)(1994-5#2)(1995-2#2)(1995-8#1)(1995-9#2)(1997-3#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)
10(4)-10(5) CFU/ml)##2##2##(2012-2#2)
10(4)-10(5)##3##1##(2008-8#1)(2012-2#2)
10(4)-fold##2##1##(2008-10#2)
10(5) and##3##2##(2008-10#2)(2012-2#1)
10(5) cells##7##2##(1995-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-6#1)
10(5) theoretical plates##2##3##(2008-10#2)
10(5) times##2##2##(2008-10#1)(2008-11#1)
10(5) to 10(7)##2##3##(2008-10#2)
10(5) to##3##2##(2008-10#3)
10(5)##56##1##(1990-5#2)(1992-10#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-12#1)(2008-10#34)(2008-11#6)(2008-3#4)(2008-9#2)(2010-6#1)(2012-2#1)
10(5))##4##1##(1991-9#1)(1997-9#1)(2008-10#2)
10(6##3##1##(2008-10#1)(2008-11#2)
10(6) CFU##4##2##(2008-10#4)
10(6) CFU/ml##3##2##(2008-10#2)(2012-2#1)
10(6) V/cm##2##2##(2008-3#2)
10(6) cells ml(-1))##4##3##(2008-11#4)
10(6) cells##14##2##(2008-10#2)(2008-11#10)(2011-2#2)
10(6) cells/ml##6##2##(2008-11#4)(2008-7#2)
10(6) or##2##2##(1991-11#1)(2008-10#1)
10(6) to##3##2##(2008-10#2)(2008-11#1)
10(6)##91##1##(1990-12#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-2#1)(1992-4#3)(1993-1#1)(1993-8#1)(1994-5#2)(1995-2#3)(1996-5#2)(2008-10#31)(2008-11#25)(2008-2#1)(2008-3#5)(2008-7#4)(2008-9#3)(2011-2#2)(2012-2#1)
10(7) CFU##6##2##(2008-10#6)
10(7) CFU/ml##3##2##(2008-10#3)
10(7) conidia per##3##3##(2008-10#3)
10(7) ml(-1)##2##2##(2008-11#2)
10(7) or##2##2##(2008-10#2)
10(7)##36##1##(1995-2#1)(2008-10#21)(2008-11#11)(2008-12#1)(2008-7#1)(2008-9#1)
10(7))##2##1##(1990-12#1)(2010-11#1)
10(8) CFU/ml##2##2##(2008-10#2)
10(8) CFU/ml)##3##2##(2008-10#3)
10(8) pfu##2##2##(2008-9#2)
10(8) to##2##2##(2008-10#2)
10(8)##21##1##(1990-12#3)(1991-11#1)(1993-1#1)(2008-10#9)(2008-11#2)(2008-8#1)(2008-9#2)(2012-2#2)
10(9) CFU/ml##3##2##(2008-10#3)
10(9) cells##5##2##(2008-10#2)(2008-11#3)
10(9) pfu##2##2##(2008-9#2)
10(9)##27##1##(1990-11#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#3)(2012-2#2)
10) and the##2##3##(2008-10#1)(2008-3#1)
10) and##5##2##(1995-6#1)(2008-10#2)(2008-3#1)(2013-1#1)
10) at##2##2##(2008-10#2)
10)##53##1##(1992-11#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#3)(2008-10#22)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#2)(2011-3#1)(2013-1#7)(2013-8#1)
10+/-0##2##1##(2008-10#2)
10- and##5##2##(1994-8#1)(2008-10#3)(2010-8#1)
10- to##6##2##(1994-2#1)(1996-12#2)(2008-10#2)(2008-9#1)
10-##14##1##(1994-2#1)(1994-8#1)(1995-8#1)(1996-12#2)(1997-9#1)(2008-10#5)(2008-9#1)(2010-8#1)(2013-1#1)
10-1##3##1##(2008-10#2)(2013-1#1)
10-10##2##1##(2008-10#1)(2008-11#1)
10-100##6##1##(1994-8#1)(2008-10#4)(2008-11#1)
10-12##8##1##(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
10-120##2##1##(2008-10#1)(2008-3#1)
10-13##3##1##(1990-6#1)(2008-11#1)(2013-1#1)
10-15 min##2##2##(1995-12#1)(2008-10#1)
10-15 years##2##2##(1992-5#1)(2009-6#1)
10-15##9##1##(1992-5#1)(1995-12#1)(1996-11#2)(1997-7#1)(2007-12#1)(2008-10#2)(2009-6#1)
10-15% of the##2##3##(2008-10#1)(2008-2#1)
10-15% of##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
10-15%##5##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
10-20##8##1##(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-8#1)
10-20% of cases##2##3##(2008-7#1)(2012-3#1)
10-20% of the##2##3##(1990-9#1)(2008-5#1)
10-20% of##5##2##(1990-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
10-20%##9##1##(1990-9#1)(1992-6#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
10-4##2##1##(2008-10#2)
10-40##3##1##(1994-2#1)(1996-6#1)(2008-9#1)
10-5 m##2##2##(2008-5#2)
10-5##3##1##(2008-10#1)(2008-5#2)
10-60##2##1##(1995-11#1)(2008-10#1)
10-7##2##1##(2008-10#1)(2008-5#1)
10-800##2##1##(2008-10#2)
10-GHz##2##1##(2007-11#2)
10-Hz##2##1##(2008-2#2)
10-Methylenetetrahydrofolate reductase##2##2##(2008-8#2)
10-anthraquinone derivatives in##2##3##(2008-10#2)
10-anthraquinone derivatives##4##2##(2008-10#4)
10-anthraquinone##6##1##(2008-10#6)
10-cm##4##1##(2008-10#3)(2008-12#1)
10-day##7##1##(2008-10#2)(2008-11#2)(2010-5#2)(2013-8#1)
10-day-old##4##1##(2008-10#4)
10-diaza-2##3##1##(2008-10#3)
10-dihydrodiol##2##1##(2011-1#2)
10-dione##3##1##(2008-10#1)(2008-11#2)
10-diphenylanthracene##2##1##(1995-6#1)(2008-10#1)
10-fold higher in##2##3##(2008-10#1)(2008-11#1)
10-fold higher##3##2##(2008-10#2)(2008-11#1)
10-fold in##2##2##(1995-6#1)(1996-3#1)
10-fold increase in the##2##4##(1992-3#1)(2008-11#1)
10-fold increase in##5##3##(1990-6#1)(1992-3#1)(2008-10#1)(2008-11#1)(2010-1#1)
10-fold more##2##2##(1995-8#2)
10-fold when##2##2##(2008-10#1)(2008-7#1)
10-fold##32##1##(1990-6#2)(1992-1#1)(1992-3#1)(1992-6#1)(1995-11#1)(1995-6#1)(1995-8#4)(1996-3#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#2)(2010-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
10-item##3##1##(2008-11#1)(2008-12#1)(2008-9#1)
10-mer primers##2##2##(2008-10#1)(2008-8#1)
10-mer##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
10-min##2##1##(1994-2#1)(2008-10#1)
10-month##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
10-phenanthrolinate) on##2##2##(2008-10#2)
10-phenanthrolinate)##3##1##(2008-10#3)
10-phenanthroline (phen)##5##2##(2008-10#5)
10-phenanthroline and##4##2##(2008-10#4)
10-phenanthroline as complexing agent##2##4##(2008-10#2)
10-phenanthroline as##6##2##(2008-10#6)
10-phenanthroline complex##3##2##(2008-10#3)
10-phenanthroline sub-unit##2##2##(2008-10#2)
10-phenanthroline##41##1##(2008-10#41)
10-phenanthroline)##2##1##(2008-10#1)(2013-1#1)
10-phenantroline##2##1##(2008-10#2)
10-s##2##1##(2008-10#2)
10-second##3##1##(1995-6#1)(2008-11#1)(2010-8#1)
10-week##3##1##(2012-3#1)(2013-1#2)
10-year actuarial##2##2##(1991-8#2)
10-year period##8##2##(1991-8#1)(1992-2#1)(1993-2#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-7#1)
10-year results##2##2##(1993-11#1)(2009-5#1)
10-year survivorship##2##2##(2013-1#2)
10-year##29##1##(1991-2#2)(1991-8#3)(1992-2#1)(1993-11#1)(1993-2#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2008-10#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#5)
10/11##2##1##(1991-2#1)(2012-3#1)
100 +/- 1##2##3##(2008-10#2)
100 +/-##3##2##(1991-6#1)(2008-10#2)
100 000 and##2##3##(2008-10#1)(2008-5#1)
100 000##5##2##(1996-2#1)(2008-10#3)(2008-5#1)
100 E coli/100 mL##2##4##(2008-10#2)
100 Hz EA##4##3##(1996-12#4)
100 Hz##5##2##(1996-12#4)(2010-1#1)
100 M##2##2##(2008-10#1)(2011-3#1)
100 MPa for 20 min##2##5##(2008-11#2)
100 RP-18##2##2##(2008-10#1)(2008-5#1)
100 U##2##2##(1996-2#1)(2008-11#1)
100 and 200##4##3##(2008-10#2)(2012-2#2)
100 and##17##2##(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#11)(2011-2#1)(2012-2#2)
100 cells##2##2##(2008-10#2)
100 chlamydospores per##2##3##(2008-10#2)
100 codons##2##2##(1996-3#1)(1996-6#1)
100 consecutive##4##2##(1990-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
100 days##2##2##(2008-11#1)(2008-7#1)
100 degrees C##8##3##(1997-2#1)(1997-8#1)(2008-10#4)(2008-5#1)(2013-8#1)
100 degrees##10##2##(1997-2#1)(1997-8#1)(2008-10#5)(2008-5#1)(2009-3#1)(2013-8#1)
100 different##2##2##(2008-9#1)(2011-2#1)
100 g/L##2##2##(2008-7#2)
100 grams##2##2##(1993-11#1)(2008-10#1)
100 healthy##2##2##(2011-2#2)
100 in##2##2##(1992-2#1)(2008-10#1)
100 kDa and##2##3##(2008-10#2)
100 kDa##4##2##(2008-10#4)
100 l scale##2##3##(2008-11#2)
100 l##6##2##(2008-10#1)(2008-11#5)
100 lice##3##2##(1996-12#3)
100 m##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
100 m/s##2##2##(2009-7#2)
100 mM ethanol##2##3##(1992-7#2)
100 mM##6##2##(1992-7#2)(2008-10#3)(2008-7#1)
100 mV##5##2##(2008-10#5)
100 mW of##2##3##(2007-11#1)(2008-3#1)
100 mg M/kg or##2##4##(2008-5#2)
100 mg M/kg##3##3##(2008-5#3)
100 mg kg(-1)##2##3##(2008-12#2)
100 mg l(-1)##5##3##(2008-10#5)
100 mg of##7##3##(1994-5#1)(2008-10#4)(2010-7#1)(2011-2#1)
100 mg##20##2##(1994-5#1)(2008-10#11)(2008-12#2)(2008-5#3)(2010-7#1)(2011-2#2)
100 mg/kg##4##2##(1991-3#1)(1992-3#1)(2008-10#1)(2008-11#1)
100 mg/kg)##2##2##(2011-2#2)
100 microM##9##2##(1990-12#1)(1990-8#2)(1995-11#2)(1995-12#1)(1996-2#1)(2008-10#1)(2009-6#1)
100 microM)##7##2##(1991-5#1)(1992-8#1)(1995-12#3)(1997-4#1)(2008-12#1)
100 microg##2##2##(2008-10#2)
100 micrograms##3##2##(1990-6#1)(1991-12#1)(1992-3#1)
100 micromol L(-1)##2##3##(2008-10#1)(2011-3#1)
100 ml min(-1)##3##3##(2008-10#2)(2010-4#1)
100 ml of##4##3##(2008-10#4)
100 ml##14##2##(1993-2#1)(2008-10#11)(2008-11#1)(2010-4#1)
100 mmHg##2##2##(2008-7#1)(2008-8#1)
100 molecules of##2##3##(2008-10#1)(2008-9#1)
100 muM of##2##3##(2008-10#1)(2008-7#1)
100 muM##5##2##(2008-10#2)(2008-11#1)(2008-7#2)
100 mug l(-1)##11##3##(2008-10#11)
100 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
100 mug of##3##3##(2008-10#3)
100 mug##20##2##(2008-10#19)(2008-11#1)
100 mul of sample##2##4##(2008-10#2)
100 mul of##7##3##(2008-10#7)
100 mul##14##2##(2008-10#14)
100 mum PDMS##3##3##(2008-10#3)
100 mum pore##2##3##(2008-11#2)
100 mum##7##2##(2008-10#4)(2008-11#2)(2008-3#1)
100 nM of##2##3##(2008-11#1)(2008-5#1)
100 nM##12##2##(1994-11#1)(1994-5#1)(1994-8#3)(1995-2#3)(1997-4#1)(2008-11#2)(2008-5#1)
100 ng ml(-1) of##2##4##(2008-10#2)
100 ng ml(-1)##10##3##(2008-10#10)
100 ng##11##2##(2008-10#11)
100 ng/ml##5##2##(1995-6#2)(2008-10#1)(2008-12#1)(2010-3#1)
100 ng/ml)##4##2##(1990-12#1)(2008-6#2)(2010-5#1)
100 nm##2##2##(1997-3#1)(2008-10#1)
100 nmol/L##2##2##(2008-8#2)
100 or##4##2##(2008-10#4)
100 patients##13##2##(1991-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#5)
100 percent juice exposure##2##4##(2012-2#2)
100 percent juice##3##3##(2012-2#3)
100 percent##4##2##(1993-3#1)(2012-2#3)
100 pg of##2##3##(2008-10#2)
100 pg##3##2##(2008-10#2)(2011-3#1)
100 ppm##4##2##(2008-10#3)(2008-5#1)
100 ps##2##2##(2008-2#1)(2008-8#1)
100 s##6##2##(2008-10#5)(2008-3#1)
100 samples##2##2##(2008-10#2)
100 species were##2##3##(2008-8#2)
100 subjects##2##2##(1990-6#1)(2008-5#1)
100 times excess of##2##4##(2008-10#2)
100 times more sensitive than##2##5##(2008-10#2)
100 times##11##2##(2008-10#10)(2008-11#1)
100 to 10##2##3##(2008-10#1)(2013-8#1)
100 to##17##2##(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-1#1)(2013-8#1)
100 trials##2##2##(2008-11#1)(2013-8#1)
100 was achieved##2##3##(2008-10#2)
100 was##3##2##(2008-10#3)
100 years ago##2##3##(2008-11#1)(2008-8#1)
100 years of age##2##4##(2008-7#1)(2012-12#1)
100 years##11##2##(1993-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-12#1)
100 °C##4##2##(2010-12#1)(2011-2#3)
100 µg/mL##3##2##(2011-1#3)
100##611##1##(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-6#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-7#2)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#4)(1995-11#4)(1995-12#7)(1995-2#6)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#9)(1996-2#5)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#275)(2008-11#40)(2008-12#9)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#16)(2008-6#2)(2008-7#16)(2008-8#14)(2008-9#10)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#6)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#27)(2011-3#4)(2012-12#2)(2012-2#12)(2012-3#1)(2013-1#10)(2013-8#9)
100% 5-FU##2##2##(1993-8#2)
100% RH but not##2##4##(2008-10#2)
100% RH but##3##3##(2008-10#3)
100% RH##4##2##(1996-12#1)(2008-10#3)
100% and##7##2##(1996-12#1)(2008-10#2)(2008-12#1)(2009-8#1)(2010-6#1)(2011-2#1)
100% at##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
100% by##2##2##(2008-10#1)(2008-2#1)
100% for all##2##3##(2008-10#1)(2008-5#1)
100% for##13##2##(2008-10#9)(2008-5#1)(2011-2#1)(2013-1#2)
100% higher than that##2##4##(2008-11#2)
100% higher##3##2##(1992-8#1)(2008-11#2)
100% homology with##2##3##(1990-11#1)(2011-2#1)
100% homology##3##2##(1990-11#1)(2008-10#1)(2011-2#1)
100% identical to##3##3##(1993-2#1)(1995-9#2)
100% identical##4##2##(1993-2#1)(1995-9#2)(2008-10#1)
100% in the##3##3##(1990-2#1)(1994-12#1)(2012-12#1)
100% in##10##2##(1990-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#3)(2011-2#1)(2012-12#1)
100% of patients with##2##4##(1990-3#1)(1996-1#1)
100% of the##4##3##(1993-8#1)(2008-10#2)(2011-2#1)
100% of##21##2##(1990-3#1)(1991-2#1)(1993-8#1)(1995-12#1)(1995-5#1)(1996-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
100% oxygen##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
100% protection##2##2##(2013-1#2)
100% relative humidity and##3##4##(2008-10#3)
100% relative humidity##6##3##(2008-10#6)
100% relative##7##2##(2008-10#7)
100% specificity##3##2##(2009-8#1)(2010-8#1)(2011-2#1)
100% water mobile phase##5##4##(2008-10#5)
100% water##6##2##(2008-10#6)
100% were observed##2##3##(1990-8#1)(2008-10#1)
100% were obtained##2##3##(2008-10#2)
100% were##5##2##(1990-8#1)(2008-10#4)
100% with##4##2##(2008-10#3)(2008-9#1)
100%##209##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-8#3)(1994-11#1)(1994-12#3)(1994-2#1)(1995-12#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#107)(2008-11#9)(2008-12#4)(2008-2#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-8#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#11)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#1)
100%) and##2##2##(2008-10#1)(2011-2#1)
100%)##13##1##(1996-12#1)(2008-10#9)(2010-6#1)(2011-2#2)
100)##8##1##(1991-2#1)(1993-11#1)(1997-1#1)(2008-10#4)(2010-8#1)
100+/-1##3##1##(2008-10#3)
100-##2##1##(1994-8#1)(2008-10#1)
100-1000 times of excess of Fe(III)##2##6##(2008-10#2)
100-1000##5##1##(1992-12#1)(1996-12#1)(2008-10#3)
100-110%##2##1##(2008-10#1)(2013-1#1)
100-150##3##1##(1990-9#1)(1997-3#1)(2013-1#1)
100-200##5##1##(1996-11#1)(2008-10#4)
100-2000##2##1##(2008-10#2)
100-fold higher than##2##3##(1992-6#1)(2008-10#1)
100-fold more##3##2##(1994-5#1)(2008-11#2)
100-fold##22##1##(1992-6#1)(1994-5#1)(1995-6#1)(1996-2#2)(2008-10#10)(2008-11#5)(2008-5#1)(2008-9#1)
100-kb##2##1##(2008-10#2)
100-mW##2##1##(2007-11#1)(2008-3#1)
1000 PST##2##2##(2008-10#2)
1000 and##7##2##(2008-10#6)(2008-7#1)
1000 g or##2##3##(1991-6#1)(2008-11#1)
1000 h##4##2##(1990-3#2)(2008-10#1)(2008-11#1)
1000 m##5##2##(1996-12#4)(2008-3#1)
1000 mg##2##2##(2008-10#2)
1000 ml##5##2##(2008-10#5)
1000 mug##3##2##(2008-10#3)
1000 mul##2##2##(2008-10#2)
1000 ppm##3##2##(1995-11#1)(2008-10#2)
1000 times more##2##3##(1997-5#1)(2008-10#1)
1000 times##4##2##(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
1000 to 1400##2##3##(2008-10#2)
1000 to##3##2##(2008-10#3)
1000 unrelated individuals from the Lodz region of Poland##2##9##(2008-12#2)
1000##89##1##(1990-3#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#4)(1997-2#1)(1997-5#3)(1997-8#1)(2007-12#1)(2008-10#37)(2008-11#8)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#3)(2009-11#2)(2010-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
1000)##5##1##(1997-2#3)(2008-10#1)(2008-11#1)
1000-2000##2##1##(2008-10#1)(2008-3#1)
1000-fold##7##1##(1995-2#1)(1996-12#1)(2008-10#4)(2008-8#1)
10000##2##1##(2008-10#1)(2011-3#1)
1000 µg/L##3##1##(2013-1#3)
1002/tcr##2##1##(2011-2#2)
1008##2##1##(1993-12#1)(2008-11#1)
100mL##2##1##(2008-10#2)
100mM##4##1##(2008-10#3)(2011-2#1)
100mg of##4##2##(2008-10#3)(2011-2#1)
100ml of##2##2##(2008-10#2)
100ml##3##1##(2008-10#3)
100ms##2##1##(2008-10#2)
100mug/L##2##1##(2008-10#2)
100mugL(-1)##2##1##(2008-10#2)
100mugl(-1)##3##1##(2008-10#3)
100mugml(-1)##2##1##(2008-10#2)
100mul##3##1##(2008-10#3)
101 patients##2##2##(1992-1#1)(2008-7#1)
101##45##1##(1990-9#1)(1992-1#1)(1992-11#1)(1992-8#1)(1997-3#1)(2008-10#28)(2008-12#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
101% for##3##2##(2008-10#3)
101%##10##1##(2008-10#10)
101-109##2##1##(2006-6#2)
1012##2##1##(2008-1#1)(2013-8#1)
1015##3##1##(2008-11#2)(2008-3#1)
1016/j##6##1##(2008-11#5)(2012-3#1)
101F6 protein##4##2##(2009-9#4)
101F6##5##1##(2009-9#5)
102 strains##2##2##(2008-10#2)
102##31##1##(1990-6#1)(1994-11#2)(1996-12#1)(1997-8#2)(2008-10#21)(2008-9#1)(2011-2#1)(2013-1#2)
102%##9##1##(2008-10#9)
103 cases##2##2##(1991-8#1)(2008-5#1)
103##28##1##(1991-8#2)(1992-11#1)(1995-11#1)(1996-1#1)(1996-12#2)(1997-7#1)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)
103% for##6##2##(2008-10#6)
103%##15##1##(2008-10#15)
104 participants##2##2##(1997-3#1)(2008-8#1)
104 patients##2##2##(2011-2#1)(2012-3#1)
104##29##1##(1991-1#1)(1991-6#1)(1993-8#1)(1994-2#1)(1997-3#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#3)
104% were obtained##2##3##(2008-10#2)
104%##10##1##(2008-10#10)
1047-1051##2##1##(2008-11#1)(2008-3#1)
1047-nm##2##1##(2008-3#2)
105 A-group isolates##2##3##(2008-10#2)
105 and##3##2##(1995-12#1)(2008-10#2)
105 cases##2##2##(1991-8#1)(2013-1#1)
105 kDa##2##2##(1995-12#1)(2008-10#1)
105##48##1##(1990-11#1)(1990-2#2)(1991-8#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-12#1)(1997-3#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#3)(2013-8#1)
105%##12##1##(2008-10#11)(2008-7#1)
1050##2##1##(1994-11#1)(2008-2#1)
1054##2##1##(1994-11#1)(2011-3#1)
1059##4##1##(1994-11#1)(1995-2#1)(2008-10#2)
106 isolates of##2##3##(2008-10#2)
106 patients##3##2##(1997-8#1)(2011-2#1)(2012-3#1)
106##24##1##(1992-8#1)(1993-12#1)(1994-11#1)(1994-5#2)(1997-3#1)(1997-8#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-8#1)(2011-2#1)(2012-3#1)
106%##9##1##(2008-10#9)
1064 nm##7##2##(2008-10#3)(2008-2#2)(2008-3#2)
1064##8##1##(2008-10#3)(2008-2#3)(2008-3#2)
1064-nm##3##1##(2008-3#3)
10644##5##1##(2008-10#5)
1066##2##1##(2008-10#2)
107##20##1##(1991-3#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
107%##3##1##(2008-10#3)
108 mug##2##2##(2008-10#2)
108 patients##2##2##(2013-1#2)
108##28##1##(1990-6#1)(1991-5#1)(1994-8#2)(1995-2#2)(1996-12#1)(2008-10#14)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#3)
109##19##1##(1990-12#1)(1992-3#1)(1995-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
109%##4##1##(2008-10#4)
1093##2##1##(1994-3#1)(2008-10#1)
1098##2##1##(2008-10#1)(2008-11#1)
10L##2##1##(2008-11#2)
10V##3##1##(2008-10#1)(2013-1#2)
10]##2##1##(1991-2#1)(2008-11#1)
10a beta##2##2##(1990-11#2)
10a##3##1##(1990-11#2)(2008-10#1)
10cm of##2##2##(2008-10#2)
10cm##3##1##(2008-10#3)
10h(-1)##4##1##(2008-10#4)
10kDa##2##1##(2007-12#1)(2008-10#1)
10mL##3##1##(2008-10#3)
10mM phosphate##2##2##(2008-10#2)
10mM sodium##2##2##(2008-10#2)
10mM##12##1##(2008-10#11)(2011-2#1)
10mg##2##1##(2008-10#2)
10mg/l##2##1##(2008-10#2)
10mgl(-1)##3##1##(2008-10#3)
10min##21##1##(2008-10#21)
10ml##7##1##(2008-10#7)
10mmoll(-1)##2##1##(2008-10#2)
10muM##5##1##(2008-10#5)
10mug##2##1##(2008-10#2)
10mugL(-1)##2##1##(2008-10#2)
10mugl(-1) of##2##2##(2008-10#2)
10mugl(-1)##6##1##(2008-10#6)
10mugml(-1)##6##1##(2008-10#6)
10mul of##3##2##(2008-10#3)
10mul##7##1##(2008-10#7)
10mumol/L##2##1##(2008-10#2)
10nM##4##1##(2008-10#4)
10ngml(-1)##6##1##(2008-10#6)
10pM##2##1##(1992-8#1)(2008-10#1)
10ppb##3##1##(2008-10#3)
10ppm##3##1##(2008-10#3)
10s and##2##2##(2008-10#2)
10s##8##1##(2008-10#7)(2008-11#1)
10s)##3##1##(2008-10#3)
10th day##2##2##(2008-5#1)(2012-3#1)
10th##10##1##(1991-11#1)(1991-2#1)(1995-3#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
10°C##6##1##(2011-2#6)
10 min##2##1##(2011-1#1)(2013-1#1)
11 (73##2##2##(2013-7#2)
11 (9##2##2##(2011-2#2)
11 May 2007]##2##3##(2009-5#2)
11 and 12##2##3##(1996-12#1)(1996-5#1)
11 and a##2##3##(2008-10#1)(2008-12#1)
11 and##22##2##(1994-12#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#10)(2008-12#3)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
11 beta-hydroxylation##3##2##(1990-11#3)
11 beta-hydroxysteroid dehydrogenase##2##3##(1990-11#2)
11 by##3##2##(1996-3#1)(2008-10#2)
11 cDNA library by hybridization to mouse transferase cDNA clone##2##10##(2008-11#2)
11 cDNA library##3##3##(2008-11#2)(2008-8#1)
11 cases##6##2##(1990-5#1)(1990-8#1)(1992-12#1)(1995-5#1)(2007-8#1)(2011-2#1)
11 children##3##2##(1991-6#1)(2008-12#1)(2010-9#1)
11 clones##2##2##(2008-10#1)(2008-9#1)
11 cm##2##2##(2008-9#1)(2013-7#1)
11 consecutive##2##2##(2008-10#1)(2012-2#1)
11 days##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
11 degrees C##5##3##(2008-10#3)(2008-12#2)
11 degrees##6##2##(2008-10#4)(2008-12#2)
11 different##2##2##(2008-10#2)
11 female##2##2##(1997-8#1)(2013-8#1)
11 groups##2##2##(2008-10#2)
11 in##2##2##(1992-6#1)(2008-10#1)
11 isolates of##2##3##(2008-10#2)
11 isolates##5##2##(2008-10#5)
11 kb of##2##3##(1997-7#1)(2008-10#1)
11 kb##4##2##(1996-3#1)(1996-8#1)(1997-7#1)(2008-10#1)
11 months after##2##3##(2008-10#1)(2008-9#1)
11 months##8##2##(1990-9#1)(1991-6#1)(1993-11#1)(2008-10#3)(2008-11#1)(2008-9#1)
11 new##2##2##(2008-10#1)(2008-9#1)
11 of the##3##3##(1997-5#1)(2008-1#1)(2008-7#1)
11 of##11##2##(1994-8#1)(1996-12#2)(1997-5#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#2)
11 out of##2##3##(2008-10#1)(2009-8#1)
11 patient with##2##3##(2012-3#2)
11 patient##3##2##(2012-3#3)
11 patients (55%)##2##3##(1996-9#2)
11 patients with##4##3##(1990-6#1)(1996-9#1)(1997-7#1)(2008-7#1)
11 patients##21##2##(1990-6#2)(1991-11#1)(1991-3#1)(1992-5#1)(1996-9#4)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#1)
11 potato differentials##2##3##(2008-10#2)
11 potato##3##2##(2008-10#3)
11 red flag items##2##4##(2008-12#2)
11 replicate determinations of##4##4##(2008-10#4)
11 replicate measurements##2##3##(2008-10#2)
11 replicate##8##2##(2008-10#8)
11 samples containing##2##3##(2008-10#2)
11 samples##3##2##(2008-10#3)
11 sites##2##2##(2008-10#1)(2008-9#1)
11 species of##3##3##(1995-8#1)(2008-10#1)(2010-4#1)
11 subjects##2##2##(1996-8#1)(2013-1#1)
11 times##2##2##(2008-10#1)(2013-1#1)
11 to 13##2##3##(2008-10#1)(2012-3#1)
11 to 15##2##3##(2008-9#1)(2013-1#1)
11 to##12##2##(1992-3#1)(1995-2#1)(1996-12#1)(2008-10#4)(2008-9#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
11 weeks of##2##3##(1992-8#1)(1995-8#1)
11 weeks##5##2##(1991-2#1)(1992-8#1)(1995-8#1)(2008-10#2)
11 x##2##2##(2008-10#2)
11 years##7##2##(1996-12#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
11##547##1##(1990-11#10)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#3)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#1)(1993-8#3)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#5)(1995-8#6)(1995-9#2)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#3)(1996-5#6)(1996-6#3)(1996-8#2)(1996-9#4)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#196)(2008-11#19)(2008-12#18)(2008-3#9)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#9)(2008-9#15)(2009-10#3)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#3)(2010-12#2)(2010-3#3)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#25)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#20)(2013-1#20)(2013-7#3)(2013-8#7)
11% and##2##2##(2011-2#1)(2011-3#1)
11% for##4##2##(2007-12#2)(2008-10#1)(2008-2#1)
11% of the##3##3##(1991-3#1)(2008-10#2)
11% of##7##2##(1990-12#1)(1990-6#1)(1991-3#1)(2008-1#1)(2008-10#3)
11%##36##1##(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1992-11#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-12#3)(2008-2#2)(2008-6#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
11%)##4##1##(1996-11#1)(2008-10#1)(2011-2#2)
11) =##2##2##(2013-8#2)
11) and##4##2##(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)
11) at##2##2##(1991-11#1)(2010-3#1)
11) have##2##2##(1996-3#1)(2012-3#1)
11) of##2##2##(2008-10#1)(2008-8#1)
11) were##3##2##(2008-10#1)(2010-1#1)(2010-8#1)
11)##26##1##(1990-5#1)(1991-11#1)(1991-2#1)(1993-3#1)(1995-5#3)(1996-3#2)(1997-2#1)(2008-10#4)(2008-11#3)(2008-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
11+/-0##2##1##(2008-10#2)
11-0##3##1##(2008-10#2)(2008-5#1)
11-12##3##1##(2008-10#2)(2008-5#1)
11-13##2##1##(2008-3#1)(2012-2#1)
11-14 weeks of gestation##2##4##(2008-11#2)
11-14##5##1##(2008-11#2)(2009-7#1)(2010-10#1)(2010-3#1)
11-15##2##1##(1995-6#1)(2008-7#1)
11-18##2##1##(2008-10#1)(2009-7#1)
11-KT##2##1##(2010-8#2)
11-deoxycorticosterone##2##1##(1990-5#1)(2008-4#1)
11-diene##2##1##(2008-10#2)
11-hydroxynaphthacene-5##2##1##(2008-10#2)
11-mm/h##2##1##(2008-10#2)
11-point##2##1##(2008-12#1)(2012-2#1)
11-year-old boy##6##2##(2008-10#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
11-year-old##10##1##(2008-10#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
11/12##2##1##(1990-8#1)(1996-2#1)
110 and##2##2##(1995-12#1)(2008-10#1)
110 days##3##2##(1992-12#1)(2008-10#2)
110 isolates##3##2##(2008-10#3)
110 kDa##3##2##(1990-11#1)(1995-12#1)(1995-6#1)
110 mg##2##2##(2008-10#1)(2008-11#1)
110 microM and##2##3##(1992-3#1)(1995-8#1)
110 min##2##2##(1993-1#1)(2013-8#1)
110##44##1##(1990-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2010-1#1)(2011-2#1)(2011-3#1)(2013-1#3)(2013-8#1)
110-kDa protein##2##2##(1993-12#2)
110-kDa##3##1##(1993-12#2)(1995-6#1)
1100 and##2##2##(2008-10#2)
1100 degrees C##5##3##(2008-10#3)(2010-4#2)
1100##10##1##(2008-10#5)(2008-11#3)(2010-4#2)
1100-kb chromosome##2##2##(1996-6#2)
1100-kb##3##1##(1996-6#3)
111##12##1##(1990-2#1)(1997-2#1)(2008-10#6)(2008-12#1)(2010-8#1)(2013-1#2)
111%##2##1##(2008-10#2)
11195##3##1##(2012-2#3)
112 mug/ml##3##2##(2008-10#3)
112 of which##2##3##(2008-10#2)
112 participants##2##2##(2008-11#1)(2012-12#1)
112 patients##2##2##(1990-3#1)(2011-2#1)
112##28##1##(1990-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#16)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#1)
112% for##2##2##(2008-10#2)
112%##5##1##(1993-3#1)(2008-10#4)
113##15##1##(1992-3#1)(1993-12#1)(1995-12#1)(1996-12#2)(2007-12#1)(2008-10#5)(2008-7#2)(2010-8#1)(2013-1#1)
114 strains##2##2##(2008-10#2)
114##11##1##(1992-5#2)(1994-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#4)(2012-2#1)
114)##2##1##(2008-5#1)(2009-7#1)
115 kDa##3##2##(1990-11#1)(1994-11#1)(1996-3#1)
115 patients with##3##3##(1996-1#1)(2008-7#1)(2013-1#1)
115##21##1##(1990-11#2)(1991-1#1)(1994-11#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-3#1)(2008-10#5)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
115%##2##1##(2008-10#1)(2013-8#1)
116 isolates##2##2##(2008-10#2)
116##14##1##(1990-12#1)(1996-3#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
117##18##1##(1993-2#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2012-3#1)
117)##3##1##(2008-11#1)(2012-3#2)
118 IPMNs##2##2##(2012-2#2)
118##19##1##(1993-8#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-4#1)(2010-8#2)(2012-2#2)(2012-3#1)
118)##2##1##(1993-8#1)(2009-4#1)
1188##2##1##(2008-9#1)(2013-1#1)
119##22##1##(1992-5#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-6#2)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-8#2)
11a beta##2##2##(1990-11#2)
11alpha-hydroxyprogesterone##2##1##(2008-10#2)
11b##2##1##(1990-11#2)
11beta##2##1##(2008-11#2)
11beta-hydroxylase##2##1##(1995-8#1)(2008-4#1)
11q13##4##1##(1997-7#1)(1997-8#3)
11q22##2##1##(1995-6#2)
11th##2##1##(2008-11#1)(2010-3#1)
12 +/- 0##2##3##(1993-1#1)(2009-8#1)
12 +/-##3##2##(1993-1#1)(1994-8#1)(2009-8#1)
12 A##2##2##(1992-4#1)(2008-3#1)
12 PAHs##2##2##(2008-10#2)
12 alleles##2##2##(2008-10#1)(2008-9#1)
12 and 1##2##3##(1993-12#1)(2008-10#1)
12 and 18 months of##2##5##(1990-2#1)(1993-12#1)
12 and 18 months##3##4##(1990-2#1)(1993-1#1)(1993-12#1)
12 and 36 h after##2##5##(1996-12#1)(2008-10#1)
12 and the##2##3##(2008-8#1)(2010-12#1)
12 and##29##2##(1990-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1995-12#2)(1996-12#2)(1996-5#2)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
12 bacterial##2##2##(2008-10#1)(2008-7#1)
12 cases of##3##3##(1990-6#1)(1991-6#1)(2008-5#1)
12 cases##7##2##(1990-6#1)(1991-6#2)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
12 chromosomes##2##2##(2009-10#1)(2011-3#1)
12 compared with##2##3##(2008-10#1)(2013-1#1)
12 cultivars##3##2##(2008-10#3)
12 days after##4##3##(1992-1#1)(1996-12#1)(2008-10#2)
12 days##12##2##(1992-1#1)(1996-12#1)(1997-3#2)(2008-10#4)(2008-11#4)
12 days)##2##2##(2008-7#1)(2011-2#1)
12 degrees C##4##3##(2008-10#4)
12 degrees##6##2##(2008-10#5)(2008-3#1)
12 different##3##2##(2008-10#2)(2009-3#1)
12 elements##2##2##(2008-10#2)
12 for##2##2##(1992-12#1)(2013-1#1)
12 genes##3##2##(2009-10#2)(2011-2#1)
12 h after##6##3##(1993-8#1)(2008-10#4)(2008-7#1)
12 h##28##2##(1991-9#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-6#1)(2012-2#1)
12 h)##2##2##(2008-10#2)
12 hours of##2##3##(1994-11#1)(2008-3#1)
12 hours##10##2##(1990-12#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(2008-3#1)(2009-11#1)(2010-2#1)(2010-7#1)
12 hr##5##2##(2008-11#1)(2008-5#1)(2008-6#3)
12 in##2##2##(2008-10#1)(2011-2#1)
12 mM glutamate##2##3##(2008-11#2)
12 major##2##2##(2008-10#2)
12 mg l(-1)##5##3##(2008-10#5)
12 mg##6##2##(2008-10#6)
12 million##2##2##(1997-2#1)(2008-10#1)
12 min in##3##3##(2008-10#3)
12 min##8##2##(1993-2#1)(2008-10#7)
12 months after##9##3##(1996-11#1)(1997-1#1)(1997-6#1)(2008-10#1)(2009-10#2)(2009-8#1)(2011-1#1)(2013-1#1)
12 months and##2##3##(2011-2#2)
12 months following##2##3##(2008-12#1)(2011-2#1)
12 months in##3##3##(1990-6#1)(1994-8#1)(2008-10#1)
12 months of follow-up##2##4##(2013-1#2)
12 months of##4##3##(1990-2#1)(1995-1#1)(2013-1#2)
12 months was##2##3##(2009-5#1)(2010-10#1)
12 months were##2##3##(1994-12#1)(2009-5#1)
12 months##70##2##(1990-2#1)(1990-6#1)(1991-2#1)(1993-1#1)(1993-12#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-10#3)(2009-5#5)(2009-8#1)(2010-1#3)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#9)
12 months)##3##2##(2009-5#3)
12 mug l(-1)##5##3##(2008-10#5)
12 mug##6##2##(2008-10#5)(2008-11#1)
12 new##4##2##(1996-3#1)(2009-10#1)(2011-2#1)(2012-3#1)
12 of the##3##3##(1992-12#1)(1993-2#1)(1997-8#1)
12 of which##2##3##(1997-2#1)(2008-10#1)
12 of whom##2##3##(1991-6#1)(1995-11#1)
12 of##13##2##(1991-5#1)(1991-6#1)(1992-12#1)(1993-2#1)(1995-11#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2012-3#1)
12 on##2##2##(2008-10#2)
12 or 24##2##3##(1996-12#1)(2008-5#1)
12 or##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
12 patients had##2##3##(1997-3#1)(2011-2#1)
12 patients the##2##3##(1996-3#1)(2013-1#1)
12 patients##20##2##(1990-2#1)(1991-11#1)(1992-9#1)(1993-2#1)(1994-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#2)(1997-8#1)(2008-10#1)(2008-7#1)(2011-2#3)(2011-3#1)(2012-5#1)(2013-1#2)
12 phosphomolybdic##2##2##(2008-10#2)
12 rice##2##2##(2008-10#1)(2008-9#1)
12 samples per hour##2##4##(2008-10#2)
12 samples##6##2##(2008-10#6)
12 segments of##2##3##(2008-10#2)
12 subjects##2##2##(2013-8#2)
12 times##5##2##(1990-8#1)(1991-9#1)(2008-1#1)(2008-10#1)(2008-2#1)
12 to 24 h##4##4##(2008-10#4)
12 to 24##7##3##(2008-10#6)(2008-11#1)
12 to 25##4##3##(1993-8#1)(1997-5#1)(2008-10#2)
12 to##33##2##(1993-8#1)(1997-5#1)(1997-8#1)(2008-10#23)(2008-11#2)(2008-4#1)(2009-12#1)(2009-7#1)(2011-2#2)
12 was##2##2##(1996-5#1)(2008-10#1)
12 weeks after the##2##4##(2008-7#1)(2009-7#1)
12 weeks after##5##3##(2008-10#2)(2008-7#1)(2009-11#1)(2009-7#1)
12 weeks of##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
12 weeks##26##2##(1991-2#1)(1992-12#1)(1997-5#1)(2008-1#2)(2008-10#12)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2012-3#1)(2013-1#3)
12 were##5##2##(1996-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-3#1)
12 with##3##2##(1993-8#1)(1995-3#1)(1996-5#1)
12 years##15##2##(1991-2#1)(1993-3#2)(1994-6#1)(1997-3#1)(1997-5#2)(2008-10#2)(2009-10#1)(2010-12#1)(2010-6#3)(2011-2#1)
12##818##1##(1990-12#2)(1990-2#6)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#3)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#6)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#6)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#5)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#4)(1993-6#2)(1993-8#6)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#4)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-12#13)(1996-2#1)(1996-3#6)(1996-5#6)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#7)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#297)(2008-11#43)(2008-12#13)(2008-2#5)(2008-3#11)(2008-4#3)(2008-5#24)(2008-6#3)(2008-7#19)(2008-8#7)(2008-9#13)(2009-1#1)(2009-10#9)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#9)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#33)(2011-3#5)(2012-12#4)(2012-2#12)(2012-3#21)(2012-4#1)(2012-5#1)(2013-1#36)(2013-8#9)
12% and##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
12% at##2##2##(2008-10#1)(2011-2#1)
12% for##4##2##(2008-10#4)
12% in##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
12% of the##4##3##(1991-9#1)(2008-8#1)(2012-3#1)(2013-8#1)
12% of##7##2##(1991-9#1)(1996-1#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
12% to##2##2##(2008-5#1)(2008-8#1)
12%##42##1##(1991-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#2)(1997-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
12%)##2##1##(1990-3#1)(2011-2#1)
12(4)##2##1##(2008-11#2)
12(R)-HETE##2##1##(1992-8#2)
12) and##2##2##(1994-11#1)(2008-10#1)
12) or##2##2##(1994-5#1)(2008-11#1)
12) was##2##2##(1991-5#1)(2013-1#1)
12) were##2##2##(1994-2#1)(2008-10#1)
12)##35##1##(1991-11#1)(1991-5#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#2)(1997-2#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-8#1)(2010-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
12+/-0##3##1##(2008-10#3)
12- and##2##2##(2008-10#1)(2008-4#1)
12-##6##1##(1994-11#1)(2008-10#3)(2008-4#1)(2008-6#1)
12-13##3##1##(2008-10#3)
12-14 years old##2##3##(2011-2#1)(2012-3#1)
12-14 years##3##2##(2011-2#2)(2012-3#1)
12-14##5##1##(2008-12#1)(2011-2#3)(2012-3#1)
12-15##4##1##(1993-8#1)(1994-12#1)(2008-11#1)(2008-12#1)
12-16##3##1##(1995-5#1)(2008-5#1)(2011-2#1)
12-2##2##1##(2010-4#1)(2011-2#1)
12-24 h##2##2##(1996-12#1)(2011-2#1)
12-O-tetradecanoyl##2##1##(1994-6#1)(1995-8#1)
12-O-tetradecanoyl-phorbol-13-acetate##3##1##(1993-3#1)(1993-8#1)(1995-6#1)
12-O-tetradecanoylphorbol 13-acetate (TPA)##2##3##(1994-11#1)(1996-12#1)
12-O-tetradecanoylphorbol-13-acetate (TPA)##2##2##(1997-1#1)(2008-9#1)
12-O-tetradecanoylphorbol-13-acetate##6##1##(1992-8#3)(1995-12#1)(1997-1#1)(2008-9#1)
12-dibenzo-18-crown-6##2##1##(2008-10#2)
12-fold more##2##2##(2008-11#2)
12-fold##4##1##(1996-12#1)(2008-10#1)(2008-11#2)
12-h periods of##2##3##(2008-10#2)
12-h##9##1##(1994-8#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2013-1#1)
12-hydroxy 5##2##2##(1994-8#2)
12-lead ECG##2##2##(2009-10#1)(2009-4#1)
12-lead##3##1##(2009-10#1)(2009-4#1)(2010-1#1)
12-lipoxygenase##7##1##(1992-8#1)(1994-11#5)(1994-8#1)
12-mo-old##3##1##(2008-8#3)
12-month follow-up##2##2##(2009-1#1)(2013-1#1)
12-month##8##1##(1992-1#1)(1994-9#1)(2008-10#1)(2008-12#1)(2009-1#1)(2010-4#1)(2010-5#1)(2013-1#1)
12-month-old rats##2##2##(1995-8#1)(2009-8#1)
12-month-old##3##1##(1995-8#1)(2009-8#1)(2012-3#1)
12-quinone and flame atomic absorption spectrometry##2##6##(2008-10#2)
12-step activities##2##2##(2008-6#2)
12-step##7##1##(2008-6#7)
12-tetraaza cyclotetradeca-1##2##2##(2008-10#2)
12-tetradecadienyl acetate##2##2##(2008-10#2)
12-week##7##1##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2013-1#1)
12-year-old##5##1##(1994-6#1)(2008-10#1)(2008-11#2)(2008-7#1)
120 and 60##2##3##(2008-10#2)
120 and##6##2##(1991-5#1)(2008-10#3)(2008-11#1)(2008-3#1)
120 days after##2##3##(1995-11#1)(2013-1#1)
120 days##6##2##(1995-11#1)(2008-10#2)(2013-1#3)
120 degrees##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
120 for##2##2##(2008-10#2)
120 h##3##2##(2008-8#3)
120 h(-1)##2##2##(2008-10#2)
120 kb##2##2##(1993-12#1)(1997-7#1)
120 mg/kg/day of##2##3##(2011-2#2)
120 min##4##2##(1996-1#1)(2008-10#2)(2008-11#1)
120 minutes##2##2##(1996-6#1)(2008-1#1)
120 mmol##2##2##(2008-9#2)
120 s of##2##3##(2008-10#2)
120 s##20##2##(2008-10#20)
120 to##3##2##(2008-10#3)
120 were##2##2##(1995-2#1)(2008-10#1)
120##120##1##(1990-6#1)(1990-8#1)(1991-5#2)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#62)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
120%##7##1##(2008-10#7)
120) in the##2##3##(2008-10#1)(2009-8#1)
120)##6##1##(2008-10#1)(2008-12#1)(2009-10#1)(2009-8#1)(2012-3#1)(2013-8#1)
1200 J/cm(2)##2##2##(2008-7#2)
1200 mg##2##2##(1992-12#1)(2008-10#1)
1200##13##1##(1991-5#1)(1992-12#1)(1992-8#1)(1997-2#1)(2008-10#6)(2008-7#2)(2011-2#1)
120mV##2##1##(2008-10#2)
120s preconcentration time##2##3##(2008-10#2)
120s##6##1##(2008-10#6)
120°##2##1##(2012-3#2)
121 amino acids##2##3##(2008-10#2)
121##21##1##(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1996-2#1)(2008-10#9)(2008-12#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
122 patients##2##2##(2008-3#1)(2012-3#1)
122##15##1##(1990-2#1)(1996-6#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-3#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
122)##3##1##(2008-10#3)
123##25##1##(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
123-I MIBG imaging##5##3##(2012-2#5)
1231##2##1##(2012-3#2)
1233##2##1##(1996-12#1)(2008-11#1)
124 women##2##2##(2011-2#1)(2013-1#1)
124##19##1##(1990-12#1)(1990-8#2)(1991-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-3#1)
12449##4##1##(2008-10#4)
125 and##2##2##(2008-7#1)(2008-9#1)
125 degrees C##2##3##(2008-10#2)
125##31##1##(1990-5#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-1#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#4)(2010-8#1)(2011-2#3)(2013-8#1)
125)##2##1##(2008-9#1)(2011-3#1)
1250##2##1##(2008-10#1)(2008-2#1)
1254##4##1##(1993-8#2)(2008-10#2)
1258##2##1##(1990-8#1)(1994-11#1)
125I-##2##1##(1993-11#2)
125I-EGF##4##1##(1991-7#1)(1993-3#3)
125I-FGF##3##1##(1991-12#3)
125I-LDL##3##1##(1993-6#1)(1994-8#2)
125I-NGF was##2##2##(1991-12#2)
125I-[Y39] exendin-4##2##2##(1994-8#2)
125I-[Y39]exendin-4##3##1##(1994-8#3)
125I-acetylated LDL##2##2##(1993-8#2)
125I-bFGF into the##2##3##(1991-12#2)
125I-bFGF##5##1##(1991-12#5)
125I-insulin##4##1##(1996-3#1)(1997-1#3)
125IUdR in##2##2##(1993-11#2)
125IUdR##7##1##(1993-11#7)
126##17##1##(1990-12#1)(1991-6#1)(1993-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#4)(2009-8#1)(2011-2#1)(2012-5#2)
1262##2##1##(2008-10#1)(2008-7#1)
1266##2##1##(2008-10#2)
127##13##1##(1990-5#1)(1991-9#1)(1995-3#1)(1997-7#1)(2008-10#5)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
127)##5##1##(1992-9#1)(1995-12#1)(2009-4#1)(2010-10#2)
1279##2##1##(2011-2#2)
128 and 256 mg/kg##3##4##(2008-9#3)
128##25##1##(1991-2#2)(1993-1#1)(1993-12#1)(1993-6#1)(1995-11#1)(1996-6#2)(1997-8#1)(2008-10#6)(2008-7#1)(2008-9#7)(2011-2#2)
129 to##2##2##(2008-10#1)(2008-5#1)
129##14##1##(1991-12#1)(1994-9#1)(1995-11#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
129-Trp53tm1Brd (N5) haploinsufficient] mice##2##4##(2008-9#2)
1295-22##4##1##(2008-10#4)
12R/59T/116Y mutations##2##2##(1993-11#2)
12h##2##1##(2008-10#1)(2008-7#1)
12mM##2##1##(2008-10#2)
12mugl(-1)##5##1##(2008-10#5)
12th##11##1##(1991-3#1)(1992-8#2)(1994-6#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2013-1#1)(2013-8#1)
12 months##2##1##(2012-2#2)
13 +/-##5##2##(1991-6#1)(1994-8#1)(2008-10#1)(2010-6#1)(2012-3#1)
13 North American##2##3##(1991-12#1)(2008-10#1)
13 accessions##3##2##(2008-10#3)
13 amino acids##2##3##(2008-10#1)(2008-11#1)
13 and 17##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
13 and 4##2##3##(2008-10#1)(2008-12#1)
13 and##11##2##(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
13 cases##5##2##(1991-12#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-5#1)
13 days##4##2##(1990-11#1)(2008-10#2)(2008-7#1)
13 degrees C##3##3##(2008-10#3)
13 degrees##4##2##(2008-10#4)
13 different##2##2##(1994-5#1)(2012-2#1)
13 distinct##2##2##(2008-10#2)
13 female##2##2##(2011-2#1)(2012-3#1)
13 generations##2##2##(2008-9#1)(2012-3#1)
13 genes were##2##3##(1995-8#2)
13 genes##3##2##(1995-8#2)(2011-2#1)
13 isolates##2##2##(2008-10#2)
13 kb##2##2##(1991-6#1)(2008-10#1)
13 min##2##2##(2008-10#2)
13 mm##5##2##(1995-3#1)(1996-11#1)(2007-12#1)(2012-12#1)(2013-8#1)
13 months after##2##3##(2008-11#1)(2009-1#1)
13 months##8##2##(1991-6#1)(1992-5#1)(2008-10#2)(2008-11#2)(2009-1#1)(2012-3#1)
13 mug##3##2##(2008-10#3)
13 ng ml(-1)##2##3##(2008-10#2)
13 ng##3##2##(2008-10#3)
13 of##4##2##(1993-3#1)(2008-10#1)(2008-9#1)(2012-3#1)
13 or##2##2##(2008-10#2)
13 other##2##2##(2008-10#1)(2011-2#1)
13 out of the##2##4##(2008-10#1)(2010-8#1)
13 out of##5##3##(1990-11#1)(2008-10#2)(2010-8#1)(2011-1#1)
13 patients with##4##3##(1991-11#1)(1995-11#1)(2010-7#1)(2011-2#1)
13 patients##18##2##(1990-2#1)(1991-11#1)(1991-8#1)(1992-1#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#1)
13 populations##2##2##(2008-10#1)(2009-5#1)
13 s-1)##2##2##(1990-9#2)
13 studies##3##2##(1993-1#1)(2011-2#1)(2012-2#1)
13 to##9##2##(1991-6#1)(1993-1#1)(1993-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)
13 variable sites##2##3##(2008-10#2)
13 was##2##2##(1992-12#1)(2009-11#1)
13 were##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
13 with##2##2##(2008-7#1)(2012-3#1)
13 wpi##2##2##(2008-12#2)
13 years after##2##3##(1991-11#1)(2013-1#1)
13 years of##2##3##(2008-11#1)(2008-12#1)
13 years old##2##3##(2010-12#1)(2013-1#1)
13 years##14##2##(1991-11#1)(1995-10#1)(1996-12#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-12#3)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
13##386##1##(1990-11#3)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#4)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#3)(1992-5#3)(1992-6#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#5)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#124)(2008-11#20)(2008-12#12)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#9)(2008-8#4)(2008-9#11)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#4)(2010-12#5)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#22)(2012-12#4)(2012-2#5)(2012-3#12)(2012-5#2)(2013-1#9)(2013-8#2)
13% (v/v)##2##2##(2008-10#2)
13% for##3##2##(1990-6#1)(2008-10#2)
13% in##2##2##(2008-10#1)(2012-3#1)
13% of all##2##3##(2008-11#1)(2011-9#1)
13% of the##2##3##(2008-8#1)(2013-8#1)
13% of##8##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2011-9#1)(2013-8#1)
13% to##2##2##(2008-10#1)(2013-1#1)
13% were##2##2##(1991-9#1)(2008-10#1)
13%##36##1##(1990-12#1)(1990-6#1)(1991-9#1)(1996-12#1)(1997-3#2)(2008-10#19)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#2)(2011-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
13%)##3##1##(2008-10#1)(2008-5#2)
13)##17##1##(1991-2#1)(1994-12#1)(1996-2#1)(1997-2#1)(2008-10#5)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
13-1##2##1##(2008-10#1)(2012-12#1)
13-17##2##1##(2008-11#2)
13-2##2##1##(2011-2#1)(2013-1#1)
13-acetate (TPA)##3##2##(1994-11#1)(1994-6#1)(1996-12#1)
13-acetate##13##1##(1994-11#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-11#3)
13-diacetate##3##1##(1995-11#1)(1995-2#2)
13-fold##4##1##(2006-6#1)(2008-11#1)(2012-3#1)(2013-1#1)
13-month##2##1##(2008-8#2)
13-pentaoxa-16-azacyclooctadecane##2##1##(2008-10#2)
13-tetraoxa-7##7##1##(2008-10#7)
13-tetrathiacyclotetradec-1-oxy)hexanoic acid##2##2##(2008-10#2)
13-year-old boy##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
13-year-old##5##1##(2007-9#1)(2008-10#1)(2008-11#1)(2013-1#2)
13-yr##3##1##(2008-9#3)
130 kDa##3##2##(1994-8#1)(2008-11#2)
130 million##2##2##(2007-12#1)(2009-5#1)
130 years##3##2##(1990-3#1)(1991-2#1)(2009-8#1)
130##43##1##(1990-3#1)(1991-2#1)(1992-12#2)(1993-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-6#1)(2007-12#2)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#3)
130%##2##1##(2008-10#2)
130)##2##1##(2009-4#1)(2013-8#1)
130-fold##2##1##(2008-11#2)
1300 degrees C##6##3##(2008-10#6)
1300##9##1##(1991-5#1)(2008-10#8)
131 and##2##2##(2008-10#2)
131##18##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#1)(1994-11#1)(2008-10#9)(2008-9#1)(2010-6#1)(2010-8#1)(2012-2#1)
131I##2##1##(1990-8#1)(1993-9#1)
132 patients##2##2##(1990-12#1)(2008-1#1)
132##13##1##(1990-12#2)(1993-9#1)(1995-2#2)(1996-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)
133 isolates##2##2##(2008-10#2)
133##18##1##(1990-6#1)(1991-6#1)(1994-5#1)(1995-8#1)(1997-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2010-1#1)(2010-4#1)(2010-7#1)
134 and 0##2##3##(2008-10#1)(2008-9#1)
134 and##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
134 for##2##2##(2008-10#2)
134##9##1##(1996-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
135##26##1##(1990-2#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-8#3)(2011-2#1)(2013-1#1)
1350 degrees C##3##3##(2008-10#3)
1350##4##1##(2008-10#3)(2008-6#1)
1350-kb chromosome##2##2##(1996-6#2)
1350-kb##3##1##(1996-6#3)
136 micromol/L/year and progressed to ESRD in a mean##2##9##(2008-1#2)
136##12##1##(2008-1#2)(2008-10#8)(2008-9#1)(2013-1#1)
1364##3##1##(2008-8#3)
137 isolates##2##2##(2008-10#2)
137##14##1##(1993-2#1)(1996-9#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
1370##2##1##(2008-10#2)
1378- and 1385-nm##2##3##(2008-3#2)
138 patients##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
138##16##1##(1993-11#1)(1994-11#1)(1994-9#1)(2007-11#1)(2008-10#5)(2008-7#1)(2008-8#2)(2010-4#1)(2012-3#2)(2013-8#1)
139 patients##2##2##(2008-7#1)(2012-2#1)
139##21##1##(1990-8#3)(1991-7#1)(1991-9#1)(1994-1#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
139) and##2##2##(2008-4#1)(2008-5#1)
139)##3##1##(2008-11#1)(2008-4#1)(2008-5#1)
1392##2##1##(2008-3#2)
13C NMR spectra##3##3##(1992-10#1)(1992-12#2)
13C NMR spectroscopy##3##3##(1991-5#1)(1993-3#1)(1996-5#1)
13C NMR##13##2##(1991-5#1)(1992-10#3)(1992-12#3)(1993-3#1)(1994-11#1)(1996-5#1)(2008-11#1)(2009-7#1)(2011-3#1)
13C and 15N NMR##2##4##(1992-3#1)(2009-7#1)
13C and 15N resonance assignment of##2##6##(2009-7#2)
13C and 15N resonance assignments of the##2##7##(2009-7#2)
13C and 15N resonance assignments of##3##6##(2009-7#3)
13C and 15N resonance assignments##4##5##(2009-7#4)
13C and 15N resonance##6##4##(2009-7#6)
13C and 15N##10##3##(1992-3#1)(2009-7#9)
13C and##11##2##(1992-3#1)(2009-7#10)
13C##44##1##(1990-9#1)(1991-5#2)(1992-10#3)(1992-12#3)(1992-3#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-5#1)(2008-11#1)(2009-7#28)(2011-3#1)
13C(alpha)##2##1##(2009-7#2)
13C(beta)##3##1##(2009-7#3)
13C-1H##2##1##(1992-4#2)
13C-NMR##3##1##(1990-5#1)(1997-1#2)
13C-label##2##1##(1997-1#2)
13C-labelled##5##1##(1997-1#5)
13]##3##1##(1991-2#1)(2008-10#1)(2013-1#1)
13th day##2##2##(2008-8#1)(2011-2#1)
13th##7##1##(1992-4#1)(1992-8#1)(1996-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
14 +/- 0##5##3##(1993-1#1)(1994-5#1)(1995-12#1)(2008-10#1)(2011-3#1)
14 +/-##8##2##(1993-1#1)(1994-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2010-4#1)(2011-2#1)(2011-3#1)
14 S(T)S(V)##2##2##(2008-10#2)
14 Spanish isolates##2##3##(2008-10#2)
14 a##2##2##(1991-11#1)(1991-6#1)
14 after##3##2##(2006-6#1)(2008-9#1)(2011-2#1)
14 alpha-methyl demethylase##2##3##(1991-5#2)
14 amino acid##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
14 amino acids##2##3##(2008-10#2)
14 amino##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
14 and 0##2##3##(1993-8#1)(2008-10#1)
14 and 15##3##3##(1996-5#1)(2008-10#2)
14 and 19 months##2##4##(1990-5#2)
14 and 21##7##3##(2008-10#1)(2008-5#6)
14 and##27##2##(1990-3#1)(1990-5#2)(1990-6#1)(1993-8#2)(1994-12#1)(1996-5#1)(1997-7#1)(2008-10#10)(2008-5#6)(2008-9#1)(2009-11#1)
14 cases##4##2##(1990-2#1)(1991-11#1)(2008-5#2)
14 colleagues##2##2##(2012-2#2)
14 days (p less than 0##2##6##(1990-12#2)
14 days after inoculation##3##4##(2008-10#3)
14 days after##6##3##(1997-1#1)(2008-10#4)(2008-12#1)
14 days of exposure##2##4##(2008-10#1)(2008-12#1)
14 days of##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
14 days##42##2##(1990-12#2)(1990-9#1)(1991-11#1)(1994-1#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#5)(2008-12#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#2)
14 days)##2##2##(2008-10#1)(2011-2#1)
14 degrees C##3##3##(2008-10#3)
14 degrees##4##2##(2008-10#4)
14 different##2##2##(2008-10#2)
14 dpi##6##2##(2008-10#6)
14 farms##2##2##(2008-10#2)
14 h##2##2##(2008-10#2)
14 isolates##3##2##(2008-10#3)
14 kDa##2##2##(2008-11#1)(2008-5#1)
14 microM##3##2##(1991-5#1)(1994-8#1)(2008-10#1)
14 months##7##2##(1990-6#1)(1991-2#1)(1991-8#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
14 mug##2##2##(2008-10#2)
14 multi-stakeholder alliances participating in the Aligning Forces for Quality##2##10##(2013-1#2)
14 multi-stakeholder##3##2##(2013-1#3)
14 ng##3##2##(2008-10#3)
14 nmol GRF-antagonist##2##3##(1991-9#2)
14 nmol##3##2##(1991-9#3)
14 of the##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
14 of them##2##3##(1995-12#2)
14 of which##2##3##(2008-10#1)(2010-9#1)
14 of##13##2##(1990-9#1)(1991-6#1)(1994-1#1)(1995-12#2)(1995-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#1)
14 patients with##5##3##(1990-9#2)(1993-1#1)(2008-9#1)(2011-2#1)
14 patients##15##2##(1990-2#1)(1990-9#2)(1991-8#1)(1993-1#1)(1996-11#3)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
14 peptides##2##2##(1993-8#1)(2009-6#1)
14 species of##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
14 species##5##2##(2008-10#2)(2008-6#1)(2008-8#2)
14 subscales##3##2##(2012-2#3)
14 times##2##2##(1996-11#1)(2008-3#1)
14 to 18##2##3##(2008-10#2)
14 to##11##2##(1991-6#1)(1991-8#1)(1993-12#1)(2008-10#7)(2008-7#1)
14 vs##2##2##(1992-11#1)(2011-1#1)
14 weeks##7##2##(1991-6#1)(1994-12#1)(2007-8#1)(2008-10#2)(2010-7#1)(2013-1#1)
14 were##3##2##(1990-12#1)(1995-2#1)(1997-8#1)
14 years after##3##3##(2008-7#2)(2011-2#1)
14 years##11##2##(1991-11#1)(1991-2#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
14 years]##2##2##(2011-2#1)(2013-1#1)
14##510##1##(1990-12#6)(1990-2#3)(1990-3#5)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#4)(1991-11#5)(1991-12#4)(1991-2#4)(1991-5#5)(1991-6#10)(1991-8#3)(1991-9#5)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#2)(1993-3#1)(1993-8#9)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#4)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#7)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#3)(1997-9#1)(2006-6#3)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#143)(2008-11#15)(2008-12#14)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#18)(2008-6#1)(2008-7#15)(2008-8#12)(2008-9#9)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#21)(2011-3#3)(2012-12#6)(2012-2#10)(2012-3#8)(2013-1#25)(2013-8#3)
14% had##3##2##(1994-6#1)(2007-11#1)(2008-10#1)
14% of the##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
14% of##8##2##(1990-12#1)(1992-6#1)(1992-8#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
14%##36##1##(1990-12#2)(1990-6#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-6#2)(2011-2#3)(2013-8#2)
14%)##3##1##(2008-12#1)(2011-2#2)
14) and##5##2##(2008-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
14)##20##1##(1990-11#1)(1991-5#1)(1993-11#1)(1993-8#2)(1995-2#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-8#2)
14+/-0##2##1##(2008-10#2)
14- and##4##2##(2008-10#4)
14-##6##1##(2008-10#5)(2013-1#1)
14-16##3##1##(1994-3#1)(1995-2#1)(1996-9#1)
14-18##2##1##(1993-8#1)(2011-1#1)
14-2##2##1##(2008-10#2)
14-3-3 family##2##2##(2008-11#2)
14-3-3 protein##4##2##(2008-11#3)(2010-12#1)
14-3-3 proteins and CK8##3##4##(2008-11#3)
14-3-3 proteins and##4##3##(2008-11#4)
14-3-3 σ protein##2##3##(2010-12#2)
14-3-3 σ##4##2##(2010-12#4)
14-3-3##17##1##(2008-11#10)(2008-9#1)(2010-12#6)
14-3-3beta##5##1##(2008-9#5)
14-day-old##2##1##(2008-5#2)
14-eicosatetraenoic acid##2##2##(1992-8#1)(1994-8#1)
14-eicosatetraenoic##3##1##(1992-8#1)(1994-8#1)(1995-11#1)
14-kDa protein##3##2##(2008-10#3)
14-kDa subunit##2##2##(1995-6#2)
14-kDa subunits##2##2##(1995-6#2)
14-kDa trypsin inhibitor##2##3##(2008-10#2)
14-kDa##11##1##(1995-6#4)(2008-10#7)
14-year-old girl##4##2##(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#1)
14-year-old##6##1##(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#1)
140 min##2##2##(2008-10#1)(2010-8#1)
140 mul##2##2##(2008-10#2)
140 ng##2##2##(2008-10#1)(2012-12#1)
140##38##1##(1990-5#3)(1990-9#1)(1991-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-3#1)(1997-8#1)(2008-10#13)(2008-11#4)(2008-6#1)(2008-8#1)(2010-8#2)(2011-2#3)(2012-12#1)(2013-1#1)
140%##2##1##(2008-11#1)(2008-12#1)
1400 degrees C##2##3##(2008-10#2)
1400##8##1##(2008-10#6)(2008-3#1)(2013-8#1)
1401##2##1##(1995-3#1)(1997-6#1)
141##4##1##(1990-8#1)(1995-8#1)(2008-10#1)(2010-11#1)
142 patients##2##2##(1996-6#1)(2008-9#1)
142##8##1##(1990-2#1)(1996-11#1)(1996-6#1)(2008-10#2)(2008-9#2)(2013-1#1)
142-bp##2##1##(1996-6#2)
143##16##1##(2008-10#10)(2008-2#1)(2008-3#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
143)##3##1##(2008-10#2)(2008-5#1)
144##25##1##(1990-6#1)(1992-8#1)(1997-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#2)
145##17##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-6#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#4)(2012-12#1)
1450 ppm fluoride##5##3##(2011-2#5)
1450##7##1##(2008-10#1)(2008-5#1)(2011-2#5)
146##12##1##(1991-6#1)(1996-12#1)(1997-6#2)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
147##8##1##(1993-11#1)(1996-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
147%##2##1##(2008-9#1)(2010-8#1)
1470##3##1##(1996-6#1)(2008-10#2)
148##8##1##(1991-6#1)(1994-8#1)(2008-10#5)(2008-9#1)
149##13##1##(1993-8#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-2#1)
14CO2 generated from##2##3##(1991-3#2)
14CO2 generated##3##2##(1991-3#3)
14CO2 production via##2##3##(1991-3#2)
14CO2 production##3##2##(1991-3#3)
14CO2##8##1##(1991-3#8)
14F7 Mab##2##2##(2012-3#2)
14F7##6##1##(2012-3#6)
14ngml(-1)##2##1##(2008-10#2)
14q subtelomeric DNA##2##3##(1997-6#2)
14q##4##1##(1997-6#4)
14th##4##1##(1990-9#2)(2008-10#1)(2011-2#1)
15 +/-##2##2##(1992-9#1)(2013-1#1)
15 A##2##2##(1992-4#1)(2008-10#1)
15 August##2##2##(2008-10#2)
15 Gy##2##2##(2008-11#2)
15 K##2##2##(2008-10#2)
15 M NaCl##2##3##(1992-10#2)
15 M##5##2##(1992-10#3)(1994-8#1)(2008-10#1)
15 MV##2##2##(2009-11#2)
15 STR loci##2##3##(2008-12#2)
15 STR##3##2##(2008-12#3)
15 V##4##2##(2008-10#4)
15 and 20 degrees C##2##5##(2008-10#2)
15 and 25##2##3##(2008-10#1)(2009-5#1)
15 and 30##3##3##(2008-10#2)(2011-2#1)
15 and 35##2##3##(1990-6#1)(2008-10#1)
15 and##26##2##(1990-6#1)(1993-3#1)(1994-2#1)(1996-12#2)(1996-8#1)(2008-10#14)(2008-11#1)(2008-9#2)(2009-5#1)(2010-8#1)(2011-2#1)
15 cases of##2##3##(2008-7#2)
15 cases##7##2##(2008-7#3)(2009-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
15 cm##4##2##(1996-2#1)(2008-10#3)
15 d##2##2##(2008-8#1)(2008-9#1)
15 day##2##2##(2008-10#1)(2008-12#1)
15 days after##2##3##(2008-10#2)
15 days for##2##3##(2008-10#1)(2008-11#1)
15 days of##2##3##(2008-10#1)(2008-11#1)
15 days##26##2##(1990-12#1)(1995-2#2)(2008-10#10)(2008-11#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
15 degrees C and##2##4##(2008-10#2)
15 degrees C with##2##4##(2008-10#1)(2008-2#1)
15 degrees C##18##3##(1990-8#1)(2008-10#15)(2008-2#1)(2008-9#1)
15 degrees##21##2##(1990-8#1)(2008-10#16)(2008-2#1)(2008-9#1)(2009-3#1)(2011-2#1)
15 different##4##2##(1997-4#1)(2008-10#3)
15 female p53 haploinsufficient mice##3##5##(2008-9#3)
15 female##8##2##(2008-9#7)(2011-2#1)
15 fg##2##2##(2008-10#2)
15 for##2##2##(2008-10#2)
15 g##4##2##(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
15 generations##2##2##(2008-10#2)
15 genotypes##2##2##(2008-10#2)
15 h##2##2##(1994-2#1)(2008-5#1)
15 h(-1)##3##2##(2008-10#3)
15 healthy volunteers##2##3##(2010-6#1)(2011-2#1)
15 healthy##4##2##(2008-5#2)(2010-6#1)(2011-2#1)
15 in##2##2##(1990-6#1)(2008-8#1)
15 isolates from##2##3##(2008-10#2)
15 isolates##3##2##(2008-10#3)
15 kDa##2##2##(1995-8#1)(2008-10#1)
15 kV##2##2##(2008-10#2)
15 loci##2##2##(2008-12#2)
15 mM sodium##3##3##(2008-10#3)
15 mM##12##2##(1990-5#1)(1991-12#1)(1994-5#1)(1995-8#1)(2008-10#7)(2008-7#1)
15 mg l(-1)##2##3##(2008-10#2)
15 mg##5##2##(2008-10#3)(2008-11#2)
15 micromol/l##3##2##(2008-7#3)
15 min and##2##3##(1994-8#1)(2012-3#1)
15 min before##2##3##(1994-2#1)(2006-6#1)
15 min light##2##3##(2008-5#2)
15 min of##7##3##(1993-9#1)(1996-12#1)(2008-10#2)(2010-3#2)(2011-2#1)
15 min##47##2##(1991-12#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-9#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(2006-6#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#2)(2011-2#1)(2012-3#2)(2013-8#1)
15 min)##4##2##(1992-8#1)(1993-1#1)(1995-8#1)(1997-4#1)
15 minutes##5##2##(1991-1#1)(1992-3#1)(1994-9#1)(2010-7#1)(2011-2#1)
15 ml and##2##3##(2008-10#1)(2008-11#1)
15 ml of##3##3##(2008-10#3)
15 ml##6##2##(2008-10#5)(2008-11#1)
15 mm in##3##3##(1995-12#2)(2008-8#1)
15 mm##6##2##(1995-12#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)
15 months after##2##3##(2011-2#1)(2013-1#1)
15 months##9##2##(2008-10#1)(2010-12#1)(2010-6#5)(2011-2#1)(2013-1#1)
15 mug ml(-1)##5##3##(2008-10#5)
15 mug##7##2##(2008-10#7)
15 mumol l(-1)##2##3##(2008-10#2)
15 nm##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2009-5#1)
15 of the 18##2##4##(1997-7#1)(2008-10#1)
15 of the##4##3##(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)
15 of these##2##3##(2008-10#1)(2008-12#1)
15 of##8##2##(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)
15 or 30##3##3##(1994-2#1)(1995-12#1)(2008-10#1)
15 or##5##2##(1994-2#1)(1995-12#1)(2008-10#2)(2008-11#1)
15 other##4##2##(1995-9#1)(2008-10#3)
15 out of##5##3##(1990-5#1)(1990-6#1)(2008-10#2)(2011-1#1)
15 papers##2##2##(2008-3#1)(2013-1#1)
15 patent##2##2##(2010-12#2)
15 patients with##5##3##(1990-2#1)(1990-9#1)(1997-1#1)(2008-10#1)(2008-7#1)
15 patients##17##2##(1990-2#2)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-1#1)(1994-3#1)(1997-1#1)(2008-10#1)(2008-7#3)(2011-2#1)(2012-3#3)
15 percent of##2##3##(1995-12#1)(1996-6#1)
15 percent##3##2##(1994-2#1)(1995-12#1)(1996-6#1)
15 pg##2##2##(2008-10#1)(2011-3#1)
15 points##2##2##(2008-3#1)(2008-9#1)
15 ppm##2##2##(2008-10#1)(2010-1#1)
15 pts)##3##2##(2010-12#3)
15 rabbits in the##2##4##(2008-11#2)
15 s and##4##3##(2008-10#4)
15 s##8##2##(2008-10#7)(2009-7#1)
15 samples h(-1)##3##3##(2008-10#3)
15 samples##5##2##(2008-10#4)(2013-1#1)
15 species##5##2##(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#2)
15 studies##2##2##(1990-6#1)(2012-12#1)
15 subjects##3##2##(1995-5#1)(2008-7#1)(2008-9#1)
15 to 20 degrees C##2##5##(2008-10#2)
15 to 20##4##3##(1991-12#1)(2008-10#2)(2008-11#1)
15 to 20%##3##3##(2008-10#1)(2009-12#1)(2013-1#1)
15 to 30##3##3##(2008-10#3)
15 to##20##2##(1990-2#1)(1991-12#1)(1995-5#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-5#1)(2009-12#1)(2013-1#1)
15 undergoing##2##2##(1994-2#2)
15 weeks after injury##2##4##(2012-3#2)
15 weeks after inoculation##2##4##(2008-10#2)
15 weeks after##4##3##(2008-10#2)(2012-3#2)
15 weeks##9##2##(1995-11#1)(2008-10#3)(2008-5#2)(2008-9#1)(2012-3#2)
15 were##4##2##(1993-2#1)(2008-11#2)(2010-3#1)
15 with##2##2##(1990-2#1)(2008-11#1)
15 women##2##2##(2010-6#1)(2011-2#1)
15 years after##2##3##(1991-6#1)(2008-12#1)
15 years ago##2##3##(2008-10#1)(2008-11#1)
15 years and##2##3##(2008-10#1)(2013-1#1)
15 years of age##2##4##(1995-11#1)(2009-7#1)
15 years of##4##3##(1995-11#1)(2008-10#1)(2009-7#1)(2013-8#1)
15 years or##3##3##(1994-6#2)(2008-10#1)
15 years##39##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-6#3)(1995-11#1)(1997-5#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#2)(2011-7#1)(2012-2#2)(2013-1#2)(2013-8#2)
15 years)##2##2##(1995-5#1)(2013-1#1)
15##788##1##(1990-12#3)(1990-2#7)(1990-3#3)(1990-5#2)(1990-6#6)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-8#2)(1992-9#2)(1993-1#6)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#9)(1994-3#3)(1994-5#2)(1994-6#6)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#6)(1995-9#1)(1996-12#6)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#8)(2006-6#2)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#298)(2008-11#37)(2008-12#15)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#21)(2008-6#2)(2008-7#22)(2008-8#11)(2008-9#32)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#5)(2009-8#1)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#8)(2010-7#3)(2010-8#4)(2011-1#3)(2011-2#30)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#5)(2012-3#17)(2013-1#25)(2013-7#1)(2013-8#7)
15% after##2##2##(1990-2#1)(2011-2#1)
15% and##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
15% at##3##2##(1991-5#1)(1992-12#1)(2008-10#1)
15% flaxseed flour##3##3##(2010-4#3)
15% in##3##2##(2008-10#2)(2013-8#1)
15% of the##6##3##(1991-11#1)(1996-6#1)(2008-10#1)(2008-3#2)(2013-1#1)
15% of women##3##3##(1990-6#1)(2008-1#1)(2011-2#1)
15% of##19##2##(1990-6#1)(1991-11#2)(1994-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
15%##85##1##(1990-2#1)(1990-6#1)(1991-11#3)(1991-3#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2010-4#4)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
15%)##6##1##(1994-2#1)(2008-10#2)(2008-4#1)(2011-3#1)(2012-3#1)
15'- monooxygenase##2##2##(2009-6#2)
15) and##5##2##(1997-3#1)(2008-10#3)(2008-7#1)
15)##19##1##(1991-11#1)(1994-5#1)(1996-3#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
15+/-0##7##1##(2008-10#5)(2008-11#2)
15- and 22-month-old##2##3##(1994-3#2)
15- and##4##2##(1994-3#3)(2008-2#1)
15-##6##1##(1994-3#4)(2008-10#1)(2008-2#1)
15-(2##2##1##(2008-10#2)
15-0##3##1##(2008-10#3)
15-19 years old##2##3##(1996-6#1)(2008-12#1)
15-19 years##3##2##(1996-6#1)(2008-12#1)(2013-1#1)
15-24##3##1##(1997-6#1)(2008-11#1)(2013-1#1)
15-25 min and##2##3##(1997-2#1)(2008-10#1)
15-25##3##1##(1997-2#1)(2008-10#1)(2013-8#1)
15-29-years age##2##2##(1994-12#2)
15-30##4##1##(1994-8#1)(1995-8#1)(1996-11#1)(2008-10#1)
15-45##3##1##(2008-10#1)(2008-7#1)(2012-3#1)
15-49 years##2##2##(1993-11#1)(2012-3#1)
15-crown-5##3##1##(2008-10#3)
15-day##2##1##(2008-10#1)(2008-11#1)
15-deoxyspergualin##2##1##(1993-8#2)
15-fold##4##1##(1990-10#1)(2008-10#3)
15-lipoxygenase##2##1##(2008-5#2)
15-mer##2##1##(2008-10#1)(2008-8#1)
15-min##2##1##(2008-11#1)(2013-1#1)
15-year period##2##2##(1991-8#1)(2011-2#1)
15-year##3##1##(1991-8#1)(2008-11#1)(2011-2#1)
15/15##2##1##(2008-10#2)
150 F(8) RILs##2##3##(2008-10#2)
150 and##2##2##(2008-10#2)
150 cases##4##2##(1990-12#1)(1996-3#1)(2011-2#1)(2013-1#1)
150 cells##2##2##(2009-12#2)
150 degrees C##6##3##(1997-2#1)(2008-10#5)
150 kDa##2##2##(1997-2#2)
150 m##2##2##(2008-10#1)(2008-3#1)
150 mM##4##2##(1991-5#1)(1994-5#2)(1997-2#1)
150 mOsm kg(-1)##3##3##(2008-11#3)
150 medicinal plants##2##3##(2008-5#2)
150 microm##2##2##(2008-10#1)(2010-8#1)
150 ml##3##2##(2008-10#3)
150 mm##2##2##(2008-10#1)(2010-12#1)
150 mum##2##2##(2008-10#1)(2008-11#1)
150 patients##4##2##(1992-1#1)(1996-3#1)(2010-6#1)(2013-1#1)
150 samples##2##2##(2008-10#1)(2008-5#1)
150 to##2##2##(1993-1#1)(2008-9#1)
150##119##1##(1990-11#1)(1990-12#3)(1991-12#1)(1991-5#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-5#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-2#4)(1997-7#1)(2008-1#1)(2008-10#45)(2008-11#6)(2008-3#2)(2008-5#8)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#3)(2009-8#2)(2010-1#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
150%##3##1##(1993-8#1)(2008-10#1)(2008-2#1)
150-200##3##1##(1993-6#1)(2008-10#1)(2008-11#1)
150-350##2##1##(2008-10#1)(2008-5#1)
150-mul##2##1##(2008-10#2)
1500 and##3##2##(2008-10#3)
1500 degrees C##3##3##(2008-10#1)(2009-7#2)
1500 degrees##4##2##(2008-10#2)(2009-7#2)
1500 paediatric patients##2##3##(2013-1#2)
1500 patients##2##2##(1994-3#1)(2008-5#1)
1500##20##1##(1991-5#1)(1992-2#1)(1994-3#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#2)(2009-9#1)(2013-1#3)
1505##4##1##(2008-10#3)(2012-3#1)
150IU 3 times##2##3##(2007-11#2)
151 patients##2##2##(1990-9#2)
151##13##1##(1990-2#1)(1990-9#2)(1991-3#1)(1997-2#1)(1997-5#2)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
1515 Apple##2##2##(2008-10#2)
1515##3##1##(2008-10#3)
1515)##2##1##(2008-10#2)
152##18##1##(1990-3#1)(1993-12#1)(1994-8#1)(1996-2#1)(2008-10#9)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
153 and##4##2##(1997-8#3)(2008-10#1)
153##15##1##(1990-5#1)(1991-2#1)(1993-8#1)(1997-8#4)(2008-10#3)(2008-11#1)(2008-7#1)(2010-4#1)(2011-3#1)(2013-8#1)
154##9##1##(1990-3#1)(1991-6#1)(2008-10#1)(2008-5#1)(2011-2#4)(2013-8#1)
155 bp##2##2##(2008-10#2)
155 patients##2##2##(1994-3#1)(2008-10#1)
155##19##1##(1993-3#1)(1994-3#1)(2008-10#10)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-8#2)
1550 nm##2##2##(2007-11#1)(2008-3#1)
1550##5##1##(1997-8#1)(2007-11#1)(2008-10#2)(2008-3#1)
1553 and 1593 cm(-1)##2##4##(2008-10#2)
1553##3##1##(2008-10#2)(2010-4#1)
156 instruments were collected (from 1 to 10 per ward) evaluating 55 different actual or potential patient problems##2##18##(2013-1#2)
156 patients##2##2##(1996-6#1)(2011-2#1)
156##18##1##(1991-2#1)(1994-12#1)(1996-6#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#3)(2013-1#2)
1562##2##1##(2008-10#2)
157##13##1##(1991-2#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#2)
158##10##1##(1990-11#1)(1991-6#1)(1991-8#1)(2008-10#6)(2008-9#1)
1580##2##1##(2008-3#2)
159##10##1##(1990-2#1)(1993-12#1)(1993-8#1)(1996-12#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
15C5 complexes##2##2##(2008-10#2)
15C5##5##1##(2008-10#5)
15C5-774##2##1##(2008-10#2)
15N and##2##2##(2009-7#2)
15N##33##1##(1992-3#1)(1995-2#1)(2008-11#1)(2009-7#30)
15N-NMR##2##1##(1997-1#2)
15N-labeled##3##1##(1995-2#1)(2008-4#2)
15V##3##1##(2008-10#3)
15h(-1)##2##1##(2008-10#2)
15kV and##2##2##(2008-10#2)
15mgl(-1)##3##1##(2008-10#3)
15min##9##1##(2008-10#9)
15ml##2##1##(2008-10#2)
15mug of##2##2##(2008-10#2)
15mugl(-1) of##3##2##(2008-10#3)
15mugl(-1)##7##1##(2008-10#7)
15mugml(-1) of##2##2##(2008-10#2)
15ng/mL##2##1##(2008-10#2)
15ngml(-1)##2##1##(2008-10#2)
15ppm##2##1##(2008-10#2)
15q##2##1##(1997-6#2)
15s##3##1##(2008-10#3)
15s)##2##1##(2008-10#1)(2013-1#1)
15th day##2##2##(2008-7#1)(2008-8#1)
15th##12##1##(1995-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)
15years ofage##2##2##(2013-8#2)
15years##4##1##(2009-8#1)(2012-2#1)(2013-8#2)
16 +/- 0##5##3##(1993-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
16 +/-##7##2##(1993-1#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
16 000##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
16 alpha-OHE1##4##2##(1995-9#4)
16 and 18##5##3##(1990-5#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-11#1)
16 and##23##2##(1990-5#1)(1993-3#1)(1994-12#1)(1996-5#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)
16 are##3##2##(1995-2#1)(2008-8#1)(2013-1#1)
16 cases##7##2##(1990-2#1)(1990-5#1)(1995-11#1)(2007-11#1)(2008-11#2)(2009-8#1)
16 cm##2##2##(2009-10#2)
16 days##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#1)
16 degrees C##2##3##(2008-10#2)
16 diaza-2##2##2##(2008-10#2)
16 different##3##2##(1990-2#1)(1995-6#1)(2008-10#1)
16 exons##2##2##(1997-2#2)
16 h##10##2##(1997-1#1)(2008-10#5)(2008-11#2)(2011-2#1)(2012-2#1)
16 human##2##2##(1996-2#1)(2013-1#1)
16 isolates##4##2##(2008-10#4)
16 males##3##2##(1994-12#1)(2008-7#1)(2012-3#1)
16 mm (95% CI 0##2##5##(2013-1#2)
16 mmol/L##2##2##(1993-1#2)
16 months after##2##3##(2008-9#1)(2013-8#1)
16 months##8##2##(1991-11#1)(1996-3#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
16 mug ml(-1)##2##3##(2008-10#2)
16 mug##3##2##(2008-10#3)
16 multi-stakeholder##2##2##(2013-1#2)
16 ng##2##2##(2008-10#2)
16 of the##2##3##(1997-5#1)(2008-10#1)
16 of##4##2##(1994-1#1)(1997-5#1)(2008-10#1)(2011-2#1)
16 out of##2##3##(1994-6#1)(2008-9#1)
16 papers##2##2##(2008-3#1)(2008-8#1)
16 participants##2##2##(1994-12#1)(2013-1#1)
16 patients with##5##3##(1991-2#1)(2008-5#1)(2010-1#1)(2011-2#2)
16 patients##19##2##(1990-2#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-8#1)(1994-3#1)(1997-4#1)(1997-8#2)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#4)(2012-4#1)(2013-1#2)
16 percent##5##2##(1991-1#1)(1991-12#1)(1991-2#1)(1997-3#1)(2008-11#1)
16 species##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
16 tissues examined##2##3##(1994-11#1)(2008-9#1)
16 to##14##2##(1990-6#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
16 weeks##4##2##(2008-10#3)(2013-1#1)
16 were##2##2##(2008-10#2)
16 with a##2##3##(1996-5#1)(2008-7#1)
16 with##5##2##(1994-12#1)(1996-5#1)(2008-5#1)(2008-7#1)(2012-3#1)
16 women##3##2##(1990-8#1)(1991-8#1)(1994-3#1)
16 x##2##2##(2008-11#1)(2008-8#1)
16 years##8##2##(1997-8#1)(2011-2#3)(2012-3#1)(2013-1#3)
16##429##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#3)(1991-7#1)(1991-8#2)(1992-12#7)(1992-2#2)(1992-9#2)(1993-1#5)(1993-12#5)(1993-3#2)(1993-8#1)(1994-1#5)(1994-11#2)(1994-12#5)(1994-3#3)(1994-6#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#5)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#120)(2008-11#21)(2008-12#10)(2008-3#5)(2008-5#9)(2008-7#12)(2008-8#17)(2008-9#8)(2009-10#3)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#19)(2012-12#1)(2012-2#9)(2012-3#11)(2012-4#1)(2012-9#1)(2013-1#26)(2013-8#15)
16% and##2##2##(2008-10#1)(2008-11#1)
16% of the##3##3##(1991-9#1)(1997-8#1)(2008-5#1)
16% of##6##2##(1991-9#1)(1993-12#1)(1997-8#1)(2008-12#1)(2008-5#1)(2010-8#1)
16%##28##1##(1990-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2010-8#2)(2011-2#1)(2013-1#1)
16%) of##2##2##(1990-8#1)(2008-10#1)
16%)##4##1##(1990-8#1)(2008-10#3)
16)##10##1##(1990-8#1)(1992-1#1)(1992-9#1)(1997-1#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-8#1)
16-1##2##1##(2008-10#2)
16-18##3##1##(1992-12#1)(1997-2#1)(2013-8#1)
16-20##2##1##(2008-11#1)(2008-7#1)
16-crown-5##3##1##(2008-10#3)
16-diazacyclooctadecane##5##1##(2008-10#5)
16-fold##3##1##(1994-11#1)(2008-10#1)(2008-11#1)
16-membered cyclic##3##2##(2008-10#3)
16-way valve##2##2##(2008-10#2)
16-way##4##1##(2008-10#4)
16-week##3##1##(2010-4#3)
16-year-old male##4##2##(2008-7#1)(2010-1#1)(2010-5#1)(2013-1#1)
16-year-old##8##1##(2008-7#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)
16/23S spacer region##3##3##(2008-10#3)
16/83-E1##2##1##(2008-10#2)
160 (rest of the Netherlands)##2##5##(1991-8#2)
160 and##2##2##(1992-6#1)(1994-8#1)
160 h##2##2##(2008-11#2)
160 isolates##2##2##(2008-10#2)
160 mumol/kg##2##2##(1993-12#2)
160 patients with##2##3##(1990-9#1)(2008-12#1)
160 patients##3##2##(1990-9#2)(2008-12#1)
160##39##1##(1990-9#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-6#1)(1993-12#2)(1994-6#1)(1994-8#1)(1996-12#2)(2007-12#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
160%##2##1##(2008-11#1)(2008-12#1)
160-##2##1##(2006-6#1)(2008-10#1)
160-fold##2##1##(2008-10#2)
1600##7##1##(1992-3#1)(1994-12#1)(1995-8#1)(2008-10#4)
1609 cells##2##2##(2008-10#2)
1609##6##1##(2008-10#6)
161 patients##2##2##(1997-8#1)(2011-1#1)
161##11##1##(1994-12#1)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
162 nt##2##2##(1995-2#2)
162##4##1##(1992-9#1)(1995-2#2)(2008-10#1)
1628##2##1##(2008-10#1)(2008-9#1)
1629-bp open reading frame##2##4##(1993-12#2)
1629-bp##4##1##(1993-12#4)
163 and##2##2##(1997-3#1)(2013-1#1)
163##10##1##(1997-3#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
163(6)##27##1##(2013-1#27)
1632c##2##1##(2008-10#2)
164##7##1##(1992-7#1)(1993-2#1)(1995-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
1640##6##1##(2008-10#1)(2008-11#5)
1648##17##1##(2006-6#1)(2008-10#15)(2008-7#1)
1648)##2##1##(2008-10#2)
1649##2##1##(2008-10#2)
1649a##4##1##(2008-10#4)
165 +/-##2##2##(2008-11#1)(2013-1#1)
165 episodes of fungemia##2##4##(2008-5#2)
165 kDa##3##2##(1990-12#3)
165##21##1##(1990-12#4)(1991-2#1)(1991-9#1)(1992-10#1)(1995-8#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#2)
166##7##1##(2008-10#4)(2008-11#2)(2008-3#1)
167##7##1##(1990-11#1)(1994-11#1)(1994-6#1)(2007-12#1)(2008-10#3)
168 h##2##2##(2013-1#2)
168##18##1##(1990-9#2)(1991-3#1)(1995-12#2)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
168-hr dosimeter##2##2##(1993-1#2)
169##9##1##(1992-5#1)(2008-10#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)
16C5##8##1##(2008-10#8)
16D##3##1##(2008-9#3)
16S and 23S##2##3##(1992-3#1)(2008-10#1)
16S rDNA and hrpL genes##2##5##(2008-10#2)
16S rDNA and##4##3##(2008-10#4)
16S rDNA##17##2##(2008-10#14)(2008-12#2)(2008-5#1)
16S rRNA gene sequence##5##4##(2009-6#2)(2010-6#1)(2011-2#2)
16S rRNA gene sequences##3##4##(2008-10#2)(2011-2#1)
16S rRNA gene##17##3##(2008-10#4)(2008-12#1)(2009-6#3)(2010-6#2)(2011-2#4)(2012-2#1)(2013-8#2)
16S rRNA genes##6##3##(2008-10#4)(2011-2#1)(2012-2#1)
16S rRNA sequence##2##3##(2011-2#1)(2012-2#1)
16S rRNA##35##2##(1996-8#1)(1997-2#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#3)(2010-6#2)(2011-1#1)(2011-2#6)(2012-2#4)(2013-8#2)
16S ribosomal RNA##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
16S##62##1##(1992-3#1)(1996-8#1)(1997-2#1)(2008-10#31)(2008-12#3)(2008-5#3)(2008-9#1)(2009-6#3)(2010-6#2)(2011-1#1)(2011-2#8)(2012-2#4)(2013-1#1)(2013-8#2)
16S-23S rDNA##5##2##(2008-10#5)
16S-23S##7##1##(2008-10#7)
16SrI-A##6##1##(2008-10#6)
16SrI-B##5##1##(2008-10#5)
16min##2##1##(2008-10#2)
16p##2##1##(1994-11#2)
16s##3##1##(2008-10#2)(2008-12#1)
16th##6##1##(1996-11#1)(1997-4#1)(2008-11#2)(2008-7#1)(2012-3#1)
17 (10##2##2##(1990-12#1)(2008-5#1)
17 +/- 0##3##3##(1992-3#1)(2008-10#1)(2008-5#1)
17 +/-##4##2##(1992-3#1)(2008-10#1)(2008-12#1)(2008-5#1)
17 ORFs##2##2##(1995-12#1)(1996-3#1)
17 PCDD/F##2##2##(2008-10#2)
17 and 0##2##3##(1996-2#1)(2008-10#1)
17 and 3##2##3##(1991-3#1)(2008-10#1)
17 and##13##2##(1991-3#1)(1995-12#1)(1996-2#1)(2008-10#7)(2008-8#3)
17 beta-diol (5##2##3##(1990-11#2)
17 beta-estradiol (E2)##2##3##(1990-11#1)(2008-11#1)
17 beta-estradiol##8##2##(1990-11#1)(1990-2#1)(1995-11#3)(1995-6#1)(2008-11#2)
17 beta-hydroxysteroid##2##2##(1994-6#1)(1995-11#1)
17 cases##5##2##(1991-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
17 children##2##2##(2008-12#1)(2008-9#1)
17 days##2##2##(2008-10#1)(2011-2#1)
17 elements##3##2##(2008-10#3)
17 h(-1)##2##2##(2008-10#2)
17 had##2##2##(2012-3#1)(2012-4#1)
17 in##2##2##(1990-3#1)(2013-8#1)
17 kDa##2##2##(1995-12#1)(2008-10#1)
17 loci##2##2##(2008-10#1)(2008-8#1)
17 months##4##2##(1996-12#1)(1996-9#1)(1997-2#1)(2008-10#1)
17 of the##3##3##(1992-5#1)(1996-3#1)(2008-10#1)
17 of##5##2##(1992-5#1)(1996-3#1)(1996-8#1)(2008-10#2)
17 patients (9##2##3##(2011-2#1)(2013-1#1)
17 patients with##3##3##(1990-2#1)(1994-1#1)(1995-12#1)
17 patients##24##2##(1990-11#1)(1990-2#2)(1990-8#2)(1991-11#2)(1991-2#1)(1991-3#1)(1994-1#2)(1995-12#1)(1996-11#1)(1997-4#1)(2008-1#1)(2008-12#1)(2008-7#3)(2008-9#1)(2011-2#2)(2013-1#2)
17 percent##2##2##(1993-1#1)(1996-5#1)
17 samples##2##2##(2008-10#2)
17 to 0##2##3##(1996-2#1)(2008-10#1)
17 to##8##2##(1996-2#2)(1997-4#1)(2008-10#3)(2008-11#2)
17 were##4##2##(1992-5#1)(1994-3#1)(1995-2#1)(2008-10#1)
17 women##2##2##(1991-8#1)(2011-2#1)
17 years after##2##3##(1990-2#1)(2008-10#1)
17 years of##2##3##(1993-12#1)(2012-12#1)
17 years##8##2##(1990-2#1)(1990-6#1)(1992-9#1)(1993-12#1)(2008-10#1)(2012-12#3)
17 yr##2##2##(2008-9#2)
17##350##1##(1990-11#7)(1990-12#2)(1990-2#5)(1990-3#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#2)(1992-11#1)(1992-3#3)(1992-5#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#3)(1994-1#2)(1994-3#2)(1994-6#4)(1994-8#1)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#4)(1996-5#2)(1996-8#1)(1996-9#2)(1997-2#6)(1997-3#3)(1997-4#3)(1997-6#1)(1997-8#2)(2007-11#1)(2008-1#4)(2008-10#97)(2008-11#16)(2008-12#13)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#11)(2008-9#16)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#19)(2012-12#5)(2012-2#1)(2012-3#9)(2012-4#1)(2013-1#8)(2013-8#3)
17% and##2##2##(1994-8#1)(2010-6#1)
17% for##2##2##(2008-10#2)
17% of all##2##3##(1990-6#1)(2008-11#1)
17% of##6##2##(1990-6#1)(1994-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
17%##28##1##(1990-6#1)(1993-3#2)(1994-12#1)(1994-8#1)(1996-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-11#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
17%)##2##1##(2007-11#1)(2011-2#1)
17)##11##1##(1991-9#2)(1992-1#1)(1993-1#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-12#1)(2009-7#1)(2011-2#1)(2012-3#1)
17+/-0##3##1##(2008-10#3)
17-0##3##1##(1990-11#1)(2007-12#1)(2008-10#1)
17-19##5##1##(1990-9#1)(1997-1#1)(2008-10#2)(2008-7#1)
17-20##3##1##(2008-10#1)(2008-7#1)(2012-2#1)
17-23 years##2##2##(1995-3#1)(2012-3#1)
17-25]##2##1##(1993-12#1)(2008-9#1)
17-49##2##1##(2008-10#1)(2009-3#1)
17-kDa protein was##2##3##(2008-10#2)
17-kDa protein##7##2##(2008-10#7)
17-kDa##9##1##(1995-2#1)(2008-10#8)
17-tetrapropionic acid or coproporphyrin-I (CPI) with##2##6##(2008-10#2)
17-yr cicadas##2##2##(2008-9#2)
17-yr##3##1##(2008-9#3)
17/2##4##1##(1990-11#1)(1991-3#2)(1993-3#1)
170 +/-##2##2##(2008-12#1)(2008-2#1)
170##28##1##(1991-2#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1995-2#1)(1996-2#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2012-12#1)(2012-2#1)
1700##5##1##(1994-12#1)(2008-10#2)(2008-12#1)(2008-7#1)
1701 residents##2##2##(2013-8#2)
17025##2##1##(2008-12#1)(2011-2#1)
171 in##2##2##(2008-7#1)(2013-1#1)
171##14##1##(1991-12#1)(1991-9#1)(1995-12#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2013-1#2)
172##8##1##(1993-6#1)(1995-6#1)(2008-10#4)(2008-7#1)(2011-2#1)
173##15##1##(1990-5#1)(1991-12#1)(1992-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-9#3)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
1737cm(-1)##2##1##(2008-10#2)
174##8##1##(1995-6#1)(1996-12#1)(2008-1#2)(2008-10#2)(2009-1#1)(2013-1#1)
1747##2##1##(1991-2#1)(2008-10#1)
175 adolescents##2##2##(1993-3#2)
175 and##2##2##(2008-10#1)(2008-3#1)
175##14##1##(1990-3#1)(1990-7#1)(1990-8#1)(1992-12#1)(1993-3#2)(1994-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2011-2#1)
175%##2##1##(1990-8#1)(2013-1#1)
1758##2##1##(2007-12#2)
1758)##2##1##(2008-12#2)
175R protein##4##2##(1993-2#4)
175R##9##1##(1993-2#9)
176##12##1##(1990-6#1)(1991-12#4)(1991-3#1)(2008-10#3)(2009-4#1)(2010-1#1)(2010-6#1)
1763##2##1##(2008-12#1)(2012-3#1)
177##10##1##(1992-3#1)(1993-2#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-9#1)(2010-12#1)
178 patients##2##2##(1992-5#1)(2013-1#1)
178##10##1##(1990-3#1)(1992-5#1)(1995-8#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
1788##5##1##(1990-12#4)(2008-7#1)
179 bp##2##2##(2008-10#1)(2011-2#1)
179##7##1##(1992-10#1)(1992-4#1)(1992-9#1)(1995-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
17E8##6##1##(1995-2#6)
17mM##2##1##(2008-10#1)(2008-7#1)
17p##3##1##(1994-12#1)(2009-8#2)
17p11##4##1##(1997-3#3)(2011-2#1)
17p12##2##1##(1997-3#2)
17p13##5##1##(1993-11#1)(1997-3#3)(2008-8#1)
17th##6##1##(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-3#1)
18 (25##2##2##(2013-1#2)
18 (40%)##2##2##(1993-11#1)(1996-11#1)
18 (43%)##2##2##(1990-6#1)(2011-2#1)
18 +/-##2##2##(2011-3#1)(2012-3#1)
18 -##2##2##(2008-11#2)
18 July##2##2##(1995-6#2)
18 and 0##2##3##(2008-10#2)
18 and 20##2##3##(1995-11#1)(1995-12#1)
18 and 7##2##3##(2008-10#2)
18 and##22##2##(1995-11#1)(1995-12#1)(1996-5#1)(2008-10#14)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
18 bp##2##2##(2008-9#2)
18 cases##5##2##(2007-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)
18 crown 6##5##3##(2008-10#5)
18 days##4##2##(2008-10#2)(2008-11#1)(2009-4#1)
18 degrees C in##3##4##(2008-10#2)(2008-12#1)
18 degrees C##12##3##(2008-10#11)(2008-12#1)
18 h of##2##3##(2008-10#1)(2008-8#1)
18 h##14##2##(1990-6#1)(1995-11#5)(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-6#1)(2012-2#1)
18 h(-1)##3##2##(2008-10#2)(2011-2#1)
18 had##5##2##(1991-6#1)(1993-3#1)(2008-10#1)(2008-7#2)
18 hours##6##2##(1991-12#1)(1993-8#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-1#1)
18 in##6##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)
18 isolates##3##2##(2008-10#3)
18 kDa Translocator Protein (TSPO)##2##5##(2012-2#2)
18 kDa##6##2##(2008-10#1)(2012-2#5)
18 kb##2##2##(1997-7#1)(1997-8#1)
18 mm##2##2##(2008-8#1)(2012-2#1)
18 months after##2##3##(1994-12#1)(2013-1#1)
18 months of age##6##4##(1993-12#2)(2008-10#1)(2008-7#1)(2008-9#2)
18 months of##8##3##(1990-2#1)(1990-6#1)(1993-12#2)(2008-10#1)(2008-7#1)(2008-9#2)
18 months##34##2##(1990-2#1)(1990-6#2)(1991-11#1)(1991-8#2)(1993-1#1)(1993-12#2)(1994-12#1)(1996-1#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#3)(2009-10#1)(2010-2#1)(2010-6#3)(2011-2#2)(2013-1#3)
18 months)##2##2##(1990-6#1)(1996-11#1)
18 mug l(-1) for##2##4##(2008-10#2)
18 mug##5##2##(2008-10#5)
18 mum##2##2##(2008-10#1)(2009-5#1)
18 of the##3##3##(1992-12#1)(2008-8#2)
18 of##12##2##(1992-12#1)(1994-3#1)(2008-10#1)(2008-8#5)(2009-8#1)(2011-2#1)(2013-1#2)
18 patients and##2##3##(2008-10#1)(2008-7#1)
18 patients had##2##3##(1995-12#2)
18 patients with##4##3##(1990-2#1)(1992-11#1)(1996-11#1)(2008-7#1)
18 patients##15##2##(1990-2#1)(1992-11#1)(1995-12#2)(1996-11#1)(1996-6#1)(2008-10#3)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#2)
18 s-1)##2##2##(1990-9#2)
18 samples of##2##3##(2008-10#2)
18 samples##5##2##(2008-10#5)
18 to 28##2##3##(2008-10#1)(2013-1#1)
18 to##16##2##(1992-1#2)(1996-2#2)(2008-1#1)(2008-10#6)(2008-11#1)(2012-3#1)(2013-1#3)
18 volatile organohalogen compounds##2##4##(2008-10#2)
18 weeks of##2##3##(1993-3#1)(2008-5#1)
18 weeks##5##2##(1993-3#1)(2008-5#1)(2010-12#2)(2012-3#1)
18 were##4##2##(1996-5#1)(2008-10#2)(2008-7#1)
18 x##2##2##(2008-12#1)(2009-5#1)
18 years were##2##3##(1997-3#1)(2011-1#1)
18 years##12##2##(1994-9#1)(1997-3#1)(2008-10#1)(2009-12#1)(2010-1#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)
18##464##1##(1990-11#3)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#7)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#4)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#6)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-3#3)(1994-9#1)(1995-11#7)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#1)(1996-9#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#151)(2008-11#22)(2008-12#10)(2008-3#2)(2008-4#4)(2008-5#6)(2008-7#14)(2008-8#17)(2008-9#9)(2009-1#1)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#6)(2010-1#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#6)(2010-8#1)(2011-1#4)(2011-2#19)(2011-3#1)(2012-12#2)(2012-2#13)(2012-3#12)(2013-1#25)(2013-8#4)
18% of patients with##2##4##(1991-8#1)(2012-3#1)
18% of the##8##3##(1990-12#1)(1990-2#1)(1991-8#1)(1993-11#1)(1993-6#1)(2008-10#2)(2008-11#1)
18% of##14##2##(1990-12#1)(1990-2#1)(1991-8#2)(1992-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
18% to##2##2##(2008-10#1)(2008-8#1)
18%##34##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-8#2)(1992-5#2)(1993-11#2)(1993-6#1)(1993-8#1)(1996-12#2)(1996-2#1)(2008-10#7)(2008-11#2)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
18%)##3##1##(1990-2#1)(1990-3#1)(1996-11#1)
18)##14##1##(1992-1#1)(1994-3#1)(2008-10#5)(2009-8#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
18)(q32##2##1##(2009-8#1)(2010-11#1)
18)+##2##1##(2009-8#2)
18-20 years##2##2##(2010-1#1)(2012-2#1)
18-24##2##1##(1995-2#1)(2013-1#1)
18-40##2##1##(1996-2#2)
18-64 years##2##2##(1990-8#1)(2011-2#1)
18-crown-6 (18C6)##2##2##(2008-10#2)
18-crown-6 and##4##2##(2008-10#4)
18-crown-6 ether##4##2##(2008-10#4)
18-crown-6##13##1##(2008-10#13)
18-day##2##1##(1995-11#1)(2008-10#1)
18-fold##2##1##(2008-10#1)(2008-11#1)
18-hydroxycorticosterone##2##1##(1990-5#1)(2008-4#1)
18-kDa peptide##2##2##(1995-12#1)(2008-10#1)
18-kDa##4##1##(1993-9#1)(1995-12#1)(2008-10#2)
18-month follow-up##2##2##(2008-5#1)(2011-2#1)
18-month##10##1##(1996-5#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
18-month-old##5##1##(1993-12#1)(2008-10#2)(2008-9#1)(2010-6#1)
18-octabromo-5##2##1##(2008-10#2)
18-tetramethyl-21H##2##1##(2008-10#2)
18-year##2##1##(2008-10#1)(2012-7#1)
180 days##4##2##(1990-12#1)(2008-10#2)(2011-2#1)
180 degrees -phase##2##3##(2008-10#1)(2008-8#1)
180 degrees backscatter##3##3##(2008-2#3)
180 degrees##8##2##(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)
180 isolates##2##2##(2008-10#2)
180 s preconcentration time##2##4##(2008-10#2)
180 s##5##2##(2008-10#5)
180##53##1##(1990-12#1)(1990-5#1)(1991-6#1)(1992-10#1)(1996-12#2)(1996-6#1)(2008-10#22)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-7#1)(2010-11#1)(2011-2#2)
180-200##2##1##(2008-10#1)(2010-4#1)
1800##6##1##(1992-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
180s)##2##1##(2008-10#2)
181##7##1##(1990-12#1)(1991-2#1)(2008-10#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-2#1)
181-bp PRE##3##2##(2012-3#3)
181-bp##4##1##(2008-10#1)(2012-3#3)
182##12##1##(1991-6#1)(1996-1#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2011-2#1)
182)##4##1##(1990-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
1829##2##1##(2011-2#2)
183##8##1##(1990-6#2)(1997-1#1)(2008-10#3)(2008-8#1)(2011-2#1)
183-aa##2##1##(1993-2#1)(2013-8#1)
1836) and Camerotrombidium pexatum (C##2##5##(2007-12#2)
184##8##1##(1993-11#1)(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#2)
1840##3##1##(1994-12#1)(2008-12#1)(2012-12#1)
1848##2##1##(2012-2#2)
185 mg##2##2##(2008-10#1)(2008-11#1)
185##9##1##(1994-6#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-4#1)(2011-2#1)
1850##3##1##(2008-3#1)(2009-10#1)(2011-2#1)
1854##2##1##(2008-11#2)
18558 and##2##2##(2008-10#2)
186##7##1##(1994-8#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
187 patients##2##2##(2011-2#1)(2012-5#1)
187##13##1##(1991-8#1)(1993-3#2)(1996-12#1)(2006-6#1)(2008-10#1)(2008-12#1)(2009-10#1)(2011-2#2)(2012-2#2)(2012-5#1)
1870##3##1##(2008-8#2)(2011-2#1)
188##4##1##(1992-2#1)(1994-12#1)(2011-3#1)(2012-12#1)
189##5##1##(1990-12#1)(1994-12#1)(2008-10#1)(2011-2#2)
1897##2##1##(1991-6#1)(2008-7#1)
18C6##7##1##(2008-10#7)
18F-FDG##2##1##(2012-3#2)
18O##3##1##(1991-9#3)
18O-labeled##3##1##(2008-4#3)
18S and 5##2##3##(2008-10#1)(2008-9#1)
18S rRNA##2##2##(2008-9#1)(2013-1#1)
18S ribosomal DNA##2##3##(2008-10#2)
18S##12##1##(2008-10#8)(2008-9#3)(2013-1#1)
18]##2##1##(2011-2#1)(2012-3#1)
18mugl(-1)##2##1##(2008-10#2)
18q##2##1##(1997-3#1)(1997-6#1)
18th century##5##2##(1993-11#2)(2008-12#2)(2010-1#1)
18th##11##1##(1993-11#3)(2008-1#1)(2008-10#1)(2008-12#3)(2008-6#1)(2010-1#1)(2011-2#1)
18 nm##2##1##(2012-2#2)
18 weeks##2##1##(2013-8#2)
19 (53%)##2##2##(2011-2#1)(2013-1#1)
19 (58%)##2##2##(2012-12#1)(2013-1#1)
19 +/- 0##2##3##(1994-11#1)(2009-11#1)
19 +/-##3##2##(1994-11#1)(2009-11#1)(2011-2#1)
19 -##2##2##(2008-11#2)
19 and 22##3##3##(1994-3#1)(2008-10#2)
19 and##10##2##(1994-3#1)(2008-10#6)(2008-3#1)(2008-7#1)(2011-2#1)
19 cases##5##2##(1990-2#1)(1991-11#2)(2007-8#1)(2008-10#1)
19 counties##2##2##(1991-6#1)(1995-2#1)
19 degrees C##3##3##(2008-10#3)
19 different##2##2##(2008-10#1)(2008-5#1)
19 elements##2##2##(2008-10#2)
19 for##2##2##(2008-10#1)(2011-1#1)
19 in##2##2##(1990-6#1)(2008-10#1)
19 kDa##2##2##(1994-8#1)(2007-12#1)
19 mmol l(-1)##2##3##(2008-10#2)
19 months##5##2##(1990-5#2)(1994-1#1)(1994-12#1)(1996-3#1)
19 of the##3##3##(2008-10#1)(2011-2#2)
19 of##4##2##(1995-12#1)(2008-10#1)(2011-2#2)
19 patients were##2##3##(1993-2#1)(2012-3#1)
19 patients##15##2##(1993-2#2)(1995-12#1)(1996-11#1)(1997-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#4)(2012-3#2)
19 percent##2##2##(1993-3#1)(1995-3#1)
19 races##2##2##(2008-10#2)
19 to##4##2##(2008-10#3)(2008-11#1)
19 transgenic##2##2##(2008-10#2)
19 weeks##3##2##(1995-9#1)(2008-10#2)
19 were##2##2##(1990-2#1)(2013-1#1)
19 years)##2##2##(2008-11#1)(2010-1#1)
19##277##1##(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#2)(1991-1#3)(1991-11#3)(1991-3#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-3#1)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#90)(2008-11#12)(2008-12#10)(2008-3#3)(2008-5#5)(2008-7#7)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#16)(2012-12#4)(2012-2#2)(2012-3#7)(2013-1#11)(2013-8#5)
19% of cases##2##3##(1992-5#1)(1994-3#1)
19% of the##2##3##(2008-10#1)(2008-7#1)
19% of##10##2##(1990-3#1)(1992-5#1)(1994-3#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2013-1#1)
19%##30##1##(1990-3#1)(1991-6#1)(1992-5#1)(1994-3#1)(1997-2#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
19%)##3##1##(2008-5#2)(2012-2#1)
19) in##2##2##(2008-11#1)(2009-9#1)
19)##10##1##(1990-6#1)(1990-9#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-11#3)(2009-9#1)(2011-3#1)
19-20##3##1##(2008-11#1)(2008-9#1)(2011-2#1)
19-crown-6##2##1##(2008-10#2)
19-day-old##3##1##(1996-12#2)(2008-10#1)
190 patients##2##2##(1997-8#1)(2011-2#1)
190##16##1##(1990-12#1)(1990-2#1)(1992-10#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-10#6)(2010-11#1)(2010-4#1)(2011-2#1)
1900##11##1##(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#2)(2011-2#1)
1901##3##1##(2011-2#3)
1902##3##1##(2008-10#1)(2010-1#2)
1903 to##2##2##(2008-10#2)
1904##2##1##(2007-12#1)(2010-1#1)
1905)##2##1##(1990-8#2)
1906##6##1##(1990-11#3)(2008-10#2)(2011-4#1)
1907##3##1##(2008-10#1)(2008-12#1)(2008-7#1)
191##9##1##(1991-1#1)(1997-8#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#2)
1910##3##1##(1991-8#1)(2010-1#1)(2011-2#1)
1912 to 1998##2##3##(2008-10#2)
1912 to##3##2##(2008-10#3)
1912##7##1##(2008-10#4)(2008-12#1)(2008-8#2)
1913##3##1##(1991-8#1)(2011-2#1)(2011-4#1)
1913)##2##1##(2011-2#2)
1914 to##2##2##(2008-10#2)
1915 to##2##2##(2008-10#2)
1915##4##1##(2008-10#3)(2010-1#1)
1917##4##1##(2010-1#1)(2011-2#3)
1917)##2##1##(2010-10#1)(2010-7#1)
1918##4##1##(2008-10#1)(2010-1#1)(2010-5#1)(2013-8#1)
1919 to##2##2##(2008-10#2)
192 patients##2##2##(1994-12#1)(1997-8#1)
192##13##1##(1991-3#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-6#1)(1997-8#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
1920##3##1##(2008-10#2)(2008-8#1)
1921 to##2##2##(1991-3#1)(2008-10#1)
1921##5##1##(1991-3#1)(1996-9#1)(2008-10#1)(2011-2#2)
1923##2##1##(1993-6#1)(2011-2#1)
1925##2##1##(2010-1#1)(2011-2#1)
1926##2##1##(2008-10#2)
1927 and##2##2##(2010-1#1)(2010-7#1)
1927##4##1##(2008-10#2)(2010-1#1)(2010-7#1)
1928##3##1##(2008-10#2)(2008-7#1)
193##9##1##(1991-3#1)(1994-12#1)(2008-10#2)(2008-3#3)(2010-8#1)(2013-8#1)
193-nm##2##1##(2008-3#2)
1930 to 2003##2##3##(2008-10#2)
1930##5##1##(1991-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
1936 to##2##2##(2008-10#2)
194##7##1##(1993-3#1)(1995-1#1)(1995-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
1940##4##1##(1990-8#1)(1994-5#1)(2008-10#1)(2009-10#1)
1940s##7##1##(1991-12#1)(1993-6#1)(2008-8#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
1942##3##1##(1994-12#1)(2011-2#2)
1944##2##1##(2008-12#1)(2010-1#1)
1946##4##1##(1991-12#1)(1997-8#1)(2011-4#2)
1947##2##1##(2008-10#1)(2010-1#1)
1949##2##1##(1994-6#1)(2008-10#1)
195 and##2##2##(1991-3#1)(2012-12#1)
195 isolates##3##2##(2008-10#3)
195 to##2##2##(1991-3#1)(2008-5#1)
195##24##1##(1991-3#3)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
1950##6##1##(1990-8#2)(1991-3#1)(1993-6#1)(2008-10#2)
1950s##8##1##(1992-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-10#1)
1951##2##1##(2008-10#1)(2010-8#1)
1953##2##1##(2008-10#1)(2012-3#1)
1954##2##1##(1994-9#1)(2008-12#1)
1955##2##1##(1994-3#1)(2013-7#1)
1956##4##1##(1996-1#1)(2008-10#3)
1956)##2##1##(1993-3#1)(2011-2#1)
1957##3##1##(1997-8#1)(2008-9#2)
1958##2##1##(1993-12#1)(2008-9#1)
1959 and##2##2##(1991-12#1)(2008-10#1)
1959##5##1##(1991-12#2)(2008-10#2)(2008-9#1)
196##8##1##(1991-11#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2013-1#1)
1960##9##1##(1991-2#1)(1993-6#1)(1995-2#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-7#1)(2010-1#1)
1960s by##2##2##(2008-10#1)(2010-7#1)
1960s##18##1##(1992-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-7#1)(2013-1#1)
1964##5##1##(1994-1#1)(2008-10#2)(2008-9#1)(2009-7#1)
1965 to##2##2##(1991-12#1)(2008-10#1)
1965##6##1##(1991-12#1)(1992-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
1966##6##1##(1990-3#1)(1991-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)
1967##2##1##(1990-12#1)(2008-10#1)
1968##5##1##(1992-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)
1969##2##1##(1995-2#1)(2008-11#1)
197##11##1##(1990-12#1)(1991-6#1)(1992-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
1970 and##2##2##(1997-4#1)(2012-12#1)
1970 to##6##2##(1991-2#1)(1994-9#1)(1997-4#2)(1997-8#1)(2008-12#1)
1970##20##1##(1990-11#2)(1990-6#1)(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1994-9#1)(1995-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2008-12#1)(2010-6#1)(2010-8#1)(2012-12#1)
1970-1987##2##1##(1992-2#2)
1970s and 1980s##3##3##(1996-9#1)(2008-10#1)(2008-12#1)
1970s and##4##2##(1996-5#1)(1996-9#1)(2008-10#1)(2008-12#1)
1970s the##2##2##(1991-3#1)(2008-11#1)
1970s##30##1##(1991-2#2)(1991-3#3)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#3)(2009-6#1)(2009-7#1)
1971##4##1##(1993-6#1)(1994-9#1)(1997-6#1)(2008-10#1)
1972 through##2##2##(1991-3#1)(1996-3#1)
1972 to##2##2##(1991-9#1)(1992-9#1)
1972##10##1##(1991-12#1)(1991-3#1)(1991-9#1)(1992-9#1)(1996-3#2)(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
1974 to##2##2##(1995-12#1)(2008-10#1)
1974##8##1##(1990-3#1)(1990-5#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-10#2)(2008-3#1)
1975 and##4##2##(1992-6#1)(1994-3#1)(1997-2#1)(2012-12#1)
1975##17##1##(1990-9#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#2)
1976 and##2##2##(1990-9#1)(2008-10#1)
1976##8##1##(1990-9#1)(1996-3#2)(1997-2#1)(2008-10#2)(2008-12#1)(2011-2#1)
1977 to 1992##2##3##(1993-12#2)
1977 to##3##2##(1991-8#1)(1993-12#2)
1977##10##1##(1991-2#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-12#2)(1994-9#2)(1995-12#1)(2008-10#1)
1978 to##3##2##(1991-2#1)(1993-2#1)(1993-6#1)
1978##16##1##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-12#1)
1978-93##2##1##(1996-3#2)
1979 and##2##2##(1992-3#1)(2012-12#1)
1979 to##3##2##(2008-12#1)(2012-12#2)
1979##13##1##(1990-6#1)(1992-3#1)(1993-12#2)(1995-2#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#3)
1979-88##2##1##(1990-6#2)
198 patients##2##2##(1994-12#1)(2013-8#1)
198##6##1##(1991-12#1)(1993-12#1)(1994-12#1)(2008-10#1)(2012-12#1)(2013-8#1)
1980 and 1989##2##3##(1990-9#1)(1993-2#1)
1980 and 1995##2##3##(2008-7#1)(2010-7#1)
1980 and##11##2##(1990-3#1)(1990-9#1)(1993-2#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
1980 to 1988##2##3##(1990-3#1)(1990-5#1)
1980 to##6##2##(1990-3#1)(1990-5#1)(1994-2#1)(1994-3#1)(1997-8#1)(2008-10#1)
1980##31##1##(1990-3#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#2)(1992-3#1)(1993-2#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-3#1)(1997-5#1)(1997-8#1)(2008-10#6)(2008-7#2)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#2)
1980's##4##1##(1997-2#1)(2008-10#1)(2008-11#2)
1980-1994##2##1##(1997-1#2)
1980-87##3##1##(1990-2#1)(1990-9#1)(1996-2#1)
1980-89##2##1##(1990-9#1)(1997-8#1)
1980-90##2##1##(1993-3#1)(1994-2#1)
1980-92##2##1##(1996-3#2)
1980s and##4##2##(1991-3#1)(2008-10#2)(2008-5#1)
1980s##28##1##(1991-11#1)(1991-3#2)(1992-2#1)(1993-3#2)(1994-2#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#2)(1996-9#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
1981 and##7##2##(1991-2#1)(1991-8#1)(1992-12#1)(1995-12#1)(2008-10#1)(2012-12#1)(2012-3#1)
1981##24##1##(1990-12#2)(1990-3#1)(1991-1#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-1#2)(1994-3#1)(1995-12#1)(2008-10#3)(2008-5#2)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
1981-84##2##1##(1992-12#1)(1993-3#1)
1981/1982##3##1##(2009-10#3)
1982 New Beneficiary Survey##2##4##(1993-1#1)(1995-2#1)
1982 and##5##2##(1991-1#1)(1993-6#1)(1996-5#1)(1997-6#1)(2008-11#1)
1982 to 1987##2##3##(1992-1#1)(1992-5#1)
1982 to##5##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-5#1)(1994-9#1)
1982##26##1##(1990-12#1)(1991-1#2)(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#2)
1982-83##2##1##(1993-3#2)
1982-90##2##1##(1995-3#2)
1983 the##2##2##(1990-3#1)(1990-9#1)
1983 through 1986##2##3##(1991-12#2)
1983 to 1991##2##3##(2008-10#2)
1983 to 2000##2##3##(2008-10#2)
1983 to##6##2##(1991-9#1)(1994-2#1)(2008-10#4)
1983##37##1##(1990-11#1)(1990-12#1)(1990-3#5)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-9#2)(1992-2#4)(1994-2#2)(1995-2#1)(1995-6#1)(1996-11#1)(2008-10#8)(2008-8#1)(2010-1#1)(2011-2#2)
1983)##3##1##(2008-12#2)(2011-2#1)
1984 National Long-Term Care##2##4##(1991-1#1)(1993-3#1)
1984 and 1985##2##3##(1993-3#1)(1996-11#1)
1984 and##10##2##(1990-6#1)(1991-2#1)(1992-12#2)(1993-1#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-3#1)
1984 through##2##2##(1992-12#1)(2008-8#1)
1984 to 1989##2##3##(1993-8#1)(1994-3#1)
1984 to##8##2##(1991-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-9#1)(2008-10#2)(2011-2#1)
1984##40##1##(1990-3#2)(1990-6#2)(1990-9#1)(1991-1#2)(1991-2#2)(1991-3#1)(1992-12#3)(1992-2#2)(1992-3#2)(1993-1#3)(1993-3#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#1)
1984)##2##1##(1990-8#1)(2011-2#1)
1984-92##2##1##(1995-12#1)(1996-1#1)
1985 and##4##2##(1991-1#1)(1991-8#1)(1997-7#1)(2008-9#1)
1985 through 1987##3##3##(1991-12#1)(1993-1#1)(1993-12#1)
1985 through##5##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#1)
1985 to##5##2##(1992-5#1)(1993-3#1)(1994-1#1)(1996-3#1)(2012-3#1)
1985##50##1##(1990-2#2)(1990-3#1)(1990-8#2)(1991-1#3)(1991-12#2)(1991-3#4)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#2)(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
1985-1988##2##1##(1990-12#1)(1995-1#1)
1985-1989##2##1##(1991-1#1)(1991-11#1)
1985-88##2##1##(1991-3#1)(1992-12#1)
1985-89##2##1##(1991-11#1)(1992-1#1)
1985-90##3##1##(1991-6#2)(1993-3#1)
1986 and 1988##3##3##(1992-2#1)(1993-1#2)
1986 and##9##2##(1990-3#1)(1991-2#1)(1992-2#1)(1993-1#2)(1994-6#2)(1995-2#1)(2008-10#1)
1986 the##2##2##(1991-1#1)(1991-6#1)
1986 to 1989##2##3##(2008-10#2)
1986 to##10##2##(1990-12#1)(1991-2#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1996-11#1)(2008-10#2)(2011-2#1)
1986##55##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#2)(1991-12#3)(1991-2#9)(1991-3#1)(1991-6#1)(1992-2#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-2#2)(1996-11#1)(1996-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2011-2#3)
1986-1991##2##1##(1994-12#1)(1996-1#1)
1986]##2##1##(1993-2#1)(2008-12#1)
1987 and 1988##2##3##(1991-1#1)(1992-2#1)
1987 and December##2##3##(1990-12#1)(1994-12#1)
1987 and##6##2##(1990-12#1)(1991-1#1)(1992-2#1)(1994-12#1)(2008-10#1)(2008-8#1)
1987 to 1992##2##3##(1995-3#1)(2008-10#1)
1987 to##5##2##(1993-12#1)(1995-3#2)(2008-10#2)
1987##56##1##(1990-12#2)(1990-2#1)(1990-3#2)(1991-1#4)(1991-12#1)(1991-2#6)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#6)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-6#1)(1995-3#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2011-3#1)
1988 and##10##2##(1990-6#1)(1991-1#2)(1997-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-3#1)
1988 to##8##2##(1994-9#1)(1995-12#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-9#2)
1988##94##1##(1990-12#6)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#4)(1991-12#1)(1991-2#6)(1991-3#8)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#4)(1993-1#4)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#6)(2008-12#1)(2008-5#4)(2008-7#1)(2008-9#3)(2012-3#1)
1988)##4##1##(1991-2#1)(1994-8#2)(2008-11#1)
1988-1992##3##1##(1994-9#1)(1997-7#2)
1989 and 1991##2##3##(1995-1#1)(1996-1#1)
1989 and 1996##2##3##(1997-8#1)(2008-10#1)
1989 and##11##2##(1991-8#1)(1992-12#2)(1994-3#1)(1995-1#2)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#2)
1989 in##2##2##(1992-5#1)(1993-2#1)
1989 physician payment##2##3##(1994-1#1)(1995-12#1)
1989 through##2##2##(1997-2#1)(2008-10#1)
1989 to##10##2##(1990-12#1)(1992-9#1)(1995-1#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-9#1)
1989 was##3##2##(1990-6#2)(1994-1#1)
1989##115##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-6#6)(1990-8#2)(1990-9#2)(1991-1#6)(1991-12#2)(1991-2#2)(1991-3#6)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#5)(1992-1#3)(1992-12#9)(1992-2#5)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#3)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#2)(1996-3#3)(1996-5#1)(1997-2#1)(1997-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)
1989)##3##1##(1991-6#1)(2008-11#1)(2008-12#1)
1989-1990##3##1##(1990-12#1)(1996-1#1)(2008-10#1)
1989-90##4##1##(1992-6#4)
1989]##2##1##(1990-2#1)(1990-6#1)
199##6##1##(1990-11#1)(1994-12#1)(1995-12#2)(2008-9#1)(2011-2#1)
1990 a##3##2##(1991-6#1)(1992-5#1)(2008-11#1)
1990 and 1995##2##3##(1996-11#2)
1990 and##12##2##(1994-12#1)(1994-2#1)(1996-11#2)(2007-8#1)(2008-10#5)(2013-1#2)
1990 contract##2##2##(1990-3#2)
1990 in##3##2##(1990-12#1)(1995-3#1)(1996-6#1)
1990 is##2##2##(2009-10#1)(2011-2#1)
1990 to##15##2##(1991-2#1)(1992-2#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2011-2#1)(2012-12#1)
1990##118##1##(1990-11#6)(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#2)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#4)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#2)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#4)(1997-5#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-5#2)(2009-10#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
1990's##3##1##(2008-10#1)(2008-11#2)
1990)##4##1##(1994-5#1)(1995-3#1)(1997-1#1)(2011-2#1)
1990-1991##4##1##(1991-8#1)(1994-6#2)(1996-3#1)
1990-2005##2##1##(1992-3#1)(1993-1#1)
1990-91##4##1##(1991-1#1)(1992-6#3)
1990/91##3##1##(2008-5#3)
1990]##2##1##(1990-2#1)(1991-2#1)
1990s##49##1##(1990-11#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-6#1)(2010-12#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#2)
1991 and##13##2##(1992-5#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#1)
1991 the##3##2##(1993-1#1)(1993-6#1)(1997-4#1)
1991 to 1993##3##3##(1995-12#1)(1995-3#1)(2008-10#1)
1991 to##9##2##(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#1)(2008-10#2)(2010-12#2)
1991##92##1##(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#5)(1992-3#5)(1992-5#2)(1992-6#1)(1992-9#3)(1993-1#5)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#3)(1994-12#2)(1994-3#1)(1994-9#3)(1995-1#5)(1995-12#5)(1995-2#1)(1995-3#2)(1996-1#2)(1996-11#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#14)(2008-12#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-3#1)(2010-12#2)(2010-3#1)(2011-2#3)
1991)##9##1##(1992-4#1)(1992-9#1)(1994-5#1)(1994-6#1)(1997-6#1)(2008-11#2)(2009-10#1)(2011-2#1)
1991/1992##3##1##(2009-10#3)
1992 and 1993##6##3##(1995-12#1)(2008-10#5)
1992 and##12##2##(1995-1#1)(1995-12#1)(1996-2#1)(1996-9#1)(2008-10#5)(2008-7#1)(2012-3#1)(2013-1#1)
1992 data##2##2##(1996-3#1)(1996-5#1)
1992 from##2##2##(1994-9#1)(2008-10#1)
1992 to 1995##3##3##(2008-10#3)
1992 to##12##2##(1993-12#1)(1994-6#1)(1995-5#1)(1996-9#1)(2008-10#5)(2008-3#1)(2009-10#1)(2010-8#1)
1992##113##1##(1990-12#1)(1990-6#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#4)(1995-5#1)(1996-1#4)(1996-11#1)(1996-2#1)(1996-3#13)(1996-5#1)(1996-9#2)(1997-3#3)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
1992)##7##1##(1994-8#2)(1997-1#2)(2008-12#2)(2010-3#1)
1992-1993##2##1##(1996-1#1)(2008-3#1)
1992-1994##2##1##(1997-3#1)(2012-2#1)
1992-93##3##1##(1994-3#1)(1994-9#1)(1995-12#1)
1993 and 1994##2##3##(1996-6#1)(2008-10#1)
1993 and##8##2##(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-9#1)(2012-3#1)
1993 from##2##2##(2008-10#1)(2011-2#1)
1993 through##2##2##(1994-9#1)(2008-10#1)
1993 to 1995##2##3##(2008-10#2)
1993 to 1998##3##3##(2008-1#1)(2008-10#2)
1993 to##11##2##(1996-9#1)(2008-1#1)(2008-10#9)
1993##111##1##(1993-12#1)(1993-6#1)(1994-1#2)(1994-12#4)(1994-3#6)(1994-5#1)(1994-6#4)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#6)(1995-3#5)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#35)(2008-11#6)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-3#1)
1993)##5##1##(1994-11#1)(1994-6#2)(1996-9#1)(1997-7#1)
1993-1994##2##1##(1995-3#1)(2008-11#1)
1993]##2##1##(1994-5#1)(1997-3#1)
1994 and 1995##5##3##(1996-11#1)(2008-10#4)
1994 and##12##2##(1996-11#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-5#1)(2012-3#1)
1994 in##2##2##(1996-2#1)(2008-10#1)
1994 through 1996##3##3##(2008-10#3)
1994 to 1996##6##3##(1994-1#1)(1997-6#1)(2008-10#4)
1994 to##14##2##(1994-1#1)(1997-6#1)(2008-10#7)(2008-7#2)(2008-9#1)(2011-2#2)
1994##126##1##(1992-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#10)(1995-12#5)(1995-2#3)(1995-3#6)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#4)(1996-11#3)(1996-2#5)(1996-3#3)(1996-6#2)(1997-2#5)(1997-3#4)(1997-6#4)(2008-10#40)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2012-6#1)
1994)##15##1##(1994-11#1)(1994-5#2)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#4)(2009-10#1)(2011-2#1)
1994-1998##2##1##(2007-8#2)
1994-2005##2##1##(1996-2#1)(1997-1#1)
1995 and 1996##10##3##(2008-10#10)
1995 and##21##2##(1997-2#1)(2008-10#15)(2008-11#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
1995 are##2##2##(1995-12#1)(2008-7#1)
1995 as part of a##2##5##(1995-6#1)(2008-2#1)
1995 for##2##2##(2008-11#1)(2008-7#1)
1995 the##3##2##(1996-11#1)(2008-11#1)(2008-7#1)
1995 to 1996##4##3##(2008-10#4)
1995 to 1997##4##3##(2007-12#1)(2008-10#3)
1995 to 1998##3##3##(2008-10#2)(2008-11#1)
1995 to##20##2##(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#1)(2010-12#1)(2012-12#1)
1995 was##2##2##(1996-11#1)(1997-3#1)
1995 we##3##2##(1996-11#1)(1996-9#1)(2008-7#1)
1995##134##1##(1992-6#1)(1994-6#1)(1995-12#8)(1995-3#3)(1995-6#3)(1996-1#3)(1996-11#8)(1996-3#1)(1996-5#5)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#6)(1997-8#3)(2007-12#1)(2008-10#53)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#9)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)
1995)##9##1##(1992-6#1)(1995-12#1)(1996-11#1)(1997-6#1)(2008-10#3)(2008-11#1)(2011-2#1)
1995]##2##1##(1995-12#1)(1997-3#1)
1996 and 1997##16##3##(1996-1#1)(2008-10#13)(2008-11#2)
1996 and##26##2##(1996-1#1)(2008-10#20)(2008-11#3)(2011-2#1)(2012-3#1)
1996 as##2##2##(2008-11#2)
1996 at##2##2##(2008-10#2)
1996 in the##2##3##(2008-10#1)(2008-11#1)
1996 in##4##2##(2008-10#3)(2008-11#1)
1996 is the type species of the genus##2##8##(2011-2#2)
1996 is##3##2##(1994-1#1)(2011-2#2)
1996 to 1997##4##3##(2008-10#4)
1996 to##13##2##(2008-10#9)(2008-11#1)(2011-7#1)(2012-12#1)(2013-1#1)
1996 were##4##2##(1997-6#2)(2008-10#1)(2008-7#1)
1996##144##1##(1994-1#1)(1995-6#2)(1996-1#2)(1996-11#5)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#11)(1997-8#2)(2007-12#1)(2008-10#73)(2008-11#13)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#5)(2008-9#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
1996)##7##1##(1997-4#1)(2008-10#3)(2008-11#2)(2011-2#1)
1996-97##2##1##(2008-10#2)
1996]##3##1##(1997-5#1)(2008-11#1)(2008-12#1)
1997 (P = 0##2##4##(2008-10#2)
1997 and 1998##9##3##(2008-10#9)
1997 and 1999##2##3##(2008-10#2)
1997 and##21##2##(2008-10#17)(2008-11#1)(2009-12#1)(2011-1#1)(2013-8#1)
1997 for the##2##3##(2008-10#2)
1997 for##3##2##(2008-10#2)(2008-8#1)
1997 in##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
1997 of the##2##3##(2008-11#1)(2008-9#1)
1997 through##2##2##(2008-10#2)
1997 to 1998##2##3##(2008-10#2)
1997 to 1999##2##3##(2008-10#2)
1997 to 2000##2##3##(2008-10#2)
1997 to##10##2##(2008-10#8)(2008-11#1)(2013-1#1)
1997 was##2##2##(2008-10#2)
1997 were##4##2##(2008-10#4)
1997##223##1##(1994-12#1)(1996-1#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#94)(2008-11#11)(2008-12#7)(2008-3#2)(2008-5#7)(2008-7#73)(2008-8#1)(2008-9#2)(2009-12#3)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
1997)##10##1##(2008-10#2)(2008-11#6)(2008-5#1)(2012-2#1)
1997-1998##2##1##(2008-10#1)(2008-12#1)
1997-98##3##1##(2008-10#3)
1997a##2##1##(2008-11#2)
1998 and 1999 were##2##4##(2008-10#2)
1998 and 1999##8##3##(2008-10#8)
1998 and##17##2##(2008-10#16)(2012-12#1)
1998 in##2##2##(2008-10#1)(2008-5#1)
1998 through##3##2##(2008-10#2)(2008-12#1)
1998 to 1999##3##3##(2008-10#3)
1998 to 2000##4##3##(2008-10#4)
1998 to##12##2##(2008-10#10)(2008-11#1)(2008-12#1)
1998 were##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
1998##134##1##(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#89)(2008-11#13)(2008-12#3)(2008-3#2)(2008-5#12)(2008-7#1)(2008-9#3)(2010-10#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
1998)##7##1##(2008-10#3)(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#1)
1998-1999##2##1##(2008-10#1)(2010-1#1)
1998-99 and 1999-2000##2##3##(2008-10#2)
1998-99##3##1##(2008-10#3)
1998b)##2##1##(2008-11#2)
1999 and 2000##6##3##(2008-10#5)(2008-5#1)
1999 and##12##2##(2008-10#10)(2008-11#1)(2008-5#1)
1999 growing##2##2##(2008-10#2)
1999 in##3##2##(2008-10#2)(2009-10#1)
1999 to##9##2##(2008-10#5)(2008-11#1)(2010-5#1)(2010-8#1)(2013-8#1)
1999 were##5##2##(2008-10#4)(2008-9#1)
1999##119##1##(2008-10#68)(2008-11#24)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
1999)##14##1##(2008-11#7)(2008-12#3)(2008-9#2)(2009-10#1)(2011-2#1)
1999-2000##6##1##(2008-10#5)(2011-3#1)
1999-2002##3##1##(2010-8#1)(2012-2#2)
1999]##2##1##(2008-11#2)
1999a##2##1##(2008-11#2)
1999a)##2##1##(2008-11#2)
1999b##2##1##(2008-11#2)
19C6##7##1##(2008-10#7)
19F NMR spectroscopy##3##3##(1994-8#3)
19F NMR##4##2##(1994-8#4)
19F##5##1##(1994-8#4)(1996-2#1)
19NUIG##2##1##(2008-11#2)
19mM for Sherry wines##2##4##(2008-10#2)
19th century##8##2##(1991-6#1)(1993-11#1)(1994-5#1)(1996-1#1)(2008-10#1)(2008-12#1)(2010-1#1)(2012-2#1)
19th##11##1##(1991-6#1)(1993-11#2)(1994-5#1)(1995-11#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#1)(2012-2#1)
1A##14##1##(1995-12#2)(1997-3#1)(2008-10#8)(2008-8#1)(2009-8#1)(2011-1#1)
1A1##2##1##(2008-11#1)(2011-1#1)
1AS##4##1##(2008-10#4)
1B##5##1##(2008-10#4)(2008-11#1)
1B1##2##1##(2011-2#2)
1BL##3##1##(2008-10#3)
1D and 2D NMR##2##4##(2010-6#1)(2013-1#1)
1D and##3##2##(2010-11#1)(2010-6#1)(2013-1#1)
1D objects##2##2##(2008-6#2)
1D##10##1##(1993-12#2)(2008-10#1)(2008-6#3)(2008-9#1)(2010-11#1)(2010-6#1)(2013-1#1)
1DUVS##4##1##(2008-10#4)
1H NMR studies##2##3##(1994-5#2)
1H NMR##16##2##(1990-9#2)(1992-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#8)(2011-3#2)
1H and 13C NMR##3##4##(1991-5#1)(1992-12#1)(2008-11#1)
1H and##6##2##(1991-5#1)(1992-12#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)
1H magnetic resonance##2##3##(2008-11#2)
1H##59##1##(1990-9#2)(1991-5#1)(1992-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-5#10)(1995-2#1)(2008-10#4)(2008-11#3)(2009-7#28)(2011-3#2)
1H-NMR and molecular modeling##2##4##(1994-5#2)
1H-NMR spectroscopy##3##2##(1991-12#2)(1994-3#1)
1H-NMR urinalysis is##2##3##(1993-2#2)
1H-NMR urinalysis##4##2##(1993-2#4)
1H-NMR##11##1##(1990-5#2)(1991-12#2)(1993-2#4)(1994-3#1)(1994-5#2)
1M HCl##7##2##(2008-10#7)
1M KCl##3##2##(2008-10#3)
1M NaOH##2##2##(2008-10#1)(2011-2#1)
1M phosphate buffer##3##3##(2008-10#3)
1M potassium##2##2##(2008-10#2)
1M##40##1##(2008-10#38)(2011-2#2)
1O2##2##1##(1992-9#2)
1P##4##1##(2010-12#4)
1PP)##2##1##(2008-11#2)
1PS paper was##2##3##(2008-10#2)
1PS paper##8##2##(2008-10#8)
1PS##10##1##(2008-10#10)
1RS##2##1##(2008-10#2)
1S##3##1##(2008-10#1)(2012-3#2)
1]##10##1##(1990-2#1)(1990-3#1)(1991-2#1)(1993-5#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-5#1)(2008-6#1)
1]octane##3##1##(1996-5#3)
1a and 1b##2##3##(1992-12#1)(2008-10#1)
1a##13##1##(1992-12#1)(1995-11#1)(1996-5#4)(2008-10#3)(2008-11#1)(2008-8#1)(2009-10#1)(2009-9#1)
1a)##2##1##(1994-3#1)(2009-9#1)
1alpha##13##1##(1997-1#2)(2008-1#1)(2008-10#4)(2008-11#5)(2009-8#1)
1b##5##1##(1992-10#1)(1992-12#1)(1995-11#1)(1996-5#1)(2008-10#1)
1b)##2##1##(1994-3#1)(2008-10#1)
1beta##2##1##(2006-6#1)(2008-10#1)
1c and##2##2##(1996-5#1)(2011-2#1)
1cm##2##1##(2008-10#2)
1er trimestre##2##2##(2011-2#1)(2013-1#1)
1g of##3##2##(2008-10#3)
1g##6##1##(1993-8#2)(2008-10#3)(2008-7#1)
1h##5##1##(2007-8#2)(2008-10#1)(2008-11#1)(2010-6#1)
1l##2##1##(2008-10#2)
1mL of##2##2##(2008-10#2)
1mL##3##1##(2008-10#3)
1mM##10##1##(1996-2#1)(2008-10#8)(2012-2#1)
1mVdecade(-1)##2##1##(2008-10#2)
1mgL(-1)##2##1##(2008-10#2)
1mgl(-1)##4##1##(2008-10#4)
1min##8##1##(2008-10#8)
1ml of a##2##3##(2008-10#2)
1ml of##6##2##(2008-10#6)
1ml sample##2##2##(2008-10#2)
1ml##11##1##(2008-10#11)
1mm##3##1##(2008-10#3)
1mol/L##2##1##(2008-10#2)
1molL(-1)##3##1##(2008-10#3)
1moll(-1)##8##1##(2008-10#8)
1muM##2##1##(2008-10#2)
1mug/mL##2##1##(2008-10#2)
1mugL(-1)##2##1##(2008-10#2)
1mugl(-1) and##2##2##(2008-10#2)
1mugl(-1) for##2##2##(2008-10#2)
1mugl(-1)##13##1##(2008-10#13)
1mugl(-1))##2##1##(2008-10#2)
1mugml(-1) of##2##2##(2008-10#2)
1mugml(-1)##8##1##(2008-10#8)
1mum##3##1##(2008-10#3)
1nM##5##1##(1992-8#1)(1993-3#1)(2008-10#3)
1ng/ml##2##1##(2008-10#1)(2013-1#1)
1ngg(-1) for##2##2##(2008-10#2)
1ngml(-1) for##2##2##(2008-10#2)
1ngml(-1)##5##1##(2008-10#5)
1nm to##2##2##(2008-10#2)
1p)##2##1##(2009-12#2)
1ppb##4##1##(2008-10#4)
1ppm and##2##2##(2008-10#2)
1ppm##4##1##(2008-10#4)
1st##17##1##(1993-11#1)(1995-8#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
1x##3##1##(2008-10#1)(2008-11#1)(2008-3#1)
1x10(-1) to##2##2##(2008-10#2)
1x10(-1)##3##1##(2008-10#3)
1x10(-2) and##2##2##(2008-10#2)
1x10(-2)##6##1##(2008-10#6)
1x10(-3) M##4##2##(2008-10#4)
1x10(-3) mol l(-1)##3##3##(2008-10#3)
1x10(-3) to##3##2##(2008-10#3)
1x10(-3)##11##1##(2008-10#11)
1x10(-3)M##4##1##(2008-10#4)
1x10(-4) mol l(-1)##3##3##(2008-10#3)
1x10(-4) mol##4##2##(2008-10#4)
1x10(-4)##6##1##(2008-10#6)
1x10(-4)M##2##1##(2008-10#2)
1x10(-5) M##3##2##(2008-10#3)
1x10(-5) to##6##2##(2008-10#6)
1x10(-5)##15##1##(2008-10#15)
1x10(-5)M##3##1##(2008-10#3)
1x10(-6) M##4##2##(2008-10#4)
1x10(-6) to##5##2##(2008-10#5)
1x10(-6)##13##1##(2008-10#13)
1x10(-6)moldm(-3)##2##1##(2008-10#2)
1x10(-7) M##3##2##(2008-10#3)
1x10(-7) mol l(-1)##2##3##(2008-10#2)
1x10(-7) to##4##2##(2008-10#4)
1x10(-7)##9##1##(2008-10#9)
1x10(-7)M and##2##2##(2008-10#2)
1x10(-7)moldm(-3)##2##1##(2008-10#2)
1x10(-8) mol l(-1)##2##3##(2008-10#2)
1x10(-8)##6##1##(2008-10#6)
1x10(-8)M##5##1##(2008-10#5)
1x10(-9) M##3##2##(2008-10#3)
1x10(-9)##5##1##(2008-10#5)
1x10(4) l mol(-1)##2##3##(2008-10#2)
1x10(5)##2##1##(2008-10#2)
1 mg/kg##2##1##(2013-1#2)
2 %##6##2##(2008-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
2 %)##2##2##(2012-12#2)
2 (6##2##2##(2011-2#2)
2 (95%##2##2##(1991-11#1)(1994-12#1)
2 (metal to ligand)##2##4##(2008-10#2)
2 (metal##3##2##(2008-10#3)
2 +##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
2 +/- 0##3##3##(1996-12#1)(2008-10#2)
2 +/- 1##6##3##(1991-11#1)(1992-2#1)(1993-2#1)(1994-3#1)(2008-10#1)(2008-12#1)
2 +/- 10##2##3##(2008-10#1)(2010-7#1)
2 +/- 3##2##3##(1995-12#1)(2010-4#1)
2 +/-##19##2##(1990-2#1)(1991-11#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-12#2)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-4#1)(2010-7#1)(2011-2#3)
2 -##4##2##(1990-9#1)(1994-5#1)(2009-6#1)(2012-2#1)
2 100##2##2##(1996-2#1)(2008-8#1)
2 =##6##2##(1990-8#1)(1997-8#2)(2008-8#1)(2011-2#1)(2013-1#1)
2 Hz and 100 Hz EA##2##6##(1996-12#2)
2 Hz and##3##3##(1996-12#2)(2011-2#1)
2 Hz##7##2##(1996-12#3)(2011-2#4)
2 J/cm(2))##3##2##(2012-2#3)
2 K##4##2##(2008-10#4)
2 M HCl##2##3##(2008-10#2)
2 M HNO(3)##2##3##(2008-10#2)
2 M NaCl##4##3##(1991-9#1)(2008-10#2)(2011-2#1)
2 M sodium##2##3##(2008-10#2)
2 M##24##2##(1991-9#1)(1994-8#2)(1995-2#1)(2008-10#17)(2009-10#1)(2009-3#1)(2011-2#1)
2 MAbs##2##2##(1992-2#2)
2 Mb##2##2##(1995-6#1)(1996-6#1)
2 Mcllvaine buffer##2##3##(2008-10#2)
2 V##7##2##(2008-10#7)
2 W/kg##3##2##(1992-3#3)
2 adjusted##2##2##(2008-10#2)
2 and 0##10##3##(2008-10#8)(2008-12#1)(2008-6#1)
2 and 1##9##3##(2008-10#9)
2 and 11##2##3##(1994-3#1)(2008-10#1)
2 and 15##3##3##(2008-10#3)
2 and 2##6##3##(2008-10#6)
2 and 23##2##3##(2008-10#1)(2008-12#1)
2 and 3 trials##2##4##(2008-11#1)(2013-1#1)
2 and 3 were##2##4##(2008-10#2)
2 and 3##24##3##(1990-5#1)(1992-2#2)(1993-6#1)(1994-3#1)(1997-7#1)(2008-10#11)(2008-11#2)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
2 and 33##2##3##(2008-10#2)
2 and 4 h##2##4##(1994-12#1)(1995-11#1)
2 and 4 weeks##4##4##(2008-10#3)(2009-3#1)
2 and 4##15##3##(1991-6#1)(1994-12#1)(1995-11#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2009-3#1)
2 and 5##13##3##(1993-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2012-2#1)
2 and 6##5##3##(1997-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
2 and 7##6##3##(2008-10#4)(2008-12#1)(2013-1#1)
2 and 8##4##3##(1996-2#1)(2008-10#2)(2008-5#1)
2 and 9##2##3##(2008-10#2)
2 and Km*3##2##3##(1997-8#2)
2 and a##2##3##(2008-7#1)(2010-11#1)
2 and glucose##3##3##(2012-5#3)
2 and that##2##3##(2008-10#1)(2008-5#1)
2 and##185##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-6#1)(1992-2#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-11#4)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#3)(2008-10#94)(2008-11#7)(2008-12#8)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-5#3)(2013-1#4)(2013-8#1)
2 approximately##2##2##(2008-10#2)
2 are##4##2##(1991-3#1)(1993-3#1)(2008-10#1)(2008-7#1)
2 at the##2##3##(1992-1#1)(1992-3#1)
2 at##3##2##(1991-9#1)(1992-1#1)(1992-3#1)
2 beats/min##2##2##(2008-7#1)(2013-1#1)
2 beta##2##2##(1993-8#1)(1994-5#1)
2 billion people##2##3##(2009-8#1)(2012-2#1)
2 blue complex##3##3##(2008-10#3)
2 by##4##2##(1993-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
2 cM##4##2##(2008-10#3)(2008-9#1)
2 carotid##2##2##(1996-6#2)
2 cases of##9##3##(1991-11#1)(1991-6#1)(1994-12#1)(1997-3#1)(2009-1#1)(2009-10#1)(2012-3#2)(2013-1#1)
2 cases were##2##3##(1991-12#1)(2013-8#1)
2 cases##23##2##(1990-2#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#2)(1994-12#1)(1996-6#2)(1997-3#1)(2007-8#1)(2008-11#1)(2009-1#1)(2009-10#1)(2012-3#3)(2013-1#3)(2013-8#1)
2 cases]##3##2##(1992-5#1)(1993-6#1)(1996-3#1)
2 cells##2##2##(2008-11#1)(2008-7#1)
2 children##3##2##(1990-9#1)(2008-10#1)(2012-2#1)
2 chromosomes##2##2##(1997-2#1)(2008-10#1)
2 clinical trial##2##3##(2011-2#2)
2 clinical##3##2##(1997-4#1)(2011-2#2)
2 cm in##2##3##(2010-6#1)(2012-12#1)
2 cm to##2##3##(1993-12#1)(2012-12#1)
2 cm##17##2##(1990-9#2)(1991-12#1)(1993-12#1)(1997-4#1)(2008-1#1)(2008-10#3)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#1)(2012-12#3)
2 complex of##2##3##(2008-10#2)
2 complex##6##2##(1995-11#1)(2008-10#4)(2009-7#1)
2 complexes##2##2##(2008-10#2)
2 consisted of##2##3##(2008-10#1)(2010-8#1)
2 courses##2##2##(1990-12#1)(2008-10#1)
2 days after##7##3##(1997-8#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-12#1)
2 days and##2##3##(2008-10#1)(2008-11#1)
2 days before##2##3##(2008-10#1)(2009-6#1)
2 days for##2##3##(2008-10#2)
2 days of##2##3##(2008-10#1)(2008-12#1)
2 days##35##2##(1993-1#1)(1993-6#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-5#1)(2009-6#1)(2010-12#2)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
2 decades##5##2##(1994-12#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-2#1)
2 degrees C##9##3##(2008-10#8)(2008-12#1)
2 degrees##16##2##(1991-2#1)(1992-9#1)(2007-12#1)(2008-10#8)(2008-12#4)(2008-8#1)
2 deletion syndrome##2##3##(1997-3#2)
2 deletion##4##2##(1997-3#3)(2012-12#1)
2 describes##2##2##(2008-11#1)(2008-4#1)
2 diabetes (T2D)##2##3##(2012-3#1)(2013-8#1)
2 diabetes and##5##3##(1994-12#1)(2008-1#1)(2008-11#1)(2012-4#1)(2013-1#1)
2 diabetes has##3##3##(2008-3#2)(2012-5#1)
2 diabetes in##4##3##(1994-12#1)(2009-12#2)(2010-10#1)
2 diabetes is##2##3##(2008-1#1)(2010-12#1)
2 diabetes mellitus and##2##4##(2008-3#1)(2013-1#1)
2 diabetes mellitus##11##3##(2008-1#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-10#2)(2012-5#1)(2013-1#1)
2 diabetes##73##2##(1994-12#3)(1996-11#3)(2008-1#10)(2008-10#3)(2008-11#2)(2008-3#9)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#2)(2010-1#1)(2010-10#7)(2010-12#2)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#3)(2012-4#4)(2012-5#4)(2013-1#3)(2013-8#1)
2 diabetic patients##7##3##(1993-2#3)(2008-1#1)(2010-10#1)(2011-2#2)
2 diabetic##10##2##(1993-2#3)(1994-12#1)(2008-1#1)(2010-10#1)(2011-2#2)(2012-3#1)(2012-5#1)
2 diaminopropane##2##2##(2008-10#2)
2 did not##3##3##(1993-6#1)(2008-10#2)
2 different##2##2##(2013-8#2)
2 domain##3##2##(2009-6#1)(2013-1#2)
2 examined##2##2##(2008-12#1)(2009-5#1)
2 fold##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
2 for##10##2##(1994-5#1)(2008-10#7)(2010-1#1)(2011-3#1)
2 from the##2##3##(2011-1#1)(2011-2#1)
2 from##6##2##(1997-8#1)(2008-10#3)(2011-1#1)(2011-2#1)
2 g of##2##3##(2008-10#2)
2 g##7##2##(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#1)
2 gastric neuroendocrine tumor##2##4##(1997-1#2)
2 gene##2##2##(2009-8#1)(2010-1#1)
2 groups##13##2##(1990-2#1)(1991-11#5)(1997-3#1)(2008-7#1)(2010-1#1)(2010-4#1)(2012-3#2)(2013-1#1)
2 h after light initiation##3##5##(2008-10#3)
2 h after surgery##2##4##(1995-3#2)
2 h after the##4##4##(1990-5#1)(1996-2#1)(2008-10#2)
2 h after##13##3##(1990-5#1)(1991-2#1)(1995-3#2)(1996-2#1)(2008-10#7)(2008-7#1)
2 h and##3##3##(1996-2#1)(2008-10#2)
2 h at##2##3##(1995-8#1)(2008-10#1)
2 h before##2##3##(2008-10#2)
2 h following##3##3##(1996-2#1)(2008-7#1)(2010-8#1)
2 h of incubation##2##4##(1994-8#1)(2008-10#1)
2 h of##4##3##(1994-8#1)(1996-12#1)(2008-10#2)
2 h was##2##3##(1990-2#1)(2008-7#1)
2 h##51##2##(1990-2#1)(1990-5#1)(1991-2#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-3#3)(1995-8#3)(1996-12#1)(1996-2#3)(2008-10#24)(2008-6#2)(2008-7#4)(2009-6#1)(2010-8#1)
2 had##5##2##(1991-12#1)(1991-2#1)(1994-12#1)(2009-8#1)(2010-1#1)
2 hours##3##2##(1993-8#1)(2010-6#1)(2011-2#1)
2 hr##4##2##(1993-8#1)(2008-11#2)(2008-6#1)
2 hrs##2##2##(2011-2#1)(2012-2#1)
2 in the##6##3##(1990-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
2 in##23##2##(1990-3#3)(1994-2#2)(1995-2#1)(1996-2#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2013-1#4)
2 inclusion##2##2##(2008-10#2)
2 is##4##2##(1994-12#2)(2008-10#1)(2010-5#1)
2 isolate##4##2##(2008-10#4)
2 isolates were##2##3##(2008-10#2)
2 isolates##6##2##(2008-10#6)
2 kDa##6##2##(1993-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-12#1)
2 kJ mol(-1)##3##3##(2008-10#3)
2 kJ##5##2##(1992-10#1)(2008-10#3)(2008-9#1)
2 kb of##2##3##(1991-6#1)(1993-2#1)
2 kb##6##2##(1991-6#1)(1993-2#1)(2008-11#1)(2008-8#2)(2008-9#1)
2 l##3##2##(2008-10#1)(2008-11#2)
2 l/min##2##2##(2011-2#2)
2 log##2##2##(2008-10#1)(2012-2#1)
2 log(10)##2##2##(2008-11#1)(2013-1#1)
2 m##3##2##(2008-10#2)(2010-8#1)
2 mL)##2##2##(1996-3#1)(2010-1#1)
2 mM##8##2##(1993-8#2)(1994-5#1)(2008-10#4)(2008-11#1)
2 mM)##3##2##(1994-8#1)(1995-8#1)(1997-1#1)
2 mV decade(-1)##2##3##(2008-10#2)
2 mV##7##2##(2008-10#7)
2 mg L(-1)##3##3##(2008-10#1)(2008-12#2)
2 mg l(-1) of##2##4##(2008-10#2)
2 mg l(-1)##11##3##(2008-10#11)
2 mg of##5##3##(2008-10#1)(2008-11#1)(2010-12#2)(2010-6#1)
2 mg##33##2##(1990-11#1)(1993-2#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-5#2)(2010-12#2)(2010-6#1)(2011-2#1)(2011-3#1)
2 mg/L##3##2##(2008-8#3)
2 mg/kg##5##2##(1991-10#1)(1993-1#1)(1996-12#1)(2008-11#1)(2012-3#1)
2 mgl(-1)##3##2##(2008-10#2)(2008-11#1)
2 microM##5##2##(1990-8#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-11#1)
2 microM)##4##2##(1990-11#1)(1991-5#1)(1994-8#1)(1995-11#1)
2 microg##2##2##(2008-10#2)
2 microg/ml##2##2##(2008-10#1)(2008-7#1)
2 micromol L(-1)##2##3##(2008-10#1)(2011-3#1)
2 micron plasmid##2##3##(1993-9#1)(1996-6#1)
2 microns plasmid##5##3##(1993-9#4)(1996-6#1)
2 microns##8##2##(1991-5#1)(1993-9#4)(1996-3#1)(1996-6#2)
2 million##10##2##(1992-6#1)(1993-8#1)(2008-10#2)(2008-11#3)(2009-12#1)(2010-5#1)(2011-2#1)
2 min after ejaculation##2##4##(1992-12#2)
2 min for##2##3##(2008-10#2)
2 min of##2##3##(2008-10#1)(2009-12#1)
2 min##20##2##(1992-12#2)(1993-1#1)(2008-10#13)(2008-9#1)(2009-12#1)(2011-2#2)
2 min)##2##2##(2008-10#2)
2 ml min(-1)##4##3##(2008-10#4)
2 ml of Ringer water solution##2##6##(2008-12#2)
2 ml of##7##3##(2008-10#5)(2008-12#2)
2 ml##16##2##(1996-12#1)(2008-10#12)(2008-12#2)(2011-2#1)
2 mm##13##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-5#2)(2010-7#1)(2010-8#2)(2013-1#3)
2 mm)##3##2##(2008-11#1)(2009-12#1)(2013-1#1)
2 mmol l(-1)##2##3##(2008-10#2)
2 mmol/L##2##2##(2008-8#2)
2 mmol/kg##2##2##(1994-5#2)
2 mmol/kg)##3##2##(1994-5#3)
2 mol l(-1) HCl##4##4##(2008-10#4)
2 mol l(-1) HNO(3)##3##4##(2008-10#3)
2 mol l(-1) NH(4)-oxalate buffer##2##5##(2008-10#2)
2 mol l(-1)##16##3##(2008-10#16)
2 mol##18##2##(1994-5#1)(2008-10#17)
2 mol%)##2##2##(2008-10#2)
2 molar ratio##2##3##(1990-5#1)(1993-8#1)
2 month##2##2##(1994-3#1)(2008-3#1)
2 months after##4##3##(1996-12#2)(2008-11#1)(2012-12#1)
2 months and##3##3##(1996-12#1)(2008-10#2)
2 months before##2##3##(1996-5#1)(2008-10#1)
2 months in##2##3##(2008-10#2)
2 months later##2##3##(2008-12#1)(2008-4#1)
2 months of##6##3##(1996-12#2)(2006-5#2)(2008-10#1)(2008-12#1)
2 months old##2##3##(2008-10#1)(2012-12#1)
2 months to##2##3##(1996-12#1)(2009-3#1)
2 months without##3##3##(2008-10#3)
2 months##58##2##(1990-2#1)(1993-6#1)(1994-12#2)(1996-12#7)(1996-5#1)(2006-5#2)(2008-10#18)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#2)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
2 months)##4##2##(2008-10#1)(2008-12#1)(2009-3#1)(2011-3#1)
2 muM##2##2##(2008-10#2)
2 mug g(-1)##3##3##(2008-10#3)
2 mug l(-1) for##7##4##(2008-10#7)
2 mug l(-1)##15##3##(2008-10#15)
2 mug ml(-1) of##3##4##(2008-10#3)
2 mug ml(-1)##8##3##(2008-10#8)
2 mug ml(-1))##2##3##(2008-10#2)
2 mug rvWF/106 cells x day##2##6##(2008-11#2)
2 mug##37##2##(2008-10#33)(2008-11#3)(2008-5#1)
2 mug/ml##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
2 mugml(-1) for##2##3##(2008-10#2)
2 mugml(-1)##3##2##(2008-10#3)
2 mul##2##2##(2008-10#2)
2 mum in diameter)##2##4##(2008-5#2)
2 mum##7##2##(1993-2#1)(2008-10#2)(2008-3#2)(2008-5#2)
2 mum)##2##2##(1992-2#1)(2008-10#1)
2 mumol g(-1)##2##3##(2008-10#2)
2 mumol##5##2##(2008-10#5)
2 mumol/l for##2##3##(1994-6#2)
2 mumol/l##3##2##(1994-6#2)(2008-10#1)
2 nM##2##2##(1993-3#1)(1994-8#1)
2 ng m(-3)##2##3##(2008-10#2)
2 ng ml(-1) for##4##4##(2008-10#4)
2 ng ml(-1)##15##3##(2008-10#15)
2 ng##23##2##(2008-10#22)(2012-3#1)
2 ng/ml##2##2##(2008-10#1)(2011-2#1)
2 nmol##2##2##(1990-11#1)(2008-10#1)
2 nmol/h/mg protein##2##3##(1990-5#1)(1991-12#1)
2 of 3##2##3##(2008-10#1)(2008-7#1)
2 of 90##2##3##(2008-10#2)
2 of both##2##3##(2008-10#2)
2 of the##6##3##(1991-2#1)(2008-10#4)(2009-1#1)
2 of##30##2##(1990-11#1)(1991-2#1)(1991-3#3)(1991-8#1)(1992-2#1)(1992-4#2)(1993-2#1)(1994-12#1)(1997-3#1)(2008-10#15)(2008-7#1)(2009-1#1)(2011-2#1)
2 on a##2##3##(1995-8#1)(2013-1#1)
2 on the##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
2 on##6##2##(1995-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
2 or 3##6##3##(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
2 or 4##2##3##(2008-7#1)(2011-2#1)
2 or##14##2##(1991-6#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
2 orders of magnitude higher than##2##6##(2007-11#1)(2008-10#1)
2 orders of magnitude##8##4##(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-4#1)
2 others##2##2##(1990-6#1)(2008-5#1)
2 out of##3##3##(1990-12#1)(1990-6#1)(2010-2#1)
2 patients had##2##3##(1991-8#1)(1994-3#1)
2 patients were##3##3##(1993-12#1)(1996-11#1)(1997-3#1)
2 patients with low##2##4##(2013-1#2)
2 patients with##5##3##(1991-6#1)(1996-3#1)(1997-3#1)(2013-1#2)
2 patients##33##2##(1990-12#2)(1990-6#1)(1991-1#1)(1991-6#1)(1991-8#3)(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-3#1)(1997-3#2)(2007-11#3)(2008-3#1)(2008-7#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)
2 percent of##2##3##(1991-1#1)(1991-12#1)
2 percent##5##2##(1991-1#1)(1991-12#1)(1992-12#2)(1995-3#1)
2 pi##2##2##(1996-2#1)(2008-3#1)
2 ppb##2##2##(2008-10#1)(2008-3#1)
2 ppm##3##2##(1990-8#1)(2008-10#2)
2 precursors##2##2##(2013-1#2)
2 proteins##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
2 receptor##4##2##(1994-11#2)(2008-11#1)(2011-1#1)
2 region alone or the##2##5##(2008-10#2)
2 required##2##2##(1992-12#1)(2009-10#1)
2 resulted in##2##3##(2008-10#2)
2 s##5##2##(1996-2#1)(2008-10#3)(2008-3#1)
2 seconds##2##2##(2007-9#1)(2013-8#1)
2 showed that##2##3##(1993-6#1)(2008-10#1)
2 showed##6##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2010-6#1)(2013-1#1)
2 sites##3##2##(1994-8#1)(2012-3#1)(2013-1#1)
2 species of##2##3##(2011-2#1)(2013-1#1)
2 species##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
2 strains##2##2##(2008-10#2)
2 subunit##8##2##(1993-8#1)(1995-11#4)(1995-12#3)
2 t gypsum ha(-1)##2##4##(2008-12#2)
2 t##3##2##(2008-12#3)
2 than##2##2##(2008-10#1)(2009-6#1)
2 the##2##2##(2008-10#2)
2 times greater##2##3##(2008-10#1)(2013-8#1)
2 times##8##2##(2008-10#1)(2008-11#3)(2008-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
2 to 0##3##3##(2008-10#2)(2013-1#1)
2 to 1##3##3##(2008-10#3)
2 to 10##4##3##(2008-10#3)(2008-11#1)
2 to 14##2##3##(1991-2#1)(2008-10#1)
2 to 15##2##3##(2008-10#2)
2 to 19##2##3##(2008-10#1)(2008-11#1)
2 to 20##3##3##(1997-8#1)(2008-10#2)
2 to 3 days##4##4##(2008-10#4)
2 to 3##8##3##(1991-8#1)(2008-10#7)
2 to 4 weeks##5##4##(2008-10#5)
2 to 4 years##2##4##(2008-10#1)(2008-9#1)
2 to 4##14##3##(1992-3#1)(2008-10#9)(2008-9#2)(2012-2#1)(2013-1#1)
2 to 5##5##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)
2 to 5%##2##3##(2008-10#1)(2009-12#1)
2 to 6 days##2##4##(2008-10#2)
2 to 6##5##3##(1992-12#1)(2008-10#3)(2009-12#1)
2 to 7##3##3##(2008-10#2)(2008-5#1)
2 to 8##2##3##(1991-8#1)(2008-10#1)
2 to 9##2##3##(2008-10#2)
2 to##106##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-12#2)(1996-3#1)(1997-8#1)(2008-10#64)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
2 using##2##2##(2008-10#2)
2 versus##3##2##(1990-11#1)(2008-4#1)(2008-7#1)
2 vs##5##2##(1994-12#1)(2008-1#1)(2008-7#2)(2011-2#1)
2 w/w% triclosan##2##3##(2008-5#2)
2 was used##3##3##(1990-8#1)(2008-11#1)(2008-5#1)
2 was##18##2##(1990-3#1)(1990-8#1)(1991-2#1)(1992-3#2)(1994-2#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-5#4)(2013-1#2)
2 weeks after inoculation##3##4##(2008-10#3)
2 weeks after the##2##4##(1996-12#1)(2010-9#1)
2 weeks after##12##3##(1996-12#1)(2008-10#7)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
2 weeks and they matured##2##5##(2008-11#2)
2 weeks and##4##3##(1996-2#1)(2008-10#1)(2008-11#2)
2 weeks before being##2##4##(1990-12#1)(1996-12#1)
2 weeks before##3##3##(1990-12#1)(1996-12#1)(2008-10#1)
2 weeks following the##2##4##(2008-7#1)(2009-3#1)
2 weeks later##4##3##(1992-1#1)(1994-9#1)(2008-10#1)(2008-12#1)
2 weeks of treatment##3##4##(1996-2#1)(2008-6#2)
2 weeks of##6##3##(1995-1#1)(1996-2#1)(2008-10#2)(2008-6#2)
2 weeks postinoculation##2##3##(2008-10#2)
2 weeks##74##2##(1990-12#1)(1991-8#1)(1992-1#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-12#4)(1996-2#2)(1997-3#1)(1997-8#2)(2008-10#34)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-8#1)
2 weeks)##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
2 were##22##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-7#1)
2 with respect to##2##4##(2008-10#1)(2008-5#1)
2 with##7##2##(1992-5#1)(1994-3#1)(2008-10#3)(2008-5#1)(2008-7#1)
2 women##2##2##(1993-12#1)(2011-3#1)
2 x 10(-3) mg/L for##2##5##(2008-10#2)
2 x 10(-3)##3##3##(2008-10#3)
2 x 10(-4)moll(-1)##2##3##(2008-10#2)
2 x 10(-6) M##2##4##(1991-5#1)(2008-10#1)
2 x 10(-6)##5##3##(1991-5#1)(2008-10#3)(2008-3#1)
2 x 10(-7)##2##3##(1990-10#1)(2008-10#1)
2 x 10(-8)##2##3##(2008-10#1)(2008-3#1)
2 x 10(4)##3##3##(2008-10#2)(2008-11#1)
2 x 10(5)##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
2 x 10(6)##9##3##(1991-12#1)(1992-4#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
2 x 10(7) CFU ml(-1)##2##5##(2008-10#2)
2 x 10(7) CFU##3##4##(2008-10#3)
2 x 10(7)##4##3##(2008-10#4)
2 x 10(8)##2##3##(2008-10#2)
2 x 2##7##3##(1994-3#1)(1995-9#2)(2008-11#1)(2008-2#1)(2011-2#2)
2 x##65##2##(1990-10#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-9#2)(2008-10#37)(2008-11#6)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#2)
2 year old##2##3##(1991-11#1)(2012-2#1)
2 year##3##2##(1991-11#1)(2008-10#1)(2012-2#1)
2 years after the##3##4##(1994-5#1)(1997-4#1)(2008-10#1)
2 years after##7##3##(1994-5#1)(1997-4#1)(2008-10#2)(2008-7#2)(2012-3#1)
2 years and##5##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
2 years at##2##3##(1995-11#1)(2008-10#1)
2 years by##2##3##(2008-10#1)(2012-3#1)
2 years for##2##3##(2008-10#1)(2010-10#1)
2 years in##2##3##(2008-10#2)
2 years of the##2##4##(2008-10#1)(2011-2#1)
2 years of##10##3##(1995-1#1)(2008-10#4)(2008-8#1)(2011-2#1)(2013-1#3)
2 years old##2##3##(1997-2#1)(1997-7#1)
2 years was##2##3##(1991-11#1)(2008-9#1)
2 years without##2##3##(2008-10#1)(2008-11#1)
2 years##86##2##(1990-6#1)(1991-11#2)(1993-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#29)(2008-11#5)(2008-5#1)(2008-7#9)(2008-8#2)(2008-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#4)
2 years)##6##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#2)
2 yellow complex##2##3##(2008-10#2)
2 yr##2##2##(2008-11#1)(2008-9#1)
2 ± 0##2##3##(2012-3#2)
2 ± 1##2##3##(2010-9#1)(2011-2#1)
2 ± 4##3##3##(2010-11#2)(2011-2#1)
2 ±##7##2##(2010-11#2)(2010-9#1)(2011-2#2)(2012-3#2)
2##4620##1##(1990-10#1)(1990-11#9)(1990-12#21)(1990-2#18)(1990-3#6)(1990-5#14)(1990-6#13)(1990-7#5)(1990-8#17)(1990-9#8)(1991-1#3)(1991-10#4)(1991-11#20)(1991-12#12)(1991-2#17)(1991-3#12)(1991-5#22)(1991-6#12)(1991-7#2)(1991-8#13)(1991-9#6)(1992-1#7)(1992-10#5)(1992-11#5)(1992-12#29)(1992-2#19)(1992-3#32)(1992-4#9)(1992-5#4)(1992-6#9)(1992-8#6)(1992-9#5)(1993-1#12)(1993-11#4)(1993-12#18)(1993-2#21)(1993-3#13)(1993-6#20)(1993-8#25)(1993-9#7)(1994-1#1)(1994-11#17)(1994-12#37)(1994-2#16)(1994-3#26)(1994-5#25)(1994-6#5)(1994-8#30)(1994-9#2)(1995-1#4)(1995-11#45)(1995-12#13)(1995-2#17)(1995-3#12)(1995-5#2)(1995-6#12)(1995-8#16)(1995-9#5)(1996-1#3)(1996-11#11)(1996-12#33)(1996-2#19)(1996-3#12)(1996-5#35)(1996-6#14)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#12)(1997-3#25)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#27)(1997-9#3)(2006-5#2)(2007-11#4)(2007-12#11)(2007-8#4)(2007-9#1)(2008-1#22)(2008-10#2106)(2008-11#233)(2008-12#88)(2008-2#13)(2008-3#76)(2008-4#16)(2008-5#91)(2008-6#23)(2008-7#83)(2008-8#55)(2008-9#59)(2009-1#6)(2009-10#14)(2009-11#6)(2009-12#14)(2009-2#4)(2009-3#8)(2009-4#3)(2009-5#4)(2009-6#15)(2009-7#5)(2009-8#24)(2009-9#4)(2010-1#14)(2010-10#13)(2010-11#7)(2010-12#17)(2010-2#1)(2010-3#3)(2010-4#15)(2010-5#7)(2010-6#17)(2010-7#8)(2010-8#16)(2010-9#7)(2011-1#17)(2011-10#1)(2011-2#155)(2011-3#18)(2012-12#30)(2012-2#55)(2012-3#52)(2012-4#4)(2012-5#9)(2013-1#128)(2013-7#2)(2013-8#38)
2% (n =##2##3##(2008-10#2)
2% (n=10)##3##2##(2008-10#3)
2% (range##2##2##(2008-7#1)(2008-8#1)
2% (v/v) HNO(3)##2##3##(2008-10#2)
2% (v/v)##3##2##(2008-10#3)
2% (w/v) of##2##3##(2008-10#2)
2% (w/v)##3##2##(2008-10#3)
2% HNO(3)##3##2##(2008-10#3)
2% NaF for 3 min##2##5##(2013-1#2)
2% NaF##3##2##(2013-1#3)
2% R##4##2##(2008-10#4)
2% RSD##2##2##(2008-10#2)
2% and 6##2##3##(2008-10#2)
2% and##22##2##(1991-6#1)(1991-8#1)(1991-9#1)(1993-8#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2010-1#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
2% as##2##2##(2008-10#1)(2008-6#1)
2% at 20##2##3##(2008-10#1)(2008-3#1)
2% at the 5##2##4##(2008-10#2)
2% at##10##2##(1990-5#1)(2008-10#6)(2008-11#1)(2008-3#2)
2% bupivacaine-lipospheres##4##2##(1993-1#4)
2% chlorhexidine gluconate (CHX)##2##4##(2013-1#2)
2% during##2##2##(2008-10#1)(2012-3#1)
2% for a##2##3##(2008-10#2)
2% for molybdenum##2##3##(2008-10#2)
2% for the##5##3##(1997-7#2)(2008-10#2)(2009-11#1)
2% for##27##2##(1997-7#3)(2007-8#3)(2008-10#18)(2008-5#1)(2009-11#1)(2012-3#1)
2% had DD and PD##2##5##(2008-12#2)
2% had##5##2##(1991-11#1)(1995-10#1)(2008-12#2)(2011-2#1)
2% higher than##2##3##(2008-10#1)(2008-11#1)
2% higher##3##2##(2008-10#2)(2008-11#1)
2% in the##2##3##(2008-10#2)
2% in##6##2##(1991-6#1)(1993-8#1)(2008-10#3)(2008-11#1)
2% lidocaine##2##2##(1993-1#2)
2% males##2##2##(1994-6#2)
2% nitric acid##2##3##(2008-10#2)
2% of all##5##3##(1992-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
2% of the cases##2##4##(1992-5#1)(2010-1#1)
2% of the phenotypic##2##4##(2008-10#2)
2% of the total##2##4##(2008-10#1)(2011-10#1)
2% of the variance##2##4##(2010-2#1)(2010-5#1)
2% of the##17##3##(1991-6#1)(1992-5#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-10#1)(2011-2#1)
2% of##42##2##(1990-2#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-6#1)(1996-9#1)(1997-2#2)(1997-8#1)(2008-10#12)(2008-11#4)(2008-7#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-10#1)(2011-2#2)(2012-3#2)(2013-1#1)
2% relative##2##2##(2008-10#2)
2% respectively##4##2##(1997-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
2% sodium##2##2##(2008-10#2)
2% to 7%##2##3##(2010-1#1)(2012-12#1)
2% to##10##2##(1992-11#1)(1995-12#2)(2008-10#2)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
2% v/v##2##2##(2008-10#2)
2% w/w##2##2##(2008-10#2)
2% were##8##2##(1996-8#1)(1997-6#1)(2008-10#1)(2008-12#2)(2010-1#1)(2013-1#2)
2%##379##1##(1990-2#5)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#2)(1991-6#4)(1991-8#3)(1991-9#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#6)(1993-3#1)(1993-8#4)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-10#1)(1995-12#4)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#192)(2008-11#18)(2008-12#5)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-7#1)(2009-8#2)(2010-1#4)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-10#2)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#9)(2013-1#15)(2013-8#1)
2%) and the##2##3##(2008-10#1)(2013-8#1)
2%) and##9##2##(1992-9#1)(2008-10#3)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
2%) had CIN##2##3##(2011-2#2)
2%) in##2##2##(1990-12#2)
2%) patients##3##2##(2008-1#1)(2010-8#1)(2011-2#1)
2%) were##2##2##(2008-10#1)(2010-6#1)
2%)##70##1##(1990-12#2)(1990-2#3)(1990-8#1)(1991-12#1)(1991-3#1)(1992-9#1)(1996-12#2)(2008-1#5)(2008-10#19)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#5)(2008-9#1)(2009-1#1)(2010-6#1)(2010-8#1)(2011-2#9)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
2&gt##2##1##(2008-10#2)
2'##15##1##(1990-10#2)(1991-3#1)(1993-12#4)(1994-11#2)(1994-8#1)(2008-10#3)(2008-11#2)
2'-O-TOM-5'-O-dimethoxytrityl-N-acetyl ribonucleosides##2##2##(2008-4#2)
2'-[1##2##1##(2008-10#2)
2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)##3##2##(2008-10#3)
2'-bipyridine##3##1##(2008-10#3)
2'-bipyridine)##5##1##(2008-10#4)(2008-12#1)
2'-bipyridine)ruthenium(II)##4##1##(2008-10#4)
2'-bipyridyl in##2##2##(2008-10#2)
2'-bipyridyl##4##1##(2008-10#4)
2'-bipyridyl) ruthenium##2##2##(2008-10#2)
2'-bipyridyl) ruthenium(II)##2##2##(2008-10#2)
2'-bipyridyl)##5##1##(2008-10#5)
2'-bipyridyl)ruthenium(II) chemiluminescence detection##5##3##(2008-10#5)
2'-bipyridyl)ruthenium(II) chemiluminescence##6##2##(2008-10#6)
2'-bipyridyl)ruthenium(II) electrochemiluminescence detection##2##3##(2008-10#2)
2'-bipyridyl)ruthenium(II)##12##1##(2008-10#12)
2'-dipyridyl##3##1##(2008-10#3)
2'-dipyridyl-2-pyridylhydrazone (DPPH)##3##2##(2008-10#3)
2'-dipyridyl-2-pyridylhydrazone complex formation##2##3##(2008-10#2)
2'-dipyridyl-2-pyridylhydrazone##5##1##(2008-10#5)
2'-dithiodianiline##3##1##(2008-10#3)
2'-silylation##2##1##(2008-4#2)
2'3'-dideoxyadenosine##2##1##(1994-8#2)
2(2) factorial with a center point##2##6##(2008-10#2)
2(2)##3##1##(2008-10#2)(2011-2#1)
2(3)##3##1##(2008-10#2)(2008-11#1)
2(4)##2##1##(2008-10#1)(2008-5#1)
2(4-1) factorial##2##2##(2008-10#2)
2(4-1)##4##1##(2008-10#3)(2011-2#1)
2(5-nitro-2-pyridylazo)-5-(N-propyl-N-3-sulfopropylamino)phenol(5-NO(2)##2##1##(2008-10#2)
2(Sr0##2##1##(2008-3#2)
2(n)##3##1##(2008-7#3)
2) In##2##2##(1991-2#1)(2008-5#1)
2) and the calibration curve is linear##2##7##(2008-10#2)
2) and the##3##3##(1993-2#1)(2008-10#2)
2) and##18##2##(1990-12#1)(1990-5#1)(1993-2#1)(1994-12#1)(1994-5#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)
2) as##4##2##(1992-7#1)(2008-10#3)
2) at##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
2) in##5##2##(1992-3#1)(1993-6#1)(2008-11#1)(2011-2#1)(2012-12#1)
2) is##4##2##(1994-12#1)(2008-10#2)(2012-2#1)
2) the##8##2##(1991-3#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-9#1)(2008-11#1)(2008-6#1)(2008-7#1)
2) to##3##2##(2008-10#2)(2012-3#1)
2) was##3##2##(1995-8#1)(2008-10#1)(2008-11#1)
2) were##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
2) x##2##2##(1992-10#1)(2008-2#1)
2) μm to 8##2##4##(2010-10#2)
2) μm to##3##3##(2010-10#3)
2)##181##1##(1990-12#1)(1990-2#4)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-2#1)(1993-6#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(2008-10#54)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#5)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#9)(2011-9#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-4#1)(2013-1#7)(2013-8#3)
2))##2##1##(1990-5#1)(1995-2#1)
2))(0)##3##1##(2008-10#3)
2)-O-[6-deoxy-alpha-L-mannopyranosyl-(1--&gt##2##1##(2008-11#2)
2)-beta-D-glucopyranoside##2##1##(2010-6#2)
2)O(3-δ)##2##1##(2012-2#2)
2+##3##1##(1993-8#2)(2010-8#1)
2+/-0##18##1##(2008-10#17)(2008-11#1)
2+/-1##3##1##(2008-10#3)
2+/-12##2##1##(2008-7#1)(2009-7#1)
2- and 1##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
2- and##8##2##(1992-3#1)(2008-10#4)(2008-11#3)
2- to##5##2##(1993-6#1)(1995-2#1)(2008-10#1)(2008-4#1)(2010-1#1)
2-##23##1##(1992-12#1)(1992-3#1)(1993-6#1)(1995-2#1)(2008-10#10)(2008-11#4)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
2-(1##2##1##(1996-5#2)
2-(2-quinolylazo)-5-diethylaminoaniline##2##1##(2008-10#2)
2-(2-thiazolylazo)-5-diethylaminophenol##2##1##(2008-10#2)
2-(3##4##1##(2008-10#3)(2008-5#1)
2-(5-bromo-2-pyridylazo)-5-(diethylamino)phenol##2##1##(2008-10#2)
2-(5-bromo-2-pyridylazo)-5-diethylaminophenol (5-Br-PADAP)##4##2##(2008-10#4)
2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##12##1##(2008-10#12)
2-(9-carbazole)-ethyl chloroformate (CEOC)##2##3##(2008-10#2)
2-(alpha-pyridyl) thioquinaldinamide##2##2##(2008-10#2)
2-(dimethylthio)ethanol##2##1##(1994-8#2)
2-(methylthio)ethanol##2##1##(1994-8#2)
2-(thiopyran-4-ylidene)-1##2##1##(1996-5#2)
2-/3-methylbutanal##2##1##(2008-10#2)
2-0##8##1##(1990-5#1)(1991-6#1)(1995-11#1)(2008-10#3)(2010-5#1)(2011-2#1)
2-1##14##1##(2008-10#12)(2011-2#2)
2-10 and##2##2##(2008-10#2)
2-10 mug ml(-1)##2##3##(2008-10#2)
2-10##11##1##(1990-6#1)(1995-3#1)(2008-10#7)(2008-9#1)(2010-5#1)
2-10%##2##1##(1997-2#1)(2008-3#1)
2-100##3##1##(2008-10#3)
2-11##3##1##(2008-10#3)
2-12##4##1##(2008-10#2)(2008-12#1)(2008-7#1)
2-15##3##1##(2008-10#2)(2012-12#1)
2-2##9##1##(1995-12#1)(2008-10#8)
2-20##4##1##(2008-10#3)(2010-4#1)
2-3 and##4##2##(1996-2#1)(2008-12#1)(2008-8#1)(2012-3#1)
2-3 fold higher##2##3##(1993-8#1)(2008-11#1)
2-3 fold##4##2##(1992-7#1)(1993-8#1)(2008-11#1)(2012-2#1)
2-3 h##2##2##(2008-10#1)(2008-9#1)
2-3 orders of magnitude##3##4##(2008-10#2)(2008-3#1)
2-3 times##2##2##(1994-5#1)(2008-5#1)
2-3 weeks##4##2##(1993-2#1)(2008-10#3)
2-3 years##3##2##(1990-6#1)(1993-3#1)(2008-12#1)
2-3##43##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-2#2)(2008-10#14)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2012-2#1)(2012-3#1)
2-3%##3##1##(2008-10#2)(2008-3#1)
2-3-fold##2##1##(1992-9#1)(1995-6#1)
2-30##2##1##(2008-10#1)(2012-2#1)
2-33##2##1##(2008-10#2)
2-4 times##2##2##(1990-5#1)(2008-11#1)
2-4 weeks##2##2##(1995-11#1)(2010-5#1)
2-4##18##1##(1990-5#1)(1995-11#1)(1996-2#1)(1997-3#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
2-4%##3##1##(2008-10#1)(2008-11#1)(2008-3#1)
2-40##2##1##(1995-3#1)(2008-10#1)
2-5 days##2##2##(1994-12#1)(1995-12#1)
2-5##15##1##(1991-9#1)(1994-12#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-6#1)
2-5%##3##1##(1991-2#1)(1997-7#1)(2008-10#1)
2-6##8##1##(1995-11#1)(2008-10#7)
2-7##10##1##(1992-12#1)(1994-1#1)(1994-2#1)(1994-5#1)(2008-10#5)(2008-9#1)
2-8 mug ml(-1)##2##3##(2008-10#2)
2-8 years)##2##2##(2008-9#2)
2-8##14##1##(2008-1#1)(2008-10#8)(2008-5#1)(2008-9#2)(2010-9#1)(2011-2#1)
2-BP##2##1##(2008-10#2)
2-D##5##1##(2008-11#2)(2010-12#2)(2010-8#1)
2-DE##5##1##(2008-12#1)(2010-12#2)(2011-3#2)
2-HPbetaCD##6##1##(2008-11#6)
2-OH##2##1##(1993-8#1)(2009-8#1)
2-[125I]BraMT##2##1##(1993-6#2)
2-[125I]iodomelatonin binding##3##2##(1995-12#3)
2-[125I]iodomelatonin##5##1##(1993-6#1)(1995-12#4)
2-alkylsulfanyl-6-benzyl-3##2##1##(2011-2#2)
2-amino-1##3##1##(2008-10#3)
2-amino-1-butanol##2##1##(2008-10#2)
2-amino-1-methoxy-propane##2##1##(2008-10#2)
2-amino-1-pentanol##2##1##(2008-10#2)
2-amino-1-propanol##2##1##(2008-10#2)
2-amino-3-hydroxypyridine##2##1##(2008-10#2)
2-amino-4##2##1##(2008-10#1)(2008-11#1)
2-aminothiophenol##3##1##(2008-10#2)(2012-2#1)
2-benzo-3##9##1##(2008-10#9)
2-benzoylpyridine-2-pyridylhydrazone##2##1##(2008-10#2)
2-bis(4-chlorophenyl)ethane (p##2##2##(2008-10#2)
2-butanone##2##1##(2008-10#1)(2008-12#1)
2-butyne##2##1##(2010-7#2)
2-chloro-1-methylpyridinium iodide##3##2##(2008-10#3)
2-day##3##1##(1993-3#1)(2008-10#1)(2013-1#1)
2-deoxyglucose transport##2##2##(1994-11#1)(1994-8#1)
2-deoxyglucose uptake##2##2##(1995-6#2)
2-deoxyglucose##4##1##(1994-11#1)(1994-8#1)(1995-6#2)
2-deoxyribosylation of Glu-98##2##3##(1995-6#2)
2-deoxyribosyltransferase##5##1##(1995-6#5)
2-diacylglycerol##3##1##(1990-5#1)(1991-5#1)(1993-8#1)
2-diaminobenzene) film##2##2##(2008-10#2)
2-diaminobenzene)-coated platinum electrode##2##3##(2008-10#2)
2-dicarboxylic anhydride##5##2##(1995-11#5)
2-dichlorobenzene##2##1##(2008-10#2)
2-dichloroethane (DCE)##2##2##(2008-10#2)
2-dichloroethane as##2##2##(2008-10#2)
2-dichloroethane solution##2##2##(2008-10#2)
2-dichloroethane##14##1##(2008-10#14)
2-dihydro-2-methyl-3-phenylpyrido[3##2##1##(1993-1#2)
2-dihydroxy-1##3##1##(2008-10#3)
2-dihydroxybenzene##3##1##(2008-10#3)
2-diiminocyclohexane##2##1##(2008-10#2)
2-dimensional##6##1##(1990-11#2)(2008-7#1)(2009-2#1)(2009-6#1)(2010-8#1)
2-diolein##2##1##(1990-10#2)
2-ethanediamine##2##1##(2008-10#2)
2-ethoxyethanol in complex matrices##2##4##(2008-5#2)
2-ethoxyethanol in##4##2##(2008-5#4)
2-ethoxyethanol##7##1##(2008-5#7)
2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester##3##5##(2008-10#3)
2-ethylhexyl##6##1##(2008-10#3)(2008-5#3)
2-exo##2##1##(1996-5#2)
2-fold in##2##2##(1990-5#1)(1992-1#1)
2-fold increase in the##3##4##(1993-3#1)(2008-11#1)(2010-1#1)
2-fold increase in##6##3##(1993-3#1)(1993-8#1)(1995-6#1)(2008-11#2)(2010-1#1)
2-fold##27##1##(1990-5#1)(1992-1#1)(1992-4#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-6#2)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#6)(2010-1#1)(2011-3#2)(2013-1#1)
2-fold)##2##1##(2008-10#2)
2-h##4##1##(1994-12#2)(2008-10#2)
2-heptanone##3##1##(2008-10#3)
2-hr##2##1##(1994-8#1)(2008-11#1)
2-hydroxy-1-naphthaldehyde thiosemicarbazone (Fe(III)-HNT)##2##3##(2008-10#2)
2-hydroxypropyl-beta-cyclodextrin##5##1##(2008-10#2)(2008-11#2)(2008-5#1)
2-hydroxysaclofen##3##1##(2008-8#3)
2-iminobiotin EC50##2##2##(1995-2#2)
2-iminobiotin##5##1##(1995-2#5)
2-iodomelatonin##2##1##(1993-6#1)(1995-12#1)
2-kb##9##1##(1992-3#1)(1993-12#2)(1995-11#2)(1995-2#1)(1997-3#1)(2008-10#2)
2-mercaptobenzothiazole loaded##2##2##(2008-10#2)
2-mercaptobenzothiazole self-assembled monolayer##2##3##(2008-10#2)
2-mercaptobenzothiazole##6##1##(2008-10#6)
2-mercaptoethanol and##2##2##(1994-8#1)(2008-10#1)
2-mercaptoethanol to##3##2##(1990-8#1)(1994-8#2)
2-mercaptoethanol##13##1##(1990-8#1)(1991-12#1)(1992-12#1)(1994-8#5)(2008-10#5)
2-mercaptopyrimidine (I) and##2##3##(2008-10#2)
2-methacryloyloxyethyl phosphorylcholine##2##2##(2008-11#2)
2-methacryloyloxyethyl##3##1##(2008-11#3)
2-methoxy-1##4##1##(1996-5#4)
2-methyl-3-methoxy-4-phenylbutanoic acid (MMPB)##2##3##(2012-12#2)
2-methyl-8-quinolinol##6##1##(2008-10#6)
2-methylthio-ATP##2##1##(1995-8#2)
2-min preconcentration##2##2##(2008-10#2)
2-min##8##1##(1994-3#2)(2008-10#4)(2008-3#1)(2013-8#1)
2-mm##7##1##(1994-2#1)(2008-10#3)(2013-1#3)
2-mm-thick##2##1##(2007-12#1)(2013-1#1)
2-month follow-up##3##2##(2009-9#1)(2010-10#2)
2-month##5##1##(2008-10#1)(2008-5#1)(2009-9#1)(2010-10#2)
2-month-old##4##1##(1996-12#1)(2008-10#1)(2010-6#2)
2-mum output##2##2##(2008-3#2)
2-mum##3##1##(2008-10#1)(2008-3#2)
2-naphthol##4##1##(2008-10#4)
2-nd##2##1##(2008-11#2)
2-nitrophenyl octyl ether (NPOE)##3##4##(2008-10#3)
2-nitrophenyl octyl ether##6##3##(2008-10#6)
2-nitroso-1-naphthol-4-sulfonic##3##1##(2008-10#3)
2-oxathiaphospholane)s##2##1##(2008-4#2)
2-oxoglutarate##6##1##(1991-3#4)(2008-10#2)
2-phenylethyl isothiocyanate and##2##3##(2008-10#2)
2-phenylhistamines##2##1##(2008-12#2)
2-phosphate##2##1##(1993-8#1)(2008-7#1)
2-picolyl##2##1##(2008-10#2)
2-propanedione-2-oxime##2##1##(2008-10#2)
2-propanol and##3##2##(2008-10#3)
2-propanol##14##1##(2008-10#14)
2-thioorotic acid (V)##2##3##(2008-10#2)
2-thioxothiazolidine-4-carboxylic##2##1##(2008-10#2)
2-week##15##1##(1995-12#1)(1995-2#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)(2013-1#2)
2-week-old seedlings##2##2##(2008-10#2)
2-week-old##4##1##(2008-10#3)(2008-8#1)
2-year follow-up##2##2##(2008-8#2)
2-year study##2##2##(2008-10#2)
2-year survival for##3##3##(1990-6#1)(1990-8#2)
2-year survival##4##2##(1990-6#2)(1990-8#2)
2-year##30##1##(1990-6#2)(1990-8#2)(1991-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#8)(2008-4#1)(2008-8#2)(2008-9#1)(2009-1#1)(2011-2#1)(2012-3#3)(2012-5#1)(2013-1#4)
2-year-old boy##2##2##(2008-10#1)(2011-2#1)
2-year-old##10##1##(1996-2#1)(1997-9#1)(2008-10#5)(2009-5#1)(2011-2#1)(2013-8#1)
2-{[1-(3##2##1##(2008-10#2)
2/3 of the##4##3##(1990-6#1)(1994-9#1)(1996-12#1)(2008-11#1)
2/3##8##1##(1990-6#2)(1994-9#1)(1996-12#1)(2008-11#3)(2013-1#1)
2/h##2##1##(2008-5#2)
20 +/-##2##2##(1993-8#1)(2008-10#1)
20 -##2##2##(1992-2#1)(2011-2#1)
20 V##3##2##(2008-10#2)(2009-9#1)
20 after##2##2##(1990-2#1)(1995-12#1)
20 amino acids##2##3##(1992-6#1)(1995-12#1)
20 and 0##6##3##(1992-6#1)(2008-10#5)
20 and 10##2##3##(2008-10#1)(2008-7#1)
20 and 22##2##3##(2008-10#2)
20 and 25 degrees C##3##5##(2008-10#3)
20 and 25##4##3##(1994-8#1)(2008-10#3)
20 and 30 degrees C##2##5##(2008-10#2)
20 and 30##6##3##(1994-3#1)(2008-10#3)(2008-5#1)(2011-2#1)
20 and 50 mg/kg/dose##2##4##(2008-10#2)
20 and 50##3##3##(2008-10#3)
20 and##46##2##(1992-6#1)(1993-8#1)(1994-3#2)(1994-8#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#30)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
20 approximately##2##2##(2008-10#2)
20 bases##2##2##(1991-9#1)(1995-12#1)
20 by##2##2##(2008-10#1)(2008-11#1)
20 cM##2##2##(1995-9#1)(2008-10#1)
20 cases of##2##3##(1991-11#1)(2008-9#1)
20 cases##6##2##(1991-11#1)(1997-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
20 children##2##2##(1994-5#1)(2008-9#1)
20 cm##3##2##(1994-6#1)(1997-8#1)(2008-10#1)
20 cycles##2##2##(2008-10#1)(2008-11#1)
20 d##2##2##(2008-9#1)(2010-12#1)
20 days after##8##3##(1995-12#2)(2008-10#3)(2008-9#1)(2012-3#1)(2013-8#1)
20 days##18##2##(1995-12#2)(1997-3#1)(1997-4#1)(1997-9#1)(2008-10#9)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
20 degrees C and##6##4##(2008-10#4)(2008-12#1)(2010-4#1)
20 degrees C##35##3##(1991-5#1)(1995-8#1)(2008-10#28)(2008-12#2)(2008-3#1)(2009-8#1)(2010-4#1)
20 degrees C) and##2##4##(2008-10#2)
20 degrees C)##6##3##(2008-10#6)
20 degrees##45##2##(1991-5#1)(1993-1#1)(1995-8#1)(2008-10#34)(2008-12#2)(2008-3#3)(2009-8#1)(2010-4#1)(2013-1#1)
20 fertilizer##3##2##(2008-10#3)
20 fmol for##2##3##(2008-10#2)
20 g of##2##3##(2008-10#2)
20 g##6##2##(1993-3#1)(2008-10#5)
20 g/day)##2##2##(1997-8#1)(2008-3#1)
20 general practitioners##2##3##(1993-11#1)(1994-6#1)
20 generations##2##2##(2008-10#2)
20 genes##4##2##(1996-2#2)(2008-10#2)
20 h after##2##3##(1995-11#1)(2008-11#1)
20 h##8##2##(1995-11#1)(2008-10#3)(2008-11#2)(2008-9#1)(2012-2#1)
20 h(-1)##4##2##(2008-10#4)
20 healthy##4##2##(1992-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
20 in the mixed sample##2##5##(2008-10#2)
20 in the##3##3##(2008-10#2)(2009-11#1)
20 in##5##2##(2008-10#2)(2009-11#1)(2011-2#1)(2012-3#1)
20 injections##2##2##(2008-10#2)
20 isolates of##2##3##(2008-10#2)
20 isolates##3##2##(2008-10#3)
20 kDa##4##2##(1994-11#1)(1995-12#1)(1997-7#1)(2011-2#1)
20 kb##3##2##(1995-5#1)(2012-3#2)
20 m##3##2##(1991-6#1)(2008-10#2)
20 mM##12##2##(1997-2#1)(2008-10#6)(2008-11#2)(2008-7#1)(2011-2#2)
20 mV##2##2##(1990-5#1)(2008-10#1)
20 men)##2##2##(1996-6#1)(2011-2#1)
20 meqg(-1) of##2##3##(2008-10#2)
20 mg l(-1) for##2##4##(2008-10#2)
20 mg l(-1)##3##3##(2008-10#3)
20 mg##8##2##(1990-2#1)(1991-2#1)(1991-8#1)(2008-10#5)
20 mg/kg##7##2##(1993-2#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-7#1)
20 microM and##2##3##(1994-8#1)(2008-10#1)
20 microM##10##2##(1990-5#1)(1993-3#2)(1994-8#2)(1995-8#3)(1996-2#1)(2008-10#1)
20 microM)##4##2##(1994-11#2)(1995-8#1)(2009-9#1)
20 microg ml(-1)##2##3##(2008-10#2)
20 microg##4##2##(2008-10#3)(2010-8#1)
20 microm##2##2##(2007-12#1)(2008-11#1)
20 min in##2##3##(2008-10#2)
20 min of##4##3##(1994-12#2)(2008-10#1)(2013-8#1)
20 min to##2##3##(1992-3#1)(1994-8#1)
20 min##34##2##(1992-3#1)(1994-12#2)(1994-3#1)(1994-8#2)(1996-2#1)(1997-1#3)(1997-4#1)(2008-10#16)(2008-11#3)(2008-5#2)(2013-8#2)
20 minutes for##2##3##(2011-2#1)(2013-8#1)
20 minutes##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
20 ml of##4##3##(2008-10#4)
20 ml##7##2##(2008-10#7)
20 mm##5##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
20 mmol##2##2##(2008-10#2)
20 mmol/L##3##2##(1993-1#1)(2008-8#1)(2008-9#1)
20 months##2##2##(2008-9#1)(2011-2#1)
20 ms##2##2##(1996-2#1)(2008-11#1)
20 muM##5##2##(2008-10#3)(2008-11#2)
20 mug l(-1)##3##3##(2008-10#3)
20 mug ml(-1)##4##3##(2008-10#3)(2008-11#1)
20 mug##14##2##(2008-10#12)(2008-11#2)
20 mug/ml##2##2##(2008-10#1)(2008-11#1)
20 mul injection volume##2##4##(2008-10#2)
20 mul of##4##3##(2008-10#3)(2008-11#1)
20 mul volumes##3##3##(2008-10#3)
20 mul##18##2##(2008-10#16)(2008-11#2)
20 mum##5##2##(2008-10#2)(2008-11#2)(2008-7#1)
20 nM##2##2##(1992-6#1)(1996-2#1)
20 ng ml(-1) and##2##4##(2008-10#2)
20 ng ml(-1) for##3##4##(2008-10#3)
20 ng ml(-1)##9##3##(2008-10#9)
20 ng of##2##3##(2008-10#2)
20 ng##15##2##(2008-10#15)
20 ng/g##3##2##(2008-10#3)
20 ng/ml##2##2##(1993-3#1)(1997-1#1)
20 nm##4##2##(2008-3#1)(2008-5#1)(2008-9#2)
20 nmol/l cells##2##3##(1995-8#2)
20 of##6##2##(1993-12#1)(1995-12#1)(1995-9#1)(2008-5#1)(2011-1#1)(2013-1#1)
20 on##2##2##(2008-6#1)(2008-9#1)
20 or more##2##3##(1991-12#1)(2008-7#1)
20 or##7##2##(1991-12#1)(1993-8#1)(2008-10#3)(2008-7#1)(2008-9#1)
20 patients (62##2##3##(2008-10#2)
20 patients with chronic##2##4##(2009-8#1)(2010-4#1)
20 patients with##6##3##(1991-11#1)(1992-5#1)(2008-11#1)(2009-8#1)(2010-4#1)(2013-1#1)
20 patients##27##2##(1991-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-12#2)(1996-6#1)(1996-9#2)(1997-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#3)(2013-1#2)
20 percent of the##3##4##(1991-1#1)(1997-2#1)(2008-10#1)
20 percent of##4##3##(1991-1#1)(1994-12#1)(1997-2#1)(2008-10#1)
20 percent##5##2##(1991-1#1)(1994-12#1)(1996-1#1)(1997-2#1)(2008-10#1)
20 ppb##3##2##(2008-10#3)
20 rpm##2##2##(2008-11#2)
20 s and can be used for##2##7##(2008-10#2)
20 s##12##2##(1990-2#1)(2008-10#8)(2008-3#1)(2008-7#1)(2013-1#1)
20 samples h(-1)##3##3##(2008-10#3)
20 samples per h##2##4##(2008-10#2)
20 samples per hour##4##4##(2008-10#4)
20 samples per##6##3##(2008-10#6)
20 samples##10##2##(2008-10#10)
20 soybean stem pieces##2##4##(2008-10#2)
20 soybean##3##2##(2008-10#3)
20 times higher than##2##4##(1992-8#1)(2008-8#1)
20 times higher##3##3##(1992-8#1)(1995-12#1)(2008-8#1)
20 times##8##2##(1992-8#1)(1995-12#1)(2008-10#4)(2008-8#2)
20 to 0##2##3##(2008-10#2)
20 to 24##2##3##(2008-10#1)(2008-12#1)
20 to 25 degrees C##4##5##(2008-10#4)
20 to 25##5##3##(2008-10#4)(2009-1#1)
20 to 30##3##3##(1993-8#1)(2008-10#2)
20 to 30% in##2##4##(2008-10#2)
20 to 60##2##3##(2008-10#1)(2010-7#1)
20 to 60%##2##3##(1996-12#1)(2008-10#1)
20 to##46##2##(1993-8#1)(1996-12#1)(1997-5#1)(2008-10#35)(2008-12#1)(2009-1#1)(2010-11#1)(2010-7#1)(2011-2#2)(2013-8#2)
20 weeks of pregnancy##2##4##(1994-3#1)(2009-1#1)
20 weeks##10##2##(1993-6#1)(1994-3#1)(2008-12#1)(2008-9#2)(2009-1#1)(2011-2#4)
20 were##4##2##(2008-10#1)(2008-7#1)(2011-2#2)
20 with##2##2##(1996-5#1)(2008-10#1)
20 x##4##2##(1996-12#1)(2008-11#1)(2008-12#1)(2009-5#1)
20 years after##2##3##(2008-10#1)(2008-12#1)
20 years ago##5##3##(2008-10#4)(2008-7#1)
20 years in##3##3##(1995-12#1)(1996-5#1)(2008-10#1)
20 years of age##2##4##(1997-4#1)(2013-1#1)
20 years of experience##2##4##(2008-10#1)(2010-12#1)
20 years of##5##3##(1991-12#1)(1997-4#1)(2008-10#1)(2010-12#1)(2013-1#1)
20 years##40##2##(1991-12#2)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2013-1#1)
20 yr##2##2##(2008-8#2)
20 ×##2##2##(2011-2#2)
20##926##1##(1990-12#4)(1990-2#5)(1990-3#1)(1990-5#4)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#6)(1991-12#4)(1991-2#6)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#4)(1992-8#1)(1993-1#6)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#7)(1993-6#1)(1993-8#7)(1993-9#1)(1994-11#3)(1994-12#5)(1994-3#9)(1994-5#1)(1994-6#2)(1994-8#8)(1995-1#1)(1995-11#5)(1995-12#12)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#9)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#8)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#6)(1997-9#1)(2007-11#1)(2007-12#6)(2008-1#4)(2008-10#415)(2008-11#43)(2008-12#20)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#19)(2008-6#2)(2008-7#25)(2008-8#10)(2008-9#16)(2009-1#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#5)(2009-9#4)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#36)(2011-3#3)(2012-12#2)(2012-2#6)(2012-3#9)(2013-1#23)(2013-8#13)
20% after##2##2##(2008-5#1)(2010-8#1)
20% and##4##2##(1995-3#1)(2008-10#2)(2013-8#1)
20% for##6##2##(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)
20% glycerin##3##2##(2008-5#3)
20% in the##2##3##(2008-5#1)(2008-7#1)
20% in##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
20% of all##4##3##(1992-12#1)(1992-6#1)(2013-1#2)
20% of the cases##5##4##(1991-8#1)(1992-5#1)(1995-12#1)(1996-3#1)(2013-1#1)
20% of the##14##3##(1991-8#1)(1992-5#1)(1995-12#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-8#1)(2008-11#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
20% of those##2##3##(1992-6#1)(2008-10#1)
20% of##37##2##(1991-8#2)(1992-12#1)(1992-5#1)(1992-6#2)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#6)(2008-7#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#7)
20% overall##2##2##(1995-12#1)(1996-3#1)
20% to##2##2##(2008-7#1)(2009-8#1)
20% total body surface area burn injury##2##7##(2008-8#2)
20% were##3##2##(1990-9#1)(2008-11#2)
20%##147##1##(1990-8#3)(1990-9#1)(1991-5#1)(1991-8#2)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#17)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#10)(2008-7#4)(2008-8#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-4#1)(2010-6#3)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#3)
20%) and##2##2##(2008-10#2)
20%)##11##1##(2008-10#6)(2008-11#1)(2008-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
20%fatigue and 60%fatigue##2##3##(2013-8#2)
20%fatigue##3##1##(2013-8#3)
20) and##2##2##(2008-10#1)(2008-5#1)
20) that##2##2##(1993-3#1)(2008-1#1)
20) were##5##2##(1993-3#1)(2008-10#3)(2010-8#1)
20)##32##1##(1990-11#1)(1990-5#1)(1993-1#1)(1993-3#3)(1997-3#2)(1997-8#1)(2008-1#2)(2008-10#6)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#4)
20+/-0##3##1##(2008-10#3)
20+/-2 degrees C##2##3##(2008-10#2)
20- to##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
20-##7##1##(1995-8#1)(1996-12#1)(2008-10#3)(2008-8#1)(2013-1#1)
20-1##2##1##(2008-10#2)
20-100##6##1##(1995-12#1)(2008-10#3)(2008-5#1)(2009-12#1)
20-15##2##1##(2008-10#2)
20-21##3##1##(1992-8#1)(2008-10#1)(2008-7#1)
20-23##2##1##(2008-7#1)(2013-8#1)
20-24##2##1##(2008-10#1)(2008-11#1)
20-25##3##1##(1990-5#1)(1992-3#1)(2008-10#1)
20-25%##3##1##(2008-12#1)(2008-5#1)(2012-2#1)
20-30 ms##2##2##(2008-10#1)(2008-11#1)
20-30##9##1##(1996-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
20-30% of the##2##3##(1994-5#1)(1997-3#1)
20-30% of##3##2##(1993-12#1)(1994-5#1)(1997-3#1)
20-30%##8##1##(1993-12#1)(1994-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2011-3#1)
20-40##3##1##(1994-2#1)(2008-10#1)(2008-6#1)
20-50##3##1##(1994-8#1)(2008-3#1)(2008-5#1)
20-50%##2##1##(2008-10#1)(2008-11#1)
20-500 mug l(-1)##2##3##(2008-10#2)
20-500##3##1##(2008-10#3)
20-60##2##1##(2008-10#1)(2008-11#1)
20-64)##2##1##(2008-3#1)(2011-2#1)
20-L bioreactor##2##2##(2008-7#2)
20-alpha-hydroxy-4- pregnen-3-one##2##2##(1990-11#2)
20-diphenylporphyrin and 5##2##3##(2008-10#2)
20-diphenylporphyrin##4##1##(2008-10#4)
20-fold##7##1##(1990-10#1)(1990-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
20-folds##2##1##(2008-10#2)
20-mer##2##1##(2008-10#1)(2008-4#1)
20-min MRI scans at a##2##5##(1992-3#2)
20-min MRI##3##2##(1992-3#3)
20-min##4##1##(1991-9#1)(1992-3#3)
20-percent##3##1##(1991-12#2)(1994-12#1)
20-ps pulses##2##2##(2007-12#1)(2008-3#1)
20-tetrakis (4-N-trimethylammino-phenyl) porphyrin##2##3##(2008-10#2)
20-tetrakis##5##1##(2008-10#5)
20-tetrakis(4-carboxylphenyl)porphyrin##2##1##(2008-10#2)
20-tetrakis(4-sulfonatophenyl)porphyrin##2##1##(2008-10#2)
20-tetraphenylporphyrin##2##1##(2008-10#2)
20-triphenylporphyrin##2##1##(2008-10#2)
20-year experience##2##2##(1993-9#1)(2009-11#1)
20-year##6##1##(1993-8#1)(1993-9#1)(2009-11#1)(2013-1#1)(2013-8#2)
20-year-old male##2##2##(1994-11#1)(2008-7#1)
20-year-old man##3##2##(2008-7#1)(2008-9#1)(2010-6#1)
20-year-old##8##1##(1994-11#1)(1994-6#1)(2008-7#2)(2008-9#1)(2010-6#2)(2012-3#1)
20/100 bp##2##2##(2008-10#2)
20/100##4##1##(2008-10#2)(2010-10#1)(2010-9#1)
200 (w/w)##2##2##(2008-10#2)
200 and##14##2##(1995-2#2)(1997-2#1)(2007-11#1)(2008-10#8)(2008-11#1)(2012-3#1)
200 base pairs (bp)##2##4##(2008-10#1)(2008-11#1)
200 days##2##2##(1990-8#1)(2008-10#1)
200 degrees C##4##3##(2008-10#4)
200 degrees##5##2##(2008-10#4)(2009-5#1)
200 individuals##2##2##(1996-3#1)(2009-4#1)
200 kDa##2##2##(1996-12#2)
200 mV##4##2##(2008-10#4)
200 mg l(-1)##3##3##(2008-10#3)
200 mg##6##2##(1997-2#1)(2008-10#4)(2008-5#1)
200 mg/kg##6##2##(1991-12#2)(2008-10#2)(2012-2#2)
200 microM##2##2##(1990-12#1)(1992-3#1)
200 microg##2##2##(2008-10#1)(2011-2#1)
200 micrograms ml-1##2##3##(1996-2#2)
200 micrograms##4##2##(1990-6#1)(1996-2#3)
200 microl##3##2##(2008-10#3)
200 ml of##2##3##(2008-10#2)
200 ml##3##2##(2008-10#3)
200 ms##5##2##(2008-11#1)(2008-3#2)(2010-6#1)(2010-9#1)
200 muM SA to##2##4##(2008-10#2)
200 muM SA##3##3##(2008-10#3)
200 muM##4##2##(2008-10#4)
200 mug##2##2##(2008-10#2)
200 mug/ml##4##2##(2008-10#4)
200 mul of##2##3##(2008-10#1)(2008-11#1)
200 mul##4##2##(2008-10#3)(2008-11#1)
200 mul)##4##2##(2008-10#3)(2008-11#1)
200 nM##2##2##(1990-2#1)(1990-5#1)
200 ng##5##2##(2008-10#3)(2008-11#2)
200 nm##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
200 patients##3##2##(1996-3#1)(1997-8#1)(2011-2#1)
200 ppm##2##2##(2008-10#2)
200 times##3##2##(2008-10#2)(2008-7#1)
200 to 1##2##3##(2008-10#2)
200 to 400##3##3##(2007-11#1)(2008-10#2)
200 to##9##2##(2007-11#1)(2008-10#5)(2008-12#1)(2012-12#1)(2012-2#1)
200 x##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
200##223##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#3)(1992-2#1)(1992-3#3)(1993-1#2)(1994-11#1)(1994-12#2)(1995-2#2)(1995-6#4)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#2)(1997-2#4)(1997-8#1)(2007-11#4)(2008-1#1)(2008-10#112)(2008-11#8)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
200%##3##1##(1996-2#1)(2008-10#1)(2008-12#1)
200)##2##1##(1993-12#1)(2008-10#1)
200-1000##2##1##(2008-10#2)
200-250##2##1##(2008-10#1)(2008-5#1)
200-300##2##1##(2008-10#1)(2008-3#1)
200-500##3##1##(2008-10#2)(2008-11#1)
200-bp intron##2##2##(2008-10#2)
200-bp##4##1##(1993-9#1)(2008-10#2)(2010-5#1)
200-fold##7##1##(1994-8#1)(1997-8#1)(2008-10#4)(2008-5#1)
2000 Journal of Advanced Nursing 31(1)##2##6##(2008-11#2)
2000 and 2001##5##3##(2008-10#5)
2000 and 2005##3##3##(2008-10#1)(2008-12#2)
2000 and 2007##2##3##(2010-12#1)(2013-8#1)
2000 and##29##2##(1997-3#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-5#1)(2009-10#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
2000 by##2##2##(1997-3#1)(2008-10#1)
2000 for##2##2##(2008-10#1)(2008-5#1)
2000 had##3##2##(2008-10#3)
2000 in##3##2##(2008-10#1)(2008-6#2)
2000 is the##2##3##(2011-2#2)
2000 is##3##2##(1996-11#1)(2011-2#2)
2000 mg/kg/day##2##2##(2010-1#2)
2000 to 2005##5##3##(2008-10#2)(2008-11#2)(2008-12#1)
2000 to 2007##2##3##(2010-12#1)(2011-2#1)
2000 to 2010##2##3##(2013-1#2)
2000 to##16##2##(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#2)
2000 using##2##2##(2008-10#2)
2000 was##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
2000 were##3##2##(2008-10#2)(2008-12#1)
2000 when##2##2##(1995-2#1)(2008-11#1)
2000##251##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#3)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1997-2#3)(1997-3#3)(1997-6#4)(2008-1#3)(2008-10#74)(2008-11#73)(2008-12#10)(2008-3#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#1)(2010-1#3)(2010-12#5)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#10)(2011-3#2)(2012-12#3)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#8)(2013-8#2)
2000)##9##1##(2008-10#2)(2008-11#5)(2008-9#1)(2010-10#1)
2000-2006##3##1##(2010-8#1)(2011-2#1)(2012-12#1)
2000-2007##2##1##(2011-3#1)(2013-1#1)
2000-2008##2##1##(2011-2#2)
2001 and 2002##4##3##(2008-10#4)
2001 and##11##2##(2008-10#7)(2008-12#1)(2008-9#1)(2010-3#1)(2010-6#1)
2001 to 2003##2##3##(2008-10#1)(2008-11#1)
2001 to##12##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-8#1)(2013-8#5)
2001##98##1##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#41)(2008-11#20)(2008-12#4)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2013-8#5)
2001)##9##1##(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#1)
2002 National Health Interview##2##4##(2008-10#2)
2002 and 2003##7##3##(2008-10#4)(2008-11#2)(2011-2#1)
2002 and##20##2##(2008-10#8)(2008-11#2)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
2002 have been##2##3##(2008-1#1)(2008-10#1)
2002 to##8##2##(2008-10#3)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)
2002##99##1##(2007-8#2)(2008-1#3)(2008-10#41)(2008-11#16)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
2002)##9##1##(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-11#1)(2010-3#1)(2011-2#1)
2003 and 2004##5##3##(2008-10#4)(2011-2#1)
2003 and##12##2##(2008-10#6)(2008-11#2)(2008-12#1)(2010-8#1)(2011-2#2)
2003 to##6##2##(2008-10#1)(2008-11#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#1)
2003 until##2##2##(2008-10#1)(2013-1#1)
2003##80##1##(2007-11#1)(2008-10#30)(2008-11#23)(2008-12#4)(2008-6#2)(2008-7#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#5)(2011-3#1)(2012-3#1)(2013-1#2)
2003) was##2##2##(2008-12#1)(2012-3#1)
2003)##10##1##(2008-10#2)(2008-12#2)(2008-4#1)(2009-10#1)(2010-1#1)(2011-2#1)(2012-3#2)
2004 and 2005##6##3##(2008-10#4)(2008-12#2)
2004 and##12##2##(2008-10#7)(2008-12#2)(2012-3#2)(2013-8#1)
2004 to 2008##2##3##(2012-3#1)(2013-8#1)
2004 to##6##2##(2008-12#1)(2008-7#1)(2012-3#1)(2013-8#3)
2004 were##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
2004 with the aim of##2##5##(2010-12#1)(2010-6#1)
2004##97##1##(2008-1#3)(2008-10#31)(2008-11#15)(2008-12#7)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-6#4)(2010-7#1)(2010-8#4)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#5)
2004)##10##1##(2008-10#3)(2008-11#2)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-2#1)
2004-2005##2##1##(2008-10#1)(2010-11#1)
2004/2005##2##1##(2008-11#1)(2009-4#1)
2005 and 2006##2##3##(2008-12#1)(2012-3#1)
2005 and 2008##3##3##(2010-11#1)(2011-3#1)(2012-12#1)
2005 and 2011##2##3##(2013-1#1)(2013-8#1)
2005 and##9##2##(2008-10#1)(2008-12#1)(2010-11#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
2005 in##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
2005 to##3##2##(2013-1#2)(2013-8#1)
2005##100##1##(1994-2#1)(1995-12#1)(1996-2#2)(2008-1#2)(2008-10#18)(2008-11#19)(2008-12#14)(2008-4#1)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
2005)##6##1##(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#2)
2006 and 2007##3##3##(2010-4#1)(2011-2#1)(2013-1#1)
2006 and##11##2##(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#2)(2013-1#4)
2006 in##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
2006 to 2007##2##3##(2010-4#1)(2011-2#1)
2006 to 2009##2##3##(2011-9#2)
2006 to##12##2##(2010-4#2)(2011-2#2)(2011-9#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
2006 was##2##2##(2010-2#1)(2010-9#1)
2006##99##1##(2008-10#11)(2008-11#13)(2008-12#7)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-2#14)(2011-3#1)(2011-9#3)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#1)
2006)##7##1##(2008-11#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-4#1)(2013-8#1)
2006-2007##2##1##(2008-11#1)(2008-12#1)
2006-2008##3##1##(2012-12#2)(2013-1#1)
2007 and 2008##4##3##(2011-2#2)(2012-5#1)(2013-8#1)
2007 and 2009##2##3##(2012-3#1)(2013-1#1)
2007 and##11##2##(2010-12#1)(2011-2#4)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
2007 to##7##2##(2011-2#4)(2012-2#1)(2012-3#1)(2012-5#1)
2007##81##1##(2008-10#5)(2008-11#12)(2008-12#2)(2009-11#2)(2009-12#1)(2009-4#3)(2009-5#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2012-5#2)(2013-1#3)(2013-8#6)
2007) for##2##2##(2011-2#1)(2012-2#1)
2007)##9##1##(2008-8#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
2007-2008##3##1##(2011-2#1)(2013-8#2)
2007-2009##2##1##(2012-12#2)
2007-2010##4##1##(2010-3#3)(2013-8#1)
2007]##6##1##(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#2)
2007b)##2##1##(2008-12#1)(2009-5#1)
2008 Beijing##2##2##(2010-1#1)(2013-8#1)
2008 and##6##2##(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#2)
2008 at##2##2##(2010-7#1)(2011-2#1)
2008 in##3##2##(2011-2#3)
2008 to##4##2##(2011-2#2)(2011-7#1)(2012-3#1)
2008 update##2##2##(2009-8#1)(2012-12#1)
2008 were##2##2##(2011-2#1)(2012-3#1)
2008##112##1##(2009-12#1)(2009-4#2)(2009-6#4)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#6)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#31)(2011-3#1)(2011-7#1)(2012-12#8)(2012-2#7)(2012-3#10)(2012-5#1)(2013-1#8)(2013-8#12)
2008)##2##1##(2010-6#1)(2013-8#1)
2009 and 2010##2##3##(2013-1#2)
2009 and##3##2##(2012-12#1)(2013-1#2)
2009 pandemic A/H1##3##3##(2011-2#3)
2009 to##3##2##(2012-2#2)(2012-3#1)
2009 were##2##2##(2011-2#1)(2012-5#1)
2009##87##1##(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#31)(2011-3#1)(2011-9#4)(2012-12#6)(2012-2#7)(2012-3#9)(2012-5#2)(2013-1#12)(2013-8#2)
2009)##7##1##(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
2009]##3##1##(2012-12#1)(2012-3#1)(2013-8#1)
200mgL(-1)##2##1##(2008-10#2)
200mugl(-1)##2##1##(2008-10#2)
200mul##3##1##(2008-10#3)
201##4##1##(1990-6#1)(1993-2#1)(2008-10#1)(2010-1#1)
2010 and##5##2##(2012-12#1)(2013-1#2)(2013-8#2)
2010 in##2##2##(2012-12#1)(2013-1#1)
2010 were##2##2##(2012-3#2)
2010##128##1##(1996-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#62)(2011-3#1)(2011-7#3)(2012-12#10)(2012-2#7)(2012-3#6)(2013-1#21)(2013-7#1)(2013-8#9)
2010)##4##1##(2011-2#2)(2012-3#1)(2013-8#1)
2010-2011##2##1##(2011-2#1)(2012-12#1)
2010]##3##1##(2011-2#2)(2013-8#1)
2011 in##2##2##(2010-11#1)(2013-1#1)
2011 to##2##2##(2012-12#1)(2013-8#1)
2011 were##2##2##(2012-12#1)(2013-7#1)
2011##85##1##(2010-11#1)(2011-2#38)(2012-12#9)(2012-2#7)(2012-3#13)(2013-1#8)(2013-7#1)(2013-8#8)
2011) was##2##2##(2013-1#2)
2011)##3##1##(2013-1#3)
2011]##3##1##(2013-1#1)(2013-8#2)
2012 were##2##2##(2013-1#1)(2013-8#1)
2012##65##1##(2011-4#1)(2012-12#2)(2012-2#3)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#42)(2013-8#12)
2012)##5##1##(2012-2#1)(2013-1#3)(2013-8#1)
2013##6##1##(1993-12#1)(2008-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
2015##3##1##(1994-9#1)(2008-11#1)(2008-12#1)
202 patients##2##2##(2008-7#1)(2009-6#1)
202##10##1##(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-7#1)(2009-6#1)
2020##7##1##(2008-1#2)(2009-10#2)(2011-2#3)
2025##2##1##(1996-2#1)(2013-1#1)
203##8##1##(1997-2#3)(2008-10#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
2030##2##1##(1993-3#2)
204 amino##2##2##(1997-7#1)(2010-5#1)
204##10##1##(1993-6#1)(1994-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#2)
205##6##1##(2008-10#3)(2010-4#1)(2011-2#2)
205)##2##1##(1993-8#1)(1994-11#1)
206##8##1##(1994-11#1)(2008-10#1)(2008-5#3)(2010-1#1)(2010-7#1)(2011-2#1)
207##7##1##(1990-3#1)(2008-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
208##11##1##(1991-9#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2012-3#1)
209##10##1##(1990-11#1)(1991-6#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-8#1)(2011-2#1)
20Gy/5##2##1##(2008-10#2)
20S proteasome##8##2##(2008-4#5)(2008-5#2)(2010-7#1)
20S##10##1##(2008-4#6)(2008-5#3)(2010-7#1)
20h(-1)##2##1##(2008-10#2)
20mM phosphate##2##2##(2008-10#2)
20mM##6##1##(2008-10#4)(2008-11#1)(2008-6#1)
20mg of##3##2##(2008-10#3)
20mgl(-1)##2##1##(2008-10#2)
20min with a##2##3##(2008-10#2)
20min##10##1##(2008-10#10)
20ml##6##1##(2008-10#6)
20mug##3##1##(2008-10#3)
20mugL(-1)##4##1##(2008-10#4)
20mugl(-1)##4##1##(2008-10#4)
20mugml(-1)##4##1##(2008-10#4)
20mul of##2##2##(2008-10#2)
20mul##3##1##(2008-10#3)
20ngg(-1)##2##1##(2008-10#2)
20s##8##1##(1997-3#1)(2008-10#7)
20th Century##2##2##(1997-8#1)(2008-8#1)
20th International Symposium on##2##4##(1997-2#1)(2008-11#1)
20th century##13##2##(1994-12#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-7#1)
20th##24##1##(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-10#1)(2010-6#1)(2011-7#1)(2012-3#1)(2013-1#1)
21 +/-##2##2##(2008-3#1)(2011-3#1)
21 V##2##2##(2009-9#2)
21 and 0##3##3##(2008-10#2)(2008-12#1)
21 and 23##2##3##(1996-5#2)
21 and##18##2##(1990-11#1)(1991-5#1)(1994-11#1)(1996-12#1)(1996-5#2)(2008-10#8)(2008-11#2)(2008-12#1)(2012-3#1)
21 cases##5##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-8#1)(2007-11#1)
21 days after##3##3##(2008-10#3)
21 days##19##2##(1991-6#1)(1994-3#1)(1995-11#1)(2008-10#7)(2008-11#2)(2008-5#2)(2010-8#2)(2011-2#2)(2012-3#1)
21 days)##3##2##(1996-2#3)
21 degrees C##8##3##(2008-10#7)(2008-5#1)
21 different plant##2##3##(2008-10#2)
21 different##3##2##(2008-10#3)
21 h##3##2##(1995-12#2)(2008-5#1)
21 in##5##2##(1992-12#1)(2006-6#1)(2010-1#1)(2010-5#1)(2013-1#1)
21 kDa##2##2##(1990-7#1)(1995-12#1)
21 mm##2##2##(1990-11#1)(2008-7#1)
21 months##3##2##(1990-12#1)(2010-11#1)(2011-1#1)
21 ng ml(-1)##2##3##(2008-10#2)
21 ng##3##2##(2008-10#3)
21 of the##2##3##(2011-2#1)(2012-3#1)
21 of these##2##3##(1997-4#1)(2009-10#1)
21 of##5##2##(1997-4#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-3#1)
21 out of##2##3##(2009-8#1)(2011-2#1)
21 p##6##2##(2008-5#6)
21 patients with##5##3##(1992-11#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
21 patients##14##2##(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2011-1#1)(2011-2#1)
21 samples##2##2##(2008-10#2)
21 times##4##2##(1995-8#1)(2008-10#2)(2008-11#1)
21 to##7##2##(1990-11#1)(1991-5#1)(2008-10#3)(2008-5#1)(2013-1#1)
21 weeks##2##2##(2008-11#1)(2013-1#1)
21 years##2##2##(2010-7#1)(2013-8#1)
21##305##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#8)(1996-3#3)(1996-5#4)(1997-2#3)(1997-3#1)(1997-4#4)(1997-8#2)(2006-6#2)(2007-11#1)(2007-12#1)(2008-10#89)(2008-11#21)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#14)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#2)(2012-12#3)(2012-2#5)(2012-3#7)(2012-6#1)(2013-1#7)(2013-8#6)
21% of patients##2##3##(1992-2#1)(2013-1#1)
21% of the##3##3##(1991-3#1)(1996-3#1)(2008-10#1)
21% of##8##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1996-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
21% were##2##2##(2007-12#1)(2013-8#1)
21%##21##1##(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1994-12#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
21%)##2##1##(2008-10#1)(2008-12#1)
21(st)##2##1##(2008-11#1)(2012-12#1)
21) and##4##2##(1997-2#1)(2010-1#1)(2011-2#1)(2011-3#1)
21) from##2##2##(1991-12#2)
21)##16##1##(1991-12#2)(1993-11#1)(1995-6#1)(1996-3#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-12#1)(2010-1#2)(2011-2#1)(2011-3#1)(2013-8#1)
21-##2##1##(2008-10#1)(2008-5#1)
21-22##2##1##(2008-11#1)(2012-12#1)
21-bp##2##1##(1994-11#2)
21-day##3##1##(2008-10#2)(2008-11#1)
21-year##2##1##(2011-2#1)(2013-1#1)
21-year-old##4##1##(1991-8#1)(2007-12#1)(2009-1#1)(2013-1#1)
210 nm##2##2##(2008-10#2)
210##24##1##(1990-2#1)(1994-9#1)(1995-2#1)(1996-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#3)(2012-3#3)(2013-8#1)
2100 degrees C##2##3##(2008-10#2)
2100##7##1##(2007-12#1)(2008-10#4)(2008-11#1)(2009-11#1)
211##7##1##(1991-2#1)(1991-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-4#1)
212##8##1##(1994-3#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-5#1)
213##13##1##(1990-10#1)(1994-3#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-8#1)(2010-11#1)(2013-1#1)
214 nm##2##2##(2008-10#2)
214 to 2##2##3##(2008-10#2)
214##14##1##(1990-12#1)(1993-11#2)(1995-12#1)(2008-10#6)(2008-3#2)(2012-2#1)(2013-8#1)
215 nm##4##2##(2008-10#4)
215##11##1##(2008-10#6)(2008-7#1)(2008-9#2)(2010-10#1)(2013-1#1)
216##9##1##(1996-3#1)(1997-8#1)(2008-10#3)(2008-9#2)(2010-11#1)(2011-2#1)
217##3##1##(2008-10#1)(2008-9#1)(2013-8#1)
217-230##2##1##(2010-3#2)
218##9##1##(1993-2#1)(1996-1#1)(2008-10#5)(2010-4#1)(2010-6#1)
219##6##1##(1993-6#1)(2008-10#2)(2008-5#1)(2013-1#2)
21CFR11##3##1##(2008-10#3)
21q22##7##1##(1997-2#3)(1997-8#4)
21st Century##3##2##(1994-1#1)(1995-12#1)(2011-2#1)
21st century##32##2##(1990-12#1)(1991-12#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#3)(2007-12#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)
21st##40##1##(1990-12#1)(1991-12#1)(1994-1#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1996-12#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#3)(2007-12#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
22 (sensitivity##2##2##(2011-1#2)
22 +/- 0##2##3##(1996-2#1)(2008-12#1)
22 +/- 1##2##3##(1997-8#1)(2011-3#1)
22 +/-##5##2##(1996-2#1)(1997-8#1)(2008-11#1)(2008-12#1)(2011-3#1)
22 ACL graft patients##2##4##(1997-8#2)
22 V##3##2##(2008-10#2)(2009-9#1)
22 aa##2##2##(1990-11#1)(1993-2#1)
22 alpha##2##2##(2008-11#2)
22 and 1##2##3##(2008-10#2)
22 and##13##2##(1990-11#1)(1991-8#2)(1993-12#1)(1993-3#1)(2008-10#6)(2008-3#1)(2012-12#1)
22 cochlear implant##2##3##(2008-9#1)(2012-2#1)
22 days##5##2##(2008-10#2)(2011-2#1)(2012-2#2)
22 degrees C and##2##4##(1992-3#1)(2008-11#1)
22 degrees C##18##3##(1992-3#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-9#1)(2011-2#1)
22 degrees##22##2##(1992-3#1)(1994-8#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
22 distinct##2##2##(1997-2#1)(2008-10#1)
22 for##2##2##(2008-10#2)
22 h##2##2##(1992-8#1)(2008-12#1)
22 healthy##2##2##(2008-11#1)(2011-2#1)
22 hr##2##2##(2008-11#1)(2011-2#1)
22 isolates##2##2##(2008-10#2)
22 kDa c-type cytochrome##2##4##(1994-11#2)
22 kDa##4##2##(1994-11#2)(2008-10#1)(2013-1#1)
22 kHz ultrasonic vocalization##3##4##(1994-8#3)
22 months##2##2##(2011-2#2)
22 nm##2##2##(2008-8#1)(2013-8#1)
22 of them##2##3##(1993-6#1)(2008-10#1)
22 of##6##2##(1993-6#1)(1994-1#1)(2008-10#1)(2010-10#1)(2010-11#1)(2011-2#1)
22 patients had been##2##4##(2012-3#1)(2013-1#1)
22 patients were##2##3##(2012-3#1)(2013-1#1)
22 patients with##8##3##(1991-12#1)(1991-6#1)(1997-3#1)(2008-1#1)(2008-7#1)(2011-2#2)(2013-8#1)
22 patients##15##2##(1991-12#1)(1991-6#1)(1992-2#1)(1997-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
22 strains##2##2##(2008-10#2)
22 to 23##2##3##(1992-3#1)(2008-10#1)
22 to 26 degrees C##2##5##(2008-10#2)
22 to##11##2##(1992-3#1)(1997-2#1)(2008-10#9)
22 were##4##2##(1992-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
22 with##3##2##(1996-2#1)(2008-11#1)(2010-1#1)
22 women##3##2##(1995-8#1)(2011-2#1)(2012-3#1)
22 x##2##2##(2008-10#1)(2008-11#1)
22 years old female contact lenses wearer##2##7##(2011-2#2)
22 years##4##2##(2009-10#1)(2011-2#2)(2012-3#1)
22##296##1##(1990-11#3)(1990-2#1)(1990-5#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-6#3)(1991-8#4)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#5)(1994-8#6)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-3#2)(1996-6#2)(1996-8#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-8#4)(2007-8#1)(2008-1#1)(2008-10#81)(2008-11#19)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#10)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#33)(2011-3#1)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#7)(2013-8#10)
22% and##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
22% for##2##2##(2008-10#2)
22% of the##8##3##(1991-2#1)(1991-9#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-5#1)(2010-9#1)
22% of##14##2##(1990-3#1)(1991-2#1)(1991-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-9#1)(2012-2#1)
22% with##3##2##(2008-10#2)(2011-2#1)
22%##40##1##(1990-3#1)(1991-2#1)(1991-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#2)
22%)##2##1##(2008-10#1)(2013-8#1)
22)##13##1##(1990-11#1)(1992-12#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-8#2)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
22-1##2##1##(2008-10#1)(2008-11#1)
22-24##3##1##(1995-9#1)(2008-1#1)(2008-10#1)
22-25##2##1##(2008-8#1)(2011-2#1)
22-kDa##3##1##(1995-6#2)(2008-10#1)
22-month animals##2##2##(1994-3#2)
22-month-old animals##2##2##(1994-3#2)
22-month-old##4##1##(1994-3#4)
22-year-old female patient##2##3##(2010-3#1)(2011-2#1)
22-year-old female##3##2##(2008-7#1)(2010-3#1)(2011-2#1)
22-year-old##4##1##(2008-7#1)(2010-3#1)(2011-2#1)(2012-3#1)
220 ng##2##2##(2008-10#2)
220 nm##3##2##(2008-10#3)
220 patients##3##2##(1995-11#1)(2012-3#1)(2013-8#1)
220##20##1##(1994-11#1)(1995-1#1)(1995-11#1)(2008-10#10)(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#3)
2200 degrees C##2##3##(2008-10#2)
2200##3##1##(2008-10#2)(2012-2#1)
221##3##1##(1996-6#1)(2008-12#1)(2011-2#1)
222 and##2##2##(2008-10#2)
222##9##1##(1996-6#1)(2008-10#4)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
223 and 243 nm by##2##5##(2008-2#2)
223 and##3##2##(1990-2#1)(2008-2#2)
223##12##1##(1990-2#1)(1992-4#1)(1994-3#1)(1996-11#1)(2008-10#3)(2008-2#2)(2008-8#1)(2009-7#1)(2013-1#1)
224##13##1##(1992-9#1)(1994-1#1)(1996-1#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-5#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
225 and##3##2##(1995-6#1)(2008-10#2)
225 isolates##2##2##(2008-10#2)
225 nm##2##2##(1997-2#1)(2008-10#1)
225##16##1##(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-3#3)(2011-2#1)
226 local##2##2##(2008-10#2)
226 nm##3##2##(2008-10#2)(2012-2#1)
226##12##1##(1995-6#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
227##8##1##(1996-2#1)(2008-10#2)(2008-3#3)(2008-5#1)(2011-2#1)
227)##3##1##(1992-3#1)(2008-10#1)(2012-3#1)
228 (North Holland)##2##3##(1991-8#2)
228##14##1##(1990-5#1)(1990-6#1)(1991-8#2)(1992-10#1)(1993-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#2)(2012-3#1)
2280##2##1##(1996-8#2)
229##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
22nd##3##1##(1990-12#1)(1991-2#1)(2011-2#1)
22q11##9##1##(1997-3#6)(2012-12#3)
22 nm##2##1##(2012-2#2)
23 (##2##2##(2013-1#2)
23 +/- 0##3##3##(1993-1#1)(2013-1#2)
23 V##2##2##(2008-10#1)(2009-9#1)
23 amino##3##2##(1990-8#1)(1993-8#1)(1994-11#1)
23 and##4##2##(1994-1#1)(2008-10#3)
23 days##4##2##(2008-10#2)(2008-7#1)(2011-3#1)
23 degrees C##7##3##(1993-9#2)(2008-10#5)
23 degrees##8##2##(1993-8#1)(1993-9#2)(2008-10#5)
23 followed by##2##3##(1996-5#1)(2008-12#1)
23 h##4##2##(2008-10#4)
23 isolates##4##2##(2008-10#4)
23 items##2##2##(2010-10#2)
23 mm##2##2##(2010-8#1)(2012-12#1)
23 months##3##2##(1992-12#1)(1994-2#1)(2008-7#1)
23 mug l(-1)##2##3##(2008-10#2)
23 mug##4##2##(2008-10#3)(2008-11#1)
23 of the##2##3##(1995-6#1)(2013-1#1)
23 pairs of chromosomes##2##4##(2012-3#2)
23 patients who##2##3##(1991-2#1)(1996-6#1)
23 patients with##3##3##(1991-2#1)(1996-12#1)(2007-8#1)
23 patients##11##2##(1991-2#2)(1991-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)
23 percent of##2##3##(1992-3#1)(1997-2#1)
23 strains from##2##3##(2008-10#2)
23 to##4##2##(1995-3#1)(1996-5#1)(2008-10#1)(2009-3#1)
23 with##2##2##(1995-3#1)(2008-1#1)
23 years before##2##3##(1990-3#1)(1991-7#1)
23 years of##2##3##(1992-6#1)(2008-7#1)
23 years##5##2##(1990-3#1)(1991-2#1)(1991-7#1)(1992-6#1)(2008-7#1)
23##238##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-7#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#77)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#2)(2009-3#1)(2009-5#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#7)(2013-1#11)(2013-8#5)
23% in##2##2##(1996-3#1)(2009-5#1)
23% of the##2##3##(2008-10#1)(2008-7#1)
23% of##8##2##(1991-11#1)(1992-1#1)(1993-12#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
23% were##2##2##(2008-12#1)(2012-2#1)
23%##31##1##(1990-6#1)(1991-11#2)(1991-2#1)(1992-1#1)(1993-12#2)(1993-3#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
23%)##3##1##(1992-3#1)(2008-10#1)(2013-1#1)
23) and##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
23)##8##1##(1995-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2012-12#1)(2013-8#1)
23+/-0##3##1##(2008-10#1)(2008-11#2)
23-1##2##1##(1994-12#1)(2008-10#1)
23-17-1b##2##1##(2008-10#2)
23-25##2##1##(2011-2#1)(2012-2#1)
23-26##3##1##(1995-12#1)(1996-2#1)(2008-10#1)
23-year-old##9##1##(1990-6#1)(1997-8#1)(2008-7#2)(2009-5#1)(2010-12#1)(2013-1#2)(2013-8#1)
230 and##3##2##(1994-5#1)(2008-3#2)
230 bp##2##2##(1994-2#1)(2008-10#1)
230 nm##4##2##(2008-10#4)
230##22##1##(1990-2#1)(1990-9#1)(1994-2#1)(1994-5#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-9#1)(2010-12#1)(2013-1#1)
2300 degrees C##4##3##(2008-10#4)
2300##7##1##(2008-10#6)(2009-11#1)
2302##9##1##(1992-4#1)(2008-10#8)
2308##5##1##(1996-12#5)
231##3##1##(1991-2#1)(2013-1#1)(2013-8#1)
232##7##1##(1991-2#1)(1991-9#1)(1994-11#1)(1997-3#1)(2008-10#2)(2011-2#1)
232-CG##2##1##(2008-10#2)
233 patients##2##2##(2011-2#1)(2013-1#1)
233##7##1##(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#2)
23390##2##1##(1994-2#1)(1996-2#1)
234##4##1##(1994-11#1)(2008-10#1)(2008-8#1)(2012-2#1)
235##17##1##(1991-2#1)(1992-12#1)(1992-5#1)(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
2350##2##1##(2011-2#1)(2012-9#1)
236##6##1##(1991-3#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
237##5##1##(1997-8#1)(2008-10#2)(2008-11#1)(2012-3#1)
238 patients##2##2##(1993-3#1)(2010-11#1)
238##16##1##(1991-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#3)(2010-1#1)(2010-11#1)
238)##2##1##(1996-2#1)(2008-10#1)
239 nm##2##2##(1997-2#1)(2008-10#1)
239##9##1##(1995-12#1)(1997-2#1)(2008-10#4)(2008-4#1)(2008-8#1)(2013-1#1)
23H-porphine-2##2##1##(2008-10#2)
23S##3##1##(1992-3#2)(2008-10#1)
23rd##2##1##(2008-10#1)(2009-9#1)
24 +/- 0##4##3##(1993-1#1)(1994-11#1)(1996-2#2)
24 +/- 2##2##3##(1993-11#1)(2008-12#1)
24 +/-##7##2##(1990-5#1)(1993-1#1)(1993-11#1)(1994-11#1)(1996-2#2)(2008-12#1)
24 -##2##2##(2008-11#1)(2008-9#1)
24 Kd##3##2##(1993-8#3)
24 and 0##2##3##(2008-10#2)
24 and 29##2##3##(2008-6#1)(2013-1#1)
24 and 30##2##3##(1995-8#1)(2008-10#1)
24 and 48##2##3##(2008-5#1)(2010-5#1)
24 and 96 h##2##4##(2008-12#2)
24 and##17##2##(1991-6#1)(1992-2#1)(1994-8#1)(1995-8#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)
24 barley genotypes##2##3##(2008-10#2)
24 children##2##2##(1994-1#1)(2008-1#1)
24 cochlear implant##9##3##(2008-9#9)
24 days##3##2##(1990-10#1)(1995-12#1)(2008-10#1)
24 degrees C and##2##4##(2008-10#1)(2008-11#1)
24 degrees C##19##3##(1997-1#1)(2008-10#16)(2008-11#1)(2008-5#1)
24 degrees##20##2##(1997-1#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-9#1)
24 h after inoculation##4##4##(2008-10#4)
24 h after the last##2##5##(1996-12#1)(2008-10#1)
24 h after the##4##4##(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
24 h after treatment##2##4##(2008-10#2)
24 h after##22##3##(1994-5#1)(1995-12#1)(1996-12#1)(2008-10#12)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
24 h and##5##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-9#2)
24 h at##4##3##(2008-10#3)(2008-12#1)
24 h before inoculation with##2##5##(2008-10#2)
24 h before##4##3##(2008-10#2)(2008-7#1)(2010-8#1)
24 h following##2##3##(1994-8#1)(2008-10#1)
24 h in a##2##4##(2008-8#1)(2012-3#1)
24 h in##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
24 h later##2##3##(1994-2#1)(2008-11#1)
24 h of##11##3##(1990-10#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-7#2)(2012-2#1)
24 h postinoculation##3##3##(2008-10#3)
24 h prior to##2##4##(1995-12#1)(2008-7#1)
24 h urine##2##3##(1997-2#1)(2011-3#1)
24 h when a##2##4##(2008-10#2)
24 h with##2##3##(2008-11#2)
24 h withdrawal##2##3##(1996-12#2)
24 h##143##2##(1990-10#1)(1990-12#4)(1991-3#2)(1993-12#1)(1994-2#2)(1994-5#3)(1994-8#1)(1995-12#3)(1996-12#7)(1996-2#3)(1997-2#2)(1997-4#1)(1997-7#2)(2008-10#59)(2008-11#10)(2008-12#4)(2008-5#6)(2008-7#8)(2008-8#4)(2008-9#3)(2009-12#1)(2010-11#1)(2010-3#2)(2010-8#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
24 h(-1)##2##2##(2008-10#2)
24 h)##5##2##(1997-1#2)(2008-10#2)(2012-3#1)
24 hour##4##2##(1990-3#1)(1993-8#1)(1997-8#1)(2008-11#1)
24 hours after##4##3##(2010-1#1)(2012-12#2)(2013-1#1)
24 hours before##2##3##(1993-11#1)(2008-10#1)
24 hours of##5##3##(1990-5#1)(1993-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
24 hours the##2##3##(1992-6#1)(2011-2#1)
24 hours##30##2##(1990-11#1)(1990-5#1)(1992-6#3)(1993-11#1)(1993-2#1)(1993-6#1)(1995-8#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)
24 hr##9##2##(1994-8#1)(1996-3#1)(2008-11#3)(2008-5#2)(2008-6#1)(2013-8#1)
24 isolates##3##2##(2008-10#3)
24 lines with the##2##4##(2008-10#2)
24 min##2##2##(2008-10#2)
24 months after surgery##3##4##(1990-6#1)(1992-9#1)(1994-8#1)
24 months of##3##3##(1990-3#1)(1991-12#1)(2012-3#1)
24 months##17##2##(1990-3#1)(1990-6#2)(1991-12#1)(1992-9#1)(1993-11#1)(1994-8#1)(1997-9#1)(2008-11#1)(2008-12#1)(2008-4#2)(2010-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
24 of##4##2##(1990-12#1)(1995-11#1)(2008-10#1)(2008-8#1)
24 or 48 h##2##4##(2008-10#2)
24 patients with##2##3##(2008-7#1)(2013-1#1)
24 patients##15##2##(1990-3#1)(1990-6#1)(1993-3#1)(1994-12#1)(1995-12#1)(2007-8#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
24 proteins##2##2##(1997-6#1)(2011-1#1)
24 samples##4##2##(2008-10#4)
24 to 0##2##3##(2008-10#1)(2008-11#1)
24 to 29##2##3##(1993-12#1)(2008-10#1)
24 to 36##2##3##(1993-3#1)(2008-11#1)
24 to 48 h##2##4##(2008-10#2)
24 to##13##2##(1991-4#1)(1993-12#2)(1993-3#1)(2008-10#6)(2008-11#2)(2013-1#1)
24 was##2##2##(1996-12#1)(2013-1#1)
24 weeks in##2##3##(2008-10#1)(2008-5#1)
24 weeks of##3##3##(2008-5#1)(2009-8#1)(2012-3#1)
24 weeks##11##2##(2008-10#2)(2008-5#2)(2009-8#2)(2010-4#2)(2011-2#1)(2012-3#1)(2013-8#1)
24 were##2##2##(1991-8#1)(1996-3#1)
24 women##2##2##(2011-2#1)(2013-1#1)
24 years##2##2##(1993-2#1)(2011-2#1)
24##535##1##(1990-10#2)(1990-11#6)(1990-12#5)(1990-3#3)(1990-5#7)(1990-6#3)(1990-8#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#7)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#6)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#7)(1995-6#1)(1995-8#3)(1995-9#2)(1996-12#9)(1996-2#5)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2007-8#2)(2008-1#2)(2008-10#166)(2008-11#24)(2008-12#15)(2008-2#2)(2008-4#2)(2008-5#21)(2008-6#3)(2008-7#21)(2008-8#8)(2008-9#21)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#5)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#4)(2010-9#2)(2011-1#3)(2011-2#17)(2011-3#2)(2012-12#4)(2012-2#4)(2012-3#13)(2012-6#1)(2013-1#14)(2013-8#4)
24% and##2##2##(2008-9#1)(2011-2#1)
24% for##3##2##(1990-6#1)(2008-10#2)
24% of the##2##3##(2008-10#2)
24% of##7##2##(1994-2#1)(1994-3#1)(2008-10#3)(2008-11#1)(2012-2#1)
24% were##2##2##(2008-10#1)(2008-11#1)
24%##25##1##(1990-6#1)(1990-8#1)(1994-2#1)(1994-3#2)(2008-10#10)(2008-11#3)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
24%)##3##1##(1994-2#1)(2008-10#1)(2008-12#1)
24(R##3##1##(1991-5#3)
24) and##4##2##(2009-12#1)(2012-2#2)(2012-3#1)
24)##17##1##(1990-11#1)(1990-5#1)(1995-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-12#3)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#3)
24+/-0##2##1##(2008-10#2)
24-##3##1##(2008-11#2)(2013-1#1)
24-18-7##3##1##(2008-10#3)
24-25##3##1##(1993-12#1)(1996-2#1)(2008-8#1)
24-29##2##1##(1991-9#1)(1997-7#1)
24-48 h##2##2##(1996-2#1)(2010-11#1)
24-48##3##1##(1994-8#1)(1996-2#1)(2010-11#1)
24-base pair##2##2##(1995-6#2)
24-base##3##1##(1993-2#1)(1995-6#2)
24-h faecal excretion of arsenic##2##5##(1995-11#2)
24-h urinary excretion of arsenic metabolites##3##6##(1995-11#3)
24-h urinary excretion of both##2##5##(1995-11#2)
24-h urinary excretion of##7##4##(1995-11#7)
24-h##32##1##(1990-3#2)(1994-8#1)(1995-11#11)(2008-10#12)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#1)
24-hour PAS##4##2##(1996-1#4)
24-hour recall##2##2##(1991-2#1)(2013-1#1)
24-hour##21##1##(1990-11#4)(1991-1#1)(1991-12#1)(1991-2#1)(1993-11#1)(1995-9#3)(1996-1#4)(1996-8#1)(1997-8#2)(2013-1#3)
24-hr Holter ECG##2##3##(1996-3#2)
24-hr oesophageal pH-metry and Holter ECG monitoring##2##7##(1996-3#2)
24-hr##4##1##(1996-3#4)
24-hydroxylase##4##1##(1994-11#4)
24-kDa oleosin##3##2##(2009-10#3)
24-kDa protein##2##2##(1995-6#2)
24-kDa##6##1##(1995-6#2)(2008-10#1)(2009-10#3)
24-mer##3##1##(2008-10#3)
24-methylene-24##2##1##(1992-3#2)
24-month##5##1##(2008-4#2)(2013-1#3)
24-week##3##1##(2008-4#1)(2009-8#1)(2011-2#1)
24-well##2##1##(2008-11#1)(2012-3#1)
24-year-old##3##1##(2008-10#1)(2010-11#1)(2010-9#1)
240 min##3##2##(1995-11#1)(2010-1#2)
240 s##2##2##(2008-10#2)
240##30##1##(1990-5#1)(1995-11#1)(1996-12#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)(2010-1#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
240-m distance##2##2##(2008-3#2)
2400 degrees C##2##3##(2008-10#2)
2400 degrees##4##2##(2008-10#4)
2400##7##1##(1990-5#2)(2008-10#5)
240nm##2##1##(2008-10#2)
241##7##1##(1993-9#2)(2008-10#2)(2008-5#1)(2011-2#2)
242##7##1##(1992-4#1)(1996-11#1)(1996-2#1)(2008-10#2)(2008-3#1)(2013-1#1)
243##11##1##(1990-11#1)(1991-3#1)(2008-10#2)(2008-2#2)(2008-8#1)(2010-1#1)(2011-2#2)(2013-8#1)
244##9##1##(1990-10#3)(2008-10#2)(2008-11#2)(2010-1#1)(2010-11#1)
245 K##2##2##(2008-10#2)
245 and##2##2##(1994-5#1)(2013-8#1)
245 bp##2##2##(1997-6#1)(1997-8#1)
245 isolates##2##2##(2008-10#2)
245##13##1##(1994-5#1)(1997-6#1)(1997-8#1)(2008-10#8)(2009-7#1)(2013-8#1)
245-310##2##1##(2008-10#2)
246##4##1##(1995-12#1)(2008-10#3)
247##5##1##(1994-3#1)(2008-11#2)(2008-8#1)(2010-1#1)
248##6##1##(1990-5#1)(1994-12#1)(1996-6#1)(2008-10#2)(2011-1#1)
249 bp AT rich region##2##5##(2008-8#2)
249##8##1##(1992-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#2)(2010-1#1)
24h##14##1##(1990-11#1)(2008-10#6)(2008-12#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
24th##4##1##(1993-8#1)(1995-8#2)(1996-11#1)
24 h##2##1##(2012-7#1)(2013-1#1)
24 hours post##4##2##(2013-1#4)
25 % of##3##3##(2009-1#1)(2011-2#2)
25 %##4##2##(2009-1#1)(2011-2#2)(2012-3#1)
25 (OH) vitamin D##4##4##(2012-3#4)
25 (OH)##8##2##(2012-3#8)
25 +/- 0##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
25 +/-##7##2##(1993-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)
25 Gy##2##2##(2008-11#2)
25 M##6##2##(1991-7#1)(1992-6#1)(2008-10#4)
25 V (vs##2##3##(2008-10#2)
25 V##3##2##(2008-10#3)
25 and 0##5##3##(1991-2#1)(2008-10#4)
25 and 100##2##3##(2008-10#1)(2008-5#1)
25 and 30##6##3##(1993-12#5)(2008-12#1)
25 and 37 degrees C##2##5##(2008-10#2)
25 and 50##2##3##(2008-12#1)(2010-1#1)
25 and##41##2##(1991-2#1)(1993-12#5)(1993-6#1)(1994-3#1)(1994-8#2)(2008-10#20)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#3)(2010-1#1)(2012-3#1)(2013-8#1)
25 cases and##2##3##(1995-5#1)(2010-9#1)
25 cases##5##2##(1990-6#1)(1995-5#1)(2008-10#1)(2010-11#1)(2010-9#1)
25 cm##4##2##(2008-10#4)
25 days##3##2##(2008-10#2)(2008-5#1)
25 degrees C and##20##4##(2008-10#19)(2008-5#1)
25 degrees C are##3##4##(2008-10#3)
25 degrees C but##2##4##(2008-10#2)
25 degrees C by##4##4##(2008-10#4)
25 degrees C for##3##4##(2008-10#3)
25 degrees C in the##3##5##(1995-11#1)(2008-10#2)
25 degrees C in##5##4##(1995-11#1)(2008-10#4)
25 degrees C is##2##4##(1991-3#1)(2008-11#1)
25 degrees C were##5##4##(1993-8#1)(2008-10#3)(2008-11#1)
25 degrees C##134##3##(1990-10#1)(1991-3#1)(1991-5#1)(1993-8#2)(1995-11#1)(2008-10#110)(2008-11#4)(2008-12#1)(2008-5#5)(2008-7#1)(2008-8#4)(2009-7#2)(2010-4#1)
25 degrees C)##10##3##(2008-10#9)(2008-11#1)
25 degrees##151##2##(1990-10#1)(1990-9#2)(1991-3#1)(1991-5#1)(1993-8#2)(1995-11#1)(2008-10#119)(2008-11#6)(2008-12#1)(2008-5#8)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#2)(2010-4#1)
25 ethnic groups##2##3##(2008-9#2)
25 g##2##2##(2008-10#2)
25 h(-1)##2##2##(2008-10#2)
25 in##2##2##(2008-10#2)
25 is##2##2##(2008-10#1)(2008-3#1)
25 isolates##2##2##(2008-10#1)(2008-5#1)
25 kDa##6##2##(1992-8#2)(1995-12#1)(1997-7#1)(2008-11#2)
25 kV##3##2##(2008-10#3)
25 kb##2##2##(2008-8#2)
25 mL##3##2##(1993-1#1)(2008-10#2)
25 mM##10##2##(1995-8#1)(2008-10#9)
25 mg DBTC/L##3##3##(2008-10#3)
25 mg l(-1)##2##3##(2008-10#2)
25 mg##10##2##(2008-10#7)(2010-7#1)(2011-2#2)
25 mg/0##2##2##(2011-2#2)
25 mg/kg##2##2##(1992-12#1)(2008-9#1)
25 microns##2##2##(1991-2#1)(1996-12#1)
25 million##3##2##(1993-6#1)(2008-10#1)(2009-10#1)
25 min##10##2##(1991-2#1)(1993-1#1)(1993-2#1)(1994-3#1)(2008-10#5)(2008-7#1)
25 ml of##3##3##(2008-10#3)
25 ml##8##2##(2008-10#8)
25 mm calibration and its##2##5##(2013-1#2)
25 mm calibration##3##3##(2013-1#3)
25 mm##10##2##(2008-10#3)(2008-11#1)(2013-1#6)
25 mol l(-1) Na(2)SO(4)##2##4##(2008-10#2)
25 mol l(-1)##5##3##(2008-10#5)
25 months##4##2##(1990-12#1)(1991-8#1)(1997-3#1)(1997-5#1)
25 mu##2##2##(2008-10#1)(2008-11#1)
25 muM##4##2##(2008-10#3)(2008-11#1)
25 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
25 mug##8##2##(2008-10#6)(2008-11#1)(2010-2#1)
25 mum##5##2##(2008-10#3)(2008-3#2)
25 ng ml(-1)##2##3##(2008-10#2)
25 nm resolution##2##3##(2008-8#1)(2008-9#1)
25 nm##7##2##(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-5#2)
25 normal##2##2##(1993-12#1)(2008-7#1)
25 of which were##2##4##(2008-10#1)(2012-2#1)
25 of##6##2##(1993-2#1)(1994-9#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
25 or 50##2##3##(2008-10#1)(2008-5#1)
25 or##4##2##(2008-10#3)(2008-5#1)
25 patients with##3##3##(2008-7#3)
25 patients##14##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-3#1)(1993-11#1)(2008-7#4)(2011-2#3)(2012-3#1)
25 percent of##3##3##(1993-2#1)(1996-3#1)(1997-1#1)
25 percent##5##2##(1993-2#1)(1994-3#1)(1995-1#1)(1996-3#1)(1997-1#1)
25 ppm##2##2##(2008-10#1)(2008-5#1)
25 randomly selected##3##3##(1993-12#2)(2008-10#1)
25 samples per hour##3##4##(2008-10#3)
25 samples per##4##3##(2008-10#4)
25 samples##9##2##(2008-10#9)
25 species##2##2##(2007-12#1)(2008-10#1)
25 to 30##3##3##(2008-10#2)(2008-11#1)
25 to 35 degrees C##2##5##(2008-10#2)
25 to 35##5##3##(2008-10#2)(2013-1#3)
25 to##25##2##(1991-12#1)(1995-8#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#3)
25 were##2##2##(1990-6#1)(1991-12#1)
25 x 10(-5)##2##3##(1990-8#1)(1992-6#1)
25 x##7##2##(1990-8#1)(1992-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)
25 years ago##2##3##(1996-3#1)(2009-3#1)
25 years##17##2##(1992-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-3#1)
25##682##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#4)(1990-8#1)(1990-9#4)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#2)(1993-1#3)(1993-11#3)(1993-12#10)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#6)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#5)(2007-12#5)(2008-1#3)(2008-10#343)(2008-11#32)(2008-12#13)(2008-3#7)(2008-5#20)(2008-7#19)(2008-8#12)(2008-9#10)(2009-1#3)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#17)(2011-3#1)(2012-2#4)(2012-3#18)(2013-1#20)(2013-8#2)
25% (v/v)##3##2##(2008-10#3)
25% and the##2##3##(1991-8#1)(2008-11#1)
25% and##6##2##(1991-8#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
25% at##2##2##(2008-2#1)(2011-1#1)
25% for##2##2##(2010-6#1)(2011-2#1)
25% higher##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
25% in##5##2##(2008-10#2)(2008-7#2)(2013-1#1)
25% of all##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
25% of the cells##2##4##(1994-8#1)(2008-11#1)
25% of the phenotypic##2##4##(2008-10#1)(2008-8#1)
25% of the##18##3##(1990-8#1)(1991-2#1)(1992-11#1)(1993-11#1)(1993-8#1)(1994-8#2)(1997-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
25% of##29##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-8#1)(1994-8#2)(1997-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
25% suppressive soil##2##3##(2008-10#2)
25% to##2##2##(2008-7#1)(2012-3#1)
25% were##2##2##(1992-12#1)(2010-1#1)
25% with##2##2##(2008-10#1)(2011-2#1)
25%##113##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-8#2)(1995-2#1)(1996-12#2)(1997-4#1)(1997-5#1)(1997-9#1)(2007-8#1)(2008-10#36)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-7#1)(2010-1#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#1)
25%)##7##1##(1991-8#1)(2008-10#5)(2011-2#1)
25(OH)(2)D(3)##3##1##(2008-11#3)
25(OH)2D##5##1##(1994-11#5)
25(OH)2D3 and##2##2##(1990-11#1)(1995-2#1)
25(OH)2D3 in##2##2##(1990-11#1)(1995-2#1)
25(OH)2D3 or##3##2##(1990-11#3)
25(OH)2D3##25##1##(1990-11#11)(1992-1#2)(1993-6#2)(1995-12#4)(1995-2#2)(1997-1#4)
25(OH)2D3)##3##1##(1992-1#1)(1995-12#1)(1997-1#1)
25(OH)D concentration##2##2##(2011-2#2)
25(OH)D level##2##2##(2011-1#2)
25(OH)D levels##6##2##(2011-1#5)(2011-2#1)
25(OH)D##11##1##(2011-1#7)(2011-2#4)
25)##8##1##(1994-5#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-4#1)(2013-1#1)
25)0##2##1##(2008-3#2)
25+/-0##5##1##(2008-10#5)
25+0##2##1##(2008-10#2)
25-(OH)(2)-D(3)##2##1##(2008-10#2)
25-(OH)2-D3##2##1##(1991-5#2)
25-(OH)2D3 formation##2##2##(1994-3#2)
25-(OH)2D3##4##1##(1994-3#4)
25-0##5##1##(1994-11#1)(1994-12#1)(2008-12#1)(2008-9#1)(2013-1#1)
25-100##2##1##(2008-10#2)
25-200##2##1##(1995-8#1)(2008-10#1)
25-25##2##1##(2008-10#2)
25-30 samples##2##2##(2008-10#2)
25-30##5##1##(1990-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
25-300##3##1##(2008-10#3)
25-36##2##1##(2008-1#1)(2008-12#1)
25-4##2##1##(2008-10#2)
25-40%##2##1##(2008-11#1)(2011-2#1)
25-5##2##1##(2008-10#2)
25-50##3##1##(2011-2#3)
25-50%##2##1##(1993-9#1)(2008-10#1)
25-500 ng ml(-1)##2##3##(2008-10#2)
25-dihydrolanosterol##4##1##(1992-3#4)
25-dihydroxy-vitamin##2##1##(1997-1#2)
25-dihydroxyvitamin D(3)##2##2##(2008-11#1)(2012-12#1)
25-dihydroxyvitamin D-24-hydroxylase##2##2##(1994-11#2)
25-dihydroxyvitamin D3 (1##3##3##(1992-1#1)(1994-11#1)(1995-12#1)
25-dihydroxyvitamin D3##7##2##(1992-1#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-2#1)(2008-11#1)
25-dihydroxyvitamin##12##1##(1992-1#1)(1994-11#4)(1994-3#1)(1995-12#2)(1995-2#1)(2008-11#2)(2012-12#1)
25-fold lower##2##2##(1996-2#1)(2008-10#1)
25-fold##8##1##(1993-9#1)(1996-2#1)(2006-6#1)(2008-10#5)
25-hydroxyvitamin D##3##2##(2011-1#1)(2011-2#2)
25-hydroxyvitamin##5##1##(1995-12#1)(2008-10#1)(2011-1#1)(2011-2#2)
25-mum##2##1##(2007-11#1)(2008-3#1)
25-year period##2##2##(2008-10#1)(2008-7#1)
25-year##5##1##(1995-3#1)(1996-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
25-year-old##4##1##(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)
250 and 500##3##3##(2008-10#2)(2008-11#1)
250 degrees C##4##3##(2008-10#4)
250 kb downstream from c-myc##2##5##(1993-2#2)
250 kb##3##2##(1993-2#2)(2008-8#1)
250 mg l(-1)##3##3##(2008-10#3)
250 mg##6##2##(1996-3#1)(2008-10#4)(2008-5#1)
250 ml sample volume##2##4##(2008-10#2)
250 ml sample##3##3##(2008-10#3)
250 ml##7##2##(2008-10#7)
250 mm##2##2##(2008-11#1)(2008-5#1)
250 muM##2##2##(2008-6#2)
250 mug/ml##2##2##(2008-11#1)(2008-5#1)
250 nm and##2##3##(2008-10#2)
250 occupations##2##2##(1991-1#1)(1993-1#1)
250 or##2##2##(2008-5#1)(2008-9#1)
250 to##5##2##(2008-10#4)(2008-2#1)
250##158##1##(1990-11#1)(1990-12#3)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-3#4)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#6)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#9)(1994-3#1)(1994-5#15)(1994-8#4)(1995-11#1)(1995-3#3)(1995-5#1)(1996-2#3)(1996-3#1)(1996-8#1)(2008-10#44)(2008-11#6)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-8#1)
250%##2##1##(1996-12#1)(1996-2#1)
250-fold##4##1##(1991-12#1)(2008-10#3)
2500##11##1##(1991-2#1)(1994-3#2)(1997-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2013-1#1)
250mugl(-1)##3##1##(2008-10#3)
251##6##1##(2008-10#4)(2010-1#1)(2011-1#1)
252##5##1##(1990-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)
253##7##1##(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#2)
254 nm##5##2##(2008-10#4)(2009-8#1)
254##11##1##(2008-10#7)(2008-11#2)(2009-8#1)(2013-1#1)
254nm##4##1##(2008-10#3)(2011-2#1)
255##10##1##(1990-9#1)(1991-11#1)(1991-3#1)(1995-8#1)(1996-11#1)(2008-10#4)(2011-2#1)
256 mg/kg females##5##3##(2008-9#5)
256 mg/kg males and##3##4##(2008-9#3)
256 mg/kg males##7##3##(2008-9#7)
256 mg/kg##13##2##(2008-9#13)
256 patients##3##2##(2008-7#1)(2010-8#1)(2011-2#1)
256 x##2##2##(1997-8#1)(2008-3#1)
256##27##1##(1992-5#1)(1997-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#15)(2010-8#2)(2011-2#1)(2013-1#1)
257##11##1##(1993-1#1)(1993-12#1)(1994-5#1)(1996-11#1)(1996-6#1)(2008-10#1)(2008-7#1)(2011-2#3)(2013-1#1)
258##9##1##(1991-3#1)(1992-5#1)(1996-1#1)(1996-2#1)(1997-2#2)(2008-10#2)(2011-2#1)
259##7##1##(1991-5#1)(1992-9#1)(1993-8#1)(1995-6#1)(1997-6#2)(1997-8#1)
2596 and##3##2##(2008-10#3)
2596##5##1##(2008-10#5)
25D##5##1##(2011-2#1)(2012-12#4)
25D-induced differentiation of##2##3##(2012-12#2)
25D-induced##3##1##(2012-12#3)
25M##2##1##(2008-10#2)
25h(-1)##3##1##(2008-10#3)
25mL##4##1##(2008-10#4)
25mM##3##1##(2008-10#2)(2011-2#1)
25mg of##4##2##(2008-10#4)
25mg##5##1##(2008-10#4)(2010-7#1)
25mgL(-1)##2##1##(2008-10#2)
25mgl(-1)##2##1##(2008-10#2)
25min##2##1##(2008-10#2)
25ml of##2##2##(2008-10#2)
25ml##5##1##(2008-10#5)
25mug##2##1##(2008-10#2)
25mug/ml##2##1##(2008-10#2)
25mugL(-1)##2##1##(2008-10#2)
25mugl(-1)##4##1##(2008-10#4)
25ngml(-1)##3##1##(2008-10#3)
25ppb##2##1##(2008-10#2)
25th##3##1##(1991-2#1)(2008-4#1)(2008-9#1)
25x10(-5)##2##1##(2008-10#2)
26 +/- 1##2##3##(1995-11#1)(2012-3#1)
26 +/-##3##2##(1995-11#1)(2012-3#2)
26 V##2##2##(2008-10#2)
26 and 0##2##3##(1994-8#1)(2008-10#1)
26 and##8##2##(1994-8#1)(1996-11#1)(1996-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-3#1)
26 cases##4##2##(1996-11#2)(2007-11#1)(2012-3#1)
26 days##2##2##(1991-6#1)(2008-11#1)
26 degrees C##3##3##(2008-10#3)
26 kDa##2##2##(1993-12#1)(2009-9#1)
26 of them##2##3##(1996-6#1)(1997-7#1)
26 of##3##2##(1996-6#1)(1997-7#1)(1997-8#1)
26 or##8##2##(2008-10#1)(2008-9#7)
26 patients were##2##3##(1997-8#1)(2008-8#1)
26 patients who##2##3##(1995-2#1)(2009-10#1)
26 patients##12##2##(1991-11#1)(1992-11#1)(1994-9#1)(1995-2#1)(1997-8#1)(2007-11#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#3)
26 to##5##2##(2007-12#1)(2008-10#4)
26 weeks and##3##3##(2008-9#3)
26 weeks##17##2##(2008-7#3)(2008-9#14)
26 were##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
26 with##2##2##(1991-3#1)(1992-11#1)
26 women##2##2##(2011-2#2)
26 years old##2##3##(2012-2#1)(2013-1#1)
26 years##7##2##(1992-12#1)(1993-11#1)(1994-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
26##215##1##(1990-12#2)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#2)(1992-12#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-1#2)(1994-12#6)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#4)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#1)(2008-10#51)(2008-11#9)(2008-12#3)(2008-2#3)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#27)(2009-10#2)(2009-6#1)(2009-9#3)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#17)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#3)
26% and##2##2##(1993-8#1)(1994-11#1)
26% of the##6##3##(1993-2#1)(1995-2#1)(1996-1#1)(2008-10#3)
26% of##11##2##(1993-2#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)
26%##31##1##(1991-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-2#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-7#3)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
26)##8##1##(2008-10#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
26+/-0##2##1##(2008-10#2)
26- AND 41-WEEK DRINKING WATER STUDIES IN##2##7##(2008-9#2)
26- AND##3##2##(2008-9#3)
26-##4##1##(2008-9#4)
26-0##2##1##(1997-8#1)(2008-7#1)
26-2-1a##2##1##(2008-10#2)
26-29##3##1##(1994-5#1)(2008-5#1)(2008-8#1)
26-kDa##2##1##(2008-10#2)
26-year-old man presented with##2##4##(2008-7#1)(2010-1#1)
26-year-old man##3##2##(2008-12#1)(2008-7#1)(2010-1#1)
26-year-old##6##1##(1990-3#1)(1994-12#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-6#1)
260 patients##2##2##(1993-2#1)(2010-8#1)
260##18##1##(1990-2#2)(1990-8#1)(1993-2#1)(1995-8#1)(1996-2#2)(2008-10#5)(2008-11#1)(2010-8#1)(2011-1#4)
261 patients##2##2##(1990-8#1)(2012-2#1)
261##7##1##(1990-5#1)(1990-8#1)(1995-1#1)(2008-10#3)(2012-2#1)
262 HCC cases##2##3##(2013-8#2)
262##4##1##(2008-3#1)(2008-9#1)(2013-8#2)
263##11##1##(1990-5#1)(1990-9#1)(1991-8#1)(1992-4#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-9#1)(2011-2#1)
264##14##1##(1991-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#3)(2012-12#3)(2013-8#1)
265##9##1##(1990-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
266 nm##3##2##(2012-2#3)
266##13##1##(1991-6#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#3)
266nm##2##1##(2008-10#2)
267##7##1##(1992-8#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-2#1)
268##6##1##(1994-5#2)(1995-11#1)(1997-3#2)(2011-3#1)
269##6##1##(1990-6#1)(1991-7#1)(1994-11#1)(1994-9#1)(1995-6#1)(2011-1#1)
26S proteasome##3##2##(1993-9#1)(2008-4#2)
26S##4##1##(1993-9#1)(2008-4#3)
26th##2##1##(2010-5#1)(2012-2#1)
27 +/-##3##2##(1994-6#1)(2008-11#1)(2010-8#1)
27 and 29##2##3##(1991-1#1)(2010-3#1)
27 and##10##2##(1991-1#1)(1996-12#1)(2008-1#1)(2008-10#5)(2010-3#1)(2011-2#1)
27 cm##2##2##(2010-7#2)
27 days##3##2##(2008-10#3)
27 degrees C##4##3##(1990-9#1)(1994-5#1)(2008-10#1)(2008-12#1)
27 different##2##2##(1990-11#1)(2008-10#1)
27 for##2##2##(2008-10#2)
27 h##2##2##(2008-7#2)
27 males)##2##2##(2011-2#1)(2013-1#1)
27 mug##2##2##(2008-10#2)
27 of##7##2##(1990-9#1)(1994-1#1)(1994-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
27 or##5##2##(2007-12#1)(2008-9#4)
27 samples per hour##3##4##(2008-10#3)
27 samples per##4##3##(2008-10#4)
27 to##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
27 weeks##12##2##(1991-7#1)(2008-9#11)
27 were##3##2##(2008-10#2)(2013-8#1)
27 x##2##2##(2008-10#1)(2008-7#1)
27 year old##2##3##(1990-2#1)(1991-1#1)
27 years##2##2##(2008-10#1)(2012-3#1)
27##218##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#3)(1991-5#1)(1991-7#1)(1992-1#2)(1992-2#1)(1992-9#1)(1993-8#3)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#5)(1996-8#1)(1997-3#3)(1997-8#3)(2007-12#1)(2008-1#3)(2008-10#64)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#5)(2008-7#10)(2008-8#1)(2008-9#17)(2009-11#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#14)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#5)
27% in##3##2##(2010-12#1)(2011-2#1)(2013-8#1)
27% of the##3##3##(1991-9#1)(1996-12#1)(2011-1#1)
27% of##5##2##(1991-9#1)(1996-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
27%##28##1##(1991-9#1)(1992-9#1)(1994-11#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
27%)##2##1##(2008-10#1)(2008-12#1)
27) was##2##2##(2008-10#1)(2010-10#1)
27)##10##1##(1990-8#1)(1991-12#1)(1991-8#1)(1995-5#1)(2008-10#3)(2008-11#1)(2010-10#1)(2013-1#1)
27- AND 43-WEEK DRINKING WATER STUDIES IN##2##7##(2008-9#2)
27-bis(1-propyloxy)calix[4]arene##2##1##(2008-10#2)
27-dibenzoiloxy-26##2##1##(2008-10#2)
27-week##2##1##(2008-9#1)(2009-12#1)
270 kDa##2##2##(1995-2#1)(2009-7#1)
270 samples##2##2##(2008-10#2)
270##18##1##(1995-2#1)(2008-10#13)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)
2700##3##1##(1994-3#1)(2008-10#2)
271##2##1##(1996-6#1)(2008-10#1)
272##6##1##(1990-11#1)(1993-8#1)(1996-1#1)(2008-10#3)
273##4##1##(2008-10#2)(2010-4#1)(2011-2#1)
2733##2##1##(1995-2#1)(2008-12#1)
274##6##1##(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
275##4##1##(2008-10#2)(2008-9#1)(2013-1#1)
276##4##1##(1991-9#1)(1994-8#1)(2011-3#1)(2012-3#1)
277##5##1##(1990-6#1)(1996-6#1)(2008-10#2)(2011-3#1)
278##7##1##(2008-10#4)(2008-11#1)(2011-2#1)(2013-1#1)
278)##2##1##(1992-1#1)(2008-10#1)
279 for##2##2##(2008-10#2)
279##9##1##(1992-1#1)(2008-10#5)(2008-11#1)(2011-2#1)(2013-8#1)
27th##4##1##(2008-10#1)(2008-7#1)(2010-3#1)(2013-8#1)
28 +/- 0##3##3##(1996-2#1)(2011-2#1)(2011-3#1)
28 +/-##4##2##(1994-12#1)(1996-2#1)(2011-2#1)(2011-3#1)
28 OSM)##2##2##(1991-11#2)
28 and##7##2##(1990-6#1)(1991-8#1)(2008-12#1)(2008-7#2)(2010-4#1)(2010-6#1)
28 cases##4##2##(1991-12#1)(1994-2#1)(2013-1#2)
28 days after##2##3##(2008-10#1)(2011-2#1)
28 days of##4##3##(1996-12#1)(2008-12#1)(2008-7#1)(2013-1#1)
28 days##22##2##(1992-2#1)(1996-12#3)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#2)(2011-2#1)(2013-1#3)
28 degrees C and 37 degrees C)##2##7##(2008-10#2)
28 degrees C and 37 degrees##3##6##(2008-10#2)(2008-5#1)
28 degrees C and##4##4##(2008-10#3)(2008-5#1)
28 degrees C##19##3##(2008-10#15)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)
28 degrees##21##2##(2008-10#16)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-3#1)
28 dpi##3##2##(2008-10#3)
28 in the##2##3##(2008-11#1)(2009-12#1)
28 isolates of F##2##4##(2008-10#2)
28 isolates of##4##3##(2008-10#4)
28 isolates##5##2##(2008-10#5)
28 kDa##2##2##(1995-11#1)(2008-10#1)
28 mmHg##2##2##(2011-2#2)
28 months##2##2##(1990-6#1)(2008-9#1)
28 of##3##2##(1990-8#1)(2008-10#1)(2012-2#1)
28 patients with##2##3##(2011-2#1)(2013-1#1)
28 patients##5##2##(1994-3#1)(2008-7#2)(2011-2#1)(2013-1#1)
28 pituitary adenomas##2##3##(1990-12#2)
28 samples##2##2##(2008-10#2)
28 to##5##2##(1991-11#1)(2008-10#4)
28 weeks of gestation##2##4##(2013-1#2)
28 weeks postconception##2##3##(1995-8#2)
28 weeks##4##2##(1995-8#2)(2013-1#2)
28 weeks' gestation##2##3##(2008-1#1)(2008-11#1)
28 were##2##2##(2008-10#1)(2010-6#1)
28 x##2##2##(2008-10#2)
28 years##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
28##228##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#4)(1991-12#1)(1991-3#3)(1991-8#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-8#2)(1996-12#7)(1996-2#1)(1996-5#3)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-1#2)(2008-10#84)(2008-11#5)(2008-12#5)(2008-3#2)(2008-5#4)(2008-7#9)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#2)(2010-6#4)(2010-9#2)(2011-2#15)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#17)(2013-8#2)
28% and##2##2##(1994-12#1)(2008-11#1)
28% had##2##2##(1995-10#1)(2008-9#1)
28% in##6##2##(1990-6#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
28% of the##7##3##(1991-12#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-8#1)
28% of##9##2##(1991-12#1)(1992-12#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-8#1)(2013-8#1)
28% with##2##2##(2008-9#1)(2012-2#1)
28%##41##1##(1990-3#1)(1990-6#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-3#1)(1997-6#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#2)
28%)##4##1##(2008-10#2)(2011-2#2)
28)##7##1##(1992-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-2#2)
28-0##2##1##(1990-5#1)(2008-3#1)
28-30##2##1##(1995-5#1)(2008-10#1)
28-bis-[3-propyloxy]-calix[4]arene-bonded silica gel##2##3##(2008-10#2)
28-day cycles of##2##3##(2008-10#1)(2009-12#1)
28-day##6##1##(2008-10#4)(2009-12#1)(2010-6#1)
28-kDa glutathione S-transferase##2##3##(1993-2#2)
28-kDa##6##1##(1990-5#1)(1991-10#1)(1993-2#3)(1995-6#1)
28-year-old male##3##2##(2013-1#1)(2013-8#2)
28-year-old##10##1##(2008-12#2)(2008-7#1)(2011-2#2)(2013-1#3)(2013-8#2)
280 and##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
280 nm##6##2##(2008-10#6)
280 nm)##3##2##(1994-5#1)(1996-5#1)(2008-10#1)
280##25##1##(1994-5#2)(1996-5#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-8#1)(2012-3#1)
281##2##1##(2008-8#1)(2012-2#1)
282##11##1##(1991-3#1)(1993-12#1)(1993-3#1)(1996-3#1)(2008-10#3)(2008-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
283##6##1##(1993-2#1)(2008-10#2)(2008-3#1)(2009-7#1)(2011-2#1)
283/Coulter##2##1##(2008-10#2)
284##5##1##(2008-10#2)(2008-5#1)(2009-11#1)(2010-4#1)
285 and##3##2##(2008-10#3)
285 nm##5##2##(1997-2#1)(2008-10#4)
285##17##1##(1991-12#1)(1997-2#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
285-298##2##1##(2012-3#2)
286##5##1##(1990-8#1)(1997-7#1)(2012-3#1)(2013-8#2)
287##14##1##(1990-8#1)(1991-6#1)(1993-2#1)(1993-8#1)(2008-10#3)(2010-10#2)(2011-2#1)(2013-1#4)
288##4##1##(1990-8#1)(1991-12#1)(1994-11#1)(2012-12#1)
288)##2##1##(1996-2#1)(2008-11#1)
289##5##1##(1992-3#1)(2008-10#2)(2008-7#1)(2013-1#1)
28S rRNA##2##2##(1995-3#1)(2010-4#1)
28S##6##1##(1995-3#1)(2008-10#4)(2010-4#1)
29 +/-##2##2##(1994-3#1)(2008-12#1)
29 and 1##2##3##(2008-10#2)
29 and##7##2##(1996-9#1)(2008-10#5)(2008-12#1)
29 cases##6##2##(1991-12#1)(1992-12#1)(1992-9#1)(1996-9#1)(2008-10#1)(2008-8#1)
29 children##4##2##(1996-9#2)(2008-9#1)(2009-3#1)
29 days##2##2##(2006-5#1)(2008-11#1)
29 degrees C##2##3##(2008-10#1)(2008-6#1)
29 h##2##2##(2008-11#2)
29 healthy##2##2##(1990-2#1)(2010-12#1)
29 in the##2##3##(1993-6#1)(2011-2#1)
29 in##4##2##(1993-6#1)(1997-4#1)(2008-10#1)(2011-2#1)
29 isolates of##2##3##(2008-10#2)
29 kDa##2##2##(1990-11#1)(1995-6#1)
29 mg##2##2##(2008-10#2)
29 months##4##2##(1997-3#1)(2010-1#1)(2010-2#1)(2011-2#1)
29 of##2##2##(1990-12#1)(2008-10#1)
29 patients##4##2##(1997-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
29 percent##2##2##(1991-12#1)(1994-2#1)
29 pine (Pinus) species##2##4##(2008-8#2)
29 plant species##2##3##(2008-10#2)
29 plant##3##2##(2008-10#3)
29 to##7##2##(1990-8#1)(1993-1#1)(2006-5#1)(2008-10#2)(2008-5#1)(2009-6#1)
29 years of##2##3##(2007-12#1)(2008-11#1)
29 years##4##2##(1990-9#1)(2007-12#1)(2008-11#1)(2010-3#1)
29##179##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#4)(1997-3#3)(1997-4#3)(1997-8#2)(2006-5#2)(2007-12#1)(2008-10#47)(2008-11#9)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#13)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#2)
29% in##2##2##(1993-11#1)(2008-10#1)
29% of the##4##3##(1991-9#1)(2008-1#1)(2008-10#1)(2013-1#1)
29% of##6##2##(1991-9#1)(2008-1#1)(2008-10#2)(2012-2#1)(2013-1#1)
29%##27##1##(1990-12#1)(1991-9#2)(1993-11#1)(1993-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
29)##5##1##(1997-4#1)(2008-10#1)(2009-7#1)(2013-1#1)(2013-8#1)
29+/-0##2##1##(2008-10#1)(2008-8#1)
29-##2##1##(2008-10#1)(2012-7#1)
29-0##2##1##(1997-8#2)
29-30 October 1998##2##3##(2008-10#2)
290 K##2##2##(1994-5#1)(2008-3#1)
290 nm##5##2##(2008-10#3)(2008-2#1)(2008-5#1)
290##15##1##(1994-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2010-4#1)(2013-8#1)
290)##2##1##(1997-8#1)(2011-2#1)
291##2##1##(2008-10#1)(2011-2#1)
292 bp##2##2##(2008-10#1)(2008-8#1)
292##10##1##(1990-3#1)(1991-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
293 cell line##2##3##(2008-11#2)
293 cell##3##2##(2008-11#3)
293 cells adapted to suspension growth in serum-free medium in##2##10##(2008-11#2)
293 cells and##4##3##(1992-10#1)(1995-2#1)(2008-11#1)(2008-9#1)
293 cells in##2##3##(2008-11#2)
293 cells is##2##3##(2008-11#2)
293 cells on##2##3##(2008-11#2)
293 cells were##2##3##(2008-11#2)
293 cells##28##2##(1992-10#3)(1995-2#1)(2008-11#23)(2008-9#1)
293##38##1##(1992-10#3)(1995-2#1)(2008-11#31)(2008-9#1)(2011-2#1)(2013-8#1)
293(EBNA) cells grown in serum-free suspension culture##2##7##(2008-11#2)
293(EBNA) cells##3##2##(2008-11#3)
293-EBNA##2##1##(2008-11#2)
293cells##2##1##(2008-11#2)
294 K##4##2##(2008-3#4)
294##8##1##(1990-11#1)(1996-6#1)(2008-10#1)(2008-3#4)(2011-2#1)
295 nm##2##2##(2008-10#2)
295 to##2##2##(2008-10#1)(2008-8#1)
295##10##1##(1996-11#1)(2008-10#6)(2008-8#2)(2013-1#1)
296 isolates##2##2##(2008-10#2)
296##12##1##(1991-3#1)(2008-10#6)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
297##2##1##(1996-11#1)(2010-1#1)
298##16##1##(1991-11#1)(1993-1#1)(2008-10#10)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)
299##6##1##(1991-3#1)(2008-10#3)(2008-11#2)
29G11 is##2##2##(1995-2#2)
29G11##4##1##(1995-2#4)
2A and##2##2##(1995-8#2)
2A##21##1##(1991-5#1)(1992-8#1)(1992-9#12)(1994-11#2)(1995-8#3)(2008-10#1)(2010-1#1)
2A1-9E-1 was##2##2##(2008-11#2)
2AID##5##1##(2008-5#5)
2B##4##1##(1995-8#1)(2008-10#2)(2013-8#1)
2BL##2##1##(2008-10#2)
2C##5##1##(1993-8#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#1)
2C(12)N(+)PA(-) films##2##2##(2008-10#2)
2C(12)N(+)PA(-)##5##1##(2008-10#5)
2D NMR experiments##3##3##(1994-5#1)(2011-2#1)(2013-1#1)
2D NMR##7##2##(1994-5#3)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
2D and 3D##3##3##(2008-11#1)(2010-12#2)
2D and##5##2##(2008-11#1)(2009-10#1)(2010-12#2)(2012-3#1)
2D information spaces##2##3##(2008-6#2)
2D##36##1##(1990-12#1)(1993-8#1)(1994-5#3)(1996-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#6)(2009-10#2)(2010-12#5)(2010-2#1)(2010-6#1)(2011-2#2)(2011-7#3)(2012-12#1)(2012-3#1)(2013-1#3)
2D/E##2##1##(1995-12#2)
2DG uptake in##2##3##(1991-10#2)
2DG uptake##3##2##(1991-10#3)
2E3-O##3##1##(2008-11#3)
2F10##3##1##(1995-2#3)
2H NMR##2##2##(1994-5#2)
2H##4##1##(1994-2#1)(1994-5#2)(2008-10#1)
2H(2)O-H(2)O system##3##2##(2008-10#3)
2H-pyran-2-one moiety of##2##3##(2008-11#2)
2L##9##1##(1995-11#5)(2008-11#2)(2008-9#2)
2M nitric acid##4##3##(2008-10#4)
2M##12##1##(1995-1#1)(2008-10#9)(2013-1#2)
2Man##2##1##(1992-10#2)
2P##4##1##(2010-12#4)
2S##6##1##(1990-11#1)(1992-3#1)(1995-11#2)(1996-5#1)(1997-7#1)
2T##2##1##(1993-3#1)(2008-10#1)
2V##4##1##(1994-11#1)(2008-10#3)
2]##11##1##(1990-5#1)(1990-9#2)(1996-5#2)(2008-10#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-4#1)
2]octane-2##4##1##(1996-5#4)
2]p##2##1##(2008-10#2)
2a protein##2##2##(2008-10#2)
2a##8##1##(1992-12#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-9#1)
2a-5a##2##1##(2009-8#2)
2a-g##2##1##(2012-3#2)
2b protein##3##2##(2012-2#3)
2b##9##1##(1992-12#1)(1996-5#2)(2008-10#1)(2012-2#5)
2b)##2##1##(1992-12#1)(2008-10#1)
2f detection##4##2##(2008-3#4)
2f##5##1##(2008-3#5)
2g##3##1##(2008-10#2)(2008-3#1)
2h##3##1##(2008-10#2)(2012-3#1)
2m(th)-order##2##1##(2013-1#2)
2mL##3##1##(2008-10#2)(2008-8#1)
2mM##4##1##(2008-10#4)
2mV)##2##1##(2008-10#2)
2mg##4##1##(2008-10#2)(2008-11#1)(2010-7#1)
2mgl(-1)##2##1##(2008-10#2)
2min##8##1##(2008-10#8)
2ml of sample##2##3##(2008-10#2)
2ml of##7##2##(2008-10#7)
2ml##11##1##(2008-10#11)
2mmolL(-1))##2##1##(2008-10#2)
2moll(-1) HCl##3##2##(2008-10#3)
2moll(-1)##7##1##(2008-10#7)
2muM##4##1##(2008-10#4)
2mugL(-1)##5##1##(2008-10#5)
2mugg(-1)##2##1##(2008-10#2)
2mugl(-1) for##3##2##(2008-10#3)
2mugl(-1)##7##1##(2008-10#7)
2mugml(-1) of##2##2##(2008-10#2)
2mugml(-1)##4##1##(2008-10#4)
2mumoll(-1)##2##1##(2008-10#2)
2n =##2##2##(2008-10#2)
2n##3##1##(2008-10#2)(2008-8#1)
2nM##4##1##(1993-3#2)(2008-10#2)
2nM)##2##1##(1990-11#1)(2008-10#1)
2nd International Congress on Leukemia##2##5##(2010-11#2)
2nd and##3##2##(2008-12#1)(2010-12#2)
2nd##20##1##(1991-3#1)(1991-8#1)(1995-8#3)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#2)(2010-12#2)(2010-5#1)(2012-3#1)
2ng##2##1##(2008-10#2)
2ngg(-1) for##2##2##(2008-10#2)
2ngg(-1)##4##1##(2008-10#4)
2ngmL(-1)##2##1##(2008-10#2)
2ngml(-1)##4##1##(2008-10#4)
2pi##3##1##(2008-3#3)
2ppm##2##1##(2008-10#2)
2s##4##1##(2008-10#4)
2sigma level##2##2##(2008-10#2)
2x##8##1##(1993-8#1)(2008-10#2)(2009-12#5)
2x10(-10) mol##2##2##(2008-10#2)
2x10(-10)##4##1##(2008-10#4)
2x10(-2)##3##1##(2008-10#3)
2x10(-3) M with a##2##4##(2008-10#2)
2x10(-3) M##8##2##(2008-10#8)
2x10(-4) M##3##2##(2008-10#2)(2008-11#1)
2x10(-4) and##2##2##(2008-10#2)
2x10(-4) moll(-1)##2##2##(2008-10#2)
2x10(-4) to##3##2##(2008-10#3)
2x10(-4)##14##1##(2008-10#13)(2008-11#1)
2x10(-4)moll(-1)##2##1##(2008-10#2)
2x10(-5) M##3##2##(2008-10#3)
2x10(-5) mol l(-1)##3##3##(2008-10#3)
2x10(-5) to##2##2##(2008-10#2)
2x10(-5)##8##1##(2008-10#8)
2x10(-5)moll(-1)##2##1##(2008-10#2)
2x10(-6) M##4##2##(2008-10#4)
2x10(-6) and##3##2##(2008-10#3)
2x10(-6) mol l(-1)##2##3##(2008-10#2)
2x10(-6) to##2##2##(2008-10#2)
2x10(-6)##11##1##(2008-10#11)
2x10(-7) M for##2##3##(2008-10#2)
2x10(-7) M##3##2##(2008-10#3)
2x10(-7) to 2x10(-3) M for##2##5##(2008-10#2)
2x10(-7) to##4##2##(2008-10#4)
2x10(-7)##8##1##(2008-10#8)
2x10(-8) moll(-1)##2##2##(2008-10#2)
2x10(-8)##5##1##(2008-10#5)
2x10(-8)M##2##1##(2008-10#2)
2x10(-9) mol dm(-3)##2##3##(2008-10#2)
2x10(-9) mol##4##2##(2008-10#4)
2x10(-9)##8##1##(2008-10#8)
2x10(4)##2##1##(2008-10#2)
2x10(6)##3##1##(2008-10#2)(2008-11#1)
2x2##3##1##(2007-11#1)(2010-1#2)
2 weeks##2##1##(2013-8#2)
3 %##3##2##(1997-8#1)(2011-2#1)(2012-12#1)
3 %) and##2##3##(2012-12#2)
3 %)##7##2##(1997-8#1)(2012-12#6)
3 &amp##2##2##(2008-11#2)
3 (20%)##2##2##(1997-8#2)
3 (4%) patients##2##3##(2011-2#1)(2012-3#1)
3 +/- 0##7##3##(1990-5#1)(1992-10#1)(1992-6#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-8#1)
3 +/- 1##3##3##(1992-12#1)(1996-12#1)(2008-1#1)
3 +/- 2##2##3##(1993-8#1)(2008-1#1)
3 +/- 3##3##3##(1990-12#1)(1995-12#1)(2008-5#1)
3 +/- 4##2##3##(1994-12#1)(2010-1#1)
3 +/- 5##2##3##(1994-12#2)
3 +/-##25##2##(1990-12#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1995-12#1)(1996-12#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)
3 -##2##2##(2008-3#1)(2011-2#1)
3 =##4##2##(1990-8#1)(2008-8#1)(2011-2#1)(2013-1#1)
3 A##3##2##(1992-9#1)(1994-12#1)(2008-8#1)
3 M HCl or##2##4##(1997-2#1)(2008-10#1)
3 M HCl##3##3##(1997-2#1)(2008-10#2)
3 M KCl and##2##4##(2008-10#2)
3 M##10##2##(1991-7#1)(1995-11#1)(1997-2#1)(2008-10#7)
3 MPa and##2##3##(2008-10#1)(2009-7#1)
3 MPa##3##2##(2008-10#2)(2009-7#1)
3 MT##3##2##(2008-10#3)
3 V##3##2##(2008-10#3)
3 W##2##2##(2008-3#1)(2008-9#1)
3 X 10(-7) M##4##4##(1990-5#4)
3 X##5##2##(1990-5#5)
3 Zr alloy is##2##4##(2009-7#2)
3 alpha##8##2##(1990-11#6)(1995-6#1)(1996-2#1)
3 alpha-HSOR##2##2##(1990-11#2)
3 alpha-hydroxysteroid dehydrogenase##2##3##(1990-11#2)
3 alpha-hydroxysteroid oxidoreductase##2##3##(1990-11#2)
3 alpha-hydroxysteroid##4##2##(1990-11#4)
3 alpha-reduction of##2##3##(1990-11#2)
3 and 0##11##3##(2008-10#7)(2008-12#2)(2008-2#1)(2013-1#1)
3 and 1##9##3##(1993-8#1)(1997-4#1)(2008-10#7)
3 and 10##3##3##(2008-10#2)(2008-3#1)
3 and 11##2##3##(2008-7#1)(2009-10#1)
3 and 12##3##3##(1991-2#1)(2008-10#1)(2013-1#1)
3 and 14##2##3##(1991-9#1)(2008-10#1)
3 and 2##5##3##(1996-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
3 and 2%##2##3##(2008-10#2)
3 and 3##2##3##(2008-10#2)
3 and 30##3##3##(1994-8#1)(1997-7#2)
3 and 35##2##3##(2008-10#1)(2008-12#1)
3 and 4 of##2##4##(2008-10#2)
3 and 4 were##2##4##(2008-7#1)(2011-2#1)
3 and 4##21##3##(1994-12#1)(1997-3#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
3 and 5 h##2##4##(2008-10#1)(2008-11#1)
3 and 5##12##3##(2008-10#6)(2008-11#1)(2008-12#2)(2008-9#1)(2013-1#2)
3 and 5%##2##3##(2008-10#2)
3 and 6 months after##2##5##(2008-7#1)(2009-11#1)
3 and 6 months##8##4##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#2)(2013-1#1)
3 and 6##15##3##(1993-12#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#2)(2013-1#1)
3 and 7##6##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)
3 and 8##2##3##(2008-7#1)(2011-1#1)
3 and 93##2##3##(1997-1#1)(2008-12#1)
3 and 98##3##3##(2008-10#3)
3 and MCA##3##3##(1990-8#3)
3 and the##2##3##(2008-10#1)(2008-8#1)
3 and##170##2##(1990-6#1)(1990-8#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#2)(2007-12#1)(2008-10#86)(2008-11#7)(2008-12#11)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#6)
3 approximately##3##2##(1997-7#1)(2008-10#2)
3 are##2##2##(1995-8#1)(2013-8#1)
3 as##2##2##(2008-10#2)
3 at##3##2##(1990-5#1)(1996-5#1)(2008-10#1)
3 beta##12##2##(1992-3#1)(1992-4#1)(1995-11#8)(1995-12#1)(1995-6#1)
3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one##2##3##(1992-3#1)(1993-6#1)
3 billion##3##2##(1995-6#1)(2008-10#1)(2011-2#1)
3 by##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
3 cM from##2##3##(2008-10#1)(2008-9#1)
3 cM##3##2##(2008-10#2)(2008-9#1)
3 cM)##3##2##(2008-10#3)
3 cas##2##2##(2013-1#2)
3 cases of##8##3##(1991-8#1)(1992-2#1)(2008-10#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
3 cases##20##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
3 cases]##2##2##(1991-11#1)(2008-11#1)
3 children##2##2##(2010-5#1)(2012-2#1)
3 clones are genes involved in##2##6##(2008-9#2)
3 cm##8##2##(1992-3#1)(2008-10#2)(2008-12#1)(2009-1#1)(2009-5#1)(2011-1#1)(2013-1#1)
3 compared##2##2##(2008-5#1)(2009-5#1)
3 cycles of##2##3##(1992-12#1)(2008-10#1)
3 days after inoculation##4##4##(2008-10#4)
3 days after surgery##2##4##(2011-2#2)
3 days after the##2##4##(1996-12#1)(2010-12#1)
3 days after##13##3##(1990-5#1)(1991-5#1)(1996-12#1)(1996-2#1)(2008-10#4)(2010-12#1)(2011-2#4)
3 days and##4##3##(1991-2#1)(1997-3#1)(2008-5#2)
3 days at##2##3##(1994-3#1)(2008-10#1)
3 days in##2##3##(1995-2#1)(2008-10#1)
3 days of##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
3 days per week##2##4##(2008-10#1)(2013-1#1)
3 days post-transfection##2##3##(2011-2#2)
3 days prior to sampling##2##5##(1996-12#2)
3 days prior to##5##4##(1996-12#3)(2008-10#2)
3 days to##2##3##(2008-10#2)
3 days##71##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1993-6#1)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#4)(1996-2#2)(1997-3#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#5)(2009-4#1)(2010-12#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
3 degrees##4##2##(1991-5#1)(2008-10#1)(2008-12#1)(2008-9#1)
3 different##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
3 doses##2##2##(1991-3#1)(1994-9#1)
3 drugs##3##2##(2008-10#2)(2010-12#1)
3 families##2##2##(2008-9#2)
3 for the##2##3##(2008-10#1)(2008-3#1)
3 for##5##2##(2008-10#4)(2008-3#1)
3 from##4##2##(1992-8#1)(1993-6#1)(2008-10#1)(2008-8#1)
3 g##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
3 groups##5##2##(2008-10#1)(2009-3#1)(2012-4#1)(2013-1#2)
3 h after##4##3##(1991-9#1)(2008-10#3)
3 h at##4##3##(2008-10#1)(2013-1#3)
3 h before##2##3##(2008-12#1)(2010-8#1)
3 h##28##2##(1991-9#1)(1993-12#1)(1994-5#1)(1995-11#1)(1997-2#1)(2008-10#13)(2008-12#2)(2008-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2013-1#4)
3 h) and##2##3##(2008-10#1)(2011-3#1)
3 had a##2##3##(1996-6#1)(2012-3#1)
3 had the##2##3##(2008-10#1)(2008-11#1)
3 had##10##2##(1991-11#1)(1992-12#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#3)(2012-3#1)
3 hospitals##3##2##(1990-6#2)(1995-1#1)
3 hours##5##2##(1993-3#1)(1994-11#1)(2008-8#2)(2013-8#1)
3 hr##3##2##(1993-1#1)(1995-2#2)
3 in the B##2##4##(2008-10#2)
3 in the##6##3##(1996-12#1)(1996-5#1)(2008-10#3)(2011-2#1)
3 in##17##2##(1992-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#3)
3 is##5##2##(1996-12#1)(1996-5#1)(2008-10#2)(2013-7#1)
3 isolates##5##2##(2008-10#5)
3 kDa##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
3 kJ##2##2##(2008-10#1)(2008-9#1)
3 kb in##2##3##(1994-11#1)(2008-8#1)
3 kb to##2##3##(1997-2#1)(2012-3#1)
3 kb##19##2##(1993-2#1)(1994-11#1)(1995-9#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
3 lesions##2##2##(2008-10#1)(2008-11#1)
3 mM NEM##2##3##(1995-8#2)
3 mM##10##2##(1991-5#1)(1994-11#1)(1995-2#1)(1995-8#3)(2008-10#3)(2011-2#1)
3 mM)##3##2##(1995-8#2)(2011-2#1)
3 mV per concentration##2##4##(2008-10#2)
3 mV##3##2##(2008-10#3)
3 mg 6-APA h(-1) mg(-1) wet##2##6##(2008-12#2)
3 mg l(-1)##2##3##(2008-10#2)
3 mg of##3##3##(2008-10#1)(2010-12#2)
3 mg##16##2##(1995-11#1)(2008-10#7)(2008-11#2)(2008-12#2)(2010-12#2)(2010-8#1)(2011-2#1)
3 mg/kg i##2##3##(1996-2#2)
3 mg/kg##6##2##(1994-2#1)(1996-2#2)(2008-10#1)(2008-5#1)(2012-2#1)
3 mg/liter propiconazole)##2##3##(2008-10#2)
3 microM for##2##3##(1992-12#1)(1994-8#1)
3 microM##5##2##(1992-12#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-11#1)
3 microM)##3##2##(1994-11#1)(1997-4#1)(2013-1#1)
3 microg l(-1)##5##3##(2008-10#5)
3 microm for##2##3##(2008-2#1)(2008-3#1)
3 microm##7##2##(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)
3 million##8##2##(1992-6#2)(1994-9#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
3 million)##3##2##(1996-11#3)
3 min after##2##3##(1993-8#1)(2013-8#1)
3 min of##4##3##(2008-10#4)
3 min##25##2##(1990-11#1)(1993-8#1)(1997-8#1)(2008-10#13)(2008-11#2)(2008-9#1)(2013-1#5)(2013-8#1)
3 ml min(-1)##2##3##(2008-10#2)
3 ml of 1##2##4##(2008-10#2)
3 ml of##6##3##(2008-10#6)
3 ml##13##2##(1995-3#1)(2008-10#12)
3 mm in diameter##2##4##(2008-12#1)(2011-2#1)
3 mm in##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
3 mm of the floret##2##5##(2008-10#2)
3 mm of##4##3##(2008-10#3)(2013-1#1)
3 mm##22##2##(1993-1#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#4)
3 mmHg)##2##2##(1997-3#1)(2008-11#1)
3 mol l(-1)##4##3##(2008-10#4)
3 mol##6##2##(1994-5#1)(2008-10#5)
3 months after surgery##2##4##(2008-7#1)(2011-2#1)
3 months after the##2##4##(1994-1#1)(2013-1#1)
3 months after##12##3##(1990-6#1)(1991-6#1)(1994-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#4)(2013-1#1)
3 months at##3##3##(2008-10#2)(2008-5#1)
3 months later##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
3 months of age##3##4##(1993-12#1)(1995-8#2)
3 months of##8##3##(1991-8#1)(1993-12#1)(1995-8#2)(2008-10#2)(2010-6#1)(2011-2#1)
3 months was##2##3##(2008-10#1)(2013-1#1)
3 months with##3##3##(2008-10#2)(2013-1#1)
3 months without any##7##4##(2008-10#7)
3 months without##8##3##(2008-10#8)
3 months##87##2##(1990-6#1)(1991-3#1)(1991-6#1)(1991-8#2)(1993-12#3)(1994-1#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#32)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-6#4)(2010-7#1)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
3 months)##3##2##(2008-10#2)(2011-2#1)
3 mug kg(-1)##3##3##(2008-10#1)(2008-5#2)
3 mug l(-1) for the##2##5##(2008-10#2)
3 mug l(-1) for##4##4##(2008-10#4)
3 mug l(-1)##7##3##(2008-10#7)
3 mug ml(-1)##6##3##(2008-10#5)(2008-11#1)
3 mug##24##2##(2008-10#20)(2008-11#1)(2008-5#3)
3 mum##4##2##(1992-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
3 nM##2##2##(1992-6#1)(1995-8#1)
3 nM) and##2##3##(1994-8#1)(1995-8#1)
3 nM)##3##2##(1994-8#1)(1995-11#1)(1995-8#1)
3 ng cm(-2)##2##3##(2008-10#2)
3 ng l(-1)##2##3##(2008-10#2)
3 ng ml(-1) for##2##4##(2008-10#2)
3 ng ml(-1)##5##3##(2008-10#5)
3 ng##16##2##(1995-2#1)(2008-10#15)
3 ngl(-1))##2##2##(2008-10#2)
3 nm##6##2##(2008-10#2)(2008-3#1)(2008-8#3)
3 ns##2##2##(2008-3#2)
3 of the##9##3##(1991-2#1)(1992-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-4#1)(2012-12#1)
3 of##25##2##(1991-2#1)(1992-9#1)(1995-11#1)(1995-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-12#1)(2013-1#1)
3 on##2##2##(2008-10#2)
3 or 4##5##3##(1993-1#1)(1993-12#1)(1996-3#1)(2008-10#1)(2011-2#1)
3 or 4)##2##3##(2008-10#2)
3 or 5##4##3##(1994-11#1)(1996-3#1)(2008-10#1)(2013-1#1)
3 or MCA##2##3##(1990-8#2)
3 or##14##2##(1990-8#2)(1992-2#1)(1993-1#1)(1993-12#1)(1994-11#1)(1996-3#2)(2008-10#4)(2011-2#1)(2013-1#1)
3 orders of magnitude##4##4##(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
3 orders##5##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)
3 out of##2##3##(2008-10#1)(2010-2#1)
3 patients had##4##3##(2008-11#1)(2009-3#1)(2010-3#2)
3 patients in##2##3##(2008-7#1)(2011-2#1)
3 patients were##2##3##(1991-8#1)(1996-11#1)
3 patients##32##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-8#4)(1992-1#1)(1993-12#1)(1994-12#2)(1995-11#1)(1996-11#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-3#2)(2011-2#4)(2013-1#2)
3 per cent##2##3##(1990-6#1)(2008-7#1)
3 per##3##2##(1990-6#1)(2008-7#1)(2012-3#1)
3 pg (recommended##2##3##(2008-10#2)
3 pg##5##2##(2008-10#5)
3 points##2##2##(2008-3#1)(2013-1#1)
3 points)##2##2##(2008-7#1)(2008-9#1)
3 pops##2##2##(2008-12#2)
3 ppb##3##2##(2008-10#3)
3 ppm##3##2##(2008-10#3)
3 protein##2##2##(2008-9#2)
3 ratio##2##2##(2008-10#2)
3 recurrences##2##2##(1990-3#1)(2008-11#1)
3 region##2##2##(1997-2#1)(1997-7#1)
3 s)##2##2##(2008-10#2)
3 secretory cells##2##3##(2007-12#2)
3 secretory##3##2##(2007-12#3)
3 strain##2##2##(1993-12#2)
3 subunit##2##2##(1995-11#1)(2010-12#1)
3 that##2##2##(1995-6#1)(1997-2#1)
3 through##2##2##(1995-1#1)(2009-7#1)
3 times a day##2##4##(1996-2#1)(2007-11#1)
3 times a##3##3##(1996-2#1)(2007-11#1)(2013-1#1)
3 times higher##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
3 times more##2##3##(1996-12#1)(2008-11#1)
3 times the##2##3##(2008-10#1)(2009-4#1)
3 times##17##2##(1994-5#1)(1996-12#1)(1996-2#1)(2007-11#2)(2008-10#2)(2008-11#5)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
3 to 1##4##3##(1992-3#1)(2008-10#1)(2008-3#2)
3 to 10##3##3##(2008-10#2)(2010-2#1)
3 to 102##3##3##(2008-10#3)
3 to 108##3##3##(2008-10#3)
3 to 12##2##3##(2008-10#1)(2013-8#1)
3 to 22##2##3##(2008-10#1)(2008-7#1)
3 to 4 weeks##2##4##(2008-10#1)(2008-5#1)
3 to 4##6##3##(1992-5#1)(2008-10#3)(2008-5#1)(2008-7#1)
3 to 5 weeks##4##4##(2008-10#3)(2011-2#1)
3 to 5##11##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2010-1#2)(2011-2#1)
3 to 7##2##3##(1990-11#1)(1996-5#1)
3 to 8 weeks of age##2##6##(2008-10#1)(2011-2#1)
3 to 8##4##3##(1990-11#1)(2008-10#1)(2010-11#1)(2011-2#1)
3 to 9##2##3##(2008-10#1)(2012-3#1)
3 to 97##2##3##(2008-10#1)(2012-3#1)
3 to##82##2##(1990-11#2)(1990-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1996-5#1)(1997-7#1)(2008-10#49)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
3 trials##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
3 university##2##2##(1990-12#2)
3 using##2##2##(1997-8#1)(2008-8#1)
3 vs##5##2##(2008-12#1)(2008-7#1)(2011-2#2)(2012-3#1)
3 was##17##2##(1991-8#1)(1994-2#1)(1996-5#1)(2008-10#9)(2008-11#2)(2008-9#1)(2011-2#1)(2012-3#1)
3 weeks after inoculation##2##4##(2008-10#2)
3 weeks after##6##3##(1994-5#1)(1996-2#1)(2008-10#4)
3 weeks before##3##3##(2008-10#3)
3 weeks of##5##3##(1993-8#1)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)
3 weeks##38##2##(1990-7#1)(1991-2#1)(1991-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-10#16)(2008-11#3)(2008-5#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
3 weeks)##2##2##(1992-12#1)(2008-10#1)
3 were treated with##2##4##(2008-7#2)
3 were##13##2##(1991-2#1)(1995-12#1)(2008-10#4)(2008-12#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-3#1)(2013-8#1)
3 with##9##2##(1990-9#2)(1992-12#1)(2008-10#3)(2008-11#1)(2008-7#2)
3 women##2##2##(2008-11#1)(2012-12#1)
3 x 10(-4)##2##3##(1994-5#1)(2008-3#1)
3 x 10(-5)##2##3##(1994-11#1)(2008-3#1)
3 x 10(-6)##3##3##(1992-3#1)(1997-8#1)(2008-3#1)
3 x 10(-9) M##2##4##(1991-5#1)(1995-11#1)
3 x 10(-9)##4##3##(1991-5#1)(1995-11#1)(2008-10#1)(2008-3#1)
3 x 10(6) M-1)##2##4##(1992-4#2)
3 x 10(6)##7##3##(1992-4#2)(1993-1#1)(1996-5#1)(2008-10#2)(2008-11#1)
3 x 10(7)##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
3 x##39##2##(1991-5#1)(1992-3#1)(1992-4#2)(1993-1#1)(1994-11#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-5#1)(1997-8#3)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2009-7#1)
3 year period##3##3##(2008-7#2)(2010-6#1)
3 year##5##2##(2008-10#1)(2008-11#1)(2008-7#2)(2010-6#1)
3 years after##4##3##(2008-10#2)(2010-3#1)(2011-2#1)
3 years and 9 months##2##5##(1997-7#1)(2012-3#1)
3 years and##5##3##(1994-1#1)(1994-9#1)(1997-7#1)(2011-2#1)(2012-3#1)
3 years at three##2##4##(2008-10#2)
3 years at##3##3##(2008-10#3)
3 years in##2##3##(2008-10#1)(2013-8#1)
3 years of field##2##4##(2008-10#2)
3 years of##14##3##(1991-8#1)(1994-1#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-3#1)(2012-2#1)
3 years##71##2##(1990-9#1)(1991-3#1)(1991-8#1)(1992-12#1)(1994-1#2)(1994-9#2)(1995-12#2)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#2)(2010-1#1)(2010-3#4)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
3 years)##4##2##(2008-10#2)(2008-11#1)(2010-1#1)
3 yr##2##2##(2008-7#2)
3 ±##2##2##(2012-3#2)
3##3344##1##(1990-11#31)(1990-12#14)(1990-2#20)(1990-3#4)(1990-5#23)(1990-6#11)(1990-7#6)(1990-8#10)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#13)(1991-12#6)(1991-2#13)(1991-3#7)(1991-5#15)(1991-6#7)(1991-7#1)(1991-8#14)(1991-9#8)(1992-1#2)(1992-10#1)(1992-12#20)(1992-2#11)(1992-3#15)(1992-4#8)(1992-5#4)(1992-6#9)(1992-8#2)(1992-9#3)(1993-1#10)(1993-11#2)(1993-12#23)(1993-2#5)(1993-3#3)(1993-5#1)(1993-6#8)(1993-8#28)(1993-9#1)(1994-1#4)(1994-11#19)(1994-12#14)(1994-2#18)(1994-3#14)(1994-5#16)(1994-6#1)(1994-8#18)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#38)(1995-12#12)(1995-2#12)(1995-3#8)(1995-5#1)(1995-6#11)(1995-8#22)(1995-9#2)(1996-11#12)(1996-12#17)(1996-2#21)(1996-3#4)(1996-5#23)(1996-6#5)(1996-8#4)(1996-9#1)(1997-1#10)(1997-2#19)(1997-3#17)(1997-4#6)(1997-5#4)(1997-6#3)(1997-7#13)(1997-8#22)(1997-9#7)(2007-11#3)(2007-12#14)(2007-8#1)(2008-1#8)(2008-10#1466)(2008-11#155)(2008-12#55)(2008-2#11)(2008-3#60)(2008-4#12)(2008-5#48)(2008-6#5)(2008-7#64)(2008-8#45)(2008-9#57)(2009-1#4)(2009-10#8)(2009-11#9)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#11)(2009-8#8)(2009-9#3)(2010-1#9)(2010-10#6)(2010-11#3)(2010-12#9)(2010-2#2)(2010-3#8)(2010-4#8)(2010-5#7)(2010-6#18)(2010-7#5)(2010-8#7)(2010-9#3)(2011-1#16)(2011-2#134)(2011-3#12)(2012-12#25)(2012-2#37)(2012-3#56)(2012-4#1)(2012-6#1)(2013-1#97)(2013-3#1)(2013-7#5)(2013-8#35)
3% (n=10)##3##2##(2008-10#3)
3% (n=5)##2##2##(2008-10#2)
3% (v/v)##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
3% (w/v)##2##2##(2008-10#2)
3% (w/w)##2##2##(2008-10#2)
3% R##2##2##(2008-10#2)
3% SDS##2##2##(2012-2#2)
3% after##2##2##(2008-10#2)
3% and 1##2##3##(2008-10#2)
3% and that of##2##4##(2008-10#1)(2008-3#1)
3% and the##8##3##(1993-3#1)(1996-12#1)(2008-10#5)(2008-7#1)
3% and##34##2##(1990-11#1)(1993-3#1)(1994-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
3% at the##2##3##(2008-10#2)
3% at##6##2##(1991-8#1)(2008-10#5)
3% expressed##2##2##(2008-10#2)
3% for the##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
3% for##25##2##(1991-3#1)(1992-11#1)(1996-12#1)(2008-10#19)(2008-11#1)(2008-12#1)(2011-2#1)
3% had had##2##3##(1991-11#1)(2010-6#1)
3% had##4##2##(1991-11#1)(2010-6#1)(2012-3#1)(2013-8#1)
3% in young cirrhotics vs##2##5##(2012-3#2)
3% in##12##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-8#1)(2011-2#3)(2012-3#3)(2013-8#1)
3% increase##2##2##(1995-5#1)(2013-8#1)
3% indicating##2##2##(2008-10#2)
3% of all##2##3##(1997-2#1)(2008-10#1)
3% of patients##2##3##(2007-8#1)(2012-3#1)
3% of the patients##3##4##(1990-12#1)(1990-2#1)(1991-3#1)
3% of the total##4##4##(1990-7#1)(2008-10#1)(2010-11#1)(2013-1#1)
3% of the##20##3##(1990-12#2)(1990-2#1)(1990-7#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
3% of total##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
3% of##43##2##(1990-12#2)(1990-2#1)(1990-7#1)(1991-3#2)(1991-8#1)(1993-12#1)(1994-12#1)(1994-6#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
3% p &lt##2##3##(2009-8#2)
3% reagent in xylene from##2##5##(2008-10#2)
3% relative standard deviation##2##4##(2008-10#2)
3% to##4##2##(1990-3#1)(1993-3#1)(1994-12#1)(2013-8#1)
3% vs##6##2##(1993-1#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
3% w/v##2##2##(2008-10#2)
3% was##2##2##(1991-3#1)(2008-10#1)
3% were##8##2##(2008-10#4)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
3% with##3##2##(2008-10#1)(2008-12#1)(2011-3#1)
3%##340##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-3#4)(1991-8#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-3#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#2)(1995-2#1)(1995-5#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#158)(2008-11#14)(2008-12#8)(2008-2#2)(2008-3#6)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#6)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#18)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#14)(2013-1#10)(2013-8#10)
3%) and in##2##3##(1990-8#1)(2013-1#1)
3%) and##13##2##(1990-8#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-5#2)(2011-2#1)(2013-1#2)(2013-8#1)
3%) for##5##2##(2008-10#3)(2011-2#1)(2012-2#1)
3%) in the##3##3##(1991-12#1)(2008-10#2)
3%) in##8##2##(1991-12#1)(1993-1#1)(1996-1#1)(2008-1#1)(2008-10#2)(2011-1#2)
3%) of##2##2##(2008-9#1)(2011-2#1)
3%) patients##5##2##(1995-12#1)(1997-8#2)(2011-1#1)(2012-12#1)
3%) were##6##2##(1990-2#1)(1994-12#1)(1997-8#1)(2008-12#1)(2008-9#1)(2011-2#1)
3%)##101##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-1#1)(1994-12#1)(1995-12#2)(1996-1#1)(1997-8#4)(2007-11#1)(2007-8#1)(2008-1#5)(2008-10#15)(2008-11#7)(2008-12#4)(2008-3#1)(2008-5#6)(2008-7#2)(2008-9#8)(2009-8#1)(2010-11#3)(2010-6#3)(2010-8#1)(2011-1#5)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#2)
3&lt##2##1##(2008-10#1)(2013-1#1)
3' UTR##6##2##(1996-12#2)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)
3' end of the##14##4##(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2013-1#1)
3' end of##20##3##(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-8#2)(2013-1#1)
3' end sequences of##2##4##(2008-11#1)(2008-8#1)
3' end with##2##3##(2008-10#1)(2008-8#1)
3' end##31##2##(1990-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-8#6)(2013-1#1)(2013-8#1)
3' ends of##2##3##(2008-8#1)(2008-9#1)
3' ends##6##2##(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#1)
3' expression##3##2##(2012-3#3)
3' flanking region of##2##4##(1993-12#2)
3' genomic region##2##3##(2008-10#2)
3' kinase##3##2##(1996-2#3)
3' non-coding region##2##3##(1993-12#1)(2008-8#1)
3' non-coding##3##2##(1993-12#1)(1997-7#1)(2008-8#1)
3' splice site##2##3##(1993-6#1)(1993-8#1)
3' splice##3##2##(1993-6#2)(1993-8#1)
3' splice-site selection##3##3##(1993-6#3)
3' splice-site##4##2##(1993-6#4)
3' termini##5##2##(2008-10#2)(2008-5#1)(2008-8#2)
3' terminus##2##2##(2008-10#2)
3' untranslated region of##2##4##(1994-11#1)(1995-2#1)
3' untranslated region##9##3##(1991-9#1)(1993-12#1)(1994-11#1)(1995-2#2)(1996-12#1)(2008-10#2)(2008-8#1)
3' untranslated regions of the##2##5##(1990-5#1)(1993-2#1)
3' untranslated regions##3##3##(1990-5#1)(1993-2#1)(1997-8#1)
3' untranslated##13##2##(1990-5#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-2#2)(1996-12#1)(1997-8#1)(2008-10#2)(2008-8#1)
3'##163##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-12#10)(1993-2#1)(1993-3#1)(1993-6#7)(1993-8#4)(1993-9#1)(1994-11#5)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#4)(1995-8#3)(1996-12#4)(1996-2#3)(1996-6#2)(1997-2#1)(1997-3#4)(1997-7#9)(1997-8#2)(2008-10#51)(2008-11#5)(2008-4#1)(2008-5#1)(2008-8#16)(2008-9#3)(2010-4#1)(2010-5#3)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
3'-##3##1##(1990-5#1)(1997-6#1)(2010-5#1)
3'-NTR##3##1##(2008-10#3)
3'-NTR)##2##1##(2008-10#2)
3'-UTR of##2##2##(2008-9#1)(2013-1#1)
3'-UTR##3##1##(1995-12#1)(2008-9#1)(2013-1#1)
3'-dideoxycytidine##2##1##(1994-11#2)
3'-end joining##2##2##(1997-3#2)
3'-end processing and joining##2##4##(1997-3#2)
3'-end processing and##3##3##(1997-3#3)
3'-end processing##4##2##(1997-3#4)
3'-end##15##1##(1993-8#1)(1993-9#1)(1994-8#1)(1997-3#6)(2008-10#3)(2008-8#1)(2013-1#2)
3'-phosphate##2##1##(1991-3#2)
3'-phosphoglycolate and##2##2##(1991-3#2)
3'-phosphoglycolate##3##1##(1991-3#3)
3'-terminal regions of##2##3##(2008-10#2)
3'-terminal sequence (5'-AUUGCUCU-3')##2##3##(2008-10#2)
3'-terminal##8##1##(1993-8#1)(2008-10#6)(2008-9#1)
3'-triiodo-L-thyronine##2##1##(1991-5#1)(2008-10#1)
3'-triiodo-l-thyronine##2##1##(2008-10#2)
3'-untranslated region (3'-UTR)##2##3##(1995-12#1)(2013-1#1)
3'-untranslated region of##2##3##(1995-12#1)(2011-2#1)
3'-untranslated region##8##2##(1993-12#1)(1993-2#1)(1995-12#2)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
3'-untranslated##10##1##(1993-12#2)(1993-2#2)(1995-12#2)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
3'3'-tetramethylindocarbocyanine perchlorate##2##2##(1997-3#2)
3'ESTs##2##1##(2008-9#2)
3'NTR##3##1##(2008-10#3)
3'UTR alone##2##2##(2008-10#2)
3'UTR##10##1##(1994-12#3)(2008-10#2)(2008-11#2)(2008-9#1)(2010-5#1)(2011-2#1)
3'untranslated region##3##2##(2008-11#3)
3'untranslated##4##1##(2008-11#4)
3(rd)##4##1##(2008-5#1)(2011-1#2)(2012-2#1)
3) a##3##2##(1993-1#1)(2008-10#1)(2008-4#1)
3) and##7##2##(1993-12#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
3) families derived from##2##4##(2008-10#2)
3) families##4##2##(2008-10#4)
3) in##3##2##(1992-9#1)(1997-2#1)(2008-3#1)
3) is##3##2##(2008-10#2)(2012-2#1)
3) of##2##2##(1993-6#1)(2008-10#1)
3) relationship##2##2##(2008-2#2)
3) the##4##2##(1991-3#1)(1995-11#1)(1995-6#1)(2008-7#1)
3) was##9##2##(1992-10#2)(1994-5#1)(2008-10#5)(2008-9#1)
3) were##2##2##(1990-9#1)(1997-8#1)
3) x##2##2##(1992-10#1)(1994-5#1)
3) years##2##2##(1994-12#1)(2008-12#1)
3)##140##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-10#4)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#2)(1994-6#2)(1995-11#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-10#40)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#6)(2011-9#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#1)(2013-8#2)
3)]##2##1##(2008-10#2)
3+##3##1##(2010-4#1)(2010-8#2)
3+/-0##13##1##(2008-10#10)(2008-11#1)(2008-2#1)(2008-7#1)
3+/-2##2##1##(2007-11#1)(2008-10#1)
3+/-3##2##1##(2008-10#2)
3+1##2##1##(2008-10#1)(2012-3#1)
3- and##7##2##(1991-5#1)(1994-8#1)(1995-8#1)(1997-8#2)(2008-10#1)(2008-5#1)
3- or##2##2##(1991-5#1)(2008-11#1)
3- to 4-week-old##2##3##(2008-10#1)(2008-9#1)
3- to##5##2##(2008-10#2)(2008-9#1)(2009-11#1)(2013-1#1)
3-##20##1##(1991-5#2)(1992-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-8#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2013-1#2)
3-(2-pyridyl)-5##3##1##(2008-10#3)
3-(3##2##1##(2008-11#1)(2008-5#1)
3-(N-tert-butylcarboxamido)-1-propyl##3##1##(2008-4#3)
3-0##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
3-1##6##1##(1990-2#1)(1991-5#2)(2008-10#3)
3-10##5##1##(1991-12#1)(1994-12#1)(2008-10#1)(2009-11#1)(2013-1#1)
3-101##2##1##(2008-10#2)
3-103##2##1##(2008-10#2)
3-11##2##1##(2008-3#1)(2008-7#1)
3-12##6##1##(1994-3#1)(1995-3#1)(2008-10#2)(2008-8#1)(2013-1#1)
3-2##5##1##(1993-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
3-20##5##1##(2008-10#4)(2008-2#1)
3-3##11##1##(1997-4#1)(2008-10#8)(2008-5#1)(2012-12#1)
3-30##2##1##(1993-12#1)(2008-7#1)
3-4 days##5##2##(2008-11#3)(2008-8#1)(2011-2#1)
3-4 years##2##2##(1994-12#1)(1994-9#1)
3-4##18##1##(1991-3#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#3)(2011-2#1)
3-4-fold##4##1##(1994-5#1)(1994-8#1)(2008-10#1)(2008-8#1)
3-5##21##1##(1991-6#1)(1992-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
3-5%##3##1##(1993-2#1)(2008-10#1)(2013-1#1)
3-6##10##1##(1997-2#1)(2008-10#3)(2008-5#1)(2008-9#2)(2009-7#1)(2010-12#1)(2010-3#1)
3-7##8##1##(1991-9#2)(1993-2#1)(1995-2#1)(1996-12#1)(2008-10#1)(2010-3#1)(2012-12#1)
3-8##4##1##(2008-10#3)(2013-8#1)
3-8%##2##1##(2008-7#1)(2011-2#1)
3-A resolution##3##2##(1993-8#3)
3-D and##2##2##(2008-10#1)(2011-2#1)
3-D coordinates##2##2##(2008-3#2)
3-D culture##5##2##(2008-11#4)(2009-3#1)
3-D follicles with##2##3##(2012-3#2)
3-D matrix##2##2##(2008-11#2)
3-D model##5##2##(2008-11#1)(2008-3#1)(2008-8#2)(2009-3#1)
3-D##41##1##(1994-5#1)(2008-10#1)(2008-11#14)(2008-12#1)(2008-3#7)(2008-8#4)(2009-3#2)(2010-7#1)(2010-9#1)(2011-2#6)(2012-3#2)(2013-1#1)
3-DNB##3##1##(2008-10#3)
3-DNB)##2##1##(2008-10#2)
3-Deazaadenosine##2##1##(2011-2#2)
3-Epoxy##2##1##(1996-5#2)
3-Glucanase Genes in##2##3##(2008-10#2)
3-Glucanase##7##1##(2008-10#7)
3-Mb##2##1##(1997-8#2)
3-Methylcholanthrene (1 nM)##2##3##(2008-11#2)
3-O-methyltransferase##2##1##(2008-11#2)
3-OHDBTL##3##1##(1993-12#3)
3-alternate calix[4]azacrown ethers##2##3##(2008-10#2)
3-alternate conformation##3##2##(2008-10#3)
3-alternate thiacalix[4]biscrown-6##3##2##(2008-10#3)
3-alternate##11##1##(2008-10#11)
3-amino-4-hydroxyphenylarsonic acid##2##2##(2008-10#2)
3-benzenedisulfonic acid##3##2##(2008-10#3)
3-beta-glucanases##2##1##(2008-10#2)
3-butadiene##2##1##(1996-5#2)
3-butanediol to acetoin##2##3##(2013-1#2)
3-butanediol##5##1##(2013-1#5)
3-butanedione monoxime##2##2##(2008-11#2)
3-carboxy A-ring aryl steroids##3##4##(1990-11#3)
3-cd)pyrene##2##1##(2008-10#2)
3-chlorophenol##2##1##(2008-10#2)
3-cyclohexanedione dithiosemicarbazone monohydrochloride##2##3##(2008-10#2)
3-cyclohexanedione##3##1##(2008-10#3)
3-d][1##2##1##(1996-5#2)
3-day-old##2##1##(2008-11#1)(2008-5#1)
3-di-O-glycosyl derivatives of methyl alpha-L-rhamnopyranoside##2##5##(1992-12#2)
3-diamino esters##2##2##(2008-11#2)
3-diaminobenzene)##2##1##(2008-10#2)
3-diaminophenazine##2##1##(2008-10#2)
3-diaminopropane##3##1##(2008-10#3)
3-dicarboxaldehyde##2##1##(2008-10#2)
3-dichloro-5##6##1##(2008-10#5)(2008-11#1)
3-dichlorobenzene##2##1##(2008-10#2)
3-dichloropropene##3##1##(2008-10#3)
3-dichloroquinoxaline##2##1##(2008-10#2)
3-dimensional structure of the##3##4##(2008-11#1)(2011-2#2)
3-dimensional##7##1##(2008-11#1)(2008-5#2)(2009-10#1)(2011-2#2)(2013-1#1)
3-dimercaptosuccinic acid (DMSA)##2##3##(1992-12#1)(2008-8#1)
3-dimercaptosuccinic acid##3##2##(1992-12#2)(2008-8#1)
3-dimethyl-4-quinolone##2##1##(2008-10#2)
3-dimethylnaphthalene##2##1##(2008-3#2)
3-dinitrobenzene##3##1##(2008-10#3)
3-dione##8##1##(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#2)
3-dioxane##2##1##(1996-5#2)
3-dioxo-2-indanylidene) acetonitrile derivatives##2##3##(2008-10#2)
3-dioxo-2-indanylidene) acetonitrile##7##2##(2008-10#7)
3-dioxolan-2-yl]nucleosides##2##1##(1996-5#2)
3-dioxolane##3##1##(1996-5#3)
3-dioxygenase (IDO)##2##2##(2008-11#2)
3-dioxygenase##4##1##(1990-5#1)(2008-11#3)
3-disubstituted##2##1##(1996-5#1)(2010-3#1)
3-dithiolan-2-yl]nucleosides##2##1##(1996-5#2)
3-dithiole (TPDT)##2##2##(1996-5#2)
3-dithiole##4##1##(1996-5#4)
3-fold higher than that##2##4##(1991-5#1)(2008-11#1)
3-fold higher than##4##3##(1990-11#1)(1991-5#1)(2008-11#2)
3-fold higher##5##2##(1990-11#1)(1991-5#1)(2008-11#3)
3-fold in the##2##3##(1990-5#1)(2008-11#1)
3-fold in##5##2##(1990-12#1)(1990-5#1)(1995-6#1)(2008-11#1)(2012-3#1)
3-fold increase in##3##3##(1990-7#1)(1994-8#1)(1995-2#1)
3-fold increase##6##2##(1990-7#1)(1994-12#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-5#1)
3-fold lower##2##2##(1990-11#1)(1992-10#1)
3-fold more##2##2##(1994-8#1)(2008-8#1)
3-fold##30##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1991-5#2)(1992-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#2)(1995-8#3)(2007-12#1)(2008-11#5)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
3-glucan##2##1##(2008-10#1)(2008-11#1)
3-glucanase (EC 3##2##3##(2008-10#2)
3-glucanase activities##4##2##(2008-10#4)
3-glucanase activity in##3##3##(2008-10#3)
3-glucanase activity##11##2##(2008-10#11)
3-glucanase and##4##2##(2008-10#4)
3-glucanase in##2##2##(2008-10#2)
3-glucanase isoforms##3##2##(2008-10#3)
3-glucanase##38##1##(2008-10#37)(2009-8#1)
3-glucanase)##4##1##(2008-10#4)
3-glucanases##5##1##(2008-10#5)
3-h##5##1##(1993-6#1)(2008-10#4)
3-hour##2##1##(1990-9#1)(2008-11#1)
3-hydroxy BaP##2##2##(2011-1#2)
3-indanedione##4##1##(2008-10#4)
3-indoxyl phosphate##2##2##(2008-10#2)
3-kb##7##1##(1993-12#2)(1993-6#1)(1996-2#1)(2008-10#3)
3-keto##2##1##(1990-11#1)(1996-5#1)
3-ketoacyl-ACP##2##1##(1992-4#2)
3-kinase (PI 3-kinase)##6##3##(1993-8#1)(1994-11#2)(1995-8#1)(1996-2#1)(2008-11#1)
3-kinase (PI##7##2##(1993-8#1)(1994-11#2)(1995-8#1)(1996-2#1)(2008-11#1)(2008-7#1)
3-kinase (PI3K)##2##2##(1996-2#1)(2008-11#1)
3-kinase and##4##2##(1994-11#1)(1995-8#1)(2008-3#1)(2008-7#1)
3-kinase##30##1##(1993-6#1)(1993-8#1)(1994-11#10)(1995-6#1)(1995-8#2)(1996-2#4)(2008-11#5)(2008-3#3)(2008-7#3)
3-kinases##2##1##(1996-2#2)
3-lead##2##1##(2010-8#2)
3-mJ##2##1##(2008-3#2)
3-methyl-2-hexenoic acid##2##2##(2008-5#2)
3-methylcholanthrene##7##1##(1992-8#1)(1994-8#1)(2008-11#5)
3-min##4##1##(2008-10#3)(2009-1#1)
3-mm##2##1##(1997-8#1)(2008-2#1)
3-month follow-up##3##2##(2009-11#1)(2011-2#1)(2012-3#1)
3-month##16##1##(1994-3#2)(1997-8#1)(2008-10#6)(2009-11#1)(2010-9#1)(2011-2#3)(2012-3#2)
3-month-old##2##1##(1994-3#1)(2008-10#1)
3-mum##2##1##(1994-2#1)(2008-3#1)
3-naphthalene disulfonic acid##2##3##(2008-10#2)
3-naphthalene##3##1##(2008-10#3)
3-nitrofluoranthene##2##1##(2008-10#1)(2008-11#1)
3-oxathiolan-2-yl]nucleosides##2##1##(1996-5#2)
3-oxazolidine-2-thione##3##1##(2008-10#3)
3-oxo##2##1##(1990-11#2)
3-pentadecylcatechol##3##1##(2008-10#3)
3-phenyl-4-benzoyl-5-isoxazolone (HPBI)##2##2##(2008-10#2)
3-phenyl-4-benzoyl-5-isoxazolone##4##1##(2008-10#4)
3-phosphate##6##1##(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-9#2)
3-propanediol##3##1##(2008-10#3)
3-propanetricarboxylate##3##1##(2008-10#3)
3-propanetriol 1##2##2##(2008-5#2)
3-s##2##1##(2008-10#1)(2008-6#1)
3-sialyltransferase##2##1##(2008-11#2)
3-tert-butyl-4-hydroxyanisole (BHA) and##2##3##(2008-10#2)
3-tert-butyl-4-hydroxyanisole##3##1##(2008-10#3)
3-trimethyl-2-oxabicyclo[2##2##1##(2008-5#2)
3-week follow-up##2##2##(2008-12#2)
3-week##5##1##(1996-1#1)(2008-12#2)(2008-5#1)(2013-8#1)
3-week-old##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
3-year period##9##2##(1993-12#1)(1995-1#1)(2008-10#4)(2008-9#1)(2012-12#1)(2012-2#1)
3-year##21##1##(1991-6#1)(1993-12#1)(1995-1#1)(1996-3#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-9#1)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#1)
3-year-old girl##2##2##(1994-2#1)(2008-10#1)
3-year-old##4##1##(1994-2#1)(2008-10#2)(2012-3#1)
3/10##2##1##(2008-8#1)(2013-1#1)
3/4-fucosyltransferase##2##1##(1995-2#2)
30 % of##2##3##(1997-8#1)(2011-2#1)
30 +/- 0##2##3##(1995-11#1)(2013-1#1)
30 +/-##6##2##(1995-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-3#1)(2013-1#1)
30 000##2##2##(2008-10#2)
30 V##3##2##(2008-10#3)
30 amino acids##3##3##(1993-2#2)(1995-6#1)
30 amino##4##2##(1993-2#2)(1995-6#1)(2011-3#1)
30 and 40##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
30 and 45 days' incubation##3##5##(2008-5#3)
30 and 45 min##2##4##(2013-1#2)
30 and 45##6##3##(2008-11#1)(2008-5#3)(2013-1#2)
30 and 50##2##3##(1997-3#1)(2006-6#1)
30 and 60 min##2##4##(1990-12#1)(2008-10#1)
30 and 60##3##3##(1990-12#1)(1994-11#1)(2008-10#1)
30 and 70%##4##3##(2008-10#3)(2008-5#1)
30 and##38##2##(1990-12#1)(1991-8#1)(1994-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-5#5)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
30 cases##3##2##(1990-2#1)(2008-10#1)(2012-3#1)
30 children##2##2##(1995-1#1)(1996-11#1)
30 days after inoculation##4##4##(2008-10#4)
30 days after the##2##4##(2008-10#1)(2011-2#1)
30 days after##7##3##(1995-5#1)(2008-10#5)(2011-2#1)
30 days and##3##3##(2008-11#2)(2012-3#1)
30 days in##2##3##(2008-10#1)(2008-11#1)
30 days of age##2##4##(2008-5#1)(2012-2#1)
30 days of##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
30 days##42##2##(1990-12#2)(1991-2#1)(1993-3#1)(1995-2#1)(1995-5#1)(2008-10#11)(2008-11#5)(2008-5#3)(2009-11#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
30 days)##4##2##(1991-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
30 degrees C and##7##4##(2008-10#7)
30 degrees C during##2##4##(2008-10#2)
30 degrees C for##2##4##(2008-10#2)
30 degrees C had##2##4##(1997-8#1)(2008-10#1)
30 degrees C in##2##4##(2008-10#1)(2010-4#1)
30 degrees C##50##3##(1997-2#1)(1997-8#2)(2008-10#39)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)
30 degrees##59##2##(1993-8#1)(1997-2#1)(1997-8#3)(2008-10#42)(2008-12#4)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)
30 g##3##2##(1993-3#1)(2008-10#1)(2008-12#1)
30 h(-1)##7##2##(2008-10#7)
30 healthy##4##2##(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
30 in the##2##3##(1990-2#1)(1993-9#1)
30 in##5##2##(1990-2#1)(1993-9#1)(2006-6#1)(2009-10#1)(2011-2#1)
30 kDa##7##2##(1990-5#1)(1995-6#2)(2011-2#2)(2012-2#1)(2013-1#1)
30 kGy##2##2##(2009-7#2)
30 ku##3##2##(2008-8#1)(2008-9#2)
30 m##2##2##(2008-10#2)
30 mM##6##2##(1990-8#1)(1992-4#1)(1997-1#1)(2008-10#2)(2011-2#1)
30 mg##6##2##(2008-10#3)(2009-12#1)(2011-3#2)
30 mg/day##2##2##(1997-7#2)
30 mg/kg##6##2##(1992-3#1)(1993-3#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#1)
30 mg/kg/day##2##2##(2011-2#2)
30 microM of##2##3##(1990-11#2)
30 microM##6##2##(1990-11#2)(1993-6#1)(1995-8#1)(1997-8#2)
30 microl of##3##3##(2008-10#3)
30 microl saline##2##3##(2008-10#2)
30 microl##6##2##(2008-10#6)
30 min after the##2##4##(2010-10#1)(2011-2#1)
30 min after##7##3##(1994-2#2)(1996-12#1)(1997-8#1)(2008-11#1)(2010-10#1)(2011-2#1)
30 min and the##2##4##(1990-12#1)(1994-3#1)
30 min and##3##3##(1990-12#1)(1994-3#1)(2008-10#1)
30 min aromatherapy massage##2##4##(2008-10#2)
30 min before the##2##4##(1994-2#1)(1995-12#1)
30 min before##6##3##(1994-2#1)(1994-5#4)(1995-12#1)
30 min dynamic##2##3##(2008-10#2)
30 min following##2##3##(1993-1#1)(2008-7#1)
30 min incubation##4##3##(1994-3#2)(1994-8#1)(2008-9#1)
30 min of##7##3##(1996-12#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
30 min was##4##3##(1994-3#3)(2008-7#1)
30 min##77##2##(1990-12#1)(1990-8#1)(1991-5#1)(1993-1#4)(1994-2#3)(1994-3#6)(1994-5#5)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1997-2#1)(1997-8#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#1)(2010-1#2)(2010-10#1)(2011-2#4)(2012-3#1)(2013-8#2)
30 min)##11##2##(1990-12#1)(1993-3#1)(1995-8#1)(1997-3#1)(2008-10#2)(2009-9#2)(2012-3#3)
30 minutes of##2##3##(1991-12#1)(2012-12#1)
30 minutes##8##2##(1990-8#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-1#1)(1994-11#1)(2012-12#1)(2012-2#1)
30 ml##2##2##(2008-10#2)
30 mm##2##2##(2008-2#1)(2008-8#1)
30 mmol##2##2##(2008-10#2)
30 mol %##2##3##(1994-5#2)
30 months of##2##3##(1993-1#1)(2008-9#1)
30 months##8##2##(1990-12#1)(1993-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)
30 ms##2##2##(1996-2#1)(2008-3#1)
30 muM##2##2##(2008-10#1)(2008-11#1)
30 mug l(-1)##5##3##(2008-10#5)
30 mug##9##2##(2008-10#7)(2008-11#1)(2010-2#1)
30 mul of##2##3##(2008-10#2)
30 mul##4##2##(2008-10#4)
30 nM##2##2##(1991-5#1)(1994-11#1)
30 nM)##2##2##(1995-8#1)(2008-10#1)
30 ng ml(-1)##3##3##(2008-10#3)
30 ng##4##2##(2008-10#4)
30 nm##2##2##(2008-10#2)
30 nucleotides##2##2##(2008-10#2)
30 of##4##2##(1997-8#1)(2008-10#3)
30 or more##3##3##(1991-12#1)(1992-1#2)
30 or##4##2##(1991-12#1)(1992-1#2)(2011-2#1)
30 patients with##4##3##(1997-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
30 patients##19##2##(1990-5#1)(1990-6#1)(1990-8#2)(1991-2#1)(1993-12#1)(1996-6#1)(1997-1#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-8#2)(2010-8#1)(2011-2#1)(2013-1#3)
30 percent##5##2##(1991-1#1)(1995-2#1)(1997-1#1)(2010-12#1)(2013-1#1)
30 pg##3##2##(2008-10#3)
30 s and##2##3##(2008-10#2)
30 s##19##2##(1990-5#1)(2008-10#14)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
30 s)##3##2##(2008-10#2)(2013-1#1)
30 samples can be##2##4##(2008-10#2)
30 samples h(-1)##3##3##(2008-10#3)
30 samples per hour can be##2##6##(2008-10#2)
30 samples per hour##5##4##(2008-10#5)
30 samples per##7##3##(2008-10#7)
30 samples##13##2##(2008-10#13)
30 samplesh(-1)##3##2##(2008-10#3)
30 seconds##2##2##(1991-5#1)(2011-2#1)
30 subjects##2##2##(2008-12#1)(2008-5#1)
30 to 40##5##3##(2008-10#5)
30 to 40%##3##3##(2008-10#2)(2008-11#1)
30 to 60##4##3##(1993-1#1)(2008-10#3)
30 to##37##2##(1993-1#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#24)(2008-11#2)(2008-5#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
30 weeks##2##2##(1995-8#1)(2007-12#1)
30 women##3##2##(1992-2#1)(1994-2#1)(2011-2#1)
30 years ago##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
30 years and##2##3##(2012-2#2)
30 years before##2##3##(2008-1#1)(2008-7#1)
30 years in##2##3##(1996-11#1)(2011-2#1)
30 years of##6##3##(1993-12#1)(1994-2#1)(2008-10#2)(2009-8#1)(2012-12#1)
30 years old##2##3##(1997-2#1)(1997-3#1)
30 years##37##2##(1991-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-11#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)
30 years)##2##2##(1997-2#1)(2013-1#1)
30 ±##2##2##(2012-3#1)(2013-1#1)
30##814##1##(1990-11#2)(1990-12#8)(1990-2#4)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#6)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#3)(1991-5#3)(1991-6#3)(1991-8#3)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#8)(1993-12#8)(1993-2#3)(1993-3#8)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#2)(1994-11#5)(1994-12#2)(1994-2#6)(1994-3#6)(1994-5#8)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#5)(1996-1#2)(1996-11#7)(1996-12#4)(1996-2#5)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#3)(1997-1#3)(1997-2#5)(1997-3#5)(1997-7#13)(1997-8#17)(1997-9#1)(2006-6#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#7)(2008-10#315)(2008-11#21)(2008-12#14)(2008-2#4)(2008-3#7)(2008-5#18)(2008-6#1)(2008-7#23)(2008-8#8)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#37)(2011-3#5)(2012-12#3)(2012-2#14)(2012-3#14)(2013-1#33)(2013-8#6)
30% (P##2##2##(1990-8#1)(2008-9#1)
30% (w/w)##3##2##(2008-10#3)
30% at##3##2##(1991-6#1)(2008-10#1)(2009-5#1)
30% for##2##2##(1990-6#1)(1995-3#1)
30% higher than##2##3##(2008-10#1)(2011-2#1)
30% higher##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
30% in the##2##3##(2008-8#1)(2013-1#1)
30% in##10##2##(1994-8#1)(1996-12#1)(1996-9#1)(1997-9#1)(2008-10#3)(2008-8#1)(2013-1#1)(2013-8#1)
30% increase in##2##3##(1996-12#1)(2010-6#1)
30% lower##2##2##(2008-10#1)(2008-8#1)
30% of all##2##3##(1990-6#1)(1992-6#1)
30% of the energy##2##4##(2008-3#2)
30% of the overall##2##4##(1991-5#1)(2008-10#1)
30% of the total##2##4##(2008-10#1)(2008-8#1)
30% of the##16##3##(1991-5#1)(1992-6#1)(1992-8#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#2)
30% of##30##2##(1990-6#1)(1991-5#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#1)(1994-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#5)
30% reduction##2##2##(2008-10#2)
30% to 50%##2##3##(2008-7#1)(2012-12#1)
30% to 60%##2##3##(2010-12#1)(2012-12#1)
30% to##6##2##(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)
30%##127##1##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#40)(2008-11#7)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
30%) and##4##2##(2008-12#1)(2010-4#1)(2011-2#2)
30%) patients##2##2##(2011-2#2)
30%)##12##1##(1990-2#1)(1990-5#1)(1997-2#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-4#1)(2011-2#5)
30%-40%##2##1##(2008-12#1)(2009-7#1)
30) and##2##2##(1990-8#1)(2008-10#1)
30)##16##1##(1990-8#1)(1993-1#1)(1993-2#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-9#1)(2012-3#1)(2013-8#3)
30+##2##1##(1992-1#2)
30+/-0##3##1##(2008-10#3)
30+/-1##4##1##(2008-10#4)
30+/-2##2##1##(2008-10#2)
30- to##3##2##(1996-12#1)(1997-2#1)(2008-4#1)
30-##5##1##(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-4#1)
30-100##3##1##(1994-11#1)(2008-10#1)(2008-3#1)
30-120##2##1##(2008-10#1)(2008-6#1)
30-35% of##2##2##(1991-3#1)(2012-8#1)
30-4##3##1##(2008-10#3)
30-40##8##1##(1993-8#1)(1995-2#1)(1996-11#1)(2008-10#3)(2010-4#1)(2010-5#1)
30-40% of##3##2##(1990-11#1)(1993-3#1)(1995-8#1)
30-40%##5##1##(1990-11#1)(1993-3#1)(1995-8#1)(2011-2#1)(2013-8#1)
30-41 and 120-145##2##3##(1995-12#2)
30-50% of##3##2##(1996-11#1)(1996-6#1)(2010-1#1)
30-50%##6##1##(1995-2#1)(1996-11#1)(1996-6#1)(2008-5#1)(2010-1#1)(2012-2#1)
30-60 min##2##2##(1996-2#1)(2008-10#1)
30-60 years##2##2##(1995-8#1)(2012-2#1)
30-60##5##1##(1995-8#1)(1996-2#1)(2008-10#2)(2012-2#1)
30-70%##2##1##(1997-4#1)(2008-10#1)
30-cm##2##1##(2008-10#1)(2008-3#1)
30-cm-diameter##2##1##(2008-2#2)
30-day mortality##2##2##(2010-6#1)(2011-3#1)
30-day period##3##2##(1990-8#1)(2008-10#2)
30-day##10##1##(1990-8#1)(1995-2#1)(2008-10#4)(2008-7#1)(2010-6#1)(2011-3#1)(2013-1#1)
30-fold##3##1##(1995-11#1)(1995-3#1)(2008-10#1)
30-kDa enzyme from red blood cells##2##6##(1994-11#2)
30-kDa enzyme##3##2##(1994-11#3)
30-kDa##5##1##(1994-11#3)(1995-2#1)(2008-10#1)
30-m##2##1##(2008-10#2)
30-mer ODNs##2##2##(2008-10#2)
30-mer##3##1##(2008-10#3)
30-min##4##1##(1993-6#2)(2008-10#1)(2010-12#1)
30-mm/h##2##1##(2008-10#2)
30-year##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
300 000##3##2##(2008-10#3)
300 K##2##2##(2008-10#1)(2008-3#1)
300 and 450 mW/cm2##2##4##(1993-8#2)
300 and##9##2##(1993-8#2)(2008-10#6)(2011-10#1)
300 bp##5##2##(1995-12#2)(1995-9#1)(1996-3#1)(2008-12#1)
300 cases of##2##3##(2008-10#1)(2008-7#1)
300 cases##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
300 degrees C##5##3##(2008-10#4)(2010-4#1)
300 mOsm##3##2##(2008-11#3)
300 mg##15##2##(1990-2#1)(1990-9#3)(1991-3#2)(1992-11#1)(1993-2#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)
300 mg%##2##2##(2008-10#2)
300 micrograms##2##2##(1992-3#1)(1996-2#1)
300 million##2##2##(2012-12#1)(2012-2#1)
300 ml##2##2##(2008-10#2)
300 ms##2##2##(1997-2#1)(2008-11#1)
300 muM##2##2##(2008-11#2)
300 mul##2##2##(2008-10#2)
300 patients##3##2##(1993-6#1)(2008-11#2)
300 s##2##2##(2008-10#2)
300 times##3##2##(2008-10#2)(2009-5#1)
300 to##4##2##(1992-9#1)(2008-10#2)(2008-3#1)
300##146##1##(1990-12#1)(1990-2#1)(1990-9#4)(1991-3#3)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#55)(2008-11#20)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
300)##2##1##(1997-1#1)(2008-11#1)
300-400##2##1##(1991-2#1)(2008-10#1)
300-500##2##1##(2010-8#1)(2011-2#1)
300-fold##2##1##(1990-8#1)(2008-10#1)
300-m##2##1##(2008-3#2)
3000 cases##2##2##(2007-12#1)(2012-3#1)
3000 ppm##2##2##(1990-5#1)(2008-10#1)
3000##18##1##(1990-5#1)(1990-8#1)(1992-12#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
300mg gallic acid per liter##2##5##(2008-10#2)
300mg##3##1##(2008-10#3)
300nm##2##1##(2008-10#2)
301 and##2##2##(2008-10#2)
301 var##3##2##(2008-12#3)
301##18##1##(1997-2#1)(2008-10#9)(2008-12#8)
301)##2##1##(2008-10#2)
302##5##1##(1996-8#1)(2008-10#3)(2008-11#1)
303##8##1##(2008-1#1)(2008-10#4)(2008-5#1)(2010-12#1)(2013-8#1)
304##7##1##(1990-5#1)(1992-9#1)(1997-2#1)(2008-1#1)(2008-11#1)(2009-11#1)(2011-2#1)
305##6##1##(1993-12#1)(2008-10#2)(2008-5#2)(2008-8#1)
306##8##1##(1993-8#1)(2008-10#4)(2010-1#1)(2011-2#1)(2012-3#1)
307##7##1##(1997-8#1)(2008-10#2)(2008-5#3)(2012-12#1)
308##5##1##(1996-3#1)(2008-10#2)(2011-2#1)(2012-12#1)
309##5##1##(2008-10#2)(2010-8#1)(2012-2#1)(2013-1#1)
30Gy/10##2##1##(2008-10#2)
30K##2##1##(1997-3#2)
30h(-1)##3##1##(2008-10#3)
30mM##3##1##(2008-10#3)
30mg##2##1##(2008-10#2)
30mgL(-1)##2##1##(2008-10#2)
30min##15##1##(2007-12#1)(2008-10#14)
30mug##3##1##(2008-10#1)(2010-7#2)
30mugl(-1)##3##1##(2008-10#3)
30mum##2##1##(2008-10#2)
30s and##4##2##(2008-10#4)
30s##13##1##(1994-1#2)(2008-10#10)(2008-8#1)
30th day of##2##3##(2008-12#1)(2012-3#1)
30th day##3##2##(2008-12#1)(2008-7#1)(2012-3#1)
30th##9##1##(1995-8#1)(2008-12#2)(2008-5#2)(2008-7#1)(2011-2#1)(2011-4#1)(2012-3#1)
30 years##4##1##(2011-2#1)(2012-2#3)
30°C##7##1##(2011-2#7)
31 +/- 0##2##3##(1994-5#1)(2010-4#1)
31 +/-##5##2##(1991-5#1)(1994-5#1)(1996-2#1)(1997-1#1)(2010-4#1)
31 and##5##2##(2008-10#3)(2010-10#1)(2013-1#1)
31 cases##2##2##(1993-9#1)(2008-5#1)
31 days##3##2##(2008-10#3)
31 degrees C for##2##4##(2008-11#2)
31 degrees C##6##3##(2008-10#2)(2008-11#3)(2008-5#1)
31 degrees##7##2##(2008-10#2)(2008-11#3)(2008-5#1)(2013-1#1)
31 kDa##2##2##(1990-5#1)(1993-8#1)
31 patients and##2##3##(2008-11#1)(2011-2#1)
31 patients with##2##3##(1990-6#1)(2008-5#1)
31 patients##8##2##(1990-2#1)(1990-6#1)(1991-8#1)(1992-1#1)(1996-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
31 strains##2##2##(2008-10#2)
31 to 0##2##3##(2008-10#1)(2012-2#1)
31 to##6##2##(1990-12#1)(2007-12#1)(2008-10#3)(2012-2#1)
31 years##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
31##149##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-8#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-5#3)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#42)(2008-11#7)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-1#1)(2009-6#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-4#2)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#2)
31% of the##4##3##(1990-2#1)(1994-2#1)(2008-10#2)
31% of##8##2##(1990-2#1)(1994-2#1)(2008-10#4)(2008-11#1)(2013-8#1)
31%##23##1##(1990-2#1)(1990-9#1)(1993-3#1)(1994-2#1)(1994-8#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-9#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-8#2)
31%)##3##1##(2008-10#1)(2009-4#1)(2011-2#1)
31)##5##1##(1996-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
310##10##1##(1995-12#1)(1997-7#1)(2008-10#6)(2008-5#2)
311##6##1##(1990-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-6#1)
311-2##2##1##(2008-11#2)
312##9##1##(1993-12#1)(2008-10#4)(2010-10#1)(2010-4#1)(2011-2#2)
3125##2##1##(2008-7#2)
313##4##1##(1991-12#1)(1991-6#1)(2008-8#1)(2009-7#1)
314 kg/ha##2##2##(2008-10#2)
314##6##1##(2008-10#5)(2011-2#1)
315##9##1##(1992-9#1)(2008-10#5)(2008-11#2)(2008-8#1)
316##4##1##(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
317##7##1##(1991-7#1)(2008-10#1)(2008-11#1)(2012-2#3)(2013-8#1)
318##3##1##(2008-10#1)(2008-3#1)(2008-7#1)
319##3##1##(1992-9#1)(1994-11#1)(2008-4#1)
31P magnetic resonance spectroscopy##2##4##(1994-2#1)(2008-11#1)
31P##6##1##(1994-2#4)(2008-11#1)(2010-8#1)
31P-NMR##3##1##(1990-8#2)(1994-3#1)
31st##3##1##(2008-1#1)(2011-2#1)(2013-8#1)
32 +/- 0##2##3##(2008-12#2)
32 +/-##4##2##(1996-2#1)(2008-10#1)(2008-12#2)
32 and 0##2##3##(2008-10#1)(2008-3#1)
32 and##12##2##(1995-8#1)(1996-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2013-8#2)
32 cases##2##2##(1993-8#1)(2008-12#1)
32 degrees C##19##3##(1991-2#3)(2008-10#11)(2008-11#3)(2008-5#2)
32 degrees C)##4##3##(2008-10#1)(2008-11#2)(2010-4#1)
32 degrees##24##2##(1991-2#3)(2008-10#12)(2008-11#5)(2008-5#2)(2008-8#1)(2010-4#1)
32 different##3##2##(1995-6#1)(2008-10#1)(2013-8#1)
32 is##2##2##(1997-3#1)(2008-10#1)
32 kDa##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
32 mg l(-1)##2##3##(2008-10#2)
32 mg##3##2##(2008-10#2)(2008-12#1)
32 microM##4##2##(1991-5#1)(1994-8#1)(2008-10#2)
32 months##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
32 ng ml(-1) for##2##4##(2008-10#2)
32 ng ml(-1)##3##3##(2008-10#3)
32 ng##5##2##(2008-10#5)
32 of##3##2##(1990-5#1)(1997-8#1)(2008-10#1)
32 patients with##4##3##(1995-2#1)(1997-4#1)(2008-10#2)
32 patients##9##2##(1994-3#1)(1995-2#1)(1996-3#2)(1997-4#1)(2008-10#3)(2011-2#1)
32 per##2##2##(1990-12#1)(1992-2#1)
32 percent##2##2##(1993-3#1)(1996-3#1)
32 primary##2##2##(1994-12#1)(2008-11#1)
32 samples of##2##3##(2008-10#1)(2008-11#1)
32 samples##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
32 times##2##2##(2008-10#1)(2012-3#1)
32 to##3##2##(2008-10#2)(2008-11#1)
32 was##2##2##(2008-10#1)(2008-9#1)
32 weeks##3##2##(1991-6#1)(2008-10#1)(2013-1#1)
32 years##3##2##(1996-8#1)(2008-7#1)(2013-1#1)
32##220##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#4)(1997-8#4)(2007-8#1)(2008-1#2)(2008-10#74)(2008-11#13)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#6)(2013-8#8)
32% and##2##2##(1997-6#1)(2012-2#1)
32% in##2##2##(1996-9#1)(2012-3#1)
32% of the##4##3##(2008-10#3)(2008-5#1)
32% of##8##2##(1992-1#1)(2008-10#5)(2008-5#2)
32% were##2##2##(2008-10#1)(2010-8#1)
32%##29##1##(1990-3#1)(1992-1#1)(1992-3#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-6#1)(2008-10#16)(2008-5#2)(2009-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
32%)##4##1##(2008-10#2)(2008-7#1)(2011-2#1)
32)##7##1##(1993-11#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)
32+/-0##3##1##(2008-10#2)(2008-8#1)
32- and##2##2##(1995-6#1)(2006-6#1)
32-##5##1##(1995-6#1)(2006-6#1)(2008-10#2)(2013-1#1)
32-0##2##1##(2008-10#1)(2008-3#1)
32-40##2##1##(1995-3#1)(2008-10#1)
32-fold range of##2##3##(1994-8#1)(2010-3#1)
32-fold##3##1##(1994-8#1)(2008-10#1)(2010-3#1)
32-kDa##4##1##(1992-4#1)(1994-11#1)(2008-10#2)
32-year-old man presenting with##2##4##(2012-12#1)(2012-3#1)
32-year-old man with##2##3##(2009-1#1)(2011-2#1)
32-year-old man##5##2##(2009-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
32-year-old##11##1##(1995-12#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
320 nm##3##2##(1991-3#1)(2008-10#1)(2012-2#1)
320##18##1##(1991-2#1)(1991-3#1)(1992-6#1)(1996-8#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#2)(2012-2#1)
320)##2##1##(2008-10#1)(2008-11#1)
3200##2##1##(2011-2#1)(2012-9#1)
320937##2##1##(2008-10#2)
321##4##1##(1992-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
322##2##1##(1995-6#1)(2011-2#1)
323##4##1##(1994-6#1)(2008-10#2)(2008-7#1)
324 nm##2##2##(2008-10#2)
324##8##1##(1995-11#1)(1997-3#1)(2008-10#4)(2008-7#2)
3243A&gt##5##1##(2013-8#5)
325##3##1##(2008-10#1)(2008-3#1)(2013-8#1)
326##3##1##(2008-10#2)(2010-5#1)
327 microm##2##2##(2007-12#2)
327##6##1##(2007-12#2)(2008-10#2)(2011-2#2)
328##8##1##(1992-3#1)(1993-3#1)(1997-3#1)(2008-10#2)(2010-11#1)(2010-12#1)(2010-3#1)
329 +/-##2##2##(1992-10#1)(2009-8#1)
329##9##1##(1992-10#2)(1996-6#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
32D cells##3##2##(1997-7#3)
32D##4##1##(1997-7#4)
32P incorporation##2##2##(1997-1#1)(1997-2#1)
32P##3##1##(1996-2#1)(1997-1#1)(1997-2#1)
32P-labeled##3##1##(1995-2#2)(1995-6#1)
32P-labelled##2##1##(1994-6#1)(1996-2#1)
32nd##3##1##(1996-11#1)(2008-8#2)
33 +/-##4##2##(1995-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
33 V##2##2##(2008-10#1)(2009-9#1)
33 abattoir workers##2##3##(2011-2#2)
33 amino##2##2##(1993-3#1)(1996-3#1)
33 and##9##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
33 cases##3##2##(1991-11#2)(2008-10#1)
33 degrees C##3##3##(2008-11#3)
33 degrees##4##2##(2008-11#3)(2008-9#1)
33 different##2##2##(2008-10#1)(2008-7#1)
33 in##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
33 mg##2##2##(2008-10#1)(2008-11#1)
33 mug##3##2##(2008-10#3)
33 mugl(-1) for##2##3##(2008-10#2)
33 patients with##2##3##(2008-7#2)
33 patients##4##2##(1991-9#2)(2008-7#2)
33 to##4##2##(2008-10#3)(2008-5#1)
33 weeks##2##2##(2008-7#1)(2013-1#1)
33 x##3##2##(2008-10#2)(2008-11#1)
33 years##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
33 years)##2##2##(1996-3#1)(2008-5#1)
33##180##1##(1990-2#1)(1990-6#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1993-12#1)(1993-3#1)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-6#4)(1996-12#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-5#1)(2007-12#3)(2008-1#1)(2008-10#60)(2008-11#10)(2008-12#5)(2008-3#2)(2008-5#4)(2008-7#9)(2008-8#2)(2008-9#7)(2009-10#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#4)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#7)(2013-8#1)
33% in##2##2##(1994-12#1)(2008-10#1)
33% of patients##2##3##(1990-3#1)(2011-2#1)
33% of the##4##3##(1990-5#1)(2008-10#2)(2008-12#1)
33% of##11##2##(1990-3#1)(1990-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#1)(2011-3#1)
33%##35##1##(1990-3#2)(1990-5#1)(1990-6#1)(1991-2#2)(1994-12#2)(1994-6#1)(1994-8#2)(1995-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-5#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-7#1)
33%)##7##1##(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#2)(2013-7#2)
33)##11##1##(1994-3#1)(1994-5#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
33-6##2##1##(2008-10#1)(2009-5#1)
33-year-old##2##1##(1997-5#1)(2008-7#1)
330##13##1##(1991-11#2)(1995-8#1)(1997-8#1)(2008-10#8)(2012-3#1)
3300##2##1##(1996-6#1)(2008-10#1)
331 patients##3##2##(1990-2#1)(1990-9#1)(2012-2#1)
331##4##1##(1990-2#1)(1990-9#1)(2008-10#1)(2012-2#1)
332##16##1##(1994-3#1)(2008-10#2)(2008-3#1)(2013-8#12)
333##6##1##(1992-10#1)(1994-11#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
334##9##1##(1992-5#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-12#1)
335##3##1##(1991-2#1)(2008-10#1)(2008-11#1)
336 K##2##2##(1992-10#2)
336##11##1##(1990-11#1)(1992-10#2)(1993-12#1)(2008-10#5)(2010-1#1)(2013-1#1)
337##10##1##(1991-9#1)(1993-12#2)(2008-10#3)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)
338##3##1##(1996-1#1)(2008-9#1)(2010-11#1)
339##7##1##(1991-2#2)(2008-10#2)(2009-5#1)(2011-1#1)(2011-2#1)
34 +/- 0##2##3##(1994-6#1)(1996-2#1)
34 +/-##4##2##(1994-6#1)(1996-2#1)(2008-10#1)(2009-8#1)
34 and 0##3##3##(2008-10#3)
34 and##4##2##(2008-10#4)
34 degrees C##2##3##(2008-11#2)
34 kDa##6##2##(2008-10#1)(2008-11#1)(2009-7#4)
34 nucleotides##2##2##(1990-8#1)(1994-11#1)
34 of##4##2##(1990-5#1)(1997-8#1)(2008-10#1)(2009-10#1)
34 patients##6##2##(1990-6#1)(2008-7#2)(2011-2#2)(2012-5#1)
34 percent##3##2##(1995-2#1)(1995-3#1)(1997-1#1)
34 to##2##2##(2008-10#2)
34 years##3##2##(2007-8#1)(2008-7#1)(2008-9#1)
34##140##1##(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(1997-9#1)(2007-8#1)(2008-10#41)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#6)(2009-10#1)(2009-7#4)(2009-8#2)(2010-1#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#4)
34% of##2##2##(1994-12#1)(2011-2#1)
34%##13##1##(1994-11#1)(1994-12#1)(1995-10#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)
34%)##3##1##(2008-10#2)(2008-12#1)
34)##5##1##(1990-8#1)(2008-10#1)(2008-12#1)(2010-4#1)(2013-8#1)
34-39##2##1##(2008-11#1)(2008-9#1)
340##12##1##(1993-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#5)(2008-11#2)
341##5##1##(1991-6#1)(1993-3#2)(2008-10#1)(2010-11#1)
342##3##1##(1994-11#1)(1997-8#1)(2008-8#1)
343##3##1##(1994-11#1)(2008-10#1)(2012-3#1)
344##14##1##(1990-3#1)(1990-6#3)(1990-8#1)(1992-12#2)(1994-3#3)(1994-5#2)(2008-7#1)(2013-1#1)
345##6##1##(2008-10#4)(2011-2#2)
346##8##1##(2008-10#4)(2008-11#2)(2008-9#1)(2011-1#1)
347##6##1##(1992-4#1)(1993-12#1)(1997-6#1)(2010-7#2)(2011-2#1)
348##4##1##(2008-10#2)(2008-3#1)(2013-1#1)
349##3##1##(1997-8#1)(2008-11#1)(2008-5#1)
34th##2##1##(1997-8#1)(2008-11#1)
35 DPI##3##2##(2008-10#3)
35 Ncm##3##2##(2013-1#3)
35 amino##3##2##(1997-4#1)(2008-6#1)(2010-10#1)
35 and 0##2##3##(2008-10#1)(2008-11#1)
35 and 36##3##3##(2008-10#2)(2008-11#1)
35 and##17##2##(1990-6#1)(1990-8#1)(1993-12#1)(1995-6#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-9#1)(2010-4#1)(2013-1#1)
35 days##2##2##(2008-10#1)(2008-12#1)
35 degrees C and##4##4##(2008-10#4)
35 degrees C##30##3##(2008-10#26)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
35 degrees##32##2##(2008-10#28)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
35 high risk patients on##2##5##(2010-10#2)
35 in##4##2##(1990-6#1)(1996-3#1)(2008-8#1)(2010-2#1)
35 kDa##5##2##(1996-6#1)(1997-8#1)(2008-10#3)
35 ku##3##2##(2008-8#1)(2008-9#2)
35 mM sodium##2##3##(2008-10#2)
35 mM##3##2##(1993-8#1)(2008-10#2)
35 mM)##2##2##(2008-10#2)
35 medulloblastomas##2##2##(1991-2#2)
35 min##2##2##(2008-10#2)
35 mm##2##2##(2008-10#2)
35 pathosystems##2##2##(2008-10#2)
35 patients with##3##3##(1990-3#1)(1990-9#1)(2008-9#1)
35 patients##8##2##(1990-3#1)(1990-9#2)(1991-3#1)(2008-9#2)(2011-2#1)(2012-4#1)
35 percent of##4##3##(1991-12#1)(1994-2#1)(1994-3#1)(1997-1#1)
35 to 0##2##3##(2008-10#2)
35 to##7##2##(2008-10#6)(2008-7#1)
35 x##4##2##(1995-11#1)(2008-10#3)
35 years of age##4##4##(2008-10#2)(2012-3#2)
35 years of##5##3##(2008-10#2)(2012-3#3)
35 years##15##2##(1991-3#1)(1992-3#1)(1995-11#1)(2008-10#5)(2010-8#1)(2012-12#1)(2012-3#5)
35##276##1##(1990-2#1)(1990-3#4)(1990-6#3)(1990-8#2)(1990-9#3)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#2)(1991-8#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-11#2)(1995-2#3)(1995-6#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#2)(1997-8#3)(2008-10#123)(2008-11#6)(2008-12#6)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#12)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#4)(2010-8#2)(2011-2#11)(2012-12#5)(2012-2#3)(2012-3#10)(2012-4#1)(2013-1#6)(2013-8#2)
35% and##2##2##(2008-8#1)(2012-2#1)
35% of the##7##3##(1990-5#1)(1995-2#1)(1997-2#1)(2008-10#3)(2009-8#1)
35% of total##2##3##(2008-10#1)(2009-3#1)
35% of##15##2##(1990-5#2)(1995-2#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2009-3#1)(2009-8#1)
35% with respect to##2##4##(2007-12#1)(2008-10#1)
35%##39##1##(1990-5#2)(1992-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
35%)##4##1##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
35)##7##1##(1993-1#1)(1993-12#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)
35- to##2##2##(2008-10#1)(2008-11#1)
35-0##2##1##(1991-8#1)(2008-7#1)
35-39##2##1##(1990-6#1)(2008-12#1)
35-45##2##1##(1990-5#1)(1993-12#1)
35-fold##3##1##(1990-10#1)(1992-3#1)(2008-10#1)
35-min##2##1##(1993-6#1)(2009-11#1)
35-mm##2##1##(1995-11#1)(2008-11#1)
35-year-old##4##1##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
350 g##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
350 h##2##2##(2008-11#1)(2008-2#1)
350 kb and##2##3##(1996-12#1)(1997-2#1)
350 nm##2##2##(1991-5#1)(2008-10#1)
350 ppm##2##2##(2008-10#2)
350 to##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
350##38##1##(1991-5#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-7#3)(2011-2#2)(2012-2#1)(2013-1#2)
3500##2##1##(1993-3#1)(2008-5#1)
351##7##1##(1990-9#1)(1992-9#1)(1994-12#1)(1996-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
352##4##1##(1992-10#1)(2008-10#3)
353##2##1##(1995-2#1)(2011-2#1)
354##2##1##(1991-9#1)(2008-2#1)
355 and##2##2##(2008-3#1)(2012-2#1)
355 nm##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
355##14##1##(1997-7#1)(2008-10#6)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#2)
357##9##1##(1995-6#1)(2008-1#1)(2008-10#2)(2008-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
358##5##1##(1990-11#1)(1993-2#1)(2008-12#1)(2010-2#1)(2013-1#1)
359##7##1##(1991-5#1)(1992-3#1)(1995-8#1)(2008-5#1)(2011-2#2)(2012-12#1)
35S promoter and terminator##2##4##(2008-8#2)
35S promoter##10##2##(1997-8#1)(2008-10#2)(2008-8#3)(2008-9#2)(2009-8#1)(2011-10#1)
35S##12##1##(1990-5#2)(1997-8#1)(2008-10#2)(2008-8#3)(2008-9#2)(2009-8#1)(2011-10#1)
35S-labelled##2##1##(1995-11#1)(1996-2#1)
35V##2##1##(2008-10#2)
35min##3##1##(2008-10#3)
35mugl(-1)##2##1##(2008-10#2)
35s##2##1##(2008-10#2)
35 min##2##1##(2013-1#2)
36 +/- 0##4##3##(2008-11#2)(2011-2#1)(2013-1#1)
36 +/-##7##2##(1990-5#1)(1991-5#1)(2008-11#2)(2008-3#1)(2011-2#1)(2013-1#1)
36 V##3##2##(2008-10#1)(2009-9#2)
36 and 48##3##3##(1991-8#1)(2008-10#1)(2008-12#1)
36 and##10##2##(1991-8#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-12#2)(2008-8#1)(2011-2#1)
36 cases##2##2##(2008-10#1)(2011-2#1)
36 days##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
36 degrees C##7##3##(2008-10#7)
36 for##3##2##(2008-10#3)
36 h after inoculation##3##4##(2008-10#2)(2008-11#1)
36 h after##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
36 h at##2##3##(2008-10#2)
36 h of##2##3##(2008-10#1)(2008-9#1)
36 h##14##2##(1996-12#1)(2008-10#10)(2008-11#1)(2008-8#1)(2008-9#1)
36 h(-1)##2##2##(2008-10#2)
36 isolates of##2##3##(2008-10#1)(2011-2#1)
36 isolates##4##2##(2008-10#3)(2011-2#1)
36 kDa##2##2##(1994-8#1)(1995-6#1)
36 kDa)##2##2##(2011-2#2)
36 mg##2##2##(2008-10#2)
36 months of##2##3##(1995-1#1)(2012-2#1)
36 months##6##2##(1990-6#1)(1995-1#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
36 of##2##2##(1995-12#1)(2013-1#1)
36 patients with##2##3##(2008-7#2)
36 patients##7##2##(1995-10#1)(1997-5#1)(1997-8#1)(2008-7#3)(2011-2#1)
36 samples##2##2##(2008-10#2)
36 to 0##2##3##(2008-10#1)(2008-11#1)
36 to##8##2##(2008-10#3)(2008-11#2)(2008-12#2)(2011-2#1)
36 was##2##2##(2008-10#1)(2013-1#1)
36 women##2##2##(1994-2#1)(2013-1#1)
36##220##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-2#2)(1993-3#2)(1994-11#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-3#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#87)(2008-11#13)(2008-12#7)(2008-2#2)(2008-3#2)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#17)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#9)
36% and##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
36% for##2##2##(2008-10#1)(2008-5#1)
36% in##2##2##(2008-10#1)(2008-2#1)
36% of the##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
36% of##8##2##(1991-8#1)(1991-9#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
36%##30##1##(1990-2#2)(1991-8#1)(1991-9#1)(1993-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-1#1)(2011-2#4)
36%)##4##1##(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
36) and##2##2##(2010-9#1)(2013-1#1)
36)##6##1##(2008-10#1)(2009-12#1)(2010-7#2)(2010-9#1)(2013-1#1)
36+/-0##2##1##(2008-10#1)(2009-7#1)
36-0##2##1##(1997-8#1)(2008-10#1)
36-2##4##1##(2008-10#3)(2011-2#1)
36-residue peptide##2##2##(1995-2#2)
36-year-old man##2##2##(2010-6#1)(2012-3#1)
36-year-old##5##1##(2009-11#1)(2010-6#2)(2011-2#1)(2012-3#1)
360 and##4##2##(2008-10#4)
360 degrees##2##2##(2008-3#2)
360 nm and##2##3##(1996-2#1)(2008-10#1)
360 nm##5##2##(1993-2#1)(1996-2#1)(2008-10#2)(2008-5#1)
360##28##1##(1990-9#1)(1992-12#1)(1993-2#1)(1993-8#2)(1996-2#1)(2008-10#17)(2008-3#2)(2008-5#3)
360nm##3##1##(2008-10#3)
361##5##1##(1991-11#1)(2008-10#2)(2008-11#1)(2012-2#1)
362##2##1##(1994-2#1)(2008-10#1)
363##5##1##(1991-11#1)(1994-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
364##3##1##(2008-10#3)
365 days##2##2##(1990-12#2)
365 nm##5##2##(1993-8#2)(2008-10#2)(2009-11#1)
365##11##1##(1990-12#2)(1993-8#2)(2008-10#3)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)
365)##3##1##(2008-10#3)
366 mOsmol kg-1 was##2##4##(2008-11#2)
366 mOsmol kg-1##4##3##(2008-11#4)
366 mOsmol##5##2##(2008-11#5)
366##8##1##(1992-10#1)(2008-10#1)(2008-11#5)(2008-7#1)
367##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
368##4##1##(1996-11#1)(2008-10#2)(2008-5#1)
368)##2##1##(1991-2#1)(2010-10#1)
369##3##1##(1995-6#1)(2008-11#1)(2011-2#1)
369)##3##1##(2008-10#3)
36c##2##1##(1996-5#2)
37 +/-##2##2##(1990-5#1)(1994-5#1)
37 and##2##2##(1993-2#1)(2013-8#1)
37 degrees C and##7##4##(1990-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-1#1)
37 degrees C##73##3##(1990-12#1)(1991-12#1)(1991-2#4)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-3#1)(1994-8#3)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#3)(1997-1#1)(2008-10#13)(2008-11#16)(2008-5#10)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)
37 degrees C)##7##3##(1990-12#1)(1992-3#2)(2008-10#3)(2008-11#1)
37 degrees C-grown C##2##4##(2008-5#2)
37 degrees C-grown##3##3##(2008-5#3)
37 degrees##85##2##(1990-12#2)(1991-12#1)(1991-2#4)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-3#1)(1994-8#4)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#3)(1997-1#1)(2008-10#17)(2008-11#17)(2008-5#13)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)
37 different##2##2##(2008-10#2)
37 for##2##2##(2008-10#2)
37 kDa##2##2##(1996-2#2)
37 microM##2##2##(1990-2#1)(1996-2#1)
37 mm##2##2##(2008-10#1)(2008-7#1)
37 of##3##2##(1994-1#1)(2008-10#2)
37 patients were##2##3##(2008-11#1)(2008-7#1)
37 patients##6##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#2)
37 to 2##2##3##(1996-2#1)(2008-10#1)
37 to##10##2##(1992-9#1)(1996-2#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-7#1)
37 weeks##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
37 weeks' gestation##3##3##(2007-12#1)(2011-2#2)
37##217##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#5)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-8#3)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#3)(1996-12#3)(1996-2#7)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-12#2)(2008-1#1)(2008-10#48)(2008-11#28)(2008-12#3)(2008-3#1)(2008-5#17)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#2)(2010-1#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#3)
37% for##4##2##(2007-12#1)(2008-10#3)
37% in##4##2##(1992-8#1)(1994-8#1)(2008-10#1)(2011-1#1)
37% of patients##2##3##(2008-7#1)(2013-1#1)
37% of the patients##2##4##(1991-2#1)(1994-3#1)
37% of the##3##3##(1991-2#1)(1994-3#1)(1997-8#1)
37% of##10##2##(1990-6#1)(1991-2#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-6#1)(1997-8#1)(2008-7#1)(2012-3#1)(2013-1#1)
37%##34##1##(1990-6#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
37%)##4##1##(1990-3#1)(1992-2#1)(2007-8#1)(2011-2#1)
37)##2##1##(1990-2#1)(1997-2#1)
37-amino acid peptide##2##3##(1992-6#2)
37-amino acid##3##2##(1992-6#3)
37-year-old female##2##2##(1997-6#1)(2008-12#1)
37-year-old male##2##2##(2011-2#1)(2013-1#1)
37-year-old woman##2##2##(1991-3#1)(2013-7#1)
37-year-old##7##1##(1991-3#1)(1997-6#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
370 and##2##2##(2008-10#1)(2008-11#1)
370##10##1##(1996-12#1)(1996-3#1)(1997-7#1)(2008-10#6)(2008-11#1)
371##2##1##(2010-11#1)(2012-3#1)
372##3##1##(2010-8#1)(2013-1#1)(2013-8#1)
373##2##1##(1996-5#1)(1997-8#1)
374##2##1##(2008-8#1)(2011-2#1)
375 amino##2##2##(1996-3#1)(1997-7#1)
375##9##1##(1992-3#1)(1994-6#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#1)
376##3##1##(1990-5#1)(1997-3#1)(2008-10#1)
377##4##1##(2008-10#3)(2008-9#1)
378##4##1##(1990-2#1)(2008-10#2)(2008-12#1)
379##3##1##(1990-2#1)(1996-2#1)(2009-10#1)
37ºC##2##1##(2013-1#2)
38 +/- 0##2##3##(1991-5#1)(2008-1#1)
38 +/-##3##2##(1991-5#1)(2008-1#1)(2008-3#1)
38 and##4##2##(2008-10#3)(2013-1#1)
38 degrees C##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
38 degrees##5##2##(1994-12#1)(2008-10#2)(2008-12#1)(2011-2#1)
38 genes##2##2##(2011-2#2)
38 ku##4##2##(2008-9#4)
38 min##2##2##(1995-3#1)(2008-10#1)
38 mmol g(-1)##2##3##(2008-10#2)
38 mug##2##2##(2008-10#1)(2008-11#1)
38 patients##7##2##(2008-12#2)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
38 samples per##2##3##(2008-10#2)
38 to##2##2##(2008-10#1)(2011-2#1)
38 x##2##2##(2008-11#1)(2008-9#1)
38##159##1##(1990-2#2)(1990-3#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-5#1)(1992-6#1)(1993-1#3)(1993-12#1)(1993-8#1)(1994-1#5)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-1#3)(2008-10#44)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#7)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#11)(2009-3#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#1)
38% and##3##2##(1991-8#1)(2008-10#1)(2012-3#1)
38% for##2##2##(1997-2#1)(2008-10#1)
38% in##4##2##(2008-10#3)(2008-7#1)
38% of the total##2##4##(2008-7#1)(2011-2#1)
38% of the##4##3##(1990-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
38% of##8##2##(1990-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
38%##33##1##(1990-6#1)(1991-8#1)(1997-2#1)(1997-3#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)
38%)##3##1##(1996-1#1)(2008-9#1)(2011-2#1)
38) and##2##2##(2008-8#1)(2013-1#1)
38)##3##1##(2008-8#1)(2013-1#2)
38))(2)CO(3)##2##1##(2008-10#2)
38-year-old man##2##2##(1997-3#2)
38-year-old##5##1##(1997-3#2)(2008-12#1)(2008-7#1)(2011-2#1)
380##9##1##(1991-2#1)(1997-4#2)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
381##2##1##(1990-7#1)(2008-10#1)
382##15##1##(1991-9#1)(1993-8#1)(1996-6#1)(2008-10#9)(2008-7#3)
383##3##1##(1994-11#1)(1996-12#1)(2008-10#1)
38393##2##1##(1996-2#2)
384##2##1##(1993-8#1)(2008-10#1)
384)##2##1##(1993-8#1)(2013-1#1)
384-wells##2##1##(2008-10#2)
385 K##2##2##(2008-10#2)
385##10##1##(2008-10#9)(2008-11#1)
385)##2##1##(2008-10#1)(2008-11#1)
386)##2##1##(2008-10#1)(2012-3#1)
387##2##1##(2008-10#1)(2008-11#1)
388 g##2##2##(2008-10#1)(2008-12#1)
388##3##1##(2008-10#2)(2008-12#1)
389##6##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#1)
39 +/- 0##2##3##(2011-2#1)(2013-1#1)
39 +/- 1##2##3##(2008-12#1)(2011-3#1)
39 +/-##5##2##(2008-10#1)(2008-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
39 and 0##3##3##(2008-10#3)
39 and##13##2##(1990-5#1)(1992-4#1)(1996-2#1)(2008-10#7)(2008-7#1)(2008-9#1)(2013-1#1)
39 kDa##3##2##(2008-5#3)
39 microg/ml##2##2##(2008-5#2)
39 or##2##2##(2008-10#1)(2008-9#1)
39 patients##5##2##(1990-6#1)(1990-9#1)(1997-2#1)(1997-8#1)(2008-7#1)
39 pg##2##2##(2008-10#2)
39 to##4##2##(2008-10#4)
39 vs##2##2##(2008-10#1)(2013-1#1)
39 weeks and##2##3##(1996-11#1)(2008-9#1)
39 weeks##17##2##(1996-11#1)(2007-12#1)(2008-9#15)
39 years##2##2##(2009-5#1)(2010-3#1)
39##139##1##(1990-5#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-8#3)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#3)(2008-10#44)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#2)(2008-9#18)(2009-5#2)(2009-8#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)
39% of##3##2##(1997-8#1)(2009-4#1)(2011-1#1)
39%##14##1##(1991-12#1)(1991-3#1)(1994-11#1)(1994-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-4#1)(2011-1#1)(2011-2#2)(2012-3#1)
39)##7##1##(2008-10#4)(2012-3#2)(2013-8#1)
39-52##4##1##(1992-4#4)
39-WEEK DERMAL STUDIES IN Tg##2##5##(2008-9#2)
39-kDa##3##1##(1991-10#1)(1992-6#2)
39-year old##2##2##(1997-6#1)(2010-2#1)
390 isolates##2##2##(2008-10#2)
390 nm##2##2##(2008-10#2)
390##10##1##(2008-10#5)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
390nm##2##1##(2008-10#2)
391##4##1##(1991-9#1)(1996-12#1)(1997-8#2)
392##3##1##(2008-10#2)(2012-12#1)
393##4##1##(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
394##6##1##(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-3#1)
395##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
396##5##1##(1996-1#1)(2008-10#2)(2008-12#1)(2011-1#1)
397##3##1##(2008-10#2)(2011-2#1)
398##3##1##(1991-6#1)(2008-10#1)(2008-5#1)
398D97 and##3##2##(2008-10#3)
398D97##4##1##(2008-10#4)
399##3##1##(2008-5#3)
39K deletion##2##2##(1997-3#2)
39K##5##1##(1997-3#5)
39x10(5) l##2##2##(2008-10#2)
3A4##3##1##(1994-5#1)(2008-10#2)
3A6##2##1##(2011-1#2)
3B##3##1##(1996-12#1)(2008-10#2)
3BS##2##1##(2008-10#2)
3C##2##1##(1995-8#1)(2008-10#1)
3CaO##4##1##(2008-10#4)
3D PC##2##2##(1995-11#2)
3D cell culture within##2##4##(2011-2#2)
3D display##4##2##(1995-11#3)(2008-3#1)
3D image##3##2##(2008-3#1)(2008-9#1)(2010-12#1)
3D information##2##2##(2008-3#2)
3D interaction position##3##3##(2010-3#3)
3D object##4##2##(2007-12#1)(2008-3#3)
3D reconstruction of the##3##4##(2009-1#1)(2012-3#2)
3D reconstruction of##4##3##(2009-1#1)(2009-3#1)(2012-3#2)
3D reconstruction##6##2##(2009-1#2)(2009-3#1)(2012-3#3)
3D reconstructions##2##2##(2010-12#1)(2011-2#1)
3D retinal renderings##2##3##(2011-7#2)
3D retinal##3##2##(2011-7#3)
3D texture features##2##3##(2010-8#2)
3D texture##3##2##(2010-8#3)
3D##94##1##(1995-11#6)(1996-2#1)(2007-12#4)(2008-10#2)(2008-11#5)(2008-3#10)(2008-5#1)(2008-6#6)(2008-9#2)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#6)(2009-3#2)(2010-12#4)(2010-3#7)(2010-5#1)(2010-8#7)(2011-1#1)(2011-2#8)(2011-7#4)(2012-2#1)(2012-3#8)(2012-4#1)(2013-1#1)(2013-8#1)
3D-CTA is##2##2##(2008-7#2)
3D-CTA##4##1##(2008-7#4)
3D-QSAR##2##1##(2009-3#1)(2012-3#1)
3D5##2##1##(2008-8#2)
3E10##2##1##(1996-12#1)(2008-11#1)
3E9##3##1##(2008-11#3)
3G11##2##1##(2008-9#2)
3H and##2##2##(2008-10#2)
3H##7##1##(2008-10#7)
3H(2)O##2##1##(2008-10#2)
3H-labelled##2##1##(1990-5#1)(1993-8#1)
3H-thymidine incorporation##3##2##(1991-6#1)(1994-8#1)(1995-3#1)
3H-thymidine uptake##2##2##(1994-8#1)(1995-3#1)
3H-thymidine##6##1##(1991-6#1)(1994-8#2)(1995-3#2)(2008-7#1)
3He##2##1##(1990-12#1)(1996-9#1)
3JH alpha##2##2##(1992-4#2)
3M KCl##2##2##(2008-10#1)(2008-6#1)
3M##6##1##(1997-2#1)(2008-10#4)(2008-6#1)
3MC-induced##3##1##(1994-8#3)
3P##2##1##(2007-12#1)(2010-12#1)
3R##4##1##(1997-7#1)(2008-10#1)(2008-9#1)(2010-4#1)
3R)-ACPD##3##1##(1996-5#3)
3S##2##1##(2007-12#1)(2008-10#1)
3S-1##2##1##(2013-1#2)
3SR##2##1##(1997-6#2)
3T3 cells were##2##3##(1995-2#1)(2008-11#1)
3T3 cells##11##2##(1994-3#4)(1995-2#3)(2008-11#4)
3T3##14##1##(1992-7#1)(1994-3#4)(1994-8#1)(1995-2#3)(1997-1#1)(2008-11#4)
3T3-F442A cells##3##2##(1995-11#1)(2008-11#1)(2012-2#1)
3T3-F442A##4##1##(1995-11#1)(2008-11#2)(2012-2#1)
3T3-L1 adipocytes##6##2##(1993-8#2)(1995-8#4)
3T3-L1##7##1##(1993-8#2)(1995-8#4)(2008-11#1)
3V versus##2##2##(2008-10#2)
3V##3##1##(2008-10#3)
3]##5##1##(1997-3#1)(2008-10#1)(2008-5#3)
3]dioxole-6##2##1##(1996-5#2)
3a and##2##2##(2008-8#1)(2011-1#1)
3a##9##1##(1990-11#3)(1996-5#2)(2008-10#1)(2008-8#1)(2009-9#1)(2011-1#1)
3a-Ld##3##1##(2008-10#3)
3a-d##3##1##(1996-5#3)
3alpha-hydroxysteroid dehydrogenase##2##2##(2008-10#2)
3beta-HSD deficiency CAH##3##3##(2008-4#3)
3beta-HSD deficiency##4##2##(2008-4#4)
3beta-HSD##6##1##(2008-4#6)
3beta-hydroxysteroid dehydrogenase##2##2##(2008-4#2)
3c##2##1##(1996-5#2)
3delta) for##2##2##(2008-10#2)
3delta)##3##1##(2008-10#3)
3h after##2##2##(1994-11#1)(2008-10#1)
3h of##3##2##(2008-10#3)
3h##7##1##(1994-11#1)(2008-10#6)
3mM##2##1##(2008-10#2)
3mV per##2##2##(2008-10#2)
3mV/decade##2##1##(2008-10#2)
3mVdecade(-1)##2##1##(2008-10#2)
3mgkg(-1)##2##1##(2008-10#2)
3min##9##1##(2008-10#8)(2008-11#1)
3mm##2##1##(2008-12#2)
3moll(-1)##3##1##(2008-10#3)
3mu-1S##2##1##(2008-11#2)
3muM##2##1##(2008-10#2)
3mugl(-1) for##2##2##(2008-10#2)
3mugl(-1)##4##1##(2008-10#4)
3mugml(-1)##2##1##(2008-10#2)
3nM##2##1##(2008-10#2)
3ngml(-1)##6##1##(2008-10#6)
3p##2##1##(1993-5#1)(2009-9#1)
3pi/2##3##1##(2008-3#3)
3rd and 4th##3##3##(1992-9#1)(1994-11#1)(2008-12#1)
3rd and##4##2##(1992-9#1)(1994-11#1)(1995-8#1)(2008-12#1)
3rd instar##2##2##(2008-10#1)(2013-8#1)
3rd##27##1##(1990-9#2)(1991-3#1)(1991-8#2)(1992-9#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#1)(2013-8#1)
3s##6##1##(2008-10#5)(2008-11#1)
3sigma detection limit##5##3##(2008-10#5)
3sigma detection limits##3##3##(2008-10#3)
3sigma detection##8##2##(2008-10#8)
3sigma limit of detection##3##4##(2008-10#3)
3sigma##17##1##(2008-10#17)
3x10(-11)##2##1##(2008-10#2)
3x10(-3) mol l(-1)##2##3##(2008-10#2)
3x10(-3)##3##1##(2008-10#3)
3x10(-4)##2##1##(2008-10#2)
3x10(-5)##3##1##(2008-10#3)
3x10(-5)M##2##1##(2008-10#2)
3x10(-6) M##2##2##(2008-10#2)
3x10(-6)##4##1##(2008-10#4)
3x10(-7) M##3##2##(2008-10#3)
3x10(-7)##4##1##(2008-10#4)
3x10(-8) g ml(-1)##2##3##(2008-10#2)
3x10(-8)##4##1##(2008-10#4)
3x10(-9) mol l(-1)##2##3##(2008-10#2)
3x10(-9)##6##1##(2008-10#6)
3 years##2##1##(2010-10#1)(2013-1#1)
4 % of##2##3##(2008-9#1)(2012-12#1)
4 %##4##2##(2008-10#2)(2008-9#1)(2012-12#1)
4 %) and##2##3##(2012-12#2)
4 %)##7##2##(1997-8#1)(2012-12#5)(2013-1#1)
4 (26##2##2##(2013-7#2)
4 (3##2##2##(1997-8#1)(2011-2#1)
4 (5%)##2##2##(2008-10#1)(2011-2#1)
4 (95% confidence##2##3##(2008-11#1)(2013-8#1)
4 +/- 0##7##3##(1990-12#1)(1994-6#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-12#1)
4 +/- 1##6##3##(1992-2#1)(1996-12#1)(2008-12#1)(2009-8#2)(2013-1#1)
4 +/- 2##2##3##(1992-2#2)
4 +/- 3##4##3##(1993-8#1)(2009-8#1)(2011-2#2)
4 +/- 4##2##3##(2010-1#1)(2013-7#1)
4 +/- 5##2##3##(1992-10#1)(1995-8#1)
4 +/-##35##2##(1990-12#1)(1992-10#1)(1992-2#3)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-12#2)(2009-1#1)(2009-8#3)(2010-1#2)(2011-2#5)(2013-1#1)(2013-7#1)
4 -##2##2##(1993-8#1)(2008-12#1)
4 =##2##2##(1990-8#1)(2013-1#1)
4 M HCl##3##3##(2008-10#3)
4 M NaCl##2##3##(1990-5#1)(1994-5#1)
4 M##12##2##(1990-5#1)(1994-5#1)(2008-10#10)
4 V##7##2##(2008-10#7)
4 a##2##2##(1990-2#1)(2008-8#1)
4 and 0##8##3##(2008-10#7)(2009-2#1)
4 and 1##6##3##(1994-5#1)(2008-10#5)
4 and 10##3##3##(2008-10#2)(2008-9#1)
4 and 13##2##3##(2008-10#2)
4 and 2##9##3##(1991-12#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-3#1)
4 and 20 ng##2##4##(2008-10#2)
4 and 20##4##3##(2008-10#4)
4 and 3##2##3##(2008-10#2)
4 and 4##3##3##(2008-10#2)(2008-11#1)
4 and 5 weeks##2##4##(1990-5#1)(2013-8#1)
4 and 5##15##3##(1990-5#1)(1995-6#1)(1996-5#2)(2008-10#7)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
4 and 6 ml/kg body##2##5##(2008-10#2)
4 and 6##15##3##(1991-12#1)(1992-12#1)(2008-10#10)(2008-5#2)(2008-8#1)
4 and 7 were##2##4##(1997-2#2)
4 and 7##8##3##(1990-2#1)(1994-5#1)(1997-2#3)(2008-10#1)(2008-5#1)(2008-8#1)
4 and 8 mg L(-1))##2##5##(2008-12#2)
4 and 8##9##3##(1996-12#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
4 and at##2##3##(2008-10#2)
4 and the##3##3##(2008-10#2)(2008-12#1)
4 and##127##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#2)(1992-12#1)(1993-8#1)(1994-11#1)(1994-5#3)(1995-11#2)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#3)(1997-3#1)(1997-8#1)(2008-10#73)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
4 as##2##2##(1992-12#1)(1997-7#1)
4 beta-methyl group of substrate##2##5##(1992-3#2)
4 beta-methyl group of##3##4##(1992-3#3)
4 beta-methyl group##4##3##(1992-3#4)
4 billion##2##2##(1995-6#1)(2008-10#1)
4 by##3##2##(2008-10#3)
4 cDNA##2##2##(1993-3#1)(1995-11#1)
4 cM from##2##3##(2008-10#1)(2008-9#1)
4 cM##3##2##(2008-10#1)(2008-9#2)
4 cM)##4##2##(2008-10#4)
4 cases and##2##3##(1991-8#1)(2012-3#1)
4 cases in##2##3##(1996-11#1)(2013-1#1)
4 cases of##2##3##(1994-12#1)(2012-3#1)
4 cases with brain##2##4##(1991-2#2)
4 cases with##3##3##(1991-1#1)(1991-2#2)
4 cases##16##2##(1990-12#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-8#1)(1994-12#1)(1996-11#1)(2008-11#1)(2011-2#1)(2012-3#2)(2013-1#1)
4 classes##2##2##(1995-8#1)(2009-10#1)
4 clones are##2##3##(2008-9#2)
4 cm##6##2##(1991-3#1)(2008-12#1)(2008-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
4 cm(-1)##2##2##(2008-10#1)(2008-3#1)
4 dB##3##2##(2008-3#2)(2008-7#1)
4 days after inoculation##2##4##(2008-10#2)
4 days after##7##3##(1991-2#1)(1995-11#1)(2008-10#5)
4 days and##3##3##(1996-2#1)(2008-10#1)(2010-5#1)
4 days later##3##3##(2008-10#1)(2010-5#1)(2010-7#1)
4 days of treatment##2##4##(1995-2#1)(2008-10#1)
4 days of##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
4 days##29##2##(1990-2#1)(1991-12#1)(1991-2#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-5#2)(2010-5#2)(2010-7#1)
4 degrees C at##2##4##(1990-11#1)(1996-12#1)
4 degrees C##47##3##(1990-11#3)(1990-12#1)(1991-11#1)(1993-8#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(2007-12#1)(2008-10#24)(2008-11#4)(2008-5#2)(2008-8#3)(2008-9#1)
4 degrees##52##2##(1990-11#3)(1990-12#1)(1991-11#1)(1993-8#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(2007-12#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)
4 died##2##2##(1992-12#1)(1994-12#1)
4 different##3##2##(1991-3#1)(1996-2#1)(2008-10#1)
4 doses##2##2##(1994-2#1)(2008-10#1)
4 females##2##2##(2008-10#1)(2012-2#1)
4 fold higher than##2##4##(1993-8#1)(2011-2#1)
4 fold##4##2##(1992-8#1)(1993-8#1)(1996-12#1)(2011-2#1)
4 for##6##2##(1994-5#1)(2008-10#4)(2008-9#1)
4 from##3##2##(1993-12#1)(2008-10#1)(2009-10#1)
4 g##5##2##(1990-9#1)(2008-10#2)(2008-11#1)(2008-3#1)
4 genes##2##2##(2008-11#1)(2008-7#1)
4 groups##7##2##(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
4 h after angiotensin II stimulation##3##6##(1995-11#3)
4 h after inoculation##2##4##(2008-10#2)
4 h after the##2##4##(1994-5#1)(2008-11#1)
4 h after##12##3##(1994-5#1)(1995-11#3)(1997-2#2)(2008-10#4)(2008-11#1)(2008-9#1)
4 h and##2##3##(2008-10#2)
4 h at 37 degrees##2##5##(1990-12#2)
4 h at##3##3##(1990-12#2)(2008-5#1)
4 h of##3##3##(1995-12#1)(1997-2#1)(2008-10#1)
4 h post-infection##2##3##(1996-12#2)
4 h##45##2##(1990-12#2)(1991-5#1)(1991-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#5)(2008-10#13)(2008-11#2)(2008-5#1)(2008-9#2)(2013-1#3)
4 h)##2##2##(2008-10#1)(2012-2#1)
4 has##2##2##(1993-3#1)(2009-10#1)
4 hours after##2##3##(1992-5#1)(1993-8#1)
4 hours##4##2##(1992-5#1)(1993-8#1)(2011-2#1)(2012-2#1)
4 hr##4##2##(1995-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
4 hydrotropic agents##2##3##(2012-2#2)
4 in the##2##3##(1994-5#1)(2008-10#1)
4 in##13##2##(1991-3#1)(1991-8#1)(1993-3#1)(1994-5#1)(2008-10#4)(2008-5#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
4 is##3##2##(1992-4#1)(2009-7#1)(2009-8#1)
4 kb##5##2##(1996-12#1)(2008-10#2)(2008-8#2)
4 kcal/mol##2##2##(2008-11#2)
4 kg (SE##2##3##(1996-12#2)
4 kg##3##2##(1996-12#2)(2008-12#1)
4 knees were tested under##2##5##(2009-3#2)
4 l min(-1)##2##3##(2008-10#2)
4 l##3##2##(2008-10#2)(2011-2#1)
4 l/min##4##2##(2011-2#4)
4 m waveguide##2##3##(2008-10#2)
4 m##5##2##(2008-10#5)
4 mJ##2##2##(2007-12#1)(2008-3#1)
4 mL of##2##3##(1993-1#2)
4 mL##3##2##(1993-1#2)(2008-10#1)
4 mM##7##2##(1990-12#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-5#1)
4 mV per decade##2##4##(2008-10#2)
4 mV##3##2##(2008-10#3)
4 mers##2##2##(2008-10#2)
4 mg L(-1)##3##3##(2008-10#2)(2008-7#1)
4 mg g(-1) for##2##4##(2008-10#2)
4 mg l(-1)##4##3##(2008-10#3)(2008-11#1)
4 mg##15##2##(1993-2#1)(2008-10#9)(2008-11#3)(2008-7#1)(2008-9#1)
4 mg/dl##2##2##(1994-12#1)(2013-8#1)
4 mg/kg##2##2##(2008-10#2)
4 mg/liter##2##2##(2008-10#2)
4 mg/ml##2##2##(2008-10#1)(2008-5#1)
4 microM)##2##2##(1990-11#1)(1996-2#1)
4 microg##5##2##(2008-10#3)(2008-11#1)(2011-3#1)
4 microm)##2##2##(2008-3#1)(2008-8#1)
4 million##4##2##(1994-3#1)(1995-12#1)(1997-5#1)(2012-3#1)
4 min with##2##3##(2008-10#2)
4 min##15##2##(1994-8#2)(2008-10#11)(2008-7#1)(2013-1#1)
4 min)##2##2##(1993-1#1)(2008-10#1)
4 minutes##3##2##(1992-2#2)(2008-6#1)
4 ml##5##2##(1996-2#1)(2008-10#3)(2011-1#1)
4 mm and##2##3##(2009-7#1)(2013-1#1)
4 mm##6##2##(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2012-3#1)(2013-1#1)
4 mmol l(-1)##2##3##(2008-10#2)
4 mol l(-1)##2##3##(2008-10#2)
4 mol##5##2##(2008-10#4)(2008-9#1)
4 months after treatment##4##4##(2013-1#4)
4 months after##7##3##(2008-7#1)(2010-5#1)(2013-1#5)
4 months and##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
4 months in##3##3##(2008-10#2)(2008-7#1)
4 months later##4##3##(1993-1#1)(1993-12#1)(2013-1#2)
4 months of age##3##4##(1991-11#1)(1995-12#1)(2008-11#1)
4 months of##7##3##(1991-1#1)(1991-11#1)(1991-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2010-8#1)
4 months##49##2##(1991-1#1)(1991-11#1)(1991-6#1)(1991-8#2)(1992-5#1)(1993-1#1)(1993-12#2)(1995-12#3)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-5#1)(2008-7#3)(2008-9#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#9)
4 months)##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
4 muM##6##2##(2008-10#6)
4 mug l(-1)##6##3##(2008-10#6)
4 mug m(-3))##2##3##(2009-7#2)
4 mug ml(-1)##7##3##(2008-10#7)
4 mug##19##2##(2008-10#17)(2009-7#2)
4 mug/ml)##4##2##(2008-5#4)
4 mum##3##2##(2008-10#1)(2008-3#1)(2009-5#1)
4 nA##2##2##(2008-10#2)
4 nM##5##2##(1990-8#1)(1996-2#1)(2008-10#3)
4 ng g(-1)##2##3##(2008-10#1)(2010-5#1)
4 ng ml(-1) (S/N=3) for##2##5##(2008-10#2)
4 ng ml(-1) (S/N=3)##3##4##(2008-10#3)
4 ng ml(-1) for##2##4##(2008-10#2)
4 ng ml(-1)##10##3##(2008-10#10)
4 ng##16##2##(2008-10#14)(2010-5#2)
4 ng/ml##2##2##(2008-10#1)(2011-2#1)
4 nm##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
4 nmol##3##2##(1990-11#1)(1991-3#1)(2008-10#1)
4 nmol/h/mg##2##2##(1991-12#2)
4 of the 7##2##4##(2008-5#1)(2012-12#1)
4 of the##6##3##(1991-9#1)(1993-12#1)(1996-11#1)(2008-10#1)(2008-5#1)(2012-12#1)
4 of##18##2##(1991-9#1)(1993-12#1)(1994-1#1)(1996-11#1)(1997-5#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)
4 or 6##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
4 or##13##2##(1994-5#1)(1994-8#1)(1996-11#1)(2008-10#6)(2008-7#2)(2011-2#1)(2012-9#1)
4 orders of magnitude##2##4##(2008-10#1)(2008-3#1)
4 out of##4##3##(1992-3#1)(1994-3#1)(1997-7#1)(2008-10#1)
4 parameters of coagulation and fibrinolysis##2##6##(2010-3#2)
4 patients were alive##2##4##(1991-2#1)(1991-8#1)
4 patients were##5##3##(1991-2#1)(1991-8#1)(1996-3#1)(2011-2#2)
4 patients##28##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-12#1)(1994-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#4)(2009-8#1)(2011-2#3)(2012-3#2)(2013-1#3)
4 per##3##2##(1996-8#2)(2011-2#1)
4 percent##4##2##(1992-12#1)(1994-1#1)(1995-3#1)(1996-3#1)
4 percent)##2##2##(1994-1#1)(1997-3#1)
4 phases##3##2##(2013-8#3)
4 ppb##2##2##(2008-10#2)
4 ppm for##2##3##(2008-10#2)
4 ppm##5##2##(2008-10#5)
4 respectively##2##2##(1996-11#1)(1997-3#1)
4 stages##2##2##(2009-2#1)(2009-3#1)
4 strains in##2##3##(2008-10#1)(2011-2#1)
4 strains##4##2##(2008-10#3)(2011-2#1)
4 subunit##3##2##(1995-11#3)
4 through##2##2##(1993-9#1)(2008-12#1)
4 times higher##2##3##(2008-10#1)(2008-7#1)
4 times##11##2##(1990-9#1)(1992-3#1)(1997-3#1)(2008-10#2)(2008-7#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
4 to 0##2##3##(1993-6#1)(2008-10#1)
4 to 1##2##3##(2008-10#1)(2008-11#1)
4 to 11##3##3##(2008-10#3)
4 to 14##2##3##(2008-1#1)(2008-10#1)
4 to 2##2##3##(2008-10#2)
4 to 20%##2##3##(2008-10#2)
4 to 24##2##3##(2008-10#2)
4 to 4##2##3##(2008-10#1)(2008-6#1)
4 to 5 months##2##4##(2013-1#2)
4 to 5 years##3##4##(2012-12#3)
4 to 5##10##3##(1992-11#1)(2008-10#4)(2012-12#3)(2013-1#2)
4 to 6 weeks##3##4##(1996-8#1)(2008-10#1)(2008-5#1)
4 to 6##5##3##(1996-8#1)(2008-10#1)(2008-12#1)(2008-5#2)
4 to 7##3##3##(1996-11#1)(1997-5#1)(2008-10#1)
4 to 8##4##3##(1993-8#1)(1997-4#1)(2008-10#1)(2012-12#1)
4 to 9##2##3##(2008-10#1)(2008-11#1)
4 to the##2##3##(1994-5#1)(2008-11#1)
4 to##72##2##(1992-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#40)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2011-2#1)(2012-12#4)(2013-1#4)(2013-8#1)
4 training trials##3##3##(1993-6#3)
4 training##4##2##(1993-6#3)(1994-12#1)
4 vs##4##2##(1994-12#1)(2008-7#2)(2013-1#1)
4 was##9##2##(1995-3#1)(2008-10#8)
4 week##5##2##(1996-1#2)(1996-12#1)(2008-11#2)
4 weeks after the##2##4##(1994-12#1)(2012-2#1)
4 weeks after##8##3##(1992-12#1)(1994-12#1)(2008-10#3)(2012-2#2)(2013-8#1)
4 weeks in##5##3##(1993-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
4 weeks later##2##3##(2008-10#2)
4 weeks of TRZ##2##4##(1996-12#2)
4 weeks of##6##3##(1996-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)
4 weeks postbloom##2##3##(2008-10#2)
4 weeks##60##2##(1990-12#1)(1991-6#1)(1992-12#1)(1993-6#1)(1994-12#1)(1996-12#5)(2008-10#27)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#2)(2009-3#2)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#1)
4 weeks)##2##2##(1992-12#2)
4 were##15##2##(1991-3#1)(1993-1#1)(1993-3#1)(1995-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
4 which##2##2##(1993-3#1)(2009-8#1)
4 with methyl vinyl ether##2##5##(1996-5#2)
4 with##9##2##(1990-9#1)(1996-3#1)(1996-5#5)(2008-7#1)(2013-1#1)
4 x 10(-3)##2##3##(1994-5#1)(2008-10#1)
4 x 10(-4)##2##3##(1990-8#1)(2008-10#1)
4 x 10(-8)##2##3##(2008-10#2)
4 x 10(6)##2##3##(2008-10#1)(2008-11#1)
4 x##23##2##(1990-8#1)(1994-5#1)(1995-11#1)(2008-10#12)(2008-11#4)(2008-3#2)(2008-9#1)(2010-1#1)
4 years after##4##3##(1994-12#1)(2008-7#2)(2011-3#1)
4 years ago##3##3##(2008-10#1)(2012-2#2)
4 years and##2##3##(1997-6#1)(2008-10#1)
4 years of##2##3##(1994-12#1)(2009-8#1)
4 years##39##2##(1991-8#1)(1993-12#1)(1994-12#4)(1996-11#1)(1997-6#2)(1997-8#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)
4 years)##6##2##(1997-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
4 ± 7##2##3##(2011-2#1)(2013-8#1)
4 ±##4##2##(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
4##2645##1##(1990-11#15)(1990-12#16)(1990-2#18)(1990-3#4)(1990-5#11)(1990-6#6)(1990-8#8)(1990-9#6)(1991-1#3)(1991-10#4)(1991-11#6)(1991-12#11)(1991-2#6)(1991-3#12)(1991-5#6)(1991-6#6)(1991-8#14)(1991-9#5)(1992-10#2)(1992-11#1)(1992-12#15)(1992-2#11)(1992-3#11)(1992-4#4)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#10)(1993-11#1)(1993-12#13)(1993-2#7)(1993-3#12)(1993-6#13)(1993-8#25)(1993-9#2)(1994-1#4)(1994-11#13)(1994-12#21)(1994-2#4)(1994-3#14)(1994-5#17)(1994-6#2)(1994-8#9)(1994-9#1)(1995-10#1)(1995-11#27)(1995-12#19)(1995-2#12)(1995-3#6)(1995-5#3)(1995-6#8)(1995-8#8)(1996-1#3)(1996-11#11)(1996-12#22)(1996-2#14)(1996-3#8)(1996-5#22)(1996-6#4)(1996-8#3)(1996-9#2)(1997-1#18)(1997-2#28)(1997-3#8)(1997-4#4)(1997-5#5)(1997-6#2)(1997-7#3)(1997-8#17)(2007-11#2)(2007-12#8)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#1123)(2008-11#99)(2008-12#45)(2008-2#7)(2008-3#33)(2008-4#6)(2008-5#64)(2008-6#7)(2008-7#61)(2008-8#31)(2008-9#52)(2009-1#3)(2009-10#14)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#9)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#12)(2009-8#10)(2009-9#1)(2010-1#7)(2010-10#3)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#19)(2010-6#2)(2010-7#9)(2010-8#8)(2010-9#3)(2011-1#8)(2011-2#93)(2011-3#9)(2012-12#28)(2012-2#23)(2012-3#47)(2012-4#1)(2012-9#1)(2013-1#90)(2013-3#1)(2013-7#4)(2013-8#24)
4% (n =##2##3##(2008-10#2)
4% (n=5)##2##2##(2008-10#2)
4% (v/v)##3##2##(2008-10#3)
4% =##2##2##(1991-6#2)
4% R##2##2##(2008-10#2)
4% and the##2##3##(2008-10#2)
4% and##21##2##(1990-2#1)(1990-6#1)(1991-2#1)(1992-3#2)(1994-12#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#2)
4% at##10##2##(1991-8#1)(1992-4#1)(2008-10#7)(2008-2#1)
4% females)##2##2##(1994-6#2)
4% for 10##3##3##(2008-10#3)
4% for a##2##3##(2008-10#1)(2011-2#1)
4% for the##2##3##(2008-10#2)
4% for##38##2##(1992-11#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#27)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
4% had##2##2##(1993-2#1)(1994-12#1)
4% in adult cirrhotics) and##2##5##(2012-3#2)
4% in adult cirrhotics)##4##4##(2012-3#4)
4% in the##3##3##(1995-2#1)(1996-3#1)(2008-10#1)
4% in##20##2##(1990-9#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-2#1)(1996-3#1)(2008-10#4)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#5)(2013-1#1)
4% of all##5##3##(1990-2#2)(2010-12#1)(2011-2#1)(2013-1#1)
4% of genomic DNA##2##4##(1993-12#2)
4% of the##15##3##(1991-12#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
4% of##43##2##(1990-2#2)(1990-6#2)(1991-12#1)(1991-6#1)(1993-12#2)(1993-9#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-3#1)(1997-6#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#2)(2009-9#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
4% or##2##2##(2008-10#2)
4% that##2##2##(2008-10#2)
4% to##5##2##(1992-11#1)(1997-3#1)(2008-10#2)(2008-11#1)
4% vs##2##2##(1993-2#1)(2013-8#1)
4% w/w) of##2##3##(2008-5#2)
4% was##3##2##(2008-10#3)
4% were NPD and##2##4##(2008-12#2)
4% were NPD##3##3##(2008-12#3)
4% were##6##2##(2008-10#1)(2008-12#3)(2008-7#1)(2013-1#1)
4%##318##1##(1990-11#1)(1990-2#4)(1990-3#2)(1990-6#4)(1990-9#1)(1991-12#2)(1991-2#2)(1991-6#4)(1991-8#2)(1991-9#1)(1992-11#2)(1992-3#4)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#5)(1994-3#1)(1994-6#3)(1994-8#2)(1995-12#3)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-6#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-10#141)(2008-11#11)(2008-12#8)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#14)(2012-12#2)(2012-2#7)(2012-3#11)(2013-1#10)(2013-8#5)
4%) and##10##2##(2008-1#2)(2008-10#3)(2008-12#1)(2008-5#1)(2012-3#3)
4%) for##2##2##(2008-10#2)
4%) had##5##2##(2008-1#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
4%) in##2##2##(1993-1#1)(2011-1#1)
4%) of##4##2##(1990-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
4%) patients with##2##3##(2008-1#2)
4%) patients##6##2##(2008-1#4)(2010-10#1)(2011-2#1)
4%) were##3##2##(1990-12#1)(2008-10#1)(2013-1#1)
4%) with##2##2##(2008-5#1)(2008-7#1)
4%)##77##1##(1990-12#2)(1990-2#2)(1990-5#1)(1991-8#1)(1992-9#1)(1993-1#2)(1994-11#1)(1994-12#2)(1996-11#1)(1996-12#1)(1997-8#1)(2008-1#7)(2008-10#12)(2008-12#4)(2008-3#1)(2008-5#7)(2008-7#3)(2008-9#4)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#6)(2013-1#5)(2013-8#1)
4&lt##2##1##(2008-10#1)(2013-1#1)
4'##21##1##(1993-12#3)(1994-8#1)(1996-5#1)(2008-10#13)(2008-11#2)(2008-9#1)
4''##2##1##(2008-10#2)
4'''-tetraaminophthalocyanine##2##1##(2008-10#2)
4''-disulphonate (ferrozine)##2##2##(2008-10#2)
4'-##2##1##(1991-3#2)
4'-chemistry##4##1##(1991-3#4)
4'-diaminodiphenylether##2##1##(2008-10#2)
4'-diaminophenyl)-difluoroboradiaza-s-indacence##2##1##(2008-10#2)
4'-diaminophenyl)-difluoroboradiaza-s-indacene##2##1##(2008-10#2)
4'-methylenebis(N##2##1##(2008-10#2)
4'-tetraphenylferrocene##2##1##(2008-10#2)
4(th)##2##1##(2011-1#1)(2013-1#1)
4) and the##2##3##(2008-10#1)(2008-5#1)
4) and##11##2##(1993-8#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)
4) at##2##2##(1997-1#1)(2008-10#1)
4) have been##2##3##(2008-10#2)
4) or##2##2##(1994-6#1)(2008-12#1)
4) the##3##2##(1991-3#1)(1995-11#1)(2008-6#1)
4) was##5##2##(1990-5#1)(1992-3#1)(1992-6#1)(2008-11#1)(2011-3#1)
4) were identified##2##3##(2008-10#1)(2011-1#1)
4) were similar##2##3##(2008-10#1)(2012-3#1)
4) were##6##2##(2008-10#3)(2011-1#1)(2011-2#1)(2012-3#1)
4)##116##1##(1990-2#1)(1990-5#8)(1990-8#3)(1991-10#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-3#2)(2008-10#29)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#7)(2011-3#1)(2011-9#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
4)]-beta-D-glucopyranoside##2##1##(2008-11#2)
4)]octane##2##1##(1996-5#2)
4+/-0##8##1##(2008-10#6)(2008-11#1)(2008-7#1)
4+/-1##8##1##(2008-10#8)
4+/-3##2##1##(2008-10#1)(2009-3#1)
4- and 2##3##3##(2008-10#3)
4- and##5##2##(2008-10#3)(2008-11#2)
4- to 3##2##3##(1993-8#1)(2008-10#1)
4- to##6##2##(1990-12#1)(1993-8#1)(1994-8#1)(2008-10#2)(2010-1#1)
4-##16##1##(1990-12#1)(1993-8#1)(1994-8#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#1)(2010-1#1)(2013-8#1)
4-(1-aryl-3-oxo-5-phenylpentylamino)##2##1##(2011-3#2)
4-(2-pyridylazo) resorcinol (PAR)##3##3##(2008-10#3)
4-(2-pyridylazo) resorcinol##4##2##(2008-10#4)
4-(2-pyridylazo)-resorcinol (PAR)##3##2##(2008-10#3)
4-(2-pyridylazo)-resorcinol##4##1##(2008-10#4)
4-(2-pyridylazo)resorcinol (PAR)##6##2##(2008-10#6)
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone##2##1##(1990-6#1)(1993-11#1)
4-1##5##1##(1990-2#1)(1993-8#1)(2008-10#1)(2010-3#2)
4-10##2##1##(2008-10#1)(2012-2#1)
4-12##3##1##(2008-10#3)
4-14##2##1##(1994-5#1)(2008-11#1)
4-18##2##1##(2008-1#1)(2008-10#1)
4-2##5##1##(2008-10#4)(2008-11#1)
4-25##2##1##(2008-10#1)(2013-8#1)
4-27##2##1##(1990-8#1)(2008-10#1)
4-3##6##1##(1991-9#1)(1994-12#1)(2008-10#4)
4-4##4##1##(1990-5#1)(2008-10#3)
4-4-20##4##1##(1992-6#4)
4-5##17##1##(1993-1#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-5#1)(2008-10#7)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
4-6 weeks##4##2##(1994-11#1)(1995-11#1)(2008-10#1)(2008-5#1)
4-6##20##1##(1994-11#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
4-7##7##1##(1993-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
4-8##3##1##(1990-10#1)(2008-10#2)
4-9##3##1##(2008-10#3)
4-BP##3##1##(2008-10#3)
4-D and 2##2##3##(2008-10#1)(2008-12#1)
4-D and##6##2##(2008-10#3)(2008-12#3)
4-D esters##2##2##(2008-10#2)
4-D for##2##2##(2008-12#2)
4-D in##3##2##(2008-10#3)
4-D is##2##2##(2008-11#2)
4-D were##2##2##(2008-10#2)
4-D with##2##2##(2008-10#1)(2008-12#1)
4-D##39##1##(2008-10#19)(2008-11#8)(2008-12#12)
4-D) and##3##2##(2008-10#3)
4-D) in##2##2##(2008-10#2)
4-D) is##2##2##(2008-10#2)
4-D) were##2##2##(2008-10#1)(2008-11#1)
4-D)##13##1##(2008-10#8)(2008-11#2)(2008-12#2)(2008-8#1)
4-DAPG producers and##2##3##(2008-10#2)
4-DAPG producers in the##2##4##(2008-10#2)
4-DAPG producers##10##2##(2008-10#10)
4-DAPG##16##1##(2008-10#16)
4-DAPG) are##2##2##(2008-10#2)
4-DAPG)##4##1##(2008-10#4)
4-DAPG-producing P##3##2##(2008-10#3)
4-DAPG-producing Pseudomonas spp##3##3##(2008-10#3)
4-DAPG-producing fluorescent Pseudomonas spp##2##4##(2008-10#2)
4-DAPG-producing##10##1##(2008-10#10)
4-DBP##2##1##(2008-10#2)
4-DCP##3##1##(2008-10#3)
4-DCP)##3##1##(2008-10#3)
4-DHP##2##1##(2012-3#2)
4-DNT and##2##2##(2008-10#2)
4-DNT##11##1##(2008-10#11)
4-DNT)##3##1##(2008-10#2)(2008-11#1)
4-Diacetylphloroglucinol##2##1##(2008-10#2)
4-Diacetylphloroglucinol-Producing Pseudomonas fluorescens in the Rhizosphere##2##6##(2008-10#2)
4-Diacetylphloroglucinol-Producing Pseudomonas fluorescens##3##3##(2008-10#3)
4-Diacetylphloroglucinol-Producing Pseudomonas##4##2##(2008-10#4)
4-Diacetylphloroglucinol-Producing##5##1##(2008-10#5)
4-Dihydroxyphenyl)methylidene]amino}benzoic acid##2##2##(2008-10#2)
4-NP was##2##2##(2008-10#2)
4-NP##7##1##(2008-10#7)
4-Nonylphenol##2##1##(2008-10#1)(2008-11#1)
4-W##2##1##(2007-12#1)(2008-2#1)
4-amino-2##10##1##(1994-5#9)(2008-10#1)
4-aminoantipyrine in##4##2##(2008-10#4)
4-aminoantipyrine##8##1##(2008-10#8)
4-aminophenol and##3##2##(2008-10#3)
4-aminophenol in##2##2##(2008-10#2)
4-aminophenol##11##1##(1990-2#1)(2008-10#10)
4-aminopyridine (10mM)##2##2##(1993-3#2)
4-aminopyridine##3##1##(1990-12#1)(1993-3#2)
4-aminoquinoline derivatives##2##2##(1993-8#2)
4-benzenetriol##5##1##(2008-10#5)
4-benzoquinone##11##1##(2008-10#8)(2008-11#2)(2009-9#1)
4-beta-glucanase##3##1##(1991-5#1)(2008-10#2)
4-bis(3-indolyl)-1H-pyrrole-2##2##1##(2008-10#2)
4-bis(prop-2'-enyloxy)-9##2##1##(2008-10#2)
4-bis-(N-methyl-acetohydroxamic##2##1##(2008-10#2)
4-bisphosphate##2##1##(1993-8#2)
4-butanetetracarboxylate##2##1##(2008-10#2)
4-catechol##3##1##(2008-11#3)
4-cell stage##3##2##(1993-3#2)(2007-12#1)
4-cell##6##1##(1993-3#2)(2007-12#1)(2008-9#3)
4-chloro-3-methylphenol##2##1##(2008-10#2)
4-chlorophenol##4##1##(2008-10#4)
4-diacetylphloroglucinol (2##3##2##(2008-10#3)
4-diacetylphloroglucinol##7##1##(2008-10#7)
4-diaminotoluene##2##1##(2008-10#2)
4-diaryl-3-azabicyclo[3##2##1##(1996-5#2)
4-dicarboxylic acid##2##2##(1995-12#1)(2008-10#1)
4-dichloroaniline##3##1##(2008-10#3)
4-dichlorobenzene##2##1##(2008-10#2)
4-dichlorobenzophenone##2##1##(2008-10#2)
4-dichlorophenol (2##3##2##(2008-10#2)(2008-11#1)
4-dichlorophenol (DCP)##2##2##(2008-10#2)
4-dichlorophenol and##2##2##(2008-10#1)(2008-11#1)
4-dichlorophenol##16##1##(2008-10#14)(2008-11#2)
4-dichlorophenol)##2##1##(2008-10#1)(2008-11#1)
4-dichlorophenoxy acetic acid (2##2##4##(2008-10#1)(2008-8#1)
4-dichlorophenoxy acetic acid##4##3##(2008-10#3)(2008-8#1)
4-dichlorophenoxyacetic acid (2##7##3##(2008-10#5)(2008-11#2)
4-dichlorophenoxyacetic acid##11##2##(2008-10#8)(2008-11#3)
4-dichlorophthalazine reactive##2##2##(2008-10#2)
4-dichlorophthalazine##3##1##(2008-10#3)
4-difluoro-1##2##1##(2008-10#2)
4-dihydro-2##3##1##(2012-3#3)
4-dihydrocarbazole functional group##2##3##(2008-10#2)
4-dihydrocarbazole-9-ethyl chloroformate (BCEOC)##2##3##(2008-10#2)
4-dihydrocarbazole-9-ethyl##3##1##(2008-10#3)
4-dihydrolutidine##2##1##(2008-10#2)
4-dihydropyridine##3##1##(2008-10#2)(2008-5#1)
4-dihydropyridines##3##1##(2008-10#3)
4-dihydroxy##3##1##(2008-10#2)(2008-11#1)
4-dihydroxybenzoic acid and##3##3##(2008-10#3)
4-dihydroxybenzoic acid##6##2##(2008-10#6)
4-dihydroxyphenylacetic acid (DOPAC)##3##3##(1994-2#1)(2008-10#2)
4-dimethyl-1##2##1##(2008-10#1)(2008-5#1)
4-dimethylaminoazobenzene##2##1##(2008-10#2)
4-dimethylphenylformamide at##2##2##(2008-10#2)
4-dimethylthiazolium dipolar ion##2##3##(1993-8#2)
4-dinitrobenzene##3##1##(1995-6#1)(2008-10#2)
4-dinitrophenyl##6##1##(1992-8#1)(2008-10#5)
4-dinitrophenylhydrazine (DNPH)##2##2##(2008-10#2)
4-dinitrophenylhydrazine##5##1##(2008-10#5)
4-dinitrophenylhydrazones by gas chromatography##2##4##(2008-10#2)
4-dinitrotoluene (2##3##2##(2008-10#2)(2008-11#1)
4-dinitrotoluene##9##1##(2008-10#8)(2008-11#1)
4-dione##3##1##(2008-10#3)
4-disubstituted##2##1##(2008-10#1)(2012-2#1)
4-ethylenedioxythiophene)##3##1##(2008-10#3)
4-exoglucanase##2##1##(2008-10#2)
4-fold at##2##2##(1990-10#1)(2008-11#1)
4-fold increase##2##2##(1996-12#1)(2008-11#1)
4-fold##13##1##(1990-10#1)(1991-5#1)(1994-8#1)(1996-12#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#3)(2013-8#1)
4-fold)##3##1##(1993-1#1)(1993-8#1)(1996-2#1)
4-galactosyltransferase##3##1##(2008-9#3)
4-glucanase and beta-1##2##3##(1992-11#2)
4-glucanase##4##1##(1991-5#1)(1992-11#2)(2008-10#1)
4-glucanases and beta-1##2##3##(1992-7#2)
4-h##8##1##(2008-10#6)(2008-6#1)(2008-9#1)
4-hour##2##1##(2011-2#2)
4-hydroxybenzaldehyde##2##1##(2008-10#2)
4-hydroxybenzoic acid##3##2##(1990-5#1)(1997-2#1)(2008-10#1)
4-hydroxycoumarin##2##1##(1990-6#1)(2008-10#1)
4-hydroxyestrone##2##1##(2008-11#2)
4-hydroxylase##2##1##(2008-10#2)
4-hydroxytamoxifen##2##1##(1990-12#2)
4-kb##5##1##(1991-6#1)(1995-2#1)(2008-10#2)(2008-11#1)
4-methylcatechol##2##1##(2013-8#2)
4-min##3##1##(2008-10#2)(2013-8#1)
4-month##5##1##(1991-8#2)(1993-1#1)(2013-1#1)(2013-7#1)
4-month-old##3##1##(2008-11#2)(2008-5#1)
4-mu##2##1##(2007-12#2)
4-n-NP was##2##2##(2008-11#2)
4-n-NP##4##1##(2008-11#4)
4-n-heptylphenol##2##1##(2008-10#2)
4-n-hexylphenol##2##1##(2008-10#2)
4-n-nonylphenol##3##1##(2008-10#1)(2008-11#2)
4-n-octylphenol##2##1##(2008-10#2)
4-n-pentylphenol##2##1##(2008-10#2)
4-naphthoquinone##8##1##(1993-8#1)(2008-10#2)(2008-11#3)(2009-9#2)
4-nitrotoluene##3##1##(2008-10#3)
4-oxadiazol-2-yl)-3##2##1##(2010-6#2)
4-oxopentyl groups##2##2##(2008-4#2)
4-oxopentyl##3##1##(2008-4#3)
4-pentamethylene-1##3##1##(2008-4#3)
4-phenylenediamine##3##1##(2008-10#3)
4-phosphate##6##1##(1993-8#1)(1997-8#2)(2008-7#1)(2008-8#1)(2013-8#1)
4-pyridinoporphirazinatocopper(II)##2##1##(2008-10#2)
4-quinolone antibacterials##2##2##(2008-10#2)
4-styrenesulfonate)-coated##3##1##(2008-10#3)
4-tert-butylcalix[4]arene##2##1##(2008-10#2)
4-tetrahydroisoquinoline##3##1##(1994-2#3)
4-thiadiazole##2##1##(2008-10#2)
4-thiadiazole-2##2##1##(2008-10#2)
4-thiadiazole-2-sulfonamide##3##1##(2008-10#3)
4-triazine##3##1##(2008-10#2)(2008-11#1)
4-triazine-4'##2##1##(2008-10#2)
4-triazole (amitrole)##2##2##(2008-10#2)
4-triazole##5##1##(1994-11#1)(2008-10#2)(2010-12#1)(2012-2#1)
4-vinylpyridine (4-VP)##2##2##(2008-10#2)
4-week##8##1##(1996-12#1)(1996-2#1)(1997-8#1)(2008-12#1)(2008-5#3)(2008-7#1)
4-week-old##6##1##(1995-12#1)(2008-10#4)(2008-9#1)
4-xylanase from the##2##3##(1992-11#2)
4-xylanases##3##1##(1992-7#2)(2008-10#1)
4-year data set##2##3##(2008-10#2)
4-year period##7##2##(1994-12#1)(2008-10#5)(2008-5#1)
4-year##20##1##(1993-12#1)(1994-12#1)(1995-5#1)(1996-3#1)(2008-10#11)(2008-11#1)(2008-5#1)(2010-6#1)(2012-3#1)(2013-1#1)
4-year-old boy##2##2##(2008-10#1)(2008-7#1)
4-year-old girl##3##2##(1997-3#1)(2008-10#2)
4-year-old##8##1##(1997-3#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
4/4 and##2##2##(2008-10#2)
4/4##7##1##(2008-10#6)(2008-11#1)
40 %##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
40 000##2##2##(2008-10#1)(2009-12#1)
40 and 20##2##3##(2008-10#1)(2008-5#1)
40 and##19##2##(1990-5#1)(1995-10#1)(1995-12#2)(1997-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#3)(2013-1#1)(2013-8#1)
40 blood##2##2##(1996-12#1)(2008-10#1)
40 cases##6##2##(1997-3#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#1)
40 cm##4##2##(2008-10#4)
40 days##4##2##(2008-10#3)(2013-8#1)
40 degrees C for##2##4##(2008-10#2)
40 degrees C##22##3##(2007-12#1)(2008-10#16)(2008-5#3)(2008-7#1)(2010-4#1)
40 g kg(-1)##2##3##(2008-12#2)
40 h##2##2##(2008-11#1)(2008-7#1)
40 h(-1)##5##2##(2008-10#5)
40 isolates##2##2##(2008-10#2)
40 kDa##5##2##(1992-10#1)(1993-1#1)(1993-8#1)(1995-11#1)(2009-7#1)
40 mg l(-1)##2##3##(2008-10#2)
40 mg##9##2##(1997-8#1)(2008-10#2)(2008-11#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-3#1)
40 mg/kg/day##2##2##(1995-8#2)
40 microg g(-1)##2##3##(2010-8#2)
40 min##9##2##(1996-12#1)(2008-10#6)(2008-12#1)(2008-7#1)
40 ml##4##2##(2008-10#4)
40 mm or larger##2##4##(1992-5#2)
40 mm x 40 mm##2##5##(2008-3#2)
40 mm x##3##3##(2008-10#1)(2008-3#2)
40 mm##11##2##(1992-5#3)(1996-6#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-4#1)(2011-2#1)
40 mug l(-1)##2##3##(2008-10#2)
40 mug##6##2##(2008-10#5)(2008-11#1)
40 mul##3##2##(2008-10#3)
40 ng ml(-1)##3##3##(2008-10#3)
40 of##3##2##(1990-8#1)(2008-10#2)
40 or##4##2##(1994-2#1)(1995-8#1)(2008-9#1)(2009-5#1)
40 patients suffering from##2##4##(2008-5#1)(2012-3#1)
40 patients with##4##3##(1990-2#1)(2008-10#1)(2013-1#2)
40 patients##16##2##(1990-2#1)(1990-9#1)(1991-3#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-12#1)(2011-2#3)(2012-3#2)(2013-1#2)
40 percent of##3##3##(1994-3#2)(2008-10#1)
40 percent##6##2##(1994-12#1)(1994-2#1)(1994-3#2)(2008-10#1)(2008-11#1)
40 samples per hour##4##4##(2008-10#4)
40 samples per##5##3##(2008-10#5)
40 samples##7##2##(2008-10#7)
40 times##6##2##(1991-5#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
40 to 60%##3##3##(2008-10#2)(2011-2#1)
40 to##19##2##(1993-8#1)(1995-9#1)(2008-10#11)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-3#1)
40 x 10(6)##2##3##(2008-10#1)(2008-11#1)
40 x##3##2##(2008-10#2)(2008-11#1)
40 years ago##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
40 years of age##3##4##(2008-7#1)(2012-12#1)(2013-8#1)
40 years of##5##3##(2008-7#2)(2012-12#1)(2012-2#1)(2013-8#1)
40 years##22##2##(1991-12#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
40##424##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-5#3)(1992-9#1)(1993-1#1)(1993-2#2)(1993-8#3)(1994-11#7)(1994-12#2)(1994-2#2)(1994-3#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-6#4)(1995-8#7)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-6#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#6)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#156)(2008-11#19)(2008-12#10)(2008-3#13)(2008-5#18)(2008-7#10)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#22)(2011-3#2)(2012-12#7)(2012-2#4)(2012-3#10)(2013-1#11)(2013-8#5)
40% (v/v)##3##2##(2008-10#3)
40% and 60% of maximal voluntary contraction##2##7##(2010-6#1)(2010-9#1)
40% and##8##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
40% for##2##2##(1990-6#1)(1991-5#1)
40% in##9##2##(1994-9#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)
40% more##2##2##(2008-10#1)(2008-3#1)
40% of all##2##3##(1991-11#1)(2013-1#1)
40% of cases##2##3##(2011-2#1)(2013-1#1)
40% of patients##3##3##(1994-2#1)(2008-10#1)(2012-12#1)
40% of the##10##3##(1991-11#1)(1991-5#1)(1995-2#1)(1996-6#1)(2008-3#2)(2008-7#3)(2009-8#1)
40% of total##2##3##(1994-8#1)(2008-8#1)
40% of##27##2##(1991-11#2)(1991-5#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
40% reduction##2##2##(2012-2#1)(2013-8#1)
40%##110##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-5#2)(1991-8#1)(1992-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-6#2)(1997-3#1)(2007-8#1)(2008-10#25)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2009-11#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#1)
40%)##2##1##(1992-4#1)(2008-12#1)
40)##11##1##(1990-5#1)(1997-5#1)(2008-10#3)(2008-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
40+##6##1##(2008-9#6)
40- and##3##2##(2008-10#1)(2009-10#1)(2012-7#1)
40-##5##1##(1995-8#1)(2008-10#2)(2009-10#1)(2012-7#1)
40-1000##2##1##(2008-10#2)
40-50##2##1##(1996-11#1)(1997-2#1)
40-50%##3##1##(2008-10#1)(2008-11#2)
40-60##3##1##(2008-10#2)(2011-2#1)
40-60%##2##1##(1994-8#1)(2008-7#1)
40-70%##2##1##(1997-2#1)(1997-7#1)
40-fold##3##1##(1994-5#1)(2008-10#2)
40-kDa##6##1##(1993-1#1)(1995-2#1)(1997-1#4)
40-year-old woman##4##2##(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)
40-year-old##9##1##(1996-9#1)(2008-10#1)(2008-12#2)(2008-7#2)(2009-3#1)(2010-11#1)(2011-2#1)
40/40+##2##1##(2008-9#2)
400 MHz##2##2##(1994-5#1)(2008-10#1)
400 and 800 mg/L females##4##5##(2008-9#4)
400 and 800 mg/L males##2##5##(2008-9#2)
400 and 800 mg/L##6##4##(2008-9#6)
400 and 800##9##3##(2008-10#2)(2008-9#7)
400 and##13##2##(2008-10#5)(2008-9#7)(2010-5#1)
400 m##2##2##(2008-3#1)(2013-1#1)
400 mOsm##3##2##(2008-11#3)
400 mOsmol kg-1##2##3##(2008-11#2)
400 mV##2##2##(2008-10#2)
400 mg##2##2##(1991-3#1)(2008-10#1)
400 mg/L##2##2##(2008-9#2)
400 microg/day##2##2##(2007-11#2)
400 micrograms##3##2##(1991-3#1)(1992-8#1)(1995-12#1)
400 million years of evolution##2##5##(1994-11#1)(2009-8#1)
400 million years##3##3##(1994-11#1)(2009-8#2)
400 million##5##2##(1994-11#1)(1996-2#1)(2009-8#2)(2012-12#1)
400 ml##2##2##(2008-10#1)(2010-4#1)
400 nm after##2##3##(2008-10#1)(2010-1#1)
400 nm##7##2##(2008-10#4)(2008-2#1)(2009-12#1)(2010-1#1)
400 nm)##2##2##(2008-10#1)(2010-1#1)
400 times##3##2##(2008-10#3)
400 to##11##2##(1990-12#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)
400##140##1##(1990-12#1)(1990-2#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-2#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-6#4)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#43)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#18)(2009-12#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
400%##2##1##(2008-10#2)
400-fold##2##1##(1994-11#1)(2008-7#1)
400-mum core-diameter optical##2##3##(2008-3#2)
4000##7##1##(1992-11#1)(1994-9#2)(2008-10#1)(2008-11#1)(2010-9#1)(2012-12#1)
400nm##3##1##(2008-10#3)
401##4##1##(2008-10#3)(2008-11#1)
402##2##1##(2008-10#1)(2010-10#1)
403##2##1##(1992-8#1)(1996-12#1)
404##4##1##(1995-6#1)(2008-10#2)(2008-12#1)
405##3##1##(1993-2#1)(2008-10#1)(2013-1#1)
407##4##1##(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)
408 and##2##2##(1993-9#1)(2008-10#1)
408##5##1##(1993-2#1)(1993-9#1)(2008-10#1)(2009-5#1)(2012-2#1)
409##5##1##(2008-10#2)(2010-4#1)(2012-3#2)
40min##3##1##(2008-10#1)(2010-4#2)
40ml##2##1##(2008-10#2)
40mul of##2##2##(2008-10#2)
40s##2##1##(1992-2#1)(2008-10#1)
41 +/-##2##2##(2008-1#1)(2008-11#1)
41 and##7##2##(2008-10#4)(2008-11#1)(2008-7#1)(2010-8#1)
41 cases##3##2##(1990-2#1)(1990-8#1)(2007-11#1)
41 nm##2##2##(2010-11#1)(2013-8#1)
41 patients with##2##3##(1990-2#1)(1996-11#1)
41 patients##3##2##(1990-2#1)(1991-8#1)(1996-11#1)
41 to##2##2##(1993-8#1)(2008-10#1)
41 weeks##10##2##(2008-9#10)
41 were##2##2##(2008-10#1)(2011-2#1)
41 years##2##2##(2012-2#1)(2012-3#1)
41##121##1##(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#2)(1995-12#2)(1995-8#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#33)(2008-11#7)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#11)(2009-1#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#2)(2012-3#6)(2013-1#6)(2013-8#1)
41% in##2##2##(2008-10#1)(2012-2#1)
41% of the##3##3##(2008-1#1)(2008-10#2)
41% of##4##2##(2008-1#1)(2008-10#2)(2013-1#1)
41%##25##1##(1991-8#1)(1995-9#1)(1996-2#1)(2008-1#1)(2008-10#10)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
41%) and##2##2##(2008-10#2)
41%)##3##1##(2008-10#2)(2008-9#1)
41)##6##1##(1991-3#1)(2008-1#1)(2008-8#1)(2010-3#1)(2011-2#2)
41-year-old female patient##2##3##(1993-6#1)(2008-12#1)
41-year-old female##3##2##(1993-6#1)(2008-12#1)(2012-3#1)
41-year-old##7##1##(1993-6#1)(2008-11#1)(2008-12#2)(2012-3#2)(2013-1#1)
410 nm##3##2##(1993-2#1)(2008-10#2)
410##11##1##(1993-2#1)(1994-11#1)(1996-11#2)(2008-10#4)(2008-11#1)(2009-11#1)(2011-2#1)
411##4##1##(2008-10#2)(2008-11#1)(2010-7#1)
412 demented patients##2##3##(2008-7#2)
412##5##1##(1990-11#1)(2008-7#2)(2010-11#1)(2013-8#1)
414##4##1##(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
415##5##1##(2008-10#3)(2008-11#1)(2008-3#1)
415nm##2##1##(2008-10#2)
416##5##1##(1991-6#1)(1992-3#1)(1996-8#1)(2008-5#2)
417##3##1##(1991-6#1)(1997-8#1)(2008-8#1)
418##3##1##(2008-10#1)(2011-2#2)
419##2##1##(1990-12#1)(2008-10#1)
42 +/- 0##2##3##(1996-2#1)(2008-12#1)
42 +/-##5##2##(1996-2#1)(1997-1#1)(2008-12#1)(2008-3#1)(2011-2#1)
42 V##2##2##(1990-5#1)(2008-10#1)
42 cases##2##2##(2008-7#1)(2012-2#1)
42 days##5##2##(1991-2#1)(2008-10#4)
42 degrees C for##2##4##(2008-10#2)
42 degrees C##4##3##(1991-5#1)(2008-10#2)(2008-5#1)
42 degrees##7##2##(1991-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
42 exhibited##2##2##(1994-5#1)(2008-10#1)
42 for##2##2##(2008-10#2)
42 in##2##2##(2008-9#1)(2010-2#1)
42 isolates of##2##3##(2008-10#2)
42 isolates##3##2##(2008-10#3)
42 mm##2##2##(2009-7#1)(2013-1#1)
42 mug l(-1)##2##3##(2008-10#2)
42 mum##2##2##(2008-10#1)(2008-3#1)
42 of##2##2##(1991-3#1)(1995-8#1)
42 patients##5##2##(1990-9#1)(1992-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
42 species##2##2##(1995-12#1)(2008-9#1)
42 to##2##2##(2008-10#1)(2011-2#1)
42 year old##2##3##(1994-8#1)(2011-2#1)
42 years##2##2##(1992-5#1)(2013-1#1)
42##164##1##(1990-12#1)(1990-2#4)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(2008-10#56)(2008-11#7)(2008-12#5)(2008-3#4)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-7#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#14)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#11)(2013-8#2)
42% for##2##2##(2008-10#2)
42% of the##4##3##(1995-11#1)(2008-10#3)
42% of##7##2##(1994-2#1)(1995-11#1)(1997-3#1)(2007-8#1)(2008-10#3)
42%##26##1##(1992-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1995-11#1)(1997-1#1)(1997-3#2)(2007-8#1)(2008-10#9)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
42)##9##1##(1994-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-1#1)(2010-11#1)(2012-2#1)(2013-1#1)
42-year-old man with no##2##4##(2012-3#1)(2013-8#1)
420 and##2##2##(1996-2#1)(2008-10#1)
420 nm##6##2##(1991-3#1)(2008-10#5)
420##14##1##(1991-3#2)(1994-8#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-2#1)(2008-7#1)
421##3##1##(1991-8#1)(1993-2#1)(2013-1#1)
422##3##1##(2010-11#1)(2013-1#2)
423##5##1##(2008-10#2)(2010-6#1)(2010-8#1)(2011-2#1)
425 nm##3##2##(2008-10#3)
425##8##1##(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)
426##4##1##(1996-6#1)(2008-10#1)(2008-8#1)(2009-7#1)
427##5##1##(1994-9#1)(1997-6#1)(2008-10#2)(2012-3#1)
428##5##1##(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
429##7##1##(1992-3#1)(1996-8#2)(1997-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
42mm##2##1##(2008-10#2)
42mmolg(-1) for##2##2##(2008-10#2)
42nd##3##1##(2008-11#1)(2008-8#2)
43 +/- 0##2##3##(2008-10#1)(2012-3#1)
43 +/-##3##2##(2008-10#2)(2012-3#1)
43 U/mg##2##2##(1995-8#2)
43 and##4##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
43 days##3##2##(2008-11#2)(2008-12#1)
43 degrees C##2##3##(1995-12#1)(2008-11#1)
43 episodes##2##2##(1993-1#1)(2012-3#1)
43 g##2##2##(2008-10#2)
43 kD##2##2##(1993-3#2)
43 kDa##3##2##(1996-6#1)(2009-7#1)(2010-12#1)
43 kb##2##2##(1996-3#1)(2008-10#1)
43 mg##2##2##(1993-2#1)(2008-10#1)
43 patients##2##2##(2008-7#2)
43 pg/mL##2##2##(2011-1#2)
43 to##2##2##(2008-10#1)(2008-12#1)
43 weeks##14##2##(2008-9#14)
43 years##3##2##(1991-8#1)(2012-12#1)(2013-1#1)
43##124##1##(1990-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-11#2)(1994-2#2)(1995-12#2)(1995-8#3)(1995-9#2)(1996-3#2)(1996-5#1)(1996-6#3)(1997-4#1)(1997-6#1)(2008-10#28)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#18)(2009-11#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#3)
43% and##2##2##(2008-10#1)(2008-7#1)
43% compared##2##2##(1995-12#1)(2008-11#1)
43% in##3##2##(2008-10#2)(2010-12#1)
43% of the##2##3##(2008-1#1)(2013-8#1)
43% of##5##2##(2008-1#1)(2008-10#1)(2010-4#1)(2012-3#1)(2013-8#1)
43%##24##1##(1991-8#1)(1995-12#1)(1995-8#1)(1996-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
43) and##3##2##(1994-3#1)(2008-10#1)(2008-12#1)
43)##8##1##(1991-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
43-year-old##6##1##(1991-6#1)(1996-11#1)(2008-12#1)(2008-9#1)(2010-7#1)(2013-8#1)
430 nm##3##2##(2008-10#3)
430##11##1##(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
432##3##1##(2008-10#2)(2008-3#1)
434 and##3##2##(2008-10#1)(2011-2#2)
434 repressor##4##2##(2008-8#4)
434##10##1##(2008-10#3)(2008-8#5)(2011-2#2)
4343##2##1##(2008-3#1)(2013-8#1)
435##12##1##(1990-11#1)(2008-10#8)(2008-3#1)(2008-8#1)(2011-2#1)
436##2##1##(2008-10#2)
437##3##1##(2008-10#2)(2011-2#1)
438##5##1##(1990-11#1)(2008-10#3)(2008-11#1)
439 patients##2##2##(1990-8#1)(2008-11#1)
439##3##1##(1990-8#1)(2007-12#1)(2008-11#1)
44 +/- 0##2##3##(2011-2#1)(2013-1#1)
44 and##7##2##(1993-8#2)(1996-11#1)(1996-2#1)(1997-8#1)(2008-10#2)
44 for##4##2##(1995-11#1)(2008-10#3)
44 in##3##2##(1991-7#1)(2008-12#1)(2008-5#1)
44 mg kg(-1))##2##3##(2008-12#2)
44 patients##4##2##(1991-8#2)(2008-12#1)(2008-7#1)
44 to##2##2##(2008-10#1)(2010-11#1)
44 years##2##2##(1990-12#1)(2011-2#1)
44##113##1##(1990-12#2)(1990-5#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-5#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#3)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#6)(2008-3#2)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#3)(2009-5#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
44% and##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
44% of the##7##3##(1992-2#1)(2008-10#6)
44% of##10##2##(1992-2#1)(1993-8#1)(2008-10#6)(2011-1#1)(2012-3#1)
44%##34##1##(1991-12#1)(1992-2#1)(1993-11#1)(1993-8#1)(1997-1#1)(2008-10#15)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
44%)##4##1##(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
44)##7##1##(1991-2#1)(1994-3#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
44+/-0##3##1##(2008-10#3)
44-year-old##5##1##(1996-3#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
440 K##2##2##(2008-10#2)
440 mOsmol kg-1##2##3##(2008-11#2)
440 nm##6##2##(2008-10#4)(2008-2#1)(2008-8#1)
440##17##1##(1993-3#1)(1996-11#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)
440nm##3##1##(2008-10#3)
441##3##1##(2008-2#1)(2008-3#1)(2010-11#1)
442##2##1##(2008-12#1)(2008-7#1)
444##4##1##(1991-8#1)(1996-8#1)(2008-10#1)(2009-7#1)
447##2##1##(2008-10#1)(2011-1#1)
448 nm##2##2##(2008-10#2)
448##4##1##(2008-10#3)(2008-5#1)
449##2##1##(1994-11#1)(2008-10#1)
45 %##2##2##(2008-11#1)(2011-2#1)
45 +/- 0##2##3##(1993-6#1)(1994-12#1)
45 Chinese herbs##3##3##(2008-10#3)
45 and##11##2##(1990-5#1)(1991-11#1)(1991-3#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#2)(2011-2#1)(2013-1#1)
45 d##2##2##(2008-11#2)
45 days##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
45 degrees C and##4##4##(1997-2#1)(2008-10#3)
45 degrees C for##8##4##(1994-8#2)(2008-10#2)(2008-5#2)(2010-4#2)
45 degrees C##24##3##(1994-8#2)(1997-2#1)(2008-10#15)(2008-5#2)(2008-7#2)(2010-4#2)
45 degrees and##2##3##(2011-2#2)
45 degrees##36##2##(1994-8#2)(1997-2#1)(2008-10#17)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-9#1)(2010-4#2)(2011-2#4)
45 kDa##2##2##(1993-1#2)
45 min##11##2##(1990-12#1)(1993-1#1)(2008-10#4)(2008-7#1)(2010-11#1)(2013-1#2)(2013-8#1)
45 min)##3##2##(1997-7#1)(2008-11#2)
45 mug l(-1)##2##3##(2008-10#2)
45 mug##3##2##(2008-10#3)
45 mumol##2##2##(2008-10#2)
45 ng##2##2##(2008-10#2)
45 of##4##2##(1993-11#1)(1994-1#2)(2013-8#1)
45 patients##9##2##(1990-3#1)(1991-11#1)(1992-9#1)(1996-11#1)(1996-3#2)(1996-6#1)(2012-2#1)(2012-3#1)
45 s##3##2##(2008-10#3)
45 samples per hour##2##4##(2008-10#2)
45 samples per##3##3##(2008-10#3)
45 to##10##2##(1992-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-3#1)(2010-7#1)(2013-8#1)
45 were##2##2##(2008-10#1)(2008-9#1)
45 years##3##2##(1990-12#1)(1997-4#1)(2013-1#1)
45##257##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#3)(1993-12#2)(1993-3#2)(1993-6#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-6#1)(1997-2#2)(1997-4#2)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#86)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#11)(2009-10#1)(2009-3#4)(2009-4#1)(2009-7#2)(2010-11#3)(2010-12#1)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#11)(2013-8#4)
45% and##3##2##(2008-10#1)(2011-2#2)
45% for##2##2##(2008-10#2)
45% of patients##2##3##(2012-3#1)(2013-8#1)
45% of the total##2##4##(2008-10#1)(2008-8#1)
45% of the##4##3##(1991-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
45% of##9##2##(1991-2#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
45%##36##1##(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1993-1#1)(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#9)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
45%)##2##1##(2007-11#1)(2008-10#1)
45)##6##1##(1990-6#1)(1991-2#1)(1996-2#1)(2008-10#2)(2013-8#1)
45+/-0##3##1##(2008-10#3)
45-3##2##1##(2007-12#1)(2008-10#1)
45-50##2##1##(1995-6#1)(2008-10#1)
45-aa##2##1##(1990-11#1)(1993-2#1)
45-fold##4##1##(1993-1#2)(1994-5#1)(2011-2#1)
45-kDa protein##2##2##(1993-12#1)(1994-11#1)
45-kDa##4##1##(1993-1#1)(1993-12#1)(1994-11#1)(1995-6#1)
45-min##2##1##(2013-1#2)
45-year-old##4##1##(2008-10#1)(2008-11#1)(2010-5#1)(2010-6#1)
450 W##2##2##(2008-10#2)
450 bp##2##2##(1995-8#1)(1996-6#1)
450 kDa##2##2##(1990-5#1)(1996-2#1)
450 ng ml(-1)##3##3##(2008-11#3)
450 nm##4##2##(1993-8#1)(2008-10#2)(2008-11#1)
450##34##1##(1990-2#1)(1990-5#1)(1992-1#1)(1993-8#3)(1994-8#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-3#1)(2008-5#1)(2011-2#1)
4500)##2##1##(1990-11#1)(1991-2#1)
451##2##1##(2009-5#1)(2009-9#1)
452##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
453##2##1##(2008-3#2)
454##7##1##(1990-12#1)(1997-3#1)(2008-9#1)(2011-2#3)(2013-8#1)
454-sequencing##2##1##(2012-2#2)
455##5##1##(2008-11#3)(2009-5#1)(2011-2#1)
456##2##1##(2008-12#1)(2012-3#1)
457##4##1##(1994-12#1)(2008-11#1)(2010-5#1)(2011-2#1)
458##3##1##(2008-10#2)(2011-2#1)
459##3##1##(1992-3#1)(1993-12#1)(2013-8#1)
459+1G &gt##2##2##(1997-3#2)
45Ca##5##1##(1993-3#4)(1993-6#1)
45Ca2+ uptake and##2##3##(1995-11#2)
45Ca2+ uptake##8##2##(1994-5#1)(1995-11#2)(1997-1#5)
45Ca2+##9##1##(1994-11#1)(1994-5#1)(1995-11#2)(1997-1#5)
45Gy##2##1##(2008-10#2)
45S5##2##1##(2009-7#2)
45V##2##1##(2008-10#2)
45min##2##1##(2008-10#2)
45ngml(-1)##2##1##(2008-10#2)
45th Annual Meeting##2##3##(2008-10#2)
45th##3##1##(2008-10#2)(2008-7#1)
46 +/- 0##4##3##(1993-1#1)(2008-8#1)(2013-1#2)
46 V##2##2##(1990-5#1)(2008-10#1)
46 and##6##2##(1997-2#1)(2008-10#3)(2008-12#1)(2012-12#1)
46 kDa##2##2##(1994-11#1)(2008-10#1)
46 mg##3##2##(2008-10#3)
46 patients who##2##3##(1991-3#2)
46 patients with##2##3##(1991-3#1)(1992-1#1)
46 patients##8##2##(1990-2#1)(1991-3#3)(1992-1#1)(1997-3#1)(2011-2#1)(2012-3#1)
46 to##3##2##(2008-10#2)(2009-11#1)
46 x##2##2##(2008-10#2)
46##111##1##(1990-2#3)(1990-5#1)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-8#2)(1993-1#1)(1994-11#1)(1994-2#1)(1996-2#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-6#2)(2007-12#1)(2008-1#1)(2008-10#39)(2008-11#3)(2008-12#4)(2008-3#3)(2008-7#4)(2008-8#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
46% of the##4##3##(2008-10#2)(2008-12#1)(2010-4#1)
46% of##9##2##(1990-12#1)(2008-10#5)(2008-12#1)(2010-12#1)(2010-4#1)
46%##25##1##(1990-12#1)(1990-2#1)(1990-9#1)(1993-3#1)(1994-11#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2013-8#1)
46%)##3##1##(2008-10#2)(2011-2#1)
46)##4##1##(1990-6#1)(2008-10#2)(2008-7#1)
46-60-kDa component##2##2##(1995-6#2)
46-year-old man##2##2##(2008-12#1)(2008-9#1)
46-year-old##5##1##(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
460 nm for##3##3##(2008-10#3)
460 nm##6##2##(2008-10#6)
460##18##1##(1995-2#2)(2008-10#9)(2008-11#1)(2008-3#3)(2009-3#1)(2011-2#2)
461##2##1##(1994-9#1)(2008-7#1)
462##4##1##(1997-8#1)(2008-10#2)(2011-2#1)
463##5##1##(2008-10#2)(2008-5#1)(2011-2#2)
465 nm##3##2##(1994-3#1)(1996-2#1)(2008-10#1)
465##8##1##(1994-3#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-5#2)
466##5##1##(1996-12#1)(1997-6#1)(2008-11#1)(2008-8#1)(2009-7#1)
467##3##1##(1992-3#1)(1994-12#1)(2013-8#1)
469##8##1##(1993-12#1)(1994-12#1)(2008-10#3)(2008-11#2)(2011-2#1)
47 +/- 0##3##3##(1994-3#1)(1994-5#1)(2013-1#1)
47 +/-##4##2##(1994-3#1)(1994-5#1)(1996-2#1)(2013-1#1)
47 and##3##2##(2008-10#2)(2013-8#1)
47 degrees C##3##3##(2008-10#3)
47 patients with##2##3##(1991-8#1)(2013-1#1)
47 patients##5##2##(1991-8#1)(1995-12#1)(2007-11#1)(2008-3#1)(2013-1#1)
47 to##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
47 years##2##2##(2011-2#2)
47##83##1##(1990-2#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#3)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
47% in the##2##3##(1990-2#1)(2008-11#1)
47% in##3##2##(1990-2#1)(2008-10#1)(2008-11#1)
47% of the##4##3##(1992-6#1)(2008-1#1)(2008-10#2)
47% of##10##2##(1990-6#1)(1992-6#1)(1993-8#1)(2008-1#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
47%##29##1##(1990-2#1)(1990-5#1)(1990-6#1)(1992-6#1)(1993-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
47%)##2##1##(1990-6#1)(2008-10#1)
47)##3##1##(1997-8#1)(2008-10#1)(2009-10#1)
47-year-old##3##1##(2009-9#1)(2013-1#1)(2013-8#1)
470 K##2##2##(2008-3#2)
470 nm##8##2##(2008-10#6)(2008-11#2)
470##19##1##(1992-9#1)(1996-6#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#2)
470nm##5##1##(2008-10#5)
472##3##1##(1991-2#1)(1994-9#1)(2008-10#1)
473##2##1##(1997-7#1)(2008-10#1)
474##6##1##(1997-4#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
475 nm##4##2##(2008-10#4)
475##6##1##(1992-12#1)(2008-10#4)(2013-8#1)
476 patients##2##2##(1993-6#1)(2008-7#1)
476##3##1##(1993-6#1)(2008-7#2)
477##2##1##(2010-8#1)(2012-3#1)
4780 and##2##2##(2008-10#2)
4780##7##1##(2008-10#7)
479##4##1##(1991-12#1)(2008-10#2)(2010-11#1)
48 and 72 h##2##4##(1996-12#1)(2008-10#1)
48 and##8##2##(1994-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
48 cases##2##2##(2008-10#1)(2011-2#1)
48 cells##2##2##(1994-6#2)
48 cosmetics##2##2##(2008-5#2)
48 for##2##2##(2008-10#2)
48 h after inoculation##6##4##(2008-10#6)
48 h after##13##3##(1990-6#1)(1992-12#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-7#1)(2010-5#1)(2012-3#1)
48 h and##5##3##(1995-3#1)(1996-12#1)(2008-10#2)(2008-12#1)
48 h of inoculation##2##4##(2008-10#2)
48 h of##10##3##(1992-6#1)(1995-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-8#2)
48 h on##2##3##(2008-10#1)(2013-1#1)
48 h prior to##3##4##(2008-10#3)
48 h##71##2##(1990-11#1)(1990-6#1)(1990-7#1)(1992-12#1)(1992-6#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-12#3)(1995-3#1)(1996-12#3)(1996-2#1)(2008-10#32)(2008-11#7)(2008-12#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#3)
48 h)##4##2##(1991-3#2)(2008-10#1)(2008-11#1)
48 hours##7##2##(1990-12#1)(1993-12#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-6#1)(2012-12#1)
48 hr of##2##3##(2008-11#2)
48 hr##8##2##(1994-8#1)(1995-2#2)(2008-10#1)(2008-11#3)(2008-12#1)
48 hrs##4##2##(2008-12#2)(2008-8#1)(2012-3#1)
48 months##6##2##(1990-12#2)(1991-8#1)(1992-12#1)(2008-8#1)(2012-12#1)
48 months)##3##2##(2008-7#1)(2012-12#2)
48 of##3##2##(1990-9#1)(1997-3#1)(2008-12#1)
48 patients##2##2##(2008-10#1)(2011-2#1)
48 samples##3##2##(2008-10#3)
48 to 72 h after inoculation##2##6##(2008-10#2)
48 to 72 h##3##4##(2008-10#3)
48 to 72 hours##2##4##(1990-6#1)(1992-2#1)
48 to 72##5##3##(1990-6#1)(1992-2#1)(2008-10#3)
48 to##11##2##(1990-6#2)(1992-2#1)(2008-10#6)(2008-8#1)(2012-3#1)
48 weeks##2##2##(1990-6#1)(2008-5#1)
48 years##2##2##(2008-9#2)
48 ±##2##2##(2012-3#1)(2013-8#1)
48##229##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#5)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-5#1)(2007-12#1)(2008-1#4)(2008-10#71)(2008-11#17)(2008-12#8)(2008-3#2)(2008-5#10)(2008-7#5)(2008-8#9)(2008-9#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#8)(2012-12#4)(2012-2#2)(2012-3#7)(2013-1#5)(2013-8#4)
48% and##2##2##(2013-1#1)(2013-7#1)
48% of the##3##3##(1990-5#1)(1991-2#1)(2008-5#1)
48% of##5##2##(1990-5#1)(1991-2#1)(2008-5#1)(2010-8#1)(2011-2#1)
48%##19##1##(1990-5#2)(1991-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
48)##6##1##(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)
48-h CT treatment##2##3##(1994-2#2)
48-h##7##1##(1993-6#1)(1994-2#2)(1994-8#1)(2008-10#3)
48-kDa proteins##2##2##(2008-10#2)
48-kDa##3##1##(2008-10#3)
48-well##4##1##(1992-6#1)(2008-11#2)(2013-1#1)
48-year-old##6##1##(2009-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
480 and##2##2##(1994-11#1)(2008-3#1)
480 nm##2##2##(2008-10#2)
480##14##1##(1991-2#1)(1991-7#1)(1994-11#1)(2008-10#6)(2008-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
481##5##1##(1991-2#1)(1994-11#1)(1995-9#1)(2008-10#1)(2013-8#1)
482##2##1##(1996-12#1)(2012-12#1)
483##3##1##(2008-10#2)(2013-1#1)
484##2##1##(1990-8#1)(1992-9#1)
485##3##1##(1995-6#1)(2008-10#1)(2008-7#1)
486##3##1##(1992-1#1)(2008-10#1)(2011-2#1)
487##4##1##(1991-12#1)(2008-10#1)(2011-1#2)
488 nm##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
488##6##1##(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)
488-nm##2##1##(2008-9#2)
488H##3##1##(1997-2#3)
489##2##1##(1997-2#1)(2013-1#1)
49 +/- 0##2##3##(2008-5#1)(2011-2#1)
49 +/-##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
49 and##6##2##(1996-8#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#2)
49 years##2##2##(1995-9#1)(2011-2#1)
49##74##1##(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-10#2)(1995-12#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-1#3)(2008-10#21)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#1)
49% of the##3##3##(1991-8#1)(2008-10#2)
49% of##5##2##(1991-8#1)(1994-8#1)(2008-10#3)
49% reported##2##2##(2012-12#1)(2013-1#1)
49%##23##1##(1991-8#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-12#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
49%)##3##1##(2008-10#2)(2008-9#1)
49)##4##1##(1997-7#1)(2010-10#1)(2012-2#2)
490 nm##7##2##(2008-10#5)(2008-5#1)(2008-7#1)
490##12##1##(1994-8#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)
493##4##1##(1996-6#1)(1996-9#1)(2008-3#1)(2012-2#1)
495 nm##3##2##(2008-10#3)
495##7##1##(2008-10#3)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
496##2##1##(2008-10#1)(2008-11#1)
497 bp##2##2##(1993-8#1)(2011-2#1)
497##4##1##(1993-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
498 nm##2##2##(2008-10#1)(2008-8#1)
498##4##1##(2008-10#3)(2008-8#1)
499##3##1##(1997-8#2)(2008-10#1)
49th##3##1##(2008-9#1)(2009-4#1)(2010-1#1)
4A##2##1##(2008-10#2)
4AP##3##1##(2008-10#3)
4B##4##1##(1995-12#1)(1996-2#1)(2008-10#1)(2011-2#1)
4BL##2##1##(2008-10#2)
4C and##2##2##(2008-11#1)(2013-1#1)
4C##3##1##(2008-11#1)(2013-1#2)
4Cl-D-Phe2##2##1##(1994-8#2)
4D THRIVE##3##2##(2010-12#3)
4D##6##1##(2008-10#2)(2008-11#1)(2010-12#3)
4F(3/2)##2##1##(2008-3#2)
4GlcNAc beta 1##3##3##(1992-10#3)
4M##3##1##(1990-5#1)(2008-10#2)
4M5NC##5##1##(2008-10#5)
4MC##4##1##(2013-8#4)
4P2##2##1##(1993-6#2)
4R##9##1##(2008-10#9)
4S##3##1##(1996-5#2)(2007-12#1)
4S)-I and (S)-II##2##3##(2008-10#2)
4V##2##1##(2008-10#2)
4]##4##1##(1990-2#1)(1991-3#1)(1996-2#1)(2008-5#1)
4]B##2##1##(1991-3#2)
4a##5##1##(2008-10#3)(2009-9#1)(2010-7#1)
4a-diaza-s-indacene##2##1##(2008-10#2)
4cm(-1)##2##1##(2008-10#2)
4d##2##1##(1996-5#1)(2008-8#1)
4g##3##1##(2008-10#1)(2010-12#2)
4g/dl##4##1##(1996-12#3)(2008-10#1)
4g/kg##2##1##(2007-8#2)
4h##6##1##(2008-10#6)
4mV per decade of activity##2##5##(2008-10#2)
4mV per decade##3##3##(2008-10#3)
4mgcm(-3) for##2##2##(2008-10#2)
4min##6##1##(2008-10#6)
4ml##2##1##(2008-10#2)
4mlmin(-1)##2##1##(2008-10#2)
4mm##2##1##(2008-10#1)(2013-1#1)
4mugl(-1) and##2##2##(2008-10#2)
4mugl(-1)##4##1##(2008-10#4)
4mumolL(-1)##2##1##(2008-10#2)
4nM##2##1##(1993-3#1)(2008-10#1)
4ngg(-1)##5##1##(2008-10#5)
4ngml(-1)##3##1##(2008-10#3)
4pg for##2##2##(2008-10#2)
4q32→q35##3##1##(2012-3#3)
4th age##2##2##(1992-9#2)
4th##24##1##(1990-12#1)(1992-9#2)(1994-11#1)(1994-3#1)(1995-3#1)(1997-2#1)(2008-10#3)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#2)
4x10(-4)##3##1##(2008-10#3)
4x10(-5)##2##1##(2008-10#2)
4x10(-6)##4##1##(2008-10#3)(2008-11#1)
4x10(-7)##3##1##(2008-10#3)
4x10(-8) mol l(-1)##3##3##(2008-10#3)
4x10(-8) to##5##2##(2008-10#5)
4x10(-8)##10##1##(2008-10#10)
4x10(-8)M##2##1##(2008-10#2)
4x10(-9)##2##1##(2007-12#1)(2008-10#1)
4x10(2)##2##1##(2008-10#2)
4x10(3)##2##1##(2008-10#2)
4×##2##1##(2013-1#2)
4 weeks##2##1##(2011-2#1)(2013-1#1)
5 %##5##2##(1997-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
5 %)##4##2##(2011-2#1)(2012-12#3)
5 &lt##2##2##(2008-10#2)
5 (4##2##2##(2008-10#1)(2013-1#1)
5 (wt/wt)##3##2##(2008-10#3)
5 +/- 0##6##3##(1994-5#1)(1994-8#1)(1996-3#1)(2008-10#2)(2008-11#1)
5 +/- 1##2##3##(1994-8#1)(2008-12#1)
5 +/- 2##3##3##(1992-2#1)(2008-11#1)(2008-12#1)
5 +/- 3##4##3##(1993-8#1)(1994-12#1)(2008-12#1)(2010-1#1)
5 +/- 5##7##3##(1993-8#1)(1994-12#1)(2008-10#1)(2008-12#2)(2010-7#1)(2010-8#1)
5 +/- 9##2##3##(1996-3#1)(2009-1#1)
5 +/-##31##2##(1992-2#1)(1993-8#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1996-3#2)(2008-10#5)(2008-11#2)(2008-12#6)(2009-1#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#2)
5 -##4##2##(1996-3#1)(2008-5#1)(2011-3#2)
5 A Day Program##2##4##(1997-1#2)
5 A Day for Better Health Program##2##7##(1997-1#2)
5 A Day##4##3##(1997-1#4)
5 A##7##2##(1995-2#1)(1997-1#4)(2008-10#2)
5 Gy##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
5 Hz##3##2##(2008-7#3)
5 J/cm2##2##2##(2012-2#1)(2013-1#1)
5 K##3##2##(2008-3#1)(2008-8#1)(2010-6#1)
5 Kb##2##2##(1992-3#1)(2008-11#1)
5 L##2##2##(2008-11#1)(2008-7#1)
5 M CdCl(2)##2##3##(2008-10#2)
5 M H(2)SO(4)##3##3##(2008-10#3)
5 M HCl##3##3##(2008-10#3)
5 M HNO(3)##2##3##(2008-10#2)
5 M KNO(3)##2##3##(2008-10#2)
5 M NaCl##5##3##(1990-12#2)(2008-10#3)
5 M for##4##3##(2008-10#4)
5 M hydrochloric acid##2##4##(2008-10#2)
5 M##34##2##(1990-12#2)(1991-7#1)(1995-11#1)(1997-8#1)(2008-10#27)(2010-8#1)(2011-2#1)
5 M)##2##2##(2008-10#2)
5 MHz##2##2##(2007-12#1)(2008-2#1)
5 MPa##2##2##(2008-10#1)(2008-3#1)
5 T##3##2##(1995-11#1)(1997-8#2)
5 V versus Ag/AgCl##2##4##(2008-10#2)
5 V vs##2##3##(2008-10#2)
5 V##7##2##(2008-10#7)
5 W of##3##3##(2008-3#3)
5 W##5##2##(2008-2#1)(2008-3#3)(2008-9#1)
5 W-1##2##2##(2009-7#2)
5 We##2##2##(2009-6#2)
5 acetate##2##2##(2008-10#2)
5 adjusted with##2##3##(2008-10#2)
5 alpha-DHP##3##2##(1990-11#3)
5 alpha-dihydroprogesterone##3##2##(1990-11#2)(1996-2#1)
5 alpha-dihydrotestosterone##3##2##(1990-11#1)(1996-2#2)
5 alpha-reductase activity##2##3##(1990-11#1)(1995-9#1)
5 alpha-reductase##5##2##(1990-11#4)(1995-9#1)
5 alpha-tetrahydroprogesterone##2##2##(1990-11#1)(1996-2#1)
5 amino##2##2##(1997-9#1)(2008-11#1)
5 and 0##10##3##(1993-8#1)(1997-8#1)(2008-10#7)(2008-7#1)
5 and 1##19##3##(2008-10#17)(2008-7#1)(2011-2#1)
5 and 10 micrograms/ml##2##4##(1990-2#1)(1994-11#1)
5 and 10##16##3##(1990-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2012-2#1)
5 and 10%##2##3##(2008-10#1)(2013-1#1)
5 and 100##3##3##(2008-10#3)
5 and 102##2##3##(2008-10#2)
5 and 103##3##3##(2008-10#3)
5 and 104##2##3##(2008-10#2)
5 and 10years##2##3##(2011-3#2)
5 and 11%##2##3##(2008-10#2)
5 and 14##2##3##(1992-12#1)(2008-10#1)
5 and 15 min##2##4##(1993-1#1)(2008-10#1)
5 and 15##4##3##(1993-1#1)(1993-9#1)(2008-10#2)
5 and 15%##2##3##(2008-10#2)
5 and 18##3##3##(2008-10#2)(2011-1#1)
5 and 2##12##3##(2007-12#1)(2008-10#10)(2008-8#1)
5 and 20##6##3##(1993-8#1)(1995-3#1)(2008-10#1)(2011-2#1)(2012-3#2)
5 and 25 degrees C##3##5##(2008-10#2)(2009-7#1)
5 and 25##6##3##(1994-2#1)(2008-10#4)(2009-7#1)
5 and 3##8##3##(1990-2#1)(1995-3#1)(2008-10#5)(2011-2#1)
5 and 37##2##3##(1993-8#1)(2008-10#1)
5 and 4##6##3##(1990-2#1)(1995-6#1)(2008-10#3)(2008-11#1)
5 and 5##10##3##(1993-8#2)(2008-10#7)(2008-12#1)
5 and 6##10##3##(1991-3#1)(1992-4#1)(1993-2#1)(2008-10#5)(2008-11#1)(2008-7#1)
5 and 7##3##3##(2008-10#1)(2008-5#2)
5 and 8##8##3##(2008-10#6)(2008-6#1)(2010-1#1)
5 and 9##2##3##(2008-10#1)(2008-6#1)
5 and a##3##3##(1996-2#1)(2008-10#1)(2012-12#1)
5 and decreased when p approached 0 or 1##2##9##(2008-10#2)
5 and in##3##3##(1993-8#1)(2008-10#2)
5 and the##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
5 and then##2##3##(1993-8#1)(2008-10#1)
5 and were##2##3##(2008-10#2)
5 and##232##2##(1990-2#3)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-12#3)(1992-4#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-8#8)(1993-9#1)(1994-11#1)(1994-2#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#151)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
5 approximately##3##2##(2008-10#2)(2008-11#1)
5 are##3##2##(2008-10#2)(2012-2#1)
5 at##5##2##(2008-10#4)(2008-3#1)
5 billion##5##2##(1996-5#2)(1997-3#1)(2008-10#1)(2008-11#1)
5 buffers##2##2##(2008-10#2)
5 cM##3##2##(2008-10#2)(2008-9#1)
5 cases per##2##3##(1990-9#1)(1997-5#1)
5 cases##10##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-8#3)(1997-5#1)(2007-8#1)
5 cm depth##2##3##(2008-10#1)(2009-11#1)
5 cm in##2##3##(2012-3#1)(2013-8#1)
5 cm was##2##3##(1991-12#1)(2013-1#1)
5 cm##30##2##(1991-12#1)(1992-5#1)(1992-6#1)(1993-3#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#4)(2011-1#2)(2012-3#1)(2013-1#7)(2013-8#1)
5 cm(3)##2##2##(2008-10#2)
5 cm)##2##2##(1991-6#1)(2008-7#1)
5 cm2 or less##2##4##(1996-1#2)
5 cm2 or##3##3##(1996-1#3)
5 consecutive days##2##3##(1991-2#1)(2008-10#1)
5 consecutive##3##2##(1991-2#1)(1994-11#1)(2008-10#1)
5 dB##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
5 daily##2##2##(1990-10#1)(1992-12#1)
5 days a week for##2##5##(2008-9#2)
5 days after inoculation##3##4##(2008-10#3)
5 days after##8##3##(2008-10#8)
5 days and then##2##4##(2008-10#2)
5 days and##3##3##(2008-10#2)(2010-5#1)
5 days at##3##3##(2008-10#3)
5 days in##2##3##(2008-10#1)(2008-11#1)
5 days of##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
5 days per week for 26 weeks##2##7##(2008-9#2)
5 days per week for##3##5##(2008-9#2)(2013-1#1)
5 days per week##4##4##(2008-9#2)(2013-1#2)
5 days##47##2##(1990-11#1)(1990-2#1)(1993-12#1)(1993-3#1)(1994-5#1)(2008-10#21)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#4)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#4)
5 days)##4##2##(1992-2#2)(2007-8#1)(2011-2#1)
5 degrees C for##2##4##(2008-10#1)(2008-9#1)
5 degrees C##22##3##(1993-2#1)(1995-6#1)(2008-10#16)(2008-11#1)(2008-9#1)(2009-8#1)(2010-4#1)
5 degrees C)##3##3##(2008-10#2)(2008-7#1)
5 degrees##33##2##(1990-3#1)(1993-2#1)(1995-6#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2013-1#2)
5 different##3##2##(1991-7#1)(2008-8#1)(2008-9#1)
5 dph##2##2##(2010-8#2)
5 fmol of##2##3##(2008-10#1)(2008-6#1)
5 for##7##2##(1992-6#1)(2008-10#4)(2008-11#1)(2008-3#1)
5 from##3##2##(2008-10#3)
5 g kg(-1))##3##3##(2008-10#3)
5 g l(-1)##4##3##(2008-10#3)(2008-11#1)
5 g of sample is##2##5##(2008-10#2)
5 g of##6##3##(2008-10#4)(2008-12#2)
5 g##18##2##(1991-11#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2011-2#1)
5 g/L of the##2##4##(2008-11#2)
5 g/L of##3##3##(2008-11#2)(2008-7#1)
5 g/L##5##2##(2008-11#3)(2008-7#2)
5 g/l##3##2##(2008-11#1)(2008-5#2)
5 h after##6##3##(1995-11#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#2)
5 h and##5##3##(1992-3#1)(2008-10#3)(2008-8#1)
5 h in##3##3##(1995-6#1)(2008-10#2)
5 h##23##2##(1991-2#1)(1992-3#1)(1995-11#1)(1995-6#1)(1997-1#2)(1997-7#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-8#1)
5 has been##2##3##(1997-7#1)(2008-10#1)
5 have been##4##3##(1991-6#1)(1994-11#1)(2008-10#1)(2009-8#1)
5 have##5##2##(1991-6#2)(1994-11#1)(2008-10#1)(2009-8#1)
5 hours##6##2##(1991-12#1)(1992-6#1)(1993-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
5 in the##7##3##(1992-2#1)(1992-6#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
5 in##16##2##(1990-9#1)(1992-2#1)(1992-6#1)(1996-5#4)(1997-6#1)(2008-10#6)(2008-5#1)(2008-7#1)
5 infected##2##2##(1990-6#1)(2008-10#1)
5 is##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
5 kDa##12##2##(1990-5#2)(1991-12#2)(1993-2#1)(1993-6#1)(2008-10#3)(2008-12#1)(2008-6#1)(2011-2#1)
5 kDa) and##2##3##(1995-11#1)(2008-10#1)
5 kDa)##4##2##(1995-11#1)(2008-10#2)(2010-11#1)
5 kHz##2##2##(2008-10#1)(2008-3#1)
5 kJ##2##2##(2008-10#1)(2008-5#1)
5 kPa##2##2##(2008-10#2)
5 kb and##3##3##(1993-12#1)(1994-11#1)(2008-11#1)
5 kb in length##2##4##(1993-2#2)
5 kb in the##3##4##(1990-2#1)(2008-11#2)
5 kb in##5##3##(1990-2#1)(1993-2#2)(2008-11#2)
5 kb of##2##3##(1993-2#1)(1996-12#1)
5 kb on##2##3##(1996-6#1)(1997-7#1)
5 kb##19##2##(1990-2#2)(1993-12#2)(1993-2#3)(1993-3#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2008-11#3)(2012-3#1)
5 kb)##4##2##(1994-11#1)(1995-6#1)(1997-2#1)(2008-10#1)
5 kg##2##2##(2008-10#1)(2008-12#1)
5 km##5##2##(2008-2#1)(2008-3#3)(2008-7#1)
5 ku##2##2##(2008-8#2)
5 l##4##2##(2008-11#4)
5 labeled anti-BSM monoclonal antibody##2##5##(2008-10#2)
5 m##10##2##(2008-10#7)(2008-3#1)(2010-8#2)
5 m/s##2##2##(2009-7#2)
5 mJ at##2##3##(2008-2#1)(2008-3#1)
5 mJ##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
5 mM and##4##3##(1994-6#1)(2008-11#2)(2011-2#1)
5 mM aspirin##3##3##(2008-11#3)
5 mM glucose##4##3##(1992-8#1)(1995-8#1)(1997-1#1)(2008-10#1)
5 mM phosphate buffer (pH##2##5##(2008-10#2)
5 mM potassium##2##3##(2008-10#2)
5 mM##45##2##(1990-8#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-8#2)(1996-2#1)(1997-1#3)(1997-8#1)(2008-10#23)(2008-11#9)(2011-2#1)
5 mM)##6##2##(1993-11#1)(1994-11#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-11#1)
5 mV per decade##6##4##(2008-10#6)
5 mV##7##2##(2008-10#7)
5 mg DBTC/kg BW##2##4##(2008-10#2)
5 mg DBTC/kg##3##3##(2008-10#3)
5 mg L(-1) BAP##2##4##(2008-12#2)
5 mg L(-1)##4##3##(2008-12#4)
5 mg kg(-1)##2##3##(2008-10#2)
5 mg l(-1) Cl##2##4##(2008-10#2)
5 mg l(-1) copper##2##4##(2008-10#2)
5 mg l(-1) for##2##4##(2008-10#2)
5 mg l(-1)##16##3##(2008-10#16)
5 mg l(-1)) was##2##4##(2008-10#2)
5 mg l(-1))##5##3##(2008-10#5)
5 mg ml(-1)##2##3##(2008-10#2)
5 mg of##4##3##(1992-12#1)(1997-1#1)(2008-10#2)
5 mg plain bupivacaine##2##4##(2011-2#2)
5 mg##48##2##(1992-12#1)(1993-2#1)(1996-3#1)(1997-1#1)(2008-10#34)(2008-12#4)(2008-5#2)(2010-1#1)(2011-2#2)(2013-1#1)
5 mg)##2##2##(1990-6#1)(2008-10#1)
5 mg/L for##3##3##(2008-10#3)
5 mg/L##4##2##(2008-10#3)(2013-1#1)
5 mg/L)##2##2##(2013-1#2)
5 mg/dl##2##2##(1994-12#1)(2012-3#1)
5 mg/kg i##3##3##(1991-2#1)(1992-3#1)(1996-2#1)
5 mg/kg##17##2##(1990-7#1)(1991-2#2)(1992-3#1)(1994-2#3)(1995-11#1)(1996-2#4)(2008-10#2)(2008-9#2)(2011-2#1)
5 mg/kg)##8##2##(1991-2#1)(1992-8#2)(1993-6#1)(1994-2#1)(1994-8#1)(2008-10#1)(2012-2#1)
5 mg/liter##4##2##(2008-10#4)
5 mg/ml##5##2##(1990-9#1)(2008-10#1)(2012-3#3)
5 microM##13##2##(1990-2#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#2)(1997-8#1)(2008-10#2)(2008-8#2)
5 microM)##6##2##(1991-5#2)(1993-6#1)(1995-11#2)(2008-8#1)
5 microg l(-1)##5##3##(2008-10#5)
5 microg ml(-1)##3##3##(2008-10#3)
5 microg##12##2##(2008-10#12)
5 microg/kg remifentanil##2##3##(2011-2#2)
5 microg/ml##2##2##(2008-10#1)(2008-7#1)
5 micrograms/ml##3##2##(1990-6#1)(1993-6#1)(1994-11#1)
5 microl##3##2##(2008-10#3)
5 microm##5##2##(2008-10#2)(2008-2#2)(2008-7#1)
5 microm)##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-3#1)
5 micron##3##2##(1992-12#1)(2008-10#1)(2012-3#1)
5 million##4##2##(1992-6#1)(1997-3#1)(2008-10#1)(2012-3#1)
5 min accumulation##2##3##(2008-10#2)
5 min after histamine treatment##2##5##(2008-12#2)
5 min after##5##3##(2008-12#3)(2010-10#1)(2012-3#1)
5 min and##4##3##(1990-5#1)(2008-10#1)(2008-9#1)(2013-1#1)
5 min at##2##3##(2008-10#2)
5 min for##3##3##(2008-10#3)
5 min of##3##3##(1993-1#1)(2008-10#2)
5 min to##2##3##(1994-8#1)(1997-2#1)
5 min with##2##3##(2008-10#2)
5 min##67##2##(1990-5#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#43)(2008-12#4)(2008-9#2)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
5 min(-1)##2##2##(2008-10#1)(2011-3#1)
5 min)##5##2##(1993-1#1)(1997-2#1)(2008-10#2)(2008-6#1)
5 minutes##3##2##(1994-11#1)(1995-3#1)(2012-3#1)
5 ml min(-1)##5##3##(2008-10#5)
5 ml of a##3##4##(2008-10#3)
5 ml of dimethylformamide##4##4##(2008-10#4)
5 ml of##24##3##(2008-10#23)(2013-1#1)
5 ml sample##2##3##(2008-10#2)
5 ml##44##2##(1992-2#1)(1994-12#1)(2008-10#41)(2013-1#1)
5 ml/min##2##2##(1997-2#1)(2008-4#1)
5 mm calcium hydroxide apical plug##2##6##(2013-1#2)
5 mm i##2##3##(2008-10#2)
5 mm in diameter##2##4##(2008-10#2)
5 mm in##4##3##(2008-10#3)(2013-1#1)
5 mm is##2##3##(2008-10#1)(2011-2#1)
5 mm with##2##3##(2013-1#2)
5 mm x 0##2##4##(2008-2#2)
5 mm##43##2##(1991-1#2)(1991-12#2)(1993-3#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2011-2#2)(2012-12#1)(2013-1#13)(2013-8#1)
5 mm)##5##2##(2008-10#2)(2012-2#3)
5 mmol l(-1)##3##3##(2008-10#3)
5 mmol##5##2##(2008-10#5)
5 mmol/kg##3##2##(1992-12#1)(1994-5#1)(2008-11#1)
5 mmol/l##5##2##(1990-2#1)(1990-6#1)(1991-11#1)(1994-6#2)
5 mol dm(-3)##4##3##(2008-10#4)
5 mol l(-1) HCl##3##4##(2008-10#3)
5 mol l(-1) sulfuric acid for##2##6##(2008-10#2)
5 mol l(-1)##11##3##(2008-10#11)
5 mol##16##2##(1993-8#1)(2008-10#15)
5 months (range##2##3##(2008-10#1)(2010-3#1)
5 months after##3##3##(1991-2#1)(1996-12#1)(2013-1#1)
5 months and the##2##4##(2008-10#1)(2013-1#1)
5 months and##4##3##(1990-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
5 months for##2##3##(1994-8#1)(2011-2#1)
5 months later##2##3##(2008-7#1)(2013-1#1)
5 months to##2##3##(2008-7#1)(2012-12#1)
5 months with##2##3##(2008-10#2)
5 months without any##2##4##(2008-10#2)
5 months without##3##3##(2008-10#3)
5 months##41##2##(1990-3#1)(1990-9#1)(1991-2#2)(1991-8#1)(1992-2#1)(1994-8#3)(1995-2#1)(1995-8#1)(1996-12#1)(1996-9#1)(2008-1#1)(2008-10#14)(2008-7#3)(2009-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#4)
5 months)##3##2##(1997-9#1)(2008-10#1)(2013-1#1)
5 mouse##3##2##(1997-7#1)(2008-10#2)
5 mu##2##2##(2008-10#1)(2008-11#1)
5 muA##2##2##(2008-10#2)
5 muM##8##2##(2008-10#6)(2008-11#2)
5 muM)##2##2##(2008-10#2)
5 mug a##2##3##(2008-10#2)
5 mug g(-1)##4##3##(2008-10#4)
5 mug l(-1) for##7##4##(2008-10#7)
5 mug l(-1)##14##3##(2008-10#14)
5 mug ml(-1) and##2##4##(2008-10#2)
5 mug ml(-1) for##4##4##(2008-10#4)
5 mug ml(-1)##13##3##(2008-10#13)
5 mug ml(-1))##2##3##(2008-10#2)
5 mug of##2##3##(2008-10#2)
5 mug##44##2##(2008-10#41)(2008-11#2)(2008-5#1)
5 mug/ml##2##2##(2008-10#1)(2008-11#1)
5 mul##2##2##(2008-10#2)
5 mum and##3##3##(2008-11#1)(2008-3#2)
5 mum##18##2##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#6)(2008-7#1)(2009-8#1)
5 mumol##2##2##(2008-10#2)
5 mumoll(-1))##2##2##(2008-10#2)
5 nM##8##2##(1990-8#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-10#3)
5 nM)##2##2##(1991-5#1)(1994-8#1)
5 ng ml(-1) for##3##4##(2008-10#3)
5 ng ml(-1)##14##3##(2008-10#14)
5 ng of##4##3##(2008-10#3)(2008-11#1)
5 ng##25##2##(2008-10#22)(2008-11#2)(2008-12#1)
5 ng/g for##2##3##(2008-10#2)
5 ng/ml in##2##3##(1990-12#2)
5 ng/ml##6##2##(1990-12#2)(1992-6#1)(1994-3#1)(2008-10#2)
5 ngml(-1)##2##2##(2008-10#2)
5 nm##9##2##(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-5#2)
5 nmol##2##2##(1991-3#1)(2010-4#1)
5 nmol/mol##2##2##(2008-3#2)
5 of the##5##3##(1997-7#1)(2008-8#1)(2011-2#2)(2012-12#1)
5 of these##4##3##(1991-6#1)(1996-11#1)(1997-8#1)(2008-10#1)
5 of##16##2##(1990-6#1)(1991-6#1)(1996-11#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-8#2)(2011-2#3)(2012-12#1)(2012-2#1)
5 on##5##2##(2008-10#4)(2008-7#1)
5 or 10##3##3##(2008-10#2)(2013-8#1)
5 or##10##2##(2008-10#6)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
5 orders of magnitude##3##4##(2008-10#2)(2008-3#1)
5 other##2##2##(1991-8#1)(2013-1#1)
5 out of##2##3##(2011-2#1)(2013-1#1)
5 over a##2##3##(1992-3#1)(2008-10#1)
5 over##3##2##(1992-3#1)(2008-10#2)
5 pM##2##2##(2008-10#1)(2008-11#1)
5 patients who did not##2##5##(1994-12#1)(2013-1#1)
5 patients with##2##3##(1990-3#1)(2008-7#1)
5 patients##14##2##(1990-12#1)(1990-3#1)(1992-6#1)(1992-9#2)(1994-12#3)(2007-11#1)(2008-7#1)(2009-3#1)(2011-2#2)(2013-1#1)
5 per cent##3##3##(1990-6#1)(1996-6#2)
5 per cent)##2##3##(1991-11#2)
5 per##8##2##(1990-6#1)(1991-11#2)(1996-6#2)(2008-10#3)
5 percent of their total##2##5##(1996-3#2)
5 percent of##5##3##(1992-2#1)(1994-1#1)(1994-3#1)(1996-3#2)
5 percent##10##2##(1991-3#1)(1992-2#2)(1994-1#1)(1994-3#1)(1995-6#2)(1996-3#2)(1997-3#1)
5 pg ml(-1)##2##3##(2008-10#2)
5 pg##7##2##(2008-10#7)
5 pg)##2##2##(2008-10#2)
5 pg/ml##2##2##(1995-8#1)(2011-2#1)
5 plants##2##2##(2008-10#1)(2008-8#1)
5 points##2##2##(1991-2#1)(2012-3#1)
5 ppb (for##2##3##(2008-10#2)
5 ppb for##2##3##(2008-10#2)
5 ppb##6##2##(2008-10#6)
5 ppm of##2##3##(2008-10#2)
5 ppm##9##2##(1990-3#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-3#1)
5 s##6##2##(1997-1#1)(1997-2#3)(2008-10#2)
5 samples##2##2##(2008-10#2)
5 sec##2##2##(2008-5#1)(2010-7#1)
5 sets of##2##3##(2009-1#2)
5 software##2##2##(2008-10#2)
5 the##2##2##(1994-5#1)(2011-1#1)
5 times as##2##3##(1994-9#1)(2013-8#1)
5 times greater than the##2##5##(1991-2#1)(1996-2#1)
5 times greater##3##3##(1991-2#1)(1996-2#1)(2008-11#1)
5 times higher##2##3##(2008-11#2)
5 times the##2##3##(1992-9#1)(2010-3#1)
5 times##19##2##(1991-2#1)(1992-4#1)(1992-9#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-8#2)(2010-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
5 to $4##2##3##(1992-3#1)(1994-1#1)
5 to +2##2##3##(2008-10#2)
5 to 0##4##3##(2008-10#3)(2012-3#1)
5 to 1##10##3##(1993-11#1)(1993-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)
5 to 10##7##3##(2008-10#7)
5 to 10% of##2##4##(1996-12#1)(2009-12#1)
5 to 101##2##3##(2008-10#2)
5 to 11##5##3##(2008-10#4)(2012-3#1)
5 to 14##2##3##(2012-12#2)
5 to 2##3##3##(2007-12#1)(2008-10#2)
5 to 20##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
5 to 25##4##3##(2008-10#4)
5 to 3##3##3##(2008-11#2)(2013-1#1)
5 to 4##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
5 to 40##2##3##(2008-10#1)(2013-1#1)
5 to 5##6##3##(2008-10#4)(2008-5#1)(2013-1#1)
5 to 50##2##3##(2008-10#2)
5 to 6 days##2##4##(2008-10#1)(2008-11#1)
5 to 6##9##3##(1990-9#1)(2008-10#5)(2008-11#1)(2013-1#2)
5 to 7##3##3##(2008-10#3)
5 to 8##2##3##(2008-10#2)
5 to 8%##2##3##(1991-5#1)(2008-11#1)
5 to 9##4##3##(1994-5#1)(2007-12#1)(2008-11#1)(2012-3#1)
5 to##136##2##(1990-6#2)(1990-9#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-1#2)(1994-5#1)(1995-11#1)(1996-12#2)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#84)(2008-11#8)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#1)(2009-12#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)
5 versus##2##2##(2008-4#1)(2010-11#1)
5 vs##3##2##(1994-8#1)(2010-1#1)(2012-3#1)
5 was achieved for##2##4##(2008-10#2)
5 was achieved##3##3##(2008-10#3)
5 was##11##2##(1990-3#1)(1992-12#1)(1996-5#1)(2008-10#6)(2010-3#1)(2011-2#1)
5 week##2##2##(1995-12#2)
5 weeks after##5##3##(1995-12#1)(1995-2#1)(2008-10#2)(2013-8#1)
5 weeks before##2##3##(2008-10#2)
5 weeks of age##2##4##(2011-2#2)
5 weeks of##4##3##(2008-5#1)(2011-2#2)(2013-8#1)
5 weeks##18##2##(1990-5#1)(1995-12#1)(1995-2#1)(2008-10#7)(2008-5#2)(2011-2#3)(2013-1#1)(2013-8#2)
5 were##14##2##(1990-5#1)(1993-8#1)(1994-5#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2010-9#1)(2011-1#1)
5 with glutaraldehyde 0##3##4##(2008-5#3)
5 with##14##2##(1991-11#1)(1994-5#1)(1996-5#4)(2008-10#3)(2008-5#3)(2008-7#2)
5 without##2##2##(2008-10#1)(2011-2#1)
5 wt##10##2##(2008-10#8)(2008-5#2)
5 x 0##2##3##(2008-10#2)
5 x 10(-10)##2##3##(1995-11#1)(2008-10#1)
5 x 10(-11)##3##3##(2008-10#3)
5 x 10(-4)##2##3##(2008-10#1)(2008-3#1)
5 x 10(-5)##5##3##(1994-5#1)(2008-10#3)(2010-1#1)
5 x 10(-6) M##3##4##(1991-5#1)(1994-5#1)(2008-10#1)
5 x 10(-6) to##2##4##(2008-10#2)
5 x 10(-6)##8##3##(1991-5#1)(1994-5#1)(2008-10#6)
5 x 10(-6)-1 x##2##4##(2008-10#2)
5 x 10(-7) mol##2##4##(2008-10#2)
5 x 10(-7)##4##3##(1990-8#1)(2008-10#2)(2008-2#1)
5 x 10(-9)##2##3##(2008-10#1)(2008-3#1)
5 x 10(3) CFU##2##4##(1996-12#2)
5 x 10(3)##7##3##(1996-12#3)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
5 x 10(4)##4##3##(1993-8#1)(2008-10#3)
5 x 10(5) and##2##4##(2008-10#2)
5 x 10(5)##5##3##(2008-10#4)(2008-3#1)
5 x 10(6) cells##2##4##(2008-11#2)
5 x 10(6) cells/ml##2##4##(2008-7#2)
5 x 10(6)##5##3##(2008-11#3)(2008-7#2)
5 x 10(9) cells##2##4##(2008-10#1)(2008-11#1)
5 x 10(9)##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
5 x##71##2##(1990-8#1)(1991-5#2)(1993-8#1)(1994-5#2)(1995-11#1)(1995-2#1)(1996-12#3)(1996-5#1)(2008-10#40)(2008-11#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)
5 year survival rate##2##4##(1990-6#2)
5 year survival##3##3##(1990-6#2)(2011-2#1)
5 year##8##2##(1990-6#2)(1993-9#1)(2008-10#3)(2008-12#1)(2011-2#1)
5 years (range##3##3##(1991-8#1)(2013-1#2)
5 years after the##2##4##(2009-3#1)(2011-2#1)
5 years after##6##3##(1991-6#1)(2008-12#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#1)
5 years ago##2##3##(2010-6#1)(2011-2#1)
5 years and##3##3##(1991-8#1)(2011-1#1)(2013-1#1)
5 years at##2##3##(2008-10#1)(2012-2#1)
5 years experience##2##3##(1991-2#1)(1994-12#1)
5 years for##2##3##(2011-2#1)(2013-1#1)
5 years in##2##3##(1997-7#1)(2010-6#1)
5 years of age##4##4##(2008-1#1)(2008-10#1)(2008-11#2)
5 years of##9##3##(1990-6#1)(1991-2#1)(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2012-3#1)
5 years old##2##3##(1994-9#1)(1996-11#1)
5 years were##2##3##(1994-12#1)(2012-12#1)
5 years##97##2##(1990-6#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#4)(1992-1#1)(1992-6#1)(1994-12#4)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-11#3)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#2)(2010-11#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#8)
5 years)##5##2##(1990-12#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-3#1)
5 yr##2##2##(2008-8#1)(2008-9#1)
5 ± 0##4##3##(2010-11#1)(2011-2#1)(2012-3#2)
5 ±##8##2##(2010-11#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
5 ×##2##2##(2010-12#1)(2012-3#1)
5 μm##2##2##(2012-2#2)
5##3542##1##(1990-10#1)(1990-11#32)(1990-12#16)(1990-2#13)(1990-3#8)(1990-5#13)(1990-6#19)(1990-7#3)(1990-8#7)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#11)(1991-12#16)(1991-2#14)(1991-3#6)(1991-5#12)(1991-6#10)(1991-7#3)(1991-8#11)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#11)(1992-2#11)(1992-3#12)(1992-4#4)(1992-5#2)(1992-6#8)(1992-8#4)(1992-9#7)(1993-1#7)(1993-11#3)(1993-12#13)(1993-2#14)(1993-3#12)(1993-6#15)(1993-8#30)(1993-9#3)(1994-1#3)(1994-11#17)(1994-12#17)(1994-2#11)(1994-3#7)(1994-5#18)(1994-6#9)(1994-8#17)(1994-9#3)(1995-1#2)(1995-11#28)(1995-12#9)(1995-2#10)(1995-3#6)(1995-6#17)(1995-8#13)(1995-9#2)(1996-1#3)(1996-11#7)(1996-12#14)(1996-2#17)(1996-3#12)(1996-5#23)(1996-6#5)(1996-9#1)(1997-1#14)(1997-2#20)(1997-3#9)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#9)(1997-8#30)(1997-9#3)(2006-6#1)(2007-11#5)(2007-12#9)(2007-8#7)(2008-1#6)(2008-10#1750)(2008-11#159)(2008-12#48)(2008-2#21)(2008-3#66)(2008-4#6)(2008-5#84)(2008-6#16)(2008-7#66)(2008-8#49)(2008-9#50)(2009-1#5)(2009-10#5)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#7)(2009-5#3)(2009-6#4)(2009-7#7)(2009-8#8)(2009-9#3)(2010-1#11)(2010-10#3)(2010-11#13)(2010-12#6)(2010-3#3)(2010-4#6)(2010-5#6)(2010-6#9)(2010-7#5)(2010-8#9)(2010-9#1)(2011-1#15)(2011-2#103)(2011-3#10)(2012-12#23)(2012-2#29)(2012-3#52)(2012-4#1)(2013-1#86)(2013-3#2)(2013-8#21)
5% (4##2##2##(2008-7#1)(2013-1#1)
5% (n =##2##3##(2008-10#2)
5% (n=5) for##2##3##(2008-10#2)
5% (n=5)##3##2##(2008-10#3)
5% (v/v) acetic acid##2##4##(2008-10#2)
5% (v/v) nitric acid##2##4##(2008-10#2)
5% (v/v)##10##2##(2008-10#10)
5% (w/v) sodium##2##3##(2008-10#2)
5% (w/v)##3##2##(2008-10#3)
5% (w/w) of##3##3##(2008-10#3)
5% (w/w)##4##2##(2008-10#4)
5% Alkamuls##2##2##(2008-10#2)
5% BSA##2##2##(2008-10#2)
5% CO(2) supply##3##3##(2008-11#3)
5% CO(2)##8##2##(2008-11#8)
5% CO2##3##2##(1996-2#1)(2008-5#1)(2013-1#1)
5% FBS##3##2##(1997-8#1)(2008-11#1)(2008-9#1)
5% H(2)##2##2##(2008-10#2)
5% NaCl intake##2##3##(1997-4#2)
5% NaCl##4##2##(1997-4#3)(2008-10#1)
5% NaOCl##3##2##(2013-1#3)
5% R##6##2##(2008-10#6)
5% RSD##3##2##(2008-10#3)
5% acetonitrile##2##2##(2008-10#2)
5% and 10% formalin##2##4##(1996-12#2)
5% and 2##2##3##(1997-2#1)(2008-10#1)
5% and R##2##3##(2008-10#2)
5% and a##3##3##(1996-3#1)(2008-10#2)
5% and the##5##3##(1996-3#1)(2008-10#4)
5% and##47##2##(1991-8#1)(1992-11#1)(1992-12#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#4)(1996-3#2)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
5% as##2##2##(1994-12#1)(1994-8#1)
5% at a##2##3##(2008-10#1)(2008-3#1)
5% at the##3##3##(1990-11#1)(2008-10#2)
5% at##12##2##(1990-11#1)(1991-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
5% between##4##2##(1997-2#1)(1997-7#1)(2008-10#2)
5% bupivacaine with##2##3##(1993-1#2)
5% bupivacaine##4##2##(1993-1#3)(1995-3#1)
5% confidence##2##2##(2008-10#1)(2010-4#1)
5% ethanol##2##2##(1993-8#1)(2008-10#1)
5% for a##2##3##(2008-10#2)
5% for both##4##3##(2008-10#4)
5% for ten##2##3##(2008-10#2)
5% for the##8##3##(2008-10#7)(2010-11#1)
5% for##43##2##(1991-6#1)(1994-12#2)(2007-8#1)(2008-1#1)(2008-10#33)(2008-12#1)(2008-2#1)(2008-5#1)(2010-11#1)(2011-2#1)
5% glucose##2##2##(2008-10#1)(2009-6#1)
5% higher than##2##3##(2009-3#1)(2013-1#1)
5% in the##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
5% in##12##2##(1990-9#1)(1994-3#1)(1994-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
5% increase)##2##2##(1995-5#1)(2013-1#1)
5% lower in##2##3##(1991-6#1)(2011-2#1)
5% nitric acid+Triton X-100##2##4##(2008-10#2)
5% of all##4##3##(2011-2#2)(2012-2#1)(2013-1#1)
5% of cases##3##3##(2008-9#1)(2010-11#1)(2013-1#1)
5% of females##2##3##(1994-6#2)
5% of its##2##3##(1995-6#1)(2013-1#1)
5% of patients##3##3##(1990-6#1)(2008-10#1)(2008-5#1)
5% of the cases##2##4##(1990-9#1)(2008-5#1)
5% of the patients##4##4##(1990-11#1)(1992-11#1)(2008-1#1)(2012-3#1)
5% of the total##2##4##(2008-10#1)(2010-2#1)
5% of the##31##3##(1990-11#1)(1990-12#1)(1990-9#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-6#1)(1995-2#2)(1997-2#1)(2008-1#1)(2008-10#10)(2008-5#3)(2008-9#1)(2009-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#2)
5% of those##3##3##(1992-11#1)(1994-3#2)
5% of##77##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-6#1)(1994-3#2)(1994-6#3)(1995-2#2)(1995-6#1)(1996-2#2)(1997-2#2)(2008-1#1)(2008-10#21)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-9#3)(2009-11#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#4)
5% on##2##2##(2008-10#2)
5% or##2##2##(1996-1#1)(2008-10#1)
5% polarization in spectral regions with##2##6##(2008-3#2)
5% respectively##3##2##(2008-10#3)
5% sodium##2##2##(2008-10#2)
5% to 10%##3##3##(2008-3#1)(2008-9#1)(2010-1#1)
5% to##6##2##(2008-3#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-6#1)(2013-1#1)
5% total##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
5% tri-n-octylphosphine oxide (TOPO) dissolved in##2##6##(2008-10#2)
5% v/v)##3##2##(2008-10#1)(2008-7#2)
5% vs##4##2##(1994-2#1)(1995-8#1)(2011-2#1)(2012-3#1)
5% was##3##2##(2008-10#2)(2008-3#1)
5% were obtained##2##3##(2008-10#2)
5% were##7##2##(1991-2#1)(2008-10#3)(2009-10#2)(2012-3#1)
5% when##3##2##(1997-1#1)(2008-10#1)(2008-2#1)
5% with##8##2##(1993-8#2)(2008-1#1)(2008-10#2)(2008-8#1)(2009-4#1)(2011-2#1)
5%##588##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#3)(1990-9#3)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#3)(1993-3#1)(1993-6#1)(1993-8#4)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#4)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#5)(1996-1#1)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#4)(1997-1#2)(1997-2#6)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#3)(2007-11#1)(2007-8#1)(2008-1#5)(2008-10#270)(2008-11#25)(2008-12#10)(2008-2#6)(2008-3#12)(2008-5#20)(2008-7#15)(2008-8#8)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#22)(2011-3#1)(2012-12#2)(2012-2#11)(2012-3#8)(2013-1#25)(2013-8#3)
5%) and##15##2##(1990-8#1)(1992-9#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-5#2)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
5%) by##2##2##(1991-3#2)
5%) had a##2##3##(1990-3#1)(2013-8#1)
5%) had##5##2##(1990-3#1)(2008-1#1)(2008-10#1)(2009-5#1)(2013-8#1)
5%) has been achieved##2##4##(2008-10#2)
5%) in the##2##3##(2008-10#1)(2011-2#1)
5%) in##5##2##(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
5%) of the##2##3##(2008-10#2)
5%) of##6##2##(1990-3#1)(1990-6#1)(2008-10#3)(2013-1#1)
5%) patients had##2##3##(1997-8#1)(2012-3#1)
5%) patients##4##2##(1991-12#1)(1997-8#1)(2011-2#1)(2012-3#1)
5%) showed##2##2##(1991-3#1)(2012-2#1)
5%) to##2##2##(2008-10#2)
5%) was##2##2##(2008-5#1)(2008-7#1)
5%) were##9##2##(1992-9#1)(1996-3#1)(2008-10#3)(2008-5#2)(2012-2#1)(2012-3#1)
5%)##134##1##(1990-3#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#5)(1992-2#2)(1992-9#3)(1993-11#1)(1994-12#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#9)(2008-10#30)(2008-11#5)(2008-12#4)(2008-5#9)(2008-7#3)(2008-9#4)(2009-10#1)(2009-5#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#10)(2012-2#3)(2012-3#10)(2013-1#3)(2013-8#2)
5' NCR##4##2##(2008-9#4)
5' RACE protocol##2##3##(1994-11#2)
5' UTR##5##2##(1993-12#1)(2008-10#2)(2008-8#1)(2010-5#1)
5' and 3' ends##3##4##(2008-10#2)(2008-8#1)
5' and 3'##11##3##(1993-2#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-8#2)(2010-5#2)
5' and##14##2##(1993-2#1)(1993-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-8#2)(2010-5#2)
5' end and##2##3##(2008-8#1)(2013-8#1)
5' end of the##7##4##(1991-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
5' end of##9##3##(1991-5#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
5' end to##2##3##(1992-6#1)(2008-8#1)
5' end##20##2##(1991-5#1)(1992-6#1)(1993-6#1)(1996-6#1)(1997-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#4)(2008-9#1)(2012-3#1)(2013-8#1)
5' ends##2##2##(1993-12#1)(2008-10#1)
5' exonuclease##4##2##(1997-8#4)
5' flanking DNA of##2##4##(2008-11#2)
5' flanking DNA##3##3##(1991-6#1)(2008-11#2)
5' flanking region of##2##4##(1991-5#1)(1993-12#1)
5' flanking region##7##3##(1991-5#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-11#1)
5' flanking regions##3##3##(1992-3#1)(1993-6#1)(1994-11#1)
5' flanking sequence##2##3##(1990-8#1)(1993-12#1)
5' flanking##19##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#2)(1993-12#3)(1993-2#1)(1993-6#4)(1994-11#2)(1995-2#1)(2008-11#2)(2011-10#1)
5' long terminal repeat (LTR)##2##5##(1993-8#1)(1997-8#1)
5' long terminal repeat##4##4##(1993-8#2)(1994-12#1)(1997-8#1)
5' non-coding region##2##3##(1991-9#1)(1995-6#1)
5' non-coding##3##2##(1991-9#1)(1993-12#1)(1995-6#1)
5' noncoding region##2##3##(1995-5#1)(2008-9#1)
5' noncoding##3##2##(1995-5#1)(2008-10#1)(2008-9#1)
5' of the##2##3##(1996-6#2)
5' of##3##2##(1991-6#1)(1996-6#2)
5' position##2##2##(1994-8#1)(2008-8#1)
5' region of the gene##2##5##(1997-7#1)(2008-8#1)
5' region of the human##3##5##(1991-6#1)(1991-7#2)
5' region of the##9##4##(1991-6#3)(1991-7#2)(1995-2#1)(1997-7#1)(2008-10#1)(2008-8#1)
5' region##10##2##(1991-6#3)(1991-7#2)(1995-2#1)(1997-7#2)(2008-10#1)(2008-8#1)
5' regulatory##2##2##(1994-12#1)(2008-11#1)
5' sequence##2##2##(1993-12#1)(1997-2#1)
5' terminus##3##2##(2008-10#2)(2008-11#1)
5' to the transcription start##2##5##(1993-12#1)(1995-2#1)
5' to the##6##3##(1991-6#1)(1991-9#1)(1993-12#1)(1993-2#1)(1995-2#2)
5' to##8##2##(1991-6#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-2#2)(2008-10#1)
5' untranslated region##6##3##(1993-6#1)(1994-11#1)(1997-8#1)(2008-10#2)(2008-8#1)
5' untranslated regions##3##3##(1993-12#2)(1994-11#1)
5' untranslated##10##2##(1993-12#2)(1993-6#1)(1994-11#2)(1995-8#1)(1997-8#1)(2008-10#2)(2008-8#1)
5' upstream region##3##3##(1995-2#2)(2008-9#1)
5' upstream regions of##2##4##(1993-6#1)(2008-9#1)
5' upstream##5##2##(1993-6#1)(1995-2#2)(2008-9#2)
5'##170##1##(1990-5#1)(1990-8#2)(1991-5#5)(1991-6#7)(1991-7#2)(1991-9#2)(1992-3#2)(1992-6#1)(1993-12#14)(1993-2#4)(1993-3#1)(1993-6#11)(1993-8#3)(1994-11#8)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#6)(1995-5#1)(1995-6#2)(1995-8#2)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-7#4)(1997-8#9)(2008-10#32)(2008-11#7)(2008-12#1)(2008-4#3)(2008-8#14)(2008-9#9)(2010-5#3)(2011-10#1)(2012-3#1)(2013-8#1)
5')##2##1##(1991-3#2)
5'- and 3'-terminal##2##3##(2008-10#2)
5'- and##4##2##(1993-12#1)(2008-10#3)
5'-##5##1##(1993-12#1)(2008-10#4)
5'-0-(3-thiotriphosphate)##4##1##(1991-6#1)(1995-8#3)
5'-GC##3##1##(1993-12#1)(2008-11#2)
5'-O-DMTr-N-protected-deoxyribonucleoside-3'-O-(2-thio-spiro-4##2##1##(2008-4#2)
5'-O-dimethoxytritylated##2##1##(2008-4#2)
5'-UTR##3##1##(2008-10#1)(2010-5#1)(2012-3#1)
5'-biotinylated##3##1##(1995-6#1)(1995-8#1)(2008-12#1)
5'-chemistry##2##1##(1991-3#2)
5'-cyclic monophosphate##4##2##(1994-11#1)(1995-8#3)
5'-cyclic##5##1##(1993-6#1)(1994-11#1)(1995-8#3)
5'-decyl-2##3##1##(2008-10#3)
5'-dithiobis(2-nitrobenzoic##2##1##(1993-8#1)(2008-10#1)
5'-dithiobis-(2-nitrobenzoic acid)##2##2##(2008-10#2)
5'-end of the oligonucleotide##2##4##(2008-10#2)
5'-end of the##3##3##(1993-8#1)(2008-10#2)
5'-end of##4##2##(1993-8#1)(1995-8#1)(2008-10#2)
5'-end##6##1##(1990-5#1)(1993-8#1)(1995-8#1)(2008-10#3)
5'-flanking DNA sequence of the##2##5##(1994-2#1)(1997-1#1)
5'-flanking DNA sequence##4##3##(1994-2#3)(1997-1#1)
5'-flanking region and the first##2##5##(1994-11#1)(2010-5#1)
5'-flanking region and##3##3##(1991-7#1)(1994-11#1)(2010-5#1)
5'-flanking region of the##2##4##(1993-8#1)(1997-8#1)
5'-flanking region of##3##3##(1993-8#1)(1997-8#2)
5'-flanking region##15##2##(1991-6#1)(1991-7#2)(1993-6#1)(1993-8#1)(1994-11#4)(1997-8#2)(2010-5#4)
5'-flanking sequence of##2##3##(1993-3#1)(2008-8#1)
5'-flanking sequence##4##2##(1993-3#1)(1995-6#1)(1997-7#1)(2008-8#1)
5'-flanking sequences##2##2##(1995-6#2)
5'-flanking##26##1##(1991-6#1)(1991-7#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-2#3)(1995-6#3)(1997-1#1)(1997-7#1)(1997-8#2)(2008-8#1)(2010-5#4)
5'-monophosphate##5##1##(1991-10#1)(1994-11#3)(1995-2#1)
5'-noncoding region##3##2##(2008-9#3)
5'-region##2##1##(1992-6#1)(2008-11#1)
5'-splice##2##1##(1995-6#2)
5'-terminal##3##1##(1993-3#1)(2008-10#2)
5'-tetramethylbenzidine (TMB)##4##2##(1992-3#1)(2008-10#3)
5'-tetramethylbenzidine using##2##2##(2008-10#2)
5'-tetramethylbenzidine##10##1##(1990-12#1)(1992-3#1)(2008-10#8)
5'-triphosphate##4##1##(1990-5#1)(1993-6#1)(1993-8#2)
5'-untranslated region (UTR)##2##3##(1997-7#1)(2008-10#1)
5'-untranslated region##6##2##(1991-7#2)(1993-12#1)(1997-7#1)(2008-10#1)(2010-5#1)
5'-untranslated regions##3##2##(1991-7#1)(1993-2#1)(1996-8#1)
5'-untranslated##9##1##(1991-7#3)(1993-12#1)(1993-2#1)(1996-8#1)(1997-7#1)(2008-10#1)(2010-5#1)
5'UTR##2##1##(2008-11#1)(2010-5#1)
5(2)##5##1##(2008-11#1)(2011-2#4)
5(b)##6##1##(2012-12#6)
5) and the##2##3##(1996-12#1)(2008-3#1)
5) and##19##2##(1996-12#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#2)(2009-11#1)
5) are##2##2##(2008-10#2)
5) as##2##2##(2008-10#1)(2009-8#1)
5) at##2##2##(2008-10#2)
5) concentration and##2##3##(2008-5#2)
5) concentration##3##2##(2008-5#3)
5) elemental concentrations##2##3##(2008-5#2)
5) gene had been##2##4##(1995-2#2)
5) in the##2##3##(2008-1#1)(2008-10#1)
5) instilled mice##2##3##(2008-10#2)
5) of##3##2##(2008-10#3)
5) or a##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
5) solution##2##2##(2008-10#2)
5) to##2##2##(2008-10#2)
5) was##5##2##(1991-6#1)(1994-5#1)(2008-10#3)
5) were##3##2##(1992-6#1)(2008-10#1)(2013-1#1)
5) with lambda(exc)=230 nm and##2##5##(2008-10#2)
5) with##4##2##(2008-10#4)
5)##165##1##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-11#2)(1994-3#2)(1994-5#2)(1994-8#3)(1995-2#4)(1996-12#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#82)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#1)(2009-11#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
5)) and##2##2##(2008-5#2)
5))##3##1##(2008-10#1)(2008-5#2)
5)0##2##1##(2008-3#2)
5)C(0##2##1##(2008-5#2)
5)G(0##6##1##(2008-5#6)
5)Na(0##2##1##(2009-5#2)
5)P(2) in##2##2##(2009-6#2)
5)P(2)##3##1##(2009-6#3)
5)P3 production##3##2##(1997-1#3)
5)P3##4##1##(1997-1#4)
5)R(0##2##1##(2008-5#2)
5)T(0##2##1##(2008-5#2)
5)trisphosphate production##2##2##(1994-11#2)
5)trisphosphate##5##1##(1994-11#5)
5+/-0##18##1##(2008-10#16)(2008-11#1)(2008-2#1)
5+/-1##4##1##(2008-10#4)
5+/-2##2##1##(2008-10#2)
5- and 10-year##2##3##(1991-8#1)(1993-11#1)
5- and 2##3##3##(1993-6#1)(1994-8#2)
5- and##8##2##(1990-12#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-8#2)(2008-10#1)(2011-2#1)
5- to##5##2##(1994-5#1)(2008-11#1)(2008-4#1)(2008-5#2)
5-##17##1##(1990-12#1)(1990-5#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-8#2)(1997-9#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#1)
5-(PO(4))(3)##2##1##(2008-3#2)
5-0##5##1##(1994-12#1)(1994-3#1)(2008-10#1)(2008-8#1)(2009-11#1)
5-1##11##1##(1990-9#1)(1991-7#1)(1991-9#1)(1992-11#1)(1994-2#1)(2008-10#3)(2009-11#1)(2011-2#1)(2012-12#1)
5-10 ml##3##2##(1994-9#1)(2008-10#2)
5-10 years##2##2##(1990-12#1)(1994-9#1)
5-10##24##1##(1990-12#1)(1994-9#2)(1995-11#1)(1996-2#2)(2008-10#16)(2010-3#1)(2012-2#1)
5-10%##7##1##(1990-2#1)(1990-6#1)(1991-5#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-11#1)
5-100 mug l(-1)##2##3##(2008-10#2)
5-100 mug##3##2##(2008-10#3)
5-100##4##1##(2008-10#4)
5-100%##2##1##(2008-10#2)
5-1000 ng ml(-1)##2##3##(2008-10#2)
5-1000##4##1##(2008-10#3)(2008-12#1)
5-102##2##1##(2008-10#2)
5-11##5##1##(1992-11#1)(1997-3#1)(2008-10#2)(2012-12#1)
5-12##4##1##(2008-10#2)(2008-2#1)(2008-7#1)
5-15##5##1##(1997-2#1)(1997-3#1)(2008-10#3)
5-2##19##1##(1993-12#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
5-2-1-AN behaviors##2##2##(2010-8#2)
5-2-1-AN##6##1##(2010-8#6)
5-20##6##1##(2008-10#6)
5-200##3##1##(2008-10#3)
5-22##2##1##(2008-10#1)(2008-12#1)
5-220##3##1##(2008-10#2)(2008-11#1)
5-24##2##1##(1995-2#1)(2008-10#1)
5-25##4##1##(2008-10#4)
5-28##2##1##(1990-6#1)(2008-10#1)
5-3##14##1##(1992-6#1)(2008-10#11)(2008-7#1)(2010-5#1)
5-30##5##1##(1994-12#1)(1997-4#1)(2008-10#3)
5-4##15##1##(1992-12#1)(1992-6#1)(2008-10#13)
5-40##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
5-5##14##1##(2008-10#10)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
5-5%##3##1##(1991-6#1)(2008-11#1)(2011-3#1)
5-50##4##1##(2008-10#2)(2008-9#1)(2011-2#1)
5-500 ng ml(-1) of##2##4##(2008-10#2)
5-500##4##1##(2008-10#3)(2008-11#1)
5-50muM##2##1##(2008-10#2)
5-55##2##1##(2008-10#1)(2013-8#1)
5-6 h##2##2##(2008-10#1)(2008-9#1)
5-6 million##2##2##(1992-6#2)
5-6 times##2##2##(2008-8#1)(2008-9#1)
5-6##32##1##(1990-5#1)(1991-9#1)(1992-6#2)(1993-8#1)(1995-11#1)(1996-11#1)(1996-12#1)(2008-10#16)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)
5-6%##2##1##(2008-10#2)
5-7 (R##2##2##(2008-10#2)
5-7 with a lower detection limit of 0##2##8##(2008-10#2)
5-7##19##1##(1995-8#1)(2008-10#16)(2008-5#1)(2013-1#1)
5-8##17##1##(1990-5#1)(2008-10#11)(2008-11#1)(2008-2#2)(2009-8#1)(2011-2#1)
5-80##2##1##(2008-10#2)
5-9##15##1##(1996-3#1)(2008-10#12)(2008-11#1)(2013-1#1)
5-A##2##1##(1993-8#1)(1994-5#1)
5-ASA##5##1##(2008-10#2)(2011-3#3)
5-Bis(hydroxymethyl)-1##3##1##(1996-5#3)
5-Br-PADAP##7##1##(2008-10#7)
5-Br-PSAA##2##1##(2008-10#2)
5-CLA##4##1##(1992-3#4)
5-CLA-PBGS is##2##2##(1992-3#2)
5-CLA-PBGS##4##1##(1992-3#4)
5-FCyt##2##1##(1994-5#2)
5-FU U2##2##2##(1993-8#2)
5-FU incorporation##4##2##(1993-8#4)
5-FU##10##1##(1993-8#8)(2008-11#2)
5-HIAA levels##2##2##(1992-1#2)
5-HIAA##4##1##(1992-1#2)(1993-1#1)(2008-10#1)
5-HT content##2##2##(1996-12#1)(2008-6#1)
5-HT fiber##2##2##(1996-12#2)
5-HT fibers##3##2##(1996-12#3)
5-HT in this##2##3##(1994-2#1)(1995-12#1)
5-HT in##4##2##(1990-5#1)(1994-2#1)(1995-12#1)(2008-6#1)
5-HT levels##3##2##(1992-1#1)(1994-2#2)
5-HT receptor##2##2##(1994-2#1)(2008-7#1)
5-HT receptors##2##2##(2008-5#2)
5-HT release in##2##3##(2008-7#2)
5-HT release##5##2##(2008-7#5)
5-HT transporter##5##2##(1994-2#2)(2008-7#3)
5-HT##58##1##(1990-5#4)(1992-1#1)(1993-3#2)(1994-2#9)(1995-12#1)(1996-12#10)(2008-10#1)(2008-5#3)(2008-6#2)(2008-7#21)(2008-8#3)(2011-3#1)
5-HT(1A)##2##1##(2008-7#2)
5-HT(1B/1D)##2##1##(2008-7#2)
5-HT(2A)##2##1##(2008-11#2)
5-HT(3) receptors##2##2##(2008-11#1)(2008-7#1)
5-HT(3)##3##1##(2008-11#2)(2008-7#1)
5-HT(7)##2##1##(2008-7#2)
5-HT)##2##1##(1990-5#1)(1993-2#1)
5-HT-induced##4##1##(2011-3#4)
5-HT1##2##1##(1994-2#1)(2008-5#1)
5-HT1A and 5-HT2 receptors and##2##5##(1994-2#2)
5-HT1A and 5-HT2##3##3##(1994-2#3)
5-HT1A and##4##2##(1992-12#1)(1994-2#3)
5-HT1A receptor agonists##2##3##(1994-2#2)
5-HT1A receptor densities##2##3##(1994-2#2)
5-HT1A receptor gene##2##3##(1993-3#2)
5-HT1A receptor mRNA##2##3##(1993-3#1)(1994-2#1)
5-HT1A receptor##14##2##(1993-3#7)(1994-2#7)
5-HT1A receptors represented the##2##4##(1994-2#2)
5-HT1A receptors##7##2##(1994-2#6)(2012-3#1)
5-HT1A##30##1##(1992-12#1)(1993-3#7)(1994-2#19)(2008-4#1)(2008-5#1)(2012-3#1)
5-HT1D and 5-HT1E binding sites##2##5##(1994-2#2)
5-HT1D and 5-HT1E sites##2##4##(1994-2#2)
5-HT1D and 5-HT1E##4##3##(1994-2#4)
5-HT1D sites##3##2##(1994-2#3)
5-HT1D##8##1##(1994-2#8)
5-HT1E sites represented##2##3##(1994-2#2)
5-HT1E sites##7##2##(1994-2#7)
5-HT1E##11##1##(1994-2#11)
5-HT2 receptor densities##2##3##(1994-2#2)
5-HT2##6##1##(1994-2#5)(2008-5#1)
5-HT2C receptor##6##2##(1996-12#6)
5-HT2C##7##1##(1996-12#7)
5-HT3 antagonist##2##2##(1994-2#2)
5-HT3 receptor##4##2##(1990-12#1)(1994-2#2)(2008-11#1)
5-HT3##8##1##(1990-12#1)(1994-2#5)(2008-11#1)(2008-5#1)
5-HT4 receptors##3##2##(1996-12#2)(2008-5#1)
5-HT4##4##1##(1996-12#3)(2008-5#1)
5-HT7 receptor##5##2##(2008-5#5)
5-HT7##7##1##(2008-5#7)
5-HTR1D##2##1##(1993-2#2)
5-HTT##2##1##(1996-12#2)
5-HTT55 and 5-HTT315##2##3##(1996-12#2)
5-HTT55##3##1##(1996-12#3)
5-HTTN##5##1##(1996-12#5)
5-MTA##3##1##(1995-12#3)
5-MTO##3##1##(1995-12#3)
5-Mb##2##1##(1997-3#2)
5-NO(2)##3##1##(2008-10#3)
5-OglycolylNeu5Gc was##4##2##(1994-11#4)
5-OglycolylNeu5Gc##5##1##(1994-11#5)
5-P3##2##1##(1997-1#2)
5-P4 accumulation##3##2##(1997-1#3)
5-P4##5##1##(1997-1#5)
5-THT##2##1##(2008-10#2)
5-VOT in##2##2##(2008-10#2)
5-VOT##8##1##(2008-10#8)
5-alpha-reductase##4##1##(1990-11#1)(2008-10#1)(2008-5#2)
5-amino-1##2##1##(2008-10#2)
5-aminosalicylic acid##2##2##(2008-10#2)
5-azacytidine##5##1##(2008-11#1)(2008-9#3)(2013-8#1)
5-benzo[1##2##1##(1996-5#2)
5-bis(2-pyridyl)-3-sulphophenyl methylene thiocarbonohydrazide##2##3##(2008-10#2)
5-bis(hydroxymethyl)-1##3##1##(1996-5#3)
5-bisphosphate (PIP2)##2##2##(1993-6#1)(1993-8#1)
5-bisphosphate in##2##2##(1997-1#1)(2008-7#1)
5-bisphosphate##10##1##(1990-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1997-1#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
5-bromo-2'-deoxyuridine (BrdU)##2##2##(1995-12#1)(2008-11#1)
5-bromodeoxyuridine##2##1##(2008-9#2)
5-day##4##1##(1992-12#1)(2008-10#2)(2008-6#1)
5-diacetyl-1##2##1##(2008-10#2)
5-diamino-6-chloropyrazinecarboxyl) guanidine##2##2##(2008-10#2)
5-dicarboxylates (2a-g)##2##2##(2012-3#2)
5-dicarboxylates (3a-g)##2##2##(2012-3#2)
5-dicarboxylates##5##1##(2012-3#5)
5-dichloro-3##2##1##(2008-10#2)
5-dichlorophenol and influent wastewater##2##4##(2008-10#2)
5-dichlorophenol##3##1##(2008-10#3)
5-dihydroxy-1##2##1##(2008-10#2)
5-dihydroxycinnimate##2##1##(1996-12#2)
5-dihydroxyphenyl]squaraine##2##1##(2008-10#2)
5-dimercapto-1##2##1##(2008-10#2)
5-dimethoxyaniline##2##1##(2008-10#2)
5-dimethylcyclohexane-1##2##1##(2008-10#2)
5-dimethylhydantoin##2##1##(2008-10#2)
5-dimethylphenyl carbamate) chiral stationary phase##2##5##(2008-10#2)
5-dimethylphenyl carbamate)##3##2##(2008-10#3)
5-dimethylphenylcarbamate) chiral stationary phases##2##4##(2008-10#2)
5-dimethylphenylcarbamate) chiral stationary##3##3##(2008-10#3)
5-dinitrobenzoic acid##2##2##(2008-10#2)
5-diol##2##1##(1996-5#2)
5-dione##4##1##(1996-5#2)(2008-10#2)
5-diones##2##1##(1996-5#2)
5-dioxahexyl)-15-methyl-16-crown-5##2##1##(2008-10#2)
5-diphenylcarbazide##4##1##(2008-10#4)
5-diphenylcarbazone complex##2##2##(2008-10#2)
5-diphenylcarbohydrazide##2##1##(2008-10#2)
5-disubstituted 1H-pyrazole##2##2##(2008-10#2)
5-disulfonate##2##1##(2008-10#2)
5-enolpyruvylshikimate 3-phosphate synthase##2##3##(2008-9#2)
5-f]quinoxaline)##2##1##(1997-2#2)
5-fluorouracil##11##1##(1990-12#3)(1992-12#2)(1992-2#4)(1993-1#1)(1997-7#1)
5-fluorouridine##3##1##(1993-8#3)
5-fold greater##2##2##(1990-12#1)(1991-5#1)
5-fold higher##2##2##(1993-2#1)(2008-11#1)
5-fold increase in##3##3##(1996-12#1)(2008-10#1)(2008-7#1)
5-fold more than##2##3##(2008-10#2)
5-fold more##3##2##(2008-10#2)(2012-12#1)
5-fold reduction in##3##3##(1993-6#1)(1995-9#1)(2008-10#1)
5-fold##28##1##(1990-10#1)(1990-12#1)(1991-5#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-7#4)(2010-1#2)(2010-8#1)(2011-10#1)(2012-12#1)(2013-8#1)
5-fold)##2##1##(1993-6#1)(1996-2#1)
5-hexatriene##2##1##(1991-5#1)(2008-10#1)
5-hydroxyindole-3-acetic acid##2##2##(2008-10#2)
5-hydroxyindoleacetic acid (5-HIAA)##2##3##(1992-1#1)(1993-1#1)
5-hydroxytryptamine (5-HT)##2##2##(1995-12#1)(2008-10#1)
5-hydroxytryptamine 1D##2##2##(1993-12#2)
5-hydroxytryptamine##9##1##(1990-12#1)(1990-5#2)(1993-12#2)(1995-12#1)(1996-3#1)(2008-10#1)(2012-3#1)
5-item##2##1##(2009-11#1)(2010-4#1)
5-kDa##2##1##(1990-5#1)(1992-4#1)
5-kb DNA fragment##2##3##(1991-5#1)(2008-10#1)
5-kb fraction##2##2##(1995-2#2)
5-kb##12##1##(1991-5#1)(1993-2#1)(1993-9#1)(1995-2#3)(1997-7#2)(2008-10#3)(2008-6#1)
5-lipoxygenase##2##1##(2008-11#1)(2013-1#1)
5-m##2##1##(2008-10#1)(2008-3#1)
5-methoxytryptamine##3##1##(1993-6#2)(1995-12#1)
5-methoxytryptophol##2##1##(1995-12#2)
5-methyltetrahydrofolate##5##1##(1994-6#5)
5-min temporal##2##2##(2008-2#2)
5-min##7##1##(1991-2#1)(2008-10#3)(2008-2#3)
5-ml##5##1##(2008-10#5)
5-mm##4##1##(2006-6#1)(2008-10#1)(2008-2#1)(2009-3#1)
5-mol##2##1##(2008-2#2)
5-month-old##5##1##(1995-8#1)(1997-9#3)(2009-11#1)
5-mum emissions from##2##3##(2007-12#2)
5-mum##7##1##(2007-12#2)(2008-10#2)(2008-3#3)
5-n-Alkylresorcinols from##2##2##(2008-11#2)
5-nm##2##1##(2008-10#1)(2008-2#1)
5-phosphate##2##1##(2008-7#2)
5-sulfaminouracil##3##1##(2008-10#3)
5-sulfosalicylic##3##1##(2008-10#3)
5-tetrachlorophenol##2##1##(2008-10#2)
5-triazine (RDX)##2##2##(2008-10#2)
5-triazine modified carbon paste electrode##2##5##(2008-10#2)
5-triazine##5##1##(2008-10#4)(2008-11#1)
5-trichlorophenoxyacetic##2##1##(2008-10#2)
5-triiodo-L-thyronine##2##1##(1993-8#2)
5-trimethylcyclohexanol##3##1##(1994-8#3)
5-trimethylene-2##5##1##(2008-10#5)
5-trinitro-1##3##1##(2008-10#2)(2008-7#1)
5-trinitro-s-triazine (RDX)##2##2##(2008-10#1)(2008-3#1)
5-trinitrobenzene##4##1##(2008-10#4)
5-trisphosphate [PtdIns(3##2##2##(2009-7#1)(2012-2#1)
5-trisphosphate##14##1##(1990-8#1)(1991-6#1)(1993-8#4)(1995-2#1)(1997-1#1)(2008-11#1)(2008-8#2)(2009-7#2)(2012-2#1)
5-week##2##1##(2011-2#1)(2013-8#1)
5-year disease-free survival##3##3##(1991-8#1)(1997-7#2)
5-year disease-free##4##2##(1991-8#1)(1997-7#3)
5-year follow-up##2##2##(2008-7#2)
5-year mortality##2##2##(2008-7#2)
5-year survival rate was##3##4##(1990-9#1)(1997-7#2)
5-year survival rate##5##3##(1990-9#1)(1997-7#3)(2013-1#1)
5-year survival rates##2##3##(2012-3#1)(2013-8#1)
5-year survival##9##2##(1990-9#1)(1997-7#3)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
5-year##34##1##(1990-9#1)(1991-2#1)(1991-8#1)(1992-3#1)(1997-7#10)(1997-8#2)(2008-10#2)(2008-7#5)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
5-year-old Labrador retriever##2##3##(2013-8#2)
5-year-old boy##3##2##(1990-6#1)(2008-10#1)(2013-1#1)
5-year-old##8##1##(1990-6#1)(2008-10#2)(2011-2#1)(2013-1#2)(2013-8#2)
5/20##3##1##(2008-10#3)
5/5##3##1##(2008-10#2)(2008-9#1)
50 % of the##3##4##(2012-12#3)
50 (v/v)##3##2##(2008-10#3)
50 +/-##3##2##(2008-10#2)(2013-8#1)
50 000##2##2##(2008-10#1)(2013-1#1)
50 V##3##2##(2008-10#3)
50 and 0##3##3##(2008-10#1)(2008-5#1)(2009-3#1)
50 and 100%##2##3##(2008-10#1)(2012-12#1)
50 and 200##3##3##(1991-12#1)(1995-6#1)(2008-10#1)
50 and 500##2##3##(2008-10#2)
50 and 70%##2##3##(2008-10#2)
50 and##41##2##(1991-12#1)(1993-2#1)(1995-12#2)(1995-6#1)(1997-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-5#3)(2009-3#1)(2010-3#1)(2012-12#1)
50 children##2##2##(1991-2#2)
50 cm##2##2##(2008-10#2)
50 cows##2##2##(1992-2#2)
50 cycles of##2##3##(2008-10#2)
50 days##3##2##(2008-10#2)(2008-5#1)
50 degrees C and##5##4##(1990-2#1)(2008-10#4)
50 degrees C for both##2##5##(2008-5#1)(2008-7#1)
50 degrees C for##5##4##(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)
50 degrees C##25##3##(1990-2#1)(1991-5#2)(1994-5#1)(1996-2#1)(2008-10#16)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
50 degrees##27##2##(1990-2#1)(1991-5#2)(1994-5#1)(1996-2#1)(2008-10#16)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
50 fg##2##2##(2008-10#2)
50 g of##3##3##(2008-10#2)(2012-3#1)
50 g##5##2##(2008-1#1)(2008-10#3)(2012-3#1)
50 h##4##2##(2008-10#2)(2008-11#2)
50 h(-1)##3##2##(2008-10#3)
50 in##3##2##(2008-10#3)
50 is##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
50 kDa in##2##3##(2008-10#2)
50 kDa##5##2##(1997-2#1)(2008-10#4)
50 kHz##2##2##(2008-3#2)
50 location-years##2##2##(2008-10#2)
50 mA cm(-2) for##2##4##(2008-10#2)
50 mM K+##2##3##(1994-2#2)
50 mM sodium##2##3##(2008-10#2)
50 mM##9##2##(1994-2#3)(2008-10#4)(2008-11#1)(2008-7#1)
50 mM) and 35 degrees C were obtained as the optimum##2##11##(2008-10#2)
50 mM) and 35 degrees C were##3##7##(2008-10#3)
50 mV##5##2##(2008-10#5)
50 mg l(-1)##3##3##(2008-10#3)
50 mg of##3##3##(1991-11#1)(2008-10#2)
50 mg per##2##3##(1995-11#1)(2008-10#1)
50 mg##17##2##(1990-11#1)(1991-11#1)(1994-8#1)(1995-11#1)(2008-10#10)(2008-11#1)(2008-5#2)
50 mg/kg##7##2##(1991-12#2)(1994-12#1)(1996-2#1)(2008-10#2)(2010-1#1)
50 mg/kg/dose##4##2##(2008-10#4)
50 microM##7##2##(1990-12#1)(1994-3#2)(1995-8#2)(2010-3#1)(2010-6#1)
50 microM)##2##2##(1992-8#1)(1995-6#1)
50 microg l(-1)##4##3##(2008-10#4)
50 microm##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
50 microm)##2##2##(1997-3#2)
50 million people##2##3##(2008-10#1)(2010-11#1)
50 min of##2##3##(2013-8#2)
50 min##6##2##(1995-12#1)(2008-10#2)(2008-11#1)(2013-8#2)
50 mix of##2##3##(2008-8#1)(2009-12#1)
50 ml of##3##3##(2008-10#3)
50 ml##14##2##(1991-2#1)(1993-2#2)(2008-10#9)(2008-12#2)
50 mm Hg##2##3##(1997-5#1)(2013-8#1)
50 mm##5##2##(1997-5#1)(2008-10#2)(2010-12#1)(2013-8#1)
50 muM apicidin resulted in##2##5##(2008-10#2)
50 muM apicidin##3##3##(2008-10#3)
50 muM##10##2##(2008-10#9)(2008-11#1)
50 mug l(-1)##8##3##(2008-10#8)
50 mug l(-1))##3##3##(2008-10#3)
50 mug ml(-1) with a##2##5##(2008-10#2)
50 mug ml(-1) with##3##4##(2008-10#3)
50 mug ml(-1)##6##3##(2008-10#6)
50 mug##18##2##(2008-10#18)
50 mugl(-1)##2##2##(2008-10#2)
50 mul##5##2##(2008-10#5)
50 mum##5##2##(2008-10#2)(2008-3#2)(2009-5#1)
50 mumol l(-1)##2##3##(2008-10#2)
50 nM##3##2##(1995-8#1)(2008-10#2)
50 ng ml(-1)##2##3##(2008-10#2)
50 ng##5##2##(1995-8#1)(2008-10#4)
50 ng/ml##2##2##(1993-3#1)(2008-10#1)
50 nm in diameter##2##4##(2008-7#1)(2009-10#1)
50 nm in##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)
50 nm##6##2##(2008-10#3)(2008-7#1)(2008-8#1)(2009-10#1)
50 of the##2##3##(1992-8#1)(1992-9#1)
50 of##3##2##(1992-8#1)(1992-9#1)(2008-5#1)
50 or##3##2##(1990-6#1)(2008-5#1)(2012-12#1)
50 pM##2##2##(1992-6#1)(2008-11#1)
50 patients (100 joints) undergoing bilateral total##2##7##(2009-3#2)
50 patients suffering from##2##4##(1991-2#1)(2011-2#1)
50 patients##14##2##(1990-3#1)(1991-2#1)(1991-3#1)(1996-6#1)(1997-3#1)(2009-3#2)(2011-2#6)(2012-3#1)
50 per cent of##2##4##(1990-9#1)(1997-5#1)
50 per##3##2##(1990-9#1)(1991-2#1)(1997-5#1)
50 percent##4##2##(1995-2#1)(1996-1#1)(1996-6#1)(1996-9#1)
50 pg of##2##3##(2008-10#1)(2008-5#1)
50 pg##4##2##(2008-10#3)(2008-5#1)
50 poly[DL-lactide-co-glycolide] microspheres##2##3##(1993-1#2)
50 ppm psoralen##2##3##(2008-11#2)
50 ppm##6##2##(2008-11#3)(2008-3#1)(2008-5#2)
50 s##5##2##(1990-5#1)(2008-10#4)
50 samples per##2##3##(2008-10#2)
50 samples##5##2##(2008-10#5)
50 times##5##2##(2008-10#4)(2011-2#1)
50 to 100##2##3##(2008-10#2)
50 to 100%##3##3##(2008-10#3)
50 to##27##2##(1990-6#1)(1992-12#1)(2008-10#17)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
50 x##3##2##(2008-10#2)(2008-12#1)
50 years from##2##3##(2008-10#1)(2008-7#1)
50 years of##2##3##(2011-3#1)(2013-8#1)
50 years##26##2##(1990-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1997-4#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-1#3)(2013-8#1)
50 °C##2##2##(2011-1#1)(2011-2#1)
50##641##1##(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#7)(1990-6#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#1)(1991-5#3)(1991-6#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#5)(1994-2#4)(1994-3#5)(1994-5#2)(1994-8#2)(1995-11#4)(1995-12#5)(1995-2#2)(1995-6#2)(1995-8#7)(1996-1#3)(1996-2#4)(1996-3#3)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#4)(1997-9#1)(2006-6#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#306)(2008-11#20)(2008-12#11)(2008-3#12)(2008-4#1)(2008-5#29)(2008-6#2)(2008-7#14)(2008-8#7)(2008-9#4)(2009-10#2)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#2)(2011-1#2)(2011-2#20)(2011-3#2)(2012-12#11)(2012-2#4)(2012-3#6)(2013-1#14)(2013-8#7)
50% (v/v) ethanol-water medium##2##4##(2008-10#2)
50% (v/v)##5##2##(2008-10#5)
50% after##2##2##(1993-11#1)(2008-10#1)
50% and 70% of##2##4##(1994-5#1)(2013-8#1)
50% and 80%##2##3##(1993-3#1)(2008-10#1)
50% and##10##2##(1990-8#1)(1993-3#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
50% aqueous##2##2##(1994-5#1)(2008-10#1)
50% are##2##2##(2008-12#1)(2008-2#1)
50% as compared##2##3##(2008-10#2)
50% as##3##2##(2008-10#3)
50% by##3##2##(2008-10#1)(2008-11#2)
50% during the##2##3##(2008-10#1)(2008-7#1)
50% duty cycle##2##3##(2008-2#1)(2008-3#1)
50% effective concentration##2##3##(2008-10#2)
50% effective dose##2##3##(2008-10#2)
50% effective##5##2##(2008-10#5)
50% for##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
50% greater than##2##3##(1997-1#1)(2008-9#1)
50% growth##2##2##(2008-10#2)
50% had##2##2##(1990-6#1)(2012-12#1)
50% in the##3##3##(2008-11#1)(2008-5#2)
50% in##11##2##(1994-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-8#2)
50% inhibition##2##2##(2008-11#1)(2011-3#1)
50% inhibitory concentration##2##3##(1995-11#1)(2013-1#1)
50% micorwave power##2##3##(2008-10#2)
50% more##3##2##(1990-12#1)(2008-10#1)(2013-1#1)
50% of all##2##3##(1994-11#1)(2013-1#1)
50% of cases##5##3##(1991-2#1)(1993-3#1)(1997-3#1)(2008-10#1)(2011-2#1)
50% of patients##5##3##(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
50% of score##2##3##(2013-1#2)
50% of that##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
50% of the control##2##4##(1992-6#1)(2008-11#1)
50% of the inoculated##2##4##(2008-10#1)(2008-5#1)
50% of the sample##2##4##(1993-1#1)(2008-10#1)
50% of the##40##3##(1990-12#1)(1992-3#2)(1992-6#1)(1993-1#1)(1994-11#1)(1997-6#2)(1997-8#2)(2008-10#14)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
50% of their##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
50% of these##3##3##(1995-2#1)(2011-2#1)(2013-1#1)
50% of whom##2##3##(1990-6#1)(2012-12#1)
50% of##96##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#3)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#2)
50% on##2##2##(2008-10#1)(2008-11#1)
50% or greater##2##3##(1994-3#1)(2008-12#1)
50% reduction in##4##3##(1995-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
50% reduction of##2##3##(2008-10#2)
50% reduction##6##2##(1995-2#1)(2008-10#3)(2008-6#1)(2013-1#1)
50% relative humidity##2##3##(1995-3#1)(2008-5#1)
50% v/v##2##2##(2008-10#2)
50% was##2##2##(1990-12#1)(2008-10#1)
50% were##4##2##(2008-11#2)(2008-3#1)(2013-1#1)
50% with##2##2##(1990-6#1)(2008-10#1)
50% without##2##2##(1993-3#1)(2010-8#1)
50%##317##1##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#4)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#5)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#5)(1995-2#3)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-6#3)(1997-7#1)(1997-8#3)(2008-1#2)(2008-10#92)(2008-11#23)(2008-12#3)(2008-2#3)(2008-3#6)(2008-5#8)(2008-6#2)(2008-7#15)(2008-8#2)(2008-9#6)(2009-10#3)(2009-8#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#17)(2011-3#2)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#18)(2013-8#8)
50%) in the##2##3##(1990-12#1)(2009-8#1)
50%) in##4##2##(1990-12#1)(1995-2#1)(2008-11#1)(2009-8#1)
50%)##12##1##(1990-12#1)(1990-2#2)(1995-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#3)
50)##15##1##(1990-6#1)(1990-8#2)(1991-5#1)(1993-11#1)(2008-10#5)(2008-12#1)(2008-7#1)(2010-9#1)(2011-3#1)(2013-1#1)
50-0##2##1##(2008-10#2)
50-100##5##1##(1994-8#1)(2008-10#3)(2008-5#1)
50-103##2##1##(2008-10#1)(2008-5#1)
50-300##4##1##(2008-10#3)(2010-6#1)
50-500##5##1##(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)
50-59 years##2##2##(1990-6#1)(1992-2#1)
50-60 degrees C##2##3##(1997-2#1)(2008-10#1)
50-60 years##2##2##(1990-2#1)(2008-5#1)
50-60##8##1##(1990-2#1)(1990-5#1)(1994-3#1)(1997-2#1)(2008-10#3)(2008-5#1)
50-60% of##3##2##(2008-7#1)(2013-1#2)
50-60%##4##1##(1993-11#1)(2008-7#1)(2013-1#2)
50-69##2##1##(1990-6#1)(2008-7#1)
50-70##2##1##(1991-2#1)(1996-2#1)
50-day-old fruit##2##2##(2008-10#2)
50-day-old##3##1##(1996-12#1)(2008-10#2)
50-fold higher##2##2##(1993-6#1)(1994-8#1)
50-fold##9##1##(1990-11#2)(1993-6#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-10#3)
50-ha##3##1##(2008-8#2)(2008-9#1)
50-kDa protein##3##2##(1993-6#2)(2008-10#1)
50-kDa##6##1##(1993-12#1)(1993-6#2)(2008-10#3)
50-year##2##1##(2008-11#1)(2011-2#1)
50-year-old woman##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
50-year-old##5##1##(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
500 +/-##2##2##(1994-3#2)
500 and##14##2##(1995-8#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)
500 bar##2##2##(2008-10#2)
500 cells##2##2##(2008-10#1)(2012-12#1)
500 g##2##2##(1994-1#1)(2012-2#1)
500 kb##2##2##(1997-8#2)
500 m##2##2##(2008-8#2)
500 mg kg(-1)##3##3##(2008-10#2)(2008-11#1)
500 mg x 2/day by##2##5##(2011-2#2)
500 mg x 2/day##3##4##(2011-2#3)
500 mg##17##2##(1991-4#1)(1993-1#1)(1996-11#1)(2008-10#6)(2008-11#2)(2008-9#1)(2011-2#5)
500 mg/L##2##2##(2008-9#2)
500 mg/kg females##2##3##(2008-9#2)
500 mg/kg males and females at##2##6##(2008-9#2)
500 mg/kg males and females##3##5##(2008-9#3)
500 mg/kg males##5##3##(2008-9#5)
500 mg/kg##10##2##(2008-9#10)
500 microM##2##2##(1993-8#1)(1994-11#1)
500 microg##2##2##(2008-10#2)
500 microm##2##2##(2008-10#1)(2008-11#1)
500 ml min(-1)##2##3##(2008-10#2)
500 ml of##2##3##(2008-10#1)(2008-11#1)
500 ml##7##2##(2008-1#1)(2008-10#4)(2008-11#2)
500 mug l(-1)##3##3##(2008-10#3)
500 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
500 mug##8##2##(2008-10#6)(2008-11#2)
500 mul of##3##3##(2008-10#3)
500 mul##4##2##(2008-10#4)
500 mum pore##2##3##(2008-11#2)
500 mum##6##2##(2008-10#1)(2008-11#3)(2008-3#2)
500 nM##3##2##(1991-5#1)(1996-2#1)(2008-10#1)
500 ng##3##2##(2008-10#3)
500 nm or##2##3##(2008-10#1)(2008-3#1)
500 nm##8##2##(2008-10#6)(2008-2#1)(2008-3#1)
500 nm)##2##2##(2008-10#1)(2008-3#1)
500 pM##2##2##(2008-11#2)
500 patients##4##2##(1990-2#1)(1991-3#1)(1995-10#2)
500 rpm##4##2##(2008-10#1)(2008-11#3)
500 to##4##2##(1992-1#1)(2008-10#2)(2008-11#1)
500##198##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#2)(1992-2#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#73)(2008-11#24)(2008-2#2)(2008-3#7)(2008-7#1)(2008-8#6)(2008-9#18)(2009-1#1)(2009-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)
500-fold##4##1##(1994-8#1)(1995-6#1)(2008-10#2)
500-mg##2##1##(2008-10#2)
5000##14##1##(1990-3#1)(1990-9#1)(1991-12#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)
500ml##4##1##(2008-10#4)
500mul of a homogeneous bead suspension of an##2##8##(2008-10#2)
500mul##3##1##(2008-10#3)
500ngml(-1) of##2##2##(2008-10#2)
500ngml(-1)##3##1##(2008-10#3)
500nm##3##1##(2008-10#3)
501##4##1##(1995-12#1)(1995-8#1)(2008-10#1)(2011-2#1)
502##4##1##(1995-5#1)(2008-10#2)(2008-12#1)
503##8##1##(1993-8#1)(1995-8#1)(2008-10#2)(2009-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
505 nm##5##2##(2008-10#4)(2008-7#1)
505##7##1##(2006-6#1)(2008-10#4)(2008-7#1)(2013-1#1)
5052 aluminum alloy##2##3##(2013-8#2)
5064##7##1##(2008-10#7)
509##6##1##(1994-12#1)(1997-7#1)(2008-10#2)(2008-7#2)
50V##2##1##(2008-10#2)
50mM##4##1##(1990-9#1)(2008-10#3)
50mg/m2/day on days##2##3##(2008-10#2)
50moll(-1)##3##1##(2008-10#3)
50mugl(-1) of Bi##2##3##(2008-10#2)
50mugl(-1)##4##1##(2008-10#4)
50mugml(-1) of##2##2##(2008-10#2)
50mugml(-1)##3##1##(2008-10#3)
50mul##2##1##(2008-10#2)
50mum spot size for 50s at 10Hz##2##7##(2008-10#2)
50mum##5##1##(2008-10#5)
50nm##2##1##(2008-10#2)
50wt##2##1##(2008-10#2)
50x10(3)##2##1##(2008-10#2)
51 +/-##3##2##(1992-11#1)(1994-11#1)(2010-7#1)
51 and##2##2##(1996-2#1)(2008-10#1)
51 cases of##2##3##(1990-9#1)(2008-7#1)
51 for##3##2##(2008-10#3)
51 min##2##2##(2008-10#1)(2013-8#1)
51 patients##5##2##(1995-3#1)(2008-7#1)(2012-3#2)(2013-1#1)
51 samples##2##2##(2008-10#1)(2008-12#1)
51 to##2##2##(2011-2#1)(2013-1#1)
51##98##1##(1990-11#1)(1990-8#1)(1990-9#5)(1991-6#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#30)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#8)(2009-7#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#9)(2012-12#2)(2012-3#3)(2013-1#7)(2013-8#4)
51% in##3##2##(2008-10#1)(2010-12#1)(2012-3#1)
51% of##4##2##(1991-9#1)(2008-1#1)(2008-10#2)
51%##17##1##(1991-9#1)(1996-11#1)(1996-6#1)(2008-1#1)(2008-10#7)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
51)##8##1##(1993-1#1)(1995-11#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-8#1)(2012-2#1)
51-100##2##1##(2011-2#2)
510 nm##5##2##(2008-10#4)(2008-11#1)
510##10##1##(1991-2#1)(2008-10#7)(2008-11#1)(2013-1#1)
511##3##1##(1996-11#1)(2010-4#1)(2013-8#1)
512##7##1##(1992-6#1)(1996-11#1)(1996-2#1)(2008-10#3)(2010-1#1)
513##7##1##(1991-9#1)(2007-12#1)(2008-10#4)(2008-7#1)
514##7##1##(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)
515 nm##3##2##(2008-10#3)
515 women##2##2##(1990-12#1)(2012-3#1)
515##9##1##(1990-12#1)(1990-3#1)(2008-10#3)(2008-8#1)(2009-6#1)(2011-3#1)(2012-3#1)
516##5##1##(1993-1#1)(2008-10#1)(2008-12#1)(2011-2#2)
517##7##1##(1994-2#1)(2010-2#6)
518##2##1##(2008-10#1)(2012-3#1)
51Cr##3##1##(1990-12#2)(1993-8#1)
52 +/-##3##2##(1992-11#1)(1992-12#1)(2013-8#1)
52 and##4##2##(1992-4#1)(1993-1#1)(1995-12#1)(2008-10#1)
52 degrees C##4##3##(1991-5#1)(2008-10#2)(2008-5#1)
52 mug##2##2##(2008-10#2)
52 patients with##2##3##(1993-2#1)(2008-7#1)
52 patients##8##2##(1990-9#1)(1993-2#1)(1993-8#1)(1997-5#1)(1997-8#1)(2008-7#3)
52 to##4##2##(1990-11#1)(2008-10#3)
52##99##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#5)(2013-8#3)
52% and##2##2##(1993-8#1)(2011-3#1)
52% for##2##2##(2008-10#1)(2010-6#1)
52% of##3##2##(1992-12#1)(2008-5#1)(2012-3#1)
52%##22##1##(1990-12#1)(1990-3#1)(1991-2#1)(1992-12#3)(1993-8#1)(1994-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-3#1)
52) and##3##2##(1994-1#1)(2008-10#1)(2008-7#1)
52)##8##1##(1991-7#1)(1994-1#1)(1997-2#1)(2008-10#3)(2008-7#1)(2013-8#1)
52)Na(0##2##1##(2008-10#2)
52-year-old##6##1##(1992-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
520 nm with##2##3##(2008-10#2)
520 nm##9##2##(2008-10#9)
520##14##1##(2008-10#10)(2008-12#1)(2008-7#1)(2008-8#2)
521 cases##2##2##(2011-2#2)
521)##5##1##(1991-8#4)(2008-10#1)
5217##2##1##(1990-2#2)
522##3##1##(2008-10#2)(2008-8#1)
524##2##1##(1994-12#1)(2013-1#1)
525 nm##6##2##(2008-10#5)(2008-11#1)
525 patients##2##2##(2008-10#2)
525##15##1##(1990-5#1)(1996-12#1)(2008-10#7)(2008-11#4)(2011-2#1)(2012-3#1)
527##2##1##(2008-10#1)(2011-2#1)
528##4##1##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
529##3##1##(1990-2#1)(2008-11#2)
5294##2##1##(2008-10#2)
52 nm##3##1##(2012-2#3)
53 and 0##2##3##(2008-10#1)(2008-7#1)
53 and##5##2##(1995-2#1)(2008-10#2)(2008-7#2)
53 cases of##2##3##(1990-3#1)(1991-8#1)
53 healthy##2##2##(2008-10#2)
53 patients who##4##3##(1994-3#1)(2011-2#2)(2012-5#1)
53 patients##8##2##(1994-3#1)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#1)
53 to##2##2##(2008-10#1)(2011-2#1)
53 years##3##2##(1997-6#1)(2011-7#1)(2013-8#1)
53##98##1##(1990-12#2)(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-8#2)(1993-1#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#2)(1995-10#1)(1995-2#3)(1995-6#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-8#4)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#11)(2011-7#1)(2012-2#3)(2012-3#3)(2012-5#2)(2013-1#5)(2013-8#3)
53% and##5##2##(1994-1#1)(1996-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
53% of the##5##3##(1990-11#1)(1990-12#1)(1993-2#1)(2008-10#1)(2009-11#1)
53% of##8##2##(1990-11#1)(1990-12#1)(1990-6#1)(1993-2#1)(1994-12#1)(2008-10#1)(2009-11#1)(2012-12#1)
53%##34##1##(1990-11#2)(1990-12#1)(1990-6#1)(1991-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-7#2)(2009-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
53%)##2##1##(2008-10#1)(2013-8#1)
53)##2##1##(2008-11#1)(2012-3#1)
53-kDa##4##1##(1993-8#3)(1995-9#1)
53-year-old man##2##2##(2008-11#1)(2013-1#1)
53-year-old##4##1##(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
530 nm with an##2##4##(2008-10#1)(2008-3#1)
530 nm##4##2##(2008-10#3)(2008-3#1)
530##11##1##(1995-11#1)(2008-10#7)(2008-3#1)(2010-4#1)(2013-1#1)
530-##2##1##(2008-10#2)
531 nm##2##2##(2008-10#1)(2008-2#1)
531##3##1##(1991-2#1)(2008-10#1)(2008-2#1)
532 nm##5##2##(2008-2#2)(2008-3#3)
532##17##1##(1991-5#10)(2008-2#3)(2008-3#4)
532)##2##1##(1991-2#2)
532-nm##2##1##(2008-3#2)
535 nm##2##2##(2008-10#1)(2008-8#1)
535##5##1##(1993-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
537##2##1##(1996-11#1)(2011-2#1)
538##4##1##(1992-4#1)(2008-10#2)(2008-3#1)
539)##2##1##(2008-11#1)(2008-12#1)
54 +/- 0##3##3##(1992-9#1)(2009-11#2)
54 and 1##2##3##(1997-2#1)(2008-10#1)
54 and##9##2##(1997-2#1)(2008-10#7)(2008-11#1)
54 cases of##2##3##(1990-9#1)(2008-11#1)
54 cases##6##2##(1990-2#1)(1990-9#1)(1996-11#2)(2008-10#1)(2008-11#1)
54 days##2##2##(1996-12#1)(2011-2#1)
54 h(-1)##2##2##(2008-10#2)
54 mV##2##2##(1997-7#1)(2008-10#1)
54 mum##2##2##(2008-3#2)
54 ng##2##2##(2008-10#2)
54 patients##3##2##(1991-2#1)(1997-3#1)(2013-1#1)
54 scores of the m/z##2##5##(2008-10#2)
54 subjects with##2##3##(1996-2#1)(2013-1#1)
54 to##5##2##(1995-3#1)(2008-10#2)(2010-11#1)(2013-1#1)
54 were##2##2##(1990-2#1)(2008-1#1)
54 years)##2##2##(1990-6#1)(1992-9#1)
54##110##1##(1990-2#3)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-8#1)(1995-3#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#46)(2008-11#5)(2008-12#1)(2008-3#5)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)
54% of##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
54%##17##1##(1991-3#1)(1992-2#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-8#1)
54%)##4##1##(2008-10#1)(2008-7#2)(2011-2#1)
54)##5##1##(2008-10#1)(2009-7#1)(2012-2#2)(2013-1#1)
54+/-0##3##1##(2008-10#3)
54-##2##1##(1995-2#1)(2008-3#1)
54-kDa##3##1##(1994-11#1)(1995-8#2)
54-year-old woman##3##2##(2009-3#1)(2013-1#2)
54-year-old##4##1##(2008-12#1)(2009-3#1)(2013-1#2)
540 km##2##2##(2008-8#2)
540 nm##6##2##(2008-10#6)
540 nm)##2##2##(2008-10#2)
540##15##1##(2008-10#11)(2008-8#2)(2008-9#1)(2009-5#1)
5400##2##1##(2008-10#1)(2008-11#1)
541##2##1##(2008-10#1)(2008-11#1)
542##2##1##(2008-10#2)
545##4##1##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
546##5##1##(2008-10#2)(2009-12#1)(2012-3#1)(2013-8#1)
5460S##4##1##(2008-8#4)
548##2##1##(2008-10#1)(2008-7#1)
549##4##1##(1996-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
55 +/- 0##2##3##(2008-5#1)(2010-6#1)
55 +/-##7##2##(1994-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-6#1)
55 amino##2##2##(1997-3#1)(2012-3#1)
55 and 1##2##3##(2008-10#2)
55 and 58 kDa##2##4##(1996-12#2)
55 and##10##2##(1996-12#2)(2008-10#6)(2011-2#1)(2013-1#1)
55 children##2##2##(1995-3#1)(1997-8#1)
55 degrees C and pH 8##2##6##(2008-6#2)
55 degrees C and##3##4##(2008-12#1)(2008-6#2)
55 degrees C##10##3##(1990-5#1)(2008-10#6)(2008-12#1)(2008-6#2)
55 degrees##12##2##(1990-5#1)(1990-9#1)(2008-10#6)(2008-12#1)(2008-6#2)(2008-9#1)
55 kD##2##2##(2008-11#2)
55 kDa##2##2##(1994-11#1)(1996-6#1)
55 ku##2##2##(2008-8#2)
55 microm##3##2##(2008-3#3)
55 min##2##2##(2008-10#2)
55 mmol/l##2##2##(1991-6#2)
55 mul##2##2##(2008-10#2)
55 mum##4##2##(2008-3#4)
55 of##2##2##(2008-10#1)(2008-5#1)
55 patients##3##2##(2006-6#1)(2008-3#1)(2011-2#1)
55 to##8##2##(1991-5#1)(1992-2#1)(2008-10#4)(2008-7#1)(2013-1#1)
55 years##3##2##(1991-11#1)(2011-2#2)
55##154##1##(1990-11#2)(1990-5#1)(1990-9#2)(1991-11#2)(1991-5#1)(1991-6#3)(1992-11#2)(1992-2#2)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#1)(1995-3#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#54)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#10)(2008-5#3)(2008-6#2)(2008-7#13)(2008-8#3)(2008-9#1)(2009-10#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#11)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
55% of the##5##3##(2008-10#1)(2008-3#2)(2008-8#1)(2012-12#1)
55% of##7##2##(1991-6#1)(2008-10#1)(2008-3#2)(2008-8#1)(2012-12#2)
55%##29##1##(1991-6#1)(1992-5#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
55)##5##1##(1994-1#1)(2008-10#1)(2008-9#2)(2013-1#1)
55+/-0##2##1##(2008-10#2)
55-microm distributed-feedback diode laser##2##4##(2008-2#2)
55-mum wavelength##4##2##(2007-11#1)(2008-3#3)
55-mum##6##1##(2007-11#1)(2008-3#5)
55-year-old##4##1##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
550 nm with an##2##4##(2008-10#2)
550 nm##3##2##(2008-10#3)
550##14##1##(1992-1#1)(1993-1#1)(2008-10#8)(2008-11#2)(2008-9#1)(2013-8#1)
551 nm##3##2##(2008-10#3)
551##4##1##(2008-10#4)
552##3##1##(2008-10#2)(2008-9#1)
554##3##1##(2008-10#3)
556##3##1##(1997-1#1)(2008-10#1)(2013-1#1)
558##4##1##(2008-10#3)(2010-12#1)
55°C##3##1##(2011-2#1)(2013-1#2)
56 and 64##2##3##(1991-1#2)
56 and##7##2##(1991-1#2)(2008-10#4)(2011-2#1)
56 cases##2##2##(2008-7#1)(2013-1#1)
56 days##3##2##(1993-1#1)(2008-10#1)(2011-2#1)
56 degrees##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
56 min##2##2##(1994-3#1)(2008-10#1)
56 of##2##2##(1997-3#1)(2008-5#1)
56 percent of##2##3##(1996-3#1)(2009-9#1)
56 to##2##2##(2008-11#1)(2009-7#1)
56 x 10(-5)##2##3##(1992-6#1)(2010-4#1)
56 x##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2010-4#1)
56##146##1##(1990-12#2)(1990-3#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#33)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#28)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-3#5)(2013-1#6)(2013-8#4)
56% of the##2##3##(2008-10#1)(2009-12#1)
56% of##5##2##(2008-10#2)(2009-12#1)(2010-1#1)(2012-3#1)
56%##23##1##(1990-9#1)(1991-2#1)(2008-10#10)(2009-12#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
56%)##2##1##(1990-8#1)(2008-5#1)
56)##4##1##(2008-3#1)(2010-2#1)(2010-4#1)(2012-12#1)
56-kDa##2##1##(1994-11#1)(1995-2#1)
56-year-old##5##1##(1997-6#1)(2010-12#1)(2010-6#2)(2011-2#1)
560 nm)##2##2##(2008-10#2)
560##10##1##(1995-11#1)(2008-10#8)(2011-2#1)
5600##3##1##(1995-2#1)(1995-6#1)(1997-5#1)
560nm for##2##2##(2008-10#2)
561##4##1##(1994-11#1)(1997-4#1)(2009-9#2)
562 nm##5##2##(2008-10#4)(2008-3#1)
562##6##1##(2008-10#4)(2008-3#1)(2011-2#1)
563##5##1##(2008-10#2)(2008-5#2)(2011-2#1)
564##2##1##(2008-10#1)(2011-2#1)
565##5##1##(1990-2#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-8#1)
569##2##1##(1996-12#1)(2011-2#1)
57 +/-##3##2##(2008-12#1)(2010-4#1)(2011-3#1)
57 000##2##2##(1997-9#1)(2008-8#1)
57 and 0##2##3##(2008-10#2)
57 and##6##2##(1994-5#1)(1997-5#1)(2008-10#3)(2009-7#1)
57 patients##6##2##(1990-8#2)(1991-8#1)(1993-1#1)(1993-11#1)(2012-3#1)
57 to##3##2##(1991-3#1)(2008-10#2)
57 vs 1##2##3##(2012-3#1)(2013-1#1)
57 with##2##2##(1991-8#1)(2013-1#1)
57 years##2##2##(1991-4#1)(1996-9#1)
57##97##1##(1990-3#2)(1990-6#1)(1990-8#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-12#2)(1995-8#2)(1996-12#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#2)
57% of##3##2##(2008-10#2)(2010-4#1)
57%##18##1##(1996-12#1)(1996-6#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-3#2)
57) and##2##2##(2008-10#2)
57)##8##1##(1993-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
57-kDa##3##1##(1995-8#3)
57-year-old man##3##2##(1997-8#1)(2011-2#1)(2013-1#1)
57-year-old##5##1##(1991-12#1)(1997-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
570 nm)##2##2##(2008-10#1)(2011-2#1)
570##6##1##(1996-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
573##5##1##(1992-1#1)(1996-6#1)(2008-10#2)(2008-11#1)
575##3##1##(1990-12#1)(2008-11#1)(2008-8#1)
576 which##2##2##(2008-11#2)
576##5##1##(1997-2#1)(2008-11#2)(2008-3#1)(2011-2#1)
577 nm##2##2##(1994-5#1)(2008-10#1)
577##5##1##(1994-5#1)(1997-3#1)(2008-10#2)(2011-2#1)
578##3##1##(1993-2#1)(2008-5#1)(2010-12#1)
579##2##1##(1996-3#1)(2011-2#1)
57th##2##1##(2009-6#2)
58 +/-##3##2##(1990-8#1)(2008-1#1)(2008-10#1)
58 TKAs##2##2##(2009-3#2)
58 V##2##2##(2008-10#1)(2009-9#1)
58 and##6##2##(2007-8#1)(2008-10#4)(2011-2#1)
58 different##2##2##(2008-5#2)
58 kDa##4##2##(1995-12#1)(1996-12#2)(2008-10#1)
58 mg##2##2##(2008-10#1)(2008-7#1)
58 of##2##2##(1994-5#1)(2013-8#1)
58 to##4##2##(2008-10#3)(2011-2#1)
58 x##3##2##(2008-10#3)
58 years##2##2##(1990-3#1)(2009-8#1)
58 years)##2##2##(1990-2#2)
58##105##1##(1990-2#3)(1990-3#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-6#2)(1996-1#2)(1996-12#3)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#44)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
58% for##3##2##(2008-10#3)
58% of the##6##3##(1991-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(2008-10#1)(2013-1#1)
58% of##9##2##(1990-6#1)(1991-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
58%##27##1##(1990-6#1)(1991-9#1)(1993-1#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1997-4#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#3)(2013-1#1)
58%)##4##1##(1992-2#1)(2008-10#2)(2011-1#1)
58)##6##1##(1997-9#1)(2008-10#3)(2013-1#2)
58+/-0##3##1##(2008-10#3)
58-kDa##2##1##(1994-11#1)(1995-12#1)
58-year-old##4##1##(1991-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
580 nm##6##2##(2008-10#5)(2008-8#1)
580##10##1##(1994-5#1)(2008-10#8)(2008-8#1)
580nm for##2##2##(2008-10#2)
580nm##3##1##(2008-10#3)
585 nm##4##2##(1996-11#1)(2008-10#2)(2008-3#1)
585##7##1##(1996-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-3#1)
587##3##1##(1996-3#1)(2008-10#1)(2008-6#1)
588##3##1##(2008-10#2)(2008-12#1)
5883##2##1##(2008-10#2)
589##4##1##(2008-10#2)(2008-8#1)(2011-2#1)
58K MP##3##2##(1997-3#3)
58K protein##2##2##(2008-8#2)
58K##6##1##(1997-3#3)(2008-8#3)
58K-like protein in##2##3##(2008-8#2)
58K-like protein##4##2##(2008-8#4)
59 (1955) 34-39)##2##3##(2008-10#2)
59 +/-##2##2##(1996-2#1)(2010-7#1)
59 and##5##2##(1994-5#1)(2008-10#2)(2008-12#1)(2008-8#1)
59 cases##2##2##(1991-8#1)(1993-9#1)
59 isolates of##2##3##(2008-10#1)(2012-3#1)
59 isolates##3##2##(2008-10#2)(2012-3#1)
59 percent##2##2##(1994-1#1)(1997-3#1)
59 to##2##2##(2008-1#1)(2008-10#1)
59 years old##2##3##(1990-6#1)(1993-2#1)
59 years##3##2##(1990-6#1)(1993-2#1)(2008-12#1)
59##81##1##(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-7#3)(1997-8#2)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#4)(2013-8#2)
59% of##3##2##(1995-2#1)(2008-1#1)(2008-7#1)
59%##13##1##(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
59%) and##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
59%)##6##1##(2008-10#1)(2012-2#1)(2013-1#3)(2013-8#1)
59)##6##1##(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-3#1)
59-kDa protein was##3##3##(1990-5#3)
59-kDa protein##7##2##(1990-5#7)
59-year-old male##2##2##(2011-2#1)(2012-12#1)
59-year-old woman##2##2##(2012-12#1)(2013-8#1)
59-year-old##6##1##(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
590##4##1##(2008-10#3)(2010-10#1)
591##5##1##(1991-3#1)(2008-10#3)(2012-2#1)
592##4##1##(1996-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
593##3##1##(2008-10#3)
594##2##1##(2008-10#1)(2013-1#1)
595##16##1##(1990-5#6)(1993-12#1)(2008-10#6)(2010-12#1)(2011-2#1)(2012-5#1)
596##4##1##(2008-9#1)(2011-2#2)(2012-3#1)
597##3##1##(1997-9#1)(2008-10#1)(2011-2#1)
598##2##1##(2008-10#1)(2008-12#1)
599##2##1##(1996-6#1)(2008-9#1)
59mug/l##2##1##(2008-10#2)
5A##2##1##(1994-11#1)(1997-1#1)
5BL##4##1##(2008-10#4)
5BSL3##2##1##(2013-1#2)
5D4##4##1##(2008-8#4)
5F##3##1##(1997-3#3)
5FU##4##1##(1992-2#4)
5HT and DA##3##3##(1996-12#3)
5HT##5##1##(1996-12#5)
5HT(3) receptor##2##2##(2010-12#2)
5HT1D alpha##4##2##(1993-12#4)
5HT1D pseudogene##3##2##(1993-12#3)
5HT1D##9##1##(1993-12#9)
5J/cm(2) and##2##2##(2012-3#2)
5J/cm(2) was##2##2##(2012-3#2)
5J/cm(2)##7##1##(2012-3#7)
5M H(2)SO(4)##2##2##(2008-10#2)
5M HCl##2##2##(2008-10#2)
5M##11##1##(1996-8#1)(2008-10#10)
5MTN##2##1##(2012-2#2)
5Na0##2##1##(2008-3#2)
5P##2##1##(1990-2#1)(2010-12#1)
5P(2)##4##1##(2013-1#4)
5P(3/2)##3##1##(2008-3#3)
5P3 and##2##2##(1993-6#2)
5P3##5##1##(1993-6#5)
5RZ107##2##1##(2008-9#2)
5S NGF##2##2##(1990-8#2)
5S rDNA spacer sequence analysis##2##5##(2008-8#1)(2008-9#1)
5S##14##1##(1990-11#3)(1990-8#2)(1992-3#1)(2008-10#5)(2008-8#1)(2008-9#1)(2012-3#1)
5T##2##1##(2008-5#1)(2010-12#1)
5V (logic 1) to 1##2##5##(2008-10#2)
5V##3##1##(2008-10#3)
5]##2##1##(1990-3#1)(2011-2#1)
5alpha-reductase##2##1##(2008-5#2)
5alphaR##7##1##(2008-5#7)
5cm##4##1##(2008-10#2)(2008-12#1)(2009-1#1)
5g of##3##2##(2008-10#3)
5g##4##1##(2008-10#4)
5g/L)##2##1##(2013-1#2)
5h##2##1##(2008-10#2)
5mL of##3##2##(2008-10#3)
5mL##4##1##(2008-10#4)
5mLmin(-1)##3##1##(2008-10#3)
5mM##10##1##(2008-10#9)(2011-2#1)
5mV per pl-carnitine##2##3##(2008-10#2)
5mV per##3##2##(2008-10#3)
5mg##3##1##(2008-10#2)(2010-7#1)
5mgL(-1)##3##1##(2008-10#3)
5mgkg(-1))##2##1##(2008-10#2)
5mgl(-1)##8##1##(2008-10#8)
5min at##2##2##(2008-10#2)
5min##27##1##(2008-10#27)
5ml of 1##2##3##(2008-10#2)
5ml of a##2##3##(2008-10#2)
5ml of##5##2##(2008-10#5)
5ml portion of a 0##2##5##(2008-10#2)
5ml##14##1##(2008-10#14)
5mlmin(-1)##3##1##(2008-10#3)
5mm##2##1##(2008-10#1)(2011-2#1)
5mmoll(-1) phosphate buffer##2##3##(2008-10#2)
5mmoll(-1)##3##1##(2008-10#3)
5molL(-1) HNO(3)##2##2##(2008-10#2)
5molL(-1)##4##1##(2008-10#4)
5muM##4##1##(2008-10#4)
5mug##2##1##(2008-10#1)(2008-5#1)
5mug)##2##1##(2008-10#2)
5mug/l##2##1##(2008-10#2)
5mugL(-1)##3##1##(2008-10#3)
5mugl(-1) formaldehyde##2##2##(2008-10#2)
5mugl(-1)##14##1##(2008-10#14)
5mugl(-1)) and##2##2##(2008-10#2)
5mugml(-1)##10##1##(2008-10#10)
5mul##5##1##(2008-10#5)
5mum column##2##2##(2008-10#2)
5mum##7##1##(2008-10#7)
5mum)##3##1##(2008-10#3)
5mumolL(-1)##2##1##(2008-10#2)
5nM##3##1##(1993-3#1)(2008-10#2)
5ng##2##1##(2008-10#2)
5ng/ml##2##1##(2008-10#2)
5ngmL(-1) for##2##2##(2008-10#2)
5ngmL(-1)##3##1##(2008-10#3)
5ngml(-1)##7##1##(2008-10#7)
5pg for##2##2##(2008-10#2)
5ppm##5##1##(2008-10#5)
5s##3##1##(2008-10#3)
5th##14##1##(1991-2#1)(1991-9#3)(2008-10#1)(2008-11#2)(2008-12#3)(2008-7#2)(2011-2#1)(2013-1#1)
5wt##2##1##(2013-1#2)
5x10##2##1##(1992-12#1)(2008-10#1)
5x10(-10)##3##1##(2008-10#3)
5x10(-10)M##2##1##(2008-10#2)
5x10(-11)##2##1##(2008-10#2)
5x10(-2) M##2##2##(2008-10#2)
5x10(-2) mol l(-1)##2##3##(2008-10#2)
5x10(-2)##5##1##(2008-10#5)
5x10(-3) M with a detection limit of##2##7##(2008-10#2)
5x10(-3) M##3##2##(2008-10#3)
5x10(-3) mol l(-1)##2##3##(2008-10#2)
5x10(-3) mol##3##2##(2008-10#3)
5x10(-3)##8##1##(2008-10#8)
5x10(-3)M##2##1##(2008-10#2)
5x10(-3)molL(-1) for##2##2##(2008-10#2)
5x10(-4) mol l(-1)##3##3##(2008-10#3)
5x10(-4) to##4##2##(2008-10#4)
5x10(-4)##13##1##(2008-10#13)
5x10(-4)%##2##1##(2008-10#2)
5x10(-4)moll(-1)##2##1##(2008-10#2)
5x10(-5) M##3##2##(2008-10#3)
5x10(-5) mol l(-1)##5##3##(2008-10#5)
5x10(-5) mol##6##2##(2008-10#6)
5x10(-5) to 1##2##3##(2008-10#2)
5x10(-5) to##3##2##(2008-10#3)
5x10(-5)##14##1##(2008-10#14)
5x10(-5)-5x10(-4)##2##1##(2008-10#2)
5x10(-5)M with##2##2##(2008-10#2)
5x10(-5)M##5##1##(2008-10#5)
5x10(-5)moll(-1)##3##1##(2008-10#3)
5x10(-6) M##6##2##(2008-10#6)
5x10(-6) and##2##2##(2008-10#2)
5x10(-6) g##2##2##(2008-10#2)
5x10(-6) mol/l##2##2##(2008-10#2)
5x10(-6) to##4##2##(2008-10#4)
5x10(-6)##17##1##(2008-10#17)
5x10(-6)-5##2##1##(2008-10#2)
5x10(-6)molL(-1)##2##1##(2008-10#2)
5x10(-7) M for##2##3##(2008-10#2)
5x10(-7) M##5##2##(2008-10#5)
5x10(-7) mol l(-1)##3##3##(2008-10#3)
5x10(-7) to##3##2##(2008-10#3)
5x10(-7)##11##1##(2008-10#11)
5x10(-7)molL(-1)##3##1##(2008-10#3)
5x10(-7)moll(-1)##2##1##(2008-10#2)
5x10(-8) M##2##2##(2008-10#2)
5x10(-8) moll(-1) for##2##3##(2008-10#2)
5x10(-8) to 1x10(-5)##2##3##(2008-10#2)
5x10(-8) to##3##2##(2008-10#3)
5x10(-8)##9##1##(2008-10#9)
5x10(-8)-3##2##1##(2008-10#2)
5x10(-8)M##4##1##(2008-10#4)
5x10(-9) M##2##2##(2008-10#2)
5x10(-9) mol l(-1)##2##3##(2008-10#2)
5x10(-9)##7##1##(2008-10#7)
5x10(3)##2##1##(2008-10#2)
5x10(5)##5##1##(2008-10#2)(2008-11#2)(2008-12#1)
5x10(6)##2##1##(2008-10#1)(2008-11#1)
5x10(7)##2##1##(2008-11#1)(2008-8#1)
5 mg/L) and cyclic##2##3##(2010-4#2)
5 mg/L) and##3##2##(2010-4#3)
5 mg/L)##4##1##(2010-4#4)
5°C##4##1##(2011-1#1)(2011-2#2)(2013-1#1)
5±1##2##1##(2010-12#2)
5±3##2##1##(2010-12#1)(2013-1#1)
5 min##2##1##(2013-1#2)
5 years##2##1##(2011-1#2)
6 %##2##2##(2012-12#2)
6 (2)##2##2##(2008-10#2)
6 (3##2##2##(2008-5#2)
6 (3)##2##2##(2008-11#1)(2008-12#1)
6 (n##2##2##(2013-1#2)
6 (range##3##2##(1992-5#1)(1993-11#1)(2008-1#1)
6 +/- 0##6##3##(1990-5#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-9#1)
6 +/- 1##2##3##(1992-2#1)(1993-2#1)
6 +/- 2##4##3##(1994-12#1)(1995-11#1)(2010-1#1)(2013-7#1)
6 +/- 22##2##3##(1996-3#1)(2011-2#1)
6 +/- 6##2##3##(1995-8#1)(2008-10#1)
6 +/-##21##2##(1990-2#1)(1990-5#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-12#2)(1995-11#2)(1995-8#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-12#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
6 -##2##2##(1993-2#2)
6 CRF07_BC infected##2##3##(2013-8#2)
6 Gy##3##2##(2009-2#3)
6 L/min##2##2##(1996-3#1)(2010-7#1)
6 M##7##2##(1993-6#1)(2008-10#5)(2008-11#1)
6 M-4##2##2##(2008-11#2)
6 M-4-TR7##2##2##(2008-11#2)
6 Mb##2##2##(1996-12#1)(1997-6#1)
6 V##5##2##(2008-10#4)(2009-10#1)
6 X##2##2##(1996-2#2)
6 alpha##2##2##(1991-5#2)
6 and 0##2##3##(2008-10#2)
6 and 1##7##3##(1996-12#1)(2008-10#4)(2008-7#1)(2009-11#1)
6 and 10##2##3##(1996-5#1)(2008-11#1)
6 and 100##2##3##(2008-10#2)
6 and 12 months##6##4##(1993-12#1)(2008-7#1)(2010-5#1)(2011-2#2)(2013-1#1)
6 and 12##7##3##(1993-12#1)(2008-7#1)(2010-5#1)(2011-2#3)(2013-1#1)
6 and 14##2##3##(2008-10#1)(2010-7#1)
6 and 18 weeks##2##4##(2010-12#2)
6 and 18##3##3##(1994-3#1)(2010-12#2)
6 and 2##6##3##(2008-10#4)(2008-5#1)(2009-2#1)
6 and 3##3##3##(2008-10#3)
6 and 4##4##3##(1997-2#1)(2008-10#2)(2009-3#1)
6 and 5##5##3##(1995-12#1)(1995-6#1)(2008-10#2)(2008-11#1)
6 and 7 December 2007##2##5##(2009-4#2)
6 and 7##11##3##(1996-5#1)(2008-10#5)(2008-11#1)(2009-4#2)(2011-2#1)(2013-1#1)
6 and 8 mm##4##4##(2013-1#4)
6 and 8##15##3##(1990-8#1)(1991-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-10#5)(2013-1#5)
6 and a##2##3##(1996-2#1)(2008-10#1)
6 and at##2##3##(2008-10#2)
6 and the##2##3##(2008-10#2)
6 and was##3##3##(2008-10#2)(2008-7#1)
6 and##112##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(2008-10#57)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#7)(2012-2#1)(2013-1#7)
6 as well as##2##4##(2008-10#1)(2012-3#1)
6 as##3##2##(2008-10#2)(2012-3#1)
6 at##3##2##(1994-11#1)(1994-3#1)(2008-10#1)
6 basic##2##2##(1995-6#2)
6 cM##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
6 cases of##2##3##(1990-6#1)(2008-7#1)
6 cases##9##2##(1990-6#3)(1991-1#1)(1992-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
6 categories##2##2##(2008-10#1)(2010-1#1)
6 caused less disease on##2##5##(2008-10#2)
6 caused##3##2##(2008-10#3)
6 cells##2##2##(1994-2#1)(1997-1#1)
6 cm in diameter##2##4##(1992-2#1)(2008-7#1)
6 cm##12##2##(1992-2#1)(1992-9#1)(1993-12#1)(2008-10#6)(2008-7#1)(2010-6#1)(2010-7#1)
6 cycles of##3##3##(1991-6#1)(2009-12#1)(2012-3#1)
6 days after treatment##2##4##(1990-10#1)(2008-10#1)
6 days after##6##3##(1990-10#1)(2008-10#5)
6 days and##3##3##(2008-10#1)(2008-11#2)
6 days at##2##3##(1995-8#1)(2008-10#1)
6 days in##3##3##(1995-8#2)(2008-10#1)
6 days later##2##3##(1994-2#1)(2008-10#1)
6 days##30##2##(1990-10#1)(1994-2#1)(1995-11#1)(1995-8#4)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#9)(2008-11#5)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#3)
6 degrees C##6##3##(2008-10#5)(2008-2#1)
6 degrees##8##2##(1992-4#1)(2008-10#5)(2008-12#1)(2008-2#1)
6 different##5##2##(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#2)
6 fold by##2##3##(1994-11#1)(2011-3#1)
6 fold##3##2##(1990-2#1)(1994-11#1)(2011-3#1)
6 for##8##2##(1991-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)
6 g kg(-1)##2##3##(2008-10#1)(2008-12#1)
6 g##3##2##(2008-10#2)(2008-12#1)
6 g/l##3##2##(1991-6#1)(2008-1#1)(2008-5#1)
6 h after##7##3##(1991-2#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-5#1)
6 h in##2##3##(1995-11#1)(2008-11#1)
6 h of##5##3##(1995-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
6 h##39##2##(1990-12#2)(1991-2#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-2#1)(2008-10#14)(2008-11#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)
6 hours##5##2##(1990-2#1)(1993-8#1)(1994-11#1)(2008-7#1)(2011-2#1)
6 hr and 12 hr##2##5##(2008-6#2)
6 hr and##3##3##(2008-5#1)(2008-6#2)
6 hr##7##2##(1995-2#1)(2008-5#2)(2008-6#4)
6 in the presence of##2##5##(1990-8#1)(2008-10#1)
6 in the##7##3##(1990-8#1)(1991-3#1)(1992-2#1)(2008-10#3)(2008-7#1)
6 in##14##2##(1990-8#1)(1991-3#1)(1992-2#1)(1995-2#1)(2008-10#7)(2008-7#1)(2011-2#1)(2013-1#1)
6 kDa##4##2##(1990-12#1)(1993-6#1)(1995-11#1)(2008-12#1)
6 kb DNA fragment##2##4##(2008-8#1)(2008-9#1)
6 kb mRNA##2##3##(1993-8#1)(1997-2#1)
6 kb##9##2##(1993-8#1)(1994-8#1)(1996-6#1)(1997-2#2)(2008-11#1)(2008-8#2)(2008-9#1)
6 kg##2##2##(2008-9#1)(2012-3#1)
6 km)##2##2##(2008-10#1)(2010-6#1)
6 lesions per##2##3##(2008-10#2)
6 m wide##2##3##(2008-10#2)
6 m##5##2##(2008-10#5)
6 mM calcium##3##3##(1994-3#3)
6 mM##7##2##(1994-3#3)(2008-10#4)
6 mV per##2##3##(2008-10#2)
6 mg l(-1) of##2##4##(2008-10#2)
6 mg l(-1)##5##3##(2008-10#3)(2008-11#2)
6 mg##10##2##(1993-2#1)(2008-10#4)(2008-11#4)(2010-8#1)
6 mg/kg rocuronium##2##3##(2011-2#2)
6 mg/kg##5##2##(1992-12#1)(1992-3#1)(2008-10#1)(2011-2#2)
6 microM##5##2##(1993-6#1)(1993-8#1)(1995-8#1)(2008-10#1)(2008-7#1)
6 microM)##2##2##(1990-11#1)(1994-6#1)
6 microW##2##2##(2008-9#2)
6 microg l(-1)##2##3##(2008-10#2)
6 microg##3##2##(2008-10#3)
6 microg/l##2##2##(2008-10#2)
6 microns##3##2##(1991-5#1)(1996-2#1)(1996-3#1)
6 microns)##2##2##(1995-3#1)(1996-2#1)
6 million##4##2##(1997-6#1)(2008-10#2)(2012-12#1)
6 min##13##2##(1990-11#1)(1990-2#1)(1994-3#1)(1996-1#1)(1997-7#1)(2008-10#8)
6 min)##2##2##(2008-10#1)(2011-2#1)
6 ml##2##2##(2008-10#2)
6 mm i##6##3##(2008-10#5)(2008-5#1)
6 mm in##2##3##(1991-2#1)(2008-10#1)
6 mm##17##2##(1991-2#2)(1991-9#1)(1997-2#1)(2008-10#10)(2008-5#1)(2013-1#2)
6 mm)##5##2##(2008-10#2)(2009-8#1)(2011-2#1)(2011-3#1)
6 mmHg##2##2##(2008-10#1)(2008-11#1)
6 mmHg)##2##2##(1991-6#1)(2008-11#1)
6 mmol##2##2##(2008-10#2)
6 mmol/l##5##2##(1990-6#1)(1991-11#3)(2008-7#1)
6 mo##2##2##(2012-2#2)
6 mol l(-1)##2##3##(2008-10#2)
6 mol##4##2##(1990-10#1)(1994-5#1)(2008-10#2)
6 month##3##2##(1993-6#1)(2011-2#1)(2013-1#1)
6 months after initial##2##4##(2011-2#1)(2013-1#1)
6 months after the##4##4##(1991-8#1)(2008-7#2)(2011-2#1)
6 months after##15##3##(1991-8#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#4)(2013-1#2)
6 months and##5##3##(1990-12#1)(2008-10#2)(2008-12#1)(2008-5#1)
6 months at room##2##4##(2008-10#1)(2008-8#1)
6 months at##3##3##(2008-10#2)(2008-8#1)
6 months before##3##3##(2008-1#1)(2013-1#2)
6 months following the start of##2##6##(2008-1#1)(2008-10#1)
6 months following##3##3##(2008-1#1)(2008-10#2)
6 months in the##3##4##(2008-10#2)(2008-11#1)
6 months in##7##3##(1990-6#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
6 months later##2##3##(1997-5#1)(2008-7#1)
6 months of age##5##4##(1991-2#1)(1995-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
6 months of treatment##3##4##(1991-8#1)(2007-11#1)(2012-3#1)
6 months of##12##3##(1991-2#1)(1991-8#1)(1995-5#1)(2007-11#1)(2008-10#3)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)
6 months old##2##3##(1993-12#1)(2008-10#1)
6 months was##2##3##(2008-10#1)(2013-1#1)
6 months##111##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#3)(1991-8#3)(1993-12#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-11#2)(2008-1#3)(2008-10#23)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#2)(2010-10#1)(2010-6#3)(2011-2#12)(2012-12#4)(2012-3#4)(2013-1#18)
6 months)##4##2##(1996-11#1)(1997-3#1)(2010-12#1)(2011-2#1)
6 mug l(-1) for##2##4##(2008-10#2)
6 mug l(-1)##4##3##(2008-10#4)
6 mug ml(-1)##7##3##(2008-10#7)
6 mug ml(-1))##2##3##(2008-10#2)
6 mug##19##2##(2008-10#17)(2008-11#1)(2008-5#1)
6 mum##4##2##(2008-3#3)(2008-7#1)
6 nM##5##2##(1992-6#1)(1993-6#1)(1993-8#1)(2008-10#2)
6 ng g(-1)##2##3##(2008-10#2)
6 ng ml(-1) for##2##4##(2008-10#2)
6 ng ml(-1)##11##3##(2008-10#11)
6 ng##16##2##(2008-10#16)
6 nm##6##2##(1990-11#1)(2008-10#3)(2008-3#1)(2013-8#1)
6 of the##2##3##(1990-3#1)(2008-10#1)
6 of##17##2##(1990-3#1)(1991-12#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-6#1)(1997-3#1)(2008-10#6)(2008-11#1)(2009-3#1)(2010-2#1)(2012-2#1)
6 or 10 h after CCl4##2##6##(1994-5#2)
6 or 11##2##3##(1994-1#1)(2008-6#1)
6 or##7##2##(1990-3#1)(1994-1#1)(1994-5#2)(1996-11#1)(2008-10#1)(2008-6#1)
6 out of##2##3##(2008-12#2)
6 parts per##2##3##(2008-10#1)(2008-3#1)
6 patients were##3##3##(1992-3#1)(2008-7#1)(2012-12#1)
6 patients with##2##3##(1995-12#1)(1997-3#1)
6 patients##15##2##(1990-12#1)(1991-3#1)(1992-3#2)(1994-12#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
6 per cent##2##3##(1990-6#1)(2008-7#1)
6 per##3##2##(1990-6#1)(2008-7#1)(2011-3#1)
6 percent##6##2##(1991-3#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-12#1)(2008-11#1)
6 percent) were knowledgeable##2##4##(2013-1#2)
6 percent)##3##2##(1997-3#1)(2013-1#2)
6 pg##2##2##(2008-10#2)
6 ppm##4##2##(2008-10#3)(2010-1#1)
6 reduced##2##2##(2008-10#2)
6 respectively##2##2##(1996-12#1)(2008-8#1)
6 strains##2##2##(2008-10#2)
6 through##2##2##(2008-10#1)(2009-7#1)
6 times in##2##3##(1995-8#1)(2010-12#1)
6 times more##2##3##(1992-6#1)(2013-8#1)
6 times that##2##3##(2008-11#1)(2008-3#1)
6 times##9##2##(1992-6#1)(1995-6#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
6 to 0##4##3##(2008-10#4)
6 to 10##2##3##(2008-10#1)(2008-9#1)
6 to 100##2##3##(2008-10#1)(2008-11#1)
6 to 102##2##3##(2008-10#2)
6 to 12##2##3##(2008-10#1)(2011-1#1)
6 to 17##3##3##(2008-10#2)(2012-12#1)
6 to 18##2##3##(2008-10#2)
6 to 20##2##3##(2008-10#1)(2008-11#1)
6 to 3##3##3##(2008-10#2)(2013-1#1)
6 to 30##2##3##(2008-10#2)
6 to 5##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
6 to 7 weeks##2##4##(2008-10#2)
6 to 7##3##3##(1996-12#1)(2008-10#2)
6 to 8 days##2##4##(1997-3#1)(2008-10#1)
6 to 8 weeks##5##4##(1992-11#1)(2008-10#2)(2009-11#1)(2009-5#1)
6 to 8##9##3##(1992-11#1)(1997-3#1)(2008-10#4)(2009-11#1)(2009-5#1)(2009-8#1)
6 to 9##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
6 to##65##2##(1990-2#1)(1991-11#1)(1992-11#1)(1993-8#1)(1995-3#1)(1996-12#1)(1997-3#1)(2008-10#39)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
6 using##2##2##(1991-3#1)(1995-6#1)
6 vs##5##2##(1997-7#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-3#1)
6 was##3##2##(2008-10#2)(2011-2#1)
6 weeks after inoculation##2##4##(2008-10#2)
6 weeks after the##2##4##(1990-12#1)(2008-7#1)
6 weeks after##9##3##(1990-12#1)(1994-8#1)(1996-8#1)(2008-10#5)(2008-7#1)
6 weeks and##3##3##(1991-2#1)(1994-3#1)(2008-7#1)
6 weeks following##2##3##(2008-4#1)(2008-5#1)
6 weeks##54##2##(1990-12#2)(1990-9#1)(1991-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-8#1)(2008-10#19)(2008-11#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)
6 weeks)##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
6 were##15##2##(1990-6#1)(1994-5#1)(1995-11#1)(1996-3#1)(2008-10#7)(2010-3#1)(2011-2#1)(2011-3#1)(2013-8#1)
6 with##11##2##(1991-3#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
6 women##2##2##(1990-2#1)(2009-5#1)
6 x 10(-10)##2##3##(1993-8#1)(1995-11#1)
6 x 10(-6)##2##3##(1992-3#1)(1995-11#1)
6 x 10(-6)-1##2##3##(2008-10#2)
6 x 10(-7)##2##3##(2008-10#2)
6 x 10(-8)##3##3##(1995-11#1)(2008-10#2)
6 x 10(4)##2##3##(1994-5#1)(1997-3#1)
6 x 10(5)##3##3##(1994-8#1)(2008-11#1)(2008-3#1)
6 x 10(6)##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
6 x 10(7)##2##3##(2008-11#1)(2008-9#1)
6 x 10(8)##2##3##(1990-12#1)(2008-9#1)
6 x 10(9)##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
6 x##39##2##(1990-12#2)(1991-9#1)(1992-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-8#2)(1997-3#1)(2008-10#13)(2008-11#3)(2008-3#3)(2008-7#2)(2008-9#4)
6 y 9 h after inoculation##2##6##(2008-5#2)
6 years (mean##2##3##(2013-1#2)
6 years (range##2##3##(1993-2#1)(2012-12#1)
6 years after stereotactic radiosurgery##2##5##(2011-2#2)
6 years after##4##3##(2008-7#1)(2011-2#2)(2012-12#1)
6 years and##2##3##(2009-3#1)(2011-2#1)
6 years in##2##3##(2008-10#1)(2013-1#1)
6 years##29##2##(1990-6#1)(1991-3#1)(1993-2#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-4#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#2)(2009-3#1)(2011-2#5)(2012-12#2)(2013-1#3)
6 years) than##2##3##(2008-10#1)(2011-2#1)
6 years)##6##2##(1993-1#1)(2008-10#1)(2010-9#1)(2011-2#2)(2013-1#1)
6 ±##4##2##(2011-2#2)(2013-1#2)
6##1869##1##(1990-10#3)(1990-11#4)(1990-12#12)(1990-2#9)(1990-3#3)(1990-5#5)(1990-6#10)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#3)(1991-11#7)(1991-12#6)(1991-2#11)(1991-3#11)(1991-5#11)(1991-6#4)(1991-7#1)(1991-8#6)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#11)(1992-2#6)(1992-3#5)(1992-4#4)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#12)(1993-2#12)(1993-3#5)(1993-6#8)(1993-8#16)(1994-1#2)(1994-11#4)(1994-12#14)(1994-2#6)(1994-3#12)(1994-5#8)(1994-6#4)(1994-8#11)(1994-9#2)(1995-11#17)(1995-12#9)(1995-2#10)(1995-3#4)(1995-5#2)(1995-6#7)(1995-8#17)(1996-1#2)(1996-11#5)(1996-12#13)(1996-2#10)(1996-3#9)(1996-5#7)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#12)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#6)(1997-9#1)(2007-11#2)(2007-12#2)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#787)(2008-11#90)(2008-12#26)(2008-2#4)(2008-3#22)(2008-4#4)(2008-5#37)(2008-6#14)(2008-7#42)(2008-8#25)(2008-9#32)(2009-1#2)(2009-10#2)(2009-11#7)(2009-12#1)(2009-2#5)(2009-3#8)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#8)(2009-9#1)(2010-1#5)(2010-10#5)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#7)(2010-7#8)(2010-8#1)(2010-9#2)(2011-1#10)(2011-2#75)(2011-3#10)(2012-12#15)(2012-2#10)(2012-3#27)(2013-1#76)(2013-3#1)(2013-7#1)(2013-8#18)
6% (SEM##2##2##(1992-6#2)
6% (at##2##2##(2008-10#2)
6% (n =##2##3##(1995-8#1)(2012-3#1)
6% (n=9)##2##2##(2008-10#2)
6% (w/w)##2##2##(2008-10#1)(2011-2#1)
6% acetonitrile in##2##3##(2008-10#2)
6% and a##2##3##(2008-10#1)(2008-8#1)
6% and the##3##3##(2008-10#3)
6% and##22##2##(1992-11#1)(1993-1#1)(1993-3#1)(2008-10#10)(2008-11#2)(2008-8#3)(2010-8#2)(2012-2#1)(2012-3#1)
6% at the##5##3##(2008-10#5)
6% at##11##2##(1995-12#1)(2008-10#8)(2008-12#1)(2008-7#1)
6% for ten determinations of##2##5##(2008-10#2)
6% for the##3##3##(1997-7#1)(2008-10#2)
6% for##29##2##(1990-5#1)(1991-6#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-3#1)(2011-2#2)(2012-3#2)
6% had##2##2##(1995-10#1)(2008-12#1)
6% in##7##2##(1991-6#1)(1994-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
6% nucleotide identity##2##3##(2008-10#1)(2008-8#1)
6% nucleotide##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
6% of all##2##3##(1991-3#1)(2008-7#1)
6% of males##3##3##(1990-6#1)(1994-6#2)
6% of patients##4##3##(1991-12#1)(2008-7#1)(2010-4#1)(2012-3#1)
6% of the patients##5##4##(1990-9#1)(1991-3#1)(1995-12#1)(2008-1#1)(2008-11#1)
6% of the phenotypic##2##4##(2008-10#2)
6% of the total##2##4##(2008-10#1)(2010-1#1)
6% of the##26##3##(1990-12#2)(1990-9#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-8#1)
6% of##52##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-7#2)(2009-5#1)(2010-1#1)(2010-4#3)(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
6% on##2##2##(2010-1#1)(2013-1#1)
6% recovery##2##2##(2008-10#2)
6% to##6##2##(1991-9#1)(1993-3#1)(1995-12#1)(2010-8#1)(2013-1#2)
6% vs##2##2##(1993-2#1)(2011-2#1)
6% was##3##2##(2008-10#2)(2009-7#1)
6% were##5##2##(1994-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
6% with that of##2##4##(2008-10#1)(2008-8#1)
6% with##8##2##(1990-12#1)(1995-3#1)(1996-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
6%##318##1##(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#6)(1991-9#2)(1992-11#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-2#2)(1993-3#5)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#5)(1994-6#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#4)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#2)(1997-1#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#140)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#8)(2008-8#5)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-4#5)(2010-5#1)(2010-8#5)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#8)(2012-3#11)(2013-1#15)(2013-8#8)
6%) and##14##2##(1991-12#2)(1992-11#1)(1996-11#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2010-8#1)(2013-1#1)
6%) had##4##2##(1990-12#1)(1992-9#1)(2011-2#2)
6%) in##2##2##(2008-1#1)(2008-3#1)
6%) of##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
6%) patients##6##2##(1997-8#2)(2011-2#3)(2013-1#1)
6%) were##4##2##(1996-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
6%) with##3##2##(1991-6#1)(2008-11#1)(2011-2#1)
6%)##76##1##(1990-12#2)(1990-6#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1996-11#1)(1996-6#2)(1996-8#1)(1997-8#2)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-9#2)(2009-12#1)(2009-6#1)(2010-8#3)(2011-2#13)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#2)
6'-nonaCB##2##1##(1993-12#2)
6) and a##2##3##(2008-10#2)
6) and##9##2##(1990-5#1)(1993-8#1)(2008-10#5)(2010-9#1)(2011-2#1)
6) containing##2##2##(2008-10#2)
6) could##2##2##(1997-2#1)(2011-2#1)
6) for##4##2##(1993-12#1)(2008-7#1)(2010-6#1)(2011-2#1)
6) in##2##2##(1992-4#1)(2008-10#1)
6) were##4##2##(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
6)##65##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-6#1)(1993-8#2)(1995-8#1)(1996-8#1)(1997-2#1)(1997-8#2)(2008-10#23)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#6)(2012-3#2)(2013-1#1)(2013-8#1)
6+/-0##8##1##(2008-10#7)(2008-2#1)
6- and##4##2##(1993-12#1)(1993-9#1)(2008-10#2)
6- to##2##2##(2008-10#1)(2010-8#1)
6-##10##1##(1993-12#1)(1993-9#1)(2008-10#3)(2008-11#2)(2010-8#2)(2011-2#1)
6-0##3##1##(1997-8#1)(2008-8#1)(2008-9#1)
6-1##5##1##(2008-10#3)(2008-3#1)(2011-2#1)
6-10##8##1##(1992-11#1)(1994-12#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-3#1)
6-100##2##1##(2008-10#1)(2008-11#1)
6-12 hours after##2##3##(1990-12#1)(2009-11#1)
6-12##5##1##(1990-12#1)(1996-2#1)(2008-10#2)(2009-11#1)
6-15##3##1##(1995-12#2)(2008-10#1)
6-2##4##1##(1990-5#1)(2008-10#3)
6-23##2##1##(1995-3#1)(2010-6#1)
6-3##5##1##(1993-12#1)(2008-10#2)(2012-12#2)
6-4##4##1##(2008-10#4)
6-5##2##1##(2008-10#2)
6-7 weeks##2##2##(2008-7#1)(2013-1#1)
6-7##7##1##(1996-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
6-8 weeks##5##2##(1993-11#2)(1993-6#1)(2011-2#1)(2012-2#1)
6-8##16##1##(1993-11#2)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-3#1)(2008-10#4)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#2)
6-9##6##1##(1992-10#1)(1995-2#2)(2008-1#1)(2008-10#1)(2009-12#1)
6-90##2##1##(2008-10#2)
6-APA##8##1##(2008-12#8)
6-DBP##3##1##(2008-10#3)
6-DCP##2##1##(2008-10#2)
6-DNP##4##1##(2008-10#4)
6-MM##2##1##(2008-10#2)
6-MP##5##1##(2008-10#4)(2010-12#1)
6-Mb region##2##2##(1996-2#2)
6-Mb##3##1##(1996-2#3)
6-P2 content##4##2##(1994-3#4)
6-P2##7##1##(1994-3#7)
6-TBA##2##1##(2008-10#2)
6-TBP##2##1##(2008-10#2)
6-TBP)##2##1##(2008-10#2)
6-TNT##3##1##(2008-10#3)
6-W##2##1##(2008-10#1)(2008-3#1)
6-amidino-2-naphthyl p-guanidinobenzoate##2##2##(1990-5#2)
6-anhydro##2##1##(1996-5#2)
6-bisphosphatase to##3##2##(2008-9#3)
6-bisphosphatase##7##1##(1994-8#1)(2008-9#6)
6-bisphosphate##2##1##(1994-3#1)(1996-6#1)
6-bromo-2-naphthol##4##1##(2008-10#4)
6-chloronicotinic acid##3##2##(2008-10#3)
6-cm##2##1##(2008-7#1)(2009-2#1)
6-day culture##2##2##(1995-8#1)(2008-11#1)
6-diamidino-2-phenylindole (DAPI)##2##2##(2008-10#1)(2008-9#1)
6-diamidino-2-phenylindole##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
6-diamino-1##2##1##(2008-10#2)
6-dicarbethoxy-8-(3'##2##1##(2008-10#2)
6-dichlorophenol bath concentrations of 5 x##2##6##(1994-5#2)
6-dichlorophenol bath concentrations of##3##4##(1994-5#3)
6-dichlorophenol##10##1##(1994-5#9)(2008-10#1)
6-dichlorophenolindophenol##4##1##(2008-10#4)
6-dicyano-1##4##1##(2008-10#2)(2008-11#2)
6-diisopropylphenol##3##1##(1993-6#3)
6-dimethyl-2##2##1##(1990-11#2)
6-dimethyl-2-mercaptopyrimidine (III)##2##2##(2008-10#2)
6-dimethyl-4-(3-aryl-1-phenyl-4-pyrazolyl)pyridine-3##4##1##(2012-3#4)
6-dimethyl-Tyr1##2##1##(1992-3#2)
6-dimethyl-benzimidazole##2##1##(2008-10#2)
6-dinitro-o-cresol (4##2##2##(2008-10#2)
6-dinitrophenol##3##1##(2008-10#3)
6-dinitrotoluene to mutagenic metabolites##2##4##(1990-6#2)
6-dinitrotoluene##6##1##(1990-6#3)(2008-10#3)
6-diphenyl-1##5##1##(1991-5#1)(2008-10#4)
6-diphenyl-4-benzo-9-crown-3-pyridine##3##1##(2008-10#3)
6-disulfonate##2##1##(2008-10#2)
6-disulfonic acid##5##2##(2008-10#5)
6-disulfonic##6##1##(2008-10#6)
6-fold more##3##2##(1994-8#1)(1997-1#1)(2008-11#1)
6-fold##9##1##(1993-6#2)(1994-8#1)(1995-11#1)(1997-1#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
6-fold)##2##1##(1993-8#1)(1995-11#1)
6-hydroxydopamine lesions##2##2##(1996-5#1)(1997-2#1)
6-hydroxydopamine##7##1##(1993-3#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-7#1)(2012-2#1)
6-kb##5##1##(1991-9#1)(1995-6#1)(1997-7#1)(2008-10#1)(2009-10#1)
6-mercaptopurine (6-MP)##2##2##(2008-10#1)(2010-12#1)
6-mercaptopurine##5##1##(2008-10#4)(2010-12#1)
6-methyl##3##1##(1996-5#1)(2008-11#2)
6-min walk distance##2##3##(2013-1#2)
6-mm##3##1##(2008-10#1)(2013-1#2)
6-month follow-up##3##2##(2008-8#1)(2010-10#1)(2013-1#1)
6-month period##3##2##(1991-1#1)(2008-10#1)(2012-12#1)
6-month randomized controlled##2##3##(2010-10#1)(2012-3#1)
6-month##19##1##(1990-6#1)(1991-1#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-8#2)(2010-10#3)(2010-12#1)(2012-12#2)(2012-3#2)(2013-1#2)
6-month-old##3##1##(1990-3#1)(2008-12#1)(2013-8#1)
6-naphthalenedisulphonic##2##1##(2008-10#2)
6-o'-clock Nd##3##2##(2011-2#3)
6-phosphate and##2##2##(1996-6#1)(2008-5#1)
6-phosphate##7##1##(1995-6#2)(1996-6#2)(2008-10#1)(2008-5#1)(2008-7#1)
6-phosphogluconate dehydrogenase##2##2##(1991-5#1)(2010-12#1)
6-point##2##1##(2008-12#1)(2012-2#1)
6-pyruvoyl tetrahydropterin##2##2##(1997-8#2)
6-response categories version##2##3##(2010-1#2)
6-sialyltransferase##3##1##(2008-11#3)
6-tetrachloro-1##2##1##(2008-10#2)
6-tetrahydrophthalic anhydride##2##2##(1995-11#2)
6-tetrahydropyridine (MPTP)##4##2##(1990-7#1)(1995-11#1)(1996-12#1)(2008-7#1)
6-tetrahydropyridine##7##1##(1990-7#2)(1995-11#1)(1996-12#1)(2008-5#1)(2008-7#2)
6-tetrathiapentalene##2##1##(1996-5#2)
6-thiopurine##2##1##(2008-10#2)
6-tri(3##2##1##(2008-10#2)
6-trichlorobenzoic acid##2##2##(2008-10#2)
6-trimethyl-1##2##1##(1996-5#2)
6-trinitramine (RDX)##4##2##(2008-10#4)
6-trinitramine##5##1##(2008-10#5)
6-trinitrotoluene (TNT)##13##2##(2008-10#9)(2008-11#3)(2008-3#1)
6-trinitrotoluene##16##1##(2008-10#12)(2008-11#3)(2008-3#1)
6-week trial##2##2##(2010-2#2)
6-week##6##1##(2008-10#1)(2008-4#1)(2010-2#2)(2011-2#2)
6-week-old rats##2##2##(2008-11#2)
6-week-old##3##1##(2008-10#1)(2008-11#2)
6-well##2##1##(2008-11#2)
6-year experience##2##2##(1997-4#1)(2008-11#1)
6-year period##4##2##(2008-10#3)(2013-1#1)
6-year##8##1##(1997-4#1)(2008-10#3)(2008-11#1)(2009-11#1)(2013-1#2)
6-year-old##4##1##(2008-10#1)(2008-9#1)(2010-3#1)(2010-5#1)
6/1##2##1##(2013-1#2)
6/10##2##1##(2008-12#1)(2008-9#1)
6/12##3##1##(1991-6#1)(2010-10#1)(2012-3#1)
6/9##2##1##(1995-11#1)(2012-3#1)
60 V##2##2##(2008-10#2)
60 and 0##3##3##(2008-10#2)(2010-4#1)
60 and##17##2##(1994-8#1)(1995-11#1)(1996-6#1)(1997-2#1)(2008-10#10)(2008-5#1)(2010-4#1)(2011-2#1)
60 cases##5##2##(2008-12#1)(2008-7#2)(2013-1#1)(2013-8#1)
60 cm##3##2##(2008-10#3)
60 days of age##2##4##(2006-5#1)(2013-1#1)
60 days of##3##3##(2006-5#1)(2008-5#1)(2013-1#1)
60 days##11##2##(1990-12#1)(1992-1#1)(1995-5#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#4)
60 degrees C and##4##4##(2008-10#3)(2008-6#1)
60 degrees C for##4##4##(2008-10#3)(2008-5#1)
60 degrees C##16##3##(2008-10#13)(2008-5#1)(2008-6#2)
60 degrees C)##3##3##(2008-10#3)
60 degrees##22##2##(2008-10#16)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)(2013-1#1)
60 determinations per hour##2##4##(2008-10#2)
60 determinations##3##2##(2008-10#3)
60 g##2##2##(1993-3#1)(2011-2#1)
60 h(-1)##9##2##(2008-10#9)
60 injections##2##2##(2008-10#2)
60 isolates of F##2##4##(2008-10#2)
60 isolates##3##2##(2008-10#3)
60 kDa IGBP##3##3##(1996-12#3)
60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme##3##7##(1997-2#3)
60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase##5##6##(1997-2#5)
60 kDa##15##2##(1996-12#7)(1997-2#6)(2008-10#2)
60 mM##2##2##(2008-12#1)(2008-7#1)
60 mV##2##2##(1997-2#1)(2008-10#1)
60 mg##5##2##(1991-3#2)(2008-10#1)(2008-11#1)(2008-12#1)
60 mg/L##2##2##(2008-7#2)
60 mg/dL##2##2##(2010-2#2)
60 mg/m2##2##2##(1992-12#1)(2008-5#1)
60 min after##3##3##(1991-3#1)(1997-1#1)(2008-10#1)
60 min in##2##3##(1994-2#1)(1997-1#1)
60 min of##5##3##(1990-12#1)(1994-11#1)(2008-10#1)(2013-8#2)
60 min##33##2##(1990-12#1)(1991-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-1#3)(1997-8#1)(2008-10#12)(2008-12#1)(2008-6#1)(2008-9#2)(2011-2#2)(2012-12#1)(2013-8#2)
60 minutes##2##2##(1991-12#1)(1994-11#1)
60 ml##3##2##(2008-10#3)
60 mm##3##2##(2008-11#2)(2009-3#1)
60 mmol/l##2##2##(1992-12#2)
60 months##5##2##(1991-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
60 mug l(-1)##2##3##(2008-10#2)
60 mug ml(-1)##2##3##(2008-10#2)
60 mug##4##2##(2008-10#4)
60 ng ml(-1)##2##3##(2008-10#2)
60 or##2##2##(2008-7#1)(2011-2#1)
60 patients with##6##3##(1992-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
60 patients##9##2##(1992-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2011-2#2)(2012-3#2)(2013-1#1)
60 s##16##2##(1993-8#1)(2008-10#14)(2008-7#1)
60 samples h(-1)##4##3##(2008-10#4)
60 samples per hour##2##4##(2008-10#2)
60 samples##9##2##(2008-10#9)
60 scenarios##2##2##(2009-10#2)
60 times##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
60 to 1##2##3##(2008-11#1)(2008-3#1)
60 to 120 cm##3##4##(2008-10#3)
60 to 120##4##3##(1993-1#1)(2008-10#3)
60 to 90##3##3##(1994-12#1)(2008-10#2)
60 to##16##2##(1993-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-3#1)
60 years and##2##3##(2008-10#1)(2012-3#1)
60 years old##3##3##(2008-7#1)(2012-3#2)
60 years old)##2##3##(2013-8#2)
60 years##21##2##(1992-5#1)(1996-2#1)(1996-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-7#1)(2011-2#3)(2012-3#4)(2013-1#1)(2013-8#3)
60##389##1##(1990-12#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#12)(1996-2#1)(1996-6#2)(1997-1#4)(1997-2#10)(1997-4#1)(1997-6#1)(1997-8#5)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#160)(2008-11#12)(2008-12#8)(2008-3#6)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#5)(2009-10#2)(2009-11#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#28)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#11)(2012-5#1)(2013-1#10)(2013-8#11)
60% compared##2##2##(2008-10#1)(2008-11#1)
60% for##3##2##(1996-12#1)(2008-10#1)(2010-12#1)
60% identity##3##2##(1996-6#1)(2008-10#2)
60% in##4##2##(2008-10#2)(2010-7#1)(2012-3#1)
60% of all##4##3##(1994-2#1)(1996-11#1)(2008-5#1)(2011-2#1)
60% of cases##2##3##(2011-2#1)(2013-1#1)
60% of control##2##3##(2008-11#1)(2008-7#1)
60% of the cases##2##4##(1993-2#1)(2008-10#1)
60% of the##19##3##(1990-12#1)(1990-3#1)(1993-2#1)(1994-9#1)(1996-6#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#2)(2013-1#1)
60% of##44##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#6)(2012-12#3)(2013-1#3)(2013-8#1)
60% to##3##2##(1993-1#1)(2008-10#1)(2008-8#1)
60% was##2##2##(1994-12#1)(2008-11#1)
60% were##2##2##(2009-10#1)(2010-11#1)
60%##108##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1991-7#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-12#2)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#23)(2008-11#8)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#7)(2012-12#3)(2012-3#3)(2013-1#5)(2013-8#1)
60%)##2##1##(1992-9#1)(2010-4#1)
60%fatigue##4##1##(2013-8#4)
60)##10##1##(1991-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-9#1)(2013-1#1)
60+/-0##3##1##(2008-10#2)(2008-11#1)
60- to##2##2##(2008-11#1)(2008-9#1)
60-70##3##1##(1990-7#1)(1992-2#1)(2008-2#1)
60-70% of the##2##3##(1995-2#1)(1995-8#1)
60-70%##3##1##(1993-11#1)(1995-2#1)(1995-8#1)
60-80% of the##2##3##(1990-5#1)(2009-10#1)
60-80%##4##1##(1990-5#1)(2008-10#2)(2009-10#1)
60-90%##3##1##(1993-11#1)(2008-12#1)(2009-7#1)
60-kDa##2##1##(1990-5#1)(1995-6#1)
60-year-old male##2##2##(2012-3#1)(2013-1#1)
60-year-old man##2##2##(2008-7#1)(2009-11#1)
60-year-old woman with##2##3##(2008-8#1)(2009-1#1)
60-year-old woman##3##2##(2008-8#1)(2009-1#1)(2012-3#1)
60-year-old##8##1##(1990-2#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)(2012-3#2)(2013-1#1)
60/40##2##1##(2008-10#2)
600 and##2##2##(2008-10#2)
600 bp of##2##3##(1994-2#1)(2008-9#1)
600 bp##4##2##(1993-6#2)(1994-2#1)(2008-9#1)
600 degrees##2##2##(2008-10#2)
600 mg##7##2##(1991-11#1)(1991-2#1)(1991-3#1)(2008-10#2)(2008-12#1)(2008-9#1)
600 microM##2##2##(1995-6#1)(2008-10#1)
600 mul of##2##3##(2008-10#2)
600 nm##5##2##(1994-5#1)(2008-10#4)
600 per##2##2##(1990-12#1)(2008-7#1)
600 s##2##2##(1991-2#1)(2008-10#1)
600 to##4##2##(1991-5#1)(2008-10#3)
600##73##1##(1990-12#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-6#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#33)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#3)(2010-10#1)(2010-7#1)(2010-8#3)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)
600)##2##1##(1995-12#1)(2010-8#1)
6000 and##2##2##(1991-8#1)(2008-12#1)
6000 was##2##2##(2008-10#2)
6000##14##1##(1990-2#1)(1991-8#1)(2008-10#2)(2008-12#6)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
600nm##3##1##(2008-10#3)
603 bp for D##2##4##(2008-10#2)
603##3##1##(2008-10#2)(2011-2#1)
604##5##1##(2008-10#4)(2012-3#1)
605 nm##3##2##(2008-10#2)(2008-11#1)
605##5##1##(1991-11#1)(2008-10#3)(2008-11#1)
609##2##1##(2008-10#1)(2009-10#1)
60K##2##1##(1996-12#2)
60min##4##1##(2008-10#3)(2013-1#1)
60mugl(-1)##3##1##(2008-10#3)
60s deposition time##2##3##(2008-10#2)
60s##7##1##(2008-10#6)(2009-4#1)
60x10(-6)##2##1##(2008-10#2)
61 and##2##2##(1992-4#1)(2008-10#1)
61 days##2##2##(2008-10#1)(2009-11#1)
61 in##2##2##(2008-10#1)(2008-12#1)
61 min##2##2##(2008-10#2)
61 patients##9##2##(1991-11#1)(1991-2#1)(1994-12#1)(2008-1#1)(2008-12#2)(2011-2#3)
61 to##2##2##(2008-10#1)(2009-3#1)
61##67##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
61% for##2##2##(1990-12#1)(2013-8#1)
61% in##2##2##(2008-10#1)(2008-11#1)
61% of the##2##3##(2008-11#1)(2008-12#1)
61% of##6##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)
61%##17##1##(1990-12#1)(1991-8#1)(1995-11#1)(1996-5#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#2)
61%) and##2##2##(2008-12#1)(2011-2#1)
61(2)##2##1##(2008-10#2)
61) and##2##2##(2008-10#1)(2008-9#1)
61)##4##1##(1993-1#1)(1994-12#1)(2008-10#1)(2008-9#1)
61+/-0##2##1##(2008-10#2)
61-69##3##1##(1992-4#3)
61-8##2##1##(2008-10#1)(2010-10#1)
61-year-old man##2##2##(2008-11#1)(2011-2#1)
61-year-old##5##1##(1996-3#1)(2008-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
610##5##1##(1990-2#1)(2008-10#3)(2008-11#1)
610nm was##2##2##(2008-10#2)
610nm##4##1##(2008-10#4)
611##6##1##(1991-9#1)(1997-2#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)
612 and##2##2##(2008-10#2)
612 nm##3##2##(2008-10#3)
612##7##1##(2008-10#6)(2013-8#1)
615 nm##2##2##(2008-10#1)(2008-11#1)
615##5##1##(1990-11#1)(1992-8#1)(1993-3#1)(2008-10#1)(2008-11#1)
616##3##1##(2008-10#2)(2008-8#1)
62 and##5##2##(1996-6#1)(2008-10#4)
62 cases##2##2##(2009-10#1)(2009-5#1)
62 in##4##2##(2008-11#1)(2008-2#1)(2010-4#1)(2012-3#1)
62 of##2##2##(1991-3#1)(2012-2#1)
62 patients with##2##3##(1992-3#1)(2013-1#1)
62 patients##4##2##(1992-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
62 percent##2##2##(1995-12#1)(1996-1#1)
62##87##1##(1990-2#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#2)(2009-3#1)(2009-5#1)(2010-4#2)(2011-2#10)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
62% for##2##2##(1993-1#1)(2008-10#1)
62% of the##2##3##(1993-12#1)(2010-4#1)
62% of##4##2##(1993-12#1)(2008-10#1)(2010-11#1)(2010-4#1)
62%##20##1##(1990-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-8#2)
62%)##3##1##(1990-3#1)(2008-12#1)(2008-7#1)
62)##7##1##(2008-10#3)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
62+/-0##2##1##(2008-10#2)
62-kb##2##1##(2008-10#2)
62-year-old man##2##2##(1994-3#1)(2009-8#1)
62-year-old woman##4##2##(1991-11#1)(1991-9#1)(1994-6#1)(2008-10#1)
62-year-old##7##1##(1991-11#1)(1991-9#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-12#1)(2009-8#1)
620 nm##3##2##(2008-10#2)(2008-8#1)
620 to##2##2##(2008-10#1)(2008-3#1)
620##11##1##(1993-11#1)(1995-2#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
621##5##1##(1997-6#1)(1997-8#1)(2008-10#3)
623##2##1##(2008-10#1)(2013-1#1)
624##2##1##(2008-10#1)(2013-1#1)
625##3##1##(2008-7#1)(2011-1#1)(2013-8#1)
627##4##1##(1996-8#1)(2008-10#1)(2008-9#1)(2010-10#1)
629##3##1##(1991-2#1)(2008-8#1)(2011-3#1)
62±0##2##1##(2010-12#1)(2012-2#1)
63 +/- 0##2##3##(1993-1#1)(2009-11#1)
63 +/-##3##2##(1993-1#1)(2009-11#1)(2011-3#1)
63 and 0##3##3##(2008-10#3)
63 and##6##2##(1994-8#1)(2008-10#5)
63 kDa##3##2##(1997-2#1)(1997-7#1)(2008-11#1)
63 mmol l(-1)N##2##3##(2008-10#2)
63 of the##2##3##(2012-2#2)
63 of##3##2##(2008-10#1)(2012-2#2)
63 patients##4##2##(1990-6#1)(1993-11#1)(1996-11#1)(1997-8#1)
63 times##3##2##(2008-10#2)(2008-11#1)
63 x##2##2##(2008-10#2)
63 years##5##2##(1991-11#1)(1991-7#1)(2007-8#1)(2009-3#1)(2013-7#1)
63##105##1##(1990-3#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-7#1)(1991-8#1)(1993-1#4)(1993-11#1)(1993-2#1)(1994-1#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#2)(2007-8#1)(2008-10#37)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#6)(2009-11#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
63% at##2##2##(2008-1#1)(2012-2#1)
63% for##2##2##(2008-10#2)
63% in##3##2##(1995-12#1)(2008-10#2)
63% of the##2##3##(2008-10#2)
63% of##5##2##(2008-10#4)(2010-6#1)
63%##28##1##(1991-6#1)(1994-11#2)(1995-12#1)(1995-8#1)(1997-5#1)(2008-1#1)(2008-10#13)(2008-11#1)(2010-6#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#2)
63%)##2##1##(2008-12#1)(2008-2#1)
63)##2##1##(2011-2#1)(2012-3#1)
63-year-old woman##3##2##(1991-8#1)(2008-5#1)(2013-8#1)
63-year-old##6##1##(1991-8#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
630 days##3##2##(2008-10#3)
630 nm##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
630##13##1##(1996-12#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-7#2)
631##5##1##(2008-10#4)(2013-1#1)
632##4##1##(2008-10#1)(2008-11#1)(2008-3#2)
633##3##1##(2008-3#3)
634##2##1##(1991-2#1)(2012-2#1)
635 nm##4##2##(2008-10#3)(2008-3#1)
636 and##2##2##(1993-1#1)(2008-12#1)
636##3##1##(1993-1#1)(2008-12#1)(2010-1#1)
638##4##1##(1997-2#1)(2008-10#1)(2010-4#1)(2012-12#1)
639##2##1##(2008-8#1)(2011-3#1)
64 and##4##2##(1994-8#1)(2008-10#2)(2008-8#1)
64 clones from the##2##4##(2008-9#2)
64 isolates##2##2##(2008-10#1)(2008-5#1)
64 kDa##3##2##(1994-8#1)(1996-12#2)
64 patients with##2##3##(1992-5#1)(1993-1#1)
64 to##2##2##(2008-10#2)
64##103##1##(1990-2#1)(1990-5#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-5#1)(1993-1#2)(1993-2#5)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#3)(1996-12#3)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#24)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#5)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
64% for##2##2##(2008-10#2)
64% of the##4##3##(2008-10#3)(2008-12#1)
64% of##5##2##(2008-10#3)(2008-12#1)(2010-11#1)
64% to 92% of the genome##3##6##(1995-8#2)(1996-6#1)
64%##18##1##(1993-2#1)(1995-8#2)(1996-6#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
64%)##2##1##(1996-1#1)(2013-8#1)
64)##7##1##(1993-1#1)(1996-2#1)(2008-10#2)(2010-8#1)(2013-1#2)
64-kDa##2##1##(1995-6#2)
64-slice multidetector##2##2##(2008-12#1)(2009-10#1)
64-year-old##3##1##(1996-11#1)(2008-12#1)(2013-1#1)
640 and##2##2##(2008-10#2)
640 nm##3##2##(2008-10#2)(2008-3#1)
640##11##1##(1992-6#1)(1996-12#1)(1997-8#1)(2008-10#6)(2008-3#1)(2008-7#1)
641##3##1##(1997-4#1)(2008-10#1)(2012-2#1)
642)##2##1##(1994-8#1)(2008-3#1)
6421##2##1##(2008-2#1)(2008-3#1)
643##3##1##(1992-12#1)(2011-1#1)(2011-2#1)
644##2##1##(1990-5#1)(2012-3#1)
646##2##1##(2008-10#1)(2013-1#1)
649##2##1##(2008-10#1)(2008-8#1)
649)##2##1##(2012-2#1)(2013-8#1)
65 and 0##2##3##(2008-10#2)
65 and##7##2##(2008-10#4)(2008-3#1)(2010-10#1)(2011-2#1)
65 bp##2##2##(1993-2#1)(2010-5#1)
65 degrees C##3##3##(2008-10#2)(2008-5#1)
65 degrees##4##2##(1992-6#1)(2008-10#2)(2008-5#1)
65 kDa##3##2##(1993-12#1)(1993-6#2)
65 min##2##2##(2008-10#1)(2013-8#1)
65 mmol##2##2##(2008-10#2)
65 mum##2##2##(2008-10#1)(2008-3#1)
65 nm##2##2##(2007-12#1)(2008-10#1)
65 of##2##2##(1991-11#1)(2008-10#1)
65 or##2##2##(1990-12#1)(1993-1#1)
65 patients (10##2##3##(2012-3#2)
65 patients with##2##3##(1991-8#1)(2008-7#1)
65 patients##5##2##(1990-3#1)(1991-8#1)(2008-7#1)(2012-3#2)
65 to##4##2##(1994-3#1)(2008-10#3)
65 years of age or over##3##6##(1991-12#1)(1991-3#1)(1992-1#1)
65 years of age##9##4##(1991-12#1)(1991-3#1)(1992-1#1)(1995-12#1)(2008-12#1)(2011-2#4)
65 years##33##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-6#1)(1995-12#1)(1997-4#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-1#1)(2009-8#5)(2010-3#2)(2011-2#11)(2012-12#2)(2013-8#1)
65 years)##2##2##(1990-3#1)(2008-7#1)
65 °C##2##2##(2011-1#1)(2011-2#1)
65##162##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-11#3)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#40)(2008-11#8)(2008-12#4)(2008-3#5)(2008-5#4)(2008-7#9)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-5#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#17)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
65% of the##8##3##(1990-12#1)(1991-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-7#1)(2012-12#1)
65% of##17##2##(1990-12#1)(1990-6#1)(1991-9#1)(1993-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
65% were##4##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
65%##48##1##(1990-12#1)(1990-6#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-6#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-1#2)(2012-12#1)
65%)##2##1##(1991-8#1)(2008-12#1)
65)##5##1##(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
65-74##2##1##(2008-10#1)(2010-10#1)
65-fold##2##1##(2008-10#1)(2008-11#1)
65-year-old female##3##2##(2010-5#1)(2011-2#1)(2012-2#1)
65-year-old woman##2##2##(2008-11#1)(2013-8#1)
65-year-old##5##1##(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
650 bp##2##2##(2008-10#1)(2011-2#1)
650##11##1##(2008-10#6)(2008-11#2)(2008-9#1)(2009-10#1)(2011-2#1)
650nm##2##1##(2008-10#2)
652##2##1##(2012-3#1)(2013-1#1)
653##4##1##(2008-10#2)(2008-11#2)
656##4##1##(1990-6#1)(1991-12#1)(1995-2#1)(2012-3#1)
657##2##1##(2008-10#2)
659##4##1##(2008-10#1)(2008-9#1)(2009-7#1)(2012-2#1)
65mumol/L##2##1##(2008-10#2)
66 and 56 kDa##2##4##(1990-12#2)
66 and##7##2##(1990-12#2)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
66 children##2##2##(1994-6#2)
66 degrees##2##2##(2008-8#1)(2008-9#1)
66 kDa##4##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
66 mg##2##2##(2008-10#1)(2008-12#1)
66 of##2##2##(1990-2#1)(1991-8#1)
66 to##4##2##(2008-10#2)(2009-8#1)(2011-2#1)
66 years##4##2##(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
66##94##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-6#1)(1991-3#1)(1991-8#3)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-3#1)(1996-1#1)(1997-7#1)(1997-8#2)(2008-10#21)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#2)(2013-8#2)
66% and##3##2##(1990-12#1)(2008-10#1)(2008-2#1)
66% for##2##2##(1994-8#1)(2008-10#1)
66% in##2##2##(2008-11#1)(2013-7#1)
66% of the##3##3##(1997-3#1)(2008-10#2)
66% of##5##2##(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#2)
66% over##2##2##(2008-10#1)(2008-12#1)
66%##27##1##(1990-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
66%) and##2##2##(1997-3#1)(2011-2#1)
66%)##4##1##(1997-3#1)(2011-2#1)(2013-7#2)
66)##4##1##(1993-11#1)(2008-12#1)(2010-8#1)(2011-2#1)
66+/-0##2##1##(2008-10#2)
66-year-old man##3##2##(2009-1#1)(2011-2#1)(2012-12#1)
66-year-old##6##1##(1992-2#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
660 nm##3##2##(2008-10#2)(2012-2#1)
660##12##1##(1990-11#1)(1991-6#1)(1992-1#1)(2008-10#5)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
661##2##1##(1995-12#1)(2010-4#1)
663)##2##1##(1995-2#1)(2008-10#1)
664##4##1##(1997-4#1)(2008-10#2)(2008-11#1)
665##4##1##(1997-8#1)(2008-10#3)
667##3##1##(1992-3#1)(2008-10#1)(2011-2#1)
67 K outer membrane protein##2##5##(1995-12#2)
67 K##9##2##(1995-12#9)
67 and##2##2##(2008-10#1)(2008-11#1)
67 mol/l##2##2##(2008-10#2)
67 patients with##2##3##(1994-12#1)(2008-12#1)
67 patients##5##2##(1990-12#1)(1991-9#1)(1994-12#1)(1997-8#1)(2008-12#1)
67 ±##2##2##(2013-1#1)(2013-8#1)
67##84##1##(1990-12#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-5#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#11)(1995-6#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#22)(2008-11#5)(2008-12#4)(2008-3#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
67% and##2##2##(1994-8#1)(2009-4#1)
67% for##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
67% of the##2##3##(1990-12#1)(2008-10#1)
67% of##5##2##(1990-12#1)(1990-2#1)(1996-9#1)(2008-10#1)(2008-11#1)
67%##28##1##(1990-12#1)(1990-2#1)(1991-8#2)(1992-5#1)(1994-8#1)(1995-3#1)(1996-9#1)(2008-10#10)(2008-11#2)(2008-7#3)(2009-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
67%) belonged to##2##3##(2008-10#2)
67%)##12##1##(1994-8#1)(2008-10#10)(2013-1#1)
67)##5##1##(1992-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
67+/-4##2##1##(2008-10#2)
670##7##1##(1990-12#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-10#1)
672##4##1##(1995-2#1)(1997-6#1)(2008-3#1)(2008-7#1)
675 nm##2##2##(2008-10#1)(2008-3#1)
675##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
676##2##1##(2008-11#1)(2011-2#1)
677##2##1##(2008-10#1)(2011-3#1)
678##3##1##(1995-6#1)(2010-11#1)(2011-2#1)
679##3##1##(2008-12#2)(2010-7#1)
68 +/-##2##2##(1997-1#1)(2008-12#1)
68 and##6##2##(1993-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
68 isolates of##3##3##(2008-10#3)
68 isolates##4##2##(2008-10#3)(2013-8#1)
68 kDa##5##2##(1994-5#2)(1995-12#1)(1997-2#1)(2010-3#1)
68 ng ml(-1) for##2##4##(2008-10#2)
68 ng ml(-1)##3##3##(2008-10#3)
68 patients##3##2##(1990-2#1)(1991-8#1)(2012-4#1)
68 to##4##2##(1995-6#1)(2008-10#2)(2010-4#1)
68 with##2##2##(1995-3#1)(2008-10#1)
68##87##1##(1990-2#2)(1990-5#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#2)(2008-1#1)(2008-10#28)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-3#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#2)
68% and##2##2##(2008-1#1)(2008-11#1)
68% identity to##2##3##(1993-6#1)(2008-10#1)
68% of the##2##3##(2008-11#1)(2013-8#1)
68% of##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
68%##21##1##(1993-6#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-8#1)(2013-1#2)(2013-8#2)
68%)##4##1##(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
68)##2##1##(2008-10#1)(2013-1#1)
68+/-0##3##1##(2008-10#3)
68-kDa##3##1##(1992-6#1)(1995-6#1)(2008-4#1)
68-year-old##3##1##(2008-12#1)(2010-12#1)(2012-12#1)
680##9##1##(1993-8#1)(1995-6#1)(1996-2#1)(2008-10#5)(2012-6#1)
6803##3##1##(1996-12#2)(1996-8#1)
681##3##1##(1996-6#1)(2008-10#1)(2009-5#1)
682##3##1##(1996-9#1)(2008-8#1)(2012-3#1)
684##3##1##(2010-11#1)(2011-2#1)(2012-5#1)
685-kb##2##1##(1997-2#2)
687##8##1##(1991-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
688##2##1##(1997-2#1)(2008-10#1)
69 +/-##2##2##(1991-11#1)(2011-2#1)
69 and##2##2##(2008-10#2)
69 patients##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
69 to##2##2##(2008-10#2)
69 were##2##2##(1992-5#1)(2009-8#1)
69 years##5##2##(1996-2#1)(1997-5#1)(2011-2#1)(2012-12#2)
69##64##1##(1990-11#1)(1990-8#3)(1991-11#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-5#1)(1993-2#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#5)
69% and##2##2##(1995-6#1)(2008-10#1)
69% of##4##2##(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)
69%##15##1##(1990-3#1)(1995-6#1)(1995-8#1)(2008-10#6)(2008-12#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
69%)##3##1##(2008-5#2)(2011-2#1)
69) and##3##2##(1995-11#1)(2011-3#1)(2012-4#1)
69)##7##1##(1995-11#1)(2008-10#1)(2009-6#1)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#1)
69+/-0##3##1##(2008-10#3)
690##2##1##(2008-10#2)
692##2##1##(2008-11#1)(2008-12#1)
693##4##1##(1993-9#1)(1994-8#1)(2008-8#1)(2013-8#1)
695##5##1##(1993-2#1)(2008-10#2)(2008-8#1)(2012-3#1)
698##2##1##(2008-10#1)(2010-10#1)
699##2##1##(2008-10#1)(2008-11#1)
6A-1##2##1##(1997-7#2)
6A8 cDNA##2##2##(2008-8#2)
6A8##10##1##(2008-8#10)
6B##3##1##(1991-12#1)(1996-2#1)(2008-8#1)
6C10##2##1##(2008-9#2)
6C10(-)##2##1##(2008-9#2)
6DNOC) was##2##2##(2008-10#2)
6DNOC)##3##1##(2008-10#3)
6G and phosphomolybdate##2##3##(2008-10#2)
6G and##5##2##(2008-10#4)(2008-3#1)
6G##22##1##(2007-11#1)(2008-10#16)(2008-3#5)
6H(2)O##3##1##(2008-10#2)(2010-4#1)
6M HCl##2##2##(2008-10#2)
6M##3##1##(2008-10#3)
6MP##6##1##(2008-10#6)
6PGD gene expression pattern##2##4##(2010-12#2)
6PGD gene##3##2##(2010-12#3)
6PGD##5##1##(2010-12#5)
6]##3##1##(1993-11#1)(1994-8#2)
6cm##2##1##(2009-1#2)
6f detection##2##2##(2008-3#2)
6mLmin(-1)##3##1##(2008-10#3)
6mV per decade##2##3##(2008-10#2)
6mV per##3##2##(2008-10#3)
6mg for##2##2##(2008-10#2)
6mg##4##1##(2008-10#4)
6min##2##1##(2008-10#2)
6mlmin(-1)##3##1##(2008-10#3)
6mm i##3##2##(2008-10#3)
6mm##6##1##(2008-10#6)
6mm)##2##1##(2008-10#2)
6mug/kg##2##1##(2008-10#2)
6mugl(-1)##3##1##(2008-10#3)
6mugml(-1)##2##1##(2008-10#2)
6ngml(-1) for##2##2##(2008-10#2)
6ngml(-1)##4##1##(2008-10#4)
6pg##2##1##(2008-10#2)
6q##2##1##(1997-6#2)
6q21 region##2##2##(1997-3#2)
6th FECS##2##2##(2008-11#2)
6th##11##1##(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#1)(2011-4#1)(2012-3#1)
6x10(-3) mol##2##2##(2008-10#2)
6x10(-3)##3##1##(2008-10#3)
6x10(-5)##2##1##(2008-10#2)
6x10(-6) M##2##2##(2008-10#2)
6x10(-6)##3##1##(2008-10#3)
6x10(-7) M##2##2##(2008-10#2)
6x10(-7) mol l(-1)##2##3##(2008-10#2)
6x10(-7)##5##1##(2008-10#5)
6x10(-7)moll(-1)##2##1##(2008-10#2)
6x10(-8) M##3##2##(2008-10#3)
6x10(-8)##5##1##(2008-10#5)
6x10(-9)##3##1##(2008-10#3)
6x10(4)##3##1##(2008-10#3)
6x10(5)##2##1##(2008-10#2)
6x10(7) PIBs ml(-1))##2##3##(2008-11#2)
6 weeks##2##1##(2013-8#2)
7 %##5##2##(1997-8#1)(2011-2#1)(2012-12#3)
7 %)##3##2##(2012-12#3)
7 (1##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
7 (6##5##2##(1997-8#2)(2011-2#2)(2013-8#1)
7 (95% CI##2##3##(2010-9#1)(2012-3#1)
7 +/- 0##4##3##(1996-3#1)(2008-10#2)(2008-2#1)
7 +/- 1##4##3##(1992-10#1)(1995-12#1)(2010-7#1)(2011-3#1)
7 +/- 2##4##3##(1990-2#1)(1992-2#1)(2009-1#1)(2011-2#1)
7 +/-##22##2##(1990-2#1)(1992-10#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-12#2)(1996-2#1)(1996-3#2)(2008-10#4)(2008-2#1)(2009-1#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-3#1)
7 95 %CI)##2##3##(2012-12#2)
7 A##2##2##(1992-9#1)(2008-10#1)
7 MPa##3##2##(2008-10#3)
7 V##4##2##(2008-10#4)
7 after##2##2##(2008-10#1)(2013-8#1)
7 amino acids##3##3##(2008-10#2)(2008-9#1)
7 amino##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
7 and 0##7##3##(2008-10#5)(2008-12#1)(2009-11#1)
7 and 1##7##3##(1994-11#1)(2008-10#6)
7 and 10##4##3##(1993-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
7 and 14 days##3##4##(1996-12#1)(2008-12#1)(2008-7#1)
7 and 14##6##3##(1996-12#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#1)
7 and 15##2##3##(2008-10#1)(2008-5#1)
7 and 16##3##3##(1995-12#1)(2008-11#1)(2008-5#1)
7 and 16%##2##3##(2008-10#2)
7 and 2##5##3##(1991-9#1)(2008-10#3)(2011-3#1)
7 and 28##2##3##(1996-12#1)(2008-7#1)
7 and 3##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
7 and 4##4##3##(1994-5#1)(1995-12#1)(2008-10#1)(2008-12#1)
7 and 6##2##3##(2008-10#2)
7 and 8##5##3##(1993-8#2)(2008-10#3)
7 and an##2##3##(2008-10#1)(2008-3#1)
7 and##95##2##(1990-5#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#4)(1996-12#3)(1997-6#1)(2007-12#1)(2008-10#42)(2008-11#4)(2008-12#4)(2008-3#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#3)
7 approximately##2##2##(2008-10#1)(2008-11#1)
7 as##2##2##(2008-10#1)(2008-11#1)
7 at##2##2##(2008-10#1)(2013-8#1)
7 bp##2##2##(1997-2#1)(2008-9#1)
7 cM##2##2##(2008-10#2)
7 cM) and##2##3##(2008-10#2)
7 cM)##3##2##(2008-10#3)
7 cases##7##2##(1991-11#1)(1991-6#1)(1992-5#1)(1992-9#1)(1997-8#1)(2011-2#1)(2013-1#1)
7 cells and RBL 2H3##2##5##(2011-2#2)
7 cells##11##2##(1997-1#1)(2008-11#6)(2011-2#3)(2012-12#1)
7 cm##5##2##(1990-3#1)(2008-10#1)(2008-7#1)(2009-3#1)(2013-1#1)
7 consecutive days##3##3##(2008-11#1)(2011-2#2)
7 d after##2##3##(2008-8#2)
7 days after inoculation##10##4##(2008-10#10)
7 days after the##2##4##(1995-8#1)(1996-12#1)
7 days after##17##3##(1990-2#1)(1994-5#1)(1995-8#1)(1996-12#1)(2008-10#12)(2011-2#1)
7 days and##3##3##(2008-11#1)(2010-1#1)(2011-2#1)
7 days of##6##3##(1993-6#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-8#2)
7 days old##2##3##(2008-10#1)(2008-12#1)
7 days or##3##3##(1994-3#1)(1996-12#1)(2008-10#1)
7 days prior to anthesis##3##5##(2008-10#3)
7 days prior to##6##4##(1996-12#2)(2008-10#4)
7 days to##2##3##(2008-12#1)(2008-5#1)
7 days##70##2##(1990-2#2)(1993-6#1)(1994-3#1)(1994-5#1)(1995-3#2)(1995-8#2)(1996-12#4)(1997-5#1)(2008-10#29)(2008-11#4)(2008-12#5)(2008-5#2)(2008-7#3)(2008-8#3)(2009-6#1)(2009-8#1)(2010-1#1)(2011-2#5)(2012-3#1)(2013-1#1)
7 days)##4##2##(1994-6#1)(2008-10#2)(2008-11#1)
7 degrees C and##2##4##(2008-10#2)
7 degrees C##4##3##(2008-10#3)(2008-5#1)
7 degrees##6##2##(1994-5#1)(2008-10#3)(2008-3#1)(2008-5#1)
7 drainages##2##2##(1991-3#2)
7 families##2##2##(2008-6#2)
7 for##3##2##(1997-8#1)(2008-12#1)(2012-12#1)
7 from##3##2##(2008-10#2)(2008-11#1)
7 g##5##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
7 genes##2##2##(1995-8#1)(2013-1#1)
7 h##2##2##(2008-10#1)(2010-8#1)
7 had##2##2##(2013-1#2)
7 hyperplastic glands##2##3##(2008-5#2)
7 in the##3##3##(2008-10#3)
7 in##8##2##(2008-10#6)(2008-12#1)(2008-8#1)
7 kDa##3##2##(1995-8#1)(2008-10#2)
7 kDa)##2##2##(1995-11#1)(2008-10#1)
7 kJ mol(-1) n(-1)##2##4##(2008-10#2)
7 kJ mol(-1)##3##3##(2008-10#3)
7 kb in##2##3##(1997-7#1)(2008-8#1)
7 kb segment##3##3##(1996-6#2)(2008-11#1)
7 kb##10##2##(1993-8#1)(1996-6#2)(1997-2#2)(1997-7#2)(2008-11#1)(2008-8#2)
7 kb)##3##2##(2008-11#1)(2008-6#2)
7 kcal/mol)##2##2##(1993-8#2)
7 kg/ha##2##2##(2011-1#2)
7 log(10)##2##2##(2008-10#1)(2013-1#1)
7 m(2)##2##2##(2008-10#1)(2009-11#1)
7 mM##3##2##(1991-5#1)(1994-8#1)(1995-8#1)
7 mV per concentration decade##2##5##(2008-10#2)
7 mV##5##2##(2008-10#5)
7 mg##9##2##(1993-2#1)(2008-10#6)(2008-12#2)
7 mg/kg##3##2##(1990-6#1)(2008-11#1)(2012-3#1)
7 micro##2##2##(2008-10#1)(2013-1#1)
7 microM)##3##2##(1992-3#1)(1993-8#2)
7 microg l(-1)##4##3##(2008-10#4)
7 microm##2##2##(2008-10#1)(2011-2#1)
7 micromol##2##2##(2008-10#2)
7 million##3##2##(1992-6#1)(1996-3#1)(2008-11#1)
7 min in##2##3##(2008-10#2)
7 min##8##2##(2008-10#7)(2008-11#1)
7 ml of##3##3##(2008-10#3)
7 ml##7##2##(2008-10#6)(2008-7#1)
7 mm and##2##3##(2013-1#2)
7 mm respectively##2##3##(2013-1#2)
7 mm##6##2##(2008-7#1)(2010-3#1)(2013-1#4)
7 mmol/l##2##2##(1990-6#1)(1991-11#1)
7 mol##2##2##(1993-8#1)(2008-10#1)
7 months (range##2##3##(1992-2#1)(2012-3#1)
7 months of##2##3##(1995-8#1)(2008-10#1)
7 months to##2##3##(1990-12#1)(1996-11#1)
7 months##15##2##(1990-12#1)(1992-2#1)(1994-3#1)(1994-8#1)(1995-8#2)(1996-11#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
7 mug l(-1)##2##3##(2008-10#2)
7 mug ml(-1) for##2##4##(2008-10#2)
7 mug ml(-1)##4##3##(2008-10#4)
7 mug##13##2##(2008-10#11)(2008-11#2)
7 mug/ml)##2##2##(2008-5#2)
7 mumol##2##2##(2008-10#2)
7 ng ml(-1) for##2##4##(2008-10#2)
7 ng ml(-1)##3##3##(2008-10#3)
7 ng##6##2##(2008-10#6)
7 nm##5##2##(2008-3#4)(2011-1#1)
7 nucleotides##2##2##(1996-12#1)(2008-10#1)
7 of the##7##3##(1994-5#1)(1995-2#1)(2008-10#4)(2010-4#1)
7 of##17##2##(1994-5#1)(1995-2#1)(1996-5#1)(2008-10#8)(2008-6#1)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#2)
7 or##2##2##(1990-6#1)(1990-8#1)
7 out of##4##3##(1990-12#1)(1991-11#1)(2008-7#1)(2013-1#1)
7 patients with##4##3##(1993-11#1)(1995-12#1)(2008-11#1)(2012-12#1)
7 patients##22##2##(1990-3#1)(1991-2#1)(1992-12#1)(1993-11#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-12#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)
7 per##5##2##(1996-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
7 percent##2##2##(1991-1#1)(1994-12#1)
7 ppm##2##2##(2008-10#2)
7 relapsing##2##2##(1991-2#2)
7 s-1##2##2##(1993-9#1)(1995-8#1)
7 showed##2##2##(2008-10#2)
7 subunit##3##2##(1996-12#2)(2010-8#1)
7 times##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
7 to 10 years##3##4##(2008-10#2)(2012-12#1)
7 to 10##8##3##(1994-2#1)(1995-11#1)(2008-10#5)(2012-12#1)
7 to 11##2##3##(2008-10#2)
7 to 18##2##3##(2008-10#2)
7 to 2##2##3##(1993-3#1)(2008-11#1)
7 to 4##3##3##(2008-10#2)(2012-3#1)
7 to 5##2##3##(2008-10#2)
7 to 50##2##3##(2008-10#1)(2008-3#1)
7 to##51##2##(1992-8#1)(1993-3#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#35)(2008-11#3)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
7 was determined##2##3##(1994-5#1)(2008-10#1)
7 was##6##2##(1992-12#1)(1994-5#1)(2008-10#3)(2011-2#1)
7 weeks##7##2##(1991-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)
7 were##9##2##(1991-6#1)(1993-1#1)(1993-3#1)(1997-2#2)(2008-10#3)(2013-8#1)
7 with##6##2##(1994-12#1)(2008-10#2)(2008-7#2)(2011-2#1)
7 women##2##2##(1992-2#1)(1995-8#1)
7 x 10(-10) M##2##4##(1993-3#1)(1995-11#1)
7 x 10(4)##2##3##(1994-5#1)(2008-10#1)
7 x 10(6)##2##3##(2008-11#2)
7 x 10(7)##2##3##(2008-11#2)
7 x##23##2##(1990-12#1)(1991-5#2)(1991-9#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-11#1)(2008-10#7)(2008-11#5)(2008-3#2)(2012-3#1)
7 years##17##2##(1991-11#1)(1991-8#1)(1992-2#1)(1996-11#1)(1996-5#1)(1997-7#1)(2008-12#1)(2008-7#2)(2009-4#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#2)
7 yr##3##2##(2008-7#2)(2008-8#1)
7 ±##2##2##(2013-1#1)(2013-8#1)
7##1568##1##(1990-11#6)(1990-12#6)(1990-2#9)(1990-3#6)(1990-5#6)(1990-6#3)(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#7)(1991-12#4)(1991-2#6)(1991-3#3)(1991-5#9)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#4)(1992-10#5)(1992-12#4)(1992-2#6)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#6)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#8)(1993-6#2)(1993-8#24)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#10)(1994-2#3)(1994-3#6)(1994-5#19)(1994-6#2)(1994-8#12)(1994-9#4)(1995-11#10)(1995-12#12)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#11)(1996-1#2)(1996-11#10)(1996-12#20)(1996-2#4)(1996-3#4)(1996-5#8)(1996-6#11)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#7)(1997-9#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#701)(2008-11#81)(2008-12#30)(2008-2#8)(2008-3#18)(2008-4#1)(2008-5#31)(2008-6#9)(2008-7#39)(2008-8#19)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#4)(2009-3#6)(2009-4#4)(2009-6#2)(2009-8#4)(2010-1#7)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#9)(2011-2#63)(2011-3#10)(2012-12#21)(2012-2#6)(2012-3#19)(2012-9#1)(2013-1#48)(2013-8#12)
7% (n = 2)##2##4##(2012-3#2)
7% (n =##4##3##(2012-3#4)
7% (n=5)##2##2##(2008-10#2)
7% R##4##2##(2008-10#4)
7% and 50##2##3##(2008-10#2)
7% and 78##2##3##(2011-2#1)(2012-3#1)
7% and a##3##3##(2008-10#2)(2008-2#1)
7% and the##3##3##(2008-10#2)(2012-12#1)
7% and##26##2##(1991-8#2)(1994-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
7% at##5##2##(1990-5#1)(2008-10#3)(2008-3#1)
7% by##2##2##(2008-10#1)(2010-11#1)
7% confidence level##2##3##(2008-10#2)
7% confidence##3##2##(2008-10#3)
7% for Fe##2##3##(2008-10#2)
7% for a##3##3##(2008-10#3)
7% for the##2##3##(1997-7#1)(2008-10#1)
7% for##25##2##(1992-11#2)(1994-12#2)(1997-7#1)(2008-10#18)(2008-5#2)
7% had##2##2##(2010-1#1)(2010-6#1)
7% in the##5##3##(1996-6#1)(2008-10#3)(2008-7#1)
7% in those who##2##4##(1990-6#1)(2012-3#1)
7% in##14##2##(1990-6#1)(1994-3#1)(1996-6#1)(2008-10#5)(2008-12#1)(2008-7#1)(2011-1#2)(2012-3#1)(2013-8#1)
7% increase##2##2##(1995-5#1)(2013-1#1)
7% increase)##2##2##(1995-5#1)(2013-1#1)
7% negative predictive value##2##4##(2011-2#2)
7% nucleotide##2##2##(2008-10#2)
7% of all##2##3##(1997-4#1)(2007-8#1)
7% of cases##2##3##(1990-3#1)(2013-1#1)
7% of patients##2##3##(1991-8#1)(2008-10#1)
7% of the patients had##2##5##(1990-2#1)(2010-6#1)
7% of the patients##3##4##(1990-12#1)(1990-2#1)(2010-6#1)
7% of the phenotypic##2##4##(2008-10#2)
7% of the##14##3##(1990-12#1)(1990-2#1)(1993-2#1)(1994-12#1)(2008-10#6)(2008-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
7% of##38##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#1)(1991-8#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-6#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-5#1)(2008-7#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#2)
7% to##3##2##(1991-3#1)(2012-3#2)
7% vs##4##2##(1995-8#1)(2009-8#1)(2012-3#1)(2013-8#1)
7% were##6##2##(1994-12#1)(2008-10#2)(2008-12#2)(2010-1#1)
7% with##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
7%##294##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#5)(1991-9#1)(1992-11#4)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#6)(1994-3#2)(1994-6#1)(1994-8#1)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#123)(2008-11#10)(2008-12#5)(2008-2#4)(2008-3#1)(2008-5#5)(2008-7#9)(2008-8#5)(2008-9#4)(2009-11#1)(2009-8#1)(2010-1#4)(2010-11#3)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2011-1#2)(2011-2#12)(2012-12#3)(2012-3#14)(2013-1#12)(2013-8#4)
7%) and##12##2##(1991-8#1)(2008-10#5)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
7%) are##2##2##(2008-7#2)
7%) had##2##2##(1994-12#1)(2012-3#1)
7%) of the wards did not use any instrument##2##9##(2013-1#2)
7%) of the##4##3##(2008-10#1)(2012-2#1)(2013-1#2)
7%) patients##4##2##(1997-8#1)(2011-2#2)(2012-12#1)
7%) than##3##2##(1990-6#1)(2012-3#2)
7%) were##3##2##(2008-11#1)(2009-12#1)(2012-3#1)
7%) with##2##2##(1993-1#1)(1997-7#1)
7%)##74##1##(1990-2#1)(1990-6#1)(1991-8#2)(1992-11#1)(1992-5#1)(1992-9#2)(1993-1#2)(1994-1#1)(1994-12#2)(1996-11#3)(1996-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#10)(2013-8#1)
7) and##4##2##(1997-1#1)(2008-10#3)
7) has##2##2##(2008-7#1)(2010-7#1)
7) in##2##2##(1993-1#1)(2011-2#1)
7) was##2##2##(2008-10#2)
7) with##2##2##(1994-12#1)(2008-10#1)
7)##57##1##(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1993-1#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-1#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
7)%##2##1##(2008-10#2)
7+/-0##12##1##(2008-10#11)(2008-7#1)
7+/-1##3##1##(2008-10#3)
7+/-2##2##1##(2008-10#1)(2009-3#1)
7+/-4##2##1##(2008-10#2)
7- to##6##2##(2008-10#6)
7-##10##1##(2008-10#6)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
7-1##7##1##(1993-12#1)(2008-10#4)(2008-8#1)(2008-9#1)
7-10##6##1##(1990-8#1)(1994-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2012-3#1)
7-10%##2##1##(1991-9#1)(2012-2#1)
7-100##3##1##(1993-2#1)(2008-10#2)
7-12##2##1##(2008-3#1)(2009-7#1)
7-14##3##1##(2011-2#3)
7-17##3##1##(1991-6#1)(1996-12#1)(2008-11#1)
7-2##4##1##(1993-2#1)(2008-10#3)
7-28##2##1##(1996-6#2)
7-3##3##1##(2008-10#3)
7-4##3##1##(2008-10#2)(2013-1#1)
7-6##3##1##(2008-10#3)
7-7##3##1##(2008-10#2)(2008-8#1)
7-8##6##1##(1997-8#1)(2008-10#2)(2010-11#1)(2013-1#2)
7-9##6##1##(1991-5#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-3#1)
7-A##2##1##(1992-4#2)
7-AAD##2##1##(2008-10#1)(2008-9#1)
7-DAY##2##1##(2008-11#2)
7-DCKA##2##1##(1995-11#2)
7-DHT injected animals##4##3##(2008-5#4)
7-DHT injected##5##2##(2008-5#5)
7-DHT##8##1##(2008-5#6)(2008-6#2)
7-DHT)##3##1##(1991-7#1)(2008-5#1)(2008-6#1)
7-ERD##3##1##(1992-3#3)
7-O-beta-(6-O-malonyl)glucopyranoside##2##1##(2010-6#2)
7-O-beta-D-glucopyranosiduronic acid-(1--&gt##2##2##(2010-6#2)
7-O-beta-D-glucoside##4##1##(2008-11#4)
7-W##2##1##(2007-12#1)(2008-3#1)
7-bit##2##1##(2008-3#2)
7-day intervals##2##2##(2008-10#2)
7-day##5##1##(1992-12#1)(2008-10#3)(2012-3#1)
7-day-old##2##1##(1996-12#1)(2008-11#1)
7-deoxycholic amide##3##2##(2008-10#3)
7-diaminoheptane##3##1##(1997-1#2)(2008-10#1)
7-dicarboxylic acid##2##2##(1996-5#2)
7-dichloroquinoline-8-ol modified benzophenone##2##3##(2008-10#2)
7-dichloroquinoline-8-ol##3##1##(2008-10#3)
7-dihydroxytryptamine (5##2##2##(2008-5#1)(2008-6#1)
7-dihydroxytryptamine##3##1##(1996-12#1)(2008-5#1)(2008-6#1)
7-dihydroxyxanthone##2##1##(2008-11#2)
7-diphenyl-1##3##1##(2008-10#3)
7-ethyl-dGp adducts##2##2##(2008-12#2)
7-ethyl-dGp levels##2##2##(2008-12#2)
7-ethyl-dGp##7##1##(2008-12#7)
7-fold and##2##2##(1995-11#1)(2008-11#1)
7-fold##11##1##(1990-12#1)(1991-5#1)(1992-3#2)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#3)(2008-8#1)
7-hydroxy##2##1##(2008-10#1)(2009-3#1)
7-hydroxycoumarin##2##1##(1990-6#2)
7-hydroxymethylnalidixic acid (OH-NA)##2##3##(2008-10#2)
7-hydroxymethylnalidixic acid##3##2##(2008-10#3)
7-kDa##3##1##(2008-10#2)(2011-2#1)
7-kb region of##2##3##(1993-6#1)(2008-10#1)
7-kb##4##1##(1993-6#1)(1996-8#1)(1997-7#1)(2008-10#1)
7-methyl-dGp##4##1##(2008-12#4)
7-methylxanthine##2##1##(2010-1#2)
7-month-old##3##1##(1995-8#1)(1997-3#1)(2008-10#1)
7-mx for##2##2##(2010-1#2)
7-mx##5##1##(2010-1#5)
7-order S-matrix##2##2##(2013-8#2)
7-pentahydroxyflavone##2##1##(2008-10#2)
7-pentahydroxyflavone)##2##1##(2008-10#2)
7-tetramethyl-2##2##1##(2008-10#2)
7-tetramethyl-4-bora-3a##2##1##(2008-10#2)
7-tetramethyl-8-(3'##2##1##(2008-10#2)
7-tetranitro-1##3##1##(2008-10#3)
7-tetrazocine (HMX)##3##2##(2008-10#3)
7-tetrazocine##4##1##(2008-10#3)(2008-11#1)
7-trihydroxyl-6-fluorone##2##1##(2008-10#2)
7-trinitro-9-fluorenon##2##1##(2008-10#2)
7-week##2##1##(1994-1#1)(2011-2#1)
7-year period##3##2##(1994-1#1)(2008-10#1)(2011-2#1)
7-year##5##1##(1991-11#1)(1994-1#1)(2008-10#1)(2010-6#1)(2011-2#1)
7-year-old boy##3##2##(2008-10#1)(2010-9#1)(2012-12#1)
7-year-old##4##1##(2008-10#1)(2010-9#1)(2012-12#1)(2013-8#1)
7/10##2##1##(2008-9#1)(2011-2#1)
7/1000##2##1##(1990-3#1)(1991-3#1)
70 +/-##2##2##(1991-11#1)(2011-2#1)
70 V##2##2##(2008-10#2)
70 and##12##2##(1994-1#2)(2008-10#9)(2010-4#1)
70 days##2##2##(2008-10#1)(2008-12#1)
70 degrees C for##2##4##(2008-10#2)
70 degrees C##6##3##(2008-10#5)(2008-11#1)
70 degrees##7##2##(2008-10#5)(2008-11#1)(2009-3#1)
70 h##2##2##(2008-11#2)
70 in##3##2##(1992-2#1)(2012-3#2)
70 isolates of##2##3##(2008-10#2)
70 mg##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
70 mg/kg##4##2##(2008-9#4)
70 mothers##2##2##(2011-1#2)
70 mug##3##2##(2008-10#3)
70 ng l(-1)##2##3##(2008-10#2)
70 ng##3##2##(2008-10#3)
70 nm##2##2##(2008-3#1)(2008-8#1)
70 patients##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
70 percent of##2##3##(1995-3#1)(1996-3#1)
70 percent##3##2##(1994-3#1)(1995-3#1)(1996-3#1)
70 protein##2##2##(2008-10#1)(2010-12#1)
70 samples##2##2##(2008-10#2)
70 to 79##2##3##(2008-7#1)(2013-1#1)
70 to 90##2##3##(1992-2#1)(1995-6#1)
70 to##9##2##(1992-2#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2013-1#1)
70 wards were included##2##4##(2013-1#2)
70 years ago##2##3##(2008-10#2)
70 years old##3##3##(1990-6#1)(2008-1#1)(2008-7#1)
70 years##11##2##(1990-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#4)(2011-2#2)
70 ± 0##3##3##(2010-11#1)(2010-9#1)(2013-1#1)
70##207##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#8)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#2)(1997-2#1)(1997-7#2)(1997-8#1)(2008-1#4)(2008-10#84)(2008-11#8)(2008-12#4)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#6)(2009-3#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#9)(2013-8#2)
70% (w/w)##2##2##(2008-10#2)
70% and##2##2##(2008-5#1)(2011-2#1)
70% at##2##2##(1992-6#1)(2008-7#1)
70% had##2##2##(1990-9#1)(2012-2#1)
70% of cases##2##3##(2012-2#1)(2013-1#1)
70% of oxygen uptake reserve##3##5##(2013-8#3)
70% of the##20##3##(1991-5#1)(1992-10#1)(1993-12#1)(1994-5#1)(1995-6#1)(2008-10#10)(2008-11#1)(2008-7#2)(2008-8#2)
70% of##41##2##(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-10#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-7#2)(2008-8#2)(2010-10#1)(2012-2#2)(2013-1#2)(2013-8#3)
70% reported##2##2##(1993-1#1)(2009-5#1)
70% were##2##2##(2008-10#2)
70%##100##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#1)(1997-3#1)(1997-9#1)(2007-8#1)(2008-1#1)(2008-10#35)(2008-11#6)(2008-12#2)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-5#1)(2010-10#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
70%) of##2##2##(2008-10#1)(2013-8#1)
70%)##6##1##(2008-10#2)(2008-8#1)(2010-8#1)(2011-1#1)(2013-8#1)
70) and##4##2##(1995-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
70)##10##1##(1995-11#2)(1995-12#1)(2008-10#4)(2012-2#1)(2012-3#1)(2013-1#1)
70+/-0##3##1##(2008-10#2)(2008-11#1)
70-80% of the##2##3##(1990-5#1)(1997-5#1)
70-80% of##3##2##(1990-5#1)(1997-5#1)(2013-1#1)
70-80%##5##1##(1990-5#1)(1997-2#1)(1997-5#1)(2008-3#1)(2013-1#1)
70-fold##3##1##(1994-8#1)(1996-3#1)(2008-10#1)
70-kDa protein##2##2##(1993-6#1)(1995-11#1)
70-year-old female##2##2##(1993-6#1)(2013-1#1)
70-year-old woman##4##2##(1991-12#1)(2008-12#1)(2011-2#1)(2012-3#1)
70-year-old##10##1##(1991-12#1)(1992-2#1)(1993-6#1)(2008-12#3)(2011-2#1)(2012-3#1)(2013-1#2)
700 and##2##2##(2008-10#1)(2008-3#1)
700 cm(-1)##2##2##(2008-10#2)
700 kDa##2##2##(2008-10#1)(2008-6#1)
700 nm##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
700##27##1##(1991-2#1)(1992-9#1)(1994-8#1)(1995-2#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
700-bp##3##1##(1991-6#1)(1994-11#1)(2008-8#1)
7000##5##1##(1990-2#1)(1990-3#1)(2008-10#1)(2008-11#2)
700nm##5##1##(2008-10#5)
701##2##1##(2008-10#2)
702##2##1##(2008-10#1)(2011-2#1)
704 var##3##2##(2008-12#3)
704 variety were higher than 301 variety##2##7##(2008-12#2)
704 variety##3##2##(2008-12#3)
704##8##1##(2008-12#7)(2008-3#1)
705##2##1##(2008-10#2)
706##2##1##(1996-8#1)(2008-11#1)
706)##2##1##(1991-2#2)
707##2##1##(2008-5#1)(2011-2#1)
70T01##11##1##(2008-10#11)
70V##2##1##(2008-10#2)
70ms##3##1##(2008-10#3)
70mugL(-1)##2##1##(2008-10#2)
70th birthday##2##2##(1997-6#2)
70th##3##1##(1997-6#2)(2008-12#1)
71 %##2##2##(2012-12#2)
71 +/-##4##2##(1990-5#1)(1994-8#1)(2008-10#1)(2011-2#1)
71 and##2##2##(2008-12#1)(2008-8#1)
71 in##2##2##(2008-11#1)(2013-8#1)
71 to##2##2##(2008-10#1)(2010-6#1)
71##71##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-8#1)(1996-12#2)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#16)(2008-11#4)(2008-12#4)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#4)(2009-1#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-8#4)
71% and##2##2##(1997-2#1)(2010-8#1)
71% in##2##2##(1993-1#1)(2008-10#1)
71% of the##4##3##(2008-10#4)
71% of##8##2##(1992-9#1)(2008-10#4)(2008-7#1)(2008-9#1)(2013-8#1)
71%##30##1##(1991-12#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-2#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
71%)##4##1##(2008-10#1)(2008-12#2)(2011-2#1)
71)##3##1##(2008-12#1)(2011-2#2)
71+/-0##4##1##(2008-10#3)(2008-8#1)
71-year-old##4##1##(1992-12#1)(1992-2#1)(2010-12#1)(2010-4#1)
710##2##1##(1991-9#1)(2008-10#1)
7100##2##1##(2008-8#2)
7117##2##1##(2008-3#2)
712##3##1##(2008-10#2)(2008-11#1)
713##4##1##(2008-10#4)
714##2##1##(2008-12#1)(2008-5#1)
717##2##1##(2008-10#2)
718##6##1##(1996-6#1)(2008-10#3)(2011-2#1)(2013-8#1)
7185##2##1##(2008-3#2)
71V##2##1##(2008-10#2)
72 (2000)##2##2##(2008-10#2)
72 and##5##2##(1995-12#1)(2008-10#2)(2009-4#1)(2013-1#1)
72 cases##2##2##(1991-2#1)(2013-1#1)
72 cm from the##2##4##(2008-10#2)
72 h after inoculation##5##4##(2008-10#5)
72 h after##6##3##(2008-10#6)
72 h and##2##3##(2008-10#1)(2008-12#1)
72 h following##2##3##(1996-12#1)(2008-10#1)
72 h of incubation##2##4##(2008-12#1)(2008-7#1)
72 h of##9##3##(1995-11#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)
72 h##37##2##(1993-12#1)(1995-11#2)(1995-8#2)(1996-12#1)(1997-2#1)(2008-10#19)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#1)
72 h) was##2##3##(1993-6#2)
72 hours after##2##3##(1993-11#1)(2013-1#1)
72 hours and##2##3##(2010-1#1)(2011-3#1)
72 hours of##2##3##(2013-1#2)
72 hours##11##2##(1990-6#1)(1992-2#1)(1993-11#1)(1993-3#1)(2010-1#1)(2011-3#1)(2013-1#5)
72 isolates##2##2##(2008-10#2)
72 months##2##2##(1992-5#1)(1995-1#1)
72 proteins##2##2##(1996-8#1)(1997-2#1)
72 to##2##2##(2008-10#1)(2010-11#1)
72 years##2##2##(1997-8#1)(2011-2#1)
72 ±##2##2##(2012-3#2)
72##150##1##(1990-5#1)(1990-6#2)(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-2#3)(1997-6#1)(1997-8#3)(2008-10#45)(2008-11#2)(2008-12#7)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#8)(2011-3#2)(2012-2#1)(2012-3#4)(2013-1#13)(2013-8#2)
72% and##2##2##(2013-1#1)(2013-8#1)
72% in##2##2##(2008-10#1)(2008-9#1)
72% of##4##2##(1992-1#1)(2008-10#1)(2013-1#2)
72%##25##1##(1990-12#1)(1992-1#1)(1994-2#1)(1996-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
72)##6##1##(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
72+/-0##2##1##(2008-10#2)
72-h hydrolysis of the SPCS substrate##2##6##(2011-2#2)
72-h##6##1##(1995-12#1)(1997-2#1)(2008-10#2)(2011-2#2)
72-kDa##2##1##(1992-6#1)(1993-6#1)
72-year-old man##3##2##(2008-12#1)(2010-6#1)(2011-2#1)
72-year-old##9##1##(2007-8#1)(2008-12#2)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)
720 mg/liter##3##2##(2008-10#3)
720##9##1##(1991-8#1)(1992-12#1)(2008-10#7)
721##3##1##(1990-5#1)(2011-2#1)(2011-3#1)
723##3##1##(2008-10#3)
7233##2##1##(2008-12#2)
725##4##1##(2008-10#3)(2011-3#1)
727##3##1##(1994-11#1)(1996-12#1)(2013-1#1)
727)##2##1##(2008-10#1)(2012-2#1)
727-736##2##1##(2008-3#1)(2008-7#1)
728##2##1##(2008-11#1)(2011-3#1)
72mugl(-1)##2##1##(2008-10#2)
73 (2##2##2##(2008-10#1)(2013-1#1)
73 (2001) 4301'##2##3##(2008-10#2)
73 (2001)##3##2##(2008-10#3)
73 cases of##2##3##(1991-11#1)(2013-1#1)
73 cases##3##2##(1991-11#1)(2007-11#1)(2013-1#1)
73 for##2##2##(2008-10#2)
73 patients##2##2##(1991-11#1)(2007-8#1)
73 percent##2##2##(1993-12#1)(1995-3#1)
73 to##3##2##(2008-10#3)
73##76##1##(1990-11#1)(1991-11#5)(1991-6#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#1)(2012-5#2)(2013-1#4)(2013-8#4)
73% and##2##2##(2008-7#1)(2011-2#1)
73% for##2##2##(2008-10#1)(2008-12#1)
73% in##2##2##(2008-10#2)
73% of the##3##3##(2008-10#2)(2012-2#1)
73% of##6##2##(2008-1#1)(2008-10#4)(2012-2#1)
73% were##2##2##(2008-3#1)(2009-10#1)
73%##25##1##(1993-3#1)(1994-2#1)(1996-11#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
73%)##3##1##(1993-8#1)(1996-2#1)(2007-11#1)
73) and##2##2##(2008-10#1)(2008-9#1)
73)##11##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#2)
73-year-old man##3##2##(2008-7#1)(2013-1#2)
73-year-old##5##1##(2008-7#2)(2010-6#1)(2013-1#2)
730##5##1##(1994-8#1)(2008-10#3)(2008-3#1)
731##2##1##(2011-2#1)(2013-8#1)
732##3##1##(2008-10#1)(2012-12#1)(2012-3#1)
735##4##1##(2011-2#2)(2012-12#1)(2013-1#1)
74 +/- 0##2##3##(2008-5#1)(2009-11#1)
74 +/-##3##2##(2008-10#1)(2008-5#1)(2009-11#1)
74 and##5##2##(1993-1#1)(1996-12#1)(2008-10#3)
74 kDa##2##2##(1992-10#1)(1995-11#1)
74 to##2##2##(2008-6#1)(2010-4#1)
74##72##1##(1992-10#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1996-12#4)(1996-3#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#2)
74% and##2##2##(1994-12#1)(2007-12#1)
74% in##3##2##(1996-9#1)(2008-10#2)
74% of the##2##3##(2008-10#1)(2009-12#1)
74% of##5##2##(2008-10#2)(2008-11#1)(2009-12#1)(2010-3#1)
74%##22##1##(1991-8#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-9#1)(2007-12#1)(2008-10#6)(2008-11#2)(2009-12#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#1)
74%)##3##1##(1990-3#1)(2008-10#1)(2011-2#1)
74)##5##1##(1997-2#1)(1997-8#1)(2012-2#1)(2012-4#2)
74+/-0##2##1##(2008-10#2)
74-year-old woman##3##2##(2009-1#1)(2011-2#1)(2012-12#1)
74-year-old##6##1##(2009-1#1)(2010-6#1)(2011-2#3)(2012-12#1)
740##7##1##(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#2)
740nm##2##1##(2008-10#2)
744##3##1##(1991-11#1)(2008-10#1)(2012-3#1)
745 cm(-1)##2##2##(2008-10#2)
745##5##1##(1997-7#1)(2008-10#2)(2012-12#1)(2013-8#1)
746##3##1##(1991-3#1)(2008-10#2)
747 bp##2##2##(1990-8#1)(2011-2#1)
747##6##1##(1990-8#1)(2008-10#3)(2008-7#1)(2011-2#1)
75 %##4##2##(2008-8#1)(2012-12#3)
75 +/-##8##2##(1991-11#1)(1991-6#1)(1994-5#1)(1995-12#1)(2008-10#1)(2010-6#1)(2010-7#2)
75 and 0##2##3##(2008-10#2)
75 and 1##2##3##(2008-12#1)(2011-2#1)
75 and 90%##2##3##(2008-10#2)
75 and##19##2##(1993-11#1)(1997-9#1)(2008-10#10)(2008-12#2)(2008-7#3)(2011-2#1)(2013-8#1)
75 cm##2##2##(2008-10#2)
75 degrees##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
75 kDa##7##2##(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#3)
75 mg l(-1)##2##3##(2008-10#2)
75 mg##6##2##(2008-10#3)(2008-11#2)(2008-5#1)
75 microM##4##2##(1992-3#1)(1993-6#2)(1994-8#1)
75 mug##3##2##(2008-10#3)
75 mum##2##2##(2008-10#2)
75 of##2##2##(1994-9#1)(2008-5#1)
75 or##2##2##(2008-10#1)(2008-8#1)
75 patients##3##2##(1990-12#1)(1990-9#1)(2011-2#1)
75 to 0##3##3##(2008-3#1)(2013-1#2)
75 to##13##2##(2008-10#5)(2008-11#3)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#2)
75 years of age##3##4##(2011-2#3)
75 years old##2##3##(2008-5#1)(2013-1#1)
75 years##8##2##(1991-2#1)(1992-9#1)(2008-5#1)(2011-2#4)(2013-1#1)
75##199##1##(1990-12#1)(1990-2#1)(1990-9#2)(1991-11#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#2)(1993-6#4)(1993-8#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#2)(2008-10#76)(2008-11#9)(2008-12#2)(2008-3#3)(2008-5#9)(2008-7#10)(2008-8#4)(2008-9#11)(2010-10#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
75% and the##2##3##(2008-10#2)
75% and##4##2##(1997-1#1)(1997-3#1)(2008-10#2)
75% for the##2##3##(1993-1#1)(1995-3#1)
75% for##4##2##(1990-6#1)(1993-1#1)(1995-3#1)(2008-11#1)
75% of the##7##3##(1995-8#1)(1996-11#1)(2008-10#3)(2011-2#1)(2011-3#1)
75% of these##2##3##(2011-1#1)(2012-3#1)
75% of##22##2##(1990-3#1)(1992-12#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-6#1)(2008-10#6)(2008-11#1)(2010-1#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
75% or##2##2##(2009-12#1)(2011-2#1)
75% reduction##2##2##(2008-11#2)
75%##68##1##(1990-3#1)(1990-6#1)(1992-11#2)(1992-12#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#2)(1996-12#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#23)(2008-11#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-1#4)(2013-8#1)
75%)##8##1##(1994-3#1)(1995-11#1)(2008-10#2)(2008-5#2)(2012-2#1)(2013-8#1)
75)##5##1##(1992-2#1)(2008-10#1)(2012-3#2)(2013-8#1)
75-79##2##1##(1994-11#1)(2012-12#1)
75-80##2##1##(1996-3#1)(2008-10#1)
75-year-old##5##1##(1991-11#1)(1991-8#1)(2008-7#1)(2013-1#2)
750 women##2##2##(1992-1#2)
750##18##1##(1992-1#2)(1996-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
751##3##1##(2008-10#1)(2008-3#1)(2010-7#1)
753 and##2##2##(1991-5#1)(2011-2#1)
753##8##1##(1990-6#1)(1991-5#4)(2008-9#1)(2009-10#1)(2011-2#1)
754##4##1##(1993-1#1)(2008-10#2)(2013-8#1)
7554/eLife##5##1##(2013-8#5)
756##4##1##(2008-10#3)(2013-1#1)
757 and discrimination power from 0##2##6##(2013-1#2)
757##6##1##(1993-1#1)(1996-12#2)(2008-10#1)(2013-1#2)
758##2##1##(2010-8#1)(2011-3#1)
75Ba0##2##1##(2008-3#2)
75mg/m2##2##1##(2008-10#2)
75mug##2##1##(2008-10#2)
76 and 0##2##3##(2008-10#2)
76 and##6##2##(2008-10#5)(2010-10#1)
76 kDa##3##2##(1992-6#1)(2008-10#1)(2009-6#1)
76 patients with##2##3##(1991-8#1)(2011-2#1)
76 patients##5##2##(1991-8#1)(2011-2#4)
76 percent##2##2##(1994-1#1)(1996-1#1)
76 x##3##2##(2008-10#2)(2008-11#1)
76 years##3##2##(1991-2#1)(2008-11#1)(2008-12#1)
76##83##1##(1990-11#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-1#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#3)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-2#8)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#2)
76% and##3##2##(1997-2#1)(2008-7#1)(2012-3#1)
76% of patients##2##3##(1992-5#1)(2009-3#1)
76% of##7##2##(1992-5#1)(1994-2#1)(1996-9#1)(1997-6#1)(2008-7#1)(2008-8#1)(2009-3#1)
76%##26##1##(1992-5#1)(1993-1#1)(1993-3#1)(1994-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-7#3)(2008-8#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
76%) had TSH levels between 4##2##6##(2012-3#2)
76%)##4##1##(2008-10#1)(2011-2#1)(2012-3#2)
76)##3##1##(2008-10#1)(2010-8#1)(2013-1#1)
760##6##1##(2008-10#4)(2008-3#2)
762##2##1##(2008-10#1)(2010-6#1)
763##5##1##(1993-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-6#1)
765##6##1##(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)
767##2##1##(2008-10#1)(2011-2#1)
7676 bp##2##2##(1996-6#2)
768##2##1##(2008-10#1)(2008-11#1)
769##4##1##(2008-10#1)(2009-10#1)(2011-2#1)(2012-3#1)
77 K##5##2##(2008-10#2)(2009-11#3)
77 and##5##2##(1991-1#1)(1996-12#1)(1997-2#1)(2008-10#2)
77 microg l(-1)##2##3##(2008-10#2)
77 patients##2##2##(2011-2#1)(2013-1#1)
77 to##3##2##(2008-10#3)
77 x##2##2##(1990-8#1)(2008-10#1)
77 years##2##2##(2010-1#1)(2011-2#1)
77 ±##2##2##(2010-11#1)(2013-8#1)
77##81##1##(1990-12#2)(1990-3#1)(1990-6#3)(1990-8#1)(1991-1#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#3)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#4)(2013-8#1)
77% and##2##2##(1990-9#1)(2008-10#1)
77% identical to##2##3##(1992-10#2)
77% of the##4##3##(1991-2#1)(1991-6#1)(1992-12#1)(2008-10#1)
77% of##6##2##(1991-2#1)(1991-6#1)(1992-12#1)(2008-10#2)(2008-12#1)
77%##23##1##(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#2)(1992-12#1)(2008-10#12)(2008-12#1)(2011-2#1)(2012-3#1)
77)##5##1##(1994-12#1)(1996-12#1)(2008-10#1)(2010-11#1)(2013-1#1)
77-3##3##1##(2008-10#3)
770##6##1##(1990-3#1)(1996-2#1)(2008-2#2)(2008-8#1)(2012-12#1)
7700##2##1##(2008-10#1)(2011-2#1)
771##3##1##(2008-10#1)(2009-3#1)(2011-2#1)
772##2##1##(1993-9#1)(1995-6#1)
773##2##1##(2008-3#1)(2010-12#1)
774##4##1##(1991-12#1)(2008-10#1)(2008-11#1)(2010-10#1)
775##2##1##(1990-3#1)(1997-7#1)
777##2##1##(1994-11#1)(2009-3#1)
78 kDa##2##2##(1992-6#1)(1993-12#1)
78 patients##4##2##(1991-3#1)(1996-3#1)(2007-8#1)(2008-12#1)
78 to 0##3##3##(2008-10#1)(2010-6#1)(2013-1#1)
78 to##5##2##(2008-10#2)(2010-6#1)(2010-9#1)(2013-1#1)
78 women with##2##3##(2011-2#2)
78 ± 0##2##3##(2010-11#1)(2013-8#1)
78##89##1##(1990-2#2)(1990-5#1)(1991-12#2)(1991-3#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-8#2)(2008-10#25)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
78% and 71%##2##3##(2008-9#1)(2013-1#1)
78% and##5##2##(1993-2#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
78% nucleotide identity##2##3##(2008-10#2)
78% of the##5##3##(1991-6#1)(1997-6#1)(2008-10#2)(2008-3#1)
78% of##8##2##(1991-6#1)(1992-9#1)(1996-9#1)(1997-6#1)(2008-10#2)(2008-3#1)(2013-8#1)
78%##21##1##(1991-6#2)(1992-9#1)(1993-2#1)(1996-9#1)(1997-6#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
78%)##3##1##(2008-10#2)(2008-12#1)
78)##5##1##(2008-10#2)(2008-12#1)(2013-1#1)(2013-8#1)
78-62##5##1##(2008-10#5)
780##7##1##(1991-12#1)(2008-10#4)(2010-10#1)(2012-12#1)
780-nm##2##1##(2008-2#1)(2008-3#1)
781##2##1##(1991-2#1)(2008-10#1)
782 bp##2##2##(2011-2#2)
782##3##1##(2008-10#1)(2011-2#2)
788##3##1##(2008-10#1)(2008-5#1)(2010-7#1)
789##2##1##(2008-11#1)(2011-3#1)
78V##2##1##(2008-10#2)
79 +/-##5##2##(1991-6#1)(1992-11#1)(1997-1#1)(1997-3#1)(2008-1#1)
79 and 0##2##3##(2008-10#2)
79 and##7##2##(1992-10#1)(1996-12#1)(2008-10#4)(2008-11#1)
79 degrees C##2##3##(2008-10#2)
79 to##4##2##(2008-10#4)
79##69##1##(1990-6#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-2#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#2)(2008-1#2)(2008-10#26)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#1)
79% of the##3##3##(1993-2#1)(2008-12#1)(2013-8#1)
79% of##8##2##(1993-2#1)(1995-12#1)(2008-12#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
79%##15##1##(1991-6#1)(1992-2#1)(1993-2#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
79%)##3##1##(2008-10#1)(2008-5#1)(2008-7#1)
79)##6##1##(1991-6#1)(2008-7#1)(2011-3#1)(2012-2#2)(2013-1#1)
79+/-1##2##1##(2008-10#2)
79-year-old##2##1##(2011-2#1)(2013-7#1)
790##2##1##(2010-9#1)(2011-2#1)
791##3##1##(1990-2#1)(2008-10#1)(2010-7#1)
793##3##1##(1990-8#1)(2008-10#1)(2008-11#1)
793/B isolates##3##2##(2008-5#3)
793/B##7##1##(2008-5#7)
795##4##1##(2008-3#1)(2008-8#2)(2011-2#1)
799##6##1##(2008-10#3)(2008-12#1)(2011-2#1)(2011-3#1)
7998##5##1##(2008-10#5)
799BglIIalpha-AE##2##1##(2008-11#2)
7A in##2##2##(2008-10#2)
7A of##3##2##(2008-10#3)
7A##10##1##(2008-10#10)
7D of##2##2##(2008-10#2)
7D##7##1##(2008-10#5)(2008-11#2)
7DL##5##1##(2008-10#5)
7DS##4##1##(2008-10#4)
7M##3##1##(2008-10#3)
7MENT##4##1##(1990-11#4)
7NSK2##5##1##(2008-10#5)
7V (logic##2##2##(2008-10#2)
7V versus##2##2##(2008-10#2)
7V##4##1##(2008-10#4)
7]##5##1##(1990-5#1)(1990-9#1)(2008-10#3)
7a##2##1##(1992-3#2)
7cm##2##1##(2008-10#1)(2009-1#1)
7min##5##1##(2008-10#5)
7muM##2##1##(2008-10#2)
7mugL(-1) for##2##2##(2008-10#2)
7mugL(-1)##3##1##(2008-10#3)
7mugml(-1)##2##1##(2008-10#2)
7ngg(-1) As in levender and rose oil##2##7##(2008-10#2)
7ngg(-1)##3##1##(2008-10#3)
7ngml(-1)##2##1##(2008-10#2)
7q and 14q##2##3##(1997-6#2)
7q##4##1##(1997-6#4)
7q11##2##1##(2008-12#2)
7th and##2##2##(1990-9#1)(1991-9#1)
7th day##2##2##(1990-9#1)(2011-2#1)
7th grade##2##2##(1994-5#1)(1996-6#1)
7th##13##1##(1990-9#2)(1991-9#1)(1992-12#1)(1992-5#1)(1994-5#1)(1996-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
7x10(-10)##3##1##(2008-10#2)(2008-7#1)
7x10(-4) M##2##2##(2008-10#2)
7x10(-5) M##2##2##(2008-10#2)
7x10(-9)##3##1##(2008-10#3)
7x10(3)##4##1##(2008-10#4)
7 cm##2##1##(2010-12#1)(2013-8#1)
7±0##2##1##(2013-1#2)
7±6##2##1##(2013-1#2)
8 % of the##2##4##(2011-1#1)(2012-12#1)
8 %##6##2##(2008-10#2)(2011-1#1)(2012-12#2)(2013-1#1)
8 %)##3##2##(2011-2#1)(2012-12#2)
8 (1##2##2##(1993-12#2)
8 (6##2##2##(2011-2#2)
8 (R##2##2##(2008-10#2)
8 (range##3##2##(1992-2#1)(2008-1#1)(2013-1#1)
8 +/- 0##6##3##(1993-2#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
8 +/- 1##4##3##(1992-2#1)(1995-12#1)(2008-10#1)(2008-12#1)
8 +/- 2##3##3##(1992-2#1)(1994-12#1)(2008-12#1)
8 +/- 3##2##3##(1994-2#1)(2012-3#1)
8 +/-##22##2##(1992-11#1)(1992-2#2)(1993-2#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#4)(2008-12#3)(2008-7#1)(2011-2#2)(2012-3#2)
8 ? 0##2##3##(2008-3#2)
8 A##3##2##(1993-8#1)(1997-7#1)(2008-8#1)
8 M##4##2##(1993-6#1)(2008-10#1)(2009-7#2)
8 MPa##2##2##(2009-7#1)(2010-4#1)
8 U/ml##2##2##(1993-1#2)
8 V##3##2##(2008-10#3)
8 W##2##2##(2008-10#2)
8 and 0##5##3##(2008-10#5)
8 and 1##2##3##(1996-11#1)(2008-10#1)
8 and 10##4##3##(2008-10#3)(2008-12#1)
8 and 11##2##3##(1993-8#1)(1995-8#1)
8 and 12##5##3##(1991-2#1)(1991-6#1)(2008-10#1)(2008-5#1)(2009-10#1)
8 and 12 weeks##2##3##(2011-2#2)
8 and 15##2##3##(1996-12#1)(2008-10#1)
8 and 2##6##3##(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
8 and 24##2##3##(1995-12#1)(2008-10#1)
8 and 28##2##3##(2008-12#2)
8 and 3##5##3##(1994-8#1)(2008-10#4)
8 and 4##4##3##(2008-10#4)
8 and 6##5##3##(2008-10#3)(2008-11#1)(2010-1#1)
8 and 7##3##3##(2008-10#2)(2013-1#1)
8 and 8##2##3##(2008-10#2)
8 and 9##8##3##(1990-6#1)(1996-12#4)(1997-8#1)(2008-10#2)
8 and the##2##3##(1990-5#1)(2008-10#1)
8 and##91##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#6)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#53)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-1#1)(2011-2#4)(2012-4#1)(2013-1#1)
8 are##2##2##(1997-8#1)(2007-12#1)
8 billion##2##2##(1991-1#1)(1992-12#1)
8 cM##3##2##(1997-2#1)(2008-10#2)
8 cases of##2##3##(2009-4#1)(2013-1#1)
8 cases##9##2##(1991-11#1)(1996-11#1)(2009-4#1)(2009-8#1)(2011-3#1)(2012-3#1)(2013-1#3)
8 children##2##2##(1990-6#1)(2013-7#1)
8 cm##5##2##(2008-10#1)(2009-10#2)(2012-12#1)(2012-3#1)
8 cm)##2##2##(1993-9#1)(2008-12#1)
8 congeners##2##2##(2008-10#2)
8 dB/0##2##2##(2010-8#2)
8 days after inoculation##4##4##(2008-10#4)
8 days after##8##3##(1996-2#1)(2008-10#6)(2008-7#1)
8 days postlesion##2##3##(1997-3#2)
8 days##23##2##(1991-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
8 degrees C##12##3##(1993-8#2)(2007-12#1)(2008-10#9)
8 degrees C)##2##3##(2008-10#2)
8 degrees##17##2##(1992-4#1)(1993-8#2)(2007-12#1)(2008-10#12)(2008-12#1)
8 exons##2##2##(1996-8#1)(2008-9#1)
8 expression##2##2##(2012-3#2)
8 expressions##2##2##(2012-3#2)
8 fmol for##2##3##(2008-10#2)
8 for##4##2##(1993-12#1)(2008-10#3)
8 from##2##2##(2008-10#2)
8 g l(-1)##2##3##(2008-10#1)(2008-11#1)
8 g sucrose·kg-1·h-1##2##3##(2013-1#2)
8 g##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
8 h after a single GH injection##3##7##(1995-12#3)
8 h after the##2##4##(1992-10#1)(2008-10#1)
8 h after##6##3##(1992-10#1)(1995-12#3)(2008-10#2)
8 h or##2##3##(2008-10#2)
8 h post-infection in##2##4##(1996-12#2)
8 h with##2##3##(1995-11#1)(2008-10#1)
8 h##23##2##(1992-10#1)(1995-11#1)(1995-12#3)(1996-12#2)(1996-2#1)(2008-10#12)(2008-11#1)(2008-7#1)(2013-8#1)
8 has been##2##3##(1996-5#2)
8 hours##3##2##(1990-6#1)(2008-11#1)(2008-7#1)
8 in the##3##3##(1993-8#1)(1996-12#1)(2008-7#1)
8 in##7##2##(1993-8#1)(1996-11#1)(1996-12#1)(2008-10#2)(2008-7#1)(2013-8#1)
8 isolates from##3##3##(2008-10#3)
8 kDa##3##2##(1990-5#1)(1995-6#1)(2008-10#1)
8 kDa)##2##2##(2008-10#2)
8 kb DNA##2##3##(1992-3#1)(2008-8#1)
8 kb on the 3' side##2##6##(1993-12#1)(1993-6#1)
8 kb##10##2##(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-8#2)
8 kb)##2##2##(1994-11#1)(2008-11#1)
8 kcal/mol)##2##2##(1993-8#2)
8 kg##3##2##(1994-3#1)(2008-12#1)(2008-4#1)
8 l##2##2##(2008-10#2)
8 m)##2##2##(2008-3#1)(2009-8#1)
8 mM##5##2##(1993-8#1)(1994-11#1)(2008-10#2)(2008-11#1)
8 mg l(-1) of##4##4##(2008-10#4)
8 mg l(-1)##8##3##(2008-10#8)
8 mg of##2##3##(2008-10#2)
8 mg##16##2##(1997-2#1)(2008-10#12)(2008-12#3)
8 mg)##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
8 mg/kg##3##2##(1991-6#1)(1991-7#1)(1996-2#1)
8 mg/kg)##5##2##(1991-7#3)(2006-6#2)
8 mgl(-1)##2##2##(2008-10#1)(2008-11#1)
8 microM##2##2##(1992-6#1)(1995-8#1)
8 microg##2##2##(2008-12#1)(2011-3#1)
8 microg/ml##2##2##(2008-10#1)(2008-5#1)
8 microm##4##2##(2007-12#2)(2008-3#2)
8 microns s-1##2##3##(1993-9#2)
8 million##3##2##(1991-3#1)(1997-2#1)(2008-11#1)
8 min##9##2##(1996-1#1)(2008-10#8)
8 ml min(-1)##6##3##(2008-10#6)
8 ml of##2##3##(2008-10#2)
8 ml##11##2##(1997-8#1)(2008-10#10)
8 mm in diameter##2##4##(2008-5#1)(2008-8#1)
8 mm in##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
8 mm respectively##2##3##(2013-1#2)
8 mm##17##2##(1991-2#1)(1995-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-5#1)(2013-1#6)
8 mm)##2##2##(2008-9#1)(2013-1#1)
8 mmHg##2##2##(2008-10#1)(2008-11#1)
8 mmol##4##2##(1991-12#1)(2008-10#2)(2008-11#1)
8 mmol/l##2##2##(1991-6#1)(2008-7#1)
8 mol l(-1) NaCl medium##2##5##(2008-10#2)
8 mol##3##2##(1990-2#1)(2008-10#2)
8 months after##2##3##(2008-10#1)(2008-7#1)
8 months of##4##3##(1992-1#1)(2008-10#1)(2008-9#2)
8 months##31##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-6#1)(1994-3#1)(1994-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#4)(2010-3#3)(2012-3#1)(2013-1#2)
8 months)##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
8 muM##2##2##(2008-11#2)
8 mug l(-1) for##2##4##(2008-10#2)
8 mug l(-1)##7##3##(2008-10#7)
8 mug ml(-1)##7##3##(2008-10#7)
8 mug##17##2##(2008-10#16)(2008-5#1)
8 mug/ml for##2##3##(2008-10#1)(2008-5#1)
8 mugml(-1)##2##2##(2008-10#2)
8 mum##8##2##(1992-2#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)
8 nM)##4##2##(1993-8#1)(1994-3#1)(1996-12#1)(2008-10#1)
8 ng l(-1)##2##3##(2008-10#2)
8 ng ml(-1)##4##3##(2008-10#4)
8 ng##11##2##(1996-12#1)(2008-10#10)
8 ng/ml##2##2##(1990-2#1)(1992-11#1)
8 nm##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
8 nm)##2##2##(2008-3#2)
8 of the##4##3##(1993-2#1)(1993-8#1)(1996-2#1)(2012-2#1)
8 of##15##2##(1990-6#1)(1991-2#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2012-2#2)
8 on a scale of 0-10##2##6##(2013-1#2)
8 or##4##2##(2008-10#3)(2010-8#1)
8 out of##2##3##(2009-8#1)(2013-1#1)
8 patients had##2##3##(1994-12#1)(2010-3#1)
8 patients were##2##3##(1997-8#1)(2011-2#1)
8 patients##14##2##(1990-12#1)(1991-11#1)(1991-3#1)(1992-1#1)(1994-12#1)(1996-3#1)(1997-8#2)(2008-7#1)(2010-3#2)(2011-2#2)(2013-1#1)
8 per cent##2##3##(1990-6#2)
8 per##3##2##(1990-6#2)(1991-11#1)
8 percent##4##2##(1992-12#1)(1992-2#1)(2008-8#1)(2013-1#1)
8 pg##4##2##(2008-10#3)(2011-3#1)
8 respectively##2##2##(1996-12#1)(2008-9#1)
8 times for##2##3##(1995-6#2)
8 times in##2##3##(2010-12#2)
8 times##9##2##(1993-6#1)(1995-6#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#2)
8 to 10##4##3##(2008-10#3)(2008-3#1)
8 to 100##2##3##(2008-10#2)
8 to 12##2##3##(1994-12#1)(2008-10#1)
8 to 16##2##3##(1991-12#1)(2008-10#1)
8 to 17##2##3##(2008-10#1)(2008-12#1)
8 to 42##2##3##(2008-10#1)(2010-8#1)
8 to 5##2##3##(2008-10#2)
8 to 98##2##3##(2008-10#2)
8 to##34##2##(1991-12#1)(1992-12#1)(1994-12#1)(1995-3#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-1#1)(2010-11#1)(2010-8#1)(2012-2#1)
8 was##2##2##(1994-12#1)(1996-5#1)
8 weeks after the##2##4##(2008-10#1)(2009-3#1)
8 weeks after##4##3##(2008-10#3)(2009-3#1)
8 weeks and##2##3##(2008-5#1)(2012-3#1)
8 weeks following##3##3##(2008-10#2)(2009-3#1)
8 weeks in##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
8 weeks later##2##3##(1996-11#1)(2008-10#1)
8 weeks of##7##3##(1991-11#1)(1992-11#1)(2008-10#2)(2011-2#1)(2013-1#2)
8 weeks##39##2##(1991-11#1)(1992-11#1)(1996-11#1)(2008-10#15)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#6)(2009-5#1)(2010-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#3)
8 were##4##2##(2008-10#2)(2010-1#1)(2011-2#1)
8 with##7##2##(1991-11#1)(1992-2#1)(1994-12#1)(1996-5#1)(1997-4#1)(2008-10#2)
8 x 10(-18)##2##3##(2008-11#1)(2008-12#1)
8 x 10(-6)##2##3##(1991-5#1)(2008-10#1)
8 x 10(-9)##3##3##(1995-11#1)(2008-10#2)
8 x 10(4)##6##3##(1993-1#1)(2008-10#4)(2008-7#1)
8 x 10(6)##4##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
8 x 8##4##3##(1993-9#1)(2008-10#1)(2008-3#2)
8 x##33##2##(1990-12#2)(1991-5#1)(1993-1#1)(1993-9#1)(1995-11#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#2)
8 years##24##2##(1991-11#2)(1994-1#1)(1996-3#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-7#2)(2009-3#2)(2010-11#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
8 years)##6##2##(1991-8#1)(1997-3#1)(2008-7#1)(2010-1#1)(2011-2#2)
8 ±##2##2##(2011-2#1)(2013-8#1)
8##1411##1##(1990-11#6)(1990-12#4)(1990-2#9)(1990-5#10)(1990-6#11)(1990-8#8)(1991-1#1)(1991-11#11)(1991-12#3)(1991-2#5)(1991-3#4)(1991-5#2)(1991-6#6)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#9)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-12#9)(1993-2#5)(1993-3#3)(1993-6#5)(1993-8#19)(1993-9#6)(1994-1#1)(1994-11#8)(1994-12#14)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#6)(1995-10#1)(1995-11#8)(1995-12#9)(1995-2#4)(1995-3#2)(1995-6#6)(1995-8#4)(1996-1#3)(1996-11#5)(1996-12#16)(1996-2#4)(1996-3#9)(1996-5#9)(1996-6#1)(1996-8#1)(1997-2#8)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#10)(1997-9#1)(2006-6#2)(2007-11#1)(2007-12#10)(2008-1#4)(2008-10#597)(2008-11#59)(2008-12#30)(2008-2#2)(2008-3#27)(2008-4#4)(2008-5#19)(2008-6#6)(2008-7#33)(2008-8#24)(2008-9#33)(2009-1#2)(2009-10#5)(2009-11#2)(2009-12#3)(2009-3#12)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#8)(2010-1#7)(2010-10#4)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#4)(2011-2#59)(2011-3#4)(2012-12#11)(2012-2#11)(2012-3#22)(2012-4#1)(2013-1#41)(2013-7#1)(2013-8#12)
8% (P &lt##3##3##(2008-9#1)(2013-1#2)
8% (n =##3##3##(2008-10#1)(2012-3#2)
8% (v/v)##2##2##(2008-10#1)(2008-11#1)
8% L-menthol##3##2##(2012-2#3)
8% after##3##2##(2008-10#3)
8% and 95##2##3##(1990-2#1)(2013-8#1)
8% and##23##2##(1990-2#1)(1991-6#1)(1991-8#2)(1993-1#1)(1996-3#1)(2008-10#8)(2008-3#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#3)(2013-8#2)
8% at##9##2##(2008-10#8)(2008-12#1)
8% for 20##2##3##(2008-10#2)
8% for the##2##3##(2008-10#2)
8% for##35##2##(1991-3#1)(1996-12#1)(2008-1#1)(2008-10#29)(2008-5#1)(2011-2#1)(2012-3#1)
8% had##6##2##(1990-6#1)(1991-2#1)(1992-1#1)(1995-10#1)(2008-12#1)(2010-1#1)
8% higher##2##2##(2008-10#1)(2008-3#1)
8% in the##2##3##(1994-8#1)(2008-7#1)
8% in##9##2##(1992-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-8#1)
8% of the patients##2##4##(1991-3#1)(2008-1#1)
8% of the##12##3##(1990-5#1)(1991-3#1)(1993-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
8% of total##2##3##(2008-10#1)(2013-8#1)
8% of##22##2##(1990-12#1)(1990-5#1)(1991-3#1)(1993-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#2)(2013-8#2)
8% over##2##2##(1995-8#1)(2008-12#1)
8% relative standard deviation (R##2##5##(2008-10#2)
8% relative standard deviation##3##4##(2008-10#3)
8% respectively##2##2##(1994-12#1)(2008-9#1)
8% sensitivity##2##2##(2011-2#2)
8% specificity##2##2##(2011-2#1)(2012-12#1)
8% vs##3##2##(1990-3#1)(2009-8#1)(2013-8#1)
8% were obtained for##2##4##(2008-10#2)
8% were obtained##4##3##(2008-10#4)
8% were##11##2##(1990-12#1)(1990-2#2)(1991-2#1)(1993-2#1)(2008-10#5)(2010-8#1)
8% with##2##2##(2008-8#1)(2009-11#1)
8%##316##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#4)(1991-5#3)(1991-6#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-8#2)(1995-10#1)(1995-8#1)(1996-11#2)(1996-12#4)(1996-3#2)(1997-4#2)(1997-8#1)(2008-1#2)(2008-10#144)(2008-11#8)(2008-12#7)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#5)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#13)(2012-3#7)(2013-1#8)(2013-8#11)
8%) and##8##2##(1992-9#1)(1996-12#1)(2008-10#2)(2010-1#1)(2012-2#2)(2013-8#1)
8%) for##2##2##(2009-11#1)(2012-2#1)
8%) had##4##2##(2008-7#1)(2013-1#2)(2013-8#1)
8%) of##2##2##(2008-1#1)(2008-12#1)
8%) patients##3##2##(1997-8#1)(2008-11#1)(2013-1#1)
8%) was##2##2##(2011-2#1)(2012-5#1)
8%) were obtained##2##3##(2008-10#2)
8%) were##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)
8%) with##3##2##(1991-6#1)(2008-5#1)(2009-10#1)
8%)##71##1##(1990-8#1)(1991-3#1)(1991-6#1)(1992-9#2)(1994-12#1)(1995-12#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2010-1#1)(2011-2#5)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#7)(2013-8#3)
8&quot##3##1##(2008-8#1)(2013-1#2)
8) and##4##2##(1996-3#1)(1997-3#1)(2008-10#1)(2012-2#1)
8) as##2##2##(2008-10#2)
8) or##2##2##(1993-6#1)(2008-10#1)
8) were##2##2##(2008-10#2)
8)##63##1##(1990-11#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-3#1)(1993-2#2)(1993-6#3)(1994-5#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#30)(2008-11#2)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
8)Fe(0##2##1##(2012-2#2)
8+/-0##11##1##(2008-10#10)(2008-2#1)
8+/-2##2##1##(2008-10#1)(2008-7#1)
8+/-8##2##1##(2008-10#1)(2008-7#1)
8- and##3##2##(1990-10#1)(1992-4#1)(2013-1#1)
8-##6##1##(1990-10#1)(1992-4#1)(1996-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
8-1##2##1##(2008-10#2)
8-10 years##2##2##(1995-1#1)(2011-1#1)
8-10##7##1##(1994-5#1)(1995-1#1)(2008-10#3)(2008-7#1)(2011-1#1)
8-11 years##2##2##(1991-6#2)
8-11##4##1##(1991-6#2)(1996-5#1)(2009-4#1)
8-12##8##1##(1990-12#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-2#2)
8-125##2##1##(2008-10#2)
8-14##4##1##(1991-11#1)(1991-9#2)(2008-9#1)
8-2##6##1##(1993-12#1)(1997-1#1)(2008-10#3)(2008-8#1)
8-3##3##1##(2008-10#3)
8-4##2##1##(2008-10#2)
8-5##8##1##(1993-3#1)(2008-10#5)(2008-11#1)(2012-2#1)
8-6##3##1##(1990-5#1)(2008-10#1)(2008-7#1)
8-7##3##1##(1993-8#1)(2008-10#2)
8-87##2##1##(1995-3#1)(2008-10#1)
8-9##9##1##(1994-12#1)(2008-10#5)(2008-11#1)(2010-5#1)(2011-2#1)
8-Hydroxyquinoline##2##1##(2008-10#2)
8-OH-DPAT##7##1##(1993-3#3)(1994-2#4)
8-TCDD##3##1##(2008-10#3)
8-aminoquinoline and##3##2##(2008-10#3)
8-benzoflavone##6##1##(1994-5#6)
8-bp sequence##5##2##(1995-6#4)(1996-2#1)
8-bromo-cAMP##2##1##(1994-11#1)(1995-6#1)
8-cell stage##2##2##(2008-9#1)(2012-3#1)
8-diaminonaphthalen##2##1##(2008-10#2)
8-diene##2##1##(2008-10#2)
8-difluorobenzo[c]cinnoline##3##1##(2008-10#3)
8-dihydro-2'-deoxyguanosine##2##1##(2008-10#2)
8-dihydrodiol##2##1##(2011-1#2)
8-dihydroguanine##2##1##(2008-10#2)
8-dihydroxy-1##2##1##(2008-10#2)
8-dihydroxy-3##2##1##(2008-10#2)
8-dihydroxy-9##2##1##(2008-10#2)
8-fold increase in##2##3##(1994-11#1)(2008-11#1)
8-fold##8##1##(1994-11#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-11#4)
8-h##5##1##(2008-10#2)(2008-7#1)(2010-10#1)(2013-1#1)
8-hydroxy##3##1##(2008-10#2)(2009-3#1)
8-hydroxy-2'-deoxyguanosine##2##1##(2008-10#2)
8-hydroxydeoxyguanosine##2##1##(1995-6#1)(2012-5#1)
8-hydroxyquinoline immobilized##4##2##(2008-10#4)
8-hydroxyquinoline##14##1##(1990-2#1)(2008-10#13)
8-hydroxyquinoline-5-sulphonic acid cellulose##2##3##(2008-10#2)
8-iso-PGF2α##2##1##(2012-5#2)
8-kDa##2##1##(2008-10#2)
8-kb RNA was##2##3##(2008-10#2)
8-kb RNA were##2##3##(2008-10#2)
8-kb RNA##6##2##(2008-10#6)
8-kb dsRNA##2##2##(2008-10#2)
8-kb##17##1##(1993-2#1)(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#12)(2008-11#1)
8-mm##2##1##(2008-10#1)(2010-5#1)
8-nm Nd##2##2##(2008-3#2)
8-oxo-7##4##1##(2008-10#4)
8-oxoGua and 8-oxodGuo##3##3##(2008-10#3)
8-oxoGua##4##1##(2008-10#4)
8-sulfonamidoquinoline##2##1##(2008-10#2)
8-tetrachlorodibenzo-p-dioxin (TCDD)##4##2##(1992-12#1)(1994-5#1)(1995-11#1)(2008-10#1)
8-tetrachlorodibenzo-p-dioxin##9##1##(1992-12#2)(1993-6#1)(1994-5#2)(1995-11#1)(2008-10#3)
8-tetracyanoquinodimethane (TCNQ)##2##2##(2008-10#2)
8-tetracyanoquinodimethane##3##1##(2008-10#3)
8-week clinical##2##2##(2011-2#2)
8-week treatment period##2##3##(1994-12#2)
8-week treatment##4##2##(1994-12#2)(2008-11#1)(2012-3#1)
8-week##12##1##(1994-12#3)(2008-11#1)(2010-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
8-year##7##1##(1990-9#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
80 % of##2##3##(1997-8#1)(2011-2#1)
80 %##3##2##(1997-8#1)(2011-2#1)(2012-12#1)
80 Ncm)##2##2##(2013-1#2)
80 V##2##2##(2008-10#2)
80 and 0##4##3##(2008-10#3)(2008-9#1)
80 and 85 years##2##4##(2008-7#2)
80 and##22##2##(1991-6#1)(1992-11#1)(1996-12#1)(2008-10#14)(2008-12#2)(2008-7#2)(2008-9#1)
80 degrees C for##4##4##(2008-10#4)
80 degrees C##17##3##(1991-5#1)(2007-12#1)(2008-10#14)(2008-7#1)
80 degrees##18##2##(1991-5#1)(2007-12#1)(2008-10#15)(2008-7#1)
80 for##2##2##(2008-10#2)
80 generations##2##2##(2008-10#1)(2008-7#1)
80 in##2##2##(1992-2#1)(2008-10#1)
80 isolates##2##2##(2008-10#2)
80 kDa form##3##3##(1992-6#3)
80 kDa protein##2##3##(1995-8#2)
80 kDa##8##2##(1992-6#3)(1995-8#2)(1996-2#1)(2008-11#1)(2011-2#1)
80 min##4##2##(1997-1#1)(2008-11#1)(2012-12#1)(2013-8#1)
80 mol/l##2##2##(2008-10#2)
80 mug##3##2##(2008-10#2)(2008-11#1)
80 nmol)##2##2##(1997-4#2)
80 patients with##2##3##(1992-3#1)(2010-3#1)
80 patients##4##2##(1992-3#1)(2008-11#1)(2008-3#1)(2010-3#1)
80 per cent of the##2##5##(1995-9#1)(1996-3#1)
80 per cent of##3##4##(1992-9#1)(1995-9#1)(1996-3#1)
80 per cent##4##3##(1992-9#1)(1995-12#1)(1995-9#1)(1996-3#1)
80 percent of the##2##4##(1992-12#2)
80 percent of##4##3##(1992-12#2)(1994-2#1)(2009-9#1)
80 samples per hour##4##4##(2008-10#4)
80 to 86%##2##3##(2008-10#2)
80 to##16##2##(1991-11#1)(1997-8#1)(2008-10#13)(2008-7#1)
80 years old##2##3##(1992-6#1)(2008-9#1)
80 years##9##2##(1991-1#1)(1992-6#1)(2008-7#1)(2008-9#1)(2012-12#2)(2012-2#1)(2013-1#2)
80##260##1##(1990-10#6)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-4#2)(1997-6#2)(1997-8#3)(2007-12#2)(2008-10#117)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#14)(2008-8#3)(2008-9#10)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#10)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#9)(2013-8#4)
80% and##4##2##(1990-12#1)(1995-2#1)(1995-3#1)(1995-8#1)
80% by##4##2##(1990-5#1)(1995-5#2)(1997-3#1)
80% for##3##2##(2008-10#2)(2012-12#1)
80% in##4##2##(1994-9#2)(1997-3#1)(2012-12#1)
80% methanol##2##2##(2008-5#2)
80% of patients##4##3##(2007-8#1)(2008-11#1)(2010-4#1)(2011-2#1)
80% of the total##2##4##(2008-10#1)(2008-12#1)
80% of the variation##2##4##(2008-10#2)
80% of the##22##3##(1990-2#1)(1991-2#2)(1991-9#1)(1993-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#2)
80% of##48##2##(1990-2#1)(1990-5#2)(1991-2#2)(1991-6#1)(1991-9#1)(1992-6#1)(1993-6#1)(1995-6#1)(1997-8#1)(1997-9#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#5)
80% to##2##2##(1990-9#1)(2011-2#1)
80%##124##1##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#3)(1990-9#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-12#1)(1994-3#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-8#1)(1997-9#1)(2007-8#1)(2008-10#37)(2008-11#4)(2008-12#4)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-3#4)(2013-1#5)(2013-8#1)
80%) and##2##2##(2008-10#1)(2013-8#1)
80%) in##2##2##(1995-11#1)(2008-11#1)
80%) of##2##2##(2008-10#2)
80%)##12##1##(1995-11#1)(2008-10#7)(2008-11#1)(2009-10#1)(2010-8#1)(2013-8#1)
80)##6##1##(1993-11#1)(2008-10#3)(2008-12#1)(2013-1#1)
80+/-0##3##1##(2008-10#3)
80-##2##1##(1992-11#1)(2008-10#1)
80-100##2##1##(1993-8#2)
80-90% of##2##2##(2008-1#1)(2008-6#1)
80-90%##5##1##(1992-6#2)(2008-1#1)(2008-11#1)(2008-6#1)
80-cm(3)##2##1##(2008-10#2)
80-fold##4##1##(1994-8#1)(1995-2#1)(2008-10#2)
80-year-old##3##1##(2008-12#1)(2008-7#1)(2009-1#1)
800 and##3##2##(2008-10#2)(2010-4#1)
800 degrees C for##2##4##(2008-10#2)
800 degrees C##3##3##(2008-10#3)
800 fg##2##2##(2008-10#2)
800 mg/L females at##3##4##(2008-9#3)
800 mg/L females in both studies##2##6##(2008-9#2)
800 mg/L females##7##3##(2008-9#7)
800 mg/L males and females at 43 weeks##2##8##(2008-9#2)
800 mg/L males and females at##3##6##(2008-9#3)
800 mg/L males and females##5##5##(2008-9#5)
800 mg/L males at##4##4##(2008-9#4)
800 mg/L males##9##3##(2008-9#9)
800 mg/L##21##2##(2008-9#21)
800 nm##4##2##(2008-10#3)(2010-1#1)
800 to##3##2##(2008-10#2)(2011-7#1)
800##77##1##(1990-12#1)(1990-3#2)(1990-8#1)(1992-12#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#25)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#2)(2011-7#1)(2012-2#1)
800%##2##1##(2008-10#1)(2008-8#1)
8000##6##1##(1990-2#1)(1991-8#1)(2008-10#2)(2011-2#2)
800T)##2##1##(2008-10#2)
800nm##2##1##(2007-11#1)(2008-10#1)
802##2##1##(1995-3#1)(2008-10#1)
803##4##1##(1990-11#1)(1993-3#1)(2008-10#1)(2011-2#1)
8036E27##4##1##(2008-10#4)
804##4##1##(2008-10#2)(2010-5#1)(2011-2#1)
805##4##1##(1990-5#1)(1997-8#1)(2008-10#1)(2008-11#1)
806##4##1##(2008-10#2)(2008-12#1)(2008-6#1)
807##2##1##(1991-12#1)(2013-8#1)
808##2##1##(2008-10#1)(2008-11#1)
809##7##1##(2008-10#3)(2008-5#1)(2008-8#1)(2013-1#2)
80h(-1)##2##1##(2008-10#2)
80mugml(-1)##2##1##(2008-10#2)
80nM##2##1##(2008-10#2)
80s##2##1##(2008-10#2)
80 kg##3##1##(2013-1#3)
81 +/-##2##2##(1991-12#1)(1992-11#1)
81 amino##2##2##(1993-3#1)(1993-8#1)
81 and##2##2##(2008-10#2)
81 cases##2##2##(2008-7#2)
81 isolates of##2##3##(2008-10#2)
81 to##5##2##(1993-6#1)(2008-10#3)(2012-3#1)
81##76##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1996-12#2)(1996-6#1)(1997-4#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#32)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
81% amino acid##2##3##(1994-5#1)(2008-8#1)
81% for##2##2##(2008-10#2)
81% of the##2##3##(2008-8#1)(2010-6#1)
81% of##5##2##(1990-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)
81%##20##1##(1990-12#1)(1994-5#1)(2008-10#7)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
81)##7##1##(1993-12#1)(1994-12#1)(2008-10#1)(2010-12#1)(2011-2#2)(2013-8#1)
810##4##1##(2008-10#3)(2008-3#1)
812##6##1##(1990-6#2)(1992-12#1)(2008-10#2)(2010-11#1)
813##3##1##(1996-12#1)(2008-10#1)(2011-2#1)
814##3##1##(1990-5#1)(2008-10#2)
816##2##1##(2008-10#1)(2012-12#1)
818##2##1##(1995-12#1)(1995-8#1)
819##3##1##(1991-3#1)(2008-10#1)(2011-3#1)
82 +/-##2##2##(2008-10#2)
82 and##7##2##(1995-11#1)(2008-10#4)(2008-2#1)(2008-9#1)
82 patients who underwent##2##4##(2013-1#2)
82 patients##3##2##(1997-8#1)(2013-1#2)
82 to 0##2##3##(2008-10#1)(2010-6#1)
82 to##5##2##(2008-10#4)(2010-6#1)
82 x##3##2##(2008-10#3)
82##78##1##(1990-6#2)(1991-6#1)(1992-7#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-12#3)(1996-2#1)(1997-8#3)(2008-10#31)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
82% and##2##2##(1991-8#1)(2008-10#1)
82% of the##3##3##(1990-9#1)(1993-2#1)(2008-10#1)
82% of##8##2##(1990-2#1)(1990-9#1)(1993-2#1)(2008-10#2)(2008-11#2)(2012-2#1)
82%##21##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-8#1)(1993-2#1)(1995-2#1)(1996-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
82%)##5##1##(2008-10#3)(2011-2#1)(2012-3#1)
82)##2##1##(2010-12#2)
820##2##1##(2008-10#1)(2012-12#1)
821##6##1##(2008-10#5)(2011-2#1)
822##3##1##(2011-2#2)(2013-1#1)
823##2##1##(2013-1#2)
824##2##1##(2008-10#1)(2008-12#1)
826##5##1##(1995-12#1)(1997-6#2)(2008-10#1)(2010-6#1)
828##2##1##(1997-7#1)(2011-2#1)
83 +/-##3##2##(1991-12#1)(1994-2#1)(1994-8#1)
83 3##2##2##(2008-10#2)
83 and##3##2##(2008-12#1)(2008-8#1)(2010-11#1)
83 for##2##2##(2008-10#2)
83 to##3##2##(1992-12#1)(1997-2#1)(2008-10#1)
83##70##1##(1990-12#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-9#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
83% and##2##2##(1995-2#1)(2009-6#1)
83% in##2##2##(1996-9#1)(2008-10#1)
83% of the##3##3##(1990-2#1)(1992-6#1)(2008-10#1)
83% of##7##2##(1990-2#1)(1992-6#1)(2008-10#3)(2008-9#2)
83%##23##1##(1990-2#1)(1991-8#1)(1992-6#2)(1995-2#1)(1996-12#1)(1996-9#1)(2008-10#11)(2008-9#2)(2009-6#1)(2011-2#1)(2012-3#1)
83%)##4##1##(1991-8#1)(2008-12#1)(2009-4#1)(2013-8#1)
83)##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
83+/-0##5##1##(2008-10#5)
83-year-old##2##1##(2012-2#1)(2013-1#1)
830##2##1##(2008-5#1)(2011-3#1)
831##2##1##(1996-12#1)(2010-12#1)
833##4##1##(1993-8#3)(2008-10#1)
835##2##1##(2008-10#1)(2008-12#1)
837##2##1##(2010-7#1)(2013-1#1)
84 and 0##3##3##(2008-10#3)
84 and##8##2##(1995-11#1)(2008-10#6)(2009-12#1)
84 days##3##2##(1996-12#2)(2008-10#1)
84 h##2##2##(2008-10#1)(2010-8#1)
84 hemorrhages##3##2##(2012-3#3)
84 kDa##2##2##(1992-10#1)(2008-10#1)
84 patients##3##2##(1994-3#1)(2008-3#1)(2012-3#1)
84 vs##2##2##(2008-10#1)(2011-1#1)
84 years##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
84##94##1##(1990-10#1)(1990-11#2)(1990-6#1)(1992-10#1)(1993-8#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#2)(2007-8#1)(2008-1#2)(2008-10#32)(2008-11#1)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#11)(2013-1#3)(2013-8#1)
84% and##4##2##(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
84% identity to##2##3##(1993-2#1)(1996-12#1)
84% identity with##2##3##(1993-3#1)(2008-10#1)
84% identity##4##2##(1993-2#1)(1993-3#1)(1996-12#1)(2008-10#1)
84% of cases##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
84% of the##4##3##(1997-8#1)(2008-10#3)
84% of##13##2##(1991-5#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)
84%##33##1##(1990-2#2)(1990-8#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-8#1)
84%)##3##1##(2008-10#1)(2008-7#1)(2012-3#1)
84)##4##1##(2008-10#3)(2013-8#1)
84-A resolution##2##2##(1992-4#2)
84-year-old##2##1##(2008-7#1)(2010-6#1)
840##7##1##(1990-12#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-3#1)
842##3##1##(1993-1#1)(1995-12#1)(2011-2#1)
843 nm##2##2##(2008-10#1)(2008-3#1)
844 and##2##2##(2008-10#1)(2008-12#1)
844##4##1##(1992-9#1)(2008-10#2)(2008-12#1)
845##4##1##(1993-8#2)(2008-7#1)(2012-12#1)
849##2##1##(2010-11#2)
85 +/-##2##2##(2008-10#1)(2008-3#1)
85 and 1##2##3##(2008-10#2)
85 and##6##2##(2008-10#6)
85 dB (A)##2##3##(2011-2#2)
85 degrees C##5##3##(2008-10#2)(2008-2#2)(2008-7#1)
85 degrees##6##2##(2008-10#3)(2008-2#2)(2008-7#1)
85 mm##2##2##(1994-6#1)(2013-8#1)
85 mug##2##2##(2008-10#2)
85 mum PA##2##3##(2008-10#2)
85 mum##3##2##(2008-10#3)
85 patients##2##2##(2008-8#1)(2009-8#1)
85 to 95%##2##3##(2008-10#2)
85 to##8##2##(1995-12#1)(1996-12#1)(2008-10#6)
85 vs##3##2##(2012-3#3)
85 years old##2##3##(2008-7#1)(2009-8#1)
85 years##8##2##(2008-7#4)(2009-8#2)(2012-12#1)(2013-1#1)
85##109##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#2)(2007-12#1)(2008-1#1)(2008-10#43)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-7#6)(2008-8#2)(2009-5#1)(2009-8#3)(2010-1#1)(2010-12#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#4)
85% and##3##2##(2008-10#1)(2008-8#2)
85% answered##2##2##(1990-6#1)(1996-6#1)
85% at##3##2##(1996-11#1)(2008-10#1)(2008-5#1)
85% for##3##2##(1995-3#1)(2008-10#2)
85% in##3##2##(1994-9#1)(2009-8#1)(2010-5#1)
85% of the##8##3##(1996-2#1)(1997-3#1)(2008-10#5)(2008-12#1)
85% of##15##2##(1990-8#1)(1991-1#1)(1996-2#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)
85%##61##1##(1990-6#1)(1990-8#1)(1991-1#1)(1991-8#2)(1993-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2008-10#28)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-8#2)(2009-3#1)(2009-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
85%)##7##1##(1992-12#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
85) and##2##2##(1993-2#1)(2013-1#1)
85)##4##1##(1993-2#1)(2008-10#2)(2013-1#1)
85-90%##2##1##(1996-5#1)(2008-11#1)
85-95%##2##1##(2008-10#2)
850 and##2##2##(1990-12#1)(2008-2#1)
850 kb##2##2##(1995-6#1)(1996-6#1)
850##18##1##(1990-12#4)(1995-6#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2010-8#1)(2011-2#1)(2013-8#2)
851##4##1##(1990-12#2)(2008-10#1)(2008-8#1)
852##3##1##(1990-12#2)(2008-3#1)
854##4##1##(1990-12#1)(1994-2#1)(1994-6#1)(2010-7#1)
856 nm##2##2##(2008-10#2)
856##4##1##(1991-5#1)(2008-10#3)
858##4##1##(2007-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
859##2##1##(2008-10#1)(2008-7#1)
86 and##7##2##(2008-10#2)(2008-12#1)(2008-9#1)(2010-4#1)(2011-2#2)
86 of the##2##3##(2008-10#1)(2008-12#1)
86 to 100%##2##3##(1990-11#1)(2008-10#1)
86 to##6##2##(1990-11#1)(2008-10#5)
86 x##6##2##(2008-10#5)(2008-11#1)
86##74##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#35)(2008-11#5)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
86% for##2##2##(1990-12#1)(2008-11#1)
86% of##4##2##(1992-6#1)(1995-8#1)(1996-11#1)(2008-3#1)
86%##19##1##(1990-12#1)(1992-6#1)(1995-8#2)(1996-11#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-9#1)(2013-8#1)
86%)##2##1##(2013-1#1)(2013-8#1)
86) and##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
86)##9##1##(1993-2#1)(1997-8#2)(2008-10#3)(2008-8#1)(2013-1#2)
86+/-0##2##1##(2008-10#2)
860##3##1##(2008-10#1)(2009-7#1)(2011-7#1)
862##2##1##(1990-5#1)(2008-10#1)
863##2##1##(1997-2#1)(2012-12#1)
864##4##1##(2008-10#4)
865 nm##4##2##(2008-2#3)(2008-3#1)
865##5##1##(1991-9#1)(2008-2#3)(2008-3#1)
866 isolates##3##2##(2008-10#3)
866##4##1##(2008-10#3)(2011-2#1)
86Rb efflux##2##2##(1994-3#2)
86Rb##3##1##(1994-3#3)
87 +/- 0##2##3##(2008-5#1)(2010-4#1)
87 +/-##5##2##(1990-3#1)(2008-1#1)(2008-5#1)(2010-4#1)(2012-3#1)
87 and##4##2##(2007-8#1)(2008-10#3)
87##65##1##(1990-12#1)(1990-3#1)(1990-4#1)(1991-6#2)(1993-1#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-1#4)(2008-10#22)(2008-11#2)(2008-5#3)(2008-8#1)(2009-11#1)(2010-10#2)(2010-4#1)(2011-2#5)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#1)
87% of the##4##3##(1995-9#1)(1996-6#1)(2008-11#1)(2008-7#1)
87% of##6##2##(1994-2#1)(1995-9#1)(1996-6#1)(1997-3#1)(2008-11#1)(2008-7#1)
87%##24##1##(1991-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-3#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#3)(2013-8#1)
87%)##4##1##(2008-10#2)(2009-6#1)(2013-8#1)
87)##6##1##(2008-10#3)(2008-12#1)(2008-5#1)(2013-1#1)
870##7##1##(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#1)
872##5##1##(1995-11#3)(2011-2#2)
874##4##1##(2008-10#3)(2008-11#1)
875##2##1##(2008-11#1)(2011-2#1)
877##3##1##(2008-11#1)(2008-8#2)
878##4##1##(1994-5#1)(2008-10#2)(2008-12#1)
88 and##2##2##(2008-10#1)(2008-12#1)
88 to 0##3##3##(2008-10#1)(2013-1#2)
88 to##9##2##(2008-10#6)(2008-8#1)(2013-1#2)
88##67##1##(1990-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#3)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#3)(2013-8#1)
88% and##4##2##(1990-12#1)(1992-3#1)(1993-2#1)(2008-10#1)
88% in##3##2##(1994-8#1)(2010-12#1)(2010-4#1)
88% of the##3##3##(1992-3#1)(2008-10#2)
88% of##11##2##(1990-11#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1997-3#1)(2008-10#2)(2008-12#1)(2010-7#1)
88%##40##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
88%)##2##1##(1990-6#1)(2008-10#1)
88)##4##1##(1991-5#1)(2008-10#1)(2013-1#2)
88+/-0##2##1##(2008-10#2)
880 and 945 nm)##2##4##(2008-11#2)
880 and 945##3##3##(2008-11#3)
880##8##1##(2008-10#1)(2008-11#4)(2010-1#1)(2011-2#2)
881##2##1##(2008-10#1)(2008-11#1)
887##2##1##(2008-10#1)(2008-12#1)
889##4##1##(1991-12#1)(2012-3#3)
89 +/-##2##2##(1994-11#1)(2008-11#1)
89 and 0##3##3##(2008-10#3)
89 and##6##2##(2008-10#5)(2008-11#1)
89 patients##3##2##(1990-2#1)(1992-9#1)(2009-11#1)
89 per##2##2##(1991-11#1)(1995-12#1)
89##50##1##(1990-2#1)(1990-8#1)(1991-11#1)(1992-10#1)(1992-9#1)(1994-11#1)(1995-12#1)(1996-12#1)(2008-10#24)(2008-11#5)(2008-12#2)(2008-5#1)(2009-11#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
89% for##2##2##(2008-10#2)
89% of the##3##3##(1995-2#1)(2008-10#2)
89% of##4##2##(1995-2#1)(2008-10#3)
89%##25##1##(1991-2#1)(1993-6#2)(1995-12#1)(1995-2#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
89%)##3##1##(2008-10#1)(2011-2#1)(2013-8#1)
89)##4##1##(1996-8#1)(2008-10#1)(2008-12#1)(2012-12#1)
890##4##1##(1996-2#1)(1997-8#1)(2008-8#2)
891##4##1##(1994-2#1)(1996-1#1)(2008-10#1)(2012-3#1)
893##12##1##(2008-10#10)(2009-4#1)(2011-2#1)
896##3##1##(2008-10#1)(2008-2#1)(2011-2#1)
89B61##3##1##(2008-10#3)
8CH exchange##2##2##(1992-4#2)
8CH##5##1##(1992-4#5)
8Gy##5##1##(2008-10#5)
8M##3##1##(2008-10#3)
8Neu5Gc##4##1##(1994-11#4)
8S gene##2##2##(2008-10#2)
8S rDNA##3##2##(2008-10#2)(2012-2#1)
8S rRNA##2##2##(2008-10#2)
8S regions##2##2##(2008-10#1)(2008-9#1)
8S ribosomal DNA##3##3##(2008-10#3)
8S ribosomal##4##2##(2008-10#4)
8S##22##1##(1997-7#1)(2008-10#16)(2008-12#2)(2008-8#1)(2008-9#1)(2012-2#1)
8S-ITS 2)##2##2##(2008-10#2)
8S-ITS2 sequences##2##2##(2008-10#2)
8S-ITS2##3##1##(2008-10#3)
8U of##2##2##(2008-10#2)
8a##3##1##(1996-5#3)
8cm)##2##1##(2009-1#1)(2009-10#1)
8mM##3##1##(2008-10#3)
8mV/decade##2##1##(2008-10#2)
8min##3##1##(2008-10#3)
8ml##2##1##(2008-10#2)
8muM##2##1##(2008-10#2)
8mugl(-1)##2##1##(2008-10#2)
8mugml(-1)##5##1##(2008-10#5)
8ngml(-1)##3##1##(2008-10#3)
8s##3##1##(2008-10#3)
8th and##2##2##(1991-3#1)(2012-3#1)
8th##11##1##(1991-3#1)(1992-3#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-2#1)(2011-4#1)(2012-2#1)(2012-3#2)
8x10(-10) and##2##2##(2008-10#2)
8x10(-10)##3##1##(2008-10#3)
8x10(-3) mol l(-1)##2##3##(2008-10#2)
8x10(-3) mol##3##2##(2008-10#3)
8x10(-3)##4##1##(2008-10#4)
8x10(-4)##2##1##(2008-10#2)
8x10(-5) M##4##2##(2008-10#3)(2008-11#1)
8x10(-5)##5##1##(2008-10#4)(2008-11#1)
8x10(-6)##2##1##(2008-10#2)
8x10(-6)M and##2##2##(2008-10#2)
8x10(-6)M##5##1##(2008-10#5)
8x10(-7)##3##1##(2008-10#3)
8x10(-8)##2##1##(2008-10#2)
8x10(-9) to##3##2##(2008-10#3)
8x10(-9)##4##1##(2008-10#4)
8x10(4)##3##1##(2008-10#3)
9 % of the##2##4##(2011-1#1)(2012-12#1)
9 %##4##2##(2011-1#1)(2011-2#1)(2012-12#2)
9 %)##6##2##(2011-2#1)(2012-12#5)
9 (1##3##2##(1990-8#2)(2011-2#1)
9 (75%)##2##2##(1991-12#1)(1992-12#1)
9 (95% C##3##3##(1994-12#3)
9 (±1##2##2##(2010-10#2)
9 + 2##2##3##(2008-7#2)
9 +##3##2##(2008-7#3)
9 +/- 0##4##3##(1991-5#1)(2008-10#2)(2008-12#1)
9 +/- 1##2##3##(1991-11#1)(1993-8#1)
9 +/- 2##3##3##(1994-2#1)(1995-11#1)(2013-1#1)
9 +/- 5##2##3##(1992-11#1)(1996-3#1)
9 +/- 6##2##3##(1994-2#1)(2008-11#1)
9 +/-##21##2##(1991-11#1)(1991-5#1)(1992-11#1)(1993-8#2)(1994-2#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
9 A##2##2##(1992-9#1)(2008-8#1)
9 U/ml##2##2##(1993-1#2)
9 W##2##2##(2007-12#1)(2008-2#1)
9 am##2##2##(1990-3#1)(2008-5#1)
9 and 1##4##3##(1995-6#1)(2008-10#3)
9 and 10##3##3##(1996-5#1)(2008-10#2)
9 and 11 of Actinobacillus pleuropneumoniae##2##6##(1996-12#2)
9 and 11##6##3##(1996-12#4)(2008-3#1)(2008-9#1)
9 and 12 months##2##4##(2013-1#2)
9 and 3##4##3##(2008-10#3)(2008-11#1)
9 and 4##6##3##(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)
9 and##55##2##(1990-8#1)(1991-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#30)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
9 billion##2##2##(1992-3#1)(1994-1#1)
9 by##3##2##(1997-7#1)(1997-8#1)(2008-10#1)
9 cm in##2##3##(2008-10#1)(2009-3#1)
9 cm##4##2##(2008-10#3)(2009-3#1)
9 dB##3##2##(2008-3#2)(2008-7#1)
9 days after##2##3##(1995-12#1)(2008-10#1)
9 days##13##2##(1990-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-3#2)
9 degrees C##3##3##(1993-8#1)(2007-12#1)(2008-10#1)
9 degrees##5##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-3#2)
9 for##3##2##(1994-6#1)(2008-10#1)(2008-7#1)
9 h after inoculation##3##4##(2008-10#1)(2008-5#2)
9 h##5##2##(1994-2#1)(2008-10#2)(2008-5#2)
9 hours##2##2##(2008-3#1)(2008-7#1)
9 in##6##2##(1991-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
9 kDa##2##2##(1993-8#1)(2008-10#1)
9 kb in##2##3##(2008-10#1)(2008-8#1)
9 kb of##2##3##(1996-12#1)(2008-10#1)
9 kb on the 5' side and by 1##2##9##(1993-12#1)(1993-6#1)
9 kb##8##2##(1993-12#1)(1993-6#1)(1996-12#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
9 mg##7##2##(2008-10#5)(2008-11#1)(2010-12#1)
9 mg/kg##2##2##(1993-12#1)(2011-2#1)
9 microM##4##2##(1992-3#1)(2008-12#2)(2008-8#1)
9 microg##2##2##(2008-10#2)
9 microm##2##2##(2007-12#1)(2008-3#1)
9 million in##2##3##(1992-6#1)(1997-3#1)
9 million years##2##3##(1994-3#1)(2008-10#1)
9 million##6##2##(1991-3#1)(1992-12#1)(1992-6#1)(1994-3#1)(1997-3#1)(2008-10#1)
9 minutes##2##2##(2008-6#1)(2013-1#1)
9 ml min(-1))##2##3##(2008-10#2)
9 ml##4##2##(2008-10#4)
9 mm and##2##3##(2013-1#2)
9 mm##7##2##(2008-10#1)(2008-2#1)(2009-11#1)(2009-2#1)(2013-1#3)
9 mmHg##2##2##(1991-6#1)(2009-8#1)
9 mmol##2##2##(2008-10#2)
9 mmol/l##3##2##(1994-12#2)(1994-3#1)
9 months (range##2##3##(1990-12#1)(2011-2#1)
9 months after the##2##4##(1991-12#1)(1997-8#1)
9 months after##4##3##(1991-12#1)(1995-2#1)(1996-5#1)(1997-8#1)
9 months following##2##3##(2011-2#1)(2013-1#1)
9 months of##2##3##(2008-10#1)(2012-3#1)
9 months##20##2##(1990-12#1)(1991-12#1)(1992-9#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
9 ms##2##2##(2008-10#1)(2011-2#1)
9 mug ml(-1)##2##3##(2008-10#1)(2008-11#1)
9 mug##6##2##(2008-10#4)(2008-11#1)(2008-5#1)
9 mum##2##2##(1993-2#1)(2008-7#1)
9 mumol##2##2##(2008-10#2)
9 nM##3##2##(1991-5#1)(1994-8#1)(2008-10#1)
9 ng g(-1)##2##3##(2008-10#1)(2010-5#1)
9 ng ml(-1)##2##3##(2008-10#2)
9 ng##8##2##(2008-10#7)(2010-5#1)
9 ng/ml of##2##3##(2008-10#2)
9 of the##4##3##(1996-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
9 of##13##2##(1996-11#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
9 or less is associated with increased risk for both coronary heart disease and total cardiovascular disease morbidity and mortality##2##20##(1993-12#2)
9 or##3##2##(1993-12#2)(2008-10#1)
9 out of##5##3##(1990-12#2)(2008-12#2)(2013-1#1)
9 patients who##2##3##(2008-3#1)(2008-7#1)
9 patients##11##2##(1992-12#1)(1995-12#1)(2008-3#1)(2008-7#3)(2010-3#1)(2011-2#4)
9 per cent)##3##3##(1996-8#3)
9 percent##4##2##(1993-1#1)(1994-1#1)(1996-2#1)(2008-8#1)
9 pg##2##2##(2008-10#2)
9 pmol##3##2##(2008-10#2)(2008-7#1)
9 pmol/mg (n =##2##4##(2008-8#2)
9 s-1##2##2##(1995-8#2)
9 samples##2##2##(1990-2#1)(2008-9#1)
9 showed##2##2##(2008-10#1)(2013-1#1)
9 times higher##2##3##(2008-10#1)(2011-3#1)
9 times##3##2##(2008-10#1)(2011-3#1)(2013-1#1)
9 to 10##2##3##(1992-3#1)(2008-10#1)
9 to 104##2##3##(2008-10#2)
9 to 11##2##3##(2008-10#2)
9 to 12##2##3##(1991-12#1)(2008-10#1)
9 to 18##2##3##(2008-10#1)(2012-2#1)
9 to 93##2##3##(2008-12#1)(2010-11#1)
9 to##37##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-3#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-11#1)(2012-2#1)
9 tumors##2##2##(1994-12#1)(1997-7#1)
9 vs##2##2##(1994-12#1)(2008-7#1)
9 was##3##2##(2008-10#3)
9 weeks##5##2##(1990-3#1)(1994-5#1)(2008-11#2)(2012-3#1)
9 were##2##2##(1996-12#1)(2008-10#1)
9 when##2##2##(1996-12#1)(2008-3#1)
9 with##4##2##(1991-7#1)(1996-12#1)(2008-10#1)(2008-7#1)
9 x 10(-5)##2##3##(2008-10#1)(2008-2#1)
9 x##16##2##(1995-11#2)(1996-3#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-8#1)(2010-6#1)
9 years old##2##3##(2008-12#1)(2008-8#1)
9 years##13##2##(1990-11#1)(1994-12#2)(1996-6#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-3#1)
9 years)##4##2##(2008-7#1)(2012-12#1)(2013-1#2)
9 ±##4##2##(2010-9#1)(2012-3#2)(2013-8#1)
9 µm##2##2##(2013-1#2)
9##912##1##(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#3)(1990-8#7)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#8)(1991-2#1)(1991-3#2)(1991-5#4)(1991-6#4)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#6)(1993-1#5)(1993-12#5)(1993-2#4)(1993-3#6)(1993-6#5)(1993-8#8)(1994-1#3)(1994-11#1)(1994-12#13)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#4)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#7)(1995-8#5)(1996-11#3)(1996-12#16)(1996-2#5)(1996-3#7)(1996-5#4)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#4)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#6)(1997-8#7)(1997-9#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-10#346)(2008-11#32)(2008-12#19)(2008-2#6)(2008-3#20)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#33)(2008-8#14)(2008-9#10)(2009-1#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#5)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#33)(2011-3#5)(2012-12#8)(2012-2#7)(2012-3#28)(2012-7#1)(2013-1#34)(2013-3#1)(2013-8#9)
9% NaCl##3##2##(1994-8#1)(2008-12#1)(2012-3#1)
9% NaCl)##2##2##(2008-5#1)(2012-3#1)
9% SI to S##2##4##(2008-10#2)
9% and##8##2##(1992-3#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
9% compared with##2##3##(2008-10#1)(2012-3#1)
9% for a##2##3##(2008-10#2)
9% for the##4##3##(1997-7#1)(2008-10#3)
9% for##19##2##(1997-7#1)(2008-10#15)(2008-11#1)(2008-5#1)(2013-1#1)
9% had a##2##3##(1994-12#1)(2008-7#1)
9% had##5##2##(1990-8#1)(1994-12#1)(1995-2#1)(2008-12#1)(2008-7#1)
9% in the##4##3##(1996-6#1)(2008-10#1)(2012-2#1)(2013-1#1)
9% in##9##2##(1992-9#1)(1996-6#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
9% isolates were resistant to##2##5##(2008-5#2)
9% of all##2##3##(1990-2#1)(1991-3#1)
9% of cases##2##3##(1995-12#1)(2010-6#1)
9% of the total##2##4##(2008-10#2)
9% of the##11##3##(1994-6#1)(1997-4#1)(2008-10#6)(2008-12#1)(2008-9#1)(2011-2#1)
9% of##27##2##(1990-2#1)(1991-3#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-4#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
9% saline##4##2##(1995-3#1)(2011-2#1)(2013-1#2)
9% to##3##2##(2013-1#3)
9% vs##3##2##(1994-3#1)(2012-12#1)(2012-3#1)
9% was##2##2##(1994-6#1)(2009-1#1)
9% were not formally validated##2##5##(2013-1#2)
9% were##6##2##(1994-8#1)(2008-10#1)(2008-12#1)(2010-1#1)(2013-1#2)
9% with##2##2##(2008-10#2)
9%##216##1##(1990-2#2)(1990-8#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#3)(1995-12#3)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#83)(2008-11#7)(2008-12#9)(2008-2#1)(2008-3#2)(2008-5#8)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-7#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#16)(2013-8#6)
9%) and##6##2##(1997-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-8#2)
9%) had a##2##3##(2012-2#1)(2013-8#1)
9%) of##2##2##(2008-10#1)(2013-1#1)
9%) than##2##2##(1995-8#1)(2012-3#1)
9%) were found##2##3##(2012-3#1)(2013-8#1)
9%) were##6##2##(1996-3#1)(1997-7#1)(2008-5#1)(2010-4#1)(2012-3#1)(2013-8#1)
9%) with##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
9%)##56##1##(1992-9#2)(1994-12#1)(1995-8#1)(1996-3#1)(1997-7#2)(1997-8#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#8)(2008-7#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#5)
9(11)-dehydro-17alpha-methyl-testosterone##2##1##(2008-11#2)
9) and##4##2##(1993-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
9) were##2##2##(2008-10#2)
9) μm based on##2##4##(2010-10#2)
9)##55##1##(1990-12#1)(1990-8#1)(1992-6#1)(1993-12#4)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-5#1)(1997-3#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-9#1)(2010-10#2)(2010-3#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
9+/-0##13##1##(2008-10#10)(2008-11#2)(2008-7#1)
9+/-1##4##1##(2008-10#3)(2008-7#1)
9+/-4##2##1##(2008-7#1)(2009-10#1)
9-##3##1##(1990-12#1)(2008-10#1)(2011-2#1)
9-1##3##1##(1993-2#1)(2008-10#2)
9-10##3##1##(1992-8#1)(2008-10#2)
9-100##2##1##(2008-10#2)
9-12##2##1##(1994-12#1)(1996-12#1)
9-14##2##1##(2008-10#1)(2008-8#1)
9-15##2##1##(2012-2#1)(2013-1#1)
9-16##2##1##(1990-5#2)
9-18##2##1##(2008-10#1)(2008-9#1)
9-3##3##1##(2008-10#1)(2008-5#1)(2012-3#1)
9-5##4##1##(2008-10#3)(2013-1#1)
9-[2-fluoro-4-hydroxy-3-hydroxymethyl-2-butenyl]adenine and its related compounds##2##5##(2008-11#2)
9-dimethyl-1##4##1##(2008-10#4)
9-fluorenylmethyl chloroformate (FMOC)##2##3##(2008-10#2)
9-fluorenylmethyl chloroformate##3##2##(2008-10#3)
9-fold##6##1##(1993-6#1)(1994-8#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
9-kb##4##1##(2008-10#3)(2008-11#1)
9-microm scintillometer##2##2##(2008-2#2)
9-month##3##1##(1993-12#1)(2008-10#1)(2010-6#1)
9-tetrahydrocannabinol##5##1##(1991-10#2)(1991-4#2)(1996-2#1)
90 +/-##2##2##(1995-12#1)(2011-2#1)
90 amino acids##2##3##(1995-6#1)(2008-10#1)
90 and 0##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
90 and##15##2##(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)
90 days after##3##3##(1995-11#1)(2008-10#1)(2011-2#1)
90 days##20##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-2#4)(2013-1#1)
90 degrees C for##2##4##(2008-10#2)
90 degrees C##5##3##(2008-10#4)(2008-12#1)
90 degrees to##2##3##(2008-3#1)(2009-3#1)
90 degrees##16##2##(1991-7#1)(1992-11#1)(1993-8#4)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2013-1#1)
90 determinations per##2##3##(2008-10#2)
90 h##3##2##(1994-12#1)(2008-10#1)(2008-5#1)
90 h(-1)##6##2##(2008-10#6)
90 injections##2##2##(2008-10#2)
90 kDa##4##2##(1997-4#1)(2008-7#3)
90 m##2##2##(2008-10#2)
90 microM##2##2##(1990-12#1)(2011-2#1)
90 min of##2##3##(1990-5#1)(1994-2#1)
90 min##11##2##(1990-5#1)(1992-6#1)(1994-2#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2013-1#1)
90 mm##2##2##(2008-7#1)(2011-2#1)
90 mmol##2##2##(2008-10#2)
90 ng##3##2##(2008-10#3)
90 patients##2##2##(2008-1#1)(2013-1#1)
90 s##6##2##(2008-10#6)
90 samples##2##2##(2008-10#2)
90 to 120##2##3##(2008-10#1)(2008-7#1)
90 to##14##2##(1990-2#1)(1996-12#1)(2008-10#11)(2008-7#1)
90 tubers##2##2##(2008-10#2)
90 years##2##2##(2008-5#1)(2012-2#1)
90##229##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#4)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#3)(1995-6#5)(1996-12#3)(1996-3#2)(1997-2#1)(1997-4#1)(1997-5#1)(2008-1#3)(2008-10#94)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#8)(2008-7#11)(2008-8#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-6#2)(2011-2#13)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#10)(2013-8#2)
90% and the##3##3##(2008-10#2)(2012-12#1)
90% and##6##2##(2008-10#4)(2011-2#1)(2012-12#1)
90% confidence##3##2##(2008-10#2)(2008-7#1)
90% for##3##2##(1997-3#1)(2008-10#2)
90% in##2##2##(1997-3#1)(2008-10#1)
90% leaf##2##2##(2008-10#2)
90% mastery##2##2##(2008-12#2)
90% of cases##3##3##(1990-6#1)(2007-8#1)(2010-12#1)
90% of patients##3##3##(1991-6#1)(2010-4#1)(2013-1#1)
90% of the patients##4##4##(1990-12#1)(1992-1#1)(1994-9#1)(2010-8#1)
90% of the time##2##4##(1997-6#1)(2008-9#1)
90% of the total variance##2##5##(2008-10#2)
90% of the total##3##4##(2008-10#3)
90% of the##30##3##(1990-12#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-6#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-11#3)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
90% of those##2##3##(2008-10#1)(2008-5#1)
90% of##60##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#17)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#3)
90% probability##2##2##(2008-10#1)(2010-5#1)
90% relative##2##2##(2008-10#2)
90% survival##2##2##(1996-11#1)(2008-8#1)
90% were##6##2##(1990-2#1)(1993-11#1)(2008-10#1)(2008-12#1)(2010-6#1)(2013-1#1)
90% when compared##2##3##(2008-10#1)(2008-7#1)
90% with##3##2##(1991-5#1)(1993-6#1)(2008-10#1)
90%##174##1##(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-8#1)(2007-8#1)(2008-10#72)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)
90%) were##2##2##(2008-10#2)
90%)##6##1##(1993-1#1)(2008-10#5)
90) with##2##2##(2008-10#1)(2008-12#1)
90)##13##1##(1993-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#2)
90-100%##2##1##(2008-10#1)(2008-12#1)
90-166##7##1##(2008-10#7)
90-day##2##1##(2008-11#1)(2011-2#1)
90-kDa##2##1##(1994-11#1)(1996-12#1)
90-sec##2##1##(2013-1#2)
900 degrees C for##3##4##(2008-10#3)
900 degrees C##5##3##(2008-10#5)
900 degrees##6##2##(2008-10#6)
900##22##1##(1991-3#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(2008-10#11)(2008-2#1)(2008-7#1)(2008-8#1)(2012-3#1)
9000##2##1##(1992-12#1)(2007-12#1)
908##2##1##(2008-10#1)(2010-10#1)
908)##2##1##(2008-10#1)(2008-12#1)
909##2##1##(1993-6#1)(2012-2#1)
90min##3##1##(2008-10#2)(2012-2#1)
90s##7##1##(1991-3#1)(2008-10#6)
90°C##3##1##(2011-1#2)(2013-1#1)
91 +/- 0##3##3##(1994-11#1)(1994-5#1)(1995-11#1)
91 +/-##6##2##(1994-11#1)(1994-5#1)(1995-11#1)(2008-10#2)(2011-2#1)
91 and##3##2##(2008-10#3)
91 to##11##2##(1990-12#1)(1993-12#1)(2008-10#8)(2010-11#1)
91##80##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#35)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
91% and##2##2##(1990-2#1)(2010-5#1)
91% of the##4##3##(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
91% of##7##2##(1993-3#1)(1994-3#1)(2008-10#2)(2008-7#1)(2012-12#1)(2013-8#1)
91%##18##1##(1990-2#1)(1990-8#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-8#1)(2008-10#6)(2008-6#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
91%)##2##1##(2008-10#1)(2011-2#1)
91)##7##1##(1993-2#1)(1993-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
91-year-old##3##1##(1992-12#1)(1996-5#1)(2008-11#1)
911##2##1##(2008-10#1)(2010-11#1)
914##4##1##(2008-10#2)(2011-2#1)(2012-3#1)
916##2##1##(2008-10#1)(2011-3#1)
917##4##1##(1990-12#1)(1996-12#1)(2008-10#1)(2010-3#1)
92 and##12##2##(2008-10#12)
92 g pot(-1)##3##3##(2008-10#3)
92 to##5##2##(2008-10#5)
92##105##1##(1990-2#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-3#2)(1997-8#1)(2008-1#2)(2008-10#55)(2008-11#3)(2008-12#4)(2008-5#2)(2008-8#2)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
92% and##4##2##(1991-8#1)(1992-11#1)(1993-6#1)(1995-11#1)
92% for##4##2##(1992-3#1)(1996-12#1)(2008-10#1)(2009-11#1)
92% of the##7##3##(1992-12#1)(1995-8#2)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
92% of##10##2##(1992-12#1)(1995-8#2)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
92%##34##1##(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-8#2)(1996-12#1)(1996-6#1)(1996-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-12#1)
92%)##5##1##(2008-10#3)(2010-9#1)(2011-1#1)
92)##5##1##(1993-12#1)(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
920##3##1##(1991-6#1)(2008-10#1)(2008-2#1)
921 clinical specimens##2##3##(2013-8#2)
921##4##1##(2008-10#1)(2009-7#1)(2013-8#2)
924##3##1##(1995-8#1)(2008-10#1)(2011-2#1)
925##3##1##(2008-10#2)(2013-8#1)
927##3##1##(2007-12#1)(2008-10#1)(2012-3#1)
93 +/-##2##2##(1994-8#1)(1997-1#1)
93 and 0##2##3##(2008-10#2)
93 and##7##2##(2008-10#6)(2008-3#1)
93 patients##2##2##(1995-12#1)(1996-9#1)
93 to##4##2##(2008-10#3)(2009-12#1)
93##69##1##(1991-3#1)(1992-5#1)(1993-1#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#1)(1996-9#2)(1997-1#1)(1997-2#1)(2008-10#32)(2008-11#1)(2008-12#5)(2008-3#2)(2008-7#1)(2009-12#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
93% and##2##2##(1995-3#1)(2008-10#1)
93% for##3##2##(1995-2#1)(2008-10#2)
93% homology##2##2##(1990-8#1)(2008-8#1)
93% of the##3##3##(1996-8#1)(2008-10#1)(2012-2#1)
93% of##7##2##(1996-8#1)(2008-10#2)(2008-7#1)(2009-3#1)(2012-12#1)(2012-2#1)
93%##34##1##(1990-8#1)(1993-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(1996-9#1)(2008-10#14)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
93%)##2##1##(1990-3#1)(2011-2#1)
93)##4##1##(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
930##2##1##(1990-5#1)(1995-6#1)
931##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
933##3##1##(1995-12#1)(2008-6#2)
934##4##1##(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)
936##5##1##(1997-3#1)(2008-9#1)(2013-1#3)
937##3##1##(2008-10#1)(2008-2#1)(2013-1#1)
9375 mW/cm(2)##2##2##(2008-7#2)
938##2##1##(2008-11#1)(2010-5#1)
938)##2##1##(2008-10#1)(2011-3#1)
93ID6##3##1##(2008-10#3)
94 +/-##3##2##(1991-5#1)(2008-10#1)(2010-4#1)
94 and 1##2##3##(2008-10#2)
94 and##8##2##(1995-8#1)(2008-10#6)(2010-11#1)
94 for##2##2##(2008-10#2)
94 mum) laser may be##2##5##(1991-2#2)
94 mum) laser##3##3##(1991-2#3)
94 to 0##2##3##(2013-1#2)
94 to##6##2##(2008-10#3)(2008-5#1)(2013-1#2)
94##86##1##(1990-5#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-3#1)(1993-8#2)(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#39)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-9#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
94% of the##2##3##(2008-10#1)(2011-2#1)
94% of##5##2##(1997-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
94% were##2##2##(1994-8#1)(2008-10#1)
94%##25##1##(1990-11#1)(1991-3#1)(1994-8#1)(1997-3#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
94%)##2##1##(2011-2#1)(2012-3#1)
94) and##3##2##(1993-2#1)(2009-11#1)(2010-6#1)
94) was##2##2##(2008-10#2)
94)##11##1##(1991-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(2008-10#4)(2009-11#1)(2010-6#1)(2013-1#1)
94-##2##1##(1995-2#1)(2012-2#1)
94-100%##3##1##(2008-10#3)
94-kDa protein##2##2##(2008-10#2)
94-kDa##4##1##(2008-10#4)
940##3##1##(2008-10#1)(2008-8#1)(2010-6#1)
944##2##1##(2008-10#1)(2012-3#1)
945##6##1##(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#3)
946##6##1##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-12#1)
948##3##1##(2008-10#2)(2011-2#1)
94x10(-6) to##2##2##(2008-10#2)
94x10(-6)##3##1##(2008-10#3)
95 % confidence intervals##2##4##(2011-2#2)
95 %##5##2##(1997-8#1)(2008-10#1)(2011-2#2)(2013-1#1)
95 %CI) and##2##3##(2011-2#1)(2012-12#1)
95 %CI)##8##2##(2011-2#5)(2012-12#3)
95 +/-##2##2##(1990-3#1)(2008-12#1)
95 V##3##2##(2008-10#3)
95 and##8##2##(2008-10#6)(2010-4#1)(2012-12#1)
95 environments##2##2##(2008-8#2)
95 of##3##2##(2008-10#2)(2008-11#1)
95 percent of##2##3##(1995-6#1)(2010-2#1)
95 percent##6##2##(1992-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(2008-11#1)(2010-2#1)
95 to 98%##2##3##(2008-10#2)
95 to##7##2##(2008-10#5)(2008-7#2)
95 ±##2##2##(2013-1#1)(2013-8#1)
95##135##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-8#4)(2008-1#2)(2008-10#62)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#14)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
95% CI 0##4##3##(2008-12#1)(2011-2#3)
95% CI 1##14##3##(1993-12#1)(2008-11#2)(2011-2#10)(2012-12#1)
95% CI 2##2##3##(1993-12#1)(2012-12#1)
95% CI 3##2##3##(2008-11#1)(2011-2#1)
95% CI##63##2##(1993-12#2)(1994-12#7)(2008-10#7)(2008-11#4)(2008-12#4)(2010-10#1)(2010-11#1)(2010-4#10)(2011-2#15)(2012-12#6)(2012-3#2)(2013-1#4)
95% [CI] = 1##2##4##(2011-2#2)
95% and the##2##3##(2008-10#1)(2008-12#1)
95% and##9##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2010-7#1)
95% at the##2##3##(2008-10#2)
95% at##4##2##(1997-1#1)(2008-10#2)(2008-11#1)
95% by##2##2##(1995-6#1)(2008-2#1)
95% confidence interval (CI) 1##2##5##(2011-2#1)(2012-12#1)
95% confidence interval 0##2##4##(1990-6#1)(2010-6#1)
95% confidence interval [CI]##4##4##(1993-12#1)(2010-10#1)(2010-4#2)
95% confidence interval of##3##4##(1991-7#1)(2008-10#1)(2010-3#1)
95% confidence interval##20##3##(1990-6#1)(1991-2#2)(1991-7#1)(1993-12#1)(2008-10#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#4)
95% confidence intervals##8##3##(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#4)
95% confidence level and##3##4##(2008-10#3)
95% confidence level was observed##6##5##(2008-10#6)
95% confidence level##43##3##(2008-10#43)
95% confidence level)##2##3##(2008-10#2)
95% confidence limits##3##3##(1994-3#2)(1997-3#1)
95% confidence##79##2##(1990-6#1)(1991-2#2)(1991-7#1)(1993-12#1)(1994-3#2)(1997-3#1)(2008-10#51)(2008-11#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-2#5)(2012-12#1)(2013-1#4)
95% control##2##2##(2008-10#2)
95% credible##2##2##(2008-10#2)
95% for##5##2##(1996-12#1)(2008-10#3)(2011-2#1)
95% identity##2##2##(1994-11#1)(2013-1#1)
95% in the##2##3##(2008-10#1)(2012-2#1)
95% in##4##2##(1997-3#1)(2008-10#2)(2012-2#1)
95% level##2##2##(2008-10#2)
95% of confidence##2##3##(2008-10#2)
95% of patients##2##3##(1996-1#1)(2008-11#1)
95% of the##13##3##(2008-10#11)(2008-9#1)(2010-8#1)
95% of##23##2##(1993-1#1)(1994-8#1)(1996-1#1)(2008-10#15)(2008-11#2)(2008-9#1)(2010-8#1)(2011-2#1)
95% or more##2##3##(2008-10#1)(2011-2#1)
95% or##3##2##(2008-10#2)(2011-2#1)
95% power frequencies existed among##2##5##(2012-2#2)
95% power frequencies##3##3##(2012-2#3)
95% power##4##2##(2012-2#4)
95% relative humidity##2##3##(2008-5#1)(2013-1#1)
95%##259##1##(1990-6#1)(1991-2#2)(1991-7#1)(1991-8#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#7)(1994-3#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-8#1)(2008-10#125)(2008-11#11)(2008-12#6)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-10#2)(2010-11#2)(2010-3#1)(2010-4#12)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#25)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#16)(2013-8#2)
95%) and##2##2##(1997-8#1)(2008-10#1)
95%) at##2##2##(2008-10#2)
95%)##12##1##(1996-5#1)(1997-8#2)(2007-11#1)(2008-10#7)(2013-1#1)
95%CI##6##1##(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#3)
95%CI)##2##1##(2012-12#2)
95) and##2##2##(2008-7#1)(2013-1#1)
95) p &lt##2##3##(2010-8#2)
95)##9##1##(1990-6#1)(2008-10#3)(2008-7#1)(2010-8#2)(2012-2#1)(2013-1#1)
95-1##2##1##(2006-6#1)(2013-1#1)
95-105% for##3##2##(2008-10#3)
95-105%##5##1##(2008-10#5)
95-kDa##2##1##(1996-12#2)
950 degrees C##2##3##(2010-4#2)
950##6##1##(2008-10#1)(2010-4#2)(2011-2#1)(2013-1#2)
951##3##1##(1992-10#1)(1994-11#1)(2009-7#1)
953##2##1##(1992-4#1)(2011-2#1)
954##2##1##(1990-12#1)(2008-10#1)
956##2##1##(1990-6#1)(2011-2#1)
95x10(-5) to 1x10(-1)moldm(-3) and##2##4##(2008-10#2)
96 +/- 0##3##3##(1992-11#2)(1994-11#1)
96 +/-##4##2##(1992-11#2)(1993-11#1)(1994-11#1)
96 and 0##2##3##(1990-6#1)(2008-10#1)
96 and##11##2##(1990-6#1)(2008-10#8)(2008-8#1)(2010-12#1)
96 for the##2##3##(2008-10#2)
96 h LC50##2##3##(2008-12#2)
96 h after##5##3##(2008-10#5)
96 h##27##2##(1993-6#1)(1997-1#1)(2008-10#17)(2008-12#5)(2008-7#1)(2008-8#2)
96 h)##2##2##(2008-10#2)
96 hours##4##2##(1990-5#1)(2011-2#2)(2012-2#1)
96 nM##2##2##(2008-10#2)
96 well plates##2##3##(2008-11#2)
96 well##4##2##(2008-10#1)(2008-11#3)
96 x##2##2##(2008-10#1)(2008-7#1)
96##161##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-11#3)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1995-1#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#90)(2008-11#8)(2008-12#8)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#5)
96% and the##2##3##(2008-10#2)
96% of the##4##3##(1994-12#1)(2008-10#2)(2008-8#1)
96% of##5##2##(1994-12#1)(2008-10#3)(2008-8#1)
96% with a##2##3##(2008-10#1)(2012-3#1)
96% with##3##2##(2008-10#2)(2012-3#1)
96%##33##1##(1990-6#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-8#2)(2008-10#21)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#2)
96%)##5##1##(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
96)##5##1##(1993-2#1)(1994-8#1)(1995-5#1)(2008-10#2)
96-103%##2##1##(2008-10#2)
96-105%##2##1##(2008-10#2)
96-microwell plate##2##2##(2008-10#2)
96-well microtiter plate##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
96-well microtiter##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
96-well plates##3##2##(2008-11#2)(2011-2#1)
96-well##20##1##(2008-10#6)(2008-11#10)(2008-4#1)(2008-9#1)(2011-2#2)
960##9##1##(1995-6#1)(1997-6#1)(2008-10#4)(2008-12#1)(2009-11#1)(2010-10#1)
961##2##1##(1997-8#1)(2008-11#1)
964##4##1##(2008-10#1)(2008-11#1)(2010-6#1)(2010-8#1)
967##5##1##(1994-2#1)(1996-2#1)(2008-10#3)
968##3##1##(1991-6#1)(1993-12#1)(1995-2#1)
96mug/l##2##1##(2008-10#2)
97 and##5##2##(2008-10#5)
97 cases##2##2##(1996-11#1)(2011-2#1)
97 to 99%##2##3##(2008-10#2)
97 to##8##2##(2008-10#7)(2009-12#1)
97##107##1##(1990-12#1)(1990-6#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-12#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#57)(2008-11#1)(2008-12#7)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
97% for##2##2##(2008-10#2)
97% identity with##2##3##(1995-6#1)(2008-10#1)
97% in the##2##3##(2008-10#1)(2010-10#1)
97% in##4##2##(2008-10#2)(2008-3#1)(2010-10#1)
97% of the##3##3##(1991-2#1)(2008-10#2)
97% of##7##2##(1991-2#1)(1997-4#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
97% with##2##2##(2008-10#2)
97%##38##1##(1990-2#1)(1991-2#1)(1993-6#1)(1995-6#1)(1997-4#1)(2008-10#17)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#1)
97%)##4##1##(1996-5#1)(2008-10#2)(2008-7#1)
97) and##2##2##(2008-10#1)(2013-1#1)
97)##4##1##(1990-8#1)(2008-10#2)(2013-1#1)
97+/-5%##2##1##(2008-10#2)
97-kDa##2##1##(1995-2#2)
970##4##1##(1994-9#1)(2008-10#3)
972##2##1##(2008-3#1)(2008-7#1)
973##2##1##(2009-7#1)(2011-2#1)
974##2##1##(1994-11#1)(2008-10#1)
975##2##1##(1996-6#1)(2008-10#1)
976##2##1##(2008-11#1)(2011-2#1)
976)##2##1##(1990-12#1)(2008-10#1)
979##2##1##(2008-10#2)
98 +/- 0##2##3##(2008-3#1)(2011-2#1)
98 +/-##6##2##(1993-8#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-3#1)
98 and##2##2##(2008-10#1)(2012-3#1)
98 cases##2##2##(2008-7#2)
98 for the##2##3##(2008-10#1)(2009-3#1)
98 to 99%##2##3##(2008-10#2)
98 to##5##2##(2008-10#3)(2010-6#1)(2013-1#1)
98##119##1##(1990-2#1)(1990-3#2)(1990-9#1)(1991-11#1)(1991-3#1)(1992-11#3)(1993-8#2)(1995-6#1)(1996-12#2)(2008-10#58)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-2#3)(2010-4#2)(2010-5#3)(2010-6#1)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
98% and##2##2##(2008-10#1)(2011-2#1)
98% ee)##2##2##(1996-5#2)
98% identical##3##2##(1993-2#1)(1993-6#1)(2012-3#1)
98% of enzyme activity##2##4##(1997-6#2)
98% of the##5##3##(2008-10#2)(2008-12#1)(2010-12#1)(2011-2#1)
98% of##13##2##(1990-5#1)(1992-6#1)(1994-2#1)(1997-6#2)(2008-10#5)(2008-12#1)(2010-12#1)(2011-2#1)
98% to##3##2##(2008-10#2)(2011-2#1)
98% was obtained##2##3##(1994-6#1)(2008-10#1)
98%##58##1##(1990-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-5#2)(1996-9#1)(1997-6#2)(2008-10#35)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-3#1)
98%)##4##1##(1997-3#1)(2008-10#2)(2011-2#1)
98) and##2##2##(2008-10#2)
98)##9##1##(1992-2#1)(2008-10#5)(2008-11#1)(2009-8#1)(2013-1#1)
98-101%##2##1##(2008-10#2)
980##6##1##(1990-11#1)(1993-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
9816##2##1##(2008-10#1)(2009-7#1)
984##2##1##(1994-11#1)(2008-10#1)
985##7##1##(1997-2#1)(1997-6#1)(2007-12#2)(2008-10#3)
986)##2##1##(2008-10#2)
987##2##1##(2008-10#1)(2012-2#1)
988##7##1##(1992-9#1)(1996-2#4)(2008-10#1)(2011-2#1)
99 +/-##2##2##(2008-10#2)
99 and##2##2##(2008-10#1)(2013-1#1)
99 isolates##2##2##(2008-10#2)
99 kDa polypeptide##2##3##(1991-9#2)
99 kDa protein##2##3##(1991-9#2)
99 kDa##4##2##(1991-9#4)
99 to##5##2##(2008-10#5)
99##149##1##(1990-11#1)(1990-9#1)(1991-9#5)(1992-11#1)(1992-12#1)(1993-2#1)(1994-11#1)(1995-2#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(2007-8#1)(2008-1#2)(2008-10#104)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)
99% for##3##2##(1996-12#1)(2008-10#2)
99% of all##2##3##(2008-10#2)
99% of the##5##3##(1995-3#1)(2008-10#2)(2008-8#2)
99% of##11##2##(1992-2#1)(1995-3#1)(2008-10#7)(2008-8#2)
99% pure)##2##2##(2008-9#2)
99% relative humidity##2##3##(2008-10#2)
99% were obtained by elution of the##2##7##(2008-10#2)
99% were##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
99%##50##1##(1990-9#1)(1992-2#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#2)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)
99%)##6##1##(2008-10#5)(2008-11#1)
99) and##2##2##(1994-12#1)(2008-10#1)
99) for##2##2##(2008-10#1)(2013-1#1)
99)##9##1##(1994-12#1)(2008-10#7)(2013-1#1)
99+/-0##2##1##(2008-10#2)
99+/-1##2##1##(2008-10#2)
99-457##2##1##(1991-12#1)(1994-1#1)
99-kb##3##1##(1995-12#1)(1996-8#2)
990##3##1##(2008-10#2)(2008-8#1)
991##3##1##(2011-2#1)(2012-12#2)
992 and##4##2##(2008-10#4)
992##6##1##(2008-10#6)
9927)##2##1##(2008-10#2)
994##6##1##(1992-2#1)(2008-10#3)(2008-11#2)
995##5##1##(2008-10#5)
995)##3##1##(2008-10#3)
9954##2##1##(2008-10#2)
9959)##2##1##(2008-10#2)
996##7##1##(1994-11#1)(2008-10#6)
9961##2##1##(2008-10#1)(2008-5#1)
9962)##2##1##(2008-10#2)
997##7##1##(1993-12#1)(1993-3#1)(2008-10#4)(2008-3#1)
9975##2##1##(2008-10#2)
9978##5##1##(2008-10#4)(2008-5#1)
998 and a detection limit of 0##2##7##(2008-10#2)
998 and##3##2##(2008-10#3)
998##14##1##(1992-2#1)(2008-10#12)(2013-1#1)
998) tarabine PFS and for##2##5##(2008-10#2)
998) with##2##2##(2008-10#2)
998)##10##1##(2008-10#9)(2013-1#1)
9984##4##1##(2008-10#4)
9985##3##1##(2008-10#3)
9987##3##1##(2008-10#3)
9989##5##1##(2008-10#5)
999 and relative standard deviation of##2##6##(2008-10#2)
999 and##4##2##(2008-10#4)
999##22##1##(2008-10#21)(2012-3#1)
999) adriblastina##2##2##(2008-10#2)
999) and##2##2##(2008-10#2)
999)##19##1##(2008-10#19)
999+/-0##2##1##(2008-10#2)
9990##2##1##(2008-10#2)
9991##2##1##(2008-10#2)
9991)##3##1##(2008-10#3)
9992 and 0##2##3##(2008-10#2)
9992##5##1##(2008-10#5)
9992) for##2##2##(2008-10#2)
9992)##4##1##(2008-10#4)
9993##3##1##(2008-10#3)
9993)##2##1##(2008-10#2)
9994 and relative standard deviation##2##5##(2008-10#2)
9994##5##1##(2008-10#5)
9994)##2##1##(2008-10#2)
9995 and##2##2##(2008-10#1)(2008-5#1)
9995##6##1##(2008-10#5)(2008-5#1)
9995)##3##1##(2008-10#3)
9996##5##1##(2008-10#5)
9996)##4##1##(2008-10#4)
9997##7##1##(2008-10#7)
9997)##3##1##(1997-2#1)(2008-10#2)
9998##5##1##(2008-10#4)(2008-5#1)
9998)##3##1##(2008-10#3)
9999##9##1##(2008-10#8)(2008-5#1)
9999) and##3##2##(2008-10#3)
9999) with##2##2##(2008-10#2)
9999)##13##1##(2008-10#13)
99m##2##1##(1992-2#1)(2007-11#1)
99mTc labelled##3##2##(1990-12#2)(1996-1#1)
99mTc##7##1##(1990-12#4)(1994-2#2)(1996-1#1)
9S##2##1##(1990-11#1)(1995-2#1)
9alpha##2##1##(2008-11#2)
9alpha-hydroxylase system##3##2##(2008-11#3)
9alpha-hydroxylase##11##1##(2008-11#11)
9mV per##2##2##(2008-10#2)
9muM##2##1##(2008-10#2)
9mugl(-1)##4##1##(2008-10#4)
9ngml(-1)##2##1##(2008-10#2)
9p-linking hereditary melanoma##2##3##(1997-7#2)
9p-linking##3##1##(1997-7#3)
9th and 10th##2##3##(2013-1#2)
9th grade##4##2##(1991-9#4)
9th##10##1##(1991-9#4)(2008-10#1)(2008-11#2)(2008-8#1)(2013-1#2)
9x10(-6) to 1##2##3##(2008-10#2)
9x10(-6)##3##1##(2008-10#3)
9x10(-6)M##3##1##(2008-10#3)
9x10(-7) to 3##2##3##(2008-10#2)
9x10(-7)##3##1##(2008-10#3)
9x10(-8) to##2##2##(2008-10#2)
9±0##2##1##(2010-12#1)(2011-2#1)
9 ± 5##2##1##(2013-1#2)
9 mU/l)##2##1##(2012-3#2)
</AbstractText> </Abstract> <Affiliation>Department of Clinical Studies##2##6##(2013-8#2)
</AbstractText> </Abstract> <Affiliation>Department of##4##4##(2013-8#4)
</AbstractText> </Abstract>##10##2##(2013-8#10)
</Affiliation> <AuthorList CompleteYN="Y"> <Author ValidYN="Y">##10##5##(2013-8#10)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo> <Country>Canada</Country> <MedlineTA>Can Vet J</MedlineTA> <NlmUniqueID>0004653</NlmUniqueID> <ISSNLinking>0008-5286</ISSNLinking> </MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <OtherAbstract Language="fre" Type="Publisher"> <AbstractText>Abstract available from the publisher##10##25##(2013-8#10)
</Author> <Author ValidYN="Y">##25##3##(2013-8#25)
</Author>##35##1##(2013-8#35)
<Author ValidYN="Y">##35##2##(2013-8#35)
<Initials>A</Initials> </Author> <Author ValidYN="Y">##4##4##(2013-8#4)
<Initials>A</Initials> </Author>##5##2##(2013-8#5)
<Initials>D</Initials> </Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo> <Country>Canada</Country> <MedlineTA>Can Vet J</MedlineTA> <NlmUniqueID>0004653</NlmUniqueID> <ISSNLinking>0008-5286</ISSNLinking> </MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <OtherAbstract Language="fre" Type="Publisher"> <AbstractText>Abstract available from the publisher##2##26##(2013-8#2)
<Initials>D</Initials> </Author> <Author ValidYN="Y">##2##4##(2013-8#2)
<Initials>D</Initials> </Author>##4##2##(2013-8#4)
<Initials>M</Initials> </Author> <Author ValidYN="Y">##2##4##(2013-8#2)
= &gt##2##2##(2008-10#1)(2008-8#1)
= &lt##3##2##(2008-11#1)(2008-3#1)(2010-12#1)
= (0##2##2##(2008-10#1)(2008-3#1)
= (1##2##2##(2008-10#2)
= (2##2##2##(2008-2#1)(2008-3#1)
= -##4##2##(2008-9#2)(2010-9#1)(2012-3#1)
= -0##60##2##(1991-2#2)(1992-9#1)(1993-2#5)(1995-11#3)(1995-8#2)(2008-1#4)(2008-10#11)(2008-12#2)(2009-8#1)(2009-9#9)(2010-2#2)(2010-4#5)(2010-6#1)(2011-2#2)(2011-3#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
= -1##4##2##(1993-8#1)(2008-2#1)(2013-8#2)
= 0##666##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#2)(1991-8#7)(1992-11#1)(1992-12#3)(1992-2#3)(1992-9#3)(1993-1#9)(1993-11#4)(1993-12#1)(1993-2#7)(1993-6#1)(1993-8#5)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#5)(1995-11#5)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#7)(1996-1#1)(1996-2#4)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-5#2)(1997-8#5)(2008-1#2)(2008-10#218)(2008-11#23)(2008-12#6)(2008-2#2)(2008-3#14)(2008-5#14)(2008-7#27)(2008-8#8)(2008-9#21)(2009-11#4)(2009-3#1)(2009-8#2)(2009-9#2)(2010-1#7)(2010-11#5)(2010-2#10)(2010-4#17)(2010-6#3)(2010-8#2)(2010-9#6)(2011-2#78)(2011-3#6)(2012-12#3)(2012-2#3)(2012-3#26)(2013-1#31)(2013-8#12)
= 0)##7##2##(2008-10#2)(2008-11#1)(2008-3#4)
= 1 -##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
= 1 and##2##3##(2008-9#1)(2012-12#1)
= 1##87##2##(1990-11#3)(1990-8#4)(1991-2#1)(1991-5#1)(1991-9#2)(1994-12#5)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-9#1)(2011-2#8)(2012-12#3)(2012-3#5)(2013-1#3)(2013-8#1)
= 1)##18##2##(1994-3#7)(1996-11#3)(2008-10#1)(2011-2#2)(2012-12#4)(2012-3#1)
= 10 +/-##2##3##(1994-5#1)(2010-7#1)
= 10##13##2##(1992-8#1)(1994-5#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-1#2)(2010-12#1)(2010-7#1)
= 10(5)##2##2##(1996-12#1)(2008-3#1)
= 10) and##3##3##(2008-10#2)(2013-1#1)
= 10)##20##2##(1992-11#1)(1993-6#1)(1995-2#1)(2008-10#13)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
= 100##7##2##(1993-2#1)(1994-8#1)(2008-10#1)(2010-2#1)(2011-2#2)(2012-3#1)
= 1000##2##2##(1997-5#1)(2009-11#1)
= 11)##5##2##(1993-3#1)(1995-5#3)(1996-3#1)
= 117)##2##2##(2012-3#2)
= 12##9##2##(1990-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
= 12)##16##2##(1991-5#1)(1993-1#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2012-3#2)
= 120)##3##2##(2008-12#1)(2009-8#1)(2012-3#1)
= 127)##4##2##(1992-9#1)(2009-4#1)(2010-10#2)
= 13##7##2##(1992-6#1)(2008-10#1)(2009-11#1)(2009-7#2)(2010-1#1)(2010-8#1)
= 13)##3##2##(1996-2#1)(2008-10#1)(2013-8#1)
= 14##7##2##(1990-8#1)(1992-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
= 14)##3##2##(1991-5#1)(2013-8#2)
= 145)##2##2##(2008-9#1)(2009-7#1)
= 15##7##2##(1994-12#1)(1995-8#1)(2008-10#4)(2009-7#1)
= 15)##4##2##(1997-3#1)(2008-10#3)
= 16##2##2##(1993-1#1)(2008-10#1)
= 16)##3##2##(1990-8#1)(1992-1#1)(1997-1#1)
= 17##2##2##(2008-10#1)(2013-8#1)
= 18##6##2##(1996-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-1#1)
= 18)##7##2##(1992-1#1)(2008-10#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
= 19##4##2##(1996-5#1)(2008-10#1)(2009-1#1)(2012-3#1)
= 2##42##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#1)(1992-9#1)(1993-12#1)(1993-8#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-11#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#2)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
= 2) and##2##3##(2008-10#1)(2008-11#1)
= 2)##6##2##(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-3#2)
= 20##12##2##(1995-8#4)(1997-1#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-7#1)
= 20) were##2##3##(1993-3#1)(2008-10#1)
= 20)##11##2##(1993-1#1)(1993-3#2)(1997-8#1)(2008-10#3)(2013-1#4)
= 200##2##2##(1992-3#1)(1995-6#1)
= 21##2##2##(2008-10#1)(2010-9#1)
= 21)##5##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
= 22##3##2##(2008-10#1)(2008-12#1)(2010-2#1)
= 22)##5##2##(1992-12#1)(1996-2#1)(2008-10#1)(2008-8#1)(2010-8#1)
= 23##4##2##(1991-5#1)(1993-1#1)(2008-10#1)(2012-3#1)
= 24##2##2##(1992-12#1)(2008-10#1)
= 24) and##3##3##(2009-12#1)(2012-2#1)(2012-3#1)
= 24)##9##2##(1990-5#1)(2008-10#1)(2008-7#1)(2009-12#3)(2012-2#1)(2012-3#2)
= 25##2##2##(1994-6#1)(2010-8#1)
= 25)##3##2##(1997-8#1)(2008-12#1)(2010-4#1)
= 26##2##2##(1991-5#1)(2009-6#1)
= 27##5##2##(2008-10#1)(2008-5#2)(2010-8#1)(2012-2#1)
= 27)##5##2##(1990-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
= 2x =##4##3##(2008-10#1)(2009-12#3)
= 3##39##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-8#5)(1994-3#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-3#2)(2009-11#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
= 3%)##3##2##(2008-10#2)(2008-11#1)
= 3) was##3##3##(2008-10#2)(2008-9#1)
= 3)##16##2##(1990-8#1)(1993-8#1)(1994-6#2)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
= 30 degrees##3##3##(1997-8#1)(2008-12#1)(2008-2#1)
= 30##7##2##(1994-12#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
= 30)##9##2##(1990-8#1)(1993-1#1)(1995-8#1)(2009-1#1)(2009-9#1)(2012-3#1)(2013-8#3)
= 31##2##2##(1996-1#1)(2009-6#1)
= 32##2##2##(1995-8#1)(1997-8#1)
= 34)##2##2##(2010-4#1)(2013-8#1)
= 35##4##2##(2008-12#1)(2008-7#1)(2012-3#2)
= 39) and##2##3##(2008-10#1)(2012-3#1)
= 39)##3##2##(2008-10#1)(2012-3#2)
= 4##30##2##(1990-2#1)(1990-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-2#1)(1994-3#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-8#2)(2008-10#1)(2008-12#2)(2008-2#2)(2008-5#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
= 4)##13##2##(1990-5#4)(1994-6#2)(1995-2#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)
= 40##2##2##(2008-10#1)(2008-8#1)
= 40)##3##2##(2011-2#1)(2013-1#2)
= 42##4##2##(1992-3#1)(1993-8#1)(2008-10#1)(2010-2#1)
= 43)##2##2##(1991-2#1)(2011-1#1)
= 45)##2##2##(1991-2#1)(2008-10#1)
= 46##2##2##(1991-12#1)(1992-8#1)
= 48)##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
= 5##21##2##(1990-5#1)(1991-5#1)(1992-8#2)(1992-9#1)(1994-11#1)(1994-3#3)(1994-8#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)
= 5) and##2##3##(1996-12#1)(2009-11#1)
= 5)##16##2##(1994-11#1)(1994-3#2)(1995-2#1)(1996-12#2)(2008-10#8)(2009-11#2)
= 50##3##2##(1990-12#1)(1996-1#1)(1997-5#1)
= 50)##7##2##(1990-8#2)(1993-11#1)(2008-10#2)(2008-12#1)(2010-9#1)
= 52) and##2##3##(1994-1#1)(2008-10#1)
= 55)##3##2##(1994-1#1)(2008-9#2)
= 58##2##2##(1995-6#1)(1996-1#1)
= 6##14##2##(1992-11#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-7#2)
= 6) and##2##3##(1993-8#1)(2010-9#1)
= 6)##8##2##(1991-5#1)(1993-6#1)(1993-8#1)(1997-8#2)(2010-6#2)(2010-9#1)
= 60##5##2##(1995-11#1)(1997-8#1)(2008-10#2)(2008-5#1)
= 60)##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2009-9#1)
= 64)##3##2##(1993-1#1)(1996-2#1)(2010-8#1)
= 65##2##2##(2010-1#1)(2011-2#1)
= 66##2##2##(1992-3#1)(1994-5#1)
= 7##10##2##(1993-1#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-12#4)(2008-5#2)
= 7)##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
= 70##6##2##(1994-1#2)(1995-11#2)(2008-1#1)(2008-10#1)
= 71##5##2##(2008-3#2)(2009-1#1)(2009-7#1)(2010-1#1)
= 72##5##2##(1992-3#1)(1996-1#1)(2008-3#1)(2009-1#1)(2009-4#1)
= 8##18##2##(1990-5#1)(1992-11#1)(1992-9#1)(1993-12#1)(1995-11#1)(1996-11#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
= 8)##12##2##(1990-5#2)(1993-6#2)(1994-5#1)(1997-1#1)(2008-10#3)(2010-7#1)(2012-3#1)(2013-1#1)
= 88##2##2##(1992-11#1)(2008-7#1)
= 9##9##2##(1993-6#1)(1995-8#1)(2008-10#2)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
= 9)##12##2##(1990-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2012-3#1)
= 90 degrees##2##3##(1992-11#1)(2008-8#1)
= 97##2##2##(1992-9#1)(1993-2#1)
= ADP##2##2##(1995-8#2)
= ATP##2##2##(1995-11#1)(1995-8#1)
= Ala##2##2##(1990-5#2)
= Demineralized enamel##2##3##(2013-1#2)
= H##2##2##(1996-5#1)(2009-9#1)
= Remineralized enamel##2##3##(2013-1#2)
= UTP##3##2##(1993-8#1)(1995-8#2)
= gamma##3##2##(1992-11#1)(2008-3#2)
= most##2##2##(2008-10#2)
= non##2##2##(1994-11#1)(2008-11#1)
=##1896##1##(1990-10#5)(1990-11#3)(1990-12#6)(1990-2#3)(1990-4#1)(1990-5#18)(1990-6#4)(1990-8#17)(1990-9#1)(1991-11#3)(1991-12#6)(1991-2#12)(1991-3#2)(1991-5#11)(1991-6#4)(1991-8#12)(1991-9#3)(1992-1#4)(1992-11#12)(1992-12#10)(1992-2#5)(1992-3#11)(1992-6#2)(1992-8#8)(1992-9#15)(1993-1#24)(1993-11#6)(1993-12#6)(1993-2#18)(1993-3#4)(1993-6#8)(1993-8#30)(1994-1#4)(1994-11#10)(1994-12#13)(1994-2#4)(1994-3#29)(1994-5#12)(1994-6#6)(1994-8#12)(1995-11#17)(1995-12#10)(1995-2#9)(1995-3#1)(1995-5#6)(1995-6#4)(1995-8#27)(1996-1#6)(1996-11#8)(1996-12#10)(1996-2#17)(1996-3#3)(1996-5#9)(1996-6#2)(1996-8#6)(1997-1#11)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#6)(1997-6#1)(1997-8#23)(2006-6#1)(2008-1#8)(2008-10#405)(2008-11#60)(2008-12#50)(2008-2#12)(2008-3#53)(2008-4#1)(2008-5#32)(2008-7#41)(2008-8#35)(2008-9#43)(2009-1#7)(2009-10#2)(2009-11#11)(2009-12#9)(2009-3#1)(2009-4#4)(2009-5#8)(2009-6#3)(2009-7#17)(2009-8#10)(2009-9#31)(2010-1#15)(2010-10#9)(2010-11#8)(2010-12#4)(2010-2#15)(2010-3#1)(2010-4#39)(2010-5#3)(2010-6#8)(2010-7#6)(2010-8#12)(2010-9#18)(2011-1#1)(2011-2#133)(2011-3#10)(2012-12#20)(2012-2#17)(2012-3#80)(2013-1#70)(2013-8#35)
=)##2##1##(2008-3#2)
=-0##2##1##(2008-7#1)(2009-3#1)
=0##11##1##(2008-10#8)(2008-11#1)(2013-1#2)
=1##13##1##(2008-10#7)(2008-12#3)(2011-2#1)(2012-12#1)(2012-3#1)
=10##3##1##(2008-1#1)(2008-10#1)(2010-3#1)
=120##2##1##(2008-10#1)(2008-8#1)
=2##3##1##(2008-10#2)(2011-2#1)
=3##7##1##(2008-10#6)(2008-7#1)
=4##4##1##(2008-10#3)(2011-2#1)
=8##2##1##(2008-1#1)(2011-2#1)
=9##2##1##(2008-10#2)
==&gt##3##1##(1993-8#1)(2008-11#2)
?##15##1##(1994-1#1)(2008-12#1)(2008-2#1)(2008-3#8)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
?0##2##1##(2008-3#2)
????best##2##1##(2012-2#2)
?erenkov##2##1##(2008-2#2)
A &quot##6##2##(2008-10#3)(2008-4#1)(2010-11#1)(2010-7#1)
A (BPA) in the presence of phenol##2##7##(2008-10#2)
A (BPA) in##3##3##(2008-10#2)(2009-8#1)
A (BPA)##5##2##(2008-10#3)(2009-8#1)(2010-9#1)
A (Con A) and##2##4##(2008-10#1)(2012-3#1)
A (Con A)##7##3##(1990-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#2)(2012-3#1)
A (Con##8##2##(1990-6#1)(1991-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#2)(2012-3#1)
A (ConA)##2##2##(1995-12#2)
A (CsA)##3##2##(1991-9#1)(1994-3#1)(1994-8#1)
A (CyA) and its major##2##5##(2008-10#2)
A (H1N1)##2##2##(2010-5#1)(2012-12#1)
A (OTA)##3##2##(2008-10#2)(2011-2#1)
A + T##2##3##(1993-2#1)(2008-8#1)
A 0##4##2##(2008-10#3)(2008-8#1)
A 1##8##2##(2008-10#6)(2008-11#1)(2008-8#1)
A 10-year##3##2##(1995-2#1)(1997-8#1)(2012-12#1)
A 12##2##2##(1996-9#1)(2008-10#1)
A 13-year-old##2##2##(2008-11#1)(2013-1#1)
A 14##2##2##(2008-2#1)(2008-8#1)
A 14-year-old##2##2##(2008-10#1)(2008-8#1)
A 16-year-old male presented##2##4##(2008-7#1)(2010-5#1)
A 16-year-old male##3##3##(2008-7#1)(2010-5#1)(2013-1#1)
A 2##5##2##(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)
A 2(IV)(6-2) fractional factorial design was employed for##2##8##(2008-10#2)
A 2-year-old##2##2##(2008-10#1)(2013-8#1)
A 20-year-old man##2##3##(2008-7#1)(2010-6#1)
A 20-year-old##5##2##(1994-6#1)(2008-7#2)(2010-6#1)(2012-3#1)
A 21-year-old##2##2##(2007-12#1)(2009-1#1)
A 22##2##2##(2011-2#1)(2012-2#1)
A 22-year-old##2##2##(2010-3#1)(2012-3#1)
A 25-year-old##2##2##(2010-3#1)(2011-2#1)
A 26##2##2##(1997-4#1)(2013-1#1)
A 26-year-old man##2##3##(2008-12#1)(2010-1#1)
A 28-year-old##4##2##(2008-7#1)(2011-2#2)(2013-8#1)
A 2Sigma+(v' = 1##2##4##(2008-2#2)
A 3##3##2##(1996-12#1)(2008-10#1)(2010-5#1)
A 3-year##3##2##(1997-8#1)(2008-10#2)
A 34-year-old##2##2##(2009-3#1)(2013-1#1)
A 36-year-old##3##2##(2010-6#2)(2011-2#1)
A 37-year-old##2##2##(1997-6#1)(2013-7#1)
A 38-year-old woman##2##3##(2008-12#1)(2011-2#1)
A 38-year-old##3##2##(1997-3#1)(2008-12#1)(2011-2#1)
A 3D##2##2##(2008-3#1)(2008-6#1)
A 4##3##2##(1990-11#1)(2008-8#1)(2009-5#1)
A 4-year-old girl##2##3##(1997-3#1)(2008-10#1)
A 4-year-old##4##2##(1997-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
A 40-year-old##2##2##(1996-9#1)(2009-3#1)
A 41-year-old##2##2##(1993-6#1)(2008-12#1)
A 43##3##2##(1995-9#2)(1997-6#1)
A 43-year-old##2##2##(1996-11#1)(2010-7#1)
A 44-year-old man##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
A 44-year-old##4##2##(1996-3#1)(2008-12#1)(2008-7#1)(2012-3#1)
A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40##2##14##(1996-12#2)
A 47-year-old##2##2##(2013-1#1)(2013-8#1)
A 48-year-old##2##2##(2013-1#1)(2013-8#1)
A 5##2##2##(2008-3#1)(2013-1#1)
A 5-year-old##2##2##(2008-10#1)(2013-8#1)
A 50##2##2##(1991-5#1)(2008-10#1)
A 52-year-old##3##2##(1992-12#1)(2008-7#1)(2012-3#1)
A 53-year-old##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
A 55-year-old##2##2##(2008-10#1)(2013-1#1)
A 56-year-old woman##2##3##(2010-6#2)
A 56-year-old##4##2##(1997-6#1)(2010-6#2)(2011-2#1)
A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28##2##14##(1996-12#2)
A 59-year-old##2##2##(2011-2#1)(2012-3#1)
A 6##2##2##(1996-2#1)(2008-9#1)
A 6-month##2##2##(1996-3#1)(2010-10#1)
A 60##2##2##(2008-10#2)
A 60-year-old##3##2##(1990-2#1)(2009-11#1)(2012-3#1)
A 62-year-old##2##2##(1991-9#1)(1994-3#1)
A 63-year-old##3##2##(1991-8#1)(2010-6#1)(2011-2#1)
A 64-year-old##2##2##(2008-12#1)(2013-1#1)
A 65-year-old##2##2##(2011-2#1)(2013-8#1)
A 7##2##2##(2008-6#1)(2008-7#1)
A 7-year-old boy presented##2##4##(2008-10#1)(2012-12#1)
A 7-year-old##3##2##(2008-10#1)(2012-12#1)(2013-8#1)
A 70-year-old##3##2##(1993-6#1)(2008-12#2)
A 700-bp fragment##2##3##(1991-6#1)(1994-11#1)
A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12##2##14##(1996-6#2)
A 72-year-old man with##2##4##(2008-12#1)(2011-2#1)
A 73-year-old##3##2##(2008-7#2)(2010-6#1)
A 74-year-old##3##2##(2010-6#1)(2011-2#2)
A 75-year-old female##2##3##(2013-1#2)
A 75-year-old##3##2##(1991-8#1)(2013-1#2)
A 77-year-old woman##2##3##(2008-10#1)(2008-7#1)
A 77-year-old##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
A 799 (1998)##2##3##(2008-10#2)
A Bayesian approach##2##3##(2009-12#1)(2011-2#1)
A Bayesian##3##2##(2008-11#1)(2009-12#1)(2011-2#1)
A Brief##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
A CT scan##4##3##(2011-2#1)(2012-2#1)(2013-1#2)
A Canadian##4##2##(2007-12#1)(2008-11#2)(2010-11#1)
A Case Report and##2##4##(2011-2#2)
A Case Report##14##3##(1997-7#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#7)
A Case of##2##3##(2010-6#2)
A Case##19##2##(1994-12#1)(1997-7#1)(2008-12#2)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#8)
A Combination of##2##3##(2008-10#1)(2010-6#1)
A Combination##3##2##(1997-7#1)(2008-10#1)(2010-6#1)
A Comparative##2##2##(2008-12#1)(2010-7#1)
A Comparison of##2##3##(2010-1#1)(2013-1#1)
A Comparison##4##2##(2008-10#1)(2009-10#1)(2010-1#1)(2013-1#1)
A Controversial##2##2##(1997-7#1)(2011-2#1)
A Convenient##2##2##(1996-5#1)(2009-12#1)
A DNA##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-7#1)
A DNA-based piezoelectric biosensor##2##4##(2008-10#2)
A Doehlert matrix was used##2##5##(2008-10#2)
A Doehlert matrix was##3##4##(2008-10#3)
A Federal judge has refused to##2##6##(1995-12#1)(1995-6#1)
A Federal judge has##3##4##(1995-12#2)(1995-6#1)
A Field##3##2##(1996-9#1)(2008-10#1)(2009-6#1)
A Gene-for-Gene Relationship##2##3##(2008-10#2)
A HPLC method##3##3##(2008-10#3)
A Hamilton##2##2##(2008-10#2)
A Key to##2##3##(2008-10#1)(2011-2#1)
A Minor##2##2##(1993-12#1)(1993-3#1)
A Model for##2##3##(2008-10#1)(2008-11#1)
A Model##3##2##(2008-10#2)(2008-11#1)
A Molecular Marker##2##3##(2008-10#2)
A Narrative Review##2##3##(2012-12#1)(2012-2#1)
A New Approach for##2##4##(2008-10#1)(2011-2#1)
A New Way of Doing##2##5##(2012-2#2)
A New##13##2##(1995-6#1)(1996-5#4)(2008-10#4)(2011-2#1)(2012-2#2)(2013-1#1)
A Newly##2##2##(2008-10#2)
A Novel##9##2##(1996-5#3)(1996-9#1)(2008-10#2)(2012-12#1)(2012-3#1)(2013-8#1)
A PVC membrane electrode for##4##5##(2008-10#4)
A PVC membrane electrode##5##4##(2008-10#5)
A PVC membrane##7##3##(2008-10#7)
A PVC-based##3##2##(2008-10#3)
A Pilot Study##2##3##(2008-12#1)(2013-1#1)
A Plackett-Burmann design is used for the study of the factors that influence the absorption signal##2##16##(2008-10#2)
A Polymerase Chain##2##3##(2008-10#2)
A Population-based##2##2##(2012-3#1)(2013-1#1)
A Potential##2##2##(2011-2#1)(2013-8#1)
A QTL##3##2##(2008-10#2)(2012-3#1)
A Quantitative##2##2##(2008-10#2)
A Rapid##2##2##(2008-10#2)
A Rare Cause of##2##4##(2012-3#1)(2013-1#1)
A Retrospective##2##2##(2013-8#2)
A Review##2##2##(2008-10#1)(2010-10#1)
A Second##2##2##(2008-12#1)(2009-8#1)
A Simple##3##2##(2008-11#1)(2013-1#2)
A Single##3##2##(1995-11#1)(2008-10#2)
A Statistical##2##2##(1996-9#1)(2008-10#1)
A Study of the##2##4##(2008-12#1)(2010-1#1)
A Study of##3##3##(2008-12#1)(2009-10#1)(2010-1#1)
A Study##4##2##(2008-12#1)(2009-10#1)(2010-1#1)(2013-1#1)
A Survey##2##2##(2009-3#1)(2013-1#1)
A Systematic Review##2##3##(2013-1#2)
A Systematic##3##2##(2012-2#1)(2013-1#2)
A T-flask##2##2##(2008-11#2)
A Teflon##2##2##(2008-10#2)
A UV##2##2##(2008-10#2)
A activity##3##2##(1992-9#1)(1994-8#1)(2006-6#1)
A also##2##2##(1992-6#1)(2008-10#1)
A and B and##2##4##(1990-5#1)(2008-5#1)
A and B are##5##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
A and B components were##2##5##(2008-10#2)
A and B components##4##4##(2008-10#4)
A and B was##2##4##(2008-10#1)(2008-5#1)
A and B were##5##4##(1997-2#1)(2008-10#3)(2008-11#1)
A and B##55##3##(1990-5#2)(1992-5#1)(1993-11#1)(1994-5#2)(1995-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#27)(2008-11#3)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#4)
A and C##4##3##(1995-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
A and C=0##3##3##(2008-10#3)
A and glycogen##2##3##(2008-10#2)
A and##112##2##(1990-12#1)(1990-5#4)(1991-9#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-5#4)(1995-11#2)(1995-2#1)(1995-6#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#46)(2008-11#4)(2008-12#1)(2008-5#5)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#1)(2010-5#2)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#1)
A as##5##2##(1990-12#1)(1990-5#1)(1997-6#1)(2009-10#1)(2012-3#1)
A balanced scorecard##2##3##(1995-12#2)
A balanced##4##2##(1995-12#2)(2008-11#1)(2008-8#1)
A band of##2##3##(2008-10#1)(2008-3#1)
A band##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
A basic protocol for##2##4##(2008-2#1)(2008-4#1)
A basic##4##2##(1994-12#1)(2008-2#1)(2008-4#1)(2012-2#1)
A beta 1-40 was##2##4##(1994-11#2)
A beta 1-40##5##3##(1994-11#5)
A beta 1-42/43##5##3##(1994-11#5)
A beta 40 and A beta 42##2##7##(1995-12#2)
A beta species##2##3##(1994-11#1)(1995-12#1)
A beta##39##2##(1994-11#17)(1995-12#10)(1996-12#3)(1996-2#7)(2010-5#1)(2012-2#1)
A better understanding of the##3##5##(2008-10#2)(2010-7#1)
A better understanding of##6##4##(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)
A better##9##2##(1995-2#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)
A big loop##2##3##(2008-11#2)
A big##3##2##(2008-11#2)(2009-1#1)
A binding site##2##3##(1994-5#1)(1997-8#1)
A bioassay##2##2##(2008-10#1)(2008-4#1)
A biological##3##2##(1992-12#1)(2008-10#2)
A biosensor based on##2##4##(2008-10#2)
A biosensor for the specific determination of##2##7##(2008-10#2)
A biosensor for##3##3##(2008-10#3)
A biosensor##5##2##(2008-10#5)
A bivariate##2##2##(2008-10#1)(2013-1#1)
A body of##2##3##(2008-11#1)(2010-10#1)
A book to make you think##3##6##(2008-8#3)
A brief comment##2##3##(2008-5#1)(2010-7#1)
A brief description of the##3##5##(1992-2#1)(2008-11#2)
A brief description of##4##4##(1992-2#1)(1997-3#1)(2008-11#2)
A brief history of##2##4##(2008-11#1)(2008-5#1)
A brief history##4##3##(1995-5#1)(1996-12#1)(2008-11#1)(2008-5#1)
A brief overview of the##2##5##(1992-12#1)(2008-10#1)
A brief overview of##4##4##(1992-12#1)(2008-10#2)(2008-5#1)
A brief overview##6##3##(1992-1#1)(1992-12#1)(1995-9#1)(2008-10#2)(2008-5#1)
A brief review of##2##4##(2010-1#1)(2010-9#1)
A brief review##3##3##(2009-12#1)(2010-1#1)(2010-9#1)
A brief##25##2##(1992-1#1)(1992-12#1)(1992-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-5#3)(2008-8#1)(2009-12#1)(2010-1#1)(2010-7#1)(2010-9#1)
A broad range of##3##4##(1997-8#1)(2008-10#2)
A broad##6##2##(1992-3#1)(1997-8#1)(2008-10#3)(2011-2#1)
A broader##2##2##(1997-3#1)(2012-2#1)
A but not by##2##4##(1995-11#1)(2010-5#1)
A by##2##2##(1993-6#1)(1995-2#1)
A cDNA clone encoding##2##4##(1995-6#1)(1997-1#1)
A cDNA clone##4##3##(1992-10#1)(1995-6#1)(1997-1#1)(2008-8#1)
A cDNA coding for##2##4##(1992-3#1)(1994-11#1)
A cDNA encoding the##3##4##(1993-8#1)(1995-11#1)(1995-6#1)
A cDNA encoding##4##3##(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)
A cDNA for##2##3##(1990-8#1)(1997-8#1)
A cDNA fragment##2##3##(1997-7#1)(2008-10#1)
A cDNA library was##2##4##(1994-11#1)(2008-9#1)
A cDNA library##3##3##(1990-8#1)(1994-11#1)(2008-9#1)
A cDNA##21##2##(1990-8#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-8#1)(1994-11#3)(1995-11#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
A calibration curve was##3##4##(2008-10#3)
A calibration curve##5##3##(2008-10#5)
A calibration method##2##3##(2008-10#2)
A calibration##12##2##(2008-10#12)
A call for##4##3##(1997-1#1)(2008-11#3)
A call to##2##3##(1992-2#1)(2007-12#1)
A call##6##2##(1992-2#1)(1997-1#1)(2007-12#1)(2008-11#3)
A capillary electrophoresis method has been developed for the##2##9##(2008-10#2)
A capillary electrophoresis##3##3##(2008-10#3)
A capillary##5##2##(2008-10#5)
A carbon fiber##2##3##(2008-10#2)
A carbon##3##2##(2008-10#3)
A careful##4##2##(1991-8#1)(2008-11#2)(2008-9#1)
A case control##2##3##(2011-2#1)(2012-12#1)
A case history##2##3##(1992-2#1)(1993-2#1)
A case is presented##3##4##(1992-2#1)(1993-1#1)(2008-7#1)
A case is##5##3##(1990-6#1)(1992-2#1)(1993-1#1)(2008-10#1)(2008-7#1)
A case of a##9##4##(2008-11#1)(2008-7#3)(2010-6#1)(2011-2#1)(2013-1#3)
A case of bilateral##2##4##(2008-10#1)(2008-9#1)
A case of early##2##4##(1990-8#1)(2008-9#1)
A case of fatal##2##4##(1995-11#1)(2011-2#1)
A case of idiopathic##2##4##(1997-8#1)(2010-10#1)
A case of##70##3##(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-2#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-8#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#10)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#8)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#2)
A case report and review of literature##3##7##(2010-11#1)(2010-12#1)(2013-1#1)
A case report of##3##4##(2011-2#1)(2012-12#1)(2012-3#1)
A case report on##2##4##(1990-3#1)(2013-1#1)
A case report##36##3##(1990-12#3)(1990-3#1)(1991-12#1)(1991-8#2)(1992-2#7)(1994-6#2)(1994-8#1)(1996-9#1)(2008-10#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)
A case report]##6##3##(1992-9#1)(1997-8#1)(2007-8#1)(2009-5#1)(2011-2#2)
A case series##3##3##(2008-10#2)(2012-12#1)
A case study in##2##4##(1995-2#1)(2008-10#1)
A case study of##3##4##(2008-11#1)(2008-9#1)(2010-2#1)
A case study##11##3##(1993-2#1)(1994-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-10#1)(2010-2#1)
A case##140##2##(1990-12#3)(1990-3#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-8#2)(1992-2#10)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-6#1)(1996-9#2)(1997-8#3)(2007-8#1)(2008-10#11)(2008-11#4)(2008-12#4)(2008-7#11)(2008-9#5)(2009-10#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#8)(2011-2#16)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#2)
A case-control study##2##3##(1992-9#1)(2008-9#1)
A catalytic##4##2##(2008-10#3)(2010-12#1)
A cause##2##2##(1992-1#1)(2008-11#1)
A cell##2##2##(2008-11#1)(2008-7#1)
A central composite design was##3##5##(2008-10#2)(2008-11#1)
A central##7##2##(1992-6#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-8#1)
A chain##6##2##(1990-12#2)(1993-11#2)(2008-6#1)(2008-9#1)
A challenge for##2##3##(1991-11#1)(2008-11#1)
A challenge##3##2##(1991-11#1)(2008-11#1)(2008-5#1)
A change in##2##3##(1993-3#1)(2012-12#1)
A change##4##2##(1993-3#1)(2008-10#2)(2012-12#1)
A changing##2##2##(1991-6#1)(2009-1#1)
A checkerboard##2##2##(1994-8#1)(2008-10#1)
A checklist##2##2##(2011-2#2)
A chelating resin##2##3##(2008-10#2)
A chelating##3##2##(2008-10#3)
A chemical##3##2##(2008-10#3)
A chemically modified carbon paste electrode with##2##7##(2008-10#2)
A chemically modified electrode##3##4##(2008-10#3)
A chemically modified##5##3##(2008-10#5)
A chemiluminescence (CL)##3##3##(2008-10#3)
A chemiluminescence##5##2##(1995-8#1)(2008-10#4)
A chemiluminescent method using flow injection is described for the determination of##2##12##(2008-10#2)
A chemometric methodology##2##3##(2008-10#2)
A chemometric##6##2##(2008-10#6)
A child##4##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
A chromatographic##4##2##(2008-10#3)(2008-8#1)
A classification system##2##3##(1992-2#1)(1996-6#1)
A clean##2##2##(2008-10#2)
A clear difference in survival##2##5##(1990-8#1)(1991-8#1)
A clear##9##2##(1990-12#1)(1990-8#1)(1991-8#1)(1997-2#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
A climate-based##2##2##(2008-10#1)(2008-11#1)
A clinical assessment of##2##4##(1997-2#1)(2008-10#1)
A clinical assessment##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
A clinical case##3##3##(1990-3#1)(1991-3#2)
A clinical##21##2##(1990-3#1)(1990-9#1)(1991-3#2)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
A clinically##2##2##(1993-12#1)(2008-12#1)
A cloned gene##2##3##(1992-1#1)(2008-8#1)
A close##4##2##(2008-10#3)(2008-8#1)
A cluster of##2##3##(1996-6#1)(2008-10#1)
A cluster##3##2##(1996-6#1)(2008-10#2)
A coated##3##2##(2008-10#3)
A cohort of##3##3##(2008-9#1)(2010-12#1)(2011-2#1)
A collection of##3##3##(2008-10#3)
A collection##4##2##(2008-10#4)
A colorimetric##3##2##(1992-11#1)(2008-10#2)
A column##3##2##(2008-10#2)(2008-8#1)
A combination of the##2##4##(1997-3#1)(2008-3#1)
A combination of these##3##4##(1990-8#1)(1991-6#1)(1996-12#1)
A combination of##21##3##(1990-8#1)(1991-12#1)(1991-6#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#2)(2013-1#1)
A combination##22##2##(1990-8#1)(1991-12#1)(1991-6#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#2)(2013-1#1)
A combined##3##2##(2008-10#2)(2010-3#1)
A comment##4##2##(1993-3#1)(2013-8#3)
A commercial##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
A commercially available##3##3##(2008-10#3)
A common feature of##2##4##(2008-11#2)
A common##13##2##(1992-9#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-3#1)(2009-8#1)(2010-3#1)(2011-2#1)
A community##2##2##(1992-1#1)(2013-1#1)
A compact##5##2##(2008-10#3)(2008-3#2)
A companion##2##2##(2008-3#1)(2010-8#1)
A comparable##2##2##(1991-3#1)(2008-10#1)
A comparative analysis of the##2##5##(2008-10#2)
A comparative analysis of##6##4##(1993-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
A comparative analysis##9##3##(1993-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
A comparative perspective##2##3##(1995-2#1)(2009-8#1)
A comparative study of the##6##5##(1993-6#1)(1997-6#1)(2008-10#3)(2008-9#1)
A comparative study of##18##4##(1993-6#1)(1996-2#1)(1997-6#1)(2008-10#10)(2008-9#1)(2010-10#1)(2010-3#1)(2013-1#2)
A comparative study on the##3##5##(2008-10#1)(2010-12#1)(2010-6#1)
A comparative study was made##2##5##(2008-10#2)
A comparative study was##3##4##(2008-10#3)
A comparative study##30##3##(1993-6#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2013-1#2)
A comparative##50##2##(1993-6#2)(1994-6#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#4)
A comparison between the##2##4##(2008-10#2)
A comparison between##5##3##(2008-10#3)(2008-5#1)(2012-2#1)
A comparison is made##3##4##(2008-10#1)(2010-7#1)(2012-3#1)
A comparison is##5##3##(2008-10#3)(2010-7#1)(2012-3#1)
A comparison of laparoscopically assisted vaginal hysterectomy##2##7##(1993-12#1)(1994-2#1)
A comparison of methods for##2##5##(1995-9#1)(2008-10#1)
A comparison of the deduced##2##5##(1993-6#2)
A comparison of the experimental and##2##6##(2008-3#2)
A comparison of the##19##4##(1993-11#1)(1993-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#3)(2009-8#1)(2013-1#1)
A comparison of two##5##4##(1991-1#1)(1992-3#1)(1994-9#1)(2008-10#1)(2008-3#1)
A comparison of##65##3##(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#6)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
A comparison study##2##3##(1992-2#1)(2008-10#1)
A comparison with the##4##4##(1994-1#1)(2008-10#2)(2008-11#1)
A comparison with##8##3##(1994-1#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)
A comparison##87##2##(1991-1#1)(1991-3#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-3#7)(2008-5#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-7#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
A competitive##7##2##(1991-9#1)(1995-12#1)(2008-10#2)(2008-11#3)
A complementary##2##2##(2008-3#1)(2008-9#1)
A complete analysis##3##3##(2008-10#3)
A complete##13##2##(1991-8#1)(1992-2#1)(1995-3#1)(2008-10#6)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
A complex##5##2##(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)
A component of##2##3##(2008-10#1)(2008-11#1)
A composite##3##2##(2008-10#2)(2008-8#1)
A comprehensive assessment##2##3##(1994-1#1)(2010-12#1)
A comprehensive comparison was made among the modifiers##2##8##(2008-10#2)
A comprehensive evaluation of##2##4##(2010-7#1)(2011-2#1)
A comprehensive evaluation##3##3##(2010-7#1)(2011-2#1)(2013-1#1)
A comprehensive review of the##2##5##(2008-10#1)(2013-1#1)
A comprehensive review of##4##4##(2008-10#1)(2010-8#1)(2013-1#2)
A comprehensive review##5##3##(2008-10#2)(2010-8#1)(2013-1#2)
A comprehensive##24##2##(1991-2#1)(1993-12#1)(1994-1#1)(1994-9#1)(2008-10#8)(2008-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#4)(2013-8#1)
A computational##3##2##(2008-10#2)(2008-3#1)
A computed tomography scan##3##4##(2010-10#1)(2010-12#1)(2012-2#1)
A computed tomography##4##3##(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
A computed##5##2##(2008-7#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
A computer program##4##3##(1993-3#1)(2008-10#2)(2008-3#1)
A computer search of the##2##5##(1990-2#1)(1996-2#1)
A computer##9##2##(1990-2#1)(1993-3#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
A computer-controlled##2##2##(2008-10#2)
A concentration of##2##3##(2008-10#2)
A concentration##3##2##(2008-10#3)
A concept##3##2##(1991-6#1)(1997-1#1)(2008-3#1)
A conceptual##2##2##(1997-2#1)(2008-12#1)
A concerted##2##2##(1996-12#1)(2008-10#1)
A concise##3##2##(2008-10#3)
A conformational##2##2##(1990-5#1)(1995-6#1)
A consecutive##2##2##(2007-12#1)(2008-9#1)
A consensus paper from the EU Thematic Network &quot##2##9##(2008-10#2)
A conservative##2##2##(1991-6#1)(2012-3#1)
A considerable##5##2##(1991-3#1)(1993-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
A consideration of the##2##4##(1993-3#1)(2009-12#1)
A consideration of##3##3##(1993-3#1)(2008-10#1)(2009-12#1)
A consistent##3##2##(1990-12#1)(1996-2#1)(2008-11#1)
A consortium of##2##3##(1997-1#1)(2008-7#1)
A constant##4##2##(1995-3#1)(2008-10#1)(2008-11#2)
A continuous flow system##2##4##(2008-10#2)
A continuous##6##2##(1996-11#1)(1996-12#1)(2008-10#4)
A continuous-flow##3##2##(2008-10#3)
A contribution##2##2##(1993-8#1)(1995-2#1)
A control group##2##3##(2009-12#1)(2013-1#1)
A control strategy##2##3##(1997-2#1)(2012-2#1)
A control##7##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-2#1)(2013-1#1)
A controlled trial of##2##4##(1991-12#1)(1997-7#1)
A controlled##5##2##(1991-12#1)(1991-2#1)(1991-3#1)(1997-3#1)(1997-7#1)
A convenience sample of 37##2##5##(2008-12#1)(2013-8#1)
A convenience sample of##4##4##(1993-2#1)(2008-12#1)(2010-11#1)(2013-8#1)
A core##2##2##(1991-3#1)(1995-2#1)
A correct##2##2##(2008-10#2)
A correction factor##2##3##(2008-11#1)(2008-3#1)
A correction##4##2##(2008-11#1)(2008-3#3)
A correlation between##2##3##(2008-10#1)(2013-8#1)
A correlation was established##2##4##(2008-10#2)
A correlation was##3##3##(2008-10#2)(2011-2#1)
A correlation##7##2##(2008-10#5)(2011-2#1)(2013-8#1)
A cost##2##2##(1997-2#1)(2008-11#1)
A coulometric##3##2##(2008-10#3)
A critical analysis of the##2##5##(1992-1#1)(1997-5#1)
A critical analysis of##3##4##(1992-1#1)(1995-1#1)(1997-5#1)
A critical comparison of##2##4##(1992-3#1)(2008-10#1)
A critical evaluation of##3##4##(1990-5#1)(2008-2#1)(2013-8#1)
A critical examination of##2##4##(2008-10#2)
A critical review of##2##4##(2008-10#1)(2013-1#1)
A critical step##2##3##(2008-9#1)(2011-2#1)
A critical##20##2##(1990-5#1)(1990-8#1)(1992-1#1)(1992-3#1)(1993-3#1)(1995-1#1)(1997-5#1)(2008-10#7)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
A cross-sectional study was carried out##2##6##(2008-7#1)(2011-2#1)
A cross-sectional study was##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
A cross-sectional study##8##3##(2008-10#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
A cross-sectional survey##2##3##(2011-1#1)(2011-2#1)
A cross-sectional##15##2##(2008-10#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)
A culture##2##2##(2008-11#1)(2008-4#1)
A current##4##2##(1991-11#1)(1992-1#1)(2008-9#1)(2011-2#1)
A cw##2##2##(2008-3#2)
A cycle time of 10 min allowed##2##7##(2008-11#2)
A cystoscopy##2##2##(2008-10#1)(2012-2#1)
A cytological##2##2##(1997-2#1)(2008-10#1)
A data base##2##3##(1991-2#1)(2008-11#1)
A data##3##2##(1991-2#1)(2008-11#1)(2009-12#1)
A database for##2##3##(1994-9#1)(2008-1#1)
A database##4##2##(1994-9#1)(2008-1#1)(2008-10#1)(2009-2#1)
A decade of##3##3##(1990-11#1)(1992-3#1)(1994-3#1)
A decade##4##2##(1990-11#1)(1992-3#1)(1994-3#1)(2010-7#1)
A decision##5##2##(1994-6#1)(2008-10#2)(2008-12#1)(2008-6#1)
A decrease in the##2##4##(1990-7#1)(2012-3#1)
A decrease in##6##3##(1990-12#1)(1990-7#1)(1994-8#1)(2008-10#1)(2009-8#1)(2012-3#1)
A decrease##9##2##(1990-11#1)(1990-12#1)(1990-7#1)(1994-8#1)(2008-10#3)(2009-8#1)(2012-3#1)
A definition of##3##3##(1991-2#1)(2008-6#1)(2008-7#1)
A definitive##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
A degree of##2##3##(2008-10#1)(2008-3#1)
A deletion##2##2##(1993-6#1)(2008-10#1)
A demonstration##2##2##(2008-10#2)
A dendrogram##2##2##(2008-10#2)
A description of the##3##4##(1992-1#1)(1993-1#1)(2008-11#1)
A descriptive cross-sectional study##2##4##(2011-2#1)(2012-12#1)
A descriptive study##2##3##(2007-12#1)(2012-12#1)
A descriptive survey##2##3##(2008-12#1)(2010-8#1)
A descriptive##12##2##(1997-4#1)(2007-12#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#3)
A design##2##2##(1996-12#1)(2008-3#1)
A detailed analysis of##2##4##(2008-10#1)(2009-10#1)
A detailed comparison##2##3##(2008-10#2)
A detailed description of##2##4##(2008-10#1)(2008-7#1)
A detailed study of##3##4##(2008-10#2)(2009-12#1)
A detailed##17##2##(1997-3#1)(1997-6#1)(2008-10#8)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2013-8#1)
A detection limit (3sigma) of 0##2##6##(2008-10#2)
A detection limit for##2##4##(2008-10#2)
A detection limit of 0##4##5##(2008-10#4)
A detection limit of 6##2##5##(2008-10#2)
A detection limit of##15##4##(2008-10#15)
A detection limit##22##3##(2008-10#21)(2008-3#1)
A detection##27##2##(2008-10#25)(2008-3#2)
A diagnosis of a##2##4##(2011-1#1)(2013-1#1)
A diagnosis of##9##3##(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
A diagnosis##11##2##(1993-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
A diagnostic procedure##2##3##(2007-12#1)(2008-10#1)
A diagnostic##5##2##(1991-11#1)(2007-12#1)(2008-10#1)(2010-3#1)(2013-1#1)
A difference in##2##3##(1997-4#1)(2013-8#1)
A difference##3##2##(1992-2#1)(1997-4#1)(2013-8#1)
A differential diagnosis##2##3##(1990-12#1)(2008-10#1)
A differential pulse##2##3##(2008-10#2)
A differential##7##2##(1990-12#1)(1995-6#1)(2008-10#4)(2008-2#1)
A differentiation##2##2##(1997-2#1)(2008-11#1)
A diffraction##2##2##(2008-3#2)
A dilemma in##2##3##(1994-12#1)(2009-5#1)
A diode##2##2##(2008-10#2)
A direct##13##2##(1994-11#1)(1996-12#1)(2008-10#8)(2008-5#1)(2008-9#1)(2009-9#1)
A discussion of the##2##4##(2008-3#2)
A discussion of##8##3##(1992-3#1)(1997-3#1)(2008-3#2)(2008-4#2)(2009-9#1)(2012-3#1)
A discussion on the##2##4##(2008-10#1)(2008-3#1)
A discussion on##3##3##(2008-10#1)(2008-3#1)(2011-3#1)
A discussion##11##2##(1992-3#1)(1997-3#1)(2008-10#1)(2008-3#3)(2008-4#2)(2009-9#1)(2011-3#1)(2012-3#1)
A distinction##2##2##(1991-1#1)(2010-1#1)
A diverse##2##2##(2008-10#1)(2011-2#1)
A dominant gene##2##3##(2008-10#2)
A dose##2##2##(2008-11#1)(2012-2#1)
A double##2##2##(1995-9#1)(2008-10#1)
A double-blind randomized vehicle-controlled clinical##2##5##(2008-5#2)
A double-blind##5##2##(1991-1#1)(1996-1#2)(2008-5#2)
A doubled haploid##2##3##(2008-10#1)(2008-8#1)
A dramatic##2##2##(1990-12#1)(2008-8#1)
A drop##2##2##(1993-2#1)(2008-9#1)
A dual column system##2##4##(2008-10#2)
A dual##4##2##(1997-3#1)(2008-10#3)
A dual-wavelength resonance##2##3##(2008-10#2)
A dynamic##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2013-1#1)
A facile##2##2##(2008-12#1)(2012-3#1)
A factor##2##2##(1991-11#1)(2008-10#1)
A factorial design was used##2##5##(2008-10#2)
A factorial design was##3##4##(2008-10#3)
A factorial design##6##3##(2008-10#6)
A fair##2##2##(1995-2#1)(2012-2#1)
A fast and simple##2##4##(2008-10#2)
A fast and##7##3##(2008-10#7)
A fast##14##2##(2008-10#11)(2008-11#1)(2008-3#1)(2012-2#1)
A feasibility study of##2##4##(1990-12#1)(1994-6#1)
A feasibility study##3##3##(1990-12#1)(1994-6#1)(2013-1#1)
A fee##2##2##(1992-5#1)(1997-5#1)
A female##4##2##(1991-6#1)(1994-12#1)(2008-7#1)(2012-3#1)
A few recent##2##3##(2008-10#1)(2008-11#1)
A few studies##2##3##(2013-1#2)
A few##18##2##(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
A field experiment was##3##4##(2008-10#2)(2008-12#1)
A field study at##2##4##(2008-10#1)(2008-12#1)
A field##10##2##(1995-3#1)(2008-10#6)(2008-12#2)(2009-8#1)
A fifth##3##2##(1997-8#1)(2008-10#1)(2012-12#1)
A final##2##2##(2008-10#2)
A firm##2##2##(2010-3#1)(2013-8#1)
A first##9##2##(1995-3#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-1#1)
A fixed##2##2##(1996-12#1)(2008-3#1)
A flexible##2##2##(2008-9#1)(2013-8#1)
A flow cell##3##3##(2008-10#3)
A flow injection (FI) method##2##5##(2008-10#2)
A flow injection (FI) spectrophotometric##3##5##(2008-10#3)
A flow injection (FI)##7##4##(2008-10#7)
A flow injection analysis (FIA)##3##5##(2008-10#2)(2008-11#1)
A flow injection analysis##7##4##(2008-10#6)(2008-11#1)
A flow injection method for the##2##6##(2008-10#2)
A flow injection method has been##2##6##(2008-10#2)
A flow injection method is##3##5##(2008-10#3)
A flow injection method on the basis of gas phase molecular absorption is described for the##2##16##(2008-10#2)
A flow injection method##9##4##(2008-10#9)
A flow injection spectrophotometric method##2##5##(2008-10#2)
A flow injection system##2##4##(2008-10#2)
A flow injection##38##3##(2008-10#37)(2008-11#1)
A flow system for the spectrophotometric determination of lead in##2##10##(2008-10#2)
A flow system for the##3##5##(2008-10#3)
A flow system with##2##4##(2008-10#2)
A flow system##8##3##(2008-10#8)
A flow type##2##3##(2008-10#2)
A flow##58##2##(1993-8#1)(2008-10#54)(2008-11#1)(2008-4#2)
A flow-based enzyme-linked immunosorbent assay##2##5##(2008-10#2)
A flow-based##3##2##(2008-10#3)
A flow-batch##2##2##(2008-10#2)
A flow-injection chemiluminescence##2##3##(2008-10#2)
A flow-injection method for the##2##5##(2008-10#2)
A flow-injection method##3##3##(2008-10#3)
A flow-injection procedure for##2##4##(2008-10#2)
A flow-injection procedure##3##3##(2008-10#3)
A flow-injection spectrophotometric##2##3##(2008-10#2)
A flow-injection system##2##3##(2008-10#2)
A flow-injection##22##2##(2008-10#22)
A flow-through fluorescent sensor##2##4##(2008-10#2)
A flow-through##5##2##(2008-10#5)
A fluorescence##2##2##(2008-10#1)(2008-2#1)
A fluorescent chemical sensor for Hg(II)##2##6##(2008-10#2)
A fluorescent##7##2##(2008-10#7)
A focus group##2##3##(2008-9#1)(2010-2#1)
A focus on##2##3##(2011-2#2)
A focus##4##2##(2008-9#1)(2010-2#1)(2011-2#2)
A focused##3##2##(2008-3#2)(2009-7#1)
A follow-up study##2##3##(1994-3#1)(1995-1#1)
A follow-up survey##2##3##(1997-1#1)(2008-9#1)
A follow-up##9##2##(1990-3#1)(1991-9#1)(1994-3#1)(1995-1#1)(1997-1#1)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
A for all heavy atoms##2##5##(1994-5#2)
A for all##3##3##(1994-5#3)
A for backbone atoms and##2##5##(1994-5#2)
A for##8##2##(1992-4#1)(1993-8#1)(1994-5#6)
A force##2##2##(1994-9#1)(2012-3#1)
A formal##2##2##(1996-1#1)(2008-6#1)
A formula for##2##3##(2008-3#1)(2008-8#1)
A formula##3##2##(2008-3#1)(2008-5#1)(2008-8#1)
A four##2##2##(1992-12#1)(2012-3#1)
A fraction of##2##3##(2008-10#1)(2008-3#1)
A fraction##3##2##(1992-6#1)(2008-10#1)(2008-3#1)
A fractional##2##2##(2008-10#1)(2008-3#1)
A framework for##3##3##(1997-1#1)(2008-12#1)(2010-12#1)
A framework to##2##3##(2007-9#1)(2008-11#1)
A framework##6##2##(1997-1#1)(2007-9#1)(2008-11#1)(2008-12#1)(2010-12#1)(2013-1#1)
A from Staphylococcus aureus##2##4##(1990-12#1)(1996-12#1)
A from the##2##3##(1991-12#1)(1992-4#1)
A from##7##2##(1990-12#1)(1991-12#1)(1992-4#1)(1996-12#1)(2008-10#1)(2008-9#1)(2009-8#1)
A full understanding of the##2##5##(2008-10#1)(2008-11#1)
A full##8##2##(1991-2#1)(2008-10#3)(2008-11#1)(2010-10#2)(2010-7#1)
A full-length cDNA clone##2##4##(1994-11#1)(1994-6#1)
A full-length cDNA##4##3##(1994-11#1)(1994-6#1)(1996-3#1)(2008-8#1)
A full-length##6##2##(1992-3#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-3#1)(2008-8#1)
A fully automated##5##3##(1993-2#1)(2008-10#4)
A fully##8##2##(1993-2#1)(2008-10#7)
A functional##2##2##(1997-2#1)(2008-9#1)
A functionally##2##2##(1993-12#2)
A fundamental##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
A further##10##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
A fusion##3##2##(1995-12#1)(2008-11#1)(2009-6#1)
A game##3##2##(2008-8#1)(2008-9#2)
A gas Chromatographic method for the detection and determination of##2##10##(2008-11#2)
A gas diffusion##2##3##(2008-10#2)
A gas##7##2##(2008-10#5)(2008-11#2)
A gene encoding##2##3##(2008-10#1)(2008-7#1)
A gene that##2##3##(2008-10#2)
A gene##17##2##(1991-5#3)(1993-9#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-8#1)(1997-9#1)(2008-10#5)(2008-7#1)(2008-8#1)(2010-6#1)
A gene-for-gene##2##2##(2008-10#2)
A general##19##2##(1992-1#1)(1992-11#1)(1992-2#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-8#1)
A generalized##2##2##(2008-10#1)(2008-7#1)
A genetic linkage##2##3##(2008-10#1)(2011-3#1)
A genetic model##2##3##(2008-10#1)(2008-8#1)
A genetic##12##2##(1995-2#1)(2008-10#5)(2008-7#3)(2008-8#1)(2008-9#1)(2011-3#1)
A genome##2##2##(2008-10#2)
A genomic clone of##2##4##(1993-6#1)(1996-6#1)
A genomic clone##4##3##(1993-3#1)(1993-6#1)(1996-6#1)(1996-8#1)
A genomic##6##2##(1993-3#1)(1993-6#1)(1994-9#1)(1996-6#1)(1996-8#1)(2008-9#1)
A genotype##6##2##(2008-10#6)
A genotypes##2##2##(2008-10#2)
A glass##3##2##(2008-10#3)
A glimpse##2##2##(1994-12#1)(2008-6#1)
A glucose biosensor##3##3##(2008-10#3)
A gold##2##2##(2008-10#2)
A good agreement##2##3##(2008-10#2)
A good correlation was observed between the##2##7##(2008-10#1)(2008-7#1)
A good correlation was##4##4##(2008-10#3)(2008-7#1)
A good correlation##7##3##(1990-12#1)(2008-10#5)(2008-7#1)
A good linear##2##3##(2008-10#2)
A good result was##2##4##(2008-10#1)(2008-9#1)
A good separation of##2##4##(2008-10#2)
A good##30##2##(1990-12#1)(1995-2#1)(2008-10#21)(2008-5#1)(2008-7#1)(2008-9#2)(2010-8#2)(2011-10#1)
A gradient anion exchange chromatographic##2##5##(2008-10#2)
A graphical##2##2##(1992-12#1)(2008-9#1)
A graphite furnace atomic absorption method##3##6##(2008-10#3)
A graphite furnace atomic absorption##4##5##(2008-10#4)
A graphite##5##2##(2008-10#5)
A great proportion##2##3##(2008-7#1)(2009-8#1)
A great##7##2##(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
A greater understanding of the##2##5##(2008-10#1)(2008-8#1)
A greater##6##2##(1992-2#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-9#1)
A green##3##2##(2008-10#2)(2008-12#1)
A group of##14##3##(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-9#1)(2011-3#1)(2013-1#1)
A growing body of##2##4##(1990-9#1)(2008-11#1)
A growing number of studies##2##5##(2011-2#1)(2012-12#1)
A growing number of##4##4##(1994-12#1)(2011-2#2)(2012-12#1)
A growing##8##2##(1990-9#1)(1994-12#1)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#2)(2012-12#1)
A guide to##6##3##(1993-12#1)(1995-11#1)(1995-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
A guide##7##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
A had##2##2##(2008-10#1)(2008-9#1)
A hallmark of##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
A healthy##2##2##(2008-8#1)(2009-9#1)
A heterogeneous##2##2##(1990-12#1)(1990-2#1)
A hierarchical analysis##2##3##(2008-10#2)
A hierarchical##3##2##(2008-10#2)(2012-12#1)
A high degree of##4##4##(1991-6#1)(1993-2#1)(1996-5#1)(1996-6#1)
A high percentage of##2##4##(1991-6#1)(2012-3#1)
A high performance liquid chromatography (HPLC) method##2##7##(2008-10#2)
A high performance liquid chromatography (HPLC)##3##6##(2008-10#3)
A high performance liquid chromatography##5##5##(2008-10#5)
A high performance liquid##7##4##(1990-12#1)(2008-10#6)
A high preconcentration##2##3##(2008-10#2)
A high##37##2##(1990-12#1)(1991-6#2)(1993-2#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
A high-performance liquid chromatographic (HPLC) method##2##6##(2008-10#2)
A high-performance liquid chromatographic method##2##5##(1997-2#2)
A high-performance liquid chromatographic##4##4##(1997-2#2)(2008-10#2)
A high-performance liquid##5##3##(1997-2#2)(2008-10#3)
A higher proportion of##2##4##(2008-11#1)(2012-3#1)
A higher##13##2##(2008-10#4)(2008-11#3)(2010-12#1)(2010-4#1)(2011-10#1)(2012-12#1)(2012-3#2)
A highly selective and sensitive##3##5##(2008-10#3)
A highly selective##8##3##(2008-10#8)
A highly sensitive and selective method##2##6##(2008-10#2)
A highly sensitive and selective second derivative spectrophotometric method has been developed for the determination of##2##16##(2008-10#2)
A highly sensitive and selective spectrophotometric method##2##7##(2008-10#2)
A highly sensitive and selective##7##5##(2008-10#7)
A highly sensitive and simple##2##5##(2008-10#2)
A highly sensitive and##10##4##(2008-10#10)
A highly sensitive optical##2##4##(2008-10#2)
A highly sensitive potentiometric flow injection##2##6##(2008-10#2)
A highly sensitive procedure##2##4##(2008-10#2)
A highly sensitive spectrophotometric##2##4##(2008-10#2)
A highly sensitive##29##3##(2008-10#29)
A highly significant##2##3##(2008-10#1)(2013-8#1)
A highly##47##2##(1997-9#1)(2008-10#41)(2008-11#1)(2009-3#1)(2009-9#1)(2012-12#1)(2013-8#1)
A histological##2##2##(2008-10#2)
A histologically##2##2##(1990-2#1)(1994-1#1)
A historical perspective##2##3##(1991-1#1)(2010-4#1)
A historical##4##2##(1991-1#1)(2008-10#1)(2010-4#1)(2013-1#1)
A history of##7##3##(1991-3#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)
A holistic##2##2##(1997-3#1)(2009-9#1)
A home made##2##3##(2008-10#2)
A home##3##2##(1997-6#1)(2008-10#2)
A homology search for the products deduced from the##2##9##(1996-8#1)(1997-7#1)
A homology search for the##3##5##(1995-12#1)(1996-8#1)(1997-7#1)
A hospital##5##2##(1991-2#1)(1991-8#1)(1992-1#1)(2008-11#1)(2011-2#1)
A human small##2##3##(1990-8#1)(1994-8#1)
A human##6##2##(1990-8#1)(1992-3#2)(1994-11#1)(1994-8#1)(1997-1#1)
A hundred and##2##3##(2010-1#1)(2010-6#1)
A hybrid##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
A hydride generation##4##3##(2008-10#4)
A hydrogen peroxide biosensor##2##4##(2008-10#2)
A hydrogen##4##2##(2008-10#4)
A hydrophobic##3##2##(2008-10#3)
A hypothesis of##2##3##(2008-8#1)(2008-9#1)
A hypothesis##4##2##(2008-12#1)(2008-8#1)(2008-9#2)
A in the##4##3##(1990-12#1)(1990-5#1)(1991-12#1)(2008-10#1)
A in##26##2##(1990-12#4)(1990-5#1)(1991-12#2)(1992-9#1)(1994-8#1)(1995-8#1)(1996-5#2)(1997-7#2)(2008-10#6)(2010-4#1)(2012-12#3)(2012-2#1)(2012-3#1)
A increased [Ca2+]i in##2##4##(1992-6#2)
A induced a##3##3##(1995-8#3)
A into##4##2##(1997-1#2)(2008-10#2)
A is a##3##3##(1995-8#1)(2008-9#1)(2013-1#1)
A is an##2##3##(2008-10#1)(2011-2#1)
A is##13##2##(1990-12#1)(1995-8#2)(2008-10#4)(2008-5#2)(2008-9#1)(2011-2#2)(2013-1#1)
A joint##2##2##(2008-10#1)(2008-11#1)
A key feature of the##2##5##(1996-12#1)(2008-10#1)
A key issue##2##3##(1996-5#1)(2009-5#1)
A key##15##2##(1996-12#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-8#1)
A kind of##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
A kinetic method for the##2##5##(2008-10#2)
A kinetic model##3##3##(1994-5#1)(2008-11#2)
A kinetic study##3##3##(2008-10#2)(2008-7#1)
A kinetic##10##2##(1990-5#1)(1991-3#1)(1994-5#1)(2008-10#4)(2008-11#2)(2008-7#1)
A known##2##2##(2008-11#1)(2008-3#1)
A laboratory##2##2##(2008-10#1)(2008-3#1)
A large body of##3##4##(1992-5#1)(2008-6#1)(2009-3#1)
A large linear dynamic range from##2##6##(2008-10#2)
A large majority##2##3##(2010-8#1)(2011-2#1)
A large number of different##2##5##(2008-10#1)(2008-11#1)
A large number of##12##4##(1990-6#1)(1991-6#1)(1997-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
A large proportion of##2##4##(2008-11#1)(2008-5#1)
A large##30##2##(1990-6#1)(1991-6#1)(1992-5#1)(1995-5#1)(1997-9#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
A large-scale##2##2##(1992-12#1)(2008-10#1)
A larger value of##3##4##(2008-10#3)
A larger##8##2##(1992-3#1)(2008-10#5)(2009-8#1)(2010-10#1)
A left##6##2##(1997-3#1)(1997-8#1)(2012-3#2)(2013-1#2)
A lesson in##2##3##(1991-3#1)(1995-12#1)
A level##2##2##(1994-11#1)(2008-10#1)
A library of##2##3##(1991-9#1)(2011-1#1)
A light##6##2##(1991-12#1)(2007-12#1)(2008-10#3)(2012-3#1)
A likelihood ratio##2##3##(2008-10#1)(2008-11#1)
A likelihood##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
A limit of detection of##4##5##(2008-10#4)
A limit of detection##6##4##(2008-10#6)
A limit of##8##3##(2008-10#8)
A limited##4##2##(1994-5#1)(2008-10#2)(2012-3#1)
A linear calibration curve was##2##5##(2008-10#2)
A linear calibration curve##5##4##(2008-10#5)
A linear calibration graph was obtained in the##2##8##(2008-10#2)
A linear calibration graph was obtained##7##6##(2008-10#7)
A linear calibration graph##10##4##(2008-10#10)
A linear calibration was obtained in the range of##2##9##(2008-10#2)
A linear calibration##19##3##(2008-10#19)
A linear correlation was found##2##5##(1995-8#1)(2008-10#1)
A linear correlation##4##3##(1995-8#1)(2008-10#3)
A linear dependence of##2##4##(2008-10#2)
A linear dynamic range##2##4##(2008-10#2)
A linear range##2##3##(2008-10#2)
A linear relationship between the concentration of cationic polyelectrolyte and the end-point volume of the titrant exists in the concentration range from##2##22##(2008-10#2)
A linear relationship between the concentration of##3##7##(2008-10#3)
A linear relationship between the##6##5##(2008-10#5)(2010-4#1)
A linear relationship between##9##4##(2008-10#7)(2008-12#1)(2010-4#1)
A linear relationship was found between##2##6##(1995-8#1)(2008-10#1)
A linear relationship was found##3##5##(1995-8#1)(2008-10#2)
A linear relationship was observed between##2##6##(2008-10#2)
A linear relationship was##9##4##(1995-8#1)(2008-10#8)
A linear relationship##20##3##(1995-8#1)(2008-10#17)(2008-12#1)(2010-4#1)
A linear response is observed##2##5##(2008-10#2)
A linear response is##3##4##(2008-10#3)
A linear response range of##2##5##(2008-10#2)
A linear response was obtained between the detection limit##2##9##(2008-10#2)
A linear response was obtained##3##5##(2008-10#3)
A linear response was##4##4##(2008-10#4)
A linear response##13##3##(2008-10#13)
A linear working##2##3##(2008-10#2)
A linear##68##2##(1995-8#2)(2008-10#64)(2008-12#1)(2010-4#1)
A linkage##2##2##(2008-10#2)
A liquid##5##2##(2008-10#4)(2011-3#1)
A liquid-liquid extraction method using##2##5##(2008-10#2)
A literature review of##3##4##(2008-12#1)(2009-7#1)(2010-9#1)
A literature review was##2##4##(2008-10#1)(2012-12#1)
A literature review##7##3##(2008-10#2)(2008-12#1)(2008-8#1)(2009-7#1)(2010-9#1)(2012-12#1)
A literature search##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
A literature##11##2##(1997-8#1)(2008-10#3)(2008-12#1)(2008-8#2)(2009-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
A local##5##2##(1990-6#1)(1995-6#1)(1996-6#1)(2008-10#1)(2011-2#1)
A locus##2##2##(1993-11#1)(2008-10#1)
A logistic regression analysis##2##4##(2008-7#1)(2013-8#1)
A logistic regression##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
A logistic##4##2##(2008-10#2)(2008-7#1)(2013-8#1)
A long##3##2##(1991-12#1)(2008-10#2)
A long-term##3##2##(1995-11#1)(2008-5#1)(2012-3#1)
A longitudinal study of the##2##5##(2008-11#1)(2009-7#1)
A longitudinal##4##2##(1993-1#1)(2008-11#1)(2009-7#1)(2011-1#1)
A look at the##2##4##(1995-12#1)(2011-2#1)
A look at##4##3##(1995-12#1)(1995-3#1)(2011-2#1)(2012-2#1)
A look##5##2##(1995-12#1)(1995-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
A lot of##3##3##(1990-6#1)(2008-10#1)(2010-8#1)
A low temperature##2##3##(2008-10#2)
A low##12##2##(1990-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
A low-cost##2##2##(2008-10#2)
A lower##4##2##(1995-5#1)(2008-10#1)(2008-2#1)(2012-12#1)
A magnetic resonance imaging##2##4##(2009-8#1)(2012-2#1)
A magnetic resonance##3##3##(1997-8#1)(2009-8#1)(2012-2#1)
A magnetic##4##2##(1997-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
A major challenge for##2##4##(2008-11#1)(2008-7#1)
A major challenge in##2##4##(1996-11#1)(2009-12#1)
A major challenge##6##3##(1996-11#1)(2008-11#1)(2008-7#1)(2009-12#1)(2012-2#1)(2012-3#1)
A major component of##2##4##(1994-1#1)(2008-7#1)
A major focus##3##3##(1996-2#1)(1997-3#1)(2008-9#1)
A major gene for resistance to##2##6##(2008-10#2)
A major gene for##3##4##(2008-10#3)
A major goal##2##3##(2008-11#1)(2008-9#1)
A major limitation##2##3##(1997-1#1)(2008-11#1)
A major quantitative trait locus for##2##6##(2008-10#2)
A major##38##2##(1994-1#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-7#2)(2008-9#3)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
A majority of the##3##4##(2008-10#2)(2012-12#1)
A majority of##11##3##(1992-2#1)(1997-2#1)(2008-10#3)(2008-12#1)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
A majority##12##2##(1992-2#1)(1993-1#1)(1997-2#1)(2008-10#3)(2008-12#1)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
A mapping population of##3##4##(2008-10#3)
A marked##3##2##(1993-12#1)(1996-12#1)(2012-12#1)
A mass##5##2##(1991-3#1)(2008-10#2)(2008-11#1)(2010-5#1)
A mathematical model is presented##2##5##(2008-7#2)
A mathematical model of##4##4##(2008-10#1)(2008-7#2)(2013-8#1)
A mathematical model##10##3##(2008-10#2)(2008-7#6)(2008-9#1)(2013-8#1)
A mathematical##15##2##(1992-9#1)(2008-10#5)(2008-7#7)(2008-9#1)(2013-8#1)
A maximal##2##2##(1995-8#1)(2013-1#1)
A maximum##7##2##(2008-10#3)(2008-11#1)(2008-2#2)(2013-1#1)
A may be##2##3##(1990-12#1)(1993-8#1)
A mean##6##2##(1997-8#1)(2008-10#2)(2008-3#2)(2012-2#1)
A mechanism for the##3##4##(2008-10#1)(2008-8#1)(2009-6#1)
A mechanism for##5##3##(1995-2#1)(2008-10#2)(2008-8#1)(2009-6#1)
A mechanism is proposed to##2##5##(1996-5#1)(2008-10#1)
A mechanism is proposed##3##4##(1996-5#1)(2008-10#2)
A mechanism of##3##3##(1992-6#1)(2008-2#1)(2009-8#1)
A mechanism##17##2##(1992-6#1)(1995-2#1)(1996-5#3)(2008-10#6)(2008-2#1)(2008-8#3)(2009-6#1)(2009-8#1)
A media##2##2##(2010-2#1)(2010-8#1)
A mediator-free##2##2##(2008-10#2)
A medical##2##2##(1990-6#1)(2012-3#1)
A membrane##4##2##(1991-5#1)(2008-10#3)
A mentor##2##2##(1993-12#1)(2008-7#1)
A meta-analysis of##3##3##(2008-10#1)(2008-9#1)(2010-2#1)
A meta-analysis##8##2##(1992-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-2#1)(2013-8#1)
A metabolic##2##2##(2008-3#1)(2008-5#1)
A method based on the##3##5##(2008-10#3)
A method based on##11##4##(2008-10#10)(2008-5#1)
A method developed##2##3##(2008-10#1)(2009-6#1)
A method for determination of##2##5##(2008-10#2)
A method for preconcentrating Zr from large volumes of seawater using MnO(2)-impregnated fibers##2##13##(2008-10#2)
A method for simultaneous##2##4##(2008-10#2)
A method for spectrophotometric determination of##2##6##(2008-10#2)
A method for the determination of trace amounts of##2##9##(2008-10#2)
A method for the determination of##18##6##(2008-10#18)
A method for the measurement of##2##6##(1990-11#1)(2008-11#1)
A method for the preconcentration and##2##6##(2008-10#2)
A method for the preconcentration##3##5##(2008-10#3)
A method for the preparation of##2##6##(1990-12#1)(2008-11#1)
A method for the simultaneous determination of##2##7##(2008-10#2)
A method for the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
A method for the simultaneous##5##5##(2008-10#5)
A method for the trace analysis of##2##7##(2008-10#2)
A method for the##41##4##(1990-11#1)(1990-12#1)(2008-10#36)(2008-11#3)
A method for##68##3##(1990-11#1)(1990-12#1)(1991-12#1)(2008-10#55)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2013-1#1)
A method has been described for the direct##2##8##(2008-10#2)
A method has been developed for the##2##7##(2008-10#2)
A method has been developed for##4##6##(2008-10#3)(2008-3#1)
A method has been developed##5##5##(1992-12#1)(2008-10#3)(2008-3#1)
A method has been##7##4##(1992-12#1)(2008-10#5)(2008-3#1)
A method is described for the##3##6##(2008-10#2)(2008-2#1)
A method is described for##5##5##(2008-10#2)(2008-11#2)(2008-2#1)
A method is described##6##4##(1991-2#1)(2008-10#2)(2008-11#2)(2008-2#1)
A method is developed for##2##5##(2008-10#2)
A method is proposed for the extraction and individual separation of trivalent gallium##2##13##(2008-10#2)
A method is proposed for the simultaneous determination of##3##9##(2008-10#3)
A method is proposed for the##7##6##(2008-10#7)
A method is##17##3##(1991-2#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#1)
A method of##16##3##(1992-2#1)(1993-1#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)
A method to##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
A method using a##3##4##(2008-10#2)(2011-2#1)
A method using##4##3##(2008-10#3)(2011-2#1)
A method was developed for the determination of##2##8##(2008-10#2)
A method was developed for the##4##6##(2008-10#4)
A method was developed for##5##5##(2008-10#5)
A method was developed##6##4##(1997-2#1)(2008-10#5)
A method##140##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1997-2#1)(2007-12#1)(2008-10#101)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
A methodology based on##2##4##(2008-10#1)(2011-2#1)
A methodology for##3##3##(1994-12#1)(2008-10#2)
A methodology##7##2##(1994-12#1)(2008-10#5)(2011-2#1)
A micellar##2##2##(2008-10#2)
A micro##3##2##(2008-10#2)(2008-8#1)
A microcomputer##2##2##(2008-10#2)
A microdrop of##2##3##(2008-10#2)
A microfabricated##3##2##(2008-10#3)
A microspray nozzle##2##3##(1994-2#2)
A microwave digestion##3##3##(2008-10#3)
A microwave##4##2##(2008-10#4)
A microwave-assisted##2##2##(2008-10#2)
A middle##2##2##(2011-2#1)(2013-1#1)
A minimal##2##2##(2008-8#1)(2008-9#1)
A minimally##2##2##(2011-2#1)(2012-2#1)
A minimum of##4##3##(1990-9#1)(1992-9#1)(2008-10#2)
A minimum##6##2##(1990-9#1)(1992-9#1)(2008-10#2)(2008-3#2)
A minor procedure? Paediatr Child Health 2007##2##7##(2008-11#2)
A minor procedure?##3##3##(2008-11#3)
A mixed##4##2##(2008-10#4)
A mixture of TNT##2##4##(2008-10#2)
A mixture of##8##3##(2008-10#4)(2008-11#2)(2008-7#2)
A mixture##10##2##(2008-10#6)(2008-11#2)(2008-7#2)
A model based on##2##4##(2008-10#1)(2008-7#1)
A model for the solution structure of##2##7##(1994-5#2)
A model for the##5##4##(1994-5#2)(1996-3#1)(2008-10#1)(2008-7#1)
A model for##16##3##(1990-8#1)(1994-3#1)(1994-5#2)(1996-2#1)(1996-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2011-2#1)
A model is##2##3##(1996-2#2)
A model of movement dysfunction provides a classification system guiding diagnosis and therapeutic care in spinal pain and related musculoskeletal syndromes##2##21##(2008-12#2)
A model of the##3##4##(2008-10#1)(2008-8#2)
A model of##10##3##(1991-1#1)(1992-4#1)(2008-10#1)(2008-12#2)(2008-8#3)(2008-9#2)
A model system##2##3##(1995-9#1)(2009-8#1)
A model was developed##4##4##(2008-10#3)(2008-3#1)
A model##46##2##(1990-8#1)(1991-1#1)(1992-12#1)(1992-4#1)(1993-8#1)(1994-3#1)(1994-5#3)(1995-3#1)(1995-9#1)(1996-2#3)(1996-3#1)(2008-10#8)(2008-12#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-8#1)(2011-2#1)
A model-based approach##2##3##(2008-10#1)(2013-8#1)
A modern##2##2##(2012-12#1)(2013-1#1)
A modification of the##5##4##(1994-8#1)(2008-10#1)(2008-7#2)(2008-9#1)
A modification of##6##3##(1994-8#1)(2008-10#2)(2008-7#2)(2008-9#1)
A modified##14##2##(1993-1#1)(1996-12#1)(2008-10#8)(2008-11#2)(2008-8#1)(2009-10#1)
A molecular marker##2##3##(2008-10#2)
A molecular##7##2##(1995-11#1)(2008-10#3)(2011-2#3)
A monoclonal antibody against##2##4##(1995-6#1)(1997-1#1)
A monoclonal antibody##5##3##(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#2)
A more##13##2##(1990-11#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2009-5#1)
A morphological study##2##3##(2008-7#1)(2011-2#1)
A morphological##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
A mouse##2##2##(1996-12#1)(2008-4#1)
A much##2##2##(1995-8#1)(2008-11#1)
A multi-center##2##2##(1997-7#1)(2008-11#1)
A multi-method##2##2##(2008-11#1)(2008-12#1)
A multicentre##2##2##(2008-3#1)(2008-5#1)
A multicommutated##3##2##(2008-10#3)
A multicommutation-based##2##2##(2008-10#2)
A multicommuted flow system for##2##5##(2008-10#2)
A multicommuted flow system##3##4##(2008-10#3)
A multidisciplinary approach##4##3##(1991-3#1)(1994-1#1)(1994-3#1)(2011-2#1)
A multidisciplinary##8##2##(1991-3#1)(1991-6#1)(1994-1#1)(1994-3#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
A multilevel##2##2##(2008-12#1)(2013-8#1)
A multiple regression model##3##4##(1992-1#1)(2008-10#1)(2013-1#1)
A multivariate##7##2##(1990-8#1)(1991-3#1)(1996-12#1)(2008-10#3)(2008-5#1)
A multiwavelength##2##2##(2008-10#1)(2008-3#1)
A murine##3##2##(1995-6#1)(2008-10#1)(2008-4#1)
A mutant##4##2##(1995-2#1)(1995-6#1)(2008-9#2)
A national consensus on approved and validated instruments for nursing assessment should be made available in the wards as a priority##2##21##(2013-1#2)
A national survey##2##3##(1991-11#1)(1991-12#1)
A national##7##2##(1991-11#1)(1991-12#1)(1994-12#1)(1997-2#1)(2011-1#1)(2013-1#2)
A natural##3##2##(1994-12#1)(2008-10#2)
A naturally occurring##2##3##(1994-11#1)(2008-10#1)
A naturally##3##2##(1994-11#1)(1995-9#1)(2008-10#1)
A nebulizer system##2##3##(1995-3#2)
A negative correlation##2##3##(2008-10#1)(2008-11#1)
A negative effect of##2##4##(1992-11#1)(2008-10#1)
A negative##9##2##(1992-11#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2011-2#1)
A neighbor-joining##2##2##(2008-12#1)(2013-8#1)
A neonate with a challenging##2##5##(2013-8#2)
A nested##2##2##(2008-10#2)
A neural network model##2##4##(2008-11#1)(2008-8#1)
A neural##4##2##(2008-11#2)(2008-8#1)(2009-5#1)
A new PVC membrane##2##4##(2008-10#2)
A new algorithm for##2##4##(2008-10#1)(2008-3#1)
A new algorithm##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
A new amperometric biosensor##2##4##(2008-10#2)
A new amperometric##3##3##(2008-10#3)
A new analytical method for the determination of##3##8##(2008-10#3)
A new analytical method for the##4##6##(2008-10#4)
A new analytical method##5##4##(2008-10#5)
A new analytical procedure for the##2##6##(2008-10#2)
A new analytical procedure##3##4##(2008-10#3)
A new analytical##9##3##(2008-10#8)(2010-11#1)
A new and simple method##2##5##(2008-10#2)
A new and##6##3##(2008-10#6)
A new antibody immobilization strategy##2##5##(2008-10#2)
A new application of##3##4##(2008-10#2)(2008-11#1)
A new approach for##3##4##(1997-3#1)(2008-10#2)
A new approach has been developed and##2##7##(2008-10#1)(2008-11#1)
A new approach to the##2##5##(2008-10#1)(2012-2#1)
A new approach to##9##4##(1992-1#1)(1993-12#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#3)(2012-2#1)
A new approach##16##3##(1992-1#1)(1993-12#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#2)(2012-2#1)
A new bulk acoustic wave (BAW)##2##6##(2008-10#2)
A new capillary electrophoresis (CE)##2##5##(2008-10#2)
A new catalytic kinetic##2##4##(2008-10#2)
A new catalytic##3##3##(2008-10#3)
A new chelating polymeric sorbent##2##5##(2008-10#2)
A new chelating resin##3##4##(2008-10#3)
A new chelating##8##3##(2008-10#8)
A new chemiluminescence (CL) method##2##5##(2008-10#2)
A new chemiluminescence (CL)##3##4##(2008-10#3)
A new class of##5##4##(1997-1#1)(2008-10#3)(2009-9#1)
A new device##3##3##(1995-1#2)(2008-5#1)
A new electrochemical immunoassay strategy##2##5##(2008-10#2)
A new electrochemical##3##3##(2008-10#3)
A new experimental##3##3##(2008-3#1)(2008-5#1)(2008-9#1)
A new family of##2##4##(1996-5#1)(2008-12#1)
A new flow injection on-line##2##5##(2008-10#2)
A new flow injection##6##4##(2008-10#6)
A new flow##7##3##(2008-10#7)
A new flow-injection##2##3##(2008-10#2)
A new functionalized resin##2##4##(2008-10#2)
A new functionalized##3##3##(2008-10#3)
A new gene##2##3##(2008-8#2)
A new generation of##2##4##(1991-12#1)(2008-10#1)
A new graphical method##2##4##(1995-12#1)(2008-10#1)
A new highly sensitive and selective chromogenic reagent##2##8##(2008-10#2)
A new highly sensitive##3##4##(2008-10#3)
A new highly##4##3##(2008-10#4)
A new ion-selective##2##3##(2008-10#2)
A new kind of##2##4##(2008-10#2)
A new kinetic##2##3##(2008-10#2)
A new mechanism of##3##4##(1992-8#1)(2008-5#1)(2008-8#1)
A new method for determination of##2##6##(2008-10#2)
A new method for the determination of##8##7##(2008-10#8)
A new method for the##15##5##(2008-10#14)(2008-5#1)
A new method for##26##4##(1995-3#1)(2008-10#22)(2008-3#2)(2008-5#1)
A new method has been developed##2##6##(2008-10#2)
A new method is presented##2##5##(2008-10#1)(2008-2#1)
A new method is##4##4##(2008-10#3)(2008-2#1)
A new method of preparing fiber-optic DNA biosensor and its array for##2##12##(2008-9#2)
A new method of##6##4##(2008-10#3)(2008-3#1)(2008-9#2)
A new method to##4##4##(1993-3#1)(2008-10#2)(2008-5#1)
A new method using a##2##5##(2008-10#2)
A new method using##4##4##(2008-10#4)
A new method was developed##2##5##(2008-10#2)
A new method##53##3##(1990-2#1)(1993-3#1)(1995-3#1)(2008-10#41)(2008-2#1)(2008-3#4)(2008-5#2)(2008-9#2)
A new micelle-mediated phase separation of metal ions##2##8##(2008-10#2)
A new model for##4##4##(1991-7#1)(1994-12#1)(2008-12#1)(2008-9#1)
A new model of##2##4##(2008-8#1)(2010-6#1)
A new model##7##3##(1991-7#1)(1994-12#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-6#1)
A new optical##2##3##(2008-10#1)(2008-3#1)
A new pH-metric method##2##4##(2008-10#2)
A new paradigm for##2##4##(2008-4#1)(2013-1#1)
A new potentiometric##2##3##(2008-10#2)
A new preparation##2##3##(1994-11#1)(2008-11#1)
A new procedure is##2##4##(2008-10#2)
A new procedure##5##3##(2008-10#5)
A new program##2##3##(1991-2#1)(2008-8#1)
A new rapid and##2##4##(1994-5#1)(2008-10#1)
A new resin##2##3##(2008-10#2)
A new sample preparation procedure##2##5##(2008-10#2)
A new sample preparation##3##4##(2008-10#3)
A new selenite##2##3##(2008-10#2)
A new sensitive##7##3##(1990-2#1)(2008-10#6)
A new sequential injection##2##4##(2008-10#2)
A new series of##2##4##(1996-6#1)(2008-11#1)
A new simple and reliable method##2##6##(2008-10#2)
A new simple and##5##4##(2008-10#5)
A new simple##8##3##(2008-10#8)
A new solid-phase##2##3##(1995-6#1)(2008-10#1)
A new species of##2##4##(2008-6#2)
A new spectrofluorimetric##2##3##(2008-10#2)
A new spectrophotometric method##2##4##(2008-10#2)
A new strategy for##5##4##(1995-3#1)(2008-10#4)
A new strategy##6##3##(1995-3#1)(2008-10#5)
A new study of the##2##5##(2008-10#2)
A new study##3##3##(1994-8#1)(2008-10#2)
A new technique for##2##4##(1990-9#1)(2008-10#1)
A new technique##6##3##(1990-9#1)(2008-10#4)(2008-3#1)
A new theoretical##2##3##(2008-3#2)
A new type of a##2##5##(2008-10#2)
A new type of##11##4##(2008-10#8)(2008-11#1)(2008-12#1)(2012-3#1)
A new way to##2##4##(1995-12#1)(2008-6#1)
A new way##3##3##(1995-12#1)(2008-6#2)
A new##440##2##(1990-12#3)(1990-2#2)(1990-8#3)(1990-9#2)(1991-12#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#4)(1995-6#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#4)(2008-10#278)(2008-11#18)(2008-12#5)(2008-2#1)(2008-3#22)(2008-4#1)(2008-5#8)(2008-6#6)(2008-7#2)(2008-8#7)(2008-9#7)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
A newer##2##2##(2008-10#1)(2008-5#1)
A newly##4##2##(1991-1#1)(1997-8#1)(2008-10#1)(2011-2#1)
A noise-equivalent##2##2##(2008-3#1)(2009-5#1)
A normal##2##2##(2010-4#1)(2011-2#1)
A not##2##2##(2008-10#1)(2008-7#1)
A notable advantage of the method is that##2##8##(2008-10#1)(2008-3#1)
A notable##3##2##(1996-6#1)(2008-10#1)(2008-3#1)
A note on##2##3##(1992-9#1)(2008-12#1)
A note##3##2##(1992-9#1)(2008-12#1)(2008-6#1)
A novel analytical##2##3##(2008-10#1)(2008-2#1)
A novel and simple##2##4##(2008-10#2)
A novel and##6##3##(2008-10#5)(2008-9#1)
A novel approach for##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
A novel approach to##3##4##(2008-10#3)
A novel approach##10##3##(1993-8#1)(2008-10#6)(2008-6#1)(2008-8#1)(2013-8#1)
A novel biosensor for##2##4##(2008-10#2)
A novel capillary microliter##2##4##(2008-10#2)
A novel capillary##3##3##(2008-10#3)
A novel chemiluminescence (CL) flow system for the determination of##2##10##(2008-10#2)
A novel chemiluminescence (CL) system for##2##6##(2008-10#2)
A novel chemiluminescence (CL) system##4##5##(2008-10#4)
A novel chemiluminescence (CL)##9##4##(2008-10#9)
A novel chemiluminescence##10##3##(2008-10#10)
A novel electrochemical sensor##2##4##(2008-10#2)
A novel electrochemical##3##3##(2008-10#3)
A novel ex vivo technique##2##5##(2008-5#2)
A novel feeding strategy##2##4##(2008-7#2)
A novel film##2##3##(2008-10#2)
A novel flow##3##3##(1990-12#1)(2008-10#2)
A novel flow-injection chemiluminescence##2##4##(2008-10#2)
A novel flow-injection##4##3##(2008-10#4)
A novel fluorescent##2##3##(2008-10#2)
A novel gene encoding a##2##5##(1992-9#1)(1997-7#1)
A novel kinetic##2##3##(2008-10#2)
A novel method for determination of##2##6##(2008-10#2)
A novel method for storage of medical records and documents##2##10##(1994-3#2)
A novel method for the determination of##3##7##(2008-10#3)
A novel method for the##5##5##(2008-10#5)
A novel method for##14##4##(1994-3#2)(2008-10#10)(2008-8#1)(2010-6#1)
A novel method is proposed for the##2##7##(2008-10#2)
A novel method is##3##4##(2008-10#3)
A novel method of##3##4##(2008-10#2)(2011-2#1)
A novel method##20##3##(1994-3#2)(2008-10#15)(2008-8#1)(2010-6#1)(2011-2#1)
A novel potentiometric##2##3##(2008-10#2)
A novel procedure##3##3##(2008-10#2)(2008-6#1)
A novel sensitive##2##3##(2008-10#2)
A novel simple##2##3##(2008-10#1)(2008-5#1)
A novel spectrofluorimetric##2##3##(2008-10#2)
A novel spectrophotometric##2##3##(2008-10#2)
A novel stopped flow injection-amperometric##2##5##(2008-10#2)
A novel strategy for##2##4##(2008-10#1)(2008-8#1)
A novel strategy##3##3##(2008-10#2)(2008-8#1)
A novel system##2##3##(2008-3#1)(2012-3#1)
A novel technique##2##3##(2008-10#1)(2008-9#1)
A novel tetrachlorothallate##2##3##(2008-10#2)
A novel thin-layer amperometric detector##2##5##(2008-10#2)
A novel##217##2##(1990-12#1)(1990-5#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-2#2)(1997-3#1)(1997-7#1)(2007-11#2)(2008-10#135)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#2)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
A nuclear##2##2##(1992-1#1)(2008-7#1)
A nucleotide sequence##2##3##(1995-6#1)(2008-9#1)
A number of new crown-formazans with 14 and 15 membered rings have been##2##13##(2008-10#2)
A number of regulatory##2##4##(2008-10#1)(2010-10#1)
A number of studies have##3##5##(1992-2#1)(2008-11#1)(2008-12#1)
A number of synthetic peptides are significant commercial or pharmaceutical products##2##11##(2008-4#2)
A number of##70##3##(1990-11#2)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-4#1)(2013-8#1)
A numerical##3##2##(1990-11#1)(2008-3#1)(2013-8#1)
A of applied current##2##4##(2008-10#2)
A of the##2##3##(1990-5#1)(1994-5#1)
A of##5##2##(1990-5#1)(1994-5#1)(1995-5#1)(2008-10#2)
A one-step##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
A or B##4##3##(1993-11#1)(2008-10#2)(2008-9#1)
A or##16##2##(1990-11#1)(1990-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#2)(1994-8#1)(1997-3#1)(2008-10#4)(2008-8#1)(2008-9#1)
A pH##3##2##(2008-10#3)
A pair of well-defined redox waves##2##6##(2008-10#2)
A pair of##8##3##(1991-12#1)(2008-10#4)(2008-3#1)(2008-8#1)(2011-3#1)
A panel of##7##3##(1995-2#1)(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-5#1)
A paradigm##2##2##(2008-11#1)(2013-1#1)
A parallel##5##2##(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)
A parent##2##2##(2008-11#1)(2008-12#1)
A parent's##2##2##(1992-3#1)(2008-11#1)
A part of the##3##4##(1992-12#1)(2008-11#1)(2011-3#1)
A partial cDNA##2##3##(1993-6#1)(1995-2#1)
A partial least squares##2##4##(2008-10#2)
A partial##12##2##(1992-12#1)(1993-6#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-8#1)
A particular##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
A passive##2##2##(2008-10#2)
A patient who##4##3##(1992-3#1)(2008-11#1)(2008-8#1)(2008-9#1)
A patient with##6##3##(1990-12#1)(1994-9#1)(1996-9#1)(2008-7#1)(2010-10#1)(2012-2#1)
A patient##16##2##(1990-12#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-9#1)(1996-9#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
A patients##2##2##(2010-7#1)(2012-12#1)
A pediatric##2##2##(2011-2#1)(2013-1#1)
A period of##2##3##(2008-5#2)
A permanent##2##2##(1991-11#1)(1996-1#1)
A personal perspective##2##3##(2008-11#2)
A personal view of##2##4##(1994-12#1)(1995-12#1)
A personal##6##2##(1994-12#1)(1995-12#1)(1996-12#1)(2008-11#3)
A perspective on management development in##2##6##(1994-1#2)
A perspective on##3##3##(1994-1#2)(1995-5#1)
A perspective##4##2##(1994-1#2)(1995-5#1)(2008-10#1)
A phase II study##2##4##(1992-2#1)(1993-2#1)
A phase II##3##3##(1992-2#1)(1993-2#1)(2008-5#1)
A phase##5##2##(1992-2#1)(1993-2#1)(2008-5#2)(2012-2#1)
A phenomenological study##2##3##(2008-11#1)(2008-12#1)
A phenomenological##5##2##(2008-11#2)(2008-12#1)(2008-7#1)(2013-8#1)
A phloem-restricted##2##2##(2008-10#2)
A photoacoustic##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
A photochemical##2##2##(2008-10#2)
A phylogenetic analysis of##2##4##(2008-10#2)
A phylogenetic tree##4##3##(1997-7#1)(2008-10#3)
A phylogenetic##6##2##(1997-7#1)(2008-10#5)
A physical##4##2##(1996-3#1)(2007-11#1)(2008-3#1)(2008-9#1)
A piezoelectric##5##2##(2008-10#4)(2008-3#1)
A pilot study of##2##4##(2009-12#1)(2010-7#1)
A pilot study was##2##4##(1991-12#1)(2008-10#1)
A pilot study##9##3##(1990-6#1)(1991-12#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-7#1)(2013-1#2)(2013-8#1)
A pilot##13##2##(1990-6#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
A placebo-controlled##2##2##(2008-5#1)(2012-3#1)
A plasmid##3##2##(1990-5#1)(2008-11#2)
A platinum##2##2##(1993-11#1)(2008-10#1)
A plausible##3##2##(1993-6#1)(1997-2#1)(2008-3#1)
A plot of##2##3##(1991-5#1)(1997-2#1)
A point mutation##2##3##(1992-8#1)(1996-2#1)
A point##3##2##(1992-8#1)(1996-2#1)(2008-3#1)
A polarographic##2##2##(2008-10#2)
A policy##2##2##(2009-4#1)(2013-1#1)
A polyclonal antibody raised against##2##5##(1995-2#1)(2007-12#1)
A polyclonal antibody##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
A polyclonal##4##2##(1995-2#1)(2007-12#1)(2008-10#2)
A polyethylene glycol##2##3##(1990-12#1)(2008-10#1)
A polyethylene##3##2##(1990-12#1)(2008-10#2)
A polymerase chain reaction (PCR)##2##5##(1996-12#1)(2008-10#1)
A polymerase chain reaction (PCR)-based method##2##6##(2008-10#2)
A polymerase chain reaction (PCR)-based##3##5##(2008-10#3)
A polymerase chain reaction##7##4##(1996-12#1)(2008-10#6)
A polymerase chain##9##3##(1996-12#1)(2008-10#8)
A population of##8##3##(1991-11#1)(1991-12#1)(2008-10#6)
A porous##2##2##(2008-10#2)
A portable##2##2##(2008-10#2)
A portion of the##2##4##(2008-10#2)
A portion of##4##3##(2008-10#3)(2008-12#1)
A positive correlation was##3##4##(1995-12#1)(2008-10#1)(2009-8#1)
A positive correlation##4##3##(1995-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
A positive##11##2##(1990-2#1)(1995-12#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
A possible explanation##3##3##(1996-12#1)(2008-3#1)(2010-1#1)
A possible mechanism for the##2##5##(2008-10#2)
A possible mechanism of the extraction is discussed##2##8##(2008-10#2)
A possible mechanism of the##3##5##(2008-10#3)
A possible mechanism of##4##4##(2008-10#4)
A possible mechanism##6##3##(2008-10#6)
A possible##24##2##(1990-8#1)(1992-2#1)(1996-12#1)(2008-10#8)(2008-12#3)(2008-3#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)
A postal survey was sent to##2##6##(2011-2#1)(2012-2#1)
A postal##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
A potential##8##2##(1990-12#1)(1991-5#1)(1991-7#1)(1994-8#1)(2008-10#4)
A potentiometric flow injection determination method for##2##7##(2008-10#2)
A potentiometric flow injection##3##4##(2008-10#3)
A potentiometric##12##2##(2008-10#12)
A practical approach to##3##4##(2008-11#1)(2008-6#1)(2012-2#1)
A practical approach##4##3##(2008-11#2)(2008-6#1)(2012-2#1)
A practical guide##2##3##(2008-10#1)(2008-3#1)
A practical implication##2##3##(2008-10#1)(2008-7#1)
A practical##11##2##(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
A pre-column derivatization method for the sensitive determination of##2##9##(2008-10#2)
A precise##3##2##(2008-10#3)
A precision of##2##3##(2008-10#2)
A precision##3##2##(2008-10#3)
A preconcentration factor of##5##4##(2008-10#5)
A preconcentration factor##6##3##(2008-10#6)
A preconcentration method##2##3##(2008-10#2)
A preconcentration##11##2##(2008-10#11)
A predictive model for production of apothecia##2##7##(2008-10#2)
A predictive model for##3##4##(2008-10#3)
A predictive model##4##3##(2008-10#3)(2012-12#1)
A preliminary study on the##2##5##(2008-9#1)(2012-3#1)
A preliminary study on##3##4##(2008-9#1)(2012-2#1)(2012-3#1)
A preliminary study##5##3##(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
A preliminary##14##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
A previous study##3##3##(2008-10#2)(2011-2#1)
A previous##6##2##(1992-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)
A previously undescribed##2##3##(2008-10#2)
A previously##8##2##(2008-10#7)(2008-2#1)
A primary##8##2##(1995-2#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
A primer##6##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
A principal component##3##3##(2008-10#3)
A principal components analysis##2##4##(2008-10#2)
A principal##5##2##(2008-10#5)
A probe##2##2##(1995-6#1)(1996-12#1)
A problem##2##2##(2008-8#1)(2012-12#1)
A procedure for the determination of##6##6##(2008-10#6)
A procedure for the simultaneous##2##5##(2008-10#2)
A procedure for the##11##4##(2008-10#11)
A procedure for##20##3##(1995-12#1)(2008-10#17)(2008-3#1)(2008-4#1)
A procedure is described for the##2##6##(2008-10#2)
A procedure is described for##4##5##(2008-10#2)(2008-4#2)
A procedure is##7##3##(2008-10#3)(2008-4#3)(2008-9#1)
A procedure to##3##3##(2008-10#2)(2012-2#1)
A procedure was developed for##2##5##(2008-10#2)
A procedure##36##2##(1995-12#1)(2008-10#27)(2008-3#1)(2008-4#5)(2008-9#1)(2012-2#1)
A process##2##2##(2008-11#2)
A proficient mentor##2##3##(2008-7#2)
A profile of##2##3##(1995-2#1)(1995-3#1)
A program for##3##3##(1992-3#1)(1995-9#1)(2008-10#1)
A program to##2##3##(1995-12#1)(2008-4#1)
A program##7##2##(1992-3#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-9#1)(2008-10#1)(2008-4#1)
A promising new method##2##4##(2009-8#1)(2010-8#1)
A promising##9##2##(1994-6#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)
A proposal for a##2##4##(1993-11#1)(2008-3#1)
A proposal for##4##3##(1993-11#1)(1993-2#1)(2008-11#1)(2008-3#1)
A proposed mechanism##2##3##(2008-5#1)(2012-3#1)
A proposed##6##2##(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
A prospective cohort of##2##4##(2012-12#1)(2013-1#1)
A prospective pilot study##2##4##(1994-1#1)(2012-3#1)
A prospective randomized##3##3##(1991-2#1)(2008-10#1)(2010-7#1)
A prospective study on##2##4##(1990-3#1)(2008-10#1)
A prospective study was##2##4##(1992-12#1)(2012-3#1)
A prospective study##7##3##(1990-3#1)(1992-12#1)(2008-10#1)(2009-8#1)(2012-3#1)(2012-5#1)(2013-8#1)
A prospective##21##2##(1990-3#2)(1991-2#1)(1992-12#2)(1994-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#1)(2013-8#1)
A protein with a##2##4##(1994-8#1)(2008-11#1)
A protein##8##2##(1990-5#2)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)(2010-12#1)
A protocol for the##2##4##(2008-4#2)
A protocol for##4##3##(2008-10#1)(2008-4#3)
A protocol is##2##3##(2008-4#2)
A protocol##7##2##(2008-10#1)(2008-11#1)(2008-4#5)
A prototype##5##2##(2008-10#2)(2008-11#1)(2008-2#2)
A public health##2##3##(1997-1#1)(2012-12#1)
A public##3##2##(1997-1#1)(2012-12#1)(2013-1#1)
A pulsed##2##2##(2008-10#1)(2008-3#1)
A purposive##2##2##(2008-11#1)(2009-9#1)
A putative##8##2##(1992-6#1)(1992-8#1)(1995-6#1)(2008-10#3)(2008-8#1)(2009-9#1)
A qualitative case study##2##4##(2008-11#1)(2010-8#1)
A qualitative research methodology was used##2##6##(1995-3#1)(2008-9#1)
A qualitative research##4##3##(1995-3#1)(2008-1#1)(2008-9#1)(2012-3#1)
A qualitative study##3##3##(2008-11#1)(2008-12#1)(2013-8#1)
A qualitative##15##2##(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
A quality##3##2##(1996-2#1)(1997-1#1)(2012-12#1)
A quantitative analytical method##2##4##(2008-10#1)(2012-2#1)
A quantitative assessment of##2##4##(2008-10#1)(2008-11#1)
A quantitative relationship##2##3##(2008-10#1)(2008-12#1)
A quantitative##22##2##(1993-6#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#2)
A quarter##2##2##(2008-7#1)(2011-2#1)
A quasi-experimental study##2##3##(2008-4#1)(2013-1#1)
A quasi-experimental##3##2##(2008-4#1)(2013-1#2)
A questionnaire study##2##3##(1993-6#1)(1995-2#1)
A questionnaire survey was carried out##2##6##(1997-3#1)(2010-5#1)
A questionnaire survey was##3##4##(1997-3#1)(2008-11#1)(2010-5#1)
A questionnaire survey##4##3##(1994-6#1)(1997-3#1)(2008-11#1)(2010-5#1)
A questionnaire was given##2##4##(1993-12#1)(2011-2#1)
A questionnaire was sent to a##3##6##(1993-2#1)(1997-3#1)(2013-1#1)
A questionnaire was sent to##5##5##(1990-2#1)(1993-2#1)(1997-3#1)(2008-1#1)(2013-1#1)
A questionnaire was used to##2##5##(1990-9#1)(2008-10#1)
A questionnaire was used##3##4##(1990-9#1)(2008-10#1)(2012-12#1)
A questionnaire was##12##3##(1990-2#1)(1990-9#1)(1992-1#1)(1993-12#1)(1993-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
A questionnaire##26##2##(1990-2#2)(1990-9#1)(1991-11#1)(1992-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-6#1)(1995-2#1)(1997-3#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
A quick and##2##3##(2008-10#1)(2008-9#1)
A quick##6##2##(2008-10#5)(2008-9#1)
A rabbit##4##2##(1995-6#1)(2008-10#2)(2008-5#1)
A radioassay##2##2##(1992-3#2)
A rain##2##2##(2008-10#1)(2008-8#1)
A random sample of##5##4##(1994-12#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-8#1)
A random##9##2##(1993-11#1)(1994-12#1)(1994-3#1)(2008-1#1)(2008-10#4)(2008-8#1)
A randomized controlled trial##4##4##(2010-3#1)(2012-3#1)(2013-1#2)
A randomized controlled##6##3##(2010-3#1)(2012-3#1)(2013-1#4)
A randomized trial of##3##4##(1994-3#1)(1997-7#1)(2010-4#1)
A randomized trial##4##3##(1993-11#1)(1994-3#1)(1997-7#1)(2010-4#1)
A randomized##15##2##(1992-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(1997-7#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#5)
A range of##5##3##(1994-3#1)(2008-10#1)(2008-7#1)(2013-1#2)
A rapid and sensitive flow injection chemiluminescence##2##7##(2008-10#2)
A rapid and sensitive immunoassay for the determination of##2##9##(2008-10#2)
A rapid and sensitive method for the trace level determination of##2##11##(2008-10#2)
A rapid and sensitive method for the##3##7##(2008-10#3)
A rapid and sensitive method is described for the##2##9##(2008-10#2)
A rapid and sensitive method##6##5##(2008-10#6)
A rapid and sensitive##15##4##(1993-12#1)(2008-10#14)
A rapid and simple##4##4##(2008-10#4)
A rapid and##25##3##(1993-12#1)(1994-11#1)(2008-10#22)(2008-7#1)
A rapid method for the##2##5##(2008-10#2)
A rapid method for##4##4##(2008-10#4)
A rapid method##6##3##(2008-10#6)
A rapid ultrasound-assisted##2##3##(2008-10#2)
A rapid##56##2##(1990-12#2)(1990-2#2)(1993-12#1)(1994-11#1)(1995-2#1)(2008-10#44)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
A rare case of##7##4##(1992-2#1)(2008-7#2)(2010-5#1)(2011-2#2)(2013-7#1)
A rare case report##2##4##(2010-10#1)(2013-1#1)
A rare case##10##3##(1992-2#1)(2008-7#2)(2010-10#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-7#1)
A rare cause is##2##4##(1996-6#1)(2013-1#1)
A rare cause of##3##4##(2011-1#1)(2012-3#1)(2013-8#1)
A rare cause##6##3##(1996-6#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
A rare##24##2##(1991-11#1)(1992-2#1)(1996-6#1)(1996-9#1)(1997-7#1)(2008-7#2)(2009-11#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
A rarity##2##2##(1992-9#1)(2013-1#1)
A rat brain##2##3##(1992-6#2)
A rat##3##2##(1992-6#2)(2011-2#1)
A rating##2##2##(1993-2#1)(1993-3#1)
A rational##2##2##(2008-7#1)(2012-2#1)
A reaction##3##2##(2008-10#3)
A real-time polymerase chain reaction (PCR) assay was developed##2##9##(2008-10#2)
A real-time##4##2##(2008-10#4)
A recent study##2##3##(1997-7#1)(2011-2#1)
A recent##13##2##(1992-8#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#3)(2011-7#1)(2013-1#1)
A recently##3##2##(1994-9#1)(2008-10#1)(2010-11#1)
A recombinant adenoviral vector carrying human TIMP-2 was##2##8##(2010-1#2)
A recombinant##11##2##(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#3)
A recovery of##3##3##(2008-10#2)(2009-8#1)
A recovery##4##2##(2008-10#3)(2009-8#1)
A reduced##2##2##(1992-8#1)(2008-10#1)
A reduction in the AAI to 0##2##7##(1993-12#2)
A reduction in the##3##4##(1993-12#2)(2008-10#1)
A reduction in##6##3##(1993-12#2)(2008-10#3)(2009-12#1)
A reduction of the##3##4##(2008-10#2)(2008-11#1)
A reduction of##4##3##(1992-12#1)(2008-10#2)(2008-11#1)
A reduction##10##2##(1992-12#1)(1993-12#2)(2008-10#5)(2008-11#1)(2009-12#1)
A reference##3##2##(1992-3#1)(2008-10#2)
A region##4##2##(1993-9#1)(2008-10#2)(2008-3#1)
A regression##2##2##(2008-10#2)
A related##5##2##(1991-3#1)(1995-6#1)(1996-9#1)(2008-12#2)
A relationship between the##2##4##(1995-9#1)(2008-10#1)
A relationship between##3##3##(1995-9#1)(2008-10#1)(2010-9#1)
A relationship was found between##2##5##(2008-10#1)(2011-2#1)
A relationship##6##2##(1995-9#1)(2008-10#2)(2010-9#1)(2011-2#2)
A relative standard deviation (R##2##5##(2008-10#2)
A relative standard deviation##4##4##(2008-10#4)
A relatively high##2##3##(1997-2#1)(2008-10#1)
A relatively##4##2##(1991-12#1)(1992-3#1)(1997-2#1)(2008-10#1)
A reliable and very sensitive procedure for the determination of##2##10##(2008-10#2)
A reliable##6##2##(2008-10#4)(2008-7#1)(2011-2#1)
A remarkable##4##2##(2008-10#3)(2008-5#1)
A renal biopsy showed a##2##5##(2013-8#2)
A renal##3##2##(2008-10#1)(2013-8#2)
A repeated measures##2##3##(2008-10#1)(2013-1#1)
A repeated##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
A reply##3##2##(1993-3#1)(2013-8#2)
A report from##2##3##(2008-11#2)
A report of four cases##2##5##(1990-12#1)(2011-2#1)
A report of three cases##2##5##(2010-10#1)(2013-1#1)
A report of##11##3##(1990-12#1)(1992-5#3)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
A report was compiled##2##4##(1993-12#1)(2008-11#1)
A report##17##2##(1990-12#1)(1992-5#3)(1993-12#1)(1995-12#1)(1996-1#1)(2008-11#4)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
A representative sample of##2##4##(1996-6#1)(2008-1#1)
A reproducible and##5##3##(2008-10#4)(2008-5#1)
A reproducible##6##2##(2008-10#5)(2008-5#1)
A requirement for##2##3##(2011-2#1)(2013-1#1)
A research##3##2##(1991-1#1)(2008-10#1)(2008-12#1)
A reservoir type of##2##4##(2008-10#2)
A resolution##4##2##(1992-11#1)(1994-12#1)(1995-2#1)(1995-8#1)
A response to##2##3##(2008-11#1)(2009-11#1)
A response##3##2##(2008-10#1)(2008-11#1)(2009-11#1)
A retrospective analysis of##8##4##(1990-6#1)(1993-11#1)(1994-12#1)(1997-3#1)(1997-8#1)(2011-2#1)(2012-12#2)
A retrospective analysis##9##3##(1990-6#1)(1993-11#1)(1994-12#1)(1995-11#1)(1997-3#1)(1997-8#1)(2011-2#1)(2012-12#2)
A retrospective chart review##2##4##(2008-12#1)(2011-2#1)
A retrospective chart##3##3##(1994-3#1)(2008-12#1)(2011-2#1)
A retrospective cohort##2##3##(1996-11#1)(2013-1#1)
A retrospective review of##5##4##(1995-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#1)
A retrospective review##7##3##(1995-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)
A retrospective study of##3##4##(1995-1#1)(2007-8#1)(2012-3#1)
A retrospective study was##4##4##(1990-12#1)(1990-6#1)(1997-8#1)(2012-12#1)
A retrospective study##11##3##(1990-12#1)(1990-6#1)(1995-1#1)(1996-11#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
A retrospective##40##2##(1990-12#1)(1990-6#2)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-11#2)(1997-3#1)(1997-5#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)
A retrovirus##2##2##(2008-5#1)(2008-8#1)
A reusable##2##2##(2008-10#2)
A reverse##5##2##(2008-10#4)(2011-1#1)
A reversed phase C(18) column with gradient elution was utilized##2##10##(2008-10#2)
A reversed phase C(18) column##3##5##(2008-10#3)
A reversed##6##2##(1993-8#1)(2008-10#4)(2008-9#1)
A reversed-phase##3##2##(2008-10#3)
A reversible##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
A review of clinical##2##4##(1994-3#1)(1995-9#1)
A review of the current##2##5##(2008-10#1)(2008-11#1)
A review of the literature showed##2##6##(2011-2#2)
A review of the literature shows that##2##7##(2008-10#1)(2011-3#1)
A review of the literature suggests that##2##7##(2008-11#2)
A review of the literature##19##5##(1993-1#1)(1996-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#2)(2011-2#4)(2011-3#1)(2012-2#1)(2013-7#1)
A review of the##32##4##(1992-5#1)(1993-1#1)(1995-1#1)(1996-12#1)(2008-10#9)(2008-11#6)(2008-12#3)(2008-7#3)(2011-2#4)(2011-3#1)(2012-2#1)(2013-7#1)
A review of##62##3##(1990-3#1)(1990-9#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-7#6)(2008-8#2)(2010-2#1)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
A review on the##2##4##(2008-10#1)(2008-12#1)
A review on##5##3##(2008-10#2)(2008-12#1)(2009-12#1)(2010-12#1)
A review##82##2##(1990-3#1)(1990-9#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#2)(2008-10#16)(2008-11#10)(2008-12#4)(2008-7#6)(2008-8#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
A revision##2##2##(2008-10#2)
A rice##2##2##(1994-11#1)(2008-9#1)
A right##2##2##(1995-2#1)(2009-1#1)
A rigorous##3##2##(2008-10#1)(2008-3#2)
A robust##4##2##(2008-10#3)(2011-2#1)
A role for##7##3##(1994-6#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-2#1)
A role##8##2##(1994-6#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-8#1)(2012-2#1)
A room-temperature##2##2##(2007-12#1)(2008-10#1)
A routine##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
A sample of##8##3##(1991-2#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
A sample preparation method based on##2##6##(2008-10#2)
A sample solution##4##3##(2008-10#4)
A sample throughput of 80 samples per hour and relative standard deviation##2##12##(2008-10#2)
A sample throughput of##7##4##(2008-10#7)
A sample##25##2##(1991-2#1)(1995-12#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-6#1)(2012-2#1)(2013-8#1)
A sampling frequency##2##3##(2008-10#2)
A sampling##6##2##(2008-10#5)(2008-11#1)
A sandwich enzyme-linked immunosorbent assay##2##5##(1995-11#2)
A sandwich##4##2##(1995-11#2)(2008-10#2)
A satisfactory result##2##3##(2008-10#2)
A satisfactory##3##2##(2008-10#3)
A scan##2##2##(2008-10#1)(2012-2#1)
A scenario##3##2##(1992-9#1)(2008-9#1)(2010-8#1)
A scheme for##2##3##(2008-10#1)(2008-3#1)
A scoring and ranking system for persistent##3##7##(2008-11#3)
A screen-printed##2##2##(2008-10#2)
A search##4##2##(2008-11#1)(2008-3#1)(2013-1#2)
A seasonal##2##2##(2008-10#1)(2008-5#1)
A second round of##2##4##(1997-7#1)(2008-10#1)
A second##27##2##(1991-3#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-2#2)(1997-7#2)(2008-10#9)(2008-11#2)(2008-2#1)(2010-10#1)
A secondary objective##2##3##(2008-12#1)(2013-1#1)
A secondary##5##2##(2007-8#1)(2008-12#1)(2010-7#1)(2012-12#1)(2013-1#1)
A section##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
A segregating##2##2##(2008-10#2)
A selection of the##2##4##(2008-10#2)
A selection of##3##3##(2008-10#2)(2008-11#1)
A selective method##2##3##(2008-10#2)
A selective##15##2##(1993-3#1)(2008-10#12)(2008-7#1)(2012-2#1)
A semi-automated##2##2##(2008-10#2)
A semi-structured##2##2##(2008-11#1)(2012-3#1)
A sensitive and rapid method##2##5##(2008-10#2)
A sensitive and rapid##3##4##(2008-10#3)
A sensitive and selective flow injection##2##6##(2008-10#2)
A sensitive and selective method##4##5##(2008-10#4)
A sensitive and selective##12##4##(2008-10#12)
A sensitive and specific##3##4##(1990-2#1)(1992-6#1)(2008-10#1)
A sensitive and##21##3##(1990-2#1)(1992-6#1)(2008-10#19)
A sensitive flow-injection##2##3##(2008-10#2)
A sensitive method for the detection of catecholamine based on##2##10##(2008-10#2)
A sensitive method for the determination of##2##7##(2008-10#2)
A sensitive method for the##6##5##(2008-10#6)
A sensitive method for##7##4##(2008-10#7)
A sensitive method is described for the determination of##2##9##(2008-10#2)
A sensitive method is##3##4##(2008-10#3)
A sensitive method##12##3##(2008-10#12)
A sensitive spectrophotometric method for the determination of##2##8##(2008-10#2)
A sensitive spectrophotometric method for##3##5##(2008-10#3)
A sensitive spectrophotometric method##4##4##(2008-10#4)
A sensitive spectrophotometric##5##3##(2008-10#5)
A sensitive##67##2##(1990-2#1)(1991-2#2)(1992-6#1)(2008-10#62)(2009-6#1)
A sensitivity analysis##2##3##(2008-10#2)
A sensitivity##6##2##(2007-12#1)(2008-10#4)(2008-11#1)
A sensor for##4##3##(2008-10#3)(2008-3#1)
A sensor##8##2##(2008-10#7)(2008-3#1)
A separate##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
A separation##2##2##(2008-10#2)
A sequence of##2##3##(1996-3#1)(2008-3#1)
A sequential extraction of##2##4##(2008-10#2)
A sequential extraction procedure for separating and##2##7##(2008-10#2)
A sequential extraction procedure for separating##3##6##(2008-10#3)
A sequential extraction##5##3##(2008-10#5)
A sequential injection analysis (SIA) system is##2##7##(2008-10#2)
A sequential injection analysis (SIA) system was developed##2##8##(2008-10#2)
A sequential injection analysis (SIA) system##4##6##(2008-10#4)
A sequential injection analysis (SIA)##7##5##(2008-10#7)
A sequential injection analysis system##2##5##(2008-10#2)
A sequential injection analysis##9##4##(2008-10#9)
A sequential injection spectrophotometric method for the##2##7##(2008-10#2)
A sequential injection spectrophotometric##3##4##(2008-10#3)
A sequential injection system##4##4##(2008-10#4)
A sequential injection##19##3##(2008-10#19)
A sequential##32##2##(1992-3#2)(2008-10#28)(2008-11#1)(2012-2#1)
A series of experiments##3##4##(1993-3#1)(1993-8#1)(2008-10#1)
A series of new##2##4##(2012-2#1)(2012-3#1)
A series of novel##2##4##(1992-3#1)(2011-3#1)
A series of plasmids##2##4##(1993-9#1)(1997-3#1)
A series of samples##2##4##(2008-10#2)
A series of synthetic##2##4##(2008-10#2)
A series of##65##3##(1990-12#1)(1990-3#2)(1990-5#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-5#2)(1994-8#2)(1996-3#1)(1996-5#2)(1997-3#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
A series##66##2##(1990-12#1)(1990-3#2)(1990-5#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-5#2)(1994-8#2)(1996-3#1)(1996-5#2)(1997-3#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
A serologic##2##2##(1996-12#2)
A serum##2##2##(2008-11#1)(2011-1#1)
A serum-free medium formulation##2##4##(2008-11#2)
A serum-free##5##2##(2008-11#5)
A set of##15##3##(1993-12#1)(2007-12#1)(2008-10#9)(2008-4#1)(2008-9#1)(2009-10#1)(2013-1#1)
A severe##2##2##(1993-3#1)(2011-2#1)
A short exposure to##2##4##(2008-7#1)(2011-2#1)
A short review##2##3##(2008-10#1)(2008-11#1)
A short##9##2##(1993-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#1)
A shorter##2##2##(1994-2#1)(2008-10#1)
A sideways glance##2##3##(2008-10#2)
A sideways##3##2##(1994-9#1)(2008-10#2)
A significant association##2##3##(1996-12#1)(2011-2#1)
A significant correlation was found between##2##6##(2008-10#1)(2013-1#1)
A significant correlation##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
A significant decrease in##3##4##(1993-6#1)(1996-12#1)(2009-8#1)
A significant difference was found between##2##6##(1990-8#1)(1993-2#1)
A significant difference was found##3##5##(1990-8#1)(1993-2#1)(2008-10#1)
A significant difference##7##3##(1990-8#1)(1993-2#1)(2008-10#4)(2008-5#1)
A significant effect of##3##4##(1996-12#1)(2008-9#1)(2009-8#1)
A significant effect##4##3##(1996-12#1)(2008-9#1)(2009-8#1)(2011-1#1)
A significant improvement in##2##4##(1991-3#1)(2008-7#1)
A significant increase in##3##4##(1994-3#1)(2008-10#1)(2013-1#1)
A significant increase##4##3##(1994-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
A significant interaction##2##3##(2008-10#2)
A significant level of##2##4##(2009-10#1)(2010-4#1)
A significant negative correlation##2##4##(2008-10#1)(2008-7#1)
A significant negative##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
A significant number of##2##4##(2008-7#1)(2013-8#1)
A significant reduction in##2##4##(2008-10#1)(2009-12#1)
A significant##53##2##(1990-6#1)(1990-8#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1996-12#4)(2008-10#13)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
A significantly higher##2##3##(1996-8#1)(2011-2#1)
A significantly##4##2##(1991-11#1)(1991-2#1)(1996-8#1)(2011-2#1)
A similar effect##2##3##(1995-2#1)(2008-2#1)
A similar level of##2##4##(1994-5#1)(2008-10#1)
A similar pattern was##2##4##(1993-6#1)(2008-10#1)
A similar pattern##3##3##(1993-6#1)(1994-11#1)(2008-10#1)
A similar result##2##3##(2008-11#2)
A similar##33##2##(1991-12#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-5#3)(1995-11#1)(1995-2#2)(1996-2#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2013-1#2)
A simple and fast method for##3##6##(2008-10#2)(2008-11#1)
A simple and fast method##4##5##(2008-10#3)(2008-11#1)
A simple and fast##7##4##(2008-10#6)(2008-11#1)
A simple and highly##2##4##(2008-10#2)
A simple and rapid method for##3##6##(2008-10#3)
A simple and rapid method##4##5##(2008-10#4)
A simple and rapid procedure for##2##6##(2008-10#2)
A simple and rapid procedure##3##5##(1994-8#1)(2008-10#2)
A simple and rapid##18##4##(1990-12#1)(1994-8#1)(2008-10#15)(2008-11#1)
A simple and reliable method for##2##6##(2008-10#2)
A simple and reliable method##3##5##(2008-10#3)
A simple and reliable##7##4##(2008-10#6)(2008-3#1)
A simple and robust##2##4##(2008-10#2)
A simple and selective method for rapid##2##7##(2008-10#2)
A simple and selective method##4##5##(2008-10#4)
A simple and selective##6##4##(2008-10#6)
A simple and sensitive capillary electrophoretic##2##6##(2008-10#2)
A simple and sensitive flow injection##2##6##(2008-10#2)
A simple and sensitive flow##3##5##(1990-12#1)(2008-10#2)
A simple and sensitive method for the determination of##2##9##(2008-10#2)
A simple and sensitive method for the##3##7##(2008-10#3)
A simple and sensitive method##6##5##(2008-10#5)(2011-1#1)
A simple and sensitive##24##4##(1990-12#1)(2008-10#22)(2011-1#1)
A simple and##79##3##(1990-12#2)(1994-8#1)(1996-5#1)(1997-3#1)(2008-10#68)(2008-11#2)(2008-3#3)(2011-1#1)
A simple but##2##3##(2008-10#2)
A simple fabrication technique##2##4##(2008-3#1)(2009-5#1)
A simple flow injection system##2##5##(2008-10#2)
A simple flow injection##7##4##(2008-10#7)
A simple flow##8##3##(2008-10#8)
A simple method for the rapid##2##6##(2008-10#2)
A simple method for the##6##5##(2008-10#6)
A simple method for##12##4##(2008-10#10)(2008-3#1)(2012-2#1)
A simple method has been developed for##2##7##(2008-10#2)
A simple method of##2##4##(2008-10#1)(2008-3#1)
A simple method to##2##4##(2008-8#1)(2011-2#1)
A simple method##20##3##(2008-10#15)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)
A simple methodology##2##3##(1996-3#1)(2008-7#1)
A simple model##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2013-8#1)
A simple procedure for the determination of##2##7##(2008-10#2)
A simple procedure for the##3##5##(2008-10#3)
A simple procedure##5##3##(2008-10#4)(2008-4#1)
A simple quantitative##2##3##(2008-10#2)
A simple reverse##2##3##(2008-10#2)
A simple spectrophotometric##2##3##(2008-10#2)
A simple technique##3##3##(2008-10#2)(2011-2#1)
A simple theoretical model##2##4##(1990-12#1)(2008-10#1)
A simple theoretical##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
A simple##235##2##(1990-12#4)(1990-2#1)(1991-11#1)(1992-1#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#195)(2008-11#5)(2008-12#1)(2008-3#8)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
A simplified model##2##3##(2008-7#1)(2009-8#1)
A simplified##7##2##(1990-12#1)(1992-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-3#1)
A simulation study was##2##4##(2008-10#1)(2008-7#1)
A simulation##3##2##(1995-1#1)(2008-10#1)(2008-7#1)
A simultaneous##8##2##(2008-10#7)(2013-1#1)
A single amino##2##3##(2008-10#2)
A single gene##2##3##(2008-10#2)
A single population of##2##4##(1990-8#1)(1996-2#1)
A single##55##2##(1990-7#1)(1990-8#2)(1991-12#1)(1992-8#1)(1995-6#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
A skin biopsy specimen##2##4##(2007-9#1)(2010-6#1)
A skin##4##2##(2007-9#1)(2008-5#1)(2010-6#1)(2011-2#1)
A slight##3##2##(1993-12#1)(1996-9#1)(2012-3#1)
A small aliquot##2##3##(2008-10#2)
A small portion##2##3##(2008-10#2)
A small scale##2##3##(2010-8#1)(2011-2#1)
A small##28##2##(1993-8#2)(1994-2#1)(1994-9#1)(1995-12#1)(1996-12#2)(2008-10#10)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)
A smaller##2##2##(1991-5#1)(2008-7#1)
A social##3##2##(1991-12#1)(1993-12#1)(2012-3#1)
A software##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
A sol-gel##2##2##(2008-10#2)
A solid##2##2##(2008-10#2)
A solid-liquid extraction##2##3##(2008-10#2)
A solid-phase extraction##2##3##(2008-10#2)
A solid-phase##3##2##(2008-10#3)
A soluble##2##2##(1990-5#1)(2008-10#1)
A solution of 0##3##4##(2008-10#3)
A solution of the##2##4##(2008-10#2)
A solution of##7##3##(2008-10#7)
A solution##10##2##(2008-10#9)(2008-3#1)
A spatially##2##2##(2008-10#1)(2008-3#1)
A special##12##2##(1990-6#1)(1993-6#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-9#2)
A specially designed##2##3##(2008-1#1)(2008-10#1)
A speciation##3##2##(2008-10#2)(2013-1#1)
A specific##10##2##(1990-11#1)(1994-5#1)(2008-10#6)(2008-11#1)(2011-2#1)
A spectral##2##2##(2008-3#1)(2012-2#1)
A spectrofluorimetric method for the determination of##2##7##(2008-10#2)
A spectrofluorimetric method for the##3##5##(2008-10#3)
A spectrofluorimetric method has been developed for the determination of##2##10##(2008-10#2)
A spectrofluorimetric method to determine##2##5##(2008-10#2)
A spectrofluorimetric method##7##3##(2008-10#7)
A spectrometric##2##2##(2008-10#2)
A spectrophotometric method for the determination of##3##7##(2008-10#3)
A spectrophotometric method for##4##4##(2008-10#4)
A spectrophotometric method was##3##4##(2008-10#3)
A spectrophotometric method##8##3##(2008-10#8)
A spectrophotometric##12##2##(2008-10#12)
A spokesman for##2##3##(1995-6#2)
A spot##2##2##(2008-10#1)(2008-11#1)
A square wave##2##3##(2008-10#2)
A square-wave##2##2##(2008-10#2)
A stable##5##2##(1992-4#1)(2008-10#2)(2008-11#1)(2011-2#1)
A standard operational definition of CS would enable consistency as clinicians interpret research findings and facilitate translating research to practice##2##20##(2013-1#2)
A standard or sample##2##4##(2008-10#2)
A standard##12##2##(2008-10#7)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
A standardized##3##2##(1994-12#1)(1997-1#1)(2013-8#1)
A statement of the##2##4##(2008-3#1)(2009-11#1)
A statistical analysis of the##3##5##(2008-10#1)(2008-11#2)
A statistical analysis##4##3##(1990-5#1)(2008-10#1)(2008-11#2)
A statistical##9##2##(1990-5#1)(1995-12#1)(2008-10#5)(2008-11#2)
A statistically significant difference##2##4##(1993-2#1)(2009-11#1)
A statistically significant##7##3##(1990-8#1)(1993-2#1)(1994-12#1)(2008-5#1)(2009-11#1)(2009-3#1)(2013-1#1)
A steady-state##2##2##(2008-10#1)(2008-7#1)
A step##2##2##(2008-10#1)(2013-1#1)
A sterile##2##2##(2008-10#1)(2012-2#1)
A stimulation##2##2##(2008-9#1)(2011-2#1)
A stimulus##2##2##(1997-2#1)(2008-9#1)
A stochastic##4##2##(2008-10#3)(2008-3#1)
A stoichiometric##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
A stopped-flow##5##2##(2008-10#4)(2008-4#1)
A straightforward##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
A strain of##2##3##(2008-10#1)(2008-8#1)
A strain##4##2##(1991-7#1)(2008-10#2)(2008-8#1)
A strains##6##2##(2008-10#3)(2008-9#1)(2011-2#1)(2012-3#1)
A strategy for the##3##4##(1992-9#1)(1995-3#1)(2008-11#1)
A strategy for##6##3##(1992-9#1)(1995-3#1)(1997-3#1)(2008-11#2)(2008-12#1)
A strategy that##2##3##(1995-6#1)(2008-10#1)
A strategy##11##2##(1992-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)
A streptococcal##2##2##(1991-8#1)(2008-10#1)
A stretch of##2##3##(1995-8#2)
A striking feature##2##3##(1994-5#1)(1996-6#1)
A striking##3##2##(1993-11#1)(1994-5#1)(1996-6#1)
A strong correlation##2##3##(2008-10#1)(2008-11#1)
A strong##16##2##(1991-12#1)(1993-2#1)(1994-2#1)(1997-3#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
A strongly##2##2##(1993-8#1)(2008-10#1)
A structural##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
A structured interview##2##3##(2008-1#1)(2012-3#1)
A structured##3##2##(2008-1#1)(2012-3#1)(2013-1#1)
A study in##3##3##(1991-8#1)(2009-8#1)(2013-8#1)
A study is##2##3##(2008-10#2)
A study of a##2##4##(2008-10#1)(2012-3#1)
A study of the effect of##2##6##(2008-10#1)(2008-7#1)
A study of the##13##4##(1990-2#1)(1990-3#1)(1992-2#1)(1994-5#1)(1996-2#1)(2008-10#6)(2008-3#1)(2008-7#1)
A study of##37##3##(1990-2#1)(1990-3#1)(1990-6#1)(1992-2#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
A study on the interaction##2##5##(2008-10#2)
A study on the##6##4##(2008-10#3)(2008-12#1)(2008-5#1)(2009-10#1)
A study on##10##3##(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#2)
A study was conducted to##2##5##(2008-10#1)(2009-5#1)
A study was conducted##3##4##(1993-1#1)(2008-10#1)(2009-5#1)
A study was designed to##2##5##(1992-1#1)(2008-10#1)
A study was##7##3##(1990-11#1)(1991-1#1)(1992-1#1)(1993-1#1)(2008-10#2)(2009-5#1)
A study##68##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-5#1)(1995-2#1)(1996-2#2)(2008-10#28)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-10#3)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#2)(2012-3#2)(2013-8#2)
A sub-second##2##2##(2008-10#2)
A subsequent##2##2##(1992-2#1)(2008-10#1)
A subset of these##3##4##(1995-5#1)(2008-10#2)
A subset of##5##3##(1995-5#1)(2008-10#4)
A substantial increase in##2##4##(2008-10#1)(2008-11#1)
A substantial##5##2##(2008-10#2)(2008-11#3)
A subunit##2##2##(1995-2#1)(1995-6#1)
A success##2##2##(2008-10#1)(2008-11#1)
A successful pregnancy##2##3##(2010-8#1)(2012-3#1)
A successful##9##2##(1991-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
A suitable##6##2##(2008-10#3)(2008-11#3)
A summary of the##2##4##(2008-11#1)(2010-5#1)
A summary of##4##3##(2008-11#2)(2008-9#1)(2010-5#1)
A support protocol describes##4##4##(2008-4#3)(2008-9#1)
A support protocol##6##3##(2008-4#5)(2008-9#1)
A surface plasmon resonance (SPR)##3##5##(2008-10#3)
A surface plasmon resonance##5##4##(2008-10#5)
A surgical##2##2##(1991-8#1)(2008-11#1)
A survey in##2##3##(1997-8#1)(2008-10#1)
A survey of mycotic otitis externa of dogs in##2##9##(2008-5#2)
A survey of##20##3##(1991-1#1)(1991-3#1)(1992-3#1)(1992-7#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2009-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
A survey was conducted##3##4##(2008-10#1)(2013-1#2)
A survey was##5##3##(1994-1#1)(2008-10#1)(2008-12#1)(2013-1#2)
A survey##37##2##(1990-8#1)(1991-1#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-1#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-5#2)(2008-7#1)(2009-11#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
A sustained##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
A synopsis of##2##3##(2008-11#1)(2010-12#1)
A synopsis##3##2##(1991-3#1)(2008-11#1)(2010-12#1)
A synthetic peptide##2##3##(1995-2#1)(2008-8#1)
A synthetic##6##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
A system for##6##3##(2008-10#4)(2008-11#1)(2010-8#1)
A system of##4##3##(1992-3#1)(2008-12#1)(2008-3#2)
A system##12##2##(1992-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2010-8#1)
A systematic review of##4##4##(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
A systematic review was##2##4##(2011-2#1)(2012-12#1)
A systematic review##7##3##(2008-11#1)(2011-2#2)(2012-12#3)(2013-1#1)
A systematic study of the##2##5##(2008-10#2)
A systematic study##3##3##(2008-10#3)
A systematic##22##2##(1991-6#1)(1997-9#1)(2008-10#5)(2008-11#3)(2008-3#1)(2009-1#1)(2010-10#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#2)
A systemic##3##2##(1996-6#1)(2009-10#1)(2013-1#1)
A systems approach##2##3##(1992-2#1)(2008-11#1)
A t##2##2##(1995-1#1)(2008-11#1)
A tail##7##2##(1994-11#1)(2011-2#6)
A tale of two##2##4##(1993-9#1)(2009-3#1)
A target##2##2##(2008-10#1)(2008-3#1)
A team approach##2##3##(1994-2#1)(2010-5#1)
A team##3##2##(1994-2#1)(2010-5#2)
A technique based on##2##4##(1996-2#1)(2008-10#1)
A technique based##3##3##(1996-2#1)(2008-10#2)
A technique for##5##3##(1991-5#1)(2008-10#2)(2008-3#1)(2009-2#1)
A technique is presented##2##4##(2008-3#2)
A technique##13##2##(1991-5#1)(1996-2#1)(2008-10#7)(2008-3#3)(2009-2#1)
A temperature##2##2##(2007-12#1)(2008-10#1)
A tendency##2##2##(2008-10#1)(2008-11#1)
A tentative approach##2##3##(2008-10#2)
A tentative##3##2##(1996-5#1)(2008-10#2)
A test##4##2##(1992-1#1)(2008-10#1)(2008-4#1)(2013-8#1)
A testicular##3##2##(1995-6#1)(1997-3#1)(2009-11#1)
A theoretical analysis##2##3##(1993-9#1)(2008-3#1)
A theoretical model##5##3##(2008-10#2)(2008-12#1)(2008-3#2)
A theoretical study has been##2##5##(2008-10#1)(2008-3#1)
A theoretical##16##2##(1991-1#1)(1991-2#1)(1992-3#1)(1993-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)
A theory of##2##3##(2008-3#1)(2008-8#1)
A theory##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)
A therapeutic##4##2##(1991-2#1)(1992-12#1)(2010-6#1)(2013-1#1)
A thin##3##2##(2008-10#2)(2008-5#1)
A thioester##2##2##(1994-8#2)
A third##10##2##(1991-8#1)(1993-12#1)(1995-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#1)
A thorough understanding of the##2##5##(2008-8#1)(2011-2#1)
A three##4##2##(1991-5#1)(2008-10#2)(2008-12#1)
A three-dimensional##3##2##(1991-6#1)(2008-3#2)
A three-electrode##3##2##(2008-10#2)(2009-9#1)
A three-layered feed-forward artificial neural network (ANN)##2##7##(2008-10#2)
A three-year##2##2##(1996-6#1)(2008-12#1)
A threshold##3##2##(2008-10#2)(2012-12#1)
A throughput of##2##3##(2008-10#2)
A time##3##2##(1990-12#1)(1993-2#1)(2008-10#1)
A to G##3##3##(1990-8#1)(2008-12#1)(2008-6#1)
A to##5##2##(1990-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-6#1)
A tool to##2##3##(2008-10#1)(2008-11#1)
A tool##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
A total of 1##6##4##(1990-9#2)(1991-6#1)(2008-10#2)(2012-12#1)
A total of 10##3##4##(2008-10#1)(2010-11#1)(2013-1#1)
A total of 100##2##4##(2008-7#1)(2008-9#1)
A total of 103##2##4##(1995-11#1)(1996-1#1)
A total of 105##2##4##(2008-10#1)(2008-7#1)
A total of 108##2##4##(2008-10#1)(2008-8#1)
A total of 11##2##4##(2008-10#2)
A total of 124##3##4##(1997-8#1)(2012-2#1)(2013-3#1)
A total of 126##2##4##(2008-10#1)(2008-5#1)
A total of 14##3##4##(1993-12#1)(2008-10#1)(2013-1#1)
A total of 15##4##4##(2008-10#1)(2008-11#2)(2013-7#1)
A total of 153##2##4##(2008-11#1)(2013-8#1)
A total of 161##2##4##(1994-12#1)(2008-12#1)
A total of 171##2##4##(1995-8#1)(2008-7#1)
A total of 19##6##4##(1997-8#1)(2010-4#1)(2010-9#1)(2013-1#2)(2013-8#1)
A total of 2##2##4##(1996-3#1)(2010-10#1)
A total of 20##3##4##(1997-6#1)(2008-10#2)
A total of 22##2##4##(2008-7#1)(2012-2#1)
A total of 23##2##4##(2010-5#1)(2013-1#1)
A total of 237##2##4##(2008-10#1)(2012-3#1)
A total of 24##4##4##(1990-12#1)(1993-1#1)(2008-9#1)(2009-1#1)
A total of 25##2##4##(2012-2#1)(2013-1#1)
A total of 3##3##4##(1991-9#1)(1993-1#1)(2013-1#1)
A total of 30 patients##2##5##(2008-10#1)(2013-1#1)
A total of 30##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
A total of 300##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
A total of 32##2##4##(2008-10#1)(2013-8#1)
A total of 40##4##4##(2008-10#1)(2013-1#3)
A total of 45##2##4##(2008-10#1)(2011-2#1)
A total of 469##2##4##(1994-12#1)(2008-10#1)
A total of 50##2##4##(2008-11#1)(2008-8#1)
A total of 56##2##4##(2008-10#1)(2013-8#1)
A total of 80##3##4##(2008-10#2)(2008-7#1)
A total of 9##2##4##(2008-7#1)(2011-2#1)
A total of##206##3##(1990-12#3)(1990-3#1)(1990-9#2)(1991-6#2)(1991-9#1)(1993-1#2)(1993-12#1)(1994-12#3)(1994-3#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-3#3)(1996-8#1)(1997-6#2)(1997-7#1)(1997-8#4)(2008-1#4)(2008-10#47)(2008-11#8)(2008-12#5)(2008-5#4)(2008-7#13)(2008-8#4)(2008-9#4)(2009-1#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#15)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#21)(2013-3#1)(2013-7#1)(2013-8#11)
A total##213##2##(1990-12#3)(1990-3#1)(1990-9#2)(1991-6#2)(1991-9#1)(1992-5#1)(1993-1#2)(1993-12#1)(1994-12#3)(1994-3#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-3#3)(1996-8#1)(1997-6#2)(1997-7#1)(1997-8#4)(2008-1#4)(2008-10#48)(2008-11#10)(2008-12#5)(2008-3#1)(2008-5#4)(2008-7#13)(2008-8#4)(2008-9#4)(2009-1#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#4)(2011-2#15)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#21)(2013-3#1)(2013-7#1)(2013-8#11)
A traditional##3##2##(2008-3#1)(2012-2#1)(2012-3#1)
A training set##2##3##(2008-10#1)(2009-3#1)
A training##3##2##(1993-6#1)(2008-10#1)(2009-3#1)
A transgenic##2##2##(1996-5#1)(2013-8#1)
A transversion##2##2##(1992-8#1)(1994-11#1)
A treatment##2##2##(1991-2#1)(1997-7#1)
A trend##3##2##(1991-2#1)(1994-2#1)(2013-1#1)
A trial##2##2##(1991-9#1)(2008-3#1)
A tribute to##2##3##(2008-11#1)(2008-3#1)
A tripartite##2##2##(1997-2#1)(2008-11#1)
A truly##2##2##(2008-10#1)(2012-3#1)
A tube##2##2##(1990-12#1)(2008-10#1)
A two##2##2##(2008-10#1)(2008-11#1)
A two-phase##2##2##(1992-12#1)(1996-5#1)
A two-stage##2##2##(2008-10#1)(2008-11#1)
A two-step##3##2##(1996-5#1)(2008-9#1)(2010-8#1)
A typical##10##2##(2008-10#9)(2009-12#1)
A unilateral##3##2##(1994-2#2)(1996-12#1)
A unique approach##2##3##(1995-2#1)(2008-7#1)
A unique case of##2##4##(2008-11#1)(2013-1#1)
A unique feature of##2##4##(2008-10#1)(2008-9#1)
A unique##19##2##(1991-7#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-5#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
A unit increase in RVUs was##2##6##(2013-1#2)
A useful##3##2##(2008-10#2)(2011-2#1)
A vaccine##2##2##(1997-7#1)(2008-7#1)
A validated##3##2##(2008-10#3)
A validation##4##2##(2008-1#1)(2008-10#2)(2010-8#1)
A value of##2##3##(2008-10#1)(2008-5#1)
A variable##2##2##(2008-10#2)
A variant##3##2##(1995-6#1)(2010-12#1)(2012-2#1)
A variation in##2##3##(2008-12#1)(2008-5#1)
A variation##3##2##(1994-12#1)(2008-12#1)(2008-5#1)
A variety of molecular##2##4##(2008-10#1)(2010-10#1)
A variety of##14##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-6#1)(2012-2#1)
A very sensitive flow##2##4##(2008-10#2)
A very sensitive##3##3##(2008-10#3)
A very simple and##3##4##(2008-10#3)
A very simple##10##3##(2008-10#9)(2009-6#1)
A very small##3##3##(1991-5#1)(2008-11#1)(2013-7#1)
A very stable chelating resin##2##5##(2008-10#2)
A very stable##3##3##(2008-10#2)(2008-5#1)
A very##27##2##(1991-5#1)(1997-4#1)(2008-10#17)(2008-11#2)(2008-5#2)(2009-6#1)(2009-8#1)(2011-2#1)(2013-7#1)
A view from##2##3##(2008-11#1)(2009-11#1)
A virus (HAV)##3##3##(2007-12#1)(2008-7#1)(2009-5#1)
A virus##8##2##(2007-12#1)(2008-10#1)(2008-7#2)(2009-5#1)(2011-2#2)(2013-8#1)
A viruses##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
A visual##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
A voltammetric##2##2##(2008-10#2)
A volume##2##2##(2008-10#1)(2008-3#1)
A was found##2##3##(2008-10#1)(2012-3#1)
A was the##2##3##(2013-8#2)
A was##16##2##(1990-5#1)(1992-6#1)(1995-8#1)(1997-1#2)(2008-10#4)(2008-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
A water-soluble##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
A wavelength##2##2##(1991-3#1)(2008-10#1)
A way to improve##2##4##(1993-3#1)(1997-3#1)
A way to##3##3##(1991-12#1)(1993-3#1)(1997-3#1)
A way##4##2##(1991-12#1)(1993-3#1)(1997-3#1)(2009-9#1)
A weak##2##2##(2008-10#2)
A well-defined##3##2##(2008-10#3)
A well-developed##2##2##(2008-10#1)(2008-7#1)
A well-known##3##2##(2008-10#2)(2009-8#1)
A were isolated##2##3##(2008-5#1)(2012-2#1)
A were##8##2##(1992-6#1)(1994-3#1)(2008-5#2)(2010-12#1)(2012-12#1)(2012-2#2)
A whole##2##2##(1995-2#1)(2011-2#1)
A wide linear##3##3##(2008-10#3)
A wide range of##8##4##(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
A wide variety of##3##4##(1994-12#1)(2008-2#1)(2012-2#1)
A wide##17##2##(1994-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#2)(2013-1#1)
A wild-type##2##2##(1995-8#1)(2008-10#1)
A with##6##2##(1990-12#1)(1996-6#1)(2008-10#2)(2010-8#1)(2012-12#1)
A woman aged##2##3##(1997-8#1)(2011-2#1)
A woman##3##2##(1997-8#1)(2008-11#1)(2011-2#1)
A working##2##2##(1994-1#1)(2010-1#1)
A worldwide collection of##3##4##(2008-10#3)
A worldwide##4##2##(1994-3#1)(2008-10#3)
A young##3##2##(1990-2#1)(2012-2#1)(2012-3#1)
A##8739##1##(1990-10#3)(1990-11#18)(1990-12#54)(1990-2#24)(1990-3#15)(1990-4#1)(1990-5#29)(1990-6#18)(1990-7#3)(1990-8#26)(1990-9#14)(1991-1#14)(1991-10#3)(1991-11#13)(1991-12#39)(1991-2#28)(1991-3#25)(1991-5#21)(1991-6#23)(1991-7#4)(1991-8#24)(1991-9#17)(1992-1#25)(1992-10#3)(1992-11#9)(1992-12#40)(1992-2#33)(1992-3#31)(1992-4#9)(1992-5#10)(1992-6#23)(1992-7#3)(1992-8#12)(1992-9#25)(1993-1#20)(1993-11#19)(1993-12#45)(1993-2#32)(1993-3#32)(1993-6#32)(1993-8#44)(1993-9#10)(1994-1#11)(1994-11#43)(1994-12#40)(1994-2#22)(1994-3#35)(1994-5#46)(1994-6#13)(1994-8#37)(1994-9#13)(1995-1#11)(1995-11#28)(1995-12#59)(1995-2#52)(1995-3#28)(1995-5#11)(1995-6#54)(1995-8#28)(1995-9#14)(1996-1#20)(1996-11#12)(1996-12#56)(1996-2#42)(1996-3#21)(1996-5#37)(1996-6#25)(1996-8#8)(1996-9#16)(1997-1#32)(1997-2#38)(1997-3#58)(1997-4#7)(1997-5#9)(1997-6#17)(1997-7#28)(1997-8#39)(1997-9#6)(2006-6#2)(2007-11#6)(2007-12#43)(2007-8#4)(2007-9#2)(2008-1#19)(2008-10#3512)(2008-11#469)(2008-12#145)(2008-2#44)(2008-3#243)(2008-4#58)(2008-5#143)(2008-6#45)(2008-7#188)(2008-8#160)(2008-9#161)(2009-1#10)(2009-10#27)(2009-11#15)(2009-12#25)(2009-2#4)(2009-3#13)(2009-4#10)(2009-5#20)(2009-6#12)(2009-7#15)(2009-8#50)(2009-9#18)(2010-1#21)(2010-10#34)(2010-11#20)(2010-12#33)(2010-2#11)(2010-3#21)(2010-4#26)(2010-5#29)(2010-6#38)(2010-7#36)(2010-8#37)(2010-9#12)(2011-1#26)(2011-10#2)(2011-2#302)(2011-3#21)(2011-7#2)(2012-12#80)(2012-2#114)(2012-3#129)(2012-4#1)(2012-5#1)(2012-6#1)(2013-1#251)(2013-3#1)(2013-7#11)(2013-8#127)
A(1) and##2##2##(2008-10#2)
A(1)##7##1##(2008-10#5)(2008-11#1)(2008-5#1)
A(2) and C##2##3##(2008-11#2)
A(2) and##4##2##(2008-11#4)
A(2) mating##2##2##(2008-10#2)
A(2)##11##1##(2008-10#3)(2008-11#7)(2011-2#1)
A(490##2##1##(2008-11#2)
A(549) cell##2##2##(2008-9#2)
A(549) cells##2##2##(2008-9#2)
A(549)##5##1##(2008-9#5)
A(549)/DDP cells to##2##3##(2008-9#2)
A(549)/DDP cells##6##2##(2008-9#6)
A(H3N2) viruses##4##2##(1994-9#1)(2013-8#3)
A(H3N2)##6##1##(1994-9#2)(2013-8#4)
A(section)E((R))##4##1##(2008-9#4)
A) and##11##2##(1990-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#1)
A) in the##2##3##(1993-8#1)(2010-8#1)
A) in##4##2##(1993-8#1)(2008-10#1)(2008-9#1)(2010-8#1)
A) is##2##2##(2008-10#1)(2009-6#1)
A) or##3##2##(2008-10#3)
A)##44##1##(1990-6#2)(1991-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-6#1)(1997-1#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-3#1)
A+T content##2##2##(2008-8#2)
A+T-rich##4##1##(1993-2#1)(2008-10#3)
A- and B-type lamins##2##4##(2011-2#2)
A- and B-type##4##3##(1993-9#1)(2011-2#3)
A- and##7##2##(1990-2#1)(1993-9#1)(1994-11#1)(2008-10#1)(2011-2#3)
A-##9##1##(1990-2#1)(1993-9#1)(1994-11#1)(1994-8#1)(2008-10#1)(2011-2#3)(2013-1#1)
A--&gt##2##1##(1993-6#1)(1994-11#1)
A-25 gel##3##2##(2008-10#3)
A-25##5##1##(2008-10#5)
A-50##2##1##(2008-10#1)(2008-8#1)
A-G##2##1##(2008-8#1)(2013-7#1)
A-H##2##1##(2010-6#1)(2010-7#1)
A-Sepharose and##2##2##(2006-6#1)(2008-11#1)
A-Sepharose##5##1##(1990-11#1)(1992-12#1)(2006-6#1)(2008-11#1)(2008-8#1)
A-T-rich##2##1##(1993-8#2)
A-agarose##2##1##(1991-5#1)(1993-6#1)
A-band absorption correction##3##3##(2008-2#3)
A-band absorption##7##2##(2008-2#7)
A-based##2##1##(2008-10#2)
A-cells##2##1##(1994-11#1)(2008-1#1)
A-group isolates##4##2##(2008-10#4)
A-positive##2##1##(1991-8#1)(2008-9#1)
A-ring##4##1##(1990-11#3)(2008-10#1)
A-s##2##1##(2008-10#2)
A-side ALA##2##2##(1992-3#2)
A-type lamins##7##2##(2008-8#1)(2011-2#6)
A-type##11##1##(2006-6#1)(2008-10#2)(2008-8#1)(2011-2#7)
A/B ratio was##2##3##(1994-3#2)
A/B ratio##3##2##(1994-3#3)
A/B##4##1##(1994-3#3)(2013-1#1)
A/H1##8##1##(2011-2#8)
A/H1N1##5##1##(2011-2#4)(2011-9#1)
A/H3N2##4##1##(2011-2#4)
A/J alleles##2##2##(2011-2#2)
A/J##5##1##(2011-2#5)
A/WSN/33##2##1##(1990-5#1)(2012-3#1)
A0##2##1##(1990-8#2)
A1 and A2 isolates##2##4##(2008-10#2)
A1 and A2##8##3##(1993-6#1)(2008-10#7)
A1 and##11##2##(1993-6#1)(1994-6#1)(1997-8#1)(2008-10#8)
A1 isolate##2##2##(2008-10#2)
A1 mating type##2##3##(2008-10#2)
A1 receptor##3##2##(1993-6#1)(1997-1#2)
A1 region##2##2##(1990-5#2)
A1 were##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
A1##64##1##(1990-5#5)(1993-3#1)(1993-6#4)(1994-11#1)(1994-5#1)(1994-6#2)(1996-2#1)(1997-1#6)(1997-8#1)(2008-10#24)(2008-11#2)(2008-12#2)(2008-9#3)(2010-12#1)(2010-6#1)(2011-2#3)(2013-1#1)(2013-8#5)
A10 dopamine##3##2##(1991-1#1)(1994-2#2)
A12C4##2##1##(2008-10#2)
A1AR##2##1##(1993-6#2)
A1C##2##1##(2008-10#1)(2012-2#1)
A2 (all##2##2##(1992-4#2)
A2 allele##2##2##(2008-12#2)
A2 and one##2##3##(2008-10#2)
A2 and##11##2##(1991-6#2)(1996-2#4)(2008-10#4)(2008-12#1)
A2 gene##3##2##(1992-6#2)(1994-11#1)
A2 isolates##6##2##(2008-10#6)
A2 mating type##7##3##(2008-10#7)
A2 mating##8##2##(2008-10#8)
A2 population##3##2##(2008-10#3)
A2 receptors##2##2##(1993-6#1)(1994-6#1)
A2 segment##4##2##(1996-3#4)
A2 to##2##2##(1995-11#1)(2008-10#1)
A2 which##2##2##(1990-5#1)(1991-5#1)
A2##96##1##(1990-5#1)(1990-8#3)(1991-12#1)(1991-5#1)(1991-6#3)(1992-4#2)(1992-6#2)(1992-8#2)(1993-6#4)(1994-11#7)(1994-3#3)(1994-5#5)(1994-6#3)(1995-11#6)(1996-2#4)(1996-3#4)(1997-1#1)(2008-10#35)(2008-12#3)(2008-8#3)(2008-9#1)(2012-2#1)(2013-8#1)
A2)##2##1##(2008-10#1)(2008-9#1)
A2-receptor-mediated inhibition of phagocytosis##2##4##(1994-6#2)
A2-receptor-mediated##3##1##(1994-6#3)
A20##11##1##(1992-7#6)(1993-3#1)(2008-4#1)(2008-9#2)(2010-10#1)
A23187 and##2##2##(1993-8#1)(1995-11#1)
A23187 or##2##2##(1995-11#1)(2008-10#1)
A23187 treatment##2##2##(1991-5#1)(1994-3#1)
A23187 was##2##2##(1991-5#1)(1992-6#1)
A23187##20##1##(1991-5#4)(1992-6#1)(1993-8#3)(1994-11#1)(1994-3#2)(1995-11#4)(2008-10#1)(2008-11#2)(2008-8#2)
A23187-stimulated##2##1##(1991-5#1)(1993-2#1)
A24##4##1##(2008-10#4)
A3##8##1##(1990-12#4)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
A4##9##1##(1991-1#1)(1991-5#2)(1991-6#4)(1994-5#1)(2008-10#1)
A431 cells##3##2##(1992-7#3)
A46 cells into##2##3##(2013-1#2)
A506 and Pantoea agglomerans strains##2##5##(2008-10#2)
A506 and##3##2##(2008-10#3)
A506 in##2##2##(2008-10#2)
A506 is##2##2##(2008-10#2)
A506##30##1##(2008-10#30)
A506)##2##1##(2008-10#2)
A511##3##1##(2012-2#3)
A5314##3##1##(2008-10#3)
A5387##2##1##(2008-10#2)
A549 cell line##2##3##(2008-11#2)
A549##14##1##(2008-11#12)(2008-9#1)(2011-3#1)
A5DC7##2##1##(2008-11#2)
A6##4##1##(1993-6#1)(1994-5#2)(2008-10#1)
A7 monoclonal antibody was##2##4##(2008-11#2)
A7 monoclonal antibody##4##3##(2008-11#4)
A7##7##1##(2008-11#7)
A9 allele##2##2##(2008-9#2)
A9 cells##2##2##(1996-6#2)
A9##4##1##(1996-6#2)(2008-9#2)
A=0##3##1##(2008-10#3)
AA 231-1 in##2##3##(1992-12#2)
AA 231-1##3##2##(1992-12#3)
AA and DA in##2##4##(2008-10#2)
AA and DA##4##3##(2008-10#4)
AA and##6##2##(1993-3#1)(2008-10#5)
AA genotype##4##2##(2011-2#4)
AA in the##3##3##(2008-10#2)(2008-8#1)
AA in##8##2##(1992-12#2)(2008-10#5)(2008-8#1)
AA is##3##2##(2008-10#2)(2008-11#1)
AA or its##2##3##(2008-5#2)
AA or##3##2##(2008-5#3)
AA was##5##2##(2008-10#5)
AA with##2##2##(2008-10#1)(2008-8#1)
AA##62##1##(1992-12#6)(1993-3#3)(1993-8#3)(1997-2#3)(2008-10#35)(2008-11#1)(2008-5#3)(2008-8#4)(2011-2#4)
AA-I and AA-II##3##3##(2008-10#3)
AA560##7##1##(1990-11#7)
AAA 99-2##3##2##(2008-10#3)
AAA and##2##2##(2008-8#1)(2010-12#1)
AAA##13##1##(2008-10#3)(2008-8#2)(2009-7#3)(2010-12#1)(2010-7#1)(2013-1#3)
AABB##6##1##(1995-6#6)
AABB's##2##1##(1995-6#2)
AAC in##2##2##(2008-10#2)
AAC##10##1##(2008-10#9)(2010-7#1)
AAF modified##4##2##(1991-5#4)
AAF##6##1##(1991-5#5)(2008-10#1)
AAI may be of particular interest to insurers dealing in the elderly market##2##13##(1993-12#2)
AAI will appear more common in attending physician's statements##2##9##(1993-12#2)
AAI##6##1##(1993-12#6)
AAL-TA##5##1##(2008-10#5)
AAL-TB##3##1##(2008-10#3)
AANAT##6##1##(2008-5#6)
AAP##6##1##(2008-10#6)
AAPCC##11##1##(1991-3#2)(1993-3#9)
AAPs##4##1##(2008-10#4)
AARE##2##1##(1996-2#2)
AAS after##3##2##(2008-10#3)
AAS and##5##2##(2008-10#5)
AAS determination of##3##3##(2008-10#3)
AAS for##2##2##(2008-10#2)
AAS method##3##2##(2008-10#3)
AAS signal##2##2##(2008-10#2)
AAS technique##2##2##(2008-10#2)
AAS using##2##2##(2008-10#2)
AAS was##4##2##(2008-10#4)
AAS##59##1##(2008-10#59)
AAS)##5##1##(2008-10#5)
AAS-found metal##3##2##(2008-10#3)
AAT##2##1##(2008-4#1)(2010-7#1)
AAV vectors##2##2##(2008-9#1)(2011-3#1)
AAV##4##1##(2008-8#1)(2008-9#1)(2011-3#2)
AAV-2 genome##2##2##(2008-8#2)
AAV-2 rep and cap##2##4##(2008-8#2)
AAV-2##7##1##(2008-8#7)
AB 136 and##2##3##(2008-10#2)
AB 136##4##2##(2008-10#4)
AB##17##1##(2008-10#9)(2008-11#4)(2008-5#1)(2009-4#2)(2010-11#1)
AB)##2##1##(2008-11#1)(2008-8#1)
ABA accumulation is##2##3##(2008-8#2)
ABA accumulation##8##2##(2008-8#8)
ABA concentration in##3##3##(2008-8#3)
ABA production##3##2##(2009-6#3)
ABA##25##1##(2008-10#2)(2008-8#14)(2008-9#1)(2009-6#5)(2009-8#3)
ABA-binding##2##1##(2008-8#2)
ABBP##5##1##(2008-8#5)
ABC is##2##2##(1993-12#1)(1994-3#1)
ABC neurotomy##2##2##(1994-3#2)
ABC of##4##2##(1990-3#1)(1990-9#1)(1996-8#1)(1997-5#1)
ABC##15##1##(1990-3#1)(1990-9#1)(1993-12#2)(1994-3#4)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
ABC155##2##1##(2008-10#2)
ABI##3##1##(2008-10#1)(2008-9#2)
ABI3 and ABI5 expression##2##4##(2009-8#2)
ABI3 and ABI5##3##3##(2009-8#3)
ABL height##2##2##(2008-2#2)
ABL##6##1##(2008-2#5)(2010-11#1)
ABLEDATA##2##1##(1992-3#2)
ABO blood group and##2##4##(1990-6#1)(2013-1#1)
ABO blood group##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
ABO##6##1##(1990-6#1)(2008-10#3)(2011-2#1)(2013-1#1)
ABSTRACT A collection##2##3##(2008-10#2)
ABSTRACT A field experiment was##2##5##(2008-10#2)
ABSTRACT A field##3##3##(2008-10#3)
ABSTRACT A leaf##2##3##(2008-10#2)
ABSTRACT A multiplex##3##3##(2008-10#3)
ABSTRACT A new##8##3##(2008-10#8)
ABSTRACT A novel##3##3##(2008-10#3)
ABSTRACT A panel of##2##4##(2008-10#2)
ABSTRACT A polymerase chain reaction##3##5##(2008-10#3)
ABSTRACT A polymerase chain##5##4##(2008-10#5)
ABSTRACT A potential##2##3##(2008-10#2)
ABSTRACT A previously uncharacterized##2##4##(2008-10#2)
ABSTRACT A previously##4##3##(2008-10#4)
ABSTRACT A quantitative##3##3##(2008-10#3)
ABSTRACT A random##2##3##(2008-10#2)
ABSTRACT A series of##2##4##(2008-10#2)
ABSTRACT A set of##2##4##(2008-10#2)
ABSTRACT A technique was developed to##2##6##(2008-10#2)
ABSTRACT A technique##3##3##(2008-10#3)
ABSTRACT A total of##8##4##(2008-10#8)
ABSTRACT A worldwide collection of##2##5##(2008-10#2)
ABSTRACT A##129##2##(2008-10#129)
ABSTRACT Aflatoxins are carcinogens produced mainly by Aspergillus flavus during infection of susceptible crops such as maize##2##17##(2008-10#2)
ABSTRACT Aflatoxins are carcinogens produced##3##5##(2008-10#3)
ABSTRACT Aflatoxins are toxic##2##4##(2008-10#2)
ABSTRACT Aflatoxins are##5##3##(2008-10#5)
ABSTRACT After##2##2##(2008-10#2)
ABSTRACT Agrobacterium tumefaciens-mediated transformation##2##4##(2008-10#2)
ABSTRACT Agrobacterium##3##2##(2008-10#3)
ABSTRACT Alfalfa##2##2##(2008-10#2)
ABSTRACT Alternaria citri##2##3##(2008-10#2)
ABSTRACT Alternaria spp##2##3##(2008-10#2)
ABSTRACT Alternaria##8##2##(2008-10#8)
ABSTRACT Although##5##2##(2008-10#5)
ABSTRACT Amplified fragment length##2##4##(2008-10#2)
ABSTRACT An##19##2##(2008-10#19)
ABSTRACT Anthracnose##3##2##(2008-10#3)
ABSTRACT Antisera##2##2##(2008-10#2)
ABSTRACT Apple##3##2##(2008-10#3)
ABSTRACT As a##2##3##(2008-10#2)
ABSTRACT Aspergillus flavus is##2##4##(2008-10#2)
ABSTRACT Aspergillus flavus##4##3##(2008-10#4)
ABSTRACT Aspergillus##5##2##(2008-10#5)
ABSTRACT Bacterial blight##2##3##(2008-10#2)
ABSTRACT Bacterial##5##2##(2008-10#5)
ABSTRACT Barley yellow dwarf virus##2##5##(2008-10#2)
ABSTRACT Barley yellow dwarf##3##4##(2008-10#3)
ABSTRACT Barley##6##2##(2008-10#6)
ABSTRACT Bayesian##2##2##(2008-10#2)
ABSTRACT Bean##2##2##(2008-10#2)
ABSTRACT Because##2##2##(2008-10#2)
ABSTRACT Biocontrol##2##2##(2008-10#2)
ABSTRACT Botrytis cinerea##3##3##(2008-10#3)
ABSTRACT Botrytis##4##2##(2008-10#4)
ABSTRACT Breeding##2##2##(2008-10#2)
ABSTRACT Burkholderia##2##2##(2008-10#2)
ABSTRACT Cassava##2##2##(2008-10#2)
ABSTRACT Cephalosporium##2##2##(2008-10#2)
ABSTRACT Changes in##2##3##(2008-10#2)
ABSTRACT Chemical##3##2##(2008-10#3)
ABSTRACT Citrus exocortis viroid (CEVd)##2##5##(2008-10#2)
ABSTRACT Citrus tristeza virus (CTV)##2##5##(2008-10#2)
ABSTRACT Citrus##7##2##(2008-10#7)
ABSTRACT Colletotrichum gloeosporioides##3##3##(2008-10#3)
ABSTRACT Colletotrichum##6##2##(2008-10#6)
ABSTRACT Colonization of##2##3##(2008-10#2)
ABSTRACT Common bacterial blight (CBB)##2##5##(2008-10#2)
ABSTRACT Common##3##2##(2008-10#3)
ABSTRACT Controlled##2##2##(2008-10#2)
ABSTRACT Cranberry stem gall is characterized by tumors that girdle stems##2##11##(2008-10#2)
ABSTRACT Crown rust##3##3##(2008-10#3)
ABSTRACT Crown##4##2##(2008-10#4)
ABSTRACT Cucurbit##2##2##(2008-10#2)
ABSTRACT Culture##2##2##(2008-10#2)
ABSTRACT DNA##4##2##(2008-10#4)
ABSTRACT Data##3##2##(2008-10#3)
ABSTRACT Development of##2##3##(2008-10#2)
ABSTRACT Disease##3##2##(2008-10#3)
ABSTRACT Diverse##3##2##(2008-10#3)
ABSTRACT Dothistroma##2##2##(2008-10#2)
ABSTRACT Double-stranded##3##2##(2008-10#3)
ABSTRACT During##5##2##(2008-10#5)
ABSTRACT Effects of##2##3##(2008-10#2)
ABSTRACT Eight##2##2##(2008-10#2)
ABSTRACT Epidemics of##4##3##(2008-10#4)
ABSTRACT Epidemiological##2##2##(2008-10#2)
ABSTRACT Eutypa dieback is a##2##5##(2008-10#2)
ABSTRACT Experiments were conducted in##2##5##(2008-10#2)
ABSTRACT Experiments##4##2##(2008-10#4)
ABSTRACT Expression of##2##3##(2008-10#2)
ABSTRACT Eyespot of wheat is caused by##2##7##(2008-10#2)
ABSTRACT Field observations##2##3##(2008-10#2)
ABSTRACT Field##3##2##(2008-10#3)
ABSTRACT Fire blight##2##3##(2008-10#2)
ABSTRACT Five##3##2##(2008-10#3)
ABSTRACT For##2##2##(2008-10#2)
ABSTRACT Four##9##2##(2008-10#9)
ABSTRACT Fungi in##2##3##(2008-10#2)
ABSTRACT Fusarium head blight (FHB)##4##5##(2008-10#4)
ABSTRACT Fusarium head blight##5##4##(2008-10#5)
ABSTRACT Fusarium oxysporum f##3##4##(2008-10#3)
ABSTRACT Fusarium oxysporum##5##3##(2008-10#5)
ABSTRACT Fusarium species##2##3##(2008-10#2)
ABSTRACT Fusarium wilt of##3##4##(2008-10#3)
ABSTRACT Fusarium wilt##4##3##(2008-10#4)
ABSTRACT Fusarium##24##2##(2008-10#24)
ABSTRACT Genetic diversity was##2##4##(2008-10#2)
ABSTRACT Genetic diversity##3##3##(2008-10#3)
ABSTRACT Genetic resistance##2##3##(2008-10#2)
ABSTRACT Genetic variation##2##3##(2008-10#2)
ABSTRACT Genetic##12##2##(2008-10#12)
ABSTRACT Gibberella zeae##2##3##(2008-10#2)
ABSTRACT Grapevine##2##2##(2008-10#2)
ABSTRACT Gray leaf spot##5##4##(2008-10#5)
ABSTRACT Greasy spot##2##3##(2008-10#2)
ABSTRACT Host##2##2##(2008-10#2)
ABSTRACT In a##3##3##(2008-10#3)
ABSTRACT In an attempt to##3##5##(2008-10#3)
ABSTRACT In an##5##3##(2008-10#5)
ABSTRACT In order to##5##4##(2008-10#5)
ABSTRACT In the present##2##4##(2008-10#2)
ABSTRACT In the##10##3##(2008-10#10)
ABSTRACT In this study##2##4##(2008-10#2)
ABSTRACT In this##4##3##(2008-10#4)
ABSTRACT In##41##2##(2008-10#41)
ABSTRACT Infection of##5##3##(2008-10#5)
ABSTRACT Infection##6##2##(2008-10#6)
ABSTRACT Interactions between##2##3##(2008-10#2)
ABSTRACT Isolates of Colletotrichum spp##2##5##(2008-10#2)
ABSTRACT Isolates of Colletotrichum##3##4##(2008-10#3)
ABSTRACT Isolates of Puccinia triticina collected from##2##7##(2008-10#2)
ABSTRACT Isolates of Puccinia##3##4##(2008-10#3)
ABSTRACT Isolates of Rhizoctonia solani##2##5##(2008-10#2)
ABSTRACT Isolates of Rhizoctonia##3##4##(2008-10#3)
ABSTRACT Isolates of the##2##4##(2008-10#2)
ABSTRACT Isolates of##18##3##(2008-10#18)
ABSTRACT It##2##2##(2008-10#2)
ABSTRACT Karnal bunt of wheat##2##5##(2008-10#2)
ABSTRACT Late##2##2##(2008-10#2)
ABSTRACT Leaf rust##3##3##(2008-10#3)
ABSTRACT Leaf##6##2##(2008-10#6)
ABSTRACT Leptosphaeria maculans##2##3##(2008-10#2)
ABSTRACT Little cherry disease (LChD) is a##2##7##(2008-10#2)
ABSTRACT Little##3##2##(2008-10#3)
ABSTRACT Magnaporthe grisea##2##3##(2008-10#2)
ABSTRACT Modeling##2##2##(2008-10#2)
ABSTRACT Molecular##4##2##(2008-10#4)
ABSTRACT Monilinia fructicola##2##3##(2008-10#2)
ABSTRACT Monilinia##3##2##(2008-10#3)
ABSTRACT Most##2##2##(2008-10#2)
ABSTRACT Mycosphaerella##4##2##(2008-10#4)
ABSTRACT Natural##2##2##(2008-10#2)
ABSTRACT Observations##2##2##(2008-10#2)
ABSTRACT One hundred##3##3##(2008-10#3)
ABSTRACT One##6##2##(2008-10#6)
ABSTRACT Our##2##2##(2008-10#2)
ABSTRACT Papaya ringspot virus (PRSV)##2##5##(2008-10#2)
ABSTRACT Partial resistance to##3##4##(2008-10#3)
ABSTRACT Partial##4##2##(2008-10#4)
ABSTRACT Pathogenic##2##2##(2008-10#2)
ABSTRACT Pathogenicity##2##2##(2008-10#2)
ABSTRACT Pear##2##2##(2008-10#2)
ABSTRACT Penicillium##2##2##(2008-10#2)
ABSTRACT Pepper##2##2##(2008-10#2)
ABSTRACT Peronospora tabacina is an##2##5##(2008-10#2)
ABSTRACT Phytophthora capsici##3##3##(2008-10#3)
ABSTRACT Phytophthora infestans##3##3##(2008-10#3)
ABSTRACT Phytophthora nicotianae##3##3##(2008-10#3)
ABSTRACT Phytophthora ramorum##2##3##(2008-10#2)
ABSTRACT Phytophthora root##2##3##(2008-10#2)
ABSTRACT Phytophthora##14##2##(2008-10#14)
ABSTRACT Plant##7##2##(2008-10#7)
ABSTRACT Planting##2##2##(2008-10#2)
ABSTRACT Polymerase chain reaction##3##4##(2008-10#3)
ABSTRACT Population##3##2##(2008-10#3)
ABSTRACT Potato##3##2##(2008-10#3)
ABSTRACT Powdery mildew##3##3##(2008-10#3)
ABSTRACT Previous##2##2##(2008-10#2)
ABSTRACT Production of the##2##4##(2008-10#2)
ABSTRACT Production of##4##3##(2008-10#4)
ABSTRACT Pseudomonas fluorescens##3##3##(2008-10#3)
ABSTRACT Pseudomonas spp##2##3##(2008-10#2)
ABSTRACT Pseudomonas##6##2##(2008-10#6)
ABSTRACT Pyrenophora tritici-repentis##3##3##(2008-10#3)
ABSTRACT Pyrenophora##4##2##(2008-10#4)
ABSTRACT Pythium##3##2##(2008-10#3)
ABSTRACT Quantitative##2##2##(2008-10#2)
ABSTRACT Reliable##2##2##(2008-10#2)
ABSTRACT Resistance to##4##3##(2008-10#4)
ABSTRACT Resistance##6##2##(2008-10#6)
ABSTRACT Restriction fragment length polymorphism (RFLP) markers were used to##2##10##(2008-10#2)
ABSTRACT Restriction fragment length polymorphisms (RFLPs)##2##6##(2008-10#2)
ABSTRACT Restriction fragment length##4##4##(2008-10#4)
ABSTRACT Rhizoctonia solani##2##3##(2008-10#2)
ABSTRACT Rhizoctonia##3##2##(2008-10#3)
ABSTRACT Rice##4##2##(2008-10#4)
ABSTRACT Root and stem rot##2##5##(2008-10#2)
ABSTRACT Root and##3##3##(2008-10#3)
ABSTRACT Root-knot nematodes##2##3##(2008-10#2)
ABSTRACT Sclerotinia sclerotiorum##2##3##(2008-10#2)
ABSTRACT Sclerotinia##3##2##(2008-10#3)
ABSTRACT Seed treatment with##2##4##(2008-10#2)
ABSTRACT Seed##4##2##(2008-10#4)
ABSTRACT Selected isolates of##2##4##(2008-10#2)
ABSTRACT Septoria speckled leaf blotch (SSLB)##2##6##(2008-10#2)
ABSTRACT Septoria##3##2##(2008-10#3)
ABSTRACT Sequential##2##2##(2008-10#2)
ABSTRACT Seven##2##2##(2008-10#2)
ABSTRACT Several##4##2##(2008-10#4)
ABSTRACT Severe##2##2##(2008-10#2)
ABSTRACT Since the early 1990s##2##5##(2008-10#2)
ABSTRACT Since##4##2##(2008-10#4)
ABSTRACT Six##3##2##(2008-10#3)
ABSTRACT Sixty##2##2##(2008-10#2)
ABSTRACT Soil##4##2##(2008-10#4)
ABSTRACT Soybean rust##2##3##(2008-10#2)
ABSTRACT Soybean##3##2##(2008-10#3)
ABSTRACT Spatial and temporal##2##4##(2008-10#2)
ABSTRACT Spatial##3##2##(2008-10#3)
ABSTRACT Specific##4##2##(2008-10#4)
ABSTRACT Spiroplasma citri##2##3##(2008-10#2)
ABSTRACT Spot blotch##3##3##(2008-10#3)
ABSTRACT Spread of##2##3##(2008-10#2)
ABSTRACT Stem##3##2##(2008-10#3)
ABSTRACT Stenotrophomonas maltophilia strain C3##2##5##(2008-10#2)
ABSTRACT Strains of Pseudomonas##2##4##(2008-10#2)
ABSTRACT Strains of the##2##4##(2008-10#2)
ABSTRACT Strains of##10##3##(2008-10#10)
ABSTRACT Strawberry##2##2##(2008-10#2)
ABSTRACT Striga##2##2##(2008-10#2)
ABSTRACT Stripe rust##2##3##(2008-10#2)
ABSTRACT Structural##2##2##(2008-10#2)
ABSTRACT Studies##2##2##(2008-10#2)
ABSTRACT Sudden death syndrome##2##4##(2008-10#2)
ABSTRACT Sudden oak death##2##4##(2008-10#2)
ABSTRACT Sudden##4##2##(2008-10#4)
ABSTRACT Sugarcane mosaic##2##3##(2008-10#2)
ABSTRACT Sugarcane##3##2##(2008-10#3)
ABSTRACT Suppressive##2##2##(2008-10#2)
ABSTRACT Tan spot##2##3##(2008-10#2)
ABSTRACT Temperature##2##2##(2008-10#2)
ABSTRACT Tests##2##2##(2008-10#2)
ABSTRACT The ability of##6##4##(2008-10#6)
ABSTRACT The ability##7##3##(2008-10#7)
ABSTRACT The abundance##2##3##(2008-10#2)
ABSTRACT The aggressiveness of##3##4##(2008-10#3)
ABSTRACT The biological and molecular properties of##2##7##(2008-10#2)
ABSTRACT The capacity of the##2##5##(2008-10#2)
ABSTRACT The causal##2##3##(2008-10#2)
ABSTRACT The complete nucleotide##2##4##(2008-10#2)
ABSTRACT The complete##3##3##(2008-10#3)
ABSTRACT The course of##2##4##(2008-10#2)
ABSTRACT The development of##4##4##(2008-10#4)
ABSTRACT The development##5##3##(2008-10#5)
ABSTRACT The dynamics of the##2##5##(2008-10#2)
ABSTRACT The dynamics of##3##4##(2008-10#3)
ABSTRACT The effect of##17##4##(2008-10#17)
ABSTRACT The effect##18##3##(2008-10#18)
ABSTRACT The effects of temperature##2##5##(2008-10#2)
ABSTRACT The effects of##14##4##(2008-10#14)
ABSTRACT The efficacy of##2##4##(2008-10#2)
ABSTRACT The epidemiology##2##3##(2008-10#2)
ABSTRACT The fungus##4##3##(2008-10#4)
ABSTRACT The genetic diversity of##2##5##(2008-10#2)
ABSTRACT The genetic structure of field populations of##2##8##(2008-10#2)
ABSTRACT The genetic structure of populations of##2##7##(2008-10#2)
ABSTRACT The genetic structure of##5##5##(2008-10#5)
ABSTRACT The genetic##9##3##(2008-10#9)
ABSTRACT The genome of##2##4##(2008-10#2)
ABSTRACT The germination##2##3##(2008-10#2)
ABSTRACT The incidence of##2##4##(2008-10#2)
ABSTRACT The induction of##3##4##(2008-10#3)
ABSTRACT The infection of##2##4##(2008-10#2)
ABSTRACT The influence##2##3##(2008-10#2)
ABSTRACT The inheritance of resistance to##3##6##(2008-10#3)
ABSTRACT The inheritance of##4##4##(2008-10#4)
ABSTRACT The mechanism of##2##4##(2008-10#2)
ABSTRACT The nucleotide sequence of the##2##6##(2008-10#2)
ABSTRACT The population structure of##4##5##(2008-10#4)
ABSTRACT The population##6##3##(2008-10#6)
ABSTRACT The potential of the##2##5##(2008-10#2)
ABSTRACT The potential of##3##4##(2008-10#3)
ABSTRACT The potential##5##3##(2008-10#5)
ABSTRACT The presence of##2##4##(2008-10#2)
ABSTRACT The recent##2##3##(2008-10#2)
ABSTRACT The relationship between##2##4##(2008-10#2)
ABSTRACT The role of the##2##5##(2008-10#2)
ABSTRACT The role of##10##4##(2008-10#10)
ABSTRACT The roles of##2##4##(2008-10#2)
ABSTRACT The rust fungus Puccinia##2##5##(2008-10#2)
ABSTRACT The spatial pattern of##2##5##(2008-10#2)
ABSTRACT The spatial##3##3##(2008-10#3)
ABSTRACT The temporal and spatial##2##5##(2008-10#2)
ABSTRACT The use of##2##4##(2008-10#2)
ABSTRACT The##293##2##(2008-10#293)
ABSTRACT This paper##2##3##(2008-10#2)
ABSTRACT This study examined##2##4##(2008-10#2)
ABSTRACT This study reports the##2##5##(2008-10#2)
ABSTRACT This study##11##3##(2008-10#11)
ABSTRACT This##14##2##(2008-10#14)
ABSTRACT Three##10##2##(2008-10#10)
ABSTRACT To determine the##2##4##(2008-10#2)
ABSTRACT To determine##3##3##(2008-10#3)
ABSTRACT To investigate the##3##4##(2008-10#3)
ABSTRACT To investigate##5##3##(2008-10#5)
ABSTRACT To understand the##2##4##(2008-10#2)
ABSTRACT To##25##2##(2008-10#25)
ABSTRACT Tobacco##2##2##(2008-10#2)
ABSTRACT Tomato yellow leaf curl##2##5##(2008-10#2)
ABSTRACT Tomato##10##2##(2008-10#10)
ABSTRACT Transgenic##4##2##(2008-10#4)
ABSTRACT Transmission##2##2##(2008-10#2)
ABSTRACT Trichoderma##2##2##(2008-10#2)
ABSTRACT Two biocontrol agents##2##4##(2008-10#2)
ABSTRACT Two field experiments were conducted to study the##2##9##(2008-10#2)
ABSTRACT Two strains of##2##4##(2008-10#2)
ABSTRACT Two##29##2##(2008-10#29)
ABSTRACT Using##6##2##(2008-10#6)
ABSTRACT Ustilago hordei##2##3##(2008-10#2)
ABSTRACT Verticillium##2##2##(2008-10#2)
ABSTRACT We developed a##2##4##(2008-10#2)
ABSTRACT We developed##3##3##(2008-10#3)
ABSTRACT We evaluated##4##3##(2008-10#4)
ABSTRACT We examined the##2##4##(2008-10#2)
ABSTRACT We have developed a##3##5##(2008-10#3)
ABSTRACT We have##6##3##(2008-10#6)
ABSTRACT We investigated the##3##4##(2008-10#3)
ABSTRACT We used molecular markers to identify quantitative trait loci (QTL) that##2##12##(2008-10#2)
ABSTRACT We##35##2##(2008-10#35)
ABSTRACT Wheat (Triticum aestivum)##2##4##(2008-10#2)
ABSTRACT Wheat##4##2##(2008-10#4)
ABSTRACT When##5##2##(2008-10#5)
ABSTRACT While##2##2##(2008-10#2)
ABSTRACT Xanthomonas campestris pv##2##4##(2008-10#2)
ABSTRACT Xanthomonas##5##2##(2008-10#5)
ABSTRACT Xylella fastidiosa is##2##4##(2008-10#2)
ABSTRACT Xylella fastidiosa##4##3##(2008-10#4)
ABSTRACT##1521##1##(2008-10#1510)(2011-2#1)(2012-2#7)(2012-3#3)
ABT-737##2##1##(2009-12#2)
ABTM##2##1##(2008-10#2)
ABTS##4##1##(2008-10#4)
ABTS(+)##3##1##(2008-10#3)
ABU in the##2##3##(2008-12#2)
ABU was##2##2##(2008-12#2)
ABU##4##1##(2008-12#4)
ABZ1##2##1##(2012-3#2)
AC HEMIZYGOUS MICE##5##3##(2008-9#5)
AC Hemizygous) mice##2##3##(2008-9#2)
AC Taber##4##2##(2008-10#4)
AC and##3##2##(1994-12#1)(2009-7#2)
AC hemizygous and p53 haploinsufficient mice##3##6##(2008-9#3)
AC hemizygous mice exposed to sodium bromate##2##7##(2008-9#2)
AC hemizygous mice exposed to##5##5##(2008-9#5)
AC hemizygous mice exposed##8##4##(2008-9#8)
AC hemizygous mice received dermal applications of 0##2##8##(2008-9#2)
AC hemizygous mice received##3##4##(2008-9#3)
AC hemizygous mice were exposed to drinking water containing 0##3##10##(2008-9#3)
AC hemizygous mice were##6##4##(2008-9#6)
AC hemizygous mice##22##3##(2008-9#22)
AC hemizygous##27##2##(2008-9#27)
AC was##3##2##(2008-10#2)(2009-7#1)
AC##58##1##(1994-12#2)(2008-10#15)(2008-9#35)(2009-7#6)
AC-##2##1##(2008-10#2)
AC1##2##1##(2008-10#2)
AC133(+) cells##2##2##(2013-1#2)
AC133(+)##3##1##(2013-1#3)
AC133(bright)##3##1##(2013-1#3)
AC2##4##1##(2008-10#1)(2008-9#3)
ACA##6##1##(2011-2#3)(2013-8#3)
ACASS##2##1##(2012-12#2)
ACAT##2##1##(1990-8#2)
ACBP by##2##2##(1994-8#2)
ACBP concentrations##2##2##(1994-8#2)
ACBP was##2##2##(1994-8#2)
ACBP##8##1##(1994-8#8)
ACC content##2##2##(2011-2#2)
ACC in##3##2##(2008-10#2)(2011-10#1)
ACC of the##2##3##(2013-1#1)(2013-8#1)
ACC synthase##2##2##(1995-2#2)
ACC was##2##2##(1991-11#1)(2010-7#1)
ACC##24##1##(1991-11#4)(1993-6#2)(1995-2#2)(2008-10#4)(2009-6#2)(2010-7#1)(2011-10#1)(2011-2#2)(2013-1#1)(2013-8#5)
ACC-infected##2##1##(2008-10#2)
ACCH##2##1##(1992-3#2)
ACD##8##1##(2009-8#2)(2011-2#6)
ACDF##8##1##(2012-12#8)
ACE activity##3##2##(1993-12#3)
ACE in##2##2##(1993-12#2)
ACE inhibitor##2##2##(1997-3#1)(2008-7#1)
ACE inhibitors##3##2##(1996-6#1)(2008-7#2)
ACE was##2##2##(1993-12#1)(2008-9#1)
ACE##24##1##(1991-11#1)(1993-12#9)(1996-6#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-9#7)
ACE-inhibitors and##2##2##(1993-2#1)(2008-10#1)
ACG##2##1##(1995-2#1)(2010-7#1)
ACGMRF model##2##2##(2008-6#2)
ACGs##2##1##(1995-2#2)
ACL graft##3##2##(1997-8#2)(2013-1#1)
ACL grafts##2##2##(1997-8#2)
ACL reconstruction with hamstrings##3##4##(2013-1#3)
ACL reconstruction##6##2##(2012-2#2)(2013-1#4)
ACL reconstructions using Achilles tendon allografts in patients##2##8##(2012-2#2)
ACL##26##1##(1997-8#8)(2012-2#4)(2013-1#14)
ACLSV##7##1##(2008-10#7)
ACLU##2##1##(1996-5#2)
ACM##2##1##(2012-2#2)
ACM941 significantly##2##2##(2008-10#2)
ACM941##9##1##(2008-10#9)
ACMs##2##1##(2012-2#2)
ACN##6##1##(2008-10#6)
ACN-water mixtures##2##2##(2008-10#2)
ACN-water##3##1##(2008-10#3)
ACO##3##1##(2011-2#2)(2012-3#1)
ACP##9##1##(1991-11#2)(1992-4#2)(1993-12#1)(1995-6#1)(2013-1#1)(2013-8#2)
ACPC##2##1##(1995-11#2)
ACR##10##1##(2008-10#9)(2013-1#1)
ACR-toxin##3##1##(2008-10#3)
ACS and##4##2##(2010-4#1)(2011-2#3)
ACS were##2##2##(2011-2#1)(2012-2#1)
ACS##27##1##(1997-1#1)(2008-10#3)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#2)(2010-4#2)(2011-2#4)(2012-2#4)
ACT produced##2##2##(2008-10#2)
ACT##4##1##(2008-10#3)(2011-2#1)
ACT-toxin and##2##2##(2008-10#2)
ACT-toxin##8##1##(2008-10#8)
ACTH and corticosterone##3##3##(1995-12#1)(1996-12#2)
ACTH and##5##2##(1995-12#2)(1996-12#2)(2011-2#1)
ACTH expression in##2##3##(1995-12#2)
ACTH receptor##2##2##(2011-1#2)
ACTH response to##2##3##(1992-8#1)(1994-2#1)
ACTH secretion##2##2##(2008-4#2)
ACTH##25##1##(1992-8#4)(1994-2#1)(1995-12#8)(1995-2#1)(1996-12#2)(2008-4#2)(2011-1#4)(2011-2#3)
ACTH-ir##5##1##(1995-12#5)
ACh at##2##2##(2008-8#2)
ACh receptor##2##2##(2008-8#2)
ACh##12##1##(1992-8#1)(1996-5#3)(1997-1#1)(2008-8#5)(2009-8#1)(2012-3#1)
ACh-mediated system##2##2##(2009-8#2)
ACh-mediated##3##1##(2009-8#3)
ACh-release##2##1##(2008-8#2)
AChE activity##3##2##(2008-11#3)
AChE and##2##2##(2009-8#2)
AChE##25##1##(1990-5#4)(1994-5#2)(2008-10#6)(2008-11#5)(2009-8#8)
AChEs##4##1##(2009-8#4)
AChR##6##1##(1997-5#3)(2009-8#3)
AD and PD##5##3##(2011-2#5)
AD and VaD##2##3##(2008-7#2)
AD and##11##2##(2008-10#1)(2008-7#3)(2009-10#1)(2011-2#6)
AD duration##5##2##(1992-12#3)(1994-2#2)
AD height gain##3##3##(2011-2#3)
AD patients and##2##3##(2008-7#2)
AD patients##5##2##(2008-5#1)(2008-7#4)
AD##77##1##(1991-1#6)(1991-7#1)(1992-12#3)(1994-11#1)(1994-2#2)(1994-5#2)(1995-12#4)(1995-8#3)(1996-2#2)(1997-2#4)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#20)(2009-10#3)(2011-2#14)
ADA and##2##2##(1995-12#1)(2013-1#1)
ADA is##2##2##(1996-1#1)(2008-10#1)
ADA##26##1##(1990-8#1)(1992-11#1)(1994-1#2)(1995-12#7)(1995-6#2)(1996-1#3)(1996-5#3)(2008-10#3)(2008-3#2)(2008-8#1)(2013-1#1)
ADAM##6##1##(1990-9#1)(2008-11#1)(2008-8#2)(2008-9#2)
ADAM22 and 14-3-3beta##3##3##(2008-9#3)
ADAM22##7##1##(2008-9#7)
ADAM29##5##1##(2008-8#5)
ADAMTS13##12##1##(2009-7#12)
ADAMs##2##1##(2008-8#1)(2008-9#1)
ADAVS##3##1##(1996-9#3)
ADBI##5##1##(2008-10#5)
ADC##6##1##(1992-12#1)(2009-11#4)(2009-4#1)
ADCI is##2##2##(2008-5#2)
ADCI##7##1##(2008-5#7)
ADE##4##1##(2008-10#2)(2008-8#2)
ADG cell line##4##3##(2008-11#4)
ADH activity and ADH CRM##2##5##(1997-8#2)
ADH activity and##3##3##(1997-8#3)
ADH activity##4##2##(1997-8#4)
ADH mRNA##2##2##(1997-8#2)
ADH##10##1##(1997-8#9)(2008-10#1)
ADH-I was##3##2##(2008-11#3)
ADH-I##8##1##(2008-11#8)
ADHD and ODD##2##3##(2012-2#2)
ADHD and##8##2##(2010-8#1)(2011-2#1)(2012-2#5)(2012-3#1)
ADHD treatment##2##2##(2008-11#1)(2009-9#1)
ADHD was##2##2##(1996-6#1)(2008-9#1)
ADHD##33##1##(1996-6#2)(2008-11#3)(2008-2#6)(2008-8#1)(2008-9#2)(2009-9#4)(2010-8#4)(2011-2#3)(2012-2#7)(2012-3#1)
ADHD-Inattentive##2##1##(2010-8#2)
ADI 1015##2##2##(2008-11#2)
ADK-expression from astrogliosis##2##3##(2009-8#2)
ADK-expression##3##1##(2009-8#3)
ADL##11##1##(1995-2#2)(2008-7#1)(2011-2#4)(2012-2#4)
ADLs was##2##2##(1995-2#1)(2008-7#1)
ADLs##3##1##(1995-2#1)(2008-7#2)
ADM##6##1##(1992-3#2)(2008-8#1)(2013-1#3)
ADP and AMP##2##3##(2008-10#2)
ADP and ATP in##2##4##(2008-7#1)(2013-1#1)
ADP and ATP##4##3##(2008-11#1)(2008-7#1)(2013-1#2)
ADP and TxA(2)##3##3##(2006-6#3)
ADP and##15##2##(1993-6#1)(2006-6#4)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#2)
ADP in the regulation of respiration##2##6##(2008-7#2)
ADP in##4##2##(2006-6#2)(2008-7#2)
ADP##48##1##(1991-9#8)(1993-6#1)(1995-11#2)(1995-2#1)(1995-8#2)(2006-6#9)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#10)(2008-8#2)(2008-9#1)(2009-8#1)(2013-1#4)
ADP-ribose##2##1##(1994-11#1)(2008-12#1)
ADP-ribosylarginine hydrolases##2##2##(1992-6#2)
ADP-ribosylated##2##1##(1990-3#1)(1995-6#1)
ADP-ribosylation of HMG 2##2##4##(1990-3#2)
ADP-ribosylation of HMG proteins##2##4##(1990-3#2)
ADP-ribosylation of HMG##6##3##(1990-3#6)
ADP-ribosylation of an##2##3##(1993-3#1)(1995-11#1)
ADP-ribosylation of the##2##3##(1992-9#1)(1993-3#1)
ADP-ribosylation of##20##2##(1990-3#9)(1992-3#1)(1992-9#4)(1993-3#5)(1995-11#1)
ADP-ribosylation##28##1##(1990-3#9)(1992-3#2)(1992-9#6)(1993-3#7)(1993-8#1)(1995-11#2)(2011-2#1)
ADP-ribosyltransferase##2##1##(1992-3#1)(1995-2#1)
ADPKD##2##1##(1997-1#1)(2013-1#1)
ADR and##2##2##(1990-2#1)(2008-10#1)
ADR cases were##3##3##(2011-2#3)
ADR cases##8##2##(2011-2#8)
ADR monitoring##2##2##(2011-2#2)
ADR reporting##3##2##(2008-11#2)(2011-2#1)
ADR reports of##2##3##(2011-2#2)
ADR reports##5##2##(2011-2#5)
ADR was##2##2##(1997-7#1)(2011-2#1)
ADR##41##1##(1990-2#4)(1993-12#2)(1997-7#1)(2008-10#3)(2008-11#3)(2011-2#26)(2011-3#2)
ADR-ONE with##2##2##(2008-10#2)
ADR-ONE##3##1##(2008-10#3)
ADR/AE in##2##2##(2011-2#2)
ADR/AE reporting##2##2##(2011-2#2)
ADR/AE##19##1##(2011-2#19)
ADRs include##2##2##(2011-2#2)
ADRs were##2##2##(2011-2#2)
ADRs##15##1##(2008-11#2)(2011-2#13)
ADS##3##1##(2008-10#2)(2009-10#1)
ADSCs##3##1##(2012-3#3)
ADT increases##2##2##(1994-2#2)
ADT procedure##4##2##(2012-2#4)
ADT##12##1##(1994-2#5)(2012-2#7)
ADV##3##1##(2008-11#2)(2011-2#1)
AE1/AE3##2##1##(2008-11#1)(2010-12#1)
AE6##2##1##(2008-11#2)
AE6F4 antibody was##2##3##(2008-11#2)
AE6F4 antibody##6##2##(2008-11#6)
AE6F4##9##1##(2008-11#9)
AEDs##2##1##(2008-8#2)
AET##4##1##(1994-5#4)
AEs##2##1##(2008-11#2)
AF and##2##2##(2011-2#2)
AF in##5##2##(2011-2#4)(2012-12#1)
AF initiation##2##2##(2011-2#2)
AF is##2##2##(2010-12#1)(2011-2#1)
AF patients##3##2##(2008-10#1)(2010-12#2)
AF tissue##3##2##(2012-2#3)
AF was not##2##3##(2011-2#2)
AF was##3##2##(2011-2#3)
AF##44##1##(1997-2#1)(2008-10#2)(2010-12#8)(2011-2#17)(2012-12#7)(2012-2#6)(2012-3#3)
AF36##2##1##(2008-10#2)
AF4Q alliance##2##2##(2013-1#2)
AF4Q alliances##2##2##(2013-1#2)
AF4Q initiative##11##2##(2013-1#11)
AF4Q##20##1##(2013-1#20)
AFC and##2##2##(2008-10#1)(2011-2#1)
AFC assay is##2##3##(2008-10#2)
AFC assay##7##2##(2008-10#7)
AFC##16##1##(1993-8#1)(2008-10#9)(2011-2#6)
AFDC beneficiaries##2##2##(1992-2#1)(1996-3#1)
AFDC##9##1##(1992-2#4)(1996-1#1)(1996-12#2)(1996-3#2)
AFLP analyses##6##2##(2008-10#6)
AFLP analysis##7##2##(2008-10#7)
AFLP and##3##2##(2008-10#3)
AFLP bands were##2##3##(2008-10#2)
AFLP data##8##2##(2008-10#8)
AFLP fingerprint##2##2##(2008-10#2)
AFLP groups##3##2##(2008-10#3)
AFLP haplotypes##2##2##(2008-10#2)
AFLP loci##3##2##(2008-10#3)
AFLP marker##3##2##(2008-10#3)
AFLP markers showed##2##3##(2008-10#2)
AFLP markers were##5##3##(2008-10#5)
AFLP markers##15##2##(2008-10#15)
AFLP patterns##3##2##(2008-10#3)
AFLP products##2##2##(2008-10#2)
AFLP profiles and##2##3##(2008-10#2)
AFLP profiles##4##2##(2008-10#4)
AFLP##91##1##(2008-10#90)(2011-2#1)
AFLP-based##2##1##(2008-10#1)(2008-2#1)
AFM images##3##2##(2008-10#2)(2013-8#1)
AFM on##2##2##(2008-4#2)
AFM tip##3##2##(2008-10#1)(2008-7#2)
AFM tips##2##2##(2008-10#2)
AFM were##2##2##(2008-10#2)
AFM##25##1##(2008-10#16)(2008-4#2)(2008-7#3)(2008-8#2)(2012-2#1)(2013-8#1)
AFM1##2##1##(2008-12#2)
AFP mRNA expression in blood##3##5##(2008-10#3)
AFP mRNA in HCC patients##2##5##(2008-10#2)
AFP mRNA in the##2##4##(2008-10#2)
AFP mRNA in##4##3##(2008-10#4)
AFP mRNA was##2##3##(2008-10#2)
AFP mRNA##17##2##(2008-10#17)
AFP positive hepatoma cells##3##4##(2008-8#3)
AFP values##2##2##(2008-10#1)(2013-1#1)
AFP##33##1##(1990-9#1)(2008-10#25)(2008-8#4)(2011-1#1)(2013-1#2)
AFPplus by a practitioner cooperating with a private laboratory thus reveals a detection rate comparable to that known from larger centers##2##21##(1997-4#2)
AFPplus##6##1##(1997-4#6)
AFS detection##4##2##(2008-10#4)
AFS##12##1##(1996-12#2)(2008-10#10)
AG##20##1##(2008-10#14)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)(2012-4#1)
AG)##4##1##(2008-10#1)(2008-11#1)(2009-11#1)(2012-4#1)
AG-1-IA##3##1##(2008-10#3)
AG-12 and##2##2##(2008-10#2)
AG-12##7##1##(2008-10#7)
AG-13##7##1##(2008-10#7)
AG-2 and##2##2##(2008-10#2)
AG-2##11##1##(2008-10#11)
AG-3##4##1##(2008-10#4)
AG-4##4##1##(2008-10#4)
AG-6 GV##3##2##(2008-10#3)
AG-6 HG##3##2##(2008-10#3)
AG-6##10##1##(2008-10#10)
AG-8##4##1##(2008-10#4)
AG-A##3##1##(2008-10#3)
AG-BI and the##2##3##(2008-10#2)
AG-BI and##3##2##(2008-10#3)
AG-BI##4##1##(2008-10#4)
AG-CUT##5##1##(2008-10#5)
AG-G##4##1##(2008-10#4)
AG-MIN##5##1##(2008-10#5)
AG-T and##2##2##(2008-10#2)
AG-U##2##1##(2008-10#2)
AG1##2##1##(2008-10#2)
AG1-IC##2##1##(2008-10#2)
AG490 inhibited##2##2##(2011-2#2)
AG490##6##1##(2011-2#6)
AGA##7##1##(1993-12#3)(2012-3#4)
AGF2##4##1##(1993-3#4)
AGP##2##1##(1991-12#1)(2009-8#1)
AGPp##2##1##(1991-12#2)
AGR##3##1##(2012-2#3)
AGS and HEF cell lines##2##5##(2008-12#2)
AGS##4##1##(2008-12#4)
AGT activity##4##2##(1993-11#3)(2008-5#1)
AGT##7##1##(1993-11#4)(2008-5#2)(2010-7#1)
AGTa-20c and##2##2##(2008-10#2)
AGU patients##2##2##(1991-7#2)
AGs of R##4##3##(2008-10#4)
AGs of binucleate Rhizoctonia spp##2##5##(2008-10#2)
AGs of##6##2##(2008-10#6)
AGs##11##1##(2008-10#11)
AH##13##1##(1993-8#4)(1995-1#2)(2009-7#4)(2010-3#2)(2011-2#1)
AH109A cells and##2##3##(2008-11#2)
AH109A cells were##2##3##(2008-11#2)
AH109A cells##21##2##(2008-11#21)
AH109A invasion##6##2##(2008-11#6)
AH109A##40##1##(1993-8#1)(2008-11#39)
AH66 cells##2##2##(1993-8#2)
AH66##3##1##(1993-8#3)
AH66F cells##2##2##(1993-8#2)
AH66F##3##1##(1993-8#3)
AH8##4##1##(2010-5#4)
AHA##9##1##(1991-12#3)(1991-9#1)(1997-3#2)(2008-3#1)(2008-5#1)(2011-3#1)
AHL##2##1##(2008-10#2)
AHO##5##1##(2010-6#4)(2011-1#1)
AHP##3##1##(1993-3#1)(1995-1#1)(2008-10#1)
AHP's##3##1##(1992-3#2)(1993-1#1)
AHRA Statistical Resource Committee##4##4##(1991-3#1)(1993-1#1)(1995-1#1)(1995-2#1)
AHRA Trends##2##2##(1991-1#1)(1996-1#1)
AHRA members##2##2##(1991-2#1)(1994-3#1)
AHRA survey##2##2##(1994-3#1)(1995-2#1)
AHRA##14##1##(1991-1#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-3#3)(1995-1#1)(1995-2#2)(1996-1#3)(1996-2#1)
AI and AII##3##3##(2008-10#3)
AI and B##2##3##(2008-10#2)
AI and##7##2##(2008-10#6)(2013-1#1)
AI group##4##2##(2013-1#4)
AI on##2##2##(2013-1#2)
AI protocol and##2##3##(2013-1#2)
AI##26##1##(1991-12#1)(1993-12#2)(2008-10#10)(2011-1#2)(2013-1#11)
AI-2##4##1##(2009-6#4)
AIBN##2##1##(2009-10#2)
AID is##2##2##(2011-2#2)
AID##9##1##(2011-2#9)
AIDS Confidentiality Act##2##3##(1992-9#2)
AIDS Foundation Houston##2##3##(1996-5#2)
AIDS and HIV##2##3##(1995-6#1)(1997-6#1)
AIDS and other##3##3##(1993-9#1)(1994-3#1)(1995-5#1)
AIDS and the##3##3##(1992-12#1)(2008-9#1)(2009-1#1)
AIDS and##21##2##(1992-12#1)(1992-2#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#3)(1996-11#4)(1996-5#1)(1997-6#1)(2008-11#2)(2008-9#1)(2009-1#1)(2010-1#1)(2011-2#1)
AIDS are##5##2##(1992-9#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-11#1)
AIDS as an##3##3##(1990-11#1)(1992-2#2)
AIDS as##4##2##(1990-11#1)(1992-2#2)(1997-6#1)
AIDS case##2##2##(1994-2#1)(1995-12#1)
AIDS cases##4##2##(1995-12#4)
AIDS diagnosis##5##2##(1991-12#1)(1995-12#1)(1995-2#2)(1995-6#1)
AIDS education##2##2##(1995-12#1)(2008-10#1)
AIDS epidemic and##2##3##(1990-12#2)
AIDS epidemic on the##2##4##(1995-1#1)(1996-5#1)
AIDS epidemic##14##2##(1990-12#4)(1990-3#3)(1994-9#1)(1995-1#2)(1996-5#2)(1997-6#1)(2008-5#1)
AIDS in Africa##2##3##(1990-12#1)(1993-3#1)
AIDS in the##4##3##(1990-11#1)(1996-3#1)(1997-6#1)(2012-3#1)
AIDS in##11##2##(1990-11#1)(1990-12#1)(1992-9#1)(1993-3#1)(1994-9#1)(1996-3#1)(1997-6#3)(2012-3#2)
AIDS incidence in the##2##4##(1992-9#2)
AIDS incidence in##3##3##(1992-9#3)
AIDS incidence##8##2##(1992-9#4)(1994-9#2)(1995-12#1)(1997-6#1)
AIDS information##2##2##(1991-2#1)(1997-6#1)
AIDS is a##2##3##(1996-9#1)(2008-11#1)
AIDS is##6##2##(1995-12#1)(1996-11#1)(1996-9#1)(1997-6#1)(2008-11#1)(2011-2#1)
AIDS knowledge##2##2##(1996-9#1)(2010-7#1)
AIDS medication##2##2##(1995-6#2)
AIDS mortality##3##2##(1991-12#1)(1992-9#1)(1997-6#1)
AIDS patients##10##2##(1992-2#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-5#5)(2011-2#1)
AIDS policy##2##2##(1990-3#1)(1996-5#1)
AIDS prevention##6##2##(1990-3#1)(1995-12#1)(1995-6#1)(1996-9#1)(2008-10#2)
AIDS research##2##2##(1993-6#1)(1995-12#1)
AIDS service organizations##2##3##(1996-3#2)
AIDS service##3##2##(1992-12#1)(1996-3#2)
AIDS to##3##2##(1997-6#3)
AIDS volunteers##5##2##(1993-12#2)(1994-3#3)
AIDS was##5##2##(1990-3#1)(1995-12#2)(1997-6#1)(2008-10#1)
AIDS will##2##2##(1990-12#1)(1995-12#1)
AIDS##287##1##(1990-11#12)(1990-12#8)(1990-3#11)(1990-5#1)(1990-6#5)(1991-1#2)(1991-12#2)(1991-2#3)(1991-9#1)(1992-1#1)(1992-12#5)(1992-2#7)(1992-3#1)(1992-9#18)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#5)(1994-9#4)(1995-1#5)(1995-12#25)(1995-2#7)(1995-5#1)(1995-6#28)(1996-11#10)(1996-2#3)(1996-3#4)(1996-5#11)(1996-9#4)(1997-1#2)(1997-3#1)(1997-6#28)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-5#10)(2008-8#1)(2008-9#3)(2009-1#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#6)(2011-3#4)(2012-3#6)(2013-1#2)
AIDS-related complications##2##2##(1995-6#2)
AIDS-related diffuse large B-cell##2##4##(2009-8#2)
AIDS-related##13##1##(1991-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-6#2)(2007-12#1)(2009-6#1)(2009-8#2)
AII binding##2##2##(1991-5#2)
AII or##2##2##(1994-8#1)(1995-12#1)
AII receptor##2##2##(1991-5#2)
AII##16##1##(1991-5#5)(1994-8#2)(1995-12#2)(2008-10#7)
AII-induced contractions of##2##3##(1991-5#2)
AII-induced##3##1##(1991-5#3)
AIII##5##1##(1994-2#5)
AIM##11##1##(2008-12#1)(2009-1#3)(2010-11#3)(2010-9#1)(2012-2#2)(2013-1#1)
AIM-1 was##2##2##(1995-2#2)
AIM-1##5##1##(1995-2#5)
AIM6##3##1##(2008-10#3)
AIMH##3##1##(2008-9#3)
AIMS##7##1##(1992-11#1)(1993-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
AIN/PIN##3##1##(2008-9#3)
AIP##3##1##(2013-1#3)
AIPP characterization##4##2##(2013-1#4)
AIPP##5##1##(2013-1#5)
AIS##5##1##(2008-10#4)(2010-7#1)
AIs in##2##2##(2011-1#2)
AJ##2##1##(2009-10#2)
AK-##2##1##(2008-10#2)
AK-toxin##3##1##(2008-10#3)
AKG##4##1##(2007-8#4)
AKR lymphoma##2##2##(1990-6#2)
AKT homologs##2##2##(2008-10#2)
AKT##5##1##(2008-10#4)(2013-1#1)
AKT1##2##1##(2008-10#1)(2012-3#1)
AL and##2##2##(2008-10#2)
AL formation in the resistant cactus##2##6##(2008-10#2)
AL formation##3##2##(2008-10#3)
AL##9##1##(2008-10#6)(2008-12#1)(2011-2#2)
AL-1##4##1##(2009-3#4)
AL-B##3##1##(1993-3#3)
ALA##5##1##(1992-3#3)(2008-1#1)(2008-6#1)
ALA)##2##1##(1992-3#2)
ALD##4##1##(1993-3#1)(1995-2#3)
ALDP##2##1##(1995-2#2)
ALG-2##6##1##(2009-4#6)
ALGs were##2##2##(2008-11#2)
ALGs##4##1##(2008-11#4)
ALH(r)##4##1##(2008-10#4)
ALI##4##1##(2010-12#4)
ALI1 gene product##2##3##(1993-12#2)
ALI1##4##1##(1991-9#2)(1993-12#2)
ALL and##2##2##(2011-2#2)
ALL##8##1##(1994-12#2)(2010-11#1)(2010-6#1)(2011-2#4)
ALL-1 and##2##2##(1997-7#2)
ALL-1##6##1##(1997-7#6)
ALM in situ##4##3##(2010-6#4)
ALM##8##1##(2010-6#8)
ALP activity##2##2##(2008-11#2)
ALP##15##1##(2008-10#4)(2008-11#9)(2012-3#2)
ALR##5##1##(1997-7#5)
ALS##10##1##(1996-5#2)(2008-10#1)(2008-4#2)(2008-7#2)(2009-9#3)
ALSD##2##1##(2008-10#2)
ALT##8##1##(2008-10#5)(2008-11#1)(2009-8#1)(2013-8#1)
ALT/d-LDH##3##1##(2008-10#3)
ALTE##3##1##(2011-2#3)
AM and##2##2##(1994-2#1)(2008-9#1)
AM fungal##2##2##(2008-11#2)
AM transplantation##2##2##(2011-2#2)
AM we##2##2##(2008-10#1)(2011-2#1)
AM##19##1##(1992-6#1)(1994-2#2)(2008-10#2)(2008-11#6)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#5)
AM's##2##1##(2008-10#2)
AM-kindled seizures##2##2##(1994-2#2)
AM-toxin##4##1##(2008-10#4)
AM1 and PM3##2##3##(2008-10#2)
AM1 level##2##2##(1996-5#2)
AM1##18##1##(1996-5#2)(1997-7#4)(2008-10#8)(2008-11#3)(2011-3#1)
AM19##2##1##(2008-10#2)
AMA##4##1##(1992-11#1)(2008-8#1)(2009-6#1)(2013-1#1)
AMA-1/RPB-1##2##1##(2012-3#2)
AMCV-P19##2##1##(2011-2#2)
AMD development##2##2##(2011-2#2)
AMD##16##1##(2008-10#1)(2011-2#11)(2011-7#1)(2013-1#3)
AMD3100 at##2##2##(2008-7#2)
AMD3100##9##1##(2008-7#9)
AMF population biology##2##3##(2008-8#2)
AMF##5##1##(2008-8#5)
AMG 517##6##2##(2010-2#6)
AMI and##3##2##(1990-12#1)(2008-10#1)(2010-12#1)
AMI cases##2##2##(1995-2#2)
AMI in##2##2##(1995-2#1)(2008-12#1)
AMI patients##2##2##(1995-2#1)(2009-6#1)
AMI transformants##2##2##(2008-10#2)
AMI##27##1##(1990-12#4)(1992-3#4)(1995-12#2)(1995-2#4)(2008-10#5)(2008-12#1)(2008-5#1)(2009-6#4)(2010-12#2)
AML and##2##2##(1994-5#1)(2011-2#1)
AML blast proliferation##2##3##(2006-6#2)
AML blast##3##2##(2006-6#3)
AML blasts##3##2##(2006-6#2)(2011-2#1)
AML cases##2##2##(2008-10#2)
AML cells##6##2##(2011-2#4)(2012-12#1)(2013-1#1)
AML##33##1##(1994-5#1)(2006-6#5)(2008-10#7)(2010-1#2)(2011-2#13)(2012-12#1)(2013-1#4)
AML1/ETO fusion gene##4##3##(2008-10#4)
AML1/ETO fusion##5##2##(2008-10#5)
AML1/ETO positive##2##2##(2008-10#2)
AML1/ETO##8##1##(2008-10#8)
AMND is##2##2##(2008-10#2)
AMOVA##3##1##(2008-10#2)(2008-12#1)
AMP (cAMP)##3##2##(1997-2#1)(2008-10#2)
AMP and##4##2##(1993-6#1)(1995-11#1)(2008-9#2)
AMP is##2##2##(1993-6#1)(2008-9#1)
AMP response element (CRE)##2##4##(1997-2#2)
AMP response##3##2##(1995-8#1)(1997-2#2)
AMP##55##1##(1993-6#3)(1993-8#1)(1994-11#2)(1994-2#7)(1994-6#2)(1995-11#11)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-1#1)(1997-2#3)(1997-4#1)(2008-10#7)(2008-11#1)(2008-8#3)(2008-9#7)
AMP-activated protein kinase##3##3##(1994-11#1)(2010-10#1)(2011-2#1)
AMP-activated##4##1##(1994-11#1)(1997-2#1)(2010-10#1)(2011-2#1)
AMPA and NMDA receptors##2##4##(1995-11#2)
AMPA receptor antagonist##3##3##(1994-2#2)(2008-8#1)
AMPA receptor subunit GluR-B##2##4##(1993-12#2)
AMPA receptor subunit##3##3##(1993-12#2)(2008-7#1)
AMPA receptor##10##2##(1993-12#2)(1994-2#2)(1995-11#1)(2008-7#3)(2008-8#2)
AMPA receptors were##4##3##(1996-2#4)
AMPA receptors##8##2##(1996-2#6)(2008-7#2)
AMPA##26##1##(1993-12#2)(1994-2#2)(1995-11#3)(1996-2#6)(2008-7#6)(2008-8#7)
AMPA/kainate-like receptors##2##2##(2008-7#2)
AMPH exposure##2##2##(2013-8#2)
AMPH##4##1##(2013-8#4)
AMPs##2##1##(2011-2#2)
AMT##4##1##(1991-3#1)(2008-10#1)(2009-11#1)(2011-2#1)
AMV RNAs##2##2##(2008-10#2)
AMV isolates was##2##3##(2008-10#2)
AMV isolates##3##2##(2008-10#3)
AMV##12##1##(2008-10#11)(2008-7#1)
AN##7##1##(1991-11#2)(2008-10#1)(2010-12#1)(2013-1#3)
ANA##3##1##(1991-2#2)(2013-8#1)
ANALYSIS##2##1##(2009-11#1)(2010-12#1)
AND METHOD##2##2##(2010-9#1)(2012-2#1)
AND METHODS##32##2##(2008-6#1)(2009-1#1)(2009-8#1)(2010-11#2)(2011-2#11)(2012-2#7)(2012-3#3)(2013-1#6)
AND RESULTS##7##2##(2008-11#2)(2008-12#3)(2012-2#2)
AND##76##1##(1993-12#1)(1993-2#1)(2008-11#5)(2008-12#4)(2008-6#1)(2008-9#7)(2009-1#1)(2009-11#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-9#1)(2011-2#13)(2011-7#1)(2012-2#19)(2012-3#4)(2013-1#8)
ANF values were##2##3##(1990-9#2)
ANF##9##1##(1990-9#8)(2008-6#1)
ANG I##2##2##(1994-8#2)
ANG II##6##2##(1991-5#4)(1994-8#2)
ANG##9##1##(1991-5#5)(1994-8#4)
ANN classifier##2##2##(2008-10#1)(2010-8#1)
ANN model##4##2##(2008-10#4)
ANN models##3##2##(2008-10#3)
ANN structure##3##2##(2008-10#3)
ANN with##2##2##(2008-10#1)(2010-8#1)
ANN##40##1##(2008-10#35)(2010-8#5)
ANN/FTIR-ATR##2##1##(2008-10#2)
ANNs are##2##2##(2008-10#2)
ANNs##11##1##(2008-10#11)
ANOVA and##7##2##(1990-2#1)(2009-3#1)(2011-2#1)(2013-1#4)
ANOVA showed##2##2##(2010-9#1)(2013-1#1)
ANOVA##23##1##(1990-2#1)(1991-2#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#5)
ANOVA)##3##1##(1994-8#2)(2013-1#1)
ANP and BNP##4##3##(1991-5#2)(2008-11#1)(2009-5#1)
ANP infusion##4##2##(2008-5#4)
ANP is a##2##3##(2008-5#2)
ANP is##3##2##(2008-5#2)(2009-5#1)
ANP##20##1##(1991-5#3)(1993-8#2)(2008-11#1)(2008-5#10)(2009-5#2)(2011-2#1)(2012-3#1)
ANS activity##2##2##(2013-8#2)
ANS dysfunction##3##2##(2009-11#3)
ANS##11##1##(1991-9#1)(2009-11#4)(2013-8#6)
AO and BSA##2##3##(2008-10#2)
AO##4##1##(2008-10#4)
AOAC##4##1##(2008-10#4)
AOBs system##2##2##(2011-2#2)
AOBs##4##1##(2011-2#4)
AOD##10##1##(2012-12#6)(2012-3#4)
AOFAS score##3##2##(2008-8#1)(2009-10#1)(2010-11#1)
AOFAS##4##1##(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#1)
AOM##4##1##(1990-6#1)(1993-11#2)(2011-2#1)
AOP##3##1##(2008-10#3)
AOR =##2##2##(2012-12#1)(2013-1#1)
AOS metabolism##2##2##(2008-10#2)
AOTF##6##1##(2008-10#6)
AOU##2##1##(2008-10#2)
AOX##7##1##(2008-9#5)(2009-8#2)
AP and##5##2##(1993-12#1)(2008-10#1)(2012-3#3)
AP neurons##2##2##(1997-3#2)
AP severity##2##2##(2013-1#2)
AP was##4##2##(2008-5#1)(2009-8#1)(2012-3#2)
AP##41##1##(1991-10#3)(1993-12#1)(1997-3#2)(2008-10#5)(2008-11#4)(2008-5#6)(2008-9#1)(2009-11#1)(2009-8#1)(2012-2#1)(2012-3#9)(2013-1#7)
AP's cover)##3##2##(2012-3#3)
AP-1 and NF-kappa B##2##4##(1992-8#2)
AP-1 and NF-kappaB##3##3##(2008-9#3)
AP-1 and##6##2##(1992-8#3)(2008-9#3)
AP-1##20##1##(1992-8#4)(1993-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-2#4)(1997-7#2)(2008-11#2)(2008-9#4)
AP-2##4##1##(1991-7#1)(1994-11#2)(2012-2#1)
AP1##3##1##(1993-6#1)(1997-8#1)(2008-9#1)
AP2##4##1##(1997-8#2)(2008-8#1)(2008-9#1)
AP3/F7##2##1##(1991-9#2)
AP5##4##1##(1997-7#4)
APA beads##2##2##(2008-11#2)
APA##4##1##(1994-12#1)(2008-11#2)(2008-8#1)
APACHE II##2##2##(2009-8#1)(2012-3#1)
APACHE##3##1##(2009-5#1)(2009-8#1)(2012-3#1)
APB##2##1##(1993-8#2)
APC##7##1##(1997-2#2)(2008-10#2)(2008-4#1)(2013-1#2)
APC-PY##3##1##(2008-8#3)
APC-resistance##3##1##(1997-3#3)
APCI##2##1##(2008-10#1)(2008-5#1)
APD##5##1##(2010-2#2)(2011-10#3)
APDC##10##1##(2008-10#10)
APDC-AC##2##1##(2008-10#2)
APDs and TBZ##2##3##(2011-10#2)
APG##2##1##(1994-3#1)(2008-10#1)
APGWamide##2##1##(1990-2#1)(1991-5#1)
APGs##2##1##(1994-3#2)
APLP2 mRNA levels##2##3##(1996-12#2)
APLP2 mRNA was##2##3##(1996-12#2)
APLP2 mRNA##13##2##(1996-12#13)
APLP2##14##1##(1996-12#14)
APOAC##2##1##(2008-11#2)
APOE##2##1##(1995-12#1)(1996-12#1)
APP KPI##3##2##(1996-12#3)
APP and APLP2 mRNA in##2##5##(1996-12#2)
APP and APLP2 mRNA##5##4##(1996-12#5)
APP and APLP2##6##3##(1996-12#6)
APP and##8##2##(1995-12#1)(1996-12#6)(2008-11#1)
APP expression##3##2##(1991-10#2)(1996-12#1)
APP fragments##2##2##(1992-12#2)
APP in##4##2##(1991-10#1)(1992-12#2)(1995-12#1)
APP is##2##2##(1992-12#1)(1996-12#1)
APP mRNA##7##2##(1996-12#7)
APP processing##3##2##(1992-12#1)(1995-12#1)(1996-12#1)
APP was##2##2##(1996-12#1)(2008-11#1)
APP##56##1##(1991-10#7)(1992-12#9)(1994-11#4)(1995-12#3)(1996-12#29)(2008-11#4)
APPI##2##1##(2008-10#2)
APR##4##1##(2008-10#4)
APS Abstracts Submitted for Presentation at the##9##7##(2008-11#9)
APS Annual Meeting##15##3##(2008-11#15)
APS stability##2##2##(2008-10#2)
APS##38##1##(2008-10#9)(2008-11#25)(2008-8#1)(2009-8#2)(2012-3#1)
APSs##2##1##(2008-8#1)(2012-3#1)
APW##2##1##(2012-2#2)
APs##6##1##(2008-10#4)(2012-3#1)(2013-8#1)
AR and##4##2##(2010-1#1)(2011-2#2)(2012-12#1)
AR cDNA##4##2##(1995-12#4)
AR has##2##2##(1990-11#1)(2012-12#1)
AR in##5##2##(1990-11#3)(2010-1#1)(2012-12#1)
AR is##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
AR mRNA down-regulation##2##3##(1995-12#2)
AR mRNA##7##2##(1995-12#7)
AR protein##3##2##(1995-12#3)
AR root powder##2##3##(2008-10#2)
AR root##6##2##(2008-10#6)
AR was##4##2##(2008-8#3)(2010-1#1)
AR##65##1##(1990-11#9)(1995-12#16)(2008-10#9)(2008-7#2)(2008-8#5)(2010-1#3)(2010-12#1)(2011-2#6)(2012-12#10)(2013-8#4)
AR-JP##4##1##(2008-7#4)
AR-mediated cardiac hypertrophy##8##3##(2010-12#8)
AR-mediated##9##1##(2008-9#1)(2010-12#8)
ARC derivatives##2##2##(2008-10#2)
ARC##6##1##(1992-1#1)(2008-10#2)(2012-3#3)
ARDS##11##1##(1990-2#1)(1993-2#4)(1997-1#5)(2009-5#1)
ARE##4##1##(2008-9#1)(2009-4#1)(2009-8#2)
ARF##6##1##(2008-10#3)(2008-11#1)(2009-8#1)(2012-3#1)
ARF-C isolates##4##2##(2008-10#4)
ARF-C##5##1##(2008-10#5)
ARF-L isolates parasitized##2##3##(2008-10#2)
ARF-L isolates##3##2##(2008-10#3)
ARF-L##6##1##(2008-10#6)
ARF18 and##2##2##(2008-10#2)
ARF18##6##1##(2008-10#6)
ARF18-C isolates##2##2##(2008-10#2)
ARF18-C##5##1##(2008-10#5)
ARF18-L isolates##2##2##(2008-10#2)
ARF18-L##4##1##(2008-10#4)
ARG##2##1##(2013-8#2)
ARG1(+/-) and##2##2##(2013-8#2)
ARG1(+/-)##4##1##(2013-8#4)
ARG2(-/-) mice##3##2##(2013-8#3)
ARG2(-/-)##4##1##(2013-8#4)
ARI values##2##2##(2008-10#2)
ARI##3##1##(2008-10#2)(2012-12#1)
ARM in##4##2##(1994-8#1)(2011-2#3)
ARM##16##1##(1994-8#4)(2011-2#12)
ARMD and hearing##2##3##(2011-2#2)
ARMD and##5##2##(2011-2#5)
ARMD is##4##2##(2011-2#4)
ARMD##17##1##(2011-2#17)
AROM in##2##2##(2008-12#2)
AROM##11##1##(2008-12#11)
ARP1##4##1##(2008-9#4)
ARS##9##1##(2008-10#8)(2008-3#1)
ART and##2##2##(1992-2#1)(2011-2#1)
ART##7##1##(1992-2#3)(2011-2#3)(2013-1#1)
ARV##3##1##(2012-2#1)(2013-1#2)
AS 3##2##2##(2008-8#2)
AS and NAS mastectomies##3##4##(2011-2#3)
AS and##6##2##(2008-11#1)(2011-2#3)(2013-8#2)
AS##30##1##(2008-10#4)(2008-11#5)(2008-12#1)(2008-8#5)(2010-10#3)(2011-2#5)(2012-3#4)(2013-8#3)
AS) and##2##2##(2008-10#2)
AS-OCT##4##1##(2010-9#4)
AS4-12 and metalaxyl##2##3##(2008-10#2)
AS4-12##5##1##(2008-10#5)
ASA and CF##2##3##(2008-10#2)
ASA and##5##2##(2008-10#4)(2009-5#1)
ASA in##2##2##(2008-10#2)
ASA physical status##2##3##(1993-1#1)(2010-7#1)
ASA was##2##2##(1997-6#2)
ASA##24##1##(1993-1#1)(1997-3#1)(1997-6#6)(2008-10#10)(2009-5#1)(2010-5#1)(2010-7#4)
ASAD (n=26)##2##2##(2012-2#2)
ASAD individuals##2##2##(2012-2#2)
ASAD patients##2##2##(2012-2#2)
ASAD##10##1##(2012-2#10)
ASC and##2##2##(2008-11#1)(2012-4#1)
ASC##4##1##(2008-11#2)(2009-3#1)(2012-4#1)
ASCO##2##1##(2012-3#1)(2013-1#1)
ASCs in the##2##3##(2012-4#2)
ASCs in##3##2##(2012-4#3)
ASCs##5##1##(1997-1#1)(2012-4#4)
ASD mouse models##4##3##(2010-7#4)
ASD patient##3##2##(2011-2#3)
ASD were##2##2##(2012-12#2)
ASD##27##1##(2008-11#1)(2008-3#1)(2010-7#4)(2011-2#5)(2012-12#7)(2012-2#2)(2012-3#7)
ASE##7##1##(2008-10#6)(2008-3#1)
ASGPR##2##1##(2008-9#2)
ASGV##2##1##(2008-10#2)
ASH##2##1##(2008-10#2)
ASIA motor classification levels##2##4##(2012-2#2)
ASK1##2##1##(2008-9#2)
ASL##3##1##(2011-2#3)
ASLE##2##1##(2008-10#2)
ASM##8##1##(2008-10#8)
ASM-treated##3##1##(2008-10#3)
ASOB2##5##1##(2008-5#5)
ASOs that##2##2##(1996-3#2)
ASOs##4##1##(1996-3#4)
ASP##8##1##(2013-1#8)
ASPV in##2##2##(2008-10#2)
ASPV##5##1##(2008-10#5)
ASPs##8##1##(2013-1#8)
ASRC##7##1##(1996-12#7)
AST##10##1##(1993-12#1)(1994-5#2)(2008-10#2)(2011-2#1)(2011-3#3)(2013-1#1)
ASTIV##3##1##(1993-12#3)
ASTM##5##1##(2008-10#3)(2009-7#1)(2013-1#1)
ASV determination of##3##3##(2008-10#3)
ASV##8##1##(2008-10#7)(2008-7#1)
ASY and HAP##2##3##(2008-9#2)
ASY and##4##2##(2008-8#1)(2008-9#3)
ASY interacting protein##2##3##(2008-8#1)(2008-9#1)
ASY or HAP##2##3##(2008-9#2)
ASY##11##1##(2008-8#2)(2008-9#9)
ASYIP##3##1##(2008-8#3)
AT and##2##2##(1993-8#1)(2013-1#1)
AT from baseline was##2##4##(2013-1#2)
AT in##2##2##(2013-1#2)
AT revealed##2##2##(2008-10#2)
AT rich##3##2##(2008-12#1)(2008-8#2)
AT##117##1##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-3#4)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#14)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#10)(1994-3#2)(1994-5#16)(1994-8#4)(1995-3#3)(1995-5#1)(1995-6#6)(1996-2#3)(2008-10#5)(2008-12#1)(2008-4#2)(2008-8#2)(2010-11#3)(2013-1#5)
AT(1) receptor##3##2##(2008-9#3)
AT-DNA RFLP##2##2##(2008-10#2)
AT-DNA##3##1##(2008-10#3)
AT-cut quartz crystal##2##3##(2008-10#2)
AT-rich DNA##3##2##(2008-10#1)(2008-12#2)
AT-rich##7##1##(1995-6#2)(2008-10#2)(2008-12#2)(2008-8#1)
AT1 receptor##3##2##(1994-8#2)(1997-2#1)
AT1##5##1##(1991-5#2)(1994-8#2)(1997-2#1)
AT2 receptor##4##2##(1994-8#4)
AT2##5##1##(1994-8#5)
AT2R##3##1##(1994-11#3)
ATA)##2##1##(2011-3#2)
ATCC 14579##3##2##(2011-1#1)(2011-2#2)
ATCC##22##1##(1994-5#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#6)(2009-6#1)(2011-1#1)(2011-2#2)
ATCO##3##1##(2008-10#3)
ATF5##3##1##(2011-2#3)
ATG##5##1##(1996-8#1)(1997-7#1)(2008-8#1)(2010-7#2)
ATG12##5##1##(2013-1#5)
ATIII##3##1##(1992-10#3)
ATL cells are##2##3##(2011-2#2)
ATL##4##1##(2008-11#1)(2011-2#3)
ATLD##2##1##(2008-10#2)
ATMP##3##1##(2008-10#3)
ATMT protocol##2##2##(2008-10#2)
ATMT##3##1##(2008-10#3)
ATP &gt##3##2##(1993-8#1)(1995-11#1)(1995-8#1)
ATP and ADP##7##3##(1991-9#6)(2008-7#1)
ATP and pH##2##3##(2008-8#2)
ATP and the##2##3##(1993-6#1)(1996-2#1)
ATP and##18##2##(1991-9#6)(1992-12#1)(1993-6#1)(1993-8#2)(1994-3#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#2)(2013-1#1)(2013-8#1)
ATP binding of##3##3##(1993-6#2)(1995-2#1)
ATP binding##9##2##(1993-6#4)(1995-2#2)(2008-11#2)(2011-2#1)
ATP bioluminescence##2##2##(2008-5#2)
ATP by##2##2##(2008-7#1)(2012-2#1)
ATP depletion and##2##3##(1994-8#2)
ATP effect is##2##3##(1990-5#2)
ATP hydrolysis is a key reaction in living cells that drives many cellular processes##2##14##(2013-1#2)
ATP hydrolysis##10##2##(1996-6#1)(1997-8#1)(2013-1#8)
ATP in the regulation of##2##5##(2008-7#2)
ATP in the##3##3##(2008-7#2)(2009-7#1)
ATP in##6##2##(1993-6#1)(1995-2#1)(2008-7#2)(2009-7#1)(2013-1#1)
ATP level##2##2##(2008-11#1)(2011-2#1)
ATP levels and##2##3##(2008-11#2)
ATP levels##5##2##(1994-8#1)(1997-1#1)(2008-11#2)(2011-2#1)
ATP or##2##2##(1993-8#1)(1994-2#1)
ATP production##3##2##(1994-11#1)(2008-10#1)(2012-2#1)
ATP receptor##3##2##(1993-8#3)
ATP site##2##2##(2008-5#2)
ATP site-directed##2##2##(2008-5#2)
ATP synthase subunits##2##3##(2008-8#2)
ATP synthase##4##2##(2008-8#4)
ATP to##2##2##(1991-9#1)(2008-11#1)
ATP was##6##2##(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-6#1)(2008-8#1)
ATP##152##1##(1990-5#9)(1991-5#2)(1991-6#1)(1991-9#8)(1992-12#1)(1992-6#1)(1993-6#17)(1993-8#15)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#7)(1995-11#3)(1995-2#5)(1995-8#3)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#7)(2008-11#18)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#7)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#4)(2012-2#3)(2013-1#13)(2013-8#1)
ATP)##3##1##(1994-3#1)(1995-6#1)(2013-1#1)
ATP-binding cassette##2##2##(2008-11#1)(2011-2#1)
ATP-binding motifs##4##2##(1996-2#4)
ATP-binding proteins##2##2##(1993-9#1)(1995-9#1)
ATP-binding##10##1##(1993-9#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#4)(2008-11#1)(2011-2#1)
ATP-dependent##5##1##(1991-6#1)(1995-12#1)(1995-6#1)(2008-11#1)(2011-9#1)
ATP-induced##7##1##(1995-11#3)(1995-2#4)
ATP-sensitive K+ channels##2##3##(1994-11#1)(1997-1#1)
ATP-sensitive K+##3##2##(1994-11#2)(1997-1#1)
ATP4-##3##1##(1990-5#3)
ATP7A##3##1##(2012-2#3)
ATPase activity of##4##3##(1993-12#1)(1996-2#3)
ATPase activity##11##2##(1993-12#2)(1993-8#1)(1993-9#1)(1994-8#1)(1996-2#4)(2008-7#1)(2008-9#1)
ATPase on##2##2##(1995-8#1)(1997-8#1)
ATPase was##2##2##(1995-6#1)(1997-8#1)
ATPase##33##1##(1993-12#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-6#4)(1995-8#4)(1996-2#4)(1997-8#5)(2006-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)
ATPases##8##1##(2008-7#7)(2011-2#1)
ATPgammaS##5##1##(1996-2#5)
ATR##6##1##(2008-10#4)(2011-2#2)
ATR-FT-IR spectroscopy and multivariate control charts##2##6##(2008-10#2)
ATR-FTIR##6##1##(2008-10#5)(2008-5#1)
ATRA##2##1##(2011-2#1)(2013-1#1)
ATryn##2##1##(2010-11#2)
AU##4##1##(2008-9#1)(2011-2#3)
AUC of##2##2##(2008-11#1)(2011-2#1)
AUC##14##1##(1994-12#3)(2008-11#3)(2008-7#2)(2010-8#1)(2011-2#4)(2012-4#1)
AUC(0-4)##3##1##(2008-6#3)
AUC/MIC &gt##2##2##(2011-2#2)
AUC/MIC##6##1##(2011-2#6)
AUD severity factor##3##3##(2013-8#3)
AUD severity##8##2##(2013-8#8)
AUDPC values##2##2##(2008-10#2)
AUDPC was reduced##2##3##(2008-10#2)
AUDPC##8##1##(2008-10#8)
AUDPCs of the##2##3##(2008-10#2)
AUDPCs##3##1##(2008-10#3)
AUGPC##2##1##(2008-10#2)
AULEC##2##1##(2008-10#2)
AUPHA##3##1##(1991-1#1)(1994-2#1)(2009-8#1)
AURKAIP1##2##1##(2013-8#2)
AUS##2##1##(2008-10#2)
AUV and PUV##2##3##(2008-10#2)
AV##8##1##(1996-3#1)(1996-9#2)(2008-7#1)(2010-7#1)(2011-3#3)
AV-nodal reentrant tachycardia##2##3##(1993-2#2)
AV1##2##1##(2008-10#2)
AVF has##2##2##(2008-7#2)
AVF##10##1##(1996-9#6)(2008-7#4)
AVM (nine cases)##2##3##(2008-7#2)
AVM has##3##2##(1997-6#1)(2008-7#2)
AVM in the##3##3##(2008-7#3)
AVM is##2##2##(2008-7#2)
AVM nidus##2##2##(2008-7#1)(2012-3#1)
AVM rupture##5##2##(2008-7#1)(2012-3#4)
AVM was##2##2##(2008-7#1)(2012-3#1)
AVM were##2##2##(2008-7#2)
AVM##55##1##(1996-6#1)(1997-3#4)(1997-6#3)(2008-7#34)(2012-3#13)
AVM's##5##1##(1996-3#5)
AVM-ICH##5##1##(2012-3#5)
AVM-oICH##2##1##(2012-3#2)
AVMs in##4##2##(2008-7#4)
AVMs with##3##2##(1997-3#3)
AVMs##33##1##(1993-9#1)(1997-3#7)(1997-6#1)(2008-7#21)(2012-3#3)
AVP cell##2##2##(1990-5#2)
AVP cells##3##2##(1990-5#3)
AVP##9##1##(1990-5#5)(1995-12#2)(2008-11#1)(2008-8#1)
AVR gene cluster##2##3##(2008-10#2)
AVR gene##3##2##(2008-10#3)
AVR##4##1##(2008-10#4)
AVR-Pita##3##1##(2008-10#3)
AVS##3##1##(2008-10#3)
AW##2##1##(1994-8#1)(2012-9#1)
AWR##6##1##(2008-10#6)
AXAD-16-DMABA##2##1##(2008-10#2)
AY##2##1##(2008-10#2)
AY-BD2##2##1##(2008-10#2)
AY-BW##2##1##(2008-10#2)
AY-S##2##1##(2008-10#2)
AY-SG##2##1##(2008-10#2)
AY-SS##2##1##(2008-10#2)
AY-WB##4##1##(2008-10#4)
AYA patients##2##2##(2008-11#2)
AYP and S##2##3##(2008-10#2)
AYP##5##1##(2008-10#5)
AYP-infected shoots##3##2##(2008-10#3)
AYP-infected##4##1##(2008-10#4)
AYRSV##3##1##(2008-10#3)
AYVV-[Java]##4##1##(2008-10#4)
AZ##2##1##(1990-8#1)(2008-10#1)
AZA##2##1##(2010-12#1)(2011-2#1)
AZT##12##1##(1990-8#3)(1995-6#3)(1996-5#1)(2008-10#4)(2011-3#1)
Ab production##4##2##(2008-11#4)
Ab##9##1##(1993-12#1)(2008-10#2)(2008-11#6)
Ab0##2##1##(2013-8#2)
Abbe##2##1##(2008-3#2)
Abbreviations used in this manual##2##5##(2008-9#2)
Abdominal##9##1##(1994-1#1)(2007-12#1)(2008-12#1)(2010-1#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#1)
Abel##2##1##(1995-12#1)(2008-3#1)
Abelson##2##1##(2008-9#1)(2009-7#1)
Aberrant##5##1##(1993-9#1)(1995-8#1)(1997-8#1)(2008-10#1)(2011-2#1)
Ability of bone mineral density to predict osteoporotic fractures##2##9##(1996-8#2)
Ability of##6##2##(1996-8#2)(2008-10#4)
Ability to##4##2##(2008-10#2)(2010-1#1)(2012-2#1)
Ability##12##1##(1993-11#1)(1996-8#2)(2008-10#6)(2010-1#1)(2012-2#1)(2013-1#1)
Abiotic##3##1##(2008-10#3)
Abl kinase activity##2##3##(2011-2#2)
Abl##8##1##(2011-2#8)
Ablation of##2##2##(1993-1#1)(2013-1#1)
Ablation##4##1##(1993-1#1)(2010-6#1)(2013-1#2)
Abnormal iron##2##2##(2013-8#2)
Abnormal levels of##2##3##(2010-1#2)
Abnormal##11##1##(1992-3#1)(1993-11#1)(1993-3#1)(2008-7#1)(2010-1#2)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
Abnormalities##4##1##(1994-11#1)(2008-2#1)(2008-9#1)(2011-3#1)
Aboriginal Australian##2##2##(2008-12#2)
Aboriginal Health Workers##3##3##(2008-6#3)
Aboriginal nurses##2##2##(2008-12#2)
Aboriginal nursing students##2##3##(2008-12#2)
Aboriginal nursing##3##2##(2008-12#3)
Aboriginal##17##1##(1996-12#1)(2008-12#8)(2008-6#7)(2008-8#1)
Abortion##6##1##(1990-6#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-5#1)
About 0##2##2##(1990-2#1)(1992-12#1)
About 10%##2##2##(2008-10#1)(2011-2#1)
About 20##2##2##(1990-8#1)(2008-10#1)
About 50##2##2##(1990-9#1)(2008-10#1)
About 50% of the##2##4##(1997-6#1)(1997-8#1)
About 50% of##5##3##(1994-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2013-1#1)
About 70% of##2##3##(2008-11#1)(2013-1#1)
About 70%##3##2##(2008-11#1)(2013-1#2)
About 80%##2##2##(1990-6#1)(2013-1#1)
About half of the##2##4##(2008-10#1)(2010-11#1)
About half of##4##3##(2008-10#1)(2009-6#1)(2010-11#1)(2013-7#1)
About half##5##2##(1990-3#1)(2008-10#1)(2009-6#1)(2010-11#1)(2013-7#1)
About one half of the##2##5##(1993-12#1)(2008-9#1)
About the##5##2##(1994-6#1)(2008-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
About##67##1##(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-6#2)(1997-8#1)(1997-9#1)(2008-10#13)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
Above all##5##2##(2008-10#2)(2010-12#1)(2012-2#1)(2012-3#1)
Above##12##1##(1991-11#1)(1997-4#1)(2008-10#6)(2008-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
Abraham##2##1##(1991-8#1)(1995-12#1)
Abs##7##1##(2008-11#1)(2011-2#6)
Abscess##2##1##(2012-3#2)
Abscisic acid##2##2##(2008-10#1)(2009-6#1)
Absence of the##2##3##(2008-10#1)(2013-1#1)
Absence of##15##2##(1990-9#1)(1991-12#1)(1992-8#1)(1993-5#1)(1994-12#1)(2008-10#4)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
Absidia corymbifera##2##2##(2008-5#2)
Absidia##3##1##(2008-11#1)(2008-5#2)
Absolute detection limits##2##3##(2008-10#2)
Absolute testis weights##2##3##(2008-9#2)
Absolute##13##1##(1992-11#2)(1996-5#2)(2008-10#3)(2008-9#4)(2009-8#1)(2012-2#1)
Absorbance of##2##2##(2008-10#1)(2008-3#1)
Absorbance##10##1##(2008-10#8)(2008-3#2)
Absorption Spectrometry##3##2##(2008-10#3)
Absorption Spectroscopy##2##2##(2008-10#1)(2008-3#1)
Absorption and##2##2##(1992-3#1)(1996-1#1)
Absorption by##2##2##(2008-11#2)
Absorption of energy as light by some molecules and emission of energy as fluorescence can occur only at certain wavelengths##2##20##(2008-1#1)(2008-4#1)
Absorption of##5##2##(1992-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)
Absorption spectra of##2##3##(2008-10#1)(2008-3#1)
Absorption##26##1##(1992-3#1)(1992-8#1)(1996-1#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#7)(2008-4#1)(2008-5#1)
Abstract The##3##2##(2013-8#3)
Abstract from acta neurochirurgica and surgery for cerebral stroke (Japan)##2##10##(1996-6#1)(1996-9#1)
Abstract##16##1##(1996-6#1)(1996-9#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-1#1)(2013-8#9)
Abstracts Submitted for Presentation at the 2001 APS/MSA/SON Joint Meeting##3##10##(2008-11#3)
Abstracts Submitted for Presentation at the##11##6##(2008-11#11)
Abstracts of Special Session Presentations at the##7##7##(2008-11#7)
Abstracts of papers presented at the 2002 Pittsburgh Conference##2##9##(2008-10#2)
Abstracts of papers presented at the ISLAR (International##2##8##(2008-10#2)
Abstracts of papers presented at the##5##6##(2008-10#5)
Abstracts of presentations at the 1999##5##6##(2008-11#5)
Abstracts of presentations at the 2000##6##6##(2008-11#6)
Abstracts of presentations at the 2001##4##6##(2008-11#4)
Abstracts of presentations at the 2002##4##6##(2008-11#4)
Abstracts of presentations at the 2003##6##6##(2008-11#6)
Abstracts of presentations at the 2004##5##6##(2008-11#5)
Abstracts of presentations at the 2005##6##6##(2008-11#6)
Abstracts of presentations at the 2006##6##6##(2008-11#6)
Abstracts of presentations at the 2007##2##6##(2008-11#2)
Abstracts of presentations at the##45##5##(2008-11#45)
Abstracts of the##13##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
Abstracts of##72##2##(2008-1#1)(2008-10#6)(2008-11#55)(2008-12#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2011-2#2)(2012-12#1)
Abstracts##92##1##(1995-3#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#66)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
Abundance of##2##2##(2008-10#1)(2010-7#1)
Abundance##3##1##(2008-10#2)(2010-7#1)
Abundant##3##1##(1992-3#1)(2008-10#1)(2012-3#1)
Abyssinian 14##3##2##(2008-10#3)
Ac element##2##2##(2012-3#2)
Ac elements##7##2##(2012-3#7)
Ac stocks##2##2##(2012-3#2)
Ac##21##1##(1991-3#6)(2012-3#15)
Ac-Arg-Ala-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2##2##1##(1991-9#2)
Ac-LDL##2##1##(1990-8#2)
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2##2##1##(1991-9#2)
Ac61##2##1##(2008-10#2)
AcFL##2##1##(2008-10#2)
AcIGPD##2##1##(2008-10#2)
AcLDL##2##1##(1995-2#2)
AcNPV##5##1##(1997-3#3)(2008-11#1)(2008-8#1)
AcNPV-bcl2 coinfection##2##2##(2008-7#2)
AcNPV-bcl2##3##1##(2008-7#3)
AcNPV-betagal alone##2##2##(2008-7#2)
AcNPV-betagal##3##1##(2008-7#3)
AcNPV-tPA##2##1##(2008-7#2)
AcOEC2##4##1##(2008-10#4)
AcP##2##1##(2008-10#2)
Acad##10##1##(1990-10#1)(1990-5#1)(1992-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1995-6#2)
Academic Press##2##2##(1990-8#1)(2008-12#1)
Academic buoyancy##2##2##(2008-12#2)
Academic medical centers##2##3##(1994-3#1)(1995-3#1)
Academic programs##2##2##(1993-1#2)
Academic##14##1##(1990-8#1)(1993-1#2)(1994-2#2)(1994-3#1)(1995-3#1)(1996-2#1)(2008-11#1)(2008-12#3)(2009-7#1)(2013-1#1)
Academies##2##1##(1993-9#1)(2013-1#1)
Academy of Sciences##3##3##(1994-12#1)(2010-12#2)
Academy of##17##2##(1994-12#2)(1996-11#1)(1996-6#2)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
Academy##18##1##(1994-12#2)(1996-11#1)(1996-6#2)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#1)
Acala NemX##5##2##(2008-10#5)
Acala SJ-2##2##2##(2008-10#2)
Acala##8##1##(2008-10#8)
Acanthocephala##3##1##(2008-7#2)(2011-2#1)
Acanthophora spicifera##2##2##(2008-11#2)
AccI##4##1##(2008-12#4)
Accelerated##8##1##(1996-11#1)(1996-8#1)(2007-12#1)(2008-10#4)(2008-11#1)
Accelerating##2##1##(2008-10#1)(2008-12#1)
Acceptability E-scale##3##2##(2010-10#3)
Acceptability##4##1##(2010-10#3)(2013-1#1)
Acceptable results##2##2##(2007-11#1)(2008-10#1)
Acceptable##5##1##(2007-11#1)(2008-10#2)(2008-6#1)(2012-3#1)
Acceptance and##2##2##(2012-2#2)
Acceptance##3##1##(2008-10#1)(2012-2#2)
Access (R)##2##2##(2008-1#2)
Access Control##2##2##(2010-8#2)
Access and##4##2##(1994-2#1)(1994-3#2)(1995-12#1)
Access to care##3##3##(1995-12#1)(1996-3#1)(2011-2#1)
Access to##18##2##(1992-2#1)(1994-2#1)(1995-1#1)(1995-12#3)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#1)(2008-1#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
Access##35##1##(1991-3#1)(1992-2#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#5)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-5#4)(2008-1#3)(2008-12#1)(2008-9#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-8#1)
Accessibility##2##1##(2009-5#1)(2012-2#1)
Accessions##3##1##(2008-10#3)
Accessory##3##1##(1993-8#1)(2012-2#2)
Accident occurrence and functional health patterns##2##6##(2013-1#2)
Accident##5##1##(1994-2#1)(2009-10#2)(2013-1#2)
Accompanying the##2##2##(1993-12#1)(2008-7#1)
Accompanying##3##1##(1993-12#1)(2008-12#1)(2008-7#1)
According to a##2##3##(1990-6#1)(2012-12#1)
According to data##2##3##(2008-10#1)(2008-11#1)
According to our experience##2##4##(2008-10#1)(2008-11#1)
According to our##5##3##(2008-10#2)(2008-11#1)(2008-5#2)
According to previous##2##3##(2008-12#1)(2012-12#1)
According to the author##3##4##(1991-1#1)(1991-3#2)
According to the chromatographic data##2##5##(2008-10#2)
According to the current##2##4##(1991-9#1)(2012-3#1)
According to the outcomes model##2##5##(2008-4#2)
According to the results##3##4##(2008-5#1)(2008-8#1)(2013-1#1)
According to the traditional model##2##5##(2008-4#2)
According to the##60##3##(1990-2#1)(1991-1#1)(1991-3#2)(1991-9#2)(1993-2#1)(1993-3#1)(1995-12#1)(1995-6#2)(1996-5#2)(1996-6#2)(1996-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#3)
According to their##2##3##(1995-12#1)(2008-10#1)
According to these findings##2##4##(2008-5#1)(2009-1#1)
According to these results##2##4##(2008-10#1)(2008-5#1)
According to these##7##3##(1997-8#1)(2008-10#3)(2008-5#2)(2009-1#1)
According to this professional paper##2##5##(1994-3#2)
According to this##10##3##(1994-3#2)(1995-2#1)(1997-6#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)
According to##125##2##(1990-11#1)(1990-2#2)(1990-6#1)(1991-1#1)(1991-3#2)(1991-9#2)(1992-4#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-12#2)(1995-2#1)(1995-6#3)(1996-11#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#26)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-1#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
According##126##1##(1990-11#1)(1990-2#2)(1990-6#1)(1991-1#1)(1991-3#2)(1991-9#2)(1992-4#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-12#2)(1995-2#1)(1995-6#3)(1996-11#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#26)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-1#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
Accordingly##43##1##(1991-5#1)(1991-9#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Accountability##2##1##(1995-1#1)(1997-2#1)
Accounting for##2##2##(2008-12#1)(2010-5#1)
Accounting##4##1##(1992-3#1)(1993-12#1)(2008-12#1)(2010-5#1)
Accreditation of##3##2##(1994-12#1)(1995-3#1)(2008-3#1)
Accreditation##9##1##(1990-8#1)(1992-1#1)(1992-2#1)(1994-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-12#1)(2008-3#1)
Acculturation##2##1##(2012-2#1)(2013-8#1)
Accumulating evidence suggests that##2##4##(2008-8#1)(2012-2#1)
Accumulating evidence##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
Accumulation and##2##2##(2008-10#2)
Accumulation of##16##2##(1993-6#1)(1994-6#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-7#2)(2008-8#1)(2012-3#1)
Accumulation##26##1##(1993-6#1)(1994-6#1)(1997-7#1)(2008-10#18)(2008-11#1)(2008-7#2)(2008-8#1)(2012-3#1)
Accuracy and precision of the##2##5##(2008-10#2)
Accuracy and##4##2##(2008-10#2)(2008-3#1)(2009-12#1)
Accuracy of a##2##3##(2008-3#1)(2008-7#1)
Accuracy of the proposed##2##4##(2008-10#2)
Accuracy of the##5##3##(2008-10#4)(2008-12#1)
Accuracy of##12##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
Accuracy profiles##2##2##(2008-10#2)
Accuracy was assessed##2##3##(2008-10#2)
Accuracy was determined##2##3##(1990-6#1)(2008-10#1)
Accuracy was##7##2##(1990-6#1)(2008-10#6)
Accuracy##35##1##(1990-6#1)(2008-10#17)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
Accurate values##3##2##(2008-10#3)
Accurate##25##1##(1993-3#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-4#1)(2013-1#1)
Accutase and##2##2##(2008-11#2)
Acer##2##1##(2008-9#1)(2013-8#1)
Aceria##2##1##(2008-10#2)
Acervuli##2##1##(2008-10#2)
Acetabular fractures in the elderly##2##5##(2008-8#2)
Acetaminophen##3##1##(1994-6#1)(2013-1#2)
Acetate kinase##2##2##(2008-6#2)
Acetate##4##1##(1997-7#1)(2008-10#1)(2008-6#2)
Acetic acid##2##2##(1996-5#1)(2008-10#1)
Acetic##6##1##(1996-5#1)(2008-10#5)
Acetohalobium arabaticum##2##2##(2011-2#2)
Acetone##2##1##(2008-10#1)(2008-7#1)
Acetylated##2##1##(1996-2#1)(2009-8#1)
Acetylsalicylic acid##2##2##(1990-12#1)(1990-9#1)
Ach injection to##2##3##(2011-2#2)
Ach injection##3##2##(2011-2#3)
Ach##9##1##(2011-2#9)
Achatina achatina##3##2##(2008-12#3)
Achatina##6##1##(1991-5#3)(2008-12#3)
Acheilognathus##3##1##(2010-8#3)
Achieved##2##1##(2007-8#1)(2008-10#1)
Achievement##3##1##(2008-11#1)(2008-12#1)(2009-12#1)
Achieving a##2##2##(2008-10#1)(2010-1#1)
Achieving##8##1##(1993-12#2)(2008-10#1)(2008-11#2)(2010-1#1)(2010-8#1)(2013-1#1)
Achilles tendinosis##8##2##(2009-10#4)(2010-3#4)
Achilles tendon rupture following##2##4##(2010-3#2)
Achilles tendon rupture##3##3##(2010-3#3)
Achilles tendon##8##2##(1996-6#1)(2009-10#2)(2010-3#3)(2012-2#2)
Achilles tendons##2##2##(1995-8#1)(1997-8#1)
Achilles##23##1##(1995-8#1)(1996-6#1)(1997-8#1)(2008-5#1)(2009-10#7)(2010-3#7)(2011-2#1)(2012-2#4)
Achilles' heel##2##2##(1990-5#1)(2008-8#1)
Acholeplasma##3##1##(1993-12#2)(2008-10#1)
Acid and##3##2##(1996-9#1)(2008-10#1)(2008-5#1)
Acid diffusion##2##2##(2008-10#2)
Acid from##2##2##(2008-10#1)(2013-1#1)
Acid in##6##2##(2008-10#3)(2009-8#1)(2011-2#1)(2012-2#1)
Acid on##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
Acid##51##1##(1996-5#3)(1996-9#1)(1997-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)
Acid-base equilibria of##2##3##(2008-10#2)
Acid-base equilibria##3##2##(2008-10#3)
Acid-base##5##1##(2008-10#5)
Acid-producing bacteria##2##2##(2008-10#2)
Acid-producing##3##1##(1995-6#1)(2008-10#2)
Acidaminococcus fermentans##2##2##(2011-2#2)
Acidaminococcus##3##1##(2011-2#3)
Acidic##3##1##(1997-7#1)(2008-10#1)(2011-2#1)
Acidification##2##1##(2008-10#1)(2008-11#1)
Acidity##2##1##(2008-10#2)
Acidothermus cellulolyticus##2##2##(2011-2#2)
Acidovorax avenae subsp##6##3##(2008-10#6)
Acids Res##3##2##(1991-9#1)(1993-12#1)(1997-6#1)
Acids in##2##2##(2008-10#2)
Acids##14##1##(1991-9#1)(1993-12#1)(1996-5#3)(1997-6#1)(2008-10#3)(2008-11#2)(2009-8#1)(2012-2#1)(2013-1#1)
Acinetobacter baumannii##3##2##(2009-5#1)(2012-2#1)(2013-8#1)
Acinetobacter##5##1##(2007-11#1)(2009-5#1)(2012-2#2)(2013-8#1)
Acinic cell carcinoma of minor salivary gland of the base of tongue##2##12##(2013-1#2)
Acipenser##3##1##(2008-8#2)(2010-8#1)
Acipenseriformes##4##1##(2008-8#4)
Ackermann [Appl##2##2##(2008-2#1)(2008-3#1)
Acknowledgements##2##1##(2010-12#2)
Acknowledgment of reviewers##5##3##(2008-10#5)
Acknowledgment##6##1##(2008-10#5)(2008-8#1)
Acne##3##1##(1997-8#2)(2010-6#1)
Aconitum##3##1##(2008-10#3)
Acoustic##3##1##(1992-8#1)(2009-3#1)(2012-3#1)
Acquired##5##1##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
Acquisition and##3##2##(2008-10#3)
Acquisition of##5##2##(1993-6#1)(2008-10#3)(2010-6#1)
Acquisition##10##1##(1993-6#1)(2008-10#7)(2009-9#1)(2010-6#1)
Acral Lentiginous Melanoma##2##3##(2010-6#2)
Acral##3##1##(2010-6#3)
Acremonium##2##1##(2011-1#2)
Acridine Orange##5##2##(2008-10#5)
Acropora##3##1##(2008-6#2)(2012-2#1)
Across all##3##2##(2008-10#3)
Across trials##2##2##(2008-10#2)
Across##23##1##(1991-3#1)(2008-10#10)(2008-12#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-7#1)(2012-2#1)(2012-3#3)(2012-9#1)
Acrylic##3##1##(1997-3#1)(2008-10#1)(2009-10#1)
Act 1998##2##2##(2008-11#2)
Act and the##4##3##(1991-1#2)(1994-1#1)(1997-5#1)
Act and##7##2##(1991-1#2)(1994-1#1)(1995-12#2)(1996-5#1)(1997-5#1)
Act of 1989##2##3##(1991-3#1)(1992-1#1)
Act of 1990##4##3##(1991-12#1)(1993-1#1)(1995-1#1)(1995-2#1)
Act of 1997##2##3##(1997-4#1)(2008-11#1)
Act of##19##2##(1990-6#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-1#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)
Act was passed##2##3##(1991-1#1)(1993-1#1)
Act##95##1##(1990-6#1)(1991-1#7)(1991-12#5)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#9)(1994-2#2)(1994-3#3)(1995-1#2)(1995-12#11)(1995-2#1)(1995-3#2)(1995-6#4)(1996-1#2)(1996-3#1)(1996-5#4)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2008-10#1)(2008-11#8)(2008-12#1)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
Act)##3##1##(1996-3#2)(1996-8#1)
Acta##12##1##(1991-5#1)(1993-8#2)(1994-3#1)(1996-2#1)(2008-10#6)(2008-11#1)
Actigard##2##1##(2008-10#2)
Actin Binding##2##2##(2008-6#1)(2011-2#1)
Actin filaments##3##2##(2009-10#2)(2009-12#1)
Actin organization##2##2##(2008-11#1)(2008-9#1)
Actin##11##1##(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2011-2#3)(2012-2#1)
Actin-binding##2##1##(1993-8#1)(2012-2#1)
Actinobacillus##4##1##(1996-12#3)(2008-5#1)
Actinobacteria##4##1##(2011-2#1)(2012-2#3)
Actinomyces spp##2##2##(2013-1#2)
Actinomyces##4##1##(2010-12#1)(2013-1#3)
Actinomycin##2##1##(1993-12#1)(2008-11#1)
Actinomycosis is##2##2##(2008-1#2)
Actinomycosis##4##1##(2008-1#3)(2010-12#1)
Action and##3##2##(2008-10#2)(2008-11#1)
Action learning groups##2##3##(2008-11#2)
Action##25##1##(1993-3#2)(1994-2#1)(2008-1#2)(2008-10#2)(2008-11#10)(2008-12#1)(2008-5#1)(2008-7#2)(2010-10#3)(2011-1#1)
Actions##4##1##(2008-11#1)(2009-8#1)(2011-2#1)(2013-8#1)
Activated##15##1##(1992-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-3#1)(2011-2#2)(2013-1#2)
Activates##2##1##(2008-10#1)(2008-11#1)
Activating##4##1##(1991-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
Activation by IVC##2##3##(1990-2#2)
Activation by##4##2##(1990-2#2)(2011-2#1)(2013-8#1)
Activation in##2##2##(2011-2#1)(2012-3#1)
Activation of both##3##3##(1994-6#1)(1994-8#1)(1996-2#1)
Activation of protein kinase C##2##5##(1992-12#1)(1993-8#1)
Activation of the glucocorticoid receptor##2##5##(1996-12#2)
Activation of the##12##3##(1992-8#1)(1993-9#2)(1994-6#1)(1995-8#1)(1996-12#3)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)
Activation of##46##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-8#3)(1996-12#4)(1996-2#3)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Activation##58##1##(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-8#3)(1996-12#4)(1996-2#3)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
Activator##2##1##(1995-8#1)(2012-3#1)
Active ingredients##2##2##(2008-10#1)(2008-5#1)
Active packaging##2##2##(2010-7#2)
Active##28##1##(1993-2#1)(1996-5#2)(1996-6#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-7#2)(2011-2#2)(2012-2#1)
Activin A is##2##3##(1995-8#2)
Activin A##5##2##(1992-6#2)(1995-8#3)
Activin-A##2##1##(1994-11#2)
Activists##2##1##(1993-9#1)(1995-12#1)
Activities in##3##2##(2008-10#2)(2010-11#1)
Activities of Daily Living (ADL) and##2##6##(2008-7#2)
Activities of Daily Living##7##4##(2008-7#5)(2011-2#1)(2012-2#1)
Activities of daily living##2##4##(1992-12#1)(1995-2#1)
Activities of##15##2##(1992-12#1)(1992-6#1)(1995-2#1)(2008-11#2)(2008-7#6)(2008-8#1)(2011-2#2)(2012-2#1)
Activities##20##1##(1992-12#1)(1992-6#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#6)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)
Activity Toward##2##2##(2008-10#2)
Activity and##6##2##(2008-10#2)(2011-2#3)(2013-1#1)
Activity in the##2##3##(2008-10#1)(2011-2#1)
Activity in##8##2##(1990-11#1)(1993-11#1)(2008-10#3)(2011-2#1)(2013-1#2)
Activity of a##2##3##(2008-10#1)(2008-11#1)
Activity of the##8##3##(1990-5#1)(1993-12#1)(2008-10#5)(2012-2#1)
Activity of##27##2##(1990-5#1)(1992-9#1)(1993-12#1)(1995-9#1)(1997-7#1)(2008-10#14)(2008-11#3)(2008-9#1)(2010-6#1)(2012-2#2)(2012-3#1)
Activity was##2##2##(1992-3#1)(1995-8#1)
Activity##75##1##(1990-11#1)(1990-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-8#1)(1995-9#1)(1997-7#1)(2008-10#32)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#2)(2009-6#1)(2010-6#1)(2011-2#5)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#1)
Acts##5##1##(1992-2#1)(1994-12#1)(2008-10#1)(2008-3#1)(2010-1#1)
Actual##3##1##(1990-11#1)(1992-12#1)(2013-1#1)
Actually##2##1##(2008-10#1)(2011-3#1)
Actuarial##3##1##(1990-6#1)(1991-12#1)(2011-2#1)
Acuity##2##1##(1996-1#1)(2013-1#1)
Acupuncture##6##1##(2008-10#4)(2013-1#2)
Acute Care##2##2##(2009-3#1)(2010-10#1)
Acute Coronary Syndrome##2##3##(2008-3#1)(2012-2#1)
Acute Coronary##3##2##(2008-3#2)(2012-2#1)
Acute Myeloid Leukemia Cells##2##4##(2012-12#1)(2013-1#1)
Acute Myeloid Leukemia##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
Acute Myocardial Infarction##2##3##(2008-12#1)(2012-3#1)
Acute and chronic##2##3##(1991-9#1)(2012-5#1)
Acute and##3##2##(1991-1#1)(1991-9#1)(2012-5#1)
Acute coronary syndrome##2##3##(2008-11#1)(2010-4#1)
Acute effects of##3##3##(1991-1#1)(2010-7#1)(2012-2#1)
Acute haemorrhagic presentation of##2##4##(2008-7#2)
Acute hepatitis##2##2##(1995-2#1)(2007-12#1)
Acute myeloid leukemia (AML)##2##4##(2011-2#1)(2013-1#1)
Acute pancreatitis (AP) is a##2##5##(2009-8#1)(2013-1#1)
Acute pancreatitis (AP)##3##3##(2009-8#2)(2013-1#1)
Acute pancreatitis is##2##3##(2012-12#1)(2013-1#1)
Acute pancreatitis##7##2##(2008-12#1)(2009-8#2)(2012-12#2)(2013-1#2)
Acute renal##2##2##(1997-5#1)(2011-2#1)
Acute##94##1##(1990-5#1)(1991-1#6)(1991-6#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-2#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-3#2)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#5)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#5)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#12)
Acyl Radical##2##2##(1996-5#2)
Acyl##4##1##(1990-12#2)(1996-5#2)
Acyrthosiphon pisum##4##2##(1996-12#1)(2007-12#1)(2008-10#2)
Ad Libitum group##2##3##(1990-3#2)
Ad libitum##2##2##(2013-8#2)
Ad##10##1##(1990-3#2)(1997-3#1)(2008-10#1)(2008-11#3)(2011-3#1)(2013-8#2)
Ad-GFP##3##1##(2008-9#3)
Ad-HGF##10##1##(2008-9#10)
Ad5##2##1##(1997-3#2)
Ad9##4##1##(1992-9#4)
AdSV##3##1##(2008-10#3)
AdSV)##2##1##(2008-10#2)
Adair##2##1##(1990-8#2)
Adamantinoma##2##1##(2010-11#2)
Adaptation and##2##2##(2008-10#1)(2009-7#1)
Adaptation of##4##2##(2008-10#2)(2008-11#1)(2011-1#1)
Adaptation to##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
Adaptation##14##1##(1996-9#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
Adapted##2##1##(2008-11#1)(2009-12#1)
Adapting##2##1##(1994-12#1)(2012-2#1)
Adaptive mutation##2##2##(1994-9#2)
Adaptive##11##1##(1992-3#1)(1994-9#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-3#1)
Add-on devices##2##2##(1997-1#2)
Added to the##2##3##(2008-10#1)(2008-7#1)
Added##4##1##(1994-6#1)(1997-8#1)(2008-10#1)(2008-7#1)
Addiction to##2##2##(2011-2#1)(2012-2#1)
Addiction##5##1##(1992-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
Adding##8##1##(1990-3#1)(2008-10#2)(2011-2#2)(2013-1#3)
Addison's disease##3##2##(1990-12#2)(2012-3#1)
Addition of a##5##3##(1993-1#1)(2008-10#4)
Addition of the##3##3##(1992-9#1)(2008-10#1)(2009-3#1)
Addition of##58##2##(1990-5#4)(1991-5#1)(1992-9#1)(1993-1#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-2#1)(1996-5#4)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#18)(2008-11#11)(2009-3#2)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#2)
Addition##60##1##(1990-5#4)(1991-5#1)(1992-9#1)(1993-1#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-2#1)(1996-5#5)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#18)(2008-11#11)(2008-12#1)(2009-3#2)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#2)
Additional analyses##2##2##(2008-9#1)(2013-1#1)
Additional experiments##4##2##(1993-6#1)(2008-10#2)(2008-11#1)
Additional groups of 10 male and 10 female Tg##2##9##(2008-9#2)
Additional groups of 10 male and 10 female##3##8##(2008-9#3)
Additional groups##4##2##(1993-6#1)(2008-9#3)
Additional information is provided regarding common side reactions and synthesizing modified residues##2##12##(2008-4#2)
Additional information is##3##3##(2008-1#1)(2008-4#2)
Additional information##4##2##(2008-1#1)(2008-10#1)(2008-4#2)
Additional isolates##2##2##(2008-10#2)
Additional microbiological tests##2##3##(2012-2#2)
Additional protocols describe##2##3##(2008-4#2)
Additional protocols##3##2##(2008-4#3)
Additional research is warranted##2##4##(2009-4#1)(2012-2#1)
Additional research is##3##3##(2009-4#1)(2012-2#1)(2013-1#1)
Additional research##5##2##(1996-9#1)(2008-10#1)(2009-4#1)(2012-2#1)(2013-1#1)
Additional studies##4##2##(2008-11#1)(2008-5#1)(2009-3#1)(2013-1#1)
Additional study is##2##3##(2011-2#1)(2012-3#1)
Additional support protocols##3##3##(2008-4#3)
Additional support##4##2##(1995-12#1)(2008-4#3)
Additional value of##3##3##(2008-11#1)(2009-10#1)(2010-10#1)
Additional work##2##2##(1997-8#1)(2008-11#1)
Additional##83##1##(1992-10#1)(1993-2#1)(1993-6#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-3#2)(2008-4#8)(2008-5#2)(2008-7#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
Additionally##160##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#3)(1995-12#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#50)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#4)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#7)(2013-1#6)(2013-7#1)(2013-8#4)
Addressing the##2##2##(2008-12#1)(2008-8#1)
Addressing##8##1##(2008-1#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Ade##2##1##(1995-6#1)(2008-9#1)
Adenocarcinoma##3##1##(1992-2#1)(2013-1#2)
Adenoma##2##1##(2011-2#1)(2012-3#1)
Adenomatoid##2##1##(2007-12#1)(2008-12#1)
Adenosine##5##1##(1994-8#1)(1995-8#1)(2006-6#1)(2008-7#1)(2013-8#1)
Adenovirus##5##1##(1992-5#1)(1992-6#1)(2008-8#2)(2011-2#1)
Adenovirus-mediated##2##1##(2008-8#1)(2010-1#1)
Adenoviruses##5##1##(2008-8#4)(2013-8#1)
Adequate nutrition##2##2##(2011-2#1)(2012-2#1)
Adequate##15##1##(1993-1#1)(1997-3#2)(2008-10#6)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)
Adequately##2##1##(1992-6#1)(2013-8#1)
Adh##3##1##(1997-8#3)
Adh(F) and Adh(S) strains##2##4##(1997-8#2)
Adh(F) and##3##2##(1997-8#3)
Adh(F)##4##1##(1997-8#4)
Adh(S)##3##1##(1997-8#3)
Adherence to##6##2##(1995-9#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-8#1)
Adherence##9##1##(1994-3#1)(1995-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-8#1)
Adherent cells were##2##3##(2012-4#1)(2013-1#1)
Adhesion and biofilm##2##3##(2008-7#2)
Adhesion molecules##2##2##(2008-5#2)
Adhesion of##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
Adhesion reformation##2##2##(1992-1#2)
Adhesion to##2##2##(2008-10#1)(2009-10#1)
Adhesion##15##1##(1992-1#2)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#3)(2009-10#1)(2011-1#1)(2013-1#1)
Adhesions##2##1##(1992-1#2)
Adhesive AH109A cells##2##3##(2008-11#2)
Adhesive##4##1##(1997-1#1)(2008-11#2)(2008-5#1)
Adiabatic##4##1##(1992-11#1)(1992-8#1)(2007-12#2)
Adipocytes##3##1##(2008-10#1)(2008-11#1)(2010-7#1)
Adipogenesis##2##1##(2008-11#1)(2012-2#1)
Adipose##2##1##(2010-6#1)(2013-1#1)
Adjacent segment disease##2##3##(2012-12#1)(2012-3#1)
Adjacent to the##2##3##(1991-6#1)(2010-12#1)
Adjacent##5##1##(1991-6#1)(2010-12#1)(2012-12#1)(2012-3#2)
Adjunct##2##1##(2011-2#1)(2013-1#1)
Adjunctive##4##1##(2010-6#1)(2011-2#2)(2012-3#1)
Adjusted##2##1##(1994-1#1)(2012-12#1)
Adjusting##2##1##(1991-5#1)(2008-12#1)
Adjustment##2##1##(2008-9#1)(2010-5#1)
Adjuvant Chemoendocrine Therapy for Breast##2##5##(1997-7#2)
Adjuvant chemotherapy in breast cancer##3##5##(1995-8#3)
Adjuvant therapy##3##2##(1992-12#1)(2010-7#2)
Adjuvant##11##1##(1992-12#2)(1995-8#3)(1997-7#3)(2008-10#1)(2010-7#2)
Adk-gene##2##1##(2009-8#2)
Adk-tg mice##2##2##(2009-8#2)
Adler##2##1##(2010-1#1)(2013-1#1)
Administered##2##1##(1991-2#1)(1996-12#1)
Administration and##4##2##(1994-3#1)(1995-2#1)(2010-6#1)(2012-2#1)
Administration for##2##2##(1991-1#1)(2012-3#1)
Administration has##2##2##(1991-12#1)(1994-12#1)
Administration is##3##2##(1992-1#1)(1992-2#1)(1997-3#1)
Administration of the##2##3##(1994-5#1)(2008-10#1)
Administration of##17##2##(1991-1#1)(1991-2#1)(1994-5#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-4#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
Administration##91##1##(1991-1#4)(1991-12#3)(1991-2#3)(1991-3#1)(1992-1#4)(1992-2#2)(1993-3#1)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#4)(1996-5#3)(1997-2#6)(1997-3#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#3)
Administration's##7##1##(1991-12#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-2#2)(2008-11#1)
Administrative costs##2##2##(1993-2#1)(1996-3#1)
Administrative##7##1##(1993-2#2)(1994-12#1)(1995-1#1)(1996-3#1)(1997-2#1)(2013-8#1)
Administrators##6##1##(1991-2#1)(1991-9#1)(1992-1#2)(1993-3#1)(1997-2#1)
Admission to##2##2##(1997-8#1)(2013-1#1)
Admission##4##1##(1997-2#1)(1997-8#1)(2012-3#1)(2013-1#1)
Adolescence##3##1##(2008-11#1)(2009-12#1)(2012-3#1)
Adolescent Girls##2##2##(2013-1#2)
Adolescent##20##1##(1990-12#1)(1995-1#1)(2008-11#5)(2009-7#1)(2010-1#2)(2010-11#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#5)(2013-8#1)
Adolescents With##2##2##(2013-1#1)(2013-8#1)
Adolescents and young adults##2##4##(2008-11#2)
Adolescents and##3##2##(2008-11#3)
Adolescents who##3##2##(2008-11#1)(2010-1#1)(2013-8#1)
Adolescents##30##1##(2008-11#4)(2009-7#2)(2009-8#1)(2010-1#1)(2010-6#1)(2010-9#2)(2011-1#3)(2012-2#1)(2013-1#13)(2013-8#2)
Adolescents'##2##1##(2010-1#1)(2013-8#1)
Adopting##2##1##(2008-10#1)(2012-3#1)
Adoption##3##1##(1997-8#1)(2008-5#1)(2009-11#1)
Adoptive transfer of##2##3##(2008-11#1)(2011-2#1)
Adoptive##4##1##(2008-11#2)(2010-11#1)(2011-2#1)
Adr##2##1##(1993-8#2)
Adrenal gland##2##2##(1992-12#2)
Adrenal##7##1##(1990-12#1)(1992-12#2)(1995-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Adrenoleukodystrophy##3##1##(1993-3#2)(1995-2#1)
AdsiRNA-survivin##3##1##(2010-1#3)
Adsorption of Pb(2+) ions on##2##5##(2008-10#2)
Adsorption of##8##2##(2008-10#8)
Adsorption##16##1##(2008-10#16)
Adsorptive stripping voltammetric determination of##4##5##(2008-10#4)
Adsorptive stripping voltammetric##5##3##(2008-10#5)
Adsorptive##6##1##(2008-10#6)
Adult Branch##2##2##(2008-11#1)(2008-12#1)
Adult Separation Anxiety##2##3##(2012-2#2)
Adult T cell leukemia (ATL)##2##5##(2008-11#1)(2011-2#1)
Adult and##2##2##(2008-10#1)(2008-11#1)
Adult males##2##2##(2010-4#2)
Adult rat##2##2##(2008-11#1)(2008-7#1)
Adult##37##1##(1991-1#1)(1993-2#1)(1993-3#1)(1994-8#1)(1996-12#2)(1997-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-4#2)(2011-2#2)(2012-2#2)(2012-3#2)
Adulthood##3##1##(2009-12#1)(2009-7#1)(2013-1#1)
Adults in the##2##3##(2008-10#1)(2013-1#1)
Adults in##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
Adults of##2##2##(2008-10#2)
Adults with##3##2##(1995-2#1)(2008-9#1)(2013-1#1)
Adults##21##1##(1991-1#1)(1995-2#1)(2008-10#4)(2008-12#1)(2008-8#3)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
Advance##5##1##(2008-8#3)(2009-3#1)(2012-12#1)
Advanced Oxidation Process##2##3##(2008-10#2)
Advanced age##2##2##(2008-7#1)(2013-7#1)
Advanced breeding lines##2##3##(2008-10#2)
Advanced trauma life support##2##4##(1992-5#2)
Advanced##50##1##(1990-11#1)(1992-5#2)(1994-12#2)(1994-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
Advancement##4##1##(2008-8#1)(2011-2#3)
Advances in the understanding of##2##5##(2009-1#1)(2012-2#1)
Advances in the##10##3##(2008-10#4)(2009-1#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
Advances in##33##2##(1990-8#1)(1992-7#1)(1995-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-1#1)(2009-10#1)(2010-12#2)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Advances##35##1##(1990-8#1)(1992-7#1)(1995-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-1#1)(2009-10#1)(2010-12#2)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#5)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Advancing practice##2##2##(2013-8#2)
Advancing##6##1##(1995-2#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-8#2)
Advantages and disadvantages of using##2##5##(1991-3#1)(1996-1#1)
Advantages and disadvantages of##4##4##(1991-3#1)(1996-1#1)(2008-10#2)
Advantages and disadvantages##5##3##(1991-3#1)(1996-1#1)(2008-10#2)(2011-7#1)
Advantages and##7##2##(1991-3#1)(1996-1#1)(2008-10#3)(2008-11#1)(2011-7#1)
Advantages of the##3##3##(2008-10#3)
Advantages of##9##2##(1992-3#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-7#1)
Advantages##19##1##(1991-3#1)(1992-3#1)(1993-3#1)(1996-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-7#1)
Adventitial reactions##2##2##(1997-8#2)
Adverse drug reactions##2##3##(2011-2#2)
Adverse effects of##2##3##(1990-9#1)(2013-8#1)
Adverse effects##5##2##(1990-9#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
Adverse events##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)
Adverse##19##1##(1990-9#1)(1991-11#1)(1996-12#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Advisor##2##1##(2010-1#1)(2013-1#1)
Advisory Committee##8##2##(1994-2#1)(1994-9#1)(1995-11#2)(2008-10#1)(2008-5#1)(2012-3#2)
Advisory Council on HIV/AIDS##3##4##(1995-12#1)(1995-6#2)
Advisory Council##4##2##(1995-12#1)(1995-6#3)
Advisory##15##1##(1992-2#1)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#3)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#2)
Ae##3##1##(2008-8#3)
Aedes aegypti##3##2##(2008-5#1)(2011-2#2)
Aedes communis is a##2##4##(2011-2#2)
Aedes communis##3##2##(2011-2#3)
Aedes##6##1##(2008-5#1)(2011-2#5)
Aegean##2##1##(2008-10#2)
Aegilops speltoides##3##2##(2008-10#3)
Aegilops##6##1##(2008-10#5)(2008-8#1)
Aelia##3##1##(2013-8#3)
Aerial photography##2##2##(2008-10#2)
Aerial##4##1##(2008-10#4)
Aerobic##4##1##(1996-12#1)(2009-1#1)(2013-1#2)
Aerococcus##2##1##(2008-10#2)
Aerodynamic##2##1##(2008-2#1)(2008-3#1)
Aeromonas strains isolated##2##3##(2008-10#2)
Aeromonas strains##4##2##(2008-10#4)
Aeromonas##5##1##(2008-10#4)(2008-11#1)
Aerosol bolus dispersion##3##3##(1997-2#3)
Aerosol##23##1##(1992-12#1)(1993-3#1)(1996-1#1)(1996-3#1)(1997-1#4)(1997-2#3)(2008-10#4)(2008-11#2)(2008-3#4)(2008-5#1)(2013-1#1)
Aerosolized##5##1##(1990-9#1)(1992-3#1)(1994-12#2)(1997-1#1)
Aerosols are##2##2##(2008-9#2)
Aerosols##6##1##(1995-3#1)(1996-2#1)(1997-1#1)(2008-3#1)(2008-9#2)
Aetiology and##2##2##(1995-10#1)(2011-2#1)
Affairs##12##1##(1990-11#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#2)(1995-2#1)(2008-6#1)(2009-11#1)(2011-2#1)(2013-1#1)
Affected by##5##2##(2008-10#5)
Affected individuals##2##2##(2011-1#1)(2011-2#1)
Affected##10##1##(2008-10#6)(2008-7#1)(2011-1#1)(2011-2#2)
Affective##2##1##(2008-11#1)(2009-9#1)
Affects the##2##2##(2008-10#2)
Affects##3##1##(2008-10#3)
Affinity##4##1##(1993-6#1)(1995-8#1)(2008-10#2)
Affymetrix##3##1##(2008-8#1)(2009-10#1)(2010-11#1)
Aflatoxin B(1)##3##2##(2008-10#3)
Aflatoxin Contamination##3##2##(2008-10#3)
Aflatoxin M1##3##2##(2008-12#1)(2013-1#2)
Aflatoxin Production##2##2##(2008-10#1)(2013-1#1)
Aflatoxin contamination##2##2##(2008-10#2)
Aflatoxin##16##1##(2008-10#12)(2008-12#1)(2013-1#3)
Aflatoxins##6##1##(2008-10#6)
Africa and the##3##3##(1994-3#1)(2008-10#2)
Africa and##12##2##(1994-3#1)(1997-7#1)(2008-10#7)(2011-2#2)(2013-8#1)
Africa are##4##2##(1997-7#1)(2008-1#1)(2011-2#1)(2012-2#1)
Africa can##2##2##(2011-2#1)(2012-2#1)
Africa is##2##2##(2010-3#1)(2010-5#1)
Africa were##2##2##(1997-8#1)(2008-10#1)
Africa##133##1##(1990-12#3)(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#3)(1994-9#1)(1995-1#1)(1995-12#1)(1996-8#1)(1997-6#1)(1997-7#6)(1997-8#2)(2008-1#2)(2008-10#55)(2008-11#2)(2008-12#5)(2008-5#2)(2008-8#1)(2009-6#1)(2010-1#9)(2010-11#3)(2010-3#1)(2010-5#2)(2011-2#7)(2012-2#8)(2012-3#1)(2013-1#8)(2013-8#4)
Africa)##2##1##(2008-10#1)(2008-9#1)
Africa]##2##1##(1993-11#1)(2008-10#1)
African American and Latino##2##4##(1996-3#1)(2008-12#1)
African American and##4##3##(1996-3#1)(2008-12#1)(2010-10#1)(2012-12#1)
African American children##2##3##(2010-9#1)(2011-1#1)
African American male##2##3##(2008-12#1)(2009-5#1)
African American men aged##2##4##(2009-5#2)
African American men with prostate cancer##4##6##(2009-5#4)
African American men##18##3##(2009-5#17)(2010-7#1)
African American men's##2##3##(2009-5#2)
African American women##2##3##(2009-11#1)(2011-2#1)
African American##44##2##(1996-3#1)(2008-12#5)(2009-11#1)(2009-12#1)(2009-5#21)(2009-7#3)(2010-10#1)(2010-7#3)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
African Americans and##3##3##(2013-1#3)
African Americans were more##2##4##(2010-10#1)(2013-1#1)
African Americans were##4##3##(2008-12#1)(2010-10#1)(2013-1#2)
African Americans with##4##3##(2010-4#4)
African Americans##25##2##(1995-12#1)(2008-12#3)(2010-10#5)(2010-4#5)(2010-7#1)(2011-2#2)(2013-1#7)(2013-8#1)
African and##3##2##(2008-1#1)(2008-10#2)
African clawed frogs (Xenopus laevis)##2##5##(1996-6#2)
African cultivated rice##3##3##(2009-10#3)
African origin##2##2##(1994-3#1)(2008-8#1)
African populations##5##2##(2010-5#5)
African strain XcmN##2##3##(2008-10#2)
African strains of Xanthomonas##2##4##(2008-10#2)
African strains##9##2##(2008-10#9)
African swine fever##2##3##(2011-2#2)
African##147##1##(1991-11#1)(1991-5#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-9#1)(1996-3#1)(1996-6#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#11)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#22)(2009-7#3)(2010-1#5)(2010-10#6)(2010-11#1)(2010-3#2)(2010-4#5)(2010-5#7)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#11)(2013-8#2)
African-American and##2##2##(2008-4#1)(2008-5#1)
African-American boy##2##2##(1997-3#2)
African-American hair and##2##3##(2008-5#2)
African-American hair fibre##2##3##(2008-5#2)
African-American hair##6##2##(2008-5#6)
African-American##19##1##(1995-9#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#7)(2009-11#1)(2009-6#1)(2010-3#1)(2010-6#1)(2013-1#1)
African-Americans and##2##2##(2013-1#2)
African-Americans##9##1##(1994-1#1)(1997-3#2)(2010-6#3)(2013-1#2)(2013-8#1)
Africans from##2##2##(2008-12#1)(2010-5#1)
Afro-American hair##2##2##(2008-5#2)
Afro-American##3##1##(2008-5#3)
Afro-Andean isolates##2##2##(2008-10#2)
Afro-Andean##8##1##(2008-10#8)
After 1##5##2##(1993-6#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
After 10##3##2##(2008-10#2)(2010-8#1)
After 12 weeks##2##3##(1991-2#1)(2008-3#1)
After 12##3##2##(1991-2#1)(2008-3#1)(2013-1#1)
After 14 days##2##3##(2008-12#1)(2013-1#1)
After 14##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
After 15##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
After 2##4##2##(1994-3#1)(1996-2#1)(2008-12#1)(2008-7#1)
After 20##2##2##(2008-10#1)(2008-11#1)
After 24 h##6##3##(2008-10#2)(2008-12#1)(2008-7#1)(2010-3#1)(2013-1#1)
After 24 hours##2##3##(1992-6#1)(2008-5#1)
After 24##8##2##(1992-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
After 2 years##2##2##(2011-1#2)
After 3 days##2##3##(1994-3#1)(2008-10#1)
After 3 weeks##2##3##(1993-8#1)(2008-11#1)
After 3##6##2##(1993-8#1)(1994-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
After 4 months of##2##4##(2008-10#1)(2010-8#1)
After 4 months##5##3##(1991-8#1)(2008-10#2)(2010-8#1)(2013-1#1)
After 4 weeks in culture##2##5##(2008-11#2)
After 4 weeks##3##3##(2008-11#2)(2008-7#1)
After 4##10##2##(1991-8#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
After 48 h##2##3##(1992-6#1)(2008-10#1)
After 48##3##2##(1992-6#1)(2008-10#2)
After 5 days##2##3##(2008-10#1)(2008-11#1)
After 5##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
After 6 weeks##3##3##(1990-12#1)(2008-10#1)(2013-1#1)
After 60##2##2##(1994-11#1)(2013-1#1)
After 7##3##2##(2008-10#2)(2013-1#1)
After 8##2##2##(1991-8#1)(2008-10#1)
After Arteriovenous##2##2##(2012-3#2)
After DNA sequencing##2##3##(2008-8#2)
After DNA##3##2##(2008-8#3)
After Transposition of##2##3##(2008-10#2)
After a complete##2##3##(2013-1#2)
After a median follow-up##2##4##(1990-8#1)(1992-12#1)
After a median##3##3##(1990-8#1)(1991-8#1)(1992-12#1)
After a review of##2##4##(1993-6#1)(2008-10#1)
After a single##2##3##(1997-2#1)(2008-2#1)
After a##38##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
After adjusting for##2##3##(2012-3#1)(2013-8#1)
After adjustment for##6##3##(1991-7#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-6#1)(2012-3#1)
After an##8##2##(1992-1#1)(1993-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2013-1#2)
After application of##2##3##(2008-10#1)(2008-11#1)
After applying these to three moral issues--marketing##2##7##(1994-1#2)
After being##4##2##(2008-10#1)(2008-8#3)
After careful##2##2##(1992-2#1)(2008-10#1)
After centrifugation##5##2##(1990-2#1)(2008-10#3)(2008-11#1)
After collecting the available instruments used by nurses and/or patients in the measurement of patients' problems or perceptions of those problems (actual and/or potential)##2##24##(2013-1#2)
After collecting the##3##3##(2008-10#1)(2013-1#2)
After completing##3##2##(1994-12#1)(2009-6#1)(2010-10#1)
After completion of##2##3##(1991-8#1)(2008-10#1)
After consideration of the##2##4##(2008-10#1)(2010-6#1)
After controlling for a variety of##2##6##(1995-2#1)(2008-11#1)
After controlling for##4##3##(1995-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
After derivatization##3##2##(2008-10#2)(2008-11#1)
After developing a##2##3##(2008-11#1)(2010-12#1)
After discussing##3##2##(1991-2#1)(2008-10#1)(2010-8#1)
After each##2##2##(2008-10#1)(2013-1#1)
After elution with##2##3##(2008-10#2)
After elution##3##2##(2008-10#3)
After exposure##4##2##(1993-12#1)(2008-10#2)(2008-3#1)
After filtration##5##2##(2008-10#5)
After identifying##2##2##(1995-2#1)(2012-3#1)
After incubation##2##2##(2008-10#1)(2013-1#1)
After induction##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
After initial##3##2##(1997-8#1)(2008-7#2)
After injecting##2##2##(1994-8#1)(2008-10#1)
After injection##3##2##(1992-12#1)(1994-9#1)(2008-10#1)
After inoculation of##2##3##(2008-10#1)(2008-11#1)
After inoculation##3##2##(2008-10#2)(2008-11#1)
After making##2##2##(2008-6#1)(2011-3#1)
After nine months##2##3##(1993-1#1)(1993-3#1)
After nine##3##2##(1993-1#1)(1993-3#1)(1995-11#1)
After one year##2##3##(1994-12#1)(2011-2#1)
After one##3##2##(1994-12#1)(2008-5#1)(2011-2#1)
After optimisation##3##2##(2008-10#2)(2008-11#1)
After optimization of the##4##4##(2008-10#3)(2011-2#1)
After optimization of##5##3##(2008-10#4)(2011-2#1)
After optimization##6##2##(2008-10#5)(2011-2#1)
After pre-treatment with acids##2##4##(2008-10#2)
After providing##2##2##(2009-4#1)(2011-1#1)
After purification##3##2##(1994-5#1)(1995-3#1)(2008-11#1)
After receiving##2##2##(2008-12#1)(2012-12#1)
After removal of the##2##4##(2008-10#1)(2008-11#1)
After removal of##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
After removing##2##2##(2008-7#1)(2012-4#1)
After reviewing the##2##3##(1995-3#1)(1996-12#1)
After reviewing##4##2##(1990-8#1)(1995-3#1)(1996-12#1)(2008-10#1)
After separation##4##2##(1992-6#1)(2008-10#2)(2011-2#1)
After several##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
After six months of##2##4##(2013-1#2)
After storage##2##2##(2008-11#1)(2013-1#1)
After surgery##6##2##(1990-6#1)(2008-1#1)(2008-12#1)(2011-2#2)(2013-1#1)
After testing the##2##3##(2008-10#1)(2008-11#1)
After testing##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
After that##4##2##(1995-9#1)(2008-10#3)
After the Second World War##2##5##(2008-11#1)(2011-4#1)
After the application of##2##4##(2008-12#1)(2008-5#1)
After the competitive##2##3##(2008-10#2)
After the enrichment##2##3##(2008-10#2)
After the exposure of the sample to microwave radiation##2##9##(2008-10#2)
After the first##4##3##(1996-3#1)(1997-2#1)(2008-8#1)(2013-8#1)
After the##69##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1993-1#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#27)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-2#1)(2011-2#1)(2011-4#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
After this##7##2##(1993-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
After three##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
After treatment with##3##3##(1996-3#1)(1996-6#1)(2009-12#1)
After treatment##5##2##(1991-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(2009-12#1)
After washing the column with##2##5##(2008-10#2)
After washing the##3##3##(2008-10#3)
After washing##5##2##(2008-10#5)
After##652##1##(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#3)(1990-5#3)(1990-6#4)(1990-8#3)(1990-9#4)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#4)(1992-1#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-6#3)(1992-9#1)(1993-1#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-6#5)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#205)(2008-11#37)(2008-12#17)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#17)(2008-6#1)(2008-7#21)(2008-8#27)(2008-9#14)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#30)(2011-3#3)(2011-4#3)(2012-12#5)(2012-2#7)(2012-3#26)(2012-4#1)(2013-1#41)(2013-8#11)
After-School##2##1##(2012-12#1)(2013-1#1)
Afterwards##2##1##(2008-10#2)
Ag (I)##5##2##(2008-10#4)(2010-11#1)
Ag and Cu##2##3##(2008-10#2)
Ag and##7##2##(1991-5#1)(2008-10#6)
Ag##41##1##(1990-8#1)(1991-5#2)(1993-1#1)(1993-5#1)(2008-10#30)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#1)
Ag(+) and Cu(2+) ions##2##4##(2008-10#2)
Ag(+) and Zn(2+)##3##3##(2008-10#3)
Ag(+) and##10##2##(2008-10#10)
Ag(+) ions##3##2##(2008-10#3)
Ag(+) to##2##2##(2008-10#1)(2010-11#1)
Ag(+)##27##1##(2008-10#24)(2010-11#3)
Ag(+)-ISEs##2##1##(2008-10#2)
Ag(110)##2##1##(1991-9#1)(1992-11#1)
Ag(2)S##3##1##(2008-10#3)
Ag(2+)##2##1##(2008-10#2)
Ag(CN)(2)(-)##2##1##(2008-10#2)
Ag(I) and Pd(II)##3##3##(2008-10#3)
Ag(I) and##5##2##(2008-10#5)
Ag(I) by##2##2##(2008-10#2)
Ag(I)##20##1##(2008-10#20)
Ag-NOR and##2##2##(2008-12#2)
Ag-zeolite (silver-exchanged zeolite)##2##3##(2008-5#2)
Ag-zeolite##8##1##(2008-5#8)
Ag/AgCl (saturated KCl)##2##3##(2008-10#2)
Ag/AgCl and##2##2##(2008-10#2)
Ag/AgCl electrode##3##2##(2008-10#3)
Ag/AgCl electrodes##2##2##(2008-10#2)
Ag/AgCl in##6##2##(2008-10#6)
Ag/AgCl reference electrode##7##3##(2008-10#7)
Ag/AgCl reference##13##2##(2008-10#13)
Ag/AgCl to detect##2##3##(2008-10#2)
Ag/AgCl to##3##2##(2008-10#3)
Ag/AgCl was##3##2##(2008-10#3)
Ag/AgCl##64##1##(2008-10#64)
Ag/AgCl) for##3##2##(2008-10#3)
Ag/AgCl) in##2##2##(2008-10#2)
Ag/AgCl)##26##1##(2008-10#26)
Ag/AgCl/KCl(s))##2##1##(2008-10#2)
Ag/Au core-shell and pure gold##2##5##(2008-10#2)
Ag/Au core-shell nanoparticles##3##3##(2008-10#3)
Ag/Au core-shell##5##2##(2008-10#5)
AgBr##2##1##(2008-3#2)
AgCl precipitates##2##2##(2008-10#2)
AgCl##3##1##(2008-10#3)
AgGaS(2) as a nonlinear medium##2##5##(2008-3#2)
AgGaS(2) crystal##2##2##(2008-2#2)
AgGaS(2)##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
AgL##4##1##(2008-10#4)
AgMNPV polyhedra##2##2##(2008-11#2)
AgMNPV##5##1##(2008-11#5)
Again##7##1##(1992-3#1)(1995-8#1)(1996-2#1)(2008-10#3)(2009-12#1)
Against Botrytis cinerea##4##3##(2008-10#4)
Against Fusarium##2##2##(2008-10#2)
Against the##3##2##(2008-10#3)
Against##40##1##(1991-6#1)(1997-7#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
Agar##4##1##(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
Agaricus bisporus##6##2##(1997-1#2)(2008-10#3)(2011-1#1)
Agaricus##9##1##(1997-1#2)(2008-10#5)(2010-5#1)(2011-1#1)
Agave spp##2##2##(2009-8#2)
Agave##4##1##(2009-8#4)
Age and##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#1)
Age at first##2##3##(1990-9#1)(2009-5#1)
Age for##2##2##(2008-10#1)(2013-8#1)
Age of##6##2##(1993-12#1)(1996-5#1)(2008-12#3)(2011-2#1)
Age related##2##2##(1994-3#1)(1994-6#1)
Age##38##1##(1990-8#1)(1990-9#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-10#8)(2008-12#3)(2008-7#2)(2008-8#3)(2009-5#1)(2009-7#3)(2011-2#6)(2013-8#1)
Age-Related Macular Degeneration (AMD)##2##4##(2011-2#2)
Age-Related Macular Degeneration##3##3##(2011-2#3)
Age-Related##4##1##(2011-2#3)(2013-7#1)
Age-related changes in plasma##2##4##(2008-7#2)
Age-related changes in the##2##4##(1990-3#1)(2008-8#1)
Age-related changes in##8##3##(1990-3#1)(1995-8#1)(2008-7#5)(2008-8#1)
Age-related differences in##2##3##(2008-11#2)
Age-related##18##1##(1990-11#1)(1990-3#1)(1992-12#1)(1995-8#1)(2008-11#2)(2008-7#6)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Age-specific##2##1##(1993-12#1)(1995-8#1)
Aged##3##1##(1992-1#1)(1992-12#1)(2009-11#1)
Ageing##2##1##(1996-3#1)(2008-11#1)
Agelenopsis aperta##2##2##(1990-5#2)
Agence de la biomédecine##2##4##(2011-3#2)
Agence de la##3##3##(2011-3#3)
Agency and the##2##3##(1991-3#1)(2008-9#1)
Agency and##4##2##(1991-3#1)(1994-6#1)(1997-3#1)(2008-9#1)
Agency for##7##2##(1992-8#1)(1993-12#1)(1997-2#1)(2008-10#3)(2009-4#1)
Agency of##2##2##(2008-3#1)(2011-1#1)
Agency##34##1##(1991-3#1)(1992-1#1)(1992-8#2)(1993-12#1)(1994-2#1)(1994-6#1)(1995-3#2)(1997-2#1)(1997-3#2)(2008-10#11)(2008-11#2)(2008-3#2)(2008-9#3)(2009-4#1)(2009-9#1)(2011-1#1)(2013-1#1)
Agency's##2##1##(1992-8#1)(2008-11#1)
Agent of Potato##2##3##(2008-10#2)
Agent of##18##2##(2008-10#18)
Agent##32##1##(2008-1#1)(2008-10#30)(2013-1#1)
Agent-based models##2##2##(2010-5#2)
Agents Chemother##2##2##(2008-5#1)(2008-7#1)
Agents##10##1##(1993-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-8#1)
Ageratum yellow vein China virus##2##5##(2008-10#2)
Ageratum yellow vein virus##2##4##(2008-10#2)
Ageratum yellow vein##4##3##(2008-10#4)
Ageratum##5##1##(2008-10#5)
Ages##4##1##(1997-8#1)(2009-10#1)(2013-8#2)
Aggregated resources and timing were estimated to obtain vital implementation sponsorship##2##11##(2012-2#2)
Aggregated##3##1##(1991-11#1)(2012-2#2)
Aggregation of##2##2##(2008-10#2)
Aggregation was##3##2##(1994-11#1)(2008-10#2)
Aggregation##9##1##(1994-11#1)(1995-8#1)(2008-10#6)(2008-11#1)
Aggression##3##1##(2008-10#1)(2008-11#2)
Aggressive##3##1##(1995-11#1)(2008-8#1)(2012-3#1)
Aggressiveness of##4##2##(2008-10#4)
Aggressiveness##7##1##(2008-10#7)
Aging is associated with##2##4##(2011-2#1)(2013-1#1)
Aging is##4##2##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
Aging##16##1##(1993-12#2)(1994-2#1)(1995-3#1)(1997-3#1)(2008-11#2)(2008-7#1)(2010-1#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Agonis##2##1##(2010-3#2)
Agrammatism##2##1##(2008-10#2)
Agreement between the##2##3##(2008-10#1)(2008-3#1)
Agreement between##5##2##(1996-2#1)(2008-10#2)(2008-3#1)(2013-1#1)
Agreement is##2##2##(2008-10#2)
Agreement##11##1##(1995-1#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2013-1#1)
Agricultural University##2##2##(2008-12#2)
Agricultural##16##1##(1995-3#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-8#1)(2010-10#1)(2011-3#1)
Agriculture##10##1##(1990-11#1)(1996-3#1)(2008-10#3)(2010-7#1)(2011-2#2)(2012-2#2)
Agrobacterium radiobacter strain K84##2##4##(2008-10#2)
Agrobacterium radiobacter##3##2##(2008-10#3)
Agrobacterium tumefaciens cells##4##3##(2008-10#4)
Agrobacterium tumefaciens##10##2##(2008-10#7)(2008-9#1)(2011-2#2)
Agrobacterium tumefacients##2##2##(2008-10#2)
Agrobacterium vitis##3##2##(2008-10#3)
Agrobacterium##25##1##(2008-10#19)(2008-8#3)(2008-9#1)(2011-2#2)
Agrobacterium- mediated##2##2##(2008-8#2)
Agrobacterium-Mediated##2##1##(2008-10#2)
Agrobacterium-mediated transformation##2##2##(2008-10#1)(2011-1#1)
Agrobacterium-mediated##6##1##(2008-10#3)(2008-8#1)(2008-9#1)(2011-1#1)
Agropyron##3##1##(2008-12#1)(2008-9#2)
Ag|AgCl)##2##1##(2008-10#2)
Ah receptor in##2##3##(1992-12#1)(1993-12#1)
Ah receptor##6##2##(1992-12#2)(1993-12#2)(1995-11#1)(2008-10#1)
Ah##9##1##(1992-12#2)(1993-12#4)(1993-6#1)(1995-11#1)(2008-10#1)
AhR ligands##3##2##(2008-10#3)
AhR##9##1##(1993-6#2)(2008-10#7)
Ahvaz##4##1##(2008-12#3)(2013-1#1)
Aicardi syndrome##2##2##(2011-2#2)
Aid to Families with Dependent Children (AFDC)##2##7##(1996-1#1)(1996-12#1)
Aid to Families with Dependent Children##4##6##(1992-2#1)(1996-1#1)(1996-12#1)(1996-3#1)
Aid##6##1##(1992-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2012-12#1)(2013-1#1)
Aim of the present study##2##5##(2011-2#1)(2013-1#1)
Aim of the present##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
Aim of the study was to##2##6##(2008-12#1)(2012-3#1)
Aim of the study##3##4##(2008-12#1)(2012-3#2)
Aim of the##6##3##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
Aim of this study is##2##5##(2008-12#1)(2013-1#1)
Aim of this study was to evaluate##2##7##(2011-2#1)(2013-1#1)
Aim of this study was to##5##6##(2011-2#3)(2011-7#1)(2013-1#1)
Aim of this study##7##4##(2008-12#1)(2011-2#3)(2011-7#1)(2013-1#2)
Aim of this##9##3##(2008-10#1)(2008-12#1)(2011-2#4)(2011-7#1)(2013-1#2)
Aim of##17##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#5)(2011-7#1)(2012-3#3)(2013-1#3)
Aim##70##1##(1991-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2010-10#11)(2011-1#2)(2011-2#8)(2011-7#1)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#18)(2013-8#10)
Aiming at##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
Aiming to##3##2##(2008-10#3)
Aiming##6##1##(2008-10#3)(2011-2#1)(2012-3#1)(2013-8#1)
Aims and objectives##2##3##(2010-10#2)
Aims##7##1##(2010-10#3)(2013-1#4)
Ain Shams University hospitals and##2##5##(2008-10#2)
Ain Shams University hospitals##3##4##(2008-10#3)
Air##9##1##(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2010-4#1)(2012-3#1)(2012-6#1)
Airborne Lidar LEANDRE II for Water-Vapor Profiling in the Troposphere##2##10##(2008-3#2)
Airborne##11##1##(2008-10#4)(2008-3#5)(2012-7#1)(2013-1#1)
Airway##3##1##(1997-2#1)(2010-7#1)(2011-2#1)
Aitaiyin 2##2##2##(2008-9#2)
Akt##7##1##(2009-9#1)(2010-1#2)(2010-12#1)(2013-1#3)
Al amendment##3##2##(2008-10#3)
Al and Fe##2##3##(2008-10#2)
Al and##5##2##(2008-10#5)
Al by##2##2##(2008-10#2)
Al from##3##2##(2008-10#3)
Al g(-1) of medium##2##4##(2008-10#2)
Al g(-1)##3##2##(2008-10#2)(2009-8#1)
Al have been##2##3##(2008-10#2)
Al in hemodialysis solutions was##2##5##(2008-10#2)
Al in the##2##3##(2009-8#1)(2013-8#1)
Al in##11##2##(2008-10#9)(2009-8#1)(2013-8#1)
Al is##3##2##(2008-10#1)(2013-8#2)
Al species##5##2##(2008-10#5)
Al##120##1##(2008-10#104)(2008-7#1)(2009-6#1)(2009-7#2)(2009-8#5)(2013-8#7)
Al(2)(SO(4))(3) solution at##2##3##(2008-10#2)
Al(2)(SO(4))(3)##6##1##(2008-10#6)
Al(2)O(3)##3##1##(2008-10#3)
Al(2)O(3)-AChE biosensor##2##2##(2008-10#2)
Al(2)O(3)-CaSO(4)##4##1##(2008-10#4)
Al(3+) and##5##2##(2008-10#5)
Al(3+) ion##2##2##(2008-10#2)
Al(3+)##19##1##(2008-10#19)
Al(III) and Fe(III) were##2##4##(2008-10#2)
Al(III) and Fe(III)##8##3##(2008-10#8)
Al(III) and##15##2##(2008-10#15)
Al(III) in##3##2##(2008-10#3)
Al(III) ion##2##2##(2008-10#2)
Al(III)##38##1##(2008-10#38)
Al(OH)(4)(-)##3##1##(2008-10#3)
Al)##4##1##(2008-10#4)
Al-Hassa##2##1##(2008-12#2)
Al-Khadoud##2##1##(2008-12#2)
Al-citrate in##4##2##(2008-10#4)
Al-citrate##13##1##(2008-10#13)
Al-mediated suppression of plant pathogens##2##5##(2008-10#2)
Al-tetrabromophthalate##2##1##(2008-10#2)
Al-treated cells##3##2##(2009-6#3)
Al-treated##4##1##(2009-6#4)
Al2O3##4##1##(2008-2#1)(2008-3#3)
AlCl(3) and##2##2##(2008-10#1)(2008-11#1)
AlCl3##4##1##(1993-3#2)(2008-10#2)
AlGaAs##3##1##(2007-12#2)(2008-2#1)
AlMV##2##1##(2008-10#2)
Ala at##2##2##(1991-6#1)(1995-2#1)
Ala enzyme##6##2##(1995-6#6)
Ala##22##1##(1990-5#2)(1991-6#1)(1992-4#2)(1994-5#2)(1995-2#3)(1995-6#9)(2010-6#1)(2011-2#1)(2012-2#1)
Ala)##4##1##(1990-5#1)(1991-12#1)(1993-2#1)(1993-8#1)
Ala-##3##1##(1991-5#3)
Ala-Pro##2##1##(1992-6#1)(1994-11#1)
Ala147Thr SNP##3##2##(2012-2#3)
Ala147Thr##4##1##(2012-2#4)
Alabama##4##1##(1992-12#1)(1997-2#1)(2008-10#1)(2010-4#1)
Alamine 336##2##2##(2008-10#2)
Alan C##2##2##(1994-1#2)
Alanine aminotransferase##2##2##(2008-10#1)(2012-3#1)
Alanine##3##1##(2008-10#2)(2012-3#1)
Alaska##5##1##(1996-12#2)(2008-8#1)(2011-2#1)(2012-2#1)
Alaskan Native people infected with##2##5##(2013-1#2)
Alb method##3##2##(2008-7#3)
Albania##3##1##(2011-2#3)
Albanian immigration##2##2##(2008-10#2)
Albanian##8##1##(2008-10#5)(2008-12#1)(2011-2#2)
Albanians##2##1##(2008-10#2)
Alberta Health##2##2##(2012-12#1)(2012-2#1)
Alberta and Ontario##2##3##(1995-2#1)(2007-12#1)
Alberta and##3##2##(1995-2#1)(2007-12#1)(2008-11#1)
Alberta hospitals##2##2##(1995-12#1)(2012-12#1)
Alberta##29##1##(1992-12#5)(1992-3#1)(1993-12#5)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#2)(2007-12#1)(2008-10#2)(2008-11#3)(2012-12#6)(2012-2#1)
Alberta's##2##1##(2012-2#2)
Albino##3##1##(2008-10#1)(2008-11#1)(2012-3#1)
Alboaggregin-B##2##1##(1993-3#2)
Albright hereditary osteodystrophy (AHO)##2##4##(2010-6#1)(2011-1#1)
Albugo candida##3##2##(2008-10#3)
Albumin##4##1##(1991-12#1)(1992-9#1)(1995-2#1)(2008-5#1)
Alcaligenes##2##1##(2008-7#1)(2012-3#1)
Alcian##2##1##(1991-1#1)(2008-7#1)
Alcohol Screening##2##2##(2008-11#1)(2013-1#1)
Alcohol Use##2##2##(2010-9#1)(2013-8#1)
Alcohol consumption##2##2##(1991-8#1)(1995-11#1)
Alcohol is##2##2##(1990-8#1)(2009-7#1)
Alcohol sensing##2##2##(2008-10#2)
Alcohol use disorders are##2##4##(2009-12#1)(2012-3#1)
Alcohol use disorders##3##3##(2008-11#1)(2009-12#1)(2012-3#1)
Alcohol use##4##2##(2008-11#2)(2009-12#1)(2012-3#1)
Alcohol##32##1##(1990-8#1)(1991-1#1)(1991-8#1)(1992-6#1)(1995-11#1)(2008-10#6)(2008-11#7)(2009-12#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#5)
Alcoholic##3##1##(2009-7#1)(2012-12#1)(2012-3#1)
Alcohols##3##1##(1996-5#1)(2008-8#1)(2009-8#1)
Aldehyde##2##1##(2009-12#1)(2010-7#1)
Aldol##4##1##(1996-5#4)
Aldose reductase inhibitors##3##3##(1994-8#1)(2007-7#1)(2013-1#1)
Aldose reductase##5##2##(1994-8#1)(1996-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
Aldosterone##4##1##(1995-12#1)(2008-4#2)(2010-12#1)
Alert##7##1##(1991-12#2)(2008-11#3)(2008-6#1)(2008-8#1)
Alex##2##1##(2008-5#1)(2010-11#1)
Alexandria University##3##2##(2008-10#3)
Alexandria##5##1##(2008-10#4)(2013-8#1)
Alfalfa mosaic virus (AMV)##2##4##(2008-10#2)
Alfalfa mosaic virus in##4##4##(2008-10#4)
Alfalfa mosaic virus##9##3##(2008-10#9)
Alfalfa##14##1##(2008-10#14)
Alfred##3##1##(1991-3#1)(2008-7#2)
Alfredson##2##1##(1993-1#1)(1993-3#1)
Algeria##4##1##(2010-1#4)
Algerian##2##1##(2010-1#2)
Alginate pellets##2##2##(2008-10#2)
Algorithm for##3##2##(2008-10#1)(2011-10#1)(2013-1#1)
Algorithm##5##1##(2008-10#1)(2008-3#1)(2010-8#1)(2011-10#1)(2013-1#1)
Algorithms for##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
Algorithms##4##1##(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
Aligning Forces for Quality (AF4Q) alliances##2##6##(2013-1#2)
Aligning Forces for Quality (AF4Q) initiative is the##2##8##(2013-1#2)
Aligning Forces for Quality (AF4Q) initiative##3##6##(2013-1#3)
Aligning Forces for Quality (AF4Q)##5##5##(2013-1#5)
Aligning Forces for Quality##7##4##(2013-1#7)
Alignment of##2##2##(1990-11#1)(1992-3#1)
Alignment##7##1##(1990-11#1)(1992-3#1)(2008-10#1)(2008-4#1)(2008-9#2)(2013-1#1)
Aliphatic##3##1##(1996-5#2)(2008-11#1)
Aliquots of##2##2##(2008-10#2)
Alizarin Red S (ARS)##4##4##(2008-10#4)
Alizarin Red S in##2##4##(2008-10#2)
Alizarin Red S##12##3##(2008-10#10)(2008-11#2)
Alizarin Red##13##2##(2008-10#11)(2008-11#2)
Alizarin##14##1##(2008-10#12)(2008-11#2)
Alkaline##3##1##(2008-10#2)(2008-11#1)
Alkyl Radicals##2##2##(1996-5#2)
Alkyl##4##1##(1996-5#2)(2009-8#1)(2012-2#1)
All 15##2##2##(2011-1#1)(2012-3#1)
All 3##3##2##(2008-11#2)(2008-7#1)
All 62 patients##2##3##(2008-7#1)(2009-10#1)
All Kids Count##2##3##(1996-12#2)
All analyses##3##2##(1994-8#1)(2008-10#1)(2010-4#1)
All animals##5##2##(1993-1#1)(1996-12#1)(2007-12#1)(2008-7#1)(2008-9#1)
All but four##2##3##(1992-3#1)(1994-6#1)
All but one of the isolates##2##6##(2008-10#2)
All but one of the##7##5##(1992-3#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-11#1)
All but one##10##3##(1991-2#1)(1992-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-11#1)
All but two##2##3##(2008-10#1)(2008-9#1)
All but##14##2##(1991-2#1)(1992-3#2)(1994-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-9#2)(2009-11#1)
All cases were##2##3##(1991-8#1)(2008-11#1)
All cases##5##2##(1991-8#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
All chemical##2##2##(2008-10#2)
All clones##2##2##(2008-10#1)(2008-11#1)
All compounds##2##2##(1991-3#1)(2011-2#1)
All determinations were done##2##4##(2008-10#1)(2008-5#1)
All devices##2##2##(1992-3#1)(2008-9#1)
All eight##2##2##(2008-10#2)
All except##4##2##(1993-8#1)(1997-8#1)(2008-10#2)
All five patients##2##3##(2009-12#1)(2013-1#1)
All five##6##2##(1991-4#1)(2009-12#1)(2010-11#1)(2011-2#2)(2013-1#1)
All forms##2##2##(1990-5#1)(2009-10#1)
All four groups##2##3##(1993-3#1)(2008-10#1)
All four species##2##3##(2008-10#2)
All four##11##2##(1993-3#1)(2008-10#6)(2008-12#2)(2008-9#1)(2009-6#1)
All genotypes##2##2##(2008-10#2)
All groups##4##2##(1994-3#1)(2008-11#1)(2009-3#1)(2011-2#1)
All had##4##2##(2008-12#1)(2008-5#1)(2010-1#1)(2012-3#1)
All inoculated##2##2##(2008-10#2)
All isolates from##2##3##(2008-10#2)
All isolates in##2##3##(2008-10#2)
All isolates produced##4##3##(2008-10#4)
All isolates were##4##3##(2008-10#3)(2012-2#1)
All isolates##22##2##(2008-10#20)(2008-5#1)(2012-2#1)
All known##2##2##(1990-8#1)(2008-12#1)
All measurements##2##2##(2008-10#2)
All measures of##3##3##(2008-10#2)(2013-1#1)
All methods##2##2##(2008-10#2)
All of the patients##2##4##(1990-6#1)(2013-1#1)
All of the samples##2##4##(2008-11#1)(2008-12#1)
All of the three##2##4##(1996-5#1)(2011-2#1)
All of the variables have been optimized and the##2##9##(2008-10#2)
All of the##23##3##(1990-12#1)(1990-6#1)(1993-6#1)(1995-12#1)(1996-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
All of them##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
All of these disorders##2##4##(2008-6#2)
All of these##14##3##(1993-1#1)(1993-3#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-9#1)(2009-10#1)(2010-9#1)(2012-2#1)(2012-3#1)
All of##44##2##(1990-12#1)(1990-6#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-5#2)(1997-7#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
All other important analytical parameters were studied and practical applicability of the method has been verified by the analysis of some biological materials##2##23##(2008-10#2)
All other patients##2##3##(1991-11#1)(2011-2#1)
All other##7##2##(1991-11#1)(1993-8#1)(2008-10#2)(2009-9#1)(2011-2#2)
All participants underwent##2##3##(2011-2#1)(2012-3#1)
All participants##8##2##(1991-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-8#1)
All patients are##2##3##(1992-5#2)
All patients had##4##3##(1991-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
All patients have##2##3##(2007-8#2)
All patients in##2##3##(2008-5#1)(2012-3#1)
All patients survived##3##3##(1990-2#1)(1992-5#1)(2011-2#1)
All patients underwent##10##3##(1992-12#1)(1995-10#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#3)
All patients were followed##3##4##(1996-1#1)(2008-11#1)(2013-1#1)
All patients were treated with##3##5##(1995-2#1)(1997-3#1)(2008-12#1)
All patients were treated##5##4##(1991-8#1)(1995-2#1)(1997-3#1)(2008-12#1)(2012-3#1)
All patients were##26##3##(1991-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-3#1)(2006-6#1)(2008-11#2)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#5)(2012-3#3)(2013-1#3)(2013-7#1)
All patients with##3##3##(1995-10#1)(2008-10#1)(2008-7#1)
All patients##68##2##(1990-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-5#3)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-3#1)(1997-8#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#10)(2012-12#1)(2012-3#5)(2013-1#6)(2013-7#1)
All plants were##2##3##(2008-10#2)
All populations##2##2##(2008-10#2)
All rats##2##2##(2008-10#2)
All reagents##2##2##(2008-10#2)
All reflectance measurements were carried out##2##6##(2008-10#2)
All residents aged 40-42 were invited##2##6##(1991-6#2)
All respondents were##2##3##(2008-9#1)(2013-1#1)
All results obtained for##2##4##(2008-10#2)
All results obtained##3##3##(2008-10#3)
All results##4##2##(2008-10#4)
All samples were##2##3##(1992-12#1)(2008-10#1)
All samples##3##2##(1992-12#1)(2008-10#2)
All six isolates##2##3##(2008-10#1)(2008-5#1)
All six##5##2##(1997-8#1)(2008-10#3)(2008-5#1)
All species##3##2##(1996-1#1)(2012-2#1)(2012-5#1)
All specimens##2##2##(2007-12#1)(2009-7#1)
All strains grew##2##3##(2008-10#1)(2010-4#1)
All strains produced##2##3##(2008-10#2)
All strains were##5##3##(2008-10#5)
All strains##15##2##(2008-10#12)(2008-5#2)(2010-4#1)
All subjects underwent##2##3##(2008-7#1)(2011-2#1)
All subjects were examined##2##4##(2012-3#1)(2013-1#1)
All subjects were##4##3##(1993-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
All subjects##10##2##(1991-12#1)(1993-12#1)(2008-10#1)(2008-7#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
All ten##2##2##(1990-10#1)(2008-12#1)
All tested##7##2##(1995-12#2)(2008-10#3)(2009-9#1)(2010-1#1)
All tests##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
All the children##2##3##(2008-9#2)
All the compounds##3##3##(1994-8#1)(2008-10#2)
All the cultivars##2##3##(2008-10#2)
All the experimental parameters were optimized for the determination of##2##10##(2008-10#2)
All the experimental##3##3##(2008-10#3)
All the films were found to be amorphous##2##8##(2008-10#2)
All the images##2##3##(2008-3#1)(2012-3#1)
All the isolates were##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
All the isolates##5##3##(2008-10#2)(2008-5#1)(2011-2#2)
All the parameters##2##3##(2008-10#2)
All the patients were##2##4##(1993-1#1)(2013-7#1)
All the patients##7##3##(1992-5#1)(1993-1#1)(1995-11#1)(1997-8#1)(2007-8#1)(2012-3#1)(2013-7#1)
All the procedures were##2##4##(1996-3#1)(2011-3#1)
All the procedures##3##3##(1996-3#1)(2009-8#1)(2011-3#1)
All the results obtained##2##4##(2008-10#2)
All the results##6##3##(2008-10#2)(2008-8#3)(2012-3#1)
All the three##2##3##(2008-9#1)(2012-2#1)
All the variables##2##3##(2008-10#2)
All the##101##2##(1990-11#1)(1990-12#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#3)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#3)(1996-12#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#5)(2009-12#1)(2009-7#1)(2009-8#2)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
All these effects##2##3##(1990-6#1)(2008-10#1)
All these observations##2##3##(2008-10#1)(2009-10#1)
All these results##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)
All these##27##2##(1990-6#1)(1992-3#1)(1993-2#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2011-1#1)(2011-3#1)(2013-1#1)
All this##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
All three are##2##3##(2008-11#1)(2008-8#1)
All three had##2##3##(1991-12#1)(1997-5#1)
All three strains##2##3##(2008-10#2)
All three##27##2##(1991-12#1)(1993-6#1)(1993-8#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#8)(2008-11#2)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
All together##2##2##(1990-8#1)(2010-11#1)
All treatments were##2##3##(2008-10#1)(2008-12#1)
All treatments##4##2##(2008-10#3)(2008-12#1)
All types of##2##3##(1996-6#1)(2008-7#1)
All variables were##2##3##(2008-10#2)
All variables##3##2##(2008-10#2)(2009-7#1)
All were##5##2##(1991-11#1)(2008-10#1)(2008-12#1)(2010-7#1)(2013-8#1)
All##701##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#2)(1991-6#3)(1991-8#4)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#5)(1992-6#1)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#4)(1993-6#3)(1993-8#3)(1994-1#2)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#6)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#4)(1996-11#1)(1996-12#6)(1996-3#6)(1996-5#2)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#5)(2006-6#1)(2007-11#2)(2007-12#7)(2007-8#5)(2008-1#1)(2008-10#247)(2008-11#24)(2008-12#14)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#22)(2008-6#4)(2008-7#21)(2008-8#9)(2008-9#22)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#42)(2011-3#3)(2012-12#2)(2012-2#11)(2012-3#21)(2012-5#1)(2013-1#23)(2013-7#4)(2013-8#9)
All-solid-state##3##1##(2008-10#2)(2008-3#1)
Allan##2##1##(1996-5#1)(2008-3#1)
Allee effect##10##2##(2008-10#4)(2008-8#6)
Allee effects##4##2##(2008-8#1)(2008-9#3)
Allee##16##1##(2008-10#5)(2008-8#8)(2008-9#3)
Allele frequencies for##2##3##(2008-12#2)
Allele frequencies##5##2##(2008-10#1)(2008-12#4)
Allele##11##1##(2008-10#3)(2008-12#5)(2010-12#1)(2011-2#1)(2012-3#1)
Alleles##5##1##(2008-10#4)(2012-3#1)
Allelic##7##1##(1995-12#1)(1997-9#1)(2008-10#4)(2008-7#1)
Allergen##2##1##(2008-11#1)(2012-2#1)
Allergens##2##1##(1994-9#1)(2013-1#1)
Allergic Rhinitis and##2##3##(2012-12#2)
Allergic rhinitis is a##2##4##(2012-12#2)
Allergic rhinitis##5##2##(2011-2#1)(2012-12#4)
Allergic##9##1##(2011-2#2)(2012-12#6)(2013-1#1)
Allergy and##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
Allergy to##3##2##(1990-6#1)(1991-6#1)(2011-2#1)
Allergy##11##1##(1990-6#1)(1991-6#1)(2008-8#1)(2011-2#2)(2012-12#4)(2013-1#2)
Alliance in##2##2##(1997-1#1)(2013-1#1)
Alliance##6##1##(1994-12#1)(1997-1#2)(2008-10#1)(2008-4#1)(2013-1#1)
Alliances were##2##2##(2013-1#2)
Alliances##6##1##(2013-1#6)
Alliant Health System##2##3##(1994-2#2)
Alliant##5##1##(1994-2#5)
Allied Force&quot##2##2##(2008-11#2)
Allied Healthcare Products##2##3##(2011-1#2)
Allied##7##1##(2008-11#2)(2011-1#3)(2013-1#2)
Allison##2##1##(1992-1#1)(2008-7#1)
Allium cepa##2##2##(1993-12#2)
Allium spp##4##2##(2008-10#4)
Allium##10##1##(1993-12#2)(2008-10#8)
AlloMap molecular expression##2##3##(2008-10#2)
AlloMap test classifier##2##3##(2008-10#2)
AlloMap test##4##2##(2008-10#4)
AlloMap##6##1##(2008-10#6)
Allocating##2##1##(1994-1#1)(2008-10#1)
Allocation##2##1##(2008-10#1)(2008-9#1)
Allodynia##2##1##(2008-9#1)(2011-2#1)
Allogeneic##4##1##(2008-11#1)(2012-3#1)(2013-1#2)
Allograft bone##2##2##(1996-3#1)(2009-10#1)
Allograft##5##1##(1996-3#1)(2009-10#1)(2010-5#1)(2012-3#1)(2013-1#1)
Allonemobius##2##1##(2008-8#2)
Alloy and colleagues'##2##3##(2010-7#2)
Alloy##4##1##(1996-9#1)(2009-7#1)(2010-7#2)
Allura red and Ponceau 4R##2##5##(2008-10#2)
Allura red##3##2##(2008-10#3)
Allura##4##1##(2008-10#4)
Allylic##2##1##(1996-5#2)
Almond##5##1##(2008-10#5)
Almost all of##5##3##(1997-2#1)(2008-10#2)(2008-7#1)(2012-12#1)
Almost all##18##2##(1991-12#1)(1992-6#3)(1997-2#1)(2008-10#7)(2008-7#2)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
Almost##29##1##(1991-12#1)(1992-6#3)(1993-1#1)(1997-2#2)(2008-10#9)(2008-11#2)(2008-7#3)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Along these##2##2##(1992-2#1)(2008-11#1)
Along with a##2##3##(1996-12#1)(2012-2#1)
Along with the##4##3##(1993-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
Along with##9##2##(1993-12#1)(1994-12#1)(1996-12#1)(2008-11#3)(2008-3#1)(2011-2#1)(2012-2#1)
Along##13##1##(1992-2#1)(1993-12#1)(1994-12#1)(1996-12#1)(2008-11#4)(2008-3#2)(2011-2#1)(2012-2#1)(2013-8#1)
Alopecia##2##1##(2010-6#1)(2012-3#1)
Alpha and##3##2##(1990-2#1)(1991-12#1)(2008-10#1)
Alpha##13##1##(1990-2#1)(1991-12#2)(1996-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-8#1)
AlphaSeal##2##1##(2013-1#2)
Alpine##3##1##(2008-10#2)(2012-6#1)
Alpinia katsumadai (IC50##2##3##(2008-5#2)
Alps##4##1##(2008-11#3)(2012-6#1)
Already##2##1##(1997-6#1)(2008-3#1)
Also adding##2##2##(2008-10#1)(2008-12#1)
Also discussed are##2##3##(1992-12#1)(2008-3#1)
Also in##3##2##(2008-10#2)(2013-1#1)
Also included in##2##3##(2008-10#2)
Also included is a discussion of##2##6##(2008-9#2)
Also included is an##2##4##(1992-1#1)(2008-4#1)
Also included is##4##3##(1992-1#1)(2008-4#1)(2008-9#2)
Also included##7##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)
Also of##2##2##(1997-4#1)(2007-12#1)
Also presented is##2##3##(1990-8#1)(2008-7#1)
Also presented##3##2##(1990-8#1)(2008-4#1)(2008-7#1)
Also provided is a##2##4##(2008-4#2)
Also the degraded products were well##2##6##(2008-10#2)
Also the##22##2##(1990-9#1)(1991-6#1)(1995-11#1)(2008-10#12)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
Also we##3##2##(2008-11#2)(2009-3#1)
Also##230##1##(1990-8#2)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-5#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-2#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-8#3)(2007-12#2)(2008-1#2)(2008-10#82)(2008-11#14)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#4)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#14)(2012-2#6)(2013-1#12)(2013-7#2)(2013-8#3)
Alström syndrome##2##2##(2011-1#2)
Alter##2##1##(2008-10#2)
Alteration of the##2##3##(1993-3#1)(2010-9#1)
Alteration of##7##2##(1992-5#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-9#1)
Alterations in the##2##3##(1991-1#1)(1996-2#1)
Alterations in##11##2##(1990-2#1)(1991-1#1)(1991-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#1)(2009-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
Alterations of##8##2##(1991-12#1)(1992-12#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)
Alterations that##2##2##(1994-8#1)(2008-2#1)
Alterations##24##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
Altered expression of##2##3##(1996-12#1)(2011-2#1)
Altered##10##1##(1993-1#1)(1993-12#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-3#2)
Alternanthera tenella##2##2##(2008-10#2)
Alternaria alternata##22##2##(2008-10#22)
Alternaria brown spot##3##3##(2008-10#3)
Alternaria citri##11##2##(2008-10#11)
Alternaria dauci##2##2##(2008-10#2)
Alternaria isolates were##2##3##(2008-10#2)
Alternaria isolates##3##2##(2008-10#3)
Alternaria leaf##2##2##(2008-10#2)
Alternaria solani##4##2##(1992-8#1)(2008-10#3)
Alternaria species##2##2##(2008-10#2)
Alternaria spp##12##2##(2008-10#10)(2013-1#2)
Alternaria##73##1##(1992-8#1)(2008-10#67)(2008-5#2)(2010-5#1)(2013-1#2)
Alternate Protocol##4##2##(2008-4#2)(2008-9#2)
Alternate protocols describe##2##3##(2008-4#2)
Alternate protocols##4##2##(2008-4#3)(2008-9#1)
Alternate##11##1##(1991-12#1)(1993-12#1)(2008-10#1)(2008-4#5)(2008-9#3)
Alternating##3##1##(2008-10#1)(2008-11#1)(2010-9#1)
Alternative geographic##2##2##(1991-1#1)(1993-1#1)
Alternative medicine##2##2##(1993-12#1)(2011-2#1)
Alternative##22##1##(1991-1#1)(1992-12#2)(1993-1#1)(1993-12#2)(1993-6#2)(1995-2#1)(1996-3#1)(1997-2#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
Alternatively##29##1##(1990-12#1)(1990-2#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-12#1)(1996-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-4#4)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-3#1)(2013-8#2)
Alternatives for##2##2##(1991-1#1)(2008-12#1)
Alternatives##4##1##(1991-1#1)(1993-11#1)(1997-7#1)(2008-12#1)
Alters##2##1##(2008-10#2)
Although HIV##2##2##(1996-11#1)(1996-5#1)
Although UV##2##2##(2008-10#1)(2010-4#1)
Although a high##2##3##(1992-12#1)(1997-8#1)
Although a large##2##3##(1992-3#1)(2008-8#1)
Although a variety of##2##4##(2008-9#1)(2010-8#1)
Although a##19##2##(1991-12#1)(1992-12#1)(1992-3#1)(1995-8#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
Although all of the##2##4##(2008-10#1)(2012-3#1)
Although all three##2##3##(2008-10#1)(2011-2#1)
Although all##12##2##(1995-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#2)
Although almost##2##2##(2008-10#1)(2008-11#1)
Although an##6##2##(1993-3#1)(1995-12#1)(2008-10#1)(2008-8#1)(2011-2#2)
Although application of##2##3##(2008-10#2)
Although bats##2##2##(2013-1#2)
Although both##4##2##(1992-6#1)(2008-10#3)
Although commonly##2##2##(1991-7#1)(2008-10#1)
Although considerable##2##2##(1995-1#1)(2008-10#1)
Although different##2##2##(2009-9#1)(2010-10#1)
Although efforts##2##2##(2007-9#1)(2008-10#1)
Although evidence##2##2##(1993-3#1)(2008-10#1)
Although females##2##2##(2008-10#1)(2008-8#1)
Although few##2##2##(2008-10#2)
Although for a##2##3##(2008-10#1)(2008-5#1)
Although future##2##2##(1994-1#1)(2008-7#1)
Although heat##2##2##(1996-12#1)(2008-11#1)
Although imaging##2##2##(2008-7#1)(2011-7#1)
Although in recent years##2##4##(2008-9#1)(2013-1#1)
Although in##5##2##(1993-1#1)(2007-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
Although incubation##2##2##(1995-11#1)(2008-10#1)
Although infection##2##2##(2007-12#1)(2008-5#1)
Although it has been suggested that##2##6##(2008-8#1)(2010-11#1)
Although it has been##3##4##(2008-11#1)(2008-8#1)(2010-11#1)
Although it is recognized that##2##5##(2008-10#1)(2008-5#1)
Although it is##10##3##(1995-1#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-4#1)(2011-2#1)
Although it##16##2##(1992-2#1)(1994-12#1)(1995-1#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2010-11#1)(2010-4#1)(2011-2#1)
Although many of##2##3##(2008-10#1)(2010-12#1)
Although many##11##2##(1991-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#2)(2010-12#1)(2013-1#2)
Although microscopic##2##2##(2008-10#1)(2011-2#1)
Although molecular##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
Although most of the##2##4##(2008-10#1)(2008-11#1)
Although most of##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
Although most##5##2##(1996-2#1)(2008-10#1)(2008-11#2)(2013-1#1)
Although much##2##2##(2008-10#1)(2012-2#1)
Although no##5##2##(1991-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
Although not##7##2##(1996-2#1)(1997-3#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)
Although numerous##2##2##(1991-2#1)(1995-1#1)
Although nursing##2##2##(2008-11#1)(2008-12#1)
Although oral##2##2##(2008-11#1)(2011-2#1)
Although other##2##2##(2008-10#2)
Although our##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
Although patients with##2##3##(1992-12#1)(1996-2#1)
Although previous studies have##2##4##(2008-9#1)(2010-8#1)
Although primarily##2##2##(1995-2#1)(2008-10#1)
Although rare##2##2##(2008-7#1)(2009-12#1)
Although recombinant##2##2##(1995-2#1)(2008-10#1)
Although relatively##2##2##(2008-10#1)(2011-2#1)
Although several##8##2##(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#2)(2012-3#1)
Although similar##2##2##(1997-3#1)(2008-10#1)
Although some of these##2##4##(1997-7#1)(2012-2#1)
Although some strains##2##3##(2008-10#1)(2012-3#1)
Although some##14##2##(1991-3#1)(1993-1#1)(1993-12#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#2)
Although still##2##2##(1991-1#1)(2011-7#1)
Although strain##2##2##(2008-10#2)
Although such##2##2##(2008-10#1)(2008-11#1)
Although surgery##2##2##(1995-5#1)(2008-9#1)
Although the achievement of##2##4##(1994-3#1)(2009-7#1)
Although the amino acid##2##4##(1992-10#1)(2008-10#1)
Although the data##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
Although the derived##2##3##(2007-12#1)(2008-10#1)
Although the exact##3##3##(1991-3#1)(2008-11#1)(2008-7#1)
Although the findings##2##3##(1991-12#1)(2008-11#1)
Although the imaging##2##3##(2012-2#2)
Although the importance of##2##4##(2008-11#1)(2008-12#1)
Although the influence of##2##4##(2008-9#2)
Although the majority of##4##4##(2008-10#2)(2012-2#1)(2013-8#1)
Although the majority##5##3##(2008-10#2)(2008-12#1)(2012-2#1)(2013-8#1)
Although the mean##2##3##(2008-1#1)(2011-1#1)
Although the mechanism##2##3##(2008-10#2)
Although the molecular##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
Although the most##2##3##(2008-12#1)(2011-2#1)
Although the patient was##2##4##(1994-12#1)(2013-1#1)
Although the patient##3##3##(1992-3#1)(1994-12#1)(2013-1#1)
Although the present##3##3##(2008-10#2)(2011-2#1)
Although the results##2##3##(2008-10#1)(2009-12#1)
Although the risk##2##3##(2008-1#1)(2012-3#1)
Although the sexual##2##3##(1996-11#1)(2012-2#1)
Although the use of##4##4##(1993-12#1)(1994-1#1)(2011-2#1)(2012-3#1)
Although the##195##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#38)(2008-11#17)(2008-12#4)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#9)(2008-8#6)(2008-9#6)(2009-10#2)(2009-12#2)(2009-3#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-12#3)(2012-2#4)(2012-3#4)(2012-6#1)(2013-1#5)(2013-8#3)
Although their##3##2##(1995-12#1)(2008-8#1)(2012-2#1)
Although there are several##3##4##(1996-2#1)(2008-10#1)(2008-9#1)
Although there are##6##3##(1996-2#1)(2008-10#2)(2008-9#1)(2010-8#1)(2011-2#1)
Although there has been##3##4##(1992-1#1)(2008-10#1)(2012-3#1)
Although there is a considerable##2##5##(1997-8#1)(2010-9#1)
Although there is a##3##4##(1997-8#1)(2010-8#1)(2010-9#1)
Although there is no##2##4##(2008-8#2)
Although there is##15##3##(1990-2#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Although there was no##2##4##(2008-10#1)(2011-2#1)
Although there was##5##3##(1993-8#1)(2008-10#2)(2010-7#1)(2011-2#1)
Although there##33##2##(1990-2#1)(1992-1#1)(1993-8#1)(1994-12#1)(1996-2#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
Although these results##2##3##(1993-3#1)(2008-10#1)
Although these##17##2##(1990-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
Although they##3##2##(1996-9#1)(2008-10#1)(2012-3#1)
Although this is##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
Although this study##3##3##(2008-12#1)(2011-2#2)
Although this##26##2##(1991-1#1)(1994-2#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
Although traumatic##3##2##(2008-12#1)(2008-7#1)(2011-2#1)
Although uncommon##2##2##(2010-12#1)(2011-2#1)
Although various##2##2##(2008-11#1)(2011-2#1)
Although very##2##2##(1995-1#1)(2008-9#1)
Although viral##2##2##(2008-10#1)(2010-11#1)
Although we have##2##3##(1991-12#1)(2008-12#1)
Although we##5##2##(1991-12#1)(2008-12#1)(2008-3#2)(2012-2#1)
Although with##2##2##(1994-8#1)(2008-10#1)
Although##807##1##(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#3)(1991-12#6)(1991-2#7)(1991-3#4)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#6)(1992-2#4)(1992-3#6)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#7)(1993-8#3)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#4)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#6)(1995-11#2)(1995-12#3)(1995-2#10)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#10)(1996-3#7)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#11)(1997-4#2)(1997-7#5)(1997-8#6)(2007-11#2)(2007-12#5)(2007-9#1)(2008-1#6)(2008-10#171)(2008-11#53)(2008-12#18)(2008-2#1)(2008-3#11)(2008-4#7)(2008-5#12)(2008-6#1)(2008-7#32)(2008-8#36)(2008-9#22)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#4)(2009-3#5)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#6)(2010-10#3)(2010-11#4)(2010-12#8)(2010-3#5)(2010-4#4)(2010-5#5)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#7)(2011-2#50)(2011-7#2)(2012-12#5)(2012-2#26)(2012-3#22)(2012-6#1)(2012-9#1)(2013-1#30)(2013-8#11)
Althoughthe##2##1##(2008-11#2)
Altman##9##1##(1994-12#3)(1997-1#1)(2008-11#3)(2008-12#2)
Altogether##16##1##(1991-3#1)(1995-6#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Altruism##3##1##(2008-8#3)
Alu family##2##2##(1991-5#2)
Alu repeat##3##2##(1991-2#1)(1993-12#1)(1993-2#1)
Alu sequence##2##2##(1993-2#1)(1997-2#1)
Alu sequences##2##2##(1991-5#2)
Alu##13##1##(1991-2#1)(1991-5#7)(1993-12#2)(1993-2#2)(1997-2#1)
AluI##6##1##(1995-12#1)(2008-10#5)
Aluminium##5##1##(2008-10#4)(2013-8#1)
Aluminum##6##1##(1995-5#1)(2008-10#3)(2009-6#1)(2011-2#1)
Alumni Association##2##2##(2008-8#2)
Alveolar macrophages##2##2##(1993-3#1)(2008-12#1)
Alveolar##4##1##(1990-2#1)(1993-3#1)(1994-3#1)(2008-12#1)
Alzheimer amyloid precursor protein##2##4##(1993-8#2)
Alzheimer amyloid protein precursor##2##4##(1994-11#2)
Alzheimer amyloid##4##2##(1993-8#2)(1994-11#2)
Alzheimer disease (AD)##2##3##(1997-2#1)(2008-7#1)
Alzheimer disease##6##2##(1997-2#2)(2008-7#1)(2010-6#1)(2011-2#1)(2013-7#1)
Alzheimer##19##1##(1992-12#1)(1992-6#2)(1993-2#1)(1993-8#2)(1994-11#2)(1996-11#1)(1997-2#2)(2008-7#3)(2010-4#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
Alzheimer's Disease##5##2##(1992-12#2)(2008-4#1)(2011-2#1)(2011-3#1)
Alzheimer's and##2##2##(1993-1#1)(1996-2#1)
Alzheimer's dementia##3##2##(1990-11#1)(1992-1#1)(1996-11#1)
Alzheimer's disease (AD) and##2##4##(1995-12#1)(2008-5#1)
Alzheimer's disease (AD) is##2##4##(2008-7#1)(2011-2#1)
Alzheimer's disease (AD)##18##3##(1991-1#1)(1992-12#1)(1995-12#1)(1995-8#1)(1996-2#2)(2008-5#2)(2008-6#2)(2008-7#5)(2009-10#1)(2011-2#2)
Alzheimer's disease and vascular##2##4##(1993-2#1)(2008-7#1)
Alzheimer's disease and##4##3##(1993-2#1)(2008-7#2)(2013-1#1)
Alzheimer's disease in##4##3##(1992-12#1)(1995-8#1)(2008-6#1)(2008-7#1)
Alzheimer's disease is##2##3##(1996-12#1)(2013-1#1)
Alzheimer's disease post-mortem##2##3##(1996-12#2)
Alzheimer's disease##81##2##(1991-1#2)(1991-10#2)(1991-7#2)(1992-12#5)(1992-2#2)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-12#3)(1995-3#1)(1995-8#4)(1996-12#10)(1996-2#3)(1996-8#1)(2008-10#1)(2008-11#3)(2008-5#5)(2008-6#3)(2008-7#18)(2009-10#1)(2009-9#1)(2011-2#2)(2011-3#2)(2013-1#4)(2013-8#2)
Alzheimer's disease?##2##2##(2008-8#1)(2009-10#1)
Alzheimer's disease]##3##2##(1991-8#1)(1997-5#1)(2013-8#1)
Alzheimer's type##2##2##(2008-6#2)
Alzheimer's##108##1##(1990-11#1)(1991-1#2)(1991-10#2)(1991-3#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-12#8)(1992-2#4)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-12#3)(1995-3#2)(1995-8#4)(1996-11#2)(1996-12#11)(1996-2#5)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#19)(2008-8#1)(2009-10#2)(2009-9#1)(2011-2#3)(2011-3#3)(2013-1#4)(2013-8#3)
Am and Cm##3##3##(2008-10#3)
Am and##4##2##(2008-10#4)
Am##17##1##(1992-4#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2010-1#1)(2010-7#1)
Am(III)##4##1##(2008-10#4)
AmB interacts with##2##3##(1997-2#2)
AmB is##3##2##(1997-2#3)
AmB##9##1##(1997-2#9)
Amanita phalloides##2##2##(1991-11#2)
Amanita##3##1##(1991-11#2)(2008-10#1)
Amantadine##5##1##(1991-1#1)(1992-3#1)(1997-2#2)(2011-2#1)
Amaranth##2##1##(2008-10#1)(2008-11#1)
Amaranthaceae##4##1##(2008-10#4)
Amaranthus##2##1##(2008-11#1)(2013-1#1)
Amaurosis##2##1##(2011-2#2)
Amavadin##4##1##(2008-10#4)
Amberlite IR 120##2##3##(2008-10#2)
Amberlite IRC 718##2##3##(2008-10#2)
Amberlite IRC 76 and##2##4##(2008-10#2)
Amberlite IRC##4##2##(2008-10#4)
Amberlite IRC-718##2##2##(2008-10#2)
Amberlite XAD-16 (AXAD-16)##2##3##(2008-10#2)
Amberlite XAD-16 resin##4##3##(2008-10#4)
Amberlite XAD-16##13##2##(2008-10#13)
Amberlite XAD-2 functionalized with##2##4##(2008-10#2)
Amberlite XAD-2 loaded with##2##4##(2008-10#2)
Amberlite XAD-2 resin loaded with PAN##2##6##(2008-10#2)
Amberlite XAD-2 resin loaded with##4##5##(2008-10#4)
Amberlite XAD-2 resin##8##3##(2008-10#8)
Amberlite XAD-2##20##2##(2008-10#20)
Amberlite XAD-4 as a##2##4##(2008-10#2)
Amberlite XAD-4 coated with##2##4##(2008-10#2)
Amberlite XAD-4 coated##3##3##(2008-10#3)
Amberlite XAD-4 resin##4##3##(2008-10#4)
Amberlite XAD-4##16##2##(2008-10#16)
Amberlite XAD-7##4##2##(2008-10#4)
Amberlite##71##1##(1992-12#1)(2008-10#70)
Amberlyst 36##3##2##(2008-10#3)
Ambrosiella sp##2##2##(2008-10#2)
Ambulatory##6##1##(1993-3#1)(1994-3#1)(1995-2#3)(1997-1#1)
Amended with##2##2##(2008-10#2)
Amended##3##1##(2008-10#3)
Amending##2##1##(2008-10#2)
Amendment##12##1##(1993-12#2)(1995-6#1)(2008-10#4)(2011-2#5)
Amendments of##4##2##(1993-1#2)(1995-3#1)(1997-2#1)
Amendments##8##1##(1993-1#2)(1994-2#1)(1995-3#1)(1997-2#2)(2008-10#1)(2013-1#1)
America and the##4##3##(1991-3#1)(2008-11#1)(2008-2#1)(2008-5#1)
America and##26##2##(1991-3#1)(1992-1#1)(1997-1#1)(1997-7#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-10#1)(2011-2#1)(2012-2#1)
America because of##2##3##(2008-10#1)(2008-11#1)
America for##2##2##(1992-5#1)(2008-10#1)
America have##4##2##(2008-11#2)(2008-8#1)(2012-2#1)
America was##3##2##(1992-5#1)(2008-10#2)
America where##2##2##(1993-3#1)(2008-10#1)
America##155##1##(1990-6#2)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#81)(2008-11#14)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#8)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-10#1)(2011-2#5)(2011-9#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
America's##2##1##(1993-3#1)(1995-12#1)
American Academy of##7##3##(1996-6#2)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
American College of Healthcare Executives and##2##6##(1991-1#1)(1994-12#1)
American College of##9##3##(1991-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(2008-3#1)(2009-6#1)(2010-12#1)(2013-1#1)
American Health##4##2##(1992-5#1)(1994-1#1)(1994-9#1)(2013-1#1)
American Heart Association##8##3##(1996-6#2)(2008-11#1)(2008-3#1)(2009-5#1)(2010-1#1)(2010-9#1)(2012-12#1)
American Heart##9##2##(1996-6#2)(2008-11#1)(2008-3#2)(2009-5#1)(2010-1#1)(2010-9#1)(2012-12#1)
American Hospital Association##5##3##(1991-12#1)(1992-2#2)(2008-11#2)
American Indian##7##2##(1996-2#1)(1997-1#1)(2008-8#1)(2011-2#2)(2013-8#2)
American Indians##2##2##(2011-2#1)(2013-8#1)
American Life##2##2##(1995-6#1)(2010-10#1)
American Medical Association##3##3##(1991-8#2)(1992-12#1)
American Orthopaedic Foot and Ankle Society (AOFAS)##2##7##(2008-8#1)(2009-10#1)
American Orthopaedic Foot and Ankle Society##3##6##(2008-8#1)(2009-10#2)
American Phytopathological Society##3##3##(2008-10#3)
American Society for##4##3##(1997-7#1)(2010-10#1)(2011-2#2)
American Society of Anesthesiologists##2##4##(2008-7#1)(2009-3#1)
American Society of Clinical Oncology##4##5##(2008-7#2)(2010-11#1)(2013-1#1)
American Society of Clinical##5##4##(2008-7#2)(2009-4#1)(2010-11#1)(2013-1#1)
American Society of Hematology##3##4##(2008-7#1)(2009-4#1)(2010-11#1)
American Society of##12##3##(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#2)(2010-11#2)(2013-1#2)
American Society##16##2##(1997-7#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-11#2)(2011-2#2)(2013-1#2)
American Type Culture Collection##2##4##(2008-12#1)(2008-5#1)
American adolescents##2##2##(2009-7#2)
American and European##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
American and##10##2##(1996-3#1)(2008-10#1)(2008-12#2)(2008-6#1)(2010-10#2)(2012-12#1)(2012-3#1)(2013-1#1)
American center of origin##2##4##(2008-10#1)(2011-2#1)
American children##6##2##(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#2)
American college of##3##3##(1997-8#1)(2009-6#1)(2012-3#1)
American countries##5##2##(1992-5#2)(2008-10#1)(2011-2#1)(2013-1#1)
American ginseng##3##2##(2008-10#3)
American health care##7##3##(1992-12#2)(1992-2#1)(1994-1#1)(1995-12#1)(1997-3#1)(2012-3#1)
American health##8##2##(1992-12#2)(1992-2#1)(1993-2#1)(1994-1#1)(1995-12#1)(1997-3#1)(2012-3#1)
American isolates##4##2##(2008-10#4)
American parents##2##2##(2010-10#2)
American physicians##2##2##(2008-11#1)(2010-8#1)
American population##3##2##(2008-10#1)(2008-9#1)(2010-10#1)
American populations##3##2##(2008-10#2)(2008-12#1)
American psychology##2##2##(1994-12#2)
American society of##2##3##(2009-9#1)(2012-2#1)
American students##2##2##(2008-12#2)
American women##3##2##(2008-9#1)(2009-11#1)(2011-2#1)
American##304##1##(1990-5#1)(1991-1#6)(1991-12#4)(1991-2#3)(1991-3#2)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#3)(1992-5#4)(1993-12#4)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#6)(1994-2#2)(1994-9#1)(1995-12#2)(1995-6#5)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#4)(1997-1#3)(1997-3#2)(1997-7#1)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#10)(2008-12#13)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#7)(2008-7#6)(2008-8#6)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#22)(2009-6#2)(2009-7#9)(2009-9#1)(2010-1#4)(2010-10#12)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#3)(2011-2#35)(2012-12#3)(2012-2#4)(2012-3#8)(2013-1#7)(2013-8#4)
American)##4##1##(2008-10#2)(2009-7#1)(2010-7#1)
Americans With Disabilities Act##5##4##(1991-12#2)(1994-1#2)(1995-1#1)
Americans are##2##2##(1996-3#1)(2008-12#1)
Americans in##3##2##(1993-1#1)(1994-9#1)(2011-2#1)
Americans with Disabilities Act##22##4##(1991-12#1)(1992-12#1)(1993-1#3)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)
Americans with Disabilities##23##3##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)
Americans with##29##2##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#3)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-1#1)(2010-4#4)
Americans##76##1##(1991-12#3)(1991-3#1)(1992-12#1)(1992-6#1)(1993-1#4)(1993-12#1)(1993-3#3)(1994-1#5)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#6)(1995-6#2)(1996-1#2)(1996-12#2)(1996-3#3)(1996-5#2)(1997-1#1)(2008-12#3)(2008-3#2)(2009-9#1)(2010-10#5)(2010-12#1)(2010-4#5)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
Americans'##2##1##(1993-3#1)(2009-5#1)
Americas and##3##2##(1994-9#1)(2008-10#2)
Americas##9##1##(1994-9#2)(2008-10#7)
Amerindians##2##1##(2008-12#1)(2008-5#1)
Ames##4##1##(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)
Amides##2##1##(1996-5#1)(2010-8#1)
Amiloride##3##1##(1991-6#1)(2008-10#2)
Amines##2##1##(1991-5#1)(1996-5#1)
Amino Acid Substitutions in the##2##5##(2008-10#1)(2012-3#1)
Amino Acids##3##2##(1996-5#1)(2008-11#2)
Amino acid analysis##4##3##(1990-11#1)(1990-2#1)(1994-8#1)(2008-10#1)
Amino acid sequence analysis##2##4##(1994-11#1)(1994-5#1)
Amino acid sequence##4##3##(1991-10#1)(1994-11#1)(1994-5#1)(2008-10#1)
Amino acid sequences of##2##4##(1995-6#1)(2008-10#1)
Amino acid sequences##4##3##(1991-5#1)(1995-6#1)(2008-10#1)(2008-11#1)
Amino acid##17##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-10#1)(1991-5#1)(1991-7#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)
Amino acids##4##2##(1992-11#1)(1995-2#1)(2008-11#2)
Amino##27##1##(1990-11#1)(1990-12#2)(1990-2#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-8#1)(2008-10#4)(2008-11#5)(2008-5#1)(2012-3#1)
Aminobacterium colombiense##2##2##(2011-2#2)
Aminobacterium##4##1##(2011-2#4)
Aminoglycosides##2##1##(2009-8#1)(2011-2#1)
Amlodipine##2##1##(2008-10#1)(2008-6#1)
Ammonia and##2##2##(2008-10#2)
Ammonia##10##1##(2008-10#5)(2008-11#3)(2008-3#2)
Ammonia-forming cytochrome c nitrite reductase from Sulfurospirillum deleyianum##2##8##(1994-11#2)
Ammonium##14##1##(1990-11#1)(1996-5#1)(1997-1#1)(2008-10#10)(2008-11#1)
Amniocentesis##2##1##(2012-3#2)
Amniotic##2##1##(2011-2#1)(2012-3#1)
Among Adolescent##2##2##(2013-1#2)
Among HIV-Infected##2##2##(2011-2#2)
Among Isolates of##4##3##(2008-10#4)
Among Populations of##2##3##(2008-10#2)
Among Strains of##3##3##(2008-10#3)
Among a##3##2##(1995-11#1)(2008-10#1)(2012-12#1)
Among all the##2##3##(2011-2#1)(2012-2#1)
Among all##6##2##(1990-6#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
Among individuals with diabetes##2##4##(2013-1#2)
Among many##2##2##(2007-8#1)(2011-2#1)
Among other##3##2##(1995-2#1)(1997-8#1)(2010-7#1)
Among others##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
Among our specimens##2##3##(2013-1#2)
Among patients with##6##3##(1991-11#1)(1993-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
Among patients##9##2##(1990-12#1)(1991-11#1)(1993-1#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
Among six##2##2##(2008-7#1)(2008-8#1)
Among subjects with##2##3##(2008-7#1)(2012-3#1)
Among teens##2##2##(2013-1#2)
Among the 42##3##3##(1990-2#1)(1990-6#2)
Among the different##2##3##(2008-10#2)
Among the eight##2##3##(2008-10#2)
Among the four##2##3##(1994-8#1)(2008-10#1)
Among the genes##2##3##(1996-2#1)(2012-3#1)
Among the isolates in VCG##2##5##(2008-10#2)
Among the many##2##3##(2008-10#1)(2010-12#1)
Among the most##3##3##(2008-10#1)(2009-10#1)(2011-3#1)
Among the numerous##2##3##(2008-10#1)(2008-11#1)
Among the several##2##3##(1991-5#1)(2008-12#1)
Among the three##3##3##(2008-10#3)
Among the##99##2##(1990-2#1)(1990-6#3)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#3)(1996-3#2)(1996-6#2)(1997-4#1)(2007-11#1)(2008-10#30)(2008-11#2)(2008-12#2)(2008-5#4)(2008-7#4)(2008-8#1)(2009-10#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#3)
Among them the##2##3##(2011-1#1)(2011-2#1)
Among them##29##2##(1990-6#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#3)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Among these factors##2##3##(1995-11#1)(2012-2#1)
Among these isolates##2##3##(2008-10#2)
Among these##23##2##(1991-9#1)(1992-3#1)(1994-12#1)(1995-11#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#3)
Among those##2##2##(2008-10#2)
Among various##3##2##(1990-6#1)(2008-5#1)(2012-3#1)
Among women##3##2##(1990-6#1)(2009-5#1)(2013-8#1)
Among##302##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#7)(1990-8#1)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-9#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#90)(2008-11#16)(2008-12#2)(2008-5#8)(2008-7#11)(2008-8#7)(2008-9#5)(2009-10#5)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#13)(2011-3#2)(2012-12#2)(2012-2#7)(2012-3#9)(2012-5#1)(2013-1#28)(2013-8#4)
Amongst the##5##2##(2008-10#4)(2008-5#1)
Amongst##8##1##(2008-10#6)(2008-5#1)(2008-7#1)
Amorphous##2##1##(1995-3#1)(1996-9#1)
Amount of##3##2##(2008-10#2)(2008-12#1)
Amounts of##5##2##(2008-10#3)(2008-6#1)(2009-8#1)
Amounts##6##1##(1997-2#1)(2008-10#3)(2008-6#1)(2009-8#1)
Amoxycillin##2##1##(1990-3#1)(1991-3#1)
AmpFlSTR##2##1##(2008-12#2)
Ampelomyces quisqualis##2##2##(2008-10#2)
Amperometric biosensors##2##2##(2008-10#2)
Amperometric detection of##3##3##(2008-10#3)
Amperometric detection##5##2##(2008-10#5)
Amperometric determination of##6##3##(2008-10#6)
Amperometric sensor for##2##3##(2008-10#2)
Amperometric##28##1##(2008-10#28)
Amperometry and cyclic voltammetry##2##4##(2008-4#2)
Amperometry##3##1##(2008-10#1)(2008-4#2)
Amphetamine##2##1##(1993-6#2)
Amphiprion clarkii##2##2##(2010-8#2)
Amphiprion##3##1##(2010-8#3)
Amphotericin B and##2##3##(2011-2#2)
Amphotericin B##5##2##(1997-2#1)(2008-5#1)(2009-11#1)(2011-2#2)
Amphotericin##6##1##(1997-2#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-2#2)
Amplatzer##2##1##(1997-8#1)(2012-12#1)
AmpliDet RNA system##3##3##(2008-10#3)
AmpliDet RNA##5##2##(2008-10#5)
Amplification of the##2##3##(1994-12#1)(2008-10#1)
Amplification of##5##2##(1994-12#2)(2008-10#2)(2008-11#1)
Amplification##14##1##(1992-6#1)(1994-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-8#1)
Amplified Fragment Length Polymorphism Markers##2##5##(2008-10#2)
Amplified Fragment Length Polymorphism and##2##5##(2008-10#2)
Amplified Fragment Length Polymorphism##6##4##(2008-10#6)
Amplified Polymorphic##5##2##(2008-10#5)
Amplified Region##2##2##(2008-10#2)
Amplified fragment length polymorphism (AFLP)##3##5##(2008-10#3)
Amplified fragment length polymorphism markers##2##5##(2008-10#2)
Amplified fragment length polymorphism##6##4##(2008-10#6)
Amplified fragment length##7##3##(2008-10#7)
Amplified rDNA##2##2##(2008-10#1)(2008-9#1)
Amplified##27##1##(1997-8#1)(2008-10#24)(2008-9#1)(2013-1#1)
Amsterdam##5##1##(1990-3#2)(1990-6#3)
Amy1 was##2##2##(2008-10#2)
Amy1##3##1##(2008-10#3)
Amy3##10##1##(1994-11#9)(2008-10#1)
Amygdaloid##3##1##(1994-2#1)(2008-10#2)
Amylase##3##1##(2008-10#3)
Amyloid precursor protein (APP)##2##4##(1996-12#2)
Amyloid##7##1##(1995-12#1)(1996-12#2)(1996-2#1)(2008-5#1)(2012-3#1)(2013-8#1)
Amyotrophic lateral sclerosis (ALS) is a progressive##2##7##(2008-4#1)(2009-9#1)
An &quot##4##2##(1991-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
An 11-year-old boy presented with##2##5##(2008-10#1)(2010-9#1)
An 11-year-old boy##3##3##(2008-10#1)(2010-9#1)(2011-1#1)
An 11-year-old##4##2##(2008-10#1)(2010-6#1)(2010-9#1)(2011-1#1)
An 80-year-old##2##2##(2008-12#1)(2009-1#1)
An Allee##2##2##(2008-10#2)
An Alternate Protocol describes a##2##5##(2008-4#1)(2008-9#1)
An Australian##3##2##(1991-2#1)(1992-1#1)(2008-7#1)
An Bord Altranais##3##3##(2008-11#3)
An ELISA procedure for the determination of##2##7##(1990-12#2)
An ELISA##5##2##(1990-12#4)(1992-11#1)
An Efficient##5##2##(1996-5#2)(2008-10#1)(2010-7#1)(2010-8#1)
An Evaluation of##2##3##(2008-10#1)(2012-3#1)
An HPLC##2##2##(2008-10#2)
An RNA##2##2##(1994-3#1)(2008-6#1)
An SV 40 DNA fraction##2##5##(1990-7#2)
An Update for Neurosurgeons##2##4##(2011-2#2)
An X-ray structure##2##3##(1996-5#1)(2008-11#1)
An abdominal computed tomography##2##4##(2010-1#1)(2011-2#1)
An abdominal##3##2##(2007-12#1)(2010-1#1)(2011-2#1)
An absolute##2##2##(1994-6#1)(2008-10#1)
An accumulation##2##2##(2008-10#1)(2008-12#1)
An accurate##5##2##(1990-12#1)(2008-10#3)(2008-7#1)
An acid##2##2##(2008-10#2)
An action research##2##3##(1991-2#1)(2008-12#1)
An activating##2##2##(2009-8#1)(2011-2#1)
An acute##5##2##(1992-3#2)(2007-12#1)(2012-2#1)(2013-8#1)
An adaptive##3##2##(1997-2#1)(2008-3#2)
An addition of##2##3##(2008-10#2)
An additional benefit##3##3##(1991-12#1)(1994-3#1)(2008-10#1)
An additional##24##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#12)(2008-2#1)(2008-3#1)(2009-8#2)(2012-3#1)
An adequate##4##2##(2008-10#2)(2012-2#1)(2012-5#1)
An advanced##3##2##(2008-10#1)(2008-12#1)(2011-3#1)
An algorithm is proposed##2##4##(2008-10#2)
An algorithm##5##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-8#1)
An aliquot of##3##3##(2008-10#3)
An alternate protocol is##2##4##(2008-4#2)
An alternate protocol##4##3##(2008-4#3)(2008-9#1)
An alternate##5##2##(2008-11#1)(2008-4#3)(2008-9#1)
An alternative approach##3##3##(1994-1#1)(2008-4#1)(2012-2#1)
An alternative method for the##2##5##(2008-10#2)
An alternative method of##2##4##(2008-10#1)(2008-4#1)
An alternative method##5##3##(2008-10#3)(2008-4#2)
An alternative strategy##2##3##(1993-1#1)(2008-7#1)
An alternative##19##2##(1993-1#1)(1994-1#1)(1994-8#1)(2008-10#7)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#1)
An amino acid##2##3##(1997-9#1)(2013-1#1)
An amperometric biosensor was##2##4##(2008-10#2)
An amperometric biosensor##4##3##(2008-10#4)
An amperometric immunosensor##2##3##(2008-10#2)
An amperometric##12##2##(2008-10#12)
An amplified##2##2##(2008-11#1)(2008-7#1)
An analog of##2##3##(2008-11#2)
An analogous##2##2##(1997-6#1)(2008-3#1)
An analysis and##2##3##(1992-3#1)(2010-5#1)
An analysis based on##2##4##(1997-4#1)(2010-6#1)
An analysis is##3##3##(2008-3#1)(2008-5#1)(2009-5#1)
An analysis of the effect of##2##6##(2008-3#2)
An analysis of the##11##4##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
An analysis of variance##2##4##(2008-10#2)
An analysis of##27##3##(1991-12#1)(1992-12#2)(1994-3#1)(1995-12#1)(1996-1#1)(1997-8#2)(2007-12#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-7#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
An analysis was made of the##2##6##(1991-1#1)(1994-1#1)
An analysis was##3##3##(1991-1#1)(1994-1#1)(1995-12#1)
An analysis##39##2##(1991-1#1)(1991-12#1)(1992-12#2)(1992-3#1)(1994-1#1)(1994-3#1)(1995-12#2)(1996-1#1)(1997-4#1)(1997-8#2)(2007-12#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
An analytic##2##2##(1990-8#1)(2008-10#1)
An analytical expression for the##2##5##(2007-11#1)(2008-10#1)
An analytical expression##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
An analytical method based on the##2##6##(2008-10#2)
An analytical method for the determination of##4##7##(2008-10#4)
An analytical method for##6##4##(1993-3#1)(2008-10#5)
An analytical method##9##3##(1993-3#1)(2008-10#8)
An analytical methodology##3##3##(2008-10#3)
An analytical procedure was##2##4##(2008-10#2)
An analytical##26##2##(1993-3#1)(2007-11#1)(2008-10#22)(2008-2#1)(2008-3#1)
An anion-exchange fast protein liquid##2##5##(2008-10#2)
An anonymous##2##2##(1997-4#1)(2008-10#1)
An antiserum to##4##3##(1991-1#3)(2008-10#1)
An antiserum##5##2##(1991-1#3)(2008-10#2)
An apparent##2##2##(2008-10#1)(2011-2#1)
An application of the##3##4##(2008-10#2)(2008-3#1)
An application of##6##3##(2008-10#4)(2008-11#1)(2008-3#1)
An application to the##2##4##(2008-10#2)
An application to##3##3##(2008-10#2)(2012-3#1)
An application##13##2##(2008-10#7)(2008-11#1)(2008-3#2)(2009-10#1)(2012-3#1)(2013-1#1)
An appraisal of##3##3##(1991-1#1)(2008-11#1)(2008-12#1)
An approach for preparing##2##4##(2008-10#1)(2008-9#1)
An approach to##7##3##(1993-2#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-4#1)
An approach##12##2##(1993-2#1)(1995-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-8#1)(2012-4#1)
An appropriate##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
An approximate##2##2##(2008-10#1)(2008-3#1)
An aqueous extract of##2##4##(2008-10#1)(2008-11#1)
An aqueous solution##2##3##(2008-10#1)(2011-2#1)
An aqueous two-phase system of##3##5##(2008-10#3)
An aqueous##9##2##(2008-10#7)(2008-11#1)(2011-2#1)
An array of##2##3##(2010-8#1)(2013-1#1)
An artificial neural network (ANN) model##2##6##(2008-10#2)
An artificial neural network (ANN)##3##5##(2008-10#2)(2013-1#1)
An artificial neural network##4##4##(2008-10#2)(2008-3#1)(2013-1#1)
An assay##2##2##(2008-10#1)(2011-2#1)
An assessment of the##4##4##(1992-6#1)(1993-12#1)(2008-5#1)(2012-2#1)
An assessment of##5##3##(1992-6#1)(1993-12#1)(1996-8#1)(2008-5#1)(2012-2#1)
An assessment##6##2##(1992-6#1)(1993-12#1)(1996-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
An association between##3##3##(1991-12#1)(2009-12#1)(2011-2#1)
An association of##2##3##(1990-3#1)(1997-8#1)
An association##6##2##(1990-3#1)(1991-12#1)(1996-3#1)(1997-8#1)(2009-12#1)(2011-2#1)
An asymmetric##2##2##(2008-10#2)
An asymptotic##2##2##(1996-3#1)(2008-3#1)
An attempt has been made to##2##6##(2008-10#1)(2013-1#1)
An attempt to##5##3##(1995-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)
An attempt was made to##3##5##(2008-10#1)(2008-12#1)(2008-5#1)
An attempt was##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
An attempt##12##2##(1995-11#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
An audit of##2##3##(2008-11#1)(2008-7#1)
An automated analyser##2##3##(2008-10#2)
An automated system for##2##4##(2008-10#2)
An automated system##4##3##(2008-10#3)(2010-12#1)
An automated##16##2##(1990-12#1)(1990-2#1)(2008-10#12)(2008-7#1)(2010-12#1)
An automatic flow-injection##2##3##(2008-10#2)
An automatic method for the determination of##2##7##(2008-10#2)
An automatic photometric method##2##4##(2008-10#2)
An automatic##10##2##(2008-10#9)(2008-3#1)
An autopsy##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
An average density of the genes and/or gene##2##8##(1997-6#1)(1997-8#1)
An average of##2##3##(1997-2#1)(2012-12#1)
An average recovery of##2##4##(2008-10#2)
An average##10##2##(1990-12#1)(1993-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-3#1)(2012-12#1)
An awareness##2##2##(1992-2#1)(1997-1#1)
An early##7##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#1)
An ecological##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
An economic##2##2##(2008-10#1)(2008-6#1)
An educational##4##2##(1994-2#1)(2008-11#1)(2008-12#2)
An effective way##2##3##(1991-2#1)(2008-12#1)
An effective##8##2##(1991-2#1)(2008-10#5)(2008-12#1)(2010-7#1)
An efficient method was##2##4##(2008-10#1)(2012-2#1)
An efficient method##3##3##(2008-10#2)(2012-2#1)
An efficient##10##2##(1990-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2012-2#1)(2013-1#2)
An electro-optic##2##2##(2008-3#2)
An electroanalytical method##2##3##(2008-10#2)
An electrocatalytic##2##2##(2008-10#2)
An electrochemical method for##2##4##(2008-10#2)
An electrochemical##6##2##(2008-10#6)
An electron##3##2##(2008-10#2)(2008-7#1)
An electronic nose##2##3##(2008-10#1)(2008-11#1)
An electronic##5##2##(2008-10#3)(2008-11#1)(2012-2#1)
An emergency##3##2##(1995-12#1)(2009-9#1)(2011-2#1)
An emerging##2##2##(2009-10#1)(2013-1#1)
An empirical##3##2##(1992-2#1)(2008-10#1)(2008-2#1)
An end-channel amperometric detector##2##4##(2008-10#2)
An endogenous##3##2##(1993-8#1)(2008-10#1)(2008-8#1)
An enhancement##3##2##(2008-10#2)(2013-1#1)
An enrichment factor of##7##4##(2008-10#7)
An enrichment factor##8##3##(2008-10#8)
An enzymatic##3##2##(2008-10#3)
An enzyme##3##2##(1990-2#1)(1995-6#1)(2008-10#1)
An epidemiological model##2##3##(2008-10#2)
An epidemiological survey##2##3##(1990-3#1)(2008-5#1)
An epidemiological##8##2##(1990-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
An equation##2##2##(1994-2#1)(2008-10#1)
An error##2##2##(2008-10#1)(2008-3#1)
An essential##3##2##(1994-9#1)(1995-2#1)(2008-11#1)
An estimate of##2##3##(2007-12#1)(2008-10#1)
An estimated 1##2##3##(2009-12#1)(2009-5#1)
An estimated##6##2##(1990-3#1)(1992-9#1)(1993-12#1)(2009-12#1)(2009-5#1)(2012-12#1)
An evaluation of a##3##4##(1993-1#1)(1994-1#1)(2008-11#1)
An evaluation of the##9##4##(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#1)(2013-1#1)
An evaluation of##24##3##(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
An evaluation##26##2##(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#3)
An even##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
An evidence-based##3##2##(2009-12#1)(2010-9#1)(2012-2#1)
An evolutionary perspective on the##2##5##(2008-8#1)(2012-3#1)
An evolutionary##4##2##(2008-8#2)(2010-5#1)(2012-3#1)
An examination of the##7##4##(1994-3#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-8#1)(2012-3#1)
An examination of##11##3##(1994-3#1)(1997-1#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-3#1)
An examination##12##2##(1994-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-3#1)
An example is given##2##4##(1997-3#1)(2008-11#1)
An example is##3##3##(1997-3#1)(2008-11#1)(2008-3#1)
An example of##4##3##(1990-12#1)(2008-10#2)(2008-5#1)
An example##10##2##(1990-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2013-8#1)
An exception##3##2##(1993-1#1)(1994-9#1)(1995-6#1)
An excess of##2##3##(2008-10#1)(2008-5#1)
An expanding##2##2##(1992-3#1)(2010-6#1)
An experiment was conducted to investigate the##2##7##(1992-2#1)(2008-12#1)
An experiment was conducted##4##4##(1992-2#1)(2008-12#1)(2008-5#1)(2011-1#1)
An experiment was##6##3##(1992-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)
An experiment##9##2##(1992-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
An experimental design was##2##4##(2008-10#2)
An experimental design##4##3##(2008-10#4)
An experimental method##2##3##(1992-9#1)(2008-3#1)
An experimental study was##2##4##(2008-11#1)(2010-8#1)
An experimental study##4##3##(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)
An experimental##17##2##(1992-9#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
An expert##2##2##(2008-10#1)(2008-11#1)
An explanation##2##2##(2008-10#1)(2011-2#1)
An exploration of##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
An exploratory study##3##3##(2008-11#1)(2010-10#1)(2011-2#1)
An exploratory##9##2##(1992-1#1)(1995-5#1)(2008-10#1)(2008-11#2)(2010-10#2)(2011-2#1)(2012-3#1)
An expression profile of##2##4##(1996-2#2)
An expression##4##2##(1996-2#2)(2008-2#1)(2008-8#1)
An extension of##2##3##(2008-3#1)(2008-9#1)
An extensive literature##2##3##(2011-2#1)(2012-2#1)
An extensive##8##2##(1996-1#1)(1997-5#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-2#1)
An external##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
An extraction procedure##2##3##(2008-10#2)
An extraction##4##2##(2008-10#3)(2008-7#1)
An extremely##2##2##(1990-5#1)(2008-10#1)
An ideal##3##2##(2008-10#1)(2008-7#2)
An immunohistochemical##3##2##(1995-2#1)(2007-12#1)(2008-10#1)
An important aspect of the##2##5##(1991-1#1)(2008-10#1)
An important aspect of##3##4##(1991-1#1)(2008-10#1)(2011-2#1)
An important issue in##2##4##(2008-8#1)(2009-9#1)
An important role##2##3##(1995-5#1)(1996-2#1)
An important##20##2##(1991-1#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
An improved method##2##3##(2008-10#1)(2008-11#1)
An improved##10##2##(1996-2#1)(2008-10#7)(2008-11#1)(2012-12#1)
An improvement##2##2##(2008-10#2)
An in vitro study##4##4##(2013-1#4)
An in vitro##12##3##(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(2008-10#2)(2009-4#1)(2012-3#1)(2013-1#4)
An in##14##2##(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(2008-10#4)(2009-4#1)(2012-3#1)(2013-1#4)
An increase in the concentration##2##5##(2008-10#1)(2011-2#1)
An increase in the##7##4##(1997-1#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-12#1)(2011-2#1)
An increase in##20##3##(1994-12#1)(1994-8#1)(1995-11#2)(1996-1#1)(1997-1#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)
An increase of##5##3##(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
An increase##26##2##(1994-12#1)(1994-8#1)(1995-11#2)(1996-1#1)(1997-1#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#1)
An increased##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
An increasing##3##2##(1993-2#1)(2009-6#1)(2013-8#1)
An independent##3##2##(2008-10#2)(2011-1#1)
An index of##2##3##(2008-10#1)(2008-11#1)
An index##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
An indirect##6##2##(1990-12#1)(1996-12#1)(2008-10#3)(2008-7#1)
An individual##3##2##(1993-3#1)(1994-12#1)(2008-7#1)
An inexpensive##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
An inhibitor##2##2##(2008-7#1)(2008-8#1)
An initial quality-by-design (QbD) framework was assembled##2##7##(2012-2#2)
An initial##9##2##(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2012-2#2)(2013-1#1)
An injected##2##2##(2008-10#2)
An injection##4##2##(2008-10#4)
An innovative approach##2##3##(2011-2#1)(2013-1#1)
An innovative##7##2##(2008-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
An insight into the##2##4##(2008-10#1)(2012-2#1)
An instrument to##2##3##(2008-9#1)(2010-11#1)
An insufficient##2##2##(1993-11#1)(1997-8#1)
An integrated##10##2##(1995-3#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2010-4#1)(2011-2#1)
An integrative functional model largely based upon##2##7##(2008-12#2)
An integrative##4##2##(1991-2#1)(2008-12#2)(2010-10#1)
An intelligent##3##2##(2008-10#3)
An inter-laboratory##2##2##(2008-10#2)
An interdisciplinary##3##2##(1992-1#1)(1992-2#1)(2009-9#1)
An interesting case of##2##4##(2008-10#1)(2013-1#1)
An interesting##6##2##(2008-10#4)(2008-2#1)(2013-1#1)
An interference study##4##3##(2008-10#4)
An interference##6##2##(2008-10#4)(2008-3#2)
An internal standard##3##3##(1992-12#1)(1993-6#1)(2008-10#1)
An internal##4##2##(1992-12#1)(1993-6#1)(1997-7#1)(2008-10#1)
An international##4##2##(2006-6#1)(2008-11#1)(2009-12#1)(2012-3#1)
An interpretation of the##2##4##(1991-12#1)(2008-10#1)
An interpretation of##3##3##(1991-12#1)(2008-10#1)(2008-2#1)
An interview with##5##3##(1994-1#1)(2008-5#1)(2009-8#1)(2012-12#1)(2013-1#1)
An interview##6##2##(1994-1#1)(2008-5#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
An intestinal##2##2##(1991-12#1)(1994-8#1)
An intravenous##2##2##(2008-7#1)(2011-2#1)
An inverse##4##2##(2008-11#1)(2008-3#1)(2009-3#1)(2009-7#1)
An investigation into the##2##4##(2008-10#1)(2008-9#1)
An investigation of the##2##4##(1995-9#1)(2013-1#1)
An investigation of##8##3##(1991-11#1)(1995-9#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
An investigation##12##2##(1991-11#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
An ion##2##2##(2008-10#2)
An isocratic##3##2##(2008-10#3)
An isometric virus##2##3##(2008-10#2)
An objective##2##2##(1991-6#1)(2008-5#1)
An observational##2##2##(2012-12#1)(2013-1#1)
An obvious##2##2##(1990-12#1)(2008-6#1)
An off-line##2##2##(2008-10#2)
An oligonucleotide##4##2##(1993-1#1)(2008-10#3)
An on-line automated flow injection system with microwave-assisted sample digestion##2##10##(2008-10#2)
An on-line automated##3##3##(2008-10#3)
An on-line flow injection (FI)##2##5##(2008-10#2)
An on-line flow##3##3##(2008-10#3)
An on-line system for preconcentration and determination of##2##8##(2008-10#2)
An on-line system##3##3##(2008-10#3)
An on-line##22##2##(2008-10#21)(2008-11#1)
An online##2##2##(1991-11#1)(2008-12#1)
An open reading frame##2##4##(1990-11#1)(1992-4#1)
An open##11##2##(1990-11#1)(1990-9#1)(1991-1#1)(1992-4#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-8#1)
An operational##2##2##(2008-10#1)(2010-5#1)
An optical chemical sensor##2##4##(2008-10#2)
An optical fiber##2##3##(2008-10#2)
An optical sensor for##2##4##(2008-10#1)(2008-3#1)
An optical##15##2##(2008-10#8)(2008-2#2)(2008-3#4)(2009-5#1)
An optimization study of##2##4##(2008-10#2)
An optimization##4##2##(2008-10#3)(2008-6#1)
An optimized##7##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
An optimum##3##2##(2008-10#1)(2008-5#1)(2009-5#1)
An original##2##2##(1990-8#1)(2008-10#1)
An orthogonal##2##2##(2008-10#2)
An orthopedic group that recently moved to a new location needed to boost its image##2##15##(1994-3#2)
An orthophosphate##2##2##(2008-10#2)
An outbreak investigation practicum##2##4##(1996-1#2)
An outbreak of anthrax##2##4##(1990-9#2)
An outbreak of peste des petits ruminants##2##7##(2011-2#2)
An outbreak of##6##3##(1990-9#2)(1992-5#1)(2007-12#1)(2011-2#2)
An outbreak##9##2##(1990-3#1)(1990-9#2)(1992-5#1)(1996-1#2)(2007-12#1)(2011-2#2)
An outcomes##2##2##(1994-2#1)(1997-1#1)
An overall##3##2##(2008-6#1)(2012-2#1)(2013-8#1)
An overlapping##2##2##(1996-12#1)(2009-8#1)
An overview of the##5##4##(1993-11#1)(2008-10#1)(2008-11#3)
An overview of##22##3##(1992-3#1)(1993-11#1)(1994-2#1)(1995-2#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-4#2)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)
An overview on##2##3##(2008-10#1)(2008-4#1)
An overview##27##2##(1992-3#1)(1993-11#2)(1994-2#1)(1995-2#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)
An ultrasonic##2##2##(2008-10#2)
An ultrasound scan##2##3##(1997-3#1)(2008-10#1)
An ultrastructural##2##2##(2008-10#1)(2008-7#1)
An uncommon##3##2##(1992-9#1)(2008-10#1)(2012-3#1)
An understanding of the##3##4##(2008-11#1)(2011-2#2)
An understanding of##4##3##(2008-11#1)(2011-2#2)(2012-2#1)
An understanding##5##2##(2008-11#1)(2011-2#2)(2012-2#2)
An uneven##2##2##(2008-10#1)(2011-1#1)
An unexpected##5##2##(1992-12#1)(2008-12#1)(2012-2#2)(2012-3#1)
An untapped##2##2##(1992-1#1)(2008-11#1)
An unusual case of##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
An unusual cause of##2##4##(2009-10#1)(2013-1#1)
An unusual presentation of##2##4##(2010-11#1)(2013-1#1)
An unusual##15##2##(1990-3#1)(1990-6#1)(1991-11#1)(1991-8#1)(1992-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#2)
An unweighted pair-group method##2##4##(2008-10#2)
An update on##2##3##(1994-1#1)(2008-11#1)
An update##5##2##(1994-1#1)(2008-11#2)(2012-3#1)(2013-1#1)
An upstream region##2##3##(1992-3#1)(1994-2#1)
An##1405##1##(1990-11#4)(1990-12#12)(1990-2#4)(1990-3#7)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#7)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#6)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#5)(1992-11#1)(1992-12#7)(1992-2#8)(1992-3#10)(1992-4#3)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#4)(1993-11#4)(1993-12#5)(1993-2#4)(1993-3#6)(1993-6#1)(1993-8#4)(1993-9#3)(1994-1#5)(1994-11#3)(1994-12#7)(1994-2#7)(1994-3#6)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#6)(1995-12#6)(1995-2#9)(1995-3#3)(1995-5#3)(1995-6#6)(1995-8#1)(1995-9#2)(1996-1#8)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#4)(1996-5#8)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#3)(1997-3#7)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#7)(1997-9#1)(2006-6#1)(2007-11#4)(2007-12#6)(2007-8#1)(2008-1#5)(2008-10#473)(2008-11#88)(2008-12#35)(2008-2#15)(2008-3#54)(2008-4#15)(2008-5#25)(2008-6#10)(2008-7#33)(2008-8#22)(2008-9#19)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#7)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#13)(2009-9#6)(2010-1#6)(2010-10#7)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#9)(2010-5#4)(2010-6#4)(2010-7#6)(2010-8#8)(2010-9#3)(2011-1#7)(2011-10#1)(2011-2#49)(2011-3#4)(2012-12#22)(2012-2#27)(2012-3#21)(2012-4#1)(2012-5#1)(2013-1#52)(2013-8#14)
An0##2##1##(2013-8#2)
An1 mRNA##2##2##(1993-6#2)
An1##5##1##(1993-6#5)
An1a and An1b##2##3##(1993-6#2)
AnFBV##4##1##(2008-10#4)
Anabaena sp##6##2##(1995-6#1)(2008-8#5)
Anabaena##7##1##(1995-6#1)(2008-11#1)(2008-8#5)
Anaesthesia for conjoined twins##2##4##(2010-7#2)
Anaesthesia for##3##2##(1995-10#1)(2010-7#2)
Anaesthesia##5##1##(1995-10#1)(2010-7#3)(2011-2#1)
Anaesthetic management of##3##3##(2010-7#3)
Anal##18##1##(1991-10#1)(1991-6#1)(2008-10#13)(2008-12#1)(2012-12#2)
Analgesia and##2##2##(1993-1#1)(2010-1#1)
Analgesia##4##1##(1993-1#1)(2008-7#2)(2010-1#1)
Analog##4##1##(2008-11#1)(2008-12#1)(2012-3#2)
Analogous##3##1##(1992-12#1)(2008-10#2)
Analogously##2##1##(1997-1#1)(2008-10#1)
Analogue##4##1##(1991-2#1)(2008-11#1)(2009-11#1)(2013-1#1)
Analogues##3##1##(1994-8#1)(2009-8#1)(2011-2#1)
Analyser##4##1##(2008-10#2)(2008-5#2)
Analyses for##2##2##(2008-10#2)
Analyses of a##2##3##(2008-6#1)(2008-8#1)
Analyses of the##10##3##(1994-5#1)(2008-10#4)(2008-6#1)(2008-8#2)(2009-8#1)(2012-2#1)
Analyses of these##2##3##(2008-10#1)(2010-10#1)
Analyses of##37##2##(1991-10#1)(1994-3#1)(1994-5#1)(2008-10#21)(2008-11#1)(2008-6#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
Analyses were performed##3##3##(2008-10#3)
Analyses were##6##2##(2008-10#5)(2008-3#1)
Analyses##59##1##(1991-10#1)(1993-12#1)(1994-3#1)(1994-5#1)(1997-7#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-3#1)(2008-6#3)(2008-8#4)(2008-9#2)(2009-7#2)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Analysing the##3##2##(2008-5#1)(2011-2#1)(2012-12#1)
Analysing##5##1##(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#2)
Analysis (SFA)##2##2##(2008-11#1)(2013-8#1)
Analysis Critical Control##3##3##(1997-3#1)(2009-3#2)
Analysis Identifies##2##2##(2008-10#1)(2012-3#1)
Analysis and##12##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#2)(2013-1#1)
Analysis by##6##2##(1990-6#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-9#1)
Analysis for##5##2##(2008-10#5)
Analysis of DNA content and##3##5##(2008-9#3)
Analysis of DNA##5##3##(2008-9#5)
Analysis of Host Species Specificity of Magnaporthe grisea Toward##2##9##(2008-10#2)
Analysis of Host Species Specificity of Magnaporthe##3##7##(2008-10#3)
Analysis of Host##4##3##(2008-10#4)
Analysis of Isolates of##2##4##(2008-10#2)
Analysis of Leptosphaeria maculans##2##4##(2008-10#2)
Analysis of SMV##2##3##(2008-10#2)
Analysis of a simple##2##4##(2008-11#1)(2008-2#1)
Analysis of a##15##3##(1991-2#1)(1992-2#1)(1992-9#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2009-10#1)(2013-1#1)
Analysis of an##2##3##(2008-10#1)(2008-2#1)
Analysis of both##2##3##(2008-10#1)(2008-11#1)
Analysis of cell##3##3##(1995-6#1)(2008-7#1)(2008-9#1)
Analysis of data##3##3##(1991-2#1)(2008-9#1)(2010-2#1)
Analysis of drug utilization##2##4##(2008-11#2)
Analysis of extracts##2##3##(2008-10#2)
Analysis of gene expression##3##4##(2008-10#2)(2010-10#1)
Analysis of molecular variance##5##4##(2008-10#5)
Analysis of molecular##6##3##(2008-10#6)
Analysis of other##2##3##(1995-6#1)(2008-10#1)
Analysis of protein##2##3##(2008-2#1)(2008-4#1)
Analysis of the influence of##2##5##(2008-3#1)(2013-1#1)
Analysis of the mechanism of##2##5##(2008-11#1)(2008-5#1)
Analysis of the molecular##2##4##(1993-8#1)(2008-10#1)
Analysis of the nucleotide sequence of##2##6##(1990-11#1)(1995-8#1)
Analysis of the nucleotide##4##4##(1990-11#1)(1990-7#1)(1995-8#1)(2008-10#1)
Analysis of the predicted##2##4##(1993-12#1)(1995-8#1)
Analysis of the rate##2##4##(2008-4#1)(2013-7#1)
Analysis of the sequence revealed##2##5##(1996-12#1)(1996-3#1)
Analysis of the sequence##3##4##(1996-12#1)(1996-3#1)(2008-10#1)
Analysis of the##84##3##(1990-11#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#17)(2008-11#9)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#2)(2012-3#4)(2013-1#4)(2013-7#1)
Analysis of these##3##3##(1991-11#1)(2008-10#1)(2009-12#1)
Analysis of three##3##3##(1993-6#1)(1993-9#1)(1996-6#1)
Analysis of tissue##2##3##(1991-12#1)(2008-9#1)
Analysis of variance (ANOVA)##2##4##(1994-2#1)(2008-10#1)
Analysis of variance and##2##4##(2008-10#1)(2013-1#1)
Analysis of variance##7##3##(1994-2#1)(2008-10#4)(2013-1#2)
Analysis of volatiles##2##3##(2008-10#2)
Analysis of##375##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#5)(1997-3#1)(1997-7#2)(1997-8#2)(2007-11#1)(2008-10#156)(2008-11#24)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#17)(2009-1#2)(2009-10#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#2)(2010-10#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#11)(2012-5#1)(2013-1#13)(2013-7#1)(2013-8#2)
Analysis revealed##2##2##(2008-10#1)(2009-3#1)
Analysis showed that##2##3##(1991-6#1)(2008-10#1)
Analysis to##2##2##(1994-12#1)(2008-10#1)
Analysis using##2##2##(2008-10#1)(2010-4#1)
Analysis was performed by##2##4##(1995-12#1)(2008-10#1)
Analysis was performed##4##3##(1991-2#1)(1995-12#1)(2008-10#2)
Analysis was##11##2##(1991-2#1)(1995-12#2)(2008-10#5)(2010-9#1)(2012-2#1)(2012-3#1)
Analysis##471##1##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#5)(1997-3#2)(1997-7#2)(1997-8#3)(2007-11#1)(2008-10#197)(2008-11#28)(2008-12#4)(2008-2#4)(2008-3#12)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#18)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#16)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#6)
Analysts##4##1##(2008-10#1)(2008-5#3)
Analyte##4##1##(2008-10#4)
Analytes were##5##2##(2008-10#4)(2011-3#1)
Analytes##7##1##(2008-10#6)(2011-3#1)
Analytic##3##1##(2008-3#1)(2010-7#1)(2011-2#1)
Analytical Chemistry##2##2##(2008-10#2)
Analytical and##2##2##(2008-10#2)
Analytical applications of##4##3##(2008-10#4)
Analytical chemistry of##2##3##(2008-10#1)(2010-7#1)
Analytical chemistry##4##2##(2008-10#1)(2010-7#3)
Analytical curves##2##2##(2008-10#2)
Analytical data##2##2##(2008-10#2)
Analytical evaluation of##2##3##(2008-10#2)
Analytical investigation of##2##3##(2008-10#2)
Analytical methods for##2##3##(2008-10#2)
Analytical parameters##2##2##(2008-10#1)(2009-8#1)
Analytical properties of##2##3##(2008-10#2)
Analytical recoveries##2##2##(2008-10#2)
Analytical results for the##3##4##(2008-10#3)
Analytical results obtained by##3##4##(2008-10#3)
Analytical results obtained##4##3##(2008-10#4)
Analytical results of##2##3##(2008-10#2)
Analytical results##9##2##(2008-10#9)
Analytical studies##2##2##(1996-12#1)(2008-10#1)
Analytical study##2##2##(2008-10#2)
Analytical##78##1##(1996-12#1)(1997-2#2)(2008-10#62)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#4)(2012-2#1)
Analyzer##2##1##(2008-10#1)(2008-11#1)
Analyzing the##3##2##(1991-3#1)(2008-10#1)(2008-8#1)
Analyzing##9##1##(1991-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2013-1#1)
Anaphylaxis##5##1##(1995-11#1)(1997-7#1)(2010-6#1)(2013-1#2)
Anaplasma phagocytophilum##2##2##(2008-12#2)
Anaplasma##7##1##(1996-12#2)(2008-12#3)(2013-1#2)
Anarrhichomenum##7##1##(2008-10#7)
Anastomosis Group##6##2##(2008-10#6)
Anastomosis reactions##3##2##(2008-10#3)
Anastomosis##14##1##(2008-10#14)
Anastrepha suspensa##2##2##(2007-12#2)
Anatolia##2##1##(2012-9#1)(2013-8#1)
Anatomic and##2##2##(1996-3#1)(2010-7#1)
Anatomic##4##1##(1996-3#1)(1996-6#1)(2010-7#1)(2013-1#1)
Anatomical and##3##2##(2011-2#1)(2013-1#2)
Anatomical##12##1##(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
Anatomy of##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
Anatomy##6##1##(1990-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-1#2)
Ancient Theory about Public Health through Physical Activity against Hyperlipidemia and Ischemic Heart Disease##2##14##(2013-1#2)
Ancient##6##1##(1991-2#1)(2008-10#2)(2013-1#2)(2013-8#1)
Ancillary##2##1##(1997-2#1)(2008-10#1)
And a##2##2##(1994-3#1)(2008-8#1)
And also##3##2##(1990-12#1)(2008-10#2)
And finally##3##2##(1991-2#1)(1993-2#1)(2008-11#1)
And it##3##2##(1991-3#1)(1996-1#1)(2010-8#1)
And less important ones were Changing##2##6##(1991-2#2)
And the##11##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
And then##3##2##(1991-2#1)(2008-11#1)(2010-9#1)
And while##2##2##(1992-11#1)(1993-12#1)
And you##2##2##(1994-3#2)
And##69##1##(1990-12#2)(1991-2#4)(1991-3#2)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-2#3)(1994-3#4)(1995-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-10#2)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
Andean and##3##2##(2008-10#3)
Andean isolates from Africa##3##4##(2008-10#3)
Andean isolates from##4##3##(2008-10#4)
Andean isolates##5##2##(2008-10#5)
Andean##23##1##(2008-10#21)(2008-11#1)(2013-8#1)
Anderson sampler technique##2##3##(2008-10#2)
Anderson##14##1##(1993-6#1)(1994-12#2)(1995-6#1)(1996-5#4)(2008-10#2)(2010-11#1)(2010-4#1)(2011-2#2)
Anderson's##2##1##(1991-3#1)(1996-5#1)
Andes##5##1##(1990-6#1)(2008-10#2)(2008-5#2)
Andre##2##1##(2008-10#1)(2009-1#1)
Andreev##2##1##(1992-3#1)(1996-9#1)
Andrew##4##1##(1992-3#1)(1992-8#1)(1996-2#1)(2011-2#1)
Andrews##6##1##(2008-10#5)(2012-2#1)
Androgen binding##2##2##(1990-11#2)
Androgen receptor##2##2##(1992-12#1)(1995-12#1)
Androgen##8##1##(1990-11#2)(1992-12#1)(1995-12#3)(2008-4#2)
Androgenic##3##1##(1995-12#1)(2012-3#2)
Andross##5##1##(2008-10#5)
Anemia is##2##2##(2008-1#1)(2008-7#1)
Anemia of##2##2##(2008-1#1)(2012-2#1)
Anemia##7##1##(1997-3#1)(2008-1#3)(2008-7#1)(2011-2#1)(2012-2#1)
Anesthetic##2##1##(1993-1#1)(2013-1#1)
Aneurysm##5##1##(1997-6#1)(2008-12#1)(2010-7#1)(2012-3#2)
Aneurysmal Subarachnoid Hemorrhage##2##3##(2011-2#1)(2012-3#1)
Aneurysmal##5##1##(1996-3#2)(2011-2#1)(2012-12#1)(2012-3#1)
Aneurysms##8##1##(1991-6#1)(1995-11#2)(1997-3#3)(2008-12#1)(2012-3#1)
AngCP##6##1##(2008-9#6)
Angeles##11##1##(1991-2#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-12#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Angelica##5##1##(2008-10#2)(2013-1#1)(2013-8#2)
Angelman's syndrome##3##2##(1990-9#3)
Angelman's##4##1##(1990-9#4)
Angelonia flower##2##2##(2008-10#2)
Angelonia##6##1##(2008-10#6)
Angiogenesis##7##1##(1994-12#2)(2008-11#2)(2010-1#1)(2013-1#1)(2013-8#1)
Angiogenic##2##1##(2009-8#1)(2013-8#1)
Angiographic findings##2##2##(1997-8#2)
Angiographic##7##1##(1997-3#2)(1997-8#3)(2008-11#2)
Angiography showed##3##2##(2008-7#3)
Angiography##15##1##(1990-9#1)(1991-8#1)(1995-11#1)(1997-6#2)(2008-7#4)(2009-5#1)(2011-2#4)(2012-3#1)
Angiomyolipoma##2##1##(1992-2#2)
Angiomyxolipoma##2##1##(2010-6#2)
Angioplasty##2##1##(2008-11#1)(2012-3#1)
Angiosperm##2##1##(2008-10#1)(2009-12#1)
Angiotensin II##4##2##(1995-11#3)(2008-11#1)
Angiotensin##7##1##(1993-12#1)(1995-11#3)(2008-1#1)(2008-11#1)(2008-7#1)
Angiotensin-converting enzyme inhibitors and beta-blockers##2##5##(2011-2#2)
Angle##6##1##(2008-3#1)(2012-3#5)
Anglo youths reported more##2##4##(2008-9#2)
Anglo youths##3##2##(2008-9#3)
Anglo##8##1##(2008-9#5)(2011-2#1)(2012-2#2)
Angular Leaf Spot##2##3##(2008-10#2)
Angular##4##1##(2008-10#2)(2008-2#1)(2013-1#1)
Animal Cell##2##2##(2008-11#2)
Animal Farm##2##2##(2008-11#2)
Animal Health##7##2##(2011-2#6)(2013-8#1)
Animal and human studies##2##4##(2008-10#1)(2012-2#1)
Animal and##3##2##(2008-10#1)(2010-6#1)(2012-2#1)
Animal experiments##2##2##(2008-8#1)(2010-3#1)
Animal models for##2##3##(2008-4#1)(2010-6#1)
Animal models have##2##3##(2008-10#1)(2008-5#1)
Animal models of##5##3##(2008-12#1)(2008-4#3)(2008-7#1)
Animal models##11##2##(2008-10#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#2)(2010-6#1)(2012-3#1)
Animal studies##2##2##(1996-3#1)(2008-7#1)
Animal##47##1##(1991-1#1)(1993-11#1)(1994-3#1)(1996-3#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-4#8)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-3#1)(2010-6#2)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
Animals are##2##2##(2008-11#1)(2008-6#1)
Animals in##3##2##(1994-2#1)(2006-6#1)(2008-10#1)
Animals treated with##2##3##(1993-1#1)(2008-10#1)
Animals were##4##2##(1993-6#1)(1996-2#1)(2008-9#1)(2012-3#1)
Animals##26##1##(1991-2#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1996-2#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-9#1)(2010-1#3)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Anion##8##1##(1993-12#1)(2008-10#4)(2011-2#3)
Anions##2##1##(2008-10#2)
Anisogramma anomala##5##2##(2008-10#5)
Anisotropic##4##1##(1992-8#1)(1996-9#1)(2008-3#2)
Anisotropy##3##1##(1995-3#1)(2008-10#1)(2008-2#1)
Anita Schweiger]##2##2##(1997-2#1)(1997-8#1)
Anita##3##1##(1994-12#1)(1997-2#1)(1997-8#1)
Ankara##3##1##(2008-10#2)(2008-11#1)
Anker##3##1##(1995-6#3)
Ankle impingement##3##2##(2011-2#3)
Ankle##11##1##(2008-12#2)(2008-8#1)(2009-10#2)(2010-11#1)(2011-2#4)(2012-3#1)
Ankle/arm blood pressure index##2##4##(1993-12#2)
Ann Arbor##2##2##(1990-8#1)(1992-2#1)
Ann##5##1##(1990-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(2008-11#1)
Anne##3##1##(2008-11#2)(2010-6#1)
Annealing##3##1##(2007-12#1)(2008-2#1)(2012-3#1)
Annelida and Arthropoda##2##3##(2009-6#2)
Annelida##3##1##(2009-6#3)
Annetocin##2##1##(2008-5#2)
Annex II B of EU Directive 94/15/EC##2##7##(2008-11#2)
Annex II B##3##3##(2008-11#3)
Annex II##4##2##(2008-11#4)
Annex##6##1##(2008-11#5)(2008-5#1)
Annexin-V-FLUOS staining##2##2##(2008-8#2)
Annexin32##5##1##(2008-9#5)
Annotating##2##1##(2010-12#1)(2013-1#1)
Announcement##3##1##(2008-10#3)
Annual Conference##3##2##(2008-11#1)(2008-12#2)
Annual Future of Supportive Therapy in Oncology##2##7##(2008-7#2)
Annual Meeting of the American Society of Clinical Oncology##2##9##(2008-7#2)
Annual Meeting of the American Society of##3##7##(2008-7#3)
Annual Meeting of the##9##4##(2008-10#1)(2008-11#1)(2008-7#3)(2010-1#1)(2010-10#1)(2011-2#2)
Annual Meeting of##10##3##(2008-10#1)(2008-11#1)(2008-7#3)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#1)
Annual Meeting##28##2##(2008-10#3)(2008-11#16)(2008-7#3)(2010-1#1)(2010-10#1)(2011-2#3)(2013-1#1)
Annual Report##2##2##(2008-10#1)(2011-7#1)
Annual influenza vaccination##3##3##(2011-2#3)
Annual##61##1##(1990-3#1)(1991-1#1)(1992-2#1)(1993-1#1)(1994-3#1)(1996-2#1)(2008-10#7)(2008-11#21)(2008-12#2)(2008-7#6)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#12)(2011-7#1)(2013-1#1)
Anocentor nitens##2##2##(2008-10#2)
Anodic oxidation of##2##3##(2008-10#2)
Anodic stripping voltammetric determination of##2##5##(2008-10#2)
Anodic stripping##4##2##(2008-10#4)
Anodic voltammetric##2##2##(2008-10#2)
Anodic##9##1##(2008-10#9)
Anodonta anatina##2##2##(2008-12#2)
Anodonta##3##1##(2008-12#2)(2010-8#1)
Anomalies in the##2##3##(1993-5#1)(2008-10#1)
Anomalies##3##1##(1993-5#1)(2008-10#1)(2012-12#1)
Anomalous##6##1##(1996-9#1)(2008-12#1)(2008-3#1)(2009-9#1)(2010-5#1)(2013-2#1)
Anopheles darlingi##2##2##(2012-12#2)
Anopheles##10##1##(2010-1#6)(2012-12#4)
Anoplotettix fuscovenosus##2##2##(2008-10#2)
Anorexia Nervosa##2##2##(2008-11#1)(2013-1#1)
Anorexia##5##1##(1996-2#1)(2008-11#2)(2012-3#1)(2013-1#1)
Anostraca)##2##1##(2007-12#2)
Another group##2##2##(1993-3#1)(1997-8#1)
Another major##2##2##(1997-1#1)(2008-10#1)
Another physician##2##2##(1995-12#2)
Another possible##3##2##(1996-11#1)(2008-7#1)(2011-2#1)
Another##66##1##(1991-1#2)(1991-3#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-3#1)(1995-12#2)(1995-6#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-8#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-8#1)
Ant##2##1##(2008-5#1)(2008-8#1)
Antagonism of the##2##3##(1992-6#1)(2008-10#1)
Antagonism of##4##2##(1992-6#1)(2008-10#3)
Antagonism##6##1##(1992-6#1)(2008-10#5)
Antagonist Ulocladium atrum##2##3##(2008-10#2)
Antagonist##9##1##(2008-10#6)(2008-7#1)(2009-10#1)(2011-2#1)
Antagonistic interactions##2##2##(2008-10#2)
Antagonistic##10##1##(2008-10#8)(2008-9#1)(2012-3#1)
Antagonists of##2##2##(1997-7#1)(2008-10#1)
Antagonists##5##1##(1997-7#1)(2008-10#4)
Antarctic##6##1##(1991-5#1)(1996-1#1)(2008-10#1)(2013-8#3)
Antarctica##2##1##(2008-10#2)
Antecedents of##3##2##(1992-3#1)(1993-3#1)(1994-9#1)
Antecedents##4##1##(1992-3#1)(1993-3#1)(1994-9#1)(2008-12#1)
Antega stem##4##2##(2013-1#4)
Antega##6##1##(2013-1#6)
Antegren##4##1##(2008-5#4)
Antenatal##3##1##(2008-10#1)(2013-1#1)(2013-8#1)
Anterior Cervical Discectomy and Fusion##2##5##(2012-3#1)(2013-8#1)
Anterior Cruciate Ligament##2##3##(2013-1#2)
Anterior cervical##2##2##(2008-7#2)
Anterior urethral##2##2##(2008-10#2)
Anterior##27##1##(1996-6#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-7#2)(2008-9#1)(2009-9#1)(2010-9#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Anther##2##1##(2008-10#1)(2008-8#1)
Anthocyanin content in##2##3##(2008-10#2)
Anthracnose in##2##2##(2008-10#2)
Anthracnose##11##1##(2008-10#11)
Anthrasteroids##2##1##(1990-11#2)
Anthrax edema toxin##2##3##(2010-1#2)
Anthropogenic##2##1##(2008-10#1)(2008-11#1)
Anthropometric##3##1##(2008-3#1)(2011-1#1)(2011-2#1)
Anti##4##1##(1991-11#1)(2008-11#2)(2012-3#1)
Anti-Inflammatory Drugs##2##2##(2008-10#1)(2008-12#1)
Anti-Inflammatory##4##1##(2008-10#1)(2008-12#1)(2010-6#1)(2013-1#1)
Anti-TNFs##2##1##(2010-12#2)
Anti-angiogenic##2##1##(2013-1#2)
Anti-apoptotic##2##1##(2009-12#1)(2011-2#1)
Anti-inflammatory and##2##2##(2008-12#1)(2013-1#1)
Anti-inflammatory##5##1##(2008-12#2)(2008-5#1)(2009-8#1)(2013-1#1)
Anti-malware software##2##2##(2011-2#2)
Anti-tumor##2##1##(2008-11#1)(2011-2#1)
Antibacterial activity and##2##3##(2008-12#1)(2013-8#1)
Antibacterial activity of##2##3##(2008-7#1)(2009-6#1)
Antibacterial activity##4##2##(2008-12#1)(2008-7#1)(2009-6#1)(2013-8#1)
Antibacterial##10##1##(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
Antibiosis and##2##2##(2008-10#2)
Antibiosis##3##1##(2008-10#3)
Antibiotic susceptibility##2##2##(2010-8#1)(2012-3#1)
Antibiotic##9##1##(1992-6#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
Antibiotics##5##1##(2008-10#1)(2008-7#1)(2010-12#2)(2013-1#1)
Antiblastic treatment of##2##3##(2013-1#2)
Antiblastic treatment##3##2##(2013-1#3)
Antibodies against##2##2##(1996-6#1)(2008-9#1)
Antibodies that##2##2##(1991-9#1)(2008-4#1)
Antibodies to##6##2##(1990-6#1)(1992-11#1)(2008-1#1)(2008-10#2)(2008-5#1)
Antibodies were##2##2##(1996-12#1)(2008-10#1)
Antibodies##19##1##(1990-6#1)(1991-5#1)(1991-9#1)(1992-11#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
Antibody response##2##2##(1990-12#1)(2008-10#1)
Antibody titer##2##2##(2008-12#1)(2012-3#1)
Antibody titers##2##2##(2008-12#1)(2012-3#1)
Antibody##22##1##(1990-12#1)(1991-5#1)(1997-7#1)(2006-6#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-9#1)(2012-3#3)(2013-1#2)(2013-8#1)
Anticarsia gemmatalis multicapsid nucleopolyhedrovirus##3##4##(2008-11#3)
Anticarsia gemmatalis##8##2##(2008-11#8)
Anticoagulant##2##1##(2010-12#1)(2012-12#1)
Anticoagulation control##2##2##(2009-12#2)
Anticoagulation##4##1##(2008-3#1)(2008-5#1)(2009-12#2)
Antidepressant##4##1##(2009-12#1)(2010-1#1)(2011-2#1)(2012-2#1)
Antidiuretic##2##1##(2008-5#1)(2011-2#1)
Antiestrogen##2##1##(2008-11#2)
Antiestrogenic##2##1##(2008-11#2)
Antifungal Activity of##2##3##(2008-10#1)(2012-2#1)
Antifungal Activity##4##2##(2008-10#3)(2012-2#1)
Antifungal Peptide##2##2##(2008-10#2)
Antifungal activity##2##2##(2008-10#1)(2012-2#1)
Antifungal##14##1##(2008-10#8)(2008-11#1)(2008-5#1)(2012-2#3)(2013-8#1)
Antigen##5##1##(2008-11#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-2#1)
Antigen-Specific##3##1##(2008-11#2)(2013-8#1)
Antigen-specific##2##1##(2008-12#1)(2008-5#1)
Antigenic##3##1##(1991-1#1)(1996-12#1)(2008-5#1)
Antigens from##2##2##(2008-10#2)
Antigens##4##1##(2008-10#2)(2008-4#1)(2012-2#1)
Antihepatotoxic##2##1##(2008-11#2)
Antihyperglycemic##2##1##(2012-3#1)(2013-1#1)
Antihypertensive##2##1##(1997-8#1)(2008-1#1)
Antimicrobial Activity##2##2##(2008-10#1)(2012-2#1)
Antimicrobial Resistance##2##2##(2008-10#1)(2013-8#1)
Antimicrobial resistance##3##2##(2012-2#1)(2013-8#2)
Antimicrobial stewardship in##2##3##(2013-1#2)
Antimicrobial stewardship programs (ASPs)##2##4##(2013-1#2)
Antimicrobial stewardship##5##2##(2013-1#5)
Antimicrobial susceptibility##2##2##(2008-7#1)(2012-3#1)
Antimicrobial##23##1##(1994-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#3)
Antimony(V)##2##1##(2008-10#2)
Antioxidant activity of##2##3##(2008-10#2)
Antioxidant and##2##2##(2010-4#1)(2013-1#1)
Antioxidant capacity##2##2##(2008-10#2)
Antioxidant functions##2##2##(1992-9#2)
Antioxidant response##2##2##(1992-9#1)(2010-5#1)
Antioxidant##18##1##(1992-9#4)(1993-2#1)(2008-10#5)(2008-11#3)(2008-5#1)(2009-10#1)(2010-4#1)(2010-5#1)(2013-1#1)
Antioxidants##2##1##(2008-10#1)(2008-7#1)
Antiplatelet therapy##2##2##(2007-7#1)(2011-2#1)
Antiplatelet##3##1##(1993-12#1)(2007-7#1)(2011-2#1)
Antirrhinum##2##1##(2008-8#1)(2009-5#1)
Antisense oligodeoxynucleotides##2##2##(1992-6#1)(1996-12#1)
Antisense oligonucleotide##2##2##(1995-12#1)(2008-11#1)
Antisense##9##1##(1992-6#2)(1995-12#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
Antisera to##2##2##(1990-5#1)(2008-10#1)
Antisera##7##1##(1990-5#1)(1994-8#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-11#1)
Antiserum##3##1##(1990-8#1)(1992-6#1)(1996-12#1)
Antiviral##3##1##(2009-7#1)(2013-1#2)
Antonio##5##1##(2008-1#1)(2008-7#2)(2011-2#1)(2012-12#1)
Ants##3##1##(2008-10#3)
Antwerp##3##1##(2008-10#3)
Anxiety Disorder##2##2##(2010-5#1)(2012-2#1)
Anxiety Inventory##5##2##(2008-10#1)(2010-6#2)(2012-2#1)(2013-1#1)
Anxiety and##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
Anxiety in Children##2##3##(2009-12#1)(2013-8#1)
Anxiety##17##1##(1996-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-5#1)(2010-6#2)(2012-2#3)(2013-1#1)(2013-8#1)
Anxiolytic##2##1##(1993-3#1)(2008-10#1)
Any of these##2##3##(1991-2#1)(1996-2#1)
Any of##3##2##(1991-2#1)(1996-2#1)(2012-3#1)
Any##25##1##(1991-2#1)(1991-3#1)(1992-2#1)(1994-12#1)(1994-3#2)(1995-2#2)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#3)(2009-12#1)(2009-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
Anyang##2##1##(2008-10#2)
Anyone##2##1##(1997-4#1)(2010-7#1)
Anzali Lagoon##3##2##(2012-2#3)
Aortic dissection##3##2##(1991-2#1)(2008-11#2)
Aortic root##2##2##(1997-8#1)(2009-10#1)
Aortic##8##1##(1991-2#1)(1991-9#1)(1997-8#1)(2008-11#2)(2009-10#1)(2012-2#1)(2013-7#1)
Aortico-left ventricular tunnel##2##3##(2008-11#2)
Aotearoa##4##1##(2008-1#4)
Août##3##1##(2013-1#3)
ApMV isolates##2##2##(2008-10#2)
ApMV##3##1##(2008-10#3)
Apart from genetically##2##3##(2008-10#1)(2008-5#1)
Apart from the##7##3##(1993-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2009-12#1)
Apart from##22##2##(1993-6#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2012-2#1)(2012-3#4)(2013-8#1)
Apex##3##1##(2008-10#1)(2011-2#1)(2013-7#1)
Apgar##3##1##(1994-3#1)(1996-6#2)
Aph1##4##1##(2008-10#4)
Aph2##3##1##(2008-10#3)
Aphanomyces euteiches##16##2##(2008-10#16)
Aphanomyces root rot##6##3##(2008-10#6)
Aphanomyces##26##1##(2008-10#26)
Apheresis##10##1##(2011-2#10)
Aphid Transmission##2##2##(2008-10#2)
Aphid Vector##2##2##(2008-10#2)
Aphid##11##1##(2008-10#11)
Aphids##2##1##(2008-10#2)
Aphis craccivora##2##2##(2008-10#2)
Aphis fabae##4##2##(2008-10#1)(2009-8#3)
Aphis gossypii##5##2##(2008-10#5)
Aphis##13##1##(2008-10#10)(2009-8#3)
Aphrodes makarovi##2##2##(2008-10#2)
Apical##3##1##(2008-10#1)(2011-2#2)
Apis mellifera##5##2##(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)
Aplysia ganglia##2##2##(2008-10#2)
Aplysia##3##1##(2008-10#2)(2008-4#1)
Apo##4##1##(1995-8#1)(2008-7#1)(2013-1#2)
ApoAI##4##1##(1993-12#4)
Apocytochrome P450cam is##2##3##(1993-8#2)
Apolipoprotein B is##2##3##(1995-2#2)
Apolipoprotein E type epsilon 4##2##5##(1995-12#2)
Apolipoprotein E##5##2##(1990-2#1)(1995-12#2)(1996-12#1)(1996-2#1)
Apolipoprotein L1##2##2##(2008-10#2)
Apolipoprotein##9##1##(1990-2#1)(1995-12#2)(1995-2#2)(1996-12#1)(1996-2#1)(2008-10#2)
Apoplexy##2##1##(2011-2#2)
Apoptosis and##2##2##(1995-2#1)(2008-11#1)
Apoptosis is a##2##3##(2009-3#1)(2011-2#1)
Apoptosis is an active##2##4##(2008-11#1)(2011-2#1)
Apoptosis is##5##2##(1994-11#1)(2008-11#1)(2009-3#1)(2011-2#2)
Apoptosis of##6##2##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2011-3#1)
Apoptosis signaling pathways##2##3##(2008-4#1)(2008-9#1)
Apoptosis was##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
Apoptosis##32##1##(1993-2#1)(1994-11#3)(1995-12#1)(1995-2#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#3)
Apoptotic Cell Death##3##3##(2008-10#1)(2011-2#2)
Apoptotic cell death##2##3##(1996-12#1)(2012-2#1)
Apoptotic##9##1##(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#3)(2012-2#1)
Apothecia##3##1##(2008-10#3)
Apparent Km##2##2##(1992-3#1)(1995-8#1)
Apparent##9##1##(1992-3#2)(1995-8#2)(2008-10#1)(2008-5#1)(2008-9#2)(2011-2#1)
Apparently##10##1##(1990-6#1)(1991-5#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-8#1)
Appeal##2##1##(1990-2#1)(2012-2#1)
Appeals##14##1##(1993-1#1)(1995-12#4)(1995-6#5)(1996-5#3)(1997-6#1)
Appearance##2##1##(1994-11#1)(2010-9#1)
Appellate Division##3##2##(1993-1#1)(1995-6#1)(1996-5#1)
Appetite##3##1##(2013-8#3)
Appin##2##1##(2008-5#2)
Appl##4##1##(2008-10#2)(2008-11#1)(2008-2#1)
Apple Fruit##3##2##(2008-10#3)
Apple Leaves##2##2##(2008-10#2)
Apple Scab##3##2##(2008-10#3)
Apple and##2##2##(2008-10#2)
Apple chlorotic leaf spot virus (ACLSV)##3##6##(2008-10#3)
Apple chlorotic leaf spot virus##5##5##(2008-10#5)
Apple stem pitting virus##3##4##(2008-10#3)
Apple stem##4##2##(2008-10#4)
Apple##43##1##(1991-12#2)(2008-10#41)
Apple-Leaves##2##1##(2008-10#2)
Apples##5##1##(2008-10#5)
Applicability of the##2##3##(2008-10#1)(2008-3#1)
Applicability of##5##2##(2008-10#4)(2008-3#1)
Applicability to##4##2##(2008-10#4)
Applicability##9##1##(2008-10#8)(2008-3#1)
Application and##2##2##(2008-10#1)(2008-9#1)
Application for##3##2##(1990-12#1)(2008-10#2)
Application in##3##2##(1991-12#1)(2008-10#2)
Application of Candida##2##3##(2008-10#2)
Application of Doehlert##2##3##(2008-10#2)
Application of EMLA for##2##4##(1993-1#2)
Application of a flow##2##4##(2008-10#2)
Application of a##15##3##(1994-3#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-2#1)(2011-2#1)
Application of an##4##3##(1995-5#1)(2008-10#3)
Application of artificial neural networks##2##5##(2008-10#2)
Application of artificial neural##3##4##(2008-10#3)
Application of capillary electrophoresis to##2##5##(2008-10#2)
Application of capillary electrophoresis##3##4##(2008-10#3)
Application of factorial design in optimization of##2##7##(2008-10#2)
Application of flowing stream techniques to water analysis##2##8##(2008-10#2)
Application of multivariate data analysis##2##5##(2008-10#2)
Application of multivariate##3##3##(2008-10#3)
Application of sequential##2##3##(2008-10#2)
Application of statistical##2##3##(2008-3#1)(2008-9#1)
Application of the extended boundary condition method to##2##8##(2008-3#2)
Application of the method to real samples##2##7##(2008-10#2)
Application of the method to the##3##6##(2008-10#3)
Application of the method to##7##5##(1996-3#1)(2008-10#6)
Application of the method##8##4##(1996-3#1)(2008-10#6)(2008-11#1)
Application of the##36##3##(1990-5#1)(1990-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-10#20)(2008-11#2)(2008-3#3)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
Application of this##3##3##(2008-10#2)(2008-3#1)
Application of two##2##3##(2008-10#1)(2012-3#1)
Application of##177##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-1#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#110)(2008-11#6)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
Application on##2##2##(2008-10#2)
Application to the determination of##2##5##(2008-10#2)
Application to the##9##3##(2008-10#7)(2008-3#1)(2008-8#1)
Application to##27##2##(1997-2#1)(2008-10#20)(2008-3#3)(2008-8#1)(2010-10#1)(2011-2#1)
Application##220##1##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-6#1)(1993-1#2)(1993-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#139)(2008-11#7)(2008-2#1)(2008-3#12)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#3)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Applications and##2##2##(2008-10#1)(2008-12#1)
Applications in##2##2##(2008-2#1)(2008-5#1)
Applications of the method to##4##5##(1997-6#1)(2008-10#3)
Applications of the##9##3##(1997-6#1)(2008-10#8)
Applications of##25##2##(1994-9#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#14)(2008-12#2)(2010-1#1)(2010-7#3)
Applications on##2##2##(2008-10#2)
Applications to water##2##3##(2008-10#2)
Applications to##8##2##(1991-12#1)(2008-10#6)(2008-3#1)
Applications##46##1##(1991-12#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-7#3)(2011-2#1)
Applied to##3##2##(2008-10#1)(2012-3#2)
Applied##16##1##(1994-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-3#2)(2013-1#2)
Applying a##2##2##(2011-9#1)(2013-1#1)
Applying the##9##2##(1991-2#1)(1994-1#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-3#1)
Applying this method##2##3##(2008-10#1)(2009-5#1)
Applying this##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
Applying##27##1##(1991-2#1)(1992-1#1)(1993-12#1)(1994-1#1)(1995-2#1)(1996-3#1)(2008-10#7)(2008-11#4)(2008-3#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-9#1)(2013-1#3)(2013-8#1)
Appreciation of music##2##3##(2008-9#2)
Appressoria of Colletotrichum acutatum##2##4##(2008-10#2)
Appressoria were##2##2##(2008-10#2)
Appressoria##6##1##(2008-10#6)
Appressorium Formation##2##2##(2008-10#2)
Approach for##6##2##(2008-10#3)(2009-10#1)(2009-6#1)(2011-2#1)
Approach to the##7##3##(1996-5#1)(1997-2#1)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-3#1)
Approach to##13##2##(1990-11#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
Approach##34##1##(1990-11#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#5)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
Approaches for##5##2##(2008-10#1)(2010-5#1)(2012-3#2)(2013-1#1)
Approaches to##7##2##(1991-1#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
Approaches##20##1##(1991-1#1)(1992-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#5)
Appropriate##21##1##(1992-3#1)(1994-2#1)(1995-12#2)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Appropriately##3##1##(2008-11#2)(2010-6#1)
Appropriateness of##3##2##(2010-12#3)
Appropriateness##5##1##(2010-12#5)
Approved##4##1##(2008-10#2)(2012-2#2)
Approximate##4##1##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
Approximately 25%##2##2##(2012-2#1)(2012-3#1)
Approximately 80% of##2##3##(1991-2#1)(2008-12#1)
Approximately two-thirds of the##2##4##(2008-1#1)(2008-10#1)
Approximately two-thirds##3##2##(2008-1#1)(2008-10#1)(2009-4#1)
Approximately##47##1##(1991-11#1)(1991-2#1)(1991-6#1)(1993-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)
Apricot pseudo-chlorotic leaf spot virus##2##5##(2008-10#2)
Apricot##3##1##(2008-10#3)
April 1989##2##2##(1990-6#1)(1991-1#1)
April 1990##2##2##(1992-6#1)(1993-1#1)
April 1992##2##2##(1992-5#1)(1994-6#1)
April 1993##2##2##(1994-6#1)(1995-11#1)
April 2##2##2##(2008-11#1)(2009-6#1)
April 2006##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
April 2008##5##2##(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#2)
April 2010##2##2##(2012-2#1)(2013-1#1)
April and May##5##3##(2008-10#5)
April and##8##2##(2008-10#6)(2010-10#1)(2010-8#1)
April to##4##2##(2008-10#3)(2012-3#1)
April##65##1##(1990-6#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-5#1)(1992-6#3)(1993-1#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-3#2)(1996-5#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#9)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
Apropos of##2##2##(1990-3#1)(1997-3#1)
Aptamers generated##2##2##(2008-4#1)(2010-5#1)
Aptamers##3##1##(2008-4#1)(2010-5#1)(2010-7#1)
Apteronotus leptorhynchus##2##2##(1995-12#2)
Aquatic##2##1##(2008-10#2)
Aqueous and##3##2##(2010-4#1)(2012-2#1)(2013-8#1)
Aqueous solutions of##2##3##(2008-10#2)
Aqueous solutions##3##2##(2008-10#3)
Aqueous suspensions of##2##3##(2008-10#2)
Aqueous##17##1##(1992-3#1)(1995-3#1)(2008-10#10)(2008-12#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-8#1)
Ar flow rate##2##3##(2008-10#2)
Ar flow##3##2##(2008-10#3)
Ar##17##1##(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2010-5#1)
Ar'##2##1##(2008-11#2)
ArCl##4##1##(2008-10#4)
Ara h1##3##2##(2008-11#3)
Ara##6##1##(2008-10#1)(2008-11#3)(2008-6#2)
Arab population##2##2##(2008-6#2)
Arab##12##1##(2008-10#4)(2008-12#2)(2008-6#2)(2012-2#1)(2013-1#3)
Arabia##17##1##(1994-2#1)(2008-1#8)(2008-10#4)(2008-12#2)(2013-1#2)
Arabian crude oil residue##2##4##(2008-10#2)
Arabic-speaking##2##1##(2013-1#2)
Arabidopsis ESTs##2##2##(1997-6#1)(1997-8#1)
Arabidopsis and tomato##2##3##(2008-10#2)
Arabidopsis and##10##2##(2008-10#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-10#2)(2012-2#1)
Arabidopsis by##2##2##(2008-9#2)
Arabidopsis cell death mutation locus##2##5##(2008-8#2)
Arabidopsis genome##3##2##(2007-12#2)(2009-10#1)
Arabidopsis plants grown in the compost##2##6##(2008-10#2)
Arabidopsis plants##7##2##(2008-10#5)(2009-8#2)
Arabidopsis roots##2##2##(2008-10#1)(2009-8#1)
Arabidopsis sp##2##2##(2008-10#2)
Arabidopsis thaliana and##4##3##(2008-10#1)(2008-9#2)(2013-8#1)
Arabidopsis thaliana ecotypes##2##3##(2008-10#1)(2012-3#1)
Arabidopsis thaliana is##3##3##(1993-2#1)(2008-9#1)(2009-8#1)
Arabidopsis thaliana##54##2##(1991-6#2)(1993-2#1)(1994-12#1)(1997-6#2)(1997-8#3)(2008-1#1)(2008-10#20)(2008-12#1)(2008-9#10)(2009-10#1)(2009-8#3)(2011-10#1)(2011-2#2)(2012-3#4)(2013-8#2)
Arabidopsis##157##1##(1991-6#2)(1993-2#1)(1994-12#2)(1995-2#3)(1997-6#3)(1997-8#6)(2007-12#8)(2008-1#1)(2008-10#48)(2008-12#1)(2008-8#4)(2008-9#18)(2009-10#13)(2009-5#1)(2009-8#25)(2011-10#5)(2011-2#4)(2012-2#5)(2012-3#5)(2013-8#2)
Arabidopsis-thrips system##2##2##(2009-8#2)
Arabis mosaic virus##3##3##(2008-10#3)
Arabs##2##1##(1994-12#1)(1997-8#1)
Araceae##7##1##(2008-10#7)
Aras dam##2##2##(2008-12#2)
Arbitrarily primed polymerase chain reaction and A+T-rich DNA analyses##2##9##(2008-10#2)
Arbitrarily primed polymerase chain reaction##3##5##(2008-10#3)
Arbitrarily##4##1##(2008-10#4)
Arbuscular mycorrhizal##2##2##(2008-10#1)(2008-8#1)
Arcanobacterium haemolyticum##2##2##(2011-2#2)
Arcanobacterium##4##1##(2011-2#4)
Arceuthobium on##2##2##(2008-10#2)
Arceuthobium##3##1##(2008-10#3)
Archaeoglobus profundus##2##2##(2011-2#2)
Archaeology##2##1##(1990-8#1)(2012-9#1)
Archezoa are##2##2##(2008-8#2)
Archezoa##4##1##(2008-8#4)
Architecture##3##1##(1997-3#1)(2010-8#2)
Archives of##2##2##(2008-12#1)(2009-4#1)
Archives##3##1##(2008-12#1)(2009-4#1)(2010-1#1)
Arcobacter nitrofigilis##2##2##(2011-2#2)
Arcobacter##5##1##(2011-2#5)
Arctic##4##1##(1991-5#2)(2008-10#1)(2008-11#1)
Are Associated with##2##3##(2012-12#1)(2013-7#1)
Are Associated##3##2##(2012-12#1)(2013-7#1)(2013-8#1)
Are We##2##2##(2009-4#1)(2009-6#1)
Are fiberoptic lasers better than CO 2 lasers for operative laparoscopy?##2##11##(1991-3#2)
Are the##2##2##(2008-8#1)(2009-5#1)
Are there differences in##2##4##(2007-11#1)(2012-2#1)
Are there##7##2##(1991-8#1)(1992-8#1)(2007-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-2#1)
Are they##2##2##(2008-11#1)(2013-8#1)
Are we##8##2##(1992-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#1)(2012-3#1)
Are you##3##2##(1991-3#1)(2011-2#1)(2012-3#1)
Are##56##1##(1991-3#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1995-3#1)(2007-11#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
Area Mental Health Service##2##4##(2008-11#2)
Area of##5##2##(1994-6#1)(1995-5#1)(2008-10#2)(2008-11#1)
Area under the disease progress curve##2##6##(2008-10#2)
Area under the disease progress##3##5##(2008-10#3)
Area##25##1##(1994-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(2008-10#6)(2008-11#6)(2008-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
Areas of##2##2##(1994-2#1)(2010-7#1)
Areas##7##1##(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2013-1#1)
Areca catechu (IC50##3##3##(2008-5#3)
Areca catechu L##3##3##(2008-5#3)
Areca catechu##7##2##(2008-5#7)
ArfB##4##1##(2009-8#4)
Arg and##4##2##(1992-4#1)(1995-3#1)(1995-6#1)(1996-2#1)
Arg residues##2##2##(1992-4#1)(1995-8#1)
Arg##22##1##(1990-5#1)(1992-4#4)(1993-2#3)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#1)(2008-10#1)(2008-11#3)(2008-8#4)
Arg- Phe- Tyr-##2##3##(1991-5#2)
Argentina and##2##2##(2008-10#1)(2013-8#1)
Argentina##24##1##(1996-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-10#2)(2013-1#1)(2013-8#1)
Argentine##3##1##(2008-5#3)
Argentinean isolates##2##2##(2008-10#2)
Arginine##2##1##(1990-12#1)(2008-5#1)
Argon laser laparoscopy##2##3##(1992-1#2)
Argon##3##1##(1992-1#2)(2013-1#1)
Argon-photocoagulator##2##1##(1991-9#2)
Argonne##2##1##(2008-11#2)
Argus X-8##3##2##(2008-12#3)
Argyle##2##1##(2008-10#2)
Arina##4##1##(2008-10#4)
Arizona and##2##2##(1990-8#1)(2011-2#1)
Arizona is##2##2##(1992-2#1)(2011-2#1)
Arizona##24##1##(1990-8#2)(1991-3#1)(1992-2#1)(1995-12#3)(2008-10#7)(2008-5#2)(2008-9#1)(2009-8#2)(2011-2#5)
Arkansas Medicaid##2##2##(1997-2#2)
Arkansas##7##1##(1997-2#3)(2008-10#3)(2013-8#1)
Arlington##2##1##(1993-12#1)(2010-11#1)
Arm##6##1##(1993-6#1)(2008-12#2)(2008-9#3)
Armed##3##1##(1995-6#1)(2008-10#1)(2008-5#1)
Armenia##3##1##(1995-12#1)(2008-10#1)(2008-12#1)
Armenian isolates##2##2##(1995-12#2)
Armenian##3##1##(1995-12#2)(2008-12#1)
Armillaria ostoyae##3##2##(2008-10#3)
Armillaria spp##3##2##(2008-10#3)
Armillaria##10##1##(2008-10#9)(2012-2#1)
Army Hospitals##2##2##(2012-2#2)
Army hospitals in Iran##2##4##(2012-2#2)
Army hospitals##3##2##(2012-2#3)
Army##9##1##(1990-3#1)(1992-12#2)(2012-2#5)(2012-3#1)
Arnold##2##1##(2010-1#1)(2012-2#1)
Aroclor 1254##2##2##(1993-8#2)
Aroclor##4##1##(1993-8#2)(2008-10#2)
Arom-IR cells##2##2##(1994-2#2)
Arom-IR neurones were##3##3##(1994-2#3)
Arom-IR##5##1##(1994-2#5)
Aromatase inhibitors##2##2##(2011-1#2)
Aromatase##4##1##(1993-8#1)(1994-2#1)(2011-1#2)
Aromatic amines##2##2##(2008-10#2)
Aromatic azo compounds##2##3##(2008-10#2)
Aromatic##9##1##(1996-5#1)(2008-10#7)(2008-11#1)
Around 1900##2##2##(2008-10#1)(2010-1#1)
Around##6##1##(1995-2#1)(2008-10#2)(2010-1#1)(2010-7#1)(2011-2#1)
Arp3 (actin-related protein 3##2##4##(2012-2#2)
Arp3 to##2##2##(2012-2#2)
Arp3##6##1##(2012-2#6)
Array##7##1##(1995-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-3#2)
Arrays##3##1##(2008-10#2)(2008-4#1)
Arrhenius plot##2##2##(1994-8#1)(2008-10#1)
Arrhenius##7##1##(1991-5#1)(1994-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)
Arrhenotokous##2##1##(2008-10#2)
ArsA protein##4##2##(1994-5#4)
Arsenazo III procedure was tested by##2##6##(2008-10#2)
Arsenazo III procedure##3##3##(2008-10#3)
Arsenazo III##8##2##(2008-10#8)
Arsenic compounds were##2##3##(2008-10#2)
Arsenic compounds##3##2##(2008-10#3)
Arsenic in##3##2##(2008-10#3)
Arsenic is##2##2##(2008-10#2)
Arsenic speciation in##3##3##(2008-10#3)
Arsenic speciation##5##2##(2008-10#5)
Arsenic##23##1##(2008-10#21)(2008-12#1)(2013-1#1)
Arsenic(V)##2##1##(2008-10#2)
Arsenite##3##1##(1994-11#1)(2008-10#2)
Arsine##4##1##(2008-10#4)
Art##2##1##(1995-3#1)(2010-7#1)
Artemia sp##3##2##(2008-9#2)(2010-8#1)
Artemia##5##1##(2007-12#2)(2008-9#2)(2010-8#1)
Artemisia monosperma##2##2##(2008-10#1)(2013-1#1)
Artemisia##5##1##(2008-10#3)(2012-2#1)(2013-1#1)
Arterial blood##2##2##(2011-2#1)(2012-3#1)
Arterial##9##1##(1993-1#1)(1997-8#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-8#1)
Arteries##4##1##(1995-8#1)(1996-9#1)(2009-8#1)(2011-2#1)
Arteriovenous Malformations##3##2##(1995-11#1)(1997-6#1)(2012-3#1)
Arteriovenous malformation of the pregnant uterus##2##6##(2008-8#2)
Arteriovenous##10##1##(1995-11#1)(1996-3#1)(1996-9#1)(1997-6#2)(2008-8#2)(2012-3#3)
Artery Stenosis##2##2##(2008-11#1)(2012-3#1)
Artery##8##1##(2008-11#4)(2008-12#1)(2012-3#3)
Arthrex AR-6400 and AR-6475##2##4##(2011-2#2)
Arthrex##3##1##(2009-10#1)(2011-2#2)
Arthritis##6##1##(1993-1#2)(2008-10#1)(2008-9#1)(2010-12#1)(2013-1#1)
Arthrobacter sp##2##2##(1995-3#2)
Arthrobacter##4##1##(1994-11#1)(1995-3#2)(2008-10#1)
Arthroplasty##6##1##(2012-3#2)(2013-1#4)
Arthropoda##3##1##(2009-6#3)
Arthroscopic##5##1##(2008-12#1)(2010-7#1)(2012-12#1)(2013-1#2)
Arthur##2##1##(2008-10#2)
Arthus##3##1##(1992-12#1)(2008-7#2)
Artichoke isolates##2##2##(2008-10#2)
Artichoke yellow ringspot virus##2##4##(2008-10#2)
Artichoke##6##1##(2008-10#5)(2011-2#1)
Article##8##1##(1991-3#1)(2008-10#3)(2008-11#3)(2010-1#1)
Articles were excluded if they did not##2##7##(2012-12#2)
Articles##5##1##(1994-12#1)(2010-12#1)(2012-12#2)(2012-3#1)
Artificial Neural Network (ANN)##2##4##(2008-10#1)(2010-8#1)
Artificial Neural Networks##4##3##(2008-10#3)(2008-11#1)
Artificial Neural##6##2##(2008-10#4)(2008-11#1)(2010-8#1)
Artificial inoculation##3##2##(2008-10#3)
Artificial neural networks (ANNs) are among the most popular techniques for nonlinear multivariate calibration in complicated mixtures using spectrophotometric data##2##20##(2008-10#2)
Artificial neural networks (ANNs) are##3##5##(2008-10#3)
Artificial neural networks (ANNs)##5##4##(2008-10#5)
Artificial neural networks##6##3##(2008-10#6)
Artificial neural##7##2##(2008-10#7)
Artificial sapphire contact probes##2##4##(1993-1#2)
Artificial##28##1##(1993-1#2)(2008-10#19)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)
Artificially damaged##2##2##(1990-11#1)(2008-5#1)
Artificially##5##1##(1990-11#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-8#1)
Artogeia rapae##2##2##(1997-8#2)
As (III) and As (V)##2##5##(2008-10#2)
As a conclusion##2##3##(2008-10#1)(2013-1#1)
As a consequence of the##2##5##(1990-11#1)(2012-2#1)
As a consequence of##6##4##(1990-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
As a consequence##28##3##(1990-11#1)(1995-6#1)(1997-5#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-5#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
As a first step toward##3##5##(2008-10#1)(2009-7#1)(2012-3#1)
As a first step##6##4##(1993-2#1)(1994-11#1)(1996-6#1)(2008-10#1)(2009-7#1)(2012-3#1)
As a first##9##3##(1993-2#1)(1994-11#1)(1995-2#1)(1996-6#1)(2008-10#2)(2009-7#1)(2011-2#1)(2012-3#1)
As a matter of##2##4##(2008-8#1)(2013-1#1)
As a measure##2##3##(2008-6#1)(2012-5#1)
As a model system##3##4##(2008-10#2)(2008-11#1)
As a model##7##3##(1993-1#1)(1993-8#1)(2008-10#2)(2008-11#2)(2008-6#1)
As a new##4##3##(1993-12#1)(2008-10#2)(2013-1#1)
As a part of##3##4##(1997-3#1)(2008-11#1)(2008-12#1)
As a preliminary##2##3##(2008-10#2)
As a result of the##8##5##(2008-10#4)(2008-11#2)(2010-10#1)(2013-1#1)
As a result of these##2##5##(1997-2#1)(2008-11#1)
As a result of this study##2##6##(2008-3#1)(2013-1#1)
As a result of this##6##5##(2008-11#2)(2008-3#1)(2010-3#1)(2010-5#1)(2013-1#1)
As a result of##24##4##(1992-5#1)(1993-2#1)(1995-8#1)(1997-2#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2013-1#2)
As a result we##2##4##(1997-7#1)(2008-9#1)
As a result##108##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#1)(2008-10#21)(2008-11#14)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
As a rule##2##3##(1995-11#1)(2008-10#1)
As a standard##2##3##(2008-10#1)(2008-12#1)
As a starting point##3##4##(1996-2#1)(1996-3#1)(2008-10#1)
As a step##2##3##(1997-2#1)(2008-11#1)
As a test of this##2##5##(1992-7#1)(2012-2#1)
As a test##3##3##(1992-7#1)(2008-12#1)(2012-2#1)
As a##220##2##(1990-11#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-5#1)(1997-7#1)(1997-8#2)(2008-10#55)(2008-11#24)(2008-12#12)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#3)(2012-5#1)(2013-1#9)(2013-8#2)
As administrators##2##2##(1994-3#2)
As an alternative approach##2##4##(2012-12#1)(2012-3#1)
As an alternative to##2##4##(2008-10#1)(2011-1#1)
As an alternative##8##3##(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
As an application##4##3##(2008-10#2)(2008-3#1)(2011-3#1)
As an example of the##2##5##(1997-1#1)(2008-10#1)
As an example of##4##4##(1997-1#1)(2008-10#2)(2008-7#1)
As an example we##2##4##(2008-5#1)(2009-3#1)
As an example##13##3##(1997-1#1)(2008-10#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)
As an##39##2##(1990-8#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#2)
As analyzing##2##2##(1990-12#1)(2008-10#1)
As and Sb in##2##4##(2008-10#2)
As and Sb##10##3##(2008-10#10)
As and Se in##3##4##(2008-10#3)
As and Se speciation##2##4##(2008-10#2)
As and Se##18##3##(2008-10#18)
As and##36##2##(2008-10#36)
As anticipated##2##2##(1992-6#1)(2008-10#1)
As at##7##2##(2008-10#6)(2008-12#1)
As both##3##2##(1992-1#1)(2008-10#1)(2008-11#1)
As compared to the##5##4##(1993-2#1)(1994-11#1)(1996-8#1)(2008-11#1)(2008-7#1)
As compared to##9##3##(1993-2#1)(1994-11#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)
As compared with the##5##4##(1995-6#1)(1995-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
As compared with##9##3##(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
As compared##18##2##(1993-2#1)(1994-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
As content##3##2##(2008-10#3)
As cord blood##2##3##(2008-11#1)(2008-9#1)
As could be##2##3##(2008-10#2)
As demonstrated by##2##3##(2008-10#1)(2008-11#1)
As described in##2##3##(1995-2#1)(2008-4#1)
As described##3##2##(1995-2#1)(2008-4#2)
As determination##2##2##(2008-10#2)
As each department##2##3##(1994-3#1)(1996-1#1)
As expected by##2##3##(2008-10#1)(2008-6#1)
As expected##18##2##(1992-9#1)(1993-6#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-8#2)
As far as the authors##2##5##(1991-1#1)(2011-2#1)
As far as the##4##4##(1991-1#1)(2008-10#1)(2010-1#1)(2011-2#1)
As far as we know##2##5##(2008-10#1)(2008-2#1)
As far as##6##3##(1991-1#1)(2008-10#2)(2008-2#1)(2010-1#1)(2011-2#1)
As for the##8##3##(1993-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
As for##16##2##(1990-9#1)(1993-8#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
As found in##2##3##(1995-8#1)(2008-10#1)
As from groundwater samples##2##4##(2013-1#2)
As from groundwater##3##3##(2013-1#3)
As from##5##2##(1990-11#1)(2008-10#1)(2013-1#3)
As has been##2##3##(1997-7#1)(2008-10#1)
As has##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
As hypothesized##2##2##(2008-10#1)(2009-8#1)
As illustrated##2##2##(2008-11#1)(2008-4#1)
As in other##2##3##(1996-12#1)(2007-12#1)
As in previous##2##3##(2008-10#1)(2008-8#1)
As in the case of##2##5##(2008-10#1)(2010-7#1)
As in the first case##2##5##(1993-2#1)(2008-10#1)
As in the##9##3##(1993-2#1)(1996-11#1)(2008-10#5)(2010-7#1)(2012-3#1)
As in##26##2##(1991-8#1)(1993-2#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-8#1)(2010-7#1)(2012-3#1)
As indicated##2##2##(2008-8#1)(2010-6#1)
As is##2##2##(2008-10#2)
As it##2##2##(1991-3#1)(2008-12#1)
As judged by##2##3##(1997-2#1)(2008-11#1)
As l(-1)##4##2##(2008-10#4)
As little##2##2##(1995-11#1)(2008-10#1)
As long as##2##3##(2008-10#1)(2008-7#1)
As low as##3##3##(2008-10#2)(2008-7#1)
As many as##2##3##(1996-11#1)(2010-8#1)
As many##6##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2013-1#1)
As more##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
As new##5##2##(1992-3#1)(1995-1#1)(1995-5#1)(2008-7#1)(2013-8#1)
As no##4##2##(2008-10#3)(2008-9#1)
As observed in other##2##4##(2008-5#1)(2010-4#1)
As of##5##2##(1991-1#1)(2008-10#2)(2008-4#1)(2008-5#1)
As opposed to the##2##4##(2008-10#2)
As our##2##2##(2008-8#1)(2008-9#1)
As part of a U##2##5##(1991-2#1)(1992-1#1)
As part of a##9##4##(1991-2#1)(1992-1#1)(1995-1#1)(2008-10#2)(2008-7#1)(2009-12#1)(2009-8#1)(2013-8#1)
As part of an##4##4##(2008-10#2)(2008-5#1)(2011-2#1)
As part of our##2##4##(1996-2#1)(2009-7#1)
As part of the##5##4##(1994-1#1)(1997-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
As part of##25##3##(1990-6#1)(1991-2#1)(1992-1#1)(1993-8#1)(1994-1#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#2)
As predicted##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)
As regards the##2##3##(2008-10#2)
As regards##4##2##(1990-2#1)(1991-8#1)(2008-10#2)
As reported in##2##3##(2008-5#1)(2013-1#1)
As reported##4##2##(1996-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
As shown by##2##3##(1996-3#1)(2008-9#1)
As shown in##2##3##(1995-2#1)(2008-10#1)
As shown##5##2##(1995-2#1)(1996-3#1)(2008-10#2)(2008-9#1)
As soon as the##2##4##(2008-10#2)
As speciation##2##2##(2008-10#2)
As species in##3##3##(2008-10#3)
As species##6##2##(2008-10#6)
As such##23##2##(1992-2#1)(1993-3#1)(1994-1#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
As the field##2##3##(2008-10#2)
As the final##2##3##(1995-2#1)(2008-10#1)
As the first step of##2##5##(2008-10#1)(2013-8#1)
As the first step##4##4##(1993-8#1)(1995-12#1)(2008-10#1)(2013-8#1)
As the growth##2##3##(2008-11#1)(2011-1#1)
As the level##2##3##(1991-5#1)(2008-6#1)
As the method could effectively separate the drug from its degradation products##2##12##(2008-10#2)
As the protein##2##3##(1994-3#1)(2011-2#1)
As the result of a##2##5##(1991-2#1)(2012-2#1)
As the result of##3##4##(1991-2#1)(2008-7#1)(2012-2#1)
As the result##4##3##(1991-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
As the results##2##3##(1996-12#1)(2010-6#1)
As the##121##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-4#1)(2008-10#25)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#2)(2011-7#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
As these##9##2##(1992-2#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)
As this professional paper##2##4##(1993-1#1)(1997-1#1)
As this##6##2##(1993-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-11#1)(2012-6#1)
As to the##4##3##(1995-8#1)(2008-7#1)(2011-2#2)
As to##5##2##(1995-8#1)(2008-10#1)(2008-7#1)(2011-2#2)
As was##6##2##(2008-10#6)
As we have##2##3##(1994-2#1)(2008-10#1)
As we##7##2##(1994-2#1)(1996-2#1)(2008-10#2)(2008-4#1)(2010-12#1)(2013-7#1)
As well as##8##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)
As well##19##2##(1994-1#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
As with all##2##3##(2009-10#1)(2010-6#1)
As with any##2##3##(1991-3#1)(1996-1#1)
As with many##2##3##(2012-3#1)(2013-1#1)
As with other##2##3##(2008-6#1)(2012-12#1)
As with the##2##3##(2008-11#1)(2012-2#1)
As with##18##2##(1991-3#1)(1992-12#1)(1992-3#1)(1995-2#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
As##990##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#4)(1991-5#2)(1991-8#2)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#5)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-1#4)(1993-12#5)(1993-2#9)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#8)(1994-1#4)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#7)(1994-5#2)(1994-9#1)(1995-1#6)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#7)(1995-9#1)(1996-1#8)(1996-11#2)(1996-12#7)(1996-2#5)(1996-3#10)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#7)(1997-2#10)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#3)(2008-1#2)(2008-10#358)(2008-11#73)(2008-12#23)(2008-2#5)(2008-3#14)(2008-4#12)(2008-5#23)(2008-6#7)(2008-7#16)(2008-8#19)(2008-9#21)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#27)(2011-3#4)(2011-4#1)(2011-7#1)(2012-12#5)(2012-2#17)(2012-3#18)(2012-5#2)(2012-6#1)(2013-1#27)(2013-7#2)(2013-8#13)
As(2)O(3) induced##2##2##(2008-8#2)
As(2)O(3)##5##1##(2008-8#5)
As(DDTP)(3)##2##1##(2008-10#2)
As(III) and As(V) in##9##4##(2008-10#9)
As(III) and As(V) were##2##4##(2008-10#2)
As(III) and As(V)##21##3##(2008-10#21)
As(III) and##26##2##(2008-10#26)
As(III) by silver diethyldithiocarbamate##2##4##(2008-10#2)
As(III) concentration##2##2##(2008-10#2)
As(III) determination##2##2##(2008-10#2)
As(III) in##7##2##(2008-10#7)
As(III) is##5##2##(2008-10#5)
As(III) to##3##2##(2008-10#3)
As(III) was 1##2##3##(2008-10#2)
As(III) was##6##2##(2008-10#6)
As(III)##94##1##(2008-10#94)
As(III+V)##5##1##(2008-10#5)
As(V) and##6##2##(2008-10#6)
As(V) at##2##2##(2008-10#2)
As(V) based##2##2##(2008-10#2)
As(V) in##11##2##(2008-10#11)
As(V) species##2##2##(2008-10#2)
As(V) to As(III)##2##3##(2008-10#2)
As(V) with##2##2##(2008-10#2)
As(V)##67##1##(2008-10#67)
As)##4##1##(2008-10#4)
As51 satellite DNA##3##3##(2010-8#3)
As51##4##1##(2010-8#4)
AsA in##3##2##(2008-10#3)
AsA suppressed the##2##3##(2008-11#2)
AsA##14##1##(2008-10#8)(2008-11#6)
AsB and AsC##3##3##(2008-10#3)
AsB was##2##2##(2008-10#2)
AsB##5##1##(2008-10#5)
AsC##5##1##(2008-10#5)
AsH(3)##3##1##(2008-10#3)
Asbestos disease##2##2##(1991-12#2)
Asbestos exposure and##2##3##(1991-12#2)
Asbestos exposure##3##2##(1991-12#3)
Asbestos fibers##2##2##(1991-12#2)
Asbestos in place##2##3##(1991-12#2)
Asbestos in##3##2##(1991-12#3)
Asbestos##14##1##(1991-12#13)(1995-2#1)
Asbestos-associated##2##1##(1991-12#2)
Asbestos-related disease in##2##3##(1991-12#2)
Asbestos-related disease##3##2##(1991-12#3)
Asbestos-related##5##1##(1991-12#5)
Asc I##2##2##(1996-2#1)(1997-2#1)
Ascites##4##1##(1991-12#1)(1993-9#1)(2008-10#1)(2008-11#1)
Ascocarps##2##1##(2008-10#2)
Ascochyta blight##3##2##(2008-10#3)
Ascochyta spp##2##2##(2008-10#2)
Ascochyta##7##1##(2008-10#7)
Ascomycetes##4##1##(2008-10#1)(2008-12#1)(2009-6#1)(2010-7#1)
Ascomycota##2##1##(2008-10#1)(2009-6#1)
Ascorbic acid (AA)##2##3##(2008-10#2)
Ascorbic acid and##2##3##(1993-3#1)(2008-10#1)
Ascorbic acid is##2##3##(2008-10#1)(2008-5#1)
Ascorbic acid was also##2##4##(2008-10#2)
Ascorbic acid was##3##3##(2008-10#3)
Ascorbic acid##18##2##(1992-9#3)(1993-12#2)(1993-3#2)(2008-10#9)(2008-5#2)
Ascospore Production of##2##3##(2008-10#2)
Ascospore maturation##2##2##(2008-10#2)
Ascospore release##5##2##(2008-10#5)
Ascospore##14##1##(2008-10#14)
Ascospores in##3##2##(2008-10#3)
Ascospores of Monosporascus cannonballus##2##4##(2008-10#2)
Ascospores of Venturia inaequalis##2##4##(2008-10#2)
Ascospores of##8##2##(2008-10#8)
Ascospores##15##1##(2008-10#15)
Asellus aquaticus##3##2##(2008-12#3)
Aseptic##4##1##(1991-2#3)(2012-2#1)
Asexual##4##1##(2008-10#3)(2008-8#1)
Ash##3##1##(2008-10#1)(2008-8#1)(2013-8#1)
Ashkenazi Jews##2##2##(2008-12#2)
AsiA##4##1##(1995-2#4)
Asia Pacific##4##2##(2008-8#1)(2010-10#1)(2012-12#2)
Asia and Australia##2##3##(2008-6#1)(2013-8#1)
Asia and North America##3##4##(2008-10#1)(2008-8#2)
Asia and##15##2##(1994-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Asia##67##1##(1993-3#1)(1994-3#1)(1994-9#1)(1995-3#1)(1997-2#1)(1997-7#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-6#2)(2008-8#9)(2008-9#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
Asia-Pacific countries##2##2##(2008-8#1)(2009-8#1)
Asia-Pacific##9##1##(1995-12#1)(2008-10#5)(2008-8#2)(2009-8#1)
Asian American##3##2##(2008-12#1)(2009-7#1)(2010-10#1)
Asian and Pacific Islander##2##4##(1997-2#2)
Asian and##6##2##(1997-2#2)(2008-1#1)(2009-10#1)(2010-3#1)(2011-2#1)
Asian countries##6##2##(1990-6#1)(1997-8#1)(2009-8#1)(2013-1#2)(2013-8#1)
Asian population##3##2##(2010-6#1)(2011-2#1)(2013-3#1)
Asian populations##3##2##(2008-9#1)(2010-10#1)(2010-3#1)
Asian##57##1##(1990-6#1)(1995-3#2)(1996-3#1)(1997-2#2)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-3#2)(2010-6#1)(2010-8#5)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-3#2)(2013-8#1)
Asian-Pacific consensus statement on the management of chronic hepatitis##2##9##(2009-8#2)
Asian-Pacific##3##1##(2008-10#1)(2009-8#2)
Asians and##4##2##(2008-10#1)(2011-2#2)(2012-2#1)
Asians with##2##2##(2011-2#1)(2012-2#1)
Asians##17##1##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-6#2)(2011-2#6)(2012-2#4)
Asiatic citrus canker (ACC)##3##4##(2008-10#3)
Asiatic##4##1##(2008-10#3)(2008-5#1)
Asking##2##1##(1994-12#1)(2013-8#1)
Asn at##2##2##(1993-8#1)(2008-8#1)
Asn##8##1##(1992-10#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-2#1)(1997-3#1)(2008-8#2)
Asp##7##1##(1993-2#1)(1993-3#1)(1993-8#1)(1995-6#2)(1997-3#1)(2008-11#1)
Asp-##2##1##(1991-5#2)
Asp-156##6##1##(1992-3#6)
Asp20##2##1##(1994-5#2)
Asp369##2##1##(1995-6#2)
Asparagus##7##1##(2008-10#6)(2013-1#1)
Aspartate##2##1##(1991-12#1)(2008-5#1)
Aspartic acid##2##2##(1990-10#1)(2008-5#1)
Aspects of the##3##3##(2008-10#3)
Aspects of##16##2##(1991-12#1)(1991-2#1)(1992-3#1)(1996-9#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-6#1)
Aspects on##2##2##(2008-11#2)
Aspects##18##1##(1991-12#1)(1991-2#1)(1992-3#1)(1996-9#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-6#1)
Aspergillosis##3##1##(2008-5#1)(2011-2#1)(2013-8#1)
Aspergillums can produce and secrete directly aflatoxin M1##2##8##(2013-1#2)
Aspergillus and##2##2##(1993-12#1)(2008-10#1)
Aspergillus ear rot##7##3##(2008-10#7)
Aspergillus ear##12##2##(2008-10#12)
Aspergillus ficuum phytase##2##3##(1992-12#1)(1995-3#1)
Aspergillus flavus and A##3##4##(2008-10#3)
Aspergillus flavus and Fusarium##2##4##(2008-10#2)
Aspergillus flavus and##8##3##(2008-10#8)
Aspergillus flavus was studied##2##4##(2008-10#2)
Aspergillus flavus was##3##3##(2008-10#3)
Aspergillus flavus##31##2##(2008-10#30)(2013-1#1)
Aspergillus fumigatus##5##2##(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)
Aspergillus giganteus##4##2##(1993-2#2)(2008-10#2)
Aspergillus infections##2##2##(2008-10#1)(2011-2#1)
Aspergillus nidulans##19##2##(1996-6#1)(1997-2#1)(1997-4#4)(1997-7#2)(1997-8#2)(2008-10#1)(2008-5#2)(2009-6#1)(2009-8#2)(2010-7#2)(2011-1#1)
Aspergillus niger glucoamylase##2##3##(2008-7#2)
Aspergillus niger##17##2##(1991-9#2)(1993-2#1)(1997-2#4)(2008-10#2)(2008-5#2)(2008-7#4)(2008-9#1)(2012-2#1)
Aspergillus spp##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
Aspergillus terreus##3##2##(2008-5#2)(2012-2#1)
Aspergillus##117##1##(1990-3#1)(1991-9#2)(1992-12#1)(1993-12#1)(1993-2#4)(1995-3#1)(1996-6#2)(1997-2#6)(1997-4#4)(1997-7#2)(1997-8#2)(2008-10#55)(2008-11#1)(2008-5#10)(2008-7#5)(2008-9#2)(2009-6#1)(2009-8#2)(2010-7#3)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#4)
Aspergillus/Penicillium##2##1##(2010-5#2)
Aspirin##7##1##(1991-8#1)(1995-10#1)(2008-11#3)(2011-2#1)(2013-1#1)
Assay conditions##2##2##(1991-5#1)(2008-10#1)
Assay for the##2##3##(2008-10#2)
Assay for##5##2##(2008-10#4)(2008-11#1)
Assay of##3##2##(1992-1#1)(1992-9#2)
Assay sensitivity##2##2##(1990-12#1)(2008-9#1)
Assay##35##1##(1990-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-9#2)(1995-9#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-9#1)(2012-3#2)(2013-8#1)
Assay)##2##1##(2008-11#1)(2009-3#1)
Assaying##3##1##(2008-4#2)(2010-12#1)
Assays for the##2##3##(2008-1#1)(2008-10#1)
Assays for##5##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
Assays of##3##2##(1990-7#1)(2008-10#1)(2008-9#1)
Assays##17##1##(1990-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#2)(2012-12#1)(2012-2#3)
Assemblage A##2##2##(2012-3#2)
Assemblage E##2##2##(2012-3#2)
Assemblage##4##1##(2012-3#4)
Assembly of##3##2##(1991-2#1)(1995-6#1)(2008-10#1)
Assembly##8##1##(1991-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#2)(2012-3#1)
Assertiveness is##2##2##(2008-11#2)
Assessing the needs of##2##4##(1994-2#1)(1994-3#1)
Assessing the##12##2##(1992-12#1)(1992-3#2)(1994-2#2)(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-12#1)
Assessing##32##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1994-2#2)(1994-3#2)(1994-9#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
Assessment Protocol for Excellence in Public Health##2##7##(1996-2#1)(1997-2#1)
Assessment Scale##2##2##(2008-11#1)(2008-7#1)
Assessment Tool##2##2##(2008-1#1)(2009-4#1)
Assessment Tools##2##2##(2008-11#1)(2008-12#1)
Assessment and##5##2##(1991-12#1)(1996-12#1)(1997-2#1)(2011-2#1)(2013-1#1)
Assessment in##2##2##(1997-3#1)(2012-2#1)
Assessment is a##2##3##(1996-1#1)(2010-9#1)
Assessment is##3##2##(1996-1#1)(2008-6#1)(2010-9#1)
Assessment of Cancer##2##3##(2008-7#2)
Assessment of cell##2##3##(2008-9#2)
Assessment of the Effects of##2##5##(2008-10#2)
Assessment of the##8##3##(2008-10#3)(2008-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
Assessment of##57##2##(1991-1#1)(1995-3#1)(1995-5#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#5)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-3#1)(2013-8#2)
Assessment##104##1##(1990-12#2)(1991-1#1)(1991-12#1)(1993-12#1)(1993-2#1)(1994-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#19)(2008-11#15)(2008-12#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-9#5)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-8#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-3#1)(2013-8#3)
Assessments##4##1##(2008-11#1)(2008-5#1)(2009-11#1)(2013-1#1)
Asset management##2##2##(2013-8#2)
Assignment of##4##2##(1995-6#1)(1996-12#1)(1997-2#1)(2009-7#1)
Assistance##7##1##(1991-1#1)(1992-1#1)(1993-2#1)(1995-1#1)(1997-3#1)(2008-11#1)(2011-7#1)
Assisted living and##2##3##(2008-12#2)
Assisted living##3##2##(2008-12#3)
Assisted##8##1##(1997-4#1)(2008-10#2)(2008-12#3)(2009-1#1)(2011-7#1)
Assisting##2##1##(2009-7#1)(2010-9#1)
Assoc##2##1##(2008-10#2)
Associated With##3##2##(2013-1#2)(2013-8#1)
Associated risk factors of##2##4##(1994-12#1)(2012-12#1)
Associated with a##4##3##(2008-10#4)
Associated with##44##2##(1994-12#1)(2008-1#1)(2008-10#32)(2008-7#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Associated##56##1##(1990-8#1)(1994-12#2)(2008-1#1)(2008-10#32)(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
Association (AHA)##2##2##(1991-12#1)(2008-3#1)
Association and the##4##3##(1991-2#1)(1996-6#1)(2008-1#1)(2008-10#1)
Association and##7##2##(1991-2#1)(1996-5#1)(1996-6#2)(2008-1#1)(2008-10#1)(2010-9#1)
Association between##7##2##(1993-9#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Association constants of##2##3##(2008-10#2)
Association constants##3##2##(2008-10#3)
Association for Healthcare##3##3##(1991-12#1)(1992-12#1)(1993-3#1)
Association for Volunteer Administration##3##4##(1994-3#2)(1995-12#1)
Association for the##3##3##(1992-3#1)(1994-3#1)(1997-6#1)
Association for##15##2##(1991-1#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-3#3)(1995-12#1)(1996-3#1)(1997-6#1)(2008-9#1)(2013-8#1)
Association have##2##2##(1995-6#1)(2010-1#1)
Association of Clinical##2##3##(1994-12#1)(2008-1#1)
Association of Private Psychiatric##5##4##(1991-1#2)(1992-2#2)(1992-3#1)
Association of University Programs in Health Administration##2##7##(1991-1#2)
Association of the##5##3##(1992-6#1)(1994-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
Association of urodynamic##2##3##(2008-7#1)(2012-12#1)
Association of##53##2##(1991-1#4)(1992-2#2)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-6#2)(1996-5#2)(1997-3#2)(1997-4#1)(2006-6#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-4#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-7#1)
Association was founded##2##3##(2008-8#1)(2011-4#1)
Association was##4##2##(2008-8#1)(2011-4#3)
Association with##4##2##(2008-10#3)(2008-7#1)
Association##146##1##(1990-6#3)(1991-1#6)(1991-12#3)(1991-2#3)(1991-3#3)(1991-8#2)(1992-12#2)(1992-2#4)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#6)(1994-3#3)(1994-5#1)(1995-12#3)(1995-6#3)(1996-3#1)(1996-5#3)(1996-6#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2006-6#1)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#7)(2011-4#6)(2012-12#8)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
Association)##3##1##(2008-5#1)(2008-8#2)
Associations among##2##2##(2008-8#1)(2009-7#1)
Associations between##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
Associations have##2##2##(2008-11#1)(2013-8#1)
Associations with##2##2##(1991-8#1)(2010-12#1)
Associations##18##1##(1991-8#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#2)
Assuming a##3##2##(1995-12#1)(2008-3#1)(2008-9#1)
Assuming that##2##2##(1991-5#1)(2008-8#1)
Assuming##9##1##(1991-1#1)(1991-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)
Assumptions##2##1##(2008-11#1)(2008-3#1)
Astacus leptodactylus##4##2##(2008-12#2)(2008-7#2)
Astacus##5##1##(2008-12#3)(2008-7#2)
Astaxanthin##3##1##(2008-12#1)(2013-8#2)
Asteraceae##3##1##(2008-10#3)
Asthma in##2##2##(2012-12#2)
Asthma is##2##2##(2010-9#1)(2011-1#1)
Asthma##20##1##(1993-1#1)(1995-12#1)(1997-1#1)(2010-1#1)(2010-5#1)(2010-9#3)(2011-1#2)(2011-2#1)(2012-12#5)(2013-1#3)(2013-8#1)
Astrix##3##1##(2008-10#3)
Astrocytes and microglia##2##3##(2008-7#1)(2013-7#1)
Astrocytes and##3##2##(1995-2#1)(2008-7#1)(2013-7#1)
Astrocytes##8##1##(1994-2#1)(1995-2#1)(2008-11#3)(2008-12#1)(2008-7#1)(2013-7#1)
Astronomers##3##1##(1990-11#1)(1990-8#1)(1995-6#1)
Astyanax bimaculatus lacustris##2##3##(2008-7#2)
Astyanax##6##1##(2008-7#2)(2008-8#1)(2010-8#3)
Aswan##3##1##(1994-9#2)(2008-10#1)
Asymmetric logistic equations##2##3##(2008-11#2)
Asymmetric##11##1##(1993-8#1)(1996-5#1)(2007-11#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
Asymmetry of##2##2##(2008-3#1)(2008-5#1)
Asymmetry##3##1##(2008-2#1)(2008-3#1)(2008-5#1)
Asymptomatic##10##1##(1996-3#1)(1997-3#1)(2008-10#4)(2008-12#1)(2012-12#1)(2012-3#2)
Asymptotic##2##1##(1991-9#1)(2008-3#1)
Asynchronous##2##1##(2008-10#2)
At 1##6##2##(1994-8#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)
At 10##3##2##(1991-6#1)(2007-8#1)(2008-10#1)
At 100##2##2##(2008-11#1)(2010-4#1)
At 12##2##2##(2008-10#1)(2008-11#1)
At 16##2##2##(2008-10#2)
At 2##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
At 20 degrees C##2##4##(2008-10#2)
At 20##4##2##(2008-10#3)(2008-5#1)
At 23 degrees C##2##4##(2008-10#2)
At 25 degrees C##2##4##(2008-10#2)
At 25##3##2##(2008-10#3)
At 3##3##2##(2008-7#1)(2010-3#1)(2013-1#1)
At 30##2##2##(1993-1#1)(2013-1#1)
At 300##2##2##(2008-10#2)
At 35##2##2##(2008-10#1)(2012-3#1)
At 4##9##2##(1996-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#3)
At 48 h##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
At 48##4##2##(1995-12#1)(2008-11#1)(2008-8#2)
At 500##2##2##(2008-11#2)
At 6##3##2##(1991-8#1)(2008-10#1)(2008-7#1)
At 7##4##2##(1994-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
At 8##2##2##(2008-10#1)(2011-2#1)
At Day 3##2##3##(2008-10#2)
At Day##3##2##(2008-10#3)
At a Fo47 to Foln3GUS inoculum ratio of##2##8##(2008-10#2)
At a higher concentration##2##4##(2008-10#1)(2008-11#1)
At a higher##3##3##(2008-10#2)(2008-11#1)
At a mean follow-up of##3##5##(1990-6#1)(2009-10#1)(2013-1#1)
At a sample frequency of##2##5##(2008-10#2)
At a time when##3##4##(1997-2#1)(2008-11#1)(2010-1#1)
At a##34##2##(1990-11#1)(1990-6#1)(1990-9#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#14)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#2)(2010-1#1)(2010-3#1)(2012-3#2)(2013-1#1)
At all##3##2##(1993-6#2)(1993-8#1)
At an##5##2##(2008-10#3)(2010-8#1)(2013-8#1)
At baseline##5##2##(1990-9#1)(2008-10#1)(2012-3#3)
At both##3##2##(2008-10#2)(2008-12#1)
At concentrations of##3##3##(1995-11#1)(1997-4#2)
At concentrations##4##2##(1995-11#1)(1997-4#2)(2008-10#1)
At diagnosis##2##2##(2008-5#2)
At discharge##5##2##(1991-2#2)(2008-12#2)(2008-7#1)
At each##7##2##(2008-10#4)(2008-2#1)(2008-7#2)
At first##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
At follow-up after##2##3##(1993-1#1)(2013-8#1)
At follow-up##5##2##(1993-1#1)(1997-6#1)(2008-7#2)(2013-8#1)
At harvest##2##2##(2008-10#1)(2010-3#1)
At high##7##2##(1994-11#1)(2008-10#3)(2008-9#3)
At higher concentrations of##2##4##(1993-6#1)(2008-11#1)
At higher concentrations##4##3##(1991-5#1)(1993-6#1)(1994-8#1)(2008-11#1)
At higher##9##2##(1991-5#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
At intermediate##4##2##(1992-12#1)(1993-8#1)(2008-8#1)(2009-7#1)
At least four##2##3##(1993-2#1)(1995-6#1)
At least one##3##3##(1994-11#1)(2006-6#1)(2013-1#1)
At least three##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
At least two##6##3##(1990-6#1)(1995-8#1)(1996-5#1)(2008-10#2)(2013-1#1)
At least##27##2##(1990-6#1)(1991-7#1)(1993-2#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(2006-6#1)(2008-10#9)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#2)(2013-1#2)
At locus##2##2##(2008-12#2)
At low##11##2##(2008-10#4)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#2)
At lower concentrations##2##3##(1993-12#1)(2008-10#1)
At lower##3##2##(1993-12#1)(2008-10#2)
At most##2##2##(1996-11#1)(2008-10#1)
At one##2##2##(1992-2#1)(2008-1#1)
At optimized conditions##2##3##(2008-10#2)
At optimum##3##2##(2008-10#3)
At our##3##2##(2008-10#2)(2008-9#1)
At pH 3##3##3##(2008-10#3)
At pH 4##3##3##(1994-11#1)(2008-10#2)
At pH 5##2##3##(2008-10#2)
At pH 6##2##3##(2008-10#1)(2008-11#1)
At pH 7##6##3##(1993-8#1)(1994-5#1)(2008-10#4)
At pH 8##3##3##(2008-10#2)(2012-2#1)
At pH 9##2##3##(2008-10#2)
At pH##24##2##(1993-8#1)(1994-11#2)(1994-5#1)(2008-10#17)(2008-11#1)(2012-2#1)(2013-1#1)
At posttest##2##2##(2010-4#2)
At present the##2##3##(1993-6#1)(2008-11#1)
At present there##2##3##(2008-11#1)(2013-8#1)
At present##23##2##(1990-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-5#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-9#1)(2013-8#1)
At sites##2##2##(2008-10#1)(2008-11#1)
At some##2##2##(1991-12#1)(2008-10#1)
At surgery the##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
At surgery##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
At temperatures##2##2##(2008-10#2)
At that time##3##3##(1995-12#1)(2010-3#1)(2011-2#1)
At the age of##3##4##(1996-3#1)(1997-3#1)(2008-10#1)
At the concentration##2##3##(2008-10#1)(2008-11#1)
At the core of the##2##5##(2008-5#1)(2009-12#1)
At the early stage of##2##5##(2008-5#1)(2008-9#1)
At the end of the analysis##2##6##(2008-10#2)
At the end of the study##2##6##(2008-11#1)(2008-5#1)
At the end of the trial##2##6##(1991-3#1)(2008-8#1)
At the end of the##13##5##(1990-11#1)(1990-2#1)(1991-3#1)(1991-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)
At the end of this##2##5##(2008-10#1)(2011-3#1)
At the end of##25##4##(1990-11#1)(1990-2#1)(1991-3#1)(1991-6#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#2)(2011-2#1)(2011-3#1)(2013-1#3)
At the end##26##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-3#1)(1991-6#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#2)(2011-2#1)(2011-3#1)(2013-1#3)
At the follow-up##2##3##(2013-1#2)
At the global level##2##4##(2007-12#1)(2008-10#1)
At the higher##3##3##(1990-5#1)(2008-10#1)(2010-8#1)
At the highest##2##3##(2010-8#1)(2013-8#1)
At the lowest##2##3##(2008-10#1)(2013-1#1)
At the moment##2##3##(2008-10#1)(2008-9#1)
At the optimum##2##3##(2008-10#2)
At the present time##4##4##(1992-3#1)(1993-3#1)(1996-3#1)(2008-7#1)
At the same time the##2##5##(1991-5#1)(2008-10#1)
At the same time##35##4##(1990-11#1)(1990-2#1)(1991-5#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-5#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-3#1)(2011-7#1)(2012-2#2)(2013-1#1)
At the second##2##3##(2008-10#1)(2008-12#1)
At the time of the##2##5##(1990-6#1)(2008-11#1)
At the time of##9##4##(1990-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2012-12#1)(2012-2#1)
At the time##11##3##(1990-6#1)(1991-8#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2012-12#1)(2012-2#1)
At the##179##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#2)(1993-3#2)(1994-12#2)(1994-6#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-6#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-12#5)(2008-1#2)(2008-10#40)(2008-11#12)(2008-12#3)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#9)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-5#2)(2010-8#4)(2011-1#2)(2011-2#6)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#1)
At these##3##2##(2008-10#2)(2008-3#1)
At this concentration##2##3##(1993-3#1)(2008-10#1)
At this stage##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
At this time##6##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-4#1)
At this##16##2##(1993-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-4#1)(2012-3#1)
At urethroscopy##2##2##(2008-10#2)
At variance with##2##3##(1995-6#1)(1996-6#1)
At week 24##2##3##(2008-5#1)(2011-2#1)
At week##3##2##(2008-5#1)(2011-2#2)
At##611##1##(1990-11#4)(1990-12#3)(1990-2#3)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#4)(1993-6#5)(1993-8#4)(1994-11#4)(1994-12#4)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#4)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#6)(1996-5#1)(1996-6#4)(1996-9#2)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#3)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#4)(2008-10#189)(2008-11#38)(2008-12#12)(2008-2#2)(2008-3#15)(2008-5#19)(2008-6#5)(2008-7#21)(2008-8#18)(2008-9#22)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#3)(2010-1#5)(2010-10#1)(2010-12#1)(2010-3#4)(2010-4#4)(2010-5#2)(2010-8#6)(2011-1#3)(2011-10#1)(2011-2#26)(2011-3#3)(2011-4#1)(2011-7#1)(2012-12#4)(2012-2#8)(2012-3#12)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#25)(2013-8#4)
AtT-20 cells##4##2##(1990-12#4)
AtT-20##6##1##(1990-12#5)(1995-12#1)
Ataxia telangiectasia##3##2##(1995-6#2)(2008-7#1)
Ataxia##4##1##(1995-6#2)(2008-7#2)
Atencion Primaria]##2##2##(1995-5#1)(1996-3#1)
Athena Neurosciences##2##2##(2008-5#2)
Athens##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
Atherosclerosis is a##2##3##(2011-2#1)(2012-2#1)
Atherosclerosis is##3##2##(2010-12#1)(2011-2#1)(2012-2#1)
Atherosclerosis##5##1##(2008-11#1)(2010-12#2)(2011-2#1)(2012-2#1)
Atherosclerotic##4##1##(2008-12#1)(2009-6#1)(2012-2#2)
Athlete##3##1##(1993-3#1)(2010-7#1)(2013-1#1)
Atkins##7##1##(2008-3#7)
Atlanta##3##1##(1997-2#1)(2008-11#1)(2012-12#1)
Atlantic Ocean##2##2##(2011-2#1)(2012-3#1)
Atlantic cod Gadus morhua in the##2##6##(2010-8#2)
Atlantic cod Gadus morhua##3##4##(2010-8#3)
Atlantic salmon (Salmo salar)##2##4##(1992-9#1)(1995-11#1)
Atlantic salmon##4##2##(1991-8#1)(1992-9#1)(1995-11#1)(2009-6#1)
Atlantic##16##1##(1991-8#1)(1992-9#1)(1995-11#1)(2008-10#3)(2008-7#1)(2009-6#1)(2010-8#5)(2011-2#1)(2012-3#1)(2013-8#1)
Atlantoaxial##2##1##(2012-3#2)
Atlas##3##1##(2008-11#1)(2008-5#2)
Atmosphere##3##1##(2008-3#3)
Atmospheric correction##2##2##(2008-2#1)(2008-3#1)
Atmospheric##17##1##(1992-2#1)(1995-3#1)(2008-10#2)(2008-2#2)(2008-3#11)
Atomic Absorption Spectrometry##2##3##(2008-10#2)
Atomic Absorption##3##2##(2008-10#3)
Atomic absorption spectrometric determination of##2##5##(2008-10#2)
Atomic absorption spectrometry##2##3##(2008-10#2)
Atomic absorption##4##2##(2008-10#4)
Atomic fluorescence##2##2##(2008-10#2)
Atomic force microscopy (AFM)##4##4##(2008-10#3)(2008-7#1)
Atomic force microscopy##7##3##(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
Atomic force##8##2##(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)
Atomic##24##1##(1991-9#1)(1996-9#1)(1997-8#1)(2008-10#15)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-12#1)
Atomization##2##1##(2008-10#2)
Atoms##3##1##(1996-9#3)
Atopic dermatitis##2##2##(1991-2#1)(2013-1#1)
Atopic##3##1##(1991-2#1)(2013-1#2)
Atoxigenic##2##1##(2008-10#2)
Atpk5##3##1##(1993-2#3)
Atr##3##1##(2008-10#2)(2008-8#1)
Atrazine##3##1##(2008-10#3)
Atrial Septal##2##2##(2008-11#1)(2012-3#1)
Atrial fibrillation is##2##3##(2008-7#1)(2013-1#1)
Atrial fibrillation##4##2##(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
Atrial flutter##2##2##(2010-11#1)(2011-2#1)
Atrial natriuretic peptide (ANP)##2##4##(1993-8#1)(2008-5#1)
Atrial natriuretic peptide##3##3##(1993-8#2)(2008-5#1)
Atrial##13##1##(1993-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
Atropine##2##1##(1990-5#1)(2011-2#1)
Atta cephalotes##2##2##(2008-8#2)
Atta##3##1##(2008-8#3)
Attachment and##3##2##(2008-11#2)(2008-7#1)
Attachment of##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
Attachment##10##1##(1995-6#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2012-2#1)
Attacks##3##1##(1990-6#1)(1991-9#1)(2008-10#1)
Attempt has also been made to##2##6##(2008-10#2)
Attempt##3##1##(2008-10#3)
Attempts of##2##2##(1990-5#1)(1995-5#1)
Attempts to increase##2##3##(2008-11#1)(2008-3#1)
Attempts to##10##2##(1990-5#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-5#1)
Attempts were made to##2##4##(1993-2#1)(2008-10#1)
Attempts##16##1##(1990-5#2)(1993-2#1)(1994-2#1)(1995-5#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#1)(2009-5#1)
Attendance##5##1##(1991-6#3)(2008-12#2)
Attention Deficit Hyperactivity Disorder##2##4##(2010-8#2)
Attention Deficit Hyperactivity##3##3##(2010-8#3)
Attention Deficit##4##2##(1990-2#1)(2010-8#3)
Attention deficit##2##2##(1996-6#1)(2008-11#1)
Attention has been##2##3##(2008-10#2)
Attention has##4##2##(2008-10#3)(2008-9#1)
Attention is drawn to##2##4##(1994-3#1)(2008-5#1)
Attention is##4##2##(1994-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
Attention to these##2##3##(2008-11#1)(2013-1#1)
Attention##23##1##(1990-2#1)(1992-12#1)(1994-3#1)(1996-6#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#4)(2011-2#1)(2013-1#1)
Attentional##3##1##(2011-2#1)(2013-8#2)
Attenuated total reflection Fourier##2##4##(2008-10#2)
Attenuated total##3##2##(2008-10#3)
Attenuated##5##1##(2008-10#4)(2009-11#1)
Attitude of##2##2##(2008-1#1)(2011-1#1)
Attitudes of##2##2##(2008-7#1)(2010-10#1)
Attitudes were##2##2##(1991-2#1)(1994-3#1)
Attitudes##9##1##(1991-2#1)(1994-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#1)(2013-1#1)
Atypical##8##1##(1990-12#1)(2008-11#2)(2008-3#1)(2009-8#1)(2011-2#2)(2012-3#1)
Au and Pd##2##3##(2008-10#2)
Au and##4##2##(2008-10#4)
Au at SiO(2) nanoparticles##2##4##(2008-10#2)
Au at SiO(2)##3##3##(2008-10#3)
Au at##4##2##(2008-10#4)
Au disk##2##2##(2008-10#2)
Au electrode##3##2##(2008-10#2)(2008-8#1)
Au electrodes##4##2##(2008-10#4)
Au surface##3##2##(2008-10#3)
Au##44##1##(1992-11#1)(2008-10#41)(2008-8#1)(2010-7#1)
Au(III)##15##1##(2008-10#15)
Au-NP/SAM-modified electrodes##3##2##(2008-10#3)
Au-electrode##2##1##(2008-10#2)
AuNPs self-assembly with 6MP##2##4##(2008-10#2)
AuNPs##4##1##(2008-10#4)
AuTM##6##1##(1994-5#6)
Auckland##3##1##(2008-1#2)(2008-12#1)
Audio##2##1##(2007-9#1)(2013-1#1)
Audiologists##2##1##(2008-9#2)
Audit##2##1##(1993-1#1)(2013-1#1)
Auditing##2##1##(1994-12#1)(2012-3#1)
Auditory##6##1##(1991-1#1)(2008-8#1)(2008-9#3)(2010-9#1)
Augmentation of##2##2##(1992-8#1)(2008-11#1)
Augmentation##3##1##(1992-8#1)(2008-10#1)(2008-11#1)
Augmenting##2##1##(1996-12#1)(2008-11#1)
August 1##2##2##(1992-1#1)(2008-9#1)
August 1993##2##2##(1994-12#1)(1994-9#1)
August 2001##2##2##(2008-10#2)
August 2004##2##2##(2008-10#1)(2008-11#1)
August 2006##2##2##(2008-10#1)(2012-12#1)
August 2009##2##2##(2011-2#1)(2012-2#1)
August and##2##2##(2008-10#2)
August##52##1##(1992-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-12#2)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)
August)##3##1##(2008-10#3)
Augustine##4##1##(1991-9#1)(2008-10#1)(2008-12#2)
Augustine's conversion to Christianity##3##4##(2008-12#3)
Augustine's conversion##4##2##(2008-12#4)
Augustine's##6##1##(2008-12#6)
Augustinegrass and##3##2##(2008-10#3)
Augustinegrass following M##2##3##(2008-10#2)
Augustinegrass##14##1##(2008-10#14)
Aujeszky's disease virus (ADV)##2##4##(2008-11#1)(2011-2#1)
Aujeszky's disease virus##4##3##(2008-11#2)(2011-2#2)
Aulacorthum solani##3##2##(2008-10#3)
Aureobasidium pullulans##3##2##(2008-10#3)
Aurora kinases##4##2##(2013-1#4)
Aurora##9##1##(2008-10#1)(2011-2#1)(2013-1#7)
Austin##3##1##(1991-9#1)(1994-1#1)(1996-1#1)
Australasia##2##1##(2008-6#1)(2008-8#1)
Australia and New Zealand##2##4##(2008-5#1)(2009-3#1)
Australia and the##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
Australia and##11##2##(1992-1#1)(1994-12#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)
Australia has##2##2##(2008-10#2)
Australia in##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
Australia were##2##2##(2008-10#2)
Australia##125##1##(1991-2#1)(1991-8#1)(1992-1#7)(1992-2#2)(1992-6#1)(1993-2#1)(1994-12#4)(1994-2#1)(1994-9#1)(1995-6#1)(1996-1#1)(1997-7#1)(2008-10#53)(2008-11#8)(2008-12#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#3)(2010-3#5)(2010-8#3)(2011-10#1)(2011-2#9)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
Australia's##4##1##(2008-11#1)(2008-6#3)
Australia)##2##1##(2008-10#1)(2011-1#1)
Australian Aboriginal Community Controlled Health Services##2##6##(2008-6#2)
Australian Aboriginal##3##2##(1996-12#1)(2008-6#2)
Australian and Indian isolates##2##4##(2008-10#2)
Australian and##4##2##(2008-10#3)(2008-12#1)
Australian health care##2##3##(1992-1#1)(2011-2#1)
Australian health##4##2##(1992-1#3)(2011-2#1)
Australian isolates##2##2##(2008-10#2)
Australian nursing##3##2##(2008-11#2)(2008-12#1)
Australian perspective##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
Australian study##2##2##(2008-7#1)(2011-2#1)
Australian teaching##2##2##(2008-7#2)
Australian university##2##2##(2008-11#1)(2008-12#1)
Australian veterans##3##2##(2011-2#3)
Australian white wines##2##3##(2008-10#2)
Australian##82##1##(1991-2#2)(1992-1#7)(1994-12#2)(1996-1#1)(1996-12#1)(2008-10#26)(2008-11#12)(2008-12#8)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#6)(2012-12#3)(2013-1#1)
Australian-Caucasian males##2##2##(2008-10#2)
Australians##4##1##(2008-10#1)(2012-12#3)
Australopithecus afarensis##2##2##(1994-3#2)
Austria##6##1##(1994-12#1)(1997-3#1)(2008-10#1)(2009-10#1)(2010-4#1)(2011-2#1)
Austria)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
Austrian and##3##2##(1997-3#1)(2008-10#2)
Austrian##7##1##(1997-3#1)(2008-10#4)(2008-11#1)(2009-10#1)
Authie##3##1##(2008-10#3)
Author index##16##2##(2008-11#16)
Author##17##1##(2008-11#16)(2011-2#1)
Author's response##3##2##(2008-8#2)(2011-2#1)
Author's##4##1##(1991-3#1)(2008-8#2)(2011-2#1)
Authorities##3##1##(1992-3#1)(2008-10#2)
Authority##4##1##(1995-6#1)(1996-11#1)(2008-10#1)(2010-2#1)
Authorization##2##1##(1996-5#1)(2010-11#1)
Authors conclude##3##2##(1990-5#1)(1990-9#1)(1992-9#1)
Authors describe a case##3##4##(1991-6#1)(1992-9#1)(2011-3#1)
Authors describe a##8##3##(1990-3#1)(1991-3#1)(1991-6#1)(1992-9#3)(2011-3#1)(2013-1#1)
Authors describe the##2##3##(1990-9#1)(1993-6#1)
Authors describe##11##2##(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-9#3)(1993-3#1)(1993-6#1)(2011-3#1)(2013-1#1)
Authors discuss##2##2##(1990-2#1)(1990-9#1)
Authors emphasize##4##2##(1990-5#1)(1992-9#1)(1993-6#1)(2011-2#1)
Authors evaluate##2##2##(1991-3#1)(2011-3#1)
Authors present the##2##3##(1990-3#1)(1990-5#1)
Authors present##4##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)
Authors report a##3##3##(1991-6#1)(1992-9#2)
Authors report the case of##2##5##(1991-6#1)(2013-1#1)
Authors report the##4##3##(1990-5#1)(1991-6#1)(1992-9#1)(2013-1#1)
Authors report##11##2##(1990-5#3)(1990-9#2)(1991-6#2)(1992-9#3)(2013-1#1)
Authors suggest##2##2##(1991-3#1)(1992-5#1)
Authors##58##1##(1990-2#2)(1990-3#6)(1990-5#7)(1990-9#7)(1991-3#7)(1991-6#4)(1992-5#2)(1992-9#10)(1993-3#1)(1993-6#2)(1994-12#1)(2011-2#2)(2011-3#2)(2013-1#5)
Authors'##3##1##(1997-5#1)(1997-8#1)(2008-12#1)
Autism Spectrum Disorders##2##3##(2010-7#1)(2013-8#1)
Autism and Williams syndrome##2##4##(2008-11#2)
Autism is a##2##3##(2008-11#1)(2012-3#1)
Autism##8##1##(2008-11#4)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
Autistic spectrum disorder##2##3##(2008-10#1)(2008-11#1)
Autoantibodies##3##1##(1997-5#1)(2008-4#1)(2012-3#1)
Autocrine##2##1##(1990-5#1)(2008-5#1)
Autograft##2##1##(2009-3#1)(2013-1#1)
Autographa californica multinucleocapsid nuclear polyhedrosis virus##2##6##(1993-12#2)
Autographa californica nuclear polyhedrosis virus (AcNPV)##4##6##(1994-11#1)(2008-11#1)(2008-7#1)(2008-8#1)
Autographa californica nuclear polyhedrosis virus##5##5##(1994-11#1)(1995-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
Autographa californica##10##2##(1993-12#2)(1994-11#1)(1995-12#2)(1997-3#1)(2008-11#2)(2008-7#1)(2008-8#1)
Autoimmune channelopathies##2##2##(2012-3#2)
Autoimmune neuromuscular disorders##2##3##(2012-3#2)
Autoimmune ovarian disease##2##3##(2008-4#2)
Autoimmune##14##1##(1991-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)(2012-3#6)(2013-1#1)(2013-7#1)
Autologous##7##1##(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#1)
Automated analyser for monitoring##2##4##(2008-10#2)
Automated determination of##2##3##(2008-10#2)
Automated##23##1##(1990-2#1)(1993-1#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#14)(2008-11#2)(2008-9#1)(2010-12#1)
Automatic flow##2##2##(2008-10#2)
Automatic##9##1##(2008-10#5)(2008-11#1)(2009-12#1)(2010-8#1)(2013-1#1)
Automation of a##2##3##(2008-10#2)
Automation of##6##2##(2008-10#6)
Automation##10##1##(2008-10#9)(2008-9#1)
Autonomic##6##1##(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Autophagy in##2##2##(2008-7#1)(2013-1#1)
Autophagy is##2##2##(2008-7#2)
Autophagy##6##1##(2008-7#4)(2012-3#1)(2013-1#1)
Autopsy##6##1##(1995-11#2)(1997-8#1)(2008-4#1)(2013-1#2)
Autoradiograms##2##1##(1990-10#1)(2008-7#1)
Autoradiography##2##1##(1991-12#1)(2008-4#1)
Autoregulation of androgen receptor##2##4##(1991-5#2)
Autoregulation of the##2##3##(1993-9#1)(1996-6#1)
Autoregulation of##5##2##(1991-5#2)(1993-9#1)(1996-6#1)(1997-1#1)
Autosomal dominant##2##2##(2008-11#1)(2008-7#1)
Autosomal##4##1##(2008-11#1)(2008-7#2)(2013-1#1)
Autosuture##3##1##(1995-1#3)
Aux/IAA proteins##5##2##(2009-8#5)
Aux/IAA##6##1##(2009-8#6)
AuxRE##2##1##(2008-9#2)
Auxiliary##3##1##(1996-5#1)(2008-10#1)(2008-11#1)
Auxin##4##1##(2008-10#1)(2008-9#2)(2009-6#1)
Availability of##3##2##(2008-11#1)(2012-2#2)
Available clinical##2##2##(2009-12#1)(2009-8#1)
Available evidence##2##2##(1990-6#1)(2010-11#1)
Available##10##1##(1990-6#1)(1991-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#1)
Avena sativa##4##2##(2008-10#1)(2008-9#3)
Avena##6##1##(2008-10#3)(2008-9#3)
Avenue##5##1##(2008-8#3)(2013-8#2)
Avenues of##2##2##(2008-4#1)(2008-5#1)
Average recoveries of##2##3##(2008-10#2)
Average recoveries##7##2##(2008-10#7)
Average##36##1##(1991-12#1)(1991-2#1)(1992-2#2)(1993-1#1)(1994-1#1)(1995-3#2)(1997-2#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-3#4)(2011-2#3)(2012-12#1)
Averaged over##2##2##(2008-10#1)(2012-6#1)
Avian Adenoviruses##2##2##(2008-8#2)
Avian##7##1##(2008-5#2)(2008-8#3)(2008-9#1)(2013-1#1)
Avicenna has##2##2##(2013-1#2)
Avicenna##4##1##(2013-1#4)
Avirulence Gene of##2##3##(2008-10#2)
Avirulence Gene##3##2##(2008-10#3)
Avirulence Genes##2##2##(2008-10#2)
Avirulence on##2##2##(2008-10#2)
Avirulence to##2##2##(2008-10#2)
Avirulence##12##1##(2008-10#12)
Avirulent##2##1##(2008-10#2)
Avocado Fruits##2##2##(2008-10#2)
Avoid##3##1##(1993-3#1)(1997-2#1)(2008-11#1)
Avoiding##3##1##(1994-1#1)(2008-11#1)(2011-2#1)
Avr loci##3##2##(2008-10#3)
Avr##7##1##(2008-10#7)
AvrLm2##2##1##(2008-10#2)
AvrLm3 and##2##2##(2008-10#2)
AvrLm3##3##1##(2008-10#3)
AvrLm7##2##1##(2008-10#2)
AvrLm8##2##1##(2008-10#2)
AvrLm9##2##1##(2008-10#2)
AvrPto in##2##2##(2009-8#2)
AvrPto is##2##2##(2009-8#2)
AvrPto##8##1##(2009-8#8)
AvrT10##2##1##(2008-10#2)
AvrT6##2##1##(2008-10#2)
AvrT8a##2##1##(2008-10#2)
AvrT9a##2##1##(2008-10#2)
Award in##3##2##(1994-2#1)(1994-3#1)(1995-2#1)
Award##16##1##(1991-1#1)(1991-3#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-2#4)(1996-3#1)(1997-2#1)(2008-8#1)(2008-9#1)(2010-5#2)(2013-8#1)
Awards and honors##5##3##(2008-10#5)
Awards for##2##2##(1995-12#1)(2008-12#1)
Awards##9##1##(1995-12#1)(1997-4#1)(2008-10#5)(2008-12#1)(2013-1#1)
Awareness and knowledge##2##3##(2011-2#1)(2013-1#1)
Awareness of the##3##3##(2012-2#3)
Awareness of this##2##3##(2008-10#1)(2010-5#1)
Awareness of##8##2##(1993-1#1)(1996-9#1)(2008-10#1)(2010-5#1)(2012-2#3)(2013-1#1)
Awareness##16##1##(1993-1#1)(1996-9#1)(2008-10#1)(2008-11#3)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#4)(2013-1#2)
Awwad had##3##2##(2008-10#3)
Awwad##10##1##(2008-10#10)
AxC##2##1##(2008-10#2)
AxeA##4##1##(2011-1#4)
Axial##4##1##(2010-1#2)(2013-1#2)
Axillary##5##1##(2008-5#4)(2010-7#1)
Axillo-axillary bypass##2##2##(1993-3#2)
Axis II##2##2##(2008-11#1)(2009-9#1)
Axis##7##1##(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-9#2)(2012-3#1)
Axon##2##1##(1997-3#1)(2011-2#1)
Axonal##3##1##(1997-3#1)(2008-7#2)
Ayurvedic system of medicine##2##4##(2008-10#2)
Azalomycine B##2##2##(2010-8#2)
Azar##2##1##(2008-12#2)
Azathioprine##2##1##(2010-12#1)(2011-2#1)
Azerbaijan##2##1##(2008-10#1)(2009-4#1)
Azobenzene##2##1##(1995-6#2)
Azorubin##3##1##(2008-10#3)
Azotobacter chroococcum##5##2##(2008-11#5)
Azotobacter vinelandii##2##2##(1990-11#2)
Azotobacter##7##1##(1990-11#2)(2008-11#5)
B (RB)##5##2##(2008-10#5)
B activation##2##2##(1991-3#1)(2008-10#1)
B activity##4##2##(1994-6#3)(1995-6#1)
B and C infection in##2##5##(1992-12#1)(2013-1#1)
B and C##19##3##(1991-5#1)(1992-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2010-12#5)(2010-7#2)(2013-1#1)(2013-7#1)(2013-8#1)
B and C77##2##3##(2008-10#2)
B and D##11##3##(1995-6#6)(1997-1#4)(2013-1#1)
B and E##2##3##(2008-10#1)(2011-2#1)
B and T lymphocytes##2##4##(1994-3#1)(2008-4#1)
B and T##3##3##(1994-3#1)(2008-11#1)(2008-4#1)
B and##68##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#3)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#6)(1995-8#1)(1997-1#4)(1997-2#1)(2006-6#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#6)(2010-7#2)(2010-8#1)(2011-2#6)(2013-1#3)(2013-7#1)(2013-8#1)
B as##2##2##(1990-5#1)(2008-10#1)
B at##3##2##(2008-10#2)(2011-1#1)
B by##2##2##(2008-9#1)(2010-8#1)
B cell activation##2##3##(2008-4#2)
B cell clones##2##3##(2008-11#1)(2008-5#1)
B cell differentiation##2##3##(2008-4#2)
B cell epitopes##5##3##(1995-5#4)(2008-4#1)
B cell growth factors##2##4##(1991-3#2)
B cell growth##4##3##(1991-3#4)
B cell line##7##3##(1994-3#2)(1995-2#1)(2008-11#1)(2008-8#3)
B cell lines##2##3##(2008-11#1)(2008-9#1)
B cell lymphomas##3##3##(1993-9#1)(2008-9#1)(2013-1#1)
B cell mitogen##2##3##(2008-11#2)
B cell population##2##3##(2011-2#2)
B cell progenitors##3##3##(2008-4#3)
B cell##51##2##(1991-3#5)(1992-8#1)(1993-9#1)(1994-3#2)(1995-2#1)(1995-5#6)(2008-11#9)(2008-4#12)(2008-5#1)(2008-8#3)(2008-9#3)(2009-8#3)(2011-2#2)(2013-1#2)
B cells and the##2##4##(1997-8#1)(2008-4#1)
B cells and##6##3##(1990-12#1)(1995-2#1)(1997-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
B cells by##2##3##(2008-11#1)(2008-4#1)
B cells in##2##3##(1995-5#1)(2008-11#1)
B cells were##3##3##(1992-6#1)(2008-11#2)
B cells##52##2##(1990-12#1)(1991-1#2)(1991-3#3)(1992-6#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#5)(1997-8#1)(1997-9#1)(2008-10#1)(2008-11#10)(2008-4#14)(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#2)(2013-1#2)
B chain##5##2##(1993-11#3)(2008-6#1)(2008-9#1)
B chromosome##3##2##(2008-12#3)
B chromosomes##4##2##(2008-12#4)
B component##2##2##(2008-10#2)
B concentrations##2##2##(1991-2#1)(2008-10#1)
B e antigen##2##3##(1995-2#1)(2013-1#1)
B e##3##2##(1995-2#1)(2013-1#2)
B from##2##2##(2008-10#2)
B gene in##2##3##(1997-8#2)
B gene##7##2##(1995-2#2)(1997-8#3)(2008-6#1)(2008-9#1)
B genome##5##2##(2008-10#5)
B have##2##2##(1992-8#1)(2011-2#1)
B hydroxylamide##2##2##(2008-12#2)
B in##14##2##(1992-12#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-10#4)(2008-5#2)(2009-8#1)(2011-2#2)
B is##7##2##(1992-12#1)(1995-12#1)(1995-2#2)(2008-10#1)(2008-11#1)(2013-1#1)
B isolates##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
B isothiocyanate##3##2##(2008-10#3)
B levels##3##2##(1992-8#1)(1995-2#1)(2009-12#1)
B ligand##2##2##(2008-11#1)(2013-1#1)
B lymphocyte##5##2##(1991-6#1)(2008-4#2)(2008-9#1)(2012-3#1)
B lymphocytes and##3##3##(1990-9#1)(1991-3#1)(1991-6#1)
B lymphocytes##13##2##(1990-12#1)(1990-9#1)(1991-3#2)(1991-6#2)(1992-8#2)(1994-3#2)(2008-1#1)(2008-4#1)(2008-9#1)
B of pyruvate kinase##2##4##(1990-5#2)
B of##4##2##(1990-5#2)(2008-11#2)
B on##3##2##(1991-5#1)(2010-10#2)
B or D##3##3##(2010-7#3)
B or##4##2##(2009-8#1)(2010-7#3)
B plays##2##2##(1995-2#2)
B production##4##2##(1994-8#4)
B receptor##3##2##(1994-2#2)(2011-2#1)
B respectively##2##2##(2008-10#1)(2012-3#1)
B site##3##2##(1993-9#1)(1994-5#2)
B solution##2##2##(2008-10#2)
B strains##7##2##(2008-10#6)(2008-5#1)
B surface antigen (HBsAg)##6##4##(1995-2#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
B surface antigen##9##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
B surface##11##2##(1994-11#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
B type##4##2##(1991-2#1)(1994-11#1)(2008-5#1)(2012-3#1)
B vaccination##7##2##(1993-2#1)(2008-10#3)(2009-12#2)(2012-3#1)
B vaccine##6##2##(1995-3#1)(1995-5#1)(2007-11#1)(2009-12#2)(2012-3#1)
B virus (HBV) and##2##4##(2008-10#1)(2013-8#1)
B virus (HBV) infection is##2##5##(2008-8#1)(2013-1#1)
B virus (HBV) infection##6##4##(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#2)(2013-1#1)
B virus (HBV)##19##3##(1990-8#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#4)(2013-1#4)(2013-8#1)
B virus##44##2##(1990-8#2)(1993-8#2)(1994-11#2)(1994-8#2)(1995-2#2)(1996-12#2)(1996-3#2)(2008-10#4)(2008-12#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#4)(2011-2#1)(2011-3#2)(2013-1#7)(2013-8#2)
B viruses##3##2##(1994-9#2)(2008-9#1)
B was##16##2##(1991-5#1)(1992-12#2)(1996-3#1)(1997-1#2)(2008-10#4)(2008-5#2)(2008-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
B were##10##2##(1992-2#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-11#1)
B with##4##2##(1995-5#1)(1996-6#1)(2008-10#1)(2013-1#1)
B##1201##1##(1990-11#4)(1990-12#5)(1990-2#2)(1990-5#8)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#4)(1991-3#14)(1991-5#4)(1991-6#3)(1991-7#2)(1992-11#1)(1992-12#11)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#7)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#7)(1993-9#4)(1994-1#1)(1994-11#10)(1994-2#7)(1994-3#6)(1994-5#9)(1994-6#4)(1994-8#12)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#12)(1995-2#30)(1995-3#1)(1995-5#13)(1995-6#25)(1995-8#1)(1996-12#7)(1996-2#2)(1996-3#11)(1996-6#4)(1997-1#9)(1997-2#27)(1997-3#1)(1997-4#2)(1997-7#3)(1997-8#13)(1997-9#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#448)(2008-11#47)(2008-12#28)(2008-3#2)(2008-4#32)(2008-5#29)(2008-6#8)(2008-7#8)(2008-8#21)(2008-9#25)(2009-11#1)(2009-12#14)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#22)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#8)(2010-3#9)(2010-4#1)(2010-5#2)(2010-7#10)(2010-8#3)(2011-1#4)(2011-2#61)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#12)(2012-8#2)(2013-1#29)(2013-7#2)(2013-8#13)
B&quot##5##1##(1991-3#2)(2009-8#1)(2011-2#2)
B(1)##11##1##(2008-10#11)
B(12)##25##1##(2008-10#11)(2008-11#5)(2008-7#5)(2011-1#4)
B(2) and##2##2##(2008-10#2)
B(2)##16##1##(2008-10#14)(2008-8#2)
B(4)##5##1##(2008-10#5)
B(6) and B(12)##2##3##(2008-10#2)
B(6)##5##1##(2008-10#4)(2008-8#1)
B(6)C(3)F(1) mice##8##2##(2008-10#8)
B(6)C(3)F(1)##10##1##(2008-10#10)
B(A)P for##2##2##(1993-8#2)
B(A)P of##2##2##(1993-8#2)
B(A)P##13##1##(1993-8#13)
B(In)##4##1##(2008-10#4)
B(with FT)yielded##2##2##(1997-7#2)
B) and##2##2##(1997-2#1)(2008-12#1)
B) as##2##2##(1997-8#1)(2008-8#1)
B)##27##1##(1990-6#1)(1991-5#1)(1992-12#1)(1994-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)(2011-2#1)(2011-3#1)
B- and D-cell lines##2##4##(1995-8#2)
B- and T-cell epitope##3##4##(1995-2#2)(2008-10#1)
B- and T-cell epitopes##2##4##(1994-8#1)(1995-2#1)
B- and T-cell##5##3##(1994-8#1)(1995-2#3)(2008-10#1)
B- and##9##2##(1994-8#1)(1995-2#5)(1995-8#2)(2008-10#1)
B-##12##1##(1994-3#2)(1994-8#1)(1995-2#5)(1995-8#2)(2008-10#1)(2009-8#1)
B-100##2##1##(1993-2#1)(2009-8#1)
B-CLL cells##3##2##(1995-2#2)(2008-5#1)
B-DNA##3##1##(1993-8#3)
B-EIA##3##1##(1993-2#3)
B-GOx##6##1##(2008-10#6)
B-H(2)ats##3##1##(2008-10#3)
B-MYB##9##1##(2011-2#9)
B-PE##3##1##(2008-10#3)
B-cell epitope identification##3##3##(2008-10#3)
B-cell epitope##5##2##(2008-10#5)
B-cell epitopes##4##2##(2008-10#3)(2012-2#1)
B-cell line##2##2##(1995-8#1)(2008-11#1)
B-cell lymphoma of##2##3##(2009-5#1)(2013-8#1)
B-cell lymphoma##11##2##(2008-1#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#4)(2013-1#1)(2013-8#1)
B-cell lymphomas##2##2##(1992-12#1)(1997-1#1)
B-cell##42##1##(1992-12#1)(1993-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#10)(2010-11#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
B-cells##7##1##(1997-1#1)(2008-1#1)(2008-10#3)(2009-6#2)
B-complex##3##1##(2008-10#1)(2010-1#2)
B-containing LP##2##2##(1995-8#2)
B-containing lipoproteins##2##2##(1995-8#1)(2008-6#1)
B-containing##4##1##(1995-8#3)(2008-6#1)
B-form##4##1##(1991-5#1)(2008-8#1)(2008-9#2)
B-group isolates were pathogenic on##2##5##(2008-10#2)
B-group isolates##3##2##(2008-10#3)
B-like##3##1##(1991-7#2)(2008-10#1)
B-lymphocyte##4##1##(1991-6#2)(1993-6#1)(2008-10#1)
B-lymphocytes##3##1##(1991-6#1)(2008-10#2)
B-mode US##2##2##(2010-12#2)
B-mode ultrasound##2##2##(2010-12#1)(2013-8#1)
B-mode##4##1##(2010-12#3)(2013-8#1)
B-phycoerythrin##3##1##(2008-10#1)(2008-8#2)
B-type lamins##3##2##(2008-8#1)(2011-2#2)
B-type natriuretic##2##2##(2008-11#1)(2008-3#1)
B-type##8##1##(1991-5#1)(1993-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#3)
B/C##2##1##(1991-12#1)(2013-8#1)
B/F##2##1##(1992-6#1)(2008-10#1)
B1 and B2##2##3##(2008-10#1)(2008-11#1)
B1 and##4##2##(2008-10#1)(2008-11#1)(2013-8#2)
B1 strains were##2##3##(2008-10#2)
B1##21##1##(1990-2#1)(1990-5#1)(1993-12#1)(1994-5#1)(1997-8#1)(2008-10#3)(2008-11#3)(2011-2#5)(2012-5#1)(2013-8#4)
B10##3##1##(1990-12#1)(2008-12#2)
B104 and H411E##2##3##(1993-6#2)
B104 cells##4##2##(1993-8#4)
B104##8##1##(1993-6#2)(1993-8#4)(2008-10#2)
B12 and##3##2##(1993-12#1)(2008-8#1)(2010-1#1)
B12 deficiency##6##2##(1990-3#2)(1993-12#1)(1995-11#1)(2007-9#1)(2008-8#1)
B12 status##2##2##(1993-12#2)
B12##43##1##(1990-3#9)(1992-9#3)(1993-12#12)(1995-11#3)(2007-9#1)(2008-8#4)(2010-1#11)
B13##5##1##(2011-2#5)
B15##2##1##(1997-9#2)
B16 2F2 cells##2##3##(2008-11#2)
B16 2F2##4##2##(2008-11#4)
B16 cells##2##2##(2008-11#2)
B16 melanoma cells##2##3##(2008-5#2)
B16##10##1##(1993-5#1)(2008-11#7)(2008-5#2)
B16-F10##3##1##(1997-7#2)(2013-1#1)
B16F10##2##1##(2008-9#2)
B18C6##7##1##(2008-10#7)
B2 and##2##2##(2008-11#2)
B2 production##2##2##(1992-12#1)(2008-5#1)
B2##22##1##(1990-12#5)(1991-12#1)(1991-6#2)(1992-12#1)(1994-8#1)(1995-11#1)(1996-3#4)(1997-8#1)(2008-10#1)(2008-11#4)(2008-5#1)
B22##2##1##(1996-6#2)
B245/270D##2##1##(2008-11#2)
B3##4##1##(1994-5#2)(2008-11#1)(2008-12#1)
B30 and##2##2##(1997-9#1)(2008-9#1)
B30##3##1##(1997-9#1)(2008-9#2)
B37HtN##3##1##(2008-10#3)
B39##4##1##(1997-8#4)
B3LYP##2##1##(2010-7#2)
B4 and##2##2##(1991-5#1)(1994-8#1)
B4##5##1##(1991-5#3)(1994-8#1)(2008-10#1)
B5 were##2##2##(2008-10#1)(2008-12#1)
B5##15##1##(1997-8#2)(2008-10#9)(2008-12#4)
B5*-sat##2##1##(2008-10#2)
B6 metabolism##3##2##(2013-1#3)
B6##19##1##(1991-2#1)(1992-9#5)(1997-8#1)(2008-10#1)(2011-2#3)(2012-3#1)(2013-1#7)
B6C3F1 mice##2##2##(1995-11#1)(2008-9#1)
B7##5##1##(1997-9#2)(2008-10#1)(2008-11#1)(2010-1#1)
B7(+) macrophages##4##2##(2008-10#4)
B728a##3##1##(2008-10#3)
B73 (P(1))##2##2##(2008-10#2)
B73 and LB31##2##3##(2008-10#2)
B73 and##5##2##(2008-10#5)
B73 x Tex6##5##3##(2008-10#5)
B73##19##1##(2008-10#16)(2012-3#3)
B8##2##1##(2008-10#2)
B9 cells##2##2##(2008-4#2)
B9##3##1##(2008-4#3)
B971##2##1##(2010-7#2)
BA at##2##2##(2008-10#2)
BA is##2##2##(2008-10#2)
BA##11##1##(1995-11#2)(2008-10#7)(2008-11#1)(2008-7#1)
BA) and##2##2##(2008-12#2)
BA) or##2##2##(1997-3#2)
BA)##5##1##(1997-3#2)(2008-12#3)
BA-ELISA##2##1##(2008-10#2)
BAA##5##1##(2011-2#5)
BABA and##2##2##(2009-6#2)
BABA were##2##2##(2008-10#2)
BABA##16##1##(2008-10#12)(2009-6#4)
BABA-IR and##2##2##(2009-6#2)
BABA-IR##3##1##(2009-6#3)
BABA-treated##3##1##(2008-10#3)
BAC DNA for##3##3##(2008-4#3)
BAC DNA##5##2##(2008-4#5)
BAC clone was##2##3##(2008-8#2)
BAC clone##6##2##(2008-10#1)(2008-4#1)(2008-8#4)
BAC clones mapped to##2##4##(2012-3#2)
BAC clones were##2##3##(2008-8#1)(2012-3#1)
BAC clones with##2##3##(2008-8#2)
BAC clones##12##2##(1997-8#1)(2008-10#2)(2008-8#3)(2012-3#6)
BAC contig##2##2##(2008-8#1)(2012-3#1)
BAC library with##2##3##(2008-7#1)(2008-9#1)
BAC library##4##2##(2008-7#1)(2008-8#2)(2008-9#1)
BAC transgenic mice##5##3##(2008-4#3)(2013-8#2)
BAC transgenic##8##2##(2008-4#6)(2013-8#2)
BAC##42##1##(1997-8#1)(2008-10#3)(2008-4#15)(2008-7#1)(2008-8#11)(2008-9#1)(2012-3#8)(2013-8#2)
BAC-end sequences##2##2##(2010-10#1)(2012-3#1)
BAC2##4##1##(2008-8#4)
BACKGROUND AND AIMS##2##3##(2011-2#1)(2012-2#1)
BACKGROUND AND OBJECTIVES##6##3##(2012-2#6)
BACKGROUND AND##9##2##(2010-10#1)(2011-2#1)(2012-2#7)
BACKGROUND##79##1##(2008-11#8)(2008-12#1)(2008-6#1)(2009-1#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-2#20)(2012-3#19)(2013-1#9)
BACs by homologous recombination in E##2##6##(2008-4#2)
BACs##5##1##(2008-4#4)(2010-10#1)
BAE with##2##2##(2012-3#2)
BAE##4##1##(2010-12#2)(2012-3#2)
BAGI##2##1##(2008-3#2)
BAK homologues by the##2##4##(1992-11#2)
BAK##3##1##(1992-11#3)
BAL fluid##3##2##(2008-10#3)
BAL##10##1##(2008-10#5)(2010-12#2)(2011-2#1)(2012-2#2)
BALB##4##1##(1994-5#4)
BALB/c and C57BL/6 mice##3##4##(2008-12#1)(2013-1#2)
BALB/c and##4##2##(1996-12#1)(2008-12#1)(2013-1#2)
BALB/c mice immunized##2##3##(1995-2#1)(2008-11#1)
BALB/c mice were##2##3##(2008-10#1)(2008-11#1)
BALB/c mice##19##2##(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#4)(2008-10#2)(2008-11#5)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
BALB/c or##2##2##(1996-12#1)(2013-1#1)
BALB/c##29##1##(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#8)(2008-10#2)(2008-11#5)(2008-12#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
BALB/cByJ##7##1##(1995-2#1)(2008-11#2)(2008-5#4)
BALB/cJ##4##1##(2008-5#4)
BALBc mice##2##2##(1995-12#2)
BAN##2##1##(2010-8#2)
BAP (2##2##2##(2013-1#2)
BAP##9##1##(2008-12#6)(2013-1#3)
BAPEN##2##1##(2012-12#2)
BAPP##3##1##(2008-2#3)
BAPTA##5##1##(1994-11#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-8#1)
BAQABP##2##1##(2008-10#2)
BASIC##3##1##(2008-10#3)
BAT##6##1##(2012-2#2)(2012-3#1)(2013-1#3)
BAW sensor##2##2##(2008-10#2)
BAX translocation to the mitochondria##2##5##(2008-11#2)
BAX##8##1##(2008-11#3)(2009-8#1)(2011-2#4)
BB pathotypes##2##2##(2008-10#2)
BB resistance##2##2##(2008-10#2)
BB##6##1##(2008-10#4)(2008-8#2)
BBA 2890##6##2##(2008-10#6)
BBA 809##3##2##(2008-10#3)
BBA##16##1##(2008-10#9)(2008-11#7)
BBB##2##1##(1990-5#2)
BBM##5##1##(1991-9#5)
BBMV##2##1##(2008-10#1)(2008-9#1)
BBN##2##1##(2010-6#2)
BBO crystal##2##2##(2008-3#2)
BBO##7##1##(2008-2#5)(2008-3#2)
BBOS##5##1##(2011-2#5)
BBR##4##1##(2012-3#4)
BBSV##3##1##(1995-12#3)
BBWV 2##3##2##(2008-10#3)
BBWV##5##1##(2008-10#5)
BBWV-K##3##1##(2008-10#3)
BC (2)F(2)##2##2##(2008-9#2)
BC in##2##2##(1993-3#2)
BC##16##1##(1993-3#3)(2008-10#5)(2008-9#2)(2012-9#3)(2013-1#2)(2013-8#1)
BC(1)##2##1##(2008-10#2)
BC(1)F(1)##4##1##(2008-10#4)
BC(1)r##2##1##(2008-10#2)
BC(1)s##2##1##(2008-10#2)
BC) were##2##2##(2008-10#2)
BC)##4##1##(2008-10#2)(2012-9#2)
BC1F4##3##1##(2008-10#3)
BC3-5-1-OS2A##2##1##(2008-10#2)
BCA was##2##2##(2008-10#2)
BCA##4##1##(2008-10#4)
BCAs with##2##2##(2008-10#2)
BCAs##12##1##(2008-10#12)
BCC##4##1##(2008-9#1)(2012-3#3)
BCCs##3##1##(1997-3#3)
BCE##2##1##(2008-11#1)(2008-12#1)
BCEC##3##1##(2008-10#3)
BCEOC##5##1##(2008-10#5)
BCF##5##1##(2008-12#5)
BCG as a##2##3##(2011-2#2)
BCG recombinant##2##2##(1995-5#2)
BCG vaccination##2##2##(1990-6#1)(2008-10#1)
BCG vaccine##2##2##(2009-7#1)(2011-2#1)
BCG##24##1##(1990-6#1)(1995-12#1)(1995-5#7)(1995-8#1)(1996-11#1)(1996-8#1)(2008-10#2)(2009-7#1)(2011-2#5)(2012-3#1)(2013-1#3)
BCGC cocultures##3##2##(2008-11#3)
BCL2 gene rearrangements##2##3##(2009-8#2)
BCL2 gene##3##2##(2009-8#3)
BCL2##10##1##(2009-8#9)(2010-11#1)
BCL6##2##1##(2009-8#2)
BCM gene expression in the##2##5##(2009-6#2)
BCM gene expression##3##3##(2009-6#3)
BCM##4##1##(2008-10#1)(2009-6#3)
BCMNV##2##1##(2008-10#2)
BCMoV DNA-A##2##2##(2008-10#2)
BCMoV DNA-B##2##2##(2008-10#2)
BCMoV has a##2##3##(2008-10#2)
BCMoV##8##1##(2008-10#8)
BCN-A##2##1##(2008-10#2)
BCN-like##2##1##(2008-10#2)
BCNU and prednisolone (FIB-P)##2##4##(1992-2#2)
BCNU and##3##2##(1991-6#1)(1992-2#2)
BCNU##4##1##(1991-6#2)(1992-2#2)
BCO##2##1##(2008-10#2)
BCP mutations##7##2##(2013-1#7)
BCP(1)##4##1##(2008-10#4)
BCP(1)-selfed##3##1##(2008-10#3)
BCP(1)S(1) families##2##2##(2008-10#2)
BCP(1)S(1)##4##1##(2008-10#4)
BCP(2)##4##1##(2008-10#4)
BCR CRM##2##2##(2008-10#2)
BCR procedure##4##2##(2008-10#4)
BCR protocol##2##2##(2008-10#2)
BCR sequential extraction##3##3##(2008-10#3)
BCR##20##1##(2008-10#20)
BCR-ABL##2##1##(2009-7#1)(2011-2#1)
BCS##2##1##(2008-10#1)(2011-2#1)
BCT##4##1##(1994-12#1)(2008-6#3)
BCTV##4##1##(2008-10#4)
BCTV-resistant##2##1##(2008-10#2)
BCVA##4##1##(2011-2#4)
BCaMV##2##1##(2008-10#2)
BChl a##2##2##(1996-2#2)
BChl c --&gt##2##3##(1996-2#2)
BChl c##3##2##(1996-2#3)
BChl##5##1##(1996-2#5)
BD Cell MAb medium##2##4##(2008-11#2)
BD##6##1##(2008-11#3)(2008-4#1)(2009-6#1)(2011-2#1)
BD1047##2##1##(2011-2#2)
BD9##2##1##(2008-11#2)
BDD and##4##2##(2008-10#3)(2012-12#1)
BDD electrode exhibited##2##3##(2008-10#2)
BDD electrode##6##2##(2008-10#6)
BDD##15##1##(2008-10#12)(2012-12#3)
BDES##2##1##(2008-10#2)
BDI##2##1##(2008-4#1)(2012-2#1)
BDIS as the gold standard##2##5##(2012-12#2)
BDIS##5##1##(2012-12#5)
BDJ##2##1##(2013-1#2)
BDL cell cultures##2##3##(1995-11#2)
BDL##6##1##(1995-11#3)(2009-8#1)(2013-1#1)(2013-8#1)
BDM##2##1##(2008-11#2)
BDNF and##4##2##(1996-12#1)(1997-2#1)(2008-7#1)(2011-2#1)
BDNF levels in##2##3##(2011-2#1)(2013-8#1)
BDNF levels##7##2##(2011-2#2)(2013-8#5)
BDNF mRNA in the##2##4##(1997-2#1)(2012-2#1)
BDNF mRNA##10##2##(1996-12#2)(1997-2#7)(2012-2#1)
BDNF protein levels in##2##4##(2013-8#2)
BDNF protein##5##2##(2012-2#2)(2013-8#3)
BDNF secretion##3##2##(2009-8#3)
BDNF##41##1##(1996-12#5)(1997-2#11)(2008-11#1)(2008-7#1)(2009-8#4)(2011-2#3)(2012-2#6)(2013-8#10)
BE are##2##2##(2008-10#2)
BE for the##2##3##(2008-10#2)
BE with HGD/IMCA##2##3##(2010-12#2)
BE with##3##2##(2010-12#3)
BE##12##1##(2008-10#5)(2010-11#1)(2010-12#6)
BEA##3##1##(2008-10#3)
BEFV##3##1##(2008-10#3)
BET inhibitor##3##2##(2012-12#3)
BET protein##2##2##(2012-12#2)
BET surface area##2##3##(2008-10#1)(2009-11#1)
BET##9##1##(2008-10#1)(2009-11#1)(2012-12#7)
BETWEEN##2##1##(2012-3#2)
BF##2##1##(2013-1#2)
BF%##2##1##(2012-2#2)
BF(3)##2##1##(2008-10#2)
BF(3)/methanol esterification##3##2##(2008-10#3)
BFB##2##1##(2008-10#2)
BFD patients##2##2##(2008-10#2)
BFH##2##1##(2010-12#2)
BFP##4##1##(1991-8#4)
BG##3##1##(2008-10#2)(2012-4#1)
BGC-823##2##1##(2008-9#2)
BGD##2##1##(1994-5#2)
BGMV##2##1##(2008-10#2)
BGMV-BZ##4##1##(2008-10#4)
BGMV-GA##2##1##(2008-10#2)
BGQ60 is##2##2##(1995-6#2)
BGQ60##8##1##(1995-6#8)
BGYMV from##2##2##(2008-10#2)
BGYMV##8##1##(2008-10#8)
BGYMV-MX was##2##2##(2008-10#2)
BGYMV-MX##7##1##(2008-10#7)
BH(4)(-)##2##1##(2008-10#2)
BH3 domain##2##2##(2009-12#2)
BH3##3##1##(2008-10#1)(2009-12#2)
BH4##2##1##(1994-11#2)
BHA and##2##2##(2008-10#1)(2008-12#1)
BHA##5##1##(1996-2#1)(2008-10#3)(2008-12#1)
BHK 21 C13##3##3##(2008-11#3)
BHK 21##4##2##(2008-11#4)
BHK and CHO cell##2##4##(2008-11#2)
BHK and##3##2##(2008-11#3)
BHK cell##3##2##(2008-11#3)
BHK cells##5##2##(2008-11#5)
BHK##16##1##(1995-8#1)(2008-11#15)
BHK-21 cell##2##2##(2008-11#1)(2008-8#1)
BHK-21 cells with##2##3##(2008-11#1)(2008-9#1)
BHK-21 cells##6##2##(2008-11#5)(2008-9#1)
BHK-21##8##1##(2008-11#6)(2008-8#1)(2008-9#1)
BHK/SG2##2##1##(2008-9#2)
BHK21##4##1##(2008-11#4)
BHLF1##4##1##(1997-3#4)
BHS##3##1##(2010-7#3)
BHSL##2##1##(1995-2#2)
BHT injection##2##2##(1994-5#2)
BHT was##3##2##(1994-5#1)(2008-5#1)(2011-2#1)
BHT##20##1##(1994-5#8)(1996-2#2)(2008-5#4)(2011-2#2)(2013-8#4)
BHU##4##1##(2011-2#4)
BHV-1##5##1##(1995-9#2)(2008-11#3)
BHmC-4##4##1##(2008-10#4)
BHmC-6##3##1##(2008-10#3)
BHmC-8##2##1##(2008-10#2)
BI was located in##2##4##(2012-3#2)
BI##10##1##(2008-10#3)(2011-2#1)(2012-3#6)
BI-BS-resistant isolates were##2##3##(2008-10#2)
BI-BS-resistant isolates##4##2##(2008-10#4)
BIA##2##1##(2008-10#1)(2011-2#1)
BIAcore##2##1##(1997-7#1)(2008-9#1)
BII phobia##4##2##(2012-2#4)
BII##6##1##(2012-2#4)(2013-1#2)
BIM administration##2##2##(2008-11#2)
BIM##6##1##(2008-11#6)
BINPHT##2##1##(2008-10#2)
BIRADS score##2##2##(2011-2#2)
BIRADS scores had##2##3##(2011-2#2)
BIRADS##4##1##(2011-2#4)
BIREME##2##1##(2012-3#1)(2013-1#1)
BIS##2##1##(2012-3#2)
BIS95##2##1##(2008-10#2)
BIs of##4##2##(2008-10#4)
BIs##5##1##(2008-10#5)
BK-B2 receptor##2##2##(1990-5#2)
BL##5##1##(2008-10#3)(2009-8#1)(2011-2#1)
BL21 (DE3)##4##2##(1994-5#2)(1995-12#1)(2009-3#1)
BL21##6##1##(1994-5#2)(1995-12#1)(2009-3#1)(2010-6#1)(2013-1#1)
BLAST search##2##2##(2008-10#1)(2008-9#1)
BLAST searches##3##2##(2008-4#1)(2008-9#1)(2010-4#1)
BLAST##10##1##(2008-10#2)(2008-4#3)(2008-9#3)(2010-4#2)
BLCD##2##1##(2008-10#2)
BLM##5##1##(1990-12#2)(1990-6#1)(2008-10#2)
BLO##2##1##(2008-10#2)
BLOOD##2##1##(2008-11#1)(2012-3#1)
BLOSUM##2##1##(2008-9#2)
BLPC##3##1##(2010-4#3)
BLS severity##3##2##(2008-10#3)
BLS signals##2##2##(2008-10#2)
BLS##6##1##(2008-10#6)
BLSD##2##1##(2008-10#2)
BM MNCs in##2##3##(2008-9#2)
BM aspirates with##2##3##(2008-11#2)
BM aspirates##3##2##(2008-11#3)
BM##7##1##(2008-11#5)(2008-9#2)
BM25##3##1##(2011-2#3)
BM35##2##1##(2011-2#2)
BMC of##2##2##(1991-11#2)
BMC##5##1##(1991-11#5)
BMCTV##4##1##(2008-10#4)
BMD and##3##2##(2008-8#1)(2010-3#2)
BMD at the##2##3##(2010-1#1)(2010-3#1)
BMD in the##2##3##(2010-1#1)(2011-2#1)
BMD in##4##2##(2010-1#1)(2010-3#1)(2011-2#2)
BMD was estimated##2##3##(2010-3#2)
BMD was##4##2##(2010-3#3)(2011-2#1)
BMD were##2##2##(2010-3#1)(2011-2#1)
BMD##27##1##(1991-11#2)(2008-8#1)(2010-1#5)(2010-3#11)(2011-2#8)
BMDBM##2##1##(2008-5#2)
BMI &gt##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
BMI and##4##2##(2008-10#2)(2009-7#1)(2011-2#1)
BMI was##4##2##(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
BMI were##3##2##(1994-12#1)(2008-3#1)(2012-5#1)
BMI z-scores showed significant positive correlations with insulin resistance and##2##10##(2011-1#2)
BMI##62##1##(1991-11#1)(1994-12#2)(2008-1#3)(2008-10#13)(2008-11#2)(2008-3#4)(2008-7#1)(2009-7#2)(2010-4#2)(2010-8#6)(2011-1#4)(2011-2#3)(2012-2#8)(2012-3#4)(2012-5#2)(2013-1#5)
BMI)##2##1##(2010-8#2)
BML is##2##2##(2012-3#2)
BML##7##1##(1996-11#2)(2012-3#5)
BMM##2##1##(1994-6#2)
BMP receptors and pSmad1/5/8 were##2##5##(2011-2#2)
BMP receptors and##3##3##(2011-2#3)
BMP##5##1##(2011-2#5)
BMP- 7##2##2##(2011-2#2)
BMP-2##2##1##(2011-2#1)(2012-3#1)
BMP-4##2##1##(2008-6#2)
BMP-7 expression was##2##3##(2011-2#2)
BMP-7 expression##4##2##(2011-2#4)
BMP-7##10##1##(2011-2#10)
BMPR-IA##2##1##(2011-2#2)
BMPR-IB##2##1##(2011-2#2)
BMPR-II##3##1##(2011-2#3)
BMPs##6##1##(2011-2#6)
BMR##5##1##(2008-8#2)(2008-9#3)
BMRF1##6##1##(1997-3#6)
BMRF1-induced activation of the##2##4##(1997-3#2)
BMRF1-responsiveness##2##1##(1997-3#2)
BMSC treated with##2##3##(2008-8#2)
BMSM##2##1##(2009-5#2)
BMV##6##1##(2008-10#6)
BN rats##3##2##(2008-10#3)
BN##4##1##(2008-10#4)
BN/BiRijHsd rats##2##2##(2008-7#2)
BN11##2##1##(1991-12#2)
BNCT##2##1##(2013-1#2)
BNP was##2##2##(1991-5#2)
BNP##11##1##(1991-5#6)(2008-11#1)(2009-10#1)(2009-5#3)
BNP-45##3##1##(1991-5#3)
BNR hyphae##3##2##(2008-10#3)
BNR##16##1##(2008-10#16)
BNYVV##3##1##(2008-10#3)
BO (VBBO)##2##2##(2008-11#2)
BO##3##1##(2008-11#3)
BOC##4##1##(2013-1#4)
BOD sensing film##3##3##(2008-10#3)
BOD sensing##4##2##(2008-10#4)
BOD standard##2##2##(2008-10#2)
BOD##10##1##(2008-10#10)
BODIPY##2##1##(2008-10#2)
BOLD##3##1##(1996-2#1)(2008-11#2)
BON cells display the intestinal pattern of##2##7##(1994-8#2)
BON cells##4##2##(1994-8#4)
BOP##3##1##(2013-1#3)
BOR##2##1##(2013-1#2)
BOS##5##1##(2012-2#5)
BOS-free##2##1##(2012-2#2)
BOX##3##1##(2008-10#3)
BOX-PCR##2##1##(2008-10#2)
BOX-polymerase chain reaction##2##3##(2008-10#2)
BP and HR##2##3##(2008-11#2)
BP and##3##2##(2008-10#1)(2008-11#2)
BP was##3##2##(2010-4#1)(2010-7#1)(2011-2#1)
BP##37##1##(2008-10#10)(2008-11#10)(2008-8#1)(2010-4#5)(2010-7#6)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
BP-10##3##1##(2008-8#3)
BPA in##4##2##(2008-10#2)(2009-8#1)(2010-9#1)
BPA##10##1##(2008-10#5)(2009-8#2)(2010-9#3)
BPD##3##1##(2008-4#1)(2009-9#1)(2010-5#1)
BPE##2##1##(1994-5#2)
BPHA##3##1##(2008-10#3)
BPMV isolates tested##2##3##(2008-10#2)
BPMV isolates##3##2##(2008-10#3)
BPMV##11##1##(2008-10#11)
BPMV-pCP##4##1##(2008-10#4)
BPRS-E##2##1##(2011-2#2)
BPTA-Tb(3+) labeled streptavidin##2##3##(2008-10#2)
BPW##2##1##(2008-10#2)
BPYV##3##1##(2008-10#3)
BPs##2##1##(1992-4#1)(2010-7#1)
BQ and MNQ##4##3##(2009-9#4)
BQ##6##1##(2009-9#6)
BQ-123##3##1##(1992-4#1)(1994-8#1)(2010-12#1)
BR##15##1##(1990-5#2)(1993-11#8)(2008-9#3)(2009-8#2)
BRA-3##5##1##(1993-6#5)
BRAF##6##1##(2008-9#1)(2009-12#1)(2009-4#3)(2013-8#1)
BRAV##2##1##(2008-10#2)
BRCA1##6##1##(1994-9#2)(1995-12#1)(2008-10#2)(2011-2#1)
BRCA2##5##1##(1994-9#3)(2008-10#1)(2011-2#1)
BRD2##4##1##(2008-9#1)(2012-12#3)
BRD4##2##1##(2012-12#2)
BRD7 coding protein were##2##4##(2008-9#2)
BRD7 gene##2##2##(2008-9#2)
BRD7##6##1##(2008-9#6)
BRDF for##2##2##(2008-3#2)
BRDF##4##1##(2008-3#4)
BREH##5##1##(2008-11#5)
BRL 24924 and##2##3##(1990-5#2)
BRL 24924##6##2##(1990-5#6)
BRL##7##1##(1990-5#6)(1994-2#1)
BRNs##2##1##(1994-2#2)
BRS##3##1##(1992-3#3)
BS and##2##2##(2008-10#1)(2013-1#1)
BS containing##2##2##(2008-10#2)
BS##7##1##(2008-10#4)(2012-2#1)(2013-1#2)
BSA also##2##2##(1991-5#1)(2008-3#1)
BSA and HSA##3##3##(2008-10#3)
BSA and##9##2##(2008-10#8)(2008-9#1)
BSA is##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
BSA or##2##2##(2008-10#2)
BSA protein##3##2##(2008-10#3)
BSA was##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
BSA##66##1##(1991-5#5)(1995-12#3)(2008-10#40)(2008-11#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#8)(2011-3#1)
BSA)##2##1##(2008-10#2)
BSE##6##1##(1990-11#1)(1990-6#2)(2008-11#1)(2011-2#2)
BSK-II##2##1##(2008-9#2)
BSM##3##1##(2008-10#3)
BSO##2##1##(1995-3#1)(2012-2#1)
BSR101##2##1##(2008-10#2)
BSV isolates were##2##3##(2008-10#2)
BSV##4##1##(2008-10#4)
BSV-Cav##3##1##(2008-10#3)
BSV-Onne##3##1##(2008-10#3)
BSV-RD##2##1##(2008-10#2)
BSc##2##1##(2008-11#2)
BT##6##1##(2008-10#2)(2011-2#4)
BT-549##2##1##(2011-1#2)
BT-PABA/PAS test##2##2##(1992-11#2)
BT474 cells##2##2##(2012-3#2)
BTB also##2##2##(2012-2#2)
BTB dynamics##2##2##(2009-10#1)(2012-2#1)
BTB##26##1##(2009-10#10)(2012-2#16)
BTEX##9##1##(2008-10#7)(2008-11#2)
BTH induced##2##2##(2008-10#2)
BTH treatment##2##2##(2008-10#2)
BTH##12##1##(2008-10#12)
BTI-Tn-5B1-4##4##1##(2008-7#4)
BTR and BPCR##2##3##(2008-7#2)
BTX##2##1##(2008-10#2)
BTs##4##1##(2008-11#4)
BUA difference##2##2##(2008-7#2)
BUD21##2##1##(2012-3#2)
BUN##4##1##(1990-12#1)(1994-5#1)(2011-3#1)(2013-1#1)
BUS##2##1##(2010-12#2)
BV-15##5##1##(2008-10#5)
BW##10##1##(1994-8#1)(2008-10#5)(2012-3#2)(2013-8#2)
BWYV##3##1##(2008-10#3)
BXSB and##2##2##(1994-8#2)
BY##2##1##(1997-5#1)(2010-7#1)
BY-2 cells##2##2##(2008-11#2)
BY-2##3##1##(2008-11#3)
BYDV and##3##2##(2008-10#3)
BYDV resistance gene##2##3##(2008-8#2)
BYDV resistance##4##2##(2008-8#4)
BYDV tolerance##3##2##(2008-10#3)
BYDV were##2##2##(2008-10#1)(2008-8#1)
BYDV##25##1##(2008-10#19)(2008-8#6)
BYDV-PAV RNA##2##2##(2008-10#2)
BYDV-PAV and##2##2##(2008-10#2)
BYDV-PAV##5##1##(2008-10#5)
BYDV-RMV isolates##2##2##(2008-10#2)
BYDV-RMV##8##1##(2008-10#8)
BYMV##2##1##(2008-10#2)
BYSV CP##5##2##(2008-10#5)
BYSV##9##1##(2008-10#9)
BZ susceptible##2##2##(1996-12#2)
BZ##7##1##(1996-12#4)(2008-10#3)
BZP##3##1##(2008-3#3)
B]##3##1##(1993-6#1)(2011-2#2)
Ba and##5##2##(2008-10#5)
Ba##27##1##(2008-10#27)
Ba(0##2##1##(2012-2#2)
Ba(1-x)Sr(x)TiO(3)##2##1##(2008-3#2)
Ba(2+) and##3##2##(2008-10#3)
Ba(2+)##16##1##(2008-10#16)
Ba(2+)&gt##2##1##(2008-10#2)
Ba(2+)-and Ca(2+)-evoked release were##2##4##(1995-11#2)
Ba(II)##8##1##(2008-10#8)
Ba(SO(4))(x)(CrO(4))(1-x) solid solution##2##3##(2008-10#2)
Ba)##5##1##(2008-10#5)
Ba2+ (10mM)##2##2##(1993-3#2)
Ba2+ replaces Ca2+/calmodulin in the##2##5##(1995-11#2)
Ba2+##9##1##(1993-3#2)(1994-11#1)(1995-11#6)
BaCl(2)##3##1##(2008-10#3)
BaP##9##1##(2011-1#9)
BaP-7##2##1##(2011-1#2)
BaP-9##2##1##(2011-1#2)
BaP-dione##2##1##(2011-1#2)
BaSO(4)##2##1##(2008-10#2)
BaTiO(3)##5##1##(2008-2#2)(2008-3#3)
Baby##3##1##(2008-11#1)(2009-9#1)(2013-1#1)
Bac-BH##2##1##(2008-11#2)
Baca##4##1##(1996-5#4)
Baccalaureate##2##1##(1996-2#1)(2008-12#1)
Bachelor of Nursing degree##3##4##(2008-11#1)(2008-12#2)
Bacille##2##1##(2009-7#1)(2011-2#1)
Bacilli##5##1##(2008-10#1)(2011-2#4)
Bacillus amyloliquefaciens##8##2##(1990-11#2)(1991-6#2)(2008-10#2)(2013-1#2)
Bacillus and Paenibacillus spp##3##4##(2008-10#3)
Bacillus and##4##2##(2008-10#4)
Bacillus anthracis##8##2##(1992-12#1)(2008-10#2)(2010-1#1)(2011-2#2)(2012-2#2)
Bacillus cereus ATCC 14579##2##4##(2011-1#1)(2011-2#1)
Bacillus cereus and##2##3##(2011-1#1)(2011-2#1)
Bacillus cereus group##5##3##(2011-2#5)
Bacillus cereus##23##2##(1992-3#2)(2008-10#2)(2010-12#2)(2011-1#2)(2011-2#15)
Bacillus licheniformis##4##2##(2008-10#2)(2011-2#2)
Bacillus megaterium##4##2##(2008-10#2)(2011-1#2)
Bacillus mycoides##5##2##(2008-10#5)
Bacillus pumilus##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
Bacillus sp##7##2##(1993-3#2)(2008-10#5)
Bacillus species##3##2##(2011-2#3)
Bacillus spp##14##2##(2008-10#14)
Bacillus strain##2##2##(2008-10#2)
Bacillus strains##2##2##(2008-10#2)
Bacillus subtilis and##4##3##(1995-3#1)(1996-6#1)(1997-2#1)(2011-2#1)
Bacillus subtilis flagellar proteins##2##4##(1993-12#2)
Bacillus subtilis genome##5##3##(1995-12#2)(1996-8#2)(1997-7#1)
Bacillus subtilis spores##3##3##(2008-10#1)(2008-9#1)(2010-1#1)
Bacillus subtilis##40##2##(1990-11#1)(1990-12#2)(1991-6#2)(1993-12#3)(1993-9#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-6#1)(1996-8#2)(1997-2#2)(1997-7#2)(2008-10#8)(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-1#1)(2011-1#2)(2011-2#3)
Bacillus thuringiensis subsp##2##3##(1993-12#2)
Bacillus thuringiensis##9##2##(1993-12#2)(1993-8#1)(1995-6#1)(2008-10#4)(2008-9#1)
Bacillus weihenstephanensis##3##2##(2011-2#3)
Bacillus##158##1##(1990-11#3)(1990-12#2)(1991-6#4)(1992-12#1)(1992-3#2)(1993-12#5)(1993-3#2)(1993-8#1)(1993-9#1)(1995-12#2)(1995-3#1)(1995-6#3)(1996-6#1)(1996-8#2)(1997-2#2)(1997-7#2)(2008-10#61)(2008-11#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-1#4)(2010-12#2)(2011-1#7)(2011-2#39)(2012-2#2)(2013-1#2)
Bacillus-based BCAs##3##2##(2008-10#3)
Bacillus-based##4##1##(2008-10#4)
Back##2##1##(1997-3#1)(2010-8#1)
Back-projection##2##1##(1994-9#2)
Backbone 1H##2##2##(2009-7#2)
Backbone##6##1##(2009-7#6)
Background and Objectives##2##3##(2011-2#1)(2012-2#1)
Background and aims##3##3##(2009-8#2)(2012-3#1)
Background and##12##2##(1991-6#1)(2009-8#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Background information about##2##3##(1994-2#1)(2008-9#1)
Background##128##1##(1991-6#1)(1994-2#1)(1996-9#1)(2007-11#4)(2007-8#5)(2008-10#5)(2008-11#1)(2008-3#5)(2008-7#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-8#4)(2010-10#12)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#1)(2012-3#10)(2013-1#42)(2013-8#14)
Background ##3##1##(2011-2#3)
Backscatter##5##1##(2008-2#1)(2008-3#4)
Bacteria and##30##2##(1994-9#1)(2011-2#29)
Bacteria have##2##2##(1996-12#1)(2010-7#1)
Bacteria in##2##2##(2008-9#1)(2011-2#1)
Bacteria of##2##2##(2008-10#1)(2011-2#1)
Bacteria were##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
Bacteria##52##1##(1994-9#1)(1996-12#2)(2007-12#1)(2008-10#13)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#32)
Bacterial Blight Resistance##2##3##(2008-10#2)
Bacterial Blight of##2##3##(2008-10#2)
Bacterial Blight##5##2##(2008-10#5)
Bacterial adherence##2##2##(1991-3#1)(2013-8#1)
Bacterial blight##4##2##(2008-10#3)(2009-10#1)
Bacterial colonization##2##2##(2008-10#1)(2009-6#1)
Bacterial contamination of##2##3##(1991-12#1)(1991-3#1)
Bacterial contamination##3##2##(1991-12#2)(1991-3#1)
Bacterial expression of##2##3##(1995-6#1)(1995-8#1)
Bacterial pathogens##2##2##(2008-7#1)(2009-6#1)
Bacterial spore formers are##2##4##(2011-2#2)
Bacterial##79##1##(1991-12#2)(1991-3#2)(1991-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(2007-12#1)(2008-10#37)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#3)
Bacteriol##2##1##(1993-9#1)(1995-6#1)
Bacteriophage##3##1##(1994-5#1)(1995-2#1)(2012-2#1)
Bacteriophages##2##1##(2012-2#2)
Bacterium##4##1##(2008-10#4)
Bacteriuria##2##1##(2008-12#1)(2012-3#1)
Bacteroides species##2##2##(1997-2#2)
Bacteroides##9##1##(1997-2#4)(2008-11#1)(2008-12#3)(2008-7#1)
Bactrocera##2##1##(2013-8#2)
Baculovirus Expression Vector System##2##4##(2008-11#1)(2008-7#1)
Baculovirus##4##1##(2008-11#3)(2008-7#1)
Baculovirus/insect cell##2##2##(2008-11#2)
Bad##7##1##(1990-8#1)(1992-2#1)(1994-8#1)(2008-10#2)(2011-2#1)(2012-3#1)
Bader's##2##1##(2008-10#2)
Baggiolini##2##1##(1994-5#2)
Bahia##4##1##(2008-10#3)(2010-10#1)
Bai of##2##2##(2008-9#2)
Baill##3##1##(2008-11#1)(2008-8#2)
Baja California##5##2##(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)
Baja##6##1##(2008-8#2)(2008-9#2)(2009-9#1)(2010-8#1)
Baker's yeast##3##2##(2008-10#2)(2010-7#1)
Baker's yeast-mediated##2##2##(2008-5#2)
Baker's##6##1##(1990-3#1)(2008-10#2)(2008-5#2)(2010-7#1)
Balance Master and Equitest##2##4##(2010-12#2)
Balance##5##1##(1997-1#1)(2008-11#1)(2010-12#2)(2013-1#1)
Balanced Budget Act##3##3##(2008-11#3)
Balanced Budget##4##2##(2008-11#4)
Balanced##8##1##(2008-11#6)(2008-3#1)(2008-9#1)
Balancing##2##1##(1993-1#1)(2013-1#1)
Balb/c 3T3 cells##3##3##(2008-11#3)
Balb/c mice##2##2##(1995-11#1)(2008-8#1)
Balb/c##6##1##(1995-11#1)(2008-11#3)(2008-12#1)(2008-8#1)
Baldrige Award##2##2##(1995-2#2)
Baldrige##6##1##(1994-3#1)(1995-2#4)(1995-3#1)
Bale highlands of##2##3##(2011-2#2)
Ballet##2##1##(2010-1#1)(2013-1#1)
Balloon##6##1##(1997-3#1)(1997-6#1)(2008-11#2)(2008-12#1)(2013-1#1)
Balpha##3##1##(2008-11#3)
Baltic amber##2##2##(2008-10#2)
Baltic##11##1##(1995-2#1)(2007-12#2)(2008-10#4)(2008-11#2)(2010-8#2)
Baltimore##2##1##(1992-2#1)(2008-7#1)
BamHI##6##1##(1990-5#1)(1993-6#1)(1993-8#1)(2008-10#2)(2009-3#1)
Banana streak virus##2##3##(2008-10#2)
Banana##7##1##(2008-10#7)
Band 3##2##2##(2013-7#2)
Band##9##1##(1993-12#1)(1996-9#3)(2008-10#1)(2012-12#1)(2013-1#1)(2013-7#2)
Bandar Abbas##2##2##(2008-12#2)
Banding##2##1##(1996-3#1)(2008-12#1)
Bands##2##1##(2008-10#2)
Bang##2##1##(1997-8#1)(2013-1#1)
Bangalore##6##1##(2008-10#5)(2012-2#1)
Bangladesh##20##1##(1991-8#3)(1994-9#1)(2008-10#14)(2010-11#1)(2013-8#1)
Bank##13##1##(1991-3#1)(1995-11#1)(1995-12#1)(1997-8#3)(2008-10#1)(2008-11#2)(2011-2#1)(2011-3#2)(2012-12#1)
Banksia##3##1##(2008-10#1)(2010-3#2)
Barbados##3##1##(2008-10#3)
Barcelona##10##1##(1993-3#1)(1996-2#1)(1997-5#1)(2008-10#6)(2008-5#1)
Barer-Stoddart##2##1##(2009-3#2)
Barium##3##1##(1992-9#1)(1995-11#1)(2008-10#1)
Bark##2##1##(2008-10#2)
Barker##5##1##(2008-10#5)
Barley Yellow Dwarf Virus-PAV##2##4##(2008-10#2)
Barley yellow dwarf virus (BYDV) and##2##6##(2008-10#2)
Barley yellow dwarf virus (BYDV)##3##5##(2008-10#3)
Barley yellow dwarf virus##11##4##(2008-10#11)
Barley yellow dwarf##15##3##(2008-10#15)
Barley##42##1##(2008-10#42)
Barlow##4##1##(1995-12#4)
Barnard##2##1##(1990-12#1)(1995-11#1)
Barnes et al##2##3##(1993-8#1)(2008-11#1)
Barnes##3##1##(1993-8#1)(2008-11#1)(2008-5#1)
Barrett's esophagus##6##2##(2008-12#2)(2010-12#1)(2012-3#1)(2013-1#2)
Barrett's##10##1##(2008-12#5)(2010-12#2)(2012-3#1)(2013-1#2)
Barrier cells in##2##3##(2008-7#2)
Barrier cells##3##2##(2008-7#3)
Barrier##10##1##(2008-10#1)(2008-5#3)(2008-7#3)(2009-10#2)(2009-12#1)
Barriers and##2##2##(2008-11#1)(2013-1#1)
Barriers to##3##2##(1995-9#1)(2010-11#1)(2012-12#1)
Barriers##8##1##(1995-9#1)(2008-11#2)(2010-11#3)(2012-12#1)(2013-1#1)
Basal bolus##2##2##(2008-1#2)
Basal cell##2##2##(2012-3#2)
Basal ganglia##2##2##(1997-3#1)(2013-1#1)
Basal##17##1##(1994-11#1)(1995-11#3)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#3)(2012-3#2)(2013-1#1)
Base##12##1##(1993-12#1)(1995-12#1)(2008-10#4)(2011-2#2)(2012-3#3)(2013-1#1)
Based on a combination of##2##5##(2007-12#1)(2009-6#1)
Based on a literature review##2##5##(1991-6#1)(2008-7#1)
Based on a previous##2##4##(1990-5#1)(2008-10#1)
Based on a simple##2##4##(2008-10#1)(2008-6#1)
Based on a##26##3##(1990-5#1)(1990-8#1)(1991-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-6#1)(2013-1#1)(2013-8#1)
Based on an##2##3##(1990-3#1)(1995-5#1)
Based on analysis##2##3##(2008-10#1)(2009-10#1)
Based on case study interviews with##2##6##(1997-3#2)
Based on cluster analysis##2##4##(2008-10#2)
Based on colony morphology and##2##5##(2008-10#2)
Based on current##2##3##(2012-12#1)(2013-8#1)
Based on data from##2##4##(1997-4#1)(2008-10#1)
Based on data##3##3##(1997-4#1)(2008-10#2)
Based on gaseous compound introduction as##2##6##(2008-10#2)
Based on its##2##3##(2008-10#1)(2008-9#1)
Based on model##2##3##(2008-10#2)
Based on molecular##2##3##(1997-3#1)(2010-3#1)
Based on our data##2##4##(1996-11#1)(2007-12#1)
Based on our results##4##4##(1990-12#1)(2008-10#2)(2008-7#1)
Based on our##11##3##(1990-12#1)(1993-12#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#2)
Based on previous##2##3##(1994-3#1)(2008-7#1)
Based on results from the##2##5##(1991-6#1)(2008-10#1)
Based on results##3##3##(1991-6#1)(2008-10#1)(2011-2#1)
Based on the above findings##3##5##(1997-8#1)(2008-10#2)
Based on the analysis of##3##5##(2008-10#2)(2010-9#1)
Based on the analysis##4##4##(2008-10#2)(2010-12#1)(2010-9#1)
Based on the data##2##4##(1991-5#1)(2008-10#1)
Based on the deduced amino acid sequence##2##7##(2008-10#2)
Based on the enquiry committee report##2##6##(2008-10#2)
Based on the experimental##4##4##(1990-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
Based on the findings of##2##5##(2008-7#1)(2012-2#1)
Based on the findings##4##4##(2008-7#1)(2010-5#1)(2012-2#1)(2013-8#1)
Based on the interaction between##2##5##(2008-10#2)
Based on the measurements of##2##5##(2008-10#2)
Based on the nucleotide##2##4##(1993-12#1)(2008-10#1)
Based on the observation##2##4##(1994-3#1)(2008-10#1)
Based on the obtained results##2##5##(2008-10#2)
Based on the phylogenetic##2##4##(2008-10#1)(2008-9#1)
Based on the results of##5##5##(2008-10#3)(2008-8#1)(2011-2#1)
Based on the results##8##4##(2008-10#5)(2008-5#1)(2008-8#1)(2011-2#1)
Based on the selective reaction##2##5##(2008-10#2)
Based on the##134##3##(1990-8#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-12#3)(1997-6#2)(1997-8#3)(2008-1#1)(2008-10#70)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#4)
Based on their##7##3##(1992-3#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
Based on theoretical considerations##2##4##(2008-10#1)(2010-12#1)
Based on these data##2##4##(2008-10#1)(2009-10#1)
Based on these findings we conclude##2##6##(1991-5#1)(2011-2#1)
Based on these findings##9##4##(1991-5#1)(1993-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
Based on these genetic##2##4##(2008-10#2)
Based on these observations##3##4##(1995-5#1)(2008-7#1)(2009-12#1)
Based on these results the##2##5##(2008-12#1)(2008-5#1)
Based on these results##16##4##(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)
Based on these##45##3##(1991-5#1)(1993-12#1)(1995-5#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
Based on this method##2##4##(2008-10#1)(2012-3#1)
Based on this phenomenon##2##4##(2008-10#2)
Based on this result##2##4##(2008-3#1)(2008-8#1)
Based on this study##2##4##(2008-10#1)(2013-8#1)
Based on this##29##3##(1991-6#1)(1994-8#1)(1995-5#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
Based on total##2##3##(2008-8#1)(2013-1#1)
Based on two##3##3##(1996-6#1)(2008-11#2)
Based on virulence##2##3##(2008-10#2)
Based on##399##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-5#3)(1991-6#3)(1992-1#1)(1992-12#1)(1992-3#3)(1993-1#1)(1993-12#3)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#6)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-12#3)(2008-1#2)(2008-10#183)(2008-11#20)(2008-12#5)(2008-3#5)(2008-5#14)(2008-6#4)(2008-7#14)(2008-8#13)(2008-9#8)(2009-10#4)(2009-12#3)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#4)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#14)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#3)(2013-8#13)
Based upon the##2##3##(1990-5#1)(1995-11#1)
Based upon##7##2##(1990-5#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-11#1)
Based##414##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#2)(1991-5#3)(1991-6#3)(1992-1#1)(1992-12#1)(1992-3#3)(1993-1#1)(1993-12#3)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#7)(1995-3#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#4)(2007-12#3)(2008-1#2)(2008-10#185)(2008-11#21)(2008-12#5)(2008-3#5)(2008-5#15)(2008-6#4)(2008-7#15)(2008-8#13)(2008-9#8)(2009-10#4)(2009-12#3)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#4)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#15)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#3)(2013-8#13)
Basel##2##1##(1996-8#1)(2008-1#1)
Baseline and##2##2##(2012-3#1)(2013-1#1)
Baseline separation##2##2##(2008-10#2)
Baseline##14##1##(1995-5#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-10#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#3)
Bases##3##1##(2009-12#1)(2010-4#1)(2011-2#1)
Basic Health##2##2##(1994-6#1)(1995-2#1)
Basic Local Alignment Search Tool (BLAST)##2##6##(2008-9#2)
Basic Local Alignment Search Tool##3##5##(2008-4#1)(2008-9#2)
Basic Protocol##5##2##(2008-4#4)(2008-9#1)
Basic Rule of Environmental Hygiene##2##5##(2008-11#2)
Basic features of##2##3##(2008-2#1)(2009-10#1)
Basic fibroblast growth factor##5##4##(1994-11#2)(1995-12#3)
Basic issues##2##2##(1995-2#1)(2008-4#1)
Basic principles##2##2##(2008-9#1)(2010-8#1)
Basic research##2##2##(2008-5#1)(2008-8#1)
Basic##50##1##(1992-1#1)(1992-12#1)(1992-5#1)(1994-11#2)(1994-6#2)(1995-12#4)(1995-2#2)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#8)(2008-5#1)(2008-8#1)(2008-9#5)(2009-10#1)(2010-10#1)(2010-8#1)(2012-2#2)(2013-8#1)
Basidiomycetes##2##1##(2008-10#1)(2008-12#1)
Basidiomycota##2##1##(2008-10#1)(2009-6#1)
Basin and the##2##3##(2008-6#2)
Basin and##5##2##(2008-10#2)(2008-6#2)(2011-2#1)
Basin of##4##2##(2008-10#3)(2010-8#1)
Basin##32##1##(2008-1#1)(2008-10#17)(2008-6#9)(2010-8#1)(2011-2#2)(2013-8#2)
Basis##3##1##(2008-10#2)(2008-3#1)
Bastianelli and##2##2##(2010-1#2)
Batch cultivation##2##2##(2008-11#2)
Batch experiments##2##2##(2008-10#1)(2008-11#1)
Batch##18##1##(2008-10#10)(2008-11#7)(2008-4#1)
Batesian mimicry##3##2##(2012-3#3)
Bathyaltum wareni##2##2##(2011-2#2)
Bathyergus suillus##2##2##(2011-2#2)
Bathypelta##2##1##(2011-2#2)
Bathysciadiidae##2##1##(2011-2#2)
Bathysciadium##2##1##(2011-2#2)
Battista Grassi##4##2##(2010-1#4)
Bavaria##2##1##(1994-3#1)(2008-11#1)
Bax and c-myc##3##3##(2008-5#3)
Bax and##4##2##(2008-5#4)
Bax in##2##2##(2008-9#1)(2010-12#1)
Bax was##2##2##(2008-9#2)
Bax##14##1##(2008-5#7)(2008-9#3)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)
Baxter Colleague##3##2##(2011-2#3)
Baxter Healthcare##2##2##(1994-1#1)(1996-5#1)
Baxter##12##1##(1992-3#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2011-2#5)
Baxter's##3##1##(1993-3#2)(1994-1#1)
Bay K##2##2##(1996-2#2)
Bay##15##1##(1996-1#1)(1996-2#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)(2010-8#1)(2013-8#1)
Bayer##9##1##(1996-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)
Bayes##3##1##(1995-12#1)(1995-9#1)(2009-12#1)
Bayesian analysis##4##2##(1995-12#1)(2008-10#2)(2008-11#1)
Bayesian approach##3##2##(2008-6#1)(2009-12#1)(2011-2#1)
Bayesian approaches##2##2##(1994-9#1)(1995-12#1)
Bayesian hierarchical##3##2##(1994-9#3)
Bayesian inference##4##2##(2008-10#4)
Bayesian method##3##2##(1994-9#2)(2010-5#1)
Bayesian methodology##4##2##(2008-10#4)
Bayesian methods##6##2##(2008-10#5)(2010-4#1)
Bayesian models##2##2##(1994-9#2)
Bayesian statistics##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
Bayesian##54##1##(1994-9#9)(1995-12#2)(1996-6#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-4#2)(2010-11#1)(2010-4#1)(2010-5#2)(2011-2#4)(2012-3#2)(2013-1#1)
Bb increased##2##2##(1991-3#2)
Bb##5##1##(1991-3#5)
BcEST##3##1##(2011-1#3)
BcOS1p is##2##2##(2008-10#2)
BcOS1p##3##1##(2008-10#3)
Bcl-2 and##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
Bcl-2 expression was##3##3##(2008-9#3)
Bcl-2 expression##8##2##(1994-3#1)(2008-11#2)(2008-8#1)(2008-9#3)(2011-2#1)
Bcl-2 family members##2##3##(2009-12#2)
Bcl-2 family proteins##2##3##(2011-2#2)
Bcl-2 family##11##2##(2008-11#2)(2009-12#4)(2011-2#5)
Bcl-2 into a##2##3##(2008-9#2)
Bcl-2##47##1##(1993-3#1)(1994-3#1)(2008-10#3)(2008-11#12)(2008-8#5)(2008-9#7)(2009-12#6)(2010-12#1)(2011-2#6)(2012-2#3)(2013-1#1)(2013-8#1)
Bcl-xL##9##1##(2008-11#8)(2013-7#1)
Bcl-xLtriangle up 46-83##3##3##(2008-11#3)
Bcl2 and Bax##2##3##(2008-5#2)
Bcl2 and##3##2##(2008-5#3)
Bcl2 levels##2##2##(2008-5#2)
Bcl2##10##1##(2008-5#9)(2010-1#1)
BcpLH##3##1##(2008-8#3)
Bct##4##1##(2008-10#4)
Be##7##1##(1994-2#1)(2008-10#4)(2008-7#1)(2012-3#1)
Be(+2)##4##1##(2008-10#4)
Be(II) ion##2##2##(2008-10#2)
Be(II)##9##1##(2008-10#9)
Beach##6##1##(1994-2#1)(1996-5#1)(2008-10#3)(2010-1#1)
Bead-to-bead##2##1##(2008-11#2)
BeadCons##2##1##(2008-9#2)
Beads##3##1##(1996-12#2)(2008-10#1)
Beagle dog and##2##3##(2011-3#2)
Beagle##3##1##(1994-2#1)(2011-3#2)
Beam##8##1##(2008-2#1)(2008-3#4)(2012-3#1)(2013-1#2)
Beams##2##1##(1996-9#1)(2008-3#1)
Bean Plants##3##2##(2008-10#3)
Bean calico mosaic virus##2##4##(2008-10#2)
Bean common mosaic necrosis virus (BCMNV)##2##6##(2008-10#2)
Bean common mosaic necrosis virus##5##5##(2008-10#5)
Bean common mosaic virus##2##4##(2008-10#2)
Bean common mosaic##7##3##(2008-10#7)
Bean golden mosaic virus (BGMV)##2##5##(2008-10#2)
Bean golden mosaic##3##3##(2008-10#3)
Bean golden yellow mosaic virus (BGYMV)##2##6##(2008-10#2)
Bean golden yellow mosaic virus##4##5##(2008-10#4)
Bean golden##7##2##(2008-10#7)
Bean pod mottle virus##3##4##(2008-10#3)
Bean pod mottle##4##3##(2008-10#4)
Bean##38##1##(2008-10#38)
Beard##3##1##(2008-11#3)
Bearing in mind##2##3##(2008-11#1)(2012-2#1)
Beauvericin##2##1##(2008-10#2)
Because a##2##2##(1991-2#1)(2011-2#1)
Because data##2##2##(2009-7#1)(2013-1#1)
Because flow##2##2##(2008-9#2)
Because it was##2##3##(1995-1#1)(2008-12#1)
Because it##7##2##(1991-12#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
Because many of the##2##4##(1992-2#1)(2008-9#1)
Because many##5##2##(1992-2#1)(1993-1#1)(2008-11#1)(2008-9#1)(2010-11#1)
Because most##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
Because no single##2##3##(1993-2#1)(2010-8#1)
Because no##4##2##(1993-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
Because of a##2##3##(2008-10#1)(2011-2#1)
Because of its##9##3##(1995-2#1)(2007-11#1)(2008-6#1)(2010-11#2)(2010-7#1)(2013-1#2)(2013-8#1)
Because of that##2##3##(2011-2#1)(2012-3#1)
Because of the important##2##4##(1992-3#1)(2008-1#1)
Because of the strong##2##4##(2008-10#1)(2013-1#1)
Because of the unique##2##4##(1996-1#1)(2012-3#1)
Because of the##50##3##(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-1#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Because of their##8##3##(1991-6#1)(1992-12#1)(1992-6#1)(1996-1#1)(2008-10#2)(2008-5#1)(2013-8#1)
Because of these##3##3##(2008-7#1)(2008-8#1)(2012-12#1)
Because of this##6##3##(2008-10#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#1)
Because of##99##2##(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-2#1)(1994-2#2)(1995-2#2)(1995-5#2)(1996-1#2)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-2#11)(2012-12#3)(2012-3#3)(2013-1#5)(2013-8#3)
Because the fungus##2##3##(2008-10#2)
Because the optical##2##3##(2008-2#1)(2008-3#1)
Because the physical##2##3##(2008-4#1)(2008-5#1)
Because the##43##2##(1990-5#1)(1991-1#1)(1991-5#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
Because there is no##2##4##(2010-11#1)(2012-2#1)
Because there is##4##3##(2008-11#1)(2010-11#1)(2011-10#1)(2012-2#1)
Because there##5##2##(2008-10#1)(2008-11#1)(2010-11#1)(2011-10#1)(2012-2#1)
Because these excipients are not inert##2##6##(2012-2#2)
Because these##4##2##(2008-9#1)(2012-12#1)(2012-2#2)
Because they##4##2##(1990-8#1)(2008-11#1)(2008-4#1)(2008-5#1)
Because this##9##2##(1994-1#1)(1994-2#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-12#1)(2010-7#1)(2011-2#1)
Because two##2##2##(2008-10#2)
Because we##2##2##(2008-10#1)(2008-7#1)
Because##287##1##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#2)(1994-2#5)(1994-5#1)(1994-9#1)(1995-1#2)(1995-2#3)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#60)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#11)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-10#2)(2010-11#4)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#19)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#9)(2012-3#8)(2013-1#13)(2013-8#3)
Beck Depression Inventory (BDI)##2##4##(1991-2#1)(2008-4#1)
Beck Depression Inventory##4##3##(1991-2#1)(2008-4#1)(2012-2#1)(2013-8#1)
Beck Depression##5##2##(1991-2#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
Beck##9##1##(1991-2#1)(2008-4#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
Beck's##3##1##(1992-1#1)(1992-2#2)
Becker##2##1##(1992-9#1)(1997-3#1)
Becoming##3##1##(2008-12#2)(2012-12#1)
Bed##2##1##(1991-12#1)(2008-9#1)
Bee##2##1##(2008-8#1)(2013-1#1)
Beef patties were##2##3##(2010-4#2)
Beef##3##1##(1997-2#1)(2010-4#2)
Beer's Law was obeyed over the range##2##7##(2008-10#2)
Beer's Law##6##2##(2008-10#6)
Beer's law in the concentration range of 0##2##8##(2008-10#2)
Beer's law in the range 0##3##6##(2008-10#3)
Beer's law in the range of 0##3##7##(2008-10#3)
Beer's law in the range##6##5##(2008-10#6)
Beer's law in the##8##4##(2008-10#8)
Beer's law is followed in the range##2##7##(2008-10#2)
Beer's law is obeyed for##3##5##(2008-10#3)
Beer's law is obeyed in a concentration range of##2##9##(2008-10#2)
Beer's law is obeyed in the range 0##2##8##(2008-10#2)
Beer's law is obeyed in the range of 0##3##9##(2008-10#3)
Beer's law is obeyed in the range of##4##8##(2008-10#4)
Beer's law is obeyed in the range##7##7##(2008-10#7)
Beer's law is obeyed in the##8##6##(2008-10#8)
Beer's law is obeyed in##10##5##(2008-10#10)
Beer's law is obeyed over the concentration range of 0##2##10##(2008-10#2)
Beer's law is obeyed over the concentration range##3##8##(2008-10#3)
Beer's law is obeyed over the range from 0 to##2##10##(2008-10#2)
Beer's law is obeyed over the##6##6##(2008-10#6)
Beer's law is obeyed##22##4##(2008-10#22)
Beer's law is##27##3##(2008-10#27)
Beer's law was obeyed in the##2##6##(2008-10#2)
Beer's law was obeyed in##3##5##(2008-10#3)
Beer's law was obeyed over the concentration range of##2##9##(2008-10#2)
Beer's law was obeyed over the range##4##7##(2008-10#4)
Beer's law was obeyed over the##6##6##(2008-10#6)
Beer's law was obeyed##12##4##(2008-10#12)
Beer's law was##14##3##(2008-10#14)
Beer's law##62##2##(2008-10#62)
Beer's plots were obeyed in a general concentration range of##2##10##(2008-10#2)
Beer's##71##1##(2008-10#71)
Beer-Lambert law##2##2##(2008-10#2)
Beet curly top virus##3##4##(2008-10#3)
Beet curly top##4##3##(2008-10#4)
Beet mild curly top virus##3##5##(2008-10#3)
Beet necrotic yellow vein virus##3##5##(2008-10#3)
Beet western yellows virus##2##4##(2008-10#2)
Beet western yellows##3##3##(2008-10#3)
Beet##23##1##(2008-10#22)(2012-3#1)
Beetle##4##1##(2008-10#2)(2008-6#1)(2009-10#1)
Before and after##3##3##(2011-2#2)(2013-8#1)
Before the##9##2##(1991-3#1)(1992-5#1)(1997-2#1)(2008-10#1)(2008-7#1)(2010-8#2)(2012-12#1)(2012-3#1)
Before treatment##2##2##(1996-1#1)(2010-12#1)
Before##33##1##(1991-1#1)(1991-3#1)(1991-6#1)(1992-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
Beginning##5##1##(1992-3#1)(2008-10#2)(2008-12#1)(2008-4#1)
Begomovirus Species##3##2##(2008-10#3)
Begomovirus from##2##2##(2008-10#2)
Begomovirus##12##1##(2008-10#12)
Begomoviruses Associated with##2##3##(2008-10#2)
Begomoviruses and##2##2##(2008-10#2)
Begomoviruses##7##1##(2008-10#7)
Behavior Therapy##2##2##(2008-11#1)(2013-1#1)
Behavior in##5##2##(2008-3#1)(2009-7#1)(2013-1#2)(2013-8#1)
Behavior of##3##2##(2008-10#2)(2008-6#1)
Behavior##23##1##(1990-11#1)(1992-3#1)(1993-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#5)(2013-8#1)
Behavioral Indicators of Conscientiousness##2##4##(2011-2#2)
Behavioral and##3##2##(1991-1#1)(1995-9#1)(2009-7#1)
Behavioral couples therapy##2##3##(2008-6#2)
Behavioral methods##2##2##(2010-7#2)
Behavioral##25##1##(1991-1#1)(1995-9#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)
Behaviors##12##1##(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#3)(2012-3#1)(2013-1#3)
Behaviour of##4##2##(2008-10#3)(2013-1#1)
Behaviour##12##1##(1991-2#1)(1991-9#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#3)
Behavioural##4##1##(1996-2#1)(2008-11#1)(2010-4#1)(2012-2#1)
Behind##2##1##(2011-2#2)
Beijing Normal University##2##3##(2008-10#2)
Beijing##11##1##(1990-11#1)(2008-10#6)(2008-9#1)(2010-1#1)(2013-8#2)
Being a##2##2##(2008-11#1)(2012-3#1)
Being##14##1##(2008-10#3)(2008-11#2)(2008-5#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Belarus##6##1##(2008-10#2)(2011-2#2)(2012-3#2)
Belgian coastal waters##2##3##(2008-3#2)
Belgian##8##1##(1994-12#1)(2008-10#3)(2008-3#2)(2011-2#2)
Belgium##8##1##(2008-10#2)(2008-12#1)(2010-1#1)(2011-2#2)(2013-8#2)
Beliefs About##2##2##(2009-10#1)(2010-4#1)
Beliefs##4##1##(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)
Bell Pepper##2##2##(2008-10#2)
Bell pepper##2##2##(2008-10#2)
Bell##8##1##(2008-10#8)
Bellavere's criteria##3##2##(2012-2#3)
BelloCell((R))##4##1##(2008-11#4)
Belonging to the##2##3##(2008-10#1)(2012-3#1)
Belonging to##4##2##(2008-10#2)(2010-9#1)(2012-3#1)
Belousov-Zhabotinsky reaction##2##2##(2008-10#2)
Belousov-Zhabotinsky##3##1##(2008-10#3)
Below##2##1##(1995-3#1)(2008-10#1)
Belt from##2##2##(2008-10#2)
Belt##6##1##(2007-9#2)(2008-10#4)
Beltsville##3##1##(2008-10#3)
Bemisia tabaci in Pakistan##2##4##(2008-10#2)
Bemisia tabaci##16##2##(2008-10#14)(2008-12#2)
Bench##2##1##(1992-3#1)(2011-2#1)
Benchmarks##3##1##(1996-1#3)
Bend##6##1##(2008-10#6)
Benedictine monastery##2##2##(2011-2#2)
Benedictine##4##1##(2011-2#4)
Beneficial effects##2##2##(2008-1#1)(2011-2#1)
Beneficial##5##1##(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#2)
Beneficiary Survey##13##2##(1993-1#1)(1994-1#1)(1995-12#3)(1995-2#3)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
Beneficiary##19##1##(1993-1#2)(1994-1#2)(1995-12#5)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)
Benefit##6##1##(1993-12#2)(2008-10#1)(2010-12#1)(2013-1#2)
Benefits of##7##2##(1991-11#1)(1991-9#1)(1995-5#1)(2008-9#1)(2010-8#1)(2011-2#2)
Benefits##10##1##(1991-11#1)(1991-9#1)(1992-3#1)(1995-5#1)(2008-1#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#2)
Benesi-Hildebrand method##2##2##(2008-10#2)
Benesi-Hildebrand##3##1##(2008-10#3)
Bengal##8##1##(2008-10#2)(2008-5#1)(2010-10#1)(2011-1#2)(2011-2#2)
Benign##7##1##(1993-1#1)(2010-12#1)(2011-3#1)(2012-2#1)(2012-3#3)
Benin##2##1##(2008-10#1)(2008-12#1)
Benjamin##3##1##(1993-2#2)(1995-6#1)
Bentall and##3##2##(2012-2#3)
Benzene##2##1##(2008-10#2)
Benzeneacetaldehyde-4-hydroxy-alpha-oxo-aldoxime##2##1##(2008-10#2)
Benzimidazole and Dicarboximide Fungicides##2##4##(2008-10#2)
Benzimidazole##3##1##(2008-10#2)(2012-2#1)
Benzo(a)pyrene##2##1##(2008-10#1)(2008-11#1)
Benzodiazepines##2##1##(1995-11#1)(2008-10#1)
Berberine##3##1##(2008-12#1)(2012-3#2)
Bergen##2##1##(1995-6#1)(1997-8#1)
Berlin##4##1##(1991-6#1)(1995-1#3)
Bermuda grass white leaf##2##4##(2008-10#2)
Berne##2##1##(1993-8#1)(1996-11#1)
Berries##4##1##(2008-10#4)
Berry##2##1##(2008-10#2)
Berthelot##2##1##(2008-10#2)
Beside the##2##2##(2008-7#1)(2010-12#1)
Beside##7##1##(2008-10#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-10#1)(2011-2#1)
Besides a##2##2##(1995-12#1)(2008-7#1)
Besides its##2##2##(2008-7#1)(2011-1#1)
Besides the risk##2##3##(1994-12#1)(2013-1#1)
Besides the##10##2##(1994-12#1)(1995-6#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
Besides these##2##2##(1996-11#1)(2008-11#1)
Besides this##2##2##(2008-10#1)(2008-11#1)
Besides##44##1##(1991-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-11#1)(1997-6#1)(1997-8#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)
Best##11##1##(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#2)
Best's disease##3##2##(2010-9#3)
Best's##4##1##(2010-9#4)
Beta##4##1##(1991-12#1)(1995-12#1)(1995-8#1)(2008-7#1)
Beta-2 microglobulin##2##2##(1995-1#2)
Beta-2##3##1##(1995-1#2)(2013-1#1)
Beta-cyclodextrin##2##1##(2008-10#2)
Bethesda##4##1##(1992-12#1)(1992-3#1)(1995-5#1)(2012-12#1)
Better Beginnings##8##2##(1995-3#8)
Better Futures initiative of the Government of Ontario##2##8##(1995-3#2)
Better Futures prevention project##2##4##(1995-3#2)
Better Futures##7##2##(1995-3#7)
Better intervention##2##2##(1991-1#1)(2009-11#1)
Better results in##2##3##(2008-10#2)
Better results##5##2##(2008-10#4)(2008-11#1)
Better understanding of the##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
Better##36##1##(1991-1#1)(1991-8#1)(1995-3#15)(1997-1#2)(2008-10#6)(2008-11#3)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
Between 1980 and##2##3##(1990-9#1)(2008-7#1)
Between 1989 and##2##3##(1991-8#1)(1997-8#1)
Between 1990 and##2##3##(1996-11#1)(2007-8#1)
Between 2007 and##2##3##(2011-2#1)(2013-1#1)
Between 4##2##2##(2008-10#2)
Between January##5##2##(1990-12#1)(1991-8#1)(1995-1#1)(2008-10#1)(2012-12#1)
Between Meloidogyne##2##2##(2008-10#2)
Between Verticillium##2##2##(2008-10#2)
Between and Within##2##3##(2008-10#2)
Between the##5##2##(2008-10#4)(2011-1#1)
Between##90##1##(1990-12#2)(1990-9#2)(1991-11#1)(1991-8#2)(1992-9#1)(1993-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#49)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#4)
Between-group##2##1##(2008-8#1)(2009-7#1)
Bevacizumab##4##1##(2011-2#4)
Beyond the##4##2##(1991-1#1)(1993-12#1)(2008-9#1)(2010-4#1)
Beyond this##2##2##(2008-10#1)(2008-3#1)
Beyond##23##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-12#1)(2010-4#1)(2010-7#1)
Bhutanese##2##1##(2008-10#2)
Bi and Se were##2##4##(2008-10#2)
Bi and Se##4##3##(2008-10#4)
Bi and##6##2##(2008-10#6)
Bi in##7##2##(2008-10#7)
Bi##44##1##(1991-11#1)(2008-10#43)
Bi(3+)##2##1##(2008-10#2)
Bi(III) was##2##2##(2008-10#2)
Bi(III)##15##1##(2008-10#15)
BiAS##2##1##(2008-10#2)
BiCONTACT and Antega##2##3##(2013-1#2)
BiCONTACT and##3##2##(2013-1#3)
BiCONTACT##4##1##(2013-1#4)
BiFE##6##1##(2008-10#6)
BiP##16##1##(1995-2#5)(2008-11#3)(2008-7#8)
Biapenem is##2##2##(2008-5#2)
Biapenem##3##1##(2008-5#3)
Bias in##2##2##(2011-2#1)(2012-3#1)
Bias##4##1##(1991-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
Bibliography of##2##2##(1993-6#1)(2012-3#1)
Bibliography##6##1##(1991-2#1)(1993-6#1)(2008-7#1)(2008-8#2)(2012-3#1)
Biceps femoris##5##2##(2010-4#5)
Bicycle##2##1##(1993-2#1)(2012-2#1)
Bicyclo[2##2##1##(1996-5#2)
Bicyclus anynana##2##2##(2008-9#2)
Bidens biternata##2##2##(2008-12#2)
Bidens##4##1##(2008-12#4)
Bidirectional signaling##2##2##(2008-5#1)(2009-9#1)
Bidirectional##3##1##(2008-5#1)(2009-9#1)(2013-1#1)
Bielschowsky##3##1##(1991-1#1)(2011-2#1)(2013-1#1)
Bifidobacterium breve UCC2003##3##3##(2011-1#2)(2011-2#1)
Bifidobacterium##6##1##(2008-11#2)(2011-1#2)(2011-2#1)(2013-1#1)
Big##7##1##(1993-6#1)(1994-2#1)(1995-9#1)(1996-1#1)(2008-10#1)(2010-7#1)(2013-8#1)
Bignami##2##1##(2010-1#2)
Bigo##3##1##(2008-10#3)
Bilateral single ectopic ureters with hypoplastic bladder##2##7##(2008-10#2)
Bilateral thoracic ganglion##2##3##(2013-8#2)
Bilateral##25##1##(1992-2#1)(1994-12#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
Bile duct##2##2##(2007-8#1)(2013-8#1)
Bile##4##1##(2007-8#1)(2008-11#1)(2012-2#1)(2013-8#1)
Biliary##2##1##(2012-2#2)
Bilimoria##2##1##(2011-2#2)
Bill Clinton##2##2##(1995-12#1)(1995-6#1)
Bill##4##1##(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#1)
Billroth I and Billroth II##2##5##(1991-6#1)(2013-1#1)
Billroth I and##3##3##(1991-6#1)(2013-1#2)
Billroth II##4##2##(1991-6#3)(2013-1#1)
Billroth##13##1##(1991-6#4)(2013-1#9)
Billroth's##3##1##(2013-1#3)
Bim##4##1##(2013-1#4)
Binary and ternary##2##3##(2008-10#2)
Binary and##3##2##(2008-10#3)
Binary##7##1##(2008-10#5)(2008-3#2)
Binding affinities##2##2##(1990-11#1)(1993-8#1)
Binding and##3##2##(1994-5#1)(1994-8#1)(2012-2#1)
Binding characteristics of##2##3##(1994-8#1)(2008-11#1)
Binding experiments##2##2##(1995-11#1)(1995-2#1)
Binding of polyanions by biogenic amines##3##6##(2008-10#3)
Binding of##21##2##(1990-11#1)(1990-12#1)(1990-8#1)(1993-6#1)(1993-8#2)(1994-8#2)(1995-2#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
Binding properties of##2##3##(1995-11#1)(2008-10#1)
Binding to##2##2##(2008-10#1)(2008-5#1)
Binding was##3##2##(1995-2#1)(1996-12#2)
Binding##55##1##(1990-11#3)(1990-12#1)(1990-8#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#3)(1994-5#2)(1994-8#5)(1995-11#2)(1995-2#3)(1996-12#4)(1997-2#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#3)(2013-1#1)
Bing##2##1##(2008-9#1)(2013-1#1)
Binge Eating##2##2##(2012-2#2)
Binocular OCT##2##2##(2011-7#2)
Binocular##4##1##(2008-9#1)(2011-7#3)
Bintje##5##1##(2008-10#5)
Binucleate Rhizoctonia##4##2##(2008-10#4)
Bio-Save 10 LP##2##3##(2008-10#2)
Bio-Save 11 LP##2##3##(2008-10#2)
Bio-Save##4##1##(2008-10#4)
Bio-metabolism of##2##2##(1993-8#2)
BioPAX##2##1##(2010-10#2)
BioSTAR bioabsorbable implant##2##3##(2011-2#2)
BioTrap precolumn##2##2##(2008-10#2)
Bioaccumulation##2##1##(2008-10#1)(2008-11#1)
Bioactive##2##1##(2008-10#2)
Bioanalytical##2##1##(2009-8#1)(2010-11#1)
Bioassay and##2##2##(2008-10#2)
Bioassay##6##1##(2008-10#5)(2013-1#1)
Bioassays##2##1##(2008-10#2)
Biochem##14##1##(1991-12#1)(1992-3#2)(1993-3#2)(1993-8#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-11#3)(2008-6#2)
Biochemical and molecular##2##3##(1995-6#1)(2008-10#1)
Biochemical and##4##2##(1995-6#1)(1996-2#1)(2008-10#1)(2012-5#1)
Biochemical characterization##2##2##(1995-6#1)(2009-3#1)
Biochemical evidence for the##2##4##(1994-11#1)(1995-2#1)
Biochemical parameters##2##2##(2012-3#1)(2012-9#1)
Biochemical studies##2##2##(1990-8#1)(1993-8#1)
Biochemical##21##1##(1990-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#2)(2009-3#1)(2010-7#1)(2012-3#1)(2012-5#1)(2012-9#1)
Biochemically##2##1##(1997-8#1)(2013-8#1)
Biochemistry and Molecular Biology##2##4##(1997-7#2)
Biochemistry and Molecular##3##3##(1994-12#1)(1997-7#2)
Biochemistry##19##1##(1992-3#1)(1992-4#2)(1992-8#1)(1993-3#1)(1993-8#3)(1994-12#2)(1994-5#4)(1995-6#2)(1997-7#2)(2008-10#1)
Biochim##6##1##(1991-5#1)(1993-8#2)(1994-3#1)(1996-2#1)(2008-11#1)
Biocompatible##2##1##(2008-10#2)
Biocontrol Activity##2##2##(2008-10#2)
Biocontrol Agent Candida##2##3##(2008-10#2)
Biocontrol Agent##11##2##(2008-10#10)(2013-1#1)
Biocontrol Fungus##3##2##(2008-10#3)
Biocontrol Potential of##2##3##(2008-10#2)
Biocontrol activity##2##2##(2008-10#2)
Biocontrol agents##2##2##(2008-10#2)
Biocontrol of Pythium ultimum##2##4##(2008-10#2)
Biocontrol of##4##2##(2008-10#4)
Biocontrol##38##1##(2008-10#37)(2013-1#1)
Biocorrosion##2##1##(2012-12#2)
Biodegradable##3##1##(2010-6#1)(2010-7#1)(2012-2#1)
Biodegradation of##3##2##(1992-5#1)(2008-11#2)
Biodiversity of##2##2##(2011-2#1)(2013-1#1)
Biodiversity##3##1##(2011-2#2)(2013-1#1)
Bioeng##37##1##(2008-7#36)(2013-1#1)
Bioethics##2##1##(1992-2#1)(2008-11#1)
Biofilms##2##1##(2013-1#1)(2013-8#1)
Biogenic amines are##2##3##(2008-10#1)(2008-7#1)
Biogenic amines##3##2##(2008-10#1)(2008-7#2)
Biogenic##4##1##(2008-10#1)(2008-3#1)(2008-7#2)
Bioimaging of##2##2##(2010-11#1)(2010-12#1)
Bioinformatics##7##1##(2008-7#1)(2008-9#1)(2010-11#2)(2011-2#2)(2013-8#1)
Biol##34##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#4)(1994-11#1)(1994-5#6)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(2008-11#1)(2009-9#1)(2010-7#1)(2010-9#1)
Biolog##3##1##(2008-10#3)
Biologic##3##1##(1992-12#2)(2009-12#1)
Biological Control of Bipolaris sorokiniana##2##5##(2008-10#2)
Biological Control of Botrytis cinerea by##2##6##(2008-10#2)
Biological Control of Botrytis cinerea##3##5##(2008-10#3)
Biological Control of Fusarium Wilt of Tomato by Nonpathogenic Fusarium spp##2##11##(2008-10#2)
Biological Control of Fusarium Wilt##3##5##(2008-10#3)
Biological Control of the##2##4##(2008-10#2)
Biological Control of##21##3##(2008-10#21)
Biological Control##31##2##(2008-10#31)
Biological Suppression##2##2##(2008-10#2)
Biological activity and##2##3##(1994-11#1)(2009-6#1)
Biological activity##3##2##(1993-11#1)(1994-11#1)(2009-6#1)
Biological and Molecular Characterization of##2##5##(2008-10#2)
Biological and Molecular##4##3##(2008-10#4)
Biological and molecular characterization of a##2##6##(2008-10#2)
Biological and##14##2##(1990-12#1)(1993-2#1)(2008-10#10)(2010-11#1)(2012-2#1)
Biological approaches##2##2##(2007-11#1)(2008-10#1)
Biological assay of##2##3##(1992-12#1)(2008-8#1)
Biological assay##3##2##(1992-12#1)(2008-8#2)
Biological control of##3##3##(2008-10#3)
Biological control##4##2##(2008-10#4)
Biological materials##2##2##(2008-10#1)(2009-7#1)
Biological warfare##2##2##(1992-12#2)
Biological##96##1##(1990-12#1)(1991-1#1)(1992-12#6)(1992-3#2)(1993-11#2)(1993-2#2)(1994-11#1)(1994-12#1)(1994-9#1)(2007-11#1)(2008-10#61)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-4#1)(2012-2#1)
Biologically##2##1##(2008-10#1)(2008-5#1)
Biologicals##2##1##(2012-3#1)(2013-1#1)
Biologics##3##1##(2008-10#1)(2008-11#1)(2012-3#1)
Biology and##3##2##(2010-11#1)(2011-2#1)(2013-8#1)
Biology of##2##2##(2006-6#1)(2008-10#1)
Biology##21##1##(1991-5#1)(1997-7#2)(2006-6#1)(2008-10#1)(2008-11#2)(2009-9#1)(2010-11#1)(2011-2#6)(2013-1#3)(2013-8#3)
Bioluminescence##2##1##(2008-10#1)(2013-8#1)
Biomarker discovery##2##2##(2010-5#1)(2010-7#1)
Biomarker##6##1##(2009-12#1)(2010-11#1)(2010-5#2)(2010-7#1)(2012-3#1)
Biomarkers of##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
Biomarkers##7##1##(2008-11#2)(2010-7#2)(2011-2#2)(2012-12#1)
Biomass##2##1##(2008-10#1)(2008-11#1)
Biomaterials##4##1##(2008-11#1)(2009-12#3)
Biomechanical##4##1##(2008-9#1)(2011-2#2)(2012-12#1)
Biomedical Research##2##2##(2009-12#1)(2010-4#1)
Biomedical##7##1##(1993-12#1)(1996-2#1)(1996-5#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#1)
Biomimetic##2##1##(2008-10#1)(2013-1#1)
Biomolecules##2##1##(1996-5#1)(2008-12#1)
Biomonitoring##2##1##(1996-3#1)(2008-11#1)
Biophys##13##1##(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-8#3)(1994-3#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-11#2)
Biophysical and##2##2##(1994-11#1)(2008-9#1)
Biophysical##3##1##(1994-11#1)(2008-8#1)(2008-9#1)
Biophysics##2##1##(2011-2#1)(2013-1#1)
Bioprocess Development##2##2##(2013-1#2)
Bioprocess##5##1##(2008-11#2)(2012-2#1)(2013-1#2)
Biopsy of the##2##3##(2010-5#1)(2012-3#1)
Biopsy of##3##2##(1991-12#1)(2010-5#1)(2012-3#1)
Biopsy##7##1##(1991-12#1)(1992-5#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
Bioreactor##5##1##(2008-11#4)(2008-7#1)
Biosafety##4##1##(2008-9#4)
Biosciences##4##1##(2008-11#2)(2013-1#1)(2013-8#1)
Biosensor##3##1##(2008-10#2)(2008-11#1)
Biosensors for##2##2##(2008-10#2)
Biosensors##4##1##(2008-10#4)
Biosorb##2##1##(1995-3#2)
Biosorption of##2##2##(2008-10#1)(2008-12#1)
Biosynthesis in##2##2##(1991-3#1)(2008-10#1)
Biosynthesis of##2##2##(2009-8#1)(2012-2#1)
Biosynthesis##8##1##(1990-5#1)(1991-3#1)(2008-10#3)(2009-8#1)(2011-2#1)(2012-2#1)
Biotechnol Bioeng 55##12##3##(2008-7#12)
Biotechnol Bioeng 56##24##3##(2008-7#24)
Biotechnol Bioeng##36##2##(2008-7#36)
Biotechnol##53##1##(2008-11#1)(2008-7#36)(2011-2#16)
Biotechnology##7##1##(2008-10#1)(2008-11#5)(2011-2#1)
Biotic##3##1##(2008-10#3)
Biotinylated##3##1##(2008-10#1)(2008-11#2)
Biotinylation of##2##2##(1990-5#1)(1993-6#1)
Biotransformation of##2##2##(2008-6#1)(2008-7#1)
Biovar##3##1##(2008-10#3)
Bipartite##2##1##(2013-1#2)
Biphasic##3##1##(1997-2#1)(2008-11#1)(2011-2#1)
Bipolar disorder##4##2##(2008-7#1)(2009-12#1)(2010-7#1)(2012-2#1)
Bipolar##5##1##(2008-7#1)(2009-12#1)(2010-7#2)(2012-2#1)
Bipolaris maydis##3##2##(2008-10#3)
Bipolaris sorokiniana##16##2##(2008-10#16)
Bipolaris##22##1##(2008-10#22)
Birefringence##2##1##(2008-3#2)
Birth Defects Information System##2##4##(2012-12#2)
Birth Defects##3##2##(2011-2#1)(2012-12#2)
Birth##12##1##(1991-11#1)(1991-12#1)(1996-11#1)(1997-7#1)(2009-11#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)
Bis(tri-n-butyltin)oxide##2##1##(2008-10#2)
BisEMA and BisGMA##3##3##(2013-1#3)
BisEMA##6##1##(2013-1#6)
BisGMA##6##1##(2013-1#6)
Bismuth##4##1##(2008-10#4)
Bisphenol A (BPA)##2##3##(2008-10#1)(2010-9#1)
Bisphenol A##3##2##(2008-10#2)(2010-9#1)
Bisphenol##4##1##(2008-10#2)(2010-9#2)
Bisphosphonates##2##1##(2008-11#1)(2012-12#1)
Bitter##2##1##(2008-10#2)
Bivariate analysis##2##2##(2008-9#1)(2013-8#1)
Bivariate##5##1##(2008-10#1)(2008-11#1)(2008-9#2)(2013-8#1)
Biz-2##8##1##(2010-1#8)
Bjerrum's method##2##2##(2008-10#2)
BlShV when##2##2##(2008-10#2)
BlShV##4##1##(2008-10#4)
Black Caribbeans##3##2##(2010-10#3)
Black Deaf and##2##3##(2011-2#2)
Black Deaf##4##2##(2011-2#4)
Black Hole##2##2##(2013-1#2)
Black Rot##2##2##(2008-10#2)
Black and White##2##3##(2008-11#2)
Black and##6##2##(2008-10#1)(2008-11#2)(2013-1#3)
Black men##2##2##(2009-12#1)(2009-5#1)
Black was##2##2##(2009-7#1)(2013-1#1)
Black##55##1##(1995-2#1)(1997-4#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#4)(2010-11#1)(2010-4#1)(2011-2#7)(2013-1#15)(2013-8#1)
Blackfoot disease##2##2##(2008-10#2)
Blackleg##4##1##(2008-10#4)
Blacks were##2##2##(2010-10#1)(2011-2#1)
Blacks##7##1##(2010-10#3)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
Bladder cancer##2##2##(2008-10#1)(2013-8#1)
Bladder##11##1##(1992-12#1)(1994-8#1)(1996-2#1)(2008-10#4)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Blanchard##3##1##(2010-1#3)
Bland and Altman plots##2##4##(2008-12#2)
Bland and Altman##5##3##(2008-11#3)(2008-12#2)
Blazac##2##1##(1996-5#2)
Bleeding##6##1##(1993-3#1)(1996-6#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
Bligh-Dyer method##2##2##(2008-10#1)(2008-11#1)
Bligh-Dyer##4##1##(2008-10#3)(2008-11#1)
Blight Pathogen##2##2##(2008-10#2)
Blight Resistance##3##2##(2008-10#3)
Blight of##7##2##(2008-10#7)
Blight on##2##2##(2008-10#2)
Blight##26##1##(2008-10#26)
BlightBan A506##5##2##(2008-10#5)
Blister##2##1##(2008-10#2)
Blk##4##1##(1995-6#4)
Bloch has##2##2##(2009-10#2)
Bloch##4##1##(2009-10#4)
Blockade of the##2##3##(1996-2#1)(2008-11#1)
Blockade of##7##2##(1990-5#1)(1996-2#1)(1997-4#1)(2008-11#2)(2008-8#1)(2010-11#1)
Blocking##6##1##(1990-12#1)(1996-8#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
Blocks##4##1##(1996-5#1)(2008-12#1)(2008-9#2)
Blood and urine##2##3##(1993-11#1)(2007-12#1)
Blood glucose##3##2##(1994-11#1)(2009-11#1)(2012-3#1)
Blood loss was##2##3##(1991-2#1)(1996-3#1)
Blood loss##3##2##(1991-2#1)(1996-3#1)(2013-1#1)
Blood pressure was##2##3##(1997-8#1)(2008-11#1)
Blood pressure##5##2##(1997-8#1)(2008-1#1)(2008-11#2)(2010-4#1)
Blood samples and##2##3##(1993-2#1)(2011-2#1)
Blood samples from##3##3##(1995-12#1)(2009-8#1)(2013-1#1)
Blood samples were collected##2##4##(2011-2#1)(2012-3#1)
Blood samples were obtained##2##4##(2008-5#1)(2011-2#1)
Blood samples were##8##3##(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-8#2)
Blood samples##14##2##(1993-2#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
Blood was taken##2##3##(2008-7#1)(2013-1#1)
Blood was##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
Blood##63##1##(1990-2#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#3)(1996-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#9)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
Bloom##2##1##(2008-10#1)(2011-2#1)
Blossom Blight##2##2##(2008-10#2)
Blossom blight##2##2##(2008-10#2)
Blossom##4##1##(2008-10#4)
Blossoms in##2##2##(2008-10#2)
Blossoms##5##1##(2008-10#5)
Blotch##6##1##(2008-10#6)
Blue Cross and Blue Shield##3##5##(1992-2#1)(1993-1#1)(1994-12#1)
Blue Cross##4##2##(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)
Blue Mold of##3##3##(2008-10#3)
Blue Mold##4##2##(2008-10#4)
Blue Sepharose##5##2##(1990-12#3)(1997-1#2)
Blue Shield of California##2##4##(1995-2#2)
Blue Shield of##3##3##(1992-2#1)(1995-2#2)
Blue Shield##6##2##(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#3)
Blue and##6##2##(2008-10#6)
Blue##58##1##(1990-12#5)(1992-1#1)(1992-2#2)(1993-1#2)(1994-12#2)(1994-5#1)(1995-2#3)(1997-1#2)(1997-2#2)(1997-6#1)(2008-10#30)(2008-11#3)(2008-5#2)(2008-8#2)
Blue-light##2##1##(1995-3#1)(2011-1#1)
Blueberry##6##1##(2008-10#4)(2013-1#2)
Bluemke##2##1##(1994-3#2)
Blues##3##1##(1993-5#1)(1994-2#1)(1997-6#1)
Bluetongue##2##1##(2011-2#2)
Bluetooth##2##1##(2008-10#1)(2012-3#1)
Blumeria graminis f##5##3##(2008-10#5)
Blumeriella jaapii##2##2##(2008-10#2)
Blunt##2##1##(1993-2#1)(2010-1#1)
Bm-N cells##2##2##(2008-11#2)
BmK M4##3##2##(2008-9#3)
BmK##5##1##(2008-9#5)
BmN-4 cells##4##2##(2008-11#4)
BmNPV ie-1 promoter##2##3##(2008-11#2)
BmNPV lef##2##2##(1997-3#2)
BmNPV lefs##2##2##(1997-3#2)
BmNPV##21##1##(1997-3#11)(2008-11#10)
Bmax =##4##2##(1996-2#4)
Bmax values##4##2##(1994-8#1)(1995-8#1)(1997-2#2)
Bmax##13##1##(1991-6#1)(1994-8#1)(1995-8#3)(1996-2#5)(1997-2#3)
BmorPBP##2##1##(2008-10#2)
BmuG@S##3##1##(2008-7#3)
BmuG@Sbase##2##1##(2008-7#2)
BoHV-1 sequences were##2##3##(2011-2#2)
BoHV-1 sequences##3##2##(2011-2#3)
BoHV-1##7##1##(2011-2#7)
BoNTs##3##1##(2008-5#3)
Boal##2##1##(2008-10#2)
Board of Education##4##3##(1991-12#4)
Board of Health##4##3##(1990-12#1)(1993-11#1)(1996-6#1)(1997-8#1)
Board of##15##2##(1990-12#1)(1991-12#4)(1992-2#1)(1993-11#1)(1994-12#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)
Board##36##1##(1990-12#1)(1991-1#1)(1991-12#5)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-2#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#3)(2011-2#1)(2012-2#1)(2012-3#1)
Bob##2##1##(1995-6#1)(2008-10#1)
Bochdalek##2##1##(2008-7#2)
Body Image##2##2##(2012-2#2)
Body Mass Index (BMI)##2##4##(2008-10#1)(2012-2#1)
Body Mass Index##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
Body composition and##2##3##(2011-2#2)
Body composition##3##2##(2011-2#3)
Body image and##2##3##(2012-2#2)
Body mass index##2##3##(2012-2#1)(2012-3#1)
Body mass was##2##3##(2008-9#1)(2013-8#1)
Body mass##4##2##(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
Body size##2##2##(2007-12#1)(2008-9#1)
Body weight gain##2##3##(2011-2#1)(2013-1#1)
Body weight##7##2##(1992-12#1)(2008-7#2)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
Body##37##1##(1992-12#1)(1995-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#8)(2012-3#3)(2013-1#3)(2013-8#2)
Boeing 757##2##2##(1996-12#2)
Boeing##4##1##(1996-12#3)(2008-11#1)
Bogota and Manizales##2##3##(2012-12#2)
Bogota##10##1##(2011-2#1)(2012-12#9)
Boiss##4##1##(2008-11#2)(2008-12#2)
Bolivia##5##1##(1992-5#1)(2008-10#2)(2012-12#2)
Bologna##3##1##(1991-12#1)(1991-2#2)
Bombesin##2##1##(1994-3#2)
Bombyx bombyxin##3##2##(2008-6#3)
Bombyx mori nucleopolyhedrovirus (BmNPV)##2##4##(2008-11#2)
Bombyx mori nucleopolyhedrovirus##4##3##(2008-11#4)
Bombyx mori##22##2##(1995-11#2)(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2012-2#1)
Bombyx##28##1##(1995-11#2)(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#7)(2008-5#2)(2008-6#7)(2008-7#2)(2008-9#1)(2012-2#1)
Bombyxin##4##1##(2008-6#4)
Bond##2##1##(2008-10#1)(2010-7#1)
Bondapak##2##1##(1997-2#1)(2008-10#1)
Bonded glucose##2##2##(2008-10#2)
Bonded##4##1##(2008-10#3)(2009-8#1)
Bone Marrow##5##2##(1995-12#1)(2008-11#4)
Bone formation##2##2##(2008-11#1)(2011-2#1)
Bone marrow examination showed##2##4##(2012-2#1)(2013-1#1)
Bone marrow necrosis##2##3##(2008-12#2)
Bone marrow transplantation##3##3##(2010-11#3)
Bone marrow##10##2##(2008-12#2)(2010-11#3)(2010-6#2)(2010-8#1)(2012-2#1)(2013-1#1)
Bone mineral density##6##3##(2007-8#1)(2008-7#2)(2008-8#2)(2011-2#1)
Bone mineral##7##2##(1991-11#1)(2007-8#1)(2008-7#2)(2008-8#2)(2011-2#1)
Bone morphogenetic proteins##2##3##(2011-2#2)
Bone morphogenetic##4##2##(2011-2#4)
Bone pain##2##2##(1993-3#2)
Bone resorption##4##2##(1991-11#2)(1993-6#1)(2008-10#1)
Bone##52##1##(1991-11#3)(1993-3#2)(1993-6#1)(1994-12#2)(1995-12#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-7#4)(2008-8#2)(2009-3#1)(2009-6#1)(2010-11#3)(2010-6#2)(2010-8#1)(2011-2#12)(2012-2#1)(2012-3#1)(2013-1#1)
Bone-marrow-derived##2##1##(2010-6#2)
Bonferroni##2##1##(2008-12#1)(2010-9#1)
Bonghan Kim##2##2##(2010-7#2)
Bonghan ducts##2##2##(2010-7#2)
Bonghan system##2##2##(2010-7#2)
Bonghan##9##1##(2010-7#9)
Bony##2##1##(2011-2#1)(2012-2#1)
Book review##8##2##(2008-10#2)(2008-5#5)(2008-7#1)
Book##9##1##(2008-10#2)(2008-5#6)(2008-7#1)
Boolean expressions##3##2##(1995-12#3)
Bootstrap analysis##3##2##(2008-10#3)
Bootstrap##4##1##(2008-10#3)(2010-3#1)
Bord Altranais##4##2##(2008-11#4)
Bordeaux##2##1##(2008-10#2)
Border crossing##2##2##(1994-3#2)
Border##5##1##(1994-3#2)(2008-10#3)
Borderline personality##2##2##(2009-9#2)
Borderline##7##1##(2008-11#1)(2009-9#2)(2011-2#4)
Borders##2##1##(1996-8#1)(1997-6#1)
Bordetella pertussis##5##2##(2007-12#1)(2008-4#1)(2008-7#2)(2013-1#1)
Bordetella##6##1##(2007-12#1)(2008-4#1)(2008-7#2)(2013-1#1)(2013-8#1)
Boric acid##2##2##(2008-10#2)
Borno state##2##2##(1990-3#2)
Boron##4##1##(2008-10#2)(2008-7#1)(2013-1#1)
Borquez was##2##2##(1995-12#2)
Borquez##8##1##(1995-12#8)
Borquez's##4##1##(1995-12#4)
Borrelia burgdorferi infection in##2##4##(2011-2#2)
Borrelia burgdorferi infection##3##3##(2011-2#3)
Borrelia burgdorferi##13##2##(1990-2#2)(1992-3#2)(1995-5#1)(2008-9#2)(2011-2#6)
Borrelia##21##1##(1990-12#2)(1990-2#2)(1992-3#2)(1995-5#1)(2008-9#4)(2011-2#7)(2013-8#3)
Bos taurus##6##2##(1993-12#1)(1993-2#4)(2011-2#1)
Bos##7##1##(1991-5#1)(1993-12#1)(1993-2#4)(2011-2#1)
Boschniakia rossica##2##2##(2011-2#2)
Bosentan##3##1##(2009-10#3)
Boston##12##1##(1992-3#1)(1993-5#1)(1996-5#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
Bosutinib##2##1##(2010-11#2)
Boswell was##2##2##(1990-11#2)
Boswell##4##1##(1990-11#4)
Both a##2##2##(2008-10#1)(2008-11#1)
Both alpha##2##2##(1994-5#1)(1994-6#1)
Both alpha- and beta-CGRP##2##4##(1992-6#2)
Both analyses indicated##2##3##(2008-10#2)
Both approaches##2##2##(2009-11#2)
Both are##5##2##(1993-2#1)(1994-5#1)(2008-10#1)(2008-7#1)(2010-7#1)
Both bacterial##2##2##(1991-3#1)(2008-11#1)
Both basal and##4##3##(1990-8#1)(1992-12#1)(1992-8#1)(2011-2#1)
Both bpV(pic) and vanadate##2##4##(1997-1#2)
Both cases were##2##3##(2008-12#1)(2013-1#1)
Both cell types##3##3##(1992-6#1)(2007-12#1)(2008-7#1)
Both cell##4##2##(1992-6#1)(2007-12#1)(2008-11#1)(2008-7#1)
Both compounds##6##2##(1991-5#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
Both conditions##2##2##(2008-10#1)(2008-3#1)
Both cortisol and##2##3##(1990-12#1)(1991-6#1)
Both effects##2##2##(1992-5#1)(1996-2#1)
Both ethanol##2##2##(2011-2#1)(2012-2#1)
Both experimental and##2##3##(1996-9#1)(2008-9#1)
Both experimental##3##2##(1996-9#1)(2008-7#1)(2008-9#1)
Both extracts##2##2##(2008-10#2)
Both fasting and##2##3##(1994-12#2)
Both fungi##2##2##(2008-10#2)
Both genes##2##2##(1993-8#1)(1994-11#1)
Both groups of##3##3##(1995-1#1)(1997-3#1)(2008-12#1)
Both groups were found to##3##5##(1994-3#1)(2008-10#1)(2008-11#1)
Both groups were##7##3##(1991-2#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2013-1#1)
Both groups##16##2##(1991-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-3#2)(2008-10#1)(2008-11#3)(2008-12#1)(2013-1#1)
Both have##2##2##(1997-3#1)(2008-11#1)
Both human##4##2##(2008-10#1)(2008-11#1)(2010-6#1)(2012-3#1)
Both in the##3##3##(1994-11#1)(1997-1#1)(2012-3#1)
Both in##4##2##(1994-11#1)(1997-1#1)(2008-11#1)(2012-3#1)
Both instruments##3##2##(2008-10#2)(2008-3#1)
Both male and female##2##4##(2008-10#1)(2013-1#1)
Both methods are##3##3##(1991-2#1)(2008-10#1)(2008-3#1)
Both methods have##2##3##(2008-10#2)
Both methods were##6##3##(1993-9#1)(2008-10#5)
Both methods##18##2##(1991-2#1)(1993-9#1)(2008-10#13)(2008-3#1)(2008-4#1)(2012-3#1)
Both models##5##2##(2008-10#4)(2008-8#1)
Both of the##2##3##(2008-10#1)(2008-11#1)
Both of them##2##3##(2008-9#2)
Both of these##5##3##(1995-6#2)(1996-6#1)(2008-10#1)(2009-11#1)
Both of##10##2##(1995-6#2)(1996-6#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-11#1)
Both pairs of##2##3##(2008-10#2)
Both patient##2##2##(1995-5#1)(2010-2#1)
Both patients who##2##3##(2008-10#1)(2012-12#1)
Both patients##8##2##(1993-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
Both procedures##2##2##(2007-8#1)(2008-10#1)
Both processes##2##2##(2008-3#1)(2013-8#1)
Both proposed methods##2##3##(2008-10#2)
Both proteins##4##2##(1991-6#1)(1993-6#1)(1994-8#1)(1995-6#1)
Both sets of##2##3##(1995-11#1)(2008-10#1)
Both shampoos##2##2##(2008-5#2)
Both sides##2##2##(1997-6#1)(2008-10#1)
Both sites##2##2##(2012-12#1)(2013-8#1)
Both species of##3##3##(1994-11#1)(2008-10#2)
Both species##4##2##(1994-11#1)(2008-10#3)
Both strains of##2##3##(2008-10#2)
Both subpopulations were##2##3##(2008-10#2)
Both techniques were##2##3##(2008-10#1)(2013-1#1)
Both techniques##5##2##(2008-10#3)(2008-9#1)(2013-1#1)
Both tests##2##2##(1994-3#1)(2008-10#1)
Both the mutant and the##2##5##(1994-11#1)(2008-10#1)
Both the proportion of##2##4##(1993-11#1)(2008-10#1)
Both the right and left lobes##2##6##(2013-1#2)
Both the theory and the##2##5##(1990-12#1)(2008-3#1)
Both the##65##2##(1990-12#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#27)(2008-11#1)(2008-3#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
Both theoretical##2##2##(2008-10#1)(2008-3#1)
Both these##8##2##(1991-12#1)(1994-8#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-12#1)(2010-4#1)(2013-1#1)
Both treatments##2##2##(1991-3#1)(2010-4#1)
Both twins##2##2##(2010-1#2)
Both types of##3##3##(1994-5#1)(2008-10#2)
Both types##5##2##(1994-5#1)(2007-12#1)(2008-10#3)
Both viruses were##2##3##(2008-10#1)(2008-11#1)
Both were##2##2##(1995-6#1)(1996-8#1)
Both##563##1##(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#3)(1990-8#3)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#7)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#5)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#8)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#8)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#6)(1995-5#2)(1995-6#8)(1995-8#3)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#4)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#197)(2008-11#35)(2008-12#5)(2008-3#15)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#18)(2008-8#12)(2008-9#18)(2009-10#1)(2009-11#3)(2009-12#2)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#3)(2010-11#1)(2010-2#3)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#7)(2012-4#1)(2012-5#1)(2013-1#14)(2013-8#7)
Botryoid odontogenic cyst##2##3##(2013-1#2)
Botryosphaeria dothidea##12##2##(2008-10#12)
Botryosphaeria##17##1##(2008-10#16)(2011-10#1)
Botryotinia fuckeliana##4##2##(1997-4#2)(2008-10#2)
Botryotinia##5##1##(1997-4#2)(2008-10#3)
Botrytis blight##2##2##(2008-10#2)
Botrytis cinerea Infection##2##3##(2008-10#2)
Botrytis cinerea and the##2##4##(2008-10#2)
Botrytis cinerea and##8##3##(2008-10#7)(2008-5#1)
Botrytis cinerea conidia##3##3##(2008-10#3)
Botrytis cinerea in##6##3##(2008-10#6)
Botrytis cinerea on##8##3##(2008-10#8)
Botrytis cinerea was investigated##3##4##(2008-10#3)
Botrytis cinerea was##7##3##(2008-10#7)
Botrytis cinerea##84##2##(2008-10#81)(2008-5#1)(2009-6#1)(2011-10#1)
Botrytis spp##9##2##(2008-10#9)
Botrytis##104##1##(2008-10#100)(2008-5#1)(2009-6#1)(2010-5#1)(2011-10#1)
Botswana##4##1##(1993-11#1)(2008-10#3)
Botulinum toxin##5##2##(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
Botulinum##8##1##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-3#1)
Botulism##2##1##(2007-12#2)
Bouchard##2##1##(1993-3#1)(1995-1#1)
Bound algorithms##2##2##(2008-6#2)
Bound##7##1##(1996-9#1)(2008-10#1)(2008-3#1)(2008-6#4)
Boundaries##2##1##(1995-1#1)(2008-12#1)
Bovicola ovis##2##2##(1996-12#2)
Bovine Herpesvirus##2##2##(2008-11#2)
Bovine Kidney##2##2##(2008-11#2)
Bovine alpha s2-casein D##2##4##(1993-6#2)
Bovine milk##2##2##(2012-2#2)
Bovine serum albumin##5##3##(1990-11#1)(1994-8#1)(2008-10#3)
Bovine##26##1##(1990-11#1)(1990-6#1)(1992-5#1)(1993-6#2)(1994-8#1)(1995-8#2)(1996-12#1)(2008-10#6)(2008-11#7)(2008-12#1)(2012-2#2)(2013-1#1)
Bowel bacterial overgrowth##2##3##(2011-2#2)
Bowel##8##1##(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
Bowen's disease##7##2##(2007-8#1)(2010-6#6)
Bowen's##8##1##(2007-8#1)(2010-6#7)
Bowman##9##1##(1992-1#1)(2008-10#8)
Box##4##1##(1996-8#2)(2008-11#1)(2009-10#1)
Box-Behnken design##2##2##(2013-1#2)
Box-Behnken##4##1##(2008-10#2)(2013-1#2)
Boyden chamber##2##2##(2013-8#2)
Boyden##3##1##(2008-10#1)(2013-8#2)
Boys##3##1##(2008-10#1)(2008-12#1)(2012-2#1)
BqsS-BqsR##5##1##(2009-6#5)
Br##7##1##(1994-5#1)(2006-6#4)(2008-10#1)(2008-11#1)
Br(-) ion##2##2##(2008-10#2)
Br(-)##8##1##(2008-10#8)
Br(a)/Br(b)##2##1##(2006-6#2)
BrCr##2##1##(2008-8#2)
BraMT##3##1##(1993-6#3)
Brachial##2##1##(2008-11#1)(2008-9#1)
Brachyspira murdochii##2##2##(2011-2#2)
Brachyspira##3##1##(2011-2#3)
Brachyspiraceae##4##1##(2011-2#3)(2013-8#1)
Braconidae)##2##1##(1992-6#1)(2013-8#1)
Bradford method##2##2##(2008-10#2)
Bradford##4##1##(1990-3#1)(1991-2#1)(2008-10#2)
Bradykinin##2##1##(1990-5#2)
Bragg grating##8##2##(2007-12#1)(2008-2#1)(2008-3#6)
Bragg gratings##8##2##(2007-12#2)(2008-2#2)(2008-3#3)(2013-8#1)
Bragg##26##1##(2007-12#4)(2008-2#3)(2008-3#14)(2008-7#1)(2013-8#4)
Brahman steers##2##2##(1996-12#2)
Brahman##4##1##(1996-12#3)(2013-1#1)
Brahmans##2##1##(1996-12#2)
Brahms##6##1##(2013-1#6)
Brain Derived Neurotrophic Factor##2##4##(2012-2#1)(2013-1#1)
Brain activation##2##2##(1996-2#1)(2008-5#1)
Brain biopsy##3##2##(1996-11#3)
Brain substrates activated by electroacupuncture##2##5##(1996-12#2)
Brain##51##1##(1993-5#1)(1993-9#1)(1994-12#1)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-8#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-3#6)(2013-1#1)(2013-8#1)
Brain-Derived Neurotrophic Factor (BDNF)##2##4##(2013-8#2)
Brain-Derived##3##1##(2008-11#1)(2013-8#2)
Brains and##2##2##(2008-6#1)(2009-1#1)
Branch &amp##4##2##(2008-6#4)
Branch students##2##2##(2008-11#1)(2008-12#1)
Branch##9##1##(1994-12#1)(2008-11#3)(2008-12#1)(2008-6#4)
Branches##2##1##(2008-10#1)(2008-5#1)
Brand##2##1##(1994-1#2)
Brandes##2##1##(2009-10#2)
Brasil##2##1##(2008-11#1)(2008-5#1)
Brassaia##4##1##(2008-10#4)
Brassica juncea##5##2##(2008-10#4)(2011-1#1)
Brassica napus##12##2##(2008-10#10)(2008-12#1)(2012-3#1)
Brassica napus-B##2##2##(2008-10#2)
Brassica oleracea (C genome)##2##4##(2008-10#2)
Brassica oleracea L##2##3##(2012-3#2)
Brassica oleracea##5##2##(2008-10#3)(2012-3#2)
Brassica spp##8##2##(2008-10#7)(2011-10#1)
Brassica##43##1##(2008-10#31)(2008-12#1)(2011-1#2)(2011-10#5)(2012-3#4)
Brassicaceae##4##1##(2008-10#3)(2009-8#1)
Brave##2##1##(1993-5#1)(2008-11#1)
Brazil and##7##2##(2008-10#4)(2010-1#1)(2011-2#2)
Brazil during##2##2##(2008-10#1)(2011-2#1)
Brazil were##2##2##(2008-10#1)(2010-1#1)
Brazil##88##1##(1992-5#1)(1993-3#1)(1996-12#2)(2008-10#48)(2008-11#3)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-1#5)(2010-10#3)(2010-7#1)(2011-2#7)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#3)
Brazilian and##2##2##(2008-11#1)(2013-1#1)
Brazilian isolates from##2##3##(2008-10#2)
Brazilian isolates##4##2##(2008-10#4)
Brazilian##29##1##(2008-10#15)(2008-11#4)(2008-5#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-1#3)
BrdU incorporation##2##2##(2008-9#2)
BrdU labeling##5##2##(2007-12#1)(2008-11#1)(2008-9#3)
BrdU##15##1##(1993-3#1)(2007-12#1)(2008-11#1)(2008-9#12)
Break Repair##2##2##(2012-3#1)(2013-1#1)
Break through volume and limit of detection of the membrane disks modified by##2##13##(2008-10#2)
Break##4##1##(2008-10#2)(2012-3#1)(2013-1#1)
Breakdown of the##2##3##(1992-8#1)(2008-10#1)
Breakdown of##3##2##(1992-8#1)(2008-10#2)
Breaking with tradition##2##3##(1992-12#1)(1995-12#1)
Breaking##6##1##(1992-12#1)(1993-3#1)(1995-12#1)(1996-9#1)(2012-12#1)(2012-3#1)
Breakthrough##4##1##(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
Breast Cancer Cells##2##3##(1994-12#1)(2012-3#1)
Breast Cancer in##2##3##(1994-12#1)(1997-7#1)
Breast Cancer##27##2##(1993-11#2)(1993-12#1)(1994-12#9)(1995-9#1)(1997-7#8)(2008-7#1)(2011-2#2)(2012-2#2)(2012-3#1)
Breast Conserving##2##2##(1994-12#1)(2011-2#1)
Breast Reconstruction##2##2##(2013-1#2)
Breast and Cervical Cancer##3##4##(1997-1#3)
Breast cancer risk with cyst type in cystic disease of the breast##2##12##(1997-8#2)
Breast cancer screening##2##3##(1990-2#1)(1995-10#1)
Breast cancer##12##2##(1990-2#1)(1995-10#1)(1995-9#1)(1997-8#2)(2008-9#1)(2010-8#5)(2011-2#1)
Breast feeding##2##2##(1991-8#1)(2012-12#1)
Breast screening##2##2##(1991-8#1)(1996-8#1)
Breast##66##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-8#2)(1993-11#4)(1993-12#1)(1994-12#12)(1995-10#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#3)(1997-7#10)(1997-8#2)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#5)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
Breastfeeding was##3##2##(2010-6#2)(2011-1#1)
Breastfeeding##9##1##(2008-10#4)(2010-6#3)(2011-1#1)(2012-2#1)
Breath hydrogen excretion##2##3##(1996-6#2)
Breath##4##1##(1996-6#2)(2011-2#1)(2013-8#1)
Breathing##3##1##(2008-12#1)(2011-2#1)(2012-2#1)
Breed differences in the##2##4##(2011-2#2)
Breeding for##2##2##(2008-10#2)
Breeding##10##1##(1990-11#1)(2008-10#6)(2008-8#2)(2011-2#1)
Bremia lactucae##11##2##(2008-10#11)
Brenneria##3##1##(2008-10#3)
Brescia##2##1##(1990-2#2)
Brewer's yeast##2##2##(2011-2#2)
Brewster##4##1##(1994-1#2)(2008-3#2)
Brian##2##1##(2008-12#1)(2008-4#1)
Brianne##3##1##(1995-12#3)
Brianne's##3##1##(1995-12#3)
Bridging the##3##2##(1994-12#1)(2008-11#1)(2008-2#1)
Bridging##4##1##(1994-12#1)(2008-11#1)(2008-2#1)(2013-1#1)
Brief interventions##3##2##(2008-11#3)
Brief report##2##2##(1992-12#1)(1995-8#1)
Brief##13##1##(1992-12#1)(1995-8#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-7#1)(2010-2#1)(2013-8#1)
Briefly##2##1##(2008-5#1)(2009-4#1)
Brigham and Women's Hospital##4##4##(1993-3#1)(1994-3#1)(2010-5#2)
Brigham##6##1##(1993-3#2)(1994-3#1)(2008-10#1)(2010-5#2)
Bright green##2##2##(2008-7#1)(2008-9#1)
Bright##6##1##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
Brij(R)-35##3##1##(2008-10#3)
Brij-35##2##1##(2008-10#2)
Brilliant Blue and Sunset Yellow##3##5##(2008-10#3)
Brilliant Blue##6##2##(2008-10#6)
Brilliant##8##1##(2008-10#8)
Brillouin##5##1##(1996-9#1)(2007-12#2)(2008-2#2)
Bringing##6##1##(1993-12#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2011-2#1)
Bristol-Myers##2##1##(2008-10#1)(2008-9#1)
Britain##21##1##(1990-11#1)(1990-6#2)(1991-2#1)(1991-5#1)(1996-11#1)(1996-8#2)(2008-10#2)(2008-11#1)(2008-5#5)(2008-8#1)(2010-1#3)(2013-8#1)
Britain's National##2##2##(1990-3#1)(1996-12#1)
Britain's##4##1##(1990-3#1)(1996-12#1)(1997-5#2)
British American Tobacco##2##3##(2011-1#2)
British Columbia and##2##3##(1994-2#1)(2008-10#1)
British Columbia##27##2##(1992-12#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#1)(1995-9#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-12#1)(2009-3#1)(2009-5#1)(2010-8#1)(2013-8#4)
British and German##2##3##(2008-10#1)(2008-11#1)
British and##3##2##(1991-1#1)(2008-10#1)(2008-11#1)
British isolate##2##2##(2008-10#2)
British##72##1##(1990-6#1)(1991-1#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#3)(1993-12#2)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#16)(2008-11#8)(2008-12#2)(2008-5#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#2)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-8#4)
Britton Robinson buffer##2##3##(2008-10#2)
Britton Robinson##3##2##(2008-10#3)
Britton-Robinson (BR) buffer##4##3##(2008-10#4)
Britton-Robinson buffer (pH##4##3##(2008-10#4)
Britton-Robinson buffer at pH 2##2##5##(2008-10#2)
Britton-Robinson buffer solution##3##3##(2008-10#3)
Britton-Robinson buffer##18##2##(2008-10#18)
Britton-Robinson##25##1##(2008-10#25)
Brn-3 factors##4##2##(1996-12#4)
Brn-3##6##1##(1996-12#6)
Brn-3a and##2##2##(1995-6#1)(1996-12#1)
Brn-3a##7##1##(1995-6#5)(1996-12#2)
Broad bean mottle virus##2##4##(2008-10#2)
Broad bean wilt virus##2##4##(2008-10#2)
Broad bean##4##2##(2008-10#4)
Broad##9##1##(1997-6#1)(2008-10#6)(2008-11#1)(2012-2#1)
Broad-Spectrum Resistance##2##2##(2008-10#2)
Broad-Spectrum##3##1##(2008-10#3)
Broad-sense heritabilities##2##2##(2008-10#2)
Broad-sense heritability was##2##3##(2008-10#2)
Broad-sense heritability##3##2##(2008-10#3)
Broad-sense##5##1##(2008-10#5)
Broadband##5##1##(2008-3#5)
Broadly##3##1##(1991-6#1)(1996-9#1)(2008-3#1)
Broccoli##2##1##(2008-10#2)
Brockman##2##1##(1993-3#1)(1993-6#1)
Brodmann's##2##1##(1990-11#1)(2008-11#1)
Brome mosaic virus##4##3##(2008-10#4)
Bromide##4##1##(1995-3#1)(2008-10#3)
Bromley##2##1##(1997-5#1)(2008-10#1)
Bromley's##3##1##(2008-10#3)
Bromus species hosts##2##3##(2008-10#2)
Bromus##3##1##(2008-10#2)(2008-9#1)
Bronchial artery##2##2##(2012-3#2)
Bronchial vessels##2##2##(1997-1#2)
Bronchial##7##1##(1993-9#1)(1997-1#3)(2010-2#1)(2012-3#2)
Brown Norway##5##2##(2008-10#4)(2008-7#1)
Brown Rot##3##2##(2008-10#3)
Brown Spot of##4##3##(2008-10#4)
Brown Spot##6##2##(2008-10#6)
Brown##26##1##(1990-11#1)(1991-3#1)(1992-2#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
Brownian motion model of##2##4##(2008-8#2)
Brownian motion model##3##3##(2008-8#3)
Brownian motion##5##2##(2008-8#4)(2010-12#1)
Brownian##7##1##(2008-12#1)(2008-8#4)(2010-12#1)(2012-2#1)
Bruce##2##1##(1995-6#1)(2008-7#1)
Brucella abortus strain 2308##2##4##(1996-12#2)
Brucella abortus##3##2##(1996-12#2)(2011-2#1)
Brucella canis in##2##3##(2011-2#2)
Brucella melitensis##2##2##(2008-10#1)(2009-3#1)
Brucella spp##2##2##(2011-2#2)
Brucella##11##1##(1996-12#2)(1996-6#1)(2008-10#1)(2009-3#1)(2011-2#6)
Brucellosis##3##1##(2011-2#2)(2012-3#1)
Brugada syndrome in##2##3##(2008-12#2)
Brugada syndrome##10##2##(2008-11#1)(2008-12#9)
Brugada##11##1##(2008-11#1)(2008-12#9)(2012-3#1)
Brugmansia##3##1##(2008-10#1)(2008-6#2)
Bruguiera##2##1##(2008-11#2)
Bruhat technique##4##2##(1991-12#4)
Bruhat##6##1##(1991-12#6)
Bruises in##2##2##(2010-7#2)
Bruno##2##1##(2008-11#1)(2009-10#1)
Brush##2##1##(2008-5#1)(2013-8#1)
Brussels sprouts and barley##2##4##(2008-10#2)
Brussels sprouts##3##2##(2008-10#3)
Brussels##4##1##(2008-10#4)
Bs##2##1##(2008-12#2)
Bs1##8##1##(2008-10#8)
Bs2 + Bs3)##3##3##(2008-10#3)
Bs2##9##1##(2008-10#9)
Bs2)##4##1##(2008-10#4)
Bs3)##7##1##(2008-10#7)
Bu(4)NOH (MeOH)##2##2##(2008-10#2)
BuChE##2##1##(2008-10#2)
BuONa##3##1##(1993-8#3)
Buchnera aphidicola##2##2##(1996-12#2)
Buchnera##5##1##(1996-12#2)(2007-12#3)
Bud##2##1##(2009-8#2)
Budding##2##1##(2008-10#2)
Buddleja##2##1##(2012-3#1)(2012-8#1)
Budgam##2##1##(2013-8#2)
Budget##14##1##(1991-12#2)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1996-5#1)(1997-3#1)(2008-11#4)
Bueno##2##1##(2013-8#2)
Buenos Aires##7##2##(2008-5#2)(2009-10#5)
Buenos##8##1##(2008-5#2)(2009-10#5)(2013-8#1)
Buerger disease and##2##3##(1997-8#2)
Buerger disease##9##2##(1997-8#9)
Buerger's disease in##2##3##(1996-8#1)(1997-8#1)
Buerger's disease##7##2##(1996-8#1)(1997-8#5)(2008-10#1)
Buerger's##8##1##(1990-2#1)(1996-8#1)(1997-8#5)(2008-10#1)
Buffalo rats##6##2##(1993-12#5)(2013-7#1)
Buffalo##7##1##(1993-12#6)(2013-7#1)
Buffer##3##1##(2008-10#2)(2008-11#1)
Buffon used##2##2##(2008-12#2)
Buffon was also a##2##4##(2008-12#2)
Buffon was##4##2##(2008-12#4)
Buffon##13##1##(2008-12#13)
Buffon's##5##1##(2008-12#5)
Bufo viridis viridis##2##3##(2008-12#2)
Build##2##1##(2008-7#1)(2012-12#1)
Building a##5##2##(1991-1#1)(1996-2#2)(2008-10#1)(2008-11#1)
Building an##2##2##(1993-2#1)(1997-1#1)
Building on##3##2##(1997-3#1)(2009-7#1)(2010-6#1)
Building the##3##2##(1994-2#1)(1996-1#1)(2010-8#1)
Building##24##1##(1991-1#1)(1992-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-1#1)(1996-2#2)(1996-5#1)(1997-1#3)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)
Bulgaria##5##1##(2008-11#1)(2013-1#4)
Bulimia Nervosa##2##2##(2008-11#1)(2012-2#1)
Bulimia##3##1##(2008-11#2)(2012-2#1)
Bulk##2##1##(2008-10#2)
Bulked segregant analysis and##2##4##(2008-10#2)
Bulked segregant analysis was used to##2##6##(1995-6#1)(2008-10#1)
Bulked segregant analysis##7##3##(1995-6#1)(2008-10#6)
Bulked##8##1##(1995-6#1)(2008-10#7)
Bulky##2##1##(1996-5#1)(2008-10#1)
Bulletin##2##1##(2012-2#1)(2013-1#1)
Bunyaviridae##3##1##(2008-10#2)(2013-8#1)
Bupivacaine##3##1##(1993-1#2)(1995-3#1)
Buprenorphine is##2##2##(2008-11#1)(2008-6#1)
Buprenorphine##5##1##(1991-1#1)(2008-11#3)(2008-6#1)
Burden of##2##2##(2008-8#1)(2012-2#1)
Burden##7##1##(1991-12#1)(2008-8#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
Bureau of Labor Statistics##2##4##(1993-1#1)(1994-2#1)
Bureau of Reference (BCR)##2##4##(2008-10#2)
Bureau of Reference##3##3##(2008-10#3)
Bureau of##8##2##(1993-1#1)(1994-2#1)(1997-2#1)(2008-10#5)
Bureau##11##1##(1993-1#1)(1993-12#2)(1994-2#1)(1995-3#1)(1997-2#1)(2008-10#5)
Burgos##2##1##(1995-12#1)(1997-3#1)
Burkholderia cenocepacia##2##2##(2008-10#2)
Burkholderia cepacia AMMDR1##2##3##(2008-10#2)
Burkholderia cepacia##5##2##(2008-10#5)
Burkholderia##10##1##(2008-10#9)(2008-7#1)
Burkina Faso##8##2##(1990-6#1)(1996-8#1)(2008-10#1)(2008-12#2)(2010-6#3)
Burkitt's lymphoma of the jaws##2##5##(2008-1#2)
Burkitt's lymphoma##10##2##(1993-2#3)(2008-1#6)(2008-9#1)
Burnout and##2##2##(1992-1#1)(1996-2#1)
Burnout was measured by the Maslach Burnout Inventory and health care utilization by insurance company records regarding these employees' health care costs and number of times they accessed health care services over a##2##33##(1996-2#1)(1997-1#1)
Burnout##12##1##(1991-2#1)(1992-1#1)(1996-2#3)(1997-1#3)(2008-10#1)(2008-11#1)(2010-2#1)(2010-7#1)
Bursaphelenchus xylophilus##4##2##(2008-10#4)
Burst##2##1##(2008-10#1)(2010-8#1)
Burundi##3##1##(1994-9#3)
Bush signed the Americans##2##4##(1994-1#1)(1996-1#1)
Bush##4##1##(1991-12#1)(1994-1#1)(1996-1#1)(2010-1#1)
Business process reengineering##2##3##(1994-12#2)
Business process##3##2##(1993-3#1)(1994-12#2)
Business##11##1##(1991-12#1)(1991-9#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#1)(1997-2#1)(2010-7#1)
But Congress##2##2##(1991-1#1)(2008-8#1)
But Not##2##2##(2008-10#1)(2013-8#1)
But a##3##2##(2008-7#2)(2013-8#1)
But for the##2##3##(2008-10#1)(2008-9#1)
But for##3##2##(2008-10#2)(2008-9#1)
But if##3##2##(2008-8#1)(2010-3#1)(2011-2#1)
But in this##2##3##(1995-2#1)(2013-1#1)
But in##6##2##(1994-8#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-8#1)(2013-1#1)
But the##11##2##(1991-2#1)(1992-9#1)(1993-12#1)(1995-6#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)
But these##3##2##(1992-8#1)(1994-2#1)(2010-5#1)
But this##2##2##(1990-6#1)(2012-2#1)
But##86##1##(1990-6#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#3)(2013-1#3)(2013-8#3)
Butorphanol##2##1##(2010-7#2)
Butterfly rash##2##2##(2013-1#2)
Button Personal Inhalable##2##3##(2008-5#2)
Button Samplers##3##2##(2008-5#3)
Button##13##1##(2008-10#2)(2008-5#11)
Butyltin compounds##2##2##(2008-10#1)(2008-11#1)
Butyltin##3##1##(2008-10#2)(2008-11#1)
Butyrate##2##1##(1990-6#1)(2008-11#1)
Butyric acid##2##2##(1993-8#2)
By a##3##2##(2008-10#2)(2012-2#1)
By adding##2##2##(1996-6#1)(2008-11#1)
By allowing##2##2##(2008-10#2)
By analyzing##2##2##(2008-9#1)(2012-2#1)
By applying multivariate##2##3##(2008-8#1)(2013-8#1)
By applying the##4##3##(2008-10#4)
By applying##12##2##(1995-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
By changing the##4##3##(1995-3#1)(2007-12#1)(2008-10#2)
By collecting##2##2##(2008-11#1)(2008-6#1)
By combination of##2##3##(1991-5#1)(2008-8#1)
By combination##3##2##(1991-5#1)(2008-10#1)(2008-8#1)
By combining a##2##3##(2007-12#1)(2008-10#1)
By combining##9##2##(1990-3#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-7#1)(2013-1#1)
By comparing the##6##3##(1990-7#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-9#2)
By comparing##14##2##(1990-7#1)(1991-3#1)(1994-3#1)(1996-2#1)(1997-7#2)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)
By comparison of the##2##4##(1995-6#1)(1996-8#1)
By comparison with##2##3##(1997-6#1)(2008-10#1)
By comparison##7##2##(1995-6#1)(1996-8#1)(1997-6#1)(2008-10#2)(2008-6#1)(2008-8#1)
By contrast to##2##3##(2008-5#1)(2013-1#1)
By contrast##46##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-11#3)(2011-2#1)(2012-2#3)(2013-1#2)
By controlling the##2##3##(2008-10#1)(2008-5#1)
By day##2##2##(2006-6#1)(2009-6#1)
By dividing##2##2##(1992-9#1)(2008-8#1)
By employing##2##2##(2008-10#2)
By examining##2##2##(1991-2#1)(2008-9#1)
By exploiting the##2##3##(1990-8#1)(2008-10#1)
By fitting the##2##3##(2008-2#1)(2008-5#1)
By fitting##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
By following##2##2##(1994-1#1)(2008-10#1)
By helping##2##2##(1993-1#1)(1993-2#1)
By increasing the##2##3##(2008-10#1)(2008-9#1)
By increasing##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
By integrating##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
By linking##2##2##(2008-8#1)(2012-2#1)
By loading##2##2##(2008-10#2)
By manipulating##2##2##(2008-10#1)(2011-1#1)
By mapping##3##2##(2008-10#2)(2010-3#1)
By means of a##2##4##(2008-10#1)(2009-8#1)
By means of the##2##4##(2008-10#1)(2008-6#1)
By means of this##2##4##(2008-10#2)
By means of##12##3##(1991-2#1)(1992-3#1)(1994-5#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2009-8#1)
By means##14##2##(1991-2#1)(1992-3#1)(1994-5#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-6#1)(2009-8#1)
By measuring the##3##3##(2008-10#3)
By measuring##4##2##(2008-10#3)(2008-7#1)
By monitoring the change in absorbance of the oxidation product of##2##11##(2008-10#2)
By monitoring the##3##3##(2008-10#3)
By monitoring##5##2##(2007-12#1)(2008-10#3)(2012-3#1)
By observing##2##2##(2008-10#2)
By optimizing##2##2##(2008-10#1)(2011-1#1)
By presenting##3##2##(2008-11#2)(2008-3#1)
By providing##4##2##(2007-12#1)(2008-11#1)(2010-3#1)(2011-2#1)
By reviewing##2##2##(2008-12#1)(2010-5#1)
By studying the##3##3##(1996-2#1)(2008-10#1)(2012-3#1)
By studying##6##2##(1991-6#1)(1993-11#1)(1996-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
By testing##2##2##(2008-10#1)(2008-11#1)
By the end of the##3##5##(1994-9#1)(2008-10#1)(2008-11#1)
By the end of##4##4##(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#1)
By the present method##2##4##(2008-10#2)
By the way##4##3##(2008-10#1)(2010-9#3)
By the##28##2##(1993-3#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-9#3)(2012-2#1)
By this method##2##3##(2008-5#1)(2008-8#1)
By this##5##2##(1991-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
By treatment with##2##3##(1991-12#1)(2008-10#1)
By use of a##4##4##(1991-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
By use of##8##3##(1990-12#1)(1991-9#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
By using a##11##3##(1995-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#1)
By using multivariate calibration methods##2##5##(2008-10#2)
By using the recommended procedure##2##5##(2008-10#2)
By using the##17##3##(1992-10#1)(1993-12#1)(1997-1#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-9#2)(2010-6#1)
By using these##3##3##(1990-5#1)(2008-9#2)
By using this##6##3##(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)
By using##69##2##(1990-5#1)(1992-10#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-9#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#9)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
By utilizing the##2##3##(2008-10#1)(2008-8#1)
By utilizing##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
By varying the##3##3##(2008-10#2)(2009-8#1)
By varying##4##2##(2008-10#3)(2009-8#1)
By##470##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#3)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#5)(1995-9#3)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#1)(2006-6#1)(2007-12#8)(2008-10#142)(2008-11#36)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#15)(2008-6#5)(2008-7#10)(2008-8#27)(2008-9#25)(2009-10#3)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#7)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#6)(2012-2#10)(2012-3#4)(2013-1#5)(2013-8#2)
ByT-FAS instrumentation##3##2##(2008-10#3)
ByT-FAS system##2##2##(2008-10#2)
ByT-FAS##12##1##(2008-10#12)
Bypass trapped flow analysis system (ByT-FAS)##2##6##(2008-10#2)
Bypass##4##1##(2008-10#2)(2010-8#1)(2012-3#1)
Byrd##2##1##(1991-12#2)
Byssochlamys and##2##2##(2010-3#2)
Byssochlamys##5##1##(2010-3#5)
Bystander effects##2##2##(2008-7#2)
Bystander##3##1##(2008-7#2)(2011-2#1)
C (MMC)##4##2##(1992-12#1)(1997-7#1)(2008-11#2)
C (PKC)##26##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
C =##2##2##(1993-8#1)(2008-3#1)
C activation in##2##3##(1995-11#1)(2008-11#1)
C activation##9##2##(1992-8#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-8#2)(2008-11#1)(2008-3#1)
C activity##10##2##(1990-5#1)(1990-8#2)(1993-3#1)(1993-6#1)(1993-8#3)(2008-11#1)(2008-3#1)
C after##6##2##(2008-10#5)(2013-8#1)
C alpha##6##2##(1993-6#4)(1994-5#2)
C also##2##2##(1991-2#1)(1993-8#1)
C and B##2##3##(2011-2#1)(2013-8#1)
C and D##9##3##(1991-5#1)(1993-2#1)(2008-10#1)(2008-12#1)(2008-6#3)(2011-2#1)(2013-1#1)
C and E##5##3##(1996-5#1)(2008-10#2)(2011-2#2)
C and a##5##3##(1994-6#1)(2008-10#3)(2008-3#1)
C and in##6##3##(2008-10#4)(2008-11#1)(2010-12#1)
C and protein kinase##5##4##(1995-6#1)(2008-11#3)(2008-3#1)
C and serum##2##3##(2009-8#1)(2010-7#1)
C and the##6##3##(1992-3#1)(2008-10#4)(2008-11#1)
C and##178##2##(1990-12#1)(1990-2#1)(1991-5#3)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-2#1)(1994-11#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#3)(1997-2#1)(2008-1#1)(2008-10#94)(2008-11#15)(2008-12#4)(2008-3#3)(2008-5#6)(2008-6#7)(2008-7#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#4)(2010-6#1)(2010-7#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#3)
C are##7##2##(1993-8#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
C as##4##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-5#1)
C at##17##2##(1990-11#1)(1993-3#1)(1996-12#2)(2008-10#8)(2008-12#4)(2012-3#1)
C base##2##2##(1993-1#2)
C botulinum type##2##3##(2007-12#2)
C but##11##2##(1991-2#3)(2008-10#6)(2008-7#1)(2009-9#1)
C by##12##2##(1990-12#1)(1990-5#1)(1993-8#1)(1997-2#1)(2008-10#4)(2008-3#2)(2008-8#1)(2009-5#1)
C can##2##2##(1992-9#1)(1993-8#1)
C cell##2##2##(1990-2#1)(1992-6#1)
C concentration##6##2##(2008-10#2)(2010-4#4)
C deficiency##5##2##(2008-12#4)(2013-1#1)
C derivatives##2##2##(2008-5#2)
C for##104##2##(1990-12#1)(1991-11#1)(1992-6#1)(1993-8#1)(1994-5#2)(1994-8#3)(1995-2#1)(1996-5#1)(1997-2#2)(2008-10#65)(2008-11#7)(2008-12#1)(2008-2#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2010-4#4)
C from the##2##3##(1993-8#1)(2008-10#1)
C from##4##2##(1993-8#1)(2008-10#3)
C glabrata##2##2##(2008-10#2)
C had##4##2##(1997-8#1)(2008-10#1)(2008-11#2)
C has been##3##3##(1991-5#1)(2008-10#1)(2010-4#1)
C has##4##2##(1991-5#1)(1995-6#1)(2008-10#1)(2010-4#1)
C in both##2##3##(2008-11#1)(2010-4#1)
C in the presence of##2##5##(1994-11#1)(1995-11#1)
C in the presence##3##4##(1990-5#1)(1994-11#1)(1995-11#1)
C in the##20##3##(1990-5#1)(1993-8#1)(1994-11#1)(1995-11#1)(1997-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2010-4#1)(2013-8#1)
C in##50##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-6#1)(1997-1#2)(2008-10#26)(2008-11#5)(2008-12#2)(2010-4#3)(2010-7#1)(2011-2#1)(2013-8#1)
C inhibitor##6##2##(1994-11#2)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#1)
C is##14##2##(1991-3#1)(1993-3#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
C isolates##2##2##(2008-5#2)
C levels and Ts##2##4##(2008-9#2)
C levels##6##2##(2008-9#6)
C of 0##2##3##(2008-10#2)
C of##6##2##(1995-2#1)(2008-10#3)(2012-3#1)(2012-9#1)
C on##5##2##(1992-9#1)(1993-12#1)(2008-10#2)(2008-11#1)
C or##12##2##(1990-12#1)(1993-6#1)(1994-8#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
C over 24##2##3##(2008-10#1)(2008-8#1)
C points and daisy modes##2##5##(2007-11#2)
C points##4##2##(2007-11#4)
C regions##2##2##(1992-10#1)(2008-4#1)
C status##2##2##(1992-9#2)
C tablets##4##2##(2008-10#4)
C terminal##4##2##(2008-6#1)(2008-8#1)(2008-9#2)
C terminus of the catalytic subunit##2##6##(1995-2#2)
C terminus of the##4##4##(1991-6#1)(1995-2#2)(1995-6#1)
C terminus of##5##3##(1991-6#1)(1995-2#3)(1995-6#1)
C terminus##8##2##(1991-6#1)(1993-6#1)(1995-2#4)(1995-6#2)
C to##9##2##(1991-12#1)(1994-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#1)
C treatment##2##2##(2008-10#1)(2009-7#1)
C virus (HCV) and##2##4##(2008-1#1)(2008-10#1)
C virus (HCV)##14##3##(2008-1#1)(2008-10#2)(2008-8#1)(2009-7#1)(2009-8#2)(2011-2#1)(2013-1#5)(2013-8#1)
C virus infection##5##3##(2008-5#1)(2009-8#1)(2013-1#3)
C virus##33##2##(1992-12#1)(1994-11#2)(1994-6#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#3)(2011-2#1)(2013-1#9)(2013-8#2)
C was found##2##3##(2008-10#2)
C was significantly##2##3##(2010-4#1)(2010-7#1)
C was##30##2##(1990-5#1)(1993-6#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#2)(2010-4#2)(2010-7#2)(2011-2#2)
C were##21##2##(1992-12#1)(1992-3#1)(1993-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2013-1#1)
C whereas##2##2##(1990-8#1)(2008-12#1)
C while##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
C with a##5##3##(1993-8#1)(2008-10#4)
C with##15##2##(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(2008-10#9)(2008-2#1)(2008-9#1)
C##2258##1##(1990-10#2)(1990-11#6)(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#19)(1990-6#8)(1990-8#10)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#8)(1991-3#1)(1991-5#15)(1991-6#3)(1991-7#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-3#12)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#7)(1992-9#14)(1993-1#3)(1993-12#2)(1993-2#3)(1993-3#8)(1993-6#14)(1993-8#33)(1993-9#14)(1994-1#3)(1994-11#16)(1994-12#9)(1994-3#3)(1994-5#21)(1994-6#3)(1994-8#10)(1995-11#7)(1995-12#8)(1995-2#14)(1995-3#1)(1995-6#15)(1995-8#10)(1996-1#2)(1996-12#10)(1996-2#2)(1996-3#3)(1996-5#12)(1996-6#8)(1996-9#2)(1997-1#9)(1997-2#16)(1997-3#2)(1997-5#1)(1997-7#7)(1997-8#9)(2007-11#4)(2007-12#10)(2008-1#4)(2008-10#1170)(2008-11#107)(2008-12#40)(2008-2#10)(2008-3#13)(2008-4#2)(2008-5#109)(2008-6#16)(2008-7#19)(2008-8#40)(2008-9#23)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-5#3)(2009-7#8)(2009-8#12)(2009-9#2)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#10)(2010-3#7)(2010-4#31)(2010-5#1)(2010-6#6)(2010-7#8)(2010-8#4)(2011-1#10)(2011-2#52)(2011-3#1)(2012-2#10)(2012-3#16)(2012-6#8)(2012-8#1)(2012-9#2)(2013-1#37)(2013-7#2)(2013-8#25)
C&quot##2##1##(1994-2#1)(2008-8#1)
C(10)##2##1##(2008-10#2)
C(16)-MCM-41##3##1##(2008-10#3)
C(18) analytical column##2##3##(2008-10#2)
C(18) and##4##2##(2008-10#3)(2009-8#1)
C(18) bonded silica##2##3##(2008-10#2)
C(18) bonded##4##2##(2008-10#4)
C(18) cartridge##3##2##(2008-10#3)
C(18) column and##5##3##(2008-10#4)(2012-2#1)
C(18) column with##4##3##(2008-10#4)
C(18) column##19##2##(2008-10#18)(2012-2#1)
C(18) disk##4##2##(2008-10#4)
C(18) material##2##2##(2008-10#2)
C(18) phase##3##2##(2008-10#3)
C(18) precolumn##3##2##(2008-10#3)
C(18) silica gel##2##3##(2008-10#2)
C(18)##71##1##(2008-10#69)(2009-8#1)(2012-2#1)
C(18)-bonded silica##2##2##(2008-10#2)
C(18)-bonded##3##1##(2008-10#3)
C(2)H(2)##2##1##(2008-10#2)
C(2)H(5)OH##3##1##(2008-10#3)
C(3)##2##1##(2008-8#1)(2008-9#1)
C(4##3##1##(2008-5#3)
C(4) pathway enzymes in##2##4##(2008-9#2)
C(4) pathway##4##2##(2008-9#4)
C(4)##6##1##(2008-11#1)(2008-9#5)
C(60) and##3##2##(2008-10#3)
C(60)##7##1##(1991-5#1)(2008-10#3)(2008-5#3)
C(60)-SIMS##5##1##(2012-12#5)
C(60)-[dimethyl-(beta-cyclodextrin)](2)##2##1##(2008-10#2)
C(60)-gamma-cyclodextrin and Nafion chemically modified electrode##2##6##(2008-10#2)
C(70)##3##1##(2008-10#3)
C(8) column##3##2##(2008-10#3)
C(8)##7##1##(2008-10#6)(2008-8#1)
C(DON)##4##1##(2008-10#4)
C(H(2)SO(4)##4##1##(2008-10#4)
C(IND) and C(DON)##2##3##(2008-10#2)
C(IND) and##3##2##(2008-10#3)
C(IND)##5##1##(2008-10#5)
C(S)##2##1##(2008-10#2)
C(n)(2)##2##1##(2008-2#2)
C(n)E(m) surfactants##3##2##(2008-10#3)
C(n)E(m)##6##1##(2008-10#6)
C) and##19##2##(1990-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1996-12#1)(2008-10#11)(2008-12#1)(2008-5#1)(2009-5#1)
C) at##2##2##(2008-10#2)
C) by##2##2##(2008-10#2)
C) has been##3##3##(2008-10#2)(2008-5#1)
C) on##2##2##(2008-10#1)(2008-8#1)
C) or##3##2##(2008-10#3)
C)##124##1##(1990-12#1)(1991-2#1)(1991-5#2)(1992-3#4)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1997-2#1)(2008-10#81)(2008-11#7)(2008-12#1)(2008-5#4)(2008-7#5)(2008-8#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)
C++##2##1##(2008-10#1)(2009-12#1)
C+1##2##1##(1995-6#2)
C+1/A+72##2##1##(1995-6#2)
C-##3##1##(1991-5#1)(2008-12#1)(2008-7#1)
C-10##3##1##(1992-3#2)(1994-5#1)
C-105 plants##2##2##(2008-10#2)
C-105##6##1##(2008-10#6)
C-18 column##2##2##(2008-10#2)
C-18##12##1##(2008-10#11)(2008-5#1)
C-2##7##1##(1995-3#1)(1996-5#5)(2008-5#1)
C-3##3##1##(1996-5#2)(2008-11#1)
C-4##8##1##(1993-8#3)(1996-5#4)(2008-10#1)
C-4'##2##1##(1991-3#2)
C-5' of the##2##3##(1991-3#2)
C-6 formulation##2##2##(2008-10#2)
C-6##8##1##(1996-5#1)(2008-10#7)
C-8##3##1##(1991-5#1)(2008-10#2)
C-ADR and##3##2##(2012-12#3)
C-ADR compared with ACDF##2##4##(2012-12#2)
C-ADR compared with fusion##2##4##(2012-12#2)
C-ADR compared with##5##3##(2012-12#5)
C-ADR patients##2##2##(2012-12#2)
C-ADR use##2##2##(2012-12#2)
C-ADR with multilevel##3##3##(2012-12#3)
C-ADR with##6##2##(2012-12#6)
C-ADR##41##1##(2012-12#41)
C-C bond##2##2##(1996-5#1)(2010-7#1)
C-C##6##1##(1994-11#1)(1996-5#3)(2010-7#2)
C-C-A-A-G-C-T-T-G-G##2##1##(1993-8#2)
C-Cl##2##1##(1996-5#2)
C-G method##2##2##(2008-7#2)
C-H##2##1##(2008-3#1)(2010-10#1)
C-Leg and##2##2##(2013-1#2)
C-Leg##4##1##(2013-1#4)
C-N##2##1##(1996-5#1)(2008-4#1)
C-RFa##3##1##(2008-6#3)
C-S-C linkage##2##2##(2010-2#2)
C-aryl##2##1##(2008-8#2)
C-banding##7##1##(2008-12#7)
C-blocks##2##1##(2008-12#2)
C-fiber##3##1##(1992-6#1)(1997-3#2)
C-heterochromatin##3##1##(2008-12#3)
C-kinase##4##1##(1990-10#2)(1990-12#2)
C-peptide values##5##2##(1994-12#5)
C-peptide##9##1##(1994-12#8)(2010-4#1)
C-reactive protein (CRP)##4##3##(1990-12#1)(1994-12#1)(2008-10#1)(2008-7#1)
C-reactive protein (hs-CRP)##3##3##(2011-2#1)(2012-5#1)(2013-1#1)
C-reactive protein levels##2##3##(1991-12#1)(2011-2#1)
C-reactive protein##22##2##(1990-12#1)(1991-12#2)(1993-2#1)(1994-12#1)(2008-10#3)(2008-7#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#2)(2012-5#1)(2013-1#3)
C-stem##2##1##(2013-1#2)
C-terminal domain of##3##3##(1993-8#1)(2008-9#1)(2009-7#1)
C-terminal domain##6##2##(1993-2#2)(1993-8#1)(2008-9#1)(2009-7#1)(2012-2#1)
C-terminal domains of##2##3##(2008-10#1)(2011-2#1)
C-terminal domains##4##2##(1993-8#1)(2008-10#2)(2011-2#1)
C-terminal extension region##3##3##(1993-12#3)
C-terminal fragment##2##2##(1994-5#1)(1997-4#1)
C-terminal peptide##3##2##(2008-5#2)(2011-2#1)
C-terminal propeptide of type I collagen##2##6##(1997-1#2)
C-terminal region##11##2##(1993-8#3)(1994-12#1)(1994-5#2)(1995-2#1)(1997-7#1)(1997-8#1)(2008-10#2)
C-terminal regions##2##2##(1991-10#1)(1993-8#1)
C-terminal sequence of##3##3##(1994-11#1)(1995-12#1)(2008-4#1)
C-terminal sequence##6##2##(1991-5#1)(1994-11#1)(1995-12#1)(2008-4#3)
C-terminal##101##1##(1990-2#1)(1991-10#1)(1991-5#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#8)(1993-9#2)(1994-11#3)(1994-12#1)(1994-5#6)(1995-12#1)(1995-2#3)(1995-6#4)(1996-12#3)(1996-6#1)(1997-1#2)(1997-4#1)(1997-7#2)(1997-8#1)(2008-10#8)(2008-11#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-6#2)(2009-7#5)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-8#1)
C-termini##5##1##(1993-3#1)(2010-7#2)(2011-2#1)(2013-8#1)
C-terminus of the##3##3##(1993-8#1)(1994-12#1)(2008-10#1)
C-terminus of##7##2##(1992-6#2)(1993-8#1)(1994-12#1)(2008-10#1)(2009-10#1)(2012-3#1)
C-terminus##25##1##(1991-7#1)(1992-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1996-6#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-10#1)(2010-11#1)(2011-2#2)(2012-3#1)
C-thiophenecalix[4]resorcinarene##2##1##(2008-10#2)
C-type natriuretic peptide##2##3##(1994-11#1)(1994-8#1)
C-type natriuretic##3##2##(1994-11#2)(1994-8#1)
C-type##7##1##(1992-6#1)(1993-3#2)(1994-11#2)(1994-8#1)(2010-4#1)
C/B##2##1##(2008-10#2)
C/EBP alpha##2##2##(1994-12#1)(2012-2#1)
C/EBP##11##1##(1990-5#4)(1993-12#1)(1994-12#1)(1997-8#2)(2008-5#2)(2012-2#1)
C/Fe nanocomposite##2##2##(2008-10#2)
C/N ratio and heavy##2##4##(2008-12#2)
C/N ratio##5##2##(2008-12#5)
C/N##6##1##(2008-12#5)(2012-9#1)
C0##2##1##(2008-6#2)
C01-A##2##1##(2008-10#2)
C1 and C2 averaged##2##4##(2008-10#2)
C1 and C2##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
C1 and##5##2##(1994-5#1)(2008-10#2)(2012-3#1)(2013-1#1)
C1 esterase inhibitor##2##3##(1997-5#2)
C1 to##2##2##(2008-10#2)
C1##20##1##(1991-12#1)(1994-5#1)(1997-5#2)(2008-10#8)(2008-12#2)(2012-12#3)(2012-3#1)(2013-1#2)
C1-2##4##1##(2012-3#4)
C1-C2##7##1##(1993-8#2)(2011-2#1)(2012-12#2)(2013-1#2)
C1-THF synthase##5##2##(1992-10#5)
C1-inhibitor##3##1##(2013-1#3)
C1072##2##1##(1995-6#2)
C11##2##1##(1994-5#1)(2008-10#1)
C11-C12##2##1##(2009-8#2)
C16##14##1##(1995-9#2)(2008-11#1)(2008-8#9)(2011-1#2)
C17##2##1##(2011-1#2)
C18 cartridge##2##2##(2008-10#2)
C18 cartridges and##2##3##(1993-2#1)(2008-10#1)
C18 cartridges##4##2##(1992-11#1)(1993-2#1)(2008-10#2)
C18 column with a##2##4##(2008-10#2)
C18 column with##4##3##(2008-10#4)
C18 column##10##2##(1997-2#1)(2008-10#8)(2008-5#1)
C18 reversed-phase##2##2##(1993-11#1)(2008-10#1)
C18 stationary##2##2##(2008-10#2)
C18##34##1##(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-8#1)(1997-2#1)(2008-10#23)(2008-5#1)(2010-11#1)(2011-1#1)(2011-3#1)
C19##2##1##(1990-11#1)(2013-8#1)
C1YVV isolates##6##2##(2008-10#6)
C1YVV##7##1##(2008-10#7)
C2 and C3##2##3##(2013-1#2)
C2 and C7##2##3##(2010-9#2)
C2 and##7##2##(2009-10#1)(2010-9#2)(2011-2#1)(2013-1#3)
C2 myotubes##3##2##(1995-6#3)
C2 nerve##2##2##(2012-12#1)(2012-3#1)
C2##42##1##(1991-12#2)(1992-9#1)(1995-6#4)(1997-1#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-6#2)(2008-9#2)(2009-10#1)(2010-9#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#8)
C2-C4##2##1##(1996-5#1)(2008-10#1)
C2-domain##3##1##(2009-10#3)
C20##3##1##(1997-1#3)
C21##2##1##(1990-11#1)(2008-9#1)
C24 and##3##2##(1993-8#1)(2012-3#2)
C24##6##1##(1993-8#1)(2012-3#5)
C26##2##1##(1993-8#2)
C26-CBS/diC14-PC mixture had##2##3##(1993-8#2)
C26-CBS/diC14-PC mixture##3##2##(1993-8#3)
C282Y homozygous HFE##2##3##(2008-5#2)
C282Y homozygous##4##2##(2008-5#4)
C2C12##4##1##(2008-11#4)
C2H2##2##1##(1993-2#1)(1996-6#1)
C3 activation##2##2##(1991-2#1)(1993-11#1)
C3 and##4##2##(1991-2#1)(1992-3#1)(2008-10#2)
C3 applied at##2##3##(2008-10#2)
C3 applied##3##2##(2008-10#3)
C3 cell##2##2##(2008-10#2)
C3 in##2##2##(2008-10#2)
C3 population##2##2##(2008-10#2)
C3 was##3##2##(2008-10#2)(2013-1#1)
C3##57##1##(1990-8#2)(1991-2#6)(1992-3#2)(1993-11#1)(1997-1#4)(2008-10#36)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#3)
C3H/HeJ mice##4##2##(2008-10#4)
C3H/HeJ##5##1##(1997-8#1)(2008-10#4)
C4 subgenotype##2##2##(2013-8#2)
C4##15##1##(1992-3#2)(1993-6#1)(2008-10#5)(2008-8#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-8#3)
C40/C40+##3##1##(2008-9#3)
C47T##4##1##(2008-10#4)
C4M##2##1##(2013-8#2)
C4a evolution branch##2##3##(2013-8#2)
C5##2##1##(2012-2#1)(2012-3#1)
C5-C6##4##1##(1997-8#1)(2011-2#2)(2012-3#1)
C530W##2##1##(1995-11#2)
C57 BL/6J mice##3##3##(1995-11#3)
C57 mice##2##2##(1995-12#1)(2013-8#1)
C57##7##1##(1993-12#1)(1995-11#3)(1995-12#2)(2013-8#1)
C57BL/10 mice infected with##2##4##(1996-12#2)
C57BL/10 mice##5##2##(1996-12#5)
C57BL/10##8##1##(1996-12#8)
C57BL/6 mice##10##2##(1993-12#1)(1995-2#2)(1997-3#1)(1997-8#1)(2008-12#1)(2012-3#1)(2013-1#3)
C57BL/6##17##1##(1993-12#2)(1995-2#5)(1997-3#2)(1997-8#1)(2008-12#2)(2008-4#1)(2012-3#1)(2013-1#3)
C57BL/6J mice##2##2##(1992-3#1)(2010-7#1)
C57BL/6J##5##1##(1990-7#1)(1992-3#1)(2008-9#1)(2010-7#1)(2011-2#1)
C57Bl/6 mice##2##2##(2008-10#2)
C5a##4##1##(2008-10#4)
C5lambda##3##1##(2008-11#3)
C6 and L##2##3##(1993-6#2)
C6 and##4##2##(1993-6#2)(1994-2#1)(2008-7#1)
C6 cells were##2##3##(1992-6#1)(1994-11#1)
C6 cells##4##2##(1992-6#3)(1994-11#1)
C6 glial cells##3##3##(1994-11#3)
C6 glioma cells##2##3##(1992-6#1)(2012-2#1)
C6 glioma##3##2##(1992-6#2)(2012-2#1)
C6##24##1##(1992-6#5)(1993-6#3)(1994-11#4)(1994-2#1)(1997-8#1)(2008-10#1)(2008-7#2)(2009-3#1)(2012-2#2)(2012-3#2)(2013-1#2)
C60##3##1##(1991-9#1)(1992-8#1)(2008-10#1)
C677T##2##1##(2008-11#1)(2012-3#1)
C7 vertebral body##2##3##(2009-3#2)
C7##8##1##(1994-5#1)(2008-7#1)(2009-3#3)(2010-9#2)(2011-2#1)
C77##5##1##(2008-10#5)
C8 and C18##2##3##(2008-10#2)
C8##10##1##(1994-8#1)(1997-2#1)(2008-10#5)(2008-4#2)(2012-3#1)
C9-1 and##4##2##(2008-10#4)
C9-1##7##1##(2008-10#7)
C9-1S##8##1##(2008-10#8)
C923##3##1##(2008-10#3)
C</ForeName>##2##1##(2013-8#2)
C=0##7##1##(2008-10#7)
CA 1##5##2##(1995-3#5)
CA 19-9##2##2##(1990-6#2)
CA 2##3##2##(1995-3#3)
CA 3 and CA 4##3##5##(1995-3#3)
CA 336##2##2##(2008-10#2)
CA and OR collections##2##4##(2008-10#2)
CA and OR##4##3##(2008-10#4)
CA and##7##2##(1995-11#1)(2008-10#5)(2011-2#1)
CA cells##3##2##(1995-11#3)
CA groups##2##2##(1994-2#2)
CA lesions##3##2##(1994-12#3)
CA participants##3##2##(2008-11#3)
CA to##2##2##(2008-10#2)
CA was##2##2##(2008-10#1)(2012-12#1)
CA##82##1##(1990-11#1)(1990-6#2)(1990-8#1)(1992-6#1)(1994-11#1)(1994-12#3)(1994-2#4)(1995-11#7)(1995-3#14)(1996-5#1)(1997-3#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#3)(2011-2#6)(2012-12#3)(2013-8#2)
CA) in##2##2##(1996-9#1)(2012-12#1)
CA)##5##1##(1996-9#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-12#1)
CA-100##3##1##(2008-10#3)
CA-125##7##1##(2008-10#4)(2012-3#1)(2013-1#1)(2013-8#1)
CA-CRC##4##1##(2011-2#4)
CA-clonal##4##1##(2008-10#4)
CA-variable##2##1##(2008-10#2)
CA1 and##3##2##(1990-5#1)(1996-12#1)(2008-11#1)
CA1 pyramidal neurons##2##3##(1995-8#1)(2008-11#1)
CA1 pyramidal##4##2##(1990-5#1)(1995-8#1)(2008-11#1)(2008-7#1)
CA1 region##3##2##(1995-12#1)(1996-12#2)
CA1##27##1##(1990-12#1)(1990-5#4)(1991-10#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#6)(1996-5#1)(1997-2#1)(2008-11#5)(2008-12#1)(2008-7#2)
CA15##6##1##(1990-8#6)
CA2 and CA3##2##3##(2008-12#2)
CA2 and##4##2##(1994-2#1)(2008-12#3)
CA2##5##1##(1994-2#1)(1996-12#1)(2008-12#3)
CA3 and##2##2##(1996-12#1)(2008-11#1)
CA3 pyramidal cell##5##3##(2008-11#5)
CA3 pyramidal cells##3##3##(1990-5#2)(2008-11#1)
CA3 pyramidal##8##2##(1990-5#2)(2008-11#6)
CA3##25##1##(1990-5#2)(1995-8#3)(1996-12#5)(2008-11#12)(2008-12#2)(2009-8#1)
CAA concentrations##2##2##(1994-8#2)
CAA cytotoxicity##2##2##(1994-8#2)
CAA##17##1##(1994-8#10)(2007-8#3)(2008-10#4)
CAA-induced##2##1##(1994-8#2)
CAAT box##4##2##(1993-12#1)(1993-6#2)(2010-5#1)
CAAT##5##1##(1993-12#1)(1993-6#2)(1997-7#1)(2010-5#1)
CAB transcription##2##2##(1995-2#2)
CAB2 expression##4##2##(1995-2#4)
CAB2 promoter##2##2##(1995-2#2)
CAB2##8##1##(1995-2#8)
CABG patients##2##2##(2008-12#2)
CABG##5##1##(1992-11#1)(2008-11#1)(2008-12#2)(2013-1#1)
CABS and##2##2##(2008-10#2)
CABS was##3##2##(2008-10#3)
CABS##13##1##(2008-10#13)
CACY##5##1##(1994-5#5)
CAD and##2##2##(1997-8#1)(2009-10#1)
CAD patients##2##2##(1997-8#1)(2012-2#1)
CAD##15##1##(1990-7#1)(1994-5#1)(1996-2#1)(1997-8#2)(2008-10#2)(2009-10#2)(2012-2#6)
CAD1 -A##2##2##(2008-8#2)
CAD1##4##1##(2008-8#4)
CAD1-A and##2##2##(2008-8#2)
CADCA##2##1##(2008-6#2)
CADD-Solis##3##1##(2011-2#3)
CAF##2##1##(1997-7#2)
CAF+FT##8##1##(1997-7#8)
CAF+FT+ADR##3##1##(1997-7#3)
CAG insertion##2##2##(2008-12#2)
CAG##4##1##(1993-12#1)(1996-2#1)(2008-12#2)
CAH##8##1##(2008-4#3)(2010-2#4)(2012-3#1)
CAI##6##1##(1996-12#1)(2013-1#5)
CAK##4##1##(1997-1#4)
CAL##2##1##(2008-10#1)(2008-11#1)
CALUX and##2##2##(2008-10#2)
CALUX bioassay##9##2##(2008-10#9)
CALUX results obtained##2##3##(2008-10#2)
CALUX results##4##2##(2008-10#4)
CALUX##31##1##(2008-10#31)
CAM##2##1##(2009-5#2)
CAN##6##1##(2012-2#6)
CAP##4##1##(1994-11#1)(1997-2#1)(2010-5#2)
CAP-5##2##1##(1991-8#2)
CAP/SRV2##2##1##(1995-9#2)
CAPD fluid##2##2##(2008-10#2)
CAPD fluids##7##2##(2008-10#7)
CAPD##11##1##(2008-10#11)
CAPL##3##1##(1994-5#3)
CAPS##2##1##(2008-10#1)(2008-8#1)
CAPSNet collects##2##2##(2008-11#2)
CAR/PDMS##2##1##(2008-10#2)
CARE##3##1##(1995-12#1)(1996-5#1)(2009-11#1)
CARS measurements##2##2##(2008-3#2)
CARS spectra of##2##3##(2008-2#1)(2008-3#1)
CARS spectra##4##2##(2008-2#2)(2008-3#2)
CARS##12##1##(2008-2#2)(2008-3#10)
CAS##8##1##(2008-10#1)(2010-12#1)(2011-1#2)(2011-2#4)
CASA concentrations##2##2##(1993-2#2)
CASA##4##1##(1993-2#4)
CASE DESCRIPTION##7##2##(2012-3#7)
CASE REPORT##2##2##(2008-12#1)(2013-1#1)
CASE##13##1##(1997-5#2)(2008-12#1)(2009-1#1)(2012-3#7)(2013-1#2)
CASES##2##1##(2009-1#2)
CASS-3##3##1##(2008-10#3)
CASV##2##1##(2008-10#2)
CAT activities##2##2##(1992-6#1)(1995-2#1)
CAT activity was##2##3##(1993-8#1)(2008-7#1)
CAT activity##6##2##(1993-8#2)(1995-2#1)(2008-4#1)(2008-7#2)
CAT assay##2##2##(1995-8#2)
CAT assays##2##2##(1992-6#1)(2008-9#1)
CAT expression##2##2##(1997-8#2)
CAT gene##2##2##(2008-11#1)(2008-9#1)
CAT mRNA##2##2##(2008-11#2)
CAT production##2##2##(2008-7#2)
CAT protein##2##2##(2008-11#2)
CAT##36##1##(1992-12#2)(1992-6#2)(1993-8#2)(1995-2#3)(1995-6#1)(1995-8#2)(1997-8#2)(2008-10#5)(2008-11#7)(2008-4#3)(2008-7#4)(2008-8#1)(2008-9#2)
CAV antigen##2##2##(2008-5#2)
CAV isolate##3##2##(2008-5#3)
CAV##11##1##(2008-5#10)(2012-3#1)
CA[4]##2##1##(2008-10#2)
CA[6]##2##1##(2008-10#2)
CA[8]##2##1##(2008-10#2)
CAdSV##7##1##(2008-10#7)
CArG box##5##2##(1993-8#4)(1994-11#1)
CArG boxes##4##2##(1993-8#2)(1994-11#2)
CArG motif and##2##3##(2009-8#1)(2010-5#1)
CArG##13##1##(1993-8#8)(1994-11#3)(2009-8#1)(2010-5#1)
CAsp exchange##2##2##(1995-6#2)
CAsp##4##1##(1995-6#4)
CB agonists may##2##3##(2009-12#2)
CB agonists##5##2##(2009-12#5)
CB and EA##2##3##(2008-11#2)
CB electrodes##2##2##(2008-10#2)
CB or##3##2##(1994-5#2)(2008-11#1)
CB receptor##2##2##(2009-12#2)
CB receptors##2##2##(2009-12#2)
CB##24##1##(1994-5#2)(2008-10#6)(2008-11#5)(2009-12#11)
CB(1) receptor##2##2##(2009-8#2)
CB(1)##3##1##(2009-8#3)
CB(2) receptor##4##2##(2009-8#4)
CB(2)##7##1##(2009-8#7)
CB1##3##1##(1990-5#2)(2009-12#1)
CB2##2##1##(1990-5#2)
CBA 2##3##2##(2008-10#3)
CBA##8##1##(1995-12#2)(2008-10#3)(2008-12#3)
CBB bacteria##3##2##(2008-10#3)
CBB##8##1##(2008-10#8)
CBC and##2##2##(2008-10#1)(2011-2#1)
CBC##3##1##(2008-10#1)(2011-2#2)
CBCT can be##2##3##(2013-1#2)
CBCT##7##1##(2012-3#2)(2013-1#5)
CBD##2##1##(2008-12#1)(2009-9#1)
CBF is a##3##3##(1995-2#2)(2012-2#1)
CBF studies##2##2##(2008-7#2)
CBF was##2##2##(1991-5#1)(2008-7#1)
CBF##20##1##(1991-5#2)(1995-2#3)(1995-5#1)(2008-7#11)(2012-2#3)
CBF-A and CBF-B##3##3##(1995-2#3)
CBF-A and##4##2##(1995-2#4)
CBF-A##5##1##(1995-2#5)
CBF-A-CBF-C complex##2##2##(1995-2#2)
CBF-B##8##1##(1995-2#4)(2012-2#4)
CBF-C is##2##2##(1995-2#2)
CBF-C##8##1##(1995-2#8)
CBH I##3##2##(1993-8#3)
CBL and BNM##2##3##(2008-10#2)
CBLVd##2##1##(2008-10#2)
CBP is##2##2##(2008-8#2)
CBP##6##1##(1995-11#1)(2008-4#1)(2008-8#3)(2013-1#1)
CBP2 gene##2##2##(1997-7#2)
CBS concentrations##5##2##(1993-8#5)
CBS##23##1##(1993-8#14)(1996-6#1)(2008-10#2)(2011-2#6)
CBT##2##1##(2008-11#1)(2012-2#1)
CBX1R##2##1##(2008-10#2)
CBZ ml(-1) and 0##2##4##(2008-10#2)
CBZ##6##1##(2008-10#6)
CBZ-E ml(-1)##2##2##(2008-10#2)
CBZ-E##4##1##(2008-10#4)
CBs##5##1##(2008-10#5)
CC is##2##2##(1991-8#1)(2008-11#1)
CC##23##1##(1991-8#4)(2008-10#4)(2008-11#9)(2010-1#2)(2010-5#2)(2013-1#1)(2013-8#1)
CC(4##2##1##(2008-5#2)
CC-516 showed##3##2##(2008-5#3)
CC-516##16##1##(2008-5#16)
CC-NBS-LRR subfamily##2##2##(2008-10#2)
CC-NBS-LRR##4##1##(2008-10#4)
CC9C10 hybridoma##2##2##(2008-11#2)
CCA nucleotidyltransferase##2##2##(1997-3#2)
CCA##10##1##(1997-3#2)(2010-1#4)(2011-2#4)
CCAAT binding##2##2##(1995-2#1)(2008-9#1)
CCAAT box##2##2##(1991-6#1)(2008-9#1)
CCAAT motifs in##2##3##(1995-2#2)
CCAAT##13##1##(1991-5#1)(1991-6#1)(1991-7#1)(1993-2#2)(1995-2#3)(2008-9#5)
CCAAT-binding##3##1##(2008-9#3)
CCBIP group##2##2##(2008-7#2)
CCBIP##6##1##(2008-7#6)
CCD array##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
CCD camera for the##2##4##(2008-3#1)(2010-12#1)
CCD camera##12##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-9#1)(2010-12#1)
CCD images##3##2##(2008-3#3)
CCD is##2##2##(2011-1#2)
CCD spectrometer##2##2##(2008-10#2)
CCD##37##1##(1991-2#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#13)(2008-9#2)(2010-12#1)(2011-1#4)(2011-2#2)(2013-1#1)
CCD-based##2##1##(1997-6#1)(2010-12#1)
CCE##5##1##(2008-10#4)(2008-11#1)
CCE/CC128 cell line##2##3##(2008-11#2)
CCEs prepared##2##2##(2008-10#2)
CCEs##4##1##(2008-10#4)
CCF##2##1##(1996-6#1)(2008-10#1)
CCFC##2##1##(2008-10#2)
CCH##2##1##(2008-7#1)(2010-4#1)
CCH5##5##1##(2012-3#5)
CCHF##2##1##(2012-2#2)
CCI##4##1##(2008-11#2)(2008-9#2)
CCK and dopamine##2##3##(1993-6#2)
CCK mRNA##2##2##(1996-12#2)
CCK octapeptide##3##2##(1993-6#1)(1995-8#2)
CCK type B##2##3##(1994-2#2)
CCK type##3##2##(1994-2#3)
CCK##24##1##(1991-5#2)(1992-8#2)(1993-6#6)(1994-2#3)(1995-8#2)(1996-12#3)(1996-2#1)(2008-7#5)
CCK-8 or ceruletide##2##3##(1994-2#2)
CCK-8 was attenuated by a##2##5##(1994-2#2)
CCK-8 was##3##2##(1994-2#3)
CCK-8##11##1##(1994-2#9)(2008-7#2)
CCK-B receptor##3##2##(1995-12#3)
CCK-B##4##1##(1995-12#3)(1996-2#1)
CCKA receptor antagonist##2##3##(1993-6#1)(1996-2#1)
CCKA receptor##3##2##(1993-6#1)(1996-2#2)
CCKA##4##1##(1993-6#1)(1996-2#3)
CCKB receptor##3##2##(1996-2#3)
CCL19##5##1##(2010-5#1)(2013-1#4)
CCM from##2##2##(1995-3#2)
CCM##3##1##(1995-3#3)
CCMV RNA1##2##2##(2008-10#2)
CCMV RNA3##3##2##(2008-10#3)
CCMV RdRp##2##2##(2008-10#2)
CCMV##13##1##(2008-10#13)
CCOMT were##2##2##(2008-11#2)
CCOMT##3##1##(2008-11#3)
CCPE for##2##2##(2008-10#2)
CCPE##4##1##(2008-10#4)
CCR2-64I##3##1##(2008-9#3)
CCRC##3##1##(1991-2#1)(1994-2#2)
CCRCs##2##1##(1991-2#2)
CCRMP##2##1##(2008-10#2)
CCRT##7##1##(2008-10#7)
CCSV NP##4##2##(2008-10#4)
CCSV S RNA##2##3##(2008-10#2)
CCSV##11##1##(2008-10#11)
CCT##2##1##(1994-1#1)(2013-1#1)
CCTS-NMDG resin##2##2##(2008-10#2)
CCl(4)##7##1##(1996-5#2)(2008-10#4)(2009-8#1)
CCl4##8##1##(1992-6#1)(1994-5#6)(2013-1#1)
CCl4-induced##4##1##(1994-5#3)(2013-1#1)
CCs and MCCs##2##3##(2013-1#2)
CCs and##3##2##(2013-1#3)
CD 9 monoclonal##2##3##(1990-8#2)
CD Plus MEDLINE##3##3##(1991-1#2)(1991-12#1)
CD Plus##8##2##(1991-1#5)(1991-12#3)
CD _ 2##4##3##(2008-5#4)
CD and##2##2##(2008-10#2)
CD is##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
CD isolates##2##2##(2008-10#2)
CD spectra##3##2##(2008-10#1)(2008-4#2)
CD spectrum##2##2##(1994-5#2)
CD were##2##2##(2008-7#1)(2010-12#1)
CD##72##1##(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#5)(1991-12#3)(1994-5#5)(1995-2#1)(1996-5#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-4#6)(2008-5#4)(2008-7#4)(2008-8#3)(2009-11#1)(2009-12#1)(2010-12#9)(2012-2#7)(2013-8#1)
CD-1 mice were##2##3##(1990-6#1)(2008-10#1)
CD-1 mice##5##2##(1990-6#2)(1991-6#2)(2008-10#1)
CD-1##7##1##(1990-6#2)(1991-6#2)(2008-10#1)(2008-11#2)
CD-DCI##2##1##(2012-3#2)
CD-ROM MEDLINE##3##2##(1991-3#3)
CD-ROM database##2##2##(1991-12#1)(1993-1#1)
CD-ROM##23##1##(1991-1#4)(1991-12#5)(1991-3#6)(1993-1#2)(1993-2#2)(2008-11#4)
CD-ROM-based##2##1##(1993-2#2)
CD-causing R##4##2##(2008-10#4)
CD10##4##1##(2010-12#3)(2011-2#1)
CD105(+)##6##1##(2008-11#6)
CD117##2##1##(2009-7#1)(2012-12#1)
CD11a/CD18 and##2##2##(1996-12#2)
CD11a/CD18##4##1##(1996-12#4)
CD11b##5##1##(1991-2#2)(2006-6#2)(2008-11#1)
CD11b/CD18##2##1##(1996-12#2)
CD11c on leukocytes and fibrinogen##2##5##(2006-6#2)
CD11c##4##1##(2006-6#2)(2008-10#1)(2008-11#1)
CD11c(+)/B220(-) DCs##2##2##(2008-11#2)
CD11c+##4##1##(1996-12#3)(2008-11#1)
CD120a##3##1##(1995-2#3)
CD127 expression level##2##3##(2013-1#2)
CD127##4##1##(2013-1#4)
CD127(low) pentamer(+)##2##2##(2013-1#2)
CD127(low)##4##1##(2013-1#4)
CD133##5##1##(2008-9#1)(2009-9#2)(2011-2#1)(2013-1#1)
CD133-high cells##3##2##(2009-9#3)
CD138##2##1##(2008-9#1)(2009-3#1)
CD14 mRNA##2##2##(2012-3#2)
CD14##7##1##(2008-10#3)(2008-9#1)(2012-2#1)(2012-3#2)
CD14(+)##3##1##(2008-11#3)
CD14(-)##2##1##(2008-11#2)
CD161##3##1##(2012-2#3)
CD161+ T cell##2##3##(2012-2#2)
CD161+ T cells##4##3##(2012-2#4)
CD161+ T##6##2##(2012-2#6)
CD161+##7##1##(2012-2#7)
CD19##2##1##(2008-9#2)
CD19+##2##1##(2008-11#1)(2010-11#1)
CD1a##3##1##(1996-12#1)(2008-5#1)(2012-12#1)
CD1a+ cells in the dermis##2##5##(1996-12#2)
CD1a+##5##1##(1996-12#5)
CD20##2##1##(2009-8#1)(2010-12#1)
CD20+##2##1##(1992-6#1)(2010-11#1)
CD24##2##1##(2008-9#1)(2011-2#1)
CD25 and##2##2##(1995-8#1)(2011-2#1)
CD25##8##1##(1995-8#1)(2008-11#6)(2011-2#1)
CD25+CD4+ T cells##4##3##(2011-2#4)
CD25+CD4+ regulatory##3##2##(2011-2#3)
CD25+CD4+##8##1##(2011-2#8)
CD3##5##1##(1991-6#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-9#1)
CD3(+)##2##1##(2008-5#1)(2012-3#1)
CD3+ cells##2##2##(2008-11#2)
CD3+##4##1##(1992-6#1)(2008-11#2)(2013-1#1)
CD30##3##1##(2011-2#1)(2012-3#2)
CD30+ PCLCL##2##2##(2012-3#2)
CD31##2##1##(2010-12#1)(2011-2#1)
CD31(+) cells in the bone marrow##2##6##(2010-6#2)
CD34 and##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
CD34##6##1##(2008-11#1)(2008-9#3)(2009-8#1)(2013-8#1)
CD34(+) cells were##2##3##(2008-8#2)
CD34(+) cells##12##2##(2008-8#8)(2008-9#3)(2012-2#1)
CD34(+)##16##1##(2008-8#8)(2008-9#7)(2012-2#1)
CD34(-) and weakly CD105(+)##2##4##(2008-11#2)
CD34(-)##4##1##(2008-11#4)
CD34+ cells##4##2##(2008-7#1)(2011-2#3)
CD34+ count in peripheral blood##2##5##(2011-2#2)
CD34+ hematopoietic##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
CD34+##12##1##(1993-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#6)
CD36##2##1##(2008-11#1)(2008-5#1)
CD4 +##2##2##(2008-8#2)
CD4 T cell##2##3##(2012-12#1)(2013-1#1)
CD4 T cells in##2##4##(2008-11#1)(2012-12#1)
CD4 T cells##12##3##(2008-11#6)(2012-12#5)(2013-8#1)
CD4 T##16##2##(2008-11#6)(2008-4#1)(2012-12#7)(2013-1#1)(2013-8#1)
CD4 and##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
CD4 cell##2##2##(2009-8#2)
CD4 count##3##2##(2010-12#3)
CD4##33##1##(1990-12#1)(1992-6#1)(1995-2#2)(2008-10#1)(2008-11#6)(2008-4#2)(2008-8#2)(2008-9#1)(2009-8#2)(2010-12#3)(2011-2#1)(2012-12#7)(2013-1#3)(2013-8#1)
CD4(+) CD8(-)##3##2##(2008-5#1)(2008-9#2)
CD4(+) T cell-rich population##3##4##(2008-11#3)
CD4(+) T cells and##2##4##(2008-11#1)(2013-8#1)
CD4(+) T cells to##3##4##(2008-11#3)
CD4(+) T cells with##2##4##(2008-9#1)(2010-1#1)
CD4(+) T cells##19##3##(2008-11#16)(2008-9#1)(2010-1#1)(2013-8#1)
CD4(+) T helper##2##3##(2008-11#1)(2012-3#1)
CD4(+) T##26##2##(2008-11#21)(2008-9#2)(2010-1#1)(2012-3#1)(2013-8#1)
CD4(+) T-cell-deficient chickens##2##3##(2008-5#2)
CD4(+) T-lymphocyte activation##2##3##(2008-10#2)
CD4(+) T-lymphocyte effects##2##3##(2008-10#2)
CD4(+) T-lymphocyte##4##2##(2008-10#4)
CD4(+) T-lymphocytes in##2##3##(2008-10#2)
CD4(+) T-lymphocytes##7##2##(2008-10#7)
CD4(+) or CD8(+) T-cell-deficient##2##4##(2008-5#2)
CD4(+)##57##1##(2008-10#11)(2008-11#25)(2008-5#6)(2008-9#6)(2010-1#5)(2010-5#1)(2012-3#1)(2013-8#2)
CD4(-)##2##1##(2008-5#2)
CD4+ T cells##5##3##(1995-2#1)(1996-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
CD4+ T##7##2##(1993-8#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
CD4+ and CD8+ T cells##3##5##(1995-12#2)(2013-8#1)
CD4+ and CD8+##5##3##(1995-12#3)(1995-2#1)(2013-8#1)
CD4+ cells##2##2##(1991-1#1)(2008-5#1)
CD4+##22##1##(1991-1#3)(1993-12#1)(1993-8#2)(1995-12#3)(1995-2#2)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
CD4+FOXP3+##3##1##(2013-8#3)
CD40 ligand (CD154)##2##3##(2008-9#2)
CD40 ligand##3##2##(2008-11#1)(2008-9#2)
CD40##10##1##(2008-10#5)(2008-11#2)(2008-9#2)(2012-2#1)
CD43##2##1##(1997-3#1)(2008-5#1)
CD44##2##1##(1995-10#1)(2011-2#1)
CD44(+) and CD34(-)##2##3##(2008-11#2)
CD44(+)##3##1##(2008-10#1)(2008-11#2)
CD45##3##1##(1994-6#3)
CD45(-)##5##1##(2008-11#4)(2012-4#1)
CD45RA positive##2##2##(1995-8#2)
CD45RB(high)##2##1##(2008-10#1)(2008-11#1)
CD45RO positive cells##2##3##(1995-8#2)
CD49a(+)##2##1##(2008-11#2)
CD49f(+)##2##1##(2008-11#2)
CD5(+)B cells##3##2##(2011-2#3)
CD5(+)B##4##1##(2011-2#4)
CD54##6##1##(2008-10#6)
CD56##3##1##(2008-9#1)(2010-1#1)(2012-2#1)
CD59##2##1##(2008-8#2)
CD62 and CD63##2##3##(2006-6#2)
CD62P and CD11b##2##3##(2006-6#2)
CD63##5##1##(1997-3#1)(2006-6#2)(2009-8#1)(2012-3#1)
CD8 T cells##2##3##(2007-11#1)(2012-12#1)
CD8 and CD4##2##3##(1990-12#1)(2012-12#1)
CD8 cells##2##2##(1991-6#1)(2013-1#1)
CD8##13##1##(1990-12#1)(1991-6#1)(1992-6#1)(1997-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-1#1)
CD8(+) T cells##3##3##(2008-9#1)(2010-5#1)(2013-8#1)
CD8(+) T##6##2##(2008-9#1)(2010-5#3)(2013-8#2)
CD8(+)##14##1##(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#2)(2010-1#1)(2010-5#3)(2013-1#1)(2013-8#2)
CD8(-)##4##1##(2008-5#2)(2008-9#2)
CD8+ T##4##2##(1995-12#2)(2013-8#2)
CD8+ T-cell levels##2##3##(2013-8#2)
CD8+ T-cell##4##2##(2013-8#4)
CD8+ T-cells##2##2##(2013-8#2)
CD8+ cells##2##2##(1991-1#1)(2008-11#1)
CD8+ lymphocytes##2##2##(1995-2#1)(2013-8#1)
CD8+##20##1##(1991-1#1)(1994-5#1)(1995-12#3)(1995-2#2)(1997-7#1)(2008-11#2)(2013-8#10)
CD8-##2##1##(1997-7#1)(2008-8#1)
CD8/CD3##2##1##(2008-11#2)
CD80##3##1##(2008-10#2)(2008-11#1)
CD86 expression in##2##3##(2008-10#2)
CD86 expression##6##2##(2008-10#6)
CD86##16##1##(2008-10#12)(2008-11#4)
CD8A##3##1##(1997-9#3)
CD8B##2##1##(1997-9#2)
CD8alpha##2##1##(1997-9#2)
CD9##7##1##(2009-8#7)
CD94##2##1##(2008-8#2)
CDA##5##1##(1991-6#1)(2010-8#4)
CDC INPHO##3##2##(1995-12#2)(1996-1#1)
CDC and##3##2##(1996-5#1)(1997-2#1)(1997-3#1)
CDC believes##2##2##(1996-12#1)(1997-3#1)
CDC##24##1##(1992-12#1)(1992-6#3)(1995-12#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#5)(1997-3#3)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)
CDC's##4##1##(1995-12#1)(1997-2#1)(2008-7#2)
CDC2-related protein##2##2##(1993-2#2)
CDC28##3##1##(1991-5#3)
CDC7##2##1##(2012-3#2)
CDCl(3)##4##1##(1996-5#2)(2008-10#2)
CDD/ANP-(99-126)##4##1##(1995-11#4)
CDDP##8##1##(1990-6#2)(2013-1#6)
CDER guidance##2##2##(2010-11#2)
CDER##4##1##(2010-11#4)
CDGP##5##1##(2011-1#5)
CDK##3##1##(2008-11#1)(2008-5#1)(2011-2#1)
CDK2 kinase##2##2##(1997-1#2)
CDK2 phosphorylation##2##2##(1997-1#2)
CDK2##6##1##(1997-1#5)(2008-5#1)
CDKN2A##6##1##(1997-7#4)(2008-11#1)(2011-2#1)
CDM-PSS DGT##2##2##(2008-10#2)
CDOM##3##1##(2008-2#3)
CDP##3##1##(1997-2#3)
CDR3##3##1##(1997-9#3)
CDRs##2##1##(2008-4#1)(2012-2#1)
CDS##2##1##(2010-5#2)
CDSS##3##1##(2011-2#3)
CDSs##6##1##(1996-12#6)
CDT##5##1##(1997-2#5)
CDTR-PI##3##1##(2011-2#3)
CDV##7##1##(2008-12#4)(2009-8#1)(2012-3#2)
CDY##3##1##(2008-11#3)
CDs were##2##2##(2008-10#2)
CDs##9##1##(2008-10#9)
CE and##7##2##(2008-10#6)(2011-1#1)
CE are##2##2##(2008-10#1)(2008-5#1)
CE for the##2##3##(2008-10#2)
CE for##3##2##(2008-10#3)
CE maturation##5##2##(2008-5#5)
CE maturity##2##2##(2008-5#2)
CE method##5##2##(1997-2#2)(2008-10#3)
CE modes##2##2##(2008-10#2)
CE procedure developed##3##3##(2008-10#3)
CE separations##2##2##(2008-10#2)
CE##66##1##(1996-8#1)(1997-2#2)(2008-10#40)(2008-12#2)(2008-4#1)(2008-5#12)(2010-7#1)(2011-1#5)(2012-12#1)(2013-1#1)
CE-ICP-MS##2##1##(2008-10#2)
CE-UV##4##1##(2008-10#4)
CEA and##2##2##(1990-6#1)(2008-11#1)
CEA levels##2##2##(1990-6#1)(1997-8#1)
CEA##21##1##(1990-5#2)(1990-6#3)(1991-8#1)(1992-2#1)(1994-12#1)(1994-5#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#7)(2012-12#1)
CEA-related genes##2##2##(1992-6#2)
CEC and CEP##4##3##(2010-1#4)
CEC system##2##2##(2008-10#2)
CEC##9##1##(2008-10#4)(2010-1#5)
CECT 2413##2##2##(2008-10#2)
CEE##5##1##(2013-1#5)
CEES##2##1##(2008-10#2)
CEF and##3##2##(1991-5#1)(2008-10#2)
CEF##8##1##(1991-5#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
CELISA##3##1##(1990-12#3)
CELL-ELISA##3##1##(1990-12#3)
CEM##4##1##(1994-11#1)(2008-11#2)(2011-3#1)
CEN##2##1##(2010-8#1)(2012-3#1)
CENP-B box / pJalpha##2##4##(2008-7#2)
CENP-B box##3##2##(2008-7#3)
CENTRAL and##2##2##(2009-7#1)(2013-1#1)
CEOP##2##1##(1990-12#2)
CEOs##2##1##(1994-2#1)(1996-2#1)
CEP##6##1##(1994-12#1)(2010-1#5)
CEPH##2##1##(1994-9#1)(2008-12#1)
CER##7##1##(2008-5#7)
CER3 and PA-d(31)##4##3##(2008-10#4)
CER3 and##5##2##(2008-10#5)
CER3##8##1##(2008-10#8)
CES that##2##2##(2012-3#2)
CES##7##1##(2012-3#7)
CEUS has##3##2##(2010-12#3)
CEUS in the##2##3##(2010-12#2)
CEUS in##3##2##(2010-12#3)
CEUS is##4##2##(2010-12#2)(2012-2#2)
CEUS##20##1##(2010-12#15)(2012-2#5)
CEVd and CVd-IV##2##3##(2008-10#2)
CEVd and##3##2##(2008-10#3)
CEVd##15##1##(2008-10#15)
CEf and CEr##2##3##(2008-5#2)
CEf##4##1##(2008-5#4)
CEr##3##1##(2008-5#3)
CEs are##2##2##(2008-5#2)
CEs in the##2##3##(2008-5#2)
CEs in##3##2##(2008-5#3)
CEs##16##1##(2008-10#1)(2008-5#15)
CF concentration##2##2##(2008-10#2)
CF projections##2##2##(1994-2#2)
CF was##4##2##(2008-10#2)(2012-3#2)
CF##26##1##(1994-2#3)(1997-1#4)(2008-10#11)(2008-5#1)(2009-8#2)(2011-3#1)(2012-3#4)
CF(3)SO(3)H##2##1##(2008-10#1)(2012-3#1)
CF-mediated##2##1##(1994-2#1)(2009-8#1)
CFA and##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
CFA##14##1##(2008-10#2)(2008-11#2)(2008-4#1)(2012-2#4)(2012-3#3)(2013-7#2)
CFAs##2##1##(2008-10#2)
CFC propellants##3##2##(1992-3#1)(1996-1#2)
CFC replacements##3##2##(1992-3#3)
CFC##14##1##(1991-12#1)(1992-3#5)(1996-1#4)(1996-2#2)(2008-8#2)
CFCPE##2##1##(2008-10#2)
CFCs##17##1##(1992-3#3)(1996-1#12)(1996-2#2)
CFD##2##1##(2008-11#2)
CFF##3##1##(2008-10#3)
CFH and##4##2##(2008-10#4)
CFH or Worland##2##3##(2008-10#2)
CFH##8##1##(2008-10#8)
CFI = 0##2##3##(2010-2#2)
CFLME##2##1##(2008-10#2)
CFMMV##2##1##(2008-10#2)
CFN##2##1##(2008-10#2)
CFNPE##2##1##(2008-10#2)
CFS##6##1##(2009-10#1)(2010-1#5)
CFSE is##2##2##(2008-9#2)
CFSE##3##1##(2008-4#1)(2008-9#2)
CFTR cDNA##2##2##(1997-1#1)(2011-3#1)
CFTR gene##4##2##(1997-1#2)(2011-3#2)
CFTR##12##1##(1997-1#3)(2011-3#9)
CFU counts##2##2##(2008-10#2)
CFU g(-1) of##3##3##(2008-10#3)
CFU ml(-1) on##2##3##(2008-10#2)
CFU ml(-1)##4##2##(2008-10#4)
CFU of##3##2##(1996-12#1)(2008-10#2)
CFU per gram of soil were##2##6##(2008-10#2)
CFU per kernel##2##3##(2008-10#2)
CFU per##6##2##(2008-10#6)
CFU##35##1##(1996-12#4)(2008-10#30)(2009-6#1)
CFU)##2##1##(2008-10#2)
CFU/100##2##1##(2012-2#2)
CFU/g of apple##2##3##(2008-10#2)
CFU/g of fresh##2##3##(2008-10#2)
CFU/g of root##2##3##(2008-10#2)
CFU/g of soil##2##3##(2008-10#2)
CFU/g of##9##2##(2008-10#9)
CFU/g##11##1##(2008-10#9)(2012-2#2)
CFU/ml in##2##2##(2008-10#1)(2012-2#1)
CFU/ml of a P6 strain##2##5##(2008-10#2)
CFU/ml of##3##2##(2008-10#3)
CFU/ml##16##1##(2008-10#12)(2012-2#4)
CFU/ml) were applied at##2##4##(2008-10#2)
CFU/ml) were##3##2##(2008-10#3)
CFU/ml)##8##1##(2008-10#5)(2008-12#1)(2012-2#2)
CFZ##3##1##(2008-10#3)
CFs##2##1##(1994-2#2)
CG##2##1##(2008-9#1)(2013-1#1)
CGE cycle frequency##2##3##(2010-4#2)
CGE##8##1##(2010-4#8)
CGF##2##1##(2008-10#2)
CGF-1 binding##2##2##(1995-2#2)
CGF-1##4##1##(1995-2#4)
CGH is##2##2##(2008-9#1)(2012-3#1)
CGH##6##1##(2008-12#1)(2008-9#3)(2012-3#2)
CGRP (0##2##2##(1997-4#2)
CGRP and##3##2##(1992-6#2)(1997-4#1)
CGRP in the amygdala##2##4##(1992-6#2)
CGRP in the##5##3##(1992-6#5)
CGRP in##9##2##(1992-6#9)
CGRP is released##2##3##(1992-6#2)
CGRP is##5##2##(1992-6#5)
CGRP produced##2##2##(1992-6#2)
CGRP release by##2##3##(1992-6#2)
CGRP release##3##2##(1992-6#3)
CGRP to##2##2##(1992-6#2)
CGRP was##3##2##(1992-6#1)(1997-3#1)(1997-4#1)
CGRP were##2##2##(1992-6#1)(1997-3#1)
CGRP##77##1##(1992-6#63)(1997-3#4)(1997-4#10)
CGRP(+) IENFs were##3##3##(2013-8#3)
CGRP(+) IENFs##5##2##(2013-8#5)
CGRP-LI content##2##2##(1994-8#2)
CGRP-LI##6##1##(1992-6#1)(1994-8#5)
CGRP-induced##2##1##(1992-6#2)
CGRP-like immunoreactive##3##2##(1992-6#1)(1997-3#2)
CGRP-like immunoreactivity##3##2##(1992-6#2)(1997-3#1)
CGRP-like##7##1##(1992-6#4)(1997-3#3)
CGRP1##2##1##(1997-4#2)
CGRP8-37##3##1##(1992-6#3)
CGS-9895 and CGS-9896##2##3##(1995-11#2)
CH _ 2 rocking##3##4##(2008-5#3)
CH _ 2##5##3##(2008-5#5)
CH##16##1##(2008-10#11)(2008-5#5)
CH(2) and##2##2##(2008-10#1)(2008-8#1)
CH(2) scissoring##2##2##(2008-10#2)
CH(2)##12##1##(1997-2#1)(2008-10#8)(2008-5#1)(2008-8#1)(2009-9#1)
CH(2)Cl(2)##9##1##(1996-5#3)(2008-10#5)(2009-9#1)
CH(2)OCO##2##1##(2008-10#2)
CH(3) symmetric##3##2##(2008-10#3)
CH(3)##11##1##(1996-5#1)(2008-10#8)(2008-5#1)(2008-8#1)
CH(3)CN##3##1##(2008-10#3)
CH(3)Hg(+) and Hg(2+)##3##3##(2008-10#3)
CH(3)Hg(+) and##4##2##(2008-10#4)
CH(3)Hg(+)##12##1##(2008-10#12)
CH(3)OH-modified CO(2) supercritical fluid##2##4##(2008-10#2)
CH(3)SH##2##1##(2008-10#2)
CH(4)##4##1##(2008-3#3)(2010-7#1)
CH(dT)(15)##2##1##(2008-10#2)
CH-B-15-C-5##2##1##(2008-10#2)
CH3CN##2##1##(1992-6#2)
CH4##3##1##(2008-3#3)
CHA##7##1##(1997-1#1)(1997-2#2)(2008-10#4)
CHA's accentuation##3##2##(1997-2#3)
CHA's##4##1##(1997-2#4)
CHA0 in##2##2##(2008-10#2)
CHA0 to##2##2##(2008-10#2)
CHA0##15##1##(2008-10#15)
CHA0r##4##1##(2008-10#4)
CHAID Decision##2##2##(2010-8#2)
CHAMPUS##2##1##(1996-12#2)
CHAP##3##1##(2009-6#3)
CHARGE##3##1##(2008-9#3)
CHB##2##1##(2009-8#1)(2013-1#1)
CHC profiles##3##2##(2012-3#3)
CHC##7##1##(2012-3#7)
CHCl(3) and the##2##3##(2008-10#2)
CHCl(3) and##3##2##(2008-10#3)
CHCl(3)##9##1##(2008-10#8)(2008-11#1)
CHCs##4##1##(2012-3#4)
CHD##5##1##(2010-10#1)(2010-9#2)(2012-2#2)
CHF##6##1##(1995-12#3)(2009-10#3)
CHI is##2##2##(2013-1#2)
CHI##4##1##(2013-1#4)
CHIN (community health information network)##5##5##(1996-1#5)
CHIN##12##1##(1996-1#11)(1997-1#1)
CHINs##4##1##(1996-1#1)(1997-1#3)
CHM##5##1##(2008-10#5)
CHN analysis##2##2##(2008-10#2)
CHN##5##1##(2008-10#5)
CHN1##3##1##(2008-10#3)
CHO 1-62 cells##2##3##(2008-11#2)
CHO and BHK cells##2##4##(2008-11#2)
CHO and BHK##3##3##(2008-11#3)
CHO and##5##2##(2008-11#5)
CHO cell culture##3##3##(2008-11#2)(2011-2#1)
CHO cell cultures##2##3##(2008-11#1)(2011-2#1)
CHO cell line were##2##4##(2008-11#2)
CHO cell line##19##3##(1990-8#1)(2008-11#16)(2008-8#1)(2011-2#1)
CHO cell lines##8##3##(2008-11#8)
CHO cell##36##2##(1990-8#1)(2008-11#29)(2008-8#1)(2011-2#5)
CHO cells and##3##3##(2008-11#2)(2011-2#1)
CHO cells expressing##3##3##(1995-2#2)(2008-11#1)
CHO cells in##6##3##(2008-11#5)(2008-7#1)
CHO cells overexpressing##4##3##(1994-11#1)(1995-6#2)(2008-11#1)
CHO cells was##6##3##(2008-11#5)(2008-7#1)
CHO cells were##7##3##(2008-11#7)
CHO cells##90##2##(1990-8#1)(1992-10#2)(1994-11#3)(1995-2#3)(1995-6#3)(1997-1#1)(2008-11#71)(2008-7#5)(2011-2#1)
CHO culture##2##2##(2008-11#2)
CHO##168##1##(1990-8#2)(1991-6#2)(1992-10#2)(1993-8#1)(1994-11#3)(1994-3#1)(1995-2#3)(1995-6#3)(1997-1#1)(2008-10#1)(2008-11#130)(2008-3#3)(2008-7#5)(2008-8#1)(2011-2#6)(2013-1#2)(2013-8#2)
CHO-320 cells##3##2##(2008-11#3)
CHO-DG44 cells##2##2##(2008-11#2)
CHO-IR cells##3##2##(1994-11#3)
CHO-K1 and##2##2##(2008-11#2)
CHO-K1 cell line##2##3##(2008-11#2)
CHO-K1 cell##4##2##(1997-1#1)(2008-11#3)
CHO-K1 cells##9##2##(1997-1#1)(2008-11#8)
CHO-K1##19##1##(1997-1#2)(2008-11#17)
CHO-KI##2##1##(1997-4#1)(1997-7#1)
CHO-PRO##2##1##(2013-1#2)
CHO-S cells##2##2##(2008-11#2)
CHO-TAg##2##1##(2008-11#2)
CHOE1a##2##1##(2008-11#2)
CHOICE##5##1##(1997-5#1)(2012-12#4)
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits##2##14##(2008-12#2)
CHOP##4##1##(1992-12#1)(2008-12#2)(2012-2#1)
CHOcells##2##1##(2008-11#2)
CHP-126 neuroblastomas##2##2##(1995-12#2)
CHT##3##1##(2008-10#3)
CHU##4##1##(2008-10#1)(2010-6#1)(2013-1#2)
CHUP1##2##1##(2009-8#2)
CHV1##3##1##(2008-10#3)
CHV3-type dsRNAs##4##2##(2008-10#4)
CHX and NaOCl##3##3##(2013-1#3)
CHX##11##1##(2011-3#5)(2013-1#6)
CI 0##7##2##(2008-12#1)(2011-2#3)(2013-1#3)
CI 1##18##2##(1993-12#1)(2008-11#2)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
CI 13227##5##2##(2008-10#5)
CI 2##5##2##(1993-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
CI 6##2##2##(2010-9#1)(2011-2#1)
CI 95% 1##2##3##(2013-1#2)
CI 95%##5##2##(2008-10#1)(2013-1#4)
CI 988##4##2##(1996-2#4)
CI = 1##2##3##(2010-10#1)(2011-2#1)
CI =##7##2##(1996-1#3)(2009-9#1)(2010-10#1)(2011-2#2)
CI can##2##2##(2008-8#2)
CI strains##5##2##(2008-8#5)
CI##151##1##(1992-2#1)(1993-12#2)(1993-2#1)(1994-12#7)(1996-1#3)(1996-2#4)(2008-10#21)(2008-11#9)(2008-12#8)(2008-8#14)(2008-9#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#10)(2010-9#1)(2011-2#26)(2012-12#6)(2012-2#4)(2012-3#8)(2013-1#20)
CI(-)##2##1##(2008-10#2)
CI-mixture##2##1##(2008-5#2)
CIA##3##1##(1990-12#1)(2008-11#2)
CIE and##2##2##(2008-5#2)
CII##3##1##(1996-12#1)(2008-9#2)
CIM##7##1##(2012-3#7)
CIN I variant##2##3##(1994-1#2)
CIN I##3##2##(1994-1#3)
CIN and##2##2##(2012-3#2)
CIN##23##1##(1991-2#2)(1994-1#7)(1994-12#1)(1994-2#3)(2010-10#2)(2011-2#5)(2012-3#3)
CINAHL##7##1##(1992-12#1)(1994-3#4)(2013-1#2)
CINV##3##1##(2008-7#3)
CIP and CIM##2##3##(2012-3#2)
CIP and##5##2##(2008-10#2)(2012-3#3)
CIP##12##1##(2008-10#5)(2011-2#1)(2012-3#6)
CIP1##2##1##(1997-7#1)(2008-11#1)
CIPIC##2##1##(2008-10#2)
CIPIC-conjugated CCL##4##2##(2008-10#4)
CIPs of##4##2##(2008-10#4)
CIPs##7##1##(2008-10#7)
CIRC##2##1##(2013-8#2)
CIRCADIAN##2##1##(2008-11#2)
CIS##5##1##(1994-1#1)(2008-9#4)
CITED1 expression is detected in##2##5##(2013-1#2)
CITED1 is##2##2##(2013-1#2)
CITED1##9##1##(2013-1#9)
CITP##2##1##(2008-10#2)
CIho 4780##3##2##(2008-10#3)
CIho##8##1##(2008-10#8)
CIs##4##1##(2008-8#2)(2012-2#2)
CK##14##1##(1990-11#1)(1990-2#2)(1993-6#1)(1994-12#1)(2008-11#5)(2011-2#1)(2011-3#3)
CK-II##4##1##(1993-2#4)
CK-MB and TPI##2##3##(2011-2#2)
CK-MB isoform##2##2##(1992-3#2)
CK-MB mass and troponin I##2##5##(2008-10#2)
CK-MB##10##1##(1992-3#4)(2008-10#4)(2011-2#2)
CK8##5##1##(2008-11#4)(2011-2#1)
CKD and their##2##3##(2010-4#2)
CKD stage##2##2##(2011-2#1)(2012-2#1)
CKD##19##1##(2009-1#5)(2010-10#2)(2010-4#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)
CKII##4##1##(1990-12#4)
CL and##2##2##(2008-10#1)(2008-3#1)
CL detection##12##2##(2008-10#12)
CL emission##10##2##(2008-10#10)
CL enhancement##3##2##(2008-10#3)
CL expressed##2##2##(2008-8#2)
CL flow##2##2##(2008-10#2)
CL inhibition##2##2##(2008-10#2)
CL intensity is linear with##2##5##(2008-10#2)
CL intensity is##3##3##(2008-10#3)
CL intensity was linear to the##3##6##(2008-10#3)
CL intensity was linear with##3##5##(2008-10#3)
CL intensity was linear##7##4##(2008-10#7)
CL intensity was##8##3##(2008-10#8)
CL intensity##22##2##(2008-10#22)
CL of##5##2##(2008-10#3)(2008-8#2)
CL reaction of##9##3##(2008-10#9)
CL reaction was studied##2##4##(2008-10#2)
CL reaction was##4##3##(2008-10#4)
CL reaction##19##2##(2008-10#19)
CL reagent##7##2##(2008-10#7)
CL reagents##2##2##(2008-10#2)
CL sensor##3##2##(2008-10#3)
CL signal##4##2##(2008-10#4)
CL system##8##2##(2008-10#8)
CL systems##2##2##(2008-10#2)
CL was##6##2##(2008-10#5)(2008-9#1)
CL##163##1##(1991-2#2)(2008-10#134)(2008-3#2)(2008-5#2)(2008-8#14)(2008-9#8)(2013-8#1)
CL-1000##7##1##(2008-11#7)
CL-11G##2##1##(2008-11#2)
CL-6B##2##1##(1990-12#2)
CL-emission generated##2##2##(2008-10#2)
CL-emission##7##1##(2008-10#7)
CL218##3##1##(1995-11#3)
CLA##3##1##(1993-8#3)
CLASSIFICATION##2##1##(2008-11#1)(2010-1#1)
CLB##6##1##(2008-10#6)
CLBO crystal##2##2##(2008-3#2)
CLCuV##2##1##(2008-9#2)
CLE genes##3##2##(2009-8#3)
CLIA##2##1##(1993-3#1)(1994-2#1)
CLIMEX model##3##2##(2008-10#3)
CLIMEX##5##1##(2008-10#5)
CLINICAL##2##1##(1997-5#1)(2009-4#1)
CLL cell##2##2##(1995-2#2)
CLL cells##4##2##(1995-2#4)
CLL##15##1##(1995-2#7)(2008-11#1)(2008-9#4)(2009-12#2)(2011-2#1)
CLM##3##1##(2008-10#1)(2012-3#2)
CLN##2##1##(1991-5#2)
CLN1 and CLN2 mRNAs##2##4##(1991-5#2)
CLN1 and CLN2##5##3##(1991-5#5)
CLN1##6##1##(1991-5#6)
CLN2##6##1##(1991-5#6)
CLN3##3##1##(1991-5#2)(1994-11#1)
CLND and UV##2##3##(1997-2#2)
CLO products##3##2##(2011-2#3)
CLP and SCLP##2##3##(2012-3#2)
CLP injury##3##2##(2012-3#3)
CLP##18##1##(2012-3#18)
CLS##12##1##(2008-10#8)(2012-3#4)
CLSM and MPLSM##2##3##(2008-9#2)
CLUSTERING##2##1##(2009-11#1)(2010-1#1)
CLcr=(1##2##1##(2008-7#2)
CM injection##2##2##(2011-2#2)
CM is##2##2##(2008-10#2)
CM##21##1##(1993-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2011-2#6)(2012-12#1)(2012-3#4)
CM-Cellulose##2##1##(2008-8#2)
CM-dextran##7##1##(2008-10#7)
CM-hyaluronic acid##2##2##(2008-10#2)
CMA3##5##1##(2008-12#5)
CMC was##2##2##(2008-10#2)
CMC##13##1##(2008-10#10)(2008-9#1)(2010-11#1)(2012-2#1)
CMCC##2##1##(2010-7#2)
CME surfaces##2##2##(2008-10#2)
CME was##2##2##(2008-10#2)
CME##12##1##(2008-1#1)(2008-10#9)(2010-11#1)(2012-3#1)
CME's##2##1##(2008-10#2)
CMF deposition##2##2##(2008-11#2)
CMF##10##1##(1992-12#2)(2008-11#3)(2009-1#5)
CMG groups were found to be##2##6##(1993-12#2)
CMG groups##4##2##(1993-12#4)
CMI##7##1##(1995-5#2)(2008-12#1)(2011-1#2)(2011-2#2)
CMIV gene##2##2##(2008-8#2)
CMIV##5##1##(2008-8#5)
CML hydrogel##3##2##(2009-7#3)
CML##11##1##(1990-2#2)(2009-7#3)(2010-11#4)(2011-2#2)
CMLV##7##1##(2008-10#7)
CMM##6##1##(2008-7#4)(2012-3#2)
CMOS##3##1##(2008-10#3)
CMP were##2##2##(1990-5#1)(2008-8#1)
CMP##4##1##(1990-5#1)(2008-10#1)(2008-4#1)(2008-8#1)
CMPS-PAN##2##1##(2008-10#2)
CMRI##2##1##(2013-3#2)
CMS and##2##2##(2008-11#1)(2010-9#1)
CMS##8##1##(2008-10#4)(2008-11#1)(2008-9#1)(2010-9#1)(2012-3#1)
CMT##3##1##(2011-2#2)(2013-1#1)
CMT-93##3##1##(2008-11#3)
CMT1A duplication##2##2##(1997-3#2)
CMT1A##7##1##(1997-3#7)
CMV (-)##2##2##(2008-10#2)
CMV +##3##2##(2008-10#3)
CMV and##4##2##(2008-10#4)
CMV incidence##2##2##(2008-10#2)
CMV infection##5##2##(2008-10#1)(2011-2#1)(2012-2#3)
CMV isolates from##2##3##(2008-10#2)
CMV isolates##6##2##(2008-10#6)
CMV population##2##2##(2008-10#2)
CMV promoter##5##2##(1995-12#1)(1996-12#1)(2008-11#2)(2008-8#1)
CMV strains##5##2##(2008-10#5)
CMV was detected in the##2##5##(2008-10#2)
CMV was detected##3##3##(2008-10#3)
CMV was##8##2##(2008-10#8)
CMV##74##1##(1994-11#1)(1995-12#1)(1996-12#1)(2008-10#60)(2008-11#3)(2008-8#3)(2011-2#1)(2012-2#4)
CMV-infected plants##2##2##(2008-10#1)(2012-2#1)
CMV-infected##3##1##(2008-10#2)(2012-2#1)
CMV-satRNA##3##1##(2008-10#3)
CMX##2##1##(1997-5#2)
CMoV##5##1##(2008-10#5)
CN IX##5##2##(2011-2#5)
CN and##2##2##(2008-9#2)
CN radical##2##2##(2008-10#2)
CN##22##1##(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#7)(2011-2#6)
CN(-)##8##1##(2008-10#8)
CNAs##2##1##(2008-11#1)(2010-11#1)
CNBr-Rev##2##1##(1993-8#2)
CNG channels##5##2##(2009-10#5)
CNICC##2##1##(2008-10#2)
CNL patients##4##2##(2008-7#4)
CNL##6##1##(2008-7#5)(2012-2#1)
CNP##5##1##(1994-11#3)(1994-8#2)
CNQX##2##1##(1994-11#1)(1996-2#1)
CNS and PNS##3##3##(1995-12#1)(2008-7#2)
CNS and##4##2##(1995-12#1)(1996-12#1)(2008-7#2)
CNS arousal##2##2##(2008-11#2)
CNS development##2##2##(2008-5#1)(2008-7#1)
CNS disease##2##2##(2008-7#1)(2011-2#1)
CNS involvement by##2##3##(2012-3#2)
CNS involvement in##2##3##(1997-8#1)(2012-3#1)
CNS involvement##4##2##(1997-8#1)(2012-3#3)
CNS is located on the##2##5##(2008-5#2)
CNS myelination##4##2##(2008-7#3)(2009-6#1)
CNS neurons##2##2##(1991-12#2)
CNS of##4##2##(1994-2#1)(2008-7#2)(2009-8#1)
CNS or##2##2##(1997-3#1)(2008-7#1)
CNS were##2##2##(1996-12#1)(2008-12#1)
CNS##90##1##(1990-12#1)(1990-3#1)(1990-9#4)(1991-12#5)(1991-2#1)(1992-10#3)(1992-8#1)(1994-2#2)(1995-12#4)(1996-12#4)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2008-11#4)(2008-12#3)(2008-5#9)(2008-7#19)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#3)(2011-2#4)(2012-2#1)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#1)
CNT Josephson junctions##2##3##(2008-7#2)
CNT content##2##2##(2009-11#2)
CNT##11##1##(2008-10#2)(2008-7#4)(2009-11#4)(2010-4#1)
CNT-metal##2##1##(2008-7#2)
CNTF##11##1##(1990-5#6)(1996-2#5)
CNTs are##2##2##(2008-7#2)
CNTs on##2##2##(2008-7#2)
CNTs##11##1##(2008-10#2)(2008-7#5)(2010-4#1)(2011-2#3)
CNVM##3##1##(2010-10#3)
CO 2 laser##21##3##(1991-2#3)(1991-3#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#9)(1993-1#1)
CO 2 lasers##3##3##(1991-3#2)(1992-12#1)
CO 2##26##2##(1991-2#3)(1991-3#4)(1992-1#4)(1992-12#3)(1992-2#1)(1992-3#10)(1993-1#1)
CO and##4##2##(1991-5#1)(2008-10#3)
CO concentration##3##2##(1990-5#1)(2008-3#2)
CO concentrations##4##2##(1990-5#3)(2008-3#1)
CO exposure##3##2##(1990-5#3)
CO isolate##3##2##(2008-10#3)
CO laser##2##2##(2008-2#2)
CO stretching vibration##2##3##(2008-10#2)
CO##77##1##(1990-5#9)(1990-8#1)(1991-2#3)(1991-3#4)(1991-5#3)(1992-1#4)(1992-12#3)(1992-2#1)(1992-3#10)(1992-6#1)(1993-1#1)(1995-12#1)(1995-2#6)(1996-12#1)(2008-10#16)(2008-2#2)(2008-3#8)(2008-8#1)(2009-5#1)(2013-1#1)
CO(2) Laser##2##2##(2008-3#1)(2012-3#1)
CO(2) addition##3##2##(2008-11#3)
CO(2) and##7##2##(2008-10#5)(2008-3#1)(2009-8#1)
CO(2) as##3##2##(2008-10#2)(2008-7#1)
CO(2) assimilation##4##2##(2008-10#3)(2008-9#1)
CO(2) band##2##2##(1991-5#1)(2008-10#1)
CO(2) by##2##2##(2008-10#1)(2008-3#1)
CO(2) concentration##7##2##(2008-10#6)(2008-11#1)
CO(2) concentrations in a##2##4##(2008-10#2)
CO(2) concentrations in##3##3##(2008-10#3)
CO(2) concentrations##10##2##(2008-10#9)(2008-11#1)
CO(2) condition##2##2##(2008-11#2)
CO(2) density##2##2##(2008-10#2)
CO(2) enrichment##2##2##(2008-10#2)
CO(2) exchange##3##2##(2008-10#2)(2008-8#1)
CO(2) in the##2##3##(2008-10#1)(2008-3#1)
CO(2) in##5##2##(2008-10#4)(2008-3#1)
CO(2) is##2##2##(2008-10#1)(2009-6#1)
CO(2) laser light##2##3##(2008-2#2)
CO(2) laser##15##2##(2008-10#2)(2008-2#3)(2008-3#8)(2012-3#2)
CO(2) lasers##2##2##(2008-3#2)
CO(2) on the##2##3##(2008-10#1)(2011-2#1)
CO(2) on##4##2##(2008-10#3)(2011-2#1)
CO(2) sensor##3##2##(2008-10#3)
CO(2) supercritical fluid##3##3##(2008-10#3)
CO(2) supply##10##2##(2008-11#10)
CO(2) were##2##2##(2008-3#2)
CO(2)##169##1##(1991-5#2)(2008-10#86)(2008-11#24)(2008-2#7)(2008-3#28)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-6#5)(2009-8#1)(2011-2#3)(2012-3#4)
CO(2))##2##1##(2008-10#1)(2008-11#1)
CO(2)-exchange##2##1##(2008-10#2)
CO(3)(2-)##6##1##(2008-10#6)
CO-diffusion capacity##3##2##(1992-6#3)
CO-sensing properties##2##2##(2008-10#2)
CO-sensing##3##1##(2008-10#3)
CO2 and##6##2##(1993-6#2)(1995-8#1)(1996-12#2)(2008-11#1)
CO2 in##4##2##(1996-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
CO2 laser in##3##3##(1991-6#1)(1994-12#1)(1996-1#1)
CO2 laser laparoscopy##3##3##(1995-2#3)
CO2 laser##19##2##(1991-6#2)(1994-12#4)(1995-2#3)(1996-1#5)(2008-2#2)(2008-3#3)
CO2 lidar##3##2##(2008-2#1)(2008-3#2)
CO2##50##1##(1991-6#2)(1993-6#8)(1994-12#4)(1995-2#3)(1995-8#1)(1996-1#5)(1996-12#4)(1996-2#1)(1997-1#2)(2008-11#2)(2008-2#4)(2008-3#7)(2008-5#1)(2010-8#1)(2013-1#2)(2013-8#3)
CO39##5##1##(2008-10#5)
COBRA##2##1##(1993-12#1)(1994-3#1)
COCH-modified capillary##3##2##(2008-10#3)
COD##13##1##(2008-10#11)(2008-12#1)(2013-1#1)
CODAM##2##1##(2008-11#2)
COHb levels##2##2##(1996-12#2)
COHb##8##1##(1996-12#8)
COI1##3##1##(2008-9#3)
COL1A(I) mRNA##3##2##(1992-6#3)
COL1A(I)##4##1##(1992-6#4)
COL1A2 gene##2##2##(1992-8#2)
COL1A2##3##1##(1992-8#3)
COLIPA##3##1##(2008-5#3)
COM acceleration feedback##2##3##(2013-1#2)
COM acceleration##4##2##(2013-1#4)
COM##6##1##(2012-3#2)(2013-1#4)
COMB##4##1##(1993-3#4)
COMFORT-B and FLACC scales##2##4##(2012-2#2)
COMFORT-B and##3##2##(2012-2#3)
COMFORT-B##8##1##(2012-2#8)
COMT and CCOMT##2##3##(2008-11#2)
COMT##5##1##(2008-11#3)(2011-2#1)(2012-12#1)
CONCLUSION##73##1##(1992-11#1)(1996-11#1)(2008-11#6)(2008-12#1)(2008-8#1)(2009-1#1)(2009-10#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#4)(2010-12#3)(2010-3#1)(2011-2#7)(2012-2#23)(2012-3#10)(2013-1#8)
CONCLUSIONS##105##1##(1993-2#1)(2007-12#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#4)(2011-2#15)(2011-7#1)(2012-2#7)(2012-3#31)(2013-1#30)
CONH group in##2##3##(1997-2#2)
CONH##3##1##(1997-2#3)
CONT##2##1##(2013-8#2)
COOH terminus##2##2##(1992-9#1)(1993-3#1)
COOH##5##1##(1992-9#1)(1993-3#1)(1997-2#2)(2008-10#1)
COOH-terminal domain of the RNA polymerase##2##6##(1995-6#2)
COOH-terminal domain of the##3##4##(1995-6#3)
COOH-terminal domain of##4##3##(1995-6#4)
COOH-terminal##11##1##(1990-8#1)(1992-9#1)(1995-2#1)(1995-6#7)(1997-9#1)
COOP charts##4##2##(2008-7#4)
COOP decision support##2##3##(2010-8#2)
COOP score##2##2##(2008-7#2)
COOP##12##1##(2008-7#7)(2010-8#5)
COP##4##1##(2009-7#1)(2010-9#3)
COPD and##3##2##(1995-12#1)(1997-1#1)(2010-5#1)
COPD in##2##2##(2009-1#1)(2012-12#1)
COPD patients##2##2##(2010-5#1)(2013-8#1)
COPD##28##1##(1995-12#2)(1997-1#1)(2008-1#2)(2009-1#1)(2010-1#2)(2010-10#4)(2010-5#4)(2011-2#5)(2012-12#2)(2013-8#5)
COPII##2##1##(2011-2#2)
COS 1 cells##6##3##(1995-12#2)(2008-11#4)
COS cells##10##2##(1991-3#1)(1992-3#1)(1992-9#1)(1993-6#2)(1997-9#1)(2008-11#3)(2008-8#1)
COS##18##1##(1991-3#1)(1992-3#1)(1992-9#1)(1993-6#2)(1995-12#2)(1997-9#1)(2008-11#9)(2008-8#1)
COS-1 cells and##3##3##(1992-6#1)(1993-3#1)(2008-11#1)
COS-1 cells##11##2##(1990-8#1)(1991-7#1)(1992-10#1)(1992-6#2)(1993-3#1)(1994-11#1)(1995-2#2)(1995-6#1)(2008-11#1)
COS-1##12##1##(1990-8#1)(1991-7#1)(1992-10#1)(1992-6#2)(1993-3#1)(1994-11#1)(1995-2#2)(1995-6#1)(2008-11#2)
COS-7 cells##7##2##(1990-5#1)(1993-12#1)(1994-11#2)(1995-11#1)(2008-9#2)
COS-7##9##1##(1990-5#1)(1993-12#1)(1994-11#2)(1995-11#2)(2008-11#1)(2008-9#2)
COSY##2##1##(1996-5#1)(2008-10#1)
COX-2 Inhibitors on##2##3##(2008-10#2)
COX-2 and survivin positivity were significantly correlated##2##7##(2011-2#2)
COX-2 and survivin positivity##3##4##(2011-2#3)
COX-2 and survivin##5##3##(2011-2#5)
COX-2 inhibitor##5##2##(2008-10#1)(2008-12#4)
COX-2 inhibitors##3##2##(2008-10#3)
COX-2 selective and non-selective NSAIDs##3##5##(2011-2#3)
COX-2 selective##4##2##(2011-2#4)
COX-2##28##1##(2008-10#7)(2008-12#4)(2010-12#1)(2011-2#11)(2013-1#1)(2013-8#4)
COX14##2##1##(1995-6#2)
COX5B##5##1##(2013-1#5)
COXI gene##3##2##(1993-2#1)(1995-6#2)
COXI of##2##2##(1993-2#2)
COXI##6##1##(1993-2#4)(1995-6#2)
CP ORF##2##2##(2008-10#2)
CP amino acid sequence##2##4##(2008-10#2)
CP amino acid##4##3##(2008-10#4)
CP and MP##2##3##(2008-10#2)
CP and the##3##3##(2008-10#3)
CP and##9##2##(1995-6#1)(2008-10#7)(2008-9#1)
CP by##3##2##(2008-10#2)(2011-2#1)
CP compared with##3##3##(2011-2#3)
CP gene of##4##3##(2008-10#3)(2012-3#1)
CP gene was##3##3##(2008-10#2)(2008-8#1)
CP gene##20##2##(2008-10#18)(2008-8#1)(2012-3#1)
CP genes and##2##3##(2008-10#2)
CP genes of##2##3##(2008-10#2)
CP genes##5##2##(2008-10#5)
CP in##2##2##(2008-10#1)(2011-2#1)
CP is most##2##3##(2008-10#1)(2008-12#1)
CP is##3##2##(2008-10#2)(2008-12#1)
CP of##2##2##(2008-10#2)
CP sequence##3##2##(2008-10#3)
CP was detected##2##3##(2008-10#2)
CP was##7##2##(2008-10#4)(2008-7#1)(2011-2#1)(2012-2#1)
CP were##4##2##(2008-10#3)(2011-2#1)
CP##132##1##(1990-12#1)(1992-8#1)(1995-6#1)(2008-10#102)(2008-12#3)(2008-7#2)(2008-8#4)(2008-9#2)(2011-2#9)(2012-2#6)(2012-3#1)
CP-31398##2##1##(2009-4#1)(2011-2#1)
CP-870##10##1##(2008-10#10)
CP-Chirasil-Dex CB##3##2##(2008-10#3)
CP-mediated##2##1##(2008-10#1)(2008-8#1)
CP7 mutant was##2##3##(2008-10#2)
CP7 mutant##3##2##(2008-10#3)
CPA CM##2##2##(2012-3#2)
CPA##6##1##(2011-2#1)(2012-3#5)
CPA-1##5##1##(2008-10#5)
CPAP##3##1##(2009-7#2)(2011-1#1)
CPB##6##1##(2008-10#2)(2008-11#3)(2012-3#1)
CPBSQ and FCPBSQ##2##3##(2008-10#2)
CPC##12##1##(2008-10#11)(2013-8#1)
CPD##2##1##(2011-2#1)(2013-1#1)
CPE##14##1##(2008-10#8)(2008-11#6)
CPE-mediated diseases##2##2##(2011-2#2)
CPG##2##1##(1995-3#1)(2008-10#1)
CPH##4##1##(1995-8#4)
CPI##3##1##(2008-10#3)
CPIB##4##1##(1990-2#4)
CPL##3##1##(2008-10#3)
CPM##7##1##(2008-11#2)(2008-7#5)
CPMAS##2##1##(2008-10#2)
CPP (10##2##2##(1992-8#1)(2012-2#1)
CPP after##2##2##(1993-6#2)
CPP was##2##2##(1993-6#2)
CPP##11##1##(1992-8#2)(1993-6#7)(1994-2#1)(2012-2#1)
CPPs##3##1##(2010-10#1)(2011-3#2)
CPR5##5##1##(2009-8#5)
CPRO-1##2##1##(2008-10#2)
CPS 1##2##2##(2008-10#2)
CPS##6##1##(1990-7#2)(2008-10#2)(2008-4#2)
CPSA##2##1##(2008-10#2)
CPT on##2##2##(1994-8#2)
CPT##9##1##(1992-11#1)(1994-2#1)(1994-8#6)(2007-12#1)
CPTQ##5##1##(2008-12#5)
CPU time##2##2##(2008-3#2)
CPV-2##2##1##(2012-3#2)
CPZ##2##1##(2008-10#2)
CQI in##3##2##(1994-1#1)(1994-2#1)(1994-3#1)
CQI process##2##2##(1993-3#1)(1994-3#1)
CQI team##3##2##(1994-2#1)(1994-3#1)(1996-1#1)
CQI teams##2##2##(1994-2#2)
CQI tools##2##2##(1994-3#1)(1996-1#1)
CQI##26##1##(1993-3#4)(1994-1#3)(1994-2#6)(1994-3#7)(1995-12#1)(1995-2#1)(1996-1#3)(2008-4#1)
CQI/TQM##2##1##(1993-12#1)(1994-3#1)
CR after##2##2##(2008-10#2)
CR and##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
CR or##2##2##(1997-7#1)(2008-10#1)
CR sequences##2##2##(2008-10#2)
CR##28##1##(1990-12#1)(1992-2#1)(1993-6#5)(1997-7#1)(2008-10#13)(2008-11#3)(2008-7#3)(2011-2#1)
CR-200)##2##1##(2008-5#2)
CR-induced life extension##2##3##(2008-7#2)
CR011-vcMMAE##5##1##(2009-4#5)
CR2##2##1##(2008-11#2)
CR3##2##1##(1997-3#1)(2008-11#1)
CRB assay##2##2##(2008-10#2)
CRB##3##1##(2008-10#3)
CRC and##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
CRC tissues##4##2##(2010-12#4)
CRC##18##1##(1994-5#1)(2008-10#3)(2009-12#2)(2010-12#7)(2010-6#1)(2011-2#1)(2012-3#3)
CRDI##2##1##(1995-3#2)
CRDS##7##1##(2008-2#4)(2010-7#3)
CRE and##2##2##(1993-6#1)(2013-1#1)
CRE##7##1##(1993-6#1)(1994-11#1)(1997-2#1)(2013-1#4)
CRE-binding proteins##2##2##(1996-2#2)
CREB activation in##2##3##(2008-11#2)
CREB activation##3##2##(2008-11#3)
CREB through##2##2##(2008-11#2)
CREB##15##1##(1996-12#4)(1997-8#1)(2008-11#10)
CREB-dependent##2##1##(2008-11#2)
CRF patients##2##2##(2008-1#2)
CRF##21##1##(1996-12#1)(1997-4#10)(2008-1#6)(2008-10#1)(2008-4#2)(2011-2#1)
CRF-R1##3##1##(2008-4#3)
CRF-R2##2##1##(2008-4#2)
CRF07_BC##5##1##(2013-8#5)
CRH##7##1##(1992-6#1)(1995-12#3)(1996-12#1)(2008-11#2)
CRH-LI##3##1##(1990-5#3)
CRIB##5##1##(2008-5#5)
CRLM##4##1##(2013-1#4)
CRLP and##2##2##(1995-6#2)
CRLV##3##1##(2008-10#3)
CRM No##5##2##(2008-10#5)
CRM##19##1##(1997-8#2)(2008-10#17)
CRM1##3##1##(1996-3#1)(2011-2#1)(2011-3#1)
CRMP2 functions##2##2##(2013-1#2)
CRMP2##8##1##(2013-1#8)
CRMs were##2##2##(2008-10#2)
CRMs##11##1##(1997-8#1)(2008-10#10)
CROM##4##1##(2008-12#4)
CRP levels##2##2##(1990-12#1)(2008-7#1)
CRP response##2##2##(1990-12#2)
CRP was##2##2##(2008-10#2)
CRP##14##1##(1990-12#4)(1997-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#2)(2013-1#1)
CRPS I##3##2##(2008-12#3)
CRS##5##1##(2008-10#2)(2011-2#2)(2013-8#1)
CRT##7##1##(2008-10#3)(2011-2#4)
CRVO##3##1##(2011-2#1)(2013-1#2)
CS (but not a neutral CS) passed a summation test with a##2##12##(2008-5#2)
CS and##3##2##(2008-11#2)(2012-3#1)
CS in##3##2##(2011-2#1)(2013-1#2)
CS when the CS was retrained as a##2##8##(2008-5#2)
CS##62##1##(1993-6#1)(1995-5#1)(1997-2#2)(2008-10#8)(2008-11#2)(2008-5#10)(2008-7#2)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#28)
CS(2) and##2##2##(2008-10#2)
CS(2)##7##1##(2008-10#7)
CS)##3##1##(2008-11#1)(2008-5#2)
CS-1 and CS-20##3##3##(2008-10#3)
CS-1 reduced disease##2##3##(2008-10#2)
CS-1##9##1##(2008-10#9)
CS-20 significantly##2##2##(2008-10#2)
CS-20##12##1##(2008-10#12)
CS-A##2##1##(1992-12#2)
CS-SM3-7ADS##4##1##(2008-10#4)
CS13*-1##2##1##(2008-11#2)
CS3 fimbriae##2##2##(2008-8#2)
CS3##7##1##(2008-8#7)
CS3/CTP3##2##1##(2008-8#2)
CSAvein##4##1##(2013-8#4)
CSBV##4##1##(2008-8#4)
CSC##5##1##(1993-12#1)(2008-10#1)(2011-2#1)(2013-8#2)
CSCs##7##1##(2009-9#1)(2011-2#6)
CSD##6##1##(2008-10#6)
CSF and##4##2##(1992-3#1)(1994-8#3)
CSF fistula##2##2##(2008-12#2)
CSF flow##2##2##(2008-7#2)
CSF leak##6##2##(2008-7#3)(2011-2#1)(2012-3#2)
CSF leakage##4##2##(2008-12#2)(2011-2#2)
CSF leaks##2##2##(2012-3#2)
CSF protein##2##2##(1991-2#1)(2013-7#1)
CSF was##3##2##(1990-5#1)(1993-1#1)(2011-2#1)
CSF##57##1##(1990-5#1)(1991-2#3)(1991-5#1)(1992-3#2)(1993-1#10)(1994-8#6)(1996-12#1)(2008-12#4)(2008-7#6)(2008-9#2)(2009-12#1)(2011-2#11)(2012-3#5)(2013-1#1)(2013-7#3)
CSF-1 expression##2##2##(1991-6#2)
CSF-1 gene##2##2##(1991-6#2)
CSF-1 promoter region##2##3##(1991-6#2)
CSF-1##11##1##(1991-6#8)(1997-7#3)
CSF-NSE##2##1##(1990-2#2)
CSF1PO##3##1##(2008-12#3)
CSFE##2##1##(2008-4#2)
CSFE-labeled##2##1##(2008-4#2)
CSIs##4##1##(2013-8#4)
CSM##4##1##(2008-8#4)
CSOM following##2##2##(2008-9#2)
CSOM##5##1##(2008-9#5)
CSQ##2##1##(1990-2#2)
CSS##4##1##(2008-10#3)(2010-6#1)
CSV##2##1##(2008-10#2)
CSW1##4##1##(2008-10#4)
CSW2##2##1##(2008-10#2)
CSW2-amended##3##1##(2008-10#3)
CSX##2##1##(2008-12#2)
CT alone##2##2##(2009-2#1)(2011-2#1)
CT and MR imaging##3##4##(1997-8#2)(2011-2#1)
CT and MR##7##3##(1997-8#4)(2008-1#1)(2011-2#1)(2012-2#1)
CT and MRI##4##3##(1992-6#1)(2008-1#1)(2008-2#1)(2012-2#1)
CT and##13##2##(1992-12#1)(1992-6#1)(1997-8#4)(2008-1#2)(2008-2#1)(2011-2#2)(2012-2#2)
CT and/or##2##2##(1995-11#1)(2008-2#1)
CT angiography diagnosis##2##3##(2011-2#2)
CT angiography##8##2##(1997-8#3)(2008-7#2)(2011-2#3)
CT appearances##2##2##(2012-2#2)
CT characterisation of pancreatic##2##4##(2012-2#2)
CT colonography##2##2##(2008-1#2)
CT coronary angiography##3##3##(2009-11#1)(2011-2#1)(2012-2#1)
CT data##2##2##(2009-3#1)(2012-3#1)
CT evaluation of##2##3##(1990-3#1)(2008-8#1)
CT examination##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
CT examinations of##3##3##(1996-6#1)(1997-8#2)
CT features##2##2##(2008-7#1)(2012-2#1)
CT findings and##2##3##(1990-3#1)(2012-2#1)
CT findings of a##2##4##(2012-12#2)
CT findings of##4##3##(2012-12#2)(2012-2#2)
CT findings##10##2##(1990-3#2)(1997-3#1)(1997-8#1)(2011-2#1)(2012-12#2)(2012-2#3)
CT for##3##2##(2012-2#2)(2013-1#1)
CT guided##2##2##(2008-1#1)(2008-7#1)
CT images##4##2##(1997-8#2)(2012-2#1)(2013-1#1)
CT imaging##6##2##(2012-2#5)(2012-3#1)
CT in the##2##3##(2008-1#1)(2012-2#1)
CT in##8##2##(1993-1#1)(2008-1#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
CT is useful##2##3##(2008-12#1)(2011-2#1)
CT modified KNN based materials##2##5##(2009-5#2)
CT of##2##2##(1997-8#1)(2012-2#1)
CT or##2##2##(1990-9#1)(2012-12#1)
CT release##2##2##(1992-6#2)
CT scan after##2##3##(1990-6#1)(2012-3#1)
CT scan and##2##3##(1990-12#1)(2013-8#1)
CT scan at##2##3##(2008-7#1)(2013-1#1)
CT scan confirmed##2##3##(2010-3#1)(2013-1#1)
CT scan of##2##3##(2010-3#1)(2011-2#1)
CT scan showed##4##3##(1990-6#1)(2013-1#3)
CT scan##33##2##(1990-12#2)(1990-6#2)(1991-6#1)(1991-8#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
CT scanning is##2##3##(1991-3#2)
CT scanning##5##2##(1991-3#4)(1992-9#1)
CT scans were##2##3##(2009-11#1)(2012-2#1)
CT scans##11##2##(1990-12#1)(2008-7#1)(2009-11#1)(2010-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
CT systems##2##2##(2010-9#1)(2012-2#1)
CT to##2##2##(1997-8#1)(2012-2#1)
CT treatment##3##2##(1994-2#3)
CT was##2##2##(1990-12#1)(1990-6#1)
CT with gastrografin enema##2##4##(2012-12#2)
CT with##3##2##(2009-11#1)(2012-12#2)
CT##227##1##(1990-12#4)(1990-3#4)(1990-6#3)(1990-9#1)(1991-3#4)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-6#3)(1992-9#1)(1993-1#2)(1994-12#1)(1994-2#4)(1995-11#3)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-8#21)(2008-1#7)(2008-10#3)(2008-12#7)(2008-2#4)(2008-7#12)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#3)(2009-2#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-2#25)(2012-12#12)(2012-2#36)(2012-3#10)(2013-1#25)(2013-8#2)
CT(4##2##1##(2008-5#2)
CT)##2##1##(2011-3#1)(2012-2#1)
CT-guided infiltration##2##2##(1996-9#2)
CT-guided##4##1##(1996-9#3)(2011-2#1)
CT-scan is##2##2##(1992-6#2)
CT-scan##4##1##(1992-6#2)(1997-3#1)(2013-1#1)
CT26##2##1##(2008-11#1)(2008-9#1)
CT60(∗)G##3##1##(2010-12#3)
CTA##12##1##(2008-10#6)(2008-12#3)(2009-12#1)(2011-2#1)(2013-8#1)
CTA1##2##1##(1993-9#2)
CTAB to the##2##3##(2008-11#1)(2008-8#1)
CTAB was##2##2##(2008-10#1)(2008-11#1)
CTAB##22##1##(2008-10#14)(2008-11#7)(2008-8#1)
CTAB-capped gold##2##2##(2008-10#2)
CTAD##5##1##(2008-10#5)
CTC has a sensitivity of##2##5##(2008-1#2)
CTC is##2##2##(2008-1#2)
CTC##7##1##(2008-1#6)(2008-10#1)
CTL epitope minigene##2##3##(2008-8#2)
CTL epitope##3##2##(2008-8#3)
CTL epitopes##4##2##(2008-8#3)(2011-2#1)
CTL in##2##2##(1994-5#1)(2008-11#1)
CTL##23##1##(1994-5#2)(1995-12#1)(1995-5#1)(2008-11#5)(2008-8#9)(2011-2#2)(2013-1#3)
CTLs against a##2##3##(2008-11#2)
CTLs against##4##2##(2008-11#4)
CTLs##17##1##(1994-5#1)(2008-11#10)(2011-2#2)(2013-1#4)
CTN##4##1##(1997-2#4)
CTP##2##1##(2008-11#2)
CTP3##2##1##(2008-8#2)
CTR1##2##1##(2012-2#2)
CTS##7##1##(2008-9#4)(2010-8#3)
CTSI##2##1##(2009-8#2)
CTSIM##3##1##(2009-8#3)
CTTH##4##1##(2010-9#4)
CTV isolates##6##2##(2008-10#6)
CTV sequences##2##2##(2008-10#2)
CTV spread##2##2##(2008-10#2)
CTV##30##1##(2008-10#30)
CTV-positive trees##3##2##(2008-10#3)
CTV1##2##1##(2008-10#2)
CTV2##2##1##(2008-10#2)
CTW samples##2##2##(2008-12#2)
CTW##3##1##(2008-12#3)
CTrach##5##1##(2010-7#5)
CU1##2##1##(2008-10#2)
CUF-1##3##1##(1995-2#3)
CUR##2##1##(2010-8#2)
CUSUM##2##1##(2008-10#2)
CV and##4##2##(2008-10#4)
CV in##2##2##(2008-12#1)(2008-8#1)
CV was##3##2##(2008-10#3)
CV##24##1##(2008-10#19)(2008-12#1)(2008-5#1)(2008-8#2)(2010-7#1)
CV-1 cells##2##2##(2008-11#2)
CV-1##4##1##(2008-11#4)
CV-AAS##3##1##(2008-10#3)
CVA16##4##1##(2013-8#4)
CVAAS##3##1##(2008-10#3)
CVB1 M16560##2##2##(2013-8#2)
CVB1##7##1##(2013-8#7)
CVD is##2##2##(2012-2#1)(2013-8#1)
CVD risk##6##2##(2010-12#4)(2011-1#1)(2012-12#1)
CVD##25##1##(2008-2#1)(2008-6#1)(2010-12#12)(2010-4#2)(2011-1#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
CVI children##2##2##(2011-2#2)
CVI##9##1##(2009-12#2)(2011-2#5)(2011-3#2)
CVJ tuberculosis##2##2##(2008-12#2)
CVSMC##2##1##(1993-3#2)
CVd-III were##2##2##(2008-10#2)
CVd-III##4##1##(2008-10#4)
CVd-IIa##2##1##(2008-10#2)
CVd-IIb##2##1##(2008-10#2)
CVd-IIc##4##1##(2008-10#4)
CW-SFS##2##1##(2008-10#2)
CW/TPR and PDMS/DVB fibers##2##4##(2008-10#2)
CW/TPR##4##1##(2008-10#4)
CW2 cells##3##2##(2008-11#3)
CWP treatment##2##2##(2008-10#2)
CWP##11##1##(2008-10#11)
CWT##3##1##(2008-10#3)
CWV##2##1##(2008-3#2)
CX(3)CR1##2##1##(2011-2#2)
CXB H mice##5##3##(1994-5#5)
CXB##7##1##(1994-5#5)(2008-10#2)
CXCR4##3##1##(2008-7#2)(2013-1#1)
CXR##3##1##(1997-8#3)
CY##2##1##(1995-12#2)
CYC##6##1##(1993-9#2)(2010-12#4)
CYC1 is##2##2##(1993-9#2)
CYC1##5##1##(1993-9#5)
CYDV##8##1##(2008-10#8)
CYDV-RPV##2##1##(2008-10#2)
CYL1##2##1##(1992-10#2)
CYP##3##1##(2008-12#1)(2011-2#2)
CYP1A##3##1##(1994-8#3)
CYP1A1 and CYP1B1 in##2##4##(1995-11#2)
CYP1A1 and CYP1B1##3##3##(1995-11#3)
CYP1A1 and CYP2B1##2##3##(1994-8#2)
CYP1A1 and##6##2##(1994-8#3)(1995-11#3)
CYP1A1##17##1##(1993-6#1)(1994-8#5)(1995-11#6)(2008-11#4)(2011-1#1)
CYP1A1*##3##1##(1994-8#3)
CYP1A2 and##2##2##(1994-8#2)
CYP1A2##6##1##(1994-8#6)
CYP1B1 in##3##2##(1995-11#3)
CYP1B1 protein##5##2##(1995-11#5)
CYP1B1##14##1##(1995-11#14)
CYP26A1##2##1##(2008-8#2)
CYP2B1 in##2##2##(1994-8#2)
CYP2B1##7##1##(1994-8#7)
CYP2C19 alleles##2##2##(2008-11#2)
CYP2C19##4##1##(2008-11#4)
CYP2C6##4##1##(1994-8#4)
CYP2D6 and CYP2C19##2##3##(2008-11#2)
CYP2D6 gene##2##2##(2008-10#2)
CYP2D6##7##1##(2008-10#3)(2008-11#3)(2008-7#1)
CYP2E1 protein##3##2##(2008-8#3)
CYP2E1##9##1##(2008-8#9)
CYP3A##9##1##(1994-5#2)(1994-8#1)(2011-3#6)
CYP3A4##4##1##(1994-5#2)(2008-10#2)
CYP51##3##1##(2008-10#2)(2009-9#1)
CYP52A1##2##1##(1991-9#2)
CYP52A2 is##2##2##(1991-9#2)
CYP52A2##4##1##(1991-9#4)
CYP63##2##1##(2009-9#2)
CYP71##2##1##(2008-9#2)
CYPA##2##1##(2011-2#2)
CYSDV CP gene##3##3##(2008-10#3)
CYSDV RNA##3##2##(2008-10#3)
CYSDV in##2##2##(2008-10#2)
CYSDV##20##1##(2008-10#20)
CYVD strains##7##2##(2008-10#7)
CYVD##8##1##(2008-10#8)
CZE stage##2##2##(2008-10#2)
CZE##11##1##(2008-10#11)
CZE-DAD##2##1##(2008-10#2)
Ca and Fe##2##3##(2008-10#2)
Ca and Mg##6##3##(1991-5#2)(2008-10#4)
Ca and##13##2##(1991-5#2)(2008-10#11)
Ca concentrations##2##2##(2008-5#1)(2009-6#1)
Ca depletion##3##2##(2009-6#3)
Ca in##3##2##(1993-3#1)(2008-10#1)(2008-3#1)
Ca##82##1##(1991-5#4)(1993-3#1)(1995-8#1)(2008-10#62)(2008-3#2)(2008-5#2)(2009-6#8)(2009-8#1)(2012-2#1)
Ca(2 +)##4##2##(2008-10#2)(2009-8#2)
Ca(2##5##1##(2008-10#3)(2009-8#2)
Ca(2)GeO(4) laser##2##2##(2008-3#2)
Ca(2)GeO(4)##3##1##(2008-3#3)
Ca(2+) and CaM##2##3##(2008-8#2)
Ca(2+) and Mg(2+) ions##2##4##(2008-10#2)
Ca(2+) and Mg(2+)##8##3##(2008-10#7)(2008-11#1)
Ca(2+) and##16##2##(2006-6#1)(2008-10#10)(2008-11#1)(2008-8#2)(2009-10#1)(2013-1#1)
Ca(2+) chelator##2##2##(2008-8#2)
Ca(2+) concentration ([Ca(2+)](i))##2##3##(2008-9#1)(2012-2#1)
Ca(2+) concentration##10##2##(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#1)
Ca(2+) ions##2##2##(2008-10#2)
Ca(2+) is##2##2##(1996-5#1)(2008-10#1)
Ca(2+) kinetics##2##2##(2008-11#2)
Ca(2+) levels##2##2##(2006-6#2)
Ca(2+) mobilization##2##2##(2009-6#2)
Ca(2+) or Mg(2+)##2##3##(2008-10#2)
Ca(2+) release##2##2##(2008-8#1)(2013-8#1)
Ca(2+) signaling##7##2##(2008-11#6)(2009-8#1)
Ca(2+) were##2##2##(2008-10#1)(2008-11#1)
Ca(2+)##116##1##(1996-5#3)(2006-6#5)(2008-10#44)(2008-11#22)(2008-5#1)(2008-7#3)(2008-8#19)(2008-9#4)(2009-10#2)(2009-6#3)(2009-8#3)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Ca(2+)&gt##4##1##(2008-10#4)
Ca(2+)- and##3##2##(1991-9#1)(1992-12#1)(1993-8#1)
Ca(2+)-##4##1##(1991-9#1)(1992-12#1)(1993-3#1)(1993-8#1)
Ca(2+)-ATPase##5##1##(1993-8#1)(1995-11#1)(1995-2#2)(2008-8#1)
Ca(2+)-activated K+ channels##4##3##(1994-11#2)(1996-2#2)
Ca(2+)-activated K+##6##2##(1994-11#2)(1994-3#1)(1996-2#2)(1996-5#1)
Ca(2+)-activated##8##1##(1994-11#2)(1994-3#2)(1995-11#1)(1996-2#2)(1996-5#1)
Ca(2+)-binding##3##1##(1994-11#1)(1994-5#1)(1995-6#1)
Ca(2+)-dependent and Ca(2+)-independent isoforms of PKC in the nuclei of Caco-2 cells##2##12##(1994-6#2)
Ca(2+)-dependent and##4##2##(1994-6#2)(1995-11#1)(2008-8#1)
Ca(2+)-dependent exocytosis##2##2##(1992-6#1)(2008-5#1)
Ca(2+)-dependent##18##1##(1992-6#3)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#3)(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#2)
Ca(2+)-free medium##2##2##(1995-11#1)(1996-2#1)
Ca(2+)-free##5##1##(1994-6#1)(1995-11#2)(1996-2#1)(2008-8#1)
Ca(2+)-independent lipid-stimulated kinase##2##3##(1992-9#2)
Ca(2+)-independent##5##1##(1992-9#2)(1994-11#1)(1994-6#2)
Ca(2+)-induced##3##1##(1994-5#1)(1995-8#1)(1996-5#1)
Ca(2+)-permeable##2##1##(1996-2#1)(2011-2#1)
Ca(2+)-triggered##3##1##(1992-6#1)(2012-2#2)
Ca(2+)/Mg(2+) feeding##2##2##(2008-11#2)
Ca(II) and Ba(II)##6##3##(2008-10#6)
Ca(II) and##7##2##(2008-10#7)
Ca(II)##24##1##(2008-10#24)
Ca++##2##1##(1993-3#2)
Ca-903##2##1##(2008-10#2)
Ca-depleted##2##1##(2009-6#2)
Ca-folinate##2##1##(2008-10#2)
Ca175##2##1##(2008-10#2)
Ca2(+)-induced Ca2+ release##3##3##(1990-2#3)
Ca2(+)-sensitive##2##1##(1990-8#2)
Ca2+ accumulation induced by Tg##2##5##(1991-6#2)
Ca2+ activated K+ channels##2##4##(1990-8#2)
Ca2+ and K+##3##3##(1996-2#1)(2008-10#2)
Ca2+ and Mg2+##3##3##(1990-5#1)(1995-11#2)
Ca2+ and##13##2##(1990-5#1)(1992-6#1)(1993-8#1)(1994-11#3)(1995-11#2)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#2)
Ca2+ binding##3##2##(1993-8#1)(1994-5#1)(2008-11#1)
Ca2+ channel blockers##3##3##(1995-11#2)(1996-2#1)
Ca2+ channel##6##2##(1995-11#3)(1995-6#1)(1996-12#1)(1996-2#1)
Ca2+ channels in##2##3##(1992-9#1)(2009-7#1)
Ca2+ channels##6##2##(1992-9#1)(1994-11#1)(1994-5#1)(1996-2#1)(2009-7#1)(2010-11#1)
Ca2+ chelator##3##2##(1994-3#1)(1996-2#1)(1997-1#1)
Ca2+ concentration ([Ca2+]i)##2##3##(1994-6#1)(1995-11#1)
Ca2+ concentration##13##2##(1990-2#1)(1991-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-8#2)(1996-2#3)
Ca2+ concentrations##4##2##(1995-11#1)(1995-8#1)(1996-2#1)(1997-1#1)
Ca2+ current##2##2##(1992-8#2)
Ca2+ currents##4##2##(1992-8#2)(1996-2#2)
Ca2+ distribution##2##2##(1996-2#2)
Ca2+ entry##2##2##(1995-11#2)
Ca2+ from##2##2##(1990-2#1)(1995-11#1)
Ca2+ had##2##2##(1990-5#1)(1990-8#1)
Ca2+ homeostasis##2##2##(1991-6#1)(1994-11#1)
Ca2+ in the presence of 2##2##6##(1990-8#1)(1993-8#1)
Ca2+ in the##4##3##(1990-8#1)(1993-8#1)(1995-6#1)(1997-1#1)
Ca2+ in##10##2##(1990-8#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-11#3)(1995-6#1)(1996-2#1)(1997-1#1)
Ca2+ indicator##2##2##(1990-2#1)(1990-8#1)
Ca2+ influx in##2##3##(1991-1#1)(1996-2#1)
Ca2+ influx is##2##3##(1994-2#1)(1996-2#1)
Ca2+ influx##8##2##(1991-1#2)(1992-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-2#2)
Ca2+ ionophore##3##2##(1994-3#1)(1995-11#1)(1997-1#1)
Ca2+ is##2##2##(1991-5#1)(1994-2#1)
Ca2+ level##2##2##(1990-2#1)(1994-6#1)
Ca2+ mobilization and phosphoinositide hydrolysis##2##5##(1996-2#2)
Ca2+ mobilization in##3##3##(1990-8#1)(1991-5#1)(2008-9#1)
Ca2+ mobilization##7##2##(1990-8#1)(1991-5#1)(1995-11#1)(1996-2#3)(2008-9#1)
Ca2+ oscillations##5##2##(1994-6#4)(1995-11#1)
Ca2+ pools##2##2##(1991-6#2)
Ca2+ pump inhibitor##2##3##(1996-2#2)
Ca2+ pump##3##2##(1995-11#1)(1996-2#2)
Ca2+ release by##2##3##(1995-6#2)
Ca2+ release from sarcoplasmic reticulum##2##5##(1995-6#2)
Ca2+ release from##6##3##(1990-2#1)(1994-8#1)(1995-6#4)
Ca2+ release##19##2##(1990-2#4)(1993-8#1)(1994-11#1)(1994-8#3)(1995-6#10)
Ca2+ response to##2##3##(1990-2#1)(1993-8#1)
Ca2+ response##3##2##(1990-2#2)(1993-8#1)
Ca2+ stores##2##2##(1996-5#2)
Ca2+ was required for##2##4##(1990-5#1)(1994-8#1)
Ca2+ was##3##2##(1990-5#1)(1993-8#1)(1994-8#1)
Ca2+ with##2##2##(1993-8#1)(1994-11#1)
Ca2+##233##1##(1990-10#2)(1990-2#16)(1990-5#10)(1990-8#11)(1991-1#2)(1991-5#5)(1991-6#9)(1992-4#1)(1992-6#2)(1992-8#5)(1992-9#1)(1993-8#13)(1994-11#12)(1994-12#1)(1994-2#7)(1994-3#3)(1994-5#7)(1994-6#10)(1994-8#6)(1995-11#27)(1995-12#1)(1995-2#1)(1995-6#19)(1995-8#7)(1996-12#2)(1996-2#36)(1996-5#2)(1997-1#4)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-11#1)(2013-1#1)(2013-7#1)
Ca2+)##2##1##(1990-5#1)(1993-6#1)
Ca2+-dependent##2##1##(1996-2#1)(2012-2#1)
Ca2+/CaM/CaN signal pathway##4##3##(2011-3#4)
Ca2+/calmodulin##6##1##(1995-11#3)(1996-2#1)(1997-2#1)(2013-7#1)
Ca2+/calmodulin-dependent protein kinase II##7##4##(1990-5#1)(1993-6#2)(1995-2#2)(1995-8#2)
Ca2+/calmodulin-dependent##10##1##(1990-5#2)(1993-12#2)(1993-6#2)(1995-2#2)(1995-8#2)
CaCO(3)##5##1##(2008-10#3)(2013-1#2)
CaCO3##2##1##(1995-3#2)
CaCO3)##2##1##(1995-3#2)
CaCV##2##1##(2008-10#2)
CaCl(2)##10##1##(2008-10#8)(2008-11#1)(2013-1#1)
CaCl2 and##2##2##(1994-3#1)(2008-12#1)
CaD*##5##1##(1994-5#5)
CaD*-actin-S1##2##1##(1994-5#2)
CaF(2) and##2##2##(2008-10#2)
CaF(2)##4##1##(2008-10#3)(2008-3#1)
CaF2##2##1##(1993-5#1)(2008-3#1)
CaLCV##2##1##(2008-10#2)
CaM in##4##2##(1994-3#1)(2008-8#3)
CaM kinase II exhibited##2##4##(1993-6#2)
CaM kinase II##13##3##(1990-5#4)(1993-6#9)
CaM was found##2##3##(2008-8#2)
CaM##34##1##(1990-5#4)(1993-6#9)(1994-3#2)(1996-12#1)(2008-8#16)(2011-3#2)
CaM-BP68 in the##2##3##(1994-5#2)
CaM-BP68##4##1##(1994-5#4)
CaM-kinase II##4##2##(1995-2#4)
CaMK II alpha##2##3##(1996-12#2)
CaMK II##8##2##(1995-8#6)(1996-12#2)
CaMKII##6##1##(1997-2#1)(2008-8#1)(2009-7#2)(2012-2#2)
CaMV 35S promoter##5##3##(1997-8#1)(2008-8#1)(2008-9#2)(2011-10#1)
CaMV isolates##2##2##(2008-10#2)
CaMV##13##1##(1997-8#1)(2008-10#8)(2008-8#1)(2008-9#2)(2011-10#1)
CaMV35S and rolC##2##3##(2008-9#2)
CaMV35S##5##1##(2008-9#5)
CaN was##2##2##(2011-3#2)
CaN##4##1##(2011-3#4)
CaO in##2##2##(2013-1#2)
CaO##8##1##(2008-10#2)(2013-1#6)
CaO)##2##1##(2008-10#1)(2013-1#1)
CaPKC1 gene##2##2##(1996-6#2)
CaSR mRNA expression in the##2##5##(2008-11#2)
CaSR mRNA was##2##3##(2008-11#2)
CaSR mRNA##9##2##(2008-11#9)
CaSR##11##1##(2008-11#11)
Cabar##7##1##(2011-2#7)
Cabbage##5##1##(2008-10#4)(2013-1#1)
Cabernet Sauvignon##2##2##(2008-10#2)
Cabernet##3##1##(2008-10#3)
Caco-2 cell monolayer model##2##4##(2011-3#2)
Caco-2 cell monolayer##5##3##(2008-11#2)(2011-3#3)
Caco-2 cell monolayers##3##3##(2008-11#3)
Caco-2 cell##8##2##(2008-11#5)(2011-3#3)
Caco-2 cells and##3##3##(1994-6#2)(2011-2#1)
Caco-2 cells during##2##3##(2008-11#2)
Caco-2 cells##18##2##(1994-6#4)(2008-11#13)(2011-2#1)
Caco-2##33##1##(1994-6#4)(2008-11#25)(2011-2#1)(2011-3#3)
Cadmium and##2##2##(2008-10#2)
Cadmium##11##1##(1993-12#1)(2008-10#8)(2008-7#2)
Caenorhabditis elegans##18##2##(1990-5#2)(1993-12#2)(1994-11#2)(1995-3#1)(1995-6#2)(1995-9#1)(1996-6#2)(1997-7#1)(2008-10#2)(2008-9#1)(2012-3#2)
Caesarean sections##2##2##(1996-11#1)(2008-11#1)
Caesarean##4##1##(1996-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
Caffeine##8##1##(1995-11#3)(1995-8#1)(2008-10#3)(2009-1#1)
Caféine##4##1##(2013-1#4)
CagA##2##1##(2011-2#2)
Cagliari##2##1##(1991-2#1)(1992-5#1)
Cairo University##2##2##(2008-10#1)(2008-11#1)
Cairo##11##1##(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#4)(2010-10#2)
Caki-2 and##2##2##(2011-2#2)
Cal##3##1##(2008-3#3)
Cal/Logan##2##1##(2008-10#2)
CalB variants##2##2##(2011-2#2)
Calabar##6##1##(2008-10#2)(2008-5#2)(2013-1#2)
Calcification##2##1##(1990-11#1)(2008-12#1)
Calcifying##3##1##(2007-12#2)(2012-3#1)
Calcitonin gene-related peptide in the brain##2##6##(1992-6#2)
Calcitonin gene-related peptide in the regulation of##2##7##(1992-6#2)
Calcitonin gene-related peptide in the##4##5##(1992-6#4)
Calcitonin gene-related peptide in##5##4##(1992-6#5)
Calcitonin gene-related peptide is##3##4##(1992-6#3)
Calcitonin gene-related peptide##14##3##(1992-6#13)(1997-3#1)
Calcitonin gene-related##15##2##(1992-6#14)(1997-3#1)
Calcium and##2##2##(2008-10#2)
Calcium antagonists are##2##3##(2008-3#2)
Calcium channel##3##2##(1993-6#1)(2008-10#1)(2008-7#1)
Calcium oxalate##2##2##(1995-8#1)(2008-10#1)
Calcium##26##1##(1991-5#1)(1993-6#1)(1994-2#1)(1995-8#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
Calculated##5##1##(2008-3#4)(2011-2#1)
Calculation of the##5##3##(1996-5#1)(2007-12#1)(2008-3#2)(2008-7#1)
Calculation of##6##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)
Calculation##7##1##(1996-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)
Calculations were##2##2##(2008-10#2)
Calculations##10##1##(1995-6#1)(1996-5#1)(2008-10#3)(2008-3#2)(2008-7#1)(2013-1#2)
Calendar##2##1##(2008-8#1)(2010-1#1)
Calf##2##1##(2008-10#1)(2008-11#1)
Cali##5##1##(2008-10#1)(2012-12#4)
Calibration and##3##2##(2008-10#2)(2008-2#1)
Calibration curves for##4##3##(2008-10#4)
Calibration curves were established for##2##5##(2008-10#2)
Calibration curves were linear##2##4##(2008-10#2)
Calibration curves were##6##3##(2008-10#6)
Calibration curves##14##2##(2008-10#14)
Calibration graph##4##2##(2008-10#4)
Calibration graphs are##2##3##(2008-10#2)
Calibration graphs for##2##3##(2008-10#2)
Calibration graphs were linear##3##4##(2008-10#3)
Calibration graphs were rectilinear over the##2##6##(2008-10#2)
Calibration graphs were##6##3##(2008-10#6)
Calibration graphs##12##2##(2008-10#12)
Calibration is carried out using aqueous standards##2##7##(2008-10#2)
Calibration is carried out##3##4##(2008-10#3)
Calibration matrices were##2##3##(2008-10#2)
Calibration models##2##2##(2008-10#2)
Calibration of the sensor was done##2##6##(2008-10#2)
Calibration of the##5##3##(2008-10#5)
Calibration plots of the titrant end-point consumption##2##7##(2008-10#2)
Calibration plots of##3##3##(2008-10#3)
Calibration plots##6##2##(2008-10#6)
Calibration##61##1##(2008-10#59)(2008-2#1)(2010-3#1)
Calicuchima-sib##2##1##(2008-10#2)
Calif/09##3##1##(2011-2#3)
California Fair Employment and Housing##2##5##(1990-2#1)(1995-12#1)
California and Arizona##2##3##(2008-10#1)(2011-2#1)
California and Michigan##3##3##(1992-2#2)(1992-3#1)
California and Oregon##2##3##(2008-10#2)
California and the##3##3##(2008-10#2)(2008-8#1)
California and##16##2##(1992-2#2)(1992-3#1)(1994-3#1)(2008-10#9)(2008-8#2)(2011-2#1)
California counties##2##2##(1992-2#1)(2008-10#1)
California from##2##2##(1991-12#1)(2008-10#1)
California have##2##2##(2008-10#1)(2008-9#1)
California isolates##3##2##(2008-10#3)
California pistachio##3##2##(2008-10#3)
California populations of##2##3##(2008-10#2)
California populations##3##2##(2008-10#2)(2008-9#1)
California were##3##2##(2008-10#3)
California##171##1##(1990-2#1)(1991-12#2)(1991-7#1)(1992-12#2)(1992-2#7)(1992-3#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#8)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#110)(2008-11#4)(2008-8#8)(2008-9#4)(2009-9#1)(2010-8#3)(2011-2#4)(2013-1#1)
California's##2##1##(1990-2#1)(1993-3#1)
Calimyrna figs##3##2##(2008-10#3)
Calimyrna orchards##2##2##(2008-10#2)
Calimyrna##7##1##(2008-10#7)
Call for##2##2##(1996-8#1)(2012-12#1)
Call##4##1##(1994-12#1)(1995-6#1)(1996-8#1)(2012-12#1)
Calla lily chlorotic spot virus (CCSV)##2##6##(2008-10#2)
Calla lily chlorotic spot virus##3##5##(2008-10#3)
Calmette-Guérin##2##1##(1997-2#1)(2009-7#1)
Calmodulin##2##1##(1993-6#2)
Calopteryx##5##1##(2008-8#5)
Caloric restriction##2##2##(2008-3#1)(2008-7#1)
Calpain##4##1##(1992-12#3)(1992-6#1)
Calwonder##2##1##(2008-10#2)
Calyculin A##2##2##(1993-8#2)
Cambisol)##2##1##(2008-11#2)
Cambodia##5##1##(1996-8#1)(2008-10#2)(2010-11#1)(2013-8#1)
Cambridge University Press##4##3##(1990-11#2)(1990-8#1)(2008-12#1)
Cambridge##11##1##(1990-11#2)(1990-8#1)(1992-4#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-9#1)(2013-1#1)
Cambrinus##2##1##(2008-10#2)
Camelot (carries##2##2##(2008-10#2)
Camelot##3##1##(2008-10#3)
Camera calibration##2##2##(2008-6#2)
Camera##5##1##(2008-2#1)(2008-3#1)(2008-6#2)(2011-1#1)
Cameroon##6##1##(2008-10#2)(2013-1#4)
Campaign 2000##2##2##(2008-11#2)
Campaign##5##1##(1995-12#1)(2008-11#2)(2009-10#1)(2012-2#1)
Campbell##2##1##(2008-10#1)(2010-4#1)
Campylobacter is##2##2##(2011-1#2)
Campylobacter jejuni and##2##3##(1990-3#1)(2008-10#1)
Campylobacter jejuni##6##2##(1990-3#2)(1993-9#1)(2008-10#1)(2010-12#1)(2011-1#1)
Campylobacter species##3##2##(1996-3#1)(2007-12#1)(2011-2#1)
Campylobacter was found in##2##4##(2008-10#2)
Campylobacter##26##1##(1990-3#3)(1993-9#2)(1996-3#1)(2007-12#1)(2008-10#10)(2010-12#1)(2011-1#6)(2011-2#2)
Can hospitals##2##2##(1992-5#1)(1996-1#1)
Can the##6##2##(1991-9#1)(1992-11#1)(1992-3#1)(2008-8#1)(2013-1#2)
Can urodynamic studies##2##3##(2008-10#2)
Can we##5##2##(1991-2#1)(1993-12#1)(2009-11#1)(2012-2#1)(2013-7#1)
Can you##2##2##(2008-11#1)(2012-2#1)
Can##46##1##(1991-2#2)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#2)(1995-12#1)(1995-9#1)(1996-1#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#2)(2009-12#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Canada and the United States##5##5##(1991-3#1)(1993-3#3)(2008-11#1)
Canada and the##7##3##(1991-3#1)(1993-3#3)(1996-12#1)(2008-11#1)(2009-6#1)
Canada and##17##2##(1991-3#1)(1993-3#3)(1994-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-6#1)
Canada is##5##2##(1993-12#1)(1995-1#1)(2007-12#1)(2008-11#2)
Canada needs##2##2##(2008-11#2)
Canada to determine##3##3##(2008-12#1)(2010-8#1)(2013-8#1)
Canada were##4##2##(2007-12#1)(2008-10#2)(2012-12#1)
Canada##184##1##(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#3)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#4)(1993-2#2)(1993-3#4)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#3)(1996-1#1)(1996-12#1)(1996-3#5)(1996-6#1)(1996-9#4)(1997-3#3)(2007-12#9)(2008-10#46)(2008-11#34)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#4)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#5)
Canada's##8##1##(2007-12#1)(2008-11#6)(2011-2#1)
Canada)##2##1##(2008-10#1)(2010-8#1)
Canadian AMV isolates##2##3##(2008-10#2)
Canadian Health##3##2##(1994-12#1)(2009-3#1)(2013-1#1)
Canadian Neonatal Network##2##3##(2008-11#2)
Canadian Paediatric##2##2##(2008-11#2)
Canadian Physiotherapy Association##2##3##(1993-3#2)
Canadian Public Health Laboratory Network##2##5##(2008-10#2)
Canadian and##6##2##(1994-1#1)(1996-9#1)(2008-10#1)(2008-11#2)(2013-1#1)
Canadian experience##2##2##(1995-2#1)(2012-12#1)
Canadian families are##2##3##(2008-11#2)
Canadian families##3##2##(2008-11#3)
Canadian health care##3##3##(1991-1#1)(1996-3#1)(1997-2#1)
Canadian hospitals##7##2##(1991-1#1)(1991-12#2)(1994-12#3)(1995-12#1)
Canadian medical##2##2##(1993-12#1)(1997-2#1)
Canadian obstetrical population##2##3##(2007-12#2)
Canadian paediatric##3##2##(2008-11#3)
Canadian physiotherapists' professional identity##2##4##(1993-3#2)
Canadian provinces##6##2##(1993-3#2)(2008-10#4)
Canadian##135##1##(1991-1#2)(1991-12#2)(1992-12#1)(1993-12#3)(1993-3#6)(1993-6#1)(1993-9#2)(1994-1#5)(1994-12#7)(1994-6#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-2#3)(1997-3#3)(2007-12#4)(2008-10#32)(2008-11#29)(2008-12#2)(2008-7#4)(2009-3#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
Canadians##3##1##(2007-12#1)(2008-10#1)(2008-11#1)
Canal##2##1##(2007-12#1)(2008-10#1)
Cancer 2011##2##2##(2012-3#2)
Cancer Cells##3##2##(1994-12#1)(2011-2#1)(2012-3#1)
Cancer Center between##3##3##(2008-10#2)(2013-1#1)
Cancer Center##6##2##(1991-12#1)(2008-10#2)(2011-2#2)(2013-1#1)
Cancer Information Service##2##3##(1991-3#1)(2013-1#1)
Cancer Institute of##2##3##(1990-8#1)(1993-6#1)
Cancer Institute##15##2##(1990-8#1)(1991-3#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2012-3#1)(2013-1#2)
Cancer Patients##3##2##(1994-12#2)(2010-2#1)
Cancer Prevention##2##2##(1995-9#2)
Cancer Registration##2##2##(1994-8#1)(2013-8#1)
Cancer Registry##6##2##(1990-12#1)(1991-2#1)(1992-12#1)(1995-2#2)(2012-3#1)
Cancer Society##3##2##(1994-12#1)(2012-3#2)
Cancer Therapy##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
Cancer Treatment##2##2##(2008-7#1)(2011-2#1)
Cancer and cancer treatments can##2##5##(2013-1#2)
Cancer and##7##2##(2008-10#1)(2010-10#1)(2010-7#1)(2013-1#3)(2013-7#1)
Cancer cells##6##2##(1990-11#1)(2008-11#2)(2008-12#1)(2009-3#1)(2009-9#1)
Cancer in##7##2##(1991-3#1)(1994-12#1)(1997-7#1)(2008-7#1)(2009-4#1)(2013-1#1)(2013-8#1)
Cancer is##3##2##(1994-5#1)(2009-6#1)(2013-1#1)
Cancer mortality in Italy##3##4##(1991-2#1)(1994-12#1)(1994-2#1)
Cancer mortality in##5##3##(1991-12#1)(1991-2#1)(1994-12#1)(1994-2#2)
Cancer mortality##7##2##(1991-12#2)(1991-2#1)(1994-12#1)(1994-2#2)(2010-10#1)
Cancer of the##2##3##(1992-9#1)(2008-10#1)
Cancer research in the##2##4##(1993-2#1)(2009-4#1)
Cancer research##5##2##(1991-12#1)(1993-2#1)(2009-4#3)
Cancer##184##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-8#1)(1992-12#2)(1992-5#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#12)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#2)(1995-9#2)(1996-2#1)(1997-1#5)(1997-3#1)(1997-7#10)(1997-8#3)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#6)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#4)(2010-8#1)(2011-2#13)(2012-2#7)(2012-3#13)(2013-1#14)(2013-7#1)(2013-8#6)
Cancer)##2##1##(1990-12#1)(1992-2#1)
Cancers##4##1##(1994-12#1)(2009-4#1)(2010-11#1)(2012-2#1)
Candida albicans and Candida##2##4##(2008-11#1)(2008-5#1)
Candida albicans and##4##3##(2008-11#1)(2008-5#3)
Candida albicans was##2##3##(2008-5#1)(2012-2#1)
Candida albicans##43##2##(1992-8#1)(1996-12#1)(1996-3#1)(1996-6#2)(2006-6#1)(2008-11#3)(2008-5#23)(2009-8#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)
Candida and##2##2##(2013-1#2)
Candida antarctica lipase B (CalB)##2##5##(2011-2#2)
Candida dubliniensis##2##2##(2008-5#2)
Candida glabrata##5##2##(2008-10#1)(2008-11#2)(2008-5#2)
Candida infections##2##2##(1997-1#1)(2011-2#1)
Candida isolates##2##2##(2008-5#1)(2011-2#1)
Candida krusei##3##2##(2008-5#3)
Candida maltosa was##2##3##(1993-12#1)(1996-3#1)
Candida maltosa##6##2##(1991-9#2)(1993-12#2)(1996-3#2)
Candida oleophila##6##2##(2008-10#6)
Candida parapsilosis##8##2##(1997-2#3)(2008-5#4)(2013-1#1)
Candida saitoana and##2##3##(2008-10#2)
Candida saitoana##4##2##(2008-10#4)
Candida sake CPA-1##3##3##(2008-10#3)
Candida sake##6##2##(2008-10#6)
Candida species##7##2##(2008-5#2)(2011-2#3)(2013-1#2)
Candida spp##5##2##(2008-5#1)(2010-6#1)(2011-2#3)
Candida tropicalis##8##2##(1990-5#2)(1991-9#3)(1995-3#1)(2008-10#1)(2008-5#1)
Candida utilis##3##2##(1997-2#2)(2008-11#1)
Candida##134##1##(1990-5#2)(1991-9#5)(1992-8#1)(1993-12#2)(1995-3#2)(1996-12#1)(1996-3#4)(1996-6#2)(1997-1#1)(1997-2#5)(2006-6#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-5#47)(2009-8#2)(2010-6#1)(2011-2#13)(2012-2#2)(2012-3#2)(2013-1#13)(2013-8#1)
Candidate genes##2##2##(2008-6#1)(2012-3#1)
Candidate##5##1##(2008-6#1)(2008-8#1)(2010-11#1)(2012-3#2)
Candidates##2##1##(1992-8#1)(1995-9#1)
Candidatus Phlomobacter##2##2##(2008-10#2)
Candidatus Phytoplasma australiense&quot##3##3##(2008-10#3)
Candidatus Phytoplasma##4##2##(2008-10#4)
Candidatus##7##1##(2008-10#6)(2012-3#1)
Canine rabies##2##2##(2011-2#2)
Canine##10##1##(1995-11#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#4)(2012-2#1)
Canker size##2##2##(2008-10#2)
Canker##3##1##(2008-10#3)
Cankers##2##1##(2008-10#2)
Canna and tansy leaves##2##4##(2008-10#2)
Canna##3##1##(2008-10#3)
Cannabis is##2##2##(2008-12#2)
Cannabis##3##1##(2008-1#1)(2008-12#2)
Cannon's algorithms##2##2##(2009-12#2)
Cannon's##3##1##(2009-12#3)
Canola##4##1##(2008-10#4)
Canonical correspondence analysis##2##3##(2008-10#2)
Canonical##3##1##(2008-10#2)(2008-12#1)
Canopy##2##1##(2008-10#2)
Cantaloupe##3##1##(2008-10#3)
Canton Zurich##2##2##(1996-11#2)
Canton##9##1##(1990-6#1)(1996-11#8)
Cantonese##3##1##(2008-2#1)(2008-9#2)
Cantoni##2##1##(1990-10#1)(2008-4#1)
Cap##2##1##(1993-12#1)(2008-9#1)
Capable of##2##2##(2008-10#1)(2008-11#1)
Capacity of##2##2##(2008-10#1)(2011-2#1)
Capacity##11##1##(1993-1#1)(1997-1#1)(2008-10#3)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#3)
Cape##5##1##(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#2)
Caphorn##2##1##(2011-10#2)
Capillary electrophoresis (CE) is##2##4##(2008-10#1)(2008-4#1)
Capillary electrophoresis (CE)##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
Capillary electrophoresis as##2##3##(2008-10#1)(2008-5#1)
Capillary electrophoresis##11##2##(2008-10#7)(2008-4#2)(2008-5#2)
Capillary electrophoretic##2##2##(2008-10#2)
Capillary zone electrophoresis (CZE)##4##4##(2008-10#4)
Capillary##22##1##(1991-12#1)(1997-2#1)(2008-10#14)(2008-4#3)(2008-5#2)(2010-7#1)
Capital##2##1##(1992-1#1)(2013-1#1)
Capitation##3##1##(1996-12#1)(1996-3#1)(1997-1#1)
Capkc1p##2##1##(1996-6#2)
Capnor##2##1##(2011-10#2)
Capped##2##1##(2008-10#2)
Capsaicin##2##1##(1993-11#2)
Capsaicin-enhanced Ribosomal Protein P2 Expression in Human Intestinal Caco-2 Cells##2##10##(2008-11#2)
Capsicum annuum##6##2##(2008-10#6)
Capsicum species##2##2##(2008-10#2)
Capsicum spp##3##2##(2008-10#3)
Capsicum##17##1##(1993-11#1)(2008-10#16)
Capsule endoscopy##3##2##(2011-2#3)
Capsule##4##1##(2011-2#4)
Captopril and##2##2##(1990-9#1)(2008-10#1)
Captopril##9##1##(1990-9#1)(1994-5#1)(2008-10#7)
CarMV##2##1##(2008-10#2)
Caragana##3##1##(2008-10#3)
Carassius auratus##5##2##(1994-11#1)(2008-5#1)(2008-6#1)(2010-8#2)
Carassius##7##1##(1994-11#1)(2008-5#1)(2008-6#2)(2010-8#3)
Carausius morosus##3##2##(2007-12#3)
Carazolol is##2##2##(1995-11#2)
Carazolol##3##1##(1995-11#3)
Carbachol##3##1##(1994-11#1)(1996-12#2)
Carbaryl##2##1##(2008-10#2)
Carbograph##2##1##(2008-10#2)
Carbohydrate deficient transferrin in alcoholism##2##5##(1993-12#2)
Carbohydrate##8##1##(1990-8#1)(1991-12#1)(1993-12#2)(1994-11#1)(1996-12#1)(1996-5#1)(2013-1#1)
Carbohydrate-restriction##2##1##(2008-3#2)
Carbohydrates were##3##2##(1991-7#1)(1994-5#1)(2008-10#1)
Carbohydrates##4##1##(1991-7#1)(1994-5#1)(2008-10#1)(2013-1#1)
Carbon Centers##2##2##(1996-5#2)
Carbon dioxide laser##2##3##(1991-2#1)(1991-3#1)
Carbon dioxide##4##2##(1991-2#1)(1991-3#1)(2008-10#1)(2013-1#1)
Carbon film##2##2##(2008-10#2)
Carbon monoxide (CO)##2##3##(1995-2#1)(1996-12#1)
Carbon monoxide##3##2##(1995-2#1)(1996-12#1)(2009-11#1)
Carbon nanotube##3##2##(2008-10#2)(2008-7#1)
Carbon nanotubes##2##2##(2008-10#1)(2010-12#1)
Carbon##30##1##(1991-2#1)(1991-3#1)(1995-2#1)(1996-12#1)(1996-5#3)(2008-10#16)(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
Carbon-13##2##1##(2008-10#2)
Carbonyl##2##1##(1996-5#2)
Carbopack##2##1##(2008-10#2)
Carboplatin##4##1##(1997-3#2)(2008-10#2)
Carboxin resistance was##2##3##(2008-10#2)
Carboxin##3##1##(2008-10#3)
Carboxypeptidase##2##1##(1995-6#1)(2008-4#1)
Carcinoembryonic antigen##2##2##(1990-5#1)(1997-8#1)
Carcinogenicity##2##1##(1991-12#2)
Carcinoid##4##1##(1992-5#2)(2008-10#1)(2011-2#1)
Carcinoma of the oesophagus##2##4##(2008-1#2)
Carcinoma of the##4##3##(1992-3#1)(1994-2#1)(2008-1#2)
Carcinoma##13##1##(1992-3#1)(1993-9#1)(1994-2#1)(2008-1#2)(2008-10#1)(2010-12#1)(2011-2#2)(2013-1#3)(2013-8#1)
Card##5##1##(1995-5#1)(2008-11#1)(2008-7#1)(2013-8#2)
Cardiac Hypertrophy##2##2##(2011-2#1)(2012-12#1)
Cardiac Science##3##2##(2011-2#3)
Cardiac Surgery##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
Cardiac Troponin I in##3##4##(2008-12#3)
Cardiac Troponin I##5##3##(2008-12#5)
Cardiac herniation##2##2##(2008-11#2)
Cardiac hypertrophy was##2##3##(1994-12#1)(2011-2#1)
Cardiac hypertrophy##3##2##(1994-12#1)(2011-2#1)(2012-12#1)
Cardiac magnetic resonance imaging##3##4##(2009-1#1)(2010-10#1)(2012-2#1)
Cardiac output##2##2##(1996-3#1)(2008-12#1)
Cardiac##48##1##(1991-3#1)(1993-6#1)(1994-12#1)(1996-3#1)(1996-9#1)(2008-10#4)(2008-11#5)(2008-12#8)(2008-7#1)(2009-1#1)(2010-10#1)(2010-6#2)(2010-7#1)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
CardioVascular Clinical Trialists##2##3##(2013-1#2)
CardioVascular##3##1##(2013-1#3)
Cardiolipin##2##1##(2008-8#1)(2012-2#1)
Cardiology##7##1##(2008-10#1)(2008-3#1)(2009-6#1)(2010-12#1)(2013-1#2)(2013-8#1)
Cardiopulmonary##2##1##(2009-4#1)(2012-3#1)
Cardiothoracic Critical Care##2##3##(2013-1#2)
Cardiovascular Research##2##2##(2009-12#1)(2011-2#1)
Cardiovascular Study##2##2##(2008-3#2)
Cardiovascular disease (CVD)##2##3##(2012-2#1)(2013-8#1)
Cardiovascular disease is the leading##2##5##(2010-9#1)(2012-2#1)
Cardiovascular disease is the##3##4##(2010-9#1)(2012-2#1)(2013-8#1)
Cardiovascular disease##9##2##(2008-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-8#2)
Cardiovascular##25##1##(1994-5#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-7#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
Care Committee##2##2##(1994-1#1)(1995-12#1)
Care Pairs&quot##2##2##(1994-2#2)
Care Policy##4##2##(1992-8#1)(1993-12#1)(1996-1#2)
Care Program##5##2##(1991-2#2)(1994-3#2)(1996-1#1)
Care System##5##2##(1993-12#1)(1994-1#2)(1994-12#1)(1997-3#1)
Care Unit##9##2##(1991-6#1)(1992-2#1)(2008-11#1)(2008-5#1)(2012-3#3)(2013-1#2)
Care and the##2##3##(2010-12#1)(2012-12#1)
Care and##8##2##(1993-12#1)(1993-2#1)(1994-3#1)(1996-12#1)(2008-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
Care for##3##2##(1994-2#1)(1994-3#1)(2010-10#1)
Care is##3##2##(1991-9#1)(1993-12#1)(1994-3#1)
Care of My Child##2##4##(2010-7#2)
Care of##7##2##(1992-3#1)(1994-12#1)(1994-3#1)(2010-6#1)(2010-7#2)(2012-12#1)
Care program##5##2##(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#1)
Care##163##1##(1990-6#1)(1991-1#4)(1991-2#5)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#2)(1992-2#3)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#8)(1993-2#1)(1993-3#1)(1994-1#9)(1994-12#7)(1994-2#10)(1994-3#12)(1994-6#1)(1995-12#4)(1995-2#2)(1995-3#5)(1995-8#1)(1996-1#6)(1996-12#1)(1996-2#10)(1996-3#1)(1997-1#1)(1997-2#6)(1997-3#4)(1997-8#1)(2008-10#1)(2008-11#13)(2008-5#2)(2009-10#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#7)
CareFusion Alaris##2##2##(2011-2#2)
Career development##2##2##(1994-1#1)(2008-11#1)
Career professionals##2##2##(1991-12#2)
Career##10##1##(1991-12#2)(1994-1#1)(1994-3#1)(1997-2#1)(2008-11#2)(2012-2#3)
Careers##3##1##(1994-12#1)(2007-12#1)(2009-4#1)
Careful##4##1##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
Caregivers with##2##2##(2010-7#2)
Caregivers##5##1##(1994-1#2)(2008-10#1)(2010-7#2)
Caregiving##2##1##(2010-7#1)(2012-2#1)
Caremark##4##1##(1995-12#4)
Carers reported##2##2##(2011-1#2)
Caribbean Blacks##3##2##(2010-10#3)
Caribbean and##3##2##(2008-10#2)(2008-5#1)
Caribbean division meeting##8##3##(2008-11#8)
Caribbean spiny##2##2##(2007-12#2)
Caribbean##34##1##(1991-3#1)(2007-12#4)(2008-10#13)(2008-11#10)(2008-5#1)(2010-10#3)(2010-4#1)(2011-2#1)
Carilion##2##1##(1997-3#2)
Caring for the##2##3##(1991-2#1)(1992-3#1)
Caring for##6##2##(1991-12#1)(1991-2#1)(1992-3#1)(1997-2#1)(2008-11#1)(2010-8#1)
Caring##10##1##(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1997-2#1)(2008-11#2)(2008-8#1)(2010-8#1)
Carlavirus##3##1##(2008-10#2)(2008-9#1)
Carlo##46##1##(1990-12#1)(1990-6#1)(1992-11#1)(1992-9#1)(1995-12#1)(2008-10#9)(2008-2#2)(2008-3#16)(2008-4#1)(2008-6#1)(2009-11#3)(2009-12#1)(2009-4#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
Carlson##3##1##(1996-5#1)(2008-10#1)(2012-2#1)
Carnation##5##1##(2008-10#5)
Carnitine##2##1##(1991-12#1)(1991-2#1)
Carnival##2##1##(2009-10#2)
Carolina##38##1##(1991-2#1)(1991-3#1)(1991-8#3)(1994-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-6#1)(2008-10#23)(2008-11#1)(2011-2#1)(2012-12#3)
Carolina's##4##1##(1995-12#1)(1997-2#3)
Carotenoids##3##1##(1992-9#1)(2008-12#1)(2008-8#1)
Carotid artery stenting##2##3##(2008-11#1)(2009-10#1)
Carotid artery##4##2##(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
Carotid endarterectomy##3##2##(1993-1#1)(2008-7#1)(2010-9#1)
Carotid intima-media thickness##2##3##(2008-7#1)(2009-1#1)
Carotid##20##1##(1993-1#1)(1996-9#1)(2008-11#4)(2008-7#6)(2008-8#1)(2009-1#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)
Carotid-subclavian bypass##2##2##(2008-7#2)
Carpal##2##1##(2008-12#1)(2013-8#1)
Carpinus##2##1##(2008-10#1)(2011-1#1)
Carpogenic germination of##2##3##(2008-10#2)
Carpogenic##3##1##(2008-10#3)
Carr application##2##2##(2011-10#2)
Carr##5##1##(2008-12#1)(2011-10#4)
Carrier##5##1##(2007-11#1)(2008-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
Carrot##4##1##(2008-10#4)
Carrying##2##1##(2008-10#1)(2010-7#1)
Cartagena##6##1##(2011-2#6)
Cartapip 97##3##2##(2008-10#3)
Cartilage##4##1##(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
Carvacrol##4##1##(2008-10#1)(2008-11#3)
Carvedilol##2##1##(2008-7#1)(2010-4#1)
Caryodendron orinocense##2##2##(2008-5#2)
Caryodendron##3##1##(2008-5#3)
CasD##2##1##(1993-6#2)
Casa del Mitreo in Emerita Augusta##2##6##(2008-10#2)
Cascade##5##1##(1992-2#1)(1992-3#1)(1996-5#1)(1997-2#1)(2008-10#1)
Cascades##4##1##(2008-10#2)(2008-8#1)(2013-8#1)
Case 1##10##2##(1997-6#1)(2008-11#8)(2012-3#1)
Case 2##10##2##(1997-6#1)(2008-11#8)(2012-3#1)
Case Presentation##2##2##(2013-1#2)
Case Report and Literature Review##2##5##(2011-2#2)
Case Report and Review of the Literature##2##7##(2011-2#1)(2013-1#1)
Case Report and##4##3##(2011-2#3)(2013-1#1)
Case Report of##2##3##(2010-9#1)(2013-1#1)
Case Report##19##2##(1997-6#1)(1997-7#1)(2008-12#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#8)
Case Series##2##2##(2008-12#1)(2012-3#1)
Case control study to##2##4##(2013-1#2)
Case management##7##2##(1991-12#3)(1995-3#1)(1996-2#1)(1997-3#2)
Case mix##3##2##(1992-12#1)(1995-2#2)
Case of##4##2##(2010-6#3)(2013-1#1)
Case records of the Massachusetts General Hospital##5##7##(1992-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-7#1)
Case report and review of the literature]##2##7##(1992-9#1)(1993-6#1)
Case report and review of##3##5##(1992-9#1)(1993-6#1)(2013-1#1)
Case report and##5##3##(1992-9#1)(1993-6#1)(1993-8#1)(2013-1#2)
Case report##21##2##(1992-9#1)(1993-6#1)(1993-8#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#3)(2009-9#7)(2013-1#4)
Case series##3##2##(2009-9#2)(2011-2#1)
Case study##5##2##(1995-2#1)(1996-2#1)(2008-11#1)(2013-1#2)
Case##122##1##(1991-12#4)(1992-12#3)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-3#3)(1994-6#2)(1995-2#3)(1995-3#2)(1995-8#2)(1996-2#3)(1996-6#1)(1996-8#1)(1997-3#2)(1997-6#3)(1997-7#3)(2007-12#1)(2008-10#1)(2008-11#19)(2008-12#3)(2008-5#1)(2008-9#3)(2009-12#1)(2009-9#9)(2010-12#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-3#6)(2013-1#21)(2013-8#1)
Case-control study of##2##3##(1991-7#1)(2008-10#1)
Case-control study##3##2##(1991-7#1)(2008-10#1)(2012-3#1)
Cases of##5##2##(2009-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
Cases were##4##2##(1991-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
Cases##21##1##(1991-2#2)(1991-7#1)(1993-1#1)(1995-2#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)
Casey##2##1##(1993-2#1)(1993-3#1)
Cashmere##2##1##(2008-10#2)
Casina##2##1##(2008-10#2)
Casokefamide##2##1##(1993-3#2)
Caspase##2##1##(2008-11#2)
Caspase-3##3##1##(2008-9#2)(2013-8#1)
Caspases are##2##2##(2008-11#1)(2008-4#1)
Caspases##4##1##(2008-11#2)(2008-4#2)
Caspian Sea##2##2##(2008-10#1)(2012-2#1)
Cassava##3##1##(2008-10#3)
Castleman disease##4##2##(2011-2#4)
Castleman's disease##2##2##(2012-12#2)
Catabolism of##2##2##(1993-3#1)(2011-1#1)
Catalase##3##1##(2008-10#3)
Catalyser-21(TM)##9##1##(2008-11#9)
Catalytic activity##2##2##(2008-11#1)(2008-7#1)
Catalytic adsorptive stripping voltammetry##2##4##(2008-10#2)
Catalytic adsorptive stripping##3##3##(2008-10#3)
Catalytic determination of##2##3##(2008-10#2)
Catalytic spectrophotometric determination of##2##4##(2008-10#2)
Catalytic##19##1##(1993-8#1)(1996-5#1)(2008-10#13)(2008-11#1)(2008-7#1)(2010-4#1)(2010-6#1)
Cataract##2##1##(2010-8#2)
Catecholamine##2##1##(1990-5#1)(1994-5#1)
Categories##4##1##(2008-11#1)(2008-9#3)
Category##5##1##(2012-2#4)(2013-1#1)
Cathedral##2##1##(2008-2#1)(2008-3#1)
Cathepsin D##5##2##(1990-5#1)(1994-5#3)(1995-8#1)
Cathepsin##7##1##(1990-5#1)(1994-5#3)(1995-8#2)(2006-6#1)
Catheter ablation of##2##3##(2009-10#2)
Catheter##3##1##(1997-3#1)(2009-10#2)
Cathodic adsorptive stripping voltammetric determination of##2##6##(2008-10#2)
Cathodic adsorptive stripping voltammetric##3##4##(2008-10#3)
Cathodic stripping voltammetry of##4##4##(2008-10#4)
Cathodic stripping voltammetry##6##3##(2008-10#6)
Cathodic##10##1##(2008-10#10)
Catholic health ministry##2##3##(1992-1#1)(1993-12#1)
Catholic health##3##2##(1992-1#1)(1993-12#2)
Catholic healthcare in##2##3##(1997-3#2)
Catholic healthcare##7##2##(1994-12#1)(1997-3#6)
Catholic##19##1##(1990-6#2)(1990-8#1)(1992-1#1)(1993-12#3)(1994-1#1)(1994-12#1)(1997-3#8)(2013-1#2)
Cation##4##1##(2008-10#3)(2011-2#1)
Cationic lipid-mediated NGF##2##3##(1996-12#2)
Cationic liposomes##2##2##(1994-5#2)
Cationic##9##1##(1994-5#3)(1996-12#2)(2008-10#3)(2008-5#1)
Cations##2##1##(1996-5#2)
Cats##3##1##(2012-3#1)(2013-8#2)
Cattle##3##1##(1991-8#1)(2012-2#1)(2013-8#1)
Cauca##2##1##(2012-12#2)
Caucasian man##3##2##(1990-8#1)(2010-12#1)(2011-2#1)
Caucasian or##2##2##(2008-12#1)(2008-5#1)
Caucasian populations##4##2##(2008-12#2)(2010-3#2)
Caucasian subjects##2##2##(1994-12#1)(2013-1#1)
Caucasian women##3##2##(2010-3#3)
Caucasian##34##1##(1990-8#1)(1992-2#1)(1994-12#2)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#5)(2010-12#1)(2010-3#5)(2010-5#2)(2011-2#2)(2012-3#1)(2013-1#1)
Caucasians may##2##2##(2008-10#2)
Caucasians##8##1##(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
Caucasus##9##1##(2008-10#8)(2008-11#1)
Caucus##4##1##(1996-5#4)
Cauliflower mosaic virus (CaMV)##3##4##(2008-10#3)
Cauliflower mosaic virus##5##3##(2008-10#5)
Cauliflower plants##2##2##(2008-10#2)
Cauliflower##11##1##(2008-10#11)
Causal Agent of##15##3##(2008-10#15)
Causal Agent##16##2##(2008-10#16)
Causal##18##1##(1997-3#1)(2008-10#16)(2008-11#1)
Cause a##2##2##(2008-10#2)
Cause of##11##2##(1997-6#1)(2008-10#6)(2011-2#1)(2012-3#2)(2013-1#1)
Cause##16##1##(1997-6#1)(2008-10#11)(2011-2#1)(2012-3#2)(2013-1#1)
Caused by Colletotrichum##2##3##(2008-10#2)
Caused by Monilinia fructicola##2##4##(2008-10#2)
Caused by Pseudomonas##2##3##(2008-10#2)
Caused by Pythium ultimum##3##4##(2008-10#3)
Caused by Pythium##4##3##(2008-10#4)
Caused by a##2##3##(2008-10#2)
Caused by##36##2##(2008-10#31)(2009-1#1)(2011-2#3)(2012-2#1)
Causes and##3##2##(2008-6#1)(2008-8#1)(2011-2#1)
Causes of##8##2##(1993-3#1)(1996-1#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#1)
Causes##19##1##(1990-11#1)(1993-3#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#4)(2013-1#1)(2013-8#1)
Causing Anthracnose of##2##3##(2008-10#2)
Causing Bacterial Spot of##2##4##(2008-10#2)
Causing Brown Spot of##3##4##(2008-10#3)
Causing Root##2##2##(2008-10#2)
Causing##21##1##(2008-10#18)(2010-7#1)(2011-2#1)(2012-3#1)
Caution must##2##2##(2008-11#2)
Caution##3##1##(2008-11#2)(2012-2#1)
Cavalieri principle##2##2##(2008-12#1)(2011-2#1)
Cavendish##2##1##(2008-10#2)
Caveolae are flask-shaped##2##3##(1995-2#1)(1995-6#1)
Caveolae##4##1##(1995-2#3)(1995-6#1)
Cavernous lymphangioma##2##2##(2013-1#2)
Cavernous##8##1##(1993-9#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#3)
Cavities##2##1##(1990-2#1)(2008-10#1)
Cavitron Ultrasonic Surgical Aspirator##3##4##(1995-12#3)
Cavitron##4##1##(1995-12#4)
Cavity ringdown spectroscopy##2##3##(2007-12#1)(2008-2#1)
Cavity ringdown##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
Cavity##6##1##(2007-12#2)(2008-2#1)(2008-3#3)
Cb I##3##2##(1995-12#3)
Cb II##3##2##(1995-12#3)
Cb##7##1##(1995-12#7)
Cbz-Phe-Ala##2##1##(2006-6#2)
Ccs3##2##1##(2011-2#2)
Ccs4##2##1##(2011-2#2)
Cd (II)##2##2##(2008-10#2)
Cd analysis##2##2##(2008-10#2)
Cd and Bi##2##3##(2008-10#2)
Cd and Cu were##2##4##(2008-10#1)(2008-11#1)
Cd and Pb in##8##4##(2008-10#8)
Cd and Pb were##3##4##(2008-10#3)
Cd and Pb##23##3##(2008-10#23)
Cd and Zn##8##3##(2008-10#8)
Cd and##53##2##(1990-5#4)(2008-10#48)(2008-11#1)
Cd by##4##2##(2008-10#4)
Cd concentration##2##2##(2008-10#1)(2008-7#1)
Cd concentrations##2##2##(2008-10#2)
Cd has been##2##3##(2008-10#2)
Cd hydride generation##2##3##(2008-10#2)
Cd in the##5##3##(1990-5#2)(2008-10#3)
Cd in##19##2##(1990-5#2)(2008-10#17)
Cd or##2##2##(1990-5#1)(2008-10#1)
Cd was##6##2##(1990-5#1)(2008-10#5)
Cd##227##1##(1990-5#12)(1993-12#1)(2008-10#210)(2008-11#1)(2008-7#3)
Cd(2+) and Pb(2+)##2##3##(2008-10#2)
Cd(2+) and Zn(2+)##2##3##(2008-10#2)
Cd(2+) and##7##2##(2008-10#7)
Cd(2+) from##2##2##(2008-10#2)
Cd(2+) in##3##2##(2008-10#3)
Cd(2+) inherent to MT##2##4##(2008-10#2)
Cd(2+) ions##5##2##(2008-10#5)
Cd(2+) is##4##2##(2008-10#4)
Cd(2+) with##2##2##(2008-10#2)
Cd(2+)##56##1##(2008-10#54)(2008-11#1)(2008-8#1)
Cd(II) and In(III) in##2##4##(2008-10#2)
Cd(II) and In(III)##3##3##(2008-10#3)
Cd(II) and Pb(II)##8##3##(2008-10#8)
Cd(II) and Zn(II)##3##3##(2008-10#3)
Cd(II) and##20##2##(2008-10#20)
Cd(II) was##2##2##(2008-10#2)
Cd(II)##82##1##(2008-10#82)
Cd(x)Hg(1-x)Ga(2)S(4)##2##1##(2007-11#2)
Cd)##7##1##(2008-10#7)
Cd-MT was##2##2##(1993-12#2)
Cd-MT##7##1##(1993-12#7)
Cd2+##2##1##(1993-6#1)(1997-7#1)
CdCl(2)##3##1##(2008-10#3)
CdCl(2)-pretreated filter paper##2##3##(2008-10#2)
CdH(2)L(2)##2##1##(2008-10#2)
CdL##3##1##(2008-10#3)
CdL(2) and##2##2##(2008-10#2)
CdL(2)##4##1##(2008-10#4)
CdL(2+)##2##1##(2008-10#2)
CdL(OH)(+)##2##1##(2008-10#2)
CdS and CdTe qdots##2##4##(2008-10#2)
CdS and##4##2##(2008-10#4)
CdS nanoparticles##2##2##(2008-10#2)
CdS sol##2##2##(2008-8#2)
CdS##14##1##(2008-10#8)(2008-8#6)
CdSe nanocrystals##5##2##(2008-10#5)
CdSe quantum dots##2##3##(2008-10#2)
CdSe##11##1##(2008-10#11)
CdTe nanoparticles##3##2##(2008-10#3)
CdTe quantum dots and##2##4##(2008-10#2)
CdTe quantum dots##7##3##(2008-10#7)
CdTe##14##1##(2008-10#13)(2008-3#1)
Cdc14##2##1##(2012-2#2)
Cdc14b##3##1##(2012-2#3)
Cdc7##4##1##(2012-3#4)
Cdk1 mRNA##4##2##(2012-3#4)
Cdk1##5##1##(2012-3#5)
Ce and##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
Ce##21##1##(2008-10#15)(2008-3#2)(2010-4#2)(2011-2#1)(2012-2#1)
Ce(0##2##1##(2010-4#2)
Ce(3+) and##3##2##(2008-10#3)
Ce(3+)##13##1##(2008-10#10)(2008-2#2)(2010-4#1)
Ce(III)-EDTA complex##4##2##(2008-10#4)
Ce(IV)##6##1##(2008-10#6)
Ce(IV)-quinine##2##1##(2008-10#2)
Ce-PbO(2) modified electrode##3##3##(2008-10#3)
CeA fresh leaf juice##2##4##(2008-10#2)
CeA##5##1##(2008-10#5)
CeMV##3##1##(2008-10#3)
CeO(2)/Chitosan##2##1##(2008-10#2)
Cea-2##3##1##(1992-6#3)
Cecal##2##1##(2012-3#2)
Cedex##2##1##(2008-11#2)
Ceftazidime in##2##2##(1991-3#2)
Ceftazidime##3##1##(1991-3#3)
Cel48 was##2##2##(2009-3#2)
Cel48##5##1##(2009-3#5)
Cel9##4##1##(2009-3#4)
CelS##5##1##(1990-5#5)
Celiac artery stenting##2##3##(2013-1#2)
Celiac disease##3##2##(2011-2#1)(2013-8#2)
Celiac##5##1##(2011-2#1)(2013-1#2)(2013-8#2)
Celite##4##1##(1997-2#4)
Cell Biol##2##2##(1990-7#1)(1993-12#1)
Cell Carcinoma##3##2##(2008-10#1)(2013-1#2)
Cell Culture##4##2##(2008-11#4)
Cell Death##6##2##(2008-10#2)(2009-12#1)(2011-2#2)(2012-2#1)
Cell Invasion##2##2##(2008-11#1)(2013-1#1)
Cell Line##5##2##(1997-7#1)(2008-11#3)(2011-2#1)
Cell Lung Cancer##3##3##(2008-10#2)(2008-11#1)
Cell SELEX##5##2##(2010-5#5)
Cell Wall##3##2##(2008-10#3)
Cell biological##2##2##(2008-11#1)(2008-8#1)
Cell culture##5##2##(2008-11#4)(2012-2#1)
Cell cultures##3##2##(2008-11#2)(2013-1#1)
Cell cycle analysis##3##3##(1997-1#1)(2008-9#2)
Cell cycle arrest##2##3##(1997-7#1)(2008-11#1)
Cell cycle##10##2##(1997-1#1)(1997-3#1)(1997-7#1)(2008-11#3)(2008-7#1)(2008-9#2)(2012-3#1)
Cell death##5##2##(1994-2#2)(2008-4#1)(2008-9#1)(2009-10#1)
Cell division##2##2##(1994-11#1)(2008-11#1)
Cell fractionation##2##2##(1995-2#1)(2008-4#1)
Cell growth##8##2##(1991-5#1)(1994-8#1)(2008-11#6)
Cell line##2##2##(2008-11#2)
Cell lines##2##2##(1992-12#1)(2008-11#1)
Cell proliferation was##2##3##(1995-2#1)(2010-3#1)
Cell proliferation##4##2##(1995-2#1)(2008-9#1)(2009-3#1)(2010-3#1)
Cell surface##2##2##(2008-11#1)(2012-2#1)
Cell viability##3##2##(1994-5#1)(2008-9#1)(2013-1#1)
Cell##168##1##(1990-12#1)(1990-7#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-12#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1997-1#2)(1997-3#2)(1997-7#2)(2008-10#14)(2008-11#64)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#4)(2010-10#2)(2010-3#1)(2010-5#5)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
Cell-cell##2##1##(1995-2#1)(2010-7#1)
Cell-free filtrates from##2##3##(2008-10#2)
Cell-free##5##1##(1991-7#1)(1997-7#1)(2008-10#2)(2011-2#1)
Cell-mediated##3##1##(1991-12#1)(2013-1#2)
Cells In Vitro##2##3##(2008-10#1)(2009-12#1)
Cells and##4##2##(2008-11#3)(2013-1#1)
Cells are##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
Cells by##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
Cells can##2##2##(2008-10#1)(2008-11#1)
Cells cultured##2##2##(2008-11#2)
Cells from##6##2##(1990-2#1)(2008-11#3)(2008-2#1)(2011-2#1)
Cells in a##2##3##(2008-11#1)(2012-3#1)
Cells in the##6##3##(1995-2#1)(2007-12#1)(2008-11#1)(2008-5#2)(2010-6#1)
Cells in##12##2##(1994-12#1)(1995-2#1)(2007-12#1)(2008-11#5)(2008-5#2)(2010-6#1)(2012-3#1)
Cells infected with##3##3##(1993-6#1)(2008-10#2)
Cells of the##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
Cells of##5##2##(2008-10#3)(2008-5#1)(2008-6#1)
Cells transfected with##2##3##(2008-11#1)(2008-8#1)
Cells transfected##3##2##(2008-11#2)(2008-8#1)
Cells were##7##2##(1990-5#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
Cells with##2##2##(1992-6#1)(2009-5#1)
Cells##115##1##(1990-2#1)(1990-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#15)(2008-11#43)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
Cellular Potts Model##2##3##(2008-11#2)
Cellular and humoral responses in coeliac disease##2##7##(1991-12#2)
Cellular and humoral##3##3##(1991-12#2)(1995-2#1)
Cellular and##5##2##(1991-12#2)(1995-2#1)(1997-7#1)(2008-10#1)
Cellular##35##1##(1991-12#2)(1992-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-11#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
Cellulase and laminarinase##2##3##(2008-10#2)
Cellulase##3##1##(2008-10#3)
Cellulomonas fimi##3##2##(1992-11#2)(2008-7#1)
Cellulomonas flavigena##3##2##(2008-10#1)(2011-2#2)
Cellulomonas##9##1##(1992-11#2)(2008-10#1)(2008-7#1)(2011-2#5)
Cellulose##3##1##(2008-10#3)
Celsius##3##1##(2008-10#1)(2008-8#2)
CenTrak##3##1##(2011-2#3)
Cenococcum geophilum##2##2##(2012-6#2)
Census##4##1##(1994-9#1)(1997-2#1)(2010-7#1)(2011-2#1)
Centella asiatica##3##2##(2008-10#2)(2008-5#1)
Centenarians##2##1##(2008-7#2)
Center Experience##3##2##(1995-11#1)(2008-1#1)(2012-3#1)
Center and##6##2##(1990-12#1)(1992-2#2)(1993-2#1)(2008-4#1)(2010-8#1)
Center at##4##2##(1990-11#1)(1993-3#1)(2008-7#1)(2011-2#1)
Center for##19##2##(1990-11#2)(1991-12#1)(1993-2#2)(1993-3#1)(1995-5#2)(1997-3#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-11#1)(2010-5#1)(2010-6#1)
Center from##2##2##(1990-9#1)(1997-8#1)
Center has##2##2##(1996-3#1)(2009-3#1)
Center in##6##2##(1991-12#1)(1993-2#1)(1996-9#1)(1997-3#1)(2008-3#1)(2011-2#1)
Center of Diversity##3##3##(2008-10#3)
Center of##12##2##(1990-11#2)(1992-3#1)(1995-12#1)(2008-10#6)(2010-12#1)(2013-1#1)
Center to##4##2##(1991-2#1)(1997-3#1)(2008-10#1)(2010-11#1)
Center were##2##2##(2008-12#1)(2010-8#1)
Center##122##1##(1990-11#8)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#5)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#2)(1992-2#5)(1992-3#1)(1993-12#2)(1993-2#5)(1993-3#2)(1994-12#2)(1994-2#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#5)(1997-8#1)(2008-1#4)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
Centers for Disease Control and Prevention (CDC)##12##7##(1995-12#3)(1995-6#3)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#1)(2008-10#1)
Centers for Disease Control and Prevention##17##6##(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#1)
Centers for Disease Control and##19##5##(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#1)(2008-11#1)
Centers for Disease Control##20##4##(1992-2#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#1)(2008-11#1)
Centers for##21##2##(1992-2#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
Centers in##3##2##(1990-2#1)(1996-9#1)(2008-10#1)
Centers of##3##2##(1992-1#1)(2007-9#1)(2008-10#1)
Centers##36##1##(1990-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-12#5)(1995-5#1)(1995-6#4)(1996-1#2)(1996-12#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-12#1)(2012-12#1)(2013-8#1)
Central America##4##2##(1990-6#1)(2008-10#3)
Central Asia and the Caucasus##4##5##(2008-10#4)
Central Asia##5##2##(2008-10#5)
Central Europe##5##2##(1994-12#1)(1997-3#2)(2008-10#1)(2012-9#1)
Central European##2##2##(2008-10#1)(2012-9#1)
Central Hospital##4##2##(1991-11#1)(1991-9#1)(1997-4#1)(2008-1#1)
Central Nervous System##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
Central and##3##2##(1995-3#2)(2008-10#1)
Central nervous system##3##3##(2008-4#1)(2011-3#1)(2012-3#1)
Central pontine myelinolysis##3##3##(1997-8#1)(2008-7#2)
Central to##4##2##(1992-1#1)(1993-3#1)(2008-10#1)(2011-2#1)
Central##82##1##(1990-6#1)(1991-1#1)(1991-11#3)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-3#3)(1996-5#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#24)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-5#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-9#2)(2013-1#3)
Centre for Psychiatric Nursing Research and Practice (CPNRP)##2##8##(2008-11#2)
Centre for##8##2##(1995-12#1)(2008-10#2)(2008-11#2)(2012-3#1)(2013-1#2)
Centre of the##2##3##(2008-11#1)(2011-2#1)
Centre of##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
Centre##27##1##(1990-3#1)(1993-12#3)(1995-12#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-9#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
Centres##3##1##(2011-2#2)(2012-2#1)
Centro Internacional de Agricultura Tropical##2##5##(2008-10#2)
Centro##3##1##(1993-3#1)(2008-10#2)
Centruroides noxius Hoffmann##2##3##(1993-6#2)
Centruroides##3##1##(1993-6#3)
Century##10##1##(1994-1#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
Cephalosporium gramineum##4##2##(2008-10#4)
Cephalosporium maydis##2##2##(2008-10#2)
Cephalosporium stripe##2##2##(2008-10#2)
Cephalosporium##9##1##(2008-10#9)
Cerambycidae) is a##2##3##(2013-8#2)
Cerambycidae)##4##1##(2007-12#2)(2013-8#2)
Ceramide##5##1##(1996-2#3)(2008-5#1)(2011-2#1)
Ceratitis capitata##2##2##(2007-12#2)
Ceratocystis fimbriata##7##2##(2008-10#7)
Ceratocystis##10##1##(2008-10#10)
Ceratorhiza##2##1##(2008-10#2)
Cercospora cluster##2##2##(2008-10#2)
Cercospora kikuchii##4##2##(2008-10#4)
Cercospora leaf##3##2##(2008-10#2)(2012-3#1)
Cercospora sorghi##5##2##(2008-10#5)
Cercospora zeae-maydis##9##2##(2008-10#9)
Cercospora##37##1##(2008-10#35)(2012-3#2)
Cereal yellow dwarf virus##3##4##(2008-10#3)
Cereal yellow dwarf##6##3##(2008-10#6)
Cereal##10##1##(1990-3#1)(2008-10#9)
Cereals##2##1##(2008-10#2)
Cerebellar##5##1##(1995-5#1)(2009-1#1)(2012-3#1)(2013-1#2)
Cerebellopontine Angle##2##2##(2012-3#2)
Cerebellopontine##3##1##(2011-2#1)(2012-3#2)
Cerebral Hyperperfusion##2##2##(2012-3#2)
Cerebral blood flow (CBF)##2##4##(2008-7#2)
Cerebral blood flow##4##3##(1995-5#1)(1996-12#1)(2008-7#2)
Cerebral microbleeds##2##2##(2008-8#2)
Cerebral##35##1##(1990-3#1)(1990-5#1)(1991-6#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-3#1)(2008-12#2)(2008-7#7)(2008-8#2)(2010-1#1)(2011-2#5)(2012-2#1)(2012-3#5)(2013-8#2)
Cerebrospinal fluid leaks of##2##4##(2011-2#2)
Cerebrospinal fluid##5##2##(2009-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
Cerebrovascular##5##1##(1993-3#1)(1996-11#1)(2008-11#1)(2011-2#1)(2012-3#1)
Ceriodaphnia dubia##2##2##(2008-11#2)
Cerrena unicolor##2##2##(2008-10#2)
Certain aspects of##2##3##(2008-10#1)(2008-7#1)
Certain isolates##2##2##(2008-10#2)
Certain morphological features##2##3##(1997-1#1)(2009-12#1)
Certain##18##1##(1991-10#1)(1991-6#1)(1992-6#1)(1997-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
Certainly##4##1##(1994-3#1)(2008-3#1)(2009-10#1)(2011-2#1)
Certhidea##3##1##(2008-8#3)
Certificate of##2##2##(2008-10#1)(2011-2#1)
Certification##2##1##(1996-12#1)(2008-11#1)
Certified Reference Materials (CRMs)##2##4##(2008-10#2)
Certified Reference Materials##3##3##(2008-10#3)
Certified Reference##4##2##(2008-10#4)
Certified reference##2##2##(2008-10#2)
Certified##10##1##(1992-12#1)(2008-10#8)(2010-11#1)
Certifying##2##1##(1992-12#1)(2008-1#1)
Cervical Spine##2##2##(2008-12#1)(2012-3#1)
Cervical artificial disc replacement versus fusion in the cervical spine##2##10##(2012-12#2)
Cervical artificial disc replacement##4##4##(2012-12#4)
Cervical root##2##2##(2008-7#1)(2012-3#1)
Cervical##31##1##(1990-12#1)(1996-3#1)(1997-1#3)(2008-11#1)(2008-12#4)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-7#1)(2012-12#4)(2012-3#7)(2013-1#2)(2013-8#3)
Cervicogenic headache##2##2##(2008-12#2)
Ces##2##1##(2008-11#1)(2011-2#1)
Cesium ion-selective##2##2##(2008-10#2)
Cesium##3##1##(2008-10#3)
Cette##2##1##(2013-1#2)
Cetyltrimethylammonium##2##1##(2008-10#2)
Cex##4##1##(1992-11#2)(2008-7#2)
CfoI##2##1##(2008-10#2)
Cg-14##3##1##(2008-10#3)
Cg-HTIF(I)##4##1##(2010-4#4)
Cg-M-1150 did not##3##3##(2008-10#3)
Cg-M-1150##7##1##(2008-10#7)
Cg-M-142 and Cg-M-1150##4##3##(2008-10#4)
Cg-M-142##8##1##(2008-10#8)
CgA##3##1##(2010-11#3)
ChAT activity##2##2##(1991-9#1)(1996-2#1)
ChAT##3##1##(1991-9#1)(1996-2#1)(2011-2#1)
ChEMBL##2##1##(2013-1#2)
ChL##7##1##(2008-10#7)
ChMV is related to##2##4##(2008-10#2)
ChMV is##3##2##(2008-10#3)
ChMV was##4##2##(2008-10#4)
ChMV##9##1##(2008-10#9)
ChOx##2##1##(2008-10#2)
Chadoora##4##1##(2013-8#4)
Chaetomium globosum##3##2##(2008-5#1)(2013-1#2)
Chain Reaction Detection##4##3##(2008-10#4)
Chain Reaction in##2##3##(2008-10#2)
Chain Reaction##36##2##(2008-10#35)(2008-12#1)
Chain##46##1##(1996-9#1)(2008-10#40)(2008-12#2)(2009-8#1)(2012-2#1)(2013-8#1)
Chair of##3##2##(2008-5#1)(2010-1#1)(2012-12#1)
Chair##4##1##(2008-5#2)(2010-1#1)(2012-12#1)
Chairman##2##1##(1994-1#1)(2010-1#1)
Chairs##2##1##(2009-3#1)(2009-4#1)
Chalara elegans##3##2##(2008-10#3)
Challenge testing##2##2##(2008-5#2)
Challenge##8##1##(1997-1#2)(2008-10#1)(2008-5#2)(2010-10#1)(2010-8#1)(2012-3#1)
Challenges and##5##2##(2008-12#1)(2010-4#1)(2010-5#1)(2011-2#2)
Challenges in##8##2##(1993-2#1)(1994-3#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-7#1)(2011-2#1)
Challenges to##2##2##(1993-2#1)(1996-3#1)
Challenges##18##1##(1993-12#1)(1993-2#2)(1994-3#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)
Challenging##3##1##(1996-2#1)(2011-2#1)(2012-2#1)
Chamber##4##1##(2008-11#1)(2008-5#2)(2011-2#1)
Chan##2##1##(2008-12#1)(2008-8#1)
Changbai Mountain##3##2##(2008-9#3)
Change Strategies##2##2##(1994-3#1)(2012-2#1)
Change and##2##2##(2008-4#1)(2011-2#1)
Change in##10##2##(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
Change of##4##2##(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
Change##29##1##(1994-3#2)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
Changed participation##2##2##(2012-12#2)
Changed##3##1##(1995-12#1)(2012-12#2)
Changes During##2##2##(2008-10#2)
Changes in the##24##3##(1990-5#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-6#1)(1994-5#1)(1996-1#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-6#1)(2009-8#1)(2013-1#1)
Changes in##75##2##(1990-3#2)(1990-5#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(2006-6#1)(2007-9#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2011-2#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
Changes of##7##2##(1993-8#1)(1995-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
Changes to##3##2##(1996-2#1)(2008-5#1)(2013-1#1)
Changes were##2##2##(1994-8#1)(2008-10#1)
Changes##97##1##(1990-3#2)(1990-5#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-1#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-1#1)(2006-6#1)(2007-9#1)(2008-10#19)(2008-11#6)(2008-12#2)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2011-2#5)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#2)
Changing the##6##2##(1991-10#1)(1994-1#1)(2008-10#1)(2008-5#1)(2010-1#1)(2012-2#1)
Changing##22##1##(1990-6#1)(1991-10#1)(1991-2#4)(1992-2#1)(1992-3#1)(1994-1#1)(1994-2#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)
Channel##3##1##(2008-6#1)(2008-7#1)(2010-1#1)
Channels in##2##2##(2011-2#1)(2013-1#1)
Channels##3##1##(2008-3#1)(2011-2#1)(2013-1#1)
Chaos##3##1##(1996-9#2)(2008-9#1)
Chaotic dynamics introduced in##2##4##(2008-11#2)
Chaotic dynamics##3##2##(2008-11#3)
Chaotic##6##1##(1994-2#1)(1996-9#2)(2008-11#3)
Chapter##27##1##(1992-2#2)(2008-6#1)(2008-8#7)(2008-9#16)(2012-2#1)
Characidae)##2##1##(2008-7#1)(2008-8#1)
Characidium fishes##2##2##(2010-8#2)
Characidium##3##1##(2010-8#3)
Character##2##1##(2008-8#1)(2011-2#1)
Characterisation of a##3##3##(1995-11#1)(2008-10#2)
Characterisation of the##4##3##(1993-2#1)(1994-8#1)(2008-10#1)(2008-12#1)
Characterisation of##11##2##(1993-2#1)(1994-8#1)(1995-11#1)(2008-10#4)(2008-11#3)(2008-12#1)
Characterisation##12##1##(1993-2#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-12#1)
Characteristic masses##2##2##(2008-10#2)
Characteristic##9##1##(1991-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-12#1)
Characteristics and##4##2##(1991-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
Characteristics of the##5##3##(1990-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
Characteristics of##18##2##(1990-11#1)(1990-12#1)(1992-6#1)(1993-2#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Characteristics##26##1##(1990-11#1)(1990-12#1)(1991-2#1)(1992-6#1)(1993-2#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Characterization and use##2##3##(2008-10#1)(2008-11#1)
Characterization and##15##2##(1991-9#1)(1996-8#1)(1997-7#1)(2008-10#9)(2008-11#1)(2009-12#1)(2009-7#1)
Characterization by##4##2##(2008-10#4)
Characterization of Colletotrichum acutatum##2##4##(2008-10#2)
Characterization of Phytophthora##2##3##(2008-10#2)
Characterization of Resistance##2##3##(2008-10#2)
Characterization of Two##3##3##(2008-10#3)
Characterization of a New##2##4##(2008-10#2)
Characterization of a Novel##2##4##(2008-10#2)
Characterization of a cDNA Encoding##2##5##(2008-5#1)(2008-6#1)
Characterization of a new##2##4##(1990-12#1)(1990-8#1)
Characterization of a##22##3##(1990-12#1)(1990-8#1)(1991-9#2)(1995-6#1)(2008-10#14)(2008-5#1)(2008-6#1)(2008-9#1)
Characterization of an##5##3##(1991-7#1)(2008-10#4)
Characterization of monoclonal antibodies##2##4##(1995-12#1)(1996-12#1)
Characterization of nanomaterials##2##3##(2010-7#2)
Characterization of rainbow trout##2##4##(1997-9#1)(2008-11#1)
Characterization of the electroactive process included an examination of the degree of reversibility##2##13##(2008-10#2)
Characterization of the gene##2##4##(1993-2#1)(1994-11#1)
Characterization of the murine##2##4##(1995-6#1)(1997-8#1)
Characterization of the##32##3##(1990-11#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-11#2)(1995-11#1)(1995-6#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#2)(2009-7#1)(2010-4#1)(2012-2#1)
Characterization of two##3##3##(1993-8#1)(1995-2#1)(1997-8#1)
Characterization of##171##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#2)(1997-3#2)(1997-7#1)(1997-8#5)(1997-9#1)(2008-10#87)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#6)(2009-7#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#2)
Characterization##199##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-7#2)(1991-9#3)(1992-1#1)(1992-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-8#1)(1997-3#2)(1997-7#2)(1997-8#5)(1997-9#1)(2008-10#108)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#6)(2009-12#1)(2009-7#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#2)
Characterized by##3##2##(2008-10#2)(2013-1#1)
Characterized##5##1##(2008-10#4)(2013-1#1)
Charcot arthropathy##2##2##(2008-12#2)
Charcot-Marie-Tooth disease##2##2##(2008-9#1)(2012-3#1)
Charcot-Marie-Tooth##3##1##(1997-3#1)(2008-9#1)(2012-3#1)
Chardonnay and Riesling##2##3##(2008-10#2)
Chardonnay and##3##2##(2008-10#3)
Chardonnay##5##1##(2008-10#5)
Charge##7##1##(1991-5#1)(1992-8#2)(1996-9#2)(2008-10#1)(2011-2#1)
Charge-based weights##2##2##(1993-1#2)
Charged##2##1##(2008-11#1)(2008-7#1)
Charity##2##1##(1991-3#1)(1992-8#1)
Charles Bonnet syndrome##4##3##(2011-2#2)(2013-8#2)
Charles Bonnet##6##2##(2011-2#4)(2013-8#2)
Charles Darwin##3##2##(2010-4#2)(2012-2#1)
Charles##17##1##(1995-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-1#1)(2010-4#2)(2010-5#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-8#2)
Charlotte##2##1##(1995-12#1)(2008-10#1)
Charlottetown##4##1##(2008-10#1)(2012-3#2)(2013-8#1)
Chart review was performed##2##4##(2012-3#1)(2013-1#1)
Chart##4##1##(1994-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
Charter##2##1##(1993-9#1)(1997-3#1)
Charting##2##1##(1996-1#1)(1997-3#1)
Chase##3##1##(1991-12#1)(1993-12#2)
Chayote mosaic virus##2##3##(2008-10#2)
Chałasiński##2##1##(2008-12#2)
Cheaper##2##1##(1995-2#1)(2011-3#1)
Checking##3##1##(1992-12#1)(2010-3#1)(2013-8#1)
Checklist (CBCL)##2##2##(1993-1#1)(2008-9#1)
Checklist##11##1##(1991-1#1)(1991-12#1)(1992-1#1)(1993-1#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-5#1)(2013-1#1)
Chelating agents##2##2##(1990-5#1)(2008-5#1)
Chelating##5##1##(1990-5#1)(2008-10#3)(2008-5#1)
Chelation of##2##2##(1990-12#1)(1994-11#1)
Chelation##3##1##(1990-12#1)(1994-11#1)(2011-2#1)
Chelex 100##2##2##(2008-10#2)
Chelex##3##1##(2008-10#3)
Chelex-100 resin##2##2##(2008-10#2)
Chelex-100##10##1##(2008-10#10)
Chem##41##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#1)(1994-5#5)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-10#14)(2009-9#1)
Chemical analysis of##2##3##(2008-10#2)
Chemical analysis##3##2##(1993-8#1)(2008-10#2)
Chemical and biological##2##3##(2010-7#2)
Chemical and flow variables as well as##2##7##(2008-10#2)
Chemical and##10##2##(2008-10#5)(2008-11#1)(2008-3#1)(2010-7#2)(2012-3#1)
Chemical composition and##2##3##(2008-11#1)(2008-12#1)
Chemical composition##3##2##(2008-11#2)(2008-12#1)
Chemical genomics##2##2##(2008-11#2)
Chemical imaging##3##2##(2008-10#2)(2008-5#1)
Chemical shift##3##2##(1992-11#1)(2009-7#1)(2012-2#1)
Chemical speciation##2##2##(2008-10#2)
Chemical synthesis of##2##3##(1992-6#1)(2008-4#1)
Chemical synthesis##3##2##(1992-6#1)(2008-4#1)(2011-2#1)
Chemical##88##1##(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-2#1)(2008-10#26)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#2)(2011-2#19)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
Chemically##4##1##(2008-10#2)(2009-8#1)(2011-2#1)
Chemiluminescence determination of##5##3##(2008-10#5)
Chemiluminescence emission was monitored by means of a##2##8##(2008-10#2)
Chemiluminescence flow##2##2##(2008-10#2)
Chemiluminescence of##2##2##(2008-10#2)
Chemiluminescence##23##1##(2008-10#23)
Chemiluminescent##4##1##(2008-10#3)(2010-11#1)
Chemistry and##2##2##(1994-12#1)(2008-11#1)
Chemistry for the Environment (INCA)##2##5##(2008-11#2)
Chemistry for##3##2##(2008-10#1)(2008-11#2)
Chemistry in##2##2##(1990-5#1)(2010-7#1)
Chemistry of 1##2##3##(1996-5#2)
Chemistry of##6##2##(1993-5#1)(1996-5#2)(2008-12#1)(2008-4#2)
Chemistry##29##1##(1990-5#1)(1993-5#1)(1994-12#6)(1996-5#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2009-6#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#2)
Chemometric##7##1##(2008-10#6)(2008-11#1)
Chemometrical##2##1##(2008-10#1)(2008-11#1)
Chemoprevention of##2##2##(1995-9#1)(2008-6#1)
Chemoprevention##4##1##(1995-9#1)(2008-12#1)(2008-6#1)(2009-12#1)
Chemoradiotherapy##2##1##(2008-10#1)(2012-3#1)
Chemotactic activity##2##2##(1992-6#2)
Chemotherapy of##2##2##(1990-9#1)(1997-7#1)
Chemotherapy##9##1##(1990-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-11#2)(2009-1#1)(2011-1#1)
Chemotherapy-associated##2##1##(2012-3#1)(2013-1#1)
Chemotherapy-induced##2##1##(2008-7#2)
Chen##3##1##(1990-11#1)(2008-10#1)(2008-9#1)
Chenopodiaceae##2##1##(2008-10#2)
Chenopodium quinoa and##2##3##(2008-10#2)
Chenopodium quinoa plants##2##3##(2008-10#2)
Chenopodium quinoa##6##2##(2008-10#6)
Chenopodium rubrum##2##2##(2008-11#2)
Chenopodium##10##1##(2008-10#7)(2008-11#2)(2013-1#1)
Cherry leaf roll##2##3##(2008-10#2)
Cherry leaf##3##2##(2008-10#3)
Cherry##7##1##(2008-10#5)(2008-9#2)
Chest Pain##2##2##(2008-3#2)
Chest X-ray##4##2##(1993-6#1)(2008-7#1)(2010-11#1)(2013-1#1)
Chest radiograph##2##2##(2010-2#1)(2011-2#1)
Chest##16##1##(1993-6#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-2#3)(2011-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
Chesterman##2##1##(1994-5#2)
Chestnut##3##1##(1993-1#1)(2008-10#1)(2008-5#1)
Chevron##4##1##(2008-10#4)
Chi##4##1##(1991-3#1)(2008-7#2)(2011-2#1)
Chi-square##4##1##(1996-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
Chiapas##3##1##(1997-3#1)(2008-10#2)
Chiba##6##1##(2008-10#5)(2011-2#1)
Chicago##9##1##(1990-11#2)(1996-5#1)(1997-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2013-1#1)
Chicken manure##2##2##(2008-10#2)
Chicken##8##1##(1991-12#1)(1991-3#1)(1993-12#1)(2008-10#2)(2008-11#2)(2008-6#1)
Chickpea by##2##2##(2008-10#2)
Chickpea chlorotic stunt virus##2##4##(2008-10#2)
Chickpea##11##1##(2008-10#11)
Chicks may##2##2##(2008-6#2)
Chicks were##2##2##(2008-6#1)(2011-2#1)
Chicks##6##1##(2008-5#1)(2008-6#4)(2011-2#1)
Chief of the##2##3##(2008-10#2)
Chief##6##1##(1994-1#1)(1994-8#1)(2008-10#3)(2008-12#1)
Child A##2##2##(2008-9#1)(2013-1#1)
Child Health##7##2##(1995-1#1)(1995-3#1)(2008-11#4)(2012-12#1)
Child Life##2##2##(1992-12#2)
Child Psychiatry##2##2##(1997-8#1)(2008-11#1)
Child and##6##2##(1993-1#1)(2008-11#2)(2009-9#1)(2010-1#2)
Child health##4##2##(1992-2#1)(1995-1#2)(2009-4#1)
Child life##2##2##(1992-12#2)
Child poverty##4##2##(2008-11#4)
Child with##3##2##(1996-6#1)(2010-7#1)(2010-9#1)
Child##48##1##(1990-12#1)(1991-8#1)(1992-12#4)(1992-2#1)(1993-1#2)(1995-1#3)(1995-3#1)(1996-12#1)(1996-6#1)(1997-8#1)(2008-11#14)(2008-9#2)(2009-4#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-6#2)(2010-7#2)(2010-9#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Child's##4##1##(2009-8#1)(2012-3#3)
Childhood and##2##2##(2008-12#1)(2009-12#1)
Childhood obesity##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
Childhood##12##1##(1991-3#1)(1991-8#1)(1995-3#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
Children and Adolescents##5##3##(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Children and their##2##3##(2008-3#1)(2010-12#1)
Children and##11##2##(1991-2#1)(1995-3#1)(2008-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
Children for##2##2##(1995-5#1)(2010-7#1)
Children from##2##2##(2008-11#2)
Children in##7##2##(1995-1#1)(1995-5#1)(2008-10#1)(2008-11#3)(2011-2#1)
Children whose parents were divorced or single##2##7##(1994-6#2)
Children whose##3##2##(1994-6#2)(2011-2#1)
Children with##11##2##(1992-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(2008-11#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
Children##82##1##(1991-2#2)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#3)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-1#1)(1996-12#6)(1996-3#3)(1996-9#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#3)
Children's Health Care##2##3##(1994-3#2)
Children's Health##4##2##(1992-3#1)(1994-3#3)
Children's Hospital##3##2##(1992-3#1)(1993-12#1)(2008-11#1)
Children's perceptions of##2##3##(2008-12#1)(2009-4#1)
Children's##26##1##(1991-2#1)(1991-8#1)(1992-3#2)(1993-12#1)(1994-3#3)(1994-6#1)(1995-12#1)(2008-11#3)(2008-12#3)(2008-9#1)(2009-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)
Chile and##3##2##(1990-6#1)(2008-5#1)(2013-1#1)
Chile##29##1##(1990-6#1)(1992-5#1)(1993-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-12#1)(2013-1#10)(2013-8#9)
Chilean adolescents##2##2##(2013-1#2)
Chilean##5##1##(2008-10#1)(2013-1#3)(2013-8#1)
Chim##4##1##(2008-10#4)
Chimeric##6##1##(1997-9#1)(2008-10#3)(2008-11#1)(2008-4#1)
China Sea##2##2##(2008-10#1)(2013-8#1)
China and##5##2##(2008-10#3)(2010-3#1)(2011-2#1)
China during##3##2##(2008-10#1)(2013-8#2)
China is##2##2##(2010-10#1)(2010-8#1)
China strain SHZH98##2##3##(2008-8#2)
China strain##4##2##(2008-8#4)
China virus##3##2##(2008-10#3)
China was##2##2##(2008-11#1)(2013-1#1)
China were##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
China##104##1##(1990-11#1)(1990-2#1)(1992-2#1)(1997-5#2)(2008-10#30)(2008-11#2)(2008-8#10)(2008-9#12)(2010-10#4)(2010-12#6)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#11)(2012-2#2)(2013-1#2)(2013-8#15)
China) had##2##2##(2008-10#2)
China)##6##1##(2008-10#5)(2011-2#1)
Chinese American##2##2##(2009-7#2)
Chinese Hamster Ovary (CHO) cell line##2##6##(2008-11#2)
Chinese Hamster Ovary (CHO) cell##3##5##(2008-11#3)
Chinese Hamster Ovary (CHO) cells##2##5##(2008-11#2)
Chinese Hamster Ovary (CHO)##6##4##(2008-11#6)
Chinese Hamster Ovary##9##3##(2008-11#9)
Chinese Hamster##10##2##(2008-11#10)
Chinese Sacbrood##2##2##(2008-8#2)
Chinese Science and##2##3##(2011-2#2)
Chinese Spring##4##2##(2008-10#4)
Chinese and Western medicine--a case report]##2##6##(2008-11#2)
Chinese and##4##2##(1995-12#1)(2008-11#2)(2013-8#1)
Chinese cabbage and turnip hairy roots##2##6##(2008-10#2)
Chinese cabbage##8##2##(2008-10#4)(2008-8#3)(2011-3#1)
Chinese characters##3##2##(2008-11#1)(2008-8#2)
Chinese children##2##2##(2011-2#1)(2012-2#1)
Chinese deaf##2##2##(2011-2#2)
Chinese donkey leukocyte attenuated equine infectious anemia virus##2##8##(2008-9#2)
Chinese hamster ovary (CHO) and hybridoma cells##2##7##(2008-11#2)
Chinese hamster ovary (CHO) cell line##2##6##(2008-11#2)
Chinese hamster ovary (CHO) cell##4##5##(2008-11#2)(2008-7#2)
Chinese hamster ovary (CHO) cells stably##2##6##(1994-11#1)(1995-11#1)
Chinese hamster ovary (CHO) cells transfected with the##2##8##(1995-6#1)(2008-10#1)
Chinese hamster ovary (CHO) cells were##2##6##(2008-11#1)(2008-7#1)
Chinese hamster ovary (CHO) cells##19##5##(1992-10#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#11)(2008-7#3)
Chinese hamster ovary (CHO)##26##4##(1992-10#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#16)(2008-7#5)
Chinese hamster ovary cell culture##2##5##(2008-11#1)(2008-7#1)
Chinese hamster ovary cell line##3##5##(2008-11#3)
Chinese hamster ovary cell lines##2##5##(2008-11#2)
Chinese hamster ovary cell##9##4##(2008-11#8)(2008-7#1)
Chinese hamster ovary cells with##2##5##(1995-8#1)(2008-11#1)
Chinese hamster ovary cells##20##4##(1991-5#2)(1993-3#1)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-12#1)(2008-11#9)(2008-7#1)(2008-8#1)
Chinese hamster ovary##60##3##(1991-5#2)(1992-10#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#3)(1995-6#2)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#38)(2008-7#7)(2008-8#1)
Chinese hamster##65##2##(1991-5#2)(1992-10#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#3)(1995-6#2)(1995-8#1)(1996-12#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-11#39)(2008-7#7)(2008-8#1)(2011-1#1)
Chinese herb##3##2##(2008-10#1)(2013-1#2)
Chinese herbal remedies##2##3##(2008-10#2)
Chinese herbal##13##2##(2008-10#7)(2008-8#1)(2011-2#2)(2011-3#1)(2013-8#2)
Chinese herbs##12##2##(2008-10#6)(2008-5#5)(2011-3#1)
Chinese materia medica##2##3##(2011-2#2)
Chinese medical##3##2##(2013-1#1)(2013-8#2)
Chinese medicament##2##2##(1997-2#2)
Chinese medicinal##3##2##(2008-10#3)
Chinese medicine injections##5##3##(2011-2#4)(2011-3#1)
Chinese medicine theory##2##3##(2011-2#1)(2013-1#1)
Chinese medicine##20##2##(2008-10#4)(2011-2#7)(2011-3#2)(2012-2#2)(2013-1#4)(2013-8#1)
Chinese physicians##2##2##(2011-2#2)
Chinese population##5##2##(2008-7#1)(2008-8#1)(2011-2#3)
Chinese populations##4##2##(2008-8#3)(2008-9#1)
Chinese raccoon##2##2##(2008-12#2)
Chinese rice varieties through an##2##5##(2008-8#2)
Chinese traditional##2##2##(1991-6#1)(2008-8#1)
Chinese##272##1##(1991-5#2)(1991-6#1)(1992-10#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-11#3)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-2#4)(1997-3#1)(1997-7#2)(1997-8#2)(2008-10#51)(2008-11#54)(2008-12#5)(2008-3#1)(2008-5#7)(2008-7#10)(2008-8#23)(2008-9#11)(2009-5#3)(2009-7#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-6#4)(2010-8#1)(2011-1#1)(2011-2#33)(2011-3#9)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#11)
Chinook##3##1##(2008-11#1)(2010-8#2)
Chiral polyamines##2##2##(2009-10#2)
Chiral##8##1##(1996-5#4)(2008-10#2)(2009-10#2)
Chiralpak AD##2##2##(2008-10#2)
Chiralpak##5##1##(2008-10#5)
Chiranjeevi worked##2##2##(2008-10#2)
Chiranjeevi##8##1##(2008-10#8)
Chirasil-Val##2##1##(2008-10#2)
Chironomus##4##1##(2008-11#4)
Chiropractic##2##1##(2008-12#1)(2008-5#1)
Chitin##2##1##(2008-10#2)
Chitinase activity##2##2##(2008-10#2)
Chitinase##7##1##(2008-10#7)
Chitinases##4##1##(2008-10#4)
Chitinophaga pinensis##2##2##(2011-2#2)
Chitinophaga##4##1##(2011-2#4)
Chitosan##3##1##(2008-10#3)
Chlamydia pneumoniae##2##2##(2010-12#1)(2013-1#1)
Chlamydia positive##3##2##(2008-5#3)
Chlamydia psittaci##3##2##(1990-5#1)(1992-5#1)(2013-1#1)
Chlamydia sp##4##2##(2008-5#4)
Chlamydia trachomatis##9##2##(1990-5#2)(1993-9#2)(1995-11#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
Chlamydia was detected in##2##4##(2008-5#2)
Chlamydia##31##1##(1990-5#3)(1992-5#1)(1993-9#2)(1995-11#1)(2008-5#13)(2009-8#3)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Chlamydomonas reinhardtii##4##2##(2009-10#2)(2012-3#2)
Chlamydospores of##2##2##(2008-10#2)
Chlamydospores##3##1##(2008-10#3)
Chlorella vulgaris##6##2##(2008-10#5)(2008-12#1)
Chlorella##8##1##(2008-10#7)(2008-12#1)
Chloride##2##1##(2008-10#2)
Chlorofluorocarbons##2##1##(1992-3#1)(1996-1#1)
Chloroform##2##1##(1991-8#2)
Chlorogenic acid##2##2##(2008-10#1)(2008-11#1)
Chlorophyll##3##1##(2008-10#2)(2008-12#1)
Chloroplast##3##1##(2008-11#1)(2009-8#1)(2012-3#1)
Chlorpyrifos##5##1##(2008-10#5)
Choice of##3##2##(1991-6#1)(2011-2#1)(2013-8#1)
Choice##5##1##(1991-6#1)(1995-2#1)(1996-1#1)(2011-2#1)(2013-8#1)
Choices##2##1##(1995-11#1)(2013-1#1)
Cholangiocarcinoma##2##1##(2009-9#2)
Cholecystokinin##2##1##(1993-6#1)(1994-2#1)
Cholera##5##1##(1990-6#1)(1994-2#2)(2009-8#1)(2012-3#1)
Cholesterol side-chain cleavage and 11 beta-hydroxylation##2##6##(1990-11#2)
Cholesterol##13##1##(1990-11#2)(1994-8#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
Cholesteryl##2##1##(1990-8#1)(2009-8#1)
Cholinergic##2##1##(2013-8#2)
Cholinesterases in##2##2##(1990-5#1)(1993-2#1)
Chondrocytes##2##1##(2008-11#2)
Chondrosarcoma is##2##2##(2008-1#1)(2008-5#1)
Chondrosarcoma##3##1##(1997-8#1)(2008-1#1)(2008-5#1)
Chondrosarcomas##2##1##(2008-1#1)(2008-7#1)
Choosing##5##1##(1994-3#1)(1995-3#1)(2008-11#1)(2011-2#2)
Chorea##2##1##(2008-11#1)(2011-10#1)
Chown et al##2##3##(2008-8#2)
Christ##2##1##(1993-12#1)(2008-12#1)
Christian health care##2##3##(1991-2#1)(1993-12#1)
Christian##6##1##(1991-2#1)(1993-12#1)(2008-10#1)(2008-12#2)(2009-5#1)
Christians##2##1##(1991-2#1)(2008-12#1)
Christmas##4##1##(1990-5#1)(2008-10#3)
Christopher##2##1##(1996-5#1)(2010-6#1)
ChromID ESBL agar plates##3##4##(2010-6#3)
ChromID ESBL agar##5##3##(2010-6#5)
Chromatic##3##1##(2008-3#2)(2011-2#1)
Chromatid segregation##2##2##(2008-11#2)
Chromatid##3##1##(2008-11#2)(2012-2#1)
Chromatin Immunoprecipitation##2##2##(2008-2#1)(2008-7#1)
Chromatin##4##1##(2007-12#1)(2008-2#1)(2008-7#1)(2009-8#1)
Chromatium vinosum##2##2##(1993-8#2)
Chromatium##3##1##(1993-8#3)
Chromatogr##7##1##(2008-10#7)
Chromatographic analysis##2##2##(2008-10#1)(2008-11#1)
Chromatographic and##2##2##(2008-10#2)
Chromatographic separation was##2##3##(2008-10#1)(2011-3#1)
Chromatographic##15##1##(2008-10#10)(2008-11#3)(2009-8#1)(2011-3#1)
Chromatography##14##1##(1990-5#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#3)(2009-8#3)(2010-7#1)(2012-2#1)(2013-1#2)
Chromazurol S##2##2##(2008-10#2)
Chrome Azurol S##2##3##(2008-10#1)(2013-1#1)
Chromic catgut suture should be abandoned for fascial closure of the anterior abdominal wall in favor of newer##2##18##(1991-1#2)
Chromium speciation using##2##3##(2008-10#2)
Chromium speciation##4##2##(2008-10#4)
Chromium##11##1##(2008-10#11)
Chromium(III)##4##1##(2008-10#4)
Chromogranin##2##1##(1992-12#1)(1993-8#1)
Chromolithtrade mark##2##2##(2008-10#2)
Chromophore##2##1##(1994-5#1)(2008-10#1)
Chromosomal location and##2##3##(2008-10#1)(2010-8#1)
Chromosomal##10##1##(1991-12#1)(1991-9#1)(1995-6#1)(2008-10#4)(2009-7#1)(2010-8#1)(2012-3#1)
Chromosome analysis##2##2##(1997-3#1)(2009-12#1)
Chromosome sizes of##2##3##(2008-10#2)
Chromosome study of##2##3##(2008-12#2)
Chromosome##20##1##(1997-3#1)(2008-10#9)(2008-11#1)(2008-12#5)(2008-4#1)(2009-12#1)(2012-3#2)
Chromosomes##2##1##(1997-2#1)(2008-12#1)
Chromosorb 105 and##2##3##(2008-10#2)
Chromosorb 105##4##2##(2008-10#4)
Chromosorb##5##1##(2008-10#4)(2008-7#1)
Chromosorb-107 filled in a syringe##2##5##(2008-10#2)
Chromosorb-107##3##1##(2008-10#3)
Chromotropic##2##1##(2008-10#2)
Chronic Renal##2##2##(2008-1#1)(2008-12#1)
Chronic benign pain##2##3##(2008-4#2)
Chronic exposure to Al is##2##5##(2013-8#2)
Chronic exposure to##5##3##(1991-4#1)(1995-8#1)(2010-5#1)(2013-8#2)
Chronic hepatitis B##2##3##(2009-8#2)
Chronic hepatitis##3##2##(1992-12#1)(2009-8#2)
Chronic inflammatory##2##2##(1997-1#1)(2011-2#1)
Chronic kidney disease##2##3##(2009-12#1)(2012-2#1)
Chronic obstructive pulmonary disease##3##4##(1992-1#1)(2011-2#2)
Chronic pain##2##2##(2008-12#1)(2008-4#1)
Chronic pancreatitis##2##2##(1994-3#1)(2009-7#1)
Chronic reductions in cerebral blood flow (CBF) of between 25 and 50%##2##12##(2008-7#2)
Chronic rhinosinusitis##2##2##(2013-8#2)
Chronic subcutaneous infusion of##2##4##(2011-2#2)
Chronic suppurative otitis media following##2##5##(2008-9#2)
Chronic tracheobronchial syndrome##2##3##(1992-5#2)
Chronic treatment with##3##3##(1994-6#1)(1997-2#1)(2010-6#1)
Chronic treatment##4##2##(1994-6#1)(1997-1#1)(1997-2#1)(2010-6#1)
Chronic venous insufficiency##2##3##(2011-3#1)(2013-1#1)
Chronic##80##1##(1991-1#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-5#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#3)(1997-2#3)(1997-4#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#8)(2011-3#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#6)
Chronoamperometric##3##1##(2008-10#2)(2009-9#1)
Chryseobacterium##2##1##(2008-10#2)
Chubu 32 and##2##3##(2008-10#2)
Chubu 32##5##2##(2008-10#5)
Church##2##1##(1990-6#1)(1992-2#1)
Churg-Strauss syndrome##2##2##(2010-6#1)(2012-3#1)
Cibacron Blue F3G-A##2##3##(1997-2#2)
Cibacron Blue##5##2##(1990-12#2)(1997-2#2)(2008-10#1)
Ciclesonide##2##1##(2008-8#2)
Cigarette smoking##5##2##(1991-12#1)(1997-2#1)(2008-12#1)(2013-1#2)
Cigarette##6##1##(1991-12#1)(1997-2#1)(2008-12#1)(2013-1#2)(2013-8#1)
Ciliary##2##1##(1990-5#1)(2013-1#1)
Ciliates##2##1##(2008-12#1)(2012-3#1)
Cincinnati health care##2##3##(1994-12#2)
Cincinnati##10##1##(1993-1#1)(1993-12#1)(1994-12#2)(1995-3#1)(2008-5#3)(2011-2#2)
Cine computed##2##2##(2013-1#2)
Cine##4##1##(2013-1#4)
Circadian##4##1##(2008-11#1)(2008-5#3)
Circuit##4##1##(1995-6#2)(1997-6#1)(2008-3#1)
Circuits##2##1##(1995-6#1)(2008-3#1)
Circular dichroism (CD)##2##3##(1994-5#1)(2008-4#1)
Circular dichroism##4##2##(1994-5#1)(1995-2#1)(2008-4#1)(2012-2#1)
Circular##6##1##(1994-5#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-4#1)(2012-2#1)
Circulating AFP mRNA##3##3##(2008-10#3)
Circulating##15##1##(1992-12#1)(1993-2#2)(2008-10#4)(2008-7#4)(2010-1#1)(2010-11#1)(2012-3#2)
Circulation##3##1##(2008-11#1)(2008-3#1)(2011-2#1)
Circulifer haematoceps##2##2##(2008-10#2)
Circulifer tenellus##4##2##(2008-10#4)
Circulifer##6##1##(2008-10#6)
Circumcision##3##1##(2008-11#3)
Cirrhosis##3##1##(2009-8#1)(2012-3#1)(2013-1#1)
Cirsium arvense##2##2##(2008-10#2)
Cisplatin##11##1##(1991-2#3)(1993-9#1)(2008-10#7)
Cisplatin-liposome##3##1##(2008-10#3)
Cistanche species and##3##3##(2011-2#3)
Cistanche species##6##2##(2011-2#6)
Cistanche##10##1##(2011-2#10)
Cit7##4##1##(2008-10#4)
Citation##5##1##(1991-3#1)(1992-3#1)(2010-12#2)(2013-1#1)
Cities##3##1##(1991-9#1)(1992-6#1)(2011-2#1)
Citizens'##2##1##(1992-3#1)(2012-12#1)
Citrate##2##1##(2008-10#1)(2008-7#1)
Citrobacter freundii##2##2##(2010-6#1)(2011-2#1)
Citrobacter rodentium##2##2##(2011-1#2)
Citrobacter sp##2##2##(2008-7#2)
Citrobacter##8##1##(2008-7#4)(2010-6#1)(2011-1#2)(2011-2#1)
Citrus Black##2##2##(2008-10#2)
Citrus Brown##2##2##(2008-10#2)
Citrus Fruit##3##2##(2008-10#3)
Citrus aurantium var##2##3##(2008-10#2)
Citrus bent leaf viroid (CBLVd)##2##5##(2008-10#2)
Citrus exocortis viroid (CEVd)##3##4##(2008-10#3)
Citrus exocortis viroid##4##3##(2008-10#4)
Citrus tristeza virus (CTV)##6##4##(2008-10#6)
Citrus tristeza virus##9##3##(2008-10#9)
Citrus viroid III##2##3##(2008-10#2)
Citrus viroid IV##2##3##(2008-10#2)
Citrus viroid##6##2##(2008-10#6)
Citrus##59##1##(2008-10#57)(2012-3#2)
City University##3##2##(1991-12#1)(2008-11#2)
City of##2##2##(1991-12#1)(2013-1#1)
City##68##1##(1990-11#2)(1991-1#3)(1991-12#5)(1992-3#1)(1993-5#1)(1994-9#2)(1995-12#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-3#6)(1996-5#1)(1997-1#1)(2008-10#6)(2008-11#4)(2008-12#6)(2008-7#3)(2008-9#1)(2009-5#5)(2009-7#1)(2011-2#2)(2013-1#4)(2013-8#6)
Civil##5##1##(1993-3#1)(1994-1#1)(1994-9#1)(1996-5#1)(2008-11#1)
Civilian##3##1##(1992-12#1)(1994-12#1)(1996-12#1)
Ciwujia injection was##2##3##(2011-2#2)
Ciwujia injection##6##2##(2011-2#6)
Ciwujia##7##1##(2011-2#7)
Cixius wagneri##2##2##(2008-10#2)
Cl and Na##2##3##(2008-9#2)
Cl and##6##2##(2008-10#4)(2008-9#2)
Cl##25##1##(1994-5#1)(1996-9#1)(2008-10#13)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-5#2)
Cl(-) and##3##2##(2008-10#2)(2012-7#1)
Cl(-) in##2##2##(2008-10#2)
Cl(-)##26##1##(2008-10#24)(2009-8#1)(2012-7#1)
Cl(-))##2##1##(2008-10#2)
Cl(2)##2##1##(2008-10#1)(2008-2#1)
Cl(2))##2##1##(2008-10#2)
Cl)##2##1##(2008-10#2)
Cl-##2##1##(1996-12#2)
ClO(-)/L##3##1##(2008-10#3)
ClO(3)(-) was##2##2##(2008-10#2)
ClO(3)(-)##7##1##(2008-10#7)
ClO(3)(-)-ClO(2)(-) and ClO(3)(-)-HClO##2##3##(2008-10#2)
ClO(3)(-)-ClO(2)(-)##3##1##(2008-10#3)
ClO(3)(-)-HClO##3##1##(2008-10#3)
ClO(4)(-)##2##1##(2008-10#2)
ClYVV##4##1##(2008-10#4)
Clade##4##1##(2008-10#4)
Clades##3##1##(2008-10#1)(2008-8#1)(2010-3#1)
Cladosiphon novae-caledoniae kylin##3##3##(2008-11#3)
Cladosporium carpophilum##2##2##(2008-10#2)
Cladosporium caryigenum##2##2##(2008-10#2)
Cladosporium spp##3##2##(2008-10#1)(2013-1#2)
Cladosporium tenuissimum##5##2##(2008-10#5)
Cladosporium##19##1##(2008-10#11)(2008-5#3)(2010-5#2)(2012-2#1)(2013-1#2)
Claims##3##1##(1994-12#1)(1997-1#1)(2008-11#1)
Claisen rearrangement of##2##3##(1996-5#2)
Claisen##3##1##(1996-5#3)
Clara cells##4##2##(1990-6#2)(2013-1#2)
Clara##7##1##(1990-6#2)(1995-12#1)(2010-8#1)(2013-1#3)
Clare Vaughan##3##2##(1996-8#3)
Clarification##4##1##(2008-10#1)(2012-2#2)(2012-3#1)
Clarifying##2##1##(1994-1#1)(2008-9#1)
Clarion CII##2##2##(2008-9#2)
Clarion##3##1##(2008-9#3)
Clark I##2##2##(2008-11#2)
Clark##9##1##(1991-7#1)(1992-1#1)(1994-3#1)(2008-10#4)(2008-11#2)
Class 1 cells##2##3##(2007-12#2)
Class I##10##2##(1995-12#1)(1995-8#1)(2008-11#2)(2008-7#1)(2011-2#2)(2013-1#3)
Class II malocclusion##2##3##(2013-1#2)
Class II##8##2##(1995-8#1)(2008-11#3)(2013-1#4)
Class III##2##2##(1995-8#1)(2013-1#1)
Class##40##1##(1990-2#4)(1995-12#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#3)(1996-3#1)(1996-5#1)(2007-12#3)(2008-10#3)(2008-11#6)(2008-12#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#8)
Classes##2##1##(2008-10#1)(2008-12#1)
Classic##2##1##(2008-10#1)(2008-5#1)
Classical##12##1##(1992-12#1)(1995-8#1)(1996-9#1)(2008-10#4)(2008-11#2)(2011-2#1)(2012-3#2)
Classification and##2##2##(2008-10#1)(2010-10#1)
Classification of Diseases##3##3##(1990-12#1)(1991-9#1)(2012-12#1)
Classification of Functioning##2##3##(2011-2#1)(2012-12#1)
Classification of Primary##3##3##(1991-9#2)(1994-6#1)
Classification of##15##2##(1990-12#1)(1991-12#1)(1991-9#3)(1994-6#1)(2008-10#5)(2010-12#1)(2011-2#1)(2012-12#2)
Classification##36##1##(1990-12#1)(1991-12#3)(1991-9#3)(1993-12#1)(1994-6#1)(2008-10#8)(2009-10#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#1)
Classifying##2##1##(1997-3#1)(2010-8#1)
Classroom##6##1##(2008-12#3)(2010-8#1)(2011-1#1)(2011-2#1)
Clause##2##1##(1993-9#1)(1995-6#1)
Clausthal-Zellerfeld##2##1##(2008-11#2)
Clavibacter michiganensis subsp##10##3##(2008-10#10)
Clavibacter##11##1##(2008-10#11)
Claviceps africana##3##2##(2008-10#3)
Claviceps purpurea##2##2##(2008-10#2)
Claviceps spp##2##2##(2008-10#2)
Claviceps##8##1##(2008-10#8)
Clay##2##1##(1991-1#1)(1996-9#1)
Clayton##5##1##(2008-10#5)
Clean##2##1##(1997-3#1)(2008-10#1)
Clear##5##1##(1991-2#1)(2008-10#1)(2011-2#1)(2012-4#1)(2013-1#1)
Clearinghouse is##2##2##(1994-1#1)(1996-3#1)
Clearinghouse##15##1##(1994-1#5)(1996-3#8)(2012-12#2)
Clearly##13##1##(1991-2#1)(1992-1#1)(1992-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
Cleavage of the##3##3##(1993-2#1)(1994-8#1)(2008-10#1)
Cleavage of##8##2##(1992-6#1)(1993-2#1)(1994-5#1)(1994-8#1)(1996-5#2)(2008-10#1)(2008-8#1)
Cleavage##11##1##(1992-6#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-5#2)(1997-7#1)(2008-10#1)(2008-8#1)
Cleft##2##1##(2010-11#1)(2012-3#1)
Cleidocranial dysplasia (CCD) is##2##4##(2011-1#1)(2013-1#1)
Cleidocranial dysplasia##3##2##(2011-1#2)(2013-1#1)
Cleistogamous cultivars##2##2##(2008-10#2)
Clemens##3##1##(2010-5#2)(2011-2#1)
Clenbuterol treatment in##2##3##(2010-6#2)
Clenbuterol treatment##3##2##(2010-6#3)
Clenbuterol##7##1##(2008-10#1)(2010-6#6)
Cleome arabica##2##2##(2013-8#2)
Cleome##3##1##(2010-2#1)(2013-8#2)
Cleveland Clinic##3##2##(1994-3#1)(1995-3#1)(2008-7#1)
Cleveland Health Quality Choice##2##4##(1995-2#1)(1996-1#1)
Cleveland##7##1##(1992-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-7#1)
Client##2##1##(2009-10#1)(2009-9#1)
Climate Change##2##2##(2008-11#1)(2011-2#1)
Climate change will##2##3##(2008-11#1)(2012-5#1)
Climate change##6##2##(2008-11#2)(2008-9#1)(2011-2#1)(2012-5#1)(2012-7#1)
Climate##12##1##(2008-10#1)(2008-11#3)(2008-9#1)(2011-2#3)(2012-12#1)(2012-5#1)(2012-7#2)
Clin Ter 2012##27##3##(2013-1#27)
Clin##37##1##(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#27)
Clinic of the##3##3##(2008-7#1)(2011-3#1)(2012-2#1)
Clinic of##6##2##(1996-11#1)(2008-11#1)(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
Clinic##34##1##(1991-11#1)(1993-12#7)(1994-2#2)(1994-3#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-10#1)(2011-2#3)(2011-3#3)(2012-2#2)(2012-3#1)(2013-8#1)
Clinical Biochemistry##2##2##(1994-12#2)
Clinical Biochemists##2##2##(1994-12#2)
Clinical Chemistry##5##2##(1994-12#5)
Clinical Evidence##5##2##(2008-8#4)(2010-10#1)
Clinical Hospital##3##2##(2011-2#2)(2013-1#1)
Clinical Laboratory##3##2##(1994-12#1)(1994-2#1)(2008-5#1)
Clinical Outcomes##2##2##(2008-2#1)(2013-8#1)
Clinical Practice and##2##3##(1997-4#1)(2008-11#1)
Clinical Practice##3##2##(1997-4#1)(2008-11#1)(2012-12#1)
Clinical Trials##7##2##(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-2#2)(2013-8#1)
Clinical Unit structure##2##3##(1992-12#2)
Clinical Unit##3##2##(1992-12#3)
Clinical and experimental studies have##2##5##(2009-7#1)(2010-12#1)
Clinical and pathological##2##3##(2010-6#1)(2013-1#1)
Clinical and radiologic##2##3##(2010-9#1)(2012-3#1)
Clinical and radiological##2##3##(1990-12#1)(2012-12#1)
Clinical and##22##2##(1990-12#2)(1990-9#1)(1991-2#1)(1991-8#1)(1995-9#1)(2008-5#2)(2009-7#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
Clinical applications of##4##3##(1991-2#1)(2009-9#1)(2010-8#1)(2011-7#1)
Clinical applications##5##2##(1991-2#2)(2009-9#1)(2010-8#1)(2011-7#1)
Clinical approach##2##2##(1992-3#1)(1996-3#1)
Clinical aspects and##2##3##(1993-3#1)(1996-3#1)
Clinical aspects##3##2##(1993-3#1)(1996-3#1)(1997-5#1)
Clinical biochemistry##5##2##(1994-12#5)
Clinical case##2##2##(1992-2#1)(2011-2#1)
Clinical case]##2##2##(1990-3#1)(1990-9#1)
Clinical characteristics of##2##3##(2012-12#1)(2013-8#1)
Clinical characteristics##3##2##(2006-5#1)(2012-12#1)(2013-8#1)
Clinical chemistry##3##2##(1994-12#3)
Clinical commentary##3##2##(2008-11#3)
Clinical data were##2##3##(1996-11#1)(2013-1#1)
Clinical data##4##2##(1996-11#1)(2008-7#1)(2009-10#1)(2013-1#1)
Clinical effects of##3##3##(2009-7#1)(2012-3#1)(2013-1#1)
Clinical efficacy##2##2##(1990-3#1)(2011-2#1)
Clinical evaluation of##2##3##(1996-1#1)(2012-12#1)
Clinical evaluation was performed##2##4##(1990-12#1)(2009-3#1)
Clinical evaluation##7##2##(1990-12#1)(1994-12#1)(1996-1#1)(1996-9#1)(2008-10#1)(2009-3#1)(2012-12#1)
Clinical examination##3##2##(2008-7#1)(2010-7#1)(2013-1#1)
Clinical experience##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
Clinical features and##2##3##(2008-7#1)(2009-3#1)
Clinical features##5##2##(2008-11#1)(2008-7#1)(2009-3#1)(2010-5#1)(2013-1#1)
Clinical findings##2##2##(1991-8#1)(2011-3#1)
Clinical implications##3##2##(1993-11#1)(2009-11#1)(2009-9#1)
Clinical management##2##2##(2008-11#1)(2011-2#1)
Clinical manifestations were##2##3##(2008-5#1)(2011-2#1)
Clinical manifestations##6##2##(1997-3#1)(2008-5#1)(2010-1#2)(2011-2#1)(2013-1#1)
Clinical observations##2##2##(1991-2#1)(2011-2#1)
Clinical onset is##2##3##(1996-9#1)(2008-4#1)
Clinical outcome##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
Clinical practice and##2##3##(2008-11#1)(2008-12#1)
Clinical practice##4##2##(2008-11#1)(2008-12#1)(2009-7#2)
Clinical presentation##2##2##(2012-3#2)
Clinical problem-solving##3##2##(1992-5#1)(1994-3#2)
Clinical profile of patients##2##4##(2010-5#1)(2012-3#1)
Clinical profile of##4##3##(2008-1#1)(2010-5#1)(2012-3#2)
Clinical profile##5##2##(2008-1#1)(2009-10#1)(2010-5#1)(2012-3#2)
Clinical question##2##2##(2012-12#2)
Clinical questions##4##2##(2012-12#4)
Clinical results##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
Clinical significance as it relates to evidence-based practice##2##8##(2013-1#2)
Clinical studies have shown that##2##5##(2010-12#1)(2011-2#1)
Clinical studies have##4##3##(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
Clinical studies##8##2##(1997-4#1)(2008-5#2)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
Clinical trial report##2##3##(2011-2#2)
Clinical trial##5##2##(2010-11#1)(2010-12#1)(2011-2#3)
Clinical trials have##2##3##(2008-11#1)(2012-2#1)
Clinical trials##7##2##(1992-9#1)(2008-11#2)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Clinical use of##2##3##(2008-3#1)(2011-7#1)
Clinical utility##2##2##(2008-10#1)(2010-7#1)
Clinical##315##1##(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-9#2)(1991-1#2)(1991-2#5)(1991-3#3)(1991-8#2)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#23)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-8#1)(2006-5#2)(2007-11#1)(2008-1#3)(2008-10#8)(2008-11#21)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#4)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#4)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#1)(2011-2#28)(2011-3#1)(2011-7#2)(2012-12#14)(2012-2#3)(2012-3#10)(2013-1#32)(2013-8#14)
Clinically relevant##3##2##(1991-6#1)(1993-9#1)(2010-11#1)
Clinically##20##1##(1990-2#1)(1991-6#1)(1993-9#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-8#1)
Clinicians should be aware##2##4##(2010-9#1)(2012-12#1)
Clinicians should be##4##3##(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
Clinicians should##8##2##(2008-11#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
Clinicians##14##1##(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
Clinico-pathologic##2##1##(1992-12#1)(1993-6#1)
Clinicopathologic##2##1##(2008-11#1)(2011-2#1)
Clinics##3##1##(1996-1#1)(1996-11#1)(2013-1#1)
Clinton has##2##2##(1995-6#2)
Clinton in##2##2##(1996-12#1)(2008-10#1)
Clinton plan##3##2##(1994-2#2)(1995-2#1)
Clinton##32##1##(1993-5#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#4)(1995-2#3)(1995-6#9)(1996-12#1)(1996-5#3)(1997-2#2)(2008-10#1)
Clinton's plan##2##2##(1993-5#1)(1995-6#1)
Clinton's##5##1##(1993-5#1)(1995-12#1)(1995-6#2)(1996-5#1)
Clipping##3##1##(2008-12#1)(2011-2#1)(2012-3#1)
Clob with##2##2##(2008-10#2)
Clobazam##2##1##(2008-10#2)
Clonal Lineages of Phytophthora##2##4##(2008-10#2)
Clonal Lineages##3##2##(2008-10#3)
Clonal lineages##2##2##(2008-10#2)
Clonal##8##1##(2008-10#7)(2008-5#1)
Clonality##3##1##(2008-10#2)(2008-5#1)
Cloned##10##1##(1994-12#1)(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#2)
Clones of##4##2##(2008-10#2)(2008-11#2)
Clones##6##1##(1991-6#1)(1992-2#1)(2008-10#2)(2008-11#2)
Clonidine##3##1##(1997-4#1)(2010-7#2)
Cloning and Characterization of a##3##5##(2008-10#2)(2008-5#1)
Cloning and characterization of a cDNA encoding##2##7##(1993-12#1)(2008-8#1)
Cloning and characterization of a novel##3##6##(1993-2#1)(2008-8#1)(2008-9#1)
Cloning and characterization of a##8##5##(1992-3#1)(1993-12#1)(1993-2#2)(1997-7#1)(2008-8#2)(2008-9#1)
Cloning and characterization of the##5##5##(1991-6#1)(1995-11#1)(1997-4#1)(1997-7#1)(2008-8#1)
Cloning and characterization of##15##4##(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-7#2)(2008-8#3)(2008-9#1)
Cloning and expression of the##3##5##(1992-10#1)(1996-12#1)(2008-11#1)
Cloning and expression of##8##4##(1992-10#1)(1994-12#1)(1996-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
Cloning and expression##9##3##(1992-10#1)(1994-12#1)(1996-12#2)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
Cloning and sequencing of a##4##5##(1995-12#1)(1996-8#1)(1997-7#1)(2008-9#1)
Cloning and sequencing of the##3##5##(1996-12#1)(1996-8#1)(2008-10#1)
Cloning and sequencing of##8##4##(1995-12#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-7#1)(2008-10#1)(2008-9#1)
Cloning and sequencing##10##3##(1993-2#1)(1995-12#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-7#2)(2008-10#1)(2008-9#1)
Cloning and##45##2##(1991-6#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-2#4)(1993-6#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#3)(1996-8#2)(1997-2#1)(1997-4#1)(1997-7#4)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#4)(2013-1#1)
Cloning of a cDNA##2##4##(1993-8#1)(1995-6#1)
Cloning of a##5##3##(1990-12#1)(1993-8#1)(1995-6#1)(2008-7#1)(2008-8#1)
Cloning of an##2##3##(1993-6#1)(1997-4#1)
Cloning of the##5##3##(1993-12#1)(1993-3#1)(1993-6#1)(1996-12#1)(1997-2#1)
Cloning of##14##2##(1990-12#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-7#1)(2008-8#2)(2008-9#1)
Cloning##75##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-12#4)(1993-2#4)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#3)(1996-12#4)(1996-6#1)(1996-8#2)(1997-2#2)(1997-4#2)(1997-7#4)(1997-9#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#8)(2010-12#1)(2010-5#2)(2012-2#1)(2013-1#1)
Clonostachys rosea##4##2##(2008-10#4)
Clopidogrel##4##1##(2008-10#1)(2011-2#2)(2013-1#1)
Closed reduction##2##2##(2008-12#1)(2011-2#1)
Closed##3##1##(2008-10#1)(2008-12#1)(2011-2#1)
Closely Related##3##2##(2008-10#2)(2013-8#1)
Closely related##3##2##(1995-5#1)(2008-10#1)(2012-5#1)
Closely##6##1##(1995-5#1)(2008-10#3)(2012-5#1)(2013-8#1)
Closing##3##1##(1990-11#1)(1993-1#1)(1996-5#1)
Closteroviridae##2##1##(2008-10#2)
Closterovirus##5##1##(2008-10#5)
Clostridial myonecrosis##2##2##(2011-2#2)
Clostridial##3##1##(2011-2#3)
Clostridium beijerinckii##2##2##(2013-1#2)
Clostridium botulinum in##2##3##(2011-2#2)
Clostridium botulinum type##3##3##(1992-3#2)(1993-2#1)
Clostridium botulinum##12##2##(1992-3#3)(1993-2#1)(2007-12#1)(2011-2#7)
Clostridium difficile##5##2##(2010-11#1)(2011-2#2)(2013-1#2)
Clostridium perfringens growth##2##3##(2011-2#2)
Clostridium perfringens##9##2##(1994-11#1)(2010-6#2)(2011-2#6)
Clostridium thermocellum##4##2##(1991-5#2)(2008-6#2)
Clostridium##37##1##(1991-5#2)(1992-3#4)(1993-2#1)(1994-11#1)(2007-12#1)(2008-6#3)(2010-11#1)(2010-6#2)(2011-2#18)(2013-1#4)
Closure of##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
Closure##5##1##(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
Cloud point extraction (CPE)##2##4##(2008-10#2)
Cloud point extraction of##2##4##(2008-10#2)
Cloud point extraction was##2##4##(2008-10#2)
Cloud point extraction##8##3##(2008-10#8)
Cloud point##9##2##(2008-10#9)
Cloud##11##1##(2008-10#10)(2008-2#1)
Clustal##2##1##(2008-9#2)
ClustalW##3##1##(2008-9#3)
ClustalX and##2##2##(2008-9#2)
ClustalX##5##1##(2008-9#5)
Cluster 2##2##2##(2008-10#1)(2011-2#1)
Cluster analysis based on##2##4##(2008-10#2)
Cluster analysis of multilocus genotypes##2##5##(2008-10#2)
Cluster analysis of##7##3##(2008-10#5)(2008-8#1)(2013-1#1)
Cluster analysis revealed##3##3##(2008-10#3)
Cluster analysis##22##2##(2008-10#18)(2008-12#1)(2008-8#1)(2010-12#1)(2013-1#1)
Cluster and##2##2##(2008-10#2)
Cluster of##2##2##(2008-10#2)
Cluster##35##1##(2008-10#29)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
Clustering Analysis##2##2##(2010-8#2)
Clustering of##2##2##(2008-10#2)
Clustering##8##1##(2008-10#3)(2009-6#1)(2010-1#1)(2010-8#2)(2011-2#1)
Clusters of##3##2##(2007-12#1)(2008-10#2)
Clusters##5##1##(2007-12#1)(2008-10#3)(2013-1#1)
Cm##4##1##(1991-9#1)(2008-10#3)
CmPGIP by##2##2##(2008-10#2)
CmPGIP##6##1##(2008-10#6)
CnH##4##1##(1993-6#4)
CnrN regulates##2##2##(2009-8#2)
CnrN##3##1##(2009-8#3)
Co and Cr##2##3##(2008-10#1)(2008-12#1)
Co and Fe in##2##4##(2008-10#2)
Co and##12##2##(2008-10#11)(2008-12#1)
Co as##2##2##(2008-10#2)
Co in##3##2##(2008-10#3)
Co##109##1##(1994-12#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-1#1)(2008-10#92)(2008-11#1)(2008-12#1)(2008-5#4)(2008-9#2)(2010-6#1)(2010-7#1)(2013-1#2)
Co(2+) and Cu(2+)##4##3##(2008-10#4)
Co(2+) and##5##2##(2008-10#5)
Co(2+) in water##2##3##(2008-10#2)
Co(2+)##33##1##(2008-10#28)(2008-11#2)(2008-3#3)
Co(II) and Cu(II) in##3##4##(2008-10#3)
Co(II) and Cu(II)##7##3##(2008-10#7)
Co(II) and Ni(II)##3##3##(2008-10#3)
Co(II) and##23##2##(2008-10#23)
Co(II) determination by adsorptive stripping voltammetry##2##6##(2008-10#2)
Co(II) determination in##2##3##(2008-10#2)
Co(II) determination##5##2##(2008-10#5)
Co(II) in##4##2##(2008-10#4)
Co(II) or##2##2##(2008-10#2)
Co(II) was##4##2##(2008-10#4)
Co(II) with##5##2##(2008-10#5)
Co(II)##112##1##(1990-12#1)(2008-10#111)
Co(II))=0##2##1##(2008-10#2)
Co(III)##6##1##(2008-10#6)
Co-4##5##1##(2008-10#5)
Co-expression of##2##2##(1995-8#1)(2008-11#1)
Co-infection with##3##2##(2011-2#3)
Co-infection##6##1##(2011-2#5)(2012-2#1)
Co-injection of##3##2##(1991-12#2)(2010-4#1)
Co-localization##2##1##(1990-5#1)(2008-10#1)
Co-morbidity##2##1##(2012-12#1)(2013-1#1)
Co-occurring##2##1##(2010-3#1)(2012-3#1)
Co-ordination##2##1##(2008-10#1)(2008-4#1)
Co-transfection of##2##2##(1990-8#1)(1995-6#1)
Co2+##6##1##(1993-6#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-12#1)
CoA##6##1##(1990-12#2)(1995-3#1)(1995-8#1)(2008-11#1)(2013-1#1)
CoASH##3##1##(1990-2#3)
CoCl(2)##2##1##(2008-10#1)(2008-11#1)
CoCl2##3##1##(1996-5#3)
CoHCF##3##1##(2008-10#3)
CoMFA models##2##2##(2010-12#2)
CoMFA##3##1##(2010-12#3)
CoMSIA##2##1##(2011-2#2)
CoPc##2##1##(2008-10#2)
CoPc-modified carbon paste##2##3##(2008-10#2)
CoPc-modified##3##1##(2008-10#3)
CoQ10 (200 mg daily)##2##4##(2013-1#2)
CoQ10 treatment##6##2##(2013-1#6)
CoQ10##15##1##(1993-3#4)(2013-1#11)
Coaching##4##1##(1993-1#1)(1996-1#1)(2010-9#2)
Coagulation##2##1##(1991-9#1)(2008-11#1)
Coalition##3##1##(1995-12#1)(1996-1#1)(2008-6#1)
Coast and Islands##3##3##(2011-2#3)
Coast of##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
Coast##28##1##(2008-1#1)(2008-10#14)(2008-11#1)(2010-1#5)(2010-4#1)(2011-2#4)(2012-3#1)(2013-1#1)
Coastal Bend##4##2##(2008-10#4)
Coastal##7##1##(2008-10#6)(2010-8#1)
Coat Protein Gene of##2##4##(2008-10#2)
Coat Protein Gene##5##3##(2008-10#5)
Coat Protein##6##2##(2008-10#6)
Coat##8##1##(2008-10#8)
Coated##2##1##(2008-10#1)(2008-11#1)
Coating##5##1##(2008-10#5)
Coatomer##2##1##(1994-12#2)
Cobalt##5##1##(2008-10#5)
Cobalt(II)##3##1##(2008-10#3)
Cobb##2##1##(1996-5#2)
Cocaethylene##3##1##(1991-1#1)(1996-12#2)
Cocaine##10##1##(1991-1#4)(1991-2#1)(1992-12#1)(2008-8#1)(2009-7#1)(2012-3#2)
Cochlear Implant Centre##2##3##(2008-9#2)
Cochlear Implant##3##2##(2008-9#3)
Cochlear implant##3##2##(2008-9#3)
Cochlear implantation has##2##3##(2008-9#2)
Cochlear implantation in a##4##4##(2008-9#4)
Cochlear implantation in##8##3##(2008-9#8)
Cochlear implantation is##2##3##(2008-9#2)
Cochlear implantation##15##2##(2008-9#15)
Cochlear implants##4##2##(2008-9#4)
Cochlear##30##1##(2008-9#27)(2009-8#2)(2011-2#1)
Cochliobolus carbonum##2##2##(2008-10#2)
Cochliobolus heterostrophus##4##2##(2008-10#4)
Cochliobolus miyabeanus##4##2##(2008-10#4)
Cochliobolus sativus and##3##3##(2008-10#3)
Cochliobolus sativus##8##2##(2008-10#8)
Cochliobolus sativus)##3##2##(2008-10#3)
Cochliobolus spp##3##2##(2008-10#3)
Cochliobolus##26##1##(2008-10#26)
Cochlospermum planchonii##3##2##(2008-12#3)
Cochlospermum##4##1##(2008-12#4)
Cochran##2##1##(1992-9#1)(2008-10#1)
Cochrane Database of Systematic Reviews##4##5##(1993-12#1)(2011-2#1)(2013-1#2)
Cochrane Library##3##2##(2008-12#1)(2011-2#2)
Cochrane reviews - in their own words##3##7##(2011-2#3)
Cochrane##19##1##(1993-12#4)(2008-12#1)(2009-7#1)(2011-2#6)(2012-12#2)(2013-1#5)
Cockatiel##2##1##(2008-5#2)
Cockcroft-Gault##2##1##(2011-2#1)(2013-1#1)
Cocultures of Peronospora tabacina##2##4##(2008-10#2)
Code of##4##2##(2008-10#3)(2012-2#1)
Code##10##1##(1993-9#1)(1995-12#1)(1996-1#1)(2008-10#3)(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
Coding##3##1##(1997-7#1)(2007-12#1)(2008-4#1)
Coefficient##3##1##(2008-10#1)(2008-3#1)(2013-1#1)
Coefficients of variation of##2##4##(2008-10#2)
Coefficients##4##1##(2008-10#2)(2010-1#1)(2012-2#1)
Coenzyme A##2##2##(1994-8#1)(2013-1#1)
Coenzyme##3##1##(1994-8#1)(2013-1#2)
Coercion##2##1##(2008-11#1)(2009-4#1)
Coevolution##7##1##(2008-10#5)(2008-8#2)
Coexistence times##2##2##(2008-9#2)
Coexistence##6##1##(2008-8#3)(2008-9#2)(2012-3#1)
Coexpression of##3##2##(1993-9#1)(1995-11#1)(2008-9#1)
Coffee##5##1##(2008-10#5)
Cognitive Behavioral##3##2##(2008-11#1)(2008-12#1)(2010-11#1)
Cognitive Changes##2##2##(2012-3#2)
Cognitive and##3##2##(1990-6#1)(2008-11#2)
Cognitive##27##1##(1990-6#1)(1991-1#1)(1991-12#2)(1997-8#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#3)(2013-1#1)
Cohen##2##1##(2010-11#1)(2010-8#1)
Cohen's##3##1##(1997-8#1)(2010-1#1)(2010-10#1)
Coherence##2##1##(1996-9#1)(2013-8#1)
Coherent Anti-Stokes##2##2##(2008-3#2)
Coherent##5##1##(1990-5#1)(2008-2#1)(2008-3#3)
Cohn##4##1##(2008-10#1)(2011-2#3)
Cohort Study##3##2##(2010-5#1)(2010-6#2)
Cohort##7##1##(1994-6#1)(2010-5#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#1)
Coil-1##3##1##(2008-8#3)
Coiling##2##1##(2011-2#1)(2012-3#1)
Coinfection of##2##2##(2008-10#1)(2008-7#1)
Coinfection##3##1##(2008-10#1)(2008-7#2)
Col##6##1##(1993-12#4)(2012-3#2)
Col-0##2##1##(2008-10#2)
Col1##3##1##(2008-10#3)
Colaizzi's##2##1##(2010-10#1)(2010-11#1)
Cold##2##1##(2008-11#1)(2008-9#1)
Colentina Hospital##3##2##(2008-10#3)
Colitis##3##1##(2010-11#1)(2010-12#2)
Collaboration between##3##2##(1993-12#1)(2008-11#1)(2009-12#1)
Collaboration has##2##2##(1993-12#1)(2008-11#1)
Collaboration##12##1##(1992-1#1)(1993-12#3)(1993-2#1)(2008-11#2)(2008-3#1)(2009-12#1)(2009-4#1)(2012-12#1)(2013-1#1)
Collaborative Group##3##2##(1993-11#1)(1993-12#1)(1994-8#1)
Collaborative##14##1##(1990-11#2)(1992-1#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-8#1)(1997-7#1)(2008-11#2)(2008-12#1)(2009-11#1)(2013-1#1)
Collagen##4##1##(1995-12#2)(2008-10#1)(2009-7#1)
Collagenous hydrolysates from untraditional sources of proteins##2##7##(2008-5#2)
Collagenous##4##1##(2008-5#3)(2011-2#1)
Collateral##2##1##(1991-2#1)(2008-10#1)
Colleague##5##1##(1992-3#1)(1995-2#1)(2011-2#3)
Collected data were##2##3##(2008-1#1)(2011-2#1)
Collected##6##1##(2008-1#1)(2008-10#3)(2008-12#1)(2011-2#1)
Collecting##2##1##(1997-2#1)(2008-10#1)
Collection of##6##2##(2008-10#3)(2009-6#1)(2012-3#1)(2013-1#1)
Collection##12##1##(1990-2#1)(2008-10#5)(2008-12#1)(2008-5#2)(2009-6#1)(2012-3#1)(2013-1#1)
Collections from##3##2##(2008-10#3)
Collections of##3##2##(2008-10#3)
Collections##6##1##(2008-10#6)
Collective##3##1##(2008-1#1)(2008-10#1)(2008-11#1)
Collectively##25##1##(1991-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-10#8)(2008-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
College Dublin##2##2##(2008-11#2)
College Hospital##2##2##(1993-12#1)(2011-2#1)
College Station##2##2##(2008-10#2)
College Students##2##2##(2010-10#1)(2010-7#1)
College and##2##2##(1994-1#1)(2013-1#1)
College of Cardiology##2##3##(2008-3#1)(2009-6#1)
College of Health##2##3##(1997-2#1)(2009-10#1)
College of Physicians##5##3##(1993-12#2)(1994-12#1)(1996-8#2)
College of the##3##3##(1991-3#1)(1991-8#2)
College of##28##2##(1990-3#1)(1991-1#1)(1991-3#1)(1991-8#2)(1992-1#2)(1993-12#3)(1993-3#1)(1994-12#3)(1996-8#2)(1997-2#1)(2008-12#1)(2008-3#2)(2009-10#2)(2009-6#1)(2010-12#1)(2011-2#1)(2011-4#1)(2012-12#1)(2013-1#1)
College##58##1##(1990-3#1)(1991-1#1)(1991-3#1)(1991-8#2)(1992-1#2)(1993-12#4)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1996-8#2)(1997-2#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#2)(2009-6#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-2#2)(2011-4#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#5)
Colletotrichum acutatum and C##2##4##(2008-10#2)
Colletotrichum acutatum and##3##3##(2008-10#3)
Colletotrichum acutatum from##2##3##(2008-10#2)
Colletotrichum acutatum on Symptomless##3##4##(2008-10#3)
Colletotrichum acutatum on##4##3##(2008-10#4)
Colletotrichum acutatum##24##2##(2008-10#24)
Colletotrichum capsici##2##2##(2008-11#2)
Colletotrichum coccodes##8##2##(2008-10#8)
Colletotrichum dematium##3##2##(2008-10#3)
Colletotrichum gloeosporioides from##3##3##(2008-10#3)
Colletotrichum gloeosporioides##18##2##(2008-10#18)
Colletotrichum graminicola##10##2##(2008-10#10)
Colletotrichum isolates from lupins##2##4##(2008-10#2)
Colletotrichum isolates from##4##3##(2008-10#4)
Colletotrichum isolates##6##2##(2008-10#6)
Colletotrichum lindemuthianum in Common Bean##2##5##(2008-10#2)
Colletotrichum lindemuthianum##7##2##(2008-10#7)
Colletotrichum sp##2##2##(2008-10#2)
Colletotrichum species##2##2##(2008-10#2)
Colletotrichum spp##9##2##(2008-10#9)
Colletotrichum##104##1##(1997-4#1)(2008-10#101)(2008-11#2)
Colletotricum##2##1##(2012-2#2)
Collins and##2##2##(1994-8#1)(2011-2#1)
Collins##6##1##(1994-8#4)(2011-2#2)
Colloquium##2##1##(1995-3#1)(2008-10#1)
Colo201 cells##3##2##(2008-11#3)
Colocalization of##5##2##(1994-2#2)(1995-12#1)(1997-8#1)(2011-2#1)
Colocalization##6##1##(1994-2#2)(1995-12#1)(1997-8#1)(2011-2#2)
Colocasia esculenta in##2##3##(2008-10#2)
Colocasia esculenta##3##2##(2008-10#3)
Colocasia##6##1##(2008-10#6)
Colombia is##2##2##(2012-12#2)
Colombia with##2##2##(2008-10#1)(2012-12#1)
Colombia##73##1##(1992-5#1)(2008-10#12)(2008-12#2)(2008-5#5)(2011-2#10)(2012-12#42)(2013-1#1)
Colombia's##2##1##(2011-2#2)
Colombia]##6##1##(2012-12#6)
Colombian##16##1##(2008-10#1)(2008-5#2)(2011-2#4)(2012-12#7)(2013-1#2)
Colon cancer##2##2##(1993-12#1)(2008-1#1)
Colon##3##1##(1993-12#1)(2008-1#1)(2011-2#1)
Colonic##4##1##(2009-12#1)(2009-8#2)(2012-2#1)
Colonies of##3##2##(2008-10#2)(2008-8#1)
Colonies##7##1##(2008-10#6)(2008-8#1)
Colonization and##5##2##(2008-10#5)
Colonization by##5##2##(2008-10#5)
Colonization of Tomato##2##3##(2008-10#2)
Colonization of the##2##3##(2008-10#2)
Colonization of##17##2##(2008-10#17)
Colonization##29##1##(2008-10#29)
Colonized##2##1##(2008-10#1)(2011-2#1)
Colonoscopy is##2##2##(1997-8#1)(2010-12#1)
Colonoscopy revealed##2##2##(2011-2#2)
Colonoscopy##6##1##(1997-8#1)(2008-12#1)(2009-1#1)(2010-12#1)(2011-2#2)
Colony forming units of##2##4##(2008-10#2)
Colony forming##3##2##(2008-10#2)(2008-11#1)
Colony morphology##3##2##(2008-10#3)
Colony##11##1##(2008-10#7)(2008-11#1)(2008-9#1)(2009-10#1)(2009-6#1)
Color stability##2##2##(2010-4#1)(2013-1#1)
Color##10##1##(1993-5#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-5#2)(2010-4#1)(2012-12#1)(2013-1#1)
Colorado potato beetle (Leptinotarsa##2##4##(2008-10#1)(2008-9#1)
Colorado potato beetle##4##3##(2008-10#3)(2008-9#1)
Colorado##14##1##(1995-12#2)(1997-1#1)(2008-10#8)(2008-8#2)(2008-9#1)
Colorectal Cancer##5##2##(1990-6#1)(2008-10#2)(2008-12#1)(2012-3#1)
Colorectal cancer is##2##3##(2009-12#2)
Colorectal cancer##4##2##(2008-10#1)(2009-12#2)(2012-3#1)
Colorectal##10##1##(1990-6#1)(2008-10#3)(2008-12#1)(2009-12#2)(2012-3#3)
Colorimetric##4##1##(2008-10#3)(2008-11#1)
Colovesical fistula##2##2##(2009-1#1)(2013-1#1)
Colpotomizer##2##1##(2011-2#2)
Columbia River##2##2##(2010-8#2)
Columbia and##5##2##(1994-2#1)(2008-10#3)(2013-1#1)
Columbia as a##2##3##(1992-12#1)(2008-10#1)
Columbia##52##1##(1992-12#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#2)(1995-9#2)(1997-1#1)(1997-2#1)(1997-8#2)(2007-12#2)(2008-10#21)(2008-11#2)(2008-12#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-8#3)(2012-3#1)(2013-1#1)(2013-8#4)
Columbian##2##1##(2008-8#1)(2009-5#1)
Column##7##1##(2008-10#5)(2008-12#1)(2013-1#1)
Column-switching high-performance liquid chromatographic##2##4##(2008-10#2)
Coma##2##1##(1990-2#1)(2011-2#1)
Combi 40+##2##2##(2008-9#2)
Combi##5##1##(2008-9#5)
Combination Chemotherapy##2##2##(1997-7#1)(2008-11#1)
Combination chemotherapy##2##2##(1991-6#1)(2008-11#1)
Combination live##2##2##(1995-5#2)
Combination of the##3##3##(1992-1#1)(1993-8#1)(2008-4#1)
Combination of##18##2##(1992-1#1)(1992-2#1)(1993-8#2)(2008-10#8)(2008-3#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
Combination vaccines##3##2##(1995-5#3)
Combination##36##1##(1991-6#2)(1992-1#1)(1992-2#1)(1993-8#2)(1995-5#5)(1997-7#2)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#2)
Combinations of these##2##3##(2008-9#1)(2010-7#1)
Combinations of##7##2##(1990-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-10#1)(2010-7#1)
Combinations##8##1##(1990-5#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-10#1)(2010-7#1)
Combinatorial##3##1##(1991-9#1)(1994-5#1)(2009-6#1)
Combined Treatment##2##2##(2012-3#1)(2013-1#1)
Combined and##2##2##(1995-5#1)(2010-8#1)
Combined autologous and allograft limbal cell##2##6##(2010-10#2)
Combined treatment with##3##3##(1991-9#1)(2008-12#1)(2008-5#1)
Combined with the##3##3##(2008-10#1)(2008-8#2)
Combined with##6##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2013-1#1)
Combined##41##1##(1991-9#2)(1995-5#2)(1996-5#1)(1996-6#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
Combining results from different studies##2##5##(2008-10#2)
Combining the##3##2##(2007-12#1)(2008-12#1)(2008-3#1)
Combining these##5##2##(1991-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2009-10#1)
Combining this##2##2##(2012-2#1)(2013-8#1)
Combining##30##1##(1991-12#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-12#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Combustion##2##1##(2008-3#2)
Come##2##1##(2009-9#1)(2012-12#1)
Comfort##3##1##(2008-11#3)
Comm##2##1##(1992-3#1)(1993-3#1)
Commandments##5##1##(2008-12#5)
Comment on &quot##16##3##(1990-12#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-5#2)(1994-2#1)(1996-9#2)(2008-10#1)(2008-11#1)(2008-3#4)
Comment on##20##2##(1990-12#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-5#2)(1994-2#1)(1995-11#1)(1996-9#2)(2008-10#2)(2008-11#1)(2008-3#5)(2012-12#1)
Comment##22##1##(1990-12#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-5#2)(1994-2#2)(1995-11#1)(1996-9#2)(2008-10#2)(2008-11#2)(2008-3#5)(2012-12#1)
Commentary - radiology in India##3##5##(2009-9#3)
Commentary on the##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
Commentary on##7##2##(1993-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2009-9#1)(2013-1#1)(2013-8#1)
Commentary##22##1##(1993-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#7)(2009-9#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Comments on point##3##3##(2011-2#3)
Comments on##5##2##(1994-6#1)(2010-12#1)(2011-2#3)
Comments##7##1##(1994-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#3)
Commerce##4##1##(1995-6#2)(1997-2#1)(2008-11#1)
Commercial samples were##2##3##(2008-10#2)
Commercial samples##3##2##(2008-10#3)
Commercial##16##1##(1990-12#1)(1993-3#1)(1994-3#1)(2008-10#11)(2008-12#1)(2011-7#1)
Commercially available##3##2##(2008-10#2)(2008-5#1)
Commercially##4##1##(2008-10#3)(2008-5#1)
Commission of##2##2##(1993-6#1)(2008-10#1)
Commission on##5##2##(1993-3#1)(1995-12#1)(1995-3#1)(2012-12#1)(2012-2#1)
Commission##35##1##(1990-2#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-5#1)(1997-5#1)(2008-10#11)(2008-11#2)(2008-12#2)(2012-12#1)(2012-2#4)
Commitment to##2##2##(2008-11#2)
Commitment##3##1##(2008-11#2)(2012-2#1)
Committee for##5##2##(1993-11#1)(1995-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
Committee of the##9##3##(1991-1#1)(1991-3#1)(1994-12#1)(1994-9#1)(1996-6#1)(1996-8#1)(2008-10#2)(2011-4#1)
Committee of##15##2##(1990-12#1)(1991-1#1)(1991-3#1)(1994-12#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#2)(2010-7#1)(2011-4#1)(2012-3#2)
Committee on##11##2##(1991-1#1)(1994-9#1)(1995-11#2)(1995-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
Committee##59##1##(1990-12#1)(1990-2#1)(1991-1#2)(1991-2#2)(1991-3#3)(1991-5#1)(1993-1#3)(1993-11#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-7#1)(2011-2#2)(2011-4#1)(2012-2#1)(2012-3#5)(2013-1#2)
Common Bean##9##2##(2008-10#9)
Common Foundation Programme##2##3##(2008-11#1)(2008-12#1)
Common Scab##2##2##(2008-10#2)
Common and comet##2##3##(2010-8#2)
Common themes##2##2##(2008-11#1)(2009-5#1)
Common##56##1##(1995-12#2)(1995-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
Commonly used##2##2##(2008-5#1)(2013-1#1)
Commonly##5##1##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
Commun##4##1##(1991-12#1)(1994-8#1)(1995-8#1)(2008-11#1)
Communicate##2##1##(2008-11#1)(2010-4#1)
Communicating the##2##2##(1996-1#1)(1996-3#1)
Communicating##5##1##(1993-3#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-12#1)
Communication between##2##2##(1996-1#1)(2008-11#1)
Communication with##2##2##(1993-3#1)(2012-3#1)
Communication##18##1##(1990-12#3)(1993-3#2)(1996-1#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
Communications##2##1##(1996-5#1)(2013-1#1)
Communities##8##1##(1996-2#1)(1997-2#1)(2008-10#3)(2010-8#1)(2012-3#1)(2013-1#1)
Community Anti-Drug##2##2##(2008-6#2)
Community Blood##2##2##(1995-6#2)
Community Bureau of Reference##2##4##(2008-10#2)
Community Health##3##2##(1994-1#1)(2008-11#1)(2013-7#1)
Community Hospital##5##2##(1993-1#1)(1993-3#1)(1995-2#1)(2011-2#1)(2012-3#1)
Community and##3##2##(1993-2#1)(1995-3#1)(2008-10#1)
Community based structure##2##3##(1993-12#2)
Community##65##1##(1991-1#3)(1991-3#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-6#6)(2009-10#1)(2009-12#1)(2010-10#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
Community-acquired##2##1##(2008-5#1)(2010-5#1)
Community-associated methicillin-resistant Staphylococcus aureus##3##4##(2008-10#1)(2008-11#2)
Community-based##4##1##(1991-2#1)(1995-3#1)(1996-2#1)(2010-6#1)
Community-level##2##1##(2013-1#2)
Community-onset##2##1##(2011-2#2)
Comorbidity##3##1##(2008-7#2)(2013-1#1)
Compact and##2##2##(2008-3#1)(2010-11#1)
Compact##6##1##(1991-9#1)(2008-3#4)(2010-11#1)
Companies##3##1##(1993-2#1)(2008-5#1)(2010-7#1)
Companion##2##1##(2013-1#1)(2013-8#1)
Company##15##1##(1991-2#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1997-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-1#1)(2013-8#1)
Comparability of##2##2##(1991-12#1)(2012-2#1)
Comparable##4##1##(1990-12#1)(1995-11#1)(1995-12#1)(2013-1#1)
Comparative Analysis of##2##3##(2008-10#2)
Comparative Study of##2##3##(2010-6#1)(2010-7#1)
Comparative Study##3##2##(2010-12#1)(2010-6#1)(2010-7#1)
Comparative analyses between##2##3##(1991-12#1)(2008-12#1)
Comparative analyses##3##2##(1991-12#1)(2008-12#1)(2009-10#1)
Comparative analysis of the##4##4##(2008-10#2)(2008-8#1)(2012-2#1)
Comparative analysis of##6##3##(2008-10#4)(2008-8#1)(2012-2#1)
Comparative analysis##8##2##(2008-10#4)(2008-8#1)(2008-9#2)(2012-2#1)
Comparative data##2##2##(2008-10#2)
Comparative efficacy of##2##3##(1996-12#1)(2008-10#1)
Comparative evaluation of tensile bond strength##2##6##(2013-1#2)
Comparative evaluation of##4##3##(1995-5#1)(1997-1#1)(2013-1#2)
Comparative studies on##2##3##(1990-5#1)(1997-2#1)
Comparative studies##7##2##(1990-5#2)(1997-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
Comparative study for the##2##4##(2008-10#1)(2011-2#1)
Comparative study for##3##3##(2008-10#2)(2011-2#1)
Comparative study of the##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
Comparative study of##13##3##(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
Comparative study on the##3##4##(1996-12#1)(2008-8#1)(2013-1#1)
Comparative study on##4##3##(1996-12#1)(2008-8#2)(2013-1#1)
Comparative study##21##2##(1996-12#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#2)(2013-1#2)
Comparative transcriptome analysis##2##3##(2009-8#2)
Comparative##85##1##(1990-5#2)(1990-6#2)(1991-12#2)(1991-9#1)(1992-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-5#1)(2007-12#2)(2008-10#22)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#6)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#2)(2013-1#5)
Compared to a##3##3##(1990-12#1)(2008-10#2)
Compared to conventional##2##3##(2008-10#2)
Compared to normal##2##3##(2008-11#1)(2008-5#1)
Compared to the##11##3##(1993-2#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-2#1)
Compared to##38##2##(1990-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-1#2)(1996-2#1)(1996-5#1)(1997-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-6#1)(2012-2#1)(2013-8#1)
Compared with control##2##3##(2008-10#1)(2011-3#1)
Compared with conventional##2##3##(2008-10#2)
Compared with other##2##3##(1990-11#1)(2012-3#1)
Compared with standard##2##3##(2008-10#2)
Compared with the conventional##7##4##(2008-10#5)(2011-2#1)(2013-8#1)
Compared with the reported##2##4##(2008-10#2)
Compared with the results##2##4##(2008-10#2)
Compared with the##28##3##(1991-6#1)(1992-2#1)(1993-8#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#16)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
Compared with##67##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-8#1)(2007-12#2)(2008-10#32)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Compared##108##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-1#2)(1995-2#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-8#1)(2007-12#2)(2008-10#45)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#4)(2008-9#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-6#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
Comparing the results##2##3##(1991-9#1)(1993-11#1)
Comparing the two##2##3##(2008-10#2)
Comparing the##11##2##(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
Comparing##27##1##(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2011-2#4)(2012-3#2)(2013-1#1)
Comparison and##3##2##(2008-10#2)(2012-3#1)
Comparison between the##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
Comparison between##10##2##(1997-2#1)(2008-10#2)(2009-10#2)(2009-5#1)(2011-2#1)(2012-9#1)(2013-1#1)(2013-8#1)
Comparison experiments were carried out##2##5##(2008-10#2)
Comparison experiments were##3##3##(2008-10#3)
Comparison is made##2##3##(2008-11#1)(2008-5#1)
Comparison of Clinical##2##3##(2008-11#1)(2010-7#1)
Comparison of DNA##2##3##(1993-8#1)(2008-5#1)
Comparison of amino acid sequences of##2##6##(1994-12#1)(1997-8#1)
Comparison of amino acid sequences##3##5##(1994-11#1)(1994-12#1)(1997-8#1)
Comparison of clinical##2##3##(2011-2#1)(2013-7#1)
Comparison of different##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
Comparison of results with##2##4##(2008-10#1)(2008-7#1)
Comparison of results##3##3##(2008-10#2)(2008-7#1)
Comparison of the deduced##2##4##(1991-6#1)(2008-10#1)
Comparison of the effects of##3##5##(1993-3#1)(1993-8#1)(2012-3#1)
Comparison of the nucleotide sequence of##2##6##(1990-2#1)(2008-10#1)
Comparison of the predicted##3##4##(1993-2#1)(2008-10#1)(2008-3#1)
Comparison of the results obtained##2##5##(1992-6#1)(2008-10#1)
Comparison of the results##5##4##(1992-6#1)(1994-2#1)(2008-10#3)
Comparison of the sequences of##2##5##(1995-11#1)(2010-4#1)
Comparison of the sequences##3##4##(1995-11#1)(2008-10#1)(2010-4#1)
Comparison of the##54##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-3#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-6#2)(2010-4#1)(2010-7#1)(2012-12#1)(2012-3#2)
Comparison of these##2##3##(1995-6#1)(2008-10#1)
Comparison of three##2##3##(1994-12#1)(2008-10#1)
Comparison of two##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2009-3#1)
Comparison of ultrasound-assisted extraction and##2##5##(2008-10#2)
Comparison of##191##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#2)(1991-6#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#3)(2007-12#2)(2008-10#61)(2008-11#11)(2008-12#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2009-1#1)(2009-10#1)(2009-3#4)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#3)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#3)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#3)(2013-7#1)
Comparison to the##2##3##(1993-11#1)(1997-2#1)
Comparison to##4##2##(1992-9#1)(1993-11#1)(1997-2#1)(2008-10#1)
Comparison was made in some other properties between Epo produced by these astrocyte cell lines and that by CHO cells##2##20##(2008-11#2)
Comparison was made in##3##4##(2008-10#1)(2008-11#2)
Comparison was made##4##3##(2008-10#2)(2008-11#2)
Comparison with other##3##3##(1990-12#1)(1993-8#1)(2008-5#1)
Comparison with the##3##3##(1997-1#1)(2008-10#2)
Comparison with##18##2##(1990-12#1)(1990-8#1)(1993-8#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-10#7)(2008-5#2)(2011-2#1)(2013-1#2)
Comparison##242##1##(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#2)(1991-6#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#3)(2007-12#2)(2008-10#81)(2008-11#14)(2008-12#8)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#3)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#3)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#3)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#6)(2012-5#1)(2012-9#1)(2013-1#6)(2013-7#1)(2013-8#1)
Comparisons between##8##2##(1995-12#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-5#1)
Comparisons of the##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2009-7#1)
Comparisons of##17##2##(1992-3#2)(1993-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)
Comparisons with other##3##3##(1992-12#1)(2008-10#2)
Comparisons with##8##2##(1992-12#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
Comparisons##41##1##(1991-1#1)(1991-10#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-6#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-5#1)
Compartment##2##1##(2008-12#1)(2013-8#1)
Compatibility Groups of##2##3##(2008-10#2)
Compatibility Groups##6##2##(2008-10#6)
Compatibility##11##1##(2008-10#10)(2011-2#1)
Compatible##3##1##(2008-10#2)(2011-2#1)
Compensation in##2##2##(1996-3#1)(2008-9#1)
Compensation##6##1##(1991-12#3)(1996-3#1)(2008-9#1)(2012-2#1)
Compensatory homeostasis##2##2##(2012-2#2)
Compensatory##4##1##(1994-5#1)(2012-2#3)
Competence##2##1##(2008-10#1)(2013-1#1)
Competency and##2##2##(1994-2#1)(2008-4#1)
Competing##4##1##(1997-2#1)(2008-10#1)(2012-12#1)(2013-8#1)
Competition among##2##2##(2008-10#1)(2008-9#1)
Competition between##2##2##(2008-10#1)(2008-11#1)
Competition experiments##4##2##(1993-6#1)(2006-6#1)(2008-10#2)
Competition for##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
Competition##27##1##(1990-11#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#1)(1993-6#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-8#5)(2008-9#4)(2009-10#1)
Competitive Fitness of Phytophthora infestans Isolates##2##6##(2008-10#2)
Competitive binding##2##2##(2010-11#1)(2013-1#1)
Competitive##12##1##(1992-6#1)(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2010-11#1)(2013-1#1)
Compilation of##2##2##(1996-12#1)(2011-3#1)
Complement##3##1##(1990-8#1)(1993-11#1)(2008-10#1)
Complementary DNA##3##2##(1993-6#1)(1997-8#1)(2008-10#1)
Complementary and##2##2##(2009-5#1)(2013-1#1)
Complementary##12##1##(1993-6#1)(1995-11#1)(1995-3#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2009-5#1)(2013-1#1)
Complementation of##2##2##(2008-10#2)
Complementation##3##1##(2008-10#2)(2008-9#1)
Complemented##2##1##(2008-10#2)
Complete Block Design with##2##4##(2008-12#2)
Complete data were##2##3##(1993-11#1)(2012-3#1)
Complete genome sequence of Meiothermus##2##5##(2011-2#2)
Complete genome sequence of Rhizobium leguminosarum bv##2##7##(2011-2#2)
Complete genome sequence of##32##4##(2011-2#32)
Complete genome##33##2##(2008-10#1)(2011-2#32)
Complete nucleotide sequence##2##3##(1994-9#1)(2008-8#1)
Complete protection##2##2##(1990-6#2)
Complete regression of##2##3##(1990-6#2)
Complete separation of##2##3##(2008-10#2)
Complete tumor resection was##2##4##(2011-2#2)
Complete##86##1##(1990-6#4)(1991-6#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-11#1)(2008-10#9)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#35)(2012-3#1)(2013-1#1)(2013-8#1)
Completed##2##1##(2008-10#1)(2011-2#1)
Completion of the##2##3##(2008-10#1)(2010-10#1)
Completion of##3##2##(1997-2#1)(2008-10#1)(2010-10#1)
Completion##4##1##(1990-11#1)(1997-2#1)(2008-10#1)(2010-10#1)
Complex 5(b)##2##2##(2012-12#2)
Complex formation##3##2##(1995-6#1)(2008-10#2)
Complex##43##1##(1992-8#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-1#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
Complexation and fluorescence behavior of##2##5##(2008-10#2)
Complexation and##3##2##(2008-10#3)
Complexation of##4##2##(2008-10#4)
Complexation##8##1##(2008-10#8)
Complexed##3##1##(2008-10#1)(2008-8#1)(2010-12#1)
Complexes of##2##2##(1990-5#1)(2008-10#1)
Complexes##7##1##(1990-5#1)(2008-10#3)(2008-12#1)(2010-7#1)(2013-8#1)
Complexities##2##1##(1997-2#1)(2010-1#1)
Compliance to##2##2##(1991-8#1)(2013-8#1)
Compliance was##2##2##(1996-8#1)(2008-11#1)
Compliance##11##1##(1991-8#1)(1993-11#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#3)(2013-8#2)
Complication##6##1##(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)
Complications included 1 patient with##2##5##(1994-3#1)(2008-7#1)
Complications included##4##2##(1991-1#1)(1994-3#1)(2008-7#1)(2009-10#1)
Complications of intradural##2##3##(2012-3#2)
Complications of##5##2##(2007-11#1)(2009-8#1)(2012-3#2)(2013-1#1)
Complications were##2##2##(1991-3#1)(2009-3#1)
Complications##21##1##(1991-1#1)(1991-3#1)(1993-11#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)
Component##6##1##(2008-10#4)(2008-5#1)(2009-5#1)
Components Analysis##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
Components of a##2##3##(1991-12#1)(1996-1#1)
Components of##11##2##(1991-12#1)(1994-8#1)(1996-1#1)(2008-10#4)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
Components##20##1##(1991-12#1)(1994-8#1)(1996-1#1)(2008-10#8)(2008-11#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)
Composing##2##1##(1996-3#1)(2008-9#1)
Composite interval mapping##2##3##(2008-10#1)(2012-3#1)
Composite##5##1##(1996-9#1)(2008-10#3)(2012-3#1)
Composition and##3##2##(2008-10#1)(2008-8#1)(2012-8#1)
Composition of##3##2##(1991-12#1)(2011-2#1)(2012-2#1)
Composition##13##1##(1991-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-8#1)
Compost tea##2##2##(2008-10#2)
Compost##5##1##(2008-10#5)
Composted Swine##2##2##(2008-10#2)
Composted##3##1##(2008-10#3)
Composts##2##1##(2008-10#2)
Compound 16##2##2##(1992-12#2)
Compound##10##1##(1992-12#2)(1992-3#1)(1994-8#2)(1996-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
Compounds 1 and 2 showed##2##5##(2008-11#1)(2010-6#1)
Compounds 1 and 2##3##4##(2008-11#2)(2010-6#1)
Compounds 1##5##2##(2008-11#3)(2010-6#1)(2011-3#1)
Compounds in##2##2##(1992-8#1)(2009-8#1)
Compounds##21##1##(1992-8#1)(1994-8#1)(1996-5#7)(2008-10#2)(2008-11#4)(2008-3#1)(2009-12#1)(2009-8#1)(2010-6#1)(2011-3#2)
Comprehension of##2##2##(1997-3#1)(2008-11#1)
Comprehensive Health##2##2##(1995-2#1)(2008-1#1)
Comprehensive Stroke##2##2##(2013-8#2)
Comprehensive two-dimensional gas chromatography##2##4##(2008-10#2)
Comprehensive##20##1##(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-10#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#2)
Compression of the##2##3##(2008-12#1)(2008-9#1)
Compression of##4##2##(1994-2#1)(2008-12#1)(2008-9#1)(2011-2#1)
Compression##7##1##(1994-2#1)(2008-12#2)(2008-9#1)(2010-7#1)(2011-2#2)
Compromised##2##1##(2008-10#1)(2012-3#1)
Compulsory community treatment?##2##3##(1994-1#2)
Compulsory##4##1##(1994-1#2)(1997-8#1)(2011-2#1)
Computational results##2##2##(2008-3#2)
Computational##16##1##(1993-8#1)(1995-5#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#2)
Computations##2##1##(2008-3#2)
Computed Tomography##2##2##(2009-8#1)(2012-3#1)
Computed tomographic angiography##3##3##(2011-2#1)(2013-1#2)
Computed tomographic##4##2##(2008-7#1)(2011-2#1)(2013-1#2)
Computed tomography (CT) is##2##4##(2011-3#1)(2012-2#1)
Computed tomography (CT)##5##3##(1996-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
Computed tomography and magnetic resonance imaging##3##6##(2008-7#1)(2011-2#2)
Computed tomography##15##2##(1990-11#1)(1996-9#1)(1997-8#2)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
Computed##22##1##(1990-11#1)(1996-9#1)(1997-8#2)(2008-7#3)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
ComputedTomography Severity Index##2##3##(2009-8#2)
Computer analysis of the##2##4##(1995-8#1)(2008-8#1)
Computer analysis of##3##3##(1995-8#1)(1996-6#1)(2008-8#1)
Computer analysis##4##2##(1992-9#1)(1995-8#1)(1996-6#1)(2008-8#1)
Computer literacy##2##2##(1996-1#1)(2008-11#1)
Computer modelling of##2##3##(2008-7#1)(2012-2#1)
Computer modelling##3##2##(2008-7#2)(2012-2#1)
Computer simulation##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
Computer simulations and##2##3##(2008-11#1)(2008-3#1)
Computer simulations##7##2##(1995-6#1)(2008-10#1)(2008-11#2)(2008-3#3)
Computer##33##1##(1990-11#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-2#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-6#1)(2008-10#4)(2008-11#5)(2008-3#4)(2008-7#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)
Computer-aided##2##1##(2008-10#1)(2009-11#1)
Computer-assisted decision support##2##3##(2011-2#2)
Computer-assisted##5##1##(2008-10#2)(2009-12#1)(2011-2#2)
Computerized tomography##2##2##(2008-11#2)
Computerized##7##1##(1991-2#1)(1992-2#1)(1994-3#1)(1995-2#1)(2008-11#2)(2008-8#1)
Computers##2##1##(1992-12#1)(1997-2#1)
Computing##2##1##(1993-1#1)(2009-3#1)
Con A##11##2##(1995-2#1)(2008-10#8)(2008-9#2)
Con A-His##2##2##(1994-11#2)
Con##21##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-11#3)(1995-2#1)(2006-6#1)(2008-10#8)(2008-9#2)
ConA and LPS##2##3##(1995-12#2)
ConA and##3##2##(1995-12#3)
ConA##5##1##(1995-12#5)
ConA-stimulated##2##1##(1995-12#2)
Concanavalin A (Con A)##2##4##(1994-8#1)(2012-3#1)
Concanavalin A (Con##3##3##(1991-12#1)(1994-8#1)(2012-3#1)
Concanavalin A##7##2##(1991-12#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-7#1)(2012-3#1)
Concanavalin##8##1##(1991-12#1)(1992-12#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-7#1)(2012-3#1)
Concentrated##2##1##(2008-10#1)(2008-7#1)
Concentration and##3##2##(1991-5#1)(2008-10#2)
Concentration in##2##2##(1996-9#1)(2008-3#1)
Concentration of heavy##2##3##(2008-10#1)(2008-12#1)
Concentration of##10##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
Concentration polarization##3##2##(2008-7#2)(2008-9#1)
Concentration##23##1##(1991-5#1)(1993-8#1)(1996-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#3)(2008-9#1)(2009-8#1)(2013-1#1)
Concentrations for##2##2##(2008-10#1)(2011-2#1)
Concentrations in##3##2##(2008-10#2)(2008-3#1)
Concentrations of 0##2##3##(2008-10#2)
Concentrations of##14##2##(2008-10#11)(2008-11#1)(2008-7#1)(2013-8#1)
Concentrations##22##1##(2008-10#15)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
Concentric rings##2##2##(2008-10#2)
Concentric##5##1##(1994-3#1)(2008-10#2)(2012-2#2)
Concept##9##1##(1996-5#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2011-9#1)(2012-2#1)
Concepts such as##2##3##(1993-1#1)(2008-10#1)
Concepts##8##1##(1993-1#1)(1997-6#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Conceptual##5##1##(1990-11#1)(1996-2#1)(2008-11#1)(2013-1#2)
Conceptually##3##1##(2008-8#1)(2011-2#2)
Concerning the##5##2##(2008-10#3)(2010-6#1)(2011-2#1)
Concerning##9##1##(2008-10#5)(2008-12#1)(2010-6#1)(2010-7#1)(2011-2#1)
Concerns about##4##2##(1993-3#1)(2008-12#1)(2008-5#1)(2010-1#1)
Concerns##9##1##(1993-3#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-5#1)(2010-1#1)(2011-1#1)
Concluding##2##1##(2008-8#1)(2010-2#1)
Conclusion -##2##2##(2008-11#2)
Conclusion The##3##2##(2011-2#3)
Conclusion##98##1##(1993-8#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#2)(2010-10#7)(2010-8#2)(2011-1#8)(2011-2#15)(2012-12#14)(2012-2#2)(2012-3#8)(2013-1#16)(2013-8#6)
Conclusions -##4##2##(2008-11#4)
Conclusions A##2##2##(2011-2#2)
Conclusions The prevalence of##2##4##(2011-2#1)(2012-12#1)
Conclusions The##10##2##(2011-2#6)(2012-12#4)
Conclusions This study##2##3##(2009-8#1)(2012-12#1)
Conclusions This##3##2##(2009-8#1)(2011-2#1)(2012-12#1)
Conclusions##179##1##(1991-11#2)(1992-6#1)(1993-12#1)(1996-3#1)(1996-9#2)(2007-11#3)(2007-8#3)(2008-11#4)(2008-3#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#4)(2010-1#2)(2010-10#6)(2010-12#1)(2010-8#3)(2011-1#5)(2011-2#24)(2012-12#29)(2012-2#2)(2012-3#11)(2013-1#60)(2013-8#9)
Conclusions-##3##1##(2008-11#3)
Conclusions  This study##2##3##(2011-2#1)(2013-1#1)
Conclusions ##5##1##(2011-2#4)(2013-1#1)
Concomitant with##3##2##(1990-10#1)(2008-10#2)
Concomitant##10##1##(1990-10#1)(2008-10#5)(2008-11#1)(2008-7#1)(2011-2#2)
Concomitantly##4##1##(1994-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
Concord grapes##2##2##(2008-10#2)
Concord##6##1##(2008-10#6)
Concordance between##2##2##(2012-3#2)
Concurrent##11##1##(1991-1#1)(1993-2#1)(2008-10#3)(2008-11#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#2)
Concurrently##10##1##(1995-2#1)(1997-1#1)(2008-11#3)(2008-5#1)(2009-7#2)(2010-4#1)(2013-7#1)
Condensation##2##1##(1996-5#2)
Condition##3##1##(2008-11#1)(2009-6#1)(2011-2#1)
Conditional##2##1##(2008-8#1)(2013-1#1)
Conditioning##5##1##(2008-10#2)(2008-5#1)(2010-11#1)(2012-12#1)
Conditions for##3##2##(2008-10#3)
Conditions of##2##2##(1992-3#1)(2008-10#1)
Conditions##30##1##(1992-3#1)(2008-10#22)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)(2012-12#1)(2013-8#1)
Conduct##3##1##(2010-11#1)(2011-2#2)
Conducting polymer##4##2##(2008-10#4)
Conducting##6##1##(2008-10#5)(2008-9#1)
Conductivity##3##1##(1996-9#1)(2008-10#2)
Conductometric##5##1##(2008-10#5)
Cone Beam CT##2##3##(2013-1#2)
Cone##3##1##(2008-3#1)(2013-1#2)
Conexibacter woesei##2##2##(2011-2#2)
Conexibacter##3##1##(2011-2#3)
Conexão##2##1##(2013-1#2)
Confederation##3##1##(2008-11#3)
Confer##2##1##(2008-10#2)
Conference in##4##2##(1995-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
Conference of the##2##3##(2008-12#1)(2008-7#1)
Conference of##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
Conference on##17##2##(1992-1#1)(1992-2#1)(1994-9#2)(1995-12#1)(1996-5#1)(2008-10#3)(2008-11#3)(2008-8#2)(2010-11#1)(2011-2#1)(2012-3#1)
Conference##53##1##(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-9#2)(1995-12#3)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(2008-10#9)(2008-11#8)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)
Conferences##2##1##(2008-5#1)(2008-7#1)
Conferring Resistance to##2##3##(2008-10#2)
Confers Resistance to##2##3##(2008-10#2)
Confers##6##1##(2008-10#4)(2010-12#1)(2012-3#1)
Confide##3##1##(1996-5#3)
Confidence##2##1##(2008-10#1)(2008-8#1)
Confidentiality of health care information##2##5##(1992-12#1)(1996-2#1)
Confidentiality##8##1##(1991-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1995-3#1)(1996-2#1)(1997-5#1)
Confirmation of##4##2##(1991-11#1)(1996-12#1)(2008-10#1)(2011-2#1)
Confirmatory Factor Analysis##2##3##(2012-2#2)
Confirmatory factor analysis##2##3##(2008-12#1)(2011-2#1)
Confirmatory##5##1##(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#2)
Confirmed##3##1##(1991-11#1)(2012-12#1)(2012-3#1)
Conflict of interest##26##3##(2008-8#1)(2011-1#25)
Conflict##30##1##(1996-12#1)(2008-8#2)(2009-7#1)(2011-1#25)(2011-2#1)
Conflicts##4##1##(1991-6#1)(1994-3#1)(1995-5#1)(1997-3#1)
Confocal microscopy##3##2##(2008-7#1)(2008-9#1)(2011-3#1)
Confocal##8##1##(1997-6#2)(2008-7#1)(2008-9#2)(2011-3#1)(2012-2#1)(2013-1#1)
Conformal##2##1##(2008-10#1)(2008-11#1)
Conformation##4##1##(1996-5#1)(2008-10#1)(2008-8#1)(2009-9#1)
Conformational changes##2##2##(1993-8#1)(1994-5#1)
Conformational studies on##2##3##(1990-5#1)(2008-8#1)
Conformational##10##1##(1990-5#1)(1990-9#1)(1991-5#2)(1993-8#1)(1994-5#1)(1996-5#1)(2008-12#1)(2008-5#1)(2008-8#1)
Conformer##2##1##(1991-3#2)
Confucian##4##1##(2010-8#4)
Congenital transmission##2##2##(2007-12#1)(2008-5#1)
Congenital##29##1##(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Congo##3##1##(1991-8#1)(2008-10#1)(2008-8#1)
Congress and##2##2##(1992-1#1)(1994-2#1)
Congress appropriated##2##2##(1997-1#1)(2008-5#1)
Congress in##3##2##(1993-12#1)(2011-4#2)
Congress is##2##2##(1995-8#1)(2011-4#1)
Congress of the##4##3##(2008-1#1)(2008-11#1)(2010-3#1)(2011-2#1)
Congress of##9##2##(1992-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-3#1)(2011-2#1)(2013-1#1)
Congress on##8##2##(1991-1#1)(1993-3#1)(1996-2#1)(2008-8#1)(2010-11#2)(2011-2#1)(2013-1#1)
Congress should##3##2##(1991-9#1)(1995-12#2)
Congress was##4##2##(1991-1#1)(2008-8#1)(2010-11#1)(2011-4#1)
Congress##61##1##(1990-2#1)(1990-8#1)(1991-1#8)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-5#3)(2008-6#1)(2008-8#4)(2010-11#3)(2010-3#1)(2011-2#2)(2011-4#4)(2012-3#1)(2013-1#2)
Congresses##3##1##(2008-7#2)(2011-4#1)
Congressional##4##1##(1995-12#1)(1995-6#1)(2009-6#1)(2012-3#1)
Conidia and##2##2##(2008-10#2)
Conidia from##2##2##(2008-10#2)
Conidia germinated on##2##3##(2008-10#2)
Conidia germinated##5##2##(2008-10#5)
Conidia of L##2##3##(2008-10#2)
Conidia of P##2##3##(2008-10#2)
Conidia of Trichoderma##2##3##(2008-10#2)
Conidia of##12##2##(2008-10#12)
Conidia##32##1##(2008-10#32)
Conidial germination##7##2##(2008-10#7)
Conidial production##2##2##(2008-10#2)
Conidial viability##3##2##(2008-10#3)
Conidial##23##1##(2008-10#23)
Conidiation##2##1##(2008-10#2)
Coniothyrium minitans##4##2##(2008-10#4)
Coniothyrium##5##1##(2008-10#4)(2010-3#1)
Conjoined##2##1##(2010-7#1)(2013-1#1)
Conjugates##2##1##(1997-1#1)(2008-10#1)
Conjugation of##3##2##(1990-12#1)(2008-4#1)(2008-9#1)
Conjugation##4##1##(1990-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
Connect##2##1##(1993-1#1)(2013-1#1)
Connected with this##2##3##(2008-11#1)(2008-12#1)
Connecticut physicians##2##2##(1997-3#2)
Connecticut##14##1##(1992-2#1)(1992-3#1)(1993-12#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-3#3)(2008-10#1)(2008-6#1)(2011-2#1)
Connecting##3##1##(2008-12#1)(2010-10#1)(2013-1#1)
Connection##2##1##(1996-12#1)(2008-10#1)
Connections##3##1##(2009-5#1)(2009-8#1)(2012-12#1)
Conrad##2##1##(2008-10#2)
Conrad's##2##1##(2009-11#1)(2012-2#1)
Conscious##2##1##(1993-1#1)(2008-5#1)
Consecutive transferring##2##2##(2008-10#2)
Consecutive##5##1##(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
Consed##6##1##(2008-4#6)
Consensus Conference##4##2##(2008-3#1)(2008-8#2)(2011-2#1)
Consensus on##2##2##(1990-2#1)(1997-1#1)
Consensus statement on##2##3##(1997-5#1)(2008-10#1)
Consensus statement##4##2##(1995-12#1)(1996-8#1)(1997-5#1)(2008-10#1)
Consensus##16##1##(1990-2#1)(1991-3#1)(1995-12#1)(1996-8#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#2)(2011-2#2)(2013-1#2)
Consent##2##1##(1990-2#1)(2009-4#1)
Consequences for##2##2##(1990-11#1)(2008-10#1)
Consequences of##2##2##(2008-1#1)(2008-11#1)
Consequences##4##1##(1990-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
Consequently the##2##2##(1996-1#1)(2008-10#1)
Consequently##88##1##(1991-3#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-8#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-8#2)(2007-8#1)(2008-10#26)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-2#3)(2012-6#1)(2013-1#5)(2013-8#2)
Conservation of##3##2##(1991-5#1)(1993-12#1)(2008-8#1)
Conservation##8##1##(1991-5#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
Conservative management##2##2##(2010-1#1)(2010-11#1)
Conservative treatment##3##2##(1993-2#1)(2008-7#1)(2010-11#1)
Conservative##7##1##(1993-11#1)(1993-2#1)(2008-7#1)(2010-1#1)(2010-11#2)(2013-1#1)
Conserved##3##1##(2008-10#1)(2012-2#2)
Consider##2##1##(1991-2#1)(2008-11#1)
Considerable concern was raised about the research purportedly conducted at Sri Venkateswara University##2##13##(2008-10#2)
Considerable progress has been##2##4##(1997-7#1)(2008-11#1)
Considerable variation in##3##3##(2008-10#3)
Considerable##21##1##(1991-12#1)(1992-6#1)(1993-2#1)(1994-11#1)(1996-1#1)(1997-3#2)(1997-7#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-9#1)
Consideration is given to the##2##5##(2008-3#1)(2010-6#1)
Consideration of##2##2##(2008-3#1)(2008-9#1)
Consideration##5##1##(1990-11#1)(2008-3#2)(2008-9#1)(2010-6#1)
Considerations for working with M##3##5##(2008-9#3)
Considerations for##5##2##(1997-2#1)(2008-4#1)(2008-9#3)
Considerations in##2##2##(2008-11#1)(2012-3#1)
Considerations##10##1##(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#3)(2012-3#1)
Considered##2##1##(1991-12#1)(2012-3#1)
Considering a##3##2##(2008-10#2)(2008-3#1)
Considering that##6##2##(2008-11#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-6#1)(2013-8#1)
Considering the##16##2##(1990-9#1)(1995-1#1)(1996-1#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Considering##38##1##(1990-9#1)(1995-1#1)(1996-1#1)(1997-7#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
Consistency of##3##2##(1995-5#1)(1997-8#2)
Consistency##7##1##(1995-5#1)(1996-2#1)(1997-8#2)(2007-12#1)(2008-10#1)(2010-7#1)
Consistent differences in##2##3##(2008-10#2)
Consistent with a##2##3##(1992-9#1)(1996-3#1)
Consistent with previous##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
Consistent with the##3##3##(1994-1#1)(2009-6#1)(2012-3#1)
Consistent with this##8##3##(1992-4#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
Consistent with##19##2##(1992-4#1)(1992-9#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-6#1)(2011-2#2)(2012-3#1)
Consistent##28##1##(1992-4#1)(1992-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-6#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#2)
Consonant Harmony##3##2##(2010-1#3)
Consortium##14##1##(1996-3#1)(2007-9#2)(2008-11#3)(2010-5#2)(2010-6#2)(2011-2#4)
Conspicuous##2##1##(2008-10#1)(2008-7#1)
Constant##3##1##(1996-9#1)(2008-10#1)(2008-11#1)
Constitution##3##1##(1995-6#1)(2011-2#2)
Constitutive expression of##4##3##(1991-9#1)(1992-7#1)(2008-9#2)
Constitutive resistance##2##2##(2008-8#2)
Constitutive##11##1##(1991-9#1)(1992-7#1)(1996-12#1)(2008-10#3)(2008-8#2)(2008-9#2)(2010-8#1)
Constraints on the##2##3##(2008-10#1)(2008-11#1)
Constraints on##3##2##(1991-1#1)(2008-10#1)(2008-11#1)
Constraints##5##1##(1991-1#1)(2008-10#2)(2008-11#2)
Construct validity##2##2##(2008-11#1)(2010-11#1)
Construct##4##1##(2008-11#1)(2010-11#1)(2013-1#1)(2013-8#1)
Constructing##3##1##(1990-11#1)(2008-11#1)(2008-4#1)
Construction and characterization of a##2##5##(2008-10#1)(2008-8#1)
Construction and characterization of##5##4##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
Construction and evaluation of##2##4##(2008-10#2)
Construction and##9##2##(1993-12#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#2)
Construction of YAC##2##3##(1995-6#1)(2008-4#1)
Construction of a##4##3##(2008-10#2)(2008-9#1)(2009-10#1)
Construction of an##2##3##(2008-11#1)(2010-1#1)
Construction of the##2##3##(1996-9#1)(2008-10#1)
Construction of##21##2##(1993-12#2)(1995-6#1)(1996-6#1)(1996-9#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-1#1)(2013-1#1)
Construction##33##1##(1991-2#1)(1993-12#3)(1995-6#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-4#2)(2008-8#5)(2008-9#1)(2009-10#1)(2010-1#1)(2013-1#1)
Consultant Radiologist workload##3##3##(2012-2#3)
Consultant Radiologist##5##2##(2012-2#5)
Consultants##2##1##(1991-8#1)(1991-9#1)
Consultation##2##1##(1991-2#1)(2008-11#1)
Consulting##2##1##(2007-11#1)(2010-6#1)
Consumer##11##1##(1993-1#2)(1993-3#1)(1995-2#1)(1996-1#1)(1997-3#4)(2008-11#2)
Consumers over age 50 currently comprise 40 percent of consumer demand##2##11##(1994-3#2)
Consumers##6##1##(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1997-3#1)
Consumption of##5##2##(1994-11#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-8#1)
Consumption##8##1##(1994-11#1)(1996-3#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-8#1)(2012-3#1)(2013-8#1)
Contact##3##1##(2008-10#2)(2009-7#1)
Contained in this regular feature of the journal is a section on each of the following four topics##2##18##(1991-2#1)(1992-2#1)
Contained##3##1##(1991-2#1)(1992-2#1)(2008-10#1)
Container##2##1##(2008-10#2)
Containing an##2##2##(1996-5#1)(2009-10#1)
Containing##9##1##(1994-2#1)(1996-5#3)(2008-10#2)(2009-10#1)(2012-2#1)(2012-3#1)
Containment##3##1##(1995-12#1)(2008-10#1)(2013-8#1)
Contaminated##3##1##(2008-10#2)(2011-2#1)
Contamination of##5##2##(1993-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
Contamination##12##1##(1993-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#2)
Contemporary##11##1##(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
Content analysis##3##2##(2008-11#2)(2010-10#1)
Content and##2##2##(2008-10#1)(2012-2#1)
Content##13##1##(1997-3#1)(2008-10#3)(2008-11#3)(2008-12#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
Contents of volume##3##3##(2008-11#3)
Contents of##5##2##(2008-10#1)(2008-11#3)(2010-5#1)
Contents volume##2##2##(2008-11#2)
Contents##9##1##(2008-10#2)(2008-11#5)(2010-5#1)(2011-2#1)
Context##4##1##(1992-12#1)(2008-10#1)(2010-8#1)(2012-2#1)
Context-Free Grammar##2##2##(2011-3#2)
Contextual##4##1##(1995-12#1)(2012-3#3)
Continental##2##1##(2008-10#1)(2013-8#1)
Continents##2##1##(2008-10#2)
Contingency##2##1##(2008-10#1)(2008-11#1)
Continual##2##1##(1994-3#1)(2008-9#1)
Continued##8##1##(1995-2#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-9#1)(2013-1#2)
Continuing education is##2##3##(1994-12#1)(2008-11#1)
Continuing education##5##2##(1993-12#1)(1994-12#1)(1996-3#1)(2008-11#1)(2008-9#1)
Continuing##11##1##(1993-12#2)(1994-12#2)(1996-2#1)(1996-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)
Continuity of##3##2##(1993-3#1)(2008-11#1)(2010-8#1)
Continuity##6##1##(1993-1#1)(1993-3#2)(1994-2#1)(2008-11#1)(2010-8#1)
Continuous Improvement##2##2##(1993-3#1)(1997-1#1)
Continuous Quality Improvement (CQI)##2##4##(1994-12#1)(1997-2#1)
Continuous Quality Improvement##3##3##(1994-12#2)(1997-2#1)
Continuous flow analysis of##2##4##(2008-10#2)
Continuous flow system for the determination of trace##2##8##(2008-10#2)
Continuous flow system for##3##4##(2008-10#3)
Continuous flow##7##2##(2008-10#7)
Continuous monitoring of##2##3##(1997-8#1)(2008-10#1)
Continuous monitoring##3##2##(1997-8#1)(2008-10#2)
Continuous production##2##2##(2008-11#1)(2008-7#1)
Continuous quality improvement and##3##4##(1993-12#1)(1993-3#2)
Continuous quality improvement in##2##4##(1993-3#1)(1994-1#1)
Continuous quality improvement##10##3##(1993-12#2)(1993-3#5)(1994-1#1)(1994-12#1)(1995-12#1)
Continuous quality##11##2##(1993-12#2)(1993-3#5)(1994-1#1)(1994-12#2)(1995-12#1)
Continuous treatment with##2##3##(1992-12#1)(1996-5#1)
Continuous##52##1##(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#6)(1994-1#1)(1994-12#4)(1994-3#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#13)(2008-11#6)(2008-3#1)(2008-7#2)(2009-12#1)(2012-3#2)(2013-8#1)
Continuous-Wave##6##1##(2008-3#6)
Continuous-flow##3##1##(2008-10#3)
Continuous-wave##3##1##(2008-3#3)
Contour##3##1##(2008-10#2)(2008-6#1)
Contraception##2##1##(1997-6#1)(2008-11#1)
Contraceptive##2##1##(2013-1#2)
Contract##3##1##(1992-1#1)(1995-1#1)(1997-5#1)
Contractile fields##2##2##(2008-12#2)
Contrary to expectation##2##3##(2008-7#1)(2008-8#1)
Contrary to predictions##2##3##(2008-9#1)(2012-2#1)
Contrary to the previous##2##4##(2008-5#2)
Contrary to the##6##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)
Contrary to what##2##3##(2008-10#1)(2012-3#1)
Contrary to##23##2##(1992-11#1)(1992-3#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-3#1)
Contrast##7##1##(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#2)
Contrast-enhanced harmonic##2##2##(2010-12#2)
Contrast-enhanced ultrasound (CEUS) is a##2##5##(2010-12#1)(2012-2#1)
Contrast-enhanced ultrasound (CEUS)##4##3##(2010-12#2)(2012-2#2)
Contrast-enhanced ultrasound##7##2##(2010-12#4)(2012-2#3)
Contrast-enhanced##10##1##(2010-12#7)(2012-2#3)
Contrasting##4##1##(2008-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
Contribute##2##1##(2008-10#1)(2013-1#1)
Contributes to##2##2##(2008-10#1)(2013-8#1)
Contributing factors##2##2##(2008-5#1)(2011-2#1)
Contribution of##7##2##(1994-5#1)(1996-9#1)(2008-10#2)(2008-5#1)(2008-7#2)
Contribution to##5##2##(2008-10#1)(2008-11#3)(2012-3#1)
Contribution##15##1##(1993-1#2)(1994-5#1)(1996-9#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#2)(2012-3#1)
Contributions of the##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
Contributions of##6##2##(1991-12#1)(1992-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
Contributions to##3##2##(2008-10#2)(2009-10#1)
Contributions##10##1##(1991-12#1)(1992-12#1)(2008-10#2)(2008-3#1)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
Control Program##3##2##(1997-6#2)(2013-1#1)
Control and Prevention##20##3##(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#1)(2010-6#2)(2012-12#1)
Control and##25##2##(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#2)(2011-2#2)(2012-12#1)
Control by##2##2##(2008-10#2)
Control efficacy values##2##3##(2008-10#2)
Control efficacy##3##2##(2008-10#3)
Control experiments##4##2##(1993-8#1)(1994-5#1)(2008-11#1)(2010-1#1)
Control group##5##2##(1994-3#1)(2011-2#4)
Control of Botrytis cinerea on##2##5##(2008-10#2)
Control of Botrytis cinerea##5##4##(2008-10#5)
Control of Fire Blight##2##4##(2008-10#2)
Control of Fusarium Wilt of##3##5##(2008-10#3)
Control of Fusarium Wilt##4##4##(2008-10#4)
Control of Postharvest Decay of##2##5##(2008-10#2)
Control of the lesion was satisfactory in both cases##2##9##(2011-2#2)
Control of the##8##3##(1993-8#1)(2008-10#3)(2008-3#1)(2011-2#3)
Control of##56##2##(1990-11#1)(1990-2#1)(1991-11#1)(1993-8#2)(1994-6#1)(1996-11#1)(1996-12#1)(1996-9#1)(2008-10#37)(2008-11#1)(2008-3#1)(2008-7#3)(2011-2#3)(2012-2#1)(2013-1#1)
Control over##2##2##(2008-10#1)(2010-6#1)
Control rats were##2##3##(1994-5#1)(2011-2#1)
Control##155##1##(1990-11#1)(1990-2#1)(1991-11#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#2)(2008-1#1)(2008-10#59)(2008-11#4)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#2)(2010-1#1)(2010-4#1)(2010-6#3)(2010-8#2)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
Control)##4##1##(1994-2#4)
Controlled by##3##2##(1996-5#1)(2008-10#2)
Controlled##18##1##(1991-3#1)(1991-8#1)(1992-12#1)(1996-5#1)(2008-10#8)(2008-5#1)(2008-6#2)(2008-9#1)(2011-2#1)(2013-1#1)
Controlling for##2##2##(1991-3#1)(2008-11#1)
Controlling##17##1##(1991-3#1)(1994-1#1)(1995-1#2)(1995-3#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-5#1)(2009-10#1)(2012-3#1)
Controls were##3##2##(1991-2#1)(1991-6#1)(2013-1#1)
Controls##10##1##(1990-2#2)(1991-2#1)(1991-6#1)(2008-10#1)(2011-2#1)(2013-1#4)
Controversial##4##1##(1997-7#1)(2010-12#1)(2011-2#2)
Controversies in the##3##3##(1991-8#1)(1994-12#1)(2010-7#1)
Controversies##4##1##(1991-8#1)(1994-12#1)(2008-5#1)(2010-7#1)
Controversy##2##1##(1990-11#1)(2013-1#1)
Conus parvatus##2##2##(2008-12#2)
Convenient Route to##2##3##(1996-5#2)
Convenient##6##1##(1996-5#3)(2008-1#1)(2008-10#1)(2009-12#1)
Convention##5##1##(1992-12#4)(2012-2#1)
Conventional and##2##2##(1997-8#1)(2013-1#1)
Conventional methods##3##2##(2008-10#2)(2008-9#1)
Conventional##34##1##(1990-2#1)(1990-8#1)(1994-3#1)(1997-5#1)(1997-8#1)(2008-10#9)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
Convergence##2##1##(2008-3#1)(2008-8#1)
Convergent evolution of##2##3##(2009-8#2)
Convergent##3##1##(2009-8#2)(2011-2#1)
Conversations##2##1##(1996-1#1)(2013-8#1)
Conversely##45##1##(1991-11#1)(1991-5#1)(1993-1#1)(1994-2#1)(1995-11#2)(1996-2#1)(1997-8#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
Conversion of A into B was##2##6##(1997-1#2)
Conversion of a##2##3##(2008-10#1)(2008-3#1)
Conversion of##12##2##(1992-8#1)(1995-8#1)(1996-5#1)(1997-1#2)(2008-10#3)(2008-3#1)(2009-12#1)(2009-5#1)(2010-5#1)
Conversion##16##1##(1992-8#1)(1995-8#1)(1996-5#1)(1997-1#2)(1997-6#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-5#1)
Cook Island women##2##3##(2008-1#2)
Cooling##2##1##(2008-12#1)(2008-5#1)
Coomassie Brilliant Blue##2##3##(2008-10#2)
Coomassie brilliant blue##3##3##(2008-10#2)(2008-4#1)
Coomassie##7##1##(1993-9#1)(2008-10#4)(2008-4#2)
Cooper##2##1##(1992-8#1)(2008-7#1)
CooperSurgical##2##1##(2011-2#2)
Cooperation between##2##2##(1993-6#1)(1996-11#1)
Cooperation is##2##2##(1994-1#1)(2011-4#1)
Cooperation##9##1##(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1996-11#1)(2008-9#1)(2011-4#1)
Cooperative Group##3##2##(1993-11#1)(1994-8#1)(2011-2#1)
Cooperative breeding##2##2##(2008-8#2)
Cooperative##12##1##(1990-11#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-2#1)(2011-2#2)
Cooperia oncophora##2##2##(1996-12#2)
Coordinated##4##1##(1992-3#1)(1996-3#1)(2008-11#1)(2009-8#1)
Coordinating##2##1##(1990-12#1)(2008-10#1)
Coordination##2##1##(1995-3#1)(2008-10#1)
Coordinator##2##1##(1995-6#1)(2013-1#1)
Copenhagen##8##1##(1993-3#1)(1995-5#1)(1997-3#1)(2008-11#2)(2011-4#2)(2013-1#1)
Coping with##5##2##(1991-3#1)(1997-3#2)(2010-5#1)(2013-1#1)
Coping##10##1##(1991-3#1)(1993-1#1)(1997-3#2)(2008-11#2)(2008-12#1)(2009-7#1)(2010-5#1)(2013-1#1)
Copolymers##2##1##(2008-10#1)(2009-10#1)
Copper and##3##2##(2008-10#3)
Copper determination in##2##3##(2008-10#2)
Copper is##2##2##(2008-10#1)(2012-2#1)
Copper##26##1##(1992-12#1)(1997-8#1)(2008-10#20)(2012-2#2)(2013-8#2)
Copper(II) complexes##2##2##(2008-10#2)
Copper(II)##8##1##(2008-10#8)
Copper(II)-selective##2##1##(2008-10#2)
Coprecipitation parameters and matrix effects are discussed##2##7##(2008-10#2)
Coprecipitation parameters##3##2##(2008-10#3)
Coprecipitation with##2##2##(2008-10#2)
Coprecipitation##6##1##(2008-10#6)
Coprinus##4##1##(2008-10#1)(2010-3#1)(2010-5#1)(2010-7#1)
Copyright (c) 2000 John Wiley &amp##36##6##(2008-11#36)
Copyright (c) 2005 John Wiley &amp##2##6##(2008-9#2)
Copyright (c)##38##2##(2008-11#36)(2008-9#2)
Copyright © 2010 European Peptide Society and John Wiley &amp##4##10##(2011-2#4)
Copyright © 2010 John Wiley &amp##5##6##(2011-2#3)(2012-2#2)
Copyright © 2010##9##3##(2011-2#7)(2012-2#2)
Copyright © 2011 John Wiley &amp##5##6##(2011-2#1)(2012-2#2)(2012-3#2)
Copyright © 2012 John Wiley &amp##10##6##(2012-2#1)(2012-4#1)(2012-5#1)(2013-1#7)
Copyright ©##24##2##(2011-2#8)(2012-2#5)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#7)
Copyright##62##1##(2008-11#36)(2008-9#2)(2011-2#8)(2012-2#5)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#7)
Coraliomargarita akajimensis##2##2##(2011-2#2)
Coraliomargarita##3##1##(2011-2#3)
Cord Injury##4##2##(2008-11#1)(2008-12#1)(2009-6#1)(2010-2#1)
Cord blood##2##2##(2008-9#1)(2011-2#1)
Cord##10##1##(1995-11#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#2)
Core Functions##2##2##(1995-12#2)
Core##11##1##(1994-12#1)(1995-12#2)(1995-3#2)(1996-5#1)(2008-10#3)(2010-4#1)(2011-2#1)
Corfu##2##1##(2008-5#2)
Coriolus versicolor##2##2##(2008-11#1)(2011-2#1)
Corn Flea Beetle##2##3##(2008-10#2)
Corn##16##1##(1990-11#1)(2008-10#15)
Corneal##2##1##(2010-5#1)(2011-2#1)
Corner##4##1##(1996-5#1)(2008-8#3)
Cornerstone is a##2##3##(1996-12#2)
Cornerstone##5##1##(1996-12#5)
Coronary Artery##2##2##(2008-11#2)
Coronary angiography##3##2##(1991-3#1)(2010-5#1)(2013-1#1)
Coronary artery bypass##2##3##(1990-6#1)(2013-8#1)
Coronary artery##5##2##(1990-3#1)(1990-6#1)(2009-5#1)(2013-8#2)
Coronary computed tomography angiography##2##4##(2008-12#1)(2011-2#1)
Coronary heart disease##2##3##(1991-11#1)(2010-12#1)
Coronary##27##1##(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1995-8#1)(2008-11#5)(2008-12#1)(2008-3#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Corp##8##1##(1991-9#1)(1995-6#2)(1996-5#3)(2008-5#1)(2012-12#1)
Corporation##7##1##(1993-12#1)(1994-1#1)(1997-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
Corps##2##1##(1990-3#1)(2012-3#1)
Corpus##2##1##(2008-10#1)(2010-3#1)
Correct classification##2##2##(2008-10#1)(2008-7#1)
Correct##8##1##(1993-6#2)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
Corrected##3##1##(2008-10#2)(2013-1#1)
Correcting##3##1##(2008-10#2)(2010-7#1)
Correction of##6##2##(1997-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-4#1)
Correction##7##1##(1993-2#1)(1997-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-4#1)
Corrections##3##1##(1995-3#1)(1996-9#1)(2008-11#1)
Corrective##2##1##(1996-11#1)(2008-9#1)
Correlated responses in behavioral isolation##2##5##(2008-9#2)
Correlated with##3##2##(2008-10#2)(2012-2#1)
Correlated##7##1##(1996-9#1)(2008-10#2)(2008-9#3)(2012-2#1)
Correlates of Protective Viruses Damaging to HIV Infection##2##8##(1996-5#2)
Correlates of##3##2##(1996-5#2)(2009-5#1)
Correlates##5##1##(1991-2#1)(1996-5#2)(2008-10#1)(2009-5#1)
Correlation between serum##2##3##(2006-6#1)(2011-2#1)
Correlation between the##2##3##(2008-10#1)(2009-7#1)
Correlation between##9##2##(1994-11#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#2)
Correlation coefficients##2##2##(2008-10#1)(2010-12#1)
Correlation of##9##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-10#1)(2012-2#3)
Correlation with##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
Correlation##35##1##(1991-9#1)(1994-11#1)(2006-6#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-10#1)(2011-2#2)(2012-2#5)(2013-1#3)
Correlational analyses##2##2##(2010-6#1)(2012-2#1)
Correlations and differences were analysed by means of the chi2-test##2##10##(1991-8#2)
Correlations between##7##2##(1993-2#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
Correlations##16##1##(1991-8#2)(1993-2#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
Corresponding values##2##2##(1993-1#1)(2008-10#1)
Corresponding##5##1##(1991-5#1)(1991-6#1)(1993-1#1)(2008-10#2)
Correspondingly##2##1##(2008-7#1)(2009-10#1)
Corrigan##3##1##(1995-2#3)
Cortex##11##1##(2008-10#9)(2012-2#1)(2013-1#1)
Cortical activation##2##2##(1996-2#1)(2008-9#1)
Cortical##11##1##(1991-9#1)(1994-2#2)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-9#2)
Cortisol##3##1##(2008-11#2)(2008-6#1)
Coruña##2##1##(2008-10#2)
Corvallis##2##1##(2008-10#2)
Corylus##2##1##(2008-10#1)(2011-1#1)
Corynebacteria##3##1##(2008-5#3)
Corynebacterium glutamicum was##2##3##(2008-7#2)
Corynebacterium glutamicum##4##2##(2008-7#4)
Corynebacterium##11##1##(1991-8#1)(1996-11#1)(2007-11#1)(2008-5#4)(2008-7#4)
Cos-P##2##1##(1994-8#2)
Cosmetic##12##1##(2008-5#10)(2010-6#1)(2011-2#1)
Cost and##4##2##(1991-12#1)(1991-2#1)(2008-11#2)
Cost of##3##2##(2008-10#2)(2008-9#1)
Cost##23##1##(1991-12#2)(1991-2#2)(1993-12#1)(1994-1#1)(1994-3#2)(1995-12#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-9#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Cost-benefit analysis##2##2##(2008-7#1)(2009-12#1)
Cost-benefit##3##1##(2008-7#1)(2009-12#1)(2009-4#1)
Cost-effective##3##1##(2008-10#2)(2008-11#1)
Cost-effectiveness of##2##2##(2009-4#1)(2009-8#1)
Cost-effectiveness studies##2##2##(1996-9#1)(2008-2#1)
Cost-effectiveness##6##1##(1996-9#1)(2008-2#1)(2009-4#1)(2009-8#2)(2013-1#1)
Costa Rica and##3##3##(2008-10#3)
Costa Rica##8##2##(1990-6#1)(2008-10#7)
Costa##10##1##(1990-6#1)(2008-10#8)(2011-2#1)
Costs of##4##2##(1991-9#1)(1994-2#1)(2008-8#1)(2008-9#1)
Costs##7##1##(1991-9#1)(1993-12#1)(1994-2#1)(1997-2#1)(2008-12#1)(2008-8#1)(2008-9#1)
Cotesia glomerata##2##2##(2010-4#2)
Cotesia rubecula##2##2##(2008-8#2)
Cotesia##6##1##(1990-11#1)(2008-8#2)(2010-4#3)
Cotton##11##1##(2008-10#9)(2008-9#1)(2013-8#1)
Cottonball##2##1##(2008-10#2)
Cougarblight and rain##2##3##(2008-10#2)
Cougarblight and##3##2##(2008-10#3)
Cougarblight##10##1##(2008-10#10)
Could##3##1##(2008-11#1)(2008-4#1)(2011-2#1)
Coulomb##2##1##(2008-11#1)(2010-7#1)
Coulometric determination of##2##3##(2008-10#2)
Coulometric##7##1##(2008-10#7)
Coulter##4##1##(2008-10#3)(2009-5#1)
Coumarin 460##2##2##(2008-3#2)
Coumarin##4##1##(1990-6#2)(2008-3#2)
Council for##7##2##(1990-6#1)(1996-11#1)(2008-11#5)
Council of##9##2##(1992-2#1)(1995-6#1)(1996-3#4)(2008-11#1)(2010-10#1)(2012-12#1)
Council on Medical Education##2##4##(1991-8#2)
Council on##10##2##(1991-2#1)(1991-8#2)(1992-12#1)(1994-2#1)(1995-12#1)(1995-6#2)(1997-3#1)(2010-1#1)
Council will##2##2##(1995-6#2)
Council##47##1##(1990-6#2)(1991-2#2)(1991-8#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#3)(1995-6#10)(1996-1#1)(1996-11#1)(1996-3#4)(1996-8#2)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#8)(2010-1#1)(2010-10#1)(2012-12#1)(2013-1#1)
Counseling##7##1##(1991-8#1)(1997-3#1)(2008-5#2)(2010-12#1)(2013-1#2)
Counselors##3##1##(2010-11#3)
Count##3##1##(1996-12#3)
Counter##2##1##(2008-10#1)(2008-11#1)
Counterpoint##5##1##(2011-2#5)
Counties##4##1##(2008-10#3)(2008-12#1)
Counting blessings##2##2##(2008-12#2)
Counting##6##1##(1997-2#1)(2008-12#2)(2008-5#1)(2008-6#2)
Countries##4##1##(2008-1#1)(2008-10#2)(2010-3#1)
Country of birth##2##3##(2011-2#2)
Country##4##1##(1997-6#1)(2008-10#1)(2011-2#2)
County Court##2##2##(1990-11#1)(1995-12#1)
County has##2##2##(2011-2#2)
County in the##2##3##(2008-10#1)(2011-2#1)
County in##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
County##75##1##(1990-11#1)(1990-12#2)(1991-11#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#2)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#5)(1997-3#1)(2008-10#22)(2008-11#2)(2008-8#1)(2010-1#1)(2010-6#2)(2011-2#19)(2012-12#1)(2013-1#2)(2013-8#1)
Couple-based interventions for medical problems##2##5##(2012-2#2)
Coupled with microdialysis##2##3##(2008-10#2)
Coupled with##4##2##(2008-10#4)
Coupled##11##1##(2008-10#9)(2008-11#1)(2010-10#1)
Couples##2##1##(2008-6#1)(2011-2#1)
Coupling of##2##2##(2008-10#1)(2008-3#1)
Coupling##16##1##(1996-5#1)(1996-9#2)(2008-10#5)(2008-12#1)(2008-3#4)(2009-5#2)(2010-7#1)
Course of##5##2##(1991-2#1)(2008-10#1)(2010-1#1)(2010-11#1)(2012-3#1)
Course##10##1##(1991-2#1)(1996-12#2)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-1#1)(2010-11#1)(2012-3#1)
Courses##2##1##(1991-6#1)(2013-1#1)
Court Judge##3##2##(1995-12#2)(1996-5#1)
Court for##3##2##(1995-2#1)(1996-9#1)(1997-7#1)
Court of Appeals for the Fourth Circuit##2##7##(1995-6#1)(1997-6#1)
Court of Appeals for the##4##5##(1995-6#3)(1997-6#1)
Court of Appeals##11##3##(1995-12#4)(1995-6#3)(1996-5#3)(1997-6#1)
Court of Common Pleas##2##4##(1995-12#2)
Court of##18##2##(1990-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#6)(1995-6#3)(1996-3#1)(1996-5#3)(1997-6#1)
Court rejects##2##2##(1995-6#1)(1996-5#1)
Court upholds##4##2##(1990-2#1)(1992-11#1)(1995-6#2)
Court##54##1##(1990-11#2)(1990-2#2)(1991-12#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#3)(1993-9#2)(1994-12#1)(1995-1#1)(1995-12#10)(1995-2#1)(1995-6#12)(1996-2#1)(1996-3#1)(1996-5#6)(1996-9#1)(1997-6#2)(1997-7#1)(2010-6#2)
Court's decision##2##2##(1991-12#2)
Court's##4##1##(1991-12#2)(1996-5#1)(2009-9#1)
Covalent##5##1##(1991-8#1)(1992-9#1)(1996-9#1)(2008-10#1)(2008-11#1)
Covalently##2##1##(1996-5#1)(2008-9#1)
Covariance##2##1##(1996-3#1)(1997-7#1)
Cover##3##1##(2008-10#1)(2009-4#1)(2013-8#1)
Coverage##2##1##(1996-12#1)(2008-2#1)
Cowdria ruminantium##2##2##(1996-12#2)
Cowpea##2##1##(2008-10#2)
Cox model was##2##3##(2008-10#1)(2008-7#1)
Cox proportional hazards regression##2##4##(2011-2#1)(2013-1#1)
Cox proportional hazards##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
Cox regression was used to##2##5##(2008-11#1)(2013-1#1)
Cox regression##5##2##(1992-9#1)(2008-11#1)(2008-7#1)(2013-1#2)
Cox##11##1##(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-6#1)(2011-2#1)(2013-1#3)
Cox14p##3##1##(1995-6#3)
Coxiella burnetii whole cells##2##4##(1995-12#2)
Coxiella burnetii##6##2##(1991-8#1)(1992-5#1)(1995-12#4)
Coxsackievirus B3##2##2##(1994-5#2)
Cp1##3##1##(2008-10#3)
Cp2##3##1##(2008-10#3)
CpG DNA##2##2##(2008-4#2)
CpG and##2##2##(2008-10#2)
CpG dinucleotide##2##2##(1991-6#1)(2008-4#1)
CpG dinucleotides##3##2##(1991-6#1)(1993-2#2)
CpG island in the 5' region of the##2##8##(1991-6#2)
CpG island##5##2##(1991-6#3)(1996-6#2)
CpG islands##6##2##(1995-12#2)(1995-8#2)(1996-6#2)
CpG motifs##3##2##(2008-10#1)(2008-4#2)
CpG##29##1##(1991-6#5)(1993-2#2)(1994-5#1)(1995-12#2)(1995-8#2)(1996-6#4)(2008-10#5)(2008-11#1)(2008-4#6)(2011-1#1)
Cr (III) and Cr (VI)##2##5##(2008-10#2)
Cr (III)##5##2##(2008-10#5)
Cr (VI)##6##2##(2008-10#6)
Cr and Cd##2##3##(2008-10#2)
Cr and Co##2##3##(2008-10#2)
Cr and Cu##2##3##(2008-10#2)
Cr and Ni##2##3##(2008-10#1)(2008-11#1)
Cr and##11##2##(2008-10#10)(2008-11#1)
Cr had##2##2##(2008-10#2)
Cr in##6##2##(2008-10#5)(2009-12#1)
Cr l(-1)##2##2##(2008-10#2)
Cr species##3##2##(2008-10#3)
Cr with##3##2##(2008-10#3)
Cr##144##1##(2007-11#1)(2007-12#1)(2008-10#128)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2009-12#2)(2011-2#4)
Cr(3+) and##2##2##(2008-10#2)
Cr(3+)##11##1##(2007-11#1)(2008-10#10)
Cr(4+)##13##1##(2007-12#1)(2008-2#4)(2008-3#8)
Cr(6+)##4##1##(2008-10#4)
Cr(III##2##1##(2008-10#2)
Cr(III) and Cr(VI) in##8##4##(2008-10#8)
Cr(III) and Cr(VI) species##2##4##(2008-10#2)
Cr(III) and Cr(VI) were##2##4##(2008-10#2)
Cr(III) and Cr(VI)##19##3##(2008-10#19)
Cr(III) and Fe(III)##2##3##(2008-10#2)
Cr(III) and##27##2##(2008-10#27)
Cr(III) between##2##2##(2008-10#2)
Cr(III) by##3##2##(2008-10#3)
Cr(III) concentration##4##2##(2008-10#4)
Cr(III) determination##2##2##(2008-10#2)
Cr(III) ions from aqueous##2##4##(2008-10#2)
Cr(III) ions##8##2##(2008-10#7)(2011-2#1)
Cr(III) is##4##2##(2008-10#4)
Cr(III) selectively##2##2##(2008-10#2)
Cr(III) was##4##2##(2008-10#4)
Cr(III) were found to##2##4##(2008-10#2)
Cr(III) were##4##2##(2008-10#4)
Cr(III)##131##1##(2008-10#127)(2011-2#4)
Cr(III)&gt##2##1##(2008-10#2)
Cr(VI) and Cr(III) in##2##4##(2008-10#2)
Cr(VI) and Cr(III) were##2##4##(2008-10#2)
Cr(VI) and Cr(III)##11##3##(2008-10#11)
Cr(VI) and##26##2##(2008-10#26)
Cr(VI) at##2##2##(2008-10#2)
Cr(VI) by##3##2##(2008-10#2)(2011-2#1)
Cr(VI) can be##2##3##(2008-10#2)
Cr(VI) concentration##2##2##(2008-10#2)
Cr(VI) concentrations##5##2##(2008-10#5)
Cr(VI) determination##3##2##(2008-10#3)
Cr(VI) from solid samples##2##4##(2008-10#2)
Cr(VI) from##6##2##(2008-10#6)
Cr(VI) has been##2##3##(2008-10#2)
Cr(VI) in the##4##3##(2008-10#4)
Cr(VI) in##19##2##(2008-10#19)
Cr(VI) ion selectivity##2##3##(2008-10#2)
Cr(VI) ion##4##2##(2008-10#4)
Cr(VI) ions##2##2##(2008-10#1)(2011-2#1)
Cr(VI) is##7##2##(2008-10#7)
Cr(VI) on the##2##3##(2008-10#2)
Cr(VI) on##3##2##(2008-10#3)
Cr(VI) species##5##2##(2008-10#5)
Cr(VI) was determined##2##3##(2008-10#2)
Cr(VI) was found##2##3##(2008-10#2)
Cr(VI) was##11##2##(2008-10#11)
Cr(VI) were##4##2##(2008-10#3)(2011-2#1)
Cr(VI) with##5##2##(2008-10#5)
Cr(VI)##166##1##(2008-10#163)(2011-2#3)
Cr(VI)-PDC chelate##2##2##(2008-10#2)
Cr)##4##1##(2008-10#3)(2011-2#1)
Cr1 and Cr2##2##3##(2008-10#2)
Cr1##7##1##(2008-10#7)
Cr2##24##1##(2008-10#24)
Cr3##2##1##(2008-10#2)
Cr3+##2##1##(1993-6#1)(2013-8#1)
CrEL##3##1##(2008-10#3)
CrO(4)(2-)##4##1##(2008-10#4)
Crab apple##2##2##(2008-10#2)
Cranberry##3##1##(2008-10#3)
Cranial##8##1##(1994-9#1)(2008-1#1)(2008-7#1)(2011-2#3)(2012-3#2)
Craniopharyngioma##2##1##(1993-9#1)(2008-7#1)
Craniotomy##2##1##(2012-3#2)
Craniovertebral junction##3##2##(2008-12#2)(2008-7#1)
Crataegus##4##1##(1992-5#3)(2008-10#1)
Crater##2##1##(2008-10#2)
Cre recombinase##2##2##(2008-4#1)(2008-9#1)
Cre##3##1##(2008-11#1)(2008-4#1)(2008-9#1)
Cre-LoxP system##2##2##(2008-8#1)(2008-9#1)
Creatine##2##1##(1990-2#1)(1992-3#1)
Creating a##5##2##(1991-3#1)(1992-3#1)(1994-12#1)(2008-12#1)(2013-1#1)
Creating an##3##2##(1991-1#1)(1995-2#1)(2008-11#1)
Creating the##3##2##(2008-11#2)(2008-12#1)
Creating##16##1##(1991-1#1)(1991-3#1)(1992-3#1)(1994-12#1)(1995-1#1)(1995-2#2)(2008-11#3)(2008-12#3)(2008-9#1)(2013-1#2)
Creatinine deiminase (EC 3##3##4##(1991-12#2)(2008-10#1)
Creatinine deiminase##4##2##(1991-12#3)(2008-10#1)
Creatinine was##2##2##(2008-10#2)
Creatinine##10##1##(1991-12#3)(2008-10#7)
Creation and##2##2##(2008-12#1)(2010-9#1)
Creation of##3##2##(1991-12#1)(1996-3#1)(2008-9#1)
Creation##5##1##(1991-12#1)(1996-3#1)(2008-12#1)(2008-9#1)(2010-9#1)
Creative##4##1##(1990-11#1)(1992-2#1)(2008-11#1)(2012-3#1)
Creek##5##1##(2009-10#1)(2010-8#3)(2011-2#1)
Crete##2##1##(2008-10#1)(2011-2#1)
Creutzfeldt-Jakob disease and##2##3##(1991-8#1)(2008-5#1)
Creutzfeldt-Jakob disease##5##2##(1991-8#1)(1996-8#1)(2008-5#3)
Crikvenica##5##1##(2011-2#5)
Crime in hospitals##3##3##(1991-12#1)(1994-12#1)(1995-12#1)
Crime##5##1##(1991-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(2010-7#1)
Crinipellis perniciosa##3##2##(2008-10#3)
Crinivirus##2##1##(2008-10#2)
Crisis##5##1##(1990-9#1)(1991-2#1)(1995-5#2)(2013-1#1)
Criteria for##2##2##(1993-1#1)(2010-2#1)
Criteria##4##1##(1993-1#1)(2008-2#1)(2010-2#1)(2011-2#1)
Criterion##2##1##(1996-9#1)(2010-11#1)
Critical Care##4##2##(2008-10#1)(2013-1#3)
Critical Control Points##3##3##(2009-3#2)(2013-1#1)
Critical Control##4##2##(1997-3#1)(2009-3#2)(2013-1#1)
Critical Thinking##3##2##(2008-11#3)
Critical aspects##2##2##(1994-2#1)(2008-11#1)
Critical assessment of the##2##4##(1993-8#1)(2008-10#1)
Critical care##2##2##(2008-11#1)(2011-2#1)
Critical paths##2##2##(1993-3#2)
Critical pathways##2##2##(2008-3#2)
Critical thinking is##2##3##(2008-11#1)(2008-12#1)
Critical to##2##2##(2008-10#1)(2008-11#1)
Critical##57##1##(1991-1#1)(1992-2#3)(1993-11#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-2#1)(1996-3#2)(1997-3#1)(2008-10#11)(2008-11#9)(2008-12#3)(2008-3#5)(2008-7#1)(2009-10#1)(2009-3#2)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#5)
Critics##3##1##(1992-12#1)(1996-5#2)
Croatia the##2##2##(2011-2#2)
Croatia##22##1##(2008-10#5)(2009-12#1)(2011-2#16)
Croatian anatomical and physiological terminology##2##5##(2013-1#2)
Croatian universities with medical##2##4##(2013-1#2)
Croatian##18##1##(2008-10#5)(2008-11#1)(2011-2#2)(2013-1#10)
Crohn disease]##2##2##(1990-3#1)(1997-5#1)
Crohn##5##1##(1990-3#1)(1993-2#1)(1997-5#1)(1997-8#2)
Crohn's disease (CD)##6##3##(2009-12#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
Crohn's disease and ulcerative colitis##2##5##(2010-12#1)(2013-1#1)
Crohn's disease and##3##3##(1990-3#1)(2010-12#1)(2013-1#1)
Crohn's disease in##5##3##(2008-11#1)(2010-12#3)(2011-2#1)
Crohn's disease is##3##3##(2008-10#1)(2010-12#2)
Crohn's disease or##3##3##(1990-3#1)(2008-5#1)(2011-2#1)
Crohn's disease with##2##3##(1990-3#1)(1994-5#1)
Crohn's disease##68##2##(1990-3#3)(1991-8#1)(1994-5#1)(1994-6#3)(1995-8#2)(1997-5#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-12#36)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
Crohn's##73##1##(1990-3#3)(1991-8#1)(1994-5#1)(1994-6#4)(1995-8#2)(1997-5#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-12#38)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
Cronartium flaccidum and Peridermium pini##2##5##(2008-10#2)
Cronartium ribicola in##3##3##(2008-10#3)
Cronartium ribicola##14##2##(2008-10#14)
Cronartium##18##1##(2008-10#18)
Cronbach's Alpha##2##2##(2009-12#1)(2010-10#1)
Cronbach's alpha##8##2##(1990-2#1)(2008-10#1)(2009-12#2)(2010-10#2)(2010-11#1)(2013-1#1)
Cronbach's##11##1##(1990-2#1)(2008-10#1)(2009-12#3)(2010-10#3)(2010-11#1)(2013-1#2)
Crop Rotation##2##2##(2008-10#2)
Crop##12##1##(2008-10#10)(2008-12#1)(2012-2#1)
Crops and##2##2##(2008-10#2)
Crops##6##1##(2008-10#6)
Cross Between##3##2##(2008-10#3)
Cross Protection##2##2##(2008-10#2)
Cross sectional##3##2##(2010-12#1)(2011-2#1)(2013-1#1)
Cross##27##1##(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#2)(1994-12#1)(1995-6#1)(1996-5#1)(2008-10#11)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Cross-inoculation##2##1##(2008-10#1)(2008-8#1)
Cross-linking of##2##2##(1993-8#1)(1995-6#1)
Cross-linking##3##1##(1993-8#1)(1994-3#1)(1995-6#1)
Cross-national##2##1##(1990-2#1)(1993-1#1)
Cross-protection between antigenically distinct H1N1 swine influenza viruses from Europe and North America##2##13##(2011-2#2)
Cross-reactivity##3##1##(2008-10#3)
Cross-sectional study##2##2##(2010-3#1)(2013-1#1)
Cross-sectional##7##1##(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#4)
Cross-talk between##2##2##(2009-10#1)(2009-8#1)
Crossed##2##1##(2008-10#2)
Crosses between##2##2##(2008-10#2)
Crosses##4##1##(2008-10#3)(2008-8#1)
Crossflow##2##1##(2008-7#2)
Crossing##4##1##(1996-9#1)(2008-12#1)(2008-6#2)
Crotalaria##2##1##(2008-11#2)
Croup##2##1##(2008-11#2)
Crown and##4##2##(2008-10#4)
Crown dilaceration##2##2##(2013-1#2)
Crown##13##1##(2008-10#10)(2008-6#1)(2013-1#2)
Cruciate Ligament##3##2##(2013-1#3)
Crucifers##3##1##(2008-10#3)
Crude##2##1##(1992-12#1)(2008-10#1)
Crudo Hamaca and Boscán crude oils and for the Orimulsión(R)-400##2##10##(2008-10#2)
Crustacea##3##1##(2007-12#1)(2008-6#1)(2011-2#1)
Cruz##8##1##(2007-12#4)(2008-10#1)(2008-8#1)(2010-1#2)
Cruzan##2##1##(1991-12#2)
Cry##3##1##(1993-6#2)(2008-10#1)
Cry1Aa##3##1##(2008-9#3)
CryIA(b) in##2##2##(2008-10#2)
CryIA(b)##4##1##(2008-10#4)
CryoHex##2##1##(2008-11#2)
Cryopreservation of##5##2##(1996-8#1)(2008-10#1)(2012-3#2)(2013-1#1)
Cryphonectria cubensis##2##2##(2008-10#2)
Cryphonectria parasitica in##2##3##(2008-10#2)
Cryphonectria parasitica##9##2##(1995-6#1)(2008-10#7)(2008-9#1)
Cryphonectria##13##1##(1995-6#1)(2008-10#11)(2008-9#1)
Cryptic##5##1##(1996-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
Cryptococcal meningitis##2##2##(2011-2#2)
Cryptococcus gattii##2##2##(2008-10#2)
Cryptococcus laurentii##4##2##(2008-10#3)(2008-5#1)
Cryptococcus neoformans var##6##3##(2008-5#6)
Cryptococcus neoformans##11##2##(2008-11#1)(2008-5#9)(2010-7#1)
Cryptococcus spp##2##2##(2008-5#2)
Cryptococcus##23##1##(1996-6#2)(1997-1#1)(2008-10#5)(2008-11#1)(2008-5#13)(2010-7#1)
Cryptophlebia leucotreta##2##2##(2008-10#2)
Cryptorchidism##2##1##(2008-10#2)
Cryptosporidium DNA target##2##3##(2008-10#2)
Cryptosporidium DNA##3##2##(2008-10#3)
Cryptosporidium parvum##4##2##(1996-12#2)(2007-12#1)(2008-10#1)
Cryptosporidium spp##6##2##(2012-12#6)
Cryptosporidium##20##1##(1996-12#5)(2007-12#1)(2008-10#6)(2012-12#7)(2012-2#1)
Crystal structure determination##2##3##(1993-8#1)(2008-9#1)
Crystal structure of the##2##4##(1993-9#1)(1994-12#1)
Crystal structure of##4##3##(1992-12#1)(1993-9#1)(1994-12#1)(2008-8#1)
Crystal structure##7##2##(1992-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(2008-8#1)(2008-9#1)(2013-8#1)
Crystal##14##1##(1992-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
Crystallization##3##1##(1992-11#1)(2008-10#1)(2011-2#1)
Crystals of##2##2##(1992-12#1)(2008-8#1)
Crèching behavior##2##2##(2008-9#2)
Crèching##3##1##(2008-9#3)
Cs##6##1##(2008-10#6)
Cs(+) and##2##2##(2008-10#2)
Cs(+)##12##1##(2008-10#12)
Cs(+)&gt##2##1##(2008-10#2)
Cs(+)-selective##3##1##(2008-10#3)
Cs+##2##1##(1994-11#1)(2008-10#1)
CsA did not##2##3##(1994-8#2)
CsA##20##1##(1991-9#1)(1994-3#3)(1994-8#7)(2008-6#8)(2013-1#1)
CsCl##5##1##(1990-5#1)(1996-2#1)(2008-10#3)
CsLiB(6)O(10)##2##1##(2008-3#2)
CsLiB6O10##2##1##(2008-3#2)
Csp I fragments##2##3##(1992-6#2)
Csp##4##1##(1992-6#4)
Ct##2##1##(1990-5#1)(2008-10#1)
Ct0##3##1##(2008-10#3)
CtxB##2##1##(2008-9#2)
Cu and Fe was##2##4##(2008-10#1)(2008-12#1)
Cu and Fe##7##3##(2008-10#6)(2008-12#1)
Cu and Mn was##2##4##(2008-10#2)
Cu and Mn##8##3##(2008-10#8)
Cu and Ni##3##3##(2008-10#3)
Cu and Pb##9##3##(2008-10#9)
Cu and SS##2##3##(2013-8#2)
Cu and Zn in##3##4##(2008-10#3)
Cu and Zn were found to##2##6##(2008-10#2)
Cu and Zn##12##3##(2008-10#12)
Cu and##52##2##(2008-10#49)(2008-12#1)(2013-8#2)
Cu concentration##3##2##(2008-10#1)(2008-12#2)
Cu coupons##2##2##(2013-8#2)
Cu electrode##5##2##(2008-10#5)
Cu exposure##2##2##(2008-12#2)
Cu for##3##2##(2008-10#3)
Cu in a##2##3##(2008-10#2)
Cu in##9##2##(2008-10#8)(2012-2#1)
Cu on##4##2##(2008-10#3)(2008-12#1)
Cu##277##1##(1995-6#3)(1997-8#9)(2008-10#237)(2008-11#5)(2008-12#8)(2008-5#1)(2010-11#1)(2012-2#7)(2013-1#1)(2013-8#5)
Cu(+)##3##1##(2008-10#3)
Cu(2)O##2##1##(2008-2#2)
Cu(2+) and Hg(2+)##3##3##(2008-10#3)
Cu(2+) and##11##2##(2008-10#8)(2008-5#3)
Cu(2+) at##2##2##(2008-10#2)
Cu(2+) concentration##2##2##(2008-10#2)
Cu(2+) in the##2##3##(2008-10#1)(2008-12#1)
Cu(2+) in##7##2##(2008-10#6)(2008-12#1)
Cu(2+) ion##3##2##(2008-10#3)
Cu(2+) ions are##2##3##(2008-10#2)
Cu(2+) ions##11##2##(2008-10#9)(2009-8#2)
Cu(2+) is##4##2##(2008-10#3)(2008-12#1)
Cu(2+) levels##2##2##(2008-10#2)
Cu(2+) to##2##2##(2008-10#1)(2008-12#1)
Cu(2+) with a##3##3##(2008-10#3)
Cu(2+) with##7##2##(2008-10#7)
Cu(2+)##108##1##(2008-10#94)(2008-12#7)(2008-5#3)(2009-8#3)(2012-2#1)
Cu(2+)-selective##2##1##(2008-10#2)
Cu(I)##6##1##(2008-10#6)
Cu(II) and Ag(I)##3##3##(2008-10#3)
Cu(II) and Cd(II)##2##3##(2008-10#2)
Cu(II) and Co(II)##2##3##(2008-10#2)
Cu(II) and Hg(II)##2##3##(2008-10#2)
Cu(II) and Mn(II) beta-diketonates##2##4##(2008-10#2)
Cu(II) and Ni(II)##7##3##(2008-10#7)
Cu(II) and Pb(II)##2##3##(2013-1#2)
Cu(II) and Zn(II)##4##3##(2008-10#4)
Cu(II) and##34##2##(2008-10#32)(2013-1#2)
Cu(II) as the##2##3##(2008-10#2)
Cu(II) as##3##2##(2008-10#3)
Cu(II) at pH 5##2##4##(2008-10#2)
Cu(II) at pH##3##3##(2008-10#3)
Cu(II) by##3##2##(2008-10#3)
Cu(II) extraction##3##2##(2008-10#3)
Cu(II) from the##3##3##(2008-10#3)
Cu(II) from##7##2##(2008-10#7)
Cu(II) in real samples##2##4##(2008-10#2)
Cu(II) in##14##2##(2008-10#14)
Cu(II) ions at##2##3##(2008-10#2)
Cu(II) ions##11##2##(2008-10#11)
Cu(II) on the##2##3##(2008-10#2)
Cu(II) or##2##2##(2008-10#2)
Cu(II) over a wide concentration range##2##6##(2008-10#2)
Cu(II) over a wide##3##4##(2008-10#3)
Cu(II) over##4##2##(2008-10#4)
Cu(II) was##5##2##(2008-10#5)
Cu(II) with##12##2##(2008-10#12)
Cu(II)##208##1##(2008-10#205)(2013-1#3)
Cu(II)-Nc##3##1##(2008-10#3)
Cu(II)L(2)##3##1##(2008-10#3)
Cu(III)##2##1##(2008-10#2)
Cu) are##2##2##(2008-10#2)
Cu)##7##1##(2008-10#7)
Cu-EDTA(2-)##2##1##(2008-10#2)
Cu/Zn##3##1##(1996-5#1)(2008-10#1)(2013-8#1)
Cu2+##3##1##(1997-2#1)(1997-7#1)(2008-12#1)
CuCl(2)##2##1##(2008-10#2)
CuHCF##4##1##(2008-10#4)
CuLCV##2##1##(2008-10#2)
CuLCV-AZ DNA A##2##3##(2008-10#2)
CuLCV-AZ and##3##2##(2008-10#3)
CuLCV-AZ##7##1##(2008-10#7)
CuSO(4)##7##1##(2008-10#4)(2008-11#3)
CuSO₄ and ZnSO₄ exhibited##2##4##(2010-11#2)
CuSO₄##7##1##(2010-11#7)
Cuba##8##1##(1997-5#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)
Cuban##2##1##(2008-5#1)(2008-6#1)
Cucumber fruit mottle mosaic virus##2##5##(2008-10#2)
Cucumber green mottle mosaic virus##2##5##(2008-10#2)
Cucumber mosaic virus (CMV) in##2##5##(2008-10#2)
Cucumber mosaic virus (CMV)##6##4##(2008-10#6)
Cucumber mosaic virus and##2##4##(2008-10#1)(2012-2#1)
Cucumber mosaic virus##18##3##(2008-10#17)(2012-2#1)
Cucumber necrosis virus##2##3##(2008-10#2)
Cucumber##29##1##(2008-10#28)(2012-2#1)
Cucumis melo##2##2##(2008-10#2)
Cucurbit Yellow Vine Disease##2##4##(2008-10#2)
Cucurbit leaf##2##2##(2008-10#2)
Cucurbit yellow stunting disorder virus##3##5##(2008-10#3)
Cucurbit##10##1##(2008-10#10)
Cucurbit-Infecting##2##1##(2008-10#2)
Cucurbitaceae##8##1##(2008-10#8)
Cucurbits##3##1##(2008-10#3)
Cues##2##1##(2010-9#1)(2013-8#1)
Culex##4##1##(2007-12#2)(2008-10#1)(2011-2#1)
Culicidae)##2##1##(2008-5#1)(2012-12#1)
Culicoides and the##2##3##(2010-1#2)
Culicoides were##2##2##(2010-1#2)
Culicoides##7##1##(2010-1#7)
Cultivar mixtures##2##2##(2008-10#2)
Cultivar##10##1##(2008-10#9)(2009-8#1)
Cultivars and##2##2##(2008-10#2)
Cultivars of##4##2##(2008-10#4)
Cultivars to##2##2##(2008-10#2)
Cultivars##22##1##(2008-10#22)
Cultivated##5##1##(2008-10#4)(2012-2#1)
Cultivation of##5##2##(2008-10#2)(2008-11#2)(2011-1#1)
Cultivation##7##1##(2008-10#3)(2008-11#3)(2011-1#1)
Cultural characteristics##2##2##(2008-10#2)
Cultural##15##1##(1990-8#1)(1992-3#1)(1994-12#1)(1994-3#1)(1997-1#1)(2008-10#4)(2008-5#1)(2008-9#2)(2009-10#1)(2010-8#1)(2013-8#1)
Culture Collection##3##2##(2008-12#1)(2008-5#2)
Culture and##2##2##(2008-10#1)(2008-11#1)
Culture filtrates of##2##3##(2008-10#2)
Culture of##5##2##(1991-3#1)(1993-6#1)(2008-10#1)(2008-11#2)
Culture##27##1##(1991-12#1)(1991-3#1)(1993-6#1)(1996-12#1)(1996-6#1)(2008-10#7)(2008-11#9)(2008-12#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-3#1)
Cultured##6##1##(1990-8#1)(1991-5#1)(1994-3#1)(1995-11#1)(2008-11#1)(2011-2#1)
Cultures from##2##2##(1994-12#1)(2008-10#1)
Cultures of##6##2##(2008-10#3)(2008-11#1)(2008-7#2)
Cultures were incubated in alphaMEM containing fetal calf serum##2##9##(2008-11#2)
Cultures were incubated##3##3##(2008-10#1)(2008-11#2)
Cultures were##6##2##(2008-10#2)(2008-11#2)(2008-7#1)(2012-2#1)
Cultures##15##1##(1994-12#1)(2008-10#7)(2008-11#3)(2008-7#3)(2012-2#1)
Cumulative##8##1##(1991-9#1)(2008-5#1)(2008-7#2)(2009-10#2)(2013-1#2)
Cupriavidus basilensis HMF14##2##3##(2011-1#2)
Curbside Consult##4##2##(2008-8#4)
Curculionidae)##3##1##(2008-7#2)(2013-8#1)
Curcuma longa (IC50##2##3##(2008-5#2)
Curcuma longa##3##2##(2008-5#2)(2011-2#1)
Curcuma##4##1##(1996-9#1)(2008-5#2)(2011-2#1)
Curcumin or turmeric##3##3##(1994-8#3)
Curcumin##7##1##(1994-8#3)(2008-11#3)(2011-2#1)
Cure##2##1##(2011-2#1)(2011-3#1)
Curie##2##1##(1993-5#1)(2008-3#1)
Current Beneficiary##13##2##(1994-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)
Current Population##2##2##(1993-3#1)(2011-2#1)
Current World Literature##3##3##(2008-7#1)(2008-8#2)
Current and##2##2##(1992-2#1)(1994-2#1)
Current applications##2##2##(2008-10#1)(2012-3#1)
Current evidence##4##2##(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
Current guidelines for##2##3##(2010-7#1)(2011-2#1)
Current issues##2##2##(2008-11#1)(2010-2#1)
Current knowledge##2##2##(2008-10#2)
Current methods##4##2##(1995-12#2)(1997-7#1)(2008-6#1)
Current recommendations suggest##2##3##(2009-12#1)(2012-12#1)
Current research##4##2##(1997-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
Current response##2##2##(2008-10#2)
Current risk##2##2##(2008-10#1)(2013-8#1)
Current status of##6##3##(1994-3#1)(1997-8#2)(2008-11#2)(2008-9#1)
Current status##7##2##(1994-3#1)(1997-8#2)(2008-11#2)(2008-9#1)(2010-12#1)
Current therapy for##2##3##(2008-11#1)(2009-8#1)
Current treatments##2##2##(2008-2#1)(2011-2#1)
Current trends##3##2##(1994-2#1)(2008-5#1)(2009-9#1)
Current##123##1##(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-3#2)(1994-1#2)(1994-2#3)(1994-3#1)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
Currently a variety##2##3##(2008-11#1)(2011-2#1)
Currently available##3##2##(1990-5#1)(2008-10#2)
Currently there##2##2##(2009-12#1)(2011-2#1)
Currently##68##1##(1990-5#1)(1992-3#1)(1994-1#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-5#2)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
Curriculum##3##1##(1997-2#1)(2008-11#2)
Curtovirus##3##1##(2008-10#3)
Curve Analysis##2##2##(2008-10#1)(2009-11#1)
Curve##4##1##(2008-1#2)(2008-10#1)(2009-11#1)
Cusco##2##1##(2008-10#2)
Cushing's Syndrome##2##2##(2011-2#2)
Cushing's syndrome (CS)##2##3##(2011-2#2)
Cushing's syndrome##9##2##(1990-11#1)(1991-10#1)(1991-11#1)(2008-11#1)(2008-7#2)(2011-2#3)
Cushing's##13##1##(1990-11#2)(1991-10#1)(1991-11#2)(2008-11#1)(2008-7#2)(2011-2#5)
Customer service##2##2##(1991-1#1)(1995-1#1)
Customer##3##1##(1991-1#1)(1994-12#1)(1995-1#1)
Cut##6##1##(1997-2#1)(2008-9#3)(2009-5#1)(2012-3#1)
Cutaneous allodynia##2##2##(2008-9#2)
Cutaneous leishmaniasis##2##2##(1990-6#1)(1991-11#1)
Cutaneous metastases from carcinoma of##2##5##(1990-8#1)(2010-11#1)
Cutaneous metastases from internal##2##4##(2010-11#1)(2010-6#1)
Cutaneous metastases from##4##3##(1990-8#1)(2010-11#2)(2010-6#1)
Cutaneous metastases##5##2##(1990-8#1)(2010-11#3)(2010-6#1)
Cutaneous pseudosarcomatous##2##2##(2008-11#2)
Cutaneous##21##1##(1990-6#1)(1990-8#2)(1991-11#1)(1995-1#1)(2008-11#2)(2008-5#2)(2008-9#2)(2010-11#3)(2010-6#3)(2012-3#3)(2013-1#1)
Cutis laxa##2##2##(2008-7#2)
Cutting##3##1##(1990-6#1)(2008-10#1)(2008-11#1)
Cvs##2##1##(2008-10#2)
Cx40##2##1##(2012-12#2)
Cx43 transfection##4##2##(2008-11#4)
Cx43##6##1##(2008-11#6)
CxD##2##1##(2008-10#2)
Cy##2##1##(2008-10#2)
Cy3 or Cy3##4##3##(2008-10#4)
Cy3##11##1##(2008-10#9)(2010-12#2)
Cy3-AS1411##3##1##(2010-12#3)
Cy5##3##1##(2008-10#3)
Cy5-labeled anti-T3##2##2##(2008-10#2)
Cy5-labeled##3##1##(2008-10#3)
CyA and##4##2##(2008-10#4)
CyA##10##1##(2008-10#10)
CyP-CsA##2##1##(2008-9#2)
Cyanamid##2##1##(2008-5#2)
Cyanex 923##7##2##(2008-10#7)
Cyanex##11##1##(2008-10#11)
Cyanobacterium##2##1##(1997-2#2)
Cyanothece 51142##2##2##(2009-7#2)
Cybex##2##1##(2008-12#1)(2011-2#1)
CycD5##2##1##(2009-8#2)
Cyclamen##2##1##(2008-10#2)
Cyclandelate##2##1##(1994-8#2)
Cycle##7##1##(1997-3#1)(2008-10#1)(2008-11#3)(2008-6#1)(2012-2#1)
Cycles of##2##2##(2009-10#1)(2012-3#1)
Cyclic AMP##3##2##(1997-2#1)(2008-10#2)
Cyclic nucleotides##2##2##(2009-10#2)
Cyclic voltammetric experiments##2##3##(2008-10#2)
Cyclic voltammetric##4##2##(2008-10#4)
Cyclic voltammetry (CV)##2##3##(2008-10#2)
Cyclic voltammetry of##2##3##(2008-10#2)
Cyclic voltammetry was employed to##2##5##(2008-10#2)
Cyclic voltammetry was used to characterize the interfacial and redox##2##10##(2008-10#2)
Cyclic voltammetry was used to##3##5##(2008-10#3)
Cyclic voltammetry was##5##3##(2008-10#5)
Cyclic voltammetry##14##2##(2008-10#14)
Cyclic voltammograms##5##2##(2008-10#5)
Cyclic##32##1##(1993-6#1)(1994-11#1)(1997-2#1)(2008-10#26)(2009-10#3)
Cyclins##2##1##(2008-9#1)(2009-8#1)
Cyclization of##2##2##(1996-5#2)
Cyclization##3##1##(1996-5#3)
Cycloaddition##2##1##(1996-5#2)
Cyclodextrin##2##1##(2008-10#2)
Cycloheximide##3##1##(1991-5#2)(2011-3#1)
Cyclooxygenase##2##1##(1994-5#1)(2008-12#1)
Cyclophilins##2##1##(1993-9#1)(2011-2#1)
Cyclophosphamide##4##1##(2008-10#1)(2008-12#1)(2010-12#1)(2012-2#1)
Cyclosporin A (CsA)##2##3##(1994-3#1)(1994-8#1)
Cyclosporin A##3##2##(1994-3#2)(1994-8#1)
Cyclosporin##4##1##(1994-3#2)(1994-8#1)(2008-6#1)
Cyclosporine A##2##2##(2008-10#2)
Cyclosporine##4##1##(1994-6#2)(2008-10#2)
Cycloxygenase-2 (COX-2)##2##2##(2013-8#2)
Cylindrical##4##1##(2007-12#1)(2008-12#1)(2008-3#2)
Cylindrocarpon destructans##6##2##(2008-10#6)
Cylindrocarpon root rot##4##3##(2008-10#4)
Cylindrocarpon spp##2##2##(2008-10#2)
Cylindrocarpon##12##1##(2008-10#12)
Cymadothea trifolii##2##2##(2010-3#2)
Cymadothea##3##1##(2010-3#3)
Cymbidium mosaic virus (CymMV) and Odontoglossum ringspot virus (ORSV)##2##9##(2008-10#2)
Cymbidium mosaic##3##2##(2008-10#3)
Cymbidium##4##1##(2008-10#4)
Cymoxanil##2##1##(2008-10#2)
Cynodon dactylon##2##2##(2008-10#2)
Cynoglossus semilaevis##3##2##(2010-8#2)(2013-8#1)
CypA is##3##2##(2011-2#3)
Cypermethrin and Chlorpyrifos##3##3##(2008-10#3)
Cypermethrin and##4##2##(2008-10#4)
Cyphertrade mark##2##2##(2008-11#2)
Cyprinidae)##2##1##(2008-5#1)(2010-8#1)
Cyprus##3##1##(1990-6#1)(1991-12#1)(2008-10#1)
Cyps##3##1##(2011-2#3)
Cys and##3##2##(2008-10#3)
Cys residue##3##2##(1994-12#1)(1994-5#1)(2008-8#1)
Cys residues##5##2##(1991-6#1)(1993-2#1)(1994-5#1)(2008-8#2)
Cys was##2##2##(2008-10#2)
Cys##33##1##(1991-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-5#3)(1995-12#1)(1995-8#4)(2008-10#14)(2008-8#4)(2012-2#2)
Cys-138##3##1##(1993-8#3)
Cys-33##2##1##(1994-5#2)
Cys163----Ser##3##1##(1991-7#3)
Cys4]deltorphin##2##1##(1996-2#2)
Cyst Nematode##2##2##(2008-10#2)
Cyst##9##1##(2008-10#4)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Cystatin C##3##2##(2010-4#3)
Cysteine##4##1##(1995-6#1)(2008-10#2)(2011-3#1)
Cystemustine##4##1##(2008-5#4)
Cysticercosis of the CNS##2##4##(1995-12#2)
Cysticercosis of##3##2##(1995-12#2)(2008-1#1)
Cystine##2##1##(2008-10#1)(2008-7#1)
Cysts##4##1##(2008-10#3)(2012-3#1)
Cyt c(6A)##3##2##(2009-10#3)
Cyt##8##1##(1995-6#1)(2008-10#4)(2009-10#3)
CytoTherapeutics##2##1##(2008-5#2)
Cytochemical Investigation of##2##3##(2008-10#2)
Cytochemical investigations revealed that callose##2##5##(2008-10#2)
Cytochemical##9##1##(2008-10#9)
Cytochrome P450##3##2##(1993-8#1)(1994-8#1)(2008-10#1)
Cytochrome c oxidase##2##3##(1997-7#1)(2008-10#1)
Cytochrome c##4##2##(1997-7#1)(2008-10#2)(2013-1#1)
Cytochrome##9##1##(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#5)(2013-1#1)
Cytodex 1##2##2##(2008-11#2)
Cytodex-3##2##1##(2008-11#1)(2008-9#1)
Cytogenetic##6##1##(1990-8#1)(1992-12#1)(2008-12#3)(2010-11#1)
Cytohistological##2##1##(2011-2#2)
Cytokines and##2##2##(1995-12#1)(2008-4#1)
Cytokines##6##1##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)
Cytoline 1 microcarriers##3##3##(2008-11#3)
Cytoline 1##4##2##(2008-11#4)
Cytoline##5##1##(2008-11#5)
Cytologic screening##2##2##(1990-6#2)
Cytologic##3##1##(1990-6#2)(1991-8#1)
Cytological Evidence##2##2##(2008-10#2)
Cytological and##2##2##(2008-10#1)(2011-10#1)
Cytological observations indicated that##2##4##(2008-10#2)
Cytological observations##3##2##(2008-10#3)
Cytological##17##1##(2008-10#16)(2011-10#1)
Cytology##2##1##(2008-10#1)(2012-12#1)
Cytometric##3##1##(1994-12#1)(2008-9#1)(2009-9#1)
Cytometry##5##1##(2008-10#1)(2008-9#1)(2011-2#3)
Cytopathological##2##1##(2008-10#2)
Cytopilot Mini##4##2##(2008-11#4)
Cytoplasmic inhibition of##2##3##(1995-2#2)
Cytoplasmic##8##1##(1990-8#1)(1995-2#2)(2008-10#3)(2011-2#2)
Cytopore##3##1##(2008-11#3)
Cytosol##2##1##(1990-8#1)(1991-5#1)
Cytosolic##3##1##(1993-6#1)(1996-2#1)(2008-11#1)
Cytotechnology 41##2##2##(2008-11#2)
Cytotoxic Effect of##2##3##(1997-7#1)(2010-2#1)
Cytotoxic##10##1##(1990-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
Cytotoxicity of##6##2##(1993-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2013-1#1)
Cytotoxicity was assessed by##2##4##(1990-5#1)(2013-1#1)
Cytotoxicity was##4##2##(1990-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
Cytotoxicity##10##1##(1990-5#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#2)
Czech Republic and##2##3##(1994-12#2)
Czech Republic##7##2##(1994-12#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
Czech##9##1##(1994-12#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
Czochralski-grown BBO##2##2##(2008-2#2)
Czochralski-grown##3##1##(2008-2#3)
D =##4##2##(1994-11#2)(2008-10#1)(2012-12#1)
D DNA##2##2##(2008-10#2)
D DNAs##2##2##(2008-10#2)
D and##15##2##(1990-11#1)(1991-5#1)(1993-3#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
D are##3##2##(1997-1#1)(2008-10#1)(2010-4#1)
D categories##3##2##(2008-10#3)
D category##2##2##(2008-10#2)
D deficiency has##3##3##(2011-2#1)(2012-2#2)
D deficiency##13##2##(2008-11#1)(2011-1#2)(2011-2#3)(2012-2#5)(2012-3#2)
D fusion##2##2##(1995-2#2)
D gene##3##2##(1990-5#2)(2008-8#1)
D genotype##3##2##(2008-10#3)
D in##7##2##(1993-3#1)(1995-8#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
D is##5##2##(1993-6#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-2#1)
D islets##6##2##(1995-8#6)
D levels##3##2##(2011-2#1)(2012-3#2)
D of##2##2##(1994-5#1)(2008-3#1)
D on##2##2##(1992-1#1)(2010-7#1)
D possesses##2##2##(1994-5#2)
D protein##3##2##(1995-2#3)
D status##3##2##(2012-12#1)(2012-2#2)
D values##2##2##(2008-10#2)
D was##8##2##(1991-11#1)(1993-3#1)(1995-6#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-3#2)
D were##5##2##(1992-1#1)(1995-6#1)(2008-8#1)(2013-1#2)
D with##2##2##(1993-2#1)(2008-1#1)
D##831##1##(1990-11#2)(1990-5#5)(1991-1#1)(1991-11#2)(1991-12#3)(1991-5#4)(1992-1#6)(1992-11#2)(1992-12#1)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#7)(1993-6#2)(1993-8#4)(1994-1#4)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#8)(1994-5#16)(1994-8#1)(1995-12#1)(1995-2#12)(1995-3#2)(1995-6#12)(1995-8#16)(1996-1#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#6)(1997-5#1)(2007-12#2)(2008-1#2)(2008-10#505)(2008-11#20)(2008-12#11)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#6)(2008-8#10)(2008-9#2)(2009-12#1)(2009-2#2)(2009-8#6)(2010-10#1)(2010-12#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#4)(2011-1#6)(2011-2#16)(2012-12#5)(2012-2#15)(2012-3#20)(2012-9#1)(2013-1#12)(2013-8#8)
D(2)##17##1##(2008-10#13)(2008-3#2)(2008-7#1)(2010-12#1)
D(3) and FGF9##2##3##(2008-11#2)
D(3) and##7##2##(2008-10#5)(2008-11#2)
D(3)##13##1##(2008-10#8)(2008-11#3)(2012-12#2)
D(O)##2##1##(2008-10#2)
D(R)##2##1##(2008-10#2)
D(Sr) was##2##2##(2008-10#2)
D(Sr)##3##1##(2008-10#3)
D(app)##2##1##(2008-10#2)
D(f)##2##1##(2008-3#2)
D(l)##2##1##(2008-7#2)
D(m) = 6##2##3##(2010-7#2)
D(m) =##3##2##(2010-7#3)
D)##22##1##(1991-2#1)(1991-5#1)(1991-7#1)(1993-6#1)(1993-8#1)(1995-5#1)(1995-8#1)(1996-1#1)(2008-10#8)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
D-##2##1##(1992-11#1)(2008-7#1)
D-Ala10] mGnRH (analog##2##3##(1994-8#2)
D-Amphetamine##2##1##(2013-8#2)
D-Arg6##2##1##(1994-8#2)
D-Cys##2##1##(1994-5#2)
D-MRI##4##1##(2011-2#4)
D-Pen2##2##1##(1992-3#2)
D-Pen5]enkephalin##4##1##(1992-3#3)(1996-2#1)
D-Pro4]morphiceptin##2##1##(1996-2#2)
D-Pyr##5##1##(1994-12#5)
D-R##4##1##(2008-10#4)
D-Sema II##2##2##(1993-12#2)
D-Sema##3##1##(1993-12#3)
D-Trp3##3##1##(1994-8#3)
D-[3-(3)H]-glucose##2##1##(2008-8#2)
D-alanine##13##1##(1991-12#3)(1995-6#8)(1995-9#2)
D-amino acid##3##2##(1995-11#1)(1995-3#1)(2008-10#1)
D-amino acids##4##2##(1991-12#1)(1995-11#1)(2008-10#1)(2008-7#1)
D-amino##8##1##(1991-12#1)(1992-11#1)(1995-11#2)(1995-3#1)(2008-10#2)(2008-7#1)
D-amphetamine (2 mg/kg)##3##3##(1993-3#3)
D-amphetamine##15##1##(1993-3#4)(1993-6#11)
D-amphetamine-induced##2##1##(1993-6#2)
D-cell##3##1##(1995-8#3)
D-dimer and##2##2##(2008-3#1)(2010-3#1)
D-dimer level##2##2##(2011-2#2)
D-dimer levels##2##2##(2011-2#2)
D-dimer##11##1##(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#8)
D-galacturonic acid derivatives##2##3##(1992-12#2)
D-genotype##4##1##(2008-10#4)
D-glucosamine##4##1##(2008-10#1)(2011-2#3)
D-glucosaminic acid was produced##2##4##(2011-2#2)
D-glucosaminic acid was##3##3##(2011-2#3)
D-glucosaminic acid##6##2##(2011-2#6)
D-glucosaminic##7##1##(2011-2#7)
D-glucose transfer##2##2##(1991-5#2)
D-glucose##11##1##(1991-5#5)(1991-9#1)(1995-12#1)(2008-10#3)(2011-2#1)
D-glyceraldehyde-3-phosphate dehydrogenase##2##2##(2008-9#2)
D-hydantoinase by batch culture of##2##5##(2008-7#2)
D-hydantoinase##5##1##(2008-7#5)
D-lactate##3##1##(1991-12#1)(1994-3#1)(2008-7#1)
D-lactic acidosis##2##2##(1994-3#2)
D-like aspartyl protease activity##2##4##(1995-8#2)
D-loop region##2##2##(2008-5#1)(2011-2#1)
D-loop##7##1##(1990-5#1)(2008-5#3)(2008-8#2)(2011-2#1)
D-penicillamine-induced autoimmunity##4##2##(2008-10#4)
D-serine##5##1##(1995-11#1)(2008-5#1)(2012-2#3)
D/P Cr##3##2##(2011-2#3)
D/P beta2MG##2##2##(2011-2#2)
D/P##8##1##(2008-10#2)(2011-2#6)
D1 and D2 receptors##2##4##(1993-9#1)(2008-7#1)
D1 dopamine##3##2##(1993-5#1)(1994-2#2)
D1 receptor##3##2##(1996-2#3)
D1##15##1##(1993-5#1)(1993-9#1)(1994-2#2)(1995-2#1)(1996-2#3)(2008-10#1)(2008-7#1)(2010-1#2)(2013-1#2)(2013-8#1)
D11S1819 and D11S1818##2##3##(1995-6#2)
D13S317##3##1##(2008-12#3)
D16S539##3##1##(2008-12#3)
D18S51##5##1##(2008-12#5)
D19S433##3##1##(2008-12#3)
D1R- and D2R-expressing##2##3##(2013-8#2)
D1R- and##3##2##(2013-8#3)
D1S249 locus##4##2##(2008-9#4)
D2 and D3 receptors##2##4##(1993-9#1)(2008-5#1)
D2 and##3##2##(1993-9#1)(1995-11#1)(2008-5#1)
D2 receptor##2##2##(1995-2#2)
D2 receptors and##2##3##(1992-12#1)(2008-7#1)
D2 receptors in##2##3##(1993-9#2)
D2 receptors##7##2##(1992-12#1)(1993-9#3)(1995-11#1)(2008-5#1)(2008-7#1)
D2 type dopamine##2##3##(2008-7#2)
D2##32##1##(1992-12#1)(1993-9#6)(1995-11#3)(1995-2#3)(1997-8#9)(2008-3#2)(2008-5#2)(2008-7#5)(2013-8#1)
D2-like##3##1##(1993-9#1)(1995-2#1)(1996-12#1)
D21S11##3##1##(2008-12#3)
D21S246##3##1##(1995-8#3)
D29 cells##9##2##(2008-11#9)
D29##11##1##(2008-11#11)
D2S1338##3##1##(2008-12#3)
D3 (1##6##2##(1991-5#2)(1992-1#1)(1994-11#1)(1995-12#1)(1997-1#1)
D3 and##2##2##(1993-9#2)
D3 on the##2##3##(1991-5#1)(1993-3#1)
D3 receptor density and mRNA##2##5##(1995-2#2)
D3 receptor mRNA##2##3##(1995-2#2)
D3 receptor##12##2##(1993-3#1)(1995-2#11)
D3 receptors##3##2##(1993-9#1)(1995-8#1)(2008-5#1)
D3##37##1##(1991-5#4)(1992-1#2)(1993-3#3)(1993-9#3)(1994-11#1)(1994-3#2)(1995-12#3)(1995-2#12)(1995-8#1)(1997-1#1)(1997-5#1)(2008-11#1)(2008-5#1)(2011-1#2)
D3-induced##2##1##(1995-6#1)(1997-1#1)
D308##2##1##(2008-10#2)
D3S1358##3##1##(2008-12#3)
D4 receptor##6##2##(1993-6#5)(1993-9#1)
D4 receptors##3##2##(1993-9#3)
D4##14##1##(1993-6#8)(1993-9#6)
D4-specific binding to THP-1 cell membranes##2##6##(1993-6#2)
D4-specific binding##4##2##(1993-6#4)
D4T##10##1##(1991-3#4)(2008-7#6)
D5##2##1##(1990-11#2)
D5S818 and##2##2##(2008-12#2)
D5S818##3##1##(2008-12#3)
D609##2##1##(1997-2#2)
D7S820##3##1##(2008-12#3)
D8S1179##2##1##(2008-12#2)
DA and 5-HT##2##3##(1994-2#2)
DA and SA to learning##2##5##(2011-1#2)
DA and##6##2##(1994-2#2)(1996-12#1)(2008-10#1)(2011-1#2)
DA can be##2##3##(2008-10#2)
DA in##4##2##(1996-12#1)(2008-10#3)
DA rats##2##2##(1995-12#2)
DA release##2##2##(1997-2#2)
DA was##3##2##(1994-2#1)(1997-2#1)(2008-10#1)
DA##45##1##(1993-6#1)(1994-2#4)(1995-12#2)(1996-12#9)(1996-5#4)(1997-2#4)(1997-3#1)(2008-10#16)(2010-12#1)(2011-1#3)
DA-9601##5##1##(2008-11#5)
DAB2IP##5##1##(2013-1#5)
DAB2IP-deficient PCa cells##2##3##(2013-1#2)
DAC##5##1##(2013-8#5)
DAD##5##1##(1993-12#1)(2008-10#1)(2011-2#3)
DAD1 gene is##2##3##(1997-9#2)
DAD1 gene##3##2##(1997-9#3)
DAD1##5##1##(1997-9#5)
DAE##2##1##(2008-10#2)
DAGO##3##1##(1997-2#3)
DAI and##2##2##(2008-10#1)(2011-3#1)
DAI##6##1##(2008-10#3)(2011-3#3)
DAOM 175924##2##2##(2008-10#2)
DAP concentrations##2##2##(2010-5#2)
DAPI##5##1##(2008-12#3)(2008-9#1)(2009-12#1)
DAPs are##2##2##(2010-5#2)
DAPs in##4##2##(2010-5#4)
DAPs##11##1##(2010-5#11)
DARPP-32-IR##2##1##(1991-10#2)
DART##2##1##(2011-2#2)
DAS-ELISA##2##1##(2008-10#2)
DAST##4##1##(2007-12#4)
DAT mRNA level##2##3##(1996-12#2)
DAT mRNA##4##2##(1996-12#4)
DAT##8##1##(1996-12#6)(2008-6#2)
DATA SOURCES##4##2##(2013-1#4)
DATA SYNTHESIS##4##2##(2013-1#4)
DATA##11##1##(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#8)
DATAN##3##1##(2008-10#3)
DAV##3##1##(2008-8#3)
DAX-8 and XAD-8 resins from##2##5##(2008-10#2)
DAX-8 and XAD-8 resins##4##4##(2008-10#4)
DAX-8 resin##2##2##(2008-10#2)
DAX-8##6##1##(2008-10#6)
DAergic##7##1##(2013-7#7)
DArT##2##1##(2008-10#2)
DB exercise and a consistent##2##5##(2012-2#2)
DB exercise##5##2##(2012-2#5)
DB##8##1##(1990-12#1)(1997-9#1)(2008-10#1)(2012-2#5)
DB-PCR##2##1##(2008-10#2)
DB18C6##5##1##(2008-10#5)
DBA/2 and##2##2##(1994-8#2)
DBA/2 mice and##2##3##(1993-12#2)
DBA/2 mice##3##2##(1993-12#2)(1996-12#1)
DBA/2##5##1##(1993-12#2)(1994-8#2)(1996-12#1)
DBBP##2##1##(2008-10#2)
DBBT##3##1##(2008-10#3)
DBE##3##1##(2010-12#3)
DBF##2##1##(2008-10#2)
DBH immunoreactivity##2##2##(1995-12#2)
DBH##5##1##(1995-12#3)(1997-3#1)(2013-1#1)
DBP and##2##2##(2008-10#2)
DBP##12##1##(1991-5#1)(1993-12#1)(2008-10#8)(2013-8#2)
DBPh##2##1##(2008-10#2)
DBS in##3##2##(2010-12#1)(2012-3#2)
DBS##18##1##(2010-12#2)(2012-2#7)(2012-3#9)
DBS(-) and##2##2##(2008-10#2)
DBS(-)##8##1##(2008-10#8)
DBT##3##1##(2008-10#1)(2008-11#2)
DBTC##3##1##(2008-10#3)
DC and##3##2##(2008-11#1)(2009-7#1)(2013-1#1)
DC in##2##2##(2008-10#1)(2008-11#1)
DC is##2##2##(2008-11#2)
DC populations##2##2##(2008-9#2)
DC##46##1##(2008-10#13)(2008-11#15)(2008-12#1)(2008-8#2)(2008-9#5)(2009-7#1)(2011-2#1)(2012-2#4)(2013-1#3)(2013-8#1)
DC(tast)##2##1##(2008-10#2)
DC)##2##1##(2008-10#1)(2008-9#1)
DC-based##2##1##(2012-2#2)
DC3000##7##1##(2008-10#7)
DCA 2000##4##2##(2008-6#4)
DCA are##2##2##(2008-10#2)
DCA treatment##3##2##(2008-10#3)
DCA##16##1##(2008-10#12)(2008-6#4)
DCD##3##1##(2008-11#3)
DCE##4##1##(1996-5#1)(2008-10#2)(2010-12#1)
DCF##2##1##(2008-10#2)
DCG##3##1##(2008-3#3)
DCM##3##1##(2011-2#3)
DCNQ##2##1##(1993-8#2)
DCPC system##3##2##(2013-8#3)
DCPC##4##1##(2013-8#4)
DCR-10##3##1##(1997-8#3)
DCS##2##1##(2013-1#2)
DCT##5##1##(2010-8#5)
DCT1 is##2##2##(1997-7#2)
DCT1##4##1##(1997-7#4)
DCs and##2##2##(2008-10#1)(2008-11#1)
DCs from OVA-fed mice##2##4##(2008-11#2)
DCs from OVA-fed##3##3##(2008-11#3)
DCs from##6##2##(2008-11#6)
DCs had##2##2##(2011-2#1)(2012-2#1)
DCs in##2##2##(2008-11#1)(2012-2#1)
DCs into the##2##3##(2011-2#2)
DCs stimulated##2##2##(2008-11#1)(2011-2#1)
DCs were##2##2##(2008-11#2)
DCs##45##1##(2008-10#3)(2008-11#24)(2011-2#9)(2012-2#5)(2012-3#4)
DD and PD##7##3##(2008-12#7)
DD of chitosan##2##3##(2008-10#2)
DD##17##1##(2008-10#5)(2008-12#8)(2008-5#1)(2011-2#3)
DDB##2##1##(2008-10#2)
DDDs##2##1##(2008-11#2)
DDI##2##1##(1992-12#2)
DDK##7##1##(2012-3#7)
DDK's##2##1##(2012-3#2)
DDLC1##2##1##(2012-2#2)
DDQ##3##1##(2008-10#3)
DDR2 kinase##3##2##(2012-2#3)
DDR2##8##1##(2012-2#8)
DDT and##2##2##(2008-10#1)(2012-12#1)
DDT##4##1##(1994-3#1)(2008-10#2)(2012-12#1)
DDTC##5##1##(2008-10#5)
DDVP##4##1##(2008-10#4)
DE##2##1##(1990-11#1)(2008-10#1)
DEA (data envelopment analysis)##3##4##(1992-2#3)
DEA (data envelopment##4##3##(1992-2#4)
DEA##10##1##(1992-2#7)(2008-10#1)(2008-5#2)
DEAE cellulose##3##2##(1992-12#1)(2008-4#1)(2008-8#1)
DEAE##5##1##(1992-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
DEAE-Dx##3##1##(2008-7#3)
DEB##4##1##(2008-4#4)
DEET and##2##2##(2008-5#2)
DEET##11##1##(2008-5#11)
DEH##2##1##(2008-10#2)
DEHP##3##1##(2008-10#3)
DEJ width estimates##3##3##(2010-10#3)
DEJ width##4##2##(2010-10#4)
DEJ##15##1##(2008-5#5)(2010-10#10)
DELLA proteins##2##2##(2009-8#2)
DEM##2##1##(2013-1#2)
DEP##2##1##(2008-10#1)(2010-5#1)
DEPE##2##1##(2008-8#2)
DES##6##1##(2008-10#6)
DESIGN AND METHODS##5##3##(2011-2#1)(2013-1#4)
DESIGN##11##1##(2007-12#1)(2009-10#1)(2009-6#1)(2011-2#4)(2013-1#4)
DET##4##1##(2008-10#3)(2009-10#1)
DETA##5##1##(2008-10#5)
DEX exposure##5##2##(1995-12#5)
DEX treatment##3##2##(1995-12#3)
DEX##13##1##(1995-12#11)(2008-10#2)
DEXA##2##1##(2008-7#1)(2009-4#1)
DEs##2##1##(2008-10#2)
DFB##3##1##(2008-3#3)
DFC##2##1##(2008-8#2)
DFG##4##1##(2008-3#2)(2012-2#2)
DFS##3##1##(2008-10#1)(2008-5#1)(2012-3#1)
DFT##2##1##(2010-5#1)(2012-12#1)
DFWM##2##1##(2008-3#2)
DG##5##1##(1991-5#2)(1996-12#3)
DGD is##2##2##(2007-12#2)
DGD##4##1##(2007-12#3)(2008-8#1)
DGE##3##1##(2010-4#2)(2012-2#1)
DGGE gels##2##2##(2008-10#1)(2008-9#1)
DGGE##5##1##(2008-10#1)(2008-9#3)(2010-6#1)
DGN##7##1##(2012-2#7)
DGPS##5##1##(2009-10#5)
DGT device##2##2##(2008-10#2)
DGT##9##1##(2008-10#9)
DH lines were##2##3##(2008-10#2)
DH lines##5##2##(2008-10#3)(2008-8#2)
DH population##2##2##(2008-10#1)(2008-8#1)
DH##11##1##(2008-10#4)(2008-8#7)
DH(w)##3##1##(2008-10#3)
DHA##4##1##(1994-8#1)(2008-11#2)(2010-1#1)
DHAA and AA were##2##4##(1997-2#2)
DHAA and##3##2##(1997-2#3)
DHAA##9##1##(1993-3#5)(1997-2#4)
DHAD##5##1##(1991-6#5)
DHC##3##1##(2012-3#3)
DHC+S##3##1##(2012-3#3)
DHD##3##1##(1994-3#3)
DHEA##7##1##(2008-10#3)(2012-3#3)(2013-1#1)
DHFR##2##1##(2008-11#2)
DHH children##3##2##(2011-2#3)
DHHS programs##2##2##(1996-5#2)
DHHS##3##1##(1996-5#3)
DHN##2##1##(2008-10#2)
DHN1##3##1##(2008-9#3)
DHN1-mGFP4 was##2##2##(2008-9#2)
DHN1-mGFP4##3##1##(2008-9#3)
DHOdehase##2##1##(1993-2#2)
DHPM##2##1##(2013-8#2)
DHS##3##1##(1997-1#2)(2013-1#1)
DHT##7##1##(1990-11#4)(2008-5#2)(2010-1#1)
DHZS##3##1##(2008-10#3)
DI RNA containing the MHV-RI spike gene##2##7##(1997-3#2)
DI RNA species##2##3##(2008-10#2)
DI RNA##10##2##(1997-3#3)(2008-10#7)
DI RNAs in##2##3##(2008-10#2)
DI RNAs##8##2##(2008-10#8)
DI and##3##2##(1997-8#3)
DI##37##1##(1993-8#1)(1995-11#1)(1997-3#5)(1997-8#10)(2008-10#19)(2008-3#1)
DIAL analysis##2##2##(2008-2#2)
DIAL calculations##2##2##(2008-3#2)
DIAL measurements##2##2##(2008-3#2)
DIAL system##2##2##(2008-3#2)
DIAL##14##1##(2008-2#2)(2008-3#12)
DIAM##2##1##(2013-8#2)
DIANA##2##1##(2008-8#1)(2013-8#1)
DIBAL-H##2##1##(2008-10#2)
DIBELS##3##1##(2008-12#3)
DIC patients##3##2##(2010-3#3)
DIC##10##1##(2008-9#1)(2010-3#9)
DIFFERENCE##2##1##(2008-10#2)
DIGE##4##1##(2008-4#1)(2010-12#3)
DII progress curve##3##3##(2008-10#3)
DII progress curves and##2##4##(2008-10#2)
DII progress##5##2##(2008-10#5)
DII##8##1##(2008-10#8)
DIPD##5##1##(2008-10#5)
DIS##4##1##(1991-12#4)
DISCUSSION##7##1##(2011-2#1)(2012-2#3)(2013-1#3)
DISEASE##2##1##(1997-5#2)
DIV is##2##2##(2011-2#2)
DIV##5##1##(2008-10#3)(2011-2#2)
DIV112##2##1##(2008-11#2)
DIV56##2##1##(2008-11#2)
DIVs##2##1##(2008-10#2)
DJ scores##2##2##(2009-1#2)
DJ##4##1##(2009-1#3)(2009-10#1)
DK##3##1##(2007-8#3)
DKA##4##1##(1994-12#3)(2011-1#1)
DKT##5##1##(2011-2#5)
DL##7##1##(2008-10#7)
DL(50)##2##1##(2008-11#2)
DL-PCBs##3##1##(2008-10#3)
DL-beta-amino-butyric acid##2##2##(2009-6#2)
DLA-EIAV and EIAV L##3##4##(2008-9#3)
DLA-EIAV and##4##2##(2008-9#4)
DLA-EIAV##8##1##(2008-9#8)
DLVO##2##1##(2013-1#2)
DM rats' skin##2##3##(2011-3#2)
DM##27##1##(1996-11#1)(1997-4#3)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-2#6)(2012-5#1)(2013-1#4)(2013-8#2)
DM-Allo group had##2##3##(2011-2#2)
DM-Allo group##3##2##(2011-2#3)
DM-Allo##4##1##(2011-2#4)
DM2##2##1##(1994-12#2)
DMA at##2##2##(2008-10#2)
DMA in##5##2##(2008-10#5)
DMA##22##1##(2008-10#22)
DMA)##2##1##(2008-10#2)
DMABTS##3##1##(2008-10#3)
DMBA-induced##2##1##(1993-1#1)(2008-10#1)
DMCM##3##1##(1995-11#2)(2008-11#1)
DMDTPA##3##1##(2008-10#3)
DMDTPA)##3##1##(2008-10#3)
DME##11##1##(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#2)(2011-7#5)
DMEM medium containing 10%##2##4##(2008-11#2)
DMEM##6##1##(2008-11#5)(2008-7#1)
DMF solution##3##2##(2008-10#3)
DMF##13##1##(2008-1#1)(2008-10#10)(2009-9#1)(2011-2#1)
DMI treatments##2##2##(2008-10#2)
DMI##14##1##(2008-10#14)
DMI(R)##4##1##(2008-10#4)
DMIs##4##1##(2008-10#4)
DMN##6##1##(2012-3#1)(2013-8#5)
DMNQ##5##1##(2009-9#5)
DMPA##2##1##(1997-6#1)(2011-2#1)
DMPG vesicles##2##2##(2008-10#2)
DMPM##4##1##(2010-12#4)
DMR##2##1##(2008-10#2)
DMRLSR-W##3##1##(2008-10#3)
DMRT1##4##1##(2010-5#4)
DMS##4##1##(2008-10#2)(2013-8#2)
DMSA lowered the brain lead##2##5##(1992-12#2)
DMSA lowered the##3##3##(1992-12#3)
DMSA##8##1##(1992-12#7)(2008-10#1)
DMSO and DMF##3##3##(2008-10#2)(2009-9#1)
DMSO and##4##2##(2008-10#3)(2009-9#1)
DMSO solutions of##4##3##(2008-10#4)
DMSO##27##1##(1991-5#1)(1995-8#2)(2008-10#17)(2008-11#1)(2008-2#1)(2008-5#2)(2009-9#1)(2011-1#1)(2012-2#1)
DMSO-Triton X-100##2##2##(2008-10#2)
DMSO-water mixtures##2##2##(2008-10#2)
DMSO-water##3##1##(2008-10#3)
DMT##3##1##(1992-3#1)(2008-10#2)
DMY##2##1##(2008-10#2)
DN##4##1##(2008-1#3)(2013-1#1)
DN-MSTN TG13 mice##3##3##(2012-12#3)
DN-MSTN TG13##4##2##(2012-12#4)
DNA (RAPD) analysis##8##3##(2008-10#8)
DNA (RAPD)##41##2##(1995-6#1)(2008-10#40)
DNA (RAPD)-PCR##2##2##(2008-10#2)
DNA (cDNA)##4##2##(1993-6#1)(2008-10#2)(2008-9#1)
DNA (dsDNA)##4##2##(1995-2#1)(2008-10#3)
DNA (ssDNA)##5##2##(1995-2#1)(2008-10#3)(2012-3#1)
DNA Fingerprint##2##2##(2008-10#2)
DNA Fingerprinting##2##2##(2008-10#2)
DNA IQ System##3##3##(2008-12#3)
DNA ISC was##2##3##(2008-11#2)
DNA ISC##7##2##(2008-11#7)
DNA Markers##5##2##(2008-10#5)
DNA PCR##2##2##(2008-10#2)
DNA accumulation in##2##3##(2008-10#2)
DNA accumulation##3##2##(2008-10#3)
DNA adduct formation##4##3##(1993-8#3)(1995-9#1)
DNA adducts##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
DNA affinity##3##2##(1994-11#1)(1995-6#1)(2008-4#1)
DNA amplification##5##2##(1995-11#1)(2008-10#3)(2008-5#1)
DNA amplified##2##2##(2008-10#2)
DNA analyses##7##2##(1994-12#1)(2008-10#4)(2008-9#1)(2010-3#1)
DNA analysis showed##3##3##(1993-6#1)(1995-8#1)(2008-10#1)
DNA analysis##10##2##(1993-1#1)(1993-2#1)(1993-6#1)(1995-8#1)(2008-10#4)(2008-9#2)
DNA and RNA##15##3##(2008-10#3)(2008-4#2)(2008-9#5)(2009-10#2)(2009-5#2)(2011-3#1)
DNA and are##2##3##(1993-12#1)(1995-12#1)
DNA and is##2##3##(1990-7#1)(1995-2#1)
DNA and its##2##3##(2008-10#1)(2011-10#1)
DNA and mimic biomembrane##2##4##(2008-10#2)
DNA and protein##2##3##(2009-10#1)(2012-2#1)
DNA and proteins in##2##4##(1991-6#1)(2008-12#1)
DNA and proteins##5##3##(1991-6#2)(2008-10#1)(2008-12#1)(2008-9#1)
DNA and the##4##3##(1990-5#1)(1994-5#1)(2008-10#1)(2011-2#1)
DNA and##86##2##(1990-5#3)(1990-7#1)(1991-5#1)(1991-6#3)(1992-3#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#32)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#6)(2009-10#3)(2009-5#2)(2011-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
DNA aneuploidy##2##2##(1994-12#1)(1995-9#1)
DNA are##5##2##(2008-10#3)(2008-12#1)(2008-4#1)
DNA array##2##2##(2008-10#1)(2008-9#1)
DNA arrays##2##2##(2008-10#1)(2008-7#1)
DNA as a##2##3##(1995-6#1)(2008-8#1)
DNA as the##2##3##(1992-6#1)(2008-11#1)
DNA as##8##2##(1992-6#1)(1994-5#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#2)
DNA assay##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
DNA at the##5##3##(1992-6#1)(1995-6#1)(2008-10#2)(2010-4#1)
DNA at##12##2##(1992-6#1)(1995-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2010-4#1)(2013-1#1)
DNA band##2##2##(2008-10#2)
DNA bands##3##2##(1995-12#1)(2008-10#2)
DNA based on##2##3##(2008-10#2)
DNA bend sites##2##3##(1996-2#2)
DNA bending is##2##3##(1992-6#1)(1997-6#1)
DNA bending##6##2##(1992-6#2)(1995-8#1)(1997-6#2)(2008-7#1)
DNA binding activity of##2##4##(1990-12#1)(2008-9#1)
DNA binding activity##3##3##(1990-12#1)(1997-3#1)(2008-9#1)
DNA binding and##2##3##(2008-8#1)(2013-1#1)
DNA binding properties of the##2##5##(1991-3#1)(2008-9#1)
DNA binding properties of##4##4##(1991-3#2)(1996-3#1)(2008-9#1)
DNA binding protein##8##3##(1990-6#1)(1992-3#1)(1992-6#1)(1995-2#1)(1997-3#2)(2008-9#2)
DNA binding proteins in SR##3##5##(2008-8#3)
DNA binding proteins in##5##4##(2008-8#5)
DNA binding proteins##8##3##(1994-11#1)(2008-8#6)(2008-9#1)
DNA binding sites##2##3##(1995-11#1)(1995-6#1)
DNA binding##46##2##(1990-12#1)(1990-6#1)(1991-3#2)(1991-5#1)(1992-3#1)(1992-6#2)(1993-2#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#4)(1995-8#1)(1996-2#1)(1996-3#1)(1997-3#3)(2008-10#1)(2008-8#7)(2008-9#8)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#3)
DNA biosensor and##4##3##(2008-10#2)(2008-9#2)
DNA biosensor for the detection of##2##6##(2008-10#2)
DNA biosensor for the detection##3##5##(2008-10#3)
DNA biosensor for##4##3##(2008-10#4)
DNA biosensor is##4##3##(2008-10#4)
DNA biosensor##20##2##(2008-10#17)(2008-9#3)
DNA biosensors##4##2##(2008-10#2)(2008-9#2)
DNA breakage##3##2##(1995-6#2)(2011-2#1)
DNA breaks##5##2##(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
DNA by PCR##2##3##(2008-2#1)(2008-9#1)
DNA by the##4##3##(1994-12#1)(2008-10#2)(2008-11#1)
DNA by##17##2##(1990-5#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
DNA can be##6##3##(1993-9#1)(1994-8#1)(2008-10#1)(2008-8#3)
DNA can##7##2##(1990-8#1)(1993-9#1)(1994-8#1)(2008-10#1)(2008-8#3)
DNA cellulose##2##2##(1992-7#1)(2008-9#1)
DNA chip was##2##3##(2008-12#2)
DNA chip##7##2##(2008-10#2)(2008-12#5)
DNA chips##3##2##(2008-10#2)(2008-4#1)
DNA cleavage##4##2##(1993-8#1)(1995-8#1)(2008-10#1)(2013-1#1)
DNA clones to##2##3##(1996-8#1)(2008-10#1)
DNA clones##6##2##(1996-8#1)(2008-10#4)(2008-8#1)
DNA components##2##2##(1991-5#1)(2008-10#1)
DNA concentration##9##2##(1991-5#1)(2008-10#6)(2008-11#1)(2008-12#1)
DNA constituents##3##2##(2008-10#3)
DNA construct##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
DNA containing the##2##3##(2008-10#1)(2010-5#1)
DNA containing##3##2##(1993-9#1)(2008-10#1)(2010-5#1)
DNA content analysis##7##3##(2008-11#2)(2008-9#4)(2010-8#1)
DNA content and expression of##2##5##(2008-11#1)(2008-9#1)
DNA content and##15##3##(1994-12#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-9#10)
DNA content in the##2##4##(2008-11#2)
DNA content in##5##3##(1991-6#1)(2008-10#1)(2008-11#2)(2008-9#1)
DNA content is##3##3##(2008-9#3)
DNA content of cancer cells##2##5##(1991-6#2)
DNA content of##3##3##(1991-6#2)(2008-10#1)
DNA content##53##2##(1991-6#3)(1994-12#3)(1994-3#1)(1994-8#1)(1996-12#1)(2008-10#6)(2008-11#10)(2008-9#26)(2009-8#1)(2010-8#1)
DNA contents##3##2##(1993-12#1)(1997-3#1)(2008-9#1)
DNA could##2##2##(1993-8#1)(2008-10#1)
DNA damage and the##2##4##(1994-8#1)(2008-11#1)
DNA damage and##7##3##(1994-8#2)(1995-9#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-7#1)
DNA damage as##3##3##(1993-12#2)(2010-5#1)
DNA damage checkpoint pathway##2##4##(2009-6#1)(2011-2#1)
DNA damage checkpoint##5##3##(2008-11#1)(2009-6#2)(2011-2#1)(2013-1#1)
DNA damage in##6##3##(2008-10#1)(2008-4#2)(2010-5#1)(2011-2#1)(2013-1#1)
DNA damage response (DDR)##3##4##(2011-2#2)(2013-1#1)
DNA damage response##5##3##(2011-2#2)(2013-1#3)
DNA damage was##3##3##(1994-8#2)(2010-5#1)
DNA damage##69##2##(1991-5#1)(1992-9#1)(1993-12#4)(1994-8#4)(1995-9#1)(2008-10#8)(2008-11#4)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-6#2)(2010-3#1)(2010-5#4)(2011-1#1)(2011-2#11)(2012-2#1)(2013-1#11)(2013-7#1)
DNA damaging agents##4##3##(2008-7#4)
DNA damaging##6##2##(2008-7#4)(2010-10#1)(2011-1#1)
DNA delivery##4##2##(2008-11#2)(2010-8#1)(2011-2#1)
DNA demonstrated that##2##3##(1991-5#1)(2008-10#1)
DNA denaturation##3##2##(2008-9#3)
DNA derived##2##2##(2008-2#1)(2008-7#1)
DNA detection##5##2##(2008-10#4)(2008-9#1)
DNA determined##2##2##(2008-10#1)(2008-8#1)
DNA directly##3##2##(1995-6#1)(2008-10#1)(2008-8#1)
DNA double strand break##2##4##(1996-2#2)
DNA double##4##2##(1996-2#2)(2008-10#1)(2008-11#1)
DNA double-strand break repair##3##4##(1997-7#1)(2008-7#1)(2012-3#1)
DNA double-strand break##4##3##(1997-7#1)(2008-7#1)(2012-3#1)(2013-1#1)
DNA double-strand breaks (DSBs)##3##4##(1995-8#1)(2011-2#1)(2013-1#1)
DNA double-strand breaks##6##3##(1995-8#1)(1997-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
DNA double-strand##10##2##(1995-8#1)(1997-7#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#2)
DNA during##2##2##(1997-6#1)(2011-2#1)
DNA either##2##2##(1994-8#1)(2008-10#1)
DNA element##2##2##(2008-10#1)(2010-8#1)
DNA elements##5##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
DNA elimination##2##2##(2012-3#2)
DNA encapsulation##2##2##(2008-7#2)
DNA encoding##3##2##(1991-5#1)(1993-9#1)(1996-12#1)
DNA end joining##3##3##(1993-2#2)(1997-7#1)
DNA end##5##2##(1993-2#2)(1997-7#2)(2013-1#1)
DNA ends##6##2##(1993-2#1)(1996-2#1)(1997-7#2)(2008-4#2)
DNA extracted from naturally infected##2##5##(2008-10#2)
DNA extracted from##13##3##(2008-10#10)(2008-12#3)
DNA extraction and##2##3##(2008-10#2)
DNA extraction##12##2##(1996-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2011-2#3)
DNA fingerprint for##2##3##(2008-10#2)
DNA fingerprint patterns were##2##4##(2008-10#2)
DNA fingerprint patterns##4##3##(2008-10#4)
DNA fingerprint probe##3##3##(2008-10#3)
DNA fingerprint##20##2##(2008-10#20)
DNA fingerprinting analysis##2##3##(2008-10#2)
DNA fingerprinting and##2##3##(2008-10#2)
DNA fingerprinting of##2##3##(1996-12#1)(2008-10#1)
DNA fingerprinting##19##2##(1995-6#1)(1996-12#1)(2008-10#15)(2008-11#1)(2008-5#1)
DNA fingerprints of##3##3##(2008-10#2)(2008-5#1)
DNA fingerprints were##4##3##(2008-10#4)
DNA fingerprints##21##2##(2008-10#19)(2008-5#2)
DNA for##8##2##(1994-11#1)(1996-6#1)(2008-10#1)(2008-4#4)(2011-2#1)
DNA forms##2##2##(2008-10#2)
DNA fragment containing##3##3##(1993-6#2)(2008-8#1)
DNA fragment contains##2##3##(2008-8#2)
DNA fragment from##3##3##(1991-2#1)(1996-3#1)(2008-8#1)
DNA fragment in##2##3##(2008-10#1)(2008-11#1)
DNA fragment of the##2##4##(1996-6#1)(2008-10#1)
DNA fragment of##4##3##(1996-6#1)(2008-10#3)
DNA fragment was cloned##2##4##(2008-8#2)
DNA fragment was##8##3##(1990-11#1)(1992-8#1)(1997-8#1)(2008-10#2)(2008-8#3)
DNA fragment within the ITS2 region of##2##7##(2008-10#2)
DNA fragment within the##3##4##(2008-10#3)
DNA fragment##48##2##(1990-11#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-6#2)(1993-8#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-2#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-8#12)(2008-9#2)
DNA fragmentation and activation of caspase-3-like##2##6##(2008-11#2)
DNA fragmentation and##5##3##(1993-8#1)(2008-11#2)(2008-8#1)(2008-9#1)
DNA fragmentation in##2##3##(1993-8#1)(2008-9#1)
DNA fragmentation##25##2##(1993-3#1)(1993-8#6)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#2)(2008-10#1)(2008-11#5)(2008-7#1)(2008-8#3)(2008-9#2)
DNA fragments are##3##3##(1995-8#3)
DNA fragments from##2##3##(2008-10#1)(2008-7#1)
DNA fragments in##3##3##(2008-10#2)(2008-8#1)
DNA fragments of##2##3##(2008-10#1)(2008-12#1)
DNA fragments were##3##3##(1991-5#1)(2008-10#1)(2008-8#1)
DNA fragments with a##2##4##(2008-8#1)(2008-9#1)
DNA fragments##44##2##(1991-5#1)(1992-3#1)(1993-2#1)(1995-6#1)(1995-8#3)(1996-12#1)(1997-2#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#3)
DNA from a collection of##2##5##(2008-10#2)
DNA from a##6##3##(1993-2#1)(2008-10#5)
DNA from envelope flaps##2##4##(2008-12#2)
DNA from isolates##2##3##(2008-10#2)
DNA from the##6##3##(1996-6#1)(2008-10#5)
DNA from various##2##3##(1993-8#1)(2008-4#1)
DNA from##58##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-10#36)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#1)
DNA gel electrophoresis##2##3##(1994-11#1)(2008-8#1)
DNA genomes##2##2##(1995-2#1)(2013-1#1)
DNA guanine##2##2##(2008-10#2)
DNA hairpin##2##2##(1992-3#1)(2008-4#1)
DNA hairpins##4##2##(1992-3#2)(2008-10#2)
DNA haplotype##3##2##(2008-10#3)
DNA has been##4##3##(1995-8#1)(2008-10#3)
DNA has##6##2##(1990-5#1)(1995-8#1)(2008-10#3)(2010-8#1)
DNA have##2##2##(2008-10#2)
DNA helix##3##2##(1990-5#1)(1994-5#1)(2008-11#1)
DNA hybridisation##3##2##(2008-10#3)
DNA hybridization analysis##2##3##(2008-10#2)
DNA hybridization and##2##3##(2008-10#2)
DNA hybridization sensors##2##3##(2008-10#2)
DNA hybridization##19##2##(1995-12#2)(2008-10#16)(2008-4#1)
DNA immobilization##2##2##(2008-10#2)
DNA immunization##3##2##(1997-8#2)(2008-8#1)
DNA in a##6##3##(1997-7#1)(2008-10#3)(2008-11#1)(2013-1#1)
DNA in cell##2##3##(2008-11#1)(2008-9#1)
DNA in the##10##3##(1995-8#1)(2008-10#5)(2008-8#2)(2008-9#1)(2011-2#1)
DNA in##52##2##(1990-5#1)(1990-7#1)(1991-5#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-7#1)(2008-10#19)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#7)(2008-9#3)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#1)
DNA integrity##4##2##(1995-8#1)(2008-9#2)(2013-1#1)
DNA interaction##2##2##(2008-10#1)(2008-8#1)
DNA internal##6##2##(2008-10#5)(2008-12#1)
DNA into cells##3##3##(2008-11#2)(2008-4#1)
DNA into the##3##3##(1995-2#1)(1995-5#1)(2008-11#1)
DNA into yeast##2##3##(2008-4#2)
DNA into##16##2##(1993-9#2)(1995-2#1)(1995-5#1)(2008-11#4)(2008-4#7)(2008-8#1)
DNA is detected##2##3##(2008-10#1)(2008-4#1)
DNA is extracted##2##3##(2008-10#1)(2008-12#1)
DNA is the##2##3##(1997-6#1)(2008-8#1)
DNA is##29##2##(1991-5#1)(1992-4#1)(1995-8#2)(1997-6#1)(1997-8#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#3)(2008-9#3)(2009-7#1)(2010-7#1)(2010-8#1)
DNA isolated from##2##3##(1993-12#1)(2008-10#1)
DNA ladder was##2##3##(2008-8#2)
DNA ladder##7##2##(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#1)
DNA leads to##2##3##(1995-2#1)(2008-10#1)
DNA level##5##2##(1991-6#1)(1993-8#1)(2008-8#2)(2009-8#1)
DNA levels were##2##3##(2008-10#2)
DNA levels##6##2##(2008-10#4)(2009-8#2)
DNA library of Streptomyces ansochromogenes##2##5##(2008-8#2)
DNA library of##3##3##(1993-2#1)(2008-8#2)
DNA library##8##2##(1991-6#1)(1991-9#1)(1993-2#1)(1996-12#1)(2008-10#1)(2008-8#2)(2008-9#1)
DNA ligase I##2##3##(1997-7#2)
DNA ligase IV##7##3##(1997-7#7)
DNA ligase##12##2##(1993-2#1)(1997-7#10)(2008-4#1)
DNA ligases are very sensitive to mismatches at the DNA ends to be joined through ligation##2##16##(2008-4#2)
DNA ligases##5##2##(1997-7#2)(2008-4#2)(2010-7#1)
DNA ligation##2##2##(1993-2#1)(2010-7#1)
DNA loci##3##2##(2008-10#3)
DNA marker##5##2##(1997-2#1)(2008-10#4)
DNA markers and##2##3##(2008-10#1)(2008-9#1)
DNA markers for##2##3##(2008-10#2)
DNA markers from##2##3##(1996-12#1)(2008-10#1)
DNA markers linked to##3##4##(2008-10#3)
DNA markers##28##2##(1995-6#1)(1996-12#2)(1997-2#2)(2008-10#21)(2008-9#1)(2012-3#1)
DNA may##4##2##(1993-3#1)(1993-8#1)(2008-10#1)(2008-8#1)
DNA methylation and##2##3##(2009-4#1)(2011-2#1)
DNA methylation##13##2##(1995-12#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2011-2#3)(2011-9#1)(2013-8#3)
DNA microarray experiments##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
DNA microarray technology##2##3##(2008-10#1)(2012-2#1)
DNA microarray##7##2##(2008-10#2)(2008-4#1)(2011-2#1)(2012-2#2)(2013-8#1)
DNA model##2##2##(1991-5#2)
DNA molecule##7##2##(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)
DNA molecules and##3##3##(2008-10#3)
DNA molecules by##2##3##(2008-10#1)(2008-11#1)
DNA molecules in##2##3##(1997-6#1)(2012-2#1)
DNA molecules##15##2##(1995-8#1)(1997-6#2)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
DNA mutation##3##2##(2008-10#2)(2010-11#1)
DNA network##2##2##(2008-10#2)
DNA obtained from##2##3##(1991-2#1)(2008-10#1)
DNA of M##2##3##(2008-10#2)
DNA of S##2##3##(2008-10#1)(2008-8#1)
DNA of agents of##3##4##(2013-1#3)
DNA of all##2##3##(2008-10#2)
DNA of bacteriophage##2##3##(1991-5#1)(1993-9#1)
DNA of the##4##3##(1993-8#1)(1994-12#1)(2008-10#2)
DNA of##46##2##(1991-12#1)(1991-5#1)(1992-6#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1996-3#1)(2008-10#18)(2008-11#2)(2008-8#4)(2008-9#2)(2009-6#1)(2010-7#1)(2013-1#7)
DNA on##6##2##(1995-8#1)(2008-10#4)(2008-11#1)
DNA onto the##2##3##(2008-10#2)
DNA onto##3##2##(2008-10#3)
DNA or RNA##2##3##(2008-4#1)(2008-9#1)
DNA or##5##2##(1994-8#1)(1997-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
DNA packaging system##2##3##(1996-2#2)
DNA packaging##5##2##(1991-5#1)(1996-2#2)(2010-5#2)
DNA particles##2##2##(1995-2#2)
DNA photolesions##2##2##(1993-8#2)
DNA ploidy##4##2##(1994-11#1)(2008-9#3)
DNA polymerase III holoenzyme##3##4##(1992-3#2)(1994-12#1)
DNA polymerase III##4##3##(1992-3#3)(1994-12#1)
DNA polymerase accessory protein##2##4##(1997-3#2)
DNA polymerase delta##2##3##(1994-12#1)(1995-2#1)
DNA polymerase has##2##3##(1995-8#1)(1997-8#1)
DNA polymerase that##2##3##(1995-2#1)(1995-8#1)
DNA polymerase transactivates##2##3##(1993-8#2)
DNA polymerase was##2##3##(1993-12#1)(1993-8#1)
DNA polymerase##31##2##(1990-5#2)(1992-3#3)(1993-12#1)(1993-8#3)(1994-12#3)(1995-2#4)(1995-6#1)(1995-8#2)(1997-3#3)(1997-8#5)(1997-9#1)(2008-11#1)(2008-4#1)(2011-2#1)
DNA polymerases##4##2##(1992-6#2)(1997-8#1)(2008-9#1)
DNA polymorphism##5##2##(2008-10#5)
DNA polymorphisms##3##2##(2008-10#3)
DNA pool##2##2##(2008-4#1)(2008-8#1)
DNA preparations##5##2##(1990-12#2)(2008-10#2)(2008-11#1)
DNA present in##4##3##(2008-10#4)
DNA preservation##2##2##(2008-12#2)
DNA probe##11##2##(1990-5#1)(1993-9#1)(1996-3#1)(1997-6#1)(2008-10#6)(2008-9#1)
DNA probes by##2##3##(2008-4#2)
DNA probes##17##2##(1990-12#1)(1993-3#1)(1995-2#1)(1997-6#1)(2008-10#9)(2008-4#4)
DNA products##3##2##(2008-10#3)
DNA profile##2##2##(2008-11#1)(2008-12#1)
DNA profiles##6##2##(2008-10#3)(2008-12#3)
DNA profiling##5##2##(2008-11#1)(2008-12#4)
DNA purification##2##2##(2008-10#1)(2008-11#1)
DNA rearrangements##3##2##(1993-6#1)(1997-3#1)(2012-3#1)
DNA recognition##5##2##(1992-4#1)(1995-8#1)(2008-10#2)(2012-2#1)
DNA recombination##4##2##(1993-9#2)(2008-9#2)
DNA region##8##2##(1991-9#1)(1993-2#2)(1997-8#1)(2008-10#3)(2008-8#1)
DNA regions##2##2##(2008-10#1)(2009-10#1)
DNA repair and##2##3##(1993-8#1)(1996-2#1)
DNA repair genes##2##3##(2010-6#1)(2011-2#1)
DNA repair is an##2##4##(2008-11#2)
DNA repair pathways##2##3##(2008-11#2)
DNA repair##31##2##(1990-5#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#3)(1996-2#1)(2008-11#13)(2008-9#1)(2009-4#1)(2010-10#1)(2010-6#2)(2011-2#2)(2013-1#1)
DNA repeat##2##2##(1997-6#1)(2008-10#1)
DNA replication and growth of##2##5##(1997-3#2)
DNA replication and##4##3##(1997-3#2)(2008-9#1)(2012-2#1)
DNA replication##32##2##(1992-3#1)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-9#1)(1997-3#7)(1997-6#4)(2008-10#3)(2008-12#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
DNA response##2##2##(1993-3#1)(1996-2#1)
DNA restriction fragment length polymorphisms##3##5##(2008-10#3)
DNA restriction fragment length##4##4##(2008-10#4)
DNA restriction fragment##5##3##(1993-12#1)(2008-10#4)
DNA restriction##6##2##(1993-12#1)(2008-10#4)(2008-11#1)
DNA revealed##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
DNA sample##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
DNA samples from##2##3##(2008-10#1)(2008-9#1)
DNA samples##7##2##(2008-10#5)(2008-4#1)(2008-9#1)
DNA segment##5##2##(1990-11#1)(1990-5#1)(1995-8#1)(1996-8#1)(2008-11#1)
DNA segments##3##2##(1993-9#1)(2008-10#1)(2008-11#1)
DNA sensors##2##2##(2008-10#2)
DNA separation##2##2##(2008-10#2)
DNA sequence analyses##3##3##(1996-6#1)(2008-10#1)(2008-12#1)
DNA sequence analysis of the internal transcribed spacer##2##8##(2008-10#2)
DNA sequence analysis of the##6##5##(1994-11#1)(2008-10#5)
DNA sequence analysis of##7##4##(1994-11#1)(2008-10#6)
DNA sequence analysis##14##3##(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(2008-10#6)(2008-4#1)(2008-9#1)(2012-2#1)
DNA sequence and##2##3##(1990-7#1)(1996-8#1)
DNA sequence comparisons##2##3##(2008-10#2)
DNA sequence data##3##3##(2008-10#2)(2008-4#1)
DNA sequence of the Escherichia coli K-12 genome corresponding to the##6##11##(1996-12#4)(1996-6#2)
DNA sequence of the##12##4##(1993-8#1)(1994-2#1)(1996-12#4)(1996-6#2)(1997-1#1)(2008-10#2)(2008-8#1)
DNA sequence of##14##3##(1993-8#1)(1994-2#1)(1996-12#4)(1996-6#2)(1997-1#1)(2008-10#3)(2008-8#2)
DNA sequence was##2##3##(1993-12#1)(2008-10#1)
DNA sequence which##3##3##(1997-2#1)(2008-8#2)
DNA sequence with##2##3##(2008-10#1)(2008-9#1)
DNA sequence##80##2##(1990-7#1)(1991-10#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#3)(1994-8#1)(1996-12#4)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-8#1)(2008-10#27)(2008-12#1)(2008-4#4)(2008-8#15)(2008-9#2)(2011-2#1)(2012-2#1)
DNA sequences analysis##2##3##(1996-6#1)(2008-8#1)
DNA sequences from the##3##4##(2008-10#3)
DNA sequences from##5##3##(2008-10#5)
DNA sequences in situ##3##4##(2008-4#1)(2008-9#2)
DNA sequences in the##5##4##(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
DNA sequences in##9##3##(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2012-3#1)
DNA sequences of the##4##4##(2008-10#2)(2008-12#1)(2008-8#1)
DNA sequences of##13##3##(1991-2#1)(1991-5#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#2)
DNA sequences that##3##3##(1995-8#1)(2008-10#1)(2009-12#1)
DNA sequences were##2##3##(2008-10#1)(2008-12#1)
DNA sequences within##2##3##(1990-5#1)(2008-4#1)
DNA sequences##70##2##(1990-5#1)(1991-2#1)(1991-5#1)(1993-2#1)(1993-9#1)(1994-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#1)(2008-10#23)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#5)(2008-8#5)(2008-9#5)(2009-12#2)(2010-7#2)(2011-2#1)(2012-3#1)
DNA sequencing and##3##3##(1994-3#1)(2008-4#1)(2008-8#1)
DNA sequencing of##4##3##(2008-10#3)(2008-8#1)
DNA sequencing##27##2##(1990-5#1)(1991-2#1)(1992-3#1)(1994-3#1)(1995-6#2)(1995-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#6)(2008-9#1)(2009-7#1)(2012-3#1)(2013-1#1)
DNA single-strand breaks##5##3##(1993-8#1)(1994-8#4)
DNA strand breaks in##2##4##(1993-9#1)(2008-4#1)
DNA strand breaks##8##3##(1993-9#1)(2008-4#1)(2008-7#1)(2008-9#4)(2011-2#1)
DNA strand##15##2##(1993-9#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#4)(2009-10#1)(2011-2#2)
DNA strands##7##2##(1993-8#1)(2008-4#2)(2010-7#1)(2012-2#3)
DNA structure##5##2##(1994-3#1)(2008-10#1)(2008-4#3)
DNA structures##3##2##(1995-8#1)(2008-4#2)
DNA substrate##3##2##(1991-9#1)(1997-3#1)(2008-11#1)
DNA substrates##2##2##(1992-3#1)(1997-3#1)
DNA supercoiling factor##2##3##(1995-6#2)
DNA supercoiling##5##2##(1994-5#1)(1995-6#2)(2008-8#1)(2008-9#1)
DNA synthesis and cell proliferation in##2##6##(1995-11#2)
DNA synthesis and cell##5##4##(1991-2#1)(1992-8#1)(1993-8#1)(1995-11#2)
DNA synthesis and mitosis##2##4##(1995-11#1)(2008-7#1)
DNA synthesis and##10##3##(1990-11#1)(1991-2#1)(1992-8#1)(1993-8#1)(1995-11#3)(1997-1#1)(2008-11#1)(2008-7#1)
DNA synthesis at##2##3##(1994-11#1)(1995-2#1)
DNA synthesis by##4##3##(1990-11#1)(1995-11#1)(1997-1#1)(1997-3#1)
DNA synthesis in##13##3##(1990-11#1)(1993-3#2)(1994-3#1)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)
DNA synthesis was##2##3##(1992-3#1)(1995-12#1)
DNA synthesis##66##2##(1990-11#4)(1990-5#1)(1991-2#2)(1991-5#1)(1992-10#2)(1992-3#2)(1992-6#1)(1992-8#2)(1993-11#2)(1993-3#2)(1993-8#4)(1994-11#2)(1994-3#1)(1994-5#3)(1995-11#11)(1995-12#3)(1995-2#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#5)(1997-2#1)(1997-3#1)(1997-7#1)(2008-11#3)(2008-7#3)(2009-3#1)(2009-8#2)
DNA target in##2##3##(2008-10#2)
DNA target##7##2##(1994-3#1)(2008-10#5)(2008-4#1)
DNA targets from##2##3##(1995-6#1)(2008-10#1)
DNA targets##5##2##(1995-6#1)(2008-10#3)(2008-9#1)
DNA technology##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
DNA template##10##2##(1992-3#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#2)(2009-6#1)
DNA that##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
DNA to##10##2##(1990-12#1)(1991-5#1)(1997-2#1)(2008-10#2)(2008-8#2)(2010-1#1)(2011-2#2)
DNA topoisomerase II##6##3##(1993-8#1)(1995-6#3)(2008-11#2)
DNA topoisomerase##8##2##(1993-8#1)(1995-6#3)(2008-11#3)(2008-9#1)
DNA transfection and protein introduction techniques##2##6##(2008-11#2)
DNA transfection##5##2##(1991-5#1)(2008-11#3)(2008-8#1)
DNA transfer##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
DNA typing of##2##3##(1997-8#1)(2008-12#1)
DNA typing##9##2##(1993-9#2)(1995-11#1)(1997-8#5)(2008-12#1)
DNA under##2##2##(2008-8#1)(2008-9#1)
DNA using the##2##3##(1996-6#1)(2008-10#1)
DNA using##9##2##(1990-5#1)(1996-6#1)(2008-10#7)
DNA vaccination##2##2##(2008-4#1)(2010-8#1)
DNA vaccine##2##2##(2008-4#1)(2010-8#1)
DNA vaccines##4##2##(2008-4#1)(2008-5#3)
DNA virus##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
DNA viruses that cause##2##4##(2008-10#1)(2013-8#1)
DNA viruses##3##2##(2008-10#1)(2011-3#1)(2013-8#1)
DNA was also##2##3##(1997-8#1)(2008-10#1)
DNA was amplified from##2##4##(2008-10#2)
DNA was amplified##3##3##(2008-10#2)(2008-12#1)
DNA was constructed##2##3##(2008-10#1)(2008-8#1)
DNA was detected in##4##4##(1990-8#1)(2008-10#2)(2013-1#1)
DNA was detected##5##3##(1990-8#1)(2008-10#3)(2013-1#1)
DNA was extracted from##6##4##(2008-10#4)(2008-12#1)(2008-9#1)
DNA was extracted##10##3##(2008-10#5)(2008-12#3)(2008-9#1)(2013-1#1)
DNA was measured##2##3##(1991-5#1)(1996-12#1)
DNA was purified and##2##4##(2008-10#1)(2008-12#1)
DNA was spiked##2##3##(2008-10#2)
DNA was used as a template##2##6##(1993-12#1)(2008-11#1)
DNA was used as a##4##5##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
DNA was##62##2##(1990-5#1)(1990-8#2)(1991-5#1)(1991-7#1)(1993-12#1)(1993-8#4)(1994-1#2)(1994-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#29)(2008-11#4)(2008-12#6)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2012-2#1)(2013-1#2)
DNA were detected##2##3##(2008-10#2)
DNA were introduced into##2##4##(2008-11#1)(2008-8#1)
DNA were##16##2##(1990-8#1)(1991-5#1)(1994-11#1)(1995-2#1)(2008-10#9)(2008-11#1)(2008-8#1)(2008-9#1)
DNA when##2##2##(1992-6#1)(2008-10#1)
DNA which##2##2##(1990-7#1)(2008-10#1)
DNA whose##2##2##(2008-11#2)
DNA with high affinity##2##4##(1996-3#1)(2008-10#1)
DNA with the##2##3##(1990-5#1)(1990-8#1)
DNA with##14##2##(1990-5#2)(1990-8#1)(1992-6#2)(1993-8#1)(1996-12#1)(1996-3#1)(2008-10#6)
DNA##2514##1##(1990-11#6)(1990-12#8)(1990-2#2)(1990-5#25)(1990-6#2)(1990-7#8)(1990-8#7)(1991-10#1)(1991-12#4)(1991-2#7)(1991-3#6)(1991-5#28)(1991-6#12)(1991-7#2)(1991-8#4)(1991-9#5)(1992-10#3)(1992-3#27)(1992-4#2)(1992-6#22)(1992-7#1)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#28)(1993-2#15)(1993-3#9)(1993-6#10)(1993-8#53)(1993-9#16)(1994-1#4)(1994-11#26)(1994-12#14)(1994-2#3)(1994-3#13)(1994-5#14)(1994-8#17)(1994-9#2)(1995-11#16)(1995-12#16)(1995-2#27)(1995-5#2)(1995-6#34)(1995-8#35)(1995-9#5)(1996-12#22)(1996-2#14)(1996-3#11)(1996-5#1)(1996-6#12)(1996-8#4)(1997-1#6)(1997-2#16)(1997-3#27)(1997-6#24)(1997-7#26)(1997-8#23)(1997-9#1)(2007-12#3)(2008-10#887)(2008-11#156)(2008-12#74)(2008-2#8)(2008-4#96)(2008-5#13)(2008-6#4)(2008-7#26)(2008-8#124)(2008-9#146)(2009-1#1)(2009-10#5)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#8)(2009-7#6)(2009-8#10)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#6)(2010-5#11)(2010-6#2)(2010-7#10)(2010-8#12)(2011-1#2)(2011-10#1)(2011-2#47)(2011-3#2)(2011-9#1)(2012-12#1)(2012-2#16)(2012-3#18)(2012-4#1)(2013-1#45)(2013-7#1)(2013-8#11)
DNA) and##3##2##(2008-10#3)
DNA)##8##1##(2008-10#6)(2008-8#1)(2010-4#1)
DNA-2NiTMpyP##2##1##(2008-10#2)
DNA-A and -B##3##3##(2008-10#3)
DNA-A and DNA-B components##2##4##(2008-10#2)
DNA-A and DNA-B of##4##4##(2008-10#4)
DNA-A and DNA-B##9##3##(2008-10#9)
DNA-A and##13##2##(2008-10#13)
DNA-A nt##2##2##(2008-10#2)
DNA-A##25##1##(2008-10#25)
DNA-B components##3##2##(2008-10#3)
DNA-B of ToLCGV-[Var]##2##3##(2008-10#2)
DNA-B of##7##2##(2008-10#7)
DNA-B##21##1##(2008-10#21)
DNA-Based##2##1##(2008-10#2)
DNA-DNA hybridization##3##2##(2008-10#3)
DNA-DNA##9##1##(1995-12#3)(2008-10#6)
DNA-Os##2##1##(2008-10#2)
DNA-PK##5##1##(1996-2#5)
DNA-PKcs##5##1##(1996-2#2)(2013-1#3)
DNA-based##6##1##(2008-10#6)
DNA-binding activity##4##2##(1991-7#1)(2008-9#2)(2012-2#1)
DNA-binding domain##6##2##(1993-12#1)(1996-3#2)(2008-8#1)(2008-9#1)(2009-7#1)
DNA-binding protein##3##2##(1993-2#1)(2008-8#1)(2008-9#1)
DNA-binding proteins that##2##3##(1991-9#1)(1995-8#1)
DNA-binding proteins##5##2##(1991-7#1)(1991-9#1)(1995-8#1)(2008-8#2)
DNA-binding site##2##2##(1995-2#1)(2008-8#1)
DNA-binding##33##1##(1991-7#2)(1991-9#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-3#3)(1997-7#1)(2008-4#1)(2008-8#8)(2008-9#6)(2009-7#1)(2012-2#1)
DNA-bound##2##1##(1992-6#1)(1994-12#1)
DNA-damaging agent##2##2##(1996-3#1)(2013-1#1)
DNA-damaging agents in##3##3##(1992-12#1)(2008-10#2)
DNA-damaging agents##7##2##(1992-12#3)(1995-8#2)(2008-10#2)
DNA-damaging##9##1##(1992-12#3)(1995-8#2)(1996-3#1)(2008-10#2)(2013-1#1)
DNA-dependent protein kinase##3##3##(1996-2#2)(2013-1#1)
DNA-dependent##5##1##(1993-12#1)(1995-2#1)(1996-2#2)(2013-1#1)
DNA-lipids##3##1##(2008-10#3)
DNA-mediated##2##1##(1991-5#1)(2008-10#1)
DNA-modified##4##1##(2008-10#4)
DNA-nicking domains##3##2##(2008-10#3)
DNA-nicking##4##1##(1990-7#1)(2008-10#3)
DNA-pairing##3##1##(1995-2#3)
DNA-protein##6##1##(1990-5#1)(1993-6#1)(2008-10#2)(2008-4#1)(2008-9#1)
DNA-synthesizing cells##2##2##(2008-6#1)(2008-9#1)
DNA/RNA FISH##2##2##(2008-9#2)
DNA/RNA##3##1##(2008-9#3)
DNAbeta molecules##3##2##(2008-10#3)
DNAbeta##11##1##(2008-10#11)
DNAbeta01##2##1##(2008-10#2)
DNAbeta02##2##1##(2008-10#2)
DNAs from##3##2##(1993-12#1)(1996-6#1)(2008-10#1)
DNAs in##3##2##(1992-8#1)(2008-10#2)
DNAs is##2##2##(2008-10#2)
DNAs of##2##2##(1997-2#1)(2008-10#1)
DNAs preparation##2##2##(1994-8#2)
DNAs that are##2##3##(2008-10#1)(2008-11#1)
DNAs were##3##2##(1994-12#1)(1994-8#1)(2008-10#1)
DNAs##40##1##(1990-5#1)(1991-5#2)(1992-8#2)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#6)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#16)(2008-11#2)(2008-6#1)(2008-9#1)(2010-8#1)
DNAse##2##1##(1994-11#1)(2008-11#1)
DNAzyme##4##1##(2008-10#4)
DNB and NBM lesions##2##4##(1993-3#2)
DNB and NBM##3##3##(1993-3#3)
DNB and##4##2##(1993-3#4)
DNB##6##1##(1993-3#6)
DNCB##2##1##(2008-10#2)
DNL4##2##1##(1997-7#2)
DNT and##2##2##(2008-10#2)
DNT##3##1##(2008-10#2)(2008-7#1)
DNTs##2##1##(2008-7#2)
DNase I footprinting##3##3##(2008-8#1)(2008-9#2)
DNase I##5##2##(1992-4#2)(2008-8#1)(2008-9#2)
DNase##14##1##(1992-4#3)(1994-11#1)(1994-8#4)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#2)
DNaseI hypersensitive site##4##3##(1992-6#2)(2008-8#2)
DNaseI##5##1##(1992-6#2)(2008-8#3)
DO NOT##2##2##(2009-12#1)(2012-3#1)
DO in##2##2##(2008-10#2)
DO##19##1##(2008-10#12)(2008-11#2)(2008-12#1)(2009-12#2)(2010-4#1)(2012-3#1)
DOC##2##1##(2008-11#1)(2008-4#1)
DOCA-salt treatment##2##2##(2013-8#2)
DOCA-salt##5##1##(2013-8#5)
DOCA-salt-induced##2##1##(2013-8#2)
DOD##2##1##(1996-5#2)
DOE was##2##2##(2008-3#2)
DOE##6##1##(1994-12#1)(2008-3#5)
DOEHLOPT##3##1##(2008-10#3)
DOG##5##1##(2008-8#5)
DOH##2##1##(2008-11#2)
DOHH##2##1##(1994-3#2)
DOI 10##2##2##(2011-2#2)
DOI##9##1##(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#5)
DOM##6##1##(2008-10#5)(2008-11#1)
DOM-bound herbicides##2##2##(2008-11#2)
DOM-bound moieties##2##2##(2008-11#2)
DOM-bound##7##1##(2008-11#7)
DOM-flocculation##4##1##(2008-11#4)
DOM-solutions##2##1##(2008-11#2)
DON accumulation##4##2##(2008-10#4)
DON and IND##3##3##(2008-10#3)
DON and##4##2##(2008-10#4)
DON concentration##2##2##(2008-10#2)
DON content##3##2##(2008-10#3)
DON contents##2##2##(2008-10#2)
DON in##2##2##(2008-10#2)
DON##35##1##(2008-10#35)
DON-fed mice##2##2##(2008-10#2)
DON-fed##3##1##(2008-10#3)
DOP##6##1##(2008-10#5)(2008-2#1)
DOPAC##4##1##(1994-2#2)(2008-10#2)
DOPE##2##1##(2008-8#2)
DOPT##3##1##(1997-2#3)
DOR364##2##1##(2013-8#2)
DORM-1 and##2##2##(2008-10#2)
DORM-1##3##1##(2008-10#3)
DORM-2 and##3##2##(2008-10#3)
DORM-2##5##1##(2008-10#5)
DOS##7##1##(2008-10#5)(2012-2#2)
DOT in NYC##2##3##(1996-3#2)
DOT##15##1##(1996-3#14)(2013-8#1)
DOs##5##1##(2013-1#5)
DP method##4##2##(2008-2#4)
DP##9##1##(2008-10#1)(2008-2#4)(2009-10#1)(2010-1#3)
DPA##3##1##(2008-10#2)(2008-9#1)
DPASV##3##1##(2008-10#3)
DPCSV##4##1##(2008-10#4)
DPD was##2##2##(2008-10#2)
DPD##7##1##(2008-10#7)
DPDPE##2##1##(1992-3#1)(1996-2#1)
DPH##7##1##(1990-2#1)(1991-5#1)(1994-3#1)(1995-8#1)(2008-10#1)(2008-9#2)
DPH2##9##1##(1993-9#9)
DPI was##2##2##(2007-12#1)(2008-10#1)
DPI##9##1##(1997-1#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-5#1)
DPI's##4##1##(1992-3#4)
DPKSH adsorption onto silica gel was##2##6##(2008-10#2)
DPKSH##5##1##(2008-10#5)
DPM##8##1##(2008-7#8)
DPM1##3##1##(1996-6#3)
DPP and##2##2##(2008-10#2)
DPP was##2##2##(2008-10#2)
DPP##8##1##(2008-10#8)
DPPAH##2##1##(2008-10#2)
DPPC and DPPC-Chol liposomes##2##4##(1991-5#2)
DPPC and##3##2##(1991-5#3)
DPPC liposomes##8##2##(1991-5#1)(2008-10#5)(2008-8#2)
DPPC##14##1##(1991-3#1)(1991-5#4)(2008-10#7)(2008-8#2)
DPPC-Chol##3##1##(1991-5#3)
DPPH free radical scavenging##2##4##(2009-3#1)(2013-1#1)
DPPH free##3##2##(2008-12#1)(2009-3#1)(2013-1#1)
DPPH radical##4##2##(2008-10#3)(2008-11#1)
DPPH##15##1##(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#2)(2009-3#1)(2013-1#2)
DPPS##3##1##(1991-3#1)(2008-8#2)
DPR1##4##1##(1995-2#4)
DPRIS RNA##2##2##(1997-3#2)
DPRIS##3##1##(1997-3#3)
DPTH-gel##2##1##(2008-10#2)
DPV and SWV##2##3##(2008-10#2)
DPV and##3##2##(2008-10#3)
DPV##9##1##(2008-10#9)
DQA1##2##1##(1996-6#1)(1997-8#1)
DQB1(*)0602##3##1##(1997-9#3)
DR and##4##2##(1997-3#3)(2008-1#1)
DR##11##1##(1991-2#2)(1996-12#1)(1997-3#3)(1997-8#1)(2008-1#2)(2008-11#1)(2011-2#1)
DR-CALUX((R)) measured concentrations were##2##4##(2008-10#2)
DR-CALUX((R)) measured##3##2##(2008-10#3)
DR-CALUX((R))##5##1##(2008-10#5)
DR-CALUX((R))-REP##2##1##(2008-10#2)
DR-CALUX((R))-TEQ contents##2##2##(2008-10#2)
DR3##5##1##(1991-11#1)(1995-8#1)(2012-2#3)
DR3-positive##2##1##(2010-5#2)
DR4##2##1##(1995-8#1)(1997-8#1)
DR9##2##1##(1997-8#2)
DRA of the locust##2##4##(2007-12#2)
DRA##3##1##(2007-12#3)
DRAGON View##2##2##(2008-4#2)
DRAGON##5##1##(2008-4#5)
DRB1 * 1502 and DPB1 * 0901##2##7##(1997-8#2)
DRE##10##1##(1993-6#2)(1994-12#1)(1995-6#4)(2008-7#1)(2010-11#2)
DRE-containing##2##1##(1993-6#2)
DREF##3##1##(1995-6#3)
DRG and##4##2##(1994-12#1)(1997-2#1)(2008-9#2)
DRG following peripheral##2##3##(1997-2#1)(2008-9#1)
DRG neurons in##2##3##(1996-12#2)
DRG neurons##12##2##(1996-12#11)(2008-8#1)
DRG weights##2##2##(1992-12#1)(1992-2#1)
DRG##40##1##(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#6)(1993-1#1)(1994-12#7)(1996-12#13)(1997-2#3)(2008-8#3)(2008-9#3)(2010-12#1)
DRGs to##2##2##(1991-12#1)(1992-2#1)
DRGs##15##1##(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#3)(1993-12#1)(1994-12#4)(1995-2#1)(2008-7#1)
DRINKING WATER STUDIES IN Tg##2##5##(2008-9#2)
DRINKING WATER STUDIES IN p53##2##5##(2008-9#2)
DRINKING WATER STUDIES IN##4##4##(2008-9#4)
DRM proteins can be analyzed##2##5##(2008-4#2)
DRP3A##2##1##(2009-10#2)
DRP3B##2##1##(2009-10#2)
DRR206 promoter##5##2##(2008-10#5)
DRR206##7##1##(2008-10#7)
DRUJ##6##1##(2008-9#6)
DS and in##2##3##(1991-1#2)
DS and##4##2##(1991-1#3)(2012-2#1)
DS at Time##2##3##(2010-4#2)
DS cases##4##2##(1991-1#4)
DS on##2##2##(2008-10#2)
DS salt##9##2##(2008-5#9)
DS##44##1##(1990-11#1)(1991-1#8)(1991-11#2)(1996-2#4)(2008-10#8)(2008-5#9)(2010-10#1)(2010-4#3)(2011-2#3)(2012-2#5)
DS(-)##2##1##(2008-10#2)
DSA##5##1##(1993-8#4)(2008-7#1)
DSB repair and V(D)J recombination##2##5##(2013-1#2)
DSB repair and##4##3##(2011-2#1)(2013-1#3)
DSB repair##6##2##(2011-2#2)(2013-1#4)
DSB##8##1##(1995-8#2)(2011-2#2)(2013-1#4)
DSBs and##2##2##(1995-8#2)
DSBs##8##1##(1995-8#6)(2011-2#1)(2013-1#1)
DSC measurements##2##2##(1992-10#1)(2009-7#1)
DSC##7##1##(1992-10#1)(1993-8#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-3#1)(2012-2#1)
DSG is transported into##2##4##(1993-8#2)
DSG##6##1##(1993-8#6)
DSIP##4##1##(1990-5#4)
DSIP-like glycopeptide##2##2##(1990-5#2)
DSIP-related##2##1##(1990-5#2)
DSKNPH and##2##2##(2008-10#2)
DSKNPH in DMSO##3##3##(2008-10#3)
DSKNPH in##4##2##(2008-10#4)
DSKNPH##10##1##(2008-10#10)
DSM 7330##2##2##(1995-3#2)
DSM involving the##2##3##(1996-9#2)
DSM##14##1##(1992-11#1)(1995-3#2)(1996-9#5)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#3)
DSM-III criteria##2##2##(2008-7#2)
DSM-III##3##1##(1991-1#1)(2008-7#2)
DSM-III-R##2##1##(1991-2#1)(2008-7#1)
DSM-IV criteria##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
DSM-IV##12##1##(1997-8#4)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
DSM-IV-TR##3##1##(2010-4#1)(2011-2#2)
DSP is##2##2##(2010-6#2)
DSP##6##1##(2008-10#1)(2010-6#5)
DSS##3##1##(2011-2#3)
DSTD is##3##2##(2008-10#3)
DSTD##7##1##(2008-10#7)
DSU##4##1##(2008-5#4)
DT cells were##2##3##(1995-11#2)
DT cells##6##2##(1995-11#6)
DT patients##2##2##(2011-1#2)
DT##19##1##(1995-11#6)(1996-12#1)(2008-10#1)(2008-3#4)(2011-1#4)(2013-1#3)
DT-diaphorase##6##1##(1995-8#5)(2008-11#1)
DTC participants##2##2##(2010-6#2)
DTC##4##1##(2010-6#3)(2013-1#1)
DTH response##2##2##(2008-10#2)
DTH responses##2##2##(2008-10#2)
DTH##5##1##(2008-10#5)
DTP and##2##2##(1995-5#2)
DTP##3##1##(1995-5#3)
DTPA##10##1##(1990-5#1)(1997-8#1)(2008-10#3)(2008-5#5)
DTPP##6##1##(2008-10#6)
DTZ##2##1##(2008-10#2)
DTs##2##1##(2012-2#2)
DU-145##2##1##(2011-2#2)
DU145##2##1##(2010-1#1)(2011-2#1)
DUM heart-1##3##2##(1994-2#3)
DUM##4##1##(1994-2#4)
DV prevention##2##2##(2012-12#2)
DV##4##1##(1991-9#2)(2012-12#2)
DVA in the##2##3##(2012-3#2)
DVA in##3##2##(2012-3#3)
DVA##7##1##(2012-3#7)
DVD-R disc##2##2##(2008-3#2)
DVT##8##1##(1992-9#1)(2012-2#7)
DW##3##1##(2008-10#2)(2009-8#1)
DWI##2##1##(2009-11#1)(2010-12#1)
DX##6##1##(1990-2#6)
DXB11-CHO cells##2##2##(2008-11#2)
DXB11-CHO##3##1##(2008-11#3)
DXS10134 and DXS10147##2##3##(2008-12#2)
DXS10134##5##1##(2008-12#5)
DXS10146##4##1##(2008-12#4)
DXS10147##3##1##(2008-12#3)
DYS19 duplicated Y chromosomes##2##4##(2008-12#2)
DYS19##6##1##(2008-12#6)
DYS385##2##1##(2008-12#2)
DYS393##2##1##(2008-12#2)
DZA##2##1##(2011-2#2)
DZA-induced##2##1##(2011-2#2)
DZSAM##4##1##(2008-10#4)
Da and a pI of##2##5##(1992-8#1)(1995-6#1)
Da##18##1##(1990-11#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-11#1)(1995-6#2)(1997-7#1)(1997-8#1)(2008-10#4)(2008-5#1)(2010-4#1)(2011-2#1)(2011-3#1)
Da) were studied##2##3##(2008-10#1)(2008-5#1)
Da) with##2##2##(1991-9#1)(1995-2#1)
Da)##11##1##(1990-11#1)(1990-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1995-2#1)(2008-10#4)(2008-5#1)
Dabigatran##2##1##(2013-1#2)
Dacron graft##2##2##(2008-7#1)(2012-2#1)
Dacron##3##1##(2008-11#1)(2008-7#1)(2012-2#1)
Dactylella oviparasitica and Fusarium oxysporum##2##5##(2008-10#2)
Dactylella oviparasitica##3##2##(2008-10#3)
Dactylellina candidum##2##2##(2008-10#2)
Dactylellina##3##1##(2008-10#3)
Dactylobiotus dispar##3##2##(2008-12#3)
Dahlia##3##1##(2008-10#1)(2008-12#2)
Daily pain##2##2##(2008-7#2)
Daily##22##1##(1994-2#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#7)(2009-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
Dakota##10##1##(2008-10#8)(2010-5#1)(2012-3#1)
Dallas##5##1##(1990-11#3)(1991-3#1)(1992-8#1)
Damage##8##1##(1997-3#1)(2008-11#2)(2008-3#2)(2011-2#1)(2012-2#1)(2012-3#1)
Damaged##2##1##(2008-8#1)(2008-9#1)
Damages##2##1##(2009-12#1)(2011-2#1)
Damping-Off##5##1##(2008-10#5)
Dandruff##2##1##(2008-5#2)
Dang##2##1##(2012-3#2)
Danger##2##1##(1991-1#1)(2010-7#1)
Dangerous##2##1##(1990-6#1)(1991-12#1)
Danida##4##1##(1990-12#4)
Daniel##2##1##(1997-2#1)(2013-1#1)
Danio##2##1##(2008-11#1)(2012-3#1)
Danish counties##3##2##(1997-3#2)(2010-10#1)
Danish physicians##2##2##(1997-3#2)
Danish##14##1##(1990-12#5)(1990-6#1)(1997-3#4)(2010-10#2)(2012-2#2)
Dans le##2##2##(2013-1#2)
Dans##3##1##(2013-1#3)
Danshen##2##1##(2008-10#2)
Danube##3##1##(2008-10#3)
Darjeeling##2##1##(2012-2#2)
Dark##3##1##(1992-3#1)(2008-10#1)(2013-7#1)
Dartmouth##2##1##(1993-12#1)(2008-11#1)
Darwin##11##1##(2008-9#1)(2009-8#1)(2010-4#2)(2010-5#5)(2012-2#2)
Darwin's finches##3##2##(2008-8#3)
Darwin's##8##1##(2008-8#4)(2010-4#1)(2010-5#3)
Darwinian concept##2##2##(1995-2#2)
Darwinian##4##1##(1990-11#1)(1995-2#2)(2010-5#1)
Dasatinib##2##1##(2013-1#2)
Dastarcus helophoroides##2##2##(2013-8#2)
Dasypus##2##1##(2008-5#2)
Data Bank##4##2##(1991-3#1)(1995-11#1)(2011-3#2)
Data Information##2##2##(1997-3#1)(2008-10#1)
Data Protection Act##3##3##(1996-8#2)(1997-5#1)
Data Set##5##2##(1993-2#1)(1995-2#1)(2008-11#2)(2008-7#1)
Data also##4##2##(2008-10#2)(2010-10#1)(2010-8#1)
Data analyses##3##2##(1991-12#1)(1993-1#1)(2008-10#1)
Data analysis##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2013-1#1)
Data and##2##2##(1995-2#1)(2008-11#1)
Data are from##3##3##(2013-1#2)(2013-8#1)
Data are presented##5##3##(1993-2#1)(1993-6#1)(1997-8#1)(2008-3#1)(2008-9#1)
Data are##16##2##(1993-2#1)(1993-6#1)(1993-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
Data collected##2##2##(2008-10#1)(2011-2#1)
Data collection for##2##3##(2008-11#2)
Data collection was##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
Data collection##8##2##(1995-2#1)(2008-11#3)(2008-12#2)(2008-7#1)(2009-6#1)
Data for the##2##3##(2010-6#1)(2011-2#1)
Data for##4##2##(2008-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
Data from a large##2##4##(1995-9#1)(2009-7#1)
Data from a##8##3##(1994-3#1)(1995-2#1)(1995-9#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-10#1)
Data from the##13##3##(1990-8#1)(1991-2#1)(1993-1#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-10#1)
Data from this study##2##4##(2008-10#2)
Data from three##2##3##(2008-12#1)(2012-2#1)
Data from##45##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-10#3)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
Data gathered through##2##3##(1992-9#1)(2008-11#1)
Data gathered##3##2##(1992-9#1)(1997-5#1)(2008-11#1)
Data generated by##2##3##(2008-10#1)(2008-3#1)
Data mining##2##2##(2008-9#1)(2012-2#1)
Data obtained by##2##3##(2008-10#2)
Data obtained from##2##3##(2008-11#1)(2012-12#1)
Data obtained##4##2##(2008-10#2)(2008-11#1)(2012-12#1)
Data of##4##2##(1990-3#1)(1991-2#1)(2008-10#1)(2008-7#1)
Data on the##5##3##(1990-8#1)(2008-10#2)(2008-4#1)(2011-2#1)
Data on##19##2##(1990-8#1)(1993-12#2)(1995-12#1)(1996-3#1)(1997-8#2)(2008-10#5)(2008-11#2)(2008-4#1)(2011-1#1)(2011-2#3)
Data protection##2##2##(1996-8#2)
Data reduction##2##2##(2008-10#2)
Data show##2##2##(1991-1#1)(1996-3#1)
Data showed that##2##3##(2008-12#1)(2008-9#1)
Data sources##3##2##(2010-2#1)(2012-2#1)(2013-1#1)
Data suggest that##3##3##(1993-1#1)(2008-10#1)(2008-8#1)
Data suggest##4##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
Data to##2##2##(2008-10#1)(2011-9#1)
Data was##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
Data were analysed using##2##4##(2008-11#1)(2010-11#1)
Data were analysed##5##3##(2008-11#2)(2008-12#1)(2009-6#1)(2010-11#1)
Data were analyzed by##2##4##(2008-5#1)(2010-9#1)
Data were analyzed statistically##2##4##(2013-1#2)
Data were analyzed using a##2##5##(2008-10#1)(2013-1#1)
Data were analyzed using##4##4##(2008-10#1)(2009-7#1)(2010-12#1)(2013-1#1)
Data were analyzed##11##3##(1994-1#1)(1995-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#3)
Data were collected as part of the##2##7##(1996-3#1)(2008-11#1)
Data were collected at##2##4##(2008-12#1)(2013-1#1)
Data were collected between##2##4##(2010-10#1)(2011-2#1)
Data were collected by##2##4##(1992-5#1)(2008-11#1)
Data were collected for##2##4##(2008-11#1)(2011-2#1)
Data were collected from a##2##5##(2010-3#1)(2012-12#1)
Data were collected from##4##4##(2008-12#1)(2010-3#1)(2012-12#1)(2013-8#1)
Data were collected in##2##4##(2008-12#1)(2012-2#1)
Data were collected on##2##4##(1996-3#1)(2012-3#1)
Data were collected through##4##4##(1994-2#1)(2010-10#1)(2012-3#1)(2013-8#1)
Data were collected via##2##4##(1991-8#2)
Data were collected##27##3##(1991-8#2)(1992-5#1)(1993-2#1)(1994-2#1)(1996-3#2)(2008-11#4)(2008-12#3)(2010-10#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
Data were compared with##2##4##(2008-10#1)(2013-1#1)
Data were gathered##3##3##(1995-2#1)(2008-12#1)(2010-9#1)
Data were obtained from##4##4##(2009-5#1)(2012-2#1)(2013-1#2)
Data were obtained##6##3##(2009-5#1)(2012-2#1)(2013-1#4)
Data were##64##2##(1991-8#2)(1992-5#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-3#2)(2008-10#6)(2008-11#6)(2008-12#5)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#10)(2013-8#2)
Data##278##1##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-12#2)(1993-2#4)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#6)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#2)(1996-8#5)(1996-9#2)(1997-3#1)(1997-5#2)(1997-8#4)(2007-12#1)(2008-1#2)(2008-10#48)(2008-11#24)(2008-12#15)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#2)(2009-6#2)(2009-7#3)(2010-10#8)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#14)(2011-3#3)(2011-9#1)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#17)(2013-8#7)
Database##20##1##(1993-12#1)(2008-11#2)(2008-4#3)(2008-9#3)(2009-10#2)(2010-5#1)(2011-2#2)(2013-1#5)(2013-8#1)
Databases##8##1##(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2012-12#2)
Date of##2##2##(1991-2#1)(2008-10#1)
Date##4##1##(1991-2#1)(2008-10#3)
Dates##2##1##(2008-10#2)
Datura stramonium##6##2##(2008-10#4)(2008-7#1)(2013-8#1)
Datura wrightii##2##2##(2009-8#2)
Datura##10##1##(2008-10#5)(2008-7#1)(2009-8#3)(2013-8#1)
Daubenton's bat##2##2##(2011-2#2)
Daucus##3##1##(2008-11#3)
Daudi and##3##2##(1994-3#1)(2008-8#2)
Daudi##5##1##(1994-3#1)(2008-10#2)(2008-8#2)
David##9##1##(1990-11#1)(1990-8#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-10#1)
Davis##3##1##(1994-3#1)(2008-10#1)(2010-5#1)
Day 14##3##2##(2008-10#1)(2008-9#2)
Day 2##2##2##(2008-9#1)(2011-2#1)
Day 3##3##2##(1995-11#1)(2008-10#2)
Day of##2##2##(1994-12#1)(2008-11#1)
Day##36##1##(1990-11#2)(1991-2#1)(1994-1#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-3#2)(1997-1#4)(2008-10#7)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#5)(2010-4#1)(2011-2#2)
Days 6##2##2##(2008-10#2)
Days to##2##2##(2008-10#2)
Days##10##1##(1992-3#1)(1995-3#1)(2008-10#6)(2008-12#1)(2011-2#1)
Daytime##3##1##(1994-6#1)(2008-2#1)(2010-7#1)
Dbf4##2##1##(2012-3#2)
De novo##2##2##(2008-11#1)(2008-4#1)
De##10##1##(1992-1#1)(1993-2#1)(1994-8#1)(2008-11#3)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)
Deactivation##2##1##(1991-12#2)
Dead##3##1##(1990-12#1)(2008-10#1)(2008-5#1)
Deaf and##3##2##(2011-2#3)
Deaf education and the Deaf community##2##6##(2011-2#2)
Deaf individuals##4##2##(2011-2#4)
Deaf##18##1##(2008-11#1)(2011-2#16)(2012-2#1)
Deaffrication##2##1##(2010-1#2)
Deafness##2##1##(2011-2#1)(2013-8#1)
Dealing with##2##2##(1991-8#1)(2008-10#1)
Dearth##2##1##(1992-8#1)(2008-11#1)
Death Syndrome##4##2##(2008-1#2)(2008-10#2)
Death and##2##2##(1993-3#1)(2008-12#1)
Death in##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
Death occurs##2##2##(1993-2#1)(2009-9#1)
Death##28##1##(1990-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Deaths in##2##2##(1990-6#1)(2010-1#1)
Deaths##6##1##(1990-6#1)(1991-3#1)(1997-6#1)(2008-11#1)(2010-1#2)
Debilitating##2##1##(2008-11#1)(2010-8#1)
Debris##2##1##(2008-10#2)
Debye##5##1##(1997-6#5)
Debye-Hückel equation##3##2##(2008-10#3)
Decay of##5##2##(1994-2#1)(2008-10#4)
December 1988##3##2##(1990-12#2)(1990-9#1)
December 1989##5##2##(1990-2#1)(1991-1#1)(1991-6#1)(1992-5#1)(1992-6#1)
December 1990##3##2##(1991-8#1)(1994-1#1)(1995-3#1)
December 1993-January 1994##2##3##(1994-9#2)
December 1995##3##2##(1995-12#1)(2008-11#1)(2008-7#1)
December 1996##3##2##(1997-6#1)(2008-7#1)(2012-12#1)
December 1997##2##2##(2008-5#1)(2011-1#1)
December 2006##4##2##(2011-2#2)(2013-1#1)(2013-7#1)
December 2007##4##2##(2009-4#2)(2010-11#1)(2010-12#1)
December 2008##5##2##(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
December 2010##5##2##(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
December 31##5##2##(2009-6#1)(2010-12#2)(2010-6#1)(2013-7#1)
December 31st 2001##2##3##(2008-1#1)(2011-2#1)
December##87##1##(1990-12#2)(1990-2#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-1#2)(1994-1#1)(1994-12#1)(1994-9#4)(1995-12#2)(1995-3#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-5#1)(2010-6#3)(2011-1#2)(2011-2#7)(2011-7#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)
Deciphering the##2##2##(2009-8#1)(2012-3#1)
Decision##10##1##(1993-2#1)(1995-9#1)(2008-10#3)(2009-10#1)(2010-8#2)(2011-2#1)(2012-3#1)
Decision-Making##4##1##(2008-11#1)(2009-3#1)(2013-1#2)
Decisions##6##1##(1991-1#1)(1991-2#1)(1993-3#1)(1997-3#1)(2008-1#1)(2008-10#1)
Decisive##2##1##(2008-10#1)(2012-3#1)
Decline in##5##2##(1993-6#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-7#1)
Decline##7##1##(1993-6#1)(2008-10#3)(2008-7#1)(2012-12#1)(2013-7#1)
Declining##2##1##(1992-12#1)(2008-11#1)
Decomposition of##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
Decomposition##6##1##(2008-10#3)(2008-11#2)(2009-8#1)
Decompressive##3##1##(1992-12#1)(2011-2#1)(2012-3#1)
Deconvolution##2##1##(1994-5#1)(2008-10#1)
Decrease in##5##2##(1995-8#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-3#1)
Decrease of##4##2##(1995-12#1)(2008-12#3)
Decrease##10##1##(1995-12#1)(1995-8#1)(2008-10#1)(2008-12#5)(2009-7#1)(2012-3#1)
Decreased Sensitivity##2##2##(2008-10#1)(2013-7#1)
Decreased levels of##2##3##(1995-2#1)(2008-1#1)
Decreased##20##1##(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
Decreases in##3##2##(2008-11#1)(2010-7#1)(2013-8#1)
Decreasing the##2##2##(2008-10#1)(2008-11#1)
Decreasing##4##1##(2008-10#2)(2008-11#2)
Dedicated##2##1##(2008-11#1)(2008-3#1)
Dedication##2##1##(2008-11#2)
Deeds##2##1##(2008-10#1)(2008-12#1)
Deep brain stimulation##2##3##(2008-11#1)(2010-12#1)
Deep##10##1##(1992-2#1)(1992-9#1)(2008-11#1)(2008-8#1)(2010-12#2)(2010-7#1)(2012-3#2)(2013-1#1)
Defeated##2##1##(2008-10#2)
Defective Movement##2##2##(2008-10#2)
Defective RNAs##2##2##(2008-10#2)
Defective##9##1##(2008-10#6)(2008-3#1)(2008-6#1)(2011-1#1)
Defects in##4##2##(1994-12#1)(2008-4#1)(2011-2#1)(2013-8#1)
Defects##9##1##(1994-12#1)(1996-9#1)(2008-4#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
Defense Mechanisms Against##2##3##(2008-10#2)
Defense Reactions in##2##3##(2008-10#2)
Defense Responses##3##2##(2008-10#3)
Defense##21##1##(1992-12#1)(1995-6#3)(1996-12#1)(1996-5#3)(2008-10#10)(2008-6#2)(2012-3#1)
Defense-Related##3##1##(2008-10#3)
Defenses by##2##2##(2008-10#2)
Deferiprone in iron overload##3##4##(1995-8#3)
Deferribacteres##2##1##(2011-2#2)
Deficiency##3##1##(1992-9#1)(2008-9#1)(2013-7#1)
Deficit##6##1##(1990-2#1)(2010-8#3)(2012-3#1)(2013-1#1)
Define##3##1##(1994-3#1)(2008-11#1)(2012-3#1)
Defined##3##1##(2008-10#1)(2008-11#1)(2012-3#1)
Defining and evolving the &quot##2##5##(1994-2#2)
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy##2##11##(1995-5#2)
Defining the##4##2##(1994-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Defining##13##1##(1992-2#1)(1994-2#3)(1995-5#2)(1996-2#1)(2008-11#2)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
Definition and##3##2##(1995-5#1)(2008-12#1)(2008-5#1)
Definition of##3##2##(1991-1#1)(1993-11#1)(1996-3#1)
Definition##7##1##(1991-1#1)(1993-11#1)(1993-2#1)(1995-5#1)(1996-3#1)(2008-12#1)(2008-5#1)
Definitions are provided for##2##4##(1995-3#1)(2008-9#1)
Definitions of##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
Definitions##6##1##(1991-11#1)(1992-12#1)(1995-3#1)(2008-11#1)(2008-9#1)(2012-2#1)
Definitive##5##1##(1991-8#1)(2008-9#1)(2011-2#1)(2012-3#2)
Deflux injection##2##2##(2008-10#2)
Deflux##4##1##(2008-10#4)
Deformation##4##1##(2008-10#3)(2009-7#1)
Deformed##2##1##(1995-9#1)(2008-3#1)
Degenerate primers##2##2##(2008-10#2)
Degenerate##6##1##(2008-10#5)(2008-3#1)
Degeneration of the##3##3##(2008-9#1)(2012-12#1)(2012-2#1)
Degeneration of##4##2##(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
Degeneration##7##1##(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
Degenerative##2##1##(1997-6#1)(2012-3#1)
Degradation by##2##2##(2008-10#1)(2013-8#1)
Degradation of the##4##3##(1990-2#1)(1991-6#1)(2008-10#1)(2008-9#1)
Degradation of##12##2##(1990-2#1)(1991-6#1)(1994-8#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2010-4#1)
Degradation processes of##2##3##(2008-10#2)
Degradation##20##1##(1990-2#1)(1991-6#1)(1994-8#1)(1995-8#2)(2008-10#6)(2008-11#3)(2008-7#2)(2008-9#1)(2009-7#1)(2010-4#1)(2013-8#1)
Degree of##4##2##(1991-9#1)(1996-8#1)(2008-11#2)
Degree##6##1##(1991-9#1)(1996-8#1)(2008-11#3)(2008-12#1)
Dehalococcoides spp##2##2##(2011-1#2)
Dehydroabietic acid##2##2##(1997-2#1)(2008-11#1)
Dehydrogenase##2##1##(2010-12#1)(2011-2#1)
Deir Alla 105##2##3##(2008-10#2)
Del##9##1##(2008-10#6)(2008-3#2)(2010-1#1)
DelPhi##2##1##(2008-4#2)
Delaware court decision##2##3##(2008-11#2)
Delaware##6##1##(1994-12#1)(2008-11#2)(2010-8#1)(2013-1#2)
Delay##5##1##(1993-1#1)(1997-2#1)(2013-1#2)(2013-8#1)
Delayed diagnosis of##2##3##(2008-12#1)(2009-11#1)
Delayed presentation##3##2##(2008-7#1)(2009-3#1)(2011-2#1)
Delayed##23##1##(1990-11#1)(2008-10#4)(2008-12#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
Delayed-type hypersensitivity (DTH)##2##3##(2008-10#2)
Deletion of the##3##3##(1993-12#1)(1997-3#1)(2008-7#1)
Deletion of##8##2##(1993-12#1)(1993-8#1)(1996-6#1)(1997-3#2)(2008-7#1)(2009-6#1)(2012-2#1)
Deletion##13##1##(1991-6#1)(1993-12#1)(1993-8#1)(1995-8#1)(1996-6#1)(1997-3#4)(1997-8#1)(2008-7#1)(2009-6#1)(2012-2#1)
Delhi##17##1##(1994-8#1)(1994-9#6)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2009-10#1)(2009-9#1)
Delicious apple##2##2##(2008-10#2)
Delicious##5##1##(2008-10#5)
Delineation of##2##2##(1995-2#1)(2008-10#1)
Delirium##4##1##(2011-2#2)(2013-1#2)
Delivering##2##1##(2008-11#1)(2008-12#1)
Delivery of##3##2##(1992-3#1)(2008-3#1)(2013-1#1)
Delivery##8##1##(1992-3#1)(1993-1#1)(1994-5#1)(1996-3#1)(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
Delphi##3##1##(1996-3#1)(2010-8#1)(2010-9#1)
Delta and##5##2##(2008-10#3)(2013-1#2)
Delta##22##1##(1991-10#1)(1993-1#1)(2008-10#15)(2008-11#2)(2011-2#1)(2013-1#2)
Delta(7)-PGA(1) methyl ester##3##3##(2008-11#3)
Delta(R##2##1##(2008-10#2)
Delta5 steroid abnormality in##2##4##(2008-4#2)
Delta5 steroid abnormality##3##3##(2008-4#3)
DeltaFerrin(TM)##5##1##(2008-11#5)
DeltaG(0) and TDeltaS(0)##3##3##(2008-10#3)
DeltaG(0)##5##1##(2008-10#5)
DeltaH degrees and DeltaS degrees ) for##2##7##(2008-10#2)
DeltaH degrees##3##2##(2008-10#3)
DeltaH(0)##2##1##(2008-10#2)
DeltaH(cal)##2##1##(1997-2#2)
DeltaH(f)##3##1##(2008-11#3)
DeltaH(vH)##3##1##(1997-2#3)
DeltaL(1)##2##1##(2008-10#2)
DeltaR(1)##2##1##(2008-10#2)
DeltaRI##2##1##(2008-10#2)
DeltaS##3##1##(2008-10#3)
Deltaf##2##1##(2008-3#2)
Deltaf(0)##2##1##(2008-10#2)
Deltah##2##1##(2008-10#2)
Deltalambda parameter##3##2##(2008-10#3)
Deltalambda##6##1##(2008-10#6)
Demand##2##1##(2008-11#1)(2008-12#1)
Demented patients##2##2##(2008-7#2)
Dementia and##3##2##(1991-1#1)(2008-12#1)(2008-7#1)
Dementia was##2##2##(2008-7#2)
Dementia##8##1##(1991-1#1)(1993-2#1)(2008-12#1)(2008-7#4)(2012-3#1)
Demethylation Inhibitor Fungicides##2##3##(2008-10#2)
Demethylation##3##1##(2008-10#3)
Deming##3##1##(1993-12#1)(1996-1#1)(2013-1#1)
Deming's theory of##2##3##(1996-1#2)
Democratic Republic##3##2##(1995-1#1)(2008-10#1)(2013-8#1)
Democratic##5##1##(1995-1#1)(2008-10#2)(2012-2#1)(2013-8#1)
Demographic and##2##2##(2010-6#1)(2012-3#1)
Demographic data##3##2##(2008-7#1)(2009-5#1)(2013-1#1)
Demographic factors such as##2##4##(1994-3#1)(2011-1#1)
Demographic##17##1##(1994-3#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
Demographics of##2##2##(1996-3#1)(2009-8#1)
Demographics##5##1##(1995-12#1)(1996-2#1)(1996-3#1)(2008-12#1)(2009-8#1)
Demonstrate##2##1##(2008-3#1)(2013-1#1)
Demonstration of a##2##3##(2008-3#1)(2012-12#1)
Demonstration of an##2##3##(2008-3#2)
Demonstration of##11##2##(1992-3#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-7#1)(2012-12#1)
Demonstration##12##1##(1992-2#1)(1992-3#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-7#1)(2012-12#1)
Dendritic Cells from##2##3##(2008-11#2)
Dendritic Cells##4##2##(2008-10#1)(2008-11#2)(2012-3#1)
Dendritic cells (DCs)##2##3##(2008-11#1)(2012-2#1)
Dendritic cells are##2##3##(2008-11#1)(2008-9#1)
Dendritic cells##4##2##(2008-11#2)(2008-9#1)(2012-2#1)
Dendritic##13##1##(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
Dendronized##2##1##(2008-10#2)
Dendryphion penicillatum and Pleospora papaveracea##3##5##(2008-10#3)
Dendryphion penicillatum##4##2##(2008-10#4)
Deng-Fan##2##1##(2010-7#2)
Dengue##2##1##(2011-2#1)(2013-1#1)
Dengue-III virus D9964 strain##2##4##(2013-8#2)
Denitrovibrio acetiphilus##2##2##(2011-2#2)
Denitrovibrio##3##1##(2011-2#3)
Denmark##11##1##(1990-11#3)(1990-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1997-3#2)(2011-4#1)(2013-1#1)
Densitometric analysis of##2##3##(2008-10#2)
Density of##6##2##(1991-9#1)(1995-6#1)(1996-9#1)(2008-10#3)
Density##12##1##(1991-9#1)(1993-8#1)(1995-6#1)(1996-9#2)(2008-10#5)(2008-11#1)(2010-7#1)
Dental Association##2##2##(1995-6#1)(2008-1#1)
Dental College##3##2##(2013-1#3)
Dental caries##2##2##(2011-2#1)(2012-2#1)
Dental considerations for##2##3##(2008-1#1)(2008-10#1)
Dental implants##2##2##(2009-7#1)(2011-2#1)
Dental##33##1##(1990-9#1)(1993-1#2)(1995-12#1)(1995-6#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-5#2)(2009-7#1)(2011-2#5)(2012-2#1)(2013-1#12)
Dentigerous cysts##2##2##(2013-1#2)
Dentigerous##3##1##(2013-1#3)
Dentin hypersensitivity##2##2##(2011-2#2)
Dentistry##6##1##(2008-7#1)(2011-2#2)(2013-1#3)
Dentsply##2##1##(2013-1#2)
Denver##3##1##(1995-12#3)
Deoxygenation at C-4##2##3##(1996-5#2)
Department from##2##2##(2007-11#1)(2011-2#1)
Department of Agriculture##4##3##(1996-3#1)(2008-10#2)(2012-2#1)
Department of Agriculture-Agricultural Research Service##2##5##(2008-10#2)
Department of Energy (DOE)##3##4##(2008-10#2)(2008-5#1)
Department of Energy##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
Department of Health and Human Services (DHHS)##2##7##(1993-12#1)(1996-5#1)
Department of Health and Human Services##6##6##(1993-12#2)(1996-2#1)(1996-5#1)(2008-7#1)(2012-2#1)
Department of Health and Human##7##5##(1993-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
Department of Health and##8##4##(1993-12#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
Department of Health##32##3##(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#2)(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-3#4)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#7)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
Department of Health's##3##3##(2008-11#1)(2012-12#2)
Department of Justice##2##3##(1995-12#1)(1995-6#1)
Department of Neurosurgery##2##3##(1995-11#1)(2013-8#1)
Department of Oral##2##3##(2008-8#1)(2013-1#1)
Department of Surgery##2##3##(1991-9#1)(1995-12#1)
Department of Veterans Affairs (VA)##3##5##(1993-12#1)(2009-11#1)(2013-1#1)
Department of Veterans Affairs Medical Center##2##6##(1992-2#1)(1995-2#1)
Department of Veterans Affairs##6##4##(1992-2#1)(1993-12#1)(1995-2#1)(2009-11#1)(2011-2#1)(2013-1#1)
Department of the University of##2##5##(1990-9#1)(1997-6#1)
Department of the University##3##4##(1990-9#1)(1996-11#1)(1997-6#1)
Department of the##5##3##(1990-9#1)(1992-12#1)(1996-11#1)(1997-6#1)(2007-8#1)
Department of##115##2##(1990-2#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#3)(1993-3#1)(1994-12#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#5)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-8#2)(2008-10#12)(2008-11#10)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-6#2)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#6)
Department##146##1##(1990-2#1)(1990-9#2)(1991-12#4)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#3)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#5)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-11#2)(2007-8#2)(2008-10#15)(2008-11#11)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-6#2)(2011-2#9)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#11)
Departmental##3##1##(1993-1#2)(2008-12#1)
Departments of##4##2##(1991-9#1)(1994-12#1)(1996-1#1)(1997-8#1)
Departments##6##1##(1991-9#2)(1994-12#2)(1996-1#1)(1997-8#1)
Dependence in##2##2##(2008-7#1)(2013-8#1)
Dependence of##7##2##(1993-5#1)(1996-9#1)(2008-10#1)(2008-3#2)(2009-6#1)(2011-2#1)
Dependence##13##1##(1991-1#2)(1993-5#1)(1996-9#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
Dependent##7##1##(1992-2#1)(1992-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2010-7#1)(2010-9#1)
Depending on the solvent polarity##2##5##(2008-10#2)
Depending on the##22##3##(1994-5#2)(1995-5#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-5#3)(2008-8#1)(2010-9#1)(2013-1#1)
Depending on their##2##3##(2008-10#1)(2009-12#1)
Depending on##28##2##(1994-5#2)(1995-5#1)(1997-1#1)(2008-10#12)(2008-11#1)(2008-5#3)(2008-8#4)(2009-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
Depending##29##1##(1994-5#2)(1995-5#1)(1997-1#1)(2008-10#12)(2008-11#1)(2008-5#3)(2008-8#4)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
Depletion of##5##2##(1991-5#1)(1994-6#1)(1995-12#1)(2011-2#1)(2013-1#1)
Deployment of##2##2##(2008-10#2)
Deployment##3##1##(1994-12#1)(2008-10#2)
Deposition in the##3##3##(1996-3#1)(2008-11#2)
Deposition of##4##2##(1992-3#1)(2008-10#2)(2011-2#1)
Deposition probabilities are##2##3##(1994-12#2)
Deposition##11##1##(1992-3#1)(1994-12#2)(1996-3#1)(2008-10#3)(2008-11#3)(2011-2#1)
Depression Scale##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
Depression in##3##2##(2008-4#1)(2008-7#1)(2010-12#1)
Depression is##2##2##(2013-1#1)(2013-8#1)
Depression##27##1##(1991-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#3)(2009-12#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#3)
Depressive illnesses are##2##3##(2010-12#2)
Depressive symptoms were##2##3##(1992-2#1)(2009-11#1)
Depressive##9##1##(1992-2#1)(2008-10#1)(2008-6#1)(2009-11#1)(2010-10#1)(2010-12#2)(2010-5#1)(2012-3#1)
Deprivation of##2##2##(1990-12#1)(1991-5#1)
Deprivation##3##1##(1990-12#1)(1991-5#1)(1991-8#1)
Deprotonation##2##1##(1990-5#1)(1994-5#1)
Dept##2##1##(1992-8#1)(2012-2#1)
Depth of##2##2##(2009-12#1)(2013-8#1)
Depth profiles##2##2##(1992-8#1)(2008-10#1)
Depth##7##1##(1992-8#1)(2008-10#3)(2008-3#1)(2009-12#1)(2013-8#1)
Derivation of##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
Derivation##4##1##(2008-10#1)(2008-11#1)(2008-9#2)
Derivative spectrophotometric determination of##3##4##(2008-10#3)
Derivative spectrophotometric##4##2##(2008-10#4)
Derivative spectrophotometry##2##2##(2008-10#2)
Derivative##11##1##(2008-10#9)(2009-8#1)(2010-1#1)
Derivatives are##2##2##(2008-10#2)
Derivatives of##3##2##(2008-10#2)(2012-2#1)
Derivatives##8##1##(1996-5#2)(2008-10#5)(2012-2#1)
Derivatization##3##1##(2008-10#2)(2008-5#1)
Derived from##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
Derived##8##1##(2008-10#2)(2008-11#3)(2011-2#1)(2012-2#1)(2013-1#1)
Dermal##2##1##(2008-5#2)
Dermatology##4##1##(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
Dermoid##2##1##(2011-2#2)
Desacetyl-alpha-MSH##2##1##(2008-6#2)
Described in this unit are##3##5##(2008-9#1)(2010-7#1)(2012-3#1)
Described in this##4##3##(1996-1#1)(2008-9#1)(2010-7#1)(2012-3#1)
Described##12##1##(1996-1#1)(1997-3#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-7#1)(2012-3#1)
Describing##3##1##(2008-10#1)(2012-12#2)
Description and##2##2##(2008-3#1)(2011-2#1)
Description of a##2##3##(1990-9#1)(1993-6#1)
Description of##7##2##(1990-2#1)(1990-9#1)(1993-6#1)(1997-9#1)(2007-11#1)(2008-9#1)(2011-2#1)
Description##12##1##(1990-2#1)(1990-9#1)(1993-6#1)(1997-9#1)(2007-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-2#1)
Descriptions of##2##2##(2008-10#2)
Descriptions##5##1##(1995-11#1)(2008-10#2)(2008-12#1)(2008-9#1)
Descriptive analyses##2##2##(1992-3#1)(2008-11#1)
Descriptive data##2##2##(1992-3#1)(2010-7#1)
Descriptive epidemiology of##2##3##(1992-12#1)(2013-8#1)
Descriptive statistics were##3##3##(2008-11#2)(2013-1#1)
Descriptive statistics##4##2##(2008-11#2)(2010-7#1)(2013-1#1)
Descriptive##19##1##(1992-12#1)(1992-3#2)(1995-1#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#3)(2010-7#2)(2011-2#1)(2013-1#1)(2013-8#3)
Desensitization##2##1##(1997-1#1)(2008-8#1)
Desert##6##1##(1991-3#1)(2008-10#4)(2009-8#1)
Desiccations##2##1##(1992-12#2)
Design and development of a##2##5##(2008-10#2)
Design and optimization of a##2##5##(2008-3#1)(2012-2#1)
Design and optimization of##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
Design and##18##2##(1994-3#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-3#2)(2010-10#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
Design of a##7##3##(1994-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-8#1)
Design of##15##2##(1994-12#1)(1994-3#1)(1995-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2010-8#1)
Design##68##1##(1991-12#2)(1994-12#1)(1994-3#2)(1995-3#2)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-10#8)(2010-2#1)(2010-8#3)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#12)
Designed##4##1##(1997-3#1)(2008-10#2)(2008-3#1)
Designing and##2##2##(1995-2#1)(2009-12#1)
Designing##11##1##(1992-3#1)(1994-1#1)(1994-5#1)(1995-2#2)(1995-5#1)(2008-11#1)(2008-12#1)(2009-12#2)(2010-8#1)
Desorption of##3##2##(2008-10#3)
Desorption##5##1##(2008-10#4)(2010-4#1)
Despite a##13##2##(1992-3#1)(1995-10#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-10#1)(2011-2#2)
Despite advances in##4##3##(2008-11#1)(2009-10#1)(2010-6#1)(2011-7#1)
Despite an##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
Despite being the##2##3##(2008-10#1)(2013-1#1)
Despite being##3##2##(1997-7#1)(2008-10#1)(2013-1#1)
Despite extensive##3##2##(1997-1#1)(2008-7#1)(2012-3#1)
Despite increased awareness of##2##4##(1997-1#1)(2009-5#1)
Despite increased##3##2##(1997-1#2)(2009-5#1)
Despite its##8##2##(2007-12#1)(2008-7#2)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
Despite low levels of##2##4##(2010-8#1)(2013-1#1)
Despite of##3##2##(2008-8#1)(2011-3#1)(2013-1#1)
Despite ongoing##2##2##(2011-2#2)
Despite recent progress in##2##4##(1991-2#1)(2009-7#1)
Despite recent##3##2##(1991-2#1)(2008-10#1)(2009-7#1)
Despite similar##2##2##(2009-3#1)(2013-1#1)
Despite some##4##2##(2008-8#1)(2010-1#1)(2010-10#1)(2013-1#1)
Despite the fact that##8##4##(1994-2#1)(1996-2#1)(2008-10#3)(2008-9#1)(2011-2#1)(2013-1#1)
Despite the high##3##3##(1992-2#1)(2008-10#1)(2013-1#1)
Despite the increased##2##3##(1995-1#1)(2012-5#1)
Despite the lack of##2##4##(2008-10#1)(2013-8#1)
Despite the large##2##3##(2008-11#1)(2008-12#1)
Despite the presence of##3##4##(1995-6#1)(1997-8#1)(2008-10#1)
Despite the recent##2##3##(2008-10#1)(2008-7#1)
Despite the widespread##2##3##(2008-11#1)(2012-12#1)
Despite the##73##2##(1992-2#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#8)(2013-8#2)
Despite their##5##2##(1992-3#1)(1997-7#1)(2008-10#2)(2012-2#1)
Despite these##8##2##(1994-5#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#2)
Despite this##17##2##(1993-2#1)(1993-6#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#1)(2013-1#1)(2013-8#2)
Despite##216##1##(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#29)(2008-11#13)(2008-12#5)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#4)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#16)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#18)(2013-8#9)
Desquamative##2##1##(2008-5#1)(2011-2#1)
Destruction of##3##2##(1997-1#1)(2008-11#2)
Destructive##2##1##(1992-11#1)(2008-10#1)
Desulfovibrio vulgaris##3##2##(1991-12#2)(1994-5#1)
Desulfovibrio##6##1##(1991-12#2)(1994-5#4)
Detachable##3##1##(1995-11#1)(1996-9#1)(1997-3#1)
Detached##4##1##(2008-10#4)
Detail on##2##2##(1994-3#2)
Detailed analyses of##2##3##(2008-6#1)(2010-7#1)
Detailed analyses##3##2##(1997-8#1)(2008-6#1)(2010-7#1)
Detailed analysis##2##2##(1994-5#1)(2008-11#1)
Detailed descriptions##2##2##(1996-3#1)(2008-4#1)
Detailed information##2##2##(2008-10#1)(2012-3#1)
Detailed##23##1##(1994-11#1)(1994-5#1)(1995-9#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-6#2)(2008-9#2)(2009-5#1)(2010-5#1)(2010-7#1)(2012-3#2)(2013-1#1)
Details of##4##2##(1994-12#1)(2008-10#2)(2008-9#1)
Details##7##1##(1994-12#1)(2008-10#4)(2008-4#1)(2008-9#1)
Detect##3##1##(2008-10#3)
Detected##2##1##(2008-6#1)(2011-2#1)
Detecting and##2##2##(2008-10#1)(2012-3#1)
Detecting patients with acute coronary syndrome in the chest pain center of the emergency department with cardiac magnetic resonance##2##19##(2008-3#2)
Detecting##16##1##(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Detection and Quantification##2##3##(2008-10#2)
Detection and analysis of proteins modified by O-linked N-acetylglucosamine##2##9##(2008-2#1)(2008-4#1)
Detection and analysis of##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
Detection and cloning of LINE-1 elements in CHO cells##2##9##(2008-11#2)
Detection and determination##2##3##(2008-10#2)
Detection and identification of##2##4##(2008-10#2)
Detection and quantification of##2##4##(2008-11#1)(2008-5#1)
Detection and##24##2##(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
Detection limit is##3##3##(2008-10#3)
Detection limit of##4##3##(2008-10#4)
Detection limit##13##2##(2008-10#13)
Detection limits (DLs)##2##3##(2008-10#2)
Detection limits achieved##2##3##(2008-10#2)
Detection limits as low as##2##5##(2008-10#2)
Detection limits for##7##3##(2008-10#7)
Detection limits in the##2##4##(2008-10#2)
Detection limits of the##2##4##(2008-10#2)
Detection limits of##10##3##(2008-10#10)
Detection limits using##2##3##(2008-10#2)
Detection limits were calculated##2##4##(2008-10#2)
Detection limits were determined##2##4##(2008-10#2)
Detection limits were estimated as##2##5##(2008-10#2)
Detection limits were##8##3##(2008-10#8)
Detection limits##48##2##(2008-10#48)
Detection of Fusarium oxysporum f##2##5##(2008-10#2)
Detection of Grapevine##2##3##(2008-10#2)
Detection of Phytophthora ramorum##4##4##(2008-10#4)
Detection of Phytophthora##6##3##(2008-10#6)
Detection of a##3##3##(2008-3#1)(2008-9#1)(2011-6#1)
Detection of borreliacidal antibodies##2##4##(2008-9#2)
Detection of phenolic compounds##2##4##(2008-10#2)
Detection of the##6##3##(1997-7#1)(2008-10#4)(2013-1#1)
Detection of##113##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-7#1)(1992-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(1997-9#1)(2008-10#72)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#4)(2008-5#2)(2008-9#7)(2009-6#1)(2010-12#2)(2011-2#1)(2011-6#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
Detection was carried out using an##2##6##(2008-10#2)
Detection was carried out using##3##5##(2008-10#3)
Detection was carried out##5##4##(2008-10#5)
Detection was##7##2##(2008-10#7)
Detection##219##1##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-11#1)(1995-12#1)(1996-12#1)(1997-1#2)(1997-7#1)(1997-9#1)(2008-10#153)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#3)(2008-9#9)(2009-6#1)(2010-12#2)(2011-2#3)(2011-6#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
Detector##2##1##(2008-10#1)(2010-3#1)
Detergents##2##1##(1994-8#1)(2010-6#1)
Determinant##2##1##(1995-5#1)(2008-10#1)
Determinants of##8##2##(1992-2#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
Determinants##9##1##(1992-2#1)(1994-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
Determination and##2##2##(2008-10#2)
Determination in##2##2##(2008-10#2)
Determination is based on the##2##5##(2008-10#2)
Determination of Aflatoxin M1 Contamination and Integrity as well as Credibility##2##11##(2013-1#2)
Determination of Cd and##2##4##(2008-10#2)
Determination of Cd##3##3##(2008-10#3)
Determination of Mo##2##3##(2008-10#2)
Determination of ammonia##3##3##(2008-10#3)
Determination of arsenate##2##3##(2008-10#2)
Determination of arsenic compounds in##2##5##(2008-10#2)
Determination of arsenic in##3##4##(2008-10#3)
Determination of arsenic##8##3##(2008-10#8)
Determination of atrazine##2##3##(2008-10#2)
Determination of cadmium and lead in##3##6##(2008-10#3)
Determination of cadmium in urine##2##5##(2008-10#2)
Determination of cadmium in##6##4##(2008-10#6)
Determination of cadmium##13##3##(2008-10#13)
Determination of calcium##2##3##(2008-10#2)
Determination of chemical warfare agents##2##5##(2008-11#2)
Determination of chemical##3##3##(2008-10#1)(2008-11#2)
Determination of chloride##2##3##(2008-10#2)
Determination of chromium in##2##4##(2008-10#2)
Determination of chromium##4##3##(2008-10#4)
Determination of clenbuterol##2##3##(2008-10#2)
Determination of copper##2##3##(2008-10#2)
Determination of diclofenac in pharmaceutical preparations##2##6##(2008-10#2)
Determination of ethanol in##2##4##(2008-10#2)
Determination of formaldehyde in##2##4##(2008-10#2)
Determination of inorganic##5##3##(2008-10#5)
Determination of iron(III)##2##3##(2008-10#2)
Determination of lead and##3##4##(2008-10#3)
Determination of lead in##5##4##(2008-10#5)
Determination of lead##10##3##(2008-10#10)
Determination of low##2##3##(2008-10#2)
Determination of manganese in##2##4##(2008-10#2)
Determination of manganese##3##3##(2008-10#3)
Determination of mercury##2##3##(2008-10#2)
Determination of metal##2##3##(2008-10#2)
Determination of metals in##2##4##(2008-10#2)
Determination of metals##4##3##(2008-10#4)
Determination of methanol##2##3##(2008-10#2)
Determination of mono- and##2##4##(2008-10#2)
Determination of nickel##3##3##(2008-10#3)
Determination of nitrite##2##3##(2008-10#2)
Determination of paracetamol in##2##4##(2008-10#2)
Determination of phosphate in##2##4##(2008-10#2)
Determination of platinum and##2##4##(2008-10#2)
Determination of polybrominated diphenyl ethers in soil##2##7##(2008-10#2)
Determination of polybrominated##3##3##(2008-10#3)
Determination of polycyclic aromatic hydrocarbons##2##5##(2008-10#1)(2008-11#1)
Determination of proteins##2##3##(2008-10#2)
Determination of rare earth elements in##2##6##(2008-10#2)
Determination of rare earth##3##4##(2008-10#3)
Determination of residual##2##3##(2008-10#2)
Determination of rhodium##3##3##(2008-10#3)
Determination of selenium in##2##4##(2008-10#2)
Determination of selenium species in##2##5##(2008-10#2)
Determination of selenium##4##3##(2008-10#4)
Determination of some##2##3##(2008-10#2)
Determination of stability constants for##2##5##(2008-10#2)
Determination of stability constants of##2##5##(2008-10#2)
Determination of stability constants##4##4##(2008-10#4)
Determination of sulphur##2##3##(2008-10#2)
Determination of the antioxidant##2##4##(2008-10#2)
Determination of the total##3##4##(2008-10#3)
Determination of the##26##3##(1990-5#1)(1991-5#1)(1993-1#1)(1995-3#1)(2008-10#19)(2008-3#1)(2008-4#1)(2012-12#1)
Determination of tin##2##3##(2008-10#2)
Determination of total chromium##2##4##(2008-10#2)
Determination of total mercury in##2##5##(2008-10#2)
Determination of total##17##3##(2008-10#16)(2012-2#1)
Determination of trace amounts of##4##5##(2008-10#4)
Determination of trace metal ions##2##5##(2008-10#2)
Determination of trace metals##2##4##(2008-10#1)(2012-2#1)
Determination of trace##23##3##(2008-10#22)(2012-2#1)
Determination of traces of Ni##2##5##(2008-10#2)
Determination of traces of##3##4##(2008-10#3)
Determination of traces##4##3##(2008-10#4)
Determination of urinary##3##3##(2008-10#3)
Determination of volatile##2##3##(2008-10#2)
Determination of zinc in##2##4##(2008-10#2)
Determination of zinc##3##3##(2008-10#3)
Determination of##446##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1995-3#1)(1997-2#1)(2008-10#406)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#5)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Determination##457##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1995-3#1)(1996-9#1)(1997-2#1)(2008-10#415)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#5)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Determinations in##2##2##(2008-10#1)(2010-11#1)
Determinations of##4##2##(2008-10#4)
Determinations were made##2##3##(2008-10#2)
Determinations were##3##2##(2008-10#3)
Determinations##10##1##(2008-10#9)(2010-11#1)
Determine##3##1##(2008-10#1)(2008-11#1)(2010-2#1)
Determined by##3##2##(1990-11#1)(2008-10#2)
Determined##4##1##(1990-11#1)(2008-10#2)(2008-8#1)
Determining the##7##2##(1996-5#1)(2008-10#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-12#1)
Determining##17##1##(1996-5#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
Deterministic##2##1##(2008-11#1)(2008-8#1)
Dethiosulfovibrio peptidovorans##2##2##(2011-2#2)
Dethiosulfovibrio##3##1##(2011-2#3)
Detroit##3##1##(1991-1#1)(1993-12#1)(2008-5#1)
Deukhury##2##1##(2012-3#2)
Develop##5##1##(1997-2#1)(2008-10#3)(2008-11#1)
Developed##4##1##(1991-1#1)(1996-1#1)(2008-10#1)(2012-2#1)
Developing a##9##2##(1991-1#2)(1991-2#1)(1992-12#1)(1992-2#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-12#1)
Developing an##4##2##(1995-12#1)(2008-10#1)(2008-9#1)(2009-2#1)
Developing and##3##2##(1991-12#1)(1994-3#1)(2008-11#1)
Developing clinical##2##2##(2008-12#1)(2008-8#1)
Developing nursing practice##2##3##(2008-11#2)
Developing the##3##2##(2008-11#2)(2008-6#1)
Developing##39##1##(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#9)(2008-12#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2013-1#1)(2013-8#1)
Development Group in##2##3##(2008-11#2)
Development Report##2##2##(1997-6#2)
Development and Evaluation##2##3##(2008-10#1)(2012-12#1)
Development and evaluation of a##2##5##(1995-12#1)(2008-11#1)
Development and evaluation of##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
Development and implementation of##2##4##(2008-10#1)(2013-1#1)
Development and validation of a##3##5##(1992-9#1)(2008-10#1)(2009-12#1)
Development and validation of an##3##5##(1990-2#1)(1996-12#1)(2008-10#1)
Development and validation of##9##4##(1990-2#1)(1992-9#1)(1996-12#1)(2008-10#3)(2009-12#1)(2010-3#1)(2011-2#1)
Development and##27##2##(1990-2#1)(1991-12#1)(1992-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#11)(2008-11#2)(2008-8#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#3)
Development in##7##2##(2008-10#5)(2008-11#1)(2009-5#1)
Development of Root##2##3##(2008-10#2)
Development of a new##2##4##(2008-10#1)(2009-7#1)
Development of a novel##2##4##(2008-10#2)
Development of a sensitive fluorescent derivatization reagent 1##2##8##(2008-10#2)
Development of a##56##3##(1990-12#1)(1993-1#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#34)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#2)
Development of an##10##3##(2008-10#7)(2008-5#1)(2010-4#1)(2012-2#1)
Development of the##11##3##(1992-3#1)(1995-5#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-5#1)
Development of##155##2##(1990-12#1)(1992-3#4)(1993-1#1)(1993-12#1)(1994-12#1)(1994-5#2)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#84)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-7#3)(2009-8#1)(2010-4#2)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#3)
Development on##3##2##(2008-10#2)(2009-5#1)
Development##231##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-3#4)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-5#2)(1994-9#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#107)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#3)(2009-5#2)(2009-7#3)(2009-8#1)(2010-10#2)(2010-3#1)(2010-4#2)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)
Developmental and Reproductive##2##3##(2010-1#1)(2011-2#1)
Developmental and##3##2##(2008-8#1)(2010-1#1)(2011-2#1)
Developmental changes in##3##3##(1996-2#1)(2008-11#1)(2009-7#1)
Developmental##29##1##(1993-6#1)(1995-6#2)(1995-8#2)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Developmentally##2##1##(2010-7#2)
Developments in##6##2##(1997-2#1)(2008-11#2)(2009-3#1)(2010-12#1)(2011-7#1)
Developments##8##1##(1997-2#1)(1997-6#1)(2008-11#3)(2009-3#1)(2010-12#1)(2011-7#1)
Deviations from##2##2##(2008-10#1)(2010-4#1)
Deviations##3##1##(2008-10#2)(2010-4#1)
Device##10##1##(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-1#1)(2010-6#1)(2012-3#1)(2013-1#2)
Devices##9##1##(1991-2#1)(1993-3#1)(1995-3#1)(2008-3#2)(2008-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
Dew##2##1##(2008-10#2)
Dex##4##1##(2008-11#4)
Dexamethasone##9##1##(1990-3#1)(1994-3#1)(1995-8#1)(2008-11#3)(2011-2#1)(2012-2#2)
Dexamethasone-dependent modulation of##2##3##(1994-3#2)
Dexrazoxane##2##1##(2008-11#2)
Dextran##2##1##(1991-9#1)(2008-7#1)
Dextromethorphan##2##1##(1996-2#2)
Dextrose##2##1##(2009-11#1)(2013-1#1)
Di##2##1##(2008-11#2)
DiSTRIBuTE##4##1##(2011-9#4)
DiYMV##4##1##(2008-10#4)
Diabesity##2##1##(2013-8#2)
Diabetes Research##3##2##(1990-11#2)(2013-1#1)
Diabetes and##5##2##(2008-1#2)(2010-10#1)(2013-1#1)(2013-8#1)
Diabetes in##2##2##(1995-11#1)(2008-10#1)
Diabetes is##3##2##(2008-1#2)(2008-11#1)
Diabetes mellitus (DM)##4##3##(2011-3#2)(2012-2#1)(2013-8#1)
Diabetes mellitus is##4##3##(1992-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
Diabetes mellitus##13##2##(1992-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
Diabetes##38##1##(1990-11#2)(1992-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-8#1)(2008-1#7)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
Diabetic Retinopathy##2##2##(1995-9#1)(2010-10#1)
Diabetic foot ulcer##2##3##(2010-10#1)(2013-1#1)
Diabetic retinopathy##2##2##(2008-1#1)(2010-10#1)
Diabetic##18##1##(1994-12#2)(1995-9#1)(2008-1#2)(2008-8#1)(2010-10#4)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
Diacetyl production##2##2##(2008-6#2)
Diaeretiella rapae##2##2##(2009-8#2)
Diagnoses##6##1##(1991-8#2)(2008-10#1)(2008-11#3)
Diagnosing and managing polymyalgia rheumatica and temporal arteritis##5##8##(1997-8#5)
Diagnosing##12##1##(1992-2#1)(1992-3#1)(1992-5#1)(1995-12#1)(1997-8#5)(2011-2#1)(2012-2#1)(2013-8#1)
Diagnosis and therapy of##2##4##(1996-11#1)(2008-10#1)
Diagnosis and therapy##3##3##(1996-11#2)(2008-10#1)
Diagnosis and treatment##2##3##(1996-6#1)(2008-12#1)
Diagnosis and##13##2##(1991-2#1)(1991-6#2)(1993-3#1)(1996-11#2)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-12#1)(2013-1#1)
Diagnosis in##3##2##(1995-11#1)(1997-2#1)(2008-10#1)
Diagnosis is##8##2##(1991-11#1)(1996-3#1)(2008-10#1)(2009-1#1)(2009-8#1)(2012-2#3)
Diagnosis may be##2##3##(1992-2#1)(2012-3#1)
Diagnosis of a##2##3##(2012-2#1)(2013-1#1)
Diagnosis of##34##2##(1995-10#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-8#4)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#6)
Diagnosis was established##2##3##(2008-7#1)(2011-2#1)
Diagnosis was histological##2##3##(1991-11#1)(2007-8#1)
Diagnosis was##5##2##(1991-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
Diagnosis##80##1##(1991-11#2)(1991-2#1)(1991-6#2)(1992-2#1)(1993-12#1)(1993-3#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#4)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-1#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#10)
Diagnostic Test##2##2##(2008-10#2)
Diagnostic and Statistical Manual of Mental Disorders##7##7##(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#3)(2013-1#1)
Diagnostic and##9##2##(1991-2#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#3)(2013-1#1)
Diagnostic criteria for##2##3##(1997-8#1)(2012-12#1)
Diagnostic criteria##5##2##(1992-11#1)(1997-8#2)(2012-12#1)(2012-3#1)
Diagnostic delay in##2##3##(1990-12#2)
Diagnostic delay##3##2##(1990-12#3)
Diagnostic procedures##2##2##(1990-9#1)(1993-6#1)
Diagnostic##59##1##(1990-12#3)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-6#2)(1997-1#1)(1997-4#1)(1997-8#4)(2008-10#9)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-3#3)(2013-1#5)
Diagnostics##5##1##(1994-12#1)(1996-5#2)(2008-10#1)(2008-2#1)
Diaion HP-2MG resin##2##3##(2008-10#2)
Diaion HP-2MG##4##2##(2008-10#4)
Diaion##5##1##(2008-10#5)
Dialogues##2##1##(2008-11#1)(2012-3#1)
Dialysis of##2##2##(1992-12#1)(2008-10#1)
Dialysis##6##1##(1992-12#1)(1994-2#1)(2008-10#2)(2008-12#1)(2011-2#1)
Diamond##2##1##(1996-9#1)(2008-10#1)
Diaporthe and Phomopsis##2##3##(2008-10#2)
Diaporthe phaseolorum and Phomopsis longicolla##4##5##(2008-10#4)
Diaporthe phaseolorum##6##2##(2008-10#6)
Diaporthe##9##1##(2008-10#9)
Diaporthe/Phomopsis helianthi##2##2##(2008-10#2)
Diaporthe/Phomopsis##4##1##(2008-10#4)
Diastereoselective Synthesis of##2##3##(1996-5#1)(2008-10#1)
Diastereoselective##7##1##(1996-5#6)(2008-10#1)
Dibutyryl##2##1##(1993-8#1)(1995-8#1)
Dicarboximide Resistance##2##2##(2008-10#2)
Dicarboximide##5##1##(2008-10#5)
Dice Task##2##2##(2009-10#2)
Dice##4##1##(2008-10#1)(2009-10#2)(2013-8#1)
Dichelobacter nodosus##3##2##(1993-12#2)(2011-2#1)
Dichloroacetic acid is##2##3##(2008-10#1)(2008-9#1)
Dichloroacetic acid was##4##3##(2008-9#4)
Dichloroacetic acid##7##2##(2008-10#2)(2008-9#5)
Dicistronic##3##1##(1993-6#2)(1997-8#1)
Dickeya spp##2##2##(2008-10#2)
Dickeya##4##1##(2008-10#4)
Dickinson##3##1##(2008-4#2)(2011-2#1)
Dicliptera sexangularis##2##2##(2008-10#2)
Dicliptera##3##1##(2008-10#3)
Dictyostelium discoideum##5##2##(1995-6#2)(1995-8#1)(2008-9#1)(2009-8#1)
Dictyostelium##7##1##(1995-6#2)(1995-8#2)(2008-9#1)(2009-8#2)
Did##2##1##(1992-1#1)(2008-10#1)
Didactics Applied to Care##2##4##(2012-3#2)
Didymella bryoniae##2##2##(2008-10#2)
Didymella rabiei in Chickpea##2##4##(2008-10#2)
Didymella rabiei##7##2##(2008-10#7)
Didymella##11##1##(2008-10#11)
Dieback of##2##2##(2008-10#2)
Diels-Alder cycloaddition##4##2##(1996-5#4)
Diels-Alder cycloadduct##2##2##(1996-5#2)
Diels-Alder reactions##2##2##(1996-5#1)(2008-8#1)
Diels-Alder##14##1##(1996-5#12)(2008-8#1)(2011-3#1)
Diesel fuel##2##2##(2008-3#2)
Diesel##6##1##(2008-3#5)(2009-8#1)
Diessenhofen##2##1##(1996-11#2)
Diet and##2##2##(1990-8#1)(2008-3#1)
Diet is##2##2##(1997-8#1)(2011-2#1)
Diet quality of##2##3##(2011-2#2)
Diet##17##1##(1990-8#1)(1994-3#1)(1997-8#1)(2008-1#1)(2008-3#6)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)
Diet)##2##1##(2008-3#2)
Dietary Guidelines for Americans##2##4##(2012-2#2)
Dietary Guidelines##4##2##(2010-1#2)(2012-2#2)
Dietary antioxidants##2##2##(1992-9#1)(2008-10#1)
Dietary factors##2##2##(2008-10#1)(2009-8#1)
Dietary fat##2##2##(2008-1#1)(2008-4#1)
Dietary fiber##2##2##(2010-10#1)(2012-2#1)
Dietary intake##2##2##(1991-2#1)(2013-1#1)
Dietary##31##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-9#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-6#1)(2012-2#7)(2013-1#3)
Diets##2##1##(1993-11#1)(2012-2#1)
Differ in##2##2##(2008-10#2)
Difference Frequency Generation##2##3##(2008-2#1)(2008-3#1)
Difference##16##1##(1997-6#1)(2008-10#1)(2008-11#9)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
Differences among##2##2##(2008-10#2)
Differences and##2##2##(1993-12#1)(2008-10#1)
Differences between the##3##3##(1992-1#1)(1994-8#1)(2008-10#1)
Differences between##10##2##(1991-2#1)(1992-1#1)(1994-5#2)(1994-8#1)(2008-10#4)(2011-2#1)
Differences in the##18##3##(1990-12#1)(1992-4#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#2)(2010-3#1)(2013-1#1)
Differences in##51##2##(1990-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-2#1)(2010-10#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
Differences were considered##2##3##(2011-2#1)(2013-1#1)
Differences were##6##2##(1991-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
Differences##82##1##(1990-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#2)(2008-10#29)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)
Different Prunus spp##2##3##(2008-10#2)
Different analytical##3##2##(2008-10#3)
Different evaluation methods##2##3##(2008-10#2)
Different experimental variables##2##3##(2008-10#2)
Different factors including pH of sample solution##2##7##(2008-10#2)
Different factors##5##2##(2008-10#5)
Different forms of##2##3##(2008-10#1)(2011-2#1)
Different groups##2##2##(2008-10#1)(2012-2#1)
Different individual##2##2##(2008-11#1)(2008-9#1)
Different kinds of##2##3##(2008-10#1)(2008-4#1)
Different methods were used##2##4##(2008-10#1)(2008-12#1)
Different methods##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
Different parameters were tested to optimize the conditions for the determination of##2##12##(2008-10#2)
Different parameters were##3##3##(2008-10#3)
Different parameters##4##2##(2008-1#1)(2008-10#3)
Different possible##2##2##(1994-3#1)(2008-3#1)
Different procedures have been##2##4##(2008-10#1)(2011-7#1)
Different techniques##3##2##(2008-10#3)
Different types of##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
Different variables and parameters affecting the reactions were studied and optimized##2##11##(2008-10#2)
Different variables##4##2##(2008-10#4)
Different##140##1##(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#2)(1994-3#1)(1995-8#1)(1996-2#1)(2006-6#1)(2008-1#1)(2008-10#89)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#4)(2012-7#1)
Differential diagnosis and therapy##2##4##(1992-5#1)(1997-8#1)
Differential diagnosis of##2##3##(2010-7#1)(2011-2#1)
Differential diagnosis##4##2##(1992-5#1)(1997-8#1)(2010-7#1)(2011-2#1)
Differential effect of##2##3##(1994-5#1)(2008-11#1)
Differential effects of##6##3##(1992-12#1)(1993-6#1)(1995-11#1)(2009-9#1)(2010-4#1)(2011-2#1)
Differential electrolytic##2##2##(2008-10#2)
Differential expression of mRNAs##2##4##(1995-2#1)(2008-11#1)
Differential expression of##6##3##(1992-3#1)(1993-6#1)(1995-2#2)(1997-7#1)(2008-11#1)
Differential expression##8##2##(1992-3#1)(1993-6#1)(1995-2#2)(1997-7#1)(2008-11#1)(2008-8#1)(2009-10#1)
Differential gene##2##2##(1995-11#1)(2012-3#1)
Differential pulse anodic stripping##2##4##(2008-10#2)
Differential pulse polarographic determination of##6##5##(2008-10#6)
Differential pulse polarographic##7##3##(2008-10#7)
Differential pulse polarography##2##3##(2008-10#2)
Differential pulse voltammetry##2##3##(2008-10#2)
Differential pulse##15##2##(2008-10#15)
Differential scanning calorimetry##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
Differential scanning potentiometry##2##3##(2008-10#2)
Differential scanning##5##2##(2008-10#3)(2008-8#1)(2011-1#1)
Differential##85##1##(1990-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#2)(1996-12#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#37)(2008-11#3)(2008-12#1)(2008-3#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Differentially##3##1##(2008-10#2)(2011-2#1)
Differentiating##2##1##(2008-10#1)(2008-11#1)
Differentiation and##6##2##(1993-3#1)(2008-10#3)(2008-4#1)(2013-1#1)
Differentiation in##2##2##(2008-10#1)(2008-5#1)
Differentiation of Tilletia##2##3##(2008-10#2)
Differentiation of##22##2##(1993-3#1)(1994-12#1)(2008-10#11)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
Differentiation##39##1##(1993-3#2)(1994-12#1)(1995-6#1)(2008-10#20)(2008-11#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Differing##3##1##(1993-6#1)(2008-10#1)(2008-6#1)
Difficulties in##3##2##(2008-11#1)(2008-7#2)
Difficulties##6##1##(1992-1#1)(2008-10#1)(2008-11#2)(2008-7#2)
Diffraction and##2##2##(2008-2#1)(2008-3#1)
Diffraction##8##1##(2008-11#2)(2008-2#1)(2008-3#5)
Diffractive optical##2##2##(2008-3#2)
Diffractive##4##1##(2008-3#4)
Diffuse pulmonary##2##2##(2008-11#1)(2011-2#1)
Diffuse reflectance##3##2##(2008-10#3)
Diffuse##17##1##(1990-5#1)(1991-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Diffusing##2##1##(2007-12#1)(2010-10#1)
Diffusion of##5##2##(1993-2#1)(1994-12#1)(2008-11#1)(2008-6#1)(2010-10#1)
Diffusion##17##1##(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1996-9#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2010-10#1)(2013-1#1)(2013-8#2)
Digestion of the##2##3##(2008-10#2)
Digestion of##5##2##(2008-10#4)(2008-11#1)
Digestion##6##1##(1990-5#1)(2008-10#4)(2008-11#1)
Digestive##4##1##(1992-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
Digital microscopy##2##2##(2011-2#2)
Digital##13##1##(1995-11#1)(1997-3#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-8#1)
Digitaria##2##1##(2008-10#2)
Digitized##2##1##(1996-6#1)(2008-10#1)
Dignity##2##1##(2010-10#2)
Dilatation##3##1##(1990-12#2)(2008-11#1)
Dilute##3##1##(1996-9#1)(2008-10#1)(2009-5#1)
Dilution##2##1##(1995-11#1)(1995-12#1)
Dimension##4##1##(2008-10#4)
Dimensional changes in##2##3##(2007-12#1)(2012-2#1)
Dimensional changes##3##2##(2007-12#1)(2012-2#2)
Dimensional##6##1##(1992-11#1)(2007-12#1)(2008-8#2)(2012-2#2)
Dimensions##5##1##(1993-1#1)(1996-9#2)(2010-7#1)(2012-2#1)
Dimerization##2##1##(1993-8#1)(2008-9#1)
Dimethylglyoxime##2##1##(2008-10#2)
Diminution of##2##2##(2008-11#1)(2009-8#1)
Diode lasers##2##2##(2008-10#1)(2008-3#1)
Diode##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
Diode-Laser##4##1##(2008-3#4)
Diode-Pumped##6##1##(2008-3#6)
Diode-laser##2##1##(2008-3#2)
Diode-pumped##3##1##(2007-11#2)(2008-3#1)
Diol##3##1##(1996-5#1)(2013-1#2)
Dioxin##3##1##(2008-10#1)(2008-11#2)
Dioxins##2##1##(2008-10#1)(2008-11#1)
Dipicolinic acid (DPA)##2##3##(2008-10#1)(2011-2#1)
Diploid##3##1##(2008-10#1)(2008-11#1)(2009-12#1)
Diploma in Nursing##3##3##(2008-11#3)
Diploma in##6##2##(2008-11#5)(2013-1#1)
Diploma##7##1##(2008-11#6)(2013-1#1)
Diploptera punctata##3##2##(1995-11#3)
Dipping##2##1##(2010-1#2)
Dipterocarpaceae)##2##1##(2013-8#2)
Dipyridamole##2##1##(2008-7#2)
Direct Access Diagnostics##2##3##(1996-5#2)
Direct and##4##2##(1996-5#1)(2008-10#2)(2008-9#1)
Direct detection of##2##3##(2008-10#1)(2011-2#1)
Direct determination of cadmium in##2##5##(2008-10#2)
Direct determination of cadmium##4##4##(2008-10#4)
Direct determination of trace##2##4##(2008-10#2)
Direct determination of##21##3##(2008-10#21)
Direct electrochemistry and##2##3##(2008-10#2)
Direct electron transfer##2##3##(2008-10#2)
Direct gene transfer##2##3##(1994-5#2)
Direct interaction##3##2##(1995-2#1)(2011-2#2)
Direct observation of##2##3##(1991-9#1)(2008-10#1)
Direct visualization of##2##3##(2010-6#2)
Direct##95##1##(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-5#3)(1994-8#2)(1995-2#2)(1996-12#1)(1996-5#3)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#45)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
Directed evolution##2##2##(2010-4#1)(2011-1#1)
Directed##5##1##(1997-2#1)(2008-11#1)(2010-4#1)(2011-1#1)(2011-2#1)
Directional##5##1##(2008-10#1)(2008-3#2)(2008-8#1)(2013-1#1)
Directions in##2##2##(1990-8#1)(1991-3#1)
Directions##4##1##(1990-8#1)(1991-3#1)(2008-9#1)(2009-11#1)
Directive##11##1##(2008-10#6)(2008-11#4)(2008-5#1)
Directly observed therapy (DOT)##2##4##(1996-3#2)
Directly observed therapy##3##3##(1996-3#3)
Directly##7##1##(1994-2#1)(1996-3#3)(2008-10#1)(2008-3#1)(2013-1#1)
Director of the##2##3##(1995-1#1)(2008-11#1)
Director##4##1##(1991-12#1)(1995-1#1)(1995-6#1)(2008-11#1)
Directors##2##1##(1992-1#1)(2008-11#1)
Disabilities Act (ADA)##10##3##(1994-1#2)(1995-12#4)(1995-6#2)(1996-1#1)(1996-5#1)
Disabilities Act of 1990##2##4##(1993-1#1)(1995-1#1)
Disabilities Act##27##2##(1991-12#3)(1992-12#1)(1993-1#3)(1993-3#2)(1994-1#5)(1994-2#1)(1995-1#2)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)
Disabilities of the Arm##3##4##(2008-9#3)
Disabilities##34##1##(1991-12#3)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#5)(1994-2#1)(1995-1#2)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(2008-12#1)(2008-9#3)(2010-10#1)(2012-2#1)
Disability Index##10##2##(2008-12#3)(2009-3#1)(2012-12#4)(2012-3#2)
Disability Status##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
Disability and Health (ICF)##2##4##(2011-2#1)(2012-12#1)
Disability and##3##2##(1992-3#1)(2011-2#1)(2012-12#1)
Disability##22##1##(1991-1#1)(1992-12#1)(1992-3#1)(1995-12#1)(2008-11#1)(2008-12#3)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#5)(2012-3#3)(2013-1#1)
Disabled##4##1##(1995-2#1)(1996-2#1)(2008-11#1)(2010-7#1)
Disagreements were resolved by consensus##2##5##(2009-9#1)(2010-2#1)
Disappearance of##3##2##(1992-11#1)(2008-10#1)(2012-2#1)
Disappearance##4##1##(1992-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
Disaster##3##1##(2008-11#3)
Disc##2##1##(2008-7#1)(2011-2#1)
Discharge of Ascospores##2##3##(2008-10#2)
Discharge of##3##2##(2008-10#2)(2008-11#1)
Discharge##5##1##(2008-10#3)(2008-11#1)(2010-11#1)
Disclosure##2##1##(2008-10#1)(2008-11#1)
Discoid##2##1##(2013-1#2)
Discover Health Services Near##2##4##(2010-5#2)
Discovering##5##1##(1995-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
Discovery of##4##2##(2008-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
Discovery##9##1##(2008-10#4)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
Discrepancies between##2##2##(2008-7#2)
Discrepancies##3##1##(2008-12#1)(2008-7#2)
Discrepancy between##2##2##(1992-12#1)(2008-10#1)
Discrete##5##1##(1991-9#1)(1995-6#1)(2008-10#1)(2010-10#1)(2010-8#1)
Discriminant analysis and##2##3##(2008-10#1)(2008-8#1)
Discriminant analysis##3##2##(2008-10#2)(2008-8#1)
Discriminant##7##1##(1994-3#1)(2008-10#5)(2008-8#1)
Discrimination between##6##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#1)
Discrimination in##2##2##(2008-10#1)(2013-1#1)
Discrimination of individual neuronal potentials is based on action potential##2##10##(2008-4#2)
Discrimination of##5##2##(2008-10#2)(2008-4#2)(2009-6#1)
Discrimination##17##1##(1996-3#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-8#3)(2009-6#1)(2013-1#1)
Discs##3##1##(2008-5#1)(2012-3#2)
Discussion focuses on##2##3##(2009-11#2)
Discussion of##2##2##(2010-12#1)(2010-7#1)
Discussion##23##1##(1994-1#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#6)
Discussions of CS should receive greater emphasis in research journals##2##10##(2013-1#2)
Discussions of##3##2##(1996-2#1)(2013-1#2)
Discussions##7##1##(1996-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2013-1#2)(2013-8#1)
Disease (AD)##2##2##(2008-7#1)(2011-3#1)
Disease Caused by##6##3##(2008-10#6)
Disease Development and##2##3##(2008-10#2)
Disease Development##3##2##(2008-10#3)
Disease Progress##2##2##(2008-10#2)
Disease Rating Scale##3##3##(2008-7#2)(2013-8#1)
Disease Spread##2##2##(2008-10#2)
Disease Study##2##2##(1994-3#1)(2008-1#1)
Disease Surveillance##2##2##(2008-11#1)(2011-9#1)
Disease control##2##2##(2008-10#2)
Disease development over##2##3##(2008-10#2)
Disease development was##2##3##(2008-10#2)
Disease development##6##2##(2008-10#6)
Disease diversity measured by##2##4##(2008-10#2)
Disease in##9##2##(1990-9#1)(2008-10#6)(2010-9#1)(2011-2#1)
Disease incidence and severity were##2##5##(2008-10#2)
Disease incidence and severity##7##4##(2008-10#7)
Disease incidence was##3##3##(2008-10#3)
Disease incidence##18##2##(1991-12#1)(2008-10#17)
Disease of##6##2##(2008-10#6)
Disease on##3##2##(2008-10#3)
Disease onset was##2##3##(2008-10#2)
Disease progress curves##2##3##(2008-10#2)
Disease progress##5##2##(2008-10#5)
Disease progression##3##2##(2008-10#3)
Disease severity was##5##3##(2008-10#5)
Disease severity##12##2##(1997-5#1)(2008-10#11)
Disease suppression was##2##3##(2008-10#2)
Disease suppression##3##2##(2008-10#3)
Disease suppressiveness##2##2##(2008-10#2)
Disease to##2##2##(2008-11#1)(2012-12#1)
Disease was##2##2##(2008-10#1)(2013-7#1)
Disease##215##1##(1990-9#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1994-3#1)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(2008-1#3)(2008-10#127)(2008-11#7)(2008-12#4)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-10#1)(2011-2#8)(2011-3#1)(2011-8#2)(2011-9#1)(2012-12#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
Disease-free##2##1##(2008-10#1)(2011-2#1)
Disease?##2##1##(2010-8#1)(2011-2#1)
Diseased##6##1##(2008-10#5)(2011-2#1)
Diseases in##2##2##(2008-10#2)
Diseases of the##2##3##(1997-5#1)(2012-2#1)
Diseases of##4##2##(1997-5#1)(2008-10#2)(2012-2#1)
Diseases##32##1##(1990-12#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-5#1)(1994-9#1)(1996-11#1)(1997-3#2)(1997-5#1)(2007-11#1)(2008-10#8)(2008-11#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Disinfection and sterilization##2##3##(1992-12#1)(2012-12#1)
Disinfection and##3##2##(1992-12#1)(2008-7#1)(2012-12#1)
Diskhaler##2##1##(1992-3#1)(1996-2#1)
Diskus is##2##2##(1996-2#2)
Diskus##8##1##(1996-2#8)
Dislocation of temporo-mandibular joint##2##4##(2011-2#2)
Dislocation of##3##2##(1995-10#1)(2011-2#2)
Dislocation##5##1##(1995-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
Disorder##21##1##(2008-1#1)(2008-10#2)(2008-11#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#2)
Disordered##3##1##(1996-9#2)(2012-2#1)
Disorders of##3##2##(2008-10#2)(2010-1#1)
Disorders##23##1##(1990-2#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Disorganization##2##1##(2008-10#2)
Dispensing##2##1##(2010-3#1)(2010-9#1)
Dispersal of##14##2##(2008-10#14)
Dispersal##20##1##(2008-10#16)(2008-8#2)(2008-9#2)
Dispersible##3##1##(2008-7#3)
Dispersion##3##1##(2008-10#1)(2008-11#1)(2008-3#1)
Displacement##5##1##(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-7#1)
Display##7##1##(1995-11#1)(1995-2#1)(2008-10#2)(2008-3#1)(2009-10#1)(2012-2#1)
Disposable##2##1##(2008-10#1)(2008-11#1)
Disrupted##2##1##(2008-7#1)(2010-12#1)
Disruption of the fimA and fimF##2##6##(2008-10#2)
Disruption of the##3##3##(2008-10#2)(2008-9#1)
Disruption of##8##2##(1990-5#1)(1993-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#1)
Disrupts##2##1##(2008-10#1)(2012-3#1)
Dissecting##2##1##(2008-7#2)
Dissection of the##2##3##(1991-8#1)(2013-1#1)
Dissection of##5##2##(1991-8#1)(2008-10#2)(2008-8#1)(2013-1#1)
Dissection##8##1##(1991-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
Disseminated##2##1##(2010-6#1)(2012-2#1)
Dissemination of##2##2##(1993-12#1)(2008-7#1)
Dissemination##4##1##(1993-12#1)(2008-10#1)(2008-7#1)(2010-8#1)
Dissertations##2##1##(2008-3#2)
Dissociation of##2##2##(1994-8#1)(1995-6#1)
Dissociation##3##1##(1993-1#1)(1994-8#1)(1995-6#1)
Dissolution##4##1##(2008-10#2)(2012-2#2)
Dissolved##3##1##(2008-10#1)(2008-11#1)(2008-12#1)
Distal urethral##2##2##(1992-1#2)
Distal##9##1##(1991-12#2)(1992-1#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#2)
Distal-less##2##1##(2008-9#2)
Distance##3##1##(2008-10#2)(2008-11#1)
Distances between##2##2##(2008-10#2)
Distant##2##1##(1994-12#1)(2012-3#1)
Distinct from##2##2##(2008-10#1)(2011-2#1)
Distinct##23##1##(2007-12#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
Distinctive##2##1##(1991-2#1)(2008-10#1)
Distinguish##2##1##(2008-10#2)
Distinguishing##4##1##(2007-12#1)(2008-10#1)(2009-8#1)(2010-7#1)
Distorted growth of the##2##4##(1995-9#2)
Distortion##3##1##(2008-10#1)(2008-3#1)(2013-1#1)
Distraction##2##1##(2008-12#1)(2013-8#1)
Distress##4##1##(1997-1#1)(2008-10#1)(2009-4#1)(2012-3#1)
Distributed##2##1##(2008-10#1)(2011-9#1)
Distributed-Feedback##2##1##(2008-3#2)
Distributed-feedback##2##1##(2008-3#2)
Distribution and##8##2##(1996-2#1)(1997-4#1)(2008-10#6)
Distribution in##2##2##(2008-10#1)(2012-12#1)
Distribution of the##3##3##(1996-12#1)(1997-8#1)(2011-2#1)
Distribution of##26##2##(1992-6#1)(1992-8#1)(1994-11#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#1)
Distribution##42##1##(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
Distributions##6##1##(1992-2#1)(1996-3#1)(2008-3#1)(2008-9#1)(2010-1#1)(2012-2#1)
District Court Judge##2##3##(1995-12#2)
District Court for##2##3##(1996-9#1)(1997-7#1)
District Court##6##2##(1990-2#1)(1992-9#1)(1995-12#2)(1996-9#1)(1997-7#1)
District Health##3##2##(1991-2#2)(2008-12#1)
District Judge##3##2##(1995-12#2)(1996-5#1)
District of##8##2##(1990-2#1)(1992-2#1)(1992-9#1)(1996-9#1)(1997-1#1)(1997-7#1)(2009-10#1)(2010-5#1)
District##28##1##(1990-2#2)(1991-2#2)(1992-2#2)(1992-9#2)(1995-12#6)(1995-6#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-7#2)(2008-12#1)(2009-10#1)(2010-5#1)(2012-3#1)(2013-1#2)
Disturbance##2##1##(2008-8#1)(2012-2#1)
Disturbed##2##1##(1990-5#1)(1992-12#1)
Disulfide bond##2##2##(1993-8#1)(1995-12#1)
Disulfide##3##1##(1993-8#1)(1995-12#1)(1996-5#1)
Dithizone##6##1##(2008-10#6)
Ditylenchus dipsaci##5##2##(2008-10#5)
Ditylenchus##8##1##(2008-10#8)
Diuretic therapy##2##2##(1994-6#2)
Diuretic##3##1##(1994-6#2)(2012-2#1)
Diurnal##2##1##(2008-10#1)(2008-6#1)
Divergence##3##1##(2008-3#1)(2011-2#1)(2012-3#1)
Divergent##2##1##(1996-9#1)(2008-10#1)
Diverse##12##1##(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
Diversity Among Strains of##2##4##(2008-10#2)
Diversity Among##6##2##(2008-10#6)
Diversity Panel##2##2##(2008-12#1)(2012-3#1)
Diversity Within##2##2##(2008-10#2)
Diversity and##6##2##(2008-10#5)(2011-2#1)
Diversity in##12##2##(1993-9#1)(2008-10#11)
Diversity management##2##2##(1994-12#2)
Diversity of##25##2##(2008-10#23)(2012-2#1)(2012-3#1)
Diversity##66##1##(1993-9#1)(1994-12#3)(1997-8#1)(2008-10#53)(2008-12#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#3)
Division I##2##2##(2013-1#2)
Division of Human Rights##2##4##(1995-6#2)
Division of##7##2##(1991-12#1)(1995-6#2)(1996-1#1)(2008-5#1)(2008-8#2)
Division##19##1##(1991-12#1)(1992-1#1)(1993-1#1)(1995-6#3)(1996-1#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-5#1)(2008-8#2)(2010-6#1)(2012-3#2)(2013-1#3)
Divorce##2##1##(2008-12#1)(2011-2#1)
Dixon##3##1##(1997-8#1)(2008-10#1)(2008-5#1)
Dixon's##3##1##(2008-10#3)
Djourno and##2##2##(2008-9#2)
Djourno##4##1##(2008-9#4)
DnaB at the##2##3##(1991-12#2)
DnaB helicase##3##2##(1991-12#3)
DnaB##9##1##(1991-12#8)(2011-3#1)
DnaC protein##2##2##(1991-12#2)
DnaC##10##1##(1991-12#10)
DnaJ##2##1##(2011-2#2)
DnaK##3##1##(2011-2#3)
Do Not##2##2##(2008-10#1)(2010-1#1)
Do People##2##2##(2009-3#2)
Do plant##2##2##(2008-9#2)
Do we##3##2##(1992-1#1)(2012-12#2)
Do you##5##2##(1991-3#2)(2008-10#1)(2008-4#1)(2012-3#1)
Do##47##1##(1990-5#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-3#2)(1995-3#1)(1996-3#2)(1996-5#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#3)
Dobson and Brewer##2##3##(2008-3#2)
Dobson##5##1##(2008-3#4)(2008-9#1)
Doc##2##1##(2008-10#1)(2008-9#1)
Docetaxel and Cisplatin##2##3##(2008-10#2)
Docetaxel##5##1##(2008-10#5)
Docking of puppies' tails##4##4##(1995-9#4)
Docking of##5##2##(1995-9#4)(2013-8#1)
Docking##6##1##(1995-9#4)(2013-8#2)
Doctors and##2##2##(1996-6#1)(2011-2#1)
Doctors##9##1##(1990-3#1)(1993-11#1)(1996-6#1)(1997-8#2)(2008-11#1)(2009-12#1)(2011-2#1)(2012-2#1)
Document##3##1##(2008-10#1)(2008-9#1)(2010-8#1)
Documentation of red flags##2##4##(2008-12#2)
Documentation of##3##2##(2008-12#2)(2013-1#1)
Documentation##4##1##(2008-12#2)(2012-2#1)(2013-1#1)
Dodecyl##2##1##(2008-10#1)(2012-2#1)
Doe##3##1##(1992-9#1)(1993-3#1)(1995-6#1)
Doe's##2##1##(1995-6#2)
Doehlert design##2##2##(2008-10#2)
Doehlert designs##6##2##(2008-10#6)
Doehlert matrices##2##2##(2008-10#2)
Doehlert matrix##7##2##(2008-10#7)
Doehlert shells##2##2##(2008-10#2)
Doehlert##19##1##(2008-10#19)
Does Not##3##2##(2008-10#3)
Does it##2##2##(1992-5#1)(2010-10#1)
Does the##9##2##(1996-3#1)(2008-10#3)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
Does##35##1##(1991-3#1)(1992-5#2)(1993-3#1)(1994-6#1)(1996-3#1)(2008-10#9)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
Dog owner/dog walkers##2##3##(2013-1#2)
Dog##6##1##(2007-12#1)(2013-1#5)
Dogs##3##1##(2008-12#1)(2012-2#1)(2013-1#1)
Doing more##2##2##(1993-12#1)(1995-12#1)
Doing##8##1##(1993-12#2)(1995-12#1)(1996-1#1)(1996-8#1)(2012-12#1)(2012-2#2)
Dolt-2##2##1##(2008-10#2)
Domain I helix 4##2##4##(2008-9#2)
Domain I##3##2##(2008-9#3)
Domain##7##1##(1995-6#1)(2008-10#1)(2008-12#1)(2008-9#3)(2009-10#1)
Domains##3##1##(2008-11#1)(2008-9#1)(2009-10#1)
Domestic##4##1##(1997-3#1)(2011-2#1)(2012-12#2)
Dominance##2##1##(2008-10#2)
Dominant##10##1##(1995-8#1)(1996-5#1)(2008-10#3)(2010-4#1)(2012-3#3)(2013-1#1)
Dominican Republic##12##2##(2008-10#9)(2008-11#2)(2013-1#1)
Don't##7##1##(1992-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(2009-11#1)(2013-8#1)
Donaghey##2##1##(1995-12#2)
Donald##2##1##(1994-3#1)(2008-10#1)
Donnan dialysis is##3##3##(2008-10#3)
Donnan dialysis##7##2##(2008-10#7)
Donnan effect##5##2##(2011-2#5)
Donnan##15##1##(2008-10#8)(2011-2#7)
Donor##6##1##(1994-5#1)(2008-10#2)(2008-11#1)(2010-10#1)(2012-3#1)
Donors were##2##2##(2012-12#1)(2012-3#1)
Donors##5##1##(1996-5#1)(2008-10#2)(2012-12#1)(2012-3#1)
Dopamine and serotonin##2##3##(2008-7#2)
Dopamine receptors##2##2##(1993-9#1)(1995-2#1)
Dopamine##8##1##(1992-1#1)(1993-9#2)(1995-2#1)(1995-8#1)(2008-7#2)(2010-12#1)
Dopaminergic##3##1##(2012-12#1)(2013-8#2)
Doppler echocardiography##2##2##(2010-10#2)
Doppler flow measurements##2##3##(1996-6#2)
Doppler flow##3##2##(1995-3#1)(1996-6#2)
Doppler guide##2##2##(1996-6#2)
Doppler lidar at 9##2##4##(2008-2#1)(2008-3#1)
Doppler lidar at##3##3##(2008-2#1)(2008-3#2)
Doppler lidar##12##2##(2008-2#1)(2008-3#11)
Doppler shift##7##2##(2008-2#1)(2008-3#6)
Doppler shifts##2##2##(2008-3#2)
Doppler sonography##2##2##(1996-6#1)(2013-1#1)
Doppler ultrasonography##4##2##(1996-2#1)(1996-3#2)(2010-11#1)
Doppler ultrasound##5##2##(1992-6#1)(2008-12#3)(2011-2#1)
Doppler velocimetry##4##2##(1994-11#1)(1994-3#3)
Doppler##77##1##(1992-6#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-9#1)(1995-3#6)(1996-2#1)(1996-3#2)(1996-6#6)(2007-12#1)(2008-10#1)(2008-12#4)(2008-2#2)(2008-3#31)(2008-5#2)(2008-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2011-2#2)(2011-5#1)(2012-2#1)(2013-1#4)
Doppler-free##6##1##(2008-3#6)
Dor##3##1##(1992-9#1)(2008-10#1)(2011-2#1)
Dornan##2##1##(1995-6#1)(1996-5#1)
Dorsal##3##1##(2008-6#1)(2011-2#2)
Dosage##2##1##(1990-9#1)(2008-5#1)
Dose heterogeneity##2##2##(2008-10#1)(2008-11#1)
Dose intensification##2##2##(1993-9#1)(1994-8#1)
Dose intensity##2##2##(1992-2#1)(1993-11#1)
Dose##11##1##(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
Dose-dependent##2##1##(2008-4#1)(2008-8#1)
Dose-response relationships##2##2##(2008-10#1)(2008-7#1)
Dose-response##4##1##(1995-8#1)(2008-10#2)(2008-7#1)
Doses to##2##2##(1993-9#2)
Doses##7##1##(1991-8#1)(1993-9#2)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
Dosimetry##3##1##(1992-3#1)(2008-7#2)
Dot##3##1##(2008-10#1)(2008-8#1)(2013-1#1)
Dot-blot##2##1##(2008-10#1)(2008-9#1)
Dothistroma needle blight is##2##4##(2008-10#2)
Dothistroma needle blight##5##3##(2008-10#5)
Dothistroma##7##1##(2008-10#7)
Double##16##1##(1991-1#1)(1991-12#1)(1992-3#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
Double-Stranded RNA##2##2##(2008-10#2)
Double-Stranded##3##1##(2008-10#3)
Double-strand##3##1##(2008-9#2)(2013-1#1)
Double-stranded (ds)##2##2##(2008-10#2)
Double-stranded RNA##2##2##(2008-10#2)
Double-stranded##7##1##(1994-5#1)(2008-10#5)(2008-11#1)
Douglas Carnall##2##2##(1996-8#2)
Douglas##5##1##(1991-3#1)(1996-8#2)(2008-9#1)(2010-11#1)
Douglas-Fir##2##1##(2008-10#2)
Douglas-fir foliage##2##2##(2008-10#2)
Douglas-fir##8##1##(2008-10#8)
Dowex 1##2##2##(2008-10#2)
Dowex 50W X8##3##3##(2008-10#3)
Dowex 50W x##2##3##(2008-10#2)
Dowex 50W##5##2##(2008-10#5)
Dowex CM-15 and Dowex C650##2##5##(2008-10#2)
Dowex##13##1##(1992-12#1)(2008-10#12)
Dowex-1##2##1##(2008-10#2)
Down regulation of the##2##4##(1994-8#1)(1995-2#1)
Down syndrome (DS)##2##3##(1996-2#1)(2012-2#1)
Down syndrome and##2##3##(2008-8#1)(2012-12#1)
Down syndrome patients and##2##4##(2008-11#2)
Down syndrome patients##3##3##(2008-11#3)
Down syndrome##23##2##(1996-2#3)(1996-6#2)(1997-2#3)(2008-11#4)(2008-12#2)(2008-8#1)(2012-12#1)(2012-2#2)(2013-1#5)
Down to##3##2##(2008-10#2)(2008-3#1)
Down##30##1##(1993-12#1)(1994-8#1)(1995-2#1)(1996-2#3)(1996-6#2)(1997-2#3)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#2)(2013-1#6)
Down's syndrome##5##2##(1991-1#2)(1992-12#2)(1992-9#1)
Down's syndrome]##2##2##(1991-8#1)(1993-11#1)
Down's##8##1##(1991-1#2)(1991-8#1)(1992-12#2)(1992-9#1)(1993-11#1)(2008-10#1)
Down-regulation of##4##2##(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)
Downregulation of##2##2##(2009-9#1)(2011-2#1)
Downstream targets of##2##3##(2008-10#1)(2009-9#1)
Downstream##4##1##(2008-10#2)(2008-9#1)(2009-9#1)
Downy Mildew##5##2##(2008-10#4)(2012-3#1)
Downy mildew##3##2##(2008-10#3)
Downy##8##1##(2008-10#7)(2012-3#1)
Doxorubicin##3##1##(1994-8#1)(1997-7#1)(2008-11#1)
Dr Beard said##2##3##(2008-11#2)
Dr Naranjan S Dhalla##2##4##(2008-7#2)
Dr##47##1##(1991-3#2)(1991-6#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-8#2)(1995-12#3)(1995-2#1)(1995-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#4)(2008-11#5)(2008-5#4)(2008-7#2)(2010-10#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
Drainage##2##1##(2008-10#1)(2008-7#1)
Dramatic changes##2##2##(2008-10#1)(2008-11#1)
Dramatic##3##1##(2008-10#1)(2008-11#1)(2012-12#1)
Draper-Lin small composite##2##3##(2008-10#2)
Drawing on an##2##3##(2008-1#1)(2008-11#1)
Drawing on the##2##3##(1997-3#1)(2008-11#1)
Drawing on##11##2##(1997-3#1)(2008-1#1)(2008-11#3)(2008-12#1)(2009-6#2)(2009-8#1)(2012-2#1)(2013-1#1)
Drawing##15##1##(1992-3#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#2)(2009-6#2)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
Drebrin E##2##2##(2012-2#2)
Drechslera teres##2##2##(2008-10#2)
Drechslera##3##1##(2008-10#3)
Dresden##3##1##(2008-10#3)
Drew##2##1##(1995-6#1)(2008-10#1)
Dried##3##1##(2008-10#3)
Drinking##2##1##(2008-10#1)(2013-8#1)
Drip##2##1##(2008-10#1)(2013-8#1)
Dromia personata##2##2##(2007-12#2)
Dromia wilsoni##2##2##(2007-12#2)
Dromia##4##1##(2007-12#4)
Drop##5##1##(2008-10#5)
Droplet##2##1##(1995-3#1)(2011-2#1)
Droplets##4##1##(2008-10#1)(2008-12#1)(2008-3#2)
Drosophila Schneider##2##2##(1993-9#1)(2008-11#1)
Drosophila and##7##2##(1990-3#2)(2008-10#1)(2008-8#2)(2009-7#1)(2011-2#1)
Drosophila auditory##2##2##(2008-9#2)
Drosophila embryos##3##2##(1993-12#1)(2008-9#1)(2009-8#1)
Drosophila eye##2##2##(2008-9#2)
Drosophila melanogaster S2 cells##2##4##(2008-11#2)
Drosophila melanogaster and##5##3##(1993-2#1)(2008-10#1)(2012-2#1)(2012-3#2)
Drosophila melanogaster##50##2##(1993-12#1)(1993-2#6)(1993-6#2)(1993-9#1)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#1)(1997-7#6)(1997-8#4)(2007-12#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#2)(2008-9#7)(2009-7#2)(2010-1#1)(2012-2#1)(2012-3#4)
Drosophila mojavensis##4##2##(2008-8#2)(2008-9#2)
Drosophila serrata and Drosophila birchii##2##5##(2008-9#2)
Drosophila simulans##3##2##(2012-3#3)
Drosophila species##3##2##(2008-8#1)(2008-9#2)
Drosophila trithorax##2##2##(1997-7#2)
Drosophila##172##1##(1990-3#3)(1993-12#11)(1993-2#7)(1993-6#2)(1993-8#2)(1993-9#4)(1994-12#2)(1994-9#1)(1995-2#2)(1995-6#11)(1995-8#1)(1996-12#1)(1997-3#1)(1997-7#10)(1997-8#6)(2007-12#2)(2008-10#8)(2008-11#7)(2008-7#1)(2008-8#17)(2008-9#41)(2009-7#3)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#7)(2012-3#18)
Drought##5##1##(2012-5#1)(2012-6#1)(2012-7#2)(2012-8#1)
Drug Therapy##3##2##(2009-6#1)(2013-1#2)
Drug Utilization Review Network##2##4##(1997-2#2)
Drug Utilization##4##2##(1997-2#2)(2008-11#2)
Drug delivery##3##2##(1992-3#1)(1995-3#1)(1996-3#1)
Drug self-administration##2##2##(2012-3#2)
Drug treatment of##2##3##(1992-11#1)(2008-8#1)
Drug treatment##4##2##(1992-11#1)(2008-6#1)(2008-8#1)(2010-6#1)
Drug use##3##2##(1991-1#2)(2013-8#1)
Drug##81##1##(1991-1#3)(1991-3#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#3)(2008-10#5)(2008-11#11)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#6)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#1)
Drug-eluting stents have##2##3##(2008-11#2)
Drug-eluting##3##1##(2008-11#2)(2011-2#1)
Drug-induced hair##2##2##(2008-8#2)
Drug-induced##8##1##(1993-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2011-2#2)
Drugs of##2##2##(1995-3#1)(2013-8#1)
Drugs##20##1##(1994-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
Dry powder inhalers##2##3##(1992-3#2)
Dry powder##4##2##(1992-3#3)(1997-1#1)
Dry##11##1##(1992-3#4)(1997-1#1)(2008-10#4)(2008-5#1)(2008-7#1)
DsbA##5##1##(1993-9#5)
Dsquame(R) instant##2##2##(2008-5#2)
Dsquame(R)##4##1##(2008-5#4)
DuP 532 is a##2##4##(1991-5#2)
DuP 532 was##2##3##(1991-5#2)
DuP 532##10##2##(1991-5#10)
DuP 753##4##2##(1991-5#4)
DuP##14##1##(1991-5#14)
Dual##8##1##(1993-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)(2013-1#1)
Dual-wavelength##3##1##(2007-12#1)(2008-10#1)(2009-12#1)
Dubai##2##1##(2008-12#2)
Dubinin-Radushkevich (D-R)##3##2##(2008-10#3)
Dublin##4##1##(1991-12#1)(2008-11#2)(2011-2#1)
Duchenne muscular dystrophy##2##3##(2011-2#2)
Duct##2##1##(1995-2#1)(2012-12#1)
Due to a##2##3##(1996-8#1)(2008-5#1)
Due to an##2##3##(2011-2#1)(2013-1#1)
Due to high sensitivity##2##4##(2008-10#2)
Due to its##9##3##(2008-10#4)(2008-9#1)(2009-1#1)(2009-10#1)(2010-7#1)(2013-1#1)
Due to multiple##2##3##(2008-10#2)
Due to the fact that the##2##6##(2008-11#1)(2012-3#1)
Due to the fact that##5##5##(2008-10#3)(2008-11#1)(2012-3#1)
Due to the high##4##4##(2008-10#4)
Due to the lack of##8##5##(1995-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#2)
Due to the low##4##4##(2008-10#3)(2013-1#1)
Due to the presence of##2##5##(2008-10#1)(2010-11#1)
Due to the rapid development of colours at ambient temperature##2##10##(2008-10#2)
Due to the##74##3##(1992-2#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#33)(2008-11#6)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)
Due to their##9##3##(2008-10#2)(2008-11#1)(2009-10#1)(2012-2#2)(2012-3#2)(2013-1#1)
Due to this##4##3##(1991-3#1)(2008-11#1)(2012-2#1)(2013-1#1)
Due to##124##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#56)(2008-11#10)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#2)(2010-8#2)(2011-2#4)(2012-2#6)(2012-3#3)(2013-1#7)(2013-8#1)
Due##125##1##(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#56)(2008-11#10)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#2)(2010-8#2)(2011-2#4)(2012-2#6)(2012-3#4)(2013-1#7)(2013-8#1)
Duke##3##1##(2011-2#1)(2012-3#2)
Dulbecco's Modified Eagle's Medium##2##4##(2008-11#2)
Dulbecco's Modified##3##2##(2008-11#2)(2013-1#1)
Dunajec##2##1##(2008-10#2)
Duodenal##2##1##(1991-8#1)(2008-12#1)
Duplex sonography##2##2##(1993-6#2)
Duplex##6##1##(1991-8#1)(1993-6#2)(2008-10#1)(2008-12#1)(2011-2#1)
Duplication##4##1##(2008-12#1)(2012-3#3)
Durability of##2##2##(2008-10#2)
Dural Sealant##3##2##(2012-3#3)
Dural##10##1##(1996-9#2)(2008-7#2)(2012-3#6)
Durapore5 was##2##2##(2008-10#2)
Durapore5##5##1##(2008-10#5)
Duration of##5##2##(1990-6#1)(1993-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
Duration##10##1##(1990-6#1)(1993-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-9#1)(2012-3#1)
Durations##2##1##(1993-3#1)(1994-1#1)
During 1983 to##2##3##(2008-10#2)
During 1998##2##2##(2008-10#2)
During Infection of##2##3##(2008-10#2)
During a period of##2##4##(1990-12#1)(1997-8#1)
During a##15##2##(1990-12#1)(1991-2#1)(1995-12#2)(1997-8#3)(2008-10#3)(2008-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
During development of the##2##4##(1993-3#1)(1994-12#1)
During development##5##2##(1993-3#1)(1994-12#1)(2007-12#1)(2008-10#1)(2012-2#1)
During each##2##2##(2008-12#1)(2008-5#1)
During embryonic##2##2##(1996-2#1)(2010-5#1)
During exercise##2##2##(2013-8#2)
During in##2##2##(2008-10#1)(2008-5#1)
During long-term##2##2##(2008-11#1)(2008-7#1)
During our##2##2##(1994-11#1)(2008-5#1)
During pregnancy##4##2##(1991-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
During recovery under##2##3##(2013-8#2)
During that##3##2##(2008-5#1)(2008-9#1)(2010-1#1)
During the 1990s##2##3##(1994-2#1)(1997-2#1)
During the 1995##2##3##(1996-6#1)(2008-10#1)
During the 4-year period##2##4##(2008-10#2)
During the aging process##3##4##(1994-2#1)(1997-2#2)
During the course of##6##4##(1991-6#1)(1995-6#1)(1996-3#1)(1997-8#1)(2010-10#1)(2011-2#1)
During the early##2##3##(2008-11#1)(2011-2#1)
During the enzymatic reaction##2##4##(2008-10#2)
During the exercise##2##3##(2008-10#2)
During the first##5##3##(1996-11#1)(2008-10#1)(2008-11#2)(2008-12#1)
During the last decade##6##4##(1991-11#1)(1991-12#1)(1991-6#1)(2008-11#2)(2008-4#1)
During the last##17##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-8#1)(1994-6#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
During the late##2##3##(2010-1#1)(2011-3#1)
During the observation period##2##4##(1992-5#1)(1997-3#1)
During the operation##2##3##(2008-11#1)(2012-12#1)
During the past decade##5##4##(1991-3#1)(2008-10#2)(2011-1#1)(2012-3#1)
During the past several##2##4##(2008-7#1)(2011-2#1)
During the past##12##3##(1991-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
During the period of##2##4##(2011-2#1)(2012-12#1)
During the period##7##3##(1991-8#1)(1993-2#1)(1997-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
During the previous decade several papers pertaining to aflatoxin M1 have been published in different journals##2##16##(2013-1#2)
During the same period##3##4##(1990-11#1)(2008-5#1)(2010-7#1)
During the same##4##3##(1990-11#1)(2008-5#1)(2010-12#1)(2010-7#1)
During the study##2##3##(2008-11#1)(2008-12#1)
During the years##2##3##(1990-6#1)(2008-12#1)
During the##139##2##(1990-11#2)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#4)(1994-3#1)(1994-6#2)(1995-11#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#4)(2008-10#25)(2008-11#13)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#8)(2011-3#2)(2011-9#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
During this period##4##3##(1994-6#1)(1995-3#1)(2008-7#1)(2011-9#1)
During this phase##2##3##(2008-3#1)(2008-4#1)
During this time##5##3##(1995-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
During this##16##2##(1994-6#1)(1995-3#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2011-9#1)(2012-3#1)(2013-8#1)
During##314##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-6#4)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#5)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#9)(2007-12#2)(2008-1#1)(2008-10#61)(2008-11#28)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#11)(2008-7#8)(2008-8#2)(2008-9#6)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#18)(2011-3#4)(2011-9#2)(2012-12#4)(2012-2#8)(2012-3#8)(2012-8#1)(2013-1#14)(2013-7#2)(2013-8#10)
Durum##4##1##(2008-10#4)
Dust##3##1##(2008-10#3)
Dutch Society of Family Physicians]##2##5##(1996-8#1)(1997-8#1)
Dutch TAD soils##5##3##(2008-10#5)
Dutch and##2##2##(2008-10#1)(2008-5#1)
Dutch cohorts born##2##3##(2011-2#2)
Dutch elm disease##4##3##(2008-10#4)
Dutch isolates##2##2##(2008-10#2)
Dutch##43##1##(1990-6#1)(1994-12#1)(1995-12#2)(1996-11#1)(1996-3#1)(1996-8#2)(1997-8#2)(2008-10#16)(2008-3#2)(2008-5#3)(2009-12#2)(2009-8#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Duty##3##1##(1997-5#1)(2008-3#1)(2013-8#1)
Dv42 was##2##2##(2008-10#2)
Dwarf Essex seed meal amendments##2##5##(2008-10#2)
Dwarf mistletoe incidence##2##3##(2008-10#2)
Dwarf##9##1##(2008-10#9)
Dx##2##1##(2008-7#2)
Dy and Eu##4##3##(2008-10#4)
Dy##6##1##(2008-10#6)
Dye##3##1##(2008-10#2)(2012-3#1)
Dye-doped##2##1##(2008-3#2)
Dyer##2##1##(2008-10#1)(2013-8#1)
Dying in##2##2##(2010-10#1)(2010-8#1)
Dying##4##1##(1993-3#1)(2008-7#1)(2010-10#1)(2010-8#1)
Dynabeads##3##1##(1990-12#2)(2008-10#1)
Dynamic changes##2##2##(1996-2#1)(2008-9#1)
Dynamic surface tension##2##3##(2008-10#2)
Dynamic##36##1##(1994-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-2#3)(2012-2#3)(2013-1#1)
Dynamical features of higher-order correlation events##2##6##(2008-11#2)
Dynamical##4##1##(1996-9#1)(2008-11#3)
Dynamics of##20##2##(1992-11#1)(1994-3#1)(2008-10#15)(2008-11#1)(2012-2#1)(2012-3#1)
Dynamics##27##1##(1992-11#1)(1994-3#1)(1996-9#2)(2008-10#17)(2008-11#2)(2008-7#1)(2009-7#1)(2012-2#1)(2012-3#1)
Dynastab DK##2##2##(2007-8#2)
Dynastab##3##1##(2007-8#3)
Dynein##2##1##(2012-2#2)
Dyract AP##4##2##(2008-5#4)
Dysautonomia##2##1##(2008-10#2)
Dysembryoplastic neuroepithelial tumour##2##3##(2008-7#2)
Dysfunction##2##1##(2012-2#1)(2012-3#1)
Dyslexia##2##1##(2008-11#2)
Dyspepsia##2##1##(1990-3#1)(1995-10#1)
Dysplasia##2##1##(2010-12#1)(2011-2#1)
Dyspnea##3##1##(2012-3#2)(2013-8#1)
Dysregulation of##2##2##(2008-6#1)(2011-2#1)
Désirée##3##1##(2008-10#3)
E (P=0##3##2##(2008-10#3)
E =##2##2##(2008-3#2)
E and C##2##3##(1992-9#1)(2011-2#1)
E and F##4##3##(2008-6#4)
E and##25##2##(1992-9#3)(1994-5#1)(1995-11#1)(1995-6#2)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-6#4)(2011-2#1)(2012-2#3)(2012-3#1)
E by##2##2##(1992-11#1)(2012-2#1)
E coli##4##2##(1995-9#1)(1996-8#1)(2006-5#1)(2008-10#1)
E coli/100 mL##3##3##(2008-10#3)
E deficient##4##2##(1994-5#3)(2008-6#1)
E degrees '##3##3##(2008-10#3)
E degrees##6##2##(2008-10#6)
E genotyping##3##2##(1990-2#1)(2008-7#2)
E in##8##2##(1992-9#3)(1994-5#1)(1996-2#1)(1996-5#1)(2008-10#2)
E is an##2##3##(2009-8#1)(2012-2#1)
E is##6##2##(1992-12#2)(2009-8#1)(2012-2#3)
E or##2##2##(1995-11#1)(1997-2#1)
E via##2##2##(2008-11#2)
E virus##2##2##(2007-12#1)(2009-8#1)
E was##8##2##(1990-8#2)(2008-10#1)(2011-2#1)(2012-2#4)
E z##2##2##(1992-12#2)
E##522##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#6)(1990-8#4)(1991-12#7)(1991-3#3)(1991-5#2)(1992-11#1)(1992-12#4)(1992-8#1)(1992-9#16)(1993-12#6)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#3)(1994-1#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#19)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#6)(1995-12#5)(1995-2#7)(1995-6#10)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#8)(1996-2#2)(1996-5#5)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2006-5#1)(2007-12#6)(2008-1#1)(2008-10#152)(2008-11#16)(2008-12#10)(2008-3#2)(2008-4#9)(2008-5#13)(2008-6#6)(2008-7#9)(2008-8#11)(2008-9#19)(2009-12#8)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#7)(2010-4#2)(2010-5#1)(2010-6#5)(2010-8#1)(2011-1#4)(2011-2#18)(2012-12#1)(2012-2#28)(2012-3#11)(2013-1#5)(2013-8#1)
E(1)##2##1##(1996-5#2)
E(1/2)##2##1##(2008-10#2)
E(2)##3##1##(1996-5#1)(2008-11#2)
E(3)##4##1##(2008-10#4)
E(A)##2##1##(2008-5#2)
E(i)##2##1##(2008-10#2)
E(pa) and I(pa)##2##3##(2008-10#2)
E(pa)##4##1##(2008-10#4)
E)##7##1##(1992-9#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2013-1#1)
E)-9##2##1##(2008-10#2)
E- and##3##2##(1991-5#1)(1995-11#1)(2006-6#1)
E-64##2##1##(1995-6#2)
E-ACT/M-CAA-170##2##1##(2008-10#2)
E-box##3##1##(1995-6#2)(2008-11#1)
E-cadherin##9##1##(2011-2#3)(2013-1#6)
E-deficient mice##2##2##(2008-1#1)(2009-10#1)
E-dominant##2##1##(1995-11#2)
E-field components##2##2##(2008-3#2)
E-field##6##1##(2008-10#1)(2008-3#5)
E-selectin##4##1##(2006-6#1)(2008-11#3)
E-selectin-IgG protein##2##2##(2008-11#2)
E-selectin-IgG##5##1##(2008-11#5)
E-trait and##2##2##(2008-10#2)
E1 and E2##2##3##(2008-11#2)
E1 and##6##2##(2008-10#4)(2008-11#2)
E1##20##1##(1993-12#1)(1993-8#1)(1994-2#1)(2008-10#6)(2008-11#5)(2008-8#1)(2008-9#5)
E1-deleted##2##1##(2008-11#2)
E13##2##1##(2008-8#2)
E15##2##1##(2008-8#2)
E18##2##1##(2008-10#2)
E1A and ras##2##3##(2008-11#2)
E1A and##3##2##(1993-2#1)(2008-11#2)
E1A##6##1##(1993-2#2)(2008-11#4)
E1B 175R##3##2##(1993-2#3)
E1B##4##1##(1993-2#4)
E1B-19K cells##2##2##(2008-11#2)
E1B-19K myelomas##2##2##(2008-11#2)
E1B-19K##8##1##(2008-11#8)
E1a-cooperative transformation##2##2##(1993-2#2)
E2 and BE##2##3##(2008-10#2)
E2 and##4##2##(1996-2#1)(2008-10#3)
E2 at##2##2##(1997-1#1)(2008-10#1)
E2 by##2##2##(1990-11#1)(1997-1#1)
E2 in##2##2##(1995-12#1)(1997-2#1)
E2 treatment##2##2##(1990-11#1)(1993-1#1)
E2 was##3##2##(2008-10#2)(2008-8#1)
E2##79##1##(1990-11#12)(1990-12#1)(1993-1#2)(1993-12#1)(1995-12#2)(1995-6#2)(1995-9#7)(1996-2#2)(1997-1#8)(1997-2#2)(2007-11#1)(2008-10#23)(2008-11#5)(2008-8#2)(2008-9#1)(2009-7#2)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
E2)##3##1##(2008-10#2)(2008-11#1)
E2-induced growth##2##2##(2011-2#2)
E2-induced##3##1##(2011-2#3)
E278Ar##3##1##(2008-10#3)
E2F and GATA-a motifs##2##4##(2012-2#2)
E2F and##3##2##(2012-2#3)
E2F motif##4##2##(2012-2#4)
E2F##8##1##(2011-2#1)(2012-2#7)
E2F1##2##1##(2008-9#1)(2012-2#1)
E2F4 expression##4##2##(2011-2#4)
E2F4 overexpression##2##2##(2011-2#2)
E2F4##12##1##(2011-2#12)
E3 and##2##2##(2008-10#1)(2008-8#1)
E3 ligase##2##2##(2009-10#1)(2012-2#1)
E3 ubiquitin##2##2##(2009-10#2)
E3##16##1##(2008-10#5)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#3)(2012-2#1)
E4 region##4##2##(1992-9#4)
E4##7##1##(1992-9#4)(1993-6#1)(1996-2#1)(2008-8#1)
E44##2##1##(2009-12#2)
E5##2##1##(2008-8#2)
E5-1##4##1##(1995-8#4)
E6 and E7##4##3##(1995-2#4)
E6##5##1##(1995-2#4)(2008-9#1)
E98A enzyme##2##2##(1995-6#2)
EA and CoQ(10)##2##3##(2008-10#2)
EA children##2##2##(2008-11#2)
EA had been##2##3##(2008-5#2)
EA is thought to##2##4##(2008-5#2)
EA of##2##2##(1996-12#2)
EA stimulation##2##2##(1996-12#2)
EA was##2##2##(1995-12#1)(2008-5#1)
EA##29##1##(1995-12#3)(1995-2#3)(1996-12#9)(2008-10#3)(2008-11#3)(2008-5#8)
EA-induced##3##1##(1996-12#3)
EAA##5##1##(1994-11#3)(2008-11#2)
EABR##3##1##(2008-9#3)
EADmin was##2##2##(1996-2#2)
EADs##3##1##(1996-2#3)
EAE##7##1##(1995-12#2)(2010-12#2)(2011-2#3)
EAG activity##2##2##(2008-10#2)
EAG##5##1##(2008-10#5)
EAP##5##1##(1995-6#5)
EAS and ENA is##2##4##(2008-8#2)
EAS and ENA##6##3##(2008-8#6)
EAS and##9##2##(2008-8#9)
EAS##11##1##(2008-8#11)
EASE##6##1##(2008-11#6)
EAT##3##1##(2009-1#2)(2013-1#1)
EATL##2##1##(2008-12#2)
EAU##3##1##(2008-4#3)
EB was##3##2##(2008-11#2)(2008-9#1)
EB##12##1##(2008-10#3)(2008-11#5)(2008-3#2)(2008-9#1)(2010-12#1)
EBC##2##1##(2010-5#2)
EBCM##2##1##(2008-3#2)
EBL##5##1##(2008-11#1)(2008-12#4)
EBP##4##1##(2008-11#2)(2013-1#2)
EBPs##4##1##(2013-1#4)
EBV DNA polymerase##2##3##(1993-8#1)(1997-3#1)
EBV DNA##3##2##(1993-8#1)(1997-3#1)(2008-10#1)
EBV infection##7##2##(2008-10#1)(2008-2#1)(2008-5#2)(2010-6#2)(2011-2#1)
EBV involvement in renal tissue##2##5##(2011-2#2)
EBV polymerase##2##2##(1993-8#2)
EBV##32##1##(1993-8#5)(1995-2#2)(1997-3#3)(2008-10#3)(2008-2#2)(2008-5#5)(2008-8#1)(2008-9#3)(2010-6#2)(2011-2#6)
EBV-DNA##2##1##(2011-2#2)
EBV-associated##2##1##(2008-9#1)(2010-6#1)
EBV-based##2##1##(2008-11#1)(2008-8#1)
EBs##8##1##(2008-10#1)(2008-11#6)(2008-9#1)
EC 1##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
EC 2##12##2##(1990-5#2)(1990-7#1)(1992-12#1)(1992-3#1)(1994-8#2)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#2)
EC 3##7##2##(1990-2#1)(1990-7#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#2)
EC 4##5##2##(1993-12#1)(1994-5#1)(1995-2#2)(2008-10#1)
EC Standards##3##2##(2008-10#3)
EC and HRP were##2##4##(2012-4#2)
EC and HRP##3##3##(2012-4#3)
EC and##4##2##(2009-10#1)(2012-4#3)
EC deprived of L-arginine##3##4##(1990-12#3)
EC deprived of##5##3##(1990-12#5)
EC in##2##2##(2012-4#1)(2013-8#1)
EC were##2##2##(2008-10#1)(2012-4#1)
EC##64##1##(1990-12#5)(1990-2#1)(1990-5#2)(1990-7#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#3)(1995-2#3)(2008-10#15)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2011-2#3)(2012-4#7)(2013-1#1)(2013-8#9)
EC(50) values were compared with those obtained by##2##8##(2008-10#2)
EC(50) values were##3##3##(2008-10#3)
EC(50) values##6##2##(2008-10#5)(2008-11#1)
EC(50)##12##1##(2008-10#9)(2008-11#1)(2012-2#1)(2013-1#1)
EC(80)##2##1##(2008-10#2)
EC-1##5##1##(2008-10#5)
EC-2##4##1##(2008-10#4)
EC-3 and##2##2##(2008-10#2)
EC-3##3##1##(2008-10#3)
EC-SOD in Group I##2##4##(1992-11#2)
EC-SOD in Group II##2##4##(1992-11#2)
EC-SOD in Group##4##3##(1992-11#4)
EC-SOD is##2##2##(1992-11#2)
EC-SOD level##2##2##(1992-11#2)
EC-SOD##11##1##(1992-11#11)
EC/HRP and##2##2##(2012-4#2)
EC/HRP##4##1##(2012-4#4)
EC3 value##3##2##(2008-10#2)(2008-5#1)
EC3##7##1##(2008-10#4)(2008-5#2)(2012-2#1)
EC50 and##2##2##(1995-11#1)(2008-11#1)
EC50 for##2##2##(1995-2#2)
EC50 of##2##2##(2008-11#1)(2011-3#1)
EC50 value of##2##3##(1991-5#1)(1995-12#1)
EC50 values for##2##3##(1995-2#1)(2008-11#1)
EC50 values##4##2##(1995-2#1)(2008-11#3)
EC50##19##1##(1991-5#1)(1995-11#1)(1995-12#1)(1995-2#5)(1996-12#1)(1996-2#1)(2008-11#7)(2011-3#2)
EC50/IC50 estimates##2##2##(2012-2#2)
EC50/IC50 is the##2##3##(2012-2#2)
EC50/IC50 should only be used if there are at least two assay concentrations##2##13##(2012-2#2)
EC50/IC50##12##1##(2012-2#12)
ECB larvae fed##2##3##(2008-7#2)
ECB##6##1##(2008-10#4)(2008-7#2)
ECD applications##2##2##(2010-1#2)
ECD detector##2##2##(2008-10#1)(2009-8#1)
ECD##9##1##(1995-11#2)(1995-12#1)(2008-10#2)(2009-8#1)(2010-1#3)
ECDs##5##1##(2010-1#5)
ECF##3##1##(2008-6#2)(2008-8#1)
ECG and##3##2##(1993-2#1)(1996-3#1)(2008-10#1)
ECG based##2##2##(2010-8#2)
ECG changes##3##2##(2008-3#2)(2008-7#1)
ECG monitoring##4##2##(1996-3#3)(2008-7#1)
ECG signals##4##2##(2010-8#4)
ECG##38##1##(1991-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1996-1#1)(1996-3#6)(2008-10#1)(2008-12#1)(2008-3#4)(2008-7#3)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-8#10)(2011-1#1)(2012-12#1)(2012-3#1)
ECH in water samples at the concentration##2##7##(2008-10#2)
ECH in##3##2##(2008-10#3)
ECH##6##1##(2008-10#6)
ECHL players##2##2##(2010-1#2)
ECII##6##1##(2008-11#6)
ECL catalytic activity##2##3##(2008-10#2)
ECL efficiency##2##2##(2008-10#2)
ECL intensity##6##2##(2008-10#6)
ECL of Ru(bpy)(3)(2+)##3##3##(2008-10#3)
ECL of##6##2##(2008-10#6)
ECL##31##1##(1997-1#2)(2008-10#29)
ECL-generating##2##1##(2010-7#2)
ECM accumulation in##2##3##(2011-2#2)
ECM accumulation##3##2##(2011-2#3)
ECM##21##1##(1993-3#4)(2009-10#3)(2009-12#3)(2009-7#1)(2011-2#4)(2012-2#2)(2013-8#4)
ECMO##2##1##(2010-5#1)(2011-3#1)
ECOD##2##1##(2008-11#2)
ECOPD##2##1##(2011-2#2)
ECRI Institute##6##2##(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#1)
ECRI##7##1##(2010-9#2)(2011-1#1)(2011-2#3)(2013-1#1)
ECS##5##1##(1996-12#5)
ECT in##2##2##(2010-7#1)(2012-12#1)
ECT##12##1##(2010-7#1)(2012-12#11)
ECVAM##4##1##(2008-10#4)
ECW##4##1##(2008-10#4)
ECW-10R##2##1##(2008-10#2)
ECW-20R##2##1##(2008-10#2)
ECW123##5##1##(2008-10#5)
ECW12346##5##1##(2008-10#5)
ECZs##3##1##(2008-10#3)
ED and##3##2##(2008-11#1)(2009-6#1)(2010-8#1)
ED by##2##2##(1997-2#1)(2011-2#1)
ED management##3##2##(2010-10#1)(2011-2#2)
ED nurses##4##2##(2008-7#3)(2009-9#1)
ED overcrowding is##3##3##(2008-11#3)
ED overcrowding##4##2##(2008-11#4)
ED symptoms##2##2##(2012-2#2)
ED##58##1##(1993-3#4)(1996-12#1)(1997-2#3)(1997-8#1)(2008-10#1)(2008-11#12)(2008-7#3)(2009-11#1)(2009-6#3)(2009-9#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2011-9#2)(2012-2#6)(2013-1#8)
ED's##2##1##(1997-2#1)(2011-2#1)
ED(50) of##2##2##(2008-10#1)(2008-11#1)
ED(50)##10##1##(2008-10#7)(2008-11#3)
ED-ETAAS##2##1##(2008-10#2)
ED50 of##3##2##(1991-5#1)(1992-3#1)(1994-8#1)
ED50##5##1##(1991-5#1)(1992-3#1)(1994-8#2)(1996-2#1)
EDFA's##2##1##(2008-2#2)
EDI##3##1##(1993-2#1)(2008-11#2)
EDI-OCT was##2##2##(2011-7#2)
EDI-OCT##5##1##(2011-7#5)
EDN3 gene##2##2##(1994-12#2)
EDN3 with##2##2##(1994-12#2)
EDN3##6##1##(1994-12#6)
EDNAP##2##1##(2008-12#2)
EDNRB gene##2##2##(1994-12#2)
EDNRB##7##1##(1994-12#7)
EDP##3##1##(1994-6#3)
EDRF##2##1##(1994-11#2)
EDRF1 and EDRF2 might##2##4##(2008-9#2)
EDRF1 gene##2##2##(2008-9#2)
EDRF1##17##1##(2008-8#7)(2008-9#10)
EDS microanalysis detector##2##3##(2008-10#2)
EDS of deposits produced by these cells demonstrated a calcium/phosphate ratio parallel to hydroxyapatite##2##14##(2008-11#2)
EDS##5##1##(2008-10#3)(2008-11#2)
EDTA and McIlvaine buffer at pH 7##2##7##(2008-10#2)
EDTA and citric acid##2##4##(2013-1#2)
EDTA and##14##2##(1996-12#1)(2008-10#11)(2013-1#2)
EDTA as a##2##3##(2008-10#2)
EDTA as##9##2##(2008-10#9)
EDTA at 33 mug of##2##5##(2008-10#2)
EDTA at##3##2##(2008-10#3)
EDTA complexes##2##2##(2008-10#2)
EDTA exchange##3##2##(2008-10#3)
EDTA for##2##2##(2008-10#1)(2013-1#1)
EDTA in the##2##3##(2008-10#1)(2008-11#1)
EDTA in##6##2##(2008-10#5)(2008-11#1)
EDTA was added to##2##4##(2008-10#2)
EDTA was added##3##3##(2008-10#3)
EDTA was##4##2##(2008-10#4)
EDTA with##3##2##(2008-10#3)
EDTA##113##1##(1990-5#1)(1992-3#1)(1994-5#3)(1994-8#1)(1995-6#2)(1996-12#1)(2006-6#1)(2008-10#92)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2013-1#4)
EDTA-bound Fe(III) is##3##3##(2008-10#3)
EDV##2##1##(2013-8#2)
EDX##3##1##(1992-12#1)(2008-10#1)(2013-1#1)
EDXRF##4##1##(2008-10#4)
EDs##4##1##(2008-11#4)
EE and##2##2##(2013-8#2)
EE has##2##2##(2009-11#2)
EE##13##1##(1990-11#1)(2008-10#1)(2009-11#5)(2013-8#6)
EEDQ into the##2##3##(1995-2#2)
EEG activity##3##2##(1991-9#1)(2010-8#2)
EEG analysis##3##2##(1991-12#1)(2009-8#2)
EEG and##2##2##(1991-9#1)(2013-8#1)
EEG changes##4##2##(1991-9#3)(2013-8#1)
EEG data##5##2##(2008-11#1)(2008-7#1)(2010-8#2)(2013-8#1)
EEG is##2##2##(2008-4#1)(2008-7#1)
EEG of##2##2##(2008-7#1)(2009-8#1)
EEG segment##2##2##(2010-8#2)
EEG slow##2##2##(1991-9#2)
EEG spectral##2##2##(1991-1#1)(2008-7#1)
EEG was recorded##2##3##(2008-11#1)(2008-7#1)
EEG was##3##2##(2008-11#1)(2008-7#2)
EEG##70##1##(1990-9#2)(1991-1#1)(1991-12#3)(1991-9#7)(1994-8#1)(2008-11#4)(2008-4#3)(2008-7#16)(2009-8#9)(2010-7#5)(2010-8#15)(2013-8#4)
EEGs##3##1##(2008-7#2)(2010-8#1)
EEOC##2##1##(1995-12#1)(1995-6#1)
EF for##2##2##(2008-10#2)
EF group##5##2##(2011-2#5)
EF##11##1##(2008-10#4)(2009-10#1)(2011-2#5)(2013-1#1)
EF&quot##2##1##(2011-2#2)
EF-1alpha and mtSSU rDNA##2##4##(2008-10#2)
EF-1alpha and##4##2##(2008-10#4)
EF-1alpha##6##1##(2008-10#6)
EF-35##3##1##(2008-10#3)
EFA##2##1##(2008-10#1)(2012-3#1)
EFIA cDNA##4##2##(1993-2#4)
EFIA##8##1##(1993-2#8)
EFIA#1##7##1##(1993-2#7)
EFS in the presence of##2##5##(1997-4#2)
EFS##5##1##(1997-4#4)(2008-10#1)
EFs##6##1##(2008-10#6)
EG III##3##2##(2008-9#3)
EG in##2##2##(2008-10#2)
EG material##3##2##(2008-10#3)
EG##14##1##(2008-10#11)(2008-9#3)
EGCG##3##1##(1995-9#1)(2008-11#2)
EGF and##4##2##(1991-7#2)(2008-11#1)(2008-6#1)
EGF increased##3##2##(1991-12#2)(1995-8#1)
EGF on##4##2##(1991-12#3)(2008-6#1)
EGF receptor tyrosine kinase##2##4##(1990-12#1)(1992-7#1)
EGF receptor##10##2##(1990-12#1)(1992-7#1)(1993-8#3)(1994-11#1)(1997-1#1)(2008-6#1)(2008-8#1)(2013-7#1)
EGF receptors are##2##3##(1991-7#1)(2008-6#1)
EGF receptors##4##2##(1990-8#1)(1991-7#1)(2008-6#1)(2010-5#1)
EGF stimulated##2##2##(1993-3#2)
EGF##64##1##(1990-12#3)(1990-8#2)(1991-12#10)(1991-7#5)(1992-7#2)(1993-3#6)(1993-8#3)(1994-11#1)(1994-3#1)(1995-6#4)(1995-8#1)(1997-1#1)(2008-11#5)(2008-6#11)(2008-8#4)(2010-5#2)(2011-2#2)(2013-7#1)
EGF-R was##2##2##(1991-7#2)
EGF-R##10##1##(1991-7#3)(1995-6#7)
EGF-like growth factor##2##3##(1997-1#2)
EGF-stimulated tyrosine kinase##2##3##(1992-7#2)
EGF-stimulated##3##1##(1992-7#3)
EGFP expressing cells##3##3##(2008-11#3)
EGFP expression##3##2##(2008-11#3)
EGFP##9##1##(2008-11#9)
EGFP-tagged##2##1##(2008-11#2)
EGFR##7##1##(1993-8#2)(2008-11#4)(2010-5#1)
EGFR-IC was##2##2##(1993-8#2)
EGFR-IC##4##1##(1993-8#4)
EGFs##3##1##(1990-12#3)
EGG##2##1##(2008-11#2)
EGR-1##4##1##(1991-10#4)
EGTA and##2##2##(1996-2#1)(2008-10#1)
EGTA or Ca(2+)##2##3##(2008-8#1)(2008-9#1)
EGTA or##3##2##(2008-8#2)(2008-9#1)
EGTA##11##1##(1990-10#2)(1995-8#1)(1996-2#1)(2008-10#2)(2008-8#4)(2008-9#1)
EH##10##1##(2008-9#4)(2009-7#2)(2011-2#4)
EHCO##4##1##(2008-10#4)
EHEC##4##1##(2008-9#4)
EHMC##8##1##(2008-10#7)(2008-5#1)
EHR##3##1##(2008-7#1)(2010-8#1)(2012-2#1)
EI##8##1##(2013-1#8)
EIA tests##3##2##(1990-9#1)(2008-5#2)
EIA##9##1##(1990-12#1)(1990-9#1)(2008-10#3)(2008-5#2)(2008-8#1)(2012-3#1)
EIAV L##6##2##(2008-9#6)
EIAV##8##1##(2008-9#8)
EIB##5##1##(2010-1#5)
EIN##4##1##(2011-2#4)
EIS##4##1##(1993-2#1)(2008-10#2)(2008-11#1)
EIT##3##1##(2011-2#3)
EIV##2##1##(2013-1#2)
EL##3##1##(2008-10#2)(2012-3#1)
ELA##2##1##(1994-12#2)
ELBW teenagers are##2##3##(2008-11#2)
ELBW teenagers##6##2##(2008-11#6)
ELBW##7##1##(2008-11#7)
ELECTRONIC SUPPLEMENTARY MATERIAL##12##3##(2010-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
ELF##2##1##(1992-3#1)(2008-12#1)
ELISA (enzyme-linked immunosorbent assay)##2##4##(1993-2#1)(2008-8#1)
ELISA analysis##3##2##(2008-10#2)(2008-8#1)
ELISA and Western blot##2##4##(1996-12#1)(2008-8#1)
ELISA and##16##2##(1990-12#1)(1991-12#2)(1992-6#1)(1996-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-8#1)(2011-2#1)
ELISA assay of amyloid##2##4##(2008-4#2)
ELISA assay##6##2##(1993-8#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-4#2)
ELISA employing##2##2##(1990-12#2)
ELISA for the detection of##2##5##(1990-12#1)(2008-10#1)
ELISA for the##3##3##(1990-12#1)(2008-10#2)
ELISA for##10##2##(1990-12#1)(1992-12#1)(2008-10#5)(2008-4#1)(2010-12#1)(2012-12#1)
ELISA format##2##2##(1995-2#1)(2008-10#1)
ELISA in both##2##3##(2008-10#2)
ELISA in##8##2##(1995-12#1)(2008-10#4)(2008-9#2)(2010-3#1)
ELISA is##3##2##(2008-10#2)(2008-11#1)
ELISA kit##2##2##(2008-12#1)(2008-8#1)
ELISA kits##2##2##(2008-10#1)(2011-2#1)
ELISA method for##2##3##(1991-2#1)(1992-11#1)
ELISA method##8##2##(1991-2#1)(1992-11#1)(2008-10#5)(2008-11#1)
ELISA results##2##2##(1990-12#1)(2013-8#1)
ELISA system##2##2##(2008-10#1)(2008-11#1)
ELISA technique##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
ELISA test##4##2##(1995-6#1)(1996-9#1)(2008-11#1)(2008-12#1)
ELISA using##4##2##(1992-3#1)(2008-10#1)(2008-11#2)
ELISA was specific for##2##4##(1990-12#1)(1995-11#1)
ELISA was##9##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-12#1)(1995-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
ELISA were##2##2##(2008-10#1)(2011-2#1)
ELISA##175##1##(1990-12#18)(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1992-11#3)(1992-12#4)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#3)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#59)(2008-11#14)(2008-12#2)(2008-4#8)(2008-5#2)(2008-6#2)(2008-8#6)(2008-9#4)(2009-3#1)(2010-12#2)(2010-3#3)(2011-2#6)(2012-12#3)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
ELISA)##2##1##(1990-12#1)(2012-12#1)
ELISA-based assays##7##2##(2008-10#7)
ELISA-based##8##1##(2008-10#8)
ELISAs##6##1##(2008-10#4)(2008-4#1)(2013-8#1)
ELISPOT##3##1##(2008-4#2)(2013-8#1)
EM tracking##2##2##(2013-1#2)
EM##7##1##(2008-10#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
EMA treatment##2##2##(2009-6#2)
EMA##7##1##(1994-12#1)(2009-6#4)(2011-2#1)(2012-12#1)
EMBASE##9##1##(1992-12#1)(1994-3#4)(2009-7#1)(2011-2#1)(2013-1#2)
EMBL database and##2##3##(2008-8#1)(2010-7#1)
EMBL database##4##2##(1991-9#1)(1996-8#1)(2008-8#1)(2010-7#1)
EMBL##5##1##(1991-9#1)(1996-8#1)(2008-4#1)(2008-8#1)(2010-7#1)
EMBL3##2##1##(1992-3#1)(1994-11#1)
EMBO##2##1##(1995-2#1)(1997-7#1)
EMC##4##1##(2010-7#1)(2012-3#3)
EMF (60 Hz##2##3##(2011-2#2)
EMF measurements##2##2##(2008-10#2)
EMF##8##1##(2008-10#4)(2011-2#4)
EMG activity in the##2##4##(2010-9#2)
EMG activity##6##2##(1990-9#1)(2010-8#1)(2010-9#2)(2013-1#2)
EMG and EOG##2##3##(2010-8#2)
EMG and##3##2##(2009-3#1)(2010-8#2)
EMG in##2##2##(2008-9#1)(2011-2#1)
EMG of the##2##3##(2012-2#2)
EMG of##3##2##(2012-2#3)
EMG recording##5##2##(2011-2#5)
EMG signal##2##2##(2012-2#1)(2013-1#1)
EMG signals were##2##3##(2010-8#1)(2012-2#1)
EMG signals##5##2##(2010-8#2)(2012-2#3)
EMG##42##1##(1990-9#3)(2008-12#1)(2008-9#1)(2009-3#2)(2010-8#8)(2010-9#2)(2011-2#6)(2012-12#7)(2012-2#8)(2013-1#4)
EMIT##2##1##(2008-10#2)
EMLA##4##1##(1993-1#4)
EMPIRE##3##1##(2008-11#3)
EMR##2##1##(2010-8#1)(2012-3#1)
EMS##3##1##(1996-3#2)(2008-9#1)
EMSA##4##1##(1995-8#1)(2008-11#1)(2008-8#2)
EMT6-R##3##1##(2008-11#3)
EMT6-S and EMT6-R##2##3##(2008-11#2)
EMT6-S##4##1##(2008-11#4)
EMTALA##2##1##(1995-12#1)(2008-4#1)
EN##9##1##(2008-10#5)(2008-11#4)
EN-4 wild type##2##3##(2008-10#2)
EN-4 with construct pPB-FO11-45##2##4##(2008-10#2)
EN-4##7##1##(2008-10#7)
EN5 stimulations##2##2##(1996-5#2)
ENA and WNA##4##3##(2008-8#4)
ENA and##6##2##(2008-8#6)
ENA##12##1##(2008-8#12)
ENA-78 gene##3##2##(1994-11#3)
ENA-78##4##1##(1994-11#4)
ENBD tubes##2##2##(2013-1#2)
ENBD##5##1##(2013-1#5)
ENETS##3##1##(2011-2#3)
ENFET##2##1##(2008-10#2)
ENHANCE##2##1##(2009-6#2)
ENK-ir fibers##4##2##(1992-3#4)
ENK-ir terminals##3##2##(1992-3#3)
ENK-ir##9##1##(1992-3#9)
ENO##6##1##(2008-10#6)
ENOX proteins##3##2##(2009-9#3)
ENOX##5##1##(2009-9#5)
ENOX2##11##1##(2009-9#11)
ENS##5##1##(2008-8#5)
ENT##3##1##(1991-6#1)(2009-1#1)(2013-8#1)
ENU##3##1##(2010-8#3)
EO##5##1##(2013-8#5)
EOC##4##1##(2010-7#4)
EODs##4##1##(2009-8#4)
EOF##5##1##(1997-2#1)(2008-10#4)
EOFL exerted##2##2##(2008-12#2)
EOFL##3##1##(2008-12#3)
EOP##2##1##(2008-10#2)
EOS##3##1##(1990-8#1)(2008-3#1)(2008-5#1)
EP lesions and CA lesions##2##5##(1994-12#2)
EP lesions##3##2##(1994-12#3)
EP was sensed again##2##4##(2008-10#2)
EP##15##1##(1994-12#3)(2008-10#12)
EP-IPV alone##2##2##(1995-5#2)
EP-IPV followed by OPV##3##4##(1995-5#3)
EP-IPV##9##1##(1995-5#9)
EPA guidelines##2##2##(2008-10#2)
EPA##13##1##(1991-12#1)(1995-3#1)(2008-10#8)(2010-1#1)(2013-1#2)
EPACT II##3##2##(2010-12#3)
EPE##3##1##(2008-3#3)
EPEC infection##2##2##(2011-2#2)
EPEC##6##1##(1995-2#2)(2011-2#4)
EPF##2##1##(2008-10#2)
EPG##4##1##(2008-10#4)
EPIC##3##1##(1991-12#3)
EPO by##2##2##(2008-11#2)
EPO production and glycosylation##2##4##(2008-11#2)
EPO production##3##2##(2008-11#3)
EPO quality##2##2##(2008-11#2)
EPO##26##1##(2008-11#21)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)
EPOF##8##1##(1993-12#8)
EPR spin##2##2##(2008-10#1)(2008-5#1)
EPR##17##1##(1993-8#3)(1994-11#1)(1997-7#1)(2008-10#8)(2008-5#1)(2008-8#1)(2009-5#2)
EPS I and EG##2##4##(2008-10#2)
EPS I##9##2##(2008-10#9)
EPS was##3##2##(2008-10#1)(2011-2#2)
EPS##24##1##(2008-10#11)(2011-2#13)
EPS-minus strains##2##2##(2008-10#2)
EPS-minus##3##1##(2008-10#3)
EPSCs##3##1##(1996-2#3)
EPV100 emergency portable ventilators##2##4##(2011-1#2)
EPV100##3##1##(2011-1#3)
EQCM##2##1##(2008-10#2)
ER and##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
ER content##2##2##(1993-1#2)
ER distribution##2##2##(2013-1#2)
ER gene##4##2##(1993-6#2)(1997-7#2)
ER is##4##2##(1990-5#1)(1995-9#1)(2008-11#1)(2009-8#1)
ER levels##2##2##(1993-6#2)
ER mRNA##2##2##(2008-6#2)
ER status##2##2##(1993-1#1)(1994-12#1)
ER structure##2##2##(2009-8#1)(2011-2#1)
ER##75##1##(1990-5#4)(1991-2#3)(1992-3#1)(1992-6#1)(1993-1#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#5)(1994-12#3)(1995-2#2)(1995-9#1)(1997-1#1)(1997-7#3)(2008-10#2)(2008-11#9)(2008-12#1)(2008-6#4)(2008-8#1)(2008-9#1)(2009-8#13)(2011-2#5)(2012-2#1)(2013-1#4)(2013-8#1)
ER(2) =##4##2##(2009-9#4)
ER- breast cancer cell##2##4##(2011-1#2)
ER-##4##1##(1992-4#2)(2011-1#2)
ER-L##9##1##(2010-12#9)
ER-ir neurons in the##2##4##(1992-3#2)
ER-ir neurons##5##2##(1992-3#5)
ER-negative##2##1##(1990-5#1)(1997-7#1)
ER-poor##3##1##(1993-1#3)
ER-positive breast cancer##2##3##(1990-5#1)(2011-2#1)
ER-positive##3##1##(1990-5#1)(1997-7#1)(2011-2#1)
ER/LA opioid REMS##2##3##(2013-1#2)
ER/LA##3##1##(2013-1#3)
ERAP1##3##1##(2012-2#3)
ERAS##2##1##(2013-1#1)(2013-8#1)
ERCP and conservative management##2##4##(2013-1#2)
ERCP and##4##2##(1990-9#1)(2013-1#3)
ERCP was done within 72 hours##2##6##(2013-1#2)
ERCP##16##1##(1990-9#2)(1991-9#2)(2008-2#1)(2013-1#11)
ERD##3##1##(2013-8#3)
ERE-mediated transcription##2##2##(2011-2#2)
ERG##5##1##(2009-12#5)
ERIC##3##1##(2008-10#1)(2009-7#1)(2013-1#1)
ERISA##3##1##(1993-12#2)(1997-2#1)
ERK in##2##2##(2010-12#1)(2013-1#1)
ERK nuclear translocation##4##3##(2010-10#4)
ERK phosphorylation##2##2##(2008-11#1)(2013-8#1)
ERK signaling pathway##2##3##(2013-1#2)
ERK signaling##3##2##(2009-8#1)(2013-1#2)
ERK##26##1##(1996-2#1)(2008-11#1)(2009-8#2)(2010-10#8)(2010-12#1)(2011-2#2)(2013-1#5)(2013-8#6)
ERK-dependent##2##1##(2009-8#1)(2013-1#1)
ERK1##2##1##(2010-10#2)
ERK1-4##3##1##(2010-10#3)
ERK1/2##3##1##(2008-11#1)(2010-1#2)
ERKpp output is##2##3##(2009-8#2)
ERKpp output##4##2##(2009-8#4)
ERM##5##1##(2011-2#4)(2013-8#1)
ERP data##2##2##(2008-11#2)
ERP##7##1##(2008-11#4)(2013-8#3)
ERPs##4##1##(1995-2#2)(2008-11#1)(2008-8#1)
ERR##2##1##(2013-1#2)
ERT costs##2##2##(2012-12#2)
ERT##6##1##(2012-12#6)
ERW supplemented with Pt nps suppressed##2##6##(2008-11#2)
ERW supplemented with Pt nps##4##5##(2008-11#4)
ERW supplemented with synthesized Pt nps##2##6##(2008-11#2)
ERW supplemented with##6##3##(2008-11#6)
ERW##9##1##(2008-11#9)
ERalpha mRNA##3##2##(2008-12#3)
ERalpha##6##1##(2008-11#2)(2008-12#4)
ERs##3##1##(1997-7#1)(2008-10#2)
ERα positive breast##2##3##(2011-2#2)
ERα##5##1##(2011-2#4)(2013-7#1)
ES cell clones##2##3##(2008-11#1)(2008-9#1)
ES cell differentiation##2##3##(2008-11#1)(2012-2#1)
ES cell##14##2##(2008-11#10)(2008-9#1)(2012-2#3)
ES cell-derived##2##2##(2008-11#1)(2008-9#1)
ES cells and the##2##4##(2008-11#1)(2008-8#1)
ES cells and##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
ES cells by##2##3##(1997-8#1)(2008-8#1)
ES cells using##3##3##(2008-8#2)(2011-2#1)
ES cells were##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
ES cells##34##2##(1997-8#1)(2008-11#13)(2008-8#9)(2008-9#9)(2009-12#1)(2011-2#1)
ES in the##2##3##(2012-2#2)
ES in##3##2##(2012-2#2)(2013-1#1)
ES is##3##2##(2013-1#3)
ES##78##1##(1997-8#1)(2008-10#1)(2008-11#24)(2008-8#12)(2008-9#11)(2009-10#2)(2009-12#1)(2011-2#1)(2012-2#18)(2013-1#7)
ES)##5##1##(2009-10#3)(2012-2#2)
ES-MS detection##2##2##(2008-10#2)
ES/MS##2##1##(2008-10#2)
ESA##9##1##(2008-11#8)(2010-11#1)
ESAS##2##1##(2008-7#2)
ESAs##3##1##(2010-11#3)
ESBL##9##1##(2008-10#1)(2010-6#7)(2012-2#1)
ESBL-producing##2##1##(2008-10#1)(2010-6#1)
ESC##10##1##(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#2)(2013-1#1)
ESCs##3##1##(2008-9#3)
ESEM##2##1##(2008-9#2)
ESI##5##1##(1997-8#1)(2008-10#1)(2011-2#2)(2011-3#1)
ESI-IMS##2##1##(2008-10#2)
ESI-MS and##2##2##(2008-10#1)(2011-3#1)
ESI-MS##10##1##(2008-10#7)(2008-9#2)(2011-3#1)
ESIMA##2##1##(2008-11#2)
ESIMS##2##1##(2010-6#1)(2011-2#1)
ESP##2##1##(1994-12#2)
ESPU meeting in##2##3##(2008-10#2)
ESPU##4##1##(2008-10#4)
ESR##14##1##(1993-6#1)(1993-8#1)(1994-5#1)(2008-10#7)(2008-8#1)(2008-9#1)(2012-2#2)
ESR1##2##1##(2011-2#2)
ESRD HCQIP##2##2##(1996-2#2)
ESRD patients##6##2##(1995-12#4)(1996-2#2)
ESRD##20##1##(1991-3#4)(1995-1#2)(1995-12#7)(1996-2#5)(2008-1#2)
ESRT and##2##2##(2008-9#2)
ESRT##4##1##(2008-9#4)
ESS model##2##2##(2008-8#2)
ESS##9##1##(2008-8#4)(2008-9#4)(2012-3#1)
EST##13##1##(1995-8#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#6)
ESTs from##2##2##(1997-6#1)(1997-8#1)
ESTs were##3##2##(1997-6#1)(1997-8#1)(2010-4#1)
ESTs##14##1##(1995-8#1)(1997-6#3)(1997-8#4)(2008-11#1)(2008-9#1)(2010-10#2)(2010-4#2)
ESUs##2##1##(2008-8#2)
ESWL##2##1##(1994-5#1)(2013-1#1)
ET AAS##7##2##(2008-10#7)
ET and dystonia##2##3##(2013-1#2)
ET and##3##2##(2012-3#1)(2013-1#2)
ET cases than##2##3##(2008-7#1)(2013-1#1)
ET cases##5##2##(2008-7#1)(2013-1#4)
ET intubation was##2##3##(2010-7#2)
ET patients##2##2##(2008-7#2)
ET##36##1##(1995-3#2)(2008-10#11)(2008-7#4)(2008-9#1)(2010-7#2)(2012-3#9)(2013-1#7)
ET-1 was##2##2##(1993-3#1)(1994-8#1)
ET-1##32##1##(1991-5#4)(1993-3#18)(1994-11#4)(1994-8#6)
ET-1-activated migration##3##2##(1994-8#3)
ET-1-induced activation of##2##3##(1993-8#2)
ET-1-induced##3##1##(1993-8#3)
ET-AAS determination##2##2##(2008-10#2)
ET-AAS##4##1##(2008-10#4)
ETAAS determination of##2##3##(2008-10#2)
ETAAS determination##5##2##(2008-10#5)
ETAAS method##3##2##(2008-10#3)
ETAAS using##4##2##(2008-10#4)
ETAAS with##2##2##(2008-10#2)
ETAAS##47##1##(2008-10#47)
ETAAS)##2##1##(2008-10#2)
ETBE##2##1##(2009-8#2)
ETDRS##3##1##(2011-2#1)(2013-1#2)
ETH 9009##2##2##(2008-10#2)
ETH##12##1##(2008-10#12)
ETHICAL##2##1##(2009-4#2)
ETOH concentration##2##2##(1990-5#2)
ETOH##9##1##(1990-5#9)
ETR##6##1##(2011-2#6)
ETU##2##1##(2008-3#2)
ETV##5##1##(2008-10#5)
ETV-ICP-MS after##2##2##(2008-10#2)
ETV-ICP-MS##4##1##(2008-10#4)
ETeB##2##1##(2008-11#2)
EU Directive##4##2##(2008-10#1)(2008-11#3)
EU directive##2##2##(1997-8#1)(2008-10#1)
EU##22##1##(1997-8#1)(2008-10#13)(2008-11#5)(2009-8#2)(2013-8#1)
EURACHEM Guide##3##2##(2008-10#3)
EURACHEM##5##1##(2008-10#5)
EUS has a##2##3##(2008-2#2)
EUS##10##1##(2008-2#5)(2013-1#5)
EUS-guided##2##1##(2008-2#1)(2013-1#1)
EUSES##8##1##(2008-11#8)
EUV##3##1##(2008-3#3)
EV##2##1##(2008-4#1)(2013-8#1)
EV71 strains MS##2##3##(2008-8#2)
EV71 strains isolated in##2##4##(2008-12#2)
EV71 strains isolated##3##3##(2008-12#3)
EV71 strains of##2##3##(2008-12#2)
EV71 strains##11##2##(2008-12#8)(2008-8#3)
EV71##20##1##(2008-12#10)(2008-8#7)(2013-8#3)
EVA##3##1##(2008-10#1)(2008-7#2)
EVALUATION##2##1##(2011-2#2)
EVIDENCE FROM THE FIRST YEAR##2##5##(2013-1#2)
EVIDENCE##4##1##(2009-3#1)(2012-3#1)(2013-1#2)
EWR##4##1##(2009-3#4)
EX##2##1##(1995-6#2)
EX4##2##1##(1993-8#2)
EXAFS data##2##2##(2008-10#1)(2012-12#1)
EXAFS##6##1##(2008-10#4)(2012-12#2)
EXPRESSION##2##1##(2009-9#1)(2010-1#1)
EYE2##2##1##(2012-3#2)
Ea##3##1##(2008-11#3)
Ea)##2##1##(2008-11#2)
Each analysis##2##2##(2008-10#2)
Each article was##2##3##(2012-12#2)
Each element's detailed design was evaluated against internal and external established best practices##2##13##(2012-2#2)
Each group was##2##3##(2011-2#1)(2013-1#1)
Each is##3##2##(2008-12#1)(2008-9#1)(2009-8#1)
Each isolate##3##2##(1997-8#1)(2008-10#2)
Each limb was##2##3##(2012-3#2)
Each material##2##2##(2011-1#1)(2013-1#1)
Each method has its##2##4##(1992-3#1)(2008-9#1)
Each method has##4##3##(1992-3#1)(2008-10#1)(2008-9#1)(2010-11#1)
Each method##6##2##(1992-3#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-11#1)
Each month##2##2##(1996-12#1)(2008-10#1)
Each neuron##2##2##(1994-2#1)(2008-11#1)
Each of the three##3##4##(1991-9#1)(2008-10#1)(2009-10#1)
Each of the##12##3##(1991-9#1)(1992-4#1)(1993-8#1)(1995-2#1)(1996-1#1)(2008-10#3)(2009-10#1)(2009-11#1)(2010-4#1)(2013-8#1)
Each of these components##2##4##(2009-8#1)(2010-1#1)
Each of these##8##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-1#1)
Each of##21##2##(1991-9#1)(1992-4#1)(1993-8#1)(1995-2#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-4#1)(2013-8#1)
Each one##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
Each participant##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
Each patient was##2##3##(2008-12#1)(2012-2#1)
Each patient##6##2##(1991-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Each population##2##2##(2008-10#1)(2008-9#1)
Each session##2##2##(1991-11#1)(2013-1#1)
Each species was##2##3##(2008-10#2)
Each type of##3##3##(2008-11#1)(2008-5#2)
Each valve was##2##3##(1991-3#2)
Each year##3##2##(2012-2#1)(2012-6#1)(2013-1#1)
Each##166##1##(1990-5#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-9#1)(1992-3#3)(1992-4#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#46)(2008-11#9)(2008-12#8)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#3)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#1)(2009-8#3)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#4)(2012-6#1)(2013-1#9)(2013-8#2)
Eagle's##3##1##(2008-11#2)(2008-12#1)
Ear##6##1##(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)
Earlier research##2##2##(2010-3#1)(2011-3#1)
Earlier studies have##2##3##(1994-3#1)(2012-2#1)
Earlier##11##1##(1994-3#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-3#1)(2011-3#1)(2012-2#1)(2013-8#1)
Early Breast Cancer Trialists' Collaborative Group##2##6##(1993-11#1)(1993-12#1)
Early Breast Cancer##3##3##(1993-11#2)(1993-12#1)
Early Career Investigators##3##3##(2012-2#3)
Early Detection##3##2##(1997-1#2)(2008-12#1)
Early and##2##2##(2008-10#1)(2011-3#1)
Early clinical##2##2##(1995-1#1)(2010-11#1)
Early diagnosis and##3##3##(2008-12#1)(2010-11#1)(2013-1#1)
Early diagnosis is##2##3##(2010-5#1)(2011-2#1)
Early diagnosis##8##2##(1996-12#1)(1997-8#1)(2008-12#1)(2010-11#2)(2010-5#1)(2011-2#1)(2013-1#1)
Early in##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
Early initiation of##2##3##(2008-7#1)(2013-1#1)
Early intervention##3##2##(1994-1#2)(2010-9#1)
Early life##3##2##(1995-9#1)(2010-10#1)(2012-2#1)
Early postoperative##2##2##(1993-12#2)
Early recognition and##4##3##(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
Early recognition of this##2##4##(2013-1#1)(2013-7#1)
Early recognition of##4##3##(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
Early recognition##9##2##(1997-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
Early stages of##2##3##(2008-10#1)(2008-12#1)
Early studies were##2##3##(2008-11#1)(2008-9#1)
Early studies##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
Early treatment##2##2##(2008-9#1)(2012-2#1)
Early##123##1##(1990-11#1)(1990-3#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#3)(1994-1#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#13)(2008-11#13)(2008-12#6)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-11#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#11)(2011-3#1)(2011-8#1)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#1)
Earth and##3##2##(2008-10#1)(2008-3#2)
Earth##12##1##(2008-10#3)(2008-12#2)(2008-3#5)(2011-2#1)(2012-2#1)
Earth's##7##1##(1995-3#2)(2008-11#1)(2008-12#1)(2008-3#3)
Earthworm##3##1##(2008-5#2)(2008-9#1)
East Africa##3##2##(2008-10#3)
East African and New World##2##5##(2008-10#2)
East African strains##4##3##(2008-10#4)
East African##8##2##(2008-10#8)
East Asia##9##2##(2008-10#3)(2008-8#2)(2011-2#1)(2013-1#3)
East Asian##8##2##(2008-12#1)(2008-6#1)(2010-8#5)(2012-2#1)
East Chapman##5##2##(2008-10#5)
East Coast Hockey League##2##4##(2010-1#2)
East Coast fever##3##3##(2010-1#3)
East Coast##5##2##(2010-1#5)
East Germany##2##2##(2008-10#1)(2008-11#1)
East and##7##2##(1997-8#3)(2008-10#2)(2011-2#2)
East##78##1##(1995-1#2)(1995-3#3)(1997-3#1)(1997-8#3)(2008-10#30)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2010-1#6)(2010-8#6)(2011-2#6)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#3)(2013-8#2)
Eastern Europe##2##2##(1995-3#1)(2011-2#1)
Eastern North##2##2##(2008-10#1)(2012-3#1)
Eastern and Western##2##3##(2008-10#1)(2009-10#1)
Eastern and##4##2##(1992-6#1)(2008-10#2)(2009-10#1)
Eastern##24##1##(1992-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1997-7#1)(2008-10#11)(2008-5#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#3)(2012-3#1)
Easy##3##1##(1996-5#1)(2008-10#1)(2008-8#1)
Eating Behaviors##2##2##(2012-2#1)(2013-1#1)
Eating Disorder##2##2##(2012-2#1)(2012-5#1)
Eating behavior##2##2##(2012-5#2)
Eating disorders##2##2##(2008-11#1)(2012-2#1)
Eating##10##1##(2008-11#1)(2011-2#1)(2012-2#4)(2012-5#3)(2013-1#1)
Ebro river##4##2##(2008-10#4)
Ebro##5##1##(2008-10#5)
EcR/USP##2##1##(1995-8#2)
EcV may##2##2##(2009-8#2)
EcV##6##1##(2009-8#6)
Echinococcosis##2##1##(2008-7#1)(2011-2#1)
Echinococcus granulosus##3##2##(1996-12#1)(2010-11#1)(2011-2#1)
Echinococcus multilocularis##3##2##(1996-12#2)(2010-11#1)
Echinococcus##6##1##(1996-12#3)(2010-11#2)(2011-2#1)
Echocardiographic##5##1##(1997-5#1)(2008-11#2)(2012-12#1)(2012-3#1)
Echocardiography revealed##2##2##(2008-11#1)(2010-5#1)
Echocardiography##8##1##(2008-11#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
EcoRI DNA##2##2##(1992-3#2)
EcoRI and##2##2##(2008-10#2)
EcoRI fragment of##2##3##(1992-3#1)(1995-8#1)
EcoRI fragment##3##2##(1992-3#1)(1995-8#1)(2008-10#1)
EcoRI restriction##2##2##(1991-9#1)(2008-4#1)
EcoRI##15##1##(1991-9#3)(1992-3#3)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-8#1)(2008-10#3)(2008-4#1)
Ecol##2##1##(2008-10#2)
Ecological biogeography of southern ocean islands##2##6##(2008-8#1)(2008-9#1)
Ecological studies##2##2##(2008-12#1)(2009-8#1)
Ecological##16##1##(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#4)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#2)
Ecology and evolution of##2##4##(2008-8#2)
Ecology and##4##2##(1990-11#1)(2008-8#2)(2013-1#1)
Ecology of##4##2##(2008-10#3)(2009-10#1)
Ecology##14##1##(1990-11#2)(2008-10#3)(2008-8#2)(2009-10#1)(2013-1#6)
Economic Change##2##2##(1994-3#2)
Economic and##3##2##(1991-2#1)(2008-10#1)(2009-10#1)
Economic##26##1##(1990-2#1)(1991-2#3)(1992-2#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
Economics##2##1##(1990-8#1)(2008-12#1)
Ecotoxicological##2##1##(2008-11#2)
Ectopic expression of##2##3##(1994-12#1)(2008-8#1)
Ectopic opening of the vas deferens into##2##7##(2008-10#2)
Ectopic##8##1##(1994-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
Ecuador of##2##2##(2008-10#2)
Ecuador##19##1##(1992-5#1)(2008-10#15)(2008-5#2)(2008-9#1)
Ecuadorian##3##1##(2008-10#3)
Ed##2##1##(1990-11#1)(1991-1#1)
Eddy##2##1##(1991-1#1)(1996-3#1)
Edge Hill railway accident##2##4##(2009-10#2)
Edge Hill##3##2##(2009-10#3)
Edge##5##1##(2008-9#1)(2009-10#3)(2011-2#1)
Edinburgh##2##1##(1997-5#1)(2013-1#1)
Edison##2##1##(1995-12#2)
Edition##6##1##(2008-12#1)(2010-11#1)(2011-2#3)(2012-2#1)
Editor's Note##2##2##(1996-1#1)(2010-7#1)
Editor's Pick##5##2##(2008-8#5)
Editor's pick##2##2##(2008-8#2)
Editor's preface##2##2##(2009-11#1)(2010-5#1)
Editor's##11##1##(1996-1#1)(2008-8#7)(2009-11#1)(2010-5#1)(2010-7#1)
Editorial Board has now been established and consists of##3##9##(2010-12#3)
Editorial comment##13##2##(2008-11#12)(2008-9#1)
Editorial##55##1##(1995-11#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-6#2)(2006-5#1)(2008-10#6)(2008-11#17)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#3)(2009-4#1)(2010-10#2)(2010-12#3)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
Editors and peer reviewers should encourage authors to include a discussion of CS##2##13##(2013-1#2)
Editors##3##1##(2008-8#1)(2013-1#2)
Editors-in-Chief##5##1##(2008-10#5)
Edman degradation of##2##3##(1990-5#1)(2008-4#1)
Edman degradation##5##2##(1990-5#1)(1994-11#1)(1996-12#1)(2008-4#1)(2010-4#1)
Edman##6##1##(1990-5#1)(1992-3#1)(1994-11#1)(1996-12#1)(2008-4#1)(2010-4#1)
Edmonton##3##1##(1991-2#1)(1992-5#1)(2008-7#1)
Eds##6##1##(1990-11#3)(1990-8#3)
Educating for##2##2##(1995-12#1)(2008-11#1)
Educating the##2##2##(1991-1#1)(1997-8#1)
Educating##6##1##(1991-1#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-11#2)
Education Units##2##2##(2008-11#2)
Education and Communication##2##3##(2011-2#2)
Education and training##4##3##(1992-1#1)(1993-1#1)(1994-1#1)(2008-11#1)
Education and##11##2##(1992-1#1)(1992-3#2)(1993-1#1)(1994-1#1)(1994-12#1)(1995-12#1)(2008-11#1)(2010-8#1)(2011-2#2)
Education for##7##2##(1992-1#1)(1996-1#1)(1997-3#1)(2008-11#2)(2012-3#1)(2013-1#1)
Education in Practice##2##3##(2008-11#1)(2008-12#1)
Education in clinical chemistry in##2##5##(1994-12#2)
Education in clinical chemistry##4##4##(1994-12#4)
Education in clinical##5##3##(1994-12#5)
Education in##10##2##(1993-3#1)(1994-12#5)(1997-3#1)(2008-11#2)(2008-12#1)
Education of##5##2##(1991-8#1)(1994-12#1)(1995-11#1)(2008-1#1)(2008-8#1)
Education##90##1##(1991-12#6)(1991-3#1)(1991-8#3)(1992-1#2)(1992-3#2)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#9)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#1)(1997-3#2)(2008-1#2)(2008-11#24)(2008-12#11)(2008-5#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#6)(2013-1#2)
Educational##13##1##(1992-1#1)(1993-1#1)(1993-2#1)(2008-11#3)(2008-8#2)(2009-10#1)(2009-4#1)(2010-10#1)(2012-2#1)(2012-3#1)
Educators##4##1##(1996-3#1)(2008-1#1)(2008-11#1)(2009-8#1)
Edward Island##9##2##(1991-8#1)(2008-10#1)(2012-3#5)(2013-8#2)
Edward##13##1##(1991-8#1)(1995-6#1)(1996-5#1)(2008-10#3)(2012-3#5)(2013-8#2)
Edwards##4##1##(1993-12#1)(1996-1#1)(2008-11#1)(2012-3#1)
Effect in##3##2##(1996-9#1)(2008-10#1)(2008-11#1)
Effect of DNA##2##3##(2008-8#1)(2008-9#1)
Effect of Relative Humidity##2##4##(2008-10#2)
Effect of Water##2##3##(2008-10#2)
Effect of a##2##3##(2008-10#1)(2013-1#1)
Effect of acute##2##3##(1994-11#1)(2010-8#1)
Effect of age on##2##4##(1990-3#1)(2008-7#1)
Effect of age##3##3##(1990-3#1)(2008-7#1)(2010-4#1)
Effect of an##2##3##(2008-11#1)(2013-1#1)
Effect of different##6##3##(2008-10#1)(2008-12#2)(2008-9#1)(2012-12#1)(2012-2#1)
Effect of fluoride##2##3##(2013-1#2)
Effect of low##2##3##(2010-9#1)(2013-1#1)
Effect of pH##2##3##(2008-10#2)
Effect of retinoic acid on##2##5##(1993-3#1)(1994-11#1)
Effect of retinoic acid##3##4##(1993-3#1)(1994-11#1)(1995-9#1)
Effect of serum##2##3##(1995-12#1)(2008-11#1)
Effect of short-term##2##3##(1992-9#1)(2012-3#1)
Effect of substrate##2##3##(2008-3#1)(2008-7#1)
Effect of temperature on##4##4##(2008-10#3)(2008-11#1)
Effect of the##15##3##(1996-12#1)(2008-10#9)(2008-11#2)(2008-7#1)(2010-2#1)(2013-8#1)
Effect of vitamin C##2##4##(1992-9#1)(2008-5#1)
Effect of vitamin##3##3##(1992-9#1)(1993-12#1)(2008-5#1)
Effect of##251##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#6)(1994-3#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-3#1)(1995-8#2)(1995-9#2)(1996-12#2)(1996-2#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-7#2)(1997-8#1)(2008-10#73)(2008-11#18)(2008-12#10)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#15)(2013-8#5)
Effect on##7##2##(2008-10#4)(2008-8#1)(2009-8#1)(2013-1#1)
Effect sizes##4##2##(2008-10#2)(2009-9#1)(2013-8#1)
Effect##271##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#6)(1994-3#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-3#1)(1995-8#2)(1995-9#2)(1996-12#2)(1996-2#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-7#2)(1997-8#1)(2008-10#82)(2008-11#21)(2008-12#10)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#16)(2013-8#6)
Effective leadership##2##2##(1991-1#1)(2010-1#1)
Effective##28##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-3#1)(1996-3#1)(1997-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#1)
Effectively##2##1##(1993-2#1)(1994-2#1)
Effectiveness of##17##2##(1991-12#1)(1991-8#1)(1994-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
Effectiveness##18##1##(1991-12#1)(1991-8#1)(1994-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
Effects and##2##2##(1992-3#1)(1996-3#1)
Effects for##2##2##(2008-10#1)(2008-12#1)
Effects of HIV-1##2##3##(2008-11#1)(2008-2#1)
Effects of Irrigation and##2##4##(2008-10#2)
Effects of Temperature and##3##4##(2008-10#3)
Effects of a##10##3##(1993-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Effects of an intervention##2##4##(1991-2#1)(2010-4#1)
Effects of an##7##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2010-4#1)(2011-2#1)
Effects of capsaicin on##2##4##(1993-11#1)(2008-11#1)
Effects of chronic##2##3##(1991-1#1)(1996-12#1)
Effects of different##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
Effects of ethanol##3##3##(1990-5#1)(1991-1#1)(2008-10#1)
Effects of flow rate##2##4##(2008-10#1)(2010-4#1)
Effects of host##2##3##(2008-10#2)
Effects of leucine and related compounds on protein synthesis were studied in##2##12##(2008-11#2)
Effects of membrane##2##3##(1997-1#1)(2008-10#1)
Effects of organic##2##3##(2008-10#2)
Effects of pH##3##3##(2008-10#3)
Effects of plasticizers##2##3##(2008-10#2)
Effects of selected##2##3##(1994-1#1)(2012-3#1)
Effects of several##2##3##(2008-10#1)(2008-11#1)
Effects of swainsonine##2##3##(2008-11#2)
Effects of the##6##3##(1995-2#1)(2008-10#3)(2009-10#1)(2009-9#1)
Effects of##271##2##(1990-11#1)(1990-2#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-1#6)(1991-2#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#5)(1995-11#4)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#3)(1997-2#1)(1997-5#1)(2006-6#1)(2008-10#77)(2008-11#24)(2008-12#11)(2008-2#3)(2008-3#8)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#10)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-10#2)(2011-2#7)(2012-12#1)(2012-2#7)(2012-3#4)(2012-4#1)(2013-1#10)(2013-8#2)
Effects on other##2##3##(1995-6#1)(2008-11#1)
Effects on##16##2##(1991-1#2)(1995-6#1)(2008-10#8)(2008-11#2)(2009-8#1)(2012-2#1)(2012-3#1)
Effects##303##1##(1990-11#1)(1990-2#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-1#8)(1991-2#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#5)(1995-11#4)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#1)(1997-1#3)(1997-2#1)(1997-5#1)(2006-6#1)(2008-10#88)(2008-11#27)(2008-12#12)(2008-2#3)(2008-3#9)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#10)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-10#2)(2011-2#7)(2012-12#1)(2012-2#9)(2012-3#5)(2012-4#1)(2013-1#10)(2013-8#2)
Efficacy and safety of##5##4##(2008-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
Efficacy and##8##2##(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
Efficacy of##18##2##(1990-6#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
Efficacy##32##1##(1990-6#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
Efficiency in##2##2##(2012-2#1)(2013-8#1)
Efficiency of##10##2##(2008-10#7)(2008-5#1)(2012-3#1)(2013-8#1)
Efficiency##17##1##(2008-1#1)(2008-10#11)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#2)
Efficient continuous-wave##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
Efficient pulsed##2##2##(2008-2#2)
Efficient secretion of##2##3##(1993-6#1)(1995-6#1)
Efficient transfection of##2##3##(2008-11#2)
Efficient##36##1##(1992-1#1)(1992-11#1)(1993-6#1)(1995-6#1)(1996-5#2)(2007-12#2)(2008-10#1)(2008-11#5)(2008-2#7)(2008-3#7)(2008-8#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
Efforts to improve##3##3##(1993-6#1)(2012-3#1)(2013-1#1)
Efforts to##12##2##(1991-3#1)(1993-5#1)(1993-6#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
Efforts##17##1##(1991-3#1)(1993-5#1)(1993-6#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
Egg deposition##2##2##(2013-1#2)
Egg##11##1##(1996-12#1)(2008-10#1)(2008-12#3)(2010-8#3)(2012-2#1)(2013-1#2)
Eggs of##3##2##(2008-10#1)(2008-12#1)(2010-8#1)
Eggs##7##1##(1991-5#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-8#2)
Egypt in 2006##2##3##(2011-2#2)
Egypt in##3##2##(2008-10#1)(2011-2#2)
Egypt##29##1##(1994-9#1)(1996-2#1)(1997-8#1)(2008-1#2)(2008-10#15)(2008-11#1)(2010-10#2)(2011-2#3)(2013-1#3)
Egyptian blue##2##2##(2008-10#2)
Egyptian##12##1##(1991-2#1)(2008-1#1)(2008-10#8)(2010-10#2)
Eh252 and 10##2##3##(2008-10#2)
Eh252 and##5##2##(2008-10#5)
Eh252##15##1##(2008-10#15)
Ehlers-Danlos syndrome##4##2##(2008-5#1)(2013-8#3)
Eichrom##2##1##(2008-10#2)
Eigen's##2##1##(1997-6#2)
Eigenvalue##2##1##(1996-9#1)(2008-3#1)
Eight different##2##2##(2008-10#2)
Eight hundred##2##2##(2008-11#1)(2012-3#1)
Eight new##2##2##(1997-9#1)(2010-6#1)
Eight of the##2##3##(1996-6#1)(2010-4#1)
Eight of these patients##2##4##(1994-9#1)(2008-1#1)
Eight of these##4##3##(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#1)
Eight of##9##2##(1994-6#1)(1994-9#1)(1996-6#1)(2008-1#1)(2008-10#2)(2010-2#1)(2010-4#1)(2012-2#1)
Eight patients underwent##2##3##(1991-2#1)(2012-3#1)
Eight patients were##2##3##(2008-10#1)(2008-7#1)
Eight patients##7##2##(1990-9#1)(1991-2#1)(1995-11#1)(2008-10#1)(2008-7#1)(2009-11#1)(2012-3#1)
Eight public hospitals were included##2##5##(2013-1#2)
Eight replicate##2##2##(2008-10#2)
Eight studies##2##2##(2013-1#1)(2013-8#1)
Eight subjects##2##2##(1994-3#1)(2011-2#1)
Eight weeks##2##2##(1991-3#1)(2009-10#1)
Eight##71##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-1#3)(2008-10#24)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#3)
Eighteen female##2##2##(1992-3#1)(2008-11#1)
Eighteen participants##2##2##(2008-11#1)(2012-3#1)
Eighteen patients##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
Eighteen percent of##2##3##(1990-2#1)(1994-3#1)
Eighteen##20##1##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1994-3#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-9#1)(2010-10#1)(2011-2#2)(2012-3#2)(2013-1#2)
Eighty patients with##2##3##(2011-2#1)(2013-1#1)
Eighty percent of##2##3##(1997-3#1)(2012-2#1)
Eighty##10##1##(1990-3#1)(1995-3#1)(1997-3#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
Eighty-eight patients with##2##3##(1991-2#1)(1997-8#1)
Eighty-eight percent of##2##3##(1991-8#1)(1995-2#1)
Eighty-eight##6##1##(1991-2#1)(1991-8#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-10#1)
Eighty-four percent##2##2##(1991-12#1)(1992-1#1)
Eighty-four##5##1##(1991-12#1)(1992-1#1)(2008-10#1)(2008-12#1)(2008-9#1)
Eighty-nine##3##1##(1991-12#1)(2008-10#1)(2008-9#1)
Eighty-six##7##1##(1990-8#1)(1991-3#1)(1997-9#1)(2008-10#2)(2009-8#1)(2011-2#1)
Eighty-three##3##1##(1991-12#1)(2008-10#1)(2008-11#1)
Eikenella corrodens##2##2##(1997-8#1)(2013-8#1)
Eisenia fetida##3##2##(2008-12#1)(2008-9#2)
Eisenia foetida##2##2##(2008-5#2)
Eisenia##5##1##(2008-12#1)(2008-5#2)(2008-9#2)
Either the##4##2##(1992-9#1)(2008-3#1)(2008-7#1)(2008-8#1)
Either##9##1##(1992-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
Ejaculatory##2##1##(1997-8#1)(2010-11#1)
Ejp556##2##1##(2008-10#2)
El Hierro##2##2##(2008-10#2)
El Salvador##2##2##(1992-5#1)(1994-2#1)
El Tor##3##2##(1992-5#2)(2012-3#1)
El and E2##2##3##(2008-8#2)
El and##4##2##(2008-8#4)
El##17##1##(1992-5#3)(1994-2#1)(1994-9#1)(2008-10#4)(2008-12#1)(2008-8#4)(2008-9#1)(2010-8#1)(2012-3#1)
Elan##2##1##(2008-10#1)(2008-5#1)
Elastase##3##1##(2008-5#1)(2008-7#2)
Elastic##3##1##(2008-3#1)(2009-3#1)(2012-2#1)
Elasticity##2##1##(1995-3#1)(2013-8#1)
Elastography##2##1##(2010-8#2)
Elastomeric pain pumps##2##3##(2011-2#2)
Elder abuse##5##2##(1991-1#2)(1991-2#1)(1996-8#2)
Elder##7##1##(1991-1#2)(1991-2#1)(1994-12#1)(1996-8#2)(2008-5#1)
Elderly Welfare##2##2##(2011-2#2)
Elderly patients with##2##3##(2011-2#2)
Elderly patients##5##2##(1992-9#1)(2011-2#2)(2012-3#2)
Elderly##20##1##(1992-1#1)(1992-9#1)(1994-2#1)(1995-1#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#6)(2013-1#1)(2013-8#1)
Elective##4##1##(1990-2#1)(1996-8#1)(2010-7#1)(2012-3#1)
Electri-Cord Manufacturing##2##2##(2011-1#1)(2011-2#1)
Electri-Cord##3##1##(2011-1#2)(2011-2#1)
Electric stimulation of the##2##4##(2008-9#2)
Electric##5##1##(2008-3#1)(2008-9#2)(2009-8#1)(2009-9#1)
Electrical##10##1##(1990-5#1)(1992-8#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-6#1)
Electrically##2##1##(2008-3#1)(2008-9#1)
Electro-Optically##2##1##(2008-3#2)
Electroanalysis of##2##2##(2008-10#2)
Electroanalysis##5##1##(2008-10#5)
Electroanalytical##3##1##(2008-10#3)
Electrocardiographic##2##1##(2008-11#1)(2008-7#1)
Electrocatalysis of##3##2##(2008-10#3)
Electrocatalytic oxidation and detection of hydrazine##2##6##(2008-10#2)
Electrocatalytic oxidation of##2##3##(2008-10#2)
Electrocatalytic oxidation##4##2##(2008-10#4)
Electrocatalytic##11##1##(2008-10#10)(2010-6#1)
Electrochemical DNA biosensor##2##3##(2008-10#2)
Electrochemical analysis of##3##3##(2008-10#3)
Electrochemical and##2##2##(2008-10#2)
Electrochemical behavior of##4##3##(2008-10#4)
Electrochemical behavior##5##2##(2008-10#5)
Electrochemical behaviour of##4##3##(2008-10#4)
Electrochemical detection of##5##3##(2008-10#5)
Electrochemical detection##7##2##(2008-10#7)
Electrochemical determination of##4##3##(2008-10#4)
Electrochemical identification of##2##3##(2008-10#2)
Electrochemical impedance spectroscopy##6##3##(2008-10#5)(2012-2#1)
Electrochemical impedance##7##2##(2008-10#6)(2012-2#1)
Electrochemical oxidation of##3##3##(2008-10#3)
Electrochemical oxidation##4##2##(2008-10#4)
Electrochemical polymerization of##2##3##(2008-10#2)
Electrochemical reduction##2##2##(2008-10#2)
Electrochemical sensing of##2##3##(2008-10#2)
Electrochemical sensor for##2##3##(2008-10#2)
Electrochemical studies of##3##3##(2008-10#3)
Electrochemical studies##5##2##(2008-10#5)
Electrochemical study of##3##3##(2008-10#3)
Electrochemical study##4##2##(2008-10#4)
Electrochemical##75##1##(2008-10#73)(2009-9#1)(2012-2#1)
Electrochemically##2##1##(2008-10#2)
Electrochemiluminescent behavior of##2##3##(2008-10#2)
Electrochemiluminescent##3##1##(2008-10#3)
Electrochemistry and electrocatalysis of binuclear cobalt##2##6##(2008-10#2)
Electrochemistry and electrocatalysis##3##3##(2008-10#3)
Electrochemistry and##6##2##(2008-10#6)
Electrochemistry##8##1##(2008-10#8)
Electrode##8##1##(2008-10#5)(2008-9#2)(2010-12#1)
Electrodes containing##2##2##(2008-10#2)
Electrodes have##2##2##(2008-10#1)(2009-12#1)
Electrodes modified##2##2##(2008-10#2)
Electrodes were##2##2##(2008-10#2)
Electrodes##11##1##(2008-10#10)(2009-12#1)
Electrogenerated##3##1##(1995-6#1)(2008-10#1)(2010-7#1)
Electrolyzed##3##1##(2008-10#1)(2008-11#2)
Electromagnetic Fields##2##2##(2008-12#1)(2011-2#1)
Electromagnetic##6##1##(1992-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)
Electromagnetically induced transparency##2##3##(2008-3#2)
Electromyography (EMG)##2##2##(2011-2#1)(2012-2#1)
Electron microscope##2##2##(1990-2#1)(2008-10#1)
Electron microscopic examination##2##3##(2008-7#1)(2012-2#1)
Electron microscopic##4##2##(1997-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
Electron microscopy of##2##3##(1997-2#1)(1997-3#1)
Electron microscopy revealed that##3##4##(1996-12#1)(2008-11#2)
Electron microscopy revealed##4##3##(1996-12#1)(2008-11#3)
Electron microscopy showed that##2##4##(1996-1#1)(2011-2#1)
Electron microscopy##12##2##(1992-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2011-2#1)
Electron spin resonance##2##3##(2008-10#2)
Electron##31##1##(1990-2#1)(1992-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-3#3)(2008-10#10)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)
Electronic Health Record (EHR)##2##4##(2008-7#1)(2010-8#1)
Electronic Health Record##3##3##(2008-7#2)(2010-8#1)
Electronic Health Records##3##3##(2010-8#3)
Electronic Health##7##2##(2008-7#2)(2010-8#5)
Electronic databases and reference lists of key articles were searched to identify##3##12##(2012-12#3)
Electronic databases##4##2##(2011-2#1)(2012-12#3)
Electronic patient records##2##3##(1997-1#2)
Electronic patient##3##2##(1997-1#2)(2010-4#1)
Electronic##22##1##(1997-1#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-4#2)(2010-8#7)(2011-2#1)(2012-12#3)
Electrophoresis and##2##2##(2008-10#2)
Electrophoresis##4##1##(1996-5#1)(2008-10#2)(2008-12#1)
Electrophoretic mobility shift assay showed##2##5##(2008-11#1)(2008-9#1)
Electrophoretic mobility shift assay##3##4##(2008-11#1)(2008-9#2)
Electrophoretic mobility shift assays##2##4##(1995-6#1)(1997-7#1)
Electrophoretic mobility shift##5##3##(1995-6#1)(1997-7#1)(2008-11#1)(2008-9#2)
Electrophoretic separations of##2##3##(2008-10#2)
Electrophoretic##8##1##(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#2)
Electrophysiological studies of##2##3##(1992-3#1)(1993-8#1)
Electrophysiological##6##1##(1992-3#1)(1993-8#1)(2007-8#1)(2008-11#1)(2008-9#2)
Electroporation##3##1##(2008-11#3)
Electrosensory##2##1##(1995-12#2)
Electrostatic##2##1##(2008-10#2)
Electrothermal atomic absorption spectrometric determination of##3##6##(2008-10#3)
Electrothermal atomic absorption##5##3##(2008-10#5)
Electrothermal##8##1##(2008-10#8)
Element##7##1##(2008-10#5)(2008-11#1)(2010-11#1)
Elemental analysis##3##2##(2008-10#3)
Elemental##4##1##(2008-10#4)
Elements in##11##2##(2008-10#10)(2008-11#1)
Elements of##4##2##(1990-11#1)(1994-12#1)(2008-10#1)(2008-11#1)
Elements##17##1##(1990-11#1)(1994-12#1)(2008-10#13)(2008-11#2)
Elephant Trunk technique##2##3##(2012-2#2)
Elevated levels of##3##3##(1990-5#1)(2009-10#1)(2010-10#1)
Elevated##16##1##(1990-5#1)(1991-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#3)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-7#1)(2013-1#1)
Elevation##2##1##(2008-11#1)(2011-2#1)
Eleven AFLP markers##2##3##(2008-10#2)
Eleven elements##2##2##(2008-10#2)
Eleven of the##2##3##(1994-2#1)(2010-8#1)
Eleven of##4##2##(1994-2#1)(2008-5#1)(2008-7#1)(2010-8#1)
Eleven patients##4##2##(1994-3#1)(1997-8#1)(2008-7#1)(2010-4#1)
Eleven##40##1##(1990-12#2)(1990-2#1)(1991-12#1)(1992-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#2)
Eleventh##2##1##(1995-6#2)
Elgg##2##1##(1996-11#2)
Elicitation of##2##2##(2008-10#2)
Elicitin##3##1##(2008-10#3)
Elicitins##2##1##(2008-10#2)
Elicitor##2##1##(2008-10#2)
Elicitors##2##1##(2008-10#2)
Eligible patients##2##2##(2008-10#1)(2008-7#1)
Eliminating poverty among First Nations children##2##6##(2008-11#2)
Eliminating##3##1##(2008-11#2)(2012-12#1)
Elimination of##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
Elimination##5##1##(2008-10#2)(2008-3#1)(2008-9#1)(2012-3#1)
Elite##2##1##(2008-10#1)(2011-2#1)
Elizabeth##2##1##(1990-2#1)(2008-11#1)
Elle##2##1##(2013-1#2)
Elles sont##2##2##(2011-2#2)
Ellis##5##1##(1990-11#1)(1990-3#1)(1995-12#2)(2009-8#1)
Ellwood##3##1##(1994-1#3)
Elman recurrent neural networks have been defined by using##2##9##(2010-8#2)
Elman recurrent neural networks##3##4##(2010-8#3)
Elongated##2##1##(2008-11#1)(2008-6#1)
Elsevier Policy on Article Withdrawal (http##5##6##(2008-10#3)(2008-11#2)
Elsevier Policy on Article Withdrawal##6##5##(2008-10#3)(2008-11#3)
Elucidating the##4##2##(1996-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
Elucidating##5##1##(1996-5#1)(2010-12#1)(2011-2#2)(2013-1#1)
Elucidation of fundamental equilibria which##2##5##(2008-10#2)
Elucidation of fundamental equilibria##3##4##(2008-10#3)
Elucidation of the##5##3##(1990-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
Elucidation of##10##2##(1990-9#1)(1995-2#1)(2008-10#6)(2008-11#1)(2012-2#1)
Elucidation##11##1##(1990-9#1)(1995-2#1)(2008-10#7)(2008-11#1)(2012-2#1)
Elution of##2##2##(2008-10#2)
Elution##6##1##(2008-10#6)
Em = +10 mV##2##4##(1993-8#2)
Em =##5##2##(1993-8#5)
Emax##2##1##(1991-5#1)(1997-2#1)
Embase##2##1##(2011-2#2)
Embelia tsjeriam-cottam##2##2##(2012-2#2)
Embelia##5##1##(2012-2#5)
Embelin##2##1##(2012-2#2)
Embolisation of##3##2##(1997-3#2)(1997-6#1)
Embolisation was##2##2##(1995-11#1)(1996-3#1)
Embolisation##10##1##(1995-11#1)(1996-3#2)(1997-3#3)(1997-6#4)
Embryo##2##1##(1991-11#1)(1991-3#1)
Embryonic stem (ES) cells have##2##5##(2008-11#2)
Embryonic stem (ES) cells##3##4##(2008-11#2)(2008-9#1)
Embryonic stem cells (ESC)##2##4##(2008-10#1)(2008-11#1)
Embryonic stem cells##6##3##(2008-10#1)(2008-11#5)
Embryonic stem##10##2##(2008-10#1)(2008-11#8)(2008-9#1)
Embryonic##13##1##(1994-9#1)(2008-10#1)(2008-11#10)(2008-9#1)
Embryos##4##1##(2008-5#1)(2008-6#2)(2009-12#1)
Emergence of##7##2##(2008-10#2)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
Emergence##8##1##(2008-10#3)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
Emergency Department##7##2##(1991-12#1)(1997-2#1)(2008-11#1)(2008-3#1)(2012-12#1)(2013-8#2)
Emergency Medical##2##2##(2007-9#1)(2012-3#1)
Emergency Medicine##2##2##(2009-4#1)(2009-6#1)
Emergency Planning##2##2##(1991-1#1)(2009-3#1)
Emergency department##2##2##(2008-11#2)
Emergency laparotomy##2##2##(2008-12#2)
Emergency medicine##3##2##(2008-8#1)(2009-4#1)(2013-1#1)
Emergency operations and delayed operations for acute disease were encumbered with##2##11##(1997-8#2)
Emergency room##2##2##(1993-12#1)(1993-2#1)
Emergency##42##1##(1991-1#2)(1991-11#1)(1991-12#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-8#2)(2007-9#1)(2008-11#6)(2008-12#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#2)
Emerging evidence##3##2##(2010-10#1)(2010-5#1)(2011-2#1)
Emerging technologies##2##2##(2008-6#1)(2013-8#1)
Emerging##17##1##(1991-3#1)(1992-3#1)(1994-1#1)(1996-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-8#1)
Emerson-Trinder reaction##3##2##(2008-10#3)
Emile Roubaud##2##2##(2010-1#2)
Emile##4##1##(2010-1#4)
Emilia##3##1##(1992-2#1)(2008-10#1)(2012-7#1)
Emir##2##1##(2008-10#2)
Emission intensities of nonalternant PAHs##2##5##(2008-10#2)
Emission intensities of##3##3##(2008-10#3)
Emission##9##1##(1996-9#1)(2008-10#5)(2008-2#1)(2008-3#2)
Emotion regulation##2##2##(2011-2#2)
Emotion##3##1##(2011-2#3)
Emotional##11##1##(1992-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#3)(2013-8#1)
Empathy and##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
Emphasis is given##2##3##(2008-10#2)
Emphasis is made on##2##4##(1991-3#1)(2012-3#1)
Emphasis is##5##2##(1991-3#1)(1992-12#1)(2008-10#2)(2012-3#1)
Emphasis on##3##2##(1993-3#1)(2009-8#1)(2012-3#1)
Emphasis##9##1##(1991-3#1)(1992-12#1)(1993-3#1)(1996-3#1)(2008-10#2)(2009-8#1)(2012-3#2)
Empididae)##2##1##(2007-12#2)
Empire##4##1##(1990-11#1)(2008-10#1)(2008-11#2)
Empirical studies##2##2##(2008-9#2)
Empirical##16##1##(1992-1#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#3)(2008-9#3)(2010-11#1)(2012-2#2)
Employed##2##1##(2008-10#2)
Employee##7##1##(1992-3#1)(1993-1#1)(1993-2#1)(1995-1#1)(1995-12#1)(1997-3#1)(2012-3#1)
Employer Data##2##2##(1995-2#1)(1997-3#1)
Employer##4##1##(1993-3#1)(1995-12#1)(1995-2#1)(1997-3#1)
Employers##3##1##(1994-2#1)(2008-11#1)(2012-3#1)
Employing the##4##2##(2008-10#2)(2008-11#2)
Employing##13##1##(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
Employment in##2##2##(1994-3#2)
Employment of##3##2##(1991-1#2)(2008-10#1)
Employment##13##1##(1990-2#1)(1991-1#2)(1992-1#1)(1994-3#2)(1995-12#2)(1995-6#2)(1996-2#1)(2008-10#1)(2008-9#1)
Empty##3##1##(2008-11#1)(2013-1#2)
Emulsion##3##1##(2008-10#2)(2008-5#1)
Emulsions##2##1##(2008-5#2)
En##2##1##(2008-7#1)(2011-2#1)
Enabling##2##1##(1996-5#1)(2008-11#1)
Enantiomerically pure##2##2##(1996-5#1)(2011-1#1)
Enantiomerically##3##1##(1996-5#2)(2011-1#1)
Enantioselective##8##1##(1996-5#2)(2008-10#4)(2011-1#1)(2011-2#1)
Encapsulation of##2##2##(2008-10#1)(2008-5#1)
Encephalopathy##2##1##(1990-9#1)(2012-12#1)
Encoded##3##1##(2008-10#1)(2008-9#1)(2010-1#1)
Encoding an##2##2##(2008-10#1)(2008-6#1)
Encoding##5##1##(2008-10#2)(2008-5#1)(2008-6#2)
Encouraging##2##1##(1994-12#1)(1995-3#1)
Encyclopedia of##31##2##(2008-4#1)(2009-11#1)(2011-2#29)
End of the##2##3##(1995-8#1)(2008-11#1)
End of##4##2##(1993-3#1)(1995-8#1)(2008-11#1)(2012-12#1)
End points##2##2##(1991-11#1)(2012-3#1)
End##11##1##(1991-11#1)(1992-12#1)(1993-3#1)(1995-8#1)(1997-3#1)(2008-11#1)(2010-11#1)(2012-12#1)(2012-3#3)
End-Ex##3##1##(2013-1#3)
End-Stage##2##1##(2009-3#1)(2010-8#1)
Endcaps may be##2##3##(2008-4#2)
Endemic##2##1##(2011-2#1)(2012-2#1)
Endo F1##4##2##(1992-3#4)
Endo H##2##2##(1992-3#2)
Endo##6##1##(1992-3#6)
Endochitinase##2##1##(2008-10#2)
Endocrine Society##2##2##(2008-10#1)(2013-1#1)
Endocrine therapy##2##2##(1990-11#1)(1993-11#1)
Endocrine##12##1##(1990-11#2)(1993-11#3)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
Endocrinologic##2##1##(1991-11#1)(2008-5#1)
Endocrinologists##2##1##(2008-1#1)(2011-2#1)
Endocrinology##8##1##(1995-8#1)(1996-8#2)(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
Endogenous##9##1##(1993-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2013-1#1)
Endometrial ablation vs laparoscopic hysterectomy##2##5##(1996-1#2)
Endometrial carcinomas with ambiguous features##2##5##(2011-2#2)
Endometrial carcinomas##3##2##(2011-2#3)
Endometrial hyperplasia##2##2##(2011-2#2)
Endometrial intraepithelial neoplasia##2##3##(2011-2#2)
Endometrial##11##1##(1996-1#2)(2009-2#1)(2010-12#1)(2011-2#7)
Endometrioid carcinoma of the endometrium##2##5##(2011-2#2)
Endometriosis##2##1##(2009-8#1)(2013-1#1)
Endophyte##2##1##(2008-10#1)(2008-8#1)
Endophytic##4##1##(2008-10#4)
Endoplasmic reticulum##2##2##(2009-8#1)(2012-2#1)
Endopolygalacturonase##3##1##(2008-10#3)
Endoscopic resection##2##2##(2009-12#1)(2010-12#1)
Endoscopic treatment of##3##3##(1993-2#1)(1993-6#1)(2008-7#1)
Endoscopic ultrasound##2##2##(2008-2#1)(2013-1#1)
Endoscopic##25##1##(1993-2#1)(1993-6#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2009-12#2)(2009-5#1)(2010-12#3)(2011-2#3)(2012-3#2)(2013-1#4)
Endoscopy and##2##2##(1990-3#1)(2011-2#1)
Endoscopy##4##1##(1990-3#1)(1993-6#1)(2011-2#1)(2013-1#1)
Endothelial cells##4##2##(1992-9#1)(2008-11#1)(2010-11#2)
Endothelial##8##1##(1992-9#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-11#2)(2012-3#1)(2013-1#1)
Endothelin##4##1##(1992-3#1)(1993-3#1)(2008-10#1)(2013-1#1)
Endothelin-1 (ET-1)##2##2##(1993-3#1)(1994-11#1)
Endothelin-1 induces##3##2##(1991-5#1)(1993-3#2)
Endothelin-1 is##2##2##(1993-3#1)(2009-10#1)
Endothelin-1##9##1##(1991-5#1)(1992-3#2)(1993-3#4)(1994-11#1)(2009-10#1)
Endothermic##2##1##(2008-5#1)(2009-8#1)
Endotoxin##2##1##(1994-11#1)(2008-5#1)
Endovascular approach to##2##3##(1997-6#1)(2010-12#1)
Endovascular embolization##2##2##(2008-7#2)
Endovascular stent graft repair of abdominal aortic##2##7##(2010-12#2)
Endovascular stent##3##2##(2008-11#1)(2010-12#2)
Endovascular treatment##2##2##(2008-7#1)(2011-3#1)
Endovascular##18##1##(1995-11#2)(1996-9#1)(1997-6#2)(2008-11#1)(2008-7#4)(2010-12#4)(2011-3#1)(2012-3#2)(2013-8#1)
Enduring Freedom##2##2##(2013-1#2)
Energy and##3##2##(1996-9#1)(2008-8#1)(2010-6#1)
Energy expenditure##2##2##(2008-9#1)(2013-8#1)
Energy##30##1##(1996-2#1)(1996-5#1)(1996-9#3)(2008-10#4)(2008-11#3)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
Engaging##4##1##(2008-11#1)(2009-3#1)(2010-9#1)(2013-8#1)
Engineered##6##1##(1994-5#1)(2008-10#3)(2008-11#1)(2013-8#1)
Engineering##9##1##(1997-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
Engl##2##1##(1997-3#1)(2008-11#1)
England and U##2##3##(2010-8#2)
England and Wales##5##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
England and##12##2##(1990-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#2)(2012-12#4)
England##35##1##(1990-6#1)(1992-1#1)(1992-11#1)(1993-12#1)(1995-5#1)(2008-10#5)(2008-11#11)(2008-12#3)(2008-8#1)(2009-10#1)(2010-1#2)(2010-8#2)(2012-12#4)(2013-8#1)
English National Board for Nursing##2##5##(2008-11#2)
English National Board##3##3##(2008-11#3)
English University##3##2##(2008-11#1)(2008-12#2)
English and Mandarin##2##3##(2008-9#2)
English and Spanish##3##3##(2008-12#2)(2012-12#1)
English and##6##2##(2008-11#1)(2008-12#2)(2008-9#2)(2012-12#1)
English as an additional language##5##5##(2008-2#5)
English as##6##2##(2008-2#5)(2010-1#1)
English language##4##2##(2008-12#1)(2011-2#1)(2013-1#2)
English literature##6##2##(2008-12#2)(2009-3#1)(2010-6#1)(2011-2#2)
English##67##1##(1990-8#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#11)(2008-12#9)(2008-2#6)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#3)(2010-1#1)(2010-6#1)(2010-8#2)(2011-2#10)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
English-language##3##1##(2012-12#2)(2012-3#1)
Engraftment was##2##2##(2011-2#1)(2012-12#1)
Enhanced recovery##2##2##(2013-1#2)
Enhanced sensitivity##2##2##(1996-12#1)(2008-10#1)
Enhanced##52##1##(1990-12#1)(1992-8#1)(1993-5#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#4)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)(2011-7#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#3)
Enhancement by##2##2##(1996-5#1)(2008-10#1)
Enhancement factors##2##2##(2008-5#2)
Enhancement of the##5##3##(1991-9#1)(1995-6#1)(2008-10#2)(2010-4#1)
Enhancement of this MoAb production was due to the improved survival of the cells and was##2##16##(2008-11#2)
Enhancement of##22##2##(1990-5#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1995-6#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2010-4#1)
Enhancement##29##1##(1990-5#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1995-2#1)(1995-6#2)(1996-5#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2010-4#1)
Enhances##5##1##(2008-10#2)(2008-6#1)(2013-1#2)
Enhancing the##3##2##(2008-12#1)(2010-10#1)(2013-1#1)
Enhancing##16##1##(1993-12#2)(1994-12#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2010-10#2)(2012-12#1)(2012-2#2)(2013-1#1)
Ennis##2##1##(2008-10#2)
Enrichment of##2##2##(2008-10#1)(2008-9#1)
Enrichment##6##1##(2008-10#3)(2008-9#1)(2009-10#1)(2010-8#1)
Enrolled##2##1##(2008-11#1)(2008-12#1)
Ensembles of##2##2##(1995-3#1)(2008-11#1)
Ensuring##6##1##(1992-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
Entamoeba histolytica (EhCaM)##2##3##(2009-7#2)
Entamoeba histolytica##7##2##(1991-7#1)(2007-12#1)(2009-7#2)(2009-8#2)(2012-3#1)
Entamoeba##8##1##(1991-7#1)(2007-12#1)(2009-7#2)(2009-8#2)(2010-12#1)(2012-3#1)
Entecavir##4##1##(2013-1#4)
Enteric##3##1##(1992-6#1)(2010-12#1)(2013-8#1)
Enteritidis and##2##2##(2010-4#1)(2011-2#1)
Enteritidis##5##1##(2010-4#4)(2011-2#1)
Enterobacter cloacae##9##2##(2007-11#1)(2008-11#1)(2008-9#3)(2010-6#3)(2011-2#1)
Enterobacteriaceae##9##1##(1997-5#2)(2008-10#3)(2008-5#1)(2010-6#3)
Enterococcus faecalis##2##2##(2007-11#1)(2013-1#1)
Enterococcus faecium##2##2##(2011-2#1)(2013-1#1)
Enterococcus spp##2##2##(2011-2#2)
Enterococcus##9##1##(1993-12#1)(2007-11#1)(2009-8#1)(2011-2#4)(2013-1#2)
Enterocolitis##2##1##(2012-2#2)
Enteropathogenic Escherichia coli (EPEC)##2##4##(1995-2#1)(2011-2#1)
Enterovirus detection##2##2##(2012-2#2)
Enterovirus##5##1##(2008-8#2)(2012-2#3)
Enteroviruses in stool specimens##2##4##(2012-2#2)
Enteroviruses in##3##2##(2012-2#3)
Enteroviruses##5##1##(2012-2#5)
Entomology in##2##2##(2010-1#2)
Entomology##4##1##(2010-1#4)
Entrance##3##1##(1993-9#1)(1994-12#1)(2008-10#1)
Entrapment of##2##2##(2008-10#1)(2008-5#1)
Entropy##3##1##(1996-9#1)(2009-8#1)(2010-12#1)
Entry to##2##2##(1996-5#1)(2008-8#1)
Entry##8##1##(1996-5#1)(2008-10#4)(2008-8#2)(2010-10#1)
Enugu##5##1##(2011-2#1)(2013-1#4)
Enumeration of##4##2##(2008-7#1)(2008-9#2)(2012-2#1)
Enumeration##5##1##(2008-10#1)(2008-7#1)(2008-9#2)(2012-2#1)
Environment##11##1##(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2011-7#1)
Environmental Conditions on##3##3##(2008-10#3)
Environmental Conditions##4##2##(2008-10#4)
Environmental Factors Affecting##3##3##(2008-10#3)
Environmental Factors on##2##3##(2008-10#2)
Environmental Factors##8##2##(2008-10#6)(2008-11#1)(2011-2#1)
Environmental Health##4##2##(2008-1#2)(2008-9#2)
Environmental Protection Agency (EPA)##5##4##(1992-1#1)(2008-10#3)(2008-9#1)
Environmental Protection Agency##9##3##(1992-1#1)(2008-10#5)(2008-9#2)(2013-1#1)
Environmental Satellite##4##2##(2008-3#4)
Environmental Studies##2##2##(2008-10#2)
Environmental and##5##2##(1991-12#1)(2008-10#1)(2008-11#2)(2012-2#1)
Environmental factors##4##2##(2008-7#2)(2008-8#1)(2013-1#1)
Environmental risk assessment of##2##4##(2008-10#1)(2008-9#1)
Environmental sensitivity##2##2##(2008-10#2)
Environmental water samples were analyzed##2##5##(2008-10#2)
Environmental water##3##2##(2008-10#3)
Environmental##79##1##(1990-6#1)(1991-12#1)(1992-1#1)(1994-3#1)(1997-3#1)(2008-1#3)(2008-10#34)(2008-11#11)(2008-12#1)(2008-3#6)(2008-7#2)(2008-8#2)(2008-9#6)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
Environments##4##1##(2008-10#2)(2008-9#1)(2012-2#1)
Enzymatic activity was##2##3##(1991-5#1)(1993-12#1)
Enzymatic activity##3##2##(1991-5#1)(1993-12#1)(2008-11#1)
Enzymatic amplification staining##2##3##(2008-9#2)
Enzymatic amplification##3##2##(2008-9#3)
Enzymatic and##2##2##(2008-10#1)(2010-12#1)
Enzymatic determination of##2##3##(2008-10#2)
Enzymatic determination##3##2##(2008-10#3)
Enzymatic hydrolysis##3##2##(2008-10#2)(2013-1#1)
Enzymatic production of##2##3##(1995-3#1)(2008-5#1)
Enzymatic rotating biosensor for##2##4##(2008-10#2)
Enzymatic synthesis of##2##3##(1995-3#2)
Enzymatic##35##1##(1990-2#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-3#4)(2008-10#15)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#3)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
Enzymatically##3##1##(1994-6#1)(1995-12#1)(2008-10#1)
Enzyme activities were##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
Enzyme activities##5##2##(1990-5#1)(2008-10#3)(2008-5#1)
Enzyme activity##3##2##(1991-5#1)(1993-8#1)(2008-5#1)
Enzyme electrode##2##2##(2008-10#2)
Enzyme##24##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#2)(1993-8#1)(1997-2#1)(2008-10#12)(2008-12#1)(2008-5#2)(2011-3#1)
Enzyme-Linked Immunosorbent##2##2##(2008-10#2)
Enzyme-linked##2##1##(1995-8#1)(2008-11#1)
Enzymes##4##1##(1995-3#1)(2008-10#2)(2010-3#1)
Eotaxin##3##1##(1994-11#3)
Eph receptors##2##2##(2008-7#1)(2009-9#1)
Eph-ephrin##2##1##(2008-7#2)
EphB receptors##2##2##(2008-7#2)
Ephedra sinica##2##2##(2008-10#2)
Epicatechin##2##1##(2008-10#2)
Epicuticular##2##1##(2008-10#2)
Epidemic Development##2##2##(2008-10#2)
Epidemic##11##1##(1990-11#1)(1995-3#1)(2008-10#7)(2011-2#2)
Epidemics in##4##2##(2008-10#4)
Epidemics of##6##2##(2008-10#5)(2011-2#1)
Epidemics##14##1##(2008-10#13)(2011-2#1)
Epidemiologic studies##3##2##(1993-2#1)(1997-2#1)(2011-2#1)
Epidemiologic##8##1##(1992-9#1)(1993-2#1)(1995-9#1)(1997-2#1)(2011-2#3)(2012-3#1)
Epidemiological and##2##2##(2007-12#1)(2010-1#1)
Epidemiological aspects of##2##3##(2012-2#2)
Epidemiological studies and##2##3##(2010-8#1)(2013-8#1)
Epidemiological studies##5##2##(1996-8#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
Epidemiological surveillance of##2##3##(1995-2#1)(2008-10#1)
Epidemiological##24##1##(1995-2#1)(1996-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
Epidemiology and quality##2##3##(2009-7#1)(2011-2#1)
Epidemiology and##5##2##(1997-3#1)(1997-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
Epidemiology in##2##2##(2008-10#1)(2008-11#1)
Epidemiology of##10##2##(1993-2#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
Epidemiology##28##1##(1991-3#1)(1993-2#1)(1995-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#5)(2011-4#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Epidermal growth factor receptor##2##4##(1994-2#1)(1995-9#1)
Epidermal growth factor##8##3##(1991-7#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-9#1)(2008-6#2)
Epidermal##12##1##(1991-7#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-6#2)
Epidermoid##2##1##(2007-8#1)(2012-2#1)
Epidermolysis bullosa simplex##2##3##(1991-12#2)
Epidermolysis bullosa##3##2##(1991-11#1)(1991-12#2)
Epidural##2##1##(2007-8#1)(2012-3#1)
Epigenetic mechanisms##2##2##(2011-2#1)(2012-12#1)
Epigenetic##6##1##(2009-12#1)(2011-2#2)(2012-12#1)(2013-8#2)
Epigenetics##2##1##(2009-4#1)(2012-12#1)
Epilachna vigintioctopunctata##2##2##(2008-6#2)
Epilepsy and##2##2##(1993-3#1)(2009-8#1)
Epilepsy##4##1##(1993-3#1)(2008-11#1)(2008-12#1)(2009-8#1)
Epinephelus coioides##4##2##(2008-12#2)(2010-5#2)
Epiphytic##3##1##(2008-10#3)
Episodic##4##1##(2008-11#2)(2008-7#1)(2011-2#1)
Epistylis##4##1##(2008-9#4)
Epithelial Cells##5##2##(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2013-7#1)
Epithelial and##2##2##(1990-11#1)(1991-5#1)
Epithelial cells##2##2##(1990-11#1)(1997-1#1)
Epithelial##15##1##(1990-11#2)(1991-5#1)(1993-8#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-12#1)(2010-7#2)(2011-2#1)(2013-7#1)
Epitope analysis##2##2##(2008-11#2)
Epitope##5##1##(1993-1#1)(2008-11#3)(2012-2#1)
Epitopes##2##1##(2008-10#1)(2011-2#1)
Epo partially purified from the culture medium showed a neuroprotective effect similar to that of rat Epo produced by Chinese hamster ovary (CHO) cells##2##24##(2008-11#2)
Epo produced by##5##3##(2008-11#5)
Epo##20##1##(2008-11#20)
EpoR##2##1##(2008-11#1)(2008-8#1)
EpoR-gp130##2##1##(2008-11#2)
Epopeptide AB##4##2##(2008-11#4)
Epoxidation of##4##2##(1996-5#3)(2008-11#1)
Epoxidation##5##1##(1996-5#4)(2008-11#1)
Eprex##2##1##(2008-10#2)
Epristeride is##2##2##(2008-5#2)
Epristeride##3##1##(2008-5#3)
Eps15##2##1##(2009-7#1)(2012-2#1)
Eps8 (epidermal growth factor receptor pathway substrate 8##2##8##(2012-2#2)
Eps8##3##1##(2012-2#3)
Epstein-Barr Virus##2##2##(2008-9#1)(2011-2#1)
Epstein-Barr virus (EBV) DNA polymerase##2##5##(1993-8#1)(1997-3#1)
Epstein-Barr virus (EBV)##9##3##(1993-8#1)(1995-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-9#2)(2010-6#1)(2011-2#1)
Epstein-Barr virus infection##2##3##(2011-2#2)
Epstein-Barr virus transformed##2##3##(1994-3#2)
Epstein-Barr virus##19##2##(1993-8#2)(1994-3#2)(1995-2#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-9#2)(2009-1#1)(2010-6#1)(2011-2#3)
Epstein-Barr##22##1##(1993-8#2)(1994-3#2)(1995-2#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-9#3)(2009-1#1)(2010-6#2)(2011-2#4)
Equal Employment Opportunity Commission##3##4##(1995-12#1)(1995-6#2)
Equal##5##1##(1995-12#1)(1995-6#2)(2008-8#1)(2013-1#1)
Equation##3##1##(2008-10#1)(2008-3#1)(2012-2#1)
Equations##5##1##(2008-10#4)(2008-3#1)
Equilibrium studies of##2##3##(2008-10#2)
Equilibrium studies##4##2##(2008-10#4)
Equilibrium##11##1##(2008-10#9)(2008-9#1)(2013-8#1)
Equine##2##1##(2009-1#1)(2013-1#1)
Equipment design##2##2##(2008-11#2)
Equipment##7##1##(1992-3#1)(1993-1#1)(2008-11#2)(2008-3#2)(2012-3#1)
Equivalent results##2##2##(2008-10#1)(2008-7#1)
Equivalent##6##1##(2008-10#3)(2008-3#1)(2008-7#1)(2010-8#1)
Er##15##1##(1991-2#2)(2008-10#1)(2008-3#6)(2008-7#5)(2010-6#1)
Er(3+)##6##1##(2007-11#2)(2008-10#2)(2008-3#2)
Er(3+)-doped##2##1##(2008-3#2)
Er-Yb##2##1##(2008-3#2)
Era##2##1##(2008-10#1)(2011-2#1)
Eradication of##3##2##(1997-1#1)(2008-10#1)(2012-2#1)
Eradication##5##1##(1997-1#1)(2008-10#2)(2010-12#1)(2012-2#1)
Erasmus##2##1##(1991-3#1)(2008-12#1)
ErbB2##2##1##(1995-6#2)
ErbBs and Ephs##2##3##(2009-9#2)
Erbium##2##1##(1991-2#2)
Eremothecium##4##1##(2012-3#4)
Ergonomics##2##1##(1994-3#2)
Erie County##3##2##(1996-1#3)
Erik H##2##2##(2008-12#2)
Erik##4##1##(2008-10#2)(2008-12#2)
Erikson's##4##1##(2008-12#4)
Eriochrome Blue Black R##2##4##(2008-10#2)
Eriochrome black-T##2##2##(2008-10#2)
Eriochrome##6##1##(2008-10#6)
Erosion##2##1##(2008-12#1)(2012-12#1)
Erosive##2##1##(2013-1#2)
Errata##3##1##(2007-11#1)(2013-8#2)
Erratum to##3##2##(2011-2#2)(2012-2#1)
Erratum##21##1##(1990-11#1)(2008-11#4)(2008-5#1)(2008-7#6)(2009-5#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)
Erroneous##5##1##(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2011-3#1)
Error analysis of##2##3##(2008-11#1)(2008-3#1)
Error analysis##3##2##(2008-11#1)(2008-3#2)
Error##4##1##(2008-11#1)(2008-3#3)
Erwinia amylovora and##6##3##(2008-10#5)(2008-8#1)
Erwinia amylovora on##3##3##(2008-10#3)
Erwinia amylovora##22##2##(2008-10#21)(2008-8#1)
Erwinia carotovora subsp##3##3##(1990-5#2)(2008-10#1)
Erwinia carotovora##4##2##(1990-5#2)(2008-10#2)
Erwinia herbicola##2##2##(1993-8#1)(2008-10#1)
Erwinia herbicola)##2##2##(2008-10#2)
Erwinia sp##2##2##(2008-10#2)
Erwinia spp##4##2##(2008-10#4)
Erwinia##44##1##(1990-5#2)(1993-8#1)(2008-10#40)(2008-8#1)
Erysiphe graminis f##2##3##(2008-10#2)
Erysiphe graminis##3##2##(2008-10#3)
Erysiphe necator##2##2##(2008-10#2)
Erysiphe##6##1##(2008-10#6)
Erythema##2##1##(2008-5#1)(2011-2#1)
Erythrocyte##3##1##(1995-8#2)(1997-6#1)
Erythrocytes##3##1##(2008-9#1)(2009-8#2)
Erythromycin##2##1##(2008-10#1)(2009-6#1)
Erythroxylum coca##2##2##(2008-10#2)
Escape##3##1##(1993-2#1)(2008-10#2)
Escherichia Coli##2##2##(2008-11#1)(2013-8#1)
Escherichia coli (EHEC)##2##3##(2008-9#2)
Escherichia coli (EPEC)##3##3##(1995-2#1)(2011-2#2)
Escherichia coli K-12##13##3##(1991-11#2)(1996-12#6)(1996-6#3)(2008-10#1)(2009-6#1)
Escherichia coli K12##4##3##(1990-5#1)(2008-7#2)(2008-9#1)
Escherichia coli O157##5##3##(1996-3#1)(2008-10#3)(2012-2#1)
Escherichia coli RNA polymerase##2##4##(1995-2#1)(1995-6#1)
Escherichia coli acetyl-CoA carboxylase##2##4##(1992-9#2)
Escherichia coli adenylosuccinate synthetase##2##4##(1995-6#2)
Escherichia coli and##16##3##(1991-3#2)(1993-6#1)(1993-9#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#1)(2011-1#3)(2011-2#2)(2012-2#1)
Escherichia coli are##2##3##(1997-2#1)(2008-10#1)
Escherichia coli as##3##3##(1993-8#1)(2008-10#1)(2008-8#1)
Escherichia coli beta-galactosidase##2##3##(1995-12#1)(2008-7#1)
Escherichia coli by##3##3##(1993-9#1)(2008-11#1)(2009-6#1)
Escherichia coli can##2##3##(2011-2#1)(2013-1#1)
Escherichia coli cells##3##3##(1992-3#1)(1993-8#1)(2013-1#1)
Escherichia coli glutaminyl-tRNA synthetase##2##4##(1993-8#2)
Escherichia coli has been##2##4##(1994-5#1)(2008-8#1)
Escherichia coli heat-labile##2##3##(1995-2#2)
Escherichia coli host strain BL21 (DE3)##2##6##(1995-12#1)(2009-3#1)
Escherichia coli host##5##3##(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-3#1)
Escherichia coli immobilized on sepiolite##2##5##(2008-10#2)
Escherichia coli is##3##3##(1991-12#1)(1993-6#1)(2011-1#1)
Escherichia coli or##2##3##(1990-5#1)(2008-10#1)
Escherichia coli strain##3##3##(1993-8#1)(2008-8#1)(2011-1#1)
Escherichia coli strains##4##3##(1993-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
Escherichia coli to##3##3##(1993-12#1)(1997-3#1)(2009-3#1)
Escherichia coli was##6##3##(1990-5#2)(1991-5#1)(1993-9#1)(2008-10#1)(2008-8#1)
Escherichia coli were##2##3##(1996-12#1)(2011-2#1)
Escherichia coli with a##2##4##(1991-9#1)(2008-7#1)
Escherichia coli##236##2##(1990-11#3)(1990-5#6)(1990-7#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-3#3)(1991-5#6)(1991-7#2)(1991-9#3)(1992-1#1)(1992-3#3)(1992-4#2)(1992-6#3)(1992-9#2)(1993-12#7)(1993-6#4)(1993-8#8)(1993-9#8)(1994-11#2)(1994-5#6)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#9)(1995-6#11)(1996-12#10)(1996-3#2)(1996-6#6)(1996-8#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#3)(2007-12#1)(2008-10#22)(2008-11#6)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#17)(2008-8#6)(2008-9#7)(2009-3#2)(2009-6#3)(2010-4#2)(2010-6#5)(2011-1#7)(2011-2#10)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#3)
Escherichia##243##1##(1990-11#3)(1990-5#6)(1990-7#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-3#3)(1991-5#6)(1991-7#2)(1991-9#3)(1992-1#1)(1992-3#3)(1992-4#2)(1992-6#3)(1992-9#2)(1993-12#7)(1993-6#4)(1993-8#8)(1993-9#9)(1994-11#2)(1994-5#6)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#9)(1995-6#11)(1996-12#10)(1996-3#2)(1996-6#6)(1996-8#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#3)(2007-12#1)(2008-10#25)(2008-11#7)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#17)(2008-8#6)(2008-9#7)(2009-3#2)(2009-6#3)(2010-4#2)(2010-6#5)(2011-1#7)(2011-2#10)(2011-3#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#1)
Escovopsis##2##1##(2012-2#2)
Esophageal perforations##2##2##(2010-12#1)(2013-1#1)
Esophageal##6##1##(1997-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2013-1#2)
Esophagomyotomy##3##1##(1992-6#3)
Especially in##2##2##(1990-11#1)(2008-1#1)
Especially the##2##2##(2011-3#1)(2012-2#1)
Especially##14##1##(1990-11#1)(1993-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-2#1)
Essential Amino Acids##2##3##(2008-11#2)
Essential Oil##2##2##(2012-2#1)(2013-1#1)
Essential Tremor##2##2##(2012-3#1)(2013-1#1)
Essential hypertension##2##2##(1992-1#1)(2008-9#1)
Essential role##2##2##(1995-8#1)(2012-2#1)
Essential##19##1##(1992-1#1)(1995-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
Essentially##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)
Essex County##3##2##(2008-10#3)
Essex##6##1##(2008-10#6)
Establish##2##1##(1997-2#1)(2011-2#1)
Established##9##1##(1994-12#1)(1995-2#1)(1997-3#1)(2008-10#5)(2009-4#1)
Establishing a##2##2##(1991-3#1)(1993-1#1)
Establishing the prevalence of##2##4##(2012-12#2)
Establishing the##3##2##(2008-9#1)(2012-12#2)
Establishing##7##1##(1991-3#1)(1993-1#1)(1995-1#1)(2008-9#1)(2011-2#1)(2012-12#2)
Establishment and characterization of##2##4##(1991-2#1)(2008-11#1)
Establishment and##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
Establishment of human T cell clones exhibiting natural killer-like activity##2##10##(2008-11#2)
Establishment of##12##2##(1995-9#1)(2008-10#1)(2008-11#6)(2008-8#1)(2008-9#2)(2012-2#1)
Establishment##17##1##(1991-2#1)(1995-9#1)(2008-10#3)(2008-11#7)(2008-8#1)(2008-9#2)(2012-2#2)
Estate##2##1##(1993-3#1)(2008-10#1)
Ester##5##1##(1996-5#2)(2008-3#1)(2008-8#1)(2009-10#1)
Esters##2##1##(1996-5#1)(2009-8#1)
Esthetic##2##1##(2008-7#1)(2013-1#1)
Estimate##3##1##(1997-5#1)(2008-10#1)(2008-3#1)
Estimated##10##1##(1992-2#1)(2008-10#5)(2008-11#2)(2008-7#1)(2012-3#1)
Estimates from##2##2##(1991-5#1)(2012-12#1)
Estimates of CFU##2##3##(2008-10#2)
Estimates of the##7##3##(1992-2#1)(1996-3#1)(2008-10#3)(2008-3#1)(2012-3#1)
Estimates of##24##2##(1992-2#1)(1994-3#1)(1994-9#2)(1996-3#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2012-3#1)
Estimates##32##1##(1991-2#1)(1991-5#1)(1992-2#1)(1994-3#1)(1994-9#2)(1996-3#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
Estimating the cost of##3##4##(1993-1#1)(1995-1#1)(1995-12#1)
Estimating the##8##2##(1993-1#1)(1995-1#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
Estimating##15##1##(1992-9#1)(1993-1#1)(1995-1#1)(1995-12#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)
Estimation and##2##2##(2008-10#1)(2008-6#1)
Estimation of rates of recombination and migration in populations of plant##2##11##(2008-10#2)
Estimation of rates of##3##4##(2008-10#2)(2008-11#1)
Estimation of the##3##3##(1996-8#1)(2008-10#1)(2008-3#1)
Estimation of##23##2##(1996-8#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-9#1)(2010-3#1)(2010-8#1)(2012-2#3)
Estimation##28##1##(1995-5#1)(1996-8#1)(2008-10#12)(2008-11#4)(2008-3#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-2#3)(2012-3#1)
Estonian##2##1##(2008-10#1)(2013-1#1)
Estradiol##2##1##(1991-3#1)(1994-3#1)
Estrogen Receptor##2##2##(1997-7#1)(2008-6#1)
Estrogen and##2##2##(1992-3#1)(2008-7#1)
Estrogen##14##1##(1992-3#3)(1992-6#1)(1992-9#2)(1995-9#1)(1997-7#1)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#2)
Estrogens##2##1##(2009-10#1)(2012-2#1)
Estuary##2##1##(2008-10#2)
EtOH administration##3##2##(2008-10#3)
EtOH exposure##3##2##(2008-10#3)
EtOH treatment##5##2##(2008-10#5)
EtOH##22##1##(1996-5#2)(2008-10#19)(2010-6#1)
EtX##3##1##(2008-10#3)
Etching##2##1##(1996-9#1)(2008-10#1)
Eternal##2##1##(2012-3#2)
Etest##3##1##(2008-7#3)
Eth##2##1##(2008-1#1)(2008-10#1)
Ethanol##16##1##(1992-7#1)(1994-3#1)(2008-10#6)(2009-7#1)(2009-8#4)(2011-2#1)(2012-3#1)(2013-1#1)
Ethical Committee##2##2##(1991-3#2)
Ethical Committees##2##2##(1991-3#2)
Ethical considerations##2##2##(1993-6#1)(1996-6#1)
Ethical dilemmas in##2##3##(1995-3#1)(2008-12#1)
Ethical dilemmas##4##2##(1995-3#1)(2008-10#1)(2008-12#1)(2010-4#1)
Ethical principles##2##2##(1996-2#1)(2012-3#1)
Ethical##17##1##(1991-3#4)(1993-6#1)(1994-1#1)(1995-3#1)(1996-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-11#1)(2010-4#1)(2012-3#1)(2013-1#1)
Ethicists##2##1##(1994-1#1)(2012-2#1)
Ethics Committee##2##2##(2012-3#1)(2013-1#1)
Ethics and##3##2##(1991-1#1)(1992-12#1)(1992-5#1)
Ethics for medical group managers##2##5##(1994-1#2)
Ethics for##3##2##(1994-1#2)(2010-8#1)
Ethics##15##1##(1991-1#2)(1992-12#2)(1992-5#2)(1993-3#1)(1994-1#2)(1997-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Ethidium bromide##2##2##(1994-5#1)(2008-11#1)
Ethiodol/ethanol mixture##2##2##(1997-8#2)
Ethiopia##21##1##(1994-3#2)(2008-10#10)(2010-1#1)(2010-6#2)(2010-8#1)(2011-2#5)
Ethnic differences in the BMI-%BF##2##5##(2008-10#2)
Ethnic differences in##3##3##(2008-10#2)(2012-2#1)
Ethnic##7##1##(2008-10#2)(2009-10#1)(2009-7#1)(2010-10#2)(2012-2#1)
Ethyl##3##1##(2008-10#1)(2008-12#1)(2008-3#1)
Ethylene##5##1##(1993-12#1)(1995-2#1)(2008-10#2)(2008-5#1)
Etienne Sergent##2##2##(2010-1#2)
Etiologic factors##2##2##(1991-8#1)(2013-1#1)
Etiology and##2##2##(2008-10#2)
Etiology of##5##2##(2008-10#2)(2008-7#1)(2010-7#1)(2013-1#1)
Etiology##9##1##(2008-10#5)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#1)
Etoposide##2##1##(1997-7#1)(2008-10#1)
Etravirine##2##1##(2009-9#1)(2011-3#1)
Etude##2##1##(2008-2#1)(2013-1#1)
Eu and Gd)##2##3##(2008-10#2)
Eu and##6##2##(2008-10#6)
Eu were##2##2##(2008-10#2)
Eu##23##1##(2008-10#21)(2008-11#1)(2010-4#1)
Eu(3+) and##3##2##(2008-10#3)
Eu(3+)##16##1##(2008-10#11)(2008-3#2)(2010-4#3)
Eu(III) and##2##2##(2008-10#2)
Eu(III) ions##2##2##(2008-10#2)
Eu(III)##10##1##(2008-10#10)
Eu(fod)(3)##4##1##(2008-10#4)
Euborellia plebeja##2##2##(2008-6#2)
Eucalyptus camaldulensis##2##2##(2008-5#2)
Eucalyptus globulus and##2##3##(2008-10#1)(2008-5#1)
Eucalyptus globulus##3##2##(2008-10#2)(2008-5#1)
Eucalyptus spp##2##2##(2008-10#2)
Eucalyptus##16##1##(2008-10#9)(2008-5#3)(2010-3#4)
Eucheuma serra agglutinin (ESA)##2##4##(2008-11#2)
Eucheuma serra##3##2##(2008-11#3)
Euclidean distance##2##2##(2010-7#1)(2013-8#1)
Euclidean##6##1##(2008-6#2)(2010-7#1)(2011-2#2)(2013-8#1)
Eucommia ulmodies Oliv##2##3##(2008-10#2)
Eudragit RSPO alone##2##3##(2012-2#2)
Eudragit##3##1##(2012-2#3)
Eugenia uniflora L##2##3##(2008-10#2)
Eugenia##5##1##(2008-10#2)(2010-2#2)(2010-8#1)
Eukaryotic##3##1##(2008-1#1)(2008-4#1)(2012-3#1)
Euler's method##2##2##(2008-6#2)
Euphorbia heterophylla##5##2##(2008-10#2)(2013-1#3)
Euphorbia macroclada##2##2##(2008-10#2)
Euphorbia##9##1##(2008-10#5)(2013-1#4)
Euphorbiaceae)##2##1##(2013-8#2)
Euplectes##2##1##(2008-8#2)
Eur##4##1##(1991-2#1)(1992-3#1)(2008-10#1)(2008-6#1)
Eurasia##4##1##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
Eurasian##7##1##(2008-12#4)(2008-6#1)(2008-9#1)(2010-10#1)
EuroQol##2##1##(2008-10#1)(2011-2#1)
EuroQol-VAS##2##1##(2011-2#2)
Europe and North America##7##4##(2008-10#3)(2008-7#1)(2010-3#1)(2011-2#2)
Europe and the##5##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-11#1)(2011-2#1)
Europe and##24##2##(1991-12#1)(1997-6#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-3#1)(2011-2#3)
Europe is##3##2##(1994-12#1)(2009-4#1)(2012-12#1)
Europe or##2##2##(2008-10#2)
Europe the##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
Europe were##4##2##(2008-10#4)
Europe##139##1##(1991-12#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-3#3)(1997-1#1)(1997-3#3)(1997-6#1)(2008-1#1)(2008-10#57)(2008-11#4)(2008-12#4)(2008-5#3)(2008-7#2)(2008-8#8)(2009-4#5)(2010-1#4)(2010-11#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-10#1)(2011-2#17)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#1)(2013-8#4)
Europe)##2##1##(2008-11#1)(2008-12#1)
European American##5##2##(2008-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#1)
European Commission##8##2##(1996-1#1)(2008-10#6)(2012-2#1)
European Community##6##2##(1992-6#1)(1993-2#1)(1994-5#1)(2008-10#3)
European Cosmetic##2##2##(2008-5#2)
European Journal of##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
European Panel on the Appropriateness of Crohn's##2##7##(2010-12#2)
European Union (EU)##2##3##(1996-1#1)(2013-8#1)
European Union##16##2##(1996-1#1)(1996-3#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
European VCG 0094##2##3##(2008-10#2)
European and##3##2##(2008-10#1)(2008-12#2)
European avian-like##2##2##(2011-2#2)
European children##2##2##(2008-1#2)
European corn borer##5##3##(1995-6#1)(2008-10#2)(2008-7#2)
European countries and Australia##2##4##(1993-2#1)(2008-10#1)
European countries##8##2##(1991-3#1)(1993-2#1)(1996-2#1)(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)
European expert panel##3##3##(2010-12#3)
European flint maize##2##3##(2008-10#2)
European hazelnut##3##2##(2008-10#3)
European isolates##4##2##(2008-10#3)(2008-8#1)
European legislation##3##2##(2008-10#3)
European oak bark beetle (Scolytus intricatus) extracts##2##7##(2008-10#2)
European oak species##3##3##(2012-5#1)(2012-7#1)(2012-9#1)
European oak##5##2##(2008-10#2)(2012-5#1)(2012-7#1)(2012-9#1)
European oaks to##2##3##(2012-7#1)(2012-9#1)
European oaks##3##2##(2012-7#2)(2012-9#1)
European pear##3##2##(2008-10#3)
European population##2##2##(1997-6#1)(2008-10#1)
European populations##3##2##(1991-12#2)(2008-10#1)
European requirements##2##2##(2008-11#1)(2013-1#1)
European species##3##2##(2008-12#1)(2008-8#2)
European starlings Sturnus vulgaris to##2##5##(2008-8#1)(2008-9#1)
European women##2##2##(1991-11#1)(2008-1#1)
European##227##1##(1990-11#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-1#2)(1992-6#1)(1993-2#2)(1993-5#1)(1994-12#4)(1994-3#1)(1994-5#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#2)(1997-3#1)(1997-6#1)(2008-1#5)(2008-10#87)(2008-11#9)(2008-12#11)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#1)(2011-2#16)(2011-3#1)(2012-2#10)(2012-3#2)(2012-5#1)(2012-7#3)(2012-9#2)(2013-1#8)(2013-8#2)
Europeans##2##1##(2008-10#1)(2008-12#1)
Eurygaster##3##1##(2013-8#3)
Euscelidius variegatus##2##2##(2008-10#2)
Eutypa dieback##5##2##(2008-10#5)
Eutypa lata and Eutypella vitis##3##5##(2008-10#3)
Eutypa lata and##4##3##(2008-10#4)
Eutypa lata##6##2##(2008-10#6)
Eutypa##19##1##(2008-10#19)
Eutypella vitis##5##2##(2008-10#5)
Euzophera##2##1##(2008-10#2)
Evacuation##2##1##(2008-7#1)(2013-1#1)
Evaluate##6##1##(2008-11#1)(2011-2#4)(2012-3#1)
Evaluating a##2##2##(2008-11#1)(2013-1#1)
Evaluating the##19##2##(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-8#1)(2011-2#2)(2012-2#1)
Evaluating##40##1##(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-3#1)(2008-10#8)(2008-11#5)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#1)
Evaluation and Management of##2##4##(2010-9#1)(2011-2#1)
Evaluation and##7##2##(1990-9#1)(1996-6#1)(2008-10#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
Evaluation in##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
Evaluation of Pain and Accuracy Diagnostic in Hospitalized Children##2##9##(2013-1#2)
Evaluation of Tomato##2##3##(2008-10#2)
Evaluation of a new##2##4##(2008-10#1)(2008-12#1)
Evaluation of a##17##3##(1996-8#1)(1997-4#1)(1997-5#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#2)(2008-9#1)(2013-1#1)
Evaluation of an on-line##2##4##(1997-2#1)(2008-10#1)
Evaluation of an##7##3##(1997-2#1)(2008-10#3)(2008-11#1)(2012-12#1)(2013-1#1)
Evaluation of different##3##3##(2008-10#3)
Evaluation of measurement uncertainty in##2##5##(2008-10#2)
Evaluation of the data##2##4##(2008-10#1)(2012-3#1)
Evaluation of the grant program for rural health care transition##2##10##(1992-12#1)(1996-2#1)
Evaluation of the##29##3##(1991-3#1)(1992-12#1)(1993-12#1)(1996-2#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
Evaluation of two commercial##2##4##(2008-10#2)
Evaluation of two##3##3##(2008-10#3)
Evaluation of##156##2##(1991-1#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#4)(1997-4#2)(1997-5#1)(1997-6#1)(2008-10#65)(2008-11#13)(2008-12#5)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#4)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#4)
Evaluation##178##1##(1990-9#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-12#2)(1994-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2008-10#69)(2008-11#15)(2008-12#5)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-9#1)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#4)
Evaluations of##2##2##(2008-11#1)(2008-12#1)
Evaluations##6##1##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)
Evans blue##3##2##(1994-12#1)(2008-7#1)(2009-6#1)
Evans##6##1##(1994-12#1)(1997-2#1)(1997-7#1)(2008-5#1)(2008-7#1)(2009-6#1)
Evaporation of##2##2##(1995-3#1)(2008-5#1)
Evaporation rates##2##2##(2008-5#2)
Evaporation##6##1##(1995-3#2)(2008-11#1)(2008-5#3)
Evechinus chloroticus##2##2##(2008-8#2)
Even after##4##2##(1994-2#1)(1995-12#1)(2008-10#1)(2010-12#1)
Even at##3##2##(1993-8#1)(2008-10#1)(2012-3#1)
Even before the##2##3##(2008-1#1)(2011-2#1)
Even for##2##2##(2008-10#1)(2008-3#1)
Even if##4##2##(1991-2#1)(1995-12#1)(1995-3#1)(2009-7#1)
Even in the absence of##3##5##(1991-12#1)(1992-6#1)(2009-5#1)
Even in the##4##3##(1991-12#1)(1992-6#1)(2008-10#1)(2009-5#1)
Even in##6##2##(1991-12#1)(1992-6#1)(2008-10#2)(2009-5#1)(2012-3#1)
Even minor##2##2##(1994-9#1)(2008-7#1)
Even more##4##2##(1991-6#1)(2008-6#1)(2010-12#1)(2013-1#1)
Even now##2##2##(2008-10#2)
Even so##3##2##(1996-2#1)(2008-10#1)(2010-1#1)
Even the##2##2##(1995-12#1)(1997-3#1)
Even though all##2##3##(1997-8#1)(2008-10#1)
Even though the##9##3##(1991-6#1)(1992-5#1)(1996-5#1)(2008-10#3)(2008-3#1)(2012-12#1)(2013-1#1)
Even though##25##2##(1991-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
Even when a##2##3##(1996-9#1)(2012-12#1)
Even when##3##2##(1996-9#1)(2008-3#1)(2012-12#1)
Even with##5##2##(1992-3#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-1#1)
Even##86##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-9#1)(1995-12#3)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-12#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)
Event##4##1##(2008-1#1)(2009-10#1)(2010-8#1)(2013-1#1)
Event-related potentials (ERPs)##2##3##(2008-11#1)(2008-8#1)
Event-related potentials##3##2##(2008-11#1)(2008-8#2)
Events and##2##2##(1996-6#1)(2008-10#1)
Events##11##1##(1991-2#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-8#1)(2010-2#1)(2013-1#1)
Eventually##2##1##(1994-3#1)(2008-10#1)
Ever since##2##2##(2009-3#1)(2011-1#1)
Ever##3##1##(1990-12#1)(2009-3#1)(2011-1#1)
Everett Koop##2##2##(1993-3#1)(1996-5#1)
Evernia prunastri##2##2##(2008-10#1)(2008-5#1)
Every 2##2##2##(1993-1#1)(1996-12#1)
Every batch of samples was composed by three real samples and three standard solutions##2##14##(2008-10#2)
Every patient##2##2##(2012-12#1)(2012-3#1)
Every year##4##2##(1991-2#1)(2008-10#1)(2010-11#1)(2010-7#1)
Every##26##1##(1990-9#1)(1991-2#1)(1993-1#1)(1994-12#1)(1996-12#2)(1996-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
Everyday##4##1##(2007-12#2)(2008-12#1)(2013-8#1)
Evidence exists demonstrating##2##3##(2008-12#1)(2008-4#1)
Evidence for a##6##3##(1992-3#1)(1994-5#1)(1995-6#1)(2008-10#2)(2012-12#1)
Evidence for the involvement of##2##5##(1992-6#1)(1993-3#1)
Evidence for the##10##3##(1991-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-5#2)
Evidence for##33##2##(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-5#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
Evidence from the##2##3##(1991-12#1)(2013-1#1)
Evidence from##12##2##(1991-12#1)(1995-11#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Evidence has##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
Evidence indicates that##2##3##(1994-5#1)(2008-11#1)
Evidence is also presented that##2##5##(1993-6#1)(1995-6#1)
Evidence is also presented##3##4##(1993-6#1)(1995-6#1)(2008-10#1)
Evidence is also##5##3##(1993-6#1)(1995-6#1)(2008-10#2)(2010-5#1)
Evidence is presented##2##3##(1990-2#1)(1996-5#1)
Evidence is provided in this study##2##6##(2008-10#2)
Evidence is provided##4##3##(1994-3#1)(2008-10#2)(2010-8#1)
Evidence is##17##2##(1990-2#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-5#1)(2008-10#6)(2008-12#1)(2008-5#2)(2010-5#1)(2010-8#1)(2011-2#1)
Evidence of the##2##3##(1995-9#1)(2008-10#1)
Evidence of##25##2##(1991-9#1)(1992-11#2)(1992-8#1)(1993-11#1)(1993-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
Evidence suggests that the##3##4##(2009-6#1)(2011-2#1)(2013-7#1)
Evidence suggests that##8##3##(2008-11#2)(2009-6#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Evidence suggests##10##2##(2008-11#2)(2009-6#1)(2011-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
Evidence that the##3##3##(1990-5#1)(1992-9#1)(1994-5#1)
Evidence that##13##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-11#2)
Evidence was##2##2##(2008-10#1)(2008-7#1)
Evidence##132##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#2)(2008-10#34)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
Evidence-Based##2##1##(2011-2#1)(2013-1#1)
Evidence-based answer and summary##3##4##(2008-11#3)
Evidence-based##8##1##(2008-10#2)(2008-11#4)(2008-7#1)(2012-3#1)
Evoked##2##1##(1990-9#1)(2011-2#1)
Evolution in##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
Evolution of the##2##3##(2008-10#1)(2013-8#1)
Evolution of##20##2##(1990-3#1)(1991-5#1)(1992-11#1)(1995-8#1)(1997-6#1)(2008-10#6)(2008-9#2)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Evolution##31##1##(1990-3#2)(1991-5#1)(1992-11#1)(1995-8#1)(1996-9#1)(1997-6#2)(2008-10#7)(2008-8#1)(2008-9#3)(2010-10#1)(2010-7#1)(2011-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
Evolutionary Biology##2##2##(2013-1#2)
Evolutionary conservation and##2##3##(1994-11#1)(2008-9#1)
Evolutionary conservation##3##2##(1994-11#1)(2008-10#1)(2008-9#1)
Evolutionary dynamics of##2##3##(2008-8#2)
Evolutionary##24##1##(1990-11#1)(1994-11#1)(1997-6#1)(2008-10#1)(2008-8#7)(2008-9#3)(2009-12#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#2)
Evolved##5##1##(2008-10#2)(2008-8#1)(2009-12#1)(2012-3#1)
Evolving##3##1##(1996-1#1)(2007-12#1)(2008-11#1)
Ewing's Sarcoma##2##2##(2011-2#1)(2012-3#1)
Ewing's sarcoma of##2##3##(2009-5#1)(2011-2#1)
Ewing's sarcoma##4##2##(2009-5#1)(2011-2#3)
Ewing's##8##1##(2009-5#1)(2011-2#4)(2012-2#2)(2012-3#1)
Ex vivo##3##2##(2008-11#1)(2008-5#1)(2011-3#1)
Exact##6##1##(2007-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2013-1#1)
Exactly##2##1##(1994-12#1)(1995-11#1)
Examination Survey##3##2##(2008-1#1)(2009-7#1)(2010-12#1)
Examination in##2##2##(2008-10#1)(2012-2#1)
Examination of a##2##3##(2008-10#1)(2008-11#1)
Examination of the##12##3##(1990-12#1)(1991-5#1)(1994-5#1)(1997-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)
Examination of these##2##3##(1992-9#1)(2008-2#1)
Examination of##29##2##(1990-12#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-6#2)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#3)(2012-2#1)
Examination revealed##2##2##(2010-3#1)(2013-1#1)
Examination##49##1##(1990-12#1)(1991-1#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-6#2)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#2)(2012-5#1)(2013-1#3)
Examinations of##2##2##(2008-12#1)(2009-8#1)
Examine##2##1##(2008-10#1)(2008-11#1)
Examining the##3##2##(1992-12#1)(2008-12#1)(2009-10#1)
Examining##7##1##(1992-12#1)(1992-2#1)(1995-12#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-10#1)
Example##3##1##(2008-10#1)(2008-3#1)(2012-2#1)
Examples are given##2##3##(2008-10#1)(2008-5#1)
Examples are provided of##3##4##(1997-7#1)(2010-11#1)(2013-8#1)
Examples are##10##2##(1991-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2010-11#1)(2013-8#1)
Examples from##3##2##(1994-12#1)(2008-11#1)(2009-4#1)
Examples of the##3##3##(2008-11#1)(2008-9#1)(2010-11#1)
Examples of##27##2##(1992-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-7#2)
Examples showing the##2##3##(2008-10#1)(2013-1#1)
Examples##47##1##(1991-8#1)(1992-2#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-11#2)(2010-7#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
Excel##6##1##(1994-2#1)(1994-3#2)(2008-10#2)(2013-1#1)
Excellence in##3##2##(1992-3#1)(1996-2#1)(1997-2#1)
Excellence##6##1##(1992-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2012-3#1)(2013-8#1)
Excellent agreement##2##2##(2007-11#1)(2008-10#1)
Excellent linear responses were observed##2##5##(2008-10#2)
Excellent results##2##2##(2008-10#2)
Excellent##11##1##(2007-11#1)(2008-10#10)
Except for the##6##3##(1991-6#1)(1992-6#1)(2008-7#3)(2009-9#1)
Except for##15##2##(1991-6#1)(1992-6#2)(1994-6#1)(1995-8#1)(2008-10#4)(2008-7#3)(2009-9#1)(2013-8#2)
Except in##2##2##(2008-10#1)(2010-11#1)
Except##21##1##(1991-6#1)(1992-6#2)(1994-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(2008-10#5)(2008-7#3)(2008-8#2)(2009-9#1)(2010-11#1)(2013-8#2)
Excess##4##1##(1994-8#1)(1995-2#1)(2008-10#1)(2008-7#1)
Excessive##7##1##(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
Exchange##7##1##(2008-10#6)(2008-12#1)
Excipients##2##1##(2012-2#2)
Excised##2##1##(2008-10#2)
Excision##4##1##(2010-6#1)(2012-3#1)(2013-1#2)
Excisional##2##1##(2013-8#2)
Excitation of##3##2##(2008-10#2)(2008-3#1)
Excitation##6##1##(2008-10#2)(2008-3#3)(2008-9#1)
Exciting##3##1##(2008-10#1)(2010-4#1)(2013-1#1)
Excluded from##2##2##(1995-12#1)(2013-1#1)
Excluded##4##1##(1993-12#1)(1995-12#1)(2013-1#2)
Excluding##4##1##(1997-3#1)(1997-4#1)(2008-6#1)(2012-2#1)
Exclusion criteria##2##2##(2009-8#1)(2010-11#1)
Exclusion of##3##2##(1996-12#1)(2008-11#1)(2008-9#1)
Exclusion##5##1##(1996-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-11#1)
Exclusive##2##1##(1996-5#1)(2008-10#1)
Excretion of##2##2##(1993-6#1)(1994-12#1)
Executive##13##1##(1991-12#1)(1992-2#2)(1994-1#1)(1995-6#2)(1996-9#1)(2008-11#5)(2008-9#1)
Executives and##3##2##(1991-1#1)(1994-12#1)(1997-2#1)
Executives##4##1##(1991-1#1)(1994-12#2)(1997-2#1)
Exercise Training##2##2##(2012-3#1)(2013-1#1)
Exercise performance##2##2##(2008-12#1)(2011-3#1)
Exercise training##2##2##(2012-3#1)(2013-8#1)
Exercise##31##1##(1991-6#1)(2008-1#1)(2008-10#2)(2008-12#2)(2010-1#1)(2010-6#3)(2011-3#1)(2012-3#6)(2013-1#10)(2013-8#4)
Exercise-induced anaphylaxis##2##2##(2010-1#2)
Exercise-induced##6##1##(2010-1#3)(2010-6#1)(2011-2#1)(2013-1#1)
Exhaled breath##2##2##(2010-10#2)
Existence of##2##2##(2008-10#1)(2010-10#1)
Existence##3##1##(2008-10#1)(2010-10#1)(2013-8#1)
Existing##6##1##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-4#1)
Exo-beta-1##2##1##(2008-10#2)
Exocytosis##2##1##(1995-11#1)(2008-10#1)
Exogenous addition of##2##3##(2008-10#1)(2009-6#1)
Exogenous##12##1##(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2012-2#1)
Exoglc1##2##1##(2008-10#2)
Exon##2##1##(2008-9#1)(2011-1#1)
Exophiala##2##1##(2008-5#2)
Exotic##2##1##(2007-12#1)(2012-2#1)
Expanded Disability Status Scale (EDSS)##2##5##(2008-11#1)(2010-12#1)
Expanded##6##1##(1992-5#1)(2008-11#2)(2009-8#1)(2010-12#2)
Expanding adult day care##2##4##(1994-3#2)
Expanding the##3##2##(2008-7#1)(2008-8#1)(2010-8#1)
Expanding##8##1##(1991-1#1)(1993-2#1)(1994-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
Expansion of a hospital-based service systems to support a satellite clinic network##2##12##(1994-1#2)
Expansion of a##3##3##(1994-1#2)(1997-3#1)
Expansion of##7##2##(1994-1#2)(1995-12#1)(1997-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
Expansion##11##1##(1994-1#2)(1995-12#1)(1996-9#2)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
Expected final online publication date for the Annual Review of Plant Biology Volume 62 is April 29##5##17##(2011-2#5)
Expected final online publication date for the Annual Review of##6##10##(2011-2#6)
Expected##7##1##(2008-12#1)(2011-2#6)
Expenditures##4##1##(1993-3#1)(1996-1#1)(2008-7#1)(2013-1#1)
Experience Survey##2##2##(1992-1#1)(1996-1#1)
Experience from##5##2##(1993-12#1)(1996-11#1)(2008-1#1)(2008-12#1)(2013-8#1)
Experience in##6##2##(2008-10#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
Experience with##9##2##(1991-2#1)(1991-6#1)(1993-11#1)(1996-6#1)(2008-1#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-3#1)
Experience##33##1##(1991-2#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-12#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
Experienced##4##1##(1992-12#1)(1993-11#1)(2008-11#1)(2008-9#1)
Experiences Scale##3##2##(2009-11#1)(2010-6#2)
Experiences and##2##2##(1995-11#1)(2008-11#1)
Experiences from a##2##3##(1995-2#1)(2008-11#1)
Experiences from##4##2##(1990-6#1)(1994-6#1)(1995-2#1)(2008-11#1)
Experiences in##3##2##(1995-3#1)(1997-2#1)(2008-11#1)
Experiences of children treating functional bladder disturbances on##2##8##(2008-10#2)
Experiences of##5##2##(1995-1#1)(2008-10#2)(2008-12#1)(2008-8#1)
Experiences with##4##2##(1991-6#1)(1991-9#1)(1992-11#1)(1996-3#1)
Experiences##24##1##(1990-6#1)(1991-6#1)(1991-9#1)(1992-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2009-11#1)(2010-6#2)(2013-1#1)
Experiential learning is##2##3##(2008-11#1)(2009-8#1)
Experiment 1##9##2##(2008-11#2)(2008-5#3)(2008-6#2)(2011-1#1)(2013-8#1)
Experiment 2##11##2##(2008-11#1)(2008-5#3)(2008-6#3)(2010-8#1)(2011-1#1)(2013-8#2)
Experiment 3##6##2##(1994-2#1)(2008-5#4)(2008-6#1)
Experiment 4##2##2##(2008-5#1)(2009-10#1)
Experiment##43##1##(1994-2#2)(2008-11#8)(2008-3#5)(2008-5#12)(2008-6#6)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-1#2)(2013-8#4)
Experimental Lidar in Space Equipment##2##5##(2008-3#2)
Experimental and clinical studies have##2##5##(1992-2#1)(2010-10#1)
Experimental and##4##2##(1992-2#1)(2008-10#1)(2008-11#1)(2010-10#1)
Experimental approaches##2##2##(2008-11#1)(2010-11#1)
Experimental autoimmune uveoretinitis##2##3##(2008-4#2)
Experimental autoimmune##3##2##(1995-12#1)(2008-4#2)
Experimental conditions such as pH##2##5##(2008-10#2)
Experimental conditions were##4##3##(2008-10#3)(2008-11#1)
Experimental conditions##7##2##(2008-10#6)(2008-11#1)
Experimental data were##2##3##(2008-10#1)(2008-3#1)
Experimental data##9##2##(2008-10#4)(2008-3#3)(2008-7#1)(2013-8#1)
Experimental design methodologies to##2##4##(2008-10#2)
Experimental design##5##2##(1994-12#1)(2008-10#4)
Experimental determination of##2##3##(1993-5#1)(2008-5#1)
Experimental evaluation of##2##3##(2008-5#1)(2012-2#1)
Experimental evidence for##2##3##(1990-12#1)(1993-3#1)
Experimental evidence##5##2##(1990-12#1)(1993-3#1)(2007-12#1)(2008-10#2)
Experimental group submitted to##2##4##(2013-1#2)
Experimental investigation of##2##3##(2007-11#1)(2008-3#1)
Experimental investigation##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
Experimental model##2##2##(2008-11#1)(2012-3#1)
Experimental observation of##2##3##(1993-5#1)(2008-3#1)
Experimental parameters such as the##2##5##(2008-10#1)(2009-8#1)
Experimental parameters##5##2##(2008-10#4)(2009-8#1)
Experimental results are presented##2##4##(2007-12#1)(2008-7#1)
Experimental results are##4##3##(2007-12#1)(2008-3#2)(2008-7#1)
Experimental results obtained##2##3##(2008-10#1)(2008-3#1)
Experimental results show that the##4##5##(2008-10#2)(2013-8#2)
Experimental results showed that##2##4##(2008-10#2)
Experimental results showed the##2##4##(2008-10#2)
Experimental results showed##7##3##(2008-10#6)(2008-11#1)
Experimental results##29##2##(1991-12#1)(1996-12#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#7)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#2)
Experimental short-term##2##2##(2008-10#2)
Experimental studies on##2##3##(1995-11#1)(2008-9#1)
Experimental studies##6##2##(1992-4#1)(1992-9#1)(1995-11#1)(1997-6#1)(2008-9#1)(2012-3#1)
Experimental study of##2##3##(2008-10#1)(2008-2#1)
Experimental study##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Experimental##135##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-5#2)(1994-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#48)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#21)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
Experimentally##9##1##(1995-3#1)(1996-12#1)(2008-3#3)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
Experiments 1 and 2##2##4##(2008-5#1)(2011-1#1)
Experiments 1##4##2##(2008-5#2)(2008-6#1)(2011-1#1)
Experiments are performed##2##3##(2007-12#1)(2008-3#1)
Experiments are##3##2##(2007-12#1)(2008-3#2)
Experiments based on##2##3##(2008-10#1)(2010-10#1)
Experiments have##3##2##(2008-10#2)(2008-2#1)
Experiments on##3##2##(1991-6#1)(2008-10#1)(2008-9#1)
Experiments performed##2##2##(2008-10#1)(2011-2#1)
Experiments that##2##2##(2008-10#1)(2008-3#1)
Experiments to##3##2##(2008-10#2)(2008-11#1)
Experiments using##3##2##(1992-1#1)(2008-10#2)
Experiments were carried out##3##4##(2007-11#1)(2008-10#2)
Experiments were conducted in three##2##5##(2008-10#1)(2013-8#1)
Experiments were conducted in##3##4##(2008-10#2)(2013-8#1)
Experiments were conducted to##3##4##(1991-5#1)(2008-10#2)
Experiments were conducted##6##3##(1991-5#1)(2008-10#4)(2013-8#1)
Experiments were performed to##2##4##(2008-10#1)(2008-3#1)
Experiments were performed##5##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-3#1)
Experiments were##16##2##(1991-5#1)(1993-3#1)(1994-5#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
Experiments with##7##2##(1991-5#1)(1992-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
Experiments##69##1##(1991-5#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-5#1)(2007-11#1)(2007-12#2)(2008-10#25)(2008-11#6)(2008-2#3)(2008-3#7)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
Expert Panel##2##2##(2008-1#1)(2013-1#1)
Expert##8##1##(1990-11#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
Experts##4##1##(2010-12#1)(2011-10#2)(2012-12#1)
Explaining##2##1##(1991-12#1)(2008-8#1)
Explanation##2##1##(2008-10#1)(2013-1#1)
Explant##2##1##(2008-11#2)
Explants##3##1##(1990-11#1)(2008-11#1)(2008-12#1)
Explicit##6##1##(2008-12#1)(2008-3#1)(2008-8#2)(2009-9#1)(2010-12#1)
Exploitation of##6##2##(1990-11#1)(2008-10#2)(2008-3#2)(2012-3#1)
Exploitation##7##1##(1990-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-3#1)
Exploiting##8##1##(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)
Exploration of the##3##3##(1997-7#1)(2008-9#1)(2013-1#1)
Exploration of##6##2##(1997-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
Exploration##7##1##(1997-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Exploratory factor analysis##2##3##(2010-6#2)
Exploratory factor##3##2##(2010-6#2)(2012-2#1)
Exploratory laparotomy was##2##3##(1990-2#1)(2013-8#1)
Exploratory##6##1##(1990-2#1)(2008-10#1)(2010-6#2)(2012-2#1)(2013-8#1)
Exploring the##11##2##(1991-3#1)(1993-1#1)(1993-12#1)(1997-3#1)(2008-11#1)(2008-6#1)(2010-1#1)(2010-4#1)(2010-7#2)(2012-3#1)
Exploring##19##1##(1991-3#1)(1993-1#1)(1993-12#1)(1996-2#1)(1997-3#1)(2008-11#2)(2008-6#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#3)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
Exposed to##3##2##(2008-10#2)(2008-12#1)
Exposed##4##1##(2008-10#2)(2008-12#1)(2013-1#1)
Exposing the##2##2##(2008-11#2)
Exposing##5##1##(2008-10#2)(2008-11#3)
Exposure and##2##2##(1997-3#1)(2009-4#1)
Exposure of acutely compensated animals to##2##6##(1991-2#2)
Exposure of mouse##2##3##(1995-2#1)(1995-8#1)
Exposure of the##2##3##(2008-10#1)(2010-4#1)
Exposure of##20##2##(1990-2#1)(1991-2#2)(1994-2#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-4#1)
Exposure to high##2##3##(2008-10#1)(2009-8#1)
Exposure to##18##2##(1991-12#1)(1991-5#1)(1992-12#1)(1994-3#1)(2008-10#10)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
Exposure##46##1##(1990-2#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Express Five SFM##4##3##(2008-7#4)
Expressed in##2##2##(2008-10#1)(2008-11#1)
Expressed##4##1##(2008-10#1)(2008-11#1)(2009-11#1)(2009-8#1)
Expressing the##2##2##(2008-10#2)
Expressing##5##1##(2008-10#4)(2008-9#1)
Expression Analysis of##3##3##(2008-10#3)
Expression and regulation of mRNAs for insulin-like growth##2##8##(2008-8#2)
Expression and regulation of##3##4##(2008-8#2)(2010-11#1)
Expression and##8##2##(1995-11#1)(2008-6#1)(2008-8#3)(2010-11#1)(2011-2#1)(2012-3#1)
Expression in the##2##3##(2008-10#1)(2008-6#1)
Expression in##9##2##(1996-3#1)(2008-10#3)(2008-11#2)(2008-6#1)(2010-7#1)(2013-1#1)
Expression levels of##3##3##(2008-11#2)(2012-3#1)
Expression of a human##2##4##(1995-2#1)(1996-12#1)
Expression of a##3##3##(1995-2#1)(1996-12#1)(2008-10#1)
Expression of an##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
Expression of both##2##3##(1995-6#1)(2013-1#1)
Expression of human##4##3##(1991-5#1)(1993-8#1)(2008-11#1)(2008-8#1)
Expression of listeriolysin O##2##4##(1996-12#2)
Expression of mRNAs##2##3##(2008-11#1)(2008-8#1)
Expression of recombinant##5##3##(1992-10#1)(1994-6#1)(2008-8#1)(2010-5#1)(2013-8#1)
Expression of several##2##3##(2008-8#1)(2011-2#1)
Expression of the Arabidopsis##2##4##(2008-10#2)
Expression of the##26##3##(1991-6#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-7#2)(2008-10#9)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
Expression of##126##2##(1990-12#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-6#3)(1995-9#1)(1996-12#9)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#6)(1997-9#1)(2008-10#25)(2008-11#6)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#5)(2009-6#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#1)
Expression pattern##2##2##(2008-8#1)(2009-7#1)
Expression studies of##2##3##(1994-11#1)(2008-5#1)
Expression studies##4##2##(1991-7#1)(1993-2#1)(1994-11#1)(2008-5#1)
Expression was##2##2##(2008-10#1)(2008-11#1)
Expression##189##1##(1990-12#2)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-11#5)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-2#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#9)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#6)(1997-9#1)(2008-10#37)(2008-11#15)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#14)(2008-9#5)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#8)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#2)
Expressions##2##1##(2008-10#1)(2012-3#1)
Expressive##2##1##(2010-11#1)(2011-2#1)
Expt##10##1##(1992-12#4)(1993-3#2)(1993-6#4)
Exserohilum rostratum in a child##2##5##(2008-10#2)
Exserohilum##5##1##(2008-10#5)
Extended ageing of the##2##4##(2008-10#2)
Extended##7##1##(2008-10#4)(2008-2#1)(2011-2#1)(2012-3#1)
Extended-Release##2##1##(2010-4#1)(2013-1#1)
Extended-spectrum##2##1##(2011-2#2)
Extending prior##2##2##(2009-11#1)(2013-8#1)
Extending the##2##2##(1992-11#1)(2008-10#1)
Extending##6##1##(1992-11#1)(1992-3#1)(2008-10#1)(2008-8#1)(2009-11#1)(2013-8#1)
Extensible##2##1##(1992-2#1)(2010-8#1)
Extension of the##2##3##(2008-11#2)
Extension of##4##2##(1991-7#1)(2008-11#2)(2012-3#1)
Extension##9##1##(1991-2#1)(1991-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2012-3#1)(2013-7#1)
Extensive##16##1##(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-7#2)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-3#2)
External fixation##2##2##(2008-8#1)(2010-12#1)
External##14##1##(1990-6#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
Extinction##3##1##(2008-8#2)(2008-9#1)
Extra##2##1##(2008-9#1)(2011-2#1)
Extracellular ATP##2##2##(1990-5#1)(1993-8#1)
Extracellular Ca2+##2##2##(1994-8#1)(1996-2#1)
Extracellular matrix##2##2##(2008-11#1)(2009-10#1)
Extracellular##18##1##(1990-5#3)(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#3)
Extracolonic manifestations##2##2##(2009-12#2)
Extracontractual referrals##2##2##(1991-8#2)
Extracranial orbital decompression##2##3##(2008-7#2)
Extract of##4##2##(2008-10#1)(2012-2#3)
Extract##9##1##(2008-10#4)(2012-2#4)(2013-1#1)
Extracted##2##1##(1990-2#1)(1991-2#1)
Extracting##2##1##(2008-9#1)(2012-2#1)
Extraction and separation##2##3##(2008-10#2)
Extraction and spectrophotometric determination of##2##5##(2008-10#2)
Extraction and##7##2##(2008-10#7)
Extraction chromatographic##2##2##(2008-10#2)
Extraction conditions##2##2##(2008-10#2)
Extraction constants##2##2##(2008-10#2)
Extraction efficiencies &gt##2##3##(2008-10#2)
Extraction efficiencies##5##2##(2008-10#5)
Extraction efficiency and the influence of##2##6##(2008-10#2)
Extraction efficiency and##3##3##(2008-10#3)
Extraction of arsenic##2##3##(2008-10#2)
Extraction of cationic surfactant templates from##2##6##(2008-10#2)
Extraction of sodium and potassium picrates with##2##7##(2008-10#2)
Extraction of sodium and potassium##3##5##(2008-10#3)
Extraction of##25##2##(1995-6#1)(2008-10#22)(2008-7#1)(2010-4#1)
Extraction recovery of##2##3##(2008-10#2)
Extraction recovery##3##2##(2008-10#3)
Extraction spectrophotometric determination of##2##4##(2008-10#2)
Extraction##70##1##(1991-6#1)(1995-6#1)(2008-10#66)(2008-7#1)(2010-4#1)
Extraction-spectrophotometric##2##1##(2008-10#2)
Extractions were##2##2##(2008-10#2)
Extractions##4##1##(2008-10#4)
Extractive spectrophotometric##2##2##(2008-10#2)
Extractive##3##1##(2008-10#2)(2011-2#1)
Extracts from##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
Extracts of the##2##3##(2010-2#1)(2013-8#1)
Extracts of##6##2##(2008-10#3)(2008-11#1)(2010-2#1)(2013-8#1)
Extracts on##2##2##(2008-5#1)(2010-2#1)
Extracts##17##1##(2008-10#7)(2008-11#4)(2008-5#2)(2010-2#3)(2013-8#1)
Extradenticle##2##1##(2008-9#2)
Extradural##3##1##(2008-7#1)(2011-2#2)
Extramedullary##2##1##(2008-10#1)(2011-2#1)
Extraordinarily##2##1##(1996-9#1)(2008-12#1)
Extrapolation of##2##2##(2008-11#1)(2008-4#1)
Extrapolation##3##1##(2008-11#1)(2008-4#1)(2008-7#1)
Extreme##2##1##(2008-10#1)(2013-1#1)
Extremely##6##1##(1990-9#1)(1992-3#1)(2008-10#2)(2008-12#1)(2011-2#1)
Extrinsic##2##1##(2009-9#1)(2011-2#1)
Exudates##2##1##(2008-10#2)
Eye gaze##2##2##(2008-11#1)(2008-6#1)
Eye##6##1##(1991-9#1)(2008-11#2)(2008-2#1)(2008-6#1)(2010-10#1)
Eye-target synchronization##2##2##(2009-8#2)
Eyes##2##1##(2008-10#1)(2008-12#1)
Eyespot##4##1##(2008-10#2)(2012-3#2)
Eyriès##2##1##(2008-9#2)
F (2)##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
F =##3##2##(1993-2#1)(2008-3#1)(2012-3#1)
F and G##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
F and R islets##2##4##(1995-8#2)
F and##6##2##(1995-8#2)(2008-10#1)(2008-6#2)(2011-2#1)
F islets##3##2##(1995-8#3)
F statistics##2##2##(2008-10#2)
F wave##2##2##(2011-2#2)
F##431##1##(1990-6#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-7#2)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#5)(1997-2#1)(1997-8#2)(2008-10#348)(2008-11#4)(2008-12#3)(2008-3#2)(2008-5#9)(2008-6#7)(2008-7#1)(2008-8#1)(2008-9#4)(2009-8#3)(2010-7#2)(2011-10#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#4)
F(-) ion##2##2##(2008-10#2)
F(-)##9##1##(2008-10#9)
F(0) was##4##2##(2008-8#4)
F(0)##13##1##(2008-10#1)(2008-8#12)
F(1) (Japanese Black##2##3##(2013-1#2)
F(1) and F(2) populations of hybrids of group##2##8##(2008-10#2)
F(1) and F(2)##4##3##(2008-10#3)(2008-8#1)
F(1) hybrid##6##2##(2008-10#5)(2008-9#1)
F(1) hybrids were##3##3##(2008-10#3)
F(1) hybrids##10##2##(2008-10#9)(2008-8#1)
F(1) or Holstein##2##3##(2013-1#2)
F(1) plants##3##2##(2008-10#3)
F(1) progenies were##2##3##(2008-10#2)
F(1) progenies##3##2##(2008-10#3)
F(1) progeny were##4##3##(2008-10#4)
F(1) progeny##8##2##(2008-10#8)
F(1)##72##1##(2008-10#62)(2008-8#4)(2008-9#2)(2013-1#4)
F(10)##2##1##(2008-10#2)
F(2##8##1##(2008-10#8)
F(2) and F(2##2##3##(2008-10#2)
F(2) and F(3)##2##3##(2008-10#2)
F(2) and##5##2##(2008-10#5)
F(2) individuals were##2##3##(2008-10#2)
F(2) individuals##3##2##(2008-10#3)
F(2) plants##6##2##(2008-10#6)
F(2) population derived from a cross between##2##7##(2008-10#2)
F(2) population derived from##3##4##(2008-10#2)(2009-10#1)
F(2) population of##4##3##(2008-10#4)
F(2) population was##2##3##(2008-10#1)(2008-8#1)
F(2) population##19##2##(2008-10#14)(2008-8#3)(2008-9#1)(2009-10#1)
F(2) populations##9##2##(2008-10#9)
F(2) progeny##7##2##(2008-10#7)
F(2)##76##1##(2008-10#67)(2008-8#6)(2008-9#2)(2009-10#1)
F(2)(+) laser##3##2##(2008-3#3)
F(2)(+)##6##1##(2008-3#6)
F(2)(-)##2##1##(2008-2#2)
F(2)H(2)Dz-foam##2##1##(2008-10#2)
F(23)##2##1##(2008-10#2)
F(3) and F(4)##2##3##(2008-10#2)
F(3) and F(5)##2##3##(2008-10#2)
F(3) and##5##2##(2008-10#5)
F(3) families were##2##3##(2008-10#2)
F(3) families##5##2##(2008-10#5)
F(3) families)##2##2##(2008-10#2)
F(3) lines##2##2##(2008-10#2)
F(3) progeny##3##2##(2008-10#3)
F(3)##30##1##(2008-10#30)
F(4) lines##2##2##(2008-10#2)
F(4)##8##1##(2008-10#5)(2008-8#3)
F(5##2##1##(2008-10#2)
F(5) lines##2##2##(2008-10#2)
F(5)##5##1##(2008-10#5)
F(6) lines##5##2##(2008-10#5)
F(6)##8##1##(2008-10#8)
F(7)##2##1##(2008-10#2)
F(8)##3##1##(2008-10#3)
F(B) was##2##2##(2008-10#2)
F(B)##4##1##(2008-10#4)
F(ab')(2)##2##1##(2008-1#2)
F(ab')2 anti-C3 ELISA##3##3##(1990-12#3)
F(ab')2##7##1##(1990-12#3)(1990-5#2)(1997-2#2)
F(c)##3##1##(2008-1#2)(2008-8#1)
F(st)##2##1##(2008-10#1)(2008-8#1)
F)##4##1##(1995-8#1)(1997-2#1)(2008-10#1)(2013-1#1)
F+ are##2##2##(1991-11#2)
F+##6##1##(1991-11#5)(1992-7#1)
F- and G-actin in##2##4##(1992-3#2)
F- and##3##2##(1992-3#2)(2010-4#1)
F-##5##1##(1991-11#1)(1992-3#2)(1995-8#1)(2010-4#1)
F-18##2##1##(1990-12#2)
F-68##3##1##(2008-11#1)(2011-2#2)
F-MEL cells##2##2##(2008-11#2)
F-MEL-SEAP##2##1##(2008-11#2)
F-SKI249380##2##1##(2013-1#2)
F-actin and##2##2##(2009-8#1)(2011-2#1)
F-actin in##2##2##(2008-7#1)(2011-2#1)
F-actin is##2##2##(1993-8#1)(2008-11#1)
F-actin organization##2##2##(2008-10#2)
F-actin##26##1##(1991-5#1)(1992-3#1)(1993-3#1)(1993-8#3)(1994-6#3)(2008-10#6)(2008-11#3)(2008-7#1)(2009-8#1)(2011-2#5)(2012-2#1)
F-d analysis##2##2##(2008-5#2)
F-d##5##1##(2008-5#5)
F-test##4##1##(2008-10#4)
F1 and F2 populations##3##4##(2008-10#3)
F1 and F2##6##3##(2008-10#4)(2008-12#2)
F1 and##7##2##(2008-10#4)(2008-12#2)(2009-2#1)
F1 was##2##2##(2008-11#2)
F1##28##1##(1992-3#5)(1994-8#1)(2008-10#7)(2008-11#8)(2008-12#4)(2008-5#1)(2009-2#1)(2011-3#1)
F1-27 was##2##2##(2008-10#2)
F1-27##6##1##(2008-10#6)
F10##3##1##(1997-7#2)(2008-10#1)
F1009##3##1##(1997-7#3)
F1009/F1021##4##1##(1997-7#4)
F1021 and F1009/F1021 infectants##2##4##(1997-7#2)
F1021 and F1009/F1021##3##3##(1997-7#3)
F1021##4##1##(1997-7#4)
F113##5##1##(2008-10#5)
F12##6##1##(2008-11#6)
F129L##2##1##(2008-10#2)
F1F0 ATPase##4##2##(1997-8#4)
F1Fo-ATPsynthase##3##1##(2012-2#3)
F1s##2##1##(1994-8#2)
F2 and backcross##2##3##(1996-12#2)
F2 and##3##2##(1996-12#2)(2008-12#1)
F2 progeny##2##2##(2008-10#2)
F2##15##1##(1995-6#1)(1996-12#2)(2008-10#8)(2008-12#3)(2011-2#1)
F2/5##6##1##(2008-10#6)
F3##11##1##(2008-10#3)(2008-11#1)(2008-12#5)(2009-2#2)
F344 rat##3##2##(2011-2#3)
F344 rats##5##2##(1990-3#2)(1995-11#1)(2008-7#1)(2011-2#1)
F344##9##1##(1990-3#2)(1995-11#1)(2008-7#1)(2011-2#5)
F344/N rats##2##2##(1994-2#2)
F344/N##3##1##(1994-2#3)
F3TdR##5##1##(1994-8#5)
F6##3##1##(2008-10#1)(2008-11#2)
F62##3##1##(1993-9#3)
F751##2##1##(1997-7#2)
F966##3##1##(1997-7#3)
F970 and F1009 infectants##2##4##(1997-7#2)
F970##3##1##(1997-7#3)
FA can##2##2##(2008-10#2)
FA could phosphorylate##2##3##(1993-6#2)
FA could##4##2##(1993-6#4)
FA##37##1##(1992-2#2)(1993-6#5)(1997-3#2)(2008-10#14)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#5)(2013-1#2)
FA)##2##1##(1993-6#1)(2008-10#1)
FAAS after##3##2##(2008-10#3)
FAAS in##3##2##(2008-10#3)
FAAS##33##1##(2008-10#33)
FAAS)##3##1##(2008-10#3)
FAB##4##1##(1991-2#3)(2008-10#1)
FABP##3##1##(1994-8#2)(2013-1#1)
FABPs##2##1##(2013-1#2)
FACE##4##1##(1995-6#4)
FACS Calibur##4##2##(2008-4#4)
FACS analysis##5##2##(1994-5#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
FACS##15##1##(1994-5#1)(2008-11#4)(2008-4#6)(2008-8#1)(2011-2#2)(2012-3#1)
FAD and the##2##3##(1996-8#1)(2008-10#1)
FAD and##3##2##(1996-8#1)(2008-10#2)
FAD##9##1##(1992-1#2)(1996-8#3)(2008-10#3)(2009-10#1)
FAD-dependent component##2##2##(1992-12#2)
FAE activity##2##2##(2011-1#1)(2013-1#1)
FAE##6##1##(2011-1#2)(2013-1#4)
FAEES##2##1##(1992-6#2)
FALS##3##1##(1996-5#3)
FAM##2##1##(2008-10#2)
FAME analysis##2##2##(2008-10#2)
FAME profiles##2##2##(2008-10#2)
FAME was##2##2##(2008-10#1)(2009-3#1)
FAME##10##1##(2008-10#8)(2009-3#1)(2009-8#1)
FAMEs##2##1##(2008-10#2)
FAS and CTLA-4##3##3##(2009-8#3)
FAS signaling##2##2##(2009-9#2)
FAS##6##1##(2009-8#4)(2009-9#2)
FASTA##2##1##(2008-4#2)
FAs by##3##2##(2008-10#3)
FAs##9##1##(2008-10#6)(2013-1#3)
FB##2##1##(2008-11#2)
FB(1) was##2##2##(2008-10#2)
FB(1)##9##1##(2008-10#9)
FBA/NE-ISG##6##1##(2011-3#6)
FBB##3##1##(2008-11#3)
FBCA##3##1##(2008-10#3)
FBL3##2##1##(2008-9#2)
FBS and##2##2##(2008-11#2)
FBS for##2##2##(2008-11#1)(2008-9#1)
FBS##23##1##(1994-3#1)(1997-8#3)(2008-10#1)(2008-11#16)(2008-9#1)(2012-2#1)
FBs##2##1##(1991-12#2)
FC##4##1##(2008-11#3)(2008-8#1)
FCAT-SSS##2##1##(2008-12#2)
FCF##5##1##(1990-6#2)(2008-10#3)
FCFP##3##1##(2011-2#3)
FCM##6##1##(2009-6#4)(2010-1#2)
FCPAQ##2##1##(2008-10#2)
FCPBSQ##4##1##(2008-10#4)
FCS##4##1##(2008-11#4)
FD uptake##2##2##(2008-7#2)
FDA approved##6##2##(2008-10#1)(2008-7#1)(2012-3#3)(2013-1#1)
FDA for##2##2##(2008-9#1)(2011-2#1)
FDA issued a##2##3##(2008-5#1)(2013-8#1)
FDA issued##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
FDA trials reporting outcomes##2##4##(2012-12#2)
FDA trials##3##2##(2012-12#3)
FDA##39##1##(1992-3#2)(1992-9#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-5#1)(2010-6#3)(2010-9#1)(2011-2#5)(2011-3#2)(2012-12#4)(2012-3#3)(2013-1#2)(2013-8#1)
FDA's##5##1##(2008-5#1)(2010-6#2)(2013-8#2)
FDA-approved##4##1##(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
FDC-P1 cells##4##2##(1994-5#4)
FDC-P2##4##1##(1997-7#4)
FDCD##3##1##(2008-10#3)
FDG##4##1##(1991-1#1)(2008-1#2)(2011-2#1)
FDP DNA##2##2##(2008-10#2)
FDP##7##1##(2008-10#7)
FDTD##4##1##(2008-3#4)
FE's##4##1##(1994-11#4)
FE(NO)##3##1##(2010-5#3)
FEBS Lett##4##2##(1991-7#1)(1993-12#1)(1995-11#1)(1997-8#1)
FED##4##1##(1996-12#4)
FEL##3##1##(2008-3#3)
FEOET device##2##2##(2009-5#2)
FEOET##4##1##(2009-5#4)
FET##5##1##(2008-10#3)(2008-7#2)
FETV-ICP-MS##2##1##(2008-10#2)
FEV1##8##1##(2008-1#1)(2008-7#4)(2012-2#2)(2012-3#1)
FEV1%##3##1##(2011-2#1)(2012-2#2)
FEV1/FVC ratio##2##2##(2008-7#2)
FF transection##2##2##(1996-12#2)
FF##11##1##(1996-12#2)(2008-10#4)(2008-8#1)(2010-1#2)(2013-8#2)
FFA content##2##2##(2008-10#2)
FFA##6##1##(2008-10#3)(2008-12#2)(2013-8#1)
FFE##3##1##(2008-4#2)(2008-5#1)
FFF##4##1##(2008-10#4)
FFS##5##1##(1993-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-2#1)
FG##2##1##(2011-2#2)
FG-labeled perikarya in the##2##4##(1992-12#2)
FGD type 1##2##3##(2011-1#2)
FGD type 2##3##3##(2011-1#3)
FGD type##5##2##(2011-1#5)
FGD##7##1##(2011-1#7)
FGF receptor##3##2##(1997-1#2)(1997-7#1)
FGF##13##1##(1991-12#2)(1994-11#1)(1995-12#1)(1997-1#4)(1997-7#2)(2008-11#1)(2013-1#2)
FGF-1##3##1##(1993-6#1)(1997-1#2)
FGF-2##9##1##(1993-6#1)(2008-11#8)
FGFR##4##1##(1997-1#2)(2013-1#2)
FGFR1##4##1##(1997-1#4)
FGFR4 and##2##2##(1997-1#2)
FH##2##1##(2008-6#2)
FHB and##4##2##(2008-10#4)
FHB epidemics in##2##3##(2008-10#2)
FHB epidemics##3##2##(2008-10#3)
FHB incidence##2##2##(2008-10#2)
FHB infection and##2##3##(2008-10#2)
FHB resistance in##3##3##(2008-10#3)
FHB resistance##15##2##(2008-10#15)
FHB severity and DON##2##4##(2008-10#2)
FHB severity##3##2##(2008-10#3)
FHB symptoms##2##2##(2008-10#1)(2011-10#1)
FHB was##3##2##(2008-10#3)
FHB##47##1##(2008-10#43)(2011-10#4)
FHB-resistance##2##1##(2008-10#2)
FHP##3##1##(2010-9#3)
FHR monitoring##2##2##(1994-3#2)
FHR##4##1##(1994-3#4)
FI analysis##2##2##(2008-10#2)
FI manifold##2##2##(2008-10#2)
FI method for the accurate and precise##2##7##(2008-10#2)
FI method is##2##3##(2008-10#2)
FI method##10##2##(2008-10#10)
FI methods##2##2##(2008-10#2)
FI procedure##3##2##(2008-10#3)
FI system and##2##3##(2008-10#2)
FI system##13##2##(2008-10#13)
FI##49##1##(2008-10#49)
FI-BI##3##1##(2008-10#3)
FI-CV-AAS##4##1##(2008-10#4)
FI-ECL##3##1##(2008-10#3)
FI-ETAAS##2##1##(2008-10#2)
FI-FAAS and FI-BI##2##3##(2008-10#2)
FI-FAAS##5##1##(2008-10#5)
FI-in-valve##2##1##(2008-10#2)
FI-spectrophotometric##2##1##(2008-10#2)
FIA and##6##2##(2008-10#6)
FIA conditions##4##2##(2008-10#4)
FIA manifold##2##2##(2008-10#2)
FIA method was developed##2##4##(2008-10#2)
FIA method were##2##3##(2008-10#2)
FIA method##5##2##(2008-10#5)
FIA peaks##2##2##(2008-10#2)
FIA set up##2##3##(2008-10#2)
FIA system and##5##3##(2008-10#5)
FIA system for##3##3##(2008-10#3)
FIA system is##2##3##(2008-10#2)
FIA system offers##2##3##(1995-3#1)(2008-10#1)
FIA system to##2##3##(2008-10#2)
FIA system using##3##3##(2008-10#3)
FIA system##33##2##(1995-3#1)(2008-10#32)
FIA systems##3##2##(2008-10#3)
FIA to##2##2##(2008-10#2)
FIA##105##1##(1995-3#2)(2008-10#103)
FIA-potentiometric system##2##2##(2008-10#2)
FIA/DSTD##2##1##(2008-10#2)
FIB##2##1##(2008-10#1)(2008-3#1)
FID detection##2##2##(2008-10#2)
FID##5##1##(2008-10#5)
FINDINGS##12##1##(2011-2#2)(2012-3#2)(2013-1#8)
FIP##4##1##(2008-10#4)
FIPA##2##1##(2013-1#2)
FIS1##2##1##(2009-10#2)
FIS1A and FIS1B##3##3##(2009-10#3)
FIS1A##5##1##(2009-10#5)
FIS1B##5##1##(2009-10#5)
FISH analysis##7##2##(1996-6#1)(1996-8#1)(1997-3#2)(2008-11#1)(2008-9#1)(2009-8#1)
FISH and##2##2##(1997-2#1)(2008-9#1)
FISH method##2##2##(1996-8#1)(2012-3#1)
FISH probes##2##2##(2008-4#1)(2012-3#1)
FISH techniques##2##2##(2008-9#1)(2013-8#1)
FISH##37##1##(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#9)(2008-11#4)(2008-4#2)(2008-9#9)(2009-8#2)(2012-3#5)(2013-8#2)
FISO Neb##5##2##(1993-2#5)
FITC##4##1##(2008-10#1)(2008-4#2)(2008-8#1)
FITC-conjugated##3##1##(2006-6#1)(2008-5#1)(2009-12#1)
FITC-labeled##5##1##(2008-10#4)(2008-9#1)
FIV integrase##2##2##(1997-3#2)
FIX protein##4##2##(1995-2#4)
FIX##5##1##(1995-2#4)(2008-9#1)
FK506##4##1##(1990-9#1)(1991-9#2)(2008-9#1)
FK506-binding protein##2##2##(1990-9#2)
FKB1/FPR1/RBP1##2##1##(1995-9#2)
FKBP##2##1##(1991-9#2)
FL and##2##2##(2008-8#1)(2010-11#1)
FL##15##1##(2008-10#6)(2008-12#1)(2008-8#2)(2010-11#6)
FL)##3##1##(2008-10#2)(2013-1#1)
FLA653##2##1##(2008-10#2)
FLACC and COMFORT-B##2##3##(2012-2#2)
FLACC##9##1##(2012-2#9)
FLC##6##1##(2008-3#1)(2012-3#5)
FLIP regulation of HO-1##2##4##(2011-2#2)
FLIP##8##1##(2009-9#4)(2011-2#4)
FLIPL knock-down##2##2##(2011-2#2)
FLIPL##4##1##(2011-2#4)
FLK##2##1##(1995-8#1)(2008-11#1)
FLLs##3##1##(2010-12#3)
FLO11 expression##3##2##(2008-11#3)
FLO11##4##1##(2008-11#4)
FLOW##2##1##(2010-1#1)(2012-3#1)
FLOWERING LOCUS##2##2##(2009-8#1)(2012-3#1)
FLP/FRT##2##1##(2008-8#1)(2008-9#1)
FLS2 and EFR##2##3##(2009-8#2)
FLS2##3##1##(2009-8#3)
FM and##2##2##(2010-12#1)(2013-1#1)
FM patients##5##2##(2009-11#2)(2010-12#3)
FM##16##1##(1997-7#1)(2008-10#1)(2008-3#2)(2009-11#5)(2010-12#5)(2013-1#2)
FMI##2##1##(2012-2#2)
FMLP##4##1##(1993-1#3)(1993-6#1)
FMME044##2##1##(2013-1#2)
FMOC##6##1##(2008-10#6)
FMRFamide related peptide in##2##4##(1994-2#2)
FMRFamide related peptide##3##3##(1994-2#3)
FMRFamide-like##2##1##(1994-2#2)
FMS##8##1##(2011-2#8)
FN fragments##3##2##(1994-11#3)
FN##24##1##(1990-8#1)(1993-12#1)(1994-11#5)(2008-12#2)(2008-7#7)(2012-2#8)
FNAB##12##1##(1997-2#3)(2008-10#2)(2011-1#5)(2011-2#1)(2012-2#1)
FNAC##2##1##(1990-6#1)(2012-12#1)
FNP##2##1##(2008-12#2)
FO-1##2##1##(1997-9#2)
FOG and KW co-digestions##2##4##(2013-1#2)
FOG co-digestion##3##2##(2013-1#3)
FOG##5##1##(2013-1#5)
FOM1##2##1##(2008-10#2)
FOR##10##1##(1997-5#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
FP method##4##2##(2008-10#4)
FP##8##1##(1996-1#2)(1996-2#1)(2008-10#5)
FP-IX##5##1##(1994-8#5)
FPB##2##1##(2008-10#2)
FPCA##3##1##(2008-10#2)(2010-7#1)
FPD##2##1##(2008-7#2)
FPG##6##1##(1994-12#6)
FPLC##7##1##(1990-5#1)(1993-8#1)(2008-10#4)(2008-9#1)
FPLC-ICP-AES##2##1##(2008-10#2)
FPP##2##1##(1990-2#2)
FPU)##2##1##(2011-2#2)
FPs##3##1##(2008-6#3)
FQ##2##1##(1996-12#1)(2012-3#1)
FQs##2##1##(2008-10#1)(2012-3#1)
FR units##2##2##(2013-8#2)
FR##7##1##(1993-12#3)(2008-1#2)(2013-8#2)
FR1064##3##1##(2008-10#3)
FR1141 x##2##2##(2008-10#2)
FR1141##4##1##(2008-10#4)
FR5 schedule##4##2##(1993-6#3)(2008-11#1)
FRA16E##2##1##(1994-11#2)
FRDS##4##1##(1996-8#4)
FRET and##3##2##(2008-4#2)(2010-5#1)
FRET as##2##2##(2008-9#2)
FRET in##2##2##(2008-10#1)(2008-9#1)
FRET is##2##2##(2008-4#2)
FRET was##2##2##(2008-10#1)(2010-12#1)
FRET##26##1##(2008-10#2)(2008-4#7)(2008-9#11)(2010-12#5)(2010-5#1)
FRI and FLC##3##3##(2012-3#3)
FRM2##3##1##(1996-3#3)
FS workers##2##2##(1991-12#2)
FS##12##1##(1991-12#4)(2008-10#2)(2011-2#3)(2013-1#2)(2013-8#1)
FSH and##3##2##(1993-11#1)(1995-11#1)(2012-3#1)
FSH in##2##2##(1993-11#1)(2012-12#1)
FSH receptor##3##2##(1995-11#1)(2010-5#1)(2010-8#1)
FSH##25##1##(1991-6#2)(1993-11#6)(1995-11#4)(2010-5#3)(2010-8#1)(2012-12#7)(2012-3#2)
FSHbeta##3##1##(2008-8#3)
FSM##3##1##(1994-1#1)(2008-1#2)
FSTRAP protein##2##2##(2008-8#2)
FSTRAP was transcribed in##2##4##(2008-8#2)
FSTRAP##5##1##(2008-8#5)
FSW01##3##1##(2008-9#3)
FT##6##1##(1991-11#2)(2013-1#4)
FT(3) concentrations##2##2##(2008-7#2)
FT-IR and##4##2##(2008-10#2)(2008-9#1)(2011-3#1)
FT-IR method##2##2##(2008-10#2)
FT-IR spectra of pure##2##4##(2008-10#2)
FT-IR spectra were##2##3##(2008-10#2)
FT-IR spectra##8##2##(2008-10#7)(2008-5#1)
FT-IR spectrometry##2##2##(2008-10#2)
FT-IR spectroscopic##3##2##(2008-10#3)
FT-IR spectroscopy and##3##3##(2008-10#3)
FT-IR spectroscopy##11##2##(2008-10#10)(2013-8#1)
FT-IR##39##1##(2008-10#34)(2008-5#1)(2008-9#1)(2009-3#1)(2011-3#1)(2013-8#1)
FT-Raman and##2##2##(2008-10#2)
FT-Raman spectra##2##2##(2008-10#2)
FT-Raman spectrometry##3##2##(2008-10#3)
FT-Raman spectroscopy##6##2##(2008-10#6)
FT-Raman##16##1##(2008-10#16)
FT3##4##1##(2008-7#1)(2012-12#1)(2012-3#2)
FTC##3##1##(1991-9#1)(1993-1#2)
FTEs##6##1##(1991-2#1)(1994-2#1)(1994-3#1)(1996-3#3)
FTIR and##6##2##(2008-10#5)(2013-8#1)
FTIR data##2##2##(2008-10#2)
FTIR is##2##2##(2008-10#1)(2008-3#1)
FTIR spectra were##2##3##(2008-10#2)
FTIR spectra##9##2##(2008-10#9)
FTIR spectroelectrochemical##2##2##(2008-10#2)
FTIR spectroscopic##2##2##(2008-10#2)
FTIR spectroscopy coupled to##2##4##(2008-10#2)
FTIR spectroscopy coupled##3##3##(2008-10#3)
FTIR spectroscopy##9##2##(2008-10#9)
FTIR study of##2##3##(2008-10#2)
FTIR study##4##2##(2008-10#4)
FTIR techniques##2##2##(2008-10#2)
FTIR##62##1##(2008-10#57)(2008-3#2)(2009-7#1)(2011-3#1)(2013-8#1)
FTIR-ATR and FTNIR spectroscopies##2##4##(2008-10#2)
FTND##2##1##(2013-1#2)
FTNIR##3##1##(2008-10#3)
FU##2##1##(1995-3#2)
FUTHAN##3##1##(1990-5#3)
FVB/N##2##1##(1995-2#2)
FVC##7##1##(2008-1#1)(2008-7#4)(2011-2#1)(2012-2#1)
FVIII##2##1##(2012-12#2)
FW##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
FWHM##4##1##(2008-2#1)(2008-3#2)(2013-8#1)
FWL01##2##1##(2008-9#2)
FY##3##1##(1992-12#1)(1994-1#1)(2012-2#1)
FZ in##2##2##(2008-10#2)
FZ##3##1##(2008-10#3)
Fab fragment##4##2##(1993-6#2)(2011-2#2)
Fab fragments##9##2##(1992-6#2)(1992-7#1)(1993-6#4)(1996-2#1)(2011-2#1)
Fab##24##1##(1990-12#1)(1992-6#2)(1992-7#1)(1993-6#9)(1996-2#1)(2008-1#1)(2011-2#4)(2012-2#5)
Fabaceae##4##1##(2008-10#4)
Fabaceae)##2##1##(2013-8#2)
Fabricated##2##1##(2008-10#1)(2008-12#1)
Fabrication and##6##2##(2008-10#4)(2008-3#2)
Fabrication of a##2##3##(2008-10#2)
Fabrication of##5##2##(2008-10#3)(2008-2#1)(2010-9#1)
Fabrication##11##1##(2008-10#7)(2008-2#1)(2008-3#2)(2010-9#1)
Fabricius##3##1##(2007-12#1)(2008-5#1)(2008-9#1)
Fabry-Perot cavity##2##2##(2008-2#1)(2008-3#1)
Fabry-Perot interferometer and a##2##4##(2008-3#2)
Fabry-Perot interferometer##7##2##(2008-10#1)(2008-3#6)
Fabry-Perot##19##1##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#14)
Face##4##1##(2008-7#1)(2009-10#1)(2010-1#2)
Faced with##4##2##(1993-1#1)(1993-3#1)(1994-12#1)(1995-2#1)
Facial Nerve Monitoring##2##3##(2012-3#2)
Facial nerve##2##2##(2008-9#1)(2011-2#1)
Facial##9##1##(2008-11#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
Facile##3##1##(2008-12#1)(2010-10#1)(2013-8#1)
Facilitating##6##1##(2008-11#3)(2008-9#1)(2010-10#1)(2013-8#1)
Facilities should##2##2##(2010-9#1)(2011-1#1)
Facilities##4##1##(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
Facility##8##1##(1992-2#1)(1994-12#1)(2008-2#1)(2008-3#5)
Facing##3##1##(1995-3#1)(2008-11#1)(2008-7#1)
Factitious disorder##2##2##(2010-12#2)
Factitious##3##1##(2010-12#3)
Factor (BDNF)##3##2##(2008-11#1)(2013-8#2)
Factor Analysis##4##2##(2008-10#2)(2012-2#2)
Factor B##2##2##(1991-3#2)
Factor Xa##3##2##(1994-8#1)(2008-11#1)(2008-5#1)
Factor analysis##3##2##(2008-10#1)(2008-11#2)
Factor and##2##2##(1994-11#1)(2013-1#1)
Factor b##2##2##(1993-12#2)
Factor##43##1##(1991-3#2)(1991-9#2)(1992-7#1)(1992-9#1)(1993-12#2)(1994-11#2)(1994-8#1)(1995-2#1)(1997-8#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-5#2)(2009-5#1)(2009-6#3)(2009-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
Factorial design for##2##3##(2008-10#2)
Factorial design##5##2##(2008-10#5)
Factorial designs##2##2##(2008-10#2)
Factorial##8##1##(2008-10#8)
Factors Affecting the Release##2##4##(2008-10#2)
Factors Affecting the##4##3##(2008-10#4)
Factors Affecting##9##2##(2008-10#9)
Factors Influencing##3##2##(2008-10#3)
Factors affecting the##5##3##(1991-12#1)(2008-10#3)(2011-1#1)
Factors affecting##10##2##(1991-12#1)(1997-1#1)(2008-10#5)(2008-5#1)(2010-11#1)(2011-1#1)
Factors and##2##2##(2008-6#1)(2011-2#1)
Factors associated with##6##3##(2008-10#1)(2008-11#1)(2010-11#2)(2010-3#1)(2010-5#1)
Factors in##4##2##(2009-10#1)(2009-9#1)(2012-3#1)(2013-1#1)
Factors influencing the separation and detection processes were examined and optimized##2##11##(2008-10#2)
Factors influencing the separation and detection##3##6##(2008-10#3)
Factors influencing the##9##3##(1994-12#1)(2008-10#8)
Factors influencing##15##2##(1993-2#1)(1994-12#1)(1996-1#1)(2008-10#9)(2008-12#1)(2009-6#1)(2010-11#1)
Factors on##3##2##(2008-10#2)(2013-1#1)
Factors related to##3##3##(1994-12#1)(2010-9#1)(2011-2#1)
Factors such as##2##3##(2008-10#2)
Factors that##8##2##(1992-3#1)(1995-2#1)(2008-10#3)(2008-7#1)(2009-12#1)(2013-1#1)
Factors##87##1##(1990-3#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-12#3)(1995-1#1)(1995-2#1)(1996-1#1)(1997-1#1)(2008-10#40)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-1#3)
Facts for Action to Stroke##2##5##(2010-10#2)
Faculty development##2##2##(2008-11#1)(2013-8#1)
Faculty of Medicine##5##3##(2008-10#3)(2009-10#1)(2010-1#1)
Faculty of Veterinary##2##3##(1996-12#1)(2013-8#1)
Faculty of##11##2##(1996-12#1)(2008-10#4)(2009-10#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
Faculty##23##1##(1993-6#1)(1996-12#1)(1996-3#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-10#1)(2009-8#1)(2010-1#2)(2011-2#2)(2011-3#2)(2013-1#1)(2013-8#2)
Faculté de médecine##2##3##(2010-1#2)
FadR##2##1##(1992-8#2)
FadR-DNA##2##1##(1992-8#2)
Faecal consistency was##2##3##(1996-12#2)
Faecal examination##2##2##(1996-12#2)
Faecal##7##1##(1996-12#6)(2008-8#1)
Faeces were##2##2##(1996-12#1)(2008-10#1)
Failing to##3##2##(2008-10#1)(2009-9#1)(2012-3#1)
Failure of the##2##3##(1996-11#1)(2008-3#1)
Failure of##6##2##(1996-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
Failure to##8##2##(1991-10#1)(1993-12#1)(1997-1#1)(1997-7#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
Failure##17##1##(1991-10#1)(1993-12#1)(1996-11#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Fair##5##1##(1990-2#1)(1995-12#2)(1997-8#1)(2008-11#1)
Faith##4##1##(2008-12#3)(2011-1#1)
Fall##3##1##(1995-1#1)(2008-10#1)(2010-10#1)
False Claims Act##2##3##(1997-1#1)(2008-11#1)
False positive##3##2##(1992-1#1)(2009-3#1)(2011-2#1)
False##7##1##(1992-1#1)(1997-1#1)(2008-11#2)(2009-3#1)(2011-2#1)(2012-3#1)
Familial glucocorticoid deficiency##2##3##(2011-1#2)
Familial hypercholesterolaemia##2##2##(2008-6#2)
Familial##15##1##(1990-12#1)(1995-8#1)(1997-7#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-12#2)(2009-6#1)(2010-4#1)(2011-1#2)(2013-1#2)
Familiarity##2##1##(2008-7#1)(2012-2#1)
Families Program##2##2##(2013-1#2)
Families in##2##2##(1995-3#1)(2008-6#1)
Families of children with##2##4##(1995-1#1)(1995-3#1)
Families with##5##2##(1992-2#1)(1994-11#1)(1996-1#1)(1996-12#1)(1996-3#1)
Families##17##1##(1990-6#1)(1992-2#1)(1994-11#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(2008-12#1)(2008-6#1)(2009-11#1)(2010-12#1)(2012-2#2)(2013-1#2)
Family Functioning##2##2##(2008-9#1)(2013-1#1)
Family Health##3##2##(2008-11#1)(2010-10#1)(2012-3#1)
Family Physicians##2##2##(1993-12#1)(2013-1#1)
Family Planning##4##2##(1991-1#1)(1996-3#1)(2008-11#1)(2013-8#1)
Family and Community##3##3##(1993-5#1)(1997-3#1)(2010-10#1)
Family and##5##2##(1993-5#1)(1997-3#1)(2008-8#1)(2010-10#1)(2013-1#1)
Family factors##2##2##(2013-8#2)
Family history##2##2##(2008-4#1)(2008-7#1)
Family##64##1##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-9#2)(2010-10#2)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#6)(2013-8#4)
Family-centered##2##1##(1992-3#1)(2010-9#1)
Fan##2##1##(2009-10#1)(2011-2#1)
Fanconi anemia (FA) is an autosomal recessive syndrome characterized by progressive pancytopenia and a high risk of##2##17##(2008-4#2)
Fanconi anemia (FA)##3##3##(1997-3#1)(2008-4#2)
Fanconi anemia##4##2##(1997-3#2)(2008-4#2)
Fanconi##5##1##(1997-3#3)(2008-4#2)
Fao cells##3##2##(1992-10#2)(1994-11#1)
Fao##5##1##(1992-10#4)(1994-11#1)
Far##2##1##(2008-10#1)(2008-5#1)
Far-UV circular dichroism##2##3##(1992-8#1)(1993-8#1)
Far-field scattering##2##2##(2008-2#2)
Faraday##2##1##(1993-5#1)(2008-3#1)
Farm##8##1##(1990-9#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)
Fas expression##2##2##(2008-8#2)
Fas##10##1##(2008-11#1)(2008-8#7)(2008-9#1)(2012-3#1)
Fas-mediated apoptosis##3##2##(1997-8#3)
Fas/FasL##2##1##(2008-9#2)
FasL##2##1##(2008-10#1)(2008-9#1)
Fasciola eggs##5##2##(1996-12#5)
Fasciola hepatica##3##2##(1995-5#1)(2009-8#2)
Fasciola##10##1##(1995-5#1)(1996-12#6)(2009-8#2)(2012-2#1)
Fast and##3##2##(2008-10#2)(2008-3#1)
Fast determination of##3##3##(2008-10#3)
Fast green FCF##2##3##(1990-6#2)
Fast repair of##2##3##(2008-8#1)(2008-9#1)
Fast simultaneous##2##2##(2008-10#2)
Fast##33##1##(1990-2#1)(1990-6#2)(1994-9#1)(1997-8#1)(2007-11#1)(2008-10#14)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
Faster##2##1##(1995-2#1)(1996-12#1)
Fat Mass##2##2##(2012-2#2)
Fat and##2##2##(1997-7#1)(2010-4#1)
Fat grafting##2##2##(2013-1#2)
Fat##12##1##(1997-7#1)(2008-11#1)(2010-4#3)(2012-2#3)(2013-1#4)
FatB##3##1##(2011-2#3)
Fatal##8##1##(1992-2#1)(1995-11#1)(1996-12#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
Fatality##2##1##(2010-1#1)(2011-2#1)
Father##3##1##(1997-3#1)(2008-10#1)(2010-8#1)
Fatibello-Filho##2##1##(2008-10#2)
Fatigue and##2##2##(2008-7#1)(2013-8#1)
Fatigue##10##1##(2008-7#3)(2009-7#1)(2010-4#1)(2010-7#1)(2013-1#2)(2013-8#2)
Fatty Acid##2##2##(2008-10#1)(2010-1#1)
Fatty Acids##4##2##(2008-10#2)(2009-8#1)(2013-1#1)
Fatty acid composition of##2##4##(1991-12#1)(2010-4#1)
Fatty acid profiles of##2##4##(2008-10#2)
Fatty acid profiles##3##3##(2008-10#3)
Fatty acid##8##2##(1991-12#1)(2008-10#4)(2008-11#1)(2009-3#1)(2010-4#1)
Fatty acid-binding protein##2##3##(2013-1#2)
Fatty acids##5##2##(2008-10#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
Fatty liver deposition##2##3##(2012-2#2)
Fatty##24##1##(1991-12#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-4#1)(2012-2#3)(2013-1#4)
Favorable##2##1##(2008-10#1)(2012-3#1)
Favourable##2##1##(1991-11#1)(1992-9#1)
Fc portion of IgG##2##4##(1990-12#1)(2008-10#1)
Fc receptor##2##2##(1994-6#1)(1996-3#1)
Fc region##3##2##(2008-11#3)
Fc##19##1##(1990-12#4)(1993-6#1)(1994-6#2)(1996-12#1)(1996-3#1)(2008-10#3)(2008-11#5)(2009-9#2)
Fc-fusion protein##2##2##(2011-2#2)
Fc-fusion##3##1##(2011-2#3)
FcepsilonRI expression##6##2##(2008-11#6)
FcepsilonRI on##3##2##(2008-11#3)
FcepsilonRI##14##1##(2008-11#14)
FcepsilonRI-mediated##2##1##(2009-6#2)
FcgammaR##3##1##(2008-10#3)
Fd chain##2##2##(1993-6#2)
Fd##4##1##(1992-12#1)(1993-6#3)
Fe and Al##2##3##(2008-10#2)
Fe and Cu##3##3##(2008-10#3)
Fe and Mn##2##3##(2008-10#2)
Fe and Ni were##3##4##(2008-10#3)
Fe and Ni##7##3##(2008-10#7)
Fe and Ti contents in##2##5##(2013-8#2)
Fe and V##3##3##(2008-10#3)
Fe and Zn in##2##4##(2008-10#2)
Fe and Zn##6##3##(2008-10#6)
Fe and##35##2##(1996-2#1)(2008-10#32)(2013-8#2)
Fe at 56##3##3##(2008-10#3)
Fe at##4##2##(2008-10#4)
Fe binding##2##2##(1996-2#2)
Fe content##2##2##(2008-10#2)
Fe from##3##2##(1996-2#1)(2008-10#2)
Fe in the##2##3##(2008-10#2)
Fe in##11##2##(2008-10#10)(2008-12#1)
Fe levels##2##2##(2008-10#2)
Fe minus##3##2##(2008-10#1)(2013-1#2)
Fe per##2##2##(1992-8#1)(2010-11#1)
Fe were##4##2##(2008-10#4)
Fe##192##1##(1992-8#1)(1993-5#1)(1996-2#4)(2008-10#167)(2008-12#3)(2008-3#3)(2008-5#2)(2010-11#3)(2010-4#1)(2010-6#1)(2013-1#3)(2013-8#3)
Fe(2)O(3)##4##1##(2008-10#4)
Fe(2+) and##5##2##(2008-10#4)(2008-8#1)
Fe(2+)##20##1##(2008-10#18)(2008-11#1)(2008-8#1)
Fe(2+)/Fe(3+)##2##1##(2008-10#2)
Fe(3+) (0##2##2##(2008-10#2)
Fe(3+) and Zn(2+)##2##3##(2008-10#1)(2010-11#1)
Fe(3+) and##5##2##(2008-10#3)(2008-8#1)(2010-11#1)
Fe(3+) into##2##2##(2008-10#1)(2010-11#1)
Fe(3+) of##2##2##(2008-9#2)
Fe(3+) to##2##2##(2008-10#2)
Fe(3+)##44##1##(2008-10#37)(2008-8#1)(2008-9#3)(2010-11#3)
Fe(3+))##2##1##(2008-10#2)
Fe(II) and Fe(III) can be determined##2##6##(2008-10#2)
Fe(II) and Fe(III) can be##3##5##(2008-10#3)
Fe(II) and Fe(III)##17##3##(2008-10#16)(2010-4#1)
Fe(II) and##25##2##(2008-10#24)(2010-4#1)
Fe(II) by##3##2##(2008-10#3)
Fe(II) concentrations##2##2##(2008-10#2)
Fe(II) in##5##2##(2008-10#5)
Fe(II) ions##3##2##(2008-10#3)
Fe(II) levels##2##2##(2008-10#2)
Fe(II) molar##2##2##(2010-4#2)
Fe(II) or##2##2##(2008-10#2)
Fe(II) to Fe(III)##2##3##(2008-10#2)
Fe(II) to##5##2##(2008-10#5)
Fe(II) uptake and##2##3##(1996-2#2)
Fe(II) uptake##5##2##(1996-2#5)
Fe(II) was##3##2##(1996-2#1)(2008-10#2)
Fe(II) which##2##2##(2008-10#2)
Fe(II) with##3##2##(2008-10#3)
Fe(II)##110##1##(1990-8#2)(1996-2#8)(2008-10#96)(2008-5#1)(2010-4#3)
Fe(III) and Co(II)##4##3##(2008-10#4)
Fe(III) and Fe(II) ions##2##4##(2008-10#2)
Fe(III) and Fe(II)##9##3##(2008-10#9)
Fe(III) and Pb(II)##3##3##(2008-10#3)
Fe(III) and total##2##3##(2008-10#2)
Fe(III) and##24##2##(2008-10#24)
Fe(III) by##3##2##(2008-10#3)
Fe(III) can be determined in the range of 0##2##9##(2008-10#2)
Fe(III) can be determined in the##3##6##(2008-10#3)
Fe(III) can be determined##4##4##(2008-10#4)
Fe(III) can be##5##3##(2008-10#5)
Fe(III) can##6##2##(2008-10#6)
Fe(III) concentration from##2##3##(2008-10#2)
Fe(III) concentration##3##2##(2008-10#3)
Fe(III) in HCl##2##3##(2008-10#2)
Fe(III) in the presence of##4##5##(2008-10#4)
Fe(III) in the##6##3##(2008-10#6)
Fe(III) in##16##2##(2008-10#16)
Fe(III) ion##2##2##(2008-10#2)
Fe(III) ions##5##2##(2008-10#5)
Fe(III) is##6##2##(2008-10#6)
Fe(III) to Fe(II)##5##3##(2008-10#5)
Fe(III) was##4##2##(2008-10#4)
Fe(III) were##5##2##(2008-10#5)
Fe(III) with##4##2##(2008-10#4)
Fe(III)##154##1##(2008-10#152)(2008-5#1)(2010-4#1)
Fe(III)(hydr)oxide##2##1##(2008-10#2)
Fe(III))##2##1##(2008-10#2)
Fe(III)-1##2##1##(2008-10#2)
Fe(III)-Fe(II) potential buffer##2##3##(2008-10#2)
Fe(III)-reducing conditions##2##2##(2008-10#2)
Fe(III)/Fe(II) redox couple##3##3##(2008-10#3)
Fe(III)/Fe(II)##4##1##(2008-10#4)
Fe(NO(3))(3)##2##1##(2008-10#2)
Fe(OH)(3) precipitation##2##2##(2008-10#2)
Fe(OH)(3)##3##1##(2008-10#3)
Fe) in sera from patients with dilated cardiomyopathy##2##8##(1993-2#2)
Fe)##4##1##(1993-2#2)(2008-10#2)
Fe- and Mn-TCPP(g)s##2##3##(2008-10#2)
Fe- and##4##2##(2008-10#4)
Fe-##5##1##(2008-10#5)
Fe-BPANS complex##3##2##(2008-10#3)
Fe-Fe##2##1##(1995-6#2)
Fe-Mn##3##1##(2008-10#3)
Fe/V alloys##2##2##(2008-10#2)
Fe/ferritin##2##1##(1996-2#2)
Fe0##5##1##(1994-5#5)
Fe0-treated##2##1##(1994-5#2)
Fe2S2##2##1##(1994-5#2)
Fe2S2Cys4 ferredoxins##2##2##(1994-5#2)
Fe3+##6##1##(1991-5#4)(2008-3#1)(2013-8#1)
FeCl(3)##7##1##(2008-10#6)(2013-1#1)
FeLV-p27##2##1##(2008-11#2)
FeS##6##1##(1995-6#5)(2008-10#1)
FeSO(4) were##2##2##(2008-11#2)
FeSO(4)##11##1##(2008-10#2)(2008-11#9)
FeSO(4)·7H(2)O##2##1##(2013-1#2)
FeTSPc##3##1##(2008-10#3)
Fear-potentiation##2##1##(2008-11#2)
Feasibility of##5##2##(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
Feasibility##6##1##(2008-10#3)(2008-7#1)(2011-2#1)(2013-1#1)
Feature##3##1##(2010-8#1)(2012-3#1)(2013-8#1)
Features of##7##2##(1995-12#1)(2008-10#3)(2010-11#1)(2011-2#1)(2013-8#1)
Features##10##1##(1995-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
Febrile neutropenia##2##2##(2008-7#2)
Febrile seizures##2##2##(2006-5#1)(2013-1#1)
Febrile##5##1##(1991-11#1)(2006-5#1)(2008-7#2)(2013-1#1)
February 1994##2##2##(1997-2#1)(2008-7#1)
February 1996##2##2##(2008-7#2)
February 2006##2##2##(2008-7#1)(2010-2#1)
February 2008##3##2##(2009-9#1)(2011-2#2)
February 2009##5##2##(2010-3#1)(2011-2#3)(2013-1#1)
February##44##1##(1990-12#1)(1990-2#1)(1991-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-6#2)(1996-5#1)(1997-2#3)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#4)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#9)(2012-12#1)(2013-1#2)(2013-8#3)
Fecal samples##2##2##(2011-2#1)(2012-3#1)
Fed-batch culture##2##2##(2008-11#1)(2008-7#1)
Fed-batch##5##1##(2008-11#2)(2008-7#2)(2011-2#1)
Federal Agency for the Safety of the Food##2##8##(2008-10#2)
Federal and State##2##3##(1994-1#1)(2008-6#1)
Federal and##3##2##(1994-1#1)(2008-11#1)(2008-6#1)
Federal budget##3##2##(1995-6#1)(1996-3#1)(1996-5#1)
Federal judge##4##2##(1995-12#2)(1995-6#1)(1996-5#1)
Federal##42##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#3)(1992-12#1)(1994-1#1)(1995-1#1)(1995-12#6)(1995-3#3)(1995-6#2)(1996-1#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#3)(2008-11#2)(2008-6#4)(2011-2#1)(2012-3#2)(2013-1#1)
Federation and##2##2##(1995-3#2)
Federation of##2##2##(1995-3#1)(2012-3#1)
Federation##7##1##(1995-3#3)(1995-6#1)(1997-1#1)(2010-5#1)(2012-3#1)
Feed-forward##2##1##(2008-10#2)
Feedback from the##2##3##(1993-2#1)(2008-11#1)
Feedback from##4##2##(1993-2#2)(2008-11#1)(2008-12#1)
Feedback##11##1##(1992-12#1)(1993-2#2)(1996-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2009-8#2)(2011-1#1)(2013-1#1)
Feeding##12##1##(1990-12#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
Feeling##3##1##(2008-12#2)(2010-10#1)
Feingold##2##1##(1997-3#2)
Feldenkrais method##3##2##(2010-6#3)
Feldenkrais##4##1##(2010-6#4)
Feline##2##1##(1992-5#1)(2008-11#1)
Fellows and##2##2##(2009-4#2)
Fellowship in Quality Management##2##4##(1997-3#2)
Fellowship##10##1##(1994-12#1)(1996-1#5)(1996-3#1)(1997-3#2)(2008-4#1)
Female athlete triad##2##3##(2010-1#2)
Female security officers##2##3##(1993-2#2)
Female sexual problems##2##3##(2008-8#2)
Female##33##1##(1991-6#1)(1992-2#1)(1993-2#2)(1994-12#1)(1995-12#1)(1995-8#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-9#1)(2010-1#3)(2011-2#3)
Females were##2##2##(2008-8#1)(2009-8#1)
Females##15##1##(1990-11#1)(1993-2#1)(1995-2#1)(2008-11#1)(2008-8#6)(2008-9#2)(2009-1#1)(2009-8#1)(2010-4#1)
Femoral##4##1##(2008-10#1)(2008-7#1)(2013-1#2)
Femtosecond##4##1##(2007-11#1)(2008-3#3)
Fenn##3##1##(2010-7#3)
Fenn's##2##1##(2010-7#2)
Fenton reaction##7##2##(2008-10#3)(2008-5#1)(2010-4#3)
Fenton##12##1##(2008-10#6)(2008-11#1)(2008-5#1)(2010-4#4)
Fenton-like##2##1##(1997-8#1)(2008-10#1)
Fermentation##3##1##(2012-2#1)(2012-3#2)
Fermi##6##1##(1990-12#1)(1993-5#1)(1996-9#2)(2008-10#2)
Ferric##2##1##(2008-10#2)
Fetal Alcohol##2##2##(2008-11#2)
Fetal Alert Network##3##3##(2008-11#3)
Fetal and##2##2##(1990-3#1)(1994-3#1)
Fetal##22##1##(1990-10#1)(1990-2#1)(1990-3#1)(1992-6#2)(1992-7#1)(1994-3#1)(1995-12#1)(1995-8#1)(2008-10#3)(2008-11#7)(2009-9#1)(2010-11#1)(2012-2#1)
Fever in##3##2##(1994-12#1)(2009-6#1)(2013-1#1)
Fever with##2##2##(2008-11#1)(2013-7#1)
Fever##8##1##(1994-12#1)(2006-5#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Few data##2##2##(2008-1#1)(2011-2#1)
Few studies have##3##3##(1991-3#1)(2008-8#1)(2009-7#1)
Few studies##7##2##(1991-3#1)(1992-3#1)(2008-11#1)(2008-8#1)(2009-7#1)(2012-12#2)
Few##31##1##(1991-3#2)(1992-3#1)(1994-3#1)(1995-1#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)
Fewer than##2##2##(2010-1#1)(2013-1#1)
Fewer##4##1##(2008-10#2)(2010-1#1)(2013-1#1)
FgDNA content##2##2##(2008-10#2)
Fhl1##2##1##(2008-11#2)
Fib-H##2##1##(2008-9#2)
Fib75##5##1##(1990-12#5)
Fiber optic##3##2##(2008-10#2)(2008-3#1)
Fiber##8##1##(2008-10#4)(2008-3#3)(2011-2#1)
Fibres from the##2##3##(2009-7#2)
Fibres##3##1##(2009-7#3)
Fibrillation##2##1##(2009-9#1)(2012-12#1)
Fibrinolysis##2##1##(1994-5#1)(1996-6#1)
FibroTest##2##1##(2013-1#2)
Fibroblast Growth Factor##3##3##(2008-11#1)(2013-1#2)
Fibroblast Growth##4##2##(1994-11#1)(2008-11#1)(2013-1#2)
Fibroblast##5##1##(1991-12#1)(1994-11#1)(2008-11#1)(2013-1#2)
Fibroblasts##3##1##(2012-3#1)(2013-1#2)
Fibromatosis##2##1##(1997-7#2)
Fibromyalgia##2##1##(2009-11#1)(2011-2#1)
Fibrosarcoma of the##2##3##(1991-8#2)
Fibrous##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
Ficoll-Paque density gradient##2##3##(2008-9#2)
Ficoll-Paque##6##1##(2008-11#2)(2008-9#4)
Field Conditions##4##2##(2008-10#4)
Field Populations of##6##3##(2008-10#6)
Field Resistance##2##2##(2008-10#2)
Field experiments were conducted##2##4##(2008-10#2)
Field experiments##4##2##(2008-10#3)(2008-8#1)
Field studies##3##2##(2008-10#1)(2008-9#2)
Field trials##2##2##(2008-10#2)
Field##64##1##(1995-3#1)(1996-9#1)(2008-10#53)(2008-2#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2011-2#2)(2012-3#1)
Field-of-view##4##1##(2008-10#1)(2008-2#1)(2008-3#2)
Fields and##3##2##(1996-9#1)(2008-10#1)(2008-5#1)
Fields in##5##2##(2008-10#5)
Fields of##2##2##(2008-12#1)(2008-3#1)
Fields##21##1##(1990-11#1)(1996-9#1)(2008-10#14)(2008-12#2)(2008-3#1)(2008-5#1)(2011-2#1)
Fifteen days after##2##3##(1990-9#1)(2008-10#1)
Fifteen patients##3##2##(1993-1#1)(1994-1#1)(2011-2#1)
Fifteen##24##1##(1990-9#1)(1993-1#1)(1994-1#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-1#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-9#1)(2011-2#1)(2013-1#3)
Fifty eight##2##2##(2011-2#1)(2012-3#1)
Fifty one##2##2##(2013-1#1)(2013-8#1)
Fifty patients undergoing##2##3##(2011-2#1)(2012-3#1)
Fifty patients##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Fifty percent of##2##3##(2009-11#1)(2013-1#1)
Fifty percent##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
Fifty three##2##2##(2008-10#1)(2010-7#1)
Fifty##30##1##(1990-3#1)(1991-12#1)(1991-6#1)(1992-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
Fifty-eight##2##1##(2007-8#1)(2012-2#1)
Fifty-four##7##1##(1990-12#1)(1991-2#1)(1993-2#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
Fifty-nine##3##1##(1991-2#1)(1994-9#1)(2008-10#1)
Fifty-one##5##1##(1997-1#1)(2008-10#2)(2008-7#1)(2009-11#1)
Fifty-three##3##1##(1991-3#1)(2008-9#1)(2011-2#1)
Fifty-two##3##1##(1990-6#1)(1991-6#1)(2008-7#1)
Fight##2##1##(2010-10#1)(2011-2#1)
Fighting##4##1##(1992-2#1)(1997-2#1)(2008-5#1)(2008-8#1)
Figure 8&quot##2##2##(2013-1#2)
Figure##4##1##(2008-7#2)(2013-1#2)
Figures of merit##2##3##(2008-10#2)
Fiji Islands##3##2##(2008-1#3)
Fiji and##3##2##(2008-1#3)
Fiji as well as##2##4##(2008-1#2)
Fiji population##2##2##(2008-1#2)
Fiji##36##1##(2008-1#29)(2008-10#1)(2008-6#5)(2013-8#1)
Fijian##3##1##(2008-1#3)
Filling##4##1##(1991-6#1)(1993-3#1)(1997-2#1)(2008-3#1)
Films of##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
Films##11##1##(1996-9#2)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)(2010-4#1)(2012-2#2)(2013-8#1)
Filtek P90 and Z250##2##4##(2013-1#2)
Filter##3##1##(1997-6#1)(2008-10#1)(2008-3#1)
Filtering Method##2##2##(2008-3#1)(2010-8#1)
Filtration##2##1##(2008-10#1)(2013-1#1)
FimA and##2##2##(2008-10#2)
FimA or FimF mutants of X##2##6##(2008-10#2)
FimA or FimF##3##3##(2008-10#3)
FimA##6##1##(2008-10#6)
FimA- or FimF-##2##3##(2008-10#2)
FimA-##3##1##(2008-10#3)
FimF##5##1##(2008-10#5)
FimF-##3##1##(2008-10#3)
Fimbrial and##2##2##(2008-10#2)
Fimbrial##3##1##(2008-10#3)
Final results##2##2##(1993-9#1)(1997-3#1)
Final solutions obtained##2##3##(2008-10#2)
Final##23##1##(1993-3#1)(1993-9#1)(1994-5#1)(1995-10#1)(1995-12#1)(1997-3#1)(2008-10#9)(2008-3#1)(2008-9#1)(2009-4#2)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
Finally the speciation was tested on##2##6##(2008-10#2)
Finally the##10##2##(1990-11#1)(1991-12#1)(2008-10#5)(2008-8#1)(2010-10#1)(2013-8#1)
Finally we##2##2##(2008-11#1)(2009-4#1)
Finally##335##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-2#4)(1995-5#5)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-6#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#89)(2008-11#19)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#9)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#16)(2008-9#6)(2009-10#4)(2009-12#5)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#4)(2010-10#1)(2010-11#3)(2010-12#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#14)(2011-7#1)(2012-2#14)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#10)
Finance##2##1##(1992-8#1)(2013-8#1)
Financial##9##1##(1991-12#1)(1991-3#1)(1994-12#1)(1994-2#1)(1996-2#1)(2008-12#1)(2009-3#1)(2010-10#1)(2010-5#1)
Financing##30##1##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#2)(1993-12#2)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#5)(1997-2#5)(1997-3#3)
Find out which##2##3##(2011-2#2)
Find out##3##2##(2011-2#3)
Finding a##3##2##(2008-12#2)(2009-8#1)
Finding homologs to##2##3##(2008-9#2)
Finding homologs##3##2##(2008-4#1)(2008-9#2)
Finding the##3##2##(1993-1#1)(2008-11#1)(2011-2#1)
Finding##12##1##(1993-1#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Findings also##4##2##(2007-12#1)(2008-12#1)(2011-2#1)(2012-2#1)
Findings from a##2##3##(1994-12#1)(2008-12#1)
Findings from the##3##3##(1991-2#2)(2010-10#1)
Findings from this##2##3##(1995-2#1)(2013-1#1)
Findings from##11##2##(1991-2#2)(1992-3#1)(1993-12#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-10#1)(2013-1#1)
Findings include##2##2##(1994-12#1)(1996-3#1)
Findings indicate that##8##3##(1991-3#1)(1996-3#1)(2009-5#2)(2010-1#1)(2010-10#1)(2012-12#1)(2012-2#1)
Findings indicated that##3##3##(2009-10#1)(2009-7#1)(2011-2#1)
Findings indicated##4##2##(1994-1#1)(2009-10#1)(2009-7#1)(2011-2#1)
Findings of the##2##3##(2009-7#1)(2013-1#1)
Findings of##3##2##(2008-11#1)(2009-7#1)(2013-1#1)
Findings revealed that##2##3##(2008-12#2)
Findings revealed##4##2##(2008-11#1)(2008-12#2)(2008-9#1)
Findings show that##3##3##(1997-3#2)(2008-11#1)
Findings suggest that the##6##4##(1991-1#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
Findings suggest that##15##3##(1991-1#1)(2008-11#4)(2008-12#2)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Findings suggest##16##2##(1991-1#1)(2008-11#5)(2008-12#2)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Findings suggested that##2##3##(2007-12#1)(2011-1#1)
Findings support the##2##3##(1995-12#1)(2010-4#1)
Findings support##3##2##(1995-12#1)(2009-12#1)(2010-4#1)
Findings were##2##2##(2008-10#1)(2008-12#1)
Findings##81##1##(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#2)(1995-12#1)(1995-2#1)(1996-3#2)(1997-3#3)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#9)(2008-12#7)(2008-4#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#5)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#3)
Fine needle aspiration cytology##2##4##(2008-7#1)(2010-11#1)
Fine structure##3##2##(1994-2#1)(2007-12#1)(2008-8#1)
Fine##14##1##(1991-12#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2012-6#1)
Fine-needle aspiration biopsy##2##3##(2011-1#1)(2012-2#1)
Fine-needle aspiration##3##2##(2011-1#1)(2012-2#2)
Finger mark##2##2##(2012-2#2)
Finger##3##1##(2012-2#2)(2013-1#1)
Fingerprint##3##1##(2008-10#3)
Fingerprinting with##2##2##(2008-10#2)
Fingerprinting##8##1##(2008-10#7)(2010-6#1)
Finite element approximation of a population spatial adaptation model##2##9##(2013-8#2)
Finite##3##1##(2013-1#1)(2013-8#2)
Finite-difference time-domain##2##2##(2008-3#1)(2009-12#1)
Finland##14##1##(1990-11#2)(1991-2#1)(1993-2#1)(2008-10#5)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-4#1)
Finnish patients##3##2##(1991-7#2)(1994-12#1)
Finnish strains##4##2##(2008-10#4)
Finnish##14##1##(1991-7#3)(1994-12#1)(2008-10#5)(2009-12#1)(2010-5#1)(2011-1#1)(2011-10#1)(2013-1#1)
Finnmark##6##1##(1993-11#2)(1993-6#4)
Fire Blight##4##2##(2008-10#4)
Fire##9##1##(1990-8#1)(1993-12#1)(2008-10#6)(2008-8#1)
Firework##2##1##(2012-2#2)
First Dental Home##3##3##(2011-2#3)
First Nations##4##2##(2007-12#1)(2008-11#3)
First Observation of the##2##4##(1996-9#2)
First aid##2##2##(2008-11#1)(2010-8#1)
First and second dissociation constants##2##5##(2008-10#2)
First and second##3##3##(2008-10#3)
First and##4##2##(2008-10#3)(2013-8#1)
First of all##2##3##(2008-11#1)(2009-10#1)
First record of##2##3##(2008-12#1)(2010-8#1)
First results of a##2##4##(1993-2#1)(2008-1#1)
First results of##3##3##(1993-2#1)(2008-1#1)(2008-9#1)
First results##5##2##(1993-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)
First the##3##2##(1993-8#1)(2008-10#2)
First we##3##2##(1992-12#1)(1993-1#1)(2008-3#1)
First##160##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#2)(2007-12#1)(2008-1#1)(2008-10#32)(2008-11#15)(2008-12#7)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#12)(2008-9#5)(2009-10#3)(2009-12#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#3)(2010-9#2)(2011-2#6)(2011-4#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#5)
First-line##3##1##(1997-2#1)(2008-11#1)(2013-1#1)
FirstEF##3##1##(2008-4#3)
Firstly##17##1##(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-7#1)(2013-8#2)
Fis expression##2##2##(2008-7#2)
Fis##8##1##(2008-7#8)
Fiscal##3##1##(1993-12#1)(1994-3#1)(1997-2#1)
Fischer 344 rat##2##3##(1994-3#1)(1994-5#1)
Fischer 344 rats##10##3##(1990-3#1)(1990-6#3)(1992-12#2)(1994-3#2)(1994-5#1)(2008-7#1)
Fischer 344##12##2##(1990-3#1)(1990-6#3)(1992-12#2)(1994-3#3)(1994-5#2)(2008-7#1)
Fischer##28##1##(1990-3#3)(1990-6#3)(1992-1#1)(1992-12#2)(1993-12#2)(1994-3#3)(1994-5#2)(1995-6#1)(2008-10#10)(2008-7#1)
Fish##5##1##(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#2)
Fisher Exact##2##2##(2009-8#1)(2013-1#1)
Fisher##5##1##(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#2)
Fisher's equation##2##2##(2009-8#2)
Fisher's exact##2##2##(2008-12#1)(2012-2#1)
Fisher's##8##1##(2008-12#1)(2008-6#1)(2008-9#1)(2009-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
Fissure##2##1##(2008-12#1)(2011-2#1)
Fistula##4##1##(1996-9#1)(1997-3#1)(2012-12#1)(2013-1#1)
Fitness components##2##2##(2008-10#1)(2008-8#1)
Fitness for Practice##5##3##(2008-11#5)
Fitness for Practice'##2##3##(2008-11#2)
Fitness for##8##2##(2008-11#8)
Fitness of##4##2##(2008-10#4)
Fitness##21##1##(2008-10#8)(2008-11#8)(2008-8#2)(2010-1#1)(2012-3#1)(2013-8#1)
Fitting the##4##2##(1996-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
Fitting##6##1##(1996-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
Fitzpatrick##2##1##(2008-5#2)
Five QTL##2##2##(2008-10#2)
Five cases##3##2##(1991-8#1)(2010-3#1)(2012-2#1)
Five different##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
Five focus groups##2##3##(2008-12#1)(2013-1#1)
Five hundred##2##2##(1995-10#1)(2008-7#1)
Five new##2##2##(1997-9#1)(2007-12#1)
Five of the##7##3##(1995-12#1)(1996-11#1)(2008-10#5)
Five of these##2##3##(2008-10#2)
Five of##9##2##(1995-12#1)(1996-11#1)(2008-10#7)
Five patients with##2##3##(1990-9#1)(1991-11#1)
Five patients##5##2##(1990-2#1)(1990-9#1)(1991-11#1)(2011-2#2)
Five rats##2##2##(2008-12#1)(2008-7#1)
Five replicate determinations of##3##4##(2008-10#3)
Five strategies##2##2##(1992-2#1)(1997-2#1)
Five themes emerged from the##2##5##(2010-7#1)(2013-1#1)
Five were##2##2##(2009-3#1)(2011-2#1)
Five years later##2##3##(2008-9#1)(2012-12#1)
Five years##3##2##(1990-3#1)(2008-9#1)(2012-12#1)
Five##136##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-8#2)(1994-12#1)(1995-1#3)(1995-10#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-8#2)(1997-9#1)(2007-12#1)(2008-10#47)(2008-11#6)(2008-12#5)(2008-3#1)(2008-5#2)(2008-7#15)(2008-8#1)(2008-9#1)(2009-11#3)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
Five)##2##1##(2008-11#1)(2008-7#1)
Five-year##2##1##(1994-3#1)(2011-2#1)
Fivetrade mark##5##2##(2008-11#1)(2008-7#4)
Fivetrade##7##1##(2008-11#2)(2008-7#5)
Fixation##8##1##(2008-12#1)(2008-5#1)(2012-3#2)(2013-1#4)
Fixion##2##1##(2009-3#2)
Fla##5##1##(1991-9#3)(1992-8#1)(1994-2#1)
Flag##3##1##(2008-10#3)
Flame atomic absorption and emission spectrometry##2##6##(2008-10#2)
Flame atomic absorption determination of##2##5##(2008-10#2)
Flame atomic absorption spectrometric determination of##2##6##(2008-10#2)
Flame atomic absorption##8##3##(2008-10#8)
Flame atomic##9##2##(2008-10#9)
Flame ionization##2##2##(2008-10#2)
Flame##20##1##(2008-10#19)(2008-3#1)
Flash RP-18e##2##2##(2008-10#2)
Flash##3##1##(2008-10#3)
Flavobacterium columnare##2##2##(2008-9#1)(2013-1#1)
Flavobacterium meningosepticum##2##2##(1992-3#2)
Flavobacterium psychrophilum and##2##3##(2008-9#2)
Flavobacterium##8##1##(1992-3#2)(2008-10#1)(2008-9#4)(2013-1#1)
Flavonoid##2##1##(2008-10#1)(2010-6#1)
Flavonoids are##2##2##(2008-10#1)(2011-2#1)
Flavonoids##4##1##(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
Flavopiridol##3##1##(2008-5#3)
Fleming##3##1##(1995-6#3)
Flex##2##1##(1992-2#1)(2008-9#1)
Flexibility##2##1##(2008-4#1)(2010-8#1)
Flexible##4##1##(2007-12#1)(2008-11#3)
Flexner's##2##1##(1991-8#2)
Flexor##2##1##(2009-10#1)(2009-11#1)
Flexural##2##1##(2008-5#1)(2009-7#1)
FliA##2##1##(2009-8#2)
FliP##2##1##(1993-12#2)
FliQ##2##1##(1993-12#2)
FliR and FlhB##2##3##(1993-12#2)
Flies##5##1##(2008-10#1)(2008-9#2)(2012-3#1)(2013-1#1)
Flight##4##1##(1996-12#1)(2008-10#1)(2008-3#2)
Flo-Lab##3##1##(2011-2#3)
Floating##3##1##(2008-11#1)(2009-5#1)(2012-2#1)
Flocculation##2##1##(2008-11#1)(2008-7#1)
Floor##2##1##(1996-5#1)(2013-1#1)
Florence##7##1##(1991-6#2)(1992-2#2)(2009-4#1)(2010-1#1)(2013-8#1)
Florida CTV isolates##2##3##(2008-10#2)
Florida and##10##2##(2008-10#9)(2013-8#1)
Florida counties##2##2##(1994-1#2)
Florida to##2##2##(2008-10#2)
Florida were##2##2##(2008-10#2)
Florida##72##1##(1991-2#2)(1992-1#2)(1992-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(2008-10#48)(2008-12#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-8#1)
Florida's##2##1##(1996-2#1)(2008-12#1)
Floridian##2##1##(2008-10#2)
Florisil##2##1##(2008-10#2)
Floristic##3##1##(2008-8#3)
Florunner##2##1##(2008-10#2)
Flow Cytometric Analysis##2##3##(1994-12#1)(2008-9#1)
Flow Cytometry##2##2##(2008-10#1)(2008-9#1)
Flow Injection##2##2##(2008-10#2)
Flow analysis##3##2##(2008-10#2)(2008-9#1)
Flow analysis-hydride##2##2##(2008-10#2)
Flow and##2##2##(2008-10#2)
Flow cytometric analysis of##7##4##(2008-9#7)
Flow cytometric analysis##8##3##(2008-11#1)(2008-9#7)
Flow cytometric measurement of##2##4##(2008-9#2)
Flow cytometric##16##2##(2008-11#1)(2008-9#13)(2010-1#1)(2011-2#1)
Flow cytometry analysis##2##3##(1997-3#1)(2008-4#1)
Flow cytometry and##2##3##(2008-8#1)(2008-9#1)
Flow cytometry##16##2##(1994-8#1)(1997-3#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#7)(2009-6#1)(2010-2#1)(2012-3#1)
Flow injection (FI)##3##3##(2008-10#3)
Flow injection analysis for##2##4##(2008-10#1)(2008-11#1)
Flow injection analysis of##9##4##(2008-10#9)
Flow injection analysis##11##3##(2008-10#10)(2008-11#1)
Flow injection chemiluminescence determination of##4##5##(2008-10#4)
Flow injection determination of##7##4##(2008-10#7)
Flow injection determination##8##3##(2008-10#8)
Flow injection dialysis##2##3##(2008-10#2)
Flow injection hydride generation electrothermal atomic absorption##2##7##(2008-10#2)
Flow injection hydride generation##3##4##(2008-10#3)
Flow injection kinetic spectrophotometric determination of##2##6##(2008-10#2)
Flow injection on-line##3##3##(2008-10#3)
Flow injection potentiometric determination of##2##5##(2008-10#2)
Flow injection potentiometry##5##3##(2008-10#5)
Flow injection spectrophotometric determination of##9##5##(2008-10#9)
Flow injection spectrophotometric##12##3##(2008-10#12)
Flow injection##74##2##(2008-10#73)(2008-11#1)
Flow systems##2##2##(2008-10#2)
Flow##145##1##(1992-1#1)(1994-12#1)(1994-8#1)(1997-3#2)(2008-10#99)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#24)(2009-10#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)
Flow-injection analysis##2##2##(2008-10#2)
Flow-injection chemiluminescence determination of##6##4##(2008-10#6)
Flow-injection chemiluminescence##7##2##(2008-10#7)
Flow-injection chemiluminescent determination of##2##4##(2008-10#2)
Flow-injection determination of##4##3##(2008-10#4)
Flow-injection fluorimetric determination of##2##4##(2008-10#2)
Flow-injection simultaneous determination of##2##4##(2008-10#2)
Flow-injection spectrophotometric determination of##3##4##(2008-10#3)
Flow-injection spectrophotometry of##2##3##(2008-10#2)
Flow-injection##37##1##(2008-10#37)
Flow-through##4##1##(2008-10#4)
Flower Age##2##2##(2008-10#2)
Flower##5##1##(2008-10#5)
Flowers by##3##2##(2008-10#3)
Flowers##9##1##(2008-10#9)
Flt-1##3##1##(2008-8#3)
Flt4##4##1##(1997-7#4)
Flt4-L##4##1##(1997-7#4)
Flu-6plx PCR##3##2##(2011-2#3)
Flu-6plx assay##3##2##(2011-2#3)
Flu-6plx##6##1##(2011-2#6)
Fluconazole##2##1##(2008-5#2)
Fluctuating##3##1##(2008-7#1)(2008-8#1)(2012-2#1)
Fluctuation##2##1##(1996-9#1)(2008-10#1)
Fluctuations##2##1##(1991-9#1)(2008-9#1)
Fluid##11##1##(1990-12#1)(1990-8#1)(1991-12#2)(1995-3#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-11#1)
Flunitrazepam##2##1##(2008-10#2)
Fluorescein##3##1##(2008-10#1)(2010-10#1)(2011-2#1)
Fluorescence and terbium-sensitised luminescence##2##4##(2008-10#2)
Fluorescence behavior of##2##3##(2008-10#2)
Fluorescence behavior##3##2##(2008-10#3)
Fluorescence detection##3##2##(2008-10#3)
Fluorescence from##3##2##(2008-3#2)(2009-12#1)
Fluorescence in situ hybridization##2##4##(1997-8#1)(2008-4#1)
Fluorescence intensities##2##2##(2006-6#1)(2008-10#1)
Fluorescence lidar##2##2##(2008-2#1)(2008-3#1)
Fluorescence measurements are##2##3##(2008-10#2)
Fluorescence microscopes are equipped to observe the fluorescence of one or more specific fluorophores to localize specific molecules and analyzed cellular structures##2##22##(2008-1#1)(2008-4#1)
Fluorescence microscopy##4##2##(2008-1#1)(2008-10#2)(2008-4#1)
Fluorescence postlabeling assay##2##3##(1991-5#2)
Fluorescence quenching of##2##3##(2008-10#2)
Fluorescence resonance energy transfer##2##4##(2008-10#1)(2008-4#1)
Fluorescence spectra##2##2##(2008-10#2)
Fluorescence##60##1##(1990-9#1)(1991-5#4)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#33)(2008-2#2)(2008-3#7)(2008-4#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2013-8#1)
Fluorescent Polymerase Chain Reaction##2##4##(2008-10#2)
Fluorescent Pseudomonas spp##3##3##(2008-10#3)
Fluorescent speckle microscopy (FSM)##2##4##(2008-1#2)
Fluorescent##27##1##(1991-5#1)(1991-9#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-9#1)(2009-10#2)(2009-8#1)(2010-12#1)
Fluoride##7##1##(2008-10#3)(2008-12#1)(2008-5#2)(2012-2#1)
Fluorimetric determination of##10##3##(2008-10#10)
Fluorimetric##15##1##(2008-10#15)
Fluoro-substituted ketones##2##2##(2012-3#2)
Fluoro-substituted##3##1##(2012-3#3)
Fluorometric determination of##3##3##(2008-10#3)
Fluorometric##7##1##(2008-10#7)
Fluoroquinolones##3##1##(1993-8#1)(2008-10#1)(2010-12#1)
Fluoroscopy##2##1##(2010-7#1)(2013-1#1)
Fluorous##3##1##(2008-10#2)(2010-4#1)
Fluoxetine##3##1##(1991-1#1)(1991-10#1)(2013-1#1)
Flupirtine##2##1##(1991-2#2)
Fluquinconazole##3##1##(2008-10#3)
Flurbiprofen##2##1##(2008-10#2)
Flux##2##1##(2008-10#1)(2008-11#1)
Fly ash SRM##2##3##(2008-10#2)
Fly##3##1##(2007-12#1)(2008-10#2)
Fny-CMV##3##1##(2008-10#3)
Fo##3##1##(1993-8#1)(2008-10#2)
Fo-B2##7##1##(2008-10#7)
Fo47 and##4##2##(2008-10#4)
Fo47 is##2##2##(2008-10#2)
Fo47 to Foln3GUS##3##3##(2008-10#3)
Fo47##26##1##(2008-10#26)
Fo47)##2##1##(2008-10#2)
Fo47-inoculated roots##2##2##(2008-10#2)
Foc-0##3##1##(2008-10#3)
Foc-5##5##1##(2008-10#5)
Focal##7##1##(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
Foci of##3##2##(2008-10#3)
Foci##4##1##(2008-10#4)
Focus group interviews were##2##4##(2008-11#2)
Focus group interviews##3##3##(2008-11#2)(2010-10#1)
Focus group##5##2##(1992-2#1)(2008-11#3)(2010-10#1)
Focus groups were used to##2##5##(1997-3#1)(2008-11#1)
Focus groups were##4##3##(1996-1#1)(1997-3#1)(2008-11#2)
Focus groups##5##2##(1996-1#1)(1997-3#1)(2008-11#2)(2010-10#1)
Focus on the##2##3##(2008-8#1)(2009-9#1)
Focus on##5##2##(2008-11#1)(2008-8#1)(2009-10#1)(2009-9#1)(2012-3#1)
Focus##19##1##(1992-2#1)(1996-1#1)(1997-3#1)(2008-11#7)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#2)(2010-10#2)(2012-3#1)(2013-8#1)
Focused educational##2##2##(1994-1#1)(1996-3#1)
Focused microwave-assisted##2##2##(2008-10#2)
Focused##43##1##(1993-1#1)(1993-12#8)(1993-3#2)(1994-1#9)(1994-2#14)(1994-3#2)(1996-3#1)(2008-10#3)(2011-2#1)(2013-1#2)
Focusing on the##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
Focusing##6##1##(1993-5#1)(1994-12#1)(1996-9#1)(2008-10#1)(2008-11#1)(2010-5#1)
Foeniculum vulgare##2##2##(2008-10#2)
Fol007##4##1##(2008-10#4)
Folate##5##1##(1992-10#1)(1992-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
Foliage##4##1##(2008-10#3)(2012-9#1)
Foliar##4##1##(2008-10#3)(2011-10#1)
Folic##2##1##(2009-8#1)(2010-1#1)
Folimycin (concanamycin A)##2##3##(1993-6#2)
Follicle##2##1##(2008-7#1)(2012-2#1)
Follicle-stimulating hormone##2##2##(1995-11#1)(2007-7#1)
Follicular##2##1##(2008-7#1)(2010-11#1)
Follow up##3##2##(2010-3#1)(2011-2#1)(2012-2#1)
Follow##4##1##(1996-2#1)(2010-3#1)(2011-2#1)(2012-2#1)
Follow-Up##2##1##(2011-1#1)(2013-1#1)
Follow-up MR##2##2##(1996-6#1)(1997-8#1)
Follow-up in##2##2##(1995-11#1)(1997-3#1)
Follow-up of the##2##3##(2008-11#1)(2008-12#1)
Follow-up of##4##2##(1996-3#1)(2008-11#2)(2008-12#1)
Follow-up##22##1##(1990-6#1)(1991-2#1)(1994-2#1)(1995-11#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
Followed by##4##2##(1995-6#1)(2008-10#3)
Following Spine Surgery##2##3##(2012-2#2)
Following a review of the literature##2##6##(1990-3#1)(1992-5#1)
Following a review of the##3##5##(1990-3#1)(1992-5#1)(1996-1#1)
Following a review of##4##4##(1990-3#1)(1990-9#1)(1992-5#1)(1996-1#1)
Following a##19##2##(1990-3#1)(1990-5#1)(1990-9#2)(1991-5#1)(1992-11#1)(1992-5#1)(1992-9#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-4#1)(2009-6#1)(2011-2#1)
Following are summaries of the Medicare##2##6##(1991-12#1)(1994-3#1)
Following incubation##2##2##(2008-11#1)(2008-12#1)
Following the##29##2##(1991-3#1)(1992-6#1)(1993-11#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Following these##2##2##(2008-10#1)(2008-11#1)
Following this##6##2##(1995-1#1)(2008-10#2)(2008-9#1)(2010-5#1)(2013-1#1)
Following treatment##2##2##(2008-10#1)(2013-1#1)
Following##153##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-7#2)(1997-8#1)(2008-1#2)(2008-10#39)(2008-11#11)(2008-12#2)(2008-2#1)(2008-5#4)(2008-7#6)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-1#3)(2010-10#2)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#6)(2011-7#1)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#3)
Foln3GUS on##2##2##(2008-10#2)
Foln3GUS##6##1##(2008-10#6)
Fomitiporia punctata##3##2##(2008-10#3)
Food Guide Pyramid##4##3##(2008-3#4)
Food Guide##5##2##(2008-11#1)(2008-3#4)
Food and Drug Administration (FDA)##12##5##(1996-5#3)(2008-10#1)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
Food and Drug Administration and the##2##6##(2010-6#1)(2012-2#1)
Food and Drug Administration##29##4##(1995-8#1)(1996-5#3)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#2)(2010-6#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)
Food and Drug##32##3##(1995-8#1)(1996-5#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#2)(2010-6#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)
Food for thought##2##3##(1991-2#1)(2008-11#1)
Food for##3##2##(1991-2#1)(1995-12#1)(2008-11#1)
Food safety##4##2##(1991-3#1)(1994-3#1)(1997-1#1)(2007-12#1)
Food security##2##2##(1994-12#1)(2010-9#1)
Food web##2##2##(2008-8#1)(2008-9#1)
Food##72##1##(1990-3#2)(1991-2#2)(1991-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#3)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-7#2)(2009-8#2)(2010-6#2)(2010-7#1)(2010-9#3)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#2)
Foodborne##4##1##(1990-3#2)(2007-12#1)(2011-2#1)
Foods##2##1##(2008-11#1)(2011-2#1)
Foot and Ankle##4##3##(2008-8#1)(2009-10#2)(2011-2#1)
Foot and##6##2##(2008-8#1)(2009-10#2)(2010-3#1)(2010-7#1)(2011-2#1)
Foot##11##1##(2008-8#1)(2009-10#2)(2009-11#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Foothills##2##1##(1992-3#1)(2012-2#1)
For 1##2##2##(1994-11#1)(2008-10#1)
For 10##3##2##(1991-12#1)(2008-10#2)
For 90 s preconcentration##2##4##(2008-10#2)
For 90 s##3##3##(2008-10#3)
For ICD 850##2##3##(1990-12#2)
For LC##2##2##(2008-10#2)
For M##2##2##(2008-9#2)
For a fixed##2##3##(1996-3#1)(2008-8#1)
For a given##6##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)
For a period of##2##4##(1991-2#1)(2008-11#1)
For a preconcentration time of##2##5##(2008-10#2)
For a specific##2##3##(2008-10#1)(2008-3#1)
For a##53##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1993-6#2)(1994-2#1)(1994-5#1)(1995-11#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#18)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#2)
For academic##2##2##(1991-2#1)(1996-1#1)
For adolescent##2##2##(2013-1#2)
For all other##2##3##(2007-8#1)(2008-10#1)
For all species##2##3##(2008-10#1)(2010-8#1)
For all the##3##3##(1992-2#1)(2008-10#2)
For all three##2##3##(2008-10#1)(2008-8#1)
For all##28##2##(1990-8#1)(1990-9#1)(1992-2#1)(1993-1#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-8#2)(2010-12#1)(2010-8#1)
For an inhomogeneous##2##3##(2008-2#1)(2008-3#1)
For an ion-selective electrode##2##4##(2008-10#2)
For an##11##2##(1997-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
For analysis of##2##3##(2008-10#1)(2008-12#1)
For analysis##3##2##(1997-2#1)(2008-10#1)(2008-12#1)
For black##2##2##(2011-2#1)(2013-1#1)
For both compounds##2##3##(2008-10#2)
For both groups##3##3##(1991-12#1)(1994-2#1)(2011-2#1)
For both sexes##2##3##(1990-2#1)(1991-6#1)
For both##33##2##(1990-2#1)(1991-12#1)(1991-6#1)(1994-2#1)(1994-5#1)(1996-6#1)(1997-6#1)(2008-10#14)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-1#1)(2011-2#1)
For cadmium##4##2##(2008-10#4)
For cancers##2##2##(1991-12#1)(1997-3#1)
For chemical##2##2##(2008-10#2)
For chromium in##2##3##(2008-10#2)
For chromium##4##2##(2008-10#4)
For comparison##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
For complex##2##2##(2008-10#1)(2008-12#1)
For control##2##2##(1994-2#1)(2008-11#1)
For determination of##2##3##(2008-10#1)(2008-11#1)
For determination##3##2##(2008-10#2)(2008-11#1)
For differentiation diagnosis between##4##4##(2010-12#4)
For direct##2##2##(2008-10#2)
For each field##2##3##(2008-10#2)
For each of the##2##4##(1995-3#1)(2012-3#1)
For each of##5##3##(1995-3#1)(2008-10#3)(2012-3#1)
For each sample##2##3##(2008-10#2)
For each##29##2##(1995-2#1)(1995-3#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-1#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
For eight##3##2##(2008-10#3)
For evaluation##2##2##(2012-2#2)
For every diluent##2##3##(2008-10#2)
For example##65##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-5#2)(1997-1#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-7#3)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
For fast##2##2##(2008-10#1)(2008-7#1)
For five##2##2##(1991-12#1)(2008-5#1)
For four of the##2##4##(1997-8#1)(2008-8#1)
For four##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
For higher##3##2##(2008-10#2)(2008-6#1)
For illustration##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
For image##2##2##(2008-10#1)(2008-3#1)
For in vitro##2##3##(2013-1#2)
For in##3##2##(2008-10#1)(2013-1#2)
For instance##13##2##(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
For larger##2##2##(2008-10#1)(2008-11#1)
For lead##3##2##(2008-10#3)
For low pump##2##3##(2008-3#2)
For low##3##2##(2008-3#2)(2009-7#1)
For many of##2##3##(1994-3#1)(2008-10#1)
For many years##6##3##(2008-10#2)(2008-11#1)(2009-1#1)(2010-7#1)(2012-12#1)
For many##12##2##(1994-3#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-1#1)(2010-7#1)(2011-2#1)(2012-12#1)
For measurement of##2##3##(2009-7#2)
For measurements in the##2##4##(2008-3#2)
For men##2##2##(1991-6#1)(2008-10#1)
For more than##3##3##(2009-8#1)(2010-5#1)(2013-1#1)
For most of the##2##4##(1992-2#1)(2008-10#1)
For most##9##2##(1991-12#1)(1991-3#1)(1992-2#1)(2008-10#4)(2008-11#2)
For naturally contaminated raisins##2##4##(2008-10#2)
For naturally##3##2##(2008-10#3)
For older##2##2##(2010-12#1)(2013-1#1)
For one##2##2##(1991-3#1)(2008-10#1)
For our study##2##3##(2010-12#1)(2012-3#1)
For our##4##2##(2010-12#1)(2012-12#2)(2012-3#1)
For patients with##7##3##(1992-5#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
For patients##8##2##(1992-5#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
For routine##2##2##(2008-10#2)
For samples spiked with both##3##5##(2008-10#3)
For samples##5##2##(2008-10#4)(2008-5#1)
For sequential##2##2##(2008-10#2)
For several##3##2##(1991-8#1)(1997-8#1)(2008-9#1)
For some patients##2##3##(1991-1#1)(2011-2#1)
For some##14##2##(1991-1#1)(1991-3#1)(1994-3#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-8#2)(2011-2#1)(2013-7#1)
For such##2##2##(2008-10#1)(2008-3#1)
For surface##2##2##(2008-11#1)(2008-6#1)
For ten##2##2##(2008-10#1)(2012-3#1)
For test##2##2##(1994-3#2)
For that purpose##4##3##(1996-12#1)(1997-1#1)(2008-10#2)
For that reason##3##3##(2008-10#1)(2011-3#1)(2013-1#1)
For that##7##2##(1996-12#1)(1997-1#1)(2008-10#3)(2011-3#1)(2013-1#1)
For the age range##3##4##(2008-7#3)
For the analysis of##2##4##(2008-10#2)
For the case of the##2##5##(2008-10#1)(2008-5#1)
For the case of##5##4##(1995-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
For the determination of##6##4##(2008-10#5)(2008-5#1)
For the development of##2##4##(2008-10#1)(2008-11#1)
For the efficient##2##3##(2008-2#2)
For the elution##2##3##(2008-10#2)
For the entire##2##3##(2008-7#1)(2012-2#1)
For the equilibrium##2##3##(2008-10#2)
For the evaluation of##3##4##(2008-10#2)(2011-2#1)
For the first time a##2##5##(2008-10#2)
For the first time##18##4##(2008-10#14)(2008-5#1)(2010-8#1)(2012-2#1)(2012-8#1)
For the first##21##3##(2008-10#16)(2008-5#1)(2009-1#1)(2010-8#1)(2012-2#1)(2012-8#1)
For the investigation of##2##4##(2008-10#1)(2010-12#1)
For the measurement of##2##4##(2008-10#1)(2010-2#1)
For the measurement##4##3##(2008-10#3)(2010-2#1)
For the other##2##3##(2008-10#2)
For the past several##2##4##(1995-12#1)(2011-2#1)
For the past##5##3##(1992-12#1)(1993-3#1)(1995-12#2)(2011-2#1)
For the patient##6##3##(2011-2#6)
For the purpose of this study##2##6##(2008-10#1)(2008-11#1)
For the purpose of##7##4##(1990-8#1)(2008-10#4)(2008-11#2)
For the quality control of##2##5##(2008-10#2)
For the quantitative##2##3##(2008-10#2)
For the regenerated gratings from group##2##6##(2013-8#2)
For the sake of##2##4##(1994-12#1)(2008-10#1)
For the same number of##2##5##(1990-11#1)(2008-10#1)
For the same##6##3##(1990-11#1)(1996-12#1)(2008-10#4)
For the second##2##3##(1991-8#1)(2008-10#1)
For the subsequent##2##3##(2008-7#1)(2011-3#1)
For the whole##2##3##(2008-10#2)
For the##211##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#100)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#6)(2008-7#6)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#5)
For therapeutic##2##2##(2011-2#1)(2013-1#1)
For these reasons##7##3##(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
For these##22##2##(1990-8#1)(1991-3#1)(1992-2#2)(1994-2#2)(2008-10#6)(2008-11#1)(2008-8#1)(2009-10#1)(2009-12#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
For this assay##2##3##(1990-12#1)(2008-10#1)
For this purpose the##2##4##(2008-3#1)(2008-5#1)
For this purpose we have##2##5##(2008-10#1)(2008-11#1)
For this purpose##44##3##(1990-2#1)(1995-6#1)(1996-12#1)(2008-10#19)(2008-11#2)(2008-3#1)(2008-5#5)(2008-7#3)(2009-10#1)(2009-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#1)
For this reason##19##3##(1991-2#1)(1992-2#1)(1992-3#1)(1995-12#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2009-1#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
For this study##2##3##(2008-10#1)(2013-1#1)
For this to##2##3##(2008-11#1)(2008-9#1)
For this##89##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(2008-1#1)(2008-10#32)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#4)(2013-8#3)
For those##5##2##(2008-10#1)(2008-11#2)(2012-2#2)
For tin##2##2##(2008-10#2)
For total##2##2##(2008-10#1)(2008-5#1)
For two##3##2##(1994-3#1)(2008-10#1)(2013-8#1)
For validation##3##2##(2008-10#3)
For very##2##2##(2008-10#1)(2008-4#1)
For women##2##2##(1992-2#1)(2008-10#1)
For##1087##1##(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#1)(1990-8#3)(1990-9#1)(1991-1#5)(1991-12#9)(1991-2#5)(1991-3#8)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#6)(1992-5#4)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#8)(1994-3#8)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#1)(1995-9#5)(1996-1#2)(1996-11#1)(1996-12#10)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2007-12#1)(2007-8#1)(2008-1#5)(2008-10#429)(2008-11#73)(2008-12#13)(2008-2#11)(2008-3#43)(2008-4#8)(2008-5#31)(2008-6#2)(2008-7#23)(2008-8#32)(2008-9#26)(2009-1#4)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#7)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#12)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#5)(2011-1#4)(2011-2#32)(2011-3#7)(2011-7#1)(2012-12#6)(2012-2#17)(2012-3#18)(2012-5#2)(2012-8#1)(2012-9#1)(2013-1#25)(2013-7#2)(2013-8#19)
Foraging##4##1##(2008-8#1)(2008-9#2)(2009-10#1)
Force Microscopy##2##2##(2009-12#1)(2010-10#1)
Force##17##1##(1990-12#1)(1990-6#1)(1991-2#2)(1991-5#1)(1993-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
Forced##3##1##(2008-7#1)(2011-2#2)
Forces##10##1##(1992-2#1)(2008-1#1)(2008-10#1)(2013-1#7)
Forcing##3##1##(1994-1#1)(1997-3#1)(2012-8#1)
Ford##4##1##(1993-12#1)(1994-2#1)(2008-11#1)(2008-12#1)
Forecasting##4##1##(1994-12#1)(2008-10#3)
Foreign##4##1##(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
Forensic chemistry##3##2##(2010-7#3)
Forensic##13##1##(1997-8#2)(2008-10#1)(2008-12#4)(2010-7#3)(2011-2#3)
Forest##16##1##(1992-1#1)(1995-3#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-8#1)(2008-9#2)
Forestier's disease##2##2##(2008-12#2)
Forestier's##3##1##(2008-12#3)
Forests##3##1##(2008-10#3)
Foreword##6##1##(1995-11#1)(2008-10#3)(2008-8#1)(2013-8#1)
Form##11##1##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2010-10#2)(2010-8#1)(2012-12#1)
Form-12##2##1##(2009-10#1)(2012-3#1)
Formae Speciales##2##2##(2008-10#2)
Formal##9##1##(1992-1#2)(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-7#1)
Formaldehyde##5##1##(2008-10#2)(2008-7#3)
Formation and stability of protonated putrescine and cadaverine complexes with##2##10##(2008-10#2)
Formation and stability of protonated##3##5##(2008-10#3)
Formation and##7##2##(1995-8#1)(2008-10#4)(2010-4#1)(2012-2#1)
Formation by##3##2##(1996-9#1)(2008-10#1)(2013-1#1)
Formation constants##3##2##(2008-10#3)
Formation in##4##2##(1994-3#1)(2008-10#2)(2008-6#1)
Formation of the complex##3##4##(1993-9#1)(2008-10#2)
Formation of the##8##3##(1991-6#1)(1993-9#1)(1995-6#1)(2008-10#4)(2008-7#1)
Formation of##32##2##(1990-2#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#1)(2006-6#1)(2008-10#15)(2008-11#4)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)
Formation##58##1##(1990-2#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-9#1)(2006-6#1)(2008-10#27)(2008-11#6)(2008-6#2)(2008-7#2)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
Formica japonica##2##2##(2008-5#2)
Formicidae)##4##1##(2007-12#1)(2008-5#1)(2008-8#2)
Forming##2##1##(2008-10#1)(2010-7#1)
Forms##3##1##(1995-1#1)(2009-1#1)(2009-4#1)
Formulating##2##1##(2008-5#2)
Formulation and##3##2##(2008-5#2)(2012-2#1)
Formulation of Bacillus spp##2##4##(2008-10#2)
Formulation of##6##2##(2008-10#3)(2008-5#2)(2011-2#1)
Formulation##9##1##(2008-10#3)(2008-5#4)(2011-2#1)(2012-2#1)
Formulations were##2##2##(2008-10#1)(2008-5#1)
Formulations##8##1##(2008-10#5)(2008-5#3)
Fornix lesions##2##2##(1993-6#2)
Forskolin##4##1##(1993-6#2)(1995-8#1)(2008-11#1)
Forsus##3##1##(2013-1#3)
Fort##2##1##(2008-10#2)
Fortified##4##1##(2008-10#3)(2009-8#1)
Fortunately##8##1##(1991-6#1)(1992-1#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
Forty patients##2##2##(1990-6#1)(2011-2#1)
Forty percent##2##2##(2008-10#1)(2009-10#1)
Forty six##2##2##(1990-2#1)(2008-5#1)
Forty two##2##2##(1996-3#1)(2008-7#1)
Forty##26##1##(1990-2#1)(1990-6#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
Forty-eight patients##2##2##(1991-6#1)(2009-6#1)
Forty-eight##6##1##(1991-11#1)(1991-6#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-3#1)
Forty-five##4##1##(1994-2#1)(2008-9#1)(2012-12#1)(2013-1#1)
Forty-four##7##1##(1994-5#1)(2008-10#2)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#1)
Forty-nine##5##1##(1991-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
Forty-one##4##1##(1990-6#1)(1990-8#1)(2008-10#2)
Forty-seven##4##1##(1995-3#1)(2008-10#1)(2011-2#2)
Forty-six##5##1##(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
Forty-three patients##3##2##(2010-3#1)(2011-2#1)(2012-2#1)
Forty-three percent of##2##3##(2008-12#1)(2013-1#1)
Forty-three##10##1##(1997-1#1)(2008-1#1)(2008-12#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#1)
Forty-two patients##2##2##(2008-7#1)(2011-2#1)
Forty-two##4##1##(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
Forum##9##1##(1995-2#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#1)
Forward selection##2##2##(2008-10#2)
Forward##5##1##(2008-10#2)(2008-12#1)(2008-3#1)(2009-5#1)
Fos and Jun proteins##2##4##(1996-12#2)
Fos and##3##2##(1996-12#3)
Fos##6##1##(1994-2#1)(1996-12#4)(1996-2#1)
Fos-LI##4##1##(1994-2#4)
Fos-like immunoreactivity in the##2##4##(1997-2#2)
Fos-like immunoreactivity##4##2##(1994-2#1)(1996-12#1)(1997-2#2)
Fos-like##6##1##(1994-2#1)(1996-12#1)(1997-2#4)
Fossa##2##1##(2012-3#2)
Foster##11##1##(1990-2#2)(1995-2#1)(1996-5#5)(2008-10#1)(2008-12#2)
Foster/CIho 10644##2##2##(2008-10#2)
Foster/CIho##5##1##(2008-10#5)
Fot1 and##2##2##(2008-10#2)
Fot1##6##1##(2008-10#6)
Foundation and##2##2##(2008-11#1)(2013-8#1)
Foundation of##3##2##(1992-3#1)(2008-8#1)(2013-8#1)
Foundation##31##1##(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#2)(1994-3#1)(1996-1#1)(1996-5#2)(1997-2#2)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
Foundation's##9##1##(1993-2#1)(1994-3#1)(1996-12#1)(1997-6#1)(2010-10#1)(2010-12#2)(2013-1#2)
Foundations##5##1##(1990-11#1)(1995-12#1)(1997-2#1)(2008-7#1)(2012-2#1)
Founder##2##1##(2008-10#1)(2008-9#1)
Fountain##2##1##(1992-12#1)(2011-2#1)
Four cycles of##2##3##(2008-10#2)
Four different##5##2##(2008-10#4)(2013-1#1)
Four hours##2##2##(2008-11#1)(2008-12#1)
Four hundred and##2##3##(2008-10#2)
Four hundred##7##2##(1991-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2013-1#1)
Four independent##2##2##(2008-10#1)(2011-2#1)
Four isolates##2##2##(2008-10#2)
Four lesions##2##2##(2012-3#2)
Four linear##2##2##(2008-10#2)
Four main##4##2##(2008-10#2)(2008-5#2)
Four major##4##2##(1994-9#1)(2008-10#1)(2009-8#1)(2011-1#1)
Four of eight##2##3##(2008-10#1)(2010-1#1)
Four of the##12##3##(1991-8#1)(1993-6#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
Four of these##3##3##(1991-12#1)(1993-8#1)(2012-2#1)
Four of##19##2##(1991-12#1)(1991-8#1)(1993-6#1)(1993-8#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
Four parameters were assessed##2##4##(2008-10#2)
Four parameters##3##2##(2008-10#3)
Four patients had##2##3##(2008-7#1)(2012-12#1)
Four patients underwent##2##3##(2011-2#1)(2013-1#1)
Four patients with##2##3##(1990-12#1)(2008-7#1)
Four patients##14##2##(1990-12#2)(1993-2#2)(1994-3#1)(1994-8#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
Four potential##2##2##(2008-11#1)(2011-2#1)
Four simple and sensitive##2##4##(2008-10#2)
Four species##3##2##(2008-10#2)(2013-8#1)
Four studies##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
Four themes##2##2##(2008-11#2)
Four tomato##2##2##(2008-10#2)
Four treatments##2##2##(2008-10#2)
Four types of##5##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
Four variables##2##2##(2008-10#2)
Four weeks after surgery##2##4##(1992-3#2)
Four weeks after##3##3##(1992-3#2)(2008-10#1)
Four weeks later##2##3##(2008-10#2)
Four weeks##5##2##(1992-3#2)(2008-10#3)
Four years##3##2##(1995-11#1)(1996-3#1)(1997-8#1)
Four##235##1##(1990-12#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1993-2#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(1997-9#1)(2008-1#1)(2008-10#104)(2008-11#12)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#4)(2008-8#5)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#11)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#5)
Fourier Transform Infrared Spectroscopy##2##4##(2008-10#1)(2011-2#1)
Fourier Transform Infrared##4##3##(2008-10#3)(2011-2#1)
Fourier Transform##6##2##(2008-10#5)(2011-2#1)
Fourier analysis##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
Fourier coefficients##2##2##(2008-10#1)(2008-11#1)
Fourier methods##2##2##(2008-10#1)(2008-9#1)
Fourier self-deconvolution##2##2##(2008-10#2)
Fourier series##2##2##(2007-12#1)(2008-3#1)
Fourier transform IR##2##3##(2008-3#1)(2010-4#1)
Fourier transform Raman spectroscopy (FT-Raman)##2##5##(2008-10#2)
Fourier transform Raman spectroscopy##3##4##(2008-10#3)
Fourier transform infrared (FTIR) spectroscopic##2##5##(2008-10#2)
Fourier transform infrared (FTIR) spectroscopy##5##5##(2008-10#3)(2008-5#1)(2008-8#1)
Fourier transform infrared (FTIR)##11##4##(2008-10#9)(2008-5#1)(2008-8#1)
Fourier transform infrared determination of##2##5##(2008-10#2)
Fourier transform infrared spectrometer##2##4##(2008-10#2)
Fourier transform infrared spectrometric detection##2##5##(2008-10#2)
Fourier transform infrared spectrometric##3##4##(2008-10#3)
Fourier transform infrared spectrometry (FT-IR)##2##5##(1997-2#1)(2008-10#1)
Fourier transform infrared spectrometry##11##4##(1997-2#1)(2008-10#9)(2008-5#1)
Fourier transform infrared spectroscopy (FT-IR)##4##5##(2008-10#3)(2013-1#1)
Fourier transform infrared spectroscopy (FTIR)##5##5##(2008-10#5)
Fourier transform infrared spectroscopy##13##4##(2008-10#11)(2009-10#1)(2013-1#1)
Fourier transform infrared##49##3##(1997-2#1)(2008-10#43)(2008-5#2)(2008-8#1)(2009-10#1)(2013-1#1)
Fourier transform spectrometer##5##3##(2008-3#5)
Fourier transform##74##2##(1997-2#1)(2008-10#53)(2008-3#11)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
Fourier transformation##4##2##(1993-3#1)(2008-10#2)(2013-1#1)
Fourier transformed infrared##3##3##(2008-10#3)
Fourier transformed##4##2##(2008-10#3)(2008-3#1)
Fourier##119##1##(1991-3#1)(1993-3#1)(1997-2#1)(2007-12#1)(2008-10#74)(2008-11#2)(2008-2#1)(2008-3#22)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Fourier-transform infrared analysis##2##3##(2008-10#2)
Fourier-transform infrared spectroscopy##2##3##(1994-11#2)
Fourier-transform infrared##7##2##(1994-11#2)(2008-10#2)(2008-3#3)
Fourier-transform spectrometer##3##2##(2008-3#3)
Fourier-transform##13##1##(1994-11#2)(2008-10#3)(2008-3#8)
Fourier-transformed##2##1##(2008-10#1)(2008-3#1)
Fournier's gangrene##2##2##(2013-1#2)
Fournier's##3##1##(2013-1#3)
Fourteen of##2##2##(1994-2#1)(2008-9#1)
Fourteen patients were##3##3##(1990-12#1)(1997-8#1)(2010-3#1)
Fourteen patients with##2##3##(1993-12#1)(2013-1#1)
Fourteen patients##7##2##(1990-12#1)(1993-12#1)(1997-8#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
Fourteen##26##1##(1990-12#1)(1990-9#1)(1992-9#1)(1993-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-9#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
Fourth Edition criteria for##2##4##(2011-2#2)
Fourth Edition##4##2##(2010-11#1)(2011-2#3)
Fourth##13##1##(1990-2#1)(1995-5#1)(1995-6#2)(1997-6#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-11#1)(2011-2#3)
Fov1##2##1##(2008-10#2)
Fowler's##2##1##(2011-1#2)
Foxtail Millet##3##2##(2008-10#3)
Fr11##2##1##(1993-3#2)
Fraction##2##1##(2008-10#1)(2008-11#1)
Fractional##3##1##(1996-12#1)(2008-3#1)(2009-4#1)
Fractionated##3##1##(2008-10#1)(2008-4#1)(2012-3#1)
Fractionation of##5##2##(1990-2#1)(1993-8#1)(2008-10#2)(2008-4#1)
Fractionation##6##1##(1990-2#1)(1993-8#1)(2008-10#3)(2008-4#1)
Fractions were##2##2##(1997-2#1)(2008-11#1)
Fractions##7##1##(1990-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2009-8#1)
Fracture characteristics predictive of##2##4##(2008-8#2)
Fracture##8##1##(2008-12#1)(2008-8#2)(2012-3#1)(2013-1#3)(2013-8#1)
Fractures##4##1##(2008-12#2)(2010-9#1)(2013-1#1)
Fragaria x ananassa##2##3##(2008-10#2)
Fragaria##5##1##(2008-10#4)(2008-8#1)
Fragment Length Polymorphism##10##3##(2008-10#10)
Fragment Length##12##2##(2008-10#12)
Fragment##15##1##(2008-10#12)(2008-3#1)(2008-8#1)(2013-1#1)
Fragmentation of##3##2##(1996-5#1)(1997-8#1)(2008-1#1)
Fragmentation##5##1##(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)
Fragmented##3##1##(2008-9#1)(2009-10#1)(2012-3#1)
Fragments of##6##2##(1993-2#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-7#1)
Fragments##10##1##(1990-5#1)(1993-2#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
Framesearch##4##1##(2008-9#4)
Framework for##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
Framework##12##1##(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#1)(2012-2#2)
Framingham##6##1##(1993-3#1)(2008-1#2)(2009-12#1)(2010-10#1)(2013-8#1)
France and##6##2##(2008-10#5)(2013-8#1)
France are##2##2##(1990-8#1)(2008-10#1)
France##78##1##(1990-8#3)(1991-2#1)(1994-12#2)(1995-1#2)(1997-5#2)(2008-1#1)(2008-10#43)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#2)(2009-7#1)(2010-1#4)(2010-7#1)(2011-2#5)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
France)##4##1##(2008-10#2)(2008-5#1)(2011-2#1)
Francesco##2##1##(2010-1#2)
Francis##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
Francisco##14##1##(1990-11#1)(1990-9#1)(1991-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#3)(2011-2#1)
Francisella novicida##2##2##(2012-2#2)
Francisella tularensis##2##2##(2008-10#1)(2012-2#1)
Francisella##7##1##(2008-10#1)(2012-2#6)
Frank and##2##2##(2008-5#1)(2008-8#1)
Frank##5##1##(1996-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
Frankel grade B##2##3##(2008-7#2)
Frankfort##3##1##(2008-10#1)(2012-3#2)
Frankliniella fusca##3##2##(2008-10#3)
Frankliniella occidentalis##5##2##(2008-10#5)
Frankliniella##9##1##(2008-10#9)
Franz cell##3##2##(2008-10#2)(2008-5#1)
Franz diffusion cells##2##3##(2008-5#1)(2011-3#1)
Franz##5##1##(2008-10#2)(2008-5#2)(2011-3#1)
Fraser##2##1##(2008-10#1)(2008-9#1)
Frauenfeld/Aadorf##2##1##(1996-11#2)
Fraxinus##2##1##(2008-8#1)(2013-8#1)
Frederiksborg County##2##2##(1990-12#2)
Fredholm##2##1##(2009-10#2)
Free and##2##2##(1993-2#2)
Free radicals##3##2##(1992-9#1)(1993-6#1)(2009-6#1)
Free##26##1##(1990-8#1)(1991-12#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-2#2)(1993-6#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
Freedom##6##1##(1995-6#1)(2008-4#1)(2008-9#1)(2009-11#1)(2013-1#2)
Freeman##3##1##(2008-10#1)(2012-2#1)(2012-3#1)
Freeze##2##1##(1991-5#1)(2008-10#1)
Freezing##2##1##(2008-10#1)(2008-8#1)
Fremont##2##1##(1996-9#1)(1997-3#1)
French and##3##2##(2008-10#2)(2008-11#1)
French beans in##2##3##(2008-10#2)
French beans##5##2##(2008-10#5)
French children##3##2##(2009-7#3)
French##58##1##(1990-8#5)(1992-5#1)(1994-12#1)(1997-5#2)(2008-10#17)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#4)(2010-1#5)(2010-6#1)(2010-9#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
French-speaking##2##1##(2010-1#1)(2010-3#1)
Frequencies of##3##2##(2008-10#2)(2008-11#1)
Frequencies##4##1##(2008-10#3)(2008-11#1)
Frequency and##2##2##(2007-11#1)(2008-10#1)
Frequency of factors##2##3##(2007-12#1)(2012-2#1)
Frequency of##18##2##(1990-9#1)(1992-3#1)(1995-11#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#4)
Frequency##34##1##(1990-9#1)(1991-12#1)(1992-3#1)(1995-11#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)
Frequent light pulses##2##3##(2008-5#2)
Frequent##8##1##(1993-11#1)(1997-2#1)(2008-10#2)(2008-5#2)(2013-1#1)(2013-8#1)
Frequently##7##1##(2008-10#3)(2008-4#1)(2008-7#1)(2010-8#1)(2013-8#1)
Fresh##6##1##(1997-7#1)(2008-10#4)(2009-3#1)
Freshly harvested##3##2##(2008-10#3)
Freshly isolated##4##2##(1990-2#1)(1995-2#1)(2008-1#1)(2008-11#1)
Freshly##8##1##(1990-2#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-11#1)
Fresnaye##2##1##(2008-10#2)
Fresnel numbers##2##2##(2008-3#2)
Fresnel##6##1##(2007-12#1)(2008-3#5)
Freund's adjuvant##8##2##(1995-12#4)(1996-12#1)(1997-2#2)(2008-4#1)
Freund's##9##1##(1995-12#4)(1996-12#2)(1997-2#2)(2008-4#1)
Freundlich adsorption##2##2##(2008-10#2)
Freundlich and Dubinin-Radushkevich (D-R) isotherms##2##5##(2008-10#2)
Freundlich and Langmuir##2##3##(2008-10#2)
Freundlich and##4##2##(2008-10#4)
Freundlich sorption##3##2##(2008-10#2)(2008-12#1)
Freundlich##15##1##(1997-2#1)(2008-10#12)(2008-12#1)(2013-1#1)
Friction##4##1##(2008-5#1)(2010-10#2)(2012-2#1)
Friday##2##1##(2008-11#1)(2008-12#1)
Friedman test##2##2##(2010-6#1)(2013-1#1)
Friedman##3##1##(2009-8#1)(2010-6#1)(2013-1#1)
Friend##3##1##(1993-8#1)(2008-11#1)(2013-1#1)
Friendly Hills HealthCare Network##3##4##(1997-3#3)
Friendly Hills##4##2##(1997-3#4)
Friends##3##1##(2010-4#1)(2012-2#2)
Fritillaria-type embryo sac##2##3##(2009-12#2)
From 100##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
From 1974##2##2##(1995-12#1)(1996-1#1)
From 1978 to##2##3##(1991-2#1)(1993-6#1)
From 1982##2##2##(1992-5#1)(1997-2#1)
From 1986 to##2##3##(1993-6#1)(2011-2#1)
From 1996 to##2##3##(2008-10#1)(2011-7#1)
From January##3##2##(1991-6#1)(1992-5#1)(2008-1#1)
From October##4##2##(1991-3#1)(1994-9#1)(2008-10#1)(2008-7#1)
From September##2##2##(1991-2#1)(1994-9#1)
From a theoretical point of view##2##6##(2008-3#1)(2008-8#1)
From a theoretical##3##3##(2008-3#1)(2008-8#2)
From a##27##2##(1990-11#1)(1990-2#1)(1990-8#1)(1993-6#1)(1995-6#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-7#1)(2013-1#2)(2013-8#3)
From an##6##2##(1990-9#1)(2008-11#2)(2008-3#1)(2009-8#1)(2012-2#1)
From being##2##2##(2009-9#1)(2013-7#1)
From each##3##2##(1991-5#1)(1992-3#1)(2008-10#1)
From our analysis of##2##4##(2007-12#1)(2012-3#1)
From our analysis##3##3##(1991-8#1)(2007-12#1)(2012-3#1)
From our data##2##3##(1990-8#1)(1996-3#1)
From our##6##2##(1990-8#1)(1991-8#1)(1996-3#1)(2007-12#1)(2011-2#1)(2012-3#1)
From the above##2##3##(2008-12#1)(2012-2#1)
From the calculated##2##3##(2008-10#1)(2009-1#1)
From the experimental##2##3##(2009-7#1)(2010-4#1)
From the literature##2##3##(1993-2#1)(2009-10#1)
From the obtained##2##3##(2008-10#1)(2008-5#1)
From the present study##2##4##(1994-11#1)(2012-2#1)
From the results obtained##2##4##(2008-10#2)
From the results of##2##4##(1993-2#1)(2008-11#1)
From the results##6##3##(1993-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)
From the review##2##3##(2008-10#1)(2009-5#1)
From the start##2##3##(1991-3#1)(2008-12#1)
From the total##2##3##(1997-6#1)(2012-3#1)
From the two##3##3##(2008-10#1)(2008-11#2)
From the##102##2##(1990-10#1)(1990-11#1)(1991-3#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-10#33)(2008-11#8)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#4)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#3)
From these data##3##3##(1997-2#1)(1997-4#1)(2008-10#1)
From these findings##2##3##(2010-6#2)
From these results we##2##4##(2008-10#1)(2008-5#1)
From these results##16##3##(1992-3#1)(1993-12#1)(1993-8#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#3)(2011-2#1)(2012-3#1)(2012-9#1)
From these studies##4##3##(2008-10#3)(2011-2#1)
From these##32##2##(1990-12#1)(1990-9#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-8#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-5#3)(2010-6#2)(2011-1#1)(2011-2#2)(2012-3#1)(2012-9#1)
From this perspective##2##3##(1992-3#1)(2008-10#1)
From this point of view##2##5##(2008-10#1)(2010-3#1)
From this study##3##3##(2008-10#2)(2008-5#1)
From this##21##2##(1990-8#1)(1992-3#1)(1995-2#1)(2008-10#10)(2008-5#2)(2010-1#2)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
From##326##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#4)(1990-9#2)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-3#3)(1992-5#2)(1993-1#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#3)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#8)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#86)(2008-11#20)(2008-12#10)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#4)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#4)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#13)(2011-7#1)(2012-2#4)(2012-3#10)(2012-5#1)(2012-9#1)(2013-1#8)(2013-7#1)(2013-8#10)
Frontal analysis of aqueous phenol solutions in##2##7##(2008-10#2)
Frontal sinus##2##2##(2013-1#2)
Frontal##7##1##(1995-2#1)(2008-10#2)(2008-4#1)(2010-8#1)(2013-1#2)
Frozen tail or limber tail in working dogs##2##8##(1997-5#2)
Frozen##6##1##(1990-12#1)(1997-5#2)(2008-8#1)(2011-2#1)(2012-3#1)
Fru 2##6##2##(1994-3#6)
Fru##7##1##(1994-3#7)
Fructose##2##1##(1994-8#1)(1995-11#1)
Fruit Rot##2##2##(2008-10#2)
Fruit and##2##2##(2008-10#1)(2009-5#1)
Fruit by##2##2##(2008-10#2)
Fruit of##2##2##(2008-10#2)
Fruit were##2##2##(2008-10#2)
Fruit##35##1##(2007-12#1)(2008-10#31)(2009-5#1)(2012-3#2)
Fruiting bodies were##2##3##(2008-10#2)
Fruiting bodies##3##2##(2008-10#3)
Fruiting##4##1##(2008-10#4)
Fruits and##2##2##(2008-10#2)
Fruits##5##1##(2008-10#4)(2012-2#1)
FsphDNase##4##1##(2008-10#4)
Fucoidan##2##1##(2008-11#2)
Fuego##3##1##(2008-2#1)(2008-3#2)
Fuerte##7##1##(2008-10#7)
Fugu rubripes##2##2##(1995-2#2)
Fugu##5##1##(1995-2#5)
Fuhrmann (1913)##2##2##(2011-2#2)
Fuhrmann##4##1##(2011-2#4)
Fuji IX##3##2##(2008-5#3)
Fuji and resistant cv##2##4##(2008-10#2)
Fuji##10##1##(1991-2#1)(2008-10#5)(2008-5#4)
Fukuho-komugi x##2##2##(2008-10#2)
Fukuho-komugi##3##1##(2008-10#3)
Fukushima##2##1##(2013-1#2)
Full Text##3##2##(2008-12#1)(2013-1#2)
Full##19##1##(1990-3#1)(1991-1#1)(1991-5#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-9#2)(2010-1#1)(2011-2#3)(2012-5#1)(2013-1#2)
Full- and##2##2##(2008-10#1)(2008-3#1)
Full-length##3##1##(1991-3#1)(2008-10#2)
Full-thickness sclerotomy without##2##3##(2013-8#2)
Full-thickness##3##1##(2013-8#3)
Fully automated##2##2##(2008-10#1)(2008-11#1)
Fully##7##1##(1994-2#1)(1995-6#1)(2008-10#3)(2008-11#2)
Fulton##2##1##(1993-3#1)(2008-10#1)
Fumonisin B(1)##2##2##(2008-10#2)
Fumonisin levels##2##2##(2008-10#2)
Fumonisin##7##1##(2008-10#7)
Function in##2##2##(2008-10#1)(2013-1#1)
Function##16##1##(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
Functional analysis of##6##3##(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
Functional analysis##8##2##(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#2)
Functional brain imaging##2##3##(1995-2#1)(2008-8#1)
Functional classification##2##2##(2008-8#1)(2010-12#1)
Functional dissection of##2##3##(1995-2#1)(1995-6#1)
Functional expression of##2##3##(1992-9#1)(1994-8#1)
Functional expression##3##2##(1992-9#1)(1994-8#1)(2009-9#1)
Functional imaging##3##2##(2008-8#2)(2012-2#1)
Functional magnetic resonance imaging##2##4##(1996-2#2)
Functional magnetic##3##2##(1996-2#2)(2008-10#1)
Functional properties##2##2##(1995-8#1)(2008-7#1)
Functional##89##1##(1991-6#1)(1992-9#2)(1993-1#1)(1993-6#2)(1993-8#1)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#2)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-4#3)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#7)(2011-3#1)(2011-8#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#3)
Functionality##2##1##(1995-2#1)(2008-10#1)
Functionally##4##1##(1991-3#1)(1993-1#1)(1993-6#1)(2010-12#1)
Functioning of##2##2##(1997-2#1)(2012-3#1)
Functioning##12##1##(1991-2#1)(1997-2#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
Functions of##3##2##(1992-2#1)(1997-5#1)(2008-9#1)
Functions##7##1##(1992-2#1)(1995-12#2)(1997-4#1)(1997-5#1)(2008-10#1)(2008-9#1)
Fund raising in##2##3##(1991-3#1)(1992-3#1)
Fund##7##1##(1991-3#1)(1992-3#1)(1995-12#1)(1995-6#2)(2008-11#1)(2013-8#1)
Fundamental information-density limits##2##3##(2007-12#2)
Fundamental##9##1##(1992-1#1)(1993-12#1)(2007-12#2)(2008-12#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
Fundamentals of##2##2##(2008-10#2)
Fundamentals##3##1##(2008-10#3)
Funded##2##1##(2008-11#2)
Funding for##2##2##(1994-12#1)(2009-4#1)
Funding##8##1##(1991-12#1)(1992-2#1)(1994-12#1)(1995-6#1)(1997-4#1)(2009-10#1)(2009-4#2)
Fungal Pathogen##3##2##(2008-10#2)(2011-2#1)
Fungal culture filtrates##2##3##(2008-10#2)
Fungal isolates##2##2##(2008-10#2)
Fungal populations##3##2##(2008-10#3)
Fungal##27##1##(2008-10#21)(2008-8#1)(2011-2#4)(2013-8#1)
Fungi were##2##2##(2008-10#2)
Fungi##18##1##(2008-10#14)(2008-5#2)(2009-6#1)(2011-2#1)
Fungicide##9##1##(1996-3#1)(2008-10#8)
Fungicides in##4##2##(2008-10#4)
Fungicides##14##1##(2008-10#14)
Fungus Bipolaris sorokiniana##2##3##(2008-10#2)
Fungus##23##1##(2008-10#22)(2008-5#1)
Fur##3##1##(1997-7#1)(2009-6#2)
Furin##5##1##(2008-11#5)
Furnace##2##1##(2008-10#2)
Further analyses##2##2##(2008-2#1)(2008-3#1)
Further analysis of the##4##4##(1992-9#1)(2008-10#1)(2008-12#1)(2008-9#1)
Further analysis of##5##3##(1992-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
Further analysis##10##2##(1992-9#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#2)(2010-4#1)(2013-1#1)
Further characterization of the##2##4##(1991-3#1)(2008-10#1)
Further clinical studies##2##3##(2010-11#1)(2011-2#1)
Further development of##4##3##(2008-3#1)(2009-7#1)(2010-6#1)(2012-2#1)
Further development##5##2##(2008-10#1)(2008-3#1)(2009-7#1)(2010-6#1)(2012-2#1)
Further evidence for acquired undescended testicle in the UK and its incompatibility with current recommendations in the Hall Report##2##19##(2008-10#2)
Further evidence for##3##3##(1996-12#1)(2008-10#2)
Further evidence##4##2##(1996-12#1)(2008-10#3)
Further examination of##3##3##(2008-10#2)(2008-9#1)
Further examination##4##2##(2008-10#3)(2008-9#1)
Further experimentation will be##2##4##(1997-6#1)(2008-10#1)
Further experiments##2##2##(1997-2#1)(2008-8#1)
Further follow-up##2##2##(1992-2#1)(1997-8#1)
Further functional##2##2##(1995-6#1)(2010-12#1)
Further imaging##2##2##(2013-1#1)(2013-7#1)
Further information##2##2##(2008-10#1)(2011-2#1)
Further investigation##7##2##(1991-8#1)(2008-10#1)(2008-7#2)(2009-3#1)(2010-2#1)(2011-2#1)
Further investigations are needed to##2##5##(2008-10#1)(2013-8#1)
Further investigations are##5##3##(2008-10#2)(2008-5#1)(2012-12#1)(2013-8#1)
Further investigations of##2##3##(1996-12#1)(2008-10#1)
Further investigations##8##2##(1996-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-12#1)(2013-8#1)
Further research is needed to determine##2##6##(1994-12#1)(2008-12#1)
Further research is needed to##5##5##(1994-12#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-7#1)
Further research is needed##6##4##(1994-12#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-7#1)(2012-2#1)
Further research is##11##3##(1994-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-2#1)
Further research on##2##3##(1990-6#1)(2008-10#1)
Further research##19##2##(1990-6#1)(1992-9#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-10#2)(2010-3#1)(2010-7#1)(2011-2#5)(2012-2#1)(2013-1#1)
Further studies are needed to confirm##2##6##(2008-10#1)(2011-2#1)
Further studies are needed to elucidate the##2##7##(1995-6#1)(2012-12#1)
Further studies are needed to##6##5##(1995-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
Further studies are needed##7##4##(1995-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
Further studies are required to##2##5##(1993-2#1)(2011-2#1)
Further studies are required##3##4##(1993-2#1)(2008-10#1)(2011-2#1)
Further studies are warranted to##2##5##(2008-7#2)
Further studies are##13##3##(1993-2#1)(1995-6#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#2)
Further studies indicated that##2##4##(1990-11#1)(2008-8#1)
Further studies of the##2##4##(2009-8#1)(2011-3#1)
Further studies on##2##3##(2008-10#1)(2013-8#1)
Further studies show that##2##4##(2008-8#2)
Further studies using##2##3##(2008-10#2)
Further studies were##3##3##(1993-11#1)(1997-1#1)(2008-10#1)
Further studies with##4##3##(1995-5#1)(2008-11#1)(2008-12#1)(2009-3#1)
Further studies##34##2##(1990-11#1)(1993-11#1)(1993-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-7#1)(2013-8#1)
Further study is##2##3##(2008-9#1)(2011-2#1)
Further study of##2##3##(2008-7#2)
Further study##5##2##(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)
Further work##4##2##(1994-2#1)(2006-6#1)(2008-10#1)(2013-8#1)
Further##261##1##(1990-11#2)(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-2#1)(1992-9#2)(1993-11#1)(1993-2#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-6#1)(1997-8#3)(2006-6#1)(2007-12#4)(2008-1#1)(2008-10#59)(2008-11#16)(2008-12#12)(2008-2#1)(2008-3#4)(2008-5#10)(2008-6#2)(2008-7#9)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#4)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#15)(2011-3#2)(2012-12#3)(2012-2#9)(2013-1#9)(2013-7#2)(2013-8#8)
Furthermore it##2##2##(2008-11#1)(2011-2#1)
Furthermore the##9##2##(1992-5#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-9#1)(2012-12#1)
Furthermore we##2##2##(2008-11#1)(2011-2#1)
Furthermore##542##1##(1990-2#2)(1990-5#1)(1990-8#4)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#4)(1993-9#2)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#8)(1994-9#1)(1995-11#5)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#3)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-6#2)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#133)(2008-11#67)(2008-12#6)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#14)(2008-6#7)(2008-7#14)(2008-8#20)(2008-9#17)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#8)(2010-1#3)(2010-11#3)(2010-3#3)(2010-5#3)(2010-6#1)(2010-8#5)(2010-9#2)(2011-1#4)(2011-2#17)(2012-12#3)(2012-2#13)(2012-3#11)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#21)(2013-7#1)(2013-8#11)
Fusaric acid##2##2##(2008-10#2)
Fusarium Crown and Root Rot of##2##6##(2008-10#2)
Fusarium Wilt of Tomato##4##4##(2008-10#4)
Fusarium Wilt of##9##3##(2008-10#9)
Fusarium Wilt##14##2##(2008-10#14)
Fusarium and Aspergillus ear rots##2##5##(2008-10#2)
Fusarium and##4##2##(2008-10#2)(2008-5#1)(2010-5#1)
Fusarium culmorum in##2##3##(2008-10#2)
Fusarium culmorum##6##2##(2008-10#6)
Fusarium disease##2##2##(2008-10#2)
Fusarium ear and kernel rot##2##5##(2008-10#2)
Fusarium ear rot and##3##4##(2008-10#3)
Fusarium ear##5##2##(2008-10#5)
Fusarium fujikuroi culture material containing##2##5##(2008-5#2)
Fusarium fujikuroi##3##2##(2008-5#3)
Fusarium graminearum and##2##3##(2008-10#1)(2009-6#1)
Fusarium graminearum##25##2##(2008-10#21)(2009-6#1)(2010-7#1)(2011-10#2)
Fusarium graminearum)##2##2##(2008-10#2)
Fusarium head blight (FHB) caused by Fusarium graminearum##2##8##(2008-10#2)
Fusarium head blight (FHB) of wheat and barley and##2##9##(2008-10#2)
Fusarium head blight (FHB) of##3##5##(2008-10#3)
Fusarium head blight (FHB)##13##4##(2008-10#12)(2011-10#1)
Fusarium head blight index (IND##2##5##(2008-10#2)
Fusarium head blight of wheat##2##5##(2008-10#2)
Fusarium head blight were##2##4##(2008-10#2)
Fusarium head blight##24##3##(2008-10#23)(2011-10#1)
Fusarium isolates##6##2##(2008-10#6)
Fusarium moniliforme and##2##3##(2008-10#2)
Fusarium moniliforme##8##2##(2008-10#7)(2008-5#1)
Fusarium oxysporum Fo-B2##2##3##(2008-10#2)
Fusarium oxysporum Fo47 and Pseudomonas putida WCS358##2##7##(2008-10#2)
Fusarium oxysporum Fo47##4##3##(2008-10#4)
Fusarium oxysporum and F##2##4##(2008-10#2)
Fusarium oxysporum and##5##3##(2008-10#5)
Fusarium oxysporum f##76##3##(2008-10#76)
Fusarium oxysporum in##2##3##(2008-10#2)
Fusarium oxysporum##111##2##(2008-10#111)
Fusarium proliferatum##2##2##(2008-10#2)
Fusarium sambucinum##2##2##(2008-10#2)
Fusarium solani f##11##3##(2008-10#11)
Fusarium solani pisi##2##3##(1995-3#1)(2008-7#1)
Fusarium solani##14##2##(1995-3#1)(2008-10#11)(2008-7#2)
Fusarium sp##2##2##(2008-10#1)(2008-5#1)
Fusarium species was##2##3##(2008-10#2)
Fusarium species##11##2##(2008-10#11)
Fusarium spp##32##2##(2008-10#30)(2011-2#1)(2013-1#1)
Fusarium subglutinans##2##2##(2008-10#2)
Fusarium symptoms and infection##2##4##(2008-10#2)
Fusarium symptoms##3##2##(2008-10#3)
Fusarium verticillioides in##2##3##(2008-10#2)
Fusarium verticillioides##10##2##(2008-10#10)
Fusarium wilt and##2##3##(2008-10#2)
Fusarium wilt disease##3##3##(2008-10#3)
Fusarium wilt in##3##3##(2008-10#3)
Fusarium wilt of chickpea##3##4##(2008-10#3)
Fusarium wilt of tomato by##2##5##(2008-10#2)
Fusarium wilt of tomato##4##4##(2008-10#4)
Fusarium wilt of##16##3##(2008-10#16)
Fusarium wilt suppression##2##3##(2008-10#2)
Fusarium wilt symptoms##2##3##(2008-10#2)
Fusarium wilt was##3##3##(2008-10#3)
Fusarium wilt##55##2##(2008-10#55)
Fusarium##380##1##(1995-3#1)(2008-10#358)(2008-5#9)(2008-7#2)(2009-6#1)(2010-5#1)(2010-7#2)(2011-10#4)(2011-2#1)(2013-1#1)
Fusarium-selective##2##1##(2008-10#2)
Fused##2##1##(1996-5#1)(2008-10#1)
Fusicoccum sp##2##2##(2008-10#2)
Fusiform##2##1##(2008-10#1)(2008-7#1)
Fusion##19##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#6)(2013-1#2)(2013-8#1)
Fusions of##2##2##(1995-2#1)(2008-11#1)
Fusions##3##1##(1995-2#1)(2008-11#1)(2012-3#1)
Fusobacterium necrophorum##3##2##(1990-3#3)
Fusobacterium##4##1##(1990-3#3)(2008-5#1)
Futraful vs##2##2##(1997-7#2)
Future directions##3##2##(1995-1#1)(2008-11#1)(2009-3#1)
Future of##6##2##(1996-1#2)(2008-10#1)(2008-7#2)(2010-12#1)
Future research should##3##3##(2010-11#1)(2011-2#1)(2013-8#1)
Future research##6##2##(1992-9#1)(2010-11#1)(2011-2#2)(2013-8#2)
Future studies are necessary##2##4##(2009-12#1)(2012-12#1)
Future studies are##3##3##(2008-11#1)(2009-12#1)(2012-12#1)
Future studies of##2##3##(2010-5#1)(2012-3#1)
Future studies##9##2##(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
Future trends in##2##3##(2008-10#2)
Future work will##2##3##(1991-1#1)(1995-5#1)
Future work##4##2##(1991-1#1)(1995-5#1)(2008-11#1)(2010-6#1)
Future##68##1##(1991-1#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#2)(1995-1#1)(1995-5#1)(1996-1#3)(1997-2#1)(1997-3#3)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-7#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
Fuzi##2##1##(2013-1#2)
Fuzzy##7##1##(2008-10#3)(2008-8#1)(2010-8#2)(2011-2#1)
Fv fragment##4##2##(1993-8#3)(2008-10#1)
Fv##9##1##(1993-8#7)(2008-10#1)(2008-8#1)
Fyn##5##1##(1995-6#3)(2009-6#2)
Fz stimulation##3##2##(2011-2#3)
Fz##5##1##(2011-2#5)
F = 0##2##1##(2011-2#2)
G + C##2##3##(1991-6#2)
G +##3##2##(1991-6#2)(1993-6#1)
G 2M arrest##2##3##(2013-1#2)
G =##2##2##(1993-8#1)(2008-10#1)
G alpha subunit##2##3##(1993-9#2)
G alpha##4##2##(1993-9#2)(1995-6#2)
G alpha12##2##2##(1997-7#2)
G and##11##2##(1990-12#2)(1993-1#1)(1993-3#1)(1994-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2013-8#1)
G beta gamma##3##3##(1993-9#2)(1995-8#1)
G beta gamma-mediated MAP kinase activation##3##6##(1995-8#3)
G beta gamma-mediated##4##3##(1995-8#4)
G beta##8##2##(1993-9#2)(1994-2#1)(1995-8#5)
G for##4##2##(1992-9#1)(2008-10#2)(2008-3#1)
G in##3##2##(2008-10#2)(2013-1#1)
G is##3##2##(1992-9#1)(1995-6#1)(2008-10#1)
G or##3##2##(1990-12#1)(1992-12#1)(2008-10#1)
G protein alpha subunits##2##4##(1995-11#1)(1995-6#1)
G protein alpha##3##3##(1995-11#1)(1995-6#1)(1997-7#1)
G protein##25##2##(1993-6#5)(1993-8#2)(1993-9#1)(1994-3#1)(1995-11#1)(1995-6#2)(1995-8#2)(1997-1#2)(1997-2#1)(1997-7#3)(2008-9#3)(2009-12#2)
G protein-coupled receptors##3##3##(1991-5#1)(1993-6#1)(1994-12#1)
G protein-coupled##6##2##(1991-5#1)(1993-6#1)(1994-12#2)(1995-6#1)(2009-7#1)
G proteins and##3##3##(1993-1#1)(1993-9#1)(1995-6#1)
G proteins##17##2##(1993-1#1)(1993-3#1)(1993-9#2)(1995-11#3)(1995-6#5)(1995-8#1)(1997-1#1)(2008-7#1)(2008-9#2)
G response##2##2##(2008-10#1)(2013-1#1)
G to I##2##3##(2008-6#2)
G to##4##2##(1992-3#1)(2008-12#1)(2008-6#2)
G virus with##2##3##(2008-10#2)
G virus##4##2##(2008-10#4)
G was##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
G with##2##2##(2008-10#1)(2011-3#1)
G##331##1##(1990-10#2)(1990-12#7)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#7)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#5)(1993-12#1)(1993-3#2)(1993-6#7)(1993-8#9)(1993-9#7)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#6)(1995-11#7)(1995-6#17)(1995-8#9)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#4)(1997-2#1)(1997-5#2)(1997-7#5)(2007-11#1)(2008-1#1)(2008-10#116)(2008-11#7)(2008-12#5)(2008-3#3)(2008-5#2)(2008-6#7)(2008-7#6)(2008-8#2)(2008-9#14)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#5)(2010-6#1)(2010-7#4)(2010-8#5)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#9)
G(1) arrest##2##2##(2008-9#2)
G(1) cells##2##2##(2008-11#1)(2008-9#1)
G(1)##7##1##(2008-11#4)(2008-9#3)
G(2)##2##1##(2008-10#1)(2009-6#1)
G(2)/M##6##1##(2008-11#4)(2010-2#1)(2013-1#1)
G(ST) values##2##2##(2008-10#2)
G(ST)##6##1##(2008-10#6)
G(o alpha)##6##2##(1992-9#6)
G(o)##2##1##(1992-9#1)(2008-9#1)
G(o)alpha GDP##3##2##(2008-9#3)
G(o)alpha and##2##2##(2008-9#2)
G(o)alpha##9##1##(2008-9#9)
G)##5##1##(1995-6#1)(1997-2#1)(2008-12#1)(2008-8#1)(2013-1#1)
G+C##3##1##(1993-2#1)(2008-8#1)(2008-9#1)
G--&gt##2##1##(1993-6#1)(1994-12#1)
G-2##2##1##(2008-10#1)(2008-5#1)
G-CSF##4##1##(1997-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
G-II##2##1##(2012-2#2)
G-LDL exposed to Fe3+##2##4##(1991-5#2)
G-LDL##5##1##(1991-5#5)
G-actin in##3##2##(1992-3#2)(1992-4#1)
G-actin##13##1##(1992-3#2)(1992-4#10)(2011-2#1)
G-liposomal nanovesicles##9##2##(2008-10#9)
G-protein beta##2##2##(1993-9#1)(1996-2#1)
G-protein coupled membrane##2##3##(1993-6#1)(2008-11#1)
G-protein coupled receptors##3##3##(1997-1#1)(2008-11#1)(2009-3#1)
G-protein coupled##7##2##(1993-6#1)(1996-2#2)(1997-1#1)(2008-11#2)(2009-3#1)
G-protein signaling##2##2##(2009-8#1)(2012-2#1)
G-protein##17##1##(1991-5#1)(1993-6#1)(1993-9#1)(1996-2#5)(1997-1#1)(2008-11#2)(2008-8#1)(2009-3#1)(2009-8#1)(2012-2#2)(2013-8#1)
G-protein-coupled receptors##2##2##(1995-8#1)(1996-2#1)
G-protein-coupled##5##1##(1994-11#1)(1995-11#1)(1995-8#1)(1996-2#2)
G-proteins was##2##2##(1993-8#1)(1997-2#1)
G-proteins##6##1##(1991-5#1)(1992-6#1)(1993-8#1)(1996-2#1)(1997-2#1)(2013-1#1)
G/A polymorphism##4##2##(2008-10#1)(2011-2#3)
G/A##6##1##(2008-10#3)(2011-2#3)
G069##2##1##(2008-9#2)
G1 and##5##2##(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)
G1 arrest##5##2##(1996-3#1)(1997-7#1)(2008-11#2)(2009-9#1)
G1 cell cycle##3##3##(2008-11#2)(2011-2#1)
G1 cyclin##3##2##(1992-10#1)(1994-11#2)
G1 phase in##2##3##(1993-8#1)(2008-11#1)
G1 phase##12##2##(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1997-1#1)(2008-11#4)(2008-8#1)(2009-8#1)
G1 to S##3##3##(1994-5#1)(2008-11#1)(2011-2#1)
G1 to##4##2##(1994-5#1)(2008-11#2)(2011-2#1)
G1##46##1##(1991-5#1)(1992-10#2)(1993-3#1)(1993-8#2)(1994-11#4)(1994-3#1)(1994-5#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#6)(2008-11#11)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#2)(2013-1#1)
G1-phase##4##1##(1997-1#1)(2008-11#1)(2008-7#2)
G1/G2 ORF##2##2##(2008-10#2)
G1/G2##5##1##(2008-10#5)
G1/S##8##1##(1993-8#1)(1997-1#4)(1997-7#3)
G1181C##2##1##(2013-1#2)
G12 coupled thrombin receptor##2##4##(1997-7#2)
G12##10##1##(1994-5#1)(1997-7#7)(2008-10#2)
G12(pGT-trp)##3##1##(2008-10#3)
G123##2##1##(2008-10#2)
G19833##2##1##(2013-8#2)
G2 and##2##2##(2013-1#2)
G2 phase##3##2##(1996-3#1)(2008-8#2)
G2##21##1##(1994-3#1)(1994-5#1)(1995-6#2)(1996-3#2)(1997-3#2)(2008-10#3)(2008-11#4)(2008-8#2)(2008-9#1)(2013-1#3)
G2)##2##1##(1997-1#1)(2008-10#1)
G2/M =##2##2##(1994-3#2)
G2/M##8##1##(1994-3#2)(2008-11#4)(2008-8#2)
G3##6##1##(1995-6#1)(2011-2#1)(2012-3#1)(2013-1#3)
G3OH##4##1##(1990-9#4)
G4##9##1##(1991-7#3)(2008-10#2)(2013-1#4)
G418##9##1##(2008-11#9)
G418-resistance##2##1##(1997-8#1)(2008-11#1)
G418-resistant##2##1##(1996-6#1)(1997-8#1)
G4T4##2##1##(1991-7#2)
G5-##2##1##(1995-11#2)
G6 and##2##2##(2008-10#2)
G6##4##1##(2008-10#4)
G6PD deficiency##5##2##(1991-2#1)(2007-12#3)(2013-8#1)
G6PD gene##2##2##(1991-6#2)
G6PD##7##1##(1991-2#1)(1991-6#2)(2007-12#3)(2013-8#1)
G832##2##1##(2008-7#2)
G93##2##1##(1995-6#2)
GA and##2##2##(2008-10#1)(2013-1#1)
GA were##2##2##(2008-10#1)(2010-7#1)
GA##17##1##(1993-3#1)(2008-10#8)(2008-9#2)(2009-8#2)(2010-7#1)(2012-12#1)(2013-1#2)
GA(3)##2##1##(2008-8#2)
GABA in##2##2##(1995-2#1)(2008-7#1)
GABA release in##2##3##(1992-12#1)(2010-12#1)
GABA##32##1##(1992-12#2)(1992-3#5)(1994-2#2)(1995-11#2)(1995-2#1)(1996-12#2)(1997-2#5)(2008-7#3)(2008-8#6)(2008-9#3)(2010-12#1)
GABA(A) antagonist##2##2##(2008-7#1)(2008-8#1)
GABA(A) receptor##2##2##(2008-9#1)(2012-2#1)
GABA(A) receptor-mediated inhibition##2##3##(2011-2#2)
GABA(A) receptors##3##2##(2008-8#3)
GABA(A)##11##1##(1997-2#1)(2008-7#1)(2008-8#4)(2008-9#2)(2011-2#2)(2012-2#1)
GABA(C)##2##1##(2008-9#2)
GABA-immunoreactive boutons##2##2##(1997-2#2)
GABA-immunoreactive##4##1##(1994-2#1)(1997-2#3)
GABAA receptor gamma 2 subunit subtype##2##6##(1995-11#2)
GABAA receptor gamma 2 subunit##3##5##(1995-11#2)(1995-12#1)
GABAA receptor subunit##2##3##(1996-12#2)
GABAA receptor##9##2##(1995-11#6)(1995-12#1)(1996-12#2)
GABAA receptors##5##2##(1995-11#3)(1995-12#2)
GABAA##18##1##(1990-5#1)(1995-11#11)(1995-12#3)(1996-12#2)(2008-7#1)
GABAB receptor##2##2##(1990-5#1)(2013-8#1)
GABAB receptors##3##2##(1992-3#1)(2008-7#1)(2013-8#1)
GABAB##6##1##(1990-5#1)(1992-3#1)(1995-11#1)(2008-7#1)(2013-8#2)
GABABR##2##1##(2013-8#2)
GABAergic and dopaminergic##2##3##(1994-2#2)
GABAergic inhibition##3##2##(2011-2#1)(2013-8#2)
GABAergic interneurons##3##2##(2008-7#1)(2009-8#1)(2013-8#1)
GABAergic neurons in the##2##4##(1994-2#1)(1996-12#1)
GABAergic neurons##3##2##(1994-2#1)(1996-12#1)(2013-8#1)
GABAergic synaptic inhibition##2##3##(2008-7#2)
GABAergic synaptic##3##2##(1995-2#1)(2008-7#2)
GABAergic##18##1##(1990-5#1)(1994-2#3)(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-7#4)(2009-8#1)(2011-2#1)(2013-8#4)
GAC##5##1##(2008-10#5)
GAD67 mRNA levels in the##2##5##(1996-12#2)
GAD67 mRNA##3##2##(1996-12#3)
GAD67##6##1##(1996-12#4)(2013-8#2)
GADD34 and##2##2##(2012-2#2)
GAI##2##1##(2008-10#1)(2010-6#1)
GAL gene expression in##2##4##(1996-12#2)
GAL##3##1##(1996-12#3)
GAL-based##2##1##(1993-12#2)
GAL10 promoter##2##2##(1993-12#1)(1996-3#1)
GAL10##3##1##(1993-12#1)(1993-9#1)(1996-3#1)
GALA##2##1##(1994-5#2)
GAP information##3##2##(2013-1#3)
GAP##12##1##(2008-6#1)(2009-3#1)(2013-1#10)
GAP-43 is##3##2##(1994-2#1)(2008-7#2)
GAP-43##29##1##(1994-2#7)(2008-7#13)(2008-9#9)
GAPDH is##2##2##(1993-6#2)
GAPDH##9##1##(1993-6#4)(1994-5#5)
GARS##5##1##(1993-12#5)
GART##3##1##(1993-12#2)(1997-8#1)
GAS##2##1##(2008-11#1)(2008-8#1)
GASPIDs##6##1##(2008-6#6)
GATA##5##1##(1995-2#1)(2008-9#1)(2012-2#2)(2012-3#1)
GATA-1##5##1##(1997-8#1)(2008-9#4)
GATA-a##4##1##(2012-2#4)
GAmyb##4##1##(2008-8#4)
GB stone##3##2##(2013-8#3)
GB stones##5##2##(2013-8#5)
GB virus C##2##3##(2008-10#2)
GB virus##4##2##(2008-10#4)
GB##17##1##(1993-2#1)(2008-10#6)(2013-1#2)(2013-8#8)
GB03 (Bacillus subtilis)##2##3##(2008-10#2)
GB03 and##2##2##(2008-10#2)
GB03##7##1##(2008-10#7)
GBC##5##1##(2008-10#3)(2010-12#2)
GBM cells##6##2##(2011-2#6)
GBM##8##1##(2011-2#8)
GBMT##3##1##(1994-8#3)
GBP##5##1##(1992-6#3)(2008-10#2)
GBS##6##1##(2008-7#1)(2012-3#5)
GBW 07401##2##2##(2008-10#2)
GBW##9##1##(2008-10#9)
GBW07401##3##1##(2008-10#3)
GC COHb concentrations##2##3##(1996-12#2)
GC COHb##3##2##(1996-12#3)
GC analysis of acidic##2##4##(2008-10#2)
GC analysis##3##2##(2008-10#3)
GC and GC/MS##4##3##(2008-11#2)(2008-12#2)
GC and SHMT##2##3##(1997-1#2)
GC and##10##2##(1997-1#2)(2008-11#2)(2008-12#2)(2012-2#1)(2013-1#3)
GC column##2##2##(2008-10#2)
GC content##3##2##(1997-2#1)(2012-2#1)(2012-3#1)
GC coupled to##2##3##(2008-10#1)(2013-8#1)
GC electrode##7##2##(2008-10#7)
GC excess##2##2##(2008-7#2)
GC injection port##2##3##(2008-10#2)
GC injector##2##2##(2008-10#2)
GC neurons##4##2##(2008-11#4)
GC rich##3##2##(1993-3#2)(2008-12#1)
GC x##3##2##(2008-10#3)
GC##85##1##(1993-3#2)(1994-5#1)(1995-12#2)(1996-11#1)(1996-12#3)(1997-1#2)(1997-2#1)(2008-10#46)(2008-11#6)(2008-12#3)(2008-4#1)(2008-7#2)(2009-8#2)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#1)
GC-EAD responses##2##2##(2008-10#2)
GC-EAD##5##1##(2008-10#5)
GC-ECD and##2##2##(2008-10#2)
GC-ECD for##2##2##(2008-10#2)
GC-ECD method##3##2##(2008-10#3)
GC-ECD##8##1##(2008-10#8)
GC-FID##8##1##(2008-10#8)
GC-HRMS##15##1##(2008-10#15)
GC-IDTOFMS##2##1##(2008-10#2)
GC-LRMS/MS##2##1##(2008-10#2)
GC-MS analysis##6##2##(2008-10#5)(2008-5#1)
GC-MS and##2##2##(2008-11#1)(2011-2#1)
GC-MS as##2##2##(2008-10#2)
GC-MS data##2##2##(2008-10#1)(2008-11#1)
GC-MS##45##1##(1991-5#1)(1997-1#1)(2008-10#32)(2008-11#4)(2008-5#2)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#1)
GC-TEA##2##1##(2008-5#2)
GC-rich and##2##2##(1997-6#1)(2008-12#1)
GC-rich##5##1##(1991-7#1)(1997-6#1)(2008-12#3)
GC/ECD and##2##2##(2008-10#1)(2008-11#1)
GC/ECD##7##1##(2008-10#5)(2008-11#2)
GC/EI-MS/ICP-MS##2##1##(2010-11#2)
GC/FID##5##1##(2008-10#4)(2008-11#1)
GC/MS and##4##2##(2008-10#3)(2008-12#1)
GC/MS data##3##2##(2008-10#3)
GC/MS in##2##2##(2008-10#1)(2008-11#1)
GC/MS method##4##2##(2008-10#4)
GC/MS methods##2##2##(2008-10#2)
GC/MS with##2##2##(2008-10#2)
GC/MS##39##1##(1995-2#1)(2008-10#30)(2008-11#5)(2008-12#3)
GC/MS/MS##3##1##(2008-10#3)
GC/PCI/MS##3##1##(2008-10#3)
GC/PCI/MS/MS##4##1##(2008-10#4)
GC7##8##1##(1997-1#8)
GCE and##2##2##(2008-10#2)
GCE##13##1##(2008-10#11)(2013-1#2)
GCG##5##1##(2008-4#3)(2013-1#2)
GCN4 motif in##2##3##(2008-9#2)
GCN4 motif##4##2##(2008-9#4)
GCN4##5##1##(2008-9#5)
GCP##3##1##(1991-3#3)
GCS##5##1##(2009-5#1)(2011-2#3)(2013-1#1)
GCV##3##1##(1992-10#1)(2013-2#2)
GCX##2##1##(2011-2#2)
GCs on##2##2##(2008-11#2)
GCs##5##1##(2008-11#5)
GCxGC/TOFMS##2##1##(2008-10#2)
GD##4##1##(2008-10#1)(2010-2#1)(2013-1#2)
GD12 and##2##2##(2013-8#2)
GD12##9##1##(2013-8#9)
GD2##3##1##(2008-10#3)
GDC treatment##2##2##(1997-3#2)
GDC##8##1##(1997-3#2)(1997-6#4)(2008-7#2)
GDCs##5##1##(1996-9#4)(1997-6#1)
GDH##10##1##(1993-9#4)(2008-10#1)(2008-4#1)(2008-8#4)
GDI and##2##2##(2013-1#2)
GDI##4##1##(2013-1#4)
GDM##2##1##(2008-1#2)
GDME##3##1##(2008-10#3)
GDP##16##1##(1991-2#1)(1991-5#2)(1993-3#1)(1993-8#2)(1995-6#1)(1995-8#1)(1996-2#2)(2008-11#1)(2008-9#4)(2013-8#1)
GDP-ribosyl cyclase activity##2##3##(1994-11#2)
GDP/GTP exchange##3##2##(1995-6#2)(2008-9#1)
GDP/GTP##4##1##(1993-11#1)(1995-6#2)(2008-9#1)
GE activity##4##2##(1990-2#4)
GE##7##1##(1990-2#5)(2013-1#2)
GE7 gene delivery system##2##4##(2008-8#2)
GE7##6##1##(2008-8#6)
GEF##3##1##(1995-8#2)(2008-10#1)
GENE##2##1##(2010-1#1)(2012-3#1)
GENETIC TOXICOLOGY##2##2##(2008-9#2)
GENETIC##4##1##(1997-5#1)(2008-9#2)(2012-3#1)
GEP##4##1##(2008-10#2)(2009-8#1)(2010-1#1)
GEPR##5##1##(1996-12#5)
GEPR-3 and GEPR-9##3##3##(1996-12#3)
GEPR-3 compared to SD rats and GEPR-9##3##7##(1996-12#3)
GEPR-3 compared to##4##3##(1996-12#4)
GEPR-3##11##1##(1996-12#11)
GEPR-9##10##1##(1996-12#10)
GERD##5##1##(2010-12#3)(2011-2#2)
GF##2##1##(1997-7#1)(2008-10#1)
GF-AAS##4##1##(2008-10#4)
GFAAS determination of##2##3##(2008-10#2)
GFAAS determination##6##2##(2008-10#6)
GFAAS through the##2##3##(2008-10#2)
GFAAS##23##1##(2008-10#23)
GFAP and##4##2##(2008-11#1)(2008-7#3)
GFAP mRNA levels##2##3##(1997-3#2)
GFAP mRNA##3##2##(1997-3#3)
GFAP##19##1##(1990-7#5)(1997-2#2)(1997-3#5)(2008-11#2)(2008-7#3)(2011-2#2)
GFD##4##1##(2011-2#4)
GFLV RNA-2##3##2##(2008-10#3)
GFLV isolates##2##2##(2008-10#2)
GFLV##8##1##(2008-10#8)
GFP and##2##2##(2008-11#1)(2008-7#1)
GFP as a reporter##2##4##(2008-4#1)(2008-9#1)
GFP as a##3##3##(1996-6#1)(2008-4#1)(2008-9#1)
GFP could be##2##3##(2008-11#1)(2008-8#1)
GFP expression##3##2##(1996-6#1)(2008-11#1)(2008-9#1)
GFP fluorescence and##3##3##(2008-11#1)(2008-9#2)
GFP fluorescence##5##2##(2008-11#1)(2008-9#4)
GFP was an##2##3##(2008-10#1)(2008-7#1)
GFP was##5##2##(1996-6#1)(2008-10#1)(2008-7#1)(2008-8#2)
GFP##50##1##(1996-6#5)(2008-10#5)(2008-11#14)(2008-4#3)(2008-7#4)(2008-8#4)(2008-9#12)(2011-2#2)(2011-3#1)
GG##3##1##(2008-10#1)(2009-12#2)
GG12##2##1##(2008-10#2)
GGA##4##1##(1993-3#3)(2008-10#1)
GGGTCAT##2##1##(1993-12#2)
GGMs##2##1##(2013-1#2)
GGO##2##1##(1997-6#2)
GGPP##2##1##(2008-8#2)
GGR rates##2##2##(2008-11#2)
GGR##3##1##(2008-11#3)
GGT##4##1##(2006-6#1)(2009-6#2)(2009-8#1)
GH and IGF-I##5##3##(2010-5#3)(2012-3#2)
GH and##9##2##(2010-5#5)(2012-3#3)(2013-1#1)
GH concentrations##2##2##(2010-5#1)(2013-1#1)
GH in circulation)##2##3##(2011-1#2)
GH pulse frequency##2##3##(2013-1#2)
GH pulse##3##2##(2013-1#3)
GH pulses##2##2##(1997-2#1)(2013-1#1)
GH receptor and##3##3##(1996-2#3)
GH receptor mRNA##2##3##(1996-2#2)
GH receptor##6##2##(1995-8#1)(1996-2#5)
GH release##5##2##(1994-8#5)
GH replacement##2##2##(1996-11#2)
GH secretion##4##2##(1991-9#2)(1997-2#2)
GH treatment##3##2##(1995-12#1)(1995-8#2)
GH##73##1##(1991-6#2)(1991-9#2)(1994-8#6)(1995-11#1)(1995-12#5)(1995-8#6)(1996-11#6)(1996-2#7)(1997-2#4)(2008-9#1)(2010-5#15)(2011-1#3)(2012-3#5)(2013-1#10)
GH-transgenic##2##1##(2010-5#2)
GH3 cells##4##2##(1992-8#3)(1996-2#1)
GH3##7##1##(1992-8#4)(1993-8#2)(1996-2#1)
GH4C1##3##1##(1991-6#3)
GHD##7##1##(2011-1#3)(2012-3#4)
GHF##5##1##(2011-2#5)
GHPSAM is##2##2##(2008-10#2)
GHPSAM##4##1##(2008-10#4)
GHQ-12##2##1##(2008-11#2)
GHR and IGF-I gene expression##2##5##(2008-9#2)
GHR and IGF-I##3##3##(2008-9#3)
GHR##7##1##(2008-9#4)(2010-5#3)
GHR1 and GHR2##2##3##(2010-5#2)
GHR1 expression##2##2##(1995-8#2)
GHR1 mRNA##3##2##(1995-8#3)
GHR1##9##1##(1995-8#7)(2010-5#2)
GHz and##3##2##(2007-11#2)(2007-12#1)
GHz##10##1##(2007-11#2)(2007-12#2)(2008-3#4)(2008-6#1)(2009-5#1)
GI and GII norovirus##3##4##(2013-8#3)
GI diagnoses##2##2##(2008-11#2)
GI drug##2##2##(2008-11#2)
GI is##3##2##(2008-1#3)
GI malabsorption and maldigestion##2##4##(2011-2#2)
GI tract##2##2##(2009-12#1)(2009-8#1)
GI##29##1##(2008-1#6)(2008-10#2)(2008-11#7)(2009-12#1)(2009-8#1)(2011-2#5)(2012-12#1)(2012-3#3)(2013-8#3)
GIB Laboratories##2##2##(1997-2#2)
GIB##3##1##(1997-2#3)
GINV could##2##2##(2008-10#2)
GINV##9##1##(2008-10#9)
GIP gene##4##2##(1995-11#4)
GIP mRNA##2##2##(1995-11#2)
GIP transcripts##2##2##(1995-11#2)
GIP##17##1##(1995-11#12)(1997-4#5)
GIP(1-42)##3##1##(1997-4#3)
GIP(10-30)##2##1##(1997-4#2)
GIP(6-30amide)##5##1##(1997-4#5)
GIS##3##1##(2008-11#1)(2008-12#2)
GISH##3##1##(2008-8#2)(2008-9#1)
GIST was##3##2##(2009-7#2)(2012-12#1)
GIST##13##1##(2009-7#3)(2012-12#2)(2012-3#6)(2013-1#2)
GISTs##5##1##(2012-12#1)(2012-3#3)(2013-1#1)
GIT##4##1##(2008-12#2)(2012-2#1)(2013-1#1)
GL##3##1##(2008-8#1)(2010-1#1)(2011-2#1)
GLC and##2##2##(2008-10#1)(2008-11#1)
GLG6##4##1##(1990-12#4)
GLI2##2##1##(2013-1#2)
GLN##2##1##(1990-7#2)
GLP##4##1##(1995-8#4)
GLP-1 and##2##2##(1994-8#1)(2011-2#1)
GLP-1 concentrations##2##2##(2012-3#2)
GLP-1 could##2##2##(1995-8#2)
GLP-1##20##1##(1994-8#1)(1995-8#6)(1996-2#6)(2009-10#1)(2011-2#4)(2012-3#2)
GLRaV-3##2##1##(2008-10#2)
GLRaV-4##2##1##(2008-10#2)
GLRaV-5##7##1##(2008-10#7)
GLS resistance##3##2##(2008-10#3)
GLS severity##3##2##(2008-10#3)
GLS##13##1##(2008-10#13)
GLT-1##4##1##(1996-2#2)(2008-7#2)
GLUT 2 in##2##3##(1994-2#2)
GLUT 2##4##2##(1994-2#4)
GLUT family##2##2##(2008-7#2)
GLUT##8##1##(1994-2#5)(2008-5#1)(2008-7#2)
GLUT4 translocation is##2##3##(1994-11#2)
GLUT4 translocation##4##2##(1994-11#4)
GLUT4##7##1##(1994-11#4)(1994-8#2)(2008-11#1)
GLX-I##3##1##(2008-10#3)
GM modified PLGA particles##3##4##(2009-7#3)
GM##9##1##(2008-11#1)(2008-8#2)(2009-7#3)(2011-2#1)(2012-4#2)
GM-CSF and##3##2##(1994-11#1)(2006-6#1)(2008-11#1)
GM-CSF gene-modified and tumor antigen-pulsed macrophages##2##6##(2008-8#2)
GM-CSF gene-modified##3##2##(2008-8#3)
GM-CSF##13##1##(1994-11#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#6)(2008-9#1)
GM1 (30 mg/kg)##2##3##(1993-3#2)
GM1 antibody##2##2##(2008-10#2)
GM1##8##1##(1990-5#2)(1993-3#3)(2008-10#2)(2010-8#1)
GM3##8##1##(1990-5#4)(1991-5#2)(2012-3#2)
GM4##3##1##(2008-10#3)
GMI1000##3##1##(2008-10#3)
GMP##10##1##(1992-8#2)(1994-11#1)(1995-11#2)(2008-11#4)(2012-2#1)
GN##3##1##(1997-8#2)(2008-10#1)
GNAS mutations in##2##3##(2012-2#2)
GNAS mutations##4##2##(2012-2#4)
GNAS##7##1##(2011-1#1)(2012-2#6)
GNPs##3##1##(1991-1#3)
GNR##2##1##(2010-1#2)
GNRs##6##1##(2010-1#2)(2012-12#4)
GO consists of##2##3##(2013-1#2)
GO terms##3##2##(2010-4#1)(2011-2#2)
GO##12##1##(1997-7#1)(2008-9#3)(2010-1#1)(2010-4#2)(2011-2#2)(2013-1#3)
GOX##4##1##(2008-10#4)
GOx##6##1##(2008-10#6)
GP 34##3##2##(2008-10#3)
GP Ia##3##2##(2006-6#3)
GP##13##1##(1990-6#1)(1994-12#1)(1997-4#1)(2006-6#3)(2008-10#3)(2008-11#1)(2011-2#2)(2013-1#1)
GPC5##3##1##(2012-3#3)
GPCRs##2##1##(1995-8#1)(2012-2#1)
GPDH##3##1##(2008-11#3)
GPI##12##1##(1990-8#2)(1994-3#1)(1995-2#4)(1996-3#2)(1997-6#3)
GPI-anchored ALP derived from##2##4##(2008-11#2)
GPI-anchored ALP##3##2##(2008-11#3)
GPI-anchored##4##1##(2008-11#4)
GPIIIa##5##1##(2006-6#5)
GPIIb-IIIa and fibrinogen##2##3##(2006-6#2)
GPIIb-IIIa##4##1##(2006-6#4)
GPIIb/IIIa##2##1##(1993-3#1)(2008-5#1)
GPIs##3##1##(2013-8#3)
GPNMB##5##1##(2009-4#5)
GPO##2##1##(2008-10#2)
GPR54##2##1##(2009-6#2)
GPT##2##1##(2008-11#1)(2013-1#1)
GPX##5##1##(1990-3#2)(2008-10#3)
GPa##4##1##(1994-2#1)(2009-7#3)
GPs as##3##2##(1997-4#1)(2008-10#2)
GPs##8##1##(1994-12#2)(1997-4#1)(2008-10#2)(2008-11#1)(2011-2#2)
GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants##3##12##(1997-8#3)
GR had##2##2##(2010-2#1)(2011-2#1)
GR in##2##2##(1994-2#2)
GR##23##1##(1994-2#6)(1997-4#1)(2008-11#2)(2008-8#2)(2009-8#3)(2010-2#1)(2011-2#7)(2013-7#1)
GRAV##7##1##(2008-10#7)
GRE##4##1##(1993-6#1)(1997-8#3)
GRF##2##1##(1991-9#2)
GRF-antagonist##4##1##(1991-9#4)
GRH##3##1##(1992-6#3)
GRNN##4##1##(2008-10#4)
GRP##6##1##(1992-6#6)
GRP1 PH domain##2##3##(2009-7#2)
GRP1##3##1##(2009-7#3)
GRPR##7##1##(1996-12#2)(2010-6#5)
GRSV##2##1##(2008-10#2)
GRV isolates##3##2##(2008-10#3)
GRV##6##1##(2008-10#6)
GS 58##2##2##(2008-10#2)
GS is##2##2##(2008-8#1)(2011-2#1)
GS##18##1##(1993-12#1)(2008-10#7)(2008-11#4)(2008-8#2)(2010-8#1)(2011-2#3)
GS-4104##8##1##(2008-5#8)
GS-NS0##2##1##(2008-11#2)
GS-X pump##3##2##(2008-11#3)
GSC##4##1##(2008-10#1)(2011-2#3)
GSG1##6##1##(1995-9#6)
GSH and##3##2##(2008-10#3)
GSH as##2##2##(1990-12#1)(2012-3#1)
GSH concentration in##2##3##(2008-10#1)(2010-5#1)
GSH concentrations##2##2##(1990-2#1)(2008-7#1)
GSH content##3##2##(2008-10#1)(2008-7#2)
GSH depletion##4##2##(1994-8#1)(2008-7#3)
GSH in the##3##3##(1990-2#2)(2008-10#1)
GSH in##7##2##(1990-2#2)(2008-10#4)(2008-7#1)
GSH level of normal##2##4##(1990-2#2)
GSH levels of##2##3##(1990-2#1)(2012-3#1)
GSH levels##3##2##(1990-2#1)(2010-5#1)(2012-3#1)
GSH metabolism##2##2##(2008-11#1)(2008-7#1)
GSH plays##2##2##(1990-2#1)(1991-8#1)
GSH transporter##4##2##(1995-2#4)
GSH values##2##2##(1990-2#2)
GSH was##3##2##(1990-2#1)(2008-10#2)
GSH were##2##2##(2008-10#2)
GSH##70##1##(1990-12#2)(1990-2#14)(1991-5#1)(1991-8#1)(1992-12#2)(1993-8#2)(1994-8#1)(1995-2#6)(2008-10#20)(2008-11#2)(2008-7#9)(2010-5#4)(2011-3#1)(2012-3#2)(2013-1#3)
GSH+insulin##2##1##(2012-2#2)
GSI##2##1##(1994-3#2)
GSK3β activity##2##2##(2012-2#2)
GSM##6##1##(2008-9#4)(2009-6#2)
GSP##2##1##(2010-2#2)
GSR##5##1##(2012-2#5)
GSSG##2##1##(2008-10#2)
GST P subunit##2##3##(1990-2#2)
GST P##5##2##(1990-2#5)
GST activity##4##2##(1992-6#1)(1995-6#1)(2011-10#2)
GST pi##2##2##(1990-2#2)
GST was##2##2##(1995-6#1)(2010-5#1)
GST##22##1##(1990-2#8)(1992-6#1)(1993-2#1)(1994-2#1)(1995-6#4)(2008-8#1)(2008-9#1)(2010-5#2)(2011-10#3)
GST-P##2##1##(1992-6#2)
GST-lambdaN##2##1##(2008-9#2)
GST-mu##3##1##(1995-6#3)
GSTT (100##3##2##(2011-3#3)
GSTT##5##1##(2011-3#5)
GSTs##2##1##(1990-2#2)
GT families##3##2##(2006-6#1)(2009-10#2)
GT genes##2##2##(2009-10#2)
GT##15##1##(2006-6#4)(2008-5#2)(2009-10#7)(2011-2#1)(2013-1#1)
GTH-II and GH release##4##4##(1994-8#4)
GTH-II and GH##5##3##(1994-8#5)
GTH-II release##3##2##(1994-8#3)
GTH-II##8##1##(1994-8#8)
GTN##3##1##(2008-8#3)
GTP analogue##2##2##(1991-6#1)(1995-11#1)
GTP and##4##2##(1991-5#2)(1995-6#1)(1997-1#1)
GTP gamma S binding##2##4##(1993-8#2)
GTP gamma S##12##3##(1991-6#2)(1992-8#2)(1993-8#4)(1995-8#4)
GTP gamma##15##2##(1991-6#3)(1992-8#2)(1993-8#5)(1994-3#1)(1995-8#4)
GTP in##2##2##(1995-6#1)(1995-8#1)
GTP##34##1##(1991-5#2)(1991-6#4)(1992-8#2)(1993-6#1)(1993-8#5)(1994-3#2)(1995-11#1)(1995-2#1)(1995-6#4)(1995-8#6)(1996-2#1)(1997-1#1)(1997-7#1)(2008-11#2)(2008-4#1)
GTP-binding protein##7##2##(1992-8#2)(1993-8#2)(1994-11#1)(1995-11#1)(1995-8#1)
GTP-binding proteins##7##2##(1992-3#2)(1993-3#1)(1994-11#1)(1994-6#1)(1995-8#1)(1997-1#1)
GTP-binding##17##1##(1992-3#2)(1992-8#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-6#1)(1995-11#2)(1995-8#2)(1997-1#1)(2008-7#1)
GTPase activity##6##2##(1993-8#1)(1995-11#5)
GTPase##15##1##(1993-8#1)(1995-11#5)(1995-2#1)(1996-6#1)(2008-9#1)(2009-8#1)(2011-2#5)
GTPases##11##1##(1995-8#2)(1997-7#1)(2008-11#2)(2008-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
GTPgammaS binding##3##2##(2008-11#1)(2008-9#2)
GTPgammaS##5##1##(1996-2#1)(2008-11#1)(2008-9#3)
GTaS##2##1##(2013-8#2)
GTs are##2##2##(2009-10#2)
GTs##7##1##(2008-10#2)(2009-10#5)
GUS activity of the##2##4##(2008-8#1)(2008-9#1)
GUS activity of transgenic plants##2##5##(2008-8#1)(2008-9#1)
GUS activity of##6##3##(2008-8#2)(2008-9#4)
GUS activity was##3##3##(2008-10#3)
GUS activity##15##2##(2008-10#7)(2008-8#2)(2008-9#6)
GUS expression##3##2##(2008-10#3)
GUS histochemical##2##2##(2008-9#2)
GUS##31##1##(2008-10#18)(2008-11#1)(2008-8#3)(2008-9#9)
GUS-expressing transformants 398D97 and 8036E27##2##5##(2008-10#2)
GUS-expressing transformants##3##2##(2008-10#3)
GUT6##3##1##(2008-10#3)
GV than to##2##3##(2008-10#2)
GV##6##1##(2008-10#4)(2008-9#1)(2013-1#1)
GVG##3##1##(1991-12#3)
GW scale##2##2##(2009-11#2)
GW##6##1##(2008-9#2)(2009-11#3)(2011-2#1)
GWSS##2##1##(2008-10#2)
GYD##2##1##(2008-8#2)
Ga and##2##2##(2008-10#2)
Ga##11##1##(1997-3#1)(2008-10#10)
Ga(3+)##6##1##(2008-10#6)
Ga(III) and Ti(IV) ions##2##4##(2008-10#2)
Ga(III) and Ti(IV)##3##3##(2008-10#3)
Ga(III) and##4##2##(2008-10#4)
Ga(III)##8##1##(2008-10#8)
Ga2##2##1##(1990-5#2)
GaAs##16##1##(1990-12#1)(1994-2#1)(1996-9#1)(2007-12#1)(2008-2#4)(2008-3#8)
GaAs/AlGaAs quantum-cascade lasers##2##3##(2008-3#2)
GaAs/AlGaAs##3##1##(1992-11#1)(2008-3#2)
GaInAsP##2##1##(2008-3#2)
GaN##4##1##(2008-3#3)(2010-7#1)
Gadd45##4##1##(2008-9#4)
Gadd45(as)/MCF-7##3##1##(2008-9#3)
Gaeumannomyces graminis var##5##3##(2008-10#5)
Gag and##4##2##(2011-3#4)
Gag##6##1##(2009-7#1)(2011-3#5)
Gag-Pol##2##1##(2011-3#2)
Gail and Claus models##2##4##(1995-9#2)
Gail##3##1##(1993-12#1)(1995-9#2)
Gain##3##1##(2008-10#1)(2008-3#2)
Gain-of-function##2##1##(2008-4#1)(2009-8#1)
Gait##6##1##(1993-12#1)(2008-12#1)(2008-7#1)(2013-1#3)
Gal(beta1-4)GlcNAc-R##2##1##(2008-11#2)
Gal4##3##1##(1995-6#1)(2008-9#1)(2010-1#1)
GalCer##3##1##(2008-11#3)
GalN/LPS-treated##2##1##(1994-8#2)
GalNAc##2##1##(1992-10#2)
GalNAc-transferase##2##1##(1992-10#2)
Gala##2##1##(2008-10#2)
Galaxias brevipinnis##2##2##(2010-8#2)
Galaxias maculatus and##2##3##(2010-8#2)
Galaxias##4##1##(2010-8#4)
Galectin-3 is a##2##3##(2009-3#2)
Galicia (Spain)##2##2##(2008-10#2)
Galicia##4##1##(2008-10#4)
Galician##5##1##(2008-10#5)
Gall##2##1##(2008-10#1)(2009-8#1)
Gallbladder sludge##2##2##(2012-3#2)
Gallbladder##4##1##(1995-11#1)(2012-3#2)(2013-8#1)
Galleria##2##1##(2008-10#1)(2008-5#1)
Gallic acid (GA)##2##3##(2008-10#2)
Gallium##5##1##(2008-10#5)
Gallstone##3##1##(1990-9#1)(2008-12#2)
Galpha##2##1##(2009-7#2)
Galveston technique##2##2##(2008-12#2)
Galveston##4##1##(2008-12#4)
Gambia##2##1##(1996-11#1)(1997-7#1)
Gambling##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
Gambro Engström Edith##3##3##(1992-2#3)
Game theory##2##2##(2012-3#2)
Game##6##1##(2009-10#1)(2010-1#1)(2012-3#3)(2013-1#1)
Games##2##1##(1993-3#1)(1996-2#1)
Gamma Knife##4##2##(1997-4#3)(2012-3#1)
Gamma knife##2##2##(1996-3#1)(2011-2#1)
Gamma##9##1##(1996-3#1)(1997-4#3)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
Gamma-aminobutyric acid##2##2##(2008-8#1)(2011-2#1)
Gammamed plus vaginal cylinders##2##4##(2009-2#2)
Ganglion##2##1##(2011-2#1)(2013-8#1)
Ganglioside##3##1##(1990-5#1)(1991-5#1)(2012-3#1)
Gao##2##1##(2008-10#2)
Gap##2##1##(2008-7#1)(2012-12#1)
Gaps were identified and risks mitigated to assure robustness of the proposed framework##2##13##(2012-2#2)
Gaps##4##1##(1996-9#1)(2012-12#1)(2012-2#2)
Gardenswartz and##2##2##(1994-12#2)
Gardner-Diamond syndrome##2##2##(2008-11#2)
Garlic##2##1##(2008-9#1)(2012-2#1)
Gas chromatographic##5##2##(2008-10#4)(2008-11#1)
Gas chromatography##6##2##(1991-12#1)(2008-10#4)(2008-5#1)
Gas chromatography-mass##2##2##(1997-1#1)(2013-1#1)
Gas chromatography-olfactometry##2##2##(2008-10#2)
Gas##30##1##(1991-12#1)(1997-1#2)(2008-10#17)(2008-11#2)(2008-3#4)(2008-5#2)(2012-2#1)(2013-1#1)
Gaseous##4##1##(2008-10#4)
Gases##5##1##(1996-9#2)(2008-3#2)(2013-1#1)
Gasterosteus aculeatus##2##2##(2010-8#2)
Gastric acid secretion in##2##4##(1993-12#2)
Gastric acid secretion##3##3##(1993-12#2)(1997-1#1)
Gastric cancer##4##2##(1990-9#1)(2010-12#1)(2012-12#2)
Gastric##18##1##(1990-9#1)(1993-12#2)(1995-11#1)(1995-6#1)(1997-1#4)(2008-11#2)(2008-12#2)(2010-12#1)(2010-8#1)(2012-12#2)(2013-1#1)
Gastro-hep news##2##2##(2013-1#2)
Gastroesophageal reflux disease##2##3##(2010-12#2)
Gastrointestinal bleeding##3##2##(2011-2#1)(2013-1#2)
Gastrointestinal stromal tumor##2##3##(2009-7#2)
Gastrointestinal stromal tumors (GISTs)##2##4##(2012-12#1)(2013-1#1)
Gastrointestinal stromal tumors##5##3##(1992-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
Gastrointestinal stromal##7##2##(1992-9#1)(2009-7#2)(2012-12#1)(2012-3#1)(2013-1#2)
Gastrointestinal##21##1##(1992-9#1)(1997-8#2)(2008-11#2)(2008-8#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-12#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
Gateway cloning##3##2##(2008-4#3)
Gateway##4##1##(2008-4#4)
Gaucher disease##7##2##(1994-11#1)(1997-7#1)(2008-10#5)
Gaucher##9##1##(1994-11#1)(1997-7#1)(2008-10#7)
Gaussian MRF##2##2##(2008-6#2)
Gaussian and##2##2##(2008-10#1)(2008-3#1)
Gaussian beam with##2##3##(2008-2#2)
Gaussian beam##13##2##(2008-2#6)(2008-3#7)
Gaussian beams in##2##3##(2008-3#2)
Gaussian beams##3##2##(2008-3#3)
Gaussian distribution with##2##3##(2008-10#1)(2008-2#1)
Gaussian distribution##5##2##(2008-10#2)(2008-2#3)
Gaussian functions##2##2##(2008-10#2)
Gaussian noise##2##2##(2008-3#2)
Gaussian##50##1##(1996-9#1)(2007-11#1)(2008-10#7)(2008-2#12)(2008-3#26)(2008-6#2)(2012-3#1)
Gavarni##3##1##(2012-2#3)
Gay##3##1##(1991-2#1)(2008-10#1)(2009-12#1)
Gb3##2##1##(2013-1#2)
GbCLH was##2##2##(2008-11#2)
GbCLH##4##1##(2008-11#4)
Gbeta(1)gamma(2) was##2##2##(2008-9#2)
Gbeta(1)gamma(2)##6##1##(2008-9#6)
Gbogbe##3##1##(2008-10#3)
Gc##2##1##(1993-12#2)
Gcr1p binds##2##2##(1996-3#2)
Gcr1p##6##1##(1996-3#6)
Gd and Yb##2##3##(1997-8#2)
Gd and##5##2##(1997-8#2)(2008-10#3)
Gd##14##1##(1997-8#7)(2008-10#7)
Gd(2)O(3)##5##1##(2008-10#4)(2008-11#1)
Gd(3+)##8##1##(2008-10#7)(2008-11#1)
Gd(3+))##2##1##(2008-10#2)
Gd(III) and Nd(III)##2##3##(2008-10#2)
Gd(III)##8##1##(2008-10#8)
Gd-Trp-SDBS##2##1##(2008-10#2)
GdmCl##2##1##(2008-9#2)
Ge##9##1##(2008-10#7)(2009-9#2)
Ge(IV)##2##1##(2008-10#2)
GeMe(2)##2##1##(2009-9#2)
GeXP assay##2##2##(2013-8#2)
GeXP##7##1##(2013-8#7)
Gel filtration chromatography##2##3##(1994-5#1)(2008-10#1)
Gel filtration##3##2##(1994-5#1)(1995-11#1)(2008-10#1)
Gel mobility shift assays using##2##5##(1995-6#1)(2011-1#1)
Gel mobility shift##3##3##(1995-6#1)(1995-8#1)(2011-1#1)
Gel##18##1##(1990-10#1)(1990-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-9#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-1#1)
Gemcitabine and##2##2##(2008-10#2)
Gemcitabine##3##1##(2008-10#3)
Geminiviridae)##4##1##(2008-10#4)
Geminivirus##4##1##(2008-10#4)
Geminiviruses##3##1##(2008-10#3)
GenBank##14##1##(1996-2#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#4)(2013-1#1)
GenMark##6##1##(1995-12#6)
Genbank accession number##2##3##(2008-8#2)
Genbank##3##1##(2008-11#1)(2008-8#2)
Gender and##4##2##(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Gender differences in##6##3##(2008-12#2)(2008-4#2)(2008-7#1)(2011-1#1)
Gender differences##8##2##(2008-10#1)(2008-12#3)(2008-4#2)(2008-7#1)(2011-1#1)
Gender nonconformity##2##2##(2008-12#2)
Gender##26##1##(1995-12#1)(2008-10#1)(2008-12#5)(2008-4#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#2)
Gene Diversity##2##2##(2008-10#1)(2012-2#1)
Gene Expression in##3##3##(2008-10#3)
Gene Expression##6##2##(2008-10#5)(2012-3#1)
Gene Flow##3##2##(2008-10#3)
Gene Ontology (GO)##4##3##(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#1)
Gene Ontology##8##2##(2008-9#3)(2010-1#1)(2010-4#1)(2011-2#2)(2013-1#1)
Gene Silencing##2##2##(2008-10#1)(2013-1#1)
Gene Therapy##2##2##(1990-8#1)(1994-5#1)
Gene Transfer##2##2##(2008-10#2)
Gene and##2##2##(2008-10#2)
Gene discovery##2##2##(1994-9#1)(2008-10#1)
Gene disruption##2##2##(1993-9#1)(2008-9#1)
Gene diversity##2##2##(2008-10#2)
Gene expression analysis##2##3##(2008-2#1)(2008-4#1)
Gene expression of##3##3##(1992-6#1)(1995-12#1)(2011-2#1)
Gene expression profiling of##5##4##(2008-10#3)(2008-8#1)(2010-11#1)
Gene expression was##2##3##(2008-10#2)
Gene expression##18##2##(1992-3#1)(1992-6#1)(1995-12#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
Gene flow##4##2##(2008-10#3)(2008-8#1)
Gene for Resistance to##4##4##(2008-10#4)
Gene for##5##2##(2008-10#5)
Gene in##5##2##(1994-12#1)(1997-7#1)(2008-10#3)
Gene of##5##2##(2008-10#5)
Gene probes##2##2##(1996-6#1)(2008-10#1)
Gene therapy for##4##3##(1994-5#1)(2008-8#1)(2008-9#2)
Gene therapy##11##2##(1990-8#1)(1994-5#2)(2008-11#2)(2008-8#1)(2008-9#2)(2010-10#2)(2012-10#1)
Gene transfer into##2##3##(2008-11#1)(2008-9#1)
Gene transfer is##2##3##(2008-11#1)(2008-8#1)
Gene transfer##6##2##(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)
Gene##172##1##(1990-5#1)(1990-8#2)(1991-9#1)(1992-3#4)(1992-6#1)(1993-12#5)(1993-9#2)(1994-12#2)(1994-5#4)(1994-9#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-10#90)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#7)(2008-8#6)(2008-9#8)(2009-6#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-4#2)(2010-7#1)(2011-2#4)(2012-10#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)
Gene-Mediated##2##1##(2008-10#2)
Gene-for-Gene##4##1##(2008-10#4)
GeneChip##2##1##(2009-10#1)(2010-11#1)
GeneHacker##5##1##(1996-12#5)
GeneHackerTL for##2##2##(1997-6#2)
GeneHackerTL##4##1##(1997-6#4)
GeneMark and GeneMark##2##3##(2008-4#2)
GeneMark##17##1##(1995-12#6)(1996-12#1)(1996-6#1)(2008-4#9)
Genealogies##2##1##(2008-10#2)
Genebank##2##1##(2008-10#1)(2008-9#1)
General Cross Validation##2##3##(2008-10#2)
General Health##5##2##(1994-3#1)(2008-1#2)(2008-11#1)(2013-1#1)
General Hospital in##2##3##(1992-3#1)(1995-1#1)
General Hospital##17##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(1997-7#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
General Practitioners##3##2##(1994-6#2)(2008-11#1)
General Surgery##2##2##(2010-8#1)(2011-2#1)
General and##2##2##(1992-9#1)(2008-7#1)
General equations##2##2##(2008-10#1)(2008-3#1)
General practice##3##2##(1990-3#1)(1991-8#1)(1997-4#1)
General practitioners##2##2##(1995-11#1)(2008-8#1)
General practitioners' workload in primary care led NHS##3##8##(1997-8#3)
General problems##2##2##(1997-8#1)(2008-10#1)
General##79##1##(1990-12#1)(1990-3#1)(1991-12#2)(1991-8#1)(1992-12#3)(1992-3#2)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#3)(1994-1#1)(1994-3#2)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#4)(2008-1#3)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-5#1)(2013-1#4)(2013-8#1)
Generalization of##2##2##(2008-10#1)(2009-9#1)
Generalized linear##2##2##(2010-8#1)(2012-2#1)
Generalized##12##1##(1991-2#1)(1992-8#1)(1997-3#1)(2008-10#1)(2008-6#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
Generally speaking the##2##3##(2008-10#1)(2011-2#1)
Generally##23##1##(1990-8#1)(1991-3#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
Generation and##6##2##(1992-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#1)
Generation mean analysis##2##3##(2008-10#2)
Generation of##17##2##(1993-5#1)(1996-5#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2009-12#1)(2012-2#1)(2012-3#1)
Generation##29##1##(1990-11#1)(1992-11#1)(1993-5#1)(1996-5#1)(2007-11#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2009-12#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
Generic##3##1##(2009-10#2)(2011-1#1)
Genes and##3##2##(2008-10#1)(2008-4#1)(2009-11#1)
Genes for##3##2##(2008-10#3)
Genes from##2##2##(2008-10#1)(2008-8#1)
Genes in the##2##3##(2008-10#2)
Genes in##9##2##(2008-10#7)(2009-10#1)(2012-2#1)
Genes of##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
Genes that##3##2##(2011-2#1)(2012-3#2)
Genes to##2##2##(2008-10#2)
Genes##40##1##(2008-10#23)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#1)
Genetic Analysis of a##2##4##(2008-10#2)
Genetic Analysis of##7##3##(2008-10#7)
Genetic Analysis##9##2##(2008-10#9)
Genetic Characterization of##2##3##(2008-10#2)
Genetic Characterization##4##2##(2008-10#4)
Genetic Differentiation of##2##3##(2008-10#1)(2008-6#1)
Genetic Differentiation##6##2##(2008-10#5)(2008-6#1)
Genetic Diversity Among##2##3##(2008-10#2)
Genetic Diversity and##3##3##(2008-10#3)
Genetic Diversity in##4##3##(2008-10#4)
Genetic Diversity of Xanthomonas##3##4##(2008-10#3)
Genetic Diversity of##9##3##(2008-10#9)
Genetic Diversity##20##2##(2008-10#19)(2012-3#1)
Genetic Exchange##2##2##(2008-10#2)
Genetic Factors##2##2##(2008-10#2)
Genetic Markers##3##2##(2008-10#3)
Genetic Regulation of##2##3##(2008-10#1)(2011-2#1)
Genetic Structure and##2##3##(2008-10#2)
Genetic Structure of Field Populations of##2##6##(2008-10#2)
Genetic Structure of Phytophthora##3##4##(2008-10#3)
Genetic Structure of##18##3##(2008-10#18)
Genetic Structure##21##2##(2008-10#21)
Genetic Variability in##2##3##(2008-10#2)
Genetic Variability##5##2##(2008-10#5)
Genetic Variation Among##2##3##(2008-10#2)
Genetic Variation##3##2##(2008-10#3)
Genetic admixture##2##2##(2008-12#2)
Genetic analyses and##2##3##(2008-10#2)
Genetic analyses##3##2##(2008-10#2)(2012-2#1)
Genetic analysis and##3##3##(2008-10#1)(2008-9#2)
Genetic analysis in##2##3##(1993-12#1)(2008-9#1)
Genetic analysis indicated that##2##4##(2008-10#2)
Genetic analysis of##7##3##(1995-6#1)(2008-10#4)(2008-8#1)(2013-1#1)
Genetic analysis##19##2##(1993-12#1)(1995-6#1)(2008-10#9)(2008-8#1)(2008-9#5)(2012-3#1)(2013-1#1)
Genetic and Morphological##2##3##(2008-10#2)
Genetic and molecular##2##3##(2008-10#1)(2011-2#1)
Genetic and##10##2##(2008-10#7)(2008-11#1)(2011-1#1)(2011-2#1)
Genetic characteristics##2##2##(2008-10#1)(2009-12#1)
Genetic characterization##2##2##(1992-5#1)(2008-10#1)
Genetic data##4##2##(1990-11#1)(2008-12#1)(2008-9#1)(2010-12#1)
Genetic determinants of##2##3##(2010-5#1)(2013-8#1)
Genetic differentiation##3##2##(2008-10#3)
Genetic dissection of##2##3##(1994-9#1)(2011-2#1)
Genetic distances were##2##3##(2008-10#2)
Genetic distances##3##2##(2008-10#3)
Genetic diversity among X##2##4##(2008-10#2)
Genetic diversity among##3##3##(2008-10#3)
Genetic diversity of##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
Genetic diversity was##4##3##(2008-10#4)
Genetic diversity##12##2##(2008-10#10)(2008-12#1)(2013-1#1)
Genetic engineering##2##2##(1990-5#1)(1997-2#1)
Genetic factors##2##2##(2008-11#1)(2013-1#1)
Genetic influences on cellular reactions to##2##6##(1997-3#2)
Genetic influences on##3##3##(1997-3#2)(2008-8#1)
Genetic information and life insurance##2##5##(1994-12#1)(1996-2#1)
Genetic information##3##2##(1994-12#1)(1996-2#1)(1997-6#1)
Genetic linkage##4##2##(1997-9#1)(2008-10#1)(2008-11#1)(2013-8#1)
Genetic manipulation of##3##3##(1993-9#1)(2008-9#2)
Genetic modification##2##2##(2008-10#1)(2009-10#1)
Genetic mutations##2##2##(1992-12#1)(2013-1#1)
Genetic predisposition##2##2##(1996-10#1)(2008-7#1)
Genetic resistance##3##2##(2008-10#3)
Genetic structure of##2##3##(2008-10#1)(2013-8#1)
Genetic structure##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
Genetic studies have##2##3##(2008-2#1)(2012-2#1)
Genetic studies of this pathogen have been hampered##2##8##(2008-10#2)
Genetic studies##6##2##(2008-10#2)(2008-2#1)(2010-11#1)(2010-6#1)(2012-2#1)
Genetic testing and##2##3##(2011-2#2)
Genetic testing##4##2##(2011-2#3)(2013-1#1)
Genetic toxicology studies were conducted in##2##6##(2008-9#2)
Genetic tumours##2##2##(2008-7#2)
Genetic variation and##2##3##(2008-10#1)(2012-2#1)
Genetic variation was##3##3##(2008-10#3)
Genetic variation##9##2##(1997-8#1)(2008-10#5)(2012-2#1)(2012-3#2)
Genetic##249##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#147)(2008-11#3)(2008-12#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#13)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#4)(2012-3#10)(2013-1#6)(2013-8#4)
Genetically##9##1##(1995-2#1)(2008-10#4)(2008-2#1)(2010-11#1)(2012-3#2)
Genetics of##9##2##(2008-10#5)(2008-2#1)(2008-8#1)(2011-1#1)(2012-3#1)
Genetics##16##1##(1994-9#1)(1997-3#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Geneva##4##1##(1990-11#2)(1996-11#1)(2010-12#1)
Genevestigator##3##1##(2009-10#3)
Genghis##5##1##(2008-10#5)
Genistein and##2##2##(2008-11#1)(2010-3#1)
Genistein was##2##2##(2012-2#2)
Genistein##7##1##(2008-11#1)(2010-10#1)(2010-3#2)(2012-2#3)
Genital##4##1##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
Genoa syndrome##4##2##(2011-1#4)
Genome Organization##2##2##(2008-10#2)
Genome analysis##2##2##(1997-2#1)(2008-10#1)
Genome##37##1##(1991-5#1)(1994-9#4)(1995-9#1)(1997-2#2)(2008-10#10)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#5)
Genome-wide association studies##2##3##(2010-12#1)(2012-3#1)
Genome-wide association##4##2##(2010-12#1)(2011-2#1)(2012-3#2)
Genome-wide##8##1##(2009-12#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#3)
Genomes##6##1##(2008-10#3)(2008-4#1)(2009-11#1)(2012-3#1)
Genomic DNA from##3##3##(1997-3#1)(2008-10#2)
Genomic DNA was extracted from##2##5##(2008-10#2)
Genomic DNA##7##2##(1997-3#1)(2008-10#5)(2010-5#1)
Genomic DNAs##2##2##(1996-6#1)(2008-10#1)
Genomic Sequence##2##2##(2008-10#2)
Genomic Standards Consortium##4##3##(2011-2#4)
Genomic and##5##2##(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#1)
Genomic clones##2##2##(1991-5#1)(1993-2#1)
Genomic organization of##2##3##(1991-6#1)(2012-2#1)
Genomic structure##2##2##(1993-12#1)(1993-6#1)
Genomic##69##1##(1991-5#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-12#1)(1996-6#3)(1997-3#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-5#1)(2011-10#1)(2011-2#34)(2012-2#1)(2013-1#1)
Genomics and##3##2##(2008-2#1)(2008-8#1)(2013-1#1)
Genomics##6##1##(1997-2#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2013-1#1)
Genotype analysis of##2##3##(1990-4#1)(1994-12#1)
Genotype and##2##2##(2008-10#1)(2013-8#1)
Genotype imputation##2##2##(2012-3#2)
Genotype##18##1##(1990-4#1)(1994-12#1)(2008-10#12)(2012-3#3)(2013-8#1)
Genotype-specific##2##1##(2008-10#2)
Genotypes and##2##2##(2008-10#2)
Genotypes were##2##2##(2012-3#2)
Genotypes with##2##2##(1997-6#1)(2008-10#1)
Genotypes##18##1##(1997-6#1)(2008-10#14)(2012-3#2)(2012-5#1)
Genotypic and##3##2##(2008-10#3)
Genotypic diversity##2##2##(2008-10#2)
Genotypic variation##2##2##(2008-10#2)
Genotypic##10##1##(2008-10#10)
Genotyping of##2##2##(2008-10#2)
Genotyping was##2##2##(2008-9#1)(2011-2#1)
Genotyping##6##1##(2008-10#3)(2008-9#2)(2011-2#1)
Genova##5##1##(2008-4#5)
Genovesa##2##1##(2008-8#2)
Genus##5##1##(2008-10#3)(2010-2#1)(2013-8#1)
Geobacillus##5##1##(2011-2#5)
Geobacter sulfurreducens and Desulfococcus multivorans##2##5##(2011-1#2)
Geobacter##4##1##(2008-10#2)(2011-1#2)
Geodermatophilus obscurus##2##2##(2011-2#2)
Geographic Information##2##2##(2008-10#1)(2009-7#1)
Geographic distribution##2##2##(2008-10#2)
Geographic variation in##2##3##(2008-10#1)(2008-9#1)
Geographic##13##1##(1991-1#1)(1992-12#1)(1992-2#1)(2008-10#6)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)
Geographical##2##1##(2008-10#2)
Geological##2##1##(1990-11#1)(2008-10#1)
Geometrical optics##2##2##(2008-2#1)(2008-3#1)
Geometrical##3##1##(1993-8#1)(2008-2#1)(2008-3#1)
Geometry##2##1##(1996-9#1)(2008-11#1)
George Orwell's##2##2##(2008-11#2)
George Washington##2##2##(1992-12#1)(2012-2#1)
George##11##1##(1992-12#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-11#3)(2010-5#1)(2012-2#1)(2013-1#1)
Georgia##30##1##(1990-11#1)(1991-1#1)(1993-12#1)(1995-12#2)(1996-1#4)(1996-12#6)(1996-9#1)(1997-2#1)(2008-10#11)(2008-11#1)(2009-4#1)
Georgia's##2##1##(1996-12#1)(1996-9#1)
Geostatistical analyses##4##2##(2008-10#4)
Geostatistical##5##1##(2008-10#4)(2008-11#1)
Geostatistics##4##1##(2008-10#4)
Geranylgeranyl pyrophosphate##2##2##(2008-8#2)
Gerbillus##2##1##(2008-8#2)
Geriatric Depression Scale##2##3##(2008-7#2)
Geriatric##12##1##(1991-2#1)(1992-12#1)(1996-3#3)(2008-7#4)(2009-10#1)(2011-2#2)
Germ Plasm##3##2##(2008-10#3)
Germ line p53 mutations##2##4##(1990-12#2)
Germ tubes##3##2##(2008-10#3)
Germ##13##1##(1990-12#2)(1994-12#1)(2008-10#7)(2008-5#1)(2008-9#1)(2012-2#1)
German language##2##2##(2008-10#2)
German population##4##2##(1997-8#1)(2008-12#3)
German scientists##2##2##(2008-11#2)
German##44##1##(1990-11#1)(1994-6#1)(1995-1#2)(1995-11#1)(1996-1#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-7#1)(2009-7#3)(2011-2#1)(2012-12#6)(2012-2#5)(2013-1#2)(2013-8#1)
Germany and Poland##2##3##(2013-1#2)
Germany and the##5##3##(1992-12#2)(1996-1#1)(2008-10#1)(2008-11#1)
Germany and##11##2##(1992-12#2)(1996-1#1)(2008-10#4)(2008-11#1)(2011-2#1)(2013-1#2)
Germany in the##2##3##(1997-8#1)(2008-11#1)
Germany in##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
Germany was##2##2##(2008-11#2)
Germany##81##1##(1990-3#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#3)(1994-12#2)(1994-3#2)(1995-1#3)(1995-11#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-8#2)(2008-10#17)(2008-11#19)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#5)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Germany) and a FIAlab((R)) 3000 system (USA) with a six-port selection valve and##2##13##(2008-10#2)
Germany) was##2##2##(2008-10#2)
Germany) were##2##2##(2008-10#1)(2008-11#1)
Germany)##12##1##(1991-11#1)(1995-1#2)(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#1)
Germination and##5##2##(2008-10#4)(2011-2#1)
Germination of Puccinia##2##3##(2008-10#2)
Germination of Sclerotinia##2##3##(2008-10#2)
Germination of conidia##2##3##(2008-10#1)(2008-5#1)
Germination of sporangia##2##3##(2008-10#2)
Germination of##15##2##(2008-10#12)(2008-5#1)(2011-2#2)
Germination percentage##2##2##(2008-10#1)(2008-12#1)
Germination##29##1##(2008-10#24)(2008-12#1)(2008-5#1)(2011-2#3)
Germline##2##1##(1993-2#1)(2008-9#1)
Gerry##2##1##(1991-2#1)(2008-9#1)
Gestalt concept and humanistic psychology##2##5##(2010-6#2)
Gestalt##4##1##(2008-9#1)(2010-6#3)
Gestational diabetes mellitus##2##3##(2008-1#2)
Get the##2##2##(2010-9#1)(2013-7#1)
Get##3##1##(2009-5#1)(2010-9#1)(2013-7#1)
Getting the##4##2##(1994-1#1)(1994-3#1)(2012-2#1)(2013-1#1)
Getting##13##1##(1991-2#1)(1991-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-6#2)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
GhTub1##6##1##(2008-9#6)
Ghana##4##1##(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Ghanima score##2##2##(2011-2#2)
Ghanima##3##1##(2011-2#3)
Gi##3##1##(1994-2#1)(1997-1#1)(1997-2#1)
Giant cavernous##2##2##(2008-10#1)(2009-1#1)
Giant cell glioblastoma##2##3##(2013-1#2)
Giant cell hepatitis##2##3##(2008-5#2)
Giant cell##5##2##(2008-5#2)(2009-3#1)(2013-1#2)
Giant gastric##2##2##(2008-12#1)(2013-1#1)
Giant##24##1##(1993-1#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#3)(2013-1#4)
Giardia and##2##2##(2008-8#1)(2010-12#1)
Giardia duodenalis##4##2##(2012-3#4)
Giardia lamblia##2##2##(2007-12#1)(2008-8#1)
Giardia spp##8##2##(2012-12#8)
Giardia##16##1##(2007-12#1)(2008-8#2)(2010-12#1)(2012-12#8)(2012-3#4)
Gibberella zeae (anamorph##2##3##(2008-10#2)
Gibberella zeae##8##2##(2008-10#8)
Gibberella##13##1##(2008-10#13)
Gibbs free energy##2##3##(1997-2#1)(2008-10#1)
Gibbs##9##1##(1994-9#1)(1997-2#3)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)
Gibbs-Donnan model##3##2##(2008-10#3)
Gibney##2##1##(1992-9#1)(2008-8#1)
Giemsa##6##1##(1991-11#1)(2008-12#3)(2008-5#2)
Giemsa's staining##2##2##(2008-8#2)
Gilbertiodendron##3##1##(2008-8#3)
Gilead##2##1##(2008-5#2)
Gill##2##1##(1995-2#1)(2008-7#1)
Gingival##4##1##(1991-2#1)(2012-12#1)(2013-1#2)
Gingrich##2##1##(1993-12#1)(1995-12#1)
Ginkgo biloba##5##2##(2008-10#1)(2008-11#3)(2008-8#1)
Ginseng##4##1##(2008-10#2)(2008-11#2)
Giovanni##2##1##(2010-1#2)
Girls with##2##2##(1994-12#1)(2008-11#1)
Girls##8##1##(1990-2#1)(1994-12#2)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
Girls'##2##1##(2010-7#1)(2013-1#1)
Gitelman's syndrome##4##2##(1996-6#2)(1997-8#2)
Giuseppe##3##1##(1991-6#1)(2010-1#2)
Given a##2##2##(2008-3#1)(2011-2#1)
Given such##2##2##(2008-8#1)(2009-6#1)
Given that the##3##3##(2008-11#1)(2009-6#1)(2009-8#1)
Given that##15##2##(1992-12#1)(2008-11#3)(2008-12#3)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#2)(2010-7#1)(2011-2#1)(2012-2#1)
Given the complexity of##2##4##(2009-12#1)(2011-2#1)
Given the differences##2##3##(2008-10#1)(2008-9#1)
Given the increasing##2##3##(2008-10#1)(2012-2#1)
Given the large number of##2##5##(2008-10#1)(2008-11#1)
Given the low##2##3##(1996-11#1)(2012-12#1)
Given the potential##2##3##(2008-10#1)(2008-11#1)
Given the prevalence of##2##4##(2009-9#1)(2012-2#1)
Given the##52##2##(1990-9#1)(1992-2#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-2#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-6#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
Given these findings##2##3##(2008-7#1)(2009-10#1)
Given these##5##2##(1990-2#1)(1991-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
Given this##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
Given##89##1##(1990-2#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-2#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-2#2)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#3)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#2)
Giving bed baths(3##2##3##(1991-2#2)
Giving##5##1##(1991-2#4)(1993-1#1)
Gl-As-14(S)##2##1##(1990-6#2)
Gla##9##1##(1991-12#9)
Gla1##2##1##(2008-5#2)
Gland##2##1##(2013-1#2)
Glands##2##1##(2008-10#1)(2008-6#1)
Glanville fritillary butterfly##2##3##(2008-8#2)
Glanzmann's thrombasthenia##2##2##(2006-6#2)
Glasgow Outcome Scale##2##3##(1997-3#1)(2012-3#1)
Glasgow##5##1##(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
Glass##9##1##(2008-10#3)(2008-11#1)(2008-3#3)(2009-7#2)
Glasses##2##1##(1995-3#2)
Glasshouse##2##1##(2008-10#2)
Glaxo##3##1##(1996-2#1)(2008-10#2)
GlcNAc of##2##2##(1992-10#1)(2008-11#1)
GlcNAc residue##2##2##(1994-5#2)
GlcNAc##6##1##(1992-10#2)(1994-5#2)(2008-11#1)(2008-4#1)
Gleason score##3##2##(2010-11#1)(2011-2#2)
Gleason##6##1##(2008-10#1)(2010-11#3)(2011-2#2)
Glenn##4##1##(2008-10#4)
Glial##3##1##(2008-7#1)(2011-2#1)(2013-1#1)
Glibenclamide uptake was##2##3##(1992-3#2)
Glibenclamide uptake##3##2##(1992-3#3)
Glibenclamide##5##1##(1992-3#3)(1994-8#1)(2012-3#1)
Gliclazide##2##1##(1994-8#1)(2008-10#1)
GlimmerM##3##1##(2008-9#3)
Glioblastoma multiforme##2##2##(2011-3#1)(2013-1#1)
Glioblastoma##6##1##(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
Gliocladium roseum on##2##3##(2008-10#1)(2008-5#1)
Gliocladium roseum##4##2##(2008-10#3)(2008-5#1)
Gliocladium##8##1##(2008-10#6)(2008-5#2)
Glioma##3##1##(2011-2#1)(2013-1#2)
Glisoxepide uptake##2##2##(1992-3#2)
Glisoxepide##3##1##(1992-3#3)
Gln##5##1##(1991-3#1)(1994-5#1)(1995-6#1)(1997-8#1)(2008-10#1)
Gln-218 and Gln-292##2##3##(2008-8#2)
Gln-292##4##1##(2008-8#4)
Global Ozone Monitoring by Occultation of Stars##3##7##(2008-3#3)
Global Ozone Monitoring##4##3##(2008-3#4)
Global Rating of Change (GROC)##2##5##(2008-12#2)
Global climate change##2##3##(2008-9#1)(2012-6#1)
Global warming##2##2##(2009-8#1)(2012-5#1)
Global##40##1##(1991-2#1)(1994-1#1)(1995-8#1)(2008-10#3)(2008-11#8)(2008-12#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#3)(2010-1#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-5#1)(2012-6#1)
Globally##2##1##(2008-10#2)
Globin transcripts with##2##3##(2008-11#2)
Globodera pallida##2##2##(2008-10#2)
Globodera##3##1##(2008-10#3)
Glomerella cingulata##5##2##(2008-10#5)
Glomerella##9##1##(2008-10#8)(2013-1#1)
Glomus##2##1##(2008-10#1)(2010-10#1)
Glossina##4##1##(2010-1#3)(2010-4#1)
Glove integrity testing##2##3##(2012-2#2)
Glove##3##1##(1995-3#1)(2012-2#2)
Gloves##2##1##(2012-2#2)
Glu and##3##2##(1997-8#1)(2008-10#2)
Glu##8##1##(1990-5#1)(1993-12#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-8#1)
Glu-##2##1##(1991-11#1)(1991-5#1)
Glu-1 and Glu-2##2##3##(2008-10#2)
Glu-1 was##2##2##(2008-10#2)
Glu-1##5##1##(2008-10#5)
Glu-2##3##1##(2008-10#3)
Glu-50##2##1##(1995-6#2)
Glu-50--&gt##8##1##(1995-6#8)
Glu-98##8##1##(1995-6#8)
Glu1-plasminogen conformation##2##2##(1995-6#2)
Glu1-plasminogen##3##1##(1995-6#3)
GluR-B##5##1##(1993-12#5)
GluR1 in##2##2##(2008-7#2)
GluR1##5##1##(1995-2#1)(2008-7#4)
GluT-1 and GLT-1 mRNAs##2##4##(1996-2#2)
Glucagon##10##1##(1991-3#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-2#3)(2011-2#1)(2012-3#1)
Glucolevel##6##1##(2008-10#6)
Gluconacetobacter diazotrophicus PAl 5##2##4##(2011-2#2)
Glucose Oxidase##2##2##(2008-10#2)
Glucose and##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
Glucose biosensors based on##2##4##(2008-10#2)
Glucose oxidase (GOD)##2##3##(2008-10#2)
Glucose oxidase was##2##3##(2008-10#2)
Glucose oxidase##5##2##(2008-10#4)(2012-2#1)
Glucose variability##2##2##(2012-4#2)
Glucose was##2##2##(2008-10#1)(2008-11#1)
Glucose##36##1##(1991-5#1)(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#2)
Glucose-6-phosphatase##3##1##(1994-11#2)(2008-7#1)
Glucose-6-phosphate dehydrogenase##2##2##(1991-2#1)(1993-3#1)
Glucose-6-phosphate##3##1##(1991-2#1)(1993-3#1)(2008-10#1)
Glucosinolate##2##1##(2008-10#2)
Glue##2##1##(1997-3#1)(1997-6#1)
Glutamate##9##1##(1993-9#1)(1994-2#1)(1995-2#1)(2008-11#3)(2008-7#2)(2012-3#1)
Glutamine and glucose##2##3##(2008-11#2)
Glutamine##5##1##(2008-11#5)
Glutathione##5##1##(1992-6#1)(2008-10#2)(2008-11#1)(2009-8#1)
Gly##9##1##(1991-3#1)(1991-6#1)(1993-2#1)(1994-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
Gly)##3##1##(2008-10#3)
Gly- Leu- Met- NH2 (ranatachykinin##3##5##(1991-5#3)
Gly- Leu- Met- NH2##4##4##(1991-5#4)
Gly-Met-Gly##2##1##(2008-10#2)
Gly-Xaa-Yaa##2##1##(1993-12#1)(1993-3#1)
Glycation##2##1##(1992-12#1)(2012-3#1)
Glycemic##5##1##(2008-1#2)(2008-10#1)(2010-12#1)(2012-2#1)
Glycerol gradient analysis of##2##4##(1990-11#2)
Glycerol##3##1##(1990-11#2)(2008-11#1)
Glycine##3##1##(1991-5#1)(2008-10#2)
Glycogen synthesis##2##2##(1995-8#2)
Glycogen##3##1##(1995-8#2)(2008-10#1)
Glycopeptides##3##1##(1990-5#1)(1992-6#1)(1993-6#1)
Glycoprotein##3##1##(2008-10#1)(2008-4#1)(2011-2#1)
Glycoproteins##2##1##(2008-10#2)
Glycyrrhizae##2##1##(2011-2#2)
Glyphosate##4##1##(2008-10#2)(2010-1#2)
Glyptosternoids##2##1##(2008-9#2)
Glyptothorax-like##2##1##(2008-9#2)
GmbH##2##1##(2008-5#1)(2011-2#1)
GnRH antagonist##2##2##(1994-8#1)(2012-3#1)
GnRH gene##2##2##(1995-11#2)
GnRH##17##1##(1992-6#1)(1994-8#5)(1995-11#6)(1996-2#3)(2009-6#1)(2012-3#1)
Gna-1##3##1##(2008-8#3)
Gna4##3##1##(1990-5#3)
Gnotobiotic##2##1##(2008-10#1)(2008-12#1)
Go Local##4##2##(2010-5#4)
Go for##2##2##(1994-12#1)(1995-2#1)
Go##11##1##(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-1#1)(2010-5#4)(2012-3#1)
Goal##5##1##(2008-7#2)(2010-2#1)(2010-7#1)(2010-8#1)
Goals##5##1##(1991-2#2)(1993-8#1)(2008-6#1)(2013-1#1)
Goat Mb##2##2##(2010-4#2)
Goat##3##1##(2008-10#1)(2010-4#2)
Gobiodon##3##1##(2010-8#3)
God##13##1##(1991-2#1)(2008-12#2)(2009-10#1)(2010-12#1)(2013-1#8)
God's##3##1##(2008-12#2)(2009-11#1)
Goiás##3##1##(2008-10#1)(2011-2#2)
Gold electrodes##2##2##(2008-10#2)
Gold##19##1##(2008-10#13)(2008-11#1)(2010-1#1)(2011-2#2)(2012-12#2)
Golden Delicious##3##2##(2008-10#3)
Golden##7##1##(2008-10#5)(2011-2#1)(2012-2#1)
Goldfinger##3##1##(2008-10#3)
Goldfish exposed to##2##3##(2008-6#2)
Goldfish##4##1##(2008-6#4)
Goldner##2##1##(2011-2#2)
Golgi apparatus in##2##3##(2008-11#1)(2008-8#1)
Golgi apparatus is##2##3##(2008-8#1)(2012-2#1)
Golgi apparatus##12##2##(1990-5#2)(1992-12#1)(1995-5#1)(2008-11#3)(2008-5#1)(2008-8#3)(2012-2#1)
Golgi cells##5##2##(1995-2#4)(2012-2#1)
Golgi complex##4##2##(2008-7#3)(2009-8#1)
Golgi complexes##2##2##(2008-7#2)
Golgi method##2##2##(1995-8#2)
Golgi network##2##2##(1992-12#1)(1995-2#1)
Golgi stacks##2##2##(2008-7#2)
Golgi##49##1##(1990-5#2)(1992-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#8)(1995-5#1)(1995-8#3)(1997-1#1)(2008-11#9)(2008-5#1)(2008-7#7)(2008-8#4)(2009-8#3)(2010-1#1)(2012-2#3)
Gomez##3##1##(1995-12#3)
Gomori's##2##1##(2008-7#2)
Gompertz model##9##2##(2008-10#6)(2008-9#1)(2013-8#2)
Gompertz relative rate of disease progress##2##6##(2008-10#2)
Gompertz##15##1##(1993-12#1)(2008-1#1)(2008-10#10)(2008-9#1)(2013-8#2)
Gompertzian##2##1##(1993-12#1)(2013-8#1)
Gonyleptidae)##2##1##(2007-12#2)
Good Manufacturing##2##2##(2012-2#1)(2013-1#1)
Good Practices of Livestock##4##4##(2012-12#4)
Good agreement between the certified##2##5##(2008-10#2)
Good agreement between the##3##4##(2008-10#2)(2008-3#1)
Good agreement between##4##3##(2008-10#3)(2008-3#1)
Good agreement is found##2##4##(2008-10#1)(2008-3#1)
Good agreement is##3##3##(2008-10#2)(2008-3#1)
Good agreement was found between the##2##6##(2008-10#2)
Good agreement was found between##3##5##(2008-10#3)
Good agreement was##6##3##(2008-10#6)
Good agreement with certified values##2##5##(2008-10#2)
Good agreement with##4##3##(2008-10#4)
Good agreement##17##2##(2008-10#15)(2008-3#2)
Good correlation between##2##3##(2008-10#2)
Good correlation##3##2##(2008-10#3)
Good linear##2##2##(2008-10#2)
Good linearity##2##2##(2008-10#2)
Good quality##2##2##(1993-1#1)(1993-6#1)
Good recoveries were obtained##2##4##(2008-10#2)
Good recoveries were##3##3##(2008-10#3)
Good recoveries##7##2##(2008-10#7)
Good results were obtained for##2##5##(2008-10#2)
Good results were obtained##3##4##(2008-10#3)
Good results##6##2##(1995-5#1)(2008-10#4)(2008-6#1)
Good separation##2##2##(2008-10#2)
Good stability and##2##3##(2007-11#1)(2008-10#1)
Good##79##1##(1991-3#1)(1992-1#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-4#1)(2007-11#2)(2008-10#52)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-12#4)(2012-2#2)(2013-1#4)
Goodman##2##1##(2008-10#1)(2009-12#1)
Google##3##1##(2010-8#1)(2012-12#1)(2013-1#1)
Gordon James Mogenson (1931-1991)##2##4##(1993-6#2)
Gordon##5##1##(1990-11#1)(1993-6#3)(2008-2#1)
Gorski Kotar and Islands (chi2 = 4##2##7##(2011-2#2)
Gorski Kotar##6##2##(2011-2#6)
Gorski kotar##2##2##(2011-2#2)
Gorski##8##1##(2011-2#8)
Governance##3##1##(1996-3#1)(2012-3#1)(2013-7#1)
Governing##4##1##(1991-1#1)(2008-10#2)(2010-9#1)
Government of##3##2##(1995-3#2)(2008-11#1)
Government##19##1##(1995-3#3)(1996-3#2)(1997-2#1)(2008-10#2)(2008-11#5)(2008-6#2)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
Government's##2##1##(1994-2#1)(2008-6#1)
Governmental##8##1##(1993-11#1)(1994-12#1)(1996-3#4)(2008-10#1)(2008-11#1)
Governments##3##1##(1994-1#1)(1995-3#1)(2008-11#1)
Governor##2##1##(1996-5#2)
Governorate##5##1##(1994-9#2)(2008-10#2)(2008-12#1)
Gp90##2##1##(2008-9#2)
GpIIb-IIIa on platelets##2##3##(2006-6#2)
GpIIb-IIIa##3##1##(2006-6#3)
GpIIb/IIIa complex##2##2##(1993-8#2)
GpgP##3##1##(2012-2#3)
Gpi##2##1##(2008-10#2)
Gr##3##1##(2008-10#3)
Grace and##2##2##(1990-8#1)(2008-9#1)
Grace##4##1##(1990-8#1)(1995-2#1)(2008-9#1)(2010-10#1)
Grace's medium with##3##3##(2008-11#3)
Grace's medium##6##2##(2008-11#6)
Grace's##8##1##(2008-11#8)
Grade I##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
Grade II##2##2##(2008-12#1)(2008-7#1)
Grade III##2##2##(1991-2#1)(2008-7#1)
Grade IV##2##2##(2008-12#1)(2008-7#1)
Grade##15##1##(1990-6#1)(1991-2#1)(1994-12#1)(1996-3#2)(2008-12#2)(2008-7#5)(2010-7#1)(2011-2#1)(2012-12#1)
Grades##2##1##(2010-5#1)(2012-12#1)
Gradient elution##2##2##(2008-10#2)
Gradient##4##1##(2008-10#4)
Gradual##2##1##(2008-10#1)(2012-2#1)
Graduate programs in health administration##2##5##(1996-1#2)
Graduate programs in health##3##4##(1996-1#2)(1996-2#1)
Graduate##5##1##(1993-1#1)(1996-1#3)(1996-2#1)
Graft##2##1##(2008-10#1)(2009-10#1)
Graham##4##1##(1995-12#1)(1995-2#1)(1997-3#1)(2008-9#1)
Grain##6##1##(2008-10#4)(2008-11#1)(2010-1#1)
Gram negative bacteria##2##3##(1994-11#1)(2012-2#1)
Gram positive##2##2##(1994-11#1)(2012-2#1)
Gram staining and##2##3##(2010-6#2)
Gram staining##3##2##(2010-6#3)
Gram##7##1##(1994-11#2)(2010-6#3)(2012-2#2)
Gram+##2##1##(1991-3#1)(2011-2#1)
Gram-##2##1##(1993-12#1)(2011-2#1)
Gram-Positive##2##1##(2008-10#1)(2009-6#1)
Gram-negative bacilli isolated from patients##2##5##(2012-2#2)
Gram-negative bacilli##4##2##(2008-7#1)(2012-2#3)
Gram-negative bacteria##5##2##(1991-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
Gram-negative bacterial pathogens##2##3##(2008-9#1)(2011-2#1)
Gram-negative bacterial##4##2##(1995-2#1)(1997-8#1)(2008-9#1)(2011-2#1)
Gram-negative rod##2##2##(2011-2#2)
Gram-negative rods##2##2##(2007-12#1)(2011-2#1)
Gram-negative##27##1##(1991-3#2)(1995-2#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-10#1)(2011-2#7)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
Gram-positive and##4##2##(1991-3#1)(2008-5#1)(2009-6#1)(2012-3#1)
Gram-positive bacteria##3##2##(2008-5#1)(2011-1#1)(2012-2#1)
Gram-positive##13##1##(1991-3#1)(2008-5#3)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
Gramicidin S##2##2##(2011-2#2)
Gran I method##3##3##(2008-10#3)
Gran##5##1##(2008-10#5)
Granada##5##1##(2008-5#4)(2009-10#1)
Grandin##2##1##(2008-10#2)
Granger causality##2##2##(2008-11#1)(2012-2#1)
Grannelose Zweizeilige##3##2##(2008-10#3)
Grano##2##1##(2008-10#2)
Grant##2##1##(1996-3#1)(2007-12#1)
Granular##2##1##(1994-6#1)(2008-7#1)
Granule-Associated Serine Peptidases of Immune Defense##2##6##(2008-6#2)
Granulomatous angiitis##2##2##(2008-7#2)
Granulomatous##3##1##(2008-7#3)
Grape Berries##2##2##(2008-10#2)
Grape Flowers##2##2##(2008-10#2)
Grape##11##1##(2008-10#11)
Grapefruit juice##2##2##(2008-10#2)
Grapefruit##5##1##(2008-10#5)
Grapes##2##1##(2008-10#2)
Grapevine Downy Mildew##2##3##(2008-10#2)
Grapevine berry inner necrosis virus (GINV)##2##6##(2008-10#2)
Grapevine berry inner necrosis virus##4##5##(2008-10#4)
Grapevine fanleaf virus##4##3##(2008-10#4)
Grapevine leafroll-associated virus-1##2##3##(2008-10#2)
Grapevine leafroll-associated##5##2##(2008-10#5)
Grapevine virus A##2##3##(2008-10#2)
Grapevine virus##3##2##(2008-10#3)
Grapevine##28##1##(2008-10#28)
Graphic evidence##3##2##(2008-6#3)
Graphical##2##1##(2011-2#1)(2012-2#1)
Graphite##5##1##(2008-10#5)
Graphs##2##1##(1994-12#1)(1997-6#1)
Grass##2##1##(2008-8#1)(2012-2#1)
Grassi##7##1##(2010-1#7)
Grassi's##2##1##(2010-1#2)
Grating##3##1##(2008-3#2)(2013-8#1)
Gratings##4##1##(2008-3#4)
Graves' disease and##2##3##(1993-9#1)(2012-3#1)
Graves' disease##9##2##(1990-6#1)(1992-5#1)(1993-9#1)(1994-11#2)(2008-4#1)(2012-3#3)
Graves' eye disease##4##3##(2008-7#4)
Graves' thyroid##2##2##(1995-12#2)
Graves'##18##1##(1990-6#1)(1992-5#1)(1993-9#1)(1994-11#2)(1995-12#3)(2008-4#1)(2008-7#5)(2012-3#3)(2013-1#1)
Gravimetric determination of##2##3##(1993-2#1)(2008-10#1)
Gravitational##5##1##(1994-2#1)(1996-9#3)(2008-10#1)
Gravity##2##1##(1990-11#1)(2008-10#1)
Gray leaf spot is a serious disease##2##7##(2008-10#2)
Gray leaf spot##7##3##(2008-10#7)
Gray matter heterotopias##2##3##(1995-5#2)
Gray##15##1##(1992-1#1)(1995-5#2)(1996-3#1)(2008-10#8)(2008-12#1)(2008-8#1)(2010-4#1)
Grb2 and Sos##2##3##(1995-8#2)
Greasy##4##1##(2008-10#4)
Great Britain##6##2##(1991-2#1)(1996-11#1)(2008-10#1)(2008-5#2)(2013-8#1)
Great Lakes##5##2##(2008-10#1)(2008-11#4)
Great Plains of the United States##2##6##(2008-10#2)
Great Plains of##3##3##(2008-10#3)
Great Plains##13##2##(2008-10#11)(2008-2#1)(2008-3#1)
Great##32##1##(1991-2#1)(1995-2#1)(1996-11#1)(1997-7#1)(2007-8#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#3)(2012-3#1)(2013-1#1)(2013-8#2)
Greater Manchester##2##2##(2008-11#1)(2013-1#1)
Greater##23##1##(1991-12#1)(1991-2#1)(1994-1#1)(1995-12#1)(1995-2#2)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
Greatest##3##1##(1995-5#1)(2008-10#1)(2008-11#1)
Greece with##2##2##(2008-10#1)(2009-10#1)
Greece##14##1##(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
Greek Island##2##2##(2008-10#1)(2011-2#1)
Greek traditional dances and##2##4##(2010-6#2)
Greek traditional dances##4##3##(2010-6#4)
Greek##15##1##(2008-10#2)(2008-11#1)(2009-1#1)(2010-2#1)(2010-4#3)(2010-6#4)(2011-2#3)
Greeks##2##1##(2010-9#1)(2011-2#1)
Green Fluorescent Protein##2##3##(2008-10#1)(2008-11#1)
Green Fluorescent Protein-Tagged##2##3##(2008-10#2)
Green Fluorescent##6##2##(2008-10#5)(2008-11#1)
Green Mold##4##2##(2008-10#4)
Green S and Indigo##2##4##(1993-8#2)
Green S##4##2##(1993-8#4)
Green and##4##2##(2008-10#2)(2008-9#1)(2009-12#1)
Green fluorescence##3##2##(2008-10#2)(2008-9#1)
Green fluorescent protein##2##3##(1996-6#1)(2008-9#1)
Green fluorescent##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
Green##46##1##(1993-8#4)(1996-6#1)(2008-10#25)(2008-11#3)(2008-5#1)(2008-9#7)(2009-12#1)(2009-8#1)(2010-6#1)(2011-2#2)
Green's function##6##2##(2008-3#5)(2009-7#1)
Green's##8##1##(2008-3#7)(2009-7#1)
Greenhouse and##2##2##(2008-10#2)
Greenhouse inoculations##2##2##(2008-10#2)
Greenhouse##9##1##(2008-10#9)
Greenwald##2##1##(1994-12#2)
Gremmeniella abietina##5##2##(2008-10#5)
Grey College##2##2##(2008-11#2)
Grey##4##1##(2008-10#1)(2008-11#2)(2008-9#1)
Griess##3##1##(2008-10#3)
Griffith##2##1##(2008-11#1)(2011-2#1)
Griffiths' method##2##2##(1990-2#2)
Grignard##2##1##(1996-5#2)
Grimelius stain##2##2##(1992-2#2)
GroPIns4P as##2##2##(2013-8#2)
GroPIns4P##3##1##(2013-8#3)
Grodsky##2##1##(2008-10#2)
Groove##2##1##(1993-8#1)(2008-7#1)
Gross##8##1##(2008-12#1)(2008-5#4)(2008-7#1)(2010-6#1)(2013-1#1)
Ground##5##1##(1991-2#1)(1996-9#1)(1997-2#1)(2010-12#1)(2012-2#1)
Grounded##2##1##(2013-1#1)(2013-8#1)
Groundnut ringspot##2##2##(2008-10#2)
Groundnut##5##1##(2008-10#5)
Groundwater##2##1##(2008-10#1)(2013-1#1)
Group 1##14##2##(1990-5#2)(1991-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2011-1#3)(2011-2#4)
Group 2##6##2##(1990-5#1)(1991-3#1)(1995-12#1)(2011-1#2)(2011-2#1)
Group 3##6##2##(1990-5#1)(2008-10#2)(2011-2#3)
Group 4##2##2##(2008-10#2)
Group A and B strains##2##5##(2008-10#2)
Group A was##2##3##(2010-7#1)(2011-2#1)
Group A##14##2##(2008-10#5)(2008-11#1)(2010-12#1)(2010-4#1)(2010-7#3)(2011-2#2)(2012-2#1)
Group B patients##2##3##(2010-7#2)
Group B##7##2##(2008-10#2)(2010-4#1)(2010-7#3)(2011-2#1)
Group C##4##2##(2008-11#1)(2010-4#1)(2010-7#1)(2011-2#1)
Group Cohesiveness Scale (GCS)##2##4##(2013-1#2)
Group I and Group##2##4##(1993-2#1)(1995-12#1)
Group I and##3##3##(1993-2#1)(1995-12#1)(2008-10#1)
Group I is##2##3##(1992-11#1)(2008-10#1)
Group I was##3##3##(2007-8#1)(2008-10#1)(2010-7#1)
Group I##25##2##(1992-11#3)(1993-2#2)(1995-12#2)(2007-8#3)(2008-10#9)(2009-3#1)(2010-7#5)
Group II##18##2##(1992-11#2)(1993-2#1)(1995-12#2)(1996-12#1)(2007-8#3)(2008-10#8)(2012-2#1)
Group III##2##2##(2008-10#1)(2012-2#1)
Group N##2##2##(2010-7#1)(2013-1#1)
Group P##5##2##(2010-7#5)
Group and##2##2##(2008-11#1)(2011-2#1)
Group for the Study of##2##5##(1992-2#1)(1995-11#1)
Group for##6##2##(1992-2#1)(1993-11#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-1#1)
Group from##2##2##(2011-2#2)
Group in##4##2##(1994-1#1)(2008-11#2)(2012-3#1)
Group of the##2##3##(1991-8#1)(2008-10#1)
Group of##7##2##(1991-8#1)(1994-8#1)(1997-3#1)(1997-5#2)(2008-10#2)
Group on##6##2##(1993-5#1)(1996-6#1)(2007-9#1)(2011-2#1)(2013-1#2)
Group therapy##2##2##(2008-11#1)(2013-1#1)
Group to##2##2##(1994-1#1)(2010-5#1)
Group##208##1##(1990-11#2)(1990-5#6)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#2)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#7)(1993-5#1)(1993-9#2)(1994-1#2)(1994-12#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-8#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-7#2)(1997-8#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#40)(2008-11#8)(2008-12#3)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#22)(2010-8#1)(2011-1#5)(2011-2#18)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#3)
Group]##3##1##(1994-3#1)(1996-6#1)(1997-8#1)
Grouping##2##1##(2008-10#2)
Groups B and C##2##4##(2010-12#2)
Groups P and G##2##4##(2010-7#2)
Groups in##4##2##(2008-10#4)
Groups of 15 male and 15 female Tg##4##8##(2008-9#4)
Groups of 15 male and 15 female p53 haploinsufficient mice were exposed to drinking water containing 0##2##17##(2008-9#2)
Groups of 15 male and 15 female##6##7##(2008-9#6)
Groups of 15##7##3##(2008-9#7)
Groups of rats received##2##4##(1993-3#1)(2008-6#1)
Groups of##19##2##(1993-3#1)(1993-6#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-9#8)(2009-10#1)
Groups with the highest prevalence of##3##6##(2013-8#3)
Groups##55##1##(1990-5#1)(1991-1#1)(1991-12#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#3)(1996-12#1)(1996-5#1)(2008-10#14)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#8)(2009-10#2)(2009-3#1)(2010-12#2)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
Growing evidence##2##2##(2012-12#1)(2013-7#1)
Growing##10##1##(1996-2#1)(2008-10#5)(2008-11#1)(2008-9#1)(2012-12#1)(2013-7#1)
Grown in##4##2##(2008-10#3)(2008-11#1)
Grown##7##1##(2008-10#6)(2008-11#1)
Growth Factor##5##2##(1992-7#1)(2008-11#2)(2013-1#2)
Growth and Biocontrol##2##3##(2008-10#2)
Growth and##12##2##(1994-12#1)(1996-10#1)(2008-10#4)(2008-11#2)(2009-10#1)(2011-2#1)(2013-1#2)
Growth curve##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
Growth factors##2##2##(1993-11#1)(2008-7#1)
Growth hormone (GH)##2##3##(1991-9#1)(1996-11#1)
Growth hormone and##2##3##(2010-5#2)
Growth hormone deficiency##2##3##(2012-3#2)
Growth hormone##9##2##(1991-9#1)(1995-12#1)(1996-11#1)(2010-5#3)(2012-3#2)(2013-1#1)
Growth in medium consisting of##2##5##(2008-11#2)
Growth in##4##2##(1997-3#1)(2008-10#1)(2008-11#2)
Growth inhibition of##5##3##(1992-6#1)(1993-1#1)(1994-8#1)(2008-10#1)(2008-11#1)
Growth inhibition##6##2##(1992-6#1)(1993-1#1)(1994-8#1)(2008-10#1)(2008-11#1)(2009-9#1)
Growth of the##5##3##(2008-10#4)(2008-7#1)
Growth of##17##2##(1991-4#1)(1996-2#1)(2008-10#10)(2008-11#1)(2008-7#2)(2011-1#2)
Growth rates##3##2##(2008-11#3)
Growth under##2##2##(2008-11#1)(2012-2#1)
Growth##103##1##(1990-6#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-10#28)(2008-11#18)(2008-12#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#3)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
Gryllus assimilis##2##2##(2008-9#2)
Gryllus bimaculatus##6##2##(2008-5#4)(2008-6#2)
Gryllus##10##1##(2008-5#4)(2008-6#2)(2008-9#4)
Gs alpha##5##2##(1994-2#4)(1995-6#1)
Gs##6##1##(1994-2#4)(1995-6#1)(1997-7#1)
Guadeloupe##8##1##(2008-10#8)
Guadiana##2##1##(2008-10#1)(2008-12#1)
Guangzhou09##2##1##(2013-8#2)
Guard##2##1##(1994-2#1)(2012-3#1)
Guardado##2##1##(1995-12#2)
Guatemala##7##1##(1992-5#1)(2008-10#4)(2010-1#1)(2013-1#1)
Guelph##7##1##(2013-8#7)
Guglielmi detachable coils##2##3##(1995-11#1)(2008-7#1)
Guglielmi detachable##4##2##(1995-11#1)(1997-6#1)(2008-7#2)
Guglielmi##5##1##(1995-11#1)(1996-9#1)(1997-6#1)(2008-7#2)
Guha##2##1##(1994-8#2)
Guidance for##3##2##(2010-11#1)(2010-2#1)(2013-1#1)
Guidance##9##1##(1991-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#2)(2010-2#1)(2010-5#1)(2013-1#1)
Guide for##2##2##(2008-10#1)(2009-8#1)
Guide to##2##2##(2008-10#1)(2012-2#1)
Guide##14##1##(2008-10#6)(2008-11#1)(2008-3#4)(2009-8#1)(2012-2#2)
Guided by##2##2##(2009-5#1)(2009-6#1)
Guided##3##1##(2009-5#2)(2009-6#1)
Guideline##6##1##(2008-5#1)(2010-11#1)(2011-1#2)(2012-12#2)
Guidelines are provided##2##3##(2007-9#1)(2012-2#1)
Guidelines are##3##2##(2007-9#2)(2012-2#1)
Guidelines for detection##2##3##(2008-11#2)
Guidelines for the##5##3##(1996-2#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
Guidelines for##18##2##(1992-1#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
Guidelines from the##3##3##(1997-8#1)(2008-10#1)(2012-2#1)
Guidelines on##2##2##(1993-2#1)(1996-6#1)
Guidelines##36##1##(1992-1#1)(1993-2#1)(1996-2#2)(1996-6#1)(1997-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-1#2)(2011-2#2)(2012-2#5)(2013-1#3)
Guiding##2##1##(2008-11#1)(2008-3#1)
Guignardia citricarpa##2##2##(2008-10#2)
Guignardia##4##1##(2008-10#4)
Guillain-Barré syndrome and##2##3##(1990-2#1)(2012-3#1)
Guillain-Barré syndrome##4##2##(1990-2#1)(1991-11#1)(2012-3#2)
Guinea pig meat##2##3##(2013-1#2)
Guinea pig##3##2##(2013-1#3)
Guinea##9##1##(1991-12#1)(1994-9#1)(2008-1#2)(2008-12#2)(2013-1#3)
Guinea-pigs were##2##2##(1995-11#1)(2008-5#1)
Gujarat##6##1##(2008-10#6)
Gujarati Indian adolescents##3##3##(2012-2#3)
Gujarati Indian##4##2##(2012-2#4)
Gulf of##3##2##(2008-11#2)(2013-1#1)
Gulf##8##1##(1992-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2012-2#1)(2013-1#1)
Gum##2##1##(1991-12#1)(2012-2#1)
Gun##2##1##(1993-2#1)(2008-4#1)
Guo##2##1##(1990-11#1)(1994-8#1)
Gupta##2##1##(2008-10#1)(2012-3#1)
Gurleya sp##2##2##(2011-2#2)
Gus Mayer's##2##2##(1996-5#2)
Gus mRNA##3##2##(1993-8#3)
Gus##10##1##(1993-8#7)(1996-5#3)
Gut##3##1##(2008-10#1)(2008-8#2)
Guttmacher Institute##3##2##(2013-1#3)
Gwent##4##1##(2008-10#4)
Gy for##3##2##(2009-2#2)(2011-2#1)
Gy in##3##2##(1991-8#2)(2013-8#1)
Gy to the##2##3##(1990-8#2)
Gy was delivered##2##3##(1990-12#1)(1994-12#1)
Gy##29##1##(1990-12#1)(1990-8#2)(1991-2#1)(1991-8#2)(1994-12#1)(1997-4#1)(2008-10#1)(2008-11#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#5)(2011-2#2)(2013-1#1)(2013-8#3)
Gy)##5##1##(1990-6#1)(1992-12#1)(1993-8#1)(1997-4#1)(2008-7#1)
Gynecology and Obstetrics##2##3##(1995-3#1)(2012-3#1)
Gynecology##5##1##(1991-3#2)(1995-3#1)(1996-9#1)(2012-3#1)
Gypsophila paniculata##2##2##(2008-10#2)
H 7998##3##2##(2008-10#3)
H _ 2O _ 2##2##5##(2008-5#2)
H and E##2##3##(2008-12#1)(2012-3#1)
H and##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-3#1)
H beta##2##2##(1992-4#2)
H in##2##2##(1995-8#1)(2009-6#1)
H were##2##2##(1994-5#1)(2009-6#1)
H##314##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-5#6)(1991-10#1)(1991-5#2)(1991-8#2)(1992-1#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-9#1)(1993-12#2)(1993-3#5)(1993-8#6)(1994-11#2)(1994-12#2)(1994-5#15)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#3)(1995-8#3)(1996-12#4)(1996-5#1)(1997-1#18)(1997-2#2)(1997-3#9)(1997-8#5)(1997-9#3)(2006-5#1)(2007-12#5)(2008-10#82)(2008-11#11)(2008-12#16)(2008-3#2)(2008-4#1)(2008-5#10)(2008-7#4)(2008-8#8)(2009-10#1)(2009-3#1)(2009-6#12)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#3)(2011-10#1)(2011-2#16)(2012-2#6)(2012-3#1)(2012-8#2)(2013-1#6)
H'##3##1##(2008-10#1)(2008-8#2)
H(+)##16##1##(2008-10#14)(2008-8#2)
H(+)-ATPase activity and##2##3##(2008-10#2)
H(+)-ATPase from Neurospora crassa reconstituted##2##5##(1995-2#2)
H(+)-ATPase from Neurospora crassa##3##4##(1995-2#3)
H(+)-ATPase from##4##2##(1995-2#4)
H(+)-ATPase##9##1##(1993-6#1)(1995-2#6)(2008-10#2)
H(+)-chromoionophore##2##1##(2008-10#2)
H(+)-selective chromoionophore and##2##3##(2008-10#2)
H(+)-selective chromoionophore##3##2##(2008-10#3)
H(+)-selective##5##1##(2008-10#5)
H(2) O(2) concentration##2##3##(2011-2#2)
H(2) O(2)##4##2##(2011-2#4)
H(2) and CO(2)##3##3##(2008-7#3)
H(2) and##5##2##(2008-10#1)(2008-7#3)(2010-12#1)
H(2)##23##1##(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#4)(2010-12#2)(2010-4#4)(2011-2#4)(2012-2#1)
H(2)O absorption##2##2##(2008-11#1)(2008-3#1)
H(2)O and##3##2##(2008-10#2)(2008-3#1)
H(2)O molecule##2##2##(2008-10#1)(2008-8#1)
H(2)O##28##1##(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#7)(2008-8#4)
H(2)O(2) and NADH detection##2##4##(2013-1#2)
H(2)O(2) and NADH##3##3##(2013-1#3)
H(2)O(2) and##20##2##(2008-10#17)(2013-1#3)
H(2)O(2) as##2##2##(2008-10#2)
H(2)O(2) at##2##2##(2008-10#2)
H(2)O(2) concentration##4##2##(2008-10#4)
H(2)O(2) detection##3##2##(2008-10#3)
H(2)O(2) for##2##2##(2008-10#2)
H(2)O(2) from##2##2##(2008-10#1)(2008-11#1)
H(2)O(2) in a##2##3##(2008-10#2)
H(2)O(2) in real samples##2##4##(2008-10#2)
H(2)O(2) in the presence of##2##5##(2008-10#2)
H(2)O(2) in the##7##3##(2008-10#7)
H(2)O(2) in##16##2##(2008-10#15)(2008-11#1)
H(2)O(2) occurred##2##2##(2008-10#2)
H(2)O(2) produced##2##2##(2008-10#2)
H(2)O(2) production by##3##3##(2008-10#1)(2008-11#2)
H(2)O(2) production was##2##3##(2008-11#2)
H(2)O(2) production##9##2##(2008-10#1)(2008-11#8)
H(2)O(2) system containing Cu(2+) or Zn(2+)##2##6##(2008-10#2)
H(2)O(2) system containing Cu(2+)##4##4##(2008-10#4)
H(2)O(2) to##2##2##(2008-10#2)
H(2)O(2) was##6##2##(2008-10#6)
H(2)O(2) were##2##2##(2008-10#2)
H(2)O(2) with##3##2##(2008-10#3)
H(2)O(2)##148##1##(2008-10#127)(2008-11#11)(2009-8#1)(2010-4#4)(2010-7#1)(2012-2#1)(2013-1#3)
H(2)O)##3##1##(2008-10#1)(2010-7#2)
H(2)PO(4)(-)##3##1##(2008-10#3)
H(2)S and##4##2##(2008-10#4)
H(2)S##13##1##(2008-10#12)(2008-7#1)
H(2)SO(4) and 0##3##3##(2008-10#3)
H(2)SO(4) and H(2)O are##2##4##(2008-10#2)
H(2)SO(4) and H(2)O(2)##2##3##(2008-10#2)
H(2)SO(4) and##9##2##(2008-10#9)
H(2)SO(4) at##2##2##(2008-10#1)(2013-1#1)
H(2)SO(4) concentration##2##2##(2008-10#2)
H(2)SO(4) in##2##2##(2008-10#2)
H(2)SO(4) is##3##2##(2008-10#3)
H(2)SO(4) medium##2##2##(2008-10#2)
H(2)SO(4) solution##3##2##(2008-10#2)(2009-10#1)
H(2)SO(4) was##2##2##(2008-10#2)
H(2)SO(4)##53##1##(1991-5#1)(2008-10#49)(2008-3#1)(2009-10#1)(2013-1#1)
H(2)SO(4))##4##1##(2008-10#3)(2013-1#1)
H(3)(tpfc)##2##1##(2008-10#2)
H(3)AsO(3)##2##1##(2008-10#2)
H(3)BO(3)##2##1##(2008-10#2)
H(VNTR) values##2##2##(2008-10#2)
H)##7##1##(1990-12#1)(1993-8#1)(1994-5#1)(2008-10#3)(2008-12#1)
H)=-7##2##1##(2008-10#2)
H+ electrochemical potential generated by F1F0 ATPase##2##7##(1997-8#2)
H+ electrochemical potential##4##3##(1997-8#4)
H+ gradient##3##2##(1994-6#3)
H+ pumping by##2##3##(1995-2#2)
H+##14##1##(1991-5#2)(1994-6#5)(1995-2#2)(1997-8#5)
H+/K(+)-ATPase beta subunit -1035 to##2##5##(1995-6#2)
H+/K(+)-ATPase beta subunit##3##3##(1995-6#3)
H+/K(+)-ATPase##5##1##(1995-6#3)(1997-1#2)
H-##3##1##(1993-11#1)(1996-9#1)(2009-8#1)
H-2(d) restricted antigen-specific##2##3##(2008-8#2)
H-2(d) restricted##4##2##(2008-8#4)
H-2(d)##6##1##(2008-8#6)
H-2Dd expression##2##2##(1995-2#2)
H-2Dd##4##1##(1995-2#4)
H-7##5##1##(1994-11#1)(1995-8#2)(1996-12#1)(1997-2#1)
H-B scale##2##2##(2008-10#2)
H-D and H-H##2##3##(2008-12#2)
H-D##6##1##(2008-12#6)
H-FABP##2##1##(2008-10#2)
H-H##7##1##(2008-12#5)(2010-4#2)
H-Wave(R) device##11##2##(2010-1#11)
H-aggregation of NBS##2##3##(2008-10#2)
H-bonding##4##1##(1992-4#1)(2008-10#1)(2008-5#2)
H-bonds##6##1##(1992-10#4)(1992-4#1)(2008-9#1)
H-channel structure was##2##3##(2008-10#2)
H-phosphonate##2##1##(2008-4#2)
H-point and##3##2##(2008-10#3)
H-point curve isolation##2##3##(2008-10#2)
H-point standard addition method (HPSAM) for##2##6##(2008-10#2)
H-point standard addition method (HPSAM) is##2##6##(2008-10#2)
H-point standard addition method (HPSAM) was applied to##2##8##(2008-10#2)
H-point standard addition method (HPSAM)##9##5##(2008-10#9)
H-point standard addition method##25##4##(2008-10#25)
H-point standard addition##27##3##(2008-10#27)
H-point standard additions method##2##4##(2008-10#2)
H-point standard additions methods##2##4##(2008-10#2)
H-point standard additions##4##3##(2008-10#4)
H-point standard##31##2##(2008-10#31)
H-point##36##1##(2008-10#36)
H-ras##4##1##(1993-11#3)(1994-5#1)
H-strand##2##1##(2008-11#2)
H-type intramolecular##2##2##(2008-10#2)
H-type##4##1##(2008-10#4)
H1##12##1##(1990-2#1)(1990-5#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-9#2)(1994-11#1)(2011-2#3)
H1(0) mRNA##2##2##(1993-6#2)
H1(0)##8##1##(1993-6#8)
H1-##2##1##(1995-12#2)
H10##3##1##(1990-12#3)
H111##2##1##(2008-10#2)
H1N1 SIV##2##2##(2011-2#2)
H1N1 SIVs##2##2##(2011-2#2)
H1N1 influenza##4##2##(2010-4#1)(2011-2#2)(2013-8#1)
H1N1 swine influenza##3##3##(2011-2#3)
H1N1##16##1##(2010-4#1)(2011-2#10)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
H1aV##3##1##(2008-11#3)
H2 receptor antagonists##3##3##(1992-11#1)(1995-10#2)
H2 receptor##4##2##(1992-11#1)(1995-10#2)(1996-3#1)
H2##9##1##(1990-12#3)(1991-9#1)(1992-11#1)(1995-10#2)(1996-3#1)(2008-12#1)
H2-##2##1##(1995-12#2)
H2-antagonist##2##1##(1990-5#1)(1992-8#1)
H2O##10##1##(1997-4#1)(2008-11#2)(2008-2#1)(2008-3#6)
H2O2 alone##2##2##(1995-8#2)
H2O2 and##4##2##(1996-2#1)(2008-10#1)(2013-8#2)
H2O2 in##4##2##(1995-8#2)(1997-8#1)(2008-10#1)
H2O2 was##2##2##(1997-8#1)(2008-12#1)
H2O2##31##1##(1994-8#1)(1995-6#1)(1995-8#11)(1996-2#1)(1997-4#2)(1997-8#5)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-8#3)
H2O2-L-histidine##3##1##(1995-8#3)
H3 and H4##3##3##(2009-12#1)(2011-2#2)
H3##12##1##(1990-12#1)(1991-5#3)(1991-6#3)(1997-2#1)(2009-12#1)(2009-8#1)(2011-2#2)
H3K4##2##1##(2009-10#2)
H3K9 di- and tri-methylation##2##4##(2009-10#2)
H3K9##3##1##(2009-10#3)
H4##5##1##(1990-2#1)(1993-6#1)(2009-12#1)(2011-2#2)
H46A##3##1##(2012-2#3)
H5##2##1##(2008-9#1)(2013-8#1)
H5N1##2##1##(2011-2#1)(2013-8#1)
H6 and C1##2##3##(2008-10#2)
H7 in##2##2##(2010-4#1)(2012-2#1)
H7 subtype avian influenza##2##4##(2013-8#2)
H7 subtype##3##2##(2013-8#3)
H7##20##1##(1990-12#1)(1994-11#1)(1995-2#2)(1997-1#1)(1997-9#1)(2008-10#6)(2010-4#2)(2012-2#1)(2013-8#5)
H7N1##2##1##(2011-3#2)
H8##3##1##(1990-12#2)(1994-11#1)
H9 cells##6##2##(1990-8#1)(1991-5#2)(1994-11#1)(1997-1#1)(1997-3#1)
H9##9##1##(1990-10#1)(1990-8#1)(1991-5#2)(1994-11#1)(1997-1#1)(1997-3#1)(2011-3#1)(2013-8#1)
H93G Mb##3##2##(1994-5#3)
HA alone##2##2##(2008-10#1)(2009-7#1)
HA and FA##5##3##(2008-10#5)
HA and WEC bioassays##2##4##(1993-12#2)
HA and to##2##3##(2011-2#1)(2013-8#1)
HA and##17##2##(1993-12#2)(2008-10#6)(2009-7#4)(2011-2#2)(2012-3#1)(2013-8#2)
HA as##2##2##(2008-10#2)
HA did not##2##3##(2010-10#1)(2010-8#1)
HA of##2##2##(1990-5#1)(2008-5#1)
HA polymers##2##2##(2010-8#2)
HA samples##4##2##(2008-10#4)
HA titer##3##2##(2008-10#1)(2008-11#2)
HA were##2##2##(2008-10#2)
HA with carbon-13 of natural abundance##2##6##(2008-10#2)
HA with##4##2##(2008-10#4)
HA##92##1##(1990-5#2)(1993-12#3)(2008-10#40)(2008-11#5)(2008-5#2)(2008-8#1)(2009-7#6)(2010-10#3)(2010-8#9)(2011-2#9)(2012-2#1)(2012-3#1)(2013-8#10)
HA) and##2##2##(2008-10#1)(2009-7#1)
HA)##3##1##(2008-10#1)(2009-7#1)(2010-8#1)
HA-CdS and HB-CdS##2##3##(2008-8#2)
HA-metal ion##2##2##(2008-10#2)
HA/PLLA##2##1##(2009-7#2)
HA1##2##1##(2011-2#2)
HA1004##2##1##(1993-3#2)
HA5-1##2##1##(2008-10#2)
HAA##2##1##(2008-10#2)
HAART initiation##2##2##(2010-5#2)
HAART##5##1##(2009-7#1)(2010-5#3)(2011-2#1)
HAAs##2##1##(2008-10#2)
HAC##3##1##(2008-11#3)
HAD##3##1##(2008-10#2)(2011-1#1)
HAG1##4##1##(2008-8#4)
HAM's F12##2##2##(2008-11#2)
HAP##8##1##(2008-9#7)(2012-2#1)
HAP1##3##1##(2012-2#3)
HAP2##6##1##(1995-2#3)(2008-9#3)
HAP3##3##1##(1995-2#3)
HAPC sheet bed##2##3##(2008-11#2)
HAPC sheet##3##2##(2008-11#3)
HAPC##4##1##(2008-11#4)
HARV cultivation##2##2##(2008-11#2)
HARV##3##1##(2008-11#3)
HAT-sensitive mouse myeloma cell line##2##5##(2008-11#2)
HAT-sensitive mouse myeloma##3##3##(2008-11#3)
HAV and##3##2##(2007-12#1)(2009-5#2)
HAV is##2##2##(2007-12#1)(2010-8#1)
HAV##7##1##(2007-12#4)(2009-5#2)(2010-8#1)
HAVE##2##1##(1995-12#1)(2009-12#1)
HAc-NaAc buffer solution##2##3##(2008-10#2)
HAc-NaAc buffer##4##2##(2008-10#4)
HAc-NaAc##5##1##(2008-10#5)
HAs##4##1##(2008-10#4)
HB##10##1##(2008-10#1)(2008-8#3)(2011-2#5)(2013-8#1)
HB)##2##1##(2008-8#1)(2013-8#1)
HB-EGF gene transcription##3##3##(1997-1#3)
HB-EGF mRNA##4##2##(1997-1#4)
HB-EGF##11##1##(1997-1#11)
HB1##2##1##(2011-2#2)
HB4C5 cells##7##2##(2008-11#7)
HB4C5##9##1##(2008-11#9)
HBA1c##2##1##(1994-12#2)
HBV DNA decline##3##3##(2013-1#3)
HBV DNA was##2##3##(1990-8#2)
HBV DNA##13##2##(1990-8#4)(1995-2#1)(2009-8#4)(2013-1#4)
HBV and HDV##2##3##(2009-8#2)
HBV and##6##2##(1995-5#1)(2008-10#1)(2009-8#3)(2013-1#1)
HBV construct##2##2##(1995-2#2)
HBV core##2##2##(2008-8#2)
HBV genotype##2##2##(2013-1#2)
HBV genotypes##2##2##(2013-1#2)
HBV in##2##2##(1995-2#1)(2013-1#1)
HBV infection##10##2##(1995-2#2)(2008-10#4)(2009-12#1)(2009-8#2)(2013-1#1)
HBV or HDV##2##3##(2009-8#2)
HBV replication##3##2##(2013-1#3)
HBV vaccination##2##2##(2009-5#2)
HBV virions##2##2##(1995-2#2)
HBV##88##1##(1990-8#5)(1991-8#1)(1993-8#6)(1995-2#11)(1995-5#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-8#2)(2009-12#3)(2009-5#3)(2009-8#17)(2012-3#3)(2013-1#23)(2013-8#2)
HBV- and HCV-endemic##3##3##(2013-8#3)
HBV- and##4##2##(2013-8#4)
HBV/B6##2##1##(2013-1#2)
HBV/D##2##1##(2013-1#2)
HBV/F##3##1##(2013-1#3)
HBc##4##1##(1996-12#1)(2008-8#3)
HBc3-144-HCMV##2##1##(1996-12#2)
HBcAg and##2##2##(1996-12#2)
HBcAg particles##3##2##(1995-5#3)
HBcAg##13##1##(1991-8#1)(1995-5#9)(1996-12#3)
HBe-Ag positive##2##2##(1990-8#2)
HBeAg negative##2##2##(2013-1#2)
HBeAg##3##1##(2009-8#1)(2013-1#2)
HBeAg-negative patients##3##2##(2009-8#1)(2013-1#2)
HBr##4##1##(2008-10#4)
HBs antigen##2##2##(1990-8#1)(2013-1#1)
HBs##4##1##(1990-8#1)(2013-1#1)(2013-8#2)
HBsAg (-)##2##2##(2011-2#2)
HBsAg and##2##2##(2008-8#1)(2013-8#1)
HBsAg carriage in##2##3##(2013-1#2)
HBsAg loss##2##2##(2013-1#2)
HBsAg positivity##2##2##(1996-3#2)
HBsAg##19##1##(1993-2#1)(1995-2#3)(1996-3#3)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#7)(2013-8#1)
HBsAg+##3##1##(1993-2#3)
HBsAg-specific##3##1##(1995-2#2)(2012-3#1)
HC and SNP treated KU812 cells##2##6##(2008-11#2)
HC and##5##2##(2008-10#2)(2008-11#2)(2012-3#1)
HC for##2##2##(2008-11#2)
HC is##2##2##(2008-10#1)(2012-3#1)
HC treated##2##2##(2008-11#2)
HC was##2##2##(2008-10#1)(2008-8#1)
HC##37##1##(2008-10#19)(2008-11#7)(2008-8#1)(2009-10#1)(2011-3#1)(2012-3#6)(2013-8#2)
HC-Pro mRNA##2##2##(2008-10#2)
HC-Pro of##2##2##(2008-10#2)
HC-Pro##11##1##(2008-10#10)(2008-9#1)
HC-toxin##5##1##(2008-10#5)
HC-transcomplementation##3##1##(2008-10#3)
HC/HU patients##2##2##(2008-10#2)
HC/HU##5##1##(2008-10#5)
HCA cases##2##2##(2009-8#2)
HCA##6##1##(2009-8#5)(2013-1#1)
HCAs are observed in##2##4##(2009-8#2)
HCAs are##3##2##(2009-8#3)
HCAs##8##1##(2008-10#3)(2009-8#5)
HCB and##2##2##(2008-10#2)
HCB##14##1##(2008-10#11)(2008-11#3)
HCB-induced skin lesions##2##3##(2008-10#2)
HCB-induced##4##1##(2008-10#4)
HCC and##2##2##(2008-10#1)(2008-11#1)
HCC cells##6##2##(2008-10#3)(2008-8#2)(2012-5#1)
HCC development in##2##3##(2013-8#2)
HCC development##3##2##(2013-8#3)
HCC in##5##2##(1993-2#1)(2008-11#3)(2011-2#1)
HCC patients##8##2##(2008-10#8)
HCC were##2##2##(1993-2#1)(2013-8#1)
HCC##66##1##(1993-2#6)(2008-10#22)(2008-11#5)(2008-8#4)(2009-8#2)(2010-12#9)(2011-2#5)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#9)
HCFA and##2##2##(1997-3#2)
HCFA could##2##2##(1997-2#2)
HCFA##7##1##(1996-2#1)(1997-2#3)(1997-3#3)
HCFA's##3##1##(1992-2#1)(1997-3#2)
HCG##2##1##(1991-1#1)(1997-3#1)
HCHO##3##1##(2008-10#3)
HCMV infection##2##2##(1997-3#2)
HCMV strains##2##2##(1997-3#2)
HCMV##16##1##(1993-8#2)(1996-12#2)(1997-3#10)(2008-9#1)(2011-3#1)
HCMV-induced TGr##3##2##(1997-3#3)
HCMV-specific##3##1##(1993-8#1)(1997-3#2)
HCN##3##1##(2008-10#3)
HCO3-##4##1##(1993-6#3)(1995-8#1)
HCPS##2##1##(2008-10#2)
HCQIP##4##1##(1996-2#4)
HCT##2##1##(2010-11#2)
HCT-8 and##2##2##(2011-3#1)(2013-1#1)
HCT-8##3##1##(1994-8#1)(2011-3#1)(2013-1#1)
HCT116##5##1##(1994-8#2)(2011-2#3)
HCV RNA##2##2##(2008-10#2)
HCV cirrhosis##2##2##(2013-1#2)
HCV core genes##2##3##(2008-8#2)
HCV core##3##2##(2008-8#3)
HCV infection in##3##3##(2008-10#2)(2009-8#1)
HCV infection##13##2##(2008-10#3)(2009-8#2)(2011-2#4)(2013-1#3)(2013-8#1)
HCV is##2##2##(2009-8#1)(2013-1#1)
HCV patients##2##2##(2008-8#1)(2013-1#1)
HCV replication by targeting the##2##5##(2013-1#2)
HCV replication##4##2##(2013-1#4)
HCV structural genes##2##3##(2008-8#2)
HCV##59##1##(1991-8#1)(1995-10#1)(2008-1#3)(2008-10#15)(2008-8#7)(2009-5#1)(2009-8#7)(2011-2#6)(2013-1#15)(2013-8#3)
HCV-induced##2##1##(2013-1#2)
HCV-infected##2##1##(2009-7#1)(2013-1#1)
HCV-positive##2##1##(2008-1#1)(2013-1#1)
HCV-specific CTL##2##2##(2013-1#2)
HCV-specific CTLs were##2##3##(2013-1#2)
HCV-specific CTLs##4##2##(2013-1#4)
HCV-specific cytotoxic T##2##3##(2013-1#2)
HCV-specific##8##1##(2013-1#8)
HCV-treatment##2##1##(2009-7#2)
HCWA and##3##2##(2008-10#3)
HCWA##8##1##(2008-10#8)
HCb in##2##2##(1993-3#2)
HCc##3##1##(2008-8#3)
HCl 0##2##2##(2008-10#2)
HCl acid-iodine##2##2##(2008-10#2)
HCl and H(2)O(2)##3##3##(2008-10#3)
HCl and HNO(3)##4##3##(2008-10#4)
HCl and determined##2##3##(2008-10#2)
HCl and the##3##3##(1992-6#1)(2008-10#1)(2009-10#1)
HCl and##31##2##(1992-6#1)(2008-10#28)(2009-10#2)
HCl concentration in the##3##4##(2008-10#3)
HCl concentration##6##2##(2008-10#6)
HCl directly to the##2##4##(2008-10#2)
HCl for CH(3)Hg(+) and##2##4##(2008-10#2)
HCl for##6##2##(2008-10#6)
HCl in##3##2##(2008-10#2)(2009-10#1)
HCl into##2##2##(1997-1#1)(2008-10#1)
HCl medium##7##2##(2008-10#7)
HCl or HNO(3)##4##3##(2008-10#4)
HCl or##9##2##(1997-2#1)(2008-10#8)
HCl solution##7##2##(2008-10#7)
HCl to the##2##3##(2008-10#2)
HCl to##6##2##(2008-10#6)
HCl was added to the##2##5##(2008-10#2)
HCl was##4##2##(2008-10#4)
HCl which##2##2##(2008-10#2)
HCl##162##1##(1992-6#1)(1997-1#1)(1997-2#1)(2008-10#155)(2008-11#1)(2009-10#3)
HCl) and##3##2##(2008-10#3)
HCl) were##2##2##(1996-2#1)(2008-10#1)
HCl)##14##1##(1996-2#1)(2008-10#13)
HCl+0##2##1##(2008-10#2)
HCl+HNO(3)##2##1##(2008-10#2)
HCl-0##2##1##(2008-10#2)
HCl/HNO(3)##3##1##(2008-10#3)
HClO and ClO(2)(-)##3##3##(2008-10#3)
HClO##4##1##(2008-10#4)
HClO(4) and##2##2##(2008-10#2)
HClO(4) digestion##4##2##(2008-10#4)
HClO(4)##11##1##(2008-10#11)
HD and##2##2##(2008-10#1)(2008-9#1)
HD individuals##3##2##(2011-8#3)
HD##23##1##(1996-8#4)(2008-1#1)(2008-10#4)(2008-9#3)(2011-10#2)(2011-2#5)(2011-8#4)
HDC gene##2##2##(1997-1#2)
HDC##8##1##(1997-1#6)(2008-10#2)
HDL acts to reduce##2##4##(2008-6#2)
HDL cholesterol concentrations##2##3##(1991-2#1)(2008-3#1)
HDL cholesterol##7##2##(1991-2#1)(1992-11#1)(2008-10#1)(2008-3#3)(2008-6#1)
HDL##21##1##(1991-2#1)(1992-11#1)(1997-8#1)(2008-10#1)(2008-3#4)(2008-6#9)(2010-4#1)(2011-2#3)
HDL-C levels##2##2##(2013-1#2)
HDL-C##8##1##(2008-10#1)(2008-3#2)(2013-1#5)
HDL-cholesterol##10##1##(1993-2#1)(1994-12#2)(2008-6#3)(2008-7#1)(2009-11#1)(2013-1#2)
HDL3-induced##3##1##(1994-11#3)
HDR##6##1##(2009-11#1)(2009-2#3)(2013-1#2)
HDV##4##1##(2009-8#4)
HDVC##2##1##(2010-8#2)
HE##4##1##(1992-3#1)(2008-10#2)(2011-3#1)
HEALTH##6##1##(1991-12#2)(1991-3#1)(2011-2#1)(2013-1#2)
HEART score##3##2##(2012-2#3)
HEC 1A##2##2##(1995-12#2)
HEC gel##3##2##(2008-5#3)
HEC##5##1##(1995-12#2)(2008-5#3)
HEDIS##3##1##(1995-2#3)
HEDP and ATMP##2##3##(2008-10#2)
HEDP##3##1##(2008-10#3)
HEG##5##1##(2008-10#5)
HEI score##6##2##(2011-2#6)
HEI##9##1##(2008-11#1)(2011-2#8)
HEK 293 cells##4##3##(2008-11#4)
HEK 293##9##2##(2008-11#8)(2011-2#1)
HEK##10##1##(2008-11#9)(2011-2#1)
HEK-293 cells##2##2##(2008-11#2)
HEK-293##3##1##(2008-11#3)
HEK293 and##2##2##(2008-11#2)
HEK293 cells##7##2##(2008-11#4)(2010-1#2)(2011-2#1)
HEK293##9##1##(2008-11#6)(2010-1#2)(2011-2#1)
HEL 299##2##2##(2008-11#2)
HEL cells##3##2##(1990-2#3)
HEL##8##1##(1990-2#3)(2008-10#1)(2008-11#4)
HEL117##5##1##(1995-6#5)
HEPES buffer##2##2##(2008-10#1)(2008-11#1)
HEPES##4##1##(1995-11#1)(2008-10#2)(2008-11#1)
HER-2/neu overexpression##3##2##(1997-7#3)
HER-2/neu##6##1##(1997-7#6)
HER-2/neu-overexpressing xenografts##2##2##(1997-7#2)
HER-2/neu-overexpressing##4##1##(1997-7#4)
HER2 amplified breast##2##3##(1993-1#2)
HER2##8##1##(1993-1#4)(2008-11#4)
HER2-positive##3##1##(2012-12#2)(2013-1#1)
HERV-H sequences##2##2##(1996-12#2)
HERV-H##5##1##(1996-12#5)
HEV71 and CVA16##2##3##(2013-8#2)
HEV71 and##3##2##(2013-8#3)
HEV71 isolates were##2##3##(2013-8#2)
HEV71 strains in##2##3##(2013-8#2)
HEV71 strains were##2##3##(2013-8#2)
HEV71 strains##13##2##(2013-8#13)
HEV71##20##1##(2013-8#20)
HEp-2##2##1##(2008-11#2)
HF + HClO(4) digestion##3##4##(2008-10#3)
HF and##6##2##(2008-10#6)
HF##35##1##(1993-1#1)(2008-10#28)(2010-12#1)(2011-2#2)(2013-8#3)
HF-HR-IMS##3##1##(2008-10#3)
HF-SCs##2##1##(2012-2#2)
HFA propellants##2##2##(1996-1#2)
HFA##3##1##(1992-3#1)(1996-1#2)
HFA-134a and HFA-227##3##3##(1992-3#3)
HFA134a and##2##2##(1996-1#1)(1996-2#1)
HFA134a is a##2##3##(1996-1#1)(1996-2#1)
HFA134a was devoid of##2##4##(1996-1#2)
HFA134a was##4##2##(1996-1#4)
HFA134a##22##1##(1996-1#19)(1996-2#3)
HFAs##2##1##(1996-1#2)
HFD test##4##2##(2008-7#4)
HFD##7##1##(2008-7#7)
HFE haemochromatosis##2##2##(2008-5#2)
HFE##3##1##(2008-5#3)
HFHS##2##1##(1994-2#2)
HFMD patients in##2##3##(2013-8#2)
HFMD##3##1##(2013-8#3)
HFS##4##1##(2008-12#2)(2008-7#2)
HG 3 cultivars##2##3##(2008-10#2)
HG 3##4##2##(2008-10#4)
HG and##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
HG have##2##2##(1992-8#1)(2008-7#1)
HG##36##1##(1992-8#5)(2008-1#3)(2008-10#19)(2008-11#2)(2008-7#6)(2011-2#1)
HG-AAS##3##1##(2008-10#3)
HG-AFS##2##1##(2008-10#2)
HG-I##2##1##(2008-10#2)
HG-II##4##1##(2008-10#4)
HG-III##3##1##(2008-10#3)
HGD/IMCA##3##1##(2010-12#3)
HGF and EGF##6##3##(1991-12#6)
HGF and##8##2##(1991-12#6)(2008-11#1)(2011-2#1)
HGF was##8##2##(1993-3#1)(2008-11#4)(2008-9#2)(2011-2#1)
HGF##36##1##(1991-12#10)(1993-3#3)(2008-11#13)(2008-8#3)(2008-9#5)(2011-2#2)
HGF-bound ECM##2##2##(1993-3#2)
HGSCs##4##1##(2012-12#4)
HHE in##2##2##(2011-1#2)
HHE##6##1##(2011-1#6)
HHE-related hypothyroidism##2##2##(2011-1#2)
HHS##6##1##(1991-9#2)(1993-1#1)(1994-2#1)(2012-3#1)(2013-1#1)
HI to##2##2##(2008-3#2)
HI##9##1##(1996-12#4)(2008-10#1)(2008-3#3)(2010-8#1)
HIC##3##1##(2008-10#3)
HIC1##6##1##(2009-8#6)
HIF-1 activation##3##2##(2010-7#3)
HIF-1 inhibitors##3##2##(2010-7#3)
HIF-1##10##1##(2009-4#2)(2010-7#8)
HIGH##2##1##(1993-8#1)(2012-3#1)
HIIE (p &lt##2##3##(2013-8#2)
HIIE (p##3##2##(2013-8#3)
HIIE##8##1##(2013-8#8)
HIK and TES##3##3##(2009-10#3)
HIK##4##1##(2009-10#4)
HIM professionals##2##2##(2007-12#2)
HIM##5##1##(2007-12#5)
HIMA##3##1##(1993-8#3)
HINKEL##2##1##(2009-10#2)
HIP##2##1##(1995-12#2)
HIPAA privacy##2##2##(2007-12#2)
HIPAA##4##1##(2007-12#2)(2008-9#2)
HIPVs##3##1##(2009-8#3)
HIS5##2##1##(1995-9#2)
HIT##6##1##(2010-3#6)
HIT-Elisa-positive##2##1##(2010-3#2)
HIT-T15##2##1##(2008-11#2)
HITRAN##3##1##(2008-3#3)
HIV / AIDS##3##3##(1997-6#3)
HIV Infection##3##2##(1996-5#2)(2008-1#1)
HIV LTR-CAT##3##2##(1993-8#3)
HIV Reverse Transcriptase##2##3##(2008-10#2)
HIV Sequence Database##2##3##(2013-1#2)
HIV among##4##2##(1991-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
HIV and AIDS##3##3##(1995-12#1)(2009-7#1)(2011-3#1)
HIV and hepatitis C virus##2##5##(2008-10#2)
HIV and hepatitis##3##3##(2008-10#2)(2008-6#1)
HIV and##19##2##(1990-6#1)(1991-3#1)(1993-5#1)(1995-12#1)(1995-5#1)(1997-3#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#2)(2009-7#1)(2011-2#1)(2011-3#1)
HIV antibody testing##2##3##(1995-1#2)
HIV antibody##5##2##(1993-6#1)(1995-1#3)(2008-5#1)
HIV as##2##2##(2012-2#1)(2013-1#1)
HIV can be transmitted##2##4##(1996-5#1)(2008-10#1)
HIV care##4##2##(2013-1#4)
HIV cases##3##2##(1997-6#3)
HIV disclosure##2##2##(1995-6#1)(1996-5#1)
HIV disease##12##2##(1992-1#1)(1995-6#3)(1996-3#2)(2009-7#1)(2011-2#2)(2013-1#3)
HIV envelope##2##2##(2008-4#2)
HIV epidemic in##3##3##(1990-12#1)(1995-1#1)(1996-11#1)
HIV epidemic##9##2##(1990-12#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#2)(2010-5#1)
HIV from##4##2##(1995-12#1)(1996-5#1)(2012-12#2)
HIV glycoproteins##2##2##(1991-5#2)
HIV heterosexually##3##2##(1996-11#2)(1997-6#1)
HIV in##10##2##(1994-9#1)(1996-11#2)(1996-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2011-2#2)(2013-1#1)
HIV infected patients##2##3##(1990-2#1)(2010-5#1)
HIV infected##8##2##(1990-2#1)(1993-12#1)(1995-12#2)(1996-11#1)(1997-5#1)(2008-11#1)(2010-5#1)
HIV infection and##5##3##(1996-11#2)(2010-12#1)(2013-8#2)
HIV infection in Norway (population 4##2##6##(1996-11#2)
HIV infection in the##2##4##(1993-11#1)(1996-11#1)
HIV infection in##10##3##(1991-1#2)(1993-11#2)(1995-6#1)(1996-11#3)(1996-8#1)(2012-12#1)
HIV infection intensities##2##3##(1994-9#2)
HIV infection on##3##3##(1992-9#2)(2013-8#1)
HIV infection was##2##3##(1997-5#1)(2011-2#1)
HIV infection##72##2##(1990-2#1)(1990-6#1)(1991-1#2)(1992-12#1)(1992-9#3)(1993-11#2)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-1#3)(1995-12#3)(1995-6#3)(1996-11#7)(1996-3#1)(1996-5#3)(1996-8#2)(1996-9#1)(1997-5#3)(1997-6#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#2)(2009-7#1)(2010-12#3)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#11)
HIV infection]##4##2##(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)
HIV infections##9##2##(1992-9#1)(1993-3#1)(1996-9#1)(1997-6#4)(2010-7#1)(2012-2#1)
HIV is##4##2##(1996-5#1)(2009-12#1)(2009-5#1)(2011-2#1)
HIV latency##3##2##(2012-12#3)
HIV may##2##2##(1993-8#1)(2010-12#1)
HIV negative patients##2##3##(1993-11#1)(2008-5#1)
HIV or AIDS##2##3##(1995-6#2)
HIV or##5##2##(1993-1#1)(1995-6#3)(2008-6#1)
HIV organizations##2##2##(2009-5#2)
HIV positive patient##2##3##(2010-12#2)
HIV positive patients##7##3##(1993-11#1)(2008-5#5)(2010-12#1)
HIV positive##16##2##(1993-11#4)(1997-6#1)(2008-5#5)(2010-12#4)(2011-2#1)(2013-1#1)
HIV positivity##2##2##(1991-1#1)(2008-10#1)
HIV prevalence and##2##3##(1992-9#2)
HIV prevalence##7##2##(1990-6#1)(1992-9#2)(2008-10#1)(2011-2#2)(2012-3#1)
HIV prevention and##2##3##(2008-12#1)(2009-5#1)
HIV prevention community planning##4##4##(1997-2#4)
HIV prevention##12##2##(1995-12#1)(1996-11#1)(1996-5#1)(1997-2#4)(2008-1#1)(2008-12#1)(2009-5#3)
HIV replication##3##2##(1990-8#1)(1995-2#1)(2008-4#1)
HIV risk##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2010-7#1)
HIV screening##2##2##(2008-1#1)(2008-5#1)
HIV seroconversion##2##2##(1990-3#1)(2009-12#1)
HIV seropositive individuals and##2##4##(2013-8#2)
HIV seropositive##6##2##(1995-1#1)(2009-11#1)(2010-7#1)(2013-8#3)
HIV seropositivity##3##2##(1991-1#1)(1993-11#1)(2008-5#1)
HIV sexual risk behavior##3##4##(2008-12#3)
HIV spread##2##2##(1996-11#2)
HIV status##9##2##(1995-12#1)(1995-6#1)(1996-5#5)(2008-10#1)(2011-2#1)
HIV test##4##2##(1995-12#1)(1996-5#1)(2009-5#2)
HIV testing among##2##3##(2009-5#2)
HIV testing and##2##3##(2009-5#2)
HIV testing in##2##3##(1996-8#1)(2009-5#1)
HIV testing of##3##3##(1990-3#1)(1995-1#1)(1995-12#1)
HIV testing##11##2##(1990-3#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-8#1)(2009-5#6)
HIV transcription##4##2##(1995-2#1)(2008-4#1)(2012-12#2)
HIV transmission and##2##3##(1997-6#1)(2012-2#1)
HIV transmission to##2##3##(1992-12#1)(1995-6#1)
HIV transmission##12##2##(1991-1#2)(1992-12#1)(1995-6#1)(1996-5#1)(1997-6#1)(2008-10#1)(2009-5#1)(2012-2#2)(2013-1#2)
HIV##458##1##(1990-12#1)(1990-2#3)(1990-3#3)(1990-6#4)(1990-8#1)(1991-1#7)(1991-2#1)(1991-3#1)(1991-5#3)(1992-1#1)(1992-12#2)(1992-9#9)(1993-1#1)(1993-11#8)(1993-12#4)(1993-3#6)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#4)(1994-5#1)(1994-8#1)(1994-9#6)(1995-1#9)(1995-12#21)(1995-2#3)(1995-5#4)(1995-6#20)(1996-11#22)(1996-12#1)(1996-3#4)(1996-5#40)(1996-6#1)(1996-8#3)(1996-9#4)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#7)(1997-6#18)(1997-7#1)(2007-12#3)(2008-1#8)(2008-10#25)(2008-11#6)(2008-12#7)(2008-2#2)(2008-4#9)(2008-5#15)(2008-6#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#4)(2009-5#19)(2009-7#4)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#11)(2010-5#4)(2010-7#4)(2011-2#20)(2011-3#6)(2012-12#10)(2012-2#9)(2012-3#2)(2013-1#21)(2013-8#15)
HIV+##4##1##(1996-3#1)(2008-1#1)(2008-10#2)
HIV-1 CRF07_BC##2##2##(2013-8#2)
HIV-1 Infection##5##2##(2008-2#4)(2009-9#1)
HIV-1 PR were##2##3##(1991-9#2)
HIV-1 PR##5##2##(1991-9#3)(2011-3#2)
HIV-1 Rev##3##2##(1993-8#2)(2011-3#1)
HIV-1 Tat##5##2##(1993-2#2)(1994-11#1)(2009-8#2)
HIV-1 Vpr has##2##3##(1997-3#2)
HIV-1 Vpr##3##2##(1997-3#3)
HIV-1 activity in vitro##2##4##(1996-5#2)
HIV-1 and HIV-2##2##3##(1992-6#1)(2011-2#1)
HIV-1 and##3##2##(1992-6#1)(1996-9#1)(2011-2#1)
HIV-1 fusion inhibitors##2##3##(2011-3#2)
HIV-1 fusion##3##2##(2011-3#3)
HIV-1 group N##3##3##(2013-1#3)
HIV-1 in##5##2##(1992-12#1)(1992-9#2)(1994-11#1)(1994-6#1)
HIV-1 infected individuals##4##3##(1990-2#1)(2008-11#3)
HIV-1 infected##9##2##(1990-2#1)(1997-3#1)(2008-11#5)(2011-2#1)(2011-3#1)
HIV-1 infection##15##2##(1990-2#2)(1991-1#1)(2008-11#4)(2008-2#5)(2010-11#2)(2013-1#1)
HIV-1 integrase##6##2##(1992-6#2)(2011-3#4)
HIV-1 long terminal repeat##2##4##(1992-12#1)(1994-5#1)
HIV-1 matrix##2##2##(2013-1#2)
HIV-1 particles are##2##3##(1997-3#2)
HIV-1 positive##2##2##(2009-8#2)
HIV-1 preparations##2##2##(1997-3#2)
HIV-1 production##3##2##(1992-12#1)(1994-11#2)
HIV-1 protease##6##2##(1991-9#3)(1992-6#1)(2011-3#2)
HIV-1 replication##6##2##(2011-3#5)(2013-1#1)
HIV-1 replicative enzymes##3##3##(2011-3#3)
HIV-1 reverse transcriptase##4##3##(1991-9#1)(2011-2#1)(2011-3#2)
HIV-1 seropositive##2##2##(1990-2#1)(2013-8#1)
HIV-1 strain##3##2##(2011-2#1)(2011-3#2)
HIV-1 subtypes##5##2##(2013-1#5)
HIV-1##180##1##(1990-2#5)(1991-1#1)(1991-2#1)(1991-9#9)(1992-12#5)(1992-6#4)(1992-9#8)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#7)(1994-5#1)(1994-6#1)(1996-5#2)(1996-9#1)(1997-3#14)(1997-6#1)(2008-11#16)(2008-2#10)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#5)(2009-9#1)(2010-11#2)(2011-2#9)(2011-3#48)(2013-1#16)(2013-8#4)
HIV-1-infected##4##1##(1994-11#1)(1997-3#1)(2008-5#1)(2009-8#1)
HIV-1-related##2##1##(1997-5#1)(2011-3#1)
HIV-2 and##2##2##(1997-3#1)(2011-2#1)
HIV-2##7##1##(1992-6#1)(1994-11#1)(1997-3#4)(2011-2#1)
HIV-Infected Patient##2##2##(2011-2#2)
HIV-Infected##4##1##(2011-2#4)
HIV-TB-coinfected patients##2##2##(2010-5#2)
HIV-antibody home test##2##3##(1996-5#2)
HIV-antibody home##3##2##(1996-5#3)
HIV-antibody testing##5##2##(1996-5#5)
HIV-antibody##10##1##(1996-5#10)
HIV-associated nephropathy##2##2##(2008-1#1)(2012-2#1)
HIV-associated neurocognitive##2##2##(2011-2#2)
HIV-associated##5##1##(2008-1#1)(2008-11#1)(2011-2#2)(2012-2#1)
HIV-epidemic in##2##2##(1996-11#2)
HIV-epidemic##4##1##(1996-11#4)
HIV-induced##2##1##(2008-11#1)(2011-2#1)
HIV-infected hemophiliacs##2##2##(1996-5#2)
HIV-infected individuals##2##2##(2008-5#1)(2009-7#1)
HIV-infected or AIDS patients##2##4##(2008-5#2)
HIV-infected patients with##2##3##(2008-5#1)(2011-2#1)
HIV-infected patients##13##2##(1995-6#1)(1996-11#1)(1996-9#1)(2008-1#1)(2008-5#2)(2008-9#1)(2010-5#1)(2011-2#4)(2011-3#1)
HIV-infected persons##2##2##(1997-6#2)
HIV-infected subjects##2##2##(2009-12#2)
HIV-infected##39##1##(1991-5#1)(1991-9#1)(1992-12#1)(1993-3#2)(1993-9#1)(1995-12#1)(1995-6#1)(1996-11#2)(1996-5#2)(1996-9#2)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#5)(2008-9#1)(2009-12#2)(2009-7#3)(2010-5#1)(2011-2#6)(2011-3#1)(2013-1#1)
HIV-infection##3##1##(1996-9#1)(2007-12#1)(2008-1#1)
HIV-negative men##2##2##(2009-12#1)(2009-5#1)
HIV-negative##6##1##(1996-5#1)(2008-5#1)(2009-12#2)(2009-5#1)(2012-3#1)
HIV-positive individuals##3##2##(1994-1#1)(2008-1#1)(2013-1#1)
HIV-positive patients in##2##3##(2008-5#1)(2009-8#1)
HIV-positive patients##6##2##(1995-6#1)(2008-5#2)(2009-8#1)(2013-1#2)
HIV-positive service members##2##3##(1995-6#2)
HIV-positive##35##1##(1990-3#2)(1992-12#2)(1994-1#1)(1995-12#2)(1995-6#7)(1996-5#5)(1997-5#1)(1997-6#1)(2006-5#1)(2008-1#4)(2008-11#1)(2008-12#1)(2008-5#2)(2009-5#1)(2009-8#1)(2013-1#3)
HIV-related##8##1##(1991-1#1)(1995-1#1)(1995-12#2)(2008-10#1)(2008-11#1)(2009-10#1)(2010-7#1)
HIV-risk reduction##2##2##(2008-6#2)
HIV-specific responses##2##2##(2013-8#2)
HIV/AIDS and STI##2##3##(2008-10#1)(2008-12#1)
HIV/AIDS and##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2012-2#1)
HIV/AIDS conspiracy theories##3##3##(2013-1#3)
HIV/AIDS have##2##2##(1995-12#1)(2011-3#1)
HIV/AIDS in##2##2##(2008-1#1)(2009-7#1)
HIV/AIDS prevention##3##2##(2008-10#2)(2009-6#1)
HIV/AIDS surveillance##2##2##(1997-3#2)
HIV/AIDS##53##1##(1990-2#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-5#1)(1997-2#4)(1997-3#2)(1997-6#4)(2008-1#4)(2008-10#9)(2008-12#2)(2008-6#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
HIV?##2##1##(1991-1#1)(2010-5#1)
HIVAN##2##1##(2008-1#2)
HK##4##1##(1996-8#1)(2011-2#3)
HKD animals##2##2##(1991-5#2)
HKD rats##2##2##(1991-5#2)
HKD##5##1##(1991-5#5)
HL patients##3##2##(1992-12#3)
HL##8##1##(1990-12#1)(1991-2#4)(1992-12#3)
HL-1 cells##2##2##(2008-7#2)
HL-1 cells)##2##2##(2008-7#2)
HL-1##4##1##(2008-7#4)
HL-60 Cells##2##2##(2011-2#2)
HL-60 and##2##2##(1995-3#1)(1995-8#1)
HL-60 cell line##2##3##(1993-8#2)
HL-60 cell##4##2##(1993-8#2)(2008-8#1)(2008-9#1)
HL-60 cells and##3##3##(1994-8#1)(1995-6#1)(2008-11#1)
HL-60 cells by##3##3##(1993-8#2)(1994-11#1)
HL-60 cells induced by##2##4##(1994-8#1)(2008-8#1)
HL-60 cells##33##2##(1993-8#5)(1994-11#3)(1994-8#3)(1995-3#1)(1995-6#3)(1996-2#2)(2008-11#6)(2008-8#8)(2011-2#2)
HL-60##52##1##(1990-2#1)(1993-6#1)(1993-8#7)(1994-11#3)(1994-8#4)(1995-3#5)(1995-6#4)(1995-8#1)(1996-2#2)(2008-11#9)(2008-8#9)(2008-9#1)(2011-2#5)
HL-60/R-CP cells##3##2##(2008-11#3)
HL60 cells##2##2##(2012-12#2)
HL60##6##1##(1993-3#1)(2008-9#2)(2012-12#3)
HLA Class I##2##3##(2011-2#2)
HLA DR and beta 2-M##2##5##(1997-3#2)
HLA DR and beta##3##4##(1997-3#3)
HLA class I##11##3##(1994-5#1)(1997-8#1)(1997-9#6)(2008-4#1)(2008-8#1)(2011-2#1)
HLA class II##6##3##(1995-12#1)(1997-8#4)(1997-9#1)
HLA class##18##2##(1994-5#1)(1995-12#1)(1997-8#5)(1997-9#8)(2008-4#1)(2008-8#1)(2011-2#1)
HLA genes##3##2##(1991-2#1)(1997-8#2)
HLA heavy##2##2##(1991-2#1)(1997-9#1)
HLA matched##2##2##(2011-2#2)
HLA molecules##4##2##(2008-4#1)(2008-9#2)(2011-2#1)
HLA typing##2##2##(1997-8#1)(2008-11#1)
HLA##58##1##(1991-11#1)(1991-2#2)(1993-3#1)(1994-5#1)(1995-12#1)(1996-6#1)(1997-3#3)(1997-5#2)(1997-8#9)(1997-9#11)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#7)(2009-8#1)(2011-2#9)
HLA-A*0201-restricted##3##1##(2011-2#3)
HLA-A11##3##1##(2008-7#2)(2011-2#1)
HLA-A2##2##1##(2008-8#2)
HLA-B##4##1##(1997-8#4)
HLA-B52 and B39##3##3##(1997-8#3)
HLA-B52##5##1##(1997-8#5)
HLA-DQ##2##1##(1997-3#1)(1997-9#1)
HLA-DR and##3##2##(1991-2#2)(1997-9#1)
HLA-DR##7##1##(1991-2#3)(1997-3#2)(1997-9#1)(2008-3#1)
HLA-DR-containing##2##1##(1997-3#2)
HLA-Dr##3##1##(1990-12#3)
HLA-class I##2##2##(1991-3#1)(1997-8#1)
HLA-linked##2##1##(1997-8#2)
HLA-matched##2##1##(2010-11#1)(2012-12#1)
HLA/GO##2##1##(2008-10#2)
HLB##7##1##(2008-10#7)
HLE##6##1##(1992-12#3)(1993-8#3)
HLH##2##1##(2011-2#2)
HM and##4##2##(2008-10#1)(2008-9#3)
HM##13##1##(2008-10#5)(2008-9#8)
HM-heart##2##1##(2008-9#2)
HMA##7##1##(2008-10#7)
HMC-1 cells##2##2##(2011-2#2)
HMC-1##4##1##(2011-2#4)
HMDE and a##2##3##(2008-10#2)
HMDE and##3##2##(2008-10#3)
HMDE##5##1##(2008-10#5)
HMEs##6##1##(1992-2#6)
HMF##8##1##(2008-10#2)(2008-11#3)(2011-1#3)
HMG 1 was##2##3##(1990-3#2)
HMG 14##2##2##(1990-3#2)
HMG 17##2##2##(1990-3#2)
HMG 2 in young##2##4##(1990-3#2)
HMG 2 in##3##3##(1990-3#3)
HMG 2##5##2##(1990-3#5)
HMG box##2##2##(2008-8#1)(2010-5#1)
HMG domain##2##2##(1995-8#2)
HMG proteins and##3##3##(1990-3#1)(2008-8#2)
HMG proteins may##2##3##(1990-3#1)(2008-8#1)
HMG proteins##8##2##(1990-3#2)(2008-8#6)
HMG##26##1##(1990-3#13)(1993-2#1)(1995-8#3)(2008-8#7)(2010-5#1)(2013-1#1)
HMG-14##2##1##(1993-2#2)
HMG-14a is##2##2##(1993-2#2)
HMG-14a##5##1##(1993-2#5)
HMG-CoA reductase activity##2##3##(1993-6#1)(2008-10#1)
HMG-CoA reductase##5##2##(1991-12#2)(1993-6#1)(2008-10#1)(2008-11#1)
HMG1-induced##2##1##(1997-6#2)
HMG1/2##2##1##(2008-8#2)
HMG14/17##2##1##(2008-8#2)
HMGA2 by downregulating##2##3##(2012-12#2)
HMGA2 expression##2##2##(2012-12#2)
HMGA2##7##1##(2012-12#7)
HMGI proteins##2##2##(1995-8#2)
HMHs##2##1##(1992-12#2)
HMK and HSK##3##3##(1993-12#3)
HMK##6##1##(1993-12#6)
HMM##5##1##(1996-12#1)(1997-2#3)(2009-7#1)
HMO and##2##2##(1996-2#1)(2008-11#1)
HMO enrollees##4##2##(1994-3#2)(1997-2#2)
HMO payments##2##2##(1993-3#1)(1997-2#1)
HMO penetration##3##2##(2008-11#3)
HMO performance##2##2##(1991-3#1)(1996-2#1)
HMO respondents##2##2##(1997-2#2)
HMO to##2##2##(1994-12#2)
HMO##44##1##(1991-3#7)(1991-9#2)(1992-1#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#3)(1994-12#2)(1994-3#4)(1996-2#5)(1996-3#3)(1997-2#6)(2008-11#5)
HMO(4)Q##4##1##(2008-10#4)
HMOs and##3##2##(1991-3#1)(1997-2#2)
HMOs are##2##2##(1991-3#1)(1993-1#1)
HMOs offer Medicare##2##3##(1996-3#2)
HMOs that##2##2##(1991-3#1)(1997-2#1)
HMOs to##4##2##(1993-3#1)(1996-3#2)(1997-2#1)
HMOs##34##1##(1991-1#1)(1991-3#7)(1993-1#1)(1993-3#3)(1994-3#3)(1996-3#5)(1997-2#8)(1997-6#1)(2008-11#2)(2008-6#3)
HMQ##7##1##(2008-10#7)
HMQ)##2##1##(2008-10#2)
HMV-1 cells##4##2##(2008-11#4)
HMV-1##5##1##(2008-11#5)
HMW HA##2##2##(2010-8#2)
HMW PAH biodegradation##3##3##(2011-1#3)
HMW##6##1##(2008-10#1)(2010-8#2)(2011-1#3)
HMW-BCGF and Bb##2##3##(1991-3#2)
HMW-BCGF and##3##2##(1991-3#3)
HMW-BCGF but not Bb##2##4##(1991-3#2)
HMW-BCGF receptor##2##2##(1991-3#2)
HMW-BCGF##10##1##(1991-3#10)
HMW-pp185##3##1##(1992-10#3)
HMX and TNT##2##3##(2008-10#2)
HMX##10##1##(2008-10#10)
HMX)##2##1##(2008-10#1)(2008-11#1)
HN gene##3##2##(2008-11#1)(2008-9#2)
HN mRNA##2##2##(2008-9#2)
HN##7##1##(2008-11#1)(2008-9#6)
HN30##2##1##(2011-2#2)
HNE##2##1##(2008-5#2)
HNG##5##1##(2012-12#5)
HNO(3) and 0##6##3##(2008-10#6)
HNO(3) and H(2)O(2)##5##3##(2008-10#5)
HNO(3) and HF##2##3##(2008-10#2)
HNO(3) and##26##2##(2008-10#26)
HNO(3) as##2##2##(2008-10#2)
HNO(3) at a flow rate of##2##6##(2008-10#2)
HNO(3) at##3##2##(2008-10#3)
HNO(3) concentration##2##2##(2008-10#2)
HNO(3) in##5##2##(2008-10#5)
HNO(3) medium##2##2##(2008-10#2)
HNO(3) solution and##2##3##(2008-10#2)
HNO(3) solution##4##2##(2008-10#4)
HNO(3)##109##1##(1991-5#1)(2008-10#107)(2008-3#1)
HNO(3)) and##2##2##(2008-10#2)
HNO(3))##3##1##(2008-10#3)
HNO(3)-HF##2##1##(2008-10#2)
HNPP##3##1##(1997-3#3)
HNR##2##1##(2008-10#2)
HNSCC##4##1##(1997-7#4)
HO sensitivity##3##2##(1991-6#3)
HO##17##1##(1991-6#3)(1994-5#1)(1995-2#4)(2008-10#2)(2012-2#7)
HO-1##9##1##(1995-2#3)(2011-2#6)
HOE's##2##1##(2008-3#2)
HOLMES##2##1##(2008-10#2)
HOMA &gt##2##2##(2012-5#2)
HOMA##4##1##(2012-5#4)
HOMA-IR##8##1##(2010-4#3)(2011-1#3)(2013-8#2)
HOPD##2##1##(1992-12#2)
HOR type##2##2##(2008-7#2)
HOR##4##1##(2008-7#4)
HORs in##2##2##(2008-7#2)
HORs##5##1##(2008-7#5)
HP##9##1##(1991-5#4)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
HP-beta-CD##5##1##(2008-10#5)
HP1 paralogs##2##2##(2013-1#2)
HP1 proteins##3##2##(2013-1#3)
HP1##5##1##(2013-1#5)
HP1α and β##2##3##(2013-1#2)
HPA axis function##3##3##(2013-1#3)
HPA axis##9##2##(1994-2#2)(1995-12#1)(2008-11#2)(2013-1#4)
HPA##10##1##(1994-2#2)(1995-12#1)(2008-10#1)(2008-11#2)(2013-1#4)
HPA-1 platelet##2##2##(1991-11#2)
HPA-1a##3##1##(1991-11#3)
HPAEC-PAD was##3##2##(1991-7#3)
HPB##9##1##(2008-10#2)(2011-2#2)(2013-1#5)
HPCE##5##1##(2008-10#5)
HPCM##2##1##(1994-3#2)
HPD##3##1##(2013-1#3)
HPE##5##1##(2011-1#4)(2013-1#1)
HPLC after##2##2##(1990-12#1)(2008-10#1)
HPLC analysis of##3##3##(1993-8#1)(1995-8#1)(2008-11#1)
HPLC analysis##9##2##(1993-11#1)(1993-8#1)(1995-8#1)(2008-10#3)(2008-11#2)(2008-8#1)
HPLC and GC-MS##2##3##(2008-10#2)
HPLC and HPCE##2##3##(2008-10#2)
HPLC and Raman spectroscopy##2##4##(2008-10#2)
HPLC and##23##2##(1990-2#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)
HPLC as##2##2##(2008-10#2)
HPLC assay was##3##3##(2008-10#3)
HPLC assay##8##2##(1997-2#1)(2008-10#7)
HPLC column##6##2##(1997-2#1)(2008-10#4)(2009-8#1)
HPLC columns##5##2##(1997-2#1)(2008-10#2)(2008-4#2)
HPLC determination of##8##3##(2008-10#7)(2008-5#1)
HPLC equipment##3##2##(2008-10#3)
HPLC fingerprint of##2##3##(2012-3#1)(2013-8#1)
HPLC for the##3##3##(2008-10#3)
HPLC for##4##2##(2008-10#4)
HPLC gave a##2##3##(1994-5#1)(2008-10#1)
HPLC in##2##2##(2008-10#2)
HPLC is##2##2##(2008-10#1)(2008-8#1)
HPLC method can##2##3##(2008-10#2)
HPLC method for the##3##4##(2008-10#3)
HPLC method for##5##3##(2008-10#5)
HPLC method has been developed for the##2##7##(2008-10#1)(2008-11#1)
HPLC method has been##3##4##(2008-10#2)(2008-11#1)
HPLC method was##4##3##(2008-10#4)
HPLC method with##6##3##(2008-10#6)
HPLC method##41##2##(1997-2#1)(2008-10#34)(2008-11#1)(2008-5#1)(2009-8#2)(2011-1#2)
HPLC methods##8##2##(1994-8#1)(2008-10#5)(2008-9#1)(2011-2#1)
HPLC of##2##2##(2008-10#1)(2009-8#1)
HPLC on##2##2##(1992-12#1)(1996-12#1)
HPLC post-column flow injection system for##2##6##(2008-10#2)
HPLC procedure##3##2##(2008-10#3)
HPLC separation and##2##3##(2008-10#2)
HPLC separation of##4##3##(2008-10#4)
HPLC separation##10##2##(2008-10#10)
HPLC stationary phase##2##3##(2008-10#2)
HPLC system for##2##3##(2008-10#2)
HPLC system##8##2##(2008-10#7)(2008-4#1)
HPLC systems##2##2##(1990-11#1)(2008-11#1)
HPLC technique##2##2##(1992-9#1)(2008-10#1)
HPLC to##3##2##(2008-10#2)(2012-2#1)
HPLC using a##3##3##(1993-11#1)(2008-10#2)
HPLC using##9##2##(1993-11#1)(2008-10#7)(2008-11#1)
HPLC versus##2##2##(2008-10#2)
HPLC with UV detection##3##4##(2008-10#3)
HPLC with a##2##3##(2008-10#2)
HPLC with##16##2##(1990-5#1)(2008-10#15)
HPLC##297##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1992-12#2)(1992-2#2)(1992-9#1)(1993-11#2)(1993-8#1)(1994-5#1)(1994-8#3)(1995-8#1)(1996-12#2)(1997-2#7)(2008-10#215)(2008-11#10)(2008-12#1)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-6#1)(2009-8#7)(2010-2#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
HPLC)##2##1##(2008-10#2)
HPLC-(UV)-HG-AFS##3##1##(2008-10#3)
HPLC-DAD##3##1##(2008-10#3)
HPLC-EC##3##1##(2008-10#3)
HPLC-ECD method is##2##3##(2008-10#2)
HPLC-ECD method##3##2##(2008-10#3)
HPLC-ECD##6##1##(1991-3#2)(2008-10#4)
HPLC-ELSD fingerprints and biological##2##4##(2011-3#2)
HPLC-ELSD fingerprints##4##2##(2011-3#4)
HPLC-ICP-MS##6##1##(2008-10#6)
HPLC-ICPMS and##2##2##(2010-11#2)
HPLC-ICPMS##5##1##(2008-10#3)(2010-11#2)
HPLC-TLS##3##1##(2008-10#3)
HPLC-UV method##2##2##(2008-10#1)(2013-1#1)
HPLC-UV##9##1##(2008-10#7)(2013-1#1)(2013-8#1)
HPLC-fluorescence method##2##2##(2008-10#2)
HPLC-fluorescence##3##1##(2008-10#3)
HPLC-reference method##2##2##(2008-10#2)
HPLC/UV##3##1##(2008-5#3)
HPLC/fluorescence derivatization##2##2##(2008-10#2)
HPO(4)(2-)##3##1##(2008-10#3)
HPP##5##1##(2010-4#5)
HPSAM and##3##2##(2008-10#3)
HPSAM is##2##2##(2008-10#2)
HPSAM##8##1##(2008-10#8)
HPTLC method##2##2##(2008-10#2)
HPTLC##9##1##(2008-10#7)(2008-11#1)(2008-5#1)
HPTP treatment##3##2##(1996-12#3)
HPTP##4##1##(1996-12#4)
HPTP-treated##2##1##(1996-12#2)
HPV 6/11##3##2##(1994-1#3)
HPV DNA was found##2##4##(1994-1#2)
HPV DNA##5##2##(1994-1#4)(2012-3#1)
HPV infection##4##2##(1992-3#1)(2008-11#1)(2011-2#1)(2011-3#1)
HPV testing##2##2##(1994-1#1)(2008-11#1)
HPV types##4##2##(1994-1#3)(2008-11#1)
HPV vaccine##3##2##(2008-11#2)(2010-8#1)
HPV##40##1##(1992-10#1)(1992-3#7)(1994-1#14)(2008-10#1)(2008-11#6)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#3)(2013-1#2)
HPV-16 infection and##2##3##(2011-3#2)
HPV-16 infection##4##2##(2011-3#4)
HPV-16##7##1##(1995-2#2)(2011-3#5)
HPV-6/11/16/18##3##1##(2013-1#3)
HPV-related##3##1##(1994-1#2)(2008-11#1)
HPg##4##1##(1993-8#4)
HPlg or##2##2##(1993-8#2)
HPlg##3##1##(1993-8#3)
HPlm##2##1##(1993-8#2)
HQ anchored polymeric resin##2##4##(2008-10#2)
HQ anchored resin##2##3##(2008-10#2)
HQ anchored##4##2##(2008-10#4)
HQ##7##1##(2008-10#7)
HR and##7##2##(2008-10#2)(2012-2#1)(2013-1#1)(2013-8#3)
HR deceleration##3##2##(2013-8#3)
HR induction##3##2##(2008-10#3)
HR was##5##2##(2008-10#3)(2010-7#1)(2013-8#1)
HR##56##1##(1996-3#1)(1996-5#1)(2008-10#26)(2008-11#4)(2009-8#1)(2010-7#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#15)
HR-QoL##2##1##(2012-12#2)
HRANAFINA--Croatian##2##1##(2013-1#2)
HRCT findings##2##2##(2011-2#1)(2012-2#1)
HRCT##10##1##(2011-2#6)(2012-12#1)(2012-2#3)
HRG##2##1##(1995-2#2)
HRMS##3##1##(2008-10#3)
HRP and##4##2##(2008-10#3)(2012-4#1)
HRP as##2##2##(2008-10#2)
HRP catalyzes##2##2##(2008-10#2)
HRP immobilized##2##2##(2008-10#2)
HRP is##4##2##(2008-10#4)
HRP was##3##2##(2008-10#3)
HRP with##3##2##(2008-10#3)
HRP##53##1##(1990-9#1)(2008-10#44)(2012-2#1)(2012-4#7)
HRP-SjAb##5##1##(2008-10#5)
HRP-labeled##6##1##(2008-10#6)
HRQOL##2##1##(2008-7#1)(2011-2#1)
HRT in##2##2##(1997-6#1)(2010-12#1)
HRV and##2##2##(2010-12#1)(2013-8#1)
HRV measures##2##2##(2013-8#2)
HRV##23##1##(2009-11#3)(2010-12#2)(2010-5#1)(2011-2#3)(2012-2#1)(2013-8#13)
HRV-positive samples##2##2##(2013-8#2)
HRV-positive##3##1##(2013-8#3)
HS fractions##3##2##(2008-10#3)
HS were##2##2##(2008-10#2)
HS##27##1##(1996-2#1)(2008-10#25)(2008-5#1)
HS-LPME##2##1##(2008-10#2)
HS-SPME method##2##2##(2008-10#2)
HS-SPME##6##1##(2008-10#6)
HS-SPME-GC-MS##2##1##(2008-10#2)
HS-SPME-GC/ECD##2##1##(2009-8#2)
HS-metal species##2##2##(2008-10#2)
HS-metal##3##1##(2008-10#3)
HS191R##2##1##(2008-10#2)
HS2##2##1##(2008-9#2)
HS2core DNA sequence##4##3##(2008-8#4)
HSA and##3##2##(1997-2#1)(2008-10#2)
HSA binding##3##2##(2008-10#3)
HSA in##2##2##(2008-10#2)
HSA was##2##2##(2008-10#2)
HSA##32##1##(1997-2#1)(1997-6#2)(2008-10#26)(2011-2#3)
HSAG-1##4##1##(1991-6#4)
HSC##8##1##(1991-2#1)(2008-10#4)(2008-11#2)(2009-12#1)
HSC-T6##4##1##(2008-11#4)
HSC1##2##1##(1993-6#2)
HSC3##2##1##(1993-6#2)
HSC5##2##1##(1993-6#2)
HSCCC##3##1##(2008-10#3)
HSCR##3##1##(1994-12#3)
HSCT##2##1##(2010-11#2)
HSCs in##2##2##(2009-12#2)
HSCs##7##1##(1993-8#1)(2008-4#1)(2009-12#3)(2009-7#2)
HSD##2##1##(1994-2#2)
HSF##6##1##(1993-6#1)(1994-8#1)(2008-5#4)
HSG##6##1##(1993-1#1)(2011-2#5)
HSK##4##1##(1993-12#4)
HSO(3)(-)##5##1##(2008-10#5)
HSP##4##1##(1993-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
HSP28 gene expression##2##3##(1994-8#2)
HSP28 gene##3##2##(1994-8#3)
HSP28##7##1##(1994-8#7)
HSP70 and HSP28##2##3##(1994-8#2)
HSP70 and##4##2##(1993-8#1)(1994-8#2)(2008-9#1)
HSP70 gene expression##2##3##(1994-8#2)
HSP70 gene##4##2##(1993-6#1)(1994-8#3)
HSP70 mRNA and cortisol##2##4##(2008-6#2)
HSP70 mRNA expression##4##3##(2008-6#4)
HSP70 mRNA##8##2##(1994-8#1)(2008-6#7)
HSP70 sequences##3##2##(2008-10#3)
HSP70##35##1##(1993-6#1)(1993-8#2)(1993-9#2)(1994-8#9)(2008-10#7)(2008-6#7)(2008-9#2)(2009-6#1)(2010-5#4)
HSP90 levels##2##2##(1993-8#2)
HSP90##6##1##(1993-8#5)(2009-6#1)
HSRV weights##2##2##(1992-12#2)
HSS and IKDC##4##3##(2013-1#4)
HSS##6##1##(2008-8#1)(2013-1#5)
HSSPME##4##1##(2008-10#4)
HSTs produced by##2##3##(2008-10#2)
HSTs##3##1##(2008-10#3)
HSV from##2##2##(2008-11#2)
HSV##6##1##(1993-8#1)(2008-11#4)(2011-3#1)
HSV-1 amplicon##3##2##(2008-8#3)
HSV-1##9##1##(1994-11#1)(2008-8#8)
HSV-2##5##1##(2008-11#2)(2013-8#3)
HSV1-rc/DeltaUL2##2##1##(2008-9#2)
HSVd and CVd-IV##2##3##(2008-10#2)
HSVd sequences##2##2##(2008-10#2)
HSVd##4##1##(2008-10#4)
HT plan##3##2##(2008-11#3)
HT##13##1##(1996-3#4)(2008-11#4)(2008-8#3)(2011-2#2)
HT-29 cells##3##2##(1994-3#2)(1994-8#1)
HT-29##4##1##(1994-3#2)(1994-8#1)(2010-1#1)
HT-induced apoptosis##3##2##(2008-8#3)
HT-induced##4##1##(2008-8#4)
HT1080 cells##2##2##(2008-11#2)
HT1080##4##1##(2008-11#4)
HT29-19A##4##1##(1994-3#4)
HTH##2##1##(1992-4#1)(2012-2#1)
HTIFs##2##1##(2010-4#2)
HTLV-1##4##1##(1990-3#1)(1994-11#1)(2011-2#2)
HTLV-I LTR transcriptional activation##2##4##(1994-11#2)
HTLV-I LTR##4##2##(1994-11#3)(2008-8#1)
HTLV-I tax##3##2##(2008-8#3)
HTLV-I##11##1##(1991-3#1)(1994-11#4)(2008-4#1)(2008-8#5)
HTR##2##1##(1993-2#2)
HTS##3##1##(2008-10#2)(2012-2#1)
HU protein##4##2##(1994-11#1)(1997-6#3)
HU##12##1##(1994-11#3)(1997-6#3)(1997-8#4)(2012-3#2)
HU-mediated inhibition##2##2##(1994-11#2)
HUC2-13##4##1##(2008-11#4)
HUH7-ins##7##1##(2010-11#7)
HUVEC for##3##2##(2008-11#1)(2008-9#2)
HUVEC in##2##2##(2008-11#1)(2012-2#1)
HUVEC is##2##2##(2008-8#2)
HUVEC##20##1##(1994-8#1)(1997-1#2)(2008-11#6)(2008-8#4)(2008-9#4)(2010-3#1)(2012-2#2)
HV##6##1##(1992-6#1)(2008-10#1)(2010-6#2)(2011-2#2)
HVS activity##2##2##(1991-12#2)
HVS##3##1##(1991-12#3)
HW##2##1##(2008-12#1)(2010-7#1)
HWDS##2##1##(2010-1#2)
HX##4##1##(1990-5#1)(2008-10#2)(2008-11#1)
HYDRA-POINT##2##1##(2008-10#2)
HYPP in##2##2##(1991-12#2)
HYPP##3##1##(1991-12#3)
HaCaT cell line##2##3##(2008-11#2)
HaCaT cells##4##2##(2008-11#2)(2010-2#2)
HaCaT##9##1##(1997-1#2)(2008-11#4)(2010-2#3)
HaCat cells##4##2##(2011-3#4)
HaCat##5##1##(2011-3#5)
Habib##2##1##(2009-1#1)(2013-1#1)
Habitat loss##2##2##(2008-9#1)(2009-8#1)
Habitat##8##1##(1996-5#1)(2008-8#4)(2008-9#1)(2009-8#1)(2013-1#1)
Hacinas##7##1##(2009-10#7)
Hadamard transform spectral imager##3##4##(2013-8#3)
Hadamard##5##1##(2008-10#1)(2013-8#4)
Hadar##3##1##(1994-3#3)
HaeIII##2##1##(2008-10#2)
Haematococcus pluvialis##2##2##(2010-10#2)
Haematological and clinical biochemistry##2##4##(2008-5#2)
Haemonchus contortus##4##2##(1991-8#2)(1996-12#1)(2012-2#1)
Haemonetics##2##1##(2011-2#2)
Haemophilia A##2##2##(2011-2#2)
Haemophilia##3##1##(1990-5#1)(2011-2#2)
Haemophilus b##3##2##(1990-12#1)(1995-5#2)
Haemophilus influenzae type B##3##4##(1993-6#1)(1994-9#1)(2008-11#1)
Haemophilus influenzae type b (Hib)##2##5##(1997-3#1)(2008-1#1)
Haemophilus influenzae type b##12##4##(1990-12#2)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)
Haemophilus influenzae type##15##3##(1990-12#2)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)(2008-11#1)
Haemophilus influenzae##19##2##(1990-12#2)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)(2008-11#2)(2008-7#2)(2011-2#1)
Haemophilus##25##1##(1990-12#3)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#7)(1997-3#1)(2007-11#1)(2008-1#2)(2008-11#2)(2008-5#3)(2008-7#2)(2011-2#1)
Haemorrhage##2##1##(1997-6#1)(2011-2#1)
Hair is##2##2##(2008-5#1)(2012-3#1)
Hair shedding##2##2##(2008-5#2)
Hair##12##1##(2008-10#1)(2008-5#5)(2012-2#1)(2012-3#5)
Hairy##2##1##(2008-10#1)(2008-6#1)
Half of the##8##3##(1990-9#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2011-10#1)(2011-2#1)
Half of##12##2##(1990-6#1)(1990-9#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2011-10#1)(2011-2#1)
Half##15##1##(1990-6#1)(1990-9#2)(1995-11#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2011-10#1)(2011-2#1)(2013-8#1)
Hall technique##4##2##(2013-1#4)
Hall##14##1##(1992-11#2)(1993-5#1)(1994-12#2)(1997-6#1)(2008-10#3)(2008-11#1)(2013-1#4)
Halo nevi##3##2##(2011-2#3)
Halo##7##1##(2008-10#1)(2008-3#2)(2011-2#4)
Halobacteriaceae##3##1##(2011-2#3)
Halobacterium halobium##2##2##(1990-5#2)
Haloferax volcanii##2##2##(2011-2#2)
Halogenated##3##1##(1994-5#1)(2008-11#1)(2008-9#1)
Haloterrigena turkmenica##2##2##(2011-2#2)
Haloterrigena##5##1##(2011-2#5)
Halotherapy##2##1##(1996-3#2)
Hamilton PRP-X100##2##2##(2008-10#2)
Hamilton##6##1##(1995-12#1)(2008-10#3)(2008-6#1)(2009-3#1)
Hamilton-Zuk hypothesis##3##2##(2008-8#3)
Hamiltonian##3##1##(1996-9#1)(2009-5#1)(2012-3#1)
Hampshire##5##1##(1993-1#1)(1994-12#1)(2008-10#1)(2012-12#2)
Hamster Ovary##10##2##(2008-11#10)
Hamster##12##1##(2008-11#11)(2008-9#1)
Hamza##2##1##(2008-10#2)
Han Chinese populations##3##3##(2008-8#3)
Han Chinese##5##2##(2008-8#3)(2008-9#2)
Han##10##1##(2008-8#3)(2008-9#4)(2011-2#3)
Hanau##2##1##(2008-10#1)(2008-11#1)
Hand##7##1##(2008-9#5)(2010-9#1)(2013-1#1)
Handbook of##2##2##(1996-2#1)(2012-2#1)
Handbook##4##1##(1993-3#2)(1996-2#1)(2012-2#1)
Handling of##2##2##(2008-10#1)(2008-9#1)
Handling##6##1##(2008-10#1)(2008-9#4)(2012-3#1)
Hanlester Network##2##2##(1992-3#1)(1993-1#1)
Hanlester##5##1##(1992-3#1)(1993-1#4)
Hansen's##2##1##(2011-2#1)(2013-1#1)
Hansenula mrakii##2##2##(1993-12#2)
Hansenula##4##1##(1993-12#2)(1995-9#2)
Haplotype##3##1##(2008-10#1)(2008-12#2)
Haplotypes##2##1##(1997-9#1)(2008-10#1)
Hapten##2##1##(1993-8#1)(2008-10#1)
Harbor and##2##2##(2008-10#1)(2010-5#1)
Harbor##5##1##(2008-10#1)(2008-11#1)(2010-5#3)
Hard##4##1##(1990-11#1)(1996-9#1)(2008-10#1)(2013-1#1)
Hardness##3##1##(2009-7#1)(2011-2#2)
Hardy's understanding of##2##3##(2012-2#2)
Hardy's##5##1##(2012-2#5)
Hardy-Weinberg equilibrium##2##2##(2008-10#1)(2008-12#1)
Hardy-Weinberg##6##1##(2008-10#2)(2008-12#2)(2012-3#1)(2013-8#1)
Harlem##2##1##(1996-3#2)
Harnessing the##2##2##(2008-11#1)(2009-11#1)
Harris##3##1##(2009-3#1)(2013-1#2)
Harry ernest##2##2##(2008-10#2)
Harry##3##1##(1990-11#1)(2008-10#2)
Harsh issues in##3##3##(1993-1#3)
Harsh##4##1##(1993-1#3)(2008-9#1)
Harstad Hospital and##2##3##(1991-9#2)
Harstad Hospital##3##2##(1991-9#3)
Harvard Medical School##6##3##(1993-3#1)(2008-4#2)(2010-5#2)(2011-2#1)
Harvard##15##1##(1990-11#2)(1992-3#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-5#3)(2010-7#1)(2011-2#1)(2012-3#1)
Harvested##2##1##(2008-10#1)(2008-5#1)
Haryana##2##1##(1997-8#1)(2010-8#1)
Hashimoto thyroiditis##2##2##(2009-3#1)(2011-2#1)
Hassan K##2##2##(2008-10#2)
Hassan##3##1##(2008-10#2)(2011-2#1)
Hatm##2##1##(2008-10#2)
Hats##2##1##(2008-10#2)
Haukeland Hospital##2##2##(1990-2#1)(1991-11#1)
Haukeland##5##1##(1990-2#2)(1991-11#1)(1997-4#1)(1997-8#1)
Hausa/Fulani##2##1##(2009-10#2)
Haustorial##2##1##(2008-10#2)
Have you##2##2##(1994-2#1)(2013-1#1)
Have##5##1##(1994-2#1)(2009-9#1)(2012-3#2)(2013-1#1)
Haven##5##1##(1995-12#1)(1996-2#1)(1997-1#1)(2011-2#1)(2013-8#1)
Having a##2##2##(2009-7#1)(2013-1#1)
Having an##2##2##(1991-12#1)(2008-11#1)
Having been##2##2##(2008-10#2)
Having##19##1##(1990-9#2)(1991-12#1)(1991-6#1)(1992-5#1)(1993-3#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-2#3)(2013-1#2)
Hawai'i##2##1##(2008-1#2)
Hawaii 7998##2##2##(2008-10#2)
Hawaii and##2##2##(2008-10#1)(2012-2#1)
Hawaii##25##1##(1992-2#2)(1994-2#1)(2008-1#2)(2008-10#18)(2012-2#2)
Hawaiian proprietary selections##2##3##(2008-10#2)
Hawaiian##13##1##(2008-1#9)(2008-10#3)(2008-3#1)
Hawaiians##2##1##(1992-2#1)(2008-1#1)
Hazard Analysis Critical Control Points##2##5##(2009-3#2)
Hazard Analysis##3##2##(2009-3#2)(2013-1#1)
Hazard Report##3##2##(2011-2#3)
Hazard ratios##2##2##(2011-2#2)
Hazard report##25##2##(2010-9#3)(2011-1#3)(2011-2#19)
Hazard##37##1##(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-3#2)(2010-9#3)(2011-1#3)(2011-2#24)(2013-1#1)
Hazardous##5##1##(1992-2#1)(1995-11#2)(2008-1#1)(2008-10#1)
Hb and##2##2##(1991-2#1)(2008-10#1)
Hb solutions prepared in##2##4##(1992-11#2)
Hb solutions prepared##3##3##(1992-11#3)
Hb solutions##4##2##(1992-11#4)
Hb##25##1##(1991-2#1)(1992-11#4)(1996-12#5)(2008-10#14)(2008-5#1)
HbA(1c) testing on the##2##4##(2008-6#2)
HbA(1c) testing##5##2##(2008-6#5)
HbA(1c)##7##1##(2008-6#6)(2011-1#1)
HbA1##3##1##(1992-9#3)
HbA1c levels and##2##3##(2012-4#2)
HbA1c levels##9##2##(2012-4#5)(2012-5#3)(2013-8#1)
HbA1c was positively correlated with##2##5##(1994-6#2)
HbA1c was##4##2##(1994-6#4)
HbA1c##29##1##(1994-6#6)(2008-6#1)(2010-10#1)(2011-2#6)(2012-4#9)(2012-5#5)(2013-8#1)
HbO-HA ELISA can##2##3##(1990-12#2)
HbO-HA ELISA##6##2##(1990-12#6)
HbO-HA##7##1##(1990-12#7)
HbPs##2##1##(1990-12#2)
Hc2##3##1##(1993-9#3)
HcNPV attachment##3##2##(2008-11#3)
HcNPV binding##2##2##(2008-11#2)
HcNPV##6##1##(2008-11#6)
Hct##10##1##(2011-3#10)
Hcy/Au##2##1##(2008-10#2)
He also##9##2##(1991-12#1)(1991-6#1)(1993-3#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-6#1)(2010-1#2)
He believes##2##2##(1990-11#1)(1993-12#1)
He developed##4##2##(2010-3#1)(2010-7#1)(2011-2#2)
He did not##2##3##(1990-6#1)(2009-11#1)
He discusses##2##2##(1992-2#1)(1996-2#1)
He had a##4##3##(2007-12#1)(2008-12#1)(2012-12#1)(2013-1#1)
He had been##2##3##(2007-12#1)(2012-3#1)
He had no##2##3##(2007-12#2)
He had##19##2##(1997-3#3)(2007-12#6)(2008-10#4)(2008-12#1)(2012-12#1)(2012-3#3)(2013-1#1)
He has been##2##3##(1994-1#1)(2010-6#1)
He has##4##2##(1994-1#1)(2010-1#1)(2010-6#1)(2011-2#1)
He is##2##2##(1994-1#1)(2008-12#1)
He presented with##2##3##(2008-12#1)(2008-7#1)
He presented##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
He provides##2##2##(1991-1#1)(1993-12#1)
He received##2##2##(2008-7#1)(2011-2#1)
He recovered##2##2##(2008-7#1)(2013-1#1)
He should know##3##3##(1996-11#3)
He subsequently developed##2##3##(2008-7#2)
He subsequently##3##2##(2008-7#2)(2010-1#1)
He then##3##2##(1993-2#1)(2010-1#1)(2011-2#1)
He underwent##6##2##(2008-10#1)(2008-12#3)(2010-7#1)(2011-2#1)
He was admitted to the##2##5##(1993-8#1)(2013-1#1)
He was admitted##3##3##(1993-8#1)(2009-6#1)(2013-1#1)
He was diagnosed##2##3##(2011-2#1)(2012-2#1)
He was discharged##2##3##(1997-8#1)(2010-12#1)
He was successfully treated with##2##5##(2010-6#2)
He was treated with##4##4##(1996-6#2)(2008-11#1)(2013-1#1)
He was treated##5##3##(1996-6#2)(2008-10#1)(2008-11#1)(2013-1#1)
He was##26##2##(1993-8#1)(1996-2#1)(1996-6#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-6#2)(2010-12#2)(2010-6#2)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
He##142##1##(1990-11#3)(1990-6#2)(1991-1#1)(1991-12#1)(1991-6#4)(1992-2#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-11#3)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#10)(2008-10#19)(2008-11#1)(2008-12#10)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#2)(2010-1#6)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#3)(2010-7#4)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#6)
He-Ne laser##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
He-Ne##6##1##(2007-11#1)(2008-2#1)(2008-3#4)
He/H(2)/CH(4)/N(2)##2##1##(2008-10#2)
HeLa and##2##2##(1994-3#1)(2008-11#1)
HeLa cell nuclear extracts##2##4##(1993-6#2)
HeLa cell##8##2##(1993-6#2)(1995-6#1)(2008-11#2)(2008-8#2)(2010-12#1)
HeLa cells and##5##3##(1997-1#1)(2008-11#1)(2008-8#3)
HeLa cells by##2##3##(2008-9#2)
HeLa cells overexpressing Bcl-2##3##4##(2008-8#3)
HeLa cells were##3##3##(2008-11#2)(2008-8#1)
HeLa cells##40##2##(1990-5#1)(1993-3#1)(1993-8#2)(1994-11#3)(1997-1#1)(1997-7#1)(2008-11#8)(2008-12#1)(2008-8#11)(2008-9#6)(2009-4#1)(2009-9#1)(2010-12#2)(2012-2#1)
HeLa nuclear##3##2##(1993-8#2)(1995-6#1)
HeLa##63##1##(1990-5#1)(1992-6#2)(1993-3#1)(1993-6#2)(1993-8#4)(1994-11#3)(1994-3#1)(1995-6#2)(1997-1#1)(1997-7#1)(2008-11#16)(2008-12#1)(2008-8#14)(2008-9#6)(2009-4#1)(2009-9#1)(2010-12#3)(2010-3#2)(2012-2#1)
Head Start##2##2##(2009-4#1)(2012-2#1)
Head and Neck##2##3##(1990-9#1)(2011-2#1)
Head and neck##4##3##(1995-9#1)(1997-7#1)(2008-11#1)(2013-1#1)
Head and##6##2##(1990-9#1)(1995-9#1)(1997-7#1)(2008-11#1)(2011-2#1)(2013-1#1)
Head##16##1##(1990-6#1)(1990-9#1)(1991-5#1)(1995-5#1)(1995-9#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
Headache##3##1##(2008-4#1)(2008-5#2)
Headspace##7##1##(2008-10#6)(2009-8#1)
Healers##3##1##(2008-12#3)
Healing of##2##2##(2011-2#1)(2013-1#1)
Healing##7##1##(1996-1#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
Health Administration##10##2##(1991-1#2)(1991-12#1)(1992-1#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-1#1)(2008-7#2)
Health Agencies##5##2##(1996-3#4)(2008-11#1)
Health Agency##2##2##(1994-2#1)(2009-9#1)
Health Area##2##2##(1994-6#1)(1996-2#1)
Health Association##3##2##(1991-2#1)(1996-5#1)(1997-3#1)
Health Authorities##2##2##(1992-3#1)(2008-10#1)
Health Behaviour##2##2##(1991-9#1)(2013-1#1)
Health Board##2##2##(2008-12#1)(2012-3#1)
Health Care Financing Administration (HCFA) has##3##6##(1992-2#1)(1994-3#1)(1996-2#1)
Health Care Financing Administration (HCFA)##15##5##(1992-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#2)(1997-2#5)(1997-3#1)
Health Care Financing Administration is##2##5##(1992-2#1)(1997-3#1)
Health Care Financing Administration##23##4##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#2)(1997-2#5)(1997-3#2)
Health Care Financing Administration's (HCFA)##2##5##(1996-2#2)
Health Care Financing##28##3##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#2)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#5)(1997-2#5)(1997-3#3)
Health Care Quality Improvement Program (HCQIP)##2##6##(1996-2#2)
Health Care Quality Improvement Program##3##5##(1996-2#3)
Health Care Quality Improvement##6##4##(1991-1#2)(1994-1#1)(1996-2#3)
Health Care Quality##7##3##(1991-1#2)(1994-1#1)(1996-2#3)(1997-2#1)
Health Care Reform##2##3##(1992-1#1)(1995-12#1)
Health Care System is##2##4##(1994-1#1)(1994-12#1)
Health Care System##4##3##(1994-1#2)(1994-12#1)(1997-3#1)
Health Care##65##2##(1990-6#1)(1991-1#3)(1991-2#2)(1991-3#1)(1992-1#2)(1992-2#2)(1992-8#1)(1993-12#1)(1994-1#6)(1994-12#6)(1994-2#1)(1994-3#4)(1995-12#3)(1995-3#1)(1996-1#1)(1996-2#9)(1996-3#1)(1997-2#6)(1997-3#4)(2008-11#7)(2009-10#1)(2012-12#1)(2012-2#1)
Health Center##2##2##(1990-2#1)(2008-1#1)
Health Centre##4##2##(1993-12#2)(2008-1#1)(2013-7#1)
Health Council has##2##3##(1991-2#1)(1996-8#1)
Health Council##4##2##(1991-2#1)(1996-8#2)(1997-8#1)
Health Education##2##2##(2012-3#2)
Health Improvement##5##2##(1995-12#1)(1996-2#1)(2009-6#3)
Health Index Plus##2##3##(1993-1#2)
Health Index##3##2##(1993-1#2)(2008-10#1)
Health Information##2##2##(2008-7#1)(2012-12#1)
Health Insurance##3##2##(1994-2#1)(2008-10#1)(2013-8#1)
Health Interview##7##2##(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#2)(2009-7#1)(2010-11#1)
Health Maintenance##3##2##(1993-3#1)(2010-8#2)
Health Nursing##3##2##(2008-11#3)
Health Office##2##2##(1994-6#1)(2013-8#1)
Health Officials##6##2##(1995-12#3)(1996-1#3)
Health Organization at##2##3##(1994-9#1)(1997-6#1)
Health Organization##38##2##(1990-11#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-11#2)(1994-9#3)(1995-3#1)(1996-9#1)(1997-6#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#6)(2011-7#1)(2012-12#2)(2013-1#4)
Health Outcomes Institute##2##3##(1994-1#2)
Health Outcomes##4##2##(1994-1#2)(2008-11#1)(2012-12#1)
Health Plan##3##2##(1995-1#2)(1995-2#1)
Health Professional##2##2##(2012-2#1)(2013-1#1)
Health Promotion##2##2##(1997-5#1)(2008-11#1)
Health Protective Behaviors##2##3##(2013-1#2)
Health Questionnaire##4##2##(2008-1#2)(2008-11#1)(2013-1#1)
Health Science##6##2##(1992-1#1)(1992-12#1)(1995-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
Health Sciences Library##2##3##(1992-12#1)(1995-2#1)
Health Sciences##13##2##(1992-12#1)(1995-2#2)(2008-1#1)(2008-11#2)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#1)(2012-3#2)
Health Service##19##2##(1991-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-11#7)(2008-12#2)(2011-2#1)(2012-12#1)(2012-2#1)
Health Services Research##9##3##(1994-12#1)(2009-3#1)(2012-2#7)
Health Services Technology Assessment Research (HSTAR)##2##6##(1994-12#2)
Health Services##22##2##(1991-2#1)(1994-1#1)(1994-12#4)(1995-12#1)(1996-1#1)(1997-2#1)(2008-6#2)(2009-3#1)(2010-5#2)(2012-2#8)
Health Start has been##2##4##(1995-12#2)
Health Start has##3##3##(1995-12#3)
Health Statistics##2##2##(1997-3#1)(2013-1#1)
Health Study##4##2##(2009-7#1)(2010-6#3)
Health Survey##4##2##(1994-6#1)(2009-7#1)(2010-6#1)(2011-2#1)
Health System in##2##3##(1991-9#1)(2012-3#1)
Health System##13##2##(1991-9#1)(1992-1#1)(1993-3#2)(1994-1#1)(1994-2#4)(1995-11#1)(2012-12#1)(2012-3#2)
Health Training##2##2##(1991-2#1)(2010-11#1)
Health Unit##2##2##(1991-2#1)(2010-10#1)
Health administration education##3##3##(1992-3#1)(1993-2#1)(1996-3#1)
Health administration in##2##3##(1992-1#2)
Health administration##5##2##(1992-1#2)(1992-3#1)(1993-2#1)(1996-3#1)
Health and Health##3##3##(1997-2#1)(2008-11#2)
Health and Human Services##8##4##(1993-12#2)(1994-1#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-7#1)(2012-2#1)
Health and Human##9##3##(1993-12#2)(1994-1#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
Health and Nutrition##3##3##(2008-1#1)(2010-12#1)(2011-2#1)
Health and Social##3##3##(1993-6#2)(1994-1#1)
Health and Welfare##4##3##(1996-3#1)(1997-8#1)(2008-5#1)(2013-8#1)
Health and the##4##3##(1992-2#1)(1993-1#1)(1995-6#1)(2013-1#1)
Health and##50##2##(1991-2#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-6#2)(1994-1#2)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
Health as a##2##3##(1996-12#1)(2013-8#1)
Health behaviors##2##2##(2010-5#1)(2011-2#1)
Health care financing##2##3##(1991-3#1)(1993-1#1)
Health care fraud##3##3##(1993-12#2)(1993-2#1)
Health care in##2##3##(1993-12#1)(1996-12#1)
Health care indicators##10##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)
Health care is##2##3##(1995-2#1)(2013-8#1)
Health care organizations##3##3##(1994-12#1)(1997-2#1)(2008-6#1)
Health care providers##3##3##(1991-2#1)(1996-2#1)(2008-10#1)
Health care reform and the##2##5##(1991-12#1)(1995-3#1)
Health care reform in the United States##2##7##(1993-12#1)(1995-12#1)
Health care reform in the##3##5##(1993-12#1)(1995-12#1)(1997-3#1)
Health care reform##7##3##(1991-12#1)(1993-12#1)(1995-12#2)(1995-3#1)(1996-1#1)(1997-3#1)
Health care systems##2##3##(1993-2#1)(2010-11#1)
Health care##64##2##(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#2)(1993-1#2)(1993-12#6)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#4)(1994-3#1)(1995-12#4)(1995-2#5)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#1)(1997-2#3)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#3)(2008-8#1)(2010-10#1)(2010-11#2)(2013-8#1)
Health education##4##2##(1990-11#1)(1993-11#2)(2008-12#1)
Health effects of##2##3##(1991-12#1)(2013-8#1)
Health fraud##2##2##(1991-2#2)
Health has##4##2##(1997-1#1)(1997-2#2)(2010-8#1)
Health in the##2##3##(2008-9#1)(2012-3#1)
Health in##7##2##(1991-2#1)(1994-1#1)(1997-5#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
Health insurance##3##2##(1992-2#1)(1992-3#1)(1994-1#1)
Health is##2##2##(1991-6#1)(1996-1#1)
Health maintenance##2##2##(1991-3#1)(1997-2#1)
Health of the##2##3##(1997-5#1)(2008-11#1)
Health of##8##2##(1993-1#1)(1997-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2012-2#1)
Health policy##2##2##(1990-2#1)(1994-2#1)
Health professionals need to##2##4##(1994-3#1)(2008-9#1)
Health professionals##5##2##(1991-2#1)(1994-3#1)(2008-9#1)(2010-1#1)(2012-12#1)
Health reform##3##2##(1994-3#1)(1995-2#1)(2012-3#1)
Health risks##2##2##(1991-3#1)(2008-1#1)
Health services administration##2##3##(1997-2#2)
Health services##6##2##(1992-3#1)(1994-2#1)(1997-2#2)(2009-6#1)(2012-12#1)
Health status of##2##3##(1994-9#1)(1997-2#1)
Health study##2##2##(2008-7#1)(2009-5#1)
Health system reform##3##3##(1993-12#2)(1995-12#1)
Health technology##2##2##(2008-2#1)(2009-3#1)
Health to##2##2##(2008-1#1)(2008-10#1)
Health were##2##2##(2008-11#1)(2012-12#1)
Health##719##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-6#1)(1991-1#8)(1991-12#9)(1991-2#29)(1991-3#5)(1991-6#3)(1991-9#3)(1992-1#11)(1992-12#3)(1992-2#8)(1992-3#7)(1992-5#2)(1992-8#1)(1993-1#6)(1993-11#6)(1993-12#13)(1993-2#5)(1993-3#7)(1993-6#2)(1994-1#17)(1994-12#18)(1994-2#10)(1994-3#10)(1994-6#3)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#25)(1995-2#13)(1995-3#9)(1995-6#2)(1996-1#15)(1996-12#5)(1996-2#22)(1996-3#14)(1996-5#5)(1996-6#4)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#24)(1997-3#12)(1997-5#5)(1997-6#5)(1997-8#6)(2007-9#1)(2008-1#17)(2008-10#29)(2008-11#67)(2008-12#11)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#9)(2008-7#11)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#6)(2009-7#5)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#6)(2010-6#7)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#3)(2011-2#23)(2011-7#1)(2011-9#1)(2012-12#18)(2012-2#17)(2012-3#16)(2013-1#25)(2013-7#1)(2013-8#12)
Health's##5##1##(2008-11#1)(2010-10#1)(2010-8#1)(2012-12#2)
Health-related##4##1##(1994-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
HealthCare##5##1##(1991-9#1)(1993-5#1)(1997-3#3)
Healthcare Radiology##2##2##(1991-2#1)(1996-1#1)
Healthcare combinations##3##2##(1996-2#1)(1996-3#1)(1997-1#1)
Healthcare##38##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-8#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-11#3)(2008-12#2)(2008-9#1)(2009-8#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
Healthiest Babies Possible Program##2##4##(1991-12#2)
Healthy People 2010##3##3##(2008-7#1)(2010-9#1)(2011-1#1)
Healthy People##4##2##(1996-2#1)(2008-7#1)(2010-9#1)(2011-1#1)
Healthy##17##1##(1993-12#1)(1996-12#1)(1996-2#2)(2008-10#2)(2008-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
Hearing##4##1##(2010-1#1)(2011-2#3)
Heart Association##11##2##(1996-6#2)(2008-11#1)(2008-3#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
Heart Study##4##2##(2008-1#1)(2009-12#1)(2011-2#1)(2013-8#1)
Heart and##2##2##(1993-12#1)(2008-5#1)
Heart disease##2##2##(2009-6#1)(2011-2#1)
Heart failure##3##2##(1997-8#1)(2008-7#1)(2010-12#1)
Heart rate (HR) and##2##4##(2013-8#2)
Heart rate (HR)##3##3##(2013-1#1)(2013-8#2)
Heart rate variability (HRV)##2##4##(2009-11#1)(2010-5#1)
Heart rate variability##4##3##(2009-11#2)(2010-5#2)
Heart rate##7##2##(2009-11#2)(2010-5#2)(2013-1#1)(2013-8#2)
Heart##45##1##(1992-12#1)(1993-12#1)(1995-5#1)(1996-6#2)(1997-8#1)(2008-1#2)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#1)(2009-11#2)(2009-12#2)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#6)(2013-8#3)
Heartland##3##1##(2008-10#3)
Hearts##2##1##(2008-7#1)(2012-3#1)
Heat shock##3##2##(1993-8#1)(1997-7#2)
Heat##16##1##(1993-8#1)(1997-2#1)(1997-7#2)(2008-10#3)(2008-11#4)(2008-3#1)(2011-2#3)(2013-8#1)
Heat-resistant flexible-film optical waveguides##2##4##(2008-2#2)
Heath##2##1##(2009-8#1)(2013-1#1)
Heather##2##1##(2008-10#1)(2008-6#1)
Heating##4##1##(1992-12#1)(2008-10#2)(2008-2#1)
Heavy metal##2##2##(2008-10#1)(2009-12#1)
Heavy metals##2##2##(2008-10#2)
Heavy##8##1##(1995-8#1)(1996-9#2)(2008-10#3)(2009-12#1)(2012-2#1)
Hebb##3##1##(2008-11#2)(2008-7#1)
Hebbian##3##1##(2008-8#1)(2009-8#1)(2013-8#1)
Hebrew##2##1##(2009-11#1)(2013-8#1)
Hedrick (2011)##2##2##(2012-3#2)
Heg RNA and Cdk1 mRNA##2##5##(2012-3#2)
Heg RNA##4##2##(2012-3#4)
Heg##5##1##(2012-3#5)
Height and##2##2##(2011-1#2)
Height##6##1##(2011-1#3)(2011-2#2)(2013-8#1)
Heils Franken##2##2##(2008-10#2)
Hela cells##6##2##(1990-5#3)(2008-10#3)
Helferich##2##1##(1992-12#1)(2009-8#1)
Helianthus##3##1##(2008-10#2)(2008-8#1)
Heliao lead-zinc polymetallic ore district##2##5##(2013-8#2)
Helical##2##1##(2008-11#1)(2010-12#1)
Helichrysum##3##1##(2008-11#3)
Helicobacter pylori and##5##3##(1996-6#1)(1997-1#3)(2008-12#1)
Helicobacter pylori has been##2##4##(1997-1#2)
Helicobacter pylori in##2##3##(1997-8#1)(2012-12#1)
Helicobacter pylori infection in##3##4##(1992-5#1)(2011-2#1)(2012-12#1)
Helicobacter pylori infection##12##3##(1992-5#2)(1995-2#1)(1996-11#1)(1997-1#3)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Helicobacter pylori is##2##3##(1995-2#1)(2008-12#1)
Helicobacter pylori##47##2##(1990-11#1)(1992-5#3)(1995-2#2)(1996-11#3)(1996-12#5)(1996-6#1)(1997-1#11)(1997-8#2)(2008-10#2)(2008-12#5)(2009-6#2)(2010-12#1)(2011-2#5)(2012-12#3)(2013-1#1)
Helicobacter##55##1##(1990-11#1)(1990-2#1)(1991-2#1)(1992-5#3)(1995-2#2)(1996-11#3)(1996-12#5)(1996-6#1)(1997-1#13)(1997-8#2)(2008-10#2)(2008-12#5)(2008-8#1)(2009-6#2)(2009-8#1)(2010-12#2)(2011-2#5)(2012-12#4)(2013-1#1)
Heliconius##5##1##(2013-1#5)
Helicoverpa armigera##3##2##(2008-11#1)(2008-12#2)
Helicoverpa zea cell line##2##4##(2008-11#2)
Helicoverpa zea##3##2##(2008-11#3)
Helicoverpa##6##1##(2008-11#4)(2008-12#2)
Helix aspersa maxima##4##3##(2008-12#4)
Helix##6##1##(2008-10#1)(2008-12#5)
Helleborus##2##1##(1990-9#1)(2008-10#1)
Hellenic##2##1##(1991-6#1)(2008-5#1)
Helper Component-Protease##2##2##(2008-10#2)
Helper##5##1##(2008-10#5)
Helpers##2##1##(2008-8#1)(2008-9#1)
Helping hospitals spread the word about their patient focused care programs##3##11##(1993-1#1)(1993-2#1)(1993-3#1)
Helping##11##1##(1993-1#1)(1993-2#2)(1993-3#2)(1995-9#1)(1997-3#2)(2008-11#1)(2013-8#2)
Helsinki##4##1##(1993-2#1)(2008-1#1)(2008-7#2)
Hemangioblastomas##2##1##(2012-3#2)
Hemangiomas##2##1##(2011-2#2)
Hemangiopericytoma##2##1##(1993-6#1)(2011-2#1)
Hematogenous##2##1##(2008-10#1)(2009-12#1)
Hematopoiesis##2##1##(1996-2#1)(2008-11#1)
Hematopoietic Stem Cell##2##3##(2008-11#1)(2012-12#1)
Hematopoietic stem##2##2##(2009-12#1)(2010-11#1)
Hematopoietic##7##1##(2008-11#1)(2008-7#2)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)
Hemifacial spasm##2##2##(2008-12#2)
Hemiptera and##2##2##(2007-12#2)
Hemisphere##7##1##(1990-8#1)(2008-10#6)
Hemoccult##3##1##(1991-6#2)(1993-3#1)
Hemodialysis##2##1##(2008-1#1)(2013-8#1)
Hemodynamic effects##2##2##(1991-6#1)(2009-8#1)
Hemodynamic##5##1##(1991-6#1)(2009-8#1)(2012-3#2)(2013-1#1)
Hemoglobin (Hb) was##2##3##(1991-2#1)(1995-11#1)
Hemoglobin##7##1##(1990-8#1)(1991-2#2)(1993-2#2)(1995-11#1)(2008-7#1)
Hemolymph##2##1##(1997-8#1)(2008-10#1)
Hemophilia A##3##2##(2008-11#1)(2012-12#2)
Hemorrhage##8##1##(1995-11#3)(2011-2#1)(2012-3#4)
Hemorrhagic##4##1##(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
Hemosuccus pancreaticus##2##2##(2011-2#2)
Hence the##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-3#1)
Hence##88##1##(1991-5#1)(1992-12#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#2)(1997-1#1)(2008-10#20)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#6)
Henderson##2##1##(1995-12#1)(2008-10#1)
Henie##3##1##(1991-6#3)
Hennepin and Ramsey counties##2##4##(2012-12#2)
Hennepin##3##1##(1994-2#1)(2012-12#2)
Henry Ford##2##2##(1993-12#1)(1994-2#1)
Henry##3##1##(1990-11#1)(1993-12#1)(1994-2#1)
Henry's##2##1##(2008-10#1)(2008-5#1)
Hep G2##4##2##(2008-11#4)
Hep-1##2##1##(2008-11#2)
Hep-2##4##1##(2011-2#3)(2012-2#1)
HepG2 cells##9##2##(1993-6#1)(1994-6#1)(1995-2#1)(2008-11#3)(2008-8#1)(2010-11#2)
HepG2 human##2##2##(2013-1#2)
HepG2##18##1##(1993-6#1)(1994-6#2)(1995-2#1)(1997-1#1)(2008-11#6)(2008-8#1)(2010-1#1)(2010-11#2)(2013-1#3)
HepSS-1##2##1##(1995-12#2)
HepZ##2##1##(2008-11#2)
Hepa##2##1##(1993-6#1)(2008-11#1)
Heparin was##2##2##(2008-11#2)
Heparin##4##1##(2008-10#1)(2008-11#2)(2013-1#1)
Hepatic artery pseudoaneurysm##2##3##(2012-2#2)
Hepatic##12##1##(1991-6#1)(1993-12#1)(1997-8#1)(2008-11#1)(2008-6#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
Hepatitis B Virus##2##3##(2008-10#1)(2008-11#1)
Hepatitis B and C##2##4##(1992-12#1)(2008-1#1)
Hepatitis B e##2##3##(2013-1#2)
Hepatitis B surface antigen (HBsAg)##2##5##(2008-10#1)(2012-3#1)
Hepatitis B vaccination##3##3##(2008-10#1)(2009-12#1)(2012-3#1)
Hepatitis B virus (HBV)##4##4##(2008-10#1)(2008-12#1)(2013-1#2)
Hepatitis B virus##7##3##(1996-12#1)(2008-10#2)(2008-12#1)(2013-1#3)
Hepatitis B##23##2##(1992-12#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-12#1)(2012-3#3)(2013-1#6)
Hepatitis C Virus##2##3##(2008-1#1)(2011-2#1)
Hepatitis C virus (HCV)##2##4##(2008-10#1)(2013-1#1)
Hepatitis C virus##5##3##(1994-11#1)(2008-10#1)(2008-5#1)(2013-1#2)
Hepatitis C##9##2##(1994-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#2)
Hepatitis E##3##2##(2007-12#1)(2009-8#2)
Hepatitis##41##1##(1992-12#1)(1994-11#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-2#2)(2012-3#3)(2013-1#8)
Hepatoblastoma##3##1##(2011-1#1)(2013-1#2)
Hepatocellular carcinoma (HCC)##2##3##(2008-10#1)(2011-2#1)
Hepatocellular##4##1##(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
Hepatocyte##6##1##(1993-3#1)(1994-8#1)(2008-11#1)(2008-6#1)(2009-8#1)(2013-1#1)
Hepatocytes##5##1##(1990-2#1)(1994-11#1)(1994-8#1)(2008-11#2)
Hepatoma Cell##2##2##(2008-11#2)
Hepatoma cells previously cultured with##2##5##(2008-11#2)
Hepatoma##4##1##(2008-11#4)
Hepatoprotective activity of##2##3##(2010-2#1)(2013-1#1)
Hepatoprotective##3##1##(2008-10#1)(2010-2#1)(2013-1#1)
Hepes buffer##3##2##(2008-10#3)
Hepes##4##1##(1990-8#1)(2008-10#3)
Hepoxilin A3##3##2##(1990-12#3)
Her##10##1##(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#2)
Her-2/neu##2##1##(2008-10#2)
Herb##2##1##(2008-10#2)
Herba Houttuyniae injection##2##3##(2011-2#2)
Herba##5##1##(2008-11#2)(2011-2#2)(2012-2#1)
Herbal medicines##2##2##(2008-11#1)(2013-1#1)
Herbal##6##1##(2008-1#1)(2008-10#1)(2008-11#2)(2013-1#2)
Herbicide##3##1##(1996-3#1)(2008-10#1)(2008-11#1)
Herbicides##2##1##(2008-10#2)
Here I show##2##3##(2012-2#1)(2012-3#1)
Here I##5##2##(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
Here a##5##2##(1994-5#1)(1997-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
Here are##3##2##(1993-1#1)(1997-2#1)(2008-10#1)
Here it##2##2##(1993-11#1)(1995-11#1)
Here the##9##2##(1993-11#1)(1996-2#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-6#1)(2012-2#1)
Here we compare##2##3##(2008-11#1)(2008-9#1)
Here we demonstrate how##2##4##(2008-10#1)(2008-8#1)
Here we demonstrate that##3##4##(1995-8#1)(2012-2#2)
Here we demonstrate##8##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#4)
Here we describe a##3##4##(1995-2#1)(2008-11#1)(2013-8#1)
Here we describe the basic features of##2##7##(2011-2#2)
Here we describe the features of the organism##3##8##(2011-2#3)
Here we describe the features of this organism##12##8##(2011-2#12)
Here we describe the features of this##13##7##(2011-2#13)
Here we describe the features of##17##6##(2011-2#17)
Here we describe the##28##4##(1992-8#1)(1993-12#1)(1997-7#1)(2008-11#2)(2008-2#1)(2011-2#20)(2012-3#1)(2013-1#1)
Here we describe##37##3##(1992-8#1)(1993-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2009-5#1)(2011-2#21)(2012-3#2)(2013-1#1)(2013-8#1)
Here we develop##2##3##(2008-3#1)(2008-8#1)
Here we discuss the##5##4##(2008-11#2)(2009-8#2)(2011-2#1)
Here we discuss##7##3##(2008-11#2)(2009-8#3)(2011-2#2)
Here we examine the##2##4##(1991-2#1)(2008-8#1)
Here we examined##2##3##(2008-11#1)(2008-8#1)
Here we extend##2##3##(1996-12#1)(2008-11#1)
Here we have examined the##2##5##(1997-7#1)(2008-7#1)
Here we have##6##3##(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#1)
Here we identify##2##3##(2009-8#1)(2013-1#1)
Here we investigate##2##3##(2009-9#1)(2010-3#1)
Here we investigated##2##3##(2008-11#1)(2009-12#1)
Here we present a case of##2##6##(2010-11#1)(2012-3#1)
Here we present a case##3##5##(2010-11#1)(2012-12#1)(2012-3#1)
Here we present a##7##4##(2008-12#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
Here we present an##2##4##(2008-10#1)(2008-3#1)
Here we present data##2##4##(2008-8#1)(2013-8#1)
Here we present the##2##4##(1994-3#1)(2013-8#1)
Here we present##20##3##(1994-3#2)(1995-2#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#2)
Here we propose a##2##4##(1993-9#1)(1994-9#1)
Here we propose##3##3##(1993-9#1)(1994-9#1)(2008-10#1)
Here we provide##2##3##(2008-11#1)(2008-9#1)
Here we report a case of##2##6##(2008-11#1)(2010-6#1)
Here we report a##11##4##(1991-2#1)(2008-11#2)(2008-7#1)(2009-7#2)(2010-6#1)(2012-2#3)(2013-1#1)
Here we report an##4##4##(1996-12#1)(2008-11#1)(2008-7#2)
Here we report on##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
Here we report that the##3##5##(1994-8#1)(1995-8#1)(2012-2#1)
Here we report that##14##4##(1990-5#2)(1992-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-8#2)(1996-2#1)(2008-10#1)(2009-10#1)(2009-8#1)(2012-2#2)
Here we report the case##2##5##(2008-9#1)(2013-1#1)
Here we report the identification of##3##6##(1994-11#1)(2008-10#1)(2009-6#1)
Here we report the identification##4##5##(1994-11#1)(2008-10#1)(2009-6#1)(2013-8#1)
Here we report the resonance assignment of##2##7##(2009-7#2)
Here we report the results of a##2##7##(2008-11#1)(2013-1#1)
Here we report the results of##3##6##(2008-11#1)(2008-5#1)(2013-1#1)
Here we report the##30##4##(1991-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2009-6#2)(2009-7#9)(2010-4#2)(2012-2#2)(2013-1#2)(2013-8#1)
Here we report##72##3##(1990-5#2)(1991-2#2)(1992-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#7)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-6#2)(2009-7#11)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#2)(2012-2#7)(2013-1#3)(2013-8#1)
Here we review recent##4##4##(2008-11#3)(2013-1#1)
Here we review the##4##4##(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
Here we review##12##3##(2008-10#1)(2008-11#5)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Here we show for the first time##2##7##(2011-2#1)(2012-2#1)
Here we show that an##3##5##(1990-5#1)(2008-7#1)(2012-3#1)
Here we show that in##2##5##(2008-9#2)
Here we show that the##11##5##(1993-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Here we show that##37##4##(1990-5#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#2)(1997-7#3)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-4#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Here we show##42##3##(1990-5#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#2)(1997-7#3)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-4#1)(2009-8#1)(2009-9#2)(2010-3#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
Here we study##2##3##(2008-8#2)
Here we suggest##2##3##(2008-2#1)(2009-8#1)
Here we summarize##2##3##(2008-9#1)(2009-8#1)
Here we use the##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)
Here we use##9##3##(1995-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
Here we used##3##3##(2008-11#1)(2008-9#1)(2009-12#1)
Here we##276##2##(1990-5#3)(1991-2#4)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#6)(1995-6#2)(1995-8#7)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#2)(1997-7#6)(2008-10#15)(2008-11#33)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#8)(2008-8#15)(2008-9#14)(2009-10#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#11)(2009-8#14)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#32)(2012-12#1)(2012-2#18)(2012-3#8)(2013-1#8)(2013-8#9)
Here##581##1##(1990-5#4)(1991-12#1)(1991-2#4)(1991-6#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#3)(1994-11#7)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#8)(1995-5#1)(1995-6#4)(1995-8#7)(1996-12#2)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-7#7)(1997-8#1)(2008-1#1)(2008-10#57)(2008-11#60)(2008-12#10)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#15)(2008-8#36)(2008-9#25)(2009-10#6)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#7)(2009-7#16)(2009-8#22)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#6)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#8)(2010-5#2)(2010-6#4)(2010-7#3)(2011-1#8)(2011-2#58)(2012-12#3)(2012-2#31)(2012-3#31)(2012-5#2)(2013-1#22)(2013-7#1)(2013-8#18)
Hereby##2##1##(1991-8#1)(2013-1#1)
Hereditary##7##1##(1993-1#1)(2008-12#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
Herein we report a case of##3##6##(2010-6#2)(2012-3#1)
Herein we report a##4##4##(2010-6#2)(2012-12#1)(2012-3#1)
Herein we report##5##3##(2010-6#2)(2011-1#1)(2012-12#1)(2012-3#1)
Herein we##9##2##(2008-10#1)(2008-7#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
Herein##47##1##(1992-9#1)(1994-12#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-10#2)(2010-12#1)(2010-6#4)(2010-7#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#4)
Hereward##4##1##(2008-10#4)
Heritabilities##3##1##(2008-10#2)(2008-8#1)
Heritability estimates of##2##3##(2008-10#2)
Heritability estimates##3##2##(2008-10#3)
Heritability of##4##2##(2008-10#4)
Heritability##9##1##(2008-10#9)
Herlitz##2##1##(1991-11#2)
Hermite-Gaussian##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Heroin##2##1##(2008-10#1)(2008-11#1)
Herpes simplex virus##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
Herpes simplex##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
Herpes zoster##2##2##(1994-3#2)
Herpes##7##1##(1994-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
Herpetomonas sp##4##2##(2008-10#4)
Herpetosiphon giganteus strain Hpa2##2##4##(1991-9#2)
Herrera de Pisuerga##2##3##(2008-10#2)
Herring##3##1##(2008-10#3)
Hershey Medical Center##2##3##(1995-12#2)
Hertfordshire##3##1##(2008-11#2)(2010-7#1)
Heteranthelium piliferum##2##2##(2008-12#2)
Heterobasidion annosum##5##2##(2008-10#4)(2010-10#1)
Heterobasidion irregulare##2##2##(2010-10#2)
Heterobasidion occidentale##2##2##(2010-10#2)
Heterobasidion##12##1##(2008-10#4)(2010-10#8)
Heterocyclic##2##1##(1996-5#1)(2012-2#1)
Heterodera avenae##3##2##(2008-10#3)
Heterodera glycines##14##2##(2008-10#14)
Heterodera schachtii##10##2##(2008-10#7)(2008-12#3)
Heterodera##30##1##(2008-10#27)(2008-12#3)
Heterodyne##3##1##(2007-12#1)(2008-3#2)
Heterogeneity in##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
Heterogeneity of##3##2##(2008-10#2)(2008-11#1)
Heterogeneity##7##1##(1992-2#1)(1994-8#1)(2008-10#3)(2008-11#1)(2012-2#1)
Heterologous##3##1##(1996-12#1)(2008-10#2)
Heteroplexis micocephala##2##2##(2011-2#2)
Heterosexual##2##1##(1992-9#1)(2013-1#1)
Heterosis##2##1##(2009-10#1)(2012-3#1)
Heterotopic bone##2##2##(2012-2#2)
Heterotopic##3##1##(1997-8#1)(2012-2#2)
Heterozygous##3##1##(1995-2#1)(1997-4#1)(2009-6#1)
Hexaene H-85 and##2##3##(2010-8#2)
Hexapoda##2##1##(2007-12#2)
Hexavalent chromium##2##2##(2008-12#1)(2011-2#1)
Heyde's##2##1##(2012-2#2)
Heyssel##2##1##(1993-3#2)
Hf and##2##2##(2008-10#2)
Hf##13##1##(2008-10#13)
Hf(IV) ions##2##2##(2008-10#2)
Hf(IV)##12##1##(2008-10#12)
Hg and Se##2##3##(2008-10#2)
Hg and##9##2##(2008-10#7)(2008-11#1)(2010-4#1)
Hg in the##2##3##(2008-10#2)
Hg in##13##2##(1990-5#2)(2008-10#11)
Hg was achieved##2##3##(2008-10#2)
Hg was##7##2##(1990-5#3)(2008-10#4)
Hg##96##1##(1990-11#1)(1990-5#10)(1992-11#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-5#2)(2006-6#2)(2008-1#1)(2008-10#63)(2008-11#7)(2008-7#2)(2010-4#3)(2013-8#1)
Hg(0)##3##1##(2008-10#3)
Hg(2)(2+)##2##1##(2008-10#2)
Hg(2+) and CH(3)Hg(+)##5##3##(2008-10#5)
Hg(2+) and##15##2##(2008-10#15)
Hg(2+) in##3##2##(2008-10#3)
Hg(2+) interference on##2##3##(2008-10#2)
Hg(2+) interference##3##2##(2008-10#3)
Hg(2+) ion in##2##3##(2008-10#2)
Hg(2+) ion##4##2##(2008-10#4)
Hg(2+) ions##5##2##(2008-10#5)
Hg(2+) were##2##2##(2008-10#2)
Hg(2+)##54##1##(2008-10#54)
Hg(I)##4##1##(2008-10#4)
Hg(II) and Pb(II)##3##3##(2008-10#3)
Hg(II) and Zn(II)##2##3##(2008-10#2)
Hg(II) and##9##2##(2008-10#9)
Hg(II) concentration##2##2##(2008-10#2)
Hg(II) from##2##2##(2008-10#2)
Hg(II) in the presence of##2##5##(2008-10#2)
Hg(II) in the##4##3##(2008-10#4)
Hg(II) in##14##2##(2008-10#14)
Hg(II) ions##6##2##(2008-10#6)
Hg(II) is##5##2##(2008-10#5)
Hg(II) reduction##2##2##(2008-10#2)
Hg(II) solution##2##2##(2008-10#2)
Hg(II) was##5##2##(2008-10#5)
Hg(II)##83##1##(2008-10#83)
Hg(II)-imprinted##2##1##(2008-10#2)
Hg(II)-imprinting thiol-functionalized mesoporous sorbent##2##4##(2008-10#2)
Hg(SCN)(2) immobilized in##2##3##(2008-10#2)
Hg) and##2##2##(2008-10#2)
Hg)##5##1##(2008-10#5)
Hg- and##2##2##(2008-10#1)(2008-7#1)
Hg-based superconductors##2##2##(2008-10#2)
HhaI##5##1##(2008-10#5)
Hi to##2##2##(2008-5#2)
Hi##3##1##(2008-5#3)
HiRes##2##1##(2008-11#2)
Hib disease##3##2##(1995-5#2)(2008-1#1)
Hib meningitis##4##2##(2008-1#4)
Hib##13##1##(1995-5#3)(1997-3#1)(2007-12#1)(2008-1#8)
Hicks##2##1##(1991-12#2)
Hidden Markov model##2##3##(1997-6#1)(2008-4#1)
Hidden Markov models##3##3##(2008-4#1)(2009-7#2)
Hidden Markov##6##2##(1997-6#2)(2008-4#2)(2009-7#2)
Hidden##8##1##(1995-5#1)(1997-6#2)(2008-3#1)(2008-4#2)(2009-7#2)
Hierarchical Linear##2##2##(2008-12#2)
Hierarchical linear modeling##2##3##(2008-12#1)(2009-7#1)
Hierarchical linear##3##2##(2008-12#1)(2009-7#1)(2011-2#1)
Hierarchical regression analyses##2##3##(1996-2#1)(2010-11#1)
Hierarchical##14##1##(1996-2#1)(1997-1#1)(2008-10#5)(2008-12#3)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)
Hierro##3##1##(2008-10#3)
High Court##3##2##(1992-6#1)(1995-6#2)
High Five cell##4##3##(2008-7#4)
High Five cells##2##3##(2008-7#2)
High Five##6##2##(2008-7#6)
High Fivetrade mark cells##4##4##(2008-11#1)(2008-7#3)
High Genetic##3##2##(2008-10#3)
High Performance Liquid##2##3##(1997-2#1)(2008-10#1)
High Performance##4##2##(1997-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
High Pressure##2##2##(1995-6#1)(2008-10#1)
High Protein##2##2##(2008-3#2)
High competition with low similarity##2##5##(2008-9#2)
High concentration of##2##3##(1990-5#1)(2008-10#1)
High concentration##3##2##(1990-5#1)(2008-10#2)
High concentrations of##3##3##(1995-8#1)(2008-10#1)(2009-5#1)
High dose of##2##3##(1993-8#1)(2009-8#1)
High dose##5##2##(1992-2#1)(1993-11#1)(1993-8#1)(1997-3#1)(2009-8#1)
High efficiency##2##2##(1997-2#1)(2008-10#1)
High enrichment factors##2##3##(2008-10#2)
High expression of##3##3##(2008-8#1)(2011-2#2)
High genetic diversity##2##3##(2008-10#1)(2013-8#1)
High level expression##2##3##(1994-6#1)(1994-8#1)
High level##3##2##(1994-6#1)(1994-8#1)(2008-5#1)
High levels of polyamines were detected in freshly collected##2##9##(2008-10#2)
High levels of##10##3##(1990-12#1)(1997-7#1)(2008-10#5)(2008-11#1)(2010-11#1)(2011-1#1)
High molecular weight##2##3##(1991-3#1)(2008-5#1)
High performance liquid chromatographic determination of##2##6##(1993-2#1)(2008-10#1)
High performance liquid chromatographic##3##4##(1993-2#1)(1994-8#1)(2008-10#1)
High performance liquid chromatography (HPLC)##2##5##(2008-10#2)
High performance liquid chromatography##5##4##(2008-10#5)
High performance liquid##8##3##(1993-2#1)(1994-8#1)(2008-10#6)
High performance##10##2##(1993-2#1)(1994-8#1)(2008-10#7)(2008-7#1)
High prevalence of##3##3##(1990-6#1)(2008-11#1)(2012-2#1)
High rate of##2##3##(2008-11#1)(2012-2#1)
High resolution spectrophotometry##2##3##(2008-10#2)
High resolution##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
High sensitivity for##2##3##(1995-5#1)(2008-10#1)
High sensitivity##6##2##(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
High stability##3##2##(2008-10#2)(2008-9#1)
High technology##2##2##(1993-2#1)(2013-8#1)
High throughput##5##2##(2008-10#3)(2008-11#1)(2009-4#1)
High##191##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-3#1)(1992-2#1)(1992-6#3)(1993-11#3)(1993-2#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#5)(1995-8#2)(1995-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#2)(2007-8#1)(2008-1#1)(2008-10#63)(2008-11#13)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#15)(2008-8#7)(2008-9#5)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#5)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#6)(2013-8#4)
High- and low-copy-number##2##3##(1993-12#2)
High- and##3##2##(1993-12#2)(2008-10#1)
High-Density##2##1##(2008-3#1)(2013-1#1)
High-Fivetrade mark##3##2##(2008-11#3)
High-Intensity Focused Ultrasound##2##3##(2013-1#2)
High-Performance Liquid Chromatography##2##3##(2009-8#2)
High-Resolution##4##1##(2008-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
High-density##4##1##(2008-11#3)(2008-3#1)
High-dose##8##1##(1990-9#1)(1991-2#1)(1991-6#1)(1994-2#1)(1994-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
High-grade##3##1##(1997-1#1)(2010-12#1)(2011-2#1)
High-intensity##2##1##(2008-10#1)(2013-8#1)
High-level expression##2##2##(2008-11#1)(2009-3#1)
High-level##6##1##(1993-6#1)(1993-9#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-7#1)
High-performance liquid chromatographic method for the simultaneous##2##7##(2008-10#2)
High-performance liquid chromatographic method for##3##5##(2008-10#3)
High-performance liquid chromatographic##5##3##(1997-2#1)(2008-10#4)
High-performance liquid chromatography##2##3##(2008-10#2)
High-performance liquid##7##2##(1997-2#1)(2008-10#6)
High-performance##9##1##(1991-7#1)(1997-2#1)(2008-10#6)(2008-2#1)
High-power##2##1##(2008-3#2)
High-quality##4##1##(2008-3#2)(2010-5#1)(2012-2#1)
High-resolution##16##1##(1991-9#1)(1994-5#1)(2008-10#3)(2008-2#1)(2008-3#3)(2009-8#1)(2010-10#1)(2012-2#4)(2012-3#1)
High-risk##4##1##(1991-6#1)(1994-1#1)(2011-2#2)
High-salt##2##1##(1993-6#2)
High-sensitivity##3##1##(1992-8#1)(2008-3#1)(2008-9#1)
High-speed##5##1##(1991-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-5#1)
High-throughput##6##1##(2008-11#2)(2008-4#1)(2008-9#1)(2012-2#2)
High-titer##3##1##(1994-5#1)(2008-5#1)(2008-8#1)
Higher Education Institutions (HEI)##2##4##(2008-11#1)(2012-3#1)
Higher Education Institutions (HEIs)##2##4##(2008-11#2)
Higher Education Institutions##5##3##(2008-11#4)(2012-3#1)
Higher Education##11##2##(1995-3#1)(2008-11#7)(2008-12#1)(2012-3#2)
Higher concentrations##2##2##(1990-7#1)(1994-8#1)
Higher levels of##2##3##(2008-8#1)(2012-3#1)
Higher##44##1##(1990-6#1)(1990-7#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-1#2)(1995-3#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-8#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)
Highest solubility was obtained in##2##5##(2012-2#2)
Highest##7##1##(1995-5#1)(2008-10#2)(2008-11#1)(2010-5#1)(2012-2#2)
Highlighting##2##1##(1991-3#1)(2012-3#1)
Highlights from##4##2##(2008-7#4)
Highlights##6##1##(2008-7#4)(2012-3#1)(2013-8#1)
Highly active antiretroviral therapy (HAART)##2##5##(2008-11#1)(2011-3#1)
Highly efficient##2##2##(2008-2#1)(2012-3#1)
Highly linear response is obtained for##2##6##(2008-10#2)
Highly parallel##2##2##(1990-11#2)
Highly resistant##3##2##(2008-10#3)
Highly selective##2##2##(2008-10#2)
Highly sensitive detection of##3##4##(2008-10#3)
Highly sensitive##7##2##(2008-10#7)
Highly significant##2##2##(2008-10#1)(2008-7#1)
Highly##39##1##(1990-11#2)(1991-11#1)(1992-3#1)(1996-5#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-3#1)(2012-3#2)(2013-1#2)
Hilarini (Diptera##2##2##(2007-12#2)
Hilarini##3##1##(2007-12#3)
Hilbert transform##3##2##(2008-3#3)
Hill##11##1##(1990-3#1)(1991-5#1)(1993-2#2)(1993-5#1)(1993-8#1)(2008-10#1)(2009-10#3)(2012-2#1)
Hills##7##1##(1997-3#4)(2008-10#2)(2012-2#1)
Himalayas##3##1##(2008-8#2)(2008-9#1)
HindIII##4##1##(1991-9#1)(1993-8#1)(1997-7#1)(2008-10#1)
Hindus##3##1##(1996-8#1)(2011-2#2)
Hinnavin I##3##2##(1997-8#3)
Hip Score##2##2##(2011-2#1)(2013-1#1)
Hip##5##1##(2008-12#2)(2011-2#2)(2013-1#1)
Hippocampal cell death##3##3##(1996-5#3)
Hippocampal##4##1##(1994-2#1)(1996-5#3)
Hippophae rhamnoides and its medicinal preparation##2##6##(2008-10#2)
Hippophae rhamnoides##3##2##(2008-10#2)(2012-8#1)
Hiproly##3##1##(2008-10#3)
Hirsch##2##1##(2011-2#1)(2012-2#1)
Hirschsprung's disease##5##2##(1994-12#4)(2011-2#1)
Hirsutella rhossiliensis was##2##3##(2008-10#2)
Hirsutella rhossiliensis##4##2##(2008-10#4)
His 57##2##2##(1991-3#2)
His and##2##2##(1991-5#1)(2008-8#1)
His first##2##2##(2008-12#1)(2010-1#1)
His##41##1##(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-11#2)(1995-8#1)(1996-2#1)(1996-5#1)(2007-12#2)(2008-10#5)(2008-12#6)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-3#1)(2010-5#3)(2011-1#2)(2011-2#2)(2012-3#1)
His-tagged##2##1##(2008-4#2)
His6##2##1##(1991-5#1)(1993-8#1)
His85##4##1##(2008-9#4)
Hishimonoides sellatiformis##4##2##(2008-10#4)
Hishimonus sellatus##2##2##(2008-10#2)
Hispanic and Anglo##3##3##(2008-9#2)(2012-2#1)
Hispanic women##2##2##(1994-9#2)
Hispanic youths##2##2##(2008-9#2)
Hispanic##26##1##(1994-9#2)(1995-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#9)(2010-10#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Hispanic&quot##3##1##(2011-2#3)
Hispanic/Latino##2##1##(2013-1#2)
Hispanics##12##1##(1995-12#2)(2011-2#4)(2012-12#6)
Histamine is##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
Histamine##5##1##(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)
Histidine Kinase##2##2##(2008-10#2)
Histochemical and##3##2##(1990-8#1)(2008-10#1)(2008-6#1)
Histochemical##8##1##(1990-2#1)(1990-8#1)(2008-10#3)(2008-6#1)(2008-9#2)
Histograms##3##1##(2008-10#1)(2008-6#1)(2008-9#1)
Histologic examination revealed##2##3##(2008-11#2)
Histologic examination##3##2##(2008-10#1)(2008-11#2)
Histologic##12##1##(1993-6#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2009-1#2)(2012-3#3)(2013-1#1)
Histological and ultrastructural##3##3##(1992-9#1)(2008-10#1)(2008-7#1)
Histological and##5##2##(1992-9#1)(2008-10#2)(2008-5#1)(2008-7#1)
Histological examination of the resected##2##5##(1997-3#1)(2008-10#1)
Histological examination of the##3##4##(1997-3#1)(2008-10#1)(2010-10#1)
Histological examination of##5##3##(1993-12#1)(1997-3#1)(2008-10#1)(2010-10#1)(2013-1#1)
Histological examination revealed##4##3##(1993-12#1)(1994-12#1)(2008-5#1)(2011-2#1)
Histological examination##12##2##(1993-12#2)(1994-12#1)(1995-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
Histological investigations##2##2##(2008-10#2)
Histological observations##3##2##(2008-10#3)
Histological studies##2##2##(2008-10#1)(2008-11#1)
Histological##40##1##(1990-9#1)(1991-8#1)(1992-9#1)(1993-12#2)(1994-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-5#3)(2008-7#3)(2009-12#2)(2010-10#1)(2010-11#1)(2011-2#3)(2013-1#1)
Histologically##14##1##(1990-2#1)(1990-6#1)(1991-8#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-5#3)(2010-12#1)(2011-2#2)(2012-3#1)
Histology and##2##2##(2008-11#1)(2013-1#1)
Histology confirmed##2##2##(2011-2#2)
Histology revealed a##2##3##(2010-3#1)(2011-2#1)
Histology showed##2##2##(1992-12#1)(1997-3#1)
Histology##10##1##(1990-2#1)(1992-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#3)(2013-1#1)
Histomorphological##2##1##(2011-2#1)(2013-8#1)
Histone modifications##2##2##(2009-8#1)(2011-2#1)
Histone##3##1##(2008-10#1)(2009-8#1)(2011-2#1)
Histopathologic evaluation of##2##3##(2008-10#2)
Histopathologic examination revealed##2##3##(2008-11#1)(2008-9#1)
Histopathologic examination##3##2##(2008-11#1)(2008-9#1)(2010-6#1)
Histopathologic##8##1##(1990-8#1)(1994-1#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)
Histopathological examination##4##2##(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
Histopathological##13##1##(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
Histopathologically##3##1##(2010-6#1)(2013-1#1)(2013-8#1)
Histopathology and##2##2##(2008-5#1)(2011-1#1)
Histopathology confirmed##2##2##(2010-12#1)(2013-8#1)
Histopathology of##4##2##(2008-10#3)(2013-8#1)
Histopathology revealed##4##2##(1990-6#1)(2008-5#1)(2009-8#1)(2012-2#1)
Histopathology##16##1##(1990-6#1)(2008-10#4)(2008-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
Historical data##2##2##(2008-10#2)
Historical##8##1##(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#1)
Historically##15##1##(1995-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-1#2)
History and##2##2##(1997-3#1)(2010-1#1)
History of the##4##3##(2010-1#1)(2011-4#1)(2012-12#2)
History of##12##2##(1992-12#1)(1994-12#1)(1995-12#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-1#1)(2011-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
History##19##1##(1991-2#1)(1992-12#1)(1994-12#2)(1995-12#1)(1997-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#2)(2011-2#1)(2011-4#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
Hitachi##2##1##(2008-10#2)
Hizikia##2##1##(2008-10#2)
Hmgi family##2##2##(1995-8#2)
Hmgi-c##2##1##(1995-8#2)
Hn2 and Hn2-19##2##3##(2008-10#2)
Hn2 and##3##2##(2008-10#3)
Hn2##5##1##(2008-10#5)
Ho##4##1##(2008-10#1)(2008-7#2)(2008-8#1)
Hoagland's solution##3##2##(2008-10#3)
Hockey##3##1##(2010-1#3)
Hodgkin's disease##4##2##(1992-12#1)(1994-12#2)(2008-9#1)
Hodgkinson##2##1##(1995-6#2)
Hoechst 33342 dye##2##3##(2008-11#2)
Hoechst 33342##9##2##(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#4)
Hoechst is##2##2##(2008-5#1)(2008-9#1)
Hoechst##17##1##(2008-11#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#7)
Hoehn and Yahr##2##3##(2008-7#2)
Hoehn##4##1##(2008-7#3)(2013-8#1)
Hoepfl was##2##2##(1995-12#2)
Hoepfl##7##1##(1995-12#7)
Hoff and##2##2##(1997-2#1)(2008-11#1)
Hoff plots##3##2##(2008-10#3)
Hoff##9##1##(1992-10#1)(1997-2#2)(2008-10#5)(2008-11#1)
Hofmeister##3##1##(2008-10#1)(2009-8#1)(2012-2#1)
Hole##5##1##(1994-1#2)(1997-3#1)(2013-1#2)
Holland##4##1##(1991-8#3)(2008-10#1)
Holliday##2##1##(2012-3#2)
Hologic##2##1##(2008-8#2)
Holographic recording with orthogonally polarized beams in a cesium-doped##2##9##(2008-3#2)
Holographic recording##3##2##(2007-12#1)(2008-3#2)
Holographic##5##1##(2007-12#1)(2008-3#4)
Holography##2##1##(2008-2#1)(2008-3#1)
Holstein##7##1##(2013-1#7)
Holstein) and Holstein##2##3##(2013-1#2)
Holt-Oram syndrome##2##2##(1994-3#1)(1997-3#1)
Holter ECG monitoring##3##3##(1996-3#3)
Holter ECG##4##2##(1996-3#4)
Holter##5##1##(1996-3#5)
Homalodisca coagulata##3##2##(2007-12#2)(2008-10#1)
Home Care Program##3##3##(1991-2#2)(1996-1#1)
Home Office##3##2##(2008-11#3)
Home care##5##2##(1991-2#2)(1993-3#1)(1994-1#1)(1995-3#1)
Home health care##2##3##(1995-3#1)(1996-2#1)
Home health##3##2##(1995-3#2)(1996-2#1)
Home is##2##2##(1995-3#1)(2011-2#1)
Home testing##2##2##(1994-9#1)(1996-5#1)
Home##38##1##(1991-2#4)(1992-1#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#5)(1996-1#1)(1996-2#2)(1996-5#3)(2007-12#1)(2008-11#3)(2008-12#1)(2009-11#1)(2010-4#2)(2010-7#1)(2011-2#3)
Homelessness##3##1##(1993-3#1)(2013-1#2)
Homeostatic##2##1##(2008-11#1)(2010-10#1)
Homer##3##1##(2008-11#3)
Homer1a##3##1##(2008-11#3)
Homeward##2##1##(1993-1#2)
Homo sapiens##3##2##(1994-3#1)(2008-9#1)(2010-3#1)
Homocysteine##3##1##(2008-10#1)(2008-11#1)(2008-8#1)
Homogenates##2##1##(2008-10#2)
Homogeneous immunoassay##2##2##(2008-10#2)
Homogeneous time-resolved fluoroimmunoassay of##2##4##(2008-10#2)
Homogeneous##9##1##(1992-3#1)(2008-10#7)(2008-3#1)
Homologous pairing##2##2##(1990-5#1)(1995-2#1)
Homologous##5##1##(1990-5#1)(1995-2#2)(2008-10#1)(2008-8#1)
Homothorax##3##1##(2008-9#2)(2012-2#1)
Homozygous##2##1##(1995-2#1)(2008-10#1)
Honduras##2##1##(1992-5#1)(2008-10#1)
Honey##3##1##(2008-10#2)(2013-1#1)
Hong Kong were##2##3##(1994-3#1)(2008-7#1)
Hong Kong##22##2##(1994-3#1)(1996-1#1)(2008-10#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#2)(2010-11#4)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
Honolulu##2##1##(1992-2#1)(2010-8#1)
Honours##2##1##(2008-11#1)(2008-12#1)
Hook##4##1##(2008-10#1)(2008-11#1)(2008-12#2)
Hop stunt viroid##2##3##(2008-10#2)
Hop##3##1##(2008-10#3)
Hope##2##1##(2010-10#2)
Hopefully##2##1##(1997-8#1)(2008-5#1)
Hopf bifurcation##3##2##(2010-10#1)(2013-8#2)
Hopf##4##1##(2010-10#2)(2013-8#2)
Hopkins##16##1##(1992-3#1)(1993-3#5)(1994-12#1)(1994-3#1)(1995-2#2)(1996-9#1)(2011-2#4)(2013-8#1)
Hopland##2##1##(2008-10#2)
Hor 2596 and Triumph##2##4##(2008-10#2)
Hor 2596##3##2##(2008-10#3)
Hor2596##6##1##(2008-10#6)
Hordeum##3##1##(2008-10#2)(2008-12#1)
Horizons##2##1##(2008-11#2)
Horizontal transfer##2##2##(2008-10#1)(2009-6#1)
Horizontal##4##1##(1990-5#1)(1996-1#1)(2008-10#1)(2009-6#1)
Hormesis##2##1##(2008-7#2)
Hormonal regulation of##3##3##(1995-8#2)(2012-3#1)
Hormonal##4##1##(1995-8#2)(1996-12#1)(2012-3#1)
Hormone replacement therapy##2##3##(1991-3#1)(2010-12#1)
Hormone##10##1##(1991-3#1)(2008-4#2)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#2)
Hormones##2##1##(1990-2#1)(2008-6#1)
Hormozgan province##2##2##(2008-12#2)
Horner's syndrome##2##2##(2011-2#1)(2013-1#1)
Horseradish peroxidase (HRP)##3##3##(2008-10#3)
Horseradish peroxidase##8##2##(2008-10#8)
Horseradish##9##1##(2008-10#9)
Horticultural##2##1##(2008-10#2)
Hoshin planning system##2##3##(1996-1#2)
Hoshin planning##3##2##(1994-2#1)(1996-1#2)
Hoshin##4##1##(1994-2#1)(1996-1#3)
Hospice Benefit##2##2##(1993-12#2)
Hospice##6##1##(1993-12#2)(1994-12#3)(2012-12#1)
Hospital Association##7##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(2008-11#2)
Hospital Center##2##2##(1996-3#1)(2011-2#1)
Hospital Literature Index##2##3##(1991-12#2)
Hospital Medical##2##2##(1993-12#1)(2008-7#1)
Hospital Medicine in Chile##2##4##(2013-8#2)
Hospital Security##2##2##(1992-12#1)(1992-2#1)
Hospital administration primarily determined which instruments were to be used (67##2##11##(2013-1#2)
Hospital administrators are##2##3##(1991-2#1)(1995-2#1)
Hospital and##9##2##(1991-3#1)(1991-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(2010-10#1)(2010-5#1)
Hospital between##4##2##(1997-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
Hospital diversification##2##2##(2008-11#2)
Hospital during##2##2##(1991-11#1)(2013-8#1)
Hospital for Special Surgery##5##4##(2008-8#4)(2009-3#1)
Hospital for the Ruptured and Crippled##2##6##(2008-8#2)
Hospital for##11##2##(1991-2#1)(1992-1#1)(2008-11#1)(2008-7#1)(2008-8#6)(2009-3#1)
Hospital governance##2##2##(1992-3#1)(1993-12#1)
Hospital in##14##2##(1992-3#1)(1993-12#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2012-3#1)
Hospital of the##4##3##(2011-2#3)(2013-1#1)
Hospital of##15##2##(1991-9#1)(1993-12#1)(1996-11#2)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
Hospital outpatient##2##2##(1991-2#2)
Hospital security##3##2##(1992-2#3)
Hospital stay##2##2##(1995-3#1)(2012-2#1)
Hospital##249##1##(1990-2#2)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#4)(1991-2#11)(1991-3#6)(1991-9#7)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#8)(1992-3#3)(1993-1#3)(1993-12#10)(1993-2#2)(1993-3#9)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#5)(1994-6#1)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#4)(1996-11#2)(1996-2#1)(1996-3#7)(1996-5#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#15)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#6)(2009-1#1)(2009-10#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#3)(2010-7#1)(2011-2#21)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#12)(2013-8#8)
Hospital's##3##1##(1995-3#1)(1996-2#1)(2008-11#1)
Hospital)##2##1##(2008-10#1)(2011-3#1)
Hospital-based##2##1##(1993-2#1)(2008-11#1)
Hospital]##3##1##(1990-2#1)(1991-11#1)(2010-6#1)
Hospitals and health systems##2##4##(2008-11#2)
Hospitals and##5##2##(1991-1#1)(1994-12#1)(1994-3#1)(2008-11#2)
Hospitals are##2##2##(1994-1#1)(2013-1#1)
Hospitals in##2##2##(1992-8#1)(2012-12#1)
Hospitals should begin removing certain##2##5##(2011-1#1)(2011-2#1)
Hospitals should##4##2##(1997-2#1)(2011-1#1)(2011-2#2)
Hospitals that##3##2##(1991-11#1)(1993-3#1)(2008-11#1)
Hospitals with##2##2##(1992-12#2)
Hospitals##46##1##(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-11#3)(2009-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)
Hospitals'##3##1##(1994-2#1)(1995-1#1)(2012-2#1)
Host Adaptation##2##2##(2008-10#2)
Host Plants##3##2##(2008-10#3)
Host Range##3##2##(2008-10#3)
Host Specialization in the##2##4##(2008-10#2)
Host Specificity of##3##3##(2008-10#3)
Host Specificity##4##2##(2008-10#4)
Host and##2##2##(2008-10#2)
Host defense##2##2##(2008-10#1)(2008-5#1)
Host penetration was not##2##4##(2008-10#2)
Host plant##2##2##(2008-10#2)
Host range and##2##3##(2008-10#2)
Host range##4##2##(2008-10#4)
Host response##2##2##(1995-5#1)(2008-10#1)
Host specificity##2##2##(2008-10#2)
Host##69##1##(1995-5#1)(2008-10#61)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#2)(2012-3#1)(2013-1#1)
Host-Pathogen Interactions##2##2##(2008-10#2)
Host-Pathogen##3##1##(2008-10#3)
Host-Specific##3##1##(2008-10#3)
Hostility##2##1##(2008-4#2)
Hosts in California##2##3##(2008-10#2)
Hosts##10##1##(2008-10#9)(2011-2#1)
Hot##2##1##(1996-9#1)(2009-5#1)
Hotel##6##1##(1992-8#1)(1994-2#2)(1994-3#2)(2008-5#1)
House of##5##2##(1994-8#1)(1995-6#1)(1996-5#2)(2008-11#1)
House##30##1##(1991-12#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#12)(1996-5#7)(1997-2#1)(2008-11#1)(2013-1#1)
Household Food Security##2##3##(2010-9#1)(2012-2#1)
Household##4##1##(2008-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
Households##3##1##(1991-12#1)(1994-1#1)(2009-12#1)
Housing Act##2##2##(1995-12#2)
Housing##6##1##(1990-2#1)(1992-8#1)(1995-12#2)(1995-6#1)(2013-1#1)
Houston##4##1##(1994-3#1)(1996-5#2)(2008-10#1)
Houttuynia cordata##4##2##(2008-10#4)
How a##2##2##(1995-3#1)(2008-11#1)
How are##2##2##(2012-12#1)(2013-8#1)
How can we##4##3##(1991-11#1)(2010-12#2)(2012-2#1)
How can##10##2##(1991-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(2008-4#1)(2008-8#1)(2010-12#2)(2012-2#1)
How do you##2##3##(1994-3#1)(2008-9#1)
How do##13##2##(1994-1#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-1#2)
How does##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
How important is##2##3##(2008-11#1)(2011-3#1)
How medical reviewers can avoid bad faith claims and ERISA violations##2##11##(1993-12#2)
How much##2##2##(1994-2#1)(1994-9#1)
How the##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
How this##2##2##(2009-8#1)(2013-8#1)
How to apply##2##3##(1994-12#1)(2011-2#1)
How to write##2##3##(2009-4#1)(2010-7#1)
How to##31##2##(1992-1#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-8#2)(2009-12#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-8#1)
How we do it##5##4##(2008-9#5)
How well##4##2##(1996-2#2)(1997-3#1)(2008-10#1)
How you##2##2##(1994-3#1)(1997-1#1)
How##138##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#3)(2008-10#5)(2008-11#9)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#7)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-8#3)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#5)
Howard##6##1##(1994-12#2)(1996-5#1)(2008-9#1)(2013-1#2)
Howardula aoronymphium##2##2##(2008-8#1)(2008-9#1)
Howardula##3##1##(2008-8#1)(2008-9#2)
However a##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
However for##2##2##(2008-10#1)(2008-12#1)
However it is##2##3##(1995-3#1)(2013-1#1)
However it##4##2##(1995-3#1)(1997-3#1)(2008-10#1)(2013-1#1)
However its##3##2##(1990-2#1)(1996-1#1)(2008-11#1)
However no##3##2##(1990-6#1)(1996-2#1)(2013-1#1)
However the##13##2##(1992-11#1)(1994-8#2)(1995-6#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-1#1)(2013-8#1)
However there is##2##3##(2008-11#1)(2010-6#1)
However there##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)(2012-3#1)
However when##3##2##(1997-2#1)(2008-11#1)(2013-8#1)
However##1941##1##(1990-11#9)(1990-12#4)(1990-2#9)(1990-3#3)(1990-5#2)(1990-6#6)(1990-8#5)(1990-9#1)(1991-11#3)(1991-12#14)(1991-2#4)(1991-3#11)(1991-5#8)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#12)(1992-2#7)(1992-3#6)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#4)(1993-11#5)(1993-12#7)(1993-2#8)(1993-3#3)(1993-6#8)(1993-8#13)(1993-9#1)(1994-1#3)(1994-11#5)(1994-12#10)(1994-2#4)(1994-3#8)(1994-5#11)(1994-6#7)(1994-8#10)(1995-1#3)(1995-10#1)(1995-11#10)(1995-12#18)(1995-2#7)(1995-3#5)(1995-5#5)(1995-6#10)(1995-8#6)(1995-9#2)(1996-1#6)(1996-11#5)(1996-12#7)(1996-2#13)(1996-3#9)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#10)(1997-2#17)(1997-3#9)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#10)(1997-9#1)(2006-6#4)(2007-11#3)(2007-12#6)(2007-8#3)(2008-1#6)(2008-10#452)(2008-11#189)(2008-12#35)(2008-2#5)(2008-3#26)(2008-4#9)(2008-5#50)(2008-6#12)(2008-7#61)(2008-8#75)(2008-9#44)(2009-1#3)(2009-10#14)(2009-11#8)(2009-12#10)(2009-3#7)(2009-4#4)(2009-5#4)(2009-6#9)(2009-7#10)(2009-8#31)(2009-9#3)(2010-1#8)(2010-10#10)(2010-11#16)(2010-12#14)(2010-2#2)(2010-3#5)(2010-4#7)(2010-5#8)(2010-6#8)(2010-7#8)(2010-8#6)(2010-9#2)(2011-1#11)(2011-10#5)(2011-2#102)(2011-3#6)(2011-7#1)(2012-12#10)(2012-2#53)(2012-3#45)(2012-5#5)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#82)(2013-7#2)(2013-8#25)
Hox genes##4##2##(1993-12#1)(2008-9#2)(2013-8#1)
Hox proteins##2##2##(2012-2#2)
Hox##10##1##(1993-12#1)(2008-9#3)(2012-2#5)(2013-8#1)
Hoxb-4##2##1##(1995-2#2)
Hp##3##1##(1990-6#1)(2008-8#2)
HpD##5##1##(1990-6#1)(2008-7#2)(2008-9#2)
HpaG(Xooc)##7##1##(2008-10#7)
HpaII##2##1##(2008-10#2)
Hr##5##1##(1991-10#5)
Hrr1##2##1##(2012-3#2)
Hrs##4##1##(1991-10#4)
Hsp22##2##1##(2013-1#2)
Hsp25##3##1##(1993-6#3)
Hsp70 in##3##2##(1991-9#3)
Hsp70##7##1##(1991-9#7)
Hsp90 can##2##2##(2010-4#2)
Hsp90 is##3##2##(1997-4#1)(2010-4#2)
Hsp90 might##2##2##(1997-4#1)(2010-4#1)
Hsp90 on the##2##3##(1997-4#2)
Hsp90##17##1##(1997-4#8)(2010-4#9)
Htt##4##1##(2012-2#4)
HuES human embryonic stem cell lines##2##6##(2008-8#2)
HuES human embryonic stem cell##3##5##(2008-8#3)
HuES human embryonic stem##4##4##(2008-8#4)
HuES media##2##2##(2008-8#2)
HuES##7##1##(2008-8#7)
Huallaga Valley##2##2##(2008-10#2)
Huang##2##1##(2008-11#1)(2009-10#1)
Hubble##3##1##(1990-11#1)(1995-3#1)(2008-2#1)
Hubei##2##1##(2010-8#1)(2013-8#1)
Huber##3##1##(2008-10#1)(2011-2#2)
Huge##2##1##(2009-2#1)(2013-1#1)
Huh 7 cells##4##3##(2008-11#4)
Huh 7##6##2##(2008-11#6)
Huit cas de##2##3##(2013-1#2)
Human Breast##2##2##(1994-12#2)
Human Genome Project##3##3##(1994-9#2)(2008-5#1)
Human Genome##6##2##(1994-9#3)(2008-12#1)(2008-4#1)(2008-5#1)
Human Immunodeficiency Virus##2##3##(1990-2#1)(2013-8#1)
Human Immunodeficiency##3##2##(1990-2#1)(2011-2#1)(2013-8#1)
Human Intestinal##4##2##(2008-11#3)(2009-12#1)
Human Resources##2##2##(1994-1#1)(2008-11#1)
Human Rights Act##2##3##(2008-11#2)
Human Rights##6##2##(1995-12#1)(1995-6#2)(1996-5#1)(2008-11#2)
Human T cell##2##3##(2008-4#1)(2011-2#1)
Human and murine##2##3##(1993-8#1)(2008-11#1)
Human and##5##2##(1992-5#1)(1993-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
Human chorionic##2##2##(1995-8#1)(2007-7#1)
Human embryonic stem cells##2##4##(2008-8#1)(2008-9#1)
Human embryonic stem##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
Human hematopoietic##2##2##(2008-8#1)(2009-12#1)
Human immunodeficiency virus (HIV)##3##4##(1991-5#1)(1994-11#1)(2008-10#1)
Human immunodeficiency virus##6##3##(1991-5#1)(1994-11#2)(2008-10#1)(2008-4#1)(2011-2#1)
Human immunodeficiency virus-1 protease##2##4##(1991-9#2)
Human immunodeficiency virus-1##3##3##(1991-9#2)(1994-5#1)
Human immunodeficiency##10##2##(1991-5#1)(1991-9#2)(1994-11#2)(1994-5#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
Human milk##3##2##(1993-11#1)(2012-2#2)
Human papillomavirus testing in the clinical laboratory##2##7##(1994-1#2)
Human papillomavirus##5##2##(1994-1#2)(2008-11#2)(2013-1#1)
Human plasma##4##2##(1991-5#1)(1996-3#1)(2008-10#2)
Human resources##4##2##(2008-11#4)
Human serum##4##2##(2008-10#4)
Human type I interferons##2##4##(1995-12#2)
Human type##3##2##(1994-11#1)(1995-12#2)
Human##185##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#3)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-8#1)(1994-1#4)(1994-11#6)(1994-12#3)(1994-5#2)(1994-9#6)(1995-12#4)(1995-2#1)(1995-6#4)(1995-8#2)(1996-2#2)(1996-3#1)(1996-5#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-9#1)(2006-6#2)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#31)(2008-12#2)(2008-4#9)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#5)(2009-12#3)(2009-4#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#8)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#5)(2013-8#1)
Humana##2##1##(1991-3#1)(1992-1#1)
Humanities##4##1##(2011-2#3)(2012-12#1)
Humans##7##1##(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-8#1)(2012-3#1)
Humboldt penguins (Spheniscus humboldti)##2##4##(2008-5#2)
Humboldt penguins##3##2##(2008-5#3)
Humic Cambisol-DOM##4##2##(2008-11#4)
Humic acid##2##2##(2008-10#2)
Humic acids##2##2##(2008-10#2)
Humic##9##1##(2008-10#5)(2008-11#4)
Humidity##9##1##(2008-10#8)(2008-3#1)
Hummingbird##5##1##(2008-9#4)(2012-12#1)
Humoral##3##1##(2008-11#1)(2008-6#1)(2008-9#1)
Hundreds of##2##2##(2008-10#1)(2008-11#1)
Hungarian##4##1##(1996-6#2)(2008-10#1)(2008-8#1)
Hungary between##2##2##(1997-8#1)(2008-10#1)
Hungary##21##1##(1991-3#6)(1994-12#2)(1996-6#1)(1997-8#2)(2008-10#6)(2008-12#2)(2008-7#1)(2013-8#1)
Hunt and Hess grade at time of##2##7##(1995-11#1)(2008-7#1)
Hunt and Hess grade##3##4##(1995-11#2)(2008-7#1)
Hunt##4##1##(1995-11#2)(2008-11#1)(2008-7#1)
Huntington##4##1##(2008-11#1)(2010-1#1)(2011-8#2)
Huntington's disease (HD)##2##3##(1996-8#1)(2011-10#1)
Huntington's disease##13##2##(1995-12#1)(1996-8#2)(2008-5#2)(2011-10#1)(2011-2#5)(2012-2#1)(2013-8#1)
Huntington's##16##1##(1995-12#1)(1995-9#1)(1996-8#2)(2008-5#3)(2011-10#2)(2011-2#5)(2012-2#1)(2013-8#1)
Hurricane Katrina##5##2##(2008-4#1)(2011-2#2)(2012-3#2)
Hurricane##6##1##(2008-4#1)(2011-2#2)(2012-3#3)
Hwaseong##4##1##(2008-10#4)
Hx##6##1##(2008-10#6)
HxR and Hx are##2##4##(2008-10#2)
HxR and Hx##3##3##(2008-10#3)
HxfB-##2##1##(2008-10#2)
Hyacinthus##3##1##(2008-10#1)(2008-8#2)
Hyaluronan##3##1##(1993-6#1)(2010-8#2)
Hyamine 1622 (HM)##2##3##(2008-10#2)
Hybrid zones##2##2##(2008-8#1)(2013-1#1)
Hybrid##23##1##(1996-9#1)(2008-10#11)(2008-3#4)(2008-8#3)(2012-3#1)(2013-1#1)(2013-8#2)
Hybridization of amplicons##2##3##(2008-10#2)
Hybridization of##9##2##(1992-8#1)(1993-2#1)(1997-7#1)(2008-10#4)(2008-8#1)(2008-9#1)
Hybridization##19##1##(1992-8#1)(1993-2#1)(1997-6#1)(1997-7#1)(2008-10#9)(2008-8#3)(2008-9#1)(2012-3#1)(2013-1#1)
Hybridoma cell##2##2##(2008-11#2)
Hybridoma cells##2##2##(2008-11#2)
Hybridoma##8##1##(1991-12#1)(2008-11#7)
Hybridomas##2##1##(2008-11#2)
Hybrids of##3##2##(2008-10#3)
Hybrids with##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
Hybrids##10##1##(2008-10#7)(2010-4#2)(2012-3#1)
Hydathodes##2##1##(2008-10#2)
Hydatid cyst of##3##3##(2008-7#1)(2010-11#1)(2013-1#1)
Hydatid cyst##4##2##(2008-7#1)(2010-11#1)(2010-12#1)(2013-1#1)
Hydatid disease##3##2##(2008-7#1)(2013-1#2)
Hydatid##8##1##(2008-7#2)(2010-11#1)(2010-12#2)(2013-1#3)
Hydra attenuata##2##2##(1993-12#2)
Hydra##3##1##(1993-12#3)
Hydractinia##3##1##(2012-3#3)
Hydrazine and##2##2##(2008-10#2)
Hydrazine##4##1##(2008-10#3)(2009-8#1)
Hydride generation##3##2##(2008-10#3)
Hydride##5##1##(2008-10#5)
Hydroa##2##1##(2010-6#2)
Hydrocortisone was##2##2##(2008-11#1)(2012-3#1)
Hydrocortisone##3##1##(2008-11#2)(2012-3#1)
Hydrogels##2##1##(2009-7#1)(2009-9#1)
Hydrogen cyanide gas##3##3##(2008-10#3)
Hydrogen cyanide##4##2##(2008-10#4)
Hydrogen ion-selective##2##2##(2008-10#2)
Hydrogen peroxide##5##2##(2008-10#3)(2009-5#1)(2011-2#1)
Hydrogen##18##1##(1994-2#1)(1996-5#1)(2008-10#12)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
Hydrolysis of##4##2##(1991-3#1)(1995-6#1)(1996-5#1)(2010-7#1)
Hydrolysis##5##1##(1991-3#1)(1995-6#1)(1996-5#1)(2008-10#1)(2010-7#1)
Hydrophilic##2##1##(2009-7#1)(2010-10#1)
Hydrophobic interaction chromatography coupled##2##4##(2008-10#2)
Hydrophobic interaction##3##2##(2008-10#3)
Hydrophobic##9##1##(1990-5#1)(1996-5#1)(2008-10#5)(2008-7#1)(2010-10#1)
Hydrothermal##2##1##(2008-6#1)(2009-11#1)
Hydrotropism##2##1##(2009-8#2)
Hygienists##2##1##(1993-1#1)(2008-10#1)
Hylobius abietis##3##2##(2008-7#1)(2011-10#2)
Hymenolepis microsoma sensu Cohn##2##4##(2011-2#2)
Hymenolepis microsoma##3##2##(2011-2#3)
Hymenolepis##4##1##(2011-2#3)(2012-2#1)
Hymenoptera##10##1##(2007-12#3)(2008-6#1)(2008-8#5)(2008-9#1)
Hyp group##2##2##(2011-2#2)
HypSc##2##1##(2011-2#2)
Hyperhomocysteinemia##2##1##(2008-1#1)(2008-8#1)
Hypericum##2##1##(1997-8#1)(2008-10#1)
Hyperlipidemia is##2##2##(1996-11#2)
Hyperlipidemia##5##1##(1996-11#2)(2009-12#1)(2013-1#2)
Hypermagnesaemia##2##1##(2008-6#2)
Hypermethylated in Cancer 1 (HIC1)##2##5##(2009-8#2)
Hyperparathyroidism##2##1##(1991-11#1)(2008-10#1)
Hyperplasia##2##1##(2008-10#1)(2012-3#1)
Hypersensitive Response##5##2##(2008-10#5)
Hypersensitive##6##1##(2008-10#5)(2008-8#1)
Hypersensitivity##3##1##(2008-10#1)(2008-8#1)(2012-12#1)
Hypersil##2##1##(2008-10#2)
Hyperspectral##2##1##(2008-10#2)
Hypertension has##2##2##(1996-6#1)(2010-4#1)
Hypertension in##2##2##(2008-11#1)(2011-2#1)
Hypertension is##4##2##(1996-6#1)(1997-5#1)(2008-11#1)(2008-8#1)
Hypertension was the##2##3##(1997-8#1)(2008-1#1)
Hypertension was##4##2##(1997-8#1)(2008-1#2)(2013-8#1)
Hypertension##17##1##(1993-2#1)(1995-10#1)(1996-6#2)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-8#1)(2009-11#1)(2010-4#2)(2011-2#1)(2013-8#1)
Hypertensive patients should##2##3##(1993-2#1)(1993-8#1)
Hypertensive patients##3##2##(1993-2#1)(1993-8#1)(2010-4#1)
Hypertensive##4##1##(1993-2#1)(1993-8#1)(2008-8#1)(2010-4#1)
Hyperthermia##2##1##(2011-2#1)(2013-8#1)
Hyphae of##4##2##(2008-10#4)
Hyphae were##2##2##(2008-10#2)
Hyphae##10##1##(2008-10#9)(2008-7#1)
Hyphal##4##1##(2008-10#4)
Hyphenated techniques##2##2##(2008-10#2)
Hyphenated##3##1##(2008-10#3)
Hypocalcemia##4##1##(1990-9#2)(1991-8#1)(2011-2#1)
Hypocrea##6##1##(2008-10#5)(2013-1#1)
Hypocrellin##2##1##(2008-8#2)
Hypoglycemia##2##1##(1997-2#1)(2010-2#1)
Hypogonadism##2##1##(2008-3#1)(2013-8#1)
Hypothermia is##2##2##(1991-3#1)(2010-7#1)
Hypothermia##5##1##(1991-3#1)(2009-11#1)(2010-7#1)(2011-2#2)
Hypotheses are##2##2##(1995-12#1)(2008-11#1)
Hypothesis##7##1##(1994-9#1)(1997-3#1)(2008-10#1)(2008-9#4)
Hypothetical##2##1##(2008-10#1)(2008-8#1)
Hypothyroidism##4##1##(2011-1#1)(2011-2#1)(2012-3#2)
Hypovirulence##5##1##(2008-10#4)(2008-9#1)
Hypovirulent##3##1##(2008-10#3)
Hypovirus##3##1##(2008-10#3)
Hypoxanthine##2##1##(2008-10#2)
Hypoxia is##2##2##(2009-11#1)(2009-4#1)
Hypoxia##8##1##(1994-5#1)(1995-2#1)(1996-12#2)(1996-3#1)(2009-11#1)(2009-4#1)(2012-2#1)
Hypoxia-inducible factors##2##2##(2011-2#2)
Hys##3##1##(2008-8#3)
Hysteroscopic##3##1##(1991-2#1)(1991-3#1)(1992-1#1)
Hysteroscopy##2##1##(1991-2#1)(1996-1#1)
Hz EA induced a##2##4##(1996-12#2)
Hz EA##5##2##(1996-12#5)
Hz and##5##2##(1996-12#2)(2008-3#1)(2011-2#2)
Hz band##3##2##(2008-7#2)(2013-8#1)
Hz frequency##3##2##(2008-11#2)(2010-8#1)
Hz##38##1##(1994-8#1)(1996-12#7)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#4)(2009-1#1)(2010-1#1)(2010-8#2)(2011-2#9)(2013-8#2)
Hz) in##2##2##(1994-8#1)(2008-11#1)
Hz)##13##1##(1994-8#1)(1996-12#2)(1996-2#2)(2008-11#2)(2008-3#1)(2010-1#3)(2010-7#1)(2013-8#1)
Häggström (Biology and Philosophy 22##2##5##(2010-3#2)
Häggström##3##1##(2008-11#1)(2010-3#2)
I &amp##2##2##(2010-7#2)
I (p &lt##3##3##(2010-1#1)(2013-8#2)
I (p##4##2##(2010-1#1)(2010-7#1)(2013-8#2)
I = 0##2##3##(1990-5#1)(1992-9#1)
I DNA fragment##3##3##(1996-6#1)(2008-8#2)
I DNA##4##2##(1993-8#1)(1996-6#1)(2008-8#2)
I IFNs##4##2##(1995-12#4)
I R##2##2##(2008-8#2)
I activity##3##2##(1994-8#1)(2008-7#2)
I allele##3##2##(2008-10#2)(2008-8#1)
I also examined##2##3##(2008-8#2)
I also##9##2##(1996-3#1)(2008-3#1)(2008-8#3)(2008-9#2)(2010-7#1)(2012-3#1)
I am##3##2##(1992-3#1)(2011-2#2)
I analyze##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
I and Cb##2##3##(1995-12#2)
I and Hinf##2##3##(2008-12#1)(2008-9#1)
I and II and##3##4##(2011-2#1)(2012-2#1)(2012-3#1)
I and II in the##2##5##(1995-12#1)(2008-10#1)
I and II in##3##4##(1995-12#1)(2008-10#2)
I and II metal ions##2##5##(2008-10#2)
I and II of the##3##5##(1995-12#2)(2008-10#1)
I and II strains##2##4##(2008-10#2)
I and II##45##3##(1993-3#1)(1995-12#5)(1995-6#2)(2008-10#27)(2008-5#1)(2008-8#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
I and III##9##3##(1990-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#2)
I and II]##2##3##(1997-4#1)(2013-8#1)
I and IV##2##3##(1994-12#1)(2008-1#1)
I and bc-1(2)##3##3##(2008-10#3)
I and class II##4##4##(1995-5#1)(1997-8#1)(2008-4#1)(2008-9#1)
I and the##4##3##(2008-11#2)(2011-2#1)(2012-3#1)
I and type##6##3##(1995-11#1)(1995-2#1)(2008-4#1)(2008-5#2)(2011-2#1)
I and##129##2##(1990-2#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-6#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-12#2)(1995-11#1)(1995-12#16)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-9#1)(2008-1#1)(2008-10#44)(2008-11#7)(2008-12#3)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#4)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
I antigens##5##2##(1991-3#1)(1992-7#1)(1994-5#2)(2008-8#1)
I apply##2##2##(2008-8#1)(2013-1#1)
I argue that the##2##4##(2010-3#1)(2012-2#1)
I argue that this##2##4##(1997-3#1)(2010-7#1)
I argue that##8##3##(1997-3#1)(2008-11#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
I argue##10##2##(1997-3#1)(2008-11#1)(2008-9#1)(2010-3#2)(2010-4#1)(2010-7#1)(2012-2#2)(2013-1#1)
I as##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
I at##4##2##(2008-8#2)(2009-3#2)
I believe it##2##3##(1994-2#1)(2009-6#1)
I binding to immobilized##2##4##(2008-10#2)
I binding##3##2##(1997-9#1)(2008-10#2)
I by##6##2##(1993-6#1)(1993-8#1)(1994-8#1)(1996-6#1)(2008-10#2)
I cleavage##2##2##(1990-7#1)(1993-8#1)
I clinical##5##2##(1994-8#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)
I collagen##13##2##(1991-5#1)(1994-12#1)(1997-1#2)(1997-7#3)(2008-1#1)(2008-11#1)(2008-9#2)(2009-7#1)(2013-8#1)
I compare the##2##3##(1994-12#1)(2013-8#1)
I conclude that##2##3##(2008-10#1)(2008-7#1)
I conducted a##2##3##(2008-8#2)
I constructed a##2##3##(2008-8#1)(2008-9#1)
I contained##3##2##(2008-10#3)
I data##2##2##(2011-2#1)(2012-3#1)
I deliberately##2##2##(2008-9#1)(2010-3#1)
I demonstrate##2##2##(2008-10#1)(2008-8#1)
I describe##2##2##(1994-9#1)(2008-8#1)
I discuss the##4##3##(2008-7#1)(2010-3#1)(2010-4#2)
I discuss##5##2##(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#2)
I don't##2##2##(2008-4#2)
I error##10##2##(1994-9#1)(2008-10#3)(2011-2#1)(2012-2#5)
I experimentally##2##2##(2008-8#1)(2008-9#1)
I explored##2##2##(2008-12#1)(2008-9#1)
I expression##4##2##(1993-8#1)(1997-9#3)
I family##3##2##(1997-8#2)(2008-1#1)
I feel##2##2##(1992-3#1)(2008-10#1)
I find##5##2##(2008-3#1)(2008-8#2)(2012-2#2)
I first##3##2##(2008-9#1)(2010-8#1)(2012-3#1)
I focus on##2##3##(2008-12#1)(2012-2#1)
I found that##3##3##(1993-3#1)(2008-6#1)(2008-9#1)
I found##6##2##(1993-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)
I fragment##2##2##(1997-2#1)(2008-9#1)
I fragments##4##2##(1992-6#3)(2008-10#1)
I from##4##2##(1991-5#1)(1992-6#1)(1993-12#1)(1993-6#1)
I gene expression##2##3##(1995-12#1)(2012-3#1)
I gene##4##2##(1995-12#1)(2008-10#1)(2008-6#1)(2012-3#1)
I get##2##2##(1996-12#1)(2010-9#1)
I had##3##2##(2010-1#1)(2010-9#1)(2011-2#1)
I have a##2##3##(2008-11#1)(2010-12#1)
I have##11##2##(1991-1#1)(1992-2#1)(1992-3#1)(1995-12#1)(2007-12#1)(2008-11#2)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#1)
I hope##3##2##(1991-12#1)(2008-11#1)(2012-3#1)
I in the##6##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)
I in##21##2##(1992-6#2)(1993-6#2)(1994-8#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-7#1)(2008-8#3)(2010-12#1)(2010-5#1)
I inhibitors##2##2##(2008-11#2)
I investigate##2##2##(2008-8#2)
I investigated the##2##3##(2008-8#1)(2008-9#1)
I investigated##3##2##(2008-8#2)(2008-9#1)
I is a##3##3##(1991-5#1)(1993-12#1)(2008-11#1)
I is##13##2##(1990-7#1)(1991-5#1)(1992-11#1)(1993-12#1)(1996-12#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2012-3#1)
I isolates were##3##3##(2008-10#3)
I isolates##9##2##(2008-10#9)
I kappa B alpha inhibited##2##5##(1995-2#2)
I kappa B alpha##3##4##(1995-2#3)
I kappa B##4##3##(1995-2#4)
I kappa B-like##2##3##(1991-7#2)
I kappa##7##2##(1991-7#2)(1995-2#4)(1995-6#1)
I know##3##2##(1992-3#1)(2010-9#1)(2013-8#1)
I metabotropic glutamate##3##3##(1995-12#1)(1996-12#2)
I molecules of##3##3##(1990-5#1)(2008-8#2)
I molecules##12##2##(1990-5#2)(1995-2#1)(1995-5#1)(1997-9#1)(2008-11#1)(2008-4#1)(2008-8#5)
I of the##6##3##(1993-3#1)(1994-1#1)(1994-2#1)(1995-2#1)(1997-1#1)(2008-7#1)
I of##16##2##(1991-2#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-2#1)(1995-2#1)(1997-1#1)(1997-7#2)(2008-10#2)(2008-7#1)
I or II##3##3##(2008-4#1)(2012-3#1)(2013-1#1)
I or##9##2##(2008-10#3)(2008-11#1)(2008-4#3)(2012-3#1)(2013-1#1)
I phosphatidylinositol##2##2##(2008-7#1)(2013-1#1)
I present a##2##3##(2008-3#1)(2012-3#1)
I present results##2##3##(1996-3#1)(2008-2#1)
I present##5##2##(1992-9#1)(1996-3#1)(2008-2#1)(2008-3#1)(2012-3#1)
I propose a##2##3##(1992-9#1)(2008-8#1)
I propose##5##2##(1992-9#2)(1995-9#1)(2008-8#1)(2008-9#1)
I proteins##3##2##(1997-7#1)(2008-1#2)
I quantitatively##2##2##(2008-8#2)
I really##2##2##(1992-3#1)(2012-2#1)
I region##2##2##(1997-8#1)(2008-10#1)
I remains##2##2##(2008-12#1)(2008-9#1)
I report##3##2##(2008-10#2)(2008-9#1)
I restriction##2##2##(1997-2#1)(2008-9#1)
I review##4##2##(2008-7#1)(2009-5#1)(2010-10#1)(2010-7#1)
I should##2##2##(2008-10#1)(2010-12#1)
I show that the##2##4##(1995-9#2)
I show that##5##3##(1995-9#2)(2008-8#1)(2008-9#1)(2012-3#1)
I show##7##2##(1995-9#2)(2008-8#1)(2008-9#1)(2012-2#2)(2012-3#1)
I showed##3##2##(1995-12#1)(2008-10#1)(2008-8#1)
I studies##3##2##(2006-6#1)(2008-5#1)(2010-12#1)
I study##3##2##(1996-10#1)(2008-5#1)(2008-7#1)
I suggest that##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
I suggest##6##2##(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
I tested the##2##3##(2008-10#1)(2008-9#1)
I tested##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
I then##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)
I to##5##2##(1994-11#1)(1994-8#1)(2008-3#1)(2009-2#1)(2011-2#1)
I trials##5##2##(1997-1#1)(2008-5#3)(2011-2#1)
I use##2##2##(2008-9#1)(2012-3#1)
I used##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
I was##15##2##(1992-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-8#1)(2010-7#1)(2010-8#2)
I were##5##2##(1992-11#1)(2008-10#3)(2008-8#1)
I will discuss##2##3##(2010-3#1)(2013-1#1)
I will##11##2##(1992-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-3#2)(2011-2#2)(2013-1#1)
I with##4##2##(1993-6#1)(2008-10#3)
I would like to see##3##5##(1992-3#3)
I would##5##2##(1992-3#3)(2008-10#1)(2008-7#1)
I##1150##1##(1990-11#1)(1990-12#1)(1990-2#7)(1990-3#2)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#2)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#9)(1991-6#3)(1991-7#4)(1991-8#2)(1992-11#4)(1992-2#3)(1992-3#12)(1992-4#2)(1992-6#21)(1992-7#1)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#9)(1993-3#3)(1993-6#6)(1993-8#17)(1994-1#9)(1994-11#3)(1994-12#14)(1994-2#3)(1994-3#3)(1994-5#9)(1994-8#16)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#42)(1995-2#12)(1995-5#4)(1995-6#9)(1995-8#4)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#8)(1996-3#4)(1996-6#3)(1997-1#6)(1997-2#10)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#11)(1997-8#16)(1997-9#10)(2006-6#3)(2007-12#3)(2007-8#3)(2007-9#2)(2008-1#12)(2008-10#221)(2008-11#61)(2008-12#21)(2008-2#7)(2008-3#21)(2008-4#12)(2008-5#21)(2008-6#8)(2008-7#26)(2008-8#80)(2008-9#52)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#7)(2010-10#1)(2010-11#1)(2010-12#13)(2010-3#10)(2010-4#4)(2010-5#7)(2010-6#2)(2010-7#12)(2010-8#4)(2010-9#6)(2011-1#1)(2011-2#39)(2011-3#2)(2012-12#5)(2012-2#19)(2012-3#33)(2013-1#18)(2013-7#1)(2013-8#14)
I'm##3##1##(2008-10#1)(2010-12#2)
I(-) and##2##2##(2008-10#2)
I(-) ion##2##2##(2008-10#2)
I(-)##15##1##(2008-10#15)
I(0)/I(100)##2##1##(2008-10#2)
I(2)##3##1##(2008-10#2)(2008-2#1)
I(2)/Ag(2)O##2##1##(1996-5#2)
I(276##2##1##(2008-10#2)
I(3)(-)##5##1##(2008-10#5)
I(300##2##1##(2008-10#2)
I(GAba)##2##1##(2008-8#2)
I(delta)##3##1##(2008-8#3)
I(genE)##2##1##(2008-10#2)
I(m)##3##1##(2008-10#3)
I(pa)##3##1##(2008-10#3)
I) activity##2##2##(1993-6#1)(1994-8#1)
I) and##7##2##(1991-3#1)(1994-2#1)(2008-10#4)(2011-2#1)
I) in##3##2##(1994-8#1)(1996-3#1)(2008-10#1)
I) is##2##2##(1992-12#1)(2008-10#1)
I) of##3##2##(1992-12#1)(1996-12#1)(2008-10#1)
I) with##2##2##(2008-10#1)(2008-11#1)
I)##49##1##(1991-3#2)(1991-5#1)(1992-12#2)(1992-6#3)(1992-8#1)(1993-6#1)(1994-2#2)(1994-8#4)(1996-12#1)(1996-3#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#3)(2013-8#1)
I+II##4##1##(2013-7#4)
I- and##2##2##(2008-11#1)(2013-1#1)
I-1##10##1##(2008-10#10)
I-2##3##1##(2008-10#3)
I-A beta##2##2##(1993-3#2)
I-CZE##4##1##(2008-10#4)
I-Ceu I##4##2##(1997-2#4)
I-FABP##2##1##(2013-1#2)
I-II##3##1##(1990-12#1)(1991-3#1)(1993-2#1)
I-III##2##1##(1997-2#1)(2008-11#1)
I-SceIII##2##1##(1995-6#2)
I-gel##2##1##(2010-7#2)
I-high##2##1##(1996-12#2)
I-low##3##1##(1996-12#3)
I-medium and##3##2##(1996-12#3)
I-specific##2##1##(1997-9#1)(2008-10#1)
I-waves##2##1##(2008-7#2)
I/II##5##1##(1993-1#1)(1997-1#1)(2010-10#1)(2010-11#1)(2010-7#1)
I/II)##2##1##(2008-11#1)(2011-2#1)
I/R##4##1##(2010-1#1)(2010-5#3)
I1-imidazoline receptor##2##2##(1997-2#2)
I1-imidazoline##3##1##(1997-2#3)
I13##3##1##(2008-11#3)
I179S was##2##2##(1997-3#2)
I179S##3##1##(1997-3#3)
I184Y##3##1##(1992-1#3)
I5##3##1##(2008-10#3)
I=0##6##1##(2008-10#6)
IA therapy##2##2##(2011-2#2)
IA using##2##2##(2011-2#2)
IA##18##1##(1992-8#1)(1996-3#1)(2008-10#6)(2010-3#1)(2011-2#9)
IA)##3##1##(2008-10#3)
IA1##5##1##(1990-5#4)(1992-8#1)
IA2##7##1##(1990-5#7)
IAA in##3##2##(2008-10#3)
IAA than##3##2##(1994-12#1)(2008-10#2)
IAA with 2##2##3##(2008-12#2)
IAA##23##1##(1994-12#3)(2008-10#13)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#2)
IAA-producing bacteria were##2##3##(2008-10#2)
IAA-producing bacteria##5##2##(2008-10#5)
IAA20 and IAA30##2##3##(2009-8#2)
IAEA##2##1##(2008-10#2)
IAEA-Soil##2##1##(2008-10#2)
IAHSS (International Association for Healthcare Security &amp##2##7##(1991-12#1)(1992-12#1)
IAHSS##9##1##(1991-12#1)(1992-12#2)(1992-2#2)(1993-2#1)(1994-12#1)(1995-12#1)(1996-12#1)
IAI duration##2##2##(2008-12#2)
IAI##6##1##(2008-12#6)
IAL##2##1##(2008-10#2)
IAM##2##1##(2008-10#2)
IAPP##4##1##(1992-6#4)
IAVs##2##1##(2013-1#2)
IB II##2##2##(2008-8#2)
IB and##2##2##(2008-12#1)(2010-10#1)
IB##9##1##(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2010-10#2)(2013-8#1)
IB-49 and IC-17##2##3##(2008-10#2)
IB-49##4##1##(2008-10#4)
IB-DCTFM##3##1##(2010-8#3)
IBA##6##1##(2008-10#2)(2008-12#4)
IBD is##2##2##(2008-9#1)(2009-12#1)
IBD slopes##3##2##(2008-9#2)(2013-1#1)
IBD##18##1##(2008-12#2)(2008-9#7)(2009-12#5)(2010-12#3)(2013-1#1)
IBDV + IBV-inoculated##2##3##(2008-5#2)
IBM compatible##2##2##(2008-10#2)
IBM##7##1##(2008-10#2)(2008-8#2)(2010-8#1)(2012-3#2)
IBS##9##1##(2013-1#9)
IBV strains isolated between 1961 and 1994 from##2##8##(2008-5#2)
IBV strains isolated between##3##4##(2008-5#3)
IBV strains##8##2##(2008-5#8)
IBV##18##1##(2008-5#18)
IBV-inoculated ones##2##2##(2008-5#2)
IBV-inoculated##5##1##(2008-5#5)
IBW)##4##1##(2008-12#4)
IBZM##3##1##(1996-12#3)
IC _ 50##2##3##(2008-5#2)
IC and##4##2##(2008-10#3)(2008-11#1)
IC at##2##2##(2008-10#2)
IC##27##1##(2008-10#24)(2008-11#1)(2008-5#2)
IC(50) of 0##2##3##(2008-10#2)
IC(50) of##4##2##(2008-10#2)(2008-11#2)
IC(50) values of##3##3##(2008-5#1)(2010-11#1)(2011-2#1)
IC(50) values##5##2##(2008-11#2)(2008-5#1)(2010-11#1)(2011-2#1)
IC(50)##11##1##(2008-10#2)(2008-11#6)(2008-5#1)(2010-11#1)(2011-2#1)
IC(50)=0##2##1##(2008-8#2)
IC(50)=1##2##1##(2008-8#2)
IC-17##6##1##(2008-10#6)
IC-PCR##4##1##(2008-10#4)
IC50 = 5 mg/kg)##2##4##(1992-8#2)
IC50 =##4##2##(1992-3#1)(1992-8#3)
IC50 of##6##2##(1992-8#1)(1994-8#2)(1995-8#1)(1996-2#2)
IC50 value of 0##2##4##(1995-8#1)(2008-5#1)
IC50 value##3##2##(1995-8#1)(1996-2#1)(2008-5#1)
IC50 values of##5##3##(1990-8#2)(1992-3#1)(1995-11#1)(2008-11#1)
IC50 values were##2##3##(1995-8#2)
IC50 values##7##2##(1990-8#2)(1992-3#1)(1995-11#1)(1995-8#2)(2008-11#1)
IC50##29##1##(1990-8#2)(1991-5#1)(1992-3#2)(1992-6#1)(1992-8#4)(1993-3#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-8#4)(1996-2#3)(2008-11#2)(2008-12#1)(2008-5#1)(2011-3#3)
IC95% -##2##2##(2008-11#2)
ICA and##3##2##(2010-8#1)(2012-3#2)
ICA aneurysms##2##2##(2012-3#2)
ICA programs##2##2##(1997-3#2)
ICA##21##1##(1994-12#5)(1997-3#3)(2008-10#2)(2010-8#2)(2011-2#2)(2012-3#4)(2013-1#3)
ICAM-1 mRNA expression and PMNL and MPhi infiltration in##2##9##(2010-1#2)
ICAM-1 mRNA expression##3##3##(2010-1#3)
ICAM-1 mRNA##6##2##(2010-1#6)
ICAM-1##13##1##(1995-2#2)(1995-6#1)(2008-10#4)(2010-1#6)
ICB process##2##2##(2013-1#2)
ICC 14216 K##4##3##(2008-10#4)
ICC##8##1##(2008-10#4)(2010-12#3)(2011-2#1)
ICCD##2##1##(2008-10#2)
ICD 850##4##2##(1990-12#4)
ICD##9##1##(1990-12#7)(1991-9#1)(2012-3#1)
ICD-10 CA##2##2##(2012-12#2)
ICD-10 RCPCH##2##2##(2012-12#2)
ICD-10##11##1##(1997-8#2)(2008-11#1)(2012-12#8)
ICD-9##6##1##(1991-12#1)(1991-8#1)(1993-12#1)(2007-12#1)(2012-12#2)
ICDs##2##1##(2010-12#2)
ICE##2##1##(1995-6#2)
ICER##3##1##(1996-2#1)(2012-12#2)
ICEUs##4##1##(2008-7#4)
ICErel-II and ICErel-III##4##3##(1995-6#4)
ICErel-II##5##1##(1995-6#5)
ICErel-III##5##1##(1995-6#5)
ICF##10##1##(2008-3#3)(2011-2#5)(2012-12#2)
ICFIA##2##1##(2008-10#2)
ICH Score##3##2##(2012-3#3)
ICH guidelines##2##2##(2008-10#2)
ICH volume##4##2##(2012-3#4)
ICH##16##1##(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#2)(2012-3#9)
ICI D1694##7##2##(1994-8#7)
ICI##8##1##(1993-6#1)(1994-8#7)
ICLLM##2##1##(2010-11#2)
ICP MS and MC ICP MS##2##6##(2008-10#2)
ICP MS and##4##3##(2008-10#4)
ICP MS##10##2##(2008-10#10)
ICP and##3##2##(1996-9#1)(2008-10#2)
ICP atomic emission##2##3##(2008-10#2)
ICP is##2##2##(2008-7#1)(2010-5#1)
ICP management##2##2##(2008-7#2)
ICP spectrometer##2##2##(1992-3#2)
ICP##50##1##(1992-3#2)(1995-11#1)(1996-9#1)(2008-10#25)(2008-12#4)(2008-7#10)(2010-5#7)
ICP-AES analysis##3##2##(2008-10#3)
ICP-AES and##3##2##(2008-10#3)
ICP-AES determination of##5##3##(2008-10#5)
ICP-AES determination##6##2##(2008-10#6)
ICP-AES for##2##2##(2008-10#2)
ICP-AES measurement##3##2##(2008-10#3)
ICP-AES method##4##2##(2008-10#4)
ICP-AES was##2##2##(2008-10#2)
ICP-AES##58##1##(2008-10#58)
ICP-MS after##2##2##(2008-10#2)
ICP-MS analysis##3##2##(2008-10#3)
ICP-MS and ICP-AES##2##3##(2008-10#2)
ICP-MS and ICP-OES techniques##2##4##(2008-10#2)
ICP-MS and ICP-OES##3##3##(2008-10#3)
ICP-MS and##11##2##(2008-10#10)(2008-9#1)
ICP-MS as##2##2##(2008-10#2)
ICP-MS detection##6##2##(2008-10#6)
ICP-MS determination of##2##3##(2008-10#2)
ICP-MS determination##4##2##(2008-10#4)
ICP-MS for##3##2##(2008-10#3)
ICP-MS instrument##3##2##(2008-10#3)
ICP-MS or##2##2##(2008-10#2)
ICP-MS techniques##2##2##(2008-10#2)
ICP-MS was##5##2##(2008-10#5)
ICP-MS##93##1##(2008-10#92)(2008-9#1)
ICP-OES Vista-MPX##2##2##(2008-10#2)
ICP-OES elemental analysis of the##2##5##(2008-10#2)
ICP-OES for the##2##3##(2008-10#2)
ICP-OES using##2##2##(2008-10#2)
ICP-OES with##2##2##(2008-10#2)
ICP-OES##24##1##(2008-10#24)
ICP-QMS##3##1##(2008-10#3)
ICP/AES##2##1##(2008-10#2)
ICPD##7##1##(1994-9#7)
ICPMS##3##1##(2008-10#3)
ICR mice##3##2##(1992-3#1)(1996-2#1)(2008-11#1)
ICR##6##1##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
ICRP##4##1##(1995-12#1)(1997-8#1)(2008-7#1)(2013-1#1)
ICS 205-930##6##2##(1990-12#6)
ICS##10##1##(1990-12#6)(2008-8#4)
ICSA##3##1##(1994-12#3)
ICSS##9##1##(1991-2#6)(1996-2#3)
ICU admission##2##2##(1992-2#1)(2012-3#1)
ICU patients##5##2##(2008-5#1)(2011-2#3)(2013-1#1)
ICU##28##1##(1991-2#3)(1992-2#7)(1996-2#1)(1996-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-5#2)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#1)
ICUs##5##1##(1991-2#1)(2012-2#4)
ICs and##3##2##(2008-8#3)
ICs bar##2##2##(2008-8#2)
ICs sensitive cells##2##3##(2008-8#2)
ICs##12##1##(2008-10#1)(2008-8#11)
ID and##2##2##(2008-10#1)(2008-5#1)
ID##15##1##(2008-10#6)(2008-12#3)(2008-5#3)(2012-2#3)
ID(50) values##2##2##(2008-10#2)
ID1 activity and ID1 mRNA levels in##2##7##(1995-12#2)
ID1 activity and ID1 mRNA levels##3##6##(1995-12#3)
ID1 activity##5##2##(1995-12#5)
ID1 mRNA levels in female rats##2##6##(1995-12#2)
ID1 mRNA levels in##5##4##(1995-12#5)
ID1 mRNA levels##8##3##(1995-12#8)
ID1##13##1##(1995-12#13)
ID50##2##1##(1995-12#1)(1996-2#1)
IDA##3##1##(2008-10#3)
IDAVS##3##1##(1996-9#3)
IDB##2##1##(2013-8#2)
IDC##3##1##(1997-3#3)
IDDM##7##1##(1990-5#1)(1992-5#1)(1994-12#2)(1995-3#3)
IDDS##6##1##(2008-7#6)
IDH has##2##2##(2008-9#1)(2012-5#1)
IDH##8##1##(2008-9#5)(2012-5#3)
IDHR research##4##2##(2008-10#4)
IDHR##8##1##(2008-10#8)
IDO induction by IFN-gamma at the transcriptional level##2##8##(2008-11#2)
IDO##7##1##(2008-11#7)
IDs##2##1##(1991-5#1)(2008-11#1)
IE and SSE##2##3##(2013-1#2)
IE and##4##2##(1993-1#1)(2011-2#1)(2013-1#2)
IE##14##1##(1993-1#1)(1995-12#1)(2006-6#2)(2011-2#4)(2013-1#6)
IE1##5##1##(1993-8#5)
IE11##2##1##(2008-10#2)
IE86 protein##5##2##(2008-9#5)
IE86##7##1##(2008-9#7)
IEC##3##1##(2008-10#2)(2008-9#1)
IECs directly to enhance the secretion of##2##7##(2008-11#2)
IECs##11##1##(2008-11#11)
IENFs were##5##2##(2013-8#5)
IENFs##9##1##(2013-8#9)
IES##5##1##(2008-1#2)(2012-3#3)
IES-R-Gr##2##1##(2010-2#2)
IF##2##1##(2008-8#2)
IF1 binding##2##2##(1991-5#2)
IF1##4##1##(1991-5#4)
IFA##2##1##(2008-9#1)(2013-8#1)
IFM##2##1##(2008-9#2)
IFN activity was##2##3##(1993-2#2)
IFN and##2##2##(1995-12#1)(2008-11#1)
IFN gamma##2##2##(1995-5#1)(1996-2#1)
IFN molecule##2##2##(1995-12#2)
IFN was##3##2##(1992-2#1)(2008-11#1)(2008-5#1)
IFN##30##1##(1992-2#4)(1993-2#3)(1995-12#3)(1995-5#1)(1996-2#3)(2007-11#1)(2008-11#7)(2008-5#1)(2009-8#7)
IFN-alpha activity##3##2##(1993-2#3)
IFN-alpha associated side effects##2##4##(2009-7#2)
IFN-alpha associated##3##2##(2009-7#3)
IFN-alpha subtypes##2##2##(1995-12#2)
IFN-alpha##12##1##(1990-5#1)(1993-2#4)(1995-12#2)(1996-2#1)(2009-5#1)(2009-7#3)
IFN-beta##7##1##(1990-5#2)(1995-12#2)(2008-11#3)
IFN-gamma in##2##2##(1994-8#1)(2008-11#1)
IFN-gamma production from##2##3##(2008-11#1)(2008-4#1)
IFN-gamma production##9##2##(1996-12#1)(2008-11#6)(2008-4#2)
IFN-gamma secretion by##2##3##(2008-11#2)
IFN-gamma secretion##3##2##(2008-11#3)
IFN-gamma##53##1##(1994-8#1)(1996-12#8)(1996-2#1)(2008-10#2)(2008-11#25)(2008-4#2)(2008-7#2)(2008-8#4)(2009-12#2)(2010-12#5)(2013-8#1)
IFN-gamma/LPS##5##1##(2008-8#5)
IFN-omega##2##1##(1995-12#2)
IFN-γ pathway##2##2##(2012-2#2)
IFN-γ production##3##2##(2011-2#2)(2012-2#1)
IFN-γ##13##1##(2010-11#1)(2011-2#8)(2012-2#4)
IFNalpha lozenges##2##2##(2007-11#2)
IFNalpha treatment##2##2##(2007-11#2)
IFNalpha##14##1##(2007-11#14)
IFNgamma and##3##2##(2008-10#2)(2010-12#1)
IFNgamma##7##1##(2008-10#5)(2008-9#1)(2010-12#1)
IFNgamma-producing CD4(+) T-lymphocytes##2##3##(2008-10#2)
IFNgamma-producing##3##1##(2008-10#3)
IFSP process##3##2##(1991-12#3)
IFX##5##1##(2010-12#5)
IGEs##4##1##(2008-8#4)
IGF II##2##2##(2008-8#2)
IGF binding proteins##2##3##(2008-11#1)(2008-5#1)
IGF binding##5##2##(1992-4#1)(2008-11#3)(2008-5#1)
IGF##16##1##(1992-4#1)(2008-11#5)(2008-5#6)(2008-8#3)(2011-2#1)
IGF-1 receptor##2##2##(1994-11#1)(1995-11#1)
IGF-1##19##1##(1990-12#1)(1994-11#10)(1995-11#1)(1996-2#1)(2008-9#5)(2011-1#1)
IGF-I a##2##2##(2010-5#2)
IGF-I and IGF-I receptor##2##4##(1996-2#2)
IGF-I and##8##2##(1996-2#3)(1997-1#1)(2008-11#2)(2008-5#1)(2008-6#1)
IGF-I gene##3##2##(2008-11#1)(2008-9#2)
IGF-I has been##2##3##(2008-11#1)(2013-1#1)
IGF-I in the##2##3##(1995-12#1)(2010-5#1)
IGF-I levels with##2##3##(2008-5#2)
IGF-I levels##4##2##(2008-5#2)(2012-3#1)(2013-1#1)
IGF-I mRNA expression##2##3##(1996-2#1)(2008-8#1)
IGF-I mRNA##9##2##(1995-12#1)(1996-2#2)(2008-8#1)(2008-9#3)(2010-5#2)
IGF-I may be involved in##2##5##(2008-8#2)
IGF-I receptor and##2##3##(1996-2#1)(2008-11#1)
IGF-I receptor mRNA and##2##4##(1996-2#2)
IGF-I receptor##9##2##(1996-2#5)(1997-1#1)(2008-11#2)(2008-5#1)
IGF-I receptors##2##2##(1996-2#2)
IGF-I stimulated LHR##2##3##(2008-8#2)
IGF-I stimulated##3##2##(1997-1#1)(2008-8#2)
IGF-I was##2##2##(2008-6#1)(2008-8#1)
IGF-I##86##1##(1990-12#1)(1991-12#1)(1992-4#1)(1995-12#3)(1996-2#15)(1997-1#6)(2008-11#15)(2008-5#6)(2008-6#4)(2008-8#8)(2008-9#6)(2010-5#11)(2011-1#1)(2012-3#6)(2013-1#2)
IGF-II##3##1##(1991-12#1)(2008-11#1)(2008-5#1)
IGF-II/M6P receptor mRNA##2##3##(1996-2#2)
IGF-II/M6P receptor##4##2##(1996-2#4)
IGF-II/M6P receptors and GH receptors##2##5##(1996-2#2)
IGF-II/M6P##6##1##(1996-2#6)
IGF-IR##6##1##(2008-8#6)
IGF-binding protein-2##2##2##(2008-8#2)
IGF-binding##3##1##(2008-8#2)(2011-1#1)
IGF/GH ratio and##2##3##(2012-3#2)
IGF2##2##1##(2010-4#2)
IGFBP-5##4##1##(1992-4#4)
IGFBP-6##2##1##(1992-4#2)
IGFBPs##2##1##(2008-5#2)
IGFD##2##1##(2011-1#2)
IGS and##2##2##(2008-10#2)
IGS region##2##2##(2008-10#2)
IGS type##2##2##(2008-10#2)
IGS types and##2##3##(2008-10#2)
IGS types##3##2##(2008-10#3)
IGS##13##1##(2008-10#12)(2008-12#1)
IGSTK##4##1##(2009-12#4)
IH901##7##1##(2008-11#7)
IHC##5##1##(2008-4#2)(2009-8#1)(2011-2#2)
IHD and##3##2##(1995-12#3)
IHD cases##2##2##(2008-3#2)
IHD##10##1##(1995-12#3)(2008-3#5)(2012-3#2)
IHPM##3##1##(2010-12#3)
IHs##3##1##(2013-8#3)
II (12 isolates)##2##3##(2008-10#2)
II (RUG-II)##2##2##(1991-2#1)(1994-12#1)
II (p &lt##4##3##(2010-1#2)(2013-8#2)
II DNA##2##2##(1992-3#1)(1997-8#1)
II Strains##2##2##(2008-10#2)
II alleles##4##2##(1997-8#1)(2008-4#1)(2008-9#1)(2011-2#1)
II alpha and beta##2##4##(1993-6#1)(1995-6#1)
II alpha and##3##3##(1993-6#1)(1995-6#1)(1996-12#1)
II alpha##5##2##(1993-6#1)(1995-6#2)(1996-12#2)
II and III are##2##4##(2008-10#1)(2008-9#1)
II and III##9##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#2)(2012-3#2)(2013-8#1)
II and III)##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
II and IV of##2##4##(1990-8#1)(1996-6#1)
II and IV##6##3##(1990-8#1)(1994-2#1)(1996-6#2)(2008-10#1)(2011-2#1)
II and##56##2##(1990-8#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-2#3)(1994-3#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-6#3)(1997-7#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2011-2#3)(2012-2#2)(2012-3#4)(2013-8#2)
II antigens##4##2##(1991-8#1)(1995-12#1)(1997-8#2)
II are##5##2##(1992-11#1)(1993-12#1)(2007-12#1)(2008-10#2)
II as##2##2##(2008-10#1)(2008-11#1)
II but##2##2##(1995-2#1)(2006-6#1)
II clinical##5##2##(2008-12#1)(2008-5#2)(2012-3#1)(2013-1#1)
II collagen##4##2##(1991-5#1)(2008-11#3)
II contained##2##2##(2008-10#2)
II crystal##2##2##(2008-2#1)(2008-8#1)
II for##5##2##(1993-6#2)(2008-3#2)(2012-3#1)
II functional##2##2##(2008-8#1)(2010-8#1)
II gene##5##2##(1994-11#1)(1997-7#1)(2008-10#2)(2008-8#1)
II genes##5##2##(1997-8#3)(2008-10#2)
II in the##4##3##(1994-3#1)(1995-12#2)(2008-10#1)
II in##14##2##(1993-8#3)(1994-3#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-2#1)(2008-10#2)(2008-8#2)(2013-1#1)
II inhibitor##4##2##(1995-8#1)(1996-2#1)(2008-11#1)(2008-5#1)
II is the##2##3##(1991-5#1)(1996-6#1)
II is##10##2##(1991-5#1)(1992-11#1)(1993-8#1)(1995-11#1)(1996-12#1)(1996-6#1)(2008-10#1)(2012-2#1)(2012-3#2)
II isolates were##2##3##(2008-10#2)
II isolates##6##2##(2008-10#6)
II mRNA in##2##3##(1993-8#1)(1994-5#1)
II malocclusion##3##2##(2013-1#3)
II may##2##2##(1990-12#1)(1994-3#1)
II molecules##7##2##(1990-5#1)(1995-12#1)(1995-5#2)(2008-4#1)(2008-5#1)(2008-8#1)
II of the##6##3##(1991-3#1)(1995-12#2)(2008-10#1)(2008-11#1)(2008-7#1)
II of##14##2##(1990-5#1)(1991-3#1)(1995-12#2)(1995-2#1)(1996-1#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
II or##5##2##(1993-11#2)(1994-2#1)(1995-5#1)(2008-9#1)
II receptor antagonists##3##3##(1991-5#1)(1995-11#1)(2008-10#1)
II receptor##17##2##(1991-5#4)(1992-3#2)(1994-8#1)(1995-11#2)(1996-6#2)(1997-2#2)(2008-10#1)(2008-11#2)(2008-8#1)
II regulatory phosphorylation site##2##4##(1995-2#2)
II sIL-1R##3##2##(1995-2#3)
II strains##4##2##(2008-10#4)
II studies##2##2##(2008-5#1)(2013-1#1)
II the##2##2##(1993-2#1)(2008-10#1)
II to##5##2##(1994-2#2)(2008-10#1)(2008-8#1)(2011-2#1)
II trials in##2##3##(2008-5#2)
II trials##4##2##(2008-5#4)
II was##8##2##(1991-5#1)(1992-12#1)(1993-8#2)(1994-1#1)(1994-11#1)(1995-8#1)(2008-10#1)
II were##2##2##(1992-12#1)(2011-2#1)
II which##5##2##(1993-6#1)(1994-11#1)(1995-8#1)(2009-8#2)
II with##8##2##(1993-6#2)(1994-5#2)(1995-6#1)(2008-11#2)(2010-7#1)
II##742##1##(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#6)(1990-6#1)(1990-8#2)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#5)(1991-5#13)(1991-6#3)(1991-7#1)(1991-8#1)(1992-11#3)(1992-12#8)(1992-2#1)(1992-3#8)(1992-4#1)(1993-11#2)(1993-12#4)(1993-2#11)(1993-3#7)(1993-6#12)(1993-8#15)(1993-9#2)(1994-1#4)(1994-11#14)(1994-12#3)(1994-2#9)(1994-3#8)(1994-5#10)(1994-8#10)(1995-1#1)(1995-10#1)(1995-11#10)(1995-12#18)(1995-2#23)(1995-3#2)(1995-5#3)(1995-6#11)(1995-8#13)(1996-1#3)(1996-11#3)(1996-12#8)(1996-2#11)(1996-3#5)(1996-5#1)(1996-6#9)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#2)(1997-5#1)(1997-7#5)(1997-8#14)(1997-9#1)(2006-6#5)(2007-12#3)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#135)(2008-11#34)(2008-12#3)(2008-2#4)(2008-3#17)(2008-4#9)(2008-5#19)(2008-7#14)(2008-8#30)(2008-9#12)(2009-1#1)(2009-10#4)(2009-2#2)(2009-3#6)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#4)(2010-12#6)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#14)(2011-3#1)(2012-12#3)(2012-2#10)(2012-3#16)(2013-1#16)(2013-8#5)
II'##2##1##(1991-5#1)(2011-2#1)
II's##3##1##(1990-6#1)(1993-2#2)
II) and##6##2##(1992-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
II) in the##2##3##(1990-5#1)(2008-10#1)
II) in##4##2##(1990-5#1)(1996-5#1)(2008-10#2)
II) of##2##2##(2008-10#2)
II) was##4##2##(1991-5#1)(1995-6#1)(2008-7#1)(2011-2#1)
II)##63##1##(1990-5#1)(1991-3#2)(1991-5#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2011-2#4)(2013-8#2)
II-V##2##1##(2008-10#2)
II-induced##5##1##(1994-2#1)(1995-11#3)(2008-1#1)
II/III##6##1##(1992-3#2)(2008-5#2)(2012-2#1)(2013-1#1)
IIA fibres##2##2##(2011-2#2)
IIA##5##1##(2008-11#1)(2011-2#3)(2013-1#1)
IIB promoter constructs##2##3##(1995-6#2)
IIB promoter##4##2##(1995-6#4)
IIB##5##1##(1995-6#5)
IIEF5 score##2##2##(2011-2#2)
IIEF5##3##1##(2011-2#3)
IIH##2##1##(2011-2#2)
III and I##2##3##(2008-10#2)
III and IV##8##3##(1997-3#1)(2007-12#1)(2008-10#2)(2009-10#1)(2012-3#1)(2013-8#2)
III and the##2##3##(1992-3#1)(2008-10#1)
III and##22##2##(1990-6#1)(1992-3#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-9#1)(2009-10#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
III are##6##2##(1990-5#1)(1993-12#1)(2008-10#3)(2008-9#1)
III clinical##4##2##(2008-11#1)(2008-5#1)(2010-11#1)(2011-3#1)
III compared to group I at 8 weeks (P&lt##2##9##(2009-3#2)
III compared to##3##3##(2009-3#2)(2012-2#1)
III contained##2##2##(2008-10#2)
III core##6##2##(1992-3#6)
III from##2##2##(1994-2#1)(2008-9#1)
III gene expression##3##3##(1995-12#3)
III in##8##2##(1994-5#1)(2008-1#1)(2008-10#1)(2008-7#3)(2008-8#2)
III is the##2##3##(1994-3#1)(1996-6#1)
III is##4##2##(1994-3#1)(1996-6#1)(2008-10#2)
III of##6##2##(1991-1#1)(1991-5#1)(1992-12#1)(1995-1#1)(1995-6#1)(2008-10#1)
III produced##2##2##(2008-10#1)(2008-7#1)
III studies##2##2##(2008-5#1)(2012-2#1)
III to##3##2##(1991-8#1)(2008-10#1)(2008-8#1)
III trial##3##2##(2008-5#1)(2010-12#1)(2013-1#1)
III trials##3##2##(2008-5#2)(2012-3#1)
III was##3##2##(2006-6#1)(2008-10#1)(2008-8#1)
III which##2##2##(2008-8#1)(2009-8#1)
III with##4##2##(1994-5#1)(2008-10#1)(2008-9#1)(2013-1#1)
III##269##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#2)(1992-10#1)(1992-12#2)(1992-3#15)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#4)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#3)(2006-6#2)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#67)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#12)(2008-9#13)(2009-10#1)(2009-3#6)(2009-5#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#9)(2013-1#6)(2013-8#7)
III) and##2##2##(2008-10#1)(2011-2#1)
III) are##2##2##(2008-10#1)(2008-4#1)
III) were##2##2##(2008-10#1)(2008-7#1)
III)##20##1##(1993-12#1)(1994-12#1)(1994-8#1)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
III-IV##4##1##(1990-6#2)(1992-3#2)
III/IV##2##1##(1993-1#1)(2011-2#1)
IIIA and##2##2##(1992-12#1)(2008-10#1)
IIIA##4##1##(1992-12#2)(2008-10#2)
IIIB##4##1##(2008-10#3)(2010-6#1)
IIIa##8##1##(1991-11#1)(1991-2#1)(1993-11#2)(1997-7#2)(2011-3#2)
IIR and adaptive##2##3##(2010-8#2)
II]##6##1##(1993-2#1)(1993-9#1)(1994-9#1)(1997-4#1)(2008-11#1)(2013-8#1)
IIa and IIb##2##3##(2008-8#2)
IIa##3##1##(2008-8#3)
IIb patients##2##2##(2008-8#2)
IIb##6##1##(1991-2#1)(2008-8#4)(2009-1#1)
IIb-IIIa##6##1##(1990-5#5)(2006-6#1)
IK(Ca) induced by##2##3##(1996-5#2)
IK(Ca)##4##1##(1996-5#4)
IK726##6##1##(2008-10#6)
IKDC 2000##2##2##(2013-1#2)
IKDC##9##1##(2012-2#1)(2013-1#8)
IKK##2##1##(2012-3#2)
IL##12##1##(1996-5#2)(2008-10#9)(2008-11#1)
IL-1 alpha and cisplatin##2##4##(1993-8#2)
IL-1 alpha and##3##3##(1993-8#2)(1995-2#1)
IL-1 alpha##8##2##(1993-8#5)(1995-2#1)(1996-12#2)
IL-1 and##5##2##(1994-3#2)(1994-6#2)(2008-8#1)
IL-1 beta Thr9Gly##2##3##(1993-8#2)
IL-1 beta mRNA##3##3##(1996-12#3)
IL-1 beta precursor##4##3##(1995-2#4)
IL-1 beta system##3##3##(1996-12#3)
IL-1 beta##29##2##(1993-8#3)(1995-12#1)(1995-2#12)(1996-12#13)
IL-1 receptor antagonist##3##3##(1995-2#2)(1996-12#1)
IL-1 receptor##8##2##(1995-2#6)(1996-12#2)
IL-1 receptors##3##2##(1995-2#3)
IL-1 was##2##2##(1990-12#2)
IL-1##75##1##(1990-12#12)(1990-5#4)(1993-8#8)(1994-3#2)(1994-6#2)(1995-12#1)(1995-2#22)(1995-6#2)(1996-12#20)(2008-5#1)(2008-8#1)
IL-10 and##4##2##(1993-8#1)(2008-10#1)(2011-3#2)
IL-10 have##2##2##(1993-8#1)(1996-12#1)
IL-10 in##4##2##(1996-12#3)(2008-11#1)
IL-10 is##2##2##(1993-8#1)(2011-3#1)
IL-10 was##3##2##(1993-8#1)(2008-10#1)(2010-12#1)
IL-10##36##1##(1993-8#7)(1995-12#1)(1995-5#1)(1996-12#7)(2008-10#5)(2008-11#3)(2008-12#1)(2008-9#1)(2010-12#4)(2011-2#1)(2011-3#5)
IL-11##2##1##(1996-2#2)
IL-12 and IFN-γ##2##3##(2011-2#2)
IL-12 and##3##2##(2008-11#1)(2011-2#2)
IL-12 in##3##2##(2008-10#1)(2011-2#2)
IL-12 p40 and p35 mRNA##4##5##(2008-8#4)
IL-12 p40##5##2##(2008-8#4)(2008-9#1)
IL-12 p40/p35 mRNA##3##3##(2008-8#3)
IL-12 secretion##2##2##(2008-11#2)
IL-12##38##1##(2008-10#5)(2008-11#14)(2008-4#1)(2008-8#11)(2008-9#1)(2011-2#6)
IL-13##5##1##(1996-2#1)(2008-4#4)
IL-17 is##2##2##(2007-11#2)
IL-17##11##1##(2007-11#8)(2009-12#1)(2012-2#2)
IL-18 is##2##2##(2008-4#2)
IL-18##9##1##(2008-4#9)
IL-1RI and IL-1Ra mRNAs##2##4##(1996-12#2)
IL-1RI##3##1##(1996-12#3)
IL-1alpha was##3##2##(2008-10#3)
IL-1alpha##4##1##(2008-10#4)
IL-1beta##7##1##(2008-10#1)(2008-11#3)(2008-7#1)(2009-12#1)(2013-8#1)
IL-1ra in##3##2##(2008-5#1)(2008-8#2)
IL-1ra##8##1##(1995-2#3)(2008-5#1)(2008-8#4)
IL-1β and##2##2##(2011-2#1)(2013-1#1)
IL-1β##5##1##(2010-11#1)(2011-2#1)(2013-1#3)
IL-2 and IL-4##6##3##(2008-11#6)
IL-2 and##9##2##(1994-11#1)(1995-12#1)(2008-11#6)(2008-8#1)
IL-2 in##2##2##(1990-12#1)(2008-7#1)
IL-2 plasma levels##2##3##(2008-7#2)
IL-2 was##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
IL-2##55##1##(1990-12#1)(1991-6#8)(1992-12#3)(1994-11#5)(1994-5#5)(1995-12#1)(1995-5#1)(2008-10#3)(2008-11#12)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#6)(2008-9#1)
IL-28B##2##1##(2013-1#2)
IL-2SA##4##1##(2008-11#4)
IL-3 and##5##2##(1994-11#3)(1995-6#1)(2008-4#1)
IL-3 or##2##2##(1995-6#1)(2008-4#1)
IL-3 receptor##2##2##(1993-12#1)(1994-11#1)
IL-3##11##1##(1993-12#1)(1994-11#6)(1995-6#2)(2008-4#2)
IL-3R alpha##3##2##(1993-12#3)
IL-3R beta IL-3 and IL-3R beta c##2##7##(1994-11#2)
IL-3R beta IL-3##3##3##(1994-11#3)
IL-3R beta##6##2##(1994-11#6)
IL-3R##9##1##(1993-12#3)(1994-11#6)
IL-4 and IFN-gamma from##2##4##(2008-11#2)
IL-4 and##4##2##(2008-10#1)(2008-11#3)
IL-4 secretion from##2##3##(2008-10#1)(2008-11#1)
IL-4##34##1##(1995-12#1)(1995-5#1)(1996-12#6)(1996-2#1)(2008-10#5)(2008-11#13)(2008-4#1)(2009-12#1)(2010-12#5)
IL-5 and IL-10##2##3##(2010-12#2)
IL-5 and##3##2##(1995-6#1)(2010-12#2)
IL-5##15##1##(1994-11#1)(1995-5#1)(1995-6#5)(2008-10#1)(2008-11#1)(2009-12#1)(2010-12#5)
IL-6 and IL-10##2##3##(2011-3#2)
IL-6 and IL-8 levels##2##4##(1996-12#2)
IL-6 and##8##2##(1990-5#1)(1996-12#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-3#2)
IL-6 gene expression in##2##4##(1995-12#2)
IL-6 gene##3##2##(1995-12#3)
IL-6 is##2##2##(1990-5#1)(2008-11#1)
IL-6 mRNA##4##2##(1995-12#3)(2013-1#1)
IL-6 production##6##2##(2008-10#6)
IL-6 receptor##4##2##(1997-7#2)(2008-8#1)(2008-9#1)
IL-6 subfamily##3##2##(1996-2#3)
IL-6 was##2##2##(1990-5#1)(2008-11#1)
IL-6##73##1##(1990-5#6)(1994-6#2)(1995-12#8)(1996-12#6)(1996-2#4)(1997-7#8)(2008-10#12)(2008-11#6)(2008-4#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#7)(2011-3#3)(2012-3#2)(2013-1#3)
IL-6) and##4##2##(2009-12#1)(2011-3#2)(2013-1#1)
IL-6-dependent##2##1##(2008-11#2)
IL-7 gene expression##4##3##(1995-2#4)
IL-7 gene regulation and apoptosis induction##2##6##(1995-2#2)
IL-7 gene regulation##3##3##(1995-2#3)
IL-7 gene##10##2##(1995-2#10)
IL-7 mRNA expression##2##3##(1995-2#2)
IL-7##14##1##(1995-2#12)(2008-11#2)
IL-8 and##3##2##(2009-8#1)(2011-2#2)
IL-8 levels##3##2##(1996-12#3)
IL-8##15##1##(1994-11#2)(1994-5#1)(1996-12#3)(2008-10#3)(2009-10#1)(2009-8#1)(2011-2#3)(2013-1#1)
IL-8-mediated neutrophil chemotaxis##2##3##(1994-11#2)
IL-8-mediated##4##1##(1994-11#3)(2009-10#1)
IL-9 and##2##2##(2008-4#1)(2011-2#1)
IL-9 receptor##2##2##(2008-4#1)(2011-2#1)
IL-9##11##1##(1996-2#1)(2008-4#5)(2011-2#5)
IL-beta##2##1##(2008-12#1)(2010-12#1)
IL2##4##1##(1990-8#2)(1996-2#1)(2012-2#1)
IL4##5##1##(1993-2#4)(2008-9#1)
IL6##4##1##(1996-2#1)(2006-6#1)(2008-11#1)(2009-10#1)
ILI##6##1##(2008-10#5)(2011-9#1)
ILITC##3##1##(2008-10#3)
ILL##3##1##(2008-3#3)
ILP##2##1##(2009-11#2)
ILS##10##1##(2008-10#7)(2008-3#3)
ILV3##2##1##(1993-12#2)
ILs and##2##2##(2010-7#2)
ILs##6##1##(2008-10#2)(2010-7#4)
IM strain##2##2##(2012-3#2)
IM##8##1##(1995-1#1)(2008-10#2)(2010-11#1)(2010-4#1)(2012-3#3)
IM-9 cells##3##2##(1996-2#3)
IM-9 lymphoblasts##3##2##(1996-2#3)
IM-9##6##1##(1996-2#6)
IMAC would be##2##3##(2012-3#2)
IMAC##5##1##(2012-3#5)
IMAC's##2##1##(2012-3#2)
IMC##4##1##(2008-10#1)(2008-3#3)
IMDM (1##2##2##(2008-11#2)
IMID##9##1##(2011-2#9)
IMMP##3##1##(2008-11#3)
IMP dehydrogenase##4##2##(1990-10#1)(1992-8#1)(1993-8#1)(1994-11#1)
IMP##12##1##(1990-10#3)(1992-8#1)(1993-8#1)(1994-11#1)(1995-6#3)(2008-10#2)(2008-11#1)
IMPACT##3##1##(2008-10#2)(2008-11#1)
IMPLICATIONS FOR NURSING PRACTICE##2##4##(2013-1#2)
IMPLICATIONS##14##1##(2008-11#1)(2011-2#1)(2012-3#2)(2013-1#10)
IMR-90 cells##2##2##(1997-1#2)
IMR-90 human fibroblasts##2##3##(1995-12#2)
IMR-90##5##1##(1995-12#3)(1997-1#2)
IMRT for##2##2##(2011-2#2)
IMRT##6##1##(2008-11#1)(2008-2#1)(2011-2#3)(2012-3#1)
IMS are##2##2##(2008-10#2)
IMS instruments##2##2##(2008-10#1)(2010-9#1)
IMS peaks##2##2##(2008-10#2)
IMS response##3##2##(2008-10#3)
IMS was##2##2##(2008-10#2)
IMS##31##1##(2008-10#27)(2008-5#1)(2010-9#3)
IN A##2##2##(2008-11#1)(2008-12#1)
IN THE##3##2##(2009-11#1)(2012-3#2)
IN Tg##5##2##(2008-9#5)
IN isolate induced##2##3##(2008-10#2)
IN isolate##3##2##(2008-10#3)
IN p53 HAPLOINSUFFICIENT MICE##2##4##(2008-9#2)
IN p53##3##2##(2008-9#3)
IN##29##1##(2008-10#7)(2008-11#4)(2008-12#1)(2008-9#8)(2009-11#1)(2009-4#1)(2010-12#1)(2011-3#3)(2012-3#3)
IN937a##2##1##(2008-10#2)
IN937b##2##1##(2008-10#2)
INA##2##1##(2008-10#1)(2011-2#1)
IND and DON##2##3##(2008-10#2)
IND and##5##2##(2008-10#5)
IND##14##1##(2008-10#13)(2008-5#1)
INF1##5##1##(2008-10#5)
INF1-nonproducing isolates##2##2##(2008-10#2)
INH##7##1##(1996-11#1)(2008-1#1)(2008-10#5)
INO1##2##1##(1996-6#2)
INR7##3##1##(2008-10#3)
INSERM##2##1##(2008-5#2)
INSV##5##1##(2008-10#5)
INTRODUCTION##11##1##(2008-11#2)(2008-12#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#2)(2013-1#1)
IO##2##1##(2008-10#2)
IOFB were##2##2##(2009-12#2)
IOFB##5##1##(2009-12#5)
IOL##2##1##(2011-2#2)
IOP and##2##2##(2008-2#1)(2013-1#1)
IOP is##2##2##(2011-2#2)
IOP was##3##2##(2011-2#1)(2013-1#2)
IOP##17##1##(2008-2#2)(2011-2#8)(2013-1#7)
IORT and WBI were##2##4##(2011-2#2)
IORT and WBI##3##3##(2011-2#3)
IORT##9##1##(2011-2#9)
IP##12##1##(1992-7#1)(2008-10#2)(2008-7#8)(2012-3#1)
IP(3)##3##1##(2008-7#1)(2008-8#1)(2009-8#1)
IP-RPHPLC was##2##2##(2008-10#2)
IP-RPHPLC##3##1##(2008-10#3)
IP3##12##1##(1991-6#4)(1993-1#2)(1993-8#6)
IP3- and##3##2##(1991-6#1)(1996-5#2)
IPB##3##1##(2008-10#3)
IPC and##2##2##(2010-1#2)
IPC on##2##2##(2010-1#2)
IPC##6##1##(2010-1#5)(2013-8#1)
IPD CL##2##2##(2008-10#2)
IPD##7##1##(2008-10#3)(2008-7#4)
IPE as##2##2##(2008-11#2)
IPE experience##2##2##(2008-12#2)
IPE##9##1##(2008-11#5)(2008-12#4)
IPFF##2##1##(2013-1#2)
IPL-41 medium##3##2##(2008-11#3)
IPL-41##4##1##(2008-11#4)
IPM has##2##2##(2008-10#2)
IPM##9##1##(2008-10#9)
IPMCs cut from films oriented##2##5##(2010-4#2)
IPMCs##4##1##(2010-4#4)
IPMN##5##1##(2012-2#5)
IPO323##7##1##(2008-10#6)(2011-10#1)
IPO94269##3##1##(2008-10#3)
IPS##3##1##(2008-10#1)(2013-1#2)
IPSF activity at##2##3##(2008-11#2)
IPSF activity of ADH-I##2##4##(2008-11#2)
IPSF activity##5##2##(2008-11#5)
IPSF##8##1##(2008-11#8)
IPT##4##1##(2011-2#4)
IPTG##9##1##(1990-5#1)(1993-8#2)(1993-9#2)(1994-8#1)(1995-12#1)(2013-1#2)
IPV and##2##2##(2008-12#1)(2010-11#1)
IPV##15##1##(1995-5#4)(2008-12#5)(2010-11#5)(2012-12#1)
IQ and MeIQ##2##3##(2008-10#2)
IQ and##3##2##(2008-10#2)(2008-9#1)
IQ heritability##3##2##(1997-7#3)
IQ##20##1##(1992-6#1)(1994-3#1)(1997-2#1)(1997-7#6)(2008-10#2)(2008-11#1)(2008-12#3)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
IR absorption spectroscopy##2##3##(2008-3#1)(2010-4#1)
IR absorption with##2##3##(2008-3#2)
IR absorption##5##2##(2008-3#4)(2010-4#1)
IR and##9##2##(1990-5#1)(1996-5#1)(2008-10#5)(2008-11#1)(2013-1#1)
IR bands of##2##3##(1994-11#1)(2008-10#1)
IR camera##2##2##(2008-3#1)(2008-7#1)
IR gas cell##4##3##(2008-10#4)
IR images##3##2##(2008-7#3)
IR in##2##2##(1995-8#1)(2010-4#1)
IR radiation##2##2##(2008-10#1)(2008-3#1)
IR spectra##4##2##(2008-10#3)(2013-8#1)
IR spectral##3##2##(2008-10#2)(2008-3#1)
IR spectroscopy##5##2##(2008-10#5)
IR was##2##2##(1995-8#1)(2013-8#1)
IR##101##1##(1990-5#4)(1994-11#1)(1995-8#4)(1996-5#1)(2007-11#1)(2008-10#43)(2008-11#2)(2008-3#15)(2008-5#1)(2008-7#6)(2010-4#2)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#7)(2013-8#8)
IR- and##2##2##(2008-10#2)
IR-I##4##1##(2008-10#4)
IR-II##2##1##(2008-10#2)
IR64/Azucena and##2##2##(2008-10#2)
IR64/Azucena##3##1##(2008-10#3)
IRB members and##4##3##(2009-4#4)
IRB members##7##2##(2009-4#7)
IRB##17##1##(2009-4#17)
IRBs##3##1##(2009-4#3)
IRC-3##3##1##(2008-8#3)
IRC-8 GDH(+) strain##2##3##(2008-8#2)
IRF-1##5##1##(1997-7#1)(2008-11#4)
IRF-2##3##1##(1995-12#3)
IRF-8 expression in melanoma cells##2##5##(2013-1#2)
IRF-8 expression##4##2##(2013-1#4)
IRF-8##7##1##(2013-1#7)
IRF-8(-/-)##2##1##(2013-1#2)
IRI concentrations##2##2##(1994-12#2)
IRI##8##1##(1991-2#1)(1994-12#6)(2012-3#1)
IRIS##8##1##(2009-7#1)(2010-5#7)
IRMs##3##1##(2008-10#3)
IRS-1 and##2##2##(1992-10#2)
IRS-1 in##8##2##(1992-10#1)(1995-8#7)
IRS-1 was##2##2##(1992-10#2)
IRS-1##18##1##(1992-10#8)(1994-11#3)(1995-8#7)
IRS-I tyrosine phosphorylation##4##3##(1997-1#4)
IRS-I##15##1##(1997-1#15)
IRS-proteins provide##2##2##(1996-2#2)
IRS-proteins##5##1##(1996-2#5)
IRS-signalling##2##1##(1996-2#2)
IRT##2##1##(2009-12#1)(2013-8#1)
IRs##2##1##(2008-10#2)
IS susceptibility##2##2##(2012-3#2)
IS was##2##2##(1990-6#2)
IS##19##1##(1990-6#4)(1993-3#1)(1995-8#1)(2008-10#6)(2009-12#1)(2012-3#5)(2012-5#1)
IS-like elements##2##2##(1995-12#1)(1995-8#1)
IS1112##4##1##(2008-10#4)
IS1356##2##1##(2008-10#2)
IS256 arm##2##2##(1993-12#2)
ISAV##4##1##(2009-6#4)
ISBN##2##1##(2008-5#2)
ISC##8##1##(2008-10#1)(2008-11#7)
ISCN##2##1##(2008-9#2)
ISE in##2##2##(2008-10#2)
ISE membrane##2##2##(2008-10#2)
ISE membranes##2##2##(2008-10#2)
ISE##24##1##(2008-10#24)
ISEs and one##2##3##(2008-10#2)
ISEs based on##4##3##(2008-10#4)
ISEs for##2##2##(2008-10#2)
ISEs is##3##2##(2008-10#3)
ISEs were##2##2##(2008-10#2)
ISEs with##5##2##(2008-10#5)
ISEs##32##1##(2008-10#32)
ISFET sensors##2##2##(2008-10#2)
ISFET##5##1##(2008-10#5)
ISFETs with##2##2##(2008-10#2)
ISFETs##9##1##(2008-10#9)
ISFG##3##1##(2008-12#3)
ISG with Heterobasidion##2##3##(2010-10#2)
ISG##3##1##(2010-10#3)
ISGs##7##1##(2010-10#7)
ISH##2##1##(1996-12#1)(2008-9#1)
ISI Web of Knowledge##2##4##(2013-1#2)
ISIS 12449 or ISIS 2302##2##5##(2008-10#2)
ISIS 12449##3##2##(2008-10#3)
ISIS 2302##7##2##(2008-10#7)
ISIS 3082##2##2##(2008-10#2)
ISIS##13##1##(2008-10#13)
ISM1499##2##1##(1993-12#2)
ISNT##2##1##(2008-4#2)
ISO##11##1##(2008-10#5)(2008-12#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
ISO/IEC##2##1##(2008-11#1)(2011-2#1)
ISP sensor##2##2##(2008-10#2)
ISPR##3##1##(2008-7#3)
ISR by Bacillus spp##3##4##(2008-10#3)
ISR by##5##2##(2008-10#5)
ISR elicited by Bacillus spp##2##5##(2008-10#2)
ISR elicited by##4##3##(2008-10#4)
ISR in##2##2##(2008-10#2)
ISR##18##1##(2008-10#18)
ISR398##2##1##(2008-10#2)
ISR8036##2##1##(2008-10#2)
ISSCR##2##1##(2008-9#2)
IT (information technology)##2##3##(1993-2#2)
IT##10##1##(1993-2#4)(2008-11#1)(2008-9#4)(2010-8#1)
ITA1 and ITA3##3##3##(2008-10#3)
ITIES##3##1##(2008-10#3)
ITO##5##1##(2008-10#2)(2008-12#3)
ITO-TEOS-BSA-ChOx/HRP biosensor was##2##3##(2008-10#2)
ITO-TEOS-BSA-ChOx/HRP##4##1##(2008-10#4)
ITP##4##1##(2006-6#4)
ITPA variants##2##2##(2013-1#2)
ITS and LSU sequences##2##4##(2010-3#2)
ITS and##8##2##(2008-10#4)(2008-11#1)(2010-3#3)
ITS rDNA sequence analysis##2##4##(2008-10#1)(2008-11#1)
ITS region with##2##3##(2008-10#2)
ITS region##15##2##(2008-10#14)(2010-3#1)
ITS regions##4##2##(2008-10#4)
ITS sequence data##2##3##(2008-10#2)
ITS sequence##6##2##(2008-10#6)
ITS sequences of##2##3##(2008-10#2)
ITS sequences##8##2##(2008-10#8)
ITS##62##1##(2008-10#54)(2008-11#3)(2010-3#5)
ITS-1 region##2##2##(2008-9#2)
ITS-1##3##1##(2008-10#1)(2008-9#2)
ITS1 alleles##2##2##(2008-10#2)
ITS1##11##1##(2008-10#9)(2008-12#1)(2012-2#1)
ITS1-5##2##1##(2008-10#2)
ITS2 and##2##2##(2008-10#1)(2008-12#1)
ITS2 sequence analysis##2##3##(2008-10#2)
ITS2 sequence##3##2##(2008-10#3)
ITS2##11##1##(2008-10#10)(2008-12#1)
ITS2)##8##1##(2008-10#6)(2008-12#1)(2012-2#1)
ITs were##2##2##(2008-10#2)
IU##7##1##(1990-12#1)(1991-11#1)(1992-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
IU/L##2##1##(2011-2#2)
IU/l##4##1##(1994-12#1)(2008-7#3)
IU/mL##3##1##(1993-1#1)(2012-3#1)(2013-1#1)
IUC adoption##2##2##(2013-1#2)
IUC use##2##2##(2013-1#2)
IUC##8##1##(2008-10#1)(2013-1#7)
IUD##4##1##(1993-12#3)(2013-1#1)
IUDs##6##1##(1991-2#1)(1993-12#4)(2011-2#1)
IUPAC detection##2##2##(2008-10#2)
IUPAC##7##1##(2008-10#6)(2008-11#1)
IV administration of##2##3##(1997-8#1)(2012-2#1)
IV and V##2##3##(2008-10#1)(2011-3#1)
IV and V)##2##3##(2008-10#1)(2011-2#1)
IV and##19##2##(1990-2#1)(1991-8#1)(1992-6#1)(1994-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
IV contained##2##2##(2008-10#2)
IV drug use##2##3##(1995-12#1)(1997-6#1)
IV drug users##2##3##(1997-6#2)
IV drug##5##2##(1995-12#1)(1997-6#3)(2009-6#1)
IV inferior hip joint##2##4##(2008-12#2)
IV is##2##2##(1990-5#1)(1997-7#1)
IV of S##3##3##(1996-6#3)
IV of the##3##3##(1990-8#1)(1997-3#1)(2008-5#1)
IV of##7##2##(1990-8#1)(1996-3#1)(1996-6#3)(1997-3#1)(2008-5#1)
IV or##2##2##(2007-12#1)(2012-3#1)
IV##147##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-5#2)(1995-8#2)(1996-3#1)(1996-6#7)(1997-2#2)(1997-3#6)(1997-6#3)(1997-7#8)(1997-8#3)(2007-12#2)(2008-1#4)(2008-10#30)(2008-11#5)(2008-12#5)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#2)(2010-1#2)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#5)(2012-3#5)(2013-1#1)(2013-8#3)
IV) and##2##2##(2008-10#1)(2008-5#1)
IV)##10##1##(1991-3#1)(1993-12#1)(1994-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#1)
IVB and##5##2##(2011-2#5)
IVB##8##1##(2011-2#8)
IVB/IVT groups##4##2##(2011-2#4)
IVB/IVT##6##1##(2011-2#6)
IVC is##2##2##(1990-2#1)(2013-1#1)
IVC##16##1##(1990-2#4)(2008-7#1)(2011-2#8)(2013-1#3)
IVDUs and##2##2##(1992-9#2)
IVDUs##8##1##(1991-1#2)(1992-9#6)
IVF##7##1##(1994-12#1)(2008-11#3)(2012-3#2)(2013-1#1)
IVF-ET##2##1##(2012-3#2)
IVH##6##1##(2008-7#6)
IVI method##2##2##(2008-11#2)
IVI##7##1##(2008-11#6)(2013-1#1)
IVS1 -27AA##2##2##(2011-2#2)
IVS1##3##1##(2011-2#3)
IVT##2##1##(2011-2#2)
IX alpha##3##2##(1990-8#2)(1994-5#1)
IX and the##3##3##(1993-8#1)(2008-5#1)(2011-2#1)
IX and##6##2##(1993-8#1)(1995-2#2)(1996-3#1)(2008-5#1)(2011-2#1)
IX in##3##2##(1993-8#2)(2008-9#1)
IX##60##1##(1990-5#5)(1990-8#3)(1991-12#1)(1991-5#1)(1993-8#7)(1994-5#1)(1995-2#4)(1995-8#1)(1995-9#1)(1996-3#3)(2008-10#1)(2008-11#4)(2008-5#3)(2008-8#6)(2008-9#10)(2011-2#8)(2012-2#1)
IX)##4##1##(2008-10#1)(2011-2#2)(2012-3#1)
IYSV##2##1##(2008-10#2)
Ia mitochondrial##2##2##(2008-10#2)
Ia##12##1##(1991-2#1)(2006-6#3)(2007-8#1)(2008-10#6)(2011-1#1)
Iatrogenic##3##1##(1996-11#1)(2007-11#1)(2008-10#1)
Ib##9##1##(1991-2#1)(1993-3#1)(1994-11#2)(2008-10#2)(2008-3#1)(2011-3#2)
Ibacus##6##1##(2007-12#6)
Ibandronic acid##2##2##(2011-2#2)
Iberian##6##1##(2008-10#3)(2009-10#1)(2013-8#2)
Ibiá##2##1##(2008-5#2)
Ibogaine##2##1##(1991-1#1)(1997-2#1)
Ibuprofen##3##1##(1992-6#1)(2008-10#2)
Ice##5##1##(2008-10#3)(2008-3#1)(2008-8#1)
Iceland##2##1##(1991-2#1)(2011-4#1)
Ichthyophthirius multifiliis##2##2##(2010-4#2)
Id proteins##2##2##(2011-2#2)
Id##3##1##(2008-4#1)(2011-2#2)
Id1##5##1##(2013-1#5)
Id4##6##1##(2011-2#6)
Idaho##2##1##(1990-3#1)(1993-5#1)
Ideal##3##1##(2008-10#1)(2008-9#1)(2010-8#1)
Ideally##5##1##(1993-3#1)(1995-5#1)(1997-1#1)(2008-8#1)(2009-4#1)
Ideas and##2##2##(1994-3#1)(1995-3#1)
Ideas##3##1##(1994-3#1)(1995-3#1)(2008-11#1)
Identical##6##1##(1993-12#1)(1994-11#1)(2008-10#2)(2008-7#1)(2009-3#1)
Identification and Characterization of##3##4##(2008-10#3)
Identification and Differentiation of##2##4##(2008-10#1)(2012-2#1)
Identification and Molecular Mapping of a Gene##2##7##(2008-10#2)
Identification and characterization of a novel##2##6##(1997-8#1)(2008-10#1)
Identification and characterization of##6##4##(1993-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
Identification and classification##2##3##(2009-10#2)
Identification and partial characterization of##2##5##(1992-6#1)(1993-3#1)
Identification and quantification##2##3##(2008-10#1)(2009-7#1)
Identification and quantitation of##2##4##(1997-3#1)(2008-10#1)
Identification and structural##2##3##(1994-5#1)(2008-10#1)
Identification and##46##2##(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-10#2)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Identification of Molecular##2##3##(2008-10#2)
Identification of Two##2##3##(2008-10#1)(2011-2#1)
Identification of a novel##3##4##(1996-2#1)(2008-8#1)(2010-11#1)
Identification of a##20##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#1)(1993-12#1)(1995-2#3)(1995-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-11#1)
Identification of an##3##3##(1995-2#1)(1995-6#1)(2012-3#1)
Identification of novel##2##3##(1995-6#1)(2008-10#1)
Identification of proteins##2##3##(1997-2#1)(2008-1#1)
Identification of quantitative##2##3##(2008-10#2)
Identification of some##2##3##(2008-10#2)
Identification of the site of##2##5##(1994-5#2)
Identification of the##14##3##(1992-4#1)(1994-5#2)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2010-1#1)(2011-2#1)
Identification of three##2##3##(2008-11#1)(2010-4#1)
Identification of##137##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-5#4)(1995-11#1)(1995-12#1)(1995-2#5)(1995-6#6)(1995-8#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#3)(2008-1#1)(2008-10#58)(2008-11#9)(2008-12#3)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#4)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-2#5)(2012-3#1)(2013-8#1)
Identification##196##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#4)(1993-3#2)(1993-6#1)(1994-11#1)(1994-5#5)(1995-11#1)(1995-12#1)(1995-2#5)(1995-6#6)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2008-1#1)(2008-10#86)(2008-11#10)(2008-12#4)(2008-4#2)(2008-5#4)(2008-8#4)(2008-9#4)(2009-10#2)(2009-4#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
Identified##7##1##(1994-3#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
Identifies##4##1##(2008-10#2)(2012-3#2)
Identifiler##2##1##(2008-12#2)
Identify##2##1##(2008-10#1)(2008-5#1)
Identifying the##4##2##(1993-12#1)(2008-10#1)(2010-4#1)(2012-12#1)
Identifying##22##1##(1993-12#1)(1993-9#1)(1995-12#1)(2008-10#6)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#2)(2013-1#2)(2013-8#3)
Identity##3##1##(1993-3#1)(2008-11#1)(2008-5#1)
Idiopathic granulomatous##2##2##(1997-8#1)(2008-7#1)
Idiopathic pulmonary fibrosis##2##3##(2010-5#2)
Idiopathic##12##1##(1996-6#1)(1997-8#1)(2008-7#3)(2010-10#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-3#1)(2013-8#1)
If EDTA-bound Fe(III) is##2##4##(2008-10#2)
If a country were##2##4##(1992-12#2)
If a##16##2##(1992-12#2)(1993-12#1)(1994-2#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)
If both##2##2##(1992-2#1)(2008-5#1)
If it##2##2##(1997-3#1)(2009-6#1)
If not##3##2##(2008-11#1)(2010-8#1)(2012-2#1)
If the frequency of encounters##2##5##(2008-8#2)
If the##62##2##(1990-11#1)(1990-2#1)(1990-6#4)(1990-8#1)(1991-12#1)(1991-3#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-6#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#5)(2013-1#2)
If there is a##5##4##(1991-7#1)(1994-1#1)(1996-2#1)(2008-10#1)(2008-7#1)
If there is no##2##4##(1990-6#1)(2008-9#1)
If there is##8##3##(1990-6#1)(1991-7#1)(1994-1#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
If there##10##2##(1990-6#1)(1991-7#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
If these##6##2##(1994-1#1)(1996-1#1)(2008-9#2)(2011-2#1)(2013-8#1)
If this is the case##2##5##(2008-1#1)(2008-10#1)
If this##5##2##(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)
If we##4##2##(1993-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
If you##4##2##(1991-3#1)(1995-2#2)(2008-11#1)
If your facility##2##3##(2011-2#2)
If your##3##2##(1996-1#1)(2011-2#2)
If##217##1##(1990-11#1)(1990-2#1)(1990-6#5)(1990-8#2)(1991-11#1)(1991-12#2)(1991-3#5)(1991-7#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#2)(1993-8#1)(1994-1#3)(1994-2#3)(1994-3#1)(1994-5#4)(1994-9#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#27)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#16)(2008-9#18)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#5)(2013-8#2)
Ifremeria nautilei##2##2##(2008-6#2)
Ig##13##1##(1990-12#7)(1994-11#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
Ig3 domain##2##2##(2009-7#2)
IgA antibodies##2##2##(2008-4#1)(2011-2#1)
IgA levels##2##2##(1991-12#1)(2013-1#1)
IgA nephropathy##3##2##(2009-6#2)(2013-8#1)
IgA production##5##2##(2008-11#4)(2013-1#1)
IgA response##3##2##(2008-11#3)
IgA secretion##2##2##(2008-11#1)(2013-8#1)
IgA##36##1##(1990-12#1)(1991-12#2)(1993-2#1)(1996-12#1)(2008-10#3)(2008-11#13)(2008-4#1)(2009-6#2)(2010-4#1)(2011-2#2)(2013-1#5)(2013-8#4)
IgE and##5##2##(2008-11#4)(2012-3#1)
IgE antibody in##2##3##(2008-10#2)
IgE antibody##5##2##(2008-10#5)
IgE detection##2##2##(2008-10#2)
IgE in##3##2##(2008-10#2)(2008-11#1)
IgE production in##2##3##(2008-11#2)
IgE production##8##2##(2008-10#1)(2008-11#6)(2008-4#1)
IgE receptor##4##2##(1991-9#1)(2008-11#2)(2009-6#1)
IgE##50##1##(1990-3#1)(1991-9#1)(1995-11#3)(2008-10#20)(2008-11#18)(2008-4#1)(2009-6#1)(2010-5#2)(2012-2#1)(2012-3#2)
IgE/HC-##2##1##(2008-11#2)
IgE/SNP-treated KU812 cells##2##3##(2008-11#2)
IgG Langmuir-Blodgett##2##2##(2008-10#2)
IgG and##12##2##(1990-5#1)(1996-2#1)(2006-6#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)
IgG antibodies##2##2##(2008-10#2)
IgG antibody##4##2##(2008-10#4)
IgG as##2##2##(2008-10#2)
IgG at##2##2##(2008-10#1)(2008-11#1)
IgG binding##2##2##(1996-12#1)(2008-10#1)
IgG class##2##2##(1990-12#1)(1995-12#1)
IgG concentration was##2##3##(2008-10#1)(2008-12#1)
IgG concentration##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
IgG for##2##2##(2010-3#1)(2012-2#1)
IgG in##2##2##(2008-11#1)(2013-8#1)
IgG labeled with##2##3##(2008-10#1)(2008-12#1)
IgG molecules##2##2##(1990-12#2)
IgG on##2##2##(1990-12#2)
IgG or##4##2##(1991-11#1)(1996-2#1)(2008-10#1)(2011-2#1)
IgG production##5##2##(2008-11#3)(2008-7#2)
IgG response##2##2##(1993-12#1)(2012-3#1)
IgG responses##2##2##(2008-10#1)(2008-9#1)
IgG serum levels were significantly##2##5##(2008-10#2)
IgG to NeutrAvidin##2##3##(2008-10#2)
IgG was significantly##2##3##(1995-11#1)(1995-2#1)
IgG was##6##2##(1995-11#1)(1995-2#1)(2008-10#4)
IgG##133##1##(1990-12#12)(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#3)(1993-12#2)(1993-6#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-2#1)(1996-12#5)(1996-2#4)(1996-3#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#53)(2008-11#14)(2008-12#4)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-6#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
IgG-Sepharose##3##1##(1996-12#2)(1996-6#1)
IgG-binding##2##1##(1996-12#1)(1996-6#1)
IgG1 and##5##2##(1993-6#2)(1995-11#1)(1997-8#1)(2008-11#1)
IgG1##20##1##(1993-6#5)(1995-11#2)(1996-12#2)(1997-8#1)(2008-10#3)(2008-11#4)(2009-6#1)(2010-12#1)(2011-2#1)
IgG2a and IgG2b##2##3##(2008-11#1)(2009-6#1)
IgG2a##5##1##(1996-12#1)(1997-8#1)(2008-11#2)(2009-6#1)
IgG2b##5##1##(1996-12#1)(2008-11#2)(2009-6#1)(2012-2#1)
IgG3 subclass##2##2##(1993-6#1)(2011-2#1)
IgG3##9##1##(1993-6#5)(1996-12#2)(2009-6#1)(2011-2#1)
IgG4##4##1##(2011-2#3)(2012-3#1)
IgM and IgG production##2##4##(2008-11#2)
IgM and IgG##3##3##(2008-11#2)(2008-9#1)
IgM and##4##2##(2008-11#2)(2008-9#1)(2011-2#1)
IgM antibodies##9##2##(1990-12#4)(2008-10#1)(2008-11#2)(2008-4#2)
IgM antibody-forming cell##2##3##(2008-10#2)
IgM production by human-human hybridoma##2##5##(2008-11#2)
IgM production##5##2##(2008-11#5)
IgM was##4##2##(1991-11#1)(1992-12#2)(2008-10#1)
IgM##45##1##(1990-12#6)(1991-11#1)(1992-12#2)(1993-12#1)(1994-3#1)(1996-12#2)(1997-7#1)(2008-10#9)(2008-11#14)(2008-4#2)(2008-7#3)(2008-9#2)(2011-2#1)
IgV(H)##5##1##(2008-9#5)
Igbo/Bini/Urhobo##2##1##(2009-10#2)
Igh##2##1##(1997-9#2)
Ignisphaera aggregans##2##2##(2011-2#2)
Ignisphaera##4##1##(2011-2#4)
Il##3##1##(2010-1#1)(2013-1#2)
Ile-81##2##1##(1994-5#2)
Ile184##2##1##(1992-1#2)
Ile8Glu##3##1##(2008-9#3)
Iliac##3##1##(2008-12#2)(2012-3#1)
Ilizarov limb##2##2##(2013-1#2)
Ilizarov technique##3##2##(2009-3#3)
Ilizarov##9##1##(2008-12#1)(2009-3#3)(2009-4#1)(2013-1#4)
Ill##2##1##(2008-12#1)(2011-1#1)
Illinois University##2##2##(2010-1#1)(2013-8#1)
Illinois local health departments##2##4##(1996-2#2)
Illinois##28##1##(1992-8#1)(1992-9#2)(1994-12#1)(1996-12#1)(1996-2#4)(1997-2#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-1#1)(2013-8#1)
Illness##5##1##(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#2)
Illumination##2##1##(1993-3#1)(2008-3#1)
Illustration##3##1##(1996-5#1)(2012-3#1)(2013-1#1)
ImTe##3##1##(2008-9#3)
Image Analysis##3##2##(2008-10#3)
Image analysis##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
Image##16##1##(1997-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-1#1)(2012-2#4)
Image-Guided Surgery##2##2##(2009-12#2)
Image-guided##2##1##(2008-2#1)(2010-7#1)
Imagery##2##1##(2008-10#1)(2008-3#1)
Images in clinical medicine##6##4##(1994-3#1)(1994-6#3)(1995-8#1)(1997-7#1)
Images in emergency medicine##4##4##(2009-6#4)
Images in##11##2##(1994-3#1)(1994-6#3)(1995-8#1)(1997-7#1)(2009-6#5)
Images of##5##2##(1990-11#1)(2007-12#1)(2008-3#2)(2012-3#1)
Images##22##1##(1990-11#1)(1994-3#1)(1994-6#3)(1995-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-3#2)(2008-6#2)(2009-6#5)(2010-8#1)(2012-3#1)(2013-1#1)
Imaging Spectrometer##2##2##(2008-3#2)
Imaging at##2##2##(2012-3#1)(2013-8#1)
Imaging by##2##2##(2011-2#2)
Imaging of the##2##3##(2011-2#1)(2012-2#1)
Imaging of##21##2##(1991-2#1)(1997-8#1)(2008-1#2)(2008-2#2)(2008-3#4)(2010-1#1)(2011-2#7)(2012-2#3)
Imaging plays a##2##3##(2008-2#1)(2009-11#1)
Imaging studies##4##2##(2010-1#1)(2010-12#1)(2012-12#1)(2012-3#1)
Imaging the##4##2##(2008-1#1)(2009-10#1)(2009-7#1)(2011-7#1)
Imaging##64##1##(1991-2#1)(1992-3#1)(1996-9#1)(1997-8#1)(2008-1#4)(2008-2#4)(2008-3#9)(2008-4#1)(2008-7#2)(2009-10#1)(2009-11#2)(2009-5#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#14)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#4)
Imatinib and its##3##3##(2008-10#3)
Imatinib##9##1##(2008-10#7)(2009-7#1)(2013-1#1)
Imbrie##2##1##(2008-10#2)
Immature##3##1##(2008-10#1)(2008-11#1)(2008-12#1)
Immediate versus delayed##3##3##(2010-7#1)(2012-3#1)(2013-1#1)
Immediate##12##1##(2008-12#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#5)
Immediately after##5##2##(1992-6#1)(2008-10#1)(2008-7#1)(2013-8#2)
Immediately following##2##2##(2008-10#1)(2011-2#1)
Immediately##10##1##(1992-6#1)(1997-2#1)(2008-10#3)(2008-7#1)(2011-2#2)(2013-8#2)
Immigrants##3##1##(1993-2#1)(2008-11#1)(2010-12#1)
Immigration##2##1##(2008-10#1)(2008-8#1)
Immobilization of##6##2##(2008-10#6)
Immobilization##11##1##(2008-10#10)(2008-9#1)
Immobilized##2##1##(2008-11#1)(2008-12#1)
Immortalized##3##1##(1995-2#1)(2008-11#2)
Immune Response##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
Immune defense and host##2##4##(2008-8#2)
Immune defense##3##2##(2008-8#3)
Immune response##3##2##(1990-9#1)(2012-3#2)
Immune responses##3##2##(1995-5#2)(2008-10#1)
Immune##22##1##(1990-9#1)(1991-1#1)(1991-9#1)(1993-3#1)(1995-5#2)(2008-10#3)(2008-11#2)(2008-6#2)(2008-8#3)(2010-3#1)(2011-2#1)(2012-3#3)(2013-1#1)
Immune-Mediated##2##1##(2008-10#1)(2011-2#1)
Immune-mediated inflammatory diseases (IMID)##2##4##(2011-2#2)
Immune-mediated##3##1##(2008-10#1)(2011-2#2)
Immunity##3##1##(2008-10#1)(2008-12#1)(2008-8#1)
Immunization Initiative (CII)##2##3##(1995-3#1)(1996-12#1)
Immunization##13##1##(1994-9#1)(1995-11#2)(1995-3#2)(1996-1#1)(1996-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-2#1)
Immunoaffinity column##2##2##(2008-11#2)
Immunoaffinity##4##1##(1990-11#1)(2008-10#1)(2008-11#2)
Immunoblot analyses revealed##2##3##(2008-10#1)(2008-11#1)
Immunoblot analyses##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
Immunoblot analysis##2##2##(1992-9#1)(1995-2#1)
Immunoblot##6##1##(1992-9#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#2)
Immunoblotting studies##2##2##(1993-6#2)
Immunoblotting##3##1##(1993-6#2)(2012-2#1)
Immunochemical##6##1##(1996-12#1)(2008-10#3)(2008-11#2)
Immunocytochemical##6##1##(1994-2#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-9#1)
Immunodiagnostics##2##1##(2008-10#2)
Immunofluorescence microscopy##2##2##(2008-10#2)
Immunofluorescence##8##1##(1991-5#1)(1993-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-9#1)
Immunofluorescent##2##1##(1990-8#1)(2008-10#1)
Immunogenic##2##1##(2008-5#1)(2013-1#1)
Immunogenicity for##2##2##(2008-10#2)
Immunogenicity of##2##2##(1995-12#1)(2008-10#1)
Immunogenicity##8##1##(1995-12#1)(1995-5#1)(2008-10#6)
Immunoglobulin##3##1##(1991-6#1)(2008-7#1)(2013-7#1)
Immunogold electron microscopy##2##3##(1997-3#1)(2008-10#1)
Immunogold##4##1##(1997-3#2)(2008-10#2)
Immunohistochemical Localization of##2##3##(2008-5#1)(2008-6#1)
Immunohistochemical analysis of##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
Immunohistochemical analysis##8##2##(1993-12#1)(1994-12#1)(1995-12#1)(2008-10#1)(2009-1#1)(2011-2#1)(2012-3#2)
Immunohistochemical and##4##2##(1992-2#1)(2009-8#2)(2011-2#1)
Immunohistochemical localization of##2##3##(1992-6#1)(1995-12#1)
Immunohistochemical staining of##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
Immunohistochemical staining##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
Immunohistochemical study##2##2##(1997-3#1)(2011-2#1)
Immunohistochemical##30##1##(1990-5#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-12#2)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#2)(2009-1#1)(2009-8#2)(2011-2#4)(2012-2#1)(2012-3#4)(2013-8#1)
Immunohistochemically##4##1##(1994-12#1)(2008-11#2)(2009-8#1)
Immunohistochemistry##7##1##(1991-8#1)(1995-12#1)(2008-12#1)(2008-4#1)(2009-8#1)(2013-1#1)(2013-8#1)
Immunolocalization of##2##2##(2008-10#1)(2008-11#1)
Immunologic##3##1##(1992-12#1)(1995-5#1)(2008-10#1)
Immunological analysis##2##2##(2008-9#1)(2013-1#1)
Immunological##6##1##(1991-1#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
Immunology##2##1##(2008-5#1)(2012-12#1)
Immunomagnetic##3##1##(2008-10#1)(2008-9#2)
Immunomodulatory##3##1##(1993-12#1)(2010-6#1)(2012-2#1)
Immunophenotypic analysis of##4##3##(2008-9#4)
Immunophenotypic##5##1##(2008-9#5)
Immunophenotyping##3##1##(2008-9#3)
Immunoprecipitation analysis##2##2##(1994-11#1)(2012-2#1)
Immunoprecipitation##5##1##(1994-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
Immunoreactivity##4##1##(1991-12#1)(1994-8#1)(1995-6#1)(2010-12#1)
Immunosorbent##3##1##(2008-10#2)(2008-11#1)
Immunostaining for##2##2##(1991-7#1)(2011-2#1)
Immunostaining of ginsenosides##2##3##(2008-11#2)
Immunostaining of##3##2##(2008-11#2)(2010-11#1)
Immunostaining##9##1##(1991-2#1)(1991-7#1)(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-2#1)
Immunosuppressive##6##1##(1990-5#1)(1991-1#1)(1993-12#1)(1996-11#2)(2008-1#1)
Immunotoxicity##3##1##(2008-10#3)
Immunotoxicity&quot##2##1##(2008-10#2)
Impact Profile##2##2##(2011-2#1)(2013-1#1)
Impact of a##2##3##(1991-2#1)(2012-12#1)
Impact of new##2##3##(1992-2#1)(1997-3#1)
Impact of the##2##3##(1991-1#1)(2013-1#1)
Impact of##45##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)(1995-1#1)(1996-2#1)(1997-3#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#4)
Impact on Asthma##2##3##(2012-12#2)
Impact on##4##2##(2008-10#1)(2012-12#3)
Impact##55##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)(1995-1#1)(1996-2#1)(1997-3#1)(2007-11#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#6)(2011-8#1)(2012-12#4)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#7)
Impaction of##2##2##(2008-12#2)
Impaired##19##1##(1992-9#1)(1995-8#1)(1996-6#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#7)
Impairment of##3##2##(1995-11#1)(1996-5#1)(2012-3#1)
Impairment##7##1##(1995-11#1)(1996-5#1)(2008-11#2)(2009-8#1)(2011-1#1)(2012-3#1)
Impairments in##2##2##(2012-2#1)(2013-8#1)
Impairments##4##1##(2008-11#1)(2008-9#1)(2012-2#1)(2013-8#1)
Impairs##3##1##(2008-10#2)(2013-1#1)
Impala##3##1##(2008-10#3)
Impatiens necrotic spot virus##3##4##(2008-10#3)
Impatiens##4##1##(2008-10#4)
Impedance measurements##2##2##(2008-10#1)(2012-2#1)
Impedance##12##1##(2008-10#4)(2008-11#5)(2009-9#1)(2012-2#1)(2012-3#1)
Impedances were##2##2##(2008-9#2)
Impedances##4##1##(2008-9#4)
Impediments to##2##2##(1992-2#1)(1997-3#1)
Impella 2##2##2##(2010-6#2)
Imperial##4##1##(2008-10#1)(2008-5#2)(2012-2#1)
Implant rehabilitation##2##2##(2013-1#2)
Implant##9##1##(2008-9#4)(2012-2#1)(2013-1#4)
Implant-supported##2##1##(2013-1#2)
Implantable medical device##2##3##(2012-3#2)
Implantable##5##1##(1994-9#1)(2010-6#1)(2010-8#1)(2012-3#2)
Implantation of##3##2##(2008-12#2)(2012-3#1)
Implantation##6##1##(2008-11#1)(2008-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
Implementation and##2##2##(2010-8#2)
Implementation issues##2##2##(1997-2#1)(2010-8#1)
Implementation of a##4##3##(1991-2#1)(2008-10#1)(2013-1#2)
Implementation of the Water Framework Directive##2##6##(2008-10#2)
Implementation of the##3##3##(1991-1#1)(2008-10#2)
Implementation of##13##2##(1991-1#1)(1991-2#1)(2008-10#6)(2008-12#1)(2011-2#1)(2013-1#3)
Implementation strategies of measurement instruments and their validity as adopted in italian hospital nursing practice##2##15##(2013-1#2)
Implementation##25##1##(1991-1#1)(1991-2#1)(1991-3#1)(1994-2#1)(1996-1#2)(1997-2#2)(2008-10#6)(2008-12#1)(2010-8#4)(2011-2#1)(2013-1#5)
Implementing a##2##2##(1996-3#1)(2013-1#1)
Implementing the##3##2##(1991-12#1)(1994-12#1)(2008-12#1)
Implementing##11##1##(1991-12#1)(1992-12#1)(1993-1#1)(1994-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-12#2)(2008-3#1)(2013-1#1)
Implicated in##2##2##(2008-10#2)
Implication for##2##2##(2008-11#1)(2013-1#1)
Implication of##2##2##(1995-11#1)(2013-1#1)
Implication##4##1##(1995-11#1)(2008-11#1)(2013-1#2)
Implications and##4##2##(1994-3#1)(1997-3#2)(2011-2#1)
Implications are discussed##2##3##(2008-11#1)(2010-8#1)
Implications for clinical##2##3##(1994-3#1)(1995-2#1)
Implications for future research##2##4##(2008-12#1)(2010-7#1)
Implications for health##2##3##(1991-12#1)(2011-2#1)
Implications for practice##3##3##(2010-10#1)(2010-4#1)(2012-2#1)
Implications for the care of children##2##6##(2008-10#1)(2008-11#1)
Implications for the##5##3##(1995-12#1)(2008-10#1)(2008-11#2)(2009-11#1)
Implications for##45##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-4#1)(2009-11#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
Implications in##2##2##(2009-7#1)(2012-2#1)
Implications include the need for##2##5##(2009-5#1)(2010-10#1)
Implications include##3##2##(2009-5#1)(2010-10#2)
Implications of the findings##2##4##(1997-1#1)(2012-2#1)
Implications of the##6##3##(1992-1#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-12#1)(2012-2#1)
Implications of these findings##2##4##(2009-4#1)(2009-7#1)
Implications of these##5##3##(2008-3#1)(2009-4#2)(2009-7#1)(2009-9#1)
Implications of##21##2##(1992-1#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-4#2)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
Implications##81##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#2)(2008-10#11)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#3)(2009-7#2)(2009-9#2)(2010-10#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
Importance of##11##2##(1991-1#1)(1995-5#2)(2008-10#3)(2008-3#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#1)
Important##25##1##(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-9#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
Importantly##24##1##(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#7)(2013-8#1)
Imported##2##1##(2007-12#1)(2013-8#1)
Imprecision##2##1##(1993-2#1)(2008-10#1)
Impregnated##2##1##(2008-10#2)
Improve##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
Improved Control of##2##3##(2008-10#2)
Improved detection of##2##3##(1991-12#1)(2011-2#1)
Improved detection##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
Improved sensitivity##2##2##(2008-10#1)(2008-11#1)
Improved##42##1##(1991-12#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-3#4)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#3)(2013-1#2)(2013-8#1)
Improvement Act of##2##3##(1991-1#1)(2008-12#1)
Improvement Act##4##2##(1991-1#2)(1994-1#1)(2008-12#1)
Improvement in##6##2##(1996-1#1)(2008-10#2)(2008-3#1)(2008-9#2)
Improvement of a##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
Improvement of pain##3##3##(2008-9#3)
Improvement of##17##2##(1990-6#1)(1991-2#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#4)(2011-2#1)(2012-2#1)
Improvement##47##1##(1990-6#1)(1990-9#1)(1991-1#2)(1991-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-6#1)(1997-1#2)(1997-2#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#6)(2009-6#3)(2011-2#1)(2012-2#1)(2013-1#1)
Improvements in##8##2##(1996-1#1)(2008-7#3)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
Improvements##13##1##(1991-3#1)(1996-1#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#3)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
Improves##5##1##(2008-10#2)(2010-7#1)(2012-3#1)(2013-1#1)
Improving access to##2##3##(2008-11#2)
Improving health##3##2##(1993-1#1)(2008-12#1)(2013-8#1)
Improving student##2##2##(2008-12#1)(2009-8#1)
Improving the quality of##2##4##(1993-3#1)(2009-9#1)
Improving the##11##2##(1993-3#2)(1994-2#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2011-3#1)
Improving##39##1##(1991-1#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-2#1)(1996-1#1)(1997-3#2)(2008-10#2)(2008-11#3)(2008-12#4)(2008-3#1)(2008-6#2)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
Impurities##2##1##(2010-2#1)(2012-2#1)
In 0##6##2##(1994-11#1)(2008-10#5)
In 1 patient##2##3##(2007-11#1)(2011-2#1)
In 1##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
In 10##3##2##(1990-6#1)(1991-3#1)(2008-11#1)
In 11 patients##2##3##(1990-6#1)(1991-11#1)
In 12 of##3##3##(1991-5#1)(1997-8#1)(2008-10#1)
In 12 patients##3##3##(1990-2#1)(2011-2#1)(2013-1#1)
In 12##6##2##(1990-2#1)(1991-5#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
In 13 patients##2##3##(2008-11#1)(2011-2#1)
In 13##4##2##(1996-3#1)(2008-11#1)(2011-2#2)
In 14##2##2##(1996-11#1)(2008-5#1)
In 15 of the##2##4##(1997-7#1)(1997-8#1)
In 15 of##3##3##(1997-7#1)(1997-8#1)(2008-12#1)
In 15##5##2##(1990-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-12#1)
In 16 patients the##2##4##(1990-2#1)(1993-8#1)
In 16##4##2##(1990-2#1)(1993-8#1)(1997-5#1)(2008-12#1)
In 17##2##2##(1991-12#1)(2008-12#1)
In 18%##2##2##(1992-5#1)(2012-3#1)
In 1895##2##2##(2008-7#1)(2010-1#1)
In 1980##2##2##(1991-3#1)(2008-10#1)
In 1982##2##2##(1993-2#1)(1993-3#1)
In 1983##2##2##(1990-9#1)(1995-6#1)
In 1986##2##2##(1991-12#1)(1991-6#1)
In 1987##4##2##(1991-2#2)(1992-2#1)(2008-2#1)
In 1988##4##2##(1990-6#1)(1991-1#1)(1992-2#1)(1993-1#1)
In 1989##5##2##(1991-12#1)(1991-9#2)(1993-1#1)(2008-10#1)
In 1990##4##2##(1991-9#1)(1992-5#1)(2008-10#1)(2008-5#1)
In 1991##6##2##(1992-5#1)(1993-3#1)(1993-6#2)(2008-10#2)
In 1992##3##2##(1994-12#1)(1994-6#1)(2008-10#1)
In 1993##5##2##(1993-6#1)(2008-10#4)
In 1994##6##2##(1996-11#1)(1997-2#1)(2008-10#3)(2008-8#1)
In 1995 the##2##3##(1996-11#1)(2008-7#1)
In 1995##6##2##(1996-11#1)(1997-3#1)(2008-10#3)(2008-7#1)
In 1996##6##2##(2008-10#5)(2008-5#1)
In 1997##8##2##(2008-10#7)(2008-11#1)
In 1998 and##2##3##(2008-10#2)
In 1998##11##2##(2008-10#11)
In 1999##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
In 2 years of##2##4##(2008-10#2)
In 2##4##2##(1993-12#1)(2008-10#2)(2008-7#1)
In 20##2##2##(1992-12#1)(1997-5#1)
In 2000##4##2##(2008-10#3)(2008-9#1)
In 2001##5##2##(2008-10#3)(2009-8#1)(2011-1#1)
In 2002##3##2##(2008-10#3)
In 2003##4##2##(2008-10#3)(2010-8#1)
In 2006##3##2##(2010-8#1)(2011-2#1)(2013-1#1)
In 2008##4##2##(2010-9#1)(2012-2#1)(2013-1#2)
In 21##2##2##(2007-11#1)(2011-2#1)
In 26##2##2##(1994-12#1)(2007-11#1)
In 3 patients##2##3##(1991-2#1)(2013-1#1)
In 3##6##2##(1990-6#1)(1991-2#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-1#1)
In 30##2##2##(1993-12#1)(2008-10#1)
In 32##2##2##(1994-3#1)(2008-12#1)
In 4 of##2##3##(1996-11#1)(1997-5#1)
In 4##7##2##(1990-5#1)(1991-2#1)(1991-8#1)(1992-3#1)(1996-11#1)(1997-5#1)(2008-11#1)
In 45 patients the##2##4##(1990-3#1)(1996-6#1)
In 5 patients##2##3##(2007-11#1)(2009-3#1)
In 6##3##2##(1997-8#1)(2008-10#1)(2010-11#1)
In 75##2##2##(1994-12#1)(2011-2#1)
In 8##2##2##(1996-11#1)(2008-7#1)
In 80%##2##2##(1990-9#1)(1991-2#1)
In 9##3##2##(1996-11#1)(2008-9#1)(2012-3#1)
In A##2##2##(2008-10#1)(2008-12#1)
In AD##2##2##(1997-2#2)
In Alzheimer's disease##2##3##(2011-2#1)(2013-8#1)
In Anzali Lagoon##2##3##(2012-2#2)
In April##5##2##(1992-5#1)(1996-5#1)(2008-1#1)(2008-5#1)(2013-1#1)
In Arabidopsis##5##2##(2008-10#1)(2009-10#1)(2009-8#3)
In August##4##2##(1994-9#1)(1995-12#1)(2008-5#1)(2010-1#1)
In Australia##2##2##(2008-11#1)(2010-10#1)
In Brazil##2##2##(2008-10#1)(2012-3#1)
In C##3##2##(2008-10#2)(2008-9#1)
In California##2##2##(2008-10#1)(2011-2#1)
In DMSO and DMF##2##4##(2008-10#2)
In Drosophila melanogaster##3##3##(1993-9#1)(1995-8#1)(2012-3#1)
In Drosophila##6##2##(1993-9#1)(1995-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
In Europe##4##2##(2008-5#1)(2009-4#1)(2011-2#2)
In European##2##2##(2008-10#1)(2011-3#1)
In Experiment 1##6##3##(2008-11#1)(2008-5#3)(2008-6#1)(2011-1#1)
In Experiment 2##6##3##(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-8#2)
In Experiment 3##2##3##(2008-5#1)(2008-6#1)
In Experiment##15##2##(2008-11#3)(2008-5#5)(2008-6#3)(2011-1#2)(2013-8#2)
In Experiments##2##2##(2008-11#1)(2011-1#1)
In Expt##7##2##(1992-12#2)(1993-3#2)(1993-6#3)
In F##2##2##(1995-8#1)(2008-5#1)
In F(1)##2##2##(2008-10#2)
In February##2##2##(1995-6#1)(2013-1#1)
In France##4##2##(1994-12#1)(2008-10#2)(2011-3#1)
In Germany##2##2##(1995-11#1)(1996-9#1)
In Group##4##2##(1990-5#3)(2009-3#1)
In H##2##2##(2007-12#1)(2012-8#1)
In HIV##2##2##(2008-5#1)(2010-5#1)
In Hungary##3##2##(1991-3#2)(1994-12#1)
In India##3##2##(1994-9#2)(2011-2#1)
In January 1993##2##3##(1995-12#1)(1995-6#1)
In January##5##2##(1995-12#1)(1995-6#1)(2010-8#1)(2011-2#2)
In Japan##2##2##(1992-9#1)(1994-12#1)
In July##4##2##(1991-2#1)(1996-1#1)(2011-3#1)(2013-1#1)
In Lutzomyia##2##2##(2007-12#2)
In Manduca sexta##2##3##(1995-11#2)
In March##5##2##(1990-3#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-5#1)
In May##4##2##(1996-3#1)(2008-5#1)(2011-2#2)
In Mediterranean##2##2##(2012-5#1)(2012-7#1)
In New York##2##3##(1996-12#1)(2008-10#1)
In New##5##2##(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2011-2#1)
In North##3##2##(1997-1#1)(2008-10#1)(2012-2#1)
In Norway##4##2##(1990-2#1)(1991-6#1)(1994-6#1)(1997-8#1)
In October##5##2##(1992-2#1)(1996-1#2)(1996-5#1)(2010-6#1)
In P##2##2##(2008-12#1)(2008-9#1)
In PI##2##2##(2008-10#2)
In Part II##2##3##(1993-2#1)(1997-3#1)
In Planta##4##2##(2008-10#4)
In Russia##2##2##(1994-12#1)(1997-1#1)
In S##3##2##(1991-5#1)(2008-10#2)
In September##2##2##(1995-12#1)(2008-5#1)
In Situ##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
In Southeast##2##2##(1997-5#1)(2012-12#1)
In Study 1##2##3##(2009-5#1)(2010-10#1)
In Study##3##2##(2009-5#1)(2010-10#2)
In T47D cells that contained low levels of estrogen receptor (0##2##11##(2008-11#2)
In Vitro Transcripts##2##3##(2008-10#2)
In Vitro and In Vivo##2##5##(2008-10#1)(2012-2#1)
In Vitro and In##3##4##(2008-10#2)(2012-2#1)
In Vitro and##4##3##(2008-10#2)(2009-12#1)(2012-2#1)
In Vitro##16##2##(1997-7#1)(2008-10#10)(2008-11#1)(2009-12#1)(2009-8#2)(2012-2#1)
In Vivo##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
In Western##2##2##(1993-12#1)(1995-11#1)
In a direct##2##3##(2008-10#1)(2008-9#1)
In a few cases##2##4##(2008-10#2)
In a few##4##3##(2008-10#4)
In a field trial##2##4##(2008-10#2)
In a field##5##3##(2008-10#5)
In a first step##5##4##(2008-10#3)(2008-11#1)(2008-9#1)
In a greenhouse##2##3##(2008-10#2)
In a large number of##2##5##(1993-11#1)(2008-8#1)
In a pilot study##2##4##(1990-8#1)(1994-12#1)
In a preliminary##3##3##(1991-12#1)(2008-10#1)(2012-2#1)
In a previous paper##2##4##(2008-10#1)(2008-2#1)
In a previous study##6##4##(1995-12#1)(1997-2#1)(2008-10#2)(2011-2#1)(2013-1#1)
In a previous##14##3##(1990-4#1)(1995-12#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-2#1)(2009-6#1)(2011-2#1)(2013-1#1)
In a prospective study##2##4##(1990-11#1)(1990-2#1)
In a prospective##3##3##(1990-11#1)(1990-2#1)(2012-3#1)
In a recent paper in Planta##2##6##(2009-8#2)
In a recent paper##4##4##(2008-10#1)(2008-2#1)(2009-8#2)
In a recent study##5##4##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-2#1)
In a recent##14##3##(1991-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#4)(2010-4#1)(2011-2#2)
In a research##2##3##(2008-1#1)(2008-10#1)
In a retrospective study the##2##5##(1993-8#1)(1996-6#1)
In a retrospective study##4##4##(1993-8#1)(1995-5#1)(1996-11#1)(1996-6#1)
In a retrospective##5##3##(1993-8#1)(1995-5#1)(1996-11#1)(1996-6#1)(2010-12#1)
In a sample of##3##4##(2009-7#1)(2012-3#1)(2013-1#1)
In a screen for##2##4##(2008-10#1)(2008-9#1)
In a screen##3##3##(2008-10#1)(2008-9#2)
In a second experiment##3##4##(1996-12#1)(2008-10#2)
In a second field##2##4##(2008-10#2)
In a second step##3##4##(2008-10#2)(2008-11#1)
In a second##16##3##(1991-12#1)(1992-6#1)(1995-6#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-8#1)
In a simple##3##3##(1992-12#1)(2008-8#2)
In a special##2##3##(1997-3#1)(2011-2#1)
In a study of##2##4##(1991-9#1)(1995-1#1)
In a subsequent##4##3##(1990-5#1)(1996-2#1)(2008-10#1)(2008-12#1)
In a survey##2##3##(1991-5#1)(1993-6#1)
In a third##3##3##(2008-10#2)(2011-2#1)
In a total of##2##4##(1994-2#1)(2008-12#1)
In a word##2##3##(2008-8#1)(2011-3#1)
In a##224##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#73)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#5)
In about##4##2##(1991-8#2)(2008-5#1)(2009-3#1)
In absence of##2##3##(2008-10#1)(2008-11#1)
In accordance with##3##3##(1990-3#1)(2008-10#1)(2011-1#1)
In accordance##5##2##(1990-3#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
In acidic conditions##2##3##(2008-10#2)
In acidic media##2##3##(1995-8#1)(2008-10#1)
In acidic##5##2##(1995-8#1)(2008-10#4)
In addition a##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
In addition the##3##3##(1993-6#1)(2007-12#1)(2010-6#1)
In addition there##3##3##(1997-8#1)(2008-12#1)(2008-9#1)
In addition to a##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)
In addition to being##2##4##(1991-11#1)(2008-10#1)
In addition to its##5##4##(1993-12#1)(1995-11#1)(1997-3#1)(2008-10#1)(2010-7#1)
In addition to providing##3##4##(1995-3#1)(2008-4#2)
In addition to reducing##2##4##(1995-5#1)(2008-7#1)
In addition to the expected##3##5##(1991-6#1)(2008-3#1)(2008-5#1)
In addition to the##37##4##(1991-3#1)(1991-6#1)(1993-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
In addition to their##3##4##(2008-10#3)
In addition to these##3##4##(2008-10#1)(2012-2#1)(2013-8#1)
In addition to this##4##4##(2008-11#1)(2008-9#1)(2010-6#1)(2012-3#1)
In addition to##132##3##(1990-2#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2007-12#1)(2008-10#31)(2008-11#11)(2008-12#3)(2008-3#5)(2008-4#5)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#2)(2011-10#1)(2011-2#7)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
In addition we##3##3##(2008-11#1)(2010-3#1)(2011-2#1)
In addition##849##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#7)(1993-2#3)(1993-3#4)(1993-6#3)(1993-8#5)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#4)(1995-11#6)(1995-12#6)(1995-2#14)(1995-3#1)(1995-5#4)(1995-6#12)(1995-8#5)(1995-9#1)(1996-12#11)(1996-2#8)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(1997-9#2)(2007-12#7)(2008-1#5)(2008-10#221)(2008-11#67)(2008-12#13)(2008-2#2)(2008-3#17)(2008-4#14)(2008-5#22)(2008-6#6)(2008-7#31)(2008-8#24)(2008-9#31)(2009-1#2)(2009-10#6)(2009-12#3)(2009-3#2)(2009-5#4)(2009-6#3)(2009-7#7)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#4)(2011-10#2)(2011-2#37)(2012-12#3)(2012-2#22)(2012-3#15)(2012-4#1)(2013-1#20)(2013-7#1)(2013-8#13)
In adult##4##2##(2009-10#1)(2009-12#1)(2010-3#1)(2012-2#1)
In adults##6##2##(1997-4#1)(2007-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
In agreement with##3##3##(1995-11#1)(1995-12#1)(2008-10#1)
In alcoholic##2##2##(2009-7#1)(2011-1#1)
In alkaline media##2##3##(1995-8#1)(2008-10#1)
In alkaline##4##2##(1995-8#1)(2008-10#3)
In all but one case##2##5##(2008-10#1)(2008-6#1)
In all but##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
In all cases the##6##4##(1993-8#1)(1996-5#1)(2008-10#1)(2011-2#1)(2011-3#1)(2013-1#1)
In all cases##29##3##(1991-2#1)(1993-12#1)(1993-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2011-3#1)(2013-1#2)
In all instances##4##3##(1990-11#1)(1991-12#1)(1995-5#1)(1996-2#1)
In all of these##3##4##(1994-12#1)(1997-3#1)(2009-8#1)
In all of##4##3##(1994-12#1)(1995-3#1)(1997-3#1)(2009-8#1)
In all patients the##2##4##(2013-1#2)
In all patients##7##3##(1990-3#1)(1997-8#2)(2008-7#1)(2013-1#3)
In all the##2##3##(2008-10#1)(2008-9#1)
In all these cases##2##4##(2008-10#2)
In all these##3##3##(2008-10#2)(2012-3#1)
In all three##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
In all##94##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#2)(1993-12#1)(1993-8#1)(1994-12#2)(1994-5#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#2)(2008-10#35)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
In an additional##3##3##(1996-3#1)(2008-10#1)(2013-8#1)
In an attempt to achieve##2##5##(2008-3#1)(2009-12#1)
In an attempt to develop##2##5##(2008-10#2)
In an attempt to##20##4##(1991-2#1)(1993-1#1)(1994-11#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#1)
In an earlier paper##2##4##(2008-10#2)
In an earlier##4##3##(2008-10#3)(2008-12#1)
In an early##2##3##(2008-10#2)
In an effort to develop##2##5##(2008-10#2)
In an effort to gain control of the market##2##9##(1994-3#2)
In an effort to##13##4##(1993-2#1)(1994-3#2)(1997-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-9#1)(2011-2#1)
In an experiment##2##3##(1994-11#1)(2008-3#1)
In an in vitro##2##4##(1991-8#1)(2008-12#1)
In an##70##2##(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#27)(2008-11#3)(2008-12#2)(2008-3#5)(2008-7#2)(2008-8#2)(2009-12#2)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
In and Pb##2##3##(2008-10#2)
In animal cells##3##3##(2008-11#1)(2008-8#2)
In animal models##2##3##(2008-5#1)(2013-1#1)
In animal##7##2##(1997-7#1)(2008-11#1)(2008-5#2)(2008-8#2)(2013-1#1)
In another experiment##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
In another##8##2##(1990-11#1)(1991-11#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
In any case##4##3##(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
In any##8##2##(1993-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#2)
In aqueous solution##2##3##(2008-10#1)(2008-9#1)
In areas where##2##3##(1991-6#1)(2008-10#1)
In areas##3##2##(1991-6#1)(2008-10#2)
In attempts to##2##3##(2008-11#1)(2013-8#1)
In batch cultures##3##3##(2008-11#2)(2008-7#1)
In batch##6##2##(2008-10#1)(2008-11#3)(2008-7#2)
In bioassays##2##2##(2008-10#2)
In both cases the##5##4##(2008-10#3)(2008-3#1)(2010-2#1)
In both cases##21##3##(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(2006-6#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-7#1)(2009-4#1)(2010-2#1)
In both experiments##2##3##(2008-10#2)
In both groups##5##3##(1990-5#1)(1994-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
In both human and##2##4##(2008-4#1)(2012-12#1)
In both patients the##2##4##(1991-3#1)(2008-7#1)
In both procedures##2##3##(2008-4#1)(2008-9#1)
In both studies##2##3##(2008-9#2)
In both the##4##3##(1990-9#1)(1996-12#1)(2008-10#1)(2013-8#1)
In both years##4##3##(2008-10#4)
In both##85##2##(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-6#1)(2007-12#2)(2008-10#27)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-8#1)
In brain##2##2##(1996-2#2)
In breast cancer##2##3##(2011-1#1)(2011-2#1)
In case of the##2##4##(1994-8#1)(2008-10#1)
In case of##12##3##(1994-8#1)(1996-11#1)(2008-10#5)(2008-5#1)(2010-8#1)(2013-1#2)(2013-8#1)
In case##14##2##(1994-8#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-8#1)(2013-1#3)(2013-8#1)
In cases of##2##3##(2008-12#1)(2012-2#1)
In cases where##5##3##(1990-5#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
In cases with##2##3##(1997-1#1)(2011-2#1)
In cases##12##2##(1990-5#1)(1994-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
In cells##4##2##(1990-8#1)(2008-11#2)(2008-7#1)
In certain##2##2##(2008-10#2)
In children##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
In chronic##3##2##(1993-11#1)(2007-12#1)(2009-8#1)
In clinical practice##3##3##(1992-12#1)(1997-8#1)(2012-12#1)
In clinical studies##2##3##(1996-2#1)(2008-3#1)
In clinical##7##2##(1990-5#1)(1992-12#1)(1996-2#1)(1997-8#1)(2008-3#1)(2011-2#1)(2012-12#1)
In clinically##2##2##(1991-6#1)(2013-8#1)
In co-cultures of##2##3##(2008-7#2)
In column operation##2##3##(2008-10#2)
In combination with##8##3##(1995-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
In common##2##2##(1993-11#1)(2008-8#1)
In comparing##2##2##(2008-8#2)
In comparison to the##5##4##(1990-2#1)(1991-6#1)(2008-10#2)(2012-3#1)
In comparison to##11##3##(1990-2#1)(1991-6#1)(1992-12#1)(2008-10#5)(2008-12#2)(2012-3#1)
In comparison with most##2##4##(2008-10#2)
In comparison with other##2##4##(1996-5#1)(2008-10#1)
In comparison with the##4##4##(1995-9#1)(1996-11#1)(2008-10#1)(2008-8#1)
In comparison with##19##3##(1990-11#1)(1991-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-8#3)(2009-8#1)
In comparison##36##2##(1990-11#1)(1990-2#2)(1991-6#1)(1991-8#1)(1992-12#1)(1994-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(2008-10#13)(2008-11#3)(2008-12#3)(2008-8#4)(2009-8#1)(2011-2#1)(2012-3#1)
In compliance##2##2##(2008-4#1)(2008-6#1)
In conclusion we##2##3##(1995-12#1)(2011-2#1)
In conclusion##154##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1993-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-1#4)(2008-10#13)(2008-11#12)(2008-12#6)(2008-3#2)(2008-5#9)(2008-6#1)(2008-7#4)(2008-9#4)(2009-1#1)(2009-11#2)(2009-12#2)(2009-6#1)(2009-8#1)(2010-1#3)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#3)(2011-2#17)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#15)(2013-8#6)
In conjunction with##3##3##(1995-3#1)(2008-10#1)(2012-2#1)
In consequence##2##2##(2008-10#1)(2008-11#1)
In contact with##2##3##(2007-12#1)(2008-10#1)
In contrast the##5##3##(1996-12#2)(2008-11#1)(2012-2#1)(2013-8#1)
In contrast to a##2##4##(1990-10#1)(1992-12#1)
In contrast to earlier##2##4##(1993-6#1)(2008-5#1)
In contrast to other##4##4##(1996-5#1)(2008-11#1)(2009-6#1)(2010-9#1)
In contrast to previous##4##4##(1993-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
In contrast to the##28##4##(1990-10#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2013-2#1)
In contrast to these##2##4##(2008-8#2)
In contrast to this##2##4##(1992-4#1)(1997-3#1)
In contrast to##90##3##(1990-10#2)(1990-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-6#4)(1993-8#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#10)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-6#2)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-2#1)(2013-8#1)
In contrast with##2##3##(1996-8#1)(2009-12#1)
In contrast##427##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#5)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#6)(1994-5#7)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#7)(1995-12#1)(1995-2#11)(1995-5#2)(1995-6#1)(1995-8#4)(1996-11#1)(1996-12#10)(1996-2#7)(1996-5#3)(1996-8#2)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#126)(2008-11#38)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#13)(2008-8#16)(2008-9#11)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#3)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#10)(2012-3#9)(2012-7#1)(2013-1#4)(2013-2#1)(2013-8#5)
In control##6##2##(1994-11#1)(1997-3#1)(2008-11#1)(2008-7#2)(2008-8#1)
In controlled##2##2##(2008-10#2)
In crystals##2##2##(2008-3#2)
In cultured rat##2##3##(1990-12#1)(1993-8#1)
In cultured##4##2##(1990-12#1)(1993-3#1)(1993-8#1)(1995-11#1)
In cultures##2##2##(1993-12#1)(2008-11#1)
In decisions under##2##3##(2009-10#2)
In dermatitis seborrhoeica##2##3##(2008-5#2)
In developed countries##2##3##(1992-6#1)(2008-11#1)
In developing countries##2##3##(2008-10#1)(2008-11#1)
In developing##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
In discussion##2##2##(2008-10#1)(2008-11#1)
In doing so##2##3##(2007-11#1)(2010-8#1)
In doing##3##2##(2007-11#1)(2010-8#1)(2012-2#1)
In each case##6##3##(1990-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
In each experiment##5##3##(2008-10#5)
In each of 2 years##2##5##(2008-10#2)
In each of##5##3##(2008-10#5)
In each orchard##2##3##(2008-10#2)
In each##30##2##(1990-12#1)(1991-6#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#2)
In earlier studies##2##3##(2008-7#1)(2010-7#1)
In earlier##3##2##(2008-7#1)(2008-8#1)(2010-7#1)
In early##4##2##(2008-7#1)(2009-5#1)(2010-12#1)(2013-1#1)
In eight patients##2##3##(1994-9#1)(2008-9#1)
In eight##3##2##(1994-9#1)(1996-9#1)(2008-9#1)
In either##3##2##(1996-1#1)(2008-10#1)(2010-4#1)
In elderly patients##2##3##(1996-2#1)(2008-7#1)
In elderly##3##2##(1996-2#1)(2008-7#1)(2011-2#1)
In essence##2##2##(2008-3#1)(2009-10#1)
In eukaryotes##4##2##(1993-12#1)(1996-2#1)(2008-7#1)(2009-6#1)
In every##2##2##(1993-12#1)(1996-6#1)
In excised##3##2##(2008-10#2)(2013-1#1)
In experiment 1##2##3##(2008-10#1)(2010-8#1)
In experiment##5##2##(2008-10#4)(2010-8#1)
In experimental##2##2##(2008-10#1)(2008-8#1)
In experiments using##2##3##(2008-11#2)
In experiments with a race##2##5##(2008-10#2)
In experiments##7##2##(2008-10#4)(2008-11#3)
In extracellular##2##2##(1994-2#1)(2010-4#1)
In fact##35##2##(1991-12#1)(1991-2#2)(1993-12#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
In females##2##2##(1992-3#1)(2008-10#1)
In field experiments##4##3##(2008-10#3)(2008-8#1)
In field studies##3##3##(2008-10#3)
In field##9##2##(2008-10#8)(2008-8#1)
In first##2##2##(2010-8#1)(2012-3#1)
In five of these##2##4##(2008-9#1)(2013-1#1)
In five of##3##3##(1992-5#1)(2008-9#1)(2013-1#1)
In five##9##2##(1992-5#1)(1993-2#1)(1996-11#2)(1996-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
In four cases##2##3##(1990-9#1)(2008-9#1)
In four of##2##3##(2008-10#1)(2013-8#1)
In four##5##2##(1990-9#1)(1994-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
In free water##2##3##(2008-10#2)
In fresh apples##2##3##(2008-10#2)
In further##2##2##(2008-11#2)
In future studies##2##3##(1992-3#1)(2012-2#1)
In future##5##2##(1992-3#1)(1994-1#1)(2010-6#1)(2012-2#2)
In general the##2##3##(2008-11#1)(2008-2#1)
In general##70##2##(1990-3#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-3#1)(1994-1#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#23)(2008-11#4)(2008-12#3)(2008-2#2)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
In genetically normal##2##3##(2008-7#2)
In genotypes with##2##3##(2008-10#2)
In grapevine leaves##2##3##(2008-10#2)
In greenhouse experiments##4##3##(2008-10#4)
In greenhouse studies with##2##4##(2008-10#2)
In greenhouse studies##5##3##(2008-10#5)
In greenhouse tests##2##3##(2008-10#2)
In greenhouse##13##2##(2008-10#13)
In group 1##2##3##(2011-2#2)
In group B##2##3##(1990-6#1)(2008-5#1)
In group##7##2##(1990-6#1)(2008-5#1)(2011-2#4)(2012-3#1)
In growth chamber experiments##3##4##(2008-10#3)
In growth chamber##4##3##(2008-10#4)
In growth##5##2##(2008-10#4)(2008-5#1)
In growth-chamber##2##2##(2008-10#2)
In healthy skin##2##3##(2008-5#2)
In healthy##4##2##(2008-5#3)(2009-8#1)
In hematopoietic##2##2##(2008-11#1)(2008-5#1)
In higher##3##2##(1990-6#1)(2008-8#1)(2009-10#1)
In highly##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
In his##5##2##(1995-1#1)(1995-6#1)(1996-6#1)(2009-10#1)(2010-5#1)
In human breast cancer##2##4##(1993-1#1)(2011-2#1)
In human##8##2##(1990-12#1)(1993-1#1)(1994-2#1)(1994-8#1)(1995-6#1)(1997-7#1)(2010-1#1)(2011-2#1)
In humans##4##2##(2008-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
In hypertension##2##2##(2009-1#1)(2010-4#1)
In in vitro##2##3##(1991-12#1)(2008-10#1)
In in##7##2##(1991-12#1)(2008-10#6)
In infected##2##2##(2008-10#2)
In inoculated##3##2##(2008-10#3)
In intact##3##2##(1993-12#1)(1994-8#1)(2008-10#1)
In isolated##3##2##(1992-6#1)(1994-11#1)(1996-2#1)
In its##7##2##(1991-12#1)(1993-6#1)(1996-1#1)(2007-12#1)(2008-10#3)
In keeping with other##2##4##(1990-6#1)(2008-12#1)
In keeping with##5##3##(1990-6#1)(1995-6#1)(2008-12#1)(2008-8#1)(2010-4#1)
In laboratory studies##2##3##(2008-10#2)
In laboratory##3##2##(2008-10#3)
In large##2##2##(2008-11#1)(2008-9#1)
In late##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
In later stages##2##3##(2011-2#1)(2013-1#1)
In later##3##2##(2011-2#2)(2013-1#1)
In leaf##2##2##(2008-10#1)(2009-6#1)
In leaves##2##2##(2008-10#2)
In less##2##2##(2008-11#1)(2010-11#1)
In leucine-depleted##2##2##(2008-11#2)
In light of the##7##4##(2008-10#2)(2008-11#2)(2008-8#1)(2009-5#1)(2011-2#1)
In light of##14##3##(1994-1#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
In line with the##3##4##(2008-10#1)(2009-11#1)(2012-2#1)
In line with##6##3##(1995-3#1)(2008-10#1)(2008-8#1)(2009-11#1)(2012-2#2)
In long-term##2##2##(2008-11#1)(2008-5#1)
In low##2##2##(2008-10#1)(2008-11#1)
In major##2##2##(1992-9#1)(2009-8#1)
In making comparisons to national norms##2##6##(1994-3#2)
In making##3##2##(1994-3#2)(2008-11#1)
In male##2##2##(1990-11#1)(2011-2#1)
In males##3##2##(1994-6#1)(2008-10#1)(2008-11#1)
In mammals##2##2##(1997-7#1)(2009-9#1)
In many cases##5##3##(1990-9#1)(1994-2#1)(2008-3#1)(2010-7#1)(2012-3#1)
In many instances##2##3##(1992-5#1)(2013-1#1)
In many ways##2##3##(1995-3#1)(2010-5#1)
In many##22##2##(1990-9#1)(1992-5#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
In men aged##3##3##(2008-7#3)
In mice##6##2##(1994-3#1)(1997-3#1)(2008-10#1)(2008-9#1)(2013-1#2)
In mixed##2##2##(2008-10#2)
In most animals##2##3##(2008-6#1)(2008-8#1)
In most cases##14##3##(1990-12#1)(1993-1#1)(1994-2#1)(1996-11#1)(2008-10#4)(2008-5#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
In most instances##4##3##(1992-1#1)(1997-5#1)(2008-10#2)
In most of the cases##2##5##(2008-10#1)(2008-12#1)
In most of the##6##4##(1995-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
In most of##7##3##(1995-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)
In most patients##2##3##(1990-11#1)(2012-3#1)
In most##46##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-1#1)(1993-1#1)(1994-2#1)(1995-12#2)(1996-11#1)(1997-5#2)(2008-10#14)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
In multiple##2##2##(2008-6#1)(2012-3#1)
In multivariate analyses##2##3##(2008-5#1)(2013-1#1)
In my##2##2##(2009-10#1)(2013-1#1)
In nature##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
In near##2##2##(2008-10#1)(2011-3#1)
In negative##2##2##(1992-12#1)(2008-9#1)
In no case##2##3##(2008-11#1)(2012-2#1)
In no##3##2##(1990-11#1)(2008-11#1)(2012-2#1)
In none of##2##3##(2008-10#1)(2008-4#1)
In normal##4##2##(1991-5#1)(1994-11#1)(1997-2#1)(2010-5#1)
In numerous##2##2##(2008-3#1)(2012-2#1)
In older##3##2##(1990-9#1)(2008-10#1)(2011-2#1)
In one case of##2##4##(1997-3#2)
In one case##5##3##(1990-3#1)(1996-11#1)(1997-3#2)(2008-11#1)
In one field##2##3##(2008-10#2)
In one group##2##3##(1994-8#1)(2013-1#1)
In one of these##2##4##(2008-5#1)(2008-9#1)
In one of##5##3##(1991-3#1)(1991-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
In one patient##4##3##(1997-8#1)(2008-7#1)(2011-3#1)(2012-3#1)
In one##33##2##(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-12#1)(1994-8#1)(1996-1#1)(1996-11#2)(1997-3#2)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
In only one case##2##4##(1997-8#1)(2008-9#1)
In only##4##2##(1993-12#1)(1997-8#1)(2008-9#1)(2010-3#1)
In optical##2##2##(2008-3#2)
In optimized conditions##2##3##(2008-10#2)
In order for##2##3##(2010-11#1)(2012-12#1)
In order to achieve the##2##5##(2008-10#1)(2008-11#1)
In order to achieve##5##4##(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
In order to analyze##2##4##(1992-5#1)(1997-7#1)
In order to assess the##4##5##(1990-5#1)(1991-8#1)(1992-9#1)(2008-10#1)
In order to assess##7##4##(1990-5#1)(1991-8#1)(1992-9#1)(2008-10#2)(2008-7#2)
In order to be##2##4##(1993-12#1)(1997-1#1)
In order to better understand the##2##6##(1993-8#1)(2008-10#1)
In order to characterize the##2##5##(2008-10#1)(2008-11#1)
In order to characterize##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
In order to check the##2##5##(2008-12#1)(2008-5#1)
In order to clarify whether##2##5##(2008-11#1)(2008-5#1)
In order to clarify##3##4##(1991-12#1)(2008-11#1)(2008-5#1)
In order to compare##2##4##(1994-3#1)(1994-5#1)
In order to confirm##2##4##(2008-10#1)(2008-11#1)
In order to control##2##4##(2008-10#1)(2008-11#1)
In order to demonstrate##2##4##(2008-10#1)(2008-12#1)
In order to determine the enantiopurity of##2##7##(2008-10#2)
In order to determine the##6##5##(1990-3#1)(1993-3#1)(2008-10#3)(2008-9#1)
In order to determine whether##2##5##(1994-12#1)(1997-3#1)
In order to determine which##2##5##(1994-2#1)(2008-10#1)
In order to determine##17##4##(1990-2#1)(1990-3#1)(1990-5#1)(1993-3#1)(1994-12#1)(1994-2#1)(1997-3#1)(2008-10#8)(2008-8#1)(2008-9#1)
In order to develop a##4##5##(2008-10#2)(2008-7#1)(2008-8#1)
In order to develop##5##4##(2008-10#3)(2008-7#1)(2008-8#1)
In order to distinguish##2##4##(1997-3#1)(2008-10#1)
In order to elucidate the##5##5##(1992-6#1)(1992-8#1)(2008-10#1)(2008-5#1)(2011-3#1)
In order to enhance##4##4##(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
In order to ensure##2##4##(1997-8#1)(2008-10#1)
In order to eradicate##2##4##(1994-9#2)
In order to establish##3##4##(2008-11#3)
In order to estimate the##2##5##(2008-10#1)(2008-11#1)
In order to evaluate the##4##5##(1993-1#1)(1994-6#1)(2008-7#1)(2011-2#1)
In order to evaluate##5##4##(1993-1#1)(1994-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
In order to examine the##4##5##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
In order to explore the##2##5##(2008-10#1)(2008-9#1)
In order to explore##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
In order to find##3##4##(1997-6#1)(2008-11#1)(2012-3#1)
In order to further verify the accuracy of the developed method##2##11##(2008-10#2)
In order to further##3##4##(2008-10#3)
In order to gain##4##4##(1993-6#1)(2008-10#1)(2008-11#2)
In order to get a##3##5##(2008-10#2)(2013-8#1)
In order to get##5##4##(2008-10#3)(2008-11#1)(2013-8#1)
In order to help##3##4##(2008-11#1)(2008-5#1)(2009-4#1)
In order to identify genes that##2##6##(1992-9#1)(2008-7#1)
In order to identify genes##3##5##(1992-9#1)(1995-11#1)(2008-7#1)
In order to identify##8##4##(1992-9#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-7#1)(2013-8#1)
In order to illustrate##2##4##(2008-10#2)
In order to improve the##6##5##(2008-10#3)(2008-11#3)
In order to improve##10##4##(2008-10#5)(2008-11#4)(2013-8#1)
In order to increase the##2##5##(2008-10#1)(2008-11#1)
In order to increase##5##4##(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)
In order to investigate the relationship between the##2##8##(2008-9#1)(2011-2#1)
In order to investigate the##8##5##(1993-6#1)(1994-8#2)(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)
In order to investigate##14##4##(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-5#1)
In order to make##2##4##(1997-8#1)(2008-10#1)
In order to maximize the##2##5##(2008-10#1)(2008-5#1)
In order to minimize##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
In order to monitor the##2##5##(1991-12#1)(1993-6#1)
In order to obtain a##3##5##(2008-10#1)(2008-5#1)(2009-12#1)
In order to obtain good##2##5##(2008-10#1)(2008-9#1)
In order to obtain the better##2##6##(2008-10#2)
In order to obtain##13##4##(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)
In order to overcome this##2##5##(2008-5#1)(2010-11#1)
In order to overcome##6##4##(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-6#1)
In order to perform##3##4##(2008-10#3)
In order to prevent the##2##5##(1994-9#1)(2008-10#1)
In order to prevent##6##4##(1992-3#1)(1994-9#1)(2008-10#1)(2010-1#1)(2010-4#1)(2013-1#1)
In order to produce##3##4##(1991-12#1)(1994-9#1)(2008-12#1)
In order to provide##3##4##(1990-2#1)(1992-2#1)(1992-6#1)
In order to realize this##2##5##(2008-10#1)(2010-8#1)
In order to reduce the##2##5##(2008-10#1)(2008-11#1)
In order to show##2##4##(2008-10#2)
In order to study the##6##5##(1991-6#1)(1993-3#1)(1994-5#1)(1994-8#1)(2008-8#1)(2008-9#1)
In order to study this##2##5##(1991-12#1)(1993-12#1)
In order to study##10##4##(1991-12#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
In order to test the##3##5##(1991-5#1)(2008-10#1)(2008-5#1)
In order to test##5##4##(1991-5#1)(2008-10#2)(2008-5#1)(2008-7#1)
In order to understand the##6##5##(1994-5#1)(1997-8#1)(2008-10#2)(2008-5#1)(2012-3#1)
In order to understand##7##4##(1994-5#1)(1997-8#1)(2008-10#2)(2008-5#1)(2009-5#1)(2012-3#1)
In order to validate the##4##5##(1997-2#1)(2008-10#2)(2011-2#1)
In order to validate##5##4##(1997-2#1)(2008-10#3)(2011-2#1)
In order to verify the##3##5##(1997-2#1)(2008-10#1)(2008-9#1)
In order to##282##3##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1991-12#4)(1991-5#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#4)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-6#1)(1996-12#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#101)(2008-11#34)(2008-12#9)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#9)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#4)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#3)
In order##286##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1991-12#4)(1991-5#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#4)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-6#1)(1996-12#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#101)(2008-11#35)(2008-12#9)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#9)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#5)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#3)
In other experiments##4##3##(2006-6#1)(2008-10#3)
In other words##8##3##(1994-3#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-8#1)
In other##19##2##(1991-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#1)
In our case##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
In our experience##5##3##(1991-3#1)(1997-3#2)(2008-10#1)(2011-2#1)
In our experiment##4##3##(2008-10#2)(2008-9#1)(2010-8#1)
In our first##2##3##(2008-6#1)(2013-8#1)
In our opinion##4##3##(1990-11#1)(1991-6#1)(1996-11#1)(1997-8#1)
In our patient##2##3##(1995-8#1)(2011-2#1)
In our previous study##3##4##(1993-12#1)(1994-8#1)(2008-11#1)
In our previous##5##3##(1993-12#1)(1994-8#1)(2008-10#2)(2008-11#1)
In our recent paper##2##4##(2009-6#1)(2009-8#1)
In our recent study##2##4##(2009-8#1)(2011-2#1)
In our recent##6##3##(2008-5#1)(2009-6#1)(2009-8#3)(2011-2#1)
In our second##2##3##(2008-6#1)(2008-8#1)
In our series##3##3##(1990-12#1)(1990-6#1)(1991-8#1)
In our study we wanted to##2##6##(2008-10#1)(2011-2#1)
In our study we##5##4##(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
In our study##8##3##(2008-10#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
In our work##2##3##(2008-10#1)(2008-8#1)
In our##67##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-3#2)(1997-8#1)(2008-10#11)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-6#2)(2009-8#4)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-3#1)(2013-1#4)(2013-8#2)
In pH##4##2##(2008-10#4)
In parallel experiments##2##3##(1997-2#1)(2008-7#1)
In parallel to##2##3##(2008-5#1)(2012-3#1)
In parallel with##2##3##(1990-10#1)(1994-2#1)
In parallel##13##2##(1990-10#1)(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2009-6#1)(2012-3#1)
In part I##2##3##(2008-7#2)
In part II##2##3##(2008-7#2)
In part##5##2##(1991-12#1)(2008-7#4)
In particular it##2##3##(1990-9#1)(1993-1#1)
In particular the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
In particular##122##2##(1990-11#1)(1990-8#1)(1990-9#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#21)(2008-11#13)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
In pathogenicity tests##5##3##(2008-10#5)
In patients suffering from##2##4##(2008-1#1)(2011-2#1)
In patients who##2##3##(2010-12#1)(2011-2#1)
In patients with suspected##2##4##(2011-2#1)(2012-2#1)
In patients with##23##3##(1990-2#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-2#1)(1995-10#1)(1996-2#1)(1996-6#1)(2008-11#1)(2009-3#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
In patients##33##2##(1990-2#1)(1990-5#1)(1991-3#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-2#1)(1995-10#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#2)(2010-12#3)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)
In phase##5##2##(2008-5#2)(2010-8#3)
In pilot##2##2##(1995-5#1)(2008-11#1)
In planta##3##2##(2008-10#3)
In plants##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2013-8#1)
In plots##2##2##(2008-10#2)
In populations##2##2##(2008-8#2)
In practice##6##2##(1995-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
In preliminary experiments##2##3##(2008-10#1)(2008-11#1)
In preliminary##4##2##(2008-10#3)(2008-11#1)
In preparation for##2##3##(1994-12#1)(1997-2#1)
In presence##2##2##(2008-10#1)(2011-2#1)
In present study##2##3##(2008-10#1)(2011-1#1)
In previous studies##4##3##(1994-2#1)(1996-12#1)(2008-11#1)(2009-6#1)
In previous##5##2##(1994-2#1)(1995-6#1)(1996-12#1)(2008-11#1)(2009-6#1)
In primary##3##2##(1990-2#1)(1996-2#1)(2011-2#1)
In principle##2##2##(2008-11#1)(2008-2#1)
In pursuit of##2##3##(1996-1#1)(2010-11#1)
In rare cases##3##3##(2008-8#1)(2008-9#1)(2009-1#1)
In rare instances##2##3##(2008-10#2)
In rare##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2009-1#1)
In rats subjected to porta-caval anastomosis##2##6##(1993-3#2)
In rats##3##2##(1992-9#1)(1993-3#2)
In re##4##2##(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)
In reality##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
In recent decades##2##3##(2008-11#1)(2010-10#1)
In recent years it has been##2##6##(1990-11#1)(2008-12#1)
In recent years the##2##4##(1991-6#1)(2008-11#1)
In recent years there has been##2##6##(2008-3#1)(2008-7#1)
In recent years there##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
In recent years##44##3##(1990-11#1)(1991-2#1)(1991-6#1)(1993-1#1)(1993-11#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#2)
In recent##46##2##(1990-11#1)(1991-2#1)(1991-6#1)(1993-1#1)(1993-11#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#2)
In reply##2##2##(1990-11#2)
In resistant##2##2##(2008-10#2)
In response to standing##2##4##(2008-7#2)
In response to the##3##4##(1991-2#1)(2008-12#1)(2008-7#1)
In response to##14##3##(1991-2#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#6)(2012-2#1)
In response##17##2##(1991-2#1)(1996-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#6)(2010-10#1)(2012-2#1)
In rice##2##2##(2008-10#1)(2009-8#1)
In roots##2##2##(2008-10#2)
In samples of##2##3##(2008-11#1)(2013-8#1)
In samples##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
In search of the##3##4##(2008-11#2)(2008-8#1)
In search of##6##3##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#1)
In search##7##2##(1994-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#1)
In select##2##2##(2011-2#1)(2013-1#1)
In selected areas##2##3##(1997-3#1)(2008-10#1)
In selected cases##2##3##(2007-11#1)(2008-1#1)
In selected##5##2##(1994-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)
In separate experiments##5##3##(1995-11#1)(1997-3#1)(2008-10#3)
In separate##7##2##(1995-11#1)(1997-3#1)(2008-10#3)(2008-5#1)(2009-4#1)
In seven##5##2##(1993-2#1)(1996-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
In several cases##2##3##(2008-10#1)(2008-11#1)
In several##6##2##(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#1)
In severe cases##2##3##(2008-10#1)(2013-1#1)
In severe##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
In sharp contrast to the##2##5##(2008-7#1)(2009-8#1)
In short##8##2##(1996-1#1)(1997-2#1)(2008-10#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-2#2)
In similar##2##2##(2008-5#1)(2010-6#1)
In situ hybridization and##2##4##(1997-3#1)(1997-7#1)
In situ hybridization of##2##4##(1995-11#1)(2008-10#1)
In situ hybridization##10##3##(1991-5#1)(1995-11#1)(1996-12#2)(1997-3#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-8#1)
In situ measurements of##2##4##(2008-3#2)
In situ##31##2##(1990-8#1)(1991-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#2)(2010-7#1)(2012-2#1)(2013-8#1)
In six##6##2##(1996-9#2)(1997-8#1)(2008-10#2)(2012-3#1)
In slices of rats pretreated with##2##6##(1995-12#2)
In so doing##3##3##(1991-2#1)(2008-12#2)
In so##4##2##(1991-2#1)(2008-12#2)(2009-10#1)
In sodium dodecyl sulfate-polyacrylamide gel electrophoresis of dissociated purified virus preparations##2##11##(2008-10#2)
In some cases the##2##4##(1991-8#1)(2008-10#1)
In some cases##18##3##(1991-8#1)(1995-12#1)(1995-3#2)(1996-11#1)(2008-10#5)(2008-11#1)(2008-8#3)(2009-8#1)(2010-12#1)(2011-2#2)
In some instances##2##3##(1995-3#1)(2008-9#1)
In some of the##2##4##(1990-12#1)(2008-11#1)
In some patients##2##3##(1997-4#1)(2011-2#1)
In some situations##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
In some studies##2##3##(2008-7#1)(2012-2#1)
In some##40##2##(1990-12#1)(1991-8#1)(1995-12#1)(1995-3#3)(1996-11#1)(1996-2#1)(1997-4#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#2)(2010-12#1)(2011-2#4)(2012-2#1)
In southern##2##2##(2008-10#1)(2009-8#1)
In species##4##2##(1994-8#1)(2008-12#2)(2008-8#1)
In spite of a##2##4##(2008-10#1)(2010-10#1)
In spite of its rarity##2##5##(2008-12#1)(2010-7#1)
In spite of its##3##4##(2008-11#1)(2008-12#1)(2010-7#1)
In spite of the fact that##2##6##(2008-11#2)
In spite of the##7##4##(1991-8#1)(1992-12#1)(1996-8#1)(2008-10#2)(2008-11#2)
In spite of##24##3##(1991-8#1)(1992-12#1)(1993-2#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-7#2)(2009-3#1)(2010-10#1)(2010-7#1)
In spring##3##2##(2008-10#3)
In strong##2##2##(2008-10#2)
In studies##3##2##(2008-10#2)(2012-9#1)
In subsequent##2##2##(2009-4#1)(2011-2#1)
In such a##3##3##(1994-12#1)(2008-10#1)(2013-8#1)
In such cases##6##3##(1990-9#1)(1996-9#1)(1997-4#1)(2008-3#1)(2010-7#1)(2012-3#1)
In such experimental##2##3##(2008-10#1)(2013-8#1)
In such terms##2##3##(2013-1#2)
In such##18##2##(1990-9#1)(1994-12#1)(1996-12#1)(1996-9#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-8#2)
In summary##54##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#2)(1992-6#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#2)(1995-1#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
In summer##2##2##(2008-10#1)(2008-12#1)
In support of the##4##4##(1991-5#1)(1997-1#1)(2008-11#1)(2008-9#1)
In support of this##6##4##(1990-11#1)(1992-4#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-6#1)
In support of##10##3##(1990-11#1)(1991-5#1)(1992-4#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-6#1)
In susceptible##5##2##(2008-10#5)
In systems##2##2##(2008-11#1)(2008-9#1)
In ten patients##2##3##(1993-2#1)(1996-11#1)
In terms of##19##3##(1995-5#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#3)(2012-2#4)(2012-3#3)
In tests with##5##3##(2008-10#4)(2008-11#1)
In tests##6##2##(2008-10#5)(2008-11#1)
In that case##2##3##(2008-7#1)(2008-9#1)
In that##6##2##(1993-3#1)(1995-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)
In the &quot##2##3##(2011-2#2)
In the 1990s##3##3##(1996-2#1)(1996-3#1)(2008-12#1)
In the FCO##2##3##(2008-7#2)
In the Netherlands##2##3##(2008-10#1)(2009-12#1)
In the UK##2##3##(2008-11#1)(2013-8#1)
In the US##2##3##(2013-1#1)(2013-8#1)
In the United States##4##4##(2008-10#2)(2009-12#1)(2011-2#1)
In the United##5##3##(1994-12#1)(2008-10#2)(2009-12#1)(2011-2#1)
In the absence of a##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
In the absence of light##2##5##(1993-8#1)(1994-8#1)
In the absence of nitrate##2##5##(2008-11#2)
In the absence of testosterone##2##5##(1990-11#1)(2012-2#1)
In the absence of the##2##5##(2008-10#1)(2012-2#1)
In the absence of##39##4##(1990-11#1)(1990-2#1)(1991-9#1)(1992-2#1)(1993-6#1)(1993-8#3)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-3#2)(2008-8#4)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#2)
In the absence##40##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-2#1)(1993-6#1)(1993-8#3)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-3#2)(2008-8#4)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-2#2)
In the acidic##2##3##(2008-10#2)
In the adult##2##3##(1994-8#1)(2010-7#1)
In the age group##2##4##(1990-2#1)(2008-7#1)
In the age##3##3##(1990-2#1)(2008-7#2)
In the analysis of##3##4##(2008-10#1)(2008-11#1)(2010-11#1)
In the anterior##2##3##(2008-7#1)(2010-5#1)
In the area of##2##4##(1997-8#1)(2011-2#1)
In the brain##2##3##(1994-2#1)(2008-7#1)
In the business##2##3##(1994-1#1)(1995-2#1)
In the calibration range 0##2##5##(2008-10#2)
In the case of a##3##5##(1991-3#1)(2008-3#2)
In the case of the##12##5##(1990-11#1)(2008-10#7)(2008-3#1)(2008-5#2)(2010-4#1)
In the case of##56##4##(1990-11#2)(1990-5#1)(1991-3#1)(1992-5#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-3#1)(1997-6#2)(2006-6#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#1)(2012-2#1)(2013-1#2)
In the case##57##3##(1990-11#2)(1990-5#1)(1991-3#1)(1992-5#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-3#1)(1997-6#2)(2006-6#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#1)(2012-2#1)(2013-1#2)
In the cases##2##3##(1993-8#1)(2008-10#1)
In the central nervous system##3##5##(2008-11#2)(2008-7#1)
In the ceramide##2##3##(2008-5#2)
In the competitive assay##2##4##(2008-10#2)
In the complex##2##3##(1994-5#1)(2008-10#1)
In the context of a##2##5##(1996-2#1)(2008-11#1)
In the context of##7##4##(1994-1#1)(1996-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)
In the control group##5##4##(2008-1#1)(2008-11#1)(2011-1#2)(2012-3#1)
In the control##6##3##(2008-1#1)(2008-11#1)(2011-1#2)(2012-2#1)(2012-3#1)
In the course of screening##2##5##(2008-11#2)
In the course of##11##4##(1993-2#1)(1995-5#1)(2008-10#1)(2008-11#4)(2008-6#1)(2012-2#1)(2013-1#2)
In the current study we##2##5##(2008-11#1)(2012-3#1)
In the current study##16##4##(1995-2#1)(2008-10#7)(2008-11#5)(2010-6#1)(2012-3#1)(2013-8#1)
In the current##22##3##(1995-2#1)(1996-12#1)(2008-10#7)(2008-11#6)(2008-5#1)(2010-10#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-8#2)
In the dermal##2##3##(2008-5#1)(2008-7#1)
In the detection of##2##4##(2008-10#1)(2013-8#1)
In the development of##3##4##(1995-5#1)(2008-10#1)(2008-11#1)
In the early 1970s##3##4##(1994-3#2)(2008-11#1)
In the early##7##3##(1994-3#2)(2008-11#1)(2008-12#2)(2008-6#1)(2011-2#1)
In the event of a##2##5##(1990-9#1)(2008-7#1)
In the event of##6##4##(1990-3#1)(1990-9#1)(1997-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
In the event##7##3##(1990-3#1)(1990-9#1)(1997-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)
In the fall of##3##4##(1991-2#1)(2008-3#1)(2011-9#1)
In the fed-batch##2##3##(2008-7#1)(2013-1#1)
In the field of##2##4##(2008-7#1)(2008-8#1)
In the field##13##3##(2008-10#10)(2008-7#1)(2008-8#2)
In the fifth##2##3##(1995-5#1)(2008-11#1)
In the final##4##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-4#1)
In the first approach##2##4##(2008-10#1)(2008-3#1)
In the first case##5##4##(1991-2#1)(2008-10#1)(2008-12#1)(2010-7#1)(2011-2#1)
In the first experiment##4##4##(1996-12#1)(2008-10#3)
In the first group##3##4##(2011-2#1)(2013-1#2)
In the first part of this review##2##7##(2008-10#1)(2012-2#1)
In the first part of this##3##6##(2008-10#2)(2012-2#1)
In the first part##4##4##(2008-10#2)(2012-2#1)(2013-8#1)
In the first section##2##4##(1992-6#1)(2008-4#1)
In the first step##2##4##(2008-10#2)
In the first system##2##4##(2008-10#1)(2008-11#1)
In the first type##2##4##(2008-10#2)
In the first##52##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-11#1)(1991-2#2)(1992-6#1)(1993-2#2)(1995-2#1)(1996-12#1)(1996-3#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
In the flow##2##3##(2008-10#2)
In the following##3##3##(1997-3#2)(2012-3#1)
In the former##7##3##(1990-6#1)(2008-10#2)(2010-4#1)(2012-2#3)
In the fourth##2##3##(2008-10#1)(2013-1#1)
In the future##10##3##(1991-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
In the gas##2##3##(2008-10#1)(2008-3#1)
In the greenhouse##3##3##(2008-10#3)
In the group of##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
In the group with##3##4##(1992-1#1)(1995-2#1)(1997-8#1)
In the group##10##3##(1992-1#1)(1993-8#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-12#1)(2011-2#3)(2013-1#1)
In the growth chamber##2##4##(2008-10#2)
In the growth##3##3##(1990-12#1)(2008-10#2)
In the hot plate test##2##5##(1992-3#1)(1996-2#1)
In the in##2##3##(1994-5#2)
In the initial##2##3##(2008-12#1)(2010-2#1)
In the interim##2##3##(2008-11#1)(2012-2#1)
In the investigated##2##3##(1990-2#1)(2007-12#1)
In the last 10 years##3##5##(1992-5#1)(1995-9#1)(2011-1#1)
In the last decade##4##4##(1995-12#1)(2009-10#1)(2011-2#1)(2012-2#1)
In the last few years##7##5##(1990-11#1)(1991-3#2)(1994-9#1)(2008-11#1)(2008-5#1)(2010-12#1)
In the last few##8##4##(1990-11#1)(1991-3#2)(1994-9#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
In the last three##2##4##(2009-4#1)(2011-2#1)
In the last two decades##2##5##(2008-8#1)(2011-2#1)
In the last years##3##4##(2009-10#1)(2011-2#2)
In the last##33##3##(1990-11#1)(1991-3#2)(1992-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#1)
In the late##2##3##(2008-10#1)(2008-12#1)
In the latter case##10##4##(1991-2#1)(1991-8#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-8#1)
In the latter##17##3##(1991-2#1)(1991-8#1)(1993-2#1)(1993-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2012-2#1)(2013-8#1)
In the light of the##2##5##(1995-12#1)(2010-7#1)
In the light of##4##4##(1992-12#1)(1995-12#1)(2008-11#1)(2010-7#1)
In the lipid peroxidation assay##2##5##(2008-11#1)(2008-5#1)
In the literature##3##3##(1990-5#1)(2008-10#2)
In the majority of cases the##2##6##(1997-4#1)(2008-9#1)
In the majority of cases##5##5##(1997-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
In the majority of##9##4##(1995-2#1)(1997-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
In the male##2##3##(2010-5#1)(2011-1#1)
In the meantime##4##3##(1992-3#1)(1996-11#1)(2011-2#1)(2013-8#1)
In the medium of##2##4##(1991-5#1)(2008-10#1)
In the medium##3##3##(1991-5#1)(1992-6#1)(2008-10#1)
In the method##2##3##(2008-10#1)(2008-11#1)
In the model##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
In the modern##2##3##(2008-10#1)(2013-1#1)
In the most##2##3##(2008-10#1)(2008-8#1)
In the mouse##2##3##(1997-2#1)(2012-12#1)
In the next step we##2##5##(2008-10#1)(2008-7#1)
In the next##4##3##(1996-3#1)(2008-10#1)(2008-7#1)(2010-9#1)
In the non-treated specimen of the##2##6##(2008-10#2)
In the northern##2##3##(2008-10#1)(2010-8#1)
In the only##2##3##(2008-5#1)(2010-10#1)
In the optimization studies of the biosensor##2##7##(2008-10#2)
In the optimization studies##3##4##(2008-10#3)
In the optimization##5##3##(2008-10#5)
In the optimized##2##3##(2008-10#2)
In the optimum conditions##3##4##(2008-10#3)
In the other two##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
In the other##6##3##(1991-5#1)(1996-3#1)(2008-10#2)(2008-7#1)(2013-1#1)
In the ovary##2##3##(1995-12#1)(2008-6#1)
In the paper##4##3##(2008-11#1)(2010-8#1)(2011-3#1)(2013-8#1)
In the past decade##6##4##(1991-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#1)
In the past few years##2##5##(2008-4#1)(2008-5#1)
In the past##22##3##(1990-12#1)(1991-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
In the period##2##3##(2007-11#1)(2013-8#1)
In the postnatal##2##3##(1990-5#1)(1994-11#1)
In the prepubertal##2##3##(2011-1#1)(2012-2#1)
In the presence of 0##2##5##(2008-10#1)(2008-11#1)
In the presence of 2##2##5##(1995-8#1)(1996-2#1)
In the presence of a##6##5##(1990-10#1)(2008-10#3)(2008-11#1)(2012-3#1)
In the presence of an##2##5##(2008-10#1)(2010-12#1)
In the presence of low##2##5##(1995-3#1)(2008-5#1)
In the presence of sodium##2##5##(2008-10#2)
In the presence of the##3##5##(1995-6#1)(1997-4#1)(2008-12#1)
In the presence of##65##4##(1990-10#1)(1990-11#1)(1990-2#2)(1991-7#1)(1992-9#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#4)(1996-2#2)(1997-4#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-12#1)(2011-2#1)(2012-3#2)
In the present article##6##4##(2008-10#1)(2008-11#3)(2010-1#1)(2010-10#1)
In the present case##2##4##(2010-6#1)(2011-2#1)
In the present experiments##2##4##(1993-3#1)(2008-5#1)
In the present investigation##6##4##(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
In the present method##2##4##(2008-10#2)
In the present paper we##5##5##(1991-9#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-2#1)
In the present paper##25##4##(1990-8#1)(1991-9#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
In the present report##3##4##(2008-11#1)(2011-2#2)
In the present review##5##4##(1994-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
In the present study a##3##5##(2008-10#2)(2008-12#1)
In the present study an##2##5##(1990-6#1)(2008-11#1)
In the present study the##3##5##(1991-8#1)(1996-2#1)(2008-10#1)
In the present study we evaluated the##2##7##(1992-12#1)(1997-2#1)
In the present study we have investigated##2##7##(1994-2#1)(1995-12#1)
In the present study we have##7##6##(1994-2#1)(1995-12#2)(1996-12#1)(2009-7#1)(2010-7#1)(2012-3#1)
In the present study we investigated the effect of##2##9##(1996-2#1)(2008-7#1)
In the present study we investigated the##5##7##(1996-2#1)(1997-1#1)(1997-2#1)(2008-7#1)(2013-8#1)
In the present study we investigated##6##6##(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-7#1)(2013-8#1)
In the present study we##21##5##(1992-12#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#2)(2008-7#2)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
In the present study##134##4##(1990-11#2)(1990-6#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-8#4)(1995-11#2)(1995-12#5)(1995-2#3)(1995-8#2)(1996-12#2)(1996-2#6)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(2008-10#19)(2008-11#18)(2008-12#5)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#2)(2009-7#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#8)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
In the present work a##2##5##(2008-10#1)(2009-10#1)
In the present work the##2##5##(2008-10#2)
In the present work we##2##5##(2008-10#1)(2011-2#1)
In the present work##38##4##(1992-10#1)(1992-3#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#28)(2009-10#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-3#1)
In the present##234##3##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-8#5)(1995-11#3)(1995-12#5)(1995-2#4)(1995-8#2)(1996-12#2)(1996-2#8)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(2007-12#1)(2008-10#66)(2008-11#28)(2008-12#6)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#14)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#6)(2013-8#1)
In the presentstudy##3##3##(2008-11#3)
In the process of##5##4##(1997-8#1)(2008-10#2)(2008-8#1)(2013-8#1)
In the process##7##3##(1997-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2013-8#1)
In the proposed##2##3##(2008-10#2)
In the range of##4##4##(1994-11#1)(1994-12#1)(1997-6#1)(2008-11#1)
In the range##5##3##(1994-11#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-11#1)
In the rat##3##3##(1990-5#1)(1995-11#1)(2008-4#1)
In the recent past##2##4##(2008-10#1)(2008-11#1)
In the recent years##3##4##(2008-12#1)(2012-2#1)(2012-3#1)
In the recent##6##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
In the region##2##3##(2008-10#2)
In the regression model##2##4##(2008-10#1)(2010-4#1)
In the remaining 52 wards##2##5##(2013-1#2)
In the remaining##6##3##(1993-12#1)(1994-9#1)(1995-11#1)(2008-7#1)(2013-1#2)
In the review##2##3##(2012-3#2)
In the same##11##3##(1991-8#1)(1993-3#1)(1993-6#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-8#1)(2012-2#1)
In the search for##3##4##(2008-11#1)(2008-8#1)(2013-1#1)
In the second approach##2##4##(1995-2#1)(2008-3#1)
In the second case##2##4##(2008-10#1)(2011-2#1)
In the second experiment##5##4##(1996-12#1)(2008-10#3)(2008-3#1)
In the second method##2##4##(2008-10#2)
In the second part of##2##5##(1997-4#1)(2008-11#1)
In the second part##6##4##(1997-4#1)(2008-10#1)(2008-11#2)(2009-5#1)(2013-8#1)
In the second period##3##4##(2011-2#3)
In the second phase##2##4##(2008-4#1)(2008-6#1)
In the second section##5##4##(1991-1#1)(1992-6#1)(2008-4#1)(2012-2#2)
In the second##44##3##(1990-12#1)(1991-1#1)(1991-6#1)(1992-6#1)(1993-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-4#1)(2008-10#11)(2008-11#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#4)(2012-2#2)(2013-8#1)
In the selected conditions##2##4##(2008-10#2)
In the selected##3##3##(2008-10#3)
In the serum-free##2##3##(2008-11#1)(2008-4#1)
In the simulations##2##3##(2008-10#1)(2008-3#1)
In the spring of 2000##2##5##(2008-10#2)
In the spring##3##3##(2008-10#3)
In the standard##2##3##(1996-2#1)(2008-8#1)
In the studied##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
In the studies##3##3##(1994-8#1)(2008-10#2)
In the study##7##3##(1990-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-8#1)
In the subjects##2##3##(1991-2#1)(2008-5#1)
In the summer of##2##4##(1997-1#1)(2008-11#1)
In the system##2##3##(1993-8#1)(2008-10#1)
In the third and##2##4##(2008-10#1)(2012-2#1)
In the third experiment##2##4##(2008-10#2)
In the third year##2##4##(2008-10#2)
In the third##8##3##(2008-10#5)(2008-11#1)(2008-5#1)(2012-2#1)
In the three##2##3##(1992-5#1)(2008-9#1)
In the treatment of##3##4##(1990-9#1)(1992-11#1)(1993-11#1)
In the two##3##3##(1996-9#1)(2008-10#1)(2011-3#1)
In the volunteer##2##3##(1993-2#1)(2008-5#1)
In the wheat rhizosphere##2##4##(2008-10#2)
In the work##4##3##(2008-10#3)(2011-2#1)
In the year after random assignment##2##6##(2013-1#2)
In the years##2##3##(1997-8#1)(2008-5#1)
In the##1320##2##(1990-10#1)(1990-11#13)(1990-12#6)(1990-2#8)(1990-3#2)(1990-5#10)(1990-6#2)(1990-8#1)(1990-9#5)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#13)(1991-3#5)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#5)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#6)(1993-3#4)(1993-6#4)(1993-8#10)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#4)(1994-2#8)(1994-3#4)(1994-5#8)(1994-6#3)(1994-8#13)(1994-9#2)(1995-1#1)(1995-11#6)(1995-12#12)(1995-2#12)(1995-3#2)(1995-5#5)(1995-6#1)(1995-8#7)(1995-9#2)(1996-1#4)(1996-11#4)(1996-12#9)(1996-2#21)(1996-3#7)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#7)(1997-3#7)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#5)(2006-6#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-1#5)(2008-10#360)(2008-11#111)(2008-12#29)(2008-2#2)(2008-3#22)(2008-4#10)(2008-5#40)(2008-6#9)(2008-7#50)(2008-8#35)(2008-9#26)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#4)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#6)(2009-7#4)(2009-8#6)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#6)(2010-8#7)(2010-9#2)(2011-1#6)(2011-2#64)(2011-3#3)(2011-9#1)(2012-12#4)(2012-2#36)(2012-3#17)(2012-4#3)(2012-7#1)(2013-1#42)(2013-8#17)
In their##5##2##(1990-9#1)(1991-3#1)(1994-2#1)(2008-7#1)(2011-2#1)
In these cases the##3##4##(1997-6#1)(2008-10#1)(2008-9#1)
In these cases##5##3##(1997-6#1)(2008-10#2)(2008-7#1)(2008-9#1)
In these cells##5##3##(1990-2#1)(1990-5#1)(1991-5#1)(1994-11#1)(2008-7#1)
In these circumstances##3##3##(1993-12#1)(1994-8#1)(2008-11#1)
In these conditions a##2##4##(2008-10#2)
In these conditions##8##3##(1995-2#1)(2008-10#5)(2008-7#2)
In these patients##6##3##(1990-12#1)(1990-5#1)(1990-6#1)(1992-12#1)(2011-2#2)
In these plants##2##3##(2008-10#2)
In these studies##4##3##(1993-3#1)(1995-11#1)(2008-10#1)(2010-6#1)
In these two##2##3##(1997-8#1)(2008-10#1)
In these##66##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-11#2)(1995-2#1)(1996-11#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-8#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-3#2)
In this addendum we propose##2##5##(2009-8#2)
In this addendum we##4##4##(2009-8#4)
In this addendum##6##3##(2009-8#6)
In this approach##2##3##(1996-12#1)(2008-10#1)
In this article I##2##4##(1992-2#1)(2009-6#1)
In this article we describe##2##5##(1994-1#1)(2010-7#1)
In this article we discuss##2##5##(1992-12#1)(2011-2#1)
In this article we present a##2##6##(1990-9#1)(2008-11#1)
In this article we present##5##5##(1990-9#1)(2008-11#2)(2009-1#1)(2010-12#1)
In this article we review the##2##6##(2008-10#1)(2010-12#1)
In this article we##16##4##(1990-9#1)(1992-12#2)(1994-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#1)
In this article##167##3##(1990-11#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-2#4)(1991-3#4)(1992-1#2)(1992-12#7)(1992-2#6)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#3)(1995-1#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#18)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#12)(2008-9#8)(2009-1#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#5)(2011-2#10)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
In this assay##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
In this case report##2##4##(2010-10#1)(2011-2#1)
In this case study##2##4##(1993-1#1)(1996-1#1)
In this case the##3##4##(1995-12#1)(2008-10#1)(2008-3#1)
In this case there##2##4##(1995-5#1)(2008-7#1)
In this case##45##3##(1991-2#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
In this chapter##4##3##(2009-10#1)(2010-5#2)(2013-1#1)
In this communication##3##3##(1991-5#1)(1994-11#1)(1996-3#1)
In this condition##2##3##(1997-1#1)(2008-11#1)
In this context##21##3##(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#1)
In this cross-sectional study##2##4##(2010-4#1)(2013-1#1)
In this exercise##2##3##(2008-10#2)
In this experiment##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
In this investigation##11##3##(1994-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-9#1)(2012-12#1)
In this issue of##2##4##(2009-9#1)(2013-1#1)
In this issue##3##3##(2009-9#1)(2013-1#2)
In this manuscript##5##3##(2009-1#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
In this method the##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
In this method##18##3##(2007-11#1)(2008-10#15)(2008-3#2)
In this mini-review##2##3##(2008-10#1)(2012-3#1)
In this model##6##3##(1991-9#1)(2008-3#1)(2008-5#2)(2008-8#2)
In this new##3##3##(1993-12#1)(2008-10#1)(2013-8#1)
In this overview##2##3##(2008-11#1)(2011-1#1)
In this paper I##2##4##(1995-12#1)(1995-9#1)
In this paper a method##2##5##(2008-10#2)
In this paper a##5##4##(2008-10#5)
In this paper an##2##4##(2008-10#2)
In this paper the##7##4##(1992-9#2)(1993-3#1)(2008-10#2)(2008-12#1)(2011-3#1)
In this paper we are going to have a bird's eye view on some articles published on this topic##2##19##(2013-1#2)
In this paper we describe a##2##6##(1990-12#1)(2008-10#1)
In this paper we describe the application of the dual grid##2##11##(2013-1#2)
In this paper we describe##5##5##(1990-12#1)(2008-10#1)(2012-2#1)(2013-1#2)
In this paper we discuss##3##5##(1995-9#1)(2008-10#2)
In this paper we focus##2##5##(2008-11#1)(2010-10#1)
In this paper we introduce##2##5##(2010-10#1)(2013-8#1)
In this paper we present##5##5##(1995-8#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
In this paper we propose##2##5##(2008-5#1)(2013-8#1)
In this paper we report##2##5##(2008-11#1)(2012-2#1)
In this paper we review the##2##6##(2008-11#1)(2009-7#1)
In this paper we review##3##5##(2008-11#1)(2009-7#1)(2012-2#1)
In this paper we##38##4##(1990-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-10#2)(2011-2#1)(2012-2#3)(2013-1#5)(2013-8#5)
In this paper##231##3##(1990-12#1)(1991-12#1)(1991-3#1)(1992-9#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#91)(2008-11#21)(2008-12#10)(2008-5#1)(2008-6#7)(2008-7#1)(2008-9#2)(2009-10#3)(2009-3#4)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#5)(2011-3#3)(2012-2#6)(2012-3#3)(2013-1#11)(2013-8#8)
In this preliminary investigation##3##4##(2008-9#2)(2011-2#1)
In this preliminary##4##3##(2008-10#1)(2008-9#2)(2011-2#1)
In this present##2##3##(2008-10#1)(2008-8#1)
In this procedure##2##3##(2008-10#1)(2008-4#1)
In this process##2##3##(2008-9#1)(2011-2#1)
In this prospective study##2##4##(2008-12#1)(2012-3#1)
In this prospective##6##3##(2008-12#2)(2011-2#3)(2012-3#1)
In this publication##4##3##(2008-10#1)(2008-11#2)(2013-1#1)
In this reaction##2##3##(2008-10#2)
In this regard##10##3##(1992-5#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2010-1#1)
In this report the##2##4##(1994-11#1)(2008-5#1)
In this report we demonstrate that##2##6##(1992-7#1)(1993-8#1)
In this report we describe##4##5##(1990-8#1)(1997-9#1)(2012-3#2)
In this report we have##2##5##(1990-5#1)(1996-3#1)
In this report we##13##4##(1990-5#1)(1990-8#1)(1991-3#1)(1992-7#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-9#1)(2008-12#1)(2008-7#1)(2012-3#3)
In this report##40##3##(1990-5#1)(1990-8#1)(1991-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-8#2)(1994-11#1)(1995-2#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#3)(2013-1#1)
In this research we##2##4##(2008-12#1)(2010-1#1)
In this research##9##3##(2008-10#2)(2008-12#4)(2008-9#1)(2010-1#1)(2011-2#1)
In this respect##7##3##(1991-6#1)(2008-10#1)(2008-11#2)(2011-7#1)(2012-12#1)(2013-1#1)
In this retrospective study##2##4##(2007-8#1)(2011-2#1)
In this retrospective##4##3##(1996-11#1)(2007-8#1)(2011-2#2)
In this review article we##2##5##(2008-11#1)(2012-3#1)
In this review article##5##4##(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
In this review the##5##4##(2007-12#1)(2008-11#2)(2009-12#1)(2011-2#1)
In this review we describe the##2##6##(2009-7#1)(2013-1#1)
In this review we describe##3##5##(2009-7#1)(2012-2#1)(2013-1#1)
In this review we focus on##2##6##(2010-10#1)(2012-2#1)
In this review we will discuss the##2##7##(2009-3#1)(2010-10#1)
In this review we will##4##5##(2008-11#1)(2009-3#1)(2010-10#1)(2011-1#1)
In this review we##22##4##(2008-10#1)(2008-11#3)(2008-7#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#1)
In this review##96##3##(1996-11#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#12)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#2)(2010-5#2)(2010-7#4)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#6)
In this scheme##2##3##(1994-12#1)(2009-7#1)
In this second##2##3##(1994-1#1)(1994-3#1)
In this sense##2##3##(2008-10#2)
In this series##3##3##(1994-12#1)(1995-8#1)(2011-2#1)
In this setting##2##3##(1995-5#1)(2012-2#1)
In this short##2##3##(2011-2#1)(2013-1#1)
In this small##2##3##(1996-9#1)(2008-11#1)
In this species##2##3##(2008-6#1)(2008-8#1)
In this study a##3##4##(2008-10#3)
In this study it was shown that##2##7##(1994-11#1)(1996-12#1)
In this study the##13##4##(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-3#1)(2012-2#1)(2012-3#1)
In this study two##2##4##(2008-10#1)(2008-5#1)
In this study we examined the effects of##2##8##(1995-8#1)(2009-7#1)
In this study we examined##3##5##(1995-8#1)(2009-7#1)(2010-7#1)
In this study we have used##2##6##(1996-12#1)(2008-7#1)
In this study we have##5##5##(1992-10#1)(1996-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
In this study we investigated##3##5##(2008-11#1)(2010-6#1)(2012-7#1)
In this study we show that##3##6##(1990-5#1)(1993-8#1)(1995-9#1)
In this study we use a##2##6##(2008-10#1)(2008-7#1)
In this study we used##2##5##(2008-12#1)(2012-2#1)
In this study we##36##4##(1990-11#1)(1990-5#1)(1991-3#1)(1992-10#1)(1993-11#1)(1993-8#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-7#2)(2009-7#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-5#1)(2012-7#1)(2013-1#2)
In this study##366##3##(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#4)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#9)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#3)(2007-12#2)(2008-1#1)(2008-10#97)(2008-11#38)(2008-12#16)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#9)(2009-10#3)(2009-11#3)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#5)(2011-1#4)(2011-10#1)(2011-2#20)(2011-3#1)(2012-12#3)(2012-2#16)(2012-3#11)(2012-5#2)(2012-7#1)(2013-1#9)(2013-8#2)
In this survey##2##3##(1993-2#1)(2008-10#1)
In this system##12##3##(2008-10#9)(2008-11#2)(2008-7#1)
In this technique##2##3##(2008-10#1)(2008-3#1)
In this tutorial##3##3##(1993-12#1)(1993-3#1)(1994-12#1)
In this unit##24##3##(2008-2#2)(2008-4#17)(2008-9#5)
In this view##2##3##(2008-11#2)
In this way a##3##4##(1990-9#1)(1992-6#1)(2008-8#1)
In this way the##2##4##(2008-10#1)(2008-2#1)
In this way we##4##4##(2007-8#1)(2008-11#1)(2008-3#2)
In this way##36##3##(1990-9#1)(1992-6#1)(1993-3#1)(1996-1#1)(1996-11#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)
In this work a new##2##5##(2008-10#2)
In this work a##5##4##(2008-10#4)(2011-2#1)
In this work the##5##4##(2008-10#4)(2008-5#1)
In this work we have studied##2##6##(1990-5#1)(2008-11#1)
In this work we##15##4##(1990-5#1)(2008-10#6)(2008-11#4)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
In this work##129##3##(1990-5#1)(1992-11#1)(1995-6#1)(1997-2#1)(2008-10#91)(2008-11#8)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#4)(2011-3#2)(2012-2#2)(2012-3#2)(2013-8#1)
In this##1418##2##(1990-11#2)(1990-12#3)(1990-5#5)(1990-8#2)(1990-9#2)(1991-1#7)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#7)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#6)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#9)(1993-2#4)(1993-3#8)(1993-6#3)(1993-8#8)(1994-1#4)(1994-11#4)(1994-12#9)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#4)(1995-1#2)(1995-11#3)(1995-12#5)(1995-2#9)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#5)(1995-9#4)(1996-1#6)(1996-11#3)(1996-12#13)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#2)(1997-3#4)(1997-5#1)(1997-7#2)(1997-8#6)(1997-9#1)(2006-6#1)(2007-11#2)(2007-12#7)(2007-8#3)(2008-1#6)(2008-10#404)(2008-11#124)(2008-12#40)(2008-2#4)(2008-3#18)(2008-4#21)(2008-5#18)(2008-6#15)(2008-7#33)(2008-8#28)(2008-9#41)(2009-1#4)(2009-10#9)(2009-11#3)(2009-12#5)(2009-3#12)(2009-5#6)(2009-6#4)(2009-7#12)(2009-8#15)(2009-9#5)(2010-1#9)(2010-10#8)(2010-11#10)(2010-12#11)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#9)(2010-6#10)(2010-7#11)(2010-8#14)(2010-9#8)(2011-1#10)(2011-10#1)(2011-2#72)(2011-3#8)(2011-7#1)(2012-12#8)(2012-2#42)(2012-3#34)(2012-5#2)(2012-7#2)(2013-1#40)(2013-2#1)(2013-7#1)(2013-8#23)
In those patients who##2##4##(2012-3#2)
In those patients##3##3##(2011-2#1)(2012-3#2)
In those undergoing##2##3##(2008-7#2)
In those##7##2##(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#2)
In three of four##2##4##(2008-10#2)
In three of##4##3##(2008-10#4)
In three patients##4##3##(1993-2#1)(1996-11#1)(1997-5#1)(2013-1#1)
In three##13##2##(1993-2#1)(1994-12#1)(1996-11#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2013-1#1)
In total##20##2##(1993-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-10#1)(2011-2#2)(2012-3#2)(2013-1#3)
In turn##8##2##(1993-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
In twelve##2##2##(1991-6#1)(2008-8#1)
In two experiments##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
In two field trials##2##4##(2008-10#2)
In two of##2##3##(2008-10#1)(2013-1#1)
In two patients##2##3##(1990-3#1)(1996-9#1)
In two separate##2##3##(2008-10#1)(2008-5#1)
In two##27##2##(1990-3#1)(1991-12#1)(1992-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-8#1)(1996-9#1)(2008-10#10)(2008-12#2)(2008-5#3)(2009-4#1)(2011-2#1)(2013-1#2)
In type##2##2##(2008-8#1)(2011-2#1)
In uncomplicated##3##2##(1990-9#1)(2010-12#1)(2011-3#1)
In untreated##4##2##(1991-11#1)(1995-12#1)(2008-10#2)
In view of the increasing##2##5##(1990-11#1)(2010-5#1)
In view of the##14##4##(1990-11#1)(1991-6#1)(1992-3#1)(1994-1#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)
In view of these findings##2##5##(1994-3#1)(2007-12#1)
In view of these##4##4##(1994-3#1)(1995-11#1)(2007-12#1)(2008-10#1)
In view of##23##3##(1990-11#1)(1990-6#1)(1991-6#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-11#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-3#1)
In vitro analysis of##2##4##(1995-2#1)(2008-1#1)
In vitro and in vivo evaluation of##2##7##(2008-5#1)(2011-2#1)
In vitro and in vivo##7##5##(2008-5#3)(2011-2#2)(2012-12#1)(2013-1#1)
In vitro antifungal susceptibility##2##4##(2008-5#2)
In vitro culture##2##3##(2008-11#2)
In vitro effects of##2##4##(1995-9#1)(2013-1#1)
In vitro experiments##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
In vitro expression##2##3##(1995-8#1)(2008-10#1)
In vitro immunization##4##3##(2008-11#4)
In vitro incubation##2##3##(1990-2#1)(2008-10#1)
In vitro metabolism##2##3##(1990-11#1)(1990-6#1)
In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells##2##24##(2008-11#2)
In vitro protein##2##3##(1993-12#1)(1995-3#1)
In vitro selection##2##3##(2008-4#2)
In vitro stimulation##2##3##(2008-5#1)(2011-2#1)
In vitro studies demonstrated that the##2##6##(2008-11#1)(2011-2#1)
In vitro studies demonstrated that##3##5##(2008-11#1)(2011-2#1)(2013-1#1)
In vitro studies demonstrated##4##4##(1994-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
In vitro studies have shown##2##5##(1997-1#1)(2008-5#1)
In vitro studies have##3##4##(1997-1#1)(2008-5#2)
In vitro studies##9##3##(1994-2#1)(1996-12#1)(1997-1#1)(2008-11#2)(2008-5#2)(2011-2#1)(2013-1#1)
In vitro translated##2##3##(1991-7#1)(1995-2#1)
In vitro##115##2##(1990-11#1)(1990-2#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-9#1)(1994-2#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#2)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#17)(2008-11#17)(2008-12#2)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-7#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)
In vivo and in vitro##3##5##(1994-5#1)(2008-5#1)(2013-1#1)
In vivo response##2##3##(1994-8#1)(2008-11#1)
In vivo##38##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2008-10#3)(2008-11#4)(2008-5#3)(2008-7#2)(2009-10#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
In weakly acidic##2##3##(2008-10#2)
In western##2##2##(2008-10#1)(2009-10#1)
In women##3##2##(1991-8#1)(1994-2#1)(2008-5#1)
In yeast##2##2##(1990-5#1)(2008-11#1)
In young##3##2##(1995-3#1)(2013-1#1)(2013-7#1)
In##7811##1##(1990-10#4)(1990-11#42)(1990-12#27)(1990-2#26)(1990-3#15)(1990-4#1)(1990-5#37)(1990-6#19)(1990-7#1)(1990-8#15)(1990-9#27)(1991-1#15)(1991-10#5)(1991-11#12)(1991-12#40)(1991-2#47)(1991-3#30)(1991-5#26)(1991-6#26)(1991-7#3)(1991-8#17)(1991-9#12)(1992-1#7)(1992-10#2)(1992-11#5)(1992-12#33)(1992-2#20)(1992-3#19)(1992-4#5)(1992-5#16)(1992-6#23)(1992-7#1)(1992-8#4)(1992-9#14)(1993-1#21)(1993-11#15)(1993-12#55)(1993-2#30)(1993-3#34)(1993-6#30)(1993-8#40)(1993-9#8)(1994-1#13)(1994-11#27)(1994-12#42)(1994-2#46)(1994-3#27)(1994-5#28)(1994-6#15)(1994-8#45)(1994-9#17)(1995-1#11)(1995-10#1)(1995-11#45)(1995-12#53)(1995-2#69)(1995-3#21)(1995-5#20)(1995-6#36)(1995-8#34)(1995-9#12)(1996-1#29)(1996-11#29)(1996-12#69)(1996-2#58)(1996-3#24)(1996-5#17)(1996-6#18)(1996-8#9)(1996-9#16)(1997-1#36)(1997-2#45)(1997-3#43)(1997-4#17)(1997-5#13)(1997-6#15)(1997-7#30)(1997-8#40)(1997-9#3)(2006-6#5)(2007-11#16)(2007-12#45)(2007-8#6)(2008-1#32)(2008-10#2108)(2008-11#597)(2008-12#173)(2008-2#19)(2008-3#110)(2008-4#73)(2008-5#212)(2008-6#56)(2008-7#252)(2008-8#204)(2008-9#205)(2009-1#10)(2009-10#40)(2009-11#11)(2009-12#26)(2009-3#27)(2009-4#8)(2009-5#24)(2009-6#35)(2009-7#31)(2009-8#70)(2009-9#14)(2010-1#34)(2010-10#29)(2010-11#31)(2010-12#44)(2010-2#7)(2010-3#15)(2010-4#29)(2010-5#28)(2010-6#28)(2010-7#38)(2010-8#51)(2010-9#16)(2011-1#41)(2011-10#6)(2011-2#349)(2011-3#32)(2011-7#1)(2011-9#1)(2012-12#40)(2012-2#176)(2012-3#141)(2012-4#7)(2012-5#5)(2012-7#7)(2012-8#1)(2012-9#1)(2013-1#226)(2013-2#2)(2013-7#5)(2013-8#109)
In(2)O(3)##2##1##(2008-10#2)
In(3+)##3##1##(2008-10#3)
In(III) in##4##2##(2008-10#4)
In(III)##15##1##(2008-10#15)
In-depth interviews were##3##3##(2008-12#1)(2008-9#1)(2010-6#1)
In-depth interviews##4##2##(2008-12#1)(2008-9#1)(2010-10#1)(2010-6#1)
In-depth##7##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-6#1)(2011-2#1)
In-flight##2##1##(1994-3#1)(1996-12#1)
In-house##2##1##(1992-2#1)(2008-5#1)
In-situ##4##1##(2008-10#2)(2008-11#1)(2010-6#1)
InBr(-)(4)##4##1##(2008-10#4)
InGaAs laser##2##2##(2008-3#2)
InGaAs##5##1##(2008-3#5)
InGaAs/InP##4##1##(2008-3#4)
InP##5##1##(2008-3#5)
InP-based##2##1##(2008-3#2)
Inability to##2##2##(1994-11#1)(1997-3#1)
Inaccurate##2##1##(1994-3#1)(2009-7#1)
Inactivated##2##1##(1990-2#1)(1995-5#1)
Inactivation of##9##2##(1992-12#1)(1994-11#1)(1994-3#1)(1995-6#1)(2008-10#2)(2012-2#2)(2013-8#1)
Inactivation##13##1##(1992-12#1)(1993-8#2)(1994-11#2)(1994-3#1)(1995-6#1)(2008-10#2)(2010-4#1)(2012-2#2)(2013-8#1)
Inactive##3##1##(1992-12#1)(2008-8#1)(2009-6#1)
Inadequate##2##1##(1992-3#1)(2010-6#1)
Inappropriate##3##1##(2008-7#1)(2011-2#1)(2013-1#1)
Inasmuch as##4##2##(2008-3#2)(2009-5#1)(2013-7#1)
Inbred Line##2##2##(2008-10#2)
Inbred mouse strains##2##3##(1996-12#1)(2008-2#1)
Inbred##6##1##(1996-12#2)(2008-10#3)(2008-2#1)
Inbreds##2##1##(2008-10#2)
Inbreeding##2##1##(2008-9#1)(2012-3#1)
Inc##85##1##(1990-2#2)(1991-1#2)(1992-1#2)(1993-2#1)(1994-1#1)(1995-12#3)(1995-2#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#36)(2009-11#1)(2010-1#1)(2010-6#1)(2011-2#18)(2012-2#1)(2012-3#2)(2013-1#2)
Inc)##2##1##(1995-3#2)
Incentives##2##1##(1996-12#1)(1997-1#1)
Incidence and severity increased##2##4##(2008-10#2)
Incidence and severity of Verticillium wilt##2##6##(2008-10#2)
Incidence and severity of##3##4##(2008-10#3)
Incidence and severity##5##3##(2008-10#5)
Incidence and##9##2##(1993-11#1)(2008-10#8)
Incidence of ARMD is##2##4##(2011-2#2)
Incidence of adverse##2##3##(1996-8#1)(2008-11#1)
Incidence of##25##2##(1990-9#1)(1996-8#2)(2008-10#11)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
Incidence was##2##2##(1993-2#1)(1994-9#1)
Incidence##43##1##(1990-9#1)(1993-11#1)(1993-2#1)(1994-9#1)(1996-8#2)(2008-10#23)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
Incident##4##1##(1991-6#1)(2008-10#1)(2008-7#1)(2012-3#1)
Incidental##2##1##(1991-3#1)(2013-1#1)
Incilaria fruhstorferi##2##2##(2008-6#2)
Incisional##2##1##(2010-8#1)(2012-3#1)
Incited by##2##2##(2008-10#2)
Included in the##2##3##(2008-10#1)(2011-2#1)
Included in this##4##3##(1992-1#1)(2008-10#1)(2008-11#1)(2010-12#1)
Included in##6##2##(1992-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)
Included studies were##2##3##(2013-1#2)
Included were##2##2##(1994-12#1)(2011-1#1)
Included##14##1##(1992-1#1)(1994-12#1)(2008-10#2)(2008-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
Including##10##1##(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#2)(2011-3#1)(2012-12#1)
Inclusion bodies##2##2##(2008-10#1)(2009-3#1)
Inclusion criteria were##2##3##(2008-9#1)(2010-11#1)
Inclusion criteria##3##2##(2008-9#1)(2010-11#1)(2012-12#1)
Inclusion of an##2##3##(2008-9#1)(2010-5#1)
Inclusion of the##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
Inclusion of##14##2##(1995-11#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
Inclusion##22##1##(1995-11#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Inclusions##3##1##(2008-10#2)(2008-3#1)
Income##7##1##(1991-1#1)(1992-2#2)(1993-3#1)(1995-12#2)(1996-1#1)
Incompatible##2##1##(2008-10#2)
Inconel##2##1##(2008-7#2)
Incontinentia pigmenti##2##2##(2012-3#2)
Incorporating a##2##2##(1994-12#1)(2008-10#1)
Incorporating##8##1##(1994-12#1)(1994-6#1)(2008-10#3)(2009-11#1)(2012-2#1)(2013-1#1)
Incorporation of the##3##3##(2008-10#2)(2008-5#1)
Incorporation of##22##2##(1995-6#1)(1997-1#1)(1997-2#1)(2008-10#13)(2008-5#4)(2008-9#1)(2010-7#1)
Incorporation##23##1##(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#13)(2008-5#4)(2008-9#1)(2010-7#1)
Incorrect##2##1##(2007-11#1)(2008-2#1)
Increase in##12##2##(1990-2#1)(1991-3#1)(1992-6#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-7#1)
Increase of##5##2##(1990-12#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
Increase##18##1##(1990-12#1)(1990-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1996-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#2)(2010-7#1)
Increased awareness of##2##3##(1991-3#1)(1995-1#1)
Increased awareness##4##2##(1991-3#1)(1995-1#1)(2011-2#1)(2013-1#1)
Increased levels of lipid peroxides in aged##2##7##(1990-5#2)
Increased levels of##3##3##(1990-5#2)(2008-5#1)
Increased numbers of##3##3##(1992-3#1)(1996-12#1)(2008-10#1)
Increased serum##2##2##(2009-5#1)(2009-8#1)
Increased susceptibility to##2##3##(1991-12#1)(2008-7#1)
Increased##84##1##(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-3#4)(1992-6#1)(1993-12#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#3)(1997-6#2)(2008-10#14)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
Increases Resistance to##2##3##(2008-10#2)
Increases in the##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
Increases in##14##2##(1994-12#1)(1995-2#1)(1997-1#2)(1997-3#2)(2008-10#4)(2008-7#1)(2008-9#1)(2011-2#2)
Increases##20##1##(1994-12#1)(1995-2#1)(1997-1#2)(1997-3#2)(2008-10#7)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
Increasing age##3##2##(2008-8#1)(2012-12#1)(2012-3#1)
Increasing amounts of##2##3##(2008-10#1)(2008-8#1)
Increasing constraints##2##2##(2008-8#2)
Increasing evidence suggests that##2##4##(2008-11#1)(2008-12#1)
Increasing evidence##4##2##(2008-11#1)(2008-12#2)(2009-8#1)
Increasing levels of##2##3##(2008-10#1)(2011-2#1)
Increasing the number of##2##4##(1993-1#1)(2008-11#1)
Increasing the##10##2##(1993-1#1)(1994-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-4#2)
Increasing##48##1##(1990-6#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1997-6#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-4#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)
Increasingly##5##1##(1992-3#1)(1993-1#1)(1993-12#1)(2008-10#1)(2008-7#1)
Incremental##4##1##(2008-7#1)(2010-12#1)(2013-1#2)
Incubation at##2##2##(2008-10#1)(2011-2#1)
Incubation of##15##2##(1991-5#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1997-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)
Incubation##19##1##(1991-5#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1997-1#2)(2008-10#3)(2008-11#2)(2008-8#1)(2009-8#1)(2011-2#1)
Indeed##46##1##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
Indentation##2##1##(2009-7#1)(2010-10#1)
Independent Medicare Advisory Committee##2##4##(2012-3#2)
Independent risk factors for##2##4##(2011-2#1)(2013-1#1)
Independent variables##2##2##(2008-5#1)(2013-1#1)
Independent##25##1##(1991-1#1)(1992-3#1)(1993-12#1)(1995-2#1)(1995-3#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#3)(2013-1#3)
Independently##2##1##(2009-8#1)(2013-1#1)
Index (CPI)##2##2##(1993-3#1)(2008-10#1)
Index and##4##2##(1991-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
Index for volume##10##3##(2008-10#10)
Index for##15##2##(1993-1#2)(1995-2#1)(2008-10#10)(2008-11#1)(2012-3#1)
Index##68##1##(1991-12#2)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#3)(1993-1#5)(1993-3#1)(1995-2#1)(1996-9#1)(2008-10#14)(2008-11#4)(2008-12#4)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#3)(2010-11#1)(2010-12#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#1)
India and Thailand##2##3##(1996-9#2)
India and##8##2##(1996-9#2)(2008-10#4)(2008-11#1)(2011-2#1)
India are##2##2##(2009-12#1)(2010-12#1)
India at##2##2##(2011-2#2)
India for##2##2##(2008-11#1)(2011-2#1)
India has##3##2##(1994-9#2)(2008-3#1)
India in##2##2##(1994-9#1)(2008-10#1)
India is##4##2##(1994-9#1)(1995-10#1)(2007-12#1)(2009-12#1)
India may##2##2##(1994-9#1)(1995-12#1)
India with the alleged involvement of##2##6##(2008-10#2)
India##128##1##(1992-11#1)(1994-3#1)(1994-8#2)(1994-9#13)(1995-10#2)(1995-12#4)(1996-1#1)(1996-9#8)(1997-8#1)(2007-12#2)(2008-10#27)(2008-11#7)(2008-12#4)(2008-3#5)(2008-7#2)(2009-10#2)(2009-12#5)(2009-4#1)(2009-9#3)(2010-10#3)(2010-12#7)(2010-2#1)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#4)
India)##3##1##(2008-10#2)(2013-8#1)
Indian Grocery##2##2##(2008-10#2)
Indian and##2##2##(2011-2#1)(2013-1#1)
Indian clade##2##2##(2008-10#2)
Indian isolates##3##2##(2008-10#2)(2013-1#1)
Indian patients##7##2##(1997-8#6)(2009-11#1)
Indian perspective##3##2##(2008-8#1)(2009-11#2)
Indian population##9##2##(1997-8#2)(2008-11#1)(2010-5#1)(2012-2#5)
Indian subcontinent##4##2##(1996-8#1)(2008-10#2)(2011-2#1)
Indian##77##1##(1994-8#1)(1995-10#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#9)(2008-10#12)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#4)(2009-6#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#9)(2013-1#5)(2013-8#4)
Indiana and##4##2##(2008-10#4)
Indiana tester isolate##2##3##(2008-10#2)
Indiana were##2##2##(2008-10#2)
Indiana##13##1##(1991-3#1)(2008-10#12)
Indians##8##1##(1997-8#1)(1997-9#1)(2008-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#2)
Indicates##2##1##(2008-10#2)
Indication##4##1##(1992-6#1)(1994-5#1)(1996-8#1)(2012-3#1)
Indications and##2##2##(1990-2#1)(1996-3#1)
Indications for surgery were##2##4##(1990-6#1)(2008-7#1)
Indications for the##3##3##(1991-3#1)(1992-2#1)(2013-1#1)
Indications for##6##2##(1990-6#1)(1991-3#1)(1992-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
Indications##9##1##(1990-2#1)(1990-6#1)(1991-3#1)(1992-2#1)(1996-3#1)(2008-10#1)(2008-7#2)(2013-1#1)
Indicator##5##1##(1992-2#2)(2008-10#1)(2012-2#1)(2013-1#1)
Indicators for##2##2##(2008-11#2)
Indicators of##5##2##(2008-12#2)(2011-2#2)(2013-1#1)
Indicators##10##1##(1997-3#1)(2008-11#3)(2008-12#2)(2011-2#2)(2013-1#2)
Indices of##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
Indices that##2##2##(2008-11#1)(2008-4#1)
Indices##8##1##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
Indigenous##13##1##(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#2)(2012-3#2)(2013-1#4)
Indigo carmine##5##2##(1990-6#2)(1993-8#3)
Indigo##6##1##(1990-6#2)(1993-8#4)
Indirect determination of##2##3##(2008-10#2)
Indirect evidence suggests##2##3##(1990-12#1)(1994-3#1)
Indirect immunofluorescent##2##2##(2008-5#1)(2008-8#1)
Indirect##22##1##(1990-12#1)(1994-3#1)(1996-5#1)(1997-1#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)
Individual differences##2##2##(1993-6#1)(2010-2#1)
Individual plants##2##2##(2008-10#2)
Individual sclerotia##2##2##(2008-10#2)
Individual##34##1##(1990-9#1)(1993-6#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#4)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#2)(2013-1#1)
Individualized##2##1##(1991-12#1)(2013-8#1)
Individualizing##2##1##(2010-11#1)(2010-6#1)
Individually##5##1##(1992-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#1)
Individuals were then##2##3##(2008-10#1)(2008-12#1)
Individuals were##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
Individuals who received##2##3##(2008-11#1)(2008-12#1)
Individuals who##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
Individuals with Disabilities Education##2##4##(2008-12#1)(2012-2#1)
Individuals with the##2##3##(1997-3#1)(2011-2#1)
Individuals with##13##2##(1997-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
Individuals##34##1##(1991-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
Indomethacin##4##1##(1996-2#1)(2008-10#2)(2012-2#1)
Indonesia##4##1##(1990-11#1)(2008-10#2)(2008-12#1)
Indonesian##4##1##(2008-10#1)(2008-11#3)
Indoor##3##1##(2008-10#1)(2013-1#1)(2013-8#1)
Induce##4##1##(2008-10#3)(2008-11#1)
Induced Resistance in##3##3##(2008-10#3)
Induced Resistance##6##2##(2008-10#6)
Induced Systemic Resistance##2##3##(2008-10#2)
Induced by##10##2##(1996-9#1)(2008-10#6)(2008-11#2)(2008-5#1)
Induced in##2##2##(2008-10#2)
Induced resistance was##2##3##(2008-10#2)
Induced resistance##6##2##(2008-10#5)(2008-8#1)
Induced##40##1##(1991-3#1)(1991-5#1)(1992-11#1)(1996-9#2)(2008-10#26)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
Induces##6##1##(2008-10#2)(2010-1#1)(2011-2#2)(2013-1#1)
Inducible##2##1##(1997-8#1)(2008-10#1)
Inducing##2##1##(2008-11#1)(2008-4#1)
Induction of Defense##2##3##(2008-10#2)
Induction of Soil##2##3##(2008-10#2)
Induction of Systemic Resistance##2##4##(2008-10#2)
Induction of a##2##3##(2008-11#1)(2011-2#1)
Induction of preference and##2##4##(2008-8#2)
Induction of the##4##3##(2008-11#3)(2011-2#1)
Induction of##36##2##(1991-5#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-7#2)(2008-10#13)(2008-11#6)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#3)
Induction##44##1##(1991-5#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-7#2)(2008-10#17)(2008-11#8)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#3)(2013-1#1)
Inductively Coupled Plasma##2##3##(2008-10#2)
Inductively Coupled##3##2##(2008-10#3)
Inductively coupled plasma optical emission##3##5##(2008-10#2)(2011-2#1)
Inductively coupled##4##2##(2008-10#3)(2011-2#1)
Inductively##7##1##(2008-10#6)(2011-2#1)
Industrial##12##1##(1991-12#1)(1995-3#2)(1996-6#1)(2008-10#4)(2008-11#1)(2009-12#1)(2010-7#1)(2012-2#1)
Industry##6##1##(1995-5#1)(1996-9#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-7#1)
Ineffective##2##1##(2008-10#1)(2011-2#1)
Inequality in##2##2##(1994-12#1)(2012-12#1)
Inequality##3##1##(1993-11#1)(1994-12#1)(2012-12#1)
Inexpensive##3##1##(1991-12#1)(2008-10#1)(2008-11#1)
Infant with##2##2##(2008-11#1)(2012-3#1)
Infant##11##1##(1993-12#1)(1993-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
Infantile hemangiomas##2##2##(2013-8#2)
Infantile##3##1##(2008-12#1)(2013-8#2)
Infants and Children (WIC)##2##4##(1996-12#2)
Infants and Children##3##3##(1996-12#3)
Infants and##4##2##(1996-12#3)(2008-11#1)
Infants with##3##2##(1996-2#1)(2010-12#1)(2010-9#1)
Infants##14##1##(1993-12#1)(1996-12#3)(1996-2#2)(1996-9#1)(2006-5#3)(2008-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
Infected and##2##2##(2008-10#1)(2012-2#1)
Infected by the##2##3##(2008-10#2)
Infected by##3##2##(2008-10#3)
Infected with##4##2##(2008-10#3)(2012-2#1)
Infected##25##1##(1997-1#1)(2008-10#15)(2008-11#1)(2008-7#1)(2011-3#1)(2012-2#5)(2013-1#1)
Infecting##8##1##(2008-10#6)(2008-11#1)(2008-9#1)
Infection and##5##2##(2008-10#5)
Infection by Monilinia vaccinii-corymbosi##2##4##(2008-10#2)
Infection by Pythium##3##3##(2008-10#3)
Infection by the##2##3##(2008-10#1)(2008-9#1)
Infection by##14##2##(2008-10#13)(2008-9#1)
Infection control##2##2##(2006-5#1)(2008-11#1)
Infection efficiency##3##2##(2008-10#3)
Infection hyphae##2##2##(2008-10#2)
Infection in##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
Infection is##3##2##(1991-3#1)(2008-8#1)(2009-5#1)
Infection of Rice##2##3##(2008-10#2)
Infection of Spodoptera frugiperda##2##4##(1993-6#1)(1994-11#1)
Infection of Strawberry##2##3##(2008-10#2)
Infection of##41##2##(1991-8#1)(1993-6#1)(1994-11#1)(1997-3#1)(2008-10#33)(2008-11#1)(2010-5#1)(2012-2#2)
Infection was##3##2##(1996-12#1)(2008-10#2)
Infection with##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
Infection##127##1##(1991-3#1)(1991-4#1)(1991-8#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-5#2)(1997-3#1)(2006-5#1)(2008-1#1)(2008-10#85)(2008-11#3)(2008-12#2)(2008-2#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#2)(2011-2#6)(2012-2#3)(2013-1#3)(2013-8#2)
Infections in##4##2##(2008-10#4)
Infections of the##2##3##(1997-4#1)(2010-12#1)
Infections of##3##2##(1997-4#1)(2008-10#1)(2010-12#1)
Infections##16##1##(1997-4#1)(2008-10#5)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#5)(2012-2#1)(2013-1#1)
Infectious Diseases##3##2##(1994-9#1)(1996-11#1)(2011-2#1)
Infectious RNA##2##2##(2008-10#2)
Infectious diseases in the emergency setting Part 1##2##8##(2006-5#2)
Infectious myositis is##2##3##(2011-2#2)
Infectious##18##1##(1994-9#1)(1996-11#1)(1997-5#1)(1997-8#1)(2006-5#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#4)(2012-3#1)
Infective endocarditis##2##2##(2011-2#2)
Infective##4##1##(1991-3#1)(2008-10#1)(2011-2#2)
Infectivity##4##1##(2008-10#4)
Inferior##2##1##(2008-12#1)(2013-1#1)
Inferred from##2##2##(2008-10#2)
Inferring##2##1##(2008-12#1)(2008-4#1)
Infertility##2##1##(1990-3#1)(1992-1#1)
Infestation Foci of Potato Cyst Nematodes##2##6##(2008-10#2)
Infestation of##3##2##(2008-10#2)(2011-2#1)
Infestation##10##1##(2008-10#8)(2008-12#1)(2011-2#1)
Infested##2##1##(2008-10#2)
Inflammaging##2##1##(2010-1#2)
Inflammation##4##1##(1991-3#1)(2008-10#1)(2009-1#1)(2009-10#1)
Inflammatory fibroid##2##2##(2013-8#2)
Inflammatory pseudotumor##2##2##(1991-9#1)(2010-12#1)
Inflammatory pseudotumour of the lung##2##5##(2008-7#1)(2013-1#1)
Inflammatory##25##1##(1991-3#1)(1991-8#1)(1991-9#1)(1997-8#1)(2008-10#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-12#3)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
Infliximab is a##2##3##(2010-12#2)
Infliximab is##3##2##(2010-12#3)
Infliximab##7##1##(2010-12#6)(2012-3#1)
Influence of Environmental Conditions on##2##5##(2008-10#2)
Influence of Temperature and##3##4##(2008-10#3)
Influence of a##3##3##(2008-10#1)(2009-7#1)(2012-3#1)
Influence of applied##2##3##(2008-5#1)(2009-12#1)
Influence of different##4##3##(1992-6#1)(2008-10#2)(2013-1#1)
Influence of pH##2##3##(2008-10#2)
Influence of the##11##3##(2008-10#3)(2008-3#2)(2008-5#3)(2008-7#1)(2011-2#1)(2013-1#1)
Influence of##99##2##(1991-1#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#2)(1994-8#1)(1995-10#1)(1995-11#1)(1996-9#1)(2007-12#1)(2008-10#34)(2008-11#9)(2008-12#4)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
Influence on the##2##3##(2008-11#1)(2008-5#1)
Influence on##4##2##(1992-9#1)(2008-11#1)(2008-5#2)
Influence##107##1##(1991-1#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#3)(1994-8#1)(1995-10#1)(1995-11#1)(1996-9#1)(2007-12#1)(2008-10#35)(2008-11#10)(2008-12#4)(2008-3#2)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#1)
Influenced##2##1##(1995-12#1)(2008-10#1)
Influences in##2##2##(2008-11#1)(2010-9#1)
Influences of the##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
Influences of##5##2##(1991-2#1)(2008-10#3)(2008-9#1)
Influences on##2##2##(2008-10#1)(2010-10#1)
Influences##10##1##(1991-2#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-10#1)(2010-9#1)
Influencing##5##1##(1995-1#1)(2008-10#3)(2013-1#1)
Influential##2##1##(2008-12#1)(2008-7#1)
Influenza and Other Respiratory Viruses 5(2)##4##6##(2011-2#4)
Influenza in##2##2##(2011-2#1)(2013-1#1)
Influenza virus##2##2##(2011-2#2)
Influenza##26##1##(1992-5#1)(1994-9#1)(2008-11#1)(2008-7#2)(2008-9#3)(2011-2#13)(2011-9#2)(2012-2#1)(2013-1#2)
Info##2##1##(2010-5#1)(2011-2#1)
Informal caregivers##2##2##(2009-5#2)
Informal##3##1##(2008-10#1)(2009-5#2)
Informatic surgery##2##2##(2011-2#2)
Information Network for Public Health Officials (INPHO)##3##7##(1995-12#2)(1996-1#1)
Information Network for Public Health Officials##5##6##(1995-12#2)(1996-1#3)
Information Service##4##2##(1991-3#1)(1992-1#2)(2013-1#1)
Information Services##2##2##(1991-12#1)(2013-1#1)
Information Set##2##2##(1995-2#1)(1997-3#1)
Information System##3##2##(2009-7#1)(2012-12#2)
Information Technology##2##2##(2008-7#1)(2013-1#1)
Information about##3##2##(1994-3#1)(2008-7#1)(2010-10#1)
Information and##3##2##(1994-2#1)(1997-3#1)(2013-1#1)
Information for##2##2##(2008-11#1)(2011-2#1)
Information in##2##2##(1997-3#1)(2008-10#1)
Information is##2##2##(1992-12#1)(2008-4#1)
Information management##2##2##(1994-2#1)(1995-2#1)
Information of the##2##3##(1993-8#1)(2013-1#1)
Information of##4##2##(1993-8#1)(2011-3#1)(2012-12#1)(2013-1#1)
Information on sample size##2##4##(2009-9#1)(2010-2#1)
Information on the##6##3##(1990-6#1)(1992-3#1)(2008-10#3)(2010-4#1)
Information on##13##2##(1990-6#1)(1991-6#1)(1992-3#1)(1993-3#1)(2008-10#3)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
Information pamphlets##2##2##(1990-2#2)
Information provided includes##2##3##(2012-2#2)
Information provided##3##2##(1997-2#1)(2012-2#2)
Information systems##3##2##(1994-1#1)(1996-3#1)(1997-1#1)
Information technology##2##2##(1994-12#1)(2008-10#1)
Information was obtained from##2##4##(1997-4#1)(2008-11#1)
Information##83##1##(1990-2#2)(1990-6#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-12#3)(1995-2#2)(1996-1#3)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#4)(2011-3#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#6)
Informed consent##2##2##(1993-3#1)(1995-2#1)
Informed price setting##2##3##(1993-2#2)
Informed##6##1##(1993-2#2)(1993-3#1)(1995-2#1)(2008-12#1)(2009-4#1)
Infrared and##2##2##(2008-10#1)(2008-3#1)
Infrared ellipsometry##2##2##(2008-10#1)(2008-3#1)
Infrared spectra##3##2##(1997-2#1)(2008-10#2)
Infrared spectroscopy and##2##3##(2008-10#2)
Infrared spectroscopy##6##2##(2008-10#5)(2008-5#1)
Infrared##24##1##(1991-1#1)(1992-2#1)(1997-2#1)(2008-10#15)(2008-3#4)(2008-5#1)(2011-2#1)
Infrastructure##3##1##(2011-2#2)(2013-8#1)
Infrequent##2##1##(1995-12#1)(2008-12#1)
Infusion of##4##2##(1992-6#1)(1993-6#1)(2009-9#1)(2013-8#1)
Infusion##6##1##(1990-5#1)(1992-6#1)(1993-6#1)(2008-11#1)(2009-9#1)(2013-8#1)
Infusions of##2##2##(1994-2#1)(2013-1#1)
Ingestion of##3##2##(1994-11#1)(2009-8#1)(2013-1#1)
Ingestion##5##1##(1994-11#1)(2008-10#1)(2009-8#1)(2013-1#2)
Inh##5##1##(2008-10#5)
Inhalation of##2##2##(1992-3#2)
Inhalation##5##1##(1992-3#4)(2012-3#1)
Inhaled corticosteroids##2##2##(2008-8#1)(2011-2#1)
Inhaled nitric oxide##3##3##(1997-1#1)(2008-12#2)
Inhaled##10##1##(1997-1#5)(2007-11#1)(2008-12#2)(2008-8#1)(2011-2#1)
Inherent##4##1##(1995-3#1)(2008-11#1)(2008-2#1)(2009-10#1)
Inheritance is##2##2##(1997-3#1)(2008-12#1)
Inheritance of Race-Specific Resistance to##2##5##(2008-10#2)
Inheritance of Resistance to##4##4##(2008-10#4)
Inheritance of resistance to##4##4##(2008-10#4)
Inheritance of resistance##5##3##(2008-10#5)
Inheritance of##15##2##(2008-10#14)(2008-12#1)
Inheritance##26##1##(1997-3#1)(2008-10#17)(2008-12#2)(2008-4#4)(2008-9#2)
Inherited##4##1##(1994-3#1)(2008-10#1)(2008-7#1)(2013-8#1)
Inhibited##3##1##(1995-6#1)(2008-10#1)(2008-8#1)
Inhibition by##4##2##(1991-9#1)(1994-3#1)(1994-8#1)(1997-1#1)
Inhibition of DNA##3##3##(1992-6#1)(1993-8#1)(1995-9#1)
Inhibition of appressorium formation by##2##5##(2008-10#2)
Inhibition of arachidonate release from##2##5##(2008-11#2)
Inhibition of cell##3##3##(1995-2#1)(1995-6#1)(2009-8#1)
Inhibition of protein##2##3##(2010-5#1)(2012-3#1)
Inhibition of the##8##3##(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
Inhibition of these##2##3##(1994-11#1)(2008-5#1)
Inhibition of##66##2##(1990-2#1)(1990-5#1)(1991-9#1)(1992-6#4)(1993-8#3)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#4)(1995-9#3)(2006-6#1)(2008-10#10)(2008-11#7)(2008-5#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#2)
Inhibition was##2##2##(1994-11#1)(2008-11#1)
Inhibition##74##1##(1990-2#1)(1990-5#1)(1991-9#2)(1992-6#4)(1993-8#3)(1994-11#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#4)(1995-9#3)(1997-1#1)(2006-6#1)(2008-10#10)(2008-11#8)(2008-5#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#3)
Inhibitor##12##1##(1994-12#1)(2008-10#5)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#3)
Inhibitors of##13##2##(1990-10#1)(1990-9#1)(1992-3#1)(1996-5#3)(2008-10#4)(2008-11#1)(2008-5#1)(2010-7#1)
Inhibitors##18##1##(1990-10#1)(1990-9#1)(1992-12#1)(1992-3#1)(1996-5#4)(2008-10#7)(2008-11#1)(2008-5#1)(2010-7#1)
Inhibitory Effects of##2##3##(2008-10#1)(2008-5#1)
Inhibitory effect of##5##3##(1992-3#1)(2008-11#2)(2008-7#1)(2010-11#1)
Inhibitory effects of##7##3##(1993-8#1)(1995-9#1)(2008-10#1)(2008-11#4)
Inhibitory effects##8##2##(1993-8#1)(1995-11#1)(1995-9#1)(2008-10#1)(2008-11#4)
Inhibitory##22##1##(1992-3#1)(1993-8#2)(1995-11#1)(1995-2#1)(1995-9#1)(1997-1#1)(2008-10#4)(2008-11#6)(2008-5#1)(2008-7#1)(2009-6#2)(2010-11#1)
Inhibits##11##1##(1994-12#1)(2008-10#4)(2008-11#1)(2011-2#3)(2012-2#1)(2012-3#1)
Initial Experience##2##2##(2008-12#1)(2011-2#1)
Initial approach to the child who presents with##3##8##(2006-5#3)
Initial approach to the child who presents##5##7##(2006-5#5)
Initial approach to the##6##4##(2006-5#6)
Initial findings##2##2##(1993-2#1)(2013-8#1)
Initial results of##2##3##(2008-11#1)(2012-2#1)
Initial results##3##2##(2008-11#1)(2012-2#2)
Initial studies##2##2##(2008-10#1)(2008-6#1)
Initial##59##1##(1990-2#1)(1991-5#1)(1991-9#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-6#1)(1997-9#1)(2006-5#6)(2007-12#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#3)(2008-5#2)(2008-6#1)(2008-8#3)(2009-12#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Initially##21##1##(1990-12#1)(1995-12#1)(1996-11#1)(2008-10#9)(2008-4#1)(2008-9#2)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#2)
Initiating##3##1##(2009-10#1)(2012-2#1)(2013-1#1)
Initiation of##3##2##(1992-8#1)(1994-11#1)(1995-8#1)
Initiation##6##1##(1992-8#1)(1994-11#1)(1995-8#1)(2008-10#2)(2013-1#1)
Initiative##11##1##(1995-3#3)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2010-12#1)(2012-12#1)
Initiative)##2##1##(2008-4#1)(2008-7#1)
Injecting##2##1##(2008-10#1)(2008-8#1)
Injection in rat of##2##4##(1992-8#2)
Injection of##9##2##(1993-8#1)(1996-2#2)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
Injection##21##1##(1992-8#2)(1993-8#1)(1996-2#2)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#2)(2011-2#2)(2013-1#2)(2013-8#1)
Injections of##3##2##(1997-2#1)(1997-3#1)(2008-7#1)
Injured##2##1##(2008-10#2)
Injuries of the##2##3##(2010-1#1)(2013-8#1)
Injuries##6##1##(1991-3#1)(1996-6#1)(2008-10#1)(2010-1#2)(2013-8#1)
Injury##12##1##(1990-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-1#2)(2010-12#2)(2010-2#2)
Innate##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
Inner Mongolia HEV71 strains##4##4##(2013-8#4)
Inner Mongolia in 2010 and##2##5##(2013-8#2)
Inner Mongolia in 2010##3##4##(2013-8#3)
Inner Mongolia##13##2##(2008-9#1)(2013-1#1)(2013-8#11)
Inner##14##1##(1995-3#1)(2008-9#1)(2013-1#1)(2013-8#11)
Innervation##2##1##(1997-1#1)(2008-5#1)
Innovation##5##1##(1991-2#1)(2008-6#1)(2010-10#1)(2010-5#1)(2012-2#1)
Innovations##2##1##(2008-1#1)(2008-6#1)
Innovatis##2##1##(2008-11#2)
Innovative revenue generation##2##3##(1991-12#2)
Innovative##10##1##(1991-12#2)(1994-12#1)(1995-12#1)(2008-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2012-3#2)
Ino##3##1##(1994-8#3)
Inocula##2##1##(2008-10#2)
Inoculated plants##2##2##(2008-10#2)
Inoculated with##4##2##(2008-10#4)
Inoculated##13##1##(2008-10#13)
Inoculation of bean##2##3##(2008-10#2)
Inoculation of the##3##3##(2008-10#3)
Inoculation of these##2##3##(2008-10#2)
Inoculation of##10##2##(2008-10#10)
Inoculation with a##2##3##(2008-10#2)
Inoculation with##7##2##(2008-10#7)
Inoculation##24##1##(2008-10#23)(2008-8#1)
Inoculations of##3##2##(2008-10#3)
Inoculations##5##1##(2008-10#5)
Inoculum Density and##2##3##(2008-10#2)
Inoculum Density##4##2##(2008-10#4)
Inoculum##14##1##(2008-10#13)(2008-11#1)
Inorganic and##2##2##(2008-10#2)
Inorganic arsenic##2##2##(2008-10#2)
Inorganic mercury##2##2##(2008-10#2)
Inorganic##9##1##(1994-2#1)(1994-3#1)(2008-10#7)
Inosine monophosphate##2##2##(2008-10#2)
Inosine##4##1##(2008-10#4)
Inpatient treatment##2##2##(1991-2#2)
Inpatient##7##1##(1991-2#2)(1993-12#1)(2008-11#2)(2012-3#1)(2013-8#1)
Inquiry##3##1##(1993-6#1)(2008-11#1)(2012-3#1)
Ins 1##7##2##(1997-1#7)
Ins##8##1##(1997-1#8)
Ins(1##4##1##(1997-1#4)
Ins1##2##1##(1993-6#2)
InsP(3) binding##3##2##(2008-8#3)
InsP(3) receptor could##2##3##(2008-8#2)
InsP(3) receptor##6##2##(2008-8#6)
InsP(3)##9##1##(2008-8#9)
Insect cell##2##2##(2008-11#2)
Insect##11##1##(1995-11#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2009-8#1)(2012-2#1)
Insecta##2##1##(1995-6#1)(2010-1#1)
Insecticide##2##1##(1996-3#1)(2008-10#1)
Insects##6##1##(1990-11#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-1#2)
Insensitivity##5##1##(2008-10#5)
Inserted##2##1##(1993-8#1)(2012-3#1)
Insertion of##3##2##(1991-10#1)(1995-6#1)(2008-10#1)
Insertion##6##1##(1991-10#1)(1992-8#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-11#1)
Insertional##3##1##(1995-6#1)(2008-10#2)
Inside the##2##2##(2008-10#1)(2009-12#1)
Inside##6##1##(1992-2#1)(1995-1#1)(2008-10#3)(2009-12#1)
Insight and Responsibility##2##3##(2008-12#2)
Insight##3##1##(2008-10#1)(2008-12#2)
Insights from the##2##3##(1996-2#1)(2008-11#1)
Insights from##4##2##(1996-2#1)(2008-11#1)(2008-9#1)(2011-3#1)
Insights into the##2##3##(2008-12#1)(2008-4#1)
Insights into##3##2##(2008-12#1)(2008-4#1)(2012-2#1)
Insights##11##1##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)
Insoluble##2##1##(2008-10#2)
Inspection##4##1##(1991-9#1)(1992-5#1)(1995-2#1)(2012-2#1)
Inspector General v##2##3##(1992-3#1)(1993-1#1)
Inspector General##4##2##(1992-3#1)(1993-1#2)(1993-12#1)
Inst##4##1##(2007-12#4)
Instability in##2##2##(2008-10#2)
Instability of##2##2##(2008-10#1)(2010-9#1)
Instability##5##1##(2008-10#3)(2010-9#1)(2012-3#1)
Instead of being##2##3##(2008-8#1)(2012-2#1)
Instead of the##2##3##(2008-10#1)(2008-8#1)
Instead of using##2##3##(2008-10#1)(2010-8#1)
Instead of##16##2##(1997-1#1)(1997-2#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
Instead##44##1##(1993-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#14)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
Institut##10##1##(1992-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2010-1#3)
Institute and##2##2##(1990-11#1)(2010-1#1)
Institute for Health and Clinical Excellence (NICE)##2##7##(2012-3#1)(2013-8#1)
Institute for Health##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
Institute for Medical Research##2##4##(1990-3#1)(2008-12#1)
Institute for##16##2##(1990-3#1)(1990-6#1)(1995-2#1)(1997-5#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
Institute in##2##2##(2008-10#1)(2011-2#1)
Institute is##2##2##(1994-1#1)(2011-2#1)
Institute of Health##3##3##(1997-5#1)(2008-12#1)(2012-3#1)
Institute of Public Health##4##4##(1996-6#1)(2008-10#2)(2010-6#1)
Institute of Standards and##5##4##(2008-10#3)(2008-3#2)
Institute of the##2##3##(1992-12#1)(2009-9#1)
Institute of##62##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#3)(1992-12#2)(1992-5#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-1#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#2)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#20)(2012-2#1)(2012-3#1)
Institute##133##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#4)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-8#1)(1995-10#1)(1995-2#2)(1996-1#2)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#3)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#3)(2009-4#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#26)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#4)
Institute's##2##1##(2008-9#1)(2010-7#1)
Institutes of##14##2##(1994-2#1)(1996-5#1)(1996-9#1)(1997-8#2)(2007-9#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-8#1)(2012-3#2)
Institutes##18##1##(1994-12#2)(1994-2#1)(1996-5#1)(1996-9#1)(1997-8#2)(2007-9#1)(2008-12#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#2)
Institution##5##1##(1990-12#1)(2008-11#3)(2013-1#1)
Institutional Review##3##2##(1997-8#1)(2009-4#2)
Institutional##8##1##(1990-2#1)(1991-1#1)(1995-2#1)(1997-8#1)(2008-11#1)(2009-4#2)(2013-1#1)
Institutions##6##1##(2008-11#4)(2008-7#1)(2012-3#1)
Instructions for##3##2##(2008-11#2)(2008-9#1)
Instructions to authors##4##3##(2008-11#3)(2010-12#1)
Instructions##9##1##(2008-11#5)(2008-4#1)(2008-9#1)(2010-12#1)(2011-3#1)
Instrument##6##1##(1993-2#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-3#1)
Instrumental Activities of Daily Living (IADL)##2##6##(2008-7#2)
Instrumental methods##2##2##(2008-10#2)
Instrumental##8##1##(2008-10#5)(2008-3#1)(2008-7#2)
Instrumented##3##1##(2012-3#3)
Instruments##2##1##(2008-10#1)(2008-12#1)
Insufficient##2##1##(2008-12#1)(2008-9#1)
Insulin Resistance##2##2##(2008-1#1)(2011-1#1)
Insulin and##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
Insulin resistance in##2##3##(1994-12#1)(2008-4#1)
Insulin resistance##8##2##(1994-12#2)(2008-11#1)(2008-3#1)(2008-4#2)(2012-2#1)(2012-5#1)
Insulin secretion##3##2##(1991-6#1)(1995-8#1)(2008-11#1)
Insulin##36##1##(1991-6#1)(1992-10#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-8#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-4#1)(2012-5#1)
Insulin-like growth##2##2##(2008-11#1)(2008-5#1)
Insulin-like##3##1##(2008-11#1)(2008-5#1)(2011-1#1)
Insurance##12##1##(1992-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-3#1)(2008-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
Int##3##1##(2008-12#2)(2010-11#1)
Intact enamel##2##2##(2013-1#2)
Intact##9##1##(1990-5#1)(1992-3#1)(1997-3#1)(2008-10#2)(2008-11#2)(2013-1#2)
Integrated delivery systems##2##3##(1996-1#1)(2008-11#1)
Integrated optical##2##2##(2008-2#1)(2008-3#1)
Integrated##26##1##(1995-1#1)(1996-1#1)(1997-1#1)(2007-11#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Integrating total quality management##2##4##(1994-1#1)(1994-2#1)
Integrating##19##1##(1992-3#1)(1993-1#1)(1993-3#2)(1994-1#1)(1994-2#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2010-10#1)(2010-12#1)
Integration of clinical##2##3##(1994-2#1)(1994-3#1)
Integration of these##3##3##(2008-10#2)(2011-2#1)
Integration of##22##2##(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#6)(2008-3#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-8#4)(2011-2#1)(2012-3#1)
Integration##32##1##(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-8#4)(2010-9#1)(2011-2#2)(2012-3#1)
Integrative approaches to couple therapy##2##5##(2012-2#2)
Integrative##5##1##(2008-10#1)(2008-8#1)(2012-2#3)
Integrity##4##1##(2008-11#1)(2009-4#1)(2013-1#2)
Intelligence##2##1##(2008-10#1)(2013-8#1)
Intense##6##1##(1990-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)
Intensity##9##1##(1991-12#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-6#1)(2013-8#1)
Intensity-modulated##2##1##(2008-2#2)
Intensive Care Unit##8##3##(1991-6#1)(1992-2#1)(2008-11#1)(2008-5#1)(2012-3#3)(2013-1#1)
Intensive Care##10##2##(1991-6#1)(1992-2#1)(2008-11#2)(2008-5#1)(2012-3#3)(2013-1#2)
Intensive Medicines Monitoring Programme (IMMP)##2##5##(2008-11#2)
Intensive care##4##2##(1991-2#1)(1995-11#2)(1997-2#1)
Intensive psychotherapy##2##2##(1993-1#1)(2010-1#1)
Intensive##26##1##(1991-2#1)(1991-6#1)(1992-2#1)(1993-1#1)(1995-11#2)(1995-3#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-5#1)(2010-1#1)(2010-12#2)(2010-5#1)(2012-3#4)(2013-1#2)
Intentionally staged##2##2##(2008-7#2)
Inter##2##1##(2008-10#1)(2008-11#1)
Inter-professional##4##1##(2008-11#4)
Inter-retrotransposon##2##1##(2008-10#2)
Interaction Between Tomato##2##3##(2008-10#2)
Interaction Between the##2##3##(2008-10#2)
Interaction Between##9##2##(2008-10#9)
Interaction between the##2##3##(1996-5#1)(2008-11#1)
Interaction between##6##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
Interaction of Fusarium##2##3##(2008-10#2)
Interaction of##27##2##(1991-1#1)(1992-3#3)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-5#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2013-8#1)
Interaction with##3##2##(1992-6#1)(2008-10#1)(2013-1#1)
Interaction##50##1##(1991-1#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-5#1)(2008-10#24)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Interactions Among##2##2##(2008-10#2)
Interactions Between Strains of##2##4##(2008-10#2)
Interactions Between Trichoderma##2##3##(2008-10#2)
Interactions Between the##2##3##(2008-10#2)
Interactions Between##10##2##(2008-10#10)
Interactions between the##3##3##(2008-10#2)(2009-8#1)
Interactions between##13##2##(1992-3#1)(1993-1#1)(1995-5#1)(2008-10#7)(2008-11#1)(2008-8#1)(2009-8#1)
Interactions of##10##2##(1994-8#1)(1995-6#1)(2008-10#6)(2008-4#1)(2009-12#1)
Interactions with##2##2##(2008-10#1)(2013-1#1)
Interactions##50##1##(1991-8#1)(1992-3#1)(1993-1#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#32)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#2)(2012-2#1)(2013-1#2)
Interactive##5##1##(2008-11#3)(2008-6#1)(2011-2#1)
Interampatteness##2##1##(2010-10#2)
Interceed (TC7) plus heparin##2##4##(1992-1#2)
Interceed (TC7) plus##4##3##(1992-1#4)
Interceed (TC7)##7##2##(1992-1#7)
Interceed##8##1##(1991-1#1)(1992-1#7)
Interdisciplinary education and##2##3##(1996-1#1)(2008-12#1)
Interdisciplinary##3##1##(1996-1#1)(2008-12#1)(2009-9#1)
Interest in the##2##3##(2008-5#1)(2011-2#1)
Interest in##9##2##(1991-6#1)(1997-5#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
Interesting##4##1##(2008-10#2)(2011-2#2)
Interestingly the##2##2##(1991-5#1)(1996-12#1)
Interestingly##93##1##(1991-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-8#3)(1996-12#2)(1996-5#1)(1997-2#1)(1997-7#1)(2006-6#2)(2008-10#18)(2008-11#16)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#7)(2010-5#1)(2011-2#3)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#1)
Interface##5##1##(1991-9#1)(1996-9#1)(2008-10#1)(2008-3#1)(2013-8#1)
Interference from##7##2##(2008-10#7)
Interference of##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
Interference studies were##2##3##(2008-10#2)
Interference studies##3##2##(2008-10#3)
Interference##22##1##(1994-11#1)(1995-5#1)(2008-10#16)(2008-3#3)(2010-12#1)
Interference-free##2##1##(2008-10#2)
Interferences from metal ions could be##2##6##(2008-10#2)
Interferences from##6##2##(2008-10#6)
Interferences in##2##2##(2008-10#2)
Interferences##14##1##(2008-10#14)
Interfering##3##1##(2008-10#2)(2008-7#1)
Interferometer##5##1##(2008-3#5)
Interferon regulatory factor-2##2##3##(1995-12#2)
Interferon##6##1##(1995-10#1)(1995-12#2)(1996-2#1)(2007-11#1)(2013-8#1)
Interim##4##1##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
Interlaboratory study of the##2##4##(2008-10#2)
Interlaboratory##5##1##(2008-10#5)
Interleukin 1##5##2##(1990-12#2)(1990-5#2)(1996-2#1)
Interleukin##9##1##(1990-12#2)(1990-5#2)(1993-8#1)(1996-2#1)(2006-6#1)(2007-11#1)(2008-11#1)
Interleukin-1 beta##2##2##(1990-10#1)(1996-12#1)
Interleukin-1##5##1##(1990-10#1)(1993-8#1)(1996-12#1)(2008-10#2)
Interleukin-2 (IL-2)##2##2##(1994-11#1)(1994-5#1)
Interleukin-2 concentration##2##2##(2008-11#2)
Interleukin-2##5##1##(1994-11#1)(1994-5#1)(2008-11#3)
Interleukin-6 (IL-6)##2##2##(1995-12#1)(1997-7#1)
Interleukin-6 and Tumor Necrosis Factor-alpha##2##5##(2008-10#1)(2008-11#1)
Interleukin-6##5##1##(1995-12#2)(1997-7#1)(2008-10#1)(2008-11#1)
Interleukins##2##1##(1990-9#2)
Intermediate##11##1##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-7#1)
Intermittent##5##1##(1990-9#1)(1995-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
Intermountain Health Care##2##3##(1996-1#1)(1996-2#1)
Internal Medicine##4##2##(1996-11#2)(2008-11#1)(2013-1#1)
Internal Transcribed Spacer##5##3##(2008-10#4)(2012-2#1)
Internal Transcribed Spacer-rDNA##2##3##(2008-10#2)
Internal Transcribed##8##2##(2008-10#7)(2012-2#1)
Internal and##2##2##(2008-12#1)(2012-3#1)
Internal consistency##3##2##(2009-11#1)(2009-12#1)(2010-11#1)
Internal transcribed spacer##2##3##(2008-10#2)
Internal##38##1##(1990-3#1)(1995-6#1)(1996-11#2)(1997-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Internally##2##1##(2008-10#2)
International Classification of Diseases##2##4##(1991-9#1)(2012-12#1)
International Classification of Primary Care##2##5##(1991-9#1)(1994-6#1)
International Classification of##6##3##(1991-12#1)(1991-9#2)(1994-6#1)(2012-12#2)
International Classification##9##2##(1991-12#1)(1991-9#2)(1994-6#1)(2012-12#2)(2013-1#2)(2013-8#1)
International Code of Nomenclature of Bacteria##2##6##(2008-10#2)
International Code of##3##3##(2008-10#3)
International Conference in##2##3##(1995-12#1)(2008-12#1)
International Conference on Harmonization##2##4##(2008-10#1)(2010-11#1)
International Conference on Population and Development##3##6##(1994-9#2)(2008-11#1)
International Conference on##11##3##(1992-1#1)(1994-9#2)(2008-10#2)(2008-11#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-3#1)
International Conference##17##2##(1992-1#1)(1994-9#2)(1995-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)
International Congress of##2##3##(1997-7#1)(2010-3#1)
International Congress on##4##3##(1996-2#1)(2010-11#2)(2011-2#1)
International Congress##7##2##(1996-2#1)(1997-7#1)(2008-1#1)(2010-11#2)(2010-3#1)(2011-2#1)
International Journal of##2##3##(2008-11#1)(2009-4#1)
International Meeting##2##2##(2008-5#1)(2013-8#1)
International Prognostic##2##2##(2010-11#2)
International Society for##6##3##(2008-11#1)(2008-12#1)(2011-2#3)(2011-9#1)
International Standard##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
International Symposium on the##2##4##(2008-11#1)(2008-4#1)
International Symposium on##5##3##(1997-2#1)(2008-11#2)(2008-4#1)(2008-8#1)
International Symposium##6##2##(1997-2#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-10#1)
International Workshop on##2##3##(2008-4#1)(2011-2#1)
International Workshop##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
International advisory board##2##3##(2008-5#2)
International and local students##2##4##(2008-11#2)
International disease surveillance##2##3##(1996-6#1)(2009-6#1)
International disease##3##2##(1996-6#1)(2009-6#2)
International##144##1##(1990-11#2)(1991-12#3)(1991-9#2)(1992-1#1)(1993-1#1)(1993-2#1)(1994-6#2)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-6#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#19)(2008-11#22)(2008-12#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2010-10#1)(2010-11#5)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#8)(2011-3#1)(2011-9#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
Internet access##2##2##(1996-2#1)(1996-5#1)
Internet and information technology##3##4##(2008-11#3)
Internet and##8##2##(1994-3#1)(2008-1#1)(2008-11#3)(2008-4#1)(2010-12#1)(2010-8#1)
Internet as##3##2##(2009-5#2)(2013-1#1)
Internet is##3##2##(1994-3#1)(1996-2#1)(1996-5#1)
Internet use##5##2##(2009-5#3)(2013-1#2)
Internet##61##1##(1994-3#3)(1995-12#1)(1996-2#9)(1996-5#4)(1996-8#1)(1997-3#1)(2008-1#2)(2008-10#4)(2008-11#11)(2008-12#2)(2008-4#2)(2008-8#1)(2009-5#10)(2010-12#1)(2010-8#2)(2011-1#2)(2013-1#5)
Internet-based##2##1##(2009-5#1)(2012-2#1)
Interobserver variation##2##2##(1991-12#1)(2009-11#1)
Interobserver##3##1##(1991-12#1)(2009-11#1)(2011-5#1)
Interparental conflict##2##2##(2010-1#2)
Interpersonal##2##1##(2008-1#1)(2010-8#1)
Interplay##2##1##(1993-5#1)(2010-7#1)
Interpolation##2##1##(1990-12#1)(2008-10#1)
Interpower##2##1##(2011-2#2)
Interpretation of the##2##3##(1992-2#1)(1992-4#1)
Interpretation of##8##2##(1992-2#1)(1992-4#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-6#1)
Interpretation##11##1##(1992-2#1)(1992-4#1)(1996-5#1)(2008-10#2)(2008-12#2)(2008-5#1)(2010-6#1)(2011-2#2)
Interprofessional Capability Framework##2##3##(2008-11#2)
Interprofessional education##4##2##(2008-11#3)(2008-12#1)
Interprofessional##10##1##(2008-11#8)(2008-12#2)
Interrupted##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
Intersex##2##1##(2008-10#2)
Interspecific crosses##2##2##(2008-10#2)
Interspecific##9##1##(2008-10#7)(2008-8#2)
Interstitial##3##1##(1991-8#1)(1997-3#2)
Interval##5##1##(1995-12#1)(2008-10#3)(2008-6#1)
Intervention on##2##2##(2012-2#1)(2012-3#1)
Intervention##17##1##(1992-9#1)(2008-12#3)(2008-4#4)(2008-8#2)(2010-10#2)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Interventional radiology##2##2##(2009-9#1)(2011-2#1)
Interventional##6##1##(1996-9#1)(1997-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2011-2#1)
Interventions in##2##2##(2008-2#1)(2013-1#1)
Interventions to##2##2##(2010-1#1)(2010-4#1)
Interventions##12##1##(2008-11#1)(2008-2#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#3)
Intervertebral##2##1##(1996-9#1)(2012-3#1)
Interview by Dr##8##3##(1996-9#2)(1997-2#1)(1997-6#1)(1997-8#4)
Interview by Elisabeth##2##3##(1996-3#1)(1997-2#1)
Interview by Marie E##7##4##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Interview by Steven Harulow##2##4##(2008-6#2)
Interview by Terry G##2##4##(1996-2#1)(1997-1#1)
Interview by##44##2##(1990-2#1)(1990-6#1)(1991-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#4)(2008-11#1)(2008-5#1)(2008-6#5)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
Interview for##2##2##(2008-11#1)(2013-1#1)
Interview with##2##2##(2010-5#1)(2010-8#1)
Interview##60##1##(1990-2#1)(1990-6#1)(1991-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#5)(2008-7#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
Interviews were analyzed using##2##4##(2010-10#1)(2013-1#1)
Interviews were analyzed##3##3##(2010-10#1)(2010-8#1)(2013-1#1)
Interviews were conducted with##2##4##(2009-5#1)(2009-9#1)
Interviews were##5##2##(2009-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2013-1#1)
Interviews with##2##2##(2008-11#1)(2013-1#1)
Interviews##7##1##(2008-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2013-1#2)
Intestinal Epithelial Cells##2##3##(2008-11#1)(2009-12#1)
Intestinal ischemia/reperfusion##2##2##(2010-5#2)
Intestinal obstruction##2##2##(2012-3#1)(2013-1#1)
Intestinal##15##1##(1990-5#1)(2008-11#4)(2009-12#1)(2010-5#2)(2012-12#2)(2012-3#2)(2013-1#3)
Inthe##2##1##(2008-11#2)
Inthis article##2##2##(2008-11#2)
Inthis##3##1##(2008-11#3)
Intimal hyperplasia##2##2##(1992-9#1)(2006-6#1)
Intimate##3##1##(1994-5#1)(2008-12#1)(2010-11#1)
Into Practice##2##2##(1996-2#1)(2009-12#1)
Into the##3##2##(1992-2#1)(2008-10#2)
Into##7##1##(1992-2#1)(1996-2#1)(2008-10#4)(2009-12#1)
Intra- and##2##2##(1990-11#1)(2008-10#1)
Intra-arterial##3##1##(1994-2#1)(1997-3#1)(2008-3#1)
Intra-articular##2##1##(2013-1#2)
Intra-day and inter-day##2##3##(2008-10#2)
Intracavity##3##1##(2008-3#3)
Intracellular calcium##2##2##(1994-2#1)(2008-10#1)
Intracellular free##2##2##(1992-6#1)(2008-9#1)
Intracellular recordings were made from##2##5##(2008-8#1)(2008-9#1)
Intracellular sodium##2##2##(1994-3#2)
Intracellular##26##1##(1990-5#1)(1990-8#2)(1991-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#3)(1996-2#1)(2008-10#2)(2008-11#6)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)
Intracerebral Hemorrhage##2##2##(2012-3#2)
Intracerebral hemorrhage##2##2##(2007-9#1)(2008-7#1)
Intracerebral##5##1##(2007-9#1)(2008-12#1)(2008-7#1)(2012-3#2)
Intraclass correlation##4##2##(2008-10#2)(2010-12#1)(2013-1#1)
Intracranial Aneurysms##2##2##(1995-11#1)(1997-3#1)
Intracranial##14##1##(1993-6#1)(1994-8#1)(1995-11#1)(1996-6#2)(1997-3#1)(2008-7#2)(2010-11#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Intractable##2##1##(1994-3#1)(1997-8#1)
Intracystic##2##1##(1992-2#1)(2011-2#1)
Intraductal papillary mucinous##2##3##(2012-2#1)(2012-3#1)
Intradural##2##1##(2010-9#1)(2012-3#1)
Intrafix device##2##2##(2008-11#2)
Intramedullary arthrodesis##2##2##(2008-8#2)
Intramedullary##8##1##(2008-7#3)(2008-8#2)(2010-5#1)(2012-3#2)
Intramolecular##5##1##(1996-5#3)(2008-8#1)(2010-6#1)
Intramuscular haemangioma of##2##3##(2010-5#2)
Intramuscular##6##1##(1990-12#1)(1991-8#1)(1997-8#1)(2007-11#1)(2010-5#2)
Intraoperative##15##1##(1991-3#1)(1996-9#1)(2008-10#1)(2008-7#3)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Intraoperatively##3##1##(2008-12#2)(2010-12#1)
Intraosseous##2##1##(2007-12#1)(2010-3#1)
Intrapleural##2##1##(1991-6#1)(1994-6#1)
Intraspecific variation in##2##3##(2012-2#2)
Intraspecific variation##3##2##(2008-10#1)(2012-2#2)
Intraspecific##9##1##(2008-10#6)(2012-2#2)(2012-3#1)
Intrathecal injection of##2##3##(2008-12#1)(2010-12#1)
Intrathecal##5##1##(1991-1#1)(1996-12#1)(2008-12#1)(2008-7#1)(2010-12#1)
Intratumoral##2##1##(1993-9#1)(2012-3#1)
Intrauterine##3##1##(1990-9#1)(2013-1#2)
Intravascular##3##1##(1996-6#1)(2008-11#1)(2008-7#1)
Intravenous administration of##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
Intravenous##14##1##(1991-1#1)(1991-6#1)(1993-1#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-8#1)
Intraventricular##2##1##(2008-7#2)
Intravesical##2##1##(1993-11#1)(2008-10#1)
Intravitreal bevacizumab##2##2##(2010-10#1)(2011-2#1)
Intravitreal##4##1##(2010-10#1)(2010-9#1)(2011-2#2)
Intriguingly##4##1##(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
Intrinsic and##2##2##(2008-11#1)(2010-10#1)
Intrinsic##5##1##(2008-11#1)(2008-3#1)(2009-8#1)(2010-10#1)(2011-2#1)
Introduced##3##1##(1996-5#1)(2008-10#2)
Introducing a##2##2##(1994-3#1)(1996-1#1)
Introducing the##4##2##(2008-10#1)(2008-11#2)(2010-2#1)
Introducing##19##1##(1992-12#2)(1993-3#1)(1994-3#2)(1994-5#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-11#4)(2008-8#1)(2010-2#1)(2010-9#1)(2011-2#2)(2013-1#1)
Introduction of a##3##3##(1994-3#1)(1995-2#1)(2008-8#1)
Introduction of pchBA into##2##4##(2008-10#2)
Introduction of##14##2##(1993-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
Introduction to peptide synthesis##2##4##(2008-4#2)
Introduction to the special issue##2##5##(2008-4#1)(2013-1#1)
Introduction to the##5##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
Introduction to##14##2##(1990-12#1)(1992-1#1)(2008-10#1)(2008-11#2)(2008-4#6)(2010-11#1)(2010-12#1)(2013-1#1)
Introduction##74##1##(1990-12#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(2006-5#1)(2008-10#6)(2008-11#8)(2008-12#3)(2008-4#7)(2008-8#1)(2008-9#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-12#10)(2012-2#1)(2012-3#3)(2013-1#11)(2013-8#1)
Introgression##2##1##(2008-10#1)(2008-2#1)
Introgressions##2##1##(2008-10#2)
Introns were identified in approximately##2##5##(1997-6#1)(1997-8#1)
Inuit##3##1##(2007-12#1)(2013-1#2)
Inula helenium L##3##3##(2008-10#1)(2008-5#2)
Inula##6##1##(2008-10#4)(2008-5#2)
Invading##2##1##(2008-10#2)
Invasion and##3##2##(2008-10#2)(2008-11#1)
Invasion of##2##2##(2008-10#2)
Invasion##7##1##(2008-10#4)(2008-11#2)(2013-1#1)
Invasive fungal##2##2##(2011-2#2)
Invasive##12##1##(1991-2#1)(1991-8#1)(2008-10#2)(2008-12#1)(2010-6#1)(2010-7#2)(2011-2#3)(2013-1#1)
Inventory##31##1##(1991-2#1)(1992-2#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-7#1)(2010-6#2)(2010-7#1)(2012-2#8)(2012-3#2)(2013-1#4)(2013-8#1)
Inventory)##2##1##(1992-1#1)(2008-2#1)
Inverse##7##1##(1992-11#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-3#1)(2011-2#1)
Inversion##3##1##(2008-3#2)(2009-11#1)
Investigated##2##1##(1990-2#1)(2008-7#1)
Investigating the##5##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#2)
Investigating##10##1##(2008-10#3)(2008-8#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#2)
Investigation and##2##2##(2008-10#1)(2013-8#1)
Investigation into the##2##3##(2008-10#1)(2009-1#1)
Investigation into##3##2##(2008-10#1)(2009-1#1)(2010-10#1)
Investigation of the##18##3##(1990-2#1)(1992-12#1)(1995-9#1)(2008-10#9)(2008-3#2)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#1)
Investigation of##36##2##(1990-2#1)(1992-12#1)(1995-9#1)(2008-10#20)(2008-3#4)(2008-5#2)(2008-8#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
Investigation on the##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
Investigation on##7##2##(2008-10#5)(2008-5#1)(2008-9#1)
Investigation was##2##2##(2007-11#1)(2008-10#1)
Investigation##53##1##(1990-2#1)(1992-12#1)(1995-9#1)(2007-11#1)(2008-10#28)(2008-3#4)(2008-5#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-10#2)(2010-2#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
Investigations into the##3##3##(2008-10#2)(2012-2#1)
Investigations into##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
Investigations of the##2##3##(2008-10#2)
Investigations of##6##2##(2008-10#5)(2008-11#1)
Investigations on the##2##3##(1994-5#1)(2008-10#1)
Investigations on##3##2##(1994-5#1)(2008-10#1)(2013-7#1)
Investigations revealed##3##2##(2008-11#1)(2010-9#1)(2013-1#1)
Investigations##23##1##(1991-8#1)(1992-1#1)(1994-5#1)(2008-10#11)(2008-11#3)(2008-9#1)(2009-7#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
Investigators have##2##2##(1991-3#1)(2010-11#1)
Investigators##10##1##(1991-3#1)(1994-6#1)(1995-5#1)(1995-8#1)(1997-8#1)(2010-11#1)(2010-8#1)(2012-2#3)
Investment##2##1##(2008-8#1)(2011-2#1)
Investments##2##1##(1996-3#1)(2008-5#1)
Involved in the Suppression of##2##5##(2008-10#2)
Involved in##5##2##(2008-10#4)(2008-6#1)
Involvement of protein kinase C##2##5##(1997-1#1)(2008-11#1)
Involvement of the##3##3##(1990-5#1)(1996-9#1)(1997-5#1)
Involvement of##21##2##(1990-2#1)(1990-5#1)(1994-3#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-5#3)(2008-8#1)(2011-2#3)
Involvement##24##1##(1990-2#1)(1990-5#1)(1992-12#1)(1994-3#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-5#3)(2008-8#1)(2010-10#1)(2011-2#3)
Involving patients##2##2##(2008-12#1)(2013-8#1)
Involving##4##1##(1995-9#1)(2008-12#2)(2013-8#1)
Inward##2##1##(1995-11#1)(2008-10#1)
Ioannina##4##1##(2008-10#4)
Iodide##3##1##(2008-10#3)
Iodine overload##2##2##(2011-1#2)
Iodine##5##1##(2011-1#3)(2012-3#2)
Ion channels are##2##3##(2012-2#1)(2012-3#1)
Ion chromatographic determination of some##2##5##(2008-10#2)
Ion chromatographic##3##2##(2008-10#3)
Ion exchange##2##2##(2008-10#2)
Ion mobility spectrometry##2##3##(2008-10#1)(2010-9#1)
Ion mobility##4##2##(2008-10#3)(2010-9#1)
Ion##19##1##(1996-9#1)(2008-10#12)(2008-12#1)(2009-8#1)(2010-9#1)(2012-2#2)(2012-3#1)
Ion-exchange##3##1##(2008-10#3)
Ion-pair extraction##3##2##(2008-10#3)
Ion-pair formation##2##2##(2008-10#2)
Ion-pair##6##1##(2008-10#6)
Ion-selective electrode for##2##3##(2008-10#2)
Ion-selective electrodes (ISEs)##2##3##(2008-10#2)
Ion-selective electrodes##5##2##(2008-10#5)
Ion-selective##7##1##(2008-10#7)
Ionic liquids##2##2##(2008-10#1)(2010-7#1)
Ionic##6##1##(2008-10#4)(2010-4#1)(2010-7#1)
Ions##2##1##(1996-9#1)(2008-10#1)
Iowa Gambling Task##2##3##(2008-10#1)(2013-8#1)
Iowa and##2##2##(2008-10#2)
Iowa##28##1##(1991-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#20)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
Ipomoea hederacea##2##2##(2008-8#2)
Ipomoea nil##3##2##(2008-10#3)
Ipomoea##5##1##(2008-10#3)(2008-8#2)
Ipomopsis aggregata##3##2##(2008-8#1)(2008-9#2)
Ipomopsis##4##1##(2008-8#2)(2008-9#2)
Ipsilateral##2##1##(1994-8#1)(1996-2#1)
Ir and##3##2##(2008-10#3)
Ir##15##1##(2008-10#15)
Ir(IV)##3##1##(2008-10#3)
Iralukast##2##1##(2008-5#2)
Iran and##2##2##(2008-12#1)(2013-1#1)
Iran during##2##2##(2008-12#1)(2012-2#1)
Iran##54##1##(1996-8#1)(2008-10#7)(2008-12#20)(2010-8#3)(2012-12#3)(2012-2#13)(2013-1#6)(2013-7#1)
Iran)##4##1##(2008-10#1)(2008-12#3)
Iranian##12##1##(2008-10#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)
Iraq and Afghanistan##2##3##(2013-1#2)
Iraq##3##1##(2008-10#1)(2013-1#2)
Iraqi##3##1##(2008-4#1)(2013-1#2)
Ireland##17##1##(2008-10#3)(2008-11#6)(2008-12#1)(2008-9#2)(2009-5#1)(2012-2#1)(2013-8#3)
Irgarol 1051 and##4##3##(2008-10#4)
Irgarol 1051##5##2##(2008-10#4)(2008-11#1)
Iridium##4##1##(1993-9#1)(2008-10#3)
Iris##3##1##(2008-10#1)(2008-8#1)(2013-1#1)
Irish perspective##2##2##(2008-11#2)
Irish population##2##2##(1991-12#2)
Irish##14##1##(1991-11#1)(1991-12#3)(2008-10#2)(2008-11#4)(2008-12#2)(2012-2#1)(2013-8#1)
Iron and copper##2##3##(2008-10#2)
Iron and##5##2##(1995-3#1)(2008-10#4)
Iron deficiency##2##2##(2008-1#1)(2012-2#1)
Iron is##2##2##(1993-11#1)(2008-10#1)
Iron was##2##2##(2008-10#2)
Iron##24##1##(1993-11#1)(1993-2#1)(1994-5#1)(1995-3#2)(1996-5#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-5#3)(2012-2#1)(2013-8#1)
Iron(III)##6##1##(2008-10#6)
Irradiated##3##1##(1995-8#1)(1996-9#1)(2008-11#1)
Irradiation of##2##2##(1996-5#1)(2012-2#1)
Irradiation##7##1##(1995-6#2)(1996-5#1)(2008-11#2)(2012-2#2)
Irrational##2##1##(2010-5#2)
Irrespective of the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
Irrespective of##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-8#1)
Irrigation Water##3##2##(2008-10#3)
Irrigation of##3##2##(1994-5#1)(2008-10#1)(2012-3#1)
Irrigation##11##1##(1994-5#1)(2008-10#9)(2012-3#1)
Irritable Bowel Syndrome##2##3##(2013-1#2)
Irritable##3##1##(2013-1#3)
Irritation was##2##2##(2008-5#2)
Irritation##4##1##(2008-5#4)
Irving##2##1##(1992-8#1)(1997-2#1)
Is Affected by##2##3##(2008-10#2)
Is Associated with a##2##4##(2008-10#2)
Is Associated with##5##3##(2008-10#5)
Is Caused by##2##3##(2008-10#2)
Is Characterized by##2##3##(2008-10#1)(2013-1#1)
Is It##3##2##(2011-2#2)(2012-3#1)
Is Mediated by##2##3##(2008-10#1)(2011-2#1)
Is There##2##2##(1996-9#1)(2012-2#1)
Is a Distinct##2##3##(2008-10#2)
Is a Novel##2##3##(2008-10#2)
Is a##11##2##(2008-10#8)(2011-2#2)(2013-1#1)
Is bigger really better?##2##4##(1994-3#2)
Is it just a little poke?##2##6##(2008-11#2)
Is it necessary for##2##4##(1991-1#1)(1992-2#1)
Is it##12##2##(1991-1#1)(1991-3#1)(1992-2#1)(1993-11#1)(1994-8#1)(2008-11#5)(2011-2#2)
Is laser surgery superior to cryosurgery for the treatment of high grade CIN?##2##13##(1992-1#2)
Is montelukast effective and well tolerated in the management of asthma in young children?##2##14##(2008-11#2)
Is the##10##2##(1991-11#1)(1991-2#1)(1994-8#1)(2008-10#2)(2011-2#2)(2012-2#1)(2012-3#2)
Is there a doctor in the house? (There could be another one##2##12##(2009-3#2)
Is there a place for##2##5##(1995-1#1)(2008-11#1)
Is there a role for##3##5##(2008-10#1)(2008-12#1)(2011-2#1)
Is there a##18##3##(1992-2#1)(1992-6#1)(1994-8#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Is there an##3##3##(2008-10#2)(2009-10#1)
Is there##23##2##(1992-2#1)(1992-6#1)(1993-1#1)(1994-8#1)(1995-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Is##131##1##(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#2)(1992-2#2)(1992-6#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-8#3)(1995-1#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(2008-10#43)(2008-11#11)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#3)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#13)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#4)(2013-7#2)
Isabella volatiles##3##2##(2008-10#3)
Isabella##5##1##(2008-10#5)
Isatis##2##1##(2012-3#1)(2013-8#1)
Ischaemic##2##1##(2008-10#1)(2013-1#1)
Ischemia##4##1##(1992-9#1)(1996-12#1)(2012-3#1)(2013-1#1)
Ischemic Damage##2##2##(2008-11#1)(2012-3#1)
Ischemic Heart Disease##3##3##(2008-1#1)(2013-1#2)
Ischemic##13##1##(1992-5#1)(1993-6#2)(2008-1#1)(2008-11#2)(2008-3#2)(2012-3#2)(2013-1#3)
Isfahan##7##1##(2008-10#1)(2008-12#4)(2012-12#2)
Ishikawa's criteria##3##2##(1997-8#3)
Ising model##2##2##(1992-11#1)(1993-5#1)
Ising##3##1##(1991-9#1)(1992-11#1)(1993-5#1)
Islam##3##1##(2008-12#2)(2012-2#1)
Islamabad##4##1##(2012-2#1)(2013-7#3)
Island of New Zealand##2##4##(2008-12#1)(2011-1#1)
Island of##5##2##(2008-12#1)(2011-1#1)(2011-2#3)
Island##39##1##(1990-11#1)(1991-8#1)(1992-3#1)(2008-1#4)(2008-10#11)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#6)(2012-3#5)(2013-8#2)
Islander##5##1##(1997-2#2)(2008-8#1)(2012-2#2)
Islanders##4##1##(1996-3#1)(2008-1#1)(2012-2#2)
Islands##17##1##(2008-1#5)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#7)(2011-4#1)
Islet cell antibodies (ICA)##2##4##(1994-12#2)
Islet cell##5##2##(1994-12#2)(2008-1#1)(2010-10#1)(2013-1#1)
Islet transplantation##2##2##(2010-10#1)(2010-12#1)
Islet##10##1##(1992-6#1)(1994-12#2)(2008-1#2)(2008-11#1)(2010-10#2)(2010-12#1)(2013-1#1)
Isocyanates##2##1##(1996-5#2)
Isoelectric focusing##2##2##(1991-12#1)(2008-11#1)
Isoflavonoids##2##1##(2011-1#2)
Isoflurane##3##1##(2010-7#1)(2012-3#2)
Isolate CS-1##2##2##(2008-10#2)
Isolate CS-20##2##2##(2008-10#2)
Isolate of##5##2##(2008-10#5)
Isolate##24##1##(2008-10#23)(2008-11#1)
Isolate-Specific##2##1##(2008-10#2)
Isolated cerebral##2##2##(2008-12#2)
Isolated dissection of##2##3##(2013-1#2)
Isolated fibroblast-like cells were cultured in the presence of osteogenic factors and differentiation determined by Alizarin Red S staining##2##19##(2008-11#2)
Isolated from##15##2##(2008-10#14)(2013-8#1)
Isolated##39##1##(1992-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-12#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-4#1)(2008-9#2)(2009-11#2)(2012-3#1)(2013-1#4)(2013-8#3)
Isolates Causing##2##2##(2008-10#2)
Isolates Collected from Potato##2##4##(2008-10#2)
Isolates Collected from##3##3##(2008-10#3)
Isolates derived from parent##2##4##(2008-10#2)
Isolates derived from##3##3##(2008-10#3)
Isolates from Wheat##3##3##(2008-10#3)
Isolates from a##2##3##(2008-10#2)
Isolates from all##2##3##(2008-10#2)
Isolates from the##5##3##(2008-10#5)
Isolates from these##2##3##(2008-10#2)
Isolates from##34##2##(2008-10#33)(2011-2#1)
Isolates in the##2##3##(2008-10#1)(2012-2#1)
Isolates in##6##2##(2008-10#5)(2012-2#1)
Isolates obtained from##2##3##(2008-10#2)
Isolates obtained##3##2##(2008-10#3)
Isolates of Bean pod mottle virus##2##6##(2008-10#2)
Isolates of Botrytis cinerea##3##4##(2008-10#3)
Isolates of C##6##3##(2008-10#6)
Isolates of Colletotrichum spp##3##4##(2008-10#3)
Isolates of Colletotrichum##5##3##(2008-10#5)
Isolates of F##3##3##(2008-10#3)
Isolates of Fusarium##2##3##(2008-10#2)
Isolates of P##5##3##(2008-10#5)
Isolates of Phytophthora infestans##2##4##(2008-10#2)
Isolates of Phytophthora##3##3##(2008-10#3)
Isolates of Puccinia##4##3##(2008-10#4)
Isolates of Rhizoctonia solani##3##4##(2008-10#3)
Isolates of Rhizoctonia##4##3##(2008-10#4)
Isolates of S##2##3##(2008-10#2)
Isolates of Venturia inaequalis##2##4##(2008-10#2)
Isolates of Verticillium dahliae Pathogenic##2##5##(2008-10#2)
Isolates of Verticillium##3##3##(2008-10#3)
Isolates of a##2##3##(2008-10#2)
Isolates of the##6##3##(2008-10#6)
Isolates of##75##2##(2008-10#73)(2009-6#1)(2011-2#1)
Isolates resistant to##2##3##(2008-10#1)(2008-5#1)
Isolates resistant##3##2##(2008-10#2)(2008-5#1)
Isolates that were##3##3##(2008-10#3)
Isolates that##6##2##(2008-10#6)
Isolates were found to##2##4##(2008-10#2)
Isolates were identified##2##3##(2008-10#1)(2012-3#1)
Isolates were sampled in##3##4##(2008-10#3)
Isolates were scored for##2##4##(2008-10#2)
Isolates were##19##2##(2008-10#18)(2012-3#1)
Isolates with##5##2##(2008-10#5)
Isolates##188##1##(2008-10#178)(2008-5#2)(2009-6#1)(2011-2#2)(2012-2#3)(2012-3#2)
Isolating##2##1##(2008-10#1)(2008-11#1)
Isolation and Characterization of a##2##5##(2008-10#2)
Isolation and Characterization of##7##4##(2008-10#5)(2008-11#1)(2013-8#1)
Isolation and analysis of##3##4##(1991-6#1)(2008-10#1)(2008-9#1)
Isolation and characterization of a##5##5##(1992-8#1)(1994-11#1)(1996-6#1)(2008-8#2)
Isolation and characterization of##11##4##(1990-11#1)(1991-6#2)(1992-8#1)(1993-9#1)(1994-11#1)(1996-6#1)(2008-10#1)(2008-8#2)(2011-1#1)
Isolation and identification of##2##4##(2008-5#1)(2012-2#1)
Isolation and structural characterization of##2##5##(1993-8#1)(2008-10#1)
Isolation and##45##2##(1990-11#1)(1990-8#1)(1991-6#3)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-11#1)(1996-6#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#5)(2008-9#2)(2009-10#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-8#1)
Isolation of a##6##3##(1993-9#1)(1994-6#1)(1997-7#1)(2008-5#1)(2008-8#1)(2012-2#1)
Isolation of human##3##3##(1995-12#1)(2008-9#2)
Isolation of mesenchymal stem cells from##2##6##(2008-9#2)
Isolation of progenitor cells from cord blood using adhesion matrices##2##10##(2008-11#2)
Isolation of the##6##3##(1993-12#1)(1993-2#1)(2008-4#1)(2008-5#2)(2010-2#1)
Isolation of##53##2##(1990-5#1)(1991-5#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-6#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#7)(2008-8#2)(2008-9#9)(2010-2#1)(2010-5#1)(2011-2#3)(2012-2#1)
Isolation##106##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#2)(1991-6#3)(1992-8#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-6#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#8)(2008-5#8)(2008-8#8)(2008-9#11)(2009-10#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-8#2)
Isolators##2##1##(2012-2#2)
Isometric##2##1##(2008-10#1)(2012-2#1)
Isophya stysi##2##2##(2013-8#2)
Isophya##18##1##(2013-8#18)
Isoprocarb##2##1##(2008-10#2)
Isoproterenol increased##2##2##(2008-11#1)(2011-2#1)
Isoproterenol##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
Isothiocyanates##3##1##(1996-5#1)(2008-10#2)
Isotope##2##1##(2008-10#1)(2008-11#1)
Isotopic##3##1##(1991-5#1)(2008-10#1)(2010-3#1)
Isovalerylcarnitine##2##1##(1990-2#2)
Isozyme Q2##3##2##(1993-6#3)
Isozyme##7##1##(1993-6#3)(2008-10#4)
Israel and the United States##2##5##(2008-10#1)(2008-5#1)
Israel and##5##2##(2008-10#4)(2008-5#1)
Israel during##2##2##(2008-10#2)
Israel were##2##2##(2008-10#2)
Israel##51##1##(1993-12#1)(1996-2#1)(1997-1#1)(2008-10#41)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2013-8#1)
Israeli and##2##2##(2008-10#2)
Israeli isolates##2##2##(2008-10#2)
Israeli##17##1##(1997-8#1)(2008-10#13)(2008-8#1)(2010-8#1)(2013-1#1)
Issue##6##1##(2008-11#3)(2008-12#1)(2008-3#1)(2011-2#1)
Issues and##3##2##(1995-5#1)(2008-12#1)(2012-3#1)
Issues in##6##2##(1991-1#1)(1994-1#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-11#1)
Issues related to##2##3##(1996-6#1)(2008-2#1)
Issues such as##2##3##(2008-10#2)
Issues that##2##2##(2008-11#1)(2012-2#1)
Issues##24##1##(1991-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1994-1#1)(1995-2#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2012-2#1)(2012-3#1)
Istituto Nazionale##3##2##(1990-12#1)(1991-6#1)(2008-4#1)
Istituto##5##1##(1990-12#1)(1991-6#1)(2008-10#1)(2008-4#2)
It addresses the##2##3##(2008-12#1)(2008-9#1)
It addresses##4##2##(1997-1#1)(2008-11#1)(2008-12#1)(2008-9#1)
It affects##2##2##(1997-1#1)(2012-3#1)
It aims to##2##3##(2008-7#2)
It allows for##2##3##(2013-1#2)
It allows##6##2##(2008-10#2)(2008-11#1)(2008-4#1)(2013-1#2)
It also allows##2##3##(1996-6#1)(2010-12#1)
It also considers##4##3##(2008-11#2)(2008-8#1)(2010-12#1)
It also demonstrates that##2##4##(2008-3#1)(2013-1#1)
It also demonstrates##3##3##(1995-12#1)(2008-3#1)(2013-1#1)
It also describes the##2##4##(2008-11#1)(2008-7#1)
It also discusses##5##3##(1991-12#1)(1996-9#1)(2008-1#1)(2008-4#2)
It also has##2##3##(2008-5#1)(2009-3#1)
It also offers##2##3##(2007-12#1)(2008-4#1)
It also presents##4##3##(1991-3#1)(1996-1#1)(2008-12#1)(2010-11#1)
It also produces##2##3##(2008-10#1)(2008-7#1)
It also provides a##2##4##(1993-3#1)(2008-8#1)
It also provides##5##3##(1993-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
It also reviews the##2##4##(1991-2#1)(2008-2#1)
It also reviews##3##3##(1991-2#1)(2008-2#1)(2013-1#1)
It also showed##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
It also shows that##2##4##(2010-7#1)(2011-2#1)
It also tells##3##3##(1994-6#2)(2008-7#1)
It also will##2##3##(2008-10#1)(2008-9#1)
It also##78##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-12#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#8)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#4)(2013-1#3)
It appeared that the##4##4##(2008-10#2)(2008-5#1)(2012-3#1)
It appeared##10##2##(1991-3#1)(1993-12#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-3#1)
It appears that the##6##4##(1991-6#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#1)
It appears that##17##3##(1991-6#1)(1991-7#1)(1992-3#2)(1992-9#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-2#1)
It appears to be a##2##5##(2008-10#1)(2010-7#1)
It appears##21##2##(1991-6#1)(1991-7#1)(1992-3#2)(1992-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#2)(2010-7#1)(2011-2#2)(2012-2#1)
It argues that##2##3##(1995-1#1)(2008-1#1)
It assesses##2##2##(2008-11#1)(2012-2#1)
It avoids the##2##3##(2010-12#1)(2012-3#1)
It avoids##3##2##(1993-3#1)(2010-12#1)(2012-3#1)
It became##3##2##(1991-1#1)(2008-11#1)(2008-5#1)
It begins by##2##3##(2008-11#2)
It begins##3##2##(2008-11#2)(2008-12#1)
It binds##2##2##(2008-6#1)(2012-2#1)
It can also be used##2##5##(2008-10#1)(2008-4#1)
It can also be##3##4##(2008-10#1)(2008-4#1)(2010-7#1)
It can also##5##3##(2008-10#3)(2008-4#1)(2010-7#1)
It can be clearly##2##4##(1991-2#1)(2008-3#1)
It can be concluded that##4##5##(1994-8#1)(1996-11#1)(2008-10#1)(2011-3#1)
It can be concluded##5##4##(1994-8#1)(1996-11#1)(2008-10#1)(2011-3#1)(2013-1#1)
It can be said that##2##5##(1990-2#1)(2011-2#1)
It can be used to##2##5##(2008-11#1)(2010-7#1)
It can be used##6##4##(1994-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)(2013-8#1)
It can be##33##3##(1990-2#1)(1991-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#2)
It can occur in##2##4##(2008-12#1)(2011-2#1)
It can##48##2##(1990-2#1)(1991-2#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-11#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
It causes##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
It compares##2##2##(2008-10#1)(2008-9#1)
It comprised##2##2##(1991-9#1)(2008-10#1)
It concludes that##2##3##(1996-12#1)(2013-8#1)
It concludes with a discussion of##2##6##(2008-9#1)(2012-2#1)
It concludes with##6##3##(1996-3#1)(1996-9#1)(1997-2#1)(2008-9#1)(2009-3#1)(2012-2#1)
It concludes##8##2##(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
It consisted of##2##3##(2008-5#1)(2012-3#1)
It consists in##2##3##(1994-5#1)(2008-10#1)
It consists of##5##3##(1994-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
It consists##7##2##(1994-5#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
It contains##5##2##(1993-2#1)(1995-12#1)(2008-1#1)(2008-8#1)(2010-8#1)
It could be inferred that##2##5##(2008-8#1)(2010-6#1)
It could be shown##3##4##(1997-1#2)(2008-10#1)
It could be used##3##4##(2008-10#3)
It could be##9##3##(1997-1#2)(2008-10#5)(2008-8#1)(2010-6#1)
It could detect##2##3##(2008-10#2)
It could##15##2##(1995-6#1)(1997-1#2)(2008-10#8)(2008-8#2)(2010-6#1)(2012-2#1)
It covers##2##2##(2008-9#2)
It defines##2##2##(2008-2#1)(2008-4#1)
It demonstrated##2##2##(2008-9#1)(2013-1#1)
It describes the##2##3##(1994-12#1)(2008-1#1)
It describes##6##2##(1994-12#1)(1997-3#1)(2008-1#1)(2008-4#3)
It did not##3##3##(1995-6#1)(2008-10#2)
It did##4##2##(1992-6#1)(1995-6#1)(2008-10#2)
It discusses selecting the solid support and common coupling reagents##2##10##(2008-4#2)
It discusses the##4##3##(1995-12#1)(1996-2#1)(1996-3#1)(2008-6#1)
It discusses##7##2##(1995-12#1)(1996-2#1)(1996-3#1)(2008-12#1)(2008-4#2)(2008-6#1)
It does not interfere with the coupling reaction and leads to very good coupling yields under DNA-coupling conditions##2##18##(2008-4#2)
It does not##7##3##(1991-3#1)(1994-6#1)(1995-2#1)(2008-3#1)(2008-4#3)
It does##8##2##(1991-3#1)(1994-6#1)(1995-2#1)(2008-12#1)(2008-3#1)(2008-4#3)
It enables##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
It exhibits##4##2##(2008-10#3)(2008-11#1)
It exists in##2##3##(1990-6#1)(2012-3#1)
It explores the##2##3##(2008-11#1)(2013-8#1)
It facilitates##2##2##(2008-10#1)(2010-10#1)
It further##4##2##(1994-12#1)(1996-2#2)(2012-2#1)
It generally##2##2##(2008-10#1)(2008-7#1)
It gives##2##2##(1994-12#1)(2008-10#1)
It had a##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
It had been applied to the determination of##2##8##(2008-10#2)
It had been applied to the##3##6##(2008-10#3)
It had been##4##3##(2008-10#3)(2012-3#1)
It had##9##2##(2007-8#1)(2008-10#6)(2012-3#1)(2013-1#1)
It has a fast response time of &lt##3##8##(2008-10#3)
It has a fast response time of about 10 s and##2##11##(2008-10#2)
It has a fast response time of##6##7##(2008-10#6)
It has a response time of &lt##3##7##(2008-10#3)
It has a response time of##4##6##(2008-10#4)
It has a significant impact on##2##6##(2009-8#1)(2011-2#1)
It has a##19##3##(1996-2#1)(2008-10#12)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#3)
It has also been found##2##5##(2008-10#1)(2008-12#1)
It has also been shown that##3##6##(1994-8#1)(2008-3#1)(2008-7#1)
It has also been##9##4##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)
It has also##10##3##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)
It has become a##2##4##(2009-9#1)(2012-2#1)
It has become##3##3##(2008-9#1)(2009-9#1)(2012-2#1)
It has been also found that##2##6##(2008-10#2)
It has been applied to##2##5##(2008-10#2)
It has been assumed that##2##5##(2008-11#1)(2008-2#1)
It has been concluded that##2##5##(1990-9#1)(2008-10#1)
It has been confirmed that##2##5##(1995-8#1)(2008-10#1)
It has been demonstrated that the##2##6##(2008-11#1)(2008-12#1)
It has been demonstrated that##10##5##(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)
It has been demonstrated##11##4##(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)
It has been established that##3##5##(2008-10#1)(2008-11#1)(2011-2#1)
It has been estimated that##2##5##(1994-2#1)(2008-11#1)
It has been found that the##3##6##(2008-10#2)(2008-5#1)
It has been found that##6##5##(2008-10#3)(2008-5#2)(2010-4#1)
It has been found##8##4##(2008-10#5)(2008-5#2)(2010-4#1)
It has been hypothesized that##2##5##(2009-8#1)(2011-3#1)
It has been observed that the##2##6##(2008-10#2)
It has been postulated that##3##5##(1990-5#1)(1991-2#1)(2008-10#1)
It has been previously demonstrated that##2##6##(1995-6#1)(2011-2#1)
It has been previously shown that##2##6##(2008-12#1)(2009-7#1)
It has been previously##5##4##(1994-2#1)(1995-6#1)(2008-12#1)(2009-7#1)(2011-2#1)
It has been proposed that the##2##6##(1990-5#1)(1994-2#1)
It has been proposed that##6##5##(1990-5#1)(1994-2#1)(2008-11#2)(2008-8#1)(2009-8#1)
It has been proposed##7##4##(1990-5#1)(1994-2#1)(2008-11#3)(2008-8#1)(2009-8#1)
It has been proved that##4##5##(2008-10#2)(2008-9#1)(2011-2#1)
It has been proven##2##4##(2008-11#2)
It has been recently demonstrated that##2##6##(1994-8#1)(2011-1#1)
It has been recommended that##2##5##(2008-1#1)(2008-12#1)
It has been reported that##10##5##(1991-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-10#1)(2011-2#2)
It has been shown that the##3##6##(1997-7#1)(2008-10#2)
It has been shown that##14##5##(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
It has been shown to##2##5##(1993-3#1)(2008-5#1)
It has been shown##18##4##(1993-3#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
It has been speculated that##2##5##(2008-10#1)(2008-5#1)
It has been speculated##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
It has been stated that##2##5##(2008-11#1)(2010-10#1)
It has been successfully applied to##3##6##(2008-10#3)
It has been successfully used as an indicator electrode in##2##10##(2008-10#2)
It has been successfully##5##4##(2008-10#5)
It has been suggested that the##2##6##(1997-3#1)(2008-8#1)
It has been suggested that##16##5##(1990-5#1)(1991-2#1)(1993-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
It has been used for the##2##6##(2008-10#2)
It has been used for##4##5##(2008-10#4)
It has been widely used##2##5##(2008-10#1)(2012-3#1)
It has been##141##3##(1990-5#3)(1990-9#1)(1991-2#3)(1993-3#1)(1993-6#1)(1994-2#4)(1994-8#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#41)(2008-11#17)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
It has long been##2##4##(2011-2#1)(2012-2#1)
It has previously been##2##4##(1994-2#1)(2008-8#1)
It has recently##2##3##(2008-8#1)(2013-1#1)
It has the##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
It has##208##2##(1990-2#1)(1990-5#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1992-8#1)(1993-3#1)(1993-6#1)(1994-2#5)(1994-8#3)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#63)(2008-11#21)(2008-12#7)(2008-2#3)(2008-3#4)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#14)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
It highlights some##2##3##(2008-10#1)(2008-11#1)
It highlights##5##2##(2008-10#1)(2008-11#3)(2008-12#1)
It includes a##3##3##(1994-2#1)(2008-4#1)(2013-1#1)
It includes the##2##3##(2011-2#1)(2013-7#1)
It includes##7##2##(1994-2#1)(1996-2#1)(2007-11#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
It involves a##2##3##(1992-3#1)(2008-7#1)
It involves the##3##3##(1990-12#1)(2008-10#1)(2012-2#1)
It involves##10##2##(1990-12#1)(1992-3#1)(1992-6#1)(2008-10#3)(2008-7#1)(2010-8#1)(2012-2#2)
It is a relatively##2##4##(2008-1#1)(2012-3#1)
It is a simple##2##4##(2008-10#1)(2012-2#1)
It is a##45##3##(1990-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-1#1)(1994-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)
It is also found in##2##5##(1997-2#1)(2008-5#1)
It is also found##3##4##(1997-2#1)(2008-5#1)(2010-7#1)
It is also important to##2##5##(1993-6#1)(2008-7#1)
It is also of##2##4##(1993-11#1)(2008-9#1)
It is also possible to##2##5##(1997-4#1)(2008-6#1)
It is also shown that##4##5##(2007-11#1)(2008-3#1)(2008-4#1)(2009-7#1)
It is also##26##3##(1990-12#1)(1991-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-7#1)(2012-2#1)
It is an##7##3##(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-6#1)(2011-2#2)
It is anticipated that##2##4##(1991-2#1)(1997-7#1)
It is anticipated##3##3##(1991-2#1)(1997-7#1)(2008-12#1)
It is apparent that the##2##5##(2006-6#1)(2008-10#1)
It is apparent that##4##4##(1995-12#1)(2006-6#1)(2008-10#1)(2011-1#1)
It is argued that nursing outcomes and interventions that include findings of CS are difficult to interpret due to lack of an operational definition##2##24##(2013-1#2)
It is argued that the##2##5##(2008-10#1)(2008-9#1)
It is argued that##10##4##(1991-3#1)(1994-8#1)(2008-10#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2013-1#2)
It is associated with##3##4##(1995-2#1)(1997-1#1)(2009-8#1)
It is assumed that##3##4##(2008-10#1)(2009-8#1)(2012-2#1)
It is based on a##4##5##(1997-2#1)(2008-10#1)(2008-3#2)
It is based on the adsorption of##2##7##(2008-10#2)
It is based on the catalytic effect of##2##8##(2008-10#2)
It is based on the direct##2##6##(2008-10#2)
It is based on the reaction between##2##7##(2008-10#2)
It is based on the reaction##3##6##(2008-10#3)
It is based on the##27##5##(1995-12#1)(2008-10#24)(2008-3#1)(2008-9#1)
It is based on##39##4##(1991-9#1)(1995-12#1)(1997-2#1)(2008-10#32)(2008-3#3)(2008-9#1)
It is believed that##5##4##(1991-3#1)(1997-6#1)(2008-10#2)(2011-2#1)
It is characterized by an##2##5##(2008-11#1)(2008-12#1)
It is characterized by##8##4##(1995-3#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#1)(2010-6#1)
It is clear from the##3##5##(2008-11#2)(2009-1#1)
It is clear that the##2##5##(2008-10#1)(2008-11#1)
It is clear that##9##4##(1995-11#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-8#1)(2011-2#1)
It is clear##14##3##(1995-11#1)(1996-3#1)(2008-10#1)(2008-11#6)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2011-2#1)
It is completely stable to all reaction conditions applied during assembly and the first deprotection step##2##16##(2008-4#2)
It is composed of##5##4##(1994-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
It is conceivable that##3##4##(1995-6#1)(2008-7#1)(2009-10#1)
It is concluded from##3##4##(2008-12#1)(2008-6#1)(2011-2#1)
It is concluded that both##2##5##(1993-2#1)(1995-11#1)
It is concluded that it is##2##6##(2008-11#1)(2008-8#1)
It is concluded that it##3##5##(2008-11#1)(2008-8#1)(2010-10#1)
It is concluded that the##13##5##(1991-2#1)(1991-6#1)(1992-12#1)(1993-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
It is concluded that##65##4##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#3)(1996-3#2)(1997-2#3)(1997-3#1)(1997-8#4)(1997-9#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
It is concluded##71##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#3)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#3)(1996-3#2)(1997-2#3)(1997-3#1)(1997-8#4)(1997-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
It is considered that the##2##5##(2008-10#1)(2008-6#1)
It is considered that##4##4##(2008-10#2)(2008-6#1)(2009-7#1)
It is considered##6##3##(2008-10#2)(2008-6#1)(2008-8#1)(2009-7#1)(2013-7#1)
It is contended that the##2##5##(2008-11#2)
It is critical to##2##4##(2008-11#1)(2011-2#1)
It is critical##3##3##(1996-3#1)(2008-11#1)(2011-2#1)
It is crucial that##3##4##(1995-5#1)(2010-9#1)(2013-1#1)
It is crucial##4##3##(1995-5#1)(2008-5#1)(2010-9#1)(2013-1#1)
It is demonstrated for the first time that##2##8##(2008-10#2)
It is demonstrated that##11##4##(1993-8#1)(2007-12#1)(2008-10#4)(2008-3#4)(2013-1#1)
It is demonstrated##14##3##(1993-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#4)(2013-1#1)
It is determined##2##3##(2008-10#1)(2008-3#1)
It is difficult to##6##4##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
It is difficult##7##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
It is discussed##2##3##(1994-8#1)(2012-3#1)
It is doubtful that##2##4##(1994-8#1)(2008-10#1)
It is easy to##2##4##(2008-10#1)(2008-11#1)
It is emphasized that##4##4##(1996-12#1)(2008-1#1)(2008-7#1)(2010-11#1)
It is emphasized##5##3##(1991-3#1)(1996-12#1)(2008-1#1)(2008-7#1)(2010-11#1)
It is essential to##3##4##(1992-3#1)(1997-7#1)(2008-11#1)
It is essential##5##3##(1992-3#1)(1997-2#1)(1997-7#1)(2008-11#2)
It is established##2##3##(2011-2#2)
It is estimated that about##2##5##(1990-2#1)(2009-8#1)
It is estimated that##8##4##(1990-2#1)(1991-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)
It is estimated##9##3##(1990-2#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)
It is evident that##7##4##(1992-1#1)(1993-12#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-3#1)
It is expected from these findings that##2##7##(2008-11#2)
It is expected that##8##4##(1991-1#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2012-3#1)
It is expected##10##3##(1991-1#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-3#1)(2012-3#1)
It is found that the fluorescence intensity of##2##8##(2008-10#2)
It is found that the##6##5##(1990-8#1)(2008-10#2)(2008-3#2)(2010-3#1)
It is found that##20##4##(1990-3#1)(1990-8#1)(1994-9#1)(1996-5#1)(2008-10#8)(2008-3#4)(2008-5#1)(2008-8#2)(2010-3#1)
It is found##22##3##(1990-3#1)(1990-8#1)(1994-9#1)(1996-5#1)(2008-10#8)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2010-3#1)(2012-3#1)
It is free##2##3##(1991-8#1)(2008-10#1)
It is further argued that the absence of a consistent operational definition is incompatible with EBPs which require standardization of terminology##2##21##(2013-1#2)
It is further argued that the##3##6##(2008-9#1)(2013-1#2)
It is further proposed that the##2##6##(1993-8#1)(2013-8#1)
It is further##7##3##(1993-8#1)(2008-9#1)(2009-12#1)(2013-1#3)(2013-8#1)
It is generally accepted that##2##5##(2008-11#1)(2012-3#1)
It is generally agreed that##3##5##(1992-3#1)(2008-10#1)(2009-8#1)
It is generally##12##3##(1992-3#1)(1995-2#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-10#1)(2012-3#2)(2013-8#1)
It is highly##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
It is hoped that by##2##5##(2008-11#1)(2013-1#1)
It is hoped that our##2##5##(2008-11#1)(2010-8#1)
It is hoped that the preliminary findings from the concept analysis presented in this article will facilitate the work of such a consensus forum##2##24##(2013-1#2)
It is hoped that the##7##5##(1991-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#2)
It is hoped that this##6##5##(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2012-2#1)
It is hoped that##18##4##(1991-1#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)
It is however##2##3##(1992-9#1)(2008-11#1)
It is hypothesized that the##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
It is hypothesized that this##2##5##(2008-10#1)(2009-8#1)
It is hypothesized that##7##4##(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
It is important for##5##4##(1992-3#1)(1995-9#1)(2008-11#1)(2009-9#1)(2012-3#1)
It is important that the##2##5##(2008-12#1)(2008-7#1)
It is important that we##2##5##(1991-1#1)(2008-5#1)
It is important that##10##4##(1991-1#1)(1992-1#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2013-1#1)
It is important to be##2##5##(1995-2#1)(2008-2#1)
It is important to determine##2##5##(2008-5#1)(2008-8#1)
It is important to realize that##2##6##(1991-2#1)(2008-10#1)
It is important to understand the##2##6##(2008-10#1)(2008-5#1)
It is important to understand##4##5##(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
It is important to##23##4##(1991-11#1)(1991-2#1)(1991-6#1)(1993-6#1)(1995-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#3)(2013-1#2)(2013-8#1)
It is important##40##3##(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-6#1)(1995-2#2)(1995-9#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
It is in phase##2##4##(2008-5#2)
It is in##5##3##(2008-11#1)(2008-5#2)(2009-11#1)(2012-12#1)
It is increasingly##3##3##(2009-9#1)(2010-1#1)(2012-3#1)
It is interesting that##3##4##(1992-12#1)(2008-11#1)(2008-9#1)
It is interesting##4##3##(1992-12#1)(2008-11#2)(2008-9#1)
It is involved in##2##4##(2008-5#1)(2012-2#1)
It is known that##5##4##(1991-3#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
It is known##9##3##(1991-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)
It is likely that##5##4##(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2013-1#1)
It is likely##8##3##(1991-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-9#1)(2013-1#1)
It is more##3##3##(2010-8#1)(2011-2#2)
It is most##4##3##(1992-1#1)(1996-11#1)(2008-10#1)(2008-5#1)
It is necessary to##6##4##(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
It is necessary##7##3##(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
It is neither##2##3##(2008-5#1)(2008-9#1)
It is not always easy##2##5##(2008-11#1)(2010-9#1)
It is not clear whether these##2##6##(2008-11#2)
It is not clear whether##4##5##(2008-10#2)(2008-11#2)
It is not clear yet##2##5##(2008-10#1)(2008-11#1)
It is not clear##7##4##(1993-12#1)(2008-10#3)(2008-11#3)
It is not known whether##3##5##(1990-5#1)(2008-11#1)(2008-7#1)
It is not known##7##4##(1990-5#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-7#2)
It is not##30##3##(1990-5#1)(1991-12#1)(1991-6#1)(1993-12#1)(1994-1#1)(1995-5#1)(1996-11#1)(1997-7#2)(2008-10#4)(2008-11#7)(2008-5#3)(2008-7#2)(2010-11#2)(2010-9#1)(2011-2#1)(2013-1#1)
It is noteworthy that there##2##5##(1992-12#1)(2008-8#1)
It is noteworthy that##4##4##(1992-12#1)(1995-8#1)(2008-3#1)(2008-8#1)
It is now becoming##2##4##(2008-7#1)(2009-3#1)
It is now clear that##2##5##(2008-7#1)(2011-2#1)
It is now known that##2##5##(2009-4#1)(2011-2#1)
It is now possible to##2##5##(2008-10#1)(2012-2#1)
It is now recognised##2##4##(2008-11#1)(2010-12#1)
It is now the##2##4##(1992-5#1)(2013-1#1)
It is now##18##3##(1992-5#1)(1995-2#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
It is observed that the##2##5##(2008-10#2)
It is observed that##3##4##(2008-10#3)
It is of phylogenetic interest because of##2##7##(2011-2#2)
It is of phylogenetic interest because##3##6##(2011-2#3)
It is of##9##3##(1990-12#1)(1991-6#1)(1997-1#1)(2008-11#1)(2008-12#2)(2011-2#3)
It is often##7##3##(1993-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-6#1)(2010-11#1)(2013-1#1)
It is one of the##2##5##(2008-1#1)(2008-10#1)
It is one of##3##4##(1994-12#1)(2008-1#1)(2008-10#1)
It is only##2##3##(2008-10#1)(2008-5#1)
It is our##3##3##(1994-6#1)(1997-3#1)(2011-2#1)
It is particularly##4##3##(2008-11#3)(2008-3#1)
It is performed##2##3##(2012-2#1)(2013-1#1)
It is possible that a##2##5##(1995-8#1)(2009-1#1)
It is possible that the##3##5##(1994-5#1)(2008-12#1)(2008-5#1)
It is possible that##12##4##(1993-2#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-8#1)(2012-2#1)
It is possible to extract##2##5##(2008-10#1)(2008-11#1)
It is possible to##6##4##(1991-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
It is possible##18##3##(1991-11#1)(1993-2#1)(1994-5#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-1#1)(2010-8#1)(2012-2#1)
It is postulated that##2##4##(2008-11#1)(2010-10#1)
It is postulated##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
It is preferable to##2##4##(2008-11#1)(2013-1#1)
It is preferable##3##3##(2008-11#2)(2013-1#1)
It is presumed that##2##4##(1995-8#1)(2011-2#1)
It is probable that##2##4##(1995-8#1)(2008-12#1)
It is probably##2##3##(1994-2#1)(2008-10#1)
It is proposed that the##5##5##(2008-1#1)(2008-10#1)(2009-6#1)(2010-10#1)(2013-8#1)
It is proposed that these##2##5##(1996-12#1)(2008-11#1)
It is proposed that##18##4##(1991-2#1)(1995-5#1)(1996-12#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-7#1)(2009-6#1)(2010-10#1)(2013-8#1)
It is proposed##20##3##(1991-2#1)(1995-5#1)(1996-12#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-7#1)(2009-6#1)(2010-10#1)(2012-2#1)(2013-8#1)
It is quite##2##3##(2008-8#1)(2008-9#1)
It is rarely##2##3##(2008-11#1)(2010-10#1)
It is recommended that##3##4##(1991-3#1)(2008-11#1)(2012-2#1)
It is recommended##6##3##(1991-3#1)(1992-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
It is reported that##2##4##(1994-5#1)(2011-2#1)
It is reported##3##3##(1994-5#1)(2011-2#1)(2013-1#1)
It is shown here that##3##5##(1992-3#1)(2008-10#1)(2008-3#1)
It is shown that a##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
It is shown that in the##2##6##(2008-10#2)
It is shown that the instrument is##2##7##(2008-10#1)(2010-12#1)
It is shown that the##24##5##(1997-2#1)(2008-10#10)(2008-2#2)(2008-3#9)(2008-6#1)(2010-12#1)
It is shown that these##2##5##(2008-10#2)
It is shown that##67##4##(1991-3#1)(1994-5#1)(1997-2#1)(2007-12#2)(2008-10#28)(2008-11#1)(2008-2#5)(2008-3#21)(2008-5#1)(2008-6#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-2#1)
It is shown##76##3##(1991-3#1)(1992-3#1)(1994-5#1)(1997-2#1)(2007-12#3)(2008-10#32)(2008-11#2)(2008-2#5)(2008-3#22)(2008-5#1)(2008-6#1)(2008-8#3)(2010-12#1)(2011-1#1)(2012-2#1)
It is speculated that##2##4##(1995-11#1)(2008-10#1)
It is still##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
It is suggested that an##2##5##(2008-7#1)(2008-8#1)
It is suggested that complete research must be performed in order to find out the source of aflatoxin M1 contamination##2##20##(2013-1#2)
It is suggested that in##2##5##(2008-11#1)(2013-1#1)
It is suggested that the##14##5##(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#2)(1993-6#1)(1997-2#1)(2006-6#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#1)
It is suggested that there##2##5##(2008-10#1)(2008-8#1)
It is suggested that this##4##5##(1990-2#1)(1997-7#1)(2008-10#1)(2008-12#1)
It is suggested that##50##4##(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#3)(1992-3#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#5)(2008-11#6)(2008-12#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#3)
It is suggested##54##3##(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#4)(1992-3#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#5)(2008-11#6)(2008-12#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#3)(2013-8#1)
It is the first##3##4##(1994-3#1)(2008-10#1)(2008-9#1)
It is the responsibility of##2##5##(1995-9#1)(2008-11#1)
It is the##18##3##(1990-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-6#1)(2012-3#1)(2013-1#1)
It is therefore desirable to##2##5##(2008-10#1)(2008-11#1)
It is therefore important that##2##5##(1996-1#1)(2010-12#1)
It is therefore important to##7##5##(1995-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
It is therefore important##9##4##(1995-8#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
It is therefore likely##2##4##(2008-10#1)(2010-3#1)
It is therefore##22##3##(1993-11#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
It is thought that##3##4##(1990-3#1)(2008-11#1)(2010-6#1)
It is thought##4##3##(1990-3#1)(2008-11#2)(2010-6#1)
It is thus##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
It is unclear what the##2##5##(2009-8#1)(2012-12#1)
It is unclear whether##2##4##(2008-11#1)(2012-3#1)
It is unclear##4##3##(2008-11#1)(2009-8#1)(2012-12#1)(2012-3#1)
It is used to##2##4##(2008-9#1)(2010-7#1)
It is used##3##3##(2008-11#1)(2008-9#1)(2010-7#1)
It is usually##8##3##(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
It is valuable##2##3##(2008-11#1)(2008-9#1)
It is very important to##2##5##(2008-10#1)(2011-2#1)
It is very##6##3##(2008-1#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-8#1)
It is well established that##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
It is well known that the##2##6##(1993-3#1)(1997-2#1)
It is well known that##12##5##(1993-3#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-3#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
It is well##16##3##(1990-9#1)(1993-3#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
It is widely accepted that##2##5##(1994-9#1)(2008-5#1)
It is widely##8##3##(1993-11#1)(1994-9#1)(1995-12#1)(2008-11#2)(2008-5#1)(2008-8#2)
It is##992##2##(1990-12#4)(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#7)(1991-3#8)(1991-5#4)(1991-6#9)(1991-8#2)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#6)(1992-5#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#5)(1994-5#7)(1994-6#3)(1994-8#3)(1994-9#3)(1995-11#4)(1995-12#4)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#5)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#9)(1996-2#1)(1996-3#7)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#14)(1997-3#3)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#6)(1997-8#9)(1997-9#1)(2006-6#4)(2007-11#4)(2007-12#6)(2008-1#9)(2008-10#174)(2008-11#96)(2008-12#20)(2008-2#8)(2008-3#49)(2008-4#8)(2008-5#34)(2008-6#8)(2008-7#32)(2008-8#34)(2008-9#25)(2009-1#4)(2009-10#4)(2009-11#3)(2009-12#5)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#5)(2009-8#9)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#7)(2010-12#8)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#3)(2011-10#1)(2011-2#50)(2011-3#1)(2012-12#7)(2012-2#19)(2012-3#21)(2013-1#41)(2013-7#1)(2013-8#16)
It looks##2##2##(1992-12#1)(2008-8#1)
It makes##4##2##(1996-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
It may also##2##3##(2008-12#1)(2008-7#1)
It may be##10##3##(1991-6#1)(1992-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)
It may occur##2##3##(2007-8#1)(2013-1#1)
It may present##2##3##(2008-8#1)(2011-1#1)
It may##27##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-6#1)(1992-6#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
It might be a##2##4##(2008-8#1)(2010-4#1)
It might be##5##3##(1996-3#1)(1997-5#1)(2008-12#1)(2008-8#1)(2010-4#1)
It might##8##2##(1996-3#1)(1997-5#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
It must be##2##3##(1994-9#1)(2008-10#1)
It not only##4##3##(1995-6#1)(2008-11#1)(2012-3#1)(2013-8#1)
It occurs##5##2##(1997-1#1)(2009-8#1)(2010-12#1)(2010-6#1)(2013-1#1)
It presents##5##2##(1994-1#1)(1994-2#2)(2008-4#1)(2013-1#1)
It provides a##3##3##(2008-10#1)(2008-12#1)(2009-3#1)
It provides an##2##3##(1993-1#1)(2008-11#1)
It provides information##2##3##(2008-2#1)(2008-5#1)
It provides##12##2##(1993-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-7#1)(2013-8#1)
It remains to be determined whether##3##6##(2008-11#1)(2010-12#1)(2010-8#1)
It remains to be##4##4##(2008-11#2)(2010-12#1)(2010-8#1)
It remains unclear##2##3##(2008-8#1)(2010-5#1)
It remains##11##2##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
It represents the first##2##4##(1991-3#1)(2008-10#1)
It represents the##4##3##(1991-3#1)(1991-9#1)(2008-10#1)(2008-9#1)
It represents##6##2##(1991-3#1)(1991-9#1)(1994-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
It required##2##2##(2008-10#1)(2008-11#1)
It requires##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)
It results from##2##3##(1991-6#1)(2008-10#1)
It results in##2##3##(2008-10#1)(2008-7#1)
It results##4##2##(1991-6#1)(2008-10#2)(2008-7#1)
It reviews the##2##3##(2008-11#1)(2008-4#1)
It reviews##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
It seems that the##2##4##(2008-10#1)(2008-11#1)
It seems that##9##3##(1995-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
It seems to##3##3##(1997-4#1)(2008-11#1)(2011-2#1)
It seems##17##2##(1995-12#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
It should be emphasized that##2##5##(1993-12#1)(2008-4#1)
It should be noted that the##3##6##(2008-10#2)(2010-6#1)
It should be noted that##4##5##(2008-10#2)(2010-6#1)(2011-2#1)
It should be##18##3##(1990-3#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-3#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-6#2)(2011-2#2)(2013-1#1)
It should##19##2##(1990-3#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-3#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-6#2)(2011-2#2)(2013-1#1)
It showed a##3##3##(1994-11#1)(2008-10#2)
It showed##11##2##(1994-11#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#2)(2009-6#1)
It shows a##2##3##(2008-10#1)(2008-8#1)
It shows good##2##3##(2008-10#2)
It shows that##6##3##(1994-3#1)(1995-1#1)(1997-8#2)(2008-10#1)(2008-11#1)
It shows##15##2##(1993-3#1)(1994-3#1)(1995-1#1)(1997-8#2)(2008-10#6)(2008-11#1)(2008-8#2)(2009-3#1)
It starts##3##2##(1994-1#1)(1996-3#1)(2009-10#1)
It suggests that the##2##4##(1990-2#1)(2008-10#1)
It suggests that##7##3##(1990-2#1)(1991-5#1)(1994-2#1)(2008-10#1)(2008-8#2)(2008-9#1)
It suggests##8##2##(1990-2#1)(1991-5#1)(1994-2#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-6#1)
It supports##2##2##(2008-11#1)(2008-8#1)
It takes into account##2##4##(2008-11#1)(2010-10#1)
It takes##5##2##(1996-2#1)(1996-3#1)(2008-11#1)(2010-10#1)(2010-12#1)
It then discusses the##2##4##(2008-5#1)(2008-9#1)
It then##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
It therefore appears that##2##4##(1990-5#1)(1992-6#1)
It therefore##5##2##(1990-5#1)(1992-6#1)(2008-11#1)(2008-9#1)(2009-8#1)
It turned out to be##2##5##(1990-3#1)(1990-5#1)
It uses##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
It usually##2##2##(2009-10#1)(2012-3#1)
It was a simple##2##4##(2008-10#2)
It was a##5##3##(1992-12#1)(2007-8#1)(2008-10#2)(2013-1#1)
It was also an##2##4##(1995-3#1)(2008-8#1)
It was also demonstrated that the##3##6##(2008-10#2)(2008-8#1)
It was also demonstrated that##5##5##(1997-1#1)(2008-10#2)(2008-8#1)(2009-3#1)
It was also found that the##6##6##(2008-10#4)(2008-7#1)(2008-8#1)
It was also found that##9##5##(1995-2#1)(2008-10#5)(2008-7#1)(2008-8#2)
It was also found##10##4##(1995-2#1)(2008-10#5)(2008-7#1)(2008-8#2)(2012-3#1)
It was also observed that##4##5##(1995-12#1)(2008-10#2)(2008-9#1)
It was also shown that##3##5##(2008-10#1)(2008-6#1)(2009-3#1)
It was also##44##3##(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-3#2)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
It was applied successfully to the determination of##2##8##(2008-10#2)
It was applied to the determination of##2##7##(2008-10#2)
It was applied to the##3##5##(2008-10#3)
It was applied##7##3##(2008-10#7)
It was based on the##4##5##(2008-10#4)
It was based on##6##4##(2008-10#6)
It was carried out at##2##5##(2008-10#1)(2012-3#1)
It was carried out##4##4##(2008-10#2)(2012-3#2)
It was concluded that a##2##5##(2009-10#1)(2013-1#1)
It was concluded that fibronectin increased adhesion rates and isolation potential of cord blood mesenchymal progenitor cells##2##17##(2008-11#2)
It was concluded that the##10##5##(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#1)(2012-2#1)
It was concluded that##35##4##(1990-6#1)(1990-9#1)(1991-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#10)(2008-11#4)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
It was concluded##37##3##(1990-6#1)(1990-9#1)(1991-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#10)(2008-11#4)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
It was confirmed that##3##4##(1991-9#1)(2008-10#2)
It was deduced from the##2##5##(2008-10#1)(2008-5#1)
It was demonstrated that the##7##5##(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)
It was demonstrated that##11##4##(1993-8#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)
It was demonstrated##13##3##(1993-8#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-8#2)(2008-9#2)
It was determined that##2##4##(1991-4#1)(2008-10#1)
It was distributed##2##3##(2008-10#2)
It was established that the##2##5##(1995-9#1)(2008-10#1)
It was established that##5##4##(1995-9#1)(2008-10#4)
It was evaluated##2##3##(2008-10#1)(2013-1#1)
It was evident##2##3##(2008-10#2)
It was firstly##2##3##(2008-9#1)(2011-2#1)
It was found that at##2##5##(1991-5#1)(1994-3#1)
It was found that both##2##5##(2008-10#1)(2008-11#1)
It was found that in the presence of##2##8##(1993-8#1)(2008-10#1)
It was found that in the##4##6##(1993-8#1)(1994-8#1)(2008-10#2)
It was found that in##5##5##(1993-1#1)(1993-8#1)(1994-8#1)(2008-10#2)
It was found that most of the##2##7##(2008-6#1)(2011-2#1)
It was found that only##3##5##(1994-5#1)(1994-8#1)(2008-10#1)
It was found that the binding of##2##7##(2008-10#1)(2008-8#1)
It was found that the##67##5##(1990-8#1)(1991-1#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)
It was found that there##4##5##(1993-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
It was found that this##2##5##(2008-10#1)(2008-3#1)
It was found that##156##4##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#74)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#4)(2013-1#1)
It was found##166##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#80)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#10)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#5)(2013-1#1)
It was further##3##3##(2008-8#1)(2008-9#2)
It was hypothesized that##4##4##(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
It was identified##2##3##(2008-9#1)(2012-3#1)
It was indicated that the##2##5##(2008-10#1)(2008-8#1)
It was indicated that##3##4##(2008-10#1)(2008-8#2)
It was inferred that##2##4##(2008-10#1)(2008-8#1)
It was interesting that##2##4##(2008-11#1)(2008-12#1)
It was lower##2##3##(1991-11#1)(1997-8#1)
It was not possible to##3##5##(2008-10#2)(2008-5#1)
It was not##7##3##(1996-2#1)(1997-7#1)(2008-10#3)(2008-5#1)(2013-1#1)
It was noticed that##2##4##(2008-8#1)(2012-3#1)
It was observed that the##6##5##(2008-10#6)
It was observed that##18##4##(1990-5#1)(1991-5#1)(1991-9#1)(1994-12#1)(2008-10#8)(2008-11#1)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
It was observed##21##3##(1990-2#1)(1990-5#1)(1991-5#1)(1991-9#1)(1994-12#1)(2008-10#9)(2008-11#1)(2008-9#1)(2012-2#2)(2012-3#2)(2013-1#1)
It was often##2##3##(2008-10#1)(2008-11#1)
It was only##2##3##(1997-5#1)(2008-12#1)
It was possible to##6##4##(2008-10#2)(2008-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
It was possible##7##3##(2008-10#2)(2008-11#1)(2008-3#1)(2010-6#1)(2012-3#1)(2013-1#1)
It was predicted##2##3##(1990-5#1)(1996-8#1)
It was previously##2##3##(1995-11#1)(2008-12#1)
It was proved that##4##4##(2008-10#1)(2008-8#1)(2008-9#2)
It was recently##4##3##(2008-8#1)(2009-6#1)(2011-2#2)
It was reported that##2##4##(2008-11#2)
It was revealed that##4##4##(2008-10#3)(2008-12#1)
It was satisfactory to apply this method to##2##8##(2008-10#2)
It was shown that in##2##5##(1990-5#1)(2008-11#1)
It was shown that the##8##5##(1992-6#1)(2008-10#5)(2008-8#2)
It was shown that##31##4##(1990-3#1)(1990-5#1)(1992-6#1)(1993-9#1)(1995-12#1)(1997-3#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2012-3#1)
It was shown##33##3##(1990-3#1)(1990-5#1)(1992-6#1)(1993-9#1)(1995-12#1)(1997-3#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2012-3#1)
It was speculated that##2##4##(1992-3#1)(2012-12#1)
It was stripped from##2##4##(2008-10#2)
It was strongly##2##3##(1990-5#1)(1995-8#1)
It was successfully applied to the##2##6##(2008-10#2)
It was successfully applied##3##4##(2008-10#3)
It was successfully##4##3##(2008-10#4)
It was suggested that##9##4##(1991-1#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
It was suggested##10##3##(1991-1#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
It was suitable for##2##4##(2008-10#2)
It was the##5##3##(1990-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2010-8#1)
It was then##3##3##(2008-10#2)(2008-12#1)
It was therefore concluded that##2##5##(1996-2#1)(2008-10#1)
It was therefore##3##3##(1996-2#1)(2008-10#2)
It was thus##3##3##(1990-8#1)(2008-10#1)(2009-8#1)
It was used as an indicator electrode in potentiometric titration of##3##11##(2008-10#3)
It was used to determine##2##5##(2008-10#2)
It was used##5##3##(2008-10#5)
It was validated##2##3##(2008-10#2)
It was verified that##3##4##(2008-10#3)
It was##540##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#6)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#5)(1996-2#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-5#1)(1997-7#1)(1997-8#3)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#231)(2008-11#27)(2008-12#19)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#15)(2008-6#4)(2008-7#7)(2008-8#34)(2008-9#19)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#2)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#7)(2012-3#14)(2013-1#13)
It will also describe##2##4##(1994-3#1)(2013-1#1)
It will also##6##3##(1994-3#1)(1996-5#1)(2008-1#1)(2008-6#1)(2013-1#1)(2013-8#1)
It will be##3##3##(1994-12#1)(2008-10#1)(2009-7#1)
It will help##2##3##(2008-8#1)(2011-2#1)
It will##19##2##(1990-2#1)(1994-12#2)(1994-3#1)(1995-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#2)(2013-8#3)
It works##2##2##(2008-10#2)
It would be##3##3##(1995-1#1)(2009-4#1)(2013-1#1)
It would##9##2##(1990-2#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-1#1)
It##2407##1##(1990-11#2)(1990-12#7)(1990-2#10)(1990-3#6)(1990-5#14)(1990-6#4)(1990-8#4)(1990-9#4)(1991-1#7)(1991-11#4)(1991-12#5)(1991-2#12)(1991-3#14)(1991-4#1)(1991-5#7)(1991-6#12)(1991-7#1)(1991-8#5)(1991-9#5)(1992-1#6)(1992-11#1)(1992-12#10)(1992-2#3)(1992-3#10)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#4)(1993-11#6)(1993-12#10)(1993-2#10)(1993-3#9)(1993-6#6)(1993-8#7)(1993-9#2)(1994-1#5)(1994-11#6)(1994-12#11)(1994-2#16)(1994-3#13)(1994-5#10)(1994-6#6)(1994-8#9)(1994-9#6)(1995-1#4)(1995-11#6)(1995-12#13)(1995-2#12)(1995-3#3)(1995-5#3)(1995-6#10)(1995-8#9)(1995-9#3)(1996-1#6)(1996-11#3)(1996-12#17)(1996-2#11)(1996-3#15)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#4)(1997-1#14)(1997-2#21)(1997-3#13)(1997-4#3)(1997-5#7)(1997-6#4)(1997-7#11)(1997-8#16)(1997-9#1)(2006-6#5)(2007-11#9)(2007-12#10)(2007-8#3)(2008-1#18)(2008-10#595)(2008-11#196)(2008-12#61)(2008-2#20)(2008-3#65)(2008-4#31)(2008-5#72)(2008-6#18)(2008-7#61)(2008-8#108)(2008-9#86)(2009-1#5)(2009-10#12)(2009-11#5)(2009-12#8)(2009-3#9)(2009-4#4)(2009-5#1)(2009-6#7)(2009-7#11)(2009-8#19)(2009-9#6)(2010-1#5)(2010-10#10)(2010-11#10)(2010-12#16)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#6)(2010-6#13)(2010-7#16)(2010-8#12)(2010-9#3)(2011-1#8)(2011-10#1)(2011-2#102)(2011-3#7)(2012-12#12)(2012-2#40)(2012-3#55)(2013-1#87)(2013-7#3)(2013-8#29)
It's a##4##2##(1991-12#1)(1991-3#1)(2008-9#1)(2013-8#1)
It's not##2##2##(1997-2#1)(2009-10#1)
It's##12##1##(1991-12#1)(1991-3#1)(1994-1#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
ItaI##2##1##(1993-12#2)
Italian National Health##2##3##(1994-6#1)(2010-11#1)
Italian National##3##2##(1990-6#1)(1994-6#1)(2010-11#1)
Italian centenarians##4##2##(2008-7#4)
Italian general denaturant##2##3##(2008-10#2)
Italian hospital##3##2##(1994-2#1)(2013-1#2)
Italian isolate##2##2##(2008-8#2)
Italian migrants##2##2##(1994-2#2)
Italian population##2##2##(1994-6#1)(2010-11#1)
Italian questionnaire##2##2##(2008-11#2)
Italian region##2##2##(1994-12#1)(2008-12#1)
Italian regions##2##2##(1991-12#1)(1992-2#1)
Italian ryegrass##2##2##(2008-10#2)
Italian seed lots##2##3##(2008-10#2)
Italian version of the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
Italian women##2##2##(1992-2#1)(1994-6#1)
Italian x perennial ryegrass##2##4##(2008-10#2)
Italian x##3##2##(2008-10#3)
Italian##89##1##(1990-3#1)(1990-6#3)(1990-8#4)(1991-12#2)(1991-2#1)(1991-8#1)(1992-2#3)(1992-9#1)(1993-11#1)(1994-12#3)(1994-2#5)(1994-6#3)(2008-1#1)(2008-10#20)(2008-11#9)(2008-12#2)(2008-7#7)(2008-8#3)(2010-1#1)(2010-11#3)(2011-2#6)(2011-3#1)(2012-5#2)(2013-1#6)
Italy and the##2##3##(2008-10#1)(2011-2#1)
Italy and##8##2##(1992-9#1)(1994-2#1)(1994-8#1)(2008-10#3)(2008-12#1)(2011-2#1)
Italy was##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)
Italy were##3##2##(1994-6#1)(2008-10#2)
Italy##86##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#3)(1992-2#1)(1992-9#4)(1993-2#4)(1993-3#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#3)(1997-5#1)(2008-10#25)(2008-11#3)(2008-12#3)(2008-4#2)(2008-7#2)(2008-8#2)(2009-10#2)(2009-4#1)(2010-1#1)(2011-2#5)(2011-3#2)(2012-7#1)(2013-8#8)
Italy)##7##1##(1990-2#1)(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-7#1)
Itch gene##2##2##(2012-2#2)
Itch promoter##2##2##(2012-2#2)
Itch##6##1##(2012-2#6)
Item##4##1##(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
Items##2##1##(2008-7#1)(2012-2#1)
Iterative optimization routine##2##3##(2009-2#2)
Iterative##3##1##(2009-2#2)(2010-9#1)
Ito cell mitogenesis occurs##2##4##(1994-6#2)
Ito cell##3##2##(1994-6#3)
Ito##4##1##(1994-6#4)
Itraconazole##2##1##(2009-11#1)(2011-2#1)
Its ability to##4##3##(1995-2#1)(2008-2#1)(2012-2#2)
Its activity was##2##3##(1992-12#1)(2008-11#1)
Its activity##3##2##(1992-12#1)(2008-11#2)
Its application to##4##3##(1994-9#1)(2008-10#2)(2008-3#1)
Its critical##2##2##(2008-10#1)(2009-4#1)
Its deduced amino acid sequence##2##5##(1995-11#1)(1997-7#1)
Its detection limit##3##3##(2008-10#3)
Its effects##2##2##(1994-8#1)(2008-11#1)
Its efficacy##2##2##(2007-11#1)(2008-11#1)
Its expression##2##2##(1995-8#1)(2008-8#1)
Its main##2##2##(1995-5#1)(2008-5#1)
Its management##2##2##(2011-2#2)
Its molecular##2##2##(1995-11#1)(2008-8#1)
Its performance was##2##3##(2008-10#1)(2010-8#1)
Its performance##3##2##(2008-10#2)(2010-8#1)
Its physiological##2##2##(1995-6#1)(2008-11#1)
Its potential##2##2##(2007-12#1)(2008-11#1)
Its precise##2##2##(2008-7#1)(2010-12#1)
Its primary##3##2##(1990-2#1)(2008-10#1)(2012-3#1)
Its role##2##2##(1996-6#1)(2009-9#1)
Its sensitivity##2##2##(2008-10#2)
Its use allows##2##3##(2008-10#1)(2011-7#1)
Its use##3##2##(1992-2#1)(2008-10#1)(2011-7#1)
Its##161##1##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#2)(1993-3#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#60)(2008-11#10)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#2)
Ivorian##2##1##(2013-1#2)
Ivory Coast##5##2##(2008-10#4)(2013-1#1)
Iwao'##2##1##(2008-10#2)
Ixodes ricinus##2##2##(2008-12#1)(2013-8#1)
Ixodes##5##1##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
I} data##2##2##(2008-10#2)
IκBα degradation##3##2##(2012-2#1)(2012-3#2)
J (O)/J(F)##2##2##(2008-8#2)
J Biol Chem##2##3##(1994-8#1)(2009-9#1)
J and##4##2##(1992-10#1)(1994-8#2)(2008-9#1)
J mol(-1) K(-1) and##2##4##(2008-10#2)
J mol(-1))##2##2##(2011-1#2)
J point and##2##3##(2008-7#1)(2012-3#1)
J point##3##2##(2008-7#2)(2012-3#1)
J pulses with a pulse width of##2##7##(2007-12#2)
J##177##1##(1990-11#3)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#7)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-5#15)(1994-8#3)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#10)(1996-5#2)(1997-2#2)(1997-3#1)(1997-8#2)(2007-12#2)(2008-10#25)(2008-11#6)(2008-12#9)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#17)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
J'##4##1##(2008-8#4)
J) and##2##2##(1994-8#1)(2008-2#1)
J)##3##1##(1994-8#1)(2008-2#1)(2011-2#1)
J/cm(2)##8##1##(2008-3#2)(2008-7#3)(2012-2#3)
J/cm2 of energy (mean ± SD 6##2##7##(2013-1#2)
J/cm2 of energy (mean ±##3##5##(2013-1#3)
J/cm2##4##1##(2012-2#1)(2013-1#3)
J/cm2)##3##1##(2013-1#3)
J2 were added##2##3##(2008-10#2)
J2##10##1##(2008-10#10)
J774 macrophages##2##2##(1995-11#1)(1996-2#1)
J774##12##1##(1990-8#1)(1994-11#1)(1994-8#4)(1995-11#1)(1996-12#3)(1996-2#1)(2008-11#1)
JA##3##1##(2009-8#3)
JAACT Issue##2##2##(2008-11#2)
JAK##3##1##(1996-2#2)(2008-1#1)
JAKs##4##1##(1996-2#4)
JAOS##2##1##(2013-1#2)
JAR cells##2##2##(1994-6#1)(2008-10#1)
JAR##3##1##(1994-6#2)(2008-10#1)
JASCO##2##1##(2008-10#2)
JAmyb##2##1##(2008-10#2)
JB25 and JB26##3##3##(2011-3#3)
JB25##5##1##(2011-3#5)
JB26##5##1##(2011-3#5)
JC##2##1##(2008-12#2)
JC-1##2##1##(2008-9#2)
JCAHO##6##1##(1995-1#6)
JCAHO's##2##1##(1995-1#1)(1997-6#1)
JCV##2##1##(2008-12#2)
JCVI##3##1##(2011-2#3)
JDBM alloy##2##2##(2012-2#2)
JDBM##3##1##(2012-2#3)
JDR##3##1##(2013-1#3)
JE##3##1##(2008-12#1)(2011-2#2)
JH is##2##2##(2012-2#2)
JH segments##2##2##(1991-6#1)(1997-9#1)
JH##18##1##(1991-6#2)(1992-6#1)(1995-11#5)(1997-9#1)(2012-2#9)
JH-binding##2##1##(2012-2#2)
JH-bound JHBP##2##2##(2012-2#2)
JHBP##4##1##(2012-2#4)
JIMT1 cells##2##2##(2013-1#2)
JIMT1##3##1##(2013-1#3)
JJ45B##3##1##(2009-6#3)
JK-21##2##1##(1993-6#2)
JM##2##1##(2008-8#1)(2010-1#1)
JMMT website##2##2##(2008-12#2)
JNDs##3##1##(1990-11#3)
JNK##6##1##(1996-2#1)(2008-7#1)(2008-9#1)(2012-2#3)
JQ1##3##1##(2012-12#3)
JR##3##1##(2008-10#2)(2011-2#1)
JUPITER trial##2##2##(2010-12#2)
JUPITER##3##1##(2010-12#3)
JW##2##1##(2008-11#2)
JY-6##2##1##(2008-11#2)
JYG-MMTV##5##1##(1994-12#5)
Jaagiella##2##1##(2008-7#2)
Jaccard index##4##2##(2008-10#4)
Jaccard##5##1##(2008-10#5)
Jaccard's similarity##2##2##(2008-10#2)
Jack bean meal##2##3##(2008-10#2)
Jack were##2##2##(2008-10#1)(2008-11#1)
Jack##12##1##(1997-4#1)(2008-10#6)(2008-11#4)(2009-8#1)
Jackson##8##1##(1994-1#2)(2008-7#4)(2011-2#1)(2013-8#1)
Jaffé reaction##2##2##(2008-10#2)
Jaffé##3##1##(2008-10#3)
Jalisco##2##1##(2008-12#1)(2011-2#1)
Jamaica##7##1##(1997-2#1)(2009-7#2)(2011-2#4)
Jamaican##6##1##(2009-7#2)(2010-1#1)(2011-2#3)
James##11##1##(1990-8#1)(1991-3#1)(1993-6#2)(1994-12#2)(1996-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)
Jan##2##1##(2008-11#1)(2010-7#1)
Jane##3##1##(1993-3#1)(1996-5#1)(2009-12#1)
Janet##2##1##(1995-2#2)
January 1##4##2##(1992-1#1)(1994-1#1)(2009-6#1)(2011-2#1)
January 1983 and##2##3##(1990-12#1)(1990-3#1)
January 1985 to December##2##4##(1992-5#1)(1994-1#1)
January 1990##2##2##(1992-2#1)(1994-12#1)
January 1991 and##2##3##(1992-5#1)(2008-7#1)
January 1991##5##2##(1992-5#1)(1992-9#2)(1997-8#1)(2008-7#1)
January 1993##6##2##(1995-12#2)(1995-6#1)(1996-2#1)(1996-5#1)(2008-9#1)
January 1994##2##2##(1994-3#1)(1994-9#1)
January 1995##3##2##(1996-1#1)(2008-5#1)(2008-7#1)
January 1st##2##2##(2008-1#1)(2011-2#1)
January 2000 to##2##3##(2008-1#1)(2008-12#1)
January 2000##4##2##(1996-1#1)(2008-1#1)(2008-12#1)(2012-12#1)
January 2002##5##2##(2008-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
January 2004##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
January 2005##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
January 2007##2##2##(2011-2#1)(2012-3#1)
January 2008##5##2##(2011-2#3)(2012-12#2)
January 2009##2##2##(2011-2#1)(2012-3#1)
January 2010##2##2##(2011-2#1)(2012-12#1)
January 31##2##2##(1997-1#1)(2011-2#1)
January and December##2##3##(2008-11#1)(2012-12#1)
January and##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
January through##2##2##(1992-6#1)(2012-3#1)
January to March##3##3##(1993-12#1)(1996-6#1)(2009-6#1)
January to##7##2##(1993-12#1)(1996-6#1)(2007-8#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-5#1)
January##105##1##(1990-12#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1994-1#3)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#3)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#2)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#3)(2009-8#2)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#13)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
Janus##5##1##(1996-2#2)(2008-4#1)(2010-11#1)(2010-3#1)
Japan and##12##2##(1997-8#1)(2008-10#5)(2008-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)
Japan for 3 years##2##4##(1997-7#1)(2008-10#1)
Japan for##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
Japan from##2##2##(2008-10#2)
Japan is##2##2##(1995-12#1)(2008-10#1)
Japan were##5##2##(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)
Japan##143##1##(1991-2#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#1)(1994-12#2)(1994-2#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-7#3)(1997-8#4)(2008-1#1)(2008-10#56)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#13)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-12#3)(2010-6#2)(2010-8#6)(2010-9#1)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#4)
Japan's##2##1##(1994-3#1)(2008-10#1)
Japan)##2##1##(2008-10#2)
Japanese Black and Holstein##2##4##(2013-1#2)
Japanese Black and##3##3##(2013-1#3)
Japanese Black##9##2##(2013-1#9)
Japanese Erwinia##3##2##(2008-10#3)
Japanese acupuncture##2##2##(2008-10#2)
Japanese adult##2##2##(2008-3#2)
Japanese advanced lung cancer##2##4##(2010-2#2)
Japanese and##2##2##(2008-10#2)
Japanese cedar pollen##5##3##(2012-12#5)
Japanese cedar pollinosis##7##3##(2012-12#7)
Japanese cedar##12##2##(2012-12#12)
Japanese encephalitis virus (JEV)##2##4##(1995-12#1)(2011-2#1)
Japanese encephalitis virus##3##3##(1995-12#2)(2011-2#1)
Japanese encephalitis##6##2##(1995-12#2)(2008-12#1)(2011-2#3)
Japanese flounder Paralichthys olivaceus##3##4##(2008-6#1)(2010-8#2)
Japanese flounder##4##2##(2008-6#2)(2010-8#2)
Japanese isolate##2##2##(2008-10#2)
Japanese medaka (Oryzias latipes)##2##4##(2008-8#2)
Japanese native horses##4##3##(2013-1#4)
Japanese nurses##4##2##(2008-11#4)
Japanese patients with##2##3##(2009-8#1)(2012-12#1)
Japanese patients##7##2##(1997-8#4)(2009-8#1)(2010-2#1)(2012-12#1)
Japanese pear scab##2##3##(2008-10#2)
Japanese pear##8##2##(2008-10#8)
Japanese plum fruit##2##3##(2011-2#2)
Japanese plum##5##2##(2008-10#2)(2011-2#3)
Japanese population##4##2##(1993-3#2)(1997-8#2)
Japanese quail##2##2##(2008-12#2)
Japanese quails with##2##3##(2008-12#2)
Japanese quails##3##2##(2008-12#3)
Japanese style acupuncture and moxibustion##2##5##(2008-10#2)
Japanese style acupuncture##3##3##(2008-10#3)
Japanese woman with##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
Japanese woman##4##2##(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
Japanese##153##1##(1991-5#1)(1992-12#1)(1993-3#2)(1994-12#6)(1995-12#2)(1995-2#1)(1996-5#2)(1997-8#9)(2008-10#38)(2008-11#10)(2008-12#6)(2008-3#3)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#4)(2010-3#1)(2010-8#2)(2011-2#8)(2011-3#1)(2012-12#17)(2012-3#2)(2013-1#19)
Jaundice##3##1##(1990-8#1)(1990-9#1)(2008-11#1)
Java##5##1##(2008-10#4)(2011-3#1)
Jean##3##1##(1994-1#1)(1995-1#1)(2009-10#1)
Jeddah##3##1##(2008-1#2)(2013-1#1)
Jefferson##2##1##(1994-3#1)(2013-1#1)
Jeffrey pine##4##2##(2008-10#4)
Jehovah's Witness##5##2##(2008-11#5)
Jeju##2##1##(2011-1#2)
Jejunal##2##1##(1991-12#1)(1995-10#1)
Jen-Chung point##3##2##(1995-12#3)
Jersey##26##1##(1991-1#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-1#1)(1995-12#2)(1995-6#1)(1996-5#2)(1997-3#1)(2008-10#8)(2008-11#1)(2008-8#5)(2010-9#1)
Jerusalem##2##1##(1995-3#1)(2013-8#1)
Jessamy##2##1##(1994-12#2)
Jessore##2##1##(2008-10#2)
Jet Propulsion Laboratory##2##3##(2008-2#2)
Jet Propulsion##3##2##(2008-2#2)(2008-3#1)
Jet##4##1##(2008-10#1)(2008-2#2)(2008-3#1)
Jewish medical##3##2##(2013-8#3)
Jewish students##3##2##(2013-8#3)
Jewish##11##1##(1992-1#1)(2008-7#1)(2009-11#1)(2013-8#8)
Jews from##2##2##(2008-12#1)(2013-8#1)
Jews##6##1##(1997-8#1)(2008-12#2)(2009-11#1)(2013-8#2)
Jialing River##2##2##(2008-10#1)(2011-2#1)
Jim##2##1##(1993-12#1)(2012-2#1)
Jinan##2##1##(2008-8#1)(2008-9#1)
Jinmi##4##1##(2008-10#4)
Jk(a-b-)##4##1##(1995-6#4)
Jlm1##3##1##(2008-10#3)
Job aids##2##2##(1991-2#2)
Job content and##2##3##(1995-1#1)(1995-2#1)
Job turnover##2##2##(1994-3#2)
Job##13##1##(1991-2#3)(1994-3#2)(1995-1#1)(1995-2#2)(1995-3#1)(2008-10#3)(2009-10#1)
Job's##2##1##(2008-10#2)
Johannes##3##1##(2013-1#2)(2013-8#1)
Johannesburg##2##1##(2008-12#1)(2010-1#1)
John B##2##2##(2010-7#2)
John Paul##2##2##(1990-6#2)
John S##2##2##(2008-10#1)(2011-2#1)
John Wiley &amp##100##3##(2008-11#36)(2008-7#36)(2008-9#2)(2011-2#8)(2012-2#6)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#7)
John Wiley##101##2##(2008-11#37)(2008-7#36)(2008-9#2)(2011-2#8)(2012-2#6)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#7)
John##124##1##(1990-6#2)(1990-8#1)(1995-12#1)(1995-6#2)(1996-5#3)(2008-10#1)(2008-11#41)(2008-12#2)(2008-7#37)(2008-9#2)(2009-11#1)(2010-7#3)(2011-2#9)(2012-2#6)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#7)(2013-8#1)
John's##2##1##(2008-11#1)(2013-8#1)
Johns Hopkins Hospital##2##3##(1993-3#1)(1994-3#1)
Johns Hopkins University##2##3##(1996-9#1)(2011-2#1)
Johns Hopkins##13##2##(1992-3#1)(1993-3#3)(1994-12#1)(1994-3#1)(1995-2#2)(1996-9#1)(2011-2#3)(2013-8#1)
Johnson Controls##2##2##(1990-2#2)
Johnson et al##2##3##(1990-11#1)(2008-12#1)
Johnson##10##1##(1990-11#2)(1990-2#2)(1992-1#1)(1993-2#1)(1996-12#1)(2008-12#1)(2013-1#2)
Johnston##4##1##(2008-10#2)(2008-11#2)
Johnston's organ##4##2##(2008-9#4)
Johnstown##2##1##(2010-1#2)
Joint Commission##3##2##(1995-3#1)(2012-2#2)
Joint Commission's##3##2##(1995-1#1)(1995-2#1)(2012-2#1)
Joint Committee##2##2##(2011-2#1)(2011-4#1)
Joint Council of Governmental Public Health Agencies##4##7##(1996-3#4)
Joint Genome Institute##2##3##(2009-9#1)(2011-2#1)
Joint##34##1##(1995-1#1)(1995-2#3)(1995-3#1)(1996-3#4)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-7#2)(2011-2#3)(2011-4#1)(2012-2#3)(2012-3#1)(2013-1#1)
Jonathan##3##1##(1990-11#1)(2008-10#2)
Jones##7##1##(1992-12#1)(1992-2#2)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)
Jordan##7##1##(1992-3#2)(2008-10#2)(2008-5#1)(2012-2#1)(2013-7#1)
Jordanian surgical##2##2##(2010-7#2)
Joseph##7##1##(1990-11#1)(1991-2#1)(1991-9#1)(1994-12#1)(1997-6#1)(2008-10#1)(2012-2#1)
Joseph's Hospital##3##2##(1991-3#2)(1995-6#1)
Joseph's##4##1##(1991-3#2)(1993-12#1)(1995-6#1)
Josephson junctions##3##2##(2008-7#3)
Joslin##2##1##(2011-2#2)
Journal Net##2##2##(2011-2#2)
Journal and the##2##3##(2011-4#1)(2013-1#1)
Journal impact factors##2##3##(1995-8#2)
Journal is##2##2##(2008-10#1)(2011-4#1)
Journal of Advanced Nursing##5##4##(2008-11#4)(2008-12#1)
Journal of Dental##2##3##(2008-11#1)(2013-1#1)
Journal of Experimental Botany##2##4##(2009-8#2)
Journal of Personality 17##2##4##(2012-3#2)
Journal of Psychiatry##4##3##(2011-3#1)(2011-4#3)
Journal of##41##2##(1990-6#1)(1993-1#1)(1997-2#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#3)(2010-12#6)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#1)(2011-4#3)(2012-3#2)(2013-1#4)
Journal##59##1##(1990-6#1)(1993-1#1)(1995-8#2)(1997-1#1)(1997-2#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-3#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#5)(2010-12#6)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2011-4#5)(2012-3#3)(2013-1#6)
Journals##2##1##(1991-12#1)(2012-3#1)
Joydebpur##2##1##(2008-10#2)
Jr##14##1##(1990-10#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#1)(1994-1#2)(1994-5#1)(1995-12#1)(1995-6#2)(2008-4#1)
Jude the##2##2##(2012-2#2)
Judge John##2##2##(1995-12#1)(1996-5#1)
Judge##10##1##(1995-12#6)(1995-6#1)(1996-5#3)
Juglans regia##2##2##(2008-10#1)(2013-1#1)
Juice##2##1##(2008-10#2)
July 1##2##2##(1991-1#1)(2013-7#1)
July 1994##3##2##(1995-6#1)(1996-1#1)(2008-10#1)
July 1995##2##2##(1996-5#1)(2008-10#1)
July 1996##2##2##(2008-10#2)
July 1997##2##2##(2008-10#2)
July 1999##2##2##(2008-3#1)(2008-6#1)
July 2002##4##2##(2008-10#4)
July 2009##3##2##(2011-3#1)(2012-3#2)
July 2010##2##2##(2010-3#1)(2012-3#1)
July 2012##3##2##(2013-1#3)
July 22##2##2##(1990-2#1)(1995-6#1)
July 26##4##2##(1991-12#1)(1994-1#1)(1995-6#1)(1996-1#1)
July and August##2##3##(2008-10#2)
July and October##2##3##(2008-10#1)(2008-5#1)
July and##7##2##(2008-10#6)(2008-5#1)
July in##2##2##(2008-10#1)(2010-8#1)
July##73##1##(1990-2#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1994-1#1)(1994-12#1)(1995-12#2)(1995-5#1)(1995-6#5)(1996-1#2)(1996-12#1)(1996-5#2)(1997-2#1)(2008-10#23)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#2)(2011-3#2)(2012-12#1)(2012-3#3)(2012-6#2)(2013-1#3)(2013-7#1)
Jun##5##1##(1995-12#1)(1995-8#1)(1996-12#2)(1996-2#1)
June 11##2##2##(1992-3#1)(1997-6#1)
June 1986##2##2##(1990-6#1)(1995-2#1)
June 1998##6##2##(2008-11#1)(2008-5#5)
June 1999##3##2##(2008-10#2)(2008-11#1)
June 2003##2##2##(2007-11#1)(2008-10#1)
June 2004##3##2##(2008-10#2)(2008-12#1)
June 2008##2##2##(2011-2#1)(2012-3#1)
June 2009##3##2##(2011-2#3)
June 30##2##2##(1991-1#1)(2013-8#1)
June and##5##2##(1994-9#1)(2008-10#1)(2010-10#1)(2011-2#2)
June for##2##2##(1995-6#1)(2008-10#1)
June from##2##2##(2008-10#2)
June to##3##2##(2008-10#2)(2008-12#1)
June##80##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-1#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-6#6)(1996-12#2)(1996-5#3)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#21)(2008-11#5)(2008-12#2)(2008-5#5)(2008-7#2)(2010-10#2)(2010-6#1)(2011-2#11)(2012-3#1)(2013-1#1)(2013-8#1)
June)##2##1##(2008-10#1)(2013-8#1)
Jupiter's##2##1##(1995-6#2)
Jurkat cell##2##2##(2008-8#1)(2012-12#1)
Jurkat cells##3##2##(1992-6#1)(1994-11#1)(1994-6#1)
Jurkat##7##1##(1992-6#1)(1993-6#1)(1994-11#1)(1994-6#1)(2008-8#2)(2012-12#1)
Just as##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
Just##12##1##(1992-2#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-9#1)(2011-2#3)
Justice Department##4##2##(1995-12#1)(1995-6#2)(1996-5#1)
Justice##10##1##(1992-8#1)(1995-1#1)(1995-12#2)(1995-6#3)(1996-3#1)(1996-5#1)(2008-11#1)
Justifying##2##1##(1991-1#1)(1994-2#1)
Juvenile growth##2##2##(2008-11#2)
Juvenile ossifying fibroma##2##3##(2013-1#2)
Juvenile polyposis syndrome##3##3##(2011-2#3)
Juvenile##10##1##(2008-11#3)(2011-2#4)(2012-2#1)(2013-1#2)
Juveniles of##2##2##(2008-10#2)
Juveniles##3##1##(2008-10#2)(2008-12#1)
K = 0##2##3##(2008-9#2)
K =##3##2##(1992-9#1)(2008-9#2)
K and##17##2##(1990-11#1)(1993-3#1)(1995-12#1)(2008-10#8)(2008-3#4)(2009-5#1)(2009-7#1)
K are##2##2##(2008-10#1)(2008-3#1)
K at##3##2##(2008-3#3)
K for##2##2##(2008-10#2)
K has been##2##3##(1992-9#1)(2008-3#1)
K in the##2##3##(2008-10#1)(2008-3#1)
K in##8##2##(2008-10#2)(2008-12#1)(2008-3#4)(2010-7#1)
K peaks were##2##3##(2008-9#2)
K protein##10##2##(1995-12#7)(2008-8#3)
K strain##2##2##(2008-10#2)
K was##3##2##(1994-8#1)(2008-10#2)
K were determined##2##3##(2008-10#2)
K with a##2##3##(1992-10#1)(2008-10#1)
K##244##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-5#1)(1991-7#2)(1992-10#5)(1992-9#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-5#3)(1994-8#6)(1995-12#13)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#2)(1997-2#3)(1997-4#1)(1997-7#5)(1997-8#1)(2008-10#110)(2008-11#1)(2008-12#4)(2008-3#23)(2008-5#3)(2008-7#1)(2008-8#9)(2008-9#8)(2009-11#3)(2009-5#1)(2009-7#2)(2010-6#2)(2010-7#1)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
K(+) and##8##2##(2008-10#8)
K(+) binding##2##2##(2008-10#1)(2012-2#1)
K(+) channel##3##2##(2008-9#1)(2013-8#2)
K(+) channels##6##2##(2008-8#6)
K(+) concentration##2##2##(2013-8#2)
K(+) ions##2##2##(2008-10#2)
K(+)##69##1##(2008-10#45)(2008-7#1)(2008-8#14)(2008-9#1)(2010-4#1)(2012-2#2)(2013-8#5)
K(+)&gt##3##1##(2008-10#3)
K(0##3##1##(2008-10#1)(2009-5#2)
K(1)##7##1##(2008-10#7)
K(2)##2##1##(2008-10#2)
K(2)CO(3)##3##1##(2008-10#3)
K(2)Cr(2)O(7) was##2##2##(2008-10#2)
K(2)Cr(2)O(7)##4##1##(2008-10#4)
K(2)S(2)O(8)##5##1##(2008-10#4)(2008-9#1)
K(3)##2##1##(2008-10#1)(2008-11#1)
K(3)Fe(CN)(6)##3##1##(2008-10#3)
K(AgL)##3##1##(2008-10#3)
K(AgLPic) and##2##2##(2008-10#2)
K(AgLPic)##3##1##(2008-10#3)
K(D)##5##1##(2008-10#5)
K(M(L16C5)A)##2##1##(2008-10#2)
K(M)##2##1##(2008-11#1)(2008-9#1)
K(MLA) value##2##2##(2008-10#2)
K(MLA) values##2##2##(2008-10#2)
K(MLA)##8##1##(2008-10#8)
K(S)##3##1##(2008-10#3)
K(TNOBS)##3##1##(2008-10#3)
K(TNOBS))##2##1##(2008-10#2)
K(TpClPB)##2##1##(2008-10#2)
K(a)##4##1##(2008-10#4)
K(alpha) x-ray##3##2##(2010-1#3)
K(cat) value and##2##3##(2008-9#2)
K(d)##2##1##(2008-10#2)
K(dist)##2##1##(2008-10#2)
K(e)##2##1##(2008-10#2)
K(ex##7##1##(2008-10#7)
K(ex) and the##2##3##(2008-10#2)
K(ex) for##3##2##(2008-10#3)
K(ex) values were##2##3##(2008-10#2)
K(ex) was##3##2##(2008-10#3)
K(ex) were##2##2##(2008-10#2)
K(ex)##17##1##(2008-10#17)
K(f)##4##1##(2008-10#4)
K(i##4##1##(2008-10#4)
K(i) of##3##2##(2008-10#1)(2008-11#2)
K(ijk)##4##1##(2008-10#4)
K(m) and##3##2##(2008-10#3)
K(m) for the alcohol##2##4##(2008-7#2)
K(m) for the##4##3##(2008-7#4)
K(m) for##7##2##(2008-7#7)
K(m) is##2##2##(2008-10#2)
K(m) of##3##2##(2008-7#2)(2008-8#1)
K(m) value##2##2##(2008-10#1)(2008-7#1)
K(m) values##2##2##(1997-2#1)(2008-11#1)
K(m) were##2##2##(2008-10#1)(2008-7#1)
K(m)##31##1##(1990-11#1)(1997-2#1)(2008-10#12)(2008-11#2)(2008-7#13)(2008-8#1)(2011-3#1)
K(obs) and##2##2##(1997-2#2)
K(p)##2##1##(2008-10#2)
K) and##2##2##(2008-10#1)(2008-3#1)
K) is presented##2##3##(2008-10#1)(2008-9#1)
K)##12##1##(1992-10#1)(1994-8#1)(2008-10#8)(2008-3#1)(2008-9#1)
K+ and NH4+##2##3##(2008-11#2)
K+ and##5##2##(1991-11#2)(2008-11#3)
K+ channel activation##2##3##(1994-11#1)(1996-2#1)
K+ channel##7##2##(1994-11#2)(1994-12#3)(1996-2#2)
K+ channels in##4##3##(1994-11#3)(1994-12#1)
K+ channels##10##2##(1990-8#2)(1994-11#3)(1994-12#2)(1996-2#2)(1997-1#1)
K+ currents##5##2##(1994-11#1)(1995-11#1)(1996-2#2)(1996-5#1)
K+ efflux in##2##3##(1994-3#2)
K+ in##2##2##(1994-12#1)(1995-12#1)
K+ ions##2##2##(2008-3#2)
K+ on##2##2##(1997-1#1)(2008-11#1)
K+ to##2##2##(1996-2#1)(1997-1#1)
K+##68##1##(1990-8#2)(1991-11#5)(1991-5#1)(1991-7#3)(1994-11#7)(1994-12#7)(1994-2#3)(1994-3#4)(1995-11#1)(1995-12#3)(1996-2#9)(1996-5#1)(1997-1#10)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#2)
K-12##18##1##(1991-11#2)(1993-9#1)(1996-12#6)(1996-6#3)(2008-10#4)(2008-12#1)(2009-6#1)
K-7259##3##1##(1995-8#3)
K-9 teams##2##2##(1992-2#2)
K-dependent##3##1##(1990-5#2)(1992-9#1)
K-means##2##1##(2010-8#2)
K-ras 116Y##3##2##(1993-11#3)
K-ras mutations##2##2##(2009-12#1)(2013-1#1)
K-ras##8##1##(1993-11#5)(2009-12#1)(2009-8#1)(2013-1#1)
K1##5##1##(2008-11#2)(2009-12#3)
K22DAP##3##1##(2008-10#3)
K252a and##2##2##(1990-8#1)(2008-10#1)
K252a##12##1##(1990-12#5)(1990-8#3)(1994-11#2)(2008-10#1)(2008-11#1)
K2O##2##1##(2008-12#2)
K2P##2##1##(2013-8#2)
K443E and##2##2##(1995-8#2)
K443E##7##1##(1995-8#7)
K562 cells in##2##3##(2008-11#2)
K562 cells##22##2##(1994-11#1)(2008-11#6)(2008-7#1)(2008-8#5)(2008-9#9)
K562##29##1##(1993-3#1)(1994-11#1)(1994-3#1)(2008-11#7)(2008-7#1)(2008-8#7)(2008-9#11)
K65R##6##1##(2013-1#6)
K70E##2##1##(2013-1#2)
K77H##2##1##(1995-6#2)
K78H)##2##1##(1995-6#2)
K84##7##1##(2008-10#7)
K=8##2##1##(2008-10#2)
KA-672##3##1##(2008-5#3)
KASH##4##1##(2008-9#4)
KAT1##4##1##(1994-12#4)
KB exercise##2##2##(1991-12#2)
KB##8##1##(1991-12#6)(2008-12#2)
KBAB4##2##1##(2011-2#2)
KBD##3##1##(2011-2#3)
KBr##9##1##(2008-10#9)
KBrO(3)##3##1##(2008-10#3)
KC70 was##4##2##(2010-5#4)
KC70##9##1##(2010-5#9)
KCN##3##1##(2008-10#3)
KCl (0##2##2##(2008-10#2)
KCl and##6##2##(1993-3#1)(1993-8#1)(2008-10#4)
KCl as##2##2##(2008-10#2)
KCl at##2##2##(2008-10#2)
KCl concentration##2##2##(1990-11#1)(1990-5#1)
KCl##39##1##(1990-11#1)(1990-5#2)(1993-3#1)(1993-8#2)(1996-2#2)(2008-10#23)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#2)
KD cases##2##2##(2012-2#2)
KD##15##1##(1992-2#1)(2011-2#7)(2012-2#7)
KD4326##3##1##(2008-10#3)
KDN-gp##4##1##(1994-5#4)
KDO(2)-Lipid A##2##2##(2012-12#2)
KDR in##2##2##(1994-11#1)(2008-9#1)
KDR##9##1##(1994-11#5)(2008-9#4)
KE and##2##2##(2008-12#2)
KE##3##1##(2008-12#3)
KEM1##2##1##(1995-9#2)
KEX2##2##1##(1997-1#2)
KEY WORDS##8##2##(2009-10#1)(2013-1#7)
KEYWORDS##7##1##(2012-3#6)(2013-1#1)
KF##7##1##(1996-5#3)(2008-10#4)
KG-1##9##1##(1990-2#1)(1993-12#3)(1995-8#2)(1996-2#3)
KGd(WO(4))(2) laser##2##2##(2007-12#2)
KHPh##3##1##(2008-10#3)
KI and##4##2##(2008-10#3)(2008-8#1)
KI oxidation##2##2##(2008-10#2)
KI##18##1##(2008-10#17)(2008-8#1)
KIF5A##3##1##(2012-2#3)
KII##2##1##(1996-12#2)
KIO(4)##4##1##(2008-10#4)
KIR##2##1##(2008-8#2)
KISS1 (GPR54)##3##2##(2009-6#3)
KIT##3##1##(2008-8#1)(2010-4#1)(2012-3#1)
KKU 40##2##2##(2008-12#2)
KLF6##3##1##(2011-2#3)
KLH##9##1##(2008-10#7)(2008-4#1)(2008-9#1)
KM##4##1##(1994-5#3)(1995-8#1)
KM110##3##1##(2012-2#3)
KM50##3##1##(2008-11#3)
KMB17 cells##6##2##(2013-8#6)
KMSKS##2##1##(1993-8#2)
KMapp and kcat/KMapp were##2##4##(1997-2#2)
KMnO(4) and##2##2##(2008-10#2)
KMnO(4) in##6##2##(2008-10#6)
KMnO(4)##17##1##(2008-10#17)
KN-04##3##1##(1996-2#3)
KN-62 and KN-04##2##3##(1996-2#2)
KN-62 inhibited##2##2##(1995-8#1)(1996-2#1)
KN-62##7##1##(1995-8#1)(1996-2#5)(2008-8#1)
KNO(3)##9##1##(2008-10#9)
KNO(3))##3##1##(2008-10#3)
KNSBN##3##1##(2008-3#3)
KNbO(3)##2##1##(2008-2#1)(2008-3#1)
KOH solution##5##2##(2008-10#5)
KOH##11##1##(2008-10#9)(2008-5#1)(2012-3#1)
KOH/IPA##3##1##(2008-10#3)
KP San Francisco Medical Center##2##5##(2010-8#2)
KP and##2##2##(2009-6#2)
KP##7##1##(2009-6#3)(2010-8#4)
KP's##2##1##(2010-8#2)
KPI##5##1##(1992-12#1)(1996-12#4)
KPI-containing##2##1##(1996-12#2)
KPLS##2##1##(2008-10#2)
KS and ND##2##3##(2008-10#2)
KS is##2##2##(1991-8#1)(2013-1#1)
KS levels in patients with##2##5##(1993-2#2)
KS levels##4##2##(1993-2#4)
KS##12##1##(1991-8#1)(1993-2#5)(2008-10#2)(2012-3#2)(2013-1#2)
KSA##6##1##(2008-7#4)(2013-1#2)
KSCN##3##1##(2008-10#3)
KSD can##2##2##(2010-4#2)
KSD exercise##2##2##(2010-4#2)
KSD##5##1##(2010-4#5)
KT and##2##2##(2008-11#1)(2013-1#1)
KT##14##1##(2008-11#2)(2011-2#3)(2013-1#9)
KTP OPO##2##2##(2008-3#2)
KTP and##2##2##(2008-3#2)
KTP crystals##3##2##(2008-3#3)
KTP##16##1##(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#10)
KTZ##2##1##(2008-5#2)
KTiOAsO(4)##4##1##(2007-12#3)(2008-3#1)
KTiOPO(4) (KTP)##2##2##(2008-3#2)
KTiOPO(4) crystal##3##2##(2007-12#2)(2008-2#1)
KTiOPO(4)##9##1##(2007-12#3)(2008-2#1)(2008-3#5)
KTiOPO4##2##1##(2008-2#1)(2008-3#1)
KTpClPB##4##1##(2008-10#4)
KU-P-M670##2##1##(2008-10#2)
KU1##2##1##(2008-10#2)
KU812 cell line##2##3##(1990-5#2)
KU812 cells into##2##3##(2008-11#2)
KU812 cells##29##2##(1990-5#2)(2008-11#27)
KU812##34##1##(1990-5#5)(2008-11#29)
KU812F cells##4##2##(2008-11#4)
KU812F##5##1##(2008-11#5)
KW co-digestions##3##2##(2013-1#3)
Ka values##4##2##(1995-2#4)
Ka##9##1##(1994-5#1)(1995-2#8)
Kadomtsev-Petviashvili##2##1##(1994-2#1)(1996-9#1)
Kaduna##2##1##(2011-2#1)(2013-1#1)
Kaiser Permanente##5##2##(1995-2#1)(2008-11#1)(2010-8#2)(2011-2#1)
Kaiser Permanente's##3##2##(1993-12#1)(2010-8#2)
Kaiser##9##1##(1993-12#1)(1995-2#1)(2008-11#1)(2010-8#4)(2011-2#2)
Kaiser's##2##1##(1993-5#1)(1997-6#1)
Kallmann's syndrome##3##2##(2008-10#3)
Kallmann's##4##1##(1992-7#1)(2008-10#3)
Kalman filter##2##2##(2008-10#2)
Kalman##3##1##(2008-10#3)
Kampo medicine##2##2##(2008-10#2)
Kangaroo Care##2##2##(1994-3#2)
Kangaroo##4##1##(1994-3#4)
Kano##2##1##(1994-12#1)(2013-1#1)
Kanpur##2##1##(2009-12#2)
Kansas##9##1##(1995-3#3)(1996-1#1)(2008-10#5)
Kaolin##2##1##(2008-10#1)(2008-9#1)
Kaplan-Meier estimates##2##2##(1990-9#1)(1995-2#1)
Kaplan-Meier survival curves##2##3##(2013-1#1)(2013-8#1)
Kaplan-Meier##7##1##(1990-9#1)(1994-1#1)(1995-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Kaposi's sarcoma (KS)##2##3##(1991-8#1)(2012-3#1)
Kaposi's sarcoma and##2##3##(1992-12#1)(2011-3#1)
Kaposi's sarcoma on a##2##4##(1992-12#2)
Kaposi's sarcoma##13##2##(1990-6#2)(1990-8#3)(1991-8#2)(1992-12#3)(2008-12#1)(2011-3#1)(2012-3#1)
Kaposi's##14##1##(1990-6#2)(1990-8#3)(1991-8#2)(1992-12#3)(2008-12#1)(2011-3#1)(2012-3#2)
Kappa##5##1##(2008-11#1)(2008-5#2)(2008-6#1)(2010-10#1)
Karachi##4##1##(2012-2#2)(2013-7#1)(2013-8#1)
Karasek##2##1##(2008-10#1)(2008-11#1)
Karl Albrecht##3##2##(1995-1#3)
Karl Fischer (KF)##3##3##(2008-10#3)
Karl Fischer titration##5##3##(2008-10#5)
Karl Fischer##10##2##(2008-10#10)
Karl##14##1##(1994-1#1)(1995-1#3)(2008-10#10)
Karlovac##2##1##(2011-2#2)
Karnal bunt##7##2##(2008-10#7)
Karnal##8##1##(2008-10#8)
Karnofsky##2##1##(1991-2#1)(2011-2#1)
Karst##2##1##(2008-5#2)
Karyotype##2##1##(1997-3#1)(2008-12#1)
Karyotypes##3##1##(2008-12#1)(2008-6#2)
Karyotypic##2##1##(2008-8#1)(2012-3#1)
Kasabach-Merritt syndrome##4##2##(2008-7#3)(2009-1#1)
Kashmir##6##1##(2011-2#5)(2013-8#1)
Kasper reduced sapstain of##2##4##(2008-10#2)
Kasper##7##1##(2008-10#6)(2012-3#1)
Katayama syndrome##2##2##(1996-8#2)
Kathleen##2##1##(1995-6#1)(2008-10#1)
Kathmandu valley##2##2##(2008-11#1)(2012-3#1)
Kathmandu##6##1##(2008-11#2)(2012-3#4)
Katrina is##2##2##(2011-2#2)
Katrina##7##1##(2008-4#1)(2011-2#4)(2012-3#2)
Katy and##2##2##(2008-10#2)
Katy##3##1##(2008-10#3)
Kava##2##1##(2008-1#2)
Kawasaki disease (KD)##2##3##(2011-2#1)(2012-2#1)
Kawasaki disease##7##2##(1993-12#1)(2008-11#3)(2011-2#1)(2012-2#2)
Kawasaki##8##1##(1993-12#1)(2008-11#3)(2011-2#1)(2012-2#2)(2013-8#1)
Kazakhstan##3##1##(2008-10#2)(2013-1#1)
Kb##4##1##(1992-3#2)(1994-11#1)(2008-11#1)
Kc cells##5##2##(1995-6#5)
Kd of##5##2##(1990-10#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-8#1)
Kd value##2##2##(1994-5#1)(1996-2#1)
Kd values of 0##2##4##(1994-3#1)(1995-8#1)
Kd values##6##2##(1991-6#1)(1994-3#1)(1994-8#1)(1995-8#2)(2008-8#1)
Kd##23##1##(1990-10#1)(1990-11#1)(1991-6#1)(1993-8#5)(1994-3#1)(1994-5#2)(1994-8#3)(1995-11#1)(1995-8#4)(1996-2#1)(1997-2#1)(2008-8#1)(2012-2#1)
Keele##2##1##(2008-11#2)
Keep##3##1##(1994-2#1)(1994-8#1)(1997-5#1)
Keeping it##2##2##(2008-11#1)(2008-8#1)
Keeping##9##1##(1991-5#1)(1994-2#1)(1997-6#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
Kefir extract##7##2##(2008-11#7)
Kefir##10##1##(2008-11#10)
Kefram-Kefir##6##1##(2008-11#6)
Kell blood group##2##3##(2012-2#1)(2013-1#1)
Kelly##2##1##(1993-12#1)(2008-11#1)
Kent County##5##2##(2008-10#5)
Kentucky nursing homes##2##3##(1995-2#2)
Kentucky##13##1##(1991-1#1)(1992-2#1)(1994-3#1)(1995-2#2)(2008-10#8)
Kenwood##2##1##(2008-10#2)
Kenya##6##1##(1990-6#1)(2008-10#4)(2011-2#1)
Kenyon cells##2##2##(2009-8#2)
Keoflo##3##1##(1995-3#3)
Keratinocyte##3##1##(1994-11#1)(2008-11#1)(2008-5#1)
Kern##3##1##(2008-10#1)(2009-5#1)(2011-2#1)
Kernel##5##1##(2008-10#5)
Kernels##4##1##(2008-10#4)
Kerr##7##1##(2007-12#3)(2008-2#3)(2008-3#1)
Kerr-lens mode-locked##3##2##(2007-11#2)(2008-3#1)
Key Words##9##2##(2008-10#9)
Key areas##3##2##(2008-11#1)(2009-10#1)(2010-6#1)
Key features of##2##3##(2009-3#1)(2013-8#1)
Key questions##3##2##(1997-2#1)(2010-12#1)(2011-2#1)
Key to the##2##3##(2008-10#1)(2008-9#1)
Key to##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
Key words##11##2##(1991-6#1)(2008-11#1)(2009-8#8)(2013-1#1)
Key##49##1##(1991-6#1)(1993-3#1)(1993-8#1)(1996-11#1)(1996-5#1)(1997-2#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#8)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Keywords##16##1##(2008-9#1)(2010-1#15)
Kg/m2)##3##1##(2008-10#3)
Khambhat (Gujarat)##2##2##(2009-12#2)
Khambhat##3##1##(2009-12#3)
Khan##2##1##(2008-12#1)(2013-8#1)
Khartoum city##2##2##(2013-1#2)
Khartoum##5##1##(2013-1#5)
Khon Kaen##3##2##(2011-2#3)
Khuzestan##2##1##(2008-12#2)
Ki =##5##2##(1991-5#1)(1992-3#2)(1993-8#1)(1994-8#1)
Ki value##2##2##(1994-11#1)(1995-6#1)
Ki values of##3##3##(1994-8#1)(1995-11#2)
Ki values##9##2##(1992-12#1)(1992-3#1)(1992-6#2)(1994-8#1)(1995-11#3)(2008-10#1)
Ki##22##1##(1991-5#2)(1992-12#1)(1992-3#3)(1992-6#2)(1993-8#3)(1994-11#1)(1994-3#1)(1994-8#2)(1995-11#3)(1995-6#1)(2008-10#2)(2012-2#1)
Ki-67 and##2##2##(2008-7#1)(2012-3#1)
Ki-67 labeling index##2##3##(2008-11#1)(2009-1#1)
Ki-67##10##1##(1993-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-1#1)(2011-2#1)(2012-3#2)
Ki14##3##1##(2012-3#3)
Kidd##4##1##(1995-6#4)
Kidney Disease##2##2##(2012-12#1)(2013-1#1)
Kidney transplantation in##2##3##(2008-10#1)(2011-2#1)
Kidney##15##1##(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#4)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Kienbock's disease##3##2##(2012-3#3)
Kikuchi's disease##3##2##(2011-2#3)
Kikuchi's##5##1##(1991-3#1)(2011-2#4)
Kill##2##1##(2008-10#2)
Kim##9##1##(1991-12#2)(1995-6#1)(1997-8#2)(2008-10#1)(2010-7#2)(2012-2#1)
Kinase Balpha##2##2##(2008-11#2)
Kinase in##2##2##(2008-10#1)(2011-2#1)
Kinase##10##1##(2008-10#3)(2008-11#3)(2008-3#1)(2011-2#2)(2013-1#1)
Kinases##2##1##(2008-4#1)(2009-8#1)
Kinematic##2##1##(2008-10#1)(2011-2#1)
Kinetic analysis##2##2##(1992-6#1)(2012-2#1)
Kinetic and equilibrium##2##3##(2008-10#2)
Kinetic and##3##2##(1991-12#1)(2008-10#2)
Kinetic determination of##5##3##(2008-10#5)
Kinetic measurements##2##2##(1991-6#1)(1994-5#1)
Kinetic modeling of##2##3##(2008-7#1)(2012-2#1)
Kinetic parameters (the Michaelis constant K(m) and the maximum##2##9##(2008-10#2)
Kinetic parameters were##2##3##(1991-5#1)(2013-8#1)
Kinetic parameters##6##2##(1991-5#1)(2008-10#4)(2013-8#1)
Kinetic resistance##2##2##(2008-11#2)
Kinetic spectrophotometric determination of##2##4##(2008-10#2)
Kinetic spectrophotometric##3##2##(2008-10#3)
Kinetic studies of##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
Kinetic studies showed##2##3##(1990-11#1)(2008-11#1)
Kinetic studies##9##2##(1990-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
Kinetic study##2##2##(2008-10#2)
Kinetic##54##1##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-5#2)(1995-6#2)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
Kinetic-spectrophotometric determination of trace amounts of##2##6##(2008-10#2)
Kinetic-spectrophotometric determination of##3##3##(2008-10#3)
Kinetic-spectrophotometric##4##1##(2008-10#4)
Kinetics and##6##2##(1996-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
Kinetics of##6##2##(1990-12#1)(1994-5#2)(2008-10#3)
Kinetics##12##1##(1990-12#1)(1994-5#2)(1996-11#1)(2008-10#4)(2008-11#2)(2008-7#1)(2011-2#1)
King##9##1##(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-3#1)
King's medium B##2##3##(2008-10#2)
Kingdom Central Council for Nursing##5##5##(2008-11#5)
Kingdom Central Council##6##3##(2008-11#6)
Kingdom and Ireland##2##3##(2008-9#2)
Kingdom and##3##2##(2008-10#1)(2008-9#2)
Kingdom of##3##2##(2008-10#1)(2009-10#1)(2013-1#1)
Kingdom##53##1##(1991-2#1)(1991-3#1)(1991-8#2)(1992-1#1)(1994-12#2)(1995-1#2)(1995-2#1)(2008-10#12)(2008-11#14)(2008-12#5)(2008-9#4)(2009-10#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Kinmen##2##1##(1994-12#2)
Kinship##4##1##(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
Kinston##3##1##(2008-10#3)
Kir3 channels##2##2##(1996-2#2)
Kirby Bauer##2##2##(2011-2#1)(2012-3#1)
Kirschner wire fixation##3##3##(2011-2#3)
Kirschner wires##2##2##(2009-3#1)(2013-1#1)
Kirschner##6##1##(2009-3#1)(2011-2#4)(2013-1#1)
Kishino-Hasegawa##2##1##(2008-10#2)
Kissei##4##1##(2008-5#4)
Kitosatospora##2##1##(2008-10#2)
Kiurushi lacquer film##2##3##(2008-10#2)
Kiurushi##3##1##(2008-10#3)
Kjeldahl digestion##3##2##(2008-10#3)
Kjeldahl method##3##2##(2008-10#3)
Kjeldahl nitrogen##4##2##(2008-10#4)
Kjeldahl##17##1##(2008-10#17)
Klaroid##2##1##(2008-9#2)
Klarsicht##6##1##(2008-9#6)
Klebsiella pneumoniae and##2##3##(2008-9#1)(2013-8#1)
Klebsiella pneumoniae##8##2##(1997-7#2)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Klebsiella##14##1##(1991-3#1)(1993-12#1)(1997-7#2)(2008-11#1)(2008-9#2)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Kleihauer##5##1##(2009-3#5)
Klenow fragment##2##2##(2008-4#2)
Klinefelter##2##1##(2008-11#1)(2013-1#1)
Klippel-Feil deformity##2##2##(2008-7#2)
Kluyveromyces lactis##3##2##(1991-5#1)(1993-2#1)(2008-10#1)
Km =##2##2##(1991-5#1)(1992-3#1)
Km and Vmax##2##3##(1994-5#1)(1994-6#1)
Km and##3##2##(1994-5#2)(1994-6#1)
Km for##10##2##(1990-11#4)(1990-2#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-6#1)
Km genotyping##2##2##(1997-8#2)
Km of##6##2##(1992-6#1)(1993-6#1)(1994-6#1)(1995-8#1)(2008-11#1)(2008-7#1)
Km value##2##2##(1991-12#1)(1993-6#1)
Km values for aspartate and##2##5##(1995-6#2)
Km values for##6##3##(1990-10#1)(1995-6#4)(2008-8#1)
Km values of##2##3##(1995-8#2)
Km values##11##2##(1990-10#1)(1990-5#1)(1992-3#1)(1994-8#1)(1995-6#4)(1995-8#2)(2008-8#1)
Km##50##1##(1990-10#1)(1990-11#4)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-3#3)(1992-6#2)(1993-6#2)(1993-8#2)(1994-5#4)(1994-6#2)(1994-8#6)(1995-2#1)(1995-6#5)(1995-8#3)(1997-8#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
Km*1##10##1##(1997-8#10)
Km*3##5##1##(1997-8#5)
Km/Ki ratio 0##2##3##(1994-6#2)
Km1##2##1##(1992-3#2)
Km2##2##1##(1992-3#2)
Kmy2##4##1##(1997-8#4)
Knee Arthroplasty##4##2##(2013-1#4)
Knee Implant##2##2##(2013-1#2)
Knee Osteoarthritis##2##2##(2013-1#2)
Knee power generated by##2##4##(2013-1#2)
Knee##18##1##(2008-12#2)(2011-2#1)(2012-2#1)(2013-1#14)
Knees were##2##2##(2008-8#1)(2012-2#1)
Knockdown of##2##2##(2011-2#1)(2012-2#1)
Knockout##2##1##(1995-2#1)(2013-7#1)
Know your##2##2##(1997-2#1)(2012-3#1)
Know##5##1##(1993-12#1)(1997-2#1)(2008-6#1)(2012-3#2)
Knowing that##2##2##(1990-11#1)(2008-10#1)
Knowing##6##1##(1990-11#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)
Knowledge about##2##2##(1991-1#1)(2008-10#1)
Knowledge and attitudes of##2##4##(1996-6#1)(2008-11#1)
Knowledge and##8##2##(1991-6#1)(1993-12#1)(1996-6#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Knowledge of the mechanism##2##4##(2008-11#1)(2008-7#1)
Knowledge of the##15##3##(2008-10#4)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
Knowledge of##28##2##(1997-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#2)
Knowledge on##2##2##(2008-10#1)(2010-12#1)
Knowledge##58##1##(1990-11#1)(1991-1#1)(1991-6#1)(1993-12#1)(1996-6#1)(1997-1#1)(1997-8#2)(2008-10#6)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-2#5)(2013-1#8)(2013-7#1)
Known##3##1##(1992-3#1)(1996-12#1)(2008-10#1)
Ko##2##1##(1993-8#2)
Koch##5##1##(1995-6#1)(2007-12#4)
Koch's postulates have not been##2##5##(2008-10#2)
Koch's postulates were##2##3##(2008-10#1)(2009-6#1)
Koch's postulates##8##2##(2008-10#7)(2009-6#1)
Kocide##2##1##(2008-10#2)
Koh##3##1##(2011-2#3)
Kohonen##5##1##(2008-10#5)
Kommerrell's##2##1##(2010-7#2)
Korea and other##2##3##(2008-10#2)
Korea and##7##2##(2008-10#5)(2008-5#1)(2013-8#1)
Korea have##2##2##(2008-10#1)(2010-12#1)
Korea##34##1##(1997-8#2)(2008-10#15)(2008-5#1)(2008-8#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-6#4)(2011-2#2)(2013-8#3)
Korean Adolescents##2##2##(2010-6#1)(2013-1#1)
Korean immigrant discipline##2##3##(2010-11#2)
Korean patients with##2##3##(1997-8#2)
Korean patients##3##2##(1997-8#2)(2013-3#1)
Korean strain##2##2##(2008-10#2)
Korean##27##1##(1992-12#1)(1994-11#2)(1997-8#3)(2006-6#1)(2008-10#8)(2010-11#2)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-3#1)
Koreans##3##1##(1997-8#3)
Korsakoff syndrome##2##2##(2008-7#2)
Korsakoff's syndrome##2##2##(2008-7#2)
Korsmeyer##2##1##(2012-2#2)
Kosman's##2##1##(2008-10#2)
Kosovo##2##1##(2008-11#1)(2008-12#1)
Kostrena##5##1##(2011-2#5)
Kotar and Islands##3##3##(2011-2#3)
Kotar and##4##2##(2011-2#4)
Kotar##8##1##(2011-2#8)
Kovats##2##1##(2008-10#2)
Kościuszko##2##1##(2008-12#2)
Kp NifA##2##2##(2008-9#2)
Kpc##4##1##(1991-5#4)
KpnI##5##1##(1993-2#1)(1993-3#1)(1993-8#1)(2008-10#1)(2009-3#1)
Kr-h1##2##1##(2012-2#2)
Kraft pulp was##2##3##(2008-6#2)
Krawczak##2##1##(2008-12#2)
Krebs##3##1##(1993-8#1)(1994-3#1)(2011-2#1)
Kribbella flavida##2##2##(2011-2#2)
Kribbella##5##1##(2011-2#5)
Krukenberg tumour##4##2##(2012-2#4)
Kruskal-Wallis##5##1##(1994-2#1)(2013-1#4)
Krüppel-like factor 6##2##3##(2011-2#2)
Ktr/Trk/HKT-type transporters##2##2##(2008-8#2)
Ku DNA binding##2##3##(2013-1#2)
Ku##6##1##(1996-2#3)(1997-7#1)(2013-1#2)
Kuala Lumpur##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
Kulm##6##1##(2008-10#6)
Kuna##3##1##(2010-4#3)
Kupffer cells treated with##4##4##(1997-4#4)
Kupffer cells##10##2##(1992-6#1)(1997-4#8)(2008-4#1)
Kuromeurushi lacquer film##2##3##(2008-10#2)
Kuromeurushi##3##1##(2008-10#3)
Kuwait##2##1##(2008-10#1)(2008-7#1)
Kv1##3##1##(1997-2#3)
Kyoto##3##1##(2008-4#1)(2009-11#1)(2010-6#1)
Kyuri green mottle mosaic virus##2##5##(2008-10#2)
Kölliker-Fuse nucleus##2##2##(1996-5#2)
L RNA##2##2##(2008-10#2)
L and##9##2##(1995-6#1)(1996-3#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)
L bioreactor##2##2##(2008-11#2)
L cells##2##2##(1993-6#1)(1997-3#1)
L chains##4##2##(1993-6#1)(1995-2#3)
L extract on##3##3##(2008-5#2)(2013-1#1)
L extract##4##2##(2008-5#3)(2013-1#1)
L genes##3##2##(2008-10#3)
L h(-1) m(-2))##2##3##(2008-7#2)
L in##2##2##(2008-10#2)
L is##2##2##(1995-6#1)(1995-8#1)
L of##2##2##(2008-11#1)(2008-12#1)
L protein##3##2##(2008-10#3)
L strain isolates##4##3##(2008-10#4)
L strain##5##2##(2008-10#5)
L was##3##2##(1990-12#1)(1996-3#1)(2008-5#1)
L were##5##2##(1990-12#1)(1995-6#1)(2008-10#3)
L##451##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-5#2)(1990-6#8)(1991-10#3)(1991-3#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#2)(1994-11#3)(1994-5#4)(1995-2#4)(1995-6#16)(1995-8#3)(1996-12#11)(1996-3#11)(1996-5#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-12#6)(2008-10#136)(2008-11#22)(2008-12#24)(2008-3#5)(2008-5#18)(2008-6#1)(2008-7#8)(2008-8#12)(2008-9#29)(2009-12#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-10#2)(2010-3#3)(2010-4#5)(2010-8#9)(2011-1#2)(2011-10#2)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#9)(2012-3#13)(2012-4#1)(2013-1#6)(2013-8#18)
L'association de la leucémie aiguë##2##5##(2013-1#2)
L'association##3##1##(2011-2#1)(2013-1#2)
L'objectif de ce travail##2##4##(2013-1#2)
L'vov platform##2##2##(2008-10#2)
L( *)##3##2##(2010-4#3)
L(##4##1##(2010-4#4)
L(+) lactic acid##2##3##(2008-5#2)
L(-1) NaCl##2##2##(2008-9#2)
L(-1) and 0##2##3##(2008-10#2)
L(-1) and 1##2##3##(2008-10#2)
L(-1) and##10##2##(2008-10#9)(2011-3#1)
L(-1) of##5##2##(2008-10#4)(2008-7#1)
L(-1) was##2##2##(2008-10#1)(2008-12#1)
L(-1)##95##1##(2008-10#50)(2008-11#5)(2008-12#19)(2008-7#5)(2008-9#7)(2011-2#2)(2011-3#7)
L(-1)) and##3##2##(2008-10#2)(2008-9#1)
L(-1)) of##2##2##(2008-10#1)(2008-12#1)
L(-1))##25##1##(2008-10#7)(2008-11#2)(2008-12#8)(2008-7#2)(2008-9#1)(2011-3#5)
L(2) = cis-dppen##3##3##(2009-9#3)
L(2) =##5##2##(2009-9#5)
L(2)##11##1##(2008-10#4)(2008-5#2)(2009-9#5)
L(OP)##2##1##(2010-8#2)
L(S)##4##1##(2010-8#4)
L(T)##2##1##(2008-10#1)(2010-8#1)
L)##12##1##(1990-5#1)(1991-2#1)(1995-12#1)(1996-3#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-8#1)
L- or D-amino##2##3##(1992-11#1)(2008-10#1)
L-##3##1##(1992-11#1)(2008-10#2)
L-15 medium##3##2##(2008-11#3)
L-6##4##1##(1995-8#3)(2008-11#1)
L-659##3##1##(2008-8#3)
L-668##2##1##(2008-8#2)
L-680##3##1##(1993-8#3)
L-Cys##2##1##(1994-5#2)
L-FABP and ACBP##3##3##(1994-8#3)
L-FABP##11##1##(1994-8#8)(2013-1#3)
L-Glu##5##1##(1997-2#5)
L-Leucine##2##1##(2008-11#1)(2012-9#1)
L-NAC##2##1##(1994-5#2)
L-NAME##2##1##(2008-11#2)
L-NG-nitroarginine methyl ester##2##3##(1995-11#2)
L-NNA##2##1##(1997-2#2)
L-OES##2##1##(2008-10#2)
L-PHP expression##2##2##(2013-7#2)
L-PHP may##3##2##(2013-7#3)
L-PHP##16##1##(2013-7#16)
L-T4##3##1##(2008-7#1)(2011-1#2)
L-TGF-beta 1##7##2##(1990-2#7)
L-alpha-H-amino acids##2##2##(1992-11#2)
L-amino acid##2##2##(1997-3#1)(2008-10#1)
L-amino acids by##2##3##(1995-3#2)
L-amino acids##5##2##(1995-11#1)(1995-3#4)
L-amino##7##1##(1995-11#1)(1995-3#4)(1997-3#1)(2008-10#1)
L-arginine and##4##2##(1990-12#1)(1994-11#1)(2008-11#1)(2010-12#1)
L-arginine by##2##2##(2008-5#1)(2010-12#1)
L-arginine##26##1##(1990-12#7)(1991-6#1)(1992-12#1)(1993-8#4)(1994-11#1)(1995-11#3)(1997-2#5)(2008-11#1)(2008-5#1)(2010-12#2)
L-ascorbic acid##4##2##(1993-12#2)(2008-10#1)(2008-11#1)
L-asparaginase##6##1##(2011-2#5)(2012-3#1)
L-carnitine caused a##2##3##(2009-8#2)
L-carnitine in##2##2##(2008-10#1)(2012-2#1)
L-carnitine##11##1##(1991-12#3)(2008-10#2)(2009-8#5)(2012-2#1)
L-chain degradation##2##2##(1995-2#2)
L-chain##3##1##(1995-2#3)
L-citrulline##3##1##(1990-12#2)(1995-11#1)
L-dopa concentration##3##2##(2008-10#1)(2008-7#2)
L-dopa in pharmaceutical formulations##2##4##(2008-10#2)
L-dopa##14##1##(1990-8#1)(2008-10#9)(2008-7#4)
L-dopa/carbidopa##5##1##(2008-7#5)
L-dsRNA##4##1##(2008-10#4)
L-erythrulose from##2##2##(2008-7#2)
L-erythrulose##3##1##(2008-7#3)
L-glutamate##5##1##(1997-2#2)(2008-7#3)
L-glutamine##4##1##(1990-12#1)(1995-8#1)(2008-11#1)(2008-8#1)
L-histidine and##2##2##(1995-8#1)(2008-11#1)
L-histidine##17##1##(1995-8#10)(1997-1#1)(2008-11#6)
L-lactate##3##1##(1991-5#1)(1994-11#1)(1994-3#1)
L-leucine and KIC##7##3##(2008-11#7)
L-leucine and##8##2##(2008-11#8)
L-leucine##9##1##(1990-2#1)(2008-11#8)
L-lysine##3##1##(2008-11#1)(2008-7#2)
L-menthol##10##1##(2012-2#10)
L-methionine for##2##2##(1992-6#1)(2008-10#1)
L-methionine##5##1##(1992-6#1)(1992-9#1)(1995-3#1)(2008-10#2)
L-proline transporter##2##2##(1995-6#2)
L-proline##3##1##(1995-6#2)(2008-10#1)
L-pyroglutamyl-L-prolyl-L-valine-p-nitroanilide##2##1##(1990-2#2)
L-selectin is##2##2##(1992-12#2)
L-selectin##4##1##(1992-12#4)
L-tryptophan##3##1##(1990-10#1)(1990-8#1)(2008-10#1)
L-type calcium##2##2##(1994-11#1)(1997-1#1)
L-type##5##1##(1994-11#2)(1996-2#1)(1997-1#1)(2010-11#1)
L-tyrosine##3##1##(2008-10#3)
L/min##3##1##(1996-3#1)(2008-8#1)(2010-7#1)
L1 elements##3##2##(2008-11#3)
L1 expression is##2##3##(1995-2#1)(2008-7#1)
L1 in CNS myelination##2##4##(2008-7#2)
L1 in##6##2##(1995-2#1)(1996-12#2)(2008-10#1)(2008-7#2)
L1 is##2##2##(1996-12#1)(2008-7#1)
L1##33##1##(1991-11#3)(1993-12#2)(1995-2#4)(1995-6#1)(1996-12#6)(1997-2#1)(2008-10#3)(2008-11#5)(2008-7#7)(2013-8#1)
L1-Fc fusion##2##2##(2008-7#2)
L100I (TTA--&gt##2##2##(2011-3#2)
L11##6##1##(1995-6#1)(2008-10#5)
L16C5##7##1##(2008-10#7)
L17A homologue##2##2##(1991-6#2)
L17A##7##1##(1991-6#7)
L2 production##2##2##(2011-2#2)
L2##8##1##(1990-5#1)(1991-11#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
L2-3 and L3-4##3##3##(2013-1#3)
L2-3##5##1##(2012-3#1)(2013-1#4)
L20B##2##1##(2012-2#2)
L24 mutant the##2##3##(2008-8#2)
L24 mutant##7##2##(2008-8#2)(2008-9#5)
L2d-dauer##2##1##(1993-12#2)
L3 and L4##2##3##(2008-10#1)(2008-8#1)
L3 and##4##2##(1996-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
L3##16##1##(1991-11#3)(1992-8#5)(1996-6#1)(2008-10#4)(2008-8#2)(2012-12#1)
L3-4 and lumbar curvature##2##4##(2013-1#2)
L3-4##6##1##(2012-3#2)(2013-1#4)
L3-L4##2##1##(2011-2#2)
L32##2##1##(1991-5#2)
L4##5##1##(1996-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
L4-5##3##1##(2012-3#3)
L4-L5##5##1##(1996-6#3)(2009-3#1)(2011-2#1)
L5 nerve##2##2##(2012-2#2)
L5##5##1##(1995-5#1)(2008-10#1)(2012-2#3)
L5-S1##7##1##(1996-6#3)(2009-3#1)(2011-2#1)(2012-2#2)
L6 and##3##2##(1992-12#1)(1993-3#2)
L6 cells##2##2##(1993-3#1)(2008-11#1)
L6 myotubes##15##2##(1994-11#2)(2008-11#13)
L6##23##1##(1992-12#1)(1993-3#4)(1994-11#3)(2008-11#15)
L929 cells##2##2##(1994-8#2)
L929##5##1##(1994-3#1)(1994-8#2)(2008-11#1)(2008-8#1)
LA and CRY##2##3##(2009-8#2)
LA and##5##2##(2009-8#2)(2011-2#3)
LA sampling##2##2##(2008-10#2)
LA##21##1##(1995-12#1)(2008-10#8)(2008-7#1)(2009-8#2)(2011-2#5)(2013-1#4)
LA-ICP-MS##14##1##(2008-10#13)(2010-11#1)
LA-ICPMS##2##1##(2008-10#2)
LA4+##5##1##(2008-10#5)
LAB and##2##2##(2013-1#2)
LAB##3##1##(2013-1#3)
LAD therapy##2##2##(2013-1#2)
LAD##8##1##(2011-2#1)(2013-1#7)
LAK cell##2##2##(1991-8#1)(2008-11#1)
LAK cells and##2##3##(1990-12#1)(1992-2#1)
LAK cells##6##2##(1990-12#3)(1992-2#1)(1994-6#1)(2008-11#1)
LAK##12##1##(1990-12#3)(1991-8#1)(1992-2#5)(1994-6#1)(2008-11#2)
LAKs##2##1##(1990-12#2)
LAMP method##3##2##(2009-6#3)
LAMP##4##1##(2009-6#4)
LAN##3##1##(2007-12#3)
LARC##2##1##(2013-1#2)
LAS surfactants##3##2##(2008-10#3)
LAS##14##1##(2008-10#14)
LAS)##2##1##(2008-10#2)
LASA##2##1##(1993-1#2)
LASIK monovision##5##2##(2011-2#5)
LAT##4##1##(1990-6#4)
LATEBLIGHT##4##1##(2008-10#4)
LAV##2##1##(2008-10#2)
LAVH##8##1##(1994-2#4)(1995-1#2)(1995-3#2)
LAY ABSTRACT##6##2##(2012-2#6)
LB and SP##2##3##(2008-10#2)
LB and XN4##2##3##(2008-10#2)
LB and##4##2##(2008-10#4)
LB film##2##2##(2008-10#2)
LB films are##2##3##(2008-10#2)
LB films were##3##3##(2008-10#3)
LB films##14##2##(2008-10#11)(2008-11#3)
LB x SP##2##3##(2008-10#2)
LB x XN4 and XN4 x SP##2##7##(2008-10#2)
LB x XN4##3##3##(2008-10#3)
LB x##6##2##(2008-10#6)
LB##35##1##(2008-10#24)(2008-11#9)(2008-9#1)(2013-1#1)
LB31##4##1##(2008-10#4)
LBL films##2##2##(2008-10#2)
LBL##3##1##(2008-10#3)
LBMA##2##1##(2008-9#2)
LBO##2##1##(2008-2#1)(2008-3#1)
LBP and##2##2##(2010-9#1)(2012-12#1)
LBP group##2##2##(2010-9#2)
LBP##11##1##(2010-3#1)(2010-9#5)(2012-12#4)(2013-1#1)
LBR##3##1##(2011-2#3)
LBVV##4##1##(2008-10#4)
LC Vs##2##2##(2008-10#2)
LC and##5##2##(2008-10#5)
LC method for simultaneous##2##4##(2008-10#2)
LC method for##3##3##(2008-10#3)
LC method##5##2##(2008-10#5)
LC methods##2##2##(2008-10#2)
LC separation and##3##3##(2008-10#3)
LC separation##5##2##(2008-10#5)
LC##50##1##(1995-6#2)(2007-12#3)(2008-10#38)(2008-4#2)(2009-8#1)(2010-11#2)(2011-2#1)(2013-1#1)
LC-ESI-MS##3##1##(2008-10#3)
LC-HG-ICP-MS##2##1##(2008-10#2)
LC-ICP-MS##6##1##(2008-10#6)
LC-ICP-ORS-MS and##2##2##(2008-10#2)
LC-MS analysis of##2##3##(2008-10#2)
LC-MS and##3##2##(2008-10#2)(2010-2#1)
LC-MS data##2##2##(2012-12#2)
LC-MS##19##1##(1997-2#1)(2008-10#11)(2010-11#1)(2010-2#2)(2011-2#1)(2012-12#3)
LC-MS/MS method##3##2##(2008-10#1)(2011-3#2)
LC-MS/MS##10##1##(2008-10#1)(2010-11#5)(2011-3#4)
LC-UV##2##1##(2008-10#2)
LC-UV-MS##2##1##(2008-10#2)
LC/ES/MS##2##1##(2008-10#2)
LC/MS##3##1##(2008-10#2)(2009-8#1)
LC2##2##1##(1993-9#2)
LC50##3##1##(2008-11#1)(2008-12#2)
LC50(7d)##2##1##(2008-11#2)
LCA##4##1##(2008-11#1)(2010-10#1)(2010-12#1)(2011-2#1)
LCAT##16##1##(1993-6#9)(1993-8#7)
LCH##2##1##(2010-10#1)(2012-3#1)
LCLs##2##1##(2008-2#2)
LCM##4##1##(2008-11#2)(2010-12#2)
LCN2-null mice##3##2##(2013-8#3)
LCV injection of PGE2 at##2##5##(1997-2#2)
LCW##3##1##(2008-10#3)
LChD##9##1##(2008-10#9)
LChV-1##3##1##(2008-10#3)
LChV-2 is##2##2##(2008-10#2)
LChV-2##5##1##(2008-10#5)
LChV-3 CP##2##2##(2008-10#2)
LChV-3 is##2##2##(2008-10#2)
LChV-3##7##1##(2008-10#7)
LCs##2##1##(1996-12#1)(2008-10#1)
LD between##2##2##(2008-12#1)(2008-9#1)
LD therapy##2##2##(2008-7#2)
LD use##2##2##(2008-7#2)
LD##22##1##(1994-2#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-7#9)(2008-8#1)(2008-9#1)(2012-5#2)
LD(50)##4##1##(2008-10#1)(2008-11#2)(2008-9#1)
LD50 value##2##2##(1992-12#1)(2008-12#1)
LD50##5##1##(1990-5#1)(1992-12#2)(2008-11#1)(2008-12#1)
LDA##3##1##(2008-10#2)(2008-6#1)
LDH activity in the medium##2##5##(2008-11#2)
LDH activity##3##2##(2008-11#2)(2011-2#1)
LDH enzyme##3##2##(2011-2#3)
LDH from rabbit muscle##3##4##(2008-11#3)
LDH is##2##2##(1994-11#1)(2008-11#1)
LDH leakage##3##2##(1994-5#2)(1995-11#1)
LDH was##4##2##(2008-11#3)(2011-2#1)
LDH##42##1##(1994-11#5)(1994-2#1)(1994-5#2)(1995-11#2)(1997-7#1)(2008-10#4)(2008-11#16)(2010-4#3)(2011-2#5)(2011-3#3)
LDH-C##2##1##(1994-11#2)
LDI-TOF MS##2##2##(2008-10#2)
LDL alpha-tocopherol##4##2##(1991-12#4)
LDL and that##2##3##(1991-12#1)(2008-10#1)
LDL and##8##2##(1991-12#1)(1991-2#1)(1992-5#1)(1995-8#1)(1997-8#1)(2008-10#2)(2009-8#1)
LDL cholesterol and##2##3##(1991-2#1)(2008-7#1)
LDL cholesterol lowering##2##3##(2008-1#1)(2010-12#1)
LDL cholesterol##12##2##(1991-2#2)(1992-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#3)(2011-2#1)(2012-2#1)(2013-8#1)
LDL concentration##4##2##(1995-8#1)(2008-9#3)
LDL in##3##2##(1991-5#1)(1992-5#1)(1996-2#1)
LDL is##2##2##(1992-5#1)(2011-1#1)
LDL metabolism was##2##3##(1993-6#2)
LDL metabolism##6##2##(1993-6#6)
LDL oxidation##5##2##(1991-12#3)(1992-9#1)(1994-11#1)
LDL particle size##5##3##(1995-8#1)(2008-3#1)(2011-1#3)
LDL particle##9##2##(1995-8#1)(1996-8#1)(2008-3#2)(2008-5#1)(2011-1#4)
LDL particles##2##2##(2008-10#1)(2009-8#1)
LDL receptor##9##2##(1990-2#1)(1991-2#2)(1993-8#1)(1995-6#1)(2008-6#4)
LDL receptors##2##2##(1995-8#1)(2012-2#1)
LDL to##3##2##(1991-12#1)(1991-5#1)(1997-8#1)
LDL was##3##2##(1991-5#1)(1995-8#1)(1996-2#1)
LDL##123##1##(1990-2#1)(1990-8#4)(1991-12#11)(1991-2#5)(1991-5#3)(1992-11#1)(1992-5#6)(1992-9#1)(1993-2#2)(1993-6#6)(1993-8#3)(1994-11#4)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#5)(1996-2#5)(1996-8#1)(1997-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#9)(2008-5#1)(2008-6#5)(2008-7#2)(2008-9#4)(2009-8#12)(2010-12#3)(2010-3#1)(2011-1#6)(2011-2#1)(2012-2#4)(2013-7#1)(2013-8#1)
LDL-C##2##1##(2008-1#2)
LDL-cholesterol##3##1##(1990-8#1)(2008-10#2)
LDLR##5##1##(1995-2#3)(2012-2#1)(2013-1#1)
LDR##10##1##(2008-10#1)(2008-7#5)(2009-2#1)(2013-1#3)
LDS##2##1##(2008-10#1)(2008-3#1)
LDs##2##1##(2008-10#2)
LE##7##1##(1995-8#2)(2008-10#5)
LEANDRE II##4##2##(2008-3#4)
LEB##2##1##(2008-10#2)
LED as##3##2##(2008-10#3)
LED colorimeter##2##2##(2008-10#2)
LED excitation##2##2##(2008-10#1)(2008-7#1)
LED is##2##2##(2008-10#2)
LED light##3##2##(2008-11#3)
LED##24##1##(2008-10#18)(2008-11#3)(2008-3#1)(2008-7#1)(2010-8#1)
LED-based photometer##2##2##(2008-10#2)
LED-based##5##1##(2008-10#5)
LEDs were##2##2##(2008-10#2)
LEDs##9##1##(1995-3#1)(2008-10#8)
LEE##2##1##(2011-1#2)
LEF-1##6##1##(1995-8#6)
LEOPARD syndrome is##2##3##(2013-8#2)
LEOPARD syndrome##4##2##(2013-8#4)
LEU4##2##1##(1996-3#2)
LEW/N##3##1##(1994-2#3)
LF##2##1##(2008-4#1)(2011-3#1)
LFD tests and##2##3##(2008-10#2)
LFD tests##3##2##(2008-10#3)
LFD##8##1##(2008-10#8)
LFLX##3##1##(2008-10#3)
LFP##2##1##(1990-5#1)(2008-11#1)
LFS##5##1##(1990-12#4)(2011-2#1)
LG##7##1##(2007-12#1)(2008-10#4)(2008-5#1)(2012-2#1)
LG2##3##1##(2008-10#3)
LG7##4##1##(2008-10#4)
LGBT-positive##2##1##(2008-12#2)
LGG##3##1##(2009-12#3)
LGN##4##1##(1996-2#2)(2008-8#2)
LGS##3##1##(2008-3#3)
LH in##2##2##(1996-2#1)(2010-3#1)
LH lesions##3##2##(2009-10#3)
LH over AH##2##3##(2010-3#2)
LH receptor and inhibin##2##4##(2008-8#2)
LH receptor##6##2##(2008-8#6)
LH release##3##2##(1996-2#3)
LH stimulation##4##2##(2009-10#4)
LH##34##1##(1991-6#2)(1995-11#1)(1996-2#7)(2008-11#1)(2008-8#6)(2009-10#11)(2010-3#3)(2013-1#1)(2013-8#2)
LH-20##5##1##(1990-11#1)(1991-12#1)(1993-2#1)(2011-2#1)(2011-3#1)
LH-RH##5##1##(1993-1#5)
LH-hCG receptor##2##2##(1993-6#2)
LH/hCG receptor##4##2##(1995-8#4)
LH/hCG##5##1##(1995-8#5)
LHCs##4##1##(2008-8#4)
LHD##2##1##(1996-2#2)
LHDs##2##1##(1996-2#2)
LHR expression##2##2##(2008-8#2)
LHR mRNA##6##2##(2008-8#6)
LHR##11##1##(2008-8#11)
LHRH agonists##3##2##(1990-11#1)(2008-4#2)
LHRH analogues##3##2##(2008-4#3)
LHRH##11##1##(1990-11#1)(2008-4#10)
LI##3##1##(2008-4#3)
LI-4##3##1##(2008-10#3)
LIBS##2##1##(2008-10#2)
LIF concentrations##2##2##(2008-11#2)
LIF detection##2##2##(2008-10#2)
LIF##24##1##(1995-11#1)(1996-2#2)(2008-10#3)(2008-11#9)(2008-2#1)(2008-3#4)(2008-4#3)(2008-8#1)
LIGHT##2##1##(2012-2#2)
LILACS##4##1##(2012-3#4)
LIM protein##2##2##(2008-9#1)(2010-6#1)
LIM##4##1##(1994-11#1)(2008-9#2)(2010-6#1)
LIMM##3##1##(1990-12#3)
LINC##2##1##(2009-8#2)
LINC1-GFP##2##1##(2009-8#2)
LINE-1##4##1##(1995-2#2)(2008-11#2)
LIP and MNP##2##3##(2008-6#2)
LIP##8##1##(1990-12#5)(2008-6#3)
LIPID MAPS##2##2##(2012-12#2)
LIPUS##5##1##(2013-1#5)
LIR##5##1##(2008-9#5)
LIS##2##1##(1996-12#1)(2008-10#1)
LIX##2##1##(2008-10#2)
LIYV##2##1##(2008-10#2)
LJUNGSKILE##2##1##(2008-10#2)
LKSD-1##2##1##(2008-10#2)
LLD##6##1##(2008-11#6)
LLE##3##1##(2008-10#3)
LLETZ cone##3##2##(1994-2#3)
LLETZ##8##1##(1994-2#8)
LLNA##3##1##(2008-5#3)
LLPS##3##1##(2008-10#3)
LLS##3##1##(2008-3#3)
LM##3##1##(2008-11#1)(2008-9#1)(2011-1#1)
LM-PCR##2##1##(2008-8#1)(2011-2#1)
LM-acupoints##2##1##(2008-9#2)
LM/SL##3##1##(2012-12#3)
LMA CTrach##3##2##(2010-7#3)
LMA##9##1##(2010-7#7)(2012-9#2)
LMD##4##1##(2008-7#1)(2013-8#3)
LMF of the##2##3##(2008-11#2)
LMF##5##1##(2008-11#5)
LMH##8##1##(1993-12#8)
LMIF##2##1##(1991-12#2)
LMM##4##1##(2011-2#4)
LMP2 as##3##2##(2012-2#3)
LMP2##8##1##(1997-9#1)(2012-2#7)
LMV isolates##4##2##(2008-10#4)
LMV##5##1##(2008-10#5)
LMV-0-GFP##2##1##(2008-10#2)
LMV-Common##2##1##(2008-10#2)
LMV-Most##5##1##(2008-10#5)
LMV-RoW##2##1##(2008-10#2)
LMW HA##2##2##(2010-8#2)
LMW species##2##2##(2008-10#2)
LMW##5##1##(2008-10#3)(2010-8#2)
LMWH have##2##2##(2008-10#2)
LMWH##6##1##(2008-10#5)(2013-1#1)
LN##3##1##(1995-1#1)(2008-10#1)(2011-2#1)
LNCaP cells##5##2##(2008-6#1)(2010-1#1)(2011-2#3)
LNCaP##7##1##(2008-6#2)(2010-1#1)(2011-2#4)
LNG##3##1##(2008-10#3)
LNK##4##1##(2012-2#4)
LNT model##3##2##(2008-7#1)(2013-1#2)
LNT##5##1##(2008-7#3)(2013-1#2)
LOD and LOQ##2##3##(2008-10#2)
LOD is 0##2##3##(2008-10#2)
LOD is##3##2##(2008-10#3)
LOD of the##3##3##(2008-10#3)
LOD of##10##2##(2008-10#10)
LOD results are lower for##2##5##(2008-10#2)
LOD results##3##2##(2008-10#3)
LOD was found to be 0##2##6##(2008-10#2)
LOD was found to be##3##5##(2008-10#3)
LOD was##5##2##(2008-10#5)
LOD##38##1##(2008-10#38)
LODs for##2##2##(2008-10#1)(2010-5#1)
LODs of##3##2##(2008-10#3)
LODs were##2##2##(2008-10#2)
LODs##9##1##(2008-10#8)(2010-5#1)
LOGSTORY##2##1##(1994-6#2)
LOH##2##1##(2008-8#1)(2013-8#1)
LOOH##4##1##(2008-10#1)(2008-11#3)
LOOH-induced cytotoxicity##2##2##(2008-11#2)
LOQ of##2##2##(2008-10#2)
LOQ##6##1##(2008-10#5)(2011-3#1)
LOS for##3##2##(1993-12#3)
LOS reduction##2##2##(1995-12#1)(1995-2#1)
LOS##19##1##(1991-12#1)(1993-12#6)(1994-3#5)(1995-12#3)(1995-2#2)(1997-2#2)
LOV##5##1##(2008-10#2)(2011-1#3)
LOX##4##1##(2008-6#2)(2011-10#2)
LP in##2##2##(2008-12#1)(2011-2#1)
LP##20##1##(1994-5#2)(1995-8#3)(2008-10#8)(2008-11#1)(2008-12#5)(2011-2#1)
LPA##7##1##(2011-2#7)
LPD##2##1##(2013-1#2)
LPG sensor##3##2##(2008-10#3)
LPG##7##1##(2008-10#6)(2009-10#1)
LPL activity##2##2##(1992-3#1)(2008-11#1)
LPL and##2##2##(1992-3#1)(2008-11#1)
LPL cDNA##3##2##(1994-11#1)(1995-6#1)(2008-11#1)
LPL gene##2##2##(1994-11#1)(2008-11#1)
LPL in##2##2##(1992-3#1)(2008-11#1)
LPL##28##1##(1991-12#5)(1992-3#8)(1994-11#4)(1995-6#4)(2008-11#7)
LPL)##2##1##(1991-12#2)
LPP##5##1##(1994-8#4)(2008-5#1)
LPS alone##2##2##(1995-12#1)(2008-11#1)
LPS and##3##2##(2008-11#1)(2008-8#2)
LPS increased##2##2##(1997-2#1)(2011-2#1)
LPS treatment##2##2##(1995-12#1)(2008-12#1)
LPS##38##1##(1995-12#8)(1996-12#1)(1997-1#2)(1997-2#2)(1997-8#1)(2008-10#6)(2008-11#9)(2008-12#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#1)(2011-2#1)
LPS-induced IL-12 p40 and p35 mRNA##2##6##(2008-8#2)
LPS-induced IL-12##3##2##(2008-8#3)
LPS-induced NF-κB/Rel##2##2##(2011-2#2)
LPS-induced cytokine production##4##3##(2008-10#4)
LPS-induced##15##1##(1997-1#1)(2008-10#5)(2008-12#1)(2008-8#5)(2011-2#3)
LPS-stimulated lymphocyte proliferation##2##3##(2008-11#2)
LPS-stimulated##3##1##(1993-12#1)(2008-11#2)
LPS-triggered activation of##2##3##(2009-8#2)
LPSN##3##1##(1994-3#3)
LR parsing algorithm##3##3##(2011-3#3)
LR parsing##4##2##(2011-3#4)
LR##8##1##(2008-10#4)(2011-3#4)
LRMC's &quot##3##2##(1994-2#3)
LRR##2##1##(2009-6#1)(2009-8#1)
LRR-containing proteins##2##2##(2009-6#2)
LRS##2##1##(2011-2#2)
LS is##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
LS method##3##2##(2008-10#3)
LS##17##1##(1997-7#4)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#4)
LS-11##4##1##(2008-10#4)
LS-28##4##1##(2008-10#4)
LS-CMV##5##1##(2008-10#5)
LS11##3##1##(2008-10#3)
LS174T##2##1##(1990-8#1)(1997-2#1)
LSC##4##1##(2008-9#3)(2013-1#1)
LSCs are##3##2##(2011-2#2)(2013-1#1)
LSCs##8##1##(2011-2#7)(2013-1#1)
LSD##7##1##(2008-10#5)(2008-12#1)(2013-1#1)
LSU##5##1##(2008-10#1)(2010-3#4)
LT##8##1##(1990-9#1)(1994-8#1)(2011-3#5)(2012-3#1)
LTA and WTA##3##3##(1995-6#3)
LTA##6##1##(1995-6#6)
LTB4##2##1##(1994-8#2)
LTC homes##2##2##(2010-10#2)
LTC##12##1##(1993-12#1)(1994-2#3)(1996-2#1)(1997-3#2)(2009-4#3)(2010-10#2)
LTD and##3##2##(1995-2#2)(2012-2#1)
LTD##6##1##(1995-2#3)(2012-2#3)
LTF for ANG II##2##4##(1991-5#2)
LTF##4##1##(1991-5#4)
LTH##2##1##(2008-10#2)
LTK7##2##1##(1995-2#2)
LTP in##3##2##(2008-7#3)
LTP induction##4##2##(1990-5#1)(1997-2#1)(2008-7#2)
LTP is##4##2##(2008-7#4)
LTP was##5##2##(1993-12#1)(1995-12#1)(2008-7#3)
LTP##40##1##(1990-5#3)(1993-12#5)(1995-12#3)(1995-2#4)(1997-2#6)(2008-7#19)
LTP-reinforcement##2##1##(2008-7#2)
LTR of##3##2##(1994-11#1)(1994-12#1)(2008-9#1)
LTR promoter##2##2##(1995-6#2)
LTR##18##1##(1990-8#1)(1991-2#1)(1992-6#2)(1993-8#1)(1994-11#5)(1994-12#2)(1995-6#3)(2008-4#1)(2008-8#1)(2008-9#1)
LTS##3##1##(2008-10#1)(2010-9#2)
LTs##3##1##(1994-8#3)
LTx##2##1##(2011-3#2)
LUCA##2##1##(2009-6#2)
LV and MTX##4##3##(2008-10#4)
LV and##7##2##(2008-10#7)
LV hypertrophy is##2##3##(2011-2#2)
LV hypertrophy##3##2##(2011-2#3)
LV twist and untwist##2##4##(2011-2#2)
LV untwisting rate##2##3##(2011-2#2)
LV vent valves##2##3##(1991-3#2)
LV vent##4##2##(1991-3#4)
LV##30##1##(1991-3#4)(2008-10#9)(2010-5#1)(2011-2#11)(2012-2#5)
LV)##2##1##(2008-10#1)(2008-11#1)
LVADs##2##1##(2010-6#2)
LVFX and MFLX##2##3##(2011-2#2)
LVH##5##1##(2009-1#5)
LVHR##2##1##(2010-8#2)
LVP and SSP##2##3##(1993-1#2)
LVP##3##1##(1993-1#3)
LVs##3##1##(2008-11#3)
LXA4 and LXB4##3##3##(1991-5#3)
LXA4##4##1##(1991-5#4)
LY294002##3##1##(1995-8#3)
L]##2##1##(2008-10#1)(2011-3#1)
La Brillante and Little Gem##2##5##(2008-10#2)
La Palma##3##2##(2008-10#3)
La and##2##2##(2008-10#2)
La pauvreté##2##2##(2008-11#2)
La survenue##2##2##(2011-2#1)(2013-1#1)
La##48##1##(1992-8#1)(1994-9#1)(1996-2#1)(1996-9#1)(2008-10#19)(2008-11#2)(2009-7#2)(2010-6#1)(2011-2#10)(2013-1#10)
La(3+) can##2##2##(2008-10#1)(2008-9#1)
La(3+) in##2##2##(2008-10#1)(2008-9#1)
La(3+) ions##2##2##(2008-10#2)
La(3+)##21##1##(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#7)
La(III) and Nd(III)##3##3##(2008-10#3)
La(III) and##5##2##(2008-10#5)
La(III)##21##1##(2008-10#21)
La2-xSrxCuO4##2##1##(1992-8#1)(1996-9#1)
La3+##7##1##(1994-8#1)(1996-2#1)(1997-2#5)
LaF(3)-membrane and stainless steel##2##4##(2008-10#2)
LaF(3)-membrane and##3##2##(2008-10#3)
LaGrue##3##1##(2008-10#3)
Lab##2##1##(2008-8#1)(2010-1#1)
Lab-at-Valve##2##1##(2008-10#2)
LabVIEW##3##1##(2008-10#3)
LabVIEW-based software for the##2##4##(2008-10#2)
LabVIEW-based##3##1##(2008-10#3)
Labeled##2##1##(1993-8#1)(2008-10#1)
Labeling with##2##2##(1991-5#1)(2008-10#1)
Labeling##6##1##(1990-6#1)(1991-12#1)(1991-5#1)(2008-10#1)(2009-8#1)(2013-1#1)
Labelled##3##1##(1990-5#1)(1993-2#1)(2008-5#1)
Labels##2##1##(1992-3#1)(2012-2#1)
Lablab##2##1##(2008-12#2)
Labor market##2##2##(1991-3#1)(1992-12#1)
Labor##6##1##(1991-3#1)(1992-12#1)(1993-1#1)(1994-2#1)(1997-2#1)(2013-1#1)
Laboratories##11##1##(1997-2#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2010-7#1)(2012-12#1)(2013-1#1)
Laboratory Improvement##2##2##(1994-2#2)
Laboratory Standards##2##2##(2008-5#1)(2013-8#1)
Laboratory and##4##2##(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)
Laboratory automation##2##2##(2008-10#2)
Laboratory evaluation##2##2##(2011-1#1)(2013-8#1)
Laboratory findings##3##2##(1991-11#1)(2010-1#1)(2013-1#1)
Laboratory for##3##2##(1994-12#1)(2008-10#1)(2010-5#1)
Laboratory investigations##2##2##(1991-11#1)(2011-1#1)
Laboratory maintenance of##3##3##(2008-9#3)
Laboratory models of##2##3##(2008-10#1)(2010-5#1)
Laboratory models##3##2##(2008-10#2)(2010-5#1)
Laboratory of##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
Laboratory studies##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)
Laboratory tests##2##2##(2008-12#1)(2010-1#1)
Laboratory##74##1##(1990-11#1)(1991-11#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1997-3#1)(2008-10#21)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-7#1)(2010-1#2)(2010-5#2)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
Laboratory's##2##1##(2008-3#1)(2010-8#1)
Labour and##2##2##(2007-12#1)(2008-10#1)
Labour##6##1##(1991-12#2)(1992-5#1)(1995-2#1)(2007-12#1)(2008-10#1)
Labrador retriever was presented##2##4##(2013-8#2)
Labrador retriever##4##2##(2013-8#4)
LacZ reporter gene##2##3##(1990-5#1)(2008-11#1)
Laccaria##6##1##(2011-1#6)
Laccase##3##1##(2008-10#2)(2011-1#1)
Lack of##21##2##(1991-12#1)(1991-2#1)(1993-12#2)(1993-8#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2012-2#2)(2012-3#2)
Lacking##5##1##(1997-1#1)(2008-10#2)(2010-12#1)(2012-3#1)
Lactate and##3##2##(1995-8#1)(2008-11#2)
Lactate dehydrogenase##3##2##(2008-11#2)(2008-9#1)
Lactate##8##1##(1991-5#1)(1995-8#1)(2008-11#4)(2008-9#1)(2013-8#1)
Lactic acid##2##2##(2008-7#2)
Lactobacilli were isolated from##2##4##(2008-12#2)
Lactobacilli##7##1##(2008-12#6)(2012-2#1)
Lactobacillus acidophilus strain isolated from##2##5##(2012-2#2)
Lactobacillus acidophilus##4##2##(2008-5#2)(2012-2#2)
Lactobacillus casei subsp##2##3##(2008-5#1)(2008-7#1)
Lactobacillus casei##4##2##(1995-6#1)(2008-5#1)(2008-7#2)
Lactobacillus reuteri##2##2##(2012-2#1)(2013-1#1)
Lactobacillus rhamnosus GG##2##3##(2009-12#2)
Lactobacillus strains##3##2##(2008-12#2)(2012-2#1)
Lactobacillus##22##1##(1993-12#1)(1995-6#1)(2008-11#2)(2008-12#4)(2008-5#3)(2008-7#2)(2009-12#2)(2012-2#5)(2013-1#2)
Lactococcus lactis spp##2##3##(2008-6#2)
Lactococcus##6##1##(1993-12#4)(2008-6#2)
Lactulose##2##1##(1990-2#2)
Lag##2##1##(2011-2#2)
Lagrangian##2##1##(2008-10#1)(2013-1#1)
Lake Tahoe##6##2##(2008-10#6)
Lake Van##4##2##(2013-8#4)
Lake##25##1##(1996-1#1)(2008-10#15)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#2)(2013-8#4)
Lam##5##1##(2008-10#4)(2010-2#1)
Lamarckian ideas##2##2##(2010-1#2)
Lamb dip##2##2##(2008-3#2)
Lambda##4##1##(1994-2#2)(1996-6#1)(2008-10#1)
Lambertian##7##1##(2008-3#7)
Lamellae##2##1##(2008-7#2)
Laminaria##2##1##(2008-10#2)
Lamins##2##1##(2008-8#1)(2011-2#1)
Lampetra fluviatilis##2##2##(1997-3#2)
Lampito mauritii##2##2##(2008-7#2)
Lamport##2##1##(1991-12#2)
Lancet##2##1##(1996-5#1)(2008-11#1)
Land##2##1##(1996-3#1)(2008-3#1)
Landolt reading##2##2##(2013-8#2)
Landolt##6##1##(2013-8#6)
Landrace##2##1##(2008-8#1)(2008-9#1)
Landscape##2##1##(2008-10#1)(2013-1#1)
Langbein et al##3##3##(2008-5#3)
Langerhans Cell Histiocytosis (LCH) is a##2##6##(2010-10#1)(2012-3#1)
Langerhans Cell Histiocytosis##3##3##(2010-10#2)(2012-3#1)
Langerhans cells##7##2##(1996-12#1)(2008-5#4)(2008-9#1)(2012-3#1)
Langerhans##18##1##(1994-8#1)(1995-8#2)(1996-12#1)(2008-1#1)(2008-5#4)(2008-9#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2012-3#2)
Langley##3##1##(2008-3#3)
Langmuir adsorption isotherm##2##3##(2008-10#2)
Langmuir adsorption##3##2##(2008-10#3)
Langmuir and Freundlich##2##3##(2008-10#1)(2008-12#1)
Langmuir equation##2##2##(2008-10#2)
Langmuir film##2##2##(1994-5#1)(2008-10#1)
Langmuir isotherm##8##2##(2008-10#8)
Langmuir isotherms##2##2##(2008-10#2)
Langmuir##29##1##(1994-5#1)(2008-10#26)(2008-12#1)(2013-1#1)
Langmuir-Blodgett (LB) and##2##3##(2008-11#2)
Langmuir-Blodgett (LB) film##2##3##(2008-10#1)(2008-8#1)
Langmuir-Blodgett (LB) films##3##3##(2008-10#3)
Langmuir-Blodgett (LB)##8##2##(2008-10#5)(2008-11#2)(2008-8#1)
Langmuir-Blodgett##14##1##(2008-10#9)(2008-11#4)(2008-8#1)
Langrangian##2##1##(2008-11#2)
Language##15##1##(2008-11#1)(2008-4#2)(2008-9#3)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#3)
Lanthanides are##2##2##(2008-10#2)
Lanthanides##3##1##(2008-10#3)
Lanthanum##3##1##(2008-10#3)
Lanzarote##3##1##(2008-10#3)
LapSVM can be##2##3##(2010-7#2)
LapSVM##4##1##(2010-7#4)
Laparoscopic assisted vaginal hysterectomy##2##4##(1995-3#2)
Laparoscopic management of##2##3##(1991-2#1)(1992-3#1)
Laparoscopic myolysis##2##2##(1994-2#2)
Laparoscopic myomectomy##2##2##(1993-12#1)(1994-2#1)
Laparoscopic resection of##2##3##(2013-1#2)
Laparoscopic supracervical##2##2##(1994-2#2)
Laparoscopic surgery has##2##3##(2012-12#1)(2013-1#1)
Laparoscopic surgery##4##2##(1992-12#1)(1994-1#1)(2012-12#1)(2013-1#1)
Laparoscopic##37##1##(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-2#6)(1994-3#2)(1995-10#1)(1995-3#2)(1996-3#1)(2008-10#4)(2009-3#1)(2009-8#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)
Laparoscopically assisted vaginal hysterectomy##2##4##(1993-12#2)
Laparoscopy##3##1##(1996-1#1)(2008-10#1)(2008-4#1)
Laparoscopy-assisted vaginal hysterectomy##2##3##(1991-3#1)(1993-2#1)
Laparoscopy-assisted##3##1##(1991-3#2)(1993-2#1)
Laparotomy##2##1##(1993-6#1)(1997-3#1)
Laplace##2##1##(2008-10#1)(2008-3#1)
Laplacian support vector machine##2##4##(2010-7#2)
Laplacian##3##1##(2008-6#1)(2010-7#2)
Large amounts of##3##3##(2008-10#2)(2009-8#1)
Large differences in##3##3##(2008-10#2)(2008-5#1)
Large numbers of##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
Large proportions##2##2##(1994-12#1)(2010-4#1)
Large scale##3##2##(2008-11#2)(2008-4#1)
Large##49##1##(1990-11#1)(1991-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
Large-scale##9##1##(1991-9#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
Larger clinical##2##2##(2008-7#1)(2011-2#1)
Larger##9##1##(1996-12#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
Laromustine##3##1##(2010-11#3)
Larvae of##2##2##(2010-8#1)(2013-8#1)
Larvae##8##1##(2008-5#2)(2008-9#1)(2009-10#1)(2010-8#2)(2012-2#1)(2013-8#1)
Larval##3##1##(2009-10#1)(2010-8#1)(2013-8#1)
Laser Diffraction Particle Sizing##2##4##(2008-11#2)
Laser Interferometer##2##2##(2008-3#2)
Laser Pulses##2##2##(2008-3#2)
Laser ablation in##2##3##(2008-10#2)
Laser ablation inductively coupled plasma mass spectrometry##2##7##(2008-10#1)(2010-11#1)
Laser ablation is##2##3##(2008-10#1)(2008-3#1)
Laser ablation##11##2##(1993-1#1)(2008-10#8)(2008-3#1)(2010-11#1)
Laser at##2##2##(2008-2#1)(2008-3#1)
Laser beam##2##2##(2008-3#2)
Laser capture microdissection##2##3##(2008-4#2)
Laser in##2##2##(2011-2#1)(2012-3#1)
Laser induced breakdown##2##3##(2008-10#2)
Laser light##2##2##(1994-3#1)(2008-3#1)
Laser radar##2##2##(2008-2#1)(2008-3#1)
Laser safety##2##2##(1993-3#2)
Laser treatment of##2##3##(1991-2#1)(1991-9#1)
Laser with a##2##3##(2008-3#2)
Laser with##5##2##(2008-3#4)(2012-2#1)
Laser##83##1##(1991-1#1)(1991-2#1)(1991-3#2)(1991-9#3)(1993-1#1)(1993-3#2)(1994-3#1)(1996-5#1)(1996-9#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#41)(2008-4#2)(2008-8#2)(2009-4#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
Laser-Induced##3##1##(2008-3#3)
Laser-assisted indocyanine green##2##3##(2013-1#2)
Laser-assisted##3##1##(2008-10#1)(2013-1#2)
Laser-induced fluorescence (LIF)##2##3##(2008-10#1)(2008-3#1)
Laser-induced fluorescence##6##2##(2008-10#3)(2008-2#1)(2008-3#2)
Laser-induced##11##1##(2008-10#6)(2008-2#2)(2008-3#2)(2008-8#1)
Lasers##5##1##(2008-2#1)(2008-3#2)(2008-9#2)
Lask et al##2##3##(2008-11#2)
Last word on point##2##4##(2011-2#2)
Last##12##1##(1992-12#1)(1994-1#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-3#1)
Lastly##19##1##(1991-6#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-9#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-1#1)(2009-7#1)(2013-1#1)(2013-8#1)
Late blight##4##2##(2008-10#4)
Late presentation##2##2##(2008-10#1)(2013-1#1)
Late##22##1##(1990-8#2)(1994-12#1)(1994-5#1)(1997-4#1)(2008-10#10)(2008-11#3)(2010-11#1)(2013-1#2)(2013-8#1)
Late-season##2##1##(2008-10#2)
Latent Infection of Prune##2##4##(2008-10#2)
Latent Infection##3##2##(2008-10#3)
Latent inhibition##2##2##(2008-4#2)
Latent##15##1##(1990-2#1)(2008-10#8)(2008-12#1)(2008-4#2)(2009-11#1)(2009-12#1)(2009-5#1)
Later##12##1##(1993-6#1)(1995-6#1)(2008-10#3)(2008-4#1)(2010-1#1)(2011-2#3)(2013-1#2)
Lateral column lengthening using allograft##2##5##(2009-10#2)
Lateral column lengthening##3##3##(2009-10#3)
Lateral##22##1##(1994-8#1)(1995-5#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#3)(2011-2#2)(2013-1#4)
Latest##2##1##(2008-10#1)(2008-8#1)
Latin America and the Caribbean##2##5##(1991-3#1)(2008-11#1)
Latin America and the##3##4##(1991-3#1)(2008-11#1)(2008-5#1)
Latin America and##4##3##(1991-3#1)(1997-7#1)(2008-11#1)(2008-5#1)
Latin America##12##2##(1990-6#1)(1991-3#1)(1992-5#1)(1993-1#1)(1993-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
Latin America]##2##2##(1990-6#1)(1992-5#1)
Latin American countries##3##3##(1992-5#2)(2013-1#1)
Latin American immigrant##2##3##(2008-12#2)
Latin American##13##2##(1992-5#3)(2008-10#3)(2008-12#4)(2009-7#1)(2010-10#1)(2013-1#1)
Latin##31##1##(1990-6#2)(1991-3#1)(1992-5#5)(1993-1#2)(1993-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-12#5)(2008-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2013-1#2)
Latin-America##3##1##(1990-6#1)(2011-2#2)
Latino children##2##2##(2012-2#2)
Latino gay and bisexual men##2##5##(2008-12#2)
Latino youth##2##2##(2012-2#2)
Latino##14##1##(1996-3#1)(2008-12#4)(2009-5#3)(2010-9#2)(2012-2#4)
Latino&quot##2##1##(2011-2#2)
Latinos##4##1##(2011-2#1)(2013-1#3)
Latium##3##1##(1992-9#3)
Laureth 4##2##2##(2008-5#2)
Lavoie et al##2##3##(2009-9#2)
Law##28##1##(1991-1#1)(1991-12#2)(1991-3#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-5#1)(1994-1#1)(1994-3#3)(1995-12#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
Lawrence Weed##2##2##(2010-8#2)
Lawrence##4##1##(1994-1#1)(2008-11#1)(2010-8#2)
Layer##9##1##(1997-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
Layered Learning##4##2##(1995-2#4)
Layered##6##1##(1994-9#1)(1995-2#5)
Layers##3##1##(2008-10#3)
Lazarillo##2##1##(2007-12#2)
Lbs##6##1##(2008-7#6)
Lck##2##1##(1995-6#1)(2013-8#1)
LdT##2##1##(2013-1#2)
Le diagnostic de##3##3##(2013-1#3)
Le diagnostic est##3##3##(2011-2#2)(2013-1#1)
Le diagnostic##7##2##(2011-2#3)(2013-1#4)
Le traitement##2##2##(2011-2#1)(2013-1#1)
Le##17##1##(2008-11#1)(2009-10#1)(2010-6#1)(2011-2#6)(2013-1#8)
LeCAS expression##3##2##(2008-10#3)
LeCAS##5##1##(2008-10#5)
Leaching tests##2##2##(2008-10#2)
Leaching##5##1##(2008-10#3)(2011-1#1)(2011-2#1)
Lead ion##2##2##(2008-10#2)
Lead is##2##2##(2008-10#2)
Lead was##2##2##(2008-10#2)
Lead##21##1##(1990-3#1)(1994-1#1)(2008-10#16)(2008-5#1)(2009-2#1)(2010-1#1)
Lead(II)##2##1##(2008-10#2)
Leader##2##1##(2008-6#1)(2013-8#1)
Leaders##4##1##(1996-5#1)(2008-11#1)(2008-6#1)(2013-1#1)
Leadership Conference##2##2##(1996-3#1)(2008-6#1)
Leadership Forum##2##2##(1995-2#1)(2008-6#1)
Leadership in##2##2##(1993-12#1)(2009-8#1)
Leadership spotlight##3##2##(1995-2#1)(1995-3#1)(1997-2#1)
Leadership##16##1##(1993-12#2)(1995-2#2)(1995-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-6#3)(2009-8#1)(2013-1#1)(2013-8#1)
Leads to##3##2##(2008-10#3)
Leaf Blight##3##2##(2008-10#3)
Leaf Curl##5##2##(2008-10#5)
Leaf Rust##7##2##(2008-10#7)
Leaf Scald##2##2##(2008-10#2)
Leaf Spot Disease##2##3##(2008-10#2)
Leaf Spot and##2##3##(2008-10#2)
Leaf Spot of##2##3##(2008-10#2)
Leaf Spot on##2##3##(2008-10#2)
Leaf Spot##11##2##(2008-10#10)(2012-3#1)
Leaf Tissue##2##2##(2008-10#2)
Leaf position##2##2##(2008-10#2)
Leaf rust resistance gene##2##4##(2008-10#2)
Leaf rust resistance##3##3##(2008-10#3)
Leaf rust##6##2##(2008-10#6)
Leaf##69##1##(2008-10#65)(2008-7#1)(2008-9#2)(2012-3#1)
Leaf-associated##2##1##(2008-10#2)
Leafhopper##3##1##(2008-10#3)
League##6##1##(1995-6#1)(2009-10#1)(2010-1#2)(2013-1#2)
Lean##4##1##(1996-12#1)(2012-2#1)(2013-8#2)
Learning Styles Inventory##2##3##(2012-2#2)
Learning and##2##2##(2008-11#1)(2008-12#1)
Learning contracts##2##2##(2008-11#2)
Learning for##2##2##(2008-12#2)
Learning how to##2##3##(2008-11#1)(2008-8#1)
Learning through##2##2##(1994-12#1)(2008-11#1)
Learning to##4##2##(1994-3#1)(1997-3#1)(2008-11#1)(2008-12#1)
Learning##45##1##(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#4)(1997-3#1)(1997-4#1)(2008-11#17)(2008-12#6)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
Least Squares##6##2##(2008-10#6)
Least squares##2##2##(2008-10#2)
Least##13##1##(2008-10#10)(2008-12#1)(2008-5#1)(2013-1#1)
Leaves by##4##2##(2008-10#4)
Leaves of##4##2##(2008-10#3)(2013-1#1)
Leaves##25##1##(1995-2#1)(2008-10#22)(2008-12#1)(2013-1#1)
Leaving##2##1##(1997-3#1)(2008-11#1)
Lebsock##2##1##(2012-3#2)
Lectin##3##1##(1994-11#1)(2008-10#2)
Lecture##6##1##(1991-1#1)(1992-3#1)(1995-2#1)(1997-2#1)(2010-1#1)(2013-8#1)
Lee##7##1##(1993-3#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-8#1)
Lee's index##2##2##(2013-1#2)
Left ventricular volume during diastasis is not the physiological in vivo equilibrium volume and is not related to diastolic suction##2##20##(2011-2#2)
Left ventricular volume during diastasis is/is not the physiological in vivo equilibrium volume and is/is not related to diastolic suction##3##20##(2011-2#3)
Left ventricular volume during diastasis##5##5##(2011-2#5)
Left ventricular##9##2##(1994-12#1)(2009-1#1)(2011-2#6)(2012-2#1)
Left##17##1##(1992-12#1)(1994-12#1)(2008-12#1)(2009-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#1)
Leg##2##1##(2008-5#1)(2009-1#1)
Legal##10##1##(1992-2#1)(1992-3#1)(1995-2#1)(1995-6#2)(1997-5#1)(2008-1#1)(2008-11#3)
Leghorn##3##1##(2008-10#2)(2008-12#1)
Legionella pneumophila##3##2##(1992-5#1)(2008-12#2)
Legionella##5##1##(1992-5#1)(1994-9#1)(2008-12#3)
Legislative##2##1##(1994-2#1)(2008-4#1)
Legius##2##1##(2012-3#2)
Legume##2##1##(2008-10#1)(2008-11#1)
Legumes##3##1##(2008-10#3)
Leguminosae##2##1##(2008-10#2)
Leiomyomatosis peritonealis disseminata##2##3##(2013-1#2)
Leisegang##2##1##(1994-2#1)(2012-3#1)
Leishmania has##2##2##(2012-2#2)
Leishmania spp##8##2##(2012-2#8)
Leishmania##21##1##(1991-11#1)(1997-7#1)(2008-11#1)(2012-2#16)(2013-1#2)
Leishmaniasis##3##1##(1991-11#1)(2012-2#2)
Leishmanicidal##2##1##(2010-2#1)(2012-2#1)
Lemhi##5##1##(2008-10#5)
Lemierre syndrome##2##2##(1990-3#2)
Lemildipine##2##1##(2008-5#2)
Lemna minor##3##2##(2008-10#2)(2008-7#1)
Lemon##8##1##(2008-10#2)(2008-12#6)
Length of##4##2##(1997-2#1)(2008-10#3)
Length##23##1##(1996-9#2)(1997-2#1)(2008-10#18)(2008-11#1)(2012-3#1)
Lengthening##2##1##(2008-10#1)(2009-3#1)
Lens##4##1##(2008-10#3)(2013-1#1)
Lentigo maligna##2##2##(2011-2#2)
Leonard##3##1##(2008-10#2)(2009-10#1)
Leonard's##2##1##(2008-10#2)
Leonie##2##1##(2008-10#2)
Leonurine##3##1##(2012-2#3)
Lepidoptera)##2##1##(2008-7#1)(2010-4#1)
Leporinus reinhardti##2##2##(2008-7#2)
Lepromatous Leprosy##2##2##(2011-2#2)
Leprosy##3##1##(2011-2#3)
Leptin##3##1##(2008-4#1)(2013-1#1)(2013-8#1)
Leptosphaeria maculans in##2##3##(2008-10#2)
Leptosphaeria maculans##20##2##(2008-10#18)(2011-10#2)
Leptosphaeria##22##1##(2008-10#20)(2011-10#2)
Leptospira biflexa##2##2##(2008-9#2)
Leptospira##4##1##(2008-9#4)
Leptospiral##2##1##(2008-9#2)
Ler##3##1##(2011-1#1)(2012-3#2)
Leri-Weill dyschondrosteosis##2##2##(2008-7#1)(2013-1#1)
Lernaea cyprinacea##2##2##(2008-12#2)
Les données##2##2##(2013-1#2)
Les suites opératoires ont été##2##5##(2013-1#2)
Les##15##1##(2008-11#1)(2008-5#2)(2009-10#1)(2011-2#1)(2013-1#10)
Lesion##9##1##(2008-10#8)(2012-3#1)
Lesions and##2##2##(1994-12#1)(2010-6#1)
Lesions in##3##2##(2008-10#1)(2013-1#2)
Lesions of the##3##3##(1993-6#1)(1994-2#2)
Lesions of##5##2##(1993-6#2)(1994-2#2)(2008-10#1)
Lesions on##3##2##(1990-6#1)(2008-10#2)
Lesions##23##1##(1990-6#1)(1993-6#2)(1994-12#1)(1994-2#2)(2008-10#10)(2008-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
Less frequent##2##2##(2009-1#1)(2012-2#1)
Less frequently##2##2##(2009-8#1)(2012-12#1)
Less than half of the##2##5##(2011-2#1)(2013-1#1)
Less than##6##2##(1996-11#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
Less##17##1##(1991-2#1)(1992-9#1)(1996-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Lessons for##3##2##(1993-12#1)(1995-5#1)(2013-1#1)
Lessons from the##5##3##(2008-11#1)(2008-12#2)(2010-3#1)(2011-2#1)
Lessons from##7##2##(2008-11#2)(2008-12#2)(2009-8#1)(2010-3#1)(2011-2#1)
Lessons learned from##2##3##(2008-11#1)(2008-12#1)
Lessons learned##5##2##(1992-1#1)(1997-1#1)(2008-11#1)(2008-12#1)(2010-7#1)
Lessons##18##1##(1991-11#1)(1992-1#1)(1993-12#1)(1995-5#1)(1997-1#1)(2008-11#3)(2008-12#3)(2009-11#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
Let##2##1##(1994-1#1)(2009-10#1)
Let's##2##1##(1991-2#1)(1994-12#1)
Let-7##3##1##(2010-7#3)
Lethal##3##1##(2008-10#3)
Lett##8##1##(1991-7#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-3#1)
Letter from the Southwest##2##4##(2008-8#2)
Letter from the editor##2##4##(2013-1#2)
Letter from the##9##3##(2008-12#1)(2008-8#4)(2012-2#1)(2013-1#3)
Letter to the Editor##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
Letter to the editor##16##4##(1996-9#1)(1997-3#1)(2008-11#3)(2008-12#8)(2008-9#2)(2011-2#1)
Letter to the##20##3##(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#8)(2008-9#2)(2009-10#1)(2011-2#2)
Letter##32##1##(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#9)(2008-8#5)(2008-9#2)(2009-10#1)(2011-2#2)(2012-2#3)(2013-1#3)
Letters##2##1##(2008-10#1)(2013-1#1)
Letting and making death happen##2##5##(1991-2#2)
Lettuce Drop Incidence##2##3##(2008-10#2)
Lettuce Drop##3##2##(2008-10#3)
Lettuce big-vein virus##2##3##(2008-10#2)
Lettuce drop incidence was##2##4##(2008-10#2)
Lettuce drop incidence##4##3##(2008-10#4)
Lettuce mosaic virus (LMV)##3##4##(2008-10#3)
Lettuce mosaic virus##4##3##(2008-10#4)
Lettuce necrotic stunt virus##2##4##(2008-10#2)
Lettuce##29##1##(2008-10#29)
Leu##4##1##(1992-4#1)(1993-12#1)(1993-3#1)(2008-8#1)
Leu21##2##1##(1994-5#2)
Leu3Pro##2##1##(2008-9#2)
Leu8##2##1##(1994-8#1)(2008-9#1)
Leucostoma##3##1##(2008-10#3)
Leukaemia##2##1##(2008-11#1)(2008-12#1)
Leukemia and##3##2##(1990-3#1)(1991-8#1)(2011-2#1)
Leukemia##10##1##(1990-3#1)(1991-8#1)(2008-10#1)(2008-9#1)(2010-11#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
Leukocyte##4##1##(1991-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
Leukocytosis##3##1##(1991-12#1)(2008-7#1)(2009-6#1)
Levamisole was##2##2##(2008-1#2)
Levamisole##3##1##(2008-1#3)
Level I##2##2##(2007-9#2)
Level II##3##2##(2007-9#2)(2008-10#1)
Level in##2##2##(2008-10#1)(2013-1#1)
Level##20##1##(1996-9#2)(2007-9#4)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
Level-2##2##1##(2011-3#2)
Levels of##16##2##(1992-12#1)(1995-11#1)(1996-12#2)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-5#1)(2013-8#1)
Levels were##2##2##(1994-3#1)(2008-5#1)
Levels##29##1##(1991-12#1)(1992-12#1)(1994-3#1)(1995-11#1)(1996-12#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
Levin##2##1##(1994-3#2)
Levine##4##1##(1992-1#1)(1995-6#1)(2010-4#2)
Levodopa (LD) is the most##2##5##(2008-7#1)(2010-12#1)
Levodopa##3##1##(2008-10#1)(2008-7#1)(2010-12#1)
Lewis acids##2##2##(1996-5#2)
Lewis##11##1##(1993-8#1)(1995-12#1)(1996-1#2)(1996-5#5)(2008-10#1)(2008-11#1)
Lewisburg Community Hospital v##2##4##(1993-1#1)(1993-3#1)
Lewisite I and##2##3##(2008-11#2)
Lewisite I##3##2##(2008-11#3)
Lewisite II and##2##3##(2008-11#2)
Lewisite II##3##2##(2008-11#3)
Lewisite##8##1##(2008-10#1)(2008-11#7)
Lewy bodies and Lewy neurites##2##5##(2008-7#2)
Lewy bodies and##5##3##(2008-7#5)
Lewy bodies##8##2##(2008-7#8)
Lewy body dementia##2##3##(1995-12#2)
Lewy body##3##2##(1995-12#2)(2008-7#1)
Lewy##14##1##(1995-12#2)(2008-7#12)
Lexington##2##1##(2008-10#1)(2008-8#1)
Leydig cell function##2##3##(1992-12#2)
Leydig cell volume##5##3##(1992-12#5)
Leydig cell##10##2##(1992-12#9)(2009-10#1)
Leydig cells in the##2##4##(2009-10#1)(2012-2#1)
Leydig cells##5##2##(1992-12#1)(2009-10#2)(2012-2#2)
Leydig##15##1##(1992-12#10)(2009-10#3)(2012-2#2)
Lgr5##5##1##(2011-2#1)(2012-2#4)
Li and Tiwari##2##3##(2012-3#2)
Li and##5##2##(2008-10#3)(2012-3#2)
Li##13##1##(2008-10#9)(2008-5#1)(2008-8#1)(2012-3#2)
Li(+) and Cu(2+)##2##3##(2008-10#2)
Li(+) and##3##2##(2008-10#3)
Li(+)##16##1##(2008-10#16)
Li(2)SO(4)##2##1##(2008-10#1)(2008-9#1)
Li+ and##2##2##(1992-8#1)(1996-12#1)
Li+##5##1##(1992-8#1)(1996-12#4)
Li-Fraumeni syndrome (LFS)##2##3##(1990-12#1)(2011-2#1)
Li-Fraumeni syndrome##4##2##(1990-12#1)(2011-2#3)
Li/Na##4##1##(2008-10#4)
LiCAF laser##2##2##(2007-11#1)(2008-2#1)
LiCAF##3##1##(2007-11#1)(2008-2#2)
LiCF(3)SO(3) and gamma-LiAlO(2)##3##3##(2008-10#3)
LiCF(3)SO(3)##4##1##(2008-10#4)
LiChrospher(R)##2##1##(2008-10#2)
LiCl##3##1##(1993-3#1)(1993-6#1)(2008-10#1)
LiF was##2##2##(2008-10#2)
LiF##11##1##(2008-10#2)(2008-2#2)(2008-3#7)
LiLuF(4)##2##1##(2007-11#2)
LiNbO(3) and##2##2##(2008-3#2)
LiNbO(3) optical parametric oscillator (OPO)##2##5##(2008-2#2)
LiNbO(3)##12##1##(2008-2#3)(2008-3#9)
LiSAF laser##2##2##(2008-2#2)
LiSAF unstable laser resonator##2##4##(2008-2#2)
LiSAF##6##1##(2008-2#6)
LiTaO(3)##7##1##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)
Liangyoupeijiu had##2##2##(2008-9#2)
Liangyoupeijiu##6##1##(2008-9#6)
Librarians at##2##2##(1991-3#1)(1992-12#1)
Librarians##3##1##(1991-12#1)(1991-3#1)(1992-12#1)
Libraries##3##1##(1991-12#1)(2008-10#1)(2008-4#1)
Library and##2##2##(1992-12#1)(2011-2#1)
Library##22##1##(1991-2#2)(1991-3#2)(1992-1#3)(1992-12#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
Libya##3##1##(1994-12#2)(2008-10#1)
License##2##1##(1997-2#1)(2013-8#1)
Licorice##3##1##(2008-10#3)
Lidar##9##1##(2008-10#1)(2008-3#8)
Lidocaine##2##1##(1996-9#1)(2008-9#1)
Life Cycle##4##2##(1997-3#1)(2008-11#2)(2012-2#1)
Life after##2##2##(2008-8#2)
Life and##2##2##(2008-11#1)(2013-1#1)
Life events##2##2##(2008-10#1)(2011-2#1)
Life expectancy##4##2##(1996-3#1)(1997-6#1)(2008-7#2)
Life in##5##2##(1994-12#1)(2009-12#1)(2012-3#1)(2013-1#2)
Life table##2##2##(1991-12#2)
Life##43##1##(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#2)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
Life-threatening##2##1##(1992-6#1)(2011-2#1)
Lifelong##2##1##(1994-1#1)(2008-12#1)
Lifesaving##2##1##(1990-5#1)(2010-8#1)
Lifespan##3##1##(2010-3#1)(2010-7#1)(2012-2#1)
Lifetime##3##1##(2008-10#1)(2009-10#1)(2013-1#1)
Ligament##5##1##(2008-11#1)(2008-12#1)(2013-1#3)
Ligand 1##2##2##(2008-10#1)(2012-3#1)
Ligand binding##3##2##(1992-3#1)(1993-1#1)(1994-5#1)
Ligand blot analysis##2##3##(1995-6#1)(2008-11#1)
Ligand##11##1##(1992-3#1)(1993-1#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#3)(2009-10#1)(2012-3#1)(2013-1#1)
Ligands##3##1##(2008-10#2)(2008-4#1)
Ligasure##5##1##(2011-2#5)
Ligation of##2##2##(1993-12#1)(1997-7#1)
Ligation##4##1##(1993-12#1)(1997-7#1)(2010-12#1)(2012-3#1)
Light absorption by##2##3##(2008-3#2)
Light and electron microscopic##2##4##(1995-6#1)(2011-2#1)
Light and electron##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
Light and transmission electron microscopy##3##5##(2008-10#1)(2008-7#2)
Light and transmission electron##4##4##(2008-10#2)(2008-7#2)
Light and##12##2##(1994-2#1)(1995-6#1)(2008-10#6)(2008-7#2)(2008-9#1)(2011-2#1)
Light emission##2##2##(2008-10#2)
Light microscopy##2##2##(2008-10#1)(2011-2#1)
Light on##2##2##(1996-9#1)(2008-10#1)
Light scattering##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
Light##51##1##(1993-3#1)(1994-2#1)(1995-6#1)(1996-9#2)(2007-12#1)(2008-10#19)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-8#2)
Light-induced##2##1##(1990-12#1)(2008-8#1)
Light-transmittance predictions under multiple-light-scattering conditions##2##5##(2008-3#2)
Like in##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
Like other##3##2##(1995-8#1)(2008-10#1)(2009-8#1)
Like the##4##2##(1993-12#1)(1993-8#1)(2008-11#1)(2009-10#1)
Like##20##1##(1991-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)
Likelihood##2##1##(2008-6#1)(2012-3#1)
Likely##3##1##(1991-10#1)(1997-2#1)(2008-10#1)
Likert Scale##2##2##(2013-1#2)
Likert scale##3##2##(1991-2#1)(2008-12#1)(2008-9#1)
Likert##7##1##(1991-2#1)(1993-3#1)(2008-12#1)(2008-9#1)(2010-1#1)(2013-1#2)
Likewise##24##1##(1990-9#1)(1991-1#1)(1991-2#1)(1993-8#1)(1995-5#1)(1996-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
Liliaceae##3##1##(2008-10#1)(2009-12#2)
Lilium and##2##2##(1995-6#2)
Lilium##5##1##(1995-6#2)(2008-8#2)(2009-12#1)
Lim15##2##1##(1995-6#2)
Limax##2##1##(1990-5#2)
Limb##4##1##(1994-11#1)(1995-8#1)(2008-10#1)(2013-1#1)
Limbal##2##1##(2008-11#1)(2010-10#1)
Limit of detection (LOD)##2##4##(2008-10#2)
Limit of detection##5##3##(2008-10#4)(2011-2#1)
Limit of detections##2##3##(2008-10#2)
Limit of##8##2##(2008-10#7)(2011-2#1)
Limit##10##1##(2008-10#7)(2008-11#1)(2011-2#1)(2013-1#1)
Limitation of##2##2##(2010-2#1)(2012-2#1)
Limitation##5##1##(1993-1#1)(2008-10#1)(2010-2#1)(2012-2#2)
Limitations of##3##2##(1993-1#1)(1993-12#1)(2008-11#1)
Limitations##6##1##(1991-12#1)(1993-1#1)(1993-12#1)(1996-5#1)(2008-11#1)(2009-11#1)
Limited information is available##2##4##(2008-12#1)(2012-3#1)
Limited##21##1##(1993-8#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-5#1)(2012-2#1)(2012-3#2)(2013-7#2)
Limits of detection (LOD)##2##4##(2008-10#2)
Limits of detection at the pg ml(-1) level were estimated for##2##11##(2008-10#2)
Limits of detection at the##3##5##(2008-10#3)
Limits of detection at##4##4##(2008-10#3)(2008-3#1)
Limits of detection for##4##4##(2008-10#4)
Limits of detection of 0##3##5##(2008-10#3)
Limits of detection##16##3##(2008-10#15)(2008-3#1)
Limits of quantitation##2##3##(2008-10#2)
Limits of##20##2##(2008-10#19)(2008-3#1)
Limits##22##1##(1992-3#1)(2008-10#19)(2008-3#1)(2013-8#1)
Limonium spp##2##2##(2008-10#2)
Limonium##3##1##(2008-10#3)
Lin##2##1##(1991-2#1)(2013-8#1)
Lin-28##3##1##(2010-7#3)
Lincoln##2##1##(1991-9#1)(2008-11#1)
Line shapes in##2##3##(2008-3#2)
Line##21##1##(1993-12#3)(1993-2#1)(1994-12#1)(1996-9#1)(1997-7#2)(1997-9#1)(2008-10#6)(2008-11#3)(2008-3#2)(2011-2#1)
Lineage##5##1##(2008-10#4)(2012-3#1)
Lineages of##3##2##(2008-10#3)
Lineages##7##1##(2008-10#7)
Linear Discriminant Analysis##3##3##(2008-10#3)
Linear Models##2##2##(2008-12#1)(2011-2#1)
Linear and##4##2##(1994-11#1)(2007-12#1)(2008-10#2)
Linear calibration curve was obtained##2##5##(2008-10#2)
Linear calibration curve##3##3##(2008-10#3)
Linear calibration curves##2##3##(2008-10#2)
Linear calibration graphs were obtained for##3##6##(2008-10#3)
Linear calibration graphs were obtained##5##5##(2008-10#5)
Linear calibration graphs were##6##4##(2008-10#6)
Linear calibration graphs##8##3##(2008-10#8)
Linear calibration in the range of 0##2##7##(2008-10#2)
Linear calibration plots were obtained for##2##6##(2008-10#2)
Linear calibration plots##4##3##(2008-10#4)
Linear calibration##22##2##(1995-3#1)(2008-10#21)
Linear calibrations were obtained##2##4##(2008-10#2)
Linear calibrations##3##2##(2008-10#3)
Linear discriminant##2##2##(2008-10#2)
Linear programming##3##2##(2008-11#3)
Linear ranges were##3##3##(2008-10#3)
Linear regression analysis##2##3##(2008-10#1)(2009-11#1)
Linear regression##5##2##(2008-10#1)(2009-11#1)(2009-3#1)(2011-2#2)
Linear relationship##2##2##(2008-10#2)
Linear relationships between##2##3##(2008-10#2)
Linear response##3##2##(2008-10#3)
Linear responses of##2##3##(2008-10#2)
Linear responses##5##2##(2008-10#5)
Linear sweep##2##2##(2008-10#2)
Linear##78##1##(1993-5#1)(1994-11#1)(1995-3#1)(1996-9#2)(2007-12#1)(2008-10#57)(2008-11#4)(2008-12#3)(2008-3#1)(2008-7#2)(2009-11#1)(2009-3#1)(2011-2#3)
Linearity of the analytical curve is##2##6##(2008-10#2)
Linearity of##4##2##(2008-10#4)
Linearity was obtained##2##3##(1993-2#1)(2008-10#1)
Linearity was##8##2##(1993-2#1)(2008-10#6)(2008-5#1)
Linearity##17##1##(1993-2#1)(2008-10#15)(2008-5#1)
Lines from##2##2##(2008-11#1)(2008-3#1)
Lines of the##2##3##(2008-10#1)(2008-3#1)
Lines of##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Lines##10##1##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)
Lineweaver-Burk plot##2##2##(2008-10#2)
Lineweaver-Burk plots##2##2##(2008-5#1)(2010-11#1)
Lineweaver-Burk##4##1##(2008-10#2)(2008-5#1)(2010-11#1)
Linkage analyses##2##2##(2008-10#1)(2011-2#1)
Linkage analysis of##2##3##(1997-3#1)(2008-10#1)
Linkage analysis##3##2##(1997-3#1)(2008-10#1)(2008-7#1)
Linkage between##2##2##(2008-10#2)
Linkage of##2##2##(1996-12#1)(2008-10#1)
Linkage##13##1##(1994-9#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-7#1)(2011-2#1)
Linked to##7##2##(2008-10#6)(2008-9#1)
Linked##11##1##(2008-10#8)(2008-12#1)(2008-9#1)(2013-8#1)
Linking the##2##2##(2008-11#1)(2008-8#1)
Linking theory##2##2##(1991-2#1)(2008-12#1)
Linking##9##1##(1991-1#1)(1991-2#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-12#1)(2012-6#1)(2013-8#1)
Links##2##1##(2010-3#1)(2011-2#1)
Linn##3##1##(2010-2#2)(2013-1#1)
Linoleic acid##2##2##(2008-11#1)(2010-3#1)
Linoleic##3##1##(2008-11#2)(2010-3#1)
Lipases secreted by##2##3##(2010-10#2)
Lipases##3##1##(2010-10#2)(2012-2#1)
Lipid levels##2##2##(1991-6#1)(2010-8#1)
Lipid##21##1##(1990-5#4)(1990-8#1)(1991-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#2)(2010-4#1)(2010-8#1)(2012-12#1)
Lipid-soluble##2##1##(2008-10#2)
Lipids##4##1##(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)
Lipocalin-2##3##1##(2012-3#1)(2013-8#2)
Lipoma##2##1##(2010-6#1)(2012-2#1)
Lipomatosis of##2##2##(2011-2#2)
Lipomatosis##3##1##(1997-5#1)(2011-2#2)
Lipophilic##2##1##(1991-5#1)(2008-10#1)
Lipopolysaccharide##2##1##(1997-1#2)
Lipoprotein creams##3##2##(2008-5#3)
Lipoprotein##7##1##(1992-3#1)(2008-11#1)(2008-5#3)(2008-6#1)(2013-1#1)
Lipoprotein(a) [Lp(a)]##2##2##(1996-8#1)(2008-6#1)
Lipoprotein(a)##6##1##(1992-3#1)(1992-9#1)(1993-2#1)(1996-8#1)(2008-6#2)
Lipoproteins##3##1##(1992-11#1)(2008-5#2)
Liposomal##3##1##(1995-5#1)(1997-1#1)(2008-11#1)
Liposome##3##1##(2008-10#3)
Liposome-mediated NGF##2##2##(1996-2#2)
Liposomes##9##1##(1991-5#1)(1995-5#1)(1997-1#1)(2008-10#5)(2008-11#1)
Liquid Chromatography##5##2##(2008-10#2)(2009-8#3)
Liquid chromatographic determination of##3##4##(2008-10#3)
Liquid chromatographic##6##2##(2008-10#6)
Liquid chromatography##2##2##(2008-1#1)(2008-10#1)
Liquid##24##1##(1995-3#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#15)(2008-7#1)(2009-8#3)(2013-1#1)
Liquid-liquid distribution of ion associates of##2##6##(2008-10#2)
Liquid-liquid extraction of##4##3##(2008-10#4)
Liquid-liquid extraction##6##2##(2008-10#6)
Liquid-liquid##8##1##(2008-10#8)
Lissorhoptrus oryzophilus##2##2##(2013-8#2)
List of##2##2##(2010-7#1)(2013-8#1)
List##3##1##(1991-11#1)(2010-7#1)(2013-8#1)
Listeners##3##1##(2008-9#1)(2011-1#1)(2013-8#1)
Listening to##2##2##(2008-11#1)(2008-9#1)
Listeria monocytogenes and Salmonella Enteritidis##2##5##(2010-4#2)
Listeria monocytogenes infection##2##3##(1996-12#1)(2012-12#1)
Listeria monocytogenes##20##2##(1996-12#5)(2008-10#4)(2008-11#1)(2010-4#4)(2011-2#3)(2012-12#1)(2012-2#2)
Listeria##27##1##(1996-12#6)(2008-10#4)(2008-11#1)(2010-4#4)(2011-2#3)(2012-12#2)(2012-2#7)
Literacy##4##1##(2008-11#2)(2008-12#1)(2011-2#1)
Literary##2##1##(2009-10#1)(2011-2#1)
Literature Review##5##2##(2011-2#3)(2012-3#2)
Literature and##3##2##(2009-11#1)(2009-5#1)(2010-12#1)
Literature in##2##2##(2009-8#2)
Literature survey##2##2##(2008-10#2)
Literature##30##1##(1991-12#2)(1991-2#1)(1997-3#1)(2008-10#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-12#1)(2011-2#5)(2012-3#4)(2013-1#4)
Lithium##10##1##(1992-2#1)(1993-6#1)(2008-10#4)(2008-3#1)(2009-7#1)(2009-8#2)
Lithuania##2##1##(2013-8#2)
Lithuanian health system##3##3##(2013-8#3)
Little attention has been given to##2##6##(1992-1#1)(2010-8#1)
Little cherry virus##4##3##(2008-10#4)
Little cherry virus-2 (LChV-2)##2##4##(2008-10#2)
Little cherry virus-2##3##3##(2008-10#3)
Little cherry##10##2##(2008-10#10)
Little empirical evidence exists to##2##5##(2008-11#1)(2008-8#1)
Little has been written about the##2##6##(1992-1#1)(1994-8#1)
Little information is available on##2##5##(1993-1#1)(2008-10#1)
Little information is available##3##4##(1993-1#1)(2008-10#2)
Little is known about the##10##5##(1993-12#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
Little is known about##11##4##(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
Little is known of how##2##5##(1992-10#1)(2008-11#1)
Little is known##15##3##(1992-10#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Little or no##3##3##(1994-11#1)(2008-10#2)
Little research##2##2##(1994-3#1)(2008-9#1)
Little##52##1##(1991-3#1)(1992-1#2)(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#2)(1994-8#1)(1995-12#1)(1996-9#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Littorina littorea##2##2##(2008-10#2)
Littorina##3##1##(2008-10#3)
Live##4##1##(1995-5#1)(2008-10#1)(2012-2#2)
Liver Cell##2##2##(2009-8#2)
Liver cytosols##2##2##(1990-11#2)
Liver resection##2##2##(2011-2#1)(2012-3#1)
Liver slices##2##2##(1995-11#2)
Liver##28##1##(1990-11#2)(1990-2#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-12#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-6#1)(2009-8#2)(2010-12#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
Liverpool##2##1##(2008-11#1)(2009-10#1)
Livers##2##1##(2008-11#1)(2010-12#1)
Living with##3##2##(1995-1#1)(1995-8#1)(2013-1#1)
Living##22##1##(1991-2#1)(1992-1#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-7#6)(2009-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#2)
Lizards from##2##2##(2008-8#2)
Lizards##3##1##(2008-10#1)(2008-8#2)
Lmo2##5##1##(2008-9#5)
LoVo##2##1##(1994-8#2)
Load increases##2##2##(2010-1#2)
Load##4##1##(2008-1#1)(2010-1#2)(2010-12#1)
Loading##4##1##(2008-10#1)(2008-4#1)(2010-11#1)(2010-7#1)
Lobar##2##1##(1997-8#1)(2012-2#1)
Local and Systemic##2##3##(2008-10#2)
Local and##3##2##(1992-3#1)(2008-10#2)
Local and/or##2##2##(2008-10#1)(2012-3#1)
Local control##2##2##(1990-6#1)(1991-8#1)
Local factors##2##2##(2008-9#1)(2013-1#1)
Local management##2##2##(2009-12#2)
Local recurrence##2##2##(1993-3#1)(1994-12#1)
Local##58##1##(1990-12#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-6#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#2)(2009-7#1)(2010-11#1)(2010-5#4)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#4)(2013-1#2)
Localization and##2##2##(1992-11#1)(2009-12#1)
Localization of a##2##3##(1994-9#1)(2008-10#1)
Localization of##16##2##(1992-12#1)(1992-6#1)(1992-7#1)(1994-9#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)
Localization##18##1##(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1994-9#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)
Localized##6##1##(1992-9#1)(2008-10#2)(2008-3#1)(2009-9#1)(2012-3#1)
Locally##3##1##(1991-8#1)(2008-10#1)(2008-3#1)
Location of##2##2##(2008-10#2)
Location##4##1##(2008-10#4)
Locations##2##1##(2008-10#2)
Loci conferring##2##2##(2008-10#2)
Loci for##6##2##(2008-10#5)(2013-8#1)
Loci in##4##2##(2008-10#3)(2012-3#1)
Loci##25##1##(2008-10#22)(2012-3#2)(2013-8#1)
Locked nucleic acids##2##3##(2008-4#2)
Locking##2##1##(2008-2#1)(2008-3#1)
Locomotor##4##1##(1993-6#1)(2007-8#1)(2008-5#2)
Locus in##2##2##(2008-10#2)
Locus##10##1##(2008-10#7)(2008-12#1)(2012-3#1)(2013-8#1)
Lodi##2##1##(2008-10#2)
Lodz##3##1##(2008-12#3)
Log TG/HDL-C ratio##4##3##(2008-3#4)
Log##9##1##(1997-7#1)(2008-10#2)(2008-3#6)
LogMAR##2##1##(2013-1#2)
Logan Rep protein##3##3##(2008-10#3)
Logan##5##1##(2008-10#5)
Logic##4##1##(2009-11#3)(2011-2#1)
Logistic regression analyses##2##3##(2008-11#1)(2008-3#1)
Logistic regression analysis showed##2##4##(2008-10#2)
Logistic regression analysis##4##3##(1995-1#1)(2008-10#2)(2010-6#1)
Logistic regression models were used to##2##6##(2012-2#1)(2013-1#1)
Logistic regression models##7##3##(2008-10#3)(2012-2#1)(2012-3#2)(2013-1#1)
Logistic regression was used to##4##5##(2008-10#2)(2010-6#1)(2013-8#1)
Logistic regression was##5##3##(2008-10#2)(2009-5#1)(2010-6#1)(2013-8#1)
Logistic regression##20##2##(1995-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2009-5#1)(2010-6#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Logistic##24##1##(1991-12#1)(1995-1#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2009-5#1)(2010-6#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Logit##2##1##(1995-2#1)(2012-2#1)
Loma Linda University##2##3##(1993-2#2)
Loma Linda##6##2##(1993-2#6)
Loma Prieta earthquake##3##3##(1990-11#2)(1992-12#1)
Loma##9##1##(1990-11#2)(1992-12#1)(1993-2#6)
Lombardy##3##1##(1994-8#1)(2011-2#2)
London##40##1##(1993-12#1)(1996-3#1)(1996-8#7)(1997-1#1)(2008-11#14)(2008-12#7)(2008-5#2)(2008-9#1)(2009-10#1)(2010-1#2)(2010-10#1)(2010-5#1)(2012-2#1)
London) were##2##2##(2008-10#1)(2008-11#1)
London)##5##1##(2008-10#1)(2008-11#4)
London]##3##1##(2008-11#2)(2008-12#1)
Loneliness##2##1##(2011-2#2)
Long Term Care##2##3##(1993-12#2)
Long Term##3##2##(1993-12#2)(2013-1#1)
Long bone osteomyelitis##2##3##(2010-6#2)
Long bone##3##2##(2010-6#2)(2011-2#1)
Long term care##2##3##(1992-2#1)(1993-1#1)
Long term##7##2##(1991-6#1)(1991-8#1)(1992-2#1)(1993-1#1)(2008-7#1)(2013-1#1)(2013-8#1)
Long##44##1##(1991-6#2)(1991-8#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#2)(1994-2#1)(1996-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-5#3)(2008-7#5)(2008-8#1)(2009-9#1)(2010-6#2)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Long(TM)R(3)IGF-I##2##1##(2008-11#2)
Long-Term##9##1##(1990-11#1)(1991-1#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-3#1)
Long-acting##2##1##(2008-11#1)(2009-9#1)
Long-distance##4##1##(1997-7#1)(2008-10#2)(2011-2#1)
Long-term care##3##2##(1994-2#1)(1994-3#1)(1997-1#1)
Long-term effects of##3##3##(1996-2#1)(1997-1#1)(2010-10#1)
Long-term effects##4##2##(1996-2#1)(1997-1#1)(2010-10#1)(2012-3#1)
Long-term exposure##2##2##(2008-7#1)(2009-8#1)
Long-term follow-up##2##2##(2008-7#1)(2011-2#1)
Long-term food restriction##2##3##(1990-3#2)
Long-term mortality in patients after a British trial of anticoagulants in acute myocardial infarction##2##14##(1993-12#2)
Long-term mortality##4##2##(1992-12#1)(1993-12#2)(1993-2#1)
Long-term outcome##2##2##(2008-10#2)
Long-term potentiation (LTP)##2##3##(1993-12#1)(1997-2#1)
Long-term potentiation##4##2##(1990-8#1)(1993-12#1)(1997-2#1)(2008-7#1)
Long-term results of##3##3##(1993-11#1)(1993-9#1)(2008-11#1)
Long-term results##4##2##(1993-11#1)(1993-9#1)(2008-11#1)(2009-3#1)
Long-term##59##1##(1990-3#2)(1990-8#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-12#2)(1996-2#2)(1997-1#4)(1997-2#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#1)
Longbow##2##1##(2008-10#2)
Longer##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
Longer-distance##2##1##(2008-10#2)
Longevity and##2##2##(1994-3#1)(2008-10#1)
Longevity##5##1##(1992-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
Longissimus##4##1##(2010-4#4)
Longitudinal Study##4##2##(2009-7#1)(2010-7#1)(2012-12#1)(2013-8#1)
Longitudinal associations between##2##3##(2010-2#1)(2012-2#1)
Longitudinal data were collected##2##4##(2010-1#1)(2013-1#1)
Longitudinal studies##3##2##(1992-11#1)(2008-11#1)(2008-8#1)
Longitudinal##18##1##(1991-12#1)(1992-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
Lonicera##2##1##(1994-11#1)(2008-9#1)
Lonidamine##2##1##(1990-6#2)
Look at##2##2##(1997-2#1)(2008-12#1)
Look##5##1##(1994-3#1)(1997-2#1)(2008-12#1)(2013-1#2)
Looking at##2##2##(1993-5#1)(2008-11#1)
Looking for##2##2##(1997-2#1)(1997-6#1)
Looking forward##2##2##(2012-12#1)(2012-2#1)
Looking##8##1##(1993-5#1)(1994-2#1)(1997-2#1)(1997-6#1)(2008-11#2)(2012-12#1)(2012-2#1)
Loop##3##1##(1990-6#1)(1997-1#1)(2012-2#1)
Loop7 region##5##2##(2008-9#5)
Loop7##6##1##(2008-9#6)
Loose##2##1##(2013-1#2)
Lopez-Neyra##3##1##(2011-2#3)
Lord##3##1##(2008-11#2)(2012-2#1)
Lorestan##2##1##(2008-12#1)(2012-2#1)
Los Alamos##2##2##(2008-2#1)(2013-1#1)
Los Angeles##8##2##(1991-2#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
Los Mochis##2##2##(2008-10#2)
Los##13##1##(1991-12#1)(1991-2#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Losartan and Valsartan##3##3##(2008-10#3)
Losartan##4##1##(2008-10#3)(2008-11#1)
Loss and##2##2##(2008-10#1)(2010-7#1)
Loss of the##2##3##(1997-3#1)(2012-3#1)
Loss of##20##2##(1992-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#3)(2012-3#2)
Loss##28##1##(1992-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-2#4)(2012-3#2)
Losses##3##1##(2008-10#3)
Lost##2##1##(2008-9#1)(2013-1#1)
Lotka-Volterra competition equations##2##3##(2008-10#1)(2008-8#1)
Lotka-Volterra equations##2##2##(2008-10#1)(2008-8#1)
Lotka-Volterra##10##1##(2008-10#2)(2008-8#6)(2013-8#2)
Lotus japonicus##2##2##(2009-8#1)(2011-2#1)
Louie##3##1##(1996-5#3)
Louie's##2##1##(1996-5#2)
Louis##8##1##(1992-8#1)(1994-1#1)(1995-12#2)(1996-5#1)(1997-5#1)(2008-11#1)(2008-12#1)
Louisiana##14##1##(1995-12#1)(2008-10#11)(2012-3#1)(2013-8#1)
Love waves##3##2##(2008-10#3)
Low CHO Diet##2##3##(2008-3#2)
Low CHO##3##2##(2008-3#3)
Low Cal##2##2##(2008-3#2)
Low and##2##2##(1993-2#1)(1996-12#1)
Low anterior resection##2##3##(1990-9#1)(2007-8#1)
Low back pain##2##3##(1991-8#1)(2008-12#1)
Low concentrations of##6##3##(1990-7#1)(1993-3#1)(2008-10#2)(2008-5#1)(2008-6#1)
Low concentrations##7##2##(1990-2#1)(1990-7#1)(1993-3#1)(2008-10#2)(2008-5#1)(2008-6#1)
Low detection##2##2##(2008-10#2)
Low dose##2##2##(2012-12#1)(2013-1#1)
Low doses of radiation##2##4##(2008-7#2)
Low doses of##4##3##(1991-1#1)(1995-8#1)(2008-7#2)
Low doses##6##2##(1991-1#1)(1995-8#1)(2008-7#3)(2013-1#1)
Low energy##2##2##(1992-8#1)(1992-9#1)
Low grade##2##2##(1994-12#1)(2011-3#1)
Low intensity##2##2##(1996-5#1)(2011-2#1)
Low levels of##6##3##(1994-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)
Low molecular weight heparin##2##4##(2008-10#1)(2008-3#1)
Low molecular weight##4##3##(1991-5#1)(2008-10#2)(2008-3#1)
Low population##2##2##(2008-10#1)(2012-7#1)
Low sulphur##2##2##(2008-10#2)
Low temperature##2##2##(2008-10#1)(2009-8#1)
Low##89##1##(1990-2#3)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#2)(2012-7#1)(2013-1#5)(2013-8#1)
Low-Field##2##1##(2011-2#2)
Low-density lipoprotein (7 micrograms/ml) induced##2##5##(1990-2#2)
Low-density lipoprotein receptor##2##3##(1990-2#2)
Low-density lipoprotein##7##2##(1990-2#7)
Low-density##8##1##(1990-2#8)
Low-dose caffeine##2##2##(1991-1#2)
Low-dose##6##1##(1991-1#2)(1994-6#1)(1997-6#1)(2008-11#1)(2009-9#1)
Low-frequency wavelength modulation spectroscopy##2##4##(2008-3#2)
Low-frequency##3##1##(2008-3#2)(2011-2#1)
Low-income##2##1##(1995-9#1)(2009-5#1)
Low-level##3##1##(2008-10#3)
Lower concentrations of##3##3##(2008-10#3)
Lower concentrations##5##2##(1990-3#1)(1991-5#1)(2008-10#3)
Lower extremity##2##2##(1995-8#1)(2009-12#1)
Lower limb##2##2##(2011-2#1)(2013-1#1)
Lower##26##1##(1990-3#1)(1991-5#1)(1994-2#1)(1995-8#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Lowering##4##1##(1994-2#1)(2008-10#1)(2008-12#1)(2010-1#1)
Lowest##2##1##(2008-10#1)(2008-12#1)
Lowry##7##1##(2008-10#6)(2008-12#1)
LoxP##2##1##(2008-9#2)
Lp##4##1##(2008-7#4)
Lp(a) concentration##4##2##(1991-12#1)(1996-8#3)
Lp(a) has##2##2##(2008-6#2)
Lp(a) in##2##2##(1991-12#1)(1996-8#1)
Lp(a) levels##6##2##(1991-12#3)(2008-6#3)
Lp(a)##32##1##(1991-12#6)(1993-2#10)(1996-8#10)(2008-6#6)
Lr##2##1##(2008-10#2)
Lr10##2##1##(2008-10#2)
Lr23##2##1##(2008-10#2)
Lr26 virulent and##2##3##(2008-10#2)
Lr26 virulent##3##2##(2008-10#3)
Lr26##11##1##(2008-10#11)
Lr2a##2##1##(2008-10#2)
Lr3##2##1##(2008-10#2)
Lr34##7##1##(2008-10#7)
Lr34/Yr18##7##1##(2008-10#7)
Lr46 and##2##2##(2008-10#2)
Lr46##7##1##(2008-10#7)
Lrd1##3##1##(2008-10#3)
Ltd##68##1##(2008-10#1)(2008-11#38)(2008-5#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-2#8)(2012-2#5)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#7)
Ltd)##8##1##(1995-3#7)(2010-7#1)
Ltnα and##2##2##(2011-1#2)
Ltnα##3##1##(2011-1#3)
Ltnβ##3##1##(2011-1#3)
Lu##3##1##(2008-10#1)(2008-9#1)(2010-4#1)
Lu(2)O(3)##4##1##(2010-4#4)
Lu(3+)##4##1##(2008-10#3)(2010-4#1)
Lu) in##2##2##(2008-10#1)(2010-4#1)
Lu)##3##1##(2008-10#2)(2010-4#1)
LuMA cells##5##2##(2008-11#5)
Lubricin and##2##2##(2010-10#2)
Lubricin##3##1##(2010-10#3)
Luciferase##2##1##(2008-10#1)(2010-5#1)
Luciferase-reporter##2##1##(2009-8#2)
Lumbar##8##1##(1991-11#1)(1993-6#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#2)
Lumigen##2##1##(2008-10#2)
Luminescence##4##1##(1996-9#1)(2008-11#1)(2010-1#1)(2012-2#1)
Luna##2##1##(2008-10#2)
Lunar##4##1##(2008-8#3)(2010-3#1)
Lung Cancer##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
Lung Institute##2##2##(2008-5#2)
Lung cancer##5##2##(1990-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2011-3#1)
Lung function##3##2##(1997-1#1)(2008-7#1)(2011-2#1)
Lung transplantation is##2##3##(2011-3#2)
Lung transplantation##4##2##(2011-3#4)
Lung##33##1##(1990-12#1)(1992-12#1)(1994-3#2)(1995-2#1)(1995-3#1)(1997-1#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#1)(2010-12#2)(2010-6#1)(2011-2#1)(2011-3#7)(2012-2#1)(2013-1#1)(2013-8#1)
Lupinus albus##2##2##(2008-10#1)(2008-12#1)
Lupus##2##1##(1994-1#1)(2012-12#1)
Luteoviridae##3##1##(2008-10#3)
Luteovirus##2##1##(2008-10#2)
Lutzomyia##7##1##(2007-12#7)
LuxA##2##1##(2008-11#2)
LuxS from Streptococcus suis serotype 2##2##6##(2009-6#2)
LuxS##5##1##(2009-6#5)
Ly-49##4##1##(1995-2#4)
Ly-49+ NK cells##3##3##(1995-2#3)
Ly-49+ subset##2##2##(1995-2#2)
Ly-49+##6##1##(1995-2#6)
Lyapunov exponent##2##2##(2008-9#1)(2010-8#1)
Lyapunov##3##1##(2008-9#2)(2010-8#1)
Lyase##3##1##(2008-10#2)(2008-4#1)
Lycopersicon esculentum##5##2##(1993-12#1)(2008-10#4)
Lycopersicon hirsutum##5##2##(2008-10#5)
Lycopersicon##12##1##(1993-12#1)(2008-10#11)
Lyme borreliosis##6##2##(1994-6#2)(2008-10#4)
Lyme disease risk##2##3##(2008-11#2)
Lyme disease##24##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1997-3#10)(1997-7#1)(2007-12#1)(2008-11#3)(2008-8#2)(2008-9#2)(2013-8#1)
Lyme##34##1##(1990-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-6#2)(1997-3#10)(1997-7#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-8#2)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
Lymnaea##2##1##(2008-12#1)(2012-2#1)
Lymph Node##5##2##(2008-10#2)(2008-11#1)(2012-12#2)
Lymph node##3##2##(1990-2#1)(2008-11#1)(2010-11#1)
Lymph nodes were##2##3##(1994-12#1)(2008-10#1)
Lymph nodes##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
Lymph##11##1##(1990-2#1)(1994-12#1)(2008-10#3)(2008-11#2)(2010-11#1)(2011-2#1)(2012-12#2)
Lymphangioma##2##1##(2013-1#2)
Lymphocyte##5##1##(1995-12#1)(2008-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
Lymphocytes were##2##2##(1995-12#1)(2013-1#1)
Lymphocytes##4##1##(1995-12#1)(2008-7#1)(2013-1#2)
Lymphoid##4##1##(1995-8#1)(1997-1#1)(2008-11#1)(2013-1#1)
Lymphoma and Myeloma##2##3##(2010-11#2)
Lymphoma##6##1##(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#2)
Lyn##4##1##(1995-6#3)(2009-6#1)
Lyncei##2##1##(2010-1#2)
Lynch syndrome##4##2##(2011-2#1)(2012-3#3)
Lynch##7##1##(2008-10#1)(2011-2#2)(2012-3#4)
Lyon##5##1##(2008-10#2)(2009-4#2)(2011-2#1)
Lyons score##2##2##(1994-3#2)
Lyons##3##1##(1994-3#2)(1995-6#1)
Lyprinol(R)##4##1##(2008-10#4)
Lys at##2##2##(2008-10#1)(2008-11#1)
Lys in##2##2##(1990-5#1)(1993-12#1)
Lys##9##1##(1990-5#1)(1990-8#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#3)
Lys- Pro-##2##2##(1991-5#2)
Lys-##3##1##(1991-5#3)
Lys-82 beta##2##2##(1993-8#2)
LysK##6##1##(2009-6#6)
Lysholm and##3##2##(2011-2#1)(2013-1#2)
Lysholm scale##2##2##(2013-1#2)
Lysholm##9##1##(2011-2#2)(2013-1#7)
Lysine##2##1##(2008-11#2)
Lysiphlebus testaceipes##2##2##(2013-8#2)
Lysis of##2##2##(1996-1#1)(2013-1#1)
Lysobacter enzymogenes Strain C3##2##4##(2008-10#2)
Lysobacter enzymogenes##4##2##(2008-10#4)
Lysosomal##5##1##(1991-12#1)(1992-12#1)(1993-12#1)(1995-6#1)(2010-8#1)
Lysosomes##3##1##(1992-12#2)(2008-7#1)
M (0##5##2##(2008-10#5)
M (H##3##2##(2008-10#3)
M (r=0##2##2##(2008-10#2)
M 5-sulfaminouracil##2##2##(2008-10#2)
M =##6##2##(1994-11#2)(1994-5#2)(2008-2#1)(2008-3#1)
M CFZ##2##2##(2008-10#2)
M Ca(2+)##2##2##(2008-10#2)
M Co(NH(3))(6)Cl(3)##2##2##(2008-10#2)
M Fe(III)##2##2##(2008-10#2)
M H(2)SO(4) and##2##3##(2008-10#2)
M H(2)SO(4) solution##2##3##(2008-10#1)(2009-10#1)
M H(2)SO(4)##10##2##(2008-10#9)(2009-10#1)
M H2SO4##3##2##(1991-7#3)
M HCl and##2##3##(2008-10#2)
M HCl as##2##3##(2008-10#2)
M HCl for##3##3##(2008-10#3)
M HCl or##4##3##(1997-2#1)(2008-10#3)
M HCl##22##2##(1997-2#1)(2008-10#21)
M HCl) as##2##3##(2008-10#2)
M HCl)##7##2##(2008-10#7)
M HNO(3) and##4##3##(2008-10#4)
M HNO(3) for##3##3##(2008-10#3)
M HNO(3)##17##2##(2008-10#17)
M KCl and##3##3##(1993-8#1)(2008-10#2)
M KCl##7##2##(1993-8#2)(2008-10#5)
M KNO(3)##3##2##(2008-10#3)
M Na(2)CO(3) and##2##3##(2008-10#2)
M NaCl at##2##3##(1994-5#1)(2008-10#1)
M NaCl##22##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-5#1)(2008-10#10)(2011-2#1)
M NaCl)##2##2##(1994-8#2)
M NaOH solution##5##3##(2008-10#4)(2008-11#1)
M NaOH##10##2##(1995-6#1)(2008-10#8)(2008-11#1)
M Pb(II)##3##2##(2008-10#3)
M RNA of WSMV##3##4##(2008-10#3)
M RNA##6##2##(2008-10#6)
M acetic acid##3##3##(1994-8#1)(2008-10#2)
M acid##4##2##(2008-10#4)
M after##3##2##(1996-3#1)(2008-10#2)
M ammonium acetate##2##3##(2008-10#2)
M ammonium##3##2##(2008-10#3)
M and 0##7##3##(2008-10#7)
M and S RNAs##2##4##(2008-10#2)
M and S##3##3##(2008-10#2)(2013-8#1)
M and a##2##3##(2008-10#2)
M and for##3##3##(2008-10#3)
M and the##4##3##(2008-10#4)
M and##39##2##(1991-3#1)(1992-6#1)(1993-6#1)(1994-5#1)(1997-4#1)(2008-10#30)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
M aqueous##2##2##(2008-10#2)
M at 25 degrees C##4##5##(2008-10#4)
M at##8##2##(1991-11#1)(2008-10#7)
M avium##2##2##(2007-12#1)(2008-11#1)
M by##2##2##(2008-10#2)
M can be##2##3##(2008-10#2)
M concentration range##3##3##(2008-10#3)
M concentration##5##2##(1993-3#1)(2008-10#3)(2010-12#1)
M could##2##2##(2008-10#1)(2008-8#1)
M for I##2##3##(2008-10#2)
M for II and 2x10(-7)##2##5##(2008-10#2)
M for III##2##3##(2008-10#2)
M for SPME and##2##4##(2008-10#2)
M for##30##2##(1990-5#1)(2008-10#29)
M genotypes were##2##3##(2008-10#2)
M genotypes##4##2##(2008-10#4)
M hydrochloric acid and##2##4##(2008-10#2)
M hydrochloric acid##10##3##(2008-10#10)
M hydrochloric##11##2##(2008-10#11)
M in 0##2##3##(2008-10#2)
M in the presence of##2##5##(2008-10#2)
M in the##5##3##(1990-5#1)(2008-10#4)
M in##14##2##(1990-11#1)(1990-5#1)(1991-11#1)(2008-10#11)
M ionic strength##3##3##(2008-10#3)
M is##2##2##(1994-11#1)(1995-6#1)
M level##3##2##(2008-10#3)
M model##2##2##(2008-10#2)
M mucosal concentration##2##3##(2010-12#2)
M nitric acid##4##3##(2008-10#4)
M of Cs(+)##2##3##(2008-10#2)
M of somatostatin##3##3##(1997-4#3)
M of##18##2##(1997-4#4)(2008-10#13)(2008-11#1)
M on##2##2##(1994-11#1)(1995-6#1)
M or greater than##2##4##(1997-4#2)
M or greater##5##3##(1990-10#1)(1994-5#2)(1997-4#2)
M or##9##2##(1990-10#1)(1990-5#1)(1994-5#3)(1997-4#3)(2008-10#1)
M pH##3##2##(2008-10#3)
M phosphate buffer##5##3##(1992-10#1)(2008-10#4)
M phosphate##7##2##(1992-10#1)(2008-10#6)
M phosphoric acid medium##2##4##(2008-10#2)
M potassium##4##2##(2008-10#4)
M proteins##2##2##(2008-5#2)
M range##2##2##(2008-10#2)
M series##2##2##(2010-9#2)
M sodium acetate buffer at pH##2##6##(2008-10#2)
M sodium borate##3##3##(1990-3#3)
M sodium chloride##2##3##(1992-10#1)(2008-10#1)
M sodium hydroxide solution##2##4##(2008-10#2)
M sodium##14##2##(1990-3#3)(1992-10#1)(1992-3#1)(2008-10#9)
M strains##2##2##(2013-1#2)
M sucrose##2##2##(2008-10#1)(2008-11#1)
M sulfadiazine##2##2##(2008-10#2)
M sulfamethazine##2##2##(2008-10#2)
M sulfamethoxazole##2##2##(2008-10#2)
M sulfasalazine##2##2##(2008-10#2)
M sulfathiazole##2##2##(2008-10#2)
M sulphuric acid##2##3##(2008-10#2)
M to##7##2##(1997-4#5)(2008-10#2)
M total iron(III)##2##3##(2008-10#2)
M urea##5##2##(1995-11#1)(2008-10#3)(2009-3#1)
M using##2##2##(2008-10#2)
M was achieved##2##3##(2008-10#2)
M was##5##2##(1994-3#1)(2008-10#4)
M were achieved##2##3##(2008-10#2)
M with a Nernstian slope of 59##2##7##(2008-10#2)
M with a detection limit of 1##3##7##(2008-10#3)
M with a detection limit of 2##3##7##(2008-10#3)
M with a detection limit of##10##6##(2008-10#10)
M with a response time##2##5##(2008-10#2)
M with a##18##3##(2008-10#18)
M with and##2##3##(1991-5#2)
M with correlation##2##3##(2008-10#2)
M with electrode II##2##4##(2008-10#2)
M with##30##2##(1991-5#2)(2008-10#28)
M without BSA##2##3##(1991-5#2)
M##1210##1##(1990-10#4)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#11)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-3#2)(1991-5#8)(1991-7#3)(1991-9#1)(1992-1#2)(1992-10#6)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#5)(1992-8#1)(1993-12#1)(1993-2#4)(1993-3#7)(1993-6#2)(1993-8#6)(1994-1#5)(1994-11#8)(1994-2#3)(1994-3#6)(1994-5#16)(1994-8#6)(1995-11#6)(1995-12#1)(1995-2#10)(1995-6#15)(1995-8#2)(1996-12#2)(1996-2#4)(1996-3#4)(1996-9#1)(1997-2#4)(1997-3#10)(1997-4#16)(1997-8#2)(2007-12#2)(2008-10#828)(2008-11#24)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#22)(2008-6#15)(2008-7#6)(2008-8#2)(2008-9#8)(2009-10#2)(2009-3#1)(2009-6#5)(2009-7#3)(2009-8#3)(2010-10#4)(2010-12#4)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#3)(2011-10#6)(2011-2#24)(2011-3#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#10)(2013-8#1)
M(-)(1) s(-)(1))##2##2##(1996-5#2)
M(-1) cm(-1)##2##2##(2008-10#2)
M(-1) for the##4##3##(2008-10#4)
M(-1) for##10##2##(2008-10#9)(2009-8#1)
M(-1) s(-1)##2##2##(2008-10#2)
M(-1)##23##1##(2008-10#21)(2008-11#1)(2009-8#1)
M(2) =##2##2##(2008-12#2)
M(2) approximately##3##2##(2008-2#1)(2008-3#2)
M(2) of##2##2##(2008-3#2)
M(2)##14##1##(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#6)
M(2))##2##1##(2008-10#1)(2008-3#1)
M(2)L##2##1##(2008-10#2)
M(2+)##3##1##(2008-10#3)
M(3))##2##1##(2008-10#2)
M(n) (GPC) =##2##3##(2008-12#2)
M(n)##5##1##(2008-12#5)
M(r) of##5##2##(1993-9#1)(1997-2#1)(2008-10#2)(2012-3#1)
M(r)##18##1##(1992-6#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-8#2)(1995-11#1)(1996-3#1)(1997-2#4)(2008-10#2)(2010-4#1)(2012-3#1)
M) and##5##2##(1991-5#1)(2008-10#4)
M) concentrations of##2##3##(1996-2#2)
M) did not##2##3##(1997-4#2)
M) for##2##2##(2008-10#1)(2008-11#1)
M) in##2##2##(1995-12#1)(2008-10#1)
M) inhibited##2##2##(1995-6#1)(2008-11#1)
M) of##2##2##(1990-7#1)(2008-10#1)
M) was used##2##3##(2008-10#2)
M) was##3##2##(2008-10#3)
M) with a Nernstian slope of##2##6##(2008-10#2)
M) with a limit of detection of##2##7##(2008-10#2)
M) with a slope of##3##5##(2008-10#3)
M) with a##8##3##(2008-10#8)
M)##72##1##(1990-12#1)(1990-5#2)(1990-7#1)(1991-5#5)(1993-3#1)(1994-11#1)(1994-2#5)(1995-12#1)(1995-6#1)(1996-2#4)(1997-4#8)(2008-10#38)(2008-11#3)(2008-6#1)
M-1 and##3##2##(1992-10#1)(1994-5#2)
M-1 min-1 for binding to##2##5##(1993-1#2)
M-1 min-1##3##2##(1993-1#3)
M-1 s-1 at##2##3##(1993-8#1)(1994-5#1)
M-1 s-1##4##2##(1993-8#1)(1994-5#3)
M-1##16##1##(1992-10#2)(1993-1#3)(1993-8#3)(1994-5#5)(1995-2#3)
M-201##2##1##(2008-10#2)
M-CSF##8##1##(1991-5#6)(2008-11#1)(2008-8#1)
M-FISH was##2##2##(2010-1#2)
M-FISH##3##1##(2010-1#3)
M-O7e cells##2##2##(2008-4#2)
M-O7e##3##1##(2008-4#3)
M-estimators##2##1##(2008-10#2)
M/Fe mole ratio of##2##4##(2008-10#2)
M/Fe mole ratio##3##3##(2008-10#3)
M/Ms were##2##2##(1991-2#2)
M/Ms##5##1##(1991-2#5)
M1 and M2##3##3##(1992-10#2)(1992-8#1)
M1 and##5##2##(1992-10#2)(1992-8#1)(2008-10#1)(2008-9#1)
M1 stimulation##2##2##(2011-2#2)
M1##30##1##(1992-10#3)(1992-8#1)(1997-3#1)(2008-10#7)(2008-12#3)(2008-9#1)(2011-2#4)(2012-2#1)(2013-1#8)(2013-8#1)
M1/M2##2##1##(1992-8#1)(2013-1#1)
M10##2##1##(1993-8#2)
M11 delta##3##2##(1993-8#3)
M11##5##1##(1993-8#4)(2008-10#1)
M13##4##1##(2008-1#1)(2008-10#2)(2008-11#1)
M16##2##1##(2008-10#2)
M2##10##1##(1990-5#1)(1992-10#2)(1992-8#3)(2007-12#2)(2008-10#1)(2010-4#1)
M2(D)##4##1##(2008-8#4)
M2)##2##1##(1990-5#1)(2008-10#1)
M2-muscarinic receptors##2##2##(1997-2#1)(2011-2#1)
M2-muscarinic##3##1##(1997-2#2)(2011-2#1)
M24 protein##2##2##(1996-12#2)
M3##7##1##(1990-8#5)(1991-2#1)(2011-2#1)
M3Ad##5##1##(1990-8#5)
M4 and M5##2##3##(1991-2#1)(2008-11#1)
M4 from##2##2##(2008-8#1)(2008-9#1)
M4 in##2##2##(2008-8#2)
M4##10##1##(1991-2#1)(2008-11#1)(2008-8#5)(2008-9#3)
M4-TNF##2##1##(1997-2#2)
M41##2##1##(2008-5#2)
M44##2##1##(1995-6#2)
M5##4##1##(1991-2#2)(2008-10#1)(2008-11#1)
M6##3##1##(1991-2#1)(2008-10#2)
M7##2##1##(1995-12#2)
M79 is##2##2##(2008-8#2)
M79##9##1##(2008-8#9)
M8##3##1##(2008-10#2)(2008-9#1)
M9 delta##2##2##(1993-8#2)
M9##3##1##(1993-8#3)
M</ForeName>##2##1##(2013-8#2)
MA and##3##2##(1994-2#1)(2008-10#2)
MA##26##1##(1992-4#1)(1994-2#9)(1995-11#1)(2008-10#7)(2008-11#2)(2010-1#1)(2013-1#2)(2013-8#3)
MA(2)##3##1##(2008-10#3)
MA) is##2##2##(2008-11#1)(2013-1#1)
MA)##5##1##(2008-10#1)(2008-11#1)(2013-1#3)
MAC genome##5##2##(2012-3#5)
MAC##8##1##(2008-10#1)(2011-2#1)(2012-3#6)
MAD-3##2##1##(1991-7#2)
MADRS##5##1##(2008-6#2)(2012-3#3)
MADS box gene##3##3##(1997-8#1)(2008-8#2)
MADS box genes that##2##4##(1997-8#2)
MADS box genes##3##3##(1997-8#2)(2008-8#1)
MADS box##10##2##(1997-8#3)(2008-8#6)(2009-8#1)
MADS##11##1##(1997-8#4)(2008-8#6)(2009-8#1)
MADS-box##6##1##(2008-8#2)(2009-8#4)
MAE of##3##2##(2008-10#3)
MAE##9##1##(2008-10#8)(2008-11#1)
MAG = 3but##2##3##(1993-8#2)
MAGE##4##1##(2012-4#1)(2012-5#3)
MAGE-A antigens##2##2##(2011-2#2)
MAGE-A4##3##1##(2011-2#3)
MAGGY##2##1##(2008-10#2)
MAIN##2##1##(1992-11#1)(2011-2#1)
MAL500##2##1##(2008-9#2)
MALDI-TOF##3##1##(2008-10#2)(2008-8#1)
MALDI-TOF-MS##3##1##(2008-10#1)(2009-9#1)(2010-12#1)
MALT lymphoma and##2##3##(1997-1#2)
MALT lymphoma##8##2##(1997-1#4)(2008-12#1)(2009-8#3)
MALT lymphomas are##2##3##(1997-1#1)(2009-8#1)
MALT lymphomas##3##2##(1997-1#2)(2009-8#1)
MALT##13##1##(1997-1#7)(2008-12#1)(2009-8#5)
MAN##2##1##(2008-10#1)(2009-5#1)
MAO B##4##2##(2009-12#4)
MAO inhibitory activity##3##3##(1994-3#3)
MAO##9##1##(1994-3#3)(1994-8#1)(2009-12#4)(2009-8#1)
MAO-A##2##1##(1994-8#2)
MAO-B##3##1##(1994-8#3)
MAP kinase activation by a##2##5##(1995-8#2)
MAP kinase activation by##3##4##(1995-8#3)
MAP kinase activation##7##3##(1995-8#7)
MAP kinase signaling##2##3##(2008-7#1)(2009-10#1)
MAP kinase##19##2##(1993-8#3)(1995-8#10)(1996-2#2)(2008-7#2)(2009-10#1)(2009-8#1)
MAP kinases##2##2##(1993-8#1)(2008-11#1)
MAP##32##1##(1993-8#4)(1994-2#1)(1995-8#10)(1996-2#2)(2008-10#2)(2008-11#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#2)(2013-8#3)
MAP-2 immunoreactivity##2##2##(2008-7#2)
MAP-2 immunostaining##4##2##(2008-7#4)
MAP-2##7##1##(2008-7#7)
MAPK activation##9##2##(1995-6#7)(1996-2#1)(2008-11#1)
MAPK pathway##4##2##(2008-11#3)(2009-8#1)
MAPK##36##1##(1995-2#3)(1995-6#9)(1996-2#1)(2008-11#9)(2009-7#1)(2009-8#8)(2010-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
MAPKs##8##1##(1995-2#1)(1995-6#4)(1996-2#1)(2008-10#1)(2009-8#1)
MAPPING OF##2##2##(2008-11#2)
MAPs##3##1##(2009-8#3)
MAR##2##1##(2008-10#1)(2008-8#1)
MAR4 and MAR5##2##3##(1992-2#2)
MARYBLYT 4##2##2##(2008-10#2)
MARYBLYT and Cougarblight##2##3##(2008-10#2)
MARYBLYT##7##1##(2008-10#7)
MAS##2##1##(2008-10#2)
MAT activity##2##2##(1992-6#2)
MAT##11##1##(1992-6#5)(2008-10#3)(2013-1#3)
MAT-1 cells##2##2##(2008-10#2)
MAT-1 pheromone##3##2##(2008-10#3)
MAT-1##6##1##(2008-10#6)
MATERIAL AND METHODS##5##3##(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
MATERIAL AND##6##2##(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
MATERIAL##19##1##(2009-8#1)(2010-1#2)(2011-2#2)(2011-7#1)(2012-2#7)(2012-3#3)(2013-1#3)
MATERIALS AND METHODS##17##3##(2008-6#1)(2011-2#9)(2012-2#5)(2012-3#2)
MAV##3##1##(2008-10#3)
MAVS##6##1##(2013-1#6)
MAVS-mediated antiviral##2##2##(2013-1#2)
MAVS-mediated##3##1##(2013-1#3)
MAX##9##1##(1995-6#9)
MAb concentration##3##2##(2008-11#2)(2008-7#1)
MAb medium##3##2##(2008-11#3)
MAb productivity as compared to##2##5##(2008-11#2)
MAb secretion##2##2##(2008-11#2)
MAb##27##1##(1990-2#2)(2008-10#6)(2008-11#18)(2008-7#1)
MAbs against##2##2##(2008-10#1)(2008-11#1)
MAbs were##3##2##(1992-2#1)(2008-11#2)
MAbs##18##1##(1990-12#1)(1992-2#3)(2008-10#8)(2008-11#4)(2008-4#1)(2008-5#1)
MB and NMB on bare SOWG##2##6##(2008-10#2)
MB and NMB on##3##4##(2008-10#3)
MB and NMB##4##3##(2008-10#4)
MB and the##2##3##(2008-10#2)
MB and##9##2##(2008-10#9)
MB in the##2##3##(2008-10#2)
MB in##3##2##(2008-10#2)(2012-2#1)
MB isoforms##2##2##(1992-3#2)
MB was##2##2##(2008-10#2)
MB##33##1##(1992-3#2)(2008-10#30)(2012-2#1)
MB-ODNs and their##2##3##(2008-4#2)
MB-ODNs##7##1##(2008-4#7)
MB0##2##1##(1992-3#2)
MB1 dominant##2##2##(1992-3#2)
MB1##6##1##(1992-3#6)
MB2 and MB1##3##3##(1992-3#3)
MB2##7##1##(1992-3#7)
MB3 was##3##2##(1992-3#3)
MB3##6##1##(1992-3#6)
MBC =1##2##2##(2008-12#2)
MBC##3##1##(2008-12#3)
MBCK I##3##2##(1993-6#3)
MBI##7##1##(2008-10#5)(2008-11#2)
MBIgG##3##1##(1991-5#3)
MBP##14##1##(1992-9#4)(1993-3#3)(1993-6#3)(1995-12#3)(2012-3#1)
MBP-ECD or##2##2##(1995-12#2)
MBRS##2##1##(2008-10#2)
MBSR and MBCT##2##3##(2013-1#2)
MBT##6##1##(2008-10#3)(2008-11#2)(2013-1#1)
MBTH##4##1##(2008-10#4)
MBr1##3##1##(1990-12#3)
MBr8##4##1##(1990-12#4)
MC ICP MS##3##3##(2008-10#3)
MC in##4##2##(2011-2#2)(2012-12#2)
MC##24##1##(2008-10#7)(2008-11#2)(2011-2#7)(2012-12#8)
MC1R##7##1##(2008-9#6)(2010-4#1)
MC540##4##1##(2008-10#3)(2008-9#1)
MCA and##3##2##(1997-6#1)(2008-10#2)
MCA bifurcation##3##2##(2008-12#3)
MCA##20##1##(1990-8#6)(1995-6#2)(1996-6#1)(1997-2#1)(1997-6#2)(2008-10#3)(2008-12#5)
MCAD##5##1##(1990-8#5)
MCAO induced##2##2##(1997-2#2)
MCAO##9##1##(1997-2#5)(2011-2#4)
MCB##3##1##(2009-7#3)
MCBS (Medicare Current Beneficiary Survey)##2##5##(1994-1#1)(1996-2#1)
MCBS##3##1##(1994-1#1)(1995-2#1)(1996-2#1)
MCC is a##2##3##(1993-3#1)(2011-2#1)
MCC##4##1##(1993-3#1)(2011-2#3)
MCCs##3##1##(2013-1#3)
MCDK##2##1##(2008-10#2)
MCF##2##1##(2008-10#1)(2008-11#1)
MCF-7 breast cancer cells##3##4##(1993-1#1)(2012-2#1)(2012-3#1)
MCF-7 cell##2##2##(1994-12#1)(2011-2#1)
MCF-7 cells##13##2##(1992-4#1)(1993-1#1)(1993-6#1)(1995-8#1)(2008-11#7)(2008-9#1)(2011-2#1)
MCF-7 human breast cancer cells##3##5##(2008-11#3)
MCF-7 human breast cancer##4##4##(2008-11#4)
MCF-7##25##1##(1992-4#1)(1993-1#3)(1993-6#1)(1994-12#1)(1995-8#1)(2008-11#12)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
MCF/HER2-18 cells##3##2##(1993-1#3)
MCF/HER2-18 tumors##3##2##(1993-1#3)
MCF/HER2-18##7##1##(1993-1#7)
MCF7 and ECC1 cells##2##4##(2011-2#2)
MCF7##5##1##(1995-6#1)(2008-11#1)(2011-2#3)
MCG##6##1##(2008-10#6)
MCGs and##2##2##(2008-10#2)
MCGs of S##2##3##(2008-10#2)
MCGs were##3##2##(2008-10#3)
MCGs##14##1##(2008-10#14)
MCI cases##3##2##(2009-10#3)
MCI in PD##4##3##(2008-6#4)
MCI##14##1##(2008-5#4)(2008-6#5)(2009-10#5)
MCL##12##1##(2008-9#2)(2009-1#4)(2009-8#6)
MCLs##2##1##(2008-9#1)(2013-1#1)
MCM##2##1##(2008-10#1)(2008-5#1)
MCM-41 mesoporous material modified carbon paste electrode##2##7##(2008-10#2)
MCM-41##7##1##(2008-10#4)(2010-4#3)
MCO##7##1##(1994-12#1)(2012-2#6)
MCOs##5##1##(1996-2#3)(2008-6#2)
MCP-1##5##1##(2008-10#2)(2008-11#2)(2013-1#1)
MCQ examinations##2##2##(2008-11#2)
MCQ##3##1##(2008-11#3)
MCQs##2##1##(2008-12#2)
MCR##3##1##(1990-11#1)(2008-11#2)
MCS##10##1##(2008-11#2)(2010-3#3)(2011-2#2)(2012-3#1)(2013-1#2)
MCS+ procedures##3##2##(2011-2#3)
MCS+##6##1##(2011-2#6)
MCT administration##3##2##(1994-5#3)
MCT##5##1##(1994-5#5)
MCT-treated rats##3##2##(1994-5#3)
MCT-treated##5##1##(1994-5#5)
MCV##2##1##(1990-3#1)(2008-5#1)
MCs##7##1##(1992-6#1)(2008-11#1)(2010-5#3)(2012-12#2)
MD Anderson Cancer##2##3##(2011-2#2)
MD phytoplasmas##2##2##(2008-10#2)
MD##30##1##(1991-8#2)(1993-1#1)(1996-5#3)(2008-10#7)(2008-4#1)(2008-5#5)(2008-6#1)(2009-4#1)(2010-11#1)(2010-5#2)(2010-8#2)(2011-2#2)(2012-2#2)
MDA and NO were##3##4##(2011-3#3)
MDA content and electrolyte leakage##2##5##(2008-12#2)
MDA##13##1##(1996-2#4)(2008-10#1)(2008-12#3)(2011-3#4)(2012-2#1)
MDA-MB-231 cells##4##2##(2008-11#2)(2013-1#2)
MDA-MB-231##6##1##(1992-4#1)(2008-11#3)(2013-1#2)
MDA-MB-435 (GRPR(-)/integrin alpha(v)beta(3)(+))##2##3##(2010-6#2)
MDC and T cells##2##4##(2010-3#2)
MDC##4##1##(2010-3#4)
MDC1##3##1##(2011-2#3)
MDCK cells##7##2##(1990-5#1)(2008-11#5)(2008-9#1)
MDCK##12##1##(1990-5#1)(1995-11#3)(2008-11#7)(2008-9#1)
MDCT##10##1##(2011-2#7)(2012-2#3)
MDD##7##1##(2008-10#2)(2008-4#1)(2011-2#2)(2012-3#2)
MDE##2##1##(2008-10#2)
MDHs##2##1##(1992-12#2)
MDI and##3##2##(1992-3#2)(1996-1#1)
MDI can be used##2##4##(1992-3#1)(1996-1#1)
MDI products##2##2##(1996-1#1)(1997-2#1)
MDI with##3##2##(1996-1#2)(1996-2#1)
MDI##31##1##(1992-3#13)(1996-1#11)(1996-2#3)(1997-1#2)(1997-2#1)(2012-4#1)
MDIs will##3##2##(1992-3#1)(1996-1#2)
MDIs##17##1##(1992-3#4)(1996-1#12)(1996-2#1)
MDL was##3##2##(1996-2#3)
MDL##6##1##(1996-2#6)
MDM2 blockade##2##2##(2013-1#2)
MDM2 gene amplification##2##3##(1994-12#2)
MDM2 gene##4##2##(1994-12#4)
MDM2 inhibition##2##2##(2013-1#2)
MDM2 protein is##2##3##(1994-12#2)
MDM2 protein##3##2##(1994-12#3)
MDM2##23##1##(1994-12#9)(2011-2#3)(2013-1#11)
MDMV##2##1##(2008-10#2)
MDPs##2##1##(2009-8#2)
MDR TB##4##2##(2011-2#4)
MDR cells##7##2##(1990-2#6)(1993-3#1)
MDR##22##1##(1990-2#6)(1993-3#1)(1997-5#1)(2008-11#9)(2010-2#1)(2011-2#4)
MDR-Enterococcus##4##1##(2011-2#4)
MDR1##3##1##(2008-11#3)
MDR2##2##1##(2008-11#2)
MDRD2##2##1##(2011-2#2)
MDS and##3##2##(2008-11#1)(2010-1#2)
MDS is##2##2##(1997-3#1)(2010-8#1)
MDS samples with##2##3##(2008-11#2)
MDS##13##1##(1997-3#1)(2008-10#1)(2008-11#4)(2010-1#2)(2010-8#4)(2011-2#1)
MDSS2 and MDSS2N##2##3##(2008-11#2)
MDSS2##7##1##(2008-11#7)
MDSS2N##9##1##(2008-11#9)
MDa##2##1##(2009-8#1)(2011-2#1)
ME1##3##1##(2008-10#3)
MECC##2##1##(2008-10#2)
MECL##2##1##(2012-3#2)
MED-EL cochlear implant users##2##4##(2008-9#2)
MED-EL cochlear implant##3##3##(2008-9#3)
MED-EL##8##1##(2008-9#8)
MEDDF##5##1##(2008-8#5)
MEDICAL##2##1##(2009-9#1)(2011-2#1)
MEDLINE and EMBASE##2##3##(1994-3#2)
MEDLINE and##6##2##(1991-1#1)(1992-12#1)(1994-3#2)(2013-1#2)
MEDLINE end-user##2##2##(1992-1#2)
MEDLINE on CD-ROM##2##3##(1991-1#2)
MEDLINE on##4##2##(1991-1#3)(1991-3#1)
MEDLINE search##2##2##(2011-7#1)(2013-1#1)
MEDLINE##36##1##(1991-1#8)(1991-12#1)(1991-3#4)(1992-1#4)(1992-12#4)(1993-2#1)(1994-3#5)(2009-7#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#5)
MEF##2##1##(2009-12#1)(2009-9#1)
MEFs##7##1##(2008-2#4)(2010-3#2)(2011-2#1)
MEG##2##1##(1996-2#1)(2008-10#1)
MEI##4##1##(1992-2#3)(1994-1#1)
MEK (MAPK/ERK kinase)##2##3##(1996-2#1)(2010-10#1)
MEK##5##1##(1995-2#2)(1996-2#1)(2008-10#1)(2010-10#1)
MEKC##7##1##(2008-10#5)(2010-7#2)
MEL##8##1##(2008-11#6)(2008-9#2)
MEL-A##4##1##(2008-11#4)
MEL-TF19##3##1##(2008-9#3)
MELAS##3##1##(1990-3#3)
MEM##3##1##(2008-11#1)(2008-7#2)
MEME##7##1##(2008-9#7)
MEMS##2##1##(2009-9#2)
MEP##10##1##(2008-11#2)(2008-7#3)(2010-7#2)(2012-2#3)
MEP2##2##1##(1995-9#2)
MEPs##3##1##(2010-7#2)(2011-2#1)
MESS-2##5##1##(2008-10#5)
MET4##2##1##(1996-3#2)
METHOD##16##1##(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#6)(2013-1#7)
METHODS #ENTITYSTARTX00026##2##2##(2010-7#1)(2012-3#1)
METHODS AND RESULTS##5##3##(2008-11#2)(2008-12#2)(2012-2#1)
METHODS AND##7##2##(2008-11#3)(2008-12#2)(2011-7#1)(2012-2#1)
METHODS##143##1##(1997-5#1)(2008-11#9)(2008-12#2)(2008-6#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#19)(2011-7#1)(2012-2#26)(2012-3#32)(2013-1#29)
MEX alleles in##2##3##(2008-10#2)
MEX1##2##1##(2008-10#2)
MF##4##1##(1993-9#1)(2008-10#1)(2010-9#1)(2013-1#1)
MFA##3##1##(2008-10#2)(2009-3#1)
MFA2##2##1##(1995-9#2)
MFAP-4 expression was##2##3##(2012-2#2)
MFAP-4##5##1##(2012-2#5)
MFB##3##1##(1991-2#1)(2008-10#2)
MFE##3##1##(2008-10#3)
MFG-IRAP##2##1##(2008-5#2)
MFN##4##1##(2008-11#4)
MFS##10##1##(1994-1#6)(1994-12#1)(1996-3#1)(2008-10#1)(2011-1#1)
MG and##2##2##(2008-10#2)
MG was found to##2##4##(2008-10#1)(2008-11#1)
MG##22##1##(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#14)(2008-11#5)
MG12 cells##2##2##(2008-11#2)
MG12##4##1##(2008-11#4)
MG2 and##2##2##(2008-10#2)
MG2##4##1##(2008-10#4)
MG96-36##4##1##(2008-10#4)
MGBG##3##1##(2008-10#3)
MGC803 cell##3##2##(2008-9#3)
MGC803##5##1##(2008-9#5)
MGCT##3##1##(2011-2#3)
MGMA##3##1##(2012-3#3)
MGR586 lineages##3##2##(2008-10#3)
MGR586##10##1##(2008-10#10)
MH##9##1##(2008-9#9)
MHA-P complexes##2##2##(2008-10#2)
MHC Class II+ cell##2##4##(1996-12#2)
MHC Class II+##3##3##(1996-12#3)
MHC class I and beta 2-microglobulin gene expression##2##8##(1995-12#2)
MHC class I and class II##2##6##(1995-5#1)(2008-9#1)
MHC class I and##4##4##(1995-12#2)(1995-5#1)(2008-9#1)
MHC class I antigens##2##4##(1994-5#1)(2008-8#1)
MHC class I is##2##4##(2008-1#2)
MHC class I molecules##6##4##(2008-11#1)(2008-4#1)(2008-8#4)
MHC class I proteins##2##4##(2008-1#2)
MHC class I##28##3##(1994-5#1)(1995-12#2)(1995-5#3)(1997-9#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#7)(2008-9#2)
MHC class II antigens##2##4##(1991-8#1)(1997-8#1)
MHC class II molecules##2##4##(1995-12#1)(2008-8#1)
MHC class II##7##3##(1991-8#1)(1995-12#1)(1995-5#1)(1997-8#1)(2008-8#1)(2008-9#1)(2012-12#1)
MHC class##41##2##(1991-8#1)(1994-5#1)(1995-12#4)(1995-5#4)(1996-10#1)(1997-8#1)(1997-9#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-4#5)(2008-8#8)(2008-9#3)(2012-12#1)(2013-8#2)
MHC gene##2##2##(1994-5#1)(2008-9#1)
MHC molecules##8##2##(1990-5#1)(1993-3#1)(1995-5#4)(2008-9#2)
MHC##70##1##(1990-5#2)(1991-8#1)(1993-3#6)(1994-5#4)(1995-12#5)(1995-5#8)(1996-10#1)(1996-12#3)(1997-8#1)(1997-9#3)(2008-1#7)(2008-10#1)(2008-11#1)(2008-4#6)(2008-8#10)(2008-9#7)(2010-5#1)(2012-12#1)(2013-8#2)
MHC-nonrestricted manner##2##2##(2008-11#2)
MHL##2##1##(2008-10#2)
MHO phenotype##5##2##(2013-1#5)
MHO##6##1##(2013-1#6)
MHTT##3##1##(2013-1#3)
MHV-A59 and##2##2##(1997-3#2)
MHV-A59##5##1##(1997-3#5)
MHV-A59-infected cells and##2##3##(1997-3#2)
MHV-A59-infected##3##1##(1997-3#3)
MHV-RI spike gene##3##3##(1997-3#3)
MHV-RI##4##1##(1997-3#4)
MHz and##5##2##(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)
MHz with##2##2##(2008-3#1)(2009-5#1)
MHz##23##1##(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#8)(2008-5#1)(2008-9#2)(2009-5#3)(2012-3#1)
MHz)##2##1##(2009-5#1)(2009-9#1)
MI##20##1##(1991-1#1)(1993-12#1)(2008-10#4)(2008-5#3)(2009-5#2)(2011-2#1)(2013-8#8)
MIBK##4##1##(2008-10#4)
MIC genome##2##2##(2012-3#2)
MIC values##3##2##(2008-11#2)(2008-5#1)
MIC##12##1##(2008-11#2)(2008-5#4)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#3)
MICA/B and ULBP2 expressions and##2##5##(2013-1#2)
MICA/B and ULBP2 expressions##3##4##(2013-1#3)
MICA/B and ULBP2##4##3##(2013-1#4)
MICE##8##1##(2008-9#8)
MICs for##2##2##(2008-7#2)
MICs of##8##2##(2008-5#6)(2010-6#1)(2011-2#1)
MICs##16##1##(2008-10#1)(2008-5#9)(2008-7#3)(2010-6#1)(2011-2#1)(2012-3#1)
MIF was##2##2##(2008-10#1)(2009-6#1)
MIF##15##1##(1993-2#1)(2008-10#5)(2009-6#9)
MIG##4##1##(1992-2#3)(2008-10#1)
MIH##8##1##(2008-6#1)(2013-1#7)
MII##2##1##(1990-2#1)(2013-1#1)
MIMS##9##1##(2008-10#9)
MIN##9##1##(2008-10#9)
MINT contains##2##2##(2008-4#2)
MINT##5##1##(2008-4#5)
MIP##8##1##(2008-10#7)(2013-1#1)
MIRU##2##1##(2011-2#2)
MIVAT##2##1##(2012-12#2)
MK##4##1##(2012-3#4)
MK-801##6##1##(1991-2#4)(1992-3#1)(1994-11#1)
MKB 249##2##2##(2008-10#2)
MKB##7##1##(2008-10#7)
MKL-4##4##1##(1994-12#4)
ML and##2##2##(2008-10#1)(2008-8#1)
ML was##2##2##(2008-8#2)
ML##10##1##(2008-10#4)(2008-8#3)(2008-9#1)(2009-11#1)(2010-3#1)
ML(2)##4##1##(2008-10#4)
ML1##2##1##(1993-3#2)
MLA(2)##2##1##(2008-10#2)
MLA))##2##1##(2008-10#2)
MLC##2##1##(2010-11#2)
MLC20 phosphorylation##2##2##(1994-11#2)
MLC20##7##1##(1994-11#7)
MLD alleles##3##2##(1997-3#3)
MLD patients##3##2##(1997-3#3)
MLD##9##1##(1997-3#7)(2008-10#2)
MLHs##2##1##(2008-10#2)
MLL proto-oncogene##2##2##(2011-3#2)
MLL##6##1##(2011-3#6)
MLN##2##1##(2008-11#2)
MLN-derived##2##1##(2008-11#2)
MLP(-/-) mice##2##2##(2010-6#2)
MLP(-/-)##4##1##(2010-6#4)
MLPA##2##1##(2012-12#1)(2012-3#1)
MLR and ANN##2##3##(2008-10#2)
MLR##5##1##(2008-10#5)
MLT and##2##2##(2013-7#2)
MLT levels##2##2##(2013-7#2)
MLT##15##1##(1992-12#2)(2013-7#13)
MM and##2##2##(2010-12#2)
MM cells##2##2##(2010-12#2)
MM##11##1##(1990-12#1)(2008-10#3)(2010-12#6)(2011-2#1)
MMA and As(V)##2##3##(2008-10#2)
MMA and DMA##2##3##(2008-10#2)
MMA and##6##2##(2008-10#6)
MMA##16##1##(1995-11#1)(2008-10#11)(2008-12#3)(2010-8#1)
MMA-SS is##2##2##(2008-10#2)
MMA-SS##6##1##(2008-10#6)
MMAA##2##1##(2008-10#2)
MMAD##4##1##(1992-2#2)(1996-12#1)(1996-2#1)
MMC##5##1##(1992-12#1)(2006-6#1)(2008-11#3)
MMD and AMD##2##3##(2013-1#2)
MMD and##3##2##(2013-1#3)
MMD##8##1##(2008-10#5)(2013-1#3)
MMG##2##1##(2009-3#2)
MML##3##1##(2008-8#3)
MMP##3##1##(2008-5#1)(2009-3#1)(2013-8#1)
MMP-1 and MMP-9 expressions##3##4##(2012-3#3)
MMP-1 and MMP-9 mRNA and protein expressions##2##7##(2012-3#2)
MMP-1 and MMP-9 mRNA expressions were##2##6##(2012-3#2)
MMP-1 and MMP-9 mRNA##4##4##(2012-3#4)
MMP-1 and MMP-9##8##3##(2012-3#8)
MMP-1 and TIMP-1##3##3##(2008-5#3)
MMP-1 and##11##2##(2008-5#3)(2012-3#8)
MMP-1##15##1##(1993-3#1)(2008-5#5)(2012-3#9)
MMP-2 activity##4##2##(2011-2#3)(2013-8#1)
MMP-2 was##3##2##(2008-9#2)(2013-8#1)
MMP-2##13##1##(1993-3#1)(2008-11#1)(2008-9#4)(2009-3#1)(2011-2#4)(2013-8#2)
MMP-9##13##1##(1993-3#1)(2010-8#1)(2012-3#11)
MMPB##2##1##(2012-12#2)
MMSE score##2##2##(2008-7#2)
MMSE##8##1##(2008-7#8)
MMTV species##2##2##(1994-12#2)
MMTV##8##1##(1994-11#4)(1994-12#3)(2013-7#1)
MN##3##1##(2008-10#2)(2010-1#1)
MN)##2##1##(2008-10#2)
MNC##3##1##(2008-5#1)(2008-9#1)(2010-6#1)
MNCs adhered to all types of matrices with the greatest adhesion rates on fibronectin##2##14##(2008-11#2)
MNCs in##3##2##(2008-9#3)
MNCs##6##1##(2008-11#3)(2008-9#3)
MNDO##2##1##(1992-10#1)(1996-5#1)
MNDO/d##4##1##(2008-11#4)
MNG##4##1##(2012-3#4)
MNP##3##1##(2008-6#3)
MNQ##6##1##(2009-9#6)
MNS is specialized##2##3##(2008-11#2)
MNS is##3##2##(2008-11#3)
MNS##9##1##(2008-11#9)
MO calculations##2##2##(1996-5#2)
MO##15##1##(1995-12#1)(1996-5#2)(2008-10#2)(2008-3#3)(2013-8#7)
MODELS##2##1##(2011-2#1)(2012-3#1)
MODELTEST##2##1##(2008-4#2)
MOEE##2##1##(2008-10#2)
MOEE- and DXM-treated rats##2##4##(2008-10#2)
MOF##7##1##(1992-5#1)(2008-10#2)(2009-7#1)(2010-12#3)
MOG##4##1##(1996-12#4)
MOI of 0##5##3##(2008-11#4)(2008-9#1)
MOI of##7##2##(2008-11#6)(2008-9#1)
MOI##15##1##(2008-11#13)(2008-9#1)(2013-8#1)
MOLT-4 cells##2##2##(2008-11#2)
MOLT-4##5##1##(1992-6#1)(1993-6#1)(2008-11#3)
MOM22 and CPT1##2##3##(1995-9#2)
MOPS buffer##2##2##(2008-10#1)(2008-9#1)
MORs##3##1##(2009-7#3)
MOS7/Nup88##3##1##(2011-2#3)
MOSFET drain current##2##3##(2009-5#2)
MOSFET##4##1##(2009-5#4)
MOmega##3##1##(2008-10#3)
MOmega)##2##1##(2008-10#2)
MOv18##3##1##(1990-2#3)
MP and##3##2##(1997-3#1)(2008-12#1)(2008-9#1)
MP flexion##3##2##(2008-9#3)
MP joint of the little finger##2##6##(2008-9#2)
MP was##2##2##(1997-3#1)(2008-10#1)
MP were detected##2##3##(2008-10#2)
MP##30##1##(1997-3#9)(2008-10#9)(2008-12#1)(2008-9#11)
MP-PCR data##2##2##(2008-10#2)
MP-PCR##3##1##(2008-10#3)
MP-RNA complexes##3##2##(1997-3#3)
MP-TMV RNA complexes that##2##4##(1997-3#2)
MP12##2##1##(1996-6#2)
MPA##8##1##(1993-1#5)(1995-11#1)(2008-10#2)
MPC is##2##2##(2008-11#2)
MPC of##2##2##(1996-2#2)
MPC##9##1##(1994-5#1)(1996-2#2)(2008-10#2)(2008-11#3)(2011-2#1)
MPD##9##1##(2012-2#9)
MPFC##5##1##(2008-11#5)
MPM##2##1##(2008-10#2)
MPN data##2##2##(2008-10#2)
MPO##6##1##(1992-10#5)(2008-12#1)
MPP(+)##3##1##(2008-7#3)
MPP+ and rotenone##2##3##(1995-11#2)
MPP+ and##4##2##(1990-5#1)(1995-11#3)
MPP+##6##1##(1990-5#2)(1995-11#4)
MPQ##8##1##(2012-2#8)
MPR images##3##2##(2011-2#3)
MPR##5##1##(2011-2#4)(2013-1#1)
MPTP and##2##2##(1990-7#1)(2008-7#1)
MPTP##15##1##(1990-7#7)(2008-7#8)
MPTP-induced##5##1##(1990-7#1)(2008-7#2)(2013-7#2)
MPa and I=0##2##3##(2008-10#2)
MPa and##8##2##(2008-10#6)(2008-2#1)(2009-7#1)
MPa for##3##2##(2008-11#2)(2009-7#1)
MPa in##2##2##(2010-4#2)
MPa on##2##2##(2008-10#1)(2013-8#1)
MPa to##3##2##(2008-10#1)(2009-7#2)
MPa was##5##2##(2008-10#2)(2008-5#1)(2009-7#2)
MPa##46##1##(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#8)(2010-4#5)(2013-8#1)
MPa)##6##1##(2008-10#4)(2008-3#1)(2013-1#1)
MPs##2##1##(1990-3#1)(2008-10#1)
MR and CT##3##3##(2008-7#2)(2012-2#1)
MR and##4##2##(2008-11#1)(2008-7#2)(2012-2#1)
MR angiography##3##2##(1995-11#1)(1997-8#1)(2013-1#1)
MR characteristics##2##2##(2012-2#2)
MR features of##2##3##(1997-8#2)
MR findings of##2##3##(1997-8#1)(2012-2#1)
MR findings##7##2##(1996-6#1)(1997-8#2)(2011-2#2)(2012-2#2)
MR image##3##2##(1995-5#1)(2009-7#2)
MR images of##3##3##(1997-8#2)(2008-5#1)
MR images##11##2##(1997-8#6)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
MR imaging findings##2##3##(1997-8#2)
MR imaging in##3##3##(2009-11#2)(2012-2#1)
MR imaging is##2##3##(2008-9#1)(2011-2#1)
MR imaging of##5##3##(1997-8#4)(2010-9#1)
MR imaging were##2##3##(1995-11#1)(1997-8#1)
MR imaging##28##2##(1991-11#1)(1995-11#1)(1997-6#1)(1997-8#16)(2008-9#1)(2009-11#2)(2010-9#1)(2011-2#2)(2012-2#3)
MR in##4##2##(1990-11#1)(1996-6#2)(2008-1#1)
MR is##2##2##(1990-11#2)
MR mammography##6##2##(1997-8#6)
MR showed##2##2##(1996-6#1)(2012-12#1)
MR spectroscopy##2##2##(2010-12#1)(2012-2#1)
MR##113##1##(1990-11#5)(1991-11#1)(1992-3#2)(1994-2#1)(1995-11#3)(1995-5#1)(1996-6#9)(1997-6#1)(1997-8#36)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#3)(2009-12#2)(2009-7#2)(2010-12#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#5)(2012-12#2)(2012-2#17)(2012-3#2)(2013-1#2)
MR-compatible bioartificial liver##2##3##(2012-2#2)
MR-compatible##4##1##(2012-2#4)
MR64##2##1##(2008-8#2)
MRA##5##1##(2008-10#5)
MRAP##2##1##(2011-1#2)
MRC##4##1##(1990-11#1)(1990-2#1)(1991-11#1)(2008-10#1)
MRCMLM##2##1##(2012-2#2)
MRI and CT##2##3##(1996-6#1)(2012-2#1)
MRI and##7##2##(1996-6#2)(1997-8#1)(2010-9#1)(2012-12#1)(2012-2#2)
MRI can##3##2##(1992-3#1)(2010-12#1)(2010-9#1)
MRI contrast##2##2##(2010-12#1)(2012-12#1)
MRI data##2##2##(2009-11#1)(2010-9#1)
MRI features##2##2##(2009-9#1)(2012-12#1)
MRI findings##6##2##(1996-11#1)(2010-9#1)(2011-2#2)(2012-12#2)
MRI has##3##2##(2010-5#1)(2012-2#2)
MRI have##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
MRI in the##4##3##(1996-11#1)(2008-1#1)(2010-12#1)(2011-2#1)
MRI in##10##2##(1996-11#1)(2008-1#1)(2009-9#1)(2010-12#3)(2010-9#1)(2011-2#1)(2012-2#2)
MRI is a##2##3##(1997-8#1)(2010-12#1)
MRI is##6##2##(1996-11#1)(1997-8#1)(2008-1#1)(2010-12#3)
MRI may be##3##3##(2009-11#1)(2012-12#1)(2012-2#1)
MRI methods for the##2##4##(2012-2#2)
MRI of the##2##3##(2009-3#1)(2010-12#1)
MRI of##7##2##(1991-11#1)(1992-3#1)(1997-8#1)(2008-1#1)(2009-3#1)(2010-12#1)(2010-9#1)
MRI or##3##2##(2008-10#1)(2010-12#1)(2010-7#1)
MRI parameters##2##2##(2008-6#1)(2012-2#1)
MRI performed##2##2##(2008-3#1)(2012-2#1)
MRI revealed##3##2##(1996-11#1)(2010-7#1)(2012-3#1)
MRI safety of##2##3##(2008-9#2)
MRI scan##3##2##(1992-3#2)(2010-6#1)
MRI scanning##2##2##(2008-7#1)(2010-3#1)
MRI scans##6##2##(1992-3#2)(1996-11#1)(2008-7#2)(2009-11#1)
MRI seems to be an##2##5##(1992-3#1)(2012-2#1)
MRI showed##5##2##(1991-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
MRI study##2##2##(2008-3#2)
MRI techniques##2##2##(2010-12#1)(2010-9#1)
MRI to##2##2##(2010-9#1)(2012-2#1)
MRI was##5##2##(1991-11#1)(2008-3#3)(2011-2#1)
MRI##189##1##(1991-11#4)(1992-3#16)(1992-6#2)(1995-11#1)(1995-5#1)(1996-11#5)(1996-6#2)(1997-8#5)(2008-1#6)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#6)(2009-12#1)(2009-3#1)(2009-9#5)(2010-12#16)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#11)(2011-2#7)(2012-12#18)(2012-2#25)(2012-3#3)(2013-1#8)(2013-8#4)
MRI-guided method##2##2##(2010-7#2)
MRL##5##1##(1993-3#2)(1997-8#2)(2008-10#1)
MRL(+/+) and##2##2##(2008-10#2)
MRL(+/+) mice exposed to##2##4##(2008-10#2)
MRL(+/+) mice##21##2##(2008-10#21)
MRL(+/+)##24##1##(2008-10#24)
MRL-lpr mice##4##2##(1993-3#4)
MRL-lpr##5##1##(1993-3#5)
MRL/gld mice##2##2##(1997-8#2)
MRL/gld##3##1##(1997-8#3)
MRL/lpr and##2##2##(1997-8#2)
MRL/lpr##3##1##(1992-9#1)(1997-8#2)
MRP NBDs##2##2##(2008-11#2)
MRP or##2##2##(2008-11#2)
MRP##13##1##(2008-11#13)
MRP/GS-X pump##3##2##(2008-11#3)
MRP1##2##1##(2008-11#2)
MRPs##5##1##(2013-8#5)
MRSA nasal##2##2##(2011-2#2)
MRSA osteomyelitis##3##2##(2012-2#3)
MRSA strains##2##2##(2011-2#2)
MRSA##10##1##(2008-10#2)(2011-2#5)(2012-2#3)
MS and##8##2##(2008-10#5)(2008-8#1)(2010-12#1)(2011-2#1)
MS basal media##2##3##(2008-12#1)(2013-1#1)
MS data##2##2##(2008-10#2)
MS detection##3##2##(2008-10#3)
MS e_nose##2##2##(2008-10#2)
MS in the##2##3##(2008-5#1)(2011-2#1)
MS is##2##2##(1995-12#1)(2012-3#1)
MS medium containing##5##3##(2008-10#2)(2013-1#3)
MS medium supplemented with##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
MS medium with##2##3##(2008-12#1)(2009-6#1)
MS medium##13##2##(2008-10#4)(2008-12#4)(2008-8#1)(2009-6#1)(2013-1#3)
MS neurons##2##2##(1996-12#2)
MS of##2##2##(2010-7#2)
MS patients##9##2##(1995-12#4)(2008-11#1)(2010-12#3)(2010-2#1)
MS was##2##2##(2008-10#2)
MS were##2##2##(2008-10#1)(2010-11#1)
MS##109##1##(1995-12#9)(1996-12#4)(2008-10#33)(2008-11#2)(2008-12#6)(2008-3#1)(2008-5#2)(2008-8#3)(2009-6#2)(2010-11#3)(2010-12#14)(2010-2#1)(2010-6#1)(2010-7#2)(2011-2#6)(2011-3#2)(2011-7#2)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#4)(2013-8#1)
MS(2) was employed for quantitative##2##5##(2008-10#2)
MS(n)##3##1##(2008-10#1)(2011-2#2)
MS)##4##1##(2008-10#3)(2008-11#1)
MS-50##2##1##(2008-10#2)
MS/MS spectra##3##2##(2008-4#3)
MS/MS spectrum of##2##3##(2008-8#2)
MS/MS spectrum##3##2##(2008-4#1)(2008-8#2)
MS/MS##11##1##(2008-10#4)(2008-4#4)(2008-8#2)(2011-1#1)
MSA##4##1##(2008-11#2)(2012-3#2)
MSC##3##1##(2008-9#1)(2009-10#1)(2012-12#1)
MSCs for##3##2##(2008-11#1)(2009-10#2)
MSCs##7##1##(2008-11#2)(2008-9#1)(2009-10#3)(2010-8#1)
MSFA method was##2##3##(2008-10#2)
MSFA##4##1##(2008-10#4)
MSH/KM9/2009 strain isolated##2##3##(2013-8#2)
MSH/KM9/2009 strain##4##2##(2013-8#4)
MSH/KM9/2009##6##1##(2013-8#6)
MSH2##2##1##(2011-2#2)
MSH27##3##1##(2008-8#3)
MSH27Ep##3##1##(2008-8#3)
MSKCC##3##1##(2011-2#3)
MSM##6##1##(2008-3#1)(2009-5#4)(2011-2#1)
MSNs##3##1##(2013-8#3)
MSOPD##3##1##(2008-10#3)
MSP##6##1##(2008-10#2)(2008-8#4)
MSP8##2##1##(1997-7#2)
MSPD##3##1##(2008-10#3)
MSTN##2##1##(2012-12#2)
MSUD##3##1##(2012-3#3)
MSV isolates##2##2##(2008-10#2)
MSV resistance##4##2##(2008-10#4)
MSV was detected in the##2##5##(2008-10#2)
MSV##11##1##(2008-10#11)
MSV-Tas and MSV-VW##3##3##(2008-10#3)
MSWV##3##1##(2008-10#3)
MSc##3##1##(2008-11#3)
MT and bZIP##2##3##(2008-10#2)
MT and##6##2##(1993-12#1)(1994-11#1)(2008-10#4)
MT contents##2##2##(2008-10#1)(2008-11#1)
MT forms##2##2##(2008-10#2)
MT in human##2##3##(2008-10#1)(2008-11#1)
MT in the##3##3##(1993-12#1)(2008-10#2)
MT in##11##2##(1993-12#1)(2008-10#6)(2008-11#4)
MT isoform##2##2##(2008-10#2)
MT isoforms can be##2##4##(2008-10#2)
MT isoforms##9##2##(2008-10#8)(2011-2#1)
MT may##2##2##(1993-12#1)(2008-10#1)
MT samples##2##2##(2008-10#2)
MT solubility##2##2##(2008-11#2)
MT was##4##2##(2008-10#1)(2008-11#3)
MT##91##1##(1993-12#7)(1994-11#4)(1997-4#1)(2008-10#51)(2008-11#21)(2009-10#2)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#2)
MT-1 isoform##3##2##(2008-10#3)
MT-1##6##1##(2008-10#6)
MT-2 cells##2##2##(2011-3#2)
MT-2 isoform was separated##2##4##(2008-10#2)
MT-2 isoform was##3##3##(2008-10#3)
MT-2##9##1##(2008-10#7)(2011-3#2)
MT-4##2##1##(2011-3#2)
MT-I##3##1##(2008-10#3)
MT-level##2##1##(2008-10#2)
MT1 receptor##5##2##(2013-7#5)
MT1##8##1##(2008-10#1)(2013-7#7)
MT2-MMP##2##1##(1997-2#2)
MT20##3##1##(2008-10#3)
MT539MG##2##1##(1995-2#2)
MTA##4##1##(2013-1#4)
MTAD##3##1##(2013-1#3)
MTB##2##1##(2008-10#2)
MTBE concentrations##3##2##(2008-12#3)
MTBE treatments##2##2##(2008-12#2)
MTBE##10##1##(2008-12#8)(2009-8#2)
MTBI##5##1##(1997-2#5)
MTEC1 cells were##2##3##(2008-8#2)
MTEC1 cells##4##2##(2008-8#4)
MTEC1##5##1##(2008-8#5)
MTHFR##4##1##(2008-8#4)
MTR##4##1##(1996-1#4)
MTS##3##1##(1994-12#1)(2007-9#1)(2010-2#1)
MTSC4 were##2##2##(2008-8#2)
MTSC4##7##1##(2008-8#7)
MTT and##3##2##(1994-5#1)(2008-8#1)(2008-9#1)
MTT assay##6##2##(2008-11#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#1)
MTT method and##2##3##(1995-8#1)(2008-9#1)
MTT method##3##2##(1995-8#1)(2008-9#1)(2011-3#1)
MTT reduction by flavonoids in the absence of cells##2##9##(2008-11#2)
MTT reduction##8##2##(2008-11#6)(2009-9#2)
MTT test##2##2##(2008-8#2)
MTT##29##1##(1994-5#1)(1995-8#1)(2008-11#10)(2008-8#4)(2008-9#2)(2009-9#2)(2011-1#1)(2011-2#1)(2011-3#4)(2012-3#2)(2013-1#1)
MTU##3##1##(2008-10#3)
MTX##14##1##(1992-8#6)(1994-2#1)(2008-10#4)(2008-11#3)
MTases##2##1##(1991-9#1)(1993-9#1)
MTs I+II##2##2##(2013-7#2)
MTs are also##2##3##(2011-2#1)(2013-7#1)
MTs are##4##2##(2008-10#1)(2011-2#2)(2013-7#1)
MTs##23##1##(2008-10#5)(2008-11#3)(2009-10#5)(2009-8#1)(2011-2#3)(2013-7#6)
MU##3##1##(2008-10#2)(2009-8#1)
MUC1##3##1##(1993-2#3)
MUFA diets##2##2##(2008-10#2)
MUFA##3##1##(2008-10#3)
MUIS-C##2##1##(2010-10#2)
MUMmer##3##1##(2008-4#3)
MV##6##1##(1991-2#1)(2009-11#2)(2009-8#1)(2013-8#2)
MVC##2##1##(2013-8#2)
MVD##7##1##(2010-12#3)(2011-2#4)
MVK##3##1##(1995-11#1)(1996-5#2)
MVP1-4 was##2##2##(2008-10#2)
MVP1-4##7##1##(2008-10#7)
MVPAs##3##1##(2008-10#3)
MVT##6##1##(2011-2#6)
MW of##3##2##(2008-10#2)(2008-9#1)
MW##18##1##(1990-5#2)(1992-2#1)(2008-10#8)(2008-5#1)(2008-9#1)(2013-8#5)
MWNT-film coated GCE##2##3##(2008-10#2)
MWNT-film##3##1##(2008-10#3)
MWNTs were##2##2##(2008-10#2)
MWNTs##8##1##(2008-10#5)(2009-3#3)
MWNTs/chitosan##2##1##(2008-10#2)
MWP symptoms##2##2##(2008-10#2)
MWP##6##1##(2008-10#6)
MWU##3##1##(2008-11#3)
MX and MXS##2##3##(2008-10#2)
MX and##3##2##(2008-10#3)
MX##11##1##(2008-10#10)(2011-2#1)
MX169##4##1##(2008-10#4)
MXS##4##1##(2008-10#4)
MXT mammary cancer##3##3##(1993-1#3)
MXT mammary tumor##2##3##(1993-1#2)
MXT mammary##5##2##(1993-1#5)
MXT##7##1##(1993-1#7)
MY##4##1##(2008-10#4)
MY(2-)##2##1##(2008-10#2)
MY(2-))##3##1##(2008-10#3)
MYCN is##2##2##(2011-2#2)
MYCN##10##1##(2011-2#10)
MZ##3##1##(2008-10#1)(2009-7#2)
MZEF##4##1##(2008-9#4)
Ma##3##1##(2010-6#1)(2011-2#1)(2013-1#1)
MaMPRV##8##1##(2008-10#8)
MaYMFV and MaMPRV##4##3##(2008-10#4)
MaYMFV are##2##2##(2008-10#2)
MaYMFV##9##1##(2008-10#9)
Maackia amurensis##2##2##(1994-11#1)(2008-7#1)
Mab detected a lipopolysaccharide##2##4##(2008-5#2)
Mab detected##3##2##(2008-5#3)
Mab yield##2##2##(2008-11#2)
Mab##8##1##(2008-10#1)(2008-11#2)(2008-5#3)(2012-3#2)
Mabs##5##1##(2008-5#5)
Mac-1##4##1##(1994-5#1)(1997-3#3)
Mac387##2##1##(1991-2#2)
Macaca##2##1##(1994-2#2)
Mach-Zehnder interferometer##3##2##(2007-11#2)(2010-4#1)
Mach-Zehnder##4##1##(2007-11#2)(2008-2#1)(2010-4#1)
Machiavellian##3##1##(2008-11#3)
Machine Learning##2##2##(2010-12#1)(2010-7#1)
Machine##4##1##(2008-11#1)(2010-12#1)(2010-7#1)(2010-8#1)
Machines##3##1##(1997-6#1)(2010-8#1)(2013-8#1)
Macintosh##2##1##(2008-9#2)
Macro##3##1##(2008-10#1)(2008-11#1)(2009-5#1)
Macrocyclic##2##1##(2008-10#2)
Macrofungi##2##1##(2008-12#2)
Macrophage Migration Inhibitory Factor##2##4##(2009-6#2)
Macrophage##4##1##(1991-5#1)(2009-6#2)(2010-12#1)
Macrophages##4##1##(1991-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
Macrophomina phaseolina##2##2##(2008-10#2)
Macroptilium lathyroides##2##2##(2008-10#2)
Macroptilium##4##1##(2008-10#4)
Macroscopic##2##1##(2012-2#1)(2013-1#1)
Macrosiphum##2##1##(2008-10#2)
Macrosteles##2##1##(2008-10#2)
Macular thickness##2##2##(2013-1#2)
Macular##7##1##(2011-2#4)(2013-1#3)
Made##2##1##(2009-9#1)(2012-3#1)
Madeira wines according to main grape varieties##2##7##(2008-10#2)
Madeira##3##1##(2008-10#3)
Madelung deformity##2##2##(2013-1#2)
Madin-Darby canine kidney (MDCK) cells##2##5##(2008-11#1)(2011-2#1)
Madin-Darby##4##1##(2008-11#3)(2011-2#1)
Madison##2##1##(1994-3#1)(2010-11#1)
Madopar Dispersible##2##2##(2008-7#2)
Madopar##4##1##(2008-10#1)(2008-7#3)
Madras##3##1##(1992-11#1)(1996-9#1)(2011-2#1)
Madrid (Spain)##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
Madrid honeys##3##2##(2011-2#3)
Madrid##13##1##(2008-10#4)(2008-11#5)(2011-2#4)
Mage##2##1##(2008-9#2)
Maggiore##3##1##(1993-3#1)(2008-10#2)
Magic 1##3##2##(1997-3#3)
Magic##4##1##(1997-3#4)
Magnaporthe grisea and##3##3##(2008-10#3)
Magnaporthe grisea in##2##3##(2008-10#2)
Magnaporthe grisea on##2##3##(2008-10#2)
Magnaporthe grisea##34##2##(1997-4#1)(2008-10#30)(2009-10#1)(2010-7#2)
Magnaporthe oryzae in##2##3##(2012-2#1)(2013-8#1)
Magnaporthe oryzae##9##2##(2008-10#5)(2009-6#1)(2012-2#2)(2013-8#1)
Magnaporthe##44##1##(1997-4#1)(2008-10#36)(2009-10#1)(2009-6#1)(2010-7#2)(2012-2#2)(2013-8#1)
Magnesium deficiency##3##2##(2008-6#3)
Magnesium is##2##2##(2008-6#1)(2011-2#1)
Magnesium##14##1##(1991-5#1)(1993-6#1)(2008-10#4)(2008-6#6)(2008-8#1)(2011-2#1)
Magnetic Resonance Imaging##6##3##(1992-3#1)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Magnetic Resonance##10##2##(1991-2#1)(1992-3#1)(2008-2#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
Magnetic beads##2##2##(2008-10#2)
Magnetic resonance images##2##3##(2008-7#1)(2012-3#1)
Magnetic resonance imaging (MRI) is##4##5##(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
Magnetic resonance imaging (MRI) showed##2##5##(2008-7#1)(2013-8#1)
Magnetic resonance imaging (MRI)##11##4##(1996-9#1)(2008-10#1)(2008-6#1)(2008-7#4)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
Magnetic resonance imaging and##4##4##(1992-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
Magnetic resonance imaging is the##2##5##(2010-6#1)(2012-12#1)
Magnetic resonance imaging of the##4##5##(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#1)
Magnetic resonance imaging of##9##4##(1997-8#1)(2009-3#1)(2010-12#4)(2010-9#1)(2011-2#1)(2012-2#1)
Magnetic resonance imaging revealed##2##4##(2008-12#1)(2013-8#1)
Magnetic resonance imaging showed##3##4##(2008-7#1)(2011-2#1)(2013-7#1)
Magnetic resonance imaging##43##3##(1990-11#1)(1992-3#1)(1996-9#1)(1997-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#7)(2008-9#1)(2009-3#1)(2010-12#8)(2010-6#1)(2010-7#2)(2010-9#2)(2011-2#4)(2012-12#3)(2012-2#3)(2013-7#1)(2013-8#2)
Magnetic resonance##50##2##(1990-11#1)(1992-3#1)(1996-9#1)(1997-8#2)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#8)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#10)(2010-6#1)(2010-7#2)(2010-9#2)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
Magnetic stimulation##3##2##(1992-3#1)(2008-7#2)
Magnetic##75##1##(1990-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-8#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-8#2)(2008-10#3)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#10)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-12#10)(2010-6#1)(2010-7#2)(2010-9#2)(2011-2#8)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
Mahasarakham##2##1##(2008-12#2)
Mahlavu cells##4##2##(1997-1#4)
Mahlavu##5##1##(1997-1#5)
Main outcome measures included##3##4##(2008-3#1)(2011-2#2)
Main outcome measures were##2##4##(2011-2#2)
Main outcome measures##6##3##(2008-3#1)(2011-2#5)
Main outcome##7##2##(2008-3#1)(2010-12#1)(2011-2#5)
Main##17##1##(1990-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#7)(2013-1#1)(2013-8#1)
Maine##11##1##(1991-1#1)(1992-2#1)(1992-3#1)(1994-2#2)(1996-3#1)(1997-2#3)(2008-10#2)
Mainly##5##1##(1990-6#1)(2007-8#1)(2008-10#2)(2013-1#1)
Maintaining##10##1##(1993-3#1)(1997-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
Maintenance of##7##2##(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
Maintenance##12##1##(1993-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-3#2)
Mainz##2##1##(1996-3#1)(1997-6#1)
Maisonneuve fracture##4##2##(2009-1#4)
Maize (Zea mays L##2##4##(2012-3#2)
Maize Inbred##2##2##(2008-10#2)
Maize Kernels##3##2##(2008-10#3)
Maize Leaves##2##2##(2008-10#2)
Maize fine streak virus##2##4##(2008-10#2)
Maize streak virus##3##3##(2008-10#3)
Maize yield in##2##3##(2008-12#2)
Maize##32##1##(2008-10#26)(2008-12#2)(2008-8#1)(2012-3#3)
Major Depressive Disorder (MDD)##2##4##(2008-10#1)(2012-3#1)
Major Depressive##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
Major Gene##3##2##(2008-10#3)
Major Genetic##2##2##(2008-10#2)
Major changes##2##2##(1991-3#1)(2009-7#1)
Major complications##2##2##(2008-11#1)(2008-9#1)
Major differences##2##2##(2008-10#1)(2011-2#1)
Major factors##2##2##(1996-1#1)(2008-10#1)
Major findings##2##2##(1991-12#1)(1993-1#1)
Major issues##2##2##(1997-3#1)(2009-4#1)
Major##51##1##(1990-9#1)(1991-12#1)(1991-3#1)(1993-1#1)(1994-12#2)(1994-2#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#14)(2008-11#4)(2008-6#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)
Majority of##3##2##(2009-10#1)(2012-3#1)(2013-1#1)
Majority##6##1##(2009-10#1)(2010-9#2)(2012-3#1)(2013-1#1)(2013-7#1)
Make##5##1##(1993-3#1)(1995-2#1)(1997-1#1)(2008-11#1)(2010-12#1)
Making a Difference (Department of Health##2##6##(2008-11#2)
Making a Difference##7##3##(2008-11#7)
Making a difference##4##3##(1997-1#1)(2008-11#1)(2008-12#1)(2009-12#1)
Making a##12##2##(1992-5#1)(1997-1#1)(2008-11#8)(2008-12#1)(2009-12#1)
Making the##4##2##(1994-1#1)(2012-3#1)(2013-8#2)
Making##30##1##(1991-12#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-1#2)(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#12)(2008-12#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-3#1)(2013-8#2)
Mal 90##2##2##(2008-11#2)
Malachite Green (MG)##2##3##(2008-10#2)
Malachite Green##3##2##(2008-10#3)
Malachite##4##1##(2008-10#4)
Malacostraca##3##1##(2007-12#3)
Malaria and Crimean-Congo##2##3##(2012-2#2)
Malaria is##2##2##(2012-12#1)(2012-3#1)
Malaria##12##1##(1997-6#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#3)
Malarial##2##1##(2012-3#2)
Malassezia furfur##5##2##(2008-5#4)(2010-6#1)
Malassezia spp##7##2##(2008-5#7)
Malassezia sympodialis##2##2##(2008-5#2)
Malassezia##21##1##(2008-5#20)(2010-6#1)
Malathion##5##1##(2008-10#2)(2008-11#3)
Malawi and##2##2##(2008-10#2)
Malawi##8##1##(1997-6#1)(2008-10#5)(2010-12#2)
Malaysia and##2##2##(2008-10#1)(2008-12#1)
Malaysia as##2##2##(2008-12#2)
Malaysia##24##1##(2008-10#12)(2008-12#10)(2008-8#1)(2013-1#1)
Malaysian##4##1##(2008-10#1)(2008-12#2)(2008-8#1)
Malcolm Baldrige National Quality Award##3##5##(1994-3#1)(1995-2#2)
Malcolm##4##1##(1994-2#1)(1994-3#1)(1995-2#2)
Male Sprague-Dawley rats were##2##4##(1997-2#1)(2013-1#1)
Male and female Tg##2##4##(2008-9#2)
Male and female##6##3##(2008-10#1)(2008-5#1)(2008-9#4)
Male##33##1##(1990-12#1)(1990-8#1)(1994-5#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#4)
Males had##2##2##(2008-9#1)(2011-2#1)
Males of##2##2##(2008-12#1)(2011-2#1)
Males were##2##2##(1995-2#1)(2008-12#1)
Males##17##1##(1990-8#1)(1995-2#1)(1995-6#1)(2008-12#3)(2008-8#4)(2008-9#2)(2009-10#1)(2010-8#1)(2011-2#2)(2013-8#1)
Malformation##5##1##(1996-3#1)(2008-10#1)(2008-7#1)(2012-3#2)
Malformations##5##1##(1995-11#1)(1996-3#1)(1997-6#1)(2012-3#2)
Mali##3##1##(2008-10#2)(2010-1#1)
Malic acid##2##2##(2008-10#2)
Malignancy##3##1##(1997-4#1)(2008-10#1)(2013-7#1)
Malignant granular cell##2##3##(2011-2#2)
Malignant melanoma##4##2##(1990-12#2)(2007-8#1)(2011-2#1)
Malignant mesothelioma is##2##3##(2010-12#1)(2010-5#1)
Malignant mesothelioma##3##2##(2010-1#1)(2010-12#1)(2010-5#1)
Malignant myoepithelioma##2##2##(2013-1#2)
Malignant pleural##2##2##(1991-6#1)(2010-5#1)
Malignant syndrome is a##2##4##(2009-11#2)
Malignant syndrome##3##2##(2009-11#3)
Malignant transformation of##2##3##(2008-7#1)(2009-1#1)
Malignant transformation##4##2##(2007-8#1)(2008-7#1)(2009-1#1)(2013-8#1)
Malignant##35##1##(1990-12#2)(1991-6#1)(1993-11#1)(1994-12#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-1#1)(2009-11#3)(2010-1#2)(2010-12#2)(2010-5#2)(2011-2#4)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
Mallet##4##1##(2008-10#2)(2013-1#2)
Mallophaga##2##1##(2011-2#2)
Malnutrition##2##1##(2012-12#2)
Malpighian tubules of##2##3##(2007-12#2)
Malpighian tubules##8##2##(2007-12#3)(2008-10#1)(2008-7#4)
Malpighian##9##1##(2007-12#3)(2008-10#1)(2008-7#5)
Malpractice##3##1##(1996-3#1)(1997-2#1)(2012-3#1)
Malus hupehensis##2##2##(2011-10#2)
Malus spp##2##2##(2008-10#2)
Malus##9##1##(2008-10#6)(2011-1#1)(2011-10#2)
Malva##3##1##(2008-10#3)
Malvaceae##4##1##(2008-10#4)
Malvazia##2##1##(2008-10#2)
Malvern##2##1##(1993-2#1)(1995-3#1)
Mammalian cell##3##2##(2008-11#3)
Mammalian cells##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
Mammalian##18##1##(1990-7#1)(1994-9#1)(1995-6#1)(1996-2#1)(2008-11#8)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2012-2#1)(2013-1#1)
Mammary Tumor##3##2##(1994-12#1)(2008-11#1)(2013-7#1)
Mammary##7##1##(1990-11#1)(1994-11#1)(1994-12#2)(2008-11#1)(2009-1#1)(2013-7#1)
Mammography##3##1##(1990-2#1)(2008-10#1)(2011-2#1)
Man##13##1##(1992-1#1)(1993-11#1)(1997-7#2)(2008-4#4)(2008-9#3)(2012-3#1)(2013-1#1)
Managed Care##3##2##(1991-3#3)
Managed care has##2##3##(1997-2#1)(2008-11#1)
Managed care in the crystal ball##4##6##(1997-7#4)
Managed care##26##2##(1993-2#1)(1993-3#7)(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#1)(1997-7#4)(2008-11#2)(2008-12#2)
Managed##32##1##(1991-3#4)(1993-2#1)(1993-3#7)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#1)(1997-7#4)(2008-11#2)(2008-12#2)(2008-6#1)
Management Agency##2##2##(2008-10#1)(2011-1#1)
Management System##2##2##(1994-1#1)(2009-10#1)
Management and##5##2##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#2)
Management at##4##2##(1991-2#1)(1996-1#1)(1997-2#1)(1997-3#1)
Management in##2##2##(1994-2#1)(2008-11#1)
Management of Acute##2##3##(2008-12#1)(2008-3#1)
Management of patients##2##3##(1990-3#1)(2013-1#1)
Management of the##6##3##(1990-6#1)(2008-1#1)(2009-1#1)(2009-12#1)(2010-12#1)(2012-3#1)
Management of##52##2##(1990-3#1)(1990-6#1)(1991-3#1)(1992-3#1)(1994-12#2)(1995-1#1)(1997-2#1)(2007-11#2)(2008-1#3)(2008-10#5)(2008-12#3)(2008-3#3)(2008-7#2)(2009-1#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
Management##115##1##(1990-3#1)(1990-6#1)(1991-2#5)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#3)(1994-1#1)(1994-12#3)(1994-2#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#2)(2008-1#3)(2008-10#11)(2008-11#6)(2008-12#4)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#2)
Manager##2##1##(2008-10#1)(2012-3#1)
Managerial##2##1##(1997-1#1)(2012-3#1)
Managers##5##1##(1992-3#1)(1993-1#1)(1994-2#1)(2008-8#1)(2010-10#1)
Managing diversity##2##2##(1991-9#1)(1994-12#1)
Managing the##4##2##(1993-1#1)(1993-2#1)(1995-2#1)(1995-6#1)
Managing##27##1##(1991-9#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-2#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)
Manchester##5##1##(1992-11#1)(2008-11#2)(2008-9#1)(2013-1#1)
Mancozeb and##3##2##(2008-10#3)
Mancozeb##10##1##(2008-10#10)
Mandarin monosyllabic lexical##2##3##(2008-9#2)
Mandarin##4##1##(2008-9#4)
Mandibular##6##1##(2012-12#2)(2012-3#4)
Manduca sexta##9##2##(1995-11#2)(1995-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-8#2)
Manduca##11##1##(1995-11#2)(1995-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-8#4)
Manfred##2##1##(1997-6#2)
Manganese##5##1##(1995-6#1)(2008-10#4)
Manganese(II)##3##1##(2008-10#3)
Mango malformation disease##2##3##(2008-10#2)
Mango##5##1##(2008-10#5)
Manhattan##3##1##(1992-1#1)(1996-5#1)(2008-12#1)
Manipulating##2##1##(2008-6#1)(2012-2#1)
Manipulation of cells##2##3##(2008-11#2)
Manipulation of the##3##3##(1996-2#1)(2008-10#1)(2013-8#1)
Manipulation of##13##2##(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-10#1)(2013-8#1)
Manipulative therapy##2##2##(2008-12#2)
Manitoba##4##1##(1993-2#1)(1994-2#1)(2008-10#2)
Manizales##3##1##(2012-12#3)
Mann hopes##2##2##(1990-11#2)
Mann##9##1##(1990-11#6)(1990-3#1)(1997-8#1)(2011-2#1)
Mann-Whitney U-test)##2##2##(1995-8#2)
Mann-Whitney##5##1##(1995-8#2)(2013-1#3)
Mannich reaction##2##2##(2008-10#2)
Mannich##3##1##(2008-10#2)(2011-3#1)
Mannitol##2##1##(2008-10#1)(2008-8#1)
Mannosylerythritol lipid##2##2##(2008-11#2)
Mantel##4##1##(2008-10#3)(2010-6#1)
Mantle cell##2##2##(2009-1#1)(2009-8#1)
Mantoux test##2##2##(1993-3#1)(2012-3#1)
Mantoux##5##1##(1990-6#3)(1993-3#1)(2012-3#1)
Manual of##8##2##(1996-2#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#3)(2013-1#1)
Manual##13##1##(1994-2#1)(1996-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-6#1)(2011-2#3)(2013-1#1)
Manufacturers##2##1##(1996-1#1)(2008-11#1)
Manufacturing##6##1##(1995-5#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Many attempts##2##2##(2008-10#1)(2008-11#1)
Many bacteria##2##2##(2008-10#1)(2008-9#1)
Many children##2##2##(1996-12#1)(2012-2#1)
Many coexisting metal ions##2##4##(2008-10#2)
Many different##6##2##(2008-4#1)(2008-9#2)(2010-11#1)(2010-12#1)(2011-2#1)
Many differential diagnoses##2##3##(2011-2#2)
Many factors are##3##3##(2009-1#1)(2011-2#1)(2013-1#1)
Many factors##5##2##(2007-12#1)(2008-10#1)(2009-1#1)(2011-2#1)(2013-1#1)
Many family##2##2##(2008-11#1)(2010-4#1)
Many groups simply run out of storage space and are in need of an efficient and cost-effective way to manage this problem##2##22##(1994-3#2)
Many health##2##2##(1996-1#1)(2013-1#1)
Many hospitals##3##2##(1991-1#1)(2008-11#2)
Many important##2##2##(1993-12#1)(2012-2#1)
Many medical groups have a problem storaging and managing inactive medical records##2##12##(1994-3#2)
Many medical groups##3##3##(1993-1#1)(1994-3#2)
Many of the##16##3##(1994-1#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
Many of these are##2##4##(2008-10#1)(2009-10#1)
Many of these injuries can be avoided in an ergonomically designed office##2##12##(1994-3#2)
Many of these##18##3##(1994-2#1)(1994-3#2)(1996-1#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-8#3)(2009-10#1)(2012-2#1)(2013-8#2)
Many of those##2##3##(1997-8#1)(2013-8#1)
Many of##39##2##(1992-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1996-1#1)(1996-12#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
Many organizations are##3##3##(1993-3#1)(1995-1#1)(1997-1#1)
Many other##5##2##(2008-8#1)(2009-10#1)(2013-1#2)(2013-8#1)
Many patients who##2##3##(2008-11#1)(2009-11#1)
Many patients with##2##3##(1997-3#1)(2008-8#1)
Many patients##12##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-3#1)(1992-5#1)(1994-12#1)(1997-3#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)
Many people##4##2##(1992-3#1)(1995-1#1)(1996-5#1)(2008-9#1)
Many physicians hire financial directors and accountants to manage their bottom line##2##12##(1994-1#2)
Many physicians##3##2##(1990-2#1)(1994-1#2)
Many plant##2##2##(2008-10#1)(2008-7#1)
Many plants##2##2##(2008-9#1)(2009-8#1)
Many research##2##2##(2006-6#1)(2008-11#1)
Many respondents##2##2##(2007-12#1)(2012-2#1)
Many studies##3##2##(1996-9#1)(2010-7#1)(2013-8#1)
Many therapeutic##2##2##(2010-12#1)(2011-2#1)
Many types of##3##3##(1993-12#1)(2006-6#1)(2008-11#1)
Many variables##2##2##(1996-1#1)(2008-9#1)
Many##244##1##(1990-11#1)(1990-2#3)(1990-3#2)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#3)(2006-6#2)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#18)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#12)(2008-9#19)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#2)(2011-10#1)(2011-2#14)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#11)(2013-8#6)
Mao-to##7##1##(2010-7#7)
Maoa##2##1##(2009-8#2)
Maori health##3##2##(2008-1#3)
Maori men's perceptions and experiences of health seeking for prostate health problems##2##12##(2008-1#2)
Maori##21##1##(2008-1#21)
Map##7##1##(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Mapping and##4##2##(2008-10#3)(2012-3#1)
Mapping of a##4##3##(2008-10#3)(2008-8#1)
Mapping of the##3##3##(2008-10#3)
Mapping of##16##2##(1994-11#1)(2008-10#12)(2008-7#1)(2008-8#1)(2012-3#1)
Mapping the##7##2##(1991-1#1)(1994-9#1)(2008-10#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
Mapping##39##1##(1991-1#1)(1994-11#1)(1994-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
Maps of##4##2##(2008-10#3)(2008-7#1)
Maps##10##1##(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)
Maquet Servo-i ventilator##2##3##(2011-2#2)
Maquet##3##1##(2008-12#1)(2011-2#2)
March 1988##2##2##(1990-8#1)(1996-5#1)
March 1990##2##2##(1991-2#1)(1995-2#1)
March 1994##2##2##(1996-6#1)(2008-7#1)
March 1998##2##2##(2008-10#1)(2008-5#1)
March 2005##2##2##(2008-12#1)(2008-9#1)
March 2006##2##2##(2012-12#1)(2012-3#1)
March 2011##2##2##(2012-3#1)(2013-1#1)
March 31##2##2##(2008-11#1)(2010-6#1)
March 5-9##2##2##(2008-10#2)
March and April##2##3##(2008-10#2)
March to##3##2##(2008-10#1)(2012-6#2)
March##55##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#2)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#2)(2013-1#2)(2013-8#4)
Marchiafava##2##1##(2010-1#2)
Marcusenius pongolensis##2##2##(2009-8#2)
Marek's disease##6##2##(2008-5#6)
Marfan syndrome##8##2##(2008-8#2)(2009-3#1)(2012-3#1)(2013-1#4)
Marfan##11##1##(2008-8#5)(2009-3#1)(2012-3#1)(2013-1#4)
Marginal##9##1##(1992-9#1)(1997-4#1)(1997-8#1)(2008-10#2)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
Maria##3##1##(2008-10#2)(2010-1#1)
Marie E##8##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Marie##9##1##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(2013-8#1)
Marine##12##1##(2008-10#2)(2008-11#4)(2008-8#1)(2009-2#1)(2009-8#1)(2010-7#2)(2013-7#1)
Marion##2##1##(2008-10#1)(2008-5#1)
Marisa cornuarietis##4##2##(2008-11#4)
Marjolin's ulcer##2##2##(2008-9#2)
Mark##3##1##(1994-2#1)(2008-5#1)(2013-1#1)
Marked##6##1##(1990-2#1)(1994-5#1)(1997-2#1)(2008-10#2)(2008-11#1)
Marker##9##1##(1993-11#1)(1994-11#1)(1994-8#1)(2008-10#4)(2012-2#1)(2013-8#1)
Markers Linked to a##2##4##(2008-10#2)
Markers Linked to the##2##4##(2008-10#2)
Markers Linked to##6##3##(2008-10#6)
Markers and##2##2##(2008-10#2)
Markers for the##2##3##(2008-10#2)
Markers for##4##2##(2008-10#4)
Markers in##4##2##(2008-10#4)
Markers of##3##2##(1994-12#1)(2008-4#1)(2012-3#1)
Markers##32##1##(1994-12#1)(2008-10#28)(2008-11#1)(2008-4#1)(2012-3#1)
Market##4##1##(1994-2#1)(1995-12#1)(2008-11#1)(2013-1#1)
Marketing medical services to an aging America##2##7##(1994-3#2)
Marketing specialty physician services##2##4##(1994-1#2)
Marketing##15##1##(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2010-11#1)
Markov chain Monte Carlo (MCMC)##2##5##(2009-12#1)(2009-4#1)
Markov chain Monte Carlo##4##4##(1995-12#1)(2008-10#1)(2009-12#1)(2009-4#1)
Markov decision##2##2##(2009-3#1)(2009-4#1)
Markov model##10##2##(1996-12#2)(1997-2#2)(1997-6#1)(2008-4#1)(2008-6#3)(2012-12#1)
Markov models##5##2##(2008-4#2)(2009-7#2)(2012-12#1)
Markov##26##1##(1995-12#1)(1995-9#1)(1996-12#2)(1997-2#2)(1997-6#2)(2008-10#1)(2008-4#3)(2008-6#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#1)(2012-12#2)(2013-8#1)
Marriage##2##1##(1990-6#1)(2008-11#1)
Married##2##1##(1990-12#1)(1995-2#1)
Mars##6##1##(1995-3#1)(1995-6#1)(2008-10#2)(2008-4#1)(2012-3#1)
Marshall McIntosh##3##2##(2008-10#3)
Marshall##4##1##(2008-10#3)(2008-3#1)
Martin##3##1##(1995-1#1)(2012-3#2)
Martina Franca##2##2##(2010-4#2)
Marx##2##1##(1994-1#2)
Mary##3##1##(1994-1#1)(1995-6#2)
Mary's Hospital##2##2##(1993-12#1)(1995-12#1)
Mary's##3##1##(1992-1#1)(1993-12#1)(1995-12#1)
Maryhaven##4##1##(2008-6#4)
Maryland and##2##2##(2008-10#2)
Maryland##15##1##(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-3#1)
Mashona heifers##3##2##(1996-12#3)
Mashona##4##1##(1996-12#4)
Masking##2##1##(2008-5#1)(2012-2#1)
Maslow##2##1##(1995-2#1)(2013-8#1)
Mason Tenders##3##2##(1995-12#3)
Mason##4##1##(1995-12#3)(2008-11#1)
Mason-Pfizer monkey virus##2##3##(2009-7#2)
Maspin is##2##2##(1995-6#2)
Mass Index##4##2##(2008-10#1)(2012-2#2)(2012-3#1)
Mass Spectrometry##2##2##(2008-10#2)
Mass distribution##2##2##(1993-2#1)(2008-10#1)
Mass spectra##2##2##(2008-10#2)
Mass spectrometry##4##2##(2008-10#3)(2008-11#1)
Mass##39##1##(1990-12#1)(1990-8#1)(1993-2#1)(1995-3#1)(1997-6#1)(2008-10#16)(2008-11#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-7#3)(2012-2#4)(2012-3#3)(2013-1#2)
Massachusetts General Hospital##8##3##(1991-12#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-7#1)(2008-4#1)(2010-5#1)
Massachusetts experience##2##2##(1997-2#2)
Massachusetts##15##1##(1991-12#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-2#2)(1997-7#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-5#1)(2013-1#1)
Massage therapy##2##2##(2008-10#1)(2008-12#1)
Massage##4##1##(2008-10#2)(2008-12#1)(2009-9#1)
Masson's trichrome##2##2##(2008-11#1)(2011-2#1)
Masson's##3##1##(2008-11#1)(2011-2#1)(2012-3#1)
Mast cell##2##2##(1995-11#1)(2011-2#1)
Mast##5##1##(1995-11#1)(2008-10#1)(2011-2#3)
Master of##3##2##(1992-1#1)(1994-12#1)(2010-3#1)
Master patient scheduling##2##3##(1996-2#2)
Master##10##1##(1992-1#1)(1993-1#1)(1993-2#1)(1994-12#1)(1996-2#2)(2008-11#1)(2010-12#2)(2010-3#1)
Master's##3##1##(1996-1#1)(2008-11#2)
Masters##2##1##(2008-12#1)(2013-8#1)
Mastoparan##6##1##(1991-5#2)(1997-1#4)
Mastrevirus)##2##1##(2008-10#2)
Mat1a(-/-)##2##1##(2013-1#2)
Matched##2##1##(1995-1#1)(2009-11#1)
Matching##5##1##(1995-5#1)(1997-1#1)(1997-2#1)(2009-10#1)(2012-12#1)
Material and Methods##15##3##(2012-3#1)(2013-1#8)(2013-8#6)
Material and methods##13##3##(2007-11#4)(2007-8#5)(2009-8#1)(2012-12#2)(2013-1#1)
Material and##30##2##(2007-11#4)(2007-8#5)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#2)(2012-3#1)(2013-1#9)(2013-8#6)
Material andMethods##2##2##(2013-8#2)
Material##37##1##(1993-2#1)(2007-11#4)(2007-8#5)(2008-10#2)(2008-11#2)(2008-3#1)(2009-8#1)(2012-12#2)(2012-3#1)(2013-1#9)(2013-8#9)
Material/Methods##10##1##(2013-1#10)
Materials and Methods##12##3##(2010-8#1)(2012-3#1)(2013-1#10)
Materials and methods##19##3##(2009-4#1)(2009-8#1)(2012-12#9)(2013-1#8)
Materials and##32##2##(2007-12#1)(2009-4#1)(2009-8#1)(2010-8#1)(2012-12#9)(2012-3#1)(2013-1#18)
Materials were##2##2##(2008-5#1)(2013-1#1)
Materials##50##1##(1994-9#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#9)(2012-3#2)(2013-1#20)
Maternal and##3##2##(1995-12#1)(2008-1#1)(2009-1#1)
Maternal self-esteem##2##2##(1993-3#2)
Maternal##24##1##(1993-3#2)(1995-12#1)(1995-3#1)(1996-3#1)(1997-7#1)(2008-1#1)(2009-1#1)(2009-10#4)(2010-1#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
Maternity##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
Mathematical analysis##2##2##(2013-1#1)(2013-8#1)
Mathematical modeling of##2##3##(2013-8#2)
Mathematical models of##3##3##(2008-10#3)
Mathematical models##6##2##(1991-12#1)(2008-10#4)(2013-8#1)
Mathematical##17##1##(1991-12#1)(2008-10#4)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#8)
Mating Type of##2##3##(2008-10#2)
Mating Type##4##2##(2008-10#4)
Mating and##2##2##(2008-10#2)
Mating type and##2##3##(2008-10#2)
Mating type##3##2##(2008-10#3)
Mating##13##1##(2008-10#11)(2008-12#1)(2012-2#1)
Matric##3##1##(2008-10#3)
Matrigel##16##1##(2008-11#9)(2008-8#1)(2012-4#2)(2012-5#4)
Matrix effect##2##2##(2008-10#1)(2010-11#1)
Matrix effects were##2##3##(2008-10#2)
Matrix effects##3##2##(2008-10#3)
Matrix ions of##2##3##(2008-10#2)
Matrix metalloproteinases##3##2##(2008-1#2)(2012-3#1)
Matrix related##2##2##(2008-10#1)(2012-12#1)
Matrix##22##1##(1994-3#1)(1996-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Matters##2##1##(1995-1#1)(2011-9#1)
Maturation and##3##2##(2008-10#3)
Maturation of##3##2##(1995-6#1)(2008-10#2)
Maturation##6##1##(1995-6#1)(2008-10#5)
Mature cultures##2##2##(2008-10#2)
Mature cystic##2##2##(2013-1#1)(2013-8#1)
Mature##11##1##(2008-10#6)(2008-4#1)(2008-7#1)(2009-7#1)(2013-1#1)(2013-8#1)
Mauthner##2##1##(1990-5#2)
Max##2##1##(1991-5#1)(2010-10#1)
Maxillofacial##2##1##(2009-12#1)(2013-1#1)
Maximal induction was##2##3##(1990-5#1)(1995-8#1)
Maximal yields close to 100%##2##5##(2008-10#2)
Maximal##13##1##(1990-5#1)(1992-6#1)(1993-9#1)(1994-3#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-8#1)(2010-8#1)(2010-9#1)
Maximizer##6##1##(2008-11#6)
Maximum absorbance is at##2##4##(2008-10#2)
Maximum absorbance##3##2##(2008-10#3)
Maximum activity##2##2##(1992-6#1)(2008-10#1)
Maximum parsimony##2##2##(2008-10#2)
Maximum pyrolysis##2##2##(2008-10#2)
Maximum sorption of##2##3##(2008-10#2)
Maximum##43##1##(1992-6#1)(1993-3#1)(1994-11#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-6#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Maxyl and##2##2##(2011-10#2)
May 15-17##2##2##(1992-3#1)(2010-1#1)
May 1989##2##2##(1990-11#1)(1992-1#1)
May 1997##5##2##(1997-6#1)(2008-11#1)(2008-5#3)
May 2004 and##2##3##(2008-10#2)
May 2004##3##2##(2008-10#2)(2008-12#1)
May 2005##2##2##(2008-12#2)
May 2006##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
May 2007 to##2##3##(2011-2#1)(2012-2#1)
May 2008##2##2##(2010-6#1)(2012-2#1)
May 2009##3##2##(2010-4#1)(2011-2#1)(2012-2#1)
May 2011##3##2##(2010-11#1)(2012-2#1)(2013-7#1)
May and##4##2##(1996-11#1)(2008-10#2)(2011-2#1)
May to September##2##3##(1996-12#1)(2013-8#1)
May to##10##2##(1995-6#1)(1996-12#2)(2008-10#3)(2010-6#1)(2011-2#1)(2013-8#2)
May##94##1##(1990-11#1)(1991-11#1)(1991-2#1)(1992-1#2)(1992-3#1)(1992-6#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#6)(1996-9#1)(1997-2#1)(1997-6#1)(2008-10#25)(2008-11#4)(2008-12#5)(2008-5#5)(2009-10#1)(2009-5#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#7)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#3)
May)##4##1##(1996-11#1)(2008-10#3)
Maybe##3##1##(1994-2#1)(2009-5#1)(2009-8#1)
Mayer's##3##1##(1996-5#2)(2013-8#1)
Mayo##5##1##(2008-9#1)(2009-4#2)(2012-3#1)(2013-1#1)
Mazurka##2##1##(2008-10#2)
Mb and##3##2##(2008-10#2)(2010-7#1)
Mb for chromosome##2##3##(1996-12#2)
Mb in##2##2##(1994-5#1)(2008-10#1)
Mb is##2##2##(1994-5#2)
Mb of##5##2##(1995-6#1)(1996-6#1)(1996-8#1)(1997-2#1)(2009-10#1)
Mb##44##1##(1994-5#7)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#3)(1996-8#1)(1997-2#2)(1997-6#1)(2008-10#12)(2009-10#1)(2010-4#9)(2010-7#2)(2011-2#1)(2013-1#1)
Mb-2C(12)N(+)PA(-) films##3##2##(2008-10#3)
Mb-PAM film electrodes##2##3##(2008-10#2)
Mb-PAM##5##1##(2008-10#5)
MbSA)##4##1##(2011-2#4)
Mbp##4##1##(1997-2#1)(2010-7#1)(2011-2#1)(2012-12#1)
McAb2C9##2##1##(2008-8#2)
McArdle's disease##2##2##(2008-7#2)
McCoy##3##1##(2008-11#3)
McCoy-Plovdiv##4##1##(2008-11#4)
McGill Pain Questionnaire##4##3##(2009-12#1)(2010-6#1)(2012-2#2)
McMurry##2##1##(1996-5#2)
Mcl-1 expression##2##2##(2013-1#2)
Mcl-1##4##1##(2013-1#4)
Mcl-1/Bim##3##1##(2013-1#3)
MeA##3##1##(1997-3#2)(2008-10#1)
MeBPHT##2##1##(2008-10#2)
MeBr##6##1##(1995-3#6)
MeHg##4##1##(2008-10#2)(2008-7#2)
MeHg(+)##6##1##(2008-10#6)
MeJA and Carr##2##3##(2011-10#2)
MeJA and##3##2##(2011-10#3)
MeJA application##2##2##(2011-10#2)
MeJA##7##1##(2008-10#2)(2011-10#5)
MeOH extract from a##2##4##(2008-11#2)
MeOH extract##3##2##(2008-11#3)
MeOH##18##1##(1996-5#1)(2008-10#13)(2008-11#4)
MeSH terms##2##2##(2011-2#2)
MeSH##7##1##(1991-1#2)(1992-12#1)(2008-1#1)(2008-6#1)(2011-2#2)
MeV linear accelerator##2##3##(1990-12#1)(1992-12#1)
MeV##5##1##(1990-12#1)(1992-12#1)(1996-9#1)(2008-10#1)(2009-11#1)
Mealybug##2##1##(2008-10#2)
Mean +/-##2##2##(2008-12#1)(2012-2#1)
Mean GSH##2##2##(1990-2#1)(2008-10#1)
Mean Square##2##2##(2008-10#1)(2010-6#1)
Mean age of##2##3##(2008-5#1)(2013-1#1)
Mean age was##6##3##(1990-11#1)(1993-11#1)(2008-7#1)(2011-2#2)(2012-3#1)
Mean age##10##2##(1990-11#1)(1993-11#1)(1997-4#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-3#2)(2013-1#1)
Mean arterial##2##2##(2009-8#1)(2011-2#1)
Mean body weights of 400##2##5##(2008-9#2)
Mean body weights of dosed males##2##6##(2008-9#2)
Mean body weights of##8##4##(2008-9#8)
Mean body weights##9##3##(2008-9#9)
Mean duration of##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
Mean number of##3##3##(1992-12#1)(2008-10#2)
Mean observation##2##2##(1993-11#1)(1997-4#1)
Mean recoveries were##2##3##(2008-10#2)
Mean recoveries##3##2##(2008-10#3)
Mean reproductive##2##2##(2010-8#2)
Mean serum##2##2##(1991-6#1)(2011-2#1)
Mean validation##3##2##(2008-10#3)
Mean values##2##2##(2008-10#1)(2013-1#1)
Mean##96##1##(1990-11#2)(1990-2#2)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-11#2)(1994-12#1)(1996-9#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-10#23)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#10)(2009-2#1)(2009-3#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#3)(2011-2#8)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#3)
Means of##3##2##(2008-12#1)(2008-3#1)(2012-2#1)
Means##4##1##(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
Meanwhile##19##1##(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#4)(2008-9#3)(2011-3#3)(2013-8#1)
Measles##2##1##(1992-5#1)(1996-6#1)
Measure of##3##2##(2008-10#1)(2010-2#1)(2011-1#1)
Measure##9##1##(1994-12#1)(1997-2#1)(2007-8#1)(2008-10#2)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
Measured values##2##2##(2008-11#2)
Measured##6##1##(2008-10#2)(2008-11#2)(2008-3#1)(2009-11#1)
Measurement and Testing##2##3##(2008-10#2)
Measurement and##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
Measurement error##2##2##(2008-12#1)(2008-3#1)
Measurement of particle##2##3##(1992-3#1)(1993-2#1)
Measurement of the ability of##2##5##(1994-8#1)(2008-9#1)
Measurement of the##11##3##(1991-11#1)(1992-3#1)(1994-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-9#2)
Measurement of##57##2##(1991-1#1)(1991-11#1)(1992-12#2)(1992-3#2)(1993-2#1)(1994-8#1)(1996-6#1)(1996-9#1)(2008-10#12)(2008-11#5)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#2)(2008-9#5)(2010-11#2)(2010-12#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
Measurement##78##1##(1991-1#1)(1991-11#1)(1992-12#2)(1992-3#2)(1993-2#1)(1994-8#1)(1995-2#1)(1996-6#1)(1996-9#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#2)(2008-9#5)(2009-1#1)(2009-11#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
Measurements and Testing Programme##2##4##(2008-10#2)
Measurements and Testing##4##3##(2008-10#4)
Measurements and##5##2##(2008-10#4)(2008-11#1)
Measurements are made at##2##4##(2008-10#1)(2008-2#1)
Measurements by##2##2##(2008-11#1)(2008-5#1)
Measurements of benzene concentration##2##4##(2008-3#2)
Measurements of the##7##3##(1991-5#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
Measurements of##28##2##(1991-11#1)(1991-5#1)(1994-11#1)(1994-8#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#10)(2008-5#2)(2011-2#1)
Measurements were carried out in the##2##6##(2008-10#1)(2008-2#1)
Measurements were made at##2##4##(2008-10#2)
Measurements were made in##2##4##(2008-10#2)
Measurements were made##7##3##(1996-2#1)(2008-10#5)(2008-9#1)
Measurements were performed at##2##4##(2008-10#1)(2008-5#1)
Measurements were performed##4##3##(2008-10#3)(2008-5#1)
Measurements were##13##2##(1996-2#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-9#1)
Measurements##59##1##(1991-11#1)(1991-5#1)(1994-11#1)(1994-8#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#22)(2008-11#5)(2008-2#4)(2008-3#13)(2008-5#4)(2008-9#2)(2010-1#1)(2011-2#1)
Measures included##3##2##(2008-12#1)(2013-1#2)
Measures of##11##2##(1991-2#1)(1993-1#1)(1994-12#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-4#2)(2010-3#1)
Measures that##2##2##(1996-3#1)(2008-12#1)
Measures##23##1##(1991-2#1)(1993-1#1)(1994-12#2)(1994-2#1)(1996-12#1)(1996-3#2)(2008-10#3)(2008-12#3)(2008-4#2)(2009-4#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
Measuring and##2##2##(1995-3#1)(2008-10#1)
Measuring natural selection##2##3##(2008-8#1)(2010-4#1)
Measuring quality of##2##3##(1996-2#1)(2011-2#1)
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting##2##16##(2010-1#2)
Measuring the##5##2##(1993-3#1)(2008-10#2)(2010-1#2)
Measuring##38##1##(1992-1#1)(1992-12#2)(1992-2#3)(1993-1#1)(1993-12#3)(1993-3#1)(1995-3#1)(1996-2#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#2)(2011-2#1)(2012-2#4)
Meat hygiene service##2##3##(1991-8#1)(1996-3#1)
Meat##5##1##(1991-8#1)(1996-3#1)(2010-4#3)
Mechanical circulatory support##2##3##(2008-11#1)(2009-10#1)
Mechanical factors such as##2##4##(1997-1#1)(2010-12#1)
Mechanical properties of non-functionalized##2##4##(2009-11#2)
Mechanical properties##3##2##(2009-11#2)(2012-2#1)
Mechanical stimulation##2##2##(2012-2#2)
Mechanical testing##2##2##(2009-11#1)(2009-7#1)
Mechanical##20##1##(1994-6#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#2)(2009-10#1)(2009-11#3)(2009-7#2)(2010-12#1)(2011-2#1)(2012-2#4)
Mechanically##4##1##(1992-12#1)(1993-5#1)(2008-10#1)(2012-2#1)
Mechanism of action##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
Mechanism of##18##2##(1993-6#1)(1993-8#1)(1994-8#1)(1995-10#1)(2008-10#6)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)
Mechanism studies##2##2##(2008-10#2)
Mechanism##24##1##(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-10#1)(2008-10#8)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
Mechanisms and##2##2##(1990-6#1)(2008-10#1)
Mechanisms for##3##2##(1991-7#1)(1994-8#1)(1996-2#1)
Mechanisms of drug##2##3##(1991-1#2)
Mechanisms of resistance##2##3##(2008-11#2)
Mechanisms of##19##2##(1990-12#1)(1990-2#1)(1991-1#2)(1991-4#1)(1992-6#1)(1994-5#2)(2008-10#5)(2008-11#2)(2008-8#1)(2009-8#1)(2010-1#1)(2012-2#1)
Mechanisms underlying##2##2##(1991-8#1)(2008-11#1)
Mechanisms##37##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-6#1)(1994-5#2)(1994-8#1)(1996-2#1)(2008-10#15)(2008-11#3)(2008-8#2)(2009-8#1)(2010-1#2)(2012-2#1)
Mechanistic##6##1##(2008-10#2)(2009-12#1)(2012-2#1)(2013-1#2)
Mechanistically##5##1##(1995-2#1)(2013-1#4)
Mechanotherapy##2##1##(2008-12#2)
Meckel's diverticulum##2##2##(2009-8#2)
Meckel's##5##1##(2009-8#2)(2011-2#3)
Med##8##1##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-12#1)
Med-El Combi##2##2##(2008-9#2)
Med-El##5##1##(2008-9#5)
MedDRA##3##1##(2008-11#3)
Medecins sans Frontieres (Doctors without Borders)##2##6##(1997-6#2)
Medecins sans Frontieres##3##3##(1997-6#3)
Medellín##2##1##(2008-5#1)(2011-2#1)
Medford##2##1##(2008-10#2)
Media##8##1##(2008-10#4)(2008-11#3)(2013-1#1)
Medial prefrontal##2##2##(2008-11#2)
Medial##7##1##(1991-2#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-11#2)(2012-2#1)
Median duration of response was##2##5##(1991-6#1)(1992-2#1)
Median duration of##5##3##(1991-6#1)(1991-8#1)(1992-2#2)(1995-2#1)
Median duration##6##2##(1991-6#1)(1991-8#1)(1992-2#2)(1992-9#1)(1995-2#1)
Median overall survival##2##3##(1990-9#1)(2011-2#1)
Median ratings##2##2##(2010-12#2)
Median survival was##2##3##(1991-2#1)(1991-6#1)
Median survival##5##2##(1991-2#1)(1991-6#1)(1997-5#1)(2008-10#1)(2008-7#1)
Median##28##1##(1990-9#2)(1991-2#1)(1991-6#2)(1991-8#1)(1992-2#2)(1992-9#1)(1994-12#1)(1995-2#1)(1996-3#1)(1997-5#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-11#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
Mediastinal##2##1##(1997-8#1)(2012-3#1)
Mediated by##4##2##(1996-5#1)(2008-10#2)(2011-2#1)
Mediated##9##1##(1991-3#1)(1996-5#2)(2008-10#3)(2008-12#1)(2009-12#1)(2011-2#1)
Mediation of##5##2##(1994-9#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-8#1)
Mediation##7##1##(1991-12#1)(1994-9#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-8#2)
Mediator##2##1##(2011-2#1)(2013-7#1)
Mediators##2##1##(1995-12#1)(2010-12#1)
Medicago sativa L##2##3##(2008-8#2)
Medicago sativa##3##2##(2008-10#1)(2008-8#2)
Medicago truncatula##8##2##(2008-10#4)(2009-10#1)(2009-8#2)(2011-2#1)
Medicago##12##1##(2008-10#5)(2008-8#2)(2009-10#1)(2009-8#3)(2011-2#1)
Medicaid Competition Demonstrations##2##3##(1991-2#2)
Medicaid Voluntary Contribution and Provider-Specific Tax Amendments of 1991 (Public Law 102-234)##2##12##(1993-1#2)
Medicaid and Medicare##3##3##(1995-12#1)(1995-3#1)(2010-5#1)
Medicaid and##12##2##(1991-1#1)(1991-3#1)(1992-2#3)(1994-3#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-3#1)(2010-5#1)
Medicaid are##2##2##(1996-2#1)(1997-2#1)
Medicaid as##2##2##(1992-2#1)(1996-1#1)
Medicaid beneficiaries to##2##3##(1996-3#1)(1997-2#1)
Medicaid beneficiaries##11##2##(1991-3#1)(1994-2#2)(1996-1#1)(1996-2#2)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)
Medicaid benefits##2##2##(1994-1#1)(1994-2#1)
Medicaid claims##2##2##(1996-1#1)(1997-1#1)
Medicaid cost-containment policies##2##3##(1992-2#1)(1993-3#1)
Medicaid cost-containment##3##2##(1992-2#1)(1993-3#2)
Medicaid data##2##2##(1996-3#1)(1997-2#1)
Medicaid eligibility##8##2##(1992-2#5)(1994-2#2)(1995-12#1)
Medicaid enrollees##4##2##(1991-2#1)(1996-2#1)(1997-3#2)
Medicaid enrollment##3##2##(1992-2#2)(1996-1#1)
Medicaid expenditure growth##3##3##(1996-1#3)
Medicaid expenditures after##2##3##(1995-2#2)
Medicaid expenditures for##3##3##(1992-3#2)(1995-12#1)
Medicaid expenditures##10##2##(1992-12#1)(1992-3#3)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)
Medicaid fees##7##2##(1994-1#2)(1996-3#5)
Medicaid health maintenance organization##2##4##(1991-2#1)(1994-3#1)
Medicaid health##3##2##(1991-2#1)(1994-3#1)(1997-2#1)
Medicaid in##2##2##(1992-2#1)(1994-3#1)
Medicaid is##2##2##(1994-1#1)(1995-12#1)
Medicaid managed care and##2##4##(1997-2#2)
Medicaid managed care plans##2##4##(1997-2#1)(2008-11#1)
Medicaid managed care program##2##4##(1995-12#1)(1997-2#1)
Medicaid managed care programs##2##4##(1994-3#1)(1996-1#1)
Medicaid managed care##18##3##(1994-3#2)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#7)(2008-11#1)(2009-6#1)
Medicaid mental health##3##3##(1997-2#3)
Medicaid nursing home reimbursement##3##4##(1994-2#3)
Medicaid patients who##2##3##(1995-2#1)(1997-2#1)
Medicaid patients##3##2##(1995-2#1)(1996-2#1)(1997-2#1)
Medicaid payments##2##2##(1992-8#1)(1995-1#1)
Medicaid policies for##2##3##(1995-1#1)(1995-2#1)
Medicaid policies##3##2##(1995-1#1)(1995-2#2)
Medicaid population##2##2##(1992-3#1)(1997-2#1)
Medicaid program##6##2##(1991-3#1)(1992-2#2)(1994-12#1)(1996-1#1)(1997-2#1)
Medicaid programs##16##2##(1991-2#1)(1994-12#1)(1995-1#3)(1995-12#1)(1995-2#3)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#3)
Medicaid recipients in##3##3##(1991-1#1)(1991-2#1)(1992-2#1)
Medicaid recipients with AIDS##2##4##(1995-2#2)
Medicaid recipients with##3##3##(1991-12#1)(1995-2#2)
Medicaid recipients##14##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#3)(1994-2#2)(1994-3#2)(1995-12#1)(1995-2#2)(1997-2#1)
Medicaid reimbursement##2##2##(1991-3#1)(1996-3#1)
Medicaid spending would increase##2##4##(1994-1#2)
Medicaid spending##5##2##(1994-1#3)(1995-1#1)(1995-6#1)
Medicaid waiver for the mentally retarded##2##6##(1991-1#2)
Medicaid waiver for##4##3##(1991-1#2)(1993-1#1)(1996-2#1)
Medicaid waiver program##2##3##(1993-1#1)(1997-2#1)
Medicaid waiver##8##2##(1991-1#2)(1992-2#1)(1993-1#2)(1996-2#1)(1997-2#2)
Medicaid was##2##2##(1992-2#1)(1995-12#1)
Medicaid##261##1##(1991-1#5)(1991-12#4)(1991-2#8)(1991-3#12)(1991-9#1)(1992-12#1)(1992-2#27)(1992-3#5)(1992-8#1)(1992-9#1)(1993-1#7)(1993-12#2)(1993-3#4)(1993-5#1)(1994-1#11)(1994-12#2)(1994-2#16)(1994-3#13)(1995-1#11)(1995-12#14)(1995-2#10)(1995-3#1)(1995-6#1)(1996-1#14)(1996-12#4)(1996-2#17)(1996-3#14)(1997-1#4)(1997-2#33)(1997-3#4)(1997-6#1)(2008-11#4)(2008-12#1)(2009-6#2)(2010-5#1)(2011-2#2)(2013-1#2)
Medical Academy##2##2##(2007-11#1)(2011-2#1)
Medical Association##8##2##(1990-6#2)(1991-2#1)(1991-8#2)(1992-12#1)(2008-10#2)
Medical Birth Registry##2##3##(1991-11#1)(1996-11#1)
Medical Center and##3##3##(1993-2#1)(2008-4#1)(2010-8#1)
Medical Center in##2##3##(1993-2#1)(1997-3#1)
Medical Center##39##2##(1990-11#3)(1991-3#2)(1992-12#2)(1992-2#1)(1993-12#2)(1993-2#3)(1993-3#1)(1994-12#1)(1994-2#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-3#2)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#2)(2010-8#3)(2012-3#1)
Medical Center's##2##2##(1992-1#1)(2010-8#1)
Medical College of the State of South Carolina##2##8##(1991-8#2)
Medical College##9##2##(1991-8#2)(1994-1#1)(1997-2#1)(2008-12#1)(2012-2#1)(2012-3#3)
Medical Device##2##2##(1997-2#1)(2012-3#1)
Medical Education##5##2##(1991-8#3)(2012-3#1)(2013-1#1)
Medical Entomology##3##2##(2010-1#3)
Medical Faculty##4##2##(1993-6#1)(2007-8#1)(2008-10#1)(2011-3#1)
Medical Humanities course##2##3##(2011-2#2)
Medical Library##2##2##(1991-3#1)(1992-12#1)
Medical Outcomes##2##2##(2008-10#1)(2010-2#1)
Medical Products##3##2##(1993-2#1)(1994-6#1)(1995-3#1)
Medical Record##2##2##(2010-8#2)
Medical Research##4##2##(1990-3#1)(1993-9#1)(2008-10#1)(2008-12#1)
Medical School and##2##3##(2010-1#1)(2013-1#1)
Medical School##15##2##(1990-9#1)(1991-6#1)(1993-3#1)(1995-11#1)(1997-8#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-5#2)(2011-2#1)(2013-1#1)
Medical Sciences##4##2##(1996-11#1)(2008-10#2)(2013-1#1)
Medical Services##3##2##(2007-9#1)(2008-11#1)(2008-6#1)
Medical University of##3##3##(2007-8#1)(2013-1#2)
Medical University on##2##3##(2009-5#2)
Medical University##6##2##(2007-8#1)(2009-5#2)(2013-1#2)(2013-8#1)
Medical abortion##2##2##(1992-2#1)(2011-2#1)
Medical and Psychiatric##2##3##(2009-4#1)(2013-8#1)
Medical and health##2##3##(1997-3#1)(2011-2#1)
Medical and##9##2##(1993-6#1)(1997-3#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-2#1)(2011-3#1)(2013-8#2)
Medical care##3##2##(1993-2#1)(2012-12#1)(2012-3#1)
Medical complications##2##2##(1995-11#1)(2012-3#1)
Medical emergencies in children of orthodox Jehovah's Witness families##4##9##(2008-11#4)
Medical emergencies in dental##2##4##(2008-1#2)
Medical emergencies in##6##3##(2008-1#2)(2008-11#4)
Medical genetics##2##2##(1994-9#1)(2013-1#1)
Medical group##2##2##(1991-1#1)(1997-3#1)
Medical groups that ignore the importance of service excellence will find themselves trailing those groups that provide superior service to their patients##2##22##(1994-1#2)
Medical groups that plan and manage for patients' service needs will achieve market differentiation##2##14##(1994-1#2)
Medical groups that##4##3##(1994-1#4)
Medical management of##2##3##(1994-2#1)(2008-8#1)
Medical schools##2##2##(2009-10#1)(2011-2#1)
Medical services provided in the group practice setting must be structured to accommodate the unique needs of their increasing number of elderly patients##2##23##(1994-3#2)
Medical##245##1##(1990-11#3)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#1)(1991-8#7)(1992-1#5)(1992-12#7)(1992-2#4)(1992-3#2)(1993-12#4)(1993-2#8)(1993-3#4)(1993-5#1)(1993-6#3)(1993-9#1)(1994-1#5)(1994-12#7)(1994-2#4)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-5#1)(1997-8#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#9)(2008-12#4)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2010-1#6)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#7)(2010-9#1)(2011-2#22)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#13)(2013-1#12)(2013-8#5)
Medically##2##1##(2009-6#1)(2013-1#1)
Medicare Alzheimer's Project##2##3##(1992-1#1)(1995-3#1)
Medicare Current Beneficiary Survey (MCBS)##10##5##(1994-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
Medicare Current Beneficiary Survey##11##4##(1994-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
Medicare ESRD populations##2##3##(1995-12#2)
Medicare Economic Index##2##3##(1992-2#2)
Medicare Fee Schedule (MFS)##2##4##(1995-12#1)(1996-3#1)
Medicare HMO enrollees##2##3##(1994-3#2)
Medicare HMO enrollment##2##3##(1994-3#2)
Medicare HMO##5##2##(1993-3#1)(1994-3#4)
Medicare PPS##4##2##(1992-12#1)(1992-2#1)(1993-3#2)
Medicare Part A##4##3##(1991-1#2)(1993-3#1)(1994-12#1)
Medicare Part##7##2##(1991-1#2)(1993-3#1)(1994-12#1)(1996-2#2)(2010-5#1)
Medicare Transaction System##2##3##(1994-12#2)
Medicare access##2##2##(1995-12#2)
Medicare aged##2##2##(1993-12#1)(1995-2#1)
Medicare and Medicaid beneficiaries##5##4##(1991-3#1)(1996-2#2)(1997-2#1)(1997-3#1)
Medicare and Medicaid##20##3##(1991-12#1)(1991-2#2)(1991-3#3)(1994-3#1)(1996-2#6)(1996-3#2)(1997-2#3)(1997-3#1)(2008-11#1)
Medicare and non-Medicare beneficiaries##2##4##(1995-12#1)(1997-3#1)
Medicare and the##3##3##(1993-3#1)(1995-3#1)(1997-3#1)
Medicare and##30##2##(1991-12#1)(1991-2#2)(1991-3#3)(1992-2#2)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#3)(1996-2#6)(1996-3#2)(1997-2#3)(1997-3#3)(2008-11#1)
Medicare antidumping provision##2##3##(1991-2#2)
Medicare beneficiaries are##3##3##(1991-3#1)(1995-12#1)(1996-2#1)
Medicare beneficiaries##37##2##(1991-1#1)(1991-2#3)(1991-3#4)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#4)(1994-1#3)(1994-12#1)(1994-3#1)(1995-12#4)(1995-2#1)(1995-3#1)(1996-2#4)(1996-3#1)(1997-2#1)(1997-3#3)(2009-12#1)
Medicare beneficiaries'##2##2##(1994-1#1)(1997-2#1)
Medicare beneficiary##4##2##(1991-1#1)(1991-3#1)(1997-3#2)
Medicare capitation payments##2##3##(1993-3#1)(1997-1#1)
Medicare claims##2##2##(1994-12#1)(1995-12#1)
Medicare coverage##6##2##(1992-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-3#1)
Medicare data to##2##3##(1995-2#1)(1997-3#1)
Medicare data##8##2##(1992-11#1)(1994-2#1)(1995-2#1)(1997-2#1)(1997-3#4)
Medicare dependent hospitals##2##3##(1992-12#2)
Medicare enrollees##9##2##(1991-3#1)(1992-2#3)(1993-1#1)(1994-2#1)(1996-3#1)(1997-1#1)(1997-2#1)
Medicare expenditures##3##2##(1992-1#2)(1992-12#1)
Medicare fee schedule (MFS)##4##4##(1994-1#3)(1994-12#1)
Medicare fee schedule##9##3##(1991-12#1)(1993-3#1)(1994-1#5)(1994-12#1)(1996-3#1)
Medicare fee##10##2##(1991-12#1)(1993-3#1)(1994-1#5)(1994-12#1)(1996-3#1)(1997-3#1)
Medicare fee-for-service (FFS)##2##3##(1993-12#1)(1995-3#1)
Medicare fees are##2##3##(1994-1#2)
Medicare fees##5##2##(1994-1#5)
Medicare for##2##2##(1995-1#1)(1997-6#1)
Medicare health maintenance organization (HMO)##2##5##(1994-3#1)(1995-3#1)
Medicare health maintenance organization##3##4##(1994-3#2)(1995-3#1)
Medicare home health##9##3##(1994-2#4)(1995-2#1)(1995-3#4)
Medicare home##10##2##(1994-2#4)(1995-2#2)(1995-3#4)
Medicare hospice benefit##3##3##(1991-3#1)(1993-12#1)(1994-12#1)
Medicare hospice##4##2##(1991-3#1)(1993-12#1)(1994-12#2)
Medicare hospital outpatient services##2##4##(1991-2#1)(1992-12#1)
Medicare hospital##6##2##(1991-2#1)(1992-12#2)(1993-1#1)(1994-12#1)(1997-2#1)
Medicare in##2##2##(1991-12#1)(1991-3#1)
Medicare inpatient##5##2##(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)
Medicare insured group##2##3##(1992-2#2)
Medicare managed care##4##3##(1997-2#4)
Medicare outpatient##2##2##(1992-2#1)(1995-1#1)
Medicare patients##12##2##(1991-12#1)(1992-12#1)(1993-12#2)(1994-12#3)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#1)
Medicare payment##11##2##(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#2)(1997-2#1)
Medicare payments for##2##3##(1992-2#1)(1994-12#1)
Medicare payments to health maintenance organizations##2##6##(1991-1#2)
Medicare payments##4##2##(1991-1#2)(1992-2#1)(1994-12#1)
Medicare physician fees##3##3##(1994-1#3)
Medicare physician payment system##2##4##(1991-12#1)(1992-1#1)
Medicare physician payment##4##3##(1991-1#1)(1991-12#1)(1992-1#1)(1995-12#1)
Medicare physician##10##2##(1991-1#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-1#3)(1994-3#1)(1995-12#1)(2012-3#1)
Medicare population and##2##3##(1991-3#1)(1995-12#1)
Medicare population##10##2##(1991-1#1)(1991-3#1)(1993-12#2)(1995-12#4)(1995-2#1)(1996-3#1)
Medicare program##12##2##(1991-1#3)(1991-2#1)(1991-3#1)(1992-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1997-3#2)
Medicare prospective payment system##7##4##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-3#1)
Medicare prospective payment##10##3##(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#3)(1993-12#1)(1993-3#1)(1996-2#1)
Medicare provider analysis and review (MEDPAR) file##2##7##(1993-12#1)(1995-2#1)
Medicare provider analysis and review (MEDPAR)##3##6##(1993-12#2)(1995-2#1)
Medicare provider analysis and review##4##5##(1991-12#1)(1993-12#2)(1995-2#1)
Medicare provider analysis##5##3##(1991-12#1)(1992-12#1)(1993-12#2)(1995-2#1)
Medicare regulations and##2##3##(1991-12#1)(2008-11#1)
Medicare reimbursement##4##2##(1992-1#1)(1994-3#1)(1995-3#1)(2012-3#1)
Medicare risk##2##2##(1996-3#2)
Medicare service##2##2##(1991-1#1)(1993-1#1)
Medicare short-stay hospital##2##3##(1991-1#1)(1992-2#1)
Medicare spending for##2##3##(1991-2#2)
Medicare spending##6##2##(1991-2#2)(1992-2#1)(1994-1#1)(1995-12#1)(2012-3#1)
Medicare##415##1##(1991-1#19)(1991-12#10)(1991-2#17)(1991-3#19)(1992-1#9)(1992-11#1)(1992-12#18)(1992-2#26)(1993-1#11)(1993-12#21)(1993-3#17)(1993-5#1)(1994-1#32)(1994-12#22)(1994-2#8)(1994-3#16)(1995-1#8)(1995-12#26)(1995-2#12)(1995-3#18)(1996-12#11)(1996-2#15)(1996-3#15)(1997-1#4)(1997-2#20)(1997-3#19)(1997-6#1)(2008-11#4)(2008-4#2)(2008-6#3)(2009-12#1)(2010-5#1)(2012-3#8)
Medicare's prospective payment system (PPS)##2##5##(1992-12#1)(1994-12#1)
Medicare's prospective payment system##3##4##(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's prospective payment##4##3##(1991-1#1)(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's prospective##5##2##(1991-1#2)(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's##17##1##(1991-1#2)(1992-12#2)(1992-2#2)(1993-3#1)(1994-12#5)(1994-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)
Medicare-covered services##2##2##(1995-1#1)(1995-12#1)
Medicare-covered##4##1##(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)
Medicare/Medicaid##3##1##(1991-9#1)(2008-11#2)
Medicare?##3##1##(1993-1#1)(1994-3#1)(1997-3#1)
Medication##2##1##(1991-11#1)(2011-2#1)
Medications##3##1##(2008-11#1)(2008-6#1)(2009-9#1)
Medicinal surface modification of silicon nanowires##2##6##(2010-3#2)
Medicinal##5##1##(2008-10#1)(2008-5#2)(2010-3#2)
Medicine Department##2##2##(1996-11#1)(2007-11#1)
Medicine and##9##2##(1996-9#1)(1997-2#2)(2008-1#1)(2008-8#1)(2009-5#2)(2012-2#1)(2012-3#1)
Medicine at the##2##3##(1992-12#1)(1996-11#1)
Medicine has##2##2##(1996-1#1)(2010-5#1)
Medicine in##6##2##(1997-8#1)(2010-1#2)(2013-8#3)
Medicine of the##2##3##(1991-12#2)
Medicine of##5##2##(1991-12#2)(1992-1#1)(1997-3#1)(2013-1#1)
Medicine were##2##2##(2009-5#1)(2012-2#1)
Medicine##97##1##(1990-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-1#4)(1992-12#1)(1994-12#2)(1995-12#1)(1995-3#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#2)(2007-11#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-1#4)(2010-4#2)(2010-5#1)(2011-2#4)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#7)
Medicine&quot##2##1##(2012-2#1)(2013-1#1)
Medicines##9##1##(1996-11#1)(1997-1#1)(2008-10#3)(2008-11#4)
Medicus##2##1##(1993-12#2)
Medigap##3##1##(1992-2#1)(1993-3#1)(1997-3#1)
Meditation##2##1##(1992-2#1)(2008-10#1)
Mediterranean Sea##2##2##(2008-10#1)(2008-2#1)
Mediterranean climate##2##2##(2008-10#2)
Mediterranean regions##2##2##(2011-2#1)(2012-7#1)
Mediterranean##36##1##(1990-8#2)(1992-9#1)(1997-5#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-7#1)(2010-1#1)(2011-2#9)(2012-5#1)(2012-7#3)
Mediterranean-African##2##1##(2008-10#2)
Medium (DMEM)##2##2##(2008-11#1)(2013-1#1)
Medium for##4##2##(2008-10#3)(2008-11#1)
Medium with##2##2##(2008-10#1)(2008-11#1)
Medium##18##1##(2008-10#9)(2008-11#6)(2008-3#1)(2008-7#1)(2013-1#1)
Medline##13##1##(1992-12#1)(1994-2#1)(2008-1#2)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#3)(2013-1#2)
Medtronic##2##1##(2010-7#2)
Medulloblastoma##2##1##(1997-3#1)(2008-7#1)
Meeting Report##3##2##(2008-10#1)(2011-2#2)
Meeting of the American##4##4##(2008-5#1)(2008-7#3)
Meeting of the##14##3##(1996-1#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#2)
Meeting of##15##2##(1996-1#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#1)
Meeting on##3##2##(2008-3#1)(2011-2#1)(2013-8#1)
Meeting the challenges of##2##4##(2008-11#1)(2008-12#1)
Meeting the##6##2##(1991-10#1)(1997-1#1)(2008-11#2)(2008-12#1)(2010-8#1)
Meeting##56##1##(1991-10#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#25)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#6)(2013-1#1)(2013-8#1)
Meetings##2##1##(2008-5#1)(2010-12#1)
Mefenoxam Insensitivity##2##2##(2008-10#2)
Megabalanus rosa##6##2##(1990-5#4)(1993-6#2)
Meiothermus ruber##2##2##(2011-2#2)
Meiothermus silvanus##2##2##(2011-2#2)
Meiothermus##8##1##(2011-2#8)
Meiotic##4##1##(2008-10#2)(2008-12#1)(2012-3#1)
Mel##2##1##(1995-12#2)
Melampsora larici-populina##11##2##(2008-10#11)
Melampsora medusae f##3##3##(2008-10#3)
Melampsora medusae##5##2##(2008-10#5)
Melampsora xcolumbiana##2##2##(2008-10#2)
Melampsora##19##1##(2008-10#19)
Melanie##2##1##(1997-3#2)
Melanie's##2##1##(1997-3#2)
Melanoma##7##1##(2009-3#1)(2010-6#3)(2011-2#1)(2012-3#1)(2013-1#1)
Melastoma malabathricum##2##2##(2009-8#2)
Melatonin and##5##2##(1995-11#1)(1995-12#1)(2008-10#1)(2013-7#2)
Melatonin treatment##2##2##(2011-2#2)
Melatonin##16##1##(1990-2#1)(1990-5#1)(1995-11#4)(1995-12#1)(1996-2#1)(2008-10#1)(2008-5#1)(2011-2#4)(2013-7#2)
Melbourne Categories##3##2##(2008-9#3)
Melbourne##7##1##(2008-10#2)(2008-8#1)(2008-9#3)(2012-2#1)
Meldola Blue##2##2##(2008-10#2)
Meldola's blue##3##2##(2008-10#3)
Melhus graduate student symposium##2##4##(2008-10#2)
Meloidogyne artiellia##2##2##(2008-10#2)
Meloidogyne baetica n##2##3##(2008-10#2)
Meloidogyne chitwoodi and M##6##4##(2008-10#6)
Meloidogyne chitwoodi##9##2##(2008-10#9)
Meloidogyne incognita##5##2##(2008-10#5)
Meloidogyne javanica##7##2##(2008-10#7)
Meloidogyne marylandi##2##2##(2008-10#2)
Meloidogyne spp##6##2##(2008-10#6)
Meloidogyne##42##1##(2008-10#42)
Melon yellow spot virus##2##4##(2008-10#2)
Melon##5##1##(2008-10#5)
Melphalan##2##1##(2011-3#1)(2012-12#1)
Melt inclusions in Nakhla##2##4##(2008-10#2)
Member of the##3##3##(2008-10#3)
Member##9##1##(1994-2#1)(2008-10#4)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
Members of a##2##3##(1996-5#1)(2008-10#1)
Members of the genus##3##4##(2008-10#1)(2011-2#2)
Members of the##11##3##(1994-12#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#3)(2009-8#1)(2011-2#3)
Members of this##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
Members of##17##2##(1994-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-10#6)(2009-8#1)(2011-2#4)
Members##20##1##(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#6)(2009-4#1)(2009-8#1)(2011-2#4)
Membrane electrodes##2##2##(2008-10#2)
Membrane filtration studies of aquatic humic substances and their metal species##2##11##(2008-10#2)
Membrane fusion##2##2##(1991-5#2)
Membrane potential and##2##3##(1994-11#1)(1997-1#1)
Membrane potential##3##2##(1990-8#1)(1994-11#1)(1997-1#1)
Membrane##28##1##(1990-8#1)(1991-5#2)(1992-6#1)(1993-3#1)(1994-11#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
Membranes##4##1##(2008-10#4)
Memorial Award##2##2##(1991-1#1)(2010-5#1)
Memorial Hospital##2##2##(1991-2#1)(1997-2#1)
Memorial##10##1##(1991-1#1)(1991-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-5#1)(2011-2#1)
Memory Self-Efficacy##2##2##(2008-12#2)
Memory and##2##2##(1997-4#1)(2008-12#1)
Memory##14##1##(1991-2#1)(1997-4#1)(2008-11#2)(2008-12#5)(2008-3#1)(2008-7#3)(2009-10#1)
Men and women##2##3##(1993-6#1)(2012-12#1)
Men were##2##2##(2008-12#1)(2009-5#1)
Men who have sex with men##2##6##(2009-5#2)
Men with##2##2##(2009-5#1)(2013-8#1)
Men##19##1##(1993-11#1)(1993-6#1)(1996-5#1)(2008-12#3)(2008-5#1)(2009-5#6)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
MenACWY-CRM##4##1##(2013-1#4)
Menadione-catalyzed H(2)O(2) production by viable##2##5##(2008-11#2)
Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to genomics researchers##3##19##(2008-4#2)(2008-9#1)
Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to##4##17##(2008-4#3)(2008-9#1)
Mendelian Inheritance in Man (OMIM)##6##5##(2008-4#4)(2008-9#2)
Mendelian ratios##2##2##(2008-10#2)
Mendelian segregation##4##2##(2008-10#3)(2012-3#1)
Mendelian##15##1##(1994-9#1)(2008-10#7)(2008-4#4)(2008-9#2)(2012-3#1)
Meniere's disease is##2##3##(2012-3#2)
Meniere's disease##4##2##(2012-3#4)
Meningiomas##2##1##(2011-2#1)(2012-3#1)
Meningitis and##2##2##(1994-9#1)(2008-9#1)
Meningitis caused by##2##3##(2009-11#1)(2011-2#1)
Meningitis##11##1##(1994-9#1)(2008-9#4)(2009-11#2)(2009-12#1)(2011-2#3)
Menkes disease##2##2##(2008-12#1)(2012-2#1)
Mental Health##18##2##(1994-1#2)(1995-2#1)(2008-10#1)(2008-11#6)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2013-1#3)
Mental State##3##2##(2008-7#1)(2011-2#1)(2011-3#1)
Mental health##14##2##(1992-2#1)(1994-1#2)(1994-2#2)(1995-1#1)(1997-4#1)(2008-11#3)(2008-12#1)(2008-6#1)(2009-6#1)(2010-1#1)
Mental time travel may##2##4##(2013-8#2)
Mental time travel##3##3##(2013-8#3)
Mental##52##1##(1991-2#1)(1992-2#1)(1994-1#4)(1994-2#2)(1995-1#2)(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-6#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#4)(2013-8#3)
Mentha arvensis L##2##3##(2013-1#2)
Mentha piperita L##3##3##(2008-10#1)(2013-1#2)
Mentha##13##1##(2008-10#7)(2013-1#6)
Mentoring##4##1##(1993-12#1)(2008-9#1)(2009-3#1)(2012-2#1)
Mentype Argus X-8##2##3##(2008-12#2)
Mepacrine##2##1##(2008-11#2)
Merck &amp##2##2##(2013-1#2)
Merck##6##1##(2008-10#1)(2008-5#3)(2013-1#2)
Mercury determination by##2##3##(2008-10#2)
Mercury determination##3##2##(2008-10#3)
Mercury##13##1##(2007-12#1)(2008-10#11)(2008-7#1)
Mercury(II)##2##1##(2008-10#2)
Merging##2##1##(1996-9#1)(2008-11#1)
Merit##2##1##(1991-12#1)(1997-1#1)
Merkel cell carcinoma##3##3##(2011-2#3)
Merkel cell##4##2##(1993-3#1)(2011-2#3)
Merocyanine 540##2##2##(2008-10#1)(2008-9#1)
Meropenem##2##1##(2008-7#1)(2011-2#1)
Merrifield chloromethylated resin##2##3##(2008-10#2)
Merrifield##3##1##(2008-10#3)
Merritt to##2##2##(1996-5#2)
Merritt##6##1##(1996-5#5)(2008-10#1)
Mersilene suture##2##2##(2012-3#2)
Mersilene##3##1##(2012-3#3)
Mesalamine##2##1##(2010-12#2)
Mesalazine##2##1##(2010-12#2)
Mesenchymal Stem Cells##3##3##(2008-11#2)(2012-12#1)
Mesenchymal Stem##4##2##(2008-11#3)(2012-12#1)
Mesenchymal stem cells##3##3##(2008-11#2)(2013-1#1)
Mesenchymal stromal##2##2##(2009-10#2)
Mesenchymal##10##1##(2008-11#5)(2008-6#1)(2009-10#2)(2012-12#1)(2013-1#1)
Mesenteric##3##1##(1992-3#1)(2008-11#2)
Mesoamerican##4##1##(2008-10#4)
Mesoporous##3##1##(2008-10#2)(2010-4#1)
Mesoscopic##3##1##(1996-9#2)(2010-10#1)
Mesostructured tin oxide##2##3##(2008-10#2)
Mesothelioma##4##1##(1991-12#2)(2008-10#2)
Mesotheliomas##2##1##(1991-12#2)
Messages##2##1##(2009-6#1)(2010-11#1)
Messenger##2##1##(1996-12#2)
Met##4##1##(1993-12#1)(2008-10#2)(2008-11#1)
Met- NH2 (ranatachykinin##4##3##(1991-5#4)
Met- NH2##6##2##(1991-5#6)
Met-Met##2##1##(2008-10#2)
Met-Phe##2##1##(2008-10#2)
MetS and obesity were not##2##5##(2013-8#2)
MetS##8##1##(2010-10#6)(2013-8#2)
Meta-analysis in##2##2##(1996-6#1)(2008-10#1)
Meta-analysis is a##2##3##(2008-10#1)(2008-9#1)
Meta-analysis is an##2##3##(1996-6#1)(2008-11#1)
Meta-analysis is##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
Meta-analysis of##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
Meta-analysis##14##1##(1996-6#5)(1997-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)
Metabolic Syndrome in##2##3##(2008-3#2)
Metabolic Syndrome##4##2##(2008-11#1)(2008-3#2)(2013-1#1)
Metabolic engineering of##2##3##(2008-7#1)(2011-1#1)
Metabolic syndrome and##2##3##(2008-3#1)(2010-10#1)
Metabolic syndrome in##2##3##(2012-12#1)(2012-3#1)
Metabolic syndrome##10##2##(2008-11#4)(2008-3#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
Metabolic##36##1##(1991-1#1)(1991-2#1)(1992-12#1)(1993-1#1)(1994-8#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-3#3)(2008-5#1)(2008-7#2)(2009-10#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Metabolism and##2##2##(2008-10#1)(2013-1#1)
Metabolism in##3##2##(2008-11#3)
Metabolism of##7##2##(1991-5#1)(1993-8#1)(2008-10#2)(2008-11#3)
Metabolism##14##1##(1991-5#1)(1993-8#1)(1996-1#1)(2008-10#3)(2008-11#6)(2011-2#1)(2013-1#1)
Metabolites##5##1##(2008-10#2)(2008-11#1)(2010-11#2)
Metal concentration was determined by flame atomic absorption spectrometry (FAAS)##2##10##(2008-10#2)
Metal ion##3##2##(2008-10#3)
Metal ions were##4##3##(2008-10#4)
Metal ions##8##2##(1997-7#1)(2008-10#7)
Metal##22##1##(1991-12#1)(1996-2#1)(1997-7#1)(2008-10#18)(2010-12#1)
Metalaxyl##5##1##(2008-10#5)
Metalfix Chelamine##2##2##(2008-10#2)
Metalfix-Chelamine##3##1##(2008-10#3)
Metallic##3##1##(1990-12#1)(1995-3#1)(2008-9#1)
Metalloproteases##2##1##(2008-4#2)
Metalloproteomics##2##1##(2010-11#2)
Metallothionein (MT)##3##2##(1994-11#1)(2008-10#2)
Metallothionein##10##1##(1990-5#1)(1993-12#1)(1994-11#1)(2008-10#6)(2013-7#1)
Metallothioneins (MT)##2##2##(2008-10#1)(2013-7#1)
Metallothioneins (MTs) are##2##3##(2011-2#1)(2013-7#1)
Metallothioneins (MTs)##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
Metallothioneins##7##1##(2008-10#4)(2011-2#1)(2013-7#2)
Metals were##2##2##(2008-10#2)
Metals##6##1##(1996-5#1)(1996-9#1)(2008-10#3)(2010-11#1)
Metanephric adenoma##2##2##(2008-10#2)
Metapopulation##3##1##(2008-8#2)(2008-9#1)
Metarhizium anisopliae##3##2##(2010-10#3)
Metastases and spinal cord compression##2##5##(1992-12#2)
Metastases##6##1##(1992-12#2)(1994-12#1)(2012-2#1)(2012-3#2)
Metastasis of##2##2##(1994-12#1)(2013-1#1)
Metastasis##6##1##(1994-12#1)(2010-11#1)(2011-2#1)(2013-1#3)
Metastatic##10##1##(1990-12#1)(1990-8#1)(2008-10#1)(2008-11#2)(2010-6#1)(2012-12#1)(2012-3#2)(2013-8#1)
Metatarsus adductus##2##2##(2012-2#1)(2012-3#1)
Meteorological##2##1##(2008-3#1)(2008-5#1)
Metered##2##1##(1992-3#2)
Metered-dose propellant-driven aerosols##2##3##(1996-1#2)
Metered-dose##3##1##(1996-1#2)(1996-2#1)
Metformin##7##1##(1994-8#2)(1995-8#2)(2010-11#1)(2011-2#1)(2012-2#1)
Meth-A cells##3##2##(1994-11#2)(1994-5#1)
Methadone##3##1##(1991-1#1)(2008-7#2)
Methamphetamine##3##1##(1994-2#1)(2008-10#1)(2013-1#1)
Methanol##8##1##(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2012-2#1)
Methicillin-resistant Staphylococcus aureus##2##3##(2008-10#1)(2013-8#1)
Methicillin-resistant##4##1##(2008-10#2)(2008-7#1)(2013-8#1)
Methiocarb##2##1##(2008-10#2)
Methionine##3##1##(1993-9#1)(2008-10#2)
Method 314##3##2##(2008-10#3)
Method This was a##2##4##(2011-2#1)(2012-12#1)
Method This was##3##3##(2011-2#2)(2012-12#1)
Method detection limits##3##3##(2008-10#3)
Method development##4##2##(1997-2#1)(2008-10#3)
Method for the##5##3##(1996-5#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-2#1)
Method for##21##2##(1996-5#2)(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-9#1)(2009-8#2)(2010-3#1)(2012-2#1)(2013-1#3)
Method performance was evaluated by##2##5##(2008-10#2)
Method to##5##2##(2008-10#2)(2008-11#2)(2010-12#1)
Method##75##1##(1991-11#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#23)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-9#1)(2009-8#2)(2010-10#5)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
Methodologic##3##1##(1991-12#2)(1996-12#1)
Methodological##4##1##(1995-5#1)(2008-12#2)(2008-8#1)
Methodologies for##2##2##(2008-10#2)
Methodologies##3##1##(2008-10#2)(2008-11#1)
Methodology A##2##2##(2012-12#2)
Methodology for##2##2##(2008-10#1)(2012-2#1)
Methodology##16##1##(2008-10#6)(2008-3#1)(2009-8#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)
Methods -##5##2##(2008-11#5)
Methods A cross-sectional##2##3##(2011-2#2)
Methods A##8##2##(2008-10#1)(2011-2#5)(2012-12#2)
Methods The study##2##3##(2011-2#2)
Methods The##4##2##(2011-2#3)(2012-12#1)
Methods This was a descriptive##2##5##(2011-2#1)(2012-12#1)
Methods This was a##6##4##(2011-2#2)(2012-12#4)
Methods We searched##2##3##(2011-2#2)
Methods and Results##3##3##(2011-2#2)(2012-3#1)
Methods are##4##2##(2008-4#2)(2008-9#2)
Methods for the direct determination of##3##6##(2008-10#3)
Methods for the##6##3##(2008-10#4)(2008-4#1)(2008-5#1)
Methods for##28##2##(1993-12#1)(1994-2#1)(1995-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-4#5)(2008-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
Methods have been developed##2##4##(2008-10#2)
Methods in##2##2##(2009-8#1)(2013-8#1)
Methods of prophylaxis and therapy for emporiatrics##2##7##(2013-1#2)
Methods of##8##2##(1990-5#1)(1995-5#1)(1997-1#1)(2008-10#2)(2009-3#1)(2013-1#2)
Methods to##8##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#1)
Methods##257##1##(1990-5#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-9#2)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#37)(2008-11#11)(2008-12#1)(2008-3#6)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#4)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#5)(2011-1#12)(2011-2#36)(2012-12#15)(2012-2#6)(2012-3#16)(2013-1#59)(2013-8#13)
Methods- The##2##2##(2008-11#2)
Methods-##5##1##(2008-11#5)
Methods ##3##1##(2011-2#3)
Methomyl##2##1##(2008-10#2)
Methotrexate##5##1##(1992-8#1)(1995-8#3)(2010-12#1)
Methyl##8##1##(1995-3#1)(1996-5#1)(2008-10#5)(2008-8#1)
Methylation of##3##2##(2008-4#1)(2010-11#1)(2011-1#1)
Methylation##4##1##(1991-2#1)(2008-4#1)(2010-11#1)(2011-1#1)
Methylene##2##1##(2008-10#1)(2012-2#1)
Methylglyoxal##2##1##(2008-11#2)
Methylphenidate##2##1##(1995-11#1)(2010-4#1)
Metolcarb##2##1##(2008-10#2)
Metopolophium##2##1##(2008-10#2)
Metro Toronto##3##2##(1994-1#2)(1997-3#1)
Metrohm 756##2##2##(2008-10#2)
Metrohm##3##1##(2008-10#3)
Metropolitan Toronto##8##2##(1991-2#2)(1993-1#1)(1994-1#3)(1996-3#2)
Metropolitan##15##1##(1991-12#1)(1991-2#2)(1993-1#1)(1994-1#3)(1996-3#2)(2008-12#1)(2008-5#1)(2011-2#2)(2013-1#2)
Mexican National Potato Program##2##4##(2008-10#2)
Mexican and##2##2##(2008-10#1)(2012-12#1)
Mexican immigrants##3##2##(2010-12#3)
Mexican isolates##2##2##(2008-10#2)
Mexican lime##2##2##(2008-10#2)
Mexican##36##1##(1993-6#1)(1997-9#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-8#2)(2010-12#5)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)
Mexicans##2##1##(2008-12#1)(2012-3#1)
Mexico City##7##2##(1996-12#1)(2008-11#1)(2008-12#5)
Mexico and the##2##3##(2008-11#1)(2008-5#1)
Mexico and##10##2##(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2012-3#1)
Mexico was##2##2##(2008-10#2)
Mexico##83##1##(1990-8#1)(1992-5#1)(1996-12#2)(1997-3#2)(1997-8#4)(1997-9#1)(2008-10#37)(2008-11#7)(2008-12#7)(2008-3#1)(2008-5#4)(2008-8#2)(2008-9#1)(2009-8#2)(2009-9#1)(2011-2#3)(2012-12#3)(2012-3#3)(2013-1#1)
Mg and##4##2##(2008-10#3)(2008-5#1)
Mg are##2##2##(2008-10#2)
Mg in##4##2##(2008-10#4)
Mg levels##3##2##(2008-10#3)
Mg was##2##2##(2008-10#2)
Mg##75##1##(1991-5#3)(1995-6#2)(2008-10#69)(2008-5#1)
Mg(+)&gt##2##1##(2008-10#2)
Mg(2+) and##4##2##(2008-10#3)(2008-9#1)
Mg(2+) for##2##2##(2008-11#1)(2008-9#1)
Mg(2+) in##5##2##(2008-10#2)(2008-9#1)(2013-1#2)
Mg(2+) ions##3##2##(2008-10#3)
Mg(2+) is##4##2##(2008-10#4)
Mg(2+) were##3##2##(2008-10#2)(2010-4#1)
Mg(2+)##61##1##(2008-10#51)(2008-11#2)(2008-9#5)(2010-4#1)(2013-1#2)
Mg(2+)&gt##2##1##(2008-10#2)
Mg(2+))##2##1##(2008-10#2)
Mg(2+)-dependent protein phosphatase alpha##2##4##(1993-8#2)
Mg(2+)-dependent##4##1##(1992-6#1)(1993-3#1)(1993-8#2)
Mg(II) and Ca(II)##2##3##(2008-10#2)
Mg(II) and##3##2##(2008-10#3)
Mg(II) with##2##2##(2008-10#2)
Mg(II)##16##1##(2008-10#16)
Mg(NO(3))(2)##3##1##(2008-10#3)
Mg)##3##1##(2008-10#3)
Mg-CPC##2##1##(2008-10#2)
Mg-W cell-electrodeposition method##2##3##(2008-10#2)
Mg-W cell-electrodeposition##4##2##(2008-10#4)
Mg-dependent protein phosphatase##3##3##(1993-6#3)
Mg2+ and##2##2##(1991-9#1)(1995-11#1)
Mg2+ ion##2##2##(1995-6#2)
Mg2+ or##2##2##(1990-5#2)
Mg2+##31##1##(1990-2#1)(1990-5#4)(1991-9#2)(1993-6#4)(1993-8#1)(1994-5#2)(1995-11#2)(1995-2#1)(1995-6#11)(1997-3#1)(2008-4#1)(2008-6#1)
MgADP##2##1##(1994-5#2)
MgAl(2)O(4) plate as##2##3##(2008-3#2)
MgAl(2)O(4)##3##1##(2008-3#3)
MgB(2)##2##1##(2010-7#2)
MgCarb##5##1##(1994-5#5)
MgCl(2)##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
MgCl2##5##1##(1991-5#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-6#1)
MgO##3##1##(2008-10#2)(2013-8#1)
MhNPR1 expression##3##2##(2011-10#3)
MhNPR1##9##1##(2011-10#9)
Mhc genes##3##2##(2008-8#3)
Mhc##7##1##(2008-8#7)
Mi and##2##2##(2008-10#2)
Mi##6##1##(2008-10#6)
MiLV##5##1##(2008-10#5)
MiR-218##2##1##(2011-2#2)
Miami##3##1##(2008-10#1)(2008-12#1)(2008-6#1)
Mice as##2##2##(1995-9#1)(2012-3#1)
Mice carrying##2##2##(1993-12#1)(1997-8#1)
Mice that##2##2##(1995-2#2)
Mice were divided into##2##4##(2008-10#1)(2008-11#1)
Mice were##6##2##(2008-10#4)(2008-11#1)(2010-7#1)
Mice with##4##2##(1994-3#1)(1997-2#1)(2008-8#1)(2010-7#1)
Mice##35##1##(1990-6#1)(1993-12#1)(1994-12#2)(1994-3#1)(1995-2#4)(1995-8#1)(1995-9#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#2)
Micellar electrokinetic capillary chromatography##3##4##(2008-10#3)
Micellar electrokinetic##4##2##(2008-10#3)(2010-7#1)
Micellar liquid chromatography##2##3##(2008-10#1)(2010-11#1)
Micellar##15##1##(1995-3#1)(2008-10#10)(2009-8#1)(2010-11#2)(2010-7#1)
Micellar-enhanced##2##1##(2008-10#2)
Micelle##2##1##(2008-10#2)
Micelles##3##1##(1996-5#2)(2008-10#1)
Michael South##2##2##(2008-5#2)
Michael addition##3##2##(2008-10#3)
Michael##10##1##(1993-11#1)(1994-2#1)(1995-12#1)(1996-5#2)(2008-10#3)(2008-5#2)
Michaelis constant and##2##3##(2008-10#2)
Michaelis constant of##2##3##(1990-5#1)(1995-3#1)
Michaelis constant##8##2##(1990-5#1)(1993-3#1)(1994-5#1)(1995-3#1)(2008-10#4)
Michaelis constants##3##2##(1991-5#1)(1993-9#1)(1994-8#1)
Michaelis##12##1##(1990-5#1)(1991-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-3#1)(2008-10#4)
Michaelis-Menten constant was##2##3##(2008-10#2)
Michaelis-Menten constant##5##2##(2008-10#4)(2009-10#1)
Michaelis-Menten kinetics##3##2##(1994-5#1)(2008-10#1)(2008-7#1)
Michaelis-Menten##11##1##(1994-5#1)(1994-8#1)(2008-10#6)(2008-7#1)(2009-10#1)(2012-2#1)
Michel Foucault has##2##3##(1993-11#2)
Michel##5##1##(1993-11#2)(2012-3#2)(2013-1#1)
Michelson interferometer##5##2##(2007-12#2)(2008-3#3)
Michelson##8##1##(2007-12#2)(2008-3#6)
Michigan orchards##3##2##(2008-10#3)
Michigan##51##1##(1991-1#1)(1991-3#1)(1992-2#4)(1992-3#2)(1993-12#1)(1994-1#1)(1994-6#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-3#3)(1997-1#1)(1997-7#1)(2008-10#26)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
Micro RNAs are##2##3##(2011-2#2)
Micro##4##1##(2008-10#1)(2010-11#1)(2011-2#2)
Micro-Cirrus##2##1##(1995-3#2)
MicroHex((R))##3##1##(2008-11#3)
MicroRNA##4##1##(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
MicroRNAs (miRNAs)##4##2##(2010-1#1)(2011-2#1)(2013-1#2)
MicroRNAs##7##1##(2008-11#1)(2010-1#2)(2010-7#1)(2011-2#1)(2013-1#2)
Microalbuminuria is##2##2##(2013-1#2)
Microarray analysis of##2##3##(2008-7#2)
Microarray analysis##3##2##(2008-7#2)(2010-6#1)
Microarray experiments##2##2##(2008-7#1)(2011-3#1)
Microarray studies##2##2##(2012-2#2)
Microarray technology##2##2##(2008-10#1)(2008-7#1)
Microarray##15##1##(2008-10#2)(2008-6#1)(2008-7#6)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#3)
Microarrays for##2##2##(2008-7#2)
Microarrays##5##1##(2008-4#1)(2008-7#3)(2012-3#1)
Microbacterium##2##1##(2008-10#2)
Microbes##2##1##(2008-10#1)(2008-7#1)
Microbial metabolomics##2##2##(2012-3#2)
Microbial##23##1##(2008-10#12)(2008-11#4)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-3#2)
Microbiol##2##1##(1992-7#1)(1995-6#1)
Microbiological##5##1##(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)
Microbiology##6##1##(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#2)
Microbodies##3##1##(2008-10#3)
Microchip capillary electrophoresis with electrochemical detector for##2##7##(2008-10#2)
Microchip capillary electrophoresis with##3##4##(2008-10#3)
Microchip capillary electrophoresis##5##3##(2008-10#5)
Microchip capillary##6##2##(2008-10#6)
Microchip electrophoresis##2##2##(2008-10#2)
Microchip##9##1##(2008-10#9)
Micrococcus luteus##2##2##(2008-12#2)
Microcracks##2##1##(2009-7#2)
Microcycle##2##1##(2008-10#2)
Microcystins##2##1##(2008-10#1)(2012-12#1)
Microdochium nivale##3##2##(2008-10#3)
Microejections of lidocaine##2##3##(1990-9#2)
Microenvironment##2##1##(2009-10#1)(2013-1#1)
Microextraction##2##1##(2008-10#1)(2009-8#1)
Microfabricated##2##1##(2008-10#2)
Microfine##2##1##(2008-5#2)
Microfluidic##4##1##(2008-10#3)(2008-12#1)
Microglial##2##1##(1997-3#2)
Microinjection of##5##2##(1993-8#2)(1997-2#2)(2008-9#1)
Microinjections of##2##2##(1993-6#1)(1994-2#1)
Microinjections##3##1##(1993-6#1)(1994-2#1)(1996-2#1)
Micromechanics-based wavelength-sensitive photonic##2##3##(2008-3#2)
Micromonospora##2##1##(2012-2#2)
Microorganisms##4##1##(2008-10#2)(2011-2#1)(2012-2#1)
Microplots##2##1##(2008-10#2)
Microsatellite markers##2##2##(2008-10#2)
Microsatellite##8##1##(2008-10#6)(2010-7#1)(2013-8#1)
Microsatellites##2##1##(2008-10#1)(2012-3#1)
Microscale##3##1##(2008-10#1)(2008-11#1)(2012-2#1)
Microsclerotia of Verticillium dahliae##2##4##(2008-10#2)
Microsclerotia##3##1##(2008-10#3)
Microscope##3##1##(2008-11#1)(2008-4#1)(2008-9#1)
Microscopic examination##2##2##(2008-5#1)(2011-2#1)
Microscopic observation##3##2##(2008-10#2)(2008-11#1)
Microscopic observations##2##2##(2008-10#2)
Microscopic##10##1##(2008-10#5)(2008-11#3)(2008-5#1)(2011-2#1)
Microscopical##4##1##(2008-10#2)(2008-5#2)
Microscopically##7##1##(1991-8#1)(1993-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
Microscopy##8##1##(1990-11#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-10#1)
Microsoft Excel 4##2##3##(1994-2#1)(1994-3#1)
Microsoft Excel##5##2##(1994-2#1)(1994-3#2)(2008-10#2)
Microsoft##9##1##(1994-2#1)(1994-3#2)(2008-1#1)(2008-10#4)(2010-8#1)
Microsomacanthus microsoma##2##2##(2011-2#2)
Microsomacanthus##12##1##(2011-2#12)
Microsomes from##2##2##(1993-11#1)(1993-8#1)
Microsphaeropsis sp##20##2##(2008-10#20)
Microsphere##2##1##(2008-3#1)(2008-9#1)
Microsporum canis##3##2##(2008-5#3)
Microsporum##4##1##(2008-5#4)
Microstructure and##2##2##(2009-7#2)
Microstructure##4##1##(2009-7#4)
Microstructures##2##1##(2009-7#1)(2013-8#1)
Microsupport with two-dimensional geometry (2D-MS)##2##5##(2008-11#2)
Microsupport with##3##2##(2008-11#3)
Microsurgical##4##1##(1994-12#1)(1995-11#1)(2011-2#1)(2012-3#1)
Microtrombidiidae)##2##1##(2007-12#2)
Microtubules are##2##2##(2009-10#2)
Microtubules##5##1##(2008-7#1)(2009-10#2)(2009-8#1)(2011-2#1)
Microtus pennsylvanicus##3##2##(1994-3#2)(1994-8#1)
Microvascular##2##1##(2009-8#1)(2012-2#1)
Microvesicles##3##1##(1997-3#3)
Microwave##4##1##(2008-10#3)(2008-12#1)
Microwave-assisted extraction (MAE)##2##3##(2008-10#2)
Microwave-assisted extraction##4##2##(2008-10#4)
Microwave-assisted##6##1##(2008-10#5)(2012-2#1)
Micturating cystourethrograms are not necessary for all cases of antenatally diagnosed##2##11##(2008-10#2)
Mid-infrared##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
Mid-term memory and swim speed were measured##2##7##(2008-12#2)
Midbrain##2##1##(2008-7#1)(2012-12#1)
Middle American beans##3##3##(2008-10#3)
Middle American##5##2##(2008-10#5)
Middle American)##2##2##(2008-10#2)
Middle East and North##3##4##(1997-8#3)
Middle East and##5##3##(1997-8#3)(2008-10#1)(2011-2#1)
Middle East##14##2##(1995-3#3)(1997-8#3)(2008-10#5)(2011-2#3)
Middle Eastern##3##2##(2008-10#2)(2011-2#1)
Middle##35##1##(1995-3#3)(1997-8#3)(2008-10#16)(2008-11#1)(2008-12#1)(2009-10#1)(2009-9#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#2)
Midgut##2##1##(2008-10#2)
Midland##3##1##(1991-2#1)(2008-11#1)(2008-5#1)
Midwest##5##1##(1993-5#1)(2008-10#3)(2009-7#1)
Midwestern##3##1##(2008-10#1)(2008-11#1)(2010-11#1)
Midwifery and Health Visiting Contribution to Health and Health Care##2##10##(2008-11#2)
Midwifery and Health Visiting Contribution to Health##3##7##(2008-11#3)
Midwifery and Health Visiting##11##4##(2008-11#11)
Midwifery and Health##12##3##(2008-11#12)
Midwifery##18##1##(2008-11#17)(2008-12#1)
Mie scattering##4##2##(2008-2#1)(2008-3#2)(2009-12#1)
Mie theory##8##2##(2008-2#1)(2008-3#7)
Mie##16##1##(2008-2#3)(2008-3#12)(2009-12#1)
Migraine##2##1##(2008-9#2)
Migrants##2##1##(2008-10#1)(2010-8#1)
Migration and##2##2##(2008-10#1)(2009-9#1)
Migration of##5##2##(1990-12#1)(1994-3#1)(1994-8#1)(2008-12#1)(2013-1#1)
Migration##14##1##(1990-12#1)(1994-3#1)(1994-8#2)(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#2)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
Milan##6##1##(1990-12#1)(1990-8#2)(1991-6#1)(1993-6#1)(2008-10#1)
Milano##2##1##(1990-12#1)(2008-6#1)
Mild and##2##2##(1996-5#1)(2013-8#1)
Mild cognitive impairment##2##3##(2008-6#1)(2009-10#1)
Mild##11##1##(1990-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-3#2)(2013-8#1)
Mildew of##2##2##(2008-10#2)
Mildew##9##1##(2008-10#8)(2012-3#1)
Military##5##1##(1996-5#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)
Milk##5##1##(2008-10#1)(2008-11#2)(2008-12#1)(2010-12#1)
Mill##2##1##(2008-10#1)(2008-11#1)
Miller##8##1##(1992-7#1)(1995-12#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#2)
Miller-Dieker syndrome##2##2##(1997-3#2)
Millions of people##2##3##(2008-11#1)(2011-2#1)
Millions of##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
Millipore##2##1##(2008-10#1)(2008-7#1)
Millipore5##2##1##(2008-10#2)
Mills##3##1##(2008-10#3)
Mills'##2##1##(2008-10#2)
Milsana treatment##2##2##(2008-10#2)
Milsana##12##1##(2008-10#12)
Minas Gerais##4##2##(2008-5#2)(2010-10#1)(2012-3#1)
Mind the##2##2##(2012-12#1)(2012-3#1)
Mind##4##1##(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#1)
Mindfulness##2##1##(2012-2#2)
Mindfulness-Based##3##1##(2013-1#3)
Mineral##4##1##(1991-12#1)(2008-10#3)
Mineralization##2##1##(2008-10#1)(2008-11#1)
Mini##7##1##(2008-11#4)(2008-7#1)(2011-2#1)(2013-1#1)
Mini-Mental State Examination (MMSE)##2##4##(2008-7#2)
Mini-Mental State Examination##6##3##(2008-7#5)(2013-1#1)
Mini-Mental State##7##2##(2008-12#1)(2008-7#5)(2013-1#1)
Miniature##4##1##(2008-10#3)(2010-7#1)
Miniaturized##2##1##(2008-10#1)(2008-11#1)
Minicontainer-test##2##1##(2008-11#2)
Minimal decreases in hematocrit##2##4##(2008-9#2)
Minimal##10##1##(1993-12#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#1)
Minimally invasive surgery##2##3##(2008-7#1)(2013-1#1)
Minimally invasive video-assisted##2##3##(2012-12#2)
Minimally invasive##9##2##(2008-7#1)(2011-2#1)(2012-12#4)(2013-1#3)
Minimally##10##1##(2008-7#1)(2011-2#1)(2012-12#4)(2013-1#4)
Minimizing##2##1##(2008-8#1)(2009-12#1)
Minimum Data Set##4##3##(1995-2#1)(2008-11#2)(2008-7#1)
Minimum inhibitory##2##2##(2008-7#1)(2010-2#1)
Minimum##14##1##(1991-11#1)(1995-2#1)(1996-9#1)(2008-10#6)(2008-11#2)(2008-7#2)(2010-2#1)
Mining is##2##2##(2012-2#1)(2013-1#1)
Mining##3##1##(2008-6#1)(2012-2#1)(2013-1#1)
Ministry of Health and Welfare##2##5##(1997-8#1)(2008-5#1)
Ministry of Health and##7##4##(1991-2#1)(1993-1#1)(1993-6#2)(1997-8#1)(2008-5#1)(2013-1#1)
Ministry of Health regulations##2##4##(2008-10#2)
Ministry of Health##21##3##(1991-2#3)(1993-1#1)(1993-6#2)(1994-1#1)(1994-12#1)(1997-8#1)(2008-1#2)(2008-10#5)(2008-5#1)(2010-8#1)(2012-12#2)(2013-1#1)
Ministry of Public##2##3##(1991-3#1)(2008-10#1)
Ministry of##28##2##(1991-2#3)(1991-3#1)(1993-1#1)(1993-6#2)(1994-1#1)(1994-12#1)(1995-3#1)(1996-8#1)(1997-8#1)(2008-1#2)(2008-10#7)(2008-5#1)(2009-10#1)(2010-10#1)(2010-8#1)(2012-12#2)(2013-1#1)
Ministry##33##1##(1991-2#4)(1991-3#1)(1993-1#1)(1993-6#2)(1994-1#2)(1994-12#1)(1994-3#1)(1995-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#7)(2008-5#1)(2009-10#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
Minneola tangelo##3##2##(2008-10#3)
Minneola##7##1##(2008-10#7)
Minnesota in##2##2##(2008-10#2)
Minnesota locations##2##2##(2008-10#2)
Minnesota##44##1##(1990-2#2)(1991-2#2)(1994-2#1)(1995-1#1)(1995-12#4)(1996-2#1)(1996-5#1)(1997-3#2)(2008-10#23)(2010-1#1)(2011-2#1)(2012-12#4)(2012-2#1)
Minocycline##2##1##(2008-7#2)
Minor##14##1##(1993-12#2)(1993-3#1)(1996-1#1)(1996-9#1)(1997-2#1)(2008-10#4)(2009-12#1)(2011-2#2)(2013-8#1)
Mint virus 1##2##3##(2008-10#2)
Minute##2##1##(1995-6#1)(2008-11#1)
Mirafiori lettuce virus##2##3##(2008-10#2)
Mirror##3##1##(2008-3#2)(2008-6#1)
Miscellaneous##3##1##(2007-12#1)(2009-6#1)(2011-2#1)
Mishel Uncertainty in Illness##2##4##(2010-10#2)
Mishel##3##1##(2010-10#3)
Misoprostol##2##1##(2008-11#2)
Miss##2##1##(1992-11#1)(1994-2#1)
Missed opportunities for##2##3##(1996-12#2)
Missed##3##1##(1996-12#2)(2013-1#1)
Missing##2##1##(1993-2#1)(2010-5#1)
Mission##2##1##(2008-3#1)(2012-3#1)
Mississippi##10##1##(2008-10#7)(2009-3#3)
Missouri Department of Health##2##4##(1991-12#1)(1995-12#1)
Missouri##27##1##(1991-12#2)(1991-2#1)(1992-3#1)(1994-1#1)(1995-12#3)(1995-6#2)(1996-2#2)(1997-1#1)(2008-10#12)(2013-8#2)
Misty##2##1##(2008-10#1)(2011-2#1)
Mitigation##2##1##(2009-5#1)(2013-1#1)
Mitochondria##4##1##(1994-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
Mitochondrial DNA control region variation in##2##6##(2008-12#2)
Mitochondrial DNA control region##3##4##(2008-12#3)
Mitochondrial DNA##7##2##(2008-10#1)(2008-12#4)(2008-6#2)
Mitochondrial Genome##2##2##(2008-10#1)(2008-5#1)
Mitochondrial##16##1##(1994-5#1)(1995-6#1)(1997-1#1)(2008-10#4)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#1)(2012-2#1)
Mitogen-activated protein##3##2##(1995-8#1)(2009-8#1)(2012-2#1)
Mitogenic##2##1##(1994-11#1)(1995-2#1)
Mitomycin C##3##2##(1992-12#1)(1997-7#1)(2008-11#1)
Mitomycin##4##1##(1992-12#1)(1994-2#1)(1997-7#1)(2008-11#1)
Mitosis is a##2##3##(2008-10#1)(2009-8#1)
Mitotic##6##1##(1995-2#1)(2008-10#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
Mitovirus##5##1##(2008-10#5)
Mitoxantrone##2##1##(1991-6#2)
Mitral valve##2##2##(1993-1#1)(2013-1#1)
Mitral##5##1##(1993-1#1)(1993-3#1)(2008-11#1)(2013-1#2)
Mixed infections of##2##3##(2008-10#2)
Mixed infections were##4##3##(2008-10#4)
Mixed infections##6##2##(2008-10#6)
Mixed reagents of##2##3##(2008-10#2)
Mixed##18##1##(2008-1#1)(2008-10#12)(2008-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
Mixing##5##1##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
Mixture##5##1##(2008-10#3)(2009-7#1)(2012-3#1)
Mixtures of##10##2##(2008-10#9)(2008-5#1)
Mixtures##14##1##(2008-10#13)(2008-5#1)
Ml 36##2##2##(2011-2#2)
Ml##3##1##(2011-2#3)
MlRE##6##1##(2008-10#6)
Mlo##5##1##(2008-10#5)
MluI##2##1##(1993-8#1)(2008-10#1)
MmLim15##3##1##(1995-6#3)
Mmd1 and Mxc3 in that##2##5##(2008-10#2)
Mmd1##9##1##(2008-10#9)
Mn and Ni##5##3##(2008-10#5)
Mn and Pb##4##3##(2008-10#4)
Mn and Zn##3##3##(2008-10#3)
Mn and##18##2##(2008-10#17)(2010-6#1)
Mn concentration##2##2##(2008-10#1)(2008-12#1)
Mn in##4##2##(2008-10#4)
Mn increased##2##2##(2008-10#2)
Mn ions in##2##3##(2008-10#1)(2008-8#1)
Mn ions##4##2##(2008-10#1)(2008-8#3)
Mn oxidation##2##2##(2008-10#2)
Mn was##3##2##(2008-10#3)
Mn##120##1##(2008-10#114)(2008-12#2)(2008-8#3)(2010-6#1)
Mn(+2) concentration##2##2##(2008-7#2)
Mn(2+) and##2##2##(2008-10#1)(2008-11#1)
Mn(2+) ions##2##2##(2008-10#1)(2008-7#1)
Mn(2+)##20##1##(2008-10#15)(2008-11#1)(2008-7#2)(2011-1#2)
Mn(2+)-dependent peroxidase##2##2##(2011-1#2)
Mn(II##2##1##(2008-10#2)
Mn(II) and Cr(III)##3##3##(2008-10#3)
Mn(II) and##7##2##(2008-10#7)
Mn(II) in##2##2##(2008-10#2)
Mn(II) were##2##2##(2008-10#2)
Mn(II)##48##1##(2008-10#48)
Mn(IV)##3##1##(2008-10#3)
Mn- and##2##2##(2008-10#2)
Mn-P(r)##2##1##(2008-10#2)
Mn-TCPP##2##1##(2008-10#2)
Mn-cluster##2##1##(2008-8#2)
Mn2+ and Ca2+ ions##2##4##(1995-6#2)
Mn2+ and Ca2+##3##3##(1995-6#3)
Mn2+ ion##2##2##(1993-8#1)(1995-6#1)
Mn2+##14##1##(1990-5#2)(1993-6#1)(1993-8#2)(1994-6#1)(1995-2#1)(1995-6#5)(1997-3#1)(1997-7#1)
Mn2O2##3##1##(2008-8#3)
MnCl(2)##2##1##(2008-10#1)(2008-7#1)
MnHCF##2##1##(2008-10#2)
MnO(2) nucleation##2##2##(2008-10#2)
MnO(2)##8##1##(2008-10#8)
MnO(2)-impregnated fibers##4##2##(2008-10#4)
MnO(4)(-)##4##1##(2008-10#4)
MnP gene##2##2##(2011-1#2)
MnP##7##1##(2008-7#4)(2011-1#3)
MnSOD activity and mRNA##2##4##(1995-6#2)
MnSOD gene##2##2##(1995-6#2)
MnSOD mRNA by irradiation##3##4##(1995-6#3)
MnSOD mRNA##6##2##(1995-6#6)
MnSOD transcripts##2##2##(1995-6#2)
MnSOD##13##1##(1995-6#13)
Mo and Bi##4##3##(2008-10#4)
Mo and##9##2##(1995-2#1)(2008-10#8)
Mo in##4##2##(2008-10#4)
Mo was##3##2##(2008-10#3)
Mo with##2##2##(2008-10#2)
Mo##52##1##(1994-2#1)(1995-2#7)(2008-10#42)(2008-5#1)(2010-1#1)
Mo(6+)##2##1##(2008-10#2)
Mo(VI) and W(VI)##3##3##(2008-10#3)
Mo(VI) and##5##2##(2008-10#5)
Mo(VI) is##2##2##(2008-10#2)
Mo(VI)##21##1##(2008-10#21)
Mo+Pd+TA or Mo+Pt+TA##2##3##(2008-10#2)
Mo17##9##1##(2008-10#9)
MoAb binding##2##2##(1993-1#2)
MoAb production##3##2##(2008-11#3)
MoAb##8##1##(1993-1#2)(2008-11#3)(2008-7#2)(2008-8#1)
MoAbs##6##1##(1991-2#1)(1993-1#2)(1995-12#2)(2008-7#1)
MoS(2)##3##1##(2010-4#3)
Mobile phase was##2##3##(2008-10#2)
Mobile##3##1##(2008-10#2)(2008-7#1)
Mobility##3##1##(1992-11#1)(2008-10#1)(2013-1#1)
Mobilization of##3##2##(1992-12#1)(2008-7#1)(2010-8#1)
Mobilization##6##1##(1992-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
Mock##3##1##(1994-5#1)(2008-8#2)
Modafinil##2##1##(2009-7#2)
Modal##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
Modalities##2##1##(2010-7#1)(2013-1#1)
Mode of##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
Mode##8##1##(1996-5#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)
Mode-Locked##2##1##(2008-3#2)
Model 2##2##2##(2008-10#1)(2008-8#1)
Model 8000##2##2##(2011-2#2)
Model and##2##2##(2008-11#2)
Model calculations##2##2##(2008-10#1)(2008-3#1)
Model for##11##2##(1992-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2011-9#1)(2012-12#1)(2012-3#1)
Model of##6##2##(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
Model parameters##3##2##(2008-10#2)(2011-2#1)
Model predictions were##2##3##(2008-10#1)(2008-7#1)
Model predictions##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)
Model simulations##2##2##(2008-7#1)(2013-8#1)
Model was designed##2##3##(2010-8#2)
Model was##3##2##(2008-10#1)(2010-8#2)
Model with##2##2##(2011-2#1)(2012-3#1)
Model##77##1##(1992-12#1)(1992-2#1)(1997-6#1)(2008-10#19)(2008-11#14)(2008-12#1)(2008-3#4)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2010-10#1)(2010-8#3)(2011-2#5)(2011-9#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
Modeled##3##1##(2008-3#2)(2011-1#1)
Modeling and optimization of##2##4##(2008-3#1)(2008-7#1)
Modeling and##3##2##(2008-3#1)(2008-7#1)(2010-7#1)
Modeling in##2##2##(2008-10#1)(2012-2#1)
Modeling of the##8##3##(1994-5#1)(2008-10#3)(2008-3#2)(2010-11#1)(2012-2#1)
Modeling of##13##2##(1994-5#1)(2008-10#6)(2008-3#2)(2009-12#2)(2010-11#1)(2012-2#1)
Modeling the##6##2##(2008-10#3)(2008-3#1)(2008-7#1)(2011-3#1)
Modeling##41##1##(1994-5#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#4)(2009-12#2)(2009-7#1)(2010-11#1)(2010-7#1)(2011-3#1)(2012-2#4)(2013-8#3)
Modelling of the##2##3##(2008-10#1)(2008-11#1)
Modelling of##5##2##(2008-10#3)(2008-11#2)
Modelling the##4##2##(2008-10#2)(2011-3#1)(2013-8#1)
Modelling##12##1##(2008-10#5)(2008-11#3)(2010-7#1)(2011-2#1)(2011-3#1)(2013-8#1)
Models for##4##2##(2008-10#2)(2008-4#1)(2010-1#1)
Models of the effects of##2##5##(2008-10#1)(2008-9#1)
Models of the##7##3##(2008-10#3)(2008-9#2)(2009-6#1)(2013-8#1)
Models of##16##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-7#1)(2012-3#1)(2013-8#1)
Models using##2##2##(2008-10#2)
Models were##2##2##(2008-10#2)
Models##46##1##(1995-3#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Moderate##9##1##(1990-10#1)(1991-5#1)(1994-6#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-11#1)(2012-3#1)
Moderately##2##1##(2008-10#1)(2013-8#1)
Modern medicine##2##2##(1993-11#1)(2008-10#1)
Modern##18##1##(1990-11#1)(1991-12#1)(1993-11#1)(1994-5#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Modernising##2##1##(2008-11#1)(2009-4#1)
Modes of##2##2##(2008-3#1)(2008-8#1)
Modes##3##1##(2008-10#1)(2008-3#1)(2008-8#1)
Modest##2##1##(1995-11#1)(2008-5#1)
Modification of Diet in Renal Disease##2##6##(1994-3#1)(2011-2#1)
Modification of the##4##3##(1997-2#1)(2008-10#2)(2008-8#1)
Modification of##18##2##(1994-3#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-2#1)
Modification##20##1##(1994-3#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#1)
Modifications of##6##2##(1993-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)
Modifications to the##2##3##(1997-5#1)(2008-11#1)
Modifications##10##1##(1993-2#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-8#2)
Modified##21##1##(1990-12#1)(1991-2#1)(1993-12#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-9#1)(2009-8#2)(2011-2#1)(2012-2#2)(2013-1#1)
Modifying##2##1##(1991-1#1)(1993-12#1)
Modular##2##1##(1991-5#1)(2009-4#1)
Modulated##2##1##(2008-10#1)(2013-8#1)
Modulating##2##1##(2012-2#1)(2013-7#1)
Modulation of cellular##2##3##(1992-12#2)
Modulation of the##2##3##(2012-3#1)(2013-1#1)
Modulation of##23##2##(1992-12#2)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-8#1)(1995-9#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-7#2)(2009-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Modulation##25##1##(1992-12#2)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-8#1)(1995-9#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Modulatory##3##1##(1996-2#1)(1997-2#1)(2009-3#1)
Module##3##1##(2008-11#1)(2008-12#1)(2008-3#1)
Modules##2##1##(2008-3#2)
Mogenson##3##1##(1993-6#3)
Moina macrocopa##2##2##(2011-2#2)
Moisture induced solid phase degradation of l-ascorbic acid part##2##9##(2008-10#2)
Moisture induced solid phase degradation of l-ascorbic acid##3##8##(2008-10#3)
Moisture induced##4##2##(2008-10#4)
Moisture##11##1##(2008-10#10)(2008-5#1)
Moisturizing##3##1##(2008-5#3)
Mol##7##1##(1990-7#1)(1991-5#1)(1993-8#1)(1995-12#1)(1997-8#1)(2008-10#1)(2010-7#1)
Molar volumes and solubility parameters of##2##6##(2008-10#2)
Molar##5##1##(2008-10#2)(2010-10#1)(2012-12#1)(2013-1#1)
Mold##9##1##(2008-10#9)
Molec##2##1##(1990-10#1)(1992-9#1)
Molecular Beacons##2##2##(2008-10#2)
Molecular Biology##3##2##(1997-7#2)(2008-10#1)
Molecular Characterization of Fusarium oxysporum##2##5##(2008-10#2)
Molecular Characterization of a##2##4##(2008-10#1)(2008-6#1)
Molecular Characterization of##9##3##(2008-10#7)(2008-6#1)(2012-2#1)
Molecular Characterization##11##2##(2008-10#9)(2008-6#1)(2012-2#1)
Molecular Detection of Phytophthora ramorum##2##5##(2008-10#2)
Molecular Detection of##4##3##(2008-10#4)
Molecular Diversity##2##2##(2008-10#2)
Molecular Dynamics##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
Molecular Ecology##5##2##(2013-1#5)
Molecular Evidence##3##2##(2008-10#3)
Molecular Identification and##2##3##(2008-10#1)(2012-2#1)
Molecular Identification##4##2##(2008-10#3)(2012-2#1)
Molecular Imaging of##2##3##(2012-2#2)
Molecular Imaging##3##2##(2012-2#2)(2013-1#1)
Molecular Mapping of the##2##4##(2008-10#2)
Molecular Mapping of##5##3##(2008-10#5)
Molecular Markers Linked to##2##4##(2008-10#2)
Molecular Markers##5##2##(2008-10#5)
Molecular Phylogenetic Analyses of##2##4##(2008-10#2)
Molecular Properties of##2##3##(2008-10#1)(2008-4#1)
Molecular Variability Within##2##3##(2008-10#2)
Molecular Variability##3##2##(2008-10#3)
Molecular analyses of the##2##4##(2008-10#2)
Molecular analyses of##4##3##(2008-10#4)
Molecular analyses##7##2##(2008-10#7)
Molecular analysis of the##3##4##(2008-11#1)(2008-5#1)(2013-1#1)
Molecular analysis of##9##3##(1993-12#1)(1994-12#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-1#1)
Molecular analysis##14##2##(1993-12#1)(1994-12#1)(1995-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
Molecular and Biological Characterization of##3##5##(2008-10#3)
Molecular and Biological##4##3##(2008-10#4)
Molecular and##15##2##(1992-3#1)(1992-6#1)(1995-3#1)(2008-10#9)(2008-11#1)(2010-1#1)(2011-2#1)
Molecular aspects of##2##3##(2008-10#1)(2009-4#1)
Molecular beacons are single-stranded nucleic acid##2##6##(2008-10#1)(2008-9#1)
Molecular beacons##3##2##(2008-10#2)(2008-9#1)
Molecular cancer vaccines##2##3##(2008-5#2)
Molecular chaperones##2##2##(1995-2#1)(2010-4#1)
Molecular characterization of a##2##4##(1997-8#1)(2008-10#1)
Molecular characterization of the##2##4##(2008-10#2)
Molecular characterization of##4##3##(1997-8#1)(2008-10#3)
Molecular cloning and characterization of the##2##6##(1993-3#1)(1997-8#1)
Molecular cloning and characterization of##4##5##(1992-3#1)(1993-3#1)(1993-8#1)(1997-8#1)
Molecular cloning and expression##2##4##(1990-5#1)(2008-8#1)
Molecular cloning and sequencing of##2##5##(1993-3#1)(1997-1#1)
Molecular cloning and##11##3##(1990-5#1)(1992-3#1)(1993-3#2)(1993-8#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-8#2)
Molecular cloning of a##3##4##(1993-3#1)(1993-8#1)(1997-7#1)
Molecular cloning of human##2##4##(1993-3#1)(1994-11#1)
Molecular cloning of rat##2##4##(1991-12#1)(1994-11#1)
Molecular cloning of##11##3##(1990-8#1)(1991-12#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-11#4)(1997-7#1)
Molecular cloning##25##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#4)(1993-8#2)(1994-11#4)(1995-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-8#4)
Molecular epidemiology##2##2##(2008-10#1)(2011-2#1)
Molecular evidence##4##2##(2007-12#1)(2008-10#1)(2008-8#2)
Molecular evolution of##2##3##(1997-6#1)(2010-5#1)
Molecular evolution##4##2##(1997-6#3)(2010-5#1)
Molecular identification##2##2##(2008-10#1)(2011-2#1)
Molecular imaging with targeted contrast agents##2##6##(2010-9#2)
Molecular imaging##3##2##(2010-9#2)(2011-1#1)
Molecular mapping of the##2##4##(2008-10#2)
Molecular mapping of##5##3##(2008-10#4)(2008-8#1)
Molecular mapping##6##2##(2008-10#5)(2008-8#1)
Molecular marker##2##2##(2008-10#2)
Molecular markers##4##2##(1995-9#1)(2008-10#3)
Molecular mechanism of##2##3##(2008-8#1)(2008-9#1)
Molecular mechanisms of##2##3##(1992-6#1)(2008-1#1)
Molecular mechanisms underlying##2##3##(1997-8#1)(2010-5#1)
Molecular mechanisms##5##2##(1992-6#1)(1997-8#1)(2008-1#1)(2008-7#1)(2010-5#1)
Molecular modeling of nucleic acid structure##3##6##(2008-4#3)
Molecular modeling of##4##3##(2008-4#3)(2011-2#1)
Molecular modeling##7##2##(1994-5#2)(2008-10#1)(2008-4#3)(2011-2#1)
Molecular orientation of##3##3##(2008-10#3)
Molecular orientation##4##2##(2008-10#4)
Molecular phylogenetic analyses##2##3##(2008-10#2)
Molecular phylogenetic##5##2##(2008-10#3)(2008-6#1)(2008-8#1)
Molecular recognition and##2##3##(2008-10#2)
Molecular recognition##3##2##(2008-10#3)
Molecular studies##3##2##(2009-8#1)(2011-2#2)
Molecular variability of##2##3##(2008-10#2)
Molecular variability##3##2##(2008-10#3)
Molecular##257##1##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#2)(1992-6#4)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-8#2)(1994-11#5)(1994-12#2)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#4)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#120)(2008-11#5)(2008-12#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#4)(2009-1#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#13)(2012-2#9)(2013-1#9)(2013-8#2)
Molecularly imprinted##2##2##(2008-10#2)
Molecules in##2##2##(1992-9#1)(2008-12#1)
Molecules##6##1##(1992-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-8#1)
Molndal technique##7##2##(2011-2#7)
Moloney murine##2##2##(2008-11#2)
Moloney##4##1##(2008-11#4)
Molt-Inhibiting##2##1##(2008-5#1)(2008-6#1)
Molten##2##1##(1996-9#1)(2007-11#1)
Molybdate##2##1##(2008-10#2)
Molybdenum##6##1##(2008-10#5)(2008-11#1)
Momentum##2##1##(1996-9#1)(2010-10#1)
Monastic##2##1##(2008-11#2)
Monastir##2##1##(2007-8#2)
Mongol of##2##2##(2008-9#2)
Mongolia##14##1##(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#11)
Monilinia fructicola and##3##3##(2008-10#3)
Monilinia fructicola##19##2##(2008-10#19)
Monilinia oxycocci##2##2##(2008-10#2)
Monilinia vaccinii-corymbosi##7##2##(2008-10#7)
Monilinia##31##1##(2008-10#31)
Monitor##3##1##(2008-10#1)(2008-3#1)(2010-7#1)
Monitoring System##2##2##(2013-1#1)(2013-8#1)
Monitoring and##3##2##(1997-2#1)(2008-10#1)(2013-1#1)
Monitoring in##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
Monitoring of pigmented##2##3##(2008-10#2)
Monitoring of##16##2##(1992-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2010-1#1)(2013-8#1)
Monitoring the##2##2##(2008-10#1)(2010-7#1)
Monitoring##58##1##(1992-12#1)(1994-1#1)(1996-6#1)(1997-2#1)(2008-10#24)(2008-11#6)(2008-3#6)(2008-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#2)
Mono Mac 6##2##3##(1997-1#2)
Mono Q HR 5/5##2##4##(2008-10#2)
Mono Q##3##2##(1994-6#1)(2008-10#2)
Mono##6##1##(1992-8#1)(1994-6#1)(1997-1#2)(2008-10#2)
Mono- and##2##2##(2008-10#1)(2012-12#1)
Monoclonal Antibodies##3##2##(2008-10#2)(2012-2#1)
Monoclonal Antibody##3##2##(1997-7#1)(2008-11#1)(2012-3#1)
Monoclonal antibodies against##2##3##(2008-11#1)(2008-9#1)
Monoclonal antibodies##9##2##(1990-5#1)(1992-12#1)(1994-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
Monoclonal antibody##7##2##(1990-5#1)(1994-5#2)(2008-11#2)(2008-5#1)(2008-8#1)
Monoclonal##23##1##(1990-5#2)(1992-12#1)(1994-5#3)(1995-12#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
Monocytes##2##1##(1995-2#1)(1996-12#1)
Monolithic##2##1##(2008-10#1)(2008-3#1)
Monomers##3##1##(2008-10#1)(2008-2#1)(2013-1#1)
Mononuclear cells (MNCs) were isolated by Ficoll-Paque gradient and plated onto 48-well culture plates precoated with##2##16##(2008-11#2)
Mononuclear cells##3##2##(2008-11#2)(2008-9#1)
Mononuclear##6##1##(1990-12#1)(2008-11#2)(2008-9#1)(2012-12#1)(2012-3#1)
Monostotic fibrous dysplasia##2##3##(2013-1#2)
Monoterpenes##4##1##(2008-10#1)(2013-1#2)(2013-8#1)
Monotherapy##2##1##(1991-6#1)(2012-12#1)
Monotone##2##1##(2008-11#2)
Montaigne##3##1##(2012-3#3)
Montana##2##1##(2008-10#1)(2008-8#1)
Montanide ISA50##3##2##(1996-12#3)
Montanide##4##1##(1995-5#1)(1996-12#3)
Monte Carlo method##6##3##(2008-10#1)(2008-3#4)(2008-6#1)
Monte Carlo numerical##2##3##(1995-12#1)(2008-3#1)
Monte Carlo simulation##8##3##(1990-12#1)(2008-10#2)(2008-4#1)(2009-11#1)(2011-2#2)(2013-8#1)
Monte Carlo simulations to##3##4##(2008-2#1)(2008-3#1)(2011-2#1)
Monte Carlo simulations##9##3##(2008-10#1)(2008-2#1)(2008-3#4)(2011-2#1)(2012-3#1)(2013-1#1)
Monte Carlo statistical##2##3##(2008-3#2)
Monte Carlo techniques##2##3##(2008-10#1)(2008-3#1)
Monte Carlo##45##2##(1990-12#1)(1992-11#1)(1992-9#1)(1995-12#1)(2008-10#9)(2008-2#2)(2008-3#16)(2008-4#1)(2008-6#1)(2009-11#3)(2009-12#1)(2009-4#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
Monte-Carlo analysis##2##2##(2008-10#2)
Monte-Carlo simulation##2##2##(2008-10#2)
Monte-Carlo##5##1##(2008-10#5)
Monterey##3##1##(2008-10#2)(2008-11#1)
Month##2##1##(2008-12#2)
Monthly fluctuations of worm burdens and##2##6##(1996-12#2)
Monthly##6##1##(1991-12#1)(1991-3#1)(1996-12#2)(2008-10#1)(2012-3#1)
Montipora##3##1##(2008-6#3)
Montreal Protocol##4##2##(1996-1#3)(1996-2#1)
Montreal##6##1##(1991-12#1)(1996-1#4)(1996-2#1)
Mood was##2##2##(2008-12#1)(2009-3#1)
Mood##4##1##(2008-12#1)(2009-3#1)(2012-12#1)(2012-3#1)
Moore##2##1##(1991-12#1)(2008-10#1)
Moral##6##1##(1991-2#1)(1997-2#1)(2008-11#3)(2013-8#1)
Moran##3##1##(2008-5#1)(2008-8#2)
Moraxella bovis##2##2##(2011-2#1)(2013-8#1)
Morbidity and##2##2##(1992-12#1)(1995-3#1)
Morbidity##12##1##(1992-12#1)(1994-6#1)(1995-3#2)(2008-1#1)(2008-12#1)(2008-7#3)(2009-10#1)(2011-9#1)(2012-12#1)
Morbus Gaucher##2##2##(2008-10#2)
More Individuals Hypothesis##4##3##(2008-9#4)
More aggressive##2##2##(2008-10#1)(2011-2#1)
More clinical trials##2##3##(1993-3#1)(2010-12#1)
More detailed##2##2##(2008-10#1)(2008-2#1)
More effective##2##2##(2008-10#1)(2013-1#1)
More highly aligned alliances##2##4##(2013-1#2)
More importantly##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-7#1)
More knowledge##2##2##(1993-6#1)(2008-7#1)
More on##2##2##(1994-6#1)(2009-12#1)
More recent##4##2##(1992-11#1)(1993-11#1)(2008-4#1)(2008-5#1)
More recently it has##2##4##(1990-9#1)(1997-8#1)
More recently it##3##3##(1990-9#1)(1997-8#1)(2011-2#1)
More recently##23##2##(1990-9#1)(1991-12#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-11#1)(2011-2#4)(2012-3#2)
More research##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
More significantly##2##2##(1997-3#1)(2013-1#1)
More specifically##7##2##(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
More studies are needed to##3##5##(1991-3#1)(2008-8#1)(2012-3#1)
More studies##4##2##(1991-3#1)(2008-8#1)(2012-12#1)(2012-3#1)
More than 3##2##3##(1990-12#1)(2008-9#1)
More than 300##2##3##(2008-10#1)(2010-12#1)
More than 60##2##3##(2012-12#1)(2013-8#1)
More than 70% of##2##4##(2008-10#1)(2012-2#1)
More than 80% of##3##4##(1992-6#1)(2008-10#1)(2008-8#1)
More than a##2##3##(2008-11#1)(2008-5#1)
More than half of the patients##2##6##(1990-9#1)(1992-6#1)
More than half of the##4##5##(1990-9#1)(1992-6#1)(2008-10#1)(2010-3#1)
More than half of##6##4##(1990-9#1)(1992-6#1)(2008-10#1)(2009-4#1)(2010-3#1)(2012-2#1)
More than half##10##3##(1990-9#1)(1992-6#2)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
More than one##4##3##(1996-8#1)(2008-10#2)(2013-1#1)
More than##47##2##(1990-12#1)(1990-9#1)(1992-6#3)(1994-3#1)(1995-8#1)(1996-8#1)(1997-6#1)(2008-10#11)(2008-11#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-11#2)(2010-12#2)(2010-3#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
More work is##2##3##(2008-10#1)(2010-4#1)
More work##4##2##(1994-3#1)(2008-10#2)(2010-4#1)
More##172##1##(1990-12#1)(1990-5#1)(1990-9#2)(1991-12#2)(1991-3#1)(1992-11#2)(1992-12#1)(1992-6#3)(1993-11#1)(1993-3#1)(1993-6#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-6#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#3)(2007-8#1)(2008-1#3)(2008-10#36)(2008-11#14)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#2)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#9)(2013-8#6)
Morene##2##1##(2008-10#2)
Moreover in##2##2##(1990-9#1)(2008-7#1)
Moreover the##4##2##(1990-3#1)(2008-10#2)(2011-3#1)
Moreover##424##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#3)(1993-9#2)(1994-11#6)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#4)(1995-12#7)(1995-2#1)(1995-6#3)(1995-8#3)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#110)(2008-11#51)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#11)(2009-1#2)(2009-10#2)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#5)(2010-10#3)(2010-11#2)(2010-3#1)(2010-5#4)(2010-6#4)(2010-7#2)(2011-1#2)(2011-10#2)(2011-2#22)(2011-3#3)(2012-12#1)(2012-2#10)(2012-3#7)(2012-5#1)(2012-9#1)(2013-1#19)(2013-8#7)
Morimoto##2##1##(1993-8#2)
Morin-APSG was##2##2##(2008-10#2)
Moringa oleifera Lam##2##3##(2008-10#2)
Moringa oleifera##4##2##(2008-10#4)
Morisita's I(delta)##2##2##(2008-8#2)
Mormyrus rume proboscirostris##2##3##(2010-8#2)
Morning##2##1##(1996-1#1)(2011-2#1)
Moroccan argan##2##2##(2011-2#2)
Moroccan##6##1##(1995-12#1)(1996-11#1)(2008-10#2)(2011-2#2)
Morocco##6##1##(2008-10#3)(2009-9#1)(2011-2#1)(2013-1#1)
Morocco]##2##1##(1994-12#1)(2013-1#1)
Morphine and##2##2##(1992-3#1)(2008-10#1)
Morphine##6##1##(1991-5#1)(1992-3#2)(1996-2#1)(2008-10#1)(2008-12#1)
Morphofunctional aspects of##2##3##(1993-5#1)(2008-7#1)
Morphogenesis##2##1##(1992-12#1)(2008-10#1)
Morphol##7##1##(2011-2#7)
Morphologic##4##1##(1992-12#1)(1992-2#1)(2008-10#1)(2010-1#1)
Morphological and##6##2##(1994-8#1)(2007-12#2)(2008-10#1)(2008-7#1)(2012-2#1)
Morphological aspects##2##2##(2007-12#1)(2008-5#1)
Morphological characteristics##2##2##(2008-10#2)
Morphological characterization##2##2##(2008-10#2)
Morphological information##2##2##(2008-10#1)(2008-9#1)
Morphological##29##1##(1994-8#1)(2007-12#4)(2008-10#15)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)
Morphologically##3##1##(2008-7#1)(2009-8#1)(2011-2#1)
Morphology and##6##2##(2008-10#3)(2008-5#1)(2010-6#1)(2011-2#1)
Morphology##11##1##(1996-6#1)(2008-10#6)(2008-5#1)(2009-3#1)(2010-6#1)(2011-2#1)
Morphometric analysis##2##2##(2007-12#1)(2008-8#1)
Morphometric##5##1##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
Morris water maze test##2##4##(2008-12#1)(2011-2#1)
Morris water maze##6##3##(1993-3#1)(1994-3#2)(2008-12#2)(2011-2#1)
Morris##10##1##(1993-3#2)(1994-2#1)(1994-3#2)(1994-8#1)(2008-12#2)(2009-7#1)(2011-2#1)
Mortality and##2##2##(1996-12#1)(2008-7#1)
Mortality from##3##2##(1992-6#1)(1994-8#1)(1996-2#1)
Mortality in a##2##3##(2009-10#1)(2012-3#1)
Mortality in patients##2##3##(1992-12#1)(1993-2#1)
Mortality in##9##2##(1990-3#1)(1991-12#1)(1992-12#1)(1993-2#1)(1994-2#1)(1996-2#1)(2009-10#2)(2012-3#1)
Mortality of##4##2##(1990-6#1)(2008-10#2)(2008-12#1)
Mortality rates were##2##3##(1995-3#1)(2013-8#1)
Mortality related to##2##3##(1993-6#1)(2011-2#1)
Mortality was##2##2##(2011-2#1)(2013-8#1)
Mortality##40##1##(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#3)
Morton##2##1##(1995-6#2)
Morton's##4##1##(1995-6#3)(2012-2#1)
Morus alba##5##2##(2008-5#1)(2011-3#4)
Morvant##4##1##(1995-6#4)
Mosaic##4##1##(2008-10#3)(2008-12#1)
Moser##2##1##(1994-5#2)
Most (&gt##2##2##(1997-3#1)(2008-10#1)
Most available##2##2##(2008-11#1)(2013-1#1)
Most cases of##2##3##(1991-12#1)(2008-7#1)
Most cases##5##2##(1991-12#1)(1996-8#1)(2008-10#1)(2008-7#2)
Most cells##2##2##(2007-12#1)(2013-1#1)
Most common##2##2##(2008-10#1)(2008-12#1)
Most current##3##2##(1995-5#1)(2008-11#1)(2011-3#1)
Most data##2##2##(2008-12#1)(2009-7#1)
Most frequently##2##2##(1995-5#1)(2010-8#1)
Most important##2##2##(2008-10#1)(2008-8#1)
Most importantly##9##2##(1994-5#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2009-6#1)(2011-2#1)
Most modern##2##2##(2008-9#1)(2011-2#1)
Most newer##2##2##(2008-9#1)(2012-2#1)
Most notably##6##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-3#1)
Most of the common##2##4##(2008-10#2)
Most of the genes##2##4##(2008-10#1)(2008-9#1)
Most of the isolates##2##4##(2008-10#1)(2008-5#1)
Most of the patients##3##4##(1996-6#1)(2010-3#1)(2010-7#1)
Most of the reported##2##4##(2008-1#1)(2011-2#1)
Most of the research##2##4##(2011-2#1)(2013-1#1)
Most of the tests##2##4##(2008-10#1)(2012-2#1)
Most of the##78##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#2)(2008-10#23)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)
Most of them are##2##4##(2008-10#1)(2012-12#1)
Most of them##8##3##(1991-8#1)(1993-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#2)
Most of these##12##3##(1992-6#1)(1993-11#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)(2011-2#2)
Most of us##2##3##(1994-2#1)(2010-8#1)
Most of##102##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#2)(2007-12#1)(2008-1#2)(2008-10#27)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)
Most patients with##2##3##(1991-1#1)(2008-7#1)
Most patients##9##2##(1991-1#1)(1991-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2012-3#1)(2013-1#1)
Most people##2##2##(2008-10#1)(2008-12#1)
Most physicians##4##2##(1990-2#2)(1994-12#1)(1995-6#1)
Most previous##2##2##(2011-1#1)(2013-1#1)
Most research has##2##3##(2012-2#2)
Most research##3##2##(2008-1#1)(2012-2#2)
Most respondents believed that##2##4##(2012-12#2)
Most respondents##5##2##(1996-1#1)(2012-12#3)(2013-1#1)
Most studies have##2##3##(2008-9#1)(2012-3#1)
Most studies of##2##3##(2008-11#1)(2008-8#1)
Most studies on##2##3##(2008-11#1)(2008-7#1)
Most studies##9##2##(1991-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)
Most##312##1##(1990-2#5)(1990-5#1)(1990-6#2)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1992-1#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#1)(2007-12#3)(2008-1#3)(2008-10#72)(2008-11#20)(2008-12#8)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#17)(2011-3#1)(2012-12#8)(2012-2#9)(2012-3#7)(2013-1#17)(2013-8#1)
Mot V##2##2##(1990-9#2)
Mot##3##1##(1990-9#2)(1995-2#1)
MotA and AsiA proteins##2##4##(1995-2#2)
Mother and##3##2##(2009-12#1)(2010-6#2)
Mother##7##1##(1994-9#1)(2008-10#1)(2008-12#1)(2009-12#1)(2010-6#2)(2012-2#1)
Mother-Infant##2##1##(1990-12#1)(2009-11#1)
Mothers in##2##2##(1995-1#1)(2013-1#1)
Mothers with##2##2##(2009-12#1)(2010-10#1)
Mothers##13##1##(1995-1#1)(1997-3#1)(2008-12#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-6#2)(2011-1#1)(2012-3#2)(2013-1#1)
Mothers'##2##1##(1993-12#1)(2009-10#1)
Motif##2##1##(1997-8#1)(2008-10#1)
Motion##2##1##(2008-10#1)(2012-2#1)
Motivated by##2##2##(2008-12#1)(2008-8#1)
Motivating##2##1##(2009-7#1)(2013-1#1)
Motivation for dietary changes##2##4##(1990-6#2)
Motivation##3##1##(1990-6#2)(1995-2#1)
Motor oil##2##2##(2008-10#2)
Motor oils##4##2##(2008-10#4)
Motor##16##1##(1996-6#1)(1997-3#1)(2008-10#6)(2008-7#1)(2010-12#1)(2011-2#1)(2011-8#1)(2012-2#1)(2012-3#1)(2013-8#2)
Mount Barker##4##2##(2008-10#4)
Mount##9##1##(1991-12#1)(1995-8#1)(1996-3#1)(2008-10#4)(2008-9#1)(2010-6#1)
Mountain##5##1##(2008-10#1)(2008-3#1)(2008-9#3)
Mountains of##2##2##(2008-10#2)
Mountains##5##1##(2008-10#4)(2008-11#1)
Moura##3##1##(1994-5#3)
Mouse Mammary Tumor Virus##2##4##(1994-12#1)(2008-11#1)
Mouse and##2##2##(1990-5#1)(1997-9#1)
Mouse##22##1##(1990-5#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-9#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#2)(2008-9#1)(2010-7#1)(2011-2#2)(2012-12#1)
Moutan Cortex##6##2##(2008-10#6)
Movement of the##2##3##(2008-10#2)
Movement of##8##2##(2008-10#7)(2008-12#1)
Movement##23##1##(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#3)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)
Moving##6##1##(1994-12#1)(1997-2#1)(1997-4#1)(2008-8#1)(2009-8#1)(2012-2#1)
Mozambican##2##1##(1997-6#2)
Mozambique##8##1##(1997-6#8)
Mozuku of Cladosiphon novae-caledoniae kylin##2##5##(2008-11#2)
Mp420##2##1##(2008-10#2)
Mr = 80##5##3##(1990-10#5)
Mr approximately 3##2##3##(2008-11#2)
Mr approximately##3##2##(2008-11#3)
Mr of##6##2##(1990-11#1)(1990-12#1)(1990-5#1)(1994-11#1)(1996-2#2)
Mr##37##1##(1990-10#6)(1990-11#1)(1990-12#1)(1990-5#5)(1991-1#2)(1991-10#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-3#4)(1995-1#1)(1996-2#2)(1997-7#2)(1997-9#1)(2008-11#3)
Mr-IAG##5##1##(2012-3#5)
MrNomogram##3##1##(2008-10#3)
Mre11 complex##4##2##(2011-2#4)
Mre11 complexes##2##2##(2011-2#2)
Mre11##9##1##(2011-2#9)
Mrs##2##1##(1993-5#1)(2010-11#1)
Ms##2##1##(1991-1#1)(1994-3#1)
MseI##4##1##(2008-10#4)
Mss4##3##1##(1995-8#3)
Mt##5##1##(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)
MtSERF1##3##1##(2009-8#3)
Mtrm##2##1##(2012-3#2)
Mu element##2##2##(2012-3#2)
Mu elements##4##2##(2012-3#4)
Mu##8##1##(1990-2#1)(2012-3#7)
Mu13 is##2##2##(2012-3#2)
Mu13##5##1##(2012-3#5)
Much effort has been##2##4##(1997-6#1)(2011-2#1)
Much effort##3##2##(1991-6#1)(1997-6#1)(2011-2#1)
Much has been written about##2##5##(2008-11#1)(2010-10#1)
Much has been written##3##4##(2008-1#1)(2008-11#1)(2010-10#1)
Much more##2##2##(1993-3#1)(2008-10#1)
Much of the##9##3##(1992-1#1)(1992-12#1)(1994-2#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
Much of this##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2009-12#1)
Much of##16##2##(1992-1#1)(1992-12#1)(1994-2#1)(1995-3#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-8#1)
Much research##3##2##(1997-5#1)(2008-10#1)(2010-5#1)
Much work##2##2##(1997-1#1)(2008-10#1)
Much##42##1##(1990-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-8#1)
Mucor##2##1##(2008-5#2)
Mucormycosis is a rare##2##4##(2010-10#1)(2013-1#1)
Mucosal##4##1##(2008-5#2)(2010-12#1)(2013-8#1)
Mueller matrices##3##2##(2008-3#3)
Mueller matrix elements##2##3##(2008-3#2)
Mueller matrix##6##2##(2008-3#6)
Mueller##10##1##(2008-3#10)
Muggli##2##1##(1995-12#2)
Muir-Torre syndrome##2##2##(1991-6#2)
Mulberry Leaves##2##2##(2008-10#2)
Mulberry##3##1##(2008-10#3)
Mullen##3##1##(1995-12#2)(2008-6#1)
Mullerian duct##2##2##(2008-10#1)(2013-1#1)
Mullerian##3##1##(2008-10#1)(2013-1#2)
Multi-element##2##1##(2008-10#2)
Multi-pumping flow systems##2##3##(2008-10#2)
Multi-walled carbon##2##2##(2008-10#2)
Multicenter Study Group##2##3##(1990-11#2)
Multicenter Study##3##2##(1990-11#2)(2008-5#1)
Multicenter##8##1##(1990-11#2)(1995-8#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-3#2)
Multicentre##2##1##(2008-5#1)(2009-1#1)
Multicommutation-NIR##2##1##(2008-10#2)
Multicomponent analysis of##3##3##(2008-10#3)
Multicomponent analysis##4##2##(2008-10#4)
Multicomponent##9##1##(1996-5#1)(2008-10#6)(2008-2#2)
Multicultural##2##1##(1997-2#1)(2010-8#1)
Multidetector computed tomography (MDCT)##2##4##(2008-12#1)(2012-2#1)
Multidimensional Measure##2##2##(2010-2#1)(2012-2#1)
Multidimensional##9##1##(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-2#2)(2012-2#2)
Multidisciplinary##3##1##(2010-2#1)(2010-8#1)(2012-3#1)
Multidrug-resistant##3##1##(1992-9#1)(2011-2#1)(2013-1#1)
Multielemental##3##1##(2008-10#3)
Multifunctional##2##1##(2007-11#2)
Multigene##2##1##(2008-10#2)
Multilayer films##2##2##(2008-10#2)
Multilayer##5##1##(2008-10#3)(2008-3#1)(2009-9#1)
Multilevel analysis of##2##3##(2010-1#1)(2012-3#1)
Multilevel modeling##3##2##(2008-12#1)(2009-7#1)(2010-9#1)
Multilevel##9##1##(2008-12#1)(2009-12#2)(2009-7#1)(2010-1#2)(2010-9#1)(2012-12#1)(2012-3#1)
Multilocus##6##1##(2008-10#4)(2008-5#1)(2012-3#1)
Multimodal##2##1##(2011-2#2)
Multimodality##2##1##(2012-2#1)(2013-1#1)
Multinational##2##1##(2009-8#1)(2010-5#1)
Multinomial##4##1##(2009-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
Multiorgan##3##1##(1992-5#1)(2007-12#1)(2013-8#1)
Multiparameter analysis of##2##3##(2008-9#2)
Multiparameter##4##1##(2008-4#1)(2008-9#2)(2010-1#1)
Multiphoton##2##1##(2008-3#1)(2008-9#1)
Multiple Myeloma##2##2##(2010-9#1)(2011-2#1)
Multiple Sclerosis##2##2##(2013-1#2)
Multiple factors##2##2##(2012-12#1)(2013-1#1)
Multiple forms of##2##3##(1990-5#1)(1995-11#1)
Multiple light scattering##2##3##(2008-3#2)
Multiple linear regression analysis showed##2##5##(1993-2#1)(2011-1#1)
Multiple linear regression analysis##3##4##(1993-2#1)(2008-10#1)(2011-1#1)
Multiple linear regression was##2##4##(2008-10#1)(2013-1#1)
Multiple linear regression##5##3##(1993-2#1)(2008-10#2)(2011-1#1)(2013-1#1)
Multiple mechanisms##3##2##(1992-6#1)(2008-10#1)(2012-2#1)
Multiple regression analyses##2##3##(2008-10#1)(2012-2#1)
Multiple regression analysis##3##3##(2008-12#1)(2008-7#1)(2012-12#1)
Multiple regression##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
Multiple response##2##2##(2008-10#2)
Multiple sclerosis (MS) is##2##4##(2011-2#1)(2012-3#1)
Multiple sclerosis##6##2##(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
Multiple systemic##2##2##(2012-3#1)(2013-1#1)
Multiple##95##1##(1990-5#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1995-11#1)(1996-12#2)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#22)(2008-11#7)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#2)
Multiplex PCR##3##2##(2008-12#2)(2011-2#1)
Multiplex Polymerase Chain Reaction##2##4##(2008-10#2)
Multiplex Real-Time Polymerase Chain Reaction##2##5##(2008-10#2)
Multiplex Real-Time##3##2##(2008-10#3)
Multiplex fluorescence in situ hybridization##2##5##(2010-1#2)
Multiplex##14##1##(2008-10#7)(2008-12#3)(2010-1#2)(2011-2#1)(2013-8#1)
Multiplexed##2##1##(2008-9#2)
Multiracial##2##1##(2013-8#2)
Multiresidue determination of##2##3##(2008-10#2)
Multiresolution##2##1##(2008-6#2)
Multisimplex program##2##2##(2008-10#2)
Multivalvular endocarditis##2##2##(2011-2#2)
Multivariable##2##1##(2008-10#1)(2010-11#1)
Multivariate analysis of the##2##4##(2008-10#1)(2008-9#1)
Multivariate analysis of##4##3##(2008-10#3)(2008-9#1)
Multivariate analysis showed that##2##4##(2008-7#1)(2010-4#1)
Multivariate analysis showed##3##3##(2008-7#1)(2010-4#1)(2013-1#1)
Multivariate analysis##15##2##(1993-12#1)(1995-12#1)(2008-10#6)(2008-7#2)(2008-9#2)(2010-4#1)(2011-2#1)(2013-1#1)
Multivariate calibration##2##2##(2008-10#2)
Multivariate logistic regression analysis##2##4##(2008-3#1)(2012-3#1)
Multivariate optimisation of##2##3##(2008-10#2)
Multivariate regression##3##2##(1991-1#1)(2008-10#2)
Multivariate statistical##2##2##(2008-10#2)
Multivariate##43##1##(1991-1#1)(1991-2#1)(1993-12#1)(1995-12#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
Multiwavelength##3##1##(2008-10#2)(2008-2#1)
Mumbai##2##1##(2013-8#2)
Mundt##2##1##(2008-10#2)
Munich##3##1##(1994-3#2)(2008-10#1)
Munich/Germany##2##1##(2008-11#2)
Municipal##3##1##(1990-2#1)(1994-1#1)(1997-5#1)
Municipalities##2##1##(2013-8#2)
Murashige and Skoog (MS)##2##4##(2008-10#1)(2008-8#1)
Murine models of##2##3##(2008-9#1)(2010-7#1)
Murine##18##1##(1990-2#1)(1992-11#2)(1994-5#1)(1995-8#1)(2008-11#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
Muscle##14##1##(1991-5#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#3)(2013-1#1)
Muscovy and Pekin ducklings##2##4##(2008-5#2)
Museum of##2##2##(2010-1#1)(2011-2#1)
Museum##5##1##(2010-1#3)(2010-6#1)(2011-2#1)
Mushroom##3##1##(2008-10#2)(2012-3#1)
Music##4##1##(1991-12#1)(2008-11#2)(2008-9#1)
Muslim Faith Healers perceptions of mental##2##6##(2008-12#2)
Muslim##5##1##(1994-9#1)(2008-12#3)(2013-1#1)
Muslims##2##1##(1996-8#1)(2011-2#1)
Must##2##1##(1997-3#1)(2012-3#1)
Mustela##3##1##(2008-6#3)
Mutagenesis of the##2##3##(1997-8#1)(2008-11#1)
Mutagenesis of##4##2##(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
Mutagenesis##6##1##(1991-5#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-11#1)
Mutant and##2##2##(2008-10#1)(2013-8#1)
Mutant##17##1##(1993-12#1)(1994-5#2)(1995-2#1)(1995-6#1)(1995-9#1)(2008-10#7)(2009-4#1)(2009-5#1)(2013-8#2)
Mutants M1##2##2##(2008-10#2)
Mutants defective in##2##3##(2008-10#1)(2011-2#1)
Mutants of##6##2##(1995-2#1)(2008-10#5)
Mutants##24##1##(1994-11#1)(1995-2#2)(1996-3#1)(1997-7#1)(2008-10#16)(2008-7#1)(2009-10#1)(2011-2#1)
Mutation and##2##2##(2012-2#1)(2013-8#1)
Mutation in the##3##3##(2008-10#3)
Mutation in##5##2##(2008-10#4)(2012-2#1)
Mutation of the##3##3##(1997-7#1)(2008-9#1)(2009-6#1)
Mutation of##7##2##(1992-3#1)(1993-9#1)(1995-6#1)(1997-7#1)(2008-9#1)(2009-6#1)(2011-2#1)
Mutation##25##1##(1992-3#1)(1993-9#1)(1995-6#1)(1995-8#1)(1997-7#2)(2008-10#4)(2008-4#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#2)
Mutational analysis of the##3##4##(1993-2#2)(2008-9#1)
Mutational analysis##4##2##(1993-2#2)(2008-10#1)(2008-9#1)
Mutational##6##1##(1993-2#2)(1995-6#1)(2008-10#1)(2008-9#1)(2009-5#1)
Mutations affecting##2##2##(1994-5#1)(1995-2#1)
Mutations and##2##2##(2008-4#1)(2012-3#1)
Mutations in the##8##3##(1994-11#1)(1997-7#1)(2008-10#2)(2011-1#1)(2012-2#1)(2012-3#2)
Mutations in##12##2##(1993-12#1)(1994-11#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
Mutations of the##2##3##(2008-4#1)(2012-2#1)
Mutations of##3##2##(1995-2#1)(2008-4#1)(2012-2#1)
Mutations that##3##2##(1992-9#1)(2008-10#2)
Mutations##29##1##(1990-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#2)(1995-8#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#3)
Mutator##4##1##(2012-3#4)
Mutual##3##1##(1996-6#1)(2008-8#1)(2013-1#1)
MxA protein##3##2##(2008-7#3)
MxA##6##1##(2008-7#6)
Mxc2##2##1##(2008-10#2)
Mxc3##3##1##(2008-10#3)
My doctor##2##2##(2008-10#1)(2010-12#1)
My##16##1##(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
MyD##2##1##(1992-12#2)
Myasthenia gravis##3##2##(1997-5#1)(2009-11#1)(2012-3#1)
Myc##7##1##(1991-5#1)(2008-11#3)(2011-2#2)(2013-1#1)
MycER##3##1##(2008-11#3)
Mycelia of##2##2##(2008-10#2)
Mycelia##4##1##(2008-10#4)
Mycelial growth##3##2##(2008-10#3)
Mycelial##11##1##(2008-10#11)
Mycelium of##5##2##(2008-10#5)
Mycelium##8##1##(2008-10#8)
Mycobacteria##2##1##(2010-11#1)(2012-2#1)
Mycobacterial##2##1##(2011-2#2)
Mycobacterium bovis##4##2##(1996-11#2)(2011-2#2)
Mycobacterium fortuitum##2##2##(2011-2#2)
Mycobacterium marinum infection##2##3##(2008-9#2)
Mycobacterium tuberculosis infection##2##3##(2008-10#1)(2011-2#1)
Mycobacterium tuberculosis##41##2##(1995-2#2)(1996-11#3)(1997-4#1)(2008-10#4)(2008-7#4)(2008-9#9)(2009-6#2)(2009-7#4)(2010-5#1)(2011-2#6)(2012-2#3)(2013-1#2)
Mycobacterium vanbaalenii##2##2##(2011-1#1)(2012-2#1)
Mycobacterium##62##1##(1995-2#2)(1996-11#5)(1997-4#1)(2007-12#5)(2008-10#5)(2008-11#2)(2008-7#4)(2008-9#11)(2009-6#2)(2009-7#4)(2010-5#1)(2011-1#1)(2011-2#12)(2012-12#1)(2012-2#4)(2013-1#2)
Mycoparasite##5##1##(2008-10#5)
Mycoplasma genitalium is##2##3##(2011-2#2)
Mycoplasma genitalium##3##2##(2011-2#3)
Mycoplasma hominis##3##2##(2007-12#1)(2011-2#1)(2012-3#1)
Mycoplasma pneumoniae and##2##3##(1992-5#2)
Mycoplasma pneumoniae##5##2##(1992-5#2)(2010-6#1)(2011-2#2)
Mycoplasma wenyonii##3##2##(2012-3#3)
Mycoplasma##23##1##(1992-5#2)(1993-12#1)(2007-12#1)(2008-11#1)(2008-5#2)(2010-6#1)(2011-2#8)(2012-3#6)(2013-8#1)
Mycoreovirus##2##1##(2008-10#2)
Mycorrhizal##2##1##(2008-10#2)
Mycosis##3##1##(1995-1#2)(2010-6#1)
Mycosphaerella citri##7##2##(2008-10#7)
Mycosphaerella fijiensis##3##2##(2008-10#3)
Mycosphaerella graminicola (anamorph Septoria tritici)##3##5##(2008-10#3)
Mycosphaerella graminicola on##3##3##(2008-10#3)
Mycosphaerella graminicola populations##2##3##(2008-10#2)
Mycosphaerella graminicola##35##2##(2008-10#33)(2011-10#2)
Mycosphaerella is##2##2##(2008-10#2)
Mycosphaerella musicola##2##2##(2008-10#2)
Mycosphaerella spp##6##2##(2008-10#6)
Mycosphaerella##74##1##(2008-10#72)(2011-10#2)
Mycosphaerellaceae##3##1##(2010-3#3)
Mycotic##2##1##(1995-9#1)(1997-8#1)
Mycotoxin Accumulation##2##2##(2008-10#2)
Mycotoxin##3##1##(2008-10#3)
Myelodysplastic syndrome##2##2##(2010-8#2)
Myeloid##5##1##(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Myeloma##5##1##(2010-11#2)(2010-9#1)(2011-2#1)(2013-1#1)
Myf-5 or MyoD##2##3##(1993-12#2)
Myf-5##5##1##(1993-12#5)
Myiasis##2##1##(2008-12#1)(2013-1#1)
MyoD##6##1##(1993-12#6)
Myocardial Infarction##4##2##(2008-11#1)(2008-12#2)(2012-3#1)
Myocardial##14##1##(1991-3#1)(1992-3#1)(1996-9#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
Myocarditis##4##1##(2008-11#2)(2010-5#1)(2010-7#1)
Myofibroma##2##1##(2010-6#2)
Myosin V##2##2##(2012-2#2)
Myosin##5##1##(1992-4#1)(1994-5#1)(2012-2#2)(2013-8#1)
Myrosma##2##1##(2008-5#2)
Mythimna separata##2##2##(2008-11#2)
Myths##3##1##(1991-3#1)(2010-11#1)(2010-6#1)
Mytilus##3##1##(1995-12#1)(1995-8#1)(2008-11#1)
Myxobacter Sp##3##2##(2009-3#3)
Myzus persicae##5##2##(2008-10#4)(2009-8#1)
Mz2-12##2##1##(1994-6#2)
Málaga##2##1##(2008-10#2)
Mäori and##2##2##(2008-1#2)
Mäori children##3##2##(2008-1#3)
Mäori##11##1##(2008-1#11)
Mérida##2##1##(2008-10#2)
Müller cell##3##2##(2008-7#3)
Müller cells##8##2##(1991-10#1)(2008-5#3)(2008-7#4)
Müller##13##1##(1991-10#1)(2008-5#3)(2008-7#7)(2011-2#1)(2013-8#1)
Müllerian duct##3##2##(2008-10#3)
Müllerian##7##1##(2008-10#4)(2011-2#2)(2013-1#1)
Münchhausen's syndrome##3##2##(1995-5#3)
Māori and non-Māori##2##3##(2012-12#2)
Māori##6##1##(2012-12#6)
N (comparing##2##2##(2012-9#2)
N =##10##2##(1994-1#4)(1994-11#1)(2008-10#3)(2009-1#1)(2013-1#1)
N Vpu##2##2##(2013-1#2)
N activity##2##2##(1990-2#1)(2008-11#1)
N and NSC concentrations##2##4##(2012-5#2)
N and NSC##4##3##(2012-5#4)
N and the##4##3##(2008-10#3)(2008-5#1)
N and##21##2##(1997-8#1)(2008-10#8)(2008-5#2)(2008-8#2)(2008-9#1)(2011-1#2)(2012-5#5)
N at 180 mg/liter##2##4##(2008-10#2)
N at##3##2##(2008-10#3)
N concentration of 360##2##4##(2008-10#2)
N concentration of##3##3##(2008-10#3)
N concentration##5##2##(2008-10#3)(2008-2#1)(2012-9#1)
N content##2##2##(2012-8#2)
N epsilon 2 of##2##4##(1991-3#2)
N epsilon##3##2##(1991-3#2)(1994-5#1)
N for##2##2##(2008-10#2)
N gene##7##2##(2008-10#7)
N in the##3##3##(2011-1#1)(2012-8#1)(2013-1#1)
N in##6##2##(1995-8#1)(2008-10#1)(2011-1#1)(2012-8#2)(2013-1#1)
N is##3##2##(2008-8#2)(2011-1#1)
N metabolism##2##2##(2008-12#1)(2012-9#1)
N neurons on##3##3##(1997-3#3)
N protein##5##2##(2008-10#5)
N proteins##2##2##(2008-10#2)
N sampling units##3##3##(2008-10#3)
N sources##2##2##(2008-10#2)
N stage##3##2##(1991-8#3)
N terminal##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
N terminus##6##2##(1992-4#1)(1993-2#1)(1995-2#1)(2008-10#2)(2008-6#1)
N to##2##2##(2008-10#2)
N##392##1##(1990-2#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#2)(1994-1#4)(1994-11#1)(1994-5#5)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#2)(1997-3#3)(1997-6#2)(1997-8#2)(2007-12#1)(2008-10#213)(2008-11#5)(2008-12#18)(2008-2#2)(2008-3#6)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#6)(2009-1#1)(2010-7#4)(2010-8#3)(2011-1#7)(2011-2#1)(2012-12#1)(2012-3#8)(2012-5#5)(2012-8#9)(2012-9#7)(2013-1#8)(2013-8#3)
N&quot##4##1##(1993-8#2)(2008-12#2)
N' = 4##2##3##(2008-2#2)
N'##23##1##(1995-8#1)(1996-2#1)(2008-10#15)(2008-12#1)(2008-2#2)(2008-5#3)
N''##3##1##(2008-10#3)
N''-pentaacetic##2##1##(2008-10#2)
N'-(o-phenylene)-bis-benzenesulfonamide##2##1##(2008-10#2)
N'-bis(2-hydroxy-3-sulfopropyl)tolidine##2##1##(2008-10#2)
N'-bis(2-hydroxy-5-bromo-benzyl)1##2##1##(2008-10#2)
N'-bis(2-hydroxyl-3-sulfopropyl)-tolidine##2##1##(2008-10#2)
N'-bis(2-hydroxyphenylmethyl)-N##2##1##(2008-10#2)
N'-bis(2-pyridylmethyl)-1##2##1##(2008-10#2)
N'-di-3-propionate##2##1##(2008-10#2)
N'-dialkylbenzylethylenediamine (alkyl=butyl##2##2##(2008-10#2)
N'-dialkylbenzylethylenediamine##3##1##(2008-10#3)
N'-dibenzyl-1##2##1##(2008-10#2)
N'-dibenzyl-18-crown-6##2##1##(2008-10#2)
N'-diphenylbenzamidine##2##1##(2008-10#2)
N'-disalicylidene-1##2##1##(2008-10#2)
N'-tetraacetate##2##1##(2008-10#2)
N'-tetraacetic acid##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
N'-tetraoctyl diglycolamide##2##2##(2008-10#2)
N(2) adsorption-desorption isotherms and##2##4##(2008-10#1)(2009-11#1)
N(2) adsorption-desorption##4##2##(2008-10#3)(2009-11#1)
N(2) and Ar##2##3##(2008-3#2)
N(2) and##5##2##(2008-10#2)(2008-3#3)
N(2)##26##1##(1997-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#12)(2008-9#1)(2009-11#1)(2012-8#1)
N(2)/CH(4) gas flow##2##3##(2008-10#2)
N(2)/CH(4)##4##1##(2008-10#4)
N(2)O treatment##2##2##(2009-12#2)
N(2)O##7##1##(2008-3#2)(2009-12#5)
N(2)O-treated##2##1##(2009-12#2)
N(7)- and N(9)-acyclonucleosides##2##3##(1994-8#2)
N(G)-hydroxy-L-arginine##2##1##(2010-12#2)
N(G)-nitro-L-arginine##3##1##(1997-2#2)(2008-11#1)
N(m)##2##1##(2008-10#2)
N(max)##2##1##(2008-3#1)(2011-2#1)
N(p)##3##1##(1997-6#3)
N)##8##1##(2008-10#6)(2008-9#1)(2010-8#1)
N- and C-terminal##2##3##(1991-5#1)(1994-5#1)
N- and O-linked##2##3##(1992-6#1)(2008-1#1)
N- and##7##2##(1991-5#1)(1992-6#2)(1994-5#1)(2008-1#1)(2009-8#1)(2011-2#1)
N- or C-terminal##3##3##(1996-12#1)(1996-6#1)(2011-2#1)
N-##10##1##(1991-5#1)(1992-6#2)(1994-5#1)(1996-12#1)(1996-6#1)(2008-1#1)(2009-8#1)(2011-2#2)
N-(3##2##1##(2008-10#1)(2008-5#1)
N-(5-dimethylamine-1-naphthalenesulfonylo)-1##2##1##(2008-10#2)
N-(phosphonomethyl)glycine##2##1##(2008-10#2)
N-1-naphthyl ethylene diamine dihydrochloride##2##4##(2008-10#2)
N-MYR##3##1##(2009-8#3)
N-N rotation##2##2##(1996-5#2)
N-N##5##1##(1996-5#2)(2008-10#3)
N-Nitrosamines##2##1##(2008-12#1)(2008-5#1)
N-Nitroso-2##2##1##(1996-5#2)
N-Vpus##3##1##(2013-1#3)
N-acetyl benzothiazole##2##2##(2010-2#2)
N-acetyl##8##1##(1991-12#1)(1993-12#1)(1994-11#2)(1994-8#1)(2008-8#1)(2010-2#2)
N-acetyl-D-glucosamine##2##1##(1992-6#1)(1994-5#1)
N-acetyl-L-cysteine (NAC)##2##2##(2008-11#2)
N-acetyl-L-cysteine##4##1##(1994-5#1)(2008-11#3)
N-acetyl-d-glucosamine##4##1##(2008-10#3)(2012-2#1)
N-acetyl-d-neuraminic acid##2##2##(2012-2#2)
N-acetyl-p-benzoquinoneimine##2##1##(2008-10#2)
N-acetylated##3##1##(1992-6#1)(2008-4#2)
N-acetylcysteine and##2##2##(2008-10#1)(2008-11#1)
N-acetylcysteine##12##1##(1991-11#4)(1992-6#1)(2008-10#6)(2008-11#1)
N-acetylgalactosamine##3##1##(2008-10#1)(2008-8#2)
N-acetylglucosamine##11##1##(1990-2#1)(1992-3#1)(1997-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)
N-acetyltransferase (NAT)##2##2##(1994-2#1)(1995-11#1)
N-acetyltransferase (NAT2)##2##2##(1993-3#1)(1995-9#1)
N-acetyltransferase##8##1##(1993-3#2)(1994-2#1)(1995-11#2)(1995-9#1)(2008-5#2)
N-acyl homoserine lactones##2##3##(2008-10#1)(2008-9#1)
N-alkyl 1- and 2-benzazepinones##2##4##(1994-11#2)
N-alkyl##3##1##(1994-11#2)(2008-10#1)
N-ammin-nickel(II)##2##1##(2008-10#2)
N-and##2##1##(1992-6#1)(1993-3#1)
N-aryl-2-[[[5-[(dimethylamino)methyl]-2-##3##1##(1992-8#3)
N-benzoyl-N-phenylhydroxylamine##2##1##(2008-10#2)
N-bromoacetyl 5-methoxytryptamine##2##2##(1993-6#2)
N-bromosuccinimide (NBS) or##2##3##(2008-10#2)
N-bromosuccinimide (NBS)##4##2##(1992-6#1)(2008-10#3)
N-bromosuccinimide##10##1##(1992-6#1)(2008-10#9)
N-bromosuccinimide-luminol##2##1##(2008-10#2)
N-chlorosuccinimide##3##1##(2008-10#3)
N-containing##3##1##(2008-10#3)
N-dealkylated##2##1##(2011-3#2)
N-dibutyl##2##1##(2008-10#2)
N-dibutyl-N'-benzoylthiourea##3##1##(2008-10#3)
N-diethyl-1##2##1##(2008-10#2)
N-diethyl-p-phenylenediamine##2##1##(2008-10#2)
N-dimethyl-p-phenylenediamine in the presence of##2##5##(2008-10#2)
N-dimethyl-p-phenylenediamine##3##1##(2008-10#3)
N-dimethylaniline (DMA) to form##2##4##(2008-10#2)
N-dimethylaniline##5##1##(2008-10#5)
N-dimethylaniline)-chloramine-T reaction##2##2##(2008-10#2)
N-dimethylenephosphonic acid##2##2##(2008-10#2)
N-dimethylformamide (DMF)##2##2##(2008-10#2)
N-dimethylformamide##9##1##(2008-10#9)
N-ethylmaleimide (NEM)##2##2##(1990-2#1)(1995-8#1)
N-ethylmaleimide##5##1##(1990-2#1)(1995-8#2)(2008-5#1)(2009-8#1)
N-formylamino acids##5##2##(2008-10#5)
N-gene transgenic##2##2##(2008-10#2)
N-glycan structures##2##2##(2008-11#2)
N-glycan##4##1##(2008-11#4)
N-glycanase##3##1##(1991-12#1)(1995-11#1)(1995-6#1)
N-glycosidase mechanism##2##2##(2008-8#2)
N-glycosylation of ZP glycoproteins##2##4##(2013-1#2)
N-glycosylation of zona##2##3##(2013-1#2)
N-glycosylation of##4##2##(2013-1#4)
N-glycosylation sites##3##2##(1991-6#1)(1993-8#1)(2011-2#1)
N-glycosylation##15##1##(1991-6#1)(1992-3#1)(1993-6#1)(1993-8#2)(2008-10#1)(2011-2#1)(2013-1#8)
N-heterocyclic carbene##2##2##(2010-3#1)(2010-7#1)
N-heterocyclic##4##1##(2010-3#1)(2010-7#1)(2012-12#2)
N-hydroxy##4##1##(1992-6#4)
N-hydroxyethylethylenediamine##2##1##(2008-10#2)
N-linked glycan##2##2##(1994-5#2)
N-linked glycosylation and##2##3##(1996-12#1)(2008-11#1)
N-linked glycosylation site of##2##4##(1994-11#2)
N-linked glycosylation sites##2##3##(1993-2#1)(2008-9#1)
N-linked glycosylation##8##2##(1993-2#1)(1994-11#2)(1996-12#1)(2008-11#2)(2008-7#1)(2008-9#1)
N-linked oligosaccharide biosynthesis##2##3##(2008-7#2)
N-linked oligosaccharide##5##2##(1994-5#1)(2008-11#1)(2008-7#3)
N-linked##25##1##(1990-5#2)(1992-10#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-5#4)(1996-12#1)(2008-11#6)(2008-7#6)(2008-9#1)
N-methyl-D-aspartate (NMDA) receptor##3##3##(1996-12#1)(1996-2#1)(1997-2#1)
N-methyl-D-aspartate (NMDA)##9##2##(1992-8#1)(1996-12#1)(1996-2#2)(1997-2#2)(2008-11#1)(2008-8#1)(2012-2#1)
N-methyl-D-aspartate and##2##2##(1990-7#1)(1995-12#1)
N-methyl-D-aspartate receptor##3##2##(1990-7#1)(1996-2#1)(2012-2#1)
N-methyl-D-aspartate##16##1##(1990-7#2)(1992-8#1)(1995-12#2)(1996-12#1)(1996-2#3)(1997-2#2)(2008-11#1)(2008-8#1)(2009-7#1)(2012-2#2)
N-methyl-N'-nitro-N-nitrosoguanidine##3##1##(1995-9#1)(1997-3#1)(2008-10#1)
N-methyl-d-glucamine##3##1##(2008-10#3)
N-methyltransferase##2##1##(2013-1#1)(2013-8#1)
N-myristoyl##3##1##(1990-12#2)(2009-8#1)
N-myristoylation##3##1##(2009-8#3)
N-n-Octylaniline in xylene is used for##2##6##(2008-10#2)
N-n-octylaniline in##2##2##(2008-10#2)
N-n-octylaniline##8##1##(2008-10#8)
N-nitrosamine##3##1##(1990-6#1)(2008-12#2)
N-nitrosamines##3##1##(1996-5#1)(2008-12#1)(2008-5#1)
N-nitrosoamines##3##1##(2008-10#3)
N-oxide at the formazyl carbon##2##5##(2008-10#2)
N-oxide metabolite in human plasma##2##5##(2008-10#2)
N-oxide##12##1##(2008-10#12)
N-oxides##2##1##(2008-10#1)(2013-8#1)
N-phenyl-2-cyano-1-azadiene 4##2##2##(1996-5#2)
N-ras gene##3##2##(1995-2#2)(2008-9#1)
N-ras##6##1##(1995-2#5)(2008-9#1)
N-terminal amino acid sequence##2##4##(1995-8#1)(2008-6#1)
N-terminal amino acid##6##3##(1993-3#1)(1993-9#1)(1994-8#2)(1995-8#1)(2008-6#1)
N-terminal amino##7##2##(1993-3#1)(1993-9#1)(1994-8#2)(1995-8#1)(2008-6#1)(2008-8#1)
N-terminal amphiphilic sequence##2##3##(1991-10#2)
N-terminal amphiphilic##4##2##(1991-10#4)
N-terminal and##2##2##(1997-3#1)(2008-6#1)
N-terminal arm##3##2##(2008-9#3)
N-terminal domain of NifA##2##4##(2008-9#2)
N-terminal domain of the##4##4##(1992-4#1)(2006-6#2)(2012-2#1)
N-terminal domain of##13##3##(1992-4#1)(2006-6#3)(2008-9#3)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
N-terminal domain##19##2##(1991-5#1)(1992-4#1)(1993-2#1)(1995-6#1)(2006-6#3)(2008-4#1)(2008-9#3)(2009-7#4)(2009-8#1)(2011-1#1)(2012-2#2)
N-terminal end##4##2##(1991-9#1)(1993-8#1)(1995-11#1)(1995-8#1)
N-terminal peptide fragments##2##3##(2008-8#2)
N-terminal peptide##3##2##(1996-12#1)(2008-8#2)
N-terminal region of##5##3##(1991-5#1)(1992-6#1)(1996-3#1)(2009-7#2)
N-terminal region##10##2##(1991-5#1)(1992-6#1)(1994-5#1)(1995-11#1)(1996-3#2)(2008-10#1)(2008-11#1)(2009-7#2)
N-terminal regions##2##2##(1991-10#1)(2008-10#1)
N-terminal residues##2##2##(1994-11#1)(1994-5#1)
N-terminal segment##2##2##(1991-5#1)(2008-8#1)
N-terminal sequence of the##2##4##(1991-10#1)(1994-11#1)
N-terminal sequence of##4##3##(1990-12#1)(1991-10#1)(1994-11#1)(2008-10#1)
N-terminal sequence##9##2##(1990-12#1)(1990-8#1)(1991-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-10#1)
N-terminal sequences that##2##3##(1993-2#1)(1996-3#1)
N-terminal sequences##3##2##(1993-2#1)(1996-3#1)(1997-7#1)
N-terminal sequencing##4##2##(1990-11#1)(1993-12#1)(1997-8#1)(2008-10#1)
N-terminal##128##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#8)(1991-5#4)(1991-6#2)(1991-9#1)(1992-10#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#4)(1993-2#5)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-5#4)(1994-8#3)(1995-11#2)(1995-2#3)(1995-6#4)(1995-8#2)(1996-12#1)(1996-3#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#4)(2008-10#13)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#7)(2009-6#1)(2009-7#8)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-2#3)
N-terminally elongated fragments of galanin(1-16)##2##5##(1994-8#2)
N-terminally elongated##4##2##(1994-8#4)
N-terminally##7##1##(1994-5#1)(1994-8#5)(2008-4#1)
N-terminus of##6##2##(1992-6#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
N-terminus##23##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#4)(2010-11#1)(2012-2#1)
N0 and N1##2##3##(1990-6#1)(1991-8#1)
N0##4##1##(1990-6#1)(1991-8#2)(1993-1#1)
N1 and##3##2##(1990-6#1)(1993-1#1)(2008-8#1)
N1##12##1##(1990-6#3)(1991-3#1)(1991-8#2)(1993-1#1)(1997-1#1)(2008-4#1)(2008-8#3)
N1-acetyltransferase##5##1##(1991-9#3)(1992-10#2)
N1-guanyl-1##2##1##(1997-1#2)
N1E-115 cells##2##2##(1994-11#2)
N1E-115##4##1##(1992-6#2)(1994-11#2)
N1E115##2##1##(1993-3#2)
N2 strains##4##2##(2008-10#4)
N2##11##1##(1990-6#1)(1991-2#1)(1991-8#1)(1991-9#1)(2008-10#4)(2008-11#2)(2008-3#1)
N2O##6##1##(1992-3#1)(1993-1#4)(2008-3#1)
N3##6##1##(1990-6#2)(1991-8#1)(1994-5#1)(2008-10#1)(2008-11#1)
N417/AMSA cells##4##2##(1994-8#4)
N417/AMSA##5##1##(1994-8#5)
N5##2##1##(1997-1#1)(2008-10#1)
N7##4##1##(2008-10#1)(2008-11#1)(2008-4#2)
N7Guo##2##1##(1994-8#2)
N7Ino##3##1##(1994-8#3)
N=10)##2##1##(2009-7#2)
N=3)##3##1##(2008-10#2)(2009-7#1)
NA and##5##2##(1994-3#2)(2008-10#3)
NA in##5##2##(2008-10#1)(2008-8#2)(2010-11#2)
NA##35##1##(1994-3#3)(2008-10#14)(2008-11#5)(2008-8#7)(2010-11#5)(2013-8#1)
NA-VCG4##2##1##(2008-10#2)
NA1##3##1##(2008-10#3)
NA2##3##1##(2008-10#3)
NA3##2##1##(2008-10#2)
NAA and##6##2##(2008-10#4)(2008-12#2)
NAA##16##1##(2008-10#7)(2008-12#5)(2008-8#1)(2013-1#3)
NAC##10##1##(1996-5#2)(2008-11#3)(2008-7#1)(2009-9#2)(2011-2#2)
NAD##11##1##(1992-6#1)(1993-8#1)(2008-10#7)(2008-11#1)(2008-7#1)
NAD(+) and NADH##4##3##(2008-10#4)
NAD(+)##10##1##(2008-10#9)(2008-11#1)
NAD(P)H fluorescence##2##2##(1996-2#2)
NAD(P)H##11##1##(1995-8#1)(1996-2#3)(2008-10#4)(2008-11#3)
NAD+ and NADH##2##3##(2008-10#1)(2009-9#1)
NAD+##14##1##(1990-10#8)(1994-11#2)(2008-10#1)(2008-4#1)(2009-9#1)(2012-2#1)
NAD-independent H##2##2##(2008-5#2)
NAD-independent bacteria##2##2##(2008-5#2)
NAD-independent##4##1##(2008-5#4)
NADA##2##1##(2008-10#2)
NADH and ascorbic acid##3##4##(2008-10#3)
NADH and##7##2##(1990-10#1)(2008-10#6)
NADH as##2##2##(2008-11#1)(2008-8#1)
NADH dehydrogenase##2##2##(1990-5#1)(2009-9#1)
NADH did##2##2##(1994-8#1)(1996-6#1)
NADH in##6##2##(2008-10#6)
NADH levels##4##2##(1994-8#2)(2008-9#1)(2009-9#1)
NADH oxidation in phosphate buffer##2##5##(2008-10#2)
NADH oxidation in##3##3##(1990-5#1)(2008-10#2)
NADH oxidation##6##2##(1990-5#1)(2008-10#5)
NADH reductase component of the steroid 9alpha-hydroxylase fromMycobacterium fortuitum##2##9##(2008-11#2)
NADH reductase component of the steroid 9alpha-hydroxylase##3##7##(2008-11#3)
NADH reductase##4##2##(2008-11#4)
NADH was##3##2##(2008-10#2)(2008-11#1)
NADH with##2##2##(1994-8#1)(2008-10#1)
NADH##79##1##(1990-10#1)(1990-5#2)(1992-1#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-8#5)(1995-8#3)(1996-6#1)(1997-8#1)(2008-10#40)(2008-11#7)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#7)(2013-1#3)
NADH-dependent##2##1##(2009-9#2)
NADP(+)##4##1##(2008-7#1)(2008-9#1)(2012-5#2)
NADP+##3##1##(1990-11#1)(1993-6#1)(2008-11#1)
NADP-dependent glutamate dehydrogenase##2##3##(1997-1#2)
NADP-dependent##3##1##(1997-1#2)(2008-10#1)
NADPH binding site##2##3##(1993-8#1)(1995-8#1)
NADPH for the##2##3##(1993-3#1)(2010-12#1)
NADPH oxidase and##2##3##(1993-6#1)(1994-6#1)
NADPH oxidase in a cell-free system##3##6##(1990-5#2)(1993-8#1)
NADPH oxidase##22##2##(1990-5#2)(1991-5#3)(1993-6#3)(1993-8#4)(1994-6#3)(1995-6#1)(1997-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
NADPH was##2##2##(2008-10#1)(2008-8#1)
NADPH##54##1##(1990-11#2)(1990-2#1)(1990-5#2)(1991-5#6)(1992-12#2)(1993-3#3)(1993-6#3)(1993-8#9)(1994-6#3)(1995-11#1)(1995-6#1)(1995-8#4)(1997-7#1)(2008-10#1)(2008-11#3)(2008-7#3)(2008-8#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2011-2#1)(2013-8#1)
NADPH-cytochrome P450 reductase##2##3##(1996-3#2)
NADPH-cytochrome##5##1##(1993-6#2)(1996-3#3)
NADPH-d histochemical activity##2##3##(1995-12#2)
NADPH-d##3##1##(1995-12#3)
NADPH-dependent##7##1##(1991-5#6)(2011-2#1)
NADPH-diaphorase##5##1##(1992-12#3)(1995-12#2)
NADPH-diaphorase-positive##4##1##(1992-12#4)
NAGO##7##1##(1995-5#7)
NAHAM's##2##1##(1995-1#1)(1997-3#1)
NAL was##2##2##(2008-10#2)
NAL##8##1##(2008-10#8)
NAM9##2##1##(1995-9#2)
NANC contractions##2##2##(1997-4#2)
NANC##6##1##(1997-4#6)
NAPPH##3##1##(1991-1#1)(1992-2#2)
NAS and##2##2##(2008-9#1)(2009-10#1)
NAS mastectomies##4##2##(2011-2#4)
NAS##18##1##(1990-11#1)(1993-6#3)(2008-10#2)(2008-9#3)(2009-10#3)(2010-11#2)(2011-2#4)
NASA##4##1##(2008-2#1)(2008-3#2)(2012-3#1)
NASICON based Na(+) ion selective##2##5##(2008-10#2)
NASICON##4##1##(2008-10#4)
NAT techniques##3##2##(2011-2#3)
NAT##10##1##(1994-2#2)(1995-11#1)(2011-2#7)
NAT2##2##1##(1993-3#2)
NATs##2##1##(2011-2#2)
NAcc rats##3##2##(1993-6#3)
NAcc##5##1##(1993-6#5)
NB cholinergic##2##2##(1991-9#2)
NB protein##2##2##(2008-10#2)
NB##9##1##(1991-9#4)(2008-10#2)(2013-8#3)
NB-RCNMV-MP(+)##3##1##(2008-10#3)
NB-TMV-MP(+)##2##1##(2008-10#2)
NB1-RGB cells cultured on##2##4##(2008-11#2)
NB1-RGB cells on the##3##4##(2008-11#3)
NB1-RGB cells on##4##3##(2008-11#4)
NB1-RGB cells##9##2##(2008-11#9)
NB1-RGB##10##1##(2008-11#10)
NBB19##3##1##(2008-9#3)
NBCCEDP##2##1##(1997-1#2)
NBCCS##5##1##(1997-3#5)
NBD peptides##5##2##(2012-3#5)
NBD##8##1##(1994-5#1)(2012-3#7)
NBD1##2##1##(2008-11#2)
NBD2##2##1##(2008-11#2)
NBDs##4##1##(2008-11#4)
NBM lesions##3##2##(1991-12#1)(1993-3#2)
NBM##11##1##(1991-12#1)(1993-3#7)(2008-8#3)
NBMPR##3##1##(1994-8#2)(1995-8#1)
NBMPR-insensitive equilibrative##2##2##(1994-8#1)(1995-8#1)
NBMPR-insensitive##4##1##(1994-8#1)(1995-8#3)
NBMPR-sensitive nucleoside##3##2##(1994-8#3)
NBMPR-sensitive transporter##3##2##(1995-8#3)
NBMPR-sensitive##7##1##(1994-8#3)(1995-8#4)
NBQX##7##1##(1994-2#7)
NBS or##2##2##(2008-10#2)
NBS with##3##2##(2008-10#3)
NBS##16##1##(1992-6#1)(2008-10#15)
NBS-AFLP markers##2##2##(2008-10#2)
NBS-LRR resistance gene##2##3##(2008-8#2)
NBT##2##1##(1993-3#1)(2008-10#1)
NBT-II cell##2##2##(2013-8#2)
NC recipient soil populations##2##4##(2008-10#2)
NC strip##3##2##(2008-10#3)
NC##25##1##(1995-12#1)(2008-10#21)(2008-11#2)(2010-5#1)
NC)##2##1##(1997-1#1)(2008-9#1)
NC300##2##1##(2008-10#2)
NC96BGTA5##6##1##(2008-10#6)
NCA##3##1##(2011-2#3)
NCBI##4##1##(2008-4#2)(2008-7#1)(2012-3#1)
NCER##3##1##(2008-10#3)
NCHS##3##1##(1996-3#1)(1997-3#2)
NCI##7##1##(1991-9#1)(1997-1#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#2)
NCI's##2##1##(1997-1#1)(2013-1#1)
NCLB##2##1##(2008-10#2)
NCR was##2##2##(2008-9#2)
NCR##6##1##(2008-9#6)
NCS DC##2##2##(2008-10#2)
NCS(-)##2##1##(2008-10#2)
NCSTI##2##1##(2013-1#2)
NCX-4016##6##1##(2008-5#6)
ND##12##1##(1995-2#4)(2008-10#6)(2008-12#2)
ND)##3##1##(2008-10#3)
ND12##2##1##(2008-10#2)
ND15##2##1##(2008-10#2)
ND4 genes##2##2##(2008-8#2)
ND4##3##1##(2008-5#1)(2008-8#2)
ND4L and##2##2##(2008-8#2)
NDA##2##1##(2008-5#2)
NDC myeloblast##2##2##(2008-11#2)
NDC##4##1##(2008-11#4)
NDELA content##3##2##(2008-5#3)
NDELA##8##1##(2008-5#8)
NDI##6##1##(2012-12#1)(2012-3#5)
NDPK is##3##2##(1996-2#1)(1997-7#2)
NDPK##11##1##(1996-2#7)(1997-7#4)
NDV in##2##2##(2008-5#2)
NDV##5##1##(2008-5#5)
NE and##3##2##(1996-12#1)(2011-2#2)
NE##14##1##(1996-12#5)(2008-10#4)(2008-7#2)(2011-2#3)
NECA##5##1##(1993-6#1)(1994-6#4)
NED##5##1##(2008-10#2)(2013-1#3)
NEE##5##1##(2008-10#5)
NEECHAM scores##2##2##(2010-10#2)
NEECHAM##4##1##(2010-10#4)
NEM at##2##2##(1995-8#2)
NEM inhibition##2##2##(1995-8#2)
NEM##9##1##(1990-2#1)(1995-8#8)
NEO##2##1##(2008-11#2)
NEO-PI-R##3##1##(2008-11#3)
NEP1 disruption##2##2##(2008-10#2)
NEP1##6##1##(2008-10#6)
NEP1-overexpressing transformant 15##2##3##(2008-10#2)
NEP1-overexpressing##3##1##(2008-10#3)
NER activity##2##2##(2008-11#2)
NER##4##1##(2008-11#4)
NET/NEP##2##1##(2008-12#2)
NEXIS##5##1##(1991-2#5)
NF##2##1##(1996-3#1)(2007-11#1)
NF-AT and NF-kappaB transcription factors##2##5##(2008-11#2)
NF-AT##3##1##(1994-11#1)(2008-11#2)
NF-B##14##1##(2010-10#14)
NF-H##3##1##(1995-12#2)(2008-8#1)
NF-L is##2##2##(2008-8#2)
NF-L##8##1##(1997-2#1)(2008-8#7)
NF-M and##4##2##(1997-2#1)(2008-8#3)
NF-M##5##1##(1997-2#1)(2008-8#4)
NF-Y##2##1##(1997-8#2)
NF-kappa B and##2##3##(1995-12#1)(2008-9#1)
NF-kappa B##26##2##(1991-7#2)(1992-8#4)(1993-9#1)(1994-11#2)(1995-12#6)(1995-2#2)(1995-6#5)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)
NF-kappa B/I kappa B##2##4##(1995-2#2)
NF-kappa##31##1##(1991-7#3)(1992-8#4)(1993-6#1)(1993-9#1)(1994-11#2)(1995-12#6)(1995-2#5)(1995-6#5)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)
NF-kappaB and##2##2##(2008-9#1)(2010-3#1)
NF-kappaB is##2##2##(2010-3#2)
NF-kappaB signal##2##2##(2008-8#2)
NF-kappaB##25##1##(2008-10#1)(2008-11#6)(2008-8#4)(2008-9#5)(2010-3#9)
NF-κB activation##2##2##(2012-2#1)(2012-3#1)
NF-κB activity##3##2##(2012-3#3)
NF-κB p65##2##2##(2012-2#2)
NF-κB signaling##2##2##(2011-2#1)(2013-1#1)
NF-κB transcriptional activity##2##3##(2012-3#2)
NF-κB##15##1##(2011-2#3)(2012-2#3)(2012-3#7)(2013-1#2)
NF-κB/Rel##6##1##(2011-2#6)
NF1##4##1##(1991-5#1)(2012-3#3)
NFP hospital##3##2##(2008-11#3)
NFP##5##1##(2008-10#1)(2008-11#4)
NFTs in the##2##3##(1991-1#2)
NFκB and##3##2##(2011-2#3)
NFκB##11##1##(2010-11#3)(2011-2#8)
NG##3##1##(1992-8#2)(2008-10#1)
NG-methyl-L-arginine##2##1##(1995-11#2)
NG-nitro-L-arginine (100 microM) or##2##4##(1993-8#2)
NG-nitro-L-arginine##3##1##(1993-8#2)(1995-11#1)
NGF and BDNF##2##3##(1996-12#1)(2008-11#1)
NGF and##5##2##(1991-12#1)(1996-12#2)(2008-11#2)
NGF cDNA##3##2##(1996-12#3)
NGF gene transfection increases##2##4##(1996-12#1)(1996-2#1)
NGF gene transfection##6##3##(1996-12#4)(1996-2#2)
NGF gene##8##2##(1990-8#2)(1996-12#4)(1996-2#2)
NGF in##5##2##(1996-2#1)(1997-2#1)(2010-8#3)
NGF is##2##2##(1996-2#1)(2010-8#1)
NGF level in the##3##4##(1996-2#3)
NGF##55##1##(1990-8#9)(1991-12#6)(1996-12#11)(1996-2#12)(1997-2#3)(2008-11#9)(2010-8#5)
NGF-producing target##2##2##(1996-2#2)
NGF-secreting implants##2##2##(2008-5#2)
NGFI-A mRNA##3##2##(1996-12#3)
NGFI-B mRNA##8##2##(1996-12#8)
NGFI-B##14##1##(1995-12#2)(1996-12#12)
NGO##2##1##(1996-5#1)(2012-12#1)
NH##2##1##(1991-5#1)(2008-10#1)
NH(2) column##2##2##(2008-10#2)
NH(2)##3##1##(2008-10#3)
NH(2)-terminal##2##1##(2008-11#2)
NH(3) and##2##2##(2008-10#1)(2012-2#1)
NH(3) gas is##2##3##(2008-10#2)
NH(3) gas##4##2##(2008-10#4)
NH(3) in##2##2##(2008-10#2)
NH(3)##21##1##(2008-10#18)(2009-8#1)(2010-7#1)(2012-2#1)
NH(3)(+)##2##1##(2008-10#2)
NH(3)-NH(4)Cl buffer##2##2##(2008-10#2)
NH(3)-NH(4)Cl##3##1##(2008-10#3)
NH(4)##4##1##(2008-10#4)
NH(4)(+) and##3##2##(2008-10#3)
NH(4)(+)##16##1##(2008-10#16)
NH(4)(+)-selective##2##1##(2008-10#2)
NH(4)Cl##3##1##(2008-10#3)
NH(4)F##4##1##(2008-10#4)
NH(4)H(2)PO(4)##4##1##(2008-10#4)
NH(4)NO(3) as##2##2##(2008-10#2)
NH(4)NO(3)##12##1##(2008-10#12)
NH(4)OH##3##1##(2008-10#3)
NH(4)SCN##4##1##(2008-10#4)
NH(4)VO(3)##5##1##(2008-10#5)
NH2 terminus##6##2##(1992-9#1)(1993-3#1)(1995-6#4)
NH2##20##1##(1991-5#6)(1992-9#9)(1993-3#1)(1995-6#4)
NH2-terminal modification of the phosphatase 2A catalytic subunit##2##8##(1992-9#2)
NH2-terminal##13##1##(1990-8#1)(1992-9#4)(1995-12#1)(1995-6#4)(1997-1#3)
NH2-terminus of##2##2##(1991-10#1)(1997-1#1)
NH2-terminus##3##1##(1991-10#1)(1992-4#1)(1997-1#1)
NH4+##5##1##(2008-11#5)
NH4Cl##3##1##(1994-6#1)(2008-11#2)
NHA##3##1##(1993-2#3)
NHE##2##1##(1997-7#1)(2008-10#1)
NHEJ##2##1##(1997-7#2)
NHI women##2##2##(2008-12#2)
NHI women's##2##2##(2008-12#2)
NHI##5##1##(2008-12#5)
NHK##3##1##(1994-3#3)
NHL##6##1##(1990-12#1)(2013-1#5)
NHS Direct##3##2##(2008-11#3)
NHS Executive##3##2##(2008-11#3)
NHS Trust##3##2##(2008-11#3)
NHS Trusts##2##2##(2008-11#2)
NHS##49##1##(1991-8#2)(1994-8#2)(1996-8#2)(1997-5#5)(1997-8#3)(2008-10#1)(2008-11#23)(2008-12#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#6)
NHS-stimulated##2##1##(1994-8#2)
NI to##2##2##(2013-8#2)
NI##7##1##(1993-2#2)(2011-2#1)(2013-8#4)
NICE##6##1##(2010-2#3)(2013-8#3)
NICU infants##2##2##(1991-12#1)(1991-2#1)
NICU stresses##2##2##(1991-1#2)
NICU##9##1##(1991-1#4)(1991-12#2)(1991-2#1)(2008-10#1)(2010-10#1)
NIDDM##4##1##(1991-7#3)(2010-2#1)
NIES CRM No##2##3##(2008-10#2)
NIES CRM##3##2##(2008-10#3)
NIES##7##1##(2008-10#7)
NIF##4##1##(2008-10#3)(2008-3#1)
NIH 3T3 cells##3##3##(1995-2#3)
NIH 3T3##4##2##(1992-7#1)(1995-2#3)
NIH guidelines##2##2##(2008-11#2)
NIH recommendations##2##2##(2008-11#2)
NIH##12##1##(1991-5#1)(1992-7#1)(1993-12#1)(1993-8#1)(1995-2#3)(1997-3#1)(2008-11#4)
NIH(ret) cells##2##2##(1993-8#2)
NIH(ret)##3##1##(1993-8#3)
NIH/3T3 cells##3##2##(1991-5#3)
NIH/3T3##6##1##(1991-5#5)(2008-11#1)
NIH3T3 cells##6##2##(1993-11#1)(1993-2#1)(1997-1#3)(2008-11#1)
NIHL##2##1##(2013-8#2)
NIL sets##3##2##(2008-10#3)
NIL##6##1##(2008-10#6)
NILs and##2##2##(2008-10#2)
NILs of##2##2##(2008-10#2)
NILs##15##1##(2008-10#15)
NIM1/NPR1 gene##2##2##(2008-10#2)
NIR dye##2##2##(2012-2#2)
NIR spectra##5##2##(2008-10#5)
NIR spectroscopy##6##2##(2008-10#6)
NIR##29##1##(2008-10#26)(2012-2#3)
NIR-conPK11195 and free##2##3##(2012-2#2)
NIRS##10##1##(2008-10#10)
NIST 1515##2##2##(2008-10#2)
NIST 1648##3##2##(2008-10#3)
NIST SRM 2670##2##3##(2008-10#2)
NIST SRM##9##2##(2008-10#9)
NIST reference material##2##3##(2008-10#2)
NIST reference##3##2##(2008-10#3)
NIST##35##1##(2008-10#35)
NIT##3##1##(2008-10#3)
NIV contents##2##2##(2008-10#2)
NIV##3##1##(2008-10#3)
NIV)##2##1##(2008-10#2)
NIV-producing##2##1##(2008-10#2)
NJ##4##1##(1991-1#1)(2008-11#1)(2008-9#1)(2010-7#1)
NJ)##2##1##(2008-11#1)(2013-1#1)
NK T cells##2##3##(2008-4#2)
NK T##5##2##(2008-4#5)
NK cell activity##3##3##(2008-10#3)
NK cell lysis##2##3##(2013-1#2)
NK cell##11##2##(1990-12#1)(2008-10#3)(2008-4#2)(2012-2#1)(2013-1#4)
NK cells is##2##3##(2008-8#1)(2008-9#1)
NK cells##23##2##(1991-6#1)(1995-2#3)(2008-10#4)(2008-4#3)(2008-8#8)(2008-9#2)(2012-3#1)(2013-1#1)
NK cytotoxicity##2##2##(2008-8#2)
NK##49##1##(1990-12#1)(1991-6#2)(1995-2#3)(2008-10#7)(2008-4#10)(2008-8#11)(2008-9#4)(2012-2#2)(2012-3#1)(2013-1#8)
NK-1##2##1##(2008-8#2)
NK-2##2##1##(2008-8#2)
NK-cell activation##2##2##(2008-9#2)
NK1##5##1##(1997-4#3)(2008-9#2)
NK2 receptor##3##2##(1997-4#3)
NK433##7##1##(1996-2#7)
NKA##3##1##(1994-8#1)(2008-8#2)
NKG2D##5##1##(2013-1#5)
NL##3##1##(2008-10#1)(2008-7#2)
NL-3 K##4##2##(2008-10#4)
NL-3##6##1##(2008-10#4)(2010-7#2)
NLM##3##1##(1991-2#1)(2010-5#2)
NLM's##2##1##(1991-2#1)(1992-1#1)
NM##8##1##(1995-5#6)(2010-12#2)
NMDA antagonist and a##2##4##(2008-5#2)
NMDA antagonist##4##2##(1996-2#1)(1997-2#1)(2008-5#2)
NMDA receptor antagonist##5##3##(1992-3#1)(1992-8#1)(1997-2#2)(2008-8#1)
NMDA receptor subunit##2##3##(1996-12#2)
NMDA receptor##18##2##(1992-3#1)(1992-8#1)(1996-12#4)(1996-2#4)(1997-2#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
NMDA receptor-mediated##2##2##(1992-3#1)(2008-7#1)
NMDA receptors are##3##3##(1996-12#1)(1997-2#1)(1997-7#1)
NMDA receptors in##2##3##(1997-2#1)(1997-7#1)
NMDA receptors produces##2##3##(1991-2#1)(1996-2#1)
NMDA receptors##15##2##(1991-2#1)(1995-11#3)(1996-12#2)(1996-2#1)(1997-2#6)(1997-7#2)
NMDA##58##1##(1991-2#1)(1992-3#2)(1992-8#5)(1994-2#1)(1995-11#3)(1996-12#6)(1996-2#7)(1997-2#13)(1997-7#3)(2008-11#1)(2008-5#4)(2008-7#4)(2008-8#7)(2010-4#1)
NMDA-induced##2##1##(2008-5#1)(2008-8#1)
NMDA-receptor##3##1##(1995-12#1)(1997-7#2)
NMDAR##2##1##(2012-2#2)
NMDAR1##5##1##(1997-2#5)
NMDAR2B mRNA expression##3##3##(1996-2#3)
NMDAR2B mRNA##5##2##(1996-2#5)
NMDARs##2##1##(2009-7#2)
NMDS analysis of##2##3##(1995-5#2)
NMDS to##2##2##(1995-5#2)
NMDS##12##1##(1995-5#12)
NMF is##3##2##(2008-10#3)
NMF##8##1##(2008-10#8)
NMO##2##1##(2013-8#2)
NMPABAO##2##1##(2008-5#2)
NMR ((1)H##2##2##(2008-10#2)
NMR and MS##2##3##(2010-6#1)(2011-3#1)
NMR and mass##2##3##(2008-11#1)(2008-12#1)
NMR and##17##2##(1994-11#1)(1994-5#2)(1997-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-7#1)(2010-6#2)(2011-3#1)
NMR assignment of the N-terminal##2##5##(2009-7#2)
NMR assignment of the##4##4##(2009-7#4)
NMR assignment of##7##3##(2008-11#1)(2009-7#6)
NMR assignments of the##3##4##(1990-9#1)(2009-7#2)
NMR assignments of##5##3##(1990-9#1)(2009-7#4)
NMR assignments##7##2##(1990-9#1)(2008-11#1)(2009-7#5)
NMR chemical shift assignments for the##2##6##(2009-7#2)
NMR chemical shift assignments##4##4##(2009-7#4)
NMR chemical shift##7##3##(1996-5#1)(2008-10#1)(2009-7#4)(2010-7#1)
NMR chemical shifts##2##3##(2008-10#1)(2012-2#1)
NMR chemical##9##2##(1996-5#1)(2008-10#2)(2009-7#4)(2010-7#1)(2012-2#1)
NMR data and##2##3##(1990-5#1)(1996-5#1)
NMR data##6##2##(1990-5#1)(1991-5#1)(1993-1#1)(1996-5#1)(2010-6#1)(2013-8#1)
NMR experiments##8##2##(1994-5#2)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#2)
NMR imaging##4##2##(1992-12#2)(1992-3#1)(2008-7#1)
NMR in##2##2##(1994-5#1)(1996-2#1)
NMR measurements##2##2##(1993-3#1)(2008-10#1)
NMR methods##3##2##(1994-5#3)
NMR of##3##2##(1993-8#1)(1994-5#1)(1994-8#1)
NMR properties##2##2##(1994-5#1)(2008-10#1)
NMR resonance assignment of the##2##5##(2009-7#2)
NMR resonance##3##2##(2009-7#3)
NMR results##2##2##(1992-3#1)(2008-10#1)
NMR signals##4##2##(1994-3#2)(1994-5#2)
NMR spectra and##2##3##(1994-5#1)(1996-5#1)
NMR spectra of the##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
NMR spectra of##7##3##(1992-12#1)(1993-8#1)(2008-10#1)(2008-5#2)(2008-9#2)
NMR spectra were##2##3##(1996-5#1)(2008-10#1)
NMR spectra##19##2##(1992-10#1)(1992-12#2)(1993-8#1)(1994-5#2)(1996-5#2)(2008-10#4)(2008-5#2)(2008-7#3)(2008-9#2)
NMR spectral##7##2##(1994-5#1)(2008-10#3)(2009-7#2)(2012-2#1)
NMR spectroscopic##4##2##(1994-8#1)(2008-10#2)(2013-1#1)
NMR spectroscopy and##4##3##(1992-4#1)(1993-3#1)(1996-5#1)(2008-10#1)
NMR spectroscopy has##2##3##(1994-8#1)(2008-7#1)
NMR spectroscopy of##3##3##(1994-2#1)(1994-8#1)(1995-2#1)
NMR spectroscopy##31##2##(1991-5#1)(1992-4#2)(1993-3#1)(1994-2#1)(1994-5#2)(1994-8#3)(1995-2#1)(1996-5#2)(2008-10#10)(2008-11#2)(2008-4#1)(2008-7#3)(2010-12#1)(2013-1#1)
NMR spectrum of##2##3##(1993-8#1)(2008-10#1)
NMR spectrum##4##2##(1993-8#2)(2008-10#2)
NMR structure##2##2##(2008-9#1)(2009-7#1)
NMR studies of##3##3##(1992-12#1)(1992-4#1)(1994-5#1)
NMR studies##8##2##(1992-12#1)(1992-3#1)(1992-4#1)(1994-5#2)(1996-5#1)(2008-10#2)
NMR study of##3##3##(1992-12#2)(2008-9#1)
NMR study##5##2##(1992-12#2)(1994-2#1)(2008-10#1)(2008-9#1)
NMR techniques##4##2##(1990-9#1)(1994-3#1)(2008-8#1)(2008-9#1)
NMR titration##2##2##(2008-10#2)
NMR to##5##2##(1992-10#1)(1992-3#1)(1995-8#1)(2009-8#1)(2012-3#1)
NMR##224##1##(1990-5#1)(1990-9#3)(1991-5#3)(1992-10#3)(1992-12#8)(1992-3#5)(1992-4#3)(1992-7#1)(1993-1#2)(1993-3#4)(1993-8#6)(1994-11#3)(1994-2#2)(1994-3#4)(1994-5#22)(1994-8#5)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#7)(1997-1#1)(2008-10#52)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#6)(2009-6#1)(2009-7#25)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#3)(2010-7#3)(2011-2#5)(2011-3#4)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
NMR)##4##1##(1991-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
NMR-derived##3##1##(1994-5#3)
NMWCO##2##1##(2008-10#2)
NN##8##1##(1996-2#3)(2008-10#5)
NN525##2##1##(2008-10#2)
NNDSS##2##1##(1997-3#2)
NNK by##4##2##(1990-6#3)(1993-11#1)
NNK##9##1##(1990-6#4)(1993-11#5)
NNRTI##2##1##(2011-3#2)
NO and##5##2##(2008-10#3)(2008-3#1)(2008-8#1)
NO are##2##2##(2008-10#1)(2010-7#1)
NO biology##2##2##(2011-2#2)
NO by##3##2##(1992-3#1)(2008-3#1)(2010-6#1)
NO concentrations##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
NO donor##2##2##(2008-11#1)(2008-7#1)
NO formation##2##2##(1992-5#1)(2011-2#1)
NO generated##2##2##(2008-10#2)
NO in biological##2##3##(2008-10#2)
NO in##9##2##(1992-5#2)(1993-8#1)(2008-10#4)(2008-3#1)(2010-12#1)
NO is##8##2##(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-10#2)(2011-2#1)
NO level##3##2##(2008-8#1)(2008-9#1)(2010-4#1)
NO may##2##2##(1992-12#1)(2011-2#1)
NO measurement##2##2##(2008-10#1)(2010-6#1)
NO production in##2##3##(1992-5#1)(2011-1#1)
NO production##8##2##(1992-5#1)(1994-11#1)(1995-11#1)(2008-10#2)(2008-4#1)(2011-1#2)
NO reduced was##2##3##(1992-3#2)
NO synthase enzyme##3##3##(1992-12#3)
NO synthase in##2##3##(1995-11#2)
NO synthase##17##2##(1992-12#4)(1995-11#8)(1996-2#2)(1997-2#1)(2008-7#1)(2010-4#1)
NO was##4##2##(2008-10#2)(2008-3#1)(2010-4#1)
NO with##2##2##(2008-10#2)
NO##143##1##(1992-12#6)(1992-3#5)(1992-5#4)(1993-8#1)(1994-11#3)(1995-11#11)(1995-2#1)(1996-2#3)(1997-2#1)(2008-10#42)(2008-11#2)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#2)(2010-12#1)(2010-4#4)(2010-6#6)(2010-7#4)(2011-1#4)(2011-2#11)(2011-3#3)(2013-8#1)
NO() in##3##2##(2008-10#3)
NO()##9##1##(2008-10#9)
NO(2) and##2##2##(2008-10#1)(2008-3#1)
NO(2) gas##2##2##(2008-10#2)
NO(2) in the air samples##2##5##(2008-10#2)
NO(2) in the air##3##4##(2008-10#3)
NO(2) in the##4##3##(2008-10#4)
NO(2) in##8##2##(2008-10#7)(2012-2#1)
NO(2)##24##1##(2008-10#16)(2008-11#3)(2008-3#4)(2012-2#1)
NO(2)(-) in##2##2##(2008-10#2)
NO(2)(-)##11##1##(2008-10#11)
NO(2)(-)-Nml(-1) and##2##2##(2008-10#2)
NO(3) and##2##2##(2008-10#2)
NO(3)##5##1##(2008-10#4)(2009-6#1)
NO(3)(-) and SO(4)(2-)##2##3##(2008-10#2)
NO(3)(-) and##3##2##(2008-10#3)
NO(3)(-)##13##1##(2008-10#13)
NO(3)(-)-Nml(-1)##2##1##(2008-10#2)
NO(A)##2##1##(2008-8#2)
NO(x)##4##1##(2008-10#2)(2008-11#2)
NO-induced##2##1##(1993-3#1)(2008-7#1)
NO2##3##1##(2008-11#1)(2008-3#1)(2011-2#1)
NO2-modification##2##1##(1990-5#2)
NO2-modified##2##1##(1990-5#2)
NOD mice##6##2##(1992-7#1)(1995-12#2)(2008-10#2)(2010-11#1)
NOD##10##1##(1992-7#1)(1995-12#3)(2008-10#3)(2010-11#3)
NOE##4##1##(1993-8#1)(1994-5#1)(2008-10#1)(2008-11#1)
NOESY##2##1##(1994-5#1)(2008-9#1)
NOK##11##1##(1990-9#1)(1992-5#1)(1993-6#1)(1994-6#1)(1995-2#4)(1997-4#3)
NOL7##8##1##(2013-1#8)
NOM##12##1##(1992-5#2)(2008-10#1)(2008-11#9)
NOR and ENO in##3##4##(2008-10#3)
NOR and##5##2##(2008-10#5)
NOR##12##1##(2008-10#9)(2008-12#1)(2013-8#2)
NOR-1 gene expression##2##3##(1995-12#2)
NOR-1##7##1##(1995-12#7)
NORs##12##1##(1993-12#11)(2008-12#1)
NOS##11##1##(1994-11#2)(2008-5#2)(2008-7#1)(2009-10#4)(2010-12#2)
NOS-2##3##1##(2008-12#3)
NOS/NO##2##1##(2009-10#2)
NOT##3##1##(2009-11#1)(2009-12#1)(2012-3#1)
NOTES##2##1##(2009-8#2)
NOW Legal Defense and Education Fund##2##6##(1995-6#2)
NP and##3##2##(2008-10#3)
NP or##2##2##(2008-10#2)
NP reacted##2##2##(2008-10#2)
NP were##2##2##(2008-10#1)(2008-8#1)
NP##19##1##(2008-10#8)(2008-8#2)(2008-9#1)(2010-1#2)(2010-10#1)(2013-8#5)
NPBnE##2##1##(2008-10#2)
NPC patients##2##2##(1990-8#2)
NPC##21##1##(1990-8#4)(2008-9#1)(2011-2#14)(2013-1#2)
NPD and##3##2##(2008-12#2)(2008-9#1)
NPD##8##1##(2008-12#5)(2008-9#3)
NPDC-1##4##1##(1995-2#4)
NPIK was##2##2##(1997-8#2)
NPIK##9##1##(1997-8#9)
NPK application##2##2##(2008-12#2)
NPK##3##1##(2008-12#3)
NPM-ALK each##2##2##(2011-2#2)
NPM-ALK##3##1##(2011-2#3)
NPOE membranes##2##2##(2008-10#2)
NPOE##5##1##(2008-10#5)
NPPs##3##1##(2009-12#3)
NPR1##4##1##(2008-10#2)(2011-10#1)(2011-2#1)
NPSLE##3##1##(2012-3#3)
NPTs##5##1##(2010-11#5)
NPV##3##1##(1997-3#1)(2008-11#1)(2012-12#1)
NPY and##2##2##(1997-4#1)(2009-8#1)
NPY or C-PON immunoreactivity##2##4##(1990-5#2)
NPY or C-PON##3##3##(1990-5#3)
NPY or##4##2##(1990-5#3)(1996-12#1)
NPY##13##1##(1990-5#3)(1996-12#2)(1997-4#7)(2009-8#1)
NPY(13-36)##3##1##(1997-4#3)
NPY-IR##2##1##(1997-4#2)
NQS##3##1##(2008-10#3)
NR apoenzyme##2##2##(1993-6#2)
NR##12##1##(1993-6#2)(2008-10#7)(2008-11#3)
NR-1##3##1##(2008-9#3)
NR-2##2##1##(2008-9#2)
NR-3 and NR-4##2##3##(2008-9#2)
NR2C##7##1##(1996-12#7)
NRAS and BRAF##2##3##(2009-4#2)
NRAS##3##1##(2009-4#3)
NRC##2##1##(1991-5#1)(2008-12#1)
NRCC##3##1##(2008-10#3)
NREMS##3##1##(1991-9#3)
NRMs##4##1##(2008-12#4)
NRRL##3##1##(2008-10#2)(2012-2#1)
NRT##6##1##(2008-9#6)
NS and##3##2##(2008-10#2)(2008-6#1)
NS##9##1##(2008-10#5)(2008-6#1)(2009-1#2)(2012-2#1)
NS)##4##1##(1994-12#2)(2011-2#1)(2013-1#1)
NS-398##2##1##(1997-1#2)
NS-49 is##2##2##(1995-11#2)
NS-49##7##1##(1995-11#7)
NS/0##4##1##(2008-11#4)
NS0 cell lines##2##3##(2008-11#2)
NS0 cell##4##2##(2008-11#3)(2008-7#1)
NS0 cells in##2##3##(2008-11#2)
NS0 cells##3##2##(2008-11#3)
NS0##12##1##(2008-11#10)(2008-7#2)
NS3##2##1##(2008-10#2)
NSAID use##2##2##(2008-11#1)(2008-8#1)
NSAID##10##1##(1991-8#1)(2008-11#4)(2008-12#1)(2008-8#1)(2011-2#2)(2012-3#1)
NSAIDs on the##2##3##(1991-2#1)(2008-10#1)
NSAIDs on##3##2##(1991-2#1)(1997-1#1)(2008-10#1)
NSAIDs to##2##2##(2008-11#1)(2008-8#1)
NSAIDs##23##1##(1990-11#1)(1991-2#1)(1993-11#1)(1993-2#1)(1995-12#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-8#3)(2011-2#5)
NSC##6##1##(2011-2#2)(2012-5#4)
NSCLC and##2##2##(1992-12#1)(2013-8#1)
NSCLC cells##3##2##(2013-1#3)
NSCLC##10##1##(1992-12#1)(2008-10#3)(2013-1#3)(2013-8#3)
NSCs cultured in suspension##2##4##(2008-11#2)
NSCs cultured in##4##3##(2008-11#4)
NSCs##11##1##(2008-11#8)(2009-10#3)
NSE concentrations in##2##3##(1992-11#2)
NSE concentrations##3##2##(1992-11#3)
NSE##16##1##(1990-6#5)(1990-8#1)(1991-8#1)(1992-11#3)(2008-11#1)(2011-2#5)
NSI##5##1##(2013-1#5)
NSP 5a3a##8##2##(2011-2#8)
NSP 5a3a's##3##2##(2011-2#3)
NSP##11##1##(2011-2#11)
NSP49##2##1##(1995-9#2)
NSS processing##2##2##(2008-9#2)
NSS##4##1##(2008-10#1)(2008-9#3)
NSTEMI##2##1##(2011-2#2)
NSW##2##1##(2011-2#1)(2013-1#1)
NSm and G1/G2 proteins##2##4##(2008-10#2)
NSm##4##1##(2008-10#4)
NSs protein##5##2##(2008-10#5)
NSs proteins##3##2##(2008-10#3)
NSs##14##1##(2008-10#14)
NT and NN##2##3##(1996-2#2)
NT and##4##2##(1996-2#2)(2008-10#1)(2008-7#1)
NT##12##1##(1994-8#1)(1996-2#3)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)
NT- and##2##2##(1994-3#1)(2008-7#1)
NT-3 modification##2##2##(2009-10#2)
NT-3##8##1##(2008-8#3)(2009-10#5)
NT-3cDNA/CHO##2##1##(2008-8#2)
NT-proBNP##6##1##(2011-2#6)
NT-stimulated##3##1##(1994-3#3)
NT/NMN precursor processing##2##3##(1994-8#2)
NT/NMN##3##1##(1994-8#3)
NTA##3##1##(2008-10#2)(2008-9#1)
NTDB data points##6##3##(2008-4#5)(2008-5#1)
NTI##2##1##(2008-7#2)
NTM disease##2##2##(2011-2#2)
NTM##3##1##(2011-2#3)
NTO##4##1##(2008-11#4)
NTP and##2##2##(2008-11#1)(2008-7#1)
NTP##7##1##(2008-11#1)(2008-7#1)(2008-9#2)(2010-7#1)(2010-8#2)
NTPs##3##1##(2008-7#1)(2010-7#2)
NTS##4##1##(1997-2#4)
NTs and NWs##2##3##(2008-7#2)
NU concepts##2##2##(2010-10#2)
NU##5##1##(2010-10#5)
NU7441 and##2##2##(2013-1#2)
NU7441##6##1##(2013-1#6)
NV##3##1##(2008-1#2)(2008-5#1)
NVivo##2##1##(2011-1#2)
NW of##3##2##(2008-10#2)(2008-11#1)
NW##4##1##(2008-10#2)(2008-11#1)(2008-7#1)
NWFP##2##1##(2008-12#2)
NWs##3##1##(2008-10#1)(2008-7#2)
NXIIts##5##1##(2008-8#5)
NY##2##1##(2008-10#2)
NYAPs were##2##2##(2008-10#2)
NYAPs##5##1##(2008-10#5)
NYC##7##1##(1991-1#2)(1996-1#1)(1996-3#4)
NYHA##2##1##(2008-10#1)(2010-7#1)
NYR##4##1##(2010-7#4)
NZ##5##1##(2008-10#2)(2008-11#2)(2008-8#1)
NZB##2##1##(1994-8#2)
Na and Cl##2##3##(2008-9#2)
Na and K##3##3##(2008-10#3)
Na and Si##3##3##(2008-10#3)
Na and##13##2##(2008-10#10)(2008-5#1)(2008-9#2)
Na concentration##2##2##(2008-5#2)
Na ions##2##2##(2008-10#1)(2008-5#1)
Na##55##1##(1992-8#1)(1997-6#1)(2008-10#35)(2008-11#3)(2008-5#7)(2008-8#2)(2008-9#4)(2012-5#2)
Na(+) and K(+) and##2##4##(2008-10#2)
Na(+) and K(+)##9##3##(2008-10#8)(2008-7#1)
Na(+) and##14##2##(2008-10#13)(2008-7#1)
Na(+) concentration##2##2##(2008-10#2)
Na(+) extraction selectivity##2##3##(2008-10#2)
Na(+) in##2##2##(2012-7#2)
Na(+) ion##3##2##(2008-10#3)
Na(+) ions##3##2##(2008-10#3)
Na(+)##69##1##(2008-10#62)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#2)(2012-7#2)
Na(+)&gt##4##1##(2008-10#4)
Na(+)-##2##1##(1995-6#1)(2008-10#1)
Na(+)-K(+) ATPase##2##2##(1994-8#2)
Na(+)-K(+)ATPase activity##2##2##(1994-8#2)
Na(+)-dependent##2##1##(1991-5#1)(1995-8#1)
Na(+)/Ca(2+)##2##1##(2008-11#2)
Na(+)/K(+)-ATPase activity##2##2##(2008-7#2)
Na(+)/K(+)-ATPase##3##1##(2008-7#3)
Na(2) SO(4)##3##2##(2012-7#3)
Na(2)CO(3) and##3##2##(2008-10#3)
Na(2)CO(3) fusion##3##2##(2008-10#3)
Na(2)CO(3)##9##1##(2008-10#9)
Na(2)O##3##1##(2008-10#3)
Na(2)SO(3)##2##1##(2008-10#2)
Na(2)SO(4) and Na(3)PO(4)##3##3##(2008-10#3)
Na(2)SO(4) and##5##2##(2008-10#5)
Na(2)SO(4)##12##1##(2008-10#12)
Na(3)PO(4)##4##1##(2008-10#4)
Na)NO(3)##2##1##(2008-10#2)
Na+ and##2##2##(2008-12#2)
Na+ channel clusters##2##3##(2008-7#2)
Na+ channel##5##2##(1995-11#1)(2008-7#4)
Na+ channels##2##2##(1995-11#1)(2008-11#1)
Na+ electrochemical potential##3##3##(1997-8#3)
Na+##25##1##(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#2)(1995-10#1)(1995-11#2)(1996-12#1)(1997-1#1)(1997-8#4)(2008-11#1)(2008-12#4)(2008-7#4)
Na+/H+ exchange activity##2##3##(1992-10#2)
Na+/H+ exchange##6##2##(1992-10#3)(1994-3#1)(1995-8#2)
Na+/H+ exchanger##4##2##(1993-3#4)
Na+/H+##11##1##(1992-10#4)(1993-3#4)(1994-3#1)(1995-8#2)
Na+/K+ and proline##2##3##(2008-12#2)
Na+/K+ and##3##2##(2008-12#3)
Na+/K+##6##1##(1993-1#2)(1997-1#1)(2008-12#3)
Na-K ATPase molecules may##2##4##(1995-8#2)
Na-K ATPase##4##2##(1995-8#4)
Na-butyrate##5##1##(2008-11#5)
Na-montmorillonite##2##1##(2008-10#2)
NaAlO(2)##3##1##(2008-10#3)
NaBH(4) and##3##2##(2008-10#3)
NaBH(4) in##4##2##(2008-10#4)
NaBH(4) were##3##2##(2008-10#3)
NaBH(4)##21##1##(1996-5#1)(2008-10#20)
NaBr##7##1##(2008-10#7)
NaCl 0##2##2##(2008-10#2)
NaCl and##10##2##(2008-10#6)(2009-10#3)(2013-1#1)
NaCl as##2##2##(2008-10#2)
NaCl at##6##2##(1993-3#1)(1994-5#1)(2008-10#4)
NaCl concentrations##3##2##(2008-10#1)(2012-7#2)
NaCl in##2##2##(2008-10#2)
NaCl is##2##2##(1994-5#1)(2008-10#1)
NaCl or##3##2##(2008-10#2)(2008-11#1)
NaCl saturated##2##2##(2008-10#1)(2012-2#1)
NaCl solution##5##2##(2008-10#3)(2013-1#2)
NaCl treatment##2##2##(1997-8#1)(2008-11#1)
NaCl were used##2##3##(1991-11#1)(2008-10#1)
NaCl were##7##2##(1990-12#1)(1991-11#1)(2008-10#5)
NaCl##124##1##(1990-12#2)(1990-5#2)(1990-8#1)(1991-11#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-6#1)(1993-3#2)(1994-5#2)(1994-8#1)(1995-11#1)(1997-4#3)(1997-8#1)(2008-10#70)(2008-11#9)(2008-12#3)(2008-5#1)(2008-9#3)(2009-10#3)(2009-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-7#3)(2013-1#3)
NaCl)##6##1##(1994-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
NaCl-best##2##1##(2009-10#2)
NaClO(4) aqueous solution##2##3##(2008-10#2)
NaClO(4) at##2##2##(2008-10#2)
NaClO(4)##12##1##(2008-10#12)
NaF for 3 min daily##2##5##(2013-1#2)
NaF for 3 min every 2 weeks##2##7##(2013-1#2)
NaF for 3 min##4##4##(2013-1#4)
NaF increased##2##2##(1993-3#2)
NaF solution##3##2##(2008-10#1)(2013-1#2)
NaF treatment##3##2##(2008-10#3)
NaF##20##1##(1993-3#4)(2008-10#8)(2013-1#8)
NaH##2##1##(1996-5#2)
NaH(2)PO(4)##5##1##(2008-10#5)
NaHCO(3)##2##1##(2008-10#2)
NaHCO(3))##2##1##(2008-10#2)
NaI##2##1##(2008-10#1)(2013-1#1)
NaNO(2)##3##1##(2008-10#3)
NaNO(3) solution##3##2##(2008-10#3)
NaNO(3)##13##1##(2008-10#13)
NaOCl and##5##2##(2008-10#2)(2012-3#1)(2013-1#2)
NaOCl##15##1##(2008-10#3)(2012-3#1)(2013-1#11)
NaOH and##4##2##(2008-10#3)(2011-2#1)
NaOH as a##2##3##(2008-10#2)
NaOH from##2##2##(2008-10#2)
NaOH solution##12##2##(2008-10#11)(2008-11#1)
NaOH##44##1##(1995-6#1)(2008-10#39)(2008-11#1)(2011-2#2)(2012-2#1)
NaOH)##2##1##(1992-3#1)(2008-10#1)
NaTPB##6##1##(2008-10#6)
Nab##3##1##(2008-10#3)
Nacional de##2##2##(2012-12#1)(2012-3#1)
Nafion and##3##2##(2008-10#3)
Nafion film##2##2##(2008-10#2)
Nafion films##5##2##(2008-10#5)
Nafion membrane##4##2##(2008-10#4)
Nafion##32##1##(2008-10#32)
Nafion((R))##2##1##(2008-10#2)
Nafion(R)##4##1##(2008-10#4)
Nafion(R)-coated carbon paste electrodes##2##4##(2008-10#2)
Nafion(R)-coated carbon paste##3##3##(2008-10#3)
Nafion(R)-coated carbon##4##2##(2008-10#4)
Nafion-modified glassy carbon electrode##2##4##(2008-10#2)
Nafion/MV modified carbon fiber##2##4##(2008-10#2)
Nafion/MV modified##5##2##(2008-10#5)
Nafion/MV##6##1##(2008-10#6)
Nafion/mercury film##2##2##(2008-10#2)
NahG plants##2##2##(2008-10#2)
NahG##5##1##(2008-10#3)(2012-2#2)
Nai##2##1##(1994-3#2)
Naive##2##1##(2008-11#1)(2008-5#1)
Najran##2##1##(2008-1#2)
Nakamurella multipartita##2##2##(2011-2#2)
Nakamurella##3##1##(2011-2#3)
Nakdong##6##1##(2008-10#6)
Nakhla##4##1##(2008-10#4)
Naloxonazine##2##1##(1996-2#2)
Namely##6##1##(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
Namibia##4##1##(1997-6#4)
Nanban lacquer film##2##3##(2008-10#2)
Nanofilter##2##1##(2008-10#2)
Nanomaterials##2##1##(2010-7#2)
Nanometer titanium dioxide immobilized on silica gel##2##7##(2008-10#2)
Nanoparticles##4##1##(2008-10#2)(2008-11#2)
Nanoscale##4##1##(2007-12#1)(2008-10#2)(2010-7#1)
Nanoscience &amp##2##2##(2013-1#2)
Nanoscience##3##1##(2008-10#1)(2013-1#2)
Nanostructured##2##1##(2008-7#1)(2009-12#1)
Nanostructures##2##1##(2010-12#1)(2012-2#1)
Nanotechnology is##2##2##(2008-10#1)(2008-12#1)
Nanotechnology##4##1##(2008-10#1)(2008-12#1)(2010-12#2)
Naples##2##1##(2008-10#2)
Naproxen##2##1##(2008-10#2)
Narrative##5##1##(2008-8#1)(2009-11#1)(2010-5#1)(2012-12#1)(2012-2#1)
Narrow-band##2##1##(2008-2#1)(2010-6#1)
Narrow-sense heritabilities##2##2##(2008-10#2)
Narrowing##2##1##(1992-12#1)(2008-7#1)
Nasal##2##1##(1990-6#1)(1997-3#1)
Nascent##3##1##(2012-3#3)
Nash##2##1##(2008-10#1)(2008-8#1)
Nasopharyngeal##2##1##(2010-7#1)(2013-8#1)
Nathan##2##1##(1991-1#1)(1991-8#1)
Nation##4##1##(1991-2#1)(1993-3#1)(1997-6#1)(2008-11#1)
National AIDS Policy##2##3##(1995-6#2)
National AIDS##3##2##(1995-6#2)(1997-6#1)
National Advisory Committee on Immunization (NACI)##3##6##(1994-9#1)(1995-11#2)
National Association of People with AIDS (NAPWA)##3##7##(1995-6#1)(1996-5#2)
National Association of Private Psychiatric Hospitals##4##6##(1991-1#2)(1992-2#1)(1992-3#1)
National Association of##8##3##(1991-1#2)(1992-2#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-5#2)
National Biological Dosimetry Response Plan##2##5##(2008-7#2)
National Board##4##2##(1990-12#1)(2008-11#3)
National Breast and Cervical Cancer Early Detection Program##2##8##(1997-1#2)
National Cancer Institute (NCI)##3##4##(1997-1#1)(1997-3#1)(2013-1#1)
National Cancer Institute##12##3##(1991-3#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
National Cancer Research Institute##2##4##(2009-4#2)
National Cancer##18##2##(1991-3#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2009-4#2)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
National Center for##4##3##(1993-2#1)(1997-3#3)
National Committee for##2##3##(1995-2#1)(2008-5#1)
National Football League##2##3##(2013-1#2)
National Guideline Clearinghouse Databases##2##4##(2012-12#2)
National Health Interview Survey##5##4##(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#1)(2010-11#1)
National Health Interview##6##3##(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#2)(2010-11#1)
National Health Service (NHS)##3##4##(2008-11#1)(2011-2#1)(2012-12#1)
National Health Service##9##3##(1995-2#1)(1996-12#1)(2008-11#4)(2008-12#1)(2011-2#1)(2012-12#1)
National Health Survey##2##3##(1994-6#1)(2011-2#1)
National Health##25##2##(1991-2#1)(1991-6#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
National Heart##3##2##(1992-12#1)(2008-5#1)(2013-1#1)
National Institute for##6##3##(1990-3#1)(2008-10#2)(2012-3#1)(2013-1#2)
National Institute of Standards and Technology (NIST)##2##7##(2008-10#2)
National Institute of Standards and Technology##4##6##(2008-10#2)(2008-3#2)
National Institute of##14##3##(1991-3#3)(1992-12#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#2)(2011-2#1)
National Institute##22##2##(1990-3#1)(1991-3#3)(1992-12#1)(1992-3#1)(1996-6#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
National Institutes of Health##12##4##(1996-5#1)(1996-9#1)(1997-8#2)(2007-9#1)(2008-5#3)(2008-7#1)(2010-8#1)(2012-3#2)
National Institutes of##13##3##(1994-2#1)(1996-5#1)(1996-9#1)(1997-8#2)(2007-9#1)(2008-5#3)(2008-7#1)(2010-8#1)(2012-3#2)
National Knowledge Infrastructure##2##3##(2011-2#2)
National Laboratory##2##2##(2008-10#1)(2008-11#1)
National Long-Term Care Surveys##2##4##(1991-1#1)(1995-3#1)
National Long-Term Care##3##3##(1991-1#1)(1993-3#1)(1995-3#1)
National Longitudinal##4##2##(2009-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
National Notifiable Diseases Surveillance System##2##5##(1997-3#2)
National Park in##2##3##(2008-10#2)
National Park##5##2##(1997-7#1)(2008-10#2)(2010-4#1)(2011-2#1)
National Public Health##3##3##(1997-3#1)(2012-3#2)
National Quality Award in 1992##2##5##(1994-2#1)(1994-3#1)
National Quality Award##4##3##(1994-2#1)(1994-3#1)(1995-2#2)
National Research Council##4##3##(1990-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
National Research##6##2##(1990-6#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
National Science Foundation's##3##3##(1997-6#1)(2010-10#1)(2010-12#1)
National Science##5##2##(1997-6#1)(2008-10#1)(2010-10#1)(2010-12#1)(2013-8#1)
National Security Committee##2##3##(1995-6#1)(1996-5#1)
National Service##2##2##(2007-12#1)(2008-11#1)
National University Hospital##2##3##(2012-12#1)(2013-8#1)
National University##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
National and##2##2##(1995-1#1)(2008-11#1)
National health expenditures##6##3##(1991-2#1)(1992-12#2)(1993-3#1)(1995-3#1)(1997-3#1)
National health##10##2##(1991-2#1)(1992-1#1)(1992-12#2)(1993-2#1)(1993-3#1)(1995-3#1)(1996-2#1)(1997-3#1)(2009-7#1)
National nursing agencies##2##3##(2013-1#2)
National##253##1##(1990-12#1)(1990-3#1)(1990-6#2)(1991-1#3)(1991-12#2)(1991-2#6)(1991-3#5)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#4)(1992-2#1)(1992-3#3)(1993-2#3)(1993-3#2)(1993-6#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#5)(1995-3#3)(1995-6#6)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#6)(1996-6#1)(1996-9#1)(1997-1#3)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#29)(2008-11#15)(2008-12#3)(2008-3#7)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#2)(2009-5#1)(2009-7#2)(2010-10#3)(2010-11#2)(2010-12#4)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#12)(2011-3#1)(2011-9#1)(2012-12#7)(2012-3#7)(2013-1#13)(2013-8#8)
Nationally##5##1##(1995-1#1)(1995-12#1)(2008-11#2)(2010-1#1)
Nations##9##1##(1996-1#1)(2007-12#1)(2008-11#6)(2011-2#1)
Nationwide##2##1##(1996-6#1)(2012-3#1)
Native American##3##2##(1995-12#1)(2008-4#1)(2010-10#1)
Native Hawaiian well-being##5##3##(2008-1#5)
Native Hawaiian women##2##3##(2008-1#2)
Native Hawaiian##9##2##(2008-1#9)
Native PAGE Zymography##2##3##(2012-2#2)
Native and##2##2##(2008-10#2)
Native people##3##2##(2011-2#1)(2013-1#2)
Native##29##1##(1992-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-1#10)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#2)
Natl##9##1##(1990-10#1)(1990-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1995-6#2)
Natrum##2##1##(2008-10#2)
Natural History##2##2##(2010-1#1)(2011-2#1)
Natural Hybrids of Phytophthora nicotianae and##2##6##(2008-10#2)
Natural and##3##2##(2008-10#2)(2012-3#1)
Natural history of##2##3##(2008-10#1)(2008-7#1)
Natural infection of##2##3##(2012-12#2)
Natural killer##3##2##(2008-11#1)(2008-4#2)
Natural selection and##2##3##(2008-9#1)(2012-3#1)
Natural##50##1##(1991-2#1)(1993-9#2)(1996-5#1)(1997-8#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-3#3)(2013-1#1)
Naturally occurring##5##2##(2008-10#2)(2010-11#1)(2012-2#1)(2012-3#1)
Naturally##10##1##(1996-12#1)(2008-10#5)(2010-11#1)(2012-2#1)(2012-3#2)
Nature and##2##2##(2008-10#1)(2010-11#1)
Nature of##2##2##(2008-10#2)
Nature##15##1##(1990-11#1)(1992-10#1)(1992-4#1)(1997-6#1)(1997-7#3)(2008-10#4)(2008-11#1)(2010-11#1)(2011-1#1)(2012-2#1)
Nature's##2##1##(1997-7#1)(2008-5#1)
Nausea and vomiting were##2##4##(1991-6#1)(2011-2#1)
Nausea##3##1##(1990-12#1)(1991-6#1)(2011-2#1)
Nautilus##2##1##(2009-8#2)
Navier-Stokes##2##1##(2008-3#2)
Navigating the##2##2##(2012-2#1)(2013-1#1)
Navon##3##1##(2008-11#3)
Nazi##2##1##(2008-12#2)
Naïve##2##1##(2010-8#1)(2013-8#1)
Nb and Mo##2##3##(2008-10#2)
Nb and Ta in##2##4##(2008-10#2)
Nb and Ta##3##3##(2008-10#3)
Nb and##5##2##(2008-10#5)
Nb##9##1##(2008-10#7)(2008-2#2)
Nb(V) and Ta(V) were##2##4##(2008-10#2)
Nb(V) and Ta(V)##3##3##(2008-10#3)
Nb-28 Ta-3##2##2##(2009-7#2)
Nc##3##1##(1992-8#1)(2008-10#2)
Ncm##5##1##(2013-1#5)
Ncm)##3##1##(2013-1#3)
Nd and Sm##2##3##(2008-10#2)
Nd concentrations##2##2##(2008-10#1)(2008-2#1)
Nd##99##1##(1991-3#2)(1992-1#2)(1993-1#2)(1993-6#2)(1994-2#1)(1995-2#3)(2007-11#2)(2007-12#6)(2008-10#16)(2008-2#18)(2008-3#41)(2011-2#3)(2012-2#1)
Nd(3+)##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
Nd(III) dipyr NO species##2##4##(2008-10#2)
Nd(III)##15##1##(2008-10#15)
Nd-1##2##1##(2008-10#2)
Nd-doped##2##1##(2007-12#1)(2008-2#1)
NdGaO(3)##2##1##(2012-2#2)
Ne##5##1##(2008-8#5)
Near infrared##3##2##(2008-10#3)
Near##13##1##(1993-3#1)(2008-10#6)(2008-3#3)(2010-5#2)(2012-9#1)
Near-Isogenic##2##1##(2008-10#2)
Near-field##2##1##(2008-2#1)(2008-3#1)
Near-infrared (NIR)##3##2##(2008-10#3)
Near-infrared##7##1##(1991-5#1)(2008-10#6)
Near-isogenic lines (NILs)##2##3##(2008-10#2)
Near-isogenic##3##1##(2008-10#3)
Nearly 1##2##2##(2008-3#1)(2010-9#1)
Nearly 50%##2##2##(1994-6#1)(2009-8#1)
Nearly all patients##2##3##(2008-6#1)(2008-8#1)
Nearly all##9##2##(1990-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2012-12#1)
Nearly##20##1##(1990-9#1)(1994-6#1)(1995-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
Nebraska##5##1##(1997-6#1)(2008-10#1)(2008-8#3)
Nebraska)##2##1##(2008-12#1)(2008-8#1)
Nebulin is##2##2##(2008-6#2)
Nebulin##3##1##(2008-6#3)
Nebulized##4##1##(1992-3#1)(1994-12#1)(2008-11#1)(2008-7#1)
Nebulizer##2##1##(1992-3#1)(1994-12#1)
Necdin and##2##2##(2008-9#2)
Necdin##4##1##(2008-9#4)
Neck Disability Index##4##3##(2008-12#2)(2012-12#2)
Neck##13##1##(1990-9#1)(1995-2#1)(1997-3#1)(1997-6#3)(2008-12#2)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
Necrosis Factor##2##2##(2011-2#1)(2012-3#1)
Necrosis and##2##2##(1991-8#1)(2008-11#1)
Necrosis of##2##2##(2008-10#2)
Necrosis##12##1##(1991-8#1)(2008-10#6)(2008-11#2)(2008-7#1)(2011-2#1)(2012-3#1)
Necrosis-Inducing##2##1##(2008-10#2)
Necrotic Leaf##2##2##(2008-10#2)
Necrotic symptoms##2##2##(2008-10#2)
Necrotic##10##1##(2008-10#9)(2008-5#1)
Necrotizing sialometaplasia##2##2##(1991-11#1)(2009-1#1)
Necrotizing##4##1##(1991-11#1)(2009-1#1)(2013-1#2)
Necrotrophic##2##1##(2008-10#2)
Nedd-8##4##1##(1993-8#4)
Need for##2##2##(1992-2#1)(2010-10#1)
Needed##2##1##(1996-1#1)(1996-12#1)
Needle and dread##2##3##(2008-11#2)
Needle##4##1##(1991-1#1)(2008-10#1)(2008-11#2)
Needs##4##1##(1994-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
Nef##8##1##(1997-3#5)(2011-2#3)
Negative##19##1##(1990-2#1)(1991-9#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-9#3)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Neglect patients##2##2##(2009-10#2)
Neglected##2##1##(2009-4#2)
Negro##5##1##(2008-10#5)
Nei's average gene diversity across seven RFLP loci was 0##2##10##(2008-10#2)
Nei's genetic##2##2##(2008-10#2)
Nei's##12##1##(2008-10#12)
Neishabour##2##1##(2008-12#2)
Neisseria gonorrhoeae##4##2##(1993-12#1)(1993-9#2)(1996-6#1)
Neisseria meningitidis##14##2##(1993-12#2)(2006-5#1)(2008-12#4)(2009-7#1)(2010-12#1)(2010-8#1)(2013-1#4)
Neisseria##23##1##(1993-12#4)(1993-9#2)(1996-6#1)(2006-5#1)(2008-12#4)(2009-7#2)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#5)
Neither indomethacin##2##2##(2008-11#2)
Neither of these two##2##4##(2008-10#2)
Neither of these##3##3##(1994-2#1)(2008-10#2)
Neither the survival rate nor the disease-free survival rate differed significantly between the groups##2##14##(1997-7#2)
Neither the##12##2##(1991-6#1)(1993-3#1)(1994-11#1)(1996-12#1)(1997-7#2)(2008-10#4)(2008-7#1)(2013-1#1)
Neither##63##1##(1990-11#1)(1990-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#2)(1993-3#3)(1994-11#1)(1994-2#2)(1994-8#3)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#2)(2008-10#17)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
Nemastoma lugubre##2##2##(2007-12#2)
Nematicidal activity of essential oils##2##5##(2008-10#2)
Nematode Meloidogyne##2##2##(2008-10#2)
Nematode##20##1##(1996-12#1)(2008-10#19)
Nematode-trapping fungi##2##2##(2008-10#2)
Nematodes##9##1##(2008-10#9)
Nematodirus##2##1##(1996-12#2)
Nematophagous Fungus##2##2##(2008-10#2)
Neoadjuvant chemotherapy##3##2##(1992-12#1)(1993-11#1)(2013-8#1)
Neoadjuvant##5##1##(1992-12#1)(1993-11#1)(2012-3#2)(2013-8#1)
Neogonodactylus oerstedii##2##2##(2007-12#2)
Neoheterobothrium hirame##2##2##(2010-8#2)
Neonatal diabetes mellitus##2##3##(2011-1#2)
Neonatal follow-up programs##2##3##(2008-11#2)
Neonatal##14##1##(1991-6#1)(1992-12#1)(1992-5#1)(1997-5#1)(2008-11#5)(2009-12#1)(2011-1#4)
Neoplasms##2##1##(2011-2#1)(2012-3#1)
Neoplastic##6##1##(1990-6#1)(1991-12#1)(1994-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
Neopterin was##2##2##(2008-10#2)
Neopterin##4##1##(2008-10#2)(2009-12#2)
Neospora##2##1##(1996-6#1)(2012-2#1)
Neotetrazolium chloride##2##2##(2008-10#2)
Nep1 (5 mug/ml)##2##3##(2008-10#2)
Nep1 in liquid culture##2##4##(2008-10#2)
Nep1 in##3##2##(2008-10#3)
Nep1 was##4##2##(2008-10#4)
Nep1##19##1##(2008-10#19)
Nepal Medical College##3##3##(2012-3#3)
Nepal during##2##2##(2008-10#1)(2012-3#1)
Nepal##53##1##(2008-10#11)(2008-11#3)(2008-8#1)(2010-11#4)(2010-8#10)(2011-2#2)(2012-3#21)(2013-8#1)
Nepalese isolates##2##2##(2008-10#2)
Nepalese male and female##2##4##(2012-3#2)
Nepalese people##3##2##(2012-3#3)
Nepalese##14##1##(2008-10#2)(2008-8#2)(2010-8#1)(2012-3#9)
Nephrocalcin##2##1##(1991-12#2)
Nephrogenic adenoma##2##2##(2008-10#2)
Nephropathy##3##1##(2008-9#1)(2012-3#1)(2013-1#1)
Nephrotic##2##1##(2008-1#2)
Nernstian behavior##2##2##(2008-10#2)
Nernstian potentiometric response##2##3##(2008-10#2)
Nernstian response for##12##3##(2008-10#12)
Nernstian response##22##2##(2008-10#22)
Nernstian slope of 29 mV per decade##2##7##(2008-10#2)
Nernstian slope of 29##5##4##(2008-10#5)
Nernstian slope of##22##3##(2008-10#22)
Nernstian slope##23##2##(2008-10#23)
Nernstian##58##1##(2008-10#58)
Nerve Root##2##2##(2012-3#2)
Nerve transfers##2##2##(2008-8#1)(2008-9#1)
Nerve##15##1##(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-9#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
Nervosa (n =##2##3##(2008-11#2)
Nervosa##5##1##(2008-11#2)(2012-2#2)(2013-1#1)
Nervous##4##1##(2011-2#1)(2012-3#1)(2013-1#2)
Nest predation##2##2##(1995-3#1)(2008-9#1)
Nest##4##1##(1995-3#1)(2008-5#1)(2008-9#1)(2009-11#1)
Nested polymerase chain reaction (PCR)##2##5##(2008-10#2)
Nested##8##1##(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#5)
Nestin##3##1##(2011-2#3)
Net analyte##2##2##(2008-10#2)
Net##8##1##(1996-5#1)(2008-10#4)(2008-8#1)(2011-2#2)
Netherlands was##2##2##(1997-8#1)(2009-9#1)
Netherlands##57##1##(1990-3#2)(1991-8#3)(1992-12#1)(1994-12#4)(1995-12#2)(1996-1#1)(1996-11#3)(1996-3#1)(1996-8#4)(1997-5#2)(1997-8#2)(2008-10#17)(2008-11#2)(2008-12#5)(2008-7#1)(2009-12#1)(2009-9#1)(2010-1#1)(2012-3#1)(2013-8#3)
Netherlands)##3##1##(1991-8#2)(2008-10#1)
Network for##6##2##(1995-12#2)(1996-1#3)(2008-11#1)
Network of##3##2##(1991-3#1)(1997-2#1)(2008-12#1)
Network##45##1##(1991-3#3)(1992-3#1)(1993-1#1)(1995-12#2)(1995-2#1)(1996-1#3)(1996-3#2)(1997-2#2)(1997-3#3)(2008-10#9)(2008-11#8)(2008-12#1)(2009-12#1)(2010-8#2)(2012-2#2)(2012-3#3)(2013-7#1)
Network)##2##1##(1995-11#1)(1995-2#1)
Networking##3##1##(1992-12#1)(1997-6#1)(2012-3#1)
Networks of##2##2##(2008-11#1)(2013-8#1)
Networks##16##1##(1995-9#1)(1996-11#1)(2008-10#3)(2008-11#4)(2010-1#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
Neu5Ac##4##1##(2012-2#4)
Neu5Gc alpha 2--&gt##9##3##(1994-11#9)
Neufeld##2##1##(1995-12#2)
Neural Network##4##2##(2008-10#2)(2010-8#2)
Neural fibrolipoma##2##2##(2009-5#2)
Neural network##2##2##(2008-10#2)
Neural response telemetry##2##3##(2008-9#2)
Neural stem cells##2##3##(2008-11#2)
Neural##26##1##(1995-11#1)(2008-10#7)(2008-11#8)(2008-9#2)(2009-5#3)(2009-8#1)(2010-8#2)(2011-2#1)(2013-8#1)
Neuraminidase##2##1##(1990-12#1)(2008-7#1)
NeuroD##6##1##(2010-11#6)
Neurobiology##2##1##(1997-7#1)(2008-4#1)
Neurochemical and##2##2##(1992-6#1)(2011-2#1)
Neurochemical##3##1##(1992-6#2)(2011-2#1)
Neurochemistry##3##1##(1992-9#1)(2008-11#1)(2008-7#1)
Neurocognitive##3##1##(2009-10#1)(2012-3#1)(2013-1#1)
Neurocysticercosis##3##1##(2008-7#2)(2012-3#1)
Neuroendocrine neoplasms are##2##3##(2012-3#2)
Neuroendocrine##6##1##(1991-6#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-3#2)
Neuroethics##2##1##(2012-2#2)
Neurofilaments##2##1##(1997-2#1)(2008-8#1)
Neurogen##2##1##(2008-5#2)
Neurogenesis##2##1##(2008-7#2)
Neurogenic##2##1##(1992-9#1)(2009-3#1)
Neuroimaging of migraine##2##3##(2008-9#2)
Neuroimaging techniques##2##2##(2011-2#1)(2013-1#1)
Neuroimaging##10##1##(2008-11#2)(2008-8#1)(2008-9#2)(2010-12#3)(2011-2#1)(2013-1#1)
Neuroinflammation##2##1##(2013-1#2)
Neuroleptic##2##1##(2012-3#2)
Neurologic##3##1##(2010-5#1)(2012-3#2)
Neurological symptoms##2##2##(1993-3#1)(1997-6#1)
Neurological##13##1##(1993-3#1)(1995-11#1)(1996-2#1)(1997-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
Neurology##7##1##(1997-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-5#1)
Neuromuscular disorders##2##2##(2012-3#2)
Neuromuscular##4##1##(1996-5#2)(2012-3#2)
Neuromyelitis optica##2##2##(2013-8#2)
Neuron##3##1##(1990-6#1)(1995-6#1)(2008-5#1)
Neuronal cell##2##2##(1991-12#1)(1994-2#1)
Neuronal responses##2##2##(1993-6#2)
Neuronal##10##1##(1991-12#1)(1993-6#2)(1994-2#2)(1995-12#1)(1995-6#1)(2008-10#1)(2009-9#1)(2012-2#1)
Neuronavigation##2##1##(2012-3#2)
Neurons in the##3##3##(1991-12#1)(1997-3#1)(2008-11#1)
Neurons were##3##2##(1991-12#1)(1991-6#1)(1997-3#1)
Neurons##10##1##(1991-12#3)(1991-6#1)(1996-12#1)(1997-3#2)(1997-7#1)(2008-11#2)
Neuropathic pain##4##2##(2008-9#3)(2010-7#1)
Neuroprotective##2##1##(2008-11#1)(2009-12#1)
Neuropsychiatric systemic lupus erythematosus##2##4##(2012-3#2)
Neuropsychiatric##5##1##(2008-2#1)(2011-2#2)(2012-3#2)
Neurosarcoidosis##4##1##(2008-7#2)(2012-3#2)
Neuroscience##4##1##(2008-11#1)(2008-4#1)(2008-5#1)(2013-8#1)
Neurospora crassa and##4##3##(2008-10#1)(2009-6#1)(2010-7#1)(2012-3#1)
Neurospora crassa##15##2##(1993-12#1)(1995-2#3)(1996-6#1)(1997-4#1)(2008-10#3)(2009-6#1)(2010-7#2)(2012-3#3)
Neurospora##17##1##(1993-12#1)(1995-2#3)(1996-6#1)(1997-4#1)(2008-10#3)(2009-6#1)(2010-7#2)(2012-3#4)(2013-1#1)
Neurosurgery##5##1##(1995-11#1)(2010-7#1)(2012-3#1)(2013-8#2)
Neurosurgical##3##1##(2012-3#3)
Neurotransmitters##2##1##(1991-1#1)(2008-5#1)
Neurotrophic Factor##4##2##(2012-2#1)(2013-1#1)(2013-8#2)
Neurotrophin##3##1##(1995-8#1)(1996-12#1)(2010-8#1)
Neurovascular##2##1##(1997-6#1)(2012-3#1)
NeutrAvidin was##2##2##(2008-10#2)
NeutrAvidin##5##1##(2008-10#5)
NeutrAvidin-tagged liposomes##4##2##(2008-10#4)
NeutrAvidin-tagged##6##1##(2008-10#6)
Neutral Red##3##2##(2008-10#3)
Neutral##4##1##(2008-10#3)(2008-11#1)
Neutralization##2##1##(1996-12#1)(2008-12#1)
Neutralizing##2##1##(1996-2#1)(2008-10#1)
Neutron##2##1##(1993-9#1)(1996-9#1)
Neutrons##2##1##(1991-5#1)(2008-10#1)
Neutropenia##5##1##(2008-10#4)(2008-5#1)
Neutrophil##2##1##(2008-10#1)(2008-11#1)
Nevada##4##1##(1996-9#1)(2008-10#3)
Never##3##1##(1991-6#1)(2008-11#2)
Nevertheless the##2##2##(2011-7#1)(2013-1#1)
Nevertheless##96##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#2)(2006-6#1)(2007-12#2)(2008-10#21)(2008-11#5)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#4)(2009-6#4)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
Nevoid basal cell carcinoma syndrome##2##5##(1997-3#2)
Nevoid##3##1##(1997-3#2)(2011-2#1)
Nevus##2##1##(2010-6#1)(2012-3#1)
New Anastomosis##2##2##(2008-10#2)
New Approach for##3##3##(2008-10#2)(2011-2#1)
New Brunswick##3##2##(1991-2#1)(1994-1#1)(1995-1#1)
New Caledonia##4##2##(2008-1#3)(2010-8#1)
New Castle County##3##3##(1994-12#1)(2013-1#2)
New Delhi##8##2##(1994-8#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)
New Drugs for##3##3##(2008-10#2)(2008-5#1)
New Guinea##3##2##(1991-12#1)(2008-1#2)
New Hampshire##4##2##(1993-1#1)(2008-10#1)(2012-12#2)
New Haven##2##2##(1997-1#1)(2011-2#1)
New Jersey##24##2##(1991-2#1)(1992-2#1)(1992-8#1)(1993-1#1)(1995-12#2)(1995-6#1)(1996-5#2)(1997-3#1)(2008-10#7)(2008-11#1)(2008-8#5)(2010-9#1)
New Jersey's##2##2##(1993-1#2)
New Method for##2##3##(1996-5#1)(2013-1#1)
New Mexico##10##2##(1990-8#1)(1997-3#2)(2008-10#5)(2008-3#1)(2008-8#1)
New Orleans##4##2##(1990-6#1)(1993-2#1)(1995-6#1)(2008-7#1)
New South Wales##5##3##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
New Treatment##2##2##(2008-11#1)(2012-3#1)
New World begomoviruses##2##3##(2008-10#2)
New World locations were##2##4##(2008-10#2)
New World strains##3##3##(2008-10#3)
New World##18##2##(2008-10#11)(2008-11#3)(2008-8#1)(2012-2#3)
New York City (NYC)##4##4##(1996-1#1)(1996-3#3)
New York City Board of Education##3##6##(1991-12#3)
New York City##30##3##(1991-1#2)(1991-12#3)(1992-3#1)(1994-9#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-3#6)(1996-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2009-5#5)(2011-2#2)(2013-8#1)
New York Heart Association functional class##2##6##(2010-10#1)(2011-2#1)
New York State Department of Health##4##6##(1994-12#1)(1996-3#2)(1997-1#1)
New York State##19##3##(1991-2#1)(1991-3#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-1#1)(1996-12#2)(1996-3#4)(1996-5#1)(1997-1#1)(2008-10#2)
New York and##3##3##(1992-12#1)(1995-5#1)(2008-10#1)
New York in##2##3##(2008-10#2)
New York state##2##3##(1992-8#2)
New York##109##2##(1990-11#4)(1990-8#2)(1991-1#3)(1991-12#5)(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-8#3)(1993-1#1)(1993-2#1)(1993-5#1)(1994-12#5)(1994-2#1)(1994-9#3)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#6)(1996-12#4)(1996-2#2)(1996-3#11)(1996-5#2)(1997-1#4)(2008-10#16)(2008-11#1)(2008-12#1)(2008-8#2)(2009-3#1)(2009-5#5)(2010-10#1)(2011-2#4)(2013-1#2)(2013-8#3)
New York's##2##2##(1992-8#1)(2008-10#1)
New York)##6##2##(1991-2#1)(1995-12#1)(2008-11#1)(2008-12#2)(2009-3#1)
New Zealand (NZ)##2##3##(2008-10#1)(2008-11#1)
New Zealand and Australia##2##4##(2008-10#1)(2011-2#1)
New Zealand and##6##3##(2008-1#2)(2008-10#2)(2008-12#1)(2011-2#1)
New Zealand health##2##3##(1991-2#1)(1992-1#1)
New Zealand mixed mice##2##4##(2008-10#2)
New Zealand rabbits were##3##4##(1992-3#2)(2012-3#1)
New Zealand rabbits##4##3##(1992-3#2)(2008-8#1)(2012-3#1)
New Zealand were##2##3##(1996-12#1)(2008-8#1)
New Zealand white rabbits##3##4##(1993-1#1)(2008-11#1)(2012-3#1)
New Zealand##72##2##(1991-2#2)(1992-1#5)(1992-3#2)(1993-1#1)(1996-12#2)(2008-1#16)(2008-10#12)(2008-11#5)(2008-12#5)(2008-5#2)(2008-8#4)(2009-3#1)(2010-6#2)(2011-1#7)(2011-2#3)(2012-12#1)(2012-3#2)
New Zealand's##3##2##(1991-2#2)(2009-12#1)
New advances in##3##3##(2010-8#1)(2012-2#1)(2013-1#1)
New approach##2##2##(2008-10#2)
New approaches to the##2##4##(1997-7#1)(2009-1#1)
New data on##2##3##(2008-11#1)(2008-5#1)
New data##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
New developments in the##3##4##(1992-11#1)(1995-3#1)(2009-8#1)
New developments in##4##3##(1992-11#1)(1995-3#1)(2008-10#1)(2009-8#1)
New developments##6##2##(1992-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2009-8#1)
New emerging##2##2##(2011-2#1)(2012-2#1)
New end##2##2##(1991-12#1)(2012-3#1)
New findings##2##2##(1993-2#1)(2008-8#1)
New insights into##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
New material##2##2##(2008-9#1)(2010-5#1)
New method for##2##3##(2008-10#1)(2012-12#1)
New method##3##2##(2008-10#2)(2012-12#1)
New methodology##2##2##(2008-10#1)(2012-3#1)
New methods##3##2##(2008-10#3)
New roles for##2##3##(1993-9#1)(2009-6#1)
New technologies##2##2##(2008-11#1)(2010-9#1)
New technology##3##2##(1995-12#1)(2008-10#1)(2008-12#1)
New##535##1##(1990-11#6)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#4)(1991-1#5)(1991-12#8)(1991-2#9)(1991-3#4)(1991-8#1)(1991-9#1)(1992-1#7)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#8)(1993-1#7)(1993-12#1)(1993-2#4)(1993-5#1)(1993-9#1)(1994-1#2)(1994-12#8)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-12#7)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#8)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#13)(1996-5#14)(1996-6#1)(1997-1#8)(1997-3#5)(1997-6#2)(1997-7#1)(1997-8#3)(2008-1#22)(2008-10#137)(2008-11#36)(2008-12#17)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#3)(2008-8#18)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#3)(2009-5#5)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#16)(2011-9#1)(2012-12#5)(2012-2#11)(2012-3#8)(2013-1#10)(2013-8#3)
Newbonnet##2##1##(2008-10#2)
Newborn screening##2##2##(2008-11#1)(2010-8#1)
Newborn##7##1##(2008-10#2)(2008-11#2)(2010-8#3)
Newcastle disease virus##2##3##(2008-11#1)(2008-5#1)
Newcastle disease##6##2##(2008-11#1)(2008-5#5)
Newer##8##1##(1993-9#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-8#1)(2011-2#1)
Newfoundland and##2##2##(2008-10#2)
Newfoundland##5##1##(2008-10#5)
Newington##2##1##(1992-3#2)
Newly Described##2##2##(2008-10#2)
Newly hatched##2##2##(2008-6#1)(2010-8#1)
Newly synthesized##2##2##(2008-10#1)(2008-7#1)
Newly##18##1##(1990-3#1)(1994-12#1)(2008-10#11)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)
News Plus##2##2##(1991-2#2)
News and##3##2##(1993-3#1)(2009-11#1)(2011-2#1)
News from the##2##3##(1991-1#1)(2008-10#1)
News##11##1##(1991-1#1)(1991-2#2)(1993-3#1)(2008-10#3)(2008-5#1)(2009-11#1)(2011-2#1)(2013-1#1)
Newtonian behavior##2##2##(2008-5#2)
Newtonian##7##1##(2008-5#3)(2013-8#4)
Next to##2##2##(2011-1#2)
Next we##2##2##(1994-1#1)(2010-11#1)
Next##24##1##(1993-6#1)(1994-1#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#2)(2012-2#1)(2012-3#1)
Ney##3##1##(1996-5#3)
NeyTumorin##6##1##(1997-4#6)
Neyman type A distribution##2##4##(2008-10#2)
Nezu##2##1##(2008-11#2)
Nf##2##1##(2008-10#2)
Nfrl##2##1##(1997-7#2)
NgoII restriction-modification##2##2##(1993-9#2)
NgoII##4##1##(1993-9#4)
Nh##2##1##(2008-8#2)
Ni and Cd by flame atomic absorption spectrophotometry##2##8##(2008-10#2)
Ni and Cd by##3##4##(2008-10#3)
Ni and Cd##5##3##(2008-10#5)
Ni and Cr in##3##4##(2008-10#3)
Ni and Cr##5##3##(2008-10#5)
Ni and Cu in##3##4##(2008-10#3)
Ni and Cu##9##3##(2008-10#9)
Ni and Pb##3##3##(2008-10#3)
Ni and Zn##5##3##(2008-10#5)
Ni and##36##2##(2008-10#36)
Ni in steel##2##3##(2008-10#2)
Ni in##13##2##(2008-10#13)
Ni##175##1##(2008-10#168)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-7#1)
Ni(2+) and##3##2##(2008-10#3)
Ni(2+) ions##2##2##(2008-10#2)
Ni(2+) was##2##2##(2008-10#2)
Ni(2+)##29##1##(2008-10#27)(2010-11#2)
Ni(3)S(2)##2##1##(2008-10#2)
Ni(4)##4##1##(2009-5#4)
Ni(II) and 0##2##3##(2008-10#2)
Ni(II) and 3##2##3##(2008-10#2)
Ni(II) and Co(II)##8##3##(2008-10#8)
Ni(II) and Cu(II) were##2##4##(2008-10#2)
Ni(II) and Cu(II)##4##3##(2008-10#4)
Ni(II) and Fe(II) were##2##4##(2008-10#2)
Ni(II) and Fe(II)##3##3##(2008-10#3)
Ni(II) and Zn(II)##2##3##(2008-10#2)
Ni(II) and##25##2##(2008-10#25)
Ni(II) are##2##2##(2008-10#2)
Ni(II) ions##3##2##(2008-10#3)
Ni(II) is##2##2##(2008-10#2)
Ni(II) protoporphyrin IX##3##3##(1993-8#3)
Ni(II) was used to##2##4##(2008-10#2)
Ni(II) was##4##2##(2008-10#4)
Ni(II) were##2##2##(2008-10#2)
Ni(II)##98##1##(1993-8#3)(2008-10#95)
Ni(II))=0##2##1##(2008-10#2)
Ni(II))=1##2##1##(2008-10#2)
Ni(II)-Fe(II) hybrid##2##2##(1993-8#2)
Ni(III)##2##1##(2008-10#2)
Ni)##2##1##(1994-5#1)(2008-10#1)
Ni+Pd+NH(4)H(2)PO(4)##3##1##(2008-10#3)
Ni-Ti alloy##3##2##(2008-10#3)
Ni-Ti##5##1##(2008-10#5)
Ni-dimethylglyoximato complex##2##2##(2008-10#2)
Ni2+##6##1##(1994-2#3)(1997-7#1)(2008-11#1)(2008-12#1)
Ni27(n)##3##1##(2008-10#3)
Ni3S2 + MgCarb##2##3##(1994-5#2)
Ni3S2 +##5##2##(1994-5#5)
Ni3S2 alone##4##2##(1994-5#4)
Ni3S2##13##1##(1994-5#13)
NiHCF films##2##2##(2008-10#2)
NiHCF##4##1##(2008-10#4)
NiHCF-modified##2##1##(2008-10#2)
NiO layer##2##2##(2008-10#2)
NiO##5##1##(2008-10#4)(2012-2#1)
NiS##11##1##(2008-10#11)
NiSO(4) and##2##2##(2008-10#2)
NiSO(4)##3##1##(2008-10#2)(2008-11#1)
NiTMpyP and##2##2##(2008-10#2)
NiTMpyP##6##1##(2008-10#6)
NiV##5##1##(2008-12#5)
Niagara##2##1##(1991-2#1)(2008-10#1)
NicOx##6##1##(2008-5#6)
Nicholas##2##1##(1995-6#1)(2008-10#1)
Nick##4##1##(2008-11#1)(2008-9#1)(2010-11#1)(2013-8#1)
Nickel and##2##2##(2008-10#2)
Nickel is quantitatively##2##3##(2008-10#2)
Nickel was##2##2##(2008-10#2)
Nickel##10##1##(1994-2#1)(2008-10#9)
Nickel(II)##2##1##(2008-10#2)
Nickel-titanium##3##1##(2008-10#2)(2008-7#1)
Nicorandil##3##1##(2010-8#3)
Nicotiana benthamiana and##2##3##(2008-10#2)
Nicotiana benthamiana plants were##2##4##(1995-2#1)(2008-10#1)
Nicotiana benthamiana plants##6##3##(1995-2#1)(2008-10#4)(2011-2#1)
Nicotiana benthamiana##24##2##(1995-2#1)(2008-10#22)(2011-2#1)
Nicotiana clevelandii##3##2##(2008-10#3)
Nicotiana hybrid##2##2##(2008-7#2)
Nicotiana occidentalis plants##2##3##(2008-10#2)
Nicotiana occidentalis##4##2##(2008-10#4)
Nicotiana tabacum##3##2##(2008-10#3)
Nicotiana##49##1##(1995-2#1)(2008-10#43)(2008-11#1)(2008-7#3)(2011-2#1)
Nicotinamide##2##1##(1992-12#1)(2008-10#1)
Nicotine could##2##2##(2013-1#2)
Nicotine dependence##2##2##(1991-1#1)(2011-2#1)
Nicotine was##2##2##(2008-10#2)
Nicotine##12##1##(1991-1#2)(1996-2#2)(2008-10#3)(2011-2#1)(2013-1#4)
NifA and NifL##2##3##(2008-9#2)
NifA central domain##7##3##(2008-9#7)
NifA is##2##2##(1993-12#1)(2008-9#1)
NifA protein is##3##3##(2008-9#3)
NifA protein##5##2##(2008-9#5)
NifA##26##1##(1993-12#2)(2008-9#24)
NifL in the##2##3##(2008-9#2)
NifL##6##1##(2008-9#6)
Nigeria and##3##2##(1990-3#1)(2008-10#2)
Nigeria##47##1##(1990-3#4)(1992-5#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#3)(2009-10#4)(2009-6#3)(2011-2#8)(2012-12#1)(2013-1#13)
Nigeria's##3##1##(2009-10#3)
Nigerian##11##1##(1990-3#1)(2008-10#1)(2009-10#2)(2012-12#4)(2013-1#3)
Nile Delta and South##2##4##(2013-1#2)
Nile River##4##2##(2008-10#4)
Nile blue##4##2##(2008-10#4)
Nile red##2##2##(2008-5#1)(2011-2#1)
Nile virus##6##2##(2008-10#3)(2009-10#2)(2010-8#1)
Nile##22##1##(2008-10#14)(2008-5#1)(2009-10#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
Nimes##3##1##(2008-10#3)
Nine of these##2##3##(2008-12#1)(2010-12#1)
Nine of##5##2##(1991-6#1)(1996-3#1)(2008-11#1)(2008-12#1)(2010-12#1)
Nine patients had##2##3##(1990-3#1)(1990-9#1)
Nine patients were##2##3##(2008-7#1)(2008-9#1)
Nine patients##7##2##(1990-3#1)(1990-9#1)(1996-3#1)(2008-7#2)(2008-9#1)(2013-1#1)
Nine##44##1##(1990-3#1)(1990-9#1)(1991-6#1)(1993-3#1)(1994-3#1)(1995-9#1)(1996-3#3)(1996-9#1)(1997-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#2)
Nineteen patients##2##2##(1991-12#1)(2008-9#1)
Nineteen##21##1##(1991-12#1)(1994-2#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)
Nineteenth##2##1##(2008-10#1)(2013-1#1)
Ninety patients##2##2##(2010-7#1)(2012-3#1)
Ninety percent of##2##3##(1994-2#1)(1997-6#1)
Ninety##12##1##(1994-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-3#3)
Ninety-eight percent of the##2##4##(2008-10#1)(2012-3#1)
Ninety-eight##3##1##(2008-10#1)(2008-3#1)(2012-3#1)
Ninety-five##2##1##(2008-10#1)(2012-2#1)
Ninety-four##4##1##(1991-6#1)(1996-2#1)(2008-10#1)(2008-7#1)
Ninety-nine##3##1##(1995-1#1)(1997-3#1)(2012-2#1)
Ninety-one##2##1##(1994-2#1)(2008-7#1)
Ninety-six percent of##2##3##(1997-6#1)(2011-2#1)
Ninety-six##7##1##(1997-6#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-3#1)
Ninety-three percent##2##2##(1990-2#1)(2008-11#1)
Ninety-three##4##1##(1990-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
Ning##2##1##(2008-10#1)(2011-3#1)
Nipah virus outbreak in Malaysia##2##5##(2008-12#2)
Nipah virus##3##2##(2008-12#3)
Nipponbare and##2##2##(1995-6#1)(2008-10#1)
Nipponbare##4##1##(1995-6#1)(2008-10#3)
Nipponbare)##2##1##(1996-12#1)(2009-10#1)
Nissl bodies##2##2##(2008-7#2)
Nissl##3##1##(1992-12#1)(2008-7#2)
Nit mutants produced##2##3##(2008-10#2)
Nit mutants##3##2##(2008-10#3)
Nit##4##1##(2008-10#4)
NitM##3##1##(2008-10#3)
Nitralin##3##1##(2008-10#3)
Nitrate and##3##2##(2008-10#1)(2008-11#2)
Nitrate##8##1##(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2010-4#1)
Nitrate-Nonutilizing##2##1##(2008-10#2)
Nitric Oxide##4##2##(2008-8#1)(2010-12#1)(2010-6#1)(2013-7#1)
Nitric oxide (NO) has##2##4##(2010-6#1)(2011-2#1)
Nitric oxide (NO) is##3##4##(2008-10#2)(2010-7#1)
Nitric oxide (NO)##8##3##(1995-11#1)(2008-10#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
Nitric oxide##15##2##(1993-3#3)(1995-11#2)(2008-10#3)(2009-10#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
Nitric##19##1##(1993-3#3)(1995-11#2)(2008-10#3)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
Nitrite##4##1##(1994-11#1)(2008-10#3)
Nitrogen##9##1##(2008-10#7)(2008-11#1)(2012-9#1)
Nitrous oxide##4##2##(1990-3#1)(1991-6#1)(2009-12#1)(2013-8#1)
Nitrous##6##1##(1990-3#1)(1991-6#1)(2008-10#1)(2008-7#1)(2009-12#1)(2013-8#1)
NleA##4##1##(2011-2#4)
Nnewi##2##1##(2013-1#2)
No DNA##2##2##(2008-10#1)(2008-11#1)
No PCR##2##2##(1996-12#1)(2008-10#1)
No accumulation of##2##3##(2008-10#1)(2010-12#1)
No adverse effects##2##3##(1996-3#1)(2013-1#1)
No adverse##7##2##(1990-9#1)(1996-3#2)(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#1)
No association between##2##3##(2008-10#1)(2011-2#1)
No cases##2##2##(1994-2#1)(2011-2#1)
No causal relationship with vaccines##2##5##(2008-10#1)(2008-11#1)
No causal##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
No change in the##2##4##(1991-11#1)(1997-2#1)
No changes were##2##3##(1996-12#1)(2008-7#1)
No clear##5##2##(1990-8#1)(1994-8#1)(1995-1#1)(2007-12#1)(2008-10#1)
No complication occurred##2##3##(2013-1#2)
No complications occurred##2##3##(1994-9#1)(1995-11#1)
No complications were##3##3##(1990-8#1)(1991-2#1)(2008-7#1)
No complications##6##2##(1990-8#1)(1991-2#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-7#1)
No connection was##2##3##(1991-2#1)(2011-2#1)
No consistent##2##2##(1994-1#1)(2008-10#1)
No correlation between##2##3##(1995-8#1)(2008-5#1)
No correlation was found between the##4##6##(2008-10#2)(2008-11#1)(2008-7#1)
No correlation was found between##9##5##(1990-12#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-4#1)
No correlation was found##10##4##(1990-12#1)(1990-2#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-4#1)
No correlation was##11##3##(1990-12#1)(1990-2#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)
No correlation##16##2##(1990-12#1)(1990-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#3)(2009-4#1)
No correlations##2##2##(1990-8#1)(2008-10#1)
No deaths##2##2##(1997-8#1)(2008-8#1)
No decrease##2##2##(1991-2#1)(2011-2#1)
No detectable amount of the##2##5##(1996-5#2)
No detectable##3##2##(1991-5#1)(1996-5#2)
No device##2##2##(2012-12#2)
No difference in##5##3##(1997-8#1)(2008-7#1)(2011-2#2)(2013-1#1)
No difference was observed between##2##5##(2008-10#1)(2008-5#1)
No difference was observed##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
No difference was##5##3##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
No difference##12##2##(1990-2#1)(1990-8#1)(1991-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#3)(2013-1#1)
No differences existed##2##3##(2009-7#1)(2012-3#1)
No differences in the##2##4##(1990-6#1)(2011-2#1)
No differences in##12##3##(1990-6#1)(1991-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-3#1)(2010-5#1)(2011-2#1)
No differences were found##2##4##(2008-10#1)(2008-12#1)
No differences were observed in##3##5##(2008-10#1)(2010-3#1)(2010-6#1)
No differences were##6##3##(1997-7#1)(2008-10#2)(2008-12#1)(2010-3#1)(2010-6#1)
No differences##20##2##(1990-6#1)(1991-5#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
No disease was##2##3##(2008-10#2)
No disease##3##2##(2008-10#3)
No effect of##4##3##(1993-1#1)(1993-3#1)(2008-8#1)(2010-8#1)
No effect was##2##3##(1991-6#1)(2008-10#1)
No effect##6##2##(1991-6#1)(1993-1#1)(1993-3#1)(2008-10#1)(2008-8#1)(2010-8#1)
No effects##2##2##(1995-12#1)(2008-9#1)
No evidence for##4##3##(1995-8#1)(2008-10#2)(2008-9#1)
No evidence of##5##3##(1994-11#1)(2008-10#2)(2012-3#1)(2013-1#1)
No evidence was found to##2##5##(1993-12#1)(2008-10#1)
No evidence was found##5##4##(1990-12#1)(1993-12#1)(1994-8#1)(2008-10#2)
No evidence##15##2##(1990-12#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-8#1)(2008-10#6)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
No firm##2##2##(1994-2#1)(2007-11#1)
No further##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
No gender##2##2##(1996-2#1)(2008-4#1)
No germination occurred at##2##4##(2008-10#2)
No germination##3##2##(2008-10#3)
No group differences were observed in##2##6##(2008-6#2)
No group##4##2##(2008-10#1)(2008-6#2)(2013-1#1)
No increase in##4##3##(2008-10#3)(2008-11#1)
No inhibition of##2##3##(1990-8#1)(2008-8#1)
No interaction between##2##3##(2008-10#2)
No interaction##3##2##(2008-10#2)(2008-11#1)
No interference from##2##3##(2008-10#2)
No interference was found##3##4##(2008-10#3)
No interference was observed from common pharmaceutical adjuvants##2##8##(2008-10#2)
No interference was observed from##4##5##(2008-10#4)
No interference was observed##6##4##(2008-10#6)
No interference was##9##3##(2008-10#9)
No interference##11##2##(2008-10#11)
No interferences were observed from excipients and the validity of the##2##11##(2008-10#2)
No interferences were observed from##3##5##(2008-10#3)
No interferences##5##2##(2008-10#5)
No isolates of##2##3##(2008-10#2)
No isolates##3##2##(2008-10#3)
No labeling##2##2##(1990-9#1)(2008-10#1)
No major##3##2##(1990-3#1)(1990-6#1)(1994-2#1)
No marked##2##2##(2008-10#2)
No neoplasms or nonneoplastic lesions##2##5##(2008-9#2)
No neoplasms##3##2##(2008-9#3)
No new##2##2##(1993-2#1)(1997-6#1)
No objective##2##2##(1992-12#2)
No obvious##2##2##(1995-3#1)(2008-8#1)
No other##3##2##(1994-5#1)(2008-9#1)(2011-2#1)
No patient##5##2##(1993-2#1)(1996-3#1)(2008-10#1)(2008-7#1)(2011-3#1)
No patients##7##2##(1990-12#1)(1990-2#1)(1997-8#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
No postoperative##2##2##(2008-10#1)(2008-7#1)
No previous##5##2##(1996-9#1)(2008-10#2)(2008-8#1)(2012-12#1)
No recurrence##2##2##(2008-7#1)(2010-11#1)
No relation was found##2##4##(1991-6#1)(2008-10#1)
No relationship was found between##2##5##(1991-2#1)(2008-10#1)
No relationship##3##2##(1991-2#1)(2008-10#1)(2011-2#1)
No sample##2##2##(2008-10#2)
No serious adverse events were reported##2##6##(1996-1#1)(2008-10#1)
No serious adverse##3##3##(1996-1#1)(2008-10#1)(2011-2#1)
No serious##6##2##(1990-11#1)(1993-11#1)(1996-1#1)(2008-10#2)(2011-2#1)
No side effects were observed##2##5##(1990-11#1)(1991-3#1)
No side effects were##3##4##(1990-11#1)(1991-3#1)(1996-11#1)
No side##4##2##(1990-11#1)(1991-3#1)(1996-11#1)(2008-10#1)
No sign of##3##3##(1990-11#1)(2008-10#1)(2011-2#1)
No significant change was##2##4##(1991-1#1)(2010-5#1)
No significant changes in##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
No significant changes were seen in##2##6##(1991-12#1)(2011-2#1)
No significant changes were##4##4##(1991-12#1)(1994-3#1)(2011-2#2)
No significant changes##8##3##(1991-12#1)(1994-3#1)(2008-10#2)(2008-3#1)(2011-2#3)
No significant correlation was##2##4##(1990-5#1)(1991-6#1)
No significant difference at##2##4##(2008-10#2)
No significant difference in the##2##5##(1991-2#1)(2008-7#1)
No significant difference in##6##4##(1991-2#1)(1992-12#1)(2008-7#2)(2011-2#2)
No significant difference was found between##2##6##(2008-10#1)(2011-2#1)
No significant difference was found##4##5##(2008-10#2)(2011-2#1)(2013-1#1)
No significant difference was##6##4##(1993-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
No significant difference##17##3##(1991-2#1)(1992-12#1)(1993-1#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#3)(2013-1#1)
No significant differences (at 95% probability level) were found between the proposed##2##12##(2008-10#2)
No significant differences in the##2##5##(1991-12#1)(2012-2#1)
No significant differences in##10##4##(1991-12#1)(2008-10#4)(2008-12#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-5#1)
No significant differences were found between the##2##7##(1992-3#1)(1993-2#1)
No significant differences were found between##4##6##(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#1)
No significant differences were found in##3##6##(2008-10#1)(2008-7#1)(2011-2#1)
No significant differences were found##7##5##(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
No significant differences were observed##3##5##(2008-10#2)(2011-2#1)
No significant differences were seen in the cellular##2##8##(2008-5#2)
No significant differences were##14##4##(1990-5#1)(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#5)(2008-5#2)(2008-7#1)(2011-2#2)
No significant differences##28##3##(1990-5#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-7#1)(2011-10#1)(2011-2#3)(2012-2#1)(2012-5#1)
No significant increase##2##3##(2008-8#1)(2013-1#1)
No significant statistical difference was found##2##6##(1994-3#1)(2010-8#1)
No significant##83##2##(1990-11#1)(1990-5#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#3)(1995-12#2)(2008-10#28)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#9)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
No single##2##2##(1994-12#1)(2008-8#1)
No statistical difference##2##3##(2008-10#1)(2008-8#1)
No statistical##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
No statistically significant difference was##2##5##(2011-2#1)(2013-1#1)
No statistically significant difference##3##4##(1992-11#1)(2011-2#1)(2013-1#1)
No statistically significant differences in##2##5##(1996-12#1)(2012-3#1)
No statistically significant differences were observed in##2##7##(2008-10#1)(2012-3#1)
No statistically significant differences were observed##3##6##(2008-10#2)(2012-3#1)
No statistically significant differences were##4##5##(1992-12#1)(2008-10#2)(2012-3#1)
No statistically significant differences##6##4##(1992-12#1)(1996-12#1)(2008-10#2)(2012-3#2)
No statistically significant##9##3##(1992-11#1)(1992-12#1)(1996-12#1)(2008-10#2)(2011-2#1)(2012-3#2)(2013-1#1)
No such##5##2##(1996-3#1)(2008-10#3)(2008-11#1)
No treatment-related neoplasms were seen in male or female Tg##2##10##(2008-9#2)
No treatment-related##3##2##(1992-2#1)(2008-9#2)
No use##2##2##(1996-6#1)(2008-10#1)
No virus##3##2##(2008-10#3)
No##596##1##(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#3)(1990-6#3)(1990-8#5)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#8)(1991-2#8)(1991-3#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-6#2)(1993-1#4)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#6)(1996-1#3)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#5)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#7)(2006-6#1)(2007-11#1)(2007-12#5)(2008-1#2)(2008-10#205)(2008-11#20)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#23)(2008-8#16)(2008-9#17)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-10#1)(2011-2#30)(2011-3#2)(2012-12#8)(2012-2#4)(2012-3#7)(2012-5#2)(2013-1#15)(2013-8#2)
Nobel Prize in##2##3##(2008-7#1)(2010-7#1)
Nobel Prize##3##2##(2008-7#1)(2010-7#1)(2010-8#1)
Nobel##4##1##(2008-7#1)(2010-1#1)(2010-7#1)(2010-8#1)
Nobre et al##2##3##(2011-2#2)
Nocardia mediterranei##2##2##(1994-8#2)
Noctuidae)##4##1##(1990-8#1)(1992-6#1)(2008-10#1)(2013-8#1)
Nod##3##1##(2011-2#3)
NodD binds to target DNA in isologous octamer##2##8##(2008-8#2)
NodD##3##1##(2008-8#3)
Nodal##3##1##(2009-3#2)(2010-4#1)
Nodules##2##1##(2008-11#1)(2008-5#1)
Noise and##2##2##(2008-10#1)(2008-9#1)
Noise##7##1##(1992-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2013-8#1)
Nomenclature##4##1##(2008-10#3)(2008-4#1)
Non##7##1##(2008-10#3)(2008-11#1)(2008-12#1)(2010-7#1)(2013-1#1)
Non-Ag##2##1##(2008-10#2)
Non-CP##2##1##(2008-10#2)
Non-Small Cell Lung Cancer##2##4##(2008-10#1)(2008-11#1)
Non-albicans Candida##2##2##(2011-2#2)
Non-chromatographic speciation##2##2##(2008-10#2)
Non-destructive##4##1##(2008-10#4)
Non-fucosylated therapeutic antibodies##2##3##(2008-11#2)
Non-interacting##2##1##(2008-11#2)
Non-invasive##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
Non-linear##4##1##(2008-10#2)(2008-7#1)(2013-1#1)
Non-parametric methods##2##2##(1995-12#2)
Non-parametric##5##1##(1995-12#3)(2008-10#2)
Non-profit##2##1##(1992-12#1)(1993-1#1)
Non-specific##2##1##(1990-2#1)(1990-5#1)
Non-steroidal anti-inflammatory drugs##2##3##(1990-3#1)(1991-8#1)
Non-traditional##2##1##(1991-12#1)(1992-12#1)
Non-traumatic##2##1##(1994-12#1)(2013-8#1)
Nonbacterial thrombotic endocarditis##2##3##(1996-11#2)
Nonbacterial##3##1##(1996-11#2)(2011-2#1)
Nonchemical management##2##2##(2008-10#2)
Nonchemical methods##2##2##(2008-10#2)
Nonchemical##4##1##(2008-10#4)
Noncoding RNAs##2##2##(2012-3#2)
Noncoding##3##1##(2012-3#3)
None declared##25##2##(2011-1#25)
None of the other##2##4##(2008-10#2)
None of the patients##5##4##(1993-2#1)(2008-1#1)(2010-3#1)(2011-3#1)(2012-5#1)
None of the studies##2##4##(1995-2#1)(2008-11#1)
None of the##43##3##(1990-11#1)(1992-6#2)(1993-11#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#3)(2012-5#1)(2013-1#2)
None of them##2##3##(1991-9#1)(2008-10#1)
None of these##5##3##(1991-11#1)(1991-5#1)(2008-11#1)(2008-8#1)(2011-2#1)
None of##55##2##(1990-11#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-5#1)(2013-1#3)
None##87##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#25)(2011-2#3)(2011-3#1)(2012-2#4)(2012-5#1)(2013-1#3)
Nonelderly patients##2##2##(2013-8#2)
Nonendometrioid##2##1##(2011-2#2)
Nonetheless##19##1##(1991-12#1)(1994-1#1)(1995-6#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
Noninvasive carcinomas showed##2##3##(1997-8#2)
Noninvasive##9##1##(1991-12#1)(1993-6#1)(1997-8#2)(2009-10#1)(2010-11#1)(2010-5#1)(2011-2#2)
Nonisotopic##3##1##(2008-10#1)(2008-4#2)
Nonlinear absorption of##2##3##(1994-2#1)(2008-3#1)
Nonlinear##14##1##(1990-8#1)(1991-9#1)(1994-2#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#4)(2009-8#2)
Nonlinearities##2##1##(2007-12#1)(2008-3#1)
Nono##2##1##(2008-10#2)
Nonoperative management##2##2##(1991-6#1)(2011-2#1)
Nonparametric tests##2##2##(2008-10#2)
Nonparametric##5##1##(2008-10#3)(2010-1#2)
Nonpathogenic Fusarium oxysporum Fo47##2##4##(2008-10#2)
Nonpathogenic Fusarium oxysporum##3##3##(2008-10#3)
Nonpathogenic Fusarium##5##2##(2008-10#5)
Nonpathogenic##13##1##(2008-10#13)
Nonprofit##2##1##(1992-3#1)(1995-3#1)
Nonsignificant##2##1##(2008-11#1)(2013-1#1)
Nonspecific##3##1##(1992-6#1)(2008-10#2)
Nonsteroidal anti-inflammatory drugs##2##3##(2012-2#1)(2013-1#1)
Nonsteroidal##3##1##(2008-10#1)(2012-2#1)(2013-1#1)
Nonsurgical##2##1##(2010-6#1)(2012-12#1)
Nontransmissible##2##1##(2008-10#2)
Nontuberculous mycobacteria##2##2##(2007-12#1)(2011-2#1)
Nonunion##3##1##(2009-3#2)(2011-2#1)
Norcantharidin##2##1##(2011-3#2)
Nordic Journal of Psychiatry##3##4##(2011-4#3)
Nordic Psychiatric Association was##2##4##(2011-4#2)
Nordic Psychiatric Association##3##3##(2011-4#3)
Nordic Psychiatric Congress in##2##4##(2011-4#2)
Nordic Psychiatric Congress##4##3##(2011-4#4)
Nordic Psychiatric##8##2##(2011-4#8)
Nordic countries##10##2##(1990-11#2)(1991-11#1)(1993-2#2)(2008-10#3)(2011-4#2)
Nordic##32##1##(1990-11#3)(1991-11#1)(1991-2#2)(1993-2#2)(2008-10#7)(2011-4#17)
Normal and##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
Normal human##2##2##(2008-10#1)(2008-11#1)
Normal##24##1##(1991-4#1)(1992-3#1)(1993-6#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
Normal-phase##2##1##(1997-2#1)(2008-10#1)
Normalization##2##1##(2008-10#1)(2008-11#1)
Normally##6##1##(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)
Normative data##2##2##(2008-9#1)(2011-1#1)
North America and is##2##4##(2008-10#2)
North America and##12##3##(1992-1#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2011-10#1)(2012-2#1)
North America have##2##3##(2008-11#1)(2008-8#1)
North America with##2##3##(1996-1#1)(2008-11#1)
North America##93##2##(1992-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-8#1)(2008-10#55)(2008-11#8)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#7)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-10#1)(2011-2#3)(2011-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
North American PVY(NTN)##2##3##(2008-10#2)
North American insulation workers##2##4##(1991-12#2)
North American isolates##3##3##(2008-10#3)
North American populations##2##3##(2008-10#2)
North American##34##2##(1991-12#2)(1993-12#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#2)(2010-10#4)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
North Carolina (NC)##2##3##(2008-10#2)
North Carolina sample##4##3##(2008-10#4)
North Carolina##22##2##(1995-1#1)(1995-12#1)(1997-6#1)(2008-10#19)
North Central##3##2##(1991-1#1)(2008-10#1)(2008-7#1)
North Dakota##9##2##(2008-10#8)(2010-5#1)
North Dakota's##2##2##(2010-5#2)
North East##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
North Indian##2##2##(1997-8#1)(2008-11#1)
North Pacific##2##2##(2008-10#1)(2010-8#1)
North Sea##5##2##(1996-6#1)(2008-10#1)(2009-10#3)
North and South##4##3##(1992-2#1)(1996-1#1)(2008-10#1)(2012-3#1)
North and##5##2##(1992-2#1)(1996-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
North of##2##2##(2008-10#1)(2008-12#1)
North to##2##2##(1992-2#1)(2011-2#1)
North##212##1##(1991-1#1)(1991-12#2)(1991-8#3)(1992-1#1)(1992-2#5)(1992-5#1)(1993-12#2)(1994-2#1)(1995-1#2)(1995-12#2)(1995-6#1)(1996-1#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#5)(2008-10#105)(2008-11#14)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#10)(2008-9#1)(2009-10#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#7)(2011-9#1)(2012-2#4)(2012-3#5)(2013-1#1)
Northeast Thailand##2##2##(2008-12#2)
Northeast##4##1##(2008-12#3)(2011-2#1)
Northeastern##2##1##(2008-10#1)(2008-6#1)
Northern Ireland##3##2##(2008-11#1)(2013-8#2)
Northern Ontario##3##2##(1994-3#3)
Northern analysis of##2##3##(1992-8#1)(2008-9#1)
Northern analysis using##2##3##(1992-6#1)(1996-12#1)
Northern analysis##11##2##(1990-8#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-5#1)(2008-9#2)
Northern and Western##2##3##(1993-8#1)(2008-8#1)
Northern and##3##2##(1993-8#1)(2008-8#1)(2009-10#1)
Northern blot analyses indicated that the##2##6##(1992-3#1)(1997-8#1)
Northern blot analyses indicated that##3##5##(1992-3#1)(1993-12#1)(1997-8#1)
Northern blot analyses of##2##4##(1993-3#1)(2008-10#1)
Northern blot analyses##6##3##(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1997-8#1)(2008-10#1)
Northern blot analysis and##2##4##(2008-6#1)(2008-8#1)
Northern blot analysis of the##3##5##(1993-9#1)(1997-8#1)(2008-10#1)
Northern blot analysis of##4##4##(1993-9#1)(1994-11#1)(1997-8#1)(2008-10#1)
Northern blot analysis revealed that the##2##6##(1997-7#1)(2008-6#1)
Northern blot analysis revealed that##4##5##(1992-4#1)(1997-7#1)(1997-8#1)(2008-6#1)
Northern blot analysis revealed##8##4##(1992-4#1)(1993-3#1)(1995-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)
Northern blot analysis showed that the##2##6##(1996-12#1)(2008-8#1)
Northern blot analysis showed that##5##5##(1995-6#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-8#1)
Northern blot analysis showed##7##4##(1994-11#1)(1995-6#1)(1996-12#2)(1996-6#1)(2008-11#1)(2008-8#1)
Northern blot analysis using##3##4##(1994-11#1)(1995-11#1)(2008-9#1)
Northern blot analysis##41##3##(1990-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#3)(1995-11#1)(1995-2#1)(1995-6#3)(1996-12#4)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#4)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#1)
Northern blot and##4##3##(1993-12#1)(1993-3#1)(2008-9#1)(2010-5#1)
Northern blot hybridization##2##3##(1992-3#1)(2008-10#1)
Northern blot##65##2##(1990-2#1)(1992-3#3)(1992-4#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#1)(1994-11#4)(1995-11#1)(1995-2#1)(1995-6#5)(1996-12#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#4)(1997-8#5)(1997-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#7)(2008-9#4)(2010-5#1)
Northern blots##2##2##(2008-10#2)
Northern blotting analysis##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
Northern blotting and##3##3##(1992-10#1)(1995-12#1)(2008-6#1)
Northern blotting##12##2##(1991-5#1)(1992-10#1)(1994-11#1)(1995-12#1)(1996-6#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
Northern hybridization analysis demonstrated that##2##5##(1995-8#1)(1996-2#1)
Northern hybridization revealed that##2##4##(2008-8#2)
Northern hybridization##11##2##(1994-11#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#4)
Northern##136##1##(1990-2#2)(1990-8#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#4)(1993-8#2)(1993-9#1)(1994-11#7)(1994-3#3)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#5)(1995-8#1)(1996-12#6)(1996-2#2)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#5)(1997-8#5)(1997-9#1)(2008-10#17)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#13)(2008-9#7)(2009-10#1)(2010-1#1)(2010-5#1)(2010-9#1)(2012-2#3)(2013-1#2)(2013-8#3)
Northern-blot##2##1##(1991-9#2)
Northern-blotting analysis##2##2##(1995-12#2)
Northumbria##3##1##(2008-11#3)
Northwest##18##1##(2008-10#15)(2008-11#1)(2008-8#1)(2008-9#1)
Northwestern University##2##2##(1997-2#1)(2008-5#1)
Northwestern##7##1##(1993-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
Norway and Sweden##2##3##(1990-11#1)(2011-4#1)
Norway and##6##2##(1990-11#1)(1991-9#1)(1996-11#1)(2008-10#2)(2011-4#1)
Norway spruce seedlings##3##3##(2008-10#3)
Norway spruce##6##2##(2008-10#6)
Norway##106##1##(1990-11#6)(1990-2#3)(1990-6#5)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#4)(1991-6#8)(1991-9#6)(1993-11#2)(1993-2#2)(1993-6#4)(1994-2#1)(1994-6#6)(1994-9#1)(1995-2#4)(1996-11#16)(1996-6#4)(1997-4#2)(1997-8#3)(2008-10#16)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)(2011-4#1)
Norway's##2##1##(1991-6#1)(1993-6#1)
Norwegian Canine Cancer##2##3##(1995-2#1)(2011-2#1)
Norwegian Gastrointestinal Cancer##2##3##(1997-8#2)
Norwegian adolescents##2##2##(1990-9#2)
Norwegian counties##3##2##(1991-6#3)
Norwegian general##2##2##(1993-2#1)(1996-6#1)
Norwegian health##2##2##(1990-9#1)(1997-8#1)
Norwegian hospitals##2##2##(1993-2#1)(1997-8#1)
Norwegian legislation##2##2##(1991-9#1)(1993-6#1)
Norwegian medical schools##2##3##(1991-2#2)
Norwegian school children##2##3##(1991-9#2)
Norwegian soldiers##2##2##(1993-2#2)
Norwegian##68##1##(1990-11#1)(1990-2#1)(1990-6#3)(1990-9#5)(1991-11#3)(1991-2#3)(1991-6#9)(1991-9#5)(1992-5#1)(1993-2#4)(1993-6#1)(1994-2#1)(1994-6#3)(1994-9#2)(1995-2#1)(1996-11#3)(1996-6#4)(1997-8#7)(2008-10#1)(2009-10#2)(2010-6#3)(2011-2#4)(2012-3#1)
Norwegians##5##1##(1990-2#1)(1991-2#1)(1991-6#1)(1996-11#1)(1996-6#1)
Nos##3##1##(2008-10#1)(2013-1#2)
Nosocomial infections##2##2##(2012-12#2)
Nosocomial##5##1##(1991-3#1)(2007-12#1)(2008-5#1)(2012-12#2)
Not I linking clones##2##4##(1995-8#1)(1997-8#1)
Not I linking##3##3##(1995-8#2)(1997-8#1)
Not I##4##2##(1995-8#2)(1997-2#1)(1997-8#1)
Not mention of their more or less scientific aspects##2##9##(2013-1#2)
Not only is##3##3##(1991-8#1)(2008-10#1)(2010-5#1)
Not only##16##2##(1991-8#1)(1992-3#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
Not the##3##2##(1990-6#1)(2008-10#2)
Not##42##1##(1990-6#1)(1991-8#1)(1992-3#1)(1995-8#2)(1996-1#1)(1997-2#3)(1997-8#1)(2008-10#11)(2008-11#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-5#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
NotI##2##1##(1993-8#1)(1995-12#1)
Notable##3##1##(1995-12#1)(2008-10#1)(2012-3#1)
Notably##12##1##(1994-3#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
Note##4##1##(1996-1#1)(1997-3#1)(2008-8#1)(2010-7#1)
Notes##4##1##(1993-1#1)(1995-9#1)(2012-2#1)(2013-1#1)
Nothobranchius furzeri##2##2##(2012-3#2)
Notification System for Infectious Diseases##2##5##(1994-9#1)(1996-11#1)
Noting##2##1##(1992-12#1)(1994-12#1)
Notre##2##1##(2011-2#2)
Nottingham##2##1##(2008-11#1)(2008-12#1)
Notwithstanding the##3##2##(2008-10#2)(2013-1#1)
Notwithstanding##5##1##(2008-10#3)(2008-9#1)(2013-1#1)
Nous rapportons le cas d'un##3##5##(2011-2#1)(2013-1#2)
Nous rapportons##7##2##(2011-2#1)(2013-1#6)
Nous##11##1##(2011-2#3)(2013-1#8)
Nova##2##1##(1993-12#1)(2008-10#1)
Novartis##4##1##(2008-5#3)(2013-1#1)
Novel vaccines##2##2##(1997-7#2)
Novel##75##1##(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#2)(1996-5#8)(1996-9#1)(1997-7#2)(2008-10#27)(2008-11#5)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#1)
November 1998##2##2##(2008-10#1)(2008-3#1)
November 2002##2##2##(2007-8#1)(2012-3#1)
November 2003##2##2##(2008-10#2)
November 2007##2##2##(2011-2#2)
November 2008##2##2##(2011-2#2)
November 2011##2##2##(2013-1#2)
November 23-26##2##2##(1996-2#1)(2008-10#1)
November 30##2##2##(1995-3#1)(2010-12#1)
November##42##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1994-12#1)(1994-9#1)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-12#1)(2010-12#1)(2011-2#8)(2012-2#1)(2012-3#2)(2013-1#2)
Novi Vinodolski and##2##3##(2011-2#2)
Now a##2##2##(2008-5#1)(2008-9#1)
Now that##4##2##(2008-4#1)(2008-8#1)(2011-2#2)
Now the##3##2##(1993-2#1)(2010-9#1)(2011-2#1)
Now##28##1##(1991-1#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1995-6#2)(1996-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#4)(2013-1#1)
Nowadays##8##1##(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Nox1 in##2##2##(2010-1#2)
Nox1-mediated##2##1##(2010-1#2)
Noxa##5##1##(2010-3#5)
Np L3##2##2##(2008-10#2)
Np##3##1##(2008-10#3)
Np(IV)##2##1##(2008-10#2)
Np(V)##2##1##(2008-10#2)
NtWIF##7##1##(2009-8#7)
Ntcp##3##1##(2008-11#3)
NuH Hair##3##2##(2012-3#3)
NuMA that##2##2##(2010-5#2)
NuMA##9##1##(2010-5#9)
Nubac disc arthroplasty via the posterior approach##3##7##(2011-2#3)
Nuclear Division##2##2##(2012-3#2)
Nuclear Magnetic Resonance##3##3##(1992-3#1)(2009-11#1)(2011-2#1)
Nuclear Medicine##4##2##(2007-11#1)(2008-10#1)(2012-2#2)
Nuclear magnetic resonance##3##3##(2008-10#3)
Nuclear matrix##2##2##(2008-8#2)
Nuclear medicine##2##2##(2010-6#1)(2013-8#1)
Nuclear pore##2##2##(2011-2#2)
Nuclear##44##1##(1991-5#1)(1992-3#1)(1994-9#1)(1995-6#2)(1996-9#1)(1997-1#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#5)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
Nuclease##3##1##(1991-5#2)(2008-4#1)
Nuclei##3##1##(1996-9#1)(2008-11#1)(2013-1#1)
Nucleic Acids Res##2##3##(1991-9#1)(1993-12#1)
Nucleic Acids##3##2##(1991-9#1)(1993-12#1)(2008-10#1)
Nucleic acid##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
Nucleic acids##2##2##(2012-2#1)(2013-8#1)
Nucleic##9##1##(1991-9#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
NucleoCounter##2##1##(2008-11#2)
Nucleolar##2##1##(1997-8#1)(2011-2#1)
Nucleophilic##3##1##(1990-8#1)(1996-5#1)(2008-10#1)
Nucleorhabdovirus##2##1##(2008-10#2)
Nucleoside 2-deoxyribosyltransferase##2##2##(1995-6#2)
Nucleoside diphosphate##2##2##(1996-2#1)(1997-7#1)
Nucleoside##6##1##(1994-8#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-7#1)
Nucleotide (nt)##2##2##(1990-11#1)(1993-12#1)
Nucleotide Binding##2##2##(2008-10#1)(2008-8#1)
Nucleotide Sequence##2##2##(1994-12#1)(2008-10#1)
Nucleotide sequence analysis##5##3##(1993-3#1)(1997-3#1)(2008-10#2)(2008-6#1)
Nucleotide sequence##9##2##(1992-10#1)(1993-3#1)(1995-8#1)(1997-3#1)(2008-10#4)(2008-6#1)
Nucleotide sequences of##5##3##(1991-6#2)(2008-10#3)
Nucleotide sequences##6##2##(1991-6#2)(1997-6#1)(2008-10#3)
Nucleotide##28##1##(1990-11#1)(1991-6#2)(1992-10#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-8#1)(1997-3#1)(1997-6#1)(2008-10#13)(2008-11#1)(2008-6#2)(2008-8#1)(2012-3#1)
Nucleus 22##2##2##(2008-9#2)
Nucleus 24 cochlear implant##8##4##(2008-9#8)
Nucleus 24##9##2##(2008-9#9)
Nucleus cochlear implant##2##3##(2008-9#2)
Nucleus##23##1##(1995-8#1)(2008-9#21)(2012-2#1)
Nueva Granada's##2##2##(2011-2#2)
Nulliparous##2##1##(2013-1#2)
Number of##15##2##(1994-2#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2010-8#1)(2013-8#1)
Number##20##1##(1992-2#1)(1993-12#1)(1994-2#1)(1995-5#1)(1996-9#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
Numbers of##5##2##(2008-10#4)(2011-3#1)
Numbers##7##1##(2008-10#4)(2008-12#1)(2011-3#1)(2012-2#1)
Numerical estimations##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Numerical results are presented for##2##5##(2008-3#2)
Numerical results##4##2##(2008-2#1)(2008-3#2)(2013-8#1)
Numerical simulations##5##2##(2008-12#1)(2008-3#2)(2013-8#2)
Numerical##23##1##(1991-9#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#9)(2012-3#1)(2013-8#3)
Numerous electron##2##2##(2007-12#1)(2008-7#1)
Numerous studies##2##2##(1995-2#1)(2008-5#1)
Numerous techniques##2##2##(2008-12#1)(2008-9#1)
Numerous##38##1##(1991-12#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-6#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
Nups are##2##2##(2011-2#2)
Nups##5##1##(2011-2#5)
Nurse Education##10##2##(2008-11#5)(2008-12#5)
Nurse education in##2##3##(2008-11#2)
Nurse education##3##2##(2008-11#2)(2008-12#1)
Nurse educators have an important role##2##6##(2008-11#2)
Nurse educators##6##2##(2008-11#3)(2008-12#2)(2013-8#1)
Nurse training##2##2##(2008-11#1)(2008-12#1)
Nurse##34##1##(1992-2#2)(1993-3#1)(2008-11#18)(2008-12#12)(2013-8#1)
Nursery##3##1##(2008-10#3)
Nurses must##2##2##(2008-12#1)(2013-8#1)
Nurses need to##2##3##(2010-11#2)
Nurses reported less agreement with the statement about the care plans offering them the ability to determine the status of their patient's nursing care needs##2##25##(2013-1#2)
Nurses reported##5##2##(2008-11#1)(2013-1#4)
Nurses##33##1##(1992-1#1)(1995-1#1)(2008-11#10)(2008-12#2)(2008-6#2)(2008-7#1)(2010-10#1)(2010-11#6)(2010-8#1)(2010-9#1)(2013-1#6)(2013-8#1)
Nurses' perceptions of##2##3##(1997-4#1)(2010-7#1)
Nurses'##7##1##(1997-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#2)
Nursing Home##3##2##(1992-3#1)(1996-2#1)(2008-12#1)
Nursing Research and##4##3##(2008-11#2)(2013-1#2)
Nursing Research##6##2##(2008-11#4)(2013-1#2)
Nursing Standard##4##2##(2008-11#2)(2008-12#2)
Nursing and Health##2##3##(2008-11#1)(2008-12#1)
Nursing and Midwifery##6##3##(2008-11#5)(2008-12#1)
Nursing and##13##2##(1996-2#1)(2008-11#7)(2008-12#2)(2013-1#3)
Nursing care in##2##3##(2012-3#2)
Nursing child Assessment##2##3##(1990-12#2)
Nursing course##2##2##(2008-11#1)(2012-3#1)
Nursing curriculum##2##2##(2008-11#1)(2008-12#1)
Nursing education##4##2##(2008-12#1)(2012-3#3)
Nursing home##3##2##(1993-2#1)(1993-3#1)(1997-1#1)
Nursing homes in##3##3##(1995-3#1)(1996-3#1)(2010-10#1)
Nursing in##2##2##(1992-2#1)(2008-11#1)
Nursing students'##2##2##(2008-12#2)
Nursing teachers' perception##2##3##(2012-3#2)
Nursing##130##1##(1990-12#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#1)(2008-11#59)(2008-12#24)(2008-3#1)(2009-12#1)(2010-10#3)(2010-8#1)(2012-3#16)(2013-1#11)
Nurturing the##2##2##(2011-2#1)(2012-3#1)
Nutrient##3##1##(1990-8#1)(2008-10#1)(2008-7#1)
Nutrients##2##1##(1994-8#1)(2008-10#1)
Nutrition in##4##2##(1990-9#1)(1991-2#1)(2012-12#1)(2013-1#1)
Nutrition knowledge##2##2##(1991-2#2)
Nutrition##16##1##(1990-9#1)(1991-2#4)(1996-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Nutritional and##2##2##(1993-12#1)(2008-3#1)
Nutritional factors##2##2##(1990-8#1)(2012-2#1)
Nutritional##11##1##(1990-8#1)(1991-2#2)(1993-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
Ny##3##1##(2008-10#3)
Nyquist plot##3##2##(2008-10#3)
Nyquist rate##2##2##(2012-2#2)
Nyquist##6##1##(2008-10#3)(2012-2#2)(2013-8#1)
N°##2##1##(2013-1#2)
O and##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
O antigen of lipopolysaccharide##2##4##(1996-12#2)
O antigen of##4##3##(1996-12#3)(2008-9#1)
O antigen##6##2##(1996-12#3)(2008-9#3)
O in##2##2##(2008-10#2)
O##111##1##(1991-3#1)(1991-7#1)(1992-4#2)(1993-2#2)(1994-5#1)(1995-2#1)(1996-12#14)(1996-2#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-4#1)(2008-10#50)(2008-11#8)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#4)(2010-8#6)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#5)
O'##2##1##(2008-10#2)
O'Brien##2##1##(1996-3#1)(2008-11#1)
O(2) A-band absorption correction##2##4##(2008-2#2)
O(2) A-band absorption##5##3##(2008-2#5)
O(2) and##9##2##(2008-10#3)(2008-11#1)(2008-3#3)(2010-4#1)(2011-2#1)
O(2) concentration##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
O(2) kg(-1)##3##2##(2008-10#1)(2010-8#2)
O(2) kg(-1))##2##2##(2008-10#2)
O(2) levels##4##2##(2011-2#4)
O(2) production##2##2##(2008-10#2)
O(2)##49##1##(2008-10#16)(2008-11#1)(2008-2#6)(2008-3#8)(2008-7#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-2#12)
O(2)(-) and##2##2##(2008-10#1)(2008-8#1)
O(2)(-)##4##1##(2008-10#3)(2008-8#1)
O(2)(a(1)D) and O(2)(X(3)?)##2##3##(2008-2#2)
O(3) and##2##2##(2008-3#2)
O(3)##16##1##(2008-10#1)(2008-11#3)(2008-3#12)
O) recombinant##2##2##(2008-10#2)
O)##6##1##(1994-5#1)(2008-10#5)
O-2##3##1##(1990-9#2)(1995-3#1)
O-301##3##1##(2008-10#3)
O-D-apio-beta-D-furanosyl-(1--&gt##2##1##(2008-11#2)
O-GlcNAc##6##1##(2008-2#2)(2008-4#4)
O-acetylated##7##1##(1990-2#4)(1992-6#3)
O-acetylation of##2##2##(1992-6#2)
O-buffer is##3##2##(2008-6#3)
O-buffer##7##1##(2008-6#7)
O-buffers##7##1##(2008-6#7)
O-dealkylase activities##2##2##(2008-11#2)
O-dealkylation##3##1##(1994-8#3)
O-deethylase##3##1##(1992-3#1)(1993-12#1)(2008-11#1)
O-diethyl-dithiophosphate##2##1##(2008-10#2)
O-glycans##2##1##(2009-8#2)
O-glycosides##5##1##(2008-12#1)(2009-8#4)
O-linked glycans##2##2##(2008-1#1)(2012-3#1)
O-linked##9##1##(1990-5#1)(1992-6#1)(1994-5#1)(2008-1#1)(2008-2#2)(2008-4#2)(2012-3#1)
O-methyl-apigenin-C-deoxyhexoside-O-hexoside##2##1##(2008-10#2)
O-phosphoseryl-tRNA([Ser]Sec)##3##1##(2012-2#3)
O/W##4##1##(2008-5#4)
O1##2##1##(1992-5#1)(2011-2#1)
O111##3##1##(2012-2#3)
O145##3##1##(2012-2#3)
O157 Phazyme##2##2##(2012-2#2)
O157##17##1##(1995-2#2)(1996-3#1)(2008-10#6)(2010-4#2)(2012-2#6)
O2 pulse##2##2##(2013-8#2)
O2##21##1##(1991-10#3)(1991-3#2)(1991-5#1)(1991-9#1)(1992-8#2)(1994-2#1)(1995-6#1)(1997-1#2)(2008-11#2)(2008-3#2)(2009-10#1)(2011-1#1)(2013-8#2)
O2- formation in HL-60 cells##2##5##(1994-8#2)
O2- formation##3##2##(1994-8#3)
O2- production##8##2##(1996-2#8)
O2-##13##1##(1994-8#3)(1995-8#1)(1996-2#9)
O2-production##2##1##(1995-6#2)
O26##4##1##(1993-9#2)(2012-2#2)
O3##2##1##(2008-3#1)(2011-2#1)
O6 is about##2##3##(1993-8#2)
OA and##3##2##(1994-11#1)(2013-1#2)
OA was##2##2##(1994-11#1)(2013-1#1)
OA##30##1##(1992-3#6)(1993-2#1)(1994-11#4)(2010-11#3)(2013-1#16)
OAH##10##1##(2008-7#10)
OAP system in CHO cells##2##5##(2008-11#2)
OAP system##4##2##(2008-11#4)
OAV##4##1##(1997-3#4)
OB interneurons##3##2##(2012-2#3)
OB##7##1##(2012-2#6)(2013-1#1)
OBJECTIVE##48##1##(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#5)(2012-2#9)(2012-3#22)(2013-1#3)
OBJECTIVES##16##1##(2011-1#3)(2011-2#1)(2011-7#1)(2012-2#9)(2013-1#2)
OBP##2##1##(2008-8#2)
OC##5##1##(1996-11#2)(2008-10#2)(2008-11#1)
OC/BC##2##1##(2008-10#2)
OCCL##2##1##(2013-8#2)
OCD in##2##2##(2008-11#1)(2013-1#1)
OCD loose body##3##3##(2013-1#3)
OCD loose##4##2##(2013-1#4)
OCD##11##1##(2008-11#2)(2013-1#7)(2013-8#2)
OCE##4##1##(2011-2#4)
OCH(3)##3##1##(2008-10#3)
OCL##2##1##(2008-11#2)
OCPs in natural##2##3##(2008-10#2)
OCPs##4##1##(2008-10#4)
OCT has the potential to##2##5##(2011-7#2)
OCT images were##2##3##(2011-7#2)
OCT images##3##2##(2011-7#3)
OCT imaging##5##2##(2011-7#5)
OCT in the diagnosis and##3##5##(2011-7#3)
OCT in the##4##3##(2010-9#1)(2011-7#3)
OCT in##6##2##(2010-9#1)(2011-7#5)
OCT systems##2##2##(2011-7#2)
OCT##46##1##(2010-9#1)(2011-2#6)(2011-7#32)(2013-1#7)
OCl(-) and##2##2##(2008-10#2)
OCl(-)##3##1##(2008-10#3)
OCs##2##1##(1996-11#2)
OD##8##1##(1990-11#1)(1991-12#1)(1995-1#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#2)
ODA##4##1##(2008-10#4)
ODA-H(2)O(2)-HRP##2##1##(2008-10#2)
ODC activity##5##2##(1995-8#2)(2008-10#3)
ODC##8##1##(1993-8#1)(1995-8#3)(2008-10#4)
ODD behavior##2##2##(2012-2#2)
ODD##3##1##(2012-2#3)
ODI##3##1##(2008-12#3)
ODN (ISIS##2##2##(2008-10#2)
ODN##20##1##(2008-10#15)(2011-2#5)
ODNs containing##2##2##(2008-10#2)
ODNs##7##1##(1996-12#1)(2008-10#4)(2008-4#2)
ODS column##4##2##(1993-2#1)(2008-10#3)
ODS##18##1##(1993-2#1)(2008-10#17)
ODS-SOWG##2##1##(2008-10#2)
OEC##6##1##(2008-7#4)(2008-8#2)
OECD countries##2##2##(1993-2#1)(1994-1#1)
OECD##6##1##(1993-2#1)(1994-1#1)(2008-5#1)(2011-1#3)
OECs and Schwann cells##2##4##(2008-7#2)
OECs##8##1##(2008-7#8)
OEG##3##1##(2013-1#3)
OES##2##1##(2008-10#2)
OF THE##7##2##(2008-11#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#2)
OF surface##2##2##(2008-10#2)
OF##38##1##(1997-5#1)(2008-10#3)(2008-11#4)(2008-3#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#4)(2009-9#2)(2010-1#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#6)(2013-1#2)
OFDS##2##1##(1997-3#2)
OFLO and ENRO##2##3##(2008-10#2)
OFLO##3##1##(2008-10#3)
OFLX##4##1##(2008-10#4)
OG-solubilized##2##1##(1994-5#2)
OGTT and CIGMA##2##3##(1994-12#2)
OH 131##2##2##(2008-10#2)
OH at##2##2##(2008-2#1)(2008-9#1)
OH concentrations were##2##3##(2008-2#2)
OH concentrations##3##2##(1992-9#1)(2008-2#2)
OH group##3##2##(2008-10#2)(2008-8#1)
OH number##2##2##(2008-3#2)
OH radical concentration in##3##4##(2008-2#2)(2008-3#1)
OH radical##4##2##(1997-8#1)(2008-2#2)(2008-3#1)
OH radicals##6##2##(1997-8#3)(2008-11#3)
OH##64##1##(1991-11#1)(1992-9#5)(1995-8#2)(1997-8#6)(2008-10#19)(2008-11#4)(2008-2#9)(2008-3#12)(2008-8#1)(2008-9#5)
OH(-) in##2##2##(2008-10#2)
OH(-)##6##1##(2008-10#5)(2008-3#1)
OH-NA##3##1##(2008-10#3)
OH-Tam##3##1##(1990-12#3)
OH-radical generation##3##2##(1993-8#3)
OH-radical##4##1##(1993-8#3)(2008-11#1)
OH-radicals##2##1##(1993-8#1)(2008-11#1)
OHIP-14##2##1##(2011-2#2)
OIs##2##1##(2008-3#2)
OK##4##1##(1991-3#1)(1992-8#1)(1994-1#1)(2008-10#1)
OK&quot##3##1##(1994-1#3)
OL##4##1##(2007-12#3)(2008-7#1)
OL1##4##1##(1992-4#4)
OLIO+ is##2##2##(1991-12#2)
OLIO+##4##1##(1991-12#4)
OLL1073R-1/SM inhibited secretion of proinflammatory cytokines##2##6##(2008-11#2)
OLL1073R-1/SM##3##1##(2008-11#3)
OLP and##2##2##(2013-1#2)
OLP##7##1##(2013-1#7)
OLV##3##1##(2011-2#3)
OM##8##1##(2008-10#1)(2011-2#1)(2012-4#1)(2013-8#5)
OMC and##2##2##(2008-5#2)
OMC reacted##2##2##(1995-12#2)
OMC##8##1##(1995-12#4)(2008-5#4)
OMIM##6##1##(2008-4#4)(2008-9#2)
OMP##2##1##(1995-12#1)(2008-5#1)
OMR##2##1##(2011-2#2)
ON THE##2##2##(2009-11#1)(2009-4#1)
ON and OFF states##4##4##(2008-7#4)
ON and##6##2##(2008-10#1)(2008-7#4)(2011-7#1)
ON##15##1##(2008-10#2)(2008-7#4)(2008-9#4)(2009-11#2)(2009-12#1)(2009-4#1)(2011-7#1)
ONCHIT##7##1##(2010-8#7)
ONOO(-)##3##1##(2008-10#1)(2008-7#2)
OOC##2##1##(2013-1#2)
OP and##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
OP in##2##2##(2008-10#1)(2011-2#1)
OP pesticides and##2##3##(2010-5#2)
OP pesticides##7##2##(2010-5#4)(2013-1#3)
OP##27##1##(2008-10#7)(2010-12#1)(2010-5#4)(2011-2#5)(2013-1#10)
OPA##3##1##(2008-10#1)(2008-2#2)
OPB03(1##2##1##(2008-10#2)
OPBP1##2##1##(2008-8#2)
OPC##8##1##(2008-5#2)(2008-7#1)(2010-10#4)(2012-4#1)
OPC2(441R)##2##1##(2008-10#2)
OPCs were##2##2##(2012-4#2)
OPCs##10##1##(2008-7#7)(2012-4#3)
OPD##3##1##(2008-10#2)(2013-1#1)
OPG##3##1##(2008-12#3)
OPG10(340)##2##1##(2008-10#2)
OPM03/04_480##2##1##(2008-10#2)
OPN expression##3##2##(2010-11#3)
OPN in##3##2##(2010-11#3)
OPN is an##2##3##(2009-7#2)
OPN is##3##2##(2009-7#2)(2010-11#1)
OPN promoter##3##2##(2010-11#3)
OPN transcription##2##2##(2010-11#2)
OPN##18##1##(2009-7#3)(2010-11#15)
OPO system##2##2##(2008-10#1)(2008-3#1)
OPO##15##1##(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#8)
OPPs##3##1##(2008-10#3)
OPV or EP-IPV##2##3##(1995-5#2)
OPV##12##1##(1994-9#2)(1995-5#10)
OPY20(830C)##3##1##(2008-10#3)
OPZ04(560) was linked in coupling phase##2##6##(2008-10#2)
OPs##5##1##(2008-10#5)
OR 1##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
OR = 1##2##3##(1990-8#2)
OR = 4##2##3##(1990-8#1)(2008-9#1)
OR =##6##2##(1990-8#5)(2008-9#1)
OR##32##1##(1990-8#5)(1994-3#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#1)
ORA##3##1##(2008-3#3)
ORAC values##3##2##(2008-10#3)
ORAC##5##1##(2008-10#3)(2008-7#2)
ORE##4##1##(2008-10#4)
ORF C##2##2##(2008-10#2)
ORF I##4##2##(2008-10#4)
ORF S2##2##2##(2008-9#2)
ORF encodes a protein of##2##5##(1997-7#1)(2008-10#1)
ORF encodes a##4##3##(1996-6#1)(1997-7#1)(2008-10#1)(2008-8#1)
ORF is##3##2##(1993-12#1)(1995-9#1)(1996-8#1)
ORF located on the viral##2##5##(2008-10#2)
ORF located##3##2##(1995-8#1)(2008-10#2)
ORF of##4##2##(1996-6#3)(2008-10#1)
ORF risk-level##2##2##(2008-12#2)
ORF was##2##2##(2008-10#1)(2008-8#1)
ORF which##2##2##(1992-3#1)(1993-2#1)
ORF with##2##2##(1993-12#1)(2008-12#1)
ORF##60##1##(1990-11#1)(1992-3#2)(1993-12#2)(1993-2#1)(1994-12#1)(1995-8#1)(1995-9#5)(1996-3#1)(1996-6#7)(1996-8#2)(1997-7#2)(2008-10#21)(2008-12#4)(2008-8#5)(2008-9#4)(2010-5#1)
ORF1##2##1##(2008-10#1)(2008-9#1)
ORF2##3##1##(2008-10#1)(2008-9#2)
ORF3##3##1##(2008-10#3)
ORF4##4##1##(2008-10#4)
ORF7##5##1##(2008-10#5)
ORFs are##2##2##(1995-9#1)(1996-3#1)
ORFs as##2##2##(1995-12#1)(1995-8#1)
ORFs encoding##2##2##(2008-8#2)
ORFs had##2##2##(1996-3#1)(2008-10#1)
ORFs of##4##2##(1996-3#3)(1997-6#1)
ORFs show##2##2##(1995-9#1)(1996-3#1)
ORFs were##5##2##(1995-12#2)(1996-12#1)(2008-10#2)
ORFs##58##1##(1991-9#2)(1993-2#1)(1995-12#10)(1995-8#3)(1995-9#6)(1996-12#1)(1996-3#16)(1996-6#5)(1996-8#2)(1997-3#1)(1997-6#3)(2008-10#6)(2008-8#2)
ORIF##3##1##(2008-8#3)
ORIGINALITY/VALUE##2##1##(2012-3#2)
ORL1 peptide-stimulated [35S]GTP gamma S binding was##2##7##(1996-2#2)
ORL1 peptide-stimulated [35S]GTP gamma S binding##3##6##(1996-2#3)
ORL1 peptide-stimulated##4##2##(1996-2#4)
ORL1##6##1##(1996-2#6)
ORNs##3##1##(2007-12#3)
ORO##4##1##(2008-11#4)
ORTHOSPHERE(®)##3##1##(2010-11#3)
OS of the##2##3##(2011-2#2)
OS rate##4##2##(1993-1#3)(2008-10#1)
OS##14##1##(1991-8#1)(1993-1#4)(2008-10#3)(2010-10#2)(2011-2#4)
OS1p##2##1##(2008-10#2)
OSA##3##1##(2009-9#1)(2010-5#2)
OSC##3##1##(2008-10#3)
OSCC##10##1##(2010-12#4)(2012-3#1)(2013-1#5)
OSCE##4##1##(2008-11#4)
OSHA##2##1##(1991-12#1)(1993-3#1)
OSM##7##1##(1991-11#6)(1996-2#1)
OSM)##3##1##(1991-11#3)
OSR##3##1##(2008-10#3)
OT alone##2##2##(2010-12#2)
OT##6##1##(1990-5#1)(2008-10#2)(2010-12#3)
OT32##2##1##(2008-10#2)
OTA plasma levels##2##3##(2011-2#2)
OTA plasma##3##2##(2011-2#3)
OTA##15##1##(1991-1#1)(2008-10#6)(2011-2#8)
OTC and SCP##3##3##(2008-10#3)
OTC and##4##2##(2008-10#4)
OTC deficiency##3##2##(2009-8#3)
OTC##12##1##(2008-10#7)(2008-5#1)(2009-8#4)
OTDR signal##2##2##(2008-3#2)
OTG##2##1##(2008-7#2)
OTU##2##1##(2012-2#2)
OTUs##2##1##(2012-2#2)
OUR##5##1##(2008-11#3)(2008-7#2)
OUTCOMES #ENTITYSTARTX00026##2##2##(2010-7#1)(2012-3#1)
OV##2##1##(2008-10#2)
OVA peptide##2##2##(2008-11#2)
OVA##12##1##(1993-12#2)(2008-10#1)(2008-11#9)
OVA-specific##5##1##(2008-11#5)
OVA/IL12 protein##4##2##(2008-11#4)
OVA/IL12##5##1##(2008-11#5)
OWC##4##1##(2008-10#4)
OWG##10##1##(2008-10#10)
OY-M and OY-NIM##2##3##(2008-10#2)
OY-M##6##1##(2008-10#6)
OY-NIM##4##1##(2008-10#4)
OY-W##5##1##(2008-10#5)
OYDV and LYSV##2##3##(2008-10#2)
OYDV and##3##2##(2008-10#3)
OYDV##4##1##(2008-10#4)
Oak##5##1##(2008-10#4)(2013-8#1)
Oakland##2##1##(1993-12#1)(1996-3#1)
Oaks##3##1##(2008-12#2)(2012-7#1)
Oasis HLB##4##2##(2008-10#4)
Oasis##6##1##(2008-10#6)
Oat##3##1##(1992-7#1)(2008-10#2)
Oats##4##1##(2008-10#4)
Ob/Gyn departments##2##2##(1997-1#2)
Ob/Gyn##3##1##(1997-1#3)
Obama##2##1##(2012-2#2)
Obese##10##1##(1994-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
Obesity and##4##2##(1993-1#1)(2008-3#1)(2009-7#1)(2010-5#1)
Obesity can##2##2##(2008-12#1)(2013-8#1)
Obesity is##7##2##(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
Obesity##22##1##(1993-1#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
Obituary##3##1##(2008-5#2)(2011-2#1)
Object##2##1##(1995-9#1)(2009-12#1)
Objective Analysing##2##2##(2011-2#1)(2012-12#1)
Objective Determining##2##2##(2011-2#2)
Objective Establishing##2##2##(2011-2#1)(2012-12#1)
Objective Identifying##2##2##(2012-12#2)
Objective The present study##2##4##(2011-2#1)(2012-12#1)
Objective The present##3##3##(2011-2#2)(2012-12#1)
Objective The##4##2##(2011-2#3)(2012-12#1)
Objective To##2##2##(2008-8#1)(2011-2#1)
Objective Using##2##2##(2011-2#1)(2012-12#1)
Objective responses##2##2##(1991-6#1)(1994-8#1)
Objective##107##1##(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-8#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-1#2)(2010-6#1)(2010-8#5)(2011-1#11)(2011-2#18)(2012-12#25)(2012-2#1)(2012-3#5)(2013-1#17)(2013-8#2)
Objectives##25##1##(1996-9#1)(2008-11#1)(2011-2#6)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#7)
Objectives ##2##1##(2011-2#2)
Obligate##3##1##(1996-6#1)(2008-10#2)
Obscure##2##1##(2012-2#2)
Observation of the##3##3##(1996-9#2)(2008-5#1)
Observation of##10##2##(1990-3#1)(1993-5#1)(1994-2#1)(1995-6#2)(1996-8#1)(1996-9#2)(2007-12#1)(2008-5#1)
Observation was the preferred strategy##2##5##(2012-3#2)
Observation##17##1##(1990-3#1)(1992-1#1)(1993-5#1)(1994-2#1)(1995-6#2)(1996-8#1)(1996-9#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#2)
Observational##4##1##(1993-12#1)(2008-11#1)(2010-8#1)(2011-2#1)
Observations of##2##2##(1991-6#1)(2007-12#1)
Observations were made##3##3##(2008-10#3)
Observations were##4##2##(2008-10#3)(2013-1#1)
Observations##16##1##(1991-12#1)(1991-6#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Observatory##2##1##(2008-3#2)
Observed##10##1##(1995-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-8#1)
Observer variation in##2##3##(1990-2#1)(1993-1#1)
Observer##3##1##(1990-2#1)(1993-1#1)(2011-2#1)
Observing patients (4##2##3##(1991-2#2)
Observing##3##1##(1991-2#3)
Obstacles to##2##2##(2008-11#1)(2013-8#1)
Obstetric##3##1##(2013-1#2)(2013-8#1)
Obstetrics and##5##2##(1991-3#2)(1996-1#1)(1996-3#1)(1996-9#1)
Obstetrics##8##1##(1991-3#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(2012-3#2)
Obstructive sleep apnea##3##3##(2009-9#1)(2010-5#2)
Obstructive sleep##4##2##(1997-8#1)(2009-9#1)(2010-5#2)
Obstructive##8##1##(1997-8#2)(2008-10#1)(2009-1#1)(2009-9#1)(2010-5#2)(2010-8#1)
Obtained by##2##2##(2008-10#1)(2008-3#1)
Obtained results were compared with##2##5##(2008-10#2)
Obtained results were##3##3##(2008-10#3)
Obtained results##6##2##(2007-8#1)(2008-10#4)(2013-1#1)
Obtained##9##1##(2007-8#1)(2008-10#6)(2008-3#1)(2013-1#1)
Obtaining##6##1##(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)(2011-2#2)
Obvious##2##1##(1995-8#1)(2008-3#1)
Obviously##2##1##(2008-11#1)(2010-12#1)
Occasionally##10##1##(1990-5#1)(1991-4#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#2)
Occipital encephalocele (max diameter##2##4##(2012-3#2)
Occipital##3##1##(2012-3#2)(2013-1#1)
Occipitocervical Fusion in##2##3##(2012-3#2)
Occluded##2##1##(1995-8#1)(2008-12#1)
Occlusion of the##3##3##(2008-12#1)(2010-3#1)(2012-3#1)
Occlusion##4##1##(2008-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
Occult##2##1##(1993-3#1)(2013-1#1)
Occultation Radiometer##2##2##(2008-3#2)
Occultation##5##1##(2008-3#5)
Occupational Outlook Handbook##2##3##(1993-3#2)
Occupational Safety and Health Administration (OSHA)##3##6##(1991-12#1)(1993-3#1)(1995-12#1)
Occupational Safety and Health##4##4##(1991-12#1)(1993-3#1)(1995-12#1)(2008-10#1)
Occupational and##2##2##(1991-10#1)(2009-12#1)
Occupational health services##2##3##(1991-3#2)
Occupational health##4##2##(1991-3#2)(2009-12#2)
Occupational therapists##2##2##(2012-2#1)(2013-8#1)
Occupational##22##1##(1991-10#1)(1991-12#2)(1991-3#2)(1993-3#3)(1995-12#1)(1995-2#1)(1996-8#1)(2008-10#2)(2008-11#2)(2009-12#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Occurrence and##3##2##(1993-11#1)(2008-10#2)
Occurrence of the##2##3##(2008-10#1)(2008-8#1)
Occurrence of##12##2##(1993-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-8#1)
Occurrence##18##1##(1993-11#2)(1997-3#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#3)(2008-8#1)
Ocean##10##1##(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
Ochnaflavone##2##1##(1994-11#2)
Ochratoxin##2##1##(2011-2#2)
Oct-4##6##1##(2008-11#6)
October 1##2##2##(1992-2#1)(2012-12#1)
October 1987##2##2##(1990-12#1)(1995-3#1)
October 1988##2##2##(1991-12#1)(1997-7#1)
October 1992##2##2##(1993-6#1)(1995-5#1)
October 1993##4##2##(1994-9#1)(1996-1#1)(2008-11#2)
October 1995##2##2##(1996-5#1)(2008-10#1)
October 1996##2##2##(2008-11#1)(2012-3#1)
October 2000##2##2##(2008-10#1)(2011-3#1)
October 2001##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
October 2004##2##2##(2008-7#1)(2010-6#1)
October 2010##2##2##(2012-12#2)
October 31##2##2##(1995-12#1)(1996-1#1)
October##69##1##(1990-12#1)(1991-1#3)(1991-12#1)(1991-3#1)(1992-2#3)(1993-6#1)(1994-9#3)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#4)(1996-11#1)(1996-5#1)(1997-7#1)(2008-10#15)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
October/November##2##1##(1991-6#1)(2008-10#1)
Octopus vulgaris##3##2##(2008-10#2)(2008-7#1)
Octopus##4##1##(2008-10#2)(2008-7#2)
Octreotide##2##1##(1992-5#1)(2008-8#1)
Ocular##4##1##(1992-2#1)(2008-11#1)(2010-10#1)(2010-5#1)
Odds##3##1##(1995-3#1)(2012-12#2)
Odontogenic##2##1##(2007-12#2)
Odontoma##2##1##(1990-3#1)(2008-9#1)
Odour perception##2##2##(2008-7#2)
Oenothera berteriana and Arabidopsis thaliana##2##5##(1991-6#2)
Oesophageal cancer with##2##3##(2011-2#2)
Oesophageal##3##1##(1995-10#1)(2011-2#2)
Oestrogen##2##1##(1990-11#1)(2011-2#1)
Oestrus ovis##2##2##(2010-10#2)
Of 15##2##2##(2008-10#1)(2008-11#1)
Of 75##2##2##(1990-2#1)(1991-8#1)
Of about##2##2##(1995-12#1)(2010-10#1)
Of all the compounds##2##4##(1994-11#1)(2008-11#1)
Of all the##5##3##(1994-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
Of all##7##2##(1994-11#1)(1995-12#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)
Of course##2##2##(1994-1#1)(1997-1#1)
Of dead sperm##3##3##(2008-12#3)
Of dead##4##2##(2008-12#4)
Of further##2##2##(2006-6#1)(2009-8#1)
Of interest##4##2##(1992-8#1)(1996-12#1)(2010-12#1)(2013-8#1)
Of particular interest is the##2##5##(1994-9#1)(2008-5#1)
Of particular##5##2##(1991-12#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-5#1)
Of patients##3##2##(1991-1#1)(1996-3#1)(2007-11#1)
Of special##2##2##(1995-2#1)(2008-11#1)
Of the 11##2##3##(2008-10#2)
Of the 14##2##3##(1993-8#1)(2008-10#1)
Of the 26##2##3##(1995-2#1)(2012-3#1)
Of the 6##2##3##(1995-12#1)(2013-8#1)
Of the compounds##2##3##(1990-12#1)(1990-5#1)
Of the five##4##3##(2008-10#2)(2009-8#1)(2011-2#1)
Of the four##4##3##(2008-10#3)(2013-1#1)
Of the instruments adopted##2##4##(2013-1#2)
Of the isolates in VCG##2##5##(2008-10#2)
Of the isolates##3##3##(1991-3#1)(2008-10#2)
Of the patients##3##3##(1991-8#1)(2008-7#2)
Of the remaining##4##3##(1994-12#1)(1996-3#1)(2008-10#1)(2012-3#1)
Of the three##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
Of the total##3##3##(1991-3#1)(2008-10#1)(2009-7#1)
Of the two##5##3##(2008-10#4)(2011-2#1)
Of the various##3##3##(2008-10#3)
Of the##126##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-1#1)(1993-1#2)(1993-3#1)(1993-8#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#1)(1996-11#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-7#2)(2008-1#2)(2008-10#43)(2008-11#5)(2008-12#1)(2008-2#1)(2008-7#8)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#2)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
Of them##3##2##(2008-1#1)(2008-9#1)(2011-2#1)
Of these patients##3##3##(2008-7#3)
Of these##35##2##(1990-3#1)(1990-6#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
Of those who##2##3##(2012-12#1)(2013-1#1)
Of those##6##2##(2008-10#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
Of##255##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-9#3)(1995-12#6)(1995-2#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-9#1)(1997-1#3)(1997-3#3)(1997-7#2)(2006-6#1)(2007-11#1)(2008-1#3)(2008-10#72)(2008-11#12)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#16)(2008-8#1)(2008-9#7)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#7)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-8#4)(2010-9#1)(2011-2#11)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#6)
Off##2##1##(1992-3#1)(2008-10#1)
Off-line##2##1##(2008-10#2)
Off-pump coronary##2##2##(2013-1#1)(2013-8#1)
Office of##7##2##(1991-1#1)(1991-2#1)(1993-12#1)(1995-2#1)(1996-1#1)(2009-4#1)(2012-12#1)
Office##27##1##(1991-1#1)(1991-12#2)(1991-2#2)(1992-12#1)(1993-12#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#4)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
Officer##3##1##(1992-12#1)(1994-1#1)(2008-12#1)
Official##6##1##(1997-6#2)(2008-10#3)(2008-9#1)
Offspring##4##1##(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)
Often##12##1##(1991-2#1)(1994-3#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2010-9#1)(2011-2#1)
Ogawa##3##1##(1990-11#1)(2012-3#2)
Ogle and##2##2##(2008-10#2)
Ogle##4##1##(2008-10#4)
Oh516##4##1##(2008-10#4)
Ohio 88119##2##2##(2008-10#2)
Ohio and##3##2##(2008-10#3)
Ohio are##2##2##(1997-1#1)(2008-10#1)
Ohio##32##1##(1991-9#1)(1995-12#2)(1997-1#1)(2008-10#26)(2008-12#1)(2010-9#1)
Oil red-O##2##2##(2008-11#2)
Oil##11##1##(1995-3#1)(2008-10#5)(2008-11#2)(2012-2#1)(2013-1#2)
Oils##3##1##(2008-10#1)(2009-8#1)(2012-2#1)
Oilseed Rape##2##2##(2008-10#2)
Okadaic acid##2##2##(1992-8#1)(1993-8#1)
Okayama Prefecture##2##2##(1993-1#2)
Okazaki fragment##4##2##(1992-3#4)
Okazaki##5##1##(1992-3#5)
Okinawa##14##1##(2008-10#13)(2008-5#1)
Oklahoma biotypes##2##2##(2008-10#2)
Oklahoma##5##1##(1994-3#1)(1995-12#2)(2008-10#2)
Olathe##3##1##(2008-10#3)
Old World##2##2##(2008-10#1)(2012-2#1)
Old and New##2##3##(2008-10#1)(2008-8#1)
Old##8##1##(1997-8#1)(2008-10#3)(2008-7#2)(2008-8#1)(2012-2#1)
Older Adults##3##2##(2012-12#1)(2013-1#2)
Older age##2##2##(2008-12#2)
Older women##4##2##(1994-2#2)(2011-2#2)
Older##23##1##(1991-12#1)(1994-2#2)(1995-2#1)(1997-3#2)(2008-1#1)(2008-12#3)(2008-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-2#3)(2012-12#3)(2013-1#2)
Olfactory tract transection##2##3##(2013-1#2)
Olfactory##6##1##(2008-7#1)(2009-10#1)(2009-8#2)(2013-1#2)
Oligo(ethylene glycol)##2##2##(2013-1#2)
Oligoculm##3##1##(2008-10#3)
Oligomers##2##1##(1991-7#1)(1994-11#1)
Oligonucleotide primers##3##2##(2008-10#3)
Oligonucleotide##7##1##(1996-12#1)(2008-10#5)(2008-9#1)
Oligonucleotides were##2##2##(1991-5#1)(2008-10#1)
Oligonucleotides##5##1##(1991-5#1)(1996-5#1)(2008-10#3)
Olive tail moment##2##3##(2008-10#2)
Olive##5##1##(2008-10#5)
Olmed##2##1##(1991-9#2)
Olmesartan##2##1##(2008-11#1)(2009-1#1)
Olpidium brassicae##2##2##(2008-10#2)
Olsenella uli##2##2##(2011-2#2)
Olsenella##4##1##(2011-2#4)
Olympics##2##1##(1996-2#1)(2008-11#1)
Omalizumab##2##1##(2010-5#2)
Omega cm##2##2##(2008-3#2)
Omega impedance change##2##3##(2008-10#2)
Omega##6##1##(2008-10#3)(2008-3#2)(2008-8#1)
Omega-3##3##1##(1992-9#1)(2008-3#1)(2010-1#1)
Omental cakes##2##2##(2012-2#2)
Omeprazole##4##1##(1991-8#1)(1995-9#1)(2012-2#2)
Omission of##2##2##(1992-4#1)(2008-10#1)
Omnibus Budget Reconciliation Act (OBRA) of##4##6##(1991-12#1)(1994-1#1)(1994-3#1)(1997-3#1)
Omnibus Budget Reconciliation Act of##4##5##(1991-12#1)(1991-3#1)(1994-1#1)(1994-3#1)
Omnibus Budget Reconciliation Act##8##4##(1991-12#2)(1991-3#1)(1994-1#2)(1994-3#2)(1997-3#1)
Omnibus Budget Reconciliation##9##3##(1991-12#2)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1997-3#1)
Omnibus##11##1##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1997-3#1)
Omphalocele##3##1##(1997-3#1)(2010-8#2)
On August##2##2##(1994-3#1)(2008-9#1)
On December##3##2##(1991-3#1)(1993-1#1)(2011-2#1)
On July 26##2##3##(1994-1#1)(1996-1#1)
On June##3##2##(1995-6#3)
On October##2##2##(1991-1#1)(2012-3#1)
On a##9##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2013-1#2)
On abdominal##2##2##(1993-6#1)(2008-10#1)
On acidic soil##2##3##(2012-6#2)
On admission##5##2##(1990-6#1)(1994-12#1)(2008-12#1)(2009-5#1)(2013-8#1)
On all##2##2##(2008-10#1)(2013-8#1)
On an average##2##3##(2008-1#1)(2008-10#1)
On an##4##2##(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
On appeal##2##2##(1990-2#1)(1996-5#1)
On average##15##2##(1994-12#1)(1994-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2009-12#1)
On basis of the##2##4##(2008-10#2)
On basis of##3##3##(2008-10#2)(2008-8#1)
On being##2##2##(1990-9#1)(2013-1#1)
On both##2##2##(2008-10#2)
On call##4##2##(2008-10#3)(2012-2#1)
On chromosome##2##2##(1995-5#1)(1997-2#1)
On day 7##2##3##(1994-5#1)(2013-8#1)
On day 8##2##3##(1993-12#1)(2008-8#1)
On day##10##2##(1993-12#1)(1994-5#1)(1995-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
On each##2##2##(2010-5#1)(2011-2#1)
On examination##4##2##(1990-9#1)(2007-12#1)(2010-10#1)(2012-3#1)
On multivariate analysis##2##3##(2012-3#2)
On multivariate logistic##2##3##(2012-3#1)(2013-1#1)
On multivariate##4##2##(2012-3#3)(2013-1#1)
On one hand##6##3##(1996-5#1)(2008-10#3)(2008-11#1)(2009-8#1)
On one##7##2##(1996-5#2)(2008-10#3)(2008-11#1)(2009-8#1)
On physical examination##3##3##(2011-1#2)(2013-8#1)
On review of##2##3##(2008-10#1)(2012-3#1)
On skin##2##2##(1997-3#1)(2008-5#1)
On the average##2##3##(1993-2#1)(1997-8#1)
On the basis of a##4##5##(1990-9#1)(1996-9#1)(2008-3#1)(2013-1#1)
On the basis of our findings##2##6##(1996-11#1)(2012-2#1)
On the basis of our##4##5##(1992-12#1)(1995-12#1)(1996-11#1)(2012-2#1)
On the basis of the analysis of##2##7##(2008-7#1)(2013-1#1)
On the basis of the data obtained##2##7##(1991-2#1)(1993-6#1)
On the basis of the data##3##6##(1991-2#1)(1993-6#1)(2008-10#1)
On the basis of the results of##3##7##(1991-9#1)(1995-12#1)(2008-10#1)
On the basis of the results##5##6##(1991-3#1)(1991-9#1)(1995-12#1)(1997-6#1)(2008-10#1)
On the basis of the##29##5##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-6#1)(2008-10#10)(2008-11#2)(2008-7#1)(2010-5#1)(2013-1#3)
On the basis of these results##6##6##(1993-1#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
On the basis of these values##2##6##(2008-10#1)(2008-3#1)
On the basis of these##14##5##(1991-3#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-6#1)
On the basis of this##3##5##(1991-2#1)(2008-3#2)
On the basis of##80##4##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-12#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-11#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#4)
On the contrary##28##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-8#2)(1994-2#1)(2008-10#4)(2008-11#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
On the one hand##3##4##(1996-3#1)(2008-9#1)(2011-2#1)
On the other hand the##3##5##(2008-11#1)(2011-2#1)(2011-7#1)
On the other hand##153##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#4)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#5)(1996-6#1)(1997-2#2)(1997-7#1)(1997-8#4)(2007-12#1)(2008-10#46)(2008-11#23)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-6#3)(2011-2#3)(2011-7#1)(2013-1#4)
On the other##155##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#4)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#6)(1996-6#1)(1997-2#2)(1997-7#1)(1997-8#4)(2007-12#1)(2008-10#46)(2008-11#23)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-6#3)(2011-2#3)(2011-7#1)(2013-1#4)
On the otherhand##2##3##(2008-11#2)
On the use of##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
On the whole##6##3##(1991-8#1)(1997-3#1)(2008-10#4)
On the##335##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#4)(1991-12#3)(1991-2#4)(1991-3#5)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#4)(1993-2#2)(1993-6#2)(1993-8#7)(1994-2#2)(1994-3#2)(1994-5#5)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#7)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#6)(2007-12#3)(2007-8#2)(2008-10#87)(2008-11#37)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#9)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-5#1)(2010-6#4)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#12)(2013-8#3)
On these##3##2##(1995-12#1)(1997-3#1)(2008-10#1)
On this basis a##2##4##(2008-10#1)(2011-2#1)
On this basis##6##3##(1992-3#1)(1995-6#1)(2008-10#2)(2009-4#1)(2011-2#1)
On this##8##2##(1992-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2009-4#1)(2011-2#1)
On three##2##2##(2008-11#1)(2013-1#1)
On##564##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#7)(1991-1#4)(1991-12#4)(1991-2#6)(1991-3#6)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#7)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#6)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-5#1)(1995-6#6)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#10)(1996-6#1)(1996-9#2)(1997-2#4)(1997-3#4)(1997-6#2)(1997-7#3)(1997-8#7)(2007-12#5)(2007-8#2)(2008-1#1)(2008-10#144)(2008-11#48)(2008-12#13)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#8)(2008-7#13)(2008-8#17)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#19)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#9)(2012-6#3)(2013-1#24)(2013-7#1)(2013-8#11)
On-line coupling of##2##3##(2008-10#2)
On-line determination of trace##2##4##(2008-10#2)
On-line determination of##4##3##(2008-10#4)
On-line dilution##2##2##(2008-10#2)
On-line microdialysis##2##2##(2008-10#2)
On-line monitoring of##2##3##(2008-10#1)(2008-11#1)
On-line monitoring##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
On-line preconcentration and determination of##4##5##(2008-10#4)
On-line preconcentration and##6##3##(2008-10#6)
On-line preconcentration of##4##3##(2008-10#4)
On-line preconcentration system for##2##4##(2008-10#2)
On-line preconcentration##14##2##(2008-10#14)
On-line##55##1##(2008-10#47)(2008-11#5)(2008-7#3)
On-site##2##1##(2008-10#2)
On-the-job##2##1##(1991-3#1)(1993-2#1)
Once a##3##2##(1995-1#1)(2011-2#1)(2013-8#1)
Once again##2##2##(1995-12#1)(2010-8#1)
Once inside the##2##3##(2008-10#1)(2008-11#1)
Once the##9##2##(1993-3#1)(1995-5#1)(2008-10#4)(2008-4#1)(2008-8#1)(2012-3#1)
Once##37##1##(1990-12#1)(1991-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-5#1)(2008-10#11)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
Oncidium orchid##3##2##(2008-10#3)
Oncogene##2##1##(2008-11#1)(2008-9#1)
Oncology Group study##2##3##(1991-6#1)(1993-9#1)
Oncology Group##6##2##(1991-2#1)(1991-6#1)(1993-9#2)(2010-2#1)(2010-5#1)
Oncology and##6##2##(2008-10#5)(2010-11#1)
Oncology##25##1##(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-9#2)(1997-4#1)(2008-10#7)(2008-7#4)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#3)(2013-1#1)
Oncolytic##3##1##(2013-1#2)(2013-8#1)
Oncorhynchus mykiss##5##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-8#1)
Oncorhynchus##10##1##(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-8#5)
One ORF##2##2##(1995-9#2)
One alternative##2##2##(1991-1#1)(2008-10#1)
One approach##3##2##(1991-2#1)(2008-6#1)(2008-8#1)
One assay##2##2##(2008-10#2)
One can##4##2##(1995-9#1)(2008-3#3)
One case of##2##3##(1992-5#1)(2011-2#1)
One case##6##2##(1991-6#1)(1992-5#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
One clone##2##2##(1993-3#1)(2008-9#1)
One common##2##2##(1996-2#1)(2008-10#1)
One component##2##2##(1994-5#1)(1997-9#1)
One enzyme##2##2##(2008-4#1)(2010-3#1)
One example is##2##3##(2008-7#1)(2011-2#1)
One example##4##2##(1991-8#1)(1997-3#1)(2008-7#1)(2011-2#1)
One fifth of##2##3##(1990-9#1)(2008-7#1)
One form##2##2##(1995-12#1)(2010-5#1)
One gene##2##2##(1993-12#1)(2008-10#1)
One group of##2##3##(2008-5#1)(2012-2#1)
One group##6##2##(1995-1#1)(2008-10#3)(2008-5#1)(2012-2#1)
One hundred and fifty##2##4##(2008-4#1)(2008-9#1)
One hundred and forty-three##2##4##(1991-8#1)(2010-2#1)
One hundred and one##2##4##(2010-2#1)(2011-2#1)
One hundred and seventy##2##4##(2008-12#1)(2008-9#1)
One hundred and thirteen##2##4##(2008-5#1)(2013-8#1)
One hundred and thirty##2##4##(2008-5#1)(2011-2#1)
One hundred and##24##3##(1990-9#1)(1991-2#1)(1991-8#1)(1993-1#1)(1993-2#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-2#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
One hundred##45##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-12#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-10#7)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#4)
One important##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
One is a##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
One is that the##2##4##(2007-11#1)(2008-3#1)
One is the##2##3##(2008-11#1)(2008-7#1)
One is##12##2##(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-7#1)(2008-8#1)(2013-1#1)
One isolate was##2##3##(2008-10#2)
One isolate##4##2##(2008-10#4)
One key to its success is its strategic planning process##2##10##(1994-2#1)(1994-3#1)
One long-standing##2##2##(2008-9#1)(2011-2#1)
One major##8##2##(1990-2#1)(1994-3#1)(2008-10#3)(2010-1#1)(2012-2#2)
One method of doing so would be to support a consensus convergence to review and select the optimal measures of CS for nursing research##2##24##(2013-1#2)
One method of##4##3##(2008-10#1)(2013-1#2)(2013-8#1)
One method##7##2##(1995-9#1)(2008-10#2)(2008-4#1)(2013-1#2)(2013-8#1)
One might##2##2##(2008-10#1)(2009-7#1)
One mole of##2##3##(1994-5#1)(2008-10#1)
One novel##2##2##(2008-8#2)
One of its##2##3##(2008-3#1)(2010-8#1)
One of the biggest problems facing##2##6##(1991-2#2)
One of the findings##2##4##(1991-6#1)(2008-12#1)
One of the four##2##4##(2008-10#2)
One of the goals of##2##5##(1994-3#1)(2008-10#1)
One of the important##2##4##(1995-5#1)(2008-8#1)
One of the key##2##4##(1995-1#1)(2009-8#1)
One of the main##2##4##(2008-11#2)
One of the major##5##4##(2008-10#2)(2008-4#2)(2011-2#1)
One of the most common##3##5##(2008-11#1)(2008-9#1)(2011-3#1)
One of the most important##2##5##(2008-10#1)(2008-9#1)
One of the most##11##4##(1992-2#1)(2008-10#3)(2008-11#1)(2008-9#2)(2011-2#1)(2011-3#1)(2013-1#2)
One of the streams##2##4##(2008-10#2)
One of the##85##3##(1990-9#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-2#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-5#2)(1995-6#1)(1996-6#1)(1997-8#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#4)(2009-1#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
One of them##4##3##(1993-2#1)(1995-2#1)(2008-10#1)(2008-7#1)
One of these genes##4##4##(1993-12#1)(2008-9#1)(2010-5#1)(2013-1#1)
One of these is##2##4##(1997-1#1)(2008-10#1)
One of these##16##3##(1990-5#2)(1990-9#1)(1991-12#1)(1993-12#1)(1995-12#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-9#1)(2009-10#1)(2010-5#1)(2013-1#1)
One of two##2##3##(1993-9#1)(1997-8#1)
One of##118##2##(1990-5#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-6#1)(1997-1#1)(1997-8#3)(2008-10#25)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
One or more##2##3##(2008-10#1)(2008-5#1)
One or##4##2##(2008-10#2)(2008-5#1)(2009-4#1)
One patient had##3##3##(1990-2#1)(2008-7#1)(2010-3#1)
One patient presented with a##2##5##(1991-8#1)(2008-7#1)
One patient received##2##3##(2008-7#1)(2009-11#1)
One patient was##3##3##(1990-8#1)(1991-8#1)(1997-6#1)
One patient with a##2##4##(1996-2#1)(2011-1#1)
One patient with##5##3##(1994-12#1)(1996-2#1)(1997-6#1)(2008-7#1)(2011-1#1)
One patient##24##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-8#2)(1993-2#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-6#3)(2008-10#1)(2008-11#1)(2008-7#5)(2008-8#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#1)
One possible##4##2##(1994-8#1)(2009-10#1)(2009-7#2)
One potential##2##2##(1997-2#1)(2008-8#1)
One procedure##2##2##(1993-9#1)(1994-2#1)
One prominent##2##2##(2008-2#1)(2008-6#1)
One question##2##2##(1997-2#1)(2008-6#1)
One reason##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
One side##2##2##(2008-10#1)(2013-1#1)
One step##2##2##(2008-10#1)(2008-7#1)
One strain##2##2##(2008-10#1)(2011-2#1)
One such##12##2##(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-4#1)(2010-5#1)(2012-3#1)
One suffered##2##2##(1993-2#1)(1996-8#1)
One third of##2##3##(2012-12#1)(2012-2#1)
One to##2##2##(1995-2#1)(2008-10#1)
One transgenic##2##2##(2008-11#1)(2008-9#1)
One type of##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
One type##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)
One was##3##2##(1993-11#1)(1993-6#1)(2008-9#1)
One way to##4##3##(2008-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
One way##6##2##(2008-5#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
One week after##2##3##(1991-2#1)(2008-8#1)
One year after##3##3##(2008-10#1)(2009-1#1)(2010-10#1)
One year##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-10#1)
One##489##1##(1990-11#1)(1990-2#4)(1990-5#4)(1990-8#1)(1990-9#5)(1991-1#1)(1991-12#5)(1991-2#5)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#5)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#4)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#3)(1997-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#97)(2008-11#22)(2008-12#10)(2008-2#2)(2008-3#12)(2008-4#8)(2008-5#17)(2008-6#3)(2008-7#19)(2008-8#17)(2008-9#14)(2009-1#3)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#3)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#16)(2011-3#2)(2012-12#7)(2012-2#12)(2012-3#14)(2013-1#13)(2013-8#10)
One-Step##3##1##(2008-10#2)(2008-3#1)
One-half of the##2##3##(1994-3#1)(2008-5#1)
One-half of##3##2##(1994-3#1)(2008-5#1)(2012-3#1)
One-hundred##2##1##(2008-5#1)(2008-7#1)
One-step##4##1##(2008-3#1)(2008-4#1)(2013-1#2)
One-third##3##1##(1994-3#1)(2008-10#1)(2012-2#1)
One-way##2##1##(2008-9#1)(2009-1#1)
OneView strategy##2##2##(1997-3#2)
OneView##3##1##(1997-3#3)
Ongoing efforts to##2##3##(2008-11#1)(2010-11#1)
Ongoing##12##1##(1993-2#1)(1995-5#1)(2008-11#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
Onion##8##1##(2008-10#8)
Online Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to genomics researchers##2##20##(2008-4#1)(2008-9#1)
Online Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to##3##18##(2008-4#2)(2008-9#1)
Online Mendelian Inheritance in Man (OMIM)##5##6##(2008-4#3)(2008-9#2)
Online databases##2##2##(2010-10#1)(2012-3#1)
Online##21##1##(1991-1#1)(1991-12#2)(1993-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-9#3)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
Only 10%##2##2##(1990-12#1)(1991-12#1)
Only 16##2##2##(1991-6#1)(2008-9#1)
Only 18 cases##2##3##(2008-7#1)(2010-6#1)
Only 18##3##2##(2008-7#1)(2010-6#1)(2011-1#1)
Only 3 of the##2##4##(1991-2#1)(2008-10#1)
Only 3##6##2##(1991-2#1)(1991-8#1)(2008-10#3)(2008-12#1)
Only 4##4##2##(2008-10#1)(2008-7#1)(2012-12#2)
Only 7##2##2##(1991-11#1)(1997-5#1)
Only 8##2##2##(1990-2#1)(2008-7#1)
Only S422##2##2##(1995-11#2)
Only a few##3##3##(2010-6#3)
Only a single##2##3##(1997-7#1)(2008-8#1)
Only a##13##2##(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#3)(2011-2#1)
Only about##4##2##(1992-8#1)(1997-2#1)(2008-1#1)(2011-2#1)
Only approximately##2##2##(1994-11#1)(1995-11#1)
Only by##3##2##(1991-12#1)(2008-11#1)(2008-8#1)
Only few cases have been reported##2##6##(2013-1#2)
Only for##2##2##(2008-10#1)(2008-8#1)
Only half of the##2##4##(1996-5#1)(2008-11#1)
Only half of##3##3##(1996-5#1)(2007-12#1)(2008-11#1)
Only if the##3##3##(1991-6#1)(2008-8#2)
Only if##5##2##(1991-6#1)(1997-4#1)(2008-8#2)(2013-8#1)
Only in the##4##3##(1991-5#1)(1995-1#1)(2008-12#1)(2010-5#1)
Only in##10##2##(1991-5#1)(1992-9#1)(1995-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#1)
Only minor##4##2##(1994-5#1)(2008-10#2)(2013-1#1)
Only one of##3##3##(1994-5#1)(2008-10#2)
Only one patient##4##3##(1991-8#1)(1996-9#1)(2008-7#2)
Only one##19##2##(1990-5#1)(1991-8#1)(1993-12#1)(1994-5#1)(1996-11#1)(1996-9#1)(1997-2#2)(2008-10#5)(2008-5#1)(2008-7#2)(2010-4#1)(2013-1#2)
Only recently##2##2##(2008-12#1)(2010-7#1)
Only six##2##2##(2008-10#2)
Only small##2##2##(2008-10#1)(2008-11#1)
Only the##19##2##(1990-9#1)(1991-12#1)(1993-2#1)(1993-3#1)(1995-6#1)(1996-12#1)(2008-10#8)(2008-5#2)(2011-2#2)(2013-8#1)
Only three##4##2##(1997-4#1)(2008-10#1)(2009-3#1)(2011-2#1)
Only two of##2##3##(1994-12#1)(2008-7#1)
Only two previous##2##3##(2008-10#1)(2011-2#1)
Only two##11##2##(1994-12#1)(1997-9#1)(2008-10#6)(2008-12#1)(2008-7#1)(2011-2#1)
Only##209##1##(1990-11#1)(1990-12#2)(1990-2#4)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#50)(2008-11#12)(2008-12#7)(2008-3#1)(2008-5#6)(2008-7#9)(2008-8#5)(2008-9#3)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#5)
Onset of##2##2##(2008-6#1)(2013-1#1)
Ontario N1G 2W1##3##3##(2013-8#3)
Ontario Veterinary College##3##3##(2013-8#3)
Ontario and##3##2##(1993-3#1)(2008-10#2)
Ontario soils##3##2##(2008-10#3)
Ontario to##2##2##(1995-3#1)(2008-10#1)
Ontario was##2##2##(1994-3#1)(2007-12#1)
Ontario##74##1##(1991-12#1)(1991-2#7)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#4)(1993-2#1)(1993-3#1)(1994-1#5)(1994-3#4)(1995-12#1)(1995-2#1)(1995-3#4)(1997-1#1)(2007-12#5)(2008-10#18)(2008-11#3)(2008-12#1)(2009-3#1)(2012-2#2)(2013-8#9)
Ontario's global budgeting system##2##4##(1993-1#2)
Ontario's##10##1##(1991-12#1)(1991-2#1)(1993-1#2)(1995-1#1)(1997-2#1)(1997-3#2)(2008-11#1)(2009-3#1)
Ontario)##2##1##(2008-11#2)
Ontogenic resistance##3##2##(2008-10#3)
Ontogenic##5##1##(2008-10#4)(2008-11#1)
Ontogeny of the##2##3##(1994-8#1)(2008-10#1)
Ontogeny of##4##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)
Ontology##9##1##(2008-9#3)(2010-1#1)(2010-4#1)(2011-2#2)(2013-1#2)
OnuMV3a##2##1##(2008-10#2)
Oocysts were more prevalent in##2##5##(1996-12#2)
Oocysts##3##1##(1996-12#2)(2012-3#1)
Oocyte##2##1##(2012-3#1)(2013-1#1)
Oolong teas##3##2##(2008-10#3)
Oolong##7##1##(2008-10#7)
Oomycete##4##1##(2008-10#4)
Oomycetes##3##1##(2008-10#3)
Oospore Formation##2##2##(2008-10#2)
Oospore##4##1##(2008-10#4)
Oospores were##2##2##(2008-10#2)
Oospores##4##1##(2008-10#4)
Opaque-2##2##1##(2009-10#2)
Opata 85##2##2##(2008-10#2)
Open tibia fractures##2##3##(2010-12#2)
Open##12##1##(1995-12#1)(1996-2#1)(1996-9#1)(1997-6#1)(2008-10#3)(2010-12#2)(2010-7#1)(2012-2#1)(2013-1#1)
Opening of##3##2##(1996-5#2)(2008-7#1)
Opening the##3##2##(1991-1#1)(2007-11#1)(2008-11#1)
Opening##9##1##(1991-1#1)(1996-5#2)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
Operated##2##1##(2008-3#1)(2012-3#1)
Operating with##2##2##(2008-10#1)(2008-3#1)
Operating##9##1##(1995-3#1)(2008-10#4)(2008-3#1)(2008-9#1)(2012-12#1)(2012-3#1)
Operation Iraqi##2##2##(2008-4#1)(2013-1#1)
Operation of##3##2##(2008-10#1)(2008-3#2)
Operation##10##1##(1991-3#1)(1995-3#1)(2008-10#2)(2008-3#3)(2008-4#1)(2012-2#1)(2013-1#1)
Operational##11##1##(1991-3#1)(1993-12#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-3#1)
Operations##5##1##(2009-3#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
Operative findings##3##2##(2008-7#1)(2008-9#1)(2010-5#1)
Operative laparoscopy##4##2##(1993-12#1)(1993-3#1)(1995-2#1)(1996-3#1)
Operative management of testicular torsion##2##5##(2008-10#2)
Operative mortality##2##2##(2008-7#2)
Operative strategies for minimizing hearing loss##2##6##(2011-2#2)
Operative##20##1##(1993-12#2)(1993-3#1)(1994-12#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-7#4)(2008-9#1)(2010-5#1)(2011-2#3)(2012-3#1)
Operators##2##1##(2010-3#1)(2011-2#1)
Ophionotus victoriae##2##2##(2013-8#2)
Ophiosphaerella agrostis##2##2##(2008-10#2)
Ophiostoma clavigerum##2##2##(2008-10#2)
Ophiostoma novo-ulmi Mitovirus##2##3##(2008-10#2)
Ophiostoma novo-ulmi mitovirus##2##3##(2008-10#2)
Ophiostoma novo-ulmi##5##2##(2008-10#5)
Ophiostoma piceae##4##2##(2008-10#4)
Ophiostoma sp##3##2##(2008-10#3)
Ophiostoma##14##1##(2008-10#14)
Ophthalmology##3##1##(2008-11#1)(2010-10#1)(2011-2#1)
Opiliones##3##1##(2007-12#3)
Opinion##2##1##(2008-6#1)(2010-9#1)
Opinions##4##1##(2008-11#1)(2009-4#1)(2010-12#1)(2013-8#1)
Opioid receptor densities were measured##2##5##(2008-11#2)
Opioid##6##1##(1991-1#2)(2008-11#2)(2008-6#1)(2008-7#1)
Opioids##2##1##(2008-7#1)(2013-1#1)
Opium##2##1##(2008-10#2)
Oppenheimer's##2##1##(2008-12#2)
Opportunities for##6##2##(1991-12#1)(1992-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(2009-2#1)
Opportunities##9##1##(1991-12#1)(1992-11#1)(1992-2#1)(1995-12#2)(1995-6#1)(1996-2#1)(2009-2#1)(2013-1#1)
Opportunity##4##1##(1995-12#1)(1995-6#2)(1997-2#1)
Opposite##2##1##(1996-2#1)(2008-5#1)
Opt##23##1##(2008-2#7)(2008-3#16)
Optetrak##3##1##(2008-8#3)
OptiMAbtrade mark##5##2##(2008-11#5)
Optic##7##1##(1990-2#1)(1992-3#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2011-7#1)
Optical Parametric Oscillator Based on##2##5##(2008-3#2)
Optical Parametric Oscillator##3##3##(2008-3#3)
Optical and##3##2##(2008-10#1)(2008-3#2)
Optical coherence tomography (OCT) has##4##5##(2011-2#1)(2011-7#3)
Optical coherence tomography (OCT)##5##4##(2011-2#1)(2011-7#4)
Optical coherence tomography in the diagnosis and management of##2##9##(2011-7#2)
Optical coherence tomography##8##3##(2011-2#2)(2011-7#6)
Optical fiber##2##2##(2008-10#2)
Optical measurements on##2##3##(2008-10#2)
Optical parametric oscillator##2##3##(2007-11#2)
Optical properties of##2##3##(2008-10#1)(2008-3#1)
Optical remote sensing of##3##4##(2008-3#3)
Optical switching##2##2##(1995-6#1)(2008-3#1)
Optical time-domain reflectometry##2##3##(2008-3#2)
Optical##71##1##(1990-8#1)(1991-2#1)(1994-3#1)(1995-6#1)(1996-5#2)(1996-9#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#26)(2008-4#1)(2009-7#1)(2011-2#3)(2011-7#6)(2012-2#2)(2013-8#1)
Optically Active##2##2##(1996-5#2)
Optically##6##1##(1996-5#3)(2008-10#1)(2008-3#2)
Optics##5##1##(2008-10#1)(2008-3#4)
Optimal conditions for the##2##4##(2008-10#2)
Optimal conditions for##4##3##(1990-2#1)(1993-9#1)(2008-10#2)
Optimal conditions were found to be##2##6##(2008-10#2)
Optimal conditions##10##2##(1990-2#1)(1993-9#1)(2008-10#8)
Optimal experimental##2##2##(2008-10#2)
Optimal foraging##2##2##(2008-9#2)
Optimal initial##2##2##(2008-10#1)(2008-7#1)
Optimal results##2##2##(1991-2#1)(2008-10#1)
Optimal##43##1##(1990-11#1)(1990-2#1)(1990-6#1)(1991-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#18)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2010-11#2)(2010-2#1)(2011-2#1)(2013-1#2)
Optimisation and##2##2##(2008-10#2)
Optimisation of the##3##3##(2008-10#2)(2008-11#1)
Optimisation of##14##2##(1991-12#1)(2008-10#11)(2008-11#2)
Optimisation##16##1##(1991-12#1)(2008-10#13)(2008-11#2)
Optimising##3##1##(2008-10#2)(2008-11#1)
Optimization and##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
Optimization by##2##2##(2008-10#2)
Optimization of a##3##3##(2008-10#3)
Optimization of an##2##3##(2008-10#1)(2008-11#1)
Optimization of experimental##2##3##(2008-10#2)
Optimization of the##7##3##(1991-6#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-6#1)
Optimization of##28##2##(1991-6#1)(1995-5#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
Optimization##36##1##(1991-6#1)(1995-5#1)(2008-10#22)(2008-11#5)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2012-2#1)
Optimized##10##1##(2008-10#6)(2008-11#1)(2008-3#2)(2009-2#1)
Optimizing##9##1##(1994-12#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
Optimum activity##2##2##(2008-10#1)(2008-6#1)
Optimum conditions for determining##4##4##(2008-10#4)
Optimum conditions for the formation of##2##6##(2008-10#2)
Optimum conditions for the##7##4##(2008-10#7)
Optimum conditions for##14##3##(2008-10#13)(2008-11#1)
Optimum conditions were found##3##4##(2008-10#3)
Optimum conditions were##4##3##(2008-10#4)
Optimum conditions##20##2##(2008-10#19)(2008-11#1)
Optimum experimental conditions##2##3##(2008-10#2)
Optimum pH##4##2##(2008-10#4)
Optimum performance##3##2##(2008-10#3)
Optimum##47##1##(2008-10#42)(2008-11#2)(2008-3#1)(2008-6#2)
Option##3##1##(1995-1#3)
Optoelectronic##2##1##(2008-3#2)
Optosensing properties of fac-Re(CO)(3)(dpknph)Cl (dpknph=di-2-pyridyl ketone p-nitrophenyl hydrazone)##2##8##(2008-10#2)
Opus 51##2##2##(2013-1#2)
Or##3##1##(1994-2#1)(2008-8#1)(2008-9#1)
Or0##2##1##(2013-8#2)
Oral Health##2##2##(2011-2#2)
Oral administration of##4##3##(1997-6#1)(2007-11#1)(2008-11#1)(2008-6#1)
Oral and##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
Oral cancer##2##2##(2009-6#1)(2010-11#1)
Oral cavity rare##2##3##(2011-7#2)
Oral fluoroquinolones##2##2##(2007-12#1)(2010-6#1)
Oral health##2##2##(2008-5#1)(2012-2#1)
Oral squamous cell carcinoma (OSCC)##2##5##(2010-12#1)(2013-1#1)
Oral##53##1##(1991-8#1)(1994-3#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2009-6#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-7#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
Orally##2##1##(2008-11#1)(2008-7#1)
Oranga Kaumatua##2##2##(2008-1#2)
Orange II##3##2##(2008-10#1)(2011-1#2)
Orange##13##1##(1991-9#1)(1992-2#1)(2008-10#9)(2011-1#2)
Orbital##8##1##(2008-11#1)(2010-10#2)(2010-11#1)(2011-2#1)(2013-1#2)(2013-7#1)
Orchards##8##1##(2008-10#8)
Order##4##1##(2008-11#1)(2008-3#1)(2008-9#1)(2010-1#1)
Ordering and##2##2##(1991-9#1)(1996-9#1)
Ordering##3##1##(1991-9#1)(1996-9#1)(2009-6#1)
Ordinary runs analysis##3##3##(2008-10#3)
Ordinary runs##4##2##(2008-10#4)
Ordinary##7##1##(1994-6#1)(2008-10#4)(2008-5#1)(2013-1#1)
Oregon Health##2##2##(1995-1#1)(1996-1#1)
Oregon Medicaid##4##2##(1992-2#3)(1992-9#1)
Oregon and Washington##2##3##(2008-10#1)(2008-9#1)
Oregon and##3##2##(2008-10#2)(2008-9#1)
Oregon is##3##2##(1995-1#2)(1996-1#1)
Oregon was##4##2##(2008-10#2)(2013-1#2)
Oregon##47##1##(1992-1#1)(1992-2#8)(1992-9#1)(1993-1#1)(1995-1#4)(1996-1#3)(2008-10#23)(2008-12#2)(2008-9#2)(2013-1#2)
Oregon's##2##1##(1995-1#1)(2008-10#1)
Org-31806##2##1##(2008-5#2)
Organ##9##1##(1993-2#1)(1993-8#1)(1995-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#1)
Organic Matter##2##2##(2008-10#2)
Organic Pollutants##2##2##(2008-11#1)(2009-8#1)
Organic acids##2##2##(1992-3#2)
Organic arsenic##2##2##(2008-10#2)
Organic##26##1##(1990-8#1)(1992-3#2)(1994-5#1)(1996-5#1)(2008-10#11)(2008-11#5)(2008-3#2)(2008-5#1)(2009-8#1)(2011-2#1)
Organic-inorganic##2##1##(2008-10#1)(2010-4#1)
Organisation for##6##2##(2008-11#1)(2010-11#1)(2011-2#4)
Organisation##10##1##(1997-8#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#1)
Organization and##2##2##(1996-6#1)(2011-2#1)
Organization for##6##2##(1993-2#1)(1993-3#2)(1994-1#1)(2008-10#1)(2011-2#1)
Organization of##3##2##(1993-11#1)(1995-6#1)(2008-10#1)
Organization##59##1##(1990-11#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-11#3)(1993-2#1)(1993-3#2)(1994-1#1)(1994-9#3)(1995-3#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-6#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#7)(2011-7#1)(2012-12#5)(2013-1#4)
Organizational##6##1##(1990-11#2)(1992-1#1)(1996-1#1)(2008-7#1)(2013-1#1)
Organizations##6##1##(1991-2#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-3#1)
Organon##2##1##(2008-5#2)
Organotins are used commercially as##2##5##(2008-10#2)
Organs##4##1##(2008-10#1)(2008-11#1)(2011-2#2)
Oriental lacquer##2##2##(2008-10#2)
Oriental##3##1##(2008-10#2)(2008-8#1)
Oriented##2##1##(1993-1#1)(1995-3#1)
Origanum##2##1##(2008-10#1)(2008-11#1)
Origin and distribution of##2##4##(1992-12#1)(2008-10#1)
Origin and##4##2##(1992-12#1)(2008-10#2)(2009-6#1)
Origin of the##2##3##(2008-10#2)
Origin of##12##2##(1996-5#1)(2008-10#7)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
Origin##19##1##(1992-12#1)(1996-5#1)(2008-10#10)(2008-7#1)(2009-6#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
Original##2##1##(2010-1#1)(2012-3#1)
Originally##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
Orlando##7##1##(1992-11#1)(1995-12#1)(2008-10#3)(2008-12#1)(2009-4#1)
Orlistat##2##1##(2008-5#2)
Orobanche crenata##2##2##(2008-10#2)
Orobanche pycnostachya##2##2##(2011-2#2)
Orobanche ramosa##2##2##(2008-10#2)
Orobanche##12##1##(2008-10#10)(2011-2#2)
Oromia##2##1##(2011-2#2)
Oropharyngeal##2##1##(1997-5#1)(2011-2#1)
Orpotrin analogs##2##2##(2011-2#2)
Orpotrin##5##1##(2011-2#5)
Orthodontic##2##1##(2008-11#1)(2013-1#1)
Orthogonal##4##1##(2008-10#2)(2008-3#1)(2009-11#1)
Orthopaedic##6##1##(2007-11#1)(2008-12#1)(2008-8#1)(2009-10#2)(2012-2#1)
Orthopaedics##4##1##(1991-9#1)(2009-4#1)(2013-1#2)
Orthopedic##2##1##(1997-6#1)(2012-3#1)
Orthopedics##4##1##(2007-8#1)(2008-8#1)(2011-2#1)(2012-3#1)
Orthophosphate##2##1##(2008-10#2)
Orthoptera##2##1##(2008-6#1)(2013-8#1)
Ortigas river##3##2##(2008-10#3)
Ory s 23##2##3##(2009-10#2)
Ory s##7##2##(2009-10#7)
Oryza isolate##2##2##(2008-10#2)
Oryza sativa L##4##3##(2008-9#4)
Oryza sativa##11##2##(2008-10#3)(2008-9#7)(2009-10#1)
Oryza##17##1##(2008-10#6)(2008-8#2)(2008-9#7)(2009-10#2)
Oryzias latipes##5##2##(2008-11#1)(2008-6#2)(2009-7#2)
Os##4##1##(2008-10#4)
OsMADS50##2##1##(2009-8#2)
OsMADS7 and 8##4##3##(1997-8#4)
OsMADS7 and##5##2##(1997-8#5)
OsMADS7##6##1##(1997-8#5)(2008-8#1)
OsPBP1 is a##2##3##(2009-10#2)
OsPBP1##7##1##(2009-10#7)
OsRLCKs##5##1##(2009-10#5)
Osaka City##4##2##(2013-8#4)
Oscillations were##2##2##(1991-5#1)(1996-6#1)
Oscillations##4##1##(1991-5#1)(1996-6#1)(2008-2#1)(2009-8#1)
Oscillator##5##1##(1996-9#1)(2008-3#4)
Oscillatory##2##1##(2008-12#2)
Osedax spp##2##2##(2009-8#2)
Oslo##16##1##(1990-11#1)(1990-2#1)(1990-9#1)(1992-5#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-2#2)(1996-6#1)(1997-4#1)(1997-8#2)(2011-2#1)
Osmotic##2##1##(1992-6#1)(2008-11#1)
Ossifying##2##1##(1994-2#1)(2008-10#1)
Osteoarthritis (OA) is a##2##4##(2010-11#1)(2013-1#1)
Osteoarthritis of##2##2##(1997-6#1)(2013-1#1)
Osteoarthritis##10##1##(1997-6#1)(2008-10#1)(2010-11#1)(2011-2#2)(2013-1#5)
Osteoblasts##2##1##(2008-11#1)(2010-10#1)
Osteochondritis dissecans (OCD)##2##3##(2013-1#2)
Osteochondritis##3##1##(2013-1#3)
Osteoclast##2##1##(1991-11#1)(1991-5#1)
Osteogenic sarcoma of the##2##4##(1992-2#1)(1993-8#1)
Osteogenic##4##1##(1992-2#1)(1993-8#1)(2008-11#1)(2012-4#1)
Osteoma cutis is##2##3##(2010-6#2)
Osteoma cutis##3##2##(2010-6#3)
Osteomyelitis of the craniofacial skeleton##2##5##(2010-6#2)
Osteomyelitis of the##4##3##(2010-11#1)(2010-6#3)
Osteomyelitis##9##1##(1995-9#1)(2008-10#1)(2010-11#1)(2010-6#6)
Osteonevus of Nanta##2##3##(2012-12#2)
Osteopathic##2##1##(1991-12#1)(2013-1#1)
Osteoporosis##3##1##(1997-6#1)(2008-7#1)(2010-10#1)
Osteotomy##2##1##(2012-3#1)(2013-1#1)
Ostertagia##3##1##(1996-12#3)
Osteryoung##2##1##(2008-10#2)
Oswaldo Cruz 33 (1938) 349] and Lutzomyia##2##7##(2007-12#2)
Oswaldo Cruz##6##2##(2007-12#4)(2010-1#2)
Oswestry Disability Index (ODI)##2##4##(2008-12#1)(2012-12#1)
Oswestry Disability Index##5##3##(2008-12#1)(2009-3#1)(2012-12#1)(2012-3#2)
Other advantages of the##2##4##(2008-10#2)
Other advantages##3##2##(2008-10#3)
Other agents##2##2##(1995-11#1)(2008-9#1)
Other aspects of##2##3##(2007-12#1)(2011-1#1)
Other aspects##3##2##(2007-12#1)(2008-11#1)(2011-1#1)
Other causes of##2##3##(1997-8#1)(2013-1#1)
Other causes##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
Other countries##2##2##(1992-5#1)(2011-2#1)
Other factors##6##2##(1996-12#1)(1996-3#2)(2010-7#1)(2012-3#1)(2013-1#1)
Other group of##2##3##(2008-10#1)(2008-5#1)
Other metals##3##2##(2008-10#2)(2010-11#1)
Other observations##2##2##(2011-2#1)(2012-2#1)
Other parameters##2##2##(2008-10#1)(2012-2#1)
Other problems##2##2##(1995-5#1)(2008-10#1)
Other profitable features such as##4##5##(2008-10#4)
Other studies##2##2##(2008-10#1)(2011-1#1)
Other than##2##2##(1992-3#1)(2011-2#1)
Other variables##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
Other##173##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#3)(2008-10#49)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#13)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)
Others##9##1##(1994-9#1)(1995-12#1)(1995-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
Otherwise##12##1##(1990-9#1)(1995-5#1)(2008-10#7)(2008-4#1)(2008-8#1)(2011-2#1)
Ots1BML##2##1##(2008-11#2)
Ottawa##6##1##(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2013-1#1)
Oulu##2##1##(2010-10#2)
Our ability to##2##3##(1993-3#1)(2010-4#1)
Our aim is to present##2##5##(2008-3#2)
Our aim is to##4##4##(2008-11#1)(2008-3#2)(2008-9#1)
Our aim was to assess the##2##6##(2008-9#1)(2012-8#1)
Our aim was to##8##4##(2008-9#1)(2009-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)(2012-8#1)
Our aim##12##2##(2008-11#1)(2008-3#2)(2008-9#2)(2009-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)(2012-8#1)
Our analyses##2##2##(2008-8#1)(2011-2#1)
Our analysis indicates that##2##4##(2008-10#1)(2008-9#1)
Our analysis of##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
Our analysis reveals##2##3##(2007-12#1)(2008-8#1)
Our analysis shows that##2##4##(2008-11#1)(2008-9#1)
Our analysis suggests that##2##4##(1997-7#1)(2008-8#1)
Our analysis##16##2##(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#4)(2011-2#1)(2012-2#1)
Our approach is##2##3##(2008-6#1)(2012-3#1)
Our approach##10##2##(1992-9#1)(1994-2#1)(2008-11#1)(2008-3#1)(2008-6#2)(2011-2#1)(2012-2#2)(2012-3#1)
Our case is##3##3##(2007-8#1)(2012-3#1)(2013-7#1)
Our case##5##2##(2007-8#1)(2008-12#1)(2010-6#1)(2012-3#1)(2013-7#1)
Our clinical##2##2##(1997-8#1)(2010-6#1)
Our current##2##2##(2008-10#1)(2008-6#1)
Our data also suggest that##2##5##(2008-8#1)(2008-9#1)
Our data also##3##3##(1994-5#1)(2008-8#1)(2008-9#1)
Our data confirm##2##3##(1994-11#1)(2007-8#1)
Our data demonstrate that##2##4##(2008-10#1)(2008-11#1)
Our data demonstrate##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
Our data do not##2##4##(2008-10#1)(2011-2#1)
Our data indicate that the##4##5##(1995-6#1)(1995-8#1)(2008-11#1)(2008-7#1)
Our data indicate that##10##4##(1990-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
Our data indicate##12##3##(1990-12#1)(1992-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
Our data provide the first##2##5##(2008-10#1)(2010-11#1)
Our data provide##5##3##(2008-10#2)(2008-7#1)(2010-11#1)(2013-1#1)
Our data reveal that##2##4##(1990-11#1)(1994-5#1)
Our data show that##6##4##(1991-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)
Our data show##7##3##(1991-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-6#1)
Our data showed that##2##4##(1997-2#1)(2011-2#1)
Our data suggest that the##5##5##(1992-6#1)(1996-11#1)(2008-11#1)(2008-5#1)(2012-3#1)
Our data suggest that##23##4##(1990-11#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-8#1)(1996-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-2#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Our data support the##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
Our data##82##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#15)(2008-11#10)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)
Our efforts to##2##3##(2008-10#1)(2008-11#1)
Our evaluation##2##2##(1994-3#1)(2008-8#1)
Our experience in##2##3##(1996-1#1)(2011-2#1)
Our experience with##3##3##(1992-5#2)(2008-9#1)
Our experience##10##2##(1991-6#1)(1992-5#2)(1996-1#1)(1997-2#1)(2008-7#1)(2008-9#1)(2011-2#3)
Our experience]##6##2##(1990-3#2)(1991-3#1)(1992-3#1)(1992-5#1)(1992-9#1)
Our experimental results##2##3##(2008-10#1)(2008-3#1)
Our experiments##6##2##(2008-10#1)(2008-6#1)(2008-9#3)(2013-1#1)
Our finding##3##2##(1996-12#1)(2008-11#1)(2009-8#1)
Our findings also##3##3##(2008-11#2)(2010-8#1)
Our findings have##2##3##(2008-8#2)
Our findings indicate that##4##4##(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
Our findings indicate##5##3##(1995-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
Our findings show that##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
Our findings show##4##3##(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
Our findings strongly suggest##2##4##(1995-12#1)(2012-3#1)
Our findings strongly##3##3##(1995-12#1)(1997-7#1)(2012-3#1)
Our findings suggest that the##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
Our findings suggest that##10##4##(1995-2#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Our findings suggest##13##3##(1995-2#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
Our findings will help##2##4##(2008-11#1)(2012-2#1)
Our findings##53##2##(1992-12#1)(1993-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
Our first##3##2##(1997-6#1)(2008-8#2)
Our genetic##2##2##(2008-10#1)(2012-3#1)
Our goal was to##2##4##(2007-12#1)(2008-10#1)
Our goal##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
Our goals##3##2##(2008-8#1)(2009-8#1)(2013-8#1)
Our hypothesis was that##2##4##(2009-8#1)(2011-1#1)
Our hypothesis was##3##3##(2008-10#1)(2009-8#1)(2011-1#1)
Our in vitro##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
Our in##4##2##(1995-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
Our initial##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
Our knowledge of##2##3##(2008-11#1)(2010-4#1)
Our laboratory has##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
Our main result##2##3##(2008-9#2)
Our main##6##2##(2008-10#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#1)
Our mathematical##2##2##(2012-2#1)(2013-8#1)
Our method is##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
Our method##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-1#1)
Our methodology##2##2##(2008-8#1)(2009-4#1)
Our model makes##2##3##(2008-8#2)
Our model predicts##2##3##(2008-8#2)
Our model shows that##2##4##(2008-8#2)
Our model##19##2##(2008-10#2)(2008-11#2)(2008-8#13)(2008-9#2)
Our modeling approach##2##3##(2008-11#1)(2013-1#1)
Our objective was to assess the##3##6##(1994-3#1)(1995-1#1)(1996-1#1)
Our objective was to determine if##2##6##(1995-3#1)(2008-10#1)
Our objective was to determine##4##5##(1995-3#1)(2008-10#3)
Our objective was to examine##2##5##(2010-2#1)(2013-1#1)
Our objective was to##16##4##(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-10#6)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Our objective##17##2##(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-10#6)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Our objectives were to##4##4##(2008-10#4)
Our objectives##5##2##(2008-10#4)(2008-9#1)
Our observation##2##2##(2008-5#1)(2012-3#1)
Our observations suggest that##3##4##(1994-2#1)(2008-7#1)(2011-2#1)
Our observations##7##2##(1994-2#1)(1997-6#1)(2008-7#2)(2010-4#1)(2011-2#2)
Our overall##2##2##(1997-1#1)(2013-1#1)
Our patient##2##2##(1990-3#1)(2013-1#1)
Our pilot##2##2##(2008-11#1)(2011-2#1)
Our preliminary data indicate that##2##5##(1992-12#1)(2008-4#1)
Our preliminary results##3##3##(2008-10#2)(2011-2#1)
Our preliminary##5##2##(1992-12#1)(2008-10#2)(2008-4#1)(2011-2#1)
Our previous studies showed that##3##5##(2008-11#1)(2008-9#2)
Our previous studies##6##3##(1997-7#1)(2008-11#1)(2008-5#1)(2008-9#2)(2013-1#1)
Our previous study##2##3##(1994-5#1)(2008-6#1)
Our previous work has##2##4##(1993-6#1)(2011-2#1)
Our previous work##3##3##(1993-6#1)(2008-10#1)(2011-2#1)
Our previous##14##2##(1993-6#1)(1994-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#3)(2011-2#1)(2013-1#1)
Our purpose is to##2##4##(2008-5#1)(2012-3#1)
Our purpose is##3##3##(2008-5#1)(2010-3#1)(2012-3#1)
Our purpose of launching##3##4##(2010-12#3)
Our purpose was to##4##4##(1995-12#1)(2013-1#3)
Our purpose##12##2##(1994-1#1)(1995-12#1)(2008-11#1)(2008-5#1)(2010-12#3)(2010-3#1)(2012-3#1)(2013-1#3)
Our recent research##2##3##(2008-11#1)(2009-8#1)
Our recent##7##2##(1992-3#1)(1993-11#1)(2008-11#1)(2009-8#3)(2011-2#1)
Our research##7##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-8#2)(2012-2#1)
Our result##2##2##(2008-11#1)(2008-5#1)
Our results also indicated that##2##5##(2008-8#1)(2008-9#1)
Our results also provide##2##4##(1992-3#1)(2008-8#1)
Our results also show that##2##5##(2008-10#1)(2008-9#1)
Our results also suggest that a##2##6##(2008-10#1)(2009-10#1)
Our results also suggest that##3##5##(2008-10#2)(2009-10#1)
Our results also##11##3##(1992-3#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-8#2)(2008-9#2)(2009-10#1)
Our results are consistent with the hypothesis that##2##8##(1995-2#1)(2007-12#1)
Our results are consistent with the##3##6##(1990-8#1)(1995-2#1)(2007-12#1)
Our results are consistent with##4##5##(1990-8#1)(1995-2#1)(1997-7#1)(2007-12#1)
Our results are##8##3##(1990-8#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#2)
Our results clearly demonstrate##2##4##(2008-5#1)(2009-7#1)
Our results clearly##5##3##(1994-5#1)(1997-1#1)(2008-10#1)(2008-5#1)(2009-7#1)
Our results confirm that##3##4##(1990-2#1)(1990-8#1)(2008-10#1)
Our results confirm the##2##4##(1996-8#1)(2008-6#1)
Our results confirm##6##3##(1990-2#1)(1990-8#1)(1996-8#1)(2008-10#1)(2008-6#1)(2011-2#1)
Our results confirmed##2##3##(2008-10#1)(2008-8#1)
Our results demonstrate that both##2##5##(1995-2#1)(2008-12#1)
Our results demonstrate that the##2##5##(2009-11#1)(2013-1#1)
Our results demonstrate that##11##4##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
Our results demonstrate##14##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
Our results demonstrated##2##3##(2008-10#1)(2012-2#1)
Our results extend##2##3##(1994-12#1)(2008-9#1)
Our results from##2##3##(1990-3#1)(2008-10#1)
Our results highlight the##2##4##(2008-8#1)(2012-3#1)
Our results imply that##2##4##(2008-3#1)(2009-8#1)
Our results indicate that a##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
Our results indicate that both##2##5##(2008-8#1)(2012-3#1)
Our results indicate that increased##2##5##(2012-6#1)(2013-8#1)
Our results indicate that the##5##5##(1994-11#1)(1996-2#1)(2008-10#2)(2008-11#1)
Our results indicate that##41##4##(1990-12#1)(1992-9#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#11)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-10#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#1)
Our results indicate##44##3##(1990-12#1)(1992-9#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#13)(2008-11#3)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-10#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#1)
Our results indicated that the##2##5##(2008-10#2)
Our results indicated that##6##4##(2008-10#4)(2008-9#1)(2010-4#1)
Our results provide evidence that##2##5##(2008-10#1)(2013-1#1)
Our results provide evidence##3##4##(1997-2#1)(2008-10#1)(2013-1#1)
Our results provide##6##3##(1991-10#1)(1997-2#1)(2008-10#1)(2008-8#1)(2010-5#1)(2013-1#1)
Our results provided##2##3##(2008-12#1)(2008-8#1)
Our results revealed that##2##4##(2008-12#2)
Our results revealed##3##3##(1997-3#1)(2008-12#2)
Our results show a##2##4##(1990-5#1)(2008-3#1)
Our results show that the##5##5##(1995-8#1)(1997-2#1)(2008-11#1)(2008-9#1)(2009-5#1)
Our results show that##34##4##(1991-12#1)(1992-10#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-3#3)(2008-7#1)(2008-9#1)(2009-5#2)(2011-2#3)(2012-3#2)(2012-6#1)
Our results show the##2##4##(2010-10#1)(2012-2#1)
Our results show##39##3##(1990-5#1)(1991-12#1)(1992-10#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-3#4)(2008-7#1)(2008-9#1)(2009-5#2)(2010-10#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-6#1)(2013-7#1)
Our results showed that both##2##5##(2008-10#1)(2008-9#1)
Our results showed that the##2##5##(2008-10#1)(2008-11#1)
Our results showed that##8##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
Our results showed##10##3##(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)
Our results suggest a##2##4##(1993-3#1)(2010-6#1)
Our results suggest that an##2##5##(1990-2#1)(2013-8#1)
Our results suggest that the##11##5##(1994-12#1)(1995-11#1)(1997-2#1)(1997-8#1)(2008-10#5)(2011-2#1)(2012-2#1)
Our results suggest that when##2##5##(2008-8#1)(2012-2#1)
Our results suggest that##41##4##(1990-2#1)(1990-6#1)(1992-3#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-11#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-10#14)(2008-11#2)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Our results suggest the##2##4##(1995-8#1)(2008-10#1)
Our results suggest##47##3##(1990-2#1)(1990-6#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-10#16)(2008-11#2)(2008-8#2)(2008-9#2)(2010-6#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Our results suggested that the##3##5##(2008-11#2)(2008-6#1)
Our results support##2##3##(2008-10#1)(2010-1#1)
Our results##249##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#5)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-7#2)(1997-8#2)(2007-12#1)(2008-10#61)(2008-11#16)(2008-12#7)(2008-2#1)(2008-3#5)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#17)(2008-9#10)(2009-10#3)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#3)(2010-4#1)(2010-5#1)(2010-6#2)(2011-10#1)(2011-2#12)(2012-12#1)(2012-2#4)(2012-3#10)(2012-6#2)(2013-1#6)(2013-7#1)(2013-8#3)
Our simulations##4##2##(2008-11#1)(2008-8#2)(2010-7#1)
Our studies demonstrate that##2##4##(2008-11#1)(2011-2#1)
Our studies indicate that the##2##5##(1997-8#1)(2008-10#1)
Our studies indicate that##3##4##(1997-8#1)(2008-10#1)(2008-5#1)
Our studies show that##2##4##(2008-10#1)(2008-9#1)
Our studies showed that##2##4##(2008-5#1)(2008-7#1)
Our studies##18##2##(1991-12#1)(1993-3#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)
Our study also##3##3##(2008-10#1)(2010-10#1)(2010-8#1)
Our study assessed##2##3##(2009-6#1)(2011-2#1)
Our study demonstrated that##2##4##(2011-2#1)(2013-8#1)
Our study demonstrated##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
Our study demonstrates that##2##4##(1993-2#1)(2013-8#1)
Our study demonstrates##3##3##(1993-2#1)(2008-10#1)(2013-8#1)
Our study further##2##3##(2008-7#1)(2009-8#1)
Our study indicates that##4##4##(1994-12#1)(1996-12#1)(2008-11#1)(2011-1#1)
Our study indicates##5##3##(1994-12#1)(1995-11#1)(1996-12#1)(2008-11#1)(2011-1#1)
Our study is##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
Our study showed that the##2##5##(2008-10#1)(2008-5#1)
Our study showed##3##3##(2008-10#1)(2008-5#1)(2012-6#1)
Our study shows that##2##4##(2011-2#2)
Our study shows##4##3##(2008-7#1)(2011-2#2)(2012-2#1)
Our study suggests that more##2##5##(2008-1#2)
Our study suggests that the##2##5##(2008-8#1)(2011-2#1)
Our study suggests that##9##4##(1995-8#1)(2008-1#3)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
Our study##49##2##(1993-11#1)(1993-2#1)(1994-12#1)(1995-11#2)(1995-8#1)(1996-12#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#3)
Our technique##3##2##(2010-8#1)(2011-2#2)
Our theoretical##3##2##(1993-12#1)(2008-3#1)(2008-8#1)
Our two##2##2##(1990-2#1)(2008-9#1)
Our understanding of##3##3##(1997-5#1)(2008-7#1)(2011-2#1)
Our understanding##4##2##(1992-9#1)(1997-5#1)(2008-7#1)(2011-2#1)
Our work is##2##3##(2008-8#1)(2010-12#1)
Our work##10##2##(2008-8#1)(2009-8#2)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
Our##798##1##(1990-11#2)(1990-12#3)(1990-2#6)(1990-3#4)(1990-5#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-3#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-5#3)(1992-6#2)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#8)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#6)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#4)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#133)(2008-11#60)(2008-12#10)(2008-2#1)(2008-3#15)(2008-4#1)(2008-5#24)(2008-6#9)(2008-7#23)(2008-8#57)(2008-9#39)(2009-10#6)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#5)(2009-8#23)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#6)(2010-7#7)(2010-8#8)(2010-9#1)(2011-1#2)(2011-10#2)(2011-2#54)(2011-3#1)(2012-12#3)(2012-2#25)(2012-3#26)(2012-6#3)(2012-8#1)(2013-1#27)(2013-7#2)(2013-8#12)
Out of a total of##2##5##(1992-9#1)(2013-8#1)
Out of the##12##3##(1990-12#2)(1990-6#2)(1991-3#1)(1991-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#1)
Out of these##2##3##(2011-1#2)
Out of##29##2##(1990-12#3)(1990-3#1)(1990-6#3)(1991-3#1)(1991-6#1)(1992-9#1)(1996-12#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-8#2)
Out##30##1##(1990-12#3)(1990-3#1)(1990-6#3)(1991-3#1)(1991-6#1)(1992-9#1)(1994-1#1)(1996-12#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-8#2)
Outbreak of##2##2##(1995-9#1)(1996-8#1)
Outbreak##3##1##(1995-9#1)(1996-8#1)(2013-1#1)
Outbreaks of##2##2##(1990-3#1)(2008-10#1)
Outbreaks##4##1##(1990-3#1)(1992-6#1)(2007-12#1)(2008-10#1)
Outcome after##2##2##(1994-3#1)(2012-3#1)
Outcome measurements included##2##3##(2007-12#1)(2010-9#1)
Outcome measures were implant##2##4##(2013-1#2)
Outcome measures were##3##3##(2013-1#3)
Outcome measures##11##2##(1992-2#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#5)
Outcome of##9##2##(1993-12#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
Outcome variables##2##2##(1994-3#1)(2013-1#1)
Outcome was##2##2##(2008-7#1)(2012-3#1)
Outcome##37##1##(1991-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-11#1)(2010-9#1)(2011-2#3)(2012-3#4)(2013-1#7)
Outcomes of##6##2##(1991-1#1)(1993-3#1)(2010-7#1)(2013-1#2)(2013-8#1)
Outcomes were##2##2##(2008-12#1)(2010-10#1)
Outcomes##32##1##(1991-1#1)(1993-12#1)(1993-3#1)(1994-1#3)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2010-10#2)(2010-2#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#2)
Outgrowth##2##1##(1997-3#1)(2008-11#1)
Outlook##5##1##(1991-1#1)(1992-3#1)(1993-3#2)(1997-6#1)
Outpatient comparison of buprenorphine and methadone maintenance##2##7##(1991-1#2)
Outpatient management of fever in selected infants##3##7##(1994-3#3)
Outpatient##14##1##(1991-1#2)(1991-6#2)(1992-12#1)(1993-3#1)(1994-3#3)(1997-8#1)(2008-11#2)(2008-9#1)(2010-6#1)
Output from##2##2##(2008-3#1)(2008-8#1)
Output##5##1##(1991-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
Outside##2##1##(1994-8#1)(2008-10#1)
Ovarian cancer##4##2##(1995-9#1)(2008-1#1)(2008-8#1)(2013-8#1)
Ovarian##11##1##(1994-2#1)(1995-9#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-7#2)(2013-8#2)
Ovariole##2##1##(2008-12#2)
Ovary##14##1##(2008-11#10)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)
Over 3 years##2##3##(2008-10#2)
Over 3##3##2##(1993-2#1)(2008-10#2)
Over 40##2##2##(1990-6#1)(2013-8#1)
Over 80% of##2##3##(2008-10#1)(2011-2#1)
Over 80%##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
Over a period of##3##4##(1997-2#1)(2008-10#1)(2008-12#1)
Over a##9##2##(1992-1#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
Over all##4##2##(2008-10#4)
Over half of##3##3##(2008-10#1)(2009-4#1)(2013-8#1)
Over the course of the##3##5##(1993-3#1)(2008-10#2)
Over the last decade there has been##2##7##(2008-12#1)(2009-7#1)
Over the last decade##4##4##(2008-12#2)(2009-7#1)(2013-1#1)
Over the last few##2##4##(2012-2#1)(2013-1#1)
Over the last##14##3##(1990-6#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-3#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
Over the past 10 years##2##5##(1997-1#1)(2008-11#1)
Over the past 30 years##2##5##(2008-11#1)(2010-11#1)
Over the past decade there has been##2##7##(2007-12#1)(2008-11#1)
Over the past decade##10##4##(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-11#3)(2011-2#2)
Over the past few##2##4##(2008-10#1)(2008-11#1)
Over the past several years##3##5##(2008-10#2)(2008-11#1)
Over the past two decades##2##5##(2008-11#2)
Over the past two##3##4##(1991-2#1)(2008-11#2)
Over the past##30##3##(1990-9#1)(1991-2#1)(1991-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#10)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#2)
Over the range##4##3##(2008-10#4)
Over the##58##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-11#10)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Over##110##1##(1990-6#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#2)(1992-1#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#3)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#26)(2008-11#10)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
Over-expression of##4##2##(1996-12#1)(2008-11#2)(2010-10#1)
Over-expression##6##1##(1996-12#1)(2008-11#2)(2008-4#1)(2010-10#1)(2010-11#1)
Overall mortality was##2##3##(1996-3#1)(2011-2#1)
Overall prevalence of##2##3##(2007-12#1)(2008-11#1)
Overall results##3##2##(1990-6#1)(1992-6#1)(2013-8#1)
Overall##143##1##(1990-6#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-6#1)(1993-1#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#3)(1996-6#1)(1997-2#4)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#15)(2008-11#11)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#15)(2013-8#8)
Overcoming##4##1##(1992-1#1)(1997-3#1)(2008-10#1)(2013-1#1)
Overdose##3##1##(1992-2#1)(2008-11#1)(2010-1#1)
Overexpression of a##2##3##(1993-3#1)(2008-10#1)
Overexpression of##16##2##(1993-3#1)(1995-2#1)(1995-6#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-10#1)(2012-3#2)(2013-1#1)
Overexpression##19##1##(1993-3#1)(1995-2#1)(1995-6#2)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-10#1)(2011-2#1)(2012-3#2)(2013-1#1)
Overhauser##6##1##(1990-5#1)(1992-4#1)(1993-8#1)(1994-5#2)(2008-11#1)
Overlapping##5##1##(1992-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-3#1)
Overnight##2##1##(2010-7#1)(2011-2#1)
Overproduction of the##2##3##(1991-10#1)(1997-7#1)
Overshadowing##2##1##(2008-5#2)
Overview of flow cytometry##2##4##(2008-4#1)(2008-9#1)
Overview of nucleic acid##2##4##(2008-4#1)(2008-9#1)
Overview of the##3##3##(2008-10#1)(2008-4#2)
Overview of##24##2##(1990-8#1)(1991-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#8)(2008-6#1)(2008-9#5)
Overview##26##1##(1990-8#1)(1991-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#8)(2008-6#1)(2008-9#5)(2013-1#1)
Overweight and obesity##2##3##(2011-2#1)(2012-2#1)
Overwintering of##2##2##(2008-10#2)
Overwintering##3##1##(2008-10#3)
Ovine##3##1##(1993-2#1)(2010-12#2)
Owensby##2##1##(1994-5#2)
Owing to its high##3##4##(2008-10#2)(2009-12#1)
Owing to its##7##3##(1991-8#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-11#1)(2011-2#1)
Owing to the high##2##4##(1992-5#1)(2008-10#1)
Owing to the##8##3##(1992-5#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-9#1)(2013-1#1)
Owing to their##3##3##(1997-8#1)(2009-8#1)(2013-7#1)
Owing to##23##2##(1990-2#1)(1991-8#1)(1992-5#1)(1995-2#1)(1997-8#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
Own##2##1##(2008-12#1)(2012-12#1)
Ownership##2##1##(1996-3#1)(2013-1#1)
Ox IgG1 Fab was##2##4##(1993-6#2)
Ox IgG1 Fab##3##3##(1993-6#3)
Ox IgG1##4##2##(1993-6#4)
Ox IgG3 Fab fragments##2##4##(1993-6#2)
Ox IgG3##4##2##(1993-6#4)
Ox##9##1##(1993-6#8)(2008-10#1)
Ox-LDL##4##1##(1990-8#4)
OxLDL##5##1##(1995-2#5)
Oxalate bioavailability##2##2##(2012-2#2)
Oxalate##10##1##(1991-11#1)(2008-10#5)(2012-2#4)
Oxamyl##2##1##(2008-10#2)
Oxford##7##1##(1994-2#2)(1996-1#1)(2008-12#2)(2008-2#1)(2011-2#1)
Oxidase in##2##2##(2008-10#2)
Oxidase##5##1##(2008-10#4)(2013-1#1)
Oxidation of the##2##3##(1996-5#2)
Oxidation of##9##2##(1992-3#1)(1996-5#2)(2008-10#3)(2008-4#1)(2009-8#1)(2010-6#1)
Oxidation##17##1##(1992-3#1)(1996-5#2)(2008-10#10)(2008-4#1)(2009-8#1)(2010-6#1)(2010-7#1)
Oxidative Modifications##2##2##(2009-8#2)
Oxidative stress and##2##3##(2008-5#1)(2010-5#1)
Oxidative stress markers##2##3##(2009-6#1)(2010-5#1)
Oxidative stress##11##2##(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#4)(2011-1#1)(2012-2#1)
Oxidative##24##1##(1991-5#2)(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#4)(2010-12#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-2#1)
Oxide##6##1##(1996-5#2)(2008-8#1)(2010-12#1)(2010-6#1)(2013-7#1)
Oxidized##2##1##(1990-8#1)(1996-2#1)
Oxygen (DO)##2##2##(2008-12#1)(2010-4#1)
Oxygen consumption##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2010-11#1)
Oxygen uptake##3##2##(1996-3#1)(2008-11#1)(2008-12#1)
Oxygen##24##1##(1992-12#1)(1993-8#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-9#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Ozer##4##1##(1995-12#4)
Ozone##13##1##(1991-6#1)(1994-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#6)
Ozonolysis of 3a-d##2##3##(1996-5#2)
Ozonolysis of the endo adducts##2##5##(1996-5#2)
Ozonolysis of the endo##3##4##(1996-5#3)
Ozonolysis of##5##2##(1996-5#5)
Ozonolysis##6##1##(1996-5#5)(2008-10#1)
P &gt##3##2##(1994-2#2)(2008-10#1)
P &lt##122##2##(1992-11#2)(1992-12#1)(1992-9#1)(1993-2#1)(1994-12#8)(1994-2#2)(1994-3#6)(1994-8#2)(1995-12#1)(1995-8#6)(2008-10#29)(2008-5#3)(2008-7#2)(2008-9#2)(2009-3#1)(2010-1#2)(2010-4#13)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#14)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#7)
P = 0##57##3##(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-8#1)(2008-10#26)(2008-9#1)(2009-11#2)(2010-1#5)(2011-2#1)(2012-12#2)(2012-3#9)(2013-1#5)
P = 1##4##3##(2008-10#1)(2012-3#3)
P =##84##2##(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-8#1)(2008-10#28)(2008-8#2)(2008-9#1)(2009-11#2)(2009-8#4)(2010-1#5)(2010-12#1)(2010-4#8)(2011-2#1)(2012-12#2)(2012-3#15)(2013-1#9)
P PO(4)(3-)l(-1)##3##2##(2008-10#3)
P and K##3##3##(2008-12#3)
P and N neurons on capsules##2##6##(1997-3#2)
P and##13##2##(1990-2#1)(1995-8#1)(1997-3#2)(2008-10#3)(2008-12#3)(2008-3#1)(2010-7#2)
P concentrations##2##2##(1995-8#1)(2011-10#1)
P dominance##2##2##(1995-11#2)
P is##3##2##(1995-6#1)(2008-10#1)(2009-10#1)
P less than 0##6##4##(1991-2#6)
P or##2##2##(1994-8#1)(1995-6#1)
P strains in##2##3##(2008-10#2)
P stress##2##2##(2011-10#2)
P value##3##2##(1997-8#1)(2008-7#1)(2011-2#1)
P was##4##2##(1995-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
P##1310##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#5)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#6)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#3)(1994-12#8)(1994-2#5)(1994-3#6)(1994-5#3)(1994-8#12)(1995-11#6)(1995-12#4)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#9)(1995-8#10)(1996-12#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#8)(1997-4#1)(1997-8#1)(2008-10#886)(2008-11#3)(2008-12#37)(2008-3#2)(2008-4#5)(2008-5#15)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#3)(2009-3#1)(2009-5#1)(2009-6#7)(2009-8#5)(2009-9#2)(2010-1#8)(2010-10#1)(2010-12#2)(2010-3#14)(2010-4#25)(2010-6#2)(2010-7#9)(2010-8#5)(2011-1#4)(2011-10#5)(2011-2#15)(2011-3#14)(2012-12#14)(2012-2#11)(2012-3#28)(2012-7#1)(2013-1#24)(2013-8#5)
P&gt##2##1##(2008-10#1)(2008-9#1)
P&lt##37##1##(2008-10#13)(2008-12#2)(2008-5#1)(2008-7#13)(2008-8#4)(2008-9#2)(2013-1#2)
P(0)##2##1##(2008-10#2)
P(1##2##1##(2008-10#2)
P(1)##2##1##(2008-10#2)
P(2)##2##1##(2008-10#2)
P(2)O(5)##3##1##(2008-10#3)
P(2)O(7)(4-) and##2##2##(2008-10#2)
P(870)##2##1##(2008-8#2)
P(N)##4##1##(2012-7#4)
P(V)##8##1##(2008-10#6)(2008-11#2)
P(app) (A --&gt##2##3##(2011-3#2)
P(app)##3##1##(2011-3#3)
P(z)##2##1##(2008-10#2)
P)##6##1##(1992-3#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
P- and##2##2##(1997-3#1)(2009-8#1)
P-##4##1##(1994-8#1)(1997-3#1)(2008-5#1)(2009-8#1)
P-2##2##1##(2008-10#2)
P-2245 and PV-61##3##3##(2008-10#3)
P-2245##6##1##(2008-10#6)
P-450 reductase##4##2##(1993-6#2)(1995-8#1)(2008-11#1)
P-450##19##1##(1991-5#2)(1992-3#2)(1993-6#2)(1993-8#1)(1994-2#1)(1994-5#1)(1995-8#3)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)
P-450(11 beta)##7##2##(1990-5#7)
P-450(14)DM##4##1##(1992-3#4)
P-450LDM##2##1##(2008-5#2)
P-450arom##9##1##(1995-8#9)
P-HA##2##1##(2008-10#2)
P-SG64 was##2##2##(1994-11#2)
P-SG64##5##1##(1994-11#5)
P-SG67##2##1##(1994-11#2)
P-dependent##2##1##(1995-11#2)
P-diastereomers##2##1##(2008-4#2)
P-dominant##2##1##(1995-11#2)
P-glycoprotein is a##2##3##(2008-11#2)
P-glycoprotein is##3##2##(2008-11#3)
P-glycoprotein on the##3##3##(2008-10#1)(2011-3#2)
P-glycoprotein##35##1##(1992-12#2)(1993-8#1)(2008-10#2)(2008-11#25)(2008-7#1)(2011-3#2)(2013-1#2)
P-glycoproteins##3##1##(2008-11#3)
P-gp and CYP3A##2##3##(2011-3#2)
P-gp##8##1##(2008-7#2)(2011-2#1)(2011-3#5)
P-selectin##7##1##(2006-6#4)(2008-1#1)(2008-9#2)
P-side Schiff base intermediate##2##4##(1992-3#2)
P-side##3##1##(1992-3#3)
P1 (P1)##2##2##(1997-8#1)(2008-10#1)
P1 and##4##2##(1996-8#1)(2008-10#2)(2008-9#1)
P1 clones and##2##3##(1996-2#2)
P1 clones##8##2##(1996-2#2)(1997-6#2)(1997-8#4)
P1 conidia##5##2##(2008-10#5)
P1 downstream sequence##2##3##(2008-9#2)
P1 expression##2##2##(2008-9#2)
P1 from##2##2##(1992-6#2)
P1 region##2##2##(2008-8#2)
P1##66##1##(1991-5#1)(1992-6#7)(1993-12#4)(1994-11#2)(1994-5#2)(1995-6#2)(1996-12#3)(1996-2#3)(1996-8#1)(1997-6#3)(1997-8#6)(2008-10#15)(2008-8#5)(2008-9#7)(2011-2#2)(2012-3#2)(2013-8#1)
P1-derived artificial chromosome##2##3##(1997-8#1)(2008-8#1)
P1-mediated fluorescence postlabeling##2##3##(1991-5#2)
P1/P7##3##1##(2008-10#3)
P11##2##1##(2008-2#1)(2008-3#1)
P130A##2##1##(2008-10#2)
P130A)##2##1##(2008-10#2)
P19 cells##3##2##(1994-11#3)
P19 teratocarcinoma cells##3##3##(1994-11#3)
P19##8##1##(1994-11#6)(1995-2#1)(2011-2#1)
P2 Tin protein##5##3##(1997-3#5)
P2 and P3##2##3##(2008-8#1)(2013-8#1)
P2 and P4##2##3##(1990-11#2)
P2 and##4##2##(1990-11#2)(2008-8#1)(2013-8#1)
P2 is##2##2##(1995-12#2)
P2 protein##3##2##(1995-12#3)
P2 purinoceptor##2##2##(1995-11#2)
P2 receptor##2##2##(1995-8#1)(2013-8#1)
P2##36##1##(1990-11#4)(1995-11#2)(1995-12#5)(1995-8#3)(1996-12#1)(1997-3#7)(2008-11#5)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
P21##2##1##(2008-10#2)
P25##2##1##(2008-10#1)(2013-1#1)
P256 induced##2##2##(1990-5#2)
P256##6##1##(1990-5#6)
P29 and T##2##3##(2008-10#2)
P29##5##1##(2008-10#5)
P2O5##2##1##(2008-12#2)
P2Y##3##1##(1995-11#2)(2013-1#1)
P2Y1##2##1##(1995-11#1)(2013-1#1)
P3 and##3##2##(2008-10#2)(2008-9#1)
P3##20##1##(1994-5#3)(2008-10#8)(2008-8#4)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
P3)##3##1##(1996-12#1)(2008-10#1)(2012-3#1)
P3-6H##2##1##(2008-10#2)
P3-X63-Ag8-653##4##1##(2008-11#4)
P300##4##1##(1991-1#1)(2008-11#3)
P327 and##3##2##(2008-10#3)
P327##4##1##(2008-10#4)
P36##3##1##(1994-11#3)
P37##7##1##(2006-6#7)
P4 cos##2##2##(1990-11#2)
P4 medicine will##2##3##(2013-8#2)
P4 medicine##3##2##(2013-8#3)
P4##6##1##(1990-11#3)(2013-8#3)
P4)##2##1##(2008-10#1)(2011-2#1)
P40##3##1##(2006-6#3)
P426L##2##1##(1997-3#2)
P450 4A4##5##2##(1993-8#5)
P450 active site##2##3##(1994-5#2)
P450 enzyme system##3##3##(2009-9#3)
P450 enzyme##5##2##(2008-10#1)(2009-9#4)
P450 enzymes##4##2##(1994-5#1)(2009-9#3)
P450 families##2##2##(2009-9#2)
P450 forms##5##2##(1994-8#5)
P450 monooxygenases##2##2##(2009-9#2)
P450 oxidoreductase##3##2##(2008-4#1)(2009-9#2)
P450 was##2##2##(1995-11#1)(2008-7#1)
P450##63##1##(1990-5#4)(1991-9#2)(1992-8#3)(1993-8#5)(1994-11#1)(1994-5#4)(1994-8#6)(1995-11#2)(1996-3#3)(2008-10#4)(2008-11#3)(2008-4#3)(2008-7#4)(2008-9#1)(2009-9#17)(2011-1#1)
P450(11beta)-related##2##1##(2008-4#2)
P450IIIA##2##1##(1991-5#2)
P450SCC##4##1##(1997-2#4)
P450c17##4##1##(2008-4#4)
P450cam##4##1##(1993-8#4)
P450s##9##1##(1994-8#1)(2008-9#6)(2009-8#1)(2009-9#1)
P450sccK201E##3##1##(2008-10#3)
P46##2##1##(2008-10#2)
P5 readthrough protein##2##3##(2008-10#2)
P5##5##1##(1994-5#1)(2008-10#3)(2008-3#1)
P50 in transgenic plants was##2##5##(2008-10#2)
P50 plants inoculated with##2##4##(2008-10#2)
P50##7##1##(2008-10#7)
P77PMC##3##1##(2008-8#3)
P8##2##1##(2008-8#2)
P85 alpha##2##2##(1995-6#2)
P89##5##1##(2008-10#5)
P95-2##2##1##(2006-6#2)
P= 0##3##2##(1997-7#3)
P=##4##1##(1997-7#3)(2011-2#1)
P=0##14##1##(1997-7#1)(2008-10#6)(2008-12#2)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
P=95%)##2##1##(2008-10#2)
PA and NA are##2##4##(2008-11#2)
PA and NA##3##3##(2008-11#3)
PA and##7##2##(2008-10#1)(2008-11#3)(2008-8#2)(2012-2#1)
PA in##2##2##(2008-10#1)(2013-1#1)
PA is##2##2##(2008-10#1)(2012-2#1)
PA system##3##2##(2008-10#3)
PA was##2##2##(2008-12#1)(2009-3#1)
PA##48##1##(1995-8#2)(1996-5#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#4)(2009-11#1)(2009-3#3)(2010-1#1)(2012-2#8)(2013-1#2)
PA-d(31) molecules##2##2##(2008-10#2)
PA-d(31)##5##1##(2008-10#5)
PAA complexes##2##2##(2008-10#2)
PAA grafted cellulose membrane##3##4##(2008-10#3)
PAA##9##1##(2008-10#9)
PABA (Cas RN##4##3##(2008-5#4)
PABA (Cas##5##2##(2008-5#5)
PABA##9##1##(1992-11#2)(2008-5#7)
PABzt##2##1##(2008-10#2)
PAC in##2##2##(2008-10#1)(2008-11#1)
PAC##8##1##(1990-12#1)(1997-8#1)(2008-10#4)(2008-11#2)
PAC579##2##1##(2008-8#2)
PACAP##9##1##(1995-11#9)
PACE##6##1##(1992-1#2)(2008-7#4)
PACNS##4##1##(2012-3#4)
PACS##4##1##(1996-2#1)(2012-2#3)
PACs##2##1##(2008-10#2)
PAD and AAC##2##3##(2008-10#2)
PAD and##4##2##(2008-10#3)(2008-8#1)
PAD response to##2##3##(2008-10#2)
PAD waveform##3##2##(2008-10#3)
PAD##17##1##(2008-10#14)(2008-8#3)
PAEC by##2##2##(2008-8#2)
PAEC##5##1##(2008-8#5)
PAEE##3##1##(2013-1#3)
PAEP##2##1##(1993-2#2)
PAF##11##1##(1991-5#2)(2008-11#2)(2009-3#3)(2012-3#2)(2013-1#2)
PAGE##8##1##(1990-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-2#2)
PAH abundance and distribution##2##4##(2008-10#2)
PAH and other mutagenic PAC##2##5##(2008-11#2)
PAH are##2##2##(2008-10#1)(2010-10#1)
PAH in##3##2##(2008-10#2)(2010-10#1)
PAH screening##2##2##(2008-10#2)
PAH##44##1##(1995-11#3)(2008-10#18)(2008-11#4)(2009-10#3)(2010-10#13)(2011-1#3)
PAH-CHD##5##1##(2010-10#5)
PAHs and the##2##3##(2008-10#2)
PAHs by##2##2##(2008-10#2)
PAHs in the aerosols##2##4##(2008-10#2)
PAHs in##12##2##(2008-10#11)(2008-11#1)
PAHs on##2##2##(2008-10#2)
PAHs recoveries##2##2##(2008-10#2)
PAHs tested##2##2##(2008-10#2)
PAHs was##4##2##(2008-10#4)
PAHs were##5##2##(2008-10#5)
PAHs with##4##2##(2008-10#4)
PAHs##73##1##(2008-10#66)(2008-11#6)(2011-1#1)
PAI synthase##2##2##(1995-2#2)
PAI##13##1##(1995-2#10)(2008-10#2)(2008-3#1)
PAI-1 and##3##2##(1995-8#2)(2011-2#1)
PAI-1 antisense ODN##3##3##(2011-2#3)
PAI-1 antisense##4##2##(2011-2#4)
PAI-1##14##1##(1995-8#7)(2011-2#7)
PAIN##2##1##(2008-3#2)
PAK##2##1##(1995-2#1)(2008-10#1)
PAL activity##2##2##(2008-10#2)
PAL##6##1##(1995-5#1)(2008-10#5)
PAM##11##1##(1993-8#4)(1996-3#1)(2008-10#1)(2008-9#3)(2012-12#2)
PAN##9##1##(2008-10#9)
PAN-treated rats##2##2##(2009-6#2)
PAN-treated##4##1##(2009-6#4)
PANDAS##2##1##(2011-2#2)
PANI film was##2##3##(2008-10#2)
PANI film##4##2##(2008-10#4)
PANI##9##1##(2008-10#9)
PAOM is##2##2##(2011-7#2)
PAOM##3##1##(2011-7#3)
PAP can##2##2##(2008-10#2)
PAP in##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
PAP was##2##2##(1990-9#1)(2008-12#1)
PAP##27##1##(1990-9#2)(1995-11#1)(2008-10#9)(2008-11#7)(2008-12#5)(2009-1#2)(2010-7#1)
PAPER##2##1##(2008-10#1)(2010-12#1)
PAPS##2##1##(2008-10#2)
PAPS) and##2##2##(2008-10#2)
PAR and##2##2##(2008-10#1)(2008-7#1)
PAR solution##2##2##(2008-10#2)
PAR##21##1##(2008-10#15)(2008-7#4)(2009-8#2)
PAR-1 and PAFR##2##3##(2009-3#2)
PAR-1##3##1##(2009-3#3)
PAR-insensitive##2##1##(2008-10#2)
PAR-sensitive cultivars##2##2##(2008-10#2)
PAR-sensitive##3##1##(2008-10#3)
PAR1 and PAR2##3##3##(2009-8#3)
PAR1 region##3##2##(2008-7#3)
PAR1##11##1##(2008-7#7)(2009-8#4)
PAR2##7##1##(2008-7#2)(2009-8#5)
PARAFAC analysis of##2##3##(2009-8#2)
PARAFAC analysis##3##2##(2008-10#1)(2009-8#2)
PARAFAC model##3##2##(2008-10#3)
PARAFAC##11##1##(2008-10#9)(2009-8#2)
PARP cleavage##2##2##(2008-12#1)(2009-9#1)
PARP##11##1##(1993-12#5)(2008-12#2)(2009-9#1)(2010-6#3)
PARTICIPANTS##2##1##(2009-10#1)(2011-2#1)
PAS and##2##2##(1996-1#1)(2009-7#1)
PAS in##2##2##(1992-11#1)(1996-1#1)
PAS stain##2##2##(1992-2#1)(2012-3#1)
PAS##10##1##(1992-11#1)(1992-2#1)(1994-2#1)(1996-1#5)(2009-7#1)(2012-3#1)
PASE##2##1##(2008-4#1)(2013-1#1)
PASMCs##5##1##(2011-3#5)
PATIENTS##2##1##(2011-2#2)
PAUP*##6##1##(2008-4#4)(2008-9#2)
PAUP*)##2##1##(2008-4#1)(2008-9#1)
PAV##8##1##(2008-10#8)
PAZoA##3##1##(2008-10#3)
PAl 5##4##2##(2011-2#4)
PB film##3##2##(2008-10#3)
PB films##3##2##(2008-10#3)
PB##22##1##(2008-10#22)
PB-induced##3##1##(1994-8#3)
PB/HC-OES method##3##2##(2010-11#3)
PBB 169##2##2##(2008-10#2)
PBB at##2##2##(2008-10#2)
PBB##11##1##(2008-10#11)
PBD##4##1##(1992-12#4)
PBDEs in##2##2##(2008-10#2)
PBDEs were detected in##2##4##(2008-10#2)
PBDEs were##3##2##(2008-10#3)
PBDEs##13##1##(2008-10#13)
PBDO-700##2##1##(2008-10#2)
PBE0##2##1##(2010-7#2)
PBFD##2##1##(2008-5#2)
PBFR##2##1##(2008-10#2)
PBGS##3##1##(1992-3#3)
PBI derivatives##2##2##(2008-11#2)
PBI##5##1##(2008-11#5)
PBL and TL##2##3##(1995-12#2)
PBL approach##2##2##(2008-11#1)(2008-12#1)
PBL as a teaching and learning strategy##2##7##(2008-11#2)
PBL in##5##2##(2008-12#5)
PBL method##2##2##(2013-8#2)
PBL was##2##2##(2008-11#1)(2008-12#1)
PBL##37##1##(1995-12#2)(2008-10#4)(2008-11#12)(2008-12#12)(2011-1#2)(2013-1#1)(2013-8#4)
PBLs##6##1##(2008-11#6)
PBMC##18##1##(2008-11#5)(2008-7#4)(2010-12#3)(2011-2#6)
PBMCs##5##1##(2008-10#1)(2008-4#1)(2008-7#2)(2011-2#1)
PBN neurons##2##2##(2009-10#2)
PBN##9##1##(1993-6#2)(2009-10#7)
PBQ and##2##2##(2008-10#2)
PBQ##3##1##(2008-10#3)
PBS in##2##2##(2008-10#1)(2008-8#1)
PBS to remove residual media##2##5##(2008-8#2)
PBS was##3##2##(2008-8#3)
PBS##19##1##(2008-10#4)(2008-11#2)(2008-8#11)(2010-1#1)(2012-3#1)
PBS)##2##1##(1990-12#1)(2013-1#1)
PBT cells for apoptosis##2##4##(1995-2#2)
PBT cells##8##2##(1995-2#8)
PBTC##2##1##(2010-5#2)
PC and##5##2##(1995-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
PC bound##2##2##(2008-10#2)
PC exposure##5##2##(2012-3#5)
PC hydrolysis##3##2##(1991-5#3)
PC is##3##2##(2008-10#2)(2008-7#1)
PC or BCP mutations##5##4##(2013-1#5)
PC software##2##2##(1994-2#1)(1994-3#1)
PC##56##1##(1991-5#3)(1993-8#2)(1994-2#2)(1994-3#1)(1995-11#2)(1995-8#6)(2008-10#14)(2008-6#1)(2008-7#4)(2009-8#1)(2010-9#1)(2011-2#3)(2012-3#6)(2013-1#10)
PC-3 prostate cancer##2##3##(2008-8#1)(2010-6#1)
PC-ACP##2##1##(2010-4#2)
PC-FILE##2##1##(1991-3#2)
PC-PLC##2##1##(1997-2#2)
PC-based##3##1##(1994-2#1)(2008-10#2)
PC12 and##2##2##(1993-8#1)(2008-11#1)
PC12 cell differentiation##3##3##(2008-11#3)
PC12 cell##6##2##(2008-11#4)(2013-8#2)
PC12 cells and##2##3##(1993-8#1)(1997-2#1)
PC12 cells by##2##3##(2008-11#2)
PC12 cells were##4##3##(1993-8#1)(2008-11#3)
PC12 cells##37##2##(1990-8#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-8#4)(1995-12#1)(1997-2#2)(2008-11#23)(2009-9#1)(2013-8#1)
PC12 pheochromocytoma cells##4##3##(1995-2#1)(1997-2#1)(2008-11#2)
PC12##59##1##(1990-8#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-8#5)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#3)(2008-11#39)(2009-9#1)(2013-8#3)
PC12D##3##1##(2008-11#3)
PCA and##3##2##(2008-10#2)(2008-6#1)
PCA is##4##2##(2008-10#2)(2010-7#2)
PCA to##2##2##(1997-6#1)(2008-10#1)
PCA was##3##2##(1995-11#1)(2008-10#2)
PCA##35##1##(1992-6#1)(1995-11#1)(1997-3#1)(1997-6#1)(2008-10#24)(2008-6#1)(2008-7#1)(2010-7#2)(2011-1#2)(2012-3#1)
PCAs##2##1##(1997-6#2)
PCB##14##1##(2008-10#11)(2008-11#1)(2012-2#1)(2013-1#1)
PCBs and PCDD/Fs##2##3##(2008-10#2)
PCBs and##6##2##(1994-3#1)(2008-10#4)(2008-11#1)
PCBs in##7##2##(2008-10#6)(2008-11#1)
PCBs##27##1##(1994-3#1)(2008-10#22)(2008-11#4)
PCC 7120##5##2##(2008-8#5)
PCC##9##1##(1996-12#2)(1996-6#2)(2008-8#5)
PCC7002##3##1##(1995-6#1)(1997-4#2)
PCCC data##2##2##(2010-6#2)
PCCC##4##1##(2010-6#4)
PCCM##2##1##(1994-3#2)
PCCOs##2##1##(1997-3#2)
PCDD/F + 4##2##3##(2008-10#2)
PCDD/F mixture##2##2##(2008-10#2)
PCDD/F##10##1##(2008-10#10)
PCDD/Fs and##3##2##(2008-10#3)
PCDD/Fs##7##1##(2008-10#7)
PCDDs/PCDFs and##3##2##(2008-10#3)
PCDFs##3##1##(2008-10#3)
PCE and##2##2##(1993-8#1)(2008-10#1)
PCE##3##1##(1993-8#2)(2008-10#1)
PCFV is##3##2##(2008-10#3)
PCFV##7##1##(2008-10#7)
PCI##2##1##(2011-2#2)
PCIOL##2##1##(2011-2#2)
PCL reconstruction##3##2##(2013-1#3)
PCL##4##1##(2013-1#4)
PCLCL##3##1##(2012-3#3)
PCNA gene##3##2##(1995-6#3)
PCNA##12##1##(1994-12#4)(1995-6#5)(2009-8#1)(2011-2#2)
PCNL##3##1##(2008-12#2)(2012-12#1)
PCNSL##2##1##(2008-7#2)
PCOS is##2##2##(2008-4#2)
PCOS to be##2##3##(2008-4#2)
PCOS##15##1##(2008-4#14)(2010-11#1)
PCP in soils##2##3##(2008-10#2)
PCP in##5##2##(2008-10#4)(2009-3#1)
PCP using##2##2##(2008-10#1)(2009-3#1)
PCP was##2##2##(2008-10#2)
PCP##17##1##(1991-1#1)(2008-10#11)(2009-3#5)
PCR Amplification##2##2##(2008-10#1)(2008-12#1)
PCR also##3##2##(2008-10#3)
PCR amplicons##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
PCR amplification with##4##3##(1996-8#1)(2008-10#3)
PCR amplification##14##2##(1993-12#2)(1993-9#1)(1996-12#1)(1996-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#2)(2011-2#1)
PCR amplifications##3##2##(1993-6#1)(1997-6#1)(2008-8#1)
PCR amplified##3##2##(1993-12#1)(2008-10#2)
PCR analysis and##2##3##(2008-9#1)(2009-8#1)
PCR analysis of##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
PCR analysis##10##2##(1993-2#1)(1997-3#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
PCR and PLS##2##3##(2008-10#2)
PCR and Southern##2##3##(2008-10#1)(2008-8#1)
PCR and immunofluorescence##2##3##(2008-5#1)(2011-2#1)
PCR and##30##2##(1994-8#3)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#9)(2008-12#1)(2008-4#2)(2008-5#3)(2008-8#5)(2008-9#1)(2011-2#2)(2013-1#1)
PCR assay for the##2##4##(1995-6#1)(2008-12#1)
PCR assay provides##2##3##(2008-10#2)
PCR assay using the##2##4##(2008-10#2)
PCR assay was##2##3##(2010-4#1)(2013-8#1)
PCR assay##21##2##(1995-6#1)(2008-10#13)(2008-12#1)(2008-5#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
PCR assays were also##2##4##(2008-10#2)
PCR assays were developed##3##4##(2008-10#3)
PCR assays were##7##3##(2008-10#6)(2012-2#1)
PCR assays##26##2##(2008-10#21)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#2)
PCR cloning##3##2##(1993-2#1)(2008-8#1)(2011-1#1)
PCR detection##3##2##(2008-10#2)(2008-8#1)
PCR for##5##2##(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#2)
PCR fragments##3##2##(2008-10#3)
PCR from the##2##3##(1995-8#1)(1996-8#1)
PCR from##4##2##(1995-8#1)(1996-8#1)(2008-9#1)(2011-2#1)
PCR has##2##2##(2008-10#1)(2008-5#1)
PCR in the##3##3##(1994-1#1)(2008-10#1)(2011-2#1)
PCR in##14##2##(1993-6#1)(1994-1#2)(1995-11#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2011-2#2)
PCR inhibitors##2##2##(1996-12#1)(2008-11#1)
PCR is a##2##3##(1993-6#1)(2011-2#1)
PCR is##6##2##(1993-6#1)(1996-8#1)(1997-7#1)(2008-10#2)(2011-2#1)
PCR method and##2##3##(1995-6#1)(2008-9#1)
PCR method##7##2##(1994-11#1)(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-8#1)
PCR or##5##2##(1995-2#1)(1997-3#1)(2008-10#2)(2008-2#1)
PCR positive##4##2##(2008-10#2)(2008-12#1)(2010-1#1)
PCR primer##2##2##(2008-10#2)
PCR primers to##2##3##(2008-10#2)
PCR primers were##2##3##(2008-10#2)
PCR primers##10##2##(2008-10#9)(2008-9#1)
PCR procedures##2##2##(2008-10#1)(2011-2#1)
PCR product##12##2##(1993-12#1)(1997-7#1)(2008-10#7)(2008-4#1)(2008-9#2)
PCR products for##3##3##(2008-10#1)(2008-4#2)
PCR products from##4##3##(1993-3#1)(1994-11#1)(1997-3#1)(2008-10#1)
PCR products of the##2##4##(1992-8#2)
PCR products of##4##3##(1992-8#2)(2008-10#2)
PCR products were##8##3##(1997-3#2)(2008-10#6)
PCR products with##2##3##(1993-6#1)(2008-10#1)
PCR products##30##2##(1992-8#3)(1993-3#1)(1993-6#1)(1994-11#1)(1996-6#2)(1997-3#3)(2008-10#15)(2008-4#2)(2008-9#2)
PCR protocol##2##2##(2008-10#1)(2008-12#1)
PCR reaction##3##2##(1994-11#1)(2008-10#2)
PCR reactions##2##2##(2008-10#1)(2008-11#1)
PCR restriction##2##2##(1997-3#1)(2008-10#1)
PCR result##2##2##(2008-10#1)(2011-2#1)
PCR results##2##2##(2008-10#1)(2009-6#1)
PCR revealed##2##2##(2008-11#1)(2013-1#1)
PCR strategy##2##2##(1993-12#1)(2010-5#1)
PCR technique##6##2##(1991-5#1)(1995-12#1)(2008-10#2)(2008-8#2)
PCR technology##2##2##(2008-11#1)(2008-9#1)
PCR to##6##2##(1994-11#1)(1995-2#1)(2008-10#2)(2008-8#1)(2010-7#1)
PCR using a##2##3##(1995-8#1)(1997-7#1)
PCR using##7##2##(1995-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)(2010-4#1)(2011-2#1)
PCR was##8##2##(1993-6#1)(1994-1#1)(1995-12#1)(2008-10#4)(2010-6#1)
PCR were##3##2##(2008-10#2)(2008-8#1)
PCR with specific##2##3##(2008-10#1)(2008-5#1)
PCR with the##2##3##(2008-10#2)
PCR with##13##2##(1996-6#1)(1997-2#3)(2008-10#6)(2008-12#2)(2008-5#1)
PCR##423##1##(1990-8#1)(1991-5#2)(1991-9#1)(1992-6#1)(1992-8#3)(1993-12#8)(1993-2#2)(1993-3#3)(1993-6#5)(1993-9#1)(1994-1#6)(1994-11#7)(1994-5#1)(1994-8#3)(1995-11#3)(1995-12#3)(1995-2#2)(1995-6#2)(1995-8#3)(1996-12#4)(1996-6#3)(1996-8#6)(1997-2#5)(1997-3#6)(1997-6#1)(1997-7#3)(1997-8#2)(2008-10#185)(2008-11#9)(2008-12#19)(2008-2#2)(2008-4#9)(2008-5#9)(2008-7#1)(2008-8#24)(2008-9#22)(2009-6#1)(2009-8#2)(2010-1#2)(2010-11#2)(2010-4#3)(2010-5#3)(2010-6#5)(2010-7#1)(2011-1#3)(2011-2#18)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#4)
PCR-DGGE patterns##2##2##(2008-10#2)
PCR-ELISA##3##1##(2008-12#3)
PCR-RFLP and##2##2##(2008-10#2)
PCR-RFLP methods##2##2##(2008-12#2)
PCR-RFLP on the##2##3##(2008-12#2)
PCR-RFLP##15##1##(1997-8#1)(2008-10#7)(2008-12#4)(2008-8#1)(2012-2#2)
PCR-amplified##11##1##(1991-7#1)(1993-12#1)(1993-6#1)(1997-4#1)(2008-10#6)(2008-9#1)
PCR-based assay##5##2##(2008-10#4)(2008-4#1)
PCR-based methods to detect##2##4##(1994-11#1)(2011-2#1)
PCR-based methods##3##2##(1994-11#1)(2008-10#1)(2011-2#1)
PCR-based##26##1##(1994-11#2)(1995-11#2)(1995-6#1)(1997-2#2)(1997-8#2)(2008-10#9)(2008-12#1)(2008-4#2)(2008-9#2)(2009-10#1)(2010-4#1)(2011-2#1)
PCR-mediated##2##1##(1995-8#1)(2008-9#1)
PCR-positive##2##1##(2008-10#1)(2008-8#1)
PCR-ribotype 027##2##2##(2011-2#2)
PCRs##4##1##(2008-7#1)(2011-2#3)
PCS##8##1##(1995-5#1)(2011-2#1)(2012-3#1)(2013-1#5)
PCSG##2##1##(2009-5#2)
PCSGs##3##1##(2009-5#3)
PCSK9 and##2##2##(2013-1#2)
PCSK9 deficiency##2##2##(2013-1#2)
PCSK9##5##1##(2013-1#5)
PCT##4##1##(2008-10#1)(2008-11#2)(2010-2#1)
PCTs##2##1##(2008-11#2)
PCV##2##1##(2008-10#1)(2008-5#1)
PCa cells##6##2##(2013-1#6)
PCa##8##1##(2013-1#8)
PCs##11##1##(1994-2#5)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#2)
PCu##3##1##(1990-5#3)
PD 146923##2##2##(1997-2#2)
PD and##14##2##(1990-5#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#3)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
PD are##2##2##(2011-2#1)(2013-8#1)
PD catheter##4##2##(2011-2#4)
PD dementia##3##2##(2008-7#3)
PD has increased##2##3##(2008-7#1)(2013-8#1)
PD height loss##3##3##(2011-2#3)
PD in##6##2##(2008-10#3)(2008-12#1)(2009-10#1)(2011-2#1)
PD is a##2##3##(2008-7#2)
PD is##8##2##(2008-10#1)(2008-6#1)(2008-7#3)(2010-12#1)(2011-2#1)(2013-8#1)
PD model##2##2##(2008-10#1)(2008-12#1)
PD patients and##3##3##(2008-7#3)
PD patients as well as##2##5##(2008-7#2)
PD patients have##2##3##(2008-7#2)
PD patients showed##3##3##(2008-7#3)
PD patients were##2##3##(2008-7#1)(2009-10#1)
PD patients with##2##3##(2008-7#2)
PD patients##41##2##(2008-7#31)(2009-10#3)(2011-2#7)
PD phytoplasma##3##2##(2008-10#3)
PD therapy##5##2##(2011-2#5)
PD##182##1##(1990-2#1)(1990-5#1)(1997-2#2)(2008-10#20)(2008-12#14)(2008-6#5)(2008-7#76)(2008-8#3)(2009-10#4)(2010-12#2)(2010-8#2)(2011-2#38)(2013-1#6)(2013-7#3)(2013-8#5)
PD+HD therapy##9##2##(2011-2#9)
PD-1 blockade##3##2##(2010-5#3)
PD-1##5##1##(2010-5#4)(2012-3#1)
PD-L1 protein##2##2##(2012-3#2)
PD-L1##9##1##(2012-3#9)
PD-infected##2##1##(2008-10#2)
PD98059 and##2##2##(1996-2#1)(2011-2#1)
PD98059##5##1##(1996-2#1)(2011-2#3)(2013-1#1)
PDA and##2##2##(2008-10#2)
PDA is##2##2##(2008-10#1)(2012-2#1)
PDA##23##1##(2008-10#10)(2008-12#4)(2010-4#1)(2012-12#3)(2012-2#5)
PDAC##2##1##(2013-1#2)
PDB##4##1##(2008-10#1)(2011-3#3)
PDC##3##1##(2008-10#3)
PDDG/PM3##4##1##(2008-11#4)
PDF1##4##1##(2009-8#4)
PDFs##2##1##(2008-10#2)
PDG##2##1##(2013-1#2)
PDGF beta receptor##2##3##(1994-6#2)
PDGF stimulation##2##2##(1994-6#1)(1997-7#1)
PDGF##13##1##(1994-6#5)(1995-11#3)(1997-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
PDGF-B##2##1##(2008-9#2)
PDGF-BB##8##1##(1991-12#2)(1995-8#1)(1997-7#3)(2008-10#2)
PDGF-betaR##5##1##(1997-7#5)
PDGF-betaR-mediated##3##1##(1997-7#3)
PDGF-betaRWT##3##1##(1997-7#3)
PDGF-induced##3##1##(1994-6#2)(1995-11#1)
PDGFB-driven##3##1##(2013-1#3)
PDGFR##2##1##(2009-7#1)(2013-1#1)
PDGFRA##4##1##(2013-1#3)(2013-8#1)
PDH##3##1##(1994-11#2)(1997-7#1)
PDI = 1##2##3##(2008-12#2)
PDI clusters##2##2##(2013-1#2)
PDI##11##1##(2008-12#2)(2008-3#2)(2013-1#7)
PDL cell lines##2##3##(2008-11#2)
PDL cells##3##2##(2013-1#3)
PDL##14##1##(1995-8#1)(2008-11#8)(2008-3#2)(2013-1#3)
PDMCs##4##1##(2008-9#4)
PDMDAAC-SiO(2)##3##1##(2008-10#3)
PDMS fiber##3##2##(2008-10#3)
PDMS microchannel##3##2##(2008-10#3)
PDMS microfluidic##2##2##(2008-10#2)
PDMS##16##1##(2008-10#13)(2008-5#3)
PDMS/DVB##5##1##(2008-10#5)
PDR##3##1##(2008-10#2)(2008-11#1)
PDS gene##3##2##(1995-2#1)(2011-1#2)
PDS##12##1##(1995-2#4)(2008-9#1)(2011-1#6)(2011-2#1)
PDSI demonstrated##2##2##(2008-7#2)
PDSI##4##1##(2008-7#4)
PDT##8##1##(1994-1#3)(2009-4#1)(2012-3#3)(2013-8#1)
PDTC##6##1##(2008-3#2)(2012-3#4)
PDV was##2##2##(2008-10#2)
PDV##7##1##(1993-12#2)(2008-10#5)
PDZ##2##1##(2011-2#2)
PDZ-binding domain##3##2##(2011-2#3)
PE and##2##2##(2012-2#2)
PE and/or DVT##4##3##(2012-2#4)
PE and/or##5##2##(2012-2#5)
PE##25##1##(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#2)(2008-9#1)(2011-2#9)(2012-2#9)
PEA3##4##1##(1994-11#1)(1997-7#1)(1997-8#2)
PEBBLE##2##1##(2008-10#2)
PEBBLEs##2##1##(2008-10#2)
PEC##3##1##(2008-8#3)
PED##5##1##(1992-5#1)(2011-2#4)
PEDF levels##4##2##(2012-5#4)
PEDF##9##1##(2012-5#9)
PEFR and##3##2##(2008-7#2)(2012-2#1)
PEFR##5##1##(1996-1#2)(2008-7#2)(2012-2#1)
PEG 6000##4##2##(2008-10#1)(2008-12#3)
PEG and##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
PEG hydrogel##7##2##(2012-3#7)
PEG molar##2##2##(2011-2#2)
PEG##37##1##(1990-12#1)(2008-10#14)(2008-12#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#4)(2012-3#7)
PEG-600 when##2##2##(2008-10#2)
PEG-600##3##1##(2008-10#3)
PEG-rich phase##3##2##(2008-10#1)(2011-2#2)
PEHR##3##1##(2010-4#3)
PEHRs##2##1##(2010-4#2)
PEI 25 kDa##2##3##(2008-11#2)
PEI but not##2##3##(2008-10#2)
PEI concentration##2##2##(2008-10#2)
PEI soils##2##2##(2008-10#2)
PEI were##2##2##(1992-9#2)
PEI##19##1##(1992-11#1)(1992-9#2)(2008-10#10)(2008-11#6)
PENs##2##1##(2011-2#2)
PEO##3##1##(2008-10#3)
PEP##7##1##(1997-3#1)(2009-12#6)
PEPCK gene transcription##4##3##(1996-2#4)
PEPCK gene##7##2##(1996-2#7)
PER1##2##1##(2008-10#2)
PET D/P Cr##2##3##(2011-2#2)
PET and CT##2##3##(2012-12#2)
PET and##4##2##(2011-1#1)(2012-12#2)(2012-2#1)
PET imaging##6##2##(2010-6#2)(2011-2#3)(2013-1#1)
PET studies##2##2##(1991-1#1)(2008-7#1)
PET tracers##2##2##(2008-1#2)
PET##38##1##(1991-1#1)(1992-11#2)(1995-2#2)(1995-5#1)(1996-2#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-6#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#4)
PET/CT fusion##2##2##(2009-2#2)
PET/CT##12##1##(2009-2#6)(2009-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
PET/MRI##3##1##(2012-2#3)
PETE1##2##1##(2009-10#2)
PETE2 in the##2##3##(2009-10#2)
PETE2##4##1##(2009-10#4)
PETN##5##1##(2008-10#3)(2008-3#2)
PEUs##5##1##(2008-11#5)
PEX##2##1##(2011-2#2)
PF contact loading##2##3##(2011-2#2)
PF contact##3##2##(2011-2#3)
PF loading##4##2##(2011-2#4)
PF##12##1##(1990-12#1)(2008-10#2)(2011-2#9)
PF-68##4##1##(2011-2#4)
PFA##2##1##(1996-2#1)(2007-8#1)
PFBBr derivatization##2##2##(2008-10#2)
PFBBr##7##1##(2008-10#7)
PFBV##3##1##(2008-10#3)
PFC and##3##2##(2013-8#3)
PFC regions##2##2##(2013-8#2)
PFC##27##1##(1993-12#2)(1996-5#3)(1997-2#7)(2008-11#4)(2008-4#2)(2013-8#9)
PFC-HC##2##1##(2013-8#2)
PFCA##3##1##(1994-2#1)(1997-3#1)(2013-1#1)
PFD##2##1##(1993-12#1)(2010-10#1)
PFDA treatment##2##2##(1994-8#2)
PFDA##6##1##(1994-8#6)
PFE locus##2##2##(2008-9#2)
PFE##7##1##(2008-9#7)
PFG-3##3##1##(2008-11#3)
PFG-3-1##2##1##(2008-11#2)
PFG-4##2##1##(2008-11#2)
PFGE analysis##4##2##(1993-12#1)(2008-10#3)
PFGE##11##1##(1992-6#2)(1993-12#2)(2008-10#6)(2008-4#1)
PFI##2##1##(2008-10#1)(2013-8#1)
PFK-1##2##1##(1994-3#2)
PFK-2##2##1##(1994-3#2)
PFK1##2##1##(1996-3#2)
PFLP##4##1##(2008-10#4)
PFO was##2##2##(2008-7#1)(2011-2#1)
PFO##4##1##(2008-7#2)(2011-2#2)
PFR##2##1##(2008-7#2)
PFS##11##1##(1991-8#1)(2008-10#7)(2008-11#3)
PFT##3##1##(1995-2#2)(2012-2#1)
PFTase##3##1##(1993-9#3)
PG activity and the##2##4##(2008-10#2)
PG activity and##3##3##(2008-10#3)
PG activity##4##2##(2008-10#4)
PG and##2##2##(2008-11#2)
PG electrodes was greatly##2##4##(2008-10#2)
PG in PD##2##3##(2013-8#2)
PG in##4##2##(2011-10#1)(2013-1#1)(2013-8#2)
PG increased##2##2##(2008-11#2)
PG isozymes##6##2##(2008-10#6)
PG students##3##2##(2013-1#3)
PG was##2##2##(1990-2#1)(2008-11#1)
PG##57##1##(1990-2#10)(2008-10#19)(2008-11#11)(2008-8#6)(2011-10#1)(2011-2#1)(2013-1#4)(2013-8#5)
PGA##4##1##(2008-12#1)(2009-7#1)(2009-8#1)(2011-2#1)
PGC-1alpha##5##1##(2008-1#5)
PGCs (male PGCs to##2##4##(2008-11#2)
PGCs to female##2##3##(2008-11#2)
PGCs to male##2##3##(2008-11#2)
PGCs to##4##2##(2008-11#4)
PGCs##14##1##(2008-11#14)
PGD##3##1##(2012-3#3)
PGE##10##1##(1994-6#4)(2008-11#5)(2008-8#1)
PGE(2) and TXB(2)##3##3##(2008-10#3)
PGE(2) and##4##2##(2008-10#3)(2008-11#1)
PGE(2)##9##1##(2008-10#3)(2008-11#3)(2008-8#1)(2012-2#2)
PGE-processing plants##3##2##(2008-11#3)
PGE-processing##4##1##(2008-11#4)
PGE1 and##2##2##(1993-12#1)(1994-2#1)
PGE1##6##1##(1993-12#2)(1993-8#1)(1994-2#3)
PGE2##14##1##(1990-11#2)(1993-12#2)(1995-11#1)(1997-1#2)(1997-2#6)(2008-5#1)
PGEs##4##1##(2008-10#4)
PGF(2alpha)##3##1##(2008-8#3)
PGGT-I##3##1##(1995-2#3)
PGH synthase-1##2##2##(1992-3#2)
PGI##2##1##(2010-10#2)
PGI2##2##1##(1994-5#1)(1995-11#1)
PGIP##2##1##(2008-10#2)
PGIPs##4##1##(2011-10#4)
PGMs and gold##2##3##(2008-10#2)
PGMs##3##1##(2008-10#3)
PGPR strains##5##2##(2008-10#5)
PGPR##8##1##(2008-10#8)
PGs##5##1##(1990-2#2)(1994-8#1)(2008-11#1)(2011-10#1)
PGx in##2##2##(2010-8#2)
PGx##5##1##(2010-8#5)
PH unit##2##2##(2008-3#2)
PH##18##1##(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-9#2)(2009-7#2)(2010-10#4)(2011-1#3)
PH(3)##3##1##(2008-10#3)
PHA and##3##2##(1995-8#2)(2011-2#1)
PHA##10##1##(1995-8#2)(2011-2#1)(2013-1#7)
PHB accumulation##2##2##(2008-7#2)
PHB concentration##2##2##(2008-7#2)
PHB##9##1##(2008-10#4)(2008-7#5)
PHF##2##1##(1992-6#2)
PHFs##2##1##(1992-6#2)
PHGPx##2##1##(2009-10#2)
PHM##2##1##(2008-10#2)
PHMB##4##1##(2008-10#4)
PHP##4##1##(2010-6#2)(2011-1#2)
PHR1##4##1##(1996-3#4)
PHS##4##1##(2012-3#4)
PHV and PepGMV##2##3##(2008-10#2)
PHV and##3##2##(2008-10#2)(2008-5#1)
PHV##8##1##(2008-10#4)(2008-5#4)
PHWE##2##1##(2008-10#2)
PI 255956##2##2##(2008-10#2)
PI 271322##2##2##(2008-10#2)
PI 3-kinase activity##3##3##(1994-11#3)
PI 3-kinase and##2##3##(1994-11#1)(1995-8#1)
PI 3-kinase is##3##3##(1994-11#1)(1996-2#1)(2008-11#1)
PI 3-kinase##14##2##(1994-11#8)(1995-8#1)(1996-2#2)(2008-11#3)
PI 345629##2##2##(2008-10#2)
PI 378159##3##2##(2008-10#3)
PI 478214##2##2##(2008-10#2)
PI 535278##2##2##(2008-10#2)
PI 548708##3##2##(2008-10#3)
PI 548734##3##2##(2008-10#3)
PI 548747##3##2##(2008-10#3)
PI 88788##7##2##(2008-10#7)
PI 94749##2##2##(2012-3#2)
PI and##2##2##(1996-2#1)(1996-6#1)
PI indices of##3##3##(2009-3#3)
PI polynomial of##3##3##(2009-3#3)
PI##91##1##(1990-5#1)(1992-12#1)(1994-11#10)(1995-8#1)(1996-1#2)(1996-2#7)(1996-6#1)(1997-3#1)(2008-10#44)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#4)(2009-3#6)(2009-6#1)(2009-8#1)(2012-3#2)(2013-1#1)
PI#555543##2##1##(2008-10#2)
PI#555573##2##1##(2008-10#2)
PI-PLC##4##1##(1993-8#1)(1995-8#3)
PI-increases upon##2##2##(2009-6#2)
PI134417##2##1##(2008-10#2)
PI3-kinases##2##1##(1996-2#2)
PI3K##7##1##(1996-2#6)(2012-3#1)
PI4##4##1##(2013-1#4)
PI478742##2##1##(2008-10#2)
PIBs production##2##2##(2008-11#2)
PIBs##9##1##(2008-11#9)
PIC and HET values of 0##3##6##(2008-12#3)
PIC##6##1##(2008-12#3)(2010-3#1)(2011-2#2)
PICA##3##1##(2008-7#3)
PICP##3##1##(1997-1#3)
PICs##3##1##(2008-1#2)(2008-8#1)
PIF##2##1##(2008-10#1)(2009-8#1)
PIGN##2##1##(2011-2#2)
PIH##11##1##(1994-3#6)(2012-2#5)
PII fractions##2##2##(1996-2#2)
PILP##5##1##(2009-11#5)
PIP##2##1##(2008-9#2)
PIP(2)##2##1##(2008-8#2)
PIP(3)##4##1##(2008-11#4)
PIP2##7##1##(1992-12#1)(1993-6#3)(1993-8#3)
PIP2-mediated##3##1##(1993-6#3)
PIP3 was##2##2##(1993-8#2)
PIP3##7##1##(1993-8#7)
PIPKIα##2##1##(2013-1#2)
PIPKs##2##1##(2013-1#2)
PIS##2##1##(2008-10#2)
PIT##2##1##(2010-8#2)
PIV insertion##3##2##(2012-2#3)
PIV##4##1##(2012-2#4)
PIs##2##1##(2008-12#1)(2009-6#1)
PK and Verysise##2##3##(2011-2#2)
PK and implantation of##2##4##(2011-2#2)
PK and##4##2##(2011-2#4)
PK##15##1##(1993-9#2)(2008-7#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#3)
PK11195##4##1##(2012-2#4)
PKA activity levels##3##3##(2008-10#3)
PKA activity##5##2##(2008-10#5)
PKA with##2##2##(1994-8#2)
PKA##25##1##(1993-3#2)(1994-8#8)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-7#2)(2011-2#2)
PKA-mediated phosphorylation of##2##3##(2010-1#1)(2011-2#1)
PKA-mediated##3##1##(1995-2#1)(2010-1#1)(2011-2#1)
PKC activator##2##2##(1995-11#2)
PKC activity##6##2##(1992-8#1)(1993-8#2)(1997-2#1)(2008-10#1)(2008-11#1)
PKC and##4##2##(1991-5#1)(1995-6#1)(1995-8#1)(2009-7#1)
PKC by##3##2##(1996-12#1)(1997-1#1)(2008-8#1)
PKC delta##2##2##(1992-9#2)
PKC epsilon##7##2##(1995-2#7)
PKC gamma##3##2##(1993-12#2)(2013-8#1)
PKC gamma-mutant mice##2##3##(1993-12#2)
PKC in##6##2##(1994-6#2)(1996-12#1)(1997-1#2)(2008-8#1)
PKC inhibitor##3##2##(1993-3#1)(1995-11#1)(1997-1#1)
PKC inhibitors##3##2##(1993-3#1)(1994-6#1)(1997-1#1)
PKC isozymes##2##2##(1995-2#1)(1996-6#1)
PKC pathway##2##2##(1996-12#1)(1997-1#1)
PKC plays a##2##3##(1993-3#1)(1997-7#1)
PKC##84##1##(1990-5#2)(1991-5#3)(1992-12#3)(1992-8#1)(1992-9#2)(1993-12#6)(1993-3#5)(1993-8#4)(1994-11#1)(1994-5#1)(1994-6#6)(1994-8#2)(1995-11#3)(1995-2#8)(1995-6#1)(1995-8#5)(1996-12#3)(1996-6#1)(1997-1#6)(1997-2#1)(1997-7#1)(1997-9#1)(2008-10#1)(2008-11#6)(2008-8#7)(2008-9#1)(2009-7#1)(2013-8#2)
PKC-alpha##3##1##(1994-6#3)
PKC-zeta##3##1##(1994-6#3)
PKC-α phosphorylation##3##2##(2012-3#3)
PKC-α siRNA##2##2##(2012-3#2)
PKC-α##7##1##(2012-3#7)
PKCalpha translocation##2##2##(2008-9#2)
PKCalpha was##3##2##(2008-9#3)
PKCalpha##7##1##(2008-9#7)
PKCγ and##2##2##(2013-8#2)
PKCγ##4##1##(2013-8#4)
PKI##4##1##(1995-2#4)
PKL##2##1##(2009-8#2)
PKs##3##1##(1993-2#3)
PL##3##1##(1991-12#1)(1993-8#1)(2008-12#1)
PL-3##2##1##(2008-10#2)
PLA2 activation##2##2##(1994-6#2)
PLA2##5##1##(1990-8#1)(1994-6#4)
PLC##2##1##(1993-8#1)(2011-2#1)
PLC-gamma 1##3##2##(1992-7#3)
PLC-gamma##5##1##(1992-7#3)(1997-7#2)
PLCgamma2##5##1##(2008-11#5)
PLD activity in##2##3##(1995-8#2)
PLD activity##3##2##(1995-8#3)
PLD##8##1##(1995-8#7)(2011-2#1)
PLE##4##1##(1990-2#2)(2008-10#2)
PLFF##2##1##(2012-2#2)
PLGA particles##6##2##(2009-7#6)
PLGA##9##1##(2009-7#9)
PLL##7##1##(1991-5#1)(2008-10#5)(2008-11#1)
PLLA##3##1##(2009-7#3)
PLMDs##3##1##(2012-3#3)
PLP##4##1##(2009-6#4)
PLRV in extracts of infected potato##2##6##(2008-10#2)
PLRV##12##1##(2008-10#12)
PLS and ANN##2##3##(2008-10#2)
PLS and##4##2##(2008-10#4)
PLS calibration##3##2##(2008-10#3)
PLS components##2##2##(2008-5#2)
PLS discriminant analysis and##2##4##(2008-5#2)
PLS regression##4##2##(2008-10#4)
PLS##46##1##(1994-12#1)(2008-10#40)(2008-5#5)
PLS)##2##1##(2008-10#2)
PLS-1 and##3##2##(2008-10#3)
PLS-1 method##2##2##(2008-10#2)
PLS-1 models were##2##3##(2008-10#2)
PLS-1 models##3##2##(2008-10#3)
PLS-1 regression##2##2##(2008-10#2)
PLS-1##16##1##(2008-10#16)
PLS-2 and PCR##2##3##(2008-10#2)
PLS-2##4##1##(2008-10#4)
PLS-DA##4##1##(2008-10#4)
PLZF##2##1##(2011-2#2)
PM 10##2##2##(2008-11#2)
PM 1648 and PM(2##4##4##(2008-10#4)
PM 1648 and##5##3##(2008-10#5)
PM 1648##10##2##(2008-10#10)
PM and##3##2##(1994-12#1)(2008-7#2)
PM in the##2##3##(2008-7#2)
PM of WGA-fed larvae##2##4##(2008-7#2)
PM of##3##2##(2008-7#3)
PM##48##1##(1994-12#2)(2008-10#19)(2008-11#4)(2008-7#20)(2009-7#2)(2011-2#1)
PM(10) concentrations##2##2##(2009-7#2)
PM(10)##6##1##(2008-10#2)(2009-7#4)
PM(2##13##1##(2008-10#5)(2008-5#8)
PM-DRGs##3##1##(1993-12#3)
PM10 concentrations##2##2##(2011-2#2)
PM10##9##1##(2008-10#1)(2009-7#1)(2011-2#7)
PM3##8##1##(1996-5#2)(2008-10#3)(2008-11#3)
PMA and that##2##3##(1995-2#1)(2008-11#1)
PMA and##5##2##(1993-6#2)(1995-2#1)(1997-1#1)(2008-11#1)
PMA was##2##2##(1994-6#1)(1995-11#1)
PMA were##2##2##(1995-6#1)(1997-1#1)
PMA##34##1##(1993-6#6)(1994-3#1)(1994-6#4)(1994-8#5)(1995-11#1)(1995-2#2)(1995-6#3)(1996-2#2)(1997-1#5)(2006-6#3)(2008-11#2)
PMA-induced MAPK##2##2##(1995-6#2)
PMA-induced##8##1##(1993-6#1)(1994-8#2)(1995-6#2)(2008-11#3)
PMBCL##6##1##(2009-8#6)
PMBCLs##2##1##(2009-8#2)
PMC##5##1##(1992-3#2)(2008-5#1)(2013-1#2)
PMCs##4##1##(2013-1#4)
PMD##3##1##(2007-11#2)(2007-12#1)
PME production##2##2##(1991-9#2)
PME##8##1##(1991-9#7)(2008-8#1)
PMET##4##1##(2009-9#4)
PML##5##1##(1991-9#4)(2013-1#1)
PML-RAR protein##2##2##(1991-9#2)
PML-RAR##3##1##(1991-9#3)
PMM and##2##2##(2007-12#2)
PMM##6##1##(2007-12#6)
PMMA microchip##2##2##(2008-10#2)
PMMA##4##1##(2008-10#3)(2010-4#1)
PMMoV##2##1##(2008-10#2)
PMN functional##2##2##(1991-2#1)(1995-6#1)
PMN##11##1##(1991-2#3)(1993-3#1)(1995-6#2)(2008-10#4)(2008-12#1)
PMNLs IP3 formation##2##3##(1993-1#2)
PMNLs and##5##2##(1993-1#1)(2010-1#4)
PMNLs##8##1##(1993-1#4)(2010-1#4)
PMNs and##3##2##(2009-10#3)
PMNs##5##1##(1995-6#2)(2009-10#3)
PMP22 locus##2##2##(1997-3#2)
PMP22##3##1##(1997-3#3)
PMS and selected dehydrogenase enzymes##2##5##(2008-10#2)
PMS##6##1##(2008-10#5)(2008-11#1)
PMT activity##3##2##(2013-8#3)
PMT##12##1##(2008-10#3)(2008-5#1)(2008-9#1)(2013-8#7)
PMTCT efforts##2##2##(2012-2#2)
PMTCT##3##1##(2012-2#3)
PMV satRNAs##2##2##(2008-10#2)
PMWaV from##2##2##(2008-10#2)
PMWaV##4##1##(2008-10#4)
PMWaV-1-free and PMWaV-1-infected plants##2##4##(2008-10#2)
PMWaV-1-free##3##1##(2008-10#3)
PMWaV-1-infected plants that##2##3##(2008-10#2)
PMWaV-1-infected plants##3##2##(2008-10#3)
PMWaV-2##5##1##(2008-10#5)
PN mode##3##2##(2008-10#3)
PN solutions in the range##2##5##(2008-10#2)
PN##8##1##(2008-10#8)
PN-2/APP is##2##2##(1992-12#2)
PN-2/APP##6##1##(1992-12#6)
PN2-3##2##1##(2009-7#2)
PNDC myeloblast counts##2##3##(2008-11#2)
PNDC##6##1##(2008-11#6)
PNF##2##1##(2009-1#2)
PNH##2##1##(2008-9#2)
PNIPAM particles##3##2##(2008-10#3)
PNIPAM##6##1##(2008-10#6)
PNMT##2##1##(1997-3#1)(2013-1#1)
PNP##3##1##(1994-8#2)(2010-4#1)
PNP)##3##1##(1994-8#3)
PNPase##2##1##(1997-2#2)
PNPs##2##1##(2010-4#2)
PNRSV##8##1##(2008-10#8)
PNS##8##1##(1995-12#1)(2008-7#6)(2011-2#1)
PNW##4##1##(2008-10#4)
PNs##3##1##(2011-2#3)
PO in the##2##3##(1993-8#1)(2011-10#1)
PO in##4##2##(1993-8#1)(2008-10#1)(2011-10#2)
PO##10##1##(1993-8#3)(2008-10#3)(2011-1#1)(2011-10#3)
PO(4)(3-)##3##1##(2008-10#3)
POA##6##1##(1991-12#3)(2008-8#3)
POB##3##1##(2008-12#2)(2013-8#1)
POC##2##1##(2008-10#2)
POD-like activity##4##2##(2008-10#4)
POD-like##5##1##(2008-10#5)
POD1##2##1##(2012-2#2)
POF's had a##2##3##(2008-3#2)
POF's##5##1##(2008-3#5)
POI duration##2##2##(2010-4#2)
POI##5##1##(2008-10#2)(2010-4#3)
POL and PLL1 are##2##4##(2009-8#2)
POL##3##1##(2008-10#1)(2009-8#2)
POL1##2##1##(1996-3#2)
POMC##2##1##(1996-12#1)(2008-4#1)
PON1 activity##3##2##(2012-12#3)
PONPE 7##2##2##(2008-10#2)
POPULATION##2##1##(2007-12#1)(2012-3#1)
POR##2##1##(1993-1#2)
POU##4##1##(1993-8#1)(1995-6#1)(1996-12#2)
POX1##2##1##(1996-3#2)
POX18##4##1##(1990-5#3)(1991-9#1)
PP DCs##4##2##(2008-11#4)
PP and SPL cells##2##4##(2008-11#2)
PP and##5##2##(2008-10#2)(2008-11#3)
PP cells##4##2##(2008-11#4)
PP##27##1##(1991-5#1)(2008-10#3)(2008-11#13)(2008-5#2)(2009-8#1)(2011-1#2)(2012-4#1)(2013-1#4)
PP)##2##1##(2008-1#1)(2012-4#1)
PP-positive##2##1##(2008-5#2)
PPA and##2##2##(1996-2#1)(2008-4#1)
PPA##4##1##(1990-9#1)(1996-2#1)(2008-10#1)(2008-4#1)
PPAR gamma 2 is##2##4##(1994-12#2)
PPAR gamma 2##5##3##(1994-12#5)
PPAR gamma##7##2##(1994-12#6)(2008-11#1)
PPAR##9##1##(1994-12#7)(2008-11#1)(2008-5#1)
PPARgamma and##2##2##(2008-11#1)(2008-5#1)
PPARgamma##7##1##(2008-11#1)(2008-5#6)
PPC##5##1##(1991-6#2)(2008-7#1)(2009-10#1)(2011-3#1)
PPCs##4##1##(2011-2#4)
PPD and BOP##2##3##(2013-1#2)
PPD##13##1##(1996-12#2)(1997-2#1)(2010-5#1)(2012-3#3)(2013-1#6)
PPE##7##1##(1991-3#2)(1996-12#2)(2008-5#3)
PPF's##4##1##(2008-3#4)
PPG##6##1##(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)
PPG-1025&gt##2##1##(2008-10#2)
PPG2000##2##1##(2008-7#2)
PPH is##2##2##(1997-5#2)
PPH was##2##2##(1997-5#2)
PPH##7##1##(1997-5#7)
PPI breakdown##2##2##(2008-8#2)
PPI##13##1##(2008-11#7)(2008-8#5)(2011-2#1)
PPIP##2##1##(1996-2#2)
PPL##2##1##(1996-3#1)(2013-1#1)
PPN##2##1##(2008-7#2)
PPO and##2##2##(2008-10#2)
PPO##8##1##(1992-2#2)(1996-2#1)(2008-10#5)
PPOs##3##1##(1992-2#2)(1994-2#1)
PPPT##2##1##(2008-12#2)
PPR antigen##2##2##(2011-2#2)
PPR##9##1##(1995-12#3)(2011-2#6)
PPS has been##3##3##(1992-2#3)
PPS has##5##2##(1992-2#5)
PPS payment##3##2##(1992-12#2)(1992-2#1)
PPS payments##2##2##(1992-12#2)
PPS##35##1##(1992-1#1)(1992-12#8)(1992-2#16)(1993-3#8)(1994-3#1)(2008-7#1)
PPS-excluded hospitals##2##2##(1992-1#2)
PPT##4##1##(2009-5#2)(2010-12#1)(2013-1#1)
PPTases##2##1##(2013-1#2)
PPTg##4##1##(1994-2#4)
PPV in##2##2##(2008-10#2)
PPV infections##2##2##(2008-10#2)
PPV spread##2##2##(2008-10#2)
PPV##13##1##(2008-10#12)(2012-12#1)
PPV-M##3##1##(2008-10#3)
PPV-M-specific monoclonal##2##2##(2008-10#2)
PPV-infected##4##1##(2008-10#4)
PPY##3##1##(1997-6#2)(2008-10#1)
PPa##5##1##(2008-8#5)
PPase##2##1##(2008-11#2)
PPy coated##2##2##(2008-10#2)
PPy film##4##2##(2008-10#4)
PPy##6##1##(2008-10#6)
PPy-calcion film##3##2##(2008-10#3)
PPy-calcion##4##1##(2008-10#4)
PPy/FeCN##2##1##(2008-10#2)
PPy/alpha-NS(-)/PMMA##2##1##(2008-10#2)
PQ##12##1##(1995-8#8)(2008-10#4)
PQC##9##1##(2008-10#9)
PQS##2##1##(2009-6#2)
PR coated on##2##3##(2008-10#2)
PR gene##3##2##(2008-10#3)
PR patients##2##2##(2010-1#2)
PR proteins##5##2##(2008-10#5)
PR were##3##2##(1991-9#2)(1997-7#1)
PR##35##1##(1990-12#2)(1991-9#3)(1997-7#1)(2008-10#20)(2010-1#4)(2011-2#1)(2011-3#2)(2013-8#2)
PR(1)##2##1##(2008-10#2)
PR(2)##2##1##(2008-10#2)
PR)##2##1##(1992-2#2)
PR-1##2##1##(2008-10#2)
PR-1B##3##1##(2008-10#3)
PRACTICE IMPLICATIONS##5##2##(2011-2#1)(2013-1#4)
PRACTICE##7##1##(2011-2#1)(2013-1#6)
PRAs##2##1##(2008-7#2)
PRC##3##1##(2008-12#1)(2010-12#2)
PRCA##5##1##(2008-10#5)
PRE##5##1##(2012-3#5)
PRES##3##1##(2013-1#3)
PRETRAHGUAD##2##1##(2008-10#2)
PRI##2##1##(2008-10#1)(2010-9#1)
PRIDE##2##1##(1991-1#1)(1992-3#1)
PRINS and##2##2##(2008-9#2)
PRINS##4##1##(2008-9#4)
PRL expression##4##2##(1994-3#2)(2008-10#2)
PRL levels##2##2##(1994-3#1)(2011-2#1)
PRL mRNA##2##2##(1994-3#2)
PRL secretion##2##2##(1994-3#2)
PRL##25##1##(1991-6#2)(1994-3#10)(2008-10#6)(2011-2#6)(2013-1#1)
PRL-R mRNA##4##2##(2011-2#4)
PRL-R##10##1##(2011-2#10)
PRO and##2##2##(2008-10#2)
PRO##5##1##(1995-12#2)(2008-10#3)
PROCEDURES##3##1##(2009-9#1)(2010-7#1)(2012-3#1)
PROLIFERA##2##1##(2008-10#2)
PROM##6##1##(2012-3#6)
PROT mRNA##2##2##(1995-6#2)
PROT protein##5##2##(1995-6#5)
PROT##9##1##(1995-6#9)
PRP##3##1##(1995-5#1)(2011-2#1)(2013-1#1)
PRRC pathogens##2##2##(2008-10#2)
PRRC##3##1##(2008-10#3)
PRSV YK##2##2##(2008-10#2)
PRSV type##2##2##(2008-10#2)
PRSV##8##1##(2008-10#8)
PRms##8##1##(2008-10#8)
PS (p=0##2##2##(2008-10#2)
PS I##2##2##(1995-12#1)(2010-7#1)
PS and PS##2##3##(2008-10#2)
PS and##3##2##(1995-8#1)(2008-10#2)
PS bonds##2##2##(2008-10#2)
PS matrix##2##2##(2008-10#2)
PS primers##2##2##(2008-10#2)
PS was##2##2##(1990-2#1)(2008-10#1)
PS##40##1##(1990-2#2)(1993-11#6)(1995-12#3)(1995-8#1)(2008-10#18)(2008-11#5)(2008-7#2)(2008-8#2)(2010-7#1)
PS-(DEA)(2) for Hg(2+)##2##3##(2008-10#2)
PS-264 and stearic acid was##2##5##(2008-10#2)
PS-264##5##1##(2008-10#5)
PS-DEA for Cu(2+)##3##3##(2008-10#3)
PS-SCL are tested for their##2##5##(2008-4#2)
PS-SCL##4##1##(2008-4#4)
PS-oligos##4##1##(2008-4#4)
PS1 and PS2##5##3##(1995-8#4)(2008-10#1)
PS1##7##1##(1995-8#6)(2008-10#1)
PS2##6##1##(1995-8#5)(2008-10#1)
PSA forms##2##2##(2010-12#2)
PSA levels##2##2##(2009-5#1)(2010-12#1)
PSA promoter##4##2##(2008-9#4)
PSA secretion##2##2##(2010-1#2)
PSA was##2##2##(1990-9#1)(2011-2#1)
PSA##36##1##(1990-9#6)(1994-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#4)(2009-5#3)(2010-1#3)(2010-11#1)(2010-12#10)(2010-8#1)(2011-2#2)(2012-3#1)
PSD structure##2##2##(1996-12#2)
PSD##14##1##(1996-12#9)(2008-11#1)(2008-3#2)(2010-8#2)
PSDs##3##1##(1996-12#3)
PSF and##2##2##(2008-3#2)
PSF##4##1##(2008-3#4)
PSG##2##1##(1990-5#1)(2012-3#1)
PSH-1##2##1##(2008-10#2)
PSH-10##2##1##(2008-10#2)
PSH-13##2##1##(2008-10#2)
PSH-14##2##1##(2008-10#2)
PSH-20##3##1##(2008-10#3)
PSH-4##2##1##(2008-10#2)
PSH-48##2##1##(2008-10#2)
PSI##2##1##(2008-10#1)(2008-8#1)
PSICAM##2##1##(2008-3#2)
PSII proteins##2##2##(2008-8#2)
PSII##8##1##(2008-10#1)(2008-8#4)(2008-9#2)(2012-7#1)
PSIS##2##1##(2009-9#2)
PSP##3##1##(2012-12#3)
PSPMH##2##1##(2008-10#2)
PSS##2##1##(2010-1#2)
PST##8##1##(2008-10#6)(2008-9#2)
PST-21 of P##2##3##(2008-10#2)
PSV CP##3##2##(2008-10#3)
PSV strains##4##2##(2008-10#4)
PSV subgroup I##2##3##(2008-10#2)
PSV subgroup II##2##3##(2008-10#2)
PSV subgroup##4##2##(2008-10#4)
PSV##17##1##(2008-10#16)(2013-8#1)
PSV-BV-15 RNA2##4##2##(2008-10#4)
PSV-BV-15##5##1##(2008-10#5)
PSV-W (subgroup II)##2##3##(2008-10#2)
PSV-W##4##1##(2008-10#4)
PT and DT cells##4##4##(1995-11#4)
PT and##6##2##(1995-11#4)(1995-5#1)(2013-1#1)
PT on##3##2##(2012-2#3)
PT##15##1##(1993-1#1)(1995-11#6)(1995-5#2)(2012-2#4)(2013-1#1)(2013-8#1)
PT-61##2##1##(1994-11#2)
PTA##5##1##(1995-2#1)(2008-7#3)(2013-1#1)
PTB cases of the##2##4##(2013-8#2)
PTB cases##3##2##(2013-8#3)
PTC##4##1##(1990-9#1)(1997-3#1)(2008-12#2)
PTCA##6##1##(1992-9#4)(2008-5#2)
PTEN and##2##2##(2010-12#1)(2011-2#1)
PTEN##4##1##(2010-12#1)(2011-2#2)(2013-8#1)
PTFE coiled reactor positioned##2##4##(2008-10#2)
PTFE in##2##2##(1990-9#1)(2008-10#1)
PTFE packed column##2##3##(2008-10#2)
PTFE reaction coil##2##3##(2008-10#2)
PTFE tube##2##2##(2008-10#2)
PTFE tubing##3##2##(2008-10#3)
PTFE##33##1##(1990-9#3)(1991-6#1)(2008-10#28)(2008-3#1)
PTGS##4##1##(2008-10#4)
PTH and 1##3##3##(1993-6#1)(1994-11#2)
PTH and##6##2##(1993-3#1)(1993-6#1)(1994-11#2)(2008-12#1)(2011-1#1)
PTH values##3##2##(2008-1#1)(2008-10#2)
PTH##31##1##(1990-11#2)(1991-12#3)(1991-3#4)(1991-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#5)(2008-1#3)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
PTH-amino acids##3##2##(2008-10#3)
PTHrP expression vectors##2##3##(1993-3#2)
PTHrP##10##1##(1993-3#9)(2013-7#1)
PTK##2##1##(1994-6#2)
PTLD##3##1##(2008-5#3)
PTM##3##1##(2008-8#1)(2009-6#1)(2010-12#1)
PTO##7##1##(1993-1#2)(2008-5#5)
PTOB##2##1##(2008-10#2)
PTOX##2##1##(2010-10#2)
PTP synthase##6##2##(1997-8#6)
PTP##8##1##(1994-6#2)(1997-8#6)
PTPN7##3##1##(2009-7#3)
PTPase##6##1##(1997-7#1)(2008-8#5)
PTPepsilon##4##1##(2009-6#4)
PTQA##2##1##(2008-10#2)
PTR##2##1##(1997-6#2)
PTS##2##1##(1997-7#1)(2011-2#1)
PTSD and##4##2##(2008-10#3)(2009-11#1)
PTSD symptoms##5##2##(2009-11#3)(2010-10#2)
PTSD was##2##2##(1991-2#1)(2013-8#1)
PTSD##21##1##(1991-2#1)(2008-10#3)(2008-6#2)(2009-11#7)(2010-10#3)(2010-7#1)(2012-12#2)(2013-8#2)
PTTH (approximately##2##2##(1995-11#2)
PTTH##6##1##(1995-11#6)
PTTH-stimulated##4##1##(1995-11#4)
PTV##3##1##(2008-11#1)(2008-7#2)
PTV-LV-GC/MS/MS##3##1##(2008-10#3)
PU foam##3##2##(2008-10#3)
PU##4##1##(2008-10#4)
PUF##12##1##(2008-10#7)(2008-11#5)
PUFA##8##1##(2008-10#1)(2010-6#2)(2013-1#5)
PUFAs on##4##2##(2010-6#1)(2013-1#3)
PUFAs##19##1##(2008-10#7)(2010-6#3)(2013-1#9)
PUO##2##1##(2008-10#2)
PUR##2##1##(2008-10#1)(2008-9#1)
PURPOSE OF THE##2##3##(2011-2#1)(2012-3#1)
PURPOSE##46##1##(2008-11#1)(2010-10#1)(2010-7#1)(2011-2#10)(2012-3#3)(2013-1#30)
PUT application##2##2##(2011-2#2)
PUT##6##1##(2011-2#6)
PUV##3##1##(2008-10#3)
PV genome##2##2##(2008-11#2)
PV in##2##2##(2008-10#1)(2008-11#1)
PV plus##3##2##(2008-10#3)
PV##20##1##(2008-10#8)(2008-11#4)(2010-5#1)(2010-7#1)(2011-2#6)
PV-61##4##1##(2008-10#4)
PVA added extraction resin##2##4##(2008-10#2)
PVA and##3##2##(2008-10#3)
PVA was##2##2##(2008-10#1)(2008-12#1)
PVA##26##1##(1997-6#1)(2008-10#22)(2008-12#1)(2012-3#2)
PVBA##3##1##(2008-12#3)
PVC (33%)##2##2##(2008-10#2)
PVC and##5##2##(2008-10#5)
PVC as##2##2##(2008-10#2)
PVC based membranes of##2##4##(2008-10#2)
PVC based##6##2##(2008-10#6)
PVC in the ratio##2##4##(2008-10#2)
PVC in##4##2##(2008-10#4)
PVC matrix##9##2##(2008-10#9)
PVC membrane based on bis-pyridine tetramide macrocycle##2##7##(2008-10#2)
PVC membrane based##3##3##(2008-10#3)
PVC membrane electrode based on 5##2##6##(2008-10#2)
PVC membrane electrode based on##6##5##(2008-10#6)
PVC membrane electrode for##5##4##(2008-10#5)
PVC membrane electrode##15##3##(2008-10#15)
PVC membrane electrodes based on##3##5##(2008-10#3)
PVC membrane electrodes##5##3##(2008-10#5)
PVC membrane ion selective electrode for the determination of##2##9##(2008-10#2)
PVC membrane##34##2##(2008-10#34)
PVC membranes and##2##3##(2008-10#2)
PVC membranes##10##2##(2008-10#10)
PVC was##2##2##(2008-10#2)
PVC##102##1##(2008-10#102)
PVC)##3##1##(2008-10#3)
PVC-COOH##2##1##(2008-10#2)
PVC-based membrane##5##2##(2008-10#5)
PVC-based##12##1##(2008-10#12)
PVM##5##1##(2012-2#1)(2013-8#4)
PVMV in##2##2##(2008-10#2)
PVMV##4##1##(2008-10#4)
PVN##3##1##(1994-8#3)
PVNS##4##1##(2010-3#1)(2013-1#3)
PVOD##3##1##(2010-10#3)
PVP##5##1##(2008-10#1)(2008-5#4)
PVP/Pd/IrO(2) modified##2##2##(2008-10#2)
PVSK##2##1##(2008-10#2)
PVSMC cultured in HG##2##4##(1992-8#2)
PVSMC##3##1##(1992-8#3)
PVV isolates##3##2##(2008-10#3)
PVV##7##1##(2008-10#7)
PVX RNA was detected##2##4##(2008-10#2)
PVX##20##1##(2008-10#20)
PVY 0 AT##2##3##(2008-10#2)
PVY 1-2##4##2##(2008-10#4)
PVY and PVA##2##3##(2008-10#2)
PVY isolates##2##2##(2008-10#2)
PVY##19##1##(2008-10#19)
PVY(N##4##1##(2008-10#4)
PVY(NTN) isolates##2##2##(2008-10#2)
PVY(NTN)##4##1##(2008-10#4)
PVY(O)##3##1##(2008-10#3)
PWB##3##1##(2008-10#1)(2010-8#2)
PWC170##3##1##(2012-2#3)
PWV and distensibility##3##3##(2013-3#3)
PWV was##2##2##(2013-3#2)
PWV##6##1##(2013-3#6)
PX##3##1##(2008-10#3)
PXP-18##5##1##(1990-5#5)
PYE##2##1##(2008-10#2)
PYK2##4##1##(1995-8#4)
PYY##2##1##(2012-3#2)
PZDE##3##1##(2008-10#3)
PZFX 500 mg x 2/day##2##5##(2011-2#2)
PZFX##5##1##(2011-2#5)
Pa##16##1##(1992-8#1)(1993-5#1)(2008-10#7)(2008-11#3)(2010-8#2)(2011-2#1)(2011-3#1)
PaEXG2##5##1##(2008-10#5)
Pacific Islander##4##2##(1997-2#2)(2012-2#2)
Pacific Islanders##2##2##(2012-2#2)
Pacific Northwest (PNW)##2##3##(2008-10#2)
Pacific Northwest##14##2##(2008-10#14)
Pacific Ocean##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)
Pacific Symposium on Biocomputing##2##4##(2011-2#2)
Pacific and##3##2##(2008-1#2)(2012-12#1)
Pacific countries##3##2##(2008-1#3)
Pacific cultural values##3##3##(2008-1#3)
Pacific island##2##2##(1994-11#1)(2008-1#1)
Pacific people##3##2##(2008-1#3)
Pacific region##2##2##(2008-1#1)(2010-10#1)
Pacific salmon##4##2##(1995-11#3)(2008-8#1)
Pacific##91##1##(1990-8#1)(1993-3#1)(1994-11#1)(1995-11#3)(1995-3#1)(1997-2#2)(2008-1#38)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-8#4)(2011-2#3)(2012-12#3)(2012-2#5)
Pacificans in New Zealand##2##4##(2008-1#2)
Pacificans##6##1##(2008-1#6)
Pacificans'##3##1##(2008-1#3)
Pacinian corpuscle hyperplasia following dog bite##2##6##(2008-12#2)
Pacinian corpuscle hyperplasia##4##3##(2008-12#4)
Package##3##1##(2008-4#3)
Padlock probes##2##2##(2008-4#2)
Padova##2##1##(2008-10#1)(2013-1#1)
Padua was##2##2##(2013-8#2)
Padua##5##1##(2013-8#5)
Paecilomyces##2##1##(2010-3#2)
Paediatr Child Health 2007##4##4##(2008-11#4)
Paediatric and##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
Paediatric asthma exacerbations##2##3##(2008-11#2)
Paediatric emergency##2##2##(2008-11#2)
Paediatric##23##1##(1997-8#1)(2008-10#2)(2008-11#14)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
Paediatricians and family##2##3##(2008-11#2)
Paediatricians##3##1##(2008-11#3)
Paediatrics##4##1##(1997-8#1)(2008-11#2)(2012-12#1)
Paedodontics##2##1##(2013-1#2)
Paenibacillus spp##4##2##(2008-10#4)
Paenibacillus##5##1##(2008-10#5)
Page serovar C##4##3##(2008-5#4)
Page serovar##6##2##(2008-5#6)
Page##7##1##(2008-5#6)(2010-5#1)
Paget's disease of the##2##4##(2008-8#1)(2011-2#1)
Paget's disease of vulva and perineum##2##6##(1993-1#2)
Paget's disease of##4##3##(1993-1#2)(2008-8#1)(2011-2#1)
Paget's disease##9##2##(1991-11#3)(1993-1#2)(1994-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
Paget's##11##1##(1991-11#3)(1993-1#2)(1994-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#2)
Paid##3##1##(1991-3#1)(1992-3#1)(2008-10#1)
Pain Syndrome##2##2##(2008-12#1)(2010-9#1)
Pain and##7##2##(1992-3#1)(2008-10#1)(2008-11#1)(2013-1#4)
Pain assessment##2##2##(2008-5#1)(2010-7#1)
Pain in##3##2##(1991-2#1)(1993-2#1)(2008-11#1)
Pain is##3##2##(1991-11#1)(2008-5#1)(2011-2#1)
Pain scores##3##2##(1995-3#2)(2011-2#1)
Pain##49##1##(1991-11#1)(1991-2#1)(1992-3#1)(1993-2#1)(1995-3#3)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#1)
Painful##2##1##(2008-12#1)(2008-7#1)
Paired##4##1##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
Pairing##3##1##(1996-9#1)(2008-10#1)(2011-2#1)
Pairs of##2##2##(1997-3#1)(2008-10#1)
Pairs##4##1##(1994-2#1)(1997-3#1)(2008-10#1)(2008-12#1)
Pairwise##5##1##(2008-10#5)
Pakistan##20##1##(1994-9#1)(2008-10#3)(2008-12#1)(2009-4#1)(2012-2#11)(2013-7#2)(2013-8#1)
Pakistani##3##1##(2012-2#1)(2013-8#2)
Palaemonetes pugio##2##2##(2010-4#2)
Palau and Thailand##2##3##(2008-10#2)
Paleozoic stromatoporoids##2##2##(1990-11#2)
Paleozoic##3##1##(1990-11#3)
Palladium and magnesium##2##3##(2008-10#2)
Palladium and##3##2##(2008-10#3)
Palladium##10##1##(2008-10#9)(2008-11#1)
Palladium(II)##2##1##(2008-10#2)
Palliation of##2##2##(1990-12#1)(1991-6#1)
Palliative##7##1##(1990-9#1)(1993-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
Palm Beach County##4##3##(1994-2#1)(2008-10#3)
Palm Beach##5##2##(1994-2#1)(1996-5#1)(2008-10#3)
Palm##9##1##(1994-2#1)(1996-5#1)(2008-10#5)(2008-3#1)(2013-8#1)
Palmar##2##1##(1997-3#1)(2008-10#1)
Palmitoyl-CoA##2##1##(1990-5#1)(1993-3#1)
Pan##4##1##(1992-5#1)(1994-9#1)(2008-11#1)(2013-1#1)
Panama##7##1##(2008-10#4)(2008-8#1)(2008-9#1)(2010-4#1)
Panax ginseng##3##2##(1995-8#2)(2008-10#1)
Panax##4##1##(1995-8#2)(2008-10#1)(2013-8#1)
Panaxynol in##2##2##(2008-10#2)
Panaxynol##3##1##(2008-10#3)
Pancreas##2##1##(2008-9#1)(2013-1#1)
Pancreatic Cancer##2##2##(2012-3#1)(2013-8#1)
Pancreatic##11##1##(1990-6#1)(1990-8#1)(1994-8#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Pancreatitis##5##1##(2008-3#1)(2009-12#2)(2011-2#2)
Pandemic##2##1##(2011-2#1)(2013-1#1)
Pandemics##2##1##(2008-10#1)(2011-2#1)
Pandora's##2##1##(1991-1#1)(2013-1#1)
Panel on##3##2##(2010-12#2)(2011-2#1)
Panel##11##1##(1991-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-12#2)(2011-2#1)(2012-3#2)(2013-1#2)
Panelists##2##1##(1995-3#1)(2008-5#1)
Paneuphorbia diet##2##2##(2013-1#2)
Panhandle##5##1##(2008-10#5)
Panicle##2##1##(2008-10#2)
Panicum mosaic virus##2##3##(2008-10#2)
Panicum##4##1##(2008-10#2)(2013-1#2)
Pantoea agglomerans strain##3##3##(2008-10#3)
Pantoea agglomerans strains Eh252 and C9-1##3##6##(2008-10#3)
Pantoea agglomerans strains##4##3##(2008-10#4)
Pantoea agglomerans##16##2##(2008-10#16)
Pantoea##21##1##(2008-10#21)
Panum's limiting case##4##3##(2008-9#4)
Panum's limiting##5##2##(2008-9#5)
Pap smear##6##2##(1990-8#3)(1992-3#3)
Pap smears and##2##3##(1990-12#1)(1992-3#1)
Pap smears##5##2##(1990-12#2)(1992-3#3)
Pap test##4##2##(1991-6#2)(1994-1#1)(2008-11#1)
Pap##18##1##(1990-12#3)(1990-8#3)(1991-6#2)(1992-3#6)(1994-1#1)(1997-2#1)(2008-11#1)(2009-6#1)
Pap1/Pap2##3##1##(2008-10#3)
Pap1/Pap3##2##1##(2008-10#2)
Papal##2##1##(1990-6#2)
Papanicolaou##3##1##(1992-1#2)(2008-11#1)
Papaver somniferum##4##2##(2008-10#4)
Papaver##5##1##(2008-10#5)
Papaverine##2##1##(2008-10#2)
Papaya ringspot virus##4##3##(2008-10#4)
Papaya##6##1##(2008-10#6)
Paper##4##1##(1990-11#1)(1994-1#1)(2008-11#1)(2013-8#1)
Papers##2##1##(2012-3#1)(2013-1#1)
Papillae##3##1##(2008-10#2)(2008-5#1)
Paracanthurus##2##1##(2008-5#2)
Paracoccus pantotrophus##2##2##(2008-7#2)
Paracoccus##4##1##(1992-3#2)(2008-7#2)
Paradigm##3##1##(1992-2#1)(2008-11#1)(2012-3#1)
Paradoxical embolism##3##2##(2008-7#2)(2009-10#1)
Paradoxical##6##1##(2008-11#1)(2008-7#2)(2009-10#2)(2013-1#1)
Paradoxically##4##1##(1991-7#1)(1994-11#1)(1997-1#2)
Parafac2##3##1##(2013-1#3)
Paraffin##2##1##(1992-6#1)(1997-8#1)
Parafilm##2##1##(2008-10#2)
Paralichthys olivaceus##4##2##(2008-6#2)(2010-8#2)
Parallel Factor Analysis (PARAFAC)##2##4##(2008-10#2)
Parallel to these changes##2##4##(1994-8#1)(1997-4#1)
Parallel##15##1##(1993-9#1)(1994-8#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
Paramagnetic##4##1##(1992-11#1)(1993-8#1)(1994-5#2)
Paramecium##11##1##(2008-12#11)
Parameter##4##1##(2008-10#3)(2008-9#1)
Parameters affecting##2##2##(2008-10#2)
Parameters influencing extraction such as sonication time##2##7##(2008-10#2)
Parameters influencing##3##2##(2008-10#3)
Parameters of##2##2##(2008-10#1)(2008-5#1)
Parameters such as the pH effect on the##2##8##(2008-10#2)
Parameters such as##7##3##(1996-12#1)(2008-10#5)(2008-7#1)
Parameters that may affect the##2##5##(2008-10#2)
Parameters that##3##2##(2008-10#3)
Parameters were##2##2##(2008-10#1)(2013-8#1)
Parameters##24##1##(1996-12#1)(2008-10#19)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
Parametric##6##1##(2008-10#1)(2008-3#4)(2013-8#1)
Paramphistomum eggs##3##2##(1996-12#3)
Paraneoplastic##2##1##(1997-8#1)(2011-2#1)
Paraplegia##2##1##(1996-3#1)(2008-7#1)
Paraquat##3##1##(1995-8#1)(2008-10#2)
Parasexual##2##1##(2008-10#2)
Parasite##4##1##(2008-9#2)(2012-2#1)(2013-1#1)
Parasite-driven##2##1##(2008-8#2)
Parasites##5##1##(2008-9#3)(2012-2#1)(2013-1#1)
Parasitic and##2##2##(2008-10#1)(2008-8#1)
Parasitic##8##1##(2007-12#1)(2008-10#3)(2008-8#1)(2011-2#2)(2012-2#1)
Parasitism of##2##2##(2008-10#2)
Parasitized##2##1##(2008-10#1)(2010-4#1)
Parasola species##2##2##(2010-3#2)
Parasola##6##1##(2010-3#6)
Parathyroid##3##1##(1993-3#1)(1994-11#1)(2008-12#1)
Paratyphi A##6##2##(2012-3#6)
Parent##7##1##(1992-2#1)(1994-3#1)(2008-11#2)(2010-8#1)(2011-2#2)
Parent-Adolescent Communication##2##2##(1990-12#2)
Parent-Adolescent##3##1##(1990-12#3)
Parental care##2##2##(2008-4#1)(2008-8#1)
Parental rights and children's best interests##2##6##(1990-6#2)
Parental##22##1##(1990-6#2)(1991-1#1)(1992-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#2)(2010-4#1)(2010-9#2)(2011-2#1)(2012-3#2)
Parenteral##2##1##(1994-6#1)(2012-12#1)
Parenthood##3##1##(1993-3#1)(1997-6#1)(2009-10#1)
Parenting##9##1##(1995-2#3)(2008-11#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2012-2#1)
Parents of children with##3##4##(1993-3#1)(1995-2#1)(2008-11#1)
Parents of##5##2##(1991-9#1)(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#1)
Parents were##2##2##(2010-2#1)(2012-3#1)
Parents##18##1##(1990-6#1)(1991-9#1)(1993-3#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-4#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#1)
Parents'##2##1##(2008-11#1)(2010-11#1)
Paridae##3##1##(2008-9#3)
Parietal##3##1##(1990-5#2)(1994-3#1)
Paris and##2##2##(2008-11#1)(2008-2#1)
Paris area##2##2##(2008-2#2)
Paris sex-ratio##2##2##(2012-3#2)
Paris##14##1##(2008-11#1)(2008-2#3)(2010-1#5)(2011-2#2)(2012-3#3)
Pariser##2##1##(2008-6#2)
Park##10##1##(1997-1#1)(1997-7#1)(2008-10#4)(2008-8#1)(2010-4#1)(2011-2#2)
Parkinson Disease##2##2##(2008-11#1)(2013-8#1)
Parkinson disease (PD)##2##3##(2013-1#1)(2013-8#1)
Parkinson disease##12##2##(1995-2#1)(2010-4#2)(2011-2#1)(2013-1#2)(2013-8#6)
Parkinson##19##1##(1995-2#1)(2008-11#1)(2008-7#2)(2010-4#2)(2011-2#1)(2013-1#2)(2013-8#10)
Parkinson's Disease Rating Scale##2##4##(2008-7#2)
Parkinson's Disease##4##2##(2008-11#1)(2008-7#2)(2010-5#1)
Parkinson's and##2##2##(2008-9#1)(2010-5#1)
Parkinson's caregivers##2##2##(2008-7#2)
Parkinson's disease (PD) are##2##4##(2008-7#1)(2010-12#1)
Parkinson's disease (PD) is a##4##5##(2008-12#1)(2008-7#1)(2008-8#1)(2010-8#1)
Parkinson's disease (PD) is an##2##5##(2008-7#2)
Parkinson's disease (PD) is associated with##2##6##(2008-7#2)
Parkinson's disease (PD) is##8##4##(2008-12#1)(2008-7#5)(2008-8#1)(2010-8#1)
Parkinson's disease (PD) patients##4##4##(2008-7#4)
Parkinson's disease (PD)##32##3##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#22)(2008-8#1)(2010-12#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
Parkinson's disease and mitochondrial encephalomyopathies##2##5##(1991-5#2)
Parkinson's disease and mitochondrial##3##4##(1991-5#3)
Parkinson's disease and##7##3##(1991-5#3)(1997-2#1)(2008-7#1)(2009-5#1)(2010-11#1)
Parkinson's disease is##4##3##(2008-7#4)
Parkinson's disease patients##4##3##(2008-7#3)(2010-5#1)
Parkinson's disease symptom inventory (PDSI)##2##5##(2008-7#2)
Parkinson's disease without##2##3##(1992-3#1)(2009-11#1)
Parkinson's disease##134##2##(1991-5#3)(1992-3#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-8#1)(1997-2#2)(2008-10#2)(2008-12#2)(2008-6#2)(2008-7#86)(2008-8#2)(2009-10#2)(2009-11#4)(2009-5#1)(2010-11#1)(2010-12#4)(2010-5#3)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
Parkinson's##145##1##(1991-5#3)(1992-3#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-8#1)(1996-2#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#92)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#4)(2009-5#1)(2010-11#1)(2010-12#4)(2010-5#5)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
Parkinsonian##5##1##(2008-10#3)(2008-7#2)
Parkinsonism##6##1##(2008-7#6)
Parks Medical Flo-Lab 2100-SX##2##4##(2011-2#2)
Parks Medical##3##2##(2011-2#3)
Parma##4##1##(2008-10#1)(2008-2#1)(2011-2#2)
Parotid##3##1##(1990-11#1)(1993-9#1)(2011-2#1)
Parry arc##5##2##(2008-3#5)
Parry##6##1##(2008-3#6)
Pars##3##1##(2008-12#1)(2013-1#2)
Parsimony##3##1##(2008-10#3)
Parson##2##1##(2008-12#2)
Part 1 of this##2##4##(1995-1#1)(1997-2#1)
Part 1##23##2##(1992-11#1)(1992-5#1)(1993-6#1)(1995-1#2)(1995-2#1)(1997-2#2)(2006-5#2)(2008-10#4)(2008-11#3)(2008-12#2)(2009-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
Part 2##13##2##(1991-6#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-12#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-6#1)(2010-9#1)(2012-2#1)
Part 6##2##2##(1993-2#1)(2013-8#1)
Part 8##2##2##(2008-10#1)(2013-8#1)
Part A##9##2##(1991-1#2)(1993-12#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-11#3)
Part B##11##2##(1991-2#2)(1992-2#1)(1993-3#1)(1994-3#1)(1996-2#2)(2008-10#1)(2008-11#3)
Part I of this##2##4##(1991-2#1)(1994-1#1)
Part I of##3##3##(1991-2#1)(1993-1#1)(1994-1#1)
Part I##29##2##(1991-2#2)(1991-5#1)(1993-1#1)(1993-2#1)(1994-1#3)(1994-12#1)(1995-1#2)(1996-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#1)(2009-2#3)(2010-5#2)(2012-2#1)(2012-3#1)
Part II of this article##2##5##(1996-1#1)(2012-3#1)
Part II of this##4##4##(1995-2#1)(1996-1#1)(1997-3#1)(2012-3#1)
Part II of##5##3##(1991-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2012-3#1)
Part II will##2##3##(1995-1#1)(1996-1#1)
Part II##31##2##(1991-1#1)(1991-2#1)(1991-3#3)(1993-2#1)(1994-1#2)(1995-1#1)(1995-2#5)(1996-1#2)(1996-3#2)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2009-10#1)(2009-2#2)(2010-5#1)(2012-3#1)(2013-1#1)
Part III##8##2##(1994-3#2)(1995-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#1)(2012-3#1)
Part IV##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
Part of##3##2##(2008-1#1)(2008-10#1)(2013-8#1)
Part##150##1##(1991-1#3)(1991-12#1)(1991-2#5)(1991-3#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#5)(1994-12#3)(1994-3#3)(1995-1#6)(1995-12#1)(1995-2#7)(1995-3#3)(1996-1#3)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#5)(1997-3#1)(2006-5#2)(2008-1#1)(2008-10#23)(2008-11#16)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#5)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#4)(2010-9#2)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#3)
Partial Least Squares Regression##2##4##(2008-10#2)
Partial Least Squares##4##3##(2008-10#4)
Partial Least##6##2##(2008-10#5)(2008-5#1)
Partial Resistance to##5##3##(2008-10#5)
Partial Resistance##7##2##(2008-10#7)
Partial amino acid sequencing##2##4##(1990-2#1)(1997-1#1)
Partial amino acid##3##3##(1990-2#1)(1997-1#1)(2008-10#1)
Partial cystectomy##2##2##(1992-3#1)(2008-10#1)
Partial hospitalization is##2##3##(1991-1#1)(1992-1#1)
Partial least square (PLS)##2##4##(2008-10#2)
Partial least squares regression##2##4##(2008-10#2)
Partial least squares##5##3##(2008-10#5)
Partial least##7##2##(2008-10#7)
Partial least-squares##2##2##(2008-10#2)
Partial purification of##2##3##(1992-9#1)(1995-6#1)
Partial purification##3##2##(1992-9#1)(1993-8#1)(1995-6#1)
Partial resistance to##4##3##(2008-10#4)
Partial resistance##6##2##(2008-10#6)
Partial##73##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#4)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-6#3)(1997-1#1)(1997-7#1)(2008-10#45)(2008-11#3)(2008-5#1)(2009-5#1)(2009-6#1)(2011-3#1)(2012-2#1)
Partial-hospitalization##2##1##(1992-1#2)
Partially Resistant Wheat Cultivars##2##4##(2008-10#2)
Partially##8##1##(1993-8#1)(2008-10#5)(2008-3#1)(2008-8#1)
Participant##2##1##(2008-10#1)(2013-1#1)
Participants completed##3##2##(1995-1#1)(2008-10#1)(2013-1#1)
Participants in##2##2##(2010-4#1)(2011-2#1)
Participants include##2##2##(2011-2#2)
Participants included##2##2##(2011-2#1)(2013-1#1)
Participants made##2##2##(2008-11#1)(2012-3#1)
Participants viewed##2##2##(2008-11#1)(2010-10#1)
Participants were asked##2##3##(2008-11#1)(2008-12#1)
Participants were divided into##2##4##(1992-1#1)(2013-8#1)
Participants were##25##2##(1992-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)(2009-7#5)(2010-1#3)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#4)
Participants with##3##2##(2008-11#1)(2010-5#1)(2012-3#1)
Participants##60##1##(1992-1#1)(1995-1#1)(2008-1#1)(2008-10#3)(2008-11#9)(2008-12#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#5)(2010-1#3)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#4)
Participants'##3##1##(2011-2#1)(2012-3#1)(2013-8#1)
Participating##2##1##(2009-5#1)(2013-1#1)
Participation Questionnaire##3##2##(1994-3#1)(2009-4#2)
Participation in##4##2##(1995-12#1)(2009-12#1)(2012-2#1)(2013-1#1)
Participation of physicians in capital punishment##6##6##(1994-3#6)
Participation of##7##2##(1994-3#6)(1997-1#1)
Participation##17##1##(1992-2#1)(1994-3#7)(1995-12#1)(1997-1#1)(2009-12#1)(2009-4#3)(2011-2#1)(2012-2#1)(2013-1#1)
Participative Conference - for##2##4##(2008-11#2)
Participatory##2##1##(1997-3#1)(2012-2#1)
Particle Sizer##2##2##(1995-3#1)(2008-3#1)
Particle size##3##2##(1994-12#1)(2008-10#2)
Particle##16##1##(1994-12#1)(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-9#1)(2010-11#1)(2013-1#1)
Particles##5##1##(1996-3#1)(1997-2#1)(2008-10#3)
Particular attention is given to the##2##6##(2008-10#1)(2008-9#1)
Particular attention is given to##4##5##(2008-10#2)(2008-5#1)(2008-9#1)
Particular attention is##5##3##(2008-10#3)(2008-5#1)(2008-9#1)
Particular attention was paid to##2##5##(2008-12#1)(2008-7#1)
Particular attention##7##2##(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
Particular emphasis is placed on##3##5##(1993-3#1)(2008-10#1)(2008-7#1)
Particular emphasis is##4##3##(1993-3#1)(2008-10#2)(2008-7#1)
Particular##19##1##(1990-5#1)(1992-1#1)(1993-11#1)(1993-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-3#1)
Particularly##10##1##(1990-9#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2010-8#1)(2011-10#1)
Particulate matter##2##2##(2008-10#2)
Particulate##6##1##(1997-1#1)(2007-12#1)(2008-10#4)
Parties to the##2##3##(1992-12#1)(1996-1#1)
Parties##4##1##(1992-12#1)(1996-1#3)
Partitioning##3##1##(2008-10#1)(2008-8#1)(2012-3#1)
Partly##2##1##(2011-3#1)(2012-2#1)
Partner##3##1##(2010-11#1)(2011-2#1)(2012-2#1)
Partners in Health##3##3##(1997-2#3)
Partners in##4##2##(1997-2#3)(2012-2#1)
Partners##6##1##(1996-2#1)(1997-2#3)(2012-2#1)(2013-1#1)
Partnership##5##1##(1993-5#1)(2008-12#1)(2012-12#2)(2013-8#1)
Partnerships##4##1##(1993-2#1)(1996-2#1)(2008-12#1)(2012-3#1)
Parts of##2##2##(1993-8#1)(2008-10#1)
Parts##4##1##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
Pascal##2##1##(2008-10#1)(2013-1#1)
Pasqua and AC Taber##2##4##(2008-10#2)
Pasqua##4##1##(2008-10#4)
Pass-35##2##1##(2008-10#2)
Passage of##2##2##(1996-1#1)(2008-3#1)
Passages were CD45(-)##2##3##(2008-11#2)
Passeriformes##2##1##(2011-2#2)
Passive##12##1##(1991-3#1)(1993-1#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#2)(2012-2#1)
Passively Q-Switched Nd##2##3##(2008-3#2)
Passively Q-Switched##3##2##(2008-3#3)
Passively##5##1##(2008-3#5)
Past research has##3##3##(1992-12#1)(2010-2#1)(2010-7#1)
Past research##4##2##(1992-12#1)(2008-9#1)(2010-2#1)(2010-7#1)
Past##20##1##(1991-2#1)(1992-12#1)(1993-8#1)(1995-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#2)
Pasteur##7##1##(2008-11#1)(2010-1#5)(2011-2#1)
Pasteurella multocida##2##2##(2011-2#1)(2012-2#1)
Pasteurella##7##1##(2008-5#5)(2011-2#1)(2012-2#1)
Pasteurization of##2##2##(2008-10#2)
Pastoral##3##1##(1991-2#2)(2010-9#1)
Patch occupancy##2##2##(2008-8#2)
Patch##9##1##(2008-11#4)(2008-8#3)(2012-2#1)(2013-1#1)
Patch-clamp##2##1##(1993-6#1)(2012-2#1)
Patches##2##1##(2008-5#1)(2013-1#1)
Patchy##2##1##(2008-8#2)
Patella##2##1##(2009-4#1)(2013-1#1)
Patellar##3##1##(2009-3#1)(2013-1#2)
Patent foramen ovale##2##3##(2008-11#1)(2011-2#1)
Patent##4##1##(2008-11#1)(2010-12#2)(2011-2#1)
Patents on##2##2##(2010-7#2)
Paternal inheritance of##2##3##(2008-8#2)
Paternal##4##1##(2008-8#2)(2010-11#1)(2012-3#1)
Paternity##2##1##(2008-12#1)(2008-9#1)
Path##2##1##(2008-9#1)(2009-10#1)
Pathobiology##2##1##(1997-1#1)(2013-8#1)
Pathogen Rhynchosporium secalis##2##3##(2008-10#2)
Pathogen ingress##2##2##(2008-10#2)
Pathogen of##3##2##(2008-10#3)
Pathogen populations##2##2##(2008-10#2)
Pathogen##42##1##(2008-10#40)(2008-7#1)(2011-2#1)
Pathogenesis of Alfalfa mosaic virus in Soybean (Glycine max) and Expression of Chimeric Rabies Peptide in Virus-Infected Soybean##2##18##(2008-10#2)
Pathogenesis of##3##2##(2008-10#3)
Pathogenesis##4##1##(1992-12#1)(2008-10#3)
Pathogenesis-Related##2##1##(2008-10#2)
Pathogenic Variation in##2##3##(2008-10#2)
Pathogenic Variation##3##2##(2008-10#3)
Pathogenic and Nonpathogenic Lifestyles in Colletotrichum acutatum##2##7##(2008-10#2)
Pathogenic and Nonpathogenic##3##3##(2008-10#3)
Pathogenic and##5##2##(2008-10#5)
Pathogenic to##4##2##(2008-10#4)
Pathogenic variation in##2##3##(2008-10#2)
Pathogenic##35##1##(1994-12#1)(2008-10#32)(2009-8#1)(2013-1#1)
Pathogenicity and##3##2##(2008-10#3)
Pathogenicity of##16##2##(2008-10#15)(2008-5#1)
Pathogenicity on##2##2##(2008-10#2)
Pathogenicity tests on##2##3##(2008-10#2)
Pathogenicity tests##5##2##(2008-10#5)
Pathogenicity to##2##2##(2008-10#2)
Pathogenicity was##2##2##(2008-10#2)
Pathogenicity##41##1##(2008-10#38)(2008-5#3)
Pathogens##10##1##(2008-10#9)(2008-7#1)
Pathologic analysis##2##2##(2011-2#1)(2013-1#1)
Pathologic##5##1##(1996-6#1)(2011-2#3)(2013-1#1)
Pathological examination##2##2##(2008-10#1)(2008-7#1)
Pathological##5##1##(1990-2#1)(2008-10#1)(2008-7#2)(2012-2#1)
Pathologically##2##1##(1994-12#1)(2008-5#1)
Pathologists##5##1##(1994-12#2)(1994-8#1)(2008-1#1)(2008-10#1)
Pathology of##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
Pathology##20##1##(1991-9#1)(1994-12#4)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#2)(2011-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
Pathophysiology and##2##2##(2010-12#1)(2011-2#1)
Pathophysiology of##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
Pathophysiology##5##1##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
Pathotype##6##1##(2008-10#6)
Pathotypes of##3##2##(2008-10#3)
Pathotypes##5##1##(2008-10#5)
Pathway of##2##2##(2008-10#2)
Pathway##15##1##(1991-6#1)(2008-10#4)(2008-3#3)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
Pathways##4##1##(1997-4#1)(2008-11#1)(2008-3#2)
Patient Access and Care##2##4##(1994-3#2)
Patient Focused Care program will##2##5##(1993-12#1)(1994-2#1)
Patient Focused Care program##4##4##(1993-12#1)(1994-1#1)(1994-2#2)
Patient Focused Care programs##2##4##(1993-1#1)(1994-2#1)
Patient Focused Care##14##3##(1993-1#1)(1993-12#5)(1994-1#3)(1994-2#5)
Patient Focused care team design##2##5##(1994-2#2)
Patient Focused care team##4##4##(1994-2#4)
Patient Focused care##5##3##(1994-2#5)
Patient Focused education##3##3##(1993-3#1)(1994-1#2)
Patient Focused program##2##3##(1994-2#1)(1994-3#1)
Patient Focused restructuring##6##3##(1993-12#3)(1994-1#1)(1994-2#1)(1994-3#1)
Patient Focused##36##2##(1993-1#1)(1993-12#8)(1993-3#2)(1994-1#9)(1994-2#14)(1994-3#2)
Patient Health##2##2##(1994-1#1)(2013-1#1)
Patient Simulator##2##2##(2008-11#1)(2013-1#1)
Patient acceptability##2##2##(1992-12#2)
Patient cohorts##2##2##(2008-11#1)(2011-2#1)
Patient focused care##2##3##(1993-2#1)(1994-2#1)
Patient satisfaction and##2##3##(1996-1#1)(2009-6#1)
Patient satisfaction##3##2##(1994-12#1)(1996-1#1)(2009-6#1)
Patient selection and##2##3##(2008-7#1)(2011-2#1)
Patient selection##4##2##(2008-7#1)(2010-12#1)(2011-2#1)(2011-3#1)
Patient underwent##2##2##(2010-11#1)(2011-2#1)
Patient was##3##2##(2012-2#1)(2013-1#2)
Patient with##5##2##(1994-12#1)(2008-12#2)(2010-7#1)(2011-1#1)
Patient##112##1##(1990-11#1)(1991-1#1)(1991-3#1)(1992-12#2)(1993-1#1)(1993-12#9)(1993-2#1)(1993-3#2)(1994-1#10)(1994-12#4)(1994-2#15)(1994-3#6)(1995-12#1)(1995-2#1)(1996-1#3)(1996-3#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#2)
Patient-centered##2##1##(1992-8#1)(1994-3#1)
Patients Treated with##2##3##(1994-12#1)(2008-10#1)
Patients after##2##2##(1994-12#1)(2012-3#1)
Patients aged##2##2##(2012-12#1)(2013-8#1)
Patients and Methods##15##3##(2008-10#6)(2011-2#3)(2013-1#5)(2013-8#1)
Patients and##20##2##(1996-1#1)(1996-11#1)(1997-5#1)(1997-7#1)(2008-10#6)(2011-2#4)(2013-1#5)(2013-8#1)
Patients are usually##2##3##(2008-1#1)(2008-12#1)
Patients are##6##2##(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-11#1)
Patients at##3##2##(1990-6#1)(1992-5#1)(2012-2#1)
Patients from##2##2##(2010-10#1)(2011-2#1)
Patients had##2##2##(2008-12#1)(2011-2#1)
Patients have##2##2##(1996-8#1)(2011-2#1)
Patients in RLE group##2##4##(2011-2#2)
Patients in group L##2##4##(1996-3#2)
Patients in the##4##3##(2008-5#1)(2008-7#1)(2009-12#1)(2012-12#1)
Patients in##10##2##(1996-3#3)(2008-1#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#2)(2012-12#1)
Patients may##3##2##(1995-2#1)(2011-1#1)(2013-1#1)
Patients of##2##2##(1990-11#1)(2012-3#1)
Patients receiving##2##2##(2008-3#1)(2008-7#1)
Patients should##2##2##(1997-8#1)(2008-3#1)
Patients undergoing##5##2##(2008-8#1)(2011-2#2)(2012-3#2)
Patients were assessed with the##2##5##(2012-2#1)(2013-8#1)
Patients were divided into##4##4##(1990-12#1)(1993-2#1)(2008-11#1)(2011-2#1)
Patients were divided##5##3##(1990-12#1)(1993-2#1)(2008-11#1)(2011-2#2)
Patients were evaluated##2##3##(2008-11#1)(2009-10#1)
Patients were examined##2##3##(2011-2#2)
Patients were followed for##2##4##(2013-1#2)
Patients were grouped##2##3##(2011-2#2)
Patients were initially##2##3##(2008-12#1)(2008-9#1)
Patients were treated##3##3##(1994-12#1)(2008-10#1)(2011-1#1)
Patients were##34##2##(1990-12#1)(1990-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#13)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
Patients who are undergoing##2##4##(2012-2#1)(2013-1#1)
Patients who are##5##3##(1991-3#1)(1992-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
Patients who experienced##2##3##(2008-7#1)(2013-1#1)
Patients who have##4##3##(1992-3#1)(2009-10#1)(2010-9#2)
Patients who underwent##3##3##(1993-2#1)(2008-11#1)(2008-7#1)
Patients who were##2##3##(1992-1#1)(2011-2#1)
Patients who##22##2##(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-2#1)(1997-4#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-4#1)(2010-9#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)
Patients with a history of##2##5##(1992-6#1)(2008-11#1)
Patients with a##5##3##(1992-6#1)(1993-1#1)(2008-11#1)(2008-6#1)(2011-2#1)
Patients with chronic liver disease##2##5##(2008-1#1)(2009-8#1)
Patients with estrogen##2##3##(1997-7#2)
Patients with less than##2##4##(2008-10#2)
Patients with more than##2##4##(2008-10#1)(2012-12#1)
Patients with severe##3##3##(2011-2#2)(2012-3#1)
Patients with suspected##2##3##(2009-8#1)(2011-2#1)
Patients with the##2##3##(1996-6#1)(2010-2#1)
Patients with##103##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-11#2)(1996-6#2)(1997-3#1)(1997-7#3)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#9)(2008-12#1)(2008-3#5)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#10)(2012-12#4)(2012-2#2)(2012-3#10)(2012-4#1)(2013-1#5)(2013-8#2)
Patients without##2##2##(1996-6#1)(2008-10#1)
Patients##286##1##(1990-11#2)(1990-12#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-2#3)(1994-12#3)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#4)(1996-11#3)(1996-3#3)(1996-6#3)(1996-8#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#5)(1997-8#5)(2007-8#1)(2008-1#4)(2008-10#16)(2008-11#17)(2008-12#6)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#5)(2009-10#4)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#45)(2011-7#1)(2012-12#7)(2012-2#6)(2012-3#21)(2012-4#1)(2012-5#1)(2013-1#19)(2013-8#9)
Patients' preferences##2##2##(1990-3#1)(2010-3#1)
Patients' views of##2##3##(1992-2#1)(2008-12#1)
Patients'##13##1##(1990-3#1)(1992-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#3)(2013-1#1)
Patna (India)##2##2##(1990-6#2)
Patsy Fleming##2##2##(1995-6#2)
Pattern and##2##2##(1991-8#1)(2012-2#1)
Pattern of##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
Pattern recognition procedures##2##3##(2008-10#2)
Pattern recognition techniques##2##3##(2008-10#2)
Pattern recognition##5##2##(2008-10#4)(2010-7#1)
Pattern##16##1##(1991-8#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-7#1)(2012-12#1)(2012-2#1)
Patterns and##2##2##(1991-3#1)(1992-8#1)
Patterns as##2##2##(2008-3#1)(2012-3#1)
Patterns of##24##2##(1991-1#1)(1991-6#1)(1992-1#1)(1995-2#2)(1996-10#1)(1996-3#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-3#1)
Patterns##30##1##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-8#1)(1995-2#2)(1996-10#1)(1996-3#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-8#2)(2010-8#2)(2011-2#1)(2012-3#2)
Paul B##2##2##(1994-2#1)(2010-5#1)
Paul##11##1##(1990-6#3)(1990-8#1)(1994-1#2)(1994-2#1)(1995-12#1)(2008-10#1)(2010-5#1)(2012-2#1)
Paulo##11##1##(1996-12#1)(2008-10#7)(2008-5#1)(2008-7#1)(2012-3#1)
Paving the##2##2##(1995-3#1)(2011-1#1)
Pawliszyn##2##1##(2008-10#2)
Paying for##2##2##(1993-2#1)(2008-4#1)
Payment##4##1##(1991-3#1)(1993-12#1)(1994-1#1)(1994-12#1)
Pb and Cu##4##3##(2008-10#4)
Pb and Ni is##2##4##(2008-10#2)
Pb and Ni##6##3##(2008-10#6)
Pb and Pd##2##3##(2008-10#2)
Pb and Tl in##2##4##(2008-10#2)
Pb and Tl##4##3##(2008-10#4)
Pb and U##2##3##(2008-10#2)
Pb and V##2##3##(2008-10#2)
Pb and Zn in##6##4##(2008-10#6)
Pb and Zn##12##3##(2008-10#12)
Pb and Zn)##3##3##(2008-10#3)
Pb and##46##2##(2008-10#46)
Pb by using the proposed modifier mixture##2##7##(2008-10#2)
Pb by using##3##3##(2008-10#3)
Pb by##8##2##(2008-10#8)
Pb content in##2##3##(2008-10#2)
Pb from##3##2##(2008-10#3)
Pb in##18##2##(2008-10#17)(2011-2#1)
Pb was 3##2##3##(2008-10#2)
Pb was##4##2##(2008-10#4)
Pb were 4##2##3##(2008-10#2)
Pb were##5##2##(2008-10#5)
Pb##218##1##(2008-10#212)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
Pb(2)Sn(2)O(6)##4##1##(2009-11#4)
Pb(2+) and Al(3+)##2##3##(2008-10#2)
Pb(2+) and Cd(2+) were##2##4##(2008-10#2)
Pb(2+) and Cd(2+)##6##3##(2008-10#6)
Pb(2+) and Zn(2+)##3##3##(2008-10#3)
Pb(2+) and##13##2##(2008-10#13)
Pb(2+) in the concentration range##2##5##(2008-10#2)
Pb(2+) in##3##2##(2008-10#3)
Pb(2+) ions##5##2##(2008-10#5)
Pb(2+) over##5##2##(2008-10#5)
Pb(2+) using##2##2##(2008-10#2)
Pb(2+) with##2##2##(2008-10#2)
Pb(2+)##58##1##(2008-10#58)
Pb(2+)-selective##2##1##(2008-10#2)
Pb(II) and Cu(II) extraction##2##4##(2008-10#2)
Pb(II) and Cu(II)##3##3##(2008-10#3)
Pb(II) and Mn(II)##2##3##(2008-10#2)
Pb(II) and Ni(II)##2##3##(2008-10#2)
Pb(II) and Zn(II)##5##3##(2008-10#5)
Pb(II) and the apparent molar absorptivity is##2##7##(2008-10#2)
Pb(II) and##20##2##(2008-10#20)
Pb(II) at pH##2##3##(2008-10#2)
Pb(II) at##5##2##(2008-10#5)
Pb(II) could##2##2##(2008-10#2)
Pb(II) from##3##2##(2008-10#3)
Pb(II) in##5##2##(2008-10#5)
Pb(II) ion-selective electrode##2##3##(2008-10#2)
Pb(II) ions were##2##3##(2008-10#2)
Pb(II) ions##5##2##(2008-10#4)(2013-1#1)
Pb(II) was##2##2##(2008-10#2)
Pb(II) with##3##2##(2008-10#3)
Pb(II)##113##1##(2008-10#111)(2013-1#2)
Pb(II))##2##1##(2008-10#2)
Pb(II)-ISE##2##1##(2008-10#2)
Pb)##5##1##(2008-10#5)
Pb-ion selective electrode##4##3##(2008-10#4)
Pb2+##11##1##(1995-11#10)(1997-7#1)
PbO(2) film##2##2##(2008-10#2)
PbO(2)##9##1##(2008-10#9)
PbS##3##1##(2008-10#2)(2008-3#1)
Pc =##2##2##(1997-8#2)
PcDNA##2##1##(1995-11#2)
PcMV and CMLV##3##3##(2008-10#3)
PcMV##10##1##(2008-10#10)
PcpD was##3##2##(2009-3#3)
PcpD##7##1##(2009-3#7)
Pcq1##3##1##(2008-10#3)
Pcq2##3##1##(2008-10#3)
Pcsk9(-/-) mice##3##2##(2013-1#3)
Pcsk9(-/-)##4##1##(2013-1#4)
Pd + NH(4)NO(3)##4##3##(2008-10#4)
Pd +##5##2##(2008-10#5)
Pd and Pt##4##3##(2008-10#3)(2008-11#1)
Pd and Pt)##2##3##(2008-10#2)
Pd and##10##2##(2008-10#8)(2008-11#2)
Pd as##3##2##(2008-10#3)
Pd coated##2##2##(2008-10#2)
Pd in##2##2##(2008-10#2)
Pd is##2##2##(2008-10#2)
Pd was used##2##3##(2008-10#2)
Pd was##3##2##(2008-10#3)
Pd##59##1##(2008-10#51)(2008-11#8)
Pd(2 +)##3##2##(2008-10#3)
Pd(II) and Pt(IV) by##2##4##(2008-10#2)
Pd(II) and Pt(IV)##4##3##(2008-10#4)
Pd(II) in##2##2##(2008-10#2)
Pd(II) ions##2##2##(2008-10#2)
Pd(II) was##2##2##(2008-10#2)
Pd(II) were##2##2##(2008-10#2)
Pd(II)##33##1##(2008-10#33)
Pd(II))=0##2##1##(2008-10#2)
Pd(II))=1##2##1##(2008-10#2)
Pd(II)TMPyP was##2##2##(2008-10#2)
Pd(II)TMPyP##5##1##(2008-10#5)
Pd(MQ)(2)##3##1##(2008-10#3)
Pd(NO(3))(2) were##2##2##(2008-10#2)
Pd(NO(3))(2)##3##1##(2008-10#3)
Pd(OAc)(2)##2##1##(2008-10#2)
Pd(acac)(2)##2##1##(2008-10#2)
Pd)##2##1##(2008-10#2)
Pd-catalyzed##2##1##(2009-5#1)(2010-8#1)
Pdx is the##2##3##(1994-5#2)
Pdx##11##1##(1994-5#11)
Pea##9##1##(2008-10#9)
Peach mosaic virus##2##3##(2008-10#2)
Peach##15##1##(2008-10#14)(2008-11#1)
Peak area ratios among##2##4##(2008-10#2)
Peak height##2##2##(2008-10#2)
Peak##16##1##(1990-12#1)(1994-12#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-3#1)(2010-3#2)(2012-2#1)(2013-8#1)
Peaks##3##1##(1997-2#1)(2008-10#2)
Peanut Stunt##2##2##(2008-10#2)
Peanut bud necrosis virus##2##4##(2008-10#2)
Peanut stunt virus##2##3##(2008-10#2)
Peanut##12##1##(2008-10#12)
Pear and Apple##2##3##(2008-10#2)
Pear and##3##2##(2008-10#3)
Pear plants inoculated with##2##4##(2008-10#2)
Pear##16##1##(2008-10#16)
Pears##2##1##(2008-10#2)
Pearson correlation coefficients##2##3##(2008-12#2)
Pearson correlation##4##2##(2008-1#1)(2008-12#2)(2012-2#1)
Pearson correlations and##2##3##(2009-12#1)(2013-1#1)
Pearson correlations##3##2##(2009-12#1)(2011-1#1)(2013-1#1)
Pearson r = 0##2##4##(2011-3#2)
Pearson##13##1##(1992-2#1)(1992-3#1)(2008-1#1)(2008-12#2)(2009-12#1)(2010-4#1)(2011-1#1)(2011-3#2)(2012-2#1)(2013-1#2)
Pearson's r##2##2##(2008-7#1)(2008-9#1)
Pearson's##3##1##(2008-7#1)(2008-9#1)(2012-2#1)
Peat##4##1##(2008-10#4)
Pectin##2##1##(2008-10#1)(2011-2#1)
Pectobacterium spp##4##2##(2008-10#4)
Pectobacterium##6##1##(2008-10#6)
Pectoral##2##1##(2008-5#1)(2009-7#1)
Ped gene##4##2##(2008-5#4)
Ped##6##1##(2008-5#6)
Pedagogical##2##1##(2011-2#2)
Pedal##2##1##(2010-2#1)(2011-2#1)
Pediatric Brain Tumor Consortium##2##4##(2010-5#2)
Pediatric Cardiac Care Consortium##2##4##(2010-6#2)
Pediatric Cardiac##3##2##(2008-11#1)(2010-6#2)
Pediatric Emergency Department##2##3##(2013-8#2)
Pediatric Endocrinology##2##2##(2008-3#1)(2010-10#1)
Pediatric##41##1##(1992-2#2)(1993-9#1)(1995-11#1)(2008-10#11)(2008-11#1)(2008-3#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-4#2)(2010-5#2)(2010-6#3)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#3)(2013-8#3)
Pediatrics##6##1##(1991-6#1)(1996-6#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
Peel##2##1##(1991-2#1)(2012-3#1)
Peer support##2##2##(1993-3#1)(2009-5#1)
Peer##7##1##(1993-3#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#3)
Peg-Interferon and ribavirin##2##3##(2013-1#2)
Peg-Interferon and##3##2##(2013-1#3)
Peg-Interferon##5##1##(2013-1#5)
Pej-SGP-III##2##1##(2008-5#2)
Peltier cooling##2##2##(2008-10#1)(2008-3#1)
Peltier##5##1##(2008-10#1)(2008-3#1)(2008-9#3)
Pelvic##3##1##(1994-1#1)(2011-2#1)(2012-12#1)
Pemberton osteotomy##3##2##(2009-3#3)
Pena##2##1##(1995-6#2)
Penaeus japonicus##4##2##(2008-5#2)(2008-6#2)
Penedés##2##1##(2008-10#2)
Penetrating##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
Penetration by##2##2##(2008-10#2)
Penetration occurred##2##2##(2008-10#2)
Penetration of the##3##3##(2008-10#3)
Penetration of##6##2##(2008-10#5)(2008-5#1)
Penetration##13##1##(2008-10#11)(2008-5#1)(2009-12#1)
Peng##2##1##(2008-11#1)(2009-10#1)
Penh##3##1##(2008-10#2)(2010-11#1)
Penicillins##2##1##(2011-1#1)(2011-2#1)
Penicillium digitatum were##2##3##(2008-10#2)
Penicillium digitatum##9##2##(2008-10#9)
Penicillium expansum##12##2##(2008-10#12)
Penicillium marneffei##2##2##(2011-2#2)
Penicillium oxalicum##4##2##(2008-10#4)
Penicillium spp##3##2##(2008-10#2)(2013-1#1)
Penicillium##41##1##(1992-5#1)(1993-12#1)(2008-10#34)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
Penile prosthesis insertion##2##3##(2013-8#2)
Penile##3##1##(2013-8#3)
Peninsula##4##1##(2008-10#2)(2010-8#1)(2013-8#1)
Peninsular##2##1##(2008-12#1)(2009-8#1)
Pennisetum flowering##2##2##(2008-10#2)
Pennisetum glaucum subsp##2##3##(2008-10#2)
Pennisetum glaucum##3##2##(2008-10#3)
Pennisetum##7##1##(2008-10#7)
Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE)##2##8##(1992-1#1)(1995-1#1)
Pennsylvania isolates##3##2##(2008-10#3)
Pennsylvania##26##1##(1990-11#1)(1992-1#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-10#10)(2008-11#1)(2010-1#1)(2010-11#1)
Pentagon##3##1##(1992-3#1)(1996-5#2)
Pentastiridius##2##1##(2008-10#2)
Pentatomidae)##3##1##(2008-7#2)(2013-8#1)
People in##2##2##(2010-11#1)(2013-1#1)
People with AIDS##4##3##(1995-6#2)(1996-5#2)
People with##8##2##(1995-6#2)(1996-5#2)(2008-11#1)(2009-6#1)(2012-2#1)(2013-1#1)
People##22##1##(1993-12#1)(1995-1#1)(1995-6#2)(1996-2#1)(1996-5#2)(1997-6#1)(2008-11#3)(2008-7#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#3)
People's##6##1##(1990-2#1)(2008-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2013-8#1)
Pep13##2##1##(2008-10#2)
PepGMV did not##2##3##(2008-10#2)
PepGMV##4##1##(2008-10#4)
PepMoV##4##1##(2008-10#4)
Pepper (Capsicum annuum)##2##3##(2008-10#2)
Pepper huasteco virus##2##3##(2008-10#2)
Pepper mild mottle virus (PMMoV)##2##5##(2008-10#2)
Pepper mild mottle virus##4##4##(2008-10#4)
Pepper plants##2##2##(2008-10#2)
Pepper veinal mottle virus##2##4##(2008-10#2)
Pepper##23##1##(2008-10#23)
Peptic ulcer##2##2##(1996-11#1)(2011-2#1)
Peptic##4##1##(1995-3#1)(1996-11#1)(1997-1#1)(2011-2#1)
Peptidase##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
Peptide in##3##2##(2008-10#3)
Peptide mapping##3##2##(1992-9#1)(2008-10#1)(2012-3#1)
Peptide##22##1##(1992-9#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#2)(2011-2#4)(2012-3#3)(2013-8#1)
Peptides and##2##2##(1995-3#1)(2011-3#1)
Peptides corresponding to##2##3##(1991-3#1)(1993-3#1)
Peptides##12##1##(1991-3#2)(1993-3#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-4#1)(2011-3#1)(2012-3#1)
Per2##2##1##(2009-8#2)
Pera##2##1##(2008-10#2)
Perceived##12##1##(2008-11#1)(2008-12#1)(2009-4#2)(2009-7#1)(2010-1#3)(2010-9#1)(2011-10#1)(2011-2#1)(2013-8#1)
Percent germination of##2##3##(2008-10#2)
Percent germination##3##2##(2008-10#3)
Percent wilt (Y)##2##3##(2008-10#2)
Percent##9##1##(1993-12#1)(2008-10#8)
Percentage Rise in##2##3##(2012-2#2)
Percentage of##4##2##(2008-10#2)(2008-12#1)(2009-6#1)
Percentage##10##1##(2008-10#3)(2008-12#1)(2009-6#1)(2012-2#5)
Percentages of##2##2##(2008-11#1)(2011-2#1)
Perception of##5##2##(1991-2#1)(2008-9#1)(2009-4#1)(2013-1#2)
Perception##7##1##(1991-2#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-1#2)
Perceptions and##3##2##(2010-10#1)(2010-11#1)(2010-4#1)
Perceptions of##7##2##(1990-6#1)(1993-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2009-5#1)(2013-1#1)
Perceptions##11##1##(1990-6#1)(1993-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2013-1#1)
Perchlorate##4##1##(2008-10#4)
Percoll gradient centrifugation##2##3##(1995-12#1)(2008-4#1)
Percoll##4##1##(1995-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
Percutaneous transluminal coronary angioplasty##3##4##(1992-9#1)(2008-11#2)
Percutaneous transluminal coronary##4##3##(1991-3#1)(1992-9#1)(2008-11#2)
Percutaneous transluminal##6##2##(1991-3#1)(1992-9#1)(1994-9#1)(2008-11#3)
Percutaneous treatment of a##2##4##(1997-8#2)
Percutaneous treatment of##3##3##(1997-8#3)
Percutaneous##19##1##(1991-3#1)(1992-9#1)(1994-9#1)(1997-8#3)(2008-11#4)(2009-10#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)
Perennial Ryegrass##2##2##(2008-10#2)
Perennial##3##1##(2008-10#3)
Perforation##2##1##(1995-10#2)
Performance Citation Award##2##3##(1991-3#1)(1992-3#1)
Performance Liquid Chromatography##2##3##(2008-10#2)
Performance Liquid##3##2##(1997-2#1)(2008-10#2)
Performance and##4##2##(1995-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
Performance in##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
Performance of the##7##3##(1993-3#1)(2008-10#4)(2008-5#1)(2011-2#1)
Performance of##14##2##(1993-3#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#2)
Performance status##2##2##(1992-2#1)(2008-7#1)
Performance##52##1##(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-2#3)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#4)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-8#2)
Performing multiple analyses of the spiked samples assessed the repeatability of the procedure##2##13##(2008-10#2)
Performing##9##1##(1991-3#1)(2008-10#4)(2008-11#2)(2010-11#1)(2010-9#1)
Perfusion##4##1##(1993-3#1)(1994-5#1)(2008-11#1)(2012-3#1)
Perhaps the##3##2##(1996-3#1)(2007-12#1)(2008-10#1)
Perhaps##6##1##(1993-3#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#1)
Peri-operative##3##1##(2008-11#1)(2013-1#2)
Perinatal##9##1##(1994-3#2)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#3)(2013-1#1)
Period in##2##2##(2008-10#1)(2012-3#1)
Period##7##1##(2008-10#5)(2008-5#1)(2012-3#1)
Periodic limb movements##2##3##(2008-11#1)(2012-3#1)
Periodic##7##1##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-3#2)(2013-7#1)
Periodically Poled##2##2##(2008-3#2)
Periodically##4##1##(2008-10#1)(2008-3#3)
Periodontal##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
Periods##3##1##(2008-10#2)(2011-1#1)
Perioperative##5##1##(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
Periosteum-derived##2##1##(2008-11#2)
Peripheral arterial disease##2##3##(2008-8#2)
Peripheral blood samples were##2##4##(2011-2#1)(2013-1#1)
Peripheral blood samples##3##3##(2010-1#1)(2011-2#1)(2013-1#1)
Peripheral blood##8##2##(1991-2#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#1)(2013-1#2)
Peripheral motor##2##2##(2008-7#2)
Peripheral##24##1##(1991-2#1)(1992-6#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2010-1#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
Periplaneta americana##2##2##(1990-5#2)
Peritoneal dialysis##4##2##(2011-2#4)
Peritoneal##9##1##(1990-2#1)(2009-8#1)(2011-2#6)(2012-2#1)
Peritonitis##3##1##(2008-5#1)(2011-2#1)(2012-3#1)
Peritrophic membrane##2##2##(2008-7#2)
Perloza##4##1##(2008-7#4)
Permanent gases inside##2##3##(1993-3#2)
Permanent##7##1##(1993-3#2)(1994-8#1)(1995-3#1)(1996-3#1)(1997-6#1)(2011-2#1)
Permanente##6##1##(1995-2#1)(2008-11#1)(2010-8#3)(2011-2#1)
Permeability##2##1##(1992-3#1)(2011-3#1)
Perna canaliculus##2##2##(2008-10#1)(2009-6#1)
Perna##3##1##(2008-10#2)(2009-6#1)
Peronospora tabacina##15##2##(2008-10#15)
Peronospora##18##1##(2008-10#18)
Peroxidase##6##1##(1994-5#1)(2008-10#5)
Peroxidase-like##2##1##(2008-10#2)
Peroxisome proliferator-activated receptor##2##3##(1994-12#1)(2008-1#1)
Peroxisome##3##1##(1993-9#1)(1994-12#1)(2008-1#1)
Peroxynitrite##4##1##(2008-10#3)(2011-1#1)
Persian Gulf##4##2##(1992-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
Persian##8##1##(1992-12#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Persistence of##5##2##(1995-9#1)(2007-11#1)(2008-10#2)(2009-6#1)
Persistence##9##1##(1995-9#1)(2007-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-6#2)(2013-1#1)
Persistent##15##1##(1990-5#1)(1992-5#2)(1993-1#1)(1995-9#1)(1996-9#1)(2008-10#2)(2009-10#1)(2010-12#2)(2010-8#1)(2013-1#3)
Persistently##2##1##(2008-11#1)(2011-2#1)
Personal experience##3##2##(1990-3#2)(1992-5#1)
Personal##14##1##(1990-3#2)(1990-9#1)(1992-5#1)(1995-2#1)(1997-3#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-3#1)(2010-4#1)
Personality characteristics of##2##3##(2009-5#1)(2010-1#1)
Personality##8##1##(2008-1#1)(2008-11#2)(2009-5#1)(2010-1#1)(2010-10#1)(2012-3#2)
Personnel##5##1##(1991-1#1)(1996-5#1)(2008-10#1)(2008-12#1)(2009-12#1)
Persons with##3##2##(1994-1#1)(1996-1#1)(2009-6#1)
Persons##7##1##(1992-3#1)(1994-1#1)(1996-1#1)(1996-11#1)(2008-11#1)(2009-6#1)(2013-1#1)
Perspective##7##1##(1991-12#1)(2008-6#1)(2009-12#1)(2010-5#1)(2010-8#1)(2012-3#2)
Perspectives in##2##2##(1997-1#1)(2008-11#1)
Perspectives on psychological burnout##2##4##(1992-1#1)(1997-1#1)
Perspectives on##8##2##(1990-8#1)(1992-1#1)(1995-3#1)(1997-1#1)(2008-11#2)(2009-4#1)(2010-1#1)
Perspectives##18##1##(1990-8#1)(1992-1#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-1#2)(1997-2#1)(2008-10#2)(2008-11#3)(2009-4#1)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#1)
Perth and Sydney##2##3##(2008-10#2)
Perth##4##1##(2008-10#3)(2008-5#1)
Perturbation of##2##2##(1993-8#1)(2009-12#1)
Perturbations##3##1##(1993-8#1)(2008-10#2)
Pertussis##4##1##(1990-11#1)(1992-9#1)(1996-2#1)(1997-8#1)
Peru##16##1##(1992-5#3)(2008-10#6)(2008-11#1)(2008-5#1)(2010-10#1)(2013-1#4)
Peruvian Andes##2##2##(2008-10#2)
Peruvian##9##1##(2008-10#4)(2011-2#1)(2013-8#4)
Pest Management Regulatory##2##3##(2008-11#2)
Pesticide##6##1##(1996-3#1)(2008-10#2)(2008-11#3)
Peter R##2##2##(1993-12#2)
Peter Torkildsen (R-MA)##2##3##(1996-5#2)
Peter##11##1##(1990-11#1)(1993-12#2)(1994-1#1)(1995-12#2)(1996-5#2)(2008-5#2)(2010-5#1)
Petersburg##4##1##(2008-12#3)(2013-8#1)
Peterson##2##1##(1994-5#2)
Petri dish##2##2##(2008-11#1)(2009-8#1)
Petri dishes##3##2##(2008-11#3)
Petri##6##1##(2008-10#1)(2008-11#4)(2009-8#1)
Petroselinum crispum (Parsley)##2##3##(2008-12#2)
Petroselinum crispum##5##2##(2008-12#5)
Petrous##4##1##(2008-7#1)(2011-2#3)
Petunia hybrida##5##2##(2008-10#2)(2008-9#3)
Petunia##6##1##(2008-10#3)(2008-9#3)
Peutz-Jeghers syndrome##3##2##(2009-12#3)
Peyer's Patch##4##2##(2008-11#3)(2013-1#1)
Peyer's patch (PP)##2##3##(2008-11#2)
Peyer's patch##4##2##(2008-11#4)
Peyer's patches##2##2##(1997-1#1)(2008-11#1)
Peyer's##12##1##(1997-1#1)(2008-11#8)(2009-9#1)(2013-1#2)
Pf-5##7##1##(2008-10#7)
PfTrx-2##6##1##(2012-2#6)
Pfam##3##1##(2008-4#1)(2009-10#1)(2009-8#1)
Pfm1##3##1##(2008-10#3)
Pg genes##4##2##(2008-10#4)
Pg10 line##2##2##(2008-10#2)
Pg10 was##2##2##(2008-10#2)
Pg10##7##1##(2008-10#7)
Pgh3-2##2##1##(1993-9#2)
Pgi##2##1##(2012-3#2)
Pgp##3##1##(2008-11#3)
Pgt-QCCJ##3##1##(2008-10#3)
Ph##10##1##(1994-12#3)(1995-2#2)(2008-10#1)(2008-12#4)
PhHg and Hg (II)##2##4##(2008-10#2)
PhIP##5##1##(1992-6#2)(1997-2#3)
Phaeocryptopus gaeumannii##5##2##(2008-10#5)
Phaeoisariopsis griseola##3##2##(2008-10#3)
Phaeosphaeria nodorum##7##2##(2008-10#7)
Phaeosphaeria##8##1##(2008-10#8)
Phage display##4##2##(1993-8#1)(2008-4#3)
Phage##10##1##(1993-8#2)(1993-9#1)(2008-10#2)(2008-4#3)(2012-2#2)
Phakopsora pachyrhizi and P##2##4##(2008-10#2)
Phakopsora pachyrhizi##4##2##(2008-10#4)
Phakopsora##5##1##(2008-10#5)
Phallusia mamillata##2##2##(2008-5#2)
Phanerochaete chrysosporium was##2##3##(2008-11#1)(2008-6#1)
Phanerochaete chrysosporium##8##2##(1990-12#1)(2008-11#1)(2008-6#3)(2008-7#2)(2009-9#1)
Pharmaceutical residues##2##2##(2008-10#2)
Pharmaceutical##14##1##(1992-1#1)(1995-1#2)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
Pharmaceuticals##3##1##(2008-10#2)(2010-11#1)
Pharmacists##2##1##(1994-12#1)(2011-1#1)
Pharmacoepidemiology##4##1##(2008-11#4)
Pharmacogenomic testing##2##2##(2013-8#2)
Pharmacogenomics##2##1##(2008-8#1)(2013-8#1)
Pharmacokinetic studies##2##2##(1997-1#1)(2008-7#1)
Pharmacokinetic##9##1##(1991-2#1)(1997-1#1)(2008-10#1)(2008-12#2)(2008-7#2)(2011-2#1)(2013-8#1)
Pharmacokinetics of##2##2##(2008-7#1)(2011-3#1)
Pharmacol##2##1##(1990-10#1)(2012-3#1)
Pharmacologic ascorbate can##2##3##(2012-2#2)
Pharmacologic##4##1##(1991-1#1)(2011-10#1)(2012-2#2)
Pharmacological and##2##2##(2011-2#1)(2012-3#1)
Pharmacological effects of##2##3##(1992-6#1)(2013-1#1)
Pharmacological studies##2##2##(1995-11#1)(2009-7#1)
Pharmacological##15##1##(1991-3#1)(1991-7#1)(1992-6#1)(1992-9#1)(1995-11#2)(2008-10#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
Pharmacology and Drug Therapy##2##4##(2013-1#2)
Pharmacopoeia procedure at##2##3##(2008-10#2)
Pharmacopoeia##10##1##(2008-10#10)
Pharmacotherapy and psychotherapy##2##3##(2008-4#1)(2013-1#1)
Pharmacotherapy for##2##2##(2008-4#1)(2009-12#1)
Pharmacotherapy##6##1##(1995-2#1)(2008-11#1)(2008-4#2)(2009-12#1)(2013-1#1)
Pharmacy##4##1##(1991-3#1)(1994-12#1)(2008-11#1)(2010-3#1)
Phase 2##2##2##(2011-2#2)
Phase I##10##2##(1994-8#1)(1994-9#1)(1995-10#1)(1996-10#1)(1997-1#1)(2008-5#1)(2012-3#4)
Phase II##2##2##(2008-10#1)(2008-5#1)
Phase III##4##2##(2008-5#1)(2010-11#1)(2012-2#1)(2013-1#1)
Phase Separations##2##2##(1997-2#1)(2008-10#1)
Phase unwrapping with the branch-cut method##2##6##(2008-3#2)
Phase##40##1##(1994-8#1)(1994-9#1)(1995-10#1)(1996-10#1)(1996-9#4)(1997-1#1)(1997-2#1)(2008-10#5)(2008-3#7)(2008-5#4)(2008-8#1)(2010-11#2)(2011-2#3)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
Phaseolus coccineus##2##2##(2008-10#1)(2008-3#1)
Phaseolus spp##2##2##(2008-10#2)
Phaseolus vulgaris##8##2##(2008-10#3)(2008-11#2)(2010-3#1)(2013-8#2)
Phaseolus##13##1##(1997-3#1)(2008-10#6)(2008-11#2)(2008-3#1)(2010-3#1)(2013-8#2)
Phases##5##1##(1994-8#1)(2008-10#2)(2009-8#1)(2012-3#1)
Phazyme assay##3##2##(2012-2#3)
Phazyme assays correctly##2##3##(2012-2#2)
Phazyme assays##3##2##(2012-2#3)
Phazyme##6##1##(2012-2#6)
Phe and Arg##2##3##(1992-4#2)
Phe or##2##2##(1992-4#1)(1995-2#1)
Phe##8##1##(1992-4#4)(1993-2#1)(1995-2#1)(2008-9#2)
Phe- Tyr- Ala- Pro- Met- NH2##2##6##(1991-5#2)
Phe- Tyr- Gly- Leu- Met- NH2 (ranatachykinin##2##7##(1991-5#2)
Phe- Tyr-##4##2##(1991-5#4)
Phe-##6##1##(1991-5#6)
Phe-Met##3##1##(2008-10#3)
Phellinus##3##1##(2008-10#3)
Phenolic compounds##2##2##(2008-10#1)(2011-2#1)
Phenolic##6##1##(1995-9#1)(2008-10#3)(2008-5#1)(2011-2#1)
Phenology##2##1##(2008-10#2)
Phenols in##2##2##(2008-10#2)
Phenomena##4##1##(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)
Phenotype analysis##2##2##(2008-5#1)(2008-8#1)
Phenotype in##2##2##(2012-3#1)(2013-1#1)
Phenotype##7##1##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Phenotypes of##2##2##(2008-10#2)
Phenotypic analysis of##2##3##(2008-10#1)(2008-9#1)
Phenotypic and##4##2##(2008-10#4)
Phenotypic diversity##2##2##(2008-10#1)(2012-3#1)
Phenotypic##15##1##(2008-10#9)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#2)
Phentanil and##2##2##(2012-3#2)
Phentanil##3##1##(2012-3#3)
Phenylephrine did not##2##3##(1991-3#1)(1994-3#1)
Phenytoin##3##1##(1994-2#1)(2008-11#2)
Pheochromocytoma##2##1##(2009-1#2)
Pheophorbide a##2##2##(2008-8#2)
Phi##3##1##(2008-10#3)
PhiC31##2##1##(2008-11#2)
Phialophora gregata##4##2##(2008-10#4)
Phialophora##6##1##(2008-10#6)
Philadelphia##8##1##(1991-1#1)(1991-12#1)(1992-2#1)(1996-5#1)(1997-6#1)(2009-5#1)(2010-1#1)(2010-11#1)
Philanthropy##3##1##(1991-1#1)(1993-3#1)(1995-1#1)
Philip##4##1##(1997-2#1)(2008-11#1)(2008-9#1)(2009-7#1)
Philippine races of##2##3##(2008-10#2)
Philippine strain##3##2##(2008-10#3)
Philippine##10##1##(1990-6#1)(1994-6#1)(2008-10#8)
Philippines##3##1##(1990-6#1)(2008-10#2)
Phillip##2##1##(2008-10#1)(2008-8#1)
Phillips##2##1##(1995-12#1)(1995-3#1)
Philosopher's##2##1##(2008-4#1)(2012-3#1)
Philosophy##3##1##(2010-3#2)(2011-2#1)
Phl p 1##3##3##(2012-2#3)
Phl production##2##2##(2008-10#2)
Phl##6##1##(2008-10#3)(2012-2#3)
Phlebotominae sand flies are##2##4##(2008-12#2)
Phlebotominae sand flies##4##3##(2008-12#4)
Phlebotominae##5##1##(2008-12#5)
Phlebotomus##3##1##(2010-1#1)(2013-1#2)
Phlebovirus is##3##2##(2013-8#3)
Phlebovirus##5##1##(2013-8#5)
Phloem##2##1##(2008-10#2)
Phlomobacter##3##1##(2008-10#3)
Phobia##2##1##(2013-1#2)
Pholidoptera##2##1##(2008-12#2)
Phoma macdonaldii##2##2##(2008-10#2)
Phoma medicaginis##2##2##(2008-10#2)
Phoma species are##2##3##(2008-10#2)
Phoma##12##1##(2008-10#12)
Phomopsis leaf blight##4##3##(2008-10#4)
Phomopsis longicolla##5##2##(2008-10#5)
Phomopsis sp##2##2##(2008-10#2)
Phomopsis viticola##4##2##(2008-10#4)
Phomopsis##29##1##(2008-10#29)
Phoracantha semipunctata##2##2##(2007-12#2)
Phorbol##2##1##(1993-8#1)(1997-1#1)
Phosphatase##2##1##(2008-11#1)(2008-12#1)
Phosphate##6##1##(2008-10#4)(2008-11#2)
Phosphatidylinositol 3-kinase (PI 3-kinase)##2##4##(1993-8#1)(1994-11#1)
Phosphatidylinositol##4##1##(1993-8#1)(1994-11#1)(1996-2#1)(2008-11#1)
Phosphatidylserine##2##1##(1995-2#1)(2012-2#1)
Phosphine##3##1##(2008-11#3)
Phosphite##3##1##(1996-5#1)(2008-10#2)
Phospholipid##2##1##(1994-8#1)(2009-8#1)
Phospholipids##3##1##(1991-5#1)(2009-8#2)
Phosphonic##3##1##(1996-5#1)(2008-10#2)
Phosphorus##5##1##(2008-10#3)(2008-11#1)(2008-12#1)
Phosphorylated##3##1##(1993-8#1)(2009-8#1)(2013-1#1)
Phosphorylation and##2##2##(1994-11#1)(1995-6#1)
Phosphorylation of the##2##3##(1990-10#1)(1992-6#1)
Phosphorylation of##8##2##(1990-10#1)(1992-6#1)(1993-8#1)(1994-11#1)(2008-1#1)(2008-11#1)(2011-2#2)
Phosphorylation##11##1##(1990-10#1)(1992-6#1)(1993-8#1)(1994-11#2)(1995-6#1)(2008-1#1)(2008-11#1)(2011-2#3)
Photo-induced##2##1##(2008-11#1)(2008-8#1)
Photoacoustic ophthalmoscopy##2##2##(2011-7#2)
Photoacoustic##7##1##(1994-11#1)(2008-10#1)(2008-3#2)(2009-12#1)(2011-7#2)
Photochemical##5##1##(1996-5#1)(2008-10#3)(2008-7#1)
Photodarkening##2##1##(2008-3#2)
Photodynamic therapy (PDT)##3##3##(1994-1#1)(2013-8#2)
Photodynamic therapy##9##2##(1992-1#1)(1993-11#1)(1994-1#1)(2008-7#1)(2012-3#2)(2013-8#3)
Photodynamic##12##1##(1992-1#1)(1993-11#1)(1994-1#1)(2008-7#1)(2009-3#1)(2012-2#1)(2012-3#2)(2013-8#4)
Photofrin II was##3##3##(1993-8#2)(1994-1#1)
Photofrin II##6##2##(1993-8#5)(1994-1#1)
Photographic and##2##2##(1994-2#1)(2008-5#1)
Photographic##3##1##(1994-2#1)(2008-5#1)(2013-1#1)
Photographs were taken##2##3##(2008-5#1)(2012-3#1)
Photographs were##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
Photoinduced##2##1##(1996-5#1)(2008-10#1)
Photolysis of##2##2##(1996-5#2)
Photometric##3##1##(2008-10#3)
Photon##5##1##(1994-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
Photonic##3##1##(1996-9#1)(2008-3#2)
Photoreceptor##2##1##(2007-12#1)(2008-7#1)
Photorefractive##3##1##(2008-3#3)
Photorhabdus luminescens##2##2##(2008-10#1)(2008-11#1)
Photosensitivity##3##1##(2011-2#3)
Photosensitizer##2##1##(2008-11#1)(2013-8#1)
Photosynthetic##3##1##(2008-10#1)(2008-8#1)(2012-6#1)
Photothermal##2##1##(2008-3#2)
Phototrophic biofilms##2##2##(2009-4#2)
Phrap##3##1##(2008-4#3)
Phred##2##1##(2008-4#2)
Phyllomedusa bicolor##2##2##(1993-3#1)(1994-5#1)
Phyllomedusa##4##1##(1993-3#2)(1994-5#2)
Phylloplane##2##1##(2008-10#2)
Phyllosphere##3##1##(2008-10#3)
Phyllosticta##4##1##(2008-10#4)
Phyllotaxis##2##1##(2009-8#2)
Phylogenetic Analyses of##3##3##(2008-10#3)
Phylogenetic Analysis of##2##3##(2008-10#2)
Phylogenetic Analysis##3##2##(2008-10#3)
Phylogenetic Relationships##2##2##(2008-10#2)
Phylogenetic analyses of##3##3##(2008-10#3)
Phylogenetic analyses revealed that the##2##5##(2008-10#1)(2010-3#1)
Phylogenetic analyses using##2##3##(2008-10#2)
Phylogenetic analyses were used for quality assurance purposes and for the determination of the haplogroup affiliation of the samples##2##19##(2008-12#2)
Phylogenetic analyses##14##2##(2008-10#10)(2008-12#2)(2010-3#1)(2011-1#1)
Phylogenetic analysis based on##2##4##(2008-10#1)(2013-8#1)
Phylogenetic analysis of the ITS##2##5##(2008-10#1)(2010-3#1)
Phylogenetic analysis of the##8##4##(1993-12#1)(2008-10#5)(2008-12#1)(2010-3#1)
Phylogenetic analysis of##17##3##(1993-12#1)(2008-10#14)(2008-12#1)(2010-3#1)
Phylogenetic analysis revealed that##2##4##(2008-10#1)(2013-8#1)
Phylogenetic analysis showed that##2##4##(2008-10#1)(2010-5#1)
Phylogenetic analysis##28##2##(1993-12#1)(2008-10#21)(2008-12#1)(2008-9#1)(2010-3#1)(2010-5#1)(2013-8#2)
Phylogenetic and##2##2##(2008-10#1)(2013-1#1)
Phylogenetic relationships among six species of Epistylis##2##7##(2008-9#2)
Phylogenetic relationships within the##2##4##(2008-6#1)(2010-4#1)
Phylogenetic relationships##7##2##(2008-6#3)(2008-9#2)(2010-3#1)(2010-4#1)
Phylogenetic studies##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
Phylogenetic tree##3##2##(2008-8#2)(2013-8#1)
Phylogenetic trees##3##2##(2008-10#3)
Phylogenetic##75##1##(1993-12#1)(1996-12#1)(1997-6#1)(2008-10#48)(2008-12#4)(2008-6#3)(2008-8#2)(2008-9#3)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#4)
Phylogenetically Different##2##2##(2008-10#2)
Phylogenetically##4##1##(2008-10#3)(2008-7#1)
Phylogenic##2##1##(1997-9#1)(2008-10#1)
Phylogenies##2##1##(2008-10#2)
Phylogeny and##2##2##(2008-10#1)(2010-3#1)
Phylogeny of##3##2##(2008-10#1)(2008-8#1)(2009-6#1)
Phylogeny##6##1##(2008-10#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-3#1)
Phylogeography and##2##2##(2008-10#1)(2013-1#1)
Phylogeography##3##1##(2008-10#2)(2013-1#1)
Phys##4##1##(2007-11#1)(2008-10#2)(2008-3#1)
Physalospora vaccinii##2##2##(2008-10#2)
Physical Activity Scale for the Elderly##2##6##(2008-4#1)(2013-1#1)
Physical Activity and##2##3##(2011-2#1)(2013-1#1)
Physical Activity##12##2##(2008-4#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#5)
Physical Functioning##2##2##(2013-1#2)
Physical Properties##2##2##(1997-3#1)(2008-10#1)
Physical Therapy##2##2##(1994-3#1)(2008-12#1)
Physical activity and##4##3##(1991-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
Physical activity##8##2##(1991-2#1)(1993-2#1)(2008-11#2)(2009-3#1)(2011-2#1)(2013-1#2)
Physical aging##2##2##(1995-3#2)
Physical and chemical##2##3##(2008-10#1)(2010-4#1)
Physical and##5##2##(2008-10#1)(2008-8#1)(2010-4#1)(2010-8#1)(2013-8#1)
Physical examination##3##2##(1991-3#1)(2008-10#1)(2009-6#1)
Physical mapping of rice chromosomes##2##5##(1996-12#1)(1997-2#1)
Physical mapping of##4##3##(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)
Physical maps of##2##3##(1997-2#2)
Physical properties of##2##3##(1991-1#1)(1996-3#1)
Physical therapists##2##2##(1992-3#2)
Physical therapy management##2##3##(2008-12#2)
Physical therapy##3##2##(1996-6#1)(2008-12#2)
Physical##72##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-3#2)(1993-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-2#3)(1997-3#2)(1997-6#1)(2008-10#6)(2008-11#3)(2008-12#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#7)(2013-1#13)(2013-8#1)
Physician leadership##2##2##(1992-1#1)(1994-1#1)
Physician payment reform##2##3##(1991-2#1)(1994-1#1)
Physician payment##4##2##(1991-2#2)(1994-1#2)
Physician##28##1##(1991-12#1)(1991-2#3)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-1#6)(1994-12#1)(1994-2#2)(1995-1#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-4#1)(2009-2#2)(2012-2#1)
Physician-patient##2##1##(1992-12#1)(2009-5#1)
Physicians and community##2##3##(2008-11#1)(2011-1#1)
Physicians and##5##2##(1994-12#1)(2008-11#2)(2011-1#1)(2013-1#1)
Physicians in a##2##3##(1996-1#1)(2008-4#1)
Physicians in##4##2##(1992-3#1)(1996-1#1)(2008-4#2)
Physicians must##3##2##(1994-2#1)(2012-12#1)(2013-8#1)
Physicians need##2##2##(2008-3#1)(2012-3#1)
Physicians of##3##2##(1993-12#1)(1996-8#2)
Physicians should##3##2##(2008-9#1)(2009-8#1)(2010-7#1)
Physicians take into account many factors when making referral decisions##2##10##(1994-1#2)
Physicians##38##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-12#3)(1994-1#2)(1994-12#3)(1994-2#2)(1996-1#2)(1996-3#1)(1996-8#2)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
Physicians'##3##1##(1993-2#1)(1995-2#1)(2010-4#1)
Physics##2##1##(1990-11#1)(2008-10#1)
PhysioDirect##3##1##(2011-2#3)
Physiol##2##1##(1994-8#1)(2008-10#1)
Physiologic##4##1##(2010-6#1)(2013-7#2)(2013-8#1)
Physiological and biochemical##2##3##(2008-10#1)(2012-6#1)
Physiological and##4##2##(2008-10#1)(2008-7#2)(2012-6#1)
Physiological##16##1##(1992-9#1)(1994-3#1)(1995-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#3)(2009-1#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#1)
Physiology##3##1##(2008-10#1)(2010-7#1)(2011-2#1)
Physiotherapists##2##1##(1993-3#1)(1994-3#1)
Physiotherapy##7##1##(1992-12#1)(1992-2#1)(1992-3#2)(1993-3#2)(2012-2#1)
Phytoestrogens are##2##2##(2008-10#2)
Phytoestrogens##3##1##(2008-10#2)(2008-11#1)
Phytohealth&quot##2##1##(2008-10#2)
Phytomonas françai##2##2##(2008-10#2)
Phytomonas##3##1##(2008-10#3)
Phytomyxea##2##1##(2012-2#2)
Phytopathogenic##3##1##(2008-10#3)
Phytopathological##4##1##(2008-10#4)
Phytophthora and##3##2##(2008-10#3)
Phytophthora cactorum##2##2##(2008-10#2)
Phytophthora capsici##17##2##(2008-10#17)
Phytophthora cinnamomi was##2##3##(2008-10#2)
Phytophthora cinnamomi##15##2##(2008-10#15)
Phytophthora infestans in##13##3##(2008-10#13)
Phytophthora infestans is##3##3##(2008-10#3)
Phytophthora infestans was##2##3##(2008-10#2)
Phytophthora infestans were##3##3##(2008-10#3)
Phytophthora infestans##75##2##(2008-10#73)(2008-8#1)(2009-6#1)
Phytophthora megasperma)##2##2##(2008-10#2)
Phytophthora multivora sp##2##3##(2010-3#2)
Phytophthora multivora##3##2##(2010-3#3)
Phytophthora nicotianae and P##4##4##(2008-10#4)
Phytophthora nicotianae and##5##3##(2008-10#5)
Phytophthora nicotianae##11##2##(2008-10#11)
Phytophthora parasitica var##2##3##(2008-10#2)
Phytophthora parasitica##14##2##(2008-10#14)
Phytophthora ramorum##18##2##(2008-10#18)
Phytophthora root rot##3##3##(2008-10#3)
Phytophthora root##4##2##(2008-10#4)
Phytophthora sojae in##3##3##(2008-10#3)
Phytophthora sojae##8##2##(2008-10#8)
Phytophthora sp##2##2##(2008-10#2)
Phytophthora sp-h isolates##6##3##(2008-10#6)
Phytophthora species##7##2##(2008-10#6)(2010-3#1)
Phytophthora spp##26##2##(2008-10#26)
Phytophthora##249##1##(2008-10#243)(2008-8#1)(2009-6#1)(2010-3#4)
Phytoplankton##3##1##(2008-8#1)(2009-8#1)(2013-8#1)
Phytoplasma and##2##2##(2008-10#2)
Phytoplasma##14##1##(2008-10#14)
Phytoplasmas were detected##2##3##(2008-10#2)
Phytoplasmas##5##1##(2008-10#5)
Pi##9##1##(1990-2#3)(1990-5#2)(1995-6#1)(1997-7#1)(2010-8#2)
Pi-ta allele##3##2##(2008-10#3)
Pi-ta and##2##2##(2008-10#2)
Pi-ta gene##2##2##(2008-10#2)
Pi-ta locus##2##2##(2008-10#2)
Pi-ta##20##1##(2008-10#20)
Pi34 and##2##2##(2008-10#2)
Pi34##8##1##(2008-10#8)
Pi7(t)##8##1##(2008-10#8)
Piaget##2##1##(2009-10#2)
Pichia anomala Strain K##2##4##(2008-10#2)
Pichia anomala strain K##2##4##(2008-10#2)
Pichia anomala##4##2##(2008-10#4)
Pichia guilermondii##5##2##(2008-10#5)
Pichia pastoris##11##2##(1994-11#2)(1997-7#2)(2008-7#2)(2009-9#1)(2010-5#2)(2011-2#2)
Pichia##21##1##(1994-11#2)(1997-7#2)(2008-10#9)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#2)(2011-2#2)
Picking the right change strategy##3##5##(1993-1#1)(1993-12#1)(1993-2#1)
Picking the##4##2##(1993-1#1)(1993-12#1)(1993-2#1)(1995-1#1)
Picosecond##4##1##(2008-2#1)(2008-3#3)
Picture##3##1##(2008-7#2)(2008-9#1)
Piedmont##2##1##(2008-10#1)(2011-2#1)
Pierce##3##1##(1995-6#3)
Pierce's disease (PD)##3##3##(2008-10#3)
Pierce's disease##6##2##(2008-10#6)
Pierce's##9##1##(2008-10#9)
Pieris rapae##2##2##(2008-6#1)(2008-8#1)
Piezoelectric##3##1##(2008-10#3)
Pigeonpea##3##1##(2008-10#1)(2010-10#2)
Pigeons##2##1##(2008-5#2)
Pigment dispersion was##2##3##(2008-8#2)
Pigment epithelium-derived factor##2##3##(2008-7#1)(2012-5#1)
Pigment##6##1##(2008-10#2)(2008-7#1)(2008-8#2)(2012-5#1)
Pigmentation##2##1##(2008-5#1)(2008-6#1)
Pigmented Bowen's disease##2##3##(2010-6#2)
Pigmented Bowen's##3##2##(2010-6#3)
Pigmented villonodular synovitis (PVNS) is a##2##6##(2010-3#1)(2013-1#1)
Pigmented villonodular synovitis##3##3##(2010-3#2)(2013-1#1)
Pigmented##8##1##(1993-9#1)(2010-3#2)(2010-6#3)(2013-1#2)
Pilates and taiji quan##4##4##(2009-3#4)
Pilates##6##1##(2009-3#6)
PileUp##2##1##(2008-4#2)
Pilot Study of##2##3##(2012-3#1)(2013-1#1)
Pilot Study##5##2##(2008-12#3)(2012-3#1)(2013-1#1)
Pilot study of##2##3##(2008-11#2)
Pilot study##3##2##(2008-11#2)(2013-1#1)
Pilot##13##1##(1995-12#1)(2008-11#5)(2008-12#3)(2008-3#1)(2012-3#1)(2013-1#2)
Pima S-7 x##2##3##(2008-10#2)
Pima S-7##6##2##(2008-10#6)
Pima##8##1##(2008-10#6)(2010-7#2)
Pimelodidae)##2##1##(2008-12#1)(2008-7#1)
Pimelodus heraldoi and##2##3##(2008-12#2)
Pimelodus sp##3##2##(2008-12#3)
Pimelodus##6##1##(2008-12#6)
Pinard had##2##2##(1995-6#2)
Pinard##6##1##(1995-6#6)
Pine##12##1##(1992-2#1)(2008-10#10)(2008-11#1)
Pineapple##3##1##(2008-10#3)
Pinning##2##1##(1991-9#1)(1996-11#1)
Pinto##2##1##(2008-10#2)
Pinus pinaster##3##2##(2008-10#1)(2011-10#2)
Pinus radiata##4##2##(2008-10#4)
Pinus sylvestris##2##2##(2011-10#2)
Pinus##17##1##(2008-10#12)(2010-3#1)(2011-10#4)
PipMaker##5##1##(2008-4#5)
Piper sarmentosum##3##2##(2013-1#3)
Pipizini and##4##2##(2008-8#4)
Pipizini##6##1##(2008-8#6)
Piq6(t)##3##1##(2008-10#3)
Pirellula staleyi##2##2##(2011-2#2)
Pirellula##3##1##(2011-2#3)
Piriformospora indica##2##2##(2008-10#2)
Piriformospora##4##1##(2008-10#4)
Pisa##2##1##(2008-10#1)(2008-12#1)
Pistachio##4##1##(2008-10#4)
Pisum sativum##2##2##(2008-10#1)(2011-2#1)
Pisum##4##1##(2008-10#2)(2008-11#1)(2011-2#1)
Pit-1##5##1##(1993-8#5)
Pit-1/GHF-1##2##1##(1993-8#2)
Pitch canker##3##2##(2008-10#3)
Pitfalls##3##1##(1995-3#1)(2008-1#1)(2009-6#1)
Pittsburgh Conference##3##2##(2008-10#3)
Pittsburgh##10##1##(1993-2#4)(2008-10#3)(2008-5#2)(2011-2#1)
Pituitary##9##1##(1990-4#1)(1995-11#1)(2008-4#1)(2008-9#1)(2010-5#2)(2011-2#1)(2012-3#1)(2013-8#1)
Pitzer equations##3##2##(2008-10#3)
Pitzer##4##1##(2008-10#4)
Place of##2##2##(1993-9#1)(1995-11#1)
Placebo Factors in##2##3##(2009-10#1)(2009-9#1)
Placebo##3##1##(2008-5#1)(2009-10#1)(2009-9#1)
Placement of##3##2##(1995-5#1)(2008-10#1)(2009-2#1)
Placement##5##1##(1991-1#1)(1995-5#1)(2008-10#1)(2008-11#1)(2009-2#1)
Placing##2##1##(2008-10#2)
Plackett-Burman design##3##2##(2008-10#3)
Plackett-Burman experimental design##3##3##(2008-10#3)
Plackett-Burman##8##1##(2008-10#8)
Plain radiography of his left##2##5##(2009-1#2)
Plain##5##1##(2008-12#1)(2009-1#2)(2010-7#1)(2011-2#1)
Plains##14##1##(2008-10#11)(2008-2#1)(2008-3#1)(2010-9#1)
Plan##18##1##(1991-2#1)(1993-1#1)(1994-2#2)(1995-1#2)(1995-12#2)(1995-2#1)(1996-2#1)(2008-1#2)(2008-12#1)(2008-7#2)(2010-8#1)(2012-2#1)(2012-3#1)
Planar##2##1##(2008-3#2)
Planctomyces limnophilus##2##2##(2011-2#2)
Planes##2##1##(1996-9#1)(2008-3#1)
Planned Parenthood of##2##3##(1993-3#1)(1997-6#1)
Planned##4##1##(1993-3#1)(1997-6#1)(2011-1#1)(2013-1#1)
Planning and##6##2##(1991-1#1)(1991-12#1)(1992-3#1)(1994-12#1)(1995-2#1)(2008-10#1)
Planning for##5##2##(1991-2#1)(1992-12#1)(1992-3#1)(1994-1#1)(1996-1#1)
Planning##21##1##(1991-1#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-8#1)(2013-8#2)
Plans##3##1##(1993-1#1)(2008-11#1)(2012-3#1)
Plant Disease##3##2##(2008-10#3)
Plant Extracts##2##2##(2008-10#1)(2008-5#1)
Plant Journal we##2##3##(2009-8#2)
Plant Material##2##2##(2008-10#2)
Plant Pathogen##2##2##(2008-10#2)
Plant Pathogenic##2##2##(2008-10#2)
Plant Resistance##2##2##(2008-10#2)
Plant age##2##2##(2008-10#2)
Plant pathogen culture collections##2##4##(2008-10#2)
Plant polyphenols##3##2##(2009-8#2)(2012-12#1)
Plant##73##1##(1990-11#1)(1990-8#1)(2007-12#1)(2008-10#42)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-8#9)(2010-10#1)(2010-7#1)(2011-10#1)(2011-2#7)(2011-3#1)(2012-12#1)
Planta##7##1##(2008-10#4)(2009-8#3)
Plantago##4##1##(2008-10#3)(2013-1#1)
Plantar##3##1##(2008-7#1)(2012-2#2)
Plantation##2##1##(2008-10#1)(2012-2#1)
Plantations##3##1##(2008-10#3)
Planting##3##1##(2008-10#3)
Plants Expressing##2##2##(2008-10#2)
Plants by the##2##3##(2008-10#2)
Plants by##4##2##(2008-10#4)
Plants can##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
Plants exposed to##2##3##(2008-10#2)
Plants from##2##2##(2008-10#2)
Plants grown##3##2##(2008-10#3)
Plants of the##2##3##(2008-10#2)
Plants were inoculated##2##3##(2008-10#2)
Plants were sampled##2##3##(2008-10#1)(2013-8#1)
Plants were##5##2##(2008-10#4)(2013-8#1)
Plants##72##1##(1997-8#1)(2008-10#57)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#2)(2011-1#1)(2011-10#1)(2011-2#4)(2013-8#1)
Plaque Assay##6##2##(2008-10#6)
Plaque##8##1##(2008-10#6)(2012-2#2)
Plasma and##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
Plasma antioxidant##2##2##(2008-10#1)(2008-7#1)
Plasma cells##2##2##(2008-9#1)(2010-12#1)
Plasma concentrations of##3##3##(1992-3#1)(2008-11#1)(2013-1#1)
Plasma homocysteine concentrations in##2##4##(2008-7#1)(2012-3#1)
Plasma homocysteine concentrations##3##3##(2008-7#2)(2012-3#1)
Plasma homocysteine##4##2##(2008-7#3)(2012-3#1)
Plasma levels of##5##3##(1991-1#1)(1997-2#1)(2008-12#1)(2008-6#1)(2011-2#1)
Plasma membrane vesicles##2##3##(1993-8#1)(2008-11#1)
Plasma membrane##4##2##(1993-8#1)(1995-12#1)(2008-11#1)(2009-9#1)
Plasma samples were##2##3##(2008-10#2)
Plasma##63##1##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-8#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-8#1)(1997-2#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-5#1)(2008-6#4)(2008-7#10)(2008-9#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#5)(2012-3#4)(2013-1#2)
Plasmid##7##1##(2008-10#6)(2011-1#1)
Plasmids##3##1##(2008-10#2)(2008-11#1)
Plasminogen activator inhibitor-1##2##3##(1995-8#1)(2011-2#1)
Plasminogen activator##4##2##(1990-11#1)(1995-8#1)(2011-2#2)
Plasminogen##6##1##(1990-11#1)(1994-11#1)(1995-8#2)(2011-2#2)
Plasmodiophora brassicae##4##2##(2008-10#4)
Plasmodium berghei##2##2##(1992-6#1)(1993-8#1)
Plasmodium falciparum CTL##2##3##(2008-8#2)
Plasmodium falciparum in##2##3##(1991-8#1)(1992-6#1)
Plasmodium falciparum##21##2##(1990-12#2)(1991-4#1)(1991-8#1)(1992-6#1)(1993-2#2)(1995-12#1)(2008-4#1)(2008-8#3)(2008-9#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#1)
Plasmodium knowlesi##2##2##(2012-12#2)
Plasmodium plasmepsins and &quot##2##4##(2008-4#2)
Plasmodium vivax##2##2##(2008-4#1)(2012-12#1)
Plasmodium##32##1##(1990-12#2)(1991-4#1)(1991-8#1)(1992-6#2)(1993-2#2)(1993-8#1)(1995-12#1)(2008-4#4)(2008-8#3)(2008-9#1)(2012-12#8)(2012-2#4)(2012-3#1)(2013-8#1)
Plasmopara viticola##12##2##(2008-10#12)
Plasmopara##14##1##(2008-10#14)
Plastic##2##1##(1997-6#1)(2008-10#1)
Plasticized##2##1##(2008-10#2)
Plate##2##1##(2008-11#1)(2013-1#1)
Plateau (QTP)##2##2##(2009-5#1)(2012-3#1)
Plateau##6##1##(2008-9#3)(2009-5#1)(2012-3#1)(2013-1#1)
Platelet aggregation##3##2##(1990-12#1)(1991-12#1)(1992-12#1)
Platelet lysate##2##2##(2008-11#2)
Platelet##18##1##(1990-12#1)(1991-12#1)(1992-12#5)(1997-6#1)(2006-6#3)(2008-1#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#1)
Platelet-activating factor##2##2##(2008-10#1)(2008-11#1)
Platelets are##2##2##(2006-6#1)(2008-9#1)
Platelets##6##1##(1993-8#1)(2006-6#3)(2008-9#2)
Platform for##2##2##(2009-9#1)(2013-8#1)
Platform##4##1##(2008-10#1)(2009-9#1)(2012-3#1)(2013-8#1)
Platinum and##2##2##(2008-10#2)
Platinum##8##1##(2008-10#6)(2008-11#1)(2009-10#1)
Platinum(II) was##2##2##(2008-10#2)
Platycopia compacta##2##2##(2008-5#2)
Platycopia is##2##2##(2008-5#2)
Platycopia##6##1##(2008-5#6)
Plausible##2##1##(1992-9#1)(2008-10#1)
Play##4##1##(1997-2#1)(2008-10#1)(2009-11#2)
Players##3##1##(2010-1#1)(2011-2#1)(2012-3#1)
Please cite this paper as##4##5##(2011-2#4)
Please see Elsevier Policy on Article Withdrawal (http##2##8##(2008-10#2)
Please see http##6##3##(2011-2#6)
Please see##8##2##(2008-10#2)(2011-2#6)
Please##12##1##(2008-10#2)(2011-2#10)
Plectropomus leopardus##2##2##(2010-8#2)
Pleomorphic xanthoastrocytoma##2##2##(2008-12#2)
Pleomorphic##4##1##(1991-12#1)(2008-12#2)(2009-6#1)
Pleospora papaveracea and##2##3##(2008-10#2)
Pleospora papaveracea##6##2##(2008-10#6)
Pleural##7##1##(1991-12#3)(2008-10#1)(2011-2#1)(2013-7#2)
Pleurotus ostreatus##5##2##(2008-10#1)(2008-5#2)(2011-1#2)
Pleurotus##9##1##(2008-10#4)(2008-5#2)(2011-1#3)
Plexiglas##5##1##(2008-10#4)(2008-5#1)
PlgB##2##1##(1995-6#2)
PlgF##2##1##(1995-6#2)
Plocamium cartilagineum##2##2##(2008-11#2)
Plots of##3##2##(2008-10#2)(2008-3#1)
Plots were##3##2##(2008-10#3)
Plots##6##1##(2008-10#5)(2008-3#1)
Plum pox virus (PPV)##3##4##(2008-10#3)
Plum pox virus##6##3##(2008-10#6)
Plum pox##8##2##(2008-10#8)
Plum##9##1##(2008-10#8)(2011-2#1)
Pluronic F-68##2##2##(2008-11#1)(2011-2#1)
Pluronic##3##1##(2008-11#2)(2011-2#1)
Plus##17##1##(1991-1#5)(1991-12#3)(1991-2#2)(1992-11#1)(1993-1#2)(2008-10#1)(2008-11#1)(2011-1#2)
Plysate##2##1##(2008-11#2)
Pm##4##1##(2011-1#4)
Pm-AMP1##5##1##(2008-10#5)
Pm3##3##1##(2008-10#3)
Pm3a##2##1##(2008-10#2)
Pm4b##3##1##(2008-10#3)
PmCh4A protein##2##2##(2008-10#2)
PmCh4A##5##1##(2008-10#5)
PmTLP in##2##2##(2008-10#2)
PmTLP was##2##2##(2008-10#2)
PmTLP##9##1##(2008-10#9)
PmV##2##1##(2008-10#2)
PmXII##2##1##(2008-10#2)
Pmax##2##1##(2008-8#2)
Pn117 for 3 days##2##4##(2008-10#2)
Pn117##6##1##(2008-10#6)
Pn198 and##2##2##(2008-10#2)
Pneumatosis intestinalis##3##2##(2010-12#1)(2012-2#2)
Pneumocephalus##2##1##(2008-7#2)
Pneumocystis carinii pneumonia##2##3##(1990-9#1)(1993-2#1)
Pneumocystis jiroveci##2##2##(2010-12#2)
Pneumocystis##6##1##(1990-9#1)(1991-12#1)(1992-2#1)(1993-2#1)(2010-12#2)
Po##2##1##(2008-10#1)(2008-11#1)
Pochapsky##2##1##(1994-5#2)
Pockels cell##2##2##(2008-2#1)(2008-3#1)
Podlasie##3##1##(2008-10#2)(2008-12#1)
Podophyllum hexandrum##2##2##(2008-11#2)
Podoplanin is##2##2##(2013-1#2)
Podoplanin##5##1##(2013-1#5)
Podospora anserina##2##2##(1993-2#1)(2009-8#1)
Poecilimon##2##1##(2013-8#2)
Poem##2##1##(2008-8#2)
Point Mutation in##2##3##(2008-10#2)
Point of view##3##3##(1994-2#2)(2008-7#1)
Point##12##1##(1994-2#2)(2008-10#5)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-2#1)
Points of##2##2##(2008-3#1)(2012-2#1)
Points##5##1##(2008-3#1)(2009-3#2)(2012-2#1)(2013-1#1)
Poiret##2##1##(2012-5#2)
Poisoning of##2##2##(1991-8#1)(2009-12#1)
Poisoning##5##1##(1991-8#1)(2008-12#1)(2009-12#1)(2013-1#2)
Poisson distribution##4##2##(1995-6#1)(2008-10#2)(2008-9#1)
Poisson process##2##2##(1996-2#1)(2012-3#1)
Poisson regression##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
Poisson spike trains##2##3##(2008-11#1)(2013-8#1)
Poisson##18##1##(1995-6#1)(1996-2#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-8#1)(2008-9#1)(2010-1#1)(2012-3#1)(2013-8#1)
Poisson-Boltzmann equation##2##2##(1997-2#1)(2013-1#1)
Poisson-Boltzmann##5##1##(1997-2#2)(2008-4#1)(2013-1#2)
Pol III core##5##3##(1992-3#5)
Pol III##6##2##(1992-3#6)
Poland and##4##2##(2008-5#1)(2012-3#1)(2013-1#2)
Poland##21##1##(1994-12#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#7)
Polar auxin transport##2##3##(2009-8#2)
Polar cap##2##2##(2008-3#2)
Polar##10##1##(1990-2#1)(1996-5#1)(1996-9#1)(2008-10#2)(2008-3#2)(2009-8#2)(2012-3#1)
Polarimetric measurements of##2##3##(2008-3#2)
Polarization##7##1##(1990-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2012-2#1)
Polarized##3##1##(1993-5#1)(2008-10#1)(2008-3#1)
Polarographic chemometric##2##2##(2008-10#2)
Polarographic determination of##5##3##(2008-10#5)
Polarographic##12##1##(2008-10#12)
Polarography##2##1##(2008-10#2)
Polerovirus##3##1##(2008-10#3)
Police and##2##2##(1992-2#1)(2008-10#1)
Police##7##1##(1992-12#1)(1992-2#2)(2008-10#3)(2009-10#1)
Policies##3##1##(1997-3#1)(1997-8#1)(2012-2#1)
Policlinico##2##1##(1993-6#1)(2013-1#1)
Policy and##3##2##(1992-8#1)(1993-12#1)(2009-7#1)
Policy implications for##2##3##(1995-2#1)(1997-3#1)
Policy##29##1##(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-6#2)(1996-1#2)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Policymakers##2##1##(1995-3#1)(2010-4#1)
Polinius##2##1##(2008-10#2)
Polio##2##1##(1994-9#1)(2008-11#1)
Polish intelligentsia##4##2##(2008-12#4)
Polish##18##1##(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#7)(2012-2#1)(2013-1#6)
Polishing##2##1##(2008-10#1)(2010-4#1)
Political##3##1##(1991-5#1)(1995-3#2)
Politics and##2##2##(1994-3#1)(1996-1#1)
Politics##5##1##(1994-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2010-11#1)
Pollen##10##1##(2008-10#2)(2008-8#1)(2009-10#3)(2011-2#2)(2012-2#1)(2013-1#1)
Pollination of##2##2##(2008-10#2)
Pollination##3##1##(2008-10#3)
Pollutants##4##1##(2008-10#1)(2008-11#2)(2009-8#1)
Polo##3##1##(2012-3#3)
Poly##2##1##(2008-8#2)
Poly(beta-hydroxybutyrate) accumulation was##2##3##(2008-7#2)
Poly(ethylene##2##1##(2008-10#2)
Poly(vinyl chloride) (PVC) based membranes##2##5##(2008-10#2)
Poly(vinyl chloride) (PVC)##3##3##(2008-10#3)
Poly(vinyl chloride) membrane##3##3##(2008-10#3)
Poly(vinyl chloride)##8##2##(2008-10#8)
Poly(vinyl chloride)-based##2##2##(2008-10#2)
Poly(vinyl##10##1##(2008-10#10)
Poly-lys##3##1##(1990-6#3)
Polyacrylamide gel##2##2##(1990-11#1)(1991-12#1)
Polyadenylation##2##1##(2008-11#1)(2010-4#1)
Polyamines and##2##2##(1992-6#1)(2008-10#1)
Polyamines##6##1##(1992-6#1)(2008-10#3)(2008-12#1)(2009-10#1)
Polyarteritis nodosa##2##2##(1997-8#2)
Polyclonal antiserum##2##2##(2008-10#1)(2008-8#1)
Polyclonal##4##1##(1992-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
Polycomb group proteins##2##3##(2012-3#2)
Polycomb group##4##2##(1997-7#1)(2012-3#3)
Polycyclic aromatic hydrocarbons (PAH)##2##4##(2008-10#2)
Polycyclic aromatic hydrocarbons (PAHs)##2##4##(1994-3#1)(2008-10#1)
Polycyclic aromatic hydrocarbons##4##3##(1994-3#1)(2008-10#3)
Polycyclic##5##1##(1994-3#1)(2008-10#4)
Polycystic Ovary Syndrome##2##3##(2008-3#1)(2008-4#1)
Polycystic##5##1##(2008-3#1)(2008-4#2)(2010-11#1)(2013-1#1)
Polyethylene##2##1##(2008-10#1)(2012-3#1)
Polygala alpestris##2##2##(2008-11#2)
Polygonum viviparum##2##2##(2009-5#2)
Polymer##7##1##(2008-10#4)(2009-5#1)(2013-8#2)
Polymerase Chain Reaction Assay for##2##5##(2008-10#2)
Polymerase Chain Reaction Assay##7##4##(2008-10#7)
Polymerase Chain Reaction Assays##2##4##(2008-10#2)
Polymerase Chain Reaction Detection of##3##5##(2008-10#3)
Polymerase Chain Reaction Identification of##2##5##(2008-10#2)
Polymerase Chain Reaction Using##2##4##(2008-10#2)
Polymerase Chain Reaction and##3##4##(2008-10#3)
Polymerase Chain Reaction##32##3##(2008-10#31)(2008-12#1)
Polymerase Chain Reaction-Based##3##3##(2008-10#3)
Polymerase Chain##37##2##(2008-10#35)(2008-12#1)(2012-2#1)
Polymerase chain reaction (PCR) amplification of##2##6##(1993-2#1)(2008-10#1)
Polymerase chain reaction (PCR)##7##4##(1993-2#1)(2008-10#6)
Polymerase chain reaction (PCR)-based assays##2##5##(2008-10#2)
Polymerase chain reaction assays##2##4##(2008-10#2)
Polymerase chain reaction##18##3##(1991-5#1)(1993-2#1)(2008-10#16)
Polymerase chain##19##2##(1991-5#1)(1993-2#1)(2008-10#17)
Polymerase##60##1##(1991-5#1)(1993-2#1)(2008-10#53)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
Polymeric##2##1##(2008-10#1)(2008-5#1)
Polymers##5##1##(2008-10#3)(2008-11#1)(2008-5#1)
Polymorphic##8##1##(1993-3#1)(2008-10#6)(2008-8#1)
Polymorphism and##4##2##(2008-10#2)(2010-1#1)(2012-3#1)
Polymorphism in the##2##3##(2008-10#1)(2008-12#1)
Polymorphism in##4##2##(2008-10#3)(2008-12#1)
Polymorphism##19##1##(1997-9#1)(2008-10#13)(2008-12#2)(2010-1#1)(2011-2#1)(2012-3#1)
Polymorphisms in the##2##3##(2008-10#1)(2011-2#1)
Polymorphisms in##5##2##(2008-10#2)(2011-2#1)(2012-3#1)(2013-8#1)
Polymorphisms of the##2##3##(1997-7#1)(2008-12#1)
Polymorphisms##11##1##(1997-7#1)(2008-10#6)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
Polymorphonuclear##2##1##(1991-11#1)(1997-1#1)
Polymyxa##3##1##(2008-10#3)
Polymyxins##2##1##(2008-10#2)
Polynesian##3##1##(2008-1#1)(2013-1#2)
Polyoxyethylene alkyl##2##2##(2008-10#2)
Polyoxyethylene##3##1##(2008-10#3)
Polyphasic##2##1##(2008-10#1)(2010-3#1)
Polyphenols##3##1##(2008-7#1)(2009-12#1)(2009-3#1)
Polyps in##2##2##(2009-12#2)
Polyps##3##1##(2009-12#3)
Polyquaternium 44##3##2##(2008-5#3)
Polyquaternium##5##1##(2008-5#5)
Polyscias##5##1##(2008-10#5)
Polyunsaturated fatty acids##3##3##(2008-10#1)(2010-11#1)(2010-6#1)
Polyunsaturated##4##1##(2008-10#1)(2010-11#1)(2010-6#1)(2013-1#1)
Polyvalent##2##1##(1994-9#1)(2009-10#1)
Polyvinyl##3##1##(2008-10#2)(2012-3#1)
Pomaceous##2##1##(2008-10#2)
Pomegranate##3##1##(2013-8#3)
Pomeranian##3##1##(2012-12#1)(2013-8#2)
Pompe disease##6##2##(2012-12#4)(2013-1#2)
Ponceau 4R##7##2##(2008-10#7)
Ponceau##10##1##(2008-10#10)
Pool##2##1##(2008-10#1)(2011-2#1)
Pooled##3##1##(2008-10#1)(2013-1#1)(2013-8#1)
Poor survival##2##2##(1993-9#1)(2009-10#1)
Poor##17##1##(1990-12#1)(1990-9#1)(1993-11#1)(1993-9#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Pope##2##1##(1990-6#1)(1995-3#1)
Poplar##6##1##(2008-10#6)
Population Analysis of##2##3##(2008-10#2)
Population Dynamics of Fusarium##2##4##(2008-10#2)
Population Dynamics of##4##3##(2008-10#4)
Population Genetic Structure of##2##4##(2008-10#2)
Population Genetic Structure##3##3##(2008-10#3)
Population Genetic##4##2##(2008-10#4)
Population Genetics of##2##3##(2008-10#2)
Population Screening##2##2##(1996-8#2)
Population Sizes##2##2##(2008-10#2)
Population Structure of Botryosphaeria dothidea from##2##6##(2008-10#2)
Population Structure of Phytophthora infestans##2##5##(2008-10#2)
Population Structure of##7##3##(2008-10#7)
Population densities of H##2##4##(2008-10#2)
Population densities##4##2##(2008-10#4)
Population differentiation##2##2##(2008-10#2)
Population dynamics of##2##3##(2008-10#2)
Population dynamics##6##2##(2008-10#2)(2008-8#1)(2008-9#1)(2013-8#2)
Population genetic##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
Population in##2##2##(2008-10#2)
Population of Phytophthora##2##3##(2008-10#2)
Population of##3##2##(2008-10#3)
Population size of##2##3##(2008-10#2)
Population sizes of##4##3##(2008-10#4)
Population structure##3##2##(2008-10#3)
Population##84##1##(1991-3#1)(1993-3#1)(1994-9#2)(1995-11#1)(1996-3#1)(1996-8#2)(2008-10#50)(2008-11#5)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-5#2)(2011-2#2)(2011-9#1)(2012-3#2)(2013-1#1)(2013-8#7)
Population-based##5##1##(2007-12#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
Populations from the Caucasus##2##4##(2008-10#2)
Populations from##10##2##(2008-10#10)
Populations in##7##2##(2008-10#7)
Populations of Alternaria spp##3##4##(2008-10#3)
Populations of Colletotrichum gloeosporioides from##2##5##(2008-10#2)
Populations of Gibberella zeae##2##4##(2008-10#2)
Populations of Mycosphaerella graminicola##3##4##(2008-10#3)
Populations of Mycosphaerella##4##3##(2008-10#4)
Populations of Phaeosphaeria nodorum##2##4##(2008-10#2)
Populations of Phytophthora infestans in##3##5##(2008-10#3)
Populations of Phytophthora infestans##5##4##(2008-10#5)
Populations of Phytophthora##7##3##(2008-10#7)
Populations of Puccinia##2##3##(2008-10#2)
Populations of Rhizoctonia solani##2##4##(2008-10#2)
Populations of Xanthomonas##2##3##(2008-10#2)
Populations of the##10##3##(2008-10#9)(2008-9#1)
Populations of##68##2##(2008-10#64)(2008-12#1)(2008-6#1)(2008-9#2)
Populations on##2##2##(2008-10#2)
Populations##101##1##(2008-10#95)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-3#1)
Populus deltoides 'S9-2'##2##3##(2008-10#2)
Populus deltoides x P##3##4##(2008-10#3)
Populus deltoides##8##2##(2008-10#8)
Populus##17##1##(2008-10#12)(2008-11#1)(2008-8#1)(2009-10#1)(2012-3#2)
PorA##3##1##(1993-12#3)
Porcine##7##1##(1992-8#1)(1994-11#1)(1994-8#1)(1995-8#1)(2008-11#2)(2008-5#1)
Pordenone##2##1##(2008-10#2)
Pore-forming peptides##2##2##(1994-5#2)
Porous##2##1##(2008-10#2)
Porphobilinogen##2##1##(1991-2#1)(1992-3#1)
Porphyrins##2##1##(1996-5#1)(2008-10#1)
Porphyromonas gingivalis and##3##3##(2008-12#2)(2013-1#1)
Porphyromonas gingivalis##6##2##(2008-12#3)(2008-9#2)(2013-1#1)
Porphyromonas##8##1##(2008-12#3)(2008-5#1)(2008-9#3)(2013-1#1)
Porta-Sonic and Respirgard II##2##4##(1993-2#2)
Porta-Sonic##5##1##(1993-2#5)
Portable##5##1##(2008-10#2)(2008-7#2)(2010-8#1)
Portal##2##1##(1995-10#2)
Portions of##3##2##(1994-5#1)(2008-10#1)(2010-5#1)
Portland cement##5##2##(2008-10#3)(2013-1#2)
Portland##6##1##(1992-1#1)(2008-10#3)(2013-1#2)
Portugal##10##1##(2008-10#8)(2008-11#1)(2011-2#1)
Portunus##2##1##(2008-10#2)
Posaconazole##2##1##(2011-2#2)
Position##3##1##(2008-10#2)(2010-3#1)
Positional##3##1##(2008-12#1)(2008-7#1)(2012-3#1)
Positioning##2##1##(1996-3#1)(2013-1#1)
Positions of Soret##2##3##(2008-10#2)
Positive and negative##3##3##(1995-11#1)(2008-11#1)(2011-2#1)
Positive and##4##2##(1995-11#1)(2008-11#1)(2011-1#1)(2011-2#1)
Positive correlations##2##2##(1991-12#1)(2011-1#1)
Positive##20##1##(1990-2#1)(1991-12#1)(1991-7#1)(1995-11#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2011-1#3)(2011-2#3)
Positively##2##1##(1993-8#1)(2013-1#1)
Positron emission tomography with##2##4##(1993-9#1)(2008-7#1)
Positron emission tomography##4##3##(1993-11#1)(1993-9#1)(2008-7#2)
Positron##5##1##(1993-11#1)(1993-9#1)(1996-9#1)(2008-7#2)
Possibilities of##4##2##(1992-5#1)(1994-9#1)(2008-10#1)(2011-3#1)
Possibilities##5##1##(1992-5#1)(1994-9#1)(2008-10#2)(2011-3#1)
Possibility of##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
Possible applications##2##2##(2008-2#1)(2012-3#1)
Possible causes##2##2##(1996-11#1)(2008-7#1)
Possible explanations for the##2##4##(2008-10#1)(2008-4#1)
Possible explanations for##4##3##(1992-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
Possible implications for##2##3##(1993-8#1)(2008-5#1)
Possible implications##3##2##(1993-8#1)(2008-11#1)(2008-5#1)
Possible interactions between##2##3##(2008-10#2)
Possible interferences##2##2##(2008-10#2)
Possible involvement of phospholipase##2##4##(2008-11#2)
Possible involvement of##4##3##(1991-10#1)(1997-2#1)(2008-11#2)
Possible reasons for##2##3##(1995-11#1)(2008-9#1)
Possible reasons##3##2##(1995-11#1)(2008-8#1)(2008-9#1)
Possible##47##1##(1990-5#1)(1991-10#1)(1991-12#3)(1991-5#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
Possibly##2##1##(2008-11#1)(2008-8#1)
Post mortem##2##2##(1995-9#1)(2008-7#1)
Post##9##1##(1995-9#1)(1996-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#3)
Post-Traumatic Stress Disorder (PTSD)##2##4##(2008-10#1)(2012-12#1)
Post-column##2##1##(2008-10#2)
Post-graduate##2##1##(1994-12#1)(2009-10#1)
Post-mortem examination##3##2##(2011-2#2)(2012-12#1)
Post-mortem##4##1##(2011-2#2)(2012-12#1)(2013-1#1)
Post-operative##2##1##(1997-7#1)(2011-2#1)
Post-translational##3##1##(1992-6#1)(2008-9#1)(2009-5#1)
Post-transplant lymphoproliferative##2##2##(2008-5#2)
Post-traumatic##3##1##(1993-8#1)(1997-3#1)(2008-7#1)
Posterior epidural disc##2##3##(2011-2#2)
Posterior##16##1##(1991-2#1)(2008-12#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#3)
Posteromedial##2##1##(2013-1#2)
Postgraduate##6##1##(1990-9#1)(1991-2#1)(1993-12#1)(1994-1#1)(1994-12#1)(1997-8#1)
Postharvest Citrus##2##2##(2008-10#2)
Postharvest Decay of##3##3##(2008-10#3)
Postharvest##8##1##(2008-10#8)
Postinfection##3##1##(2008-10#3)
Postinfectious##2##1##(2010-12#1)(2011-2#1)
Postmortem##2##1##(2008-7#2)
Postnatal##2##1##(2010-4#1)(2013-1#1)
Postnatally##2##1##(2008-10#1)(2012-12#1)
Postoperative pain##3##2##(1994-3#1)(2010-6#2)
Postoperative##29##1##(1991-2#1)(1991-8#1)(1991-9#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-7#4)(2008-9#1)(2010-6#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Postoperatively##11##1##(1992-6#1)(1993-1#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-8#1)(2011-2#3)
Postpartum##4##1##(2011-2#1)(2013-1#3)
Posttranscriptional##2##1##(2008-10#1)(2010-5#1)
Posttraumatic##3##1##(2010-10#1)(2012-12#1)(2013-1#1)
Pot2##3##1##(2008-10#3)
Potassium##9##1##(1990-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2013-1#1)
Potato (Solanum##2##2##(2008-10#2)
Potato and##2##2##(2008-10#2)
Potato in North Carolina##2##4##(2008-10#2)
Potato in##5##2##(2008-10#5)
Potato leafroll##2##2##(2008-10#2)
Potato virus A##3##3##(2008-10#3)
Potato virus X (PVX)##4##4##(2008-10#4)
Potato virus X##6##3##(2008-10#6)
Potato virus Y##3##3##(2008-10#3)
Potato virus##14##2##(2008-10#14)
Potato##50##1##(2008-10#49)(2011-2#1)
Potato-faba intercrops##2##2##(2008-10#2)
Potatoes##2##1##(2008-10#2)
Potebniamyces pyri##2##2##(2008-10#2)
Potent##2##1##(1995-5#1)(2013-1#1)
Potential advantages of##2##3##(2008-10#1)(2010-10#1)
Potential application##2##2##(1995-3#1)(2008-10#1)
Potential applications of##2##3##(2008-10#1)(2013-1#1)
Potential explanations for##2##3##(1991-2#1)(2008-8#1)
Potential for tumor##2##3##(1993-11#1)(1994-5#1)
Potential for##5##2##(1993-11#1)(1994-5#1)(2008-10#2)(2011-2#1)
Potential interference from##2##3##(2008-10#2)
Potential of##7##2##(1994-12#1)(2008-10#5)(2012-2#1)
Potential on##2##2##(2008-10#2)
Potential role of##5##3##(1992-12#1)(1992-9#1)(1997-8#1)(2009-7#1)(2012-2#1)
Potential role##6##2##(1992-12#1)(1992-9#1)(1997-8#1)(2007-12#1)(2009-7#1)(2012-2#1)
Potential roles##2##2##(1994-9#1)(2012-2#1)
Potential##79##1##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#30)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-2#5)(2013-1#2)(2013-8#3)
Potentially##8##1##(1995-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
Potentials##5##1##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
Potentiation##3##1##(1994-11#1)(1994-8#1)(1995-11#1)
Potentiometric and##2##2##(2008-10#2)
Potentiometric biosensors based on##2##4##(2008-10#2)
Potentiometric determination of##5##3##(2008-10#5)
Potentiometric evaluation of the##2##4##(2008-10#2)
Potentiometric flow injection determination of##2##5##(2008-10#2)
Potentiometric flow##3##2##(2008-10#3)
Potentiometric pH sensors based on##2##5##(2008-10#2)
Potentiometric properties of##2##3##(2008-10#2)
Potentiometric study of the##3##4##(2008-10#3)
Potentiometric study of##6##3##(2008-10#6)
Potentiometric titration of##2##3##(2008-10#2)
Potentiometric titration##3##2##(2008-10#3)
Potentiometric titrations were carried out##2##5##(2008-10#2)
Potentiometric titrations##5##2##(2008-10#5)
Potentiometric##43##1##(2008-10#43)
Pott's##2##1##(2007-8#1)(2009-4#1)
Potter##2##1##(2008-10#1)(2008-2#1)
Potting Mixes##2##2##(2008-10#2)
Potting##3##1##(2008-10#3)
Potyviridae##7##1##(2008-10#7)
Potyvirus##12##1##(2008-10#12)
Poultry##2##1##(2008-5#2)
Poverty##4##1##(1994-12#1)(2008-11#2)(2008-12#1)
Powdery Mildew##4##2##(2008-10#4)
Powdery##8##1##(2008-10#8)
Power Knee##2##2##(2013-1#2)
Power and##2##2##(2008-3#2)
Power of##3##2##(1996-9#1)(2009-11#1)(2013-1#1)
Power##16##1##(1993-12#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-3#5)(2009-11#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#3)
PowerPlex Y system##2##3##(2008-12#2)
PowerPoint presentation##2##2##(2008-10#2)
Powerful##4##1##(2007-11#1)(2007-12#1)(2010-11#1)(2011-2#1)
Powers ratio##3##2##(2012-12#3)
Pp##3##1##(1997-7#3)
Pp523##4##1##(2012-3#4)
Pp99##5##1##(2008-10#5)
PptT##8##1##(2013-1#8)
Pr with##2##2##(2008-10#2)
Pr##13##1##(2007-12#1)(2008-10#11)(2008-3#1)
Pr(3+)##6##1##(2008-10#4)(2008-3#2)
Pr55gag##2##1##(1991-9#2)
PrEP##8##1##(2012-2#6)(2013-1#2)
Practical and##2##2##(2008-12#1)(2011-2#1)
Practical applications##2##2##(2008-5#1)(2008-9#1)
Practical considerations##3##2##(1995-5#1)(2008-10#1)(2008-6#1)
Practical implications##2##2##(2008-12#1)(2010-2#1)
Practical##25##1##(1991-3#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-5#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
Practice Nurses##5##2##(2008-11#5)
Practice and##4##2##(1997-4#1)(2008-10#1)(2008-11#2)
Practice of##2##2##(1990-6#1)(2008-11#1)
Practice##45##1##(1990-6#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-3#1)(1996-2#2)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#27)(2008-12#2)(2008-8#1)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Practices on##2##2##(2008-10#2)
Practices##10##1##(2008-10#2)(2009-3#2)(2012-12#5)(2013-1#1)
Practitioner##3##1##(1991-1#1)(1991-3#1)(2008-12#1)
Practitioners in the##2##3##(1994-1#1)(2008-1#1)
Practitioners in##3##2##(1994-1#1)(2008-1#2)
Practitioners##9##1##(1993-12#1)(1994-1#1)(1994-12#1)(1994-6#2)(2008-1#2)(2008-11#1)(2008-12#1)
Prague##3##1##(1995-5#2)(1996-5#1)
Prajer##3##1##(2008-12#3)
Praseodymium##2##1##(2008-10#2)
Pratylenchus penetrans##3##2##(2008-10#3)
Pratylenchus spp##2##2##(2008-10#2)
Pratylenchus##7##1##(2008-10#7)
Pravastatin##3##1##(1991-12#3)
Prawn##3##1##(2008-5#1)(2008-6#1)(2012-3#1)
Pray For Elves##2##3##(2008-9#2)
Prc-MIH##6##1##(2008-6#6)
Pre- and postoperative##2##3##(2008-9#2)
Pre- and##6##2##(2008-11#2)(2008-9#2)(2012-5#1)(2013-1#1)
Pre-##7##1##(2008-10#1)(2008-11#2)(2008-9#2)(2012-5#1)(2013-1#1)
Pre-clinical##2##1##(2009-7#1)(2011-2#1)
Pre-concentration##2##1##(2008-10#2)
Pre-eclampsia##2##1##(1996-6#1)(2011-2#1)
Pre-emergence##2##1##(2008-10#1)(2011-1#1)
Pre-employment testing##2##2##(1997-1#2)
Pre-end##2##1##(2008-1#2)
Pre-existing##2##1##(2008-10#1)(2011-2#1)
Pre-incubation of##2##2##(1995-11#2)
Pre-inoculation of##2##2##(2008-10#2)
Pre-registration##2##1##(2008-11#2)
Pre-treatment##3##1##(1991-1#1)(2008-10#1)(2010-12#1)
PreOp group##2##2##(2011-2#2)
PreOp##3##1##(2011-2#3)
PreS1 region##2##2##(1994-8#1)(2013-1#1)
PreZad was##2##2##(1991-10#2)
Precautionary##2##1##(2008-11#1)(2012-2#1)
Precautions##2##1##(2008-10#1)(2008-9#1)
Preceptorship in##2##2##(2008-11#2)
Precise and accurate determinations were obtained##2##6##(2008-10#2)
Precise results##2##2##(2008-10#2)
Precise##12##1##(1992-3#1)(1994-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
Precision (R##2##2##(2008-10#2)
Precision IPM##2##2##(2008-10#2)
Precision of the##2##3##(2008-10#2)
Precision of##3##2##(2008-10#2)(2012-3#1)
Precision was also##2##3##(2008-10#2)
Precision was##3##2##(2008-10#3)
Precision##20##1##(1994-12#1)(2008-10#16)(2008-3#1)(2010-10#1)(2012-3#1)
Preclinical studies##3##2##(2008-5#1)(2013-1#1)(2013-8#1)
Preclinical##10##1##(1997-4#1)(2008-10#1)(2008-5#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Preconcentration and determination of##4##4##(2008-10#4)
Preconcentration and separation of##3##4##(2008-10#3)
Preconcentration and separation##4##3##(2008-10#4)
Preconcentration and speciation of chromium in##2##6##(2008-10#2)
Preconcentration and speciation of chromium##3##5##(2008-10#3)
Preconcentration and speciation of##4##4##(2008-10#4)
Preconcentration and##14##2##(2008-10#14)
Preconcentration factors##2##2##(2008-10#2)
Preconcentration of lead##2##3##(2008-10#2)
Preconcentration of trace##7##3##(2008-10#7)
Preconcentration of traces of##2##4##(2008-10#2)
Preconcentration of##17##2##(2008-10#17)
Preconcentration with membrane cell and adsorptive polarographic determination of##2##9##(2008-10#2)
Preconcentration with##3##2##(2008-10#3)
Preconcentration##43##1##(2008-10#43)
Precursor##4##1##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
Predict##4##1##(2009-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
Predicted##7##1##(1992-3#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
Predicting the##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
Predicting##16##1##(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-3#1)(2013-1#2)
Prediction of the coding sequences of unidentified human genes##3##9##(1995-8#1)(1996-2#2)
Prediction of the##6##3##(1992-9#1)(1995-8#1)(1996-2#2)(2008-10#2)
Prediction of##20##2##(1992-9#2)(1995-8#1)(1996-2#2)(1997-6#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2013-1#1)
Prediction##26##1##(1992-9#2)(1995-8#1)(1996-2#2)(1997-6#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-8#1)(2013-1#1)
Predictions##4##1##(1993-12#1)(1995-2#1)(2008-10#1)(2011-2#1)
Predictive factors##2##2##(2008-10#1)(2013-1#1)
Predictive models##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
Predictive##9##1##(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)(2010-10#1)(2013-1#2)
Predictors of##18##2##(1991-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Predictors##20##1##(1991-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2009-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
Predicts##3##1##(2008-10#1)(2013-1#2)
Predisposition##2##1##(1991-12#1)(2008-10#1)
Predominance zone diagrams##3##3##(2008-10#3)
Predominant##3##1##(1992-2#1)(1994-8#1)(2008-10#1)
Predominantly##3##1##(1994-3#1)(2010-8#1)(2012-12#1)
Preeclampsia is##2##2##(2008-11#1)(2009-8#1)
Preeclampsia##3##1##(2008-11#1)(2009-8#2)
Preface##25##1##(2008-10#9)(2008-11#9)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-2#1)
Prefecture##5##1##(1993-1#2)(1994-2#1)(2008-8#1)(2010-8#1)
Preference##5##1##(1994-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
Preferences for##4##2##(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)
Preferential##3##1##(1990-5#1)(1997-3#1)(2008-10#1)
Preferred##3##1##(1992-2#1)(1992-3#1)(2009-3#1)
Prefrontal##2##1##(2011-2#1)(2013-8#1)
Pregabalin is##3##2##(2008-9#3)
Pregabalin##6##1##(2008-9#4)(2013-8#2)
Pregnancy Risk Assessment##2##3##(2013-1#1)(2013-8#1)
Pregnancy in##2##2##(2008-10#1)(2013-1#1)
Pregnancy outcome in##2##3##(1991-12#1)(1994-3#1)
Pregnancy outcome##3##2##(1991-12#1)(1994-3#1)(2013-1#1)
Pregnancy##15##1##(1991-12#1)(1991-3#1)(1992-5#1)(1994-3#1)(2008-10#1)(2009-12#1)(2009-6#1)(2013-1#6)(2013-8#2)
Pregnant rats were##2##3##(1995-11#1)(2008-10#1)
Pregnant##7##1##(1995-11#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2011-2#1)
Pregnenolone##2##1##(1990-11#1)(1996-2#1)
Preimplantation genetic##3##2##(2012-3#3)
Preincubation of the##2##3##(1991-5#1)(1993-6#1)
Preincubation of##8##2##(1991-5#2)(1992-6#1)(1993-3#1)(1993-6#2)(1994-11#2)
Preincubation with the##2##3##(2008-11#1)(2008-7#1)
Preincubation##10##1##(1991-5#2)(1992-6#1)(1993-3#1)(1993-6#2)(1994-11#2)(2008-11#1)(2008-7#1)
Preinoculation of##3##2##(2008-10#3)
Preinoculation##5##1##(2008-10#5)
Preliminary characterization##2##2##(2008-10#1)(2008-5#1)
Preliminary data##2##2##(1995-2#1)(2008-10#1)
Preliminary experiments##3##2##(2008-10#3)
Preliminary investigation##2##2##(2008-8#1)(2010-3#1)
Preliminary report##3##2##(1990-10#1)(1991-1#1)(2013-1#1)
Preliminary results of a##2##4##(1991-3#1)(2008-10#1)
Preliminary results of##4##3##(1991-1#1)(1991-12#1)(1991-3#1)(2008-10#1)
Preliminary results##11##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1996-9#1)(2008-10#3)(2008-3#1)(2010-12#1)
Preliminary studies of##2##3##(2008-10#1)(2008-5#1)
Preliminary studies##5##2##(2008-10#2)(2008-5#3)
Preliminary study on##2##3##(1991-8#1)(2009-10#1)
Preliminary##52##1##(1990-10#1)(1990-11#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-8#2)(1992-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-3#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
Premating isolation is determined by##2##5##(2008-8#1)(2008-9#1)
Premature infants##2##2##(1994-6#1)(2008-11#1)
Premature##6##1##(1994-6#1)(1994-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-3#1)
Premier##2##1##(1993-5#1)(1994-2#1)
Prenatal diagnosis of##2##3##(1997-3#1)(2013-1#1)
Prenatal diagnosis##3##2##(1997-3#1)(2012-3#1)(2013-1#1)
Prenatal screening for Down's syndrome##3##5##(1992-12#2)(1992-9#1)
Prenatal##15##1##(1992-12#2)(1992-9#1)(1993-3#1)(1995-12#1)(1997-3#3)(2011-2#1)(2012-3#4)(2013-1#2)
Prentice-Hall##2##1##(2008-11#2)
Preoperative embolisation##2##2##(1996-9#1)(2008-7#1)
Preoperative##18##1##(1994-8#1)(1996-9#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
Preparation and application of##2##4##(2008-10#2)
Preparation and characterization of##4##4##(1995-11#1)(2008-10#3)
Preparation and evaluation of##4##4##(2008-10#4)
Preparation and properties of##2##4##(2008-10#1)(2009-7#1)
Preparation and##20##2##(1995-11#1)(2008-10#15)(2008-8#1)(2008-9#2)(2009-7#1)
Preparation for##3##2##(1991-2#1)(2012-3#1)(2013-1#1)
Preparation of a##4##3##(1992-6#1)(2008-10#2)(2012-2#1)
Preparation of the##2##3##(2008-4#2)
Preparation of##29##2##(1992-2#1)(1992-6#1)(1995-3#1)(1996-5#3)(1997-1#1)(2008-10#8)(2008-11#7)(2008-3#1)(2008-4#5)(2012-2#1)
Preparation##57##1##(1991-2#1)(1992-2#2)(1992-6#1)(1995-11#1)(1995-3#1)(1996-5#3)(1997-1#1)(2008-10#25)(2008-11#8)(2008-2#1)(2008-3#1)(2008-4#5)(2008-8#1)(2008-9#2)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
Preparations of##3##2##(1990-12#1)(2008-10#2)
Preparations##4##1##(1990-12#1)(2008-10#3)
Prepared##3##1##(1993-3#1)(1997-7#1)(2010-6#1)
Preparedness##2##1##(1991-12#2)
Preparing a##3##2##(1992-3#1)(1995-3#1)(2008-11#1)
Preparing for health care##2##4##(1994-12#1)(1995-2#1)
Preparing for##5##2##(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)
Preparing##14##1##(1991-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(2008-11#4)(2008-4#1)
Prepenetration##2##1##(2008-10#2)
Prepubertal##2##1##(2008-10#1)(2011-1#1)
Preschool##2##1##(2008-11#2)
Prescribing preventive##2##2##(2008-11#2)
Prescribing##4##1##(2008-11#3)(2009-6#1)
Prescription drug misuse##2##3##(2013-8#2)
Prescription drug##7##2##(1995-1#1)(2008-11#2)(2009-6#1)(2010-5#1)(2013-8#2)
Prescription##12##1##(1992-12#1)(1995-1#1)(2008-11#2)(2009-6#1)(2010-12#1)(2010-5#1)(2013-1#2)(2013-8#3)
Presence of##16##2##(1990-12#1)(1996-5#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
Present results showed##2##3##(2008-12#2)
Present results##4##2##(2007-12#1)(2008-10#1)(2008-12#2)
Present study##2##2##(2012-3#1)(2013-8#1)
Present##19##1##(1992-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-8#1)
Presentation of a clinical##2##4##(1990-5#1)(1993-6#1)
Presentation of a##4##3##(1990-5#1)(1991-6#1)(1993-6#1)(2009-8#1)
Presentation of##6##2##(1990-5#2)(1991-6#1)(1993-6#1)(2009-8#1)(2011-2#1)
Presentation##27##1##(1990-5#2)(1991-6#1)(1993-6#1)(1995-11#1)(1997-4#1)(2008-11#11)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
Presentations##10##1##(2008-1#1)(2008-11#8)(2009-5#1)
Presented at the##2##3##(1992-3#1)(2008-11#1)
Presented in this article are##2##5##(1991-2#1)(1992-1#1)
Presented is a##2##3##(1991-1#1)(2008-1#1)
Presented is##3##2##(1991-1#1)(2008-1#1)(2008-8#1)
Presented##10##1##(1991-1#1)(1991-2#1)(1992-1#1)(1992-3#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)
Presenting as##2##2##(2008-11#1)(2012-12#1)
Presenting##6##1##(1991-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
Presently##7##1##(1996-3#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-2#2)(2012-3#1)
Preservation of##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
Preservation##5##1##(1996-9#1)(2008-10#2)(2008-11#1)(2011-2#1)
Preservative tolerance##2##2##(2008-5#2)
Preservative##3##1##(2008-5#3)
President Bush##2##2##(1991-12#1)(1994-1#1)
President Clinton##9##2##(1995-12#1)(1995-6#2)(1996-12#1)(1996-5#3)(1997-2#2)
President Clinton's Advisory Council on HIV/AIDS##2##6##(1995-12#1)(1995-6#1)
President of the##2##3##(1992-3#1)(1994-1#1)
President of##3##2##(1992-3#1)(1994-1#1)(2010-6#1)
President##30##1##(1991-12#2)(1991-2#1)(1991-3#3)(1992-3#1)(1993-1#1)(1994-1#3)(1994-3#1)(1995-12#5)(1995-2#1)(1995-6#4)(1996-1#1)(1996-12#1)(1996-5#3)(1997-2#2)(2010-6#1)
President's##5##1##(1993-3#1)(1993-5#1)(1995-12#1)(2010-1#1)(2010-6#1)
Presidential Address##2##2##(1994-12#1)(2008-11#1)
Presidential##4##1##(1994-12#1)(1995-6#1)(2008-11#1)(2008-8#1)
Press##14##1##(1990-11#3)(1990-8#3)(2008-11#3)(2008-12#4)(2008-5#1)
Pressure##11##1##(1995-6#1)(1996-5#1)(2008-10#4)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
Prestige disc) versus##2##3##(2012-12#2)
Prestige##4##1##(2008-10#1)(2012-12#3)
Prestige's##3##1##(2008-10#3)
Presumably##6##1##(1990-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-12#1)
Presynaptic##3##1##(1995-12#1)(1996-12#1)(1997-3#1)
Preterm infants##3##2##(2007-11#1)(2010-5#1)(2011-2#1)
Preterm##4##1##(1994-3#1)(2007-11#1)(2010-5#1)(2011-2#1)
Pretreatment of##8##2##(1990-11#1)(1995-11#1)(2008-10#5)(2011-2#1)
Pretreatment with the##2##3##(1992-8#1)(1994-2#1)
Pretreatment with##14##2##(1990-11#1)(1991-2#1)(1991-6#1)(1992-8#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-11#1)(1996-2#1)(1996-5#2)(2012-3#1)(2013-1#1)
Pretreatment##23##1##(1990-11#2)(1991-2#1)(1991-6#1)(1992-8#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-11#2)(1996-2#1)(1996-5#2)(2008-10#5)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Prevalence and risk factors for##2##5##(2011-2#1)(2012-3#1)
Prevalence and##10##2##(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes##2##15##(2012-2#2)
Prevalence of##33##2##(1996-12#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#6)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
Prevalence rates were##2##3##(2012-3#2)
Prevalence##56##1##(1996-12#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#7)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#8)(2013-8#2)
Preventing##9##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#1)(2008-11#2)(2009-4#1)(2009-5#1)(2010-1#1)
Prevention Trial##2##2##(1994-6#1)(1995-9#1)
Prevention and##5##2##(1996-6#1)(1997-2#1)(1997-5#1)(2010-7#1)(2013-1#1)
Prevention in##2##2##(1995-5#1)(2008-8#1)
Prevention is##2##2##(2008-11#1)(2010-1#1)
Prevention of##20##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-9#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
Prevention##66##1##(1990-12#2)(1990-6#1)(1990-9#1)(1991-6#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#3)(1995-6#4)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#3)(2013-8#2)
Preventive measures##2##2##(1994-5#1)(2013-1#1)
Preventive##14##1##(1994-5#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(2007-11#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#4)
Previous animal##2##2##(2008-10#1)(2008-4#1)
Previous reports have##3##3##(2008-7#1)(2009-9#1)(2012-3#1)
Previous reports##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-3#1)
Previous research has##4##3##(1995-12#1)(2008-11#2)(2012-2#1)
Previous research##10##2##(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#2)
Previous results##3##2##(1994-8#1)(2008-10#1)(2012-3#1)
Previous studies have demonstrated that##2##5##(2008-9#1)(2011-3#1)
Previous studies have demonstrated the##2##5##(1992-1#1)(2012-2#1)
Previous studies have demonstrated##4##4##(1992-1#1)(2008-9#1)(2011-3#1)(2012-2#1)
Previous studies have indicated that##2##5##(1995-11#1)(2008-8#1)
Previous studies have shown that##8##5##(1994-8#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-8#1)(2009-4#1)(2010-8#1)
Previous studies have shown##9##4##(1994-8#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-8#1)
Previous studies have##21##3##(1992-1#1)(1992-10#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1997-2#1)(2008-1#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-8#2)(2011-3#1)(2012-12#1)(2012-2#1)
Previous studies indicated that##2##4##(1993-12#1)(2008-10#1)
Previous studies with##2##3##(2008-6#1)(2008-9#1)
Previous studies##37##2##(1991-3#1)(1992-1#1)(1992-10#1)(1993-12#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-4#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
Previous study##2##2##(2008-10#1)(2010-7#1)
Previous work has shown##2##4##(1994-8#1)(2008-11#1)
Previous work has##4##3##(1994-8#1)(1995-12#1)(2008-11#1)(2008-9#1)
Previous work##9##2##(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
Previous works##2##2##(2010-10#1)(2012-7#1)
Previous##107##1##(1990-6#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-10#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#4)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#18)(2008-11#10)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2012-7#1)(2013-8#1)
Previously published##2##2##(2008-10#1)(2010-10#1)
Previously we showed that##2##4##(2008-11#1)(2012-3#1)
Previously we##5##2##(1994-6#1)(2008-11#2)(2008-8#1)(2012-3#1)
Previously##39##1##(1990-2#1)(1991-7#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1997-6#1)(1997-7#2)(2008-10#7)(2008-11#8)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
Prevotella##3##1##(2008-5#1)(2013-1#2)
Prey selection and functional##2##4##(2010-8#2)
Prey##5##1##(2009-10#1)(2010-8#4)
PriB##2##1##(1991-7#2)
Priapism is##2##2##(2008-10#2)
Price##5##1##(1993-1#2)(1993-3#2)(1994-1#1)
Primary Care Policy Fellowship##2##4##(1996-1#2)
Primary Care##7##2##(1991-9#1)(1994-6#1)(1995-12#1)(1996-1#3)(1996-2#1)
Primary Care]##2##2##(1991-9#1)(1997-5#1)
Primary and Secondary##2##3##(2008-10#1)(2008-11#1)
Primary and##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
Primary care physicians and##2##4##(2008-11#1)(2008-6#1)
Primary care physicians##3##3##(2008-11#1)(2008-6#1)(2009-9#1)
Primary care##8##2##(2008-11#3)(2008-6#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-2#1)
Primary central nervous system lymphoma##2##5##(2008-7#1)(2009-8#1)
Primary cultures expressed endothelial/macrophage RNA markers whether cultured on fibronectin or polystyrene and these markers decreased upon passage##2##18##(2008-11#2)
Primary cultures were analyzed by histochemistry and third passage cells by FACS##2##12##(2008-11#2)
Primary cultures were##3##3##(2008-11#3)
Primary cultures##6##2##(1993-6#1)(2008-11#5)
Primary cutaneous##2##2##(2012-3#1)(2013-8#1)
Primary gastric T cell lymphoma##2##5##(2009-8#2)
Primary gastric##3##2##(1997-1#1)(2009-8#2)
Primary human##3##2##(2008-11#2)(2011-2#1)
Primary intrarenal neuroblastoma##2##3##(2008-10#2)
Primary lymphoma of the central nervous system##2##7##(1991-2#2)
Primary lymphoma of the##3##4##(1991-2#2)(2013-1#1)
Primary mediastinal##2##2##(2009-8#2)
Primary mucinous carcinoma of the skin##2##6##(2010-3#2)
Primary non-refluxing megaureters##2##3##(2008-10#2)
Primary ovarian##2##2##(2013-8#2)
Primary spinal epidural##2##3##(1992-12#2)
Primary synovial##2##2##(2010-5#1)(2013-1#1)
Primary treatment##2##2##(1997-3#1)(2007-8#1)
Primary##134##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-2#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-1#3)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#3)(1997-5#2)(2007-8#1)(2008-10#18)(2008-11#18)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#6)
Primatone RL##5##2##(2008-7#5)
Primatone##6##1##(2008-7#6)
Prime Time participants##2##3##(2013-1#2)
Prime Time##5##2##(2013-1#5)
Primed##2##1##(1995-5#1)(2008-10#1)
Primer design##2##2##(2008-10#2)
Primer extension analysis##3##3##(1992-10#1)(1997-7#1)(1997-8#1)
Primer extension experiments##2##3##(1993-12#1)(1993-8#1)
Primer extension##7##2##(1992-10#1)(1993-12#1)(1993-2#1)(1993-8#2)(1997-7#1)(1997-8#1)
Primer pairs##2##2##(2008-10#2)
Primer##12##1##(1992-10#1)(1993-12#1)(1993-2#1)(1993-8#2)(1997-7#1)(1997-8#1)(2008-10#5)
Primers for##3##2##(2008-10#3)
Primers were designed from##2##4##(2008-10#1)(2008-8#1)
Primers were designed##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
Primers##12##1##(2008-10#10)(2008-11#1)(2008-8#1)
Priming##2##1##(1996-12#1)(2008-10#1)
Primorsko-Goranska County##8##2##(2011-2#8)
Primorsko-Goranska##10##1##(2011-2#10)
Primula##4##1##(2008-10#4)
Prince Edward Island##8##3##(2008-10#1)(2012-3#5)(2013-8#2)
Prince##12##1##(1996-1#1)(2008-10#2)(2008-7#2)(2012-3#5)(2013-8#2)
Princely church of Curtea de Arges##3##6##(2008-10#3)
Princeton##3##1##(1993-3#1)(2008-11#2)
Principal Component Analysis##4##3##(2008-10#2)(2008-5#1)(2009-5#1)
Principal Components Analysis##2##3##(2010-7#1)(2012-2#1)
Principal Components plots##2##3##(2008-10#2)
Principal Components##5##2##(2008-10#3)(2010-7#1)(2012-2#1)
Principal component analysis (PCA) was applied##2##6##(2008-10#2)
Principal component analysis (PCA) was##3##5##(2008-10#3)
Principal component analysis (PCA)##4##4##(2008-10#4)
Principal component analysis and cluster analysis##2##6##(2008-10#2)
Principal component analysis##10##3##(2008-10#10)
Principal component and##2##3##(2008-10#2)
Principal component##15##2##(2008-10#15)
Principal components analysis##2##3##(1992-1#1)(2010-7#1)
Principal##28##1##(1992-1#1)(2008-10#20)(2008-5#2)(2009-5#1)(2010-7#2)(2012-2#1)(2012-3#1)
Principle for##2##2##(1996-9#2)
Principle##4##1##(1991-2#1)(1996-9#2)(2008-10#1)
Principles and##5##2##(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
Principles for##2##2##(1991-12#1)(1992-3#1)
Principles of##9##2##(1990-3#1)(1990-8#1)(1992-3#2)(2008-11#1)(2008-9#2)(2011-2#1)(2013-1#1)
Principles##19##1##(1990-3#1)(1990-8#1)(1991-12#1)(1992-3#3)(1993-12#1)(1993-6#1)(1995-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#3)(2011-2#1)(2013-1#1)
Prion protein immunohistochemistry##2##3##(2008-5#2)
Prior quantum chemical studies suffered from short simulation timescales failing to capture free energy contributions due to relaxation of the surrounding aqueous environment##2##23##(2013-1#2)
Prior research##2##2##(2008-8#1)(2013-8#1)
Prior to the##6##3##(1995-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
Prior to##22##2##(1991-11#1)(1992-5#1)(1995-9#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#3)
Prior##38##1##(1991-11#1)(1992-5#1)(1993-6#1)(1995-5#1)(1995-9#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#4)(2013-1#2)(2013-8#2)
Prison of Love&quot##2##3##(2012-2#2)
Prison of##3##2##(2012-2#3)
Prison##6##1##(1992-2#1)(1993-2#1)(1997-5#1)(2012-2#3)
Private accreditation##2##2##(1995-3#2)
Private##13##1##(1991-1#2)(1992-2#3)(1992-3#1)(1993-2#1)(1995-3#2)(1997-2#1)(2008-10#1)(2008-11#2)
Prize for##2##2##(1995-12#1)(2010-8#1)
Prize##7##1##(1992-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-7#1)(2010-7#1)(2010-8#1)
Pro##17##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-3#1)(1994-5#1)(1996-1#2)(1997-7#3)(2008-11#1)(2009-3#2)(2011-2#2)
Pro-##7##1##(1991-5#7)
Pro-Argin##2##1##(2011-2#2)
Pro-Pro-[3H]benzylamide##3##1##(1992-3#3)
Pro34]NPY##3##1##(1997-4#3)
Pro9-NHEt] sGnRH##3##2##(1994-8#3)
ProDisc##2##1##(2009-3#2)
ProFlu ST test was##2##4##(2011-2#2)
ProNova stent##2##2##(2008-11#2)
ProNova##5##1##(2008-11#5)
Probabilistic##4##1##(1990-11#1)(2009-11#3)
Probabilities##5##1##(1990-11#1)(2008-10#3)(2012-3#1)
Probability##2##1##(2008-3#1)(2013-8#1)
Probable##2##1##(2008-10#2)
Probably the##2##2##(1996-11#1)(2008-7#1)
Probably##5##1##(1996-11#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
Probe##6##1##(2008-10#2)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
Probes for##2##2##(2006-6#1)(2008-10#1)
Probes##6##1##(1992-6#1)(2006-6#1)(2008-10#3)(2013-1#1)
Probing RNA##2##2##(2008-4#2)
Probing with##2##2##(2008-10#2)
Probing##11##1##(1993-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#3)
Probiotics and##5##2##(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
Probiotics##8##1##(2008-10#2)(2008-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
Probit##3##1##(1992-2#1)(2008-10#1)(2009-4#1)
Problem Behaviors##2##2##(2008-9#1)(2009-7#1)
Problem of##2##2##(1992-8#1)(2012-2#1)
Problem##11##1##(1992-8#1)(1993-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
Problem-based Learning##2##2##(2008-12#2)
Problem-based learning##2##2##(2008-12#1)(2011-1#1)
Problem-based##4##1##(2008-12#3)(2011-1#1)
Problems are##2##2##(1997-2#1)(2008-11#1)
Problems in##2##2##(1991-3#1)(2008-11#1)
Problems of##5##2##(1991-1#1)(1996-9#1)(2008-10#2)(2013-8#1)
Problems with the##2##3##(1997-3#1)(2008-10#1)
Problems##27##1##(1991-1#2)(1991-3#1)(1992-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#3)(2009-6#1)(2010-12#1)(2010-8#4)(2011-1#1)(2012-2#1)(2013-8#1)
Proc##8##1##(1990-10#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1995-6#2)
Procalcitonin (PCT)##2##2##(2008-5#2)
Procalcitonin for##3##2##(2008-5#3)
Procalcitonin in##3##2##(2008-5#3)
Procalcitonin##10##1##(2008-5#9)(2011-2#1)
Procalcitonin-a new##2##2##(2008-5#2)
Procalcitonin-a##3##1##(2008-5#3)
Procambarus clarkii##2##2##(2008-6#2)
Procedure for##2##2##(2008-10#2)
Procedure##6##1##(1991-3#1)(1995-12#1)(2008-10#3)(2010-7#1)
Procedures are##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
Procedures describing##2##2##(2008-9#2)
Procedures for the##2##3##(2008-10#1)(2008-4#1)
Procedures for##6##2##(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)
Procedures##15##1##(1992-3#1)(1993-3#1)(1996-5#1)(2008-10#3)(2008-4#2)(2008-7#3)(2008-9#3)(2013-1#1)
Proceedings of a conference##5##4##(1992-12#1)(1992-3#1)(1995-12#1)(1996-9#1)(1997-1#1)
Proceedings of a##6##3##(1992-12#1)(1992-3#1)(1995-12#1)(1996-9#1)(1997-1#1)(2008-6#1)
Proceedings of an international##2##4##(1993-1#1)(1995-9#1)
Proceedings of the 2010##2##4##(2011-2#2)
Proceedings of the##16##3##(1991-1#1)(1992-3#1)(1996-5#1)(1997-2#1)(2008-10#2)(2011-2#7)(2012-3#1)(2013-8#2)
Proceedings of##24##2##(1991-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1995-12#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-6#1)(2011-2#7)(2012-3#1)(2013-8#2)
Proceedings##26##1##(1990-11#1)(1991-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-6#1)(2011-2#7)(2012-3#1)(2013-8#2)
Process Strategy Teams##3##3##(1996-1#3)
Process cheese##3##2##(2008-10#3)
Process##64##1##(1996-1#4)(1996-5#1)(1997-2#2)(2008-10#7)(2008-11#9)(2008-3#1)(2008-7#4)(2008-8#8)(2009-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#15)(2012-3#1)(2013-1#6)
Processes and##2##2##(2008-10#1)(2010-10#1)
Processes of##2##2##(2008-12#1)(2012-2#1)
Processes##10##1##(1996-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-6#1)(2010-10#1)(2011-3#1)(2012-2#1)
Processing of##7##2##(1995-8#1)(2008-10#2)(2008-11#2)(2010-5#1)(2011-1#1)
Processing##19##1##(1995-8#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-8#1)
Procrustes rotation##3##2##(2008-10#2)(2008-11#1)
Procrustes##4##1##(2008-10#3)(2008-11#1)
Prodromal##2##1##(2008-3#1)(2011-8#1)
Produced by##6##2##(1991-12#1)(2008-10#4)(2008-3#1)
Produces##3##1##(2008-10#3)
Producing##4##1##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
Product Line Management##3##3##(1993-12#3)
Product##5##1##(1993-12#4)(2008-10#1)
Production and characterization of##2##4##(1992-2#1)(2008-6#1)
Production and##9##2##(1992-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-4#1)(2011-1#1)
Production by Fusarium##2##3##(2008-10#2)
Production by##7##2##(2008-10#6)(2013-1#1)
Production for##2##2##(1996-9#1)(2008-11#1)
Production in##5##2##(1996-9#1)(2008-10#4)
Production of a##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
Production of antibodies that recognize specific tyrosine-phosphorylated peptides##2##8##(2008-1#1)(2008-4#1)
Production of interferon-beta by##2##4##(2008-11#2)
Production of interferon-beta##3##3##(2008-11#3)
Production of monoclonal antibodies##2##4##(2008-11#1)(2008-9#1)
Production of recombinant human##2##4##(2008-12#1)(2008-7#1)
Production of recombinant##4##3##(1993-6#1)(2008-11#1)(2008-12#1)(2008-7#1)
Production of secondary conidia##2##4##(2008-10#2)
Production of secondary##3##3##(2008-10#3)
Production of the##5##3##(2008-10#5)
Production of##71##2##(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#3)(1997-2#2)(2008-1#1)(2008-10#28)(2008-11#13)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2011-3#1)(2012-2#1)
Production##112##1##(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#3)(1996-9#2)(1997-2#2)(2008-1#1)(2008-10#47)(2008-11#19)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#7)(2013-1#3)
Productivity##8##1##(1992-2#1)(2008-10#1)(2008-11#5)(2008-8#1)
Products &amp##3##2##(1994-9#1)(1995-3#1)(1995-6#1)
Products in##2##2##(2012-2#1)(2012-3#1)
Products of##4##2##(1990-12#1)(1997-1#1)(2008-10#1)(2011-2#1)
Products##22##1##(1990-12#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-3#2)(1995-6#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-8#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
Prof##14##1##(1990-6#1)(1991-6#1)(2008-10#12)
Profession##2##1##(2008-11#1)(2012-3#1)
Professional confidence##2##2##(2008-11#1)(2008-12#1)
Professional identity##2##2##(1993-3#2)
Professional##19##1##(1990-2#1)(1991-3#1)(1992-2#1)(1993-3#4)(1994-1#1)(2008-11#4)(2008-12#3)(2009-7#1)(2012-2#1)(2013-1#2)
Professionalism##3##1##(1991-3#1)(1992-1#1)(2013-1#1)
Professionals##2##1##(2010-1#2)
Professor Chiranjeevi was given the opportunity to respond to these allegations##2##11##(2008-10#2)
Professor Chiranjeevi##4##2##(2008-10#4)
Professor of##3##2##(2008-10#1)(2010-1#1)(2010-5#1)
Professor##17##1##(1997-2#1)(2008-10#9)(2008-12#1)(2008-5#2)(2010-1#1)(2010-5#1)(2010-7#1)(2012-3#1)
Profile of Patients with##2##4##(2009-10#1)(2012-3#1)
Profile of##9##2##(1993-2#1)(1996-3#1)(1997-2#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-8#1)
Profile##19##1##(1993-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-6#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
Profiles of log##2##3##(1991-9#2)
Profiles of##3##2##(1991-9#2)(2008-10#1)
Profiles##7##1##(1991-9#2)(2008-10#2)(2009-4#1)(2012-2#1)(2012-3#1)
Profiling##6##1##(1997-2#1)(2008-12#1)(2008-3#2)(2008-5#1)(2013-1#1)
Prog##16##1##(2011-2#16)
Progenitor Cells##2##2##(2008-7#1)(2013-1#1)
Progeny from##2##2##(2008-10#2)
Progeny of##2##2##(2008-10#1)(2008-5#1)
Progeny##9##1##(2008-10#8)(2008-5#1)
Progesterone and##2##2##(1993-11#1)(1995-11#1)
Progesterone##4##1##(1990-11#2)(1993-11#1)(1995-11#1)
Prognosis is##2##2##(2007-8#1)(2008-7#1)
Prognosis of##2##2##(1997-5#1)(2008-7#1)
Prognosis##6##1##(1997-5#1)(1997-8#1)(2007-8#1)(2008-7#2)(2012-3#1)
Prognostic Index##2##2##(2010-11#1)(2011-2#1)
Prognostic Scoring System##2##3##(2010-11#2)
Prognostic factors and##2##3##(2012-3#1)(2013-8#1)
Prognostic factors##5##2##(1992-2#1)(2008-10#1)(2009-4#1)(2012-3#1)(2013-8#1)
Prognostic impact of##2##3##(1990-8#1)(2011-2#1)
Prognostic indicators##2##2##(1993-11#1)(2008-11#1)
Prognostic or risk models##2##4##(2008-7#2)
Prognostic significance of##4##3##(1993-1#1)(2008-12#1)(2008-7#2)
Prognostic significance##5##2##(1993-1#1)(2008-10#1)(2008-12#1)(2008-7#2)
Prognostic value of##3##3##(1993-11#1)(1997-8#1)(2012-12#1)
Prognostic##32##1##(1990-8#1)(1992-2#1)(1993-1#1)(1993-11#2)(1994-12#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#4)(2009-4#1)(2010-11#5)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
Program at##2##2##(1994-3#1)(1997-2#1)
Program for Women##2##3##(1996-12#2)
Program for##8##2##(1994-3#1)(1995-12#1)(1996-12#2)(2010-1#1)(2013-1#3)
Program has##2##2##(1997-1#1)(2008-10#1)
Program in##4##2##(1991-1#1)(1991-2#1)(1996-3#1)(2008-10#1)
Program of the##3##3##(1994-12#1)(1996-12#1)(2012-3#1)
Program of##6##2##(1991-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-5#1)(2012-3#1)
Program on##2##2##(1991-12#1)(2011-2#1)
Program##91##1##(1990-2#1)(1991-1#2)(1991-12#4)(1991-2#8)(1992-1#2)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#2)(1994-12#4)(1994-2#3)(1994-3#3)(1995-12#3)(1995-2#1)(1996-1#2)(1996-12#3)(1996-2#4)(1996-3#1)(1997-1#7)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#9)(2013-8#3)
Programme in##3##2##(2008-1#1)(2008-10#1)(2010-10#1)
Programme##19##1##(1996-1#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-9#1)(2010-10#1)(2011-2#1)
Programmed##4##1##(2008-10#1)(2012-2#1)(2012-3#2)
Programmes##2##1##(2011-2#2)
Programming##2##1##(2008-10#1)(2009-11#1)
Programs##8##1##(1991-1#2)(1992-1#1)(1992-12#1)(2008-6#1)(2009-11#1)(2012-12#1)(2013-1#1)
Progress and##2##2##(1995-5#1)(2011-3#1)
Progress in anaesthesiology and intensive care medicine&quot##2##7##(2009-5#2)
Progress in##6##2##(1997-1#1)(2008-11#1)(2009-5#2)(2010-10#1)(2012-3#1)
Progress of##3##2##(1996-6#1)(2008-10#2)
Progress##20##1##(1995-5#2)(1996-6#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-5#2)(2010-10#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
Progression by##2##2##(2008-10#1)(2013-1#1)
Progression in##2##2##(1996-6#1)(2010-9#1)
Progression of##5##2##(2008-10#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
Progression##10##1##(1996-6#1)(2008-10#2)(2010-1#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
Progressive##12##1##(1992-12#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-3#1)
Proinflammatory##2##1##(2008-10#1)(2011-2#1)
Project 2000##5##2##(2008-11#4)(2008-12#1)
Project in##3##2##(1992-1#1)(1992-2#2)
Project##33##1##(1991-1#1)(1992-1#1)(1992-2#2)(1993-12#1)(1993-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#7)(2008-12#3)(2008-5#1)(2009-12#1)(2011-2#1)(2011-9#1)(2012-2#2)(2012-3#1)
Projections##2##1##(1992-9#1)(2011-2#1)
Projects##3##1##(1993-1#1)(2008-10#2)
Prokaryotic##2##1##(2008-4#1)(2012-3#1)
Prolactin (PRL)##2##2##(1994-3#1)(2011-2#1)
Prolactin##3##1##(1994-3#1)(1997-7#1)(2011-2#1)
Proliferation of##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
Proliferation##10##1##(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2012-4#1)(2013-1#1)(2013-7#1)
Prolongation of##2##2##(2008-10#1)(2008-11#1)
Prolonged development##2##2##(2008-9#2)
Prolonged##17##1##(1990-7#1)(1992-6#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Prominent##2##1##(1994-5#1)(2008-12#1)
Promising Practices##2##2##(2009-3#2)
Promising##7##1##(2008-10#2)(2008-11#1)(2009-3#2)(2011-2#1)(2013-1#1)
Promoter regions##2##2##(1993-9#1)(1995-6#1)
Promoter##5##1##(1993-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2013-8#1)
Promoting effect of##2##3##(2008-11#1)(2008-8#1)
Promoting evidence-based##2##2##(2008-11#1)(2011-2#1)
Promoting##14##1##(1992-12#1)(1994-1#1)(2008-11#6)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#2)(2013-1#1)
Promotion of##5##2##(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
Promotion##8##1##(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2013-1#1)(2013-8#1)
Prompt diagnosis and##2##3##(2008-7#1)(2011-2#1)
Prompt##5##1##(1994-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)
Pronase E##2##2##(1994-11#2)
Pronephrium simplex##2##2##(2008-10#2)
Pronounced##3##1##(1992-6#1)(1995-8#1)(2008-2#1)
Proof##2##1##(2008-7#1)(2011-9#1)
Propagation of##3##2##(1997-7#1)(2008-3#2)
Propagation##6##1##(1997-7#1)(2008-2#1)(2008-3#2)(2010-8#1)(2013-8#1)
Propagule densities of##2##3##(2008-10#2)
Propagule##3##1##(2008-10#2)(2008-8#1)
Propanil##2##1##(2008-10#2)
Proper##16##1##(1993-2#1)(1995-12#1)(1995-9#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
Properties and##2##2##(1995-3#1)(2008-11#1)
Properties of a##5##3##(1991-5#1)(2008-10#4)
Properties of the##3##3##(2008-11#1)(2008-4#1)(2008-6#1)
Properties of##19##2##(1991-5#1)(1992-1#1)(1996-9#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
Properties##26##1##(1991-5#1)(1992-1#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Prophylactic##6##1##(1991-3#1)(2008-7#1)(2010-7#2)(2013-1#2)
Prophylaxis##2##1##(2010-7#1)(2012-2#1)
Propofol and##3##2##(1993-1#1)(2010-7#2)
Propofol##5##1##(1993-1#1)(2010-7#2)(2012-3#2)
Propolis##2##1##(2008-10#2)
Proponents of##3##2##(1995-2#1)(2008-11#1)(2008-6#1)
Proponents##4##1##(1995-2#1)(1996-5#1)(2008-11#1)(2008-6#1)
Proportion of##2##2##(2008-11#1)(2008-8#1)
Proportional##3##1##(2008-8#1)(2011-2#1)(2012-3#1)
Proportions##3##1##(2008-10#1)(2011-2#1)(2012-12#1)
Proposal for##2##2##(1990-5#1)(1995-11#1)
Proposal of##2##2##(1996-6#1)(2008-10#1)
Proposal##4##1##(1990-5#1)(1995-11#1)(1996-6#1)(2008-10#1)
Proposals to##2##2##(1991-3#1)(2008-10#1)
Proposals##4##1##(1991-2#1)(1991-3#1)(1996-3#1)(2008-10#1)
Proposed here is a##3##4##(2010-8#3)
Proposed here is##4##3##(2010-8#4)
Proposed##12##1##(1994-2#1)(1996-3#1)(2008-10#3)(2010-3#1)(2010-8#6)
Propranolol##3##1##(1994-5#1)(2008-12#1)(2013-8#1)
Prorhinotermes simplex##2##2##(2007-12#2)
Pros##2##1##(2012-2#2)
Prosopis strombulifera##2##2##(2012-7#2)
Prosopis##3##1##(2012-7#2)(2013-1#1)
Prospective Cohort##2##2##(2010-5#1)(2013-1#1)
Prospective evaluation of##2##3##(2008-7#1)(2011-2#1)
Prospective evaluation##3##2##(2008-7#1)(2010-12#1)(2011-2#1)
Prospective studies##2##2##(1997-6#1)(2008-1#1)
Prospective study##2##2##(1995-9#1)(2011-2#1)
Prospective##20##1##(1992-1#1)(1995-9#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
Prospects for##4##2##(1994-12#1)(1996-12#1)(2008-3#1)(2013-8#1)
Prospects##5##1##(1994-12#1)(1996-12#1)(2008-3#1)(2009-6#1)(2013-8#1)
Prostacyclin##3##1##(1992-6#1)(1994-5#1)(2008-11#1)
Prostaglandin E##2##2##(1994-6#1)(2012-2#1)
Prostaglandin##4##1##(1990-11#1)(1990-12#1)(1994-6#1)(2012-2#1)
Prostaglandins##2##1##(1996-2#1)(2008-11#1)
Prostate Cancer##2##2##(2008-6#1)(2013-1#1)
Prostate cancer is a##4##4##(2010-12#1)(2011-2#3)
Prostate cancer is the##2##4##(2008-5#1)(2009-5#1)
Prostate cancer is##6##3##(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#3)
Prostate cancer##12##2##(1992-2#1)(1994-3#1)(2008-4#1)(2008-5#1)(2009-5#2)(2010-12#1)(2011-2#4)(2012-3#1)
Prostate##21##1##(1992-2#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-5#2)(2010-11#1)(2010-12#1)(2011-2#5)(2012-3#1)(2013-1#1)
Prostate-specific antigen##2##2##(1990-9#1)(2010-12#1)
Prostatic acid phosphatase##2##3##(1990-9#1)(2008-12#1)
Prostatic##4##1##(1990-9#1)(2008-10#1)(2008-12#2)
Prostheses##2##1##(2009-1#2)
Prosthetic##2##1##(2011-2#1)(2013-1#1)
Protease Inhibitors##2##2##(1992-12#1)(1996-5#1)
Protease inhibition##2##2##(1992-12#2)
Protease##6##1##(1992-12#3)(1994-5#1)(1996-5#1)(2008-10#1)
Proteases and##2##2##(1992-12#1)(2009-10#1)
Proteases in##2##2##(2012-3#2)
Proteases##4##1##(1992-12#1)(2009-10#1)(2012-3#2)
Proteasome##2##1##(2008-5#1)(2008-8#1)
Protect##6##1##(2008-10#2)(2008-12#1)(2010-6#1)(2012-3#2)
Protected##2##1##(1996-2#1)(2013-1#1)
Protecting our gifts and securing our future##2##7##(2008-11#2)
Protecting our##3##2##(1997-7#1)(2008-11#2)
Protecting the##2##2##(1990-7#1)(2009-4#1)
Protecting##9##1##(1990-7#1)(1995-12#1)(1997-7#1)(2008-11#3)(2009-4#1)(2011-2#1)(2012-2#1)
Protection Against##5##2##(2008-10#4)(2009-8#1)
Protection against##2##2##(1995-8#1)(2008-9#1)
Protection by##2##2##(1993-8#1)(1994-8#1)
Protection from##2##2##(1996-10#1)(2008-5#1)
Protection in##2##2##(2008-10#2)
Protection of##5##2##(1992-12#1)(1996-5#1)(2008-10#2)(2008-11#1)
Protection was##3##2##(1994-5#1)(2008-10#1)(2011-2#1)
Protection##42##1##(1990-2#1)(1992-1#1)(1992-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-8#2)(1997-5#1)(2008-10#17)(2008-11#1)(2008-5#3)(2008-9#3)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
Protective Effect of##2##3##(2011-2#1)(2012-2#1)
Protective effect of##2##3##(2008-11#1)(2010-2#1)
Protective immunity##2##2##(1995-12#1)(1995-2#1)
Protective##17##1##(1991-1#1)(1992-9#1)(1995-12#1)(1995-2#1)(1996-5#2)(1997-6#1)(2008-11#2)(2008-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#4)
Protein A##2##2##(1990-12#1)(2008-10#1)
Protein Data Bank##2##3##(2011-3#2)
Protein G##2##2##(1990-12#1)(2008-11#1)
Protein Gene##6##2##(2008-10#5)(2013-1#1)
Protein Kinase##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
Protein and##4##2##(2008-10#3)(2010-7#1)
Protein farnesyltransferase##2##2##(1993-9#1)(2008-5#1)
Protein folding##2##2##(1994-12#1)(2010-4#1)
Protein from##3##2##(2008-10#2)(2010-12#1)
Protein in##2##2##(2008-10#2)
Protein kinase C##7##3##(1990-5#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-2#2)(1997-1#1)
Protein kinase##8##2##(1990-5#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-2#2)(1997-1#1)(2012-3#1)
Protein of Apple chlorotic leaf spot virus##2##7##(2008-10#2)
Protein of##4##2##(2008-10#4)
Protein phosphatase inhibitors##2##3##(1994-11#1)(2008-4#1)
Protein profiles##2##2##(1997-8#1)(2008-10#1)
Protein synthesis##3##2##(1991-2#1)(1993-3#1)(2008-11#1)
Protein tyrosine##2##2##(1995-8#1)(2009-6#1)
Protein##136##1##(1990-11#1)(1990-12#3)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#38)(2008-11#14)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#4)(2012-2#13)(2012-3#1)(2013-1#7)
Protein-A##2##1##(1993-8#1)(2008-10#1)
Protein-DNA##2##1##(2008-2#2)
Protein-bound##2##1##(1991-12#2)
Proteins in##2##2##(2012-3#1)(2013-1#1)
Proteins that##3##2##(1993-9#1)(2008-11#1)(2010-11#1)
Proteins were##3##2##(1996-1#2)(2010-12#1)
Proteins##25##1##(1990-7#1)(1991-12#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-1#2)(2008-10#8)(2008-11#3)(2008-5#1)(2010-11#1)(2010-12#2)(2012-3#1)(2013-1#2)
Proteolysis of##2##2##(1995-6#2)
Proteolytic##3##1##(1990-2#1)(1995-11#1)(2013-8#1)
Proteome##4##1##(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)
Proteomic analysis in##2##3##(2008-12#1)(2010-12#1)
Proteomic analysis##5##2##(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#2)
Proteomic profiling of##3##3##(2008-11#1)(2010-12#2)
Proteomic profiling##4##2##(2008-11#1)(2010-12#3)
Proteomic##13##1##(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#1)(2009-10#1)(2010-12#5)(2010-9#1)
Proteomics##3##1##(2008-2#1)(2008-4#1)(2012-3#1)
Proteus mirabilis##3##2##(2008-10#1)(2009-6#1)(2010-6#1)
Proteus##4##1##(2008-10#1)(2008-11#1)(2009-6#1)(2010-6#1)
Protocol 1##2##2##(2008-4#1)(2008-9#1)
Protocol 2##2##2##(2008-4#2)
Protocol describes##6##2##(2008-4#3)(2008-9#3)
Protocol for##4##2##(1996-2#1)(1997-2#1)(2008-10#1)(2010-7#1)
Protocol in##3##2##(1996-1#1)(2008-4#1)(2012-3#1)
Protocol##25##1##(1996-1#4)(1996-2#2)(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#9)(2008-9#5)(2010-7#1)(2012-3#1)
Protocols are provided for##2##4##(2008-4#1)(2008-9#1)
Protocols are provided##5##3##(2008-4#4)(2008-9#1)
Protocols are##11##2##(2008-4#6)(2008-9#5)
Protocols describe preparation of##2##4##(2008-4#1)(2008-9#1)
Protocols describe##5##2##(2008-4#4)(2008-9#1)
Protocols for##2##2##(2008-9#2)
Protocols in this unit describe the##2##6##(2008-9#2)
Protocols in this unit##3##4##(2008-9#3)
Protocols##26##1##(1993-5#1)(1996-6#1)(2008-10#1)(2008-4#11)(2008-9#12)
Proton NMR investigation of##2##4##(1994-5#1)(2008-9#1)
Proton NMR##3##2##(1993-8#1)(1994-5#1)(2008-9#1)
Proton##9##1##(1991-3#1)(1991-9#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#2)
Protonation and##2##2##(2008-10#2)
Protonation constant##2##2##(2008-10#2)
Protonation constants of##4##3##(2008-10#4)
Protonation of##3##2##(2008-10#3)
Protonation##13##1##(2008-10#13)
Protoplast fusion##2##2##(2008-11#2)
Protoplast##3##1##(2008-11#2)(2008-9#1)
Protoplasts from##2##2##(2008-9#2)
Protoplasts##6##1##(2008-10#1)(2008-9#5)
Prototypes##2##1##(2008-5#2)
Protozoa##2##1##(2008-12#1)(2012-2#1)
Proventil 1##2##2##(1992-2#2)
Proventil##5##1##(1992-2#5)
Provide##3##1##(2008-3#1)(2011-2#1)(2012-2#1)
Provided by##2##2##(2008-10#1)(2012-3#1)
Provided that##2##2##(1992-3#1)(2007-11#1)
Provided##6##1##(1992-3#1)(2007-11#1)(2008-10#1)(2008-9#2)(2012-3#1)
Provider##7##1##(1992-11#1)(1992-2#1)(1993-5#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-2#1)
Providers##7##1##(1992-8#1)(1994-1#1)(1994-3#1)(1995-3#1)(1997-6#1)(2008-6#1)(2013-8#1)
Provides##2##1##(2008-10#2)
Providing##5##1##(1994-1#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-2#1)
Province in China##2##3##(2008-10#1)(2013-8#1)
Province in##3##2##(2008-10#1)(2013-8#2)
Province of##5##2##(1991-2#1)(1991-6#1)(1992-12#1)(2010-3#1)(2012-2#1)
Province##28##1##(1991-2#1)(1991-6#1)(1992-12#1)(1993-2#1)(2008-10#4)(2008-8#3)(2008-9#2)(2009-10#1)(2010-3#1)(2010-8#1)(2012-2#3)(2013-8#9)
Provincial##2##1##(1992-3#1)(2008-9#1)
Proviral##2##1##(2008-9#2)
Provision of##4##2##(1995-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
Provision##7##1##(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
Proximal##6##1##(2008-12#2)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
Proximate constraints on##2##3##(1991-5#2)
Proximity Effect##2##2##(1996-9#2)
Prtp##2##1##(1993-9#2)
Prune Fruit##2##2##(2008-10#2)
Prune dwarf virus##3##3##(2008-10#3)
Prune##7##1##(2008-10#7)
Prunus necrotic ringspot virus (PNRSV)##3##5##(2008-10#3)
Prunus necrotic ringspot virus##4##4##(2008-10#4)
Prunus persica##2##2##(2008-10#2)
Prunus species##2##2##(2008-10#1)(2008-9#1)
Prunus spp##7##2##(2008-10#7)
Prunus##19##1##(2008-10#17)(2008-11#1)(2008-9#1)
Prussian Blue (PB)##3##3##(2008-10#3)
Prussian Blue and##2##3##(2008-10#2)
Prussian Blue##11##2##(2008-10#11)
Prussian blue (PB)##3##3##(2008-10#3)
Prussian blue modified##2##3##(2008-10#2)
Prussian blue##9##2##(2008-10#9)
Prussian##23##1##(2008-10#23)
Przhevalskiana##4##1##(2008-12#4)
Ps##2##1##(2012-2#2)
Ps95##6##1##(2008-10#6)
PsCV##2##1##(2008-5#2)
PsENOD12a and PsENOD5##2##3##(2011-2#2)
PsENOD12a##3##1##(2011-2#3)
PsENOD5##4##1##(2011-2#4)
Pseudacteon wasmanni##2##2##(2007-12#2)
Pseudoaneurysm of the##2##3##(2008-12#1)(2010-7#1)
Pseudoaneurysm of##3##2##(2008-12#1)(2008-7#1)(2010-7#1)
Pseudocerastes persicus##2##2##(2013-1#2)
Pseudohypoparathyroidism (PHP)##2##2##(2010-6#1)(2011-1#1)
Pseudohypoparathyroidism##3##1##(2010-6#1)(2011-1#2)
Pseudomonas aeruginosa exotoxin A##2##4##(2008-10#2)
Pseudomonas aeruginosa##26##2##(1995-2#2)(2008-10#5)(2008-11#1)(2008-7#4)(2009-6#4)(2012-2#8)(2013-1#1)(2013-8#1)
Pseudomonas and##2##2##(2008-10#1)(2008-5#1)
Pseudomonas biocontrol##2##2##(2008-10#2)
Pseudomonas chlororaphis##2##2##(2008-10#2)
Pseudomonas fluorescens A506##3##3##(2008-10#3)
Pseudomonas fluorescens B5##9##3##(2008-10#9)
Pseudomonas fluorescens Pf-5##2##3##(2008-10#2)
Pseudomonas fluorescens Strain##2##3##(2008-10#2)
Pseudomonas fluorescens and##2##3##(2008-10#2)
Pseudomonas fluorescens bv##2##3##(2008-10#2)
Pseudomonas fluorescens strain A506##3##4##(2008-10#3)
Pseudomonas fluorescens strain##6##3##(2008-10#6)
Pseudomonas fluorescens strains##2##3##(2008-10#2)
Pseudomonas fluorescens##47##2##(2008-10#46)(2008-8#1)
Pseudomonas putida 06909-rif/nal on##2##4##(2008-10#2)
Pseudomonas putida 06909-rif/nal was applied##2##5##(2008-10#2)
Pseudomonas putida 06909-rif/nal was##4##4##(2008-10#4)
Pseudomonas putida 06909-rif/nal##15##3##(2008-10#15)
Pseudomonas putida 54G biofilm##2##4##(2008-7#2)
Pseudomonas putida GNA5##3##3##(2011-2#3)
Pseudomonas putida WCS358##3##3##(2008-10#3)
Pseudomonas putida was##2##3##(2008-10#1)(2008-7#1)
Pseudomonas putida##38##2##(1994-5#1)(2008-10#28)(2008-7#3)(2011-2#4)(2012-2#2)
Pseudomonas savastanoi pv##2##3##(2008-10#2)
Pseudomonas sp##5##2##(2008-10#4)(2008-7#1)
Pseudomonas spp##34##2##(2008-10#34)
Pseudomonas strains##2##2##(1991-3#1)(2008-10#1)
Pseudomonas syringae and##3##3##(2008-10#3)
Pseudomonas syringae pv##31##3##(2008-10#31)
Pseudomonas syringae##52##2##(2008-10#50)(2009-8#2)
Pseudomonas##228##1##(1991-3#2)(1994-5#2)(1995-2#2)(1995-6#1)(2008-10#181)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#10)(2008-8#2)(2009-6#5)(2009-8#2)(2010-6#1)(2011-2#5)(2012-2#10)(2013-1#1)(2013-8#1)
Pseudonocardia##4##1##(2012-2#4)
Pseudoperonospora cubensis resistance##2##3##(2008-10#2)
Pseudoperonospora cubensis##6##2##(2008-10#6)
Pseudorecombination##2##1##(2008-10#2)
Pseudosclerotia##2##1##(2008-10#2)
Pseudothecia and##3##2##(2008-10#3)
Pseudothecia##8##1##(2008-10#8)
Pseudothecial Development##2##2##(2008-10#2)
Pseudotsuga##2##1##(2008-10#2)
Pseudotumoural soft tissue lesions of the##2##6##(2012-2#2)
Pseudozyma flocculosa##2##2##(2008-10#2)
Pseudozyma##4##1##(2008-10#4)
Psi(w)##5##1##(2008-10#5)
Psoas##2##1##(2008-10#1)(2009-4#1)
Psoriasis##4##1##(1997-8#1)(2008-6#1)(2010-6#1)(2013-1#1)
PspA##2##1##(1995-5#2)
Pssym10##2##1##(2011-2#2)
Pssym7##2##1##(2011-2#2)
Pst I DNA fragment##2##4##(1996-6#1)(2008-8#1)
PstI and##2##2##(1995-12#1)(2008-10#1)
PstI##3##1##(1995-12#1)(1997-7#1)(2008-10#1)
PsycINFO##3##1##(2009-9#1)(2013-1#2)
PsycLIT##2##1##(1991-1#2)
Psychiatric Association was##3##3##(2011-4#3)
Psychiatric Association##5##2##(2011-2#1)(2011-4#4)
Psychiatric Hospitals##6##2##(1991-1#2)(1992-2#1)(1992-3#1)(1997-8#2)
Psychiatric Nursing##4##2##(2008-11#3)(2008-12#1)
Psychiatric and##2##2##(2008-4#1)(2009-6#1)
Psychiatric##41##1##(1991-1#3)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#1)(1995-1#1)(1997-8#3)(2008-11#6)(2008-12#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-2#1)(2011-4#10)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Psychiatrists##2##1##(1990-6#1)(1993-1#1)
Psychiatry and##3##2##(1996-1#1)(2008-7#1)(2011-3#1)
Psychiatry##16##1##(1996-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#3)(2011-2#1)(2011-3#1)(2011-4#4)(2013-8#1)
Psychoanalytic##2##1##(2008-4#1)(2011-4#1)
Psychodidae)##3##1##(2007-12#2)(2013-1#1)
Psychological and##2##2##(2008-11#1)(2008-8#1)
Psychological##18##1##(1991-8#1)(1992-3#1)(1992-9#1)(1994-12#3)(1995-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Psychology and##2##2##(2010-12#1)(2010-2#1)
Psychology##7##1##(1991-12#1)(2008-12#2)(2010-12#1)(2010-2#1)(2010-6#1)(2012-2#1)
Psychometric##3##1##(1996-3#1)(2010-7#1)(2013-1#1)
Psychoneuroimmunology##2##1##(2008-2#2)
Psychosocial and##2##2##(1995-9#1)(2011-2#1)
Psychosocial##8##1##(1994-1#1)(1994-3#1)(1995-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)
Psychosomatic##2##1##(1996-11#1)(1996-9#1)
Psychotherapy##3##1##(2008-4#2)(2012-2#1)
Psychotic##2##1##(1992-3#1)(2011-2#1)
Pt and Ir modifiers##2##4##(2008-10#2)
Pt and Pd##3##3##(2008-10#2)(2008-11#1)
Pt and Pt-Ru catalysts##2##4##(2008-10#2)
Pt and##8##2##(2008-10#7)(2008-11#1)
Pt electrode##5##2##(2008-10#5)
Pt electrodes##3##2##(2008-10#3)
Pt fluxes are##2##3##(2008-11#2)
Pt in##2##2##(2008-10#1)(2008-11#1)
Pt nps is a##2##4##(2008-11#2)
Pt nps##8##2##(2008-11#8)
Pt was##2##2##(2008-10#2)
Pt##64##1##(2008-10#43)(2008-11#21)
Pt(2+)##2##1##(2010-11#2)
Pt(II) and Rh(III)##3##3##(2008-10#3)
Pt(II)##5##1##(2008-10#5)
Pt(IV)##7##1##(2008-10#7)
Pt-Bs##2##1##(2008-10#2)
Pt-Ir microelectrode##2##2##(2008-10#2)
Pt-Ir##3##1##(2008-10#3)
Pt-Ne##2##1##(2008-3#2)
Pt-Rh thermocouple##2##2##(2008-10#2)
Pt-Rh##3##1##(2008-10#3)
Pt/SAM/PB/PPy-ChOx/Nf##2##1##(2008-10#2)
PtOEP##4##1##(2008-10#4)
PtRu##2##1##(2008-10#2)
PtdIns##2##1##(1993-6#2)
PtdIns(4##3##1##(2009-6#3)
PtdInsP2 in##2##2##(1997-1#2)
PtdInsP2##5##1##(1993-6#2)(1997-1#3)
Pten##6##1##(2011-2#6)
Pterocarya fraxinifolia##3##2##(2011-1#3)
Ptilonorhynchus violaceus##2##2##(2008-8#2)
Pto##4##1##(2009-8#4)
Ptpre(-/-) mice##2##2##(2009-6#2)
Ptr ToxA is##2##3##(2008-10#2)
Ptr ToxA##13##2##(2008-10#13)
Ptr ToxB##4##2##(2008-10#4)
Ptr ToxC##4##2##(2008-10#4)
Ptr##23##1##(2008-10#23)
Pu isotope##2##2##(2008-10#2)
Pu isotopes in settling particles##2##5##(2008-10#2)
Pu isotopes##3##2##(2008-10#3)
Pu was##2##2##(2008-10#2)
Pu##17##1##(2008-10#17)
PubMed##14##1##(2008-12#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)
Public Health Improvement Plan##2##4##(1995-12#1)(1996-2#1)
Public Health Laboratory##4##3##(2008-10#2)(2012-3#2)
Public Health Service##5##3##(1991-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(2012-2#1)
Public Health Surveillance System##3##4##(1997-3#1)(2012-12#2)
Public Health Syphilis Study at Tuskegee##2##6##(2013-1#2)
Public Health and##2##3##(1996-1#1)(1997-2#1)
Public Health of##2##3##(2008-12#1)(2012-2#1)
Public Health##58##2##(1991-1#1)(1991-2#5)(1995-12#5)(1996-1#8)(1996-12#1)(1996-2#3)(1996-3#4)(1996-6#1)(1997-2#3)(1997-3#2)(2008-10#6)(2008-12#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
Public Law 101-239##2##3##(1991-3#2)
Public Law##5##2##(1991-3#2)(1994-1#1)(1997-4#1)(2012-2#1)
Public financing##2##2##(1994-2#1)(2013-8#1)
Public health and##2##3##(1991-2#1)(2011-2#1)
Public health assessment in##2##4##(1996-1#2)
Public health practice##2##3##(1996-1#1)(1996-12#1)
Public health surveillance##2##3##(1997-3#2)
Public health##28##2##(1991-12#1)(1991-2#1)(1993-12#1)(1995-12#3)(1996-1#4)(1996-12#3)(1996-2#3)(1996-3#2)(1997-1#1)(1997-3#3)(1997-4#1)(2008-1#1)(2008-11#1)(2010-9#1)(2011-2#2)
Public##110##1##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#6)(1991-3#4)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#8)(1995-2#1)(1995-3#1)(1996-1#12)(1996-12#4)(1996-2#6)(1996-3#6)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#3)
Publication##3##1##(1991-2#1)(1993-12#1)(2008-11#1)
Publications from##2##2##(1994-2#1)(2013-1#1)
Publicly##2##1##(1992-2#1)(2009-10#1)
Published reports##2##2##(2008-3#1)(2009-8#1)
Published##6##1##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)
Pubmed##2##1##(2012-12#1)(2013-1#1)
Puccinia allii##3##2##(2008-10#3)
Puccinia coronata##5##2##(2008-10#5)
Puccinia graminis f##4##3##(2008-10#4)
Puccinia graminis subsp##2##3##(2008-10#2)
Puccinia graminis##8##2##(2008-10#8)
Puccinia hordei##3##2##(2008-10#3)
Puccinia jaceae var##2##3##(2008-10#2)
Puccinia punctiformis##2##2##(2008-10#2)
Puccinia recondita##3##2##(2008-10#3)
Puccinia spp##3##2##(2008-10#3)
Puccinia striiformis f##5##3##(2008-10#5)
Puccinia striiformis##9##2##(2008-10#9)
Puccinia triticina##21##2##(2008-10#21)
Puccinia##64##1##(2008-10#64)
Puck Bay##2##2##(2008-11#2)
Pue##3##1##(2011-3#3)
Puerto Carreño municipality##2##3##(2012-12#2)
Puerto Carreño##4##2##(2012-12#4)
Puerto Rico##8##2##(2008-10#7)(2008-11#1)
Puerto##13##1##(1994-2#1)(2008-10#7)(2008-11#1)(2012-12#4)
Puff City##3##2##(2013-1#3)
Puget##2##1##(1990-11#1)(2008-10#1)
Pulling##2##1##(1995-2#2)
Pullman##2##1##(2008-10#2)
Pulmonary alveolar proteinosis##2##3##(2010-7#2)
Pulmonary alveolar##3##2##(2010-7#2)(2012-12#1)
Pulmonary and##2##2##(2012-3#1)(2013-1#1)
Pulmonary arterial hypertension##2##3##(2010-10#2)
Pulmonary artery##3##2##(1997-8#2)(2010-10#1)
Pulmonary disease##2##2##(2007-12#2)
Pulmonary function tests##3##3##(1997-3#1)(2012-2#2)
Pulmonary function##4##2##(1997-3#1)(2012-2#2)(2013-1#1)
Pulmonary hypertension##2##2##(2008-1#1)(2012-2#1)
Pulmonary tuberculosis##2##2##(2008-7#1)(2012-3#1)
Pulmonary##45##1##(1990-2#1)(1991-11#1)(1997-3#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#4)(2010-12#1)(2010-7#2)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#1)
Pulp##2##1##(2008-6#2)
Pulse Energy##2##2##(2008-3#2)
Pulse immunization##5##2##(1994-9#5)
Pulse##14##1##(1993-1#1)(1994-9#5)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-2#1)(2012-3#1)
Pulsed fast/thermal neutron analysis##2##4##(2008-10#2)
Pulsed field gel electrophoresis##2##4##(1992-6#1)(2008-10#1)
Pulsed##11##1##(1992-6#1)(2008-10#5)(2008-3#4)(2012-2#1)
Pulsed-field gel electrophoresis##2##3##(2008-4#1)(2011-2#1)
Pulsed-field##3##1##(1996-6#1)(2008-4#1)(2011-2#1)
Pulses as short as##2##4##(2007-11#1)(2008-2#1)
Pulses in##2##2##(2008-3#1)(2008-5#1)
Pulses##6##1##(2007-11#1)(2008-2#1)(2008-3#3)(2008-5#1)
Pungtungia herzi##2##2##(2010-8#2)
Punitive##2##1##(1995-12#1)(1996-2#1)
Punjab##8##1##(1997-8#1)(2008-10#4)(2008-12#1)(2010-11#1)(2011-2#1)
Punta##2##1##(2010-8#2)
PurR protein##2##2##(2008-8#2)
PurR##8##1##(2008-8#8)
Purchasing##2##1##(1996-2#1)(1996-8#1)
Pure 1##2##2##(1996-5#2)
Pure##7##1##(1996-5#2)(2008-10#2)(2008-7#1)(2009-7#1)(2013-1#1)
Purification and biochemical characterization of##2##5##(1991-9#1)(1993-8#1)
Purification and characterization of a##4##5##(1990-2#1)(1991-5#1)(1994-8#1)(1995-6#1)
Purification and characterization of##11##4##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
Purification and properties of##3##4##(1992-7#1)(1995-3#1)(2008-8#1)
Purification and##23##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-8#1)(2010-4#1)
Purification by##2##2##(1992-12#1)(1992-6#1)
Purification of a##2##3##(2008-10#1)(2010-12#1)
Purification of the##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
Purification of##15##2##(1990-12#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#3)(2010-12#1)
Purification##47##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#1)(2008-4#6)(2008-8#3)(2009-9#1)(2010-12#1)(2010-4#1)
Purified VLP preparations##2##3##(2008-10#2)
Purified fibrinogen##2##2##(2008-10#2)
Purified##25##1##(1990-2#1)(1991-10#1)(1991-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(2008-10#13)(2008-8#1)(2013-8#1)
Purinergic agents##2##2##(1995-8#2)
Purinergic##4##1##(1995-8#3)(2013-8#1)
Purity##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
Purkinje cell##4##2##(1992-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
Purkinje cells##5##2##(1991-7#1)(1992-9#1)(1994-2#1)(1997-8#2)
Purkinje neurons##3##2##(1995-8#3)
Purkinje##14##1##(1991-7#1)(1992-3#1)(1992-9#2)(1994-2#1)(1995-8#3)(1997-8#2)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
Purple##4##1##(1997-8#1)(2008-10#2)(2009-11#1)
Purpose - The##2##3##(2008-11#2)
Purpose -##4##2##(2008-11#4)
Purpose of##2##2##(1991-12#1)(2013-8#1)
Purpose##26##1##(1991-12#1)(1996-9#1)(2008-10#4)(2008-11#6)(2012-3#1)(2013-1#11)(2013-8#2)
Purpose- To##2##2##(2008-11#2)
Purpose-To##2##1##(2008-11#2)
Put##3##1##(1990-8#1)(1996-2#2)
Putative F(1)##2##2##(2008-10#2)
Putative##8##1##(2008-10#5)(2008-9#1)(2010-10#1)(2012-3#1)
Putatively nonpathogenic##2##2##(2008-10#2)
Putatively##3##1##(2008-10#2)(2012-3#1)
Putting##3##1##(1994-2#1)(1994-9#1)(2009-12#1)
Pv bZIP1##2##2##(2013-8#2)
Pv##4##1##(2013-8#4)
PvZIP12##5##1##(2013-8#5)
PvZIP13##3##1##(2013-8#3)
PvZIP16##2##1##(2013-8#2)
PvuII pp genotype##2##3##(2011-2#2)
PvuII##4##1##(2011-2#4)
Pwt1 and Pwt2##2##3##(2008-10#2)
Pwt1##3##1##(2008-10#3)
Pwt2##3##1##(2008-10#3)
Pwt3##3##1##(2008-10#3)
Pwt4##4##1##(2008-10#4)
PxB and PxE##3##3##(2008-10#3)
PxB##4##1##(2008-10#4)
PxE##4##1##(2008-10#4)
Py-GC/MS##2##1##(2008-10#2)
Pyeloureteritis cystica##2##2##(2011-2#2)
Pygmy##2##1##(1995-8#1)(2011-2#1)
Pyostomatitis vegetans##2##2##(2011-2#2)
Pyr and D-Pyr in##2##4##(1994-12#2)
Pyr and D-Pyr##3##3##(1994-12#3)
Pyr##4##1##(1994-12#4)
Pyracantha spp##3##2##(2008-10#3)
Pyracantha##5##1##(2008-10#5)
Pyramiding##2##1##(2008-10#1)(2009-10#1)
Pyrenopeziza brassicae##3##2##(2008-10#3)
Pyrenophora semeniperda##2##2##(2008-10#2)
Pyrenophora teres##5##2##(2008-10#5)
Pyrenophora tritici-repentis Race##3##3##(2008-10#3)
Pyrenophora tritici-repentis and##2##3##(2008-10#2)
Pyrenophora tritici-repentis race##2##3##(2008-10#2)
Pyrenophora tritici-repentis##20##2##(2008-10#20)
Pyrenophora##28##1##(2008-10#28)
Pyricularia grisea is##2##3##(2008-10#2)
Pyricularia grisea##12##2##(2008-10#11)(2008-9#1)
Pyricularia oryzae and##2##3##(2008-10#2)
Pyricularia oryzae##3##2##(2008-10#3)
Pyricularia##16##1##(2008-10#15)(2008-9#1)
Pyridinium##2##1##(1994-12#1)(2008-10#1)
Pyrococcus##4##1##(1993-12#1)(1993-9#2)(2008-9#1)
Pyrolysis temperatures##2##2##(2008-10#2)
Pyrolysis##3##1##(2008-10#3)
Pyrus##2##1##(2008-10#2)
Pythium Damping-Off##2##2##(2008-10#2)
Pythium and##2##2##(2008-10#2)
Pythium aphanidermatum in Cucumber Grown on Rockwool##2##7##(2008-10#2)
Pythium aphanidermatum##11##2##(2008-10#11)
Pythium arrhenomanes##3##2##(2008-10#3)
Pythium damping-off##3##2##(2008-10#3)
Pythium group F##5##3##(2008-10#5)
Pythium group##7##2##(2008-10#7)
Pythium infection##2##2##(2008-10#2)
Pythium irregulare##2##2##(2008-10#2)
Pythium oligandrum and##2##3##(2008-10#2)
Pythium oligandrum##10##2##(2008-10#10)
Pythium root##3##2##(2008-10#3)
Pythium sp##3##2##(2008-10#3)
Pythium spp##29##2##(2008-10#29)
Pythium ultimum and##3##3##(2008-10#3)
Pythium ultimum on##2##3##(2008-10#2)
Pythium ultimum var##4##3##(2008-10#4)
Pythium ultimum##20##2##(2008-10#20)
Pythium were##2##2##(2008-10#2)
Pythium##115##1##(2008-10#115)
P &lt##8##1##(2012-2#1)(2013-1#7)
P = 0##3##1##(2013-1#3)
P≤0##4##1##(2013-1#4)
Q ICP MS##3##3##(2008-10#3)
Q and##3##2##(2008-10#2)(2008-9#1)
Q switched##2##2##(2007-12#1)(2008-2#1)
Q switching is##2##3##(2008-3#2)
Q switching##5##2##(2007-12#1)(2008-3#4)
Q were obtained for##2##4##(2008-10#2)
Q were##3##2##(2008-10#3)
Q##87##1##(1990-5#1)(1991-3#1)(1991-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-1#1)(2007-12#2)(2008-10#19)(2008-12#1)(2008-2#1)(2008-3#8)(2008-9#2)(2009-8#1)(2011-10#2)(2012-5#18)(2012-6#12)(2012-7#6)(2012-9#7)(2013-8#1)
Q(+)##2##1##(2008-10#2)
Q(ST) s of##2##3##(2012-3#2)
Q(ST)##4##1##(2012-3#4)
Q(o)I fungicides##2##2##(2008-10#2)
Q(o)I##3##1##(2008-10#3)
Q)##2##1##(2008-10#2)
Q-10##2##1##(2013-1#2)
Q-PCR and##2##2##(2008-10#2)
Q-PCR##6##1##(2008-10#6)
Q-RT-PCR##2##1##(2008-10#2)
Q-Sepharose##3##1##(1995-11#1)(2008-10#2)
Q-Switched##4##1##(2008-3#4)
Q-mode factor analysis##2##3##(2008-10#2)
Q-switched Nd##2##2##(2008-2#2)
Q-switched diode-pumped Nd##3##3##(2008-3#3)
Q-switched diode-pumped##4##2##(2008-3#4)
Q-switched laser##3##2##(2007-12#1)(2008-3#2)
Q-switched operation of##2##3##(2008-2#1)(2008-3#1)
Q-switched operation##4##2##(2008-2#2)(2008-3#2)
Q-switched##27##1##(2007-12#3)(2008-2#7)(2008-3#17)
Q-switching##2##1##(2008-2#1)(2008-3#1)
Q/R site editing##2##3##(1993-12#2)
Q/R site##3##2##(1993-12#3)
Q1##2##1##(1995-6#1)(2008-11#1)
Q10##2##1##(1992-3#1)(1993-3#1)
Q2##4##1##(1993-6#3)(2011-3#1)
Q2-87##4##1##(2008-10#4)
Q3D QDs##2##2##(2009-11#2)
Q3D##3##1##(2009-11#3)
Q8r1-96##11##1##(2008-10#11)
QA##2##1##(1994-3#1)(1995-3#1)
QADEAA##2##1##(2008-10#2)
QAE##5##1##(2008-10#5)
QAS exchange center##2##3##(2008-10#2)
QAS##5##1##(2008-10#5)
QC##4##1##(2008-10#1)(2008-3#2)(2011-2#1)
QCCJ##3##1##(2008-10#3)
QCD##2##1##(1992-8#2)
QCM immunosensor##2##2##(2008-10#2)
QCM is##2##2##(2008-10#2)
QCM with##3##2##(2008-10#3)
QCM##23##1##(2008-10#23)
QCMs##2##1##(2008-10#2)
QCT##4##1##(1994-8#4)
QD##7##1##(2008-7#3)(2013-1#4)
QDA##6##1##(2008-10#6)
QDs prepared in water phase##2##5##(2008-10#2)
QDs##11##1##(2008-10#5)(2009-11#6)
QEEF##3##1##(1993-9#3)
QFT-G##2##1##(2008-10#2)
QHCl##2##1##(2009-10#2)
QI activities##7##2##(2013-1#7)
QI##11##1##(1993-2#1)(1996-2#1)(2013-1#9)
QIs##3##1##(1996-2#3)
QK##2##1##(1995-6#2)
QM and##2##2##(2008-10#1)(2009-8#1)
QM/MM simulations##3##2##(2008-10#1)(2013-1#2)
QM/MM##9##1##(2008-10#3)(2013-1#6)
QMC##3##1##(2008-7#3)
QMHC interview##7##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)
QMHC interviewed##4##2##(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)
QMHC##11##1##(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)
QOL score##3##2##(1994-12#3)
QOL##13##1##(1994-12#7)(2008-7#1)(2010-4#1)(2011-2#4)
QPCR##4##1##(2008-10#3)(2012-2#1)
QPM##5##1##(2012-2#5)
QRS duration##4##2##(1992-6#1)(2008-10#2)(2010-1#1)
QRS##14##1##(1992-6#1)(2008-10#7)(2008-11#1)(2009-10#1)(2010-1#1)(2010-8#2)(2012-12#1)
QS##4##1##(2008-10#1)(2009-6#2)(2013-1#1)
QSAR models##3##2##(2008-10#1)(2009-3#1)(2012-3#1)
QSAR studies##2##2##(2009-3#1)(2011-3#1)
QSAR##11##1##(2008-10#5)(2009-3#2)(2010-12#1)(2011-3#2)(2012-3#1)
QSR##2##1##(2008-1#1)(2011-1#1)
QSRR##3##1##(2008-10#3)
QST713##2##1##(2008-10#2)
QT##5##1##(2008-10#1)(2008-12#1)(2009-4#1)(2010-6#1)(2012-3#1)
QTL analysis##2##2##(2008-10#2)
QTL and##4##2##(2008-10#3)(2008-8#1)
QTL associated with##3##3##(2008-10#3)
QTL controlling the##2##3##(2012-3#2)
QTL controlling##5##2##(2008-10#1)(2012-3#4)
QTL detection##2##2##(2008-10#2)
QTL explained##2##2##(2008-10#1)(2012-3#1)
QTL for##24##2##(2008-10#16)(2008-12#1)(2008-8#4)(2012-3#2)(2013-8#1)
QTL intervals##2##2##(2008-10#1)(2012-3#1)
QTL mapping##4##2##(2008-10#1)(2008-8#1)(2012-3#2)
QTL markers##2##2##(2011-3#2)
QTL on LG1##2##3##(2008-10#2)
QTL on LG7##2##3##(2008-10#2)
QTL on chromosome 3##2##4##(2008-10#1)(2012-3#1)
QTL on chromosome##5##3##(2008-10#4)(2012-3#1)
QTL on chromosomes##2##3##(2008-10#2)
QTL on linkage groups##2##4##(2008-10#2)
QTL on linkage##3##3##(2008-10#3)
QTL on##24##2##(2008-10#23)(2012-3#1)
QTL to##2##2##(2008-10#2)
QTL was##3##2##(2008-10#3)
QTL were identified with##2##4##(2008-10#2)
QTL were identified##4##3##(2008-10#4)
QTL were##10##2##(2008-10#10)
QTL with##2##2##(2008-8#2)
QTL##141##1##(2008-10#94)(2008-12#2)(2008-8#11)(2009-10#3)(2011-3#2)(2012-3#28)(2013-8#1)
QTL-environment interactions##2##2##(2008-10#2)
QTLMapper##2##1##(2008-10#2)
QTLs for##14##2##(2008-10#2)(2008-8#6)(2008-9#4)(2009-10#1)(2013-8#1)
QTLs in##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
QTLs of##2##2##(2009-10#1)(2012-3#1)
QTLs on##3##2##(2008-10#3)
QTLs were detected##3##3##(2008-10#1)(2008-9#2)
QTLs were identified##2##3##(2008-10#1)(2008-9#1)
QTLs were##5##2##(2008-10#2)(2008-9#3)
QTLs##50##1##(2008-10#20)(2008-8#10)(2008-9#12)(2009-10#6)(2012-3#1)(2013-8#1)
QTP##3##1##(2009-5#1)(2012-3#2)
QTc##2##1##(2010-1#1)(2012-12#1)
QTsc##3##1##(2008-10#3)
Qa-2##3##1##(2008-5#2)(2008-9#1)
Qa-2(a)##3##1##(2008-5#3)
Qanadli##2##1##(2011-2#2)
QbD framework##3##2##(2012-2#3)
QbD##9##1##(2012-2#9)
Qc to##3##2##(1993-8#3)
Qc##5##1##(1993-8#5)
Qd##2##1##(2010-12#2)
Qd-RGD and Cy3-AS1411##2##3##(2010-12#2)
Qd-RGD##3##1##(2010-12#3)
Qdot##2##1##(2008-10#2)
Qfhs##3##1##(2008-10#3)
Qi Gong exercises and##2##4##(2010-6#2)
Qi Gong exercises##4##3##(2010-6#4)
Qi##8##1##(2008-9#1)(2010-6#4)(2013-1#1)(2013-8#2)
Qigong and##2##2##(2013-1#2)
Qigong exercise##2##2##(2013-1#2)
Qigong##8##1##(2008-10#3)(2013-1#5)
Qinghai-Tibet##4##1##(2008-9#3)(2009-5#1)
QoL and##3##2##(2008-10#2)(2011-2#1)
QoL in the##2##3##(2008-10#1)(2012-12#1)
QoL in##4##2##(2008-10#2)(2012-12#1)(2013-1#1)
QoL##18##1##(2008-10#7)(2011-2#3)(2012-12#2)(2013-1#6)
Qorf4 and##2##2##(1997-8#2)
Qu Du Zeng##2##3##(2011-3#2)
Quadriceps##3##1##(2011-2#1)(2013-1#2)
Quadricuspid aortic valve##3##3##(2008-11#2)(2009-2#1)
Quadrilateral space syndrome##2##3##(2008-8#2)
Quaker##3##1##(2012-2#3)
Quakers##2##1##(2012-2#2)
Qualitative analyses##2##2##(2008-1#1)(2009-5#1)
Qualitative and quantitative analysis of organophosphorus pesticide residues##2##8##(2008-10#2)
Qualitative and quantitative##3##3##(2008-10#2)(2010-8#1)
Qualitative##18##1##(1992-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-5#1)(2010-10#3)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
Qualitatively##3##1##(1997-5#1)(1997-8#1)(2008-10#1)
Quality Assessment##2##2##(1997-2#1)(2008-12#1)
Quality Assurance Reform Initiative (QARI)##2##5##(1996-2#1)(1997-2#1)
Quality Assurance##6##2##(1995-2#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-6#1)
Quality Improvement Program##4##3##(1996-2#3)(2013-1#1)
Quality Improvement##10##2##(1991-1#2)(1994-1#1)(1994-12#2)(1996-2#3)(1997-2#1)(2013-1#1)
Quality and##3##2##(1995-12#1)(2009-4#1)(2012-2#1)
Quality assurance##5##2##(1990-6#1)(1994-2#3)(2008-4#1)
Quality control in##2##3##(2008-9#2)
Quality control##8##2##(1997-2#1)(2008-10#5)(2008-9#2)
Quality criteria for##2##3##(2008-11#2)
Quality improvement teams##3##3##(1993-12#3)
Quality improvement##5##2##(1993-12#3)(1997-1#1)(2008-3#1)
Quality management##2##2##(1993-3#1)(1997-1#1)
Quality of Life in##4##4##(1994-12#1)(2012-3#1)(2013-1#2)
Quality of Life##9##3##(1994-12#1)(2008-10#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#4)
Quality of care##3##3##(1990-6#1)(1996-2#2)
Quality of life and psychological##2##5##(2008-9#1)(2009-11#1)
Quality of life##10##3##(1990-12#1)(1991-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#2)(2011-3#1)(2013-1#1)
Quality of##28##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-11#1)(1994-12#1)(1996-2#2)(1997-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#6)
Quality##117##1##(1990-12#1)(1990-6#2)(1991-1#2)(1991-3#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-12#5)(1993-3#1)(1994-1#3)(1994-12#6)(1994-2#4)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#4)(1996-1#2)(1996-2#6)(1996-3#1)(1997-1#4)(1997-2#6)(1997-3#2)(2008-10#11)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-4#1)(2010-4#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#15)
Quantification of Phytophthora##2##3##(2008-10#2)
Quantification of the##5##3##(2008-10#4)(2008-11#1)
Quantification of##30##2##(1996-12#1)(1997-2#1)(2008-10#24)(2008-11#2)(2008-7#2)
Quantification##36##1##(1996-12#1)(1997-2#1)(2008-10#27)(2008-11#2)(2008-7#2)(2010-11#1)(2011-2#1)(2011-3#1)
Quantify##5##1##(2008-10#5)
Quantifying the##3##2##(2008-10#2)(2012-2#1)
Quantifying##10##1##(1993-1#1)(2008-10#5)(2010-10#1)(2011-2#2)(2012-2#1)
Quantitation by##2##2##(1995-11#1)(2008-10#1)
Quantitation of##10##2##(1990-12#1)(1991-9#1)(1992-12#1)(1994-8#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)
Quantitation was##2##2##(2008-10#2)
Quantitation##14##1##(1990-12#1)(1991-9#1)(1992-12#1)(1994-8#1)(1995-11#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)
Quantitative PCR##2##2##(1993-6#1)(2008-10#1)
Quantitative RT-PCR##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
Quantitative Resistance to##2##3##(2008-10#2)
Quantitative Trait Loci in##2##4##(2008-10#2)
Quantitative Trait Loci##9##3##(2008-10#8)(2012-3#1)
Quantitative Trait##10##2##(2008-10#9)(2012-3#1)
Quantitative analyses exhibited##2##3##(2008-10#2)
Quantitative analyses##4##2##(1997-2#1)(2008-10#3)
Quantitative analysis of##11##3##(1992-11#1)(1994-8#1)(2008-10#7)(2013-1#1)(2013-8#1)
Quantitative analysis##14##2##(1992-11#1)(1994-8#1)(2008-10#10)(2013-1#1)(2013-8#1)
Quantitative and qualitative##5##3##(1994-2#1)(2008-10#3)(2010-7#1)
Quantitative and##6##2##(1994-2#1)(2008-10#4)(2010-7#1)
Quantitative approaches##2##2##(2008-11#1)(2009-5#1)
Quantitative data##2##2##(2008-10#1)(2008-11#1)
Quantitative determination of##9##3##(1990-12#1)(2008-10#8)
Quantitative determination##10##2##(1990-12#1)(2008-10#9)
Quantitative determinations have been made by##3##6##(2008-10#3)
Quantitative extractions##2##2##(2008-10#2)
Quantitative in situ hybridization##3##4##(1996-12#1)(2008-4#2)
Quantitative in situ##4##3##(1996-12#1)(2008-3#1)(2008-4#2)
Quantitative in##5##2##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#2)
Quantitative real-time PCR##2##3##(2011-2#1)(2013-1#1)
Quantitative real-time polymerase chain reaction##2##5##(2008-10#2)
Quantitative real-time##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
Quantitative recoveries (&gt##2##3##(2008-10#2)
Quantitative recoveries for##2##3##(2008-10#2)
Quantitative recoveries of##2##3##(1990-2#1)(2008-10#1)
Quantitative recoveries##8##2##(1990-2#1)(2008-10#7)
Quantitative recovery of##4##3##(2008-10#4)
Quantitative reverse##2##2##(1997-1#1)(2012-3#1)
Quantitative separation of##2##3##(2008-10#2)
Quantitative structure-retention relationship (QSRR)##2##4##(2008-10#2)
Quantitative trait Loci mapping##2##4##(2008-10#2)
Quantitative trait Loci##3##3##(2008-10#3)
Quantitative trait loci (QTLs)##2##4##(2008-10#1)(2009-10#1)
Quantitative trait##5##2##(2008-10#4)(2009-10#1)
Quantitative##142##1##(1990-12#1)(1990-2#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#88)(2008-11#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
Quantity##2##1##(2008-10#2)
Quantum and classical dynamics simulations of ATP hydrolysis in solution##2##10##(2013-1#2)
Quantum dots##2##2##(2008-10#1)(2010-12#1)
Quantum##20##1##(1990-11#1)(1991-9#1)(1992-8#1)(1993-5#1)(1996-9#5)(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)
Quartz crystal##2##2##(2008-10#2)
Quaternary##2##1##(1990-8#1)(1996-5#1)
Quebec experience##3##2##(2008-11#1)(2012-2#2)
Quebec##18##1##(1991-12#1)(1992-1#3)(1993-12#2)(1996-1#2)(1997-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2009-10#1)(2012-2#2)
Quebec's##2##1##(1997-2#1)(2008-11#1)
Queen##2##1##(1990-2#1)(2008-5#1)
Queensland##6##1##(2008-12#1)(2008-9#2)(2010-10#1)(2013-8#2)
Quercetin##3##1##(2008-10#3)
Quercus ilex##3##2##(2008-10#1)(2011-10#2)
Quercus pubescens##2##2##(2012-6#2)
Quercus robur##4##2##(2008-10#1)(2012-6#1)(2012-9#1)(2013-8#1)
Quercus species (Q##2##3##(2012-5#1)(2012-6#1)
Quercus species##6##2##(2012-5#3)(2012-6#2)(2012-9#1)
Quercus spp##3##2##(2008-10#1)(2012-5#2)
Quercus suber##2##2##(2009-12#2)
Quercus##23##1##(2008-10#4)(2008-8#1)(2009-12#2)(2011-10#2)(2012-5#6)(2012-6#5)(2012-9#2)(2013-8#1)
Questionnaire and##3##2##(2008-7#1)(2013-1#2)
Questionnaire for##2##2##(1994-12#1)(2009-4#1)
Questionnaire were##2##2##(2010-4#1)(2010-9#1)
Questionnaire##36##1##(1992-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#6)
Questionnaire-Revised##2##1##(2008-11#1)(2009-12#1)
Questionnaires were##2##2##(2008-11#1)(2011-1#1)
Questionnaires##4##1##(2008-11#1)(2009-10#1)(2011-1#1)(2012-2#1)
Questions about##2##2##(1992-12#1)(2008-9#1)
Questions and answers on immunization##2##5##(2008-11#2)
Questions were raised as to the volume of publications##2##9##(2008-10#2)
Questions were##3##2##(2008-10#2)(2008-12#1)
Questions##13##1##(1992-12#1)(1992-5#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-9#1)(2010-9#1)(2013-8#1)
Quick BASIC 4##2##3##(2008-10#2)
Quick##4##1##(2008-10#2)(2008-11#1)(2009-5#1)
QuickVue test##2##2##(2011-2#2)
QuickVue##5##1##(2011-2#5)
Quil A##2##2##(1995-5#1)(2009-6#1)
Quinoline##2##1##(2008-7#2)
Quorum sensing##2##2##(1995-2#2)
Québec##5##1##(1994-1#1)(1996-3#1)(2008-10#2)(2013-1#1)
R (2)##2##2##(2008-10#1)(2013-8#1)
R 50 595##6##3##(1990-5#6)
R =##2##2##(2008-12#1)(2009-9#1)
R and##7##2##(2008-10#2)(2008-8#3)(2010-5#2)
R factor was 0##2##4##(2008-8#1)(2008-9#1)
R factor##4##2##(1991-3#1)(2008-8#2)(2008-9#1)
R gene##5##2##(2008-10#4)(2008-8#1)
R genes in##3##3##(2008-10#3)
R genes##13##2##(2008-10#12)(2008-8#1)
R in##2##2##(2008-10#1)(2010-5#1)
R islets##4##2##(1995-8#4)
R levels##2##2##(2008-10#2)
R or##2##2##(1995-8#1)(2010-5#1)
R package##2##2##(2009-7#1)(2011-3#1)
R to the##3##3##(1990-8#2)(2008-8#1)
R to##4##2##(1990-8#2)(2008-10#1)(2008-8#1)
R wave and R/S ratio in lead aVR##2##8##(2010-1#2)
R wave##6##2##(1996-6#4)(2010-1#2)
R##548##1##(1990-10#2)(1990-11#2)(1990-2#1)(1990-5#8)(1990-6#2)(1990-7#1)(1990-8#3)(1991-12#3)(1991-2#1)(1991-3#1)(1992-1#1)(1992-4#2)(1992-7#3)(1993-12#2)(1993-6#8)(1993-8#1)(1994-3#1)(1994-5#1)(1995-12#4)(1995-6#9)(1995-8#5)(1996-5#1)(1996-6#4)(1996-8#1)(1997-2#2)(1997-8#1)(2008-10#400)(2008-11#2)(2008-12#8)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#17)(2008-9#5)(2009-6#5)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-5#8)(2010-6#2)(2011-2#4)(2011-3#2)(2012-2#3)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
R#ENTITYSTARTX000E9##2##1##(2011-2#2)
R&amp##6##1##(1995-6#1)(2008-5#2)(2008-7#1)(2008-8#2)
R&lt##2##1##(2008-10#2)
R(0)##5##1##(2008-10#5)
R(1)##6##1##(2008-10#5)(2008-9#1)
R(2) = 0##4##3##(2008-10#3)(2008-3#1)
R(2) and##2##2##(2008-10#2)
R(2) value##2##2##(2008-10#2)
R(2) values of 0##2##4##(2008-10#2)
R(2) values of ca##2##4##(2009-3#2)
R(2) values of##4##3##(2008-10#2)(2009-3#2)
R(2) values##5##2##(2008-10#3)(2009-3#2)
R(2)##21##1##(2008-10#18)(2008-3#1)(2009-3#2)
R(2)=0##8##1##(2008-10#4)(2009-7#4)
R(3)N##2##1##(2008-10#2)
R(E)##3##1##(2008-11#3)
R(T)R(V) and##2##2##(2008-10#2)
R(T)R(V)##6##1##(2008-10#6)
R(T)S(V)##3##1##(2008-10#3)
R(TRES)##2##1##(2008-8#2)
R(TRES)R(TRES)##2##1##(2008-8#2)
R(US)##3##1##(2008-10#3)
R(e-s)##4##1##(1996-6#4)
R(f)##3##1##(2008-10#2)(2008-11#1)
R(m)##2##1##(2008-10#2)
R) and##2##2##(2008-8#2)
R)##7##1##(1995-8#1)(2008-10#1)(2008-8#4)(2011-2#1)
R-##3##1##(1994-8#2)(2008-10#1)
R-(+)- and S-(-)-ofloxacin##2##3##(2008-10#2)
R-(+)- and##3##2##(2008-10#3)
R-(+)-OFLX##2##1##(2008-10#2)
R-(-)- and##2##2##(2008-10#2)
R-M system##2##2##(1991-9#1)(1993-9#1)
R-N6-phenyl-isopropyladenosine##3##1##(1995-8#3)
R-PIA##5##1##(1997-1#5)
R-captopril##3##1##(2008-10#3)
R-enantiomer##2##1##(1994-8#1)(2008-10#1)
R-factor of##3##2##(1992-4#1)(1993-8#1)(2008-8#1)
R-factor##4##1##(1992-4#2)(1993-8#1)(2008-8#1)
R-gene##3##1##(2008-10#3)
R-ibuprofen##2##1##(1994-8#2)
R-phycoerythrin##2##1##(2008-8#2)
R-state##2##1##(1995-6#2)
R-type II and##2##3##(2012-3#2)
R-type##4##1##(2012-3#4)
R-types##3##1##(2012-3#3)
R0 is##2##2##(2013-8#2)
R0##3##1##(2008-8#1)(2013-8#2)
R1 and R2##2##3##(2010-3#2)
R1##8##1##(2008-10#3)(2010-3#3)(2013-1#2)
R1408B##4##1##(2008-9#4)
R1881##5##1##(1990-11#4)(2010-1#1)
R2##11##1##(1992-9#1)(1993-12#1)(2008-10#2)(2010-3#3)(2011-2#1)(2013-1#3)
R22L TCS##2##2##(2008-8#2)
R22L##3##1##(2008-8#3)
R338W was##2##2##(1995-8#2)
R338W##11##1##(1995-8#11)
R3616##2##1##(1995-2#2)
R4009##3##1##(1995-2#3)
R514 and R1408B##3##3##(2008-9#3)
R514##4##1##(2008-9#4)
R6K##2##1##(1994-5#2)
R70A##2##1##(1995-6#2)
R=0##6##1##(2008-10#5)(2013-1#1)
RA alone##2##2##(2008-5#1)(2010-12#1)
RA and##3##2##(2008-11#2)(2012-3#1)
RA can##2##2##(1990-6#1)(2008-8#1)
RA for##2##2##(2008-11#1)(2012-3#1)
RA may##2##2##(2008-11#2)
RA patients##3##2##(1993-2#1)(2012-2#2)
RA therapy##2##2##(1991-9#1)(2013-8#1)
RA were##2##2##(1990-6#1)(1993-2#1)
RA with##3##2##(2007-8#1)(2008-11#2)
RA##54##1##(1990-6#4)(1991-9#2)(1993-2#2)(1993-3#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-11#16)(2008-5#8)(2008-8#3)(2010-12#5)(2012-2#4)(2012-3#3)(2013-8#3)
RA538 gene##2##2##(2008-8#2)
RA538##6##1##(2008-8#6)
RABA##3##1##(1990-12#3)
RAC protein##2##2##(1994-11#2)
RAC##3##1##(1994-11#2)(2012-3#1)
RAC-PK alpha and beta##3##4##(1994-11#3)
RAC-PK##5##1##(1994-11#5)
RACE##5##1##(1994-11#2)(2008-8#2)(2010-5#1)
RAD##2##1##(2008-11#2)
RAD3##4##1##(1993-12#3)(1995-9#1)
RAD9##2##1##(1996-3#2)
RAF##2##1##(1996-6#1)(1997-1#1)
RAFT polymerization of##2##3##(2008-12#2)
RAFT polymerization##3##2##(2008-12#3)
RAFT##4##1##(2008-12#3)(2009-10#1)
RAG##2##1##(1997-7#2)
RAG1##2##1##(1997-9#2)
RAM and AFLP##3##3##(2008-10#3)
RAM##7##1##(2008-10#5)(2012-2#2)
RAM1 and RAM2##3##3##(1993-9#3)
RAM1##4##1##(1993-9#4)
RANKL##4##1##(2008-11#3)(2010-7#1)
RAP140a##3##1##(2008-8#3)
RAPB##5##1##(2008-9#5)
RAPD analysis could##2##3##(2008-10#2)
RAPD analysis##8##2##(1995-6#1)(2008-10#7)
RAPD and AFLP analyses##2##4##(2008-10#2)
RAPD and##4##2##(2008-10#3)(2008-8#1)
RAPD banding patterns##2##3##(2008-10#2)
RAPD data##3##2##(2008-10#3)
RAPD group##2##2##(2008-10#2)
RAPD marker##10##2##(2008-10#10)
RAPD markers linked to the##2##5##(1995-6#1)(2008-10#1)
RAPD markers linked to##3##4##(1995-6#1)(2008-10#2)
RAPD markers that##2##3##(2008-10#2)
RAPD markers were##2##3##(1995-6#1)(2008-10#1)
RAPD markers##13##2##(1995-6#2)(2008-10#11)
RAPD or AFLP analyses##2##4##(2008-10#2)
RAPD or##3##2##(2008-10#3)
RAPD patterns and##2##3##(2008-10#2)
RAPD patterns##3##2##(2008-10#2)(2008-8#1)
RAPD primers##4##2##(2008-10#4)
RAPD profiles##2##2##(2008-10#2)
RAPD variation##2##2##(2008-10#2)
RAPD##87##1##(1995-6#3)(2008-10#82)(2008-8#2)
RAPD-PCR##4##1##(2008-10#2)(2008-12#2)
RAPs##4##1##(2008-10#4)
RAR alpha##2##2##(1991-9#2)
RAR-alpha##2##1##(2007-11#2)
RAS##2##1##(2010-12#1)(2011-3#1)
RAS2##2##1##(1996-3#2)
RASE apparatus##3##2##(2008-10#3)
RASE##5##1##(2008-10#5)
RAST##3##1##(1990-3#3)
RAUSPC##3##1##(2008-10#3)
RAW 264##7##2##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#2)
RAtreatment##2##1##(2008-11#2)
RB in##2##2##(2008-10#1)(2013-1#1)
RB protein in the##2##4##(1993-8#2)
RB protein##9##2##(1993-8#7)(1996-2#2)
RB strains have##2##3##(2008-10#2)
RB##25##1##(1993-8#7)(1996-2#2)(2008-10#10)(2010-11#1)(2013-1#5)
RBC in##2##2##(2013-1#2)
RBC##10##1##(1995-2#1)(2008-10#1)(2010-8#1)(2013-1#7)
RBCs##6##1##(1995-2#2)(2008-8#2)(2008-9#1)(2013-1#1)
RBL-2H3 cells##2##2##(1991-5#2)
RBRVS and##2##2##(1994-12#2)
RBRVS##4##1##(1994-12#4)
RBV##3##1##(2013-1#3)
RC practices##2##2##(2008-12#2)
RC##9##1##(2008-10#2)(2008-12#5)(2008-8#1)(2008-9#1)
RC-160 inhibited##2##2##(1995-2#2)
RC-160 on cell##2##3##(1995-2#2)
RC-160##11##1##(1995-2#11)
RC-2##5##1##(2008-10#5)
RC-PDDA-DMSA##2##1##(2008-8#2)
RC3/neurogranin phosphorylation##2##2##(1997-2#2)
RC3/neurogranin##5##1##(1997-2#5)
RCA and##2##2##(2011-2#1)(2013-2#1)
RCA##5##1##(2008-11#3)(2011-2#1)(2013-2#1)
RCC##14##1##(1990-2#1)(2011-2#7)(2012-3#3)(2013-1#3)
RCC1##2##1##(1995-2#2)
RCCs##2##1##(2012-3#2)
RCF medication chart##2##3##(2012-12#2)
RCF medication##3##2##(2012-12#3)
RCF##4##1##(2012-12#4)
RCK7 was##3##2##(2008-11#3)
RCK7##7##1##(2008-11#7)
RCMV and BBSV##2##3##(1995-12#2)
RCNMV##2##1##(2008-10#2)
RCT##7##1##(2008-10#2)(2010-11#2)(2011-2#1)(2012-12#2)
RCTs##4##1##(1993-12#1)(2008-10#2)(2012-12#1)
RCs##2##1##(2008-8#1)(2008-9#1)
RD##5##1##(2008-7#3)(2012-2#2)
RDKs##2##1##(2008-10#2)
RDRGs##3##1##(1993-12#3)
RDV##6##1##(2008-10#6)
RDV-I##3##1##(2008-10#3)
RDX and HMX##2##3##(2008-10#2)
RDX and##3##2##(2008-10#3)
RDX concentration range of##2##4##(2008-10#2)
RDX in##2##2##(2008-10#1)(2008-7#1)
RDX using##2##2##(2008-10#2)
RDX##24##1##(2008-10#16)(2008-3#2)(2008-7#5)(2009-3#1)
RDX)##2##1##(2008-10#1)(2008-11#1)
RE and##3##2##(2008-10#2)(2013-1#1)
RE##10##1##(2008-10#9)(2013-1#1)
RE(III)##2##1##(2008-10#2)
RE714##3##1##(2008-10#3)
RE8##3##1##(2008-10#3)
REASON##2##1##(2008-10#2)
REB##4##1##(2008-9#4)
RECK in##2##2##(2011-2#2)
RECK is##2##2##(2011-2#2)
RECK##6##1##(2011-2#6)
REE and##2##2##(2008-10#2)
REE concentrations of the##2##4##(2008-10#2)
REE concentrations##3##2##(2008-10#3)
REE##21##1##(2008-10#16)(2012-2#4)(2013-8#1)
REE-chl##2##1##(2008-9#2)
REEs in the##2##3##(2008-10#2)
REEs in##6##2##(2008-10#6)
REEs were##3##2##(2008-10#3)
REEs##23##1##(2008-10#22)(2008-9#1)
REL data##4##2##(2013-1#4)
RELATED##2##1##(2009-8#1)(2009-9#1)
REM and##2##2##(2008-10#1)(2012-3#1)
REM sleep##5##2##(1994-8#1)(2008-11#2)(2013-8#2)
REM##8##1##(1994-8#1)(2008-10#2)(2008-11#2)(2012-3#1)(2013-8#2)
REMI##2##1##(2008-10#2)
REMS for##3##2##(1991-9#1)(2013-1#2)
REMS##6##1##(1991-9#1)(2013-1#5)
REP values##3##2##(2008-10#3)
RES uptake##2##2##(1993-8#2)
RES##3##1##(1993-8#3)
RESEARCH##5##1##(2008-11#2)(2009-4#1)(2011-2#1)(2012-3#1)
RESULTS AND CONCLUSION##2##3##(2010-11#1)(2012-2#1)
RESULTS AND##4##2##(1993-2#1)(2010-11#1)(2012-2#1)(2013-1#1)
RESULTS##153##1##(1993-2#1)(2007-12#1)(2008-11#8)(2008-12#3)(2008-6#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-3#1)(2010-7#2)(2011-1#4)(2011-2#20)(2011-7#1)(2012-12#1)(2012-2#32)(2012-3#34)(2013-1#29)
RET is##2##2##(2008-2#2)
RETRACTED##3##1##(2008-10#3)
REV##4##1##(2008-5#1)(2013-8#3)
REV-S and##2##2##(2008-5#2)
REVIEW##2##1##(2008-5#1)(2009-4#1)
REp##6##1##(2008-5#6)
RF Impedance is being used##2##5##(2008-11#2)
RF Impedance is##3##3##(2008-11#3)
RF and##2##2##(1992-3#1)(1994-8#1)
RF energy##2##2##(2011-2#2)
RF lesions##2##2##(2010-6#2)
RF of##2##2##(1992-3#1)(2008-10#1)
RF power##5##2##(1992-3#3)(2008-10#2)
RF##27##1##(1992-3#10)(1994-8#1)(2008-10#4)(2008-11#3)(2008-8#1)(2010-12#2)(2010-6#3)(2011-2#3)
RF2##2##1##(1995-11#2)
RFA##8##1##(2008-9#7)(2011-2#1)
RFA-binding proteins##2##2##(2008-9#2)
RFLP analyses##3##2##(2008-10#3)
RFLP analysis of##4##3##(2008-10#1)(2008-8#3)
RFLP analysis with##2##3##(2008-10#2)
RFLP analysis##12##2##(2008-10#7)(2008-8#5)
RFLP and##4##2##(2008-10#4)
RFLP data##2##2##(2008-10#2)
RFLP group##2##2##(2008-10#2)
RFLP groups##2##2##(2008-10#2)
RFLP haplotype##2##2##(2008-10#2)
RFLP haplotypes were##4##3##(2008-10#4)
RFLP haplotypes##7##2##(2008-10#7)
RFLP linkage##2##2##(1996-8#1)(2008-8#1)
RFLP loci##8##2##(2008-10#8)
RFLP mapping##2##2##(2008-8#2)
RFLP marker##6##2##(2008-10#3)(2008-8#2)(2008-9#1)
RFLP markers##9##2##(1996-12#1)(2008-10#4)(2008-8#3)(2008-9#1)
RFLP pattern##2##2##(2008-10#2)
RFLP##78##1##(1996-12#1)(1996-8#1)(1997-9#1)(2008-10#57)(2008-12#2)(2008-8#13)(2008-9#2)(2012-2#1)
RFLPs##2##1##(2008-10#2)
RFS##3##1##(2011-2#2)(2012-3#1)
RG 26##3##2##(2008-10#3)
RG I and RG II##2##5##(2008-10#2)
RG I##4##2##(2008-10#4)
RG II##5##2##(2008-10#5)
RG III##4##2##(2008-10#4)
RG IV##3##2##(2008-10#3)
RG##19##1##(2008-10#19)
RG57 fingerprint##2##2##(2008-10#2)
RG57##11##1##(2008-10#11)
RGA##2##1##(2008-10#2)
RGAF##2##1##(2008-10#2)
RGAP marker##2##2##(2008-10#2)
RGAP markers for the##2##4##(2008-10#2)
RGAP markers##3##2##(2008-10#3)
RGAP##6##1##(2008-10#6)
RGAs were##7##2##(2008-10#7)
RGAs##13##1##(2008-10#13)
RGD peptide##2##2##(1994-11#1)(2008-7#1)
RGD##13##1##(1994-11#4)(1995-6#5)(2008-7#2)(2010-6#2)
RGD-BBN heterodimer##2##2##(2010-6#2)
RGD-BBN tracers for##2##3##(2010-6#2)
RGD-BBN tracers##3##2##(2010-6#3)
RGD-BBN##7##1##(2010-6#7)
RGR##5##1##(2008-8#5)
RH &lt##2##2##(2008-10#2)
RH ( approximately##2##3##(2008-10#2)
RH (more than##2##3##(1996-12#2)
RH but##4##2##(2008-10#4)
RH in##3##2##(2008-10#3)
RH of##2##2##(1996-12#1)(2008-10#1)
RH on##3##2##(2008-10#3)
RH or##2##2##(2008-10#2)
RH was##2##2##(2008-10#2)
RH##70##1##(1996-12#3)(2008-10#64)(2008-8#2)(2012-2#1)
RH)##3##1##(2008-10#3)
RH5344##2##1##(1991-9#2)
RHA on one side and conventional##2##6##(2012-2#2)
RHA##6##1##(2012-2#6)
RHA/Verh##3##1##(1994-2#3)
RHD##5##1##(2012-3#5)
RHR##5##1##(2008-11#5)
RI and##3##2##(1995-2#2)(2013-8#1)
RI changes of aqueous##2##4##(2008-10#2)
RI lines were##2##3##(2008-10#2)
RI lines##3##2##(2008-10#3)
RI strains##2##2##(1994-8#2)
RI##22##1##(1991-7#1)(1994-8#4)(1995-2#4)(1996-6#1)(1997-3#2)(2008-10#8)(2013-8#2)
RIA was##2##2##(1990-11#2)
RIA##6##1##(1990-11#2)(1991-6#1)(2008-7#2)(2008-9#1)
RIF effect##2##2##(2009-10#2)
RIF##3##1##(2009-10#3)
RIG##3##1##(2008-10#3)
RII beta-type PKA##2##3##(1994-8#2)
RII beta-type##3##2##(1994-8#3)
RII##7##1##(1994-8#3)(1995-2#4)
RIL population##5##2##(2008-10#5)
RIL29##2##1##(2008-10#2)
RILs were##4##2##(2008-10#4)
RILs##15##1##(2008-10#15)
RING##3##1##(1997-3#2)(2009-7#1)
RINm5F##2##1##(2010-11#2)
RIP##7##1##(1990-12#1)(2008-10#6)
RIP1##2##1##(2012-2#2)
RIPs against##2##2##(2008-10#1)(2008-8#1)
RIPs##9##1##(1990-12#2)(2008-10#3)(2008-8#4)
RIS##2##1##(1991-1#1)(1996-1#1)
RIW credit##3##2##(1991-12#3)
RIW##5##1##(1991-12#5)
RIWs##2##1##(1991-12#2)
RK motif##4##2##(1995-6#4)
RK##6##1##(1995-6#6)
RL and##3##2##(2008-10#3)
RL##13##1##(2008-10#8)(2008-7#5)
RLA/Verh rats##3##2##(1994-2#3)
RLC-16 cells##2##2##(2008-11#2)
RLC-16##4##1##(2008-11#4)
RLE##3##1##(2011-2#3)
RLS intensity##6##2##(2008-10#6)
RLS of##4##2##(2008-10#4)
RLS signals##7##2##(2008-10#7)
RLS##29##1##(1997-4#1)(2008-10#27)(2012-3#1)
RM##13##1##(1991-7#2)(1994-12#6)(1996-2#1)(2008-10#3)(2013-1#1)
RM4/TNF##5##1##(1997-2#5)
RMB##2##1##(2008-9#2)
RMEC##3##1##(1995-11#3)
RMF##4##1##(1995-11#4)
RMS##6##1##(1992-4#1)(2008-10#2)(2010-9#2)(2013-8#1)
RMSEA = 0##2##3##(2010-2#2)
RMSEP##3##1##(2008-10#3)
RMUC 176 clone##2##3##(1991-12#2)
RMUC 176##3##2##(1991-12#3)
RN 21245-02-3)##2##2##(2008-5#2)
RN as gatekeeper##3##3##(2008-12#3)
RN as##4##2##(2008-12#3)(2010-11#1)
RN##18##1##(2008-12#6)(2008-5#9)(2010-11#1)(2010-2#1)(2010-4#1)
RN's##4##1##(2010-11#4)
RNA (dsRNA)##11##2##(2008-10#9)(2008-9#1)(2013-1#1)
RNA 1 and##3##3##(2008-10#3)
RNA 2 of##3##3##(2008-10#3)
RNA 2##7##2##(2008-10#7)
RNA 3 was##3##3##(2008-10#3)
RNA 3 were##2##3##(2008-10#1)(2008-8#1)
RNA 3##8##2##(2008-10#6)(2008-8#2)
RNA Polymerase##2##2##(2008-10#1)(2012-3#1)
RNA Silencing##2##2##(2008-10#2)
RNA accumulation##3##2##(2008-10#3)
RNA analysis##2##2##(2008-4#2)
RNA and DNA##10##3##(1992-3#5)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#2)
RNA and protein levels##2##4##(1997-7#1)(2011-2#1)
RNA and protein##5##3##(1995-12#1)(1997-7#1)(2008-11#1)(2011-2#2)
RNA and proteins##3##3##(1991-8#2)(2008-10#1)
RNA and the##3##3##(2008-10#3)
RNA and##40##2##(1991-8#2)(1992-3#6)(1993-8#1)(1994-11#1)(1995-12#1)(1997-3#3)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-4#2)(2008-9#2)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#1)
RNA aptamers##2##2##(2008-4#1)(2013-1#1)
RNA arbitrarily##2##2##(2008-11#2)
RNA are##2##2##(2008-9#1)(2012-3#1)
RNA as##3##2##(1995-12#1)(2008-10#1)(2008-8#1)
RNA at##2##2##(2008-10#2)
RNA binding protein##2##3##(2009-7#2)
RNA binding##3##2##(2008-8#1)(2009-7#2)
RNA blot analysis showed##2##4##(1990-5#1)(1994-11#1)
RNA blot analysis##3##3##(1990-5#1)(1993-3#1)(1994-11#1)
RNA blot##5##2##(1990-5#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-9#1)
RNA by##6##2##(1997-3#1)(2008-10#1)(2008-4#2)(2009-5#1)(2011-2#1)
RNA component##3##2##(2008-11#1)(2008-9#2)
RNA containing##6##2##(1993-8#1)(1997-3#2)(2008-10#1)(2008-7#1)(2008-9#1)
RNA content##3##2##(2008-11#1)(2008-9#2)
RNA could be##2##3##(2008-10#1)(2011-2#1)
RNA degradation##3##2##(1997-2#1)(2008-9#1)(2010-4#1)
RNA editing of##2##3##(1993-12#1)(1997-2#1)
RNA editing##6##2##(1993-12#2)(1997-2#2)(2012-2#2)
RNA expressed##2##2##(1995-12#1)(1995-2#1)
RNA expression##3##2##(2008-4#1)(2008-5#1)(2008-8#1)
RNA extracted from the##2##4##(2008-10#2)
RNA extracted from##4##3##(2008-10#4)
RNA extraction##4##2##(2008-10#2)(2008-9#1)(2013-8#1)
RNA for##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
RNA from total RNA##2##4##(2008-2#1)(2008-9#1)
RNA from total##3##3##(1997-3#1)(2008-2#1)(2008-9#1)
RNA from##16##2##(1991-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1997-3#3)(2008-10#5)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
RNA gel blot##3##3##(2008-9#1)(2012-3#2)
RNA gene##8##2##(1996-3#1)(2008-10#3)(2008-8#1)(2011-2#2)(2013-1#1)
RNA genes and is part of the Genomic Encyclopedia of Bacteria and Archaea project##3##14##(2011-2#3)
RNA genes and##4##3##(2008-10#1)(2011-2#3)
RNA genes in##2##3##(1992-3#1)(2008-9#1)
RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##11##14##(2011-2#11)
RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##15##13##(2011-2#15)
RNA genes is##26##3##(2011-2#26)
RNA genes##35##2##(1992-3#1)(1995-8#1)(2008-10#3)(2008-9#1)(2011-2#29)
RNA genome of##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
RNA genome##6##2##(2008-10#3)(2008-9#2)(2013-1#1)
RNA genomes##3##2##(2008-9#2)(2013-1#1)
RNA granules##2##2##(2012-2#2)
RNA has been##3##3##(2008-10#2)(2008-8#1)
RNA have##2##2##(2008-8#1)(2012-3#1)
RNA helicase##4##2##(1995-6#2)(1997-7#1)(2008-10#1)
RNA in##11##2##(1993-2#2)(1993-8#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-9#3)(2012-3#1)
RNA interference in##2##3##(2009-9#1)(2010-5#1)
RNA interference##6##2##(2008-9#1)(2009-9#1)(2010-5#2)(2011-1#1)(2011-2#1)
RNA is discussed##2##3##(2008-10#1)(2008-4#1)
RNA is presented##2##3##(1990-5#1)(2011-2#1)
RNA is##20##2##(1990-5#2)(1997-7#3)(2008-10#6)(2008-11#1)(2008-4#4)(2008-9#3)(2011-2#1)
RNA isolated directly from tissue homogenate##2##6##(2008-5#2)
RNA isolated from##3##3##(1991-12#1)(2008-10#1)(2008-9#1)
RNA isolated##5##2##(1991-12#1)(2008-10#1)(2008-5#2)(2008-9#1)
RNA levels##6##2##(1996-12#2)(2008-10#3)(2008-4#1)
RNA metabolism##2##2##(2011-2#2)
RNA molecule##4##2##(2008-4#1)(2008-7#2)(2010-12#1)
RNA molecules are##2##3##(2008-7#2)
RNA molecules of##2##3##(2008-10#2)
RNA molecules##10##2##(1993-9#1)(2008-10#4)(2008-7#4)(2011-2#1)
RNA of the##3##3##(1994-11#1)(2008-10#1)(2008-9#1)
RNA of##23##2##(1990-5#1)(1994-11#1)(1996-6#1)(1997-3#2)(2008-10#14)(2008-11#1)(2008-8#2)(2008-9#1)
RNA or DNA##5##3##(1992-3#1)(1997-6#2)(2008-4#2)
RNA or##7##2##(1990-7#1)(1992-3#1)(1997-6#2)(2008-11#1)(2008-4#2)
RNA polymerase II and##2##4##(1994-3#1)(2012-2#1)
RNA polymerase II holoenzyme##2##4##(1994-3#2)
RNA polymerase II##18##3##(1993-12#1)(1994-3#8)(1997-7#2)(2008-10#1)(2008-9#1)(2011-2#2)(2012-2#2)(2012-3#1)
RNA polymerase activity##2##3##(1991-5#1)(2012-3#1)
RNA polymerase alpha subunit##2##4##(1995-6#2)
RNA polymerase and##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
RNA polymerase containing##4##3##(1990-12#1)(1993-12#1)(1995-6#1)(2008-9#1)
RNA polymerase core##2##3##(1995-6#1)(2008-10#1)
RNA polymerase in##2##3##(1990-12#1)(1995-2#1)
RNA polymerase##63##2##(1990-11#1)(1990-12#3)(1991-5#3)(1993-12#2)(1993-9#1)(1994-3#8)(1994-5#1)(1995-2#5)(1995-6#5)(1997-2#1)(1997-7#3)(2008-10#12)(2008-7#1)(2008-8#3)(2008-9#2)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
RNA polymerases##9##2##(1995-6#1)(2008-10#3)(2010-7#3)(2012-3#1)(2013-8#1)
RNA pool##3##2##(2008-11#1)(2008-4#2)
RNA preparations##2##2##(2008-10#1)(2008-4#1)
RNA probe##3##2##(1994-11#1)(1995-11#1)(2008-10#1)
RNA probes##3##2##(2008-4#2)(2008-9#1)
RNA processing and##2##3##(1992-6#1)(1995-2#1)
RNA processing##5##2##(1992-6#3)(1993-12#1)(1995-2#1)
RNA recombination##2##2##(1997-3#2)
RNA replication##3##2##(2008-10#1)(2013-1#2)
RNA samples##4##2##(1996-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
RNA secondary structure that##2##4##(1991-9#2)
RNA secondary structure##4##3##(1991-9#3)(2011-3#1)
RNA secondary structures##4##3##(1997-6#1)(2011-3#3)
RNA secondary##9##2##(1991-9#3)(1997-6#1)(2008-4#1)(2011-3#4)
RNA sequence##2##2##(2008-11#1)(2011-3#1)
RNA silencing triggering##2##3##(2011-1#2)
RNA silencing##10##2##(2008-10#3)(2011-1#4)(2011-2#1)(2012-2#2)
RNA species was##2##3##(1993-12#1)(1996-12#1)
RNA species##6##2##(1993-12#1)(1996-12#1)(2008-10#4)
RNA splicing##5##2##(1992-6#1)(1995-6#3)(2008-9#1)
RNA structural dynamics and function##2##5##(2008-4#2)
RNA structural##3##2##(2008-4#2)(2011-3#1)
RNA structure and metal-binding##2##4##(2008-4#2)
RNA structure##5##2##(1991-5#1)(1994-11#1)(2008-10#1)(2008-4#2)
RNA synthesis in##2##3##(2008-10#1)(2008-9#1)
RNA synthesis##12##2##(1995-2#4)(1996-2#1)(2008-10#2)(2008-4#1)(2008-9#3)(2012-3#1)
RNA target##2##2##(2008-10#2)
RNA template##3##2##(1997-3#2)(2008-9#1)
RNA tertiary structure##3##3##(2008-4#3)
RNA transcript##6##2##(1994-11#1)(1994-12#1)(1995-2#1)(2008-10#2)(2012-3#1)
RNA transcripts##6##2##(1993-3#1)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#1)
RNA viral vector##2##3##(1995-2#2)
RNA virus##4##2##(2008-9#2)(2012-3#1)(2013-8#1)
RNA viruses belonging to the##2##5##(2008-9#1)(2013-8#1)
RNA viruses##9##2##(2008-10#4)(2008-9#2)(2011-3#2)(2013-8#1)
RNA was detected in##2##4##(1997-3#1)(2008-10#1)
RNA was detected##4##3##(1997-3#1)(2008-10#3)
RNA was determined to be##3##5##(2008-10#2)(2008-11#1)
RNA was extracted and##2##4##(1995-11#1)(2008-10#1)
RNA was extracted from##3##4##(2008-10#1)(2008-9#1)(2010-6#1)
RNA was extracted##5##3##(1995-11#1)(2008-10#2)(2008-9#1)(2010-6#1)
RNA was isolated from##2##4##(1993-2#1)(1995-11#1)
RNA was isolated##3##3##(1993-2#1)(1993-8#1)(1995-11#1)
RNA was prepared##2##3##(1996-2#1)(2011-2#1)
RNA was##34##2##(1992-12#1)(1993-2#1)(1993-8#2)(1995-11#2)(1995-2#1)(1996-2#1)(1997-3#5)(1997-8#1)(2008-10#15)(2008-11#1)(2008-9#2)(2010-6#1)(2011-2#1)
RNA were##6##2##(1997-3#3)(2008-10#3)
RNA with a##2##3##(2008-10#2)
RNA with the##2##3##(1991-5#1)(1997-3#1)
RNA with##6##2##(1991-5#1)(1997-3#1)(2008-10#2)(2008-4#2)
RNA##788##1##(1990-11#1)(1990-12#3)(1990-5#7)(1990-7#2)(1991-12#3)(1991-3#1)(1991-5#7)(1991-8#2)(1991-9#4)(1992-12#2)(1992-3#9)(1992-6#6)(1993-1#3)(1993-12#9)(1993-2#5)(1993-3#2)(1993-6#1)(1993-8#9)(1993-9#2)(1994-11#10)(1994-12#1)(1994-3#8)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#3)(1995-2#19)(1995-5#1)(1995-6#14)(1995-8#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-6#1)(1997-2#5)(1997-3#32)(1997-6#10)(1997-7#11)(1997-8#1)(2007-12#1)(2008-10#248)(2008-11#20)(2008-2#2)(2008-4#53)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#24)(2008-9#61)(2009-10#2)(2009-12#4)(2009-5#2)(2009-7#3)(2009-9#1)(2010-12#3)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#3)(2011-1#6)(2011-2#56)(2011-3#13)(2012-2#9)(2012-3#19)(2013-1#16)(2013-8#8)
RNA)##6##1##(1990-7#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-9#1)
RNA-1##3##1##(2008-10#3)
RNA-2 from##2##2##(2008-10#2)
RNA-2##6##1##(2008-10#6)
RNA-RNA solution hybridisation-RNase protection##2##4##(1996-12#2)
RNA-based sensor##2##2##(2008-10#2)
RNA-based##4##1##(2008-10#4)
RNA-binding protein##4##2##(1993-12#1)(1997-2#1)(1997-3#1)(2008-8#1)
RNA-dependent DNA methylation##2##3##(2011-2#2)
RNA-dependent RNA polymerase##12##3##(2008-10#9)(2010-5#1)(2013-1#1)(2013-8#1)
RNA-dependent RNA##15##2##(2008-10#12)(2010-5#1)(2013-1#1)(2013-8#1)
RNA-dependent##17##1##(2008-10#12)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
RNA-encoded nonstructural##2##2##(2008-10#2)
RNA-mediated##2##1##(2008-10#2)
RNA1 and 2##2##3##(2008-10#2)
RNA1 and##3##2##(2008-10#2)(2008-8#1)
RNA1##7##1##(1995-2#1)(2008-10#5)(2008-8#1)
RNA2 and RNA3##2##3##(2008-10#2)
RNA2 and##3##2##(2008-10#3)
RNA2##11##1##(2008-10#9)(2008-8#2)
RNA3 from##2##2##(2008-10#2)
RNA3 levels##2##2##(2008-10#2)
RNA3##12##1##(2008-10#12)
RNAi was##2##2##(2008-9#1)(2011-1#1)
RNAi##14##1##(2008-9#3)(2009-10#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#2)(2012-2#4)(2013-1#1)
RNApasta##4##1##(2011-3#4)
RNAs (satRNAs)##2##2##(2008-10#2)
RNAs 1 and 2 and the##2##6##(2008-10#1)(2008-8#1)
RNAs 1 and 2##3##4##(2008-10#2)(2008-8#1)
RNAs and##6##2##(1993-9#1)(2008-10#2)(2008-2#1)(2011-2#1)(2011-3#1)
RNAs are##7##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#2)
RNAs at multiple sites##2##4##(2008-10#2)
RNAs during##2##2##(2008-10#2)
RNAs extracted from##2##3##(2008-10#2)
RNAs from##7##2##(1992-6#1)(1995-6#1)(2008-10#3)(2008-9#2)
RNAs in Cryphonectria parasitica##2##4##(2008-10#2)
RNAs in the##3##3##(2008-10#2)(2011-2#1)
RNAs in vitro##2##3##(1997-3#1)(2008-10#1)
RNAs in##15##2##(1997-3#1)(2008-10#12)(2008-11#1)(2011-2#1)
RNAs of a##2##3##(2008-8#1)(2008-9#1)
RNAs of##8##2##(2008-10#6)(2008-8#1)(2008-9#1)
RNAs that##3##2##(2010-7#2)(2013-1#1)
RNAs was##2##2##(1993-8#1)(1997-3#1)
RNAs were##9##2##(1990-12#1)(1993-8#1)(2008-10#4)(2008-8#2)(2009-10#1)
RNAs##115##1##(1990-12#1)(1992-3#1)(1992-6#1)(1993-8#4)(1993-9#1)(1995-6#2)(1996-12#1)(1997-3#3)(1997-8#1)(2008-10#59)(2008-11#5)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#8)(2008-9#9)(2009-10#1)(2010-7#2)(2011-2#6)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#1)
RNN is##3##2##(2010-8#3)
RNPs##2##1##(1993-8#1)(2008-10#1)
RNS signaling##2##2##(2011-2#2)
RNS##3##1##(2009-8#1)(2011-2#2)
RNase P##3##2##(1995-6#3)
RNase protection assay##4##3##(1993-6#1)(1997-7#1)(2008-4#2)
RNase protection assays##2##3##(1996-12#1)(2008-10#1)
RNase protection##8##2##(1993-6#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-4#3)
RNase##24##1##(1990-5#6)(1993-6#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-4#4)(2008-9#1)(2012-3#3)
RNs##8##1##(2008-11#1)(2008-12#3)(2010-10#2)(2010-4#1)(2013-8#1)
RO 11-2933##6##2##(1990-2#6)
RO##12##1##(1990-2#6)(2008-11#6)
ROC##3##1##(2008-10#1)(2008-12#1)(2010-8#1)
ROE##8##1##(2008-5#8)
ROH##3##1##(2008-10#3)
ROI-induced##2##1##(2008-7#2)
ROIs##2##1##(2008-7#2)
ROM##9##1##(2007-12#1)(2008-12#4)(2009-1#3)(2013-1#1)
ROR-C##3##1##(1996-12#3)
ROS 17/2##2##2##(1991-3#1)(1993-3#1)
ROS and RNS##2##3##(2009-8#1)(2011-2#1)
ROS and##5##2##(2008-11#1)(2009-8#2)(2010-5#1)(2011-2#1)
ROS by##3##2##(1994-5#2)(2008-11#1)
ROS can##2##2##(2008-10#1)(2009-8#1)
ROS cells##3##2##(1993-3#3)
ROS formation##4##2##(1994-6#2)(2010-1#2)
ROS in##3##2##(2008-11#2)(2011-2#1)
ROS levels in diabetes##2##4##(2011-2#2)
ROS levels##4##2##(2008-11#2)(2011-2#2)
ROS production and##2##3##(2009-8#1)(2013-1#1)
ROS production was##3##3##(1994-5#1)(2010-12#2)
ROS production##9##2##(1994-5#1)(2009-3#1)(2009-8#1)(2010-12#3)(2012-2#1)(2013-1#2)
ROS signaling##2##2##(2009-8#1)(2011-2#1)
ROS##70##1##(1991-3#1)(1993-3#4)(1994-5#4)(1994-6#3)(1997-1#2)(2008-10#7)(2008-11#14)(2008-9#1)(2009-3#1)(2009-8#6)(2010-1#2)(2010-12#5)(2010-5#1)(2011-2#10)(2012-2#1)(2012-3#2)(2012-6#3)(2013-1#3)
RP HPLC##2##2##(2008-10#1)(2012-2#1)
RP and##2##2##(2008-10#1)(2010-10#1)
RP genome##2##2##(2008-10#2)
RP##25##1##(2008-10#7)(2009-8#3)(2010-1#1)(2010-10#3)(2010-9#2)(2011-2#5)(2012-2#3)(2013-1#1)
RP-18 column using##2##3##(2008-10#2)
RP-18 column##3##2##(2008-10#3)
RP-18##9##1##(2008-10#8)(2008-5#1)
RP-18e##3##1##(2008-10#3)
RP-C(18)##2##1##(2008-10#2)
RP-HPLC analysis##2##2##(2008-10#1)(2008-5#1)
RP-HPLC determination of##2##3##(2008-10#2)
RP-HPLC method##4##2##(2008-10#3)(2008-5#1)
RP-HPLC##16##1##(2008-10#12)(2008-5#2)(2012-2#2)
RP-HPLC/UV##2##1##(2008-10#2)
RP-LC##5##1##(2008-10#5)
RPA##4##1##(2008-10#3)(2013-1#1)
RPE that corresponded to 50% of oxygen uptake reserve##2##9##(2013-8#2)
RPE that corresponded to##4##4##(2013-8#4)
RPE##7##1##(2013-1#1)(2013-8#6)
RPH was##2##2##(2008-10#2)
RPH##3##1##(2008-10#3)
RPL32##2##1##(1991-5#2)
RPLC##2##1##(2008-10#2)
RPMI 1640##4##2##(2008-11#4)
RPMI##12##1##(1990-12#4)(1992-6#1)(2008-10#1)(2008-11#6)
RPV##4##1##(2008-10#4)
RR =##4##2##(2012-3#4)
RR values##3##2##(2008-10#3)
RR##15##1##(1992-6#1)(1997-3#1)(2008-10#6)(2008-5#1)(2012-2#2)(2012-3#4)
RR(Tres)##2##1##(2008-8#2)
RRE##10##1##(1993-8#9)(2011-3#1)
RRS technology##3##2##(2008-10#3)
RRS##11##1##(2008-10#11)
RRT were##2##2##(2012-3#2)
RRT##3##1##(2012-3#3)
RS and##2##2##(2008-10#2)
RS extract##10##2##(2008-11#10)
RS were##2##2##(2008-8#2)
RS##21##1##(1995-6#1)(2008-10#5)(2008-11#11)(2008-8#3)(2010-8#1)
RS-SR##2##1##(1993-6#2)
RS13##2##1##(2008-8#2)
RS4##2##1##(2010-8#2)
RS4(XL)##3##1##(2010-8#3)
RSB##4##1##(2013-1#4)
RSC##2##1##(2008-10#2)
RSCs##2##1##(2008-10#2)
RSD and##3##2##(2008-10#3)
RSD for five##2##3##(2008-10#2)
RSD for##6##2##(2008-10#6)
RSD is##3##2##(2008-10#3)
RSD of 2##3##3##(2008-10#3)
RSD of the##6##3##(2008-10#6)
RSD of##12##2##(2008-10#12)
RSD smaller than##2##3##(2008-10#2)
RSD values##2##2##(2008-10#2)
RSD was##7##2##(2008-10#7)
RSD##55##1##(2008-10#55)
RSD% of##3##2##(2008-10#3)
RSD%##5##1##(2008-10#5)
RSD) for##2##2##(2008-10#2)
RSD)##5##1##(2008-10#5)
RSDs##6##1##(2008-10#6)
RSEP##2##1##(2008-10#2)
RSP##5##1##(2008-3#2)(2010-9#3)
RSS##4##1##(2008-12#4)
RSV LTR##2##2##(1995-6#2)
RSV##7##1##(1992-5#1)(1994-11#1)(1995-6#3)(2011-2#2)
RT activity in##3##3##(2008-11#3)
RT and##3##2##(1995-5#1)(2008-9#1)(2011-2#1)
RT##30##1##(1990-11#4)(1990-12#1)(1995-5#1)(1997-3#3)(2008-10#2)(2008-11#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2010-1#2)(2011-2#3)(2013-1#1)
RT-PCR analysis of##2##3##(2008-5#1)(2011-2#1)
RT-PCR analysis showed that##3##4##(2008-11#1)(2008-8#2)
RT-PCR analysis##10##2##(1994-11#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-5#1)(2011-2#1)
RT-PCR and electron dispersive spectroscopy (EDS)##2##6##(2008-11#2)
RT-PCR and sequencing##2##3##(2008-9#2)
RT-PCR and the##2##3##(2008-10#1)(2011-3#1)
RT-PCR and##17##2##(1996-12#1)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#3)(2010-4#1)(2010-5#1)(2011-3#2)(2012-2#1)(2013-8#2)
RT-PCR assay##8##2##(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#5)
RT-PCR data##2##2##(2008-11#1)(2008-8#1)
RT-PCR demonstrated##2##2##(1994-11#1)(2008-11#1)
RT-PCR for##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
RT-PCR in##4##2##(2008-10#2)(2008-12#1)(2011-3#1)
RT-PCR of##2##2##(2008-10#1)(2008-11#1)
RT-PCR products##3##2##(2008-10#3)
RT-PCR reaction##2##2##(2008-10#2)
RT-PCR revealed that##2##3##(2008-11#1)(2008-9#1)
RT-PCR technique##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
RT-PCR using##2##2##(2008-10#1)(2008-9#1)
RT-PCR were##2##2##(2008-5#1)(2008-8#1)
RT-PCR with##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
RT-PCR##122##1##(1994-11#2)(1995-12#1)(1996-12#2)(1997-3#3)(1997-9#1)(2008-10#28)(2008-11#16)(2008-12#1)(2008-5#7)(2008-8#15)(2008-9#17)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#4)(2011-3#3)(2012-2#5)(2013-1#1)(2013-8#12)
RT-PCR)##2##1##(2013-8#2)
RT-PCR-Based##2##1##(2008-10#2)
RTA##2##1##(2008-1#1)(2008-3#1)
RTC-CRM##2##1##(2008-10#2)
RTI##4##1##(2008-12#1)(2010-5#3)
RTI-based assessment practices##2##3##(2008-12#2)
RTI-based assessment##3##2##(2008-12#3)
RTKs##4##1##(1995-8#1)(2009-8#1)(2009-9#2)
RTLS##2##1##(2011-2#2)
RTP emission##6##2##(2008-10#6)
RTP quenching##3##2##(2008-10#3)
RTP signals##3##2##(2008-10#3)
RTP##26##1##(1993-9#2)(2008-10#24)
RTP-91E and##2##2##(2008-11#2)
RTS and AIS##2##3##(2008-10#2)
RTS and##3##2##(2008-10#3)
RTS##9##1##(2008-10#6)(2011-2#3)
RTSV##5##1##(2008-10#5)
RTX##2##1##(2013-8#2)
RTs##2##1##(2010-1#2)
RU##4##1##(1992-1#1)(2008-10#2)(2008-11#1)
RU486 treatment##2##2##(2008-9#2)
RU486##5##1##(2008-9#5)
RU9101001##2##1##(2008-10#2)
RUG-II##2##1##(1994-12#2)
RUGs##4##1##(1993-12#4)
RV is the dominant##2##4##(2008-10#2)
RV##7##1##(2008-10#7)
RVC and##2##2##(2008-10#2)
RVC##6##1##(2008-10#6)
RVF##2##1##(1994-9#2)
RVR##2##1##(2008-3#1)(2013-1#1)
RVUs##7##1##(2013-1#7)
RVUs/WTE##2##1##(2012-2#2)
RW##6##1##(2008-11#6)
RWA##3##1##(2008-9#3)
RWC##2##1##(2008-12#2)
RWJF##3##1##(2013-1#3)
RWPC##2##1##(2008-10#2)
RYSV##3##1##(2008-8#3)
RZK-6##2##1##(2011-2#2)
Rab proteins##3##2##(1995-6#1)(1995-8#1)(1997-1#1)
Rab##13##1##(1995-6#2)(1995-8#2)(1997-1#4)(2008-8#1)(2011-2#4)
Rab/Ypt##3##1##(2008-11#3)
Rab11##5##1##(1996-6#1)(1997-1#3)(2009-8#1)
Rab27B##3##1##(2011-2#3)
Rabbit##6##1##(1992-9#1)(1993-8#1)(1995-6#1)(2008-10#1)(2011-2#1)(2012-3#1)
Rabbits##3##1##(1995-12#1)(1996-3#1)(2008-9#1)
Rabies and quarantine##2##3##(1996-11#1)(1996-8#1)
Rabies requirements##2##2##(1992-2#2)
Rabies##6##1##(1992-2#2)(1996-11#1)(1996-8#1)(2008-10#2)
Rabphilin-3A##2##1##(1994-11#2)
Rabphilin-3A-interacting protein##2##2##(1994-11#2)
Rac proteins##2##2##(1997-7#2)
Rac##4##1##(1996-12#1)(1997-7#3)
Rac1##8##1##(1997-7#3)(2011-2#5)
Rac2##7##1##(1997-7#7)
Race 1##4##2##(2008-10#4)
Race 3 of##3##3##(2008-10#3)
Race 3##6##2##(2008-10#6)
Race Ct0##2##2##(2008-10#2)
Race of##3##2##(2008-10#3)
Race##26##1##(2008-10#25)(2010-10#1)
Race-Specific Resistance##3##2##(2008-10#3)
Race-Specific##4##1##(2008-10#4)
Races 0##3##2##(2008-10#3)
Races in##2##2##(2008-10#2)
Races of Pyrenophora tritici-repentis##2##4##(2008-10#2)
Races of##4##2##(2008-10#4)
Races##15##1##(2008-10#15)
Racial and ethnic##2##3##(2011-2#1)(2013-1#1)
Racial differences in##2##3##(1995-12#1)(2010-11#1)
Racial##6##1##(1995-12#1)(2008-11#1)(2010-11#1)(2011-2#2)(2013-1#1)
Rad1-Rad10##3##1##(1994-9#3)
Rad50##3##1##(2011-2#3)
Rad51##2##1##(1995-6#1)(1997-4#1)
Radial artery##3##2##(2011-2#3)
Radial growth##2##2##(2008-10#2)
Radial##12##1##(1992-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#6)
Radiation Oncology and Radiobiology##2##4##(2008-10#2)
Radiation Oncology and##5##3##(2008-10#5)
Radiation Oncology##8##2##(2008-10#7)(2011-2#1)
Radiation Therapy##2##2##(1993-9#1)(1994-12#1)
Radiation and##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
Radiation therapy##6##2##(1991-2#1)(1991-8#1)(1993-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
Radiation##33##1##(1991-2#1)(1991-8#1)(1993-9#2)(1994-12#1)(1995-10#1)(2008-10#10)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-6#1)(2011-2#3)(2013-1#2)(2013-8#1)
Radiation-induced##4##1##(1990-12#1)(2008-12#1)(2008-7#1)(2013-8#1)
Radiative Transfer##2##2##(2008-3#2)
Radiative transfer##2##2##(2008-3#2)
Radiative##4##1##(2008-3#4)
Radical##16##1##(1993-11#1)(1996-5#7)(2008-3#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
Radicals##4##1##(1996-5#3)(2010-7#1)
Radiculopathy##2##1##(2008-12#1)(2012-3#1)
Radiello((R))##4##1##(2008-10#4)
Radio-frequency##2##1##(2008-11#1)(2011-2#1)
Radioactive##3##1##(1997-1#1)(2008-10#1)(2009-7#1)
Radiobiological##2##1##(1993-9#1)(2008-10#1)
Radiobiology##3##1##(2008-10#2)(2012-3#1)
Radiochemical##2##1##(2008-10#1)(2012-12#1)
Radiographic##8##1##(1990-6#1)(2008-9#1)(2009-3#2)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
Radiographs##3##1##(1991-12#1)(2008-2#1)(2010-3#1)
Radiography##3##1##(2011-2#2)(2011-6#1)
Radioimmunoassay of##2##2##(1990-11#1)(1990-7#1)
Radioimmunoassay##3##1##(1990-11#1)(1990-7#1)(2007-11#1)
Radiolabeled##2##1##(1997-8#1)(2010-6#1)
Radiological##12##1##(1991-12#1)(1993-3#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
Radiologist workload##4##2##(2012-2#4)
Radiologist##7##1##(2012-2#7)
Radiologists##2##1##(2008-1#1)(2012-2#1)
Radiology Information Service##2##3##(1992-1#2)
Radiology##21##1##(1991-2#2)(1992-1#2)(1993-3#1)(1995-1#1)(1995-2#1)(1996-1#3)(1996-2#1)(2008-7#1)(2009-9#1)(2010-12#2)(2012-2#6)
Radiometer##3##1##(1995-6#1)(2008-3#2)
Radionuclide##2##1##(1991-2#1)(1992-3#1)
Radiosensitization##2##1##(2008-9#1)(2011-2#1)
Radiosurgery##7##1##(1996-3#1)(1997-4#1)(2008-7#2)(2011-2#1)(2012-3#2)
Radiotherapy for rectal cancer##3##4##(1997-7#3)
Radiotherapy is##2##2##(2008-10#1)(2009-11#1)
Radiotherapy was administered##2##3##(1990-8#1)(2008-7#1)
Radiotherapy was##3##2##(1990-8#1)(1992-12#1)(2008-7#1)
Radiotherapy##17##1##(1990-8#1)(1992-12#2)(1993-9#1)(1997-7#3)(2008-10#6)(2008-7#1)(2009-11#1)(2012-3#1)(2013-1#1)
Radix##7##1##(2008-10#3)(2011-2#1)(2013-1#1)(2013-8#2)
Radopholus similis##2##2##(2008-10#2)
Raf kinase##2##2##(2009-8#2)
Raf##5##1##(1994-6#1)(1996-2#1)(2008-10#1)(2009-8#2)
Ragona##3##1##(1990-11#3)
Ragusa##7##1##(1991-2#5)(1992-12#2)
Rain##3##1##(2008-10#3)
Rainbow##5##1##(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#2)
Raindrop##2##1##(1995-3#2)
Rainfall was##2##2##(2008-10#2)
Rainfall##4##1##(2008-10#4)
Raised##4##1##(1990-6#1)(1991-12#1)(2010-5#1)(2012-3#1)
Raising the bar##2##3##(2012-12#1)(2012-3#1)
Raising the##5##2##(1994-3#1)(2008-10#1)(2010-5#1)(2012-12#1)(2012-3#1)
Raising##6##1##(1994-3#1)(2008-10#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-3#1)
Raji cells##2##2##(1993-3#1)(1993-8#1)
Raji##3##1##(1993-3#1)(1993-8#1)(1995-2#1)
Ralph##3##1##(1993-12#1)(1995-6#2)
Ralstonia solanacearum in##4##3##(2008-10#4)
Ralstonia solanacearum is a##2##4##(2008-10#2)
Ralstonia solanacearum is##3##3##(2008-10#3)
Ralstonia solanacearum##29##2##(2008-10#29)
Ralstonia##30##1##(2008-10#30)
Ramalina stenospora##2##2##(2008-10#2)
Ramalina##4##1##(2008-10#2)(2008-11#2)
Raman DIAL##3##2##(2008-3#3)
Raman and##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
Raman band##2##2##(1990-8#1)(1991-5#1)
Raman conversion##2##2##(2007-12#2)
Raman differential absorption lidar##3##4##(2007-12#1)(2008-3#2)
Raman gain coefficient##3##3##(2008-3#3)
Raman gain coefficients of##2##4##(2008-3#2)
Raman gain##6##2##(2007-12#1)(2008-3#5)
Raman lidar##3##2##(2008-2#2)(2008-3#1)
Raman lidars##2##2##(2007-12#1)(2008-3#1)
Raman measurements of##2##3##(2008-2#1)(2008-3#1)
Raman microspectroscopic##3##2##(2008-9#3)
Raman microspectroscopy##3##2##(2010-10#3)
Raman or high spectral resolution##2##5##(2008-2#2)
Raman scattering for##3##3##(2008-10#1)(2008-3#2)
Raman scattering##28##2##(2007-12#2)(2008-10#13)(2008-2#2)(2008-3#9)(2010-7#2)
Raman signal##3##2##(2007-12#1)(2008-10#2)
Raman spectra can##2##3##(2008-10#2)
Raman spectra of##9##3##(2008-10#7)(2013-8#2)
Raman spectra##18##2##(1990-8#1)(2008-10#15)(2013-8#2)
Raman spectrometers##2##2##(2008-10#2)
Raman spectroscopic##4##2##(2008-10#2)(2008-8#2)
Raman spectroscopy as##2##3##(2008-10#1)(2009-12#1)
Raman spectroscopy in##2##3##(2008-10#2)
Raman spectroscopy to##2##3##(1991-5#1)(2008-10#1)
Raman spectroscopy##34##2##(1991-5#2)(2008-10#22)(2008-2#5)(2008-3#1)(2008-8#1)(2009-12#1)(2013-1#1)(2013-8#1)
Raman spectrum##4##2##(2008-10#2)(2008-2#1)(2013-8#1)
Raman tweezer##2##2##(2009-12#2)
Raman tweezers##3##2##(2009-12#3)
Raman##178##1##(1990-8#4)(1991-5#4)(1992-4#1)(1995-2#1)(2007-11#4)(2007-12#9)(2008-10#76)(2008-2#18)(2008-3#31)(2008-5#1)(2008-8#4)(2008-9#3)(2009-12#7)(2010-10#5)(2010-7#2)(2013-1#1)(2013-8#7)
Raman-scattered##2##1##(2008-2#2)
Raman-scattering##4##1##(2008-2#3)(2008-3#1)
Ran and##2##2##(1995-2#1)(2011-2#1)
Ran##6##1##(1995-2#4)(2011-2#2)
RanGAP1 is##2##2##(1995-2#2)
RanGAP1##4##1##(1995-2#4)
Rana catesbeiana##2##2##(1990-5#1)(1997-7#1)
Rana rugosa##2##2##(1994-11#2)
Rana##10##1##(1990-5#1)(1994-11#3)(1997-3#1)(1997-7#1)(2011-2#4)
Random Amplified Polymorphic DNA##4##4##(2008-10#4)
Random amplified microsatellites##2##3##(2008-10#2)
Random amplified polymorphic DNA (RAPD)##4##5##(2008-10#4)
Random amplified polymorphic DNA##8##4##(2008-10#8)
Random amplified##10##2##(2008-10#10)
Random mating##2##2##(2008-10#2)
Random##20##1##(1995-3#1)(2008-10#17)(2008-12#1)(2012-2#1)
Randomized Complete##2##2##(2008-12#2)
Randomized Trial##2##2##(2008-12#1)(2012-3#1)
Randomized controlled trials##4##3##(2008-10#1)(2009-7#1)(2009-9#1)(2013-1#1)
Randomized controlled##6##2##(2008-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2013-1#2)
Randomized trials##3##2##(1993-12#1)(1996-6#2)
Randomized##22##1##(1993-12#2)(1993-6#1)(1994-8#1)(1996-6#2)(2008-10#1)(2008-12#3)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-3#2)(2013-1#4)
Randomly##2##1##(2008-10#2)
Range of motion##2##3##(2008-12#1)(2010-12#1)
Range of##7##2##(2008-10#4)(2008-11#1)(2008-12#1)(2010-12#1)
Range quail##2##2##(2008-12#2)
Range##20##1##(1996-9#1)(2008-10#11)(2008-11#1)(2008-12#4)(2008-3#1)(2010-12#1)(2010-4#1)
Ranges##4##1##(1995-6#2)(2008-10#2)
Rangpur lime##3##2##(2008-10#3)
Ranibizumab##4##1##(2010-9#1)(2013-1#3)
Ranitidine##2##1##(1992-11#1)(1992-2#1)
Rankin##5##1##(1995-12#1)(2008-8#1)(2012-3#3)
Ranking##5##1##(1991-3#1)(2008-11#1)(2008-9#1)(2010-3#1)(2013-1#1)
Ranunculaceae##2##1##(2011-3#2)
Ranunculus asiaticus##2##2##(2008-10#2)
Ranunculus##3##1##(2008-10#3)
Rap1##2##1##(2008-11#2)
Rapamycin and##2##2##(2009-7#2)
Rapamycin##3##1##(2009-7#2)(2010-11#1)
Raphaël Blanchard##2##2##(2010-1#2)
Rapid Detection of##3##3##(2008-10#2)(2012-2#1)
Rapid Diagnostic##2##2##(2008-10#2)
Rapid and Sensitive Detection of##2##5##(2008-10#2)
Rapid and sensitive##3##3##(2008-10#3)
Rapid and##14##2##(2008-10#10)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
Rapid aqueous sample extraction of##2##5##(2008-10#2)
Rapid aqueous sample extraction##3##4##(2008-10#3)
Rapid detection of##2##3##(2008-10#1)(2008-11#1)
Rapid determination of##6##3##(2008-10#6)
Rapid progression##2##2##(2010-1#2)
Rapid screening##2##2##(2008-10#1)(2008-4#1)
Rapid separation##2##2##(2008-10#1)(2008-11#1)
Rapid##76##1##(1991-5#1)(1992-2#1)(1994-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#41)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#3)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
Rapidly##2##1##(1997-2#1)(2011-2#1)
Rare earth##2##2##(2008-10#1)(2008-7#1)
Rare##11##1##(1997-8#1)(2008-10#3)(2008-7#2)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Rarely##3##1##(1997-8#1)(2008-8#1)(2009-9#1)
Ras proteins##3##2##(1996-2#1)(1997-4#1)(2008-5#1)
Ras##21##1##(1995-8#2)(1996-2#9)(1997-4#2)(1997-7#3)(2008-10#1)(2008-5#1)(2013-8#3)
Ras-dependent MAP kinase activation##2##4##(1995-8#2)
Ras-dependent##3##1##(1995-8#2)(1997-7#1)
Ras-specific##2##1##(2013-8#2)
RasGRP1 and Ras##2##3##(2013-8#2)
RasGRP1 and##3##2##(2013-8#3)
RasGRP1 is##2##2##(2013-8#2)
RasGRP1##8##1##(2013-8#8)
Rasch analysis##2##2##(2011-2#2)
Rasch model##7##2##(2008-11#1)(2012-2#6)
Rasch modeling##3##2##(2012-2#3)
Rasch scaling##2##2##(2012-2#2)
Rasch##21##1##(2008-11#1)(2011-2#3)(2012-2#17)
Rashes##2##1##(2013-1#2)
Rassin##2##1##(2012-3#2)
Rat L6 myotubes##2##3##(2008-11#2)
Rat Model##2##2##(2011-2#1)(2012-3#1)
Rat ascites hepatoma##2##3##(1993-8#1)(2008-11#1)
Rat liver##2##2##(1993-12#1)(1994-8#1)
Rat##30##1##(1990-11#1)(1991-2#1)(1991-5#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-12#2)(2008-10#1)(2008-11#8)(2008-12#1)(2009-8#2)(2011-2#2)(2012-3#3)(2013-1#1)
RatLab##5##1##(2013-8#5)
Rate of##11##2##(1996-8#1)(2008-10#5)(2008-12#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
Rate##19##1##(1996-5#3)(1996-8#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#2)(2013-8#1)
Rate-of-processing ability##2##2##(2008-9#2)
Rates in##2##2##(1996-9#2)
Rates of##11##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-1#2)
Rates were##2##2##(1994-12#1)(2013-8#1)
Rates##16##1##(1994-12#1)(1996-9#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
Rathayibacter toxicus##2##2##(2008-10#2)
Rather than a##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
Rather than focusing##2##3##(2008-11#1)(2010-10#1)
Rather than##14##2##(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2011-2#1)(2012-2#2)(2013-8#1)
Rather##25##1##(1994-12#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
Rathke##2##1##(2012-3#2)
Rathke's cleft cysts##2##3##(2008-7#2)
Rathke's cleft##3##2##(2008-7#3)
Rathke's##4##1##(2008-7#3)(2011-2#1)
Rating Scale scores##2##3##(2011-2#1)(2012-2#1)
Rating Scale were##2##3##(1991-2#1)(2008-7#1)
Rating Scale##13##2##(1991-2#1)(1997-3#1)(2008-3#1)(2008-6#2)(2008-7#3)(2009-12#1)(2011-2#1)(2011-8#1)(2012-2#1)(2013-8#1)
Rating##18##1##(1991-2#1)(1997-3#1)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-12#1)(2011-2#2)(2011-8#1)(2012-2#2)(2013-8#1)
Ratio of##3##2##(1996-8#1)(2008-12#2)
Ratio##7##1##(1996-8#1)(1996-9#1)(2008-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
Rational##5##1##(2008-10#2)(2008-11#1)(2012-2#2)
Rationale for##3##2##(1991-3#1)(2011-7#1)(2012-3#1)
Rationale##5##1##(1991-3#1)(1996-9#1)(2008-10#1)(2011-7#1)(2012-3#1)
Rationing health care##9##3##(1996-8#9)
Rationing##10##1##(1992-5#1)(1996-8#9)
Ratios##2##1##(2008-10#1)(2012-12#1)
Rats in##2##2##(1994-8#1)(2012-3#1)
Rats treated##2##2##(2008-10#1)(2010-6#1)
Rats were fed##2##3##(2008-11#1)(2011-2#1)
Rats were treated with##2##4##(1996-2#1)(2010-6#1)
Rats were##13##2##(1991-2#1)(1992-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#2)(2012-3#1)
Rats with##5##2##(1993-6#2)(1996-2#2)(2012-2#1)
Rats##37##1##(1990-5#1)(1991-2#2)(1992-12#1)(1993-12#1)(1993-6#3)(1994-2#1)(1994-5#1)(1994-8#1)(1996-2#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-6#2)(2011-2#3)(2012-2#2)(2012-3#4)(2013-7#1)
Raw and##2##2##(2008-10#1)(2010-4#1)
Raw##3##1##(2008-10#2)(2010-4#1)
Rawalpindi##2##1##(2013-7#2)
Rayleigh backscatter##2##2##(2008-3#2)
Rayleigh light scattering (RLS)##2##4##(2008-10#2)
Rayleigh light scattering##5##3##(2008-10#5)
Rayleigh light##6##2##(2008-10#6)
Rayleigh scattering method##2##3##(2008-10#2)
Rayleigh scattering##13##2##(1992-8#1)(2008-10#6)(2008-2#1)(2008-3#5)
Rayleigh##24##1##(1992-8#1)(2008-10#12)(2008-2#1)(2008-3#10)
Raynaud's phenomenon##2##2##(1991-3#1)(2009-11#1)
Rb from##2##2##(2008-10#2)
Rb##16##1##(2008-10#12)(2008-2#1)(2008-8#3)
Rb(+) and##2##2##(2008-10#2)
Rb(+)##5##1##(2008-10#5)
Rb(+)&gt##2##1##(2008-10#2)
Rb1##3##1##(2008-11#2)(2010-12#1)
RbTiOAsO(4)##4##1##(2008-3#4)
RbsR(His) binding##2##2##(2011-1#2)
RbsR(His)##3##1##(2011-1#3)
Rcm 2##4##2##(2008-10#4)
Rcm 5##4##2##(2008-10#4)
Rcm##8##1##(2008-10#8)
Rd15##2##1##(2008-10#2)
RdRp##5##1##(2008-10#5)
Rdc##2##1##(2008-10#2)
Rdc2##2##1##(2008-10#2)
Re##13##1##(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-6#1)
Reaching##2##1##(2010-7#1)(2013-1#1)
Reaction for##2##2##(2008-10#1)(2010-4#1)
Reaction in##4##2##(1995-6#1)(1996-5#1)(2008-10#2)
Reaction kinetics were##2##3##(2008-10#2)
Reaction mechanism##2##2##(1995-3#1)(2008-10#1)
Reaction of 2-methyl-endo-tricyclo[3##2##3##(1996-5#2)
Reaction of alcohol group##2##4##(2008-10#2)
Reaction of##13##2##(1990-12#1)(1996-5#3)(2008-10#6)(2008-9#1)(2010-3#1)(2012-12#1)
Reaction with##3##2##(1996-5#3)
Reaction##78##1##(1990-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#10)(2008-10#50)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-6#1)(2012-12#1)(2012-2#1)
Reactions in##3##2##(1992-8#1)(2008-10#2)
Reactions of##4##2##(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#1)
Reactions##18##1##(1992-8#1)(1996-12#1)(1996-5#4)(1996-9#1)(2008-10#8)(2008-11#2)(2009-8#1)
Reactivation of##2##2##(2009-4#1)(2012-3#1)
Reactive Oxygen Species##2##3##(2011-2#1)(2012-2#1)
Reactive Red 41##3##3##(2008-10#3)
Reactive Red 96##3##3##(2008-10#3)
Reactive Red##7##2##(2008-10#7)
Reactive oxygen species (ROS)##2##4##(2008-11#1)(2009-8#1)
Reactive oxygen species##5##3##(1992-9#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
Reactive##21##1##(1991-5#1)(1992-9#1)(1995-11#1)(2008-10#7)(2008-11#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Reactivity of##4##2##(1996-5#1)(2008-10#2)(2012-3#1)
Reactor##4##1##(2008-10#2)(2008-11#2)
Readability##3##1##(2011-1#2)(2012-3#1)
Reading First##3##2##(2008-12#3)
Reading##8##1##(1997-7#1)(2008-12#5)(2009-11#1)(2012-3#1)
Readthrough##2##1##(2008-10#2)
Reagan##6##1##(1991-1#6)
Reagan's colon cancer episode##3##4##(1991-3#3)
Reagent##6##1##(1993-3#1)(2008-10#4)(2009-12#1)
Reagentless biosensor##2##2##(2008-10#2)
Reagentless##3##1##(2008-10#3)
Reagents##7##1##(1995-2#1)(2008-10#4)(2008-8#1)(2008-9#1)
Real Seal##3##2##(2013-1#3)
Real samples##2##2##(2008-10#2)
Real water samples##2##3##(2008-10#2)
Real##12##1##(1991-2#1)(1996-2#1)(2008-10#6)(2012-2#1)(2013-1#3)
Real-Time PCR##3##2##(2008-12#3)
Real-Time Polymerase Chain Reaction Assay##5##5##(2008-10#5)
Real-Time Polymerase Chain Reaction##13##4##(2008-10#13)
Real-Time Quantitative##2##2##(2008-10#2)
Real-Time##20##1##(2008-10#16)(2008-12#4)
Real-time PCR is##2##3##(2008-10#1)(2011-2#1)
Real-time PCR##6##2##(2008-10#4)(2010-6#1)(2011-2#1)
Real-time immunoassay of##2##3##(2008-10#2)
Real-time##22##1##(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-9#1)
RealBest DNA Anaplasma phagocytophilum/Ehrlichia muris##2##5##(2013-1#2)
Reality##3##1##(1994-2#1)(2009-1#1)(2010-9#1)
Realized heritability##2##2##(2008-10#2)
Realized##3##1##(2008-10#2)(2008-9#1)
Realizing##2##1##(2008-10#1)(2013-8#1)
Really##4##1##(1991-11#1)(1994-5#1)(2009-6#1)(2012-3#1)
Rearing##2##1##(2008-10#1)(2008-11#1)
Rearrangement of##2##2##(1996-5#2)
Rearrangement##4##1##(1996-5#4)
Reason##3##1##(1995-6#1)(2008-10#1)(2008-11#1)
Reasonable##2##1##(2008-10#1)(2008-8#1)
Reasons for this##2##3##(2008-9#1)(2010-12#1)
Reasons for##7##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#2)(2010-12#1)(2011-2#1)
Reasons##10##1##(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-2#1)
Reassessment of the##3##3##(2008-10#2)(2009-1#1)
Reassessment of##4##2##(2008-10#2)(2008-11#1)(2009-1#1)
Reassortment##2##1##(2008-10#2)
Rebleeding rate was 20##2##4##(2013-1#2)
Rebleeding##5##1##(2008-7#1)(2011-2#1)(2013-1#3)
RecA##7##1##(1995-2#1)(1997-4#3)(2008-4#1)(2009-7#2)
RecA-like##3##1##(1990-5#1)(1995-6#1)(1995-8#1)
RecB8-LacZ##2##1##(2008-11#2)
Receiver operating characteristic##2##3##(2012-2#1)(2012-3#1)
Receiver##3##1##(2008-10#1)(2012-2#1)(2012-3#1)
Receiving##3##1##(2008-10#1)(2008-12#1)(2012-3#1)
Recent advances in the##7##4##(1995-5#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
Recent advances in##24##3##(1990-9#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-7#1)
Recent advances##30##2##(1990-9#1)(1995-5#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Recent animal studies##2##3##(2008-8#1)(2009-10#1)
Recent applications of##2##3##(2008-10#2)
Recent applications##3##2##(2008-10#3)
Recent changes in##3##3##(1991-1#1)(2008-11#2)
Recent data suggest that##3##4##(1991-7#1)(1997-1#1)(2011-2#1)
Recent data##7##2##(1991-7#1)(1997-1#1)(2008-11#1)(2011-2#3)(2013-1#1)
Recent developments in the field of##2##6##(2008-10#1)(2010-9#1)
Recent developments in the##4##4##(2008-10#1)(2008-11#1)(2009-7#1)(2010-9#1)
Recent developments in##9##3##(1993-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-7#1)(2010-9#1)(2012-2#1)
Recent developments##12##2##(1993-12#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-7#1)(2010-9#1)(2012-2#1)
Recent evidence has##2##3##(2008-11#1)(2010-11#1)
Recent evidence suggests that##4##4##(2008-11#1)(2008-4#1)(2009-8#1)(2010-5#1)
Recent evidence suggests##5##3##(2008-11#1)(2008-4#1)(2009-8#1)(2010-5#1)(2010-7#1)
Recent evidence##8##2##(2008-11#2)(2008-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)
Recent experimental evidence##3##3##(1993-9#1)(2008-9#1)(2011-2#1)
Recent experiments##2##2##(1997-2#1)(2010-7#1)
Recent findings indicate that##2##4##(2008-1#1)(2012-2#1)
Recent findings##7##2##(2008-1#1)(2008-10#1)(2008-11#2)(2011-2#2)(2012-2#1)
Recent genetic##2##2##(2008-5#1)(2009-6#1)
Recent insights##2##2##(2011-2#1)(2013-1#1)
Recent interest##2##2##(2008-10#1)(2008-8#1)
Recent investigations##2##2##(2008-6#1)(2008-8#1)
Recent landmark trials in cardiology##3##5##(2008-11#3)
Recent methods##2##2##(2008-10#1)(2009-10#1)
Recent models##2##2##(2008-11#1)(2008-9#1)
Recent neuroimaging##2##2##(2008-11#1)(2010-5#1)
Recent progress in##2##3##(2007-12#1)(2008-7#1)
Recent progress##3##2##(2007-12#1)(2008-4#1)(2008-7#1)
Recent reports have##2##3##(1996-2#1)(2008-7#1)
Recent reports of##2##3##(1992-12#1)(2008-10#1)
Recent reports##6##2##(1992-12#1)(1993-6#1)(1996-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
Recent research has##5##3##(2008-10#2)(2008-5#1)(2008-6#1)(2011-9#1)
Recent research on##2##3##(2008-10#1)(2013-1#1)
Recent research##15##2##(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-9#1)(2013-1#2)(2013-8#1)
Recent results##2##2##(1991-6#1)(1997-1#1)
Recent studies conclude that the ankle/arm blood pressure index (AAI) is a useful clinical tool for refining cardiovascular risk classification in the elderly##2##23##(1993-12#2)
Recent studies have demonstrated that##2##5##(1996-2#1)(2010-11#1)
Recent studies have indicated that##2##5##(2008-9#1)(2011-2#1)
Recent studies have indicated##3##4##(2008-9#1)(2011-2#1)(2013-1#1)
Recent studies have reported##2##4##(2008-11#1)(2013-1#1)
Recent studies have revealed that##2##5##(1997-8#1)(2008-11#1)
Recent studies have shown that##6##5##(1996-12#1)(1997-2#1)(1997-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
Recent studies have##23##3##(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#4)(2013-1#3)
Recent studies in our##2##4##(2008-7#1)(2009-6#1)
Recent studies in##3##3##(2008-7#1)(2009-10#1)(2009-6#1)
Recent studies of##2##3##(2008-11#1)(2008-4#1)
Recent studies show##2##3##(2008-11#1)(2009-6#1)
Recent studies suggest that##2##4##(1992-12#1)(2012-12#1)
Recent studies##45##2##(1990-11#1)(1992-12#1)(1993-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#3)(2009-6#2)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)
Recent work has revealed##2##4##(2011-2#1)(2012-2#1)
Recent work has##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
Recent work##6##2##(1997-1#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
Recent years have seen##2##4##(2008-11#1)(2008-9#1)
Recent years have##3##3##(2008-11#1)(2008-9#1)(2009-12#1)
Recent##236##1##(1990-11#2)(1990-3#2)(1990-9#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-12#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#4)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#4)(2007-12#3)(2008-1#1)(2008-10#31)(2008-11#31)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#8)(2008-9#7)(2009-1#2)(2009-10#6)(2009-12#1)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#4)(2010-7#7)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#23)(2011-7#1)(2011-9#1)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
Recently a##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2010-12#1)
Recently developed##4##2##(1991-1#1)(1994-3#1)(2008-4#1)(2008-5#1)
Recently it has been##2##4##(1992-5#1)(2013-8#1)
Recently it##3##2##(1992-5#1)(2009-8#1)(2013-8#1)
Recently recognized##2##2##(2008-11#1)(2011-2#1)
Recently the##3##2##(1993-8#1)(2008-2#1)(2011-2#1)
Recently there has been##2##4##(1992-9#1)(2009-1#1)
Recently we have shown that##2##5##(1994-8#1)(2011-2#1)
Recently we reported##2##3##(2009-9#1)(2011-2#1)
Recently we##4##2##(1994-8#1)(2009-9#1)(2011-2#2)
Recently##130##1##(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#2)(1993-8#2)(1994-1#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2008-1#3)(2008-10#12)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#3)(2009-8#8)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#12)(2011-7#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-8#5)
Receptor activator##2##2##(2008-11#1)(2013-1#1)
Receptor for##2##2##(2008-10#1)(2012-3#1)
Receptor##19##1##(1994-11#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
Receptor-mediated##3##1##(1991-12#1)(1994-5#1)(1994-8#1)
Receptors##5##1##(1990-11#1)(1996-5#1)(2008-4#3)
Recessive##4##1##(2008-10#4)
Reciprocal changes in##2##3##(1994-12#2)
Reciprocal##4##1##(1990-11#1)(1994-12#2)(2008-11#1)
Reciprocally##2##1##(1990-11#1)(2008-5#1)
Reck##2##1##(2011-2#2)
Recklinghausen's disease##2##2##(1992-9#1)(1994-6#1)
Recognition and##2##2##(2008-10#1)(2009-12#1)
Recognition of this##2##3##(1995-5#1)(1996-9#1)
Recognition of##14##2##(1991-5#1)(1992-2#1)(1995-2#2)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-2#1)
Recognition that a##2##3##(1996-9#1)(2008-11#1)
Recognition##23##1##(1991-12#1)(1991-5#1)(1992-2#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-5#2)(1996-8#1)(1996-9#2)(2008-10#5)(2008-11#3)(2008-9#1)(2009-12#1)(2012-2#1)
Recognized##4##1##(1994-12#2)(2008-10#1)(2008-11#1)
Recognizing and##3##2##(1994-2#1)(1995-12#1)(1997-3#1)
Recognizing that##2##2##(2008-8#1)(2012-3#1)
Recognizing the##3##2##(2008-12#1)(2010-6#1)(2011-2#1)
Recognizing##11##1##(1994-2#1)(1995-12#1)(1997-3#1)(2008-12#1)(2008-8#1)(2009-1#1)(2010-6#1)(2011-2#3)(2012-3#1)
Recombinant CHO cell##2##3##(2008-11#2)
Recombinant DNA##2##2##(2008-10#1)(2008-4#1)
Recombinant adenoviruses##2##2##(1995-2#1)(2008-11#1)
Recombinant antibodies##2##2##(2008-10#1)(2013-8#1)
Recombinant baculoviruses##2##2##(1993-6#1)(1993-8#1)
Recombinant cell##2##2##(2008-10#1)(2008-7#1)
Recombinant human topoisomerase II##2##4##(1995-6#2)
Recombinant human##4##2##(1990-10#1)(1995-1#1)(1995-6#2)
Recombinant protein##2##2##(2008-11#2)
Recombinant##51##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#2)(1993-6#2)(1993-8#1)(1994-11#1)(1995-1#1)(1995-2#2)(1995-6#2)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-11#1)(2010-6#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Recombination and##2##2##(2008-10#2)
Recombination between##2##2##(1995-12#1)(2008-8#1)
Recombination in##2##2##(2008-10#1)(2013-8#1)
Recombination##14##1##(1995-12#1)(1996-9#1)(2008-10#6)(2008-12#1)(2008-8#2)(2012-3#1)(2013-8#2)
Recommendation##2##1##(1996-11#1)(2012-12#1)
Recommendations are made for##3##4##(1991-1#1)(1992-12#1)(1992-3#1)
Recommendations are made##4##3##(1991-1#1)(1992-12#1)(1992-3#1)(1995-9#1)
Recommendations are provided##2##3##(2008-12#1)(2009-8#1)
Recommendations are##8##2##(1991-1#1)(1992-12#1)(1992-3#1)(1995-9#1)(2008-11#2)(2008-12#1)(2009-8#1)
Recommendations for the##3##3##(1992-3#1)(2008-11#1)(2008-7#1)
Recommendations for##11##2##(1992-3#1)(1993-3#1)(1995-9#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
Recommendations included##2##2##(2008-11#2)
Recommendations of##2##2##(2008-10#1)(2008-3#1)
Recommendations on##2##2##(2008-12#1)(2009-8#1)
Recommendations were##2##2##(2008-12#1)(2009-5#1)
Recommendations##32##1##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-3#1)(1994-1#1)(1995-9#2)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
Recommended treatment##2##2##(1993-3#1)(2010-11#1)
Recommended##5##1##(1993-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)
Reconciliation Act of##5##3##(1991-1#1)(1991-12#1)(1991-3#1)(1994-1#1)(1994-3#1)
Reconciliation Act##9##2##(1991-1#1)(1991-12#2)(1991-3#1)(1994-1#2)(1994-3#2)(1997-3#1)
Reconciliation##10##1##(1991-1#1)(1991-12#2)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1997-3#1)
Reconciling##3##1##(1995-1#1)(1996-2#1)(2008-9#1)
Reconstitution of a##2##3##(1993-6#1)(1995-3#1)
Reconstitution of##7##2##(1992-3#1)(1993-6#1)(1993-9#1)(1995-3#1)(1995-8#2)(1996-2#1)
Reconstitution##9##1##(1991-5#1)(1992-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-3#1)(1995-8#2)(1996-2#1)
Reconstructed##3##1##(2011-2#1)(2011-7#1)(2013-1#1)
Reconstructing an##2##2##(2008-8#1)(2010-1#1)
Reconstructing the##4##2##(2008-11#1)(2010-5#1)(2012-2#1)(2013-1#1)
Reconstructing##7##1##(2007-12#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
Reconstruction in##2##2##(2012-3#2)
Reconstruction of a##2##3##(2008-9#1)(2011-2#1)
Reconstruction of osteomyelitis defects##2##4##(2010-6#2)
Reconstruction of##12##2##(2008-6#1)(2008-9#1)(2009-8#1)(2010-6#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
Reconstruction##20##1##(2008-6#1)(2008-9#2)(2009-8#1)(2010-6#3)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
Reconstructive##2##1##(1993-11#1)(2008-9#1)
Record##8##1##(1993-1#1)(2008-11#1)(2008-7#2)(2010-8#3)(2013-1#1)
Recordati##2##1##(1996-1#1)(2008-5#1)
Recording##4##1##(1991-2#1)(1997-8#1)(2008-3#1)(2008-8#1)
Records of##3##2##(1991-3#1)(1995-10#1)(2010-8#1)
Records##12##1##(1991-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-10#1)(1996-1#1)(2008-11#2)(2010-8#3)(2012-12#1)
Recovered from##2##2##(2008-10#2)
Recovered##3##1##(2008-10#3)
Recoveries are 99##2##3##(2008-10#2)
Recoveries are##3##2##(1995-12#1)(2008-10#2)
Recoveries for##4##2##(2008-10#4)
Recoveries from spiked##3##3##(2008-10#3)
Recoveries from##8##2##(1993-2#1)(2008-10#7)
Recoveries in the##2##3##(2008-10#2)
Recoveries obtained##2##2##(2008-10#2)
Recoveries of spike additions##2##4##(2008-10#2)
Recoveries of spiked##3##3##(2008-10#3)
Recoveries of##22##2##(2008-10#22)
Recoveries ranged from 99 to 101% and the relative standard deviation is around##2##13##(2008-10#2)
Recoveries ranged from##3##3##(2008-10#3)
Recoveries were 99##2##3##(2008-10#2)
Recoveries were between 92 and##2##5##(2008-10#2)
Recoveries were between##4##3##(2008-10#4)
Recoveries were##14##2##(2008-10#14)
Recoveries within##3##2##(2008-10#3)
Recoveries##68##1##(1993-2#1)(1995-12#1)(2008-10#66)
Recovering##2##1##(1993-1#1)(1997-1#1)
Recovery 1 and 2##3##4##(1994-2#3)
Recovery 1 and##4##3##(1994-2#4)
Recovery 1##5##2##(1994-2#5)
Recovery experiments have also been performed##2##6##(2008-10#2)
Recovery experiments##3##2##(2008-10#3)
Recovery from##3##2##(1996-2#1)(2008-12#1)(2013-1#1)
Recovery in samples spiked with two different##2##7##(2008-10#2)
Recovery in##4##2##(2008-10#3)(2011-1#1)
Recovery of the##6##3##(1996-5#1)(2008-10#3)(2008-11#2)
Recovery of##16##2##(1990-6#1)(1992-9#1)(1996-5#1)(2008-10#11)(2008-11#2)
Recovery studies on natural##2##4##(2008-10#2)
Recovery studies on##3##3##(2008-10#3)
Recovery studies were performed at##2##5##(2008-10#2)
Recovery studies were performed##3##4##(2008-10#3)
Recovery studies##11##2##(2008-10#11)
Recovery values from urine samples##2##5##(2008-10#2)
Recovery values from##3##3##(2008-10#3)
Recovery values##6##2##(2008-10#6)
Recovery##59##1##(1990-6#1)(1992-9#1)(1994-2#6)(1996-2#1)(1996-5#1)(2008-10#41)(2008-11#2)(2008-12#1)(2009-11#1)(2011-1#1)(2013-1#2)(2013-8#1)
Recreational##4##1##(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
Recruiting physicians for rural states##2##5##(1994-1#2)
Recruiting##4##1##(1991-12#1)(1994-1#2)(2011-2#1)
Recruitment and retention##2##3##(1994-3#1)(2008-11#1)
Recruitment and##3##2##(1994-3#1)(1997-2#1)(2008-11#1)
Recruitment of physicians to rural states is complicated by several barriers precipitated by non-metropolitan locations##2##15##(1994-1#2)
Recruitment of##5##2##(1993-3#1)(1994-1#2)(2010-8#1)(2011-2#1)
Recruitment##12##1##(1993-3#1)(1994-1#2)(1994-3#1)(1996-8#1)(1997-2#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
Rectal endometriosis##2##2##(2009-8#2)
Rectal mucosal prolapse was characterized by the protrusion of the mucosa alone in the##2##14##(2013-1#2)
Rectal##6##1##(1990-9#1)(2008-12#1)(2009-8#2)(2013-1#2)
Recurrence##5##1##(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
Recurrent meningitis in children##2##4##(2013-7#2)
Recurrent solitary##2##2##(1990-8#2)
Recurrent##16##1##(1990-8#2)(1991-2#1)(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-7#2)
Recursive partitioning analysis##3##3##(1991-12#3)
Red Cross##3##2##(1992-12#1)(1995-6#1)(2008-10#1)
Red Fortified##2##2##(2008-10#2)
Red LaSoda##3##2##(2008-10#3)
Red S-zirconium(IV)##2##2##(2008-10#2)
Red Winter Wheat##2##3##(2008-10#2)
Red and##3##2##(2008-10#3)
Red flags##2##2##(2008-12#2)
Red onion##2##2##(2008-10#2)
Red##61##1##(1992-12#2)(1993-12#1)(1995-6#1)(2008-10#46)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-9#3)(2012-2#1)
Redefining the##3##2##(1991-12#1)(1993-12#1)(1996-3#1)
Redefining##5##1##(1991-12#1)(1993-12#1)(1996-3#1)(1997-6#1)(2010-12#1)
Redisplacement##2##1##(2011-2#2)
Redox##3##1##(2008-10#3)
Reduce the##2##2##(1997-2#1)(2010-1#1)
Reduce##4##1##(1996-11#1)(1997-2#1)(2008-11#1)(2010-1#1)
Reduced energy intake##2##3##(2008-11#2)
Reduced growth##2##2##(2008-10#1)(2008-8#1)
Reduced inorganic##2##2##(2008-10#2)
Reduced##35##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#1)(1996-11#1)(1996-2#1)(1997-3#1)(2008-10#11)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Reduces##6##1##(2008-10#3)(2010-7#1)(2011-2#1)(2013-1#1)
Reducing the##6##2##(1993-1#1)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#1)
Reducing##19##1##(1992-12#1)(1993-1#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
Reduction in the##2##3##(1994-2#1)(2012-2#1)
Reduction in##13##2##(1994-2#2)(1994-3#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#3)(2013-1#2)
Reduction of mercury(II) by tropical river humic substances (Rio##2##9##(2008-10#2)
Reduction of the##3##3##(1993-8#1)(2008-10#2)
Reduction of##27##2##(1991-1#1)(1991-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-8#1)(2010-11#1)(2013-1#1)
Reduction##45##1##(1991-1#1)(1991-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-3#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#4)
Reductions in##3##2##(2008-10#3)
Reductive Amination##2##2##(1996-5#2)
Reductive##4##1##(1996-5#3)(2008-11#1)
Redundant##2##1##(2008-10#1)(2012-3#1)
Reengineering##4##1##(1994-12#2)(1995-2#1)(1996-1#1)
Reexamination##2##1##(2008-10#1)(2009-1#1)
Reference Materials##4##2##(2008-10#4)
Reference is made to##2##4##(1996-9#1)(2008-4#1)
Reference values for##2##3##(1990-2#1)(2008-10#1)
Reference values##4##2##(1990-2#1)(1994-9#1)(2008-10#2)
Reference##27##1##(1990-2#1)(1994-9#1)(1996-9#2)(2008-10#16)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#2)
Reference)##2##1##(2008-10#1)(2008-11#1)
Referral##5##1##(1990-9#1)(1993-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
Referrals##3##1##(1991-1#1)(1991-11#1)(2008-9#1)
Referred##2##1##(2008-10#1)(2010-9#1)
Refined##2##1##(1993-12#1)(2008-8#1)
Refinement##3##1##(1994-12#1)(1997-7#1)(2008-11#1)
Reflectance##3##1##(2008-10#2)(2008-3#1)
Reflecting on##2##2##(2008-11#2)
Reflecting##4##1##(2008-11#3)(2008-12#1)
Reflection##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)
Reflections of##2##2##(1993-1#1)(2008-8#1)
Reflections on the##2##3##(2008-10#1)(2008-11#1)
Reflections on##4##2##(1994-12#1)(1996-9#1)(2008-10#1)(2008-11#1)
Reflections##6##1##(1993-1#1)(1994-12#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
Reflective practice##3##2##(1997-4#1)(2008-11#2)
Reflective##4##1##(1997-4#1)(2008-11#2)(2012-12#1)
Reform and##2##2##(1993-12#1)(1995-12#1)
Reform##8##1##(1992-1#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-2#3)(2012-2#1)
Refractive index##2##2##(2008-10#1)(2008-2#1)
Refractive lens exchange##2##3##(2011-2#2)
Refractive##5##1##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)
Refractive-Index##2##1##(2008-3#2)
Refractive-index##2##1##(2008-2#1)(2008-3#1)
Refractory##2##1##(1997-7#1)(2012-12#1)
Refusal rates were##2##3##(2008-11#2)
Refusal##3##1##(1991-6#1)(2008-11#2)
RegA##5##1##(2011-1#5)
Regarding the##11##2##(1993-12#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-3#1)(2010-6#1)(2012-3#1)(2013-1#2)
Regarding to##2##2##(2008-12#2)
Regarding##24##1##(1992-3#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#2)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#2)
Regardless of temperature##2##3##(2008-10#2)
Regardless of the##10##3##(1990-5#1)(1990-9#1)(1995-1#1)(2008-4#1)(2008-7#2)(2009-7#1)(2010-11#1)(2012-2#2)
Regardless of##22##2##(1990-5#1)(1990-9#1)(1995-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#2)(2010-11#1)(2012-2#2)
Regenerated host axons##2##3##(2011-2#2)
Regenerated##3##1##(2008-10#1)(2011-2#2)
Regeneration of##6##2##(2008-10#3)(2008-11#1)(2008-8#2)
Regeneration##8##1##(2008-10#3)(2008-11#1)(2008-8#2)(2009-12#1)(2012-2#1)
Regensburg##2##1##(2008-9#2)
Regimen##2##1##(1997-7#1)(2012-3#1)
Regina##2##1##(1990-8#1)(1995-6#1)
Region in##2##2##(2008-10#1)(2011-2#1)
Region of Turkey##2##3##(2008-10#1)(2009-8#1)
Region of##8##2##(2008-10#4)(2008-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
Region##27##1##(1993-12#1)(1996-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
Regional cerebral blood flow##2##4##(1995-5#1)(1996-2#1)
Regional differences in the##2##4##(1994-2#1)(1996-12#1)
Regional differences in##3##3##(1994-2#2)(1996-12#1)
Regional variation##2##2##(1995-8#2)
Regional##35##1##(1991-2#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-3#2)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-9#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-3#2)
Regions in##2##2##(2008-10#2)
Regions of##2##2##(1990-4#1)(1991-9#1)
Regions##11##1##(1990-4#1)(1991-9#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2011-2#1)(2012-3#1)
Regioselective##4##1##(1996-5#2)(2008-4#1)(2008-8#1)
Register##5##1##(1991-11#1)(1994-12#1)(2008-10#2)(2011-2#1)
Registered nurses##2##2##(2008-11#1)(2010-8#1)
Registered##3##1##(2008-11#2)(2010-8#1)
Registrar's##2##1##(1991-2#1)(2012-12#1)
Registration##7##1##(1992-1#1)(1994-8#1)(2008-10#2)(2008-11#2)(2013-8#1)
Registry of##2##2##(1996-11#1)(2011-3#1)
Registry##18##1##(1990-12#1)(1991-11#1)(1991-2#1)(1992-12#1)(1995-2#2)(1995-9#1)(1996-11#1)(1997-3#1)(2008-11#2)(2008-3#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
Regression analyses were##2##3##(2008-10#1)(2009-7#1)
Regression analyses##6##2##(1992-3#1)(2008-10#2)(2009-7#1)(2010-2#1)(2013-1#1)
Regression analysis of Beer's##2##4##(2008-10#2)
Regression analysis of the##2##4##(2008-10#2)
Regression analysis of##4##3##(2008-10#4)
Regression analysis##7##2##(2008-10#4)(2008-8#1)(2009-3#1)(2010-12#1)
Regression and artificial neural network##2##5##(2008-10#2)
Regression equations revealed linear relationships (correlation coefficients##2##7##(2008-10#2)
Regression equations##3##2##(1996-12#1)(2008-10#2)
Regression models##2##2##(2008-10#2)
Regression of##2##2##(1990-12#1)(2008-10#1)
Regression slopes##2##2##(2008-10#2)
Regression##34##1##(1990-12#1)(1990-4#1)(1992-2#1)(1992-3#1)(1996-12#1)(1996-6#1)(2008-10#20)(2008-11#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2013-1#1)
Regular##8##1##(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
Regulate##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
Regulated##5##1##(1994-11#1)(2008-11#3)(2009-10#1)
Regulates##4##1##(2013-1#4)
Regulating##3##1##(2008-11#1)(2008-8#1)(2013-1#1)
Regulation and##2##2##(1991-1#1)(2011-1#1)
Regulation of human##2##3##(1993-6#1)(1995-2#1)
Regulation of rat##2##3##(1994-11#1)(1995-12#1)
Regulation of##29##2##(1991-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1997-1#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)
Regulation##35##1##(1991-1#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1997-1#3)(2008-10#3)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)
Regulations##3##1##(1995-3#1)(2008-11#1)(2010-5#1)
Regulator##2##1##(2012-3#1)(2013-8#1)
Regulatory Agency##2##2##(1991-3#1)(2008-11#1)
Regulatory Networks##2##2##(2010-7#1)(2011-2#1)
Regulatory##12##1##(1991-3#1)(1992-9#1)(1994-1#1)(1997-4#1)(2008-11#3)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
Rehabilitation Act##3##2##(1995-12#3)
Rehabilitation and##2##2##(2007-11#1)(2013-1#1)
Rehabilitation in##2##2##(1991-12#1)(2012-3#1)
Rehabilitation of##3##2##(2008-12#1)(2013-1#2)
Rehabilitation##18##1##(1991-12#1)(1992-3#2)(1995-12#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#4)(2013-8#1)
Rehovot##2##1##(2008-10#1)(2013-8#1)
Reimbursement##3##1##(2008-11#1)(2009-8#1)(2012-2#1)
Reinforcement##3##1##(1996-5#1)(2008-10#1)(2009-7#1)
Reitt##2##1##(2008-12#2)
Relapse##3##1##(1991-1#1)(1994-6#1)(2008-7#1)
Relapsing##2##1##(1990-6#1)(2013-7#1)
Related Pathovars##2##2##(2008-10#2)
Related Species##3##2##(2008-10#2)(2013-8#1)
Related to##4##2##(1996-5#1)(2008-10#3)
Related##26##1##(1993-12#1)(1996-5#2)(1997-2#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
Relatedness##2##1##(2008-8#1)(2009-10#1)
Relating##2##1##(2008-10#1)(2012-3#1)
Relation##9##1##(1994-2#1)(2008-10#7)(2009-10#1)
Relational##3##1##(2008-4#1)(2009-10#1)(2011-2#1)
Relations between##2##2##(2008-10#1)(2008-11#1)
Relations##4##1##(2008-10#2)(2008-11#1)(2010-2#1)
Relationship Between##6##2##(2008-10#5)(2013-8#1)
Relationship between the##4##3##(2008-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
Relationship between##34##2##(1991-11#1)(1993-6#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
Relationship of##7##2##(1992-3#1)(1992-9#1)(2008-10#2)(2008-3#1)(2011-2#2)
Relationship to##4##2##(2008-10#4)
Relationship with a##2##3##(2008-10#1)(2012-3#1)
Relationship with##4##2##(2008-10#3)(2012-3#1)
Relationship##59##1##(1991-11#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
Relationships Between##7##2##(2008-10#7)
Relationships among##5##2##(1995-3#1)(2008-10#2)(2008-4#1)(2011-2#1)
Relationships between the##4##3##(1993-12#1)(2008-10#2)(2008-9#1)
Relationships between##16##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#5)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-5#1)(2013-8#2)
Relationships of##5##2##(2008-10#5)
Relationships with##4##2##(1993-3#1)(2009-4#1)(2010-10#1)(2011-2#1)
Relationships##42##1##(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-3#2)(2008-10#22)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#2)(2011-2#3)(2012-5#1)(2013-1#1)(2013-8#2)
Relative Humidity##5##2##(2008-10#5)
Relative standard deviation (R##3##4##(2008-10#3)
Relative standard deviation was##2##4##(2008-10#2)
Relative standard deviation##8##3##(2008-10#8)
Relative standard deviations of the##2##5##(2008-10#2)
Relative standard deviations of##4##4##(2008-10#4)
Relative standard deviations##8##3##(2008-10#8)
Relative standard##16##2##(2008-10#16)
Relative strength of##2##3##(1991-2#2)
Relative to the##4##3##(1996-12#1)(2008-11#1)(2011-1#1)(2012-12#1)
Relative to##10##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Relative value units (RVUs) were##2##5##(2012-2#1)(2013-1#1)
Relative##66##1##(1991-1#1)(1991-2#4)(1992-11#1)(1993-9#1)(1996-12#2)(1996-3#1)(2008-10#36)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#1)(2008-9#2)(2009-11#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#4)
Relatively high##3##2##(2008-10#3)
Relatively little is known about the##2##6##(2008-10#1)(2012-2#1)
Relatively little is known##3##4##(2008-10#2)(2012-2#1)
Relatively##13##1##(1992-12#1)(1997-6#1)(2008-10#8)(2008-12#1)(2010-9#1)(2012-2#1)
Relatives##3##1##(2008-10#1)(2009-10#1)(2009-8#1)
Relaxin levels in##2##3##(1995-8#2)
Release and##3##2##(2008-10#3)
Release of##9##2##(1992-6#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-5#1)
Release##16##1##(1992-1#1)(1992-6#1)(1995-11#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2009-8#1)
Releasing Hormone##3##2##(2008-4#1)(2009-6#1)(2013-7#1)
Relevance to clinical practice##9##4##(2010-10#9)
Relevance to##10##2##(2008-11#1)(2010-10#9)
Relevance##13##1##(2008-10#1)(2008-11#1)(2010-10#10)(2013-1#1)
Relevant information##2##2##(2008-10#1)(2011-2#1)
Relevant literature is reviewed##2##4##(2008-10#1)(2013-1#1)
Relevant##8##1##(2008-10#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
Reliability and##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
Reliability of##4##2##(2008-10#1)(2008-11#1)(2011-5#1)(2013-1#1)
Reliability##9##1##(2008-10#2)(2008-11#2)(2008-12#1)(2009-12#1)(2011-2#1)(2011-5#1)(2013-1#1)
Reliable and##2##2##(2008-10#1)(2008-11#1)
Reliable##8##1##(1997-8#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-1#1)
Relief of dysphagia is##2##4##(1992-9#1)(1993-6#1)
Religion##4##1##(2008-12#1)(2009-11#2)(2010-8#1)
Religious##6##1##(1993-12#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#2)
Remaining##2##1##(1996-1#1)(2008-3#1)
Remarkably##10##1##(1990-12#1)(1991-2#1)(1992-2#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
Remarks on##2##2##(1990-2#1)(2008-5#1)
Remote Sensing of##2##3##(2008-3#2)
Remote Sensing##5##2##(2008-12#1)(2008-3#4)
Remote detection of##2##3##(2008-10#1)(2008-3#1)
Remote##10##1##(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#5)(2013-1#1)
Removal and recovery of chromium##2##5##(2008-10#2)
Removal and##3##2##(2008-10#2)(2008-5#1)
Removal of the##4##3##(1991-10#1)(1995-6#1)(2008-5#1)(2013-1#1)
Removal of##17##2##(1991-10#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-1#3)
Removal##21##1##(1991-10#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#3)
Removing##4##1##(2008-10#2)(2010-10#1)(2012-3#1)
Renaissance##4##1##(2008-11#2)(2008-4#1)(2011-2#1)
Renal Cell Carcinoma##2##3##(2013-1#2)
Renal Disease##6##2##(1994-3#1)(2008-1#2)(2009-3#1)(2011-2#1)(2013-1#1)
Renal Failure##2##2##(2008-1#1)(2008-12#1)
Renal and##2##2##(1994-5#1)(1994-8#1)
Renal artery stenosis##2##3##(2008-12#2)
Renal cell carcinoma##2##3##(1992-3#1)(2011-2#1)
Renal cell##3##2##(1992-3#1)(2011-2#2)
Renal##33##1##(1990-12#1)(1992-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-1#3)(2008-10#1)(2008-12#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
Renaturation of##2##2##(1990-11#1)(2008-10#1)
Rendu-Osler-Weber syndrome##2##2##(2008-7#2)
Renilla koellikeri##2##2##(2008-7#2)
Reno##3##1##(1995-6#3)
Reno-vascular disease##2##2##(2008-12#2)
Renovascular##2##1##(1994-9#1)(1997-2#1)
Reoperative##2##1##(2013-8#2)
Reorganization of the##2##3##(2008-10#1)(2009-8#1)
Rep and##2##2##(2008-10#1)(2008-9#1)
Rep gene##3##2##(2008-10#3)
Rep protein##4##2##(2008-10#4)
Rep proteins##2##2##(2008-10#2)
Rep##18##1##(1995-12#2)(1995-6#1)(1996-5#2)(2008-10#11)(2008-9#1)(2012-2#1)
Rep-PCR##2##1##(2008-10#2)
RepK##8##1##(1997-6#8)
Repair of the##2##3##(2013-1#2)
Repair of##5##2##(1994-1#1)(2008-9#1)(2012-3#1)(2013-1#2)
Repair##11##1##(1994-1#1)(2008-11#1)(2008-7#1)(2008-9#2)(2012-3#3)(2013-1#3)
Repeat##16##1##(1990-6#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
Repeatability and##4##2##(2008-10#4)
Repeatability was evaluated from 10 consecutive determinations being the results better than##2##12##(2008-10#2)
Repeatability was##5##2##(2008-10#5)
Repeatability##12##1##(2008-10#12)
Repeated application of##3##3##(2008-11#1)(2009-8#1)(2012-2#1)
Repeated injections of##2##3##(1996-12#1)(2013-8#1)
Repeated measurements##2##2##(1997-8#1)(2008-5#1)
Repeated measures##3##2##(1992-9#1)(2008-12#1)(2010-1#1)
Repeated##29##1##(1991-2#1)(1992-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#2)
Reperfusion##2##1##(2012-3#2)
Repetitive Applications of the Biocontrol##2##5##(2008-10#2)
Repetitive DNA Sequences##2##3##(2008-10#2)
Repetitive determination of##2##3##(2008-10#2)
Repetitive strain injuries##2##3##(1994-3#2)
Repetitive strain##3##2##(1990-2#1)(1994-3#2)
Repetitive transcranial magnetic stimulation##2##4##(2010-5#1)(2010-7#1)
Repetitive##27##1##(1990-2#1)(1994-3#2)(1994-6#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Replacement of the##3##3##(1993-1#1)(1994-5#1)(2012-2#1)
Replacement of##9##2##(1990-9#1)(1993-1#1)(1994-3#2)(1994-5#1)(1997-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
Replacement##13##1##(1990-9#1)(1993-1#1)(1994-3#2)(1994-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#2)
Replica##5##1##(1992-12#3)(2008-11#1)(2008-12#1)
Replicate##2##1##(2008-10#2)
Replicating##2##1##(2008-11#2)
Replication of##5##2##(1997-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
Replication##13##1##(1994-5#1)(1997-6#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#2)(2012-3#1)
Replicative##2##1##(2008-10#1)(2008-5#1)
Reply to##2##2##(2008-11#1)(2010-2#1)
Reply##5##1##(1996-9#2)(2008-11#1)(2010-2#2)
Report and##5##2##(2008-10#1)(2011-2#3)(2013-1#1)
Report from Nurse Education Tomorrow##2##5##(2008-11#2)
Report from the##2##3##(1995-2#1)(2011-2#1)
Report from##5##2##(1995-12#1)(1995-2#1)(2008-11#2)(2011-2#1)
Report of Two##2##3##(2011-2#1)(2013-1#1)
Report of a case##3##4##(1993-2#1)(2008-5#1)(2009-8#1)
Report of a##6##3##(1993-2#1)(1994-2#1)(1996-6#1)(2008-5#1)(2009-8#1)(2013-1#1)
Report of one case]##6##4##(2013-1#2)(2013-8#4)
Report of the##3##3##(1993-2#1)(2008-11#1)(2008-4#1)
Report of two cases##2##4##(1992-12#1)(2009-8#1)
Report of two##3##3##(1992-12#1)(2009-8#1)(2013-1#1)
Report of##31##2##(1992-12#1)(1993-2#2)(1994-2#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#2)(2010-9#1)(2011-2#3)(2013-1#6)(2013-8#5)
Report on the##5##3##(1994-3#1)(2008-11#3)(2008-12#1)
Report on##8##2##(1991-1#1)(1994-3#1)(2008-11#4)(2008-12#1)(2008-8#1)
Report to Congress##4##3##(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)
Report to##5##2##(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-11#1)
Report##90##1##(1991-1#1)(1991-9#1)(1992-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(2007-8#1)(2008-10#5)(2008-11#12)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#13)(2011-7#1)(2012-2#2)(2012-3#2)(2013-1#14)(2013-8#5)
Reported are##2##2##(1991-10#1)(1991-2#1)
Reported##10##1##(1991-10#1)(1991-2#1)(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
Reporter gene##2##2##(2011-2#1)(2012-2#1)
Reporter##3##1##(2008-4#1)(2011-2#1)(2012-2#1)
Reporters of gene expression##2##4##(2008-9#2)
Reporting of##4##2##(1991-3#1)(1997-3#1)(2008-12#2)
Reporting##9##1##(1991-12#1)(1991-3#1)(1992-2#2)(1997-3#1)(2008-11#1)(2008-12#2)(2013-7#1)
Reports in the##2##3##(1995-12#1)(2008-5#1)
Reports of##4##2##(1991-2#1)(2008-11#1)(2013-1#1)(2013-8#1)
Reports##13##1##(1991-1#1)(1991-2#1)(1991-3#1)(1993-5#1)(1995-12#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
Repository of##2##2##(2010-7#2)
Repository##4##1##(2008-10#1)(2010-7#2)(2012-3#1)
Representation##2##1##(1992-11#1)(1996-9#1)
Representations##2##1##(2012-2#2)
Representative strains##2##2##(2008-10#1)(2011-2#1)
Representative##10##1##(1995-6#1)(1996-5#3)(1997-3#1)(2008-10#3)(2011-2#1)(2013-1#1)
Representatives of##3##2##(1996-1#1)(2008-6#1)(2011-2#1)
Representatives##7##1##(1995-6#1)(1996-1#1)(1996-5#3)(2008-6#1)(2011-2#1)
Represses##2##1##(2008-10#1)(2013-1#1)
Repression##2##1##(1995-8#1)(2008-10#1)
Reproducibilities##2##1##(2008-10#2)
Reproducibility and stability##2##3##(2008-10#2)
Reproducibility ranged from##2##3##(2008-10#2)
Reproducibility##8##1##(2008-10#8)
Reproducible##5##1##(1995-12#1)(2008-10#2)(2008-7#1)(2010-3#1)
Reproduction by##2##2##(2008-10#2)
Reproduction of##3##2##(2008-10#3)
Reproduction##7##1##(1990-11#1)(2008-10#6)
Reproductive outcome after ovarian surgery##2##5##(1992-3#2)
Reproductive outcome after##3##3##(1992-3#2)(1993-1#1)
Reproductive##18##1##(1992-2#1)(1992-3#2)(1993-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-8#1)(2011-2#2)
Republic and##3##2##(1994-12#2)(2008-10#1)
Republic of Croatia##3##3##(2008-10#1)(2011-2#2)
Republic of South Africa##2##4##(1997-7#1)(2010-11#1)
Republic of##18##2##(1991-12#1)(1991-2#1)(1992-1#2)(1995-1#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2010-11#1)(2010-12#1)(2011-2#4)
Republic##44##1##(1991-12#1)(1991-2#1)(1992-1#2)(1994-12#3)(1995-1#2)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-5#3)(2010-11#1)(2010-12#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
Republicans##3##1##(1995-6#2)(1997-2#1)
Required for##3##2##(2012-3#2)(2013-1#1)
Requirement for##3##2##(1992-9#1)(2011-2#1)(2012-3#1)
Requirement of##3##2##(2008-8#1)(2010-7#1)(2011-2#1)
Requirement##6##1##(1992-9#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-3#1)
Requirements for##2##2##(2008-10#1)(2008-3#1)
Requirements##4##1##(2008-10#2)(2008-11#1)(2008-3#1)
Res##14##1##(1991-12#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-8#3)(1995-12#1)(1995-8#1)(1997-6#1)(2008-11#1)(2011-2#1)(2012-2#1)
Research Center##6##2##(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-7#1)(2012-3#1)
Research Centre for##2##3##(2008-10#1)(2013-1#1)
Research Conference##2##2##(2008-11#1)(2010-12#1)
Research Council##5##2##(1990-6#1)(1993-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
Research Database##2##2##(2008-11#2)
Research Foundation##4##2##(1992-12#1)(2009-3#1)(2012-2#1)(2013-8#1)
Research Group##2##2##(2008-11#1)(2012-3#1)
Research Institute of##2##3##(2008-3#1)(2011-2#1)
Research Institute##6##2##(1992-2#1)(2008-10#1)(2008-3#1)(2009-4#2)(2011-2#1)
Research Participation##2##2##(2009-4#2)
Research Program##2##2##(1992-12#1)(2010-10#1)
Research Station##2##2##(2011-1#1)(2011-2#1)
Research Triangle Park##2##3##(1997-1#1)(2008-10#1)
Research Unit##2##2##(1996-8#1)(2008-11#1)
Research and##14##2##(1994-12#1)(1994-3#1)(1997-5#1)(2008-11#3)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#3)
Research by##2##2##(2008-5#2)
Research has shown that##2##4##(1995-1#1)(2008-6#1)
Research has##3##2##(1995-1#1)(2008-6#1)(2009-8#1)
Research in##3##2##(2010-10#1)(2012-2#2)
Research indicates that##2##3##(2009-5#1)(2010-1#1)
Research into##3##2##(1997-8#1)(2008-12#1)(2008-4#1)
Research on the mechanisms##2##4##(2008-10#1)(2010-1#1)
Research on the##4##3##(1990-2#1)(2008-10#1)(2010-1#1)(2012-3#1)
Research on##16##2##(1990-2#1)(1992-12#1)(1993-1#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
Research reports##2##2##(1990-3#1)(2008-7#1)
Research shows that##2##3##(2010-12#2)
Research to increase knowledge about what constitutes measurement and change##2##10##(2013-1#2)
Research to##6##2##(2008-10#1)(2009-4#1)(2010-4#2)(2013-1#2)
Research was conducted##2##3##(2008-10#1)(2013-1#1)
Research was##3##2##(1990-2#1)(2008-10#1)(2013-1#1)
Research##171##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-5#2)(1997-6#1)(1997-8#2)(2008-10#19)(2008-11#16)(2008-12#7)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#2)(2009-3#3)(2009-4#9)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#7)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#7)(2012-2#11)(2012-3#4)(2013-1#14)(2013-8#1)
Researcher##2##1##(1994-9#1)(2009-4#1)
Researchers have##2##2##(2008-11#1)(2012-2#1)
Researchers##7##1##(1992-11#1)(1992-3#1)(2008-11#2)(2008-6#1)(2012-12#1)(2012-2#1)
Resection of##7##2##(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
Resection was##2##2##(1990-12#1)(1991-8#1)
Resection##12##1##(1990-12#1)(1991-8#1)(2008-10#1)(2008-12#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
Reserpine##2##1##(1995-2#1)(2008-12#1)
Reserve##3##1##(2011-2#1)(2012-3#1)(2013-8#1)
Reservoirs##2##1##(1992-9#1)(2008-10#1)
Residency##2##1##(1992-1#1)(1993-12#1)
Resident participation in the Better Beginnings##2##6##(1995-3#2)
Resident participation##3##2##(1995-3#3)
Resident##6##1##(1993-2#1)(1994-2#1)(1995-3#3)(2011-2#1)
Residents##3##1##(2008-11#1)(2008-12#1)(2008-4#1)
Residual##11##1##(1992-3#1)(1992-9#1)(1993-2#1)(1995-9#1)(1997-5#1)(2008-10#3)(2008-11#1)(2010-10#1)(2012-2#1)
Residue##4##1##(2008-10#3)(2008-11#1)
Residues of##5##2##(2008-10#2)(2008-11#3)
Residues##7##1##(2008-10#3)(2008-11#3)(2009-8#1)
Resilon##2##1##(2013-1#2)
Resin##3##1##(2008-10#2)(2013-1#1)
Resistance Gene to##3##3##(2008-10#3)
Resistance Gene##9##2##(2008-10#9)
Resistance Genes##3##2##(2008-10#3)
Resistance Induced by##2##3##(2008-10#2)
Resistance Locus##3##2##(2008-10#2)(2012-3#1)
Resistance Training##2##2##(2010-1#2)
Resistance and##5##2##(2008-10#5)
Resistance by##3##2##(2008-10#3)
Resistance in Barley##2##3##(2008-10#2)
Resistance in Sugar##2##3##(2008-10#1)(2012-3#1)
Resistance in Transgenic##2##3##(2008-10#2)
Resistance in an##2##3##(2008-10#2)
Resistance in##34##2##(1996-9#1)(2008-10#29)(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
Resistance of##12##2##(1997-5#1)(2008-10#8)(2008-8#1)(2009-7#1)(2013-8#1)
Resistance to Aflatoxin##2##3##(2008-10#2)
Resistance to Bean##2##3##(2008-10#2)
Resistance to Botrytis cinerea##2##4##(2008-10#2)
Resistance to Cronartium ribicola in##2##5##(2008-10#2)
Resistance to Cronartium ribicola##3##4##(2008-10#3)
Resistance to Melampsora larici-populina Leaf Rust in Hybrid Poplars##2##9##(2008-10#2)
Resistance to Melampsora##3##3##(2008-10#3)
Resistance to Mycosphaerella graminicola##2##4##(2008-10#2)
Resistance to Puccinia##3##3##(2008-10#3)
Resistance to Sclerotinia##2##3##(2008-10#2)
Resistance to Sclerotium rolfsii in##2##5##(2008-10#2)
Resistance to Striga hermonthica in##2##5##(2008-10#2)
Resistance to Xanthomonas campestris pv##2##5##(2008-10#2)
Resistance to race##2##3##(2008-10#2)
Resistance to races 1 and##2##5##(2008-10#2)
Resistance to the##5##3##(2008-10#5)
Resistance to##96##2##(1991-10#1)(1997-3#1)(2008-10#90)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
Resistance was determined##2##3##(2008-10#1)(2013-8#1)
Resistance was##12##2##(2008-10#11)(2013-8#1)
Resistance##218##1##(1991-10#1)(1992-7#1)(1996-9#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#192)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-1#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
Resistance)##2##1##(2008-11#2)
Resistance-Breaking##2##1##(2008-10#2)
Resistant and Susceptible##4##3##(2008-10#4)
Resistant and##6##2##(2008-10#6)
Resistant to##3##2##(2008-10#3)
Resistant##23##1##(1995-2#1)(2008-10#18)(2010-8#1)(2012-3#2)(2013-1#1)
Resolution enhancement in a##2##4##(2007-12#1)(2008-2#1)
Resolution of##6##2##(2008-10#3)(2008-11#1)(2008-9#1)(2009-2#1)
Resolution##16##1##(1991-12#1)(1991-3#1)(1993-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)
Resolving##6##1##(1990-6#1)(1991-12#1)(1996-12#1)(2008-10#2)(2008-9#1)
Resonance Rayleigh scattering##2##3##(2008-10#2)
Resonance light scattering##2##3##(2008-10#2)
Resonance##19##1##(1991-2#1)(1992-3#1)(1996-9#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
Resonances##3##1##(1993-8#1)(1996-9#1)(2008-3#1)
Resonant##7##1##(1990-12#1)(1993-5#1)(1996-9#3)(2008-11#1)(2008-3#1)
Resonator##2##1##(2008-3#2)
Resource Center##2##2##(1991-12#2)
Resource Utilization Groups##4##3##(1993-12#1)(1993-2#1)(1994-12#1)(2008-7#1)
Resource Utilization##5##2##(1993-12#1)(1993-2#1)(1994-12#2)(2008-7#1)
Resource utilization groups##2##3##(1991-2#1)(1993-12#1)
Resource##23##1##(1991-12#3)(1991-2#2)(1991-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(2008-11#3)(2008-7#1)(2008-8#2)(2012-3#1)
Resources of Nuclear##2##3##(2012-2#2)
Resources##8##1##(1994-1#1)(1995-6#1)(2008-11#2)(2008-8#1)(2010-7#1)(2012-2#2)
Respect##2##1##(2008-12#1)(2010-12#1)
Respiration of##2##2##(2008-5#1)(2008-7#1)
Respiration##4##1##(1993-3#1)(2008-5#1)(2008-7#2)
Respiratory rate##2##2##(1993-1#2)
Respiratory resistance##2##2##(2008-1#2)
Respiratory##22##1##(1993-1#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#8)
Respirgard II##5##2##(1993-2#5)
Respite##3##1##(1991-3#1)(1992-2#1)(1993-2#1)
Respondents##4##1##(2008-9#1)(2009-10#1)(2009-4#1)(2013-8#1)
Responding to##2##2##(1996-2#1)(2010-8#1)
Response Surface Methodology##2##3##(2008-10#2)
Response in##6##2##(2008-10#2)(2008-11#2)(2012-12#1)(2012-2#1)
Response of##13##2##(1991-8#1)(2008-10#8)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
Response surface##3##2##(2008-10#3)
Response times##3##2##(2008-10#2)(2009-12#1)
Response to##30##2##(1992-6#1)(1993-9#1)(1997-3#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#2)
Response##97##1##(1991-8#1)(1992-6#1)(1993-9#1)(1995-3#1)(1995-6#1)(1996-5#3)(1997-3#1)(1997-8#1)(2008-10#36)(2008-11#4)(2008-12#1)(2008-6#13)(2008-7#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#5)(2012-7#1)(2012-8#1)(2013-1#2)
Responses from##2##2##(2007-12#1)(2008-10#1)
Responses in##3##2##(1993-6#1)(2008-10#1)(2010-8#1)
Responses of##2##2##(2008-10#1)(2012-5#1)
Responses to##8##2##(1990-8#1)(2008-10#4)(2008-8#2)(2013-1#1)
Responses were##2##2##(2008-1#1)(2008-10#1)
Responses##25##1##(1990-8#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-5#1)(2013-1#1)
Responsibility for##2##2##(1996-8#1)(1997-5#1)
Responsibility##6##1##(1993-12#1)(1994-3#1)(1996-8#1)(1997-5#1)(2008-12#2)
Responsible for##3##2##(2008-10#2)(2012-3#1)
Responsive##5##1##(2008-10#1)(2008-11#1)(2008-12#2)(2010-6#1)
Restenosis##2##1##(1992-9#1)(2008-7#1)
Restin##5##1##(2008-9#5)
Resting##4##1##(2008-10#2)(2008-9#1)(2012-2#1)
Restoration of##10##2##(1991-5#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#3)(2013-1#1)
Restoration##12##1##(1991-5#1)(1995-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#3)(2012-2#1)(2013-1#1)
Restorative##2##1##(2011-2#2)
Restores##2##1##(2008-10#2)
Restoring##3##1##(1996-6#1)(2008-4#1)(2012-2#1)
Restraint##2##1##(2011-2#2)
Restricted##4##1##(1990-3#1)(2008-10#3)
Restriction Enzyme-Mediated Integration##2##3##(2008-10#2)
Restriction Fragment Length Polymorphism##3##4##(2008-10#3)
Restriction Fragment Length Polymorphisms##2##4##(2008-10#2)
Restriction Fragment Length##5##3##(2008-10#5)
Restriction enzyme##2##2##(2008-10#2)
Restriction fragment length polymorphism (RFLP) analysis of##3##7##(1995-12#1)(2008-10#2)
Restriction fragment length polymorphism (RFLP)##6##5##(1995-12#1)(2008-10#5)
Restriction fragment length polymorphism##9##4##(1995-12#1)(2008-10#8)
Restriction fragment length polymorphisms (RFLPs) and##2##6##(2008-10#2)
Restriction fragment length polymorphisms (RFLPs) were used to##2##8##(2008-10#2)
Restriction fragment length polymorphisms (RFLPs)##4##5##(2008-10#4)
Restriction fragment length polymorphisms##5##4##(2008-10#5)
Restriction fragment length##15##3##(1995-12#1)(2008-10#13)(2008-12#1)
Restriction fragment##16##2##(1995-12#1)(2008-10#14)(2008-12#1)
Restriction mapping of the##2##4##(1990-8#1)(2008-10#1)
Restriction mapping##3##2##(1990-8#1)(2008-10#2)
Restriction##34##1##(1990-8#1)(1992-6#1)(1995-12#1)(1997-4#1)(2008-10#29)(2008-12#1)
Restructured##2##1##(1995-2#1)(2008-11#1)
Restructuring critical care services##2##4##(1996-3#1)(1997-2#1)
Restructuring in a unionized environment##2##5##(1996-3#2)
Restructuring##7##1##(1993-12#1)(1995-1#1)(1996-3#3)(1997-2#1)(2008-11#1)
Result of##2##2##(2012-2#1)(2012-3#1)
Result##9##1##(1993-3#1)(2006-6#1)(2008-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Resulting##6##1##(1993-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
Results -##5##2##(2008-11#5)
Results A##2##2##(2011-2#2)
Results From a##2##3##(2013-1#1)(2013-8#1)
Results In the##2##3##(2009-8#1)(2011-2#1)
Results Most##2##2##(2011-2#2)
Results No##2##2##(2011-2#2)
Results The##9##2##(2011-2#4)(2012-12#5)
Results agreed with##2##3##(2008-10#2)
Results also suggested that##2##4##(1995-2#1)(2008-11#1)
Results also##7##2##(1995-2#1)(1996-1#1)(2008-11#2)(2008-12#2)(2008-9#1)
Results and##6##2##(1990-9#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2013-1#1)
Results are compared with##2##4##(2008-10#1)(2008-11#1)
Results are discussed in terms of##2##6##(2008-12#1)(2008-6#1)
Results are discussed in##4##4##(2008-10#1)(2008-12#1)(2008-6#1)(2011-1#1)
Results are discussed##5##3##(1994-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-1#1)
Results are in##2##3##(2008-10#1)(2009-11#1)
Results are precise (R##2##4##(2008-10#2)
Results are precise##3##3##(2008-10#3)
Results are presented##2##3##(2008-11#1)(2008-12#1)
Results are reported##3##3##(1997-3#1)(2008-10#1)(2008-2#1)
Results are##24##2##(1994-12#1)(1994-5#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-11#1)(2011-1#1)
Results based on##2##3##(2008-10#2)
Results demonstrate that the##2##4##(2008-10#1)(2010-8#1)
Results demonstrate the##2##3##(1991-12#1)(2008-10#1)
Results demonstrate##5##2##(1991-12#1)(2008-10#3)(2010-8#1)
Results demonstrated that##4##3##(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
Results demonstrated##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#1)(2013-1#2)
Results for##7##2##(1996-11#1)(2008-10#5)(2008-8#1)
Results from a##5##3##(1993-2#1)(1996-2#1)(1997-2#1)(2008-11#1)(2010-12#1)
Results from earlier experiments in our laboratories revealed that both selective and##2##12##(2008-10#2)
Results from in situ hybridization##2##5##(1996-12#1)(2008-4#1)
Results from the medical outcomes study##2##6##(1992-4#2)
Results from the##9##3##(1992-4#2)(1993-12#1)(2008-10#5)(2012-2#1)
Results from this study suggest that##2##6##(2008-10#2)
Results from this study##4##4##(2008-10#3)(2010-1#1)
Results from##48##2##(1990-5#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
Results further##2##2##(2010-12#1)(2013-8#1)
Results have shown that##2##4##(2008-10#1)(2008-11#1)
Results have##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2009-10#1)
Results in##3##2##(1992-6#1)(2008-10#2)
Results indicate a##2##3##(2008-12#1)(2009-7#1)
Results indicate that both##2##4##(2008-10#1)(2012-2#1)
Results indicate that the##9##4##(2008-10#4)(2008-11#1)(2009-10#1)(2009-7#2)(2012-2#1)
Results indicate that##30##3##(1993-3#2)(1996-2#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-7#2)(2010-7#1)(2012-2#3)(2012-5#1)(2013-1#2)
Results indicate the##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
Results indicate##40##2##(1993-3#2)(1996-12#1)(1996-2#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-4#1)(2008-8#1)(2009-10#2)(2009-7#4)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-5#1)(2013-1#2)
Results indicated that both##2##4##(2008-11#1)(2013-1#1)
Results indicated that the##11##4##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-2#1)
Results indicated that##33##3##(1991-2#1)(1995-8#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-5#2)(2008-9#3)(2009-11#1)(2009-7#4)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Results indicated##38##2##(1991-2#1)(1991-3#1)(1995-8#1)(2008-10#11)(2008-11#4)(2008-12#4)(2008-5#2)(2008-9#3)(2009-11#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Results may be useful to##2##5##(2008-12#1)(2008-9#1)
Results may##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2010-7#1)
Results obtained by both##3##4##(2008-10#3)
Results obtained by this method##3##5##(1990-2#1)(2008-10#2)
Results obtained by this##4##4##(1990-2#1)(2008-10#3)
Results obtained by##13##3##(1990-2#1)(2008-10#11)(2008-4#1)
Results obtained for##4##3##(2008-10#4)
Results obtained from Plackett-Burman designs suggest that##2##7##(2008-10#2)
Results obtained from##5##3##(2008-10#5)
Results obtained in##2##3##(2008-10#1)(2008-3#1)
Results obtained indicate that the##2##5##(2008-10#2)
Results obtained using##3##3##(2006-6#1)(2008-10#2)
Results obtained##37##2##(1990-2#1)(1995-6#1)(2006-6#1)(2008-10#30)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
Results of a multidisciplinary international expert panel-EPACT II##2##8##(2010-12#2)
Results of a multidisciplinary international expert##3##6##(2010-12#3)
Results of a multidisciplinary##4##4##(2010-12#4)
Results of a##17##3##(1990-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-10#1)(2010-12#4)(2010-5#1)(2013-8#1)
Results of an##3##3##(1990-9#1)(1994-3#1)(2008-6#1)
Results of in##2##3##(1995-2#1)(1996-12#1)
Results of our study##2##4##(2008-11#1)(2011-2#1)
Results of the present study##3##5##(1994-3#1)(2008-10#1)(2010-5#1)
Results of the present##4##4##(1994-3#1)(2008-10#1)(2010-5#1)(2013-8#1)
Results of the study##2##4##(1992-2#1)(2011-2#1)
Results of the##24##3##(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#1)(2010-1#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-8#2)
Results of these##2##3##(2008-10#1)(2008-4#1)
Results of this study suggest that##4##6##(2008-10#2)(2009-5#1)(2011-1#1)
Results of this study##10##4##(1990-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2009-5#1)(2011-1#1)(2013-1#1)
Results of this##12##3##(1990-6#1)(1997-8#1)(2008-10#5)(2008-11#2)(2009-5#1)(2011-1#1)(2013-1#1)
Results of##97##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-6#1)(1997-8#1)(2007-12#2)(2008-10#23)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-5#1)(2010-1#2)(2010-12#5)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#6)(2013-1#1)(2013-8#4)
Results on the##2##3##(2008-11#1)(2009-9#1)
Results on##4##2##(2008-10#1)(2008-11#1)(2009-9#1)(2010-10#1)
Results provide##2##2##(1993-12#1)(2013-8#1)
Results provided##2##2##(1993-1#1)(1995-2#1)
Results revealed that##2##3##(2010-9#1)(2012-3#1)
Results revealed##4##2##(2008-12#1)(2009-7#1)(2010-9#1)(2012-3#1)
Results show a##2##3##(2008-10#1)(2010-12#1)
Results show how##2##3##(2008-11#1)(2008-3#1)
Results show that the##11##4##(1990-5#1)(1995-12#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2013-8#2)
Results show that##36##3##(1990-5#1)(1993-12#1)(1995-12#1)(1995-9#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#2)(2013-8#2)
Results show the##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
Results show##48##2##(1990-5#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-9#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
Results showed a##3##3##(2009-12#1)(2009-4#1)(2013-1#1)
Results showed that a##2##4##(2010-10#1)(2012-2#1)
Results showed that the##12##4##(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2010-7#1)(2012-8#1)
Results showed that there was##2##5##(2008-12#1)(2008-8#1)
Results showed that##51##3##(1992-6#1)(1993-2#1)(1994-2#1)(1996-2#1)(2008-10#15)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#2)
Results showed the##2##3##(1994-1#1)(2013-8#1)
Results showed##66##2##(1992-6#1)(1993-2#1)(1994-1#1)(1994-2#1)(1996-2#1)(1997-1#1)(2006-6#1)(2008-10#17)(2008-11#4)(2008-12#5)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#2)(2012-2#2)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#4)(2013-8#1)
Results suggest that a##2##4##(1992-12#1)(2013-1#1)
Results suggest that the##6##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
Results suggest that##27##3##(1992-12#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-9#4)(2009-7#1)(2011-1#1)(2012-2#2)(2013-1#4)
Results suggest##32##2##(1991-12#1)(1992-12#1)(1993-1#1)(1996-12#1)(1997-2#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#4)(2009-7#1)(2011-1#1)(2012-2#2)(2013-1#4)
Results suggested that##2##3##(1991-12#1)(2010-7#1)
Results support##4##2##(1994-3#1)(2008-10#1)(2008-6#1)(2010-7#1)
Results were compared to##2##4##(2008-10#2)
Results were compared with##5##4##(1997-8#1)(2008-10#2)(2010-12#1)(2010-8#1)
Results were compared##8##3##(1997-8#1)(2008-10#5)(2010-12#1)(2010-8#1)
Results were in agreement with those obtained##2##7##(2008-10#2)
Results were in agreement with##3##5##(2008-10#3)
Results were in##4##3##(2008-10#4)
Results were similar in##2##4##(2008-10#1)(2012-12#1)
Results were##21##2##(1990-3#1)(1995-11#1)(1997-8#1)(2008-10#12)(2008-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Results with##6##2##(1990-11#1)(1990-8#1)(2008-10#4)
Results##822##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-9#1)(1993-1#3)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-8#2)(2006-6#2)(2007-11#4)(2007-12#2)(2007-8#5)(2008-1#2)(2008-10#196)(2008-11#46)(2008-12#26)(2008-2#5)(2008-3#18)(2008-4#7)(2008-5#11)(2008-6#4)(2008-7#4)(2008-8#10)(2008-9#18)(2009-10#6)(2009-11#2)(2009-12#2)(2009-4#4)(2009-5#1)(2009-7#11)(2009-8#6)(2009-9#3)(2010-1#6)(2010-10#12)(2010-12#11)(2010-4#1)(2010-5#3)(2010-7#6)(2010-8#8)(2010-9#2)(2011-1#19)(2011-2#53)(2011-3#2)(2012-12#45)(2012-2#16)(2012-3#28)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#97)(2013-8#25)
Results- The##2##2##(2008-11#2)
Results-##4##1##(2008-11#4)
Results-The##3##1##(2008-11#3)
Results ##5##1##(2011-2#4)(2013-1#1)
Resuscitation##3##1##(1990-3#1)(2008-11#2)
Resveratrol##6##1##(2008-10#2)(2008-5#1)(2012-4#3)
Retained##3##1##(1991-3#1)(2008-12#2)
Retention of##2##2##(2008-10#2)
Retention##6##1##(1994-8#1)(2008-10#4)(2009-9#1)
Rethinking##4##1##(1995-12#2)(1996-1#1)(1997-1#1)
Reticulated##3##1##(2006-6#1)(2008-10#1)(2008-9#1)
Reticulocyte counts were##2##3##(2008-9#2)
Retina##2##1##(2010-1#1)(2013-1#1)
Retinal vascular imaging##2##3##(2009-10#2)
Retinal vascular##3##2##(2009-10#2)(2009-7#1)
Retinal##9##1##(2008-5#1)(2009-10#2)(2009-12#1)(2009-7#1)(2009-9#1)(2011-9#1)(2013-1#1)(2013-8#1)
Retinoic acid##3##2##(1993-12#1)(1994-11#2)
Retinoids##2##1##(1994-6#1)(2009-6#1)
Retinol-binding protein and asialo-orosomucoid##2##4##(1995-6#2)
Retinol-binding protein##3##2##(1995-6#3)
Retirement##2##1##(1991-5#1)(2008-4#1)
Retrieval of##3##2##(2008-2#1)(2008-3#2)
Retrieval##7##1##(1991-2#1)(1993-1#1)(2008-2#1)(2008-3#4)
Retrograde##2##1##(1991-12#1)(2013-1#1)
Retroperitoneal##5##1##(1994-6#1)(2008-10#1)(2009-9#1)(2012-3#1)(2013-1#1)
Retroperitoneoscopically assisted##2##2##(2008-10#2)
Retrospective analysis##2##2##(1994-12#1)(2012-3#1)
Retrospective review of##2##3##(2011-1#1)(2012-2#1)
Retrospective study##2##2##(2008-9#1)(2012-12#1)
Retrospective##13##1##(1993-6#1)(1994-12#1)(1995-1#1)(2008-9#2)(2010-1#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
Retroviral##2##1##(2008-11#2)
Retrovirus##2##1##(1997-1#1)(2009-10#1)
Rett's syndrome##4##2##(1995-2#4)
Return to##3##2##(2010-1#1)(2012-12#1)(2012-3#1)
Return##4##1##(2008-12#1)(2010-1#1)(2012-12#1)(2012-3#1)
Retzius##3##1##(1997-3#3)
Reunion##2##1##(2008-10#2)
Rev M11 delta 14##2##4##(1993-8#2)
Rev proteins##2##2##(1993-2#1)(1993-8#1)
Rev responsive element##2##3##(1993-8#2)
Rev##24##1##(1992-7#1)(1993-12#2)(1993-2#2)(1993-8#15)(1995-2#2)(2007-12#1)(2011-3#1)
Rev-mediated RNA nuclear export##3##4##(2011-3#3)
Rev/Rex##2##1##(1993-8#2)
Revascularization##2##1##(2008-12#1)(2012-3#1)
Reveal a##2##2##(2008-10#1)(2012-3#1)
Reveal##3##1##(2008-10#1)(2012-3#2)
Revealed by##4##2##(2008-10#3)(2012-3#1)
Revealed##5##1##(1994-9#1)(2008-10#3)(2012-3#1)
Reveals Its##2##2##(2008-10#1)(2008-6#1)
Reveals##6##1##(2008-10#5)(2008-6#1)
Reversal of##4##2##(2008-10#1)(2010-2#1)(2012-2#1)(2013-7#1)
Reversal##5##1##(2008-10#1)(2008-6#1)(2010-2#1)(2012-2#1)(2013-7#1)
Reverse Transcriptase##3##2##(2008-10#2)(2009-9#1)
Reverse Transcription-Polymerase Chain Reaction##3##4##(2008-10#3)
Reverse flow injection spectrophotometric determination of##2##6##(2008-10#2)
Reverse transcriptase##2##2##(2008-11#1)(2012-2#1)
Reverse transcription-polymerase chain reaction##2##4##(1994-11#1)(2008-10#1)
Reverse transcription-polymerase chain##4##3##(1994-11#1)(2008-10#2)(2008-9#1)
Reverse transcription-polymerase##5##2##(1994-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
Reverse##27##1##(1993-8#1)(1994-11#1)(1995-6#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-8#1)(2012-2#1)
Reverse-transcriptase polymerase chain reaction##2##4##(2008-10#2)
Reverse-transcription##2##1##(2008-10#2)
Reversed phase liquid chromatography##3##4##(2008-10#3)
Reversed phase##5##2##(2008-10#5)
Reversed##7##1##(2008-10#7)
Reversed-phase HPLC##2##2##(1992-12#1)(2008-10#1)
Reversed-phase high-performance liquid chromatography##2##4##(2008-4#1)(2009-8#1)
Reversed-phase liquid chromatographic determination of##2##5##(2008-10#2)
Reversed-phase liquid chromatographic##3##3##(2008-10#3)
Reversed-phase##9##1##(1992-12#1)(2008-10#4)(2008-4#2)(2009-8#1)(2010-11#1)
Reversibility##2##1##(1994-11#1)(1994-5#1)
Reversible##6##1##(1993-6#1)(2006-6#1)(2008-12#1)(2008-4#1)(2009-9#1)(2013-1#1)
Reversing##2##1##(1992-5#1)(2012-2#1)
Revertant##2##1##(1995-5#1)(2008-11#1)
Review article##3##2##(2009-8#3)
Review focuses on##2##3##(1996-2#1)(2011-2#1)
Review of data from##2##4##(2012-12#1)(2012-2#1)
Review of the Literature##4##4##(1997-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
Review of the literature##5##4##(1993-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(2008-8#1)
Review of the##14##3##(1991-12#1)(1993-3#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
Review of##34##2##(1991-12#1)(1991-2#1)(1993-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-6#2)(2008-10#2)(2008-8#2)(2009-7#1)(2010-12#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)
Review##69##1##(1991-12#1)(1991-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#4)(1997-6#2)(1997-8#1)(2008-10#3)(2008-8#4)(2009-4#2)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#12)(2011-4#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#6)(2013-8#1)
Reviews##6##1##(1993-12#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
Revised Trauma Score##2##3##(2009-4#1)(2011-2#1)
Revised##9##1##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
Revision##4##1##(2012-12#1)(2012-2#1)(2013-1#2)
Revisions to the care plan terminology were completed as part of an evidence-based project by nurses at one facility##2##19##(2013-1#2)
Revisions to the##3##3##(1991-2#1)(2013-1#2)
Revisiting the##2##2##(2008-3#1)(2012-2#1)
Revisiting##3##1##(2008-3#1)(2012-2#2)
Reward Circuitry##2##2##(2012-12#2)
Reward##3##1##(2012-12#3)
Rex##2##1##(1993-8#1)(1995-2#1)
Reye's##5##1##(1991-12#5)
Reynolds number##3##2##(1993-5#1)(2008-10#1)(2013-1#1)
Rf values of 0##2##4##(1993-8#2)
Rf##4##1##(1993-8#2)(2008-10#1)(2012-2#1)
Rg1##5##1##(1995-8#3)(2008-11#1)(2010-12#1)
RgMADS1##3##1##(2008-8#3)
Rh and Ru##3##3##(2008-10#3)
Rh and##4##2##(2008-10#4)
Rh##17##1##(1996-3#3)(2008-10#13)(2008-11#1)
Rh(III) and Os(IV)##2##3##(2008-10#2)
Rh(III) and##4##2##(2008-10#4)
Rh(III) complex##2##2##(2008-10#2)
Rh(III)##10##1##(2008-10#10)
Rh)##2##1##(2008-11#2)
RhD##2##1##(2008-10#1)(2010-11#1)
RhS##2##1##(2008-10#2)
Rhabdomyolysis##4##1##(1994-12#2)(2013-1#1)(2013-8#1)
Rhap residues##2##2##(1990-9#2)
Rheological characterization##2##2##(2008-5#1)(2011-2#1)
Rheological##7##1##(1994-8#1)(1997-6#1)(2008-5#2)(2011-2#2)(2011-3#1)
Rheumatic fever##2##2##(1996-12#1)(2011-2#1)
Rheumatoid Arthritis##3##2##(1993-1#1)(2010-12#1)(2013-1#1)
Rheumatoid arthritis (RA)##2##3##(2012-2#1)(2012-3#1)
Rheumatoid arthritis##7##2##(1991-8#1)(2012-2#1)(2012-3#5)
Rheumatoid##11##1##(1991-8#1)(1993-1#1)(2010-12#2)(2012-2#1)(2012-3#5)(2013-1#1)
Rhexocercosporidium spp##2##2##(2008-10#2)
Rhexocercosporidium##5##1##(2008-10#5)
Rhino biology##2##2##(1991-5#2)
Rhino##4##1##(1991-5#4)
Rhinolith##2##1##(2013-1#2)
Rhipicephalus (Boophilus) microplus##3##3##(2010-10#3)
Rhipicephalus (Boophilus)##4##2##(2010-10#3)(2013-1#1)
Rhizobium etli G12##2##3##(2008-10#2)
Rhizobium leguminosarum bv trifolii is##2##5##(2011-2#2)
Rhizobium leguminosarum bv trifolii##3##4##(2011-2#3)
Rhizobium leguminosarum bv##4##3##(2011-2#4)
Rhizobium leguminosarum##5##2##(2008-8#1)(2011-2#4)
Rhizobium##9##1##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#4)
Rhizoctonia blight##3##2##(2008-10#3)
Rhizoctonia damping-off##4##2##(2008-10#4)
Rhizoctonia root rot of apple##2##5##(2008-10#2)
Rhizoctonia solani Anastomosis Group##4##4##(2008-10#4)
Rhizoctonia solani Anastomosis##5##3##(2008-10#5)
Rhizoctonia solani anastomosis group 5##2##5##(2008-10#2)
Rhizoctonia solani anastomosis group##6##4##(2008-10#6)
Rhizoctonia solani and##3##3##(2008-10#3)
Rhizoctonia solani by##2##3##(2008-10#2)
Rhizoctonia solani in##2##3##(2008-10#2)
Rhizoctonia solani on##2##3##(2008-10#2)
Rhizoctonia solani or##2##3##(2008-10#2)
Rhizoctonia solani were##2##3##(2008-10#2)
Rhizoctonia solani##49##2##(2008-10#49)
Rhizoctonia spp##15##2##(2008-10#15)
Rhizoctonia##87##1##(2008-10#87)
Rhizopus head rot##4##3##(2008-10#4)
Rhizopus oryzae##4##2##(2008-10#3)(2012-2#1)
Rhizopus##11##1##(2008-10#7)(2008-5#2)(2008-7#1)(2012-2#1)
Rhizosphere Colonization##2##2##(2008-10#2)
Rhizosphere priming##4##2##(2013-8#4)
Rhizosphere##15##1##(2008-10#11)(2013-8#4)
Rho GTPases##2##2##(2011-2#1)(2013-8#1)
Rho##6##1##(1997-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
Rhodamine 6G and##4##3##(2008-10#3)(2008-3#1)
Rhodamine 6G in##2##3##(2008-3#2)
Rhodamine 6G##10##2##(2007-11#1)(2008-10#4)(2008-3#5)
Rhodamine B (RB)##4##3##(2008-10#4)
Rhodamine B##6##2##(2008-10#5)(2008-12#1)
Rhodamine##17##1##(2007-11#1)(2008-10#10)(2008-12#1)(2008-3#5)
Rhodeus ocellatus ocellatus##2##3##(2008-5#2)
Rhodium##3##1##(2008-10#3)
Rhodobacter sphaeroides##5##2##(1995-2#1)(2008-8#2)(2008-9#2)
Rhodococcus##2##1##(2008-10#1)(2008-8#1)
Rhododendron and##2##2##(2008-10#2)
Rhododendron##4##1##(2008-10#4)
Rhodophyta)##2##1##(2008-11#2)
Rhodopseudomonas viridis##3##2##(1993-8#3)
Rhodotorula glutinis##4##2##(2008-10#4)
Rhodotorula species##2##2##(2009-11#2)
Rhodotorula##8##1##(2008-10#4)(2009-11#4)
Rhone-Poulenc Rorer##2##2##(1996-5#1)(2008-5#1)
Rhopalosiphum maidis##3##2##(2008-10#3)
Rhopalosiphum padi##4##2##(2008-10#4)
Rhopalosiphum##7##1##(2008-10#7)
Rhus##2##1##(2008-10#2)
Rhy##3##1##(2011-3#3)
Rhynchosporium secalis isolates##2##3##(2008-10#2)
Rhynchosporium secalis##14##2##(2008-10#14)
Rhythm##3##1##(2008-5#1)(2008-6#1)(2010-9#1)
Rhythmic##2##1##(2010-9#2)
Ribes spp##2##2##(2008-10#2)
Ribes##4##1##(2008-10#2)(2012-2#1)(2012-4#1)
Riboflavin##5##1##(2008-10#4)(2008-9#1)
Ribonucleic acid##2##2##(2008-10#2)
Ribosomal DNA##3##2##(2008-10#3)
Ribosomal##9##1##(1992-8#1)(1995-9#1)(2008-10#5)(2008-11#2)
Rice Blast Fungus##2##3##(2008-10#2)
Rice Blast##5##2##(2008-10#5)
Rice GT Database##2##3##(2009-10#2)
Rice Sheath##2##2##(2008-10#2)
Rice blast##2##2##(2008-10#1)(2012-2#1)
Rice dwarf virus (RDV) is##2##5##(2008-10#1)(2008-8#1)
Rice dwarf virus##3##3##(2008-10#2)(2008-8#1)
Rice plants##2##2##(2008-10#2)
Rice##42##1##(2008-10#27)(2008-12#1)(2008-8#3)(2008-9#3)(2009-10#3)(2012-2#1)(2013-1#1)(2013-8#3)
Rich##2##1##(1997-8#1)(2010-3#1)
Richard III##2##2##(2009-3#2)
Richard Savage##2##2##(1996-8#2)
Richard##11##1##(1990-8#1)(1994-2#1)(1995-12#1)(1996-5#1)(1996-8#2)(2008-10#1)(2008-5#1)(2009-3#2)(2009-8#1)
Richards##6##1##(1997-3#1)(2008-10#5)
Richardson##3##1##(1995-8#1)(2008-12#1)(2013-8#1)
Richmond##2##1##(1990-8#1)(2010-7#1)
Ricinus communis##4##2##(1993-11#1)(2008-11#1)(2013-1#1)(2013-8#1)
Ricinus##5##1##(1993-11#1)(2008-11#1)(2009-10#1)(2013-1#1)(2013-8#1)
Rickettsia##2##1##(1995-12#1)(2010-1#1)
Rideout##2##1##(1995-12#2)
Ridge##6##1##(1995-3#1)(1997-6#1)(2008-10#3)(2013-8#1)
Ridomil 2E##2##2##(2008-10#2)
Ridomil##4##1##(2008-10#4)
Riedel's thyroiditis##4##2##(2008-12#4)
Riemannian##2##1##(2009-10#2)
Riesling and##2##2##(2008-10#2)
Riesling##4##1##(2008-10#4)
Rifamycin B production##2##3##(1994-8#2)
Rift Valley##2##2##(1994-9#2)
Right atrial myxoma##2##3##(2008-11#1)(2012-12#1)
Right atrial myxomas##2##3##(2012-12#2)
Right atrial##4##2##(2008-11#1)(2012-12#3)
Right##13##1##(1992-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-10#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
Right-sided##2##1##(1993-9#1)(2010-5#1)
Rights Act##3##2##(1994-1#1)(2008-11#2)
Rights and##2##2##(1993-9#1)(2012-3#1)
Rights##9##1##(1993-9#1)(1994-1#1)(1995-12#1)(1995-6#2)(1996-5#1)(2008-11#2)(2012-3#1)
Rigidity##2##1##(1990-12#1)(2008-10#1)
Rijeka##5##1##(2011-2#5)
Rijswijk##2##1##(1996-8#2)
Riley##2##1##(2008-11#1)(2008-8#1)
Rinderpest##2##1##(1990-3#2)
Ring##5##1##(1994-5#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-3#1)
Ringer##4##1##(1995-11#1)(2008-10#1)(2008-12#2)
Ringer's lactate instillation##3##3##(1995-12#3)
Ringer's lactate##5##2##(1995-12#5)
Ringer's solution##4##2##(1992-1#1)(1997-1#1)(2008-10#1)(2008-5#1)
Ringer's##9##1##(1992-1#1)(1995-12#5)(1997-1#1)(2008-10#1)(2008-5#1)
Ringspot##2##1##(2008-10#2)
Rio Grande Valley##5##3##(2008-10#5)
Rio Grande##6##2##(2008-10#5)(2008-5#1)
Rio Negro##3##2##(2008-10#3)
Rio de Janeiro##5##3##(2008-10#1)(2011-2#1)(2012-3#3)
Rio##18##1##(2008-10#12)(2008-5#1)(2011-2#1)(2012-3#4)
Rioja##2##1##(2008-10#2)
Ripley's K-function##2##2##(2008-10#1)(2008-9#1)
Ripley's##3##1##(2008-10#2)(2008-9#1)
Rise##3##1##(2008-2#1)(2012-2#2)
Rising##5##1##(1994-12#1)(1997-2#1)(1997-6#1)(2008-11#1)(2009-5#1)
Risk Analysis##2##2##(2008-10#2)
Risk Factor##3##2##(1992-9#1)(2009-5#1)(2011-2#1)
Risk Factors for##4##3##(2008-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
Risk Factors##6##2##(2008-10#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
Risk Management##2##2##(2012-2#1)(2013-1#1)
Risk adjustment##2##2##(1994-3#1)(1995-2#1)
Risk and##2##2##(1990-8#1)(2010-5#1)
Risk assessment models for##2##4##(2008-10#2)
Risk assessment##3##2##(2008-10#2)(2008-11#1)
Risk factors associated with##2##4##(2011-2#1)(2013-1#1)
Risk factors for##7##3##(1992-12#1)(2008-7#1)(2010-5#1)(2010-9#1)(2013-1#3)
Risk factors##11##2##(1992-12#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#5)
Risk in##3##2##(2008-11#1)(2009-4#1)(2013-8#1)
Risk management and##3##3##(1991-3#1)(1992-2#1)(1996-2#1)
Risk management##4##2##(1991-3#1)(1992-2#1)(1995-12#1)(1996-2#1)
Risk of colorectal cancer following rectosigmoid adenomas##2##7##(1993-12#2)
Risk of##15##2##(1992-7#1)(1993-11#1)(1993-12#2)(1996-8#1)(2008-10#3)(2008-11#1)(2009-6#1)(2012-3#1)(2013-1#2)(2013-8#2)
Risk##83##1##(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-2#1)(1996-8#1)(2008-10#10)(2008-11#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-5#2)(2010-9#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#14)(2013-8#7)
Risks##2##1##(2010-5#1)(2011-2#1)
Rissa##2##1##(1991-6#1)(2008-8#1)
Rita##2##1##(2010-8#1)(2012-3#1)
Rite-Aid##2##1##(1995-6#2)
Ritz-Carlton##5##1##(1994-2#2)(1994-3#3)
River Delta##4##2##(2008-10#3)(2008-11#1)
River Sediment##2##2##(2008-10#2)
River Valley##2##2##(2008-10#1)(2008-9#1)
River and##3##2##(2008-10#2)(2008-9#1)
River at##2##2##(1992-5#1)(2008-10#1)
River in##2##2##(2008-10#1)(2011-2#1)
River water##2##2##(2008-10#2)
River##37##1##(1992-5#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-9#4)(2010-8#7)(2011-2#1)
Rivulus##2##1##(2008-8#2)
Riyadh and##2##2##(2013-1#2)
Riyadh##5##1##(2008-1#1)(2013-1#4)
Rizaben##3##1##(2008-5#3)
Rlm3##2##1##(2008-10#2)
Rlm7##2##1##(2008-10#2)
Rlm9##2##1##(2008-10#2)
RnMYRV-3##3##1##(2008-10#3)
Rna1p##5##1##(1995-2#5)
Ro 20-1724##3##2##(1994-6#3)
Ro##4##1##(1994-2#1)(1994-6#3)
Ro-1539##2##1##(2008-11#2)
Ro15-4513##2##1##(1995-11#2)
Road##2##1##(2008-10#1)(2009-10#1)
Robert Henie (1850-1919)##2##3##(1991-6#2)
Robert K##2##2##(1995-6#1)(1996-5#1)
Robert M##2##2##(1993-3#2)
Robert Oppenheimer##2##2##(2008-12#2)
Robert Wood Johnson Foundation's (RWJF's)##2##5##(2013-1#2)
Robert Wood Johnson Foundation's##3##4##(1996-12#1)(2013-1#2)
Robert Wood Johnson##4##3##(1993-2#1)(1996-12#1)(2013-1#2)
Robert##31##1##(1991-6#2)(1991-8#1)(1993-2#2)(1993-3#2)(1995-12#3)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-9#1)(2013-1#2)
Robertson's Mutator line##2##3##(2012-3#2)
Robertson's Mutator##3##2##(2012-3#3)
Robin##2##1##(2008-12#1)(2010-10#1)
Robinson##9##1##(1995-6#1)(1996-5#4)(2008-10#4)
Robles##2##1##(2010-1#2)
Robo1 expression##2##2##(2011-2#2)
Robo1 in##2##2##(2011-2#2)
Robo1##10##1##(2011-2#10)
Robot##2##1##(1992-11#1)(2009-12#1)
Robotic##5##1##(2008-10#2)(2008-11#2)(2010-7#1)
Robotics##2##1##(2008-10#1)(2009-10#1)
Robust design##2##2##(1993-3#2)
Robust##10##1##(1993-3#2)(2008-10#3)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
Robustness##3##1##(2008-10#1)(2008-11#1)(2012-2#1)
Rocc##3##1##(2008-1#3)
Roche expects##2##2##(2008-5#2)
Roche##14##1##(1990-2#1)(1990-8#1)(2008-5#12)
Rochester##8##1##(1992-12#2)(1995-12#1)(1996-2#5)
Rockville##2##1##(1993-1#1)(2008-5#1)
Rockwool##3##1##(2008-10#3)
Rocky Mountains##2##2##(2008-10#2)
Rodriguez##3##1##(1993-9#3)
Roger##2##1##(2008-10#1)(2008-9#1)
Rogers##2##1##(1993-12#1)(2008-11#1)
Roland##2##1##(2010-1#1)(2012-12#1)
Role Play##2##2##(2009-11#2)
Role for##2##2##(2008-10#1)(2011-2#1)
Role in Decision-Making##2##3##(2009-3#1)(2013-1#1)
Role in the##2##3##(1991-11#1)(2008-10#1)
Role in##6##2##(1991-11#1)(2008-10#3)(2009-3#1)(2013-1#1)
Role of calcium##2##3##(2008-8#1)(2010-5#1)
Role of iron##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
Role of the visual input in recovery of function following unilateral vestibular lesion in the goldfish##2##16##(1991-2#2)
Role of the##13##3##(1991-2#2)(1992-12#1)(1993-3#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-1#2)
Role of##83##2##(1990-6#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-6#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-3#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#8)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)
Role##95##1##(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-6#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-3#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#3)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#9)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)
Roles of##4##2##(2008-10#1)(2010-1#1)(2011-2#1)(2013-1#1)
Roles##6##1##(1997-2#1)(2008-10#2)(2010-1#1)(2011-2#1)(2013-1#1)
Rollback analysis##2##2##(2012-3#2)
Romagna##3##1##(1994-12#1)(2012-7#2)
Roman age##5##2##(2008-10#5)
Roman wall paintings##2##3##(2008-10#2)
Roman wall##3##2##(2008-10#3)
Roman##22##1##(1994-2#4)(2008-10#16)(2010-1#2)
Romania##9##1##(1991-6#1)(2008-1#1)(2008-10#6)(2013-8#1)
Romanian##10##1##(1990-5#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)
Rome III criteria##2##3##(2013-1#2)
Rome##13##1##(1990-8#4)(1992-9#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-7#1)(2013-1#4)
Ronald##2##1##(1991-3#1)(1993-3#1)
Room temperature phosphorescence##2##3##(2008-10#2)
Room temperature##3##2##(2008-10#2)(2008-12#1)
Room##6##1##(1994-8#1)(2008-10#2)(2008-12#1)(2012-3#1)(2013-1#1)
Room-temperature phosphorescence##2##2##(2008-10#2)
Room-temperature##4##1##(1991-5#1)(2007-12#1)(2008-10#2)
Root Infection##2##2##(2008-10#2)
Root Rot##6##2##(2008-10#6)
Root and Stem##2##3##(2008-10#2)
Root and##8##2##(2008-10#7)(2008-12#1)
Root colonization##2##2##(2008-10#2)
Root length density##2##3##(2008-10#2)
Root mucilage is##2##3##(2009-8#2)
Root mucilage##3##2##(2009-8#3)
Root of##2##2##(2008-10#2)
Root##48##1##(1994-12#1)(2008-10#35)(2008-12#1)(2008-9#1)(2009-8#3)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Root-Knot Nematode##4##2##(2008-10#4)
Root-Knot Nematodes##2##2##(2008-10#2)
Root-Knot##8##1##(2008-10#8)
Roots by##3##2##(2008-10#3)
Roots in##2##2##(2008-10#2)
Roots of##5##2##(2008-10#4)(2008-12#1)
Roots##14##1##(2008-10#13)(2008-12#1)
Rootstock##2##1##(2008-10#2)
Roper-Logan-Tierney##2##1##(2008-11#2)
Ropivacaine##2##1##(2012-3#2)
Rosa DeLauro (D-CT)##2##3##(1995-6#1)(1996-5#1)
Rosai-Dorfman disease##3##2##(2012-12#3)
Rosascos##4##1##(1996-5#4)
Rose Bengal##2##2##(2008-5#1)(2011-2#1)
Rosellinia necatrix##6##2##(2008-10#6)
Ross##2##1##(2008-10#1)(2010-1#1)
Rot Caused by##3##3##(2008-10#3)
Rot Fungus##2##2##(2008-10#2)
Rot Pathogen##2##2##(2008-10#2)
Rot in##2##2##(2008-10#2)
Rot of##5##2##(2008-10#5)
Rot##24##1##(2008-10#24)
Rotary##2##1##(2008-8#1)(2010-8#1)
Rotating##3##1##(2008-10#3)
Rotational##2##1##(2008-3#1)(2013-1#1)
Roth##2##1##(2012-2#1)(2013-8#1)
Rotorod Sampler##2##2##(2008-5#2)
Rotorod##4##1##(2008-5#4)
Rotylenchulus reniformis##2##2##(2008-10#2)
Rough##4##1##(1995-2#1)(2008-10#3)
Roughly##2##1##(2008-10#1)(2008-7#1)
Round##4##1##(1990-8#1)(1993-1#1)(2009-5#1)(2010-7#1)
Roundtable##4##1##(2008-11#1)(2013-1#3)
Rous sarcoma virus long terminal repeat##2##6##(1995-6#2)
Rous sarcoma virus##4##3##(1995-6#2)(1997-8#1)(2008-11#1)
Route to##5##2##(1996-5#5)
Route##6##1##(1996-5#5)(2010-6#1)
Routine visual verification of gloves by trained personnel turns out to be a very reliable technique##2##16##(2012-2#2)
Routine##9##1##(1991-11#1)(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#2)
Routinely##2##1##(2008-10#1)(2010-11#1)
Routines##2##1##(2010-9#1)(2011-2#1)
Roux's##2##1##(1991-6#2)
Roux-en-Y gastric bypass##2##3##(2010-8#2)
Roux-en-Y##3##1##(2010-8#3)
Rowe##2##1##(1994-12#2)
Royal Australian College of Medical Administrators##2##6##(1992-1#2)
Royal College of##7##3##(1990-3#1)(1994-12#2)(1996-8#2)(2011-2#1)(2012-12#1)
Royal Prince Alfred Hospital##2##4##(2008-7#2)
Royal##12##1##(1990-3#1)(1992-1#2)(1994-12#2)(1996-8#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#1)
Rp-cAMPS##4##1##(1993-6#4)
RpII LS##4##2##(1997-7#4)
Rpc1 and##4##2##(2008-10#4)
Rpc1##11##1##(2008-10#11)
Rph12##4##1##(2008-10#4)
Rph3##6##1##(2008-10#6)
Rph5 and##2##2##(2008-10#2)
Rph5##3##1##(2008-10#3)
Rph6##5##1##(2008-10#5)
Rph7##3##1##(2008-10#3)
Rph9 and Rph12##2##3##(2008-10#2)
Rph9 and##3##2##(2008-10#3)
Rph9##7##1##(2008-10#7)
RpoN##4##1##(1993-12#4)
Rps2 and##2##2##(2008-10#2)
Rps2 in L76-1988##3##3##(2008-10#3)
Rps2##6##1##(2008-10#6)
Rpt1##2##1##(2008-10#2)
Rr##2##1##(2008-10#2)
Rs=1##2##1##(2008-10#2)
RsGshT##3##1##(1995-2#3)
Rsa I##3##2##(2008-8#3)
RsaI##7##1##(1995-12#1)(2008-10#6)
RsbR##2##1##(2009-8#2)
Rsp genes on##2##3##(2008-10#2)
Rsp genes##6##2##(2008-10#6)
Rsp##8##1##(2008-10#8)
Rsp1##4##1##(2008-10#4)
Rsp2 and Rsp3##2##3##(2008-10#2)
Rsp2 at a##2##3##(2008-10#2)
Rsp2 in the Foster/CIho 4780##2##5##(2008-10#2)
Rsp2 in##4##2##(2008-10#4)
Rsp2##12##1##(2008-10#12)
Rsp3 in##2##2##(2008-10#2)
Rsp3##9##1##(2008-10#9)
Rsv1##2##1##(2008-10#2)
Rsv3##2##1##(2008-10#2)
Rsv4##3##1##(2008-10#3)
Rtx-500##2##1##(2008-10#2)
Ru (III)##4##2##(2008-10#4)
Ru##19##1##(2008-10#19)
Ru(II)##3##1##(2008-10#3)
Ru(III)##11##1##(2008-10#11)
Ru(bpy)(3)(2+) at the##2##3##(2008-10#2)
Ru(bpy)(3)(2+) modified electrode##2##3##(2008-10#2)
Ru(bpy)(3)(2+)##24##1##(2008-10#24)
Ru(bpy)(3)(3+)##3##1##(2008-10#3)
Ru-Rh##2##1##(2008-10#2)
Ru-bipy##3##1##(2008-12#3)
Rubisco##3##1##(2008-8#2)(2012-6#1)
Ruby and##2##2##(1994-1#1)(2008-4#1)
Rudá##2##1##(2008-10#2)
Rufous-breasted Hermit##4##2##(2008-9#4)
Ruggie (1990##2##2##(1995-3#2)
Rule##5##1##(2008-11#3)(2009-4#2)
Rules of##3##2##(2008-10#2)(2008-8#1)
Rumex##2##1##(2008-10#1)(2013-1#1)
Rumination##2##1##(2009-11#1)(2010-10#1)
Runaway##2##1##(2008-9#2)
Running##4##1##(1992-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
Rupture of the##4##3##(1991-8#1)(1997-3#1)(2009-9#1)(2013-1#1)
Rupture of##6##2##(1991-8#1)(1997-3#1)(2008-7#1)(2009-9#1)(2010-7#1)(2013-1#1)
Rupture##9##1##(1991-8#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-7#1)(2012-3#2)(2013-1#1)
Ruptured Cerebral Aneurysms##2##3##(1995-11#1)(1997-3#1)
Ruptured##8##1##(1995-10#1)(1995-11#1)(1997-3#2)(2008-8#2)(2013-1#1)(2013-8#1)
Rural and##2##2##(1991-12#1)(1994-2#1)
Rural health##2##2##(1991-1#1)(1993-12#1)
Rural##17##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#2)(1994-2#3)(1995-2#1)(1996-3#3)(2008-12#2)(2009-12#1)(2009-3#1)(2010-9#1)
Russell##2##1##(1995-6#1)(2013-1#1)
Russia and the##2##3##(1997-1#2)
Russia and##4##2##(1997-1#3)(2010-12#1)
Russia##28##1##(1994-12#2)(1997-1#11)(1997-6#4)(2008-11#1)(2008-12#4)(2010-12#5)(2011-2#1)
Russian health##2##2##(1997-1#2)
Russian wheat aphid##4##3##(2008-10#1)(2008-9#3)
Russian##19##1##(1992-2#1)(1995-3#1)(1997-1#3)(1997-6#3)(2008-10#1)(2008-12#2)(2008-9#3)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
Rust Fungi##2##2##(2008-10#2)
Rust Fungus Puccinia##2##3##(2008-10#2)
Rust Resistance in##3##3##(2008-10#3)
Rust Resistance##4##2##(2008-10#4)
Rust in##3##2##(2008-10#3)
Rust on##2##2##(2008-10#2)
Rust ratings were##2##3##(2008-10#2)
Rust##26##1##(2008-10#26)
Rusted##2##1##(2008-10#2)
Ruthenium##3##1##(2008-10#2)(2010-7#1)
Rutilus##2##1##(2008-10#1)(2010-8#1)
Rwanda##3##1##(1993-3#1)(1994-9#2)
Rx1##3##1##(2008-10#3)
Rx2##2##1##(2008-10#2)
Rx3##4##1##(2008-10#4)
RxNorm##5##1##(2010-8#5)
Ryan White##4##2##(1995-12#1)(1995-6#2)(1996-5#1)
Ryan##8##1##(1994-1#3)(1995-12#1)(1995-6#2)(1996-5#1)(2008-10#1)
Rye##2##1##(2008-10#2)
Rz##2##1##(2008-11#2)
Rz1 cultivars##2##2##(2008-10#2)
Rz1##3##1##(2008-10#3)
S (CAS)##3##2##(2008-10#2)(2013-1#1)
S = 1##2##3##(2012-12#2)
S = 2##2##3##(1994-3#1)(2012-12#1)
S =##6##2##(1994-3#2)(1997-2#1)(2012-12#3)
S RNA was determined to be##2##6##(2008-10#2)
S RNA##8##2##(2008-10#8)
S RNAs##3##2##(2008-10#3)
S and J'##3##3##(2008-8#3)
S and g##2##3##(2008-2#2)
S and##21##2##(1991-5#1)(1993-8#3)(1994-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-8#4)(2013-8#1)
S aureus##3##2##(1996-8#1)(2006-5#1)(2008-11#1)
S by##2##2##(2008-10#2)
S cell cycle##2##3##(2008-11#1)(2011-2#1)
S enteritidis was##2##3##(1995-9#2)
S enteritidis##6##2##(1995-9#6)
S from##3##2##(1990-2#1)(1991-9#1)(2008-10#1)
S gene##2##2##(1997-3#1)(2008-8#1)
S genes##2##2##(1997-3#2)
S genotype##2##2##(2008-10#2)
S in the presence of##2##5##(2008-10#2)
S in the##3##3##(2008-10#3)
S in##6##2##(1993-8#1)(2008-10#5)
S incidence##2##2##(2008-10#2)
S or##2##2##(2008-11#1)(2008-8#1)
S phase and##3##3##(1993-8#1)(2008-11#2)
S phase cells##2##3##(2008-11#2)
S phase##14##2##(1992-10#2)(1993-8#3)(1994-5#1)(2008-11#6)(2008-8#1)(2008-9#1)
S protein##2##2##(2008-10#1)(2008-8#1)
S region##2##2##(1997-8#1)(2008-12#1)
S strain incidence at##2##4##(2008-10#2)
S strain incidence##8##3##(2008-10#8)
S strain isolates##8##3##(2008-10#8)
S strain##21##2##(2008-10#21)
S system##2##2##(1994-9#1)(2008-10#1)
S was##4##2##(1993-8#1)(1995-8#1)(1996-3#1)(2008-10#1)
S##1230##1##(1990-10#2)(1990-11#2)(1990-2#5)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#4)(1991-6#3)(1991-9#3)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#3)(1992-8#5)(1992-9#4)(1993-1#4)(1993-12#5)(1993-2#9)(1993-3#3)(1993-8#19)(1993-9#1)(1994-1#6)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#6)(1995-8#5)(1995-9#6)(1996-1#4)(1996-12#7)(1996-2#11)(1996-3#17)(1996-5#6)(1996-6#14)(1996-8#4)(1997-1#7)(1997-2#6)(1997-3#7)(1997-6#5)(1997-7#7)(1997-8#6)(2006-5#1)(2006-6#2)(2007-12#1)(2008-1#2)(2008-10#690)(2008-11#35)(2008-12#16)(2008-2#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#20)(2008-9#18)(2009-3#2)(2009-5#1)(2009-6#7)(2009-7#9)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#5)(2010-4#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#20)(2011-3#1)(2011-9#1)(2012-12#7)(2012-2#19)(2012-3#25)(2012-7#1)(2013-1#15)(2013-8#19)
S(0)/X(0)##3##1##(2008-7#3)
S(2)O(3)(2-) in##2##2##(2008-10#2)
S(2)O(3)(2-)##4##1##(2008-10#4)
S(2-)##7##1##(2008-10#7)
S(IV) induced##2##2##(2008-10#2)
S(IV)##4##1##(2008-10#4)
S(T)R(V)##4##1##(2008-10#4)
S(T)S(V) isolates clustered together##2##4##(2008-10#2)
S(T)S(V) parent isolates##3##3##(2008-10#3)
S(T)S(V)##9##1##(2008-10#9)
S(f)##2##1##(2008-11#2)
S) among##2##2##(2008-10#2)
S) and##2##2##(1990-5#1)(1993-8#1)
S)##18##1##(1990-5#1)(1991-5#1)(1993-8#3)(1994-3#1)(1995-8#1)(1996-3#1)(1997-1#1)(2008-10#8)(2009-3#1)
S)2 +##2##2##(2008-8#2)
S-1##8##1##(1991-5#7)(1992-4#1)
S-1(A2)##8##1##(1992-4#8)
S-100 protein##4##2##(1990-8#1)(1994-8#1)(2011-2#2)
S-100##8##1##(1990-8#1)(1994-8#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#2)
S-150##2##1##(2008-8#2)
S-2##3##1##(2008-10#3)
S-7 x##4##2##(2008-10#4)
S-7##8##1##(2008-10#8)
S-D##3##1##(2008-11#3)
S-Graft##3##1##(2008-10#3)
S-HIDPA)(2)]##2##1##(2008-10#2)
S-PAC##2##1##(2008-10#1)(2008-11#1)
S-ROM prosthesis##2##2##(2009-3#2)
S-System##2##1##(2008-7#2)
S-adenosyl-L-methionine##3##1##(1992-3#1)(1995-2#1)(2008-8#1)
S-adenosylhomocysteinase##4##1##(1990-10#4)
S-adenosylhomocysteine##3##1##(1994-8#2)(2011-2#1)
S-adenosylmethionine##4##1##(1994-8#1)(1995-11#1)(2008-8#1)(2009-8#1)
S-captopril assay##2##2##(2008-10#2)
S-captopril##3##1##(2008-10#3)
S-matrix##4##1##(2008-3#1)(2013-8#3)
S-methyltransferase##2##1##(1994-8#2)
S-phase progression##2##2##(1997-1#1)(2012-3#1)
S-phase##11##1##(1993-1#1)(1993-11#3)(1994-12#1)(1997-1#2)(2008-11#2)(2009-6#1)(2012-3#1)
S-pyridinium derivative##2##2##(2008-10#2)
S-shaped##4##1##(2008-10#4)
S-strain incidence##3##2##(2008-10#3)
S-strain##5##1##(2008-10#5)
S-strand##2##1##(2008-7#2)
S-transferase P##2##2##(1992-6#2)
S-transferase##12##1##(1992-6#2)(1993-2#2)(1995-2#1)(1995-6#4)(1995-8#1)(2008-10#1)(2010-5#1)
S-type##2##1##(1995-8#2)
S/HMO##3##1##(1992-1#1)(1993-12#2)
S/N##5##1##(2008-10#5)
S/N=3) for##2##2##(2008-10#2)
S/N=3) was##2##2##(2008-10#2)
S/N=3)##6##1##(2008-10#6)
S1 nuclease protection##4##3##(1992-3#1)(1993-3#1)(2008-4#2)
S1 nuclease##8##2##(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(2008-4#2)(2008-8#1)(2008-9#1)
S1 stoichiometry in the decorated##2##5##(1992-3#2)
S1 stoichiometry##3##2##(1992-3#3)
S1##37##1##(1990-11#1)(1991-7#1)(1992-12#1)(1992-3#8)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#7)(1995-3#1)(1997-2#2)(1997-9#1)(2008-4#2)(2008-5#5)(2008-8#2)(2008-9#1)(2012-12#1)
S1)##2##1##(1997-2#1)(2011-2#1)
S100 proteins CAPL and CACY##2##5##(1994-5#2)
S100##5##1##(1992-2#1)(1994-5#2)(2008-7#1)(2012-12#1)
S100A4##3##1##(2013-1#3)
S12 mutant##3##2##(2008-8#3)
S180##4##1##(2008-9#4)
S2 and##2##2##(2013-1#2)
S2 cells##4##2##(2008-11#4)
S2##12##1##(1997-9#1)(2008-11#4)(2008-12#1)(2008-9#3)(2013-1#3)
S2MtEGFP cell cultures##2##3##(2008-11#2)
S2MtEGFP##5##1##(2008-11#5)
S2SS1 protein##2##2##(2008-8#2)
S2SS1##3##1##(2008-8#3)
S3 and##2##2##(1993-8#2)
S3##4##1##(1993-8#2)(2008-7#1)(2010-3#1)
S3a##6##1##(2008-11#6)
S4##2##1##(1997-9#1)(2008-10#1)
S422##5##1##(1995-11#5)
S465##2##1##(2008-8#2)
S6##7##1##(1993-2#1)(1996-2#2)(2008-10#1)(2013-1#3)
S9##4##1##(2008-9#4)
S96##4##1##(2008-10#4)
SA and##2##2##(2008-10#1)(2013-1#1)
SA concentration##4##2##(2008-10#2)(2008-12#2)
SA content##2##2##(2008-10#2)
SA in##3##2##(2008-10#3)
SA is##2##2##(2008-10#2)
SA levels##3##2##(2008-10#3)
SA production##2##2##(2008-10#2)
SA to learning##3##3##(2011-1#3)
SA to##5##2##(2008-10#2)(2011-1#3)
SA treatment##4##2##(2008-10#3)(2011-10#1)
SA##74##1##(1993-11#1)(1993-6#5)(1995-11#2)(2008-10#47)(2008-12#6)(2008-5#1)(2008-8#1)(2009-8#3)(2011-1#3)(2011-10#3)(2011-2#1)(2013-1#1)
SA-independent##2##1##(2008-10#2)
SAA levels##2##2##(2009-10#2)
SAA##8##1##(2008-10#1)(2009-10#7)
SAB1 gene##2##2##(1997-8#2)
SAB1##4##1##(1997-8#4)
SACD##2##1##(2008-5#2)
SACI##3##1##(2008-11#3)
SAD-3##4##1##(2012-3#4)
SAG##4##1##(2008-10#4)
SAGF medium##2##2##(2008-10#2)
SAH from##2##2##(2012-3#2)
SAH in##2##2##(2009-7#1)(2012-3#1)
SAH##21##1##(1995-11#1)(2008-7#9)(2009-7#3)(2012-3#7)(2013-8#1)
SAH-hydrolase##3##1##(1994-8#3)
SAM (r =##2##3##(1995-11#2)
SAM modified gold electrode##2##4##(2008-10#2)
SAM##20##1##(1995-11#3)(2008-10#14)(2008-7#1)(2009-8#1)(2013-8#1)
SAM-modified##2##1##(2008-10#2)
SAMDC##2##1##(2008-8#2)
SAMDCl and##2##2##(2008-8#2)
SAMP##3##1##(2010-7#3)
SAMP1TA/Ngs##2##1##(1995-8#2)
SAMP8 and SAMR1##3##3##(2008-7#3)
SAMP8##4##1##(2008-7#4)
SAMPLE##3##1##(2008-10#3)
SAMR1##4##1##(2008-7#4)
SAMs and##3##2##(2008-10#3)
SAMs##12##1##(2008-10#12)
SAP##3##1##(2013-1#1)(2013-8#2)
SAPC##3##1##(1997-2#3)
SAR in##2##2##(2008-10#2)
SAR is##2##2##(1992-3#1)(2011-10#1)
SAR of##2##2##(1992-3#1)(2011-3#1)
SAR##20##1##(1992-3#3)(2008-10#9)(2008-8#3)(2011-10#2)(2011-3#1)(2013-1#2)
SAR-inducing##4##1##(2008-10#4)
SARA##2##1##(2012-12#2)
SARM 19##2##2##(2008-10#2)
SARM##3##1##(2008-10#3)
SARS survivors##2##2##(2010-2#2)
SARS##4##1##(2008-10#1)(2010-2#3)
SARs##2##1##(1992-3#2)
SAS##5##1##(1992-1#1)(2008-10#1)(2008-7#1)(2009-8#2)
SAS8##2##1##(2008-10#2)
SAW##2##1##(2007-12#2)
SAX##2##1##(2008-10#2)
SAXS##3##1##(2008-10#1)(2008-11#2)
SB obstruction##4##2##(1997-8#4)
SB##8##1##(1997-8#4)(2008-11#3)(2010-11#1)
SBA levels##6##2##(2013-1#6)
SBI##4##1##(2006-5#4)
SBML##2##1##(2010-10#2)
SBP##7##1##(2009-8#2)(2010-4#2)(2013-8#3)
SBPAX##4##1##(2010-10#4)
SBWMV##5##1##(2008-10#3)(2008-8#2)
SC and##3##2##(2008-10#3)
SC barrier function##2##3##(2008-5#2)
SC have##2##2##(2008-5#2)
SC layer##4##2##(2008-5#4)
SC lipid##4##2##(2008-5#4)
SC may##2##2##(2008-5#1)(2011-2#1)
SC properties##2##2##(2008-5#2)
SC samples##2##2##(2008-5#2)
SC was##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
SC##57##1##(2008-10#8)(2008-5#45)(2011-2#2)(2012-3#1)(2013-1#1)
SC-236##5##1##(2008-10#5)
SC-245 and SC-791##2##3##(2008-10#2)
SC-245##6##1##(2008-10#6)
SC-791 and SC-245 were##2##4##(2008-10#2)
SC-791##9##1##(2008-10#9)
SC-CO(2) was##2##2##(2010-4#2)
SC-CO(2)##3##1##(2010-4#3)
SCA 4 l/min##3##3##(2011-2#3)
SCA##6##1##(2010-1#1)(2011-2#4)(2013-7#1)
SCAR primers##2##2##(2008-10#2)
SCAR##8##1##(2008-10#8)
SCAVM##3##1##(1995-11#1)(1997-6#2)
SCAVMs##4##1##(1995-11#2)(1997-6#2)
SCC##5##1##(1991-8#1)(2009-1#1)(2012-3#2)(2013-1#1)
SCC-DFTB##2##1##(2008-10#2)
SCC-DFTB/MM##2##1##(2008-10#2)
SCC25 and HaCaT cells##2##4##(2010-2#2)
SCC25 and HaCaT##3##3##(2010-2#3)
SCD in##3##2##(2012-3#3)
SCE in##4##2##(1990-6#1)(2008-10#3)
SCE##14##1##(1990-6#1)(1996-5#1)(2008-10#10)(2008-11#2)
SCE) for##2##2##(2008-10#2)
SCE) in Britton-Robinson (BR) buffer##2##5##(2008-10#2)
SCE) in##5##2##(2008-10#5)
SCE) on##2##2##(2008-10#2)
SCE)##25##1##(2008-10#25)
SCEs##3##1##(1990-6#2)(2008-11#1)
SCF technique##2##2##(2008-7#2)
SCF##3##1##(2008-7#3)
SCF+IL-3+HFT##2##1##(2008-8#2)
SCG##2##1##(1994-8#1)(2008-10#1)
SCH##5##1##(1996-2#1)(2008-10#1)(2012-3#3)
SCI##4##1##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
SCID mice##2##2##(1996-10#1)(2013-1#1)
SCID##3##1##(1991-1#1)(1996-10#1)(2013-1#1)
SCID-hu animals##2##2##(2008-11#2)
SCID-hu##4##1##(2008-11#4)
SCIT and SLIT with##2##4##(2011-2#2)
SCIT and##3##2##(2011-2#3)
SCIT##5##1##(2011-2#5)
SCL##2##1##(2008-4#2)
SCLP and CLP##3##3##(2012-3#3)
SCLP group##2##2##(2012-3#2)
SCLP injury##3##2##(2012-3#3)
SCLP##15##1##(2012-3#15)
SCLP/CLP genes##2##2##(2012-3#2)
SCM##3##1##(2008-10#1)(2009-9#1)(2011-2#1)
SCMV##11##1##(2008-10#10)(2008-9#1)
SCN##4##1##(1994-2#4)
SCN(-) ion##2##2##(2008-10#2)
SCN(-)##11##1##(2008-10#11)
SCN4A##3##1##(1991-12#1)(1992-3#2)
SCP##6##1##(2008-10#6)
SCR 20##2##2##(2008-10#2)
SCR##3##1##(2008-10#2)(2011-2#1)
SCR3##4##1##(2008-10#4)
SCRAM##5##1##(2008-11#5)
SCS##3##1##(2008-12#3)
SCSs##3##1##(2008-10#1)(2008-11#2)
SCr level of##3##3##(2008-1#3)
SCr level##4##2##(2008-1#4)
SCr##5##1##(2008-1#5)
SCs and astrocytes##2##3##(2008-7#2)
SCysC##3##1##(2013-1#3)
SD 6##3##2##(2008-12#1)(2013-1#2)
SD 933##2##2##(2008-6#2)
SD = 1##2##3##(2009-7#1)(2010-1#1)
SD =##5##2##(1993-1#2)(2009-7#2)(2010-1#1)
SD age##2##2##(2008-11#1)(2013-8#1)
SD of##4##2##(2008-10#1)(2012-5#3)
SD rats and GEPR-3##2##4##(1996-12#2)
SD rats and##6##3##(1996-12#5)(2010-1#1)
SD rats were##2##3##(2008-10#1)(2010-1#1)
SD rats##14##2##(1996-12#8)(2008-10#4)(2010-1#2)
SD##49##1##(1990-2#1)(1993-1#2)(1993-3#1)(1996-12#9)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-7#2)(2010-1#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2012-5#3)(2013-1#3)(2013-8#2)
SD) and##2##2##(1991-12#1)(1994-2#1)
SD)##6##1##(1991-12#1)(1992-6#1)(1993-1#1)(1994-2#1)(2007-12#1)(2008-10#1)
SD-OCT##3##1##(2011-7#3)
SDCC and TCCA##2##3##(2008-10#2)
SDF-1##2##1##(2008-7#1)(2010-8#1)
SDH mutations##2##2##(2012-2#2)
SDH##4##1##(2008-11#1)(2009-7#1)(2012-2#2)
SDHB##2##1##(2012-2#2)
SDHD mutations##2##2##(2012-2#2)
SDME##7##1##(2008-10#7)
SDO##2##1##(1992-3#2)
SDS and##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
SDS at##2##2##(1991-5#1)(2011-1#1)
SDS concentration##2##2##(2008-10#1)(2012-2#1)
SDS in##5##2##(2008-10#2)(2012-2#3)
SDS of the patients##2##4##(2011-1#2)
SDS polyacrylamide gel electrophoresis##2##4##(1993-6#1)(2008-8#1)
SDS showed##2##2##(2011-1#2)
SDS solution##2##2##(2008-10#2)
SDS was##5##2##(1990-11#1)(2008-10#2)(2012-2#2)
SDS##67##1##(1990-11#2)(1990-2#1)(1991-5#1)(1993-6#1)(2008-10#35)(2008-11#2)(2008-5#6)(2008-8#1)(2011-1#5)(2012-2#13)
SDS-PAGE analysis of the##2##4##(1994-11#1)(1994-8#1)
SDS-PAGE analysis revealed##2##3##(2008-11#1)(2009-9#1)
SDS-PAGE analysis##5##2##(1994-11#1)(1994-8#1)(2008-11#2)(2009-9#1)
SDS-PAGE and Western blot##2##4##(2008-11#1)(2008-9#1)
SDS-PAGE and Western blotting##2##4##(1995-8#1)(2010-12#1)
SDS-PAGE and Western##4##3##(1995-8#1)(2008-11#1)(2008-9#1)(2010-12#1)
SDS-PAGE and immunoblotting##3##3##(1996-12#1)(2008-12#1)(2008-4#1)
SDS-PAGE and##13##2##(1990-12#1)(1993-6#1)(1995-11#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)
SDS-PAGE electrophoresis##3##2##(1990-11#2)(2008-10#1)
SDS-PAGE to##2##2##(2010-12#2)
SDS-PAGE##51##1##(1990-11#2)(1990-12#1)(1991-5#1)(1992-10#2)(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-11#3)(1995-12#1)(1995-8#3)(1996-12#1)(1996-2#2)(2008-10#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-9#3)(2010-12#3)(2012-3#1)(2013-1#1)
SDS-degrading bacteria##2##2##(2012-2#2)
SDS-degrading##3##1##(2012-2#3)
SDS-polyacrylamide gel electrophoresis##3##3##(1991-5#1)(1997-1#1)(2008-5#1)
SDS-polyacrylamide gel##5##2##(1991-5#1)(1997-1#1)(2008-4#2)(2008-5#1)
SDS-polyacrylamide##7##1##(1991-5#1)(1994-5#1)(1997-1#1)(2008-11#1)(2008-4#2)(2008-5#1)
SDS-protein complexes and small DNA molecules##2##6##(2008-10#2)
SE is##3##2##(2008-10#2)(2008-3#1)
SE systems##3##2##(2008-10#3)
SE##19##1##(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-8#2)
SE)##3##1##(1990-5#2)(2008-8#1)
SE34##3##1##(2008-10#3)
SE5-OH##5##1##(2010-1#5)
SEA##4##1##(1993-6#3)(2010-12#1)
SEAP##12##1##(2008-11#9)(2008-7#2)(2011-2#1)
SEAs##3##1##(2011-2#3)
SEC column##2##2##(1997-2#2)
SEC##11##1##(1991-2#1)(1997-2#6)(2008-10#4)
SEC62 and##2##2##(1991-2#2)
SEC62##3##1##(1991-2#3)
SEE##2##1##(2008-10#1)(2009-11#1)
SEER##3##1##(1997-3#2)(2012-3#1)
SELDI TOF-MS analysis of the##2##5##(2011-2#2)
SELDI##4##1##(2008-10#1)(2008-4#1)(2011-2#2)
SELEX##6##1##(2008-4#1)(2010-5#5)
SEM CFA##2##2##(2012-2#2)
SEM and AFM##3##3##(2008-10#1)(2008-8#2)
SEM and##5##2##(2008-10#2)(2008-8#2)(2012-2#1)
SEM images##2##2##(2008-10#1)(2013-1#1)
SEM micrographs##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
SEM##34##1##(1991-2#1)(1995-12#1)(2008-10#11)(2008-11#1)(2008-5#5)(2008-7#2)(2008-8#2)(2009-7#1)(2011-2#1)(2012-2#4)(2013-1#4)(2013-8#1)
SEM)##2##1##(2008-12#1)(2008-7#1)
SEM/EDX##2##1##(2008-10#1)(2008-11#1)
SEM/EDXA micrographs##2##2##(2008-5#2)
SEP to##2##2##(2008-10#2)
SEP##8##1##(2008-10#7)(2009-3#1)
SER##3##1##(2011-2#3)
SERS spectrum##3##2##(2008-10#3)
SERS##8##1##(2008-10#8)
SERS-active polymers##2##2##(2008-12#2)
SERS-active substrates##3##2##(2008-10#3)
SERS-active##8##1##(2008-10#6)(2008-12#2)
SES and gender##2##3##(2011-1#2)
SES categories##2##2##(2011-1#2)
SES##15##1##(2008-11#1)(2010-11#2)(2011-1#8)(2012-2#1)(2013-1#1)(2013-8#2)
SET##2##1##(1997-7#2)
SETTING##3##1##(2007-12#1)(2009-10#1)(2011-2#1)
SF##5##1##(1994-8#4)(2008-11#1)
SF)##2##1##(2008-10#2)
SF-12##5##1##(2008-9#1)(2011-2#2)(2012-3#2)
SF-36##4##1##(2008-8#1)(2011-2#1)(2012-12#2)
SF-CO(2) at##3##2##(2008-10#3)
SF-CO(2) was determined##2##3##(2008-10#2)
SF-CO(2)##13##1##(2008-10#13)
SF36##3##1##(2008-10#1)(2012-3#2)
SF900II and##2##2##(2008-11#2)
SF900II##4##1##(2008-11#4)
SFA and cholesterol are##2##4##(2012-2#2)
SFA and cholesterol##3##3##(2012-2#3)
SFA and##4##2##(2008-10#1)(2012-2#3)
SFA##9##1##(2008-10#2)(2008-11#2)(2008-3#1)(2012-2#3)(2013-8#1)
SFC behavior##2##2##(2008-10#2)
SFC##5##1##(2008-10#5)
SFE and##3##2##(2008-10#3)
SFE conditions##3##2##(2008-10#3)
SFE was##2##2##(2008-10#2)
SFE with##2##2##(2008-10#2)
SFE##26##1##(2008-10#26)
SFLLRN##4##1##(1992-4#4)
SFM for##2##2##(2008-7#2)
SFM##10##1##(2008-11#4)(2008-7#6)
SFME cells were##2##3##(2008-11#2)
SFME cells##10##2##(2008-11#10)
SFO neurons##2##2##(1994-2#2)
SFO##5##1##(1994-2#4)(2013-1#1)
SFS##3##1##(2008-10#3)
SFT##4##1##(2012-2#3)(2013-1#1)
SFV##4##1##(2008-11#4)
SG##4##1##(1993-12#2)(2008-10#2)
SG-64##2##1##(2009-10#2)
SGA##4##1##(1994-3#1)(2013-1#1)(2013-8#2)
SGB##3##1##(2010-11#3)
SGC##3##1##(1995-2#3)
SGP involving the face##2##4##(2013-1#2)
SGP##4##1##(2013-1#4)
SGT1##2##1##(2009-6#2)
SH groups##2##2##(1993-2#1)(2008-10#1)
SH##5##1##(1993-2#1)(2006-6#1)(2007-12#1)(2008-10#2)
SH-SY5Y neuroblastoma cells##2##3##(1996-12#1)(2010-6#1)
SH-SY5Y##4##1##(1996-12#1)(2008-12#1)(2008-8#1)(2010-6#1)
SH-groups##2##1##(1993-6#2)
SH2 domain##5##2##(1995-6#2)(1997-7#3)
SH2 domains of Src family kinases##2##6##(1995-6#2)
SH2 domains of Src##3##4##(1995-6#3)
SH2 domains of##4##3##(1995-6#4)
SH2##12##1##(1995-6#7)(1996-2#1)(1997-7#3)(2009-6#1)
SHB system##2##2##(2008-3#2)
SHB##3##1##(2008-3#3)
SHBG##4##1##(2008-3#3)(2013-1#1)
SHG##3##1##(2008-10#1)(2008-2#2)
SHIP2##4##1##(2012-2#4)
SHIP2-SH2##6##1##(2012-2#6)
SHL##2##1##(2011-2#2)
SHLI ADRs##2##2##(2011-2#2)
SHLI##15##1##(2011-2#15)
SHM##11##1##(2008-8#3)(2011-2#8)
SHOX haploinsufficiency##3##2##(2008-7#1)(2013-1#2)
SHOX##6##1##(2008-7#2)(2013-1#4)
SHR##4##1##(1994-2#3)(1994-8#1)
SHZH98##5##1##(2008-8#5)
SI = 3##2##3##(2008-10#2)
SI =##3##2##(2008-10#3)
SI of subcutaneous fat##4##4##(2012-2#4)
SI system##4##2##(2008-10#4)
SI##25##1##(1996-2#1)(1997-8#2)(2007-12#2)(2008-10#14)(2008-11#1)(2011-2#1)(2012-2#4)
SI-LC##2##1##(2008-10#2)
SI-SWV##2##1##(2008-10#2)
SIA method##2##2##(2008-10#2)
SIA system was##3##3##(2008-10#3)
SIA system##13##2##(2008-10#13)
SIA##32##1##(2008-10#32)
SIA/DSTD##2##1##(2008-10#2)
SIADH in##2##2##(2011-2#2)
SIADH##3##1##(2011-2#3)
SIB 124 and SIB 139##2##5##(1990-8#2)
SIB 139##3##2##(1990-8#3)
SIB##8##1##(1990-8#5)(2008-11#3)
SIC##2##1##(2008-10#2)
SIDS among##2##2##(2008-1#2)
SIDS##11##1##(1991-11#4)(1993-12#1)(2008-1#6)
SIJ dysfunction as the cause for##2##6##(2010-1#2)
SIJ dysfunction##7##2##(2010-1#7)
SIJ##10##1##(2010-1#10)
SIL##5##1##(2012-12#5)
SILNH(2)##2##1##(2008-10#2)
SIM##2##1##(2008-5#2)
SIMCA##2##1##(2008-10#2)
SIN and##2##2##(2012-2#1)(2013-1#1)
SIN##3##1##(2012-2#2)(2013-1#1)
SIOD##3##1##(2011-2#3)
SIP influenced the##2##3##(1993-6#2)
SIP was##2##2##(1993-6#1)(2011-2#1)
SIP##10##1##(1993-6#6)(2011-2#4)
SIRT1##10##1##(2012-2#10)
SIS model with##2##3##(2013-8#2)
SIS model##3##2##(2013-8#3)
SIT administration forms##2##3##(2011-2#2)
SIT with##4##2##(2011-2#4)
SIT##13##1##(2011-2#13)
SIV Vpr##2##2##(1997-3#2)
SIV protease##3##2##(1992-6#3)
SIV##16##1##(1991-9#2)(1992-6#4)(1997-3#7)(2011-2#3)
SIV-PBj14##5##1##(1997-3#5)
SIV-PR##6##1##(1991-9#6)
SIVs and##2##2##(2011-2#1)(2013-8#1)
SIVs##5##1##(2011-2#3)(2013-8#2)
SIVsmmPBj14##2##1##(1997-3#2)
SK complex could##2##3##(1993-8#2)
SK complex##3##2##(1993-8#3)
SK##10##1##(1993-8#9)(2012-2#1)
SK-Br-3 and BT-474##2##3##(1993-1#2)
SK-N-MC cells##2##2##(1992-6#1)(2008-4#1)
SK-OV-3##2##1##(2008-11#1)(2008-8#1)
SKF 38393-induced grooming##2##3##(1996-2#2)
SKF##3##1##(1996-2#3)
SKM##7##1##(2011-2#4)(2013-1#3)
SKW6 cells in##2##3##(2008-8#2)
SKW6 cells##5##2##(2008-8#5)
SKW6##8##1##(2008-8#8)
SL##5##1##(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#2)
SL-selectin in##3##2##(1992-12#3)
SL-selectin##5##1##(1992-12#5)
SLA##3##1##(2008-8#3)
SLB resistance QTL##2##3##(2008-10#2)
SLB resistance##4##2##(2008-10#4)
SLB##7##1##(2008-10#7)
SLCO1B1##5##1##(2011-2#5)
SLCV DNA was detected in##2##5##(2008-10#2)
SLCV##7##1##(2008-10#7)
SLCV-E at##2##2##(2008-10#2)
SLCV-E##8##1##(2008-10#8)
SLCV-R##3##1##(2008-10#3)
SLE patients##6##2##(2008-10#4)(2013-1#2)
SLE##22##1##(2008-1#1)(2008-10#6)(2008-4#1)(2011-2#3)(2012-12#1)(2013-1#10)
SLES##2##1##(2008-10#1)(2008-5#1)
SLI and NLI##2##3##(2009-8#2)
SLI##9##1##(2008-11#4)(2009-8#2)(2011-1#3)
SLIT with##3##2##(2011-2#3)
SLIT##7##1##(2011-2#7)
SLM##7##1##(2008-10#5)(2008-3#1)(2009-7#1)
SLMs##2##1##(2008-10#2)
SLN dispersions##2##2##(2008-5#2)
SLN##8##1##(2008-5#8)
SLOS##3##1##(2010-7#3)
SLPs##2##1##(2009-11#2)
SLRS-4##3##1##(2008-10#3)
SLS##6##1##(2008-10#6)
SLSTT##3##1##(2012-2#3)
SLT##7##1##(2011-2#5)(2012-2#2)
SLX##2##1##(2008-5#2)
SM##8##1##(1994-8#1)(1996-2#1)(2011-2#1)(2012-2#1)(2013-1#4)
SMA##5##1##(1994-2#2)(1994-8#2)(2008-9#1)
SMARCAL1##9##1##(2011-2#9)
SMART##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
SMC were##2##2##(1994-11#2)
SMC##15##1##(1994-11#5)(1995-8#5)(2008-10#5)
SMD = -1##2##3##(2013-8#2)
SMD =##4##2##(2013-8#4)
SMD##12##1##(2008-10#7)(2009-7#1)(2013-8#4)
SMD-affected pigeonpea##2##2##(2008-10#2)
SMD-affected##3##1##(2008-10#3)
SMDE##2##1##(2008-10#2)
SMI##4##1##(1992-2#1)(2009-6#3)
SMR##3##1##(2008-10#1)(2008-3#1)(2009-7#1)
SMS##3##1##(1997-3#3)
SMT##3##1##(2013-1#3)
SMV HC-Pro##3##2##(2008-10#3)
SMV infection##4##2##(2008-10#4)
SMV isolates##3##2##(2008-10#3)
SMV strains##2##2##(2008-10#2)
SMV symptoms##2##2##(2008-10#2)
SMV##31##1##(2008-10#31)
SMV-G1##2##1##(2008-10#2)
SMV-infected##2##1##(2008-10#2)
SMVEA##6##1##(2008-10#6)
SNAP-25 gene expression##2##3##(1995-6#2)
SNAP-25 gene##5##2##(1995-6#2)(1996-12#1)(1997-7#2)
SNAP-25##19##1##(1995-2#4)(1995-6#5)(1996-12#5)(1997-7#5)
SNARE##2##1##(2009-8#2)
SNC##5##1##(1996-12#2)(2008-10#3)
SNF benefit##3##2##(1994-2#3)
SNF##5##1##(1994-12#2)(1994-2#3)
SNF2##2##1##(2011-2#2)
SNP and##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
SNP arrays##2##2##(2009-7#2)
SNP discovery##2##2##(2010-10#1)(2012-3#1)
SNP for##2##2##(2008-11#2)
SNP genotyping and##3##3##(2008-12#1)(2012-3#2)
SNP genotyping using primer single-base extension (SBE)##2##7##(2008-9#2)
SNP genotyping##6##2##(2008-12#1)(2008-9#2)(2012-3#3)
SNP treated KU812 cells##4##4##(2008-11#4)
SNP##49##1##(2008-10#5)(2008-11#8)(2008-12#5)(2008-9#2)(2009-7#3)(2010-10#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-2#4)(2012-3#12)(2012-5#2)(2013-1#2)
SNP/CGH##2##1##(2012-3#2)
SNPs and##3##2##(2008-10#2)(2012-5#1)
SNPs for##2##2##(2008-12#1)(2012-3#1)
SNPs in a##2##3##(2008-9#1)(2012-3#1)
SNPs in##5##2##(2008-9#1)(2009-8#1)(2010-6#1)(2012-3#2)
SNPs were##4##2##(2008-10#1)(2008-12#1)(2009-8#1)(2013-1#1)
SNPs##30##1##(2008-10#4)(2008-12#5)(2008-9#2)(2009-7#1)(2009-8#2)(2010-12#3)(2010-6#1)(2012-3#4)(2012-5#4)(2013-1#4)
SNR of##3##2##(2008-3#1)(2013-8#2)
SNR values of##2##3##(2008-3#2)
SNR values##3##2##(2008-3#3)
SNR##11##1##(2008-3#7)(2008-9#2)(2013-8#2)
SNV##2##1##(2008-10#2)
SNase R##2##2##(2008-8#2)
SNc-VTA##2##1##(2008-7#2)
SO##3##1##(1990-8#1)(2008-10#1)(2008-11#1)
SO(2) and##2##2##(2008-10#1)(2008-3#1)
SO(2) of the##2##3##(2008-3#2)
SO(2) was##2##2##(2008-10#2)
SO(2)##25##1##(2008-10#12)(2008-11#4)(2008-3#9)
SO(3)(2-)##2##1##(2008-10#2)
SO(4)##7##1##(2008-10#2)(2008-7#2)(2012-7#3)
SO(4)(2-) and##2##2##(2008-10#2)
SO(4)(2-)##15##1##(2008-10#15)
SO2##2##1##(1992-6#1)(1994-3#1)
SO3 and PT82##2##3##(2008-10#2)
SO3##3##1##(1994-3#1)(2008-10#2)
SO3ANL##2##1##(2008-2#2)
SO4-4GalNAc beta 1##2##3##(1992-10#2)
SOC(4)##3##1##(2011-2#3)
SOD activity##4##2##(1992-11#1)(2008-10#1)(2013-1#2)
SOD and##3##2##(1990-3#1)(2008-10#1)(2011-3#1)
SOD mimics##2##2##(2013-1#2)
SOD##21##1##(1990-3#2)(1992-11#2)(1997-8#3)(2008-10#5)(2011-3#4)(2013-1#5)
SOF##2##1##(2011-2#2)
SOG##3##1##(2008-2#3)
SOLVERSTAT##3##1##(2008-10#3)
SOM##4##1##(1992-1#2)(2013-8#2)
SOP##6##1##(2008-7#6)
SOS##4##1##(2008-10#1)(2011-2#1)(2013-8#2)
SOWG spectroelectrochemical cell##2##3##(2008-10#2)
SOWG##12##1##(2008-10#12)
SOX3##4##1##(2010-5#4)
SOX9##2##1##(2009-1#2)
SP DCs##2##2##(2008-11#2)
SP and CGRP##2##3##(1997-3#2)
SP and##3##2##(1997-3#2)(2008-10#1)
SP cells##2##2##(2008-9#1)(2010-6#1)
SP counselors##3##2##(2008-12#3)
SP##33##1##(1997-3#4)(2008-10#17)(2008-11#2)(2008-12#3)(2008-7#1)(2008-9#2)(2010-4#1)(2010-6#2)(2013-1#1)
SP(+) IENFs##2##2##(2013-8#2)
SP- and##2##2##(1994-8#1)(1997-3#1)
SP-##3##1##(1994-8#2)(1997-3#1)
SP-positive##2##1##(1997-3#2)
SP1##5##1##(2008-9#1)(2010-4#4)
SP2/0##2##1##(1995-2#1)(2008-11#1)
SP2/O##2##1##(1995-11#2)
SP3##2##1##(2012-2#2)
SP600125##2##1##(2011-2#2)
SPA##4##1##(2008-4#3)(2008-9#1)
SPAN##3##1##(1995-12#1)(2008-10#2)
SPARC##6##1##(2008-1#5)(2008-10#1)
SPB##3##1##(2012-12#3)
SPC##5##1##(1995-2#4)(2008-10#1)
SPD##5##1##(2008-1#2)(2008-5#2)(2008-7#1)
SPDS##3##1##(2013-8#3)
SPDS1##3##1##(2013-8#3)
SPE cartridge##8##2##(1997-2#2)(2008-10#6)
SPE cartridges##2##2##(2008-10#2)
SPE clean-up##3##2##(2008-10#3)
SPE column##6##2##(2008-10#6)
SPE conditions##2##2##(2008-10#2)
SPE method##4##2##(1997-2#1)(2008-10#3)
SPE preconcentration##2##2##(2008-10#2)
SPE procedure##2##2##(2008-10#2)
SPE sorption##2##2##(2008-10#2)
SPE step##3##2##(2008-10#3)
SPE using##2##2##(2008-10#2)
SPE##64##1##(1997-2#7)(2008-10#56)(2011-2#1)
SPE(60)##3##1##(2008-10#3)
SPE-LC-UV##2##1##(2008-10#2)
SPE-RTP##2##1##(2008-10#2)
SPE-based##2##1##(2008-10#2)
SPE/LC##3##1##(2008-10#3)
SPE/diffuse reflectance method##2##3##(2008-10#2)
SPEAK##4##1##(2008-9#4)
SPECIES##2##1##(2012-3#2)
SPECT##6##1##(1994-1#2)(1996-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
SPECT-CT##2##1##(2012-2#2)
SPECT/CT imaging and photothermal therapy##2##5##(2012-12#2)
SPECT/CT imaging and##3##3##(2012-12#3)
SPF value##2##2##(2008-5#2)
SPF values between##2##3##(2008-5#2)
SPF values##10##2##(2008-5#10)
SPF was##3##2##(1993-1#1)(1993-11#2)
SPF##26##1##(1993-1#2)(1993-11#4)(2008-5#20)
SPFMV and##2##2##(2008-10#2)
SPFMV isolates##2##2##(2008-10#2)
SPFMV##13##1##(2008-10#13)
SPFMV-infected##2##1##(2008-10#2)
SPL activation##2##2##(1996-2#2)
SPL cells##3##2##(2008-11#3)
SPL##12##1##(1996-2#2)(2008-11#4)(2011-1#6)
SPL-derived DCs##2##2##(2008-11#2)
SPM##4##1##(2008-10#4)
SPM2##2##1##(1996-6#2)
SPME and##4##2##(2008-10#4)
SPME conditions##2##2##(2008-10#2)
SPME fiber##7##2##(2008-10#6)(2009-8#1)
SPME fibre##6##2##(2008-10#6)
SPME fibres##2##2##(2008-10#1)(2012-12#1)
SPME method##4##2##(2008-10#4)
SPME was##2##2##(2008-10#2)
SPME##59##1##(2008-10#55)(2009-8#2)(2012-12#2)
SPME-HPLC interface##2##2##(2008-10#2)
SPME-HPLC##5##1##(2008-10#5)
SPN of the pancreas##2##4##(2013-1#2)
SPOM##3##1##(2008-8#3)
SPOMs##2##1##(2008-8#2)
SPR biosensor has##2##3##(2008-10#2)
SPR biosensor is##2##3##(2008-10#2)
SPR biosensor##8##2##(2008-10#8)
SPR detector##3##2##(2008-10#3)
SPR probe##2##2##(2008-10#2)
SPR response##2##2##(2008-10#2)
SPR sensor chip##3##3##(2008-10#2)(2008-4#1)
SPR sensor was##2##3##(2008-10#2)
SPR sensor##11##2##(2008-10#10)(2008-4#1)
SPR sensors##2##2##(2008-10#2)
SPR##40##1##(1995-2#1)(2008-10#37)(2008-4#2)
SPR-EAE##2##1##(1995-12#2)
SPRED1##2##1##(2012-3#2)
SPS activity##2##2##(2011-2#2)
SPS##7##1##(2008-12#3)(2011-2#4)
SPSS##6##1##(2008-12#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#2)
SPT##2##1##(2008-10#1)(2012-3#1)
SPVD##2##1##(2008-10#2)
SQL##2##1##(2008-10#1)(2008-4#1)
SQUAD##3##1##(2008-10#3)
SR alpha##7##2##(1995-6#7)
SR beta##2##2##(1995-6#2)
SR in##2##2##(2008-8#1)(2013-8#1)
SR##33##1##(1994-8#1)(1995-6#12)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#8)(2010-11#1)(2013-8#4)
SR2-type##3##1##(2008-10#3)
SR95531##2##1##(1995-2#2)
SRBC and##2##2##(2008-10#2)
SRBC##7##1##(2008-10#6)(2008-4#1)
SRBC-specific##2##1##(2008-10#2)
SRC##2##1##(2010-11#1)(2012-2#1)
SRF##4##1##(1994-11#4)
SRGl##2##1##(2008-8#2)
SRI##8##1##(2008-10#1)(2009-8#7)
SRIF mRNA##3##2##(1997-2#3)
SRIF pulse amplitude##2##3##(1997-2#2)
SRIF release##3##2##(1997-2#3)
SRIF##14##1##(1997-2#14)
SRM 1649a##2##2##(2008-10#2)
SRM 2670##3##2##(2008-10#3)
SRM 2710 and SRM##2##4##(2008-10#2)
SRM 2710##3##2##(2008-10#3)
SRM 621##3##2##(2008-10#3)
SRM NIST##2##2##(2008-10#2)
SRM##47##1##(2008-10#47)
SRR intervention##2##2##(2013-1#2)
SRR##5##1##(2013-1#3)(2013-8#2)
SS activity was##2##3##(2011-2#2)
SS analogues##2##2##(2011-2#2)
SS coupons##3##2##(2013-8#3)
SS from##2##2##(2010-5#2)
SS to##2##2##(2008-12#1)(2010-5#1)
SS##36##1##(1993-8#2)(2007-11#7)(2008-10#3)(2008-12#3)(2009-11#6)(2010-5#4)(2011-2#7)(2013-8#4)
SS-RTP##6##1##(2008-10#6)
SS767 is##2##2##(2008-10#2)
SS767##5##1##(2008-10#5)
SSA##3##1##(1994-1#1)(2008-10#1)(2013-1#1)
SSAT##5##1##(1991-9#1)(1992-10#4)
SSB consumption##7##2##(2012-2#7)
SSB##10##1##(2008-10#1)(2011-2#2)(2012-2#7)
SSCP analysis of##2##3##(2008-10#2)
SSCP analysis##3##2##(2008-10#3)
SSCP##8##1##(2008-10#8)
SSCT##7##1##(2008-9#7)
SSE (p = 0##2##4##(2013-8#2)
SSE##11##1##(2013-1#6)(2013-8#5)
SSE1 and SSE2##3##3##(1993-9#3)
SSE1##5##1##(1993-9#5)
SSE2##5##1##(1993-9#5)
SSEA-1 and##2##2##(2008-11#2)
SSEA-1##4##1##(2008-11#4)
SSG##7##1##(1995-11#7)
SSH##3##1##(2012-12#3)
SSI##4##1##(1995-12#1)(2010-12#3)
SSLB resistance##7##2##(2008-10#7)
SSLP markers##2##2##(2008-12#2)
SSM Health Care System##2##4##(1994-1#2)
SSP##6##1##(1991-3#1)(1993-1#2)(1997-7#1)(2010-2#2)
SSR genotypes##3##2##(2008-10#3)
SSR incidence was##2##3##(2008-10#2)
SSR incidence##5##2##(2008-10#5)
SSR loci##3##2##(2008-10#1)(2010-7#2)
SSR markers##5##2##(2008-10#5)
SSR prevalence##4##2##(2008-10#4)
SSR##30##1##(1996-8#2)(2008-10#24)(2008-9#1)(2010-7#3)
SSRI##5##1##(2008-6#2)(2012-3#2)(2013-1#1)
SSRIs##4##1##(2008-11#2)(2008-6#1)(2008-7#1)
SSRT##4##1##(2010-1#4)
SSRs are##3##2##(1996-8#2)(2010-10#1)
SSRs in##2##2##(1996-8#1)(2010-7#1)
SSRs##8##1##(1996-8#5)(2010-10#2)(2010-7#1)
SSTR1 to##2##2##(1995-2#2)
SSTR1##4##1##(1995-2#4)
SSTR2 and SSTR5##3##3##(1995-2#3)
SSTR2 and##4##2##(1994-11#1)(1995-2#3)
SSTR2##8##1##(1994-11#1)(1995-2#4)(2011-2#3)
SSTR2-expressing cells##2##2##(1995-2#2)
SSTR5##4##1##(1995-2#4)
SSTR5-expressing cells##2##2##(1995-2#2)
SSc##3##1##(2010-10#2)(2011-2#1)
ST depression and R wave amplitude##2##6##(1996-6#2)
ST elevation myocardial infarction##2##4##(2008-3#1)(2013-8#1)
ST elevation##4##2##(2008-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
ST segment depression##5##3##(2008-7#5)
ST segment elevation##2##3##(2008-12#1)(2012-3#1)
ST segment##9##2##(1996-6#2)(2008-12#1)(2008-7#5)(2012-3#1)
ST##23##1##(1993-12#3)(1996-6#4)(2008-12#2)(2008-3#2)(2008-7#5)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
ST(e-s) + R(e-s) value##3##4##(1996-6#3)
ST-7##4##1##(2008-10#4)
ST-D##3##1##(2010-12#3)
ST-R##4##1##(2010-12#4)
ST-segment elevation in leads##2##4##(2008-12#2)
ST-segment elevation myocardial infarction##2##4##(2008-11#1)(2008-3#1)
ST-segment elevation##5##2##(2008-11#1)(2008-12#2)(2008-3#2)
ST1-D10##2##1##(2008-10#2)
ST2##5##1##(2008-11#5)
ST6##3##1##(2008-10#3)
ST638##2##1##(1994-6#2)
STA ion##3##2##(2008-10#3)
STA##5##1##(2008-10#4)(2008-11#1)
STARD##4##1##(2008-12#3)(2013-7#1)
STAT##5##1##(1996-2#3)(2012-3#2)
STAT3 and survivin##2##3##(2011-2#2)
STAT3##5##1##(2011-2#3)(2012-3#2)
STAT5##2##1##(2008-8#2)
STATs 1 and 3 in cerebral##2##6##(2012-3#2)
STATs 1 and 3 in##3##5##(2012-3#3)
STATs 1 and 3##4##4##(2012-3#4)
STATs 1##5##2##(2012-3#5)
STATs##9##1##(1996-2#4)(2012-3#5)
STB##6##1##(1996-6#1)(2008-10#5)
STD/HIV##2##1##(2008-4#1)(2011-2#1)
STDP##3##1##(2009-8#3)
STDs##3##1##(1990-3#1)(1996-9#1)(2009-10#1)
STEC serogroups##2##2##(2012-2#2)
STEC##5##1##(2012-2#5)
STELLS##3##1##(2012-3#3)
STEMI##2##1##(2011-2#1)(2012-3#1)
STI and HIV##2##3##(2009-5#1)(2011-2#1)
STI and##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
STI##11##1##(2008-10#4)(2008-12#5)(2009-5#1)(2011-2#1)
STIMA-1##4##1##(2009-4#4)
STIs##2##1##(2008-12#2)
STL##2##1##(2008-10#2)
STLCV CR sequence##2##3##(2008-10#2)
STLCV is##2##2##(2008-10#2)
STLCV##11##1##(2008-10#11)
STLR and HEBB##2##3##(2008-11#2)
STM##7##1##(1994-11#2)(2008-8#1)(2010-7#3)(2010-9#1)
STMV 10##3##2##(2008-10#3)
STMV##8##1##(2008-10#8)
STN DBS did not##2##4##(2012-2#2)
STN DBS##7##2##(2012-2#7)
STN##8##1##(2012-2#8)
STP##3##1##(1994-11#3)
STP-like sequences##2##2##(1994-11#2)
STR loci in##2##3##(2008-12#2)
STR loci##11##2##(1995-11#1)(2008-12#10)
STR markers##3##2##(2008-12#3)
STR pairs##3##2##(2008-12#3)
STR profiling system for##2##4##(2008-12#2)
STR profiling##4##2##(1995-11#1)(2008-12#3)
STR##34##1##(1995-11#4)(2008-10#1)(2008-12#28)(2008-7#1)
STRs##5##1##(2008-12#5)
STS marker##2##2##(2008-10#2)
STS markers were##3##3##(2008-10#2)(2008-8#1)
STS markers##6##2##(1996-6#1)(2008-10#4)(2008-8#1)
STS##10##1##(1996-6#1)(2008-10#6)(2008-11#1)(2008-8#1)(2013-8#1)
STUDIES IN Tg##4##3##(2008-9#4)
STUDIES IN##6##2##(2008-9#6)
STUDY DESIGN##3##2##(2009-6#1)(2011-2#2)
STUDY IN##2##2##(2008-9#2)
STUDY##7##1##(2008-9#2)(2009-4#1)(2009-6#1)(2011-2#2)(2012-2#1)
STZ##2##1##(2012-3#2)
STZ-induced##2##1##(2008-10#1)(2012-3#1)
STox##4##1##(1993-6#4)
SUBJECTS AND METHODS##3##3##(2009-1#1)(2010-11#2)
SUMMARY##27##1##(2009-1#1)(2010-3#1)(2010-7#17)(2010-9#7)(2011-2#1)
SUMO##3##1##(2009-7#3)
SUN protein that##2##3##(2008-9#2)
SUN##4##1##(2008-9#4)
SUPERQUAD program##3##2##(2008-10#3)
SUPERQUAD##4##1##(2008-10#4)
SURF##2##1##(2013-8#2)
SUS##3##1##(2012-3#1)(2013-1#2)
SUV##3##1##(2008-10#2)(2013-1#1)
SUVs##3##1##(2008-10#3)
SV 40 DNA##5##3##(1990-7#5)
SV 40##6##2##(1990-7#6)
SV-toxins I and II##3##4##(2008-10#3)
SV-toxins##5##1##(2008-10#5)
SV2 from##2##2##(1993-12#2)
SV2 is##2##2##(1993-12#2)
SV2##7##1##(1993-12#7)
SV2A##2##1##(1993-12#2)
SV40 DNA##2##2##(1993-8#1)(2008-11#1)
SV40 T antigen##2##3##(1993-8#1)(2008-4#1)
SV40 TAg##2##2##(1995-6#1)(2008-11#1)
SV40 early promoter##4##3##(1995-6#1)(2008-11#3)
SV40 promoter##2##2##(1993-12#1)(2008-11#1)
SV40##16##1##(1993-12#1)(1993-8#2)(1995-12#1)(1995-6#4)(2008-11#7)(2008-4#1)
SVC syndrome##2##2##(2008-1#2)
SVC##3##1##(2008-1#3)
SVD##2##1##(2011-2#2)
SVM##3##1##(2008-11#3)
SVM-based##2##1##(2008-11#2)
SVP##3##1##(1993-6#2)(2009-8#1)
SVP-group MADS-box proteins##3##3##(2009-8#3)
SVP-group MADS-box##4##2##(2009-8#4)
SVPC are##2##2##(2010-11#2)
SVPC##6##1##(2010-11#6)
SVR##2##1##(2013-1#2)
SVV error##3##2##(2013-1#3)
SVV##4##1##(2013-1#4)
SW##15##1##(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2011-2#1)
SW1116##2##1##(1997-7#1)(2008-11#1)
SW480##2##1##(2008-11#2)
SWASV##2##1##(2008-10#2)
SWCNTs##3##1##(2013-1#3)
SWE/WRP-LC##2##1##(2008-10#2)
SWI is##3##2##(2012-2#3)
SWI##4##1##(2012-2#4)
SWISS mice##3##2##(2008-12#3)
SWNTs##3##1##(2008-7#3)
SWOT##2##1##(2008-11#1)(2009-10#1)
SWV##6##1##(2008-10#6)
SYBR Green and##2##3##(2008-10#1)(2008-9#1)
SYBR Green##8##2##(2008-10#4)(2008-9#3)(2010-6#1)
SYBR##10##1##(2008-10#5)(2008-12#1)(2008-9#3)(2010-6#1)
SYSV and WoYSV##2##3##(2008-10#2)
SYSV and##4##2##(2008-10#4)
SYSV##8##1##(2008-10#8)
SYTOX Green##4##2##(2008-10#1)(2008-9#3)
Sabin 1##2##2##(2008-11#2)
Saboraud##2##1##(2008-5#1)(2013-1#1)
Sabouraud##2##1##(2008-5#2)
Sabouraud's##3##1##(2008-5#2)(2009-11#1)
Sac##3##1##(2008-11#1)(2008-2#2)
SacII site##2##2##(2008-8#2)
Sacbrood##3##1##(2008-8#3)
Saccharomyces bayanus and Saccharomyces cerevisiae##2##5##(1996-6#2)
Saccharomyces cerevisiae and Schizosaccharomyces pombe##2##5##(1995-2#1)(2008-4#1)
Saccharomyces cerevisiae and##4##3##(1995-2#1)(1996-3#2)(2008-4#1)
Saccharomyces cerevisiae by##2##3##(1993-9#1)(1997-6#1)
Saccharomyces cerevisiae cells##3##3##(1993-8#1)(1995-9#1)(2008-4#1)
Saccharomyces cerevisiae chromosome VI##2##4##(1995-12#2)
Saccharomyces cerevisiae chromosome##9##3##(1994-9#2)(1995-12#2)(1995-9#1)(1996-3#3)(1996-6#1)
Saccharomyces cerevisiae has been##2##4##(1996-3#1)(1996-6#1)
Saccharomyces cerevisiae has##4##3##(1992-10#1)(1996-3#1)(1996-6#1)(2012-3#1)
Saccharomyces cerevisiae immobilized on sepiolite and##2##6##(2008-10#2)
Saccharomyces cerevisiae immobilized##4##3##(2008-10#4)
Saccharomyces cerevisiae is##4##3##(1993-9#2)(1996-3#1)(1996-6#1)
Saccharomyces cerevisiae mutants defective in##2##5##(1996-3#2)
Saccharomyces cerevisiae of##2##3##(1996-3#1)(1997-7#1)
Saccharomyces cerevisiae that##4##3##(1993-12#1)(1995-2#1)(1997-6#1)(1997-7#1)
Saccharomyces cerevisiae the##2##3##(1996-3#1)(1996-6#1)
Saccharomyces cerevisiae was##4##3##(1995-9#1)(1996-3#1)(1996-6#1)(1997-8#1)
Saccharomyces cerevisiae##132##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-2#1)(1991-9#1)(1992-10#2)(1992-3#1)(1993-12#4)(1993-6#1)(1993-8#3)(1993-9#8)(1994-3#1)(1994-9#3)(1995-12#2)(1995-2#3)(1995-6#3)(1995-9#7)(1996-12#2)(1996-2#2)(1996-3#16)(1996-6#12)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#6)(1997-8#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-7#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#8)(2013-1#2)
Saccharomyces douglasii##2##2##(1993-2#2)
Saccharomyces##143##1##(1990-12#1)(1990-2#2)(1990-7#1)(1991-2#1)(1991-9#1)(1992-10#2)(1992-3#1)(1993-12#5)(1993-2#3)(1993-6#1)(1993-8#3)(1993-9#8)(1994-3#1)(1994-9#3)(1995-12#2)(1995-2#3)(1995-6#3)(1995-9#7)(1996-12#2)(1996-2#2)(1996-3#16)(1996-6#14)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#7)(1997-8#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-7#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#10)(2013-1#2)
Saccharum##3##1##(2008-10#3)
Sacral##3##1##(2008-10#1)(2008-7#2)
Sacroiliac joint##3##2##(2010-1#3)
Safavi##2##1##(2008-10#2)
Safe Refuge##2##2##(1993-12#2)
Safe and##2##2##(2008-12#1)(2011-2#1)
Safe##13##1##(1991-2#1)(1993-12#2)(1993-3#1)(1994-3#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
Safety and##12##2##(1991-12#1)(1993-3#1)(1995-12#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
Safety considerations##2##2##(1992-2#1)(1992-3#1)
Safety in nuclear power plants##2##5##(2009-12#2)
Safety in##5##2##(1991-12#1)(1992-2#1)(2009-12#2)(2012-12#1)
Safety issues##2##2##(1992-9#1)(2008-11#1)
Safety of##8##2##(1992-3#1)(1996-1#1)(2008-10#3)(2008-11#1)(2010-10#1)(2012-3#1)
Safety##56##1##(1991-12#3)(1992-2#2)(1992-3#4)(1992-9#1)(1993-3#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#2)(2008-10#7)(2008-11#7)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#3)(2010-10#1)(2010-11#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
Safety)##2##1##(1991-12#1)(1992-12#1)
Safoof Mohazzil##7##2##(2013-1#7)
Safranin O##2##2##(2008-11#2)
Safranine##5##1##(2008-10#4)(2008-11#1)
Sage##5##1##(2008-12#4)(2008-7#1)
Sagnac interferometer##5##2##(2007-11#3)(2007-12#2)
Saint##2##1##(2008-10#1)(2008-9#1)
SalI##2##1##(1991-9#1)(1993-2#1)
Salamouni##3##1##(2008-10#3)
Salicaceae##2##1##(2012-3#2)
Salicylic Acid##3##2##(2008-10#3)
Salicylic##4##1##(2008-10#4)
Salinas and Sniper were##2##4##(2008-10#2)
Salinas and##3##2##(2008-10#3)
Salinas##10##1##(2008-10#10)
Saline##2##1##(2008-11#1)(2012-5#1)
Saliva##2##1##(2008-10#1)(2013-1#1)
Salivary##3##1##(1990-6#1)(2008-10#1)(2013-8#1)
Salix viminalis##2##2##(2012-3#2)
Salix##5##1##(2012-3#5)
Salmo##2##1##(2008-10#1)(2009-6#1)
Salmonella Enteritidis##3##2##(2010-4#2)(2011-2#1)
Salmonella enterica serovar Typhimurium##3##4##(2008-10#1)(2008-11#2)
Salmonella enterica serovar##5##3##(2008-10#1)(2008-11#2)(2012-3#2)
Salmonella enteritidis PT4##3##3##(1991-11#2)(1995-9#1)
Salmonella enteritidis##9##2##(1990-12#1)(1991-11#2)(1993-2#1)(1995-9#3)(1997-3#1)(2008-10#1)
Salmonella infection##3##2##(2011-2#1)(2013-8#2)
Salmonella infections##2##2##(1997-3#1)(2013-8#1)
Salmonella isolates were##2##3##(2008-10#1)(2011-2#1)
Salmonella species##3##2##(1995-5#1)(2007-12#2)
Salmonella typhi endotoxin##2##3##(1990-12#2)
Salmonella typhimurium##11##2##(1991-12#1)(1996-6#2)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-4#2)(2011-1#1)
Salmonella##66##1##(1990-12#4)(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-3#1)(1993-2#1)(1995-11#1)(1995-5#1)(1995-9#3)(1996-6#2)(1997-3#4)(2007-12#3)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#4)(2010-4#4)(2011-1#2)(2011-2#10)(2012-3#2)(2013-8#7)
Salmonella-induced migration of##2##3##(2011-2#2)
Saluda##2##1##(2008-10#2)
Salvador##5##1##(1992-5#1)(1994-2#1)(2008-10#2)(2010-10#1)
Salvage##2##1##(2009-1#1)(2012-3#1)
Salvia miltiorrhiza Bunge##2##3##(2008-10#2)
Salvia miltiorrhiza##5##2##(2008-10#5)
Salvia##12##1##(2008-10#5)(2008-11#4)(2008-12#2)(2008-5#1)
Sambucus ebulus##2##2##(2008-12#2)
Sambucus##3##1##(1994-11#1)(2008-12#2)
Same##3##1##(2008-10#2)(2012-3#1)
Samoan##3##1##(2008-1#3)
Samp1##2##1##(2011-2#2)
Sample and##3##2##(2008-10#3)
Sample collection##2##2##(2008-10#1)(2008-6#1)
Sample of##2##2##(2012-12#1)(2013-8#1)
Sample pre-treatment##2##2##(2008-10#2)
Sample preparation was##2##3##(2008-10#2)
Sample preparation##7##2##(2008-10#7)
Sample size##10##2##(1995-5#1)(1995-9#1)(1996-3#1)(2008-10#3)(2008-11#1)(2012-3#2)(2013-1#1)
Sample solutions##4##2##(2008-10#4)
Sample throughput##2##2##(2008-10#2)
Sample throughputs##2##2##(2008-10#2)
Sample##48##1##(1992-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(2008-10#33)(2008-11#1)(2008-3#1)(2008-6#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#1)
Sampler for the measurement of outdoor##2##6##(2008-5#2)
Sampler##10##1##(2008-5#9)(2010-5#1)
Samples are##3##2##(2008-10#3)
Samples from##3##2##(1992-9#1)(2008-10#1)(2011-2#1)
Samples of##14##2##(1991-12#1)(1991-6#1)(1994-8#1)(1997-5#1)(2008-10#8)(2008-12#1)(2009-7#1)
Samples were collected##3##3##(2008-10#3)
Samples were diluted##2##3##(2008-10#2)
Samples were dissolved##2##3##(2008-10#2)
Samples were extracted with##2##4##(2008-10#1)(2008-5#1)
Samples were extracted##3##3##(2008-10#2)(2008-5#1)
Samples were injected##2##3##(2008-10#2)
Samples were taken in##2##4##(2008-10#1)(2008-5#1)
Samples were taken##4##3##(2008-10#3)(2008-5#1)
Samples were##28##2##(2008-10#23)(2008-5#2)(2008-6#1)(2008-8#1)(2013-8#1)
Samples##65##1##(1991-12#1)(1991-6#1)(1992-9#1)(1993-2#1)(1994-8#1)(1996-12#1)(1997-5#1)(2008-10#46)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
Sampling and##2##2##(2008-10#1)(2013-1#1)
Sampling for##4##2##(2008-10#4)
Sampling in##2##2##(2008-10#2)
Sampling of##4##2##(2008-10#2)(2008-12#2)
Sampling rate##2##2##(2008-10#1)(2012-3#1)
Sampling strategies for the analysis of glass fragments by LA-ICP-MS Part##2##11##(2008-10#2)
Sampling was carried out##2##4##(2008-10#1)(2008-5#1)
Sampling was##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
Sampling##30##1##(2008-10#22)(2008-12#2)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Samy El-Shall##2##2##(2010-7#2)
San Antonio##3##2##(2008-1#1)(2008-7#2)
San Diego##8##2##(1990-8#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#2)
San Francisco Medical##3##3##(2010-8#3)
San Francisco##13##2##(1990-11#1)(1990-9#1)(1991-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-12#1)(2008-7#1)(2010-8#3)(2011-2#1)
San Joaquin Valley##5##3##(2008-10#4)(2011-2#1)
San Joaquin##9##2##(2008-10#8)(2011-2#1)
San##41##1##(1990-11#2)(1990-8#1)(1990-9#1)(1991-2#1)(1993-3#1)(1993-6#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#2)
Sand##4##1##(2008-12#1)(2008-3#1)(2013-1#2)
Sandell's sensitivity of##3##3##(2008-10#3)
Sandell's sensitivity##13##2##(2008-10#13)
Sanger sequencing##2##2##(2010-10#1)(2012-2#1)
Sanger##4##1##(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
Sanguinarine##3##1##(2011-2#3)
Santa Clara##2##2##(1995-12#1)(2010-8#1)
Santa Cruz##2##2##(2008-10#1)(2008-8#1)
Santa Maria##2##2##(2008-10#2)
Santa##8##1##(1995-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)
Santander and Caquetá##2##3##(2012-12#2)
Santander##3##1##(2012-12#3)
Santiago de##2##2##(2008-7#1)(2012-12#1)
Santiago##6##1##(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
Saposhnikovia divaricata##2##2##(2008-10#2)
Saprolegniales) as a mosquito larvae pathogen##2##6##(2008-5#2)
Saprophytic Activity##2##2##(2008-10#2)
Saprophytic##5##1##(2008-10#5)
Sapstain##2##1##(2008-10#2)
Sar-SP##2##1##(2008-8#2)
Sara##3##1##(2013-1#3)
Saranac##2##1##(2008-10#2)
Sarason##3##1##(1992-1#3)
Sarawak##4##1##(2008-12#4)
Sarcandra glabra and its medicinal preparations##2##6##(2008-10#2)
Sarcandra glabra and##3##3##(2008-10#3)
Sarcandra##4##1##(2008-10#4)
Sarcoidosis##2##1##(2010-6#1)(2012-3#1)
Sarcoma of the##2##3##(2010-12#1)(2011-2#1)
Sarcoma##3##1##(2010-12#1)(2011-2#1)(2012-3#1)
Sarcomas##2##1##(1994-6#2)
Sarcoptes scabiei##3##2##(2008-12#3)
Sardinia##7##1##(2008-10#5)(2013-8#2)
Sargassum sp##4##2##(2008-12#2)(2011-2#2)
Sargassum##13##1##(2008-10#4)(2008-11#2)(2008-12#2)(2011-2#5)
Saskatchewan##8##1##(1992-5#1)(1995-12#2)(2008-10#3)(2008-12#1)(2008-8#1)
Satellite RNA of##2##3##(2008-10#2)
Satellite RNA##3##2##(2008-10#3)
Satellite RNAs##2##2##(2008-10#2)
Satellite##19##1##(1992-1#2)(1993-3#1)(2008-10#7)(2008-2#1)(2008-3#7)(2008-7#1)
Satisfaction of residents and families in long-term care##2##8##(1997-1#2)
Satisfaction regarding##3##2##(2008-11#3)
Satisfaction with##4##2##(1995-1#1)(1996-2#1)(2009-11#1)(2013-1#1)
Satisfaction##14##1##(1995-1#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#3)(2009-10#1)(2009-11#1)(2010-10#2)(2010-8#1)(2013-1#1)
Satisfactory recoveries were obtained in the analysis of##2##8##(2008-10#2)
Satisfactory results were obtained in the determination of##2##8##(2008-10#2)
Satisfactory results were obtained##5##4##(2008-10#5)
Satisfactory results##6##2##(2008-10#6)
Satisfactory##15##1##(2008-10#15)
Satisfying##2##1##(2008-10#1)(2008-12#1)
Saturable Absorber##3##2##(2008-3#3)
Saturable##5##1##(1992-3#2)(2008-3#3)
Saturation##3##1##(2008-3#1)(2008-5#1)(2013-1#1)
Sau3AI##2##1##(1991-6#1)(2008-10#1)
Saudi Arabia##15##2##(1994-2#1)(2008-1#8)(2008-10#2)(2008-12#2)(2013-1#2)
Saudi##16##1##(1994-2#1)(2008-1#8)(2008-10#2)(2008-12#2)(2013-1#3)
Savanna##5##1##(2008-12#2)(2012-12#3)
Savannah##7##1##(2008-10#7)
Saving##3##1##(1995-1#1)(1996-12#1)(2010-11#1)
Savings##2##1##(1992-2#1)(2008-5#1)
Savitsky-Golay##2##1##(2008-10#2)
Saxony##4##1##(2008-11#4)
Say##3##1##(2008-10#1)(2009-1#1)(2010-4#1)
Sb and Bi##2##3##(2008-10#2)
Sb and##5##2##(2008-10#5)
Sb in##5##2##(2008-10#5)
Sb was##4##2##(2008-10#4)
Sb##54##1##(2008-10#54)
Sb(3+) and##2##2##(2008-10#2)
Sb(3+)##3##1##(2008-10#3)
Sb(III) and Bi(III)##5##3##(2008-10#5)
Sb(III) and Sb(V)##12##3##(2008-10#12)
Sb(III) and##22##2##(2008-10#22)
Sb(III) for##2##2##(2008-10#2)
Sb(III) in##6##2##(2008-10#6)
Sb(III) with##2##2##(2008-10#2)
Sb(III)##43##1##(2008-10#43)
Sb(V) and TMSbCl(2)##2##3##(2008-10#2)
Sb(V) and##6##2##(2008-10#6)
Sb(V) in##3##2##(2008-10#3)
Sb(V)##34##1##(2008-10#34)
SbDV isolates##2##2##(2008-10#2)
SbDV##5##1##(2008-10#5)
SbF(6)(-)##2##1##(2008-10#2)
SbPRP was##2##2##(2008-8#2)
SbPRP##5##1##(2008-8#5)
Sc + Pd + NH(4)NO(3)##3##5##(2008-10#3)
Sc + Pd##4##3##(2008-10#4)
Sc +##6##2##(2008-10#6)
Sc##9##1##(1995-2#1)(2008-10#8)
Sc(3+) and Y(3+)##2##3##(2008-10#2)
ScA##4##1##(2008-11#4)
ScYLV##6##1##(2008-10#6)
Sca-1##2##1##(2010-8#2)
Scab Resistance##3##2##(2008-10#3)
Scab in##2##2##(2008-10#2)
Scab##15##1##(2008-10#15)
Scald Disease##2##2##(2008-10#2)
Scald Pathogen##2##2##(2008-10#2)
Scald##5##1##(2008-10#5)
Scale (GCS)##4##2##(1991-2#1)(2011-2#1)(2013-1#2)
Scale and the##2##3##(2009-10#1)(2012-2#1)
Scale and##6##2##(1991-2#1)(2008-11#1)(2009-10#1)(2010-4#1)(2012-2#1)(2012-3#1)
Scale for##7##2##(1991-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
Scale of##2##2##(1992-1#1)(2013-1#1)
Scale were##3##2##(1991-2#1)(2008-7#2)
Scale##90##1##(1990-12#2)(1991-2#6)(1992-1#1)(1992-2#1)(1996-9#1)(1997-1#1)(1997-3#2)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#8)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#2)(2011-8#1)(2012-2#6)(2012-3#5)(2013-1#15)(2013-8#2)
Scale-up of##2##2##(2008-10#1)(2008-11#1)
Scale]##2##1##(1990-2#1)(2011-2#1)
Scales##6##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#2)
Scaling##4##1##(1991-9#1)(1992-8#1)(2008-3#1)(2008-9#1)
Scalp##3##1##(1995-2#1)(2008-9#1)(2012-3#1)
Scandinavian##5##1##(2008-10#1)(2011-4#4)
Scanning Electron##2##2##(2008-11#1)(2008-5#1)
Scanning Tunneling Microscopy##2##3##(1990-11#1)(1996-9#1)
Scanning electron microscope investigations of##2##5##(2008-10#2)
Scanning electron microscope##3##3##(2008-10#3)
Scanning electron microscopy (SEM)##2##4##(2008-10#1)(2013-1#1)
Scanning electron microscopy of##3##4##(2008-7#1)(2009-11#1)(2011-2#1)
Scanning electron microscopy revealed that##2##5##(2008-10#1)(2008-8#1)
Scanning electron microscopy revealed##3##4##(2008-10#2)(2008-8#1)
Scanning electron microscopy showed##2##4##(2007-12#1)(2008-10#1)
Scanning electron microscopy##12##3##(2007-12#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
Scanning electron##17##2##(2007-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#2)(2013-1#1)
Scanning lidar##2##2##(2008-3#2)
Scanning tunneling microscope##2##3##(2008-8#2)
Scanning tunneling##3##2##(2008-8#2)(2010-7#1)
Scanning##29##1##(1990-11#1)(1996-9#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
Scans##2##1##(2008-10#1)(2012-2#1)
Scatchard analysis and##2##3##(1994-11#1)(2008-10#1)
Scatchard analysis of##3##3##(1990-8#1)(1991-6#1)(1993-8#1)
Scatchard analysis##6##2##(1990-8#1)(1991-6#1)(1993-8#1)(1994-11#1)(1996-2#1)(2008-10#1)
Scatchard plot analysis##2##3##(1996-12#1)(2008-10#1)
Scatchard plot##6##2##(1996-12#1)(2008-10#5)
Scatchard plots##2##2##(2008-10#2)
Scatchard##16##1##(1990-11#1)(1990-8#1)(1991-6#1)(1993-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#8)
Scattering of##2##2##(1996-9#1)(2008-2#1)
Scattering##11##1##(1991-9#1)(1996-9#3)(2008-10#1)(2008-2#2)(2008-3#4)
Scenario##2##1##(2008-10#1)(2010-11#1)
Schaffer Collateral-CA1##2##2##(2008-7#2)
Schaffer collaterals##2##2##(1995-12#1)(2008-11#1)
Schaffer##7##1##(1995-12#1)(1995-2#1)(2008-11#1)(2008-7#4)
Schedule##3##1##(1995-12#1)(1996-3#1)(2008-5#1)
Scheduling##2##1##(1991-2#1)(1996-1#1)
Schefflera##3##1##(2008-10#3)
Scheme##2##1##(2012-2#1)(2013-8#1)
Scherzer##2##1##(2010-5#2)
Scheuthauer-Marie-Sainton syndrome##2##2##(2013-1#2)
Schiff Base complexes##2##3##(2008-10#2)
Schiff Base##3##2##(2008-10#3)
Schiff base as##2##3##(2008-10#1)(2009-3#1)
Schiff base complexes##2##3##(2008-10#1)(2013-1#1)
Schiff base method##2##3##(2008-10#2)
Schiff base##19##2##(1992-3#2)(1994-5#2)(2008-10#13)(2009-3#1)(2013-1#1)
Schiff bases##3##2##(2008-10#2)(2010-8#1)
Schiff##29##1##(1992-3#2)(1994-5#2)(1996-5#1)(2008-10#20)(2009-3#1)(2009-7#1)(2010-8#1)(2013-1#1)
Schiff's##3##1##(2008-10#3)
Schiff(##3##1##(2008-10#3)
Schistocerca gregaria##5##2##(2007-12#5)
Schistosoma japonicum antibody##3##3##(2008-10#3)
Schistosoma mansoni is##2##3##(1993-2#1)(2012-2#1)
Schistosoma mansoni##9##2##(1993-2#2)(1996-8#1)(1997-6#2)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Schistosoma##14##1##(1992-2#1)(1993-2#2)(1996-8#1)(1997-6#2)(2008-10#4)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Schistosomes##2##1##(2013-1#1)(2013-8#1)
Schizaphis graminum##7##2##(1996-12#2)(2008-10#5)
Schizophrenia##3##1##(1997-7#1)(2008-8#1)(2012-3#1)
Schizosaccharomyces pombe##15##2##(1995-2#2)(1995-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(2008-4#1)(2008-9#1)(2010-11#1)(2012-3#5)
Schleichera oleosa##2##2##(2012-2#2)
Schlieren effect is##2##3##(2008-10#2)
Schlieren effect##4##2##(2008-10#4)
Schmallenberg##2##1##(1995-3#1)(2013-8#1)
Schmitz##2##1##(2007-12#1)(2008-9#1)
Schneider##3##1##(1993-9#1)(1995-2#1)(2008-11#1)
Scholars##2##1##(2009-10#1)(2011-2#1)
Scholarship##2##1##(1992-3#1)(2008-11#1)
Scholtes##2##1##(1993-12#2)
School Children##2##2##(2009-7#1)(2013-1#1)
School of Medicine and##2##4##(1996-9#1)(2008-1#1)
School of Medicine of##3##4##(1991-12#1)(1992-1#1)(1997-3#1)
School of Medicine##11##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#2)(1996-9#2)(1997-3#1)(2008-1#2)(2008-5#1)
School of Nursing and Midwifery##4##5##(2008-11#3)(2008-12#1)
School of Nursing##11##3##(2008-11#6)(2008-12#5)
School of Public Health##4##4##(1991-2#2)(1996-1#1)(2008-12#1)
School of Veterinary##2##3##(2013-8#2)
School of##38##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#2)(1993-2#1)(1994-12#1)(1996-1#2)(1996-9#2)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#7)(2008-5#1)(2010-1#1)(2013-1#1)(2013-8#2)
School##61##1##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#1)(1995-11#1)(1996-1#2)(1996-9#2)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#10)(2008-4#2)(2008-5#2)(2008-7#1)(2009-7#2)(2010-1#2)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#2)
School-based health centers##2##3##(1995-12#2)
School-based##6##1##(1995-12#3)(1997-2#1)(2008-10#1)(2013-1#1)
Schools##3##1##(1997-2#1)(2009-12#1)(2012-2#1)
Schrödinger##2##1##(1994-2#1)(2007-11#1)
Schum##2##1##(2012-3#1)(2013-1#1)
Schumacher##2##1##(1994-5#1)(2011-2#1)
Schwabe##2##1##(2008-5#2)
Schwann cell incorporation of [3H]thymidine by##2##6##(1995-2#2)
Schwann cell incorporation of [3H]thymidine##3##5##(1995-2#3)
Schwann cell proliferation##2##3##(1995-2#2)
Schwann cell##6##2##(1995-2#6)
Schwann cell-like##2##2##(2008-7#2)
Schwann cells and##3##3##(1990-8#1)(1995-2#1)(2008-7#1)
Schwann cells##12##2##(1990-8#1)(1995-2#5)(2008-7#5)(2011-2#1)
Schwann##20##1##(1990-8#1)(1995-2#11)(2008-7#7)(2011-2#1)
Schwannoma##3##1##(2008-7#1)(2012-3#1)(2013-1#1)
Schwannomas##2##1##(1997-8#1)(2012-3#1)
Schwartz##2##1##(1991-1#1)(2010-4#1)
Sci##14##1##(1990-10#1)(1990-5#1)(1992-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1995-6#2)(2008-10#2)(2008-11#1)(2008-12#1)
Sciatic nerve##2##2##(2008-8#2)
Sciatic##3##1##(2008-8#3)
Science Citation Index##2##3##(2010-12#1)(2013-1#1)
Science Foundation##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
Science and Technology##2##3##(1990-11#1)(2011-2#1)
Science and##9##2##(1990-11#2)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#2)(2013-1#2)
Science##50##1##(1990-11#2)(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#3)(1995-6#2)(1997-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#1)(2011-2#7)(2011-3#1)(2012-12#1)(2013-1#6)(2013-8#2)
Sciences in##2##2##(1996-12#1)(2013-1#1)
Sciences##31##1##(1990-8#1)(1992-12#1)(1994-12#2)(1995-2#2)(1996-11#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Sciencescope##2##1##(1994-9#1)(1995-6#1)
Scientific Meeting##2##2##(2008-8#1)(2011-2#1)
Scientific##21##1##(1991-3#1)(1992-12#1)(1992-5#1)(1993-2#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#2)(2009-6#1)(2010-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Scientists##6##1##(1993-9#1)(1994-3#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-4#1)
Scintillation proximity assay (SPA)##2##4##(2008-4#2)
Scintillation##4##1##(2007-12#1)(2008-3#1)(2008-4#2)
Scleral##2##1##(2011-2#1)(2013-1#1)
Scleranthus annuus##5##2##(2008-10#5)
Scleroderma##2##1##(2008-5#2)
Scleroderris canker##2##2##(2008-10#2)
Sclerotia and##2##2##(2008-10#2)
Sclerotia of##3##2##(2008-10#3)
Sclerotia##10##1##(2008-10#10)
Sclerotial##4##1##(2008-10#4)
Sclerotinia disease##3##2##(2008-10#3)
Sclerotinia homoeocarpa##5##2##(2008-10#5)
Sclerotinia minor##6##2##(2008-10#6)
Sclerotinia sclerotiorum and##2##3##(2008-10#1)(2013-8#1)
Sclerotinia sclerotiorum in##4##3##(2008-10#4)
Sclerotinia sclerotiorum to##3##3##(2008-10#3)
Sclerotinia sclerotiorum##29##2##(2008-10#28)(2013-8#1)
Sclerotinia stem rot (SSR)##3##4##(2008-10#3)
Sclerotinia stem rot was##3##4##(2008-10#3)
Sclerotinia stem rot##10##3##(2008-10#10)
Sclerotinia trifoliorum and Sclerotium rolfsii##3##5##(2008-10#3)
Sclerotinia trifoliorum##9##2##(2008-10#9)
Sclerotinia##67##1##(2008-10#66)(2013-8#1)
Sclerotium rolfsii in##5##3##(2008-10#5)
Sclerotium rolfsii##18##2##(2008-10#18)
Sclerotium##19##1##(2008-10#19)
Scope of Regional Lymph Node Surgery##2##6##(2012-12#2)
Scopelocheirus##2##1##(2008-6#2)
Scoping##2##1##(2011-2#1)(2012-12#1)
Score##14##1##(2008-1#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
Scores from the##3##3##(2008-12#1)(2008-9#2)
Scores##11##1##(1992-1#1)(1996-3#1)(2008-10#1)(2008-12#2)(2008-9#3)(2011-2#1)(2012-12#1)(2013-8#1)
Scoring##6##1##(2008-11#1)(2008-5#1)(2010-11#2)(2011-2#1)(2012-12#1)
Scorpion probe##4##2##(2008-10#4)
Scotland##10##1##(1995-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#3)
Scots pines##2##2##(2008-10#2)
Scott A##2##2##(2012-2#2)
Scott##4##1##(1994-3#1)(1995-6#1)(2012-2#2)
Scottish##8##1##(2008-10#1)(2008-11#5)(2008-12#1)(2008-9#1)
Scp1##4##1##(1996-6#4)
ScrFI##3##1##(2008-10#3)
Screen##4##1##(2008-10#1)(2011-2#2)(2012-3#1)
Screen-printed carbon electrodes##2##3##(2008-10#2)
Screen-printed##5##1##(2008-10#5)
Screening New Drugs for Immunotoxic Potential##2##6##(2008-10#2)
Screening Program##2##2##(1991-12#1)(2010-1#1)
Screening Test##2##2##(2011-2#1)(2013-1#1)
Screening and brief intervention in the##2##6##(2008-11#2)
Screening and brief intervention in##4##5##(2008-11#4)
Screening and##7##2##(1990-3#1)(2008-11#5)(2008-8#1)
Screening for##11##2##(1991-6#1)(1991-8#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2012-12#1)(2013-1#2)
Screening of the##3##3##(1991-6#1)(1996-12#1)(2009-8#1)
Screening of##19##2##(1991-6#1)(1993-8#1)(1995-6#1)(1996-12#1)(2008-10#6)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Screening##72##1##(1990-3#1)(1991-12#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#2)(2007-12#1)(2008-10#19)(2008-11#11)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
Screw##2##1##(2012-3#1)(2013-1#1)
Screws for##2##2##(2008-12#1)(2012-3#1)
Scrotoschisis##2##1##(2008-10#2)
Sd##2##1##(1993-2#2)
Se (IV)##3##2##(2008-10#3)
Se and In in a sodium sulphate matrix##2##8##(2008-10#2)
Se and In in a##3##5##(2008-10#3)
Se and In in##4##4##(2008-10#4)
Se and Sb on titanium dioxide##2##6##(2008-10#2)
Se and Sb was##2##4##(2008-10#2)
Se and Sb were##2##4##(2008-10#2)
Se and Sb##6##3##(2008-10#6)
Se and##18##2##(2008-10#18)
Se by##2##2##(2008-10#2)
Se compounds##4##2##(2008-10#4)
Se concentration##5##2##(2008-10#5)
Se deficiency##3##2##(2012-2#3)
Se determination##3##2##(2008-10#3)
Se from##2##2##(2008-10#2)
Se in the##3##3##(2008-10#3)
Se in##12##2##(2008-10#12)
Se losses##2##2##(2008-10#2)
Se recoveries##2##2##(2008-10#2)
Se speciation in##2##3##(2008-10#2)
Se speciation##4##2##(2008-10#4)
Se species##5##2##(2008-10#5)
Se status##2##2##(2012-2#2)
Se to##2##2##(2008-10#2)
Se toxicity##2##2##(2012-2#2)
Se was 0##2##3##(2008-10#2)
Se was##3##2##(2008-10#3)
Se were##5##2##(2008-10#5)
Se##133##1##(1994-8#1)(2008-10#119)(2012-2#13)
Se(IV) (n=11)##2##2##(2008-10#2)
Se(IV) and Se(VI)##5##3##(2008-10#5)
Se(IV) and##13##2##(2008-10#13)
Se(IV) are##2##2##(2008-10#2)
Se(IV) by##2##2##(2008-10#2)
Se(IV) in##5##2##(2008-10#5)
Se(IV)##66##1##(2008-10#66)
Se(VI) and total selenium##2##4##(2008-10#2)
Se(VI) and##4##2##(2008-10#4)
Se(VI) by##2##2##(2008-10#2)
Se(VI) is##3##2##(2008-10#3)
Se(VI) to Se(IV)##6##3##(2008-10#6)
Se(VI)##32##1##(2008-10#32)
Se)##5##1##(2008-10#4)(2010-11#1)
Se-B8##2##1##(2008-10#2)
Se-H6 and Se-C1##2##3##(2008-10#2)
Se-enriched##3##1##(2008-10#2)(2010-11#1)
Se/g sample##4##2##(2008-10#4)
Se/g##7##1##(2008-10#5)(2012-2#2)
SeH(2)##2##1##(2008-10#2)
SeMet and TMSe##2##3##(2008-10#2)
SeMet##4##1##(2008-10#4)
Sea and##4##2##(2007-12#2)(2008-10#2)
Sea are##2##2##(2008-10#1)(2009-10#1)
Sea water##2##2##(2008-10#2)
Sea##25##1##(1996-6#1)(2007-12#2)(2008-10#9)(2008-11#3)(2008-2#1)(2008-5#1)(2009-10#3)(2009-8#1)(2010-8#2)(2012-2#1)(2013-8#1)
Sea-viewing Wide Field-of-view Sensor (SeaWiFS)##3##5##(2008-2#1)(2008-3#2)
SeaWiFS##18##1##(2008-2#10)(2008-3#8)
Sealant##4##1##(2012-3#4)
Search##9##1##(1992-3#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-8#2)(2011-2#1)
Searching Online Mendelian Inheritance in Man (OMIM) for information for genetic loci involved in human disease##2##16##(2008-4#1)(2008-9#1)
Searching for##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)
Searching##8##1##(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
Searle##2##1##(2008-5#2)
Season##4##1##(1997-7#1)(2008-10#3)
Seasonal##11##1##(1991-3#1)(2008-10#6)(2008-8#1)(2010-8#1)(2012-2#1)(2012-7#1)
Seawater samples##2##2##(2008-10#2)
Seawater##3##1##(2008-10#3)
Sebaldella termitidis##2##2##(2011-2#2)
Sebaldella##3##1##(2011-2#3)
Sec##6##1##(1991-2#1)(2012-2#5)
Sec62 and Sec63##2##3##(1991-2#2)
Sec7p##2##1##(1997-1#2)
SecA##4##1##(1997-8#1)(2008-10#3)
SecY in the##2##3##(1991-5#2)
SecY is an indispensable component of the##2##7##(1991-5#2)
SecY##7##1##(1991-5#7)
SecY-depleted##2##1##(1991-5#2)
Second Avenue##2##2##(2008-8#2)
Second International##2##2##(2008-5#1)(2010-10#1)
Second and third trimester exposure is##2##6##(2013-1#2)
Second and third##3##3##(1993-1#1)(2013-1#2)
Second derivative spectrophotometric##2##3##(2008-10#2)
Second derivative##3##2##(2008-10#3)
Second group##2##2##(2012-3#2)
Second##89##1##(1991-2#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-7#2)(2008-10#16)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#4)(2008-8#14)(2008-9#2)(2009-10#2)(2009-12#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-10#1)(2011-2#2)(2011-4#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
Second-harmonic generation##2##2##(2007-11#2)
Second-harmonic##3##1##(2007-11#2)(2008-2#1)
Second-line##2##1##(2008-1#1)(2010-12#1)
Second-order##2##1##(1997-7#1)(2008-10#1)
Secondary conidiation##2##2##(2008-10#2)
Secondary metabolites##4##2##(2008-10#1)(2008-9#3)
Secondary structure analysis##2##3##(2009-7#1)(2011-2#1)
Secondary structure##5##2##(2008-8#1)(2008-9#1)(2009-7#2)(2011-2#1)
Secondary##40##1##(1992-12#1)(1993-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-8#2)(2008-9#5)(2009-11#1)(2009-7#2)(2009-9#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Secondly##15##1##(1992-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2010-11#1)(2011-2#1)(2013-8#2)
Secret Service##3##2##(1995-6#3)
Secret##4##1##(1995-6#4)
Secretary of##2##2##(1994-1#1)(1996-5#1)
Secretary##3##1##(1994-1#1)(1995-6#1)(1996-5#1)
Secreted##4##1##(2008-10#1)(2008-11#2)(2008-4#1)
Secretion in##2##2##(2009-8#1)(2011-2#1)
Secretion of##9##2##(1992-12#1)(1996-12#1)(2008-10#2)(2008-11#4)(2009-8#1)
Secretion##15##1##(1990-5#1)(1992-12#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#1)(2009-8#2)(2011-2#1)
Secretory##4##1##(2007-12#2)(2008-7#1)(2011-2#1)
Section 199##2##2##(1995-12#2)
Section##7##1##(1992-3#2)(1993-9#1)(1995-12#2)(2010-6#1)(2010-9#1)
Sections##3##1##(2008-10#2)(2012-3#1)
Securing the##2##2##(1993-12#1)(2008-4#1)
Securing##3##1##(1993-12#1)(2008-11#1)(2008-4#1)
Security##29##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#4)(1992-2#4)(1993-1#2)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
Sedentary behavior##2##2##(2008-4#1)(2013-1#1)
Sedentary##4##1##(2008-10#1)(2008-4#1)(2013-1#2)
Sediment BCR-CRM##2##2##(2008-10#2)
Sediment##6##1##(2008-10#5)(2008-11#1)
Seed production##2##2##(2008-8#1)(2008-9#1)
Seed treatment with##4##3##(2008-10#4)
Seed##30##1##(2008-10#26)(2008-8#1)(2008-9#2)(2012-2#1)
Seedborne##4##1##(2008-10#4)
Seeding##2##1##(1996-9#1)(2008-10#1)
Seedling Damping-Off Caused by Pythium ultimum##2##6##(2008-10#2)
Seedling##8##1##(2008-10#7)(2008-8#1)
Seedlings in##2##2##(2008-10#2)
Seedlings of##4##2##(2008-10#4)
Seedlings were##2##2##(2008-10#2)
Seedlings##17##1##(2008-10#17)
Seeds from##2##2##(2008-10#2)
Seeds of##2##2##(2008-10#1)(2008-8#1)
Seeds##8##1##(2008-10#7)(2008-8#1)
Seehra and Jordan##2##3##(1992-3#2)
Seeking##3##1##(1990-6#1)(2009-11#1)(2012-12#1)
Segment##3##1##(1995-3#1)(2010-9#1)(2012-3#1)
Segmental##4##1##(1992-9#1)(2007-12#1)(2008-12#1)(2012-3#1)
Segmentation##3##1##(2008-6#1)(2009-5#1)(2010-1#1)
Segmenting##2##1##(2010-1#1)(2010-8#1)
Segments of the coronary arteries were received from##2##8##(2012-3#2)
Segments of##3##2##(2008-11#1)(2012-3#2)
Segments##4##1##(2008-11#1)(2008-7#1)(2012-3#2)
Segniliparus rotundus##2##2##(2011-2#2)
Segniliparus##3##1##(2011-2#3)
Segregation analyses indicated that##2##4##(2008-10#2)
Segregation analysis##2##2##(2008-10#2)
Segregation of##6##2##(1995-2#1)(2008-10#5)
Segregation##14##1##(1995-2#1)(2008-10#12)(2012-2#1)
Seine##3##1##(2008-10#3)
Seison nebaliae##2##2##(2008-7#2)
Seizure##3##1##(1993-3#1)(1997-3#1)(2010-8#1)
Seizures in##2##2##(1997-3#1)(2008-11#1)
Seizures##4##1##(1993-1#1)(1997-3#1)(1997-4#1)(2008-11#1)
Selaginella moellendorffii##3##2##(2009-8#3)
Select##2##1##(2008-11#2)
Selected for##2##2##(2008-10#2)
Selected isolates of##3##3##(2008-10#3)
Selected isolates##5##2##(2008-10#5)
Selected##27##1##(1990-8#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-6#1)(1996-1#1)(2008-10#13)(2008-11#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
Selecting the right##2##3##(1996-3#1)(2008-9#1)
Selecting the##4##2##(1993-3#1)(1996-3#1)(2008-5#1)(2008-9#1)
Selecting##11##1##(1990-9#1)(1992-12#1)(1993-3#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#2)
Selection and##2##2##(2008-11#1)(2008-8#1)
Selection for increased##2##3##(2008-10#1)(2011-2#1)
Selection for##7##2##(1997-7#1)(2008-10#4)(2008-8#1)(2011-2#1)
Selection in##2##2##(2008-10#1)(2010-1#1)
Selection of appropriate##2##3##(2008-11#1)(2008-2#1)
Selection of the appropriate##2##4##(2008-10#2)
Selection of the##4##3##(1990-8#1)(2008-10#3)
Selection of##14##2##(1990-8#1)(1995-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2009-2#1)(2009-9#1)(2011-2#2)
Selection with##2##2##(2008-10#1)(2013-1#1)
Selection##36##1##(1990-8#1)(1995-5#1)(1997-7#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#3)(2013-1#2)
Selections##2##1##(2008-10#1)(2010-8#1)
Selective Media##2##2##(2008-10#2)
Selective and sensitive##2##3##(2008-10#2)
Selective and##4##2##(2008-10#4)
Selective angiography##2##2##(1995-11#1)(1996-9#1)
Selective determination of##4##3##(2008-10#3)(2013-8#1)
Selective expression##2##2##(1994-5#2)
Selective extraction of##3##3##(2008-10#3)
Selective laser trabeculoplasty##2##3##(2011-2#2)
Selective preconcentration of##2##3##(2008-10#2)
Selective preconcentration##3##2##(2008-10#3)
Selective separation of##2##3##(2008-10#2)
Selective serotonin reuptake inhibitors (SSRIs)##2##5##(2008-6#1)(2013-1#1)
Selective transport of##2##3##(2008-10#2)
Selective use of##2##3##(2008-11#1)(2008-3#1)
Selective##66##1##(1990-5#1)(1992-10#1)(1992-12#3)(1992-9#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(2008-10#39)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#1)(2013-8#1)
Selectivity coefficient data for some common ions show negligible interference##2##10##(2008-10#2)
Selectivity coefficients for##2##3##(2008-10#2)
Selectivity coefficients##6##2##(2008-10#6)
Selectivity for##2##2##(2008-10#2)
Selectivity##19##1##(1996-5#1)(2008-10#18)
Selenium speciation##2##2##(2008-10#1)(2010-11#1)
Selenium species##2##2##(2008-10#2)
Selenium##14##1##(2008-10#8)(2008-11#1)(2008-6#1)(2009-10#2)(2010-11#1)(2012-2#1)
Selenocystine##2##1##(2008-10#2)
Selenomethionine (SeMet)##2##2##(2008-10#2)
Selenomethionine##4##1##(2008-10#3)(2010-11#1)
Selenoprotein P##2##2##(2009-10#2)
Self and peer assessment##2##4##(2008-11#2)
Self##9##1##(1996-3#1)(2008-11#5)(2009-11#1)(2010-8#1)(2012-3#1)
Self-Assessment##2##1##(2012-2#2)
Self-Efficacy##3##1##(2008-12#2)(2012-3#1)
Self-Help Clearinghouse of Metropolitan Toronto##3##5##(1994-1#1)(1996-3#2)
Self-Help Clearinghouse##4##2##(1994-1#2)(1996-3#2)
Self-assembled##3##1##(2008-10#2)(2009-11#1)
Self-care##2##1##(2010-7#1)(2013-8#1)
Self-efficacy##3##1##(2008-12#1)(2009-3#1)(2010-2#1)
Self-expanding##2##1##(1990-8#1)(2008-11#1)
Self-induced##2##1##(1991-9#1)(2007-11#1)
Self-reference##2##1##(2008-9#2)
Self-report##2##1##(2008-12#1)(2010-11#1)
Self-reported##5##1##(2008-12#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#1)
Self-similarity##2##1##(2008-8#2)
Sellers argued that##2##3##(1996-5#2)
Sellers##3##1##(1996-5#3)
Sellmeier equations##4##2##(2008-2#2)(2008-3#2)
Sellmeier##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
Semaphorin##2##1##(1993-12#2)
Semen##4##1##(2008-12#3)(2012-2#1)
Semi-quantitative##2##1##(1993-12#1)(2011-2#1)
Semi-structured interviews were used to collect data##2##7##(2008-11#1)(2012-3#1)
Semi-structured interviews were##3##3##(1995-1#1)(2008-11#1)(2012-3#1)
Semi-structured interviews##5##2##(1995-1#1)(2008-11#1)(2012-3#1)(2013-1#2)
Semi-structured##7##1##(1995-1#1)(2008-11#2)(2010-10#1)(2012-3#1)(2013-1#2)
Semiconductor##4##1##(2008-10#1)(2008-3#3)
Seminal plasmin##2##2##(1994-3#2)
Seminar##2##1##(1997-8#1)(2008-12#1)
Semiquantitative##2##1##(1991-2#1)(2008-10#1)
Semliki Forest virus##2##3##(2008-11#2)
Semliki Forest##4##2##(2008-11#4)
Sen##2##1##(1995-6#2)
Senate##12##1##(1993-5#1)(1995-6#6)(1996-5#1)(1997-2#2)(2008-8#1)(2009-9#1)
Senecio##3##1##(1991-8#1)(2008-10#2)
Senegal doves (Streptopelia senegalensis)##2##4##(2008-5#2)
Senegal doves##6##2##(2008-5#6)
Senegal##8##1##(1996-11#1)(2008-10#1)(2008-5#6)
Senescence##2##1##(2008-8#1)(2009-8#1)
Senile lentigo##2##2##(2011-2#2)
Senile##3##1##(2011-2#3)
Senior##5##1##(1994-2#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)
Seniors##2##1##(1994-3#1)(1997-2#1)
Sense and antisense##2##3##(1993-3#1)(1994-11#1)
Sense##4##1##(1993-3#1)(1994-1#1)(1994-11#1)(1997-7#1)
Sensing of##3##2##(2008-3#2)(2010-6#1)
Sensing##7##1##(2008-12#1)(2008-3#4)(2010-12#1)(2010-6#1)
Sensitive and##5##2##(2008-10#4)(2008-11#1)
Sensitive detection##2##2##(2008-10#2)
Sensitive determination of##2##3##(2008-10#2)
Sensitive##23##1##(1997-6#1)(2008-10#19)(2008-11#1)(2011-10#1)(2011-2#1)
Sensitivities of##2##2##(2008-10#2)
Sensitivity analyses##6##2##(2008-10#3)(2008-7#1)(2008-8#1)(2012-3#1)
Sensitivity analysis##5##2##(2008-10#1)(2008-3#1)(2010-10#2)(2012-3#1)
Sensitivity and detection##2##3##(2008-10#2)
Sensitivity and specificity of rapid influenza testing of children in a community##2##12##(2011-2#2)
Sensitivity and specificity of##3##4##(2011-2#3)
Sensitivity and specificity##4##3##(1990-6#1)(2011-2#3)
Sensitivity and##8##2##(1990-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#3)
Sensitivity of the##2##3##(2008-10#1)(2011-2#1)
Sensitivity of##15##2##(1994-2#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-3#2)(2011-2#2)(2012-3#1)
Sensitivity to##10##2##(1995-8#1)(2007-11#1)(2008-10#5)(2009-9#1)(2011-2#1)(2013-7#1)
Sensitivity was##7##2##(1991-6#1)(2008-10#5)(2012-6#1)
Sensitivity##56##1##(1990-6#1)(1991-6#1)(1994-2#1)(1995-8#1)(1997-8#1)(2007-11#1)(2008-10#26)(2008-11#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2011-2#6)(2012-3#3)(2012-6#1)(2013-7#1)
Sensitization to##4##2##(1991-1#1)(2013-1#3)
Sensitization##7##1##(1990-2#1)(1991-1#1)(1991-3#1)(1992-7#1)(2013-1#3)
Sensor device prepared with this membrane has##2##7##(2008-10#2)
Sensor##17##1##(2008-10#11)(2008-2#1)(2008-3#4)(2013-8#1)
Sensors##6##1##(2008-10#4)(2008-3#1)(2008-8#1)
Sensory and##2##2##(1990-5#1)(1993-1#1)
Sensory evaluation of##2##3##(2010-4#2)
Sensory##10##1##(1990-5#1)(1993-1#1)(1995-2#1)(1997-3#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#2)
Sentara##2##1##(1993-3#2)
Sentence##3##1##(2008-9#1)(2009-8#1)(2010-7#1)
Sentinel lymph node##2##3##(2010-11#1)(2011-2#1)
Sentinel##4##1##(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
Sentinels##2##1##(2008-9#2)
Seoul##4##1##(1990-12#2)(1991-2#1)(2013-8#1)
Sep-Pak C(18)##2##2##(2008-10#2)
Sep-Pak C18 cartridges##2##3##(1992-11#1)(1993-2#1)
Sep-Pak##4##1##(1992-11#1)(1993-2#1)(2008-10#2)
Separate sections are devoted to##2##5##(2008-10#2)
Separate##10##1##(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)
Separated##2##1##(2008-12#1)(2008-7#1)
Separately##2##1##(1995-8#1)(2011-2#1)
Separating##2##1##(2008-3#1)(2008-6#1)
Separation and determination of thorium##2##5##(2008-10#2)
Separation and determination of##10##4##(2008-10#10)
Separation and preconcentration of##3##4##(2008-10#3)
Separation and preconcentration##4##3##(2008-10#4)
Separation and simultaneous determination of##2##5##(2008-10#2)
Separation and##23##2##(1993-2#1)(2008-10#21)(2009-8#1)
Separation of the derivatized##2##4##(2008-10#2)
Separation of the##4##3##(2008-10#4)
Separation of##25##2##(1997-2#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
Separation was##2##2##(1991-7#1)(2008-10#1)
Separation##62##1##(1991-7#1)(1993-2#1)(1997-2#1)(2008-10#48)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#2)(2012-2#2)(2012-3#1)(2013-1#1)
Separations in##2##2##(2008-10#2)
Separations of##2##2##(2008-10#2)
Separations were performed##2##3##(2008-10#2)
Separations were##4##2##(2008-10#4)
Separations##9##1##(1997-2#1)(2008-10#8)
Sephacryl##3##1##(1990-11#1)(1997-2#1)(2008-8#1)
Sephadex G-100##2##2##(1990-11#1)(2008-11#1)
Sephadex LH-20 column##2##3##(1991-12#1)(1993-2#1)
Sephadex LH-20##4##2##(1990-11#1)(1991-12#1)(1993-2#1)(2011-3#1)
Sephadex QAE A-25 gel##2##4##(2008-10#2)
Sephadex QAE A-25##3##3##(2008-10#3)
Sephadex SP-C25##2##2##(2008-10#2)
Sephadex##21##1##(1990-11#2)(1990-2#1)(1991-12#1)(1993-2#1)(1995-6#1)(2008-10#12)(2008-11#1)(2008-8#1)(2011-3#1)
Sepharose 4B##2##2##(1996-2#1)(2011-2#1)
Sepharose 6B##2##2##(1996-2#1)(2008-8#1)
Sepharose and Perloza##3##3##(2008-7#3)
Sepharose and##4##2##(1997-1#1)(2008-7#3)
Sepharose column##2##2##(1990-12#1)(1995-12#1)
Sepharose##22##1##(1990-12#3)(1990-5#1)(1991-5#1)(1992-6#1)(1995-12#1)(1996-2#2)(1997-1#3)(2008-10#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#1)
Sepia##5##1##(2008-7#5)
Sepsis is a leading cause of##2##6##(2010-7#1)(2011-2#1)
Sepsis##5##1##(2008-5#1)(2010-7#1)(2011-2#2)(2012-3#1)
Septal##3##1##(1994-2#1)(2008-11#1)(2012-3#1)
September 1986##2##2##(1991-2#1)(1996-5#1)
September 1988 to##2##3##(1994-9#1)(1995-12#1)
September 1988##3##2##(1994-9#1)(1995-12#1)(2008-7#1)
September 1994##3##2##(1994-8#1)(1995-12#1)(1995-5#1)
September 1995##2##2##(2008-2#1)(2008-7#1)
September 1996##2##2##(1997-2#1)(2008-10#1)
September 1997##2##2##(2008-10#1)(2008-5#1)
September 1998##2##2##(2008-10#1)(2008-7#1)
September 2001##2##2##(2008-10#1)(2008-11#1)
September 2005##2##2##(2008-10#1)(2013-1#1)
September 2007##2##2##(2011-2#2)
September 2009##2##2##(2011-2#1)(2013-1#1)
September 27##2##2##(1990-12#1)(2010-12#1)
September 9-11##2##2##(2011-2#1)(2013-8#1)
September and##2##2##(1996-12#1)(2008-10#1)
September to##2##2##(2008-10#2)
September##48##1##(1990-12#1)(1991-2#2)(1991-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-2#1)(1997-6#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
Septoria Tritici Blotch##2##3##(2008-10#2)
Septoria leaf spot##2##3##(2008-10#2)
Septoria leaf##3##2##(2008-10#3)
Septoria passerinii##4##2##(2008-10#4)
Septoria speckled leaf blotch (SSLB)##3##5##(2008-10#3)
Septoria tritici Blotch##2##3##(2008-10#2)
Septoria tritici blotch##7##3##(2008-10#7)
Septoria tritici##17##2##(2008-10#17)
Septoria##39##1##(2008-10#39)
SeqLab##2##1##(2008-4#2)
Sequence analyses of the##3##4##(1990-5#1)(2008-10#2)
Sequence analyses of##4##3##(1990-5#1)(2008-10#2)(2010-4#1)
Sequence analyses##5##2##(1990-5#1)(2008-10#3)(2010-4#1)
Sequence analysis and##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
Sequence analysis of a##5##4##(1990-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-8#1)
Sequence analysis of the complete internal transcribed spacer (ITS) region##2##10##(2008-10#2)
Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp##3##11##(1995-8#1)(1996-6#2)
Sequence analysis of the genome of##4##6##(1995-8#1)(1996-6#2)(2008-10#1)
Sequence analysis of the##13##4##(1993-9#1)(1995-8#1)(1996-3#1)(1996-6#2)(2008-10#6)(2008-12#1)(2011-2#1)
Sequence analysis of these##2##4##(1993-12#1)(2008-10#1)
Sequence analysis of##30##3##(1990-12#1)(1991-2#1)(1993-12#1)(1993-9#1)(1995-8#1)(1996-3#1)(1996-6#3)(1997-2#1)(2008-10#12)(2008-12#1)(2008-8#5)(2008-9#1)(2011-2#1)
Sequence analysis revealed that the##2##5##(1996-6#1)(2008-10#1)
Sequence analysis revealed that##6##4##(1996-6#1)(1997-7#1)(2008-10#3)(2008-9#1)
Sequence analysis revealed##7##3##(1996-6#1)(1997-7#1)(2008-10#4)(2008-9#1)
Sequence analysis showed that the##5##5##(2008-10#1)(2008-8#1)(2008-9#1)(2011-10#1)(2012-3#1)
Sequence analysis showed that##7##4##(2008-10#1)(2008-8#3)(2008-9#1)(2011-10#1)(2012-3#1)
Sequence analysis showed##9##3##(1997-8#1)(2008-10#1)(2008-8#3)(2008-9#1)(2011-10#1)(2012-3#1)(2013-8#1)
Sequence analysis shows that##2##4##(1993-12#1)(2008-8#1)
Sequence analysis shows##3##3##(1991-6#1)(1993-12#1)(2008-8#1)
Sequence analysis##57##2##(1990-12#1)(1991-2#1)(1991-6#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-6#4)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#19)(2008-12#1)(2008-8#9)(2008-9#4)(2011-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
Sequence and phylogenetic analysis##2##4##(2008-10#2)
Sequence and phylogenetic##3##3##(2008-10#3)
Sequence and##9##2##(1993-6#1)(1997-2#1)(2008-10#7)
Sequence comparison of the##2##4##(1993-6#1)(2008-10#1)
Sequence comparison##4##2##(1993-6#1)(2008-10#1)(2008-6#1)(2008-9#1)
Sequence comparisons and phylogenetic##2##4##(2008-10#1)(2008-8#1)
Sequence comparisons and##3##3##(2008-10#2)(2008-8#1)
Sequence comparisons of##2##3##(1995-2#1)(2008-10#1)
Sequence comparisons showed that##2##4##(2008-10#1)(2008-9#1)
Sequence comparisons##10##2##(1993-6#1)(1995-2#1)(1997-7#1)(1997-9#1)(2008-10#4)(2008-8#1)(2008-9#1)
Sequence data##2##2##(2008-10#1)(2008-8#1)
Sequence determination of the entire genome and assignment of potential protein-coding regions##2##12##(1996-6#2)
Sequence diversity##2##2##(2008-10#2)
Sequence evaluation was performed twice and validated by a third senior##2##11##(2008-12#2)
Sequence features of the##2##4##(1997-6#1)(1997-8#1)
Sequence features##4##2##(1995-8#1)(1996-8#1)(1997-6#1)(1997-8#1)
Sequence of the##3##3##(1993-12#1)(1993-2#2)
Sequence of##9##2##(1993-12#1)(1993-2#2)(1994-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)
Sequence##141##1##(1990-12#1)(1990-5#1)(1991-2#1)(1991-6#2)(1993-12#4)(1993-2#3)(1993-6#4)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-3#1)(1996-5#2)(1996-6#6)(1996-8#1)(1997-2#3)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#1)(2008-10#53)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#3)(2008-8#12)(2008-9#8)(2009-10#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-10#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
Sequence-Characterized##2##1##(2008-10#2)
Sequence-specific 1H##2##2##(2009-7#2)
Sequence-specific##3##1##(1995-2#1)(2009-7#2)
Sequences from##3##2##(2008-10#2)(2013-1#1)
Sequences of the##4##3##(2008-10#4)
Sequences of##6##2##(1991-9#1)(2008-10#4)(2008-6#1)
Sequences##22##1##(1991-5#2)(1991-9#1)(1994-12#1)(1995-2#1)(1996-8#1)(2008-10#12)(2008-11#1)(2008-6#1)(2013-1#2)
Sequencing and Southern analysis showed that##2##6##(2008-8#2)
Sequencing and##4##2##(1991-9#1)(2008-10#1)(2008-8#2)
Sequencing data##2##2##(1990-2#1)(2008-8#1)
Sequencing of the##5##3##(2008-10#3)(2009-6#1)(2012-3#1)
Sequencing of##9##2##(1994-11#1)(2008-10#5)(2009-6#1)(2009-7#1)(2012-3#1)
Sequencing##23##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-11#1)(1996-3#1)(1997-8#1)(2008-10#6)(2008-8#4)(2009-6#1)(2009-7#1)(2012-2#1)(2012-3#2)
Sequential determination of##2##3##(2008-10#2)
Sequential extraction of##2##3##(2008-10#2)
Sequential extraction procedure for speciation of inorganic##2##7##(2008-10#2)
Sequential extraction##6##2##(2008-10#6)
Sequential injection analysis system##2##4##(2008-10#2)
Sequential injection analysis##6##3##(2008-10#6)
Sequential injection spectrophotometric determination of##4##5##(2008-10#4)
Sequential injection spectrophotometric##5##3##(2008-10#5)
Sequential injection system with higher dimensional electrochemical sensor signals Part##2##10##(2008-10#2)
Sequential injection system##3##3##(2008-10#3)
Sequential injection with##2##3##(2008-10#2)
Sequential injection##22##2##(2008-10#22)
Sequential sampling##2##2##(2008-10#2)
Sequential##51##1##(1990-6#1)(1994-8#1)(2008-10#42)(2008-2#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-3#1)(2013-8#1)
Sequestered##2##1##(2008-10#1)(2009-3#1)
Sequestration##2##1##(2008-11#1)(2013-1#1)
Ser 195##3##2##(1991-3#3)
Ser at##2##2##(1997-8#2)
Ser##18##1##(1991-3#3)(1992-12#1)(1992-4#2)(1992-8#1)(1994-11#1)(1997-7#3)(1997-8#3)(2008-10#2)(2008-11#1)(2008-2#1)
Ser- Phe-##2##2##(1991-5#2)
Ser-##4##1##(1991-5#4)
Ser-132##6##1##(1992-3#6)
Ser-159##2##1##(1995-2#2)
Sera from##3##2##(2008-5#1)(2010-4#1)(2012-5#1)
Sera##4##1##(2008-11#1)(2008-5#1)(2010-4#1)(2012-5#1)
Serbia##7##1##(2008-10#1)(2008-11#2)(2011-2#4)
Serbian##2##1##(2008-11#1)(2011-2#1)
Sercial##2##1##(2008-10#2)
Sergent##4##1##(2010-1#4)
Serial histological sections##2##3##(2011-2#2)
Serial sections##2##2##(1997-2#1)(2008-5#1)
Serial##16##1##(1990-6#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)
Sericin##2##1##(2008-11#2)
Series of##3##2##(1995-12#1)(2008-11#1)(2008-5#1)
Series##13##1##(1990-8#2)(1995-12#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-11#1)(2010-9#4)(2012-3#1)
Serine##7##1##(1997-1#2)(2008-11#2)(2008-4#1)(2008-6#2)
Serious##2##1##(2009-10#1)(2009-9#1)
Seroepidemiological##2##1##(2011-2#1)(2012-2#1)
Serogroups##2##1##(2008-10#1)(2008-12#1)
Serologic##5##1##(1990-9#1)(1996-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
Serological analysis##2##2##(2008-10#2)
Serological and biological##2##3##(2008-10#2)
Serological and##3##2##(2008-10#3)
Serological##14##1##(1990-3#1)(1997-8#1)(2008-10#9)(2009-8#1)(2012-2#1)(2013-8#1)
Serology##4##1##(2008-10#1)(2011-2#3)
Seronorm Trace##2##2##(2008-10#2)
Seronormtrade mark Trace Elements in##3##5##(2008-10#3)
Seronormtrade mark Trace Elements##4##4##(2008-10#4)
Seroprevalence of##3##2##(2008-10#1)(2012-2#2)
Seroprevalence##4##1##(2008-10#1)(2008-12#1)(2012-2#2)
Serotonergic projection neurons##2##3##(2008-7#2)
Serotonergic##3##1##(2008-7#3)
Serotonin##7##1##(1992-1#1)(1996-12#2)(2008-6#1)(2010-1#1)(2012-3#2)
Serotypes##2##1##(2008-10#2)
Serpins##3##1##(2008-4#3)
Serratia marcescens##13##2##(1996-12#3)(2008-10#6)(2009-6#2)(2010-6#1)(2011-2#1)
Serratia plymuthica##2##2##(2008-10#2)
Serratia spp##2##2##(2008-10#2)
Serratia##19##1##(1996-12#3)(2007-11#1)(2008-10#11)(2009-6#2)(2010-6#1)(2011-2#1)
Sertoli and germ cells##2##4##(2009-10#2)
Sertoli and germ##3##3##(2009-10#3)
Sertoli and##6##2##(2009-10#4)(2011-2#1)(2012-2#1)
Sertoli cell tumours##2##3##(2011-2#2)
Sertoli cell##6##2##(1990-4#1)(2009-10#1)(2011-2#2)(2012-2#2)
Sertoli cells is##2##3##(2009-10#1)(2012-2#1)
Sertoli cells##16##2##(1995-6#1)(2009-10#10)(2010-5#1)(2012-2#4)
Sertoli##30##1##(1990-4#1)(1995-6#1)(2009-10#15)(2010-5#1)(2011-2#3)(2012-2#9)
Serum 25(OH)D##4##2##(2011-1#1)(2011-2#3)
Serum PSA##2##2##(1990-9#2)
Serum and##2##2##(2008-11#1)(2011-1#1)
Serum anti-Müllerian hormone##2##3##(2012-3#2)
Serum bile##2##2##(2013-1#2)
Serum bone GLA-protein##3##3##(1990-2#3)
Serum concentrations of##3##3##(1995-2#1)(2008-7#1)(2010-10#1)
Serum corticosterone##2##2##(2008-10#2)
Serum creatinine##2##2##(1992-3#1)(2012-3#1)
Serum cystatin C##2##3##(2010-4#1)(2013-1#1)
Serum levels of tissue##2##4##(1990-8#1)(1994-3#1)
Serum levels of##6##3##(1990-8#1)(1992-12#1)(1994-3#1)(1994-6#1)(1996-6#1)(2008-10#1)
Serum magnesium was##2##3##(2011-2#2)
Serum magnesium##4##2##(2008-6#1)(2011-2#3)
Serum markers of##2##3##(2013-8#2)
Serum p53##2##2##(2011-2#2)
Serum samples were##3##3##(1995-2#1)(2008-12#1)(2011-2#1)
Serum samples##7##2##(1991-3#1)(1995-2#1)(2008-10#3)(2008-12#1)(2011-2#1)
Serum##95##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-8#2)(1990-9#2)(1991-12#3)(1991-3#2)(1992-11#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-2#2)(1996-6#1)(1997-1#1)(1997-3#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#9)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#6)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#5)
Serum-free##7##1##(2008-11#7)
Service and##2##2##(1991-3#1)(2008-12#1)
Service at##2##2##(1992-1#1)(2008-1#1)
Service in##2##2##(2012-2#1)(2013-1#1)
Service management##2##2##(1994-1#2)
Service of##3##2##(1991-3#1)(2012-3#1)(2013-1#1)
Service##60##1##(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-1#1)(1994-1#2)(1995-1#3)(1995-12#2)(1995-2#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#8)(2008-12#5)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
Services and##2##2##(1997-2#1)(2013-8#1)
Services for##2##2##(1991-1#1)(1997-3#1)
Services in##3##2##(2008-12#1)(2009-10#1)(2012-2#1)
Services to##2##2##(1997-2#1)(2008-7#1)
Services##62##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#2)(1993-2#1)(1994-1#4)(1994-12#5)(1995-12#2)(1995-3#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#4)(1997-3#2)(2007-9#1)(2008-11#2)(2008-12#2)(2008-6#3)(2008-7#1)(2009-10#1)(2009-3#1)(2010-5#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#9)(2013-1#1)(2013-8#1)
Serving##2##1##(1993-1#1)(2008-11#1)
Servo##2##1##(1992-2#1)(1994-12#1)
Session Presentations at the##8##4##(2008-11#8)
Session##10##1##(2008-10#1)(2008-11#9)
Set##11##1##(1993-2#1)(1995-2#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)(2012-3#1)
Setaria digitata##2##2##(1991-5#2)
Setaria spp##2##2##(2008-10#2)
Setaria##6##1##(1991-5#2)(2008-10#4)
Setosphaeria turcica##4##2##(2008-10#4)
Sets##2##1##(2008-10#1)(2008-3#1)
Setting the##2##2##(1994-12#1)(1996-2#1)
Setting up##2##2##(2008-10#1)(2009-12#1)
Setting##13##1##(1991-2#2)(1992-2#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-1#1)
Seven cases##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
Seven days after##2##3##(1990-5#1)(1995-12#1)
Seven different##5##2##(1993-3#1)(2008-10#2)(2008-12#1)(2008-7#1)
Seven hundred##3##2##(2008-10#2)(2012-2#1)
Seven of eight##2##3##(2008-9#1)(2010-1#1)
Seven of the##5##3##(1992-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
Seven of##10##2##(1992-6#1)(1993-8#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-1#1)(2012-12#1)
Seven out of##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
Seven patients with##2##3##(2011-2#1)(2013-1#1)
Seven patients##8##2##(1991-9#1)(1995-10#1)(1997-8#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Seven percent of##3##3##(1992-1#1)(1994-3#1)(2013-1#1)
Seven studies##2##2##(2012-12#1)(2013-1#1)
Seven##95##1##(1990-5#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-6#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#3)(2008-1#2)(2008-10#27)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
Seventeen patients##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
Seventeen##21##1##(1990-3#1)(1994-2#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#4)
Seventy percent of the##2##4##(1990-8#1)(2008-11#1)
Seventy percent of##3##3##(1990-8#1)(2008-11#1)(2011-1#1)
Seventy percent##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
Seventy##12##1##(1990-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Seventy-eight##2##1##(1996-3#1)(2008-12#1)
Seventy-five percent of##3##3##(1990-11#1)(2008-11#1)(2009-10#1)
Seventy-five percent##4##2##(1990-11#1)(2008-11#1)(2009-10#2)
Seventy-five##8##1##(1990-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#2)(2012-12#1)
Seventy-seven##2##1##(1992-3#1)(2008-10#1)
Seventy-six##2##1##(1996-1#1)(2008-10#1)
Seventy-three##2##1##(2012-3#1)(2013-1#1)
Seventy-two consecutive##2##2##(1991-8#1)(1992-12#1)
Seventy-two patients##3##2##(2008-7#3)
Seventy-two##8##1##(1991-8#1)(1992-12#1)(1992-2#1)(2008-10#1)(2008-7#3)(2013-8#1)
Several approaches##2##2##(2008-11#1)(2008-7#1)
Several aspects of##3##3##(2008-10#1)(2009-11#2)
Several aspects##4##2##(2008-10#2)(2009-11#2)
Several authors have##2##3##(1995-9#1)(2008-8#1)
Several characteristics of##2##3##(1994-5#1)(2008-10#1)
Several characteristics##3##2##(1994-5#1)(2008-10#1)(2009-4#1)
Several chemical and flow variables##2##5##(2008-10#2)
Several clinical trials have##2##4##(2008-10#1)(2012-12#1)
Several complications##2##2##(1996-11#1)(2013-1#1)
Several conserved##2##2##(1992-9#1)(1993-2#1)
Several days##2##2##(2009-3#1)(2012-2#1)
Several different##5##2##(1993-3#1)(2008-10#3)(2009-8#1)
Several examples are##2##3##(1995-5#1)(2008-10#1)
Several examples##5##2##(1992-9#1)(1993-12#1)(1995-5#1)(2008-10#1)(2013-8#1)
Several experimental##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
Several factors affecting the hydride generation##2##6##(2008-10#2)
Several factors affecting the##3##4##(2008-10#3)
Several factors##11##2##(1993-1#1)(1997-5#1)(2008-10#5)(2008-11#2)(2008-5#1)(2011-2#1)
Several forms of##2##3##(1993-8#1)(1997-8#1)
Several groups##2##2##(1992-1#1)(2011-2#1)
Several hypotheses have been proposed##2##5##(2011-1#1)(2012-3#1)
Several hypotheses##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
Several important##2##2##(1994-2#1)(2008-10#1)
Several isolates from##2##3##(2008-10#2)
Several isolates were##2##3##(2008-10#1)(2008-5#1)
Several isolates##5##2##(2008-10#4)(2008-5#1)
Several lines of evidence##3##4##(2008-10#1)(2011-2#2)
Several mechanisms##3##2##(1996-11#1)(2008-10#1)(2008-3#1)
Several methods to##2##3##(2008-10#1)(2008-11#1)
Several methods##4##2##(2008-10#2)(2008-11#1)(2009-1#1)
Several models##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
Several modified##2##2##(2008-10#2)
Several new##5##2##(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
Several novel##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
Several of these##5##3##(1993-2#1)(1994-9#1)(1996-2#1)(2008-11#1)(2011-2#1)
Several of##6##2##(1993-2#1)(1994-9#1)(1996-2#1)(2008-11#1)(2010-5#1)(2011-2#1)
Several other##5##2##(1991-8#1)(2008-10#1)(2008-7#1)(2009-1#1)(2012-2#1)
Several parameters##8##2##(2008-10#8)
Several procedures for##2##3##(2008-10#1)(2008-4#1)
Several recent##3##2##(2009-6#1)(2010-1#1)(2010-12#1)
Several reports have##2##3##(1994-3#1)(2008-11#1)
Several reports##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
Several species of##3##3##(2006-6#1)(2008-10#1)(2008-12#1)
Several studies have been##2##4##(2008-11#1)(2013-1#1)
Several studies have indicated that##2##5##(1992-12#1)(2009-8#1)
Several studies have reported##3##4##(2008-11#3)
Several studies have shown that##2##5##(2012-3#2)
Several studies have##11##3##(1992-12#1)(1997-1#1)(2008-11#5)(2009-8#1)(2012-3#2)(2013-1#1)
Several studies##19##2##(1992-12#1)(1997-1#1)(2008-11#9)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2012-3#2)(2013-1#1)
Several synthetic##2##2##(1991-9#1)(2008-9#1)
Several transcripts##2##2##(2008-10#1)(2012-2#1)
Several types of##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#2)
Several years after##2##3##(2008-11#1)(2011-2#1)
Several##323##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2006-6#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#100)(2008-11#32)(2008-12#7)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#10)(2008-7#5)(2008-8#9)(2008-9#11)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#3)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#12)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#7)(2013-8#1)
Severe VDD was##2##3##(2011-1#2)
Severe bilateral microphthalmos in a Pomeranian pup - A##2##9##(2013-8#2)
Severe bilateral##3##2##(2012-2#1)(2013-8#2)
Severe hypotension##2##2##(1990-8#1)(2008-7#1)
Severe injuries##2##2##(1990-9#2)
Severe skew foot deformity##2##4##(2012-3#2)
Severe##46##1##(1990-8#1)(1990-9#2)(1991-8#1)(1996-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#8)(2013-1#4)(2013-8#2)
Severely##2##1##(2010-8#1)(2013-1#1)
Severity Index (CTSI)##2##3##(2009-8#2)
Severity Index##6##2##(1992-2#1)(1995-2#1)(2009-8#3)(2013-8#1)
Severity of disease##2##3##(2008-10#1)(2008-7#1)
Severity of symptoms##2##3##(2008-10#2)
Severity of##10##2##(2008-10#8)(2008-7#1)(2010-1#1)
Severity on##2##2##(2008-10#2)
Severity##24##1##(1992-2#1)(1995-2#1)(2008-10#13)(2008-7#2)(2009-8#3)(2010-1#1)(2013-8#3)
Sevoflurane had##3##2##(2012-3#3)
Sevoflurane##7##1##(2012-3#7)
Sewall Wright Award##2##3##(2008-8#1)(2008-9#1)
Sex allocation##3##2##(2008-9#3)
Sex and##3##2##(2008-11#1)(2008-5#1)(2009-12#1)
Sex chromosomes and##2##3##(2008-8#1)(2010-5#1)
Sex differences in the##2##4##(1994-2#1)(2008-9#1)
Sex differences in##3##3##(1994-2#1)(2008-9#2)
Sex differences##5##2##(1994-2#1)(2008-5#1)(2008-9#3)
Sex is##2##2##(1997-7#1)(2008-1#1)
Sex ratio##2##2##(2008-8#2)
Sex##33##1##(1991-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#4)(2008-9#6)(2009-12#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#2)
Sexting##4##1##(2013-1#4)
Sexual Reproduction##2##2##(2008-10#2)
Sexual Risk Behavior in##2##4##(2013-1#2)
Sexual abuse is a problem of epidemic proportions in the United States##2##12##(2010-10#1)(2010-4#1)
Sexual abuse is a problem of epidemic proportions in##3##9##(2009-9#1)(2010-10#1)(2010-4#1)
Sexual abuse##4##2##(2009-9#1)(2010-10#2)(2010-4#1)
Sexual conflict and##2##3##(2008-8#1)(2008-9#1)
Sexual conflict##3##2##(2008-8#2)(2008-9#1)
Sexual dimorphism in##2##3##(2008-9#1)(2010-6#1)
Sexual harassment##2##2##(1996-2#1)(1996-3#1)
Sexual selection##3##2##(1995-2#3)
Sexual traits##2##2##(2012-3#2)
Sexual##41##1##(1990-6#1)(1990-8#1)(1991-3#1)(1992-12#1)(1994-2#1)(1995-2#3)(1996-2#1)(1996-3#1)(2008-10#8)(2008-12#1)(2008-8#5)(2008-9#2)(2009-9#1)(2010-10#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
Sexually Transmitted##2##2##(2011-2#2)
Sexually dimorphic##2##2##(2008-8#1)(2008-9#1)
Sexually##7##1##(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
Seymour##2##1##(1993-1#1)(2010-4#1)
Sf##3##1##(1993-8#1)(1997-8#2)
Sf-21##3##1##(2008-11#3)
Sf-9 and Trichoplusia##3##3##(2008-7#3)
Sf-9 cell cultures##3##3##(2008-11#1)(2008-7#2)
Sf-9 cell##4##2##(2008-11#2)(2008-7#2)
Sf-9 cells##6##2##(2008-11#1)(2008-7#5)
Sf-9 insect cell##3##3##(2008-11#2)(2008-7#1)
Sf-9##16##1##(2008-11#5)(2008-7#11)
Sf-900 II SFM##2##3##(2008-7#2)
Sf-900 II##4##2##(2008-7#4)
Sf9 cells##9##2##(1992-3#1)(2008-1#1)(2008-11#5)(2008-8#2)
Sf9 insect cell line##3##4##(2008-11#3)
Sf9 insect cell##5##3##(2008-11#5)
Sf9 insect cells##3##3##(1992-10#1)(1993-8#1)(2008-11#1)
Sf9 insect##9##2##(1992-10#1)(1993-8#1)(2008-11#7)
Sf9##21##1##(1992-10#1)(1992-3#1)(1993-8#1)(2008-1#1)(2008-11#14)(2008-8#2)(2008-9#1)
Sf900 II medium##2##3##(2008-11#2)
Sf900 II##3##2##(2008-11#3)
Sh12B##4##1##(2008-10#4)
Shallot##2##1##(2008-10#1)(2008-9#1)
Sham##3##1##(2013-8#3)
Shampoos##2##1##(2008-5#2)
Shams##5##1##(2008-10#5)
Shanghai##10##1##(1990-2#4)(2008-10#1)(2011-2#2)(2013-8#3)
Shannon##3##1##(2008-10#2)(2008-8#1)
Shannon's##2##1##(2008-10#2)
Shanyou63##4##1##(2008-9#4)
Shape of##2##2##(2008-3#1)(2012-3#1)
Shape##3##1##(2008-3#1)(2008-6#1)(2012-3#1)
Shaping a preferred future##2##4##(1997-2#1)(1997-3#1)
Shared medical decision-making##2##3##(2008-4#2)
Shared##6##1##(1991-1#1)(2008-4#2)(2008-8#1)(2009-7#1)(2013-1#1)
Sharing information##2##2##(1996-2#1)(1997-1#1)
Sharing##6##1##(1992-9#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2011-9#1)
Shc is##2##2##(1997-7#1)(2012-2#1)
Shc##17##1##(1995-8#3)(1997-7#10)(2012-2#4)
She had a##3##3##(2010-6#1)(2013-1#2)
She had been##2##3##(1996-11#1)(2010-11#1)
She had##14##2##(1995-12#1)(1996-11#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#4)(2013-8#2)
She is##3##2##(2013-1#2)(2013-8#1)
She presented with##4##3##(2008-11#1)(2009-1#1)(2012-3#1)(2013-1#1)
She recovered##2##2##(1995-12#1)(2013-1#1)
She responded to##2##3##(2008-12#1)(2010-11#1)
She subsequently underwent##2##3##(1994-12#1)(2013-1#1)
She subsequently##3##2##(1994-12#1)(2011-2#1)(2013-1#1)
She underwent##4##2##(1997-5#1)(2007-8#1)(2011-2#1)(2013-7#1)
She was admitted##2##3##(2009-1#1)(2011-2#1)
She was diagnosed with##2##4##(2012-3#2)
She was managed##2##3##(2013-1#1)(2013-8#1)
She was treated with##2##4##(1990-6#1)(2013-1#1)
She was##23##2##(1990-6#1)(1990-8#1)(1994-8#1)(1995-11#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-1#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#3)
She##69##1##(1990-6#1)(1990-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#2)(1996-11#1)(1996-12#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-5#2)(2008-8#2)(2009-1#2)(2009-3#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#3)(2010-9#1)(2011-2#6)(2012-12#1)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#6)
Shear##2##1##(2009-10#1)(2010-12#1)
Sheath Blight##2##2##(2008-10#2)
Sheath##3##1##(2008-10#3)
Shedding##3##1##(2008-12#1)(2012-2#1)(2013-8#1)
Sheehan's syndrome##2##2##(2011-2#2)
Sheffield##2##1##(2008-12#2)
Sheldon##3##1##(1995-12#2)(2012-3#1)
Shelter##2##1##(1995-3#1)(2010-5#1)
Shelton##2##1##(1994-3#2)
Shen##4##1##(2013-8#4)
Shepody##2##1##(2008-10#2)
Sherman##2##1##(1991-1#1)(1995-3#1)
Sherry wines##4##2##(2008-10#4)
Sherry##6##1##(2008-10#6)
Shetland sheepdog and Collie were##2##5##(2011-2#2)
Shield##7##1##(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#3)(2012-3#1)
Shift Work##2##2##(2010-7#2)
Shift and exchange of information concerning patients(4##3##7##(1991-2#3)
Shift##8##1##(1991-2#3)(2008-3#1)(2008-7#1)(2010-7#3)
Shifting the paradigm##2##3##(1997-2#1)(2013-1#1)
Shifts in##2##2##(1992-2#1)(2010-4#1)
Shiga toxin producing Escherichia coli##2##5##(2012-2#2)
Shiga##3##1##(2012-2#2)(2013-1#1)
Shigella flexneri##5##2##(1993-12#2)(2008-10#1)(2008-9#1)(2013-8#1)
Shigella sonnei##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
Shigella##12##1##(1993-12#2)(1994-9#1)(2008-10#4)(2008-9#3)(2012-2#1)(2013-8#1)
Shimadzu##3##1##(2008-10#3)
Shimla##2##1##(1995-10#1)(2013-1#1)
Shine-Dalgarno sequence##3##2##(1996-8#1)(1997-2#1)(1997-6#1)
Shiraz##4##1##(2008-10#1)(2008-12#3)
Shock-wave lithotripsy##2##2##(2008-10#2)
Shock-wave##3##1##(1993-5#1)(2008-10#2)
Shoemaker-Levy 9##3##2##(1995-6#3)
Shoot##4##1##(1997-2#1)(2008-10#3)
Shoots##5##1##(2008-10#5)
Short Form 36 (SF36)##2##4##(2008-1#1)(2008-10#1)
Short Form##4##2##(2008-1#1)(2008-10#2)(2012-12#1)
Short##24##1##(1990-3#1)(1991-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
Short-Form 36##3##2##(2010-10#1)(2012-12#1)(2013-1#1)
Short-acting##2##1##(1997-1#1)(2009-9#1)
Short-term##7##1##(1991-2#1)(1995-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
Shorter##3##1##(1992-11#1)(2008-7#1)(2009-5#1)
Shot-noise-limited##2##1##(2008-3#2)
Should I##2##2##(2008-11#1)(2010-9#1)
Should conization by hot loop or laser replace cervical biopsy?##2##10##(1992-3#2)
Should the##3##2##(1994-1#1)(1996-1#1)(1997-1#1)
Should we##2##2##(1991-2#1)(2009-5#1)
Should##24##1##(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#2)(1994-1#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-1#1)(2008-10#1)(2008-11#4)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#2)
Shoulder##7##1##(1997-1#1)(2007-12#1)(2008-9#3)(2009-1#1)(2010-7#1)
Show##2##1##(1991-3#1)(2008-10#1)
Showing##3##1##(2008-10#1)(2008-9#1)(2010-10#1)
Shpol'skii spectrometry##5##2##(2008-10#5)
Shpol'skii##8##1##(2008-10#8)
Shriver##2##1##(1994-3#2)
Shuanghuanglian injection##3##2##(2011-2#3)
Shuanghuanglian##5##1##(2011-2#4)(2011-3#1)
Si and Al##3##3##(2008-10#3)
Si and Ti)##2##3##(2008-10#2)
Si and##5##2##(2008-10#5)
Si in##2##2##(2008-10#2)
Si##40##1##(1993-1#1)(1993-5#1)(1994-2#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-9#2)(2013-8#1)
Si(+) plants##2##2##(2008-10#2)
Si(+)##3##1##(2008-10#3)
Si(100) surfaces##2##2##(2008-10#2)
Si(IV)##3##1##(2008-10#3)
Si+ plants##5##2##(2008-10#5)
Si+##6##1##(2008-10#6)
Si- plants##2##2##(2008-10#2)
Si-##4##1##(2008-10#4)
Si-sol##4##1##(2008-10#4)
Si-tot##3##1##(2008-10#3)
SiC##2##1##(2008-3#1)(2013-1#1)
SiH bonds##2##2##(2008-10#2)
SiMe(2)##2##1##(2009-9#2)
SiO(2) modified##2##2##(2008-10#2)
SiO(2)##11##1##(2008-10#10)(2008-3#1)
SiO2##4##1##(1992-8#2)(2008-10#1)(2008-11#1)
SiOEP and PtOEP##2##3##(2008-10#2)
SiOEP##4##1##(2008-10#4)
SiR-HP##4##1##(1993-8#4)
Siberian hamster##2##2##(1994-2#2)
Siberian##5##1##(1994-2#3)(2008-6#1)(2008-8#1)
Sibling##3##1##(2008-10#3)
Sichuan##2##1##(2008-8#2)
Sicily##2##1##(1991-2#1)(1992-12#1)
Sick##3##1##(1994-12#1)(2007-11#1)(2008-11#1)
Sicyonia ingentis##2##2##(2007-12#2)
Sidama##3##1##(2010-6#3)
Side effects of##2##3##(1997-6#1)(2011-2#1)
Side effects##5##2##(1990-2#1)(1990-6#1)(1997-4#1)(1997-6#1)(2011-2#1)
Side##6##1##(1990-2#1)(1990-6#1)(1997-4#1)(1997-6#1)(2011-2#1)(2013-1#1)
Side-Stream##2##1##(1995-3#2)
Siemens##2##1##(1992-2#1)(2008-8#1)
Sierra Nevada##3##2##(2008-10#3)
Sierra##4##1##(2008-10#4)
Sig-1R##4##1##(2011-2#4)
Sigatoka disease##2##2##(2008-10#2)
Sigma##7##1##(2008-10#5)(2013-1#2)
Sigmodon##3##1##(2010-4#3)
Sigmoid transfer functions were used in the hidden and output layers to facilitate nonlinear calibration##2##15##(2008-10#2)
Sigmoid##5##1##(2008-10#2)(2008-12#1)(2012-3#2)
Sigmoidal##2##1##(2008-10#2)
Sign Language (ASL)##2##3##(2011-2#2)
Sign##3##1##(2011-2#2)(2013-7#1)
Signal Detection Theory##2##3##(1991-2#1)(2008-11#1)
Signal and##2##2##(2008-2#1)(2008-3#1)
Signal transduction##2##2##(1995-8#1)(2008-9#1)
Signal##14##1##(1991-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-2#2)(2013-7#1)
Signaling##9##1##(2008-10#1)(2008-8#2)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#3)
Signalling##2##1##(1991-2#1)(1996-2#1)
Signals for##2##2##(1995-2#1)(1996-12#1)
Signals were measured as peak height by using an instrument software##2##11##(2008-10#2)
Signals were##3##2##(2008-10#3)
Signals##8##1##(1995-2#2)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
Significance of##9##2##(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
Significance##10##1##(1997-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
Significant (P = 0##3##4##(2008-10#3)
Significant (P##4##2##(2008-10#4)
Significant changes in##2##3##(1990-3#1)(2012-2#1)
Significant changes##3##2##(1990-3#1)(1991-2#1)(2012-2#1)
Significant differences (P &lt##2##4##(2008-10#2)
Significant differences among##2##3##(1993-1#1)(2008-10#1)
Significant differences in the##2##4##(2008-3#1)(2012-2#1)
Significant differences in##9##3##(1996-2#1)(2008-10#5)(2008-3#1)(2010-10#1)(2012-2#1)
Significant differences were found##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
Significant differences were##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
Significant differences##22##2##(1992-4#1)(1993-1#1)(1996-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
Significant improvement##2##2##(2008-6#1)(2008-7#1)
Significant increases in the##2##4##(2008-8#1)(2008-9#1)
Significant increases in##3##3##(1994-3#1)(2008-8#1)(2008-9#1)
Significant positive correlations were found##2##5##(2008-10#1)(2008-7#1)
Significant predictors of##2##3##(2008-11#1)(2013-1#1)
Significant progress##2##2##(1997-6#1)(2011-2#1)
Significant##91##1##(1990-3#1)(1991-2#1)(1992-4#1)(1993-1#1)(1994-3#2)(1995-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#33)(2008-11#8)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
Significantly fewer##2##2##(1997-3#1)(2008-10#1)
Significantly higher levels of##2##4##(1995-2#1)(2008-10#1)
Significantly higher levels##3##3##(1992-2#1)(1995-2#1)(2008-10#1)
Significantly higher##4##2##(1992-2#1)(1995-2#1)(2008-10#1)(2013-1#1)
Significantly more##4##2##(1995-10#1)(2008-10#2)(2011-2#1)
Significantly##23##1##(1992-2#1)(1992-3#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#2)
Signs of##3##2##(1994-3#1)(1996-3#1)(2012-12#1)
Signs##4##1##(1992-2#1)(1994-3#1)(1996-3#1)(2012-12#1)
Sil-Ntga##2##1##(2008-10#2)
Silastic##6##1##(1995-1#1)(1996-3#2)(2008-5#1)(2008-8#1)(2011-2#1)
Silencing##6##1##(2008-10#3)(2012-3#2)(2013-1#1)
Silene##4##1##(2008-8#3)(2012-7#1)
Silesia##3##1##(2008-10#2)(2013-1#1)
Silica gel was##2##3##(2008-10#2)
Silica gel##7##2##(2008-10#7)
Silica##14##1##(1996-9#1)(2008-10#13)
SilicoSec##7##1##(2008-12#7)
Silicon##11##1##(1996-9#1)(1997-4#1)(2008-10#8)(2008-11#1)
Silver halide##2##2##(2008-3#2)
Silver nitrate##2##2##(1993-12#1)(2008-10#1)
Silver##12##1##(1990-11#1)(1992-2#1)(1993-12#1)(2008-10#7)(2008-3#2)
Silver(I) ion selective##2##3##(2008-10#2)
Silver(I) was##2##2##(2008-10#2)
Silver(I)##4##1##(2008-10#4)
Silwet L-77##2##2##(2008-10#2)
Simazine and##2##2##(2008-10#2)
Simian##3##1##(1991-9#1)(1995-6#1)(2008-11#1)
Similar changes##2##2##(2008-10#1)(2008-11#1)
Similar differences were##2##3##(1994-8#1)(2008-10#1)
Similar patterns##2##2##(1996-12#1)(2008-10#1)
Similar results were found for##3##5##(1997-1#1)(2008-9#1)(2010-9#1)
Similar results were observed##2##4##(2008-5#1)(2008-8#1)
Similar results were obtained in##2##5##(2008-10#1)(2008-7#1)
Similar results were obtained using##2##5##(2008-10#2)
Similar results were obtained when##2##5##(2008-10#2)
Similar results were obtained with the##3##6##(1995-8#1)(1997-3#1)(2008-10#1)
Similar results were obtained with##4##5##(1995-8#1)(1997-3#1)(2008-10#2)
Similar results were obtained##14##4##(1990-2#1)(1995-8#1)(1997-3#1)(2008-10#9)(2008-7#1)(2009-6#1)
Similar results were##21##3##(1990-2#1)(1991-2#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)
Similar results##22##2##(1990-2#1)(1991-2#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)
Similar to other##3##3##(1997-3#1)(2008-10#1)(2010-4#1)
Similar to##9##2##(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-11#1)(2010-4#1)
Similar##82##1##(1990-2#2)(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-3#2)(1997-4#1)(2008-10#32)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#2)(2010-10#2)(2010-12#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
Similarities and differences between##2##4##(1994-6#1)(2011-2#1)
Similarities and differences##3##3##(1994-6#1)(2008-2#1)(2011-2#1)
Similarities between##2##2##(2008-10#1)(2008-7#1)
Similarities##7##1##(1994-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
Similarity##7##1##(1991-6#1)(1995-6#2)(2008-10#4)
Similarly the##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
Similarly to the##2##3##(1994-12#1)(2008-10#1)
Similarly to##3##2##(1994-12#1)(2008-10#2)
Similarly##89##1##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Simon##3##1##(1995-11#1)(2008-11#1)(2009-9#1)
Simons##3##1##(2008-12#2)(2010-11#1)
Simple Method for##2##3##(1996-5#1)(2013-1#1)
Simple Sequence Repeat##2##3##(2008-10#2)
Simple and rapid##2##3##(2008-10#2)
Simple and sensitive##2##3##(2008-10#2)
Simple and##8##2##(2008-10#7)(2008-11#1)
Simple method##2##2##(2008-2#1)(2008-3#1)
Simple models##2##2##(2008-8#2)
Simple rules##2##2##(2009-10#1)(2009-3#1)
Simple##52##1##(1990-12#1)(1992-12#1)(1992-3#1)(1994-12#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-12#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
Simplex##3##1##(2008-10#1)(2008-7#1)(2013-8#1)
Simplified##2##1##(2008-10#1)(2009-10#1)
Simplifying the##2##2##(1994-3#1)(2008-10#1)
Simply##2##1##(2008-10#1)(2008-3#1)
Simulated yield losses##2##3##(2008-10#2)
Simulated##11##1##(2008-10#9)(2008-2#1)(2008-8#1)
Simulating the##2##2##(1994-2#1)(2008-10#1)
Simulation experiments##2##2##(2008-10#2)
Simulation of##5##2##(1990-11#1)(2008-11#1)(2010-3#1)(2011-2#2)
Simulation results confirm the##2##4##(2008-10#1)(2008-11#1)
Simulation results##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
Simulation studies are##2##3##(2010-11#1)(2010-5#1)
Simulation studies##5##2##(2008-10#1)(2008-3#1)(2010-11#1)(2010-5#1)(2013-1#1)
Simulation##23##1##(1990-11#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#3)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
Simulations are##2##2##(1997-2#1)(2008-3#1)
Simulations of##2##2##(1996-9#1)(2008-3#1)
Simulations show that the##3##4##(2008-3#3)
Simulations show that##4##3##(2008-3#3)(2013-8#1)
Simulations show##6##2##(1997-6#1)(2008-3#4)(2013-8#1)
Simulations##22##1##(1996-12#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#8)(2008-7#1)(2008-8#2)(2013-8#1)
Simultaneous Detection of##2##3##(2008-10#2)
Simultaneous analysis of##3##3##(2008-10#3)
Simultaneous analysis##4##2##(2008-10#4)
Simultaneous detection of##7##3##(2006-6#1)(2008-10#6)
Simultaneous determination of Fe(II) and Fe(III)##2##6##(2008-10#2)
Simultaneous determination of cadmium##2##4##(2008-10#2)
Simultaneous determination of copper and##2##5##(2008-10#2)
Simultaneous determination of copper##4##4##(2008-10#4)
Simultaneous determination of iron and##2##5##(2008-10#2)
Simultaneous determination of iron##3##4##(2008-10#3)
Simultaneous determination of lead##2##4##(2008-10#2)
Simultaneous determination of manganese and##2##5##(2008-10#2)
Simultaneous determination of pseudoephedrine##2##4##(2008-10#2)
Simultaneous determination of three##2##4##(2008-10#2)
Simultaneous determination of tin##2##4##(2008-10#2)
Simultaneous determination of trace##4##4##(2008-10#4)
Simultaneous determination of##70##3##(2008-10#68)(2008-5#1)(2012-2#1)
Simultaneous kinetic determination of##2##4##(2008-10#2)
Simultaneous kinetic spectrophotometric determination of##2##5##(2008-10#2)
Simultaneous kinetic##4##2##(2008-10#4)
Simultaneous kinetic-spectrophotometric determination of##2##4##(2008-10#2)
Simultaneous separation##2##2##(2008-10#2)
Simultaneous spectrofluorimetric determination of##2##4##(2008-10#2)
Simultaneous spectrophotometric determination of##9##4##(2008-10#9)
Simultaneous spectrophotometric##10##2##(2008-10#10)
Simultaneous voltammetric determination of##2##4##(2008-10#2)
Simultaneous voltammetric##3##2##(2008-10#3)
Simultaneous##158##1##(1992-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-11#2)(2008-10#124)(2008-11#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Simultaneously##12##1##(1990-8#1)(1994-2#1)(1996-2#1)(2008-10#2)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
Simvastatin##2##1##(2009-6#2)
Sinai Medical Center##2##3##(1995-12#1)(1995-8#1)
Sinai##4##1##(1991-12#1)(1995-12#1)(1995-8#1)(1996-3#1)
Sinaloa##5##1##(2008-10#4)(2008-8#1)
Sinapis##2##1##(2008-10#2)
Since 1977##2##2##(1992-1#1)(1994-9#1)
Since 1981##2##2##(1990-3#1)(1994-3#1)
Since 1990##3##2##(1994-3#1)(2008-11#1)(2008-5#1)
Since 1991##4##2##(1995-2#1)(1997-4#1)(1997-8#1)(2008-10#1)
Since 1992##4##2##(1996-3#2)(2008-1#1)(2008-5#1)
Since 1994##2##2##(2009-8#1)(2012-6#1)
Since 2000##2##2##(2013-1#2)
Since a##5##2##(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
Since both##4##2##(1991-3#1)(1992-8#1)(2008-7#1)(2013-8#1)
Since early##3##2##(1990-12#1)(1991-3#1)(1992-2#1)
Since in##3##2##(1993-3#1)(1996-3#1)(2008-9#1)
Since it is##3##3##(1994-11#1)(1995-5#1)(2008-11#1)
Since it##6##2##(1994-11#1)(1994-6#1)(1995-5#1)(2008-11#1)(2009-12#1)(2011-2#1)
Since its adoption##2##3##(2008-3#2)
Since its first description##2##4##(2011-2#2)
Since its first##3##3##(2008-10#1)(2011-2#2)
Since its inception##3##3##(1996-3#1)(2008-12#1)(2008-9#1)
Since its##8##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)(2011-2#2)
Since many##4##2##(2008-7#2)(2010-11#1)(2011-2#1)
Since most##2##2##(2008-10#1)(2008-7#1)
Since no##4##2##(1996-2#1)(1997-1#1)(2008-10#1)(2008-9#1)
Since only##2##2##(2009-3#1)(2011-2#1)
Since other##2##2##(1994-6#1)(2008-10#1)
Since proteins##2##2##(1996-3#1)(2009-6#1)
Since the 1990s##2##3##(2010-12#1)(2012-2#1)
Since the advent of##2##4##(2008-11#1)(2010-7#1)
Since the beginning of##2##4##(1997-6#1)(2008-11#1)
Since the early##4##3##(1992-8#1)(2008-10#2)(2009-10#1)
Since the first##3##3##(1997-8#1)(2008-7#1)(2008-9#1)
Since the introduction of the##2##5##(1997-5#1)(2008-5#1)
Since the introduction of##6##4##(1997-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-12#1)
Since the origins until today##2##5##(2008-10#2)
Since the peaks##2##3##(2008-10#2)
Since the##90##2##(1991-12#1)(1991-3#2)(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-2#1)(1993-6#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-5#1)(1997-6#3)(1997-8#2)(2008-10#22)(2008-11#8)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
Since then##22##2##(1992-2#1)(1994-3#2)(1994-6#1)(1996-1#1)(1996-11#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#2)
Since there were no##2##4##(1991-5#1)(2011-2#1)
Since there were##3##3##(1991-5#1)(1996-12#1)(2011-2#1)
Since there##5##2##(1990-2#1)(1991-5#1)(1993-12#1)(1996-12#1)(2011-2#1)
Since these##6##2##(1992-2#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
Since this##6##2##(1994-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
Since##340##1##(1990-12#3)(1990-2#3)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#5)(1991-5#1)(1991-7#1)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#7)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#5)(1995-12#4)(1995-2#4)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#6)(1997-1#6)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#7)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#48)(2008-11#28)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#12)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#24)(2011-3#2)(2012-12#1)(2012-2#11)(2012-3#2)(2012-6#1)(2013-1#6)(2013-8#5)
Sindh##3##1##(2008-10#3)
Singapore Chinese##4##2##(2010-6#4)
Singapore##12##1##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-6#4)(2012-12#1)
Singh##2##1##(1991-9#1)(2013-1#1)
Single Center Experience##2##3##(1995-11#1)(2008-1#1)
Single incision laparoscopic surgery##2##4##(2012-12#2)
Single molecule##2##2##(2008-10#1)(2012-2#1)
Single nucleotide polymorphism##2##3##(2008-10#1)(2008-8#1)
Single nucleotide polymorphisms (SNPs)##3##4##(2008-10#2)(2012-3#1)
Single nucleotide polymorphisms##4##3##(2008-10#2)(2012-3#2)
Single nucleotide##7##2##(1993-12#1)(2008-10#3)(2008-8#1)(2012-3#2)
Single photon emission##2##3##(1994-1#1)(2012-2#1)
Single##61##1##(1990-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-9#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)
Single- and multiple-pulse##2##3##(2008-3#2)
Single-Chain##2##1##(2008-10#2)
Single-Particle##2##1##(2008-11#1)(2008-3#1)
Single-base##2##1##(2008-4#1)(2008-9#1)
Single-cell##2##1##(2008-10#1)(2010-10#1)
Single-chain##3##1##(1991-7#1)(2008-10#1)(2008-8#1)
Single-crystal sapphire-fiber optic sensors based on surface plasmon resonance##2##9##(2008-10#2)
Single-crystal##4##1##(1996-5#1)(2008-10#3)
Single-mode optical##2##2##(2008-2#1)(2008-3#1)
Single-mode##3##1##(2008-2#1)(2008-3#2)
Single-nucleotide sequence discrimination in situ using padlock probes##2##8##(2008-4#1)(2008-9#1)
Single-nucleotide##4##1##(2008-4#1)(2008-9#2)(2011-2#1)
Single-photon##2##1##(2008-3#1)(2009-10#1)
Single-step##2##1##(2008-10#2)
Single-strand conformation polymorphism analysis##2##4##(1991-12#1)(2008-10#1)
Single-strand conformation polymorphism##3##3##(1991-12#1)(2008-10#2)
Sinioris##7##1##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Sinomenine##3##1##(1994-8#3)
Sinonasal teratocarcinosarcoma##2##2##(2008-11#2)
Sinonasal##4##1##(2008-11#2)(2009-1#1)(2011-2#1)
Sinorhizobium meliloti##2##2##(2008-9#2)
Sinularia##4##1##(2010-2#4)
Sinus##3##1##(2008-6#1)(2011-2#1)(2012-3#1)
Sir##3##1##(2008-10#2)(2008-7#1)
Sister Ryan delivered##2##3##(1994-1#2)
Sister chromatid exchange##2##3##(1990-6#2)
Sister##6##1##(1990-6#2)(1994-1#3)(2012-2#1)
Sisters of##3##2##(1991-2#1)(1993-5#1)(1994-2#1)
Sisters##5##1##(1991-2#3)(1993-5#1)(1994-2#1)
Site##5##1##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#1)
Site-directed mutagenesis##2##2##(1990-10#1)(1995-2#1)
Site-specific##3##1##(1993-5#1)(1993-8#1)(2008-5#1)
Sites##6##1##(2008-10#3)(2008-9#1)(2011-2#1)(2012-3#1)
Sitisi and##2##2##(2008-1#2)
Sitisi##6##1##(2008-1#6)
Sitobion avenae##2##2##(2008-10#2)
Situ##5##1##(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
Situs inversus##2##2##(2009-8#2)
Six common##2##2##(2008-10#1)(2012-2#1)
Six different##6##2##(2008-10#4)(2008-11#1)(2011-2#1)
Six groups##2##2##(1996-12#1)(2008-10#1)
Six hours after##2##3##(1993-8#1)(2009-1#1)
Six hours##3##2##(1993-8#1)(2009-1#1)(2013-1#1)
Six hundred and##2##3##(1996-8#2)
Six hundred##4##2##(1991-12#1)(1996-8#2)(2011-1#1)
Six months after the##2##4##(2011-2#1)(2012-2#1)
Six months after##3##3##(2009-11#1)(2011-2#1)(2012-2#1)
Six months##6##2##(2008-5#1)(2009-1#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-2#1)
Six of the##4##3##(1997-5#1)(2008-10#1)(2008-11#2)
Six of these##4##3##(1996-3#1)(1996-6#1)(2008-10#1)(2008-7#1)
Six of##9##2##(1996-3#1)(1996-6#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-11#1)
Six patients died##2##3##(2012-3#1)(2013-1#1)
Six patients had##2##3##(1991-2#1)(1994-12#1)
Six patients underwent##2##3##(2008-11#1)(2008-7#1)
Six patients were##2##3##(1991-2#1)(2011-2#1)
Six patients with##2##3##(1991-6#1)(1997-3#1)
Six patients##11##2##(1991-12#1)(1991-2#2)(1991-6#1)(1994-12#1)(1997-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Six subjects##2##2##(2008-11#1)(2008-12#1)
Six synthetic samples were determined##2##5##(2008-10#2)
Six weeks##2##2##(1991-9#1)(1992-2#1)
Six##126##1##(1990-3#1)(1990-5#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-9#1)(2008-10#37)(2008-11#9)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-1#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
Six-week-old##2##1##(2008-10#2)
Sixteen##17##1##(1990-2#1)(1992-3#1)(1994-12#2)(1994-9#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
Sixth International##2##2##(2008-11#1)(2012-3#1)
Sixth##4##1##(1995-12#1)(1996-1#1)(2008-11#1)(2012-3#1)
Sixty patients were##2##3##(2011-2#1)(2012-3#1)
Sixty patients##3##2##(1996-6#1)(2011-2#1)(2012-3#1)
Sixty percent of##2##3##(2008-10#1)(2012-3#1)
Sixty##17##1##(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-11#1)(2010-7#2)(2011-2#3)(2012-3#3)(2013-1#1)
Sixty-eight##2##1##(2008-10#1)(2012-2#1)
Sixty-five patients##2##2##(1991-3#1)(2011-2#1)
Sixty-five##5##1##(1991-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
Sixty-four patients##3##2##(1992-9#1)(2008-11#1)(2013-1#1)
Sixty-four##5##1##(1992-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
Sixty-nine##3##1##(1993-12#1)(2008-10#1)(2008-11#1)
Sixty-one patients##4##2##(1990-3#2)(1991-8#1)(1995-1#1)
Sixty-one##5##1##(1990-3#2)(1991-8#1)(1995-1#1)(2008-10#1)
Sixty-six##5##1##(1992-3#1)(1995-2#1)(1997-3#1)(2008-7#1)(2010-4#1)
Sixty-three##2##1##(1991-2#1)(2008-9#1)
Sixty-two##5##1##(1997-2#1)(2008-1#2)(2009-10#1)(2009-11#1)
Size distribution did##2##3##(2008-9#2)
Size##13##1##(1992-6#1)(1996-9#1)(2008-10#6)(2008-8#2)(2008-9#2)(2009-12#1)
Size-exclusion chromatography##3##2##(1997-2#1)(2008-4#1)(2010-11#1)
SjAb in##3##2##(2008-10#3)
SjAb##6##1##(2008-10#6)
SjAg##3##1##(2008-10#3)
Sjögren's syndrome##3##2##(2007-11#2)(2012-3#1)
Skeletal muscle##2##2##(1993-9#1)(2008-1#1)
Skeletal##5##1##(1993-9#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-3#1)
Skeleton##2##1##(1994-2#2)
Skew##2##1##(1995-3#1)(2012-3#1)
Skills in##2##2##(1993-12#1)(2008-12#1)
Skills##7##1##(1993-12#1)(2008-11#2)(2008-12#2)(2011-2#1)(2012-12#1)
Skin ageing##2##2##(2008-5#2)
Skin barrier##2##2##(2008-5#2)
Skin colour##3##2##(2008-5#3)
Skin impedance##3##2##(2008-10#2)(2010-4#1)
Skin moisturisation and elasticity##2##4##(2008-5#2)
Skin penetration##2##2##(2008-5#2)
Skin surface##2##2##(2008-5#2)
Skin##43##1##(1990-8#1)(1991-6#1)(1991-8#1)(2008-10#3)(2008-11#1)(2008-5#25)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-3#2)(2013-8#1)
SkleroPro##3##1##(2008-10#3)
Skull Base##5##2##(2011-2#2)(2012-3#3)
Skull##6##1##(2011-2#2)(2012-3#4)
Sl cells##5##2##(2008-11#5)
Sl##7##1##(2008-11#7)
Sleep##11##1##(1994-8#1)(1997-4#1)(2008-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Slice##2##1##(2011-2#1)(2013-8#1)
Slight##2##1##(1995-11#1)(2008-5#1)
Slightly##4##1##(1993-2#1)(2007-12#1)(2008-10#2)
Slope##3##1##(1995-8#1)(2008-10#2)
Slovakia##3##1##(1994-12#1)(2008-10#2)
Slovenia##2##1##(2008-11#2)
Slow and##2##2##(1993-12#1)(2012-2#1)
Slow##5##1##(1993-12#1)(1995-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
Slump Test##6##2##(2008-12#6)
Slump##7##1##(2008-12#7)
Slurry sampling ETAAS##3##3##(2008-10#3)
Slurry sampling##7##2##(2008-10#7)
Slurry##10##1##(2008-10#10)
Sm##13##1##(1993-12#2)(1997-9#1)(2008-10#10)
Sm(3+)##4##1##(2008-10#4)
Sm(III)##2##1##(2008-10#2)
Sm10##4##1##(2008-10#4)
Sm10T##4##1##(2008-10#4)
Sma I##3##2##(1992-6#2)(2008-8#1)
SmaI##3##1##(1993-8#1)(1996-12#1)(2008-10#1)
Smac/DIABLO##4##1##(2008-11#4)
Smad2 conditional##4##2##(2008-9#4)
Smad2 gene##2##2##(2008-9#2)
Smad2##9##1##(2008-9#9)
Smad5 double knockout ES cells##5##5##(2008-8#5)
Smad5##12##1##(2008-8#11)(2013-8#1)
Small Bowel##2##2##(2012-3#1)(2013-1#1)
Small Grains##2##2##(2008-10#2)
Small RNA##2##2##(2008-10#1)(2008-9#1)
Small bowel obstruction##2##3##(1997-8#1)(2009-8#1)
Small bowel##4##2##(1995-10#1)(1997-8#1)(2009-8#1)(2013-1#1)
Small cell carcinoma##2##3##(1992-12#1)(2009-1#1)
Small differences##2##2##(1992-12#1)(1994-5#1)
Small grant management##2##3##(2010-7#2)
Small##47##1##(1990-3#1)(1992-12#3)(1994-11#1)(1994-5#2)(1994-6#1)(1995-10#1)(1996-1#1)(1997-3#2)(1997-8#1)(2008-10#11)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-7#2)(2012-3#1)(2013-1#3)(2013-8#1)
Smaller##4##1##(1993-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
Smart##4##1##(1994-9#1)(1995-11#1)(1996-6#1)(2008-10#1)
SmartWire##4##1##(1996-6#4)
Smead Jones##2##2##(1992-2#2)
Smith##4##1##(1995-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
Smith-Magenis syndrome##2##2##(1997-3#2)
SmithKline Beecham##3##2##(2008-5#3)
Smiths Medical CADD-Solis infusion pumps##2##5##(2011-2#2)
Smiths Medical Medfusion 3010a syringe##2##5##(2011-2#2)
Smiths Medical##6##2##(2011-2#6)
Smoke##2##1##(1996-12#2)
Smoking and##3##2##(2009-7#2)(2013-8#1)
Smoking cessation##6##2##(2008-11#2)(2008-3#1)(2009-1#1)(2009-7#1)(2011-2#1)
Smoking habits##2##2##(1990-2#1)(1991-6#1)
Smoking in##2##2##(1994-6#1)(2013-1#1)
Smoking prevalence##2##2##(1994-6#2)
Smoking##26##1##(1990-2#1)(1991-11#1)(1991-6#1)(1994-6#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-1#1)(2009-5#2)(2009-7#3)(2010-10#1)(2011-2#2)(2013-1#3)(2013-8#2)
Smooth muscle##4##2##(1993-6#1)(1994-6#1)(1995-2#1)(2011-2#1)
Smooth##6##1##(1993-6#1)(1994-6#1)(1995-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
Sms-enforcement##2##1##(1993-12#2)
Sn and Te##2##3##(2008-10#2)
Sn and##4##2##(2008-10#4)
Sn in##4##2##(2008-10#4)
Sn##21##1##(2008-10#20)(2009-9#1)
Sn(2+)##3##1##(2008-10#3)
Sn(II)##3##1##(2008-10#3)
Sn(IV)##5##1##(2008-10#5)
SnCl(2)##6##1##(2008-10#6)
SnO(2) with##2##2##(2008-10#2)
SnO(2)##7##1##(2008-10#7)
Snake##3##1##(2008-1#1)(2008-12#1)(2012-12#1)
Snodgrass##2##1##(2008-10#2)
Snow##4##1##(2008-10#1)(2008-8#1)(2009-8#2)
Snu13p##2##1##(2009-7#2)
Snyder##2##1##(1995-6#1)(2012-2#1)
So far##15##2##(1994-3#1)(1994-6#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
So it is considered that##2##5##(2008-9#2)
So it is##6##3##(2008-10#1)(2008-8#3)(2008-9#2)
So that##2##2##(2008-10#2)
So the##5##2##(2008-10#3)(2008-7#1)(2012-2#1)
So we##2##2##(2010-2#1)(2013-1#1)
So you want to be a##2##6##(2012-2#1)(2013-8#1)
So##57##1##(1994-3#1)(1994-6#1)(1995-12#1)(1996-8#1)(1997-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
Soap Chamber Test##2##3##(2008-5#2)
Soapnut oil##2##2##(2009-3#2)
Soc##4##1##(2008-11#1)(2008-2#1)(2008-3#2)
Soccer##3##1##(2010-1#1)(2012-3#2)
Social Action##4##2##(2008-11#4)
Social Activity##2##2##(2008-10#2)
Social Security Act##2##3##(1991-3#1)(1992-2#1)
Social Security and Medicare##2##4##(1994-2#1)(1995-2#1)
Social Security##10##2##(1991-3#1)(1992-2#1)(1993-1#2)(1993-3#1)(1994-2#1)(1995-2#1)(2011-2#2)(2012-12#1)
Social Services##3##2##(1994-1#1)(1995-3#1)(2013-8#1)
Social Support##4##2##(1992-1#1)(2010-1#2)(2010-3#1)
Social and##2##2##(2008-9#1)(2013-8#1)
Social phobia is##2##3##(2008-4#2)
Social relationships##2##2##(2008-11#1)(2009-5#1)
Social support and##3##3##(2010-10#1)(2010-2#1)(2012-3#1)
Social support##9##2##(1992-3#1)(1996-3#1)(2008-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)
Social##75##1##(1990-11#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-11#15)(2008-12#2)(2008-4#4)(2008-6#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-1#6)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Socialization##2##1##(2008-5#1)(2011-2#1)
Societies##2##1##(2011-4#1)(2012-12#1)
Society and the##2##3##(1994-12#1)(2008-11#1)
Society and##6##2##(1994-12#1)(2008-11#1)(2011-2#4)
Society for the Study of##2##5##(2008-5#1)(2013-1#1)
Society for the##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
Society for##22##2##(1994-12#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2011-2#8)(2011-9#1)(2013-1#3)(2013-8#2)
Society of Clinical Chemistry##3##4##(1994-12#3)
Society of Clinical##9##3##(1994-12#4)(2008-7#2)(2009-4#1)(2010-11#1)(2013-1#1)
Society of Family##3##3##(1993-5#1)(1996-8#1)(1997-8#1)
Society of General Practitioners##2##4##(1994-6#2)
Society of Hematology##4##3##(2008-7#1)(2009-4#1)(2010-11#2)
Society of India##2##3##(2008-11#1)(2008-12#1)
Society of Toxicology (SOT)##2##4##(2008-10#2)
Society of Toxicology##4##3##(2008-10#3)(2011-2#1)
Society of##47##2##(1993-5#1)(1994-12#4)(1994-6#2)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-11#3)(2011-2#2)(2012-2#9)(2013-1#4)
Society##115##1##(1992-5#1)(1993-1#1)(1993-5#1)(1994-1#1)(1994-12#7)(1994-6#2)(1995-6#1)(1996-1#1)(1996-3#1)(1996-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#5)(2009-10#2)(2009-3#1)(2009-4#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-5#1)(2011-2#18)(2011-9#1)(2012-2#9)(2012-3#3)(2013-1#10)(2013-8#3)
Society]##3##1##(1991-3#1)(1993-6#1)(1994-12#1)
Socio-demographic##3##1##(2008-11#1)(2012-12#1)(2012-3#1)
Socio-economic##4##1##(2008-3#1)(2010-11#2)(2011-2#1)
Socioeconomic##7##1##(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
Sodium bromate##3##2##(2008-9#3)
Sodium butyrate##2##2##(2008-11#2)
Sodium channel##4##2##(1996-12#4)
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis##3##5##(2008-10#3)
Sodium dodecyl sulfate-polyacrylamide gel##4##4##(1991-2#1)(2008-10#3)
Sodium dodecyl##5##2##(1991-2#1)(2008-10#4)
Sodium methyldithiocarbamate##2##2##(2008-10#2)
Sodium sulfite##2##2##(2008-10#2)
Sodium##34##1##(1991-2#1)(1991-5#2)(1995-11#1)(1996-12#4)(1996-5#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#3)(2012-2#1)(2012-3#1)
Soft Independent##2##2##(2008-10#2)
Soft##5##1##(2008-10#3)(2010-2#1)(2011-2#1)
Software for##2##2##(2009-12#1)(2009-7#1)
Software##3##1##(2008-9#1)(2009-12#1)(2009-7#1)
Soil Microbial Communities##2##3##(2008-10#2)
Soil Organic##2##2##(2008-10#2)
Soil Suppressiveness Against Heterodera schachtii##2##5##(2008-10#2)
Soil Suppressiveness Against##3##3##(2008-10#3)
Soil Texture and##2##3##(2008-10#2)
Soil and soybean stem samples##2##5##(2008-10#2)
Soil and##7##2##(2008-10#6)(2008-11#1)
Soil fumigation with methyl bromide##2##5##(2008-10#2)
Soil pH##2##2##(2008-10#2)
Soil samples collected##2##3##(2008-10#2)
Soil samples were##6##3##(2008-10#6)
Soil samples##10##2##(2008-10#9)(2008-11#1)
Soil suppressiveness##2##2##(2008-10#2)
Soil type and##2##3##(2008-10#2)
Soil type##5##2##(2008-10#5)
Soil was collected from##2##4##(2008-10#2)
Soil was##3##2##(2008-10#3)
Soil##75##1##(1995-3#1)(2008-10#69)(2008-11#4)(2008-12#1)
Soil-borne##4##1##(2008-8#4)
Soilborne wheat mosaic virus##2##4##(2008-10#2)
Soilborne##4##1##(2008-10#4)
Soils from##2##2##(2008-10#2)
Soils in##2##2##(2008-10#2)
Soils##9##1##(2008-10#9)
Sol-Gel##4##1##(2008-10#4)
Sol-gel##3##1##(2008-10#3)
Solanaceae##6##1##(1993-12#1)(2008-10#4)(2008-5#1)
Solanum hosts##2##2##(2008-10#2)
Solanum spp##10##2##(2008-10#10)
Solanum##24##1##(1993-12#1)(2008-10#21)(2008-11#1)(2008-9#1)
Solar##3##1##(2008-10#2)(2011-2#1)
Solenopsis##3##1##(2007-12#3)
Solexa##2##1##(2010-10#2)
Solid contact electrodes##2##3##(2008-10#2)
Solid dispersions of##2##3##(2012-2#2)
Solid dispersions##3##2##(2012-2#3)
Solid phase extraction (SPE)##2##4##(2008-10#2)
Solid phase extraction and determination of##2##6##(2008-10#2)
Solid phase extraction and##4##4##(2008-10#4)
Solid phase extraction##8##3##(2008-10#8)
Solid phase extractive preconcentration of uranium(VI)##2##6##(2008-10#2)
Solid phase extractive preconcentration of##3##5##(2008-10#3)
Solid phase microextraction (SPME)##2##4##(2008-10#1)(2009-8#1)
Solid phase##15##2##(1996-12#1)(2008-10#13)(2009-8#1)
Solid pseudopapillary##2##2##(2013-1#2)
Solid##38##1##(1990-6#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-10#22)(2008-11#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#4)(2013-1#2)
Solid-Phase##3##1##(1995-8#1)(2008-10#1)(2009-8#1)
Solid-State##2##1##(1990-8#1)(2012-2#1)
Solid-phase extraction and##2##3##(2008-10#2)
Solid-phase extraction with##2##3##(1991-7#1)(2008-10#1)
Solid-phase extraction##7##2##(1991-7#1)(2008-10#6)
Solid-phase microextraction##5##2##(2008-10#5)
Solid-phase##20##1##(1991-7#1)(1995-8#1)(2008-10#16)(2008-4#2)
Solitaire##2##1##(2013-8#2)
Solitary intracranial plasmacytoma##2##3##(2011-2#2)
Solitary##6##1##(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#2)(2013-1#1)
Solubility and##2##2##(2008-10#1)(2008-11#1)
Solubility##3##1##(2008-10#1)(2008-11#2)
Solubilization of##2##2##(2008-4#2)
Soluble##10##1##(1990-10#1)(1990-5#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
Solute##2##1##(2011-2#2)
Solution equilibria between##2##3##(2008-10#2)
Solution structure of##3##3##(1993-3#1)(1994-5#1)(2008-8#1)
Solution##11##1##(1993-3#1)(1994-5#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-8#1)(2009-12#1)(2009-8#1)
Solutions of##2##2##(2008-10#1)(2008-11#1)
Solutions to##2##2##(2008-10#2)
Solutions##14##1##(1992-3#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-6#1)(2009-3#1)
Solvent effect##2##2##(2008-10#2)
Solvent effects on##2##3##(2008-10#2)
Solvent extraction of##6##3##(2008-10#6)
Solvent extraction separation of##2##4##(2008-10#2)
Solvent extraction separation##3##3##(2008-10#3)
Solvent extraction was used to##2##5##(2008-10#2)
Solvent extraction##13##2##(2008-10#12)(2008-7#1)
Solvent##21##1##(1991-9#1)(2008-10#18)(2008-7#1)(2010-5#1)
Solver##4##1##(2008-10#4)
Somali##2##1##(2011-2#2)
Somatic##3##1##(2008-10#1)(2008-4#1)(2009-6#1)
Somatostatin##3##1##(1997-2#2)(1997-4#1)
Sombre Hummingbird##4##2##(2008-9#4)
Some amino acids were##2##4##(2008-10#1)(2008-11#1)
Some aspects of the potential mechanism of action of##2##9##(2008-10#2)
Some aspects of the##3##4##(2008-10#3)
Some aspects of##4##3##(2008-10#3)(2008-5#1)
Some asymmetry was also detected for some spatial autocorrelation proximity patterns##2##11##(2008-10#2)
Some challenges##2##2##(1994-6#1)(2008-5#1)
Some characteristics of##2##3##(1995-3#1)(2008-9#1)
Some clinical##3##2##(1991-3#1)(2008-5#1)(2011-1#1)
Some compounds##2##2##(2008-11#1)(2011-2#1)
Some considerations##2##2##(2008-10#1)(2011-2#1)
Some current##2##2##(2008-11#1)(2011-2#1)
Some examples##2##2##(2008-10#2)
Some experimental##2##2##(2008-10#1)(2013-1#1)
Some factors##2##2##(2008-11#1)(2008-7#1)
Some general##2##2##(1994-3#1)(2008-10#1)
Some groups of##2##3##(1991-11#1)(2008-10#1)
Some have##2##2##(1996-2#1)(2008-4#1)
Some isolates##2##2##(2008-10#2)
Some large##2##2##(1997-3#1)(2010-1#1)
Some lessons##2##2##(1993-2#1)(2008-11#1)
Some methods for##2##3##(2008-3#1)(2008-5#1)
Some new##2##2##(2008-11#1)(2008-3#1)
Some observations##2##2##(1990-3#1)(2008-11#1)
Some of the best##2##4##(1996-3#1)(2013-1#1)
Some of the most##4##4##(1990-12#1)(1994-1#1)(2007-12#1)(2010-12#1)
Some of the problems##2##4##(1990-9#1)(1996-3#1)
Some of the##49##3##(1990-12#1)(1990-9#1)(1991-5#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-8#1)(1994-1#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-3#2)(2007-12#1)(2008-10#7)(2008-11#6)(2008-5#3)(2008-9#3)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
Some of them are##2##4##(2008-10#2)
Some of them##3##3##(1994-5#1)(2008-10#2)
Some of these##17##3##(1991-6#1)(1993-8#1)(1994-3#1)(1997-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
Some of##73##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-8#2)(1994-1#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-3#2)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-5#4)(2008-7#2)(2008-9#4)(2009-10#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
Some parameters##2##2##(1992-5#1)(2008-10#1)
Some patients may##3##3##(1995-2#1)(1997-4#1)(2008-11#1)
Some patients##8##2##(1992-6#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
Some populations##2##2##(2008-10#2)
Some power cords manufactured by##2##5##(2011-1#1)(2011-2#1)
Some practical##2##2##(2008-3#1)(2013-1#1)
Some problems##2##2##(1993-12#1)(2008-11#1)
Some procedures##2##2##(2008-10#2)
Some recommendations are##2##3##(2008-12#1)(2008-3#1)
Some strains##4##2##(2008-10#1)(2008-5#2)(2010-3#1)
Some studies have##4##3##(1993-12#1)(2008-11#2)(2008-8#1)
Some studies##9##2##(1993-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-12#1)(2011-1#1)
Some thoughts##2##2##(1991-12#1)(1993-2#1)
Some transformants##3##2##(2008-10#2)(2008-8#1)
Some were##2##2##(1995-2#1)(1996-3#1)
Some##342##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#4)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#2)(2007-12#1)(2008-1#4)(2008-10#84)(2008-11#28)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#17)(2008-6#2)(2008-7#9)(2008-8#13)(2008-9#11)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#4)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#11)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#1)
Someone##3##1##(1994-1#1)(1995-1#1)(2011-2#1)
Something##2##1##(1997-4#1)(2008-11#1)
Sometimes##6##1##(1992-11#1)(1994-3#1)(1995-3#1)(1997-8#1)(2008-10#1)(2013-1#1)
Somewhat##2##1##(2008-10#1)(2008-3#1)
Sommerfeld##2##1##(2008-2#2)
Sonchus asper plants##2##3##(2008-10#2)
Sonchus asper##5##2##(2008-10#5)
Sonic hedgehog expression##2##3##(1993-12#2)
Sonic hedgehog##10##2##(1993-12#6)(1994-12#4)
Sonographic examinations##2##2##(1997-8#2)
Sonographic##3##1##(1997-8#2)(2012-12#1)
Sonography is##2##2##(2010-6#1)(2010-8#1)
Sonography##3##1##(1997-8#1)(2010-6#1)(2010-8#1)
Sonora##2##1##(2008-10#1)(2008-8#1)
Sonoran Desert##5##2##(2008-10#4)(2009-8#1)
Sons##100##1##(2008-11#36)(2008-7#36)(2008-9#2)(2011-2#8)(2012-2#6)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#7)
Soon after##2##2##(2008-2#1)(2008-9#1)
Soot##2##1##(2008-11#1)(2008-3#1)
Sorbent##2##1##(2008-10#1)(2008-12#1)
Sorbinil##2##1##(1994-8#2)
Soret band##4##2##(1990-8#3)(2008-10#1)
Soret##7##1##(1990-8#3)(2008-10#4)
Sorghum bicolor##3##2##(2008-10#3)
Sorghum ergot##2##2##(2008-10#2)
Sorghum##9##1##(2008-10#9)
Sorption behaviour of##3##3##(2008-10#3)
Sorption of##3##2##(2008-10#3)
Sorption properties of##2##3##(2008-10#2)
Sorption##11##1##(2008-10#11)
Sorting##6##1##(1992-12#1)(1995-5#1)(2008-11#1)(2008-7#2)(2013-8#1)
Sos##3##1##(1995-8#3)
Sound localization##2##2##(2008-9#1)(2012-2#1)
Sound##9##1##(1990-11#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-9#2)(2010-6#1)(2012-2#1)
Source of##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
Source##9##1##(2008-10#2)(2008-11#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#2)
Sources and##2##2##(2008-10#2)
Sources of error##2##3##(2008-10#2)
Sources of##10##2##(1994-3#1)(1996-2#1)(2008-10#5)(2008-11#2)(2011-2#1)
Sources##16##1##(1994-3#1)(1996-2#1)(2008-10#10)(2008-11#2)(2008-5#1)(2011-2#1)
South Africa##54##2##(1992-9#1)(1997-6#1)(1997-7#4)(2008-10#19)(2008-12#5)(2008-5#2)(2008-8#1)(2010-1#6)(2010-11#3)(2010-3#1)(2010-5#1)(2011-2#3)(2013-1#4)(2013-8#3)
South African specimens##2##3##(2010-3#2)
South African##17##2##(2008-10#6)(2008-12#1)(2008-8#2)(2010-1#2)(2010-11#1)(2010-3#2)(2011-2#1)(2013-1#2)
South America and Africa##2##4##(2008-10#1)(2011-2#1)
South America and Japan##3##4##(2008-10#3)
South America and##8##3##(2008-10#7)(2011-2#1)
South America##26##2##(2008-10#20)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
South American##8##2##(1991-3#1)(2007-12#1)(2008-10#2)(2011-2#3)(2013-8#1)
South Asia##3##2##(1995-3#1)(2008-10#2)
South Asian##2##2##(2009-12#1)(2011-2#1)
South Asians##4##2##(2011-2#4)
South Australia##4##2##(2008-10#3)(2008-12#1)
South Carolina Medicaid##2##3##(1991-3#1)(2011-2#1)
South Carolina##16##2##(1991-2#1)(1991-3#1)(1991-8#3)(1994-12#1)(1996-1#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-12#3)
South Carolina's HIV/AIDS community long-term care Medicaid waiver##2##8##(1997-2#2)
South Carolina's HIV/AIDS community long-term care Medicaid##3##7##(1997-2#3)
South India##2##2##(2009-10#1)(2011-2#1)
South Indian##2##2##(2008-10#1)(2009-11#1)
South Korea##4##2##(2008-5#1)(2010-1#1)(2010-12#1)(2011-2#1)
South Pacific##4##2##(2008-1#4)
South Texas was##2##3##(2008-10#2)
South Texas##7##2##(2008-10#7)
South and##2##2##(2008-10#1)(2011-2#1)
South##199##1##(1991-2#1)(1991-3#2)(1991-8#3)(1992-2#6)(1992-9#1)(1994-12#2)(1995-3#1)(1996-1#2)(1997-2#3)(1997-6#1)(1997-7#4)(2007-12#1)(2008-1#4)(2008-10#70)(2008-11#5)(2008-12#10)(2008-5#6)(2008-6#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-1#9)(2010-11#4)(2010-12#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-2#20)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#13)(2013-8#8)
South-East##2##1##(2013-1#2)
South-Western Iran##2##2##(2008-12#2)
Southeast Asia##7##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
Southeast Asian##2##2##(2008-10#2)
Southeast##15##1##(1995-2#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Southeastern Pennsylvania##2##2##(1993-3#1)(1995-6#1)
Southeastern##8##1##(1993-3#1)(1995-6#1)(1996-1#1)(2008-10#3)(2012-2#1)(2012-3#1)
Southern Alberta##2##2##(1993-12#2)
Southern California##5##2##(1992-12#1)(1995-12#1)(1995-6#1)(2008-10#1)(2013-1#1)
Southern China##2##2##(2008-11#2)
Southern Ethiopia##2##2##(2010-6#2)
Southern France##2##2##(2008-10#2)
Southern Hemisphere##2##2##(1990-8#1)(2008-10#1)
Southern analyses indicated that##2##4##(1993-6#1)(2008-10#1)
Southern analyses##3##2##(1993-6#1)(2008-10#2)
Southern analysis of##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
Southern analysis showed that##3##4##(1997-8#1)(2008-8#2)
Southern analysis##14##2##(1990-8#1)(1991-6#1)(1993-8#1)(1995-6#1)(1997-8#1)(2008-10#4)(2008-8#3)(2008-9#1)(2012-3#1)
Southern and Northern blot##2##4##(1992-3#1)(1995-6#1)
Southern and##3##2##(1992-3#1)(1995-6#1)(2008-8#1)
Southern blot analyses##3##3##(1993-12#1)(2008-10#2)
Southern blot analysis demonstrated that##2##5##(2008-5#1)(2008-8#1)
Southern blot analysis of##2##4##(2008-10#2)
Southern blot analysis showed that##2##5##(1997-4#1)(1997-8#1)
Southern blot analysis suggested the##2##5##(1993-2#1)(2008-11#1)
Southern blot analysis##16##3##(1993-12#1)(1993-2#1)(1993-8#1)(1995-6#1)(1996-6#1)(1997-4#1)(1997-8#3)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)
Southern blot hybridization analysis##2##4##(2008-10#2)
Southern blot hybridization##8##3##(2008-10#7)(2008-9#1)
Southern blot##38##2##(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#1)(1995-11#1)(1995-6#2)(1996-6#1)(1997-4#1)(1997-8#3)(2008-10#15)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#3)
Southern blots##3##2##(1993-2#1)(2008-10#2)
Southern blotting analysis##2##3##(2008-2#1)(2008-9#1)
Southern blotting##5##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
Southern hybridization analysis##3##3##(2008-10#3)
Southern hybridization to##3##3##(1992-6#1)(2008-5#1)(2008-8#1)
Southern hybridization using##3##3##(1996-12#2)(1996-6#1)
Southern hybridization##23##2##(1992-3#1)(1992-6#1)(1993-3#1)(1996-12#2)(1996-6#1)(2008-10#9)(2008-5#1)(2008-8#5)(2008-9#2)
Southern##126##1##(1990-8#3)(1991-6#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1995-11#1)(1995-12#2)(1995-6#5)(1996-12#2)(1996-6#2)(1997-4#1)(1997-7#1)(1997-8#4)(2008-10#44)(2008-11#6)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#15)(2008-9#7)(2009-10#1)(2010-6#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Southwest Iran##2##2##(2008-12#2)
Southwest##7##1##(1995-12#1)(2008-10#1)(2008-12#2)(2008-8#2)(2013-8#1)
Southwestern Medical Center##2##3##(1990-11#2)
Southwestern histochemistry##2##2##(1997-2#2)
Southwestern##5##1##(1990-11#2)(1993-12#1)(1997-2#2)
Soviet Union##5##2##(1990-3#1)(1995-3#1)(1997-1#1)(2008-12#2)
Soviet##11##1##(1990-3#4)(1995-3#1)(1997-1#1)(1997-6#2)(2008-12#2)(2013-8#1)
Sowing##4##1##(2008-10#2)(2008-12#1)(2010-1#1)
Sox genes##2##2##(2008-8#2)
Sox##3##1##(2008-8#3)
Sox9##3##1##(2010-5#3)
Sox9a was##2##2##(2010-5#2)
Sox9a##6##1##(2010-5#6)
Soxhlet and hot hexane extractions##2##5##(2008-10#2)
Soxhlet extraction and##2##3##(2008-10#2)
Soxhlet extraction##10##2##(2008-10#10)
Soxhlet extractions##2##2##(2008-10#2)
Soxhlet##27##1##(2008-10#26)(2008-11#1)
Soy milk##2##2##(2013-1#2)
Soy##5##1##(1995-12#1)(2008-12#1)(2013-1#3)
Soybean (Glycine##3##2##(2008-10#2)(2010-11#1)
Soybean Belt##2##2##(2008-10#2)
Soybean Brown Stem Rot##3##4##(2008-10#3)
Soybean Plants##2##2##(2008-10#2)
Soybean lines##2##2##(2008-10#2)
Soybean mosaic virus (SMV)##4##4##(2008-10#4)
Soybean mosaic virus##8##3##(2008-10#8)
Soybean mosaic##9##2##(2008-10#9)
Soybean##45##1##(2008-10#41)(2008-11#1)(2009-6#1)(2010-11#1)(2010-3#1)
Soybeans##2##1##(2008-10#2)
Sp##5##1##(1990-8#1)(2009-3#4)
Sp1 binding sites##2##3##(1991-7#1)(1997-3#1)
Sp1 binding##3##2##(1991-6#1)(1991-7#1)(1997-3#1)
Sp1##10##1##(1991-6#1)(1991-7#1)(1993-12#1)(1993-3#1)(1993-6#2)(1997-3#2)(1997-8#2)
Sp1-binding##3##1##(1991-6#1)(1993-2#1)(1993-6#1)
Sp1-responsiveness##3##1##(1997-3#3)
Sp2/ O-Ag14##2##2##(2008-11#2)
Sp2/##3##1##(2008-11#3)
Sp2/0-Ag14##3##1##(2008-11#3)
Sp2/0-Ag14cells##2##1##(2008-11#2)
SpM##2##1##(1995-8#2)
SpStrongylocins##2##1##(2011-2#2)
Space Shuttle##2##2##(1996-12#2)
Space##18##1##(1990-11#1)(1990-8#1)(1995-5#1)(1996-12#2)(1996-9#1)(2008-2#1)(2008-3#5)(2008-5#1)(2011-2#1)(2012-3#3)(2013-1#1)
Spaceborne##2##1##(2008-3#2)
Spacer##8##1##(2008-10#7)(2012-2#1)
Spain and the##2##3##(2008-10#2)
Spain and##11##2##(2008-10#10)(2013-8#1)
Spain as##2##2##(2008-10#1)(2013-1#1)
Spain in##5##2##(2008-10#4)(2012-2#1)
Spain##81##1##(1990-3#1)(1991-11#1)(1993-8#1)(1994-12#2)(1996-1#1)(1996-12#3)(1997-2#1)(1997-3#1)(2008-10#55)(2008-11#3)(2008-12#1)(2008-5#2)(2009-10#4)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
Spain) and##2##2##(1996-12#1)(2008-10#1)
Spain)##17##1##(1996-12#1)(2008-10#12)(2008-5#4)
Span 80 and##2##3##(2008-10#2)
Span80##2##1##(2008-11#2)
Spanco##2##1##(2008-10#2)
Spanish DO##2##2##(2008-10#2)
Spanish Society##2##2##(1993-5#1)(1994-12#1)
Spanish X##2##2##(2008-10#2)
Spanish isolates##5##2##(2008-10#5)
Spanish market##3##2##(2008-10#3)
Spanish oak##2##2##(2008-10#2)
Spanish speakers##2##2##(1995-12#1)(2011-2#1)
Spanish strains##2##2##(2008-10#1)(2008-5#1)
Spanish##59##1##(1993-12#2)(1993-5#2)(1994-12#1)(1995-12#1)(2008-10#33)(2008-11#4)(2008-12#2)(2008-5#2)(2009-10#6)(2011-2#2)(2012-12#1)(2013-1#3)
Spanish-speaking##3##1##(2010-8#1)(2011-2#2)
Spathiphyllum##2##1##(2008-10#2)
Spatial Analysis##2##2##(2008-10#2)
Spatial Patterns of##4##3##(2008-10#4)
Spatial analyses##2##2##(2008-10#2)
Spatial analysis of##3##3##(2008-10#3)
Spatial analysis##4##2##(2008-10#4)
Spatial and temporal distribution of##2##5##(2008-10#2)
Spatial and temporal##9##3##(2008-10#8)(2008-5#1)
Spatial and##11##2##(2008-10#10)(2008-5#1)
Spatial autocorrelation analysis of proximity patterns suggested that aggregation often existed among quadrats of various sizes up to##2##18##(2008-10#2)
Spatial autocorrelation analysis##3##3##(2008-10#3)
Spatial autocorrelation##5##2##(2008-10#5)
Spatial development of##2##3##(2008-11#2)
Spatial distribution of##3##3##(1992-3#1)(2008-3#1)(2013-8#1)
Spatial distribution##4##2##(1992-3#1)(2008-10#1)(2008-3#1)(2013-8#1)
Spatial heterogeneity##2##2##(2008-8#2)
Spatial pattern analysis of##3##4##(2008-10#3)
Spatial pattern##5##2##(2008-10#5)
Spatial patterns of##4##3##(2008-10#4)
Spatial patterns##6##2##(2008-10#5)(2012-2#1)
Spatial##78##1##(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-2#1)(2008-10#53)(2008-11#3)(2008-3#3)(2008-5#1)(2008-8#5)(2008-9#1)(2009-8#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-8#2)
Spatially resolved##3##2##(1995-3#1)(1997-6#1)(2012-2#1)
Spatially##5##1##(1995-3#1)(1997-6#1)(2008-3#2)(2012-2#1)
Spatiotemporal Genetic Structure of Phytophthora capsici in Michigan##2##8##(2008-10#2)
Spatiotemporal dynamics of##2##3##(2008-11#1)(2013-8#1)
Spatiotemporal##18##1##(1993-5#1)(2008-10#9)(2008-11#2)(2008-7#1)(2008-8#3)(2013-8#2)
Spawning##2##1##(2008-8#1)(2010-8#1)
Speak##2##1##(2009-7#2)
Speaker's Corner##3##2##(2008-8#3)
Speakers##2##1##(2010-5#1)(2011-2#1)
Spearman rank##2##2##(2008-10#2)
Spearman##4##1##(2008-10#3)(2011-2#1)
Spearman's##2##1##(2009-11#1)(2011-2#1)
Special Health##2##2##(1994-3#1)(1995-12#1)
Special Issue##2##2##(2008-11#1)(2011-2#1)
Special attention is devoted to##2##5##(1995-5#1)(2008-10#1)
Special attention is given to##2##5##(1992-3#1)(1997-8#1)
Special attention is paid to the##2##6##(2008-10#1)(2008-9#1)
Special attention is paid to##3##5##(2008-10#1)(2008-3#1)(2008-9#1)
Special attention is##7##3##(1992-3#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
Special attention was##2##3##(2008-10#1)(2008-7#1)
Special attention##12##2##(1991-3#1)(1992-3#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)
Special emphasis is placed on##2##5##(1992-1#1)(2008-9#1)
Special emphasis is##4##3##(1992-1#1)(2008-10#1)(2008-6#1)(2008-9#1)
Special features of the##2##4##(1991-3#1)(2008-11#1)
Special issue dedicated to##2##4##(2008-7#1)(2012-3#1)
Special issue##6##2##(1991-3#1)(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
Special##66##1##(1990-11#1)(1991-3#4)(1992-1#2)(1992-3#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-8#2)(2008-10#7)(2008-11#12)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#4)(2012-3#1)(2013-8#2)
Specialists##3##1##(1996-1#1)(2008-9#1)(2011-2#1)
Specialized##3##1##(1992-1#1)(2008-11#1)(2011-2#1)
Specialty##3##1##(1996-3#1)(1997-1#1)(2011-2#1)
Speciation analysis of##2##3##(2008-10#2)
Speciation and##2##2##(2008-10#1)(2013-1#1)
Speciation of arsenic in##3##4##(2008-10#3)
Speciation of arsenic##5##3##(2008-10#5)
Speciation of inorganic##2##3##(2008-10#2)
Speciation of iron in##2##4##(2008-10#2)
Speciation of mercury in salmon egg cell cytoplasm##2##8##(2008-10#2)
Speciation of vanadium in##2##4##(2008-10#2)
Speciation of##23##2##(2008-10#22)(2008-11#1)
Speciation studies##2##2##(2008-10#2)
Speciation##32##1##(2008-10#30)(2008-11#1)(2013-1#1)
Species Belonging to##2##3##(2008-10#2)
Species Causing##2##2##(2008-10#2)
Species Complex##3##2##(2008-10#3)
Species and##6##2##(2008-10#4)(2008-9#1)(2010-5#1)
Species formed are ALH(r)##2##4##(2008-10#2)
Species formed##3##2##(2008-10#3)
Species from##2##2##(2008-10#1)(2013-8#1)
Species of the Genus Tospovirus##2##5##(2008-10#2)
Species of the##4##3##(2008-10#3)(2008-6#1)
Species of##7##2##(2008-10#5)(2008-5#1)(2008-6#1)
Species richness and##2##3##(2008-8#2)
Species richness##4##2##(2008-8#4)
Species##71##1##(1991-5#2)(2008-10#44)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#7)(2008-9#3)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
Species-Specific Polymerase Chain Reaction##2##4##(2008-10#2)
Species-Specific##4##1##(2008-10#4)
Species-area curves##2##2##(2008-8#2)
Species-specific primer analysis was reliable##2##5##(2008-10#2)
Species-specific##6##1##(2008-10#6)
Specific IgE##2##2##(1995-11#2)
Specific Language Impairment##3##3##(2008-11#1)(2009-8#1)(2011-1#1)
Specific Polymerase Chain Reaction##2##4##(2008-10#2)
Specific Polymerase Chain##3##3##(2008-10#3)
Specific and##2##2##(1991-12#1)(2008-10#1)
Specific binding of##4##3##(1993-1#1)(1993-3#1)(1994-11#1)(1994-8#1)
Specific binding##6##2##(1990-8#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-8#1)(2008-11#1)
Specific details for the expression##2##5##(2008-4#2)
Specific details##3##2##(2008-4#3)
Specific determination of##2##3##(2008-10#2)
Specific examples of##2##3##(2008-10#1)(2010-11#1)
Specific examples##4##2##(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#1)
Specific immunotherapy (SIT)##2##3##(2011-2#2)
Specific inhibition of##2##3##(1994-11#1)(1995-2#1)
Specific interaction of##2##3##(1993-3#1)(1993-8#1)
Specific interaction##3##2##(1993-3#1)(1993-8#1)(2008-10#1)
Specific primers and##2##3##(2008-10#1)(2010-4#1)
Specific productivity was##2##3##(2008-11#2)
Specific productivity##4##2##(2008-11#4)
Specific##101##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1993-1#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#2)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#31)(2008-11#14)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-2#3)(2013-8#1)
Specifically##62##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Specificity in##2##2##(2008-10#1)(2008-11#1)
Specificity of the##3##3##(1994-2#1)(1994-6#1)(2008-10#1)
Specificity of##14##2##(1994-2#1)(1994-6#1)(2008-10#9)(2008-11#2)(2010-12#1)
Specificity##21##1##(1994-2#1)(1994-6#1)(2008-10#14)(2008-11#3)(2010-12#1)(2011-3#1)
Specimens were subjected to##2##4##(2009-7#1)(2011-2#1)
Specimens were##3##2##(2009-3#1)(2009-7#1)(2011-2#1)
Specimens##6##1##(2009-3#1)(2009-7#2)(2011-2#2)(2013-1#1)
Spectacor##4##1##(1995-6#4)
Spectator##2##1##(2008-11#2)
Spectra Optia##6##2##(2011-2#6)
Spectra of##4##2##(2008-10#3)(2008-3#1)
Spectra were##3##2##(2008-10#3)
Spectra##16##1##(2008-10#8)(2008-3#1)(2011-2#6)(2012-2#1)
Spectral analysis##2##2##(1992-6#1)(2012-2#1)
Spectral characteristics##2##2##(2008-10#2)
Spectral##18##1##(1992-6#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-6#1)(2008-9#1)(2012-2#1)
Spectrin##2##1##(1990-5#1)(2011-2#1)
Spectrochemical##2##1##(2008-10#2)
Spectrofluorimetric determination of##12##3##(2008-10#12)
Spectrofluorimetric study of the##3##4##(2008-10#3)
Spectrofluorimetric##19##1##(2008-10#19)
Spectrometer##6##1##(2008-10#1)(2008-3#5)
Spectrometric##2##1##(2008-10#2)
Spectrometry##11##1##(2008-10#9)(2008-3#1)(2008-5#1)
Spectrophotometric and##2##2##(2008-10#2)
Spectrophotometric determination of lead in##4##5##(2008-10#4)
Spectrophotometric determination of molybdenum based on charge transfer##2##8##(2008-10#2)
Spectrophotometric determination of molybdenum##3##4##(2008-10#3)
Spectrophotometric determination of nitrite##2##4##(2008-10#2)
Spectrophotometric determination of trace##3##4##(2008-10#3)
Spectrophotometric determination of##47##3##(2008-10#47)
Spectrophotometric flow-injection determination of##3##4##(2008-10#3)
Spectrophotometric flow-injection##4##2##(2008-10#4)
Spectrophotometric method for determination##2##4##(2008-10#2)
Spectrophotometric methods##3##2##(2008-10#3)
Spectrophotometric studies##2##2##(2008-10#2)
Spectrophotometric study of the##3##4##(2008-10#3)
Spectrophotometric study of##5##3##(2008-10#5)
Spectrophotometric study##6##2##(2008-10#6)
Spectrophotometric##76##1##(1990-2#1)(2008-10#74)(2008-11#1)
Spectrosc##2##1##(2008-10#2)
Spectroscopic analysis of##3##3##(2008-10#3)
Spectroscopic analysis##4##2##(2008-10#3)(2008-9#1)
Spectroscopic and##2##2##(2008-10#2)
Spectroscopic properties of##2##3##(1996-5#1)(2008-10#1)
Spectroscopic studies of##2##3##(1995-6#1)(2008-3#1)
Spectroscopic studies##3##2##(1995-6#1)(2008-10#1)(2008-3#1)
Spectroscopic techniques##2##2##(2008-10#2)
Spectroscopic##21##1##(1991-5#1)(1993-5#1)(1995-6#1)(1996-5#1)(2008-10#12)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#2)
Spectroscopy##15##1##(1992-3#1)(1996-9#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2009-9#1)(2011-2#1)(2013-8#1)
Spectrum Disorders##3##2##(2008-11#1)(2010-7#1)(2013-8#1)
Spectrum of##2##2##(2008-1#1)(2008-11#1)
Spectrum##5##1##(2008-1#1)(2008-11#2)(2010-7#1)(2013-8#1)
Specular microscopy##2##2##(2011-2#2)
Speech perception##2##2##(2008-9#2)
Speech##8##1##(2008-9#8)
Speed of##2##2##(2008-12#1)(2009-12#1)
Spencer##2##1##(2008-10#1)(2012-2#1)
Spending##2##1##(1991-2#1)(1992-12#1)
Spent##2##1##(2008-10#1)(2010-4#1)
Sperm##8##1##(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)
Spermatogenesis and##2##2##(2009-10#1)(2012-2#1)
Spermatogenesis is a complex##2##4##(2009-10#2)
Spermatogenesis is a##4##3##(2009-10#3)(2012-2#1)
Spermatogenesis##7##1##(2009-10#5)(2012-2#2)
Spermine##4##1##(1990-7#1)(1991-5#1)(1994-11#1)(1996-2#1)
Spermiogenesis in##2##2##(2008-7#2)
Speron-Thiol resin##2##2##(2008-10#2)
Sphaeropsis sapinea##4##2##(2008-10#4)
Sphaeropsis##5##1##(2008-10#5)
Sphagnum##4##1##(2008-10#3)(2008-9#1)
Spherical##5##1##(2008-11#1)(2008-2#1)(2008-3#2)(2010-11#1)
Spiders##2##1##(2008-9#1)(2009-9#1)
Spike recovery##2##2##(2008-10#2)
Spike##4##1##(2008-10#4)
Spiked samples##2##2##(2008-10#2)
Spiked##3##1##(2008-10#3)
Spikes##3##1##(2008-10#2)(2008-11#1)
Spilocaea##2##1##(2008-10#2)
Spin##4##1##(1992-11#1)(1996-9#3)
Spinach curly top virus##2##4##(2008-10#2)
Spinach##6##1##(2008-10#5)(2008-8#1)
Spinal Cord Arteriovenous Malformations##2##4##(1995-11#1)(1997-6#1)
Spinal Cord Injury##3##3##(2008-11#1)(2009-6#1)(2010-2#1)
Spinal Cord##5##2##(1995-11#1)(1997-6#1)(2008-11#1)(2009-6#1)(2010-2#1)
Spinal Fusion##2##2##(2012-3#2)
Spinal arteriovenous##2##2##(2008-7#1)(2013-1#1)
Spinal epidural abscess##2##3##(2011-2#2)
Spinal##24##1##(1993-9#1)(1995-11#1)(1996-12#1)(1997-6#2)(2007-8#1)(2008-11#1)(2008-7#3)(2009-6#1)(2010-2#1)(2011-2#3)(2012-3#6)(2013-1#3)
Spindle##2##1##(1990-12#1)(2011-2#1)
Spine Surgery##3##2##(2012-2#2)(2012-3#1)
Spine##8##1##(2007-11#1)(2008-12#2)(2012-2#3)(2012-3#2)
Spiral CT##2##2##(2012-2#1)(2012-3#1)
Spiral##4##1##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
Spirit##2##1##(1993-12#1)(1997-2#1)
Spiritual##4##1##(1991-12#1)(1997-2#1)(2008-12#1)(2009-11#1)
Spirituality as##2##2##(2008-12#2)
Spirituality##4##1##(2008-11#1)(2008-12#2)(2010-10#1)
Spirochaeta##2##1##(2013-8#2)
Spirochaetales##3##1##(2008-9#1)(2013-8#2)
Spirochaetes or its different##2##4##(2013-8#2)
Spirochaetes##8##1##(2013-8#8)
Spirometry##2##1##(2008-7#1)(2010-2#1)
Spiroplasma citri##8##2##(2008-10#8)
Spiroplasma##9##1##(2008-10#9)
Spirosoma linguale##2##2##(2011-2#2)
Spirulina platensis##4##2##(2008-10#1)(2008-8#3)
Splash Dispersal of##2##3##(2008-10#2)
Splash##3##1##(2008-10#3)
Spleen##3##1##(1994-5#1)(2008-11#2)
Splenectomized##2##1##(1994-9#2)
Splenic metastasis of colon cancer is##2##6##(2007-8#2)
Splenic##7##1##(2007-8#2)(2008-11#1)(2008-9#2)(2011-2#2)
Splicing##2##1##(1997-3#1)(1997-7#1)
Split##4##1##(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
Spodoptera frugiperda (Sf9) cell culture##2##5##(2008-11#2)
Spodoptera frugiperda (Sf9)##6##3##(1992-3#1)(2008-11#4)(2008-7#1)
Spodoptera frugiperda Sf-9 and Trichoplusia ni BTI-Tn-5B1-4 (High##2##8##(2008-7#2)
Spodoptera frugiperda Sf-9##3##3##(2008-7#3)
Spodoptera frugiperda##18##2##(1992-3#1)(1993-6#1)(1994-11#1)(2008-11#11)(2008-7#4)
Spodoptera littoralis##3##2##(2008-10#1)(2013-8#2)
Spodoptera##23##1##(1992-3#1)(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#12)(2008-7#5)(2013-8#2)
Spongospora subterranea f##2##3##(2008-10#2)
Spontaneous activity##3##2##(2008-11#2)(2013-8#1)
Spontaneous bacterial peritonitis##2##3##(2009-8#2)
Spontaneous intraorbital hematoma##2##3##(2011-2#2)
Spontaneous##38##1##(1992-2#2)(1992-8#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-9#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-8#2)(2010-11#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
Sporangia from##2##2##(2008-10#2)
Sporangia##9##1##(2008-10#9)
Spore Germination##2##2##(2008-10#2)
Spore deposition##2##2##(2008-10#2)
Spore germination##2##2##(2008-10#1)(2011-2#1)
Spore shape and##2##3##(2008-10#1)(2010-3#1)
Spore##15##1##(2008-10#13)(2010-3#1)(2011-2#1)
Spores of##7##2##(2008-10#5)(2011-2#2)
Spores produced at##2##3##(2011-2#2)
Spores##19##1##(2008-10#10)(2010-1#1)(2010-10#1)(2011-2#7)
Sporisorium reilianum f##2##3##(2008-10#2)
Sport##3##1##(2008-12#1)(2009-7#1)(2010-6#1)
Sports##7##1##(1993-3#1)(1996-6#1)(1996-8#1)(2008-11#1)(2010-1#2)(2012-3#1)
Sporulation of Bremia lactucae##2##4##(2008-10#2)
Sporulation of##9##2##(2008-10#9)
Sporulation was##3##2##(2008-10#3)
Sporulation##17##1##(2008-10#15)(2011-2#1)(2012-2#1)
Spot Pathogen##2##2##(2008-10#2)
Spot of##11##2##(2008-10#11)
Spot##28##1##(2008-10#27)(2012-3#1)
Spotfire##5##1##(2008-4#4)(2013-1#1)
Spotted##5##1##(1995-12#1)(2008-10#4)
Spr3##7##1##(2009-10#7)
Sprague Dawley rats##3##3##(2008-10#2)(2013-1#1)
Sprague Dawley##4##2##(2008-10#2)(2012-3#1)(2013-1#1)
Sprague-Dawley rat##2##2##(1993-8#1)(2008-10#1)
Sprague-Dawley rats at##2##3##(1996-2#1)(2010-1#1)
Sprague-Dawley rats were##5##3##(1993-3#1)(1997-2#1)(2008-10#1)(2009-8#1)(2013-1#1)
Sprague-Dawley rats##14##2##(1993-12#1)(1993-3#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-7#4)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
Sprague-Dawley##20##1##(1993-12#1)(1993-3#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-7#4)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
Spray inoculation##2##2##(2008-10#2)
Spray##4##1##(2008-10#2)(2013-1#2)
Spraying a##2##2##(2008-10#2)
Spraying##3##1##(2008-10#3)
Spread and##2##2##(2008-10#2)
Spread of Tomato spotted wilt virus##2##6##(2008-10#2)
Spread of endosepsis##2##3##(2008-10#2)
Spread of##20##2##(2008-10#18)(2009-5#1)(2013-1#1)
Spread##27##1##(2008-10#24)(2009-5#1)(2010-8#1)(2013-1#1)
Spring barley##2##2##(2008-12#2)
Spring##13##1##(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#1)(2012-3#2)
Springer-Verlag##3##1##(1990-11#1)(1990-8#1)(2008-11#1)
Spunta##2##1##(2008-10#2)
Spătaru##2##1##(2008-10#2)
SqVYV##4##1##(2008-10#4)
Squamometry##6##1##(2008-5#6)
Squamous cell carcinoma##4##3##(2007-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
Squamous##9##1##(1993-8#1)(1994-8#1)(2007-12#1)(2007-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Square wave voltammetry##3##3##(2008-10#3)
Square wave##6##2##(2008-10#6)
Square##11##1##(2008-10#7)(2008-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
Square-wave voltammetry##2##2##(2008-10#2)
Square-wave##6##1##(2008-10#6)
Squash leaf curl##2##3##(2008-10#2)
Squash##4##1##(2008-10#4)
Squibb)##2##1##(1991-2#1)(2008-9#1)
Sr and##2##2##(2008-10#2)
Sr in##2##2##(2008-10#2)
Sr##22##1##(1995-6#1)(2008-10#21)
Sr(2+)##5##1##(2008-10#5)
Sr(2+)&gt##3##1##(2008-10#3)
Sr(5)(PO(4))(3)F at##2##2##(2007-12#1)(2008-3#1)
Sr(5)(PO(4))(3)F##3##1##(2007-12#2)(2008-3#1)
Sr(II)##2##1##(2008-10#2)
Sr9b##2##1##(2008-10#2)
SrSRI##5##1##(2009-8#5)
Src activates Abl to##2##4##(2011-2#2)
Src and Abl##3##3##(2011-2#3)
Src and##6##2##(1995-6#2)(2011-2#3)(2013-1#1)
Src family kinases##3##3##(1995-6#3)
Src inhibitors##3##2##(2012-3#3)
Src##36##1##(1995-6#13)(1996-2#1)(2008-4#1)(2009-7#1)(2010-4#1)(2011-1#3)(2011-2#7)(2012-3#6)(2013-1#3)
Src-phosphorylated EGF-R##2##2##(1995-6#2)
Sri Lanka##4##2##(2008-10#4)
Sri##11##1##(2008-10#11)
Srinagar##2##1##(2013-8#2)
Ss275##3##1##(2008-10#3)
SsEno##4##1##(2009-6#4)
Ssa20##2##1##(2008-11#2)
Ssh12##5##1##(2008-9#5)
Ssh7 binds##2##2##(2008-9#2)
Ssh7 proteins##3##2##(2008-9#3)
Ssh7##9##1##(2008-9#9)
St chromosomes##2##2##(2008-9#2)
St##48##1##(1990-6#1)(1991-2#1)(1991-3#2)(1991-9#2)(1992-1#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-1#1)(1995-12#2)(1995-6#1)(1996-3#2)(2008-10#17)(2008-11#1)(2008-12#4)(2008-7#2)(2008-9#2)(2009-3#1)(2011-2#1)(2013-8#2)
StAR##2##1##(1995-12#2)
Stabilisation of##2##2##(2008-10#2)
Stability constants##4##2##(2008-10#4)
Stability is##2##2##(2008-10#1)(2008-6#1)
Stability of the##4##3##(2008-10#3)(2013-1#1)
Stability of##13##2##(1995-2#1)(1996-5#1)(1996-9#1)(2008-10#6)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
Stability studies##3##2##(1995-6#2)(2008-10#1)
Stability##29##1##(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#1)(1996-9#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-6#1)(2012-2#1)(2013-1#1)
Stabilization of the##2##3##(1993-8#1)(2008-10#1)
Stabilization of##5##2##(1993-8#1)(2008-10#1)(2008-2#1)(2009-3#1)(2011-2#1)
Stabilization##9##1##(1993-8#1)(1994-12#2)(1994-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-3#1)(2011-2#1)
Stable expression of##4##3##(1995-6#1)(2008-11#3)
Stable expression##5##2##(1995-6#1)(2008-11#4)
Stable transfectants##2##2##(2008-11#2)
Stable transfection of##2##3##(1990-5#1)(2008-11#1)
Stable##19##1##(1990-12#1)(1990-5#1)(1995-6#1)(2008-10#1)(2008-11#9)(2008-3#2)(2008-5#1)(2012-4#1)(2012-9#1)(2013-8#1)
Stachybotrys chartarum##2##2##(2008-11#2)
Staff##8##1##(1994-1#1)(1994-3#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-11#1)(2011-2#1)
Staffordshire##3##1##(2008-12#1)(2013-8#2)
Stage 0##2##2##(1994-12#2)
Stage 2##2##2##(1991-12#1)(2008-7#1)
Stage II##3##2##(1994-12#2)(1997-7#1)
Stage III##3##2##(1997-7#1)(2008-10#2)
Stage##21##1##(1991-12#2)(1994-12#5)(1997-3#1)(1997-7#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)
Staged##3##1##(2008-7#1)(2011-2#1)(2012-3#1)
Stages of##5##2##(2008-10#3)(2008-6#1)(2011-1#1)
Stages##7##1##(2008-10#3)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
Staging classification##2##2##(1990-2#1)(2008-1#1)
Staging##3##1##(1990-2#1)(1995-1#1)(2008-1#1)
Stagonospora blotch##3##2##(2008-10#3)
Stagonospora nodorum blotch (SNB)##2##4##(2008-10#2)
Stagonospora nodorum blotch##3##3##(2008-10#3)
Stagonospora nodorum in##2##3##(2008-10#2)
Stagonospora nodorum##9##2##(2008-10#9)
Stagonospora##12##1##(2008-10#12)
Staining##5##1##(2007-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2013-8#1)
Stakeholders##2##1##(1992-1#1)(2008-11#1)
Stalk##2##1##(2008-10#2)
Standard HPLC equipment is used throughout##2##6##(2008-10#2)
Standard addition method was used##2##5##(2008-10#2)
Standard addition method was##3##4##(2008-10#3)
Standard addition method##5##3##(2008-10#5)
Standard deviation##2##2##(2008-10#2)
Standard deviations##2##2##(2008-10#2)
Standard errors of##2##3##(2008-10#2)
Standard methods##2##2##(2008-10#1)(2013-8#1)
Standard##52##1##(1993-3#2)(2007-11#1)(2008-10#24)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#4)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
Standardization of a##2##3##(1997-2#1)(2008-10#1)
Standardization of##10##2##(1991-11#1)(1991-3#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-12#2)(2010-1#1)(2011-2#1)(2012-2#1)
Standardization##15##1##(1991-11#1)(1991-3#2)(1996-2#1)(1997-2#1)(2008-10#2)(2008-12#2)(2008-9#2)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Standardized nursing diagnoses in an electronic health record##2##8##(2013-1#2)
Standardized##8##1##(1993-1#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#2)(2013-1#2)
Standards##29##1##(1992-2#1)(1992-3#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
Stander##2##1##(2008-10#2)
Stanford##7##1##(1992-3#1)(1993-12#1)(1995-9#1)(2008-12#1)(2010-11#1)(2013-1#2)
Stanley Hall##2##2##(1994-12#2)
Stanley##5##1##(1994-12#2)(2008-11#1)(2009-10#1)(2010-8#1)
Staphylococcal toxic shock syndrome##2##4##(2011-2#2)
Staphylococcal##4##1##(1996-12#1)(2008-8#1)(2011-2#2)
Staphylococci##3##1##(2008-5#1)(2010-4#1)(2012-3#1)
Staphylococcus aureus (MRSA)##7##3##(2007-12#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
Staphylococcus aureus and Candida##2##4##(2008-11#1)(2010-6#1)
Staphylococcus aureus and Pseudomonas aeruginosa##2##5##(2009-6#1)(2012-2#1)
Staphylococcus aureus and##6##3##(1996-12#1)(1997-8#1)(2008-11#1)(2009-6#1)(2010-6#1)(2012-2#1)
Staphylococcus aureus in##5##3##(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#1)
Staphylococcus aureus is##3##3##(2006-6#1)(2008-11#1)(2010-6#1)
Staphylococcus aureus protein A##3##4##(1994-3#2)(1996-6#1)
Staphylococcus aureus was##2##3##(1996-12#2)
Staphylococcus aureus##61##2##(1990-12#1)(1990-5#3)(1991-3#1)(1992-6#1)(1994-3#2)(1995-5#1)(1996-12#6)(1996-6#1)(1996-8#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#6)(2008-12#7)(2008-9#1)(2009-6#3)(2010-2#1)(2010-6#5)(2011-2#5)(2012-2#3)(2013-8#3)
Staphylococcus epidermidis##4##2##(1991-3#1)(1993-9#1)(2008-7#1)(2012-2#1)
Staphylococcus hyicus##2##2##(2013-8#2)
Staphylococcus##75##1##(1990-12#1)(1990-5#3)(1991-3#4)(1992-6#1)(1993-9#1)(1994-3#2)(1995-5#1)(1996-12#6)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#6)(2008-12#7)(2008-7#2)(2008-9#1)(2009-6#3)(2010-2#1)(2010-6#5)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#5)
Star##4##1##(1996-5#1)(1996-9#1)(2010-6#1)(2013-1#1)
Star-PAP##9##1##(2013-1#9)
Starch##3##1##(2008-5#1)(2008-9#1)(2010-8#1)
Stark##3##1##(1990-12#1)(1990-7#1)(2008-2#1)
Start##7##1##(1995-12#3)(1997-4#1)(2009-4#2)(2012-2#1)
Starting from a##2##3##(2008-10#1)(2008-9#1)
Starting from an##2##3##(2008-11#1)(2008-4#1)
Starting from##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
Starting in##2##2##(1994-2#2)
Starting with##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
Starting##14##1##(1991-12#1)(1992-3#1)(1994-2#2)(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
Stat##2##1##(1996-2#1)(1997-7#1)
State Department of Health has##2##5##(1997-1#1)(1997-2#1)
State Department of Health##5##4##(1994-12#1)(1996-3#2)(1997-1#1)(1997-2#1)
State Exam##2##2##(2008-12#1)(2011-2#1)
State Examination##8##2##(2008-7#6)(2012-2#1)(2013-1#1)
State Health##2##2##(1995-12#1)(1996-5#1)
State Medicaid agencies##3##3##(1994-3#1)(1996-2#2)
State Medicaid programs##6##3##(1994-12#1)(1995-1#2)(1996-2#1)(1997-2#2)
State Medicaid##14##2##(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#3)(1995-2#1)(1996-2#3)(1997-2#2)
State University##5##2##(1996-1#1)(1997-6#1)(2008-10#1)(2008-5#2)
State and##8##2##(1991-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2011-3#1)
State is##2##2##(1996-12#1)(2008-10#1)
State of the art##4##4##(2008-11#3)(2011-2#1)
State of##16##2##(1990-11#1)(1991-8#2)(1996-9#2)(1997-3#1)(2008-10#2)(2008-11#3)(2009-4#1)(2010-10#2)(2011-2#2)
State residents##2##2##(1992-1#1)(1995-12#1)
State to##2##2##(1996-2#1)(1997-2#1)
State was##2##2##(1992-2#1)(2008-10#1)
State##134##1##(1990-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-8#2)(1992-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#2)(1995-1#3)(1995-12#3)(1995-2#2)(1995-6#1)(1996-1#5)(1996-12#2)(1996-2#4)(1996-3#8)(1996-5#3)(1996-9#4)(1997-1#4)(1997-2#8)(1997-3#5)(1997-6#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#6)(2009-4#1)(2010-10#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
State-Trait Anxiety Inventory##2##3##(2008-10#1)(2010-6#1)
State-level##2##1##(1996-1#1)(1996-3#1)
Statement on##3##2##(1992-1#1)(2008-4#1)(2012-2#1)
Statement##8##1##(1992-1#1)(1993-11#3)(1996-3#1)(2008-4#1)(2012-2#2)
States Food and Drug##2##4##(2008-7#1)(2008-8#1)
States and the##3##3##(1991-12#1)(1997-2#1)(2008-10#1)
States and##52##2##(1991-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#30)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
States are##5##2##(1991-2#1)(1993-1#1)(1996-3#1)(2008-10#1)(2011-2#1)
States for##5##2##(1991-1#1)(1992-12#1)(1996-9#1)(2008-10#2)
States have##9##2##(1993-3#2)(1994-3#4)(1997-2#1)(2008-10#1)(2013-1#1)
States in the##2##3##(1995-8#1)(1996-9#1)
States in##13##2##(1993-2#1)(1994-1#1)(1994-2#1)(1995-8#1)(1996-9#1)(2008-10#8)
States of##4##2##(1992-3#1)(1994-9#1)(2008-11#1)(2012-12#1)
States or##2##2##(1994-3#1)(2008-10#1)
States participated##2##2##(1995-3#1)(2008-12#1)
States pay##2##2##(1995-1#1)(1995-2#1)
States provide##2##2##(1995-1#1)(2008-4#1)
States to##4##2##(1997-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
States with##3##2##(1993-2#1)(1994-1#1)(2010-10#1)
States would##2##2##(1994-1#1)(1997-2#1)
States##430##1##(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#4)(1991-12#7)(1991-2#5)(1991-3#4)(1991-8#3)(1992-12#3)(1992-3#4)(1992-6#2)(1992-9#2)(1993-1#4)(1993-12#4)(1993-2#6)(1993-3#8)(1994-1#6)(1994-12#4)(1994-2#4)(1994-3#8)(1994-9#1)(1995-1#5)(1995-12#3)(1995-2#3)(1995-3#6)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#5)(1996-9#3)(1997-1#4)(1997-2#11)(1997-3#6)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#170)(2008-11#15)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#4)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#18)(2012-12#6)(2012-2#6)(2012-3#7)(2013-1#13)(2013-8#7)
States)##5##1##(1995-3#1)(2008-10#3)(2008-12#1)
Static and dynamic##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
Static and##4##2##(2008-3#1)(2008-5#2)(2012-2#1)
Static headspace##2##2##(2008-10#2)
Static##9##1##(1991-6#1)(2008-10#3)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
Station##6##1##(2008-10#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
Stationary##2##1##(1996-9#1)(2007-12#1)
Statistical Resource Committee##5##3##(1991-2#1)(1991-3#1)(1993-1#1)(1995-1#1)(1995-2#1)
Statistical analyses##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
Statistical analysis indicated a##2##4##(1990-6#1)(1995-3#1)
Statistical analysis indicated##3##3##(1990-6#1)(1995-3#1)(2008-9#1)
Statistical analysis of##6##3##(1995-1#1)(2008-1#1)(2008-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
Statistical analysis showed that##2##4##(2008-1#1)(2008-12#1)
Statistical analysis showed##3##3##(2008-1#1)(2008-12#1)(2008-9#1)
Statistical analysis was performed using Student's t-test##2##7##(2008-7#1)(2013-1#1)
Statistical analysis was performed using##3##5##(2008-7#1)(2008-9#1)(2013-1#1)
Statistical analysis was performed##4##4##(2008-7#1)(2008-9#1)(2013-1#2)
Statistical analysis was##6##3##(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#2)
Statistical analysis##24##2##(1990-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-8#1)(2013-1#4)(2013-8#1)
Statistical comparisons##2##2##(2008-10#1)(2008-3#1)
Statistical evaluation of##2##3##(2008-10#2)
Statistical properties of##2##3##(1990-12#1)(2008-10#1)
Statistical significance##2##2##(2008-10#1)(2012-12#1)
Statistical tests##3##2##(2008-10#2)(2011-2#1)
Statistical##70##1##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-2#2)(1993-1#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-9#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-8#1)(2010-11#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
Statistically significant differences were found##2##5##(1997-3#1)(2010-6#1)
Statistically significant differences were##3##4##(1994-1#1)(1997-3#1)(2010-6#1)
Statistically significant differences##4##3##(1994-1#1)(1997-3#1)(2010-5#1)(2010-6#1)
Statistically significant##10##2##(1994-1#1)(1997-3#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
Statistically##11##1##(1993-12#1)(1994-1#1)(1997-3#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
Statistics Department##2##2##(2012-12#2)
Statistics from##2##2##(1997-6#1)(2008-11#1)
Statistics##19##1##(1993-1#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#1)(2012-12#2)(2013-1#2)
Status and##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
Status of##4##2##(1991-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
Status##18##1##(1991-1#1)(1991-6#1)(2008-10#1)(2008-11#5)(2008-7#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#4)
Staufen protein##2##2##(1994-12#2)
Staying in the##3##3##(2009-6#1)(2010-10#2)
Staying in##4##2##(2009-6#1)(2010-10#3)
Stb4 gene##2##2##(2008-10#2)
Stb4##9##1##(2008-10#9)
Stb6##3##1##(2008-10#3)
Stb8##3##1##(2008-10#3)
Std-##2##1##(2008-10#2)
Ste7##2##1##(1996-2#2)
Steady-state##2##1##(1995-8#1)(2008-10#1)
Steering Team##2##2##(1993-12#2)
Steinert's dystrophy##3##2##(2013-1#3)
Steingelia##2##1##(2007-12#2)
Stellaria media##9##2##(2008-10#8)(2008-7#1)
Stellate##2##1##(2008-11#2)
Stem Cell##6##2##(2008-11#4)(2012-12#2)
Stem Cells in##2##3##(2008-11#1)(2012-3#1)
Stem Cells##9##2##(2008-11#4)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Stem Rot##4##2##(2008-10#4)
Stem Rust##2##2##(2008-10#2)
Stem and##2##2##(2008-10#1)(2008-11#1)
Stem cell research##3##3##(2008-10#1)(2008-11#2)
Stem cell##8##2##(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#2)
Stem cells##3##2##(2008-11#2)(2008-7#1)
Stem##43##1##(2007-12#1)(2008-10#14)(2008-11#14)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)
Stemphylium vesicarium##4##2##(2008-10#4)
Stemphylium##6##1##(2008-10#4)(2008-5#2)
Stenosis##5##1##(1994-2#1)(2008-11#1)(2012-3#1)(2013-1#2)
Stenotrophomonas maltophilia strain C3##3##4##(2008-10#3)
Stenotrophomonas maltophilia##7##2##(2008-10#7)
Stenotrophomonas##8##1##(2008-10#8)
Stent Thrombosis##2##2##(2008-11#2)
Stent##6##1##(2008-11#4)(2013-1#1)(2013-8#1)
Stents##2##1##(2008-11#2)
Step##3##1##(2008-7#1)(2009-2#1)(2009-5#1)
Stephen##6##1##(1994-3#1)(1995-12#2)(1996-5#1)(2008-10#1)(2008-11#1)
Steps in##2##2##(2008-10#2)
Steps##4##1##(2008-10#2)(2008-11#1)(2011-2#1)
Stepwise##6##1##(1991-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
Stereoselective Synthesis of##3##3##(1996-5#2)(2008-8#1)
Stereoselective##9##1##(1992-7#1)(1995-3#1)(1996-5#5)(1997-4#1)(2008-8#1)
Stereospecific##2##1##(1996-5#2)
Stereotactic radiosurgery##3##2##(1997-4#1)(2010-9#1)(2011-2#1)
Stereotactic##4##1##(1996-3#1)(1997-4#1)(2010-9#1)(2011-2#1)
Stereotypes##2##1##(2011-2#1)(2012-3#1)
Steric Mass Action parameters of the##2##6##(2008-7#2)
Steric##3##1##(1992-10#1)(2008-7#2)
Sterile##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
Stern-Volmer plots##3##2##(2008-10#3)
Stern-Volmer quenching constant##2##3##(2008-10#2)
Stern-Volmer##9##1##(2008-10#9)
Steroid 9alpha-hydroxylase is##2##3##(2008-11#2)
Steroid##8##1##(1992-5#1)(1995-12#1)(1997-8#1)(2008-11#3)(2008-8#1)(2013-8#1)
Steroids having a##2##3##(1997-1#2)
Steroids##5##1##(1997-1#2)(2008-11#1)(2010-12#1)(2012-2#1)
Stetter##2##1##(2010-6#2)
Steud##4##1##(2008-12#1)(2008-8#2)(2009-10#1)
Stewardship##3##1##(2012-2#1)(2013-1#2)
Stewart##2##1##(1994-1#1)(1994-5#1)
Stewart's disease of corn##2##4##(2008-10#2)
Stewart's wilt##3##2##(2008-10#3)
Stewart's##8##1##(2008-10#8)
Stilbene##2##1##(2008-10#2)
Still##16##1##(1994-1#1)(1995-2#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
Still's##2##1##(2011-2#2)
Stillbirth##2##1##(1992-2#1)(2008-11#1)
Stimulant##2##1##(1996-6#1)(2008-2#1)
Stimulated##4##1##(1995-12#1)(1996-9#1)(2008-3#1)(2012-12#1)
Stimulating##4##1##(1997-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
Stimulation by interleukin-1beta##2##3##(1997-1#2)
Stimulation by##3##2##(1992-3#1)(1997-1#2)
Stimulation of the##3##3##(1990-10#1)(1994-2#1)(1995-12#1)
Stimulation of##21##2##(1990-10#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)
Stimulation with a##2##3##(1997-2#2)
Stimulation with##5##2##(1995-12#1)(1997-2#2)(2008-11#2)
Stimulation##36##1##(1990-10#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-8#1)(1997-1#3)(1997-2#4)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
Stimulus##2##1##(1990-5#1)(2008-5#1)
Stochastic##7##1##(1991-2#1)(1996-9#1)(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#1)(2011-3#1)
Stock##2##1##(2008-10#1)(2008-11#1)
Stockholm##4##1##(1993-1#1)(2011-2#1)(2011-4#1)(2012-2#1)
Stokes radius##2##2##(1990-11#1)(1993-8#1)
Stokes shift##2##2##(2008-10#2)
Stokes vectors in human skin##2##5##(2007-11#2)
Stokes vectors##4##2##(2007-11#4)
Stokes wave##2##2##(2007-12#2)
Stokes waves##2##2##(2007-12#2)
Stokes##19##1##(1990-11#1)(1993-8#1)(1995-6#1)(2007-11#4)(2007-12#7)(2008-10#3)(2008-11#1)(2008-3#1)
Stolon regression##2##2##(2009-8#2)
Stomatal and##2##2##(2011-10#1)(2012-7#1)
Stomatal resistance in##2##3##(2008-10#2)
Stomatal resistance##3##2##(2008-10#3)
Stomatal##6##1##(2008-10#4)(2011-10#1)(2012-7#1)
Stone Fruit Trees##2##3##(2008-10#2)
Stone Fruit##3##2##(2008-10#3)
Stone##6##1##(2008-10#4)(2008-4#1)(2009-11#1)
Stoneville 213##2##2##(2008-10#2)
Stop##5##1##(2008-10#1)(2008-9#1)(2013-8#3)
Stopped-flow injection##2##2##(2008-10#2)
Stopped-flow spectrophotometric##2##2##(2008-10#2)
Stopped-flow##9##1##(1992-1#1)(2008-10#8)
Stopping##3##1##(1991-3#1)(1996-9#1)(2009-6#1)
Storage stability##2##2##(2008-10#2)
Storage##7##1##(1996-9#1)(2008-10#3)(2008-3#1)(2011-10#1)(2012-2#1)
Stored##6##1##(2008-10#3)(2008-9#1)(2009-7#1)(2010-8#1)
Story##2##1##(2010-5#1)(2013-8#1)
Strain A506##3##2##(2008-10#3)
Strain C3##5##2##(2008-10#5)
Strain CHA0##4##2##(2008-10#4)
Strain LS11##2##2##(2008-10#2)
Strain of##8##2##(2008-10#8)
Strain##73##1##(1993-9#1)(2007-12#1)(2008-10#62)(2008-12#2)(2008-5#1)(2008-8#1)(2009-1#1)(2011-2#3)(2012-2#1)
Strain-specific##3##1##(1996-12#1)(2008-10#1)(2008-12#1)
Strains Isolated from##2##3##(2008-10#2)
Strains from##6##2##(1996-12#1)(2008-10#5)
Strains in##3##2##(2008-10#2)(2008-5#1)
Strains isolated from##2##3##(2008-10#2)
Strains of Aphanomyces euteiches##2##4##(2008-10#2)
Strains of Botrytis cinerea##2##4##(2008-10#2)
Strains of Papaya ringspot virus##2##5##(2008-10#2)
Strains of Pseudomonas syringae pv##2##5##(2008-10#2)
Strains of Pseudomonas##3##3##(2008-10#3)
Strains of Ralstonia solanacearum##2##4##(2008-10#2)
Strains of Trichoderma##2##3##(2008-10#2)
Strains of Xanthomonas campestris pv##3##5##(2008-10#3)
Strains of Xanthomonas oryzae pv##2##5##(2008-10#2)
Strains of Xanthomonas##6##3##(2008-10#6)
Strains of the##4##3##(2008-10#3)(2011-2#1)
Strains of##39##2##(2008-10#38)(2011-2#1)
Strains that##2##2##(1993-9#1)(2008-10#1)
Strains to##2##2##(2008-10#2)
Strains were##5##2##(2008-10#4)(2013-8#1)
Strains##78##1##(1993-9#1)(1996-12#1)(2008-10#72)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
Strait##2##1##(1990-11#1)(2008-8#1)
Strand##3##1##(1996-5#1)(2008-12#1)(2012-3#1)
Strategic Plan##2##2##(1991-2#1)(1994-2#1)
Strategic planning for hotel operations##2##5##(1994-2#1)(1994-3#1)
Strategic planning for##3##3##(1991-2#1)(1994-2#1)(1994-3#1)
Strategic planning in##2##3##(1994-2#1)(2008-11#1)
Strategic planning##7##2##(1991-2#2)(1994-1#1)(1994-2#2)(1994-3#1)(2008-11#1)
Strategic##17##1##(1991-2#3)(1991-3#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#2)(1995-2#1)(1996-3#1)(2008-11#3)
Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE)##2##10##(2008-3#2)
Strategies and##7##2##(1991-8#1)(1994-3#1)(2008-10#1)(2008-3#2)(2009-12#1)(2011-3#1)
Strategies for developing##2##3##(1995-5#1)(2008-10#1)
Strategies for improving##2##3##(1993-12#1)(2009-8#1)
Strategies for the##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
Strategies for##23##2##(1990-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1995-5#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Strategies that##2##2##(2008-10#1)(2008-11#1)
Strategies to##3##2##(1995-3#1)(1996-3#1)(2008-8#1)
Strategies##46##1##(1990-12#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
Strategy##9##1##(1991-2#1)(1992-1#1)(1994-3#1)(1996-1#3)(2008-10#1)(2013-1#1)(2013-8#1)
Stratification##3##1##(1992-12#1)(1994-9#1)(2011-2#1)
Stratum corneum##2##2##(2008-5#2)
Stratum##3##1##(2008-5#3)
Strawberry Leaves##4##2##(2008-10#4)
Strawberry in##2##2##(2008-10#2)
Strawberry leaves##2##2##(2008-10#2)
Strawberry##16##1##(2008-10#16)
Streak##3##1##(2008-10#3)
Street##2##1##(2008-8#1)(2009-10#1)
Strehl ratio##2##2##(2008-3#2)
Strehl##3##1##(2008-3#3)
Strengthening the Nursing##3##3##(2008-11#3)
Strengthening the##5##2##(1994-1#1)(2008-11#3)(2008-12#1)
Strengthening##9##1##(1994-1#1)(1996-3#1)(1997-2#1)(2008-11#3)(2008-12#1)(2012-2#1)(2013-1#1)
Strengths of##2##2##(1993-12#1)(2008-10#1)
Strengths##3##1##(1993-1#1)(1993-12#1)(2008-10#1)
Strenuous physical activity##2##3##(1991-12#2)
Streptococcal##2##1##(1991-8#1)(2011-2#1)
Streptococci##2##1##(2011-1#2)
Streptococcus agalactiae##2##2##(1991-11#1)(2010-8#1)
Streptococcus mutans##4##2##(1997-8#1)(2008-5#1)(2013-1#2)
Streptococcus pneumoniae and##2##3##(1995-5#1)(2010-12#1)
Streptococcus pneumoniae isolates from otorhinolaryngological##2##5##(2011-2#2)
Streptococcus pneumoniae to##2##3##(2008-7#1)(2013-8#1)
Streptococcus pneumoniae##20##2##(1992-5#2)(1994-9#2)(1995-5#2)(1997-7#2)(2007-12#1)(2008-11#1)(2008-7#4)(2010-12#1)(2011-2#4)(2013-8#1)
Streptococcus pyogenes infections##2##3##(2011-2#2)
Streptococcus pyogenes##10##2##(1996-12#2)(2008-9#2)(2011-2#6)
Streptococcus sanguis and##2##3##(2006-6#1)(2008-5#1)
Streptococcus sanguis##3##2##(2006-6#1)(2008-5#2)
Streptococcus species##2##2##(2008-7#1)(2011-1#1)
Streptococcus suis serotype 2##3##4##(2009-6#3)
Streptococcus suis##4##2##(2009-6#4)
Streptococcus##58##1##(1991-11#1)(1992-5#2)(1993-12#1)(1994-9#2)(1995-5#2)(1996-12#2)(1996-8#2)(1997-7#2)(1997-8#2)(2006-5#1)(2006-6#1)(2007-12#1)(2008-11#2)(2008-5#4)(2008-7#5)(2008-9#2)(2009-6#6)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-2#2)(2013-1#2)(2013-8#1)
Streptokinase##2##1##(1995-8#1)(2012-2#1)
Streptomyces coelicolor##7##2##(2008-8#5)(2011-2#1)(2012-2#1)
Streptomyces ipomoeae##2##2##(2008-10#2)
Streptomyces lincolnensis##2##2##(2008-8#2)
Streptomyces scabies##3##2##(2008-10#3)
Streptomyces sp##4##2##(2009-6#2)(2012-2#2)
Streptomyces spp##4##2##(2008-10#4)
Streptomyces strains##3##2##(2008-10#2)(2009-6#1)
Streptomyces##52##1##(1992-3#1)(1994-3#1)(1994-5#1)(2008-10#14)(2008-11#1)(2008-8#13)(2008-9#3)(2009-6#3)(2010-8#2)(2011-2#3)(2012-2#6)(2012-3#4)
Streptozotocin-induced diabetes##2##2##(1993-8#1)(1994-11#1)
Streptozotocin-induced diabetic rats##2##3##(2008-10#2)
Streptozotocin-induced##4##1##(1993-8#1)(1994-11#1)(2008-10#2)
Stress Disorder##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
Stress and##5##2##(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
Stress associated with##2##3##(2008-11#1)(2008-12#1)
Stress is##2##2##(1990-3#1)(2012-3#1)
Stress was##2##2##(2008-12#1)(2008-6#1)
Stress##32##1##(1990-3#1)(2007-11#1)(2008-10#3)(2008-11#7)(2008-12#2)(2008-6#2)(2008-7#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)
Stress-induced##3##1##(2008-6#1)(2011-2#1)(2013-1#1)
Stresses##2##1##(2008-10#1)(2010-10#1)
Stressor##2##1##(1992-2#1)(1994-3#1)
Stressors##3##1##(2012-3#2)(2013-8#1)
Striatal##7##1##(1993-6#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-3#1)(2013-8#1)
Strict##6##1##(1994-1#1)(1994-6#1)(1995-2#1)(2008-10#1)(2011-2#1)(2011-3#1)
Strictures##2##1##(2010-12#1)(2013-8#1)
Striga aspera and##2##3##(2008-10#2)
Striga hermonthica##5##2##(2008-10#5)
Striga spp##4##2##(2008-10#4)
Striga##14##1##(2008-10#13)(2009-8#1)
Striking##3##1##(1991-5#1)(1997-2#1)(2013-8#1)
Strikingly##5##1##(1992-7#1)(1994-3#1)(1997-3#1)(2008-9#1)(2011-2#1)
Stripe Rust##2##2##(2008-10#2)
Stripe rust##3##2##(2008-10#3)
Stripe##7##1##(2008-10#7)
Stripping##2##1##(2008-10#1)(2008-4#1)
Stroke Centers##2##2##(2007-9#1)(2013-8#1)
Stroke Society##2##2##(2008-8#2)
Stroke and##2##2##(2008-8#1)(2012-2#1)
Stroke in the elderly treated for systolic hypertension (SHEP)##2##9##(1991-12#1)(1993-1#1)
Stroke in##4##2##(1991-12#1)(1993-1#1)(2008-8#2)
Stroke is the##2##3##(2010-10#1)(2013-1#1)
Stroke##37##1##(1991-12#1)(1993-1#1)(1997-3#1)(2007-9#6)(2008-8#15)(2009-11#2)(2010-10#3)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Stromal##6##1##(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#2)
Strong Coupling Expansion##2##3##(1996-9#2)
Strong correlations##2##2##(2009-8#1)(2013-1#1)
Strong dependence##2##2##(2008-2#1)(2008-3#1)
Strong evidence for##2##3##(1992-8#1)(2013-1#1)
Strong evidence##3##2##(1992-8#1)(2013-1#2)
Strong resistance to##2##3##(2008-10#2)
Strong##29##1##(1992-12#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-9#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2012-3#3)(2013-1#7)
Structural analysis of Arabidopsis thaliana chromosome 5##2##7##(1997-6#1)(1997-8#1)
Structural analysis of##3##3##(1997-6#1)(1997-8#1)(2013-8#1)
Structural analysis##5##2##(1994-5#1)(1995-8#1)(1997-6#1)(1997-8#1)(2013-8#1)
Structural and functional analysis of##2##5##(1997-7#1)(2008-8#1)
Structural and functional##4##3##(1995-3#1)(1996-2#1)(1997-7#1)(2008-8#1)
Structural and##8##2##(1992-8#1)(1993-3#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-8#1)(2012-12#1)
Structural basis for##3##3##(1991-5#1)(1993-8#1)(1995-8#1)
Structural basis##4##2##(1991-5#1)(1993-8#1)(1995-8#1)(2008-10#1)
Structural changes in##2##3##(2008-10#1)(2008-7#1)
Structural characterization of##2##3##(1995-2#1)(1996-12#1)
Structural equation##2##2##(2010-10#2)
Structural features##2##2##(1995-11#1)(2008-4#1)
Structural information##2##2##(2008-10#2)
Structural insights into##2##3##(2012-2#2)
Structural solarization##2##2##(2008-10#2)
Structural studies of the##2##4##(1991-3#1)(2011-2#1)
Structural study of##3##3##(1991-12#1)(1991-3#1)(2008-10#1)
Structural##48##1##(1990-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-8#2)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-2#4)(2013-8#1)
Structure and expression of##2##4##(1993-2#1)(1997-7#1)
Structure and expression##3##3##(1993-2#1)(1997-7#2)
Structure and function##2##3##(2008-8#1)(2012-2#1)
Structure and##23##2##(1991-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-7#2)(1997-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-2#1)
Structure in##3##2##(2008-10#2)(2012-3#1)
Structure of Phytophthora infestans from##2##5##(2008-10#2)
Structure of Phytophthora infestans##3##4##(2008-10#3)
Structure of Phytophthora##5##3##(2008-10#5)
Structure of the human##2##4##(1992-10#1)(1994-11#1)
Structure of the##11##3##(1990-11#1)(1990-2#1)(1992-10#1)(1993-2#1)(1994-11#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-5#1)
Structure of##43##2##(1990-11#1)(1990-2#1)(1992-10#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#27)(2008-5#1)(2008-9#1)
Structure##77##1##(1990-11#1)(1990-2#1)(1991-3#1)(1992-10#1)(1992-9#2)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-7#3)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#36)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
Structure-activity relationship of antioxidants for##2##5##(2008-11#2)
Structure-activity##5##1##(1992-6#1)(1995-11#1)(2008-10#1)(2008-11#2)
Structure-function relationships in the##2##4##(1992-4#1)(2008-7#1)
Structured Clinical##3##2##(2008-11#2)(2013-1#1)
Structured Query Language (SQL)##2##4##(2008-4#2)
Structured##8##1##(2008-11#3)(2008-4#2)(2010-11#1)(2012-3#1)(2013-1#1)
Structures and##2##2##(2008-11#1)(2013-1#1)
Structures of##2##2##(1990-5#1)(2008-8#1)
Structures##7##1##(1990-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2013-1#1)
Structuring##2##1##(1991-1#1)(1993-12#1)
Stuart H##2##2##(1994-12#2)
Student Nurse Stress Index##3##4##(2008-11#3)
Student nurses'##4##2##(2008-11#3)(2010-3#1)
Student##17##1##(1997-2#1)(2008-11#7)(2008-12#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Student's t-test##12##2##(1994-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)
Student's##15##1##(1990-9#1)(1994-2#1)(2008-10#5)(2008-12#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
Students also##4##2##(2008-11#3)(2009-7#1)
Students and##2##2##(2008-11#1)(2009-12#1)
Students are##2##2##(2008-11#2)
Students identified##2##2##(2008-11#1)(2008-12#1)
Students reported##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
Students##35##1##(1992-3#1)(1994-1#1)(2008-11#12)(2008-12#7)(2008-5#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Students'##3##1##(2008-11#1)(2012-2#2)
Studied by##2##2##(2008-10#1)(2009-8#1)
Studied##3##1##(2008-10#2)(2009-8#1)
Studies and##2##2##(2008-10#1)(2013-1#1)
Studies at##2##2##(1990-6#1)(2008-12#1)
Studies by##3##2##(1995-2#1)(2008-10#1)(2012-12#1)
Studies carried out##2##3##(2008-10#1)(2010-11#1)
Studies conducted##2##2##(2007-12#1)(2008-5#1)
Studies for##2##2##(2008-11#1)(2010-11#1)
Studies have shown that##6##4##(2008-11#1)(2010-1#2)(2010-5#1)(2011-2#1)(2013-1#1)
Studies have##15##2##(2008-10#2)(2008-11#2)(2008-9#2)(2009-1#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
Studies in humans##2##3##(2008-6#1)(2009-8#1)
Studies in mice##2##3##(1995-5#1)(2008-10#1)
Studies in##15##2##(1994-12#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-12#1)(2011-2#1)(2011-9#1)
Studies of bosentan in##2##4##(2009-10#1)(2010-10#1)
Studies of the##8##3##(1992-3#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-12#1)
Studies of##40##2##(1990-11#1)(1990-5#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
Studies on derivatization##2##3##(2008-10#2)
Studies on the##23##3##(1990-11#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-9#1)(1996-5#1)(2006-6#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-9#1)(2009-11#1)(2013-1#1)
Studies on##47##2##(1990-11#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-5#3)(2006-6#1)(2008-10#17)(2008-11#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
Studies suggest that##3##3##(1996-11#1)(2008-8#1)(2009-10#1)
Studies that##4##2##(2008-9#1)(2012-2#2)(2013-8#1)
Studies to evaluate##2##3##(2008-10#1)(2008-5#1)
Studies to##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
Studies using##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
Studies were carried out on the effect of retention and elution conditions for both##2##14##(2008-10#2)
Studies were conducted to##2##4##(2008-10#1)(2008-11#1)
Studies were conducted##3##3##(2008-10#2)(2008-11#1)
Studies were performed on##2##4##(2009-8#1)(2011-2#1)
Studies were##11##2##(1996-1#1)(1996-3#1)(2008-10#5)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
Studies with##5##2##(1994-5#1)(1994-8#1)(2008-11#1)(2008-9#1)(2009-8#1)
Studies##186##1##(1990-11#2)(1990-5#1)(1990-6#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-5#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#52)(2008-11#12)(2008-12#5)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#3)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#5)(2011-9#1)(2012-12#4)(2012-2#6)(2013-1#7)(2013-8#4)
Studies)##2##1##(1996-9#1)(2008-12#1)
Study 1##8##2##(1991-2#2)(2008-12#3)(2009-5#1)(2010-10#1)(2010-4#1)
Study 2 used##2##3##(1991-2#1)(2008-12#1)
Study 2##9##2##(1991-2#2)(2008-12#3)(2009-5#1)(2010-10#1)(2010-4#1)(2013-8#1)
Study 3##2##2##(2008-12#1)(2010-4#1)
Study Design##10##2##(2010-8#1)(2013-1#9)
Study Group##10##2##(1990-11#2)(1991-8#1)(1992-12#1)(1992-3#1)(1994-3#1)(1995-8#1)(1997-7#2)(2011-2#1)
Study and##3##2##(2008-10#3)
Study by##2##2##(1990-5#1)(1991-11#1)
Study design##15##2##(2012-12#13)(2013-1#2)
Study in##2##2##(2008-3#1)(2013-1#1)
Study limitations##2##2##(2008-1#1)(2009-11#1)
Study of a##2##3##(2008-10#1)(2010-1#1)
Study of antioxidant properties of##2##5##(2008-10#2)
Study of the##18##3##(1995-3#1)(2007-12#1)(2008-10#11)(2008-12#1)(2009-10#2)(2010-1#1)(2010-6#1)
Study of##62##2##(1991-11#1)(1992-2#1)(1995-11#2)(1995-3#1)(1995-9#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#3)(2009-7#1)(2010-1#2)(2010-6#1)(2010-7#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Study on the##9##3##(2008-10#6)(2008-12#1)(2008-8#1)(2011-2#1)
Study on##20##2##(2008-10#12)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Study participants##2##2##(2008-12#1)(2011-2#1)
Study results##2##2##(1993-3#1)(1997-5#1)
Study subjects##2##2##(2008-11#1)(2011-2#1)
Study##221##1##(1990-11#3)(1990-5#1)(1991-11#2)(1991-2#5)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-3#2)(1994-1#1)(1994-3#1)(1995-11#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-8#1)(1997-5#2)(1997-7#3)(2007-12#1)(2007-9#1)(2008-1#9)(2008-10#48)(2008-11#4)(2008-12#16)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#4)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-4#4)(2010-5#2)(2010-6#7)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#15)(2012-2#4)(2012-3#4)(2013-1#23)(2013-8#5)
Studying the##4##2##(2008-10#2)(2008-8#1)(2009-8#1)
Studying##8##1##(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-8#1)
Stunt##3##1##(2008-10#2)(2011-2#1)
Stx##3##1##(2013-1#3)
Stx2##3##1##(2013-1#3)
StxB##3##1##(2008-8#3)
Styela##3##1##(2008-6#1)(2008-7#2)
Style##3##1##(2010-10#1)(2012-2#1)(2012-3#1)
Styles Inventory##3##2##(2012-2#3)
Stylosanthes populations##2##2##(2008-10#2)
Stylosanthes scabra##2##2##(2008-10#2)
Stylosanthes spp##3##2##(2008-10#3)
Stylosanthes##10##1##(2008-10#10)
Stöber##2##1##(2008-10#2)
SuMV##6##1##(2008-10#6)
Sub-Doppler##2##1##(2007-11#1)(2008-2#1)
Subacute##2##1##(1996-6#1)(2011-2#1)
Subarachnoid Hemorrhage##4##2##(1995-11#1)(2011-2#1)(2012-3#2)
Subarachnoid##5##1##(1995-11#1)(2008-7#1)(2011-2#1)(2012-3#2)
Subcellular distribution of rare earth elements##2##6##(2008-10#2)
Subcellular distribution of##3##3##(1990-5#1)(2008-10#2)
Subcellular fractionation of tissue culture cells##2##6##(2008-4#2)
Subcellular fractionation##3##2##(1995-6#1)(2008-4#2)
Subcellular localization of##3##3##(1990-5#1)(2009-8#1)(2011-2#1)
Subcellular##9##1##(1990-5#2)(1995-6#1)(2008-10#2)(2008-4#2)(2009-8#1)(2011-2#1)
Subclavian##2##1##(1997-6#1)(2010-5#1)
Subclinical cecal impaction##2##3##(2013-8#2)
Subclinical##4##1##(2012-3#2)(2013-8#2)
Subcommittee on##2##2##(1995-6#1)(1996-5#1)
Subcutaneous emphysema##2##2##(1993-1#2)
Subcutaneous injection of##2##3##(1992-8#1)(1994-12#1)
Subcutaneous##12##1##(1991-5#1)(1992-8#1)(1993-1#2)(1994-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
Subdivision of the##2##3##(2008-10#1)(2011-2#1)
Subfamily##2##1##(2008-10#1)(2013-1#1)
Subgroup I##2##2##(2008-10#2)
Subgroup##5##1##(2008-10#5)
Subgroups##4##1##(1991-11#1)(1995-12#1)(2008-10#1)(2011-2#1)
Subject##2##1##(2008-6#1)(2013-1#1)
Subjecting##2##1##(2008-10#1)(2010-4#1)
Subjective assessment of complications was##2##5##(1992-12#2)
Subjective invulnerability##3##2##(2010-7#3)
Subjective##10##1##(1991-8#1)(1992-12#2)(2010-6#2)(2010-7#3)(2011-2#1)(2013-1#1)
Subjects and methods##2##3##(2009-8#1)(2012-3#1)
Subjects and##3##2##(2009-8#1)(2012-3#1)(2013-8#1)
Subjects are##2##2##(1990-12#1)(2008-7#1)
Subjects in the##4##3##(1991-12#1)(2008-4#3)
Subjects were instructed to##2##4##(1991-2#1)(2010-9#1)
Subjects were##13##2##(1991-12#1)(1991-2#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-1#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#2)
Subjects with##7##2##(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-1#1)
Subjects##44##1##(1990-12#1)(1991-12#2)(1991-2#1)(1993-2#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-4#4)(2008-5#2)(2008-7#5)(2009-12#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
Subpopulation##2##1##(2008-10#1)(2008-7#1)
Subpopulations##3##1##(2008-10#2)(2008-11#1)
Subretinal##2##1##(2010-9#1)(2012-3#1)
Subsequent investigation##2##2##(2011-2#2)
Subsequent investigations##2##2##(2008-10#1)(2008-11#1)
Subsequent research##2##2##(2009-7#1)(2012-12#1)
Subsequent##30##1##(1991-9#1)(1992-3#1)(1992-8#1)(1994-8#1)(1996-5#2)(2007-12#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-12#1)
Subsequently the##2##2##(2008-10#1)(2008-3#1)
Subsequently##54##1##(1993-2#1)(1993-6#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
Subsets##3##1##(2008-10#2)(2013-8#1)
Substance P##2##2##(1994-8#2)
Substance Use##4##2##(2008-9#1)(2012-12#1)(2013-1#2)
Substance abuse and##2##3##(1992-1#1)(2013-1#1)
Substance abuse##5##2##(1992-1#1)(2009-10#1)(2009-9#1)(2013-1#1)(2013-8#1)
Substance use##2##2##(1997-5#1)(2008-9#1)
Substance##16##1##(1992-1#1)(1994-8#2)(1997-5#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-11#1)(2010-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
Substances##4##1##(1995-11#1)(2008-10#1)(2008-11#1)(2010-7#1)
Substantial evidence##2##2##(2008-11#1)(2013-7#1)
Substantial##9##1##(2008-10#4)(2008-11#1)(2008-12#2)(2010-4#1)(2013-7#1)
Substituted##5##1##(1996-5#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-6#1)
Substitution of##8##2##(1991-3#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-8#1)(1997-3#1)(2008-10#1)(2011-2#1)
Substitution##10##1##(1991-3#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
Substitutions in##3##2##(1997-9#1)(2008-10#1)(2012-3#1)
Substitutions##5##1##(1994-5#1)(1997-9#1)(2008-10#1)(2008-12#1)(2012-3#1)
Substrate for##2##2##(1996-5#1)(2008-10#1)
Substrate##10##1##(1993-8#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)
Substrates##3##1##(1995-6#1)(2009-5#1)(2009-6#1)
Subsurface##2##1##(2008-10#2)
Subtalar##2##1##(2008-12#1)(2012-3#1)
Subthalamic##2##1##(2008-9#1)(2012-2#1)
Subtypes##3##1##(2010-8#1)(2013-1#1)(2013-8#1)
Subunit##3##1##(1990-5#1)(2008-8#1)(2012-3#1)
Success is##2##2##(2008-10#1)(2008-11#1)
Success of##2##2##(2008-8#1)(2012-3#1)
Success##9##1##(1997-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2011-7#1)(2012-3#1)(2013-7#1)
Successful fund raising##2##3##(1991-1#1)(1997-1#1)
Successful implementation of##2##3##(1995-2#1)(2008-10#1)
Successful implementation##4##2##(1995-2#1)(1997-2#2)(2008-10#1)
Successful management of##2##3##(2008-10#2)
Successful outcome##2##2##(1995-3#1)(2013-1#1)
Successful treatment of##4##3##(1991-4#1)(2011-2#2)(2012-3#1)
Successful treatment with##2##3##(2009-8#1)(2010-8#1)
Successful treatment##7##2##(1991-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)
Successful##50##1##(1991-1#1)(1991-11#1)(1991-4#1)(1993-1#1)(1993-12#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
Successfully##3##1##(2008-9#1)(2010-6#1)(2012-12#1)
Successive##4##1##(1995-3#1)(1996-2#1)(1996-5#1)(2008-10#1)
Such &quot##2##2##(2008-8#1)(2009-8#1)
Such a change##2##3##(2008-11#1)(2010-7#1)
Such a model##2##3##(2013-1#1)(2013-8#1)
Such a phenomenon##2##3##(2008-10#2)
Such a##39##2##(1990-5#2)(1991-12#1)(1992-3#1)(1993-1#1)(1995-6#3)(1997-3#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Such ability##2##2##(2008-10#1)(2008-8#1)
Such an##18##2##(1990-8#1)(1992-1#1)(1992-2#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-5#1)(2010-7#1)(2013-1#2)
Such changes##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
Such characteristics##2##2##(2008-11#2)
Such data##3##2##(1993-1#1)(2008-10#1)(2011-2#1)
Such electrodes##2##2##(2008-10#2)
Such evidence##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
Such information can be##2##4##(2013-1#2)
Such information can##3##3##(2008-10#1)(2013-1#2)
Such information##4##2##(2008-10#2)(2013-1#2)
Such interactions##2##2##(2008-12#1)(2008-8#1)
Such methodology##2##2##(2008-10#1)(2012-2#1)
Such methods##2##2##(1994-9#1)(2008-3#1)
Such patterns##2##2##(2008-10#2)
Such sequences have been##2##4##(1992-6#1)(1993-6#1)
Such studies##4##2##(2008-10#1)(2008-4#1)(2011-2#2)
Such systems##2##2##(2008-11#1)(2013-8#1)
Such##211##1##(1990-3#1)(1990-5#3)(1990-8#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#3)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#61)(2008-11#14)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#11)(2008-9#5)(2009-11#1)(2009-6#2)(2009-8#4)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#2)
Sucrose##3##1##(2008-10#2)(2011-2#1)
Sud##2##1##(2008-11#1)(2010-6#1)
Sudan Black##2##2##(2009-7#2)
Sudan##12##1##(2008-10#4)(2008-8#1)(2009-7#2)(2011-2#2)(2013-1#3)
Sudanese women were##3##3##(2013-1#3)
Sudanese women##8##2##(2013-1#8)
Sudanese##9##1##(2013-1#9)
Sudden Death Syndrome##2##3##(2008-10#2)
Sudden Infant Death Syndrome (SIDS) or##2##6##(2008-1#2)
Sudden Oak Death##2##3##(2008-10#2)
Sudden cardiac death in young athletes##2##6##(2012-3#2)
Sudden cardiac death##3##3##(2012-3#3)
Sudden death in##2##3##(1991-11#1)(2008-12#1)
Sudden death##5##2##(1991-11#1)(2008-10#2)(2008-12#1)(2009-10#1)
Sudden##22##1##(1991-11#1)(1994-9#2)(2008-1#2)(2008-10#8)(2008-12#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-3#4)(2013-1#1)
Suffering##2##1##(1991-8#1)(2012-12#1)
Sufficient for##2##2##(2008-10#1)(2012-3#1)
Sufficient##4##1##(2008-10#2)(2008-11#1)(2012-3#1)
Sugar Beet##6##2##(2008-10#5)(2012-3#1)
Sugar and children's behavior##5##4##(1994-6#5)
Sugar and##6##2##(1994-6#5)(2008-10#1)
Sugar##18##1##(1994-6#5)(1996-5#1)(2008-10#9)(2008-7#1)(2012-2#1)(2012-3#1)
Sugarcane##10##1##(2008-10#10)
Sugars##3##1##(2008-10#2)(2008-6#1)
Suggested##2##1##(2008-12#2)
Suggestions for future##2##3##(1997-2#1)(2010-9#1)
Suggestions for the##2##3##(1993-1#1)(2008-11#1)
Suggestions for##5##2##(1993-1#1)(1993-3#1)(1997-2#1)(2008-11#1)(2010-9#1)
Suggestions##8##1##(1993-1#2)(1993-3#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2010-9#1)
Suggests##7##1##(2008-10#7)
Suicidal##2##1##(2008-11#1)(2010-6#1)
Suicide##6##1##(1992-1#1)(1992-2#1)(1997-2#1)(1997-4#1)(2013-8#2)
Suitable##4##1##(1990-5#1)(2008-10#1)(2008-11#1)(2010-7#1)
Sulfamic##2##1##(1993-1#1)(2008-10#1)
Sulfate##4##1##(1992-12#1)(2012-2#2)(2013-8#1)
Sulfinimine-derived##2##1##(2008-11#2)
Sulfite##2##1##(2008-10#2)
Sulfolobus shibatae##2##2##(2008-9#2)
Sulfolobus##5##1##(1990-2#1)(2008-9#4)
Sulfonamides##3##1##(2008-10#2)(2010-6#1)
Sulfonylcalix[4]arenetetrasulfonate##2##1##(2008-10#2)
Sulfur##3##1##(2008-10#2)(2008-11#1)
Sulfurospirillum deleyianum##4##2##(1994-11#2)(2011-2#2)
Sulfurospirillum##6##1##(1994-11#2)(2011-2#4)
Sullivan##3##1##(1993-1#1)(2008-6#2)
Sullivan's method##3##2##(2011-2#3)
Sullivan's##4##1##(2011-2#4)
Sulphate##2##1##(2008-10#1)(2008-11#1)
Sulphoxine##2##1##(2008-10#2)
Sum##2##1##(2008-2#1)(2012-3#1)
Sumai 3##2##2##(2008-10#2)
Summary##52##1##(1994-9#1)(1995-11#5)(1995-5#1)(1996-1#1)(1996-3#5)(1996-6#6)(1996-9#7)(1997-3#9)(1997-6#6)(2008-11#2)(2010-5#1)(2013-1#7)(2013-8#1)
Summer##3##1##(1993-3#1)(2008-11#1)(2013-1#1)
Summit##2##1##(2009-12#1)(2011-2#1)
Sumner##2##1##(2008-10#2)
Sun##11##1##(1991-6#1)(1991-9#1)(2008-3#2)(2008-5#1)(2010-8#3)(2011-2#3)
Sundays##2##1##(1994-9#1)(2008-10#1)
Sunflower mosaic virus##2##3##(2008-10#2)
Sunflower mosaic##3##2##(2008-10#3)
Sunflower##8##1##(2008-10#8)
Sunnybrook Health Science##2##3##(1992-12#1)(1995-12#1)
Sunnybrook##4##1##(1992-12#2)(1995-12#1)(2007-9#1)
Sunnyvale##3##1##(1996-1#1)(1996-5#1)(2008-10#1)
Sunscreens are##3##2##(1991-6#1)(2011-2#2)
Sunscreens##4##1##(1991-6#1)(2008-5#1)(2011-2#2)
Sunset Yellow and##2##3##(2008-10#2)
Sunset Yellow##7##2##(2008-10#7)
Sunset##8##1##(2008-10#8)
Super-CHO cells##2##2##(2008-11#2)
Super-CHO##6##1##(2008-11#6)
Super-selective##2##1##(1991-6#1)(1997-3#1)
Superconducting##4##1##(1994-9#1)(1996-9#1)(2008-7#1)(2010-7#1)
Superconductivity##2##1##(1994-9#2)
Supercritical carbon dioxide extraction##2##4##(2008-10#2)
Supercritical carbon dioxide##3##3##(2008-10#3)
Supercritical fluid extraction of resveratrol from grape skin of Vitis vinifera##2##11##(2008-10#2)
Supercritical fluid extraction of##5##4##(2008-10#5)
Supercritical fluid extraction##9##3##(2008-10#8)(2012-2#1)
Supercritical fluid technology##2##3##(2012-2#2)
Supercritical fluid##12##2##(2008-10#9)(2012-2#3)
Supercritical##16##1##(2008-10#13)(2012-2#3)
Superdex 200##2##2##(2008-10#2)
Superdex##6##1##(1995-11#1)(2008-10#5)
Superficial granulomatous pyoderma##4##3##(2013-1#4)
Superficial venous vascular response##2##4##(2013-8#2)
Superficial##9##1##(1991-9#1)(2008-7#1)(2012-3#1)(2013-1#4)(2013-8#2)
Superheated##2##1##(2008-10#2)
Superinfection##2##1##(2008-8#2)
Superior Court##4##2##(1993-3#1)(1995-12#1)(1995-6#1)(1996-5#1)
Superior service is the outcome of a dedicated planning methodology##2##10##(1994-1#2)
Superior##13##1##(1993-3#1)(1994-1#2)(1995-12#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
Superlattices##2##1##(1994-9#1)(1996-9#1)
Supernatant analysis##2##2##(2008-10#2)
Supernatant##3##1##(2008-10#2)(2008-7#1)
Superoxide dismutase activity##2##3##(1990-3#1)(1991-5#1)
Superoxide dismutase##4##2##(1990-3#1)(1991-5#1)(1992-12#1)(2008-10#1)
Superoxide##6##1##(1990-3#1)(1991-5#2)(1992-12#1)(2008-10#2)
Supplement Use##2##2##(2008-10#1)(2013-8#1)
Supplement##3##1##(2008-10#1)(2011-2#1)(2013-8#1)
Supplemental Security Income##4##3##(1991-1#1)(1992-2#1)(1995-12#2)
Supplemental##8##1##(1991-1#1)(1992-2#1)(1993-1#1)(1995-12#2)(1996-12#2)(2012-3#1)
Supplementary statement on##2##3##(1994-9#1)(1995-11#1)
Supplementation of##5##2##(1996-6#1)(2008-10#1)(2008-11#3)
Supplemented with##2##2##(2008-11#2)
Supplementing##2##1##(1990-3#1)(2009-8#1)
Support Protocol describes##2##3##(2008-4#1)(2008-9#1)
Support Protocol##5##2##(2008-4#3)(2008-9#2)
Support Vector##2##2##(2010-8#2)
Support from##2##2##(1992-3#1)(2009-5#1)
Support protocols are provided for##2##5##(2008-4#1)(2008-9#1)
Support protocols are##3##3##(2008-4#2)(2008-9#1)
Support protocols cover##2##3##(2008-4#1)(2008-9#1)
Support protocols describe the##2##4##(2008-4#2)
Support protocols describe##5##3##(2008-4#4)(2008-9#1)
Support protocols for##3##3##(2008-4#2)(2008-9#1)
Support protocols##14##2##(2008-4#10)(2008-9#4)
Support##41##1##(1992-1#1)(1992-2#1)(1992-3#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#14)(2008-9#7)(2009-5#1)(2010-1#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#2)(2013-1#1)
Supported by a##2##3##(2008-8#1)(2010-5#1)
Supported liquid membrane (SLM)##3##4##(2008-10#3)
Supported##6##1##(1993-1#1)(2008-10#3)(2008-8#1)(2010-5#1)
Supporting the##2##2##(2008-11#1)(2011-2#1)
Supporting##10##1##(1995-1#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-9#1)(2011-2#1)
Supportive##6##1##(1992-2#1)(2008-12#1)(2008-7#2)(2010-9#1)(2013-1#1)
Suppress##3##1##(2008-10#2)(2012-3#1)
Suppresses##5##1##(2008-11#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Suppressing##2##1##(2008-10#1)(2013-8#1)
Suppression of Fusarium Wilt##2##4##(2008-10#2)
Suppression of Phytophthora##2##3##(2008-10#2)
Suppression of Pythium##3##3##(2008-10#3)
Suppression of Rhizoctonia##2##3##(2008-10#2)
Suppression of##34##2##(1992-10#1)(1992-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#21)(2008-11#3)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
Suppression##40##1##(1992-10#1)(1992-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#24)(2008-11#4)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#2)(2013-1#1)
Suppressive##3##1##(2008-10#3)
Suppressiveness##7##1##(2008-10#7)
Supravesical##2##1##(2008-12#2)
Supreme Court##13##2##(1990-11#1)(1991-12#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-6#3)(1996-2#1)(1996-5#1)(1997-6#1)
Supreme Court's##3##2##(1991-12#1)(1996-5#1)(2009-9#1)
Supreme##17##1##(1990-11#1)(1991-12#2)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-6#3)(1996-2#1)(1996-5#2)(1997-6#1)(2009-9#1)(2013-1#1)
Sure##2##1##(1994-3#1)(1995-3#1)
Sure-Grow 747##2##2##(2008-10#2)
Surface Plasmon##2##2##(2008-11#2)
Surface charge density of##2##4##(2008-10#1)(2009-8#1)
Surface morphology##2##2##(1991-9#1)(2008-10#1)
Surface water##2##2##(2008-10#2)
Surface##47##1##(1990-11#2)(1990-12#1)(1991-9#1)(1992-11#1)(1995-8#1)(1996-5#1)(1996-9#3)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
Surfaces##7##1##(1996-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-10#1)
Surfactant##4##1##(1994-5#1)(1996-5#1)(1997-1#2)
Surfactants##2##1##(2008-5#2)
Surg##2##1##(2008-12#1)(2008-9#1)
Surgeon General##2##2##(1993-3#1)(1996-5#1)
Surgeon##4##1##(1993-3#1)(1996-5#1)(2008-6#1)(2009-7#1)
Surgeons should##2##2##(2011-2#1)(2013-1#1)
Surgeons##10##1##(1994-12#1)(1997-3#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#3)(2013-1#2)
Surgeries##2##1##(1990-3#1)(2010-7#1)
Surgery and##3##2##(1991-9#1)(1992-5#1)(2010-12#1)
Surgery for##7##2##(1996-11#3)(2010-12#1)(2011-2#2)(2012-3#1)
Surgery in##3##2##(2008-10#1)(2009-4#1)(2012-3#1)
Surgery is##4##2##(2008-10#2)(2010-12#1)(2010-8#1)
Surgery of##4##2##(1996-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
Surgery was##5##2##(2007-8#1)(2008-7#2)(2011-2#1)(2012-3#1)
Surgery##72##1##(1990-5#1)(1990-9#1)(1991-9#2)(1992-5#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-11#3)(1996-3#1)(1996-9#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#5)(2010-8#1)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#15)(2013-1#3)(2013-8#2)
Surgibonetrade mark##3##2##(2008-7#3)
Surgical Clinic##3##2##(2011-3#3)
Surgical and##3##2##(1992-12#1)(2008-9#1)(2009-10#1)
Surgical correction of##2##3##(2008-10#1)(2012-2#1)
Surgical correction##3##2##(2008-10#1)(2010-3#1)(2012-2#1)
Surgical exploration##2##2##(2008-12#1)(2013-1#1)
Surgical exposure##2##2##(1990-5#1)(2013-1#1)
Surgical indications##2##2##(1990-3#1)(2008-7#1)
Surgical innovation##2##2##(2008-4#2)
Surgical lifestyles##2##2##(2008-4#2)
Surgical management of##4##3##(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
Surgical management##5##2##(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
Surgical margins##2##2##(1997-7#2)
Surgical procedures are##2##3##(2008-4#1)(2013-1#1)
Surgical removal of the##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
Surgical removal of##4##3##(2008-4#2)(2011-2#1)(2013-1#1)
Surgical resection##2##2##(1990-11#1)(1991-6#1)
Surgical site##2##2##(2009-3#1)(2012-3#1)
Surgical treatment is##4##3##(1990-12#1)(2008-7#1)(2011-2#2)
Surgical treatment of pericentral arteriovenous malformation##2##6##(2008-7#2)
Surgical treatment of##4##3##(2008-10#2)(2008-7#2)
Surgical treatment##17##2##(1990-12#1)(1990-3#1)(1990-6#1)(1995-2#1)(1996-8#1)(2008-10#2)(2008-7#3)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
Surgical waiting lists##2##3##(1992-12#1)(1993-2#1)
Surgical##105##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-9#2)(1991-3#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-12#3)(1995-2#1)(1996-8#1)(1997-7#2)(1997-8#3)(2008-10#5)(2008-11#1)(2008-12#7)(2008-4#9)(2008-7#5)(2008-9#5)(2009-10#2)(2009-3#1)(2010-3#2)(2010-6#1)(2010-7#2)(2011-2#9)(2011-3#3)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#13)
Surinam##2##1##(1994-12#1)(1996-11#1)
Surprisingly##13##1##(1993-12#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2012-2#1)(2012-3#1)
Surrogate end points and their role in clinical##2##8##(2010-2#2)
Surrogate##4##1##(1995-12#1)(1995-5#1)(2010-2#2)
Surveillance System##9##2##(1992-6#1)(1992-9#1)(1997-3#3)(2009-5#1)(2012-12#3)
Surveillance and##3##2##(1997-3#2)(2010-1#1)
Surveillance for##3##2##(1997-3#2)(2012-3#1)
Surveillance of##3##2##(1994-5#1)(1995-5#1)(1996-11#1)
Surveillance##32##1##(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-11#1)(1997-3#9)(2008-11#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-10#1)(2011-9#3)(2012-12#4)(2012-3#3)
Survey and##2##2##(1993-1#1)(1993-3#1)
Survey findings##2##2##(1994-2#1)(1996-1#1)
Survey for##2##2##(1992-2#1)(2009-7#1)
Survey of##8##2##(1990-3#1)(1992-2#2)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)
Survey on##4##2##(1991-3#1)(2008-10#1)(2010-6#1)(2013-1#1)
Survey results##2##2##(1997-3#1)(2011-10#1)
Survey##68##1##(1990-3#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#4)(1995-2#3)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#3)(2008-1#2)(2008-10#6)(2008-11#3)(2009-3#1)(2009-5#1)(2009-7#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#2)(2010-9#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#5)
Survey&quot##2##1##(2013-1#2)
Surveying congenital anomalies##2##3##(2008-11#2)
Surveying##3##1##(1996-2#1)(2008-11#2)
Surveys are##2##2##(1991-1#1)(2009-7#1)
Surveys for##2##2##(1993-3#1)(2008-10#1)
Surveys of##3##2##(1991-6#1)(1993-3#1)(2012-12#1)
Surveys##12##1##(1991-1#2)(1991-6#1)(1993-3#3)(1995-3#1)(1996-1#1)(2008-10#1)(2009-7#2)(2012-12#1)
Survival analysis##2##2##(1993-11#1)(2008-7#1)
Survival and##5##2##(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)
Survival in##2##2##(1993-2#1)(2008-7#1)
Survival of Fusarium##2##3##(2008-10#2)
Survival of Phytophthora infestans##2##4##(2008-10#2)
Survival of Ralstonia solanacearum##2##4##(2008-10#2)
Survival of dosed##2##3##(2008-9#2)
Survival of exposed##2##3##(2008-9#2)
Survival of patients##2##3##(1991-2#1)(2011-2#1)
Survival of the##2##3##(2008-10#1)(2012-3#1)
Survival of##31##2##(1991-2#2)(1996-1#1)(2008-10#14)(2008-11#1)(2008-9#6)(2009-10#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Survival was measured##2##3##(2008-10#1)(2008-7#1)
Survival was##8##2##(1992-12#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)
Survival##59##1##(1991-2#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-11#1)(1995-2#1)(1996-1#1)(2008-10#19)(2008-11#2)(2008-7#4)(2008-9#8)(2009-10#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-3#4)(2013-1#3)(2013-8#2)
Survivin##2##1##(2011-2#2)
Susanne Kammerer]##2##2##(1997-6#1)(1997-8#1)
Susceptibility and##2##2##(2008-10#1)(2011-2#1)
Susceptibility of##5##2##(1995-11#1)(2008-10#3)(2008-5#1)
Susceptibility to##9##2##(1995-8#1)(2008-10#6)(2008-5#1)(2010-5#1)
Susceptibility##19##1##(1995-11#1)(1995-8#1)(2008-10#12)(2008-5#2)(2010-5#1)(2011-2#2)
Susceptible Plants##2##2##(2008-10#2)
Susceptible and##3##2##(2008-10#3)
Susceptible to##2##2##(2008-10#2)
Susceptible##14##1##(2008-10#14)
Suspected##4##1##(1990-2#1)(2008-12#1)(2012-12#1)(2012-2#1)
Suspension of##2##2##(1992-3#1)(2008-11#1)
Suspension##4##1##(1992-3#1)(2008-11#3)
Suspicion of##2##2##(1997-8#1)(2008-9#1)
Sustainable##4##1##(1997-7#2)(2008-10#2)
Sustained release##3##2##(1991-1#1)(2012-2#2)
Sustained##5##1##(1991-1#1)(1996-6#1)(2008-10#1)(2012-2#2)
Suwon 92 and##2##3##(2008-10#2)
Suwon 92##5##2##(2008-10#5)
Suzuki##5##1##(1996-5#2)(2008-12#2)(2013-8#1)
Sv##2##1##(1997-8#1)(2008-7#1)
Sw 72469-6##4##2##(2008-10#4)
Sw-5##2##1##(2008-10#2)
Swan-Ganz catheter##2##2##(1995-2#2)
Swanson##4##1##(2008-9#4)
Sweden##26##1##(1990-11#2)(1991-2#2)(1993-1#1)(1993-2#1)(1994-6#1)(1995-1#3)(2008-10#1)(2008-11#3)(2009-6#1)(2010-10#4)(2010-4#1)(2011-2#1)(2011-4#1)(2012-2#1)(2012-3#2)(2013-8#1)
Sweden)##2##1##(2008-11#2)
Swedish study##2##2##(2008-5#1)(2011-2#1)
Swedish##12##1##(1991-12#1)(1997-5#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#2)
Sweeping##2##1##(2007-12#1)(2008-6#1)
Sweet potato feathery mottle virus##2##5##(2008-10#2)
Sweet##9##1##(2008-10#8)(2008-11#1)
Sweetpotato##4##1##(2008-10#4)
Swimming##3##1##(1990-11#1)(2008-5#1)(2010-8#1)
Swine##6##1##(2008-10#3)(2011-2#1)(2013-8#2)
Swiss 3T3 cells##3##3##(1994-3#3)
Swiss and##2##2##(1991-2#1)(2008-12#1)
Swiss chard##3##2##(2008-10#3)
Swiss needle cast##4##3##(2008-10#4)
Swiss##25##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-3#3)(1996-11#1)(1996-8#1)(2008-10#9)(2008-12#3)(2008-3#1)(2010-1#1)(2011-2#1)(2012-3#1)
Switched##2##1##(2008-3#2)
Switching##2##1##(1995-3#1)(2008-3#1)
Switzerland and##3##2##(1990-3#1)(2008-10#1)(2008-11#1)
Switzerland in##2##2##(1996-11#1)(2010-12#1)
Switzerland##25##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#1)(1993-8#1)(1996-11#2)(1997-4#1)(1997-5#1)(1997-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2010-12#1)(2012-5#2)
SyF spectra##2##2##(2008-10#2)
SyF##3##1##(2008-10#3)
Sydney##8##1##(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#2)
Syk##7##1##(1995-6#5)(2009-6#2)
Symbiotic symbolization by hand and mouth##2##6##(2010-5#2)
Symmetric##3##1##(1997-4#1)(2008-8#1)(2010-3#1)
Symmetry##2##1##(1997-2#1)(1997-6#1)
Sympatry##2##1##(2008-10#2)
Symposium of the##2##3##(2008-7#1)(2010-10#1)
Symposium on##15##2##(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#2)
Symposium proceedings##2##2##(1995-12#1)(1997-6#1)
Symposium##28##1##(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2013-8#1)
Symptom Checklist##3##2##(1992-1#1)(2008-4#1)(2012-5#1)
Symptom Development##2##2##(2008-10#2)
Symptom Expression##2##2##(2008-10#2)
Symptom Inventory##3##2##(2008-7#1)(2013-1#2)
Symptom##14##1##(1991-1#1)(1992-1#1)(2008-10#5)(2008-4#1)(2008-7#2)(2011-2#1)(2012-5#1)(2013-1#2)
Symptomatic##11##1##(1994-2#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#3)(2013-1#1)
Symptomless##5##1##(2008-10#5)
Symptoms and##3##2##(1997-8#1)(2008-10#1)(2011-8#1)
Symptoms include##4##2##(2008-10#2)(2008-8#1)(2009-9#1)
Symptoms of##8##2##(1991-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2013-1#1)
Symptoms on##3##2##(2008-10#2)(2010-10#1)
Symptoms##35##1##(1991-8#1)(1997-2#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#3)(2011-8#1)(2013-1#2)
Synapses##2##1##(1994-8#1)(2009-8#1)
Synaptic plasticity##2##2##(2008-4#2)
Synaptic##5##1##(1994-8#2)(1997-3#1)(2008-4#2)
Synchronization and##2##2##(1996-9#2)
Synchronization of##3##2##(2007-12#1)(2008-11#1)(2008-4#1)
Synchronization##5##1##(1996-9#2)(2007-12#1)(2008-11#1)(2008-4#1)
Synchronous fluorescence and##2##3##(2008-10#2)
Synchronous fluorescence##5##2##(2008-10#5)
Synchronous##10##1##(1993-9#1)(2008-10#8)(2011-2#1)
Synchrony of##2##2##(1990-8#1)(2008-11#1)
Syndecan-1##2##1##(2008-5#2)
Syndrome (IBS)##2##2##(2013-1#2)
Syndrome de glissement&quot##2##3##(2010-6#2)
Syndrome in##4##2##(2008-1#1)(2008-10#1)(2008-3#2)
Syndrome of##4##2##(1997-3#1)(2008-10#1)(2011-2#2)
Syndrome##47##1##(1991-11#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#4)(2008-4#1)(2008-7#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
Syndrome)##2##1##(1992-9#1)(2008-10#1)
Synechococcus elongatus BDU 130911##2##4##(2013-1#2)
Synechococcus sp##3##2##(1995-6#1)(1996-6#2)
Synechococcus##7##1##(1995-6#1)(1996-6#2)(1997-4#2)(2013-1#2)
Synechocystis sp##16##2##(1995-12#2)(1995-6#1)(1995-8#2)(1996-12#3)(1996-6#3)(1996-8#2)(1997-2#1)(1997-6#2)
Synechocystis##18##1##(1995-12#4)(1995-6#1)(1995-8#2)(1996-12#3)(1996-6#3)(1996-8#2)(1997-2#1)(1997-6#2)
Synergetic##2##1##(2008-10#1)(2008-11#1)
Synergism##4##1##(1992-10#1)(1997-1#1)(2008-10#2)
Synergistic effects of##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
Synergistic extraction of##3##3##(2008-10#3)
Synergistic##11##1##(2008-10#8)(2008-11#2)(2008-8#1)
Synergy##2##1##(1996-2#1)(2008-10#1)
Syngonium##3##1##(2008-10#3)
Synopsis##3##1##(2008-10#1)(2008-5#2)
Synovial##2##1##(2010-5#1)(2013-1#1)
Syntheses of##2##2##(2008-10#1)(2008-4#1)
Synthesis and application of a functionalized resin##2##7##(2008-10#2)
Synthesis and application of##3##4##(2008-10#3)
Synthesis and biological evaluation of##3##5##(2008-11#1)(2008-8#1)(2012-2#1)
Synthesis and biological##4##3##(1992-12#1)(2008-11#1)(2008-8#1)(2012-2#1)
Synthesis and characterization of a##2##5##(2008-10#2)
Synthesis and characterization of##7##4##(2008-10#6)(2008-12#1)
Synthesis and##35##2##(1991-5#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-1#1)(1996-5#3)(2008-10#15)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Synthesis in##3##2##(1996-5#2)(2008-10#1)
Synthesis of Substituted##2##3##(2008-12#1)(2010-6#1)
Synthesis of [4##3##3##(1996-5#3)
Synthesis of a##4##3##(1992-12#1)(2008-10#2)(2012-3#1)
Synthesis of an##3##3##(1996-5#2)(2008-10#1)
Synthesis of the##3##3##(1991-5#1)(1996-5#1)(2008-6#1)
Synthesis of##69##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-12#2)(1995-3#1)(1996-5#26)(1997-3#1)(1997-6#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-4#5)(2008-6#1)(2008-8#2)(2009-10#2)(2009-6#1)(2009-7#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Synthesis##117##1##(1990-11#1)(1991-3#1)(1991-5#2)(1992-12#4)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1995-3#1)(1996-5#31)(1997-3#1)(1997-6#1)(2008-10#31)(2008-11#7)(2008-12#2)(2008-4#6)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#2)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
Synthesized##2##1##(2008-10#1)(2010-5#1)
Synthetic peptide##2##2##(1990-5#1)(2008-10#1)
Synthetic peptides##2##2##(1994-5#1)(2008-4#1)
Synthetic##23##1##(1990-5#1)(1991-7#1)(1993-8#1)(1994-5#1)(1996-5#2)(2007-11#1)(2008-10#8)(2008-11#3)(2008-4#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)
Syphilis Study at Tuskegee##6##4##(2013-1#6)
Syphilis##10##1##(1997-6#1)(1997-7#1)(2008-10#1)(2011-2#1)(2013-1#6)
SyrM to the##2##3##(2008-8#2)
SyrM##4##1##(2008-8#4)
Syria##2##1##(2008-10#2)
Syrian golden hamster##2##3##(1990-6#2)
Syrian hamster##3##2##(1990-7#2)(1996-8#1)
Syrian##7##1##(1990-6#2)(1990-7#2)(1996-8#2)(2008-11#1)
Syrphidae)##2##1##(2008-8#2)
System and##3##2##(1992-1#1)(1993-12#1)(2012-2#1)
System for##10##2##(1994-1#1)(1994-9#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2013-1#1)
System has been##2##3##(1993-3#1)(2008-12#1)
System has##3##2##(1993-3#1)(2008-11#1)(2008-12#1)
System in##4##2##(1991-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
System is a##2##3##(1994-1#1)(2012-3#1)
System is##5##2##(1994-1#1)(1994-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
System of##2##2##(2008-10#1)(2011-2#1)
System to##5##2##(1993-1#1)(1997-3#1)(2008-3#1)(2008-4#1)(2012-2#1)
System under##2##2##(2008-10#2)
System##107##1##(1991-12#1)(1991-9#2)(1992-1#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#2)(1993-5#1)(1994-1#4)(1994-12#3)(1994-2#5)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#4)(2007-8#1)(2008-10#11)(2008-11#8)(2008-12#4)(2008-3#7)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-2#4)(2012-12#8)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#2)
System)##6##1##(1991-2#1)(1993-2#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
Systematic Review##4##2##(2009-7#1)(2013-1#3)
Systematic review##2##2##(2011-2#1)(2012-12#1)
Systematic studies##2##2##(1996-6#1)(2008-10#1)
Systematic##28##1##(1991-1#1)(1991-12#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-6#1)(2008-10#4)(2008-3#3)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#1)
Systemic Resistance##5##2##(2008-10#5)
Systemic acquired resistance##3##3##(2008-10#3)
Systemic lupus erythematosus##5##3##(1994-6#1)(2008-1#1)(2008-4#1)(2012-2#2)
Systemic##39##1##(1992-3#1)(1992-8#1)(1994-2#2)(1994-6#1)(1995-1#1)(1996-11#1)(1997-8#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-4#1)(2009-10#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
Systems Biology##3##2##(2013-1#1)(2013-8#2)
Systems biology##2##2##(2013-8#2)
Systems for##2##2##(2008-10#1)(2008-3#1)
Systems in##2##2##(1991-8#1)(2008-11#1)
Systems of##2##2##(2010-12#2)
Systems##41##1##(1991-1#1)(1991-8#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-12#1)(1996-5#1)(1996-9#7)(1997-3#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-4#1)(2013-1#1)(2013-8#5)
Systolic##5##1##(1990-9#1)(2013-1#2)(2013-8#2)
São Paulo State##2##3##(2008-10#2)
São Paulo##10##2##(1996-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2012-3#1)
T 1-weighted images suggesting the##2##5##(1997-8#2)
T 1-weighted##3##2##(1997-8#3)
T 2-weighted##2##2##(1997-8#2)
T Cells##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
T and B##3##3##(1990-9#1)(1997-8#1)(2008-4#1)
T and DHT##2##3##(1990-11#2)
T and##15##2##(1990-11#2)(1990-9#1)(1991-8#1)(1995-1#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
T antigen bind to the same region##2##7##(1993-8#2)
T antigen##10##2##(1993-2#1)(1993-8#7)(1995-6#1)(2008-4#1)
T betagamma was##2##3##(1997-1#2)
T cell activation was##2##4##(2012-3#2)
T cell activation##8##3##(1994-11#2)(2008-11#1)(2012-3#5)
T cell clones##9##3##(1993-8#1)(2008-11#6)(2008-4#2)
T cell costimulatory molecules in##2##5##(2007-12#2)
T cell development##2##3##(2008-11#1)(2008-4#1)
T cell epitopes##2##3##(2008-4#1)(2008-5#1)
T cell immune##2##3##(2008-11#1)(2008-4#1)
T cell leukemia virus##2##4##(2008-11#1)(2011-2#1)
T cell leukemia##8##3##(1992-6#1)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#2)
T cell line##4##3##(1997-8#1)(2008-11#2)(2008-8#1)
T cell lines##12##3##(1992-6#1)(1995-12#2)(2008-11#6)(2008-4#3)
T cell lymphoma is##2##4##(2009-8#2)
T cell lymphoma##5##3##(2009-8#4)(2013-1#1)
T cell lymphomas##2##3##(2008-9#1)(2013-1#1)
T cell numbers in##2##4##(1995-12#2)
T cell population##2##3##(2008-11#1)(2012-12#1)
T cell proliferation##4##3##(2008-11#2)(2012-3#2)
T cell reactivity##2##3##(2013-1#2)
T cell receptor (TCR)##2##4##(2008-11#2)
T cell receptor transgenic mice##2##5##(2008-11#2)
T cell receptor##9##3##(1991-9#1)(1995-8#1)(2007-12#1)(2008-11#4)(2008-4#1)(2009-8#1)
T cell receptors (TCR) that##2##5##(2008-4#1)(2008-9#1)
T cell responses to##2##4##(1997-8#1)(2008-4#1)
T cell responses##7##3##(1995-5#3)(1997-8#1)(2007-12#1)(2008-4#1)(2012-3#1)
T cell subpopulations##2##3##(1991-1#1)(2008-11#1)
T cell subsets##3##3##(2008-4#2)(2012-2#1)
T cell tolerance##2##3##(2008-11#2)
T cell##124##2##(1991-1#1)(1991-9#1)(1992-6#3)(1993-12#1)(1993-8#1)(1994-11#3)(1995-1#1)(1995-12#6)(1995-5#5)(1995-8#1)(1996-12#1)(1997-7#1)(1997-8#3)(2007-12#4)(2008-10#1)(2008-11#34)(2008-4#18)(2008-5#2)(2008-8#1)(2008-9#6)(2009-8#5)(2010-5#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#7)
T cell-dependent##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
T cell-mediated immune##2##3##(2012-12#1)(2012-3#1)
T cell-mediated immunity##2##3##(1995-12#1)(2008-5#1)
T cell-mediated##6##2##(1995-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-3#1)
T cell-rich population for##2##4##(2008-11#2)
T cell-rich population##4##3##(2008-11#4)
T cells and##16##3##(2008-10#3)(2008-11#2)(2008-4#1)(2009-6#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
T cells are##5##3##(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)
T cells as##2##3##(2008-8#1)(2012-2#1)
T cells by##4##3##(1995-2#1)(2008-11#2)(2011-2#1)
T cells from ovalbumin (OVA)-specific T cell receptor##2##8##(2008-11#2)
T cells from##4##3##(2008-11#2)(2008-4#1)(2012-3#1)
T cells have##2##3##(2008-11#1)(2008-8#1)
T cells in##11##3##(1993-8#2)(2008-10#1)(2008-11#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
T cells is##3##3##(1995-5#1)(2008-4#1)(2011-2#1)
T cells may##3##3##(1993-8#1)(1995-2#1)(2008-11#1)
T cells of##2##3##(1997-8#1)(2008-11#1)
T cells that are##3##4##(2008-4#1)(2010-11#1)(2012-12#1)
T cells that##5##3##(2008-4#1)(2010-11#2)(2012-12#1)(2012-2#1)
T cells to##8##3##(1992-6#1)(1995-2#1)(2008-11#4)(2008-4#1)(2013-1#1)
T cells using##2##3##(2008-11#1)(2008-9#1)
T cells were not##2##4##(1993-8#1)(2008-8#1)
T cells were##10##3##(1993-8#2)(1996-12#1)(2008-11#4)(2008-8#2)(2012-3#1)
T cells which##2##3##(2008-11#1)(2008-9#1)
T cells with MHC class##2##5##(2008-9#2)
T cells with##3##3##(2008-9#2)(2010-1#1)
T cells##190##2##(1991-11#1)(1992-6#4)(1993-12#2)(1993-8#6)(1994-3#1)(1995-12#3)(1995-2#8)(1995-5#2)(1996-12#1)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#47)(2008-4#19)(2008-7#1)(2008-8#6)(2008-9#8)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-3#4)(2010-5#3)(2011-2#13)(2012-12#17)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#8)
T currents##2##2##(1992-8#2)
T growth model##2##3##(2013-8#2)
T growth##3##2##(2013-8#3)
T helper cells##2##3##(1995-12#1)(2012-3#1)
T helper##8##2##(1991-6#1)(1995-12#1)(1995-5#1)(2008-11#3)(2011-2#1)(2012-3#1)
T in the##2##3##(1990-11#1)(1995-8#1)
T is##4##2##(1995-3#1)(2008-10#2)(2008-8#1)
T levels##4##2##(2013-8#4)
T lymphocyte##10##2##(1991-6#1)(1995-3#1)(2007-12#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-2#3)(2013-1#1)
T lymphocytes and##4##3##(1994-3#1)(1995-12#1)(1997-8#2)
T lymphocytes by##2##3##(1992-6#1)(1994-3#1)
T lymphocytes play##2##3##(1995-2#1)(1995-5#1)
T lymphocytes to##2##3##(1997-8#1)(2008-9#1)
T lymphocytes##27##2##(1991-6#1)(1992-6#2)(1994-3#4)(1995-12#1)(1995-2#1)(1995-5#2)(1997-8#3)(2008-11#4)(2008-4#2)(2008-9#3)(2010-11#1)(2011-2#2)(2013-1#1)
T model##2##2##(2013-8#2)
T stage##2##2##(1991-8#2)
T state##4##2##(1990-8#4)
T suppressor cells##2##3##(1991-6#2)
T to C at position 1578##2##6##(2008-12#2)
T to C at position##4##5##(2008-12#4)
T to##5##2##(1992-8#1)(2008-12#4)
T wave##3##2##(1993-1#2)(2008-10#1)
T waves##6##2##(1991-3#3)(1993-1#3)
T x##2##2##(2008-10#2)
T##832##1##(1990-10#1)(1990-11#4)(1990-8#7)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#8)(1991-6#7)(1991-8#3)(1991-9#1)(1992-6#9)(1992-8#5)(1993-1#5)(1993-12#3)(1993-2#5)(1993-3#1)(1993-6#1)(1993-8#19)(1994-11#3)(1994-12#1)(1994-3#5)(1994-5#2)(1995-1#2)(1995-11#3)(1995-12#14)(1995-2#13)(1995-3#2)(1995-5#10)(1995-6#7)(1995-8#2)(1996-12#9)(1996-2#5)(1996-8#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-7#4)(1997-8#17)(2007-11#2)(2007-12#8)(2008-1#1)(2008-10#218)(2008-11#100)(2008-12#13)(2008-3#7)(2008-4#46)(2008-5#16)(2008-6#12)(2008-7#8)(2008-8#17)(2008-9#21)(2009-12#5)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#2)(2010-3#10)(2010-5#5)(2010-8#1)(2011-1#1)(2011-2#28)(2012-12#19)(2012-2#18)(2012-3#21)(2012-5#2)(2013-1#15)(2013-8#27)
T(0)##2##1##(2008-8#2)
T(1) value##2##2##(2008-10#2)
T(1)##9##1##(2008-10#4)(2008-7#1)(2008-8#3)(2012-2#1)
T(2) *##4##2##(2012-2#4)
T(2)##12##1##(2008-10#5)(2010-4#1)(2012-2#6)
T(3)##6##1##(2008-7#4)(2010-4#1)(2011-2#1)
T(382) in##2##2##(2008-10#2)
T(382)##6##1##(2008-10#6)
T(4)##6##1##(2008-4#2)(2008-7#2)(2010-4#1)(2011-2#1)
T(g)##7##1##(1995-3#5)(2010-4#2)
T(i)##2##1##(2008-10#2)
T(m)##4##1##(2008-10#2)(2011-1#2)
T) and##3##2##(1993-8#1)(2008-8#2)
T)##11##1##(1993-8#2)(2008-10#1)(2008-7#1)(2008-8#5)(2012-2#1)(2012-3#1)
T--&gt##3##1##(1994-11#2)(1995-6#1)
T-2 toxin and Kashin-Beck##2##4##(2011-2#2)
T-2 toxin##5##2##(2011-2#5)
T-98##5##1##(1993-1#5)
T-CD4 T cells##10##3##(2012-12#10)
T-Cell##2##1##(2012-3#1)(2013-8#1)
T-Cells##2##1##(2008-10#1)(2013-8#1)
T-DNA##11##1##(2008-10#10)(2011-1#1)
T-DNAs##2##1##(2011-1#2)
T-LGL##3##1##(2010-1#3)
T-SEARCH##3##1##(2008-11#3)
T-antigen##4##1##(1997-7#1)(2008-11#3)
T-cell activation##2##2##(2008-10#1)(2012-9#1)
T-cell antigens##2##2##(2010-1#1)(2011-2#1)
T-cell dependent##2##2##(1993-12#1)(2008-10#1)
T-cell epitope##6##2##(1995-2#4)(2008-10#1)(2011-2#1)
T-cell epitopes##5##2##(1991-12#1)(1994-8#1)(1995-2#2)(2008-10#1)
T-cell expansion##2##2##(2011-2#1)(2013-8#1)
T-cell lymphoma##8##2##(1991-12#3)(1995-1#1)(2008-12#1)(2009-1#1)(2009-8#1)(2012-3#1)
T-cell lymphomas##3##2##(2009-8#3)
T-cell proliferation##4##2##(1990-5#1)(1995-2#1)(1995-5#1)(2008-11#1)
T-cell receptor (TCR)##2##3##(1994-3#1)(2008-11#1)
T-cell receptor##9##2##(1993-9#1)(1994-12#1)(1994-3#1)(1997-7#1)(1997-9#3)(2008-10#1)(2008-11#1)
T-cell therapy##2##2##(2010-11#2)
T-cell##87##1##(1990-10#1)(1990-5#3)(1991-12#5)(1992-12#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#13)(1995-5#2)(1995-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-9#4)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-1#2)(2009-8#4)(2010-1#2)(2010-11#3)(2011-2#4)(2012-12#1)(2012-3#1)(2012-9#1)(2013-7#1)(2013-8#6)
T-cell-deficient chickens##3##2##(2008-5#3)
T-cell-deficient##4##1##(2008-5#4)
T-cell-dependent antibody response (TDAR)##2##4##(2008-10#2)
T-cell-dependent antibody##4##2##(2008-10#4)
T-cell-dependent##8##1##(1993-12#1)(1997-1#1)(2008-10#6)
T-cells and##4##2##(2008-10#2)(2008-5#1)(2009-8#1)
T-cells in the##3##3##(2008-10#2)(2013-8#1)
T-cells in##5##2##(1996-12#1)(2008-10#3)(2013-8#1)
T-cells##25##1##(1991-12#1)(1993-6#1)(1994-5#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-10#11)(2008-11#1)(2008-5#3)(2008-6#1)(2009-8#1)(2013-8#2)
T-dependent antibody response##5##3##(2008-10#5)
T-dependent antigen##2##2##(2008-10#2)
T-dependent##7##1##(2008-10#7)
T-even phages##2##2##(1997-3#2)
T-even##4##1##(1997-3#4)
T-flask and##3##2##(2008-11#3)
T-flask based screening platform for evaluating and identifying plant hydrolysates for##2##11##(2008-11#2)
T-flask##12##1##(2008-11#12)
T-flasks##5##1##(2008-11#5)
T-helper##2##1##(1995-5#1)(2008-10#1)
T-lymphocyte IFN(gamma)##2##2##(2008-10#2)
T-lymphocyte cell##2##2##(1993-6#2)
T-lymphocyte effects##3##2##(1995-12#1)(2008-10#2)
T-lymphocyte##14##1##(1991-2#1)(1993-6#2)(1995-12#1)(2008-10#8)(2011-2#2)
T-lymphocytes (CD3 epsilon##2##3##(1996-12#2)
T-lymphocytes can##2##2##(2008-10#1)(2008-11#1)
T-lymphocytes from##3##2##(2008-10#3)
T-lymphocytes in##5##2##(1996-12#1)(2008-10#3)(2008-11#1)
T-lymphocytes that##2##2##(1997-8#1)(2008-10#1)
T-lymphocytes##29##1##(1992-3#1)(1996-12#3)(1997-8#1)(2008-10#17)(2008-11#6)(2013-8#1)
T-lymphoid##2##1##(1994-3#2)
T-maze alternation##2##2##(1991-2#1)(1994-8#1)
T-maze##8##1##(1991-2#1)(1993-3#3)(1994-8#2)(2012-2#1)(2013-1#1)
T-score##3##1##(2010-3#2)(2011-2#1)
T-structure##2##1##(2008-10#2)
T-toxin##3##1##(2008-10#3)
T-tube##3##1##(1991-3#3)
T-wave##2##1##(1993-1#1)(1994-1#1)
T/E(2)##3##1##(2008-3#3)
T1 and T2##3##3##(1991-8#1)(2009-10#2)
T1 and##9##2##(1991-11#1)(1991-6#1)(1991-8#1)(2008-10#2)(2009-10#2)(2010-9#1)(2011-2#1)
T1 patients##3##2##(1991-6#1)(1991-8#1)(2011-2#1)
T1 strains##3##2##(2008-10#3)
T1 was##2##2##(2008-10#1)(2009-10#1)
T1##37##1##(1990-2#1)(1990-6#1)(1991-11#1)(1991-6#2)(1991-8#4)(1992-4#2)(2008-10#14)(2009-10#3)(2009-7#1)(2010-9#1)(2011-2#4)(2012-12#2)(2013-1#1)
T1- and T2-weighted images##2##4##(1997-8#1)(2012-12#1)
T1- and T2-weighted##4##3##(1997-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
T1-weighted images were##2##3##(2008-7#1)(2010-12#1)
T1-weighted images##6##2##(1991-11#1)(1997-8#2)(2008-7#2)(2010-12#1)
T1-weighted##14##1##(1991-11#1)(1997-8#5)(2008-7#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
T1/2 of##2##2##(1993-11#1)(2011-3#1)
T1/2##4##1##(1993-11#1)(1996-1#2)(2011-3#1)
T12##4##1##(1991-11#1)(2008-12#1)(2013-1#2)
T1R3##2##1##(2008-2#2)
T2 and##4##2##(1990-2#1)(1990-6#1)(1991-8#1)(2009-10#1)
T2 hyperintensity in##2##3##(2009-11#2)
T2##27##1##(1990-2#2)(1990-6#2)(1991-8#3)(1993-5#1)(1996-2#2)(1997-3#1)(2008-10#1)(2008-12#2)(2009-10#3)(2009-11#2)(2009-3#1)(2009-7#1)(2011-2#3)(2012-12#1)(2013-1#2)
T2*##2##1##(1996-2#1)(2010-9#1)
T2-weighted image##2##2##(2012-3#1)(2013-8#1)
T2-weighted images##4##2##(1991-11#2)(1997-8#1)(2012-12#1)
T2-weighted##11##1##(1991-11#2)(1997-8#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
T21 was##2##2##(2008-8#2)
T21##8##1##(2008-8#5)(2008-9#3)
T22##9##1##(2008-10#9)
T2DM##4##1##(2010-10#3)(2013-1#1)
T2W##2##1##(2008-6#1)(2009-11#1)
T3 and T30##2##3##(2008-10#2)
T3 and T4##2##3##(1990-2#1)(2008-7#1)
T3 and##5##2##(1990-2#1)(1990-6#1)(2008-10#2)(2008-7#1)
T3 binding##3##2##(1991-5#2)(1993-8#1)
T3 concentration##2##2##(1990-3#1)(2008-10#1)
T3 in##4##2##(1994-11#1)(2008-10#3)
T3 receptor##2##2##(1995-8#2)
T3 strain##3##2##(2008-10#3)
T3 strains were inhibitory to##2##5##(2008-10#2)
T3 strains were##4##3##(2008-10#4)
T3 strains##5##2##(2008-10#5)
T3 was isolated from##2##4##(2008-10#2)
T3 was##5##2##(1994-11#1)(2008-10#3)(2008-12#1)
T3##67##1##(1990-2#1)(1990-3#4)(1990-6#2)(1991-5#3)(1991-8#1)(1993-8#4)(1994-11#5)(1995-8#3)(1996-2#2)(2008-10#26)(2008-12#2)(2008-6#1)(2008-7#5)(2010-11#2)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
T3-binding##2##1##(1991-5#1)(1995-8#1)
T30##5##1##(2008-10#5)
T32##3##1##(2008-9#3)
T36##8##1##(2008-10#8)
T4 DNA##4##2##(1990-5#1)(1993-2#2)(1997-3#1)
T4 and T3##5##3##(1990-3#2)(2008-7#1)(2011-1#2)
T4 gene##3##2##(1995-12#1)(1995-6#2)
T4 late transcription by##2##4##(1995-6#2)
T4 late##4##2##(1995-6#4)
T4 patients##2##2##(1991-8#2)
T4 treatment##2##2##(1990-6#1)(2008-6#1)
T4##58##1##(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#3)(1991-8#2)(1992-5#1)(1993-2#2)(1995-12#2)(1995-2#5)(1995-6#6)(1997-3#4)(1997-7#3)(2008-10#3)(2008-4#1)(2008-6#9)(2008-7#5)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)
T47D##5##1##(1992-4#1)(2008-11#3)(2010-6#1)
T5-A2##3##1##(2008-10#3)
T7 RNA polymerase##7##3##(1990-11#1)(1991-5#2)(1994-5#1)(2008-8#3)
T7 RNA##9##2##(1990-11#1)(1991-5#2)(1993-8#1)(1994-5#1)(2008-10#1)(2008-8#3)
T7 promoter and##2##3##(2008-11#1)(2008-8#1)
T7 promoter##5##2##(1991-5#1)(1994-5#1)(2008-11#1)(2008-8#2)
T7##17##1##(1990-11#1)(1991-5#4)(1993-8#1)(1994-5#2)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#6)
T8##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
T83##2##1##(2008-9#2)
T=1##2##1##(2008-8#2)
TA 28##2##2##(2008-10#2)
TA 870 and TA 874##2##5##(2008-10#2)
TA 870##3##2##(2008-10#3)
TA and##2##2##(1997-8#2)
TA is a##2##3##(2013-1#2)
TA was##2##2##(1997-8#1)(2013-1#1)
TA##28##1##(1997-8#14)(2008-10#7)(2013-1#7)
TA1##3##1##(1995-6#3)
TA100##2##1##(2008-9#2)
TA2##4##1##(1995-6#4)
TA352##2##1##(2008-8#2)
TA98##2##1##(2008-9#2)
TAC##12##1##(1990-5#1)(1992-9#1)(2008-10#9)(2013-1#1)
TAD soils from Washington State##2##5##(2008-10#2)
TAD soils##9##2##(2008-10#9)
TAD##11##1##(2008-10#11)
TADs of p65##2##3##(1995-6#2)
TAE##2##1##(2008-7#1)(2008-9#1)
TAF##2##1##(1996-12#2)
TAG##2##1##(2008-12#1)(2008-8#1)
TAH##4##1##(1994-2#3)(1995-3#1)
TAI##2##1##(2008-3#2)
TAI-27##5##1##(2008-9#5)
TAK1##4##1##(2011-2#4)
TAM O-301##2##2##(2008-10#2)
TAM##10##1##(1993-1#1)(1997-7#2)(2008-10#6)(2008-12#1)
TAPP##4##1##(2008-10#4)
TAR##2##1##(1992-12#1)(2008-9#1)
TAS-ELISA##2##1##(2008-10#2)
TASK-2 has been##3##3##(2013-8#3)
TASK-2 is##2##2##(2013-8#2)
TASK-2##9##1##(2013-8#9)
TAT##9##1##(1991-3#2)(2008-11#1)(2010-3#1)(2011-2#5)
TATA box##7##2##(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1997-8#1)(2008-9#1)(2010-5#1)
TATA boxes and other transcriptional regulatory elements in##2##8##(1993-12#1)(1993-6#1)
TATA boxes and##3##3##(1993-12#1)(1993-6#2)
TATA element##3##2##(1995-2#3)
TATA or CCAAT##2##3##(1991-6#1)(1991-7#1)
TATA##17##1##(1991-6#1)(1991-7#1)(1992-3#1)(1993-12#2)(1993-6#3)(1993-8#2)(1995-2#3)(1995-6#1)(1997-8#1)(2008-9#1)(2010-5#1)
TATA-binding protein (TBP)##4##3##(1993-2#2)(1993-8#1)(1993-9#1)
TATA-binding protein##6##2##(1993-2#2)(1993-8#2)(1993-9#2)
TAU##4##1##(2009-11#4)
TAg##3##1##(1995-6#1)(2008-11#2)
TB DOT##2##2##(1996-3#2)
TB IRIS##6##2##(2010-5#6)
TB and##5##2##(1996-3#1)(2008-10#2)(2010-5#2)
TB control##3##2##(1996-3#1)(2011-2#1)(2013-8#1)
TB directly observed therapy##2##4##(1996-3#2)
TB immune reconstitution inflammatory syndrome##2##5##(2010-5#2)
TB in##3##2##(2008-1#1)(2008-10#1)(2010-5#1)
TB infection##2##2##(2010-11#1)(2010-5#1)
TB is##3##2##(2010-5#3)
TB patients##4##2##(1996-11#2)(2011-2#2)
TB testing##3##2##(1996-3#2)(1997-2#1)
TB treatment##2##2##(2010-5#1)(2011-2#1)
TB was##2##2##(2008-1#2)
TB##84##1##(1992-9#1)(1993-5#1)(1994-12#1)(1996-11#3)(1996-3#9)(1997-2#1)(2008-1#6)(2008-10#14)(2009-12#1)(2010-11#2)(2010-5#25)(2011-2#12)(2012-3#2)(2013-8#6)
TBA##4##1##(2008-10#3)(2008-5#1)
TBAB##5##1##(1995-12#2)(2008-10#3)
TBABF(4)##2##1##(2008-10#2)
TBARS and##2##2##(2008-10#1)(2012-3#1)
TBARS concentrations##4##2##(1993-2#4)
TBARS were##2##2##(2008-10#2)
TBARS##13##1##(1993-2#4)(2008-10#6)(2010-4#1)(2012-3#1)(2012-5#1)
TBE infections##4##2##(1996-11#4)
TBE##10##1##(1996-11#10)
TBHQ##4##1##(2008-10#4)
TBHs##2##1##(2012-2#2)
TBI##12##1##(2008-10#3)(2009-10#2)(2010-4#1)(2010-9#2)(2013-1#4)
TBII activity##2##2##(1991-5#2)
TBII##3##1##(1991-5#2)(1995-12#1)
TBM##2##1##(2011-2#2)
TBO##2##1##(2008-10#2)
TBP and##2##2##(1993-8#1)(2008-10#1)
TBP##17##1##(1993-2#1)(1993-8#6)(1993-9#2)(2008-10#8)
TBPs##3##1##(1993-2#3)
TBSV##3##1##(2008-10#3)
TBT##6##1##(2008-10#1)(2008-11#5)
TBTO were##2##2##(2008-10#2)
TBTO##8##1##(2008-10#8)
TBX1##2##1##(2012-12#2)
TBZ##7##1##(2008-10#2)(2011-10#5)
TC and##2##2##(2009-5#2)
TC measurements##2##2##(1992-10#2)
TC##13##1##(1992-10#2)(1992-6#1)(2008-10#2)(2009-5#4)(2011-2#4)
TCA and glycolytic intermediates##3##4##(1997-1#3)
TCA and##6##2##(1997-1#3)(2008-10#3)
TCA cycle##3##2##(2008-11#2)(2011-2#1)
TCA overdose##4##2##(2010-1#4)
TCA therapy##2##2##(2010-12#2)
TCA was##2##2##(2008-10#1)(2010-12#1)
TCA##21##1##(1997-1#3)(2008-10#6)(2008-11#2)(2010-1#5)(2010-12#4)(2011-2#1)
TCAA##4##1##(2008-10#4)
TCAE##2##1##(1995-12#2)
TCAH did not##2##3##(2008-10#2)
TCAH##7##1##(2008-10#7)
TCAH-treated##2##1##(2008-10#2)
TCAM##9##1##(2009-6#9)
TCAs##2##1##(2008-10#1)(2010-1#1)
TCB##2##1##(2008-2#2)
TCC##2##1##(2008-10#1)(2012-3#1)
TCCCN models were##2##3##(2008-10#2)
TCCCN##4##1##(2008-10#4)
TCD was##2##2##(1996-6#2)
TCD##4##1##(1996-6#4)
TCDD and##3##2##(2008-10#3)
TCDD exposure##3##2##(2008-10#3)
TCDD treatment##3##2##(1992-12#1)(1995-11#1)(2008-10#1)
TCDD##32##1##(1992-12#4)(1993-6#2)(1994-5#4)(1995-11#3)(2008-10#16)(2008-11#3)
TCDD-induced##2##1##(1992-12#2)
TCDD-treated##2##1##(2008-10#2)
TCE and##2##2##(2008-10#2)
TCE exposure##3##2##(2008-10#3)
TCE in##4##2##(2008-10#2)(2010-4#2)
TCE or##2##2##(2008-10#2)
TCE##26##1##(2008-10#23)(2010-4#3)
TCE-exposed##3##1##(2008-10#3)
TCF##8##1##(1994-11#4)(2008-10#4)
TCID(50) mL(-1)kg(-1))##2##2##(2009-6#2)
TCID(50) ml(-1)##2##2##(2008-11#2)
TCID(50)##6##1##(2008-11#2)(2009-6#4)
TCM and##2##2##(2009-6#1)(2011-2#1)
TCM##11##1##(2008-10#9)(2009-6#1)(2011-2#1)
TCMTB##7##1##(2008-10#7)
TCNQ##3##1##(2008-10#3)
TCP##4##1##(1994-2#1)(2008-10#2)(2009-8#1)
TCPP##12##1##(2008-10#12)
TCR##14##1##(1994-3#3)(2008-11#9)(2008-4#2)
TCR-alphabeta(1)(+)##2##1##(2008-5#2)
TCRgammadelta(+)##3##1##(2008-11#3)
TCS and AMP##2##3##(2008-8#2)
TCS and##5##2##(2008-10#3)(2008-8#2)
TCS##17##1##(2008-10#11)(2008-8#6)
TD in##2##2##(2010-12#2)
TD x D##2##3##(2008-10#2)
TD##13##1##(2008-10#3)(2009-8#1)(2010-12#8)(2012-12#1)
TDAR assays##2##2##(2008-10#2)
TDAR##9##1##(2008-10#9)
TDD-organo-clay##2##1##(2008-10#2)
TDF or##2##2##(2013-1#2)
TDF##3##1##(2013-1#3)
TDFs##2##1##(2009-6#2)
TDI##6##1##(2008-10#6)
TDeltaS(0)##5##1##(2008-10#5)
TE =##2##2##(1997-8#2)
TE and TM polarizations##3##4##(2008-2#3)
TE and TM##4##3##(2008-2#3)(2008-3#1)
TE polarization##3##2##(2007-12#1)(2008-3#2)
TE##18##1##(1997-8#2)(2007-12#1)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#4)(2008-5#1)
TE1 and TE2##2##3##(1992-8#2)
TE1##3##1##(1992-8#2)(1997-2#1)
TEA##5##1##(2008-10#5)
TEA+ (30mM)##2##2##(1993-3#2)
TEA+##3##1##(1993-3#2)(1994-11#1)
TEAC(2min)##2##1##(2008-10#2)
TEE##4##1##(2008-10#2)(2011-2#2)
TEFRA##3##1##(1993-12#2)(1994-3#1)
TEG has##2##2##(2013-1#2)
TEG in patients with##2##4##(2013-1#2)
TEG##4##1##(2013-1#4)
TEGDMA presented##2##2##(2013-1#2)
TEGDMA##6##1##(2013-1#6)
TEHP##2##1##(2008-10#2)
TEM images##2##2##(2011-3#2)
TEM##8##1##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)(2011-3#2)
TEM(00) mode##2##2##(2008-3#2)
TEM(00)##4##1##(2008-3#4)
TEM00 mode##2##2##(2008-3#2)
TEMPO##3##1##(2008-8#3)
TEMPPO##2##1##(2012-3#2)
TENS##2##1##(2010-1#1)(2011-2#1)
TEP in freshwater##2##3##(2008-10#2)
TEP##4##1##(2008-10#4)
TEQ level##2##2##(2008-10#2)
TEQ values##4##2##(2008-10#4)
TEQ##13##1##(2008-10#13)
TEQ-value##2##1##(2008-10#2)
TEQ-values obtained by##2##3##(2008-10#2)
TEQ-values obtained##3##2##(2008-10#3)
TEQ-values##5##1##(2008-10#5)
TEQ/g fat##3##2##(2008-10#3)
TEQ/kg##2##1##(2008-10#2)
TER##7##1##(2008-10#6)(2008-11#1)
TERC##2##1##(2008-11#2)
TERT##4##1##(2008-11#4)
TES##8##1##(1996-2#3)(2008-3#1)(2009-10#4)
TEV##2##1##(2008-10#2)
TEVA extraction##2##2##(2008-10#2)
TEWL and skin##2##3##(2008-5#2)
TEWL and##4##2##(2008-5#4)
TEWL##13##1##(2008-5#13)
TF##2##1##(2008-11#1)(2012-2#1)
TF-1##3##1##(1993-12#1)(1995-6#2)
TFA##5##1##(2008-10#4)(2013-1#1)
TFAP groups##2##2##(2008-10#2)
TFAR19 gene##2##2##(2008-9#2)
TFAR19##5##1##(2008-9#5)
TFE##2##1##(2010-7#2)
TFF##3##1##(2008-7#3)
TFIIB and##3##2##(1995-2#2)(2008-9#1)
TFIIB##7##1##(1995-2#6)(2008-9#1)
TFOs##3##1##(2008-9#3)
TFPI##3##1##(1992-10#3)
TFs##4##1##(2008-11#2)(2012-2#2)
TG and HDL-C##2##3##(2008-3#2)
TG structures##3##2##(2012-2#3)
TG##20##1##(2008-10#3)(2008-11#1)(2008-3#6)(2008-5#1)(2012-2#8)(2013-8#1)
TG-DTG##2##1##(2008-10#2)
TG/DTA-MS##2##1##(2008-10#2)
TGA##4##1##(2008-10#3)(2009-3#1)
TGA1a##2##1##(2008-9#2)
TGB2##2##1##(2008-9#2)
TGB3##2##1##(2008-9#2)
TGF alpha##8##2##(1991-7#1)(1997-1#3)(1997-4#4)
TGF alpha-anti-Tac(Fv)-PE40##2##2##(1990-8#2)
TGF alpha-induced DNA synthesis##2##4##(1997-1#2)
TGF alpha-induced##4##2##(1997-1#4)
TGF beta 1##2##3##(1992-8#2)
TGF beta##10##2##(1992-8#4)(1995-12#5)(2013-8#1)
TGF##28##1##(1990-8#3)(1991-7#1)(1992-8#4)(1995-12#5)(1997-1#9)(1997-4#4)(2008-11#1)(2013-8#1)
TGF-beta 1##7##2##(1990-5#6)(1991-12#1)
TGF-beta RI and##2##3##(1995-2#2)
TGF-beta RI##4##2##(1995-2#4)
TGF-beta RII kinase##2##3##(1995-2#2)
TGF-beta RII##4##2##(1995-2#4)
TGF-beta is##2##2##(2008-12#2)
TGF-beta signaling##3##2##(1995-2#1)(2008-11#2)
TGF-beta##41##1##(1990-5#7)(1991-12#1)(1995-2#9)(1997-2#3)(2008-1#1)(2008-11#12)(2008-12#4)(2008-8#2)(2010-4#1)(2013-8#1)
TGF-beta-treated SFME cells##3##3##(2008-11#3)
TGF-beta1 in##2##2##(2008-11#2)
TGF-β1##2##1##(2011-2#2)
TGFB-2##2##1##(1995-11#2)
TGMS##2##1##(2008-8#2)
TGase##2##1##(2008-5#2)
TGr clones##2##2##(1997-3#2)
TGr colonies##3##2##(1997-3#3)
TGr##6##1##(1997-3#6)
TGs##2##1##(2008-10#2)
TH activity##2##2##(2008-11#2)
TH and##4##2##(1996-12#3)(2013-1#1)
TH mRNA level was significantly##2##5##(1996-12#2)
TH mRNA##3##2##(1996-12#3)
TH##14##1##(1995-5#3)(1996-12#6)(1997-3#1)(2008-11#2)(2011-2#1)(2013-1#1)
TH01##2##1##(2008-12#2)
TH1##4##1##(1993-12#3)(1995-5#1)
TH2##6##1##(1993-12#5)(1995-5#1)
TH3 alpha##3##2##(1993-12#3)
TH4 and TH5##3##3##(1993-12#3)
THA and##2##2##(1994-3#1)(2009-3#1)
THA on the other##2##4##(2012-2#2)
THA or TKA##3##3##(1994-3#3)
THA##16##1##(1994-3#4)(2008-8#1)(2009-3#3)(2012-2#4)(2013-1#4)
THAT##3##1##(2009-12#1)(2009-4#1)(2012-2#1)
THBA##4##1##(2008-10#4)
THC##7##1##(1991-10#5)(1997-8#1)(2008-10#1)
THD##4##1##(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
THE OREGON HEALTH INSURANCE EXPERIMENT##2##5##(2013-1#2)
THE##29##1##(1997-2#1)(2008-11#3)(2008-9#2)(2009-11#3)(2009-4#4)(2009-9#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#6)(2013-1#4)
THF and##2##2##(2008-10#2)
THF##8##1##(1992-10#1)(1996-5#1)(2008-10#6)
THF)##2##1##(1996-5#1)(2008-10#1)
THGA##2##1##(2008-10#2)
THIS ISSUE OF JERHRE##2##4##(2009-4#2)
THIS##4##1##(2009-4#3)(2010-12#1)
THMs##2##1##(2008-10#2)
THP##3##1##(2009-7#3)
THP-1 cell membranes##3##3##(1993-6#3)
THP-1 cell##5##2##(1993-6#5)
THP-1 cells##5##2##(1993-6#1)(2008-10#2)(2008-11#2)
THP-1##16##1##(1993-6#8)(1995-6#2)(1995-8#1)(2008-10#3)(2008-11#2)
THP-A##2##1##(2009-7#2)
THP-B##3##1##(2009-7#3)
THW patients##2##2##(2013-1#2)
THW##3##1##(2013-1#3)
THz##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
TI##8##1##(2008-10#8)
TICKSIM##2##1##(2013-8#2)
TIE and TEK##2##3##(1993-8#2)
TIEG2##3##1##(2009-12#3)
TIEG2-MAO B##3##2##(2009-12#3)
TIF2##2##1##(1996-6#2)
TIMI##4##1##(2008-3#3)(2012-2#1)
TIMP mRNA##2##2##(1990-8#1)(1992-6#1)
TIMP##7##1##(1990-8#4)(1992-6#3)
TIMP-1 and##2##2##(2008-1#1)(2008-5#1)
TIMP-1##11##1##(2008-1#1)(2008-5#6)(2008-9#3)(2010-8#1)
TIMP-2##4##1##(2010-1#4)
TIN##2##1##(2008-6#2)
TINC##3##1##(2013-1#3)
TIOA##2##1##(2008-10#2)
TIPS##3##1##(2011-2#3)
TIQ##4##1##(1994-2#4)
TIR##5##1##(2008-8#2)(2009-6#1)(2012-3#2)
TIRF-based biosensor setup##2##3##(2008-10#2)
TIRF-based biosensor##3##2##(2008-10#3)
TIVA##3##1##(2012-3#3)
TJ and##3##2##(2009-10#2)(2012-2#1)
TJ permeability in capsaicin-treated##2##4##(2008-11#2)
TJ permeability increase##2##3##(2008-11#2)
TJ permeability##6##2##(2008-11#6)
TJ##12##1##(2008-11#6)(2009-10#3)(2012-2#3)
TK1##2##1##(2011-2#2)
TK6 lymphoblastoid cells##2##3##(2008-5#2)
TKA and##2##2##(1994-3#1)(2009-3#1)
TKA##13##1##(1994-3#4)(2009-3#4)(2013-1#5)
TKAs##3##1##(2009-3#2)(2013-1#1)
TKR##4##1##(2007-8#1)(2008-8#3)
TL##6##1##(1995-12#3)(2008-3#2)(2008-8#1)
TLC analysis##2##2##(2008-10#2)
TLC and##5##2##(1990-2#1)(1996-2#1)(2008-11#1)(2008-5#2)
TLC##25##1##(1990-2#1)(1995-12#1)(1996-2#7)(2008-10#9)(2008-11#2)(2008-5#4)(2011-2#1)
TLCV##3##1##(2008-10#3)
TLE##2##1##(2008-4#2)
TLR2 population differentiation##2##3##(2012-3#2)
TLR2##4##1##(2012-3#4)
TLR4##4##1##(2008-10#4)
TLRs##2##1##(2009-3#2)
TLS##12##1##(2008-10#2)(2008-7#10)
TM polarization##3##2##(2007-12#2)(2008-3#1)
TM##16##1##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)(2009-7#6)(2012-2#1)
TMA and ovalbumin##3##3##(2008-10#3)
TMA and##4##2##(1995-11#1)(2008-10#3)
TMA concentration group##2##3##(2008-10#2)
TMA concentration##3##2##(2008-10#3)
TMA in##3##2##(2008-10#3)
TMA is##2##2##(2008-10#2)
TMA##22##1##(1995-11#1)(2008-10#21)
TMA-DPH##2##1##(1994-3#1)(2008-11#1)
TMA5##3##1##(2008-10#3)
TMAH solution##2##2##(2008-10#2)
TMAH##5##1##(2008-10#5)
TMB##2##1##(1990-12#1)(2008-10#1)
TMFE##3##1##(2008-10#3)
TMG is##2##2##(2008-10#2)
TMG##6##1##(2008-10#6)
TMJ##5##1##(2011-2#3)(2012-3#2)
TMPAB-OSu##2##1##(2008-10#2)
TMS##11##1##(2009-10#1)(2010-5#2)(2010-7#5)(2011-2#3)
TMSG-1 expression levels##2##3##(2008-9#2)
TMSG-1##9##1##(2008-9#9)
TMSe##3##1##(2008-10#3)
TMT and BT##2##3##(2008-10#2)
TMV MP##2##2##(2008-10#2)
TMV RNA##2##2##(1997-3#2)
TMV##15##1##(1997-3#2)(2008-10#12)(2008-8#1)
TMV-Cv(mp) and##2##2##(2008-9#2)
TMV-Cv(rease-mp)##2##1##(2008-9#2)
TMV-U1##2##1##(2008-8#2)
TN##3##1##(2011-2#2)(2013-8#1)
TNDR selection##3##2##(2008-10#3)
TNDR##4##1##(2008-10#4)
TNF alpha##6##2##(1994-3#1)(1994-6#1)(1995-2#3)(2008-10#1)
TNF alpha-308 polymorphism##3##3##(1995-12#3)
TNF cytotoxicity##3##2##(1992-7#3)
TNF genes##2##2##(1991-6#2)
TNF in##3##2##(1992-7#1)(2008-8#1)(2011-2#1)
TNF stimulation##2##2##(2010-10#2)
TNF##48##1##(1990-5#4)(1991-6#2)(1992-12#1)(1992-7#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#3)(1997-2#4)(1997-4#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#2)(2009-3#1)(2010-10#2)(2011-2#5)(2012-2#1)(2012-3#1)
TNF-alpha and IFN-gamma##4##3##(2008-10#2)(2008-11#1)(2009-12#1)
TNF-alpha and TNF-beta##2##3##(1991-6#2)
TNF-alpha and verotoxin##2##3##(2008-11#2)
TNF-alpha and##12##2##(1991-6#2)(1993-6#1)(1996-12#1)(2008-10#3)(2008-11#3)(2009-12#1)(2011-2#1)
TNF-alpha expressing##2##2##(1995-12#1)(2013-1#1)
TNF-alpha mRNA##3##2##(1992-8#2)(1995-12#1)
TNF-alpha or##2##2##(1993-6#1)(1996-12#1)
TNF-alpha serum##2##2##(2008-12#1)(2008-7#1)
TNF-alpha##53##1##(1991-6#3)(1992-8#3)(1993-3#1)(1993-6#3)(1995-12#7)(1996-12#4)(2008-10#4)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2010-7#2)(2011-2#2)(2013-1#11)
TNF-alpha-expressing breast cancer cells##2##4##(2013-1#2)
TNF-beta##3##1##(1991-6#3)
TNF-induced##7##1##(1992-7#4)(2011-2#3)
TNF-related##2##1##(2008-4#1)(2012-2#1)
TNF-α##2##1##(2010-11#1)(2012-3#1)
TNF-α-activated##2##1##(2012-2#2)
TNF-α-induced##2##1##(2012-2#2)
TNF2##2##1##(1995-12#2)
TNFalpha##4##1##(2006-6#1)(2008-10#1)(2008-11#1)(2010-3#1)
TNFα##3##1##(2012-2#1)(2013-1#2)
TNH##2##1##(1996-2#2)
TNM classification##2##2##(1993-11#1)(2011-2#1)
TNM staging##2##2##(2011-2#1)(2012-3#1)
TNM##4##1##(1993-11#1)(2011-2#2)(2012-3#1)
TNM-FH##4##1##(2008-11#4)
TNP solution##2##2##(2008-10#2)
TNP##4##1##(2008-10#4)
TNP-KLH conjugate##2##2##(2008-10#2)
TNP-keyhole limpet##2##2##(2008-10#2)
TNS##4##1##(2008-10#4)
TNT and##8##2##(2008-10#7)(2008-11#1)
TNT in##4##2##(2008-10#3)(2008-11#1)
TNT sensitivity##2##2##(2008-10#2)
TNT was##5##2##(2008-10#5)
TNT##43##1##(2008-10#34)(2008-11#7)(2008-3#1)(2009-3#1)
TO##9##1##(2008-10#3)(2009-4#1)(2009-9#2)(2012-2#1)(2012-3#2)
TOC##4##1##(2008-10#4)
TOF ICP MS and##2##4##(2008-10#2)
TOF##4##1##(1997-2#1)(2008-10#3)
TOP##2##1##(2008-11#1)(2010-6#1)
TOPA1##2##1##(2008-10#2)
TOPA1076##2##1##(2008-10#2)
TOPA814##2##1##(2008-10#2)
TOPO##3##1##(2008-10#3)
TORT-2##2##1##(2008-10#2)
TP##3##1##(2008-10#1)(2009-8#2)
TP53##12##1##(2009-8#4)(2011-2#4)(2013-1#4)
TP53-dependent coupling of self-renewal and senescence pathways##2##7##(2013-1#2)
TP82##2##1##(1990-8#2)
TP82-induced##3##1##(1990-8#3)
TPA and##4##2##(1990-12#1)(1990-8#3)
TPA in##2##2##(1990-8#1)(1991-8#1)
TPA treatment##2##2##(1994-6#1)(2008-9#1)
TPA was##3##2##(1990-8#2)(1997-1#1)
TPA##31##1##(1990-12#2)(1990-8#9)(1991-8#1)(1993-3#1)(1993-8#1)(1994-6#4)(1995-12#2)(1995-8#1)(1996-12#2)(1997-1#2)(2007-11#3)(2008-10#1)(2008-9#1)(2012-3#1)
TPA-induced PKC-α phosphorylation##2##3##(2012-3#2)
TPA-induced##7##1##(1993-8#2)(2008-9#1)(2012-3#4)
TPC-1 cells##2##2##(1993-8#2)
TPC-1##3##1##(1993-8#3)
TPDE spectra##2##2##(2008-10#2)
TPDE##4##1##(2008-10#4)
TPDT##2##1##(1996-5#2)
TPE##3##1##(2011-2#3)
TPER##2##1##(2008-7#2)
TPF technique##2##2##(2008-3#2)
TPF##8##1##(2008-10#3)(2008-3#4)(2010-12#1)
TPFR##2##1##(2008-7#2)
TPI##3##1##(2008-10#1)(2011-2#2)
TPKI and TPKII##3##3##(1995-12#3)
TPKI##4##1##(1995-12#4)
TPL##4##1##(1997-8#1)(2010-1#3)
TPLO##3##1##(2012-3#3)
TPN##7##1##(1992-9#1)(1994-6#4)(2008-10#1)(2009-9#1)
TPO##9##1##(1995-12#2)(2008-8#7)
TPO2##5##1##(1995-12#5)
TPOX##3##1##(2008-12#3)
TPP##3##1##(2008-10#3)
TPPS(4)##3##1##(2008-3#3)
TPR motifs##2##2##(1996-2#1)(1997-7#1)
TPR##4##1##(1996-2#2)(1997-7#2)
TPRD##2##1##(1996-2#2)
TPS##2##1##(2008-10#2)
TQM and##3##2##(1993-3#1)(1994-1#1)(1995-3#1)
TQM in health care##3##4##(1994-1#1)(1994-2#2)
TQM in##4##2##(1994-1#1)(1994-2#2)(1997-3#1)
TQM process##3##2##(1993-3#2)(1994-1#1)
TQM will##2##2##(1994-1#2)
TQM##25##1##(1993-12#2)(1993-3#4)(1994-1#8)(1994-2#8)(1995-3#2)(1997-3#1)
TR##2##1##(1995-8#1)(2008-5#1)
TRA is##2##2##(2011-2#2)
TRA##8##1##(2011-1#1)(2011-2#7)
TRAF proteins##3##2##(2008-4#3)
TRAIL##5##1##(2009-3#1)(2009-9#3)(2012-2#1)
TRAIL-induced##3##1##(2009-9#2)(2012-2#1)
TRAMP##4##1##(2008-4#4)
TRAb##3##1##(2012-3#3)
TRE-TSHalpha subunit##2##2##(1995-8#2)
TRE-pal2##2##1##(1995-8#2)
TREs##3##1##(1993-8#2)(1995-8#1)
TRF##3##1##(2008-10#3)
TRH or##2##2##(1992-8#2)
TRH stimulation##2##2##(1993-8#1)(2008-4#1)
TRH testing##2##2##(2011-1#2)
TRH was##3##2##(1992-8#1)(1994-2#1)(2008-10#1)
TRH##26##1##(1991-6#2)(1992-6#2)(1992-8#6)(1993-8#1)(1994-2#3)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#2)(2013-7#7)
TRH)##2##1##(2013-7#2)
TRH-R##2##1##(1993-8#2)
TRITC##2##1##(2008-10#1)(2008-5#1)
TRM##9##1##(2008-1#9)
TRP##3##1##(1996-12#3)
TRP-R##3##1##(1996-12#3)
TRP1 gene##2##2##(1997-8#2)
TRP1##3##1##(1996-6#1)(1997-8#2)
TRPO##2##1##(2008-10#2)
TRPV1##7##1##(2009-12#5)(2011-2#2)
TRPV2##3##1##(2011-2#3)
TRPV4##5##1##(2009-8#1)(2011-2#4)
TRS##2##1##(1994-5#2)
TRSV was##2##2##(2008-10#2)
TRSV##7##1##(2008-10#7)
TRU##2##1##(2008-10#2)
TRUS guided##2##2##(2011-2#2)
TRUS##8##1##(1997-8#3)(2011-2#5)
TRZ##5##1##(1996-12#5)
TRbeta##3##1##(1995-8#1)(1997-1#2)
TRbeta1##5##1##(1995-8#5)
TS were##2##2##(2008-1#1)(2008-7#1)
TS##17##1##(2008-1#1)(2008-10#3)(2008-11#5)(2008-7#7)(2013-1#1)
TS-TEM##2##1##(2008-3#2)
TS-gel##2##1##(2008-10#2)
TS93-71B and TS93-71F##2##3##(2008-10#2)
TSA##2##1##(2008-9#2)
TSAb activity but##2##3##(1991-5#2)
TSAb##3##1##(1991-5#3)
TSBAb activity##2##2##(1991-5#2)
TSBAb##3##1##(1991-5#3)
TSC##5##1##(1992-1#2)(1993-12#2)(2008-10#1)
TSC2##3##1##(1993-12#3)
TSE##3##1##(2009-5#3)
TSH A and TSH C##2##5##(1993-8#2)
TSH A##4##2##(1993-8#4)
TSH B##2##2##(1993-8#2)
TSH C##4##2##(1993-8#4)
TSH Receptor##2##2##(2008-4#1)(2012-3#1)
TSH and##4##2##(1991-5#1)(1991-6#1)(2008-6#1)(2008-7#1)
TSH binding##2##2##(1994-11#2)
TSH can##2##2##(2008-6#1)(2013-1#1)
TSH concentration##2##2##(2008-6#2)
TSH level##2##2##(2011-1#1)(2012-12#1)
TSH levels##8##2##(2008-4#3)(2008-7#1)(2012-12#1)(2012-3#3)
TSH receptor autoantibodies##2##3##(2012-3#2)
TSH receptor##4##2##(1991-5#2)(2012-3#2)
TSH##52##1##(1991-5#3)(1991-6#2)(1993-8#11)(1994-11#3)(1995-8#1)(2008-4#8)(2008-6#4)(2008-7#5)(2011-1#3)(2012-12#3)(2012-3#6)(2013-1#3)
TSH-binding##2##1##(1991-5#1)(1994-11#1)
TSHR##2##1##(1995-12#2)
TSHr##7##1##(1994-11#4)(2008-4#3)
TSI##6##1##(2008-3#1)(2012-3#5)
TSK mutation##4##2##(1997-8#4)
TSK##7##1##(1997-8#5)(2008-10#2)
TSP-1##3##1##(2008-1#3)
TSPO binding sites##4##3##(2012-2#4)
TSPO binding##5##2##(2012-2#5)
TSPO drug ligands##2##3##(2012-2#2)
TSPO drug##3##2##(2012-2#3)
TSPO expression levels and##2##4##(2012-2#2)
TSPO expression levels##5##3##(2012-2#5)
TSPO expression##9##2##(2012-2#9)
TSPO function##2##2##(2012-2#2)
TSPO has been##3##3##(2012-2#3)
TSPO is##6##2##(2012-2#6)
TSPO levels##2##2##(2012-2#2)
TSPO ligands with##2##3##(2012-2#2)
TSPO ligands##5##2##(2012-2#5)
TSPO##62##1##(2012-2#62)
TSPO-mediated##2##1##(2012-2#2)
TSPO-targeted##5##1##(2012-2#5)
TSST-1 molecule##3##2##(1993-3#3)
TSST-1##4##1##(1993-3#4)
TSV##3##1##(2008-5#3)
TSWV DI RNA generation##2##4##(2008-10#2)
TSWV GPs as viral attachment proteins and##2##7##(2008-10#2)
TSWV N##3##2##(2008-10#3)
TSWV and##6##2##(2008-10#6)
TSWV in##3##2##(2008-10#3)
TSWV infection in##2##3##(2008-10#2)
TSWV infection##3##2##(2008-10#3)
TSWV is##3##2##(2008-10#3)
TSWV isolates##3##2##(2008-10#3)
TSWV or##2##2##(2008-10#2)
TSWV replication##2##2##(2008-10#2)
TSWV spread to##2##3##(2008-10#2)
TSWV##68##1##(2008-10#68)
TSWV-10##2##1##(2008-10#2)
TSWV-D##3##1##(2008-10#3)
TSWV-GPs##2##1##(2008-10#2)
TSWV-infected##7##1##(2008-10#7)
TT and WFT##2##3##(2008-10#2)
TT and##5##2##(2008-10#5)
TT cells##2##2##(1992-6#2)
TT##10##1##(1992-6#2)(2008-10#8)
TT4##2##1##(2008-7#2)
TTA##3##1##(2008-10#3)
TTBD control##3##2##(1997-7#3)
TTCTOHA##4##1##(2008-10#4)
TTF##2##1##(1996-5#2)
TTF-TCNQ##3##1##(2008-10#3)
TTM at##2##2##(2013-1#2)
TTM stages##2##2##(2010-2#1)(2013-1#1)
TTM##12##1##(2010-12#4)(2010-2#2)(2013-1#6)
TTTAGGG or its variant##2##4##(2008-8#2)
TTX##2##1##(1992-6#1)(1996-2#1)
TU treatment##3##2##(2013-8#3)
TU##5##1##(2013-8#5)
TUB2##2##1##(2008-10#2)
TUNEL assay##3##2##(2008-11#2)(2010-11#1)
TUNEL reaction##2##2##(2008-7#1)(2013-1#1)
TUNEL##10##1##(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#2)(2010-11#1)(2013-1#1)
TUR-BT##2##1##(2008-10#2)
TURBISCAN MA 2000##4##3##(2008-10#4)
TURBISCAN##5##1##(2008-10#5)
TV##4##1##(1997-6#1)(2010-11#2)(2010-8#1)
TW-CY2##2##1##(2008-10#2)
TW-NT1##3##1##(2008-10#3)
TW-TC1##3##1##(2008-10#3)
TW-TN3##4##1##(2008-10#4)
TW-TNML1##3##1##(2008-10#3)
TWIST##3##1##(1991-8#3)
TX##7##1##(1990-11#3)(2008-10#3)(2008-7#1)
TX-100 and N##2##3##(2008-10#2)
TX-100##3##1##(2008-10#3)
TYLCSV population##2##2##(2008-10#2)
TYLCSV##3##1##(2008-10#3)
TYLCV DNA accumulation##2##3##(2008-10#2)
TYLCV DNA##3##2##(2008-10#3)
TYLCV and TYLCV-Mld##2##3##(2008-10#2)
TYLCV isolates##2##2##(2008-10#2)
TYLCV transmission##2##2##(2008-10#2)
TYLCV was detected in##2##4##(2008-10#2)
TYLCV was##5##2##(2008-10#5)
TYLCV##40##1##(2008-10#40)
TYLCV-Is in tomato##2##3##(2008-10#2)
TYLCV-Is in##3##2##(2008-10#3)
TYLCV-Is##8##1##(2008-10#8)
TYLCV-Mld##4##1##(2008-10#4)
TYLCV-Sr##4##1##(2008-10#4)
TYLCV-[Alm]##2##1##(2008-10#2)
TYLCV-[DO]##2##1##(2008-10#2)
TYMC-XX and##2##2##(1997-3#2)
TYMC-XX##3##1##(1997-3#3)
TYMV##9##1##(1997-3#3)(2008-10#6)
TZ##4##1##(2012-3#4)
TZDs##2##1##(2010-10#2)
Ta##4##1##(2008-10#4)
Table##2##1##(2008-3#1)(2009-4#1)
Tables and##2##2##(1994-12#1)(2010-1#1)
Tadalafil##2##1##(2008-11#2)
Tadinia##4##1##(2008-10#4)
Taenia microsoma Creplin##2##3##(2011-2#2)
Taenia##7##1##(1995-12#1)(2008-7#1)(2011-2#4)(2012-3#1)
Tafel##2##1##(2008-10#2)
Tag##2##1##(1995-6#1)(2009-8#1)
Tagetes mendocina##3##2##(2008-11#3)
Taguchi's methods as a basis##2##5##(2008-11#2)
Taguchi's methods##3##2##(2008-11#3)
Tai chi##2##2##(2008-10#2)
Tai##3##1##(2008-10#3)
Taif Governorate##2##2##(2008-10#2)
Tail DNA and##2##3##(2008-10#2)
Tail length##2##2##(2008-10#1)(2008-8#1)
Tail##9##1##(1990-3#1)(2008-10#4)(2008-8#1)(2008-9#2)(2012-2#1)
Taiwan and##4##2##(2008-10#3)(2008-11#1)
Taiwan isolates##4##2##(2008-10#4)
Taiwan was##2##2##(2008-10#2)
Taiwan##43##1##(2008-10#19)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#4)(2008-8#4)(2010-11#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#5)
Tajikistan##3##1##(2008-10#3)
Takayasu arteritis (TA) is##2##4##(1997-8#2)
Takayasu arteritis (TA)##4##3##(1997-8#4)
Takayasu arteritis in##8##3##(1997-8#8)
Takayasu arteritis is a##2##4##(1997-8#2)
Takayasu arteritis were##2##3##(1997-8#2)
Takayasu arteritis##35##2##(1997-8#35)
Takayasu disease##2##2##(1997-8#2)
Takayasu##39##1##(1997-8#39)
Takayasu's arteritis##8##2##(1997-8#8)
Take-all##3##1##(2008-10#3)
Taken together these##2##3##(1993-3#1)(1993-6#1)
Taken together with##3##3##(1990-8#1)(1996-6#1)(2008-6#1)
Taken together##61##2##(1990-8#2)(1991-5#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-1#2)(1997-7#1)(1997-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-12#1)(2011-2#3)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#1)
Taken##64##1##(1990-8#2)(1991-5#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-12#1)(2011-2#3)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#1)
Taking advantage of the##3##4##(1995-3#1)(2008-10#1)(2008-5#1)
Taking advantage##4##2##(1993-6#1)(1995-3#1)(2008-10#1)(2008-5#1)
Taking into account the importance of##2##6##(2008-10#1)(2008-11#1)
Taking into account the##5##4##(1990-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
Taking into account##7##3##(1990-6#1)(2008-10#4)(2008-11#1)(2011-2#1)
Taking the##6##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-9#2)(2013-8#1)
Taking##28##1##(1990-6#1)(1991-2#1)(1991-8#1)(1993-2#1)(1993-6#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-8#2)
Takotsubo cardiomyopathy##9##2##(2009-6#2)(2010-5#3)(2010-7#1)(2013-1#3)
Talanta##4##1##(2008-10#4)
Talar##3##1##(2009-3#1)(2010-5#1)(2011-2#1)
Talaromyces flavus##4##2##(2008-10#4)
Talbot array illuminator##3##3##(2008-3#3)
Talbot array##4##2##(2008-3#4)
Talbot interferometry##3##2##(2008-3#3)
Talbot##10##1##(2007-12#2)(2008-3#8)
Tales of##2##2##(1993-2#1)(1994-9#1)
Talk##2##1##(2012-2#1)(2013-1#1)
Talking##2##1##(1992-3#1)(2013-1#1)
Tall Fescue##3##2##(2008-10#3)
Tallimustine##4##1##(1996-3#4)
Tamarix spp##2##2##(2012-5#2)
Tamarix##3##1##(2012-5#3)
Tamoxifen##2##1##(1995-10#2)
Tan Spot of Wheat##2##4##(2008-10#2)
Tan##7##1##(1990-12#1)(2008-10#6)
Tanashi##2##1##(2008-10#2)
Tandem##9##1##(1992-3#1)(1995-11#1)(1996-5#2)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
Tang##2##1##(1990-11#1)(2008-11#1)
Tangerine##2##1##(2008-10#2)
Tangier disease##4##2##(1994-11#4)
Tanichthys albonubes was##2##3##(2010-5#2)
Tanichthys albonubes##7##2##(2010-5#7)
Tankships##2##1##(2008-11#2)
Tanne&quot##2##1##(2008-11#2)
Tantalum##2##1##(2008-10#2)
Tanzania##10##1##(1994-9#1)(1997-6#1)(2008-10#6)(2008-11#2)
Tapesia yallundae and T##3##4##(2008-10#3)
Tapesia yallundae##5##2##(2008-10#5)
Tapesia##6##1##(2008-10#6)
Taphrina deformans##6##2##(2008-10#6)
Taq DNA polymerase##4##3##(1997-8#4)
Taq or##2##2##(2008-4#1)(2008-9#1)
Taq##8##1##(1991-6#1)(1997-8#4)(2008-4#1)(2008-9#2)
TaqI##4##1##(2008-10#4)
TaqMan chemistry##4##2##(2008-10#4)
TaqMan primer/probe sets were##2##4##(2008-10#2)
TaqMan primer/probe##3##2##(2008-10#3)
TaqMan probe##2##2##(2008-10#1)(2010-4#1)
TaqMan probes and##2##3##(2008-10#2)
TaqMan probes##6##2##(2008-10#5)(2010-4#1)
TaqMan protocol##2##2##(2008-10#2)
TaqMan##28##1##(2008-10#26)(2010-4#2)
Taqman##3##1##(2013-1#1)(2013-8#2)
Tarasca embodies##2##2##(2009-10#2)
Tarasca##12##1##(2009-10#12)
Target attainment of AUC/MIC was##2##5##(2011-2#2)
Target for##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
Target in##2##2##(2011-2#2)
Target##12##1##(1995-3#1)(1997-3#1)(2008-10#2)(2008-7#1)(2011-2#5)(2013-1#1)(2013-8#1)
Targeted disruption of murine##2##4##(2008-8#1)(2008-9#1)
Targeted##11##1##(1994-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2012-2#1)(2013-1#2)
Targeting the##3##2##(2010-7#1)(2012-2#2)
Targeting##11##1##(1996-12#1)(2008-11#1)(2008-6#1)(2009-11#1)(2010-11#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#2)
Targets##2##1##(1992-6#1)(2008-6#1)
Tartrate##3##1##(2008-10#2)(2012-2#1)
Tartrazine##7##1##(2008-10#7)
Tas1r3##3##1##(2008-2#3)
Task Force##7##2##(1990-12#1)(1990-6#1)(1991-2#2)(1993-3#1)(2008-9#1)(2011-2#1)
Task performance##2##2##(2009-10#1)(2013-8#1)
Task##18##1##(1990-12#1)(1990-6#1)(1991-2#3)(1993-3#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-10#5)(2010-11#1)(2011-2#1)(2013-8#1)
Taskforce for##2##2##(2011-8#1)(2011-9#1)
Tasl was##2##2##(2008-8#2)
Tasmania##2##1##(2008-10#1)(2008-9#1)
Taste##2##1##(2008-10#1)(2008-7#1)
Tat protein##3##2##(2009-8#2)(2012-12#1)
Tat##14##1##(1993-2#2)(1994-11#1)(2009-8#8)(2012-12#3)
Tat-independent##3##1##(2012-12#3)
Tat/TAR transactivation##2##2##(2008-11#2)
Tat/TAR##3##1##(2008-11#3)
TauD and##2##2##(2012-12#2)
TauD##3##1##(2012-12#3)
Taurine##3##1##(1993-2#1)(2008-10#1)(2008-5#1)
Tavas (Denizli)##2##2##(2008-12#2)
Tax protein is##2##3##(2008-8#2)
Tax protein##4##2##(2008-8#4)
Tax##12##1##(1991-2#1)(1993-1#2)(1993-12#1)(1994-3#1)(2008-8#5)(2011-2#2)
Tax-exemption##2##1##(1991-2#1)(1993-1#1)
Tax-mediated transcription of##2##3##(1994-11#2)
Tax-mediated##4##1##(1994-11#4)
Taxol##2##1##(2008-11#1)(2008-5#1)
Taxonomy of the##2##3##(2008-10#1)(2008-5#1)
Taxonomy##4##1##(2008-10#2)(2008-12#1)(2008-5#1)
Taxus pollen##2##2##(2012-7#2)
Taxus##9##1##(2008-11#1)(2008-8#1)(2012-7#7)
Taylor Home##4##2##(1995-12#4)
Taylor##8##1##(1995-12#5)(2008-10#1)(2008-12#1)(2012-2#1)
Taylor's power-law##2##2##(2008-10#2)
Taylor's series expansion##2##3##(2008-2#2)
Taylor's##10##1##(2008-10#8)(2008-2#2)
Tb##5##1##(2008-10#5)
Tb(3+)##3##1##(2008-10#3)
Tb(III)##4##1##(2008-10#4)
Tb-TMA-beta-CD##3##1##(2008-10#3)
Tc##9##1##(1993-5#1)(1994-2#3)(1995-12#1)(2007-11#1)(2008-11#2)(2008-8#1)
Tc-99m##2##1##(2011-2#1)(2013-1#1)
TcPO2##5##1##(2013-1#5)
TdR kinase activity##3##3##(1992-8#3)
TdR kinase is##2##3##(1992-8#2)
TdR kinase which##2##3##(1992-8#2)
TdR kinase##7##2##(1992-8#7)
TdR##8##1##(1992-8#8)
TdT##11##1##(1997-9#11)
Te and Bi in milk##2##5##(2008-10#2)
Te and Bi##3##3##(2008-10#3)
Te and##4##2##(2008-10#4)
Te##10##1##(2008-10#10)
Te(IV)##2##1##(2008-10#2)
Te)##2##1##(1994-8#1)(2008-10#1)
TeBr(6)(2-)##2##1##(2008-10#2)
Tea##2##1##(2008-10#2)
Teacher##5##1##(2008-11#1)(2008-12#2)(2011-2#2)
Teachers of##2##2##(1997-5#1)(2008-11#1)
Teachers##6##1##(1997-5#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)
Teachers'##3##1##(2008-12#1)(2011-2#2)
Teaching Hospital##8##2##(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Teaching about##2##2##(1996-1#1)(2008-11#1)
Teaching and Learning##2##3##(2008-11#2)
Teaching and##3##2##(1994-12#1)(2008-11#2)
Teaching##30##1##(1990-12#1)(1991-12#1)(1991-3#1)(1993-3#1)(1994-1#1)(1994-12#2)(1996-1#1)(1996-2#1)(2008-11#6)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
Teakettle##4##1##(2008-10#4)
Team##13##1##(1993-12#2)(1994-1#1)(1995-8#1)(1995-9#1)(1997-2#2)(1997-3#1)(2007-9#1)(2008-11#2)(2008-12#1)(2011-1#1)
Teams##5##1##(1996-1#5)
Technical UK DNA working group##2##5##(2008-12#2)
Technical aspects of##3##3##(2011-2#2)(2013-1#1)
Technical note##2##2##(1997-6#1)(2011-2#1)
Technical note]##2##2##(1992-9#2)
Technical tip##2##2##(2008-9#1)(2012-2#1)
Technical##25##1##(1992-9#2)(1994-12#1)(1994-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
Technicon##2##1##(2008-10#2)
Technique for##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2010-7#1)
Technique##12##1##(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Techniques for##10##2##(1991-1#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)(2012-12#1)(2012-3#1)
Techniques##19##1##(1991-1#1)(1994-12#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#2)(2010-2#1)(2010-7#2)(2012-12#1)(2012-3#2)(2013-8#1)
Technol##2##1##(2008-10#2)
Technological##8##1##(1994-3#1)(1995-1#1)(1996-1#1)(2008-11#2)(2010-4#1)(2011-2#2)
Technologies to##2##2##(2008-5#1)(2012-3#1)
Technologies##5##1##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
Technology##27##1##(1990-11#1)(1993-3#1)(1994-12#4)(1994-8#1)(1997-2#1)(2008-10#5)(2008-11#4)(2008-3#3)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
Teddy##2##1##(1990-2#1)(2008-10#1)
Teenage##2##1##(2012-3#1)(2013-1#1)
Teenagers##2##1##(2008-11#1)(2013-1#1)
Teeth with##2##2##(1990-9#1)(2013-1#1)
Teeth##4##1##(1990-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Teflon AF-2400##3##2##(2008-10#3)
Teflon filters##3##2##(2008-10#2)(2008-5#1)
Teflon membrane##2##2##(2008-10#2)
Teflon##18##1##(1990-3#1)(2008-10#15)(2008-5#2)
Tegner##2##1##(2011-2#2)
Tehran##5##1##(2008-12#2)(2012-2#2)(2013-8#1)
Telbivudine##2##1##(2013-1#2)
TeleBAT##2##1##(2007-9#2)
Telecommunication##2##1##(1993-12#1)(2008-3#1)
Telemedicine and##2##2##(1996-2#2)
Telemedicine##6##1##(1995-2#1)(1996-2#2)(1996-3#1)(2008-10#1)(2008-8#1)
Telepathology##5##1##(2008-1#5)
Telephone##7##1##(1996-5#1)(1997-2#1)(2008-10#1)(2009-10#1)(2009-7#1)(2012-12#1)(2013-1#1)
Telescope##3##1##(1990-11#1)(1995-6#1)(2008-2#1)
Television##4##1##(1997-6#1)(2008-11#1)(2010-10#1)(2010-11#1)
Teliospore##2##1##(2008-10#2)
Teliospores from##2##2##(2008-10#2)
Teliospores##3##1##(2008-10#3)
Tell the##2##2##(2008-6#1)(2009-3#1)
Tell##3##1##(2008-6#1)(2009-3#1)(2010-3#1)
Telmatochromis temporalis##2##2##(2008-5#2)
Telomerase is##2##2##(2008-11#2)
Telomerase##10##1##(2008-11#9)(2008-9#1)
Telomere##3##1##(2011-2#1)(2012-3#2)
Telomeres##2##1##(1990-5#1)(2008-11#1)
Temecula1##2##1##(2008-10#2)
Temperate Climates##2##2##(2008-10#2)
Temperate##4##1##(2008-10#4)
Temperature and##16##2##(1995-6#1)(2008-10#11)(2008-3#2)(2008-6#1)(2013-1#1)
Temperature effects on##2##3##(2008-10#2)
Temperature effects##3##2##(2008-10#2)(2008-8#1)
Temperature on the##2##3##(2008-10#2)
Temperature on##5##2##(2008-10#5)
Temperature regimes##2##2##(2008-10#2)
Temperature treatments were##2##3##(2008-10#1)(2012-8#1)
Temperature##57##1##(1991-11#1)(1992-3#1)(1993-5#1)(1993-9#1)(1995-6#1)(1996-9#1)(2008-10#35)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2011-2#1)(2012-6#1)(2012-8#2)(2013-1#1)
Temperature-constrained cascade correlation networks (TCCCNs) were##2##6##(2008-10#2)
Temperatures of##2##2##(1991-1#1)(2008-10#1)
Temperatures##9##1##(1991-1#1)(2008-10#5)(2008-3#3)
Templeton##2##1##(2008-10#2)
Tempol##3##1##(1995-8#3)
Temporal Dynamics of##4##3##(2008-10#4)
Temporal analysis of##2##3##(2008-10#1)(2008-11#1)
Temporal and Spatial Dynamics of##2##5##(2008-10#2)
Temporal and Spatial##4##3##(2008-10#4)
Temporal and##5##2##(2008-10#5)
Temporal##27##1##(1994-9#1)(1996-2#1)(1997-2#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
Temporary##2##1##(1992-8#1)(2008-8#1)
Ten days later##3##3##(1994-2#1)(2008-9#1)(2012-3#1)
Ten days##4##2##(1994-2#1)(2008-5#1)(2008-9#1)(2012-3#1)
Ten distinct##2##2##(2008-10#2)
Ten microsatellite loci##2##3##(2008-11#1)(2013-8#1)
Ten nM estradiol##2##3##(2008-11#2)
Ten nM##3##2##(2008-11#3)
Ten of the##4##3##(1991-2#1)(1994-12#1)(2008-11#1)(2010-8#1)
Ten of##6##2##(1991-2#1)(1994-12#1)(1994-3#1)(2008-11#1)(2010-8#1)(2012-2#1)
Ten patients were treated##2##4##(1994-1#1)(2008-7#1)
Ten patients were##5##3##(1993-1#1)(1994-1#1)(2008-7#1)(2009-2#1)(2011-2#1)
Ten patients##12##2##(1990-8#1)(1993-1#1)(1994-1#2)(2008-7#4)(2009-2#1)(2011-2#1)(2012-3#2)
Ten protein spots were##2##4##(2008-10#1)(2010-12#1)
Ten specialty boards report accomplishments and plans##3##7##(2008-4#3)
Ten years after##2##3##(2009-12#1)(2013-1#1)
Ten years to VISION 2020##2##5##(2011-2#2)
Ten years##7##2##(1992-7#1)(1993-2#1)(2008-11#1)(2009-12#1)(2011-2#2)(2013-1#1)
Ten##84##1##(1990-8#1)(1991-1#1)(1991-2#2)(1992-2#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-3#1)(2007-8#1)(2008-10#19)(2008-11#7)(2008-12#3)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
Tenax((R))##2##1##(2008-10#2)
Tendon##2##1##(2009-3#1)(2013-1#1)
Tennessee##4##1##(2008-10#3)(2008-8#1)
Tensile##2##1##(2009-7#2)
Tensions##2##1##(2013-1#1)(2013-8#1)
Tenth##3##1##(2011-2#1)(2012-12#1)(2013-8#1)
Tephritidae) and##2##2##(2007-12#2)
Tephritidae)##4##1##(2007-12#2)(2008-11#1)(2013-8#1)
Teqing##3##1##(2008-10#1)(2008-8#2)
Teratology Society##2##2##(2011-2#2)
Teratoma of the##2##3##(2008-10#1)(2008-7#1)
Teratosphaeria##3##1##(2010-3#3)
Terbinafine##3##1##(2008-5#2)(2012-3#1)
Term##4##1##(1993-12#2)(2013-1#2)
Terminals which##2##2##(1997-2#2)
Terminology##3##1##(2012-2#1)(2013-1#2)
Terms##3##1##(1992-3#1)(2011-2#1)(2012-12#1)
Ternary mixtures of##2##3##(2008-10#2)
Terrestrial##3##1##(2008-6#1)(2008-8#1)(2011-2#1)
Territory##3##1##(2008-12#1)(2011-2#1)(2013-1#1)
Tertiary##2##1##(2009-10#1)(2011-2#1)
Tesla##6##1##(2008-9#3)(2012-2#1)(2012-3#2)
Tessier et al##2##3##(2008-10#2)
Tessier##4##1##(2008-10#4)
Test Guideline 487##2##3##(2011-1#2)
Test for##4##2##(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
Test results are##2##3##(2008-10#2)
Test results##4##2##(2008-10#2)(2008-3#1)(2012-12#1)
Test##50##1##(1992-2#1)(1994-3#1)(2007-11#1)(2008-10#7)(2008-11#5)(2008-12#9)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
Test-retest reliability##2##2##(2010-11#1)(2013-8#1)
Tested##2##1##(2008-10#2)
Testes##2##1##(2007-12#2)
Testicular descent##2##2##(2008-10#2)
Testicular##9##1##(1992-12#1)(2008-10#4)(2009-10#1)(2009-11#1)(2009-4#1)(2012-2#1)
Testing a##2##2##(2008-10#1)(2008-8#1)
Testing different##2##2##(2008-11#1)(2013-8#1)
Testing for##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
Testing of##4##2##(1990-4#1)(2008-10#1)(2010-11#1)(2013-1#1)
Testing the##7##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#1)
Testing visual sensitivity##2##3##(2008-10#2)
Testing with##2##2##(2008-10#1)(2010-2#1)
Testing##39##1##(1990-4#1)(1991-1#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-6#1)(1996-12#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-8#3)(2008-9#1)(2009-6#1)(2010-11#1)(2010-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
Testosterone##12##1##(1993-3#1)(1995-2#1)(1996-2#1)(2008-8#1)(2009-7#1)(2012-2#2)(2013-1#1)(2013-8#4)
Tests for##4##2##(2008-10#4)
Tests of##4##2##(1992-5#1)(2008-10#2)(2008-3#1)
Tests on a##2##3##(1996-12#1)(2008-10#1)
Tests on##4##2##(1996-12#1)(2008-10#3)
Tests that##2##2##(2008-12#1)(2013-1#1)
Tests were performed##2##3##(2008-10#1)(2008-11#1)
Tests with##4##2##(2008-10#4)
Tests##26##1##(1992-5#1)(1996-12#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
Testudines (TINC)##2##2##(2013-1#2)
Tetanus##2##1##(2008-10#1)(2012-3#1)
Tetep##3##1##(2008-10#3)
Tetr plants##5##2##(2008-10#5)
Tetr seedlings##2##2##(2008-10#2)
Tetr tobacco##2##2##(2008-10#2)
Tetr##9##1##(2008-10#9)
Tetrabenzyl pyrophosphate##2##2##(2008-10#2)
Tetrachlorodibenzo-p-Dioxin (TCDD)##2##2##(2008-10#2)
Tetrad analysis##3##2##(1995-9#1)(2008-10#2)
Tetragonia expansa##3##2##(2008-10#3)
Tetrahymena thermophila##2##2##(2012-3#2)
Tetrahymena##4##1##(1993-1#1)(2008-12#1)(2012-3#2)
Tetraploid##6##1##(2008-10#2)(2008-11#3)(2012-3#1)
Tetric Ceram##2##2##(2013-1#2)
Tettigoniidae)##2##1##(2008-12#1)(2013-8#1)
Tettigoniinae##2##1##(2008-12#2)
Tex11##6##1##(2012-2#6)
Tex6##13##1##(2008-10#13)
Texas in##2##2##(2008-10#2)
Texas were##2##2##(2008-10#2)
Texas##57##1##(1990-11#2)(1991-1#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-2#4)(1996-5#3)(1997-3#3)(2008-10#30)(2008-9#1)(2011-2#2)(2013-8#1)
Text##4##1##(2008-12#1)(2009-10#1)(2013-1#2)
Texture##3##1##(1996-9#1)(2008-10#2)
Tf has##2##2##(2010-11#1)(2013-7#1)
Tf##11##1##(2010-11#7)(2013-7#4)
Tg##43##1##(1991-6#6)(2008-11#1)(2008-9#35)(2013-1#1)
Th 5 have##2##3##(1991-6#2)
Th and##3##2##(1995-12#1)(2008-10#2)
Th cell function##2##3##(1995-5#2)
Th cell##3##2##(1995-5#2)(2008-11#1)
Th cells##2##2##(2008-11#2)
Th##29##1##(1991-6#2)(1995-12#2)(1995-5#2)(2008-10#12)(2008-11#4)(2008-8#2)(2008-9#3)(2011-2#2)
Th(4+)##7##1##(2008-10#7)
Th(IV) and La(III) from##3##4##(2008-10#3)
Th(IV) and La(III)##5##3##(2008-10#5)
Th(IV) and U(VI)##2##3##(2008-10#2)
Th(IV) and##9##2##(2008-10#9)
Th(IV) from##4##2##(2008-10#4)
Th(IV) ions##2##2##(2008-10#2)
Th(IV)##23##1##(2008-10#23)
Th(IV)-imprinted##3##1##(2008-10#3)
Th(PBI)(4) and UO(2)(PBI)(2)##2##3##(2008-10#2)
Th(PBI)(4)##3##1##(2008-10#3)
Th0##2##1##(2008-9#2)
Th1 and Th2##2##3##(2008-11#1)(2012-12#1)
Th1 and##3##2##(2008-11#1)(2012-12#1)(2012-2#1)
Th1 cytokine##2##2##(2008-11#2)
Th1##13##1##(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#4)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
Th1/Th2##2##1##(2008-11#1)(2013-1#1)
Th17##5##1##(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
Th2 cytokines##4##2##(1996-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Th2##16##1##(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-9#2)(2009-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
Th2-type cytokine producing cells##2##4##(2008-11#2)
Th2-type cytokine producing##3##3##(2008-11#3)
Th2-type cytokine##4##2##(2008-11#4)
Th2-type responses##2##2##(2008-11#1)(2011-2#1)
Th2-type##10##1##(2008-11#9)(2011-2#1)
Thai blood donors##2##3##(2011-2#2)
Thai##8##1##(2010-12#2)(2011-2#4)(2012-2#2)
Thailand##27##1##(1993-3#1)(1995-12#3)(1996-9#4)(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2011-2#7)(2012-2#1)(2013-8#1)
Thalamic##2##1##(1995-8#1)(1997-2#1)
Thalassarachna basteri from the Baltic Sea and Halacarellus thomasi from McMurdo Sound (Antarctica)##2##13##(2007-12#2)
Thalassemia Major##2##2##(1994-12#2)
Thalassemia##3##1##(1994-12#2)(2008-10#1)
Thallium scintigraphy##2##2##(1991-2#1)(1996-3#1)
Thallium was##2##2##(1994-5#1)(2008-10#1)
Thallium##5##1##(1991-2#1)(1994-5#2)(1996-3#1)(2008-10#1)
Thallium(I)##2##1##(2008-10#2)
Thanatephorus##2##1##(2008-10#2)
Thanks to##4##2##(1996-12#1)(2008-6#1)(2009-12#1)(2012-3#1)
That Is##2##2##(2008-10#1)(2012-3#1)
That is why##3##3##(2008-10#2)(2008-11#1)
That is##9##2##(1993-11#1)(1993-3#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)
That same year##2##3##(1991-2#1)(2008-8#1)
That the##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
That was##2##2##(2009-8#1)(2013-1#1)
That##52##1##(1991-1#1)(1991-2#2)(1993-11#1)(1993-3#1)(1994-9#1)(1995-1#3)(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Thatcher and##2##2##(2008-10#2)
Thatcher wheat##3##2##(2008-10#3)
Thatcher##8##1##(2008-10#8)
Thauera aromatica##2##2##(2011-1#2)
Thaumetopoea pityocampa##2##2##(2008-12#2)
Thaxtomin##2##1##(2008-10#2)
The &quot##21##2##(1991-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-3#2)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#2)(2009-9#1)(2011-3#1)
The (19)F##2##2##(2008-10#2)
The 0##3##2##(1991-10#1)(1993-8#1)(2013-1#1)
The 1##14##2##(1992-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#6)
The 12##3##2##(2008-10#1)(2008-9#1)(2009-2#1)
The 13##2##2##(2008-10#1)(2011-2#1)
The 165 kDa pro-EGF##2##4##(1990-12#2)
The 16S rRNA##2##3##(2009-6#1)(2012-2#1)
The 16S##3##2##(2008-10#1)(2009-6#1)(2012-2#1)
The 17-kDa protein##2##3##(2008-10#2)
The 1990##2##2##(1990-3#1)(1997-3#1)
The 1st##2##2##(2008-7#1)(2008-8#1)
The 2##16##2##(1996-5#1)(1996-6#2)(1997-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#4)
The 20S proteasome is the catalytic core of the major extralysosomal proteolytic system of the cell##2##16##(2008-4#2)
The 20S proteasome##3##3##(2008-4#2)(2008-5#1)
The 24 Kd##2##3##(1993-8#2)
The 2nd##3##2##(2008-7#1)(2010-11#1)(2010-5#1)
The 3##10##2##(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#7)
The 3' end##2##3##(2008-10#1)(2008-11#1)
The 3'##6##2##(1990-5#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
The 3-D structure##2##3##(2008-8#2)
The 3-D##7##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2011-2#2)
The 30##2##2##(2008-7#1)(2011-2#1)
The 30-day##2##2##(2008-7#1)(2011-3#1)
The 3D culture##2##3##(2008-11#2)
The 3D##3##2##(2008-11#2)(2012-3#1)
The 3sigma detection limit##2##4##(2008-10#2)
The 3sigma detection limits##2##4##(2008-10#2)
The 3sigma detection##4##3##(2008-10#4)
The 3sigma limit of detection##2##5##(2008-10#2)
The 3sigma##7##2##(2008-10#7)
The 4##4##2##(1992-3#1)(2011-2#3)
The 5##7##2##(1993-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2011-2#3)
The 5' end##2##3##(1996-6#1)(2008-12#1)
The 5' flanking regions of##2##5##(1992-3#1)(1993-6#1)
The 5' flanking##3##3##(1992-3#1)(1993-6#1)(1994-11#1)
The 5' terminus##2##3##(2008-10#1)(2008-11#1)
The 5'##13##2##(1991-7#1)(1991-9#1)(1992-3#1)(1993-6#2)(1994-11#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)
The 5'- and##2##3##(2008-10#2)
The 5'-flanking region##4##3##(1993-6#1)(1994-11#2)(1997-8#1)
The 5'-flanking##5##2##(1991-7#1)(1993-6#1)(1994-11#2)(1997-8#1)
The 5-HT7 receptor##2##3##(2008-5#2)
The 5-year survival rate was##2##5##(1997-7#2)
The 5-year##3##2##(1997-7#2)(2008-7#1)
The 50%##2##2##(2008-10#1)(2008-9#1)
The 5460S library##2##3##(2008-8#2)
The 6##4##2##(2008-11#2)(2011-2#2)
The 90% response time##2##4##(2008-10#2)
The 90%##3##2##(2008-10#3)
The 95%##4##2##(1991-2#1)(2008-10#2)(2012-2#1)
The A and B##2##4##(2008-10#2)
The A and##3##3##(2008-10#2)(2008-11#1)
The A##7##2##(1990-5#2)(1993-1#1)(2008-10#3)(2008-11#1)
The A1##2##2##(2008-10#1)(2008-12#1)
The A2##2##2##(2008-10#1)(2008-12#1)
The ABC##2##2##(1993-12#2)
The ABTS(+)##2##2##(2008-10#2)
The ACP##2##2##(1992-4#1)(1993-12#1)
The AF4Q initiative is##2##4##(2013-1#2)
The AFLP##2##2##(2008-10#2)
The AHRA Statistical Resource Committee presents the results of a recent survey of members about their job satisfaction##2##18##(1995-1#1)(1995-2#1)
The AI##2##2##(2008-10#1)(2013-1#1)
The AIDS##4##2##(1992-9#1)(1995-1#2)(1996-5#1)
The AMPA effect##2##3##(2008-8#2)
The ANN##2##2##(2008-10#1)(2010-8#1)
The AR##2##2##(1990-11#1)(2008-8#1)
The ATP##2##2##(1990-5#1)(1993-6#1)
The ATR##2##2##(2008-10#1)(2011-2#1)
The AUC for##2##3##(2008-7#2)
The AUC##3##2##(2008-11#1)(2008-7#2)
The Alberta##2##2##(1992-12#1)(2012-12#1)
The AlloMap test##2##3##(2008-10#2)
The American health care system--managed care##2##6##(1992-12#2)
The American##11##2##(1991-1#1)(1991-12#1)(1992-12#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
The Americans with Disabilities Act##6##5##(1991-12#1)(1993-1#3)(1994-1#2)
The Americans##7##2##(1991-12#2)(1993-1#3)(1994-1#2)
The Analysis of##2##3##(2008-10#1)(2010-1#1)
The Andrew Pattullo##2##3##(1992-3#1)(1996-2#1)
The Australian##3##2##(1992-1#1)(2008-10#1)(2011-2#1)
The Authors conclude that##2##4##(1990-5#1)(1992-9#1)
The Authors describe a case of##2##6##(1991-6#1)(1992-9#1)
The Authors describe a rare case of##2##7##(1991-3#1)(1992-9#1)
The Authors describe a##4##4##(1991-3#1)(1991-6#1)(1992-9#2)
The Authors describe##5##3##(1991-3#1)(1991-6#1)(1992-9#2)(1993-6#1)
The Authors emphasize the##2##4##(1992-9#1)(1993-6#1)
The Authors present##3##3##(1990-2#1)(1990-5#1)(1991-3#1)
The Authors report a case of##2##6##(1991-6#1)(1992-9#1)
The Authors report the##3##4##(1990-5#1)(1991-6#1)(1992-9#1)
The Authors report their experience##2##5##(1990-5#1)(1990-9#1)
The Authors report their##3##4##(1990-5#1)(1990-9#2)
The Authors report##8##3##(1990-5#2)(1990-9#2)(1991-6#2)(1992-9#2)
The Authors##31##2##(1990-2#1)(1990-3#2)(1990-5#5)(1990-9#4)(1991-3#5)(1991-6#4)(1992-9#6)(1993-6#2)(2013-1#2)
The B##2##2##(1993-11#1)(2008-10#1)
The BDD electrode provided##2##4##(2008-10#2)
The BDD electrode##3##3##(2008-10#3)
The BDD##4##2##(2008-10#3)(2012-12#1)
The BREH##2##2##(2008-11#2)
The Bacillus subtilis##2##3##(1995-6#1)(2009-8#1)
The Bacillus##3##2##(1995-6#1)(2009-8#1)(2011-2#1)
The Bali bombings##2##3##(2008-10#2)
The Basic Protocol describes##2##4##(2008-4#1)(2008-9#1)
The Basic Protocol##3##3##(2008-4#2)(2008-9#1)
The Basic##6##2##(1992-1#1)(1995-2#1)(2008-11#1)(2008-4#2)(2008-9#1)
The Baxter Foundation Prize address##3##5##(1992-3#1)(1997-2#1)(1997-3#1)
The Bland and Altman plot revealed##2##6##(2008-11#2)
The Bombyx bombyxin##2##3##(2008-6#2)
The British##4##2##(1991-6#1)(1992-2#1)(1995-9#1)(2012-12#1)
The ByT-FAS##2##2##(2008-10#2)
The C##2##2##(1991-5#1)(2008-5#1)
The C-terminal##2##2##(1994-5#1)(2008-9#1)
The C-terminus##2##2##(1991-7#1)(1993-8#1)
The C2##2##2##(1997-1#1)(2008-6#1)
The CA##4##2##(1994-12#1)(1995-11#1)(1995-3#1)(2008-11#1)
The CAD1##2##2##(2008-8#2)
The CALUX##2##2##(2008-10#2)
The CBCT##2##2##(2013-1#2)
The CC-516##2##2##(2008-5#2)
The CCSV##2##2##(2008-10#2)
The CD##2##2##(2008-10#1)(2008-4#1)
The CD-ROM##3##2##(1993-2#1)(2008-11#2)
The CDY##2##2##(2008-11#2)
The CE##2##2##(2008-10#2)
The CHO cell##2##3##(2008-11#1)(2008-8#1)
The CHO##3##2##(2008-11#2)(2008-8#1)
The CL emission##2##3##(2008-10#2)
The CL enhancement is##2##4##(2008-10#2)
The CL intensity was##2##4##(2008-10#2)
The CL signal produced by the reaction between luminol and##2##10##(2008-10#2)
The CL##16##2##(1991-2#1)(2008-10#15)
The CLIMEX model##2##3##(2008-10#2)
The CMC##2##2##(2008-10#2)
The CME##3##2##(2008-10#3)
The CO##2##2##(1992-1#1)(2008-3#1)
The CO(2) laser##2##3##(2012-3#2)
The CO(2)##3##2##(2008-10#1)(2012-3#2)
The COCH coating was##2##4##(2008-10#2)
The COCH coating##3##3##(2008-10#3)
The COMFORT-B and##2##3##(2012-2#2)
The CP amino acid##2##4##(2008-10#2)
The CP gene##2##3##(2008-10#1)(2008-8#1)
The CP##9##2##(2008-10#8)(2008-8#1)
The CT##4##2##(1997-8#2)(2012-2#1)(2013-1#1)
The Canadian##6##2##(1994-12#1)(1994-6#1)(2008-10#2)(2008-11#2)
The Caucus will##2##3##(1996-5#2)
The Cavitron Ultrasonic Surgical Aspirator##2##5##(1995-12#2)
The Center for##2##3##(2008-12#1)(2010-11#1)
The Centers for Disease Control and Prevention (CDC)##3##8##(1996-12#1)(1996-5#1)(1997-3#1)
The Centers for Disease Control and Prevention##4##7##(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)
The Cochrane Library##2##3##(2008-12#1)(2011-2#1)
The Cochrane##4##2##(1993-12#2)(2008-12#1)(2011-2#1)
The Community Medical Alliance##2##4##(1997-1#2)
The Community##3##2##(1997-1#2)(1997-4#1)
The Course##2##2##(2008-10#1)(2008-11#1)
The Court of Appeals##2##4##(1995-12#1)(1996-5#1)
The Court##3##2##(1993-9#1)(1995-12#1)(1996-5#1)
The Cr(VI) is##2##3##(2008-10#2)
The Cr(VI)##5##2##(2008-10#5)
The Cu(2+)##2##2##(2008-10#2)
The D(M)##2##2##(2008-10#2)
The D-MRI##2##2##(2011-2#2)
The D3 receptor##2##3##(1995-2#2)
The DIPD##3##2##(2008-10#3)
The DNA biosensor is assembled by##2##6##(2008-10#2)
The DNA damage##2##3##(2009-6#1)(2011-2#1)
The DNA fragmentation##2##3##(2008-8#2)
The DNA fragments##4##3##(1992-3#1)(1995-8#1)(2008-10#1)(2008-8#1)
The DNA of A##2##4##(2013-1#2)
The DNA sequence analysis##2##4##(1992-6#1)(2012-2#1)
The DNA sequence##4##3##(1992-6#1)(1997-2#1)(2008-10#1)(2012-2#1)
The DNA sequences##2##3##(1991-2#1)(2008-12#1)
The DNA##31##2##(1990-5#1)(1991-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-10#11)(2008-12#1)(2008-8#3)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
The DNA-binding##2##2##(1996-3#1)(2008-9#1)
The DNase##2##2##(1994-8#2)
The DP method##2##3##(2008-2#2)
The DPI##2##2##(2007-12#2)
The DSTD##2##2##(2008-10#2)
The Delphi##2##2##(2010-8#1)(2010-9#1)
The Department of##3##3##(1995-6#1)(2013-1#1)(2013-8#1)
The Diskus##2##2##(1996-2#2)
The Donnan##2##2##(2011-2#2)
The Doppler##2##2##(2008-3#2)
The Drosophila##4##2##(1993-2#1)(1993-9#1)(1995-2#1)(2008-9#1)
The Duke##2##2##(2012-3#2)
The Dynamics of##2##3##(2008-10#1)(2012-2#1)
The E(pa)##2##2##(2008-10#2)
The EC##2##2##(2008-10#2)
The EEG##3##2##(1990-9#1)(2008-7#2)
The ELISA##3##2##(1990-12#1)(2008-4#2)
The EMG##2##2##(2009-3#1)(2010-8#1)
The EMPIRE##2##2##(2008-11#2)
The EN##2##2##(2008-11#2)
The ENS and surrounding##2##4##(2008-8#2)
The ENS and##3##3##(2008-8#3)
The EP##2##2##(2008-10#2)
The ES##3##2##(2008-11#2)(2008-8#1)
The ESR##3##2##(2008-10#2)(2012-2#1)
The Effect of##4##3##(2008-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
The Effects of##4##3##(2008-10#1)(2008-3#1)(2010-10#1)(2012-3#1)
The English##2##2##(2008-11#1)(2013-8#1)
The Epstein-Barr virus##2##3##(1993-8#1)(1997-3#1)
The Equal Employment Opportunity Commission (EEOC)##2##6##(1995-12#1)(1995-6#1)
The Er##2##2##(2008-7#2)
The Escherichia coli##2##3##(1993-12#1)(2008-7#1)
The Etest##2##2##(2008-7#2)
The European##8##2##(1992-1#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)
The FBB##2##2##(2008-11#2)
The FDA##2##2##(1992-9#1)(2008-5#1)
The FI method was##2##4##(2008-10#2)
The FI method##3##3##(2008-10#3)
The FI##5##2##(2008-10#5)
The FIA##3##2##(2008-10#3)
The FTIR##2##2##(2008-10#2)
The Father of##2##3##(2008-10#1)(2010-8#1)
The First##2##2##(2008-10#1)(2011-2#1)
The Flu-6plx assay##2##3##(2011-2#2)
The Food and Drug Administration (FDA)##2##6##(1996-5#1)(2010-6#1)
The Fourier##2##2##(2008-11#1)(2008-3#1)
The French##2##2##(2008-5#1)(2012-3#1)
The Freundlich constants 1/n and##2##5##(2008-10#2)
The Future of Public Health##2##5##(1996-1#2)
The GC x GC##2##4##(2008-10#2)
The GC##3##2##(2008-10#3)
The Gateway cloning method allows a gene to be cloned and subsequently transferred into any vector by in vitro site-specific##2##20##(2008-4#2)
The Genetic Structure of##2##4##(2008-10#2)
The Georgia Information Network for Public Health Officials##2##8##(1996-1#2)
The Georgia##3##2##(1996-1#3)
The Gibbs conference on biothermodynamics##2##5##(1997-2#2)
The Gibbs##3##2##(1997-2#2)(2011-1#1)
The Gompertz##3##2##(2008-10#3)
The Group##3##2##(1997-5#1)(2008-10#1)(2013-1#1)
The H(2)O(2)##2##2##(2008-10#2)
The H-Wave(R) device##2##3##(2010-1#2)
The H-point standard addition method (HPSAM)##3##6##(2008-10#3)
The H-point##4##2##(2008-10#4)
The HAPC sheet##2##3##(2008-11#2)
The HC##2##2##(2008-10#2)
The HCB##2##2##(2008-10#2)
The HEART score##2##3##(2012-2#2)
The HF-HR-IMS##2##2##(2008-10#2)
The HIV##2##2##(1990-6#1)(1993-11#1)
The HIV-1##2##2##(2011-3#1)(2013-1#1)
The HMK and HSK genes##2##5##(1993-12#2)
The HMK##3##2##(1993-12#3)
The HPI is##2##3##(1992-12#2)
The HPLC method##3##3##(2008-10#2)(2011-1#1)
The HPLC##4##2##(2008-10#3)(2011-1#1)
The HPLC-EC method##2##3##(2008-10#2)
The HbO-HA ELISA##2##3##(1990-12#2)
The Health Care Financing Administration (HCFA) has##2##7##(1992-2#1)(1996-2#1)
The Health Care Financing Administration (HCFA)##3##6##(1992-2#1)(1996-2#1)(1997-2#1)
The Health Care Financing Administration##4##5##(1992-2#2)(1996-2#1)(1997-2#1)
The Health Care Financing##5##4##(1992-2#2)(1996-2#2)(1997-2#1)
The Health Care##6##3##(1992-1#1)(1992-2#2)(1996-2#2)(1997-2#1)
The Health##12##2##(1991-2#1)(1992-1#1)(1992-2#2)(1995-2#1)(1996-2#2)(1997-2#1)(1997-6#1)(2008-11#1)(2012-2#1)(2013-1#1)
The Hospital for##2##3##(2008-11#1)(2008-8#1)
The House of Representatives approved a##2##6##(1996-5#2)
The House of Representatives approved##3##5##(1995-6#1)(1996-5#2)
The House##7##2##(1995-6#3)(1996-5#4)
The Human Figure Drawing##2##4##(2008-7#2)
The Human Genome Project##2##4##(1994-9#1)(2008-5#1)
The Human Rights##2##3##(1995-12#1)(2008-11#1)
The Human##7##2##(1994-9#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#3)
The IC50 for##3##3##(1991-5#1)(1992-6#1)(1994-11#1)
The IC50 values of##2##4##(1995-11#1)(2008-11#1)
The IC50##5##2##(1991-5#1)(1992-6#1)(1994-11#1)(1995-11#1)(2008-11#1)
The ICC of left and right CSA for within day and between days reliability in##2##15##(2010-12#2)
The ICC of##3##3##(2010-12#2)(2011-2#1)
The IFN##2##2##(1995-12#1)(2008-11#1)
The IL-1-dependent proliferation of RPMI 1788##2##6##(1990-12#2)
The IMS##2##2##(2008-10#2)
The IR##4##2##(1996-5#1)(2008-10#2)(2008-7#1)
The ITS sequences##2##3##(2008-10#2)
The ITS##4##2##(2008-10#4)
The IgG##2##2##(1996-2#1)(2008-11#1)
The Impact of##3##3##(2009-12#1)(2012-3#1)(2013-1#1)
The Independent##2##2##(1995-2#1)(2012-3#1)
The Influence of##4##3##(2008-5#1)(2008-6#1)(2009-8#1)(2012-2#1)
The Institute##3##2##(1996-1#1)(2013-1#1)(2013-8#1)
The International Classification of##2##4##(1991-9#1)(2012-12#1)
The International##9##2##(1991-9#1)(1995-3#1)(1997-3#1)(2008-10#2)(2009-4#1)(2010-7#1)(2012-12#1)(2012-3#1)
The Internet as##2##3##(2009-5#1)(2013-1#1)
The Internet is##2##3##(1994-3#1)(1996-2#1)
The Internet##6##2##(1994-3#1)(1996-2#2)(1997-3#1)(2009-5#1)(2013-1#1)
The Interuniversity Consortium##2##3##(2008-11#2)
The Italian##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
The JCVI##2##2##(2011-2#2)
The Johns Hopkins Health System##2##5##(1993-3#2)
The Johns Hopkins##3##3##(1993-3#3)
The Joint##4##2##(1995-1#1)(1996-3#1)(2011-4#1)(2012-2#1)
The Journal##2##2##(2009-8#1)(2011-4#1)
The K(M(B18C6)A) value##2##3##(2008-10#2)
The K(MLA)##2##2##(2008-10#2)
The K(ex) value##2##3##(2008-10#2)
The K(ex)##3##2##(2008-10#3)
The K(m)##2##2##(2008-10#1)(2011-3#1)
The Kd##2##2##(1994-5#1)(1995-11#1)
The Kefir extract##2##3##(2008-11#2)
The Ki values for##2##4##(1992-3#1)(1992-6#1)
The Ki values##4##3##(1992-12#1)(1992-3#1)(1992-6#1)(1995-11#1)
The Km for##2##3##(1992-6#1)(1993-8#1)
The Km##5##2##(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1997-8#1)
The L##2##2##(2008-10#2)
The LB##2##2##(2008-10#2)
The LC##2##2##(2007-12#1)(2008-10#1)
The LC-MS/MS method##2##3##(2008-10#1)(2011-3#1)
The LDL##2##2##(1991-2#1)(1994-11#1)
The LED##2##2##(2008-10#2)
The LFD was##2##3##(2008-10#2)
The LOD for##3##3##(2008-10#3)
The LOD of##3##3##(2008-10#3)
The LOD was found to be##2##6##(2008-10#2)
The LOD##12##2##(2008-10#12)
The LODs##2##2##(2008-10#1)(2010-5#1)
The Log##2##2##(2008-3#2)
The Ly-49##2##2##(1995-2#2)
The M RNA##2##3##(2008-10#2)
The M##5##2##(2008-10#4)(2012-2#1)
The MDI##2##2##(1996-1#2)
The MEI##3##2##(1992-2#3)
The MHV-RI##2##2##(1997-3#2)
The MIC values of##2##4##(2008-11#2)
The MIC##4##2##(2008-11#2)(2008-5#1)(2011-2#1)
The MICs ranges of##2##4##(2008-5#2)
The MP##3##2##(2008-10#2)(2008-9#1)
The MR findings##2##3##(2012-2#2)
The MR##4##2##(1997-8#2)(2012-2#2)
The MRI findings##2##3##(1996-11#1)(2012-12#1)
The MRI was more##2##4##(2008-3#2)
The MRI##9##2##(1996-11#1)(1996-6#1)(2008-10#1)(2008-3#3)(2010-6#1)(2012-12#1)(2013-1#1)
The MS##2##2##(2008-10#2)
The MSFA##2##2##(2008-10#2)
The MT##2##2##(2008-11#2)
The Malcolm Baldrige National Quality Award##2##6##(1995-2#2)
The Medical##3##2##(1991-8#1)(2011-2#1)(2013-1#1)
The Medicare Current Beneficiary Survey (MCBS)##2##6##(1996-2#1)(1997-3#1)
The Medicare##10##2##(1991-2#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)
The Mexican##2##2##(2008-10#1)(2008-8#1)
The Michaelis-Menten constant##2##3##(2008-10#1)(2009-10#1)
The Michigan##3##2##(1996-3#1)(2008-10#1)(2013-1#1)
The Middle East##2##3##(1995-3#2)
The Molecular##2##2##(2008-10#1)(2008-4#1)
The Montreal Protocol##2##3##(1996-1#2)
The N##3##2##(2008-10#3)
The N-aryl-2-[[[5-[(dimethylamino)methyl]-2-##2##2##(1992-8#2)
The N-terminal sequence of##2##4##(1991-10#1)(2008-10#1)
The N-terminal##7##2##(1990-5#1)(1991-10#1)(1992-6#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
The NADH reductase##2##3##(2008-11#2)
The NAS##2##2##(2008-10#2)
The NDI##2##2##(2012-3#2)
The NH2-terminal amino acid sequence##2##5##(1990-8#1)(1995-6#1)
The NMR##7##2##(1992-3#1)(1993-1#1)(1993-8#1)(1994-3#1)(1996-5#1)(2008-10#1)(2009-7#1)
The NO(2)##2##2##(2008-10#2)
The NSCs cultured in##2##4##(2008-11#2)
The NSCs population cultured in##2##5##(2008-11#2)
The NSCs##4##2##(2008-11#4)
The Na(+)##3##2##(2008-10#3)
The National Association of Private Psychiatric Hospitals (NAPPH)##2##8##(1991-1#1)(1992-2#1)
The National Association of Private Psychiatric Hospitals##3##7##(1991-1#2)(1992-2#1)
The National Association of##4##4##(1991-1#2)(1992-2#1)(1996-5#1)
The National Cancer Institute##2##4##(2008-9#1)(2013-1#1)
The National Heart##2##3##(1992-12#1)(2013-1#1)
The National Institute##3##3##(1996-6#1)(2013-1#2)
The National##23##2##(1991-1#2)(1991-3#1)(1992-12#1)(1992-2#1)(1994-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-3#1)(2013-1#4)
The Netherlands##9##2##(1990-3#2)(1991-8#1)(1994-12#1)(1996-11#2)(1997-8#1)(2008-10#1)(2008-11#1)
The New York City##2##4##(2008-10#1)(2011-2#1)
The New York Supreme Court##2##5##(1995-2#1)(1995-6#1)
The New York##5##3##(1994-2#1)(1995-2#1)(1995-6#1)(2008-10#1)(2011-2#1)
The New Zealand##3##3##(1992-1#1)(2008-1#1)(2008-11#1)
The New##11##2##(1992-1#1)(1994-2#1)(1995-2#1)(1995-6#2)(2008-1#1)(2008-10#1)(2008-11#3)(2011-2#1)
The Ni##2##2##(2008-10#2)
The NifA protein##2##3##(2008-9#2)
The Nordic##2##2##(2011-4#2)
The North##2##2##(2008-10#1)(2010-5#1)
The Norwegian study##2##3##(1991-9#2)
The Norwegian##7##2##(1990-11#1)(1991-9#2)(1996-11#1)(1997-8#2)(2009-10#1)
The Nursing Diagnosis Accuracy Scale##2##5##(2013-1#2)
The O-buffer##2##2##(2008-6#2)
The OPO is##2##3##(2008-3#2)
The OPO##5##2##(2007-12#2)(2008-3#3)
The ORF##2##2##(2008-10#2)
The Oregon Medicaid##3##3##(1992-2#2)(1992-9#1)
The Oregon##4##2##(1992-2#3)(1992-9#1)
The OsMADS7 and 8##3##4##(1997-8#3)
The Ottawa##2##2##(1995-12#1)(2008-11#1)
The Oxford##2##2##(1996-1#1)(2011-2#1)
The P##2##2##(2008-10#2)
The P(V) of the##2##4##(2008-11#2)
The P-450##2##2##(1993-8#1)(2008-11#1)
The PAHs##2##2##(2008-10#2)
The PBD##2##2##(1992-12#2)
The PCA##3##2##(2008-10#3)
The PCCC##2##2##(2010-6#2)
The PCR products##4##3##(1992-8#1)(1993-3#1)(2008-10#1)(2008-9#1)
The PCR##10##2##(1991-5#1)(1992-8#1)(1993-3#1)(1995-6#1)(2008-10#3)(2008-8#1)(2008-9#2)
The PD##2##2##(2008-10#1)(2011-2#1)
The PDL##2##2##(2008-11#1)(2013-1#1)
The PDSI##2##2##(2008-7#2)
The PEG hydrogel dural sealant##2##5##(2012-3#2)
The PI##3##2##(1996-2#1)(2008-10#1)(2009-3#1)
The PLS-1##3##2##(2008-10#3)
The PP and CP viruses were most##2##7##(2008-10#2)
The PP##3##2##(2008-10#2)(2008-11#1)
The Pennsylvania##2##2##(1992-1#1)(1995-12#1)
The Phazyme##2##2##(2012-2#2)
The Phytophthora##2##2##(2008-10#2)
The Pi-ta##2##2##(2008-10#2)
The Pi34 locus##2##3##(2008-10#2)
The Public Health##2##3##(1995-12#1)(1996-2#1)
The Publisher apologizes for any inconvenience this may cause##4##9##(2008-10#1)(2008-11#3)
The Publisher regrets that this article is an accidental duplication of an article that has already been published in##3##19##(2008-11#3)
The Publisher regrets that this article is an accidental duplication of an article that has already been published##4##18##(2008-11#3)(2012-3#1)
The Publisher regrets that this article##5##6##(2008-11#4)(2012-3#1)
The Publisher##9##2##(2008-10#1)(2008-11#7)(2012-3#1)
The QOL##2##2##(1994-12#2)
The QTL on LG2##2##4##(2008-10#2)
The QTL on##5##3##(2008-10#5)
The QTL##6##2##(2008-10#5)(2012-3#1)
The QuickVue##2##2##(2011-2#2)
The R##18##2##(2008-10#18)
The RB##2##2##(1996-2#1)(2013-1#1)
The RBC##2##2##(2013-1#2)
The RI##2##2##(2008-10#2)
The RILs were##2##3##(2008-10#2)
The RNA genome of##2##4##(2008-9#1)(2013-1#1)
The RNA##6##2##(1992-3#1)(2008-10#1)(2008-8#1)(2008-9#2)(2013-1#1)
The RNN is trained##2##4##(2010-8#2)
The RRS##2##2##(2008-10#2)
The RSD is##2##3##(2008-10#2)
The RSD of the##2##4##(2008-10#2)
The RSD was 1##2##4##(2008-10#2)
The RSD was##3##3##(2008-10#3)
The RSD##8##2##(2008-10#8)
The RT-PCR##2##2##(2008-5#2)
The Rainbow Families Scale (RFS)##2##5##(2012-2#2)
The Raman spectra##2##3##(2008-10#2)
The Raman##3##2##(2008-10#2)(2009-12#1)
The Relationship between##2##3##(1996-6#1)(2012-3#1)
The Relationship##4##2##(1996-6#1)(2008-10#1)(2012-3#1)(2013-8#1)
The Ritz-Carlton Hotel Company (Part##2##5##(1994-2#1)(1994-3#1)
The Ritz-Carlton Hotel Company won the Malcolm##2##7##(1994-2#1)(1994-3#1)
The Ritz-Carlton Hotel Company##4##4##(1994-2#2)(1994-3#2)
The Role of##8##3##(2008-10#4)(2012-2#2)(2012-3#2)
The S##4##2##(1997-7#1)(2008-10#2)(2011-2#1)
The SEM##3##2##(2008-10#3)
The SI system was##2##4##(2008-10#2)
The SI##4##2##(2008-10#4)
The SIA##2##2##(2008-10#2)
The SNP module##2##3##(2012-3#2)
The SPE##3##2##(2008-10#3)
The SPME method##2##3##(2008-10#2)
The SPR sensor##2##3##(2008-10#2)
The SPR##4##2##(2008-10#4)
The STLCV##2##2##(2008-10#2)
The STS markers##3##3##(2008-10#3)
The School of Nursing##3##4##(2008-11#2)(2008-12#1)
The Sea-viewing Wide Field-of-view Sensor (SeaWiFS)##2##6##(2008-2#1)(2008-3#1)
The Senate##2##2##(1996-5#1)(1997-2#1)
The Short-Form 36##2##3##(2010-10#1)(2013-1#1)
The Sisters##3##2##(1991-2#2)(1994-2#1)
The Southern##2##2##(1995-11#1)(2008-9#1)
The State##2##2##(1991-3#1)(1996-5#1)
The Stern-Volmer##2##2##(2008-10#2)
The Subjective Exercise Experiences Scale##2##5##(2010-6#2)
The T##8##2##(1993-1#1)(1993-8#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
The TPLO##2##2##(2012-3#2)
The TRA##2##2##(2011-1#1)(2011-2#1)
The TSPO##2##2##(2012-2#2)
The Theory of##2##3##(1993-3#1)(2011-1#1)
The Trx##2##2##(1991-6#1)(2009-3#1)
The U##10##2##(1992-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-11#1)(2013-1#1)
The UK has##2##3##(1990-6#1)(2008-11#1)
The UK##3##2##(1990-6#1)(2008-11#2)
The UKCC Commission for Nursing and Midwifery Education##2##8##(2008-11#2)
The US##2##2##(2010-1#1)(2010-7#1)
The UV##2##2##(2008-10#2)
The United Kingdom Central Council##2##5##(2008-11#2)
The United States has##2##4##(1995-2#1)(2009-3#1)
The United States##3##3##(1995-2#1)(1996-9#1)(2009-3#1)
The United##7##2##(1993-12#1)(1995-2#1)(1996-9#1)(2008-11#2)(2009-3#1)(2012-3#1)
The University of##7##3##(1992-1#1)(1994-2#1)(1997-2#1)(2008-11#3)(2008-5#1)
The Use of##2##3##(2008-10#2)
The V(c)##2##2##(2008-10#2)
The VCG##2##2##(2008-10#1)(2010-8#1)
The VI##2##2##(2008-10#2)
The VLDL receptor##2##3##(1995-6#2)
The Veterans##2##2##(1991-12#2)
The WHO##4##2##(1993-3#2)(2008-10#1)(2008-11#1)
The WHOQOL-BREF##2##2##(2011-2#2)
The WRAP##5##2##(2008-11#5)
The Weibull distribution##2##3##(2008-10#2)
The Weibull##4##2##(2008-10#4)
The Wickbold decomposition method##2##4##(2008-10#2)
The Working Group##2##3##(1993-5#1)(1997-5#1)
The World Anti-Doping##2##3##(2010-7#2)
The World Health Organization##5##4##(1993-11#1)(1995-3#1)(2008-1#1)(2008-7#1)(2010-5#1)
The World Health##6##3##(1993-11#1)(1995-3#1)(2008-1#1)(2008-7#1)(2010-5#1)(2010-8#1)
The World##12##2##(1993-11#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)
The X##3##2##(2008-10#3)
The X-linked##2##2##(2008-11#1)(2008-12#1)
The YAP+##2##2##(2008-9#2)
The [(triisopropylsilyl)oxy]methyl (TOM) group is a useful protecting group for the 2'-OH of ribonucleosides to be used for oligoribonucleotide synthesis by the phosphoramidite method##2##24##(2008-4#2)
The [Ca2+]i##2##2##(1994-5#1)(1996-2#1)
The [SiO(2)]/[Al(2)O(3)] ratio##2##3##(2008-10#2)
The aa##2##2##(1990-11#1)(2008-10#1)
The abdominal##4##2##(1991-12#1)(1991-2#1)(2010-12#1)(2011-2#1)
The abilities##2##2##(2008-6#1)(2009-8#1)
The ability of a##2##4##(2008-5#1)(2012-12#1)
The ability of the new##3##5##(2008-10#1)(2008-3#1)(2009-5#1)
The ability of the##13##4##(1994-11#1)(1994-8#1)(1997-3#1)(2008-10#6)(2008-2#1)(2008-3#2)(2009-5#1)
The ability of##53##3##(1990-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-2#1)(1997-3#1)(2008-10#25)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
The ability to construct##2##4##(2008-10#1)(2008-4#1)
The ability to discriminate##2##4##(2008-9#1)(2009-12#1)
The ability to identify##3##4##(2008-10#2)(2012-12#1)
The ability to produce##2##4##(1996-3#1)(2008-10#1)
The ability to##41##3##(1990-12#1)(1990-5#1)(1991-12#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#2)(2010-6#2)(2010-7#1)(2011-7#1)(2012-12#1)
The ability##96##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2008-1#1)(2008-10#36)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-1#2)(2010-6#2)(2010-7#1)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
The above results##4##3##(2008-7#1)(2008-9#2)(2009-8#1)
The above##14##2##(1990-5#1)(1996-8#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-3#1)
The above-mentioned##4##2##(2008-10#1)(2009-11#1)(2009-6#1)(2011-3#1)
The absence of a##2##4##(2008-8#1)(2009-10#1)
The absence of##15##3##(1994-2#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-8#1)(2009-10#1)(2012-3#1)
The absolute EC50/IC50##2##3##(2012-2#2)
The absolute values of##2##4##(2008-8#2)
The absolute##12##2##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-2#2)
The absorbance at##2##3##(2008-10#2)
The absorbance intensity was##2##4##(2008-10#2)
The absorbance of the##13##4##(2008-10#13)
The absorbance of##14##3##(2008-10#14)
The absorbance##22##2##(2008-10#22)
The absorption maxima##2##3##(1994-5#1)(2008-11#1)
The absorption occurred in the postflame region##2##7##(2008-2#1)(2008-3#1)
The absorption spectra##2##3##(2008-10#2)
The absorption##15##2##(1994-5#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#3)(2011-3#1)
The abstract is##2##3##(2009-4#2)
The abundance of##3##3##(1995-2#1)(2008-10#1)(2009-10#1)
The abundance##5##2##(1995-2#1)(2008-10#3)(2009-10#1)
The accessory##5##2##(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
The accumulation of##13##3##(1991-5#1)(1994-12#1)(1995-11#1)(1997-7#2)(2008-10#5)(2008-11#2)(2013-8#1)
The accumulation##14##2##(1991-5#1)(1994-12#1)(1995-11#1)(1997-7#2)(2008-10#6)(2008-11#2)(2013-8#1)
The accumulation-export trade-off##2##3##(2008-8#2)
The accuracy and precision are##2##5##(2008-10#2)
The accuracy and precision of the##3##6##(2008-10#3)
The accuracy and precision of##4##5##(2008-10#4)
The accuracy and precision##7##4##(2008-10#7)
The accuracy and##11##3##(1997-7#1)(2008-10#10)
The accuracy of procedure was confirmed by##2##7##(2008-10#2)
The accuracy of the developed method was sufficient and evaluated by the analysis of##2##14##(2008-10#2)
The accuracy of the developed method was##3##7##(2008-10#3)
The accuracy of the developed procedure##2##6##(2008-10#2)
The accuracy of the developed##7##5##(2008-10#7)
The accuracy of the method is##2##6##(2008-10#2)
The accuracy of the method was demonstrated by##2##8##(2008-10#2)
The accuracy of the method was evaluated##2##7##(2008-10#2)
The accuracy of the method was tested##2##7##(2008-10#2)
The accuracy of the method was##11##6##(2008-10#11)
The accuracy of the method##14##5##(2008-10#14)
The accuracy of the methods was##2##6##(2008-10#2)
The accuracy of the overall##2##5##(2008-10#2)
The accuracy of the proposed method was evaluated by##3##9##(2008-10#3)
The accuracy of the proposed method was##4##7##(2008-10#4)
The accuracy of the proposed method##5##6##(2008-10#5)
The accuracy of the proposed##6##5##(2008-10#6)
The accuracy of the##45##4##(1996-6#1)(2008-10#39)(2008-3#3)(2008-6#1)(2010-7#1)
The accuracy of this diagnosis has been underexplored in the literature##2##11##(2013-1#2)
The accuracy of this##3##4##(2008-6#1)(2013-1#2)
The accuracy of##60##3##(1996-6#1)(2008-10#45)(2008-3#4)(2008-6#4)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
The accuracy was assessed through recovery experiments##3##7##(2008-10#3)
The accuracy was assessed##5##4##(2008-10#5)
The accuracy was checked for arsenic determination in##2##8##(2008-10#2)
The accuracy was checked for##3##5##(2008-10#3)
The accuracy was checked##4##4##(2008-10#4)
The accuracy was confirmed by analysis of##3##7##(2008-10#3)
The accuracy was##15##3##(1997-8#1)(2008-10#13)(2008-7#1)
The accuracy##93##2##(1996-6#1)(1997-7#1)(1997-8#1)(2008-10#74)(2008-3#4)(2008-6#4)(2008-7#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
The accurate diagnosis##2##3##(1994-1#1)(2012-3#1)
The accurate##5##2##(1994-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
The achieved limits of detection##2##5##(2008-10#2)
The achieved results##2##3##(2008-10#2)
The achieved##8##2##(2008-10#7)(2011-2#1)
The achievement of##2##3##(2008-5#1)(2009-7#1)
The acid dissociation##2##3##(1990-5#1)(2008-10#1)
The acid##6##2##(1990-5#1)(1996-3#2)(2008-10#3)
The acid-base##4##2##(2008-10#4)
The acidic protease##2##3##(1993-12#2)
The acidic##6##2##(1993-12#2)(1994-5#1)(1995-6#1)(1997-2#1)(2008-10#1)
The acidity##2##2##(2008-10#2)
The acquisition of##2##3##(2008-12#1)(2008-9#1)
The acrosome##2##2##(2008-7#1)(2012-2#1)
The actin filaments##2##3##(2008-11#2)
The actin##4##2##(2008-11#3)(2009-12#1)
The action of##7##3##(1994-11#1)(1994-3#1)(1994-5#1)(2008-10#2)(2011-2#1)(2012-2#1)
The action##8##2##(1994-11#1)(1994-3#1)(1994-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
The actions of##2##3##(1991-6#1)(2010-5#1)
The actions##3##2##(1991-6#1)(2010-5#1)(2013-1#1)
The activated##2##2##(1993-8#1)(1996-2#1)
The activation energy##4##3##(1991-5#1)(2008-10#2)(2009-7#1)
The activation of the##2##4##(1994-6#1)(2010-7#1)
The activation of##8##3##(1992-6#1)(1994-6#1)(2007-12#1)(2008-11#3)(2008-7#1)(2010-7#1)
The activation was##2##3##(2008-5#1)(2008-7#1)
The activation##18##2##(1991-5#1)(1992-6#1)(1994-6#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#2)(2008-9#3)(2009-7#1)(2010-7#1)
The active component of##2##4##(1995-12#1)(2008-11#1)
The active metabolite of vitamin D##2##6##(1992-1#1)(1995-2#1)
The active site of##2##4##(1992-4#1)(1995-8#1)
The active##17##2##(1991-9#1)(1992-1#1)(1992-4#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#5)(2008-11#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-9#1)
The activities documented in this case study arose as a result of a decision by hospital administration that it would be more cost effective to provide services with in-house departments rather than through outside vendors##2##35##(1994-1#2)
The activities of these##2##4##(2008-10#1)(2008-11#1)
The activities of##9##3##(1994-3#1)(2008-10#2)(2008-11#3)(2008-7#1)(2011-2#1)(2013-1#1)
The activities##12##2##(1990-8#1)(1994-1#2)(1994-3#1)(2008-10#2)(2008-11#3)(2008-7#1)(2011-2#1)(2013-1#1)
The activity of the##12##4##(1990-5#2)(1991-5#1)(1992-6#1)(1993-8#1)(1994-8#1)(2008-10#4)(2008-11#2)
The activity of these enzymes##2##5##(2008-10#1)(2008-11#1)
The activity of##31##3##(1990-3#1)(1990-5#3)(1991-5#2)(1992-12#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(2008-10#9)(2008-11#7)(2008-5#1)(2008-8#2)(2009-8#1)
The activity to##2##3##(1992-8#1)(2008-10#1)
The activity was##2##3##(1991-2#1)(2008-10#1)
The activity##37##2##(1990-3#1)(1990-5#3)(1991-2#1)(1991-5#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(2008-10#11)(2008-11#8)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)
The actual##6##2##(1991-2#1)(2008-10#3)(2008-8#1)(2010-3#1)
The actuarial overall survival##2##4##(1991-8#1)(1994-12#1)
The actuarial##3##2##(1991-6#1)(1991-8#1)(1994-12#1)
The acute##3##2##(1994-12#1)(2010-1#1)(2010-2#1)
The adaptive##4##2##(1997-2#1)(2008-7#1)(2008-9#1)(2009-8#1)
The added##2##2##(1993-12#1)(2008-10#1)
The addition of a##6##4##(1993-1#1)(2008-10#4)(2010-4#1)
The addition of either##2##4##(1995-6#1)(2008-10#1)
The addition of flaxseed flour##2##5##(2010-4#2)
The addition of sodium##2##4##(2008-10#1)(2011-2#1)
The addition of the signal sequence##2##6##(2008-11#2)
The addition of the##7##4##(1995-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-4#1)
The addition of##52##3##(1990-9#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-12#2)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#18)(2008-11#5)(2008-5#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#5)(2011-2#2)(2012-2#2)(2013-1#2)
The additional##5##2##(1993-8#1)(2008-10#2)(2008-9#1)(2010-6#1)
The address is##2##3##(1996-8#2)
The adenosine##2##2##(1997-1#1)(2010-1#1)
The adenylyl cyclase##2##3##(1995-11#1)(2008-9#1)
The adequate##2##2##(2008-10#1)(2011-2#1)
The adhesive##3##2##(1994-9#1)(2008-11#1)(2008-5#1)
The adjusted average per capita cost (AAPCC)##2##7##(1991-3#1)(1993-3#1)
The adjusted##6##2##(1991-3#1)(1991-6#1)(1993-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
The adjustment##3##2##(1992-12#1)(2010-7#1)(2013-8#1)
The administration of the##2##4##(1996-12#1)(2008-7#1)
The administration of##9##3##(1990-6#1)(1991-12#1)(1994-8#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-7#2)(2011-2#1)
The administration##11##2##(1990-6#1)(1991-1#1)(1991-12#1)(1994-8#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-7#2)(2011-2#2)
The administrative##2##2##(1993-2#1)(2008-11#1)
The adoption of##2##3##(2008-1#1)(2011-2#1)
The adoption##3##2##(1991-12#1)(2008-1#1)(2011-2#1)
The adsorbed complexes##2##3##(2008-10#2)
The adsorbed##7##2##(2008-10#7)
The adsorbents##2##2##(1997-2#1)(2008-10#1)
The adsorption and##2##3##(2008-10#2)
The adsorption behavior of##3##4##(2008-10#3)
The adsorption capacity of the##2##5##(2008-10#2)
The adsorption capacity of##4##4##(2008-10#4)
The adsorption mechanism of the##2##5##(2008-10#1)(2011-2#1)
The adsorption of Cu(II) and##2##5##(2008-10#1)(2013-1#1)
The adsorption of heavy metal ions##2##6##(2008-10#2)
The adsorption of heavy metal##3##5##(2008-10#2)(2013-1#1)
The adsorption of vanadium##2##4##(2008-10#2)
The adsorption of##17##3##(2008-10#15)(2013-1#2)
The adsorption##36##2##(2008-10#32)(2011-2#2)(2013-1#2)
The adsorptive##4##2##(2008-10#4)
The advanced##2##2##(2008-10#1)(2008-7#1)
The advancement of##2##3##(2010-6#2)
The advantage of this method is that##2##7##(2008-10#2)
The advantage of##10##3##(1995-1#1)(1997-7#1)(2008-10#6)(2008-11#2)
The advantages and disadvantages of##3##5##(1997-2#1)(2008-10#1)(2009-7#1)
The advantages and drawbacks of##3##5##(2008-10#2)(2012-12#1)
The advantages and drawbacks##4##4##(2008-10#2)(2009-12#1)(2012-12#1)
The advantages and limitations of##2##5##(2008-10#2)
The advantages and##9##3##(1997-2#1)(2008-10#5)(2009-12#1)(2009-7#1)(2012-12#1)
The advantages of the proposed##2##5##(2008-10#1)(2008-3#1)
The advantages of the##5##4##(2008-10#3)(2008-3#1)(2010-6#1)
The advantages of this amperometric detector are##2##7##(2008-10#2)
The advantages of this##6##4##(1994-8#1)(2007-11#1)(2008-10#4)
The advantages of using##3##4##(2008-10#3)
The advantages of##18##3##(1994-8#1)(2007-11#1)(2008-10#13)(2008-3#2)(2010-6#1)
The advantages##30##2##(1994-8#1)(1997-2#2)(2007-11#1)(2008-10#18)(2008-3#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-5#1)(2010-6#1)(2012-12#1)
The advent of the##2##4##(1994-12#1)(2008-10#1)
The advent of##12##3##(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
The advent##13##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
The adverse effect of##3##4##(2008-10#1)(2008-11#2)
The adverse##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
The aetiology of this##2##4##(2008-12#1)(2008-9#1)
The aetiology of##4##3##(1997-8#1)(2008-12#1)(2008-9#1)(2010-12#1)
The aetiology##6##2##(1992-5#1)(1993-6#1)(1997-8#1)(2008-12#1)(2008-9#1)(2010-12#1)
The affected##2##2##(1991-9#1)(2010-11#1)
The affinity constant##2##3##(2008-10#2)
The affinity of##4##3##(1993-8#2)(2008-10#1)(2008-5#1)
The affinity##8##2##(1993-8#2)(2008-10#4)(2008-5#1)(2008-7#1)
The aforementioned##3##2##(2008-10#2)(2012-12#1)
The agarose##2##2##(1993-8#1)(2008-10#1)
The age of the patients ranged from##2##7##(2012-12#1)(2013-1#1)
The age of the##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
The age of##8##3##(2008-10#3)(2008-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
The age##14##2##(1990-6#1)(1991-2#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
The age-specific##3##2##(1994-12#1)(1997-7#1)(2008-8#1)
The agent##2##2##(2008-10#1)(2008-5#1)
The aggressiveness of##4##3##(2008-10#4)
The aggressiveness##5##2##(2008-10#5)
The aging##2##2##(1991-3#1)(2013-8#1)
The agreement between the##2##4##(2008-10#1)(2008-3#1)
The agreement between##4##3##(2008-10#1)(2008-3#3)
The agreement##6##2##(2008-10#2)(2008-3#3)(2008-5#1)
The aim is to##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
The aim of our investigation was to##3##7##(2008-11#1)(2008-7#1)(2009-8#1)
The aim of our study is to##3##7##(2008-11#1)(2011-2#1)(2011-7#1)
The aim of our study was to evaluate the##2##9##(2011-2#1)(2012-3#1)
The aim of our study was to##11##7##(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-6#1)(2013-1#3)
The aim of our study was##12##6##(1990-5#1)(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-6#1)(2013-1#3)
The aim of our study##15##5##(1990-5#1)(2008-11#1)(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-3#1)(2012-6#1)(2013-1#3)
The aim of our##21##4##(1990-5#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)
The aim of the current##2##5##(2010-10#1)(2012-2#1)
The aim of the paper is to##2##7##(2012-3#1)(2013-1#1)
The aim of the paper is##3##6##(2008-12#1)(2012-3#1)(2013-1#1)
The aim of the present study is to##6##8##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2013-1#1)
The aim of the present study is##7##7##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-5#1)(2013-1#1)
The aim of the present study was to determine the##2##10##(2008-10#1)(2011-1#1)
The aim of the present study was to evaluate the##6##10##(2008-5#2)(2010-3#1)(2013-1#3)
The aim of the present study was to examine the##2##10##(1992-2#1)(2010-6#1)
The aim of the present study was to examine##4##9##(1992-2#1)(2010-10#1)(2010-6#1)(2013-1#1)
The aim of the present study was to investigate the##3##10##(2008-12#1)(2013-1#1)(2013-8#1)
The aim of the present study was to investigate##6##9##(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#1)(2013-8#1)
The aim of the present study was to##31##8##(1992-2#1)(1993-1#1)(1995-2#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-5#3)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
The aim of the present study was##32##7##(1992-2#1)(1993-1#1)(1995-2#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-5#3)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
The aim of the present study##39##6##(1992-2#1)(1993-1#1)(1995-2#1)(1995-8#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-5#5)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#1)
The aim of the present work is to##2##8##(1997-2#1)(2009-12#1)
The aim of the present work is##3##7##(1997-2#1)(2008-10#1)(2009-12#1)
The aim of the present work was to evaluate the##2##10##(1993-11#1)(2012-2#1)
The aim of the present work was to##4##8##(1993-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
The aim of the present work##7##6##(1993-11#1)(1997-2#1)(2008-10#2)(2009-12#1)(2012-2#1)(2013-1#1)
The aim of the present##48##5##(1992-2#1)(1993-1#1)(1993-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-5#6)(2009-12#1)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#7)(2013-8#1)
The aim of the study is to investigate##2##8##(2010-1#1)(2012-3#1)
The aim of the study is to##7##7##(1997-3#1)(2010-1#1)(2010-9#1)(2011-3#1)(2012-3#2)(2013-1#1)
The aim of the study was to analyse the##2##9##(2008-5#1)(2011-1#1)
The aim of the study was to analyse##3##8##(2008-5#1)(2011-1#1)(2012-3#1)
The aim of the study was to assess the##2##9##(2008-5#1)(2008-7#1)
The aim of the study was to assess##3##8##(2008-5#1)(2008-7#1)(2011-2#1)
The aim of the study was to compare the##2##9##(1997-8#1)(2013-1#1)
The aim of the study was to compare##3##8##(1997-8#1)(2013-1#2)
The aim of the study was to describe the##2##9##(2008-11#1)(2010-10#1)
The aim of the study was to determine##3##8##(1994-12#1)(2008-12#1)(2008-9#1)
The aim of the study was to evaluate the##2##9##(2010-10#1)(2013-1#1)
The aim of the study was to evaluate##3##8##(2010-10#1)(2010-11#1)(2013-1#1)
The aim of the study was to examine the##2##9##(2008-11#2)
The aim of the study was to investigate##2##8##(2008-9#1)(2009-6#1)
The aim of the study was to##28##7##(1994-12#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-11#3)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
The aim of the study was##31##6##(1994-12#1)(1996-6#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-11#3)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#5)
The aim of the study##39##5##(1994-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#2)(2008-11#3)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#6)
The aim of the##98##4##(1992-2#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#2)(2008-10#12)(2008-11#7)(2008-12#7)(2008-5#9)(2008-7#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#15)(2013-8#1)
The aim of these##2##4##(2008-10#1)(2009-8#1)
The aim of this article is to present##2##8##(1997-8#1)(2013-1#1)
The aim of this article is to provide a review of the##2##12##(2011-1#1)(2012-2#1)
The aim of this article is to##10##7##(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#2)(2013-1#2)
The aim of this article##11##5##(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-7#1)(2012-2#2)(2013-1#2)
The aim of this paper is to report##2##8##(2008-11#1)(2013-1#1)
The aim of this paper is to review##2##8##(2008-10#1)(2013-1#1)
The aim of this paper is to##12##7##(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#2)(2010-8#1)(2011-2#3)(2013-1#3)
The aim of this paper was to##4##7##(2008-11#1)(2009-8#2)(2011-2#1)
The aim of this paper##16##5##(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#2)(2009-8#2)(2010-8#1)(2011-2#4)(2013-1#3)
The aim of this pictorial essay is to##2##8##(1997-8#1)(2012-2#1)
The aim of this pictorial##3##5##(1997-8#1)(2012-2#2)
The aim of this prospective##3##5##(1997-3#1)(2010-5#1)(2011-2#1)
The aim of this qualitative##2##5##(2010-10#2)
The aim of this report is to##2##7##(2008-10#1)(2010-5#1)
The aim of this research was the development##2##8##(2008-10#1)(2008-5#1)
The aim of this research was to##3##7##(2011-1#1)(2011-2#1)(2013-1#1)
The aim of this research was##5##6##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
The aim of this research##6##5##(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
The aim of this retrospective study was to##2##8##(2011-2#2)
The aim of this retrospective##4##5##(2011-2#3)(2012-2#1)
The aim of this review is to##6##7##(2008-10#1)(2008-11#1)(2008-8#2)(2010-5#1)(2011-3#1)
The aim of this study is to evaluate the##3##9##(2008-10#1)(2010-8#1)(2011-2#1)
The aim of this study is to evaluate##6##8##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#2)(2013-1#1)
The aim of this study is to investigate the##2##9##(2010-12#1)(2011-3#1)
The aim of this study is to show##2##8##(2008-10#1)(2011-2#1)
The aim of this study is to##15##7##(2008-10#4)(2008-11#2)(2010-12#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
The aim of this study is##16##6##(2007-8#1)(2008-10#4)(2008-11#2)(2010-12#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
The aim of this study was to analyze the##2##9##(2011-2#2)
The aim of this study was to assess the##2##9##(2008-5#1)(2008-7#1)
The aim of this study was to assess##7##8##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-6#1)(2012-2#1)
The aim of this study was to compare##3##8##(2008-12#1)(2008-5#1)(2011-2#1)
The aim of this study was to describe the##2##9##(2009-3#1)(2010-5#1)
The aim of this study was to determine the##9##9##(2008-5#3)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-3#1)
The aim of this study was to determine whether##4##9##(2008-10#1)(2010-7#1)(2012-3#2)
The aim of this study was to determine##14##8##(2008-10#1)(2008-5#3)(2008-9#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-3#1)
The aim of this study was to develop optimal conditions for selective adhesion and isolation of mesenchymal progenitor cells##2##19##(2008-11#2)
The aim of this study was to develop##5##8##(2008-11#2)(2008-5#2)(2011-2#1)
The aim of this study was to evaluate the##11##9##(2007-8#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#5)
The aim of this study was to evaluate##14##8##(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#5)
The aim of this study was to examine the##5##9##(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
The aim of this study was to examine##6##8##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
The aim of this study was to explore##2##8##(2008-12#1)(2012-3#1)
The aim of this study was to identify##2##8##(2010-10#1)(2011-2#1)
The aim of this study was to investigate how##2##9##(1997-8#1)(2008-9#1)
The aim of this study was to investigate the effect of##2##11##(2011-1#1)(2012-2#1)
The aim of this study was to investigate the##9##9##(2008-12#1)(2008-5#3)(2011-1#1)(2012-2#1)(2013-1#3)
The aim of this study was to investigate##14##8##(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
The aim of this study was to present##2##8##(2008-10#2)
The aim of this study was to use##3##8##(2008-5#1)(2008-9#1)(2011-2#1)
The aim of this study was to verify##2##8##(1996-3#1)(2008-7#1)
The aim of this study was to##97##7##(1994-8#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-8#1)(2008-10#8)(2008-11#10)(2008-12#5)(2008-5#14)(2008-7#5)(2008-9#4)(2009-2#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#14)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#13)(2013-3#1)(2013-8#1)
The aim of this study was##99##6##(1994-1#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-8#1)(2008-10#8)(2008-11#10)(2008-12#5)(2008-5#14)(2008-7#5)(2008-9#4)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#14)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#13)(2013-3#1)(2013-8#1)
The aim of this study##116##5##(1991-6#1)(1994-1#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-8#2)(2008-10#12)(2008-11#12)(2008-12#5)(2008-5#14)(2008-7#5)(2008-9#4)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#14)(2013-3#1)(2013-8#2)
The aim of this work is the##2##7##(2008-10#2)
The aim of this work is to##6##7##(2008-10#4)(2012-2#1)(2013-1#1)
The aim of this work is##8##6##(2008-10#6)(2012-2#1)(2013-1#1)
The aim of this work was to determine the##2##9##(2008-12#1)(2010-5#1)
The aim of this work was to evaluate the##2##9##(2008-5#2)
The aim of this work was to investigate##2##8##(2007-12#1)(2008-5#1)
The aim of this work was to study the##2##9##(2008-10#1)(2008-5#1)
The aim of this work was to##15##7##(1997-2#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#6)(2009-8#1)(2010-5#1)
The aim of this work##24##5##(1997-2#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-5#7)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
The aim of this##207##4##(1991-6#1)(1991-9#1)(1994-1#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#4)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#29)(2008-11#16)(2008-12#7)(2008-5#24)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#30)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#9)(2012-3#5)(2013-1#23)(2013-3#1)(2013-8#2)
The aim of##334##3##(1990-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-8#5)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-10#42)(2008-11#26)(2008-12#16)(2008-5#34)(2008-7#9)(2008-8#3)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#8)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#39)(2011-3#3)(2011-7#2)(2012-12#2)(2012-2#12)(2012-3#12)(2012-5#1)(2012-6#1)(2013-1#42)(2013-3#1)(2013-8#3)
The aim was to explore##2##5##(2008-11#1)(2011-2#1)
The aim was to##12##4##(1990-5#1)(1991-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#1)
The aim was##13##3##(1990-5#1)(1991-11#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#1)
The aim##351##2##(1990-5#2)(1991-11#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-8#5)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-10#45)(2008-11#30)(2008-12#16)(2008-5#35)(2008-7#9)(2008-8#3)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#8)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#41)(2011-3#3)(2011-7#2)(2012-12#3)(2012-2#12)(2012-3#12)(2012-5#1)(2012-6#1)(2013-1#43)(2013-3#1)(2013-8#3)
The aims of the present study were##2##7##(2008-10#1)(2012-2#1)
The aims of the study were##2##6##(1992-12#1)(2012-3#1)
The aims of the study##3##5##(1992-12#1)(2008-5#1)(2012-3#1)
The aims of the##8##4##(1992-12#1)(2008-10#2)(2008-12#2)(2008-5#1)(2012-2#1)(2012-3#1)
The aims of this study were to determine the##2##9##(2008-12#1)(2011-2#1)
The aims of this study were to determine##3##8##(2008-12#1)(2011-2#1)(2013-1#1)
The aims of this study were to##9##7##(2008-11#1)(2008-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-1#2)
The aims of this study were##10##6##(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-1#2)
The aims of this study##11##5##(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
The aims of this##12##4##(1990-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
The aims of##21##3##(1990-11#1)(1992-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
The aims##22##2##(1990-11#1)(1992-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
The air##4##2##(2008-10#3)(2008-6#1)
The airborne##4##2##(2008-10#2)(2008-3#2)
The alcohol##2##2##(1997-8#1)(2008-10#1)
The algorithm is based on##2##5##(2008-10#1)(2008-3#1)
The algorithm is##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2013-8#1)
The algorithm of##2##3##(2008-10#1)(2013-1#1)
The algorithm##12##2##(2008-10#4)(2008-2#1)(2008-3#4)(2008-9#1)(2013-1#1)(2013-8#1)
The algorithms##2##2##(2008-3#2)
The alignment of##2##3##(1997-8#1)(2008-10#1)
The alpha##2##2##(1992-9#1)(2008-10#1)
The alpha-subunit##2##2##(1990-5#1)(1995-2#1)
The alpha-thiocarbocation generated from the Pummerer reaction of##2##8##(1996-5#2)
The alteration of##2##3##(1996-12#1)(2008-10#1)
The altered##3##2##(1991-10#1)(2008-4#1)(2010-12#1)
The alternative##6##2##(1990-12#1)(1994-3#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
The aluminium##2##2##(2008-10#2)
The american phytopathological society elected and appointed officers##5##8##(2008-10#5)
The american phytopathological society##7##4##(2008-10#7)
The american##8##2##(2008-10#7)(2012-3#1)
The amine##2##2##(2008-10#2)
The amino acid sequence deduced##2##5##(1993-9#1)(1995-6#1)
The amino acid sequence of the##4##6##(1990-5#1)(1992-8#1)(1994-12#1)(1996-12#1)
The amino acid sequence of##6##5##(1990-5#1)(1992-8#1)(1994-12#1)(1996-12#1)(1996-2#1)(2009-8#1)
The amino acid sequence##10##4##(1990-5#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#2)(2009-8#1)
The amino acid sequences of the##3##6##(1993-12#1)(1996-8#1)(2008-5#1)
The amino acid sequences##4##4##(1993-12#1)(1996-8#1)(1997-7#1)(2008-5#1)
The amino acid##17##3##(1990-5#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-7#1)(2008-10#4)(2008-5#1)(2009-8#1)
The amino##19##2##(1990-5#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-7#1)(2008-10#6)(2008-5#1)(2009-8#1)
The amino-acid sequence of##3##4##(1990-5#3)
The amino-acid sequence##5##3##(1990-5#5)
The amino-terminal sequence of lobster##2##5##(1990-2#2)
The amino-terminal sequence of##3##4##(1990-2#2)(1992-9#1)
The amino-terminal##5##2##(1990-2#2)(1992-9#1)(1997-4#1)(1997-8#1)
The amorphous##2##2##(2008-10#2)
The amount of formaldehyde in##2##5##(2008-10#2)
The amount of the##2##4##(1995-3#1)(2008-10#1)
The amount of##40##3##(1990-2#1)(1991-11#1)(1991-9#1)(1993-8#2)(1994-12#1)(1995-3#2)(1996-2#2)(1996-6#1)(1997-4#1)(2008-10#18)(2008-11#6)(2008-6#1)(2008-8#2)(2013-1#1)
The amount##41##2##(1990-2#1)(1991-11#1)(1991-9#1)(1993-8#3)(1994-12#1)(1995-3#2)(1996-2#2)(1996-6#1)(1997-4#1)(2008-10#18)(2008-11#6)(2008-6#1)(2008-8#2)(2013-1#1)
The amounts of##10##3##(1994-5#1)(1997-8#1)(2008-10#6)(2008-5#1)(2011-2#1)
The amperometric response of##2##4##(2008-10#2)
The amperometric##5##2##(2008-10#5)
The amplification##3##2##(2008-10#2)(2008-12#1)
The amplified DNA##2##3##(1995-8#1)(1997-2#1)
The amplified fragments were cloned##2##5##(2008-10#1)(2008-8#1)
The amplified##6##2##(1995-8#1)(1997-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
The amplitude and##2##3##(2008-10#1)(2008-9#1)
The amplitude of the##2##4##(2008-10#1)(2008-3#1)
The amplitude of##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
The amplitude##6##2##(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
The amygdala was##2##3##(2008-11#2)
The amygdala##4##2##(1991-1#1)(2008-11#3)
The analgesic##2##2##(1995-6#1)(2011-2#1)
The analog##3##2##(1993-8#1)(1994-12#1)(1997-6#1)
The analogous##2##2##(1992-1#1)(1996-8#1)
The analogs##3##2##(1992-8#1)(1994-5#1)(2011-2#1)
The analysed##2##2##(2008-10#2)
The analyses of##5##3##(2008-10#3)(2009-7#1)(2012-2#1)
The analyses revealed##2##3##(1993-11#1)(2008-10#1)
The analyses##12##2##(1992-2#1)(1993-11#1)(2008-10#6)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
The analysis indicates that##2##4##(1993-12#1)(1996-2#1)
The analysis is##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
The analysis of the##10##4##(1993-6#1)(1994-11#1)(2008-10#4)(2008-5#3)(2012-3#1)
The analysis of##51##3##(1991-2#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-9#1)(1997-7#1)(2007-8#1)(2008-10#27)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#2)(2009-6#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
The analysis shows##2##3##(2008-11#1)(2008-3#1)
The analysis time##2##3##(2008-10#2)
The analysis was completed##2##4##(2008-10#2)
The analysis was made##2##4##(2009-8#1)(2011-2#1)
The analysis was##12##3##(1991-1#1)(1993-11#1)(2008-10#5)(2008-11#2)(2009-8#1)(2011-2#1)(2013-1#1)
The analysis##101##2##(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#44)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
The analyte is##2##3##(2008-10#2)
The analyte was##2##3##(2008-10#2)
The analyte##10##2##(2008-10#10)
The analytes are##4##3##(1992-11#1)(2008-10#3)
The analytes were detected using a##2##6##(2008-10#2)
The analytes were determined##3##4##(2008-10#3)
The analytes were extracted##2##4##(2008-10#2)
The analytes were resolved by elution with supercritical fluid carbon dioxide doped with##2##13##(2008-10#2)
The analytes were##15##3##(2008-10#15)
The analytes##24##2##(1992-11#1)(2008-10#23)
The analytical and##3##3##(2008-10#3)
The analytical characteristics of the##3##5##(2008-10#3)
The analytical characteristics of##5##4##(2008-10#5)
The analytical characteristics##7##3##(2008-10#7)
The analytical conditions##2##3##(2008-10#2)
The analytical curve was linear in the##2##7##(2008-10#2)
The analytical curve was rectilinear##2##5##(2008-10#2)
The analytical curve was##4##4##(2008-10#4)
The analytical curve##6##3##(2008-10#6)
The analytical curves##2##3##(2008-10#2)
The analytical data##4##3##(2008-10#4)
The analytical expression for the##2##5##(2008-10#1)(2008-3#1)
The analytical figures of merit##5##5##(2008-10#5)
The analytical figures of##6##4##(2008-10#6)
The analytical frequency##3##3##(2008-10#3)
The analytical method is based on the detection of##2##9##(2008-10#2)
The analytical method is based on the##3##7##(2008-10#3)
The analytical method##8##3##(2008-10#7)(2009-8#1)
The analytical parameters for##3##4##(2008-10#3)
The analytical parameters have been##2##5##(2008-10#2)
The analytical parameters##5##3##(2008-10#5)
The analytical performance of the proposed method##2##7##(2008-10#2)
The analytical performance of the##3##5##(2008-10#3)
The analytical performance of##6##4##(2008-10#6)
The analytical performance##7##3##(2008-10#7)
The analytical procedure was##2##4##(2008-10#2)
The analytical procedure##4##3##(2008-10#4)
The analytical process##2##3##(2008-10#1)(2008-11#1)
The analytical properties of##3##4##(2008-10#3)
The analytical range##2##3##(2008-10#2)
The analytical reagents##2##3##(2008-10#2)
The analytical recoveries obtained by applying the##2##7##(2008-10#2)
The analytical recoveries##3##3##(2008-10#3)
The analytical results obtained by##2##5##(2008-10#2)
The analytical results obtained##5##4##(2008-10#5)
The analytical results##10##3##(2008-10#9)(2013-8#1)
The analytical signals##3##3##(2007-11#1)(2008-10#2)
The analytical throughput##2##3##(2008-10#2)
The analytical usefulness of the##2##5##(2008-10#2)
The analytical utility of the##3##5##(2008-10#3)
The analytical##120##2##(2007-11#1)(2008-10#110)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-8#1)(2010-7#1)(2013-8#1)
The analyzed ions can be quantitatively concentrated by the##2##9##(2008-10#2)
The analyzed##5##2##(2008-10#3)(2009-3#1)(2013-1#1)
The anatomic##2##2##(1991-10#1)(2012-3#1)
The anatomical##6##2##(1991-3#1)(1996-2#1)(2008-11#2)(2008-9#1)(2013-1#1)
The anatomy and##3##3##(1997-1#1)(2008-1#1)(2012-2#1)
The anatomy of the##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
The anatomy of##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
The anatomy##8##2##(1997-1#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
The aneurysm was##2##3##(1997-6#1)(2008-7#1)
The aneurysm##4##2##(1997-6#1)(2008-7#2)(2013-8#1)
The animal##2##2##(2008-4#1)(2012-2#1)
The animals were##4##3##(1991-2#1)(1994-2#1)(2009-3#1)(2013-1#1)
The animals##5##2##(1991-2#1)(1993-3#1)(1994-2#1)(2009-3#1)(2013-1#1)
The anions##2##2##(2008-10#2)
The annetocin-secretory cells##2##3##(2008-5#2)
The annual##4##2##(1992-1#1)(1996-11#1)(2008-10#1)(2008-9#1)
The anodic oxidation of##2##4##(2008-10#2)
The anodic peak potential##2##4##(2008-10#2)
The anodic peak##3##3##(2008-10#3)
The anodic stripping##2##3##(2008-10#2)
The anodic##9##2##(2008-10#9)
The anomaly##2##2##(1990-5#1)(1993-9#1)
The answer##2##2##(1991-12#1)(1997-1#1)
The answers##2##2##(2008-10#1)(2012-2#1)
The antagonist##3##2##(2008-10#2)(2010-8#1)
The antagonistic##2##2##(2008-10#2)
The antibacterial##2##2##(2008-5#1)(2012-3#1)
The antibiotic##2##2##(2008-10#2)
The antibodies##4##2##(1994-5#1)(1995-6#1)(1996-2#1)(2008-11#1)
The antibody response to##2##4##(1995-5#1)(2008-10#1)
The antibody##12##2##(1990-12#1)(1991-12#1)(1995-5#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)
The anticonvulsant##2##2##(1992-3#1)(1994-2#1)
The antigen##2##2##(2008-11#1)(2008-8#1)
The antigenic##3##2##(2008-10#1)(2008-5#2)
The antimicrobial activity##2##3##(2008-11#1)(2013-1#1)
The antimicrobial##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
The antioxidant activities of##2##4##(2008-10#1)(2013-1#1)
The antioxidant activity in##2##4##(2008-10#1)(2008-11#1)
The antioxidant activity##4##3##(2008-10#3)(2008-11#1)
The antioxidant##10##2##(1995-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2013-1#2)
The antisense##3##2##(1992-12#1)(2008-11#1)(2008-8#1)
The antisera##3##2##(2008-10#3)
The antiserum##2##2##(1990-11#1)(2008-10#1)
The apical##2##2##(2008-10#1)(2013-1#1)
The apoptosis linked##2##3##(2009-4#2)
The apoptosis##3##2##(2008-5#1)(2009-4#2)
The apparatus##5##2##(1993-2#1)(2008-10#4)
The apparent K(m)##2##3##(1997-2#1)(2008-7#1)
The apparent Km for##2##4##(1990-11#1)(1990-2#1)
The apparent Michaelis-Menten constant##2##4##(2008-10#2)
The apparent dissociation constant##3##4##(1990-11#1)(1993-8#1)(1996-3#1)
The apparent formation##2##3##(2008-10#2)
The apparent molar absorptivities##2##4##(2008-10#2)
The apparent molar absorptivity is##4##5##(2008-10#4)
The apparent molar absorptivity##5##4##(2008-10#5)
The apparent molar##8##3##(2008-10#8)
The apparent molecular weight##2##4##(1992-11#1)(1992-6#1)
The apparent molecular##3##3##(1992-11#1)(1992-6#1)(1997-7#1)
The apparent##43##2##(1990-11#2)(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-5#1)(1996-3#1)(1997-2#2)(1997-7#1)(2008-10#22)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#2)
The appeals court##4##3##(1995-12#1)(1995-6#3)
The appearance of new##2##4##(2008-10#2)
The appearance of the##4##4##(1997-8#1)(2007-12#1)(2008-11#1)(2009-9#1)
The appearance of##12##3##(1991-2#1)(1992-2#1)(1993-6#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2009-9#1)(2012-3#1)
The appearance##13##2##(1991-2#1)(1992-2#1)(1993-6#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2009-9#1)(2012-3#1)
The appendix##2##2##(1991-2#1)(2009-7#1)
The applicability of the method for##2##6##(2008-10#2)
The applicability of the method was demonstrated by the determination of##2##11##(2008-10#2)
The applicability of the method was demonstrated by##3##8##(2008-10#3)
The applicability of the method was##4##6##(2008-10#4)
The applicability of the method##6##5##(2008-10#6)
The applicability of the proposed##3##5##(2008-10#3)
The applicability of the##13##4##(2008-10#13)
The applicability of this method##2##5##(2008-10#2)
The applicability of this##4##4##(2008-10#4)
The applicability of##32##3##(1993-12#1)(1996-12#1)(2008-10#29)(2008-3#1)
The applicability##33##2##(1993-12#1)(1996-12#1)(2008-10#30)(2008-3#1)
The application of a##5##4##(2008-10#5)
The application of an##3##4##(2008-10#2)(2009-10#1)
The application of both methods##2##5##(2008-10#2)
The application of spline wavelet##2##5##(2008-10#2)
The application of the method##4##5##(2008-10#4)
The application of the methodology to the##2##7##(2008-10#1)(2009-10#1)
The application of the##20##4##(1991-5#1)(2008-10#16)(2009-10#1)(2009-8#1)(2011-2#1)
The application of these techniques to##2##6##(2008-3#2)
The application of this method was demonstrated by analyzing##2##9##(2008-10#2)
The application of this method was##4##6##(2008-10#3)(2008-8#1)
The application of this method##5##5##(2008-10#4)(2008-8#1)
The application of this methodology##2##5##(2008-10#2)
The application of this newly developed method was demonstrated by analyzing various beef##2##13##(2008-10#2)
The application of this##13##4##(2008-10#9)(2008-5#2)(2008-7#1)(2008-8#1)
The application of##75##3##(1991-5#1)(1992-12#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-10#53)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)
The application##80##2##(1991-5#1)(1992-12#1)(1994-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-10#54)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#2)
The applications##2##2##(2008-10#1)(2013-1#1)
The applied artificial neural network is composed of three layers##2##10##(2010-8#2)
The applied##8##2##(2008-10#5)(2009-8#1)(2010-8#2)
The approach can be##2##4##(2008-10#1)(2008-12#1)
The approach has been##2##4##(2008-10#2)
The approach is used##2##4##(2008-10#1)(2008-9#1)
The approach is##9##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-9#2)
The approach of##2##3##(1993-12#1)(2008-11#1)
The approach presented##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
The approach to##2##3##(2008-10#1)(2011-2#1)
The approach was##3##3##(2008-10#3)
The approach##41##2##(1992-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-8#1)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2011-2#2)
The approaches##4##2##(1992-1#1)(2008-12#1)(2010-10#1)(2011-2#1)
The appropriate##6##2##(1995-5#1)(1996-2#1)(2008-9#2)(2010-10#1)(2012-3#1)
The aquatic##2##2##(2008-10#1)(2008-7#1)
The aqueous##8##2##(2008-10#5)(2008-11#2)(2008-7#1)
The area of##2##3##(2008-10#1)(2008-8#1)
The area under the disease progress curve (AUDPC) was##2##9##(2008-10#2)
The area under the disease progress curve (AUDPC)##3##8##(2008-10#3)
The area##6##2##(1990-9#1)(2008-10#4)(2008-8#1)
The areas##2##2##(1991-1#1)(2013-1#1)
The argon##2##2##(1994-3#1)(2008-10#1)
The argument##2##2##(1995-5#1)(2008-11#1)
The arguments are##2##3##(1996-6#1)(2008-11#1)
The arguments##3##2##(1996-6#1)(1997-4#1)(2008-11#1)
The arsine##2##2##(2008-10#2)
The art of##4##3##(2008-12#2)(2010-8#1)(2012-12#1)
The art##6##2##(1993-3#1)(2008-11#1)(2008-12#2)(2010-8#1)(2012-12#1)
The article also##3##3##(1994-3#1)(1995-3#1)(2008-9#1)
The article concludes by##4##4##(1996-2#1)(1996-3#1)(1997-2#1)(2008-8#1)
The article concludes with the##2##5##(2008-12#1)(2008-4#1)
The article concludes with##4##4##(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)
The article concludes##9##3##(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)
The article considers the##2##4##(2013-1#2)
The article considers##3##3##(2013-1#3)
The article describes the##7##4##(1990-11#1)(1992-3#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
The article describes##11##3##(1990-11#3)(1991-2#1)(1992-3#1)(1994-12#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-6#1)
The article discusses the##6##4##(1991-12#1)(1994-2#1)(2013-1#4)
The article discusses##10##3##(1991-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(2008-10#1)(2013-1#4)
The article explores##3##3##(2008-11#1)(2008-12#1)(2013-8#1)
The article goes on to##2##5##(2008-12#1)(2013-7#1)
The article highlights##2##3##(2008-11#1)(2013-1#1)
The article includes##2##3##(1991-11#1)(1991-6#1)
The article is##2##3##(2010-7#1)(2012-3#1)
The article presents##2##3##(1991-9#1)(1994-2#1)
The article reviews##3##3##(1991-2#1)(1991-6#1)(2012-2#1)
The article##69##2##(1990-11#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#4)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#2)(2008-10#3)(2008-11#3)(2008-12#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
The articles##2##2##(1995-1#1)(2008-12#1)
The assay also##3##3##(1992-3#1)(2008-10#2)
The assay detected##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
The assay has a##3##4##(1991-2#1)(1992-12#1)(2008-10#1)
The assay has##4##3##(1990-2#1)(1991-2#1)(1992-12#1)(2008-10#1)
The assay is based on the##2##6##(1990-12#1)(2008-10#1)
The assay is based on##3##5##(1990-12#1)(2008-10#2)
The assay is performed##2##4##(2008-10#1)(2008-9#1)
The assay is##8##3##(1990-12#2)(1996-12#1)(2008-10#3)(2008-9#2)
The assay was linear from##2##5##(2008-10#2)
The assay was used to##2##5##(1992-3#1)(2008-10#1)
The assay was##11##3##(1992-3#1)(2008-10#7)(2008-5#1)(2013-1#1)(2013-8#1)
The assay##42##2##(1990-12#2)(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-9#1)(1994-3#1)(1996-12#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2012-2#1)(2013-1#1)(2013-8#2)
The assays##6##2##(2008-10#5)(2011-2#1)
The assembly of##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
The assertion##2##2##(1994-6#1)(2008-12#1)
The assessment of the##5##4##(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
The assessment of##17##3##(1992-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-10#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The assessment##23##2##(1992-5#1)(1993-12#1)(1994-2#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2009-10#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The assignment of##5##3##(1994-5#1)(2008-10#2)(2012-2#1)(2013-1#1)
The associated##2##2##(2008-7#2)
The association between migraine##2##4##(2008-9#2)
The association between the##2##4##(2011-2#1)(2013-1#1)
The association between##12##3##(1992-2#1)(2008-10#2)(2008-9#2)(2009-7#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
The association constants of##2##4##(2008-10#2)
The association constants##4##3##(2008-10#4)
The association of##11##3##(1991-3#1)(1995-9#1)(2006-6#1)(2007-8#1)(2008-10#5)(2011-2#1)(2012-12#1)
The association with##2##3##(1993-9#1)(2008-10#1)
The association##37##2##(1991-3#1)(1992-2#1)(1993-9#1)(1994-5#1)(1995-9#1)(2006-6#1)(2007-8#1)(2008-10#16)(2008-7#1)(2008-9#2)(2009-7#1)(2010-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The associations between the##2##4##(2008-6#1)(2011-1#1)
The associations of##2##3##(2008-10#1)(2012-2#1)
The associations##4##2##(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
The assumed##2##2##(1991-3#1)(2008-3#1)
The assumption of##2##3##(2008-11#1)(2008-7#1)
The assumption##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
The asymptotic##3##2##(1994-9#1)(2008-3#1)(2010-11#1)
The atomic##2##2##(2008-10#1)(2008-4#1)
The attachment of##3##3##(2008-10#1)(2009-10#1)(2012-2#1)
The attachment##4##2##(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
The attendance##2##2##(1991-6#2)
The attenuation of##2##3##(2008-10#1)(2008-2#1)
The attenuation##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
The attitudes of##3##3##(1994-1#1)(2008-12#1)(2008-7#1)
The author addresses the##2##4##(1994-3#1)(1996-12#1)
The author also##4##3##(1992-3#1)(1994-6#1)(1996-3#1)(2011-2#1)
The author argues that##2##4##(1991-2#1)(2008-11#1)
The author argues##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
The author believes##2##3##(1992-2#1)(1996-1#1)
The author concludes with##2##4##(2010-11#1)(2011-2#1)
The author concludes##3##3##(1993-12#1)(2010-11#1)(2011-2#1)
The author describes the##3##4##(1996-12#1)(2008-7#1)(2011-2#1)
The author describes##10##3##(1991-1#1)(1991-12#1)(1992-12#1)(1996-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#2)
The author discusses how##5##4##(1991-3#1)(1993-12#2)(1993-2#1)(1994-12#1)
The author discusses the##8##4##(1990-9#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#1)(1997-4#1)(2008-6#1)
The author discusses why##3##4##(1992-12#1)(1993-2#1)(1996-12#1)
The author discusses##19##3##(1990-9#2)(1991-1#1)(1991-3#1)(1992-12#2)(1992-2#1)(1993-12#3)(1993-2#2)(1994-12#1)(1994-2#1)(1996-12#1)(1997-4#2)(2008-6#1)(2008-9#1)
The author emphasizes##2##3##(1991-6#1)(1992-1#1)
The author examines the##2##4##(1992-1#1)(1995-2#1)
The author focuses on##2##4##(1991-1#1)(2008-4#1)
The author offers a##2##4##(1992-12#1)(2010-10#1)
The author offers##5##3##(1991-12#1)(1992-12#2)(1993-1#1)(2010-10#1)
The author presents a##4##4##(1991-3#1)(1995-2#1)(1995-5#1)(2008-9#1)
The author presents##5##3##(1991-3#1)(1991-6#1)(1995-2#1)(1995-5#1)(2008-9#1)
The author shows why##2##4##(1991-3#1)(1992-2#1)
The author suggests that##3##4##(1991-11#1)(1993-2#1)(1996-12#1)
The author##91##2##(1990-9#2)(1991-1#5)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#2)(1991-8#1)(1992-1#3)(1992-12#5)(1992-2#3)(1992-3#2)(1993-1#1)(1993-12#5)(1993-2#5)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#2)(1996-1#1)(1996-12#5)(1996-3#1)(1997-4#2)(2007-8#1)(2008-11#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#4)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2011-2#8)(2011-3#2)
The author's##2##2##(1994-3#1)(2012-12#1)
The authors also##4##3##(1990-11#1)(1992-12#1)(2008-11#1)(2008-9#1)
The authors analyze in##2##4##(1991-6#1)(1995-5#1)
The authors analyze##3##3##(1991-6#1)(1995-5#1)(1996-3#1)
The authors argue that##2##4##(2008-11#2)
The authors believe##2##3##(2008-6#1)(2008-9#1)
The authors conclude that##6##4##(1991-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(2008-10#2)
The authors conclude##7##3##(1991-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(2008-10#2)(2013-8#1)
The authors concluded that##2##4##(2009-3#1)(2010-10#1)
The authors consider##2##3##(1995-2#1)(2013-8#1)
The authors describe a case of##2##6##(1991-6#1)(2008-12#1)
The authors describe a##9##4##(1991-6#1)(1993-12#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-7#1)
The authors describe the case of##2##6##(1994-9#1)(2010-1#1)
The authors describe the##10##4##(1992-12#1)(1993-6#1)(1994-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-9#1)(2010-1#1)(2012-12#1)(2013-1#1)
The authors describe two cases##2##5##(1993-6#1)(2011-2#1)
The authors describe##25##3##(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-6#2)(1994-9#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-1#1)(2010-9#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#1)
The authors determined##2##3##(1990-9#1)(2010-10#1)
The authors discuss the##9##4##(1991-12#1)(1993-1#1)(1993-2#1)(1993-6#1)(1996-6#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-3#1)
The authors discuss##17##3##(1991-11#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-6#1)(2008-9#3)(2011-2#1)(2011-7#1)(2012-3#1)
The authors emphasize the##2##4##(1991-8#1)(2011-2#1)
The authors evaluate##2##3##(1990-3#1)(2011-3#1)
The authors found that##2##4##(1992-5#1)(2011-2#1)
The authors found##3##3##(1992-5#1)(2011-2#1)(2013-8#1)
The authors have developed##2##4##(2008-9#1)(2011-2#1)
The authors have##10##3##(1992-5#1)(1993-11#1)(1993-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
The authors investigate the##2##4##(1996-3#1)(2008-9#1)
The authors of this article##2##5##(1993-3#1)(1997-4#1)
The authors of this##4##4##(1993-3#1)(1997-4#1)(2012-3#1)(2013-1#1)
The authors of##5##3##(1993-3#1)(1997-4#1)(2009-10#1)(2012-3#1)(2013-1#1)
The authors present a case of##4##6##(1991-6#1)(2008-12#1)(2010-3#1)(2012-12#1)
The authors present a##7##4##(1991-6#1)(2008-12#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)
The authors present the case of a##3##7##(2008-1#1)(2008-10#1)(2011-2#1)
The authors present the case of##4##6##(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
The authors present the##5##4##(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
The authors present##16##3##(1991-6#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#3)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-3#2)
The authors propose a definition of CS inclusive of the multifarious uses that were revealed in the literature##2##18##(2013-1#2)
The authors propose##5##3##(1995-11#1)(2008-7#1)(2010-1#1)(2013-1#2)
The authors provide##2##3##(2008-9#2)
The authors recommend##2##3##(2008-9#1)(2012-3#1)
The authors report a case of a##4##7##(1992-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
The authors report a case of primary##2##7##(1992-2#1)(2008-1#1)
The authors report a case of##11##6##(1992-2#1)(1992-5#1)(1994-6#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-8#2)
The authors report a rare case of##2##7##(1991-12#1)(2008-12#1)
The authors report a##16##4##(1991-11#1)(1991-12#1)(1992-2#1)(1992-5#1)(1994-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#3)(2010-12#1)(2011-2#1)(2013-8#3)
The authors report an##2##4##(2011-2#1)(2012-3#1)
The authors report on a consecutive series of##2##8##(1990-8#1)(1991-8#1)
The authors report on a consecutive##3##6##(1990-12#1)(1990-8#1)(1991-8#1)
The authors report on a##4##5##(1990-12#1)(1990-8#1)(1991-8#1)(1996-3#1)
The authors report on##5##4##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1996-3#1)
The authors report the case of a##4##7##(1991-11#2)(2008-7#1)(2011-2#1)
The authors report the##8##4##(1991-11#2)(1993-12#1)(1994-2#1)(1996-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
The authors report their experience##4##5##(1990-3#1)(1991-3#1)(1992-5#2)
The authors report##41##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#5)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#4)(1993-12#1)(1994-2#1)(1994-6#1)(1996-3#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#4)(2009-10#1)(2010-12#2)(2011-2#3)(2012-3#1)(2013-8#3)
The authors reports##2##3##(1992-5#1)(2010-12#1)
The authors respond##2##3##(2008-11#2)
The authors review the published##2##5##(1995-2#1)(2008-12#1)
The authors review the##5##4##(1995-2#1)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)
The authors review##7##3##(1995-2#1)(1996-11#1)(2008-12#1)(2008-9#1)(2009-12#2)(2011-2#1)
The authors studied the##2##4##(1992-5#1)(2008-10#1)
The authors suggest that##6##4##(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
The authors suggest##7##3##(1991-3#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
The authors then##3##3##(1997-2#1)(2011-2#1)(2012-3#1)
The authors##232##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#8)(1991-12#2)(1991-2#2)(1991-3#5)(1991-6#6)(1991-8#2)(1992-12#2)(1992-2#2)(1992-5#9)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#4)(1993-6#7)(1994-12#3)(1994-2#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#6)(1996-6#2)(1997-2#2)(1997-4#1)(2008-1#2)(2008-10#5)(2008-11#11)(2008-12#6)(2008-6#3)(2008-7#9)(2008-9#17)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2010-1#2)(2010-10#6)(2010-12#4)(2010-3#2)(2010-5#1)(2010-9#1)(2011-2#19)(2011-3#2)(2011-7#4)(2012-12#4)(2012-2#1)(2012-3#9)(2013-1#5)(2013-8#6)
The authors' own experience]##2##4##(1992-3#2)
The authors'##5##2##(1992-3#2)(1994-3#1)(2008-10#1)(2010-3#1)
The automatic##3##2##(2008-10#3)
The automation of the##2##4##(2008-10#2)
The availability of complete##2##4##(2008-7#1)(2008-9#1)
The availability of the##3##4##(1997-7#1)(2008-7#1)(2008-9#1)
The availability of these##2##4##(1993-2#1)(2008-10#1)
The availability of##22##3##(1992-10#2)(1993-2#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#2)(2008-9#4)(2013-1#1)(2013-8#1)
The available evidence##3##3##(1991-12#1)(2008-10#1)(2008-9#1)
The available knowledge##2##3##(1991-12#1)(2013-1#1)
The available##9##2##(1991-12#3)(2008-10#2)(2008-9#2)(2010-12#1)(2013-1#1)
The average accuracies##2##3##(2008-10#1)(2012-2#1)
The average age at which##2##5##(1991-8#2)
The average age at##4##4##(1991-8#2)(1997-7#1)(2011-2#1)
The average age of##2##4##(2008-9#1)(2011-1#1)
The average age was##3##4##(2011-2#2)(2013-1#1)
The average age##10##3##(1991-8#2)(1997-7#1)(2008-9#1)(2011-1#1)(2011-2#3)(2013-1#2)
The average annual##3##3##(1996-8#1)(2011-2#2)
The average cell##2##3##(2008-10#1)(2008-9#1)
The average concentrations##2##3##(2008-10#2)
The average distance of##2##4##(2008-10#2)
The average duration of##2##4##(2013-1#1)(2013-8#1)
The average length of##2##4##(1992-2#1)(2008-10#1)
The average length##3##3##(1992-2#1)(2008-10#1)(2013-1#1)
The average molar absorption coefficient and Sandell's sensitivity were found to be 4##2##13##(2008-10#2)
The average molar##3##3##(2008-10#2)(2013-1#1)
The average number of##4##4##(1990-9#1)(1994-6#1)(2008-11#1)(2008-9#1)
The average number##5##3##(1990-9#1)(1994-6#1)(2008-11#1)(2008-9#1)(2013-8#1)
The average output power##2##4##(2008-3#2)
The average rate of albumin secretion for the initial##2##9##(2008-11#2)
The average recoveries of##3##4##(2008-10#2)(2008-5#1)
The average recoveries##7##3##(2008-10#6)(2008-5#1)
The average recovery for these samples was##2##7##(2008-10#2)
The average recovery for##4##4##(2008-10#3)(2008-5#1)
The average recovery of##2##4##(2008-10#2)
The average recovery##7##3##(2008-10#6)(2008-5#1)
The average survival##2##3##(1994-6#1)(1997-4#1)
The average time to##2##4##(2008-8#2)
The average time##3##3##(1996-9#1)(2008-8#2)
The average values##2##3##(2008-10#1)(2008-7#1)
The average##103##2##(1990-9#1)(1991-1#2)(1991-2#1)(1991-8#2)(1992-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#31)(2008-11#7)(2008-12#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#2)(2013-1#7)(2013-8#4)
The averages of##2##3##(2012-12#1)(2013-8#1)
The axoneme##2##2##(2008-7#2)
The azo##2##2##(2008-10#2)
The backbone##2##2##(2009-7#2)
The background##2##2##(2008-10#1)(2008-3#1)
The bacteria are##2##3##(1991-2#1)(2007-12#1)
The bacteria##5##2##(1991-2#1)(1997-4#1)(2006-5#1)(2007-12#1)(2008-10#1)
The bacterial##2##2##(1992-3#1)(2011-2#1)
The bacterium##7##2##(2008-10#3)(2008-8#1)(2009-6#1)(2011-1#2)
The balance##2##2##(2009-10#1)(2010-10#1)
The balloon was##3##3##(1997-6#3)
The barley##4##2##(1995-6#1)(2008-10#2)(2008-8#1)
The barrier##2##2##(2008-10#1)(2008-7#1)
The basal rate of hepatic glucose##2##6##(1991-7#2)
The basal##10##2##(1990-8#1)(1991-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-3#1)
The base##5##2##(2008-10#2)(2008-5#2)(2011-2#1)
The baseline##2##2##(1992-2#1)(2008-10#1)
The basic idea##2##3##(1997-2#1)(2008-10#1)
The basic procedure##2##3##(1990-12#1)(1995-8#1)
The basic protocol in this unit##2##6##(2008-4#2)
The basic protocol##6##3##(2008-4#4)(2008-9#2)
The basic##36##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-12#1)(1995-5#1)(1995-8#2)(1996-12#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#6)(2008-8#1)(2008-9#3)(2011-2#1)(2012-3#1)(2013-8#1)
The basis for the##3##4##(2008-7#1)(2008-9#1)(2013-1#1)
The basis for##5##3##(1992-9#1)(1997-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
The basis of##2##3##(2008-10#1)(2008-8#1)
The basis##7##2##(1992-9#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
The beads##2##2##(2008-10#2)
The beam quality of##2##4##(2008-2#1)(2008-3#1)
The beam##3##2##(1995-2#1)(2008-2#1)(2008-3#1)
The bean population##2##3##(2008-8#2)
The bean##3##2##(2008-10#1)(2008-8#2)
The beating##2##2##(1994-11#1)(2008-2#1)
The behavior of the##7##4##(1991-2#1)(2008-10#5)(2012-12#1)
The behavior of##12##3##(1990-6#1)(1991-2#1)(2008-10#8)(2008-9#1)(2012-12#1)
The behavior##14##2##(1990-6#1)(1991-2#1)(2008-10#10)(2008-9#1)(2012-12#1)
The behavioral##7##2##(1996-2#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
The behaviour of##5##3##(2008-10#5)
The belief that screening is useless##2##6##(1991-6#1)(1992-2#1)
The benefit of##3##3##(1995-11#1)(2008-8#1)(2011-2#1)
The benefits of##9##3##(1995-1#1)(1995-5#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)
The benefits##12##2##(1995-1#1)(1995-5#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
The benign##2##2##(1990-3#1)(2009-12#1)
The best agreement##2##3##(2008-12#1)(2008-3#1)
The best analytical##2##3##(2008-10#2)
The best conditions for##3##4##(1996-12#1)(2008-10#2)
The best known##2##3##(1995-5#1)(2008-8#1)
The best models##2##3##(2008-10#2)
The best of##2##3##(1991-6#1)(1993-2#1)
The best osteogenic differentiation was observed in MPCs cultured in osteogenic medium containing##2##13##(2008-11#2)
The best overall##2##3##(2008-10#2)
The best performance was##4##4##(2008-10#4)
The best result##2##3##(2008-10#2)
The best results for##2##4##(2008-10#2)
The best results were obtained using##4##6##(2008-10#1)(2008-5#1)(2008-7#2)
The best results were obtained with##2##6##(2008-10#1)(2008-5#1)
The best results were obtained##8##5##(2008-10#4)(2008-5#2)(2008-7#2)
The best results were##9##4##(2008-10#4)(2008-5#2)(2008-7#2)(2010-4#1)
The best results##15##3##(2008-10#10)(2008-5#2)(2008-7#2)(2010-4#1)
The best##84##2##(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-2#2)(1993-9#1)(1995-5#1)(1996-12#1)(2008-10#52)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#3)(2008-7#4)(2008-8#2)(2009-8#1)(2010-4#1)(2012-3#2)
The beta##3##2##(1995-8#1)(2008-10#1)(2010-5#1)
The beta-binomial distribution##2##3##(2008-10#2)
The beta-binomial##3##2##(2008-10#3)
The better##2##2##(2008-10#1)(2011-3#1)
The bias##2##2##(1995-12#1)(2008-10#1)
The bidirectional##2##2##(2008-3#1)(2008-7#1)
The bill##2##2##(1996-5#1)(1997-5#1)
The binary##3##2##(2008-10#2)(2008-3#1)
The binding and##2##3##(1994-5#1)(2008-10#1)
The binding characteristics##2##3##(1990-11#1)(1993-1#1)
The binding constant of the##2##5##(1993-8#1)(2008-10#1)
The binding constant of##3##4##(1993-8#1)(2008-10#2)
The binding constant##5##3##(1993-8#1)(2008-10#4)
The binding of##14##3##(1991-5#1)(1992-1#1)(1992-10#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-11#1)(2008-10#4)(2008-11#1)
The binding site for##2##4##(1993-8#1)(1995-12#1)
The binding site##3##3##(1993-8#1)(1995-12#1)(2008-10#1)
The binding to the##2##4##(1992-6#1)(2008-10#1)
The binding##40##2##(1990-11#1)(1991-5#1)(1992-1#1)(1992-10#2)(1992-6#1)(1993-1#1)(1993-3#1)(1993-8#3)(1994-3#1)(1994-5#3)(1995-11#1)(1995-12#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-8#1)
The binomial##2##2##(2008-10#2)
The bioassay##3##2##(2008-10#2)(2008-4#1)
The biochemical##5##2##(2008-10#3)(2008-11#1)(2013-1#1)
The biocontrol agent##2##3##(2008-10#2)
The biologic##4##2##(1991-2#1)(1991-3#2)(1991-6#1)
The biological activity of##2##4##(1992-6#1)(2009-6#1)
The biological behavior of##2##4##(1990-6#1)(2008-8#1)
The biological properties of##2##4##(2008-5#1)(2009-7#1)
The biological relevance of##2##4##(1995-2#1)(1997-1#1)
The biological role of##2##4##(1991-2#1)(2013-7#1)
The biological##21##2##(1990-6#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-6#1)(2009-7#1)(2012-2#1)(2013-7#1)
The biomass concentration##2##3##(2008-5#1)(2008-7#1)
The bioprocess QbD##2##3##(2012-2#2)
The bioreactor##2##2##(2008-11#2)
The biosensor can##2##3##(2008-10#2)
The biosensor is based on##2##5##(2008-10#2)
The biosensor is##4##3##(2008-10#4)
The biosensor response depends linearly on##4##6##(2008-10#4)
The biosensor showed##2##3##(2008-10#2)
The biosensor was##2##3##(2008-10#2)
The biosensor##30##2##(2008-10#30)
The biosensors were##3##3##(2008-10#3)
The biosensors##9##2##(2008-10#9)
The biosynthesis of##3##3##(1993-12#1)(2011-1#1)(2012-2#1)
The biosynthesis##4##2##(1990-5#1)(1993-12#1)(2011-1#1)(2012-2#1)
The biotherapy##2##2##(2013-1#2)
The biotinylated##2##2##(1995-6#1)(2008-10#1)
The birds##4##2##(2008-5#1)(2008-8#2)(2008-9#1)
The birth##3##2##(1994-3#1)(2007-12#1)(2008-10#1)
The blank##2##2##(2008-10#2)
The blood flow##3##3##(2006-6#1)(2007-11#1)(2008-10#1)
The blood##6##2##(1994-3#1)(1996-6#1)(2006-6#1)(2007-11#1)(2008-10#1)(2011-3#1)
The blue##3##2##(1994-5#1)(2008-10#2)
The blueprint##2##2##(1995-12#1)(1997-3#1)
The blur caused by##2##4##(2008-3#2)
The body length of##2##4##(2013-1#2)
The body##6##2##(1996-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#2)
The bone marrow##2##3##(2010-8#1)(2013-8#1)
The bone##4##2##(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
The boron##2##2##(1990-3#1)(2008-10#1)
The boundary between##2##3##(2008-10#1)(2008-12#1)
The bovine##4##2##(1993-2#1)(1994-5#1)(1997-2#1)(2008-10#1)
The brain##4##2##(1994-8#1)(1997-3#1)(1997-8#1)(2008-10#1)
The brave new world of##2##5##(1991-3#1)(1997-2#1)
The breakthrough capacity was##2##4##(2008-10#2)
The breakthrough capacity##3##3##(2008-10#3)
The breakthrough##4##2##(2008-10#4)
The breast##2##2##(2010-8#1)(2012-12#1)
The breeding##2##2##(1995-2#1)(2008-9#1)
The bright##2##2##(1991-5#1)(2013-1#1)
The broad##2##2##(2008-11#1)(2009-5#1)
The broader##2##2##(2008-10#1)(2013-1#1)
The budget##2##2##(1996-5#1)(2008-6#1)
The buffer solution used##2##4##(2008-10#2)
The buffer##3##2##(2008-10#3)
The bulk##3##2##(2008-10#2)(2008-8#1)
The burden of##2##3##(2008-10#1)(2012-12#1)
The burden##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
The c-erbA alpha##2##3##(1993-3#2)
The c-myc##2##2##(1993-2#1)(1993-3#1)
The cAMP##2##2##(1995-8#1)(2008-11#1)
The cDNA clones##2##3##(2008-11#1)(2010-4#1)
The cDNA encoding##2##3##(2008-10#1)(2008-9#1)
The cDNA for the##2##4##(1995-2#1)(1997-9#1)
The cDNA for##3##3##(1995-2#1)(1997-9#1)(2010-5#1)
The cDNA sequence##4##3##(1991-6#1)(1993-3#1)(1995-6#2)
The cDNA##18##2##(1990-7#1)(1991-6#1)(1992-10#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-6#2)(1997-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-4#1)(2010-5#3)
The cDNAs of##2##3##(2008-10#1)(2008-8#1)
The cDNAs##5##2##(1992-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
The cTR##2##2##(1991-6#2)
The cadmium##2##2##(2008-10#2)
The calculated detection##2##3##(2008-10#2)
The calculated rates of##2##4##(1991-3#1)(2008-11#1)
The calculated##14##2##(1991-3#1)(1992-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2009-1#1)(2009-5#1)(2011-2#1)
The calculation of##3##3##(2008-10#2)(2013-1#1)
The calculation##5##2##(2007-12#1)(2008-10#3)(2013-1#1)
The calculations##4##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
The calibration curve for##4##4##(2008-10#4)
The calibration curve is linear over the concentration range 0##2##10##(2008-10#2)
The calibration curve is linear over the##3##7##(2008-10#3)
The calibration curve is linear over##4##6##(2008-10#4)
The calibration curve is linear##8##5##(2008-10#8)
The calibration curve is##10##4##(2008-10#10)
The calibration curve of##2##4##(2008-10#2)
The calibration curve was linear from##2##6##(2008-10#2)
The calibration curve was linear in the range##2##8##(2008-10#2)
The calibration curve was linear in the##3##7##(2008-10#3)
The calibration curve was linear over the concentration range##2##9##(2008-10#2)
The calibration curve was linear over the range##3##8##(2008-10#3)
The calibration curve was linear over the##5##7##(2008-10#5)
The calibration curve was linear up to##3##7##(2008-10#3)
The calibration curve was linear##13##5##(2008-10#13)
The calibration curve was##15##4##(2008-10#14)(2012-2#1)
The calibration curve##34##3##(1991-5#1)(2008-10#32)(2012-2#1)
The calibration curves for##2##4##(2008-10#2)
The calibration curves of##2##4##(2008-10#2)
The calibration curves showed##2##4##(2008-10#2)
The calibration curves were linear in the range of##2##9##(2008-10#2)
The calibration curves were linear in the##3##7##(2008-10#3)
The calibration curves were linear over the range##2##8##(2008-10#2)
The calibration curves were linear over the##3##7##(2008-10#3)
The calibration curves were linear over##4##6##(2008-10#4)
The calibration curves were linear##7##5##(2008-10#7)
The calibration curves were##8##4##(2008-10#8)
The calibration curves##16##3##(2008-10#16)
The calibration function##2##3##(2008-10#2)
The calibration graph for##4##4##(2008-10#4)
The calibration graph is linear in the range of##3##9##(2008-10#3)
The calibration graph is linear in the range##4##8##(2008-10#4)
The calibration graph is linear over the range 0##2##9##(2008-10#2)
The calibration graph is linear over the##3##7##(2008-10#3)
The calibration graph is linear##8##5##(2008-10#8)
The calibration graph of##3##4##(2008-10#3)
The calibration graph using the preconcentration system for##3##8##(2008-10#3)
The calibration graph using the##4##5##(2008-10#4)
The calibration graph was linear from##3##6##(2008-10#3)
The calibration graph was linear in the range 0##2##9##(2008-10#2)
The calibration graph was linear in the range of##3##9##(2008-10#3)
The calibration graph was linear in the range##8##8##(2008-10#8)
The calibration graph was linear in the##10##7##(2008-10#10)
The calibration graph was linear over the range 0##2##9##(2008-10#2)
The calibration graph was linear over the range##3##8##(2008-10#3)
The calibration graph was linear up to##3##7##(2008-10#3)
The calibration graph was linear##20##5##(2008-10#20)
The calibration graph was##21##4##(2008-10#21)
The calibration graph##45##3##(2008-10#45)
The calibration graphs for##3##4##(2008-10#3)
The calibration graphs were linear in the concentration##2##8##(2008-10#2)
The calibration graphs were linear in the range of##2##9##(2008-10#2)
The calibration graphs were linear in the##4##7##(2008-10#4)
The calibration graphs were linear##8##5##(2008-10#8)
The calibration graphs were##10##4##(2008-10#10)
The calibration graphs##19##3##(2008-10#19)
The calibration plot was linear##2##5##(2008-10#2)
The calibration plot##5##3##(2008-10#5)
The calibration plots for##2##4##(2008-10#2)
The calibration plots##3##3##(2008-10#3)
The calibration range##2##3##(2008-10#2)
The calibration set was##3##4##(2008-10#3)
The calibration set##4##3##(2008-10#4)
The calibration was##2##3##(2008-10#2)
The calibration##142##2##(1991-5#1)(2008-10#140)(2012-2#1)
The calorimetric##2##2##(2008-10#1)(2008-8#1)
The campaign##2##2##(1992-2#1)(1997-6#1)
The candidate##2##2##(1994-12#1)(2008-10#1)
The cannabinoid##2##2##(1996-2#1)(2009-8#1)
The capabilities of##4##3##(2008-10#4)
The capability of the##3##4##(2008-10#3)
The capability of##5##3##(2008-10#5)
The capability##6##2##(1993-8#1)(2008-10#5)
The capacitance measurement##2##3##(2008-10#2)
The capacitance##3##2##(2008-10#3)
The capacities of the##2##4##(2008-10#2)
The capacity of the##5##4##(2008-10#4)(2008-11#1)
The capacity of##12##3##(2008-10#7)(2008-11#4)(2011-1#1)
The capacity##14##2##(2008-10#9)(2008-11#4)(2011-1#1)
The capillary##2##2##(1997-2#1)(2008-10#1)
The carbon##5##2##(1992-1#1)(2008-10#3)(2008-7#1)
The carboxy-terminal##2##2##(1997-4#1)(2009-7#1)
The carboxyl##2##2##(1996-12#1)(2008-10#1)
The cardiovascular##2##2##(1990-5#1)(2012-2#1)
The carpal tunnel anatomy and##2##5##(2008-9#2)
The carrier stream##2##3##(2008-10#2)
The carrier##3##2##(2008-10#3)
The case for pet wellness and routine monitoring - A##2##10##(2013-8#2)
The case for risk-based##2##4##(2008-7#2)
The case for##7##3##(1997-2#1)(2008-11#2)(2008-7#2)(2013-8#2)
The case is presented##2##4##(2008-10#1)(2012-2#1)
The case is reported of a##2##6##(1990-6#1)(1991-3#1)
The case is##5##3##(1990-6#1)(1991-3#1)(1997-6#1)(2008-10#1)(2012-2#1)
The case of a patient with##2##6##(1990-8#1)(1991-11#1)
The case of a##8##4##(1990-8#1)(1991-11#1)(1991-6#1)(1991-8#1)(1995-5#1)(2008-11#1)(2011-2#2)
The case of the##2##4##(1997-3#1)(2008-11#1)
The case of##17##3##(1990-8#1)(1991-11#1)(1991-6#1)(1991-8#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-7#1)(2011-2#3)
The case report##4##3##(1997-8#1)(2008-11#2)(2012-3#1)
The case study##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
The case##47##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-8#1)(1995-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
The cases##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
The catalytic action of##2##4##(2008-10#2)
The catalytic activities of##2##4##(1993-2#1)(1994-5#1)
The catalytic activity of##4##4##(1997-8#1)(2008-10#3)
The catalytic current##2##3##(2008-10#2)
The catalytic effect of##2##4##(2008-10#2)
The catalytic rate constant of the modified##2##7##(2008-10#2)
The catalytic rate constant##3##4##(2008-10#3)
The catalytic rate##4##3##(2008-10#4)
The catalytic##22##2##(1993-2#1)(1994-5#1)(1997-8#1)(2008-10#19)
The categories##2##2##(2008-11#2)
The catheter##3##2##(2008-7#1)(2011-2#2)
The cathodic##3##2##(2008-10#3)
The cation uptake and release##2##5##(2008-10#2)
The causal agent of##3##4##(2008-10#2)(2012-2#1)
The causal agent##5##3##(2008-10#4)(2012-2#1)
The causal relationship between malignant mesothelioma and##2##7##(1991-12#1)(1995-2#1)
The causal##10##2##(1991-12#1)(1995-2#1)(2008-10#6)(2008-8#1)(2012-2#1)
The causative##4##2##(1991-2#1)(1992-5#1)(2008-12#1)(2008-5#1)
The cause for##3##3##(1997-3#1)(2008-10#1)(2013-8#1)
The cause of the##2##4##(1995-9#1)(2011-3#1)
The cause of##5##3##(1995-11#1)(1995-9#1)(2008-10#1)(2008-7#1)(2011-3#1)
The cause##11##2##(1991-2#1)(1995-11#1)(1995-5#1)(1995-9#1)(1997-3#1)(2008-10#2)(2008-7#1)(2011-3#1)(2013-7#1)(2013-8#1)
The causes of the##2##4##(2008-8#2)
The causes of##5##3##(2008-1#1)(2008-8#2)(2012-2#1)(2013-1#1)
The cell biological##2##3##(2008-5#1)(2008-8#1)
The cell body##2##3##(2008-7#2)
The cell density##2##3##(2008-11#2)
The cell growth##3##3##(2008-11#3)
The cell line##3##3##(2008-11#3)
The cell lines##4##3##(1993-3#1)(2008-10#1)(2008-11#2)
The cell##41##2##(1990-5#1)(1993-3#1)(1993-8#1)(2008-10#4)(2008-11#19)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
The cell-free##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
The cells are##2##3##(2008-10#1)(2008-11#1)
The cells of this##2##4##(2007-12#1)(2008-9#1)
The cells of##3##3##(2007-12#2)(2008-9#1)
The cells showed a fibroblast-like morphology##2##6##(2008-11#2)
The cells were cultured##2##4##(2008-11#2)
The cells were exposed##2##4##(1993-12#1)(2011-2#1)
The cells were grown##2##4##(2008-10#1)(2008-11#1)
The cells were immobilized in##2##5##(2008-11#2)
The cells were##18##3##(1993-12#1)(1994-5#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-11#6)(2008-9#1)(2011-2#2)(2013-1#3)
The cells##39##2##(1990-5#1)(1992-6#2)(1993-12#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(2007-12#3)(2008-10#3)(2008-11#14)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#1)
The cells'##2##2##(2008-8#2)
The cellular##13##2##(1990-6#1)(1991-10#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#4)(2009-4#1)(2011-2#1)
The center##2##2##(2008-1#1)(2008-10#1)
The central##11##2##(1991-2#1)(1993-12#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2010-4#1)(2012-3#1)
The cerebellar##2##2##(2011-2#1)(2013-8#1)
The cerebral##2##2##(1994-2#1)(1994-3#1)
The cessation of##2##3##(1995-6#1)(2008-7#1)
The chain##2##2##(1992-8#1)(2008-12#1)
The challenge for##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
The challenge in##2##3##(2008-10#1)(2009-12#1)
The challenge is to##2##4##(1991-11#1)(1994-2#1)
The challenge is##3##3##(1991-11#1)(1994-2#1)(2008-10#1)
The challenge of providing##2##4##(1991-12#1)(2010-10#1)
The challenge of##8##3##(1991-12#1)(1992-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-6#1)(2008-12#1)(2010-10#1)
The challenge to the##2##4##(2008-10#1)(2008-6#1)
The challenge to##3##3##(2008-10#1)(2008-6#2)
The challenge##22##2##(1991-11#1)(1991-12#1)(1992-1#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-12#1)(2010-10#1)(2013-8#2)
The challenges facing##2##3##(2008-10#1)(2013-1#1)
The challenges of##5##3##(1994-12#1)(1997-1#1)(2008-6#1)(2009-3#1)(2012-2#1)
The challenges##11##2##(1994-12#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
The change in the##2##4##(2008-10#1)(2008-7#1)
The change in##6##3##(1991-1#1)(2008-10#3)(2008-11#1)(2008-7#1)
The change of the##2##4##(2008-10#1)(2008-3#1)
The change of##6##3##(1990-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
The change##16##2##(1990-5#1)(1991-1#1)(1991-6#1)(1996-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)
The changes in pH##2##4##(2008-10#2)
The changes in the##4##4##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
The changes in##13##3##(1994-3#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-3#2)(2011-2#1)(2013-8#1)
The changes of the##2##4##(1993-8#1)(2008-7#1)
The changes of##4##3##(1992-3#1)(1993-8#1)(2008-7#1)(2008-9#1)
The changes were##4##3##(1995-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
The changes##24##2##(1992-3#1)(1993-8#1)(1994-3#1)(1995-8#2)(1996-3#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
The changing face of##2##4##(1992-3#1)(1994-2#1)
The changing landscape of##2##4##(1993-2#1)(2008-11#1)
The changing pattern of nontuberculous mycobacterial disease##2##7##(2007-12#2)
The changing##12##2##(1991-2#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-8#1)(2007-12#2)(2008-11#2)(2013-1#1)
The channels##3##2##(1994-12#1)(2008-10#2)
The character##2##2##(2008-10#1)(2013-1#1)
The characteristic concentration##2##3##(2008-10#2)
The characteristic ions##2##3##(2008-10#2)
The characteristic mass of##2##4##(2008-10#2)
The characteristic mass was##2##4##(2008-10#2)
The characteristic mass##9##3##(2008-10#9)
The characteristic masses for##2##4##(2008-10#2)
The characteristic##20##2##(1994-12#1)(2008-10#18)(2010-6#1)
The characteristics and##2##3##(2008-10#1)(2008-3#1)
The characteristics of the##5##4##(1991-2#1)(2008-10#4)
The characteristics of these##2##4##(2008-1#1)(2008-10#1)
The characteristics of this##2##4##(2008-10#1)(2008-3#1)
The characteristics of##15##3##(1990-12#1)(1991-2#1)(1996-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)
The characteristics##21##2##(1990-12#1)(1991-2#1)(1992-2#1)(1996-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-9#1)(2010-7#1)(2013-8#1)
The characterization of a##2##4##(2008-10#2)
The characterization of the##3##4##(2008-10#2)(2008-5#1)
The characterization of##12##3##(2008-10#8)(2008-3#2)(2008-5#1)(2010-2#1)
The charge##3##2##(1991-5#1)(2008-10#2)
The chelates were##4##3##(2008-10#4)
The chelating polymer##2##3##(2008-10#2)
The chelating resin##3##3##(2008-10#3)
The chelating##8##2##(1990-5#1)(2008-10#7)
The chemical and FI variables##2##5##(2008-10#2)
The chemical and##4##3##(2008-10#4)
The chemical composition of the##2##5##(1990-5#1)(2008-11#1)
The chemical reactivity##2##3##(2008-10#2)
The chemical stability##2##3##(2008-10#2)
The chemical variables affecting the##3##5##(2008-10#3)
The chemical##33##2##(1990-5#1)(1990-8#1)(1995-6#1)(2008-10#23)(2008-11#4)(2009-3#1)(2011-3#1)(2013-1#1)
The chemicals##2##2##(2008-10#2)
The chemiluminescence intensity was##2##4##(2008-10#2)
The chemiluminescence intensity##4##3##(2008-10#4)
The chemiluminescence##8##2##(2008-10#8)
The chemiluminescent##2##2##(2008-10#2)
The chemometric##4##2##(2008-10#4)
The chest x-ray##2##3##(2010-12#1)(2012-3#1)
The chest##3##2##(2008-3#1)(2010-12#1)(2012-3#1)
The chicken##2##2##(1990-8#1)(2008-11#1)
The chief##3##2##(1995-6#1)(1997-8#1)(2008-6#1)
The child was##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
The child##6##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
The children were##4##3##(1995-5#1)(1996-11#1)(2008-9#1)(2011-1#1)
The children##12##2##(1991-6#1)(1994-6#1)(1995-5#1)(1996-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#2)(2012-12#2)
The children's##3##2##(1991-2#1)(2012-12#1)(2013-1#1)
The chimeric##2##2##(2008-11#2)
The chip##2##2##(2008-10#2)
The chiral##2##2##(2008-10#2)
The chitosan##2##2##(2008-10#1)(2008-5#1)
The chloride##2##2##(2008-10#2)
The chlorosis##2##2##(2008-10#2)
The choice of therapy for the operative treatment of endometriosis is endoscopic laser surgery##2##14##(1992-2#2)
The choice of##17##3##(1992-2#3)(1996-2#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-8#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
The choice##18##2##(1992-2#3)(1992-3#1)(1996-2#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-8#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
The chorion##2##2##(2008-12#2)
The chosen##2##2##(2008-10#1)(2008-5#1)
The chromatograms obtained##2##3##(2008-10#2)
The chromatographic analysis##3##3##(2006-6#1)(2008-10#2)
The chromatographic behaviour of##2##4##(2008-10#2)
The chromatographic method was##2##4##(2008-10#2)
The chromatographic method##4##3##(2008-10#4)
The chromatographic profiles##2##3##(2008-10#2)
The chromatographic resolution between##2##4##(2008-10#2)
The chromatographic separation##3##3##(2008-10#3)
The chromatographic##25##2##(2006-6#1)(2008-10#24)
The chromatography##2##2##(2008-10#2)
The chromatomembrane##2##2##(2008-10#2)
The chromium was##2##3##(2008-10#2)
The chromium##5##2##(2008-10#5)
The chromophore of##2##3##(2008-10#2)
The chromosomal##6##2##(1991-7#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#2)
The chromosome##3##2##(1997-8#1)(2008-12#1)(2008-9#1)
The circadian##2##2##(1994-2#1)(2009-8#1)
The circuit##2##2##(1997-6#1)(2008-11#1)
The circular##2##2##(2008-10#2)
The city##2##2##(1997-6#1)(2008-12#1)
The class##3##2##(1995-2#1)(2008-10#1)(2009-12#1)
The classic##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
The classical##4##2##(1990-6#1)(2008-10#1)(2008-11#1)(2010-5#1)
The classification of##5##3##(1993-1#1)(2008-1#1)(2008-10#3)
The classification##8##2##(1993-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2009-10#1)(2011-3#1)
The cleavage##4##2##(1991-5#1)(2008-9#3)
The clinic administrator was charged with coordinating the implementation of these services in the clinics by the hospital support departments##2##20##(1994-1#2)
The clinical and pathologic features of##2##6##(1990-6#1)(1992-2#1)
The clinical and radiological##2##4##(1995-9#1)(2008-7#1)
The clinical and##11##3##(1990-6#1)(1992-2#1)(1994-3#1)(1995-9#1)(2008-10#1)(2008-5#2)(2008-7#3)(2013-1#1)
The clinical course of##2##4##(2008-7#1)(2013-1#1)
The clinical course##4##3##(1996-11#1)(1997-5#1)(2008-7#1)(2013-1#1)
The clinical efficacy##2##3##(1993-12#1)(2011-2#1)
The clinical features of##4##4##(1997-8#1)(2007-8#1)(2008-1#1)(2008-7#1)
The clinical features##5##3##(1997-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)
The clinical implications of##2##4##(1995-2#1)(2008-6#1)
The clinical management of##2##4##(2008-11#1)(2011-2#1)
The clinical manifestations##2##3##(2008-4#1)(2011-2#1)
The clinical outcome##2##3##(1997-3#1)(2008-7#1)
The clinical presentation##3##3##(1990-12#1)(1996-3#1)(2012-2#1)
The clinical significance##2##3##(2008-10#1)(2013-1#1)
The clinical signs##2##3##(1990-3#1)(1997-5#1)
The clinical##81##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#2)(2010-8#2)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
The clone##3##2##(1993-12#1)(1993-2#1)(1995-8#1)
The cloned gene was##2##4##(1997-2#1)(1997-7#1)
The cloned##7##2##(1990-5#1)(1993-12#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-11#1)
The cloning and expression##2##4##(1993-2#1)(2008-9#1)
The cloning and##3##3##(1993-2#2)(2008-9#1)
The cloning of a##2##4##(1993-8#1)(2008-9#1)
The cloning of##4##3##(1993-3#1)(1993-8#1)(2008-8#1)(2008-9#1)
The cloning##7##2##(1993-2#2)(1993-3#1)(1993-8#1)(2008-8#1)(2008-9#2)
The close##5##2##(1996-12#1)(1996-8#1)(2008-7#2)(2012-3#1)
The closed##2##2##(2008-10#2)
The closest##4##2##(2008-10#3)(2008-12#1)
The closing##2##2##(1992-3#1)(2009-8#1)
The closure of the##2##4##(1995-6#1)(2009-8#1)
The closure of##3##3##(1995-6#1)(1997-8#1)(2009-8#1)
The cluster##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
The clustering of##2##3##(2009-5#1)(2009-8#1)
The coat protein (CP)##2##4##(2008-10#2)
The coat protein##3##3##(2008-10#3)
The coat##4##2##(2008-10#4)
The coating##2##2##(2008-10#2)
The cobalt##3##2##(2008-10#3)
The cochlear##2##2##(2008-9#1)(2013-8#1)
The coding region of##2##4##(1990-12#1)(1997-8#1)
The coding region##3##3##(1990-12#1)(1993-6#1)(1997-8#1)
The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1##2##19##(1996-2#2)
The coding sequences of 40 new genes##3##7##(1995-8#1)(1996-2#2)
The coding##7##2##(1990-12#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-2#2)(1997-8#1)
The coefficient of variation##3##4##(1996-3#1)(2008-10#1)(2010-8#1)
The coefficient variations of the method are less than##2##9##(2008-10#2)
The coefficient variations of##3##4##(2008-10#3)
The coefficient##6##2##(1996-3#1)(2008-10#4)(2010-8#1)
The coefficients of variation##2##4##(2008-10#2)
The coefficients##3##2##(2008-10#2)(2008-5#1)
The coenospermia##2##2##(2007-12#2)
The coexistence of##4##3##(2008-10#1)(2008-8#1)(2012-3#2)
The cognitive##3##2##(2008-11#1)(2008-7#1)(2010-4#1)
The collagen##5##2##(1992-6#2)(1993-12#1)(1994-12#1)(2008-5#1)
The collapse of##2##3##(1994-8#1)(2008-5#1)
The collected data are also presented in##2##7##(2008-10#2)
The collected data##4##3##(2008-10#3)(2008-11#1)
The collected##7##2##(2008-10#6)(2008-11#1)
The collection and analysis of##2##5##(1995-12#1)(2008-10#1)
The collection##5##2##(1995-12#1)(2008-10#3)(2008-5#1)
The collections##2##2##(2008-10#2)
The collimated##2##2##(2008-11#1)(2008-3#1)
The collision-induced dissociation of protonated molecular ion formed##2##8##(2008-10#2)
The collision-induced##3##2##(2008-10#2)(2008-3#1)
The colonic##2##2##(2012-2#1)(2012-3#1)
The color reaction##2##3##(2008-10#2)
The color system obeys Beer's law in the range 0##2##10##(2008-10#2)
The color##8##2##(1993-8#1)(2008-10#7)
The colour of the##3##4##(2008-10#2)(2010-4#1)
The colour##8##2##(2008-10#6)(2008-5#1)(2010-4#1)
The column##5##2##(2008-10#5)
The combination of a##2##4##(2008-10#1)(2011-3#1)
The combination of the##2##4##(2008-10#1)(2013-8#1)
The combination of these##2##4##(2008-10#1)(2010-11#1)
The combination of##45##3##(1990-5#1)(1991-6#1)(1992-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-8#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-3#4)(2013-1#1)(2013-8#2)
The combination##47##2##(1990-5#1)(1991-6#1)(1992-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-3#4)(2013-1#1)(2013-8#2)
The combined effects of##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
The combined results##3##3##(1995-11#1)(2008-10#1)(2011-2#1)
The combined use of##4##4##(1993-2#1)(2008-11#1)(2008-3#1)(2008-9#1)
The combined##29##2##(1990-5#1)(1993-2#1)(1995-11#1)(1995-3#1)(1996-3#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
The comments were##2##3##(2008-11#2)
The commercial##5##2##(2008-10#3)(2008-4#1)(2008-5#1)
The commercially available##2##3##(2008-10#2)
The common excipients used as additives##2##6##(2008-10#2)
The common wheat##2##3##(2008-10#2)
The common##20##2##(1991-3#1)(1992-1#1)(1994-12#1)(1994-6#1)(1995-8#1)(1995-9#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-7#1)(2009-8#1)(2012-5#1)(2013-1#1)
The commonest##4##2##(2008-10#1)(2008-8#1)(2009-11#1)(2012-3#1)
The commonly used##3##3##(2008-10#2)(2008-3#1)
The community##3##2##(1996-11#1)(2008-1#1)(2010-10#1)
The companies##3##2##(1996-5#1)(2008-5#2)
The company has##3##3##(2008-5#2)(2010-9#1)
The company##5##2##(1992-11#1)(2008-5#3)(2010-9#1)
The comparative analysis of##2##4##(2008-10#1)(2010-7#1)
The comparative study of##2##4##(2008-10#1)(2008-9#1)
The comparative study##3##3##(2008-10#2)(2008-9#1)
The comparative##8##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)
The comparison between##2##3##(2008-10#1)(2008-11#1)
The comparison of the##9##4##(1991-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)
The comparison of##21##3##(1991-12#1)(1991-6#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-7#1)(2012-9#1)
The comparison with##2##3##(2008-10#1)(2010-6#1)
The comparison##32##2##(1991-12#1)(1991-6#1)(1993-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-5#2)(2008-8#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-9#1)(2013-8#1)
The competitive##2##2##(2008-11#1)(2008-8#1)
The complementary##2##2##(2008-10#1)(2008-6#1)
The complete CYSDV CP gene##2##5##(2008-10#2)
The complete absence of##2##4##(2007-12#1)(2008-10#1)
The complete cycle##2##3##(2008-10#1)(2008-3#1)
The complete genome##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
The complete nucleotide (nt)##2##4##(1993-12#1)(2008-10#1)
The complete nucleotide sequence of a##2##6##(1996-6#1)(2008-10#1)
The complete nucleotide sequence of the##6##6##(1992-3#1)(1993-2#1)(1995-6#1)(2008-10#3)
The complete nucleotide sequence of##13##5##(1992-3#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-6#1)(2008-10#6)(2008-8#1)
The complete nucleotide sequences of##2##5##(2008-10#2)
The complete nucleotide##17##3##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-6#1)(2008-10#9)(2008-8#1)
The complete sequence of a##2##5##(2008-9#2)
The complete sequence of the##3##5##(2008-10#2)(2008-8#1)
The complete sequence of##8##4##(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#2)
The complete sequence##9##3##(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#3)
The complete##48##2##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-6#2)(1996-6#1)(2007-12#1)(2008-10#22)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#4)(2010-5#1)(2012-12#1)(2013-1#2)(2013-8#1)
The complex formation between##3##4##(2008-10#3)
The complex formation constants of##3##5##(2008-10#3)
The complex formation##7##3##(2008-10#7)
The complex formed between##2##4##(2008-10#2)
The complex formed##3##3##(2008-10#3)
The complex is##5##3##(1991-3#1)(2008-10#4)
The complex obeys Beer's law from 0##2##7##(2008-10#2)
The complex of##3##3##(1991-3#1)(1993-8#1)(2008-10#1)
The complex was##4##3##(1994-11#1)(2008-10#3)
The complex##45##2##(1991-3#2)(1993-8#2)(1994-11#2)(2007-12#1)(2008-1#1)(2008-10#33)(2009-10#1)(2009-11#1)(2010-11#1)(2012-3#1)
The complexant##2##2##(2008-10#2)
The complexation equilibria##2##3##(2008-10#2)
The complexation##6##2##(2008-10#6)
The complexes of##2##3##(1997-3#1)(2008-10#1)
The complexes##4##2##(1997-3#1)(2008-10#3)
The complexing properties##2##3##(2008-10#2)
The complexing##5##2##(2008-10#5)
The complexity of##3##3##(1992-1#1)(2008-4#1)(2009-6#1)
The complexity##4##2##(1992-1#1)(2008-11#1)(2008-4#1)(2009-6#1)
The compliance of##2##3##(1993-11#1)(1994-8#1)
The compliance##4##2##(1993-11#1)(1994-8#1)(1997-2#2)
The complication rate was##2##4##(1993-6#1)(2011-2#1)
The complication rate##4##3##(1993-6#1)(1996-9#1)(2011-2#1)(2012-3#1)
The complication##5##2##(1993-6#1)(1996-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
The complications##2##2##(2008-3#1)(2013-1#1)
The components##2##2##(1997-4#1)(2008-8#1)
The composite##9##2##(2008-10#6)(2009-4#1)(2009-7#2)
The composition of the complex##2##5##(2008-10#2)
The composition of the##6##4##(2008-10#4)(2008-11#1)(2010-4#1)
The composition of##8##3##(2008-10#5)(2008-11#2)(2010-4#1)
The composition##11##2##(1996-2#1)(2008-10#7)(2008-11#2)(2010-4#1)
The compositions##2##2##(2008-10#1)(2013-8#1)
The compound is##3##3##(1997-6#2)(2008-5#1)
The compound was##2##3##(1992-12#1)(2008-10#1)
The compound##11##2##(1990-8#1)(1992-12#2)(1997-6#2)(2008-10#4)(2008-5#1)(2013-1#1)
The compounds showed##2##3##(2008-10#1)(2008-11#1)
The compounds were##6##3##(1992-10#1)(1992-8#1)(1993-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
The compounds##12##2##(1992-10#1)(1992-8#1)(1993-12#1)(1994-2#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-8#1)
The comprehensive##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
The computations##2##2##(2008-10#1)(2008-11#1)
The computer##2##2##(1997-2#1)(2008-3#1)
The computer-based journal provides accurate information on the number and kind of contacts##2##13##(1994-6#2)
The computerized##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
The concentration and##5##3##(2008-10#3)(2008-11#1)(2008-2#1)
The concentration dependent##2##3##(2008-10#2)
The concentration distribution of##2##4##(2008-10#2)
The concentration factor##2##3##(2008-10#2)
The concentration gradient##2##3##(2008-10#1)(2012-2#1)
The concentration measurements are reproducible within a##2##7##(2008-10#2)
The concentration measurements##3##3##(2008-10#3)
The concentration of H(2)O(2)##2##4##(2008-10#2)
The concentration of potassium##2##4##(2008-10#1)(2008-2#1)
The concentration of the analyte##2##5##(2008-10#2)
The concentration of the##6##4##(2008-10#5)(2008-5#1)
The concentration of trace##2##4##(2008-10#2)
The concentration of##55##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-5#1)(1997-1#1)(1997-5#1)(2007-11#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)
The concentration range in##2##4##(2008-10#2)
The concentration range##9##3##(2008-10#9)
The concentration ranges##5##3##(2008-10#4)(2008-7#1)
The concentration ratio##2##3##(2008-10#2)
The concentration##97##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-5#1)(1997-1#1)(1997-5#1)(2007-11#1)(2008-10#68)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2012-2#1)
The concentrations for##2##3##(2008-10#2)
The concentrations of the other##2##5##(2008-10#2)
The concentrations of the##6##4##(1991-3#1)(1996-12#1)(2008-10#4)
The concentrations of##26##3##(1990-5#2)(1991-3#1)(1992-3#1)(1996-12#1)(1997-3#1)(2008-10#17)(2008-11#1)(2011-3#2)
The concentrations##29##2##(1990-5#2)(1991-3#1)(1992-3#1)(1996-12#1)(1997-3#1)(2008-10#20)(2008-11#1)(2011-3#2)
The concept is##2##3##(1992-2#1)(2008-10#1)
The concept of &quot##2##4##(1992-3#1)(1995-5#1)
The concept of the##3##4##(1992-12#1)(1993-1#1)(1996-9#1)
The concept of##29##3##(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1995-5#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-3#1)(2008-10#7)(2008-11#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#3)
The concept that##2##3##(1995-6#1)(2008-10#1)
The concept##34##2##(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-3#1)(2008-10#9)(2008-11#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#3)
The conceptual applications employed in this technology set are provided by way of illustration##2##14##(2010-8#2)
The conceptual##3##2##(1997-3#1)(2010-8#2)
The conclusion from the##2##4##(2008-10#1)(2010-12#1)
The conclusion is that the##3##5##(2008-7#1)(2009-7#1)(2012-3#1)
The conclusion is that##7##4##(1990-2#1)(1994-3#1)(2008-7#2)(2009-7#1)(2012-3#2)
The conclusion##12##2##(1990-2#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-7#1)(2010-12#1)(2012-3#2)
The conclusions of##2##3##(1994-12#1)(2008-12#1)
The conclusions##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
The condensed##2##2##(2008-10#1)(2008-8#1)
The condition for##2##3##(2008-10#2)
The condition is##3##3##(1990-9#1)(2008-10#1)(2012-3#1)
The condition of##2##3##(1997-3#1)(1997-5#1)
The condition was##3##3##(2008-7#1)(2008-8#1)(2012-12#1)
The condition##11##2##(1990-9#1)(1991-6#1)(1997-3#1)(1997-5#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
The conditional stability constants##2##4##(2008-10#2)
The conditional##3##2##(2008-10#3)
The conditions for the##2##4##(2008-10#2)
The conditions for##6##3##(2008-10#4)(2008-3#1)(2008-8#1)
The conditions of##5##3##(2008-10#5)
The conditions were##2##3##(2008-9#1)(2011-2#1)
The conditions##19##2##(1995-2#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
The conductivity of##2##3##(2008-10#2)
The conductivity##3##2##(2008-10#3)
The conference was##2##3##(1995-3#1)(2008-3#1)
The conference##4##2##(1995-3#1)(2008-3#1)(2010-4#1)(2010-5#1)
The confidence intervals##2##3##(2008-10#1)(2008-8#1)
The configuration##2##2##(2008-2#1)(2008-9#1)
The confinement##2##2##(2008-3#1)(2008-5#1)
The conformation of the##2##4##(1993-3#1)(2008-10#1)
The conformation of##3##3##(1993-3#1)(1995-6#1)(2008-10#1)
The conformation##5##2##(1993-3#1)(1995-6#1)(2008-10#1)(2008-12#1)(2010-12#1)
The congenital##2##2##(1995-12#1)(2012-3#1)
The conjugate##3##2##(2008-7#2)(2010-8#1)
The conjugated##2##2##(2008-10#1)(2009-5#1)
The conjugates##2##2##(1991-5#1)(2008-10#1)
The consequences of##2##3##(2008-11#1)(2011-2#1)
The consequences##3##2##(2008-11#1)(2009-1#1)(2011-2#1)
The consequent##3##2##(1991-6#1)(2008-10#1)(2013-1#1)
The conservation##2##2##(1993-2#1)(2008-10#1)
The conserved##2##2##(2008-8#1)(2009-6#1)
The considerable##2##2##(1994-5#1)(2008-10#1)
The considerations##2##2##(1993-11#1)(2008-12#1)
The consistency of the##2##4##(1992-9#1)(2008-10#1)
The consistency##3##2##(1992-9#1)(2008-10#1)(2011-2#1)
The conspicuous##2##2##(2008-10#2)
The constant##4##2##(2008-10#2)(2008-11#1)(2009-12#1)
The constants##3##2##(2008-10#3)
The construct of##2##3##(1991-12#1)(1993-3#1)
The construct##3##2##(1991-12#1)(1993-3#1)(2013-1#1)
The constructed##3##2##(1997-2#1)(2008-11#1)(2011-2#1)
The construction and##5##3##(1993-9#1)(2008-10#4)
The construction of a##3##4##(2008-10#3)
The construction of the##2##4##(2008-10#1)(2008-8#1)
The construction of##8##3##(1991-6#1)(2008-10#4)(2008-11#1)(2008-8#2)
The construction##16##2##(1991-6#1)(1993-9#1)(1995-9#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-8#2)
The consumer##2##2##(1994-3#1)(2008-5#1)
The contamination of##2##3##(2008-10#1)(2008-11#1)
The contamination##3##2##(2008-10#2)(2008-11#1)
The content of the##3##4##(1994-11#1)(2008-11#1)(2013-8#1)
The content of vanadium in##2##5##(2008-10#2)
The content of##17##3##(1990-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2013-8#1)
The contents of##9##3##(2008-10#9)
The contents##10##2##(1993-1#1)(2008-10#9)
The context##2##2##(1997-1#1)(2009-10#1)
The continued##3##2##(1996-1#1)(2008-10#1)(2013-1#1)
The continuing##3##2##(1990-6#1)(2008-11#1)(2008-8#1)
The continuous analysis using the##2##5##(2008-10#2)
The continuous##7##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-2#1)
The contraction##2##2##(1993-3#1)(2008-10#1)
The contralateral##3##2##(1990-12#1)(1992-3#1)(2008-10#1)
The contribution of##11##3##(1992-12#1)(1993-12#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2013-1#1)
The contributions of##4##3##(1994-5#1)(1995-9#1)(1997-8#1)(2008-10#1)
The control group included##2##4##(2011-2#1)(2013-1#1)
The control group##6##3##(1996-3#1)(2008-12#1)(2008-8#1)(2011-2#2)(2013-1#1)
The control of##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)
The control region was amplified in one piece and sequenced with different sequencing primers##2##14##(2008-12#2)
The control##18##2##(1990-11#1)(1993-3#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-5#2)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#1)
The controlled##2##2##(2008-10#1)(2008-5#1)
The controller##2##2##(2008-10#1)(2008-3#1)
The controversial##2##2##(1991-3#1)(2008-10#1)
The conventional method##2##3##(2008-10#2)
The conventional##7##2##(2008-10#5)(2008-7#1)(2013-1#1)
The convergence of##2##3##(2012-3#1)(2013-8#1)
The conversion of##4##3##(1992-12#1)(2008-10#2)(2009-12#1)
The conversion##7##2##(1992-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-12#1)
The coordination of##2##3##(2011-2#1)(2012-3#1)
The coordination##5##2##(1994-8#1)(2008-10#1)(2011-2#2)(2012-3#1)
The copper complex##2##3##(2008-10#2)
The copper##8##2##(1990-5#1)(1993-2#1)(2008-10#6)
The core##4##2##(1995-2#1)(2008-11#1)(2008-12#1)(2008-6#1)
The cornerstone of##2##3##(2008-4#1)(2010-1#1)
The cornified cell envelope##2##4##(2008-5#2)
The cornified##3##2##(2008-5#3)
The correct##4##2##(2008-10#1)(2008-9#1)(2009-9#1)(2010-10#1)
The correlation between the##5##4##(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
The correlation between##14##3##(1990-4#1)(1990-5#1)(1995-5#1)(1995-8#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-2#2)
The correlation coefficient was 0##3##5##(2008-10#3)
The correlation coefficient##6##3##(1993-3#1)(2008-10#5)
The correlation coefficients were##2##4##(2008-10#2)
The correlation coefficients##4##3##(1991-12#1)(2008-10#2)(2008-5#1)
The correlation of##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
The correlation##31##2##(1990-4#1)(1990-5#1)(1991-12#1)(1993-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-7#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
The correlations##3##2##(1992-3#1)(1996-12#1)(2011-1#1)
The correspondence##2##2##(2009-8#1)(2012-12#1)
The corresponding values for##3##4##(1993-8#1)(2008-10#1)(2008-7#1)
The corresponding##16##2##(1993-1#1)(1993-8#1)(1997-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-8#2)
The cosmetic##5##2##(1991-2#1)(1991-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
The cosmid##2##2##(1996-2#1)(1997-9#1)
The cost of the##3##4##(1992-12#2)(2008-10#1)
The cost of##13##3##(1991-2#1)(1992-12#3)(1996-1#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)
The cost##16##2##(1991-2#2)(1992-12#3)(1992-5#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)
The costs of##3##3##(1990-9#1)(1991-12#1)(1993-2#1)
The cotton##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
The coulometric##3##2##(2008-10#3)
The country##2##2##(1997-6#2)
The coupling of##4##3##(2008-10#3)(2008-3#1)
The course of pregnancy##2##4##(2012-3#2)
The course of the##3##4##(1996-5#1)(1996-6#1)(2008-10#1)
The course of##7##3##(1996-5#1)(1996-6#1)(2008-10#2)(2012-3#2)(2013-8#1)
The course##12##2##(1996-5#1)(1996-6#1)(2008-10#2)(2008-11#4)(2008-12#1)(2012-3#2)(2013-8#1)
The court##12##2##(1990-11#2)(1990-2#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-5#3)(1996-9#1)
The covalent immobilization of##2##4##(2008-10#2)
The covalent##3##2##(2008-10#3)
The covalently##2##2##(2008-10#2)
The cranial nerves##2##3##(2008-1#1)(2011-2#1)
The creation of a##3##4##(1992-1#1)(2008-9#1)(2011-2#1)
The creation of##4##3##(1992-1#1)(1996-3#1)(2008-9#1)(2011-2#1)
The creation##5##2##(1992-1#2)(1996-3#1)(2008-9#1)(2011-2#1)
The crisis centre for children in Prague 4-Michle##2##8##(1995-5#2)
The crisis##4##2##(1994-12#1)(1995-1#1)(1995-5#2)
The criteria used##2##3##(2012-2#1)(2013-1#1)
The criteria##4##2##(1997-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
The critical##10##2##(1991-3#1)(1991-6#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-1#1)(2010-8#1)(2012-3#1)
The cross##2##2##(2008-10#2)
The cross-reaction of##2##3##(2008-11#2)
The cross-sectional##2##2##(1997-3#1)(2013-8#1)
The cross-validation method was used to select the number of factors##3##11##(2008-10#3)
The cross-validation method was used##4##5##(2008-10#4)
The crucial##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
The crude##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
The crystal structure of the##3##5##(1994-12#1)(1995-2#1)(2013-8#1)
The crystal structure of##8##4##(1992-4#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(2013-8#2)
The crystal structure##10##3##(1992-12#1)(1992-4#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-9#1)(2013-8#2)
The crystal##12##2##(1992-12#1)(1992-4#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-9#1)(2013-8#2)
The crystals##4##2##(1992-11#1)(1992-9#1)(2008-8#1)(2008-9#1)
The cultivars##3##2##(2008-10#3)
The cultural##3##2##(1997-3#1)(2012-2#1)(2013-1#1)
The culture conditions##2##3##(1996-12#1)(2010-5#1)
The culture medium##2##3##(2008-11#1)(2008-7#1)
The culture##8##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-5#1)
The cumulative survival rate was##2##5##(1993-11#1)(2008-7#1)
The cumulative##8##2##(1993-11#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-8#1)(2012-12#1)
The current investigation##2##3##(1993-1#1)(2008-12#1)
The current literature##3##3##(2008-7#1)(2013-1#2)
The current management##3##3##(2008-7#1)(2010-6#1)(2013-1#1)
The current method##2##3##(2008-10#2)
The current paper##2##3##(2012-2#2)
The current report gives a brief overview into the##2##9##(2008-10#2)
The current report gives##3##4##(2008-10#3)
The current report##4##3##(2008-10#3)(2008-7#1)
The current research##2##3##(2008-12#1)(2009-4#1)
The current results##2##3##(2008-10#1)(2010-6#1)
The current review##2##3##(2010-1#1)(2012-2#1)
The current state of##2##4##(2013-8#2)
The current studies##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
The current study examined##2##4##(2010-1#1)(2012-3#1)
The current study was##4##4##(2008-10#1)(2008-5#1)(2012-2#2)
The current study##24##3##(2008-10#3)(2008-11#1)(2008-5#2)(2009-10#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
The current work##2##3##(2008-10#1)(2010-10#1)
The current##91##2##(1991-1#2)(1991-11#1)(1991-12#1)(1993-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-10#22)(2008-11#5)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#3)(2009-4#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#5)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#3)
The curriculum##2##2##(1997-3#1)(2008-11#1)
The curves of##2##3##(2008-10#2)
The cut-off##3##2##(1992-1#1)(2010-5#1)(2013-1#1)
The cutaneous##3##2##(2010-6#1)(2012-3#1)(2013-8#1)
The cyclic voltammograms of##2##4##(1996-5#1)(2008-10#1)
The cyclic voltammograms##3##3##(1996-5#1)(2008-10#2)
The cyclic##12##2##(1992-3#1)(1996-12#1)(1996-5#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-9#2)
The cyst##2##2##(1997-8#2)
The cystic lesion##2##3##(2008-10#1)(2008-5#1)
The cystic##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
The cysts were##3##3##(2008-7#1)(2010-11#1)(2010-12#1)
The cysts##4##2##(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)
The cytology##2##2##(2012-2#2)
The cytoplasm of##2##3##(2007-12#1)(2008-11#1)
The cytoplasm##3##2##(2007-12#1)(2008-11#1)(2008-12#1)
The cytoplasmic domain##2##3##(1991-6#1)(2008-5#1)
The cytoplasmic##5##2##(1991-6#1)(1994-6#2)(2008-5#1)(2008-7#1)
The cytosolic##3##2##(1992-12#1)(1994-11#1)(1994-6#1)
The cytotoxic effect##2##3##(1990-2#1)(2008-11#1)
The cytotoxic effects of##4##4##(1990-5#1)(2008-11#1)(2010-1#1)(2011-1#1)
The cytotoxic##7##2##(1990-2#1)(1990-5#1)(2008-11#3)(2010-1#1)(2011-1#1)
The cytotoxicity of##2##3##(2008-11#2)
The cytotoxicity##4##2##(2008-11#2)(2008-8#2)
The dAVS##2##2##(1996-9#2)
The daily##3##2##(2008-10#1)(2009-11#1)(2011-2#1)
The damage##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
The danger##2##2##(2010-5#1)(2011-2#1)
The dark##2##2##(2008-11#1)(2008-12#1)
The data also demonstrate that##2##5##(1992-3#1)(2008-10#1)
The data also demonstrate##4##4##(1992-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
The data also##8##3##(1992-3#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)
The data analysis##4##3##(2008-12#1)(2008-6#1)(2008-8#1)(2009-11#1)
The data are consistent with##3##5##(1993-8#1)(2008-10#2)
The data are consistent##4##4##(1993-8#1)(2008-10#2)(2008-11#1)
The data are##12##3##(1993-8#1)(1994-1#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
The data collected##3##3##(1990-12#1)(2008-12#1)(2012-3#1)
The data collection was conducted##2##5##(1990-12#1)(2011-2#1)
The data collection##3##3##(1990-12#1)(2011-2#1)(2012-2#1)
The data demonstrate that##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
The data demonstrate##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2009-10#1)
The data demonstrated that##2##4##(2008-10#1)(2011-3#1)
The data from##4##3##(1994-6#1)(2008-10#1)(2008-9#2)
The data generated from this study##2##6##(2008-10#2)
The data generated##3##3##(2008-10#2)(2008-5#1)
The data have been processed by a recently developed##2##9##(2008-10#2)
The data have been##3##4##(2008-10#3)
The data have##4##3##(2008-10#3)(2010-6#1)
The data indicate that the##2##5##(1997-7#1)(2008-10#1)
The data indicate that##11##4##(1991-12#1)(1993-3#1)(1994-5#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-7#1)
The data indicate##12##3##(1991-12#1)(1993-3#1)(1994-5#1)(1997-7#1)(2008-10#6)(2008-3#1)(2008-7#1)
The data indicated that##2##4##(2008-11#1)(2010-8#1)
The data is##2##3##(1993-3#1)(2008-11#1)
The data obtained by the present##2##6##(2008-10#2)
The data obtained by##4##4##(2008-10#4)
The data obtained from##4##4##(1995-6#1)(2008-10#3)
The data obtained were##2##4##(2008-12#1)(2010-6#1)
The data obtained##13##3##(1995-6#1)(2008-10#9)(2008-12#1)(2008-5#1)(2010-6#1)
The data of##3##3##(1991-3#1)(2008-12#1)(2012-2#1)
The data on the##3##4##(1991-3#1)(2008-10#1)(2011-2#1)
The data on##6##3##(1991-3#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#1)
The data presented here support##2##5##(2008-10#1)(2012-3#1)
The data presented##4##3##(2008-10#3)(2012-3#1)
The data provide##2##3##(1992-1#1)(2008-10#1)
The data set##4##3##(2008-10#3)(2008-3#1)
The data show that the##2##5##(1996-2#1)(2008-10#1)
The data show that##6##4##(1990-5#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-7#1)
The data show##7##3##(1990-5#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
The data showed that##3##4##(1996-3#1)(2008-5#1)(2008-9#1)
The data suggest that the##8##5##(1990-2#1)(1992-10#1)(1993-8#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-9#1)
The data suggest that##20##4##(1990-2#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#2)(2010-12#1)(2012-3#1)
The data suggest##22##3##(1990-2#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-12#2)(1997-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#2)(2010-12#1)(2012-3#1)
The data suggests##2##3##(1994-2#1)(2008-10#1)
The data support the hypothesis that##2##6##(1997-3#1)(2007-12#1)
The data support##3##3##(1997-3#1)(2007-12#1)(2008-10#1)
The data thus##3##3##(1990-5#1)(1997-6#1)(2008-10#1)
The data was statistically##2##4##(2012-3#1)(2013-1#1)
The data was##7##3##(1991-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
The data were analysed##2##4##(2008-9#1)(2009-6#1)
The data were analyzed##3##4##(1990-2#1)(1990-6#1)(2008-10#1)
The data were collected##4##4##(2008-5#1)(2009-12#1)(2009-5#1)(2013-1#1)
The data were obtained from##2##5##(1990-2#1)(1995-12#1)
The data were obtained##3##4##(1990-2#1)(1995-12#1)(2008-10#1)
The data were##19##3##(1990-2#2)(1990-6#1)(1995-12#1)(1996-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-6#1)(2010-8#1)(2012-3#1)(2013-1#2)
The data##192##2##(1990-12#2)(1990-2#3)(1990-5#3)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#3)(1992-1#1)(1992-10#1)(1992-3#3)(1992-9#1)(1993-1#1)(1993-3#3)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#56)(2008-11#10)(2008-12#9)(2008-2#3)(2008-3#4)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-6#2)(2010-8#2)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#7)(2013-1#6)(2013-7#2)
The database is##3##3##(1991-12#1)(2009-2#2)
The database##5##2##(1991-12#1)(1996-3#1)(2008-11#1)(2009-2#2)
The databases##2##2##(2009-10#1)(2012-3#1)
The debate over##2##3##(1994-3#1)(1995-2#1)
The debate##4##2##(1990-6#1)(1994-3#1)(1995-2#1)(2008-11#1)
The decay of##2##3##(1992-12#1)(2012-3#1)
The decision to##5##3##(2009-6#1)(2010-11#1)(2012-3#3)
The decision##12##2##(1993-1#1)(1994-3#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-7#1)(2009-6#1)(2010-11#1)(2012-3#3)
The decline in##2##3##(1995-8#1)(2008-11#1)
The decrease in absorbance of##2##5##(2008-10#2)
The decrease in##13##3##(1992-6#1)(1994-5#1)(1995-8#1)(2008-10#7)(2008-11#3)
The decrease of##4##3##(1996-6#1)(2008-10#3)
The decrease was##2##3##(1991-5#1)(2008-11#1)
The decrease##21##2##(1991-5#1)(1992-6#1)(1994-5#1)(1995-8#1)(1996-6#1)(2008-10#12)(2008-11#4)
The decreased##6##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
The deduced aa sequence##3##4##(1990-11#1)(1993-12#1)(1993-6#1)
The deduced amino acid (aa) sequence of##2##7##(1991-6#1)(1993-12#1)
The deduced amino acid sequence of##2##6##(1993-2#1)(2008-8#1)
The deduced amino acid sequence shows##2##6##(1993-12#1)(1993-2#1)
The deduced amino acid sequence was##2##6##(1992-3#1)(1996-12#1)
The deduced amino acid sequence##11##5##(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-8#2)
The deduced amino acid sequences of##2##6##(1992-9#1)(1993-6#1)
The deduced amino acid sequences##3##5##(1990-5#1)(1992-9#1)(1993-6#1)
The deduced amino acid##17##4##(1990-5#1)(1991-6#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-8#2)
The deduced primary##2##3##(1992-3#1)(1993-9#1)
The deduced protein has##2##4##(2008-8#2)
The deduced protein##4##3##(1993-2#1)(2008-8#3)
The deduced##30##2##(1990-11#1)(1990-5#1)(1991-6#1)(1992-3#2)(1992-9#2)(1993-12#3)(1993-2#4)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-8#5)
The deep##5##2##(1991-9#1)(2008-10#2)(2009-10#1)(2011-2#1)
The default##2##2##(2008-4#1)(2013-1#1)
The defect was repaired##2##4##(2008-12#1)(2012-3#1)
The defect was##3##3##(2008-12#1)(2010-3#1)(2012-3#1)
The definition of##2##3##(1996-6#1)(2008-11#1)
The definitions of##2##3##(1996-11#1)(1996-6#1)
The degradation of##2##3##(1992-12#1)(2012-3#1)
The degradation##8##2##(1992-12#1)(2008-10#5)(2008-11#1)(2012-3#1)
The degree of deacetylation##2##4##(2008-10#2)
The degree of genetic##2##4##(2008-10#2)
The degree of interference from##2##5##(2008-10#2)
The degree of##25##3##(1990-6#1)(1990-8#1)(1991-7#1)(1996-3#1)(2008-10#11)(2008-11#3)(2008-5#3)(2008-7#1)(2012-12#1)(2013-1#2)
The degree-day intercept of##2##4##(2008-10#2)
The dehydrogenase##2##2##(1990-11#1)(1992-9#1)
The delay in##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
The delay##6##2##(1991-2#1)(1996-3#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
The deletion##2##2##(1991-6#1)(2008-8#1)
The delivery of##3##3##(1995-1#1)(1996-3#1)(2008-4#1)
The delivery##4##2##(1995-1#1)(1996-3#1)(2008-4#1)(2008-5#1)
The delta##2##2##(1993-8#1)(2010-4#1)
The demand for##2##3##(1993-12#1)(1996-3#1)
The demographic variables##2##3##(1995-1#2)
The demographic##5##2##(1994-12#1)(1995-1#2)(2008-8#1)(2008-9#1)
The demonstration of##2##3##(1995-12#1)(2008-7#1)
The densities and polarities of the mobile phase were optimised from the effects of pressure##2##15##(2008-10#2)
The density of##7##3##(2008-10#2)(2008-11#3)(2008-9#1)(2013-1#1)
The deoxygenation of the##2##4##(2008-10#2)
The deoxygenation##3##2##(2008-10#3)
The dependence of the##4##4##(1993-8#1)(2008-10#2)(2008-3#1)
The dependence of##17##3##(1990-8#1)(1991-10#1)(1993-8#1)(2008-10#10)(2008-3#3)(2008-8#1)
The depletion##2##2##(2008-11#1)(2010-3#1)
The deposition of##2##3##(2008-10#2)
The deposition##3##2##(2008-10#2)(2009-11#1)
The depression##2##2##(1997-7#1)(2008-9#1)
The depressive##2##2##(1993-12#1)(2011-2#1)
The depth of the##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
The depth of##6##3##(2008-10#2)(2008-8#2)(2013-1#2)
The depth##9##2##(2008-10#3)(2008-3#2)(2008-8#2)(2013-1#2)
The derivation of##2##3##(2008-11#1)(2008-3#1)
The derivative was##2##3##(2008-10#2)
The derivative##4##2##(2008-10#4)
The derivatives showed an intense protonated molecular ion corresponding m/z##2##10##(2008-10#2)
The derivatization reagent##2##3##(2008-10#2)
The derivatization##5##2##(2008-10#5)
The derived amino acid sequence##2##5##(1990-8#1)(1996-3#1)
The derived##5##2##(1990-8#1)(1996-3#1)(2007-12#1)(2008-10#1)(2010-4#1)
The described method##2##3##(2008-10#1)(2009-8#1)
The described##8##2##(1995-3#1)(2008-10#4)(2009-10#1)(2009-8#1)(2013-7#1)
The description of##4##3##(1991-2#1)(1994-3#1)(2008-10#1)(2013-1#1)
The design and##5##3##(1996-3#1)(2008-10#1)(2008-3#2)(2009-9#1)
The design of the##5##4##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
The design of##7##3##(1992-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)
The design##21##2##(1992-3#1)(1995-3#1)(1996-3#1)(2008-10#6)(2008-12#1)(2008-3#5)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-3#1)
The designed##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
The desorption was##2##3##(2008-10#2)
The detailed study of various interferences confirmed the high selectivity of the##2##12##(2008-10#2)
The detailed study of##3##4##(2008-10#2)(2008-12#1)
The detailed##5##2##(2008-10#3)(2008-12#1)(2008-7#1)
The details of the##2##4##(2008-10#1)(2008-11#1)
The detected##2##2##(2008-10#1)(2008-11#1)
The detection and quantification limits were##2##6##(2008-10#2)
The detection and quantification limits##4##5##(2008-10#4)
The detection and##6##3##(2008-10#4)(2008-3#1)(2010-7#1)
The detection chemistry is based on the##2##7##(2008-10#2)
The detection frequency of P##2##5##(2008-10#2)
The detection is based##2##4##(2008-10#1)(2008-9#1)
The detection is##3##3##(2008-10#2)(2008-9#1)
The detection limit (3##2##4##(1991-12#1)(2008-10#1)
The detection limit (3sigma) was 0##3##6##(2008-10#3)
The detection limit (3sigma)##6##4##(2008-10#6)
The detection limit (DL) value for the preconcentration method proposed was##2##11##(2008-10#2)
The detection limit (DL)##3##4##(2008-10#3)
The detection limit (S/N=3) is##2##5##(2008-10#2)
The detection limit (S/N=3) was##2##5##(2008-10#2)
The detection limit (S/N=3)##6##4##(2008-10#6)
The detection limit (signal-to-noise##2##4##(2008-10#2)
The detection limit and linear##2##5##(2008-10#2)
The detection limit and the variation coefficient were found to be 2##2##12##(2008-10#2)
The detection limit and the##4##5##(2008-10#4)
The detection limit and##9##4##(2008-10#9)
The detection limit corresponding to three times the standard deviation of the blank was found to be 0##2##18##(2008-10#2)
The detection limit corresponding to three times the standard deviation of the blank was found to be##3##17##(2008-10#3)
The detection limit for the##4##5##(2008-10#4)
The detection limit for##21##4##(2008-10#20)(2008-12#1)
The detection limit found##2##4##(2008-10#2)
The detection limit is 0##15##5##(2008-10#15)
The detection limit is 1##2##5##(2008-10#2)
The detection limit is 2##3##5##(2008-10#3)
The detection limit is 5##3##5##(2008-10#3)
The detection limit is 8##3##5##(2008-10#3)
The detection limit is##41##4##(2008-10#41)
The detection limit obtained##2##4##(2008-10#2)
The detection limit of Cr(VI)##2##5##(2008-10#2)
The detection limit of each##2##5##(2008-10#1)(2008-11#1)
The detection limit of the method is 0##4##8##(2008-10#4)
The detection limit of the method is##6##7##(2008-10#6)
The detection limit of the method##8##6##(2008-10#8)
The detection limit of the proposed method is##2##8##(2008-10#2)
The detection limit of the proposed method##3##7##(2008-10#3)
The detection limit of the proposed##5##6##(2008-10#5)
The detection limit of the##20##5##(2008-10#18)(2008-12#1)(2013-8#1)
The detection limit of this method is##2##7##(2008-10#2)
The detection limit of this method was##3##7##(1990-2#1)(2008-10#2)
The detection limit of this method##6##6##(1990-2#1)(2008-10#5)
The detection limit of this##8##5##(1990-2#1)(1995-11#1)(2008-10#6)
The detection limit of##47##4##(1990-2#1)(1995-11#1)(2008-10#41)(2008-11#1)(2008-12#1)(2013-8#2)
The detection limit was 0##8##5##(2008-10#8)
The detection limit was 1##3##5##(2008-10#3)
The detection limit was 2##2##5##(2008-10#2)
The detection limit was 3##2##5##(2008-10#2)
The detection limit was 5##2##5##(2008-10#2)
The detection limit was 8##2##5##(2008-10#2)
The detection limit was c(L)=0##2##5##(2008-10#2)
The detection limit was determined as##2##6##(2008-10#2)
The detection limit was determined##3##5##(2008-10#3)
The detection limit was estimated to be##3##7##(2008-10#2)(2008-3#1)
The detection limit was found to be##3##7##(2008-10#3)
The detection limit was##45##4##(2008-10#44)(2008-3#1)
The detection limit##223##3##(1990-2#1)(1991-12#1)(1995-11#1)(2008-10#214)(2008-11#1)(2008-12#2)(2008-3#1)(2013-8#2)
The detection limits (3sigma##2##4##(2008-10#2)
The detection limits (3sigma) are##2##5##(2008-10#2)
The detection limits (3sigma) were##2##5##(2008-10#2)
The detection limits (3sigma)##6##4##(2008-10#6)
The detection limits (LOD)##2##4##(2008-10#2)
The detection limits (S/N=3) are##2##5##(2008-10#2)
The detection limits (S/N=3) of##3##5##(2008-10#3)
The detection limits (S/N=3)##9##4##(2008-10#9)
The detection limits achieved (3sigma) were##2##6##(2008-10#2)
The detection limits achieved##3##4##(2008-10#3)
The detection limits and##3##4##(2008-10#3)
The detection limits are 0##2##5##(2008-10#2)
The detection limits are##6##4##(2008-10#6)
The detection limits for the##2##5##(2008-10#2)
The detection limits for##16##4##(1997-2#1)(2008-10#15)
The detection limits observed##2##4##(2008-10#2)
The detection limits obtained##5##4##(2008-10#5)
The detection limits of Cd##2##5##(2008-10#2)
The detection limits of ETAAS followed by##2##7##(2008-10#2)
The detection limits of the method are##2##7##(2008-10#2)
The detection limits of the proposed electrodes were##2##8##(2008-10#2)
The detection limits of the##6##5##(2008-10#6)
The detection limits of##13##4##(2008-10#13)
The detection limits were 0##8##5##(2008-10#8)
The detection limits were 2##2##5##(2008-10#2)
The detection limits were 3##2##5##(2008-10#2)
The detection limits were 5##2##5##(2008-10#2)
The detection limits were found to be 0##2##8##(2008-10#2)
The detection limits were found to be##3##7##(2008-10#3)
The detection limits were##28##4##(2008-10#28)
The detection limits##116##3##(1997-2#1)(2008-10#114)(2012-2#1)
The detection method##2##3##(2008-10#2)
The detection of the##3##4##(2008-10#2)(2012-2#1)
The detection of##18##3##(1990-9#1)(1992-6#1)(2008-10#11)(2008-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
The detection sensitivity##2##3##(2008-10#1)(2008-2#1)
The detection system consists##2##4##(2008-10#2)
The detection system##4##3##(2008-10#4)
The detection was based on the##2##6##(2008-10#2)
The detection was##7##3##(2008-10#7)
The detection##392##2##(1990-2#1)(1990-9#1)(1991-12#1)(1992-6#1)(1995-11#1)(1997-2#1)(2008-10#368)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
The detector is##2##3##(2008-10#2)
The detector##3##2##(2008-10#3)
The determination is based on the precipitation reaction of##2##9##(2008-10#2)
The determination is based on the reaction of##2##8##(2008-10#2)
The determination is based on the##6##6##(2008-10#6)
The determination is based on##8##5##(2008-10#8)
The determination is carried out without any derivatization reaction##2##9##(2008-10#2)
The determination is##11##3##(2008-10#11)
The determination limit was##5##4##(2008-10#5)
The determination limit##8##3##(2008-10#8)
The determination of chloride##2##4##(2008-10#2)
The determination of the##12##4##(1991-11#1)(1995-12#1)(2008-10#9)(2008-5#1)
The determination of total##2##4##(2008-10#2)
The determination of trace amounts of##2##6##(2008-10#2)
The determination of trace levels of aluminum##2##7##(2008-10#2)
The determination of trace levels of##3##6##(2008-10#3)
The determination of trace##6##4##(2008-10#6)
The determination of##77##3##(1991-11#1)(1992-11#1)(1995-12#1)(2008-10#68)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)
The determination results##2##3##(2008-10#2)
The determination was##2##3##(2008-10#2)
The determination##107##2##(1991-11#1)(1992-11#1)(1995-12#1)(2008-10#98)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)
The detrimental##2##2##(2008-10#1)(2011-1#1)
The developed analytical method was##2##5##(2008-10#2)
The developed analytical##3##3##(2008-10#3)
The developed grafted##2##3##(2008-10#2)
The developed method has been successfully##2##6##(2008-10#2)
The developed method has been##4##5##(2008-10#4)
The developed method is##5##4##(2008-10#5)
The developed method was applied for##3##6##(2008-10#3)
The developed method was applied to the determination of##3##9##(2008-10#3)
The developed method was applied to the##6##7##(2008-10#6)
The developed method was applied to##12##6##(2008-10#12)
The developed method was applied##15##5##(2008-10#15)
The developed method was successfully applied to##3##7##(2008-10#2)(2008-11#1)
The developed method was##23##4##(2008-10#22)(2008-11#1)
The developed method##41##3##(2008-10#39)(2008-11#2)
The developed methodology was##2##4##(2008-10#2)
The developed methodology##9##3##(2008-10#8)(2011-2#1)
The developed methods were applied to the determination of##2##9##(2008-10#2)
The developed methods were applied to##3##6##(2008-10#3)
The developed methods were applied##4##5##(2008-10#4)
The developed methods were##5##4##(2008-10#5)
The developed procedure has been successfully utilized for the estimation of##2##11##(2008-10#2)
The developed procedure provided##2##4##(2008-10#2)
The developed procedure was##3##4##(2008-10#3)
The developed procedure##9##3##(2008-10#9)
The developed sensor was applied for the##2##7##(2008-10#2)
The developed sensor was##3##4##(2008-10#3)
The developed system was##2##4##(2008-10#2)
The developed system##4##3##(2008-10#4)
The developed##97##2##(1990-2#1)(1995-2#1)(2008-10#87)(2008-11#3)(2008-5#1)(2010-8#2)(2011-2#1)(2013-1#1)
The development and##7##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)
The development of a women's health center in an academic health center##2##12##(1994-3#2)
The development of a##17##4##(1992-1#1)(1994-3#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#2)
The development of an##3##4##(2007-12#1)(2008-10#1)(2009-10#1)
The development of specific##2##4##(2008-10#1)(2008-11#1)
The development of the serious mental illness physical Health Improvement##2##10##(2009-6#2)
The development of the##8##4##(1991-3#1)(1991-9#1)(1992-1#1)(2008-10#1)(2008-4#1)(2009-6#2)(2012-3#1)
The development of this##2##4##(1995-2#1)(2008-11#1)
The development of##85##3##(1991-1#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#3)(1994-3#2)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#2)(2007-12#1)(2008-10#28)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
The development##93##2##(1991-1#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#3)(1994-3#2)(1995-2#1)(1995-5#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#2)(2007-12#1)(2008-10#30)(2008-11#9)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
The developmental##6##2##(1990-5#1)(1991-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)
The deviation##2##2##(1992-12#1)(2008-10#1)
The device can##2##3##(1993-2#1)(2008-10#1)
The device consists of##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
The device is##2##3##(2008-3#1)(2008-5#1)
The device##15##2##(1993-2#1)(2007-11#1)(2008-10#4)(2008-3#4)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2013-1#1)
The devices##2##2##(2007-11#1)(2008-5#1)
The diabetes##2##2##(2008-10#1)(2010-7#1)
The diagnoses were##2##3##(1990-8#1)(1994-3#1)
The diagnoses##3##2##(1990-8#1)(1994-3#1)(2011-2#1)
The diagnosis and treatment##2##4##(2008-12#1)(2011-2#1)
The diagnosis and##4##3##(1993-2#1)(2008-12#1)(2009-12#1)(2011-2#1)
The diagnosis is##4##3##(1993-2#1)(2010-8#1)(2012-12#1)(2012-3#1)
The diagnosis of TB##2##4##(2008-1#1)(2010-5#1)
The diagnosis of##25##3##(1990-3#1)(1990-6#1)(1991-3#1)(1996-11#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
The diagnosis was based on##3##5##(2010-12#1)(2012-12#1)(2012-3#1)
The diagnosis was confirmed by##3##5##(1990-3#1)(2008-10#1)(2009-11#1)
The diagnosis was confirmed##4##4##(1990-3#1)(2008-10#1)(2009-11#1)(2013-8#1)
The diagnosis was##12##3##(1990-12#1)(1990-3#1)(2008-10#1)(2008-7#1)(2009-1#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
The diagnosis##51##2##(1990-12#1)(1990-3#3)(1990-6#1)(1991-3#1)(1992-5#1)(1993-2#2)(1996-11#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-7#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#5)(2013-1#4)(2013-8#1)
The diagnostic and##2##3##(2012-3#1)(2013-1#1)
The diagnostic criteria##2##3##(1990-9#1)(2008-7#1)
The diagnostic features of the##2##5##(2011-2#2)
The diagnostic##19##2##(1990-9#1)(1995-11#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)
The dialysate collected in##2##4##(2008-10#2)
The dialysis##3##2##(2008-10#3)
The diameter and##2##3##(2008-11#1)(2009-7#1)
The diameter of##2##3##(1997-5#1)(2008-8#1)
The diameter##4##2##(1997-5#1)(2008-11#1)(2008-8#1)(2009-7#1)
The diet##2##2##(2008-3#1)(2012-3#1)
The difference between the##7##4##(1991-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)
The difference between##10##3##(1991-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
The difference in the##5##4##(1995-5#1)(2008-10#3)(2013-1#1)
The difference in##14##3##(1990-6#1)(1990-8#1)(1994-6#1)(1995-5#1)(1996-5#1)(2008-10#4)(2008-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
The difference was significant##2##4##(2008-9#2)
The difference was statistically significant##3##5##(1996-12#1)(2009-6#1)(2011-2#1)
The difference was##6##3##(1996-12#1)(1997-5#1)(2008-9#2)(2009-6#1)(2011-2#1)
The difference##36##2##(1990-6#1)(1990-8#1)(1991-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-5#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
The differences between the##4##4##(1991-6#1)(1994-8#1)(2008-1#1)(2008-10#1)
The differences between##10##3##(1991-6#1)(1994-12#1)(1994-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-8#2)
The differences found##2##3##(2008-10#1)(2008-2#1)
The differences in the##2##4##(2008-10#2)
The differences in##10##3##(2008-10#7)(2010-7#1)(2012-5#1)(2013-8#1)
The differences of##2##3##(2007-8#1)(2008-8#1)
The differences##29##2##(1991-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#2)(2010-7#1)(2012-5#1)(2013-1#1)(2013-8#1)
The different experimental parameters##2##4##(2008-10#2)
The different genotypes were##2##4##(2008-10#2)
The different##32##2##(1993-6#1)(1993-8#1)(1994-12#3)(1994-8#1)(1995-8#1)(2008-10#15)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2011-2#2)(2011-3#1)
The differential diagnosis for##2##4##(2012-12#1)(2012-2#1)
The differential diagnosis of##2##4##(1990-9#1)(1991-8#1)
The differential diagnosis##6##3##(1990-9#1)(1991-8#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
The differential effect of##2##4##(1994-5#1)(2013-1#1)
The differential pulse##2##3##(2008-10#2)
The differential##17##2##(1990-9#1)(1991-8#1)(1994-5#1)(1995-12#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
The differentially expressed##2##3##(2008-9#1)(2011-3#1)
The difficulties##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
The difficulty in##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
The difficulty##5##2##(1995-2#1)(2008-10#1)(2008-11#2)(2012-3#1)
The diffraction##3##2##(2008-2#1)(2008-3#2)
The diffuse##2##2##(1991-12#1)(2008-11#1)
The diffusion coefficient##2##3##(2008-10#2)
The diffusion coefficients##2##3##(2008-10#1)(2008-5#1)
The diffusion##6##2##(2008-10#4)(2008-5#1)(2013-8#1)
The digestion##2##2##(2008-10#2)
The digests##2##2##(2008-10#2)
The digital##3##2##(1994-2#1)(2007-12#1)(2008-3#1)
The dilemma##2##2##(2010-11#1)(2013-1#1)
The dilution##2##2##(2008-10#2)
The dimensions of the ICU##2##5##(1992-2#2)
The dimensions of the##3##4##(1992-2#2)(2009-11#1)
The dimensions##5##2##(1992-2#2)(1994-12#1)(2009-1#1)(2009-11#1)
The dimeric##2##2##(2008-10#1)(2010-2#1)
The dimers##2##2##(2008-8#1)(2010-7#1)
The diphenylamido complexes##2##3##(2008-11#2)
The direct determination of trace##2##5##(2008-10#2)
The direct determination of##4##4##(2008-10#4)
The direct##14##2##(1990-11#1)(1993-8#1)(1994-2#1)(2008-10#7)(2008-12#3)(2008-6#1)
The direction of##3##3##(2008-10#1)(2008-11#2)
The direction##4##2##(2008-10#2)(2008-11#2)
The directional##2##2##(2008-3#1)(2008-8#1)
The disappearance of##2##3##(1996-3#1)(2008-7#1)
The discharge##2##2##(1993-12#1)(2008-10#1)
The discipline##2##2##(2008-12#1)(2012-3#1)
The discovery and##4##3##(2008-10#1)(2008-9#1)(2011-3#1)(2013-8#1)
The discovery of novel##2##4##(2008-5#1)(2010-5#1)
The discovery of the##2##4##(2008-11#1)(2010-1#1)
The discovery of##11##3##(1993-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
The discovery##19##2##(1990-8#1)(1993-3#1)(1994-11#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#2)
The discrepancy between##3##3##(1991-12#1)(1995-1#1)(2008-10#1)
The discussion focuses on##2##4##(2008-3#1)(2010-10#1)
The discussion is##4##3##(1991-3#1)(2008-10#1)(2008-12#1)(2008-9#1)
The discussion##15##2##(1991-3#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#3)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)
The disease has##4##3##(2008-10#3)(2008-9#1)
The disease is caused by##3##5##(2008-10#2)(2011-2#1)
The disease is characterized by##3##5##(1991-11#1)(2008-10#1)(2011-1#1)
The disease is##9##3##(1991-11#1)(2008-10#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
The disease was##5##3##(2008-10#4)(2008-5#1)
The disease##28##2##(1991-11#1)(1991-8#1)(2008-10#18)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
The diseases##2##2##(1993-11#1)(1994-6#1)
The disorder##2##2##(2010-12#1)(2011-1#1)
The dispersal of##2##3##(2008-10#2)
The dispersion##2##2##(1991-12#1)(2009-11#1)
The displaced women##2##3##(2013-1#2)
The display##2##2##(1995-2#1)(2008-3#1)
The disruption of##2##3##(2008-10#1)(2008-9#1)
The disruption##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
The dissection##2##2##(2008-10#2)
The dissociation constant##2##3##(2008-10#1)(2008-11#1)
The dissociation constants##2##3##(1995-6#1)(2008-10#1)
The dissociation##6##2##(1995-6#1)(2008-10#3)(2008-11#2)
The dissolution profiles of isoniazid fast-release##2##6##(2008-10#2)
The dissolution##4##2##(2008-10#3)(2012-2#1)
The distal##5##2##(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)
The distance between##2##3##(2008-11#1)(2011-2#1)
The distance##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
The distances between##2##3##(1994-5#1)(1996-2#1)
The distilled water##2##3##(2008-10#1)(2009-6#1)
The distilled##3##2##(2008-10#2)(2009-6#1)
The distinct##2##2##(1990-5#1)(1995-11#1)
The distribution and##2##3##(1997-3#1)(2008-10#1)
The distribution behavior of##4##4##(2008-10#4)
The distribution coefficient##4##3##(2008-10#4)
The distribution constants of##2##4##(2008-10#2)
The distribution constants##3##3##(2008-10#3)
The distribution of the##5##4##(1990-8#1)(1991-3#1)(2008-10#2)(2008-9#1)
The distribution of##33##3##(1990-5#1)(1990-8#1)(1991-3#1)(1992-5#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
The distribution##49##2##(1990-5#1)(1990-8#1)(1991-3#1)(1992-5#1)(1995-12#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-6#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
The disulfide##3##2##(1992-6#1)(1993-8#2)
The dithizone-anchored##2##2##(2008-10#2)
The divalent##2##2##(1990-5#1)(1995-11#1)
The divergence##2##2##(1991-5#1)(2008-6#1)
The diverse##2##2##(1996-12#1)(2009-6#1)
The diversity and##3##3##(2008-10#1)(2009-10#1)(2012-3#1)
The diversity of##3##3##(2008-10#2)(2011-2#1)
The diversity##7##2##(2008-10#4)(2009-10#1)(2011-2#1)(2012-3#1)
The division of##2##3##(2007-12#1)(2008-8#1)
The division##3##2##(2007-12#1)(2008-8#1)(2009-10#1)
The dlt operon##2##3##(1995-6#2)
The dominance of##2##3##(1991-12#1)(2013-1#1)
The dominant##9##2##(1990-5#1)(1996-6#1)(2008-10#4)(2008-8#1)(2009-8#1)(2010-10#1)
The dominantly inherited##2##3##(1990-12#1)(2008-6#1)
The donor##3##2##(1991-3#1)(2008-11#1)(2008-7#1)
The dopamine receptor antagonist##2##4##(1996-2#2)
The dopamine##5##2##(1993-9#1)(1996-2#3)(2008-10#1)
The dopaminergic##2##2##(1997-3#1)(2009-7#1)
The dorsal##2##2##(2007-12#1)(2011-2#1)
The dose of##2##3##(2008-1#1)(2008-10#1)
The dose##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#2)(2009-2#1)
The doses of##5##3##(1992-3#1)(1993-6#1)(1996-2#1)(2008-10#2)
The double##3##2##(2008-10#3)
The double-stranded##2##2##(1994-8#1)(2008-10#1)
The dramatic##2##2##(1991-3#1)(2008-10#1)
The dried##2##2##(2008-10#1)(2011-2#1)
The driving##2##2##(2008-10#1)(2008-11#1)
The drug undergoes degradation under acidic##2##6##(2008-10#2)
The drug was accumulated##2##4##(2008-10#2)
The drug was##7##3##(1993-6#1)(1994-8#1)(2008-10#4)(2010-12#1)
The drug##20##2##(1991-1#1)(1993-6#1)(1994-8#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
The drugs were##2##3##(2008-10#2)
The drugs##3##2##(1994-12#1)(2008-10#2)
The dry##3##2##(2008-10#2)(2008-5#1)
The dual##7##2##(1994-1#1)(1996-2#1)(1997-3#1)(2008-10#3)(2009-12#1)
The duplicate article has therefore been withdrawn##7##7##(2008-11#6)(2012-3#1)
The dural##2##2##(2008-12#1)(2012-3#1)
The duration of the##3##4##(1997-4#1)(2008-12#1)(2010-8#1)
The duration of##13##3##(1993-3#1)(1994-8#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)
The duration##15##2##(1993-3#1)(1994-2#1)(1994-8#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
The dye##2##2##(2008-10#2)
The dynamic range of the calibration graph##2##7##(2008-10#2)
The dynamic range of the##3##5##(2008-10#3)
The dynamic range was##2##4##(2008-10#2)
The dynamic range##7##3##(2008-10#7)
The dynamic##19##2##(1992-6#1)(2008-10#16)(2008-8#1)(2011-2#1)
The dynamics of the##5##4##(1990-8#1)(1992-9#1)(2008-10#3)
The dynamics of##14##3##(1990-8#1)(1992-3#1)(1992-9#1)(1993-9#1)(1996-3#1)(1997-6#2)(2008-10#7)
The dynamics##16##2##(1990-8#1)(1992-3#1)(1992-9#1)(1993-9#1)(1996-3#1)(1997-6#2)(2008-10#7)(2008-9#1)(2013-8#1)
The earlier##2##2##(2008-10#1)(2009-8#1)
The earliest##2##2##(1991-5#1)(2008-12#1)
The early development##2##3##(1993-12#1)(2008-11#1)
The early##14##2##(1992-5#1)(1992-6#1)(1993-12#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
The ease of##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
The ecological##4##2##(2008-11#2)(2008-8#1)(2010-11#1)
The ecology and##2##3##(2008-8#2)
The economic##6##2##(1995-2#1)(1996-1#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
The economics of##2##3##(2008-11#1)(2009-8#1)
The education and training##2##4##(2008-11#1)(2008-12#1)
The education##3##2##(2008-11#2)(2008-12#1)
The educational##2##2##(2008-12#1)(2010-9#1)
The efe##2##2##(2008-10#2)
The effect of CO2##2##4##(1995-2#1)(1996-12#1)
The effect of a single##2##5##(1994-8#1)(2008-10#1)
The effect of a##6##4##(1994-8#1)(1996-1#1)(2008-10#3)(2012-8#1)
The effect of activin A##2##5##(1992-6#1)(1995-8#1)
The effect of addition of##2##5##(2008-10#2)
The effect of an##3##4##(2008-10#1)(2009-6#1)(2011-1#1)
The effect of analytical and##2##5##(2008-10#2)
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy##3##8##(1994-3#3)
The effect of concentration of##2##5##(2008-10#2)
The effect of concentration##3##4##(2008-10#2)(2009-8#1)
The effect of cultivar##2##4##(2008-10#2)
The effect of different factors such as##2##7##(2008-10#2)
The effect of different parameters##2##5##(2008-10#2)
The effect of different variables##2##5##(2008-10#2)
The effect of different##14##4##(2008-10#11)(2008-12#1)(2008-5#1)(2011-1#1)
The effect of diverse ions on the##2##7##(2008-10#2)
The effect of diverse ions##3##5##(2008-10#3)
The effect of evidence-based drug coverage policies on pharmaceutical r&amp##2##10##(2009-3#2)
The effect of experimental parameters##2##5##(2008-10#2)
The effect of imagery perspectives##2##5##(1992-12#2)
The effect of increased##2##4##(2008-10#1)(2008-7#1)
The effect of interferences was studied##2##6##(2008-10#2)
The effect of interferences##4##4##(2008-10#4)
The effect of interfering ions##3##5##(2008-10#3)
The effect of low##2##4##(2008-11#1)(2010-12#1)
The effect of membrane##2##4##(1990-8#1)(2008-10#1)
The effect of mobile phase variables such as##2##8##(2008-10#2)
The effect of mobile phase variables##3##6##(2008-10#3)
The effect of other ions##2##5##(2008-10#2)
The effect of other##3##4##(2008-10#3)
The effect of pH on##2##5##(1991-5#1)(2008-10#1)
The effect of pH##7##4##(1991-5#1)(2008-10#6)
The effect of palladium##2##4##(1991-12#2)
The effect of polymeric##2##4##(2008-10#1)(2008-5#1)
The effect of postoperative immobilization on the##2##7##(2009-3#2)
The effect of several##2##4##(2008-10#2)
The effect of sodium##2##4##(1994-5#1)(2008-10#1)
The effect of surgical glove##2##5##(1995-3#2)
The effect of temperature on##2##5##(2008-10#2)
The effect of temperature##4##4##(1996-12#1)(2008-10#2)(2010-4#1)
The effect of the composition of the##2##7##(2008-10#2)
The effect of the presence of##2##6##(2008-10#2)
The effect of the##34##4##(1990-9#1)(1997-2#2)(2008-10#23)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#2)
The effect of these##2##4##(1991-12#1)(1995-6#1)
The effect of this##2##4##(2008-10#1)(2008-5#1)
The effect of treatments##2##4##(2008-10#2)
The effect of two##3##4##(2008-11#2)(2011-2#1)
The effect of variable##3##4##(2008-10#2)(2012-3#1)
The effect of various experimental parameters##2##6##(2008-10#2)
The effect of various parameters##2##5##(2008-10#1)(2013-1#1)
The effect of various##9##4##(1993-2#1)(2008-10#7)(2013-1#1)
The effect of vitamin##2##4##(2010-1#1)(2011-1#1)
The effect of water##2##4##(2008-7#2)
The effect of##347##3##(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#6)(1991-2#2)(1991-3#2)(1991-5#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-9#2)(1994-11#3)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#161)(2008-11#13)(2008-12#6)(2008-3#4)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#2)(2009-1#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-9#2)(2011-1#5)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#5)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#3)
The effect on the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
The effect on##7##3##(1993-2#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
The effect was##8##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
The effect##369##2##(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#6)(1991-2#2)(1991-3#2)(1991-5#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-9#2)(1994-11#3)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#1)(1994-8#4)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#164)(2008-11#14)(2008-12#6)(2008-3#5)(2008-5#13)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#4)(2009-1#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-9#2)(2011-1#5)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#7)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#3)
The effective dose##2##3##(2008-10#2)
The effective molar absorptivity##2##4##(2008-10#2)
The effective size of##2##4##(2008-8#2)
The effective##12##2##(2008-10#7)(2008-3#1)(2008-8#4)
The effectiveness of the##3##4##(1993-12#1)(2008-10#2)
The effectiveness of##18##3##(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
The effectiveness##19##2##(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
The effects of a##6##4##(1992-4#1)(1993-12#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-7#1)
The effects of an##2##4##(2008-10#1)(2008-3#1)
The effects of areca catechu L extract on##2##8##(2008-5#2)
The effects of both##2##4##(2008-10#2)
The effects of caffeine on##2##5##(1995-11#2)
The effects of chemical##2##4##(2008-10#1)(2008-12#1)
The effects of cognitive##2##4##(2012-2#1)(2012-3#1)
The effects of dietary##3##4##(1994-3#1)(2008-7#2)
The effects of different##4##4##(2008-10#4)
The effects of electrolytes##2##4##(2008-10#2)
The effects of endothelin-1##2##4##(1991-5#1)(1992-3#1)
The effects of experimental##3##4##(2008-10#3)
The effects of food##2##4##(1997-1#1)(2010-8#1)
The effects of foreign ions were##2##6##(2008-10#2)
The effects of foreign ions##3##5##(2008-10#3)
The effects of host diversity##2##5##(2008-10#2)
The effects of host##4##4##(2008-10#4)
The effects of metal ion##2##5##(2008-10#2)
The effects of pH of##3##5##(2008-10#3)
The effects of pH##9##4##(2008-10#9)
The effects of protein kinase C##2##6##(1995-11#2)
The effects of reaction##2##4##(2008-10#2)
The effects of rust##2##4##(2008-10#2)
The effects of several important factors were investigated to find optimum conditions##3##12##(2008-10#3)
The effects of several##7##4##(2008-10#6)(2008-11#1)
The effects of solution pH##2##5##(2008-10#2)
The effects of solution##3##4##(2008-10#3)
The effects of some##5##4##(2008-10#4)(2008-11#1)
The effects of temperature and##4##5##(2008-10#4)
The effects of temperature##8##4##(2008-10#8)
The effects of the concentration of##3##6##(2008-10#3)
The effects of the mobile phase##2##6##(2008-10#2)
The effects of the number of##3##6##(1991-2#1)(2008-10#2)
The effects of the##26##4##(1991-2#1)(1994-11#1)(1995-11#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
The effects of these##4##4##(1990-5#1)(1993-3#1)(1996-11#1)(2008-5#1)
The effects of three##2##4##(2008-10#1)(2008-7#1)
The effects of two##2##4##(1994-8#1)(2008-10#1)
The effects of various cationic interferences on the percent recovery of copper in binary mixtures were studied##2##17##(2008-10#2)
The effects of various cationic interferences on the##3##8##(2008-10#3)
The effects of various cationic interferences on##4##7##(2008-10#4)
The effects of various parameters##2##5##(2008-10#2)
The effects of various##9##4##(1994-5#1)(2008-10#7)(2009-2#1)
The effects of##286##3##(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#4)(1993-6#1)(1994-11#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#3)(1995-11#6)(1995-12#2)(1995-2#2)(1996-11#1)(1996-12#2)(1996-2#5)(1997-1#4)(1997-2#2)(1997-4#1)(1997-8#1)(2006-6#2)(2008-1#1)(2008-10#132)(2008-11#20)(2008-12#3)(2008-2#5)(2008-3#4)(2008-5#8)(2008-7#5)(2008-8#4)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#5)(2013-8#1)
The effects on the##3##4##(2008-10#3)
The effects on##5##3##(2008-10#3)(2008-11#2)
The effects were##5##3##(1991-5#1)(1995-12#1)(2008-10#2)(2013-1#1)
The effects##302##2##(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#4)(1993-6#1)(1994-11#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#3)(1995-11#6)(1995-12#3)(1995-2#2)(1996-11#1)(1996-12#2)(1996-2#6)(1997-1#5)(1997-2#2)(1997-4#1)(1997-8#1)(2006-6#2)(2008-1#1)(2008-10#137)(2008-11#23)(2008-12#3)(2008-2#5)(2008-3#4)(2008-5#8)(2008-7#5)(2008-8#4)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#2)(2011-3#2)(2012-12#3)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#6)(2013-8#1)
The efficacy and##5##3##(1991-11#1)(1991-8#1)(1993-2#1)(1994-12#1)(2011-3#1)
The efficacy of a##2##4##(2009-9#1)(2010-9#1)
The efficacy of chemical##2##4##(2008-10#2)
The efficacy of the##4##4##(1991-11#1)(2008-10#2)(2008-5#1)
The efficacy of this##2##4##(1994-5#1)(2008-10#1)
The efficacy of##33##3##(1991-11#1)(1994-5#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#6)(2008-8#2)(2009-12#1)(2009-9#1)(2010-5#1)(2010-9#1)(2013-1#1)
The efficacy##39##2##(1991-11#2)(1991-8#1)(1993-2#1)(1994-12#1)(1994-5#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#6)(2008-8#2)(2009-12#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-3#1)(2013-1#2)
The efficiency of the##9##4##(1990-5#1)(2008-10#7)(2008-9#1)
The efficiency of this##2##4##(1993-12#1)(2008-10#1)
The efficiency of##28##3##(1990-5#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-9#1)(1996-3#1)(2008-10#16)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
The efficiency##34##2##(1990-5#2)(1991-7#1)(1992-2#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-9#1)(1996-3#1)(2007-11#1)(2008-10#18)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
The efficient##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
The effort##2##2##(1996-2#2)
The efforts to##2##3##(1997-3#1)(2011-2#1)
The egg capsule##2##3##(2008-12#2)
The egg##4##2##(1996-12#1)(2007-12#1)(2008-12#2)
The eggs of##2##3##(2008-12#2)
The eight##2##2##(2008-10#2)
The elderly##2##2##(2008-10#1)(2011-2#1)
The electric##3##2##(1997-6#1)(2008-3#1)(2009-8#1)
The electroanalytical##2##2##(2008-10#2)
The electrocardiogram##2##2##(1993-1#1)(2010-8#1)
The electrocatalytic behavior is further exploited as a sensitive detection scheme for##2##12##(2008-10#2)
The electrocatalytic detection of##2##4##(1990-12#1)(2008-10#1)
The electrocatalytic reduction##2##3##(2008-10#2)
The electrocatalytic##10##2##(1990-12#1)(2008-10#9)
The electrochemical behavior of the##2##5##(2008-10#2)
The electrochemical behavior of##10##4##(2008-10#10)
The electrochemical behaviors of##3##4##(2008-10#3)
The electrochemical behaviour##3##3##(2008-10#3)
The electrochemical characteristics of##3##4##(2008-10#3)
The electrochemical characteristics##4##3##(2008-10#4)
The electrochemical copolymerization of 3##2##5##(2008-10#2)
The electrochemical detection of##2##4##(2008-10#2)
The electrochemical oxidation of the##2##5##(2008-10#2)
The electrochemical oxidation of##6##4##(2008-10#6)
The electrochemical properties of##2##4##(2008-10#2)
The electrochemical redox##2##3##(2008-10#2)
The electrochemical reduction of##3##4##(2008-10#3)
The electrochemical reduction##4##3##(2008-10#4)
The electrochemical response##2##3##(2008-10#2)
The electrochemical##48##2##(2008-10#48)
The electrochemistry of dopamine##2##4##(2008-10#2)
The electrochemistry of##5##3##(2008-10#5)
The electrode E2##2##3##(2008-10#2)
The electrode based on##3##4##(2008-10#3)
The electrode can be used in the pH range from##3##10##(2008-10#3)
The electrode can be used in the pH range##4##9##(2008-10#4)
The electrode can be##5##4##(2008-10#5)
The electrode could be##2##4##(2008-10#2)
The electrode exhibited a linear response with a##2##8##(2008-10#2)
The electrode exhibited a##3##4##(2008-10#3)
The electrode exhibited##5##3##(2008-10#5)
The electrode exhibits a Nernstian response for##3##7##(2008-10#3)
The electrode exhibits a Nernstian slope of##2##7##(2008-10#2)
The electrode exhibits a Nernstian##6##5##(2008-10#6)
The electrode exhibits a linear response##3##6##(2008-10#3)
The electrode exhibits a##11##4##(2008-10#11)
The electrode exhibits linear response to##2##6##(2008-10#2)
The electrode exhibits##16##3##(2008-10#16)
The electrode had##2##3##(2008-10#2)
The electrode has a linear dynamic range##2##7##(2008-10#2)
The electrode has a linear##3##5##(2008-10#3)
The electrode has a##4##4##(2008-10#4)
The electrode has been##2##4##(2008-10#2)
The electrode has##8##3##(2008-10#8)
The electrode is##7##3##(2008-10#7)
The electrode posses a##2##4##(2008-10#2)
The electrode response is##2##4##(2008-10#2)
The electrode response was stable over##2##6##(2008-10#2)
The electrode response was##4##4##(2008-10#4)
The electrode response##7##3##(2008-10#7)
The electrode showed##3##3##(2008-10#3)
The electrode shows a linear##2##5##(2008-10#2)
The electrode shows a##6##4##(2008-10#6)
The electrode shows##11##3##(2008-10#11)
The electrode surface##2##3##(2008-10#2)
The electrode was successfully applied for##2##6##(2008-10#2)
The electrode was used in the direct determination of##2##9##(2008-10#2)
The electrode was used in##3##5##(2008-10#3)
The electrode was used##5##4##(2008-10#5)
The electrode was##15##3##(2008-10#15)
The electrode works##2##3##(2008-10#2)
The electrode##111##2##(2008-10#111)
The electrodes based on##2##4##(2008-10#2)
The electrodes exhibit##2##3##(2008-10#2)
The electrodes have##2##3##(2008-10#2)
The electrodes possess##2##3##(2008-10#2)
The electrodes were successfully##2##4##(2008-10#2)
The electrodes were##5##3##(2008-10#5)
The electrodes##18##2##(2008-10#18)
The electrogenerated chemiluminescent##2##3##(2008-10#2)
The electrolyte##2##2##(2008-12#1)(2010-7#1)
The electrolytic cell##2##3##(2008-10#2)
The electromyographic##2##2##(2010-6#1)(2010-9#1)
The electron##6##2##(1992-9#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
The electronic##5##2##(1993-8#1)(2008-10#3)(2008-3#1)
The electrophoretic##2##2##(2008-10#2)
The electropolymerization##2##2##(2008-10#2)
The electrothermal atomic absorption##2##4##(2008-10#2)
The electrothermal##3##2##(2008-10#3)
The elemental##4##2##(2008-10#2)(2008-5#1)(2010-11#1)
The elements were determined##2##4##(2008-10#2)
The elements##6##2##(2008-10#6)
The elevated##4##2##(1996-11#1)(1997-5#1)(1997-8#1)(2012-12#1)
The elimination of##2##3##(1992-12#1)(2008-10#1)
The elimination##5##2##(1992-12#1)(2008-10#4)
The eluate was##3##3##(1993-2#1)(2008-10#2)
The eluate##4##2##(1993-2#1)(2008-10#2)(2008-5#1)
The eluent was##2##3##(2008-10#2)
The eluent##3##2##(2008-10#3)
The eluted##4##2##(2008-10#4)
The elution is##2##3##(2008-10#2)
The elution##4##2##(2008-10#4)
The embryonic##2##2##(1995-2#1)(1997-1#1)
The emergence of resistance##2##4##(2008-11#2)
The emergence of##10##3##(1994-1#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-8#1)(2011-2#1)
The emergency physician##2##3##(2009-6#1)(2012-3#1)
The emerging##5##2##(1990-8#1)(2009-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
The emission intensity is greatly enhanced##3##6##(2008-10#3)
The emission intensity is##4##4##(2008-10#4)
The emission of##2##3##(2008-11#1)(2008-3#1)
The emission##12##2##(2008-10#8)(2008-11#1)(2008-3#2)(2008-7#1)
The emitted##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
The emitter is##2##3##(2007-12#1)(2008-3#1)
The emotional##2##2##(2008-11#1)(2008-5#1)
The emphasis is on##4##4##(1991-2#1)(1997-8#1)(2008-4#2)
The emphasis##8##2##(1991-2#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#2)
The empirical##5##2##(1993-3#1)(2008-10#1)(2008-8#1)(2011-3#2)
The employed methodology##2##3##(2008-10#2)
The employed##4##2##(1990-12#1)(2008-10#3)
The employee##2##2##(1995-6#1)(1996-5#1)
The employment##2##2##(1993-3#1)(2008-10#1)
The empowerment##2##2##(1993-1#1)(1996-12#1)
The emulsion##4##2##(2008-10#3)(2008-5#1)
The enantioselectivity was determined over##3##5##(2008-10#3)
The enantioselectivity##4##2##(2008-10#4)
The end of the##2##4##(2007-12#1)(2008-4#1)
The end##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)
The end-point of the titration is detected as the##2##9##(2008-10#2)
The end-point##3##2##(2008-10#3)
The endogenous##2##2##(2008-11#1)(2013-1#1)
The endoplasmic reticulum##2##3##(2008-8#1)(2009-10#1)
The endoplasmic##3##2##(1994-11#1)(2008-8#1)(2009-10#1)
The endothelial##2##2##(2011-2#2)
The endotoxin##2##2##(1996-12#2)
The energy##2##2##(2008-3#1)(2008-7#1)
The enhanced##16##2##(1990-5#1)(1993-3#1)(1993-6#1)(1996-2#1)(2008-10#8)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)
The enhancement of the##3##4##(1997-8#1)(2008-10#1)(2008-7#1)
The enhancement of##8##3##(1990-12#1)(1993-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
The enhancement was##2##3##(1991-3#1)(1994-6#1)
The enhancement##14##2##(1990-12#1)(1991-3#1)(1993-8#1)(1994-6#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)
The enquiry##2##2##(2008-10#2)
The enrichment factor##3##3##(2008-10#3)
The enrichment factors for Cu(II)##2##5##(2008-10#2)
The enrichment factors##3##3##(2008-10#3)
The enrichment of##2##3##(2008-10#1)(2008-11#1)
The enrichment##11##2##(2008-10#9)(2008-11#1)(2008-6#1)
The ensuing##3##2##(2008-10#3)
The enteric nervous system in##2##5##(2008-8#2)
The entire##12##2##(1992-1#1)(1992-2#1)(1996-6#1)(2008-10#5)(2008-9#2)(2009-9#1)(2013-8#1)
The environment of##2##3##(1990-5#1)(2011-2#1)
The environment##3##2##(1990-5#1)(2008-3#1)(2011-2#1)
The environmental##4##2##(2008-10#3)(2008-8#1)
The enzymatic activities##2##3##(1993-2#1)(2008-10#1)
The enzymatic reaction##2##3##(2008-10#2)
The enzymatic##13##2##(1990-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(2008-10#8)(2011-2#1)
The enzyme activity was##2##4##(1990-5#1)(1994-11#1)
The enzyme activity##4##3##(1990-5#1)(1994-11#1)(2008-12#1)(2008-8#1)
The enzyme electrode##4##3##(2008-10#4)
The enzyme is##3##3##(1992-12#1)(1993-8#1)(1994-8#1)
The enzyme telomerase##2##3##(2008-11#2)
The enzyme was entrapped##2##4##(2008-10#2)
The enzyme was##9##3##(1991-12#1)(1993-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-7#1)
The enzyme##45##2##(1990-5#1)(1991-12#1)(1991-5#2)(1992-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#3)(1995-3#1)(1997-2#1)(1997-8#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-2#1)
The enzyme-linked immunosorbent assay (ELISA)##2##5##(1994-3#1)(2008-4#1)
The enzymes were##2##3##(1994-11#1)(2008-10#1)
The enzymes##7##2##(1994-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2011-1#1)
The epidemic dynamics##2##3##(1992-9#1)(2008-10#1)
The epidemic##4##2##(1992-9#1)(2008-10#3)
The epidemiological##3##2##(2008-10#2)(2008-11#1)
The epidemiology of##2##3##(2008-10#2)
The epidemiology##3##2##(2008-10#3)
The epidermal##2##2##(2008-12#1)(2008-5#1)
The epithelial lining##2##3##(1992-1#1)(2008-7#1)
The epithelial##5##2##(1991-2#1)(1992-1#1)(1995-11#1)(2008-11#1)(2008-7#1)
The epitopes##2##2##(1996-12#1)(2008-10#1)
The equation##7##2##(1996-12#1)(2008-1#1)(2008-10#3)(2008-3#2)
The equations##4##2##(2008-10#3)(2008-7#1)
The equilibrium constant##2##3##(2008-10#2)
The equilibrium constants of the##2##5##(2008-10#2)
The equilibrium constants##3##3##(2008-10#3)
The equilibrium##8##2##(1994-9#1)(2008-10#7)
The equivalent average daily doses were approximately##2##7##(2008-9#2)
The equivalent##3##2##(2008-10#1)(2008-9#2)
The error##6##2##(2008-10#1)(2008-3#4)(2013-1#1)
The errors##2##2##(2008-3#2)
The essence of##3##3##(1992-3#1)(1996-3#1)(2008-9#1)
The essential oil of##3##4##(2008-11#3)
The essential oil##5##3##(2008-10#1)(2008-11#3)(2008-12#1)
The essential##14##2##(1990-12#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-3#1)
The established method was##2##4##(2008-10#2)
The established method##3##3##(2008-10#3)
The established##9##2##(2008-10#7)(2008-11#1)(2013-1#1)
The establishment of a##2##4##(1993-2#1)(2013-1#1)
The establishment of##7##3##(1993-2#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
The estimated##22##2##(1991-8#1)(1992-4#1)(1995-1#1)(1995-12#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-7#1)(2010-4#1)
The estimates##2##2##(2008-9#1)(2011-2#1)
The estimation of the##3##4##(2008-10#2)(2008-11#1)
The estimation of##5##3##(2008-10#4)(2008-11#1)
The estimation##6##2##(2008-10#5)(2008-11#1)
The ethanol##2##2##(2008-10#2)
The ethical##5##2##(2008-11#4)(2009-11#1)
The ethics of##2##3##(1995-5#1)(2010-3#1)
The etiologic##3##2##(1991-6#1)(1997-4#1)(2008-10#1)
The etiology of halo nevi##2##5##(2011-2#2)
The etiology of the##2##4##(1991-11#1)(2008-10#1)
The etiology of this##2##4##(2008-10#1)(2013-1#1)
The etiology of##9##3##(1991-11#1)(2008-10#2)(2008-7#2)(2011-2#2)(2013-1#2)
The etiology##13##2##(1991-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#3)(2012-3#1)(2013-1#2)
The eukaryotic##2##2##(2008-4#1)(2012-2#1)
The evaluation of a##3##4##(1996-2#1)(2008-5#1)(2010-7#1)
The evaluation of the##3##4##(2008-10#2)(2013-8#1)
The evaluation of##14##3##(1990-2#1)(1996-1#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#2)(2010-11#1)(2010-7#1)(2012-3#1)(2013-8#1)
The evaluation##23##2##(1990-2#1)(1992-2#1)(1994-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2008-9#2)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
The evidence base for##2##4##(2012-12#1)(2013-1#1)
The evidence base##4##3##(2008-12#1)(2010-12#1)(2012-12#1)(2013-1#1)
The evidence indicates that##2##4##(2008-10#2)
The evidence##17##2##(1991-12#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
The evolution of the##5##4##(1997-3#1)(2008-10#2)(2008-6#1)(2010-7#1)
The evolution of##36##3##(1991-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#6)(2008-9#8)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
The evolution##39##2##(1991-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#6)(2008-9#8)(2009-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
The evolutionary relationships##2##3##(1994-11#1)(2008-10#1)
The evolutionary##11##2##(1994-11#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#1)
The evolving role of##2##4##(1997-3#1)(2009-2#1)
The evolving##5##2##(1992-3#1)(1997-3#1)(2009-2#1)(2010-12#1)(2011-2#1)
The ex vivo##2##3##(2008-11#1)(2013-1#1)
The exact mechanism##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
The exact##8##2##(1991-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2013-1#1)
The examination of##2##3##(2008-11#1)(2013-1#1)
The examination was##2##3##(1996-6#1)(2007-12#1)
The examination##5##2##(1996-6#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
The examined##2##2##(2008-10#2)
The example of##2##3##(1993-3#1)(2008-12#1)
The example##3##2##(1993-3#1)(2008-12#1)(2009-11#1)
The examples##2##2##(1992-9#1)(1994-12#1)
The excellent##2##2##(2008-10#2)
The exception was##2##3##(2008-10#2)
The excess of##2##3##(1991-6#1)(2008-10#1)
The excess##3##2##(1991-6#1)(2008-10#2)
The exchange capacity##2##3##(2008-10#2)
The exchange of##2##3##(1997-6#1)(2011-2#1)
The exchange##4##2##(1997-6#1)(2008-10#2)(2011-2#1)
The excitation and emission wavelengths##2##5##(2008-10#2)
The excitation wavelength##3##3##(2008-10#3)
The excitation##7##2##(2008-10#6)(2008-8#1)
The excitation-emission spectra of these compounds are##2##7##(2008-10#2)
The exclusion of##3##3##(2008-10#2)(2009-10#1)
The executive##2##2##(1995-3#1)(2008-11#1)
The exercise##3##2##(2008-11#1)(2008-12#2)
The existence of a##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
The existence of the##2##4##(2008-11#1)(2008-8#1)
The existence of##15##3##(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)
The existing##2##2##(2008-10#1)(2008-12#1)
The expanded##2##2##(2012-2#2)
The expansion of##2##3##(2008-10#1)(2010-1#1)
The expansion##3##2##(2008-10#1)(2010-1#1)(2012-2#1)
The expectations##3##2##(1997-1#1)(2008-11#1)(2009-11#1)
The expected##7##2##(1991-1#1)(1991-12#1)(2008-10#4)(2013-8#1)
The experience of the##3##4##(1993-11#1)(1993-12#1)(2008-10#1)
The experience of##5##3##(1993-11#1)(1993-12#1)(1995-1#1)(2008-10#1)(2008-11#1)
The experience##8##2##(1993-11#1)(1993-12#1)(1994-12#1)(1995-1#1)(2008-10#2)(2008-11#2)
The experiences of##2##3##(1994-2#1)(2008-11#1)
The experiences##3##2##(1994-2#1)(2008-11#1)(2010-8#1)
The experiment was conducted##2##4##(2008-12#1)(2012-6#1)
The experiment was##9##3##(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-9#1)(2012-6#1)
The experiment##20##2##(1992-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#3)(2008-5#1)(2008-9#2)(2012-2#1)(2012-3#1)(2012-6#2)(2013-1#1)(2013-8#1)
The experimental and##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
The experimental calibration set was composed of##2##7##(2008-10#2)
The experimental calibration##3##3##(2008-10#3)
The experimental conditions were optimized##2##5##(2008-10#2)
The experimental conditions##6##3##(2008-10#6)
The experimental data obtained##2##4##(2008-10#2)
The experimental data show that##2##5##(2008-10#1)(2008-3#1)
The experimental data##12##3##(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
The experimental group##6##3##(1991-12#1)(2008-11#2)(2008-12#2)(2010-4#1)
The experimental host range was limited to Nicotiana##2##8##(2008-10#2)
The experimental host range was limited to##3##7##(2008-10#3)
The experimental host range##4##4##(2008-10#4)
The experimental parameters##2##3##(2008-10#2)
The experimental results are##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
The experimental results for##2##4##(2008-10#2)
The experimental results indicate that the##4##6##(2008-10#3)(2012-3#1)
The experimental results obtained##2##4##(2008-10#2)
The experimental results show that the##2##6##(2008-10#1)(2013-8#1)
The experimental results show that##5##5##(2008-10#2)(2008-8#1)(2013-8#2)
The experimental results show##7##4##(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)(2013-8#2)
The experimental results showed that the##2##6##(2008-10#1)(2008-8#1)
The experimental results showed that##3##5##(2008-10#2)(2008-8#1)
The experimental results were fitted to##2##6##(2008-10#1)(2011-2#1)
The experimental results were##4##4##(2008-10#2)(2010-4#1)(2011-2#1)
The experimental results##31##3##(1995-3#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#2)
The experimental setup##2##3##(2008-3#2)
The experimental variables##2##3##(2008-10#2)
The experimental##90##2##(1991-12#1)(1995-3#1)(1995-9#1)(2008-10#56)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-3#1)(2010-4#2)(2011-2#3)(2012-3#1)(2013-8#3)
The experiments indicate that under##2##5##(2008-10#2)
The experiments indicated that##2##4##(2008-10#2)
The experiments reported here##2##4##(1990-5#1)(1993-6#1)
The experiments revealed that##2##4##(2008-10#1)(2008-8#1)
The experiments showed that##2##4##(2008-10#1)(2008-9#1)
The experiments showed##3##3##(2008-10#1)(2008-9#2)
The experiments were conducted##4##4##(2008-10#2)(2008-11#2)
The experiments were performed in##2##5##(1993-12#1)(2008-11#1)
The experiments were performed with a##2##6##(1990-12#1)(2008-10#1)
The experiments were performed##5##4##(1990-12#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-11#1)
The experiments were##11##3##(1990-12#1)(1993-12#1)(1993-8#1)(2008-10#4)(2008-11#3)(2013-1#1)
The experiments##26##2##(1990-12#1)(1990-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1996-6#1)(2008-10#12)(2008-11#3)(2008-8#1)(2008-9#2)(2010-7#1)(2013-1#1)
The expert system##2##3##(2008-10#2)
The experts##2##2##(2008-8#1)(2010-12#1)
The explanation##2##2##(1991-6#1)(2010-1#1)
The exploitation of##2##3##(2008-10#1)(2011-1#1)
The exposure of##2##3##(1997-8#1)(2008-5#1)
The exposure time##2##3##(1996-12#1)(2008-3#1)
The exposure##5##2##(1996-12#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
The expressed protein##3##3##(1993-6#1)(1994-11#1)(2008-8#1)
The expressed##10##2##(1991-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-8#2)
The expression and##2##3##(2008-10#1)(2008-9#1)
The expression level of##3##4##(2008-11#1)(2010-12#1)(2010-5#1)
The expression level##4##3##(2008-11#1)(2009-3#1)(2010-12#1)(2010-5#1)
The expression levels of##2##4##(2008-11#2)
The expression of Bcl-2 and Bax##2##6##(2008-9#2)
The expression of CYP1A1##2##4##(1995-11#1)(2008-11#1)
The expression of Glu-1##2##4##(2008-10#2)
The expression of a##3##4##(1995-6#1)(2008-10#1)(2010-10#1)
The expression of the##11##4##(1993-11#1)(1993-8#1)(1997-2#1)(2008-10#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
The expression of this##2##4##(1991-5#1)(2008-10#1)
The expression of##61##3##(1990-12#1)(1991-5#1)(1993-11#1)(1993-8#1)(1995-11#2)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2008-1#2)(2008-10#6)(2008-11#8)(2008-4#1)(2008-8#4)(2008-9#8)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)
The expression pattern of##2##4##(1996-12#1)(2007-12#1)
The expression##80##2##(1990-12#1)(1990-8#1)(1991-5#1)(1993-11#1)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#11)(2008-4#1)(2008-8#5)(2008-9#11)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-5#2)(2011-10#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)
The extended##2##2##(2008-9#1)(2010-5#1)
The extension of the##2##4##(2008-10#1)(2010-1#1)
The extension of##5##3##(1993-3#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
The extensive##4##2##(1994-6#1)(1996-12#1)(1997-8#1)(2008-10#1)
The extent and##2##3##(1993-8#1)(2008-11#1)
The extent of agreement##2##4##(1993-1#1)(1996-2#1)
The extent of the##4##4##(1993-8#1)(2008-10#2)(2011-2#1)
The extent of##23##3##(1992-9#1)(1993-1#1)(1993-8#1)(1994-12#2)(1994-2#1)(1996-2#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
The extent to which##3##4##(1994-3#1)(2008-10#1)(2012-3#1)
The extent##29##2##(1992-9#1)(1993-1#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1996-2#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
The extinction##2##2##(2008-3#1)(2008-8#1)
The extracellular domain of##3##4##(1992-12#1)(1995-2#1)(2008-11#1)
The extracellular##5##2##(1992-12#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-11#1)
The extract is also##2##4##(2008-10#1)(2008-5#1)
The extract is##5##3##(2008-10#3)(2008-5#2)
The extract was evaporated##2##4##(2008-10#1)(2008-11#1)
The extract was##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
The extract##12##2##(1990-5#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#3)
The extractability of##3##3##(2008-10#3)
The extractability with##2##3##(2008-10#2)
The extractability##6##2##(2008-10#6)
The extracted species##2##3##(2008-10#2)
The extracted##10##2##(2008-10#8)(2008-12#1)(2012-2#1)
The extracting##2##2##(2008-10#2)
The extraction ability##2##3##(2008-10#2)
The extraction behaviour of##3##4##(2008-10#3)
The extraction constant##5##3##(2008-10#5)
The extraction efficiency and##2##4##(2008-10#2)
The extraction efficiency##6##3##(2008-10#6)
The extraction is carried out##2##5##(2008-10#2)
The extraction mechanism of##2##4##(2008-10#2)
The extraction mechanism##3##3##(2008-10#3)
The extraction of the##2##4##(2008-10#2)
The extraction of uranium by##2##5##(2008-10#2)
The extraction of##20##3##(1994-6#1)(1997-2#1)(2008-10#16)(2008-6#1)(2010-8#1)
The extraction procedure was##4##4##(2008-10#4)
The extraction procedure##5##3##(2008-10#5)
The extraction process was##2##4##(2008-10#2)
The extraction rate of platinum(II)##2##5##(2008-10#2)
The extraction rate##3##3##(2008-10#3)
The extraction selectivity##2##3##(2008-10#2)
The extraction step##2##3##(2008-10#2)
The extraction was##3##3##(2008-10#3)
The extraction yield of##2##4##(2008-10#1)(2008-7#1)
The extraction##76##2##(1994-6#1)(1997-2#1)(2008-10#70)(2008-6#1)(2008-7#1)(2010-5#1)(2010-8#1)
The extractor system##2##3##(2008-10#2)
The extractor##4##2##(2008-10#4)
The extracts of##2##3##(1996-2#1)(2008-10#1)
The extracts were evaluated directly by derivative spectrophotometric measurement##2##9##(2008-10#2)
The extracts were##5##3##(2008-10#4)(2008-5#1)
The extracts##8##2##(1996-2#1)(2008-10#6)(2008-5#1)
The extreme##2##2##(1997-8#1)(2008-10#1)
The eye##3##2##(2007-12#1)(2010-1#1)(2010-8#1)
The fabricated##2##2##(2008-10#2)
The fabrication and##3##3##(2008-10#2)(2009-9#1)
The fabrication##7##2##(2008-10#6)(2009-9#1)
The face##2##2##(2008-5#1)(2010-6#1)
The facial##3##2##(1996-3#1)(1996-5#1)(2008-9#1)
The facility master plan##2##4##(1992-2#2)
The fact that the##5##4##(1992-3#1)(1992-5#1)(1993-3#1)(1996-6#1)(2008-9#1)
The fact that this##3##4##(1995-12#1)(2008-11#1)(2009-3#1)
The fact that##15##3##(1992-3#1)(1992-5#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-3#1)(2010-5#1)(2013-1#1)
The fact##16##2##(1992-3#1)(1992-5#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-3#1)(2010-5#1)(2013-1#1)
The factor is##2##3##(1995-2#1)(2008-3#1)
The factor##4##2##(1995-2#1)(1995-6#1)(2008-3#1)(2010-11#1)
The factors affecting the##2##4##(2008-10#2)
The factors influencing the##2##4##(2008-10#2)
The factors that influenced the##2##5##(2008-10#1)(2008-11#1)
The factors that##5##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#1)
The factors##17##2##(1992-12#1)(1993-12#1)(2008-10#11)(2008-11#2)(2008-2#1)(2011-1#1)
The facts##2##2##(2008-11#1)(2008-9#1)
The failure of##3##3##(1991-3#1)(1993-6#1)(2011-2#1)
The failure##6##2##(1991-3#1)(1993-6#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#1)
The families##2##2##(1990-2#1)(2013-1#1)
The family history##2##3##(1993-1#1)(2008-10#1)
The family##6##2##(1993-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)(2012-12#1)
The fast##4##2##(1991-12#1)(1992-2#1)(2007-12#1)(2008-10#1)
The fastest##2##2##(2008-10#1)(2011-2#1)
The fate of the##2##4##(2008-11#1)(2010-11#1)
The fate of##5##3##(1994-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#1)
The fate##6##2##(1994-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#1)(2011-1#1)
The fatty acid release##2##4##(1991-12#2)
The fatty acid##4##3##(1991-12#2)(2008-10#1)(2008-11#1)
The feasibility of the system was##2##6##(2008-10#2)
The feasibility of the##7##4##(2008-10#6)(2010-7#1)
The feasibility of this method##2##5##(2007-11#1)(2008-10#1)
The feasibility of this##3##4##(2007-11#1)(2008-10#2)
The feasibility of using##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
The feasibility of##23##3##(2007-11#1)(2008-10#18)(2008-11#1)(2008-3#1)(2010-7#1)(2011-2#1)
The feasibility##26##2##(1994-2#1)(2007-11#1)(2008-10#19)(2008-11#1)(2008-3#1)(2010-7#1)(2011-2#2)
The features of the##2##4##(1991-12#1)(2008-10#1)
The features of##4##3##(1991-12#1)(2008-10#2)(2008-5#1)
The features##5##2##(1991-12#1)(2008-10#2)(2008-5#2)
The feeding##2##2##(1996-9#1)(2008-10#1)
The femoral##2##2##(2008-7#1)(2011-2#1)
The fermentation##3##2##(2008-10#1)(2008-7#1)(2009-6#1)
The fetal origins of adult disease##2##6##(2013-1#2)
The fetal##5##2##(1996-3#1)(2008-7#1)(2010-11#1)(2013-1#2)
The few##2##2##(2008-1#1)(2008-10#1)
The fiber##6##2##(2008-10#3)(2008-2#2)(2008-7#1)
The fibers##2##2##(2008-10#1)(2009-7#1)
The fibres##2##2##(1997-3#1)(2008-10#1)
The field of##7##3##(1992-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
The field##11##2##(1992-1#1)(1992-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
The fields of##3##3##(1996-1#1)(2008-12#1)(2009-8#1)
The fifth##3##2##(1990-12#1)(1993-8#1)(2008-12#1)
The figures of merit of the proposed method##2##8##(2008-10#2)
The figures of merit of the##3##6##(2008-10#3)
The figures of merit##4##4##(2008-10#4)
The filamentous fungus##2##3##(1993-2#1)(2010-10#1)
The filamentous##3##2##(1993-2#1)(2008-10#1)(2010-10#1)
The files of##3##3##(1995-12#1)(1997-2#1)(2012-2#1)
The files##4##2##(1992-1#1)(1995-12#1)(1997-2#1)(2012-2#1)
The film is##2##3##(2008-10#2)
The film modified##2##3##(2008-10#2)
The film##6##2##(2008-10#5)(2008-5#1)
The films were characterized using X-ray diffraction and X-ray photoelectron spectroscopy##2##11##(2008-10#2)
The films##3##2##(2008-10#3)
The filter##2##2##(1993-8#1)(2008-2#1)
The final R value for##2##5##(1993-8#1)(1996-5#1)
The final R##3##3##(1993-8#1)(1996-5#1)(2008-8#1)
The final cleavage occurs quantitatively without concomitant destruction of the RNA product##2##12##(2008-4#2)
The final concentrations of##2##4##(2008-10#1)(2008-11#1)
The final model##3##3##(2008-10#1)(2008-9#1)(2009-7#1)
The final product##2##3##(1994-6#1)(2008-10#1)
The final sections of this article discuss new excipients##2##9##(2012-2#2)
The final steps##2##3##(1991-6#1)(2008-4#1)
The final version##2##3##(2008-9#1)(2013-1#1)
The final##42##2##(1991-12#1)(1991-6#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-5#2)(2008-10#10)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#2)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
The financial##3##2##(2008-11#2)(2008-9#1)
The finding of##4##3##(1990-12#1)(1993-2#1)(1995-8#1)(2008-7#1)
The finding that##4##3##(1993-6#1)(1997-4#1)(2008-5#2)
The finding##11##2##(1990-11#1)(1990-12#1)(1993-2#1)(1993-6#1)(1995-8#1)(1997-4#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-5#1)
The findings also##2##3##(1994-12#1)(2009-7#1)
The findings are discussed in##4##5##(1993-11#1)(2009-12#1)(2010-7#1)(2012-2#1)
The findings are discussed##6##4##(1993-11#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-7#1)(2012-2#1)
The findings are##8##3##(1993-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-12#1)(2010-7#1)(2012-2#1)
The findings from##3##3##(1993-12#1)(2007-12#1)(2010-2#1)
The findings have##2##3##(1992-2#1)(1994-12#1)
The findings highlight the need for##2##6##(2011-2#1)(2013-1#1)
The findings indicate a##3##4##(1996-6#1)(2008-11#1)(2013-8#1)
The findings indicate that##4##4##(2009-12#1)(2009-5#1)(2010-11#1)(2013-8#1)
The findings indicate##8##3##(1996-6#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-5#1)(2010-11#1)(2013-8#2)
The findings indicated that##2##4##(1994-8#1)(2008-11#1)
The findings may##2##3##(1991-2#1)(2008-4#1)
The findings obtained##2##3##(1990-8#1)(2008-10#1)
The findings of the present study##2##6##(2008-5#1)(2011-2#1)
The findings of the##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
The findings of this study are##2##6##(2008-11#1)(2008-7#1)
The findings of this study suggest that##3##7##(1994-2#1)(2008-11#1)(2008-3#1)
The findings of this study##11##5##(1994-2#1)(1994-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2009-5#1)(2010-4#1)
The findings of this##12##4##(1994-2#1)(1994-8#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-7#1)(2009-5#1)(2010-4#1)
The findings of##18##3##(1994-2#1)(1994-8#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#3)
The findings point to##2##4##(2008-10#1)(2008-12#1)
The findings reported in##2##4##(2008-12#1)(2011-3#1)
The findings revealed##5##3##(2008-12#1)(2009-12#1)(2009-5#1)(2009-6#1)(2012-3#1)
The findings show##2##3##(1990-8#1)(1991-2#1)
The findings showed that##2##4##(2008-12#1)(2011-2#1)
The findings showed##4##3##(1991-11#1)(1994-3#1)(2008-12#1)(2011-2#1)
The findings suggest a##2##4##(1990-5#1)(2010-4#1)
The findings suggest that the##3##5##(2008-11#1)(2009-12#1)(2012-3#1)
The findings suggest that##13##4##(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-12#1)(2011-1#1)(2012-3#1)
The findings suggest the##2##4##(1992-2#1)(2010-4#1)
The findings suggest##18##3##(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-12#1)(2010-4#2)(2011-1#1)(2012-2#1)(2012-3#1)
The findings suggested that##2##4##(1991-12#1)(2008-11#1)
The findings##109##2##(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#14)(2008-12#7)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#5)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-7#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
The fine structure of the##3##5##(2007-12#1)(2008-7#1)(2008-8#1)
The fine structure of##5##4##(2007-12#2)(2008-7#2)(2008-8#1)
The first ORF##2##3##(1996-6#1)(2008-10#1)
The first and##2##3##(2008-10#1)(2008-7#1)
The first attempt##2##3##(2008-10#1)(2013-1#1)
The first case of##2##4##(2012-3#1)(2013-1#1)
The first case##3##3##(2012-3#1)(2013-1#2)
The first design##2##3##(2008-2#1)(2012-2#1)
The first group of##3##4##(2007-8#1)(2012-3#2)
The first group##7##3##(1990-2#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-3#2)
The first is a##3##4##(1992-11#1)(2007-12#1)(2008-10#1)
The first is based on the##2##6##(2008-3#1)(2008-4#1)
The first is related to##2##5##(1996-6#1)(2008-10#1)
The first is to##3##4##(1996-2#1)(2008-8#1)(2012-2#1)
The first is##13##3##(1992-11#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2012-2#1)(2012-3#1)
The first issue of World Journal of##3##7##(2010-12#3)
The first issue##4##3##(2008-1#1)(2010-12#3)
The first method was##2##4##(2008-10#2)
The first method##5##3##(2008-10#3)(2008-3#1)(2012-2#1)
The first of these##2##4##(2008-10#1)(2013-1#1)
The first of##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
The first one is##2##4##(2008-11#1)(2008-3#1)
The first one##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)
The first part of the##2##5##(1993-6#1)(2009-6#1)
The first part of##3##4##(1992-1#1)(1993-6#1)(2009-6#1)
The first part##7##3##(1992-1#1)(1993-6#1)(1997-2#1)(2008-11#1)(2008-8#1)(2009-6#1)(2012-2#1)
The first patient##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
The first peak##3##3##(2008-10#2)(2008-11#1)
The first population##2##3##(2008-10#2)
The first protocol uses##2##4##(2008-4#2)
The first protocol##4##3##(2008-4#4)
The first reported##2##3##(2008-10#1)(2012-12#1)
The first results##2##3##(1997-2#1)(2008-10#1)
The first section##6##3##(1991-3#1)(2008-10#2)(2008-4#3)
The first set of##2##4##(2012-2#1)(2013-1#1)
The first set##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
The first stage##2##3##(2008-12#1)(2010-8#1)
The first step in##3##4##(1997-7#1)(2008-7#1)(2012-2#1)
The first step of##2##4##(1996-2#1)(2008-9#1)
The first step##5##3##(1996-2#1)(1997-7#1)(2008-7#1)(2008-9#1)(2012-2#1)
The first three##2##3##(1992-10#1)(2008-10#1)
The first two##7##3##(1993-12#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-5#1)(2013-1#1)
The first type of##2##4##(1997-3#1)(2008-10#1)
The first##179##2##(1990-2#1)(1990-3#1)(1991-3#2)(1992-1#1)(1992-10#1)(1992-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1997-2#2)(1997-3#1)(1997-7#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#50)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#12)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#2)(2011-4#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#8)(2013-8#2)
The first-derivative##2##2##(2008-10#2)
The fission yeast Schizosaccharomyces pombe##2##5##(1995-2#1)(2012-3#1)
The fitness##2##2##(2008-10#1)(2008-8#1)
The five##5##2##(1995-11#1)(2008-10#2)(2008-4#1)(2012-2#1)
The fixed##2##2##(1990-12#1)(2008-10#1)
The flagellum##2##2##(2008-7#2)
The flame##2##2##(2008-10#2)
The flap was##2##3##(2013-1#2)
The flow cell##2##3##(2008-10#2)
The flow cytometry##2##3##(2008-9#2)
The flow injection analysis##3##4##(2008-10#3)
The flow injection system##2##4##(2008-10#2)
The flow injection##9##3##(2008-10#9)
The flow manifold was designed##2##5##(2008-10#2)
The flow manifold was##3##4##(2008-10#3)
The flow manifold##4##3##(2008-10#4)
The flow network##2##3##(2008-10#2)
The flow rate of the##2##5##(2008-10#2)
The flow rate of##3##4##(2008-10#3)
The flow rate##7##3##(2008-10#6)(2008-8#1)
The flow system was successfully applied to the analysis of##2##10##(2008-10#2)
The flow system was##3##4##(2008-10#3)
The flow system##9##3##(2008-10#9)
The flow##48##2##(1995-3#1)(2008-10#40)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)
The flow-rate##2##2##(1997-2#1)(2008-10#1)
The flow-through coulometric titration##2##4##(2008-10#2)
The flowing##2##2##(2008-10#2)
The fluid##2##2##(2008-11#1)(2013-1#1)
The fluorescence emission##2##3##(2008-10#2)
The fluorescence energy transfer##2##4##(2008-10#2)
The fluorescence from##2##3##(2008-10#1)(2008-3#1)
The fluorescence increase is linearly related to the concentration of##2##10##(2008-10#2)
The fluorescence intensities##2##3##(2008-10#2)
The fluorescence intensity is##3##4##(2008-10#3)
The fluorescence intensity of##2##4##(2008-10#2)
The fluorescence intensity was##2##4##(2008-10#2)
The fluorescence intensity##8##3##(2008-10#8)
The fluorescence measurements to quantify##2##5##(2008-10#2)
The fluorescence of the##3##4##(2008-10#3)
The fluorescence of##6##3##(2008-10#6)
The fluorescence quenching##2##3##(2008-10#2)
The fluorescence##40##2##(2008-10#38)(2008-3#1)(2010-12#1)
The fluorescent##5##2##(2008-10#5)
The fluoride##2##2##(2008-10#2)
The fluorimetric determination##2##3##(2008-10#2)
The fluorimetric method allows the determination of##2##7##(2008-10#2)
The fluorimetric method##3##3##(2008-10#3)
The fluorimetric##8##2##(2008-10#8)
The flux of##3##3##(2008-10#2)(2008-11#1)
The flux##7##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-7#1)
The focal##2##2##(1996-5#1)(2008-2#1)
The focus is on##3##4##(1994-9#1)(2008-10#1)(2008-11#1)
The focus of the##4##4##(1991-2#1)(1996-3#1)(1997-2#1)(2008-9#1)
The focus of this paper##2##5##(2008-11#1)(2008-12#1)
The focus of this review is##3##6##(2008-10#1)(2008-12#1)(2012-2#1)
The focus of this review##4##5##(2008-10#1)(2008-12#1)(2009-10#1)(2012-2#1)
The focus of this study is##2##6##(1992-2#1)(2010-10#1)
The focus of this study##3##5##(1992-2#1)(2008-11#1)(2010-10#1)
The focus of this##12##4##(1992-2#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-10#1)(2010-10#1)(2010-2#1)(2012-2#1)(2013-8#1)
The focus of##17##3##(1991-2#1)(1992-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2012-2#1)(2013-8#1)
The focus##22##2##(1991-2#1)(1992-2#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
The follicular unit-like wigs##2##4##(2012-3#2)
The follicular##3##2##(2008-6#1)(2012-3#2)
The follow up##3##3##(2011-2#2)(2013-1#1)
The follow-up of##2##3##(1993-11#1)(1997-8#1)
The follow-up period ranged from 1 to##2##7##(2008-7#1)(2013-1#1)
The follow-up period##3##3##(2008-7#1)(2013-1#2)
The follow-up##7##2##(1990-3#1)(1991-8#1)(1993-11#1)(1997-8#1)(2008-7#1)(2013-1#2)
The following article##2##3##(1993-3#1)(2008-4#1)
The following case##2##3##(2013-1#2)
The following conclusions##3##3##(1992-3#1)(1993-12#1)(2008-8#1)
The following day##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
The following formation of##2##4##(1992-12#1)(2008-10#1)
The following parameters were##2##4##(2008-10#2)
The following sequence##2##3##(1992-12#1)(2008-10#1)
The following variables were associated with##2##6##(2011-2#2)
The following variables were##3##4##(2011-2#2)(2013-1#1)
The following##55##2##(1991-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-10#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#9)(2013-8#1)
The food##3##2##(1994-3#1)(2008-12#1)(2011-2#1)
The forest ecosystem##2##3##(2008-9#2)
The forest##4##2##(1995-12#1)(2008-10#1)(2008-9#2)
The forgotten##2##2##(1991-12#1)(2009-11#1)
The form##2##2##(1996-3#1)(2013-8#1)
The formal potential of##2##4##(2008-10#2)
The formal potential##3##3##(2008-10#3)
The formal##4##2##(2008-10#4)
The formation and stability of protonated##2##6##(2008-10#2)
The formation and stability of##3##5##(2008-10#3)
The formation constant##3##3##(2008-10#3)
The formation constants of the resulting##2##6##(2008-10#2)
The formation constants of the##3##5##(2008-10#3)
The formation constants of##5##4##(2008-10#5)
The formation constants##7##3##(2008-10#7)
The formation of the##5##4##(1994-3#1)(2008-10#2)(2008-7#1)(2009-10#1)
The formation of these novel inclusions##2##6##(2008-10#2)
The formation of these##3##4##(1996-5#1)(2008-10#2)
The formation of##29##3##(1991-3#1)(1994-12#1)(1994-3#1)(1996-5#1)(2008-10#17)(2008-11#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
The formation##46##2##(1991-3#1)(1994-12#1)(1994-3#1)(1996-5#1)(2008-10#33)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
The formed##4##2##(1994-6#1)(2008-10#2)(2008-11#1)
The former was##3##3##(1991-9#1)(1996-3#1)(2008-10#1)
The former##15##2##(1990-8#1)(1991-9#1)(1993-1#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)
The formulation was##2##3##(2011-2#1)(2013-1#1)
The formulation##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
The formulations were##2##3##(2008-10#1)(2008-5#1)
The forward##2##2##(2008-10#1)(2009-3#1)
The foundations of##2##3##(2008-10#1)(2010-4#1)
The four##15##2##(1993-3#1)(1993-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)
The fourth##5##2##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
The fraction of##5##3##(1991-11#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-7#1)
The fraction##6##2##(1991-11#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-7#1)
The fractional##2##2##(2008-10#1)(2008-3#1)
The fractions##3##2##(2008-10#2)(2008-11#1)
The fractures were##2##3##(1991-9#1)(2009-4#1)
The fragment##3##2##(1996-3#1)(2008-10#1)(2008-9#1)
The fragments were##2##3##(2008-10#1)(2008-7#1)
The framework##3##2##(1994-12#1)(2008-7#1)(2013-1#1)
The free##2##2##(2008-10#2)
The frequencies of##5##3##(1997-8#1)(2007-11#1)(2008-10#2)(2010-4#1)
The frequency and##2##3##(1995-5#1)(2012-3#1)
The frequency distribution was##2##4##(2008-10#1)(2008-7#1)
The frequency distribution##3##3##(2008-10#2)(2008-7#1)
The frequency distributions of##2##4##(2008-10#2)
The frequency of local##2##4##(1990-3#1)(1991-9#1)
The frequency of the flashes is directly proportional to the concentration of particles in the colloidal suspension##2##17##(2008-10#2)
The frequency of the##7##4##(1995-1#1)(2008-10#2)(2008-11#1)(2011-2#3)
The frequency of##36##3##(1990-12#2)(1990-3#1)(1990-6#1)(1991-6#1)(1991-9#1)(1993-2#2)(1993-3#1)(1994-9#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2011-1#1)(2011-2#6)(2013-1#1)
The frequency##47##2##(1990-12#2)(1990-3#1)(1990-6#1)(1991-6#1)(1991-9#1)(1993-2#2)(1993-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#6)(2012-3#2)(2013-1#1)
The frequent##2##2##(2008-10#1)(2010-11#1)
The frequently##2##2##(2008-1#1)(2012-12#1)
The full##7##2##(2008-10#1)(2008-11#4)(2008-3#1)(2009-4#1)
The full-length cDNA of##2##4##(2008-10#1)(2008-8#1)
The full-length cDNA##4##3##(1995-12#1)(2008-10#1)(2008-8#2)
The full-length##6##2##(1995-12#1)(2008-10#3)(2008-8#2)
The fully##3##2##(2007-12#1)(2008-10#2)
The function of the##4##4##(1990-5#1)(1991-3#1)(2008-5#1)(2009-8#1)
The function of##16##3##(1990-5#1)(1991-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)
The function##17##2##(1990-5#1)(1991-3#1)(1992-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)
The functional##22##2##(1991-2#1)(1991-3#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
The functions of##3##3##(1997-6#1)(2010-10#1)(2010-4#1)
The fundamental##5##2##(1993-3#1)(1994-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
The fungal##5##2##(1995-2#1)(2008-10#2)(2008-5#2)
The fungi were##2##3##(2008-10#2)
The fungi##5##2##(1996-6#1)(2008-10#3)(2008-8#1)
The fungicide##4##2##(2008-10#4)
The fungus was##4##3##(2008-10#3)(2008-5#1)
The fungus##14##2##(2008-10#12)(2008-5#1)(2008-8#1)
The fusion proteins##2##3##(2008-10#2)
The fusion##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#1)
The future of Britain's high security hospitals##2##7##(1997-5#2)
The future of##14##3##(1992-12#1)(1993-1#2)(1994-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#2)(2008-11#1)(2008-9#1)(2009-10#1)(2012-2#1)
The future##23##2##(1992-12#2)(1993-1#2)(1994-1#2)(1994-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-5#2)(2007-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
The gain##2##2##(1996-6#1)(2011-2#1)
The gains##2##2##(1993-3#1)(2007-11#1)
The ganglion##2##2##(2011-2#1)(2013-8#1)
The gas##5##2##(2008-10#3)(2008-11#2)
The gaseous phase is separated from the liquid##2##8##(2008-10#2)
The gaseous phase##3##3##(2008-10#3)
The gaseous##8##2##(2008-10#8)
The gel##5##2##(1996-9#2)(2008-10#1)(2008-11#2)
The gene (or allele)##2##4##(2008-10#2)
The gene coding for##2##4##(1992-8#1)(1994-5#1)
The gene encoding Escherichia coli acyl carrier protein##2##8##(1992-4#2)
The gene encoding##9##3##(1990-11#1)(1991-7#1)(1992-4#2)(1993-2#2)(1995-6#2)(2008-10#1)
The gene expression##2##3##(2008-7#1)(2008-8#1)
The gene for##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
The gene identified##2##3##(2008-10#2)
The gene is##5##3##(1993-2#1)(1993-3#1)(1995-9#1)(2008-8#1)(2008-9#1)
The gene was##5##3##(1993-2#1)(2008-10#3)(2008-7#1)
The gene##58##2##(1990-11#1)(1990-8#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-12#3)(1993-2#6)(1993-3#1)(1994-11#1)(1994-5#2)(1995-6#2)(1995-9#2)(1996-12#1)(1996-2#1)(1996-6#2)(1997-7#1)(2008-10#12)(2008-11#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2011-3#1)
The general form of##2##4##(2008-8#2)
The general##16##2##(1991-6#1)(1992-2#1)(1994-1#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#1)(2011-1#1)
The generated##2##2##(2007-12#1)(2008-10#1)
The generation of##6##3##(2008-10#3)(2008-3#1)(2008-9#1)(2012-2#1)
The genes are##2##3##(2008-10#1)(2008-6#1)
The genes encoding the##3##4##(1992-9#1)(2008-10#1)(2013-1#1)
The genes encoding##5##3##(1991-6#1)(1992-9#1)(1994-12#1)(2008-10#1)(2013-1#1)
The genes##12##2##(1991-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(2008-10#5)(2008-6#1)(2012-3#1)(2013-1#1)
The genetic basis of the##2##5##(2008-10#1)(2012-3#1)
The genetic basis of##3##4##(2008-10#1)(2008-4#1)(2012-3#1)
The genetic characteristics##2##3##(2011-2#1)(2013-8#1)
The genetic differentiation of##2##4##(2008-10#1)(2008-6#1)
The genetic distance between##2##4##(2008-10#1)(2008-6#1)
The genetic distance##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
The genetic diversity of##4##4##(2008-10#3)(2013-8#1)
The genetic diversity##8##3##(2008-10#7)(2013-8#1)
The genetic information##2##3##(2008-10#1)(2008-4#1)
The genetic polymorphisms##2##3##(2008-12#1)(2008-9#1)
The genetic structure of populations of##3##6##(2008-10#2)(2011-2#1)
The genetic structure of##8##4##(2008-10#7)(2011-2#1)
The genetic structure##10##3##(1993-2#1)(2008-10#7)(2011-2#1)(2013-1#1)
The genetic##51##2##(1993-2#1)(1995-5#1)(2008-10#30)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-9#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
The genetics##2##2##(2008-8#1)(2012-3#1)
The genome of##7##3##(2008-10#6)(2013-8#1)
The genome sizes of##2##4##(1997-2#1)(2008-10#1)
The genome##16##2##(1997-2#1)(2008-10#11)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
The genomes of two##2##4##(2008-10#2)
The genomes of##3##3##(2008-10#3)
The genomic DNA of##2##4##(2008-8#1)(2010-7#1)
The genomic DNA##5##3##(1994-11#1)(1997-8#1)(2008-6#1)(2008-8#1)(2010-7#1)
The genomic organization##2##3##(1993-12#1)(2012-2#1)
The genomic##15##2##(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1997-8#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-7#1)(2012-2#1)
The genotype##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
The genus##7##2##(2008-10#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#3)
The geographic##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
The geometries##2##2##(1997-6#1)(2013-8#1)
The geometry of##2##3##(1994-5#1)(2008-10#1)
The geometry##3##2##(1994-5#1)(2008-10#1)(2009-9#1)
The germination and##2##3##(2008-10#1)(2011-2#1)
The germination##3##2##(2008-10#2)(2011-2#1)
The giant panda##3##3##(2008-8#1)(2008-9#2)
The girls##2##2##(1996-6#1)(2008-11#1)
The glass##4##2##(2008-10#4)
The global##6##2##(1990-12#1)(1994-5#1)(2008-10#2)(2008-7#1)(2010-1#1)
The glucose biosensor##2##3##(2008-10#2)
The glucose content in##2##4##(2008-10#2)
The glucose##12##2##(1991-5#1)(2008-10#8)(2008-11#1)(2008-8#1)(2009-10#1)
The glycemic index##2##3##(2008-1#2)
The goal of our##3##4##(1997-8#1)(2011-2#1)(2012-3#1)
The goal of the study was to##2##7##(2008-7#1)(2013-1#1)
The goal of the study##3##5##(1993-3#1)(2008-7#1)(2013-1#1)
The goal of the##10##4##(1992-12#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#1)
The goal of this research was to##2##7##(2008-10#2)
The goal of this research##3##5##(1994-8#1)(2008-10#2)
The goal of this review is to##2##7##(2008-6#1)(2011-3#1)
The goal of this study is to##4##7##(2008-10#1)(2009-7#1)(2011-2#1)(2013-8#1)
The goal of this study was to determine the##3##9##(2008-10#2)(2013-8#1)
The goal of this study was to determine##5##8##(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
The goal of this study was to develop##2##8##(2008-10#1)(2012-4#1)
The goal of this study was to evaluate##2##8##(2010-8#1)(2013-8#1)
The goal of this study was to investigate the##2##9##(2009-7#1)(2012-2#1)
The goal of this study was to##13##7##(1994-2#1)(2008-10#3)(2008-11#1)(2009-7#2)(2010-8#1)(2012-2#2)(2012-4#1)(2013-8#2)
The goal of this study##17##5##(1994-2#1)(2008-10#4)(2008-11#1)(2009-7#3)(2010-8#1)(2011-2#1)(2012-2#2)(2012-4#1)(2013-8#3)
The goal of this unit is to##2##7##(2008-4#1)(2008-9#1)
The goal of this##33##4##(1994-2#1)(1994-8#1)(1996-3#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#3)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#4)(2012-4#1)(2013-1#1)(2013-8#3)
The goal of##53##3##(1992-12#1)(1993-3#2)(1994-2#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#3)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#3)(2013-8#3)
The goal was to##2##4##(1996-12#1)(2012-3#1)
The goal##57##2##(1992-12#1)(1993-3#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#3)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#5)(2012-3#4)(2012-4#1)(2013-1#3)(2013-8#3)
The goals are to##2##4##(1993-1#1)(2008-10#1)
The goals of our##2##4##(2008-3#1)(2013-1#1)
The goals of the##4##4##(1991-12#1)(1996-1#1)(2008-10#2)
The goals of##9##3##(1991-12#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-6#1)(2013-1#1)
The goals##11##2##(1991-12#1)(1993-1#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-6#1)(2013-1#1)
The gold##2##2##(2008-10#2)
The gonads##2##2##(2008-11#2)
The good##7##2##(1990-9#1)(2008-10#5)(2013-8#1)
The government is##2##3##(1997-6#2)
The government##3##2##(1992-2#1)(1997-6#2)
The government's##3##2##(1991-3#1)(2008-11#2)
The grade##2##2##(2012-2#1)(2013-8#1)
The gradual##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
The grafted##2##2##(2008-10#2)
The graphical##2##2##(2008-10#1)(2008-5#1)
The graphite paste is impregnated with##2##6##(2008-10#2)
The graphite##4##2##(2008-10#4)
The gravimetric##2##2##(1994-3#2)
The great majority of##2##4##(1991-6#1)(2010-12#1)
The great majority##4##3##(1991-6#1)(2008-10#2)(2010-12#1)
The great##11##2##(1990-6#1)(1991-6#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-7#1)(2010-12#1)(2013-1#1)
The greater##5##2##(1991-12#1)(1992-12#1)(1993-1#1)(2012-2#2)
The greatest difference##2##3##(2008-10#1)(2008-3#1)
The greatest genetic distance##2##4##(2008-10#2)
The greatest##20##2##(1993-2#1)(1994-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2011-2#2)(2012-12#1)
The green fluorescent protein (GFP)##2##5##(1996-6#1)(2008-8#1)
The green##4##2##(1996-6#1)(2008-2#1)(2008-8#1)(2010-10#1)
The greenhouse seedling##2##3##(2008-10#2)
The greenhouse##3##2##(1991-6#1)(2008-10#2)
The gross##2##2##(2007-12#1)(2008-5#1)
The group of##3##3##(1995-5#1)(2011-2#1)(2012-3#1)
The group receiving##2##3##(2008-10#2)
The group##18##2##(1993-12#1)(1995-2#2)(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
The groups##6##2##(2008-10#3)(2008-6#1)(2008-7#1)(2010-7#1)
The growing##6##2##(1991-3#1)(1995-1#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
The growth increment and##2##4##(2008-9#2)
The growth inhibitory##2##3##(1996-2#1)(2008-12#1)
The growth of the##3##4##(1993-12#1)(1993-8#1)(2013-1#1)
The growth of##8##3##(1993-12#1)(1993-8#1)(1995-1#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2013-1#1)
The growth rate##3##3##(1991-11#1)(2008-9#2)
The growth##24##2##(1991-11#1)(1991-3#1)(1991-8#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#6)(2009-8#1)(2010-1#1)(2013-1#1)
The guide##3##2##(1993-12#1)(1996-2#1)(2008-10#1)
The guidelines##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
The hAT2R##2##2##(1994-11#2)
The half-life##2##2##(2008-10#2)
The half-maximal##2##2##(1994-5#1)(1994-6#1)
The hand##3##2##(1997-3#1)(2008-11#1)(2008-9#1)
The head and neck##2##4##(1993-9#1)(2011-2#1)
The head##3##2##(1993-9#1)(2008-7#1)(2011-2#1)
The health care##4##3##(1991-12#1)(1992-12#1)(1997-3#1)(2008-11#1)
The health maintenance organization##2##4##(1994-12#2)
The health of adult women in accra##2##7##(2013-1#2)
The health of##3##3##(1991-8#1)(2013-1#2)
The health status##2##3##(1993-1#1)(1994-3#1)
The health##18##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-11#2)(2013-1#2)
The healthcare##2##2##(1996-12#1)(1997-5#1)
The heart rate##2##3##(2008-12#1)(2008-7#1)
The heart##4##2##(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
The heat##6##2##(1995-8#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
The heavy##3##2##(1994-11#1)(2008-10#1)(2008-9#1)
The height of##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
The height##4##2##(2007-8#1)(2008-10#2)(2008-11#1)
The hematological##2##2##(1992-9#1)(2013-8#1)
The heme##3##2##(1993-8#2)(2011-2#1)
The hemoglobin##2##2##(1994-3#1)(2008-8#1)
The heparin-binding##2##2##(1992-10#1)(2008-7#1)
The hepatic uptake of##2##4##(1992-3#2)
The hepatic##3##2##(1992-3#2)(1995-8#1)
The hepatitis B##2##3##(1995-5#1)(2013-8#1)
The hepatitis##3##2##(1995-5#2)(2013-8#1)
The herbicide##2##2##(2008-10#1)(2011-1#1)
The heritability of##2##3##(1997-7#1)(2008-10#1)
The heterogeneity of##4##3##(1995-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
The heterologous##2##2##(1993-9#1)(2008-10#1)
The heteropoly##2##2##(2008-10#2)
The hexapeptide##2##2##(2008-10#1)(2008-5#1)
The hh##2##2##(1993-2#2)
The hierarchical##3##2##(2008-10#2)(2009-7#1)
The high incidence of##3##4##(2010-12#1)(2010-8#1)(2011-2#1)
The high initial##2##3##(2008-10#2)
The high rate of##2##4##(1993-3#1)(2008-11#1)
The high retention##2##3##(2008-10#1)(2008-12#1)
The high selectivity##2##3##(2008-10#2)
The high sensitivity of the##2##5##(2008-10#1)(2008-3#1)
The high sensitivity of##3##4##(2008-10#1)(2008-3#1)(2010-1#1)
The high sensitivity that can be attained using an enzymatic system and mediated by##3##14##(2008-10#3)
The high sensitivity##8##3##(1996-2#1)(2008-10#5)(2008-3#1)(2010-1#1)
The high success rate##2##4##(1995-11#1)(2009-7#1)
The high values##2##3##(2008-10#2)
The high vapour pressure of##2##5##(2008-5#2)
The high##67##2##(1991-3#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
The high-resolution##3##2##(1997-7#1)(2008-10#1)(2009-10#1)
The higher the##4##3##(1991-2#1)(1991-5#1)(2008-10#1)(2013-8#1)
The higher##20##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#2)(1995-11#1)(2008-10#7)(2008-12#1)(2008-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
The highest concentration of##3##4##(1990-3#1)(2008-11#1)(2008-12#1)
The highest dose##2##3##(2008-10#1)(2008-12#1)
The highest incidence of##2##4##(2008-11#2)
The highest numbers of##2##4##(1996-12#1)(2008-10#1)
The highest production of##3##4##(2008-11#3)
The highest response for##3##4##(2008-10#3)
The highest sensitivity was obtained##2##5##(2008-10#2)
The highest sensitivity was##3##4##(2008-10#3)
The highest sensitivity##5##3##(2008-10#5)
The highest sensitization to##2##4##(2013-1#2)
The highest value##2##3##(2008-3#1)(2008-7#1)
The highest##73##2##(1990-11#1)(1990-3#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#3)(1997-2#1)(2008-10#25)(2008-11#8)(2008-12#7)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
The highly##9##2##(1993-12#1)(1994-2#1)(2008-10#5)(2009-7#1)(2012-3#1)
The histologic##5##2##(1991-8#2)(1994-12#1)(2008-11#1)(2009-3#1)
The histological diagnosis was##2##4##(2008-7#1)(2011-2#1)
The histological diagnosis##3##3##(2008-7#2)(2011-2#1)
The histological##6##2##(2008-5#1)(2008-7#3)(2011-2#1)(2013-1#1)
The histology##2##2##(2009-12#1)(2009-7#1)
The histopathologic findings showed##2##4##(2010-6#2)
The histopathologic findings##3##3##(1995-3#1)(2010-6#2)
The histopathologic study showed##2##4##(2008-5#1)(2010-6#1)
The histopathologic##7##2##(1995-3#1)(2008-5#1)(2010-6#4)(2013-8#1)
The histopathological##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
The historical##2##2##(1991-3#1)(2008-1#1)
The history of##7##3##(1993-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
The history##10##2##(1993-8#1)(2008-10#2)(2008-11#2)(2009-6#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
The home##3##2##(1991-3#1)(1995-3#1)(2010-10#1)
The homogeneity##2##2##(2008-10#2)
The homozygous##2##2##(2008-10#1)(2008-6#1)
The horizontal##3##2##(1990-11#1)(1993-3#1)(2008-5#1)
The horse##2##2##(2009-1#1)(2013-8#1)
The hospital##6##2##(1992-12#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-2#1)(2010-11#1)
The hospitals##3##2##(1991-9#1)(1995-1#1)(2008-5#1)
The host range of the virus##2##6##(2008-10#2)
The host range of the##3##5##(2008-10#3)
The host range of##5##4##(2008-10#5)
The host range##7##3##(2008-10#6)(2008-11#1)
The host##12##2##(1996-2#1)(2008-10#9)(2008-11#1)(2008-8#1)
The hot##3##2##(2008-11#2)(2009-5#1)
The hoxG gene##2##3##(1990-11#2)
The hoxK##2##2##(1990-11#2)
The human##26##2##(1990-5#1)(1990-6#1)(1990-8#1)(1992-10#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-3#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#6)(2008-9#4)(2009-7#1)(2011-2#1)(2012-3#1)
The humoral and cellular immune##2##5##(1991-12#2)
The humoral##3##2##(1991-12#2)(2008-5#1)
The hybrid##6##2##(1993-8#1)(2008-10#2)(2008-3#2)(2010-4#1)
The hybridoma##2##2##(2008-11#2)
The hydride generated in a##2##5##(2008-10#2)
The hydride generated is collected in a liquid nitrogen cryogenic trap##2##11##(2008-10#2)
The hydride generated##4##3##(2008-10#4)
The hydride##6##2##(2008-10#6)
The hydrodynamic##2##2##(2008-10#2)
The hydrogen peroxide##6##3##(2008-10#6)
The hydrogen##7##2##(2008-10#7)
The hydrolysis of the##2##4##(1991-9#1)(2008-10#1)
The hydrolysis of##5##3##(1991-9#1)(1995-3#1)(2008-10#3)
The hydrolysis rate of CMC##2##5##(2008-10#2)
The hydrolysis##8##2##(1991-9#1)(1995-3#1)(2008-10#6)
The hydropathy##2##2##(1993-3#1)(1995-6#1)
The hydroxyl group##2##3##(1991-5#1)(2011-3#1)
The hydroxyl##3##2##(1991-5#1)(2008-4#1)(2011-3#1)
The hypothesis of##3##3##(1993-9#1)(2008-10#2)
The hypothesis that a##2##4##(1997-4#1)(2008-10#1)
The hypothesis that the##2##4##(2008-5#1)(2010-1#1)
The hypothesis that##11##3##(1996-2#1)(1997-4#1)(2008-10#6)(2008-5#1)(2008-8#1)(2010-1#1)
The hypothesis##17##2##(1993-9#1)(1996-2#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)(2010-1#1)(2013-1#1)
The i##2##2##(1992-12#1)(1994-8#1)
The idea of##3##3##(1992-11#1)(2008-11#1)(2011-2#1)
The idea##4##2##(1992-11#1)(2008-11#1)(2010-5#1)(2011-2#1)
The ideal approach##2##3##(1993-12#1)(2008-10#1)
The ideal##7##2##(1991-12#1)(1993-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
The identification and characterization of##3##5##(2008-10#1)(2008-4#1)(2008-5#1)
The identification and##9##3##(1990-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)
The identification of a##3##4##(1991-6#1)(2008-10#2)
The identification of the##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
The identification of these##2##4##(1993-12#1)(1993-6#1)
The identification of##19##3##(1991-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1997-7#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-9#2)(2011-2#2)(2013-8#1)
The identification##30##2##(1990-5#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1997-7#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#2)(2013-8#2)
The identified pigments were##2##4##(2008-10#2)
The identified##4##2##(1996-12#1)(2008-10#3)
The identities of the##2##4##(2008-10#2)
The identity of the##2##4##(1990-5#1)(1994-5#1)
The identity of##7##3##(1990-5#1)(1990-8#1)(1994-5#1)(1997-2#1)(2008-10#2)(2011-2#1)
The identity##8##2##(1990-5#1)(1990-8#1)(1994-5#1)(1997-2#1)(2008-10#3)(2011-2#1)
The image quality##2##3##(2007-9#1)(2008-3#1)
The image##4##2##(2007-9#1)(2008-3#1)(2008-9#1)(2012-2#1)
The images were##2##3##(2008-3#1)(2013-1#1)
The images##5##2##(1997-8#1)(2007-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
The imaging##3##2##(1991-2#1)(2008-11#1)(2010-5#1)
The immediate##5##2##(1991-6#1)(1996-3#1)(1997-1#1)(2008-11#1)(2010-12#1)
The immobilization of##4##3##(2008-10#3)(2008-7#1)
The immobilization procedure##2##3##(2008-10#2)
The immobilization##7##2##(2008-10#6)(2008-7#1)
The immobilized##6##2##(1994-11#1)(2008-10#4)(2008-7#1)
The immune response##2##3##(1995-12#1)(1996-3#1)
The immune##6##2##(1995-12#2)(1996-3#1)(1997-9#1)(2009-7#1)(2010-3#1)
The immunoassay was based on##2##5##(2008-10#2)
The immunoassay was##3##3##(2008-10#3)
The immunoassay##6##2##(2008-10#6)
The immunoconjugate##2##2##(1997-7#2)
The immunogenicity and##2##3##(1995-12#2)
The immunogenicity of##2##3##(2007-11#2)
The immunogenicity##4##2##(1995-12#2)(2007-11#2)
The immunoglobulin production-stimulating##2##3##(2008-11#2)
The immunoglobulin##3##2##(2008-11#3)
The immunohistochemical##4##2##(1991-8#1)(2006-6#1)(2008-11#1)(2012-3#1)
The immunologic markers##2##3##(2013-1#2)
The immunologic##3##2##(1990-2#1)(2013-1#2)
The immunoreactivity of the antibody in the##3##7##(2008-7#3)
The immunosensor can be##2##4##(2008-10#2)
The immunosensor has##2##3##(2008-10#2)
The immunosensor##5##2##(2008-10#5)
The impact and##2##3##(2011-1#1)(2011-2#1)
The impact of Medicaid##2##4##(1994-1#1)(1995-12#1)
The impact of a##2##4##(1991-2#1)(2008-11#1)
The impact of clinical biochemistry on##2##6##(1994-12#2)
The impact of cost containment##2##5##(1991-3#2)
The impact of health##2##4##(1995-12#1)(2013-1#1)
The impact of managed care on##2##6##(1992-3#1)(1997-1#1)
The impact of managed care##3##5##(1992-3#1)(1995-2#1)(1997-1#1)
The impact of patient##2##4##(1996-3#1)(2013-1#1)
The impact of poverty on##2##5##(2008-11#2)
The impact of the##7##4##(1991-12#1)(1993-1#1)(1995-1#1)(1995-3#1)(2008-11#2)(2012-2#1)
The impact of##60##3##(1991-12#2)(1991-2#1)(1991-3#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1994-1#1)(1994-12#3)(1994-5#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-11#11)(2008-7#1)(2009-11#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-4#1)(2013-1#4)(2013-7#1)
The impact##64##2##(1991-12#2)(1991-2#1)(1991-3#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1994-1#1)(1994-12#3)(1994-5#1)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-11#12)(2008-7#1)(2009-11#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-4#1)(2013-1#4)(2013-7#1)
The impairment of##2##3##(1995-12#1)(2008-8#1)
The imperative to##2##3##(2013-1#2)
The implantation of##2##3##(1993-8#1)(2011-2#1)
The implementation of a##2##4##(2008-10#1)(2010-7#1)
The implementation of##6##3##(1995-2#1)(2008-10#3)(2010-7#1)(2013-1#1)
The implementation##7##2##(1995-2#1)(2008-10#3)(2010-7#1)(2012-12#1)(2013-1#1)
The implication of##2##3##(1995-11#1)(2008-3#1)
The implication##3##2##(1993-9#1)(1995-11#1)(2008-3#1)
The implications for##6##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)
The implications of the##4##4##(1996-2#1)(2008-8#1)(2009-5#1)(2009-7#1)
The implications of these findings are discussed##3##7##(1991-2#1)(1994-2#1)(2010-9#1)
The implications of these findings for##3##6##(2008-10#1)(2009-7#1)(2012-2#1)
The implications of these findings in##2##6##(1996-3#1)(2008-10#1)
The implications of these findings##12##5##(1991-2#1)(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#3)(2009-7#1)(2010-1#1)(2010-9#1)(2012-2#1)
The implications of these observations for##2##6##(2008-10#1)(2010-9#1)
The implications of these results for##2##6##(2008-10#1)(2008-8#1)
The implications of these results##3##5##(2008-10#2)(2008-8#1)
The implications of these##20##4##(1991-2#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-8#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-9#2)(2012-2#1)
The implications of this##4##4##(1995-3#1)(1995-5#1)(2008-10#1)(2008-9#1)
The implications of##39##3##(1991-2#1)(1991-3#1)(1992-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-2#1)(2010-3#1)(2010-9#2)(2012-2#1)(2012-3#1)
The implications##48##2##(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-2#2)(2010-3#1)(2010-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
The importance and##3##3##(2008-1#1)(2008-12#1)(2011-1#1)
The importance of collaboration##2##4##(1993-3#1)(2008-11#1)
The importance of the##7##4##(1991-6#1)(1993-8#1)(1997-1#1)(2008-10#2)(2008-5#1)(2009-12#1)
The importance of these##2##4##(2008-10#1)(2013-8#1)
The importance of this##2##4##(2011-2#1)(2013-1#1)
The importance of##62##3##(1991-11#1)(1991-6#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#2)(2013-8#2)
The importance##66##2##(1991-11#1)(1991-6#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#18)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#2)(2013-8#2)
The important##7##2##(1990-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)
The improved##8##2##(1994-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)
The improvement in##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
The improvement of##2##3##(2008-11#1)(2011-2#1)
The improvement##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
The in situ##5##3##(2008-10#3)(2008-3#1)(2013-8#1)
The in vitro studies##2##4##(1997-8#1)(2009-12#1)
The in vitro##21##3##(1990-3#1)(1990-6#1)(1994-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-5#3)(2008-9#1)(2009-12#2)(2011-3#1)(2012-2#1)(2012-3#1)
The in vivo##11##3##(1990-5#1)(1991-10#1)(1992-12#1)(1995-9#1)(2008-4#1)(2008-5#2)(2008-9#2)(2012-2#2)
The in##39##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-10#1)(1992-12#1)(1994-8#1)(1995-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-9#3)(2009-12#2)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#1)(2013-8#1)
The inability to##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
The incidence in##2##3##(2011-2#1)(2012-3#1)
The incidence of acute##2##4##(1994-6#1)(2012-12#1)
The incidence of brown stem rot was##2##7##(2008-10#2)
The incidence of complications was##2##5##(1991-8#1)(2008-9#1)
The incidence of congenital##2##4##(1990-9#1)(2011-1#1)
The incidence of malignant##2##4##(1995-2#1)(2010-12#1)
The incidence of melanoma##2##4##(2011-2#2)
The incidence of this##2##4##(1990-6#1)(1991-3#1)
The incidence of##69##3##(1990-3#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-12#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#1)
The incidence##81##2##(1990-3#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-2#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-3#2)(2013-1#8)(2013-7#1)
The incidences and/or severities of##2##5##(2008-9#2)
The incidences and/or##3##3##(2008-9#3)
The incidences of##7##3##(1997-7#1)(2008-9#5)(2012-3#1)
The incidences##10##2##(1997-7#1)(2008-9#8)(2012-3#1)
The included##2##2##(2011-2#2)
The inclusion criteria were##3##4##(1996-11#1)(2010-10#1)(2013-1#1)
The inclusion of these##2##4##(1992-9#1)(2008-8#1)
The inclusion of##4##3##(1992-9#1)(2008-10#1)(2008-8#1)(2010-4#1)
The inclusion##11##2##(1992-9#1)(1996-11#1)(2008-10#5)(2008-8#1)(2010-10#1)(2010-4#1)(2013-1#1)
The incorporation of##14##3##(1990-5#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2010-4#1)(2013-8#1)
The incorporation##15##2##(1990-5#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2010-4#1)(2013-8#1)
The increase in the##5##4##(1992-8#1)(1997-2#1)(2008-11#1)(2008-8#1)(2009-3#1)
The increase in##21##3##(1990-8#1)(1991-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
The increase of##3##3##(1995-8#1)(2008-10#1)(2008-12#1)
The increase was##5##3##(1995-11#1)(1995-6#1)(1996-12#1)(1997-1#1)(2008-10#1)
The increase##32##2##(1990-8#1)(1991-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-8#2)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
The increased use of##3##4##(1991-12#1)(2008-10#1)(2008-11#1)
The increased##28##2##(1990-2#1)(1991-12#2)(1992-5#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#3)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#6)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
The increasing number of##3##4##(2008-11#1)(2008-7#1)(2010-12#1)
The increasing##16##2##(1991-12#2)(1993-9#1)(1994-8#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#2)
The incubation temperature##2##3##(2008-11#1)(2011-2#1)
The incubation##6##2##(1996-8#1)(2008-10#1)(2008-11#2)(2011-2#1)(2011-3#1)
The independent##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2010-6#2)
The index is##2##3##(2008-6#1)(2009-5#1)
The index of##2##3##(2008-10#2)
The index##4##2##(2008-10#2)(2008-6#1)(2009-5#1)
The indexes##3##2##(1993-3#2)(2011-3#1)
The indication##2##2##(1993-8#1)(2011-2#1)
The indications for##4##3##(1990-3#1)(2008-7#1)(2010-6#1)(2011-2#1)
The indications##6##2##(1990-3#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
The indicator##4##2##(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
The indicators##2##2##(1996-2#1)(2012-4#1)
The indirect##5##2##(1990-12#1)(2008-10#2)(2009-7#1)(2010-7#1)
The individual##6##2##(1993-8#1)(2008-10#2)(2011-1#2)(2012-3#1)
The induced##3##2##(1992-8#1)(2008-10#1)(2008-12#1)
The induction of pathogen resistance##2##5##(2008-10#2)
The induction of##20##3##(1994-11#1)(1995-12#2)(1995-6#2)(1996-2#1)(2008-10#8)(2008-11#2)(2008-5#1)(2010-11#1)(2012-2#1)(2013-8#1)
The induction##22##2##(1994-11#1)(1995-12#2)(1995-6#2)(1996-2#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-5#1)(2010-11#1)(2012-2#1)(2013-8#1)
The industry##2##2##(1994-3#1)(2008-11#1)
The infants##2##2##(2010-5#2)
The infected##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-3#1)
The infection of##4##3##(2008-10#3)(2008-11#1)
The infection rate was highest##2##5##(2008-10#2)
The infection rate##3##3##(2008-10#3)
The infection##13##2##(1997-1#1)(2008-10#10)(2008-11#1)(2010-12#1)
The infectivity##2##2##(2008-10#2)
The inferred##4##2##(1993-2#1)(2008-10#1)(2009-10#1)(2010-10#1)
The inflammatory##6##2##(1992-12#1)(1996-2#1)(1997-8#1)(2008-8#1)(2011-2#1)(2012-3#1)
The influence exerted by##2##4##(2008-10#2)
The influence of a##2##4##(2008-10#1)(2008-5#1)
The influence of age##2##4##(1995-8#1)(2010-9#1)
The influence of common##2##4##(2008-10#2)
The influence of diabetes on the##2##6##(2008-1#1)(2011-2#1)
The influence of different##4##4##(2008-10#4)
The influence of electrolyte##2##4##(2008-10#2)
The influence of flow rates of eluent and sample solution##2##10##(2008-10#2)
The influence of foreign ions##2##5##(2008-10#2)
The influence of foreign##3##4##(2008-10#3)
The influence of moisture##2##4##(2008-10#2)
The influence of pH##2##4##(2008-10#2)
The influence of potential interfering ions was studied##2##8##(2008-10#2)
The influence of potential interfering ions##3##6##(2008-10#3)
The influence of potential interfering##4##5##(2008-10#4)
The influence of reagent##2##4##(2008-10#2)
The influence of several##5##4##(2008-10#5)
The influence of some experimental parameters##2##6##(2008-10#2)
The influence of some##5##4##(2008-10#5)
The influence of temperature##2##4##(2008-10#1)(2008-3#1)
The influence of the plasticizer##2##5##(2008-10#2)
The influence of the##23##4##(2008-10#19)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)
The influence of various parameters##2##5##(2008-10#2)
The influence of various##6##4##(2008-10#6)
The influence of##159##3##(1990-5#2)(1991-3#2)(1991-9#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-10#101)(2008-11#6)(2008-3#3)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#5)(2009-7#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-8#1)
The influence##161##2##(1990-5#2)(1991-3#2)(1991-9#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-10#103)(2008-11#6)(2008-3#3)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#5)(2009-7#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-8#1)
The influences of pH##2##4##(2008-10#2)
The influences of the##4##4##(2008-10#3)(2008-2#1)
The influences of##13##3##(2008-10#10)(2008-11#1)(2008-2#1)(2013-8#1)
The influences##14##2##(2008-10#10)(2008-11#1)(2008-2#2)(2013-8#1)
The information about##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
The information gathered##2##3##(1996-2#1)(2008-10#1)
The information includes##2##3##(1994-3#1)(2008-10#1)
The information was##3##3##(1992-1#1)(2008-11#1)(2011-2#1)
The information##22##2##(1992-1#1)(1992-5#1)(1994-3#1)(1996-11#1)(1996-2#1)(2008-10#5)(2008-11#6)(2009-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
The infrared evolved gas analysis was##2##6##(2008-10#2)
The infrared##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
The inherent##2##2##(2008-11#1)(2008-12#1)
The inheritance of resistance to##4##5##(2008-10#4)
The inheritance of##7##3##(2008-10#7)
The inhibition by##2##3##(1992-3#1)(2008-10#1)
The inhibition of the##4##4##(2006-6#1)(2008-10#2)(2009-12#1)
The inhibition of##14##3##(1990-8#1)(1992-3#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#1)
The inhibition was##2##3##(1992-3#1)(1995-2#1)
The inhibition##20##2##(1990-8#1)(1991-3#1)(1992-3#3)(1995-2#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#1)
The inhibitor##2##2##(1990-5#1)(2008-10#1)
The inhibitory activity of##2##4##(2008-10#1)(2012-2#1)
The inhibitory activity##3##3##(1990-5#1)(2008-10#1)(2012-2#1)
The inhibitory effect of##6##4##(1994-8#1)(1995-11#1)(2008-11#2)(2008-5#1)(2008-8#1)
The inhibitory effects of##5##4##(1990-11#1)(1992-3#1)(2008-10#1)(2008-5#2)
The inhibitory##15##2##(1990-11#1)(1990-5#1)(1992-3#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-11#2)(2008-5#3)(2008-8#1)(2012-2#1)
The initial rate of the##2##5##(2008-10#2)
The initial rate of##3##4##(2008-10#3)
The initial rate##5##3##(2008-10#5)
The initial##30##2##(1990-5#1)(1991-6#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2010-6#1)
The initially##2##2##(1994-11#1)(1996-5#1)
The initiating##2##2##(2008-10#1)(2009-8#1)
The injection of##2##3##(2008-10#1)(2008-11#1)
The injury##2##2##(1990-6#1)(2010-1#1)
The inner##3##2##(2008-10#2)(2011-2#1)
The input##2##2##(1992-1#1)(2008-9#1)
The inquiry##2##2##(1991-8#1)(2010-11#1)
The ins and outs of##2##5##(2008-11#1)(2011-2#1)
The insertion of##3##3##(2008-12#1)(2008-8#1)(2012-3#1)
The insertion##5##2##(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
The inspiratory flow##2##3##(1992-3#1)(1997-2#1)
The instrument is##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
The instrument was##3##3##(1993-3#1)(2008-10#2)
The instrument##20##2##(1993-2#1)(1993-3#1)(2008-10#11)(2008-2#1)(2008-3#4)(2008-9#1)(2009-12#1)
The instrumental##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
The instrumentation##4##2##(2008-10#4)
The instruments##3##2##(2008-11#1)(2008-3#1)(2010-11#1)
The insulin receptor##2##3##(1993-8#1)(1995-8#1)
The insulin##4##2##(1993-8#2)(1995-8#1)(2012-3#1)
The integrated##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
The integration of##10##3##(1991-6#1)(1993-2#1)(1996-3#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
The integration##11##2##(1991-6#1)(1993-2#1)(1996-3#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
The integrity of##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
The intensities of##2##3##(2008-10#2)
The intensity of the##5##4##(2008-10#4)(2009-7#1)
The intensity of##11##3##(1995-8#1)(2008-10#6)(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
The intensity##13##2##(1995-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
The intent is to##4##4##(1994-2#2)(2008-6#1)(2011-2#1)
The intention of##2##3##(1997-4#1)(2009-9#1)
The inter-rater reliability##3##3##(2008-11#1)(2010-10#2)
The interaction between the##4##4##(1996-5#1)(2008-10#2)(2008-8#1)
The interaction between##21##3##(1992-1#1)(1992-9#1)(1993-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
The interaction of cyclodextrins##2##4##(2008-10#2)
The interaction of the##3##4##(1990-2#1)(2008-10#1)(2008-8#1)
The interaction of##24##3##(1990-2#2)(1991-6#1)(1992-3#1)(1993-8#1)(1997-3#1)(2008-10#14)(2008-8#1)(2008-9#2)(2009-7#1)
The interaction was##2##3##(2008-10#2)
The interaction##48##2##(1990-2#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-8#2)(1995-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#25)(2008-11#1)(2008-8#3)(2008-9#3)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
The interactions between##7##3##(2008-10#6)(2008-8#1)
The interactions of##3##3##(1991-9#1)(1994-5#1)(2008-10#1)
The interactions##11##2##(1991-9#1)(1994-5#1)(2008-10#7)(2008-8#1)(2008-9#1)
The intercellular##2##2##(2008-5#1)(2009-7#1)
The interdisciplinary team##2##3##(1994-12#1)(1995-5#1)
The interdisciplinary##3##2##(1994-12#1)(1995-5#1)(2009-7#1)
The interest##5##2##(1990-5#1)(2006-6#1)(2008-3#1)(2009-1#1)(2013-1#1)
The interface##2##2##(2008-10#1)(2009-9#1)
The interfacial##2##2##(1991-3#1)(2008-10#1)
The interfacing of##2##3##(2008-10#2)
The interference by##2##3##(2008-10#2)
The interference caused by Ca(II) and Ba(II) can be easily eliminated by prior extraction with potassium iodide-methylisobutylketone##3##17##(2008-10#3)
The interference effect##2##3##(2008-10#2)
The interference effects of##2##4##(2008-10#2)
The interference from over 50 cations##2##6##(2008-10#2)
The interference from##4##3##(2008-10#4)
The interference of a large number of anions and cations##2##10##(2008-10#2)
The interference of the##2##4##(2008-10#2)
The interference of##13##3##(2008-10#13)
The interference##28##2##(2008-10#28)
The interferences from##2##3##(2008-10#2)
The interferences of some metal ions and##2##7##(2008-10#2)
The interferences of some##3##4##(2008-10#3)
The interferences of##8##3##(2008-10#8)
The interferences##10##2##(2008-10#10)
The interfering effect of##2##4##(2008-10#2)
The interfering effects of##3##4##(2008-10#3)
The interfering effects##5##3##(2008-10#5)
The interfering##9##2##(1997-2#1)(2008-10#8)
The interferometer##2##2##(2007-12#1)(2008-3#1)
The intergenic##2##2##(1993-2#1)(1996-6#1)
The intermediate##2##2##(2008-10#1)(2008-7#1)
The internal barriers of rotation for the 209 polychlorinated biphenyls##2##10##(2008-11#2)
The internal standard##2##3##(2008-10#2)
The internal transcribed spacer (ITS)##2##5##(2008-10#2)
The internal transcribed spacer##3##4##(2008-10#3)
The internal##17##2##(1991-5#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-10#10)(2008-11#2)(2011-2#1)
The internally##2##2##(1990-11#1)(2008-10#1)
The international##4##2##(1991-12#1)(2008-10#1)(2010-8#1)(2011-2#1)
The interplay between##6##3##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)
The interplay##7##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)
The interpretation of the##2##4##(1994-3#1)(2008-3#1)
The interpretation of##5##3##(1994-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
The interspecific##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
The interval##2##2##(2008-10#1)(2008-11#1)
The intervals##3##2##(2008-10#2)(2008-5#1)
The intervened##2##2##(2013-1#2)
The intervention was##2##3##(2008-8#1)(2013-1#1)
The intervention##8##2##(1994-1#2)(2008-12#1)(2008-4#1)(2008-8#2)(2012-3#1)(2013-1#1)
The interview##3##2##(1994-12#1)(2008-7#1)(2010-6#1)
The interviews focused on each measurement instrument collected##2##8##(2013-1#2)
The interviews were##4##3##(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#1)
The interviews##6##2##(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#3)
The intestinal##2##2##(2008-5#1)(2011-2#1)
The intra- and inter-assay##2##4##(2008-10#1)(2011-3#1)
The intra- and##4##3##(2008-10#2)(2011-3#2)
The intra-class correlation##2##3##(2008-10#1)(2008-9#1)
The intracellular##7##2##(1993-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
The intravesical##2##2##(1993-11#1)(2008-10#1)
The intrinsic##3##2##(1990-5#1)(2008-10#1)(2009-12#1)
The introduction of the##5##4##(1994-6#1)(1997-6#1)(2008-11#1)(2008-4#1)(2011-2#1)
The introduction of##21##3##(1994-6#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#4)
The introduction##23##2##(1994-6#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#4)
The invasion##2##2##(2008-10#1)(2013-8#1)
The investigated metal##2##3##(2008-10#2)
The investigated##8##2##(1997-4#1)(2008-10#6)(2012-3#1)
The investigation of the##2##4##(2008-10#1)(2008-7#1)
The investigation of##9##3##(1995-12#1)(2008-10#3)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)
The investigation shows##2##3##(1995-2#1)(2007-12#1)
The investigation##21##2##(1990-12#1)(1992-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2011-2#1)(2011-3#1)(2013-1#1)
The investigations were carried out##2##5##(2008-5#1)(2011-2#1)
The investigations##6##2##(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)
The involvement in##2##3##(2008-10#1)(2013-7#1)
The involvement of##10##3##(1993-9#1)(1994-11#1)(1997-2#2)(2008-10#2)(2008-12#2)(2009-8#1)(2013-1#1)
The involvement##13##2##(1993-9#1)(1994-11#1)(1997-2#2)(2008-10#3)(2008-12#2)(2009-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
The ion adsorption##2##3##(2008-10#2)
The ion association##2##3##(2008-10#2)
The ion exchange##2##3##(2008-10#2)
The ion##8##2##(2008-10#8)
The ion-associate##2##2##(2008-10#2)
The ion-exchange##2##2##(2008-10#2)
The ion-pair##3##2##(2008-10#3)
The ionic product of water##2##5##(2008-10#2)
The ionic##3##2##(2008-10#3)
The ionization constants##2##3##(2008-10#1)(2008-9#1)
The ionization##3##2##(2008-10#2)(2008-9#1)
The ionophores##2##2##(2008-10#2)
The ions were##2##3##(2008-10#1)(2008-3#1)
The ions##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
The iron##4##2##(1991-6#1)(2008-10#3)
The isoelectric point##2##3##(2008-10#1)(2008-8#1)
The isoelectric##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
The isolate from##2##3##(2008-10#1)(2008-5#1)
The isolated##10##2##(1993-8#1)(1994-6#1)(1994-8#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#1)
The isolates from##2##3##(2008-10#2)
The isolates were characterized by##3##5##(2008-10#3)
The isolates were characterized##4##4##(2008-10#4)
The isolates were##8##3##(2008-10#6)(2008-12#1)(2012-2#1)
The isolates##16##2##(2008-10#13)(2008-12#1)(2011-2#1)(2012-2#1)
The isolation and##4##3##(1996-2#1)(2008-10#2)(2011-3#1)
The isolation of##4##3##(1991-2#1)(1995-6#1)(1996-6#1)(2008-12#1)
The isolation##9##2##(1991-2#1)(1995-6#1)(1996-2#1)(1996-6#1)(2008-10#3)(2008-12#1)(2011-3#1)
The isolator##2##2##(2008-3#2)
The isotherms##2##2##(1994-5#2)
The isotopic##2##2##(2008-10#2)
The issue of##6##3##(1991-12#1)(1992-12#1)(1997-7#1)(2008-11#2)(2010-11#1)
The issue##8##2##(1991-12#1)(1991-2#1)(1992-12#1)(1997-7#1)(2008-11#2)(2009-12#1)(2010-11#1)
The issues of##2##3##(1994-8#1)(2008-12#1)
The issues##4##2##(1994-8#1)(2008-12#1)(2008-2#1)(2008-5#1)
The job##3##2##(1993-1#1)(1997-1#1)(2008-11#1)
The joint##2##2##(2008-10#1)(2008-8#1)
The journey is##2##3##(2008-1#1)(2008-9#1)
The journey of##2##3##(2008-12#1)(2010-12#1)
The journey##6##2##(2008-1#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)
The judge##4##2##(1995-12#1)(1995-6#1)(1996-5#2)
The karyotype##2##2##(2008-10#1)(2008-12#1)
The key is##2##3##(1993-2#1)(2011-2#1)
The key step in the##2##5##(1992-3#1)(2008-10#1)
The key step in##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
The key step##4##3##(1992-3#1)(1996-5#1)(2008-10#1)(2008-11#1)
The key to##6##3##(1994-2#1)(1997-4#1)(2008-11#1)(2008-8#1)(2009-12#1)(2013-1#1)
The key##28##2##(1992-3#2)(1993-2#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-8#3)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
The kinetic analysis indicated##2##4##(1993-3#1)(1994-8#1)
The kinetic and##2##3##(1991-6#1)(1993-8#1)
The kinetic of##2##3##(2008-10#2)
The kinetic parameters##3##3##(2008-10#3)
The kinetic##17##2##(1991-6#1)(1993-3#1)(1993-8#2)(1994-8#2)(2008-10#10)(2008-8#1)
The kinetics and thermodynamics of the##2##6##(1993-3#1)(2008-10#1)
The kinetics and thermodynamics of##3##5##(1993-3#1)(2008-10#1)(2008-8#1)
The kinetics and##6##3##(1993-3#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
The kinetics of the##7##4##(2008-10#6)(2011-2#1)
The kinetics of##19##3##(1990-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(2008-10#9)(2008-11#1)(2009-11#1)(2011-2#1)
The kinetics##27##2##(1990-8#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(2008-10#12)(2008-11#2)(2008-8#1)(2009-11#1)(2011-2#1)
The knowledge of##3##3##(2008-11#1)(2012-3#2)
The knowledge##7##2##(1991-2#1)(2008-11#2)(2008-7#1)(2010-3#1)(2012-3#2)
The known##4##2##(1991-8#1)(2008-10#2)(2008-11#1)
The labeled##2##2##(1994-5#1)(1997-2#1)
The labeling##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
The laboratory findings##2##3##(1990-9#1)(2010-6#1)
The laboratory##12##2##(1990-9#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#1)
The lack of a##3##4##(2008-10#1)(2008-7#1)(2010-1#1)
The lack of typical##3##4##(2007-12#1)(2008-5#1)(2013-8#1)
The lack of##34##3##(1990-12#1)(1990-2#1)(1991-12#1)(1993-8#1)(1994-1#1)(1995-9#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
The lactate##3##2##(1991-5#2)(2008-10#1)
The lag##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
The lamin##2##2##(2011-2#2)
The language of##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
The large majority of##2##4##(2008-10#1)(2013-8#1)
The large number of##2##4##(2008-3#1)(2012-3#1)
The large##15##2##(1994-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-8#1)
The larger the##2##3##(2008-10#1)(2008-3#1)
The larger##7##2##(1997-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
The largest##15##2##(1990-8#2)(1993-8#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(2008-10#3)(2008-3#1)(2010-12#1)(2011-2#2)
The larvae##2##2##(2008-6#1)(2010-8#1)
The laser linewidth##2##3##(2008-3#2)
The laser was##3##3##(1992-12#1)(2012-3#2)
The laser##16##2##(1991-3#1)(1992-12#1)(2008-11#1)(2008-2#3)(2008-3#7)(2008-9#1)(2012-3#2)
The last two##3##3##(1993-2#1)(2009-8#1)(2013-1#1)
The last##9##2##(1993-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-6#2)(2009-8#1)(2011-2#1)(2013-1#1)
The late phase##2##3##(1993-8#1)(1995-6#1)
The late##6##2##(1991-6#1)(1993-8#1)(1995-6#1)(1996-12#1)(2008-9#1)(2011-3#1)
The latent##2##2##(2008-10#2)
The lateral##8##2##(1991-10#1)(1993-3#1)(1997-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
The latest##5##2##(1990-3#1)(1991-2#1)(1994-12#1)(1997-5#1)(2008-5#1)
The latter are the##2##4##(2008-11#1)(2008-5#1)
The latter are##3##3##(2008-11#1)(2008-5#1)(2009-5#1)
The latter has##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
The latter is the##2##4##(1991-3#1)(2008-10#1)
The latter is##9##3##(1990-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1997-7#1)(2008-10#3)(2012-2#1)
The latter may be##2##4##(1997-8#1)(2008-7#1)
The latter may##4##3##(1993-11#1)(1995-3#1)(1997-8#1)(2008-7#1)
The latter method##2##3##(2008-10#1)(2008-7#1)
The latter shows##2##3##(1996-8#1)(2008-10#1)
The latter two##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
The latter was##2##3##(2008-10#1)(2013-1#1)
The latter##62##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1993-1#1)(1993-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-2#3)(2013-1#3)
The law##3##2##(1994-1#1)(1996-5#1)(2008-8#1)
The leaching##4##2##(2008-10#4)
The lead and nickel##2##4##(2008-10#2)
The lead##5##2##(2008-10#4)(2008-11#1)
The leading causes of##2##4##(1995-12#1)(2008-1#1)
The leading##4##2##(1995-12#1)(2008-1#1)(2008-10#1)(2010-11#1)
The leaf##3##2##(2008-10#2)(2008-12#1)
The learning and##2##3##(2008-11#1)(2012-2#1)
The learning##3##2##(2008-11#1)(2012-2#2)
The least##3##2##(1994-12#1)(2008-12#1)(2013-1#1)
The leaves##2##2##(1995-2#1)(2011-1#1)
The lectin (Mr 140##2##4##(1990-5#2)
The left ventricular ejection fraction##2##5##(1997-5#2)
The left ventricular##6##3##(1997-5#2)(2008-12#2)(2012-2#2)
The left##11##2##(1993-9#1)(1996-2#1)(1997-5#2)(2008-12#2)(2010-6#1)(2011-2#2)(2012-2#2)
The legal##2##2##(1996-2#1)(2008-11#1)
The length and##2##3##(1993-12#1)(2008-10#1)
The length of the##3##4##(2008-10#2)(2008-5#1)
The length of##5##3##(1992-5#1)(2008-10#3)(2008-5#1)
The length##9##2##(1992-5#1)(1993-12#1)(2008-10#4)(2008-5#1)(2010-6#1)(2013-1#1)
The lesion of##2##3##(2008-8#2)
The lesion was##7##3##(1995-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
The lesion##18##2##(1995-11#1)(1997-8#1)(2008-10#3)(2008-8#2)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#4)
The lesions caused by##2##4##(1995-11#1)(2008-10#1)
The lesions were##4##3##(1990-12#1)(2011-2#2)(2013-1#1)
The lesions##14##2##(1990-12#1)(1991-2#2)(1995-11#1)(1997-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-6#2)(2011-2#2)(2013-1#1)
The less##2##2##(2008-10#2)
The level of activity of the##2##6##(1994-2#2)
The level of appropriateness and usefulness of the instruments##2##9##(2013-1#2)
The level of detection##2##4##(2008-10#1)(2008-5#1)
The level of##37##3##(1991-2#1)(1993-11#1)(1993-6#1)(1994-2#3)(1994-8#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#2)(2009-7#2)(2009-8#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
The level##38##2##(1991-2#1)(1993-11#1)(1993-6#1)(1994-2#3)(1994-8#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-7#2)(2009-8#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
The levels of urinary factor H##2##6##(2009-6#2)
The levels of##17##3##(1991-8#1)(1992-4#1)(1992-5#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-6#2)(2012-12#1)(2012-3#1)(2012-5#2)(2013-1#1)(2013-8#1)
The levels##22##2##(1991-8#1)(1992-4#1)(1992-5#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#2)(2009-6#2)(2012-12#1)(2012-3#1)(2012-5#2)(2013-1#1)(2013-8#1)
The libraries##2##2##(1992-1#1)(1997-6#1)
The lidar measurements##2##3##(2008-10#1)(2008-2#1)
The lidar##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
The life cycle of##3##4##(2008-9#1)(2011-2#2)
The life cycle##5##3##(2008-12#2)(2008-9#1)(2011-2#2)
The life history##2##3##(2008-12#1)(2010-8#1)
The life##10##2##(1993-8#1)(2008-12#3)(2008-2#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)
The lifetime of the sensor is##2##6##(2008-10#2)
The lifetime of the##4##4##(2008-10#4)
The lifetime of##5##3##(2008-10#5)
The lifetime##8##2##(2008-10#7)(2008-4#1)
The ligand##2##2##(1995-11#1)(2008-10#1)
The ligands##2##2##(2008-10#2)
The light chain##2##3##(1994-11#2)
The light microscope is a basic tool for the cell biologist##2##11##(2008-4#2)
The light##13##2##(1994-11#2)(1995-6#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-8#1)
The likelihood of##3##3##(1991-12#1)(2008-10#2)
The likelihood that##2##3##(1997-8#1)(2008-10#1)
The likelihood##6##2##(1991-12#1)(1997-8#1)(2008-10#3)(2008-12#1)
The likely##3##2##(2008-10#2)(2012-2#1)
The limbic system has##2##4##(1992-12#2)
The limbic system##5##3##(1992-12#5)
The limit of detection (3sigma) was##2##6##(2008-10#2)
The limit of detection (3sigma)##4##5##(2008-10#4)
The limit of detection (LOD##2##5##(2008-10#2)
The limit of detection (LOD) of the##2##7##(2008-10#2)
The limit of detection (LOD) of##3##6##(2008-10#3)
The limit of detection (LOD)##8##5##(2008-10#8)
The limit of detection achieved##2##5##(2008-10#2)
The limit of detection and limit of quantification##2##8##(2008-10#1)(2012-2#1)
The limit of detection and the limit of quantification##2##9##(2008-10#2)
The limit of detection and the##3##6##(2008-10#3)
The limit of detection and##6##5##(2008-10#5)(2012-2#1)
The limit of detection for the determination of##2##8##(2008-10#2)
The limit of detection for##9##5##(2008-10#9)
The limit of detection is 0##2##6##(2008-10#2)
The limit of detection is 1##2##6##(2008-10#2)
The limit of detection is 2##3##6##(2008-10#3)
The limit of detection is##10##5##(2008-10#10)
The limit of detection of the method was##3##8##(2008-10#3)
The limit of detection of the proposed method is 0##4##10##(2008-10#4)
The limit of detection of the proposed method is##5##9##(2008-10#5)
The limit of detection of the##10##6##(2008-10#10)
The limit of detection of##15##5##(2008-10#14)(2011-2#1)
The limit of detection provided##2##5##(2008-10#2)
The limit of detection values##2##5##(2008-10#2)
The limit of detection was 0##6##6##(2008-10#6)
The limit of detection was 4##2##6##(2008-10#2)
The limit of detection was 7##2##6##(2008-10#2)
The limit of detection was estimated##2##6##(2008-10#2)
The limit of detection was found to be##2##8##(2008-10#2)
The limit of detection was##21##5##(2008-10#21)
The limit of detection##91##4##(2008-10#89)(2011-2#1)(2012-2#1)
The limit of detections##2##4##(2008-10#2)
The limit of quantification (LOQ)##2##5##(2008-10#2)
The limit of quantification##5##4##(2008-10#5)
The limit of quantitation##3##4##(2008-10#3)
The limit of##105##3##(2008-10#102)(2010-7#1)(2011-2#1)(2012-2#1)
The limitations##2##2##(2011-2#2)
The limited##4##2##(1991-6#1)(2008-9#2)(2010-11#1)
The limits of ECH detection##2##5##(2008-10#2)
The limits of detection (LOD) and quantification (LOQ)##2##8##(2008-10#2)
The limits of detection (LOD) for the##2##7##(2008-10#1)(2010-5#1)
The limits of detection (LOD)##5##5##(2008-10#4)(2010-5#1)
The limits of detection (LODs) ranged from 0##2##8##(2008-10#2)
The limits of detection (LODs)##4##5##(2008-10#4)
The limits of detection and quantification##2##6##(2008-10#2)
The limits of detection and##3##5##(2008-10#3)
The limits of detection are 0##2##6##(2008-10#2)
The limits of detection are##4##5##(2008-10#4)
The limits of detection for##5##5##(2008-10#5)
The limits of detection in urine##2##6##(2008-10#2)
The limits of detection of##3##5##(2008-10#3)
The limits of detection were 0##2##6##(2008-10#2)
The limits of detection were##8##5##(2008-10#8)
The limits of detection##45##4##(2008-10#44)(2010-5#1)
The limits of quantification (LOQ)##2##5##(2008-10#2)
The limits of quantification##5##4##(2008-10#5)
The limits of quantitation##2##4##(2008-10#2)
The limits of##59##3##(2008-10#57)(2008-12#1)(2010-5#1)
The limits##60##2##(2008-10#58)(2008-12#1)(2010-5#1)
The line##2##2##(1997-5#1)(2008-3#1)
The lineal interval was##2##4##(2008-10#2)
The linear calibration range of##2##5##(2008-10#2)
The linear calibration range was##4##5##(2008-10#4)
The linear calibration range##7##4##(2008-10#7)
The linear calibration ranges##2##4##(2008-10#2)
The linear calibration##13##3##(2008-10#13)
The linear concentration range of##3##5##(2008-10#2)(2013-1#1)
The linear concentration range was##2##5##(2008-10#2)
The linear concentration range##6##4##(2008-10#5)(2013-1#1)
The linear concentration ranges for the proposed enantioselective membrane electrodes were##2##11##(2008-10#2)
The linear concentration ranges for the proposed##3##7##(2008-10#3)
The linear concentration ranges##6##4##(2008-10#6)
The linear concentration##12##3##(2008-10#11)(2013-1#1)
The linear domain range of##2##5##(2008-10#2)
The linear dynamic range##6##4##(2008-10#6)
The linear dynamic ranges of the calibration##2##7##(2008-10#2)
The linear dynamic ranges of##4##5##(2008-10#4)
The linear dynamic ranges##6##4##(2008-10#6)
The linear dynamic##12##3##(2008-10#12)
The linear range for the determination of##2##7##(2008-10#2)
The linear range for##4##4##(2008-10#4)
The linear range is 0##2##5##(2008-10#2)
The linear range is##3##4##(2008-10#3)
The linear range of calibration##2##5##(2008-10#2)
The linear range of the assay in##2##7##(2008-10#1)(2008-11#1)
The linear range of the calibration curve##2##7##(2008-10#2)
The linear range of the determination was##2##7##(2008-10#2)
The linear range of the method for##3##7##(2008-10#3)
The linear range of the method##5##6##(2008-10#5)
The linear range of the##17##5##(2008-10#16)(2008-11#1)
The linear range of this method was##2##7##(2008-10#2)
The linear range of##28##4##(2008-10#27)(2008-11#1)
The linear range was##4##4##(2008-10#4)
The linear range##46##3##(2008-10#45)(2008-11#1)
The linear ranges were##4##4##(2008-10#4)
The linear ranges##7##3##(2008-10#7)
The linear regression analysis##2##4##(2008-10#2)
The linear regression equation of the calibration graph is C=0##2##10##(2008-10#2)
The linear regression equation of the calibration graph is##3##9##(2008-10#3)
The linear regression equation##4##4##(2008-10#4)
The linear regression##9##3##(2008-10#8)(2013-8#1)
The linear relationship between the##3##5##(2008-10#3)
The linear response of the##2##5##(2008-10#2)
The linear response range of##2##5##(2008-10#2)
The linear response##7##3##(2008-10#7)
The linear working range##2##4##(2008-10#2)
The linear##122##2##(1995-8#1)(2008-10#116)(2008-11#2)(2008-8#1)(2013-1#1)(2013-8#1)
The linearity of the##3##4##(2008-10#3)
The linearity of##8##3##(2008-10#7)(2010-3#1)
The linearity was obtained for##2##5##(2008-10#2)
The linearity was##3##3##(2008-10#3)
The linearity##14##2##(2008-10#13)(2010-3#1)
The lines##2##2##(2008-10#1)(2008-9#1)
The linewidth of##2##3##(2008-2#1)(2008-3#1)
The link between##2##3##(2008-3#1)(2009-7#1)
The linked markers##2##3##(2008-10#2)
The lipase activity##2##3##(2008-10#1)(2012-2#1)
The lipid-soluble##2##2##(1993-8#1)(2008-10#1)
The lipofuscin##2##2##(1995-3#2)
The lipophilic##2##2##(1994-3#1)(2008-10#1)
The liquid##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
The liquid-liquid extraction of##2##4##(2008-10#2)
The list##2##2##(1991-3#1)(1997-4#1)
The literature has##2##3##(1996-3#1)(2013-1#1)
The literature is reviewed and##2##5##(1993-8#1)(2008-12#1)
The literature is reviewed##6##4##(1990-9#1)(1991-3#1)(1993-8#1)(1994-12#1)(2008-12#1)(2008-5#1)
The literature is##7##3##(1990-9#1)(1991-3#1)(1993-8#1)(1994-12#1)(2008-12#2)(2008-5#1)
The literature on##3##3##(1997-8#1)(2009-1#1)(2013-1#1)
The literature search##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
The literature##25##2##(1990-9#1)(1991-3#1)(1993-11#1)(1993-8#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-1#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
The little##2##2##(2011-1#1)(2013-1#1)
The lived##2##2##(2008-12#1)(2009-5#1)
The liver and##3##3##(2008-11#1)(2008-5#1)(2010-11#1)
The liver##7##2##(2008-10#1)(2008-11#3)(2008-5#1)(2010-11#1)(2012-12#1)
The loaded##3##2##(1991-5#1)(2008-10#2)
The loading##4##2##(2008-10#4)
The local##8##2##(1991-6#1)(1992-12#1)(1993-1#1)(2008-10#2)(2008-8#1)(2010-6#1)(2013-1#1)
The localization of##3##3##(1992-3#1)(1994-2#1)(2012-2#1)
The location of the##3##4##(1994-11#1)(1997-9#1)(2008-5#1)
The location##5##2##(1991-6#1)(1994-11#1)(1997-9#1)(2008-5#1)(2013-1#1)
The locus##3##2##(2008-10#3)
The logarithm of the##3##4##(2008-10#3)
The logarithmic##3##2##(2008-10#3)
The logistic##4##2##(2008-10#3)(2010-7#1)
The long##6##2##(1991-2#1)(1993-12#1)(1996-9#1)(2008-11#1)(2008-6#1)(2010-7#1)
The long-term stability of##3##4##(2008-10#2)(2008-11#1)
The long-term##13##2##(1991-8#1)(1994-8#1)(2008-10#5)(2008-11#3)(2008-7#1)(2010-7#1)(2012-2#1)
The longest cDNA##2##3##(1991-5#1)(2008-11#1)
The longest##3##2##(1991-5#1)(2008-11#1)(2008-9#1)
The longitudinal##2##2##(2008-8#1)(2010-12#1)
The loop##2##2##(1992-4#1)(1995-1#1)
The loss of##7##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
The loss rate of wigs was##2##6##(2012-3#2)
The loss##9##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#2)
The low incidence of##2##4##(2008-8#1)(2010-1#1)
The low level of##2##4##(2008-10#1)(2008-11#1)
The low limit of##2##4##(2008-10#2)
The low##21##2##(1991-7#1)(1992-12#1)(1993-3#1)(1997-2#1)(2008-10#11)(2008-11#2)(2008-8#2)(2010-1#1)(2011-2#1)
The low-CHO diet##2##3##(2013-8#2)
The lower detection limit of##2##5##(2008-10#2)
The lower detection limit was##2##5##(1990-12#1)(2008-10#1)
The lower detection limit##7##4##(1990-12#1)(2008-10#6)
The lower detection##8##3##(1990-12#1)(2008-10#7)
The lower limit of detection (LOD) obtained under the optimal conditions was##2##12##(2008-10#2)
The lower limit of detection (LOD)##3##6##(2008-10#3)
The lower limit of detection##6##5##(2008-10#6)
The lower limit of quantitation was##2##6##(2008-10#2)
The lower limit of##9##4##(2008-10#8)(2008-2#1)
The lower##25##2##(1990-12#1)(1993-1#1)(2008-10#18)(2008-2#1)(2008-9#2)(2011-3#1)(2013-1#1)
The lowest concentration of metal##2##5##(2008-10#2)
The lowest concentration##3##3##(2008-10#3)
The lowest##11##2##(1993-8#1)(2008-10#10)
The lumbar##2##2##(1991-11#1)(1996-3#1)
The luminescence of##2##3##(2008-10#1)(2008-3#1)
The luminescence##5##2##(2008-10#3)(2008-3#1)(2013-1#1)
The lung##2##2##(2010-7#1)(2011-3#1)
The lungs and##2##3##(2009-9#1)(2010-12#1)
The lungs##3##2##(1996-3#1)(2009-9#1)(2010-12#1)
The lymphocyte##2##2##(2009-12#1)(2011-2#1)
The mRNA and protein levels of##2##6##(2011-3#2)
The mRNA expression of CaM##2##5##(2011-3#2)
The mRNA expression##3##3##(2008-9#1)(2011-3#2)
The mRNA for the rat cognate of##2##7##(1996-12#2)
The mRNA for the##3##4##(1992-8#1)(1996-12#2)
The mRNA##10##2##(1992-8#1)(1993-3#1)(1996-12#2)(2008-9#1)(2011-3#4)(2013-1#1)
The magnesium##4##2##(2008-10#4)
The magnitude and direction##2##4##(2008-10#1)(2010-5#1)
The magnitude of K(ex)##2##4##(2008-10#2)
The magnitude of the##7##4##(1990-8#1)(1992-12#1)(1993-6#1)(2008-10#3)(2008-5#1)
The magnitude of this##2##4##(2008-10#1)(2009-7#1)
The magnitude of##18##3##(1990-8#1)(1992-12#1)(1993-6#1)(1997-3#2)(2007-11#1)(2008-10#9)(2008-5#1)(2009-7#1)(2012-12#1)
The magnitude##21##2##(1990-8#1)(1992-12#1)(1993-6#1)(1997-3#2)(2007-11#1)(2008-10#11)(2008-5#1)(2009-7#1)(2010-5#1)(2012-12#1)
The magnitudes##2##2##(2008-3#1)(2009-2#1)
The main advantage of the proposed##2##6##(2008-10#2)
The main advantage of the##4##5##(2008-10#3)(2008-3#1)
The main advantage of##10##4##(2008-10#5)(2008-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
The main advantage##11##3##(2008-10#6)(2008-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
The main advantages of this##2##5##(2008-11#1)(2011-2#1)
The main advantages of##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
The main advantages##5##3##(2008-10#3)(2008-11#1)(2011-2#1)
The main aim of the study was to##2##8##(1993-2#1)(2008-11#1)
The main aim of##5##4##(1993-2#1)(2008-11#1)(2009-9#1)(2011-2#1)(2013-1#1)
The main aim##6##3##(1993-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#1)(2013-1#1)
The main analytical##2##3##(2008-10#2)
The main cause of##2##4##(1991-6#1)(2012-2#1)
The main cause##3##3##(1991-6#1)(2008-5#1)(2012-2#1)
The main causes of##3##4##(1990-9#1)(2008-1#1)(2008-8#1)
The main causes##4##3##(1990-9#1)(2008-1#1)(2008-8#1)(2009-8#1)
The main characteristics of the##3##5##(1991-12#1)(2008-10#2)
The main components of##2##4##(2008-10#1)(2008-5#1)
The main components##3##3##(1990-11#1)(2008-10#1)(2008-5#1)
The main degradation products##2##4##(2008-10#2)
The main difference between the##2##5##(2008-10#2)
The main difference between##3##4##(2008-10#3)
The main difference##5##3##(2008-10#4)(2012-3#1)
The main effects of##2##4##(2008-10#2)
The main features of the##2##5##(1990-3#1)(1992-1#1)
The main findings are##2##4##(2008-6#1)(2008-8#1)
The main findings##3##3##(2008-11#1)(2008-6#1)(2008-8#1)
The main focus of this##2##5##(2008-10#1)(2011-1#1)
The main focus##5##3##(1997-4#1)(2008-10#1)(2008-11#2)(2011-1#1)
The main goal of##2##4##(2008-10#1)(2013-1#1)
The main goal##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
The main limitations of the##2##5##(2008-10#1)(2009-1#1)
The main limitations##3##3##(2008-10#1)(2008-3#1)(2009-1#1)
The main objective of the##2##5##(2008-11#1)(2008-12#1)
The main objective of this##2##5##(1992-12#1)(2009-6#1)
The main objective of##4##4##(1992-12#1)(2008-11#1)(2008-12#1)(2009-6#1)
The main objectives of this study were to##2##8##(2008-11#1)(2013-1#1)
The main objectives of this##3##5##(2008-10#1)(2008-11#1)(2013-1#1)
The main outcome##4##3##(1993-12#1)(2008-7#1)(2008-8#1)(2010-10#1)
The main part##2##3##(1991-2#1)(1993-6#1)
The main purpose of this study##2##6##(1997-3#1)(2008-5#1)
The main reason for the##2##5##(1991-9#1)(1994-6#1)
The main result is##2##4##(2008-3#1)(2010-1#1)
The main results##4##3##(1993-8#1)(2008-10#1)(2008-5#2)
The main source##2##3##(1993-1#1)(1994-12#1)
The main thrust##2##3##(1994-9#1)(1997-7#1)
The main uncertainty##2##3##(2008-10#2)
The main##145##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#45)(2008-11#12)(2008-12#5)(2008-3#7)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#5)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#4)
The maintenance of##6##3##(1990-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
The major advantage of##2##4##(2007-12#1)(2008-10#1)
The major cause of##2##4##(1990-11#1)(1991-2#1)
The major characteristics##3##3##(1994-8#1)(2008-10#2)
The major constituents##2##3##(2008-11#1)(2008-12#1)
The major focus##2##3##(2008-11#1)(2010-11#1)
The major form of the##2##5##(2008-10#2)
The major protein##2##3##(2008-5#1)(2008-8#1)
The major##67##2##(1990-11#2)(1990-7#1)(1991-1#2)(1991-2#1)(1991-5#2)(1992-11#1)(1992-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
The majority (88%) of##2##4##(1993-12#1)(2011-1#1)
The majority of cases of##2##5##(2008-7#1)(2012-3#1)
The majority of children##2##4##(1996-12#1)(2008-11#1)
The majority of isolates##3##4##(2008-10#3)
The majority of participants##2##4##(2008-4#1)(2008-9#1)
The majority of patients##3##4##(1992-3#1)(2008-11#2)
The majority of the interventions##2##5##(2012-2#2)
The majority of the##19##4##(1993-6#1)(1993-8#1)(1994-12#1)(1995-11#1)(1996-1#1)(1997-3#1)(1997-9#1)(2008-1#1)(2008-11#2)(2008-4#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#3)
The majority of these##3##4##(2008-12#1)(2008-4#1)(2011-2#1)
The majority of women##2##4##(1996-6#1)(2011-2#1)
The majority of##66##3##(1991-1#1)(1992-3#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-9#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-4#4)(2008-5#3)(2008-7#3)(2008-9#1)(2009-8#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
The majority##83##2##(1991-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-9#1)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#2)(2008-4#4)(2008-5#3)(2008-7#3)(2008-9#1)(2009-8#2)(2010-11#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
The male to female sex ratio##2##6##(1997-7#1)(2008-7#1)
The male##3##2##(1997-7#1)(2008-12#1)(2008-7#1)
The mammalian##5##2##(1990-7#1)(1994-11#1)(1994-3#1)(1995-2#1)(2008-11#1)
The mammary##2##2##(1991-11#1)(1995-9#1)
The man##3##2##(1991-1#1)(1994-2#1)(2009-1#1)
The management of the##2##4##(2008-12#1)(2009-12#1)
The management of##19##3##(1991-8#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-2#3)(2012-3#1)(2013-1#3)
The management##23##2##(1991-8#1)(1993-9#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-2#5)(2012-3#1)(2013-1#4)
The maneuver##2##2##(2008-1#1)(2008-7#1)
The manganese##2##2##(2008-10#2)
The manifold##3##2##(2008-10#3)
The manner##2##2##(1993-2#1)(2008-10#1)
The manufacturing process##2##3##(1996-2#1)(2008-3#1)
The many##3##2##(2009-8#1)(2011-2#2)
The map has##2##3##(1994-9#1)(2008-10#1)
The map##5##2##(1994-9#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)
The mapping##2##2##(1997-6#1)(1997-9#1)
The marginal sinus is##2##4##(1996-9#2)
The marginal sinus##4##3##(1996-9#4)
The marginal##6##2##(1992-1#1)(1996-9#5)
The marked##6##2##(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#3)
The marker##2##2##(2008-10#1)(2008-12#1)
The markers##4##2##(2008-10#4)
The mass of##2##3##(1992-3#1)(1996-2#1)
The mass was##4##3##(2010-11#1)(2012-12#2)(2013-1#1)
The mass##21##2##(1992-12#1)(1992-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#9)(2008-5#1)(2010-11#1)(2012-12#3)(2013-1#1)(2013-8#1)
The massive##2##2##(1994-11#1)(1996-2#1)
The material##8##2##(1990-5#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#1)
The materials were##2##3##(2008-10#1)(2010-4#1)
The materials##4##2##(2008-10#2)(2010-4#1)(2013-1#1)
The maternal##2##2##(1993-6#1)(1995-12#1)
The mathematical model##2##3##(2008-10#2)
The mathematical##4##2##(2008-10#4)
The matrix##6##2##(2008-10#2)(2008-12#1)(2008-8#1)(2010-11#1)(2010-7#1)
The mature##3##2##(1990-5#1)(1992-8#1)(2007-12#1)
The maximal##9##2##(1991-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-8#1)
The maximum absorbance##2##3##(2008-10#2)
The maximum absorption wavelength was##2##5##(2008-10#1)(2008-3#1)
The maximum amount of##2##4##(2008-10#1)(2009-7#1)
The maximum capacity of the membrane disks modified##2##8##(2008-10#2)
The maximum concentrations##2##3##(2008-10#1)(2008-5#1)
The maximum excitation and emission wavelengths are##2##7##(2008-10#2)
The maximum excitation and emission wavelengths##4##6##(2008-10#4)
The maximum excitation##5##3##(2008-10#5)
The maximum growth rate##2##4##(2008-11#1)(2008-8#1)
The maximum number of##2##4##(2008-10#2)
The maximum sorption##2##3##(2008-10#2)
The maximum temperature##2##3##(2008-10#1)(2008-3#1)
The maximum##50##2##(1990-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-11#1)(2013-8#1)
The mean (+/-SD)##2##3##(1994-12#1)(2008-3#1)
The mean activity##2##3##(2008-10#1)(2008-8#1)
The mean age and##2##4##(1991-12#1)(1997-8#1)
The mean age at##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
The mean age of onset##2##5##(2007-8#1)(2008-7#1)
The mean age of the patients was 49##2##8##(2008-1#1)(2012-3#1)
The mean age of the patients was 54##2##8##(2008-1#1)(2010-6#1)
The mean age of the patients was##7##7##(1991-8#1)(1993-2#1)(2008-1#2)(2010-6#1)(2011-3#1)(2012-3#1)
The mean age of the##8##5##(1991-8#1)(1993-2#1)(2008-1#2)(2008-11#1)(2010-6#1)(2011-3#1)(2012-3#1)
The mean age of##16##4##(1991-8#1)(1993-2#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
The mean age was##6##4##(1991-3#1)(1997-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
The mean age##29##3##(1991-12#1)(1991-3#1)(1991-8#1)(1992-5#1)(1993-2#1)(1997-8#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#1)
The mean anteroposterior diameter of normal##2##6##(2013-1#2)
The mean change in##2##4##(2008-7#1)(2013-1#1)
The mean differences in##2##4##(2008-12#2)
The mean duration of##2##4##(1994-8#1)(2010-3#1)
The mean follow-up was##2##4##(2008-9#1)(2011-2#1)
The mean follow-up##3##3##(2008-9#1)(2011-2#2)
The mean interday##2##3##(2008-10#2)
The mean length of##2##4##(2008-10#1)(2012-3#1)
The mean number of##6##4##(1990-6#1)(1992-6#1)(2008-10#1)(2008-7#1)(2010-9#1)(2013-1#1)
The mean of##3##3##(2008-10#2)(2011-2#1)
The mean percentage of##2##4##(2008-10#2)
The mean percentage recoveries obtained using##2##6##(2008-10#2)
The mean percentage recoveries##3##4##(2008-10#3)
The mean percentage##5##3##(2008-10#5)
The mean ratio##2##3##(2008-12#2)
The mean recoveries##3##3##(2008-10#3)
The mean recovery was##2##4##(2008-10#2)
The mean recovery##3##3##(1993-3#1)(2008-10#2)
The mean score for perception of##2##6##(1991-2#2)
The mean score##3##3##(1991-2#2)(2013-8#1)
The mean serum##2##3##(2008-1#1)(2011-2#1)
The mean survival##3##3##(1990-2#1)(1991-8#1)(2008-7#1)
The mean time of##2##4##(2008-11#1)(2009-3#1)
The mean time to##2##4##(2010-3#1)(2011-2#1)
The mean time##6##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)
The mean value of##4##4##(2008-10#2)(2008-11#2)
The mean value##6##3##(1993-1#1)(2008-1#1)(2008-10#2)(2008-11#2)
The mean values of##3##4##(2008-10#2)(2010-1#1)
The mean values##7##3##(1994-12#1)(2008-10#5)(2010-1#1)
The mean##167##2##(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#3)(1992-2#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-8#2)(2007-8#1)(2008-1#4)(2008-10#46)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#8)(2008-8#2)(2008-9#7)(2009-11#3)(2009-2#2)(2009-3#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-6#2)(2010-9#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-3#9)(2013-1#13)(2013-8#3)
The meaning of##2##3##(2008-11#1)(2010-10#1)
The means##2##2##(2008-9#1)(2010-8#1)
The measure of multilocus correlation##2##5##(2008-10#2)
The measure of##3##3##(2008-10#2)(2011-2#1)
The measure##5##2##(2008-10#2)(2010-10#1)(2011-2#1)(2013-1#1)
The measured##25##2##(1991-6#1)(1993-2#2)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#9)(2009-11#1)(2009-5#1)(2009-7#1)
The measurement conditions were##2##4##(2008-10#2)
The measurement is##2##3##(2008-10#1)(2008-3#1)
The measurement of the##2##4##(2008-10#1)(2008-3#1)
The measurement of##8##3##(1991-11#1)(1994-12#1)(2008-10#5)(2008-3#1)
The measurement##25##2##(1990-12#1)(1991-11#1)(1994-12#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2012-3#1)
The measurements are##2##3##(2008-10#1)(2008-3#1)
The measurements of##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
The measurements were performed##2##4##(2008-10#2)
The measurements were##6##3##(2008-10#4)(2008-11#1)(2012-5#1)
The measurements##18##2##(1996-6#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-9#1)(2010-7#1)(2011-2#1)(2012-5#1)
The measures of##2##3##(2008-10#1)(2012-3#1)
The measuring range of##2##4##(2008-10#2)
The measuring range##4##3##(2008-10#4)
The measuring##9##2##(2008-10#8)(2008-11#1)
The mechanical properties of##5##4##(2009-7#3)(2009-9#1)(2012-2#1)
The mechanical properties##7##3##(2009-7#5)(2009-9#1)(2012-2#1)
The mechanical##9##2##(2008-10#1)(2009-7#6)(2009-9#1)(2012-2#1)
The mechanics of##2##3##(2008-5#1)(2008-8#1)
The mechanism by which##3##4##(1990-5#1)(1994-8#1)(1995-2#1)
The mechanism for the interaction of##2##6##(2008-10#2)
The mechanism for the##4##4##(2008-10#4)
The mechanism for##5##3##(2008-10#4)(2008-3#1)
The mechanism of action of##2##5##(2008-11#1)(2013-7#1)
The mechanism of action##3##4##(2008-11#1)(2008-5#1)(2013-7#1)
The mechanism of the inhibition##2##5##(2008-10#2)
The mechanism of the##13##4##(1996-2#1)(1997-7#1)(2008-10#10)(2008-9#1)
The mechanism of this effect##2##5##(1990-3#1)(1995-8#1)
The mechanism of this##7##4##(1990-3#1)(1991-3#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-7#2)
The mechanism of##46##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-3#2)(1992-1#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#26)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)(2013-7#1)
The mechanism##64##2##(1990-11#1)(1990-3#2)(1990-5#2)(1991-3#2)(1992-1#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#34)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2011-2#1)(2013-7#1)
The mechanisms by which##4##4##(1996-2#1)(2007-11#1)(2009-8#2)
The mechanisms for##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
The mechanisms of##7##3##(2008-10#3)(2008-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
The mechanisms underlying##2##3##(2008-1#1)(2012-2#1)
The mechanisms##21##2##(1992-6#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#2)
The media##4##2##(2008-11#2)(2008-12#1)(2010-8#1)
The medial##2##2##(1994-2#1)(2012-2#1)
The median age was##2##4##(1990-9#1)(2013-1#1)
The median age##3##3##(1990-9#1)(1997-8#1)(2013-1#1)
The median duration of##4##4##(1993-1#1)(1993-6#1)(1994-8#1)(2013-8#1)
The median follow-up duration was##2##5##(2008-10#2)
The median number of##2##4##(2010-12#1)(2011-2#1)
The median survival time##2##4##(1990-9#1)(1994-8#1)
The median survival was##3##4##(1990-12#1)(1992-12#1)(2008-10#1)
The median survival##8##3##(1990-12#1)(1990-9#1)(1992-12#1)(1994-8#1)(1997-5#1)(2008-10#2)(2012-3#1)
The median time##2##3##(2007-8#1)(2012-3#1)
The median##36##2##(1990-12#2)(1990-9#2)(1992-12#1)(1993-1#1)(1993-6#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-5#1)(1997-8#1)(2007-12#2)(2007-8#2)(2008-10#8)(2008-6#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
The medical director and company liability beyond the insurance policy##2##10##(1993-12#2)
The medical records of##2##4##(1996-3#1)(2008-7#1)
The medical records##3##3##(1992-3#1)(1996-3#1)(2008-7#1)
The medical##10##2##(1991-12#1)(1992-3#1)(1993-12#2)(1995-1#1)(1996-3#1)(2008-11#2)(2008-7#1)(2011-2#1)
The medium##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
The meeting##2##2##(2008-5#1)(2010-5#1)
The members of the##2##4##(1990-5#1)(2012-12#1)
The membrane having##2##3##(2008-10#2)
The membrane is##2##3##(2008-10#2)
The membrane##15##2##(1995-6#1)(2008-10#9)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#1)
The membranes were##2##3##(2008-10#2)
The membranes##5##2##(2008-10#5)
The mentioned##2##2##(2008-10#1)(2009-10#1)
The mercury##2##2##(2008-10#2)
The message##2##2##(1995-9#1)(2010-4#1)
The meta-analysis##4##2##(2010-11#2)(2010-2#1)(2013-1#1)
The metabolic syndrome is##2##4##(2008-1#1)(2008-3#1)
The metabolic syndrome##7##3##(2008-1#2)(2008-3#3)(2010-4#1)(2013-1#1)
The metabolic##15##2##(1990-11#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#3)(2010-4#1)(2012-2#1)(2013-1#1)
The metabolism of##2##3##(1990-11#1)(2008-11#1)
The metabolites##2##2##(1995-11#1)(2008-10#1)
The metal ions in the##3##5##(2008-10#3)
The metal ions were##3##4##(2008-10#3)
The metal ions##8##3##(2008-10#8)
The metal##19##2##(2008-10#18)(2008-12#1)
The metallic##2##2##(1995-3#1)(2008-10#1)
The metals##3##2##(2008-10#3)
The metapopulation##3##2##(2008-10#1)(2008-8#2)
The method affords binary separation of##3##6##(2008-10#3)
The method allowed##4##3##(2008-10#3)(2009-8#1)
The method allows a##2##4##(2008-10#1)(2008-11#1)
The method allows determination of##2##5##(2008-10#2)
The method allows immediate control of the##2##7##(2008-10#2)
The method allows the determination of##5##6##(2008-10#5)
The method allows the##7##4##(2008-10#7)
The method allows##15##3##(2008-10#13)(2008-11#1)(2013-1#1)
The method also##2##3##(2008-10#1)(2009-6#1)
The method appears##2##3##(2008-10#2)
The method based on##3##4##(2008-10#3)
The method can be applied##3##5##(2008-10#3)
The method can be used to##3##6##(2008-10#3)
The method can be##6##4##(2008-10#6)
The method can##7##3##(2008-10#7)
The method consists of##3##4##(2008-10#3)
The method could be##2##4##(2008-10#2)
The method could##3##3##(2008-10#3)
The method described is##4##4##(1990-2#1)(2008-10#2)(2008-11#1)
The method described##8##3##(1990-2#1)(1995-12#1)(2008-10#4)(2008-11#1)(2009-3#1)
The method detection limit (MDL)##3##5##(2008-10#3)
The method detection limit for##2##5##(2008-10#2)
The method detection limit##6##4##(2008-10#6)
The method developed was##2##4##(2008-10#2)
The method developed##11##3##(2008-10#11)
The method does not##3##4##(2008-10#2)(2008-3#1)
The method exhibits##2##3##(2008-10#2)
The method exploits the##2##4##(2008-10#2)
The method for##4##3##(2008-10#4)
The method gives the detection limit of##2##7##(2008-10#2)
The method gives##3##3##(2008-10#3)
The method has a detection limit of 0##2##8##(2008-10#2)
The method has a detection limit##3##6##(2008-10#3)
The method has a##10##4##(1990-2#1)(2008-10#9)
The method has also been##2##5##(2008-10#2)
The method has been applied for quantifying##2##7##(2008-10#2)
The method has been applied for the##2##7##(2008-10#2)
The method has been applied for##5##6##(2008-10#5)
The method has been applied successfully to the##2##8##(2008-10#2)
The method has been applied successfully to##3##7##(2008-10#3)
The method has been applied successfully##4##6##(2008-10#4)
The method has been applied to the determination of lead in##4##11##(2008-10#4)
The method has been applied to the determination of these##2##10##(2008-10#2)
The method has been applied to the determination of total##2##10##(2008-10#2)
The method has been applied to the determination of##18##9##(2008-10#18)
The method has been applied to the##21##7##(2008-10#21)
The method has been applied to##30##6##(2008-10#30)
The method has been applied##40##5##(2008-10#40)
The method has been fully validated##3##6##(2008-10#3)
The method has been satisfactorily applied to the determination of##5##10##(2008-10#5)
The method has been satisfactorily applied to the##6##8##(2008-10#6)
The method has been successfully applied for the##3##8##(2008-10#3)
The method has been successfully applied for##6##7##(2008-10#6)
The method has been successfully applied to determine##2##8##(2008-10#2)
The method has been successfully applied to the determination of##8##10##(2008-10#8)
The method has been successfully applied to##12##7##(2008-10#12)
The method has been successfully applied##18##6##(2008-10#18)
The method has been successfully##19##5##(2008-10#19)
The method has been used to##2##6##(2008-10#2)
The method has been used##3##5##(2008-10#3)
The method has been##76##4##(2008-10#76)
The method has high precision and accuracy##2##7##(2008-10#2)
The method has potential##2##4##(2008-10#1)(2008-9#1)
The method has##97##3##(1990-2#1)(2008-10#95)(2008-9#1)
The method here##2##3##(2008-10#2)
The method involved##4##3##(2008-10#4)
The method involves a sequential injection analysis (SIA) system equipped with a chemiluminescence detector and a##2##16##(2008-10#2)
The method involves a sequential##3##5##(2008-10#3)
The method involves a##7##4##(2008-10#6)(2011-2#1)
The method involves the##14##4##(1990-2#1)(1996-5#1)(2008-10#12)
The method involves##29##3##(1990-2#1)(1996-5#1)(2008-10#24)(2008-11#1)(2008-4#1)(2011-2#1)
The method is accurate and##2##5##(2008-10#2)
The method is accurate##3##4##(1997-2#1)(2008-10#2)
The method is applicable to the##2##6##(2008-10#2)
The method is applicable to##3##5##(2008-10#3)
The method is applicable##4##4##(2008-10#4)
The method is applied for##2##5##(2008-10#2)
The method is applied to the analysis of##2##8##(2008-10#2)
The method is applied to the determination of##2##8##(2008-10#2)
The method is applied to the##7##6##(2008-10#7)
The method is applied to##11##5##(2008-10#10)(2008-11#1)
The method is applied##15##4##(2008-10#13)(2008-11#1)(2010-7#1)
The method is based on a##5##6##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
The method is based on its catalytic effect on the oxidation of##2##12##(2008-10#2)
The method is based on the CL reaction of##2##9##(2008-10#2)
The method is based on the catalytic effect of vanadium(V) on##2##11##(2008-10#2)
The method is based on the catalytic effect of##9##9##(2008-10#9)
The method is based on the catalytic##10##7##(2008-10#10)
The method is based on the chemical##2##7##(2008-10#2)
The method is based on the chemiluminescence reaction of##2##9##(2008-10#2)
The method is based on the condensation reaction##2##8##(2008-10#2)
The method is based on the condensation##3##7##(2008-10#3)
The method is based on the derivatization reaction of the primary amine group with o-phthalaldehyde in the presence of 2-mercaptoethanol##2##20##(2008-10#2)
The method is based on the difference in the rate of##2##11##(2008-10#2)
The method is based on the enhancing effect##2##8##(2008-10#2)
The method is based on the extraction of##2##8##(2008-10#2)
The method is based on the fluorescence##2##7##(2008-10#2)
The method is based on the formation of##4##8##(2008-10#4)
The method is based on the interaction of##2##8##(2008-10#2)
The method is based on the measurement of##2##8##(2008-10#2)
The method is based on the on-line##2##7##(2008-10#2)
The method is based on the oxidation of rhodamine##2##9##(2008-10#2)
The method is based on the oxidation of##6##8##(2008-10#6)
The method is based on the oxidation##7##7##(2008-10#7)
The method is based on the reaction between the##2##9##(2008-10#2)
The method is based on the reaction between##6##8##(2008-10#6)
The method is based on the reaction of##5##8##(2008-10#5)
The method is based on the reaction##12##7##(2008-10#12)
The method is based on the reduction of##3##8##(2008-10#3)
The method is based on the separation##2##7##(2008-10#2)
The method is based on the sorption of##2##8##(2008-10#2)
The method is based on the##110##6##(2008-10#108)(2008-11#1)(2011-2#1)
The method is based on##141##5##(2007-11#1)(2008-10#135)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
The method is based upon the##2##6##(2008-10#2)
The method is based upon##4##5##(2008-10#4)
The method is based##146##4##(2007-11#1)(2008-10#140)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
The method is capable of detecting##2##6##(1995-3#1)(2008-10#1)
The method is capable of##3##5##(1995-3#1)(2008-10#2)
The method is developed by##2##5##(2008-10#2)
The method is easy##2##4##(1991-11#1)(2008-10#1)
The method is fast##2##4##(2008-10#2)
The method is free from##4##5##(2008-10#4)
The method is highly selective and the determination is little affected by the presence of other substances##2##17##(2008-10#2)
The method is highly##4##4##(2008-10#4)
The method is illustrated##3##4##(1992-9#1)(2010-1#1)(2010-6#1)
The method is rapid##4##4##(2008-10#3)(2008-9#1)
The method is sensitive and##3##5##(2008-10#2)(2008-3#1)
The method is sensitive##8##4##(1996-2#1)(2008-10#6)(2008-3#1)
The method is simple and##8##5##(1996-2#1)(2008-10#6)(2008-11#1)
The method is simple##20##4##(1990-2#1)(1996-2#1)(2008-10#16)(2008-11#1)(2008-5#1)
The method is successfully applied to##4##6##(2008-10#4)
The method is successfully applied##5##5##(2008-10#5)
The method is suitable for the determination of##2##8##(2008-10#2)
The method is suitable for the##3##6##(2008-10#3)
The method is suitable for##5##5##(2008-10#5)
The method is used##2##4##(2008-10#1)(2008-3#1)
The method is validated##2##4##(2008-10#1)(2008-5#1)
The method is very##4##4##(2008-10#3)(2008-11#1)
The method is##267##3##(1990-2#1)(1991-11#1)(1992-3#1)(1992-9#1)(1995-3#1)(1996-2#2)(1997-2#3)(2007-11#2)(2008-10#234)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-9#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)
The method makes use of##2##5##(2008-10#1)(2008-3#1)
The method of analysis##2##4##(2008-10#2)
The method of##20##3##(1996-6#1)(1997-3#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#3)(2008-8#1)
The method offered the##2##4##(2008-10#2)
The method offers##2##3##(2008-10#2)
The method performance was evaluated##2##5##(2008-10#2)
The method permits rapid and precise individual separation of gallium (III)##2##11##(2008-10#2)
The method permits the##2##4##(2008-10#2)
The method permits##5##3##(2008-10#5)
The method presented here##3##4##(2008-10#2)(2008-11#1)
The method presented##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
The method proposed for##2##4##(2008-10#2)
The method proposed here is##2##5##(1991-5#1)(2008-10#1)
The method proposed is##2##4##(2008-10#2)
The method proposed was applied##4##5##(2008-10#4)
The method proposed##14##3##(1991-5#1)(1993-6#1)(2008-10#12)
The method provided##3##3##(2008-10#3)
The method provides a dynamic range from##2##7##(2008-10#2)
The method provides a##5##4##(2008-10#4)(2008-4#1)
The method provides##10##3##(1992-11#1)(2007-11#1)(2008-10#7)(2008-4#1)
The method relies on the linear relationship between the##2##9##(2008-10#2)
The method relies on the##4##5##(2008-10#3)(2008-3#1)
The method relies##5##3##(2008-10#4)(2008-3#1)
The method requires##2##3##(2008-10#1)(2008-3#1)
The method showed a good##2##5##(2008-10#1)(2011-3#1)
The method showed a##3##4##(2008-10#2)(2011-3#1)
The method showed linear##2##4##(2008-10#2)
The method showed##6##3##(2008-10#5)(2011-3#1)
The method shows a linear range between##2##7##(2008-10#2)
The method shows a##3##4##(2008-10#3)
The method shows good##3##4##(2008-10#3)
The method shows##7##3##(2008-10#6)(2012-12#1)
The method to##2##3##(2008-11#2)
The method used a##2##4##(2008-10#2)
The method uses a##5##4##(2008-10#3)(2008-3#1)(2012-3#1)
The method uses##7##3##(2008-10#5)(2008-3#1)(2012-3#1)
The method was also##5##4##(2008-10#5)
The method was applied for the determination of##10##8##(2008-10#10)
The method was applied for the direct##2##7##(2008-10#2)
The method was applied for the evaluation of##2##8##(2008-10#2)
The method was applied for the##18##6##(2008-10#18)
The method was applied for##22##5##(2008-10#22)
The method was applied in##2##5##(2008-10#1)(2011-3#1)
The method was applied on##3##5##(2008-10#3)
The method was applied satisfactorily to##2##6##(2008-10#2)
The method was applied successfully to the determination of these##2##10##(2008-10#2)
The method was applied successfully to the determination of##6##9##(2008-10#6)
The method was applied to 1##2##6##(2008-10#2)
The method was applied to determine##5##6##(2008-10#5)
The method was applied to different##3##6##(2008-10#3)
The method was applied to samples of##2##7##(2008-10#2)
The method was applied to the analysis of##6##8##(2008-10#6)
The method was applied to the determination of##25##8##(2008-10#25)
The method was applied to the recovery and determination of##2##10##(2008-10#2)
The method was applied to the recovery of##2##8##(2008-10#2)
The method was applied to the recovery##4##7##(2008-10#4)
The method was applied to the##39##6##(2008-10#39)
The method was applied to##66##5##(2008-10#64)(2011-2#1)(2013-8#1)
The method was applied##102##4##(2008-10#99)(2011-2#1)(2011-3#1)(2013-8#1)
The method was based on the competitive reaction of##2##9##(2008-10#2)
The method was based on the##11##6##(2008-10#11)
The method was based on##12##5##(2008-10#12)
The method was based##13##4##(2008-10#13)
The method was carried out##2##5##(2008-10#2)
The method was compared with the##2##6##(2008-10#2)
The method was compared with##4##5##(2008-10#4)
The method was developed##2##4##(2008-10#2)
The method was employed for the##2##6##(2008-10#2)
The method was evaluated by##2##5##(2008-10#2)
The method was evaluated##5##4##(2008-10#5)
The method was finally applied##2##5##(2008-10#2)
The method was found to be accurate and##2##8##(2008-10#1)(2012-2#1)
The method was found to be applicable##2##7##(2008-10#2)
The method was found to be relatively selective and was applied successfully to##2##13##(2008-10#2)
The method was found to be very precise [s(r)=0##2##9##(2008-10#2)
The method was found to be##9##6##(2008-10#8)(2012-2#1)
The method was further##2##4##(2008-10#2)
The method was linear over the##2##6##(2008-10#2)
The method was linear##3##4##(2008-10#3)
The method was optimized##3##4##(2008-10#3)
The method was satisfactorily applied to the determination of##3##9##(2008-10#3)
The method was satisfactorily applied to the##4##7##(2008-10#4)
The method was satisfactorily applied##5##5##(2008-10#5)
The method was satisfactorily##6##4##(2008-10#6)
The method was successfully applied for the analysis of##2##9##(2008-10#2)
The method was successfully applied for the determination of##2##9##(2008-10#2)
The method was successfully applied for the##5##7##(2008-10#5)
The method was successfully applied in##2##6##(2008-10#1)(2011-3#1)
The method was successfully applied to determine##2##7##(2008-10#2)
The method was successfully applied to the analysis of##3##9##(2008-10#3)
The method was successfully applied to the determination of lead in##2##11##(2008-10#2)
The method was successfully applied to the determination of##21##9##(2008-10#21)
The method was successfully applied to the extraction and determination of bismuth in natural water##2##15##(2008-10#2)
The method was successfully applied to the##29##7##(2008-10#29)
The method was successfully applied to##31##6##(2008-10#31)
The method was successfully applied##38##5##(2008-10#37)(2011-3#1)
The method was successfully used##2##5##(2008-10#2)
The method was successfully##41##4##(2008-10#40)(2011-3#1)
The method was tested by##3##5##(2008-10#3)
The method was tested##6##4##(2008-10#5)(2008-12#1)
The method was then applied to the##2##7##(2008-10#2)
The method was used for the determination of##3##8##(2008-10#3)
The method was used for the##5##6##(2008-10#5)
The method was used to determine the concentration-time profiles of##2##10##(2008-10#2)
The method was used to determine the##3##7##(2008-10#3)
The method was used to determine##4##6##(2008-10#4)
The method was used to screen##2##6##(2008-10#1)(2008-9#1)
The method was used to##8##5##(2008-10#7)(2008-9#1)
The method was used##15##4##(2008-10#14)(2008-9#1)
The method was validated and##2##5##(2008-10#2)
The method was validated by the##2##6##(2008-10#2)
The method was validated by##6##5##(1996-3#1)(2008-10#5)
The method was validated for precision##2##6##(2008-10#2)
The method was validated for##4##5##(2008-10#4)
The method was validated in terms of##2##7##(2008-10#1)(2012-2#1)
The method was validated using a##2##6##(2008-10#2)
The method was validated using##3##5##(2008-10#3)
The method was validated##20##4##(1996-3#1)(2008-10#17)(2011-3#1)(2012-2#1)
The method was##258##3##(1994-11#1)(1996-3#1)(2008-10#246)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2011-3#3)(2012-2#2)(2013-8#1)
The method##875##2##(1990-2#5)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-12#2)(1995-3#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#1)(2007-11#3)(2008-10#781)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#13)(2008-4#6)(2008-5#4)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
The method's##2##2##(2008-10#2)
The methodological##4##2##(1995-11#1)(2008-10#2)(2008-12#1)
The methodologies##2##2##(2008-4#1)(2008-9#1)
The methodology developed is##2##4##(2008-10#2)
The methodology developed##4##3##(2008-10#3)(2009-10#1)
The methodology has##2##3##(2008-10#1)(2009-10#1)
The methodology is based on the##2##6##(2008-10#2)
The methodology is##6##3##(1996-5#1)(2008-10#5)
The methodology used##2##3##(2008-10#1)(2013-1#1)
The methodology##25##2##(1996-5#1)(2008-10#19)(2009-10#2)(2011-2#2)(2013-1#1)
The methods are based on the reaction of these drugs as n-electron donors with the sigma-acceptor iodine##2##17##(2008-10#2)
The methods are based on the##3##6##(2008-10#3)
The methods are based on##4##5##(2008-10#3)(2008-3#1)
The methods are##7##3##(2008-10#6)(2008-3#1)
The methods covered##2##3##(2008-10#1)(2008-9#1)
The methods described##2##3##(2008-7#1)(2008-9#1)
The methods developed##2##3##(2008-10#2)
The methods have been successfully applied to the##2##8##(2008-10#2)
The methods have been successfully applied to##3##7##(2008-10#3)
The methods have been##5##4##(2008-10#3)(2008-9#1)(2009-8#1)
The methods have##6##3##(2008-10#4)(2008-9#1)(2009-8#1)
The methods of##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
The methods require##2##3##(1994-8#1)(2008-10#1)
The methods used included##2##4##(1996-8#1)(2008-12#1)
The methods used##6##3##(1996-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#1)
The methods were applied to##4##5##(2008-10#4)
The methods were applied##5##4##(2008-10#5)
The methods were##13##3##(2008-10#13)
The methods##54##2##(1994-8#1)(1996-8#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
The mice##2##2##(1990-6#1)(2008-8#1)
The micellar##2##2##(2008-10#2)
The micro-volume ByT-FAS##2##3##(2008-10#2)
The microbial community resident in##2##5##(2008-10#2)
The microbial##8##2##(1992-8#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#2)
The microcirculation##2##2##(2009-10#1)(2010-7#1)
The microfluidic##2##2##(2009-12#2)
The microsatellite##4##2##(2008-10#4)
The microscopic##3##2##(1995-3#1)(2008-5#1)(2011-2#1)
The microstructure and##2##3##(2009-7#1)(2011-2#1)
The microstructure##4##2##(2008-10#1)(2009-7#2)(2011-2#1)
The microvascular##2##2##(2011-2#2)
The microvilli##2##2##(2007-12#2)
The microwave##2##2##(2008-10#2)
The midgut##2##2##(2007-12#2)
The migration##4##2##(2008-10#3)(2008-7#1)
The milk##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
The mineralogical##2##2##(2008-10#2)
The miniaturized##2##2##(2008-10#1)(2009-12#1)
The minigenes##2##2##(2008-8#2)
The minimal##5##2##(1995-2#1)(1997-4#1)(2008-10#2)(2008-5#1)
The minimally invasive##2##3##(2008-10#1)(2013-1#1)
The minimum detectable##2##3##(2008-10#1)(2008-3#1)
The minimum##15##2##(1991-11#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
The minor##4##2##(1992-4#1)(1993-12#1)(2008-11#1)(2011-2#1)
The mission##3##2##(1993-3#1)(2009-10#1)(2010-6#1)
The mitochondrial##4##2##(2007-8#1)(2008-8#2)(2012-2#1)
The mitogenic##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
The mixed##5##2##(2008-10#4)(2008-3#1)
The mixing##2##2##(2008-10#1)(2008-5#1)
The mixture of##4##3##(2008-10#4)
The mixture##8##2##(2008-10#8)
The mobile phase used was##5##5##(1997-2#1)(2008-10#3)(2012-2#1)
The mobile phase##7##3##(1997-2#1)(2008-10#5)(2012-2#1)
The mobile##11##2##(1995-6#1)(1997-2#1)(2008-10#6)(2008-12#1)(2008-3#1)(2012-2#1)
The mode of action of##3##5##(2008-10#2)(2008-4#1)
The mode of action##4##4##(1990-12#1)(2008-10#2)(2008-4#1)
The mode of##11##3##(1990-12#1)(1992-6#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-9#1)
The mode##13##2##(1990-12#1)(1992-6#1)(1993-3#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-9#1)(2009-7#1)
The model accounts for##2##4##(2008-3#1)(2013-8#1)
The model also##5##3##(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
The model assumes that##2##4##(1994-5#1)(1995-12#1)
The model can be used to##2##6##(2008-10#1)(2008-3#1)
The model can be##4##4##(2008-10#3)(2008-3#1)
The model can##6##3##(2008-10#3)(2008-3#3)
The model considers##2##3##(2008-10#1)(2009-8#1)
The model describes##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
The model has##2##3##(2008-10#1)(2008-6#1)
The model includes the##2##4##(2008-3#1)(2013-1#1)
The model includes##4##3##(1993-8#1)(2008-3#1)(2011-2#1)(2013-1#1)
The model incorporates##2##3##(2008-7#1)(2013-8#1)
The model is based on the##2##6##(2008-10#1)(2008-11#1)
The model is based on##4##5##(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
The model is used to##2##5##(2008-11#1)(2008-4#1)
The model is##18##3##(1995-9#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-3#3)(2008-4#2)(2008-8#2)(2010-10#1)(2010-8#1)(2011-2#1)
The model predicts a##2##4##(2008-10#1)(2008-5#1)
The model predicts that##7##4##(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)
The model predicts##9##3##(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)
The model provides##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
The model shows that##3##4##(2008-8#2)(2008-9#1)
The model simulates##2##3##(2008-10#1)(2013-8#1)
The model suggests##2##3##(2007-12#1)(2008-8#1)
The model was expanded##2##4##(2008-10#1)(2008-8#1)
The model was tested##2##4##(2008-10#1)(2008-7#1)
The model was validated with##3##5##(2008-10#2)(2008-11#1)
The model was##18##3##(2008-10#10)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-8#1)(2013-8#1)
The model##131##2##(1992-4#1)(1992-9#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-9#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#31)(2008-11#11)(2008-3#10)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#16)(2008-9#8)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#5)(2011-2#7)(2012-12#1)(2013-1#2)(2013-8#6)
The modeling##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
The modelling##3##2##(2008-10#3)
The models were##4##3##(2008-10#2)(2010-6#1)(2011-2#1)
The models##17##2##(1996-3#1)(2008-10#7)(2008-8#4)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-8#1)
The modes of action##2##4##(2008-10#2)
The modification of the##2##4##(2008-10#2)
The modification of##4##3##(1993-6#1)(2008-10#2)(2008-2#1)
The modification##6##2##(1993-6#1)(2008-10#3)(2008-2#1)(2008-3#1)
The modifications##2##2##(1996-12#1)(2008-10#1)
The modified electrode can be used for##2##7##(2008-10#2)
The modified electrode showed excellent##2##5##(2008-10#2)
The modified electrode showed##3##4##(2008-10#3)
The modified electrode shows a##2##5##(2008-10#2)
The modified electrode shows##4##4##(2008-10#4)
The modified electrode was characterized by alternating current impedance and electrochemical probe##2##12##(2008-10#2)
The modified electrode was##5##4##(2008-10#5)
The modified electrode##21##3##(2008-10#21)
The modified electrodes were##2##4##(2008-10#2)
The modified electrodes##5##3##(2008-10#5)
The modified silica gels##2##4##(2008-10#2)
The modified silica##3##3##(2008-10#3)
The modified technique##2##3##(2008-10#1)(2008-7#1)
The modified##50##2##(1997-7#1)(2008-10#43)(2008-12#1)(2008-7#1)(2009-3#1)(2009-7#1)(2012-2#1)(2013-1#1)
The modifier##2##2##(2008-10#2)
The modulation of##2##3##(2009-8#1)(2012-2#1)
The modulation##3##2##(2008-2#1)(2009-8#1)(2012-2#1)
The module##5##2##(1996-1#2)(2008-11#2)(2008-12#1)
The molar absorption coefficient##2##4##(2008-10#2)
The molar absorptivities of##2##4##(2008-10#2)
The molar absorptivity and Sandell's sensitivity are 1##2##8##(2008-10#2)
The molar absorptivity and Sandell's sensitivity are##3##7##(2008-10#3)
The molar absorptivity and Sandell's sensitivity##4##6##(2008-10#4)
The molar absorptivity and##6##4##(2008-10#6)
The molar absorptivity is##3##4##(2008-10#3)
The molar absorptivity of the complex is##2##7##(2008-10#2)
The molar absorptivity of the##5##5##(2008-10#5)
The molar absorptivity of##6##4##(2008-10#6)
The molar absorptivity##19##3##(2008-10#19)
The molar ratio of the##3##5##(2008-10#3)
The molar##28##2##(2008-10#28)
The molecular and##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
The molecular basis for##2##4##(2008-8#1)(2011-2#1)
The molecular basis of##2##4##(2008-11#1)(2008-9#1)
The molecular basis##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
The molecular characterization of##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
The molecular genetic##2##3##(2008-7#1)(2011-2#1)
The molecular mass of##2##4##(2008-10#2)
The molecular mechanisms##3##3##(1995-2#1)(2011-10#1)(2011-2#1)
The molecular size##2##3##(1997-1#1)(2008-10#1)
The molecular structure##2##3##(1992-12#1)(1996-5#1)
The molecular weight of the##2##5##(2008-11#1)(2008-8#1)
The molecular weight of##3##4##(2008-11#1)(2008-8#2)
The molecular weight##5##3##(2008-10#1)(2008-11#2)(2008-8#2)
The molecular##57##2##(1992-12#1)(1993-12#1)(1993-2#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-5#2)(1997-1#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-8#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#1)
The molecule##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
The monitoring of##2##3##(2008-10#1)(2013-1#1)
The monitoring##4##2##(2008-10#3)(2013-1#1)
The monoclonal antibody was##2##4##(2008-10#1)(2008-8#1)
The monoclonal##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
The monomer-dimer equilibrium##2##3##(2008-10#2)
The moral##2##2##(1997-8#1)(2008-1#1)
The more aggressive##2##3##(1993-11#1)(2008-10#1)
The more##14##2##(1993-11#1)(1994-12#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
The morphological##8##2##(1991-3#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-7#1)(2012-9#1)
The morphology of the films##2##5##(2008-10#1)(2009-11#1)
The morphology of the##8##4##(2008-10#2)(2008-11#1)(2008-9#1)(2009-11#1)(2011-2#3)
The morphology of##12##3##(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2009-11#1)(2011-2#3)
The morphology##15##2##(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#2)(2009-11#1)(2011-2#3)
The mortality and morbidity##2##4##(2008-7#1)(2012-3#1)
The mortality rate##2##3##(1992-5#1)(2008-7#1)
The mortality was##2##3##(1997-8#1)(2008-5#1)
The mortality##11##2##(1990-2#1)(1992-5#1)(1994-12#1)(1997-8#1)(2008-5#1)(2008-7#3)(2011-2#2)(2012-3#1)
The most characteristic##2##3##(2008-10#2)
The most common adverse##2##4##(2010-12#1)(2011-2#1)
The most common causes of##2##5##(1990-3#1)(2013-1#1)
The most common side effects##2##5##(1996-8#1)(2013-1#1)
The most common type##2##4##(2011-1#1)(2013-8#1)
The most common types are##2##5##(2012-3#1)(2013-1#1)
The most common types##3##4##(2012-3#1)(2013-1#2)
The most common##40##3##(1990-2#1)(1990-3#1)(1990-9#2)(1991-8#1)(1993-12#1)(1993-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-9#3)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
The most commonly##6##3##(1994-12#1)(1994-6#1)(2008-1#1)(2011-2#2)(2013-1#1)
The most consistent##2##3##(2008-10#2)
The most difficult##3##3##(1992-1#1)(1994-3#1)(1994-9#1)
The most effective##5##3##(2008-10#2)(2008-12#1)(2011-3#1)(2013-1#1)
The most efficient##3##3##(1997-1#1)(2008-10#2)
The most expensive hysterectomy##2##4##(1992-12#1)(1993-2#1)
The most frequent##13##3##(1991-6#1)(1992-9#1)(1996-8#1)(2008-11#2)(2008-7#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)
The most frequently found##2##4##(1996-8#1)(2008-10#1)
The most frequently mentioned##2##4##(1991-8#1)(2011-1#1)
The most frequently observed##3##4##(2008-10#1)(2008-5#1)(2010-1#1)
The most frequently prescribed##2##4##(2008-11#1)(2008-7#1)
The most frequently used##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
The most frequently##17##3##(1991-8#1)(1992-2#1)(1995-1#1)(1996-8#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#3)(2010-1#1)(2011-1#1)(2011-2#1)
The most important and##2##4##(1994-8#1)(2008-5#1)
The most important finding##2##4##(2008-10#1)(2011-1#1)
The most important in##2##4##(1990-11#1)(2008-10#1)
The most important##21##3##(1990-11#1)(1990-9#1)(1991-11#1)(1991-2#1)(1993-1#1)(1994-8#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
The most likely explanation##2##4##(1997-1#1)(2012-3#1)
The most likely##3##3##(1997-1#1)(1997-3#1)(2012-3#1)
The most marked##2##3##(1995-11#1)(1997-2#1)
The most obvious##2##3##(2008-10#1)(2008-11#1)
The most probable##2##3##(1991-10#1)(2008-10#1)
The most prominent##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
The most promising##3##3##(2007-11#1)(2008-1#1)(2011-3#1)
The most recent##6##3##(1994-12#1)(1995-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)
The most relevant##2##3##(2008-10#1)(2010-12#1)
The most remarkable##2##3##(1993-8#1)(2009-7#1)
The most representative##2##3##(2008-10#1)(2013-8#1)
The most sensitive##3##3##(2008-10#3)
The most severe##2##3##(2008-10#2)
The most significant finding##2##4##(1997-6#1)(2008-12#1)
The most significant##5##3##(1990-11#1)(1997-6#1)(2008-10#1)(2008-12#1)(2012-12#1)
The most striking##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
The most successful##2##3##(2008-10#1)(2008-8#1)
The most suitable##2##3##(2008-10#1)(2008-3#1)
The most useful predictor variables were##2##6##(2008-10#2)
The most useful##3##3##(2008-10#2)(2008-11#1)
The most##210##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#4)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#3)(1997-1#2)(1997-2#2)(1997-3#4)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#47)(2008-11#15)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#6)(2008-8#2)(2008-9#7)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#10)(2011-3#4)(2012-12#5)(2012-2#5)(2012-3#7)(2013-1#10)(2013-8#4)
The mother was##2##3##(2008-7#1)(2011-1#1)
The mother##3##2##(1997-3#1)(2008-7#1)(2011-1#1)
The mothers##3##2##(1997-3#1)(2011-2#2)
The motion##3##2##(2007-12#1)(2008-11#2)
The motor##2##2##(1990-5#2)
The mouse##5##2##(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#1)(2011-1#1)
The move##3##2##(2008-11#2)(2011-3#1)
The multidisciplinary##2##2##(2007-11#1)(2009-2#1)
The multilayer##2##2##(2008-10#1)(2010-8#1)
The multiple regression analysis##2##4##(2010-2#1)(2013-1#1)
The multiple regression##3##3##(2008-10#1)(2010-2#1)(2013-1#1)
The multiple##12##2##(2006-6#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-4#1)(2013-1#1)
The multiresolution##2##2##(2008-10#1)(2008-6#1)
The multivariate##4##2##(2008-10#3)(2008-11#1)
The murine##6##2##(1994-11#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2011-2#1)
The muscle##3##2##(2008-8#1)(2010-12#1)(2010-7#1)
The mutant enzyme##2##3##(1990-10#2)
The mutant has##2##3##(2008-8#1)(2008-9#1)
The mutant strain##2##3##(2008-10#2)
The mutant##19##2##(1990-10#2)(1991-5#1)(1993-8#1)(1994-12#1)(1996-2#2)(1997-3#1)(1997-8#1)(2008-10#5)(2008-8#3)(2008-9#2)
The mutants##4##2##(1995-6#1)(1996-3#1)(2008-10#2)
The mutation of##2##3##(2008-10#1)(2011-3#1)
The mutation##8##2##(1991-7#1)(1994-12#1)(1995-8#1)(2008-10#3)(2010-4#1)(2011-3#1)
The mutations##2##2##(1997-6#1)(2011-3#1)
The name of##2##3##(2008-10#1)(2008-11#1)
The name##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
The nanoparticles exhibit##2##3##(2008-10#2)
The nanoparticles##3##2##(2008-10#3)
The narrow##3##2##(1997-3#1)(2007-12#1)(2008-3#1)
The national##3##2##(1993-2#1)(1997-1#1)(2008-10#1)
The native enzyme##2##3##(1994-6#1)(2008-8#1)
The natural##9##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)(2012-12#1)
The nature and composition of the##2##6##(2008-10#2)
The nature and##7##3##(1993-3#1)(1994-11#1)(1994-5#1)(2008-10#3)(2008-11#1)
The nature of the genetic##2##5##(2008-10#2)
The nature of the##12##4##(1991-2#1)(1991-5#2)(1995-3#1)(1996-5#1)(2008-10#6)(2008-2#1)
The nature of##20##3##(1991-12#1)(1991-2#1)(1991-5#2)(1995-3#1)(1995-5#1)(1996-5#1)(2008-10#8)(2008-11#3)(2008-2#1)(2011-2#1)
The nature##28##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#2)(1993-3#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-5#1)(2008-10#11)(2008-11#4)(2008-2#1)(2011-2#1)
The near##3##2##(1996-5#1)(2008-10#2)
The near-infrared absorption##2##3##(2008-3#2)
The nebulizer##2##2##(1992-3#1)(1994-12#1)
The necessity of##3##3##(1991-2#1)(2008-10#2)
The necessity to##3##3##(2008-11#1)(2010-6#1)(2012-12#1)
The necessity##6##2##(1991-2#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-12#1)
The necrosis##2##2##(1994-5#1)(2008-10#1)
The need for a continuous##2##5##(2008-11#1)(2008-3#1)
The need for a##5##4##(2008-10#3)(2008-11#1)(2008-3#1)
The need for the##3##4##(1992-2#1)(2008-10#1)(2012-2#1)
The need for##26##3##(1990-11#1)(1991-12#1)(1992-2#1)(1993-12#1)(1995-2#2)(1997-3#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
The need to##13##3##(1991-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-8#2)(2010-12#1)(2011-1#1)(2012-2#1)
The need##41##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-12#1)(1995-2#2)(1997-3#1)(2008-1#1)(2008-10#10)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)
The negative effect of##2##4##(2008-10#1)(2008-11#1)
The negative##11##2##(1991-3#1)(1993-3#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#2)(2013-1#1)
The nematode##3##2##(1990-8#1)(1996-12#1)(2008-8#1)
The neoplasm##3##2##(1991-12#1)(2008-7#1)(2009-5#1)
The nerve##3##2##(1995-12#1)(2008-11#1)(2008-5#1)
The nested##2##2##(2008-10#1)(2008-12#1)
The nested-PCR##2##2##(2008-10#1)(2008-12#1)
The net effect##2##3##(1997-1#1)(2008-10#1)
The net result##2##3##(2008-10#2)
The net##6##2##(1997-1#1)(2007-12#1)(2008-10#4)
The network architecture##2##3##(2008-10#2)
The network##6##2##(1996-2#1)(2008-10#2)(2008-11#2)(2008-7#1)
The networks were##2##3##(2008-10#2)
The neural##4##2##(1996-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
The neuropsychological##2##2##(2008-10#1)(2008-11#1)
The neurotoxic effect of##2##4##(1995-11#1)(2008-7#1)
The neutral##2##2##(2008-11#2)
The new algorithm##2##3##(2008-6#2)
The new approach##2##3##(2008-10#2)
The new convexity measure##2##4##(2008-6#2)
The new electrode##2##3##(2008-10#2)
The new laser##2##3##(1992-12#1)(2008-10#1)
The new method is superior to##2##6##(2008-10#2)
The new method of##2##4##(2008-10#2)
The new method was##2##4##(2008-10#1)(2011-2#1)
The new method##12##3##(2008-10#10)(2009-12#1)(2011-2#1)
The new packing##2##3##(2008-10#2)
The new procedure##2##3##(2008-10#2)
The new protocol##3##3##(2008-10#3)
The new reagent##2##3##(2008-10#2)
The new##101##2##(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#2)(2007-8#1)(2008-10#53)(2008-11#6)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
The newly developed##4##3##(2008-10#4)
The newly##11##2##(2008-10#6)(2008-11#1)(2008-8#1)(2011-10#1)(2013-8#2)
The next era of HCV antiviral therapy finally begins##2##9##(2011-2#2)
The next step##2##3##(2007-8#1)(2008-10#1)
The next##10##2##(1992-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#3)(2012-12#1)
The nickel##2##2##(2008-10#2)
The nidation index was calculated##2##5##(1992-3#2)
The nine##2##2##(2008-10#2)
The nitrate##2##2##(2008-10#2)
The nitric oxide##2##3##(2008-10#1)(2010-12#1)
The nitric##3##2##(2008-10#1)(2008-8#1)(2010-12#1)
The nitrogen##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
The nodal##2##2##(1990-8#1)(2013-1#1)
The non##2##2##(2007-8#1)(2008-10#1)
The nonlinear absorption##2##3##(2008-3#2)
The nonlinear activation function sigmoid (sigmoid function) has been used in the hidden layer and the output layer##2##18##(2010-8#2)
The nonlinear##5##2##(2007-11#1)(2008-3#2)(2010-8#2)
The normal##4##2##(1995-3#1)(2008-1#1)(2008-10#2)
The notion of##2##3##(1992-1#1)(2011-2#1)
The notion##3##2##(1992-1#1)(1992-9#1)(2011-2#1)
The novel##14##2##(1994-8#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
The nozzle##2##2##(1994-2#1)(2008-3#1)
The nuclear and##2##3##(1996-2#2)
The nuclear pore complex (NPC)##2##5##(2011-2#2)
The nuclear##9##2##(1994-5#1)(1996-2#3)(2008-10#1)(2011-2#4)
The nucleic acid##2##3##(1995-5#1)(1996-12#1)
The nucleic##3##2##(1995-5#1)(1996-12#1)(2008-10#1)
The nucleolar##2##2##(2008-12#1)(2008-7#1)
The nucleotide and deduced amino-acid sequences of a cDNA encoding##2##10##(1994-11#2)
The nucleotide and deduced##3##4##(1994-11#3)
The nucleotide and##4##3##(1991-5#1)(1994-11#3)
The nucleotide sequence of a##7##5##(1996-2#1)(1996-3#2)(1996-8#2)(2008-10#1)(2009-3#1)
The nucleotide sequence of the##11##5##(1991-5#1)(1991-9#1)(1993-12#1)(1993-9#1)(1997-8#1)(2008-10#5)(2008-8#1)
The nucleotide sequence of##22##4##(1991-5#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1996-2#2)(1996-3#2)(1996-8#2)(1997-8#1)(2008-10#7)(2008-8#2)(2009-3#1)
The nucleotide sequence##26##3##(1991-5#1)(1991-9#1)(1993-12#1)(1993-2#2)(1993-9#1)(1996-2#2)(1996-3#2)(1996-8#2)(1997-2#1)(1997-8#1)(2008-10#8)(2008-8#2)(2008-9#1)(2009-3#1)
The nucleotide sequences of the##4##5##(1991-9#1)(2008-10#3)
The nucleotide sequences of##7##4##(1991-6#1)(1991-9#1)(2008-10#4)(2008-11#1)
The nucleotide##41##2##(1991-5#2)(1991-6#2)(1991-9#2)(1993-12#1)(1993-2#2)(1993-9#1)(1994-11#3)(1996-2#2)(1996-3#2)(1996-8#2)(1997-2#1)(1997-8#1)(2008-10#13)(2008-11#2)(2008-8#2)(2008-9#1)(2009-3#1)(2013-8#1)
The nucleus accumbens##2##3##(1994-3#1)(1996-5#1)
The nucleus##3##2##(1994-3#1)(1996-5#1)(2008-7#1)
The number and##3##3##(2008-10#3)
The number of airborne conidia##2##5##(2008-10#2)
The number of cases##2##4##(2011-2#1)(2012-2#1)
The number of channels##2##4##(2007-12#1)(2008-9#1)
The number of conidia##3##4##(2008-10#3)
The number of electrons##2##4##(2008-10#2)
The number of graduates from##2##5##(1991-2#1)(1991-8#1)
The number of older##2##4##(2010-10#1)(2010-11#1)
The number of patients with##3##5##(2011-1#2)(2011-2#1)
The number of women##2##4##(1993-6#1)(2012-2#1)
The number of##104##3##(1990-11#1)(1991-2#2)(1991-3#2)(1991-8#2)(1993-1#1)(1993-12#1)(1993-6#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2007-12#4)(2008-10#33)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#2)
The number##110##2##(1990-11#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#2)(1993-1#1)(1993-12#1)(1993-6#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2007-12#4)(2008-10#37)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#2)
The numbers of##2##3##(2008-10#1)(2010-7#1)
The numerical results##3##3##(2008-2#2)(2013-8#1)
The numerical##7##2##(2008-2#3)(2008-3#2)(2008-9#1)(2013-8#1)
The nurse##4##2##(1993-2#1)(2008-11#3)
The nurses were##2##3##(1992-2#1)(2008-11#1)
The nurses##3##2##(1992-2#1)(2008-11#2)
The nursing staff##2##3##(2008-7#1)(2010-10#1)
The nursing##5##2##(1991-2#1)(2008-12#2)(2008-7#1)(2010-10#1)
The nutrient##2##2##(1994-12#1)(2008-7#1)
The obese##2##2##(1996-12#1)(2013-8#1)
The object of this study was to##2##7##(1992-12#1)(2008-10#1)
The object of this study##3##5##(1992-12#1)(2008-10#1)(2013-8#1)
The object of this##4##4##(1992-12#1)(2008-10#2)(2013-8#1)
The object of##6##3##(1992-12#1)(1997-8#1)(2008-10#2)(2008-7#1)(2013-8#1)
The object##7##2##(1992-12#1)(1997-8#1)(2008-10#2)(2008-7#1)(2009-12#1)(2013-8#1)
The objective is to##4##4##(1995-12#2)(2008-10#1)(2008-5#1)
The objective of our study was to##2##7##(1997-8#1)(2008-10#1)
The objective of our##3##4##(1997-8#1)(2008-10#1)(2010-8#1)
The objective of the present study was to examine the##2##10##(2011-2#2)
The objective of the present study was to##4##8##(2008-10#2)(2011-2#2)
The objective of the present study was##5##7##(2008-10#2)(2011-2#2)(2012-2#1)
The objective of the present work was to##2##8##(2008-5#1)(2013-1#1)
The objective of the present##7##5##(2008-10#2)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
The objective of the##11##4##(1990-2#1)(1993-12#1)(1995-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
The objective of this paper is to##3##7##(1992-3#1)(1993-1#1)(2009-10#1)
The objective of this research was to##4##7##(2008-10#3)(2008-5#1)
The objective of this review was to##3##7##(2010-6#1)(2013-1#2)
The objective of this review##4##5##(2010-6#1)(2013-1#3)
The objective of this study is to##3##7##(2011-2#1)(2012-3#1)(2013-1#1)
The objective of this study was to assess the##3##9##(2008-5#2)(2013-8#1)
The objective of this study was to define the##2##9##(1995-2#1)(2011-2#1)
The objective of this study was to determine the effect of##2##11##(1991-8#1)(2008-10#1)
The objective of this study was to determine the##7##9##(1991-8#1)(2008-1#1)(2008-10#3)(2009-5#1)(2013-8#1)
The objective of this study was to determine whether##3##9##(1994-11#1)(1995-3#1)(2008-4#1)
The objective of this study was to determine##11##8##(1991-8#1)(1994-11#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-5#1)(2013-8#2)
The objective of this study was to develop##2##8##(2008-10#1)(2008-5#1)
The objective of this study was to evaluate the##4##9##(1997-8#2)(2008-1#1)(2013-1#1)
The objective of this study was to evaluate##7##8##(1997-8#2)(2008-1#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
The objective of this study was to examine the##2##9##(1997-3#1)(2008-8#1)
The objective of this study was to identify##2##8##(2008-10#1)(2008-9#1)
The objective of this study was to investigate the##9##9##(1994-12#1)(2008-10#3)(2008-3#1)(2008-7#3)(2011-2#1)
The objective of this study was to investigate##12##8##(1994-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#3)(2011-2#1)(2013-1#1)
The objective of this study was to##54##7##(1991-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#2)(2010-10#1)(2010-11#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
The objective of this study was##55##6##(1991-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#2)(2008-1#2)(2008-10#11)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#2)(2010-10#1)(2010-11#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
The objective of this study##59##5##(1991-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#2)(2008-1#2)(2008-10#11)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#2)(2010-10#1)(2010-11#1)(2011-2#5)(2012-3#2)(2013-1#3)(2013-8#3)
The objective of this work is to##2##7##(2008-7#1)(2011-2#1)
The objective of this work is##3##6##(2008-10#1)(2008-7#1)(2011-2#1)
The objective of this work was to##5##7##(1993-12#1)(1995-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
The objective of this work##9##5##(1993-12#1)(1995-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
The objective of this##83##4##(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#2)(1997-8#2)(2008-1#3)(2008-10#16)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#4)
The objective of##99##3##(1990-2#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1997-3#2)(1997-5#1)(1997-8#3)(2008-1#3)(2008-10#20)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#4)
The objective was to analyze##2##5##(2008-11#1)(2012-3#1)
The objective was to determine##2##5##(2008-10#1)(2008-11#1)
The objective was to study the##2##6##(2008-2#1)(2008-7#1)
The objective was to##9##4##(1994-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-8#1)(2012-3#2)
The objective##113##2##(1990-2#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1997-3#2)(1997-5#1)(1997-8#3)(2008-1#3)(2008-10#22)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#4)
The objectives of our study were to##2##7##(2008-10#1)(2008-11#1)
The objectives of the##2##4##(2008-10#2)
The objectives of this article##2##5##(1997-1#1)(2013-1#1)
The objectives of this research were to determine the##2##9##(2008-1#1)(2008-10#1)
The objectives of this research were to##4##7##(2008-1#1)(2008-10#3)
The objectives of this study were to (i)##3##8##(2008-10#2)(2010-12#1)
The objectives of this study were to evaluate##2##8##(2008-10#1)(2008-12#1)
The objectives of this study were to##12##7##(2008-10#6)(2008-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
The objectives of this study##13##5##(2008-10#7)(2008-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
The objectives of this work were to study the##2##9##(2008-10#2)
The objectives of this##21##4##(1997-1#1)(2008-1#1)(2008-10#12)(2008-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
The objectives of##25##3##(1997-1#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
The objectives were to study the##2##6##(2013-1#2)
The objectives were##3##3##(2008-7#1)(2013-1#2)
The objectives##30##2##(1997-1#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#4)
The observation of##5##3##(1990-6#1)(1991-12#1)(2008-11#1)(2008-12#1)(2010-8#1)
The observation that##4##3##(1993-6#1)(1995-12#1)(2008-10#1)(2012-3#1)
The observation##12##2##(1990-6#1)(1991-12#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2010-8#1)(2012-3#1)
The observations showed##2##3##(2008-7#1)(2008-8#1)
The observations##5##2##(1997-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
The observed increase in##2##4##(1997-1#1)(2013-8#1)
The observed##29##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-4#1)(1995-9#1)(1996-5#2)(1997-1#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
The obtained accuracy##2##3##(2008-10#1)(2010-7#1)
The obtained data##3##3##(1990-5#1)(2008-12#1)(2008-5#1)
The obtained results showed##2##4##(2008-10#1)(2008-5#1)
The obtained results suggest that the##2##6##(2007-12#1)(2008-10#1)
The obtained results were compared##3##5##(2008-10#3)
The obtained results were##6##4##(2008-10#5)(2008-12#1)
The obtained results##22##3##(2007-12#1)(2008-10#15)(2008-12#1)(2008-5#2)(2010-8#2)(2013-1#1)
The obtained values##2##3##(2008-10#2)
The obtained##57##2##(1990-5#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#39)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2009-3#1)(2010-7#1)(2010-8#3)(2012-3#1)(2013-1#1)
The occlusion##2##2##(1997-3#1)(2008-12#1)
The occurrence and##2##3##(2008-10#1)(2008-8#1)
The occurrence of##22##3##(1990-12#1)(1990-8#1)(1991-12#1)(1994-9#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
The occurrence##24##2##(1990-12#1)(1990-8#1)(1991-12#1)(1994-9#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#2)(2011-2#1)(2013-1#1)
The odds ratio for##2##4##(1991-11#1)(2008-12#1)
The odds ratio relating breastfeeding to##2##6##(1991-8#2)
The odds ratio##6##3##(1990-8#1)(1991-11#2)(1991-8#2)(2008-12#1)
The odds##8##2##(1990-8#1)(1991-11#2)(1991-8#2)(1997-7#1)(2008-12#1)(2011-2#1)
The odour##2##2##(2008-10#1)(2008-5#1)
The oil of Adenanthera pavonina L##2##6##(2008-11#2)
The oil##9##2##(2008-11#3)(2008-5#5)(2009-10#1)
The oils were analyzed by GC and##2##7##(2008-12#1)(2012-2#1)
The oils were##4##3##(2008-11#1)(2008-12#2)(2012-2#1)
The oils##6##2##(2008-11#1)(2008-12#3)(2012-2#2)
The older people's##2##3##(2010-10#2)
The older##3##2##(2008-11#1)(2010-10#2)
The olfactory bulb##2##3##(2009-12#1)(2012-2#1)
The olfactory##3##2##(2009-12#2)(2012-2#1)
The oligonucleotide##2##2##(1993-1#1)(1997-7#1)
The on line##2##3##(2008-10#2)
The on-line##9##2##(2008-10#7)(2008-7#2)
The online version of this article (doi##12##7##(2010-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
The only##19##2##(1991-11#1)(1993-2#1)(1994-12#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
The onset of##7##3##(1991-8#1)(1991-9#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-7#1)
The onset##8##2##(1991-8#1)(1991-9#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2013-7#1)
The ontogeny of##2##3##(1992-12#1)(2012-2#1)
The oocytes##2##2##(1990-7#1)(2008-8#1)
The open reading frame##5##4##(1991-5#1)(1993-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
The open##9##2##(1991-5#1)(1993-6#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-3#1)
The opening##2##2##(1997-2#1)(2008-10#1)
The operating parameters##2##3##(2008-10#1)(2008-9#1)
The operating##6##2##(1996-1#1)(2008-10#4)(2008-9#1)
The operation conditions##2##3##(2008-10#2)
The operation is##3##3##(1993-6#1)(2008-10#1)(2011-2#1)
The operation##11##2##(1993-6#1)(1996-3#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
The operational stability of the##2##5##(2008-10#2)
The operational stability##3##3##(2008-10#3)
The operational##5##2##(2008-10#4)(2012-2#1)
The operative##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
The opioid##2##2##(1995-3#1)(2008-6#1)
The opportunity##2##2##(1994-6#1)(2008-8#1)
The opposite##2##2##(1994-3#1)(1994-6#1)
The optical loss##2##3##(2008-2#2)
The optical signal##2##3##(2008-3#2)
The optical##17##2##(1994-8#1)(2008-10#3)(2008-2#4)(2008-3#7)(2008-9#1)(2011-2#1)
The optimal concentrations of the##3##5##(2008-10#2)(2008-11#1)
The optimal conditions for the detection of##2##7##(2008-10#2)
The optimal conditions for the##3##5##(2008-10#3)
The optimal conditions for##4##4##(2008-10#4)
The optimal conditions of##2##4##(2008-10#2)
The optimal conditions were##2##4##(2008-10#2)
The optimal conditions##9##3##(2008-10#8)(2008-12#1)
The optimal immersing time was##2##5##(2008-10#2)
The optimal immersing##3##3##(2008-10#2)(2009-7#1)
The optimal incubation times##2##4##(2008-10#2)
The optimal level of##2##4##(2008-8#1)(2013-1#1)
The optimal pH of##2##4##(1993-3#1)(2008-10#1)
The optimal pH##3##3##(1993-3#1)(2008-10#1)(2009-3#1)
The optimal temperature##2##3##(1997-2#1)(2008-10#1)
The optimal##38##2##(1993-3#1)(1997-2#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-10#1)(2013-1#4)(2013-8#1)
The optimisation of the##2##4##(2008-10#2)
The optimisation of##4##3##(2008-10#4)
The optimisation process was carried out##2##6##(2008-10#2)
The optimisation##6##2##(2008-10#6)
The optimised conditions##2##3##(2008-10#2)
The optimised##6##2##(2008-10#6)
The optimization of the system was##2##6##(2008-10#2)
The optimization of the##9##4##(2008-10#7)(2011-3#1)(2013-1#1)
The optimization of##14##3##(2008-10#12)(2011-3#1)(2013-1#1)
The optimization process was##2##4##(2008-10#2)
The optimization step was carried out using##2##7##(2008-10#2)
The optimization step was##3##4##(2008-10#3)
The optimization##24##2##(2008-10#21)(2008-3#1)(2011-3#1)(2013-1#1)
The optimized PAD waveform##2##4##(2008-10#2)
The optimized conditions were##4##4##(2008-10#4)
The optimized conditions##6##3##(2008-10#6)
The optimized method was##2##4##(2008-10#2)
The optimized method##3##3##(2008-10#3)
The optimized procedure##2##3##(2008-10#2)
The optimized pulsed conditions of##2##5##(2008-10#2)
The optimized system##2##3##(2008-10#2)
The optimized##28##2##(2008-10#25)(2008-4#1)(2011-2#1)(2013-8#1)
The optimum analytical conditions##3##4##(2008-10#3)
The optimum condition##2##3##(2008-10#2)
The optimum conditions are##2##4##(2008-10#2)
The optimum conditions for the##8##5##(2008-10#8)
The optimum conditions for##12##4##(2008-10#11)(2008-12#1)
The optimum conditions obtained##2##4##(2008-10#2)
The optimum conditions were##3##4##(2008-10#3)
The optimum conditions##21##3##(2008-10#20)(2008-12#1)
The optimum experimental conditions were##3##5##(2008-10#3)
The optimum experimental conditions##5##4##(2008-10#5)
The optimum extraction conditions are evaluated and described##2##8##(2008-10#2)
The optimum extraction conditions##3##4##(2008-10#3)
The optimum flow rate##2##4##(2008-10#2)
The optimum pH for the##2##5##(2008-10#2)
The optimum pH range for the##2##6##(2008-10#2)
The optimum pH range##3##4##(2008-10#3)
The optimum pH ranges for quantitative sorption are##2##8##(2008-10#2)
The optimum pH values for##2##5##(2008-10#2)
The optimum pH##14##3##(1997-2#1)(2008-10#13)
The optimum parameters##2##3##(2008-10#2)
The optimum reaction conditions and the analytical characteristics##2##8##(2008-10#2)
The optimum reaction conditions and##3##5##(2008-10#3)
The optimum reaction conditions were##5##5##(2008-10#5)
The optimum reaction conditions##8##4##(2008-10#8)
The optimum separation##2##3##(2008-10#2)
The optimum values of##2##4##(2008-10#2)
The optimum##91##2##(1997-2#1)(1997-3#1)(2008-10#83)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-10#1)
The oral##5##2##(2006-6#1)(2008-1#1)(2008-5#1)(2010-1#1)(2013-1#1)
The order of the##2##4##(1996-5#1)(2008-10#1)
The order of##11##3##(1996-5#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)
The organic and inorganic##2##4##(2008-10#1)(2009-7#1)
The organic phase##4##3##(2008-10#3)(2013-1#1)
The organic##12##2##(1996-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#1)
The organisms##2##2##(1994-3#1)(2008-5#1)
The organization and##2##3##(1991-12#1)(1996-12#1)
The organization of##2##3##(1994-3#1)(2008-8#1)
The organization##4##2##(1991-12#1)(1994-3#1)(1996-12#1)(2008-8#1)
The origin and##2##3##(1997-1#1)(2010-1#1)
The origin of the##7##4##(1994-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-6#1)
The origin of##8##3##(1994-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-6#1)
The origin##11##2##(1994-5#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-6#1)(2010-1#1)(2013-8#1)
The original data was##2##4##(2008-10#1)(2010-8#1)
The original##8##2##(1990-2#1)(1996-1#1)(2008-1#1)(2008-10#3)(2010-8#1)(2012-2#1)
The osteogenic potential##2##3##(2008-11#2)
The other experimental parameters##2##4##(2008-10#2)
The other is##3##3##(1993-3#1)(2007-11#1)(2008-11#1)
The other locus##2##3##(2008-10#2)
The other stream was passed through##2##6##(2008-10#2)
The other##49##2##(1990-6#1)(1991-3#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
The others##2##2##(1997-8#1)(2008-10#1)
The outcome measure##2##3##(2011-2#1)(2013-1#1)
The outcome of the##2##4##(2008-11#1)(2008-7#1)
The outcome of##4##3##(1991-3#1)(2008-11#1)(2008-7#1)(2012-2#1)
The outcome##12##2##(1991-11#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
The outcomes of the##2##4##(2008-11#1)(2013-1#1)
The outcomes of##5##3##(2008-11#2)(2008-8#1)(2010-1#1)(2013-1#1)
The outcomes were##2##3##(2008-3#1)(2008-7#1)
The outcomes##12##2##(1995-11#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2013-1#1)
The outer##2##2##(2008-10#1)(2011-2#1)
The output of##2##3##(2008-10#1)(2008-2#1)
The output##8##2##(1995-3#1)(2008-10#1)(2008-2#4)(2008-3#2)
The outputs of these##2##4##(2008-10#2)
The ovarian##2##2##(1990-10#1)(2008-12#1)
The overall aim##2##3##(2008-11#1)(2012-2#1)
The overall approach##2##3##(2008-10#1)(2008-9#1)
The overall complication##2##3##(2012-3#2)
The overall extraction equilibrium constants (K(ex))##2##6##(2008-10#2)
The overall frequency##2##3##(2008-10#1)(2012-2#1)
The overall incidence##2##3##(1994-12#1)(2012-3#1)
The overall method##2##3##(2008-10#2)
The overall objective of##2##4##(2008-11#1)(2012-2#1)
The overall prevalence of hypertension##2##5##(2008-11#1)(2008-7#1)
The overall prevalence of##5##4##(1990-2#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
The overall rate of##3##4##(1991-2#1)(1993-11#1)(1994-2#1)
The overall reduction process##2##4##(2008-10#2)
The overall reduction##3##3##(2008-10#3)
The overall response rate was##2##5##(1993-1#1)(2012-2#1)
The overall results of our study thus##2##7##(2008-10#2)
The overall results of our##3##5##(2008-10#3)
The overall results##5##3##(1994-8#1)(2008-10#4)
The overall sensitivity of##2##4##(1996-12#1)(1997-8#1)
The overall survival##2##3##(1990-12#1)(2008-10#1)
The overall##84##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-10#29)(2008-11#4)(2008-12#3)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)
The overestimation of##2##3##(1994-3#1)(2008-10#1)
The overexpressed##2##2##(1995-2#1)(2008-10#1)
The overexpression of##3##3##(1994-11#1)(2008-7#1)(2009-8#1)
The overlapping##3##2##(2008-10#3)
The oxidant##2##2##(2008-10#2)
The oxidation mechanism##2##3##(2008-10#2)
The oxidation of##8##3##(1992-3#1)(1994-5#1)(2008-10#6)
The oxidation peak current##2##4##(2008-10#2)
The oxidation peak##5##3##(2008-10#5)
The oxidation reaction##2##3##(2008-10#2)
The oxidation##20##2##(1992-3#1)(1994-5#1)(2008-10#18)
The oxidative##6##2##(2008-10#4)(2008-5#1)(2009-5#1)
The ozone##2##2##(2007-8#1)(2008-3#1)
The p101##2##2##(1996-2#2)
The p53##3##2##(1991-2#1)(2008-5#1)(2011-2#1)
The pH of the mixed solution was##2##7##(2008-10#2)
The pH of the##6##4##(2008-10#4)(2012-2#1)(2013-1#1)
The pH range##2##3##(1997-2#1)(2008-10#1)
The pH values##4##3##(2008-10#3)(2013-1#1)
The pH##25##2##(1990-5#1)(1991-9#1)(1993-8#1)(1997-2#1)(2008-10#17)(2009-12#1)(2012-2#1)(2013-1#2)
The pK##2##2##(1991-9#1)(1994-5#1)
The pK(00)##2##2##(2008-10#2)
The pK(a) values of##2##4##(2008-10#2)
The pK(a)##3##2##(2008-10#3)
The pKZ1##2##2##(2008-7#2)
The pace##2##2##(1991-12#1)(2008-12#1)
The pain##5##2##(2008-10#1)(2009-3#1)(2010-4#1)(2012-3#1)(2013-1#1)
The paired##3##2##(1996-3#1)(2007-12#1)(2010-9#1)
The pairing of##2##3##(1994-5#1)(2009-6#1)
The pancreas##2##2##(2012-2#2)
The panel##3##2##(1996-12#1)(2008-10#1)(2010-12#1)
The panelists also##2##3##(2008-5#1)(2008-6#1)
The paper also discusses the##2##5##(1990-6#1)(2009-10#1)
The paper also discusses##3##4##(1990-6#1)(2009-10#1)(2013-8#1)
The paper also##7##3##(1990-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-1#1)(2013-8#1)
The paper concludes by##5##4##(1992-12#1)(2008-11#3)(2008-12#1)
The paper concludes with##2##4##(2008-12#1)(2008-5#1)
The paper concludes##8##3##(1992-12#1)(1992-5#1)(2008-11#3)(2008-12#2)(2008-5#1)
The paper describes a case of##2##6##(1990-9#1)(2012-3#1)
The paper describes a##7##4##(1990-9#2)(1995-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-3#1)
The paper describes an##3##4##(2008-10#3)
The paper describes the##3##4##(2008-1#1)(2008-10#1)(2008-11#1)
The paper describes##13##3##(1990-9#2)(1995-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2009-8#1)(2012-3#1)
The paper discusses the##2##4##(2008-10#1)(2008-11#1)
The paper discusses##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)
The paper examines##2##3##(2008-1#1)(2010-8#1)
The paper focuses on the##2##5##(1991-2#1)(2008-12#1)
The paper highlights##2##3##(2008-11#1)(2012-2#1)
The paper illustrates the##2##4##(1990-9#1)(1991-3#1)
The paper indicates##2##3##(1991-9#1)(2011-2#1)
The paper is based##2##4##(2010-10#1)(2012-3#1)
The paper is##4##3##(1997-2#1)(2010-10#1)(2012-2#1)(2012-3#1)
The paper outlines##3##3##(2008-11#3)
The paper presents##4##3##(2008-10#2)(2008-12#1)(2009-8#1)
The paper proposes##2##3##(2007-12#1)(2010-8#1)
The paper provides##2##3##(2008-10#1)(2009-6#1)
The paper reports the results of a##2##7##(1991-6#1)(1993-3#1)
The paper reports the##3##4##(1991-3#1)(1991-6#1)(1993-3#1)
The paper reports##7##3##(1990-5#1)(1991-3#1)(1991-6#1)(1993-3#2)(2008-12#1)(2009-4#1)
The paper summarises##2##3##(2008-10#2)
The paper##79##2##(1990-5#1)(1990-6#1)(1990-9#3)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-3#2)(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#15)(2008-11#14)(2008-12#9)(2008-5#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
The paradigm##2##2##(2008-9#1)(2009-10#1)
The parameter estimates##3##3##(2008-10#3)
The parameter##4##2##(2008-10#4)
The parameters affecting the##3##4##(2008-10#3)
The parameters affecting##5##3##(2008-10#5)
The parameters for the##2##4##(2008-10#1)(2008-3#1)
The parameters investigated were##2##4##(1991-1#1)(2008-3#1)
The parameters investigated##3##3##(1991-1#1)(2008-10#1)(2008-3#1)
The parameters of the##3##4##(2007-11#1)(2008-10#1)(2008-6#1)
The parameters of##4##3##(2007-11#1)(2008-10#2)(2008-6#1)
The parameters related to the electrochemical hydride generation were investigated##2##10##(2008-10#2)
The parameters which##2##3##(2008-10#2)
The parameters##27##2##(1990-5#1)(1991-1#1)(1992-9#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
The parasites##2##2##(1996-12#1)(1997-7#1)
The parental##2##2##(1991-12#1)(2008-8#1)
The parents were##3##3##(1991-11#1)(1995-12#1)(1997-8#1)
The parents##7##2##(1991-11#2)(1995-1#1)(1995-12#1)(1997-8#1)(2008-10#2)
The partial##4##2##(1990-12#1)(2008-10#3)
The partially purified##2##3##(1990-5#1)(2008-10#1)
The participants in##2##3##(1996-3#1)(2011-2#1)
The participants of the study were##2##6##(2010-1#1)(2012-3#1)
The participants were##2##3##(2010-7#1)(2013-8#1)
The participants##11##2##(1992-1#1)(1996-3#1)(2008-10#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
The participation of##5##3##(1991-6#1)(1996-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
The particle##4##2##(1995-2#1)(1997-2#1)(1997-6#1)(2008-5#1)
The particles##2##2##(2008-10#1)(2008-11#1)
The partition##5##2##(1993-8#1)(2008-10#3)(2008-7#1)
The passage of the##2##4##(1997-1#1)(2008-10#1)
The passage of##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
The passive sampler##2##3##(2008-10#2)
The past##4##2##(1993-1#1)(1996-3#1)(2013-1#1)(2013-8#1)
The patch of##2##3##(2008-5#1)(2010-12#1)
The pathogen also##3##3##(2008-10#3)
The pathogen##11##2##(2008-10#10)(2011-2#1)
The pathogenesis of##9##3##(1991-2#1)(1997-6#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The pathogenesis##11##2##(1991-2#1)(1991-9#1)(1997-6#1)(2008-5#2)(2008-9#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The pathogenic##3##2##(1997-3#1)(1997-8#1)(2008-5#1)
The pathogenicity of##5##3##(2008-10#4)(2012-3#1)
The pathogens##3##2##(2008-10#3)
The pathologic##2##2##(1992-12#1)(2013-8#1)
The pathological findings##2##3##(1995-11#1)(2008-12#1)
The pathological##5##2##(1991-3#1)(1994-8#1)(1995-11#1)(2008-12#2)
The pathophysiological mechanisms##2##3##(2008-5#1)(2008-7#1)
The pathophysiological role of##2##4##(2008-12#1)(2009-10#1)
The pathophysiological##4##2##(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)
The pathophysiology of##2##3##(2008-10#1)(2010-7#1)
The pathophysiology##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
The pathway##2##2##(2008-3#1)(2009-6#1)
The pathways##2##2##(2008-3#2)
The patient developed##2##3##(2010-7#1)(2013-1#1)
The patient died##6##3##(2009-1#1)(2010-12#1)(2010-5#1)(2012-12#2)(2013-1#1)
The patient had a history of##2##6##(1996-6#1)(2010-6#1)
The patient had an uneventful recovery##4##6##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
The patient had an uneventful##5##5##(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
The patient had an##6##4##(2008-12#1)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
The patient had been##3##4##(2008-5#1)(2010-10#1)(2013-1#1)
The patient had no##6##4##(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#2)
The patient had##30##3##(1990-6#1)(1993-6#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
The patient has##4##3##(2008-12#1)(2008-7#1)(2011-2#2)
The patient is currently##2##4##(2010-3#1)(2011-2#1)
The patient is##6##3##(1990-2#1)(1990-6#1)(1996-3#1)(2010-3#1)(2011-2#1)(2012-3#1)
The patient left the##2##4##(2008-12#1)(2013-1#1)
The patient left##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
The patient made a good##2##5##(1997-6#1)(2010-5#1)
The patient made an##2##4##(1997-3#1)(2012-3#1)
The patient made##5##3##(1997-3#1)(1997-6#1)(2010-5#1)(2012-3#2)
The patient presented with a history of##2##7##(2008-11#1)(2008-7#1)
The patient presented with##6##4##(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
The patient presented##7##3##(1994-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
The patient recovered from##4##4##(1990-12#1)(2011-2#2)(2012-12#1)
The patient recovered##9##3##(1990-12#1)(1991-3#1)(1991-8#1)(1997-3#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
The patient remained##3##3##(1993-1#1)(1997-5#1)(2011-2#1)
The patient required##2##3##(2010-5#1)(2013-1#1)
The patient underwent a total##2##5##(2009-3#1)(2013-1#1)
The patient underwent a##8##4##(2008-11#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
The patient underwent partial##2##4##(2011-2#1)(2012-3#1)
The patient underwent##13##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#2)
The patient was a 40-year-old woman##2##6##(2008-12#1)(2008-7#1)
The patient was a##8##4##(1994-11#1)(1994-12#1)(2008-12#1)(2008-7#3)(2009-8#1)(2011-2#1)
The patient was admitted##2##4##(2011-2#1)(2013-1#1)
The patient was diagnosed with##3##5##(2008-12#1)(2012-12#1)(2013-1#1)
The patient was discharged on the##2##6##(2012-12#1)(2013-1#1)
The patient was discharged on##3##5##(2012-12#1)(2013-1#2)
The patient was discharged##4##4##(2010-7#1)(2012-12#1)(2013-1#2)
The patient was followed up##2##5##(2011-1#1)(2013-1#1)
The patient was free of##2##5##(2011-2#2)
The patient was referred##2##4##(1995-5#1)(2011-2#1)
The patient was successfully treated##2##5##(2008-7#1)(2013-1#1)
The patient was treated with##6##5##(1996-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
The patient was treated##10##4##(1996-11#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-2#2)(2013-1#2)(2013-8#1)
The patient was urgently##2##4##(2010-1#1)(2011-3#1)
The patient was##56##3##(1990-8#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-5#1)(2008-7#7)(2009-11#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#2)(2013-1#11)(2013-8#1)
The patient##180##2##(1990-12#1)(1990-2#2)(1990-6#2)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#10)(2008-5#3)(2008-7#19)(2008-9#2)(2009-1#2)(2009-11#2)(2009-3#2)(2009-6#3)(2009-8#1)(2010-1#3)(2010-10#4)(2010-12#1)(2010-3#2)(2010-5#4)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#30)(2011-3#1)(2012-12#7)(2012-3#8)(2013-1#28)(2013-7#1)(2013-8#2)
The patient's##13##2##(1991-6#1)(1994-11#1)(1996-3#2)(2007-12#2)(2008-10#1)(2008-11#1)(2011-2#3)(2013-1#2)
The patients do not##2##4##(1994-12#1)(2008-12#1)
The patients had##2##3##(2012-2#1)(2013-1#1)
The patients received a##2##4##(2008-10#2)
The patients received##5##3##(1990-6#1)(1991-11#1)(2008-10#2)(2008-5#1)
The patients underwent##2##3##(1991-3#1)(2013-1#1)
The patients were divided into four groups##2##7##(2008-7#1)(2011-2#1)
The patients were stratified##2##4##(1995-11#1)(2011-2#1)
The patients were treated##3##4##(1992-12#1)(1997-3#1)(2012-3#1)
The patients were##19##3##(1991-2#1)(1992-12#1)(1995-11#1)(1995-2#1)(1997-3#1)(1997-8#2)(2008-1#1)(2008-11#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
The patients who##3##3##(1997-2#1)(2008-7#1)(2012-3#1)
The patients with##5##3##(1990-3#1)(1994-12#1)(1994-3#1)(2011-1#1)(2013-1#1)
The patients##51##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1992-12#1)(1994-12#3)(1994-3#1)(1995-11#1)(1995-2#2)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#5)
The patients'##3##2##(1990-3#1)(1990-6#1)(2008-11#1)
The pattern of##13##3##(1991-12#1)(1993-12#1)(1993-8#2)(1996-2#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
The pattern##15##2##(1991-12#1)(1993-12#1)(1993-6#1)(1993-8#2)(1996-2#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
The patterns of##3##3##(2008-10#1)(2011-3#1)(2013-1#1)
The patterns##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-3#1)(2013-1#1)
The peak at##2##3##(1990-5#1)(2008-10#1)
The peak current is##3##4##(2008-10#3)
The peak current##7##3##(2008-10#7)
The peak currents##2##3##(2008-10#2)
The peak potential is##2##4##(2008-10#2)
The peak potential##3##3##(2008-10#3)
The peak##19##2##(1990-5#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-5#1)
The peaks##2##2##(2008-10#2)
The pediatric##2##2##(1991-11#1)(2008-10#1)
The penetration##2##2##(2008-5#2)
The peptide##7##2##(1991-5#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-8#1)
The peptides##3##2##(1992-9#1)(2008-10#1)(2008-9#1)
The percent##6##2##(1995-12#1)(2008-10#3)(2010-8#1)(2012-2#1)
The percentage of nematodes##2##4##(2008-10#2)
The percentage of##26##3##(1990-9#1)(1992-11#1)(1993-6#1)(1994-1#1)(1995-8#1)(1997-3#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#2)
The percentage recoveries of##2##4##(2008-10#2)
The percentage recoveries##4##3##(2008-10#4)
The percentage##38##2##(1990-9#1)(1991-12#1)(1992-11#1)(1993-6#1)(1994-1#1)(1995-2#1)(1995-8#1)(1997-3#2)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
The percentages of##6##3##(1993-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2010-4#1)
The percentages##7##2##(1993-6#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-4#1)
The perception of##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
The perception##8##2##(1991-12#1)(1991-2#1)(1991-3#1)(1997-1#1)(2008-12#1)(2011-2#1)(2013-1#2)
The perceptions of##2##3##(2008-11#1)(2010-8#1)
The performance characteristics of an##2##5##(2008-10#2)
The performance characteristics of##3##4##(2008-10#3)
The performance of a##9##4##(1993-3#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)
The performance of commercially available##2##5##(2008-10#1)(2008-3#1)
The performance of the method has been##2##7##(2008-10#2)
The performance of the method##4##5##(2008-10#4)
The performance of the proposed method was##2##7##(2008-10#2)
The performance of the proposed method##3##6##(2008-10#3)
The performance of the proposed##4##5##(2008-10#4)
The performance of the system was demonstrated in the##2##9##(2008-10#2)
The performance of the system was##4##6##(2008-10#4)
The performance of the##35##4##(1995-11#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#4)(2010-10#1)
The performance of these##6##4##(1997-2#1)(2008-10#4)(2010-7#1)
The performance of this##3##4##(2008-10#3)
The performance of##71##3##(1992-2#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#44)(2008-11#3)(2008-2#3)(2008-3#7)(2008-7#1)(2010-10#1)(2010-7#1)
The performance##77##2##(1992-2#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#49)(2008-11#3)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#1)(2010-10#1)(2010-7#1)
The performances of##2##3##(2008-10#1)(2008-3#1)
The performances##3##2##(2008-10#2)(2008-3#1)
The perfusion##2##2##(2008-11#1)(2012-3#1)
The period of##2##3##(1990-5#1)(2008-10#1)
The period##5##2##(1990-5#1)(1991-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
The periodic##2##2##(2008-3#1)(2008-8#1)
The peripheral##3##2##(1991-6#1)(2007-12#1)(2008-7#1)
The permeability of##2##3##(1991-5#1)(2008-11#1)
The permeability##3##2##(1991-5#1)(1994-5#1)(2008-11#1)
The peroxide##2##2##(1990-5#1)(2008-10#1)
The persistence of##3##3##(1994-3#1)(2012-3#1)(2013-1#1)
The persistence##4##2##(1993-8#1)(1994-3#1)(2012-3#1)(2013-1#1)
The personal##4##2##(1990-12#1)(1990-9#1)(2008-11#2)
The pesticides##3##2##(2008-10#3)
The pharmaceutical##7##2##(1996-1#1)(1996-2#1)(2008-10#2)(2011-2#2)(2011-3#1)
The pharmacokinetic parameters of the##2##5##(2008-10#1)(2008-11#1)
The pharmacokinetic parameters##3##3##(2008-10#2)(2008-11#1)
The pharmacological##3##2##(2008-4#1)(2009-9#1)(2012-2#1)
The pharmacology of the##2##4##(1995-11#1)(2008-7#1)
The phase diagrams of##2##4##(1993-8#1)(2008-5#1)
The phase##11##2##(1993-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-11#1)(2010-5#1)(2012-2#1)(2013-8#1)
The phase-boundary##2##2##(2008-10#2)
The phenolic##3##2##(2008-10#2)(2008-5#1)
The phenomenological##2##2##(2009-5#1)(2012-3#1)
The phenomenon of##5##3##(1993-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
The phenomenon##6##2##(1993-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
The phenotype of##3##3##(1997-3#1)(2008-6#1)(2012-3#1)
The phenotype##6##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)(2012-3#1)
The phenotypes##3##2##(2008-9#1)(2009-8#1)(2011-2#1)
The phenotypic##4##2##(2008-10#3)(2012-3#1)
The phenytoin##2##2##(2008-11#2)
The phosphate##4##2##(1992-6#1)(1994-11#1)(2008-10#2)
The phospholipase D activity##3##4##(1993-3#3)
The phosphorescence##3##2##(2008-10#3)
The phosphorus##2##2##(2008-10#2)
The phosphorylation##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
The photocatalytic##2##2##(2008-10#2)
The photochemical##2##2##(2008-11#1)(2009-8#1)
The photon flux density of PAR##2##6##(2008-10#2)
The photon##3##2##(2008-10#2)(2008-3#1)
The phylogenetic tree##2##3##(2008-10#1)(2010-7#1)
The phylogenetic##7##2##(2008-10#4)(2008-8#1)(2010-7#1)(2011-2#1)
The physical principles of##2##4##(1994-5#1)(2008-4#1)
The physical##9##2##(1994-5#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-4#3)(2008-5#1)
The physician##4##2##(1992-1#1)(1993-11#1)(1995-3#1)(1997-4#1)
The physicians were##2##3##(1997-4#1)(2009-2#1)
The physicians##4##2##(1990-2#1)(1993-6#1)(1997-4#1)(2009-2#1)
The physicochemical properties of##2##4##(2008-11#1)(2010-4#1)
The physicochemical##7##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
The physiological##7##2##(1990-11#1)(1991-9#1)(2007-8#1)(2008-11#1)(2009-5#1)(2010-8#1)(2012-6#1)
The physiology of##2##3##(1992-6#1)(2008-9#1)
The physiology##3##2##(1992-6#1)(2008-7#1)(2008-9#1)
The phytopathogenic##2##2##(2008-10#1)(2008-11#1)
The phytotoxic##2##2##(2008-10#2)
The piezoelectric##2##2##(2008-10#2)
The pineal hormone melatonin##2##4##(1990-5#1)(2013-7#1)
The pineal##3##2##(1990-5#1)(2008-12#1)(2013-7#1)
The place of##3##3##(1995-3#1)(2008-10#1)(2008-12#1)
The place##4##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
The placement##2##2##(2008-11#1)(2008-12#1)
The plan##3##2##(1992-12#1)(1995-12#2)
The plant material##2##3##(2008-10#1)(2008-11#1)
The plant##6##2##(2008-10#4)(2008-11#1)(2012-5#1)
The plasma CCK##2##3##(2008-7#2)
The plasma was deproteinized with acetonitrile##2##6##(2008-10#2)
The plasma##10##2##(1990-12#1)(1993-2#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-4#1)(2011-2#1)
The plasmid was##2##3##(1994-8#1)(2008-7#1)
The plasmid##3##2##(1994-8#1)(2008-7#2)
The plastic##2##2##(2008-8#1)(2009-7#1)
The plasticizer##2##2##(2008-10#2)
The platelet lysate was##2##4##(2008-11#2)
The platelet lysate##3##3##(2008-11#3)
The platelet##6##2##(2008-11#3)(2008-9#1)(2011-2#2)
The play##2##2##(2008-11#2)
The plug##2##2##(2013-1#2)
The point##3##2##(1996-2#1)(1997-6#1)(2008-11#1)
The polar##2##2##(2008-10#1)(2013-8#1)
The polarization##7##2##(1997-6#1)(2008-2#2)(2008-3#4)
The polarographic##2##2##(2008-10#2)
The policy##2##2##(1994-2#1)(1997-7#1)
The politics and economics of health care finance##2##8##(1991-2#1)(1994-3#1)
The politics and economics of##3##5##(1991-2#1)(1994-3#2)
The politics of##2##3##(1994-9#1)(1996-12#1)
The politics##5##2##(1991-2#1)(1994-3#2)(1994-9#1)(1996-12#1)
The polyamine portions of##2##4##(1990-5#2)
The polyclonal antibody showed specific recognition of##2##7##(2008-10#2)
The polyclonal antibody##3##3##(2007-12#1)(2008-10#2)
The polycystic ovary syndrome (PCOS)##2##5##(2008-4#2)
The polymer##6##2##(2008-10#5)(2008-11#1)
The polymerase chain reaction (PCR)##3##5##(1993-12#1)(2008-4#1)(2011-2#1)
The polymerase chain reaction was used to amplify##2##8##(1991-7#1)(1992-6#1)
The polymerase chain reaction##8##4##(1991-7#1)(1992-6#1)(1993-12#1)(1993-2#1)(1997-7#1)(2008-4#2)(2011-2#1)
The polymeric##3##2##(2008-10#3)
The polymers were##3##3##(2008-10#2)(2008-11#1)
The polymers##6##2##(2008-10#5)(2008-11#1)
The polymorphic markers were##2##4##(2008-10#2)
The polymorphism of##2##3##(2008-10#1)(2013-8#1)
The polypeptide##2##2##(1995-2#1)(2008-9#1)
The poor##6##2##(1990-6#1)(1995-9#1)(2008-10#2)(2008-11#2)
The popliteal##2##2##(1991-3#1)(2008-10#1)
The population density of##3##4##(2008-10#3)
The population dynamics of##2##4##(2008-10#2)
The population genetic structure of the##2##6##(2008-10#1)(2013-8#1)
The population genetic structure of##4##5##(2008-10#3)(2013-8#1)
The population genetic structure##5##4##(2008-10#4)(2013-8#1)
The population of##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
The population size of##2##4##(2008-10#1)(2010-8#1)
The population size##3##3##(2008-10#1)(2010-7#1)(2010-8#1)
The population structure of##5##4##(2008-10#5)
The population structure##6##3##(2008-10#6)
The population##32##2##(2008-10#24)(2008-12#1)(2008-6#1)(2010-7#1)(2010-8#2)(2013-1#1)(2013-8#2)
The populations##2##2##(2008-10#1)(2008-12#1)
The porcine##2##2##(1991-6#1)(2008-11#1)
The portable##4##2##(1995-5#1)(2008-10#3)
The position of the##3##4##(1995-2#1)(1996-6#1)(2008-10#1)
The position of##4##3##(1995-2#1)(1996-6#1)(2008-10#1)(2008-5#1)
The positions of exons which do not exhibit##2##8##(1997-6#1)(1997-8#1)
The positions of the##2##4##(1990-5#2)
The positions of##5##3##(1990-5#2)(1997-6#1)(1997-8#1)(2008-8#1)
The positive and negative##2##4##(2008-11#1)(2008-8#1)
The positive rate##2##3##(1994-12#1)(2013-8#1)
The positive##8##2##(1994-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-3#1)(2013-8#1)
The positivity##2##2##(1990-6#1)(1991-8#1)
The possibilities of the##2##4##(2008-10#2)
The possibilities of##4##3##(2008-10#3)(2012-12#1)
The possibilities##5##2##(1992-9#1)(2008-10#3)(2012-12#1)
The possibility of a##2##4##(2008-10#1)(2008-11#1)
The possibility of applying##2##4##(2008-10#2)
The possibility of using##3##4##(1991-1#1)(2008-10#1)(2008-8#1)
The possibility of##32##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1997-5#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-3#3)(2008-7#2)(2008-8#1)(2012-3#1)(2013-1#1)
The possibility that the##2##4##(1991-5#1)(2010-4#1)
The possibility that##8##3##(1990-9#1)(1991-5#1)(1995-12#1)(2008-10#2)(2010-4#1)(2010-8#1)(2012-3#1)
The possibility to use##2##4##(2008-10#2)
The possibility to##5##3##(2008-10#4)(2012-2#1)
The possibility##48##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-10#23)(2008-11#1)(2008-3#3)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
The possible implications of these##2##5##(1991-5#1)(1991-6#1)
The possible interferences of the most common ions have been investigated##2##11##(2008-10#2)
The possible mechanism for the##2##5##(2008-10#2)
The possible mechanism for##3##4##(1994-8#1)(2008-10#2)
The possible mechanism of##5##4##(2008-10#4)(2008-8#1)
The possible mechanism##11##3##(1994-8#1)(2008-10#8)(2008-8#2)
The possible mechanisms##2##3##(2008-10#2)
The possible reaction mechanism was##2##5##(2008-10#2)
The possible role of##4##4##(2008-10#3)(2010-12#1)
The possible roles of##2##4##(2008-10#1)(2010-8#1)
The possible underlying pathophysiological##2##4##(2009-11#1)(2011-2#1)
The possible##52##2##(1991-2#1)(1991-5#1)(1991-6#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#31)(2008-11#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
The post-translational processing and intracellular sorting of##2##7##(1995-8#2)
The posterior##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
The postoperative course was uneventful##3##5##(2008-10#1)(2010-12#1)(2011-2#1)
The postoperative course was##6##4##(1992-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
The postoperative period##2##3##(1991-11#1)(2011-3#1)
The postoperative##10##2##(1990-9#1)(1991-11#1)(1992-9#2)(2008-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#2)
The potassium##2##2##(2008-10#1)(2008-12#1)
The potency of##3##3##(1994-8#1)(2008-10#2)
The potential application of##3##4##(2008-10#2)(2013-7#1)
The potential effect of##2##4##(2008-11#1)(2008-7#1)
The potential effects of##2##4##(1991-5#1)(2008-10#1)
The potential for##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
The potential impact of##2##4##(1995-12#1)(2008-7#1)
The potential of the##3##4##(2008-10#3)
The potential of these##4##4##(1990-5#1)(2008-10#1)(2008-8#1)(2009-10#1)
The potential of this electrode##2##5##(2008-10#2)
The potential of##21##3##(1990-5#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#1)
The potential role of##4##4##(1992-1#1)(2008-5#1)(2009-1#1)(2011-2#1)
The potential utility of##3##4##(2008-10#1)(2009-4#1)(2011-2#1)
The potential##73##2##(1990-5#1)(1991-5#2)(1992-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(2008-10#35)(2008-11#7)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2013-7#1)
The potentiality of##2##3##(2008-10#2)
The potentials of##2##3##(2008-10#2)
The potentials##3##2##(1996-6#1)(2008-10#2)
The potentiating effect of##2##4##(1990-5#1)(1997-4#1)
The potentiation##2##2##(1993-6#1)(1996-2#1)
The potentiometric response characteristics of##3##5##(2008-10#3)
The potentiometric response is independent of##2##6##(2008-10#2)
The potentiometric response##6##3##(2008-10#6)
The potentiometric selectivity coefficient values as determined by match potential method (MPM) indicate##2##13##(2008-10#2)
The potentiometric selectivity##3##3##(2008-10#3)
The potentiometric##14##2##(2008-10#14)
The powdery mildew resistance##2##4##(2008-10#2)
The power and##2##3##(2008-11#1)(2010-4#1)
The power law model##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
The power of the##2##4##(1992-9#1)(1993-12#1)
The power of##4##3##(1992-9#1)(1993-12#1)(2008-12#1)(2008-9#1)
The power##11##2##(1992-1#1)(1992-9#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
The practical applicability of the##2##5##(2008-10#2)
The practical utility of the##2##5##(2008-10#2)
The practical##13##2##(1991-3#1)(1991-6#1)(2008-10#8)(2008-11#2)(2008-5#1)
The practice of##5##3##(1994-12#2)(1994-6#1)(2010-11#1)(2011-2#1)
The practitioners##2##2##(2008-1#1)(2008-10#1)
The pre-concentration##3##2##(2008-10#3)
The preceding##2##2##(1995-11#1)(2008-3#1)
The precipitate is##2##3##(2008-10#2)
The precipitate was dissolved with##3##5##(2008-10#3)
The precipitate was separated by##2##5##(2008-10#2)
The precipitate was##5##3##(2008-10#5)
The precipitate##7##2##(2008-10#7)
The precipitation of##2##3##(2008-10#2)
The precipitation##3##2##(2008-10#3)
The precise##5##2##(1995-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
The precision (R##5##3##(2008-10#5)
The precision and accuracy of the##3##6##(2008-10#2)(2008-3#1)
The precision and accuracy of##4##5##(2008-10#3)(2008-3#1)
The precision and##6##3##(2008-10#5)(2008-3#1)
The precision at##2##3##(2008-10#2)
The precision characteristics##2##3##(2008-10#2)
The precision expressed as relative standard deviation##3##7##(2008-10#3)
The precision expressed as##4##4##(2008-10#4)
The precision for 10 replicate determinations at the##2##8##(2008-10#2)
The precision for 10 replicate determinations at##4##7##(2008-10#4)
The precision for##9##3##(2008-10#9)
The precision is##2##3##(2008-10#2)
The precision obtained for##2##4##(2008-10#2)
The precision obtained##3##3##(2008-10#3)
The precision of the method was 2##2##7##(2008-10#2)
The precision of the method was estimated##2##7##(2008-10#2)
The precision of the method was tested##2##7##(2008-10#2)
The precision of the method was##7##6##(2008-10#7)
The precision of the method##16##5##(2008-10#16)
The precision of the proposed method was##2##7##(2008-10#2)
The precision of the proposed method##4##6##(2008-10#4)
The precision of the##27##4##(2008-10#27)
The precision of##31##3##(2008-10#31)
The precision was assessed from##2##5##(2008-10#2)
The precision was##8##3##(2008-10#8)
The precision##88##2##(2008-10#87)(2008-3#1)
The precisions##3##2##(2008-10#3)
The preconcentrated##2##2##(2008-10#2)
The preconcentration factor obtained##2##4##(2008-10#2)
The preconcentration factor was##2##4##(2008-10#2)
The preconcentration factor##8##3##(2008-10#8)
The preconcentration factors are##2##4##(2008-10#2)
The preconcentration factors##3##3##(2008-10#3)
The preconcentration was carried out##2##5##(2008-10#2)
The preconcentration##17##2##(2008-10#17)
The precursor##3##2##(1993-12#1)(2008-11#2)
The predicted amino acid sequence of##2##6##(1993-8#1)(1995-6#1)
The predicted amino acid sequence##4##5##(1993-12#1)(1993-8#1)(1995-6#2)
The predicted amino acid##6##4##(1993-12#1)(1993-6#1)(1993-8#1)(1995-6#2)(1997-2#1)
The predicted open reading##2##4##(1994-11#2)
The predicted protein##4##3##(1993-12#1)(1996-12#1)(1996-6#1)(1997-7#1)
The predicted slopes of plots of log(range size) versus##2##9##(2008-8#2)
The predicted##26##2##(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#2)(1995-6#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#5)(2008-7#1)(2008-8#2)
The prediction for gas chromatographic retention##2##6##(2008-10#2)
The prediction##9##2##(1997-6#1)(2008-10#8)
The predictive power of##2##4##(2010-1#1)(2012-2#1)
The predictive##7##2##(2008-10#2)(2008-7#1)(2009-3#1)(2010-1#1)(2012-2#1)(2013-1#1)
The predominance of##3##3##(2008-10#2)(2008-8#1)
The predominant##8##2##(1993-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)
The prefrontal cortex##2##3##(1994-8#1)(1996-5#1)
The pregnancy##2##2##(1992-1#1)(2013-1#1)
The preliminary results##2##3##(1992-12#1)(2008-8#1)
The preliminary##7##2##(1992-12#1)(2008-10#1)(2008-8#2)(2009-6#1)(2012-3#1)(2013-1#1)
The preoperative##4##2##(1991-6#1)(2009-4#1)(2011-2#1)(2013-1#1)
The preparation and characterization of##2##5##(2008-10#2)
The preparation and##4##3##(2008-10#3)(2008-11#1)
The preparation of a##2##4##(2008-10#1)(2010-4#1)
The preparation of##6##3##(2008-10#3)(2008-11#1)(2008-4#1)(2010-4#1)
The preparation##14##2##(2008-10#10)(2008-11#2)(2008-4#1)(2010-4#1)
The prepared##4##2##(2008-10#4)
The prescription##3##2##(2008-11#1)(2012-3#2)
The presence of EDTA##2##4##(2008-10#2)
The presence of Pi-ta##2##4##(2008-10#2)
The presence of a##12##4##(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
The presence of an##2##4##(2008-5#1)(2012-3#1)
The presence of both##2##4##(1991-8#1)(2008-10#1)
The presence of concomitant##2##4##(2008-10#1)(2012-12#1)
The presence of residual##2##4##(1992-10#1)(2009-7#1)
The presence of the##10##4##(1992-12#1)(1994-11#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-12#1)
The presence of these##2##4##(1994-8#1)(1995-12#1)
The presence of this##3##4##(1990-5#1)(1991-5#1)(1994-5#1)
The presence of two##2##4##(2008-10#1)(2010-7#1)
The presence of##144##3##(1990-12#2)(1990-5#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-6#2)(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#61)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#10)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)
The presence##146##2##(1990-12#2)(1990-5#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-6#2)(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#63)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#10)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)
The present FIA system##3##4##(2008-10#3)
The present approach##2##3##(1995-8#1)(2008-10#1)
The present article describes the##3##5##(2008-11#1)(2008-5#1)(2008-7#1)
The present article describes##4##4##(2008-11#2)(2008-5#1)(2008-7#1)
The present article highlights##2##4##(2008-10#1)(2008-11#1)
The present article is intended##2##5##(1994-6#1)(2008-11#1)
The present article reports##2##4##(1992-1#1)(2008-7#1)
The present article reviews the##4##5##(2008-11#3)(2011-2#1)
The present article reviews##7##4##(2008-11#4)(2008-7#1)(2011-2#1)(2012-3#1)
The present article##24##3##(1992-1#1)(1994-6#1)(2008-10#1)(2008-11#14)(2008-5#1)(2008-7#3)(2010-11#1)(2011-2#1)(2012-3#1)
The present case report is a##2##6##(2013-1#2)
The present case report##3##4##(1990-8#1)(2013-1#2)
The present clinical##2##3##(2007-12#1)(2013-1#1)
The present commentary##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
The present communication##3##3##(1990-12#1)(1991-12#1)(1993-8#1)
The present data suggest that##2##5##(1994-3#1)(2008-12#1)
The present data##8##3##(1992-3#1)(1993-1#1)(1993-8#1)(1994-3#1)(1996-12#1)(2008-12#1)(2008-8#1)(2012-2#1)
The present experiment has##2##4##(2008-6#1)(2008-9#1)
The present experiment was designed to##2##6##(1997-8#1)(2008-11#1)
The present experiment##5##3##(1997-8#1)(2008-11#1)(2008-6#1)(2008-9#2)
The present experiments were##2##4##(1993-3#1)(1994-2#1)
The present experiments##4##3##(1990-5#1)(1993-3#1)(1994-2#1)(2008-11#1)
The present findings##4##3##(1991-5#1)(1993-3#2)(1997-2#1)
The present investigation##3##3##(1995-12#1)(2012-2#1)(2013-1#1)
The present method allows the determination of##2##7##(2008-10#2)
The present method can be##2##5##(2008-10#2)
The present method was applied to##2##6##(2008-10#2)
The present method was successfully applied to##2##7##(2008-10#2)
The present method was##7##4##(2008-10#7)
The present method##20##3##(1991-3#1)(2008-10#19)
The present paper aims to##3##5##(1993-3#1)(2009-7#1)(2012-3#1)
The present paper deals with the##2##6##(2008-10#1)(2013-8#1)
The present paper deals with##4##5##(2008-10#3)(2013-8#1)
The present paper describes a procedure that##2##7##(2008-10#2)
The present paper describes a procedure##3##6##(2008-10#3)
The present paper describes a##6##5##(2008-10#5)(2013-1#1)
The present paper describes the##2##5##(2008-10#2)
The present paper describes##9##4##(2008-10#7)(2008-11#1)(2013-1#1)
The present paper discusses the##3##5##(2008-11#3)
The present paper focuses on the##2##6##(2008-5#2)
The present paper is##2##4##(2008-10#2)
The present paper proposes a##2##5##(2008-10#1)(2012-2#1)
The present paper provides##2##4##(2008-11#1)(2008-7#1)
The present paper##35##3##(1993-11#1)(1993-3#1)(1994-6#1)(2008-10#14)(2008-11#6)(2008-5#2)(2008-7#2)(2009-7#1)(2010-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
The present report describes##7##4##(1990-12#1)(1994-12#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
The present report##10##3##(1990-12#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#3)(2011-2#1)(2013-1#1)
The present research##4##3##(2008-10#1)(2008-12#1)(2013-8#2)
The present results are##3##4##(1991-2#1)(2008-5#1)(2012-2#1)
The present results demonstrate that##3##5##(1991-12#1)(2008-8#1)(2013-1#1)
The present results demonstrate##4##4##(1991-12#1)(1997-4#1)(2008-8#1)(2013-1#1)
The present results suggest that the##3##6##(1990-2#1)(2008-10#1)(2008-6#1)
The present results suggest that##7##5##(1990-2#1)(1991-9#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-6#1)
The present results##20##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2012-2#1)(2013-1#1)
The present review focuses on the##5##6##(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#2)
The present review focuses##6##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#2)
The present review is##2##4##(1992-6#1)(2008-10#1)
The present review summarizes the##2##5##(2008-7#1)(2012-12#1)
The present review summarizes##3##4##(2008-7#1)(2012-12#1)(2012-2#1)
The present review##15##3##(1992-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
The present sensor##2##3##(2008-10#2)
The present studies were##2##4##(1994-6#1)(1995-11#1)
The present studies##3##3##(1994-6#1)(1995-11#1)(1997-2#1)
The present study aimed to##3##5##(2009-3#1)(2011-2#1)(2012-6#1)
The present study aims to##3##5##(2008-11#1)(2008-9#1)(2013-8#1)
The present study aims##4##4##(2008-11#1)(2008-9#1)(2009-12#1)(2013-8#1)
The present study also##2##4##(2008-10#1)(2011-3#1)
The present study analyses##2##4##(1990-11#1)(2009-12#1)
The present study compared the##3##5##(1993-3#1)(2011-2#1)(2012-2#1)
The present study concerns##2##4##(1994-6#1)(2008-11#1)
The present study deals with##2##5##(2012-2#2)
The present study demonstrates that##4##5##(1994-11#2)(1994-2#1)(1994-3#1)
The present study demonstrates the##2##5##(1990-5#1)(2011-2#1)
The present study demonstrates##6##4##(1990-5#1)(1994-11#2)(1994-2#1)(1994-3#1)(2011-2#1)
The present study describes a##2##5##(2008-10#1)(2008-11#1)
The present study describes##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
The present study determined##2##4##(1997-7#1)(2012-5#1)
The present study does not support##2##6##(1991-8#1)(1993-3#1)
The present study evaluated the##3##5##(1993-1#1)(2008-10#1)(2013-1#1)
The present study evaluated##4##4##(1993-1#1)(2008-10#1)(2009-11#1)(2013-1#1)
The present study examined possible##2##5##(1996-2#1)(2009-9#1)
The present study examined the##10##5##(1991-8#1)(1994-2#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-9#1)(2010-1#2)(2010-10#1)(2011-2#1)
The present study examined whether##3##5##(1996-5#1)(2011-2#1)(2012-2#1)
The present study examined##17##4##(1991-8#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2011-2#2)(2012-2#2)
The present study examines the##2##5##(1994-2#1)(2008-5#1)
The present study examines##3##4##(1993-3#1)(1994-2#1)(2008-5#1)
The present study extends##2##4##(2008-10#1)(2010-2#1)
The present study has##3##4##(1997-8#1)(2008-12#1)(2013-1#1)
The present study investigated the##4##5##(1991-9#1)(1995-12#1)(2010-10#1)(2013-1#1)
The present study investigated##6##4##(1991-7#1)(1991-9#1)(1995-12#1)(2008-5#1)(2010-10#1)(2013-1#1)
The present study investigates the##3##5##(1991-12#1)(2008-12#1)(2011-2#1)
The present study is a##2##5##(2008-7#1)(2010-8#1)
The present study is##7##4##(2008-10#3)(2008-7#1)(2008-9#1)(2010-8#1)(2013-3#1)
The present study opens##2##4##(2008-5#1)(2011-2#1)
The present study reports##4##4##(1994-2#1)(2007-12#1)(2013-1#2)
The present study revealed that##2##5##(2008-10#1)(2008-7#1)
The present study suggests that the##2##6##(1995-12#1)(2008-10#1)
The present study was aimed to##2##6##(2008-12#1)(2012-12#1)
The present study was aimed##3##5##(1994-2#1)(2008-12#1)(2012-12#1)
The present study was carried out to investigate##2##8##(1991-6#1)(2008-11#1)
The present study was carried out to##3##7##(1991-6#1)(2008-11#1)(2008-7#1)
The present study was carried out##4##6##(1991-6#1)(2008-11#1)(2008-7#1)(2013-8#1)
The present study was conducted to determine##2##7##(1995-8#1)(2008-11#1)
The present study was conducted to##8##6##(1995-10#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
The present study was conducted##10##5##(1995-10#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
The present study was designed to compare##2##7##(2012-2#1)(2012-3#1)
The present study was designed to determine##2##7##(1990-5#1)(1994-2#1)
The present study was designed to examine##2##7##(1992-8#1)(1993-12#1)
The present study was designed to investigate the##2##8##(2009-8#1)(2012-12#1)
The present study was designed to##11##6##(1990-5#1)(1992-8#1)(1993-12#1)(1994-2#1)(2008-7#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
The present study was undertaken to establish##2##7##(2012-2#2)
The present study was undertaken to examine whether##2##8##(2008-5#1)(2011-2#1)
The present study was undertaken to examine##3##7##(2008-5#1)(2011-2#2)
The present study was undertaken to investigate the##2##8##(1994-12#1)(2008-7#1)
The present study was undertaken to##9##6##(1992-3#1)(1994-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#2)
The present study was##42##4##(1990-5#1)(1990-9#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-2#2)(1995-10#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
The present study##159##3##(1990-11#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#8)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-11#7)(2008-12#4)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#6)(2009-11#2)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#7)(2013-3#1)(2013-8#3)
The present system##5##3##(2008-10#4)(2008-8#1)
The present work describes a##2##5##(2008-10#2)
The present work describes the##4##5##(2008-10#3)(2008-11#1)
The present work describes##7##4##(2008-10#6)(2008-11#1)
The present work has##2##4##(2008-10#2)
The present work reports the##2##5##(2008-10#1)(2008-11#1)
The present work reports##3##4##(2008-10#2)(2008-11#1)
The present work was##2##4##(2008-10#1)(2013-1#1)
The present work##29##3##(1996-12#1)(1997-4#1)(2008-10#16)(2008-11#4)(2008-5#1)(2009-8#2)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
The present##397##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-3#8)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#9)(1994-3#3)(1994-6#5)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#4)(1996-2#3)(1996-5#3)(1996-6#1)(1997-2#2)(1997-4#2)(1997-7#2)(1997-8#2)(2007-12#3)(2008-10#101)(2008-11#44)(2008-12#6)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#17)(2008-8#5)(2008-9#9)(2009-11#2)(2009-12#2)(2009-3#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#15)(2011-3#1)(2012-12#3)(2012-2#18)(2012-3#5)(2012-5#1)(2012-6#1)(2013-1#17)(2013-3#1)(2013-8#8)
The presentation of##2##3##(1990-6#1)(2008-2#1)
The presentation##5##2##(1990-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
The presented system has been applied successfully to##2##8##(2008-10#2)
The presented##10##2##(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2011-3#1)(2012-12#1)
The preservation of the##2##4##(2008-10#1)(2011-2#1)
The preservation of##3##3##(2008-10#2)(2011-2#1)
The pressure##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
The pressures for##3##3##(1993-3#2)(1997-3#1)
The pressures##4##2##(1993-3#2)(1996-3#1)(1997-3#1)
The presumed##2##2##(1993-8#1)(2008-9#1)
The presynaptic##2##2##(1995-2#1)(1996-12#1)
The prevalence and##6##3##(1992-1#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
The prevalence of brown stem rot##2##6##(2008-10#2)
The prevalence of circumportal pancreas##2##5##(2012-2#2)
The prevalence of dementia##2##4##(2008-7#2)
The prevalence of diabetes##3##4##(2010-10#3)
The prevalence of smoking##2##4##(1991-11#1)(2011-2#1)
The prevalence of the##5##4##(2008-1#1)(2008-10#1)(2008-5#1)(2011-7#1)(2012-2#1)
The prevalence of this##2##4##(1991-9#1)(2008-12#1)
The prevalence of##56##3##(1990-6#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#4)(2008-8#1)(2010-10#5)(2010-3#1)(2010-4#1)(2010-6#3)(2011-2#6)(2011-7#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#1)
The prevalence##66##2##(1990-6#2)(1991-11#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-5#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-10#5)(2010-3#1)(2010-4#1)(2010-6#3)(2011-2#6)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#2)
The previous treatment of spores with lipase activity inhibitor##2##9##(2010-10#2)
The previous##7##2##(1997-2#1)(2008-10#2)(2008-11#1)(2010-10#2)(2010-11#1)
The primary aim of this study was to##3##8##(2008-1#1)(2008-11#1)(2008-7#1)
The primary cause of##2##4##(2009-10#1)(2011-2#1)
The primary effect of##2##4##(2008-11#1)(2010-1#1)
The primary focus##3##3##(1990-3#1)(2008-11#1)(2013-1#1)
The primary objective of this study was to##2##8##(2008-10#2)
The primary objective of this##4##5##(2008-10#2)(2010-4#1)(2011-1#1)
The primary objective of##5##4##(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#1)
The primary outcome##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
The primary##47##2##(1990-3#1)(1990-6#1)(1990-8#1)(1992-8#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#11)(2008-11#6)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
The primer##2##2##(1997-6#1)(2008-10#1)
The primers were##2##3##(2008-10#2)
The primers##5##2##(2008-10#5)
The primordial##2##2##(2007-12#2)
The principal component analysis##2##4##(2008-10#2)
The principal##16##2##(1991-12#1)(1991-3#1)(1992-12#1)(1996-3#1)(2008-10#4)(2008-2#1)(2008-9#2)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#2)
The principle behind##2##3##(2008-9#1)(2011-7#1)
The principle is to##2##4##(2008-10#1)(2008-4#1)
The principle is##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
The principle of the##3##4##(2008-10#3)
The principle of##8##3##(2007-11#1)(2008-10#6)(2009-6#1)
The principle##16##2##(2007-11#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-7#1)(2012-2#1)
The principles of microscopy and step-by-step alignment and adjustment procedures are described in this unit##2##15##(2008-4#2)
The principles of##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
The principles underlying the##2##4##(1992-12#1)(2008-9#1)
The principles##9##2##(1992-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)
The probability of a##4##4##(1990-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
The probability of##7##3##(1990-6#2)(2008-10#3)(2008-12#1)(2008-7#1)
The probable##4##2##(2008-10#4)
The probe##3##2##(2008-10#2)(2013-1#1)
The problem is##4##3##(1995-12#1)(2008-10#3)
The problem of the##5##4##(1990-12#1)(2008-10#3)(2008-2#1)
The problem of##15##3##(1990-12#1)(1991-2#1)(1992-9#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-2#1)(2011-3#1)(2013-8#1)
The problem##26##2##(1990-12#1)(1991-2#1)(1992-9#1)(1995-12#1)(1996-2#2)(1996-5#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2010-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
The problems associated with##2##4##(1991-3#1)(1996-12#1)
The problems in##2##3##(1992-3#1)(2008-10#1)
The problems##8##2##(1991-3#1)(1992-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-11#1)
The procedure consists of##3##4##(2008-10#2)(2008-3#1)
The procedure consists##4##3##(2008-10#3)(2008-3#1)
The procedure developed##3##3##(2008-10#3)
The procedure for##2##3##(2008-10#2)
The procedure has been##3##4##(2008-10#3)
The procedure has##4##3##(1994-12#1)(2008-10#3)
The procedure is based on the##7##6##(2008-10#7)
The procedure is based on##9##5##(2008-10#9)
The procedure is carried out##2##5##(1996-5#1)(2008-10#1)
The procedure is described in##2##5##(2008-10#1)(2011-2#1)
The procedure is suitable for##2##5##(2008-10#1)(2008-5#1)
The procedure is##26##3##(1994-9#1)(1996-5#1)(2008-10#19)(2008-11#1)(2008-4#2)(2008-5#1)(2011-2#1)
The procedure of##2##3##(2008-10#2)
The procedure offers##2##3##(2008-10#2)
The procedure proposed allowed the determination of##2##7##(2008-10#2)
The procedure used##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
The procedure was also##2##4##(2008-10#2)
The procedure was applied successfully to the determination of##2##9##(2008-10#2)
The procedure was applied to a##2##6##(2008-10#2)
The procedure was applied to the analysis of##3##8##(2008-10#3)
The procedure was applied to the##4##6##(2008-10#4)
The procedure was applied to##10##5##(2008-10#10)
The procedure was applied##14##4##(2008-10#14)
The procedure was based on the##3##6##(2008-10#3)
The procedure was based on##4##5##(1995-12#1)(2008-10#3)
The procedure was successfully applied for the##2##7##(2008-10#2)
The procedure was successfully applied to the determination of##2##9##(2008-10#2)
The procedure was successfully applied to the##3##7##(2008-10#3)
The procedure was successfully applied##5##5##(2008-10#5)
The procedure was tested##2##4##(2008-10#2)
The procedure was validated by analysis##2##6##(2008-10#2)
The procedure was validated by##4##5##(2008-10#4)
The procedure was validated##5##4##(2008-10#5)
The procedure was##38##3##(1995-12#1)(2008-10#35)(2008-12#1)(2012-12#1)
The procedure##100##2##(1991-2#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-10#84)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
The procedures are based on##2##5##(2008-10#2)
The procedures##9##2##(2008-10#6)(2008-11#1)(2008-4#1)(2008-9#1)
The process by which##2##4##(2008-10#1)(2008-7#1)
The process can be##2##4##(1994-12#1)(2011-2#1)
The process is##6##3##(1993-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-8#1)(2011-2#1)
The process of the##2##4##(1992-1#1)(2008-10#1)
The process of##17##3##(1992-1#1)(1992-3#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-3#1)(2013-8#1)
The process was##3##3##(1993-2#2)(2008-10#1)
The process##43##2##(1990-11#1)(1992-1#1)(1992-3#1)(1993-12#2)(1993-2#3)(1994-12#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#2)(2011-8#1)(2013-8#1)
The processes of the##2##4##(2008-10#2)
The processes of##3##3##(2008-10#3)
The processes##5##2##(1996-5#1)(1997-1#1)(2008-10#3)
The produced##3##2##(2008-10#3)
The product of reaction##3##4##(2008-10#3)
The product of the##4##4##(1995-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
The product of##9##3##(1994-12#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-9#1)(2011-2#1)
The product##14##2##(1994-12#1)(1995-6#1)(1995-8#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
The production of##17##3##(1991-11#1)(2008-10#4)(2008-11#7)(2008-5#2)(2008-6#1)(2008-7#1)(2012-3#1)
The production##21##2##(1991-11#1)(1992-2#1)(1993-6#1)(2008-10#4)(2008-11#8)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
The products of##4##3##(1994-8#1)(2008-10#2)(2009-8#1)
The products##6##2##(1994-8#1)(2008-10#4)(2009-8#1)
The profession of##2##3##(1994-12#1)(2008-10#1)
The profession##3##2##(1994-12#1)(2008-10#2)
The profile of##3##3##(1995-10#1)(2008-10#1)(2008-5#1)
The profile##4##2##(1995-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
The profiles of##2##3##(1996-12#1)(2008-11#1)
The profiles##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
The progeny##3##2##(1995-12#1)(2008-10#2)
The prognosis for##2##3##(2008-7#1)(2011-2#1)
The prognosis of##6##3##(1996-6#1)(2008-11#1)(2008-7#1)(2012-3#2)(2013-1#1)
The prognosis##10##2##(1996-6#1)(1996-9#1)(1997-8#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-3#2)(2013-1#1)
The prognostic significance of##3##4##(1991-12#1)(2008-7#2)
The prognostic##6##2##(1991-11#1)(1991-12#1)(2008-10#2)(2008-7#2)
The program consisted of##2##4##(2008-12#1)(2008-8#1)
The program##17##2##(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#1)(1994-12#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)
The programme##4##2##(1993-6#2)(2009-1#1)(2010-1#1)
The progress of##2##3##(1994-5#1)(2008-10#1)
The progress##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
The progression of the##2##4##(2008-10#1)(2008-7#1)
The progressive##5##2##(1994-2#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
The project was initiated##2##4##(1993-3#1)(2008-12#1)
The project was##4##3##(1993-3#1)(2008-11#1)(2008-12#1)(2011-9#1)
The project##10##2##(1992-1#1)(1993-3#1)(1995-3#1)(1996-1#1)(1997-3#1)(2008-11#2)(2008-12#1)(2011-9#1)(2013-1#1)
The projected##2##2##(2007-12#1)(2009-7#1)
The proliferation of##2##3##(2008-11#1)(2011-3#1)
The proliferation##4##2##(2008-11#2)(2008-9#1)(2011-3#1)
The promoter region##2##3##(1993-6#1)(2009-8#1)
The promoter sequence##2##3##(1993-12#1)(1997-7#1)
The promoter##6##2##(1993-12#1)(1993-6#2)(1997-7#2)(2009-8#1)
The propagation of##2##3##(2008-10#1)(2008-9#1)
The proper##4##2##(2008-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
The properties of the##4##4##(1994-8#1)(2008-10#2)(2008-3#1)
The properties of this##2##4##(1995-9#1)(2008-6#1)
The properties of##13##3##(1991-5#1)(1994-8#1)(1995-9#1)(1996-3#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)
The properties##18##2##(1991-5#1)(1994-8#1)(1995-9#1)(1996-3#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#1)(2011-3#1)
The property of##3##3##(1994-5#1)(2008-10#2)
The property##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
The prophylactic##2##2##(2008-10#1)(2010-7#1)
The proportion of cases##2##4##(2013-8#2)
The proportion of embryos##2##4##(1996-8#1)(2008-11#1)
The proportion of patients##2##4##(2012-3#1)(2013-1#1)
The proportion of the##3##4##(1991-3#1)(1995-3#1)(2010-1#1)
The proportion of##31##3##(1991-12#1)(1991-3#2)(1993-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-8#1)(1996-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
The proportions of##2##3##(2012-2#1)(2013-8#1)
The proposed FI##3##3##(2008-10#3)
The proposed SIA system##2##4##(2008-10#2)
The proposed algorithm is##2##4##(2008-6#1)(2011-3#1)
The proposed analytical method##2##4##(2008-10#1)(2012-3#1)
The proposed analytical##3##3##(2008-10#2)(2012-3#1)
The proposed approach##2##3##(2009-10#1)(2009-7#1)
The proposed electrode revealed good selectivities##2##6##(2008-10#2)
The proposed electrode revealed good sensitivities for##2##7##(2008-10#2)
The proposed electrode revealed good##5##5##(2008-10#5)
The proposed electrode revealed##6##4##(2008-10#6)
The proposed electrode shows a##2##5##(2008-10#2)
The proposed electrode was##2##4##(2008-10#2)
The proposed electrode##12##3##(2008-10#12)
The proposed electrodes could be##2##5##(2008-10#2)
The proposed electrodes##3##3##(2008-10#3)
The proposed final model##2##4##(2008-10#2)
The proposed immunosensor##2##3##(2008-10#2)
The proposed mechanism##2##3##(2008-10#1)(2008-9#1)
The proposed membrane sensor##2##4##(2008-10#2)
The proposed membrane##3##3##(2008-10#3)
The proposed method allowed the determination of##2##7##(2008-10#2)
The proposed method allows the determination of##2##7##(2008-10#2)
The proposed method allows the##3##5##(2008-10#3)
The proposed method allows##6##4##(2008-10#6)
The proposed method can be##4##5##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
The proposed method depends upon the##2##6##(2008-10#2)
The proposed method for##2##4##(2008-10#1)(2010-8#1)
The proposed method had a##2##5##(1992-11#1)(2008-10#1)
The proposed method had been##2##5##(2008-10#2)
The proposed method had##4##4##(1992-11#1)(2008-10#3)
The proposed method has a linear calibration range##2##8##(2008-10#2)
The proposed method has a##4##5##(2008-10#4)
The proposed method has been applied satisfactorily##2##7##(2008-10#2)
The proposed method has been applied to the AAS determination of##2##11##(2008-10#2)
The proposed method has been applied to the determination of nickel in##2##12##(2008-10#2)
The proposed method has been applied to the determination of trace##4##11##(2008-10#4)
The proposed method has been applied to the determination of##14##10##(2008-10#14)
The proposed method has been applied to the##17##8##(2008-10#17)
The proposed method has been applied to##21##7##(2008-10#21)
The proposed method has been applied##24##6##(2008-10#24)
The proposed method has been satisfactorily applied to##2##8##(2008-10#2)
The proposed method has been satisfactorily applied##3##7##(2008-10#3)
The proposed method has been successfully applied to the determination of##2##11##(2008-10#2)
The proposed method has been successfully applied to the##4##9##(2008-10#4)
The proposed method has been successfully applied to##7##8##(2008-10#7)
The proposed method has been successfully applied##8##7##(2008-10#8)
The proposed method has been used##2##6##(2008-10#2)
The proposed method has been##39##5##(2008-10#39)
The proposed method has##44##4##(2008-10#44)
The proposed method is applied to the##2##7##(2008-10#2)
The proposed method is applied to##3##6##(2008-10#3)
The proposed method is based on the##3##7##(2008-10#3)
The proposed method is based on##4##6##(2008-10#4)
The proposed method is fast##3##5##(2008-10#3)
The proposed method is rapid##2##5##(2008-10#2)
The proposed method is simple and##5##6##(2008-10#5)
The proposed method is simple##11##5##(2008-10#11)
The proposed method is suitable for automatic and continuous analysis##2##10##(2008-10#2)
The proposed method is very##2##5##(2008-10#2)
The proposed method is##41##4##(2008-10#41)
The proposed method permitted large enrichment factors of about 100##2##10##(2008-10#2)
The proposed method permitted large enrichment factors of about##3##9##(2008-10#3)
The proposed method permitted the##2##5##(2008-10#2)
The proposed method permitted##5##4##(2008-10#5)
The proposed method presented##2##4##(2008-10#2)
The proposed method showed##3##4##(2008-10#3)
The proposed method was also applied satisfactorily to the determination of considered metal ions in##2##15##(2008-10#2)
The proposed method was applied successfully to the determination of##2##10##(2008-10#2)
The proposed method was applied successfully to##3##7##(2008-10#3)
The proposed method was applied successfully##4##6##(2008-10#4)
The proposed method was applied to determination of##2##8##(2008-10#2)
The proposed method was applied to determine##4##7##(2008-10#4)
The proposed method was applied to tap water##2##8##(2008-10#2)
The proposed method was applied to the analysis of##2##9##(2008-10#2)
The proposed method was applied to the determination of both analytes in##2##12##(2008-10#2)
The proposed method was applied to the determination of these##2##10##(2008-10#2)
The proposed method was applied to the determination of trace##3##10##(2008-10#3)
The proposed method was applied to the determination of##17##9##(2008-10#17)
The proposed method was applied to the##22##7##(2008-10#22)
The proposed method was applied to##33##6##(2008-10#33)
The proposed method was applied##41##5##(2008-10#41)
The proposed method was compared with##3##6##(2008-10#3)
The proposed method was evaluated by analyzing##2##7##(2008-10#2)
The proposed method was evaluated##3##5##(2008-10#3)
The proposed method was sensitive##2##5##(2008-10#2)
The proposed method was simple##2##5##(2008-10#2)
The proposed method was successfully applied for the determination of##3##10##(2008-10#3)
The proposed method was successfully applied for the##4##8##(2008-10#4)
The proposed method was successfully applied for##7##7##(2008-10#7)
The proposed method was successfully applied to determine##2##8##(2008-10#2)
The proposed method was successfully applied to the determination of vanadium in##2##12##(2008-10#2)
The proposed method was successfully applied to the determination of##13##10##(2008-10#13)
The proposed method was successfully applied to the simultaneous determination of##7##11##(2008-10#7)
The proposed method was successfully applied to the##21##8##(2008-10#21)
The proposed method was successfully applied to##24##7##(2008-10#24)
The proposed method was successfully applied##32##6##(2008-10#32)
The proposed method was successfully used for the determination of##2##10##(2008-10#2)
The proposed method was successfully##36##5##(2008-10#36)
The proposed method was used to##2##6##(2008-10#2)
The proposed method was##100##4##(2008-10#100)
The proposed method##235##3##(1992-11#1)(2007-12#1)(2008-10#227)(2008-3#2)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
The proposed methodology was##3##4##(2008-10#3)
The proposed methodology##6##3##(2008-10#6)
The proposed methods have##2##4##(2008-10#2)
The proposed methods were successfully applied to the##2##8##(2008-10#2)
The proposed methods were##6##4##(2008-10#6)
The proposed methods##9##3##(2008-10#9)
The proposed model was##2##4##(2008-10#1)(2008-7#1)
The proposed model##6##3##(2008-10#2)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)
The proposed optosensor##2##3##(2008-10#2)
The proposed procedure allowed the determination of##2##7##(2008-10#2)
The proposed procedure allows##2##4##(2008-10#2)
The proposed procedure has been tested first on synthetic samples prepared in##2##12##(2008-10#2)
The proposed procedure has been tested first##3##7##(2008-10#3)
The proposed procedure has been tested##4##6##(2008-10#4)
The proposed procedure has been##6##5##(2008-10#6)
The proposed procedure has##7##4##(2008-10#7)
The proposed procedure was applied for##3##6##(2008-10#3)
The proposed procedure was applied to##2##6##(2008-10#2)
The proposed procedure was applied##6##5##(2008-10#6)
The proposed procedure was successfully applied##2##6##(2008-10#2)
The proposed procedure was##9##4##(2008-10#9)
The proposed procedure##23##3##(2008-10#22)(2010-1#1)
The proposed procedures have been##2##5##(2008-10#2)
The proposed procedures were##2##4##(2008-10#2)
The proposed procedures##6##3##(2008-10#6)
The proposed sensor displayed good selectivity for##2##7##(2008-10#2)
The proposed sensor is##2##4##(2008-10#2)
The proposed sensor shows fairly good discriminating ability towards##2##9##(2008-10#2)
The proposed sensor shows fairly##3##5##(2008-10#3)
The proposed sensor was successfully##2##5##(2008-10#2)
The proposed sensor was##4##4##(2008-10#4)
The proposed sensor##15##3##(2008-10#15)
The proposed system is##2##4##(2008-10#2)
The proposed system was applied to the##2##7##(2008-10#2)
The proposed system was##4##4##(2008-10#4)
The proposed system##10##3##(2008-10#10)
The proposed technique is##2##4##(2008-10#2)
The proposed technique##3##3##(2008-10#3)
The proposed##399##2##(1991-5#1)(1992-11#1)(1992-4#1)(1993-2#1)(1997-8#1)(2007-12#1)(2008-10#371)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)
The prospective##2##2##(1993-1#1)(1997-8#1)
The protease##2##2##(1992-12#1)(1992-6#1)
The protective effect of the##2##5##(2008-10#1)(2013-1#1)
The protective effect of##4##4##(1996-3#1)(2008-10#1)(2008-6#1)(2013-1#1)
The protective##7##2##(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2013-1#1)
The protein composition of##3##4##(2008-8#2)(2009-6#1)
The protein is##4##3##(1993-8#1)(1994-8#1)(2008-9#1)(2009-8#1)
The protein was##4##3##(1993-12#1)(1994-11#1)(1995-12#1)(2009-9#1)
The protein##27##2##(1991-6#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
The protein-free##2##2##(1993-12#1)(2008-11#1)
The proteins were##2##3##(1994-5#1)(2008-11#1)
The proteins##15##2##(1991-2#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)
The protocol##10##2##(2008-10#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2011-2#1)
The protocols are##2##3##(2008-9#2)
The protocols described##3##3##(2008-4#3)
The protocols in this unit##5##5##(2008-4#2)(2008-9#3)
The protocols##15##2##(2008-4#9)(2008-9#6)
The proton##2##2##(2008-8#1)(2008-9#1)
The protonation constants of##3##4##(2008-10#3)
The protonation##4##2##(2008-10#4)
The prototype##5##2##(2008-10#4)(2008-2#1)
The provision of##2##3##(1996-1#1)(2010-12#1)
The proximal##4##2##(1994-5#2)(1997-9#1)(2007-12#1)
The psychiatric##2##2##(2010-3#1)(2013-1#1)
The psychological##2##2##(2008-10#1)(2008-5#1)
The psychometric##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
The psychosocial##2##2##(1991-2#1)(2008-11#1)
The public##4##2##(1997-1#1)(1997-6#2)(2008-11#1)
The published##2##2##(2008-1#1)(2008-11#1)
The publisher regrets that this article is an accidental duplication of an article that has already been published in##2##19##(2008-11#2)
The pulmonary##2##2##(2010-10#1)(2011-2#1)
The pulse width##2##3##(2008-2#1)(2008-3#1)
The pump##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
The pungency##2##2##(2008-10#2)
The purification##3##2##(2008-10#2)(2008-8#1)
The purified enzyme##3##3##(1990-11#1)(1991-5#1)(2008-11#1)
The purified protein##4##3##(1992-7#2)(1992-8#1)(1995-11#1)
The purified sample was##2##4##(2008-10#1)(2008-9#1)
The purified##27##2##(1990-11#2)(1991-5#3)(1992-7#2)(1992-8#1)(1993-8#1)(1994-8#2)(1995-11#2)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2013-8#1)
The purity##4##2##(1994-8#1)(2008-10#2)(2008-11#1)
The purple##2##2##(1994-5#1)(2008-10#1)
The purpose is to identify the priority nursing diagnoses##2##9##(2013-1#2)
The purpose is to identify##3##5##(2008-2#1)(2013-1#2)
The purpose is to show that CS terminology is inconsistent in the nursing literature##2##14##(2013-1#2)
The purpose is to##6##4##(2008-10#1)(2008-2#1)(2013-1#4)
The purpose of the current##2##5##(2011-2#1)(2013-8#1)
The purpose of the present review##2##6##(2008-11#1)(2010-1#1)
The purpose of the present study is to##2##8##(2008-10#1)(2012-3#1)
The purpose of the present study was to identify the##2##10##(1994-5#1)(2011-2#1)
The purpose of the present study was to investigate the##2##10##(2009-1#1)(2013-1#1)
The purpose of the present study was to##8##8##(1990-8#1)(1993-6#1)(1994-5#1)(2008-10#1)(2009-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
The purpose of the present study##10##6##(1990-8#1)(1993-6#1)(1994-5#1)(2008-10#2)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The purpose of the present##15##5##(1990-8#1)(1992-12#1)(1993-6#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-1#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
The purpose of the study was to determine##3##8##(1990-8#1)(2008-11#1)(2013-8#1)
The purpose of the study was to##8##7##(1990-8#1)(1993-1#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-8#1)
The purpose of the study##9##5##(1990-8#1)(1993-1#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-8#1)
The purpose of the survey was to##2##7##(2008-10#1)(2008-11#1)
The purpose of the##33##4##(1990-8#2)(1992-12#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-5#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2009-1#1)(2009-5#2)(2010-1#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
The purpose of this article is to describe the structure##2##10##(1994-1#1)(2008-12#1)
The purpose of this article is to describe##3##8##(1994-1#1)(2008-12#2)
The purpose of this article is to present##2##8##(1993-12#1)(2012-3#1)
The purpose of this article is to provide a##2##9##(1997-3#1)(2010-11#1)
The purpose of this article is to provide##5##8##(1997-3#1)(2010-11#1)(2010-12#1)(2010-9#1)(2013-8#1)
The purpose of this article is to review the##3##9##(1994-3#1)(2008-3#1)(2008-8#1)
The purpose of this article is to review##5##8##(1994-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)
The purpose of this article is to##22##7##(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
The purpose of this article was to##2##7##(2010-11#1)(2012-2#1)
The purpose of this article##25##5##(1992-1#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
The purpose of this case study##2##6##(1993-1#1)(2010-5#1)
The purpose of this case##3##5##(1993-1#1)(2010-5#1)(2010-9#1)
The purpose of this investigation was to##3##7##(2006-6#1)(2009-3#1)(2013-8#1)
The purpose of this paper is to describe the##3##9##(1992-1#1)(2008-11#2)
The purpose of this paper is to describe##4##8##(1992-1#1)(2008-11#2)(2010-11#1)
The purpose of this paper is to discuss##2##8##(2008-11#1)(2012-3#1)
The purpose of this paper is to present##2##8##(2010-12#1)(2012-3#1)
The purpose of this paper is to##12##7##(1992-1#1)(2008-11#4)(2008-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-3#2)
The purpose of this paper##13##5##(1992-1#1)(1992-2#1)(2008-11#4)(2008-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-3#2)
The purpose of this pictorial essay is to review##2##9##(2012-2#2)
The purpose of this pictorial##3##5##(2012-2#3)
The purpose of this pilot study was to##3##8##(2008-12#3)
The purpose of this qualitative study was to explore##2##9##(2008-12#1)(2009-9#1)
The purpose of this report is to##3##7##(2008-7#1)(2011-2#1)(2012-3#1)
The purpose of this report##4##5##(2008-7#1)(2011-2#2)(2012-3#1)
The purpose of this research was to##4##7##(1994-3#1)(2008-12#1)(2011-2#1)(2012-2#1)
The purpose of this research##5##5##(1994-3#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
The purpose of this review is to##4##7##(2008-3#2)(2012-2#1)(2013-1#1)
The purpose of this review is##5##6##(2008-3#2)(2010-7#1)(2012-2#1)(2013-1#1)
The purpose of this review##6##5##(1996-6#1)(2008-3#2)(2010-7#1)(2012-2#1)(2013-1#1)
The purpose of this study is to examine##2##8##(2008-10#1)(2011-2#1)
The purpose of this study is to present a case of##2##11##(2011-2#1)(2012-12#1)
The purpose of this study is to present##3##8##(1996-1#1)(2011-2#1)(2012-12#1)
The purpose of this study is to##14##7##(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
The purpose of this study is##15##6##(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
The purpose of this study was to analyze##2##8##(2008-11#1)(2008-9#1)
The purpose of this study was to assess the##3##9##(2008-12#1)(2008-7#1)(2009-2#1)
The purpose of this study was to compare##2##8##(1994-12#1)(2008-9#1)
The purpose of this study was to determine if##2##9##(2008-9#1)(2010-6#1)
The purpose of this study was to determine the effects of##2##11##(2010-4#1)(2010-6#1)
The purpose of this study was to determine the prevalence of##2##11##(2008-12#1)(2013-1#1)
The purpose of this study was to determine the##13##9##(1991-11#1)(1994-5#1)(2008-12#2)(2008-9#1)(2010-2#1)(2010-4#1)(2010-6#2)(2012-2#2)(2013-1#2)
The purpose of this study was to determine whether##2##9##(1997-8#1)(2008-7#1)
The purpose of this study was to determine##17##8##(1991-11#1)(1994-5#1)(1997-8#1)(2008-12#2)(2008-7#1)(2008-9#2)(2010-2#1)(2010-4#1)(2010-6#3)(2012-2#2)(2013-1#2)
The purpose of this study was to develop an##2##9##(2008-10#1)(2008-11#1)
The purpose of this study was to develop##3##8##(2008-10#1)(2008-11#1)(2010-9#1)
The purpose of this study was to evaluate the##9##9##(1990-11#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
The purpose of this study was to evaluate##11##8##(1990-11#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#2)(2013-1#1)
The purpose of this study was to examine the effects of##2##11##(1991-12#1)(2013-8#1)
The purpose of this study was to examine the##6##9##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2012-12#1)(2013-8#1)
The purpose of this study was to examine##7##8##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2009-12#1)(2012-12#1)(2013-8#1)
The purpose of this study was to identify##4##8##(1990-2#1)(2008-12#1)(2008-9#1)(2010-11#1)
The purpose of this study was to investigate the##5##9##(2008-10#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#1)
The purpose of this study was to investigate##7##8##(1993-2#1)(1996-6#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#1)
The purpose of this study was to test a##2##9##(1993-12#1)(2012-3#1)
The purpose of this study was to##70##7##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-8#2)(2008-10#6)(2008-11#3)(2008-12#5)(2008-7#2)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
The purpose of this study was##72##6##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-8#2)(2008-10#6)(2008-11#3)(2008-12#5)(2008-7#2)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#1)
The purpose of this study##88##5##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-8#2)(2008-10#8)(2008-11#4)(2008-12#5)(2008-7#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#2)
The purpose of this unit is not##2##7##(2008-4#1)(2008-9#1)
The purpose of this unit is to##2##7##(2008-9#2)
The purpose of this unit is##5##6##(2008-4#2)(2008-9#3)
The purpose of this work was to evaluate the##2##9##(1997-8#1)(2008-10#1)
The purpose of this work was to##3##7##(1997-8#1)(2007-11#1)(2008-10#1)
The purpose of this work was##4##6##(1997-8#1)(2007-11#1)(2008-10#2)
The purpose of this##178##4##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#2)(1992-1#2)(1992-2#2)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-6#2)(1997-3#1)(1997-8#3)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#10)(2008-12#14)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#12)(2012-3#5)(2013-1#9)(2013-8#5)
The purpose of##215##3##(1990-11#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-6#2)(1997-3#1)(1997-8#3)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#16)(2008-11#13)(2008-12#16)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-1#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#12)(2012-12#2)(2012-2#12)(2012-3#7)(2013-1#11)(2013-8#9)
The purpose was to##2##4##(1991-6#1)(2009-7#1)
The purpose##224##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-6#2)(1997-3#1)(1997-8#3)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#17)(2008-11#13)(2008-12#17)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#12)(2012-12#2)(2012-2#12)(2012-3#7)(2013-1#15)(2013-8#9)
The purposes of this study##2##5##(2008-6#1)(2010-11#1)
The purposes of this##6##4##(2008-3#1)(2008-6#1)(2009-1#1)(2010-11#1)(2010-9#1)(2012-3#1)
The putative##10##2##(1990-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-6#1)(1997-4#1)(2008-10#3)
The pyrolysis and atomization temperatures##2##5##(2008-10#2)
The pyrolysis##3##2##(2008-10#3)
The qcr1##2##2##(2012-3#2)
The qualitative features##2##3##(1992-9#1)(2008-8#1)
The qualitative##7##2##(1992-9#1)(1993-1#1)(1995-5#1)(2008-8#2)(2008-9#1)(2013-1#1)
The quality of care##2##4##(1993-1#1)(2008-1#1)
The quality of the##4##4##(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
The quality of##13##3##(1993-1#1)(1993-2#1)(1995-5#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)
The quality##19##2##(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-5#1)(1997-5#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)
The quantification limit##2##3##(2008-10#2)
The quantification of##6##3##(2008-10#6)
The quantification##10##2##(2008-10#10)
The quantitative analysis of the##3##5##(2008-10#3)
The quantitative analysis of##5##4##(2008-10#5)
The quantitative analysis##6##3##(2008-10#6)
The quantitative relationships between##2##4##(1996-2#1)(2008-10#1)
The quantitative trait loci##2##4##(2008-10#1)(2008-8#1)
The quantitative##19##2##(1996-2#1)(2008-10#15)(2008-11#1)(2008-6#1)(2008-8#1)
The quantity of##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
The quartz crystal##2##3##(2008-10#2)
The quenching of##2##3##(1992-6#1)(2008-10#1)
The quenching##7##2##(1992-6#1)(1994-5#1)(2008-10#5)
The question arises##2##3##(2011-2#2)
The question of##4##3##(1992-12#1)(1996-6#1)(2011-2#1)(2013-1#1)
The question##10##2##(1992-12#1)(1993-3#1)(1996-11#1)(1996-6#1)(2007-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
The questionnaire was##3##3##(1991-1#1)(2008-10#1)(2013-1#1)
The questionnaire##7##2##(1991-1#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#2)
The questionnaires##2##2##(2009-12#1)(2010-1#1)
The questions##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
The rabbit##2##2##(1992-6#1)(2008-10#1)
The rachis##2##2##(2008-10#2)
The radar##2##2##(2008-3#2)
The radial distribution##2##3##(1992-9#1)(2008-10#1)
The radial##4##2##(1992-9#1)(2008-10#1)(2010-7#1)(2011-2#1)
The radical scavenging##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
The radiological##3##2##(2007-8#1)(2012-2#1)(2013-8#1)
The radiology department##2##3##(1996-1#2)
The random amplified polymorphic DNA##2##5##(2008-10#2)
The random##4##2##(2008-10#2)(2010-11#1)(2010-8#1)
The randomized##2##2##(1996-6#2)
The range of linearity using the##2##6##(2008-10#2)
The range of linearity##3##4##(2008-10#3)
The range of the##3##4##(2008-10#3)
The range of##13##3##(1996-9#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-11#1)(2011-2#1)
The range##15##2##(1996-9#1)(1997-2#1)(1997-4#1)(2008-10#10)(2008-11#1)(2011-2#1)
The rank order of##2##4##(1993-8#1)(1995-8#1)
The rapid development##2##3##(1994-12#1)(2013-8#1)
The rapid##11##2##(1994-1#1)(1994-12#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#2)
The rapidity of##2##3##(1992-9#1)(2008-10#1)
The rapidly##3##2##(1990-8#1)(2008-12#1)(2010-1#1)
The rare earth##2##3##(2008-10#1)(2012-2#1)
The rarity and##2##3##(1990-12#1)(2008-12#1)
The rarity##5##2##(1990-12#1)(1990-9#1)(2008-12#1)(2010-5#1)(2013-1#1)
The rat##9##2##(1991-5#1)(1992-10#1)(1992-6#1)(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2011-3#1)
The rate constant for the##2##5##(1991-5#1)(1994-5#1)
The rate constants of the repair##2##6##(2008-8#1)(2008-9#1)
The rate constants##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
The rate of change in##2##5##(2008-10#2)
The rate of growth##2##4##(1997-1#1)(2008-7#1)
The rate of increase##3##4##(1993-3#1)(2008-10#2)
The rate of temporal increase in disease##2##7##(2008-10#2)
The rate of the reaction##2##5##(2008-10#2)
The rate of the##6##4##(1995-2#1)(2008-10#4)(2010-12#1)
The rate of##46##3##(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-4#1)(1993-3#2)(1994-5#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#2)(1997-2#1)(2008-10#18)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-12#2)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)
The rate##54##2##(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-3#2)(1994-5#2)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#2)(1997-2#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)
The rates of##6##3##(1990-11#1)(1993-1#1)(2008-10#3)(2011-1#1)
The rates##7##2##(1990-11#1)(1993-1#1)(2008-10#3)(2011-1#1)(2012-12#1)
The ratio of hapten##2##4##(2008-11#2)
The ratio of signal intensity##2##5##(2009-11#2)
The ratio of the##5##4##(1996-2#1)(2008-10#3)(2008-3#1)
The ratio of##27##3##(1990-5#1)(1990-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#2)(2011-1#1)(2011-2#1)
The ratio##31##2##(1990-5#1)(1990-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#12)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#2)(2011-1#1)(2011-2#1)(2012-12#1)
The rational##3##2##(1990-3#1)(1992-5#1)(2008-11#1)
The rationale behind the##2##4##(2008-12#1)(2008-9#1)
The rationale behind##3##3##(2008-12#1)(2008-3#1)(2008-9#1)
The rationale for##7##3##(1992-3#1)(1992-9#1)(1993-1#1)(2008-11#2)(2010-8#1)(2011-2#1)
The rationale##11##2##(1992-3#1)(1992-9#1)(1993-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)
The ratios of##9##3##(1993-3#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#2)(2011-2#1)
The ratios##12##2##(1993-3#1)(1996-3#2)(1997-3#1)(2008-10#5)(2008-11#2)(2011-2#1)
The rats were##2##3##(1993-11#1)(1993-3#1)
The rats##5##2##(1993-11#1)(1993-3#1)(1994-5#1)(2008-10#1)(2012-2#1)
The reaction between##3##3##(2008-10#3)
The reaction can be##2##4##(2008-10#2)
The reaction can##3##3##(2008-10#3)
The reaction is instantaneous and absorbance##2##6##(2008-10#2)
The reaction is##8##3##(1996-5#1)(2008-10#7)
The reaction mechanism for##2##4##(2008-10#2)
The reaction mechanism##4##3##(2008-10#2)(2008-12#2)
The reaction of 3##2##4##(2008-10#2)
The reaction of aluminium chloride with##2##6##(2008-10#2)
The reaction of##19##3##(1993-3#1)(1995-9#1)(1996-5#1)(2008-10#14)(2008-8#1)(2008-9#1)
The reaction product##4##3##(2008-10#4)
The reaction rate constants##2##4##(2008-10#1)(2008-9#1)
The reaction rate##3##3##(2008-10#2)(2008-9#1)
The reaction was monitored spectrophotometrically by measuring the decrease in absorbance of carminic acid at##2##15##(2008-10#2)
The reaction was monitored spectrophotometrically by measuring the increase in absorbance of##2##12##(2008-10#2)
The reaction was monitored spectrophotometrically by measuring the##4##8##(2008-10#4)
The reaction was monitored##5##4##(2008-10#5)
The reaction was##8##3##(2008-10#8)
The reaction##67##2##(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1995-9#1)(1996-5#3)(2008-10#51)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#2)(2013-1#2)
The reactions between##2##3##(2008-10#2)
The reactions of##2##3##(2008-10#1)(2009-8#1)
The reactions##7##2##(1997-3#1)(2008-10#4)(2008-5#1)(2009-8#1)
The reactive##4##2##(1993-8#1)(1995-6#1)(2008-10#2)
The reactivity of##5##3##(1992-2#1)(1994-5#1)(2008-10#2)(2008-11#1)
The reactivity##9##2##(1992-2#1)(1994-5#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
The reactor using DAO from##2##5##(2008-10#2)
The reactor##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
The readability##2##2##(2011-1#2)
The reagent gives##2##3##(2008-10#2)
The reagent##7##2##(2008-10#7)
The reagents are dispensed##2##4##(2008-10#2)
The reagents are##3##3##(2008-10#3)
The reagents##4##2##(2008-10#4)
The real part of the refractive index##2##7##(2008-3#2)
The real samples were##2##4##(2008-10#2)
The real##10##2##(1994-1#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#2)(2012-3#1)
The real-time PCR assay##2##4##(2008-10#2)
The real-time PCR##4##3##(2008-10#4)
The real-time##7##2##(2008-10#5)(2010-4#1)(2011-2#1)
The reality of##2##3##(2008-11#1)(2013-1#1)
The realization of##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
The reason for this##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
The reason for##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
The reason##6##2##(1997-3#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
The reasons for this##2##4##(2008-10#1)(2012-2#1)
The reasons for##5##3##(1993-11#1)(1997-3#1)(1997-7#1)(2008-10#1)(2012-2#1)
The reasons##8##2##(1993-11#1)(1996-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
The recent advent of##2##4##(2008-3#1)(2010-8#1)
The recent cloning of##2##4##(1994-11#1)(2009-8#1)
The recent development of##3##4##(2008-10#1)(2008-5#1)(2009-12#1)
The recent identification of##4##4##(1996-2#2)(2008-7#1)(2011-2#1)
The recent introduction of##2##4##(2008-3#1)(2011-2#1)
The recent##33##2##(1993-2#1)(1993-8#1)(1994-11#1)(1996-2#2)(1997-6#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
The recently##4##2##(1990-11#1)(1996-12#1)(2008-10#2)
The receptor##4##2##(2008-11#2)(2008-9#1)(2010-8#1)
The recessive mouse mutant##2##4##(1996-2#2)
The recognition of##7##3##(1990-9#1)(1992-12#1)(1995-6#1)(2008-10#2)(2008-5#1)(2010-12#1)
The recognition##10##2##(1990-9#1)(1992-12#1)(1995-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-12#1)
The recombinant enzyme displayed##2##4##(1992-8#1)(2011-1#1)
The recombinant enzyme##3##3##(1992-8#2)(2011-1#1)
The recombinant human NGF was##2##5##(1990-8#2)
The recombinant protein is##2##4##(2008-8#2)
The recombinant protein##3##3##(2008-8#2)(2010-12#1)
The recombinant proteins##2##3##(1990-11#1)(1993-8#1)
The recombinant royalisin##2##3##(2011-2#2)
The recombinant##27##2##(1990-11#1)(1990-8#2)(1991-9#1)(1992-8#3)(1993-6#1)(1993-8#2)(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-8#3)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#4)
The recombination##2##2##(2009-3#1)(2013-8#1)
The recommendations##4##2##(1997-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
The recommended method has been applied to the##2##8##(2008-10#2)
The recommended method has been applied##3##6##(2008-10#3)
The recommended method##4##3##(2008-10#4)
The recommended##5##2##(2008-10#5)
The reconstructed##2##2##(2008-5#1)(2008-9#1)
The reconstruction##3##2##(2008-3#2)(2008-9#1)
The recorded##3##2##(2007-12#1)(2008-10#1)(2009-8#1)
The records of##3##3##(2008-1#1)(2008-5#1)(2008-7#1)
The recovered##2##2##(2008-10#1)(2008-12#1)
The recoveries are##3##3##(2008-10#3)
The recoveries for the##4##4##(1997-2#1)(2008-10#3)
The recoveries for##8##3##(1997-2#1)(2008-10#7)
The recoveries of a standard added in real solution samples are between##2##12##(2008-10#2)
The recoveries of the##5##4##(2008-10#5)
The recoveries of##26##3##(1992-11#1)(2008-10#25)
The recoveries ranged##2##3##(2008-10#2)
The recoveries were &gt##2##4##(2008-10#2)
The recoveries were##3##3##(2008-10#3)
The recoveries##46##2##(1992-11#1)(1997-2#1)(2008-10#44)
The recovery obtained##2##3##(2008-10#2)
The recovery of Cr(VI) was##2##5##(2008-10#2)
The recovery of Cr(VI)##3##4##(2008-10#3)
The recovery of spiked water samples was from##2##8##(2008-10#2)
The recovery of spiked##4##4##(2008-10#4)
The recovery of the assay was##2##6##(1992-6#1)(2008-10#1)
The recovery of the##4##4##(1992-6#1)(2008-10#1)(2009-8#1)(2013-1#1)
The recovery of##32##3##(1990-2#1)(1990-5#1)(1992-6#1)(1995-11#1)(2008-10#25)(2008-11#1)(2009-8#1)(2013-1#1)
The recovery rate was##2##4##(2008-10#1)(2008-11#1)
The recovery studies##2##3##(2008-10#2)
The recovery values obtained##3##4##(2008-10#3)
The recovery values##6##3##(2008-10#6)
The recovery was##4##3##(2008-10#4)
The recovery##61##2##(1990-2#1)(1990-5#1)(1992-6#1)(1995-11#1)(2008-10#51)(2008-11#2)(2009-8#1)(2012-3#1)(2013-1#2)
The recurrence rate##2##3##(1992-11#1)(1995-5#1)
The red##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
The redox reaction##3##3##(2008-10#3)
The redox##7##2##(2008-10#6)(2008-11#1)
The reduced##13##2##(1991-3#1)(1992-1#1)(1993-8#1)(2008-10#5)(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
The reducing##3##2##(1992-5#1)(2008-11#2)
The reduction current of##2##4##(2008-10#2)
The reduction current##4##3##(2008-10#4)
The reduction in##9##3##(1990-5#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-7#3)(2011-2#1)(2013-8#1)
The reduction of Hg(II)##2##4##(2008-10#2)
The reduction of##13##3##(1990-3#1)(1996-6#1)(2008-10#10)(2011-2#1)
The reduction peak##2##3##(2008-10#2)
The reduction##31##2##(1990-3#1)(1990-5#1)(1995-2#1)(1996-6#1)(1997-3#1)(2008-10#20)(2008-7#3)(2011-2#2)(2013-8#1)
The reference##3##2##(2008-10#3)
The refinement of##2##3##(2008-10#1)(2009-7#1)
The refractive-index##3##2##(2008-3#3)
The regenerated##3##2##(2008-10#2)(2013-1#1)
The regimen##2##2##(1990-6#1)(2008-10#1)
The region of the##2##4##(1990-5#1)(1993-6#1)
The region##8##2##(1990-5#1)(1991-7#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-3#1)
The regional##3##2##(1991-2#1)(1994-12#1)(2013-3#1)
The regions##4##2##(1997-8#2)(2008-10#1)(2011-2#1)
The regression equation for##2##4##(2008-10#2)
The regression equation##3##3##(2008-10#3)
The regression method##2##3##(2008-10#2)
The regression models were subsequently##2##5##(2008-10#2)
The regression models##3##3##(2008-10#2)(2008-11#1)
The regression##11##2##(2008-10#8)(2008-11#1)(2008-6#1)(2011-2#1)
The regulation of##8##3##(1993-8#1)(1996-2#1)(1997-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
The regulation was##2##3##(2008-11#1)(2008-9#1)
The regulation##10##2##(1993-8#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
The regulatory##2##2##(1990-2#1)(2012-2#1)
The relapse##3##2##(1990-6#1)(2008-1#1)(2012-3#1)
The related##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
The relation between sample concentration and reflectance is described by the Kubelka-Munk equation##2##13##(2008-10#2)
The relation between##10##3##(1990-8#1)(1992-6#1)(1992-9#1)(1993-11#1)(1997-3#1)(2008-10#3)(2008-11#1)(2010-3#1)
The relation of##2##3##(2012-12#1)(2013-8#1)
The relation##12##2##(1990-8#1)(1992-6#1)(1992-9#1)(1993-11#1)(1997-3#1)(2008-10#3)(2008-11#1)(2010-3#1)(2012-12#1)(2013-8#1)
The relationship among##2##3##(2008-10#1)(2008-8#1)
The relationship between incidence##2##4##(2008-10#2)
The relationship between peak##3##4##(2008-10#3)
The relationship between the structure##2##5##(2008-10#1)(2008-8#1)
The relationship between the##17##4##(1990-2#1)(1991-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-12#1)
The relationship between##69##3##(1990-2#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
The relationship of##6##3##(1990-2#1)(1996-3#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
The relationship##82##2##(1990-2#3)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-10#20)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
The relationships among##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
The relationships between##4##3##(2008-10#3)(2013-1#1)
The relationships##7##2##(2008-10#4)(2008-3#1)(2008-9#1)(2013-1#1)
The relative EC50/IC50##2##3##(2012-2#2)
The relative abundance of##2##4##(2008-9#1)(2012-6#1)
The relative binding##2##3##(1990-11#1)(2010-1#1)
The relative error##2##3##(2008-10#2)
The relative errors##3##3##(2008-10#3)
The relative fluorescence intensity of##2##5##(2008-10#2)
The relative fluorescence intensity##3##4##(2008-10#3)
The relative merits and##2##4##(2008-10#1)(2008-11#1)
The relative risks##2##3##(1990-6#1)(1996-11#1)
The relative roles of##2##4##(2008-8#2)
The relative standard deviation (&lt##2##5##(2008-10#2)
The relative standard deviation (R##16##5##(2008-10#16)
The relative standard deviation (n=10) was 0##2##7##(2008-10#2)
The relative standard deviation (n=11)##2##5##(2008-10#2)
The relative standard deviation (n=6)##2##5##(2008-10#2)
The relative standard deviation for 10##4##6##(2008-10#4)
The relative standard deviation for 11 replicate##3##7##(2008-10#3)
The relative standard deviation for five##2##6##(2008-10#2)
The relative standard deviation for the##3##6##(2008-10#3)
The relative standard deviation for##23##5##(2008-10#23)
The relative standard deviation is 3##2##6##(2008-10#2)
The relative standard deviation is##6##5##(2008-10#6)
The relative standard deviation of 11##2##6##(2008-10#2)
The relative standard deviation of the method##2##7##(2008-10#2)
The relative standard deviation of the proposed technique was##2##9##(2008-10#2)
The relative standard deviation of the proposed##3##7##(2008-10#3)
The relative standard deviation of the##8##6##(2008-10#8)
The relative standard deviation of##21##5##(2008-10#21)
The relative standard deviation values for##2##6##(2008-10#2)
The relative standard deviation values##3##5##(2008-10#3)
The relative standard deviation was 0##3##6##(2008-10#3)
The relative standard deviation was 1##4##6##(2008-10#4)
The relative standard deviation was 2##3##6##(2008-10#3)
The relative standard deviation was 3##2##6##(2008-10#2)
The relative standard deviation was found to be##2##8##(2008-10#2)
The relative standard deviation was##18##5##(2008-10#18)
The relative standard deviation##104##4##(2008-10#104)
The relative standard deviations (R##9##5##(2008-10#9)
The relative standard deviations for ten##3##6##(2008-10#3)
The relative standard deviations for##10##5##(2008-10#9)(2008-5#1)
The relative standard deviations of repeated measurements of##2##8##(2008-10#2)
The relative standard deviations of the determinations were below 9%##2##10##(2008-10#2)
The relative standard deviations of the##9##6##(2008-10#9)
The relative standard deviations of##15##5##(2008-10#15)
The relative standard deviations were in all instances less than##2##10##(2008-10#2)
The relative standard deviations were##5##5##(2008-10#5)
The relative standard deviations##50##4##(2008-10#48)(2008-5#2)
The relative standard##159##3##(2008-10#157)(2008-5#2)
The relative##203##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1992-12#1)(1993-8#1)(1996-11#1)(1997-3#1)(2008-10#176)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2010-1#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#1)
The relatively##9##2##(1995-11#1)(1996-11#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-10#1)(2013-1#1)
The release of ascospores##2##4##(2008-10#2)
The release of##8##3##(1992-3#1)(2008-10#5)(2008-11#1)(2008-5#1)
The release##12##2##(1992-3#1)(2008-10#5)(2008-11#2)(2008-5#4)
The relevance of these findings to##2##6##(2008-10#2)
The relevance of these##3##4##(2008-10#2)(2012-4#1)
The relevance of##8##3##(2008-10#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-4#1)
The relevance##9##2##(1991-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-4#1)
The relevant parameters##2##3##(2008-10#1)(2008-11#1)
The relevant##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
The reliability of the entire procedure was checked with the analysis of##2##12##(2008-10#2)
The reliability of the method##3##5##(2008-10#3)
The reliability of the procedures is##2##6##(2008-10#2)
The reliability of the##11##4##(2008-10#11)
The reliability of##13##3##(1990-2#1)(2008-10#12)
The reliability was##2##3##(2008-10#1)(2013-1#1)
The reliability##19##2##(1990-2#1)(1991-9#1)(2008-10#15)(2010-10#1)(2013-1#1)
The remainder of the##2##4##(1993-12#1)(2010-10#1)
The remainder##4##2##(1993-12#1)(2008-7#1)(2008-9#1)(2010-10#1)
The remaining 13##2##3##(2008-10#1)(2008-7#1)
The remaining isolates##3##3##(2008-10#3)
The remaining patients were##2##4##(1992-5#1)(2011-1#1)
The remaining patients##3##3##(1990-11#1)(1992-5#1)(2011-1#1)
The remaining##35##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
The remarkable##4##2##(1990-11#1)(1993-8#1)(2008-3#1)(2010-12#1)
The removal of##2##3##(2008-10#1)(2008-7#1)
The removal process should not##2##5##(2011-1#1)(2011-2#1)
The removal##4##2##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
The renal##2##2##(2008-5#2)
The rep-PCR fingerprints##2##3##(2008-10#2)
The rep-PCR##4##2##(2008-10#4)
The repeatability and##2##3##(2008-10#2)
The repeatability for##3##3##(2008-10#3)
The repeatability of the method##2##5##(2008-10#2)
The repeatability of the proposed sensor##2##6##(2008-10#2)
The repeatability of the##9##4##(2008-10#9)
The repeatability of##10##3##(2008-10#10)
The repeatability was##3##3##(2008-10#3)
The repeatability##24##2##(2008-10#24)
The replacement of##3##3##(1991-12#1)(1996-1#1)(2008-10#1)
The report is##2##3##(2008-7#1)(2013-1#1)
The report recommended##2##3##(1993-12#1)(2008-11#1)
The report##18##2##(1991-6#1)(1993-12#1)(1995-12#2)(1996-5#1)(2008-10#3)(2008-11#4)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
The reported values##2##3##(2008-10#2)
The reported##13##2##(1993-6#1)(1994-12#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-9#1)(2012-2#1)
The reporting##3##2##(1990-3#1)(2008-10#1)(2008-6#1)
The reports on##2##3##(1996-11#1)(1996-8#1)
The reports##4##2##(1990-3#1)(1991-1#1)(1996-11#1)(1996-8#1)
The reproducibilities were s(r##2##4##(2008-10#2)
The reproducibilities##3##2##(2008-10#3)
The reproducibility between##2##3##(2008-10#2)
The reproducibility is##2##3##(2008-10#2)
The reproducibility of the##5##4##(2008-10#3)(2010-7#1)(2012-2#1)
The reproducibility of##7##3##(2008-10#5)(2010-7#1)(2012-2#1)
The reproducibility was##5##3##(2008-10#4)(2009-11#1)
The reproducibility##18##2##(2008-10#15)(2009-11#1)(2010-7#1)(2012-2#1)
The reproducible##3##2##(2008-10#2)(2008-7#1)
The required##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
The research highlights##2##3##(1996-1#1)(2008-12#1)
The research was conducted##2##4##(1997-6#1)(2011-2#1)
The research was##4##3##(1997-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
The research##21##2##(1993-1#2)(1995-3#1)(1996-1#2)(1997-1#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-12#3)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
The researchers##3##2##(1993-2#2)(2011-2#1)
The resected##2##2##(2008-7#1)(2013-1#1)
The resection of##2##3##(2010-12#1)(2013-1#1)
The residual##6##2##(1996-8#1)(2008-10#4)(2008-8#1)
The residue##3##2##(2008-10#3)
The resin exhibits no affinity for alkali or alkaline earth metals##2##11##(2008-10#2)
The resin was used##2##4##(2008-10#2)
The resin was##5##3##(2008-10#5)
The resin##12##2##(2008-10#12)
The resins##2##2##(2008-10#2)
The resistance gene in##2##4##(2008-10#2)
The resistance gene##4##3##(2008-10#4)
The resistance genes##2##3##(2008-10#2)
The resistance is##2##3##(2008-10#2)
The resistance of##2##3##(1997-5#1)(2008-10#1)
The resistance##15##2##(1997-5#1)(2008-10#14)
The resistant and##2##3##(2008-10#1)(2008-5#1)
The resistant##9##2##(2008-10#8)(2008-5#1)
The resolution of binary mixtures of##2##6##(2008-10#2)
The resolution of##5##3##(2008-10#4)(2008-3#1)
The resolution##11##2##(1997-2#1)(2008-10#6)(2008-3#3)(2009-9#1)
The resonance##2##2##(2008-3#1)(2009-7#1)
The respective##3##2##(1990-5#1)(2008-10#1)(2009-6#1)
The respondents##3##2##(1995-1#1)(2011-1#2)
The response characteristics of the##2##5##(2008-10#2)
The response characteristics of##4##4##(2008-10#4)
The response characteristics##6##3##(2008-10#6)
The response current##2##3##(2008-10#2)
The response is##3##3##(2008-10#3)
The response mechanism##3##3##(2008-10#3)
The response of a##2##4##(2008-10#1)(2008-3#1)
The response of the electrode detector as a peak-shape signal was obtained for injected##2##14##(2008-10#2)
The response of the electrode##3##5##(2008-10#3)
The response of the sensor to##2##6##(2008-10#2)
The response of the sensor##4##5##(2008-10#4)
The response of the##9##4##(2008-10#9)
The response of##20##3##(1991-5#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)
The response patterns##2##3##(2008-10#1)(2008-11#1)
The response range of##2##4##(2008-10#2)
The response rate was##4##4##(1990-9#1)(2008-1#1)(2008-11#1)(2011-2#1)
The response rate##6##3##(1990-9#1)(1991-8#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
The response time for##2##4##(2008-10#2)
The response time of electrode##2##5##(2008-10#2)
The response time of the electrode is less than##2##9##(2008-10#2)
The response time of the electrode is##3##7##(2008-10#3)
The response time of the electrode was##2##7##(2008-10#2)
The response time of the electrode##5##6##(2008-10#5)
The response time of the sensor is##2##7##(2008-10#2)
The response time of the##8##5##(2008-10#8)
The response time of##11##4##(2008-10#11)
The response time##16##3##(2008-10#16)
The response to the inquiry was 67% (non-responders did not otherwise differ from responders)##2##14##(1991-8#2)
The response to the##3##4##(1990-12#1)(1991-8#2)
The response to##10##3##(1990-12#1)(1991-8#2)(1993-3#1)(1995-5#1)(1996-6#1)(2008-10#4)
The response was linear over##3##5##(2008-10#3)
The response was linear##5##4##(1997-2#1)(2008-10#4)
The response was##8##3##(1994-8#1)(1997-2#1)(2008-10#6)
The response##89##2##(1990-12#1)(1990-9#1)(1991-5#1)(1991-8#3)(1993-3#1)(1994-8#1)(1995-5#1)(1996-6#1)(1997-2#1)(2008-1#2)(2008-10#65)(2008-11#5)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
The responses of the##2##4##(2008-10#1)(2008-9#1)
The responses of##8##3##(2008-10#5)(2008-9#1)(2012-3#1)(2012-5#1)
The responses to##3##3##(1990-7#1)(2008-8#2)
The responses were##2##3##(2008-10#1)(2008-5#1)
The responses##13##2##(1990-7#1)(2008-10#6)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)(2012-5#1)
The rest##3##2##(1992-2#1)(2008-10#1)(2010-8#1)
The resting##2##2##(1994-3#1)(2008-4#1)
The restoration of##2##3##(2008-11#1)(2013-7#1)
The restoration##3##2##(2008-11#1)(2008-3#1)(2013-7#1)
The restricted##2##2##(2008-10#2)
The result indicated that##5##4##(2008-8#4)(2008-9#1)
The result indicates that##3##4##(1994-11#1)(2009-9#1)(2012-2#1)
The result is##4##3##(1991-12#1)(1992-3#1)(1996-12#1)(1996-3#1)
The result obtained##2##3##(1996-8#1)(2008-10#1)
The result of the##4##4##(1990-2#1)(1993-12#1)(1995-8#1)(2010-10#1)
The result of##16##3##(1990-2#1)(1993-12#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-10#1)(2012-3#1)(2013-8#1)
The result showed that##8##4##(2008-11#1)(2008-8#3)(2008-9#2)(2009-6#1)(2011-3#1)
The result shows that##3##4##(2008-10#3)
The result shows##4##3##(2008-10#4)
The result suggests that##3##4##(1997-3#1)(2010-7#1)(2013-1#1)
The result was##2##3##(1994-2#1)(2008-12#1)
The result##56##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#12)(2008-9#4)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The resultant spatial##2##3##(2008-10#1)(2011-2#1)
The resultant##19##2##(1990-5#1)(1991-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#3)(2013-1#1)
The resulting chelating resin##2##4##(2008-10#2)
The resulting data##2##3##(2008-10#2)
The resulting equations##2##3##(2008-10#2)
The resulting expression##2##3##(1990-5#1)(2010-7#1)
The resulting fusion protein was##2##5##(1994-8#1)(2008-10#1)
The resulting fusion protein##3##4##(1994-8#1)(2008-10#1)(2008-4#1)
The resulting high##2##3##(1995-12#1)(2008-3#1)
The resulting membrane##2##3##(2008-10#1)(2010-12#1)
The resulting method##2##3##(2008-10#2)
The resulting##91##2##(1990-5#2)(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#40)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#4)(2012-3#3)
The results above##2##3##(2008-8#2)
The results agree with those##2##5##(2008-10#2)
The results agree##3##3##(2008-10#3)
The results also indicate##2##4##(2008-10#1)(2013-1#1)
The results also revealed##2##4##(1992-3#1)(2008-9#1)
The results also show##2##4##(2008-10#2)
The results also showed that##2##5##(2008-7#1)(2008-9#1)
The results also suggest that the##2##6##(2008-6#1)(2008-8#1)
The results also suggest that##5##5##(1993-3#1)(2008-10#2)(2008-6#1)(2008-8#1)
The results also##20##3##(1990-5#1)(1992-3#1)(1993-3#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2013-1#2)
The results and##2##3##(1992-3#1)(2008-11#1)
The results are compared with those obtained from##2##8##(2008-10#2)
The results are compared with those obtained with##2##8##(2008-10#1)(2008-3#1)
The results are compared with those obtained##4##7##(2008-10#3)(2008-3#1)
The results are compared with##6##5##(2008-10#3)(2008-3#3)
The results are compared##8##4##(2008-10#5)(2008-3#3)
The results are consistent with the##2##6##(1993-8#1)(2008-10#1)
The results are consistent with##3##5##(1993-8#1)(2008-10#2)
The results are discussed and compared##2##6##(1993-11#1)(2010-3#1)
The results are discussed in light of##2##7##(2008-10#1)(2008-8#1)
The results are discussed in relation to##2##7##(1992-12#1)(1993-6#1)
The results are discussed in terms of##4##7##(1993-6#1)(1995-11#1)(2008-10#1)(2008-5#1)
The results are discussed in##9##5##(1992-12#1)(1993-6#2)(1995-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
The results are discussed with##2##5##(1995-12#1)(2011-1#1)
The results are discussed##15##4##(1992-12#1)(1993-11#1)(1993-6#2)(1995-11#1)(1995-12#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)
The results are in good agreement with those obtained##2##9##(2008-10#1)(2008-3#1)
The results are in good agreement with##3##7##(2008-10#1)(2008-3#2)
The results are in##5##4##(2008-10#3)(2008-3#2)
The results are##47##3##(1991-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#17)(2008-2#1)(2008-3#8)(2008-5#4)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
The results can be##2##4##(1990-12#1)(1994-5#1)
The results clearly show that##3##5##(1990-5#1)(1991-9#1)(2008-7#1)
The results clearly showed that##2##5##(1993-11#1)(2008-5#1)
The results clearly##7##3##(1990-5#1)(1991-9#1)(1993-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
The results confirm the##3##4##(2008-11#2)(2008-3#1)
The results confirm##5##3##(2008-10#1)(2008-11#2)(2008-3#1)(2012-3#1)
The results confirmed##2##3##(1994-8#1)(2010-6#1)
The results demonstrate that the##6##5##(1991-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
The results demonstrate that these metal ions are extracted into##2##10##(2008-10#2)
The results demonstrate that these##3##5##(2008-10#3)
The results demonstrate that##24##4##(1991-12#1)(1991-3#1)(1993-1#1)(1996-12#1)(1996-2#2)(2008-10#11)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
The results demonstrate the##6##4##(1995-11#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-3#1)
The results demonstrate##31##3##(1991-12#1)(1991-3#1)(1993-1#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-2#2)(2007-12#1)(2008-10#14)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#1)
The results demonstrated that the##6##5##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)
The results demonstrated that##14##4##(1990-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2013-1#1)
The results demonstrated the##2##4##(2008-10#1)(2008-8#1)
The results demonstrated##21##3##(1990-6#1)(1992-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2013-1#1)(2013-8#1)
The results determined##2##3##(2008-10#1)(2013-1#1)
The results do not support the##2##6##(1990-2#1)(2008-8#1)
The results emphasize the##2##4##(1991-12#1)(2008-5#1)
The results exemplify##2##3##(2008-10#1)(2008-9#1)
The results exhibited##2##3##(2008-10#1)(2013-8#1)
The results for##8##3##(1997-1#1)(2008-10#5)(2008-3#1)(2008-7#1)
The results found##2##3##(2008-10#1)(2009-7#1)
The results from the##5##4##(2008-10#3)(2008-11#1)(2013-1#1)
The results from these studies demonstrate that yeast is a viable trace metal enrichment##2##14##(2008-10#2)
The results from these##3##4##(1992-10#1)(2008-10#2)
The results from this study##5##5##(2008-10#3)(2010-7#1)(2010-8#1)
The results from this##7##4##(2008-10#3)(2008-12#1)(2008-3#1)(2010-7#1)(2010-8#1)
The results from##22##3##(1992-10#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
The results further##2##3##(1991-1#1)(2008-7#1)
The results has been##2##4##(1990-3#1)(1995-2#1)
The results have been discussed in##2##6##(2008-10#2)
The results have implications for##2##5##(1994-6#1)(2008-8#1)
The results have##10##3##(1994-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-5#1)(2011-3#1)
The results herein presented prove##2##5##(2010-10#2)
The results highlight the##3##4##(2008-5#1)(2012-12#1)(2012-2#1)
The results illustrate the##3##4##(1994-9#1)(2008-3#1)(2011-2#1)
The results illustrate##4##3##(1994-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
The results imply that##6##4##(1995-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
The results in##2##3##(1995-11#1)(2008-10#1)
The results indicate that in##2##5##(1997-1#1)(2008-10#1)
The results indicate that the stationary phase behaves as a##2##10##(2008-10#2)
The results indicate that the##27##5##(1992-3#1)(1993-12#1)(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#9)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
The results indicate that there##2##5##(1992-12#1)(2008-5#1)
The results indicate that these##2##5##(1994-5#1)(2008-10#1)
The results indicate that##75##4##(1990-9#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#3)(2008-3#3)(2008-5#4)(2008-6#1)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
The results indicate##80##3##(1990-9#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#3)(2008-3#3)(2008-5#4)(2008-6#1)(2008-8#4)(2008-9#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
The results indicated a##5##4##(1992-2#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
The results indicated that a##2##5##(1993-3#1)(2008-5#1)
The results indicated that the##19##5##(1996-5#1)(1996-6#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2011-3#3)
The results indicated that there was a##2##7##(2008-10#2)
The results indicated that##50##4##(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-5#1)(1996-6#2)(2008-10#23)(2008-11#2)(2008-5#2)(2008-8#3)(2008-9#5)(2010-12#1)(2011-2#1)(2011-3#4)(2012-12#1)(2013-8#1)
The results indicated##60##3##(1990-11#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1996-5#1)(1996-6#2)(1997-7#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#6)(2010-12#1)(2011-2#1)(2011-3#4)(2012-12#1)(2013-8#1)
The results obtained agree##2##4##(2008-10#2)
The results obtained analysing##2##4##(2008-10#2)
The results obtained are compared##2##5##(2008-11#1)(2008-3#1)
The results obtained are consistent with##2##6##(2008-10#2)
The results obtained are in##2##5##(2008-10#2)
The results obtained are##9##4##(2008-10#7)(2008-11#1)(2008-3#1)
The results obtained by the proposed method were##2##8##(2008-10#2)
The results obtained by the proposed##3##6##(2008-10#3)
The results obtained by the##7##5##(2008-10#7)
The results obtained by this method agreed with those by the official method##2##13##(2008-10#2)
The results obtained by this method##3##6##(2008-10#3)
The results obtained by this##4##5##(2008-10#4)
The results obtained by##16##4##(2008-10#16)
The results obtained confirm that the##2##6##(2008-10#1)(2008-7#1)
The results obtained demonstrate##2##4##(2008-10#2)
The results obtained for the determination of##2##7##(2008-10#2)
The results obtained for the##6##5##(2008-10#6)
The results obtained for##21##4##(2008-10#21)
The results obtained from the##3##5##(2008-10#2)(2008-5#1)
The results obtained from##6##4##(2008-10#5)(2008-5#1)
The results obtained in the##7##5##(1992-9#1)(2008-10#4)(2008-5#1)(2009-12#1)
The results obtained in##9##4##(1992-9#1)(2008-10#6)(2008-5#1)(2009-12#1)
The results obtained indicate that the##2##6##(2008-10#1)(2008-5#1)
The results obtained indicate that##4##5##(2008-10#3)(2008-5#1)
The results obtained indicate##7##4##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)
The results obtained indicated##2##4##(2008-10#2)
The results obtained show that##4##5##(2008-10#4)
The results obtained show##6##4##(2008-10#5)(2008-5#1)
The results obtained showed that##3##5##(1993-3#1)(2008-10#2)
The results obtained showed##4##4##(1993-3#1)(2008-10#3)
The results obtained suggest that##2##5##(2008-10#1)(2008-11#1)
The results obtained using this method were##2##7##(2008-10#2)
The results obtained using this##3##5##(2008-10#3)
The results obtained using##4##4##(2008-10#4)
The results obtained were compared with the##2##7##(2008-10#1)(2008-5#1)
The results obtained were compared with those achieved by##2##9##(2008-10#2)
The results obtained were compared with those##3##7##(2008-10#3)
The results obtained were compared with##5##6##(2008-10#4)(2008-5#1)
The results obtained were compared##6##5##(2008-10#5)(2008-5#1)
The results obtained were validated by##2##6##(2008-10#2)
The results obtained were##11##4##(2008-10#10)(2008-5#1)
The results obtained with the##5##5##(2008-10#4)(2011-2#1)
The results obtained with this##3##5##(2008-10#3)
The results obtained with##14##4##(2008-10#11)(2008-11#1)(2011-2#1)(2012-12#1)
The results obtained##132##3##(1992-9#1)(1993-11#1)(1993-3#1)(1996-12#1)(2008-10#113)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#1)(2009-12#1)(2011-2#1)(2012-12#1)
The results of a series of##2##6##(2008-3#1)(2008-4#1)
The results of a##7##4##(1995-8#1)(1997-2#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)
The results of an open##2##5##(1990-12#1)(1991-8#1)
The results of an##3##4##(1990-12#1)(1991-8#1)(1997-2#1)
The results of applying the H-point standard addition method showed that##2##11##(2008-10#2)
The results of applying##3##4##(2008-10#2)(2012-2#1)
The results of both the##2##5##(1996-6#1)(2008-7#1)
The results of both##4##4##(1996-6#1)(2008-3#1)(2008-7#2)
The results of determination for three human serum samples##2##9##(2008-10#2)
The results of determination for##3##5##(2008-10#3)
The results of determination of##2##5##(2008-10#2)
The results of determination##5##4##(2008-10#5)
The results of investigation##2##4##(2007-11#1)(2008-10#1)
The results of method detection limit and accuracy and precision studies are reported##2##13##(2008-10#2)
The results of our current study##2##6##(2013-8#2)
The results of our study##2##5##(1992-12#1)(2012-3#1)
The results of our##7##4##(1992-12#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
The results of the analysis##3##5##(1995-12#1)(2008-10#1)(2008-3#1)
The results of the present study indicate that##2##8##(2008-10#1)(2008-12#1)
The results of the present study##6##6##(2008-10#1)(2008-12#2)(2008-5#1)(2011-7#1)(2012-5#1)
The results of the present##7##5##(2008-10#1)(2008-12#2)(2008-5#1)(2011-7#1)(2012-5#1)(2013-8#1)
The results of the study##4##5##(1996-1#1)(1996-12#1)(2008-11#1)(2008-5#1)
The results of the survey##2##5##(2008-10#2)
The results of the##45##4##(1992-1#1)(1994-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-7#1)(2012-5#1)(2013-8#1)
The results of these experiments##2##5##(2008-10#2)
The results of these studies##5##5##(1991-9#1)(2008-10#3)(2008-11#1)
The results of these##13##4##(1991-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-5#2)
The results of this analysis##2##5##(2008-10#1)(2008-12#1)
The results of this case##2##5##(2008-12#1)(2012-12#1)
The results of this research show that##2##7##(1991-2#1)(2010-10#1)
The results of this research show##3##6##(1991-2#1)(2008-10#1)(2010-10#1)
The results of this research##4##5##(1991-2#1)(1997-1#1)(2008-10#1)(2010-10#1)
The results of this study are##2##6##(2008-3#1)(2008-7#1)
The results of this study demonstrate that##2##7##(2008-10#1)(2008-5#1)
The results of this study demonstrate##3##6##(1997-3#1)(2008-10#1)(2008-5#1)
The results of this study highlight##2##6##(1995-1#1)(2008-12#1)
The results of this study indicate that the##2##8##(1996-3#1)(2009-7#1)
The results of this study indicate that##8##7##(1995-1#1)(1996-3#1)(1996-6#1)(2008-10#3)(2009-7#1)(2011-2#1)
The results of this study suggest that##4##7##(1994-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
The results of this study were##2##6##(1991-2#1)(2008-11#1)
The results of this study will##2##6##(2008-10#1)(2008-5#1)
The results of this study##35##5##(1991-2#1)(1992-2#1)(1994-12#1)(1995-1#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
The results of this work show##2##6##(2008-12#1)(2010-8#1)
The results of this##52##4##(1991-2#2)(1992-2#1)(1993-12#1)(1994-12#1)(1995-1#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#11)(2008-11#3)(2008-12#9)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
The results of treatment##2##4##(1992-2#1)(2008-7#1)
The results of##213##3##(1990-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-5#2)(1997-8#1)(2007-11#1)(2008-10#67)(2008-11#8)(2008-12#16)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#7)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#3)
The results on##2##3##(1997-8#1)(2013-8#1)
The results point to the##2##5##(1990-6#1)(1995-3#1)
The results point to##3##4##(1990-6#1)(1994-2#1)(1995-3#1)
The results point##4##3##(1990-6#1)(1994-2#1)(1995-3#1)(2008-10#1)
The results presented here suggest that##2##6##(2008-10#1)(2008-7#1)
The results presented here##8##4##(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)
The results presented in this##2##5##(1993-6#1)(2008-10#1)
The results presented##13##3##(1993-6#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)
The results provide a##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
The results provide evidence that##2##5##(2008-10#2)
The results provide evidence##3##4##(2008-10#2)(2009-7#1)
The results provide##12##3##(1992-2#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
The results provided##2##3##(2008-10#2)
The results reveal that the##2##5##(1994-1#1)(2012-2#1)
The results reveal that##4##4##(1993-12#1)(1994-1#1)(2010-10#1)(2012-2#1)
The results reveal##6##3##(1993-12#1)(1994-1#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
The results revealed that the##2##5##(2008-10#1)(2008-5#1)
The results revealed that##8##4##(1994-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)
The results revealed##12##3##(1991-1#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)
The results seem to indicate##2##5##(1997-8#1)(2008-7#1)
The results seem to##3##4##(1997-8#1)(2008-10#1)(2008-7#1)
The results seem##4##3##(1990-5#1)(1997-8#1)(2008-10#1)(2008-7#1)
The results should##2##3##(2010-4#1)(2011-2#1)
The results show a high##2##5##(1993-8#1)(2008-5#1)
The results show a##4##4##(1990-5#1)(1993-8#1)(2008-3#1)(2008-5#1)
The results show that a##3##5##(1994-2#1)(2006-6#1)(2008-7#1)
The results show that both##2##5##(2008-10#2)
The results show that in##3##5##(1994-8#1)(2008-10#1)(2008-9#1)
The results show that the calix[8]arene-bonded phase exhibits high##2##9##(2008-10#2)
The results show that the calix[8]arene-bonded phase exhibits##3##8##(2008-10#3)
The results show that the##46##5##(1991-12#1)(1992-4#1)(1994-3#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#7)(2008-9#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#2)(2013-8#2)
The results show that there is##2##6##(1991-9#1)(2008-10#1)
The results show that this##3##5##(2008-10#1)(2008-5#1)(2009-8#1)
The results show that##103##4##(1990-11#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-12#1)(1996-12#1)(2006-6#2)(2008-1#1)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#5)(2008-7#3)(2008-8#9)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
The results show the effectiveness of##2##6##(1996-12#1)(2010-4#1)
The results show the##5##4##(1996-12#1)(2008-10#3)(2010-4#1)
The results show##123##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-2#2)(1994-3#1)(1994-8#2)(1995-12#1)(1996-12#2)(2006-6#2)(2008-1#1)(2008-10#49)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#6)(2008-7#3)(2008-8#9)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#3)
The results showed a significant##3##5##(2008-1#1)(2008-10#1)(2011-2#1)
The results showed a statistically significant##2##6##(2008-12#1)(2013-1#1)
The results showed a##8##4##(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
The results showed an##3##4##(1991-2#1)(2008-10#1)(2011-2#1)
The results showed high##2##4##(2008-10#1)(2013-1#1)
The results showed significant##2##4##(2010-3#1)(2010-8#1)
The results showed that (i) the##2##6##(2008-9#2)
The results showed that (i)##3##5##(2008-8#1)(2008-9#2)
The results showed that a##2##5##(2009-5#1)(2010-12#1)
The results showed that in##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
The results showed that nurses##2##5##(2012-3#2)
The results showed that simultaneous##2##5##(2008-10#2)
The results showed that the method##2##6##(2008-10#2)
The results showed that the proposed##2##6##(2008-10#2)
The results showed that the##36##5##(1997-3#1)(2008-10#11)(2008-11#2)(2008-5#3)(2008-8#7)(2008-9#6)(2009-11#1)(2011-2#2)(2011-3#3)
The results showed that there##2##5##(2008-12#1)(2008-8#1)
The results showed that these##3##5##(1996-1#1)(2008-10#1)(2008-9#1)
The results showed that trace enrichment of the metals under study with yeast##2##13##(2008-10#2)
The results showed that##113##4##(1990-12#1)(1993-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#32)(2008-11#12)(2008-12#3)(2008-5#5)(2008-8#15)(2008-9#17)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#4)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
The results showed the##6##4##(1993-1#1)(2008-10#2)(2009-10#1)(2011-1#1)(2012-3#1)
The results showed##140##3##(1990-12#1)(1991-2#1)(1993-1#1)(1993-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#40)(2008-11#12)(2008-12#4)(2008-5#5)(2008-8#17)(2008-9#18)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#4)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#3)
The results suggest a possible##2##5##(1991-5#1)(1993-6#1)
The results suggest a##5##4##(1991-12#1)(1991-5#1)(1993-6#2)(1994-3#1)
The results suggest that a##2##5##(2008-10#1)(2008-8#1)
The results suggest that in##2##5##(1990-2#1)(1993-3#1)
The results suggest that the##25##5##(1990-5#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
The results suggest that there may be##2##7##(2008-12#1)(2011-2#1)
The results suggest that##76##4##(1990-2#1)(1990-5#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#19)(2008-11#5)(2008-12#3)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#5)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
The results suggest the need for##2##6##(1995-1#1)(2008-9#1)
The results suggest the##4##4##(1995-1#1)(2008-1#1)(2008-12#1)(2008-9#1)
The results suggest##87##3##(1990-2#1)(1990-5#2)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#3)(1994-11#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#4)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#6)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
The results suggested that the##5##5##(1997-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-3#1)
The results suggested that##8##4##(1996-2#1)(1997-8#1)(2008-10#2)(2008-8#2)(2010-4#1)(2011-3#1)
The results support a##2##4##(2008-5#1)(2008-7#1)
The results support the hypothesis that##3##6##(1992-7#1)(2008-10#2)
The results support the##7##4##(1992-12#1)(1992-7#1)(2008-10#2)(2008-8#2)(2009-12#1)
The results support##12##3##(1992-12#1)(1992-7#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)
The results taken together##2##4##(1990-12#1)(2008-11#1)
The results thus obtained##2##4##(1990-3#1)(2008-10#1)
The results were also##2##4##(2008-10#1)(2010-8#1)
The results were as follows##2##5##(1990-2#1)(1995-2#1)
The results were checked##2##4##(2008-10#2)
The results were compared to those##2##6##(2008-10#2)
The results were compared with those obtained by##3##8##(2008-10#3)
The results were compared with those obtained using a##2##9##(2008-10#2)
The results were compared with those obtained using##3##8##(2008-10#3)
The results were compared with those obtained##7##7##(2008-10#7)
The results were compared with those##8##6##(2008-10#8)
The results were compared with##16##5##(1991-8#1)(2008-10#14)(2008-12#1)
The results were compared##20##4##(1991-8#1)(2008-10#18)(2008-12#1)
The results were found to be in good agreement with the##2##11##(2008-10#2)
The results were in good agreement with those##2##8##(2008-10#2)
The results were in##3##4##(2008-10#3)
The results were interpreted as##2##5##(2008-5#2)
The results were interpreted##3##4##(1993-8#1)(2008-5#2)
The results were similar##2##4##(1994-12#1)(2008-8#1)
The results were used##2##4##(2008-10#2)
The results were##65##3##(1990-2#1)(1991-1#1)(1991-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(2008-10#40)(2008-12#3)(2008-3#2)(2008-5#2)(2008-8#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
The results will##4##3##(2008-11#1)(2008-8#2)(2008-9#1)
The results##1243##2##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#6)(1990-6#2)(1990-9#1)(1991-1#3)(1991-12#4)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#7)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#9)(1993-2#4)(1993-3#5)(1993-6#11)(1993-8#5)(1994-1#2)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#7)(1995-12#5)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#4)(1996-11#1)(1996-12#8)(1996-2#7)(1996-3#2)(1996-5#1)(1996-6#4)(1997-1#5)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#5)(1997-8#4)(2006-6#2)(2007-11#1)(2007-12#4)(2008-1#5)(2008-10#488)(2008-11#56)(2008-12#38)(2008-2#9)(2008-3#35)(2008-4#1)(2008-5#47)(2008-6#3)(2008-7#23)(2008-8#72)(2008-9#52)(2009-10#6)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#4)(2009-7#6)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#10)(2010-9#1)(2011-1#7)(2011-2#22)(2011-3#11)(2011-7#1)(2012-12#4)(2012-2#11)(2012-3#14)(2012-5#1)(2012-9#1)(2013-1#28)(2013-7#1)(2013-8#18)
The resuscitation##2##2##(1996-6#1)(2011-2#1)
The retained Cr(VI)##2##3##(2008-10#2)
The retained analyte##2##3##(2008-10#2)
The retained##10##2##(2008-10#10)
The retention and##3##3##(2008-10#3)
The retention mechanism##2##3##(2008-10#2)
The retention times of##2##4##(2008-10#1)(2009-8#1)
The retention times##3##3##(2008-10#2)(2009-8#1)
The retention##15##2##(2008-10#14)(2009-8#1)
The retrieval##3##2##(2008-3#3)
The retrieved##2##2##(2008-2#1)(2008-3#1)
The retrospective##2##2##(1996-6#1)(2008-11#1)
The reverse##5##2##(1991-9#1)(2008-10#2)(2008-11#1)(2008-7#1)
The reversibility of##3##3##(2008-10#3)
The reversible##2##2##(2008-10#2)
The review concludes with##2##4##(2010-11#1)(2010-5#1)
The review concludes##3##3##(2008-11#1)(2010-11#1)(2010-5#1)
The review is##3##3##(2008-10#2)(2008-11#1)
The review of literature regarding##2##5##(2012-2#2)
The review##17##2##(2008-10#6)(2008-11#3)(2010-11#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
The reviews##2##2##(2011-2#2)
The revised##2##2##(2008-11#1)(2010-10#1)
The rheological##3##2##(2008-5#1)(2008-8#1)(2010-4#1)
The ribosomal##2##2##(1997-7#1)(2008-10#1)
The rice##4##2##(2008-10#1)(2008-12#1)(2009-10#1)(2013-8#1)
The right to##2##3##(1997-5#1)(1997-8#1)
The right##6##2##(1990-6#1)(1992-2#1)(1997-5#1)(1997-8#1)(2008-11#1)(2013-1#1)
The right-hemisphere##2##2##(2008-11#2)
The ring sinus##2##3##(2011-2#2)
The ring-disc electrode was##2##4##(2008-10#2)
The risk associated##2##3##(1991-12#1)(2009-10#1)
The risk factors##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
The risk for##2##3##(2008-7#1)(2012-3#1)
The risk of developing##2##4##(1991-2#1)(2008-7#1)
The risk of##21##3##(1991-2#2)(1991-8#1)(1992-5#1)(1994-6#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-9#1)(2013-1#1)
The risk##35##2##(1990-6#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-5#1)(1994-6#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
The risks of##5##3##(1991-8#2)(1994-6#1)(2008-10#1)(2013-1#1)
The risks##8##2##(1991-8#2)(1994-6#1)(2008-10#1)(2008-2#1)(2010-6#1)(2013-1#1)(2013-8#1)
The rms##2##2##(2008-10#1)(2008-8#1)
The robustness of the proposed##2##5##(2008-10#2)
The robustness of the##3##4##(2008-10#3)
The robustness of this##2##4##(2008-10#1)(2010-10#1)
The robustness of##5##3##(2008-10#4)(2010-10#1)
The role of a##2##4##(1990-12#1)(2008-10#1)
The role of an emergency department observation unit in a clinical pathway for atrial##2##14##(2008-3#2)
The role of an##3##4##(2008-10#1)(2008-3#2)
The role of clinical##3##4##(1996-2#1)(2008-4#1)(2013-7#1)
The role of cyclic AMP##2##5##(1994-6#2)
The role of cyclic##3##4##(1994-11#1)(1994-6#2)
The role of estrogen in##2##5##(1995-9#1)(2010-6#1)
The role of radiotherapy##2##4##(1994-8#1)(2009-1#1)
The role of the lecturer##2##5##(2008-11#1)(2008-12#1)
The role of the nurse##2##5##(2008-11#2)
The role of the##34##4##(1990-8#1)(1991-11#1)(1991-2#1)(1992-3#1)(1993-2#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#3)(2012-2#1)
The role of these##3##4##(1993-9#1)(2008-10#2)
The role of##173##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#29)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#12)(2011-3#1)(2011-7#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
The role##178##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#29)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#12)(2011-3#1)(2011-7#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
The roles and##2##3##(1991-1#1)(1994-1#1)
The roles of##8##3##(1995-9#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-8#1)
The roles##10##2##(1991-1#1)(1994-1#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-8#1)
The root mean square error of prediction##2##7##(2008-10#2)
The root mean square##4##4##(2008-10#2)(2008-9#1)(2010-9#1)
The root##8##2##(1994-12#1)(2008-10#4)(2008-12#1)(2008-9#1)(2010-9#1)
The root-mean-square##2##2##(2008-10#1)(2008-3#1)
The route of##2##3##(2008-10#2)
The routine##4##2##(1990-6#1)(2008-7#1)(2008-9#2)
The rubidium content of##2##4##(2008-10#2)
The rule##2##2##(2008-10#1)(2008-11#1)
The running buffer##2##3##(2008-10#2)
The running##3##2##(2008-10#3)
The rust##4##2##(2008-10#4)
The sIL-6R##2##2##(1997-7#2)
The safety of the##2##4##(1996-9#1)(2008-8#1)
The safety of##5##3##(1996-9#1)(2008-10#1)(2008-8#2)(2011-2#1)
The safety##7##2##(1990-12#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-8#2)(2011-2#1)
The salient##2##2##(1993-2#1)(1993-8#1)
The same rats##2##3##(1993-6#2)
The same results were##2##4##(2008-10#1)(2010-6#1)
The same samples were##2##4##(2008-10#2)
The same trend##2##3##(2008-11#1)(2010-4#1)
The same was##2##3##(2008-10#1)(2008-11#1)
The same wheat##2##3##(2008-10#2)
The same##58##2##(1990-5#2)(1990-6#1)(1992-6#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(2007-12#2)(2008-10#26)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
The sample consisted of##10##4##(1994-1#1)(1995-1#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
The sample extraction##2##3##(2008-10#2)
The sample included##2##3##(1991-2#1)(2008-11#1)
The sample is initially mixed on-line with##2##7##(2008-10#2)
The sample is##10##3##(2008-10#8)(2008-5#2)
The sample preparation##4##3##(2008-10#4)
The sample solution##3##3##(2008-10#3)
The sample throughput is##2##4##(2008-10#2)
The sample throughput rate is##2##5##(2008-10#2)
The sample throughput was##8##4##(2008-10#8)
The sample throughput##13##3##(2008-10#13)
The sample volume##2##3##(2008-10#2)
The sample was##12##3##(1995-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#2)
The sample##82##2##(1990-9#1)(1991-2#1)(1994-1#1)(1995-1#2)(2008-10#55)(2008-11#4)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
The samples are##5##3##(2008-10#5)
The samples of##2##3##(2008-10#2)
The samples were digested##2##4##(2008-10#2)
The samples were##16##3##(1997-2#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2013-1#2)(2013-8#1)
The samples##33##2##(1997-2#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)(2013-1#2)(2013-8#2)
The sampling frequency is##2##4##(2008-10#2)
The sampling frequency was##4##4##(2008-10#4)
The sampling frequency##7##3##(2008-10#7)
The sampling rate and relative standard deviation##2##7##(2008-10#2)
The sampling rate and##3##4##(2008-10#3)
The sampling rate is##3##4##(2008-10#3)
The sampling rate was##5##4##(2008-10#5)
The sampling rate##11##3##(2008-10#11)
The sampling was performed##2##4##(2008-5#2)
The sampling was##3##3##(2008-5#2)(2013-1#1)
The sampling##29##2##(2008-10#24)(2008-11#1)(2008-5#2)(2013-1#2)
The satisfaction##2##2##(1991-2#1)(2013-8#1)
The satisfactory##3##2##(1991-11#1)(2008-10#1)(2008-5#1)
The saturation##4##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
The scFv##2##2##(2008-10#2)
The scale##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
The scanning electron##3##3##(2008-10#2)(2008-5#1)
The scanning tunneling microscope##2##4##(1990-11#1)(2010-7#1)
The scanning##6##2##(1990-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)
The scattering##2##2##(2008-2#1)(2008-3#1)
The scavenging##2##2##(1993-6#1)(2008-10#1)
The scheme##2##2##(2008-10#2)
The science of##2##3##(1993-12#1)(1995-5#1)
The science##3##2##(1993-12#1)(1993-2#1)(1995-5#1)
The scientific##7##2##(1991-3#1)(1995-11#1)(2008-10#2)(2008-11#2)(2010-11#1)
The scope and##2##3##(1997-3#1)(2008-10#1)
The scope of the reaction##2##5##(1996-5#1)(2009-10#1)
The scope of the##3##4##(1996-5#1)(2008-4#1)(2009-10#1)
The scope##5##2##(1996-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2009-10#1)
The score##2##2##(1991-12#1)(2008-10#1)
The scores related to##2##4##(2008-10#1)(2010-10#1)
The scores##3##2##(2008-10#2)(2010-10#1)
The screen was##2##3##(1992-12#1)(2008-9#1)
The screening##3##2##(1991-6#1)(2008-5#1)(2011-3#1)
The search for##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
The search##9##2##(1994-3#1)(2008-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
The seasonal##3##2##(2008-10#1)(2008-5#2)
The second ORF##2##3##(1996-6#2)
The second approach##3##3##(2008-10#2)(2008-3#1)
The second derivative##2##3##(2008-10#2)
The second group##3##3##(1990-2#1)(2008-10#1)(2011-2#1)
The second is##6##3##(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)(2012-3#1)
The second method is##2##4##(2008-10#1)(2012-2#1)
The second method was##2##4##(2008-10#2)
The second method##9##3##(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
The second one##2##3##(2008-3#1)(2008-9#1)
The second part##4##3##(1997-2#1)(2008-8#1)(2009-6#1)(2013-8#1)
The second patient##3##3##(2008-1#1)(2009-1#1)(2013-1#1)
The second section##3##3##(2008-10#2)(2008-4#1)
The second type##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
The second##87##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
The second-harmonic##3##2##(2007-11#1)(2008-2#2)
The secondary##6##2##(1990-12#1)(1995-3#1)(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
The secretion of##2##3##(1991-5#1)(2008-11#1)
The secretion##3##2##(1991-5#1)(1991-6#1)(2008-11#1)
The secretory##2##2##(2007-12#1)(2011-2#1)
The secured##2##2##(1991-2#2)
The security##3##2##(1991-3#1)(1996-12#1)(2010-8#1)
The seed treatment##2##3##(2008-10#2)
The seed##4##2##(2008-10#3)(2013-8#1)
The segregation of##2##3##(2008-10#2)
The segregation##3##2##(2008-10#3)
The selected##9##2##(2008-10#5)(2008-8#2)(2009-6#1)(2012-3#1)
The selection of the##5##4##(2008-10#5)
The selection of##12##3##(1995-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2012-3#1)(2013-1#1)
The selection##18##2##(1990-8#1)(1995-5#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The selective##10##2##(1992-10#1)(2008-10#7)(2008-7#1)(2008-8#1)
The selectivity and##2##3##(2008-10#2)
The selectivity coefficient values for mono-##2##6##(2008-10#2)
The selectivity coefficient values##3##4##(2008-10#3)
The selectivity coefficient##4##3##(2008-10#4)
The selectivity coefficients for##2##4##(2008-10#2)
The selectivity coefficients##3##3##(2008-10#3)
The selectivity for##2##3##(2008-10#2)
The selectivity of the reaction##2##5##(2008-10#2)
The selectivity of the##4##4##(2008-10#4)
The selectivity of this##3##4##(2008-10#3)
The selectivity of##10##3##(2008-10#10)
The selectivity##29##2##(2008-10#29)
The selenium##3##2##(2008-10#3)
The sensing characteristics##2##3##(2008-10#2)
The sensing film##2##3##(2008-10#2)
The sensing membrane of the electrode was##2##7##(2008-10#2)
The sensing membrane##4##3##(2008-10#4)
The sensing##11##2##(2008-10#11)
The sensitive##4##2##(2008-10#4)
The sensitivities of##3##3##(2008-10#2)(2008-3#1)
The sensitivities##5##2##(2008-10#3)(2008-12#1)(2008-3#1)
The sensitivity analysis##2##3##(2008-11#2)
The sensitivity and positive predictive values##2##6##(1994-3#1)(2012-12#1)
The sensitivity and selectivity of the##2##6##(2008-10#2)
The sensitivity and specificity of##3##5##(1991-2#1)(2008-11#1)(2011-2#1)
The sensitivity and specificity##5##4##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
The sensitivity and##13##3##(1991-2#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
The sensitivity for the determination of##2##6##(2008-10#2)
The sensitivity for the##3##4##(2008-10#3)
The sensitivity for##6##3##(2008-10#5)(2013-1#1)
The sensitivity of the method is##3##6##(2008-10#3)
The sensitivity of the method##7##5##(2008-10#7)
The sensitivity of the##29##4##(1990-11#1)(1990-2#1)(2008-10#24)(2008-3#1)(2008-5#1)(2008-9#1)
The sensitivity of thermal lensing##2##5##(2008-10#2)
The sensitivity of this method##2##5##(2008-10#2)
The sensitivity of this##4##4##(2008-10#4)
The sensitivity of##49##3##(1990-11#1)(1990-12#1)(1990-2#2)(1991-6#1)(1991-8#1)(1997-3#1)(2008-10#34)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)
The sensitivity was improved##2##4##(2008-10#2)
The sensitivity was of##2##4##(2008-10#2)
The sensitivity was##9##3##(1990-2#1)(2008-10#7)(2013-8#1)
The sensitivity##92##2##(1990-11#1)(1990-12#1)(1990-2#3)(1991-2#1)(1991-6#1)(1991-8#1)(1994-3#1)(1995-11#1)(1997-3#1)(2008-10#58)(2008-11#6)(2008-2#1)(2008-3#4)(2008-5#2)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
The sensor can be##2##4##(2008-10#2)
The sensor characteristics##2##3##(2008-10#2)
The sensor could be##2##4##(2008-10#2)
The sensor exhibited##2##3##(2008-10#2)
The sensor exhibits a Nernstian response for##2##7##(2008-10#2)
The sensor exhibits a linear##2##5##(2008-10#2)
The sensor exhibits a##5##4##(2008-10#5)
The sensor exhibits adequate##2##4##(2008-10#2)
The sensor exhibits##9##3##(2008-10#9)
The sensor has a##2##4##(2008-10#2)
The sensor has been used in the potentiometric titration of##2##10##(2008-10#2)
The sensor has been used##4##5##(2008-10#4)
The sensor has been##8##4##(2008-10#8)
The sensor has##10##3##(2008-10#10)
The sensor is based on a##3##6##(2008-10#2)(2008-3#1)
The sensor is based on the##2##6##(2008-10#2)
The sensor is based on##6##5##(2008-10#5)(2008-3#1)
The sensor is fully reversible##2##5##(2008-10#2)
The sensor is stable##2##4##(2008-10#2)
The sensor is used for##2##5##(2008-10#2)
The sensor is##22##3##(2008-10#21)(2008-3#1)
The sensor performance was##2##4##(2008-10#2)
The sensor responds to##3##4##(2008-10#3)
The sensor response##4##3##(2008-10#4)
The sensor showed##2##3##(2008-10#2)
The sensor shows a linear##2##5##(2008-10#2)
The sensor shows good selectivity for##2##6##(2008-10#2)
The sensor shows good##3##4##(2008-10#3)
The sensor shows##7##3##(2008-10#7)
The sensor signals##2##3##(2008-10#2)
The sensor system is##2##4##(2008-10#2)
The sensor system##4##3##(2008-10#4)
The sensor was also used##2##5##(2008-10#2)
The sensor was also##3##4##(2008-10#3)
The sensor was applied to##2##5##(2008-10#2)
The sensor was developed in conjunction with a monochannel flow-injection analysis system with fluorimetric##2##14##(2008-10#2)
The sensor was found to have##2##6##(2008-10#2)
The sensor was##18##3##(2008-10#16)(2008-7#2)
The sensor works well in the##2##6##(2008-10#2)
The sensor works##3##3##(2008-10#3)
The sensor##113##2##(2008-10#109)(2008-3#1)(2008-7#3)
The sensors are used for direct##2##6##(2008-10#2)
The sensors are##3##3##(2008-10#3)
The sensors display##2##3##(2008-10#2)
The sensors exhibit##3##3##(2008-10#3)
The sensors were prepared by##2##5##(2008-10#2)
The sensors were##4##3##(2008-10#4)
The sensors##17##2##(2008-10#17)
The sensory##7##2##(1992-6#1)(1997-3#2)(2008-10#1)(2008-7#2)(2011-2#1)
The separate##2##2##(2008-10#2)
The separated##3##2##(2008-10#3)
The separation and detection of##3##5##(2008-10#3)
The separation and determination of##3##5##(2008-10#3)
The separation and preconcentration of##2##5##(2008-10#2)
The separation and preconcentration##3##4##(2008-10#3)
The separation and##11##3##(2008-10#10)(2008-5#1)
The separation factor##2##3##(2008-10#2)
The separation factors##2##3##(2008-10#2)
The separation is performed##2##4##(2008-10#2)
The separation is##5##3##(2008-10#4)(2012-2#1)
The separation of anions was achieved##2##6##(2008-10#2)
The separation of arsenic##2##4##(2008-10#2)
The separation of the##3##4##(2008-10#2)(2008-3#1)
The separation of##18##3##(2008-10#17)(2008-3#1)
The separation was carried out by##2##6##(2008-10#2)
The separation was carried out##4##5##(2008-10#4)
The separation was completed##2##4##(2008-10#2)
The separation was performed##2##4##(2008-10#2)
The separation was##10##3##(2008-10#10)
The separation##59##2##(1997-2#1)(2008-10#54)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
The separations##3##2##(2008-10#2)(2008-7#1)
The sequence analysis##3##3##(1993-3#1)(1997-8#1)(2008-9#1)
The sequence data and gene information are available through the World Wide Web at http##2##15##(1997-6#1)(1997-8#1)
The sequence information##2##3##(1993-2#1)(2008-4#1)
The sequence of a##2##4##(1990-11#1)(1996-3#1)
The sequence of the##4##4##(1993-2#1)(1997-2#1)(2008-10#2)
The sequence of##19##3##(1990-11#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-9#2)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#7)(2010-5#1)
The sequence was##2##3##(1995-6#1)(1996-6#1)
The sequence##40##2##(1990-11#1)(1991-5#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1994-6#1)(1995-6#1)(1995-9#4)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
The sequenced##2##2##(2008-10#2)
The sequences of the##3##4##(2008-10#3)
The sequences of##8##3##(1990-8#2)(2008-10#6)
The sequences##11##2##(1990-8#2)(1995-12#1)(1995-6#1)(2008-10#7)
The sequencing##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
The sequential extraction##4##3##(2008-10#4)
The sequential injection (SIA) technique was applied##2##7##(2008-10#2)
The sequential injection##5##3##(2008-10#5)
The sequential##14##2##(2008-10#13)(2008-11#1)
The serial##3##2##(1997-6#1)(2011-2#2)
The series##2##2##(2008-10#1)(2010-5#1)
The serious##2##2##(2008-12#1)(2012-2#1)
The serological##2##2##(2008-10#2)
The seroprevalence##2##2##(2011-2#2)
The serum EC-SOD##2##3##(1992-11#2)
The serum thyroxine##2##3##(2008-11#2)
The serum##12##2##(1991-3#1)(1991-6#1)(1992-11#2)(2006-6#1)(2008-10#2)(2008-11#2)(2008-7#2)(2011-2#1)
The serum-free##2##2##(2008-11#2)
The service##3##2##(1995-2#1)(2008-1#1)(2008-9#1)
The set of##5##3##(1993-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
The set##8##2##(1993-11#1)(1997-2#1)(2008-10#3)(2008-4#1)(2013-1#1)(2013-8#1)
The setting##2##2##(2008-11#1)(2008-7#1)
The setup##2##2##(2010-12#2)
The seven management and planning tools are##2##7##(1994-1#1)(1994-2#1)
The seven##5##2##(1994-1#1)(1994-2#1)(2008-1#1)(2008-10#2)
The severe##2##2##(2008-10#1)(2009-7#1)
The severity of these##2##4##(2008-7#1)(2012-7#1)
The severity of##11##3##(1992-6#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-7#1)(2013-1#1)
The sexual##2##2##(1996-3#1)(2008-10#1)
The shape of the##3##4##(2008-10#2)(2008-8#1)
The shape##9##2##(1992-9#1)(1995-9#1)(2008-10#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)
The share##2##2##(1994-1#1)(1995-3#1)
The shared##2##2##(1996-2#1)(1997-7#1)
The shoot##2##2##(2008-12#1)(2013-1#1)
The short##7##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2012-3#1)
The shortest##2##2##(1996-6#1)(2008-5#1)
The side effects of##2##4##(2008-1#1)(2011-2#1)
The side##4##2##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
The signal was##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
The signal##21##2##(1993-6#1)(1995-6#1)(1995-8#1)(2008-10#10)(2008-11#1)(2008-3#4)(2008-7#1)(2010-6#1)(2010-7#1)
The signals##5##2##(2008-10#4)(2008-7#1)
The significance of this##3##4##(1990-11#1)(1993-6#1)(2008-9#1)
The significance of##12##3##(1990-11#1)(1993-6#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2013-1#1)
The significance##13##2##(1990-11#1)(1993-6#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2013-1#2)
The significant##15##2##(1992-12#1)(1996-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-12#1)(2012-2#1)(2012-3#2)
The significantly##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
The silencing##2##2##(2008-9#1)(2011-1#1)
The silica gel modified with##2##5##(2008-10#2)
The silica gel##4##3##(2008-10#4)
The silica##5##2##(2008-10#5)
The similar##2##2##(2008-10#1)(2013-1#1)
The similarities##2##2##(1993-3#1)(2010-12#1)
The similarity of##3##3##(1995-2#1)(1995-3#1)(2012-2#1)
The similarity##5##2##(1995-2#1)(1995-3#1)(2008-10#1)(2011-3#1)(2012-2#1)
The simple##10##2##(2008-10#8)(2011-2#1)(2012-12#1)
The simplest##6##2##(1995-5#1)(2008-10#2)(2008-11#2)(2009-5#1)
The simplicity of the##2##4##(2008-10#1)(2011-2#1)
The simplicity of##4##3##(2008-10#3)(2011-2#1)
The simplicity##6##2##(2008-10#4)(2008-11#1)(2011-2#1)
The simulation model##3##3##(2008-8#1)(2008-9#1)(2012-12#1)
The simulation of##3##3##(2008-10#2)(2013-1#1)
The simulation results##2##3##(2008-10#1)(2012-3#1)
The simulation##11##2##(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The simulations##2##2##(2008-11#1)(2008-3#1)
The simultaneous detection of##2##4##(2007-12#1)(2008-10#1)
The simultaneous detection##3##3##(2007-12#1)(2008-10#2)
The simultaneous determination of##12##4##(2008-10#12)
The simultaneous determination##13##3##(2008-10#13)
The simultaneous enrichment and determination of all the metals##2##9##(2008-10#2)
The simultaneous##23##2##(1991-8#1)(1996-3#1)(2007-12#1)(2008-10#20)
The single##9##2##(1994-3#1)(1995-2#1)(2008-10#5)(2009-8#1)(2012-12#1)
The site of##3##3##(1990-8#1)(1994-5#1)(2008-7#1)
The site##5##2##(1990-8#1)(1991-6#1)(1994-5#1)(2008-10#1)(2008-7#1)
The situation##2##2##(1990-12#1)(2008-11#1)
The six##2##2##(1994-5#1)(2011-2#1)
The size and##4##3##(1993-6#1)(1997-8#1)(2008-10#1)(2013-1#1)
The size of the##5##4##(1995-11#1)(2008-10#3)(2010-9#1)
The size of##9##3##(1995-11#1)(2008-10#4)(2010-9#1)(2011-1#1)(2013-1#2)
The size##17##2##(1993-6#1)(1995-11#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2013-1#3)
The skewness##2##2##(2008-10#2)
The skills##2##2##(1996-3#1)(2008-11#1)
The skin lesions##3##3##(2010-6#1)(2012-3#2)
The skin##14##2##(1991-8#1)(2008-12#1)(2008-5#7)(2010-11#1)(2010-6#1)(2012-3#3)
The slight##2##2##(2008-10#2)
The slope of the##5##4##(2008-10#5)
The slope of##9##3##(1991-2#1)(2008-10#8)
The slope##10##2##(1990-9#1)(1991-2#1)(2008-10#8)
The slopes of the electrodes were##3##6##(2008-10#3)
The slow##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
The sludge##2##2##(2008-12#2)
The slurries were prepared by##2##5##(2008-10#2)
The slurry was##2##3##(2008-10#2)
The slurry##3##2##(2008-10#3)
The small##11##2##(1992-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2013-1#1)
The smaller##3##2##(1993-8#1)(2008-10#1)(2008-7#1)
The smallest##5##2##(1997-2#1)(2008-10#3)(2013-1#1)
The smoking##2##2##(1993-2#1)(2008-1#1)
The smoothing##2##2##(2008-2#1)(2008-3#1)
The snakes were##2##3##(1996-12#1)(2008-7#1)
The so-called##2##2##(2007-12#1)(2010-8#1)
The social##3##2##(1992-1#1)(1997-1#1)(2008-9#1)
The sodium##2##2##(2008-10#2)
The software##3##2##(2008-10#2)(2013-1#1)
The soil samples were##3##4##(2008-10#2)(2008-12#1)
The soil##9##2##(2008-10#5)(2008-11#1)(2008-12#1)(2009-3#1)(2012-9#1)
The soilborne fungus##2##3##(2008-10#2)
The sol-gel##3##2##(2008-10#3)
The solar##3##2##(2008-10#1)(2008-3#2)
The solid mixture consisting of the##2##6##(2008-10#2)
The solid##6##2##(2008-10#5)(2012-2#1)
The solid-phase##2##2##(2008-10#2)
The solubility of toluene##2##4##(2008-10#2)
The solubility of##5##3##(2008-10#4)(2008-11#1)
The solubility##8##2##(2008-10#7)(2008-11#1)
The solution equilibria of##2##4##(2008-10#2)
The solution is##2##3##(1994-3#1)(2008-10#1)
The solution of##2##3##(2008-10#1)(2008-7#1)
The solution was##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
The solution##16##2##(1992-4#1)(1994-3#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-3#1)
The solutions##3##2##(1990-2#1)(2008-10#2)
The solvent extraction of##4##4##(2008-10#4)
The solvent system consisted of##2##5##(2008-10#2)
The solvent##9##2##(2008-10#9)
The sorbed elements##2##3##(2008-10#2)
The sorbed##3##2##(2008-10#3)
The sorbent##2##2##(2008-10#2)
The sorption capacity of the matrix##2##6##(2008-10#2)
The sorption capacity of the##4##5##(2008-10#4)
The sorption capacity##8##3##(2008-10#8)
The sorption data##2##3##(2008-10#2)
The sorption kinetics##2##3##(2008-10#2)
The sorption of##4##3##(2008-10#4)
The sorption##23##2##(2008-10#22)(2010-4#1)
The source##2##2##(2008-10#1)(2011-2#1)
The southern##2##2##(2008-10#1)(2008-8#1)
The soybean##2##2##(2008-10#1)(2008-12#1)
The spatial and temporal##2##4##(2008-10#1)(2008-5#1)
The spatial distribution##2##3##(2008-10#2)
The spatial dynamics of##2##4##(1995-5#1)(2011-2#1)
The spatial pattern of##3##4##(2008-10#3)
The spatial pattern##4##3##(2008-10#4)
The spatial scale of##2##4##(2008-8#2)
The spatial spread of disease was simulated using a half-Cauchy distribution with median dispersal distance mu (units of distance)##2##19##(2008-10#2)
The spatial##23##2##(1995-5#1)(1996-12#1)(1997-3#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2011-2#1)
The spatially##2##2##(2008-10#1)(2008-11#1)
The spatiotemporal##3##2##(2008-10#2)(2008-11#1)
The special##3##2##(1996-6#1)(1997-8#1)(2011-2#1)
The speciation of##4##3##(2008-10#4)
The speciation performance of##2##4##(2008-10#2)
The speciation was then repeated on##2##6##(2008-10#2)
The speciation##14##2##(2008-10#14)
The species is of interest##2##5##(2011-2#2)
The species is##4##3##(2008-10#1)(2011-2#3)
The species##14##2##(2008-10#7)(2008-12#2)(2011-2#5)
The species-specific##4##2##(2008-10#4)
The specific activity of##2##4##(1994-8#1)(1995-6#1)
The specific binding##4##3##(1992-3#1)(1993-3#1)(1995-12#1)(2008-9#1)
The specific growth##4##3##(2008-11#4)
The specific primers were##2##4##(2008-10#2)
The specific primers##3##3##(2008-10#2)(2013-8#1)
The specific##42##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#2)(1992-7#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-8#1)(2008-10#9)(2008-11#8)(2008-2#1)(2008-5#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
The specificity and##2##3##(2008-11#1)(2013-8#1)
The specificity of a##2##4##(1992-9#1)(2008-10#1)
The specificity of the##5##4##(1992-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
The specificity of this##2##4##(1996-3#1)(2008-10#1)
The specificity of##14##3##(1992-6#1)(1992-9#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
The specificity##18##2##(1992-6#1)(1992-9#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
The specimens were##2##3##(2013-1#2)
The specimens##3##2##(2008-7#1)(2013-1#2)
The spectra obtained##2##3##(2008-10#2)
The spectra of the##2##4##(2008-10#2)
The spectra were##2##3##(2008-10#1)(2008-3#1)
The spectra##11##2##(2008-10#10)(2008-3#1)
The spectral##15##2##(1992-1#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-7#1)
The spectrofluorimetric determination of##2##4##(2008-10#2)
The spectrophotometric##7##2##(2008-10#7)
The spectroscopic##3##2##(2008-10#3)
The spectrum of##4##3##(1992-12#1)(2008-7#1)(2009-12#1)(2011-2#1)
The spectrum was##2##3##(2008-10#2)
The spectrum##8##2##(1992-12#1)(2008-10#3)(2008-7#1)(2009-12#1)(2011-2#1)(2013-8#1)
The spermatozoa of##2##3##(2008-7#2)
The spermatozoa##3##2##(2008-7#3)
The spiked recoveries##2##3##(2008-10#2)
The spiked##3##2##(2008-10#3)
The spinal##2##2##(1995-12#1)(2011-2#1)
The spirometric parameters##2##3##(2008-1#1)(2008-7#1)
The spores##2##2##(2008-10#1)(2008-5#1)
The spread of##3##3##(2008-10#3)
The square of##2##3##(2008-10#1)(2012-3#1)
The square##4##2##(2008-10#2)(2008-2#1)(2012-3#1)
The stability constant##2##3##(2008-10#2)
The stability constants for##2##4##(2008-10#1)(2008-5#1)
The stability constants of the##3##5##(2008-10#3)
The stability constants of these##2##5##(1992-9#1)(2008-10#1)
The stability constants of##9##4##(1992-9#1)(2008-10#8)
The stability constants##12##3##(1992-9#1)(2008-10#10)(2008-5#1)
The stability of the##9##4##(2008-10#8)(2008-11#1)
The stability of these##2##4##(2008-10#1)(2008-8#1)
The stability of##16##3##(1995-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-8#1)
The stability##37##2##(1992-12#1)(1992-9#1)(1995-8#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
The stabilization##3##2##(1994-11#1)(1996-3#1)(2008-10#1)
The stable##8##2##(1996-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)(2012-9#1)
The staff##2##2##(2010-10#1)(2010-8#1)
The stalled##2##2##(1991-9#1)(1993-3#1)
The standard addition method##4##4##(2008-10#4)
The standard addition technique##2##4##(2008-10#2)
The standard addition##6##3##(2008-10#6)
The standard curve##2##3##(2008-10#2)
The standard deviation of the##2##5##(2008-10#2)
The standard deviation##5##3##(2008-10#5)
The standard treatment##2##3##(1997-5#1)(2013-8#1)
The standard##33##2##(1992-1#1)(1995-10#1)(1996-12#1)(1997-5#1)(2008-10#23)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
The starch##2##2##(1993-6#1)(2008-5#1)
The state of##4##3##(1993-12#1)(1994-12#1)(1997-6#1)(2008-8#1)
The state##9##2##(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-6#1)(1997-7#1)(2008-8#1)(2011-2#1)
The static##3##2##(2008-10#2)(2008-3#1)
The statistical analysis of##2##4##(1990-9#1)(1995-5#1)
The statistical analysis##5##3##(1990-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
The statistical properties of##2##4##(2008-11#1)(2008-3#1)
The statistical##15##2##(1990-9#1)(1995-5#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#2)
The status of the##2##4##(1993-3#1)(2013-1#1)
The status of##6##3##(1993-3#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
The status##7##2##(1993-3#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#2)
The stay in hospital##2##4##(1997-4#1)(1997-8#1)
The steady state levels of##2##5##(1991-5#1)(2008-11#1)
The steady state##5##3##(1991-5#1)(2008-10#2)(2008-11#2)
The steady-state##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
The stem##3##2##(2008-10#2)(2008-11#1)
The stents##2##2##(1990-8#2)
The steps##2##2##(2008-4#1)(2011-2#1)
The stepwise##3##2##(1994-12#1)(2008-10#1)(2008-4#1)
The steric##2##2##(2008-10#1)(2008-11#1)
The steroid-binding##2##2##(1990-11#2)
The stimulating effect of##2##4##(1994-8#1)(1996-2#1)
The stimulation of##3##3##(1994-3#1)(1995-2#1)(2008-7#1)
The stimulatory effect of##3##4##(1992-6#1)(1994-2#1)(1995-6#1)
The stoichiometric##5##2##(1992-3#1)(1994-3#2)(2007-12#1)(2008-10#1)
The stoichiometry of the extracted##2##5##(2008-10#2)
The stoichiometry of the##4##4##(2008-10#4)
The stoichiometry of##6##3##(1997-2#1)(2008-10#5)
The stoichiometry##9##2##(1997-2#1)(2008-10#8)
The storage process involves selecting the records from inactive status##2##10##(1994-3#2)
The storage stability##3##3##(2008-10#3)
The storage##7##2##(1994-3#2)(2008-10#4)(2008-3#1)
The story##2##2##(2010-1#1)(2012-2#1)
The strain described in this study was isolated from##2##9##(2011-2#2)
The strain described in this##3##5##(2011-2#3)
The strain##8##2##(2009-1#1)(2009-7#1)(2011-2#4)(2012-2#1)(2012-3#1)
The strains##5##2##(2008-10#4)(2008-5#1)
The strategic##3##2##(1991-8#1)(1994-3#1)(2012-2#1)
The strategies##4##2##(1994-1#1)(1997-1#1)(2008-11#1)(2012-12#1)
The strategy is##2##3##(1991-6#1)(2008-10#1)
The strategy##9##2##(1991-6#1)(1995-11#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-7#1)
The stratum corneum##2##3##(2008-5#2)
The stream##2##2##(2008-10#2)
The strength of the##2##4##(1997-8#1)(2008-10#1)
The strength of##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
The strengths and##2##3##(1993-1#1)(2008-11#1)
The strengths##4##2##(1993-1#1)(1996-1#1)(2008-11#1)(2008-3#1)
The stress##3##2##(1992-5#1)(1995-1#1)(2008-11#1)
The striatum##2##2##(1991-6#1)(2013-8#1)
The stripping step was carried out by##2##7##(2008-10#2)
The stripping##6##2##(2008-10#6)
The strong influence of##2##4##(2008-3#2)
The strong##8##2##(1993-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-7#1)
The stronger##2##2##(2008-4#1)(2012-5#1)
The strongest##7##2##(1990-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
The strongly##2##2##(2008-11#1)(2011-1#1)
The structural changes##4##3##(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#1)
The structural composition##2##3##(2008-10#2)
The structural gene##2##3##(1992-3#1)(1993-2#1)
The structural##18##2##(1992-3#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#1)
The structure and##4##3##(1993-3#1)(1993-6#1)(2008-12#1)(2010-4#1)
The structure of the##9##4##(1992-4#1)(1996-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-6#1)(2012-3#1)
The structure of##18##3##(1992-4#1)(1993-8#1)(1996-8#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
The structure was refined##2##4##(1993-8#1)(2008-8#1)
The structure was##5##3##(1993-8#1)(2008-10#1)(2008-8#2)(2008-9#1)
The structure##31##2##(1992-4#1)(1993-3#1)(1993-6#1)(1993-8#2)(1995-8#1)(1996-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-6#2)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
The structure-activity relationship of##2##4##(2008-11#1)(2011-3#1)
The structures are##2##3##(1990-11#1)(1990-5#1)
The structures of the##4##4##(1990-9#1)(1991-12#1)(1994-5#1)(2008-11#1)
The structures of these##2##4##(2008-10#1)(2008-11#1)
The structures of##9##3##(1990-9#1)(1991-12#1)(1994-5#1)(1996-5#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)
The structures thus##2##3##(1994-5#1)(2008-3#1)
The structures##14##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#1)(1994-5#2)(1996-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2011-2#1)(2012-2#1)
The student##2##2##(2008-12#1)(2010-3#1)
The students were##4##3##(2008-11#2)(2008-12#1)(2013-1#1)
The students##13##2##(1992-1#1)(2008-11#6)(2008-12#1)(2010-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
The students'##2##2##(2008-12#1)(2009-12#1)
The studied parameters##2##3##(2008-10#1)(2008-7#1)
The studied##12##2##(2008-10#10)(2008-7#1)(2010-8#1)
The studies of the##2##4##(2008-10#2)
The studies of##3##3##(2008-10#3)
The studies##14##2##(1991-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(2008-10#6)(2008-11#1)(2010-7#1)(2011-2#1)(2012-3#1)
The study aimed to understand##2##5##(2012-3#2)
The study aimed##3##3##(2012-3#3)
The study aims to##3##4##(2012-2#1)(2013-1#2)
The study also##11##3##(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-9#1)(2011-1#1)
The study and##2##3##(1993-2#1)(2008-10#1)
The study concluded that##2##4##(2008-11#2)
The study concludes that the##2##5##(1991-2#1)(2008-11#1)
The study demonstrated that##2##4##(2008-10#1)(2008-9#1)
The study demonstrated##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
The study design##3##3##(1994-3#1)(2011-2#1)(2013-8#1)
The study evaluates##2##3##(2008-5#1)(2008-7#1)
The study examined the##2##4##(2008-11#1)(2011-2#1)
The study examined##4##3##(2008-11#1)(2008-12#1)(2011-2#2)
The study findings##3##3##(1991-2#1)(1995-1#1)(2009-5#1)
The study focused on##2##4##(2008-10#1)(2013-1#1)
The study focuses on##2##4##(1994-12#1)(2008-11#1)
The study for##2##3##(2008-10#1)(2010-6#1)
The study found##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
The study group comprised##2##4##(2009-6#1)(2013-1#1)
The study group consisted of##3##5##(1994-3#1)(2012-2#1)(2013-1#1)
The study group##8##3##(1994-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
The study has shown that##2##5##(2008-10#1)(2011-1#1)
The study has##6##3##(1997-4#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-1#1)
The study highlights##2##3##(2008-10#1)(2008-11#1)
The study identified##2##3##(2008-7#1)(2008-9#1)
The study included##13##3##(1990-2#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#4)
The study includes a successful attempt at##2##7##(2008-10#2)
The study includes##4##3##(2008-10#3)(2008-3#1)
The study indicates that##2##4##(1993-2#1)(2008-10#1)
The study investigated##2##3##(2008-9#1)(2013-8#1)
The study involved##8##3##(1996-1#1)(1996-9#1)(2008-11#3)(2011-2#2)(2012-4#1)
The study is##9##3##(1991-12#1)(1991-3#1)(2008-11#1)(2009-1#1)(2009-8#1)(2010-2#1)(2012-3#1)(2013-1#2)
The study of the##11##4##(1993-1#1)(1997-7#1)(2008-10#5)(2008-11#1)(2011-10#1)(2012-12#1)(2013-1#1)
The study of##32##3##(1993-1#1)(1993-2#1)(1993-3#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#2)
The study population consisted of##2##5##(2008-11#1)(2012-12#1)
The study population##4##3##(2008-11#1)(2010-1#1)(2012-12#2)
The study presents##2##3##(2010-10#1)(2013-8#1)
The study provides##2##3##(2008-10#1)(2013-1#1)
The study reported here##2##4##(2008-12#1)(2010-5#1)
The study reported##3##3##(2008-12#1)(2010-3#1)(2010-5#1)
The study results will##2##4##(2008-9#1)(2010-6#1)
The study results##5##3##(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#2)
The study revealed##4##3##(1994-12#1)(1996-1#1)(2008-10#1)(2012-3#1)
The study sample consisted of##2##5##(2010-6#1)(2012-3#1)
The study sample##4##3##(1995-1#1)(1996-9#1)(2010-6#1)(2012-3#1)
The study showed that the##5##5##(1990-11#1)(2008-1#1)(2008-10#2)(2011-2#1)
The study showed that##9##4##(1990-11#1)(1990-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
The study showed##11##3##(1990-11#1)(1990-2#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#2)
The study shows that##8##4##(1991-12#1)(1993-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2009-3#1)(2013-1#1)
The study suggests that##3##4##(1990-8#1)(1996-9#1)(2008-9#1)
The study used a##2##4##(2008-11#1)(2013-1#1)
The study used##3##3##(2008-11#1)(2013-1#2)
The study uses##3##3##(1997-3#1)(2008-2#1)(2010-7#1)
The study was a##2##4##(2008-9#1)(2010-10#1)
The study was also##3##4##(2008-10#2)(2011-2#1)
The study was carried out on##2##6##(2008-10#1)(2008-5#1)
The study was carried out##6##5##(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
The study was conducted in a##2##6##(2009-12#1)(2012-2#1)
The study was conducted to##4##5##(2008-10#1)(2008-11#1)(2008-12#2)
The study was conducted##8##4##(2008-10#2)(2008-11#2)(2008-12#2)(2009-12#1)(2012-2#1)
The study was designed##3##4##(2008-8#1)(2010-3#1)(2011-2#1)
The study was performed in##2##5##(2008-5#1)(2008-7#1)
The study was performed with##2##5##(2008-10#2)
The study was performed##7##4##(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)
The study was##41##3##(1990-12#1)(1990-6#1)(1991-6#1)(1996-12#1)(1997-4#1)(2008-10#8)(2008-11#3)(2008-12#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#1)
The study##264##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#6)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-12#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#43)(2008-11#30)(2008-12#10)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#2)(2008-9#8)(2009-1#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#3)(2010-11#1)(2010-2#2)(2010-3#3)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#14)(2011-3#1)(2012-12#6)(2012-2#5)(2012-3#10)(2012-4#1)(2013-1#20)(2013-8#6)
The study's##3##2##(1993-2#1)(2008-11#1)(2011-2#1)
The subcellular##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
The subgroup##2##2##(1990-2#1)(2011-2#1)
The subjects of##2##3##(1991-1#1)(2008-11#1)
The subjects were##12##3##(1990-12#1)(1991-2#1)(1992-2#1)(1993-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
The subjects##19##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-8#1)
The subperitoneal space##2##3##(2008-1#2)
The subsequent elution of##2##4##(2008-10#2)
The subsequent##12##2##(1996-1#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-3#1)(2012-3#1)(2013-1#1)
The substance##4##2##(1997-6#2)(2010-11#1)(2010-8#1)
The substances##2##2##(2008-7#1)(2013-1#1)
The substitution of##2##3##(1990-12#1)(2008-9#1)
The substrate is##2##3##(1992-3#2)
The substrate##4##2##(1990-8#1)(1992-3#2)(1994-5#1)
The success of PTCA in patients with##2##7##(1992-9#2)
The success of a##2##4##(1994-2#1)(2013-1#1)
The success of the##4##4##(1995-3#1)(1996-5#1)(2008-10#1)(2008-5#1)
The success of this##6##4##(1996-1#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2010-1#1)
The success of##21##3##(1992-9#2)(1994-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-11#1)(2012-7#1)(2013-1#2)
The success rate of##2##4##(2010-12#1)(2010-7#1)
The success rate##4##3##(1994-6#1)(2010-12#1)(2010-7#2)
The success##25##2##(1992-9#2)(1994-2#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#2)(2012-7#1)(2013-1#2)
The successful use of##2##4##(2008-10#1)(2008-11#1)
The successful##11##2##(1991-1#1)(1991-3#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-3#1)(2012-2#1)
The successive##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
The sugar##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
The suggested##2##2##(2008-10#1)(2010-8#1)
The suit##4##2##(1995-12#1)(1995-6#3)
The suitability for##2##3##(2008-10#1)(2008-3#1)
The suitability of the##3##4##(2008-10#3)
The suitability of##9##3##(1997-2#1)(2008-10#7)(2013-1#1)
The suitability##11##2##(1997-2#1)(2008-10#8)(2008-3#1)(2013-1#1)
The sulfur##2##2##(2008-10#2)
The sum of the##3##4##(1990-12#1)(1996-6#1)(2008-10#1)
The sum of##7##3##(1990-12#3)(1996-6#1)(2008-10#2)(2008-3#1)
The sun protection factors##2##4##(2008-5#2)
The sun##5##2##(2008-10#1)(2008-3#1)(2008-5#3)
The sunscreen##2##2##(2008-5#2)
The super##2##2##(1992-10#1)(2008-10#1)
The supercritical fluid##2##3##(2008-10#2)
The superior vena cava##2##4##(2008-1#2)
The superior##3##2##(1995-3#1)(2008-1#2)
The superiority of##2##3##(1997-2#1)(2012-2#1)
The supply of##4##3##(1991-2#1)(1992-3#1)(1993-1#1)(1994-3#1)
The support##5##2##(1991-1#1)(2008-10#2)(2009-5#2)
The supporting##2##2##(2008-10#1)(2008-8#1)
The suppression of##4##3##(1997-1#1)(2008-10#2)(2008-9#1)
The suppression##5##2##(1997-1#1)(2008-10#2)(2008-9#1)(2009-8#1)
The suppressive##2##2##(2008-10#1)(2008-9#1)
The suprameatal approach##2##3##(2008-9#2)
The supramolecular interaction of##2##4##(2008-10#2)
The supramolecular##4##2##(2008-10#4)
The surface area of##2##4##(2008-10#2)
The surface characteristics of##2##4##(2008-10#2)
The surface concentration##2##3##(2008-10#2)
The surface of the electrode can##2##6##(2008-10#2)
The surface of the##8##4##(2008-10#5)(2008-11#1)(2008-12#2)
The surface##24##2##(1997-2#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)
The surfaces of the electrodes are stable and easily renewable by polishing on alumina paper##3##15##(2008-10#3)
The surfaces of the electrodes are##4##6##(2008-10#4)
The surfaces of##5##3##(2008-10#4)(2012-2#1)
The surfaces##6##2##(1991-2#1)(2008-10#4)(2012-2#1)
The surgeon should##2##3##(2012-12#1)(2013-8#1)
The surgeon##3##2##(1992-1#1)(2012-12#1)(2013-8#1)
The surgeon's##2##2##(2011-2#1)(2012-12#1)
The surgery##2##2##(2010-5#1)(2012-2#1)
The surgical procedure##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
The surgical procedures##2##3##(2008-4#1)(2012-3#1)
The surgical technique of##2##4##(1992-9#1)(2010-11#1)
The surgical technique##5##3##(1990-9#1)(1992-9#1)(2008-7#1)(2010-11#1)(2011-2#1)
The surgical##20##2##(1990-12#1)(1990-5#1)(1990-9#1)(1992-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#3)
The survey findings indicate weaknesses warranting further exploration to identify changes needed to improve care planning documentation##2##17##(2013-1#2)
The survey identified several problematic areas related to nurses and care planning##2##12##(2013-1#2)
The survey showed that##2##4##(1993-6#1)(2008-10#1)
The survey was conducted in##2##5##(1996-1#1)(2008-10#1)
The survey was conducted##5##4##(1996-1#1)(2008-10#1)(2011-2#1)(2013-1#2)
The survey was##8##3##(1996-1#1)(1996-3#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#2)
The survey##27##2##(1993-6#1)(1994-12#2)(1994-3#2)(1995-2#1)(1996-1#1)(1996-3#1)(2008-10#4)(2008-11#4)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#6)
The survival of##2##3##(2008-10#2)
The survival rate of##3##4##(2008-11#2)(2008-9#1)
The survival##10##2##(1995-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)
The susceptibility of##4##3##(1994-8#1)(2008-10#2)(2012-12#1)
The susceptibility##6##2##(1994-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#1)
The susceptible##2##2##(2008-10#2)
The suspension##2##2##(2008-10#1)(2008-11#1)
The sustained##3##2##(1990-12#1)(1994-2#1)(1997-2#1)
The symptom##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
The symptoms are##2##3##(1993-6#1)(2008-10#1)
The symptoms##5##2##(1993-6#1)(2008-10#3)(2010-12#1)
The synchronous luminescence##2##3##(2008-10#2)
The synchronous##4##2##(2008-10#3)(2008-11#1)
The syndrome is##2##3##(1996-6#1)(2012-3#1)
The syndrome of##2##3##(1995-5#1)(2008-12#1)
The syndrome##9##2##(1992-5#1)(1995-5#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
The synergistic##3##2##(2008-10#3)
The syntheses are described of##2##5##(1992-12#2)
The synthesis and##8##3##(1994-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)
The synthesis of [4##2##4##(1996-5#2)
The synthesis of the##4##4##(1997-4#1)(2008-10#2)(2008-5#1)
The synthesis of##17##3##(1992-12#2)(1993-1#1)(1996-5#5)(1997-4#1)(2008-10#6)(2008-5#1)(2009-10#1)
The synthesis##25##2##(1992-12#2)(1993-1#1)(1994-8#1)(1996-5#5)(1997-4#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)
The synthesized compounds were##2##4##(2008-11#1)(2008-5#1)
The synthesized##4##2##(1994-8#1)(2008-11#1)(2008-5#1)(2009-10#1)
The synthetic##7##2##(1994-11#1)(1994-5#2)(1995-12#1)(1996-5#1)(2008-10#1)(2008-3#1)
The system allowed##2##3##(2008-10#1)(2009-9#1)
The system can be##2##4##(2008-10#2)
The system consists of a##2##5##(2008-10#1)(2008-11#1)
The system consists of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
The system described here##2##4##(1994-2#1)(2008-5#1)
The system exhibited##2##3##(2008-10#2)
The system for##2##3##(1992-2#1)(2008-10#1)
The system had a##2##4##(2008-10#1)(2008-11#1)
The system handles##2##3##(2008-10#2)
The system has a##3##4##(2008-10#3)
The system has been evaluated for##2##6##(2008-10#2)
The system has been tested for##2##6##(2008-10#2)
The system has been tested##3##5##(2008-10#3)
The system has been##10##4##(1993-9#1)(2008-10#7)(2010-6#1)(2010-8#1)
The system has##16##3##(1993-9#1)(2008-10#12)(2008-11#1)(2010-6#1)(2010-8#1)
The system is able to##4##5##(2008-10#2)(2008-3#1)(2009-8#1)
The system is based on##2##5##(2008-3#1)(2008-9#1)
The system is designed##2##4##(1991-1#1)(2011-2#1)
The system is##17##3##(1991-1#1)(2008-10#8)(2008-3#3)(2008-4#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)
The system offered##2##3##(2008-10#2)
The system presented##3##3##(2008-10#2)(2008-11#1)
The system uses##2##3##(2008-10#1)(2008-3#1)
The system was applied to the determination of##3##8##(2008-10#3)
The system was applied to##4##5##(2008-10#4)
The system was evaluated for##2##5##(2008-10#2)
The system was optimized and offered good performance characteristics with##2##10##(2008-10#2)
The system was tested##2##4##(2008-10#2)
The system was##23##3##(2008-10#21)(2008-12#1)(2012-2#1)
The system##126##2##(1991-1#1)(1992-2#1)(1993-9#1)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#83)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-2#2)(2013-8#1)
The systematic##5##2##(1996-3#1)(1997-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
The systems were##2##3##(2008-10#2)
The t##2##2##(2008-10#1)(2008-11#1)
The t-test##2##2##(2008-10#2)
The tagged##2##2##(2008-10#1)(2008-8#1)
The target##13##2##(1990-12#1)(1991-2#1)(1995-12#1)(1995-8#1)(1996-1#1)(2008-10#4)(2009-4#1)(2010-11#1)(2011-2#1)(2011-3#1)
The targeted##3##2##(2008-10#2)(2010-7#1)
The targets##2##2##(2008-10#1)(2013-7#1)
The task##3##2##(1993-6#1)(1997-6#1)(2008-4#1)
The taxonomy of the##2##4##(2008-5#2)
The team##4##2##(1991-6#1)(1996-1#2)(2008-11#1)
The technical details of the##2##5##(1994-9#1)(2008-10#1)
The technical##4##2##(1994-9#1)(2008-10#2)(2012-2#1)
The technique also##2##3##(2008-10#1)(2008-3#1)
The technique described in this##2##5##(2008-10#1)(2008-9#1)
The technique described##3##3##(2008-10#1)(2008-9#1)(2010-4#1)
The technique has been##2##4##(2007-12#1)(2008-10#1)
The technique has##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
The technique involves##2##3##(2008-10#1)(2011-2#1)
The technique is based on##4##5##(2008-3#2)(2008-5#1)(2011-2#1)
The technique is##13##3##(1994-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-1#1)(2010-3#1)(2010-4#1)(2011-2#2)
The technique may##2##3##(1994-2#1)(2008-9#1)
The technique of##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
The technique presented##2##3##(2008-2#1)(2008-5#1)
The technique was applied to##4##5##(2008-10#3)(2010-3#1)
The technique was applied##5##4##(2008-10#3)(2008-3#1)(2010-3#1)
The technique was##10##3##(2008-10#7)(2008-3#2)(2010-3#1)
The technique##58##2##(1990-2#1)(1991-2#1)(1994-11#1)(1994-2#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#18)(2008-2#1)(2008-3#12)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#6)(2009-1#1)(2010-3#2)(2010-4#2)(2011-2#4)(2013-1#1)
The techniques used##4##3##(1997-7#1)(2008-10#2)(2011-2#1)
The techniques##12##2##(1992-3#1)(1996-9#1)(1997-7#1)(2008-10#4)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)
The technology##2##2##(1994-2#1)(2008-9#1)
The teeth were##2##3##(1990-2#1)(2013-1#1)
The teeth##3##2##(1990-2#1)(2013-1#2)
The temperature and##2##3##(2008-3#2)
The temperature dependence of##2##4##(2008-10#2)
The temperature dependence##3##3##(2008-10#2)(2008-5#1)
The temperature of the##2##4##(2008-10#2)
The temperature of##3##3##(2008-10#2)(2011-2#1)
The temperature##21##2##(1992-2#1)(1993-6#1)(1993-8#1)(2008-10#13)(2008-3#2)(2008-5#1)(2011-2#2)
The temporal##7##2##(2008-10#5)(2008-8#1)(2010-11#1)
The ten##2##2##(2008-11#1)(2011-2#1)
The tendency##2##2##(1990-2#1)(1990-8#1)
The tensile##2##2##(2008-5#1)(2012-2#1)
The term &quot##5##3##(1994-1#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
The term##11##2##(1990-9#1)(1994-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
The terminal##5##2##(1997-3#1)(1997-5#1)(1997-6#1)(2008-8#2)
The ternary complex##2##3##(2008-10#2)
The ternary complexes of##2##4##(2008-10#2)
The ternary##6##2##(2008-10#6)
The test is##2##3##(1990-2#1)(2012-3#1)
The test system##2##3##(2008-11#2)
The test was##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2010-7#1)
The test##17##2##(1990-2#1)(1997-2#2)(1997-3#1)(2008-10#6)(2008-11#3)(2008-9#2)(2010-7#1)(2012-3#1)
The tested materials##2##3##(2008-10#1)(2013-1#1)
The tested##4##2##(2008-10#1)(2013-1#3)
The testicular##2##2##(2007-12#1)(2009-11#1)
The testing##2##2##(1993-11#1)(2008-10#1)
The tests##4##2##(1997-1#1)(2008-10#2)(2009-7#1)
The theoretical results##2##3##(2008-2#2)
The theoretical##12##2##(1997-4#1)(2008-10#3)(2008-2#2)(2008-3#2)(2010-11#1)(2010-5#1)(2010-7#1)(2012-3#1)
The theory is##2##3##(2008-3#2)
The theory of the##4##4##(2008-3#3)(2011-2#1)
The theory of##5##3##(2008-3#4)(2011-2#1)
The theory##12##2##(1990-5#1)(2008-3#7)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
The therapeutic effect##2##3##(1996-3#1)(2010-6#1)
The therapeutic potential of##2##4##(2008-11#1)(2012-12#1)
The therapeutic##12##2##(1994-8#1)(1996-3#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
The therapy for##2##3##(1996-6#1)(1997-4#1)
The therapy is##2##3##(1993-6#1)(2008-5#1)
The therapy of choice##2##4##(1992-9#1)(2013-1#1)
The therapy of##3##3##(1992-9#1)(1993-6#1)(2013-1#1)
The therapy##8##2##(1992-9#1)(1993-6#2)(1996-6#1)(1997-4#1)(2008-5#2)(2013-1#1)
The thermal analysis##2##3##(2008-10#2)
The thermal##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2010-4#1)
The thermodynamic data##2##3##(2008-10#2)
The thermodynamic dissociation constant##2##4##(2008-10#2)
The thermodynamic dissociation##3##3##(2008-10#3)
The thermodynamic model of inorganic arsenic##2##6##(2008-10#2)
The thermodynamic parameters##3##3##(2008-10#3)
The thermodynamic##16##2##(2008-10#14)(2008-9#1)(2009-6#1)
The thick##2##2##(2008-10#2)
The thickness of the##4##4##(1991-5#1)(2008-10#2)(2008-9#1)
The thickness of##5##3##(1991-5#1)(2008-10#3)(2008-9#1)
The thin##2##2##(2007-12#1)(2008-10#1)
The third ORF##2##3##(1996-6#1)(2008-10#1)
The third method was##2##4##(2008-10#2)
The third method##4##3##(2008-10#4)
The third patient##4##3##(2008-1#1)(2009-1#1)(2012-12#1)(2013-1#1)
The third phase##2##3##(1993-12#1)(2008-10#1)
The third##18##2##(1991-12#1)(1993-12#1)(1996-6#1)(2008-1#1)(2008-10#10)(2008-4#1)(2009-1#1)(2012-12#1)(2013-1#1)
The thoracic##2##2##(1991-3#1)(2011-2#1)
The three analytes could be##2##5##(2008-10#2)
The three anthropometric indicators##2##4##(2010-6#2)
The three compounds##2##3##(2008-10#1)(2011-1#1)
The three groups##2##3##(1995-5#1)(2010-7#1)
The three isolates##2##3##(2008-10#2)
The three methods##2##3##(1994-12#1)(2008-6#1)
The three##37##2##(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-10#16)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#1)
The three-dimensional structure of##2##4##(1991-12#1)(2008-7#1)
The three-dimensional structure##3##3##(1991-12#1)(2008-7#1)(2008-8#1)
The three-dimensional##7##2##(1991-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-3#1)(2013-1#1)
The threshold concentrations##2##3##(1993-12#1)(2008-10#1)
The threshold pump##2##3##(2008-2#1)(2008-3#1)
The threshold##9##2##(1993-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)
The thresholds##2##2##(1996-3#1)(2008-4#1)
The throughput of the##2##4##(2008-10#2)
The throughput was##2##3##(2008-10#2)
The throughput##4##2##(2008-10#4)
The thyroid##2##2##(2008-11#1)(2012-3#1)
The tilt##3##2##(2008-3#3)
The time course of##4##4##(1997-3#1)(2008-11#1)(2008-8#1)(2009-11#1)
The time course##5##3##(1990-8#1)(1997-3#1)(2008-11#1)(2008-8#1)(2009-11#1)
The time courses of##2##4##(1995-6#1)(2008-10#1)
The time length##2##3##(2008-11#2)
The time of##3##3##(2008-10#3)
The time required for the coprecipitation##2##6##(2008-10#2)
The time required for the##3##5##(2008-10#3)
The time required for##7##4##(2008-10#5)(2010-7#1)(2011-2#1)
The time required to##4##4##(2008-10#2)(2008-9#1)(2011-2#1)
The time required##11##3##(2008-10#7)(2008-9#1)(2010-7#1)(2011-2#2)
The time series##2##3##(2008-11#1)(2013-1#1)
The time##37##2##(1990-8#1)(1991-3#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-10#16)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-6#1)(2010-7#1)(2011-2#3)(2013-1#1)
The time-course of the##2##4##(1994-11#1)(2008-8#1)
The time-course of##3##3##(1994-11#1)(2008-8#1)(2013-8#1)
The time-dependent##2##2##(2008-3#2)
The timing of##2##3##(2008-10#1)(2010-10#1)
The timing##3##2##(2008-10#1)(2009-12#1)(2010-10#1)
The tin##2##2##(2008-10#2)
The tissue##5##2##(1993-6#1)(1994-5#1)(2008-12#1)(2011-2#1)(2011-3#1)
The titanium##2##2##(2008-10#2)
The titrant##2##2##(2008-10#2)
The titration is##2##3##(2008-10#2)
The titration##6##2##(2008-10#6)
The tolerability##2##2##(2007-11#1)(2013-1#1)
The tolerance limit##2##3##(2008-10#2)
The tolerance limits for##2##4##(2008-10#2)
The tolerance limits of electrolytes##2##5##(2008-10#2)
The tolerance limits of##5##4##(2008-10#5)
The tolerance limits##7##3##(2008-10#7)
The tolerance##12##2##(2008-10#12)
The tomato##3##2##(2008-10#2)(2008-8#1)
The tool was##2##3##(2008-11#2)
The tools##2##2##(1992-2#1)(2010-12#1)
The topic of the##2##4##(2008-12#1)(2011-2#1)
The topic of##3##3##(2008-12#1)(2011-2#1)(2013-8#1)
The topic##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
The topics##3##2##(1997-2#1)(2008-3#1)(2010-11#1)
The total amount of##3##4##(1993-1#1)(2008-10#2)
The total analysis time was##2##5##(2008-10#2)
The total concentration##2##3##(2008-10#1)(2011-10#1)
The total content of##2##4##(2008-10#2)
The total cost of##2##4##(1990-12#1)(1996-11#1)
The total error##2##3##(2008-3#2)
The total length of the sequenced regions##2##7##(1997-6#1)(1997-8#1)
The total length of the##4##5##(1996-6#1)(1997-6#1)(1997-8#1)(2012-12#1)
The total number of##8##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
The total sorption capacity of the resin was##2##8##(2008-10#2)
The total time required for##3##5##(2008-10#3)
The total time##5##3##(2008-10#5)
The total treatment##2##3##(1993-9#1)(1996-11#1)
The total##80##2##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-1#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-11#3)(1996-2#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#33)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
The town of Cabar##2##4##(2011-2#2)
The toxicity of##11##3##(1995-8#1)(2008-10#5)(2008-11#4)(2008-12#1)
The toxicity##14##2##(1995-8#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-9#1)
The toxin##3##2##(2008-10#3)
The trace element##4##3##(1993-2#2)(2008-10#2)
The trace##7##2##(1993-2#2)(2008-10#5)
The tracheal##2##2##(1997-1#1)(2007-12#1)
The trade-off##2##2##(1995-2#1)(2008-8#1)
The traditional method##2##3##(2008-10#1)(2008-9#1)
The traditional##8##2##(1992-6#1)(1994-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
The trafficking##2##2##(2008-11#1)(2009-8#1)
The training of##4##3##(1994-12#3)(2007-8#1)
The training##9##2##(1991-3#1)(1994-12#3)(2007-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2013-1#1)
The transcript##3##2##(2008-2#1)(2008-8#2)
The transcription factor##3##3##(1994-11#1)(2009-8#1)(2013-1#1)
The transcription level of the predicted genes##2##7##(1997-6#1)(1997-8#1)
The transcription start point##2##4##(1991-9#1)(1993-9#1)
The transcription##8##2##(1991-9#1)(1993-9#1)(1994-11#1)(1997-6#1)(1997-8#1)(2008-8#1)(2009-8#1)(2013-1#1)
The transcriptional start##2##3##(1994-11#2)
The transcriptional##8##2##(1991-10#1)(1993-2#1)(1994-11#2)(1996-12#1)(2008-11#1)(2008-8#1)(2010-7#1)
The transcriptome##2##2##(2009-10#2)
The transduction did not affect the expression of Fas##2##9##(2008-8#2)
The transfection activity of the lipopolylysine##2##6##(1991-5#2)
The transfection of##2##3##(1995-2#1)(2008-11#1)
The transfection##7##2##(1991-5#2)(1995-2#1)(2008-11#4)
The transfer of##6##3##(1995-12#1)(1997-2#1)(2008-10#3)(2008-11#1)
The transfer##10##2##(1993-12#1)(1995-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-9#1)
The transformants##3##2##(1993-12#1)(2008-10#2)
The transformation##3##2##(1991-2#1)(1995-2#1)(2008-8#1)
The transformed##3##2##(2008-10#3)
The transfusion##2##2##(1996-9#1)(2008-12#1)
The transgene##2##2##(1996-12#1)(2008-10#1)
The transgenic##4##2##(1992-8#1)(2008-10#1)(2008-4#1)(2009-8#1)
The transient##6##2##(1990-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
The transition from##3##3##(1994-2#1)(1994-3#1)(2013-1#1)
The transition##7##2##(1992-10#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
The translation function##2##3##(1992-9#1)(2008-8#1)
The translation##3##2##(1992-9#1)(1997-3#1)(2008-8#1)
The translocation of##2##3##(1993-8#1)(2008-11#1)
The translocation##5##2##(1991-2#1)(1993-8#1)(1996-6#1)(2008-11#1)(2008-8#1)
The translocator protein (TSPO) is a##2##6##(2012-2#2)
The translocator protein (TSPO)##3##4##(2012-2#3)
The transmission##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)
The transport of the##2##4##(2008-10#2)
The transport of##6##3##(1990-2#1)(1994-6#1)(2008-10#3)(2008-9#1)
The transport##10##2##(1990-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(2008-10#5)(2008-9#1)
The transportation of##2##3##(2008-10#1)(2009-10#1)
The transradial approach for##2##4##(2011-2#2)
The transradial approach##3##3##(2011-2#3)
The transverse##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
The trapped##3##2##(1994-11#1)(2008-10#2)
The treated##2##2##(2008-11#1)(2008-8#1)
The treatment for##2##3##(2008-10#1)(2013-1#1)
The treatment is##5##3##(1990-9#1)(1993-2#1)(1996-11#1)(2010-1#1)(2013-1#1)
The treatment may##2##3##(2010-10#1)(2013-1#1)
The treatment of mice with MPTP##2##6##(2008-7#2)
The treatment of the##2##4##(1992-7#1)(1993-3#1)
The treatment of##27##3##(1991-2#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
The treatment strategy##2##3##(1996-3#1)(1997-8#1)
The treatment was well tolerated##2##5##(1992-12#1)(2012-3#1)
The treatment was##8##3##(1992-12#1)(1993-6#1)(1994-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
The treatment##63##2##(1990-9#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-11#3)(1996-3#1)(1997-4#1)(1997-8#2)(2008-10#6)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)
The treatments available for##2##4##(2008-2#1)(2010-7#1)
The treatments##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)(2013-1#2)
The trend##6##2##(1992-1#1)(1997-2#1)(2008-3#1)(2012-12#2)(2012-7#1)
The trial##3##2##(1992-3#1)(2008-5#1)(2011-2#1)
The trials##3##2##(1995-5#1)(1997-1#1)(2008-5#1)
The trout##2##2##(2008-5#2)
The true##2##2##(1990-6#1)(2011-2#1)
The tumor necrosis factor##2##4##(2008-4#1)(2012-2#1)
The tumor suppressor##3##3##(1990-12#1)(1995-6#1)(2011-2#1)
The tumor was##4##3##(2008-12#1)(2009-1#1)(2010-2#1)(2013-1#1)
The tumor##18##2##(1990-12#1)(1990-6#1)(1994-12#1)(1995-6#1)(2008-12#1)(2008-4#1)(2009-1#1)(2009-3#2)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The tumors in##2##3##(1990-9#1)(2013-1#1)
The tumors##6##2##(1990-9#1)(1991-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
The tumour was##3##3##(1991-6#1)(2008-7#1)(2012-12#1)
The tumour##6##2##(1991-6#1)(1997-6#1)(2008-7#3)(2012-12#1)
The tungsten##2##2##(2008-10#2)
The tuning##2##2##(1996-2#1)(2008-2#1)
The two Category##2##3##(2012-2#2)
The two cell##2##3##(2008-11#2)
The two clones had##2##4##(1993-8#1)(2008-11#1)
The two clones##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
The two groups of##2##4##(2008-10#1)(2013-1#1)
The two groups were compared##2##5##(2011-1#1)(2011-2#1)
The two groups##5##3##(1996-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
The two largest##3##3##(2008-10#3)
The two main##3##3##(1996-6#1)(2008-9#1)(2010-1#1)
The two major##2##3##(1993-12#1)(1996-12#1)
The two methods are##2##4##(2008-10#2)
The two methods##3##3##(1997-2#1)(2008-10#2)
The two other##2##3##(1994-3#1)(2008-5#1)
The two pathogens##2##3##(2008-10#2)
The two species##2##3##(2008-12#1)(2008-7#1)
The two subunits in##2##4##(1991-12#1)(2008-9#1)
The two techniques##2##3##(2008-10#2)
The two##102##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#45)(2008-11#5)(2008-12#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
The two-step##2##2##(2008-10#2)
The type of surgical procedure##2##5##(2012-2#2)
The type of##8##3##(1995-12#1)(2008-10#1)(2011-1#1)(2012-2#2)(2013-1#3)
The type strain##3##3##(2011-2#3)
The type##12##2##(1995-12#1)(1995-2#1)(2008-10#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#3)
The types of##3##3##(1995-2#1)(2008-1#1)(2011-2#1)
The typical##6##2##(1996-9#1)(1997-8#1)(2008-10#2)(2008-12#1)(2010-6#1)
The tyrosine kinase inhibitor##2##4##(1996-12#1)(2010-11#1)
The tyrosine##5##2##(1994-8#1)(1996-12#1)(2008-8#1)(2010-11#1)(2012-12#1)
The ultimate##7##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#1)
The ultrasonic##2##2##(2008-4#1)(2009-12#1)
The ultrasound examination##2##3##(1991-6#1)(1996-11#1)
The ultrastructural##6##2##(2007-12#3)(2008-7#2)(2011-2#1)
The ultrastructure and function of the silk-producing basitarsus##2##8##(2007-12#2)
The ultrastructure and##3##3##(2007-12#3)
The ultrastructure of Sorubim lima##2##5##(2008-7#2)
The ultrastructure of##7##3##(2007-12#1)(2008-7#4)(2009-10#2)
The ultrastructure##10##2##(2007-12#4)(2008-7#4)(2009-10#2)
The unbiased##2##2##(1991-3#1)(2008-10#1)
The uncertainties##2##2##(2008-3#2)
The uncertainty budget##2##3##(2008-10#2)
The uncertainty##6##2##(2008-10#4)(2008-2#1)(2012-12#1)
The underlying mechanisms##2##3##(1990-2#1)(2008-11#1)
The underlying##12##2##(1990-2#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#2)(2011-1#1)(2013-1#1)(2013-7#1)
The understanding of the##2##4##(1993-8#1)(1995-5#1)
The understanding of##4##3##(1993-8#1)(1995-5#1)(2008-11#1)(2008-9#1)
The understanding##5##2##(1993-8#1)(1995-5#1)(2008-11#1)(2008-9#2)
The unexpected##3##2##(1992-2#1)(2008-7#1)(2009-6#1)
The unique features of##2##4##(2008-10#1)(2011-2#1)
The unique structure of this##2##5##(1997-3#1)(2009-3#1)
The unique##12##2##(1992-9#1)(1994-5#1)(1995-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)
The unit also##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
The unit describes the##2##4##(2008-4#1)(2008-9#1)
The unit describes##4##3##(2008-4#3)(2008-9#1)
The unit details##2##3##(2008-9#2)
The unit presents##2##3##(2008-9#2)
The unit##20##2##(1996-12#1)(2008-1#1)(2008-11#1)(2008-4#6)(2008-8#1)(2008-9#10)
The unraveling of a joint venture##2##6##(1994-3#2)
The unstable##3##2##(2008-10#2)(2008-9#1)
The unusual##4##2##(1990-9#1)(2008-7#1)(2010-5#1)(2013-1#1)
The upper##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
The uptake of##4##3##(1990-8#1)(1992-3#1)(2008-11#2)
The uptake##8##2##(1990-8#1)(1992-3#2)(2008-10#2)(2008-11#3)
The urinary##2##2##(2008-10#1)(2009-12#1)
The urine##5##2##(2008-10#5)
The usage of##2##3##(2008-1#1)(2008-10#1)
The use and##2##3##(1992-12#1)(2008-10#1)
The use of SPME##2##4##(2008-10#2)
The use of X-ray##2##4##(2008-10#1)(2008-4#1)
The use of a large##2##5##(2008-10#1)(2008-11#1)
The use of a##24##4##(1993-2#1)(1994-12#2)(2008-10#14)(2008-11#2)(2008-9#2)(2011-2#1)(2011-3#1)(2013-1#1)
The use of an##3##4##(2007-12#1)(2008-10#2)
The use of appropriate##2##4##(1993-2#1)(2009-8#1)
The use of both##2##4##(2010-10#1)(2013-1#1)
The use of cell##2##4##(2008-11#1)(2008-7#1)
The use of contrast-enhanced##2##4##(2010-12#2)
The use of flow cytometry##2##5##(2008-9#2)
The use of gating technology##2##5##(2008-11#2)
The use of genetic##2##4##(2008-10#1)(2011-2#1)
The use of human##2##4##(2008-11#1)(2008-5#1)
The use of laser##2##4##(1991-1#1)(2008-10#1)
The use of medicines##2##4##(2008-11#2)
The use of modified##2##4##(2008-10#1)(2008-4#1)
The use of molecular##2##4##(1997-7#1)(2008-11#1)
The use of monoclonal antibodies##2##5##(2008-11#2)
The use of multivariate spectrophotometric calibration for the simultaneous determination of##2##11##(2008-10#2)
The use of optical coherence tomography##2##6##(2011-7#2)
The use of order patterns##2##5##(2008-11#2)
The use of propensity scores in pharmacoepidemiologic research##2##8##(2008-11#2)
The use of reflection##2##4##(2008-11#1)(2008-12#1)
The use of scanning##2##4##(2008-10#1)(2008-7#1)
The use of such##2##4##(2008-10#1)(2008-11#1)
The use of the##23##4##(1991-11#1)(1992-1#1)(1992-3#1)(1996-6#1)(2008-10#11)(2008-11#4)(2011-2#3)(2013-1#1)
The use of these##5##4##(1991-3#1)(2008-10#3)(2008-5#1)
The use of this##2##4##(2008-10#1)(2010-9#1)
The use of##273##3##(1990-12#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#4)(1992-7#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#118)(2008-11#44)(2008-12#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#8)(2008-9#7)(2009-1#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-6#1)(2010-9#1)(2011-2#10)(2011-3#1)(2011-7#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#12)(2013-8#2)
The use##275##2##(1990-12#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-7#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#119)(2008-11#44)(2008-12#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#8)(2008-9#7)(2009-1#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-6#1)(2010-9#1)(2011-2#10)(2011-3#1)(2011-7#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#12)(2013-8#2)
The used techniques##2##3##(2008-10#1)(2013-1#1)
The useful lifetime of the##2##5##(2008-10#2)
The useful##4##2##(2008-10#4)
The usefulness of the##11##4##(2008-10#7)(2008-3#2)(2008-5#1)(2012-3#1)
The usefulness of this approach was##2##6##(2008-10#2)
The usefulness of this##3##4##(2008-10#2)(2008-5#1)
The usefulness of##26##3##(1991-8#1)(1992-9#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#1)(2012-3#1)
The usual##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
The utility of the##6##4##(2008-10#4)(2008-3#2)
The utility of this##3##4##(2008-10#2)(2008-8#1)
The utility of##13##3##(1995-12#1)(2008-10#8)(2008-3#2)(2008-8#1)(2013-1#1)
The utility##14##2##(1995-12#1)(2008-10#9)(2008-3#2)(2008-8#1)(2013-1#1)
The utilization of##8##3##(1992-12#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-7#2)
The vaccine##2##2##(1993-3#1)(2011-2#1)
The vaginal route was##2##4##(1994-2#1)(1995-12#1)
The vaginal##3##2##(1994-2#1)(1995-12#1)(2008-11#1)
The validation of the method##2##5##(2008-10#2)
The validation of the procedure was##3##6##(2008-10#3)
The validation of the##7##4##(2008-10#7)
The validation of##11##3##(2008-10#9)(2008-11#2)
The validation parameters have shown good results##2##7##(2008-10#2)
The validation##16##2##(2008-10#12)(2008-11#2)(2008-2#1)(2013-1#1)
The validity and reliability of##2##5##(1994-6#1)(2013-8#1)
The validity of the method##2##5##(2008-10#2)
The validity of the##9##4##(1990-5#1)(2008-10#4)(2008-3#3)(2008-9#1)
The validity of these##2##4##(1993-12#1)(2010-12#1)
The validity of this##2##4##(2008-10#2)
The validity of##17##3##(1990-5#1)(1993-12#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-9#1)(2010-12#1)
The validity##19##2##(1990-5#1)(1993-12#1)(1994-6#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-9#1)(2010-12#1)(2013-8#1)
The value of the##2##4##(2008-10#1)(2008-7#1)
The value of##22##3##(1990-2#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-12#2)(2008-7#1)(2008-9#2)(2012-2#1)(2013-8#1)
The value##23##2##(1990-2#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-12#2)(2008-7#1)(2008-9#2)(2012-2#1)(2013-8#1)
The values for##2##3##(1991-9#1)(2008-10#1)
The values obtained by##4##4##(2008-10#4)
The values obtained##8##3##(1991-11#1)(2008-10#6)(2008-3#1)
The values of the##5##4##(2008-10#4)(2010-8#1)
The values of##16##3##(1991-12#1)(2008-10#12)(2008-8#2)(2010-8#1)
The values were##2##3##(1993-8#1)(2008-10#1)
The values##32##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-5#1)(1993-8#1)(1996-2#1)(2008-10#22)(2008-3#1)(2008-8#2)(2010-8#1)
The vanadium##2##2##(2008-10#2)
The variability of##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
The variability##5##2##(2008-10#3)(2008-12#1)(2008-9#1)
The variable##3##2##(1996-5#1)(2008-10#2)
The variable-region peptide sequence##2##4##(1995-2#2)
The variables that##3##3##(2008-10#2)(2011-2#1)
The variables##7##2##(2008-10#6)(2011-2#1)
The variance in the##2##4##(2008-10#1)(2008-8#1)
The variation coefficient##2##3##(2008-10#2)
The variation in##6##3##(1993-9#1)(1995-1#1)(2008-10#2)(2009-9#1)(2013-8#1)
The variation of sorption with temperature yields##2##7##(2008-10#2)
The variation of sorption with temperature##3##6##(2008-10#3)
The variation of##10##3##(1992-11#1)(2008-10#7)(2008-11#1)(2008-5#1)
The variation##19##2##(1992-11#1)(1993-9#1)(1995-1#1)(2008-10#12)(2008-11#1)(2008-5#1)(2009-9#1)(2013-8#1)
The variations in##2##3##(2008-5#1)(2008-9#1)
The variations of##3##3##(2008-10#3)
The variations##6##2##(1990-8#1)(2008-10#3)(2008-5#1)(2008-9#1)
The variety of##2##3##(1993-11#1)(2008-11#1)
The various##13##2##(1990-3#1)(1991-3#1)(1992-3#1)(1995-2#1)(1995-9#1)(1997-8#1)(2008-10#6)(2010-7#1)
The vast majority of##4##4##(2008-9#1)(2011-2#2)(2012-2#1)
The vector##2##2##(2008-11#1)(2008-9#1)
The vectors##2##2##(1993-12#2)
The velocimeter was##2##3##(2008-3#2)
The velocity##2##2##(2008-2#1)(2008-3#1)
The versatility of the##5##4##(1996-5#1)(2008-10#3)(2008-4#1)
The versatility of##7##3##(1996-5#1)(2008-10#4)(2008-4#1)(2010-7#1)
The vertebral##3##2##(2007-8#2)(2011-2#1)
The vertebrate##2##2##(2008-4#1)(2011-2#1)
The vertical##2##2##(2008-3#1)(2009-11#1)
The very##8##2##(1993-2#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-6#1)
The vesicle sensor was##2##4##(2008-10#2)
The viability of##4##3##(2008-10#3)(2013-1#1)
The viable##2##2##(2008-11#2)
The vibrissal##2##2##(2011-2#2)
The view##3##2##(1994-6#2)(2009-7#1)
The views of##3##3##(2008-12#2)(2012-2#1)
The viral RNA##2##3##(1997-3#1)(2008-9#1)
The viral##6##2##(1993-6#1)(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
The virtual##2##2##(1996-2#1)(2008-11#1)
The virulence of##5##3##(2008-10#3)(2008-11#1)(2009-6#1)
The virulence##6##2##(2008-10#4)(2008-11#1)(2009-6#1)
The virus is##2##3##(2008-10#1)(2011-2#1)
The virus was transmitted by##4##5##(2008-10#4)
The virus was##13##3##(2008-10#12)(2013-8#1)
The virus##26##2##(1993-11#1)(2007-12#1)(2008-10#22)(2011-2#1)(2013-8#1)
The viruses were##2##3##(2008-10#1)(2013-8#1)
The viruses##4##2##(2008-10#2)(2013-1#1)(2013-8#1)
The visibility of##2##3##(1994-3#1)(2009-11#1)
The visual##3##2##(2011-2#1)(2013-8#2)
The vitamin##2##2##(1990-3#1)(2008-11#1)
The volatile##4##2##(2008-10#4)
The voltage##3##2##(2008-10#3)
The voltammetric behavior of##3##4##(2008-10#3)
The voltammetric behaviour of##3##4##(2008-10#3)
The voltammetric##14##2##(2008-10#14)
The voltammograms##2##2##(2008-10#2)
The volume density##2##3##(1995-8#1)(2009-11#1)
The volume of the##4##4##(1997-8#1)(2008-10#2)(2008-9#1)
The volume of##11##3##(1991-11#2)(1996-2#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
The volume##15##2##(1991-11#2)(1991-5#1)(1995-8#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)
The volunteers##2##2##(1992-1#1)(2012-2#1)
The vomeronasal##2##2##(1994-2#1)(2012-2#1)
The waiver##2##2##(1997-2#2)
The walls of the##2##4##(2008-6#1)(2012-2#1)
The water##6##2##(1993-2#1)(2008-10#3)(2008-11#1)(2008-12#1)
The water-soluble##2##2##(1992-9#1)(2008-10#1)
The wave##3##2##(2008-10#3)
The wavelength modulation##2##3##(2008-10#1)(2008-3#1)
The wavelength of the##2##4##(2008-10#1)(2008-2#1)
The wavelength range##2##3##(2008-10#1)(2008-3#1)
The wavelength##8##2##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)
The wavelength-dependent##2##2##(2008-2#1)(2008-3#1)
The wavelengths of excitation and emission were##3##7##(2008-10#3)
The wavelengths of excitation and emission##4##6##(2008-10#4)
The wavelengths of##5##3##(2008-10#4)(2008-3#1)
The way##3##2##(1994-12#1)(2008-11#1)(2008-5#1)
The weak##2##2##(2008-10#1)(2008-3#1)
The wealth of##2##3##(2008-11#1)(2008-7#1)
The well-known##3##2##(1993-8#1)(2008-10#1)(2013-1#1)
The wet##2##2##(2008-10#2)
The wheat##2##2##(2008-12#1)(2008-8#1)
The whole S1##2##3##(2008-5#2)
The whole process could be completed in 1 min##2##9##(2008-10#2)
The whole process##3##3##(2008-10#3)
The whole##12##2##(1996-2#1)(2008-10#9)(2008-5#2)
The widespread distribution of##2##4##(2008-10#1)(2012-3#1)
The widespread occurrence of##3##4##(1996-12#1)(1997-7#1)(2008-10#1)
The widespread##6##2##(1996-12#1)(1997-7#1)(2008-10#2)(2012-2#1)(2012-3#1)
The width##2##2##(2008-10#1)(2011-2#1)
The wild-type and mutant##2##4##(1993-8#1)(1997-3#1)
The wild-type##3##2##(1993-8#1)(1997-3#1)(2008-10#1)
The within-day and between-day##2##4##(1991-2#1)(2008-10#1)
The within-run and between-run##2##4##(2008-10#2)
The within-run##3##2##(2008-10#3)
The women had##2##3##(2008-11#2)
The women##5##2##(1996-1#1)(2008-11#4)
The wood##2##2##(2008-10#1)(2013-8#1)
The work of##2##3##(1997-7#1)(2012-2#1)
The work was##2##3##(2008-10#1)(2011-1#1)
The work##17##2##(1991-12#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
The working conditions##3##3##(2008-10#2)(2009-12#1)
The working electrode was a##5##5##(2008-10#5)
The working electrode##7##3##(2008-10#7)
The working pH range is 2##2##6##(2008-10#2)
The working pH range##3##4##(2008-10#3)
The working pH##4##3##(2008-10#4)
The working range##2##3##(2008-10#2)
The working##21##2##(2008-10#19)(2009-12#1)(2013-8#1)
The workshop included##2##3##(1996-2#1)(2008-10#1)
The workshop was##2##3##(2008-10#1)(2013-8#1)
The workshop##8##2##(1992-12#1)(1996-2#1)(2008-10#3)(2008-12#1)(2011-2#1)(2013-8#1)
The world##2##2##(1992-2#1)(2009-3#1)
The worldwide##4##2##(2008-10#1)(2010-3#1)(2010-5#1)(2013-1#1)
The yeast Candida##2##3##(1996-12#1)(2008-10#1)
The yeast##5##2##(1996-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
The yield of##6##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-2#1)
The yield##8##2##(1994-8#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-2#2)
The yields obtained##2##3##(2008-10#1)(2008-11#1)
The yields of##4##3##(1993-6#1)(2008-10#2)(2008-11#1)
The yields##7##2##(1993-6#1)(2008-10#3)(2008-11#2)(2008-8#1)
The young##2##2##(2007-12#1)(2008-4#1)
The zebrafish##2##2##(2008-4#1)(2012-3#1)
The zinc##3##2##(2008-10#2)(2009-12#1)
The zone of##3##3##(1993-12#1)(2008-8#1)(2013-1#1)
The zone##4##2##(1993-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
The##34741##1##(1990-10#4)(1990-11#85)(1990-12#93)(1990-2#80)(1990-3#53)(1990-4#1)(1990-5#151)(1990-6#67)(1990-7#11)(1990-8#78)(1990-9#63)(1991-1#52)(1991-10#17)(1991-11#67)(1991-12#139)(1991-2#159)(1991-3#146)(1991-4#1)(1991-5#103)(1991-6#117)(1991-7#22)(1991-8#67)(1991-9#62)(1992-1#88)(1992-10#22)(1992-11#21)(1992-12#147)(1992-2#98)(1992-3#134)(1992-4#24)(1992-5#41)(1992-6#69)(1992-7#7)(1992-8#31)(1992-9#82)(1993-1#95)(1993-11#54)(1993-12#182)(1993-2#153)(1993-3#144)(1993-5#1)(1993-6#129)(1993-8#168)(1993-9#54)(1994-1#59)(1994-11#124)(1994-12#158)(1994-2#121)(1994-3#140)(1994-5#130)(1994-6#71)(1994-8#105)(1994-9#41)(1995-1#53)(1995-10#3)(1995-11#97)(1995-12#165)(1995-2#183)(1995-3#88)(1995-5#69)(1995-6#141)(1995-8#86)(1995-9#40)(1996-1#85)(1996-10#1)(1996-11#53)(1996-12#173)(1996-2#191)(1996-3#148)(1996-5#116)(1996-6#100)(1996-8#38)(1996-9#42)(1997-1#99)(1997-2#174)(1997-3#167)(1997-4#68)(1997-5#44)(1997-6#86)(1997-7#105)(1997-8#165)(1997-9#11)(2006-5#1)(2006-6#20)(2007-11#47)(2007-12#194)(2007-8#35)(2007-9#2)(2008-1#139)(2008-10#14132)(2008-11#1992)(2008-12#645)(2008-2#185)(2008-3#728)(2008-4#242)(2008-5#732)(2008-6#162)(2008-7#770)(2008-8#751)(2008-9#770)(2009-1#45)(2009-10#132)(2009-11#66)(2009-12#99)(2009-2#17)(2009-3#59)(2009-4#31)(2009-5#64)(2009-6#85)(2009-7#147)(2009-8#162)(2009-9#57)(2010-1#107)(2010-10#126)(2010-11#108)(2010-12#135)(2010-2#29)(2010-3#47)(2010-4#91)(2010-5#86)(2010-6#115)(2010-7#112)(2010-8#156)(2010-9#44)(2011-1#117)(2011-10#7)(2011-2#1115)(2011-3#127)(2011-4#7)(2011-7#17)(2011-8#2)(2011-9#4)(2012-12#202)(2012-2#506)(2012-3#488)(2012-4#7)(2012-5#13)(2012-6#7)(2012-7#3)(2012-8#1)(2012-9#7)(2013-1#921)(2013-2#1)(2013-3#3)(2013-7#25)(2013-8#372)
Theaim of this study was to##2##6##(2009-8#2)
Theatre##3##1##(2008-11#2)(2013-1#1)
Thecaphora solani##2##2##(2008-10#2)
Thecaphora##3##1##(2008-10#3)
ThegdhA genes of##2##3##(2008-8#2)
Theil's method##2##2##(2008-10#2)
Theileria##2##1##(1997-5#1)(2008-9#1)
Thein vivo##2##2##(2008-11#1)(2008-8#1)
Their ability##2##2##(1992-9#1)(1997-3#1)
Their advantages and limitations are##2##5##(2008-10#1)(2008-3#1)
Their clinical##2##2##(2008-9#1)(2012-3#1)
Their effects##2##2##(2008-10#1)(2008-5#1)
Their expression##2##2##(2009-3#1)(2010-6#1)
Their function##2##2##(2008-12#1)(2008-7#1)
Their incorporation##2##2##(1996-6#1)(2008-5#1)
Their interaction with##2##3##(2008-10#1)(2013-1#1)
Their mean##2##2##(2008-11#1)(2011-2#1)
Their molecular weights are about##2##5##(2008-8#1)(2008-9#1)
Their most##2##2##(2008-4#1)(2008-9#1)
Their phosphatase##2##2##(2008-9#2)
Their primary##2##2##(1995-3#1)(2008-9#1)
Their results##2##2##(2010-1#1)(2010-5#1)
Their role in the##2##4##(1992-5#1)(2009-3#1)
Their role in##3##3##(1992-5#1)(2008-8#1)(2009-3#1)
Their structures were elucidated##2##4##(2011-2#1)(2011-3#1)
Their structures were##5##3##(2008-11#1)(2010-6#1)(2011-2#1)(2011-3#2)
Their use##2##2##(1991-12#1)(2008-11#1)
Their##169##1##(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#2)(1994-12#4)(1994-3#1)(1995-12#2)(1995-3#3)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#4)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#47)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#10)(2009-10#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#9)(2011-3#4)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#7)(2013-7#1)
Thematic analysis##3##2##(2009-5#1)(2010-10#1)(2010-11#1)
Thematic##6##1##(2008-10#2)(2008-11#1)(2009-5#1)(2010-10#1)(2010-11#1)
Theme##3##1##(2008-11#1)(2010-5#2)
Themes##3##1##(1995-3#1)(2008-11#1)(2010-11#1)
Then a##4##2##(2008-10#2)(2008-8#2)
Then the##23##2##(1993-8#1)(2008-10#13)(2008-8#2)(2008-9#2)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
Then we##11##2##(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2012-2#2)(2013-8#1)
Then##104##1##(1990-8#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-6#1)(2008-10#47)(2008-11#4)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#6)(2009-10#1)(2009-12#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-2#4)(2013-1#4)(2013-8#3)
Theo and Jamie##2##3##(2011-1#2)
Theodor##2##1##(2013-1#2)
Theoretical analysis of##3##3##(1993-3#1)(2008-2#1)(2013-1#1)
Theoretical and experimental results##2##4##(2008-2#1)(2008-3#1)
Theoretical and practical##2##3##(1991-12#1)(2008-3#1)
Theoretical and##7##2##(1991-12#1)(1996-5#1)(2008-2#2)(2008-3#2)(2008-9#1)
Theoretical calculations##3##2##(2008-10#2)(2010-6#1)
Theoretical investigation on##2##3##(2008-8#2)
Theoretical investigation##3##2##(2008-3#1)(2008-8#2)
Theoretical study##2##2##(2007-12#1)(2008-8#1)
Theoretical##39##1##(1990-11#1)(1990-12#1)(1991-12#1)(1992-2#1)(1993-3#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
Theoretically##5##1##(1992-9#1)(1997-1#1)(2008-10#1)(2008-3#1)(2010-1#1)
Theories##5##1##(1996-9#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)
Theory and##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
Theory of Planned Behavior##2##4##(2011-1#1)(2013-1#1)
Theory of Reasoned Action##2##4##(1993-3#1)(2011-1#1)
Theory of the##2##3##(2008-3#2)
Theory of##10##2##(1993-3#1)(2008-12#1)(2008-3#4)(2009-8#1)(2011-1#2)(2013-1#1)
Theory to##2##2##(2010-10#1)(2013-8#1)
Theory##32##1##(1990-11#1)(1991-2#1)(1993-3#1)(1996-1#1)(1996-9#1)(2008-11#2)(2008-12#2)(2008-3#8)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Thepatient##4##1##(2013-8#4)
Therapeutic Hypothermia for Out-of-Hospital Cardiac Arrest##2##6##(2011-2#2)
Therapeutic cytapheresis##2##2##(2011-2#2)
Therapeutic interventions##2##2##(1991-7#1)(2013-1#1)
Therapeutic##33##1##(1990-5#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-11#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
Therapeutics##5##1##(1993-11#1)(1996-9#1)(1997-3#1)(2008-5#1)(2011-2#1)
Therapies##4##1##(2008-11#1)(2008-3#2)(2013-8#1)
Therapist##3##1##(2008-4#1)(2013-1#2)
Therapy Trial##3##2##(2010-12#2)(2010-9#1)
Therapy consists of##2##3##(1990-9#1)(2011-2#1)
Therapy for Breast Cancer##2##4##(1994-12#1)(1997-7#1)
Therapy for Breast##3##3##(1994-12#1)(1997-7#2)
Therapy for the##2##3##(2009-1#1)(2010-9#1)
Therapy for##15##2##(1994-12#1)(1994-5#1)(1997-7#4)(2008-11#2)(2009-1#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#2)
Therapy in##3##2##(2008-11#1)(2008-7#2)
Therapy is##3##2##(1990-9#1)(1991-6#1)(1997-4#1)
Therapy of##5##2##(1991-6#1)(1993-11#1)(1995-10#1)(1997-6#2)
Therapy with##4##2##(1990-2#1)(1997-4#1)(1997-7#1)(2013-8#1)
Therapy##64##1##(1990-2#1)(1990-8#1)(1990-9#2)(1991-6#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1996-3#1)(1997-1#1)(1997-4#3)(1997-6#2)(1997-7#5)(2008-1#1)(2008-11#5)(2008-12#2)(2008-7#3)(2008-8#1)(2009-1#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-9#3)(2011-2#1)(2012-2#3)(2013-1#9)(2013-8#1)
There also##2##2##(2008-10#2)
There appears to be##2##4##(2009-9#1)(2013-1#1)
There appears##3##2##(2008-10#1)(2009-9#1)(2013-1#1)
There are a limited number of##2##6##(2012-2#1)(2013-1#1)
There are a number of factors##2##6##(2008-10#1)(2008-5#1)
There are a number of##12##5##(1991-3#1)(1992-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2013-8#1)
There are a##18##3##(1991-3#1)(1992-9#1)(1995-12#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
There are also indications that##2##5##(2008-8#1)(2011-2#1)
There are also##9##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-4#1)(2012-3#1)
There are at least##2##4##(2008-8#1)(2011-2#1)
There are currently no##3##4##(2008-11#1)(2012-12#1)(2012-2#1)
There are currently##5##3##(2008-11#2)(2012-12#1)(2012-2#2)
There are few high-quality studies##2##5##(2010-6#1)(2013-1#1)
There are few##7##3##(1992-3#1)(1994-12#1)(1997-1#1)(2007-11#1)(2009-6#1)(2010-6#1)(2013-1#1)
There are four##4##3##(1993-8#1)(2008-1#1)(2012-2#1)(2012-3#1)
There are many##11##3##(1991-5#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
There are more##2##3##(1992-2#1)(2008-5#1)
There are multiple##2##3##(2008-10#1)(2009-12#1)
There are no definitive diagnostic##2##5##(2008-12#1)(2010-12#1)
There are no##12##3##(1990-11#1)(1993-8#1)(1997-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
There are numerous##5##3##(2008-10#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
There are only##3##3##(1993-6#1)(2008-5#1)(2013-1#1)
There are pronounced##2##3##(1992-9#1)(2008-11#1)
There are reports of##3##4##(1991-2#1)(2008-10#1)(2009-11#1)
There are seven##2##3##(1996-1#1)(2011-2#1)
There are several##12##3##(2008-10#2)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
There are significant##2##3##(1995-12#1)(2008-4#1)
There are some##3##3##(2008-5#1)(2008-8#1)(2013-1#1)
There are still##2##3##(2008-11#1)(2011-3#1)
There are three##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
There are two forms##2##4##(2010-5#1)(2013-1#1)
There are two major##2##4##(2008-10#2)
There are two types of##5##5##(1991-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2012-2#1)
There are two##18##3##(1991-2#1)(1992-9#1)(1993-3#1)(1994-6#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
There are##174##2##(1990-11#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-9#5)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-1#2)(1996-2#1)(1996-3#2)(1997-1#5)(1997-5#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#16)(2008-12#5)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#10)(2011-3#1)(2011-4#1)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#11)(2013-8#3)
There exist##2##2##(1995-2#1)(2009-11#1)
There exists a##3##3##(1990-5#1)(1992-9#1)(2008-7#1)
There exists##4##2##(1990-5#1)(1992-9#1)(1995-5#1)(2008-7#1)
There has been a recent##3##5##(2008-11#3)
There has been a##7##4##(1992-1#1)(2007-12#1)(2008-10#1)(2008-11#3)(2013-1#1)
There has been an##3##4##(2006-5#1)(2010-5#1)(2011-2#1)
There has been##16##3##(1992-1#1)(1995-5#1)(1996-1#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-9#1)(2010-5#1)(2011-2#2)(2013-1#1)
There has##18##2##(1992-1#1)(1995-5#1)(1996-1#1)(1997-1#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-9#1)(2010-5#1)(2011-2#2)(2013-1#1)
There have also been##2##4##(1992-2#1)(2008-11#1)
There have been a number of##2##6##(2008-10#2)
There have been no##2##4##(1997-8#1)(2008-7#1)
There have been only##2##4##(2008-9#1)(2013-7#1)
There have been several reported##2##5##(1992-2#1)(2008-7#1)
There have been##15##3##(1992-2#1)(1994-12#1)(1994-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
There have##17##2##(1992-2#2)(1994-12#1)(1994-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
There is a constant##2##4##(2008-11#1)(2008-9#1)
There is a general##2##4##(2008-4#1)(2012-2#1)
There is a lack of##5##5##(1994-6#1)(1995-2#1)(2008-11#2)(2012-2#1)
There is a large body of##2##6##(2008-10#1)(2008-5#1)
There is a need for##7##5##(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-8#1)
There is a need to develop##2##6##(2008-10#1)(2008-5#1)
There is a need to##4##5##(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
There is a need##12##4##(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
There is a paucity of##2##5##(2012-3#1)(2013-1#1)
There is a significant##5##4##(1997-3#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
There is a strong##2##4##(1991-9#1)(2010-10#1)
There is a##57##3##(1990-5#1)(1991-2#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#2)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
There is also a##7##4##(1991-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)
There is also evidence that##2##5##(2008-11#1)(2013-1#1)
There is also evidence##3##4##(2008-11#1)(2010-5#1)(2013-1#1)
There is also##15##3##(1991-6#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-5#2)(2013-1#1)
There is an increasing need for##2##6##(2010-12#1)(2011-1#1)
There is an increasing trend##2##5##(2008-12#1)(2009-6#1)
There is an increasing##5##4##(2008-11#1)(2008-12#1)(2009-6#1)(2010-12#1)(2011-1#1)
There is an##14##3##(1990-2#1)(1993-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
There is considerable evidence that##2##5##(2008-5#1)(2008-9#1)
There is considerable##8##3##(1992-9#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
There is currently##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
There is evidence that##8##4##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-9#1)(2011-2#1)
There is evidence to suggest that##2##6##(1994-9#1)(2008-9#1)
There is evidence##12##3##(1994-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)
There is good##2##3##(2008-10#1)(2010-12#1)
There is growing evidence that##4##5##(2006-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
There is growing interest in##3##5##(1997-7#1)(2010-1#1)(2011-3#1)
There is growing##11##3##(1997-7#1)(2006-6#1)(2008-11#2)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-3#1)
There is increasing concern about##2##5##(2008-10#1)(2010-8#1)
There is increasing evidence that##4##5##(2008-11#1)(2008-6#1)(2008-7#2)
There is increasing evidence##5##4##(2008-11#1)(2008-6#1)(2008-7#3)
There is increasing##11##3##(1991-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#3)(2010-8#1)
There is little evidence##2##4##(1993-3#1)(2012-3#1)
There is little##4##3##(1993-3#1)(1993-8#1)(2008-10#1)(2012-3#1)
There is much##3##3##(1994-2#1)(1997-5#1)(2008-11#1)
There is no evidence that##2##5##(1993-3#1)(2008-10#1)
There is no evidence##3##4##(1993-3#1)(2008-10#1)(2012-2#1)
There is no##21##3##(1993-3#1)(1994-1#1)(1994-9#1)(1995-11#1)(1996-6#2)(1997-4#1)(1997-7#1)(2008-10#5)(2008-3#2)(2008-9#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
There is not##2##3##(1993-3#1)(2011-2#1)
There is now##3##3##(2008-7#1)(2008-8#1)(2009-8#1)
There is some evidence that##2##5##(1996-6#1)(2008-5#1)
There is some evidence##3##4##(1991-1#1)(1996-6#1)(2008-5#1)
There is some##6##3##(1990-8#1)(1991-1#1)(1996-6#1)(2008-5#2)(2013-1#1)
There is still##4##3##(1996-11#1)(2008-10#2)(2013-1#1)
There is strong##4##3##(1995-11#1)(2007-8#1)(2008-7#1)(2012-2#1)
There is substantial##2##3##(1992-12#1)(2008-11#1)
There is the##2##3##(1997-6#1)(2008-10#1)
There is therefore a##2##4##(2008-10#1)(2010-12#1)
There is##220##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-2#2)(1996-11#2)(1996-2#2)(1996-3#1)(1996-6#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#3)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#19)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#3)(2009-8#5)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#8)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#13)(2011-3#2)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#8)(2013-8#2)
There may be##2##3##(1993-9#1)(2012-12#1)
There must be##4##3##(1995-12#1)(2008-3#3)
There should be##3##3##(1997-8#1)(2008-1#1)(2008-9#1)
There should##4##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
There was a correlation between##4##5##(1991-6#1)(2008-10#2)(2008-9#1)
There was a correlation##6##4##(1991-6#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-9#1)
There was a general##2##4##(2008-10#2)
There was a good##2##4##(2008-10#2)
There was a high correlation between##2##6##(2008-10#1)(2008-9#1)
There was a high##4##4##(1994-6#1)(2008-10#1)(2008-12#1)(2008-9#1)
There was a higher##2##4##(1996-3#1)(1996-6#1)
There was a linear relationship between the##2##7##(2008-10#1)(2008-11#1)
There was a linear##3##4##(2008-10#2)(2008-11#1)
There was a reduction in##2##5##(1996-2#1)(1997-1#1)
There was a remarkable##2##4##(2011-2#1)(2012-3#1)
There was a significant (P &lt##2##6##(2012-2#2)
There was a significant association between##2##6##(2008-10#1)(2011-2#1)
There was a significant decrease##2##5##(2010-4#1)(2011-2#1)
There was a significant difference in##2##6##(2008-10#1)(2008-9#1)
There was a significant difference##3##5##(2008-10#1)(2008-7#1)(2008-9#1)
There was a significant effect of##2##6##(2008-10#1)(2010-7#1)
There was a significant negative correlation between the##2##8##(1994-2#1)(2008-10#1)
There was a significant negative correlation between##3##7##(1994-2#1)(2008-10#1)(2012-6#1)
There was a significant positive##2##5##(2008-8#2)
There was a significant relationship between##2##6##(1997-8#1)(2008-10#1)
There was a significant##23##4##(1994-2#1)(1997-8#1)(2008-10#6)(2008-7#2)(2008-8#2)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#3)(2012-4#1)(2012-6#1)
There was a statistical significance##2##5##(1990-12#2)
There was a statistically significant##3##5##(2010-9#1)(2012-3#1)(2013-1#1)
There was a strong correlation##2##5##(2008-10#2)
There was a strong##5##4##(2008-10#4)(2008-8#1)
There was a trend for##2##5##(1990-2#1)(2008-10#1)
There was a trend toward##2##5##(1995-11#1)(2008-10#1)
There was a trend towards##2##5##(2008-10#1)(2008-7#1)
There was a trend##7##4##(1990-2#1)(1995-11#1)(2008-10#4)(2008-7#1)
There was a weak##2##4##(2008-10#1)(2008-9#1)
There was a##90##3##(1990-12#2)(1990-2#1)(1991-2#1)(1991-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#4)(2008-9#5)(2010-4#1)(2010-7#1)(2010-9#2)(2011-2#6)(2012-2#3)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#2)(2013-8#2)
There was also a significant##2##5##(1997-8#1)(2012-2#1)
There was also a##6##4##(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-2#1)
There was also no evidence of##2##6##(2008-8#1)(2009-10#1)
There was also no evidence##3##5##(2008-8#2)(2009-10#1)
There was also##14##3##(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#1)(2012-2#1)
There was an almost equal##2##5##(1997-3#2)
There was an increase in##2##5##(2008-10#1)(2008-11#1)
There was an increase##3##4##(2008-10#2)(2008-11#1)
There was an inverse linear relationship between##2##7##(2008-10#2)
There was an inverse relationship between##2##6##(1991-5#1)(2008-10#1)
There was an inverse##4##4##(1991-5#1)(2008-10#3)
There was an##19##3##(1991-5#1)(1997-3#2)(2008-10#7)(2008-11#2)(2008-7#2)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
There was evidence of##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
There was evidence##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
There was greater than 99%##2##5##(2008-10#2)
There was greater##3##3##(1996-6#1)(2008-10#2)
There was limited##2##3##(2008-10#2)
There was little change##2##4##(2008-10#1)(2008-8#1)
There was little##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
There was no apparent##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
There was no association between##3##5##(1993-1#1)(2008-8#1)(2013-1#1)
There was no association##4##4##(1993-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
There was no consistent##2##4##(1990-12#1)(2008-10#1)
There was no correlation between the##3##6##(2008-10#2)(2008-5#1)
There was no correlation between##5##5##(1991-8#1)(1995-2#1)(2008-10#2)(2008-5#1)
There was no correlation##6##4##(1991-8#1)(1995-2#1)(2008-10#3)(2008-5#1)
There was no decrease in##2##5##(2008-10#1)(2008-9#1)
There was no difference between##3##5##(1994-3#1)(2008-10#1)(2008-9#1)
There was no difference in HR##2##6##(2013-8#2)
There was no difference in the##5##6##(1995-12#1)(1996-12#1)(1997-3#1)(2008-11#1)(2012-2#1)
There was no difference in##10##5##(1992-12#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2012-2#1)(2013-8#2)
There was no difference##14##4##(1992-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2009-6#1)(2012-2#1)(2013-8#2)
There was no effect of##2##5##(1996-12#1)(2009-3#1)
There was no effect on##2##5##(1992-2#1)(1997-6#1)
There was no effect##4##4##(1992-2#1)(1996-12#1)(1997-6#1)(2009-3#1)
There was no evidence of##7##5##(1992-5#1)(1996-1#1)(1996-3#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
There was no evidence##9##4##(1992-5#1)(1996-1#1)(1996-3#1)(2008-10#3)(2010-7#1)(2011-2#1)(2012-3#1)
There was no family history##2##5##(2012-3#1)(2013-1#1)
There was no improvement##2##4##(2008-12#1)(2011-1#1)
There was no interference from##3##5##(2008-10#3)
There was no interference##4##4##(1993-2#1)(2008-10#3)
There was no observed##2##4##(2008-10#1)(2013-1#1)
There was no relationship between##5##5##(1997-2#1)(2008-10#1)(2011-2#2)(2013-1#1)
There was no significant correlation between the##3##7##(1997-2#1)(1997-8#1)(2008-10#1)
There was no significant correlation between##6##6##(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#3)
There was no significant difference between the##2##7##(1997-9#1)(2008-10#1)
There was no significant difference between##7##6##(1993-2#1)(1997-9#1)(2008-10#3)(2008-12#1)(2012-3#1)
There was no significant difference in the##10##7##(1991-2#1)(2008-10#2)(2008-11#3)(2011-2#1)(2012-3#1)(2013-1#2)
There was no significant difference in##17##6##(1991-2#1)(1993-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
There was no significant difference##25##5##(1991-2#1)(1993-11#1)(1993-2#1)(1997-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
There was no significant##38##4##(1991-2#1)(1993-11#1)(1993-2#1)(1994-12#1)(1997-2#1)(1997-8#1)(1997-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)
There was no statistical difference between the##2##7##(1996-12#1)(2008-7#1)
There was no statistical difference between##3##6##(1996-12#1)(2008-7#1)(2012-2#1)
There was no statistical difference in##2##6##(1990-12#1)(2011-1#1)
There was no statistical difference##5##5##(1990-12#1)(1996-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
There was no statistical##6##4##(1990-12#1)(1996-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
There was no statistically##2##4##(2011-2#1)(2013-1#1)
There was no##129##3##(1990-12#2)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#4)(1996-3#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#1)(1997-9#1)(2008-1#2)(2008-10#30)(2008-11#9)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-3#2)(2009-4#1)(2009-6#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#5)(2012-8#1)(2013-1#8)(2013-8#4)
There was not a significant##2##5##(2011-2#2)
There was not##4##3##(2008-7#1)(2009-8#1)(2011-2#2)
There was one##6##3##(1993-12#1)(2007-8#1)(2008-7#2)(2011-2#1)(2013-1#1)
There was only one##2##4##(1996-12#1)(2011-1#1)
There was only##4##3##(1991-3#1)(1995-3#1)(1996-12#1)(2011-1#1)
There was significant correlation##2##4##(2008-10#2)
There was significant##6##3##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)
There was some evidence##3##4##(2008-10#2)(2009-6#1)
There was some##4##3##(2008-10#2)(2008-9#1)(2009-6#1)
There was strong##2##3##(1994-9#1)(2008-10#1)
There was substantial##2##3##(1995-1#1)(2008-7#1)
There was variability##2##3##(1990-7#1)(2012-2#1)
There was##322##2##(1990-12#4)(1990-2#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#6)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#1)(1997-8#3)(1997-9#1)(2007-8#1)(2008-1#2)(2008-10#87)(2008-11#17)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#20)(2008-8#10)(2008-9#15)(2009-10#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#19)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#11)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#7)
There were 1##2##3##(1991-3#1)(2012-12#1)
There were 10##2##3##(2008-10#1)(2011-2#1)
There were 17##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
There were 2##2##3##(1991-2#1)(2008-12#1)
There were 3##2##3##(2008-12#1)(2012-12#1)
There were 6##2##3##(2008-10#1)(2011-2#1)
There were 74##2##3##(2008-1#1)(2011-2#1)
There were 75##2##3##(1993-8#1)(2012-3#1)
There were a few##2##4##(2008-12#1)(2008-9#1)
There were a##4##3##(2007-8#1)(2008-12#1)(2008-9#1)(2013-7#1)
There were also no##2##4##(2008-10#1)(2011-2#1)
There were also##9##3##(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#3)
There were differences in##3##4##(2008-10#1)(2008-7#1)(2012-8#1)
There were few##2##3##(1995-11#1)(2008-10#1)
There were four##2##3##(2008-10#1)(2008-8#1)
There were large differences##2##4##(2008-10#1)(2008-8#1)
There were large##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
There were no cases of##2##5##(1991-2#1)(2011-2#1)
There were no changes##2##4##(2008-11#1)(2009-3#1)
There were no differences in the##2##6##(2008-11#1)(2011-2#1)
There were no differences in##5##5##(1993-1#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
There were no differences##6##4##(1993-1#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#2)
There were no increased incidences of neoplasms in male or female Tg##2##12##(2008-9#2)
There were no intraoperative complications##2##5##(1993-12#1)(2012-3#1)
There were no serious##2##4##(1990-2#1)(2013-1#1)
There were no significant changes in##2##6##(2007-8#1)(2008-9#1)
There were no significant changes##3##5##(2007-8#1)(2008-9#1)(2012-2#1)
There were no significant differences between##3##6##(1997-7#1)(2009-11#1)(2013-1#1)
There were no significant differences for##2##6##(2008-10#1)(2013-8#1)
There were no significant differences in the##2##7##(1994-12#1)(2010-12#1)
There were no significant differences in##9##6##(1994-12#1)(1995-1#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2013-8#1)
There were no significant differences##16##5##(1994-12#1)(1995-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#2)
There were no significant##25##4##(1993-1#1)(1994-12#1)(1994-8#1)(1995-1#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
There were no statistically significant differences##2##6##(2013-1#2)
There were no##72##3##(1990-2#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-3#2)(1997-7#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#7)(2009-11#1)(2009-3#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
There were only##2##3##(1991-6#1)(2008-11#1)
There were significant differences among##2##5##(2008-10#2)
There were significant differences between the##2##6##(1991-9#1)(2008-10#1)
There were significant differences between##4##5##(1991-9#1)(1993-2#1)(2008-10#1)(2013-1#1)
There were significant differences in##3##5##(2008-10#2)(2013-1#1)
There were significant differences##10##4##(1991-9#1)(1993-2#1)(2008-10#5)(2008-5#1)(2013-1#2)
There were significant##17##3##(1991-9#1)(1992-2#1)(1993-1#1)(1993-2#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#3)
There were some##3##3##(1991-6#1)(2008-11#1)(2010-1#1)
There were three##2##3##(2008-11#1)(2013-8#1)
There were trends##2##3##(1994-2#1)(2012-3#1)
There were two##6##3##(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2010-11#1)(2012-3#1)
There were##203##2##(1990-2#1)(1990-8#1)(1991-2#2)(1991-3#2)(1991-6#2)(1991-9#2)(1992-12#1)(1992-2#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#4)(1994-2#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1996-1#2)(1996-12#1)(1996-3#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-1#5)(2008-10#34)(2008-11#8)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#16)(2009-1#1)(2009-10#2)(2009-11#2)(2009-3#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#19)(2012-12#4)(2012-2#4)(2012-3#10)(2012-8#1)(2013-1#12)(2013-7#1)(2013-8#4)
There will be##3##3##(1995-8#1)(2011-2#1)(2012-12#1)
There##993##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#3)(1991-1#1)(1991-2#7)(1991-3#5)(1991-5#3)(1991-6#4)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#2)(1992-5#1)(1992-9#8)(1993-1#5)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#8)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#6)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#6)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#9)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#2)(1997-3#8)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#8)(1997-9#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-8#4)(2008-1#11)(2008-10#172)(2008-11#69)(2008-12#20)(2008-2#1)(2008-3#11)(2008-4#9)(2008-5#16)(2008-6#4)(2008-7#45)(2008-8#25)(2008-9#50)(2009-1#1)(2009-10#5)(2009-11#6)(2009-12#4)(2009-3#5)(2009-4#2)(2009-6#7)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#6)(2010-10#2)(2010-11#6)(2010-12#13)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#6)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#12)(2011-10#1)(2011-2#66)(2011-3#5)(2011-4#1)(2012-12#14)(2012-2#29)(2012-3#31)(2012-4#1)(2012-6#1)(2012-8#2)(2013-1#50)(2013-7#3)(2013-8#17)
Thereafter##15##1##(1992-10#1)(1992-12#1)(1995-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)
Thereby##5##1##(1994-3#1)(1997-3#1)(1997-6#1)(2008-10#1)(2009-8#1)
Therefore a##5##2##(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-8#1)
Therefore it is##2##3##(2008-11#1)(2008-8#1)
Therefore the aim of##2##4##(2008-7#1)(2011-2#1)
Therefore the##17##2##(1990-3#1)(1990-6#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#4)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
Therefore this##2##2##(2008-11#2)
Therefore we suggest that##2##4##(2008-11#1)(2009-1#1)
Therefore we##5##2##(1994-5#1)(2008-11#3)(2009-1#1)
Therefore##450##1##(1990-11#2)(1990-12#4)(1990-3#2)(1990-4#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#4)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-1#5)(2008-10#115)(2008-11#45)(2008-12#10)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#18)(2008-6#1)(2008-7#16)(2008-8#9)(2008-9#10)(2009-1#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#27)(2011-3#3)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#24)(2013-7#1)(2013-8#8)
Theresa##2##1##(1992-3#1)(1994-9#1)
Thermal and##2##2##(2008-10#1)(2011-2#1)
Thermal blooming##2##2##(2008-2#2)
Thermal lensing is used##2##4##(2008-10#2)
Thermal##25##1##(1992-3#1)(1992-8#1)(1995-8#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)
Thermo-optical measurements on##2##3##(2008-10#2)
Thermoanaerobacter##3##1##(2011-1#2)(2011-2#1)
Thermobispora bispora##2##2##(2011-2#2)
Thermobispora##4##1##(2011-2#4)
Thermocrinis albus##2##2##(2011-2#2)
Thermocrinis##4##1##(2011-2#4)
Thermodynamic analysis of##2##3##(1992-10#1)(2008-7#1)
Thermodynamic characterization of##3##3##(2008-10#3)
Thermodynamic parameters for the##3##4##(2008-10#3)
Thermodynamic parameters for##4##3##(1992-3#1)(2008-10#3)
Thermodynamic##16##1##(1990-9#1)(1992-10#1)(1992-3#2)(1993-8#1)(1996-9#1)(2008-10#9)(2008-7#1)
Thermodynamics##2##1##(1997-2#1)(2008-3#1)
Thermogravimetric analysis##2##2##(2008-10#2)
Thermogravimetric##3##1##(2008-10#3)
Thermophilic##2##1##(1990-3#1)(2008-7#1)
Thermosphaera aggregans##2##2##(2011-2#2)
Thermosphaera##3##1##(2011-2#3)
Thermotoga maritima##3##2##(2008-7#1)(2011-1#2)
Thermus##3##1##(1997-8#1)(2011-2#2)
These &quot##7##2##(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)
These 2##2##2##(1992-2#1)(2011-2#1)
These Guidelines##2##2##(2008-9#1)(2013-1#1)
These QTL##2##2##(2008-10#2)
These abnormalities##2##2##(2008-4#1)(2008-6#1)
These alterations##2##2##(2008-10#1)(2012-2#1)
These analyses suggest##2##3##(2008-9#2)
These analyses##12##2##(1995-12#1)(1996-2#1)(2008-10#5)(2008-5#1)(2008-9#2)(2009-12#1)(2012-3#1)
These analytical##2##2##(2008-10#2)
These and other##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
These and previous##2##3##(1995-11#1)(2008-9#1)
These and##5##2##(1994-5#1)(1995-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
These animals##2##2##(2008-5#1)(2009-8#1)
These antibodies##2##2##(2006-6#1)(2011-2#1)
These approaches are##2##3##(2011-3#1)(2012-3#1)
These approaches##6##2##(1997-1#1)(2008-10#1)(2008-5#1)(2011-3#1)(2012-3#1)(2013-1#1)
These are based on the##2##5##(2008-10#2)
These are based##4##3##(2008-10#3)(2008-12#1)
These are discussed##2##3##(1993-2#1)(2012-2#1)
These are the first##2##4##(2007-12#1)(2008-11#1)
These are the##6##3##(1995-6#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-7#1)
These are##33##2##(1991-1#1)(1992-9#1)(1993-2#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-7#1)(2011-7#1)(2012-2#2)(2013-8#1)
These areas were##2##3##(1990-8#1)(2008-5#1)
These areas##3##2##(1990-8#1)(2008-5#1)(2012-5#1)
These assays are##3##3##(2008-4#2)(2008-9#1)
These assays##10##2##(2008-1#1)(2008-10#2)(2008-4#3)(2008-8#1)(2008-9#2)(2010-4#1)
These associations##2##2##(2008-10#1)(2013-1#1)
These beads were##2##3##(2008-10#1)(2008-11#1)
These beads##3##2##(2008-10#2)(2008-11#1)
These benefits##5##2##(1993-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)
These biases##2##2##(2008-1#1)(2008-8#1)
These biochemical##3##2##(1994-2#1)(2011-2#1)(2013-1#1)
These biological##2##2##(2008-10#1)(2011-2#1)
These can##2##2##(1990-5#1)(2008-12#1)
These case##2##2##(1991-2#1)(2010-7#1)
These cases highlight the##2##4##(2008-10#1)(2008-7#1)
These cases illustrate##2##3##(2008-1#1)(2011-2#1)
These cases were##3##3##(1990-6#1)(2008-7#1)(2011-2#1)
These cases##12##2##(1990-6#1)(1991-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#3)(2011-2#2)(2012-3#1)
These categories##2##2##(2008-10#1)(2008-12#1)
These cell lines##5##3##(1995-12#1)(2008-11#3)(2012-2#1)
These cells expressed the bone-related mRNA##2##6##(2008-11#2)
These cells expressed##3##3##(2008-11#3)
These cells have been##2##4##(1997-8#1)(2008-11#1)
These cells have##4##3##(1997-8#1)(2008-11#3)
These cells were CD45(+)##2##4##(2008-11#2)
These cells were##5##3##(2008-11#4)(2009-1#1)
These cells##21##2##(1997-8#1)(2008-10#1)(2008-11#15)(2008-12#1)(2008-9#1)(2009-1#1)(2010-11#1)
These changes are##2##3##(1996-3#1)(2008-3#1)
These changes can be##2##4##(2008-10#1)(2008-9#1)
These changes can##3##3##(1995-3#1)(2008-10#1)(2008-9#1)
These changes in##3##3##(1994-8#1)(1994-9#1)(2008-10#1)
These changes may be##2##4##(1997-1#1)(2007-12#1)
These changes may##4##3##(1994-1#1)(1997-1#1)(1997-3#1)(2007-12#1)
These changes might##2##3##(2008-12#1)(2008-8#1)
These changes were##4##3##(1993-12#1)(1994-5#1)(1995-12#1)(2008-11#1)
These changes##28##2##(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
These characteristics##5##2##(1990-3#1)(1992-12#1)(1995-5#1)(2008-10#2)
These children##2##2##(1997-2#1)(1997-6#1)
These clades##2##2##(2008-10#2)
These clinical trials##2##3##(1994-5#1)(2010-6#1)
These clinical##4##2##(1994-5#1)(1995-12#1)(2008-9#1)(2010-6#1)
These clones were##2##3##(1996-2#1)(2008-10#1)
These clones##3##2##(1996-2#1)(1997-8#1)(2008-10#1)
These combined##2##2##(1992-3#1)(2008-10#1)
These complexes##3##2##(2008-10#3)
These complications##2##2##(2008-7#1)(2011-3#1)
These components are##2##3##(2008-8#1)(2013-1#1)
These components##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
These compounds also##3##3##(1993-8#1)(1994-8#1)(2008-10#1)
These compounds do not show##2##5##(2008-10#2)
These compounds may##2##3##(1991-5#1)(1993-2#1)
These compounds##16##2##(1990-5#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-8#2)(1996-5#1)(2008-10#5)(2008-12#1)(2011-2#1)(2011-3#1)
These conditions##4##2##(1996-6#1)(2008-10#1)(2008-11#2)
These constraints need to be addressed and put into proper perspective in order to attract the interest of potential candidates##2##20##(1994-1#2)
These constructs##2##2##(1993-12#1)(2008-8#1)
These could be##2##3##(2011-2#2)
These could##3##2##(2008-10#1)(2011-2#2)
These criteria##4##2##(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)
These crystals##2##2##(1992-9#1)(2008-8#1)
These cysts have##2##3##(2013-1#2)
These data also##4##3##(1993-6#1)(2008-10#2)(2011-2#1)
These data are consistent with a##2##6##(1991-5#1)(2008-10#1)
These data are consistent with the##3##6##(1994-3#1)(1997-9#1)(2012-3#1)
These data are consistent with##5##5##(1991-5#1)(1994-3#1)(1997-9#1)(2008-10#1)(2012-3#1)
These data are used to##2##5##(2009-11#1)(2013-1#1)
These data are##12##3##(1991-5#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-9#1)(2008-10#2)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
These data confirm that the##2##5##(2008-5#1)(2009-8#1)
These data confirm that##6##4##(1990-8#1)(1991-6#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
These data confirm##7##3##(1990-8#1)(1991-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
These data demonstrate that##8##4##(1992-6#1)(1993-6#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-5#1)
These data demonstrate the##2##4##(1990-11#1)(2008-10#1)
These data demonstrate##12##3##(1990-11#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-8#2)(2009-6#1)(2012-5#1)
These data highlight##3##3##(1993-3#1)(2008-10#1)(2013-1#1)
These data indicate that increased##2##5##(1994-8#1)(2013-1#1)
These data indicate that the##4##5##(1990-8#1)(1996-3#1)(2007-12#1)(2008-7#1)
These data indicate that##29##4##(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#1)
These data indicate##32##3##(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#1)
These data indicated that##2##4##(1996-2#1)(2008-10#1)
These data may##2##3##(1992-8#1)(2011-2#1)
These data provide evidence for##2##5##(1993-12#1)(1995-11#1)
These data provide evidence##4##4##(1993-12#1)(1995-11#1)(1995-8#2)
These data provide important information##2##5##(1990-8#1)(2009-6#1)
These data provide##12##3##(1990-8#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-8#2)(1996-2#1)(1997-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2012-5#1)
These data provided##2##3##(2008-11#1)(2008-8#1)
These data show that##9##4##(1992-12#1)(1993-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(2008-10#1)(2010-12#1)(2013-1#1)
These data show##10##3##(1992-12#1)(1993-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
These data suggest that a##3##5##(1995-2#1)(2008-10#1)(2012-3#1)
These data suggest that the##14##5##(1990-5#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2013-7#1)
These data suggest that##55##4##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-2#2)(1995-2#2)(1995-6#3)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)
These data suggest##58##3##(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-2#2)(1995-11#1)(1995-2#2)(1995-6#3)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-7#1)
These data suggested##2##3##(1991-5#1)(2008-11#1)
These data support##3##3##(1992-6#1)(2008-10#1)(2013-1#1)
These data were compared with##2##5##(2008-10#1)(2008-12#1)
These data were compared##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
These data were used to calculate##2##6##(2009-8#2)
These data were##10##3##(2008-10#4)(2008-11#1)(2008-12#2)(2008-9#1)(2009-8#2)
These data##190##2##(1990-11#1)(1990-5#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-6#5)(1992-7#2)(1992-8#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#5)(1996-2#4)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#33)(2008-11#13)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#5)(2009-11#1)(2009-4#1)(2009-6#3)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#8)(2012-2#2)(2012-3#3)(2012-5#2)(2013-1#6)(2013-7#1)(2013-8#1)
These developments##2##2##(1992-1#1)(2009-8#1)
These differences are##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
These differences in##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
These differences may be##3##4##(1997-7#1)(2008-7#1)(2013-1#1)
These differences may##4##3##(1995-5#1)(1997-7#1)(2008-7#1)(2013-1#1)
These differences##23##2##(1991-6#1)(1995-2#1)(1995-5#1)(1996-12#2)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
These diseases are##6##3##(1991-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
These dislocations##2##2##(2008-12#1)(2011-2#1)
These drugs are##2##3##(2008-11#1)(2009-7#1)
These drugs##4##2##(2008-11#1)(2009-12#1)(2009-7#1)(2012-12#1)
These dsRNAs##2##2##(2008-10#2)
These early##3##2##(1992-12#1)(2008-10#1)(2010-6#1)
These effects are##2##3##(2008-8#1)(2008-9#1)
These effects of##4##3##(1991-2#1)(1994-8#1)(2008-7#1)(2009-8#1)
These effects were##6##3##(2008-10#4)(2008-5#1)(2011-2#1)
These effects##20##2##(1991-2#1)(1991-5#1)(1992-5#1)(1994-3#1)(1994-8#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-7#1)
These efforts##3##2##(1996-1#1)(2012-3#1)(2013-1#1)
These electrodes##3##2##(2008-10#3)
These elements are##2##3##(1995-8#1)(2008-11#1)
These elements were##4##3##(1993-12#1)(2008-10#3)
These elements##10##2##(1993-12#1)(1993-6#1)(1995-12#1)(1995-8#1)(2008-10#4)(2008-11#1)(2011-2#1)
These enzymes##2##2##(2008-10#1)(2008-9#1)
These equations##3##2##(2008-1#1)(2008-11#1)(2008-3#1)
These estimates are##2##3##(2008-9#1)(2010-10#1)
These estimates##4##2##(1995-12#1)(1996-8#1)(2008-9#1)(2010-10#1)
These events##5##2##(1991-2#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
These examples##2##2##(1992-11#1)(2008-11#1)
These expatriated scientists##2##3##(2008-11#2)
These experimental##2##2##(2008-10#1)(2010-12#1)
These experiments confirmed##2##3##(2008-10#2)
These experiments demonstrate the##2##4##(1995-2#1)(2008-3#1)
These experiments demonstrate##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
These experiments show that the##2##5##(1990-11#1)(2008-7#1)
These experiments were##2##3##(2006-6#1)(2008-10#1)
These experiments##17##2##(1990-11#1)(1993-3#1)(1994-8#1)(1995-2#2)(2006-6#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#2)(2009-4#1)(2013-7#1)
These factors are well##2##4##(1994-11#1)(1996-1#1)
These factors are##4##3##(1994-11#1)(1996-1#1)(2009-8#1)(2013-1#1)
These factors include##4##3##(1992-12#1)(1993-1#1)(1993-3#1)(1995-2#1)
These factors##13##2##(1992-12#1)(1993-1#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-8#1)(2009-8#1)(2013-1#2)
These facts suggest that the##2##5##(1992-3#1)(2008-9#1)
These facts suggest##3##3##(1992-3#1)(2008-8#1)(2008-9#1)
These facts##5##2##(1990-5#1)(1992-3#1)(1997-1#1)(2008-8#1)(2008-9#1)
These features##9##2##(1993-2#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-4#1)(2010-6#1)(2013-8#1)
These findings also##2##3##(1995-2#1)(2010-2#1)
These findings and##4##3##(1995-5#1)(1995-6#1)(1996-2#1)(2008-10#1)
These findings are additional##2##4##(2006-6#1)(2008-12#1)
These findings are consistent with##2##5##(2008-12#1)(2011-2#1)
These findings are discussed in relation##2##6##(1990-8#1)(2008-12#1)
These findings are discussed in##3##5##(1990-8#1)(2008-10#1)(2008-12#1)
These findings are discussed##4##4##(1990-8#1)(1993-8#1)(2008-10#1)(2008-12#1)
These findings are##18##3##(1990-8#1)(1993-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#4)(2008-5#1)(2008-8#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
These findings clearly##2##3##(2008-10#1)(2010-6#1)
These findings confirm the##2##4##(2008-11#1)(2013-1#1)
These findings confirm##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
These findings confirmed##2##3##(1994-8#1)(2008-5#1)
These findings contribute to##2##4##(2009-12#1)(2013-1#1)
These findings demonstrate that##3##4##(1997-4#1)(2011-2#1)(2013-8#1)
These findings demonstrate the##2##4##(2011-2#1)(2013-1#1)
These findings demonstrate##5##3##(1997-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
These findings have##7##3##(2008-1#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)(2012-2#1)
These findings highlight##2##3##(1995-12#1)(2013-1#1)
These findings imply that##2##4##(2008-9#1)(2012-2#1)
These findings indicate that the##5##5##(1993-6#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-5#1)
These findings indicate that##25##4##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#2)(2008-10#4)(2008-11#3)(2008-5#1)(2009-12#1)(2011-1#1)
These findings indicate##30##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#2)(2008-10#4)(2008-11#4)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-1#1)
These findings indicated that##5##4##(1994-11#1)(2008-11#2)(2008-5#1)(2011-2#1)
These findings may##4##3##(1990-12#1)(1990-8#1)(2006-6#1)(2008-10#1)
These findings present##2##3##(2008-9#1)(2010-12#1)
These findings provide a##2##4##(2008-9#1)(2012-2#1)
These findings provide##7##3##(1995-2#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-2#1)
These findings shed light on the##2##6##(2008-11#1)(2012-2#1)
These findings shed##3##3##(2008-11#1)(2012-2#2)
These findings should be##2##4##(2008-11#1)(2013-1#1)
These findings should##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
These findings suggest a##5##4##(1994-11#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-12#1)
These findings suggest an##2##4##(1996-3#1)(1997-8#1)
These findings suggest that a##3##5##(1992-1#1)(1993-8#1)(2013-8#1)
These findings suggest that the##11##5##(1990-11#1)(1994-11#1)(1996-5#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2013-8#1)
These findings suggest that##55##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-8#2)(1994-11#4)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-2#2)(2008-10#9)(2008-11#7)(2008-12#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#3)
These findings suggest the##4##4##(1992-6#1)(1993-3#1)(1996-12#1)(2008-4#1)
These findings suggest##72##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-3#2)(1993-8#2)(1994-11#5)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#7)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#4)
These findings suggested that##3##4##(1994-11#1)(2008-10#1)(2008-9#1)
These findings support the##2##4##(1991-7#1)(2009-9#1)
These findings support##4##3##(1990-8#1)(1991-7#1)(2009-9#1)(2012-2#1)
These findings were validated##2##4##(2010-12#1)(2010-7#1)
These findings were##7##3##(2008-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
These findings will##2##3##(1993-2#1)(2010-5#1)
These findings##221##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-8#3)(1991-10#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#19)(2008-12#7)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#9)(2012-12#2)(2012-2#10)(2013-1#11)(2013-7#1)(2013-8#5)
These five##3##2##(2008-10#2)(2008-11#1)
These forms##2##2##(2008-10#1)(2009-9#1)
These four##2##2##(2008-1#1)(2011-10#1)
These fractions##2##2##(2008-10#1)(2008-11#1)
These fragments##2##2##(2008-8#1)(2010-6#1)
These functional##5##2##(1994-12#1)(1995-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
These functions##3##2##(1991-2#1)(2008-10#1)(2010-1#1)
These fungi##3##2##(2008-10#2)(2009-6#1)
These gene##2##2##(1991-5#1)(1995-11#1)
These genes are##2##3##(2010-10#1)(2012-3#1)
These genes were##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
These genes##6##2##(1997-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
These groups##2##2##(2008-10#2)
These have##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
These high##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
These improvements##3##2##(1995-3#1)(2008-2#1)(2008-3#1)
These include (1)##2##3##(1991-12#1)(1992-9#1)
These include the three##2##4##(1996-2#1)(2013-1#1)
These include the##9##3##(1996-2#1)(2008-10#1)(2008-11#2)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
These include##40##2##(1990-8#1)(1991-12#1)(1992-9#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#6)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)
These included##9##2##(1991-9#1)(1994-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
These increases##2##2##(1993-8#1)(1995-11#1)
These indicate that the##2##4##(1992-8#1)(2008-8#1)
These indicate that##3##3##(1992-8#1)(2008-8#1)(2012-2#1)
These individual##2##2##(1997-7#1)(2008-11#1)
These infections are##2##3##(2008-11#1)(2011-2#1)
These infections##3##2##(2008-11#1)(2011-2#2)
These initiatives may##2##3##(1996-3#1)(1997-2#1)
These interactions##2##2##(2008-10#1)(2008-11#1)
These interferences##2##2##(2008-10#2)
These isolates originated from##2##4##(2008-10#2)
These isolates were##3##3##(2008-10#3)
These isolates##8##2##(2008-10#8)
These issues are##2##3##(1995-9#1)(2008-11#1)
These issues##3##2##(1995-9#1)(2008-11#1)(2010-7#1)
These lasers##2##2##(2008-3#2)
These latter##2##2##(2010-2#1)(2011-2#1)
These lesions##3##2##(1990-5#1)(2011-2#1)(2012-3#1)
These levels##2##2##(2008-10#1)(2008-5#1)
These ligands##2##2##(2008-10#2)
These limitations##2##2##(2009-8#1)(2013-8#1)
These lines##2##2##(2008-10#2)
These loci were##2##3##(2008-10#2)
These loci##3##2##(2008-10#3)
These markers were##3##3##(2008-10#2)(2008-12#1)
These markers##6##2##(2008-10#5)(2008-12#1)
These materials were##2##3##(2008-10#1)(2008-7#1)
These materials##4##2##(2008-10#2)(2008-7#1)(2009-7#1)
These may be##2##3##(1990-11#1)(1994-12#1)
These may##3##2##(1990-11#1)(1994-12#1)(2008-11#1)
These measurements##5##2##(1996-6#1)(2008-2#1)(2008-3#2)(2009-7#1)
These measures##2##2##(2011-2#1)(2012-3#1)
These mechanisms are##2##3##(2010-12#1)(2012-2#1)
These mechanisms##5##2##(2008-10#1)(2009-12#1)(2010-12#1)(2012-12#1)(2012-2#1)
These metals##2##2##(2008-10#2)
These methods are based on##2##5##(2008-11#1)(2011-2#1)
These methods are##7##3##(2008-11#1)(2008-4#3)(2008-9#1)(2009-10#1)(2011-2#1)
These methods can be##2##4##(2008-4#2)
These methods can##4##3##(2008-4#3)(2008-9#1)
These methods have been##2##4##(1995-12#1)(2008-10#1)
These methods have##4##3##(1995-12#1)(1996-9#1)(2008-10#2)
These methods provide##2##3##(1991-2#1)(2008-9#1)
These methods were used to##2##5##(1992-11#1)(2008-10#1)
These methods were##3##3##(1992-11#1)(2008-10#2)
These methods##30##2##(1990-8#1)(1991-2#1)(1992-11#1)(1993-3#1)(1995-12#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#6)(2008-5#2)(2008-9#3)(2009-10#1)(2011-2#1)
These mice##2##2##(1993-12#1)(1995-2#1)
These models##6##2##(1994-9#1)(2008-10#2)(2008-8#1)(2008-9#2)
These modifications##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
These molecules##2##2##(2008-5#1)(2008-9#1)
These mutants##3##2##(2008-10#3)
These mutations##2##2##(1990-12#1)(2011-1#1)
These neurons##2##2##(2009-10#1)(2013-8#1)
These new formulations##2##3##(2008-11#1)(2008-5#1)
These new##8##2##(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-9#1)(2011-3#1)
These novel##2##2##(1996-2#1)(2008-10#1)
These observations are in##3##4##(1990-12#1)(1995-11#1)(2006-6#1)
These observations are##7##3##(1990-12#1)(1995-11#1)(2006-6#1)(2008-10#3)(2008-5#1)
These observations confirm the important##2##5##(1995-12#1)(2008-5#1)
These observations confirm##3##3##(1995-12#1)(2008-5#1)(2008-6#1)
These observations demonstrate that##2##4##(1996-12#1)(2008-10#1)
These observations indicate that##3##4##(1994-6#1)(1995-2#1)(2012-12#1)
These observations indicate##4##3##(1994-11#1)(1994-6#1)(1995-2#1)(2012-12#1)
These observations suggest that the##3##5##(1994-5#1)(1995-2#1)(2012-2#1)
These observations suggest that##15##4##(1991-5#1)(1993-12#2)(1994-11#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)
These observations suggest the##2##4##(2008-10#1)(2008-11#1)
These observations suggest##20##3##(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)
These observations suggested##2##3##(1997-2#1)(2008-7#1)
These observations support##2##3##(1995-8#1)(2008-10#1)
These observations therefore##2##3##(1995-5#1)(2008-3#1)
These observations##60##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-2#1)(2006-6#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
These oscillations##2##2##(2008-10#1)(2011-2#1)
These parameters are##2##3##(2008-7#1)(2011-2#1)
These parameters were##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
These parameters##12##2##(1990-2#1)(1993-8#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
These pathways##3##2##(2008-1#1)(2008-10#1)(2008-9#1)
These patients are##3##3##(2011-2#2)(2013-1#1)
These patients should be treated##2##5##(1991-3#1)(2011-2#1)
These patients were then##2##4##(1992-9#1)(2010-8#1)
These patients were##6##3##(1992-12#1)(1992-9#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-8#1)
These patients##15##2##(1991-3#1)(1992-12#1)(1992-9#1)(1994-12#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2013-1#1)
These patterns##4##2##(1994-6#1)(1995-3#1)(2010-8#1)(2012-2#1)
These peptides##3##2##(1995-2#2)(1996-12#1)
These pieces of evidence##2##4##(1996-6#1)(2008-8#1)
These polymers##3##2##(1995-6#1)(2008-10#1)(2011-3#1)
These population##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
These potentially##2##2##(1992-9#1)(2010-1#1)
These predictions were supported##2##4##(1993-12#1)(2008-8#1)
These predictions were##3##3##(1993-12#1)(2008-8#2)
These predictions##4##2##(1993-12#1)(2008-8#2)(2009-5#1)
These preliminary results##5##3##(1990-2#1)(2008-10#1)(2009-10#1)(2009-7#1)(2010-12#1)
These primers amplified##2##3##(2008-10#2)
These primers##4##2##(2008-10#3)(2008-12#1)
These principles have##2##3##(1992-2#1)(2009-4#1)
These principles##3##2##(1992-2#1)(2008-11#1)(2009-4#1)
These probes##4##2##(2008-10#4)
These problems are##2##3##(1997-5#1)(2008-10#1)
These problems can be##2##4##(2008-10#1)(2008-7#1)
These problems##9##2##(1991-3#1)(1992-2#1)(1997-5#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-11#1)(2012-2#1)
These procedures##4##2##(1992-2#1)(1994-9#1)(2008-4#1)(2012-3#1)
These processes##2##2##(2011-2#2)
These products are##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
These products##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
These properties##8##2##(1991-5#1)(1994-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
These proposed methods##2##3##(2008-10#2)
These proteins are##2##3##(1993-12#1)(2009-9#1)
These proteins can##2##3##(1994-3#1)(1997-2#1)
These proteins have been##2##4##(1995-6#1)(2009-8#1)
These proteins##9##2##(1992-10#1)(1993-12#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2009-10#1)(2009-8#1)(2009-9#1)
These protocols are##2##3##(2008-4#1)(2008-9#1)
These protocols##7##2##(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#3)
These questions##2##2##(2009-10#1)(2012-3#1)
These ratios were##2##3##(1996-12#2)
These reactions##3##2##(1992-6#1)(1997-2#1)(2008-10#1)
These reagents##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
These receptors##3##2##(1991-12#1)(2008-4#2)
These recommendations##4##2##(1992-3#1)(2008-10#1)(2009-10#1)(2011-2#1)
These regions##3##2##(2008-10#2)(2008-11#1)
These relationships##4##2##(1996-2#1)(2008-10#2)(2008-2#1)
These represent##2##2##(2008-12#1)(2009-12#1)
These responses are##2##3##(1995-5#1)(1996-2#1)
These responses##3##2##(1994-6#1)(1995-5#1)(1996-2#1)
These results also##5##3##(1993-3#1)(2008-8#2)(2010-4#1)(2013-1#1)
These results are consistent with a##5##6##(1994-5#1)(1995-2#1)(1997-6#1)(2008-10#2)
These results are consistent with the hypothesis that the##2##9##(1994-2#1)(1997-3#1)
These results are consistent with the hypothesis that##4##8##(1993-12#1)(1994-2#1)(1997-3#1)(2008-10#1)
These results are consistent with the##9##6##(1992-3#1)(1993-12#1)(1993-8#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
These results are consistent with##20##5##(1992-3#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1997-3#2)(1997-6#1)(1997-9#1)(2008-10#6)(2008-8#1)(2008-9#2)(2011-2#1)
These results are discussed in terms of the##3##8##(1990-7#1)(1993-6#1)(2008-10#1)
These results are discussed in##4##5##(1990-7#1)(1993-6#1)(2008-10#2)
These results are discussed##6##4##(1990-7#1)(1993-3#1)(1993-6#1)(1996-3#1)(2008-10#2)
These results are in agreement with previous findings##2##8##(1994-5#1)(2008-7#1)
These results are in##4##4##(1994-5#1)(1994-8#1)(2008-7#1)(2010-4#1)
These results are interpreted##3##4##(1991-5#1)(2007-12#1)(2008-3#1)
These results are##47##3##(1990-7#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-5#2)(1994-8#2)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-9#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#5)(2010-4#1)(2011-2#1)
These results can be used to##2##6##(2008-10#1)(2010-7#1)
These results can be##3##4##(1990-5#1)(2008-10#1)(2010-7#1)
These results can##4##3##(1990-5#1)(2008-10#1)(2008-11#1)(2010-7#1)
These results clearly demonstrate that##2##5##(2009-6#1)(2009-8#1)
These results clearly demonstrate##3##4##(2008-10#1)(2009-6#1)(2009-8#1)
These results confirm that##3##4##(1991-5#1)(2008-5#1)(2008-9#1)
These results confirm the##3##4##(1992-4#1)(1992-5#1)(2008-9#1)
These results confirm##8##3##(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-5#1)(2008-5#1)(2008-9#2)
These results confirmed that the##2##5##(2008-10#1)(2010-6#1)
These results confirmed that##4##4##(2008-10#2)(2008-9#1)(2010-6#1)
These results confirmed##6##3##(1994-3#1)(2008-10#2)(2008-9#1)(2010-6#1)(2013-8#1)
These results contribute to a better understanding of the##2##9##(2008-10#2)
These results demonstrate a##4##4##(1994-3#1)(1996-12#1)(2008-11#1)(2012-2#1)
These results demonstrate that both##2##5##(2008-10#1)(2008-7#1)
These results demonstrate that the##9##5##(1992-3#1)(1994-11#1)(1995-12#1)(1996-12#1)(2008-11#3)(2008-5#1)(2013-1#1)
These results demonstrate that##49##4##(1990-12#1)(1990-5#1)(1990-8#2)(1992-3#1)(1992-8#1)(1994-11#3)(1994-2#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#2)(2008-10#12)(2008-11#7)(2008-5#3)(2008-7#2)(2010-4#1)(2010-8#1)(2013-1#3)
These results demonstrate the##7##4##(1990-5#1)(1995-8#1)(1996-2#1)(2008-10#2)(2009-5#1)(2012-2#1)
These results demonstrate##65##3##(1990-12#1)(1990-5#2)(1990-8#2)(1992-3#1)(1992-8#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-1#1)(2008-10#15)(2008-11#8)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2012-2#2)(2013-1#3)
These results demonstrated that##6##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)
These results demonstrated the##2##4##(2008-10#1)(2008-9#1)
These results demonstrated##9##3##(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)
These results do not##2##4##(1991-12#1)(1991-8#1)
These results establish that##2##4##(1994-11#1)(2008-10#1)
These results have implications for##2##5##(2008-7#1)(2008-9#1)
These results have##8##3##(1997-1#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)
These results highlight the##6##4##(1992-10#1)(2008-10#2)(2009-8#1)(2013-1#1)(2013-8#1)
These results identify##2##3##(1993-12#1)(1995-6#1)
These results illustrate the##4##4##(1997-7#1)(2008-10#1)(2008-3#1)(2010-1#1)
These results illustrate##5##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)
These results implicate##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
These results implied##2##3##(1997-3#1)(2008-8#1)
These results imply that a##2##5##(1995-2#1)(2008-8#1)
These results imply that the##2##5##(2008-5#1)(2013-1#1)
These results imply that##8##4##(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
These results indicate that (i)##2##5##(1994-5#1)(2008-10#1)
These results indicate that ANP##2##5##(1993-8#1)(2008-5#1)
These results indicate that a##2##5##(1991-12#1)(2008-10#1)
These results indicate that higher##2##5##(2008-9#1)(2012-3#1)
These results indicate that in##2##5##(1997-1#1)(2008-5#1)
These results indicate that the association of##2##7##(2008-10#1)(2008-12#1)
These results indicate that the##32##5##(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
These results indicate that there is##2##6##(1990-2#1)(1997-1#1)
These results indicate that##122##4##(1990-12#1)(1990-2#1)(1991-12#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#4)(1994-11#5)(1994-2#1)(1994-5#2)(1994-8#3)(1995-11#2)(1995-12#4)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#4)(1997-1#5)(1997-2#2)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#24)(2008-11#12)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
These results indicate the##3##4##(1990-10#1)(2008-10#1)(2008-11#1)
These results indicate##127##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-12#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#4)(1994-11#5)(1994-2#1)(1994-5#2)(1994-8#3)(1995-11#2)(1995-12#4)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#4)(1997-1#5)(1997-2#2)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#26)(2008-11#13)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
These results indicated that the##4##5##(2008-10#1)(2008-11#2)(2008-8#1)
These results indicated that##9##4##(1992-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)
These results indicated##11##3##(1992-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-5#1)
These results may be##2##4##(1997-6#1)(2008-9#1)
These results may help##2##4##(2008-10#1)(2008-5#1)
These results may provide##3##4##(1995-12#1)(2008-5#1)(2010-12#1)
These results may##11##3##(1994-1#1)(1994-8#1)(1995-12#1)(1997-6#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)
These results point to the##2##5##(1993-12#1)(1995-2#1)
These results point to##3##4##(1993-12#1)(1995-2#1)(2008-11#1)
These results proved##2##3##(1990-8#1)(2008-10#1)
These results provide direct##2##4##(2008-10#2)
These results provide insights into##2##5##(1997-2#1)(2012-3#1)
These results provide the##2##4##(1995-2#1)(2008-10#1)
These results provide##18##3##(1994-8#1)(1995-2#1)(1996-8#1)(1997-2#2)(2008-10#6)(2008-11#3)(2008-6#1)(2009-10#1)(2012-3#2)
These results provided new##2##4##(2008-10#1)(2008-9#1)
These results provided##4##3##(2008-10#1)(2008-9#2)(2012-12#1)
These results reflect the##2##4##(2008-10#1)(2012-3#1)
These results show that a##2##5##(1990-11#1)(2008-8#1)
These results show that the##14##5##(1993-2#1)(1994-2#1)(2008-10#7)(2008-11#2)(2008-8#2)(2009-3#1)
These results show that##32##4##(1990-11#1)(1991-5#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-8#3)(2009-3#1)(2009-9#1)(2012-2#1)(2012-3#1)
These results show##36##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-8#3)(2008-9#1)(2009-3#1)(2009-9#1)(2012-2#1)(2012-3#1)
These results showed that the##2##5##(2008-10#2)
These results showed that##6##4##(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
These results showed their sensitivity to growth##2##7##(2008-11#2)
These results showed##8##3##(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#1)
These results strongly suggest that both L-leucine and KIC stimulate protein synthesis in##2##13##(2008-11#2)
These results strongly suggest that both##3##6##(2008-10#1)(2008-11#2)
These results strongly suggest that##7##5##(1991-12#1)(2008-10#2)(2008-11#3)(2008-5#1)
These results strongly suggest##8##4##(1991-12#1)(1994-5#1)(2008-10#2)(2008-11#3)(2008-5#1)
These results strongly##9##3##(1991-12#1)(1993-8#1)(1994-5#1)(2008-10#2)(2008-11#3)(2008-5#1)
These results suggest a possible##2##5##(1990-8#1)(1991-1#1)
These results suggest a##6##4##(1990-8#1)(1991-1#1)(1993-8#1)(1994-5#1)(1996-2#1)(2012-3#1)
These results suggest an##3##4##(1994-3#1)(1994-8#1)(2008-11#1)
These results suggest that a##4##5##(1992-6#1)(2008-10#2)(2008-7#1)
These results suggest that an##2##5##(2008-10#1)(2008-11#1)
These results suggest that at##2##5##(1995-12#1)(2008-10#1)
These results suggest that both##2##5##(1994-5#1)(2008-9#1)
These results suggest that different##2##5##(2008-9#1)(2013-1#1)
These results suggest that human##2##5##(1994-2#1)(2008-8#1)
These results suggest that in##3##5##(1993-8#2)(2008-10#1)
These results suggest that intracellular##2##5##(1995-8#1)(2008-10#1)
These results suggest that some of the##2##7##(1996-6#1)(2008-9#1)
These results suggest that the resistance of##2##7##(2008-10#2)
These results suggest that the##48##5##(1990-2#1)(1990-5#1)(1991-6#1)(1992-1#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#13)(2008-11#5)(2008-5#2)(2008-6#1)(2008-8#5)(2008-9#1)(2010-5#2)(2011-2#3)(2012-3#1)
These results suggest that there is##4##6##(2008-10#3)(2008-3#1)
These results suggest that there##6##5##(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
These results suggest that##236##4##(1990-12#1)(1990-2#3)(1990-5#4)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#5)(1993-6#1)(1993-8#10)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#4)(1996-2#6)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#49)(2008-11#30)(2008-3#1)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#12)(2008-9#9)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-12#1)(2010-4#2)(2010-5#3)(2010-8#3)(2010-9#1)(2011-2#8)(2012-12#1)(2012-3#4)(2013-1#3)(2013-8#1)
These results suggest the possibility that##2##6##(1994-11#1)(1996-12#1)
These results suggest the potential usefulness of##2##7##(2008-10#2)
These results suggest the potential##3##5##(1993-11#1)(2008-10#2)
These results suggest the presence of a##3##7##(1991-2#1)(2008-10#1)(2008-9#1)
These results suggest the presence of##4##6##(1991-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
These results suggest the usefulness of##2##6##(1990-5#1)(2008-5#1)
These results suggest the##16##4##(1990-5#1)(1991-2#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2013-8#1)
These results suggest##269##3##(1990-12#1)(1990-2#3)(1990-5#5)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#5)(1993-6#1)(1993-8#11)(1994-11#6)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#5)(1996-2#7)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#55)(2008-11#34)(2008-3#1)(2008-5#4)(2008-6#5)(2008-7#4)(2008-8#12)(2008-9#11)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-12#1)(2010-4#2)(2010-5#3)(2010-8#3)(2010-9#1)(2011-2#8)(2012-12#1)(2012-3#5)(2013-1#3)(2013-8#2)
These results suggested a##2##4##(1997-8#1)(2008-8#1)
These results suggested that the##5##5##(1997-7#1)(1997-8#1)(2008-11#1)(2008-8#1)(2013-1#1)
These results suggested that##13##4##(1991-5#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-8#2)(2012-12#1)(2013-1#1)
These results suggested##17##3##(1991-5#1)(1993-12#1)(1996-12#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-11#3)(2008-8#3)(2008-9#1)(2012-12#1)(2013-1#1)
These results support the hypotheses that##2##6##(2008-7#1)(2010-6#1)
These results support the hypothesis that##6##6##(1992-6#1)(1993-8#1)(2008-10#4)
These results support the suggestion##2##5##(1995-8#1)(1996-5#1)
These results support the##16##4##(1990-10#1)(1992-6#1)(1993-8#1)(1995-8#1)(1996-5#1)(2008-10#7)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)
These results support##19##3##(1990-10#1)(1992-6#1)(1993-8#1)(1995-8#1)(1996-5#1)(2008-10#7)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)(2013-8#1)
These results thus##3##3##(1996-5#1)(2008-10#1)(2013-1#1)
These results were compared with##2##5##(2008-10#2)
These results were confirmed by##2##5##(1994-11#1)(2011-2#1)
These results were confirmed with##2##5##(2008-10#2)
These results were confirmed##5##4##(1994-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
These results were further##2##4##(1997-1#1)(2009-6#1)
These results were interpreted to mean that##2##7##(2008-10#2)
These results were interpreted##3##4##(1990-11#1)(2008-10#2)
These results were##20##3##(1990-11#1)(1992-2#1)(1994-11#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
These results will be##2##4##(2008-6#1)(2008-8#1)
These results will facilitate##2##4##(2008-8#1)(2008-9#1)
These results will##5##3##(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)
These results##801##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#4)(1990-5#10)(1990-7#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#2)(1991-5#5)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#3)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#7)(1993-6#4)(1993-8#20)(1994-1#2)(1994-11#16)(1994-12#5)(1994-2#7)(1994-3#5)(1994-5#9)(1994-8#15)(1994-9#1)(1995-11#11)(1995-12#11)(1995-2#7)(1995-6#6)(1995-8#8)(1995-9#1)(1996-12#11)(1996-2#15)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#11)(1997-2#7)(1997-3#6)(1997-6#4)(1997-7#3)(1997-8#4)(1997-9#1)(2007-12#3)(2008-10#193)(2008-11#84)(2008-12#4)(2008-3#4)(2008-5#21)(2008-6#8)(2008-7#15)(2008-8#42)(2008-9#35)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#2)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-2#13)(2011-3#2)(2012-12#4)(2012-2#5)(2012-3#13)(2013-1#17)(2013-8#6)
These same##3##2##(1994-3#1)(2008-9#2)
These samples were##2##3##(2008-10#2)
These sequence##2##2##(1997-8#1)(2008-10#1)
These sequences##2##2##(2008-10#2)
These sera##2##2##(2008-11#1)(2010-4#1)
These simulations##2##2##(2008-7#1)(2013-8#1)
These sites##2##2##(1992-6#1)(2008-10#1)
These six##2##2##(1994-1#1)(1997-2#1)
These species##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2012-5#1)
These statistics##5##2##(1992-2#1)(1993-2#1)(1996-1#1)(1996-3#1)(2008-9#1)
These strains were##3##3##(2008-10#3)
These strains##5##2##(1994-8#1)(2008-10#4)
These strategies##3##2##(2008-12#1)(2009-10#1)(2012-2#1)
These structures##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
These students##2##2##(2008-12#2)
These studies also##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)
These studies are##2##3##(2008-9#1)(2009-8#1)
These studies demonstrate that##4##4##(1991-12#1)(2008-11#1)(2008-7#1)(2010-11#1)
These studies demonstrate##5##3##(1991-12#1)(1994-6#1)(2008-11#1)(2008-7#1)(2010-11#1)
These studies demonstrated##2##3##(2006-6#1)(2013-7#1)
These studies have##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
These studies indicate that the##2##5##(2008-11#1)(2008-5#1)
These studies indicate that##7##4##(1993-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
These studies provide a##2##4##(2008-10#1)(2013-8#1)
These studies revealed##2##3##(2008-7#1)(2012-2#1)
These studies show that##2##4##(2008-10#1)(2008-5#1)
These studies suggest that##3##4##(1994-11#1)(2008-10#2)
These studies##48##2##(1991-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-6#1)(2008-10#9)(2008-11#6)(2008-2#1)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
These symptoms##6##2##(1991-3#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-3#2)
These systems are##2##3##(2010-6#1)(2013-1#1)
These systems##8##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-5#1)(2010-6#1)(2013-1#1)
These techniques are##4##3##(2008-10#3)(2009-11#1)
These techniques have been##2##4##(2008-11#1)(2008-9#1)
These techniques have##4##3##(2008-11#2)(2008-4#1)(2008-9#1)
These techniques##15##2##(2008-10#6)(2008-11#3)(2008-4#1)(2008-9#2)(2009-11#1)(2010-7#1)(2011-2#1)
These tests##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
These themes##3##2##(1995-3#1)(1996-2#1)(2008-11#1)
These theoretical##2##2##(2008-10#1)(2008-8#1)
These three##10##2##(1992-12#1)(1993-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-3#1)
These tools were successfully applied for the identification of the presence of relevant modifications occurring on the##2##17##(2008-10#2)
These tools##4##2##(2008-10#3)(2008-4#1)
These traits can also be assimilated##2##6##(2010-4#2)
These transcriptional##2##2##(2008-9#2)
These trends are##2##3##(1991-3#1)(2008-7#1)
These trends##3##2##(1991-3#1)(1996-3#1)(2008-7#1)
These two compounds##2##3##(2008-11#1)(2008-5#1)
These two elements##2##3##(1993-6#1)(1993-9#1)
These two factors are##2##4##(2008-10#1)(2008-7#1)
These two factors##3##3##(1991-6#1)(2008-10#1)(2008-7#1)
These two methods##2##3##(1997-2#1)(2010-6#1)
These two parameters##2##3##(1994-3#1)(2008-10#1)
These two subpopulations##2##3##(2008-10#1)(2008-11#1)
These two techniques##2##3##(2008-12#1)(2008-4#1)
These two types of##3##4##(1994-12#1)(1994-5#1)(2008-11#1)
These two##49##2##(1990-2#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#2)(1997-2#1)(2008-10#12)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-6#1)(2012-3#1)
These values are##4##3##(1993-8#1)(2008-10#3)
These values decreased##2##3##(1995-8#1)(2009-11#1)
These values were##4##3##(1990-9#1)(2008-10#3)
These values##18##2##(1990-9#1)(1992-3#1)(1993-8#1)(1995-8#1)(2008-10#12)(2008-7#1)(2009-11#1)
These variables##2##2##(2008-10#1)(2013-1#1)
These variations in##3##3##(2008-10#2)(2009-11#1)
These variations##5##2##(2008-10#2)(2009-11#2)(2011-2#1)
These vectors##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
These were##16##2##(1990-12#1)(1991-12#1)(1992-5#1)(1993-12#1)(1995-8#2)(2008-10#2)(2008-11#4)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
These##2757##1##(1990-10#2)(1990-11#8)(1990-12#9)(1990-2#11)(1990-3#1)(1990-5#19)(1990-6#1)(1990-7#1)(1990-8#14)(1990-9#3)(1991-1#5)(1991-10#2)(1991-11#2)(1991-12#18)(1991-2#13)(1991-3#11)(1991-5#18)(1991-6#8)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#5)(1992-10#4)(1992-11#4)(1992-12#10)(1992-2#7)(1992-3#12)(1992-4#3)(1992-5#3)(1992-6#14)(1992-7#2)(1992-8#10)(1992-9#7)(1993-1#6)(1993-11#3)(1993-12#26)(1993-2#8)(1993-3#19)(1993-6#19)(1993-8#34)(1993-9#5)(1994-1#7)(1994-11#35)(1994-12#14)(1994-2#16)(1994-3#18)(1994-5#20)(1994-6#6)(1994-8#25)(1994-9#4)(1995-1#4)(1995-11#20)(1995-12#29)(1995-2#28)(1995-3#7)(1995-5#7)(1995-6#21)(1995-8#20)(1995-9#4)(1996-1#8)(1996-11#2)(1996-12#30)(1996-2#41)(1996-3#12)(1996-5#5)(1996-6#4)(1996-8#2)(1996-9#2)(1997-1#21)(1997-2#28)(1997-3#14)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#10)(1997-8#13)(1997-9#4)(2006-6#6)(2007-11#1)(2007-12#17)(2007-8#3)(2008-1#12)(2008-10#604)(2008-11#249)(2008-12#47)(2008-2#11)(2008-3#34)(2008-4#30)(2008-5#75)(2008-6#13)(2008-7#70)(2008-8#90)(2008-9#101)(2009-1#2)(2009-10#15)(2009-11#8)(2009-12#12)(2009-3#5)(2009-4#7)(2009-5#5)(2009-6#10)(2009-7#10)(2009-8#24)(2009-9#7)(2010-1#7)(2010-10#8)(2010-11#12)(2010-12#15)(2010-2#3)(2010-3#2)(2010-4#14)(2010-5#9)(2010-6#15)(2010-7#14)(2010-8#15)(2010-9#3)(2011-1#5)(2011-10#1)(2011-2#92)(2011-3#10)(2011-7#2)(2012-12#14)(2012-2#46)(2012-3#44)(2012-5#4)(2012-7#1)(2013-1#70)(2013-7#5)(2013-8#30)
Theseresults suggest that##2##3##(2008-11#2)
Theseresults suggest##3##2##(2008-11#3)
Theta phase##2##2##(2008-11#2)
Theta##5##1##(1991-12#1)(2008-11#2)(2013-1#2)
They also completed##2##3##(2008-11#1)(2008-7#1)
They also had##2##3##(2008-2#1)(2008-7#1)
They also indicate that##2##4##(1996-2#1)(2009-10#1)
They also suggest that##2##4##(1997-4#1)(2012-3#1)
They also suggest##3##3##(1992-2#1)(1997-4#1)(2012-3#1)
They also##31##2##(1992-2#1)(1992-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#1)
They appeared##2##2##(1990-3#1)(2008-5#1)
They are able to##3##4##(2008-10#1)(2011-3#1)(2013-1#1)
They are also##4##3##(2006-5#1)(2008-4#1)(2008-9#1)(2011-1#1)
They are based on the oxidation of##2##7##(2008-10#2)
They are based on the##3##5##(2008-10#3)
They are more##2##3##(1995-12#1)(2008-10#1)
They are not##2##3##(1993-11#1)(2012-2#1)
They are the##2##3##(1992-11#1)(2012-3#1)
They are thought to##2##4##(2008-4#1)(2012-2#1)
They are##65##2##(1990-5#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#2)(2006-5#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#3)(2011-2#4)(2011-3#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)
They both##2##2##(2009-8#1)(2010-1#1)
They can be used##3##4##(2008-10#2)(2008-9#1)
They can be##9##3##(1991-2#1)(2006-6#1)(2008-10#4)(2008-9#1)(2009-8#1)(2011-2#1)
They can##13##2##(1991-2#1)(2006-6#1)(2008-10#5)(2008-9#1)(2009-10#2)(2009-8#1)(2011-2#2)
They cause##2##2##(2011-2#1)(2013-8#1)
They conclude##2##2##(1993-3#1)(2008-11#1)
They constitute##2##2##(2008-10#1)(2013-1#1)
They contain##2##2##(1993-8#1)(2008-11#1)
They could##3##2##(1996-2#1)(2008-7#1)(2011-7#1)
They demonstrate##2##2##(2008-11#1)(2008-3#1)
They did not##5##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#2)
They emphasize##2##2##(1990-9#1)(1992-5#1)
They exhibited##2##2##(2008-12#1)(2011-1#1)
They found that##2##3##(1997-4#1)(2013-1#1)
They found##4##2##(1990-3#1)(1991-6#1)(1997-4#1)(2013-1#1)
They further##2##2##(1995-12#1)(2012-12#1)
They had a##2##3##(2009-1#1)(2010-1#1)
They had##6##2##(1991-12#1)(2008-9#1)(2009-1#1)(2010-1#1)(2011-1#1)(2011-2#1)
They have been##3##3##(1996-2#1)(2008-10#1)(2010-7#1)
They have to be##3##4##(1991-2#1)(2008-10#1)(2011-2#1)
They have##18##2##(1990-11#1)(1991-11#1)(1991-2#1)(1993-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-7#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
They include the##2##3##(2008-10#1)(2010-12#1)
They include##6##2##(1990-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-3#1)
They included##2##2##(1995-12#1)(2008-11#1)
They may be##5##3##(1996-2#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-7#1)
They may##9##2##(1994-3#1)(1996-2#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-2#2)(2011-7#1)(2012-12#1)
They noted less agreement with statements of the care plan offering information on assessment of patient outcomes of nursing care##2##20##(2013-1#2)
They play##2##2##(1990-9#1)(2011-2#1)
They present##2##2##(1993-3#1)(2013-1#1)
They provide an##2##3##(1997-6#1)(2008-4#1)
They provide##7##2##(1993-12#1)(1994-2#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
They reported that##2##3##(2008-10#1)(2011-2#1)
They represent##2##2##(2011-2#1)(2013-8#1)
They serve##3##2##(1991-2#1)(2008-11#1)(2012-3#1)
They shared##3##2##(1993-8#1)(2008-10#1)(2010-5#1)
They should##4##2##(1993-3#1)(2008-12#1)(2011-2#1)(2011-3#1)
They show##6##2##(1993-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-4#1)
They showed that##2##3##(2008-10#1)(2012-2#1)
They showed##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
They tend to be##2##4##(2011-2#1)(2012-3#1)
They tend to##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
They then##2##2##(2008-11#1)(2009-4#1)
They use##2##2##(2008-10#1)(2013-1#1)
They were also##7##3##(1994-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-12#1)(2011-2#1)
They were assessed##2##3##(2008-9#1)(2013-8#1)
They were evaluated##2##3##(2008-7#1)(2013-1#1)
They were followed up##3##4##(1991-9#1)(2008-11#1)(2012-3#1)
They were found##2##3##(2008-10#1)(2008-7#1)
They were identified##2##3##(2008-10#1)(2008-11#1)
They were used##2##3##(2008-10#2)
They were##63##2##(1990-5#1)(1991-11#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-6#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
They##387##1##(1990-11#3)(1990-3#2)(1990-5#2)(1990-6#2)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-6#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#3)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#4)(1993-6#3)(1993-8#3)(1993-9#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#7)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2006-5#1)(2006-6#1)(2007-12#1)(2008-1#3)(2008-10#57)(2008-11#26)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#12)(2008-6#2)(2008-7#17)(2008-8#8)(2008-9#9)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#4)(2010-1#4)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#7)(2011-2#26)(2011-3#7)(2011-7#2)(2012-12#8)(2012-2#8)(2012-3#11)(2013-1#14)(2013-8#4)
Thiamine and benfotiamine##2##3##(2012-4#2)
Thiamine disulfide##3##2##(1994-11#3)
Thiamine##5##1##(1994-11#3)(2012-4#2)
Thickness##2##1##(2008-11#1)(2013-8#1)
Thielaviopsis basicola##8##2##(2008-10#8)
Thielaviopsis##10##1##(2008-10#10)
Thin Layer##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
Thin film##2##2##(2008-10#2)
Thin layer##2##2##(2011-2#2)
Thin##14##1##(1992-2#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
Thin-film##2##1##(1994-9#1)(2008-3#1)
Thin-layer chromatography##2##2##(2008-10#2)
Think##3##1##(1995-2#1)(2009-3#1)(2012-2#1)
Thinking##5##1##(2008-11#4)(2012-2#1)
Thinopyrum ponticum##4##2##(2008-10#4)
Thinopyrum##8##1##(2008-10#7)(2008-8#1)
Thiobacillus ferrooxidans##2##2##(2008-8#2)
Thiobacillus##3##1##(2008-6#1)(2008-8#2)
Thiocyanate was##2##2##(2008-10#2)
Thiocyanate##3##1##(2008-10#3)
Thiodicarb##2##1##(2008-10#2)
Third##29##1##(1993-2#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-3#1)(2013-1#1)
Thirdly##4##1##(1992-12#1)(1995-12#1)(2008-11#2)
Thirteen patients with##2##3##(1990-2#1)(2012-12#1)
Thirteen patients##3##2##(1990-2#1)(1991-3#1)(2012-12#1)
Thirteen##18##1##(1990-2#1)(1991-3#1)(1992-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-9#1)(2009-2#1)(2010-9#1)(2012-12#2)(2012-2#1)(2012-3#2)
Thirteenth##6##1##(2008-10#1)(2011-2#5)
Thirty isolates##2##2##(2008-10#2)
Thirty male##3##2##(1992-12#1)(2008-12#1)(2011-1#1)
Thirty months after##2##3##(1995-9#1)(2008-5#1)
Thirty patients##2##2##(1994-12#1)(2013-1#1)
Thirty three##2##2##(2012-12#1)(2013-1#1)
Thirty two HEV71##2##3##(2013-8#2)
Thirty women were##2##3##(1991-3#1)(2011-2#1)
Thirty years of##2##3##(1996-12#2)
Thirty##37##1##(1990-6#1)(1991-1#1)(1991-3#1)(1992-12#1)(1994-12#2)(1995-1#1)(1995-9#1)(1996-12#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2008-9#3)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#3)
Thirty-eight##4##1##(1997-8#1)(2008-10#2)(2013-1#1)
Thirty-five##10##1##(1990-6#1)(1992-5#1)(1993-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)
Thirty-four patients##2##2##(1995-12#1)(2008-7#1)
Thirty-four##9##1##(1990-6#1)(1991-6#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-1#1)
Thirty-nine##5##1##(1990-6#2)(2008-10#1)(2008-11#1)(2011-2#1)
Thirty-one##5##1##(1995-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
Thirty-seven##7##1##(1990-5#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)
Thirty-six patients##2##2##(2010-12#1)(2011-2#1)
Thirty-six##6##1##(1993-2#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
Thirty-three##5##1##(1993-12#1)(2008-12#1)(2008-7#1)(2009-3#1)(2012-2#1)
Thirty-two patients with##2##3##(1994-3#1)(1997-7#1)
Thirty-two##4##1##(1994-3#1)(1997-7#1)(2008-10#1)(2008-7#1)
This &quot##4##2##(1990-11#1)(1992-2#1)(2008-8#1)(2009-6#1)
This CL##3##2##(2008-10#3)
This DNA##3##2##(1993-8#2)(2008-8#1)
This ORF##4##2##(1990-11#1)(1996-6#1)(2008-10#1)(2008-8#1)
This PCR assay##2##3##(2008-10#2)
This Phase I treatment study##2##5##(2012-3#2)
This QTL##2##2##(2008-10#1)(2012-3#1)
This RNA##2##2##(1990-5#1)(2008-8#1)
This Week in##2##3##(1991-5#1)(1995-3#1)
This ability##2##2##(2008-10#1)(2012-5#1)
This account##5##2##(2007-12#1)(2008-6#1)(2010-11#1)(2010-6#1)(2012-2#1)
This action##3##2##(1996-2#1)(1997-3#1)(2008-11#1)
This activation##2##2##(1995-2#1)(1995-6#1)
This activity was##2##3##(1997-1#1)(2010-7#1)
This activity##4##2##(1997-1#1)(2008-11#1)(2010-7#1)(2012-3#1)
This adaptive##2##2##(2008-10#1)(2008-7#1)
This adsorption##2##2##(1990-2#1)(2008-10#1)
This algorithm requires##2##3##(2008-3#1)(2013-8#1)
This algorithm##4##2##(2008-3#1)(2012-3#2)(2013-8#1)
This allowed a##2##3##(1995-6#1)(2008-10#1)
This allowed us to evaluate##2##5##(1993-8#1)(2008-5#1)
This allowed##7##2##(1993-8#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
This allows for##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
This allows the##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
This allows us to##3##4##(1995-5#1)(2008-3#1)(2008-9#1)
This allows##14##2##(1992-12#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
This also##5##2##(1992-5#1)(1997-2#1)(2008-10#2)(2012-3#1)
This alteration##2##2##(1997-1#1)(2013-1#1)
This alternative##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
This analysis is##3##3##(2008-10#1)(2008-11#1)(2009-10#1)
This analysis revealed##3##3##(1992-8#1)(1995-8#1)(2008-10#1)
This analysis##21##2##(1991-3#1)(1992-2#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#3)(2013-8#1)
This analytical##4##2##(2008-10#4)
This and other##3##3##(1990-12#1)(1995-2#1)(2008-10#1)
This and##6##2##(1990-12#1)(1995-2#1)(2008-10#3)(2008-11#1)
This antibody##2##2##(1995-2#1)(2012-2#1)
This antiserum##2##2##(2008-10#2)
This apparent paradox##2##3##(2008-5#1)(2008-9#1)
This apparent##4##2##(2008-5#1)(2008-8#1)(2008-9#2)
This appendix provides##2##3##(2008-9#2)
This appendix##6##2##(2008-4#3)(2008-9#3)
This approach allowed us to##2##5##(2008-10#1)(2011-2#1)
This approach allows##6##3##(2008-10#3)(2008-9#1)(2009-8#1)(2011-2#1)
This approach can##2##3##(2008-10#1)(2011-2#1)
This approach enabled the##2##4##(2008-10#1)(2009-10#1)
This approach has been##6##4##(1995-12#1)(2008-10#2)(2008-7#2)(2009-10#1)
This approach has##8##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-10#1)(2012-2#1)
This approach is not##2##4##(2008-12#1)(2012-2#1)
This approach is particularly##2##4##(1997-1#1)(2008-10#1)
This approach is##9##3##(1997-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#2)(2012-2#1)
This approach minimizes##2##3##(2008-10#2)
This approach provides##2##3##(2008-10#1)(2011-2#1)
This approach therefore##2##3##(2012-2#1)(2013-1#1)
This approach to##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
This approach was used##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
This approach was##7##3##(1994-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-9#1)(2012-2#1)
This approach##68##2##(1990-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#19)(2008-11#2)(2008-12#3)(2008-3#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#2)(2009-6#1)(2009-8#2)(2010-11#1)(2011-2#7)(2011-3#1)(2011-9#1)(2012-2#4)(2013-1#4)(2013-8#1)
This approximation##2##2##(2008-10#1)(2012-3#1)
This area##2##2##(2013-8#2)
This argues against##2##3##(2008-7#1)(2008-9#1)
This article addresses##4##3##(1991-12#1)(1994-2#1)(1994-3#1)(2008-11#1)
This article aims to##2##4##(2008-12#1)(2008-8#1)
This article aims##3##3##(2008-12#1)(2008-8#1)(2010-11#1)
This article also discusses##3##4##(2009-5#1)(2013-1#1)(2013-8#1)
This article also##6##3##(1991-12#1)(1997-2#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
This article analyzes a##2##4##(1992-12#1)(2008-8#1)
This article analyzes the##4##4##(1991-1#1)(1991-12#1)(1993-1#1)(2013-8#1)
This article analyzes##8##3##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1994-3#1)(1996-2#1)(2008-8#1)(2013-8#1)
This article argues that##2##4##(1991-12#1)(2013-8#1)
This article argues##3##3##(1991-12#1)(1996-3#1)(2013-8#1)
This article assesses##2##3##(1997-2#2)
This article attempts to##2##4##(1996-12#1)(2009-5#1)
This article briefly describes the##3##5##(1991-2#1)(2009-9#1)(2013-1#1)
This article briefly discusses the##2##5##(1997-2#1)(2008-12#1)
This article briefly##6##3##(1991-2#1)(1996-3#1)(1997-2#1)(2008-12#1)(2009-9#1)(2013-1#1)
This article considers the##2##4##(1991-6#1)(2008-10#1)
This article considers##6##3##(1991-6#1)(1995-1#1)(2008-10#1)(2008-11#2)(2010-12#1)
This article contains##5##3##(1991-12#1)(1991-2#1)(1993-1#1)(1997-3#1)(2008-10#1)
This article defines##3##3##(1991-1#1)(1996-2#1)(2008-10#1)
This article demonstrates##2##3##(1994-2#1)(2011-1#1)
This article describes a system of##2##6##(1992-3#1)(1997-1#1)
This article describes a##9##4##(1991-2#1)(1992-3#1)(1994-12#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
This article describes an##5##4##(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
This article describes one##2##4##(1994-2#1)(2008-12#1)
This article describes some##2##4##(1994-12#1)(1997-3#1)
This article describes the development of a##3##7##(1996-3#1)(2008-10#1)(2012-2#1)
This article describes the development##4##5##(1996-3#1)(2008-10#2)(2012-2#1)
This article describes the process##2##5##(1995-2#1)(2010-5#1)
This article describes the##34##4##(1991-6#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
This article describes##74##3##(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-11#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#6)(2008-10#9)(2008-11#8)(2008-12#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
This article details##2##3##(1992-1#1)(2010-7#1)
This article develops##2##3##(1995-2#1)(2008-9#1)
This article discusses how the##2##5##(1993-2#1)(1995-12#1)
This article discusses how##3##4##(1993-2#1)(1995-11#1)(1995-12#1)
This article discusses some of the##2##6##(1993-2#1)(2008-7#1)
This article discusses the##19##4##(1990-11#1)(1991-12#2)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
This article discusses##36##3##(1990-11#1)(1991-1#1)(1991-12#2)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
This article enumerates##2##3##(1994-1#1)(2008-7#1)
This article evaluates##2##3##(1996-2#1)(2012-2#1)
This article examines the relationship##2##5##(2008-11#1)(2013-1#1)
This article examines the##18##4##(1991-1#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(2008-10#1)(2008-11#3)(2011-2#3)(2013-1#1)
This article examines##39##3##(1991-1#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#1)(2011-2#4)(2013-1#2)
This article explains the##3##4##(1993-3#1)(1994-12#1)(2008-2#1)
This article explains##5##3##(1993-3#1)(1994-12#1)(1995-1#1)(2008-10#1)(2008-2#1)
This article explores the##6##4##(1993-3#1)(1997-1#1)(2011-1#1)(2011-2#2)(2012-2#1)
This article explores##15##3##(1993-3#1)(1995-1#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#3)(2008-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
This article focuses on the relationship##2##6##(1991-2#1)(2008-11#1)
This article focuses on the##6##5##(1991-2#1)(1992-2#1)(2008-10#1)(2008-11#2)(2008-5#1)
This article focuses on##11##4##(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)
This article focuses##12##3##(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
This article gives a brief overview of##2##7##(1994-12#1)(2011-2#1)
This article gives an account of##2##6##(2008-11#1)(2008-12#1)
This article gives##5##3##(1991-1#1)(1994-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
This article has been retracted at the request of the Editors-in-Chief##2##11##(2008-10#2)
This article has been retracted at the request of the##3##10##(2008-10#3)
This article has been withdrawn consistent with Elsevier Policy on Article Withdrawal (http##2##13##(2008-10#1)(2008-11#1)
This article has been withdrawn consistent with Elsevier Policy on Article Withdrawal##3##12##(2008-10#1)(2008-11#2)
This article has been##7##4##(2008-10#4)(2008-11#3)
This article has##12##3##(1994-2#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#4)
This article highlights##3##3##(1992-12#1)(2010-4#1)(2012-3#1)
This article introduces a##2##4##(2009-5#1)(2013-1#1)
This article introduces##3##3##(1991-2#1)(2009-5#1)(2013-1#1)
This article investigates the effect of##2##6##(1991-2#1)(2011-2#1)
This article investigates the##5##4##(1991-2#1)(2008-10#1)(2008-9#1)(2011-2#2)
This article investigates##6##3##(1991-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
This article is a##4##4##(1992-2#1)(1993-12#1)(2007-9#1)(2010-9#1)
This article is an update of##2##6##(2012-2#2)
This article is an##3##4##(1997-3#1)(2012-2#2)
This article is##12##3##(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#2)(1996-2#1)(1997-3#1)(2007-9#1)(2010-8#1)(2010-9#1)(2012-2#2)
This article looks at the##2##5##(1995-2#1)(2013-7#1)
This article looks at##3##4##(1995-2#1)(2013-7#1)(2013-8#1)
This article observes##2##3##(1994-12#1)(1995-12#1)
This article offers a##2##4##(1992-3#1)(2010-6#1)
This article offers##4##3##(1992-3#2)(1996-12#1)(2010-6#1)
This article on##2##3##(1990-12#1)(1991-1#1)
This article outlines the##4##4##(1993-3#1)(1994-2#1)(1995-3#1)(2008-11#1)
This article outlines##9##3##(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-2#2)(2008-11#1)
This article presents a case##2##5##(1997-2#1)(2013-1#1)
This article presents a##23##4##(1990-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-1#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-7#1)(2012-2#1)(2013-1#5)
This article presents an overview of##2##6##(2008-5#1)(2013-8#1)
This article presents an##3##4##(2008-5#1)(2008-9#1)(2013-8#1)
This article presents data on health care spending for the United States##2##12##(1995-3#1)(1997-3#1)
This article presents data on##3##5##(1994-2#1)(1995-3#1)(1997-3#1)
This article presents data##5##4##(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-3#1)
This article presents the results of a##2##7##(1994-3#1)(1997-3#1)
This article presents the results of##3##6##(1994-3#1)(1997-3#1)(2013-8#1)
This article presents the##6##4##(1994-2#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#1)(2013-8#1)
This article presents##48##3##(1990-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-7#1)(2012-2#1)(2013-1#5)(2013-8#2)
This article provides a brief##2##5##(2009-5#1)(2010-12#1)
This article provides a review of##3##6##(2008-4#1)(2010-12#1)(2013-1#1)
This article provides a##9##4##(1994-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-12#2)(2012-2#1)(2013-1#1)
This article provides an overview of the##8##7##(1993-3#3)(1994-1#1)(1994-12#1)(1997-1#1)(1997-2#1)(2012-3#1)
This article provides an overview of##10##6##(1993-3#3)(1994-1#1)(1994-12#1)(1997-1#1)(1997-2#2)(2011-2#1)(2012-3#1)
This article provides an##11##4##(1993-3#3)(1994-1#1)(1994-12#1)(1997-1#1)(1997-2#2)(2010-1#1)(2011-2#1)(2012-3#1)
This article provides background information##2##5##(1991-12#1)(2012-2#1)
This article provides the##2##4##(2008-9#1)(2010-9#1)
This article provides##32##3##(1991-12#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
This article reports a case of##2##6##(2010-1#1)(2011-2#1)
This article reports on the##2##5##(2008-10#1)(2008-11#1)
This article reports on##7##4##(1993-3#1)(1994-2#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#2)
This article reports the results of a##3##7##(1992-3#1)(1996-1#1)(1996-12#1)
This article reports the##4##4##(1992-3#1)(1995-1#1)(1996-1#1)(1996-12#1)
This article reports##17##3##(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(2008-10#1)(2008-11#2)(2008-9#1)(2009-5#1)(2010-1#1)(2011-2#1)
This article reviews a##2##4##(1993-12#2)
This article reviews recent##3##4##(1994-9#1)(2008-4#1)(2008-7#1)
This article reviews some of the##2##6##(2008-10#1)(2008-9#1)
This article reviews the available data regarding the different aspects of##2##11##(2013-1#2)
This article reviews the available##4##5##(2008-12#1)(2008-4#1)(2013-1#2)
This article reviews the current##4##5##(2008-11#1)(2010-11#1)(2010-12#1)(2011-7#1)
This article reviews the literature##3##5##(1996-3#1)(2010-11#1)(2013-1#1)
This article reviews the various##2##5##(2008-11#1)(2010-10#1)
This article reviews the##40##4##(1992-2#1)(1993-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#5)(2013-8#3)
This article reviews##62##3##(1992-2#1)(1993-12#3)(1994-2#2)(1994-9#1)(1995-2#1)(1996-2#3)(1996-3#1)(1997-2#2)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#3)(2011-7#2)(2012-2#1)(2013-1#5)(2013-8#5)
This article studies##2##3##(1992-3#1)(2008-7#1)
This article summarizes research##2##4##(1994-1#1)(2008-6#1)
This article summarizes the##4##4##(1992-12#1)(1995-2#1)(1996-3#1)(2009-5#1)
This article summarizes##8##3##(1992-12#1)(1994-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-6#1)(2009-5#1)(2012-2#1)
This article synthesizes##2##3##(1994-9#1)(1996-2#1)
This article takes a##2##4##(2008-8#1)(2013-8#1)
This article takes the##2##4##(2008-10#1)(2008-12#1)
This article takes##5##3##(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2013-8#1)
This article uses the##2##4##(1994-12#1)(1995-3#1)
This article uses##7##3##(1993-3#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-9#1)(2009-10#1)
This article was##2##3##(2011-2#2)
This article will explore service delivery problems and resolutions##2##9##(1994-1#2)
This article will explore##3##4##(1991-12#1)(1994-1#2)
This article will review the##3##5##(1994-3#1)(1995-2#1)(1997-1#1)
This article will review##4##4##(1994-3#1)(1995-2#1)(1997-1#1)(2008-7#1)
This article will##15##3##(1991-12#1)(1993-1#1)(1994-1#2)(1994-3#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-4#1)(2013-8#1)
This article##542##2##(1990-11#2)(1990-12#2)(1991-1#8)(1991-12#11)(1991-2#10)(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#8)(1992-2#5)(1992-3#6)(1993-1#8)(1993-11#1)(1993-12#9)(1993-2#4)(1993-3#13)(1993-6#1)(1994-1#12)(1994-12#10)(1994-2#14)(1994-3#8)(1994-9#3)(1995-1#8)(1995-11#1)(1995-12#12)(1995-2#10)(1995-3#10)(1996-1#9)(1996-11#2)(1996-12#5)(1996-2#17)(1996-3#15)(1996-6#2)(1997-1#9)(1997-2#18)(1997-3#14)(1997-8#2)(2007-9#1)(2008-1#3)(2008-10#29)(2008-11#43)(2008-12#11)(2008-2#3)(2008-4#8)(2008-5#4)(2008-6#5)(2008-7#8)(2008-8#8)(2008-9#13)(2009-10#4)(2009-11#1)(2009-12#2)(2009-5#8)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#5)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#4)(2011-2#21)(2011-3#1)(2011-7#3)(2012-12#1)(2012-2#14)(2012-3#5)(2013-1#19)(2013-7#2)(2013-8#16)
This assay is##5##3##(1990-12#2)(1995-2#1)(2008-4#1)(2008-9#1)
This assay uses##3##3##(1993-2#1)(1994-11#1)(2008-10#1)
This assay was used to##2##5##(2008-10#1)(2013-1#1)
This assay##20##2##(1990-12#3)(1990-2#1)(1991-12#1)(1993-2#1)(1994-11#1)(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-9#1)(2011-3#1)(2013-1#1)
This assembly##2##2##(2008-10#2)
This association is##2##3##(1990-2#1)(2010-12#1)
This association##4##2##(1990-2#1)(2008-11#1)(2010-12#1)(2012-12#1)
This asymmetry##2##2##(2008-8#1)(2008-9#1)
This beam##2##2##(2008-3#1)(2009-11#1)
This behavior was observed##2##4##(1994-5#1)(2008-11#1)
This behavior##4##2##(1994-5#1)(1995-3#1)(2008-11#1)(2009-10#1)
This benefit##2##2##(2008-7#1)(2008-9#1)
This binding was##2##3##(1992-8#1)(1993-6#1)
This binding##3##2##(1992-8#1)(1993-6#1)(1994-5#1)
This biosensor##4##2##(2008-10#4)
This bipolar##2##2##(1992-12#1)(2012-2#1)
This broad##2##2##(2008-11#1)(2011-2#1)
This cDNA##2##2##(1997-1#1)(1997-7#1)
This calculation##2##2##(2007-12#1)(2008-3#1)
This can be done##2##4##(2008-10#2)
This can be useful to identify##2##6##(2008-4#2)
This can be##13##3##(1994-12#1)(1997-1#1)(2008-10#4)(2008-4#3)(2009-12#2)(2009-9#1)(2013-1#1)
This can##18##2##(1994-12#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-12#1)(2008-4#3)(2009-12#2)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
This case adds to##2##4##(2012-3#1)(2013-8#1)
This case also##2##3##(2009-3#1)(2009-8#1)
This case and##2##3##(1997-3#1)(2008-12#1)
This case demonstrates##3##3##(2010-1#1)(2011-2#1)(2012-3#1)
This case describes a##2##4##(2008-9#1)(2013-1#1)
This case describes##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
This case has##2##3##(1991-3#1)(2012-2#1)
This case highlights the##2##4##(2013-1#2)
This case illustrates the##2##4##(2008-7#1)(2011-2#1)
This case illustrates##4##3##(1997-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
This case is presented to##2##5##(2008-7#1)(2013-1#1)
This case is##4##3##(1990-3#1)(2008-7#1)(2010-10#1)(2013-1#1)
This case report describes a##2##5##(2008-7#1)(2009-6#1)
This case report describes the diagnosis and##2##7##(2008-12#2)
This case report describes the##4##5##(2008-12#3)(2011-2#1)
This case report describes##6##4##(2008-12#3)(2008-7#1)(2009-6#1)(2011-2#1)
This case report presents##4##4##(1993-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
This case report##18##3##(1993-8#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-7#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
This case series##4##3##(2008-12#2)(2012-2#1)(2013-1#1)
This case shows that##2##4##(2008-12#1)(2011-2#1)
This case study addresses our efforts to educate the candidate regarding the potential foregone##2##14##(1994-1#2)
This case study addresses##3##4##(1992-1#1)(1994-1#2)
This case study describes##3##4##(2008-4#1)(2009-6#1)(2010-10#1)
This case study details the time##2##6##(1994-3#2)
This case study details the##3##5##(1994-3#2)(1996-1#1)
This case study suggests that##2##5##(2013-1#2)
This case study will show that an optical storage system provides a cost-effective method of archiving medical documents that can be easily indexed and retrieved##2##25##(1994-3#2)
This case study##25##3##(1991-1#1)(1991-3#1)(1992-1#1)(1994-1#2)(1994-3#4)(1995-2#1)(1996-1#2)(1996-3#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-10#1)(2012-12#1)(2013-1#6)
This case underlines the##2##4##(2008-11#1)(2010-3#1)
This case was##2##3##(2008-12#1)(2013-1#1)
This case##87##2##(1990-3#1)(1991-1#1)(1991-3#2)(1992-1#1)(1993-8#1)(1994-1#2)(1994-3#4)(1995-2#1)(1996-1#2)(1996-3#1)(1997-3#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#10)(2008-4#1)(2008-7#4)(2008-9#2)(2009-3#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#3)(2010-3#1)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#15)(2013-8#2)
This causes a##2##3##(2008-12#1)(2011-2#1)
This causes##3##2##(2008-12#1)(2008-3#1)(2011-2#1)
This cell line is##2##4##(1994-12#1)(2008-11#1)
This cell line##3##3##(1994-12#1)(2008-11#1)(2011-2#1)
This cell##8##2##(1991-11#1)(1994-12#1)(1997-1#1)(2008-11#3)(2008-7#1)(2011-2#1)
This cellular##2##2##(1995-2#1)(2008-11#1)
This change in##2##3##(2008-11#1)(2012-2#1)
This change##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
This chapter describes##2##3##(2008-4#1)(2013-1#1)
This chapter provides##2##3##(2008-11#1)(2012-2#1)
This chapter##6##2##(2008-11#1)(2008-4#2)(2010-8#1)(2012-2#1)(2013-1#1)
This characteristic##2##2##(1990-9#1)(2013-1#1)
This chelate##2##2##(2008-10#2)
This chemically modified carbon paste electrode was successfully used for the determination of##2##13##(2008-10#2)
This chemically modified electrode##2##4##(2008-10#2)
This chemically modified##4##3##(2008-10#4)
This classification##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
This clinical##2##2##(2010-7#1)(2013-1#1)
This clone##3##2##(1991-12#1)(1993-6#1)(2008-11#1)
This cluster##2##2##(2008-10#1)(2008-11#1)
This collateral##2##2##(1993-3#1)(1997-3#1)
This collection of##2##3##(1996-8#1)(2008-7#1)
This collection##4##2##(1996-8#1)(2008-10#2)(2008-7#1)
This combination has##2##3##(2008-4#1)(2009-10#1)
This combination of##2##3##(2008-11#1)(2008-12#1)
This combination##9##2##(1992-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-1#1)
This combined procedure##2##3##(2008-11#1)(2009-8#1)
This commentary discusses##2##3##(1996-2#1)(2013-1#1)
This commentary reviews##2##3##(1996-1#1)(2013-1#1)
This commentary##7##2##(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-9#1)(2013-1#2)
This communication describes##2##3##(2008-10#2)
This communication##3##2##(2008-10#3)
This comparison##2##2##(2008-8#1)(2010-1#1)
This complex##3##2##(2008-10#3)
This complication is##3##3##(1997-8#1)(2012-3#1)(2013-1#1)
This complication##4##2##(1997-8#1)(2011-3#1)(2012-3#1)(2013-1#1)
This compound has##2##3##(1990-8#1)(2008-5#1)
This compound inhibited the##2##4##(2008-10#1)(2008-5#1)
This compound reacts##2##3##(2008-10#2)
This compound##11##2##(1990-8#1)(1995-11#1)(2008-10#6)(2008-11#1)(2008-5#2)
This comprehensive##3##2##(1995-1#1)(2008-9#2)
This concept is##3##3##(2008-10#2)(2008-7#1)
This concept##4##2##(2008-10#2)(2008-7#1)(2010-6#1)
This conclusion is##2##3##(2008-10#2)
This conclusion was supported by##2##5##(1993-9#1)(2008-10#1)
This conclusion was##3##3##(1993-9#1)(2008-10#2)
This conclusion##6##2##(1993-9#1)(2008-10#4)(2008-8#1)
This condition is##3##3##(1992-5#1)(2008-7#1)(2010-7#1)
This condition was first##2##4##(1997-8#1)(2013-1#1)
This condition##7##2##(1992-5#1)(1997-8#1)(2008-7#2)(2010-7#1)(2011-1#1)(2013-1#1)
This conference##4##2##(1996-6#1)(2008-5#1)(2010-4#1)(2010-5#1)
This conformational change##2##3##(1994-5#1)(2008-10#1)
This consortium##2##2##(1993-12#1)(1993-2#1)
This continuous##2##2##(2008-10#1)(2008-11#1)
This contrasts with##4##3##(1996-2#1)(2006-6#1)(2008-8#1)(2012-3#1)
This contrasts##6##2##(1996-2#1)(2006-6#1)(2008-10#2)(2008-8#1)(2012-3#1)
This contribution describes##2##3##(2008-10#1)(2008-11#1)
This contribution##4##2##(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
This corrected##2##2##(2008-10#1)(2008-9#1)
This correlation##4##2##(2006-6#1)(2008-10#2)(2008-11#1)
This correlational##2##2##(2010-10#1)(2010-11#1)
This corresponded with##3##3##(1996-12#1)(2008-11#1)(2013-1#1)
This corresponded##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
This corresponds to##2##3##(2008-10#1)(2008-3#1)
This corroborates##2##2##(2008-10#1)(2008-8#1)
This could be achieved##2##4##(2008-12#1)(2011-2#1)
This could be the##2##4##(2008-10#1)(2013-1#1)
This could be##10##3##(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)
This could##13##2##(1997-7#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
This criterion##2##2##(2008-10#1)(2008-8#1)
This cross-sectional study##6##3##(2008-5#1)(2010-10#2)(2010-3#1)(2012-3#1)(2013-1#1)
This data suggests that##2##4##(2010-7#1)(2011-1#1)
This data##6##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-1#1)(2013-1#1)
This database##2##2##(2007-12#1)(2012-3#1)
This decrease is##2##3##(2008-10#1)(2013-1#1)
This decrease was##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
This decrease##6##2##(1994-3#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
This delayed##2##2##(1996-3#1)(2013-8#1)
This demonstrated##2##2##(2008-10#2)
This demonstrates that##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
This dependency##2##2##(2008-11#1)(2008-9#1)
This descriptive study##4##3##(1995-1#1)(2008-10#1)(2010-7#1)(2013-1#1)
This descriptive##6##2##(1995-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-7#1)(2013-1#1)
This design##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
This detection##4##2##(2008-10#3)(2008-3#1)
This device##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
This diagnosis was##2##3##(1992-12#1)(1996-6#1)
This diagnosis##4##2##(1992-12#1)(1996-6#1)(1997-3#1)(2012-12#1)
This difference in##4##3##(1990-11#1)(2008-10#2)(2008-8#1)
This difference is##3##3##(1991-11#1)(1991-8#1)(1993-8#1)
This difference was##3##3##(1995-5#1)(2011-1#1)(2013-1#1)
This difference##14##2##(1990-11#1)(1991-11#1)(1991-8#1)(1993-8#1)(1994-12#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
This differential diagnosis##2##3##(1993-2#1)(2010-7#1)
This differential##6##2##(1992-3#1)(1993-2#1)(1995-1#1)(2010-4#1)(2010-7#1)(2011-2#1)
This discrepancy is##2##3##(1993-9#1)(2012-3#1)
This discrepancy##4##2##(1993-9#1)(2008-11#1)(2008-5#1)(2012-3#1)
This discussion##2##2##(1992-12#1)(2009-12#1)
This disease is##4##3##(1997-8#1)(2008-12#2)(2012-3#1)
This disease##8##2##(1997-8#1)(2008-10#3)(2008-12#2)(2011-2#1)(2012-3#1)
This disorder##2##2##(2010-1#1)(2010-6#1)
This distinct##2##2##(2008-10#1)(2008-5#1)
This distribution##2##2##(1991-5#1)(1993-8#1)
This diurnal##2##2##(2008-10#1)(2008-5#1)
This document provides##2##3##(2008-10#1)(2011-2#1)
This document##3##2##(2008-10#1)(2011-2#2)
This does not##2##3##(2008-10#1)(2008-8#1)
This drug has been##2##4##(1990-3#1)(1994-6#1)
This drug##3##2##(1990-3#1)(1994-6#1)(1994-8#1)
This editorial##2##2##(2010-12#2)
This effect can be##2##4##(1992-8#1)(2008-10#1)
This effect did not occur##2##5##(1994-8#1)(2008-10#1)
This effect is##4##3##(1994-8#1)(2008-10#2)(2008-11#1)
This effect may##2##3##(1992-4#1)(2008-8#1)
This effect was not##3##4##(1991-1#1)(2008-4#1)(2008-8#1)
This effect was##19##3##(1990-11#1)(1990-6#1)(1991-1#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-12#2)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
This effect##40##2##(1990-11#1)(1990-6#1)(1991-1#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#1)(1996-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-2#2)(2013-1#1)
This efficient##3##2##(1990-2#1)(2008-10#2)
This effort##2##2##(1993-12#1)(1996-2#1)
This electrode responds to##2##4##(2008-10#2)
This electrode was##2##3##(2008-10#2)
This electrode##9##2##(2008-10#9)
This elevation##2##2##(1990-8#1)(1993-9#1)
This eliminates##2##2##(2008-10#1)(2012-3#1)
This enables us##2##3##(2008-3#1)(2009-7#1)
This enhanced##2##2##(2008-12#1)(2013-1#1)
This enhancement##4##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
This ensures##2##2##(2008-10#1)(2008-3#1)
This entity##2##2##(1991-6#1)(1992-2#1)
This enzyme is##2##3##(1990-11#1)(2008-11#1)
This enzyme##9##2##(1990-11#1)(1992-10#1)(1993-6#1)(1994-11#1)(2008-10#2)(2008-11#2)(2008-6#1)
This enzyme-less##2##2##(2008-10#2)
This essay##6##2##(2008-1#1)(2008-12#2)(2010-1#2)(2012-2#1)
This evaluation##3##2##(1993-3#1)(2008-11#1)(2008-9#1)
This evidence##4##2##(1993-3#1)(1995-6#1)(2008-11#1)(2013-1#1)
This experience##2##2##(2008-1#1)(2008-7#1)
This experiment was conducted##2##4##(1992-3#1)(2008-12#1)
This experiment##7##2##(1992-3#1)(1993-6#1)(2008-10#2)(2008-12#2)(2013-8#1)
This explained##2##2##(2008-7#1)(2010-4#1)
This explains the##2##3##(2008-10#1)(2013-1#1)
This explains##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
This exploratory##2##2##(2008-11#1)(2011-2#1)
This expression##2##2##(1993-6#1)(2012-2#1)
This extensive##3##2##(2008-5#1)(2008-9#2)
This extraction##2##2##(2008-10#1)(2008-7#1)
This fact is##3##3##(1997-4#1)(2008-10#1)(2013-1#1)
This fact##9##2##(1993-2#1)(1994-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2013-1#1)
This factor##3##2##(1990-2#1)(1991-11#1)(2008-10#1)
This family##4##2##(1996-2#1)(2009-6#1)(2010-1#1)(2011-2#1)
This feature makes##2##3##(1997-2#1)(2008-10#1)
This feature##8##2##(1997-2#2)(2008-10#3)(2008-4#1)(2010-11#1)(2012-2#1)
This fiber##2##2##(2008-10#1)(2008-3#1)
This field of##2##3##(2008-9#1)(2009-3#1)
This filter##2##2##(2007-12#1)(2008-2#1)
This finding has##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
This finding indicates that##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
This finding is consistent with##2##5##(1993-8#1)(2008-11#1)
This finding is##3##3##(1992-3#1)(1993-8#1)(2008-11#1)
This finding suggests that##6##4##(1992-2#1)(1993-6#1)(2008-10#2)(2008-12#1)(2010-12#1)
This finding suggests##8##3##(1992-2#1)(1992-6#1)(1993-6#1)(2008-10#2)(2008-12#1)(2009-8#1)(2010-12#1)
This finding supports the##2##4##(1990-11#1)(1996-3#1)
This finding supports##4##3##(1990-11#1)(1996-3#1)(2008-10#1)(2008-12#1)
This finding##38##2##(1990-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-12#1)(1996-3#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
This first##6##2##(1993-12#1)(1994-11#1)(1995-2#1)(2008-10#2)(2012-2#1)
This flow##2##2##(2008-10#2)
This foam material was found to be##2##7##(2008-10#2)
This form of##2##3##(1994-11#1)(2008-5#1)
This fraction##5##2##(1991-5#1)(1992-12#1)(1996-2#1)(2008-10#1)(2008-7#1)
This framework##3##2##(1992-12#1)(2012-3#1)(2013-1#1)
This function##2##2##(1997-2#1)(2008-10#1)
This further##2##2##(2008-10#1)(2008-9#1)
This gel##2##2##(1993-8#1)(2008-4#1)
This gene is designated as##2##5##(2008-10#2)
This gene is designated##3##4##(2008-10#3)
This gene is##5##3##(1993-2#1)(1993-3#1)(2008-10#3)
This gene was##2##3##(1993-2#1)(2013-1#1)
This gene##15##2##(1991-5#1)(1992-4#1)(1993-2#2)(1993-3#1)(1995-8#1)(2008-10#7)(2008-8#1)(2013-1#1)
This genetic##2##2##(1990-5#1)(2008-10#1)
This genus is of##2##4##(2011-2#2)
This gives rise to a##2##5##(2008-9#1)(2013-8#1)
This gives##4##2##(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
This goal##2##2##(1993-3#1)(2008-10#1)
This group is##3##3##(1993-8#1)(2010-12#1)(2011-2#1)
This group of##3##3##(2008-9#1)(2009-8#1)(2013-1#1)
This group##8##2##(1993-8#1)(1997-3#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
This has been##2##3##(2008-11#1)(2008-7#1)
This has led to##4##4##(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)
This has occurred##2##3##(2008-10#1)(2011-1#1)
This has resulted in the##2##5##(1996-9#1)(2008-11#1)
This has resulted in##3##4##(1996-9#1)(2008-11#1)(2008-9#1)
This has##26##2##(1992-9#1)(1994-2#1)(1995-2#1)(1996-9#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#2)
This heterogeneity##2##2##(2008-9#1)(2009-12#1)
This high##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
This hypothesis has##2##3##(1994-2#1)(2008-8#1)
This hypothesis was tested##2##4##(1996-3#1)(2008-9#1)
This hypothesis was##4##3##(1996-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
This hypothesis##7##2##(1994-2#1)(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#2)(2013-1#1)
This idea##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
This illustrates that##2##3##(2008-10#1)(2011-2#1)
This implied##2##2##(1997-8#1)(2008-10#1)
This implies that##13##3##(1993-3#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-5#1)
This implies##16##2##(1993-3#1)(1993-8#1)(1994-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-5#1)(2011-2#1)
This improved##2##2##(2008-11#1)(2008-7#1)
This improvement##3##2##(1990-2#1)(1993-3#1)(2008-2#1)
This in turn##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
This in vitro##2##3##(2012-3#1)(2013-1#1)
This in##7##2##(1991-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
This included##3##2##(1994-5#1)(2008-10#1)(2010-9#1)
This includes##5##2##(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
This increase in the##2##4##(1997-6#1)(2008-10#1)
This increase in##5##3##(1994-8#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
This increase is##2##3##(1995-2#1)(2008-10#1)
This increase was##6##3##(1992-12#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
This increase##17##2##(1991-2#1)(1992-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
This increased##5##2##(1991-7#1)(1992-3#1)(1995-5#1)(2008-10#1)(2008-11#1)
This increases##2##2##(2008-4#1)(2011-2#1)
This indicated a##2##3##(2008-10#2)
This indicated that the##2##4##(1995-8#1)(2008-10#1)
This indicated that##3##3##(1995-8#1)(2008-10#1)(2013-8#1)
This indicated##6##2##(1995-8#1)(1997-2#1)(2008-10#3)(2013-8#1)
This indicates a##4##3##(1996-12#1)(2007-12#1)(2008-10#1)(2012-3#1)
This indicates that the##9##4##(1990-5#1)(1991-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)
This indicates that##31##3##(1990-5#1)(1991-5#1)(1991-6#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#2)(2012-2#1)
This indicates the##3##3##(1995-2#1)(2008-10#1)(2011-1#1)
This indicates##42##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
This indicator##2##2##(2008-10#1)(2013-1#1)
This induces##2##2##(1997-4#1)(2009-7#1)
This information facilitates##2##3##(2008-11#1)(2008-9#1)
This information should##2##3##(2008-10#2)
This information will##2##3##(1994-11#1)(2010-5#1)
This information##13##2##(1991-12#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-4#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
This informative unit##2##3##(2008-9#2)
This inhibition was##4##3##(1994-8#1)(2008-10#1)(2008-7#1)(2012-7#1)
This inhibition##7##2##(1994-8#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-7#1)
This inhibitory##2##2##(1995-11#2)
This initiative##2##2##(1991-12#1)(2009-3#1)
This innovative##2##2##(2008-12#1)(2009-3#1)
This instrument is##2##3##(2008-3#2)
This instrument##3##2##(2008-3#3)
This interaction##12##2##(1990-12#1)(1994-12#1)(1995-12#1)(1995-2#2)(2008-10#2)(2008-4#1)(2008-9#2)(2011-10#1)(2011-2#1)
This interference##2##2##(2007-12#1)(2008-3#1)
This interview##3##2##(1993-12#1)(2010-7#1)(2010-8#1)
This introductory##2##2##(1996-6#1)(2008-4#1)
This investigation was undertaken##2##4##(1990-12#1)(1993-2#1)
This investigation##10##2##(1990-12#2)(1993-1#1)(1993-2#1)(1994-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2009-7#1)(2011-1#1)
This involved##2##2##(2008-12#1)(2013-7#1)
This involves##3##2##(2008-10#1)(2009-1#1)(2009-12#1)
This is a case report of a##3##7##(2008-12#2)(2009-1#1)
This is a case report of##4##6##(2008-12#2)(2009-1#1)(2011-2#1)
This is a case report##5##5##(2008-12#2)(2009-1#1)(2011-2#1)(2012-3#1)
This is a descriptive##2##4##(2008-11#1)(2013-1#1)
This is a first##2##4##(1997-7#1)(2013-1#1)
This is a new##2##4##(1993-11#1)(2008-10#1)
This is a prospective##2##4##(1995-2#1)(2008-10#1)
This is a qualitative##2##4##(2012-3#2)
This is a rare##3##4##(2012-2#1)(2013-1#2)
This is a report on##3##5##(1990-9#1)(1993-2#1)(2008-10#1)
This is a report##4##4##(1990-9#1)(1993-2#1)(2008-10#2)
This is a retrospective study##2##5##(2008-10#1)(2011-2#1)
This is a retrospective##6##4##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#2)(2012-2#1)
This is a review of##2##5##(2008-12#1)(2008-7#1)
This is a time to##2##5##(1993-12#2)
This is a##60##3##(1990-9#1)(1991-12#2)(1991-2#1)(1992-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-2#2)(2012-3#5)(2013-1#5)
This is accomplished by##3##4##(1996-12#1)(2008-11#1)(2008-4#1)
This is achieved by##4##4##(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
This is also supported by##2##5##(2008-1#1)(2008-10#1)
This is also##4##3##(2008-1#2)(2008-10#2)
This is an##14##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-3#1)
This is associated with an##3##5##(1993-8#1)(2008-10#1)(2008-9#1)
This is associated with##4##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
This is based on##2##4##(1991-6#1)(2008-6#1)
This is because the##2##4##(2008-10#2)
This is because##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
This is confirmed by##2##4##(2008-10#1)(2012-12#1)
This is consistent with the##2##5##(2008-10#1)(2013-1#1)
This is consistent with##6##4##(1992-8#1)(1994-2#1)(2008-10#2)(2008-3#1)(2013-1#1)
This is done by##2##4##(2008-10#1)(2011-2#1)
This is done##3##3##(1994-1#1)(2008-10#1)(2011-2#1)
This is due in##2##4##(2008-10#1)(2008-6#1)
This is due to the##3##5##(2008-10#3)
This is due to##4##4##(1990-6#1)(2008-10#3)
This is due##6##3##(1990-6#1)(2008-10#4)(2008-6#1)
This is especially true for##2##5##(1990-12#1)(2010-7#1)
This is especially true##4##4##(1990-12#1)(2009-5#1)(2010-11#1)(2010-7#1)
This is especially##7##3##(1990-12#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-7#1)(2013-1#1)
This is exemplified by##2##4##(2008-8#1)(2011-2#1)
This is followed by a discussion of##2##7##(2008-4#1)(2009-12#1)
This is followed by a##3##5##(2008-4#1)(2008-7#1)(2009-12#1)
This is followed by##5##4##(1992-12#1)(2008-4#2)(2008-7#1)(2009-12#1)
This is important as the##2##5##(2008-10#1)(2008-12#1)
This is important##3##3##(1993-2#1)(2008-10#1)(2008-12#1)
This is in part##2##4##(2008-10#2)
This is in sharp contrast with##2##6##(2008-10#1)(2008-5#1)
This is in##7##3##(1992-10#1)(1996-11#1)(1997-3#1)(2008-10#3)(2008-5#1)
This is likely##2##3##(2008-10#1)(2008-11#1)
This is mainly due to the##2##6##(1992-1#1)(2009-12#1)
This is mainly due to##3##5##(1992-1#1)(1994-5#1)(2009-12#1)
This is mainly##4##3##(1992-1#1)(1994-5#1)(2009-12#1)(2013-1#1)
This is not the case##2##5##(1991-6#1)(2008-10#1)
This is not##6##3##(1991-6#1)(1992-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
This is of particular concern##2##5##(1991-3#1)(2008-3#1)
This is of particular##3##4##(1991-3#1)(2008-11#1)(2008-3#1)
This is of##4##3##(1991-3#1)(2008-11#2)(2008-3#1)
This is only the second##2##5##(2008-10#1)(2012-3#1)
This is only the third##2##5##(2011-2#2)
This is only the##4##4##(2008-10#1)(2011-2#2)(2012-3#1)
This is particularly important##2##4##(1992-5#1)(2008-9#1)
This is particularly the case for##2##6##(2008-11#1)(2012-2#1)
This is particularly true in##2##5##(1992-1#1)(2012-3#1)
This is particularly true##4##4##(1992-1#1)(2008-10#2)(2012-3#1)
This is particularly##11##3##(1992-1#1)(1992-5#1)(2008-10#4)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#2)
This is partly##2##3##(2008-11#1)(2013-8#1)
This is primarily##2##3##(2008-10#1)(2012-12#1)
This is revolatilized##2##3##(2008-10#2)
This is the case##5##4##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
This is the first complete genome sequence of a member of the family##4##13##(2011-2#4)
This is the first complete genome sequence of a member of the##5##12##(2011-2#5)
This is the first complete genome sequence of a##6##9##(2011-2#6)
This is the first complete genome sequence of##7##8##(2011-2#7)
This is the first completed genome sequence for a##2##9##(2011-2#2)
This is the first completed genome sequence of the family##3##10##(2011-2#3)
This is the first completed genome sequence of the genus##3##10##(2011-2#3)
This is the first completed genome sequence of the##6##9##(2011-2#6)
This is the first completed genome sequence of##7##8##(2011-2#7)
This is the first completed genome sequence##9##7##(2011-2#9)
This is the first completed sequence of##2##7##(2011-2#2)
This is the first completed##11##5##(2011-2#11)
This is the first demonstration of##2##6##(2008-10#1)(2008-8#1)
This is the first demonstration##3##5##(2008-10#2)(2008-8#1)
This is the first description of##2##6##(1997-5#1)(2009-7#1)
This is the first direct##2##5##(1996-12#1)(2011-1#1)
This is the first evidence##2##5##(2008-10#1)(2010-6#1)
This is the first example of a##2##7##(1991-2#1)(1996-3#1)
This is the first report demonstrating that##2##7##(2008-10#1)(2008-11#1)
This is the first report describing##2##6##(2008-10#1)(2008-11#1)
This is the first report of a##5##7##(2008-10#3)(2011-2#1)(2013-1#1)
This is the first report of the##4##7##(1997-2#1)(2008-10#2)(2008-11#1)
This is the first report of##26##6##(1991-4#1)(1992-10#1)(1992-3#1)(1997-2#1)(1997-7#1)(2008-10#12)(2008-11#3)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
This is the first report on the determination of proteins##2##10##(2008-10#2)
This is the first report on the determination of##3##9##(2008-10#3)
This is the first report on the##7##7##(2008-10#6)(2008-9#1)
This is the first report on##12##6##(2008-10#7)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#2)
This is the first report that##6##6##(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)(2013-1#1)
This is the first report##51##5##(1990-5#1)(1991-4#1)(1992-10#1)(1992-3#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#22)(2008-11#8)(2008-7#2)(2008-9#1)(2009-6#1)(2010-3#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)
This is the first reported case of##5##7##(2008-7#2)(2010-7#1)(2011-2#1)(2012-3#1)
This is the first reported##7##5##(2008-10#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)
This is the first study in##2##6##(2008-10#1)(2011-2#1)
This is the first study to##3##6##(2008-10#2)(2008-8#1)
This is the first study##6##5##(2008-10#4)(2008-8#1)(2011-2#1)
This is the first time that##5##6##(1991-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
This is the first time##11##5##(1991-11#1)(1991-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#2)(2011-2#1)(2012-2#1)
This is the first##123##4##(1990-5#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-3#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#36)(2008-11#11)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#25)(2012-2#3)(2012-3#2)(2013-1#5)
This is the largest##2##4##(2009-10#1)(2011-1#1)
This is the report of##2##5##(2008-10#1)(2012-2#1)
This is the second completed genome sequence of a member of the##3##12##(2011-2#3)
This is the second completed genome sequence of a member##4##10##(2011-2#4)
This is the second##13##4##(1995-6#1)(1995-9#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#5)
This is the##153##3##(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-3#1)(1994-5#1)(1994-9#1)(1995-6#3)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-10#40)(2008-11#12)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-6#3)(2010-7#1)(2011-1#2)(2011-2#30)(2012-2#4)(2012-3#3)(2013-1#6)
This is##380##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#3)(1992-1#3)(1992-10#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-8#2)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-9#1)(1995-2#2)(1995-6#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#2)(1997-6#1)(1997-7#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#81)(2008-11#34)(2008-12#7)(2008-3#7)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#16)(2009-1#3)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#3)(2011-1#2)(2011-2#41)(2011-8#1)(2012-12#5)(2012-2#10)(2012-3#14)(2013-1#14)(2013-7#1)(2013-8#4)
This issue of Applied Optics features##2##6##(2008-3#2)
This issue of##3##3##(1996-2#1)(2008-3#2)
This issue##5##2##(1996-2#1)(2008-11#1)(2008-3#2)(2013-8#1)
This kind of##2##3##(1990-9#1)(2008-8#1)
This knowledge##2##2##(1993-1#1)(2011-2#1)
This lack of##7##3##(1993-3#1)(1995-11#1)(1996-12#1)(2008-11#2)(2008-5#1)(2009-8#1)
This large##3##2##(1995-12#1)(2008-10#1)(2012-2#1)
This laser##2##2##(2007-12#1)(2008-3#1)
This last##2##2##(1993-6#1)(2011-2#1)
This latter##4##2##(1991-3#1)(1995-2#1)(2008-10#1)(2008-5#1)
This leads to a##5##4##(1995-5#1)(1997-8#1)(2008-10#2)(2008-9#1)
This leads to##8##3##(1995-5#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)
This leads us to##2##4##(1994-8#1)(2008-5#1)
This leads##10##2##(1994-8#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
This led to the##2##4##(1992-6#1)(1997-8#1)
This led to##5##3##(1992-6#1)(1997-8#1)(2008-12#1)(2009-11#1)(2010-6#1)
This level of##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
This limited##2##2##(1996-12#1)(2008-10#1)
This line##2##2##(2008-10#2)
This literature review##3##3##(2008-11#1)(2010-11#1)(2011-2#1)
This loss of##2##3##(1997-1#1)(2013-1#1)
This loss##3##2##(1997-1#1)(2007-12#1)(2013-1#1)
This lottery provides an opportunity to gauge the effects of expanding access to public health insurance on the health care use##2##21##(2013-1#2)
This low##2##2##(2008-10#1)(2009-12#1)
This mAb##2##2##(2008-11#1)(2009-8#1)
This makes it possible to##5##5##(1994-6#1)(2008-10#2)(2008-6#1)(2008-9#1)
This makes it##7##3##(1994-6#1)(1996-11#1)(2008-10#2)(2008-6#1)(2008-9#1)(2013-8#1)
This makes the##2##3##(2007-12#1)(2008-12#1)
This makes##13##2##(1994-6#1)(1996-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-9#2)(2013-8#1)
This manuscript##9##2##(2008-10#3)(2010-6#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
This map##2##2##(1996-3#1)(2008-11#1)
This marker##2##2##(2008-10#2)
This mass##3##2##(1994-9#1)(2008-10#1)(2013-1#1)
This material was##2##3##(2008-10#2)
This material##4##2##(2008-10#3)(2008-12#1)
This may account for##2##4##(2008-11#1)(2008-8#1)
This may be attributed to##2##5##(2008-10#1)(2008-11#1)
This may be because##2##4##(1990-11#1)(2008-11#1)
This may be due to##2##5##(2008-10#2)
This may be due##3##4##(1997-3#1)(2008-10#2)
This may be especially##2##4##(2008-10#1)(2008-12#1)
This may be##14##3##(1990-11#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2013-1#1)
This may explain##3##3##(1990-11#1)(2008-10#1)(2008-8#1)
This may have##4##3##(1994-12#1)(2008-5#1)(2010-11#1)(2013-1#1)
This may indicate that##2##4##(2008-10#2)
This may result in##3##4##(2008-11#1)(2008-7#1)(2012-3#1)
This may result##4##3##(2008-11#1)(2008-7#2)(2012-3#1)
This may##39##2##(1990-11#2)(1994-11#1)(1994-12#1)(1996-12#1)(1997-3#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2009-4#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
This means that the##5##4##(2008-10#1)(2008-11#3)(2008-7#1)
This means that##12##3##(1990-6#1)(1991-6#1)(1992-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-8#1)
This means##14##2##(1990-6#1)(1991-6#1)(1992-5#1)(1996-3#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)(2009-8#1)
This measure##2##2##(2008-10#1)(2008-9#1)
This measurement##3##2##(2008-10#1)(2008-3#2)
This mechanism has been##2##4##(1996-3#1)(2008-4#1)
This mechanism is##2##3##(1990-11#1)(2008-11#1)
This mechanism##7##2##(1990-11#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)
This meeting##2##2##(2008-5#2)
This meta-analysis##2##2##(2009-9#1)(2011-2#1)
This method allows##4##3##(2008-10#2)(2008-3#1)(2012-3#1)
This method also##2##3##(2007-8#1)(2008-10#1)
This method can be applied to the determination of##2##9##(2008-10#2)
This method can be applied to the determination##3##8##(2008-10#3)
This method can be applied to##4##6##(2008-10#4)
This method can be applied##5##5##(2008-10#4)(2013-8#1)
This method can be used##3##5##(2008-10#3)
This method can be##9##4##(2008-10#7)(2013-1#1)(2013-8#1)
This method can##14##3##(1990-3#1)(2008-10#8)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
This method could be used to determine##3##7##(2008-10#3)
This method could be##5##4##(2008-10#5)
This method employs##2##3##(2008-10#2)
This method has been applied to the determination of##3##9##(2008-10#3)
This method has been applied to the##5##7##(2008-10#4)(2010-7#1)
This method has been applied to##6##6##(2008-10#5)(2010-7#1)
This method has been applied##8##5##(2008-10#7)(2010-7#1)
This method has been successfully applied to the determination of##2##10##(2008-10#2)
This method has been successfully applied to the##3##8##(2008-10#3)
This method has been successfully applied to##5##7##(2008-10#5)
This method has been successfully used to determine##2##8##(2008-10#2)
This method has been successfully##7##5##(2008-10#7)
This method has been used to determine##2##7##(2008-10#2)
This method has been used##3##5##(2008-10#3)
This method has been##23##4##(1991-6#1)(1993-3#1)(2008-10#20)(2010-7#1)
This method has##30##3##(1991-6#1)(1993-3#1)(2008-10#27)(2010-7#1)
This method involves a##2##4##(2008-10#2)
This method involves##3##3##(2008-10#3)
This method is a##2##4##(1991-12#1)(2008-10#1)
This method is also##2##4##(2008-10#1)(2010-8#1)
This method is based on the difference between the##2##9##(2008-10#2)
This method is based on the difference##3##7##(2008-10#3)
This method is based on the fact that##2##8##(2008-10#2)
This method is based on the##22##6##(1995-6#1)(2008-10#19)(2008-11#1)(2011-2#1)
This method is based on##26##5##(1995-6#1)(2008-10#23)(2008-11#1)(2011-2#1)
This method is simple##2##4##(2008-10#2)
This method is successfully applied to the##2##7##(2008-10#1)(2008-5#1)
This method is successfully applied to##3##6##(2008-10#2)(2008-5#1)
This method is very sensitive##2##5##(2008-10#2)
This method is very##4##4##(2008-10#4)
This method is##55##3##(1991-12#1)(1991-2#1)(1995-6#1)(2008-10#41)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-8#1)(2011-2#1)
This method may##2##3##(2008-10#1)(2008-11#1)
This method of##3##3##(1994-9#1)(2008-10#2)
This method provides a new##2##5##(2008-8#1)(2013-8#1)
This method provides a##6##4##(1995-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
This method provides##8##3##(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2013-8#1)
This method takes##2##3##(2008-10#2)
This method uses the##2##4##(2008-11#1)(2008-3#1)
This method uses##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
This method utilizes##2##3##(2008-4#1)(2008-9#1)
This method was applied for the determination of##2##8##(2008-10#2)
This method was applied for the##3##6##(2008-10#3)
This method was applied for##4##5##(2008-10#4)
This method was applied to the determination of##4##8##(2008-10#4)
This method was applied to the##8##6##(2008-10#8)
This method was applied to##11##5##(2008-10#11)
This method was applied##15##4##(2008-10#15)
This method was compared with##2##5##(2008-10#2)
This method was successfully applied to the determination of trace amounts of##2##12##(2008-10#2)
This method was successfully applied to the determination of##4##9##(2008-10#4)
This method was successfully applied to the##5##7##(2008-10#5)
This method was successfully applied##7##5##(2008-10#7)
This method was used for##2##5##(1996-1#1)(2008-10#1)
This method was used to##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
This method was used##5##4##(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)
This method was##45##3##(1996-1#1)(2008-10#38)(2008-11#2)(2008-3#1)(2008-5#1)(2009-6#1)(2011-3#1)
This method##215##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-3#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-8#1)(2008-10#152)(2008-11#10)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
This methodology was##2##3##(2008-10#1)(2012-2#1)
This methodology##11##2##(1994-12#1)(1996-5#1)(2008-10#6)(2008-12#1)(2008-7#1)(2012-2#1)
This might be due to##2##5##(1993-1#1)(1997-1#1)
This might be##7##3##(1992-2#1)(1993-1#1)(1997-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
This might##9##2##(1992-2#1)(1993-1#1)(1997-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
This mode of##2##3##(2008-10#1)(2008-11#1)
This model allows##2##3##(2008-8#1)(2010-7#1)
This model has##2##3##(1991-11#1)(2008-3#1)
This model is##8##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)(2013-8#2)
This model of##3##3##(1995-2#1)(2008-11#1)(2011-2#1)
This model was##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
This model##35##2##(1991-11#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-7#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2013-8#2)
This modification##4##2##(1990-8#1)(1991-2#1)(2008-10#1)(2013-1#1)
This modified electrode showed##2##4##(2008-10#2)
This modified electrode##4##3##(2008-10#4)
This modified##8##2##(2008-10#6)(2008-3#1)(2008-4#1)
This molecule##3##2##(1995-2#1)(2008-5#2)
This month in wjm##2##4##(2008-8#2)
This morphological##2##2##(2008-11#2)
This multipartite genome##2##3##(2011-2#2)
This mutant##5##2##(1993-11#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#1)
This mutation##2##2##(1991-5#1)(1994-12#1)
This narrative##2##2##(2012-3#2)
This necessitated##2##2##(1995-9#1)(2008-10#1)
This new approach##2##3##(2008-10#1)(2008-8#1)
This new procedure##2##3##(2008-10#1)(2008-5#1)
This new technique##4##3##(1997-3#1)(2008-10#2)(2008-11#1)
This new##26##2##(1997-3#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#3)
This newly##3##2##(2008-10#3)
This news brief discusses the##2##5##(1997-6#2)
This news brief##4##3##(1997-6#4)
This normative data##2##3##(2008-12#1)(2011-1#1)
This novel gene delivery system##2##5##(2008-8#1)(2008-9#1)
This novel method##2##3##(2009-11#1)(2010-7#1)
This novel##15##2##(1994-11#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#3)(2012-2#1)(2012-3#1)(2013-8#1)
This observation indicates that##2##4##(2008-7#1)(2013-1#1)
This observation suggests that##2##4##(1991-8#1)(1994-11#1)
This observation##12##2##(1991-8#1)(1992-4#1)(1994-11#1)(2008-10#4)(2008-11#2)(2008-7#2)(2013-1#1)
This opens the way##2##4##(2009-8#1)(2010-7#1)
This order##2##2##(2008-10#1)(2008-11#1)
This overall##2##2##(2008-11#1)(2008-9#1)
This overview describes the##3##4##(2008-1#1)(2008-11#1)(2008-4#1)
This overview discusses articles published in this issue of the Health Care Financing Review##2##14##(1994-12#1)(1997-3#1)
This overview discusses the##3##4##(1997-2#1)(2008-4#2)
This overview discusses##6##3##(1994-12#1)(1997-2#1)(1997-3#1)(2008-4#3)
This overview presents##2##3##(2008-4#1)(2008-9#1)
This overview unit##3##3##(2008-4#3)
This overview##18##2##(1994-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#9)(2008-9#1)(2009-8#1)
This paper addresses the##4##4##(2008-12#1)(2009-12#1)(2010-1#1)(2012-2#1)
This paper addresses##8##3##(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-1#1)(2012-2#1)
This paper aims to##6##4##(1996-3#1)(2008-11#2)(2008-12#1)(2011-1#1)(2012-2#1)
This paper also##3##3##(2008-10#1)(2008-6#1)(2010-9#1)
This paper analyses the##2##4##(2008-12#2)
This paper argues that##2##4##(2008-11#1)(2010-1#1)
This paper argues##3##3##(2008-11#1)(2008-12#1)(2010-1#1)
This paper attempts to##4##4##(1990-3#1)(1992-3#1)(2008-10#1)(2008-11#1)
This paper compares the results of##2##6##(2008-10#1)(2012-2#1)
This paper compares the##6##4##(1991-12#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#1)(2012-2#1)
This paper compares##8##3##(1991-12#1)(2008-10#1)(2008-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
This paper concludes##2##3##(2008-11#1)(2010-8#1)
This paper considers the##2##4##(1992-1#1)(2008-12#1)
This paper considers##4##3##(1992-1#1)(1995-9#1)(2008-12#2)
This paper demonstrates the##2##4##(1997-2#1)(2008-10#1)
This paper demonstrates##5##3##(1997-2#1)(2008-10#2)(2008-11#1)(2010-4#1)
This paper describes a new##2##5##(2008-10#2)
This paper describes a newly developed##3##6##(2008-10#3)
This paper describes a novel##2##5##(2008-11#1)(2009-7#1)
This paper describes a simple and##2##6##(2008-10#2)
This paper describes a##36##4##(1990-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-11#1)(1997-2#2)(2008-10#14)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
This paper describes an analytical method for##2##7##(2008-10#2)
This paper describes an analytical##3##5##(2008-10#3)
This paper describes an##8##4##(2008-10#3)(2008-11#3)(2008-12#1)(2013-1#1)
This paper describes how the##2##5##(1991-2#1)(1997-2#1)
This paper describes how##5##4##(1991-2#1)(1997-2#1)(2008-11#1)(2008-12#2)
This paper describes the construction##2##5##(2008-10#2)
This paper describes the design##3##5##(2008-10#3)
This paper describes the development and##2##6##(2008-10#2)
This paper describes the development of a##3##7##(2008-10#1)(2008-11#1)(2010-8#1)
This paper describes the development of##4##6##(2008-10#2)(2008-11#1)(2010-8#1)
This paper describes the development##6##5##(2008-10#4)(2008-11#1)(2010-8#1)
This paper describes the process##2##5##(2008-11#2)
This paper describes the use of##3##6##(2008-10#2)(2008-5#1)
This paper describes the##48##4##(1990-12#1)(1990-2#1)(1990-9#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1995-12#2)(1996-3#1)(2008-10#22)(2008-11#8)(2008-12#2)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
This paper describes##114##3##(1990-12#2)(1990-2#1)(1990-9#1)(1991-2#1)(1992-2#3)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#1)(1995-1#1)(1995-12#2)(1996-3#1)(1997-2#3)(2008-10#46)(2008-11#18)(2008-12#9)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-7#2)(2010-8#1)(2011-2#2)(2013-1#5)
This paper develops##2##3##(2008-6#1)(2012-3#1)
This paper discusses how##3##4##(1992-12#1)(2008-11#1)(2008-12#1)
This paper discusses the application of##2##6##(1995-9#1)(2008-11#1)
This paper discusses the value of##2##6##(2008-11#2)
This paper discusses the##13##4##(1993-3#1)(1995-9#1)(1997-3#1)(2008-10#3)(2008-11#5)(2009-7#1)(2013-1#1)
This paper discusses these##2##4##(2008-1#1)(2008-10#1)
This paper discusses##22##3##(1992-12#1)(1993-3#1)(1995-9#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#2)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
This paper documents the##2##4##(1994-2#1)(2008-11#1)
This paper emphasizes the##2##4##(1992-1#1)(2008-10#1)
This paper examines the##8##4##(1992-1#1)(1992-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
This paper examines##12##3##(1992-1#2)(1992-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2011-2#1)
This paper explores some of the##2##6##(2008-1#1)(2008-7#1)
This paper explores the use of##2##6##(1992-9#1)(2008-10#1)
This paper explores the##9##4##(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)
This paper explores##14##3##(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#2)(2010-10#1)
This paper focuses on the effect of##2##7##(1995-9#1)(2008-10#1)
This paper focuses on the##9##5##(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-9#1)(2011-2#1)
This paper focuses on##12##4##(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2009-10#1)(2009-9#1)(2011-2#1)
This paper focuses##13##3##(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2009-10#1)(2009-9#1)(2011-2#1)
This paper gives an overview##2##5##(2008-10#1)(2013-1#1)
This paper gives##4##3##(2008-10#1)(2008-6#1)(2009-10#1)(2013-1#1)
This paper has##2##3##(1991-1#1)(1995-5#1)
This paper highlights the##2##4##(2008-10#1)(2009-3#1)
This paper highlights##6##3##(2008-10#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
This paper intends to encourage debate##2##6##(2008-11#1)(2008-12#1)
This paper introduces a##3##4##(2008-10#1)(2008-12#1)(2008-6#1)
This paper introduces##7##3##(1995-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)
This paper investigates the##4##4##(1992-2#1)(1997-1#1)(2008-10#1)(2010-8#1)
This paper investigates##6##3##(1992-2#1)(1995-3#1)(1997-1#1)(2008-10#2)(2010-8#1)
This paper is a##4##4##(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
This paper is an##2##4##(1992-2#1)(2008-12#1)
This paper is##12##3##(1992-2#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-3#2)
This paper offers an##2##4##(2008-10#1)(2010-12#1)
This paper outlines how##2##4##(2008-11#1)(2010-9#1)
This paper outlines the development and evaluation of a##2##9##(2008-12#2)
This paper outlines the##5##4##(1997-2#1)(2008-11#1)(2008-12#2)(2008-7#1)
This paper outlines##11##3##(1997-2#1)(2008-11#3)(2008-12#3)(2008-4#2)(2008-7#1)(2010-9#1)
This paper presents a case of##2##6##(2010-12#1)(2011-2#1)
This paper presents a method for##2##6##(2008-10#1)(2008-6#1)
This paper presents a method whereby trace elements##2##8##(2008-10#2)
This paper presents a method##4##5##(2008-10#3)(2008-6#1)
This paper presents a short overview of##2##7##(2012-2#2)
This paper presents a simple##3##5##(2008-10#2)(2009-8#1)
This paper presents a summary of the##2##7##(2009-10#1)(2013-1#1)
This paper presents a##30##4##(1995-12#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-6#3)(2009-10#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
This paper presents an##6##4##(2008-10#4)(2008-11#1)(2008-7#1)
This paper presents data##2##4##(1997-2#1)(2008-10#1)
This paper presents the results of a##4##7##(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
This paper presents the results of##5##6##(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)
This paper presents the##14##4##(1992-1#1)(1992-2#1)(2007-12#1)(2008-10#4)(2008-11#3)(2009-10#1)(2010-10#1)(2010-8#1)(2011-2#1)
This paper presents##62##3##(1992-1#2)(1992-2#1)(1992-5#1)(1993-1#1)(1993-3#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#23)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#3)(2009-8#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
This paper proposes a##6##4##(1994-9#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-3#1)
This paper provides a brief##3##5##(1996-9#1)(2008-11#2)
This paper provides a##7##4##(1996-9#1)(2008-10#2)(2008-11#3)(2008-12#1)
This paper provides an overview of##3##6##(1992-1#1)(2008-10#2)
This paper provides an##5##4##(1992-1#1)(2008-10#3)(2008-11#1)
This paper provides##13##3##(1992-1#1)(1996-9#1)(2008-10#5)(2008-11#4)(2008-12#2)
This paper reports a##4##4##(1995-11#1)(2008-10#2)(2008-11#1)
This paper reports an investigation##2##5##(2008-10#1)(2008-11#1)
This paper reports an##5##4##(1992-9#1)(1994-1#1)(2008-10#2)(2008-11#1)
This paper reports findings from a##2##6##(2008-11#2)
This paper reports on a##3##5##(2008-11#2)(2013-8#1)
This paper reports on an evaluation of the##2##8##(1994-1#1)(2008-10#1)
This paper reports on an evaluation of##3##7##(1994-1#1)(2008-10#1)(2008-12#1)
This paper reports on the use of##2##7##(2008-10#2)
This paper reports on the##8##5##(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#1)
This paper reports on##18##4##(1994-1#1)(1996-3#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-7#1)(2008-9#1)(2010-10#1)(2013-8#1)
This paper reports the development of a new##2##8##(2008-10#2)
This paper reports the results of a##2##7##(1994-12#1)(2008-5#1)
This paper reports the results of##3##6##(1994-12#1)(2008-5#1)(2013-1#1)
This paper reports the results##4##5##(1994-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
This paper reports the study of##2##6##(2008-10#1)(2008-5#1)
This paper reports the use of##4##6##(2008-10#3)(2013-1#1)
This paper reports the##21##4##(1994-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-5#2)(2010-10#1)(2011-2#1)(2013-1#3)
This paper reports##53##3##(1992-9#1)(1993-12#1)(1994-1#2)(1994-12#1)(1995-11#1)(1996-3#1)(2008-1#1)(2008-10#18)(2008-11#12)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#2)(2011-2#1)(2013-1#3)(2013-8#1)
This paper reviewed##2##3##(2008-11#1)(2010-11#1)
This paper reviews recent##5##4##(2008-10#3)(2008-7#1)(2008-9#1)
This paper reviews some##2##4##(2008-10#1)(2008-11#1)
This paper reviews the current##2##5##(2011-1#1)(2013-1#1)
This paper reviews the literature on the##2##7##(2008-12#1)(2008-7#1)
This paper reviews the literature on##4##6##(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
This paper reviews the##16##4##(1993-3#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#3)(2013-1#2)
This paper reviews##37##3##(1992-1#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-11#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-7#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#2)(2013-8#1)
This paper sheds##2##3##(2012-2#1)(2013-1#1)
This paper shows that##2##4##(2008-10#1)(2008-5#1)
This paper shows the##3##4##(2008-10#3)
This paper shows##6##3##(1996-3#1)(2008-10#4)(2008-5#1)
This paper suggests a##2##4##(1996-12#1)(2008-10#1)
This paper suggests that##2##4##(1991-2#1)(2008-11#1)
This paper suggests##5##3##(1991-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
This paper summarizes the##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
This paper summarizes##7##3##(1991-12#1)(1992-1#1)(1992-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
This paper uses##3##3##(1991-3#1)(1994-9#1)(2009-7#1)
This paper will describe##2##4##(1997-2#1)(2010-10#1)
This paper will discuss the##3##5##(2008-11#2)(2011-2#1)
This paper will discuss##4##4##(2008-11#2)(2008-6#1)(2011-2#1)
This paper will focus on##2##5##(2008-10#1)(2008-2#1)
This paper will review the##3##5##(2008-5#1)(2010-12#1)(2011-2#1)
This paper will##20##3##(1992-3#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-9#1)
This paper##546##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-1#9)(1992-12#3)(1992-2#8)(1992-3#4)(1992-5#1)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#3)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#5)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#7)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#1)(2007-12#1)(2008-1#6)(2008-10#144)(2008-11#88)(2008-12#46)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#16)(2008-6#9)(2008-7#14)(2008-9#5)(2009-10#7)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#7)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#15)(2011-3#3)(2012-12#2)(2012-2#10)(2012-3#7)(2012-9#1)(2013-1#17)(2013-8#3)
This parameter##3##2##(1997-4#1)(2008-10#2)
This part##3##2##(2012-3#3)
This pathogen##2##2##(2008-10#2)
This pathology##2##2##(2008-1#1)(2008-9#1)
This pathway##3##2##(1992-12#1)(1992-6#1)(2008-9#1)
This patient died##2##3##(1994-12#1)(2010-5#1)
This patient##6##2##(1994-12#1)(1994-9#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
This pattern is##2##3##(1991-12#1)(2012-2#1)
This pattern of##5##3##(1993-1#1)(1994-5#1)(1995-8#1)(2008-7#1)(2012-2#1)
This pattern##11##2##(1991-12#1)(1993-1#1)(1994-5#1)(1995-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#2)
This peak##4##2##(1993-8#1)(2008-10#3)
This peptide represents a##2##4##(1995-2#1)(1995-6#1)
This peptide##4##2##(1991-5#1)(1992-12#1)(1995-2#1)(1995-6#1)
This permits##2##2##(1994-2#1)(2008-10#1)
This phenomenological study##4##3##(2008-11#2)(2008-12#1)(2012-3#1)
This phenomenon was##4##3##(1990-5#1)(1995-12#1)(2008-3#1)(2008-9#1)
This phenomenon##12##2##(1990-5#1)(1990-8#1)(1994-11#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
This phenotype was##2##3##(1995-2#1)(2011-1#1)
This phenotype##7##2##(1990-5#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2011-1#2)
This pictorial essay##2##3##(1997-8#1)(2012-2#1)
This pictorial##4##2##(1997-8#1)(2012-2#2)(2012-3#1)
This pilot study##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
This pilot##5##2##(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
This plasmid##2##2##(1997-6#1)(2011-2#1)
This point##2##2##(2008-9#1)(2009-3#1)
This points to the##2##4##(1994-9#1)(2008-11#1)
This points to##3##3##(1994-9#1)(2008-11#2)
This policy##3##2##(1996-2#1)(1997-5#1)(2008-7#1)
This population was##2##3##(2008-10#1)(2012-3#1)
This portable##2##2##(2008-10#2)
This positive##2##2##(1995-2#1)(2008-8#1)
This potential##2##2##(2007-12#1)(2008-10#1)
This practice##4##2##(1993-12#1)(2008-10#2)(2012-2#1)
This prediction##4##2##(2008-8#1)(2008-9#3)
This preference##2##2##(2008-3#1)(2010-3#1)
This preliminary study##3##3##(1993-3#1)(2008-7#1)(2012-3#1)
This presentation##6##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-1#1)
This prevalence was##2##3##(2010-3#1)(2013-1#1)
This prevalence##3##2##(2009-8#1)(2010-3#1)(2013-1#1)
This primer set##3##3##(2008-10#3)
This principle was##2##3##(2008-10#2)
This principle##5##2##(1992-3#1)(2008-10#3)(2008-12#1)
This probably##2##2##(2008-8#1)(2011-2#1)
This probe##2##2##(1997-4#1)(2008-10#1)
This problem is##2##3##(1993-2#1)(2008-10#1)
This problem was##3##3##(2008-10#3)
This problem##7##2##(1993-2#1)(2008-10#4)(2008-9#1)(2011-1#1)
This procedure allows the simultaneous determination of##3##7##(2008-10#3)
This procedure allows the##4##4##(2008-10#4)
This procedure allows##5##3##(2008-10#5)
This procedure has been##2##4##(2008-10#2)
This procedure has##4##3##(1993-12#1)(2008-10#3)
This procedure is##4##3##(2008-4#1)(2008-9#1)(2010-7#1)(2012-3#1)
This procedure was applied to the determination of cadmium in##2##10##(2008-10#2)
This procedure was applied to the determination of##3##8##(2008-10#3)
This procedure was applied to##4##5##(2008-10#4)
This procedure was applied##5##4##(2008-10#5)
This procedure was repeated##2##4##(1997-6#1)(2011-3#1)
This procedure was##11##3##(1997-6#1)(2008-10#9)(2011-3#1)
This procedure##41##2##(1991-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-6#1)(2008-10#24)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#2)
This process can##2##3##(1995-2#1)(2008-10#1)
This process has been##3##4##(1992-11#1)(2009-10#1)(2011-2#1)
This process has##4##3##(1992-11#1)(1995-12#1)(2009-10#1)(2011-2#1)
This process involves##2##3##(2009-10#1)(2009-7#1)
This process is##5##3##(1991-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)
This process was##2##3##(1991-2#1)(2008-9#1)
This process##24##2##(1991-2#2)(1992-11#1)(1995-12#1)(1995-2#2)(1997-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
This produced##2##2##(1991-5#1)(1997-5#1)
This produces##2##2##(2008-1#1)(2010-7#1)
This product is##2##3##(2008-10#2)
This professional paper was written in order to investigate the relationship between group size and measures of performance##2##18##(1994-3#2)
This professional paper will address the various elements in designing a women's health center in an academic health setting##2##19##(1994-3#2)
This professional paper will define several ethical theories##2##8##(1994-1#2)
This professional paper will provide a summary reference in the correct design of a &quot##2##15##(1994-3#2)
This professional paper will show that provider expertise and patient care are the most important factors in referral decisions##2##19##(1994-1#2)
This professional paper will show that##3##6##(1994-1#2)(1996-1#1)
This professional paper will##11##4##(1994-1#4)(1994-3#5)(1996-1#2)
This professional paper##16##3##(1992-3#1)(1994-1#4)(1994-3#7)(1996-1#2)(1996-3#2)
This program has##3##3##(1992-3#1)(2008-3#1)(2013-1#1)
This program was##2##3##(2008-11#1)(2008-12#1)
This program##10##2##(1992-3#1)(1993-12#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
This programme##2##2##(2012-3#2)
This project has##2##3##(2008-10#1)(2013-1#1)
This project is##2##3##(1994-3#1)(2008-11#1)
This project was##3##3##(1994-1#1)(2008-11#1)(2008-12#1)
This project##10##2##(1994-1#1)(1994-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-8#1)(2012-12#1)(2013-1#1)
This promoter##4##2##(1990-12#1)(1991-6#1)(2010-5#2)
This property##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
This proposed method can be used for the##2##8##(2008-10#2)
This proposed method can be##3##5##(2008-10#2)(2008-6#1)
This proposed method demonstrated##2##4##(2008-10#2)
This proposed method##7##3##(2008-10#6)(2008-6#1)
This proposed##8##2##(2008-10#7)(2008-6#1)
This prospective study##2##3##(2009-3#1)(2012-3#1)
This prospective##6##2##(2008-10#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2012-5#1)
This protective##2##2##(1993-2#1)(2008-11#1)
This protein is present in##2##5##(1992-6#1)(2009-8#1)
This protein is##3##3##(1992-6#1)(1994-3#1)(2009-8#1)
This protein##10##2##(1990-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
This protocol describes a##2##4##(2008-11#1)(2008-9#1)
This protocol offers##2##3##(2008-4#2)
This protocol provides a##2##4##(2008-9#2)
This protocol##10##2##(2008-10#1)(2008-11#1)(2008-4#4)(2008-9#3)(2013-1#1)
This provided a##2##3##(2008-10#1)(2008-11#1)
This provided##4##2##(1991-5#1)(2008-10#1)(2008-11#2)
This provides a##4##3##(1993-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
This provides in##2##3##(1992-10#1)(2012-2#1)
This provides##11##2##(1992-10#1)(1993-8#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#2)
This purified##2##2##(1993-8#1)(1994-5#1)
This putative##4##2##(2008-10#3)(2010-5#1)
This qualitative research##2##3##(1997-3#1)(2010-9#1)
This qualitative study aimed to describe##2##6##(2010-7#1)(2012-3#1)
This qualitative study##3##3##(2010-11#1)(2010-7#1)(2012-3#1)
This qualitative##6##2##(1997-3#1)(2010-11#1)(2010-7#1)(2010-9#2)(2012-3#1)
This quantitative##2##2##(2008-10#1)(2008-11#1)
This randomized controlled##2##3##(2008-12#1)(2009-11#1)
This range##2##2##(1992-12#1)(2008-10#1)
This rapid and##3##3##(2008-10#3)
This rapid##4##2##(2008-10#4)
This rare##5##2##(1991-11#1)(2008-10#2)(2008-7#1)(2010-7#1)
This reaction was##2##3##(2008-10#2)
This reaction##5##2##(2008-10#4)(2008-7#1)
This reagent##2##2##(2008-10#1)(2009-12#1)
This reconstructed##2##2##(2008-5#2)
This reduction in##3##3##(1996-12#1)(2008-7#1)(2012-2#1)
This reduction##5##2##(1996-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-5#1)
This region contains##3##3##(1993-12#1)(1996-6#1)(1996-8#1)
This region is##3##3##(1997-7#1)(2008-10#1)(2008-4#1)
This region of the##2##4##(2008-10#2)
This region##14##2##(1990-10#1)(1992-3#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-7#2)(2008-10#3)(2008-4#1)
This relationship is##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
This relationship persists after adjusting for traditional risk factors and known cardiovascular disease##2##13##(1993-12#2)
This relationship was##3##3##(2008-10#3)
This relationship##11##2##(1993-12#2)(2008-10#6)(2008-3#1)(2008-8#1)(2013-8#1)
This remarkable##3##2##(2008-10#1)(2008-12#1)(2010-12#1)
This report deals with##2##4##(2008-11#1)(2008-9#1)
This report demonstrates that##2##4##(2008-10#1)(2009-4#1)
This report describes a##8##4##(1993-12#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
This report describes one##2##4##(1995-3#1)(2008-10#1)
This report describes the results##2##5##(1997-7#1)(2008-5#1)
This report describes the use of a##3##7##(1992-1#1)(1995-8#1)(2013-8#1)
This report describes the use of##4##6##(1992-1#1)(1995-8#1)(1996-9#1)(2013-8#1)
This report describes the##16##4##(1992-1#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-7#2)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
This report describes##28##3##(1992-1#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-9#1)(1997-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
This report discusses the##2##4##(2008-11#1)(2008-12#1)
This report highlights the##2##4##(2008-10#2)
This report illustrates the##3##4##(1996-1#1)(2008-12#1)(2013-8#1)
This report is the first##2##5##(2008-11#2)
This report is##3##3##(2008-11#3)
This report presents the##2##4##(1995-3#1)(2008-11#1)
This report presents##4##3##(1991-11#1)(1993-12#1)(1995-3#1)(2008-11#1)
This report provides##2##3##(2008-7#1)(2008-9#1)
This report shows that##2##4##(1994-12#1)(1995-2#1)
This report summarizes the##3##4##(1994-9#1)(2011-2#2)
This report summarizes##6##3##(1994-9#3)(2010-4#1)(2011-2#2)
This report##74##2##(1991-11#1)(1991-5#1)(1992-1#1)(1993-12#3)(1994-11#1)(1994-12#1)(1994-9#3)(1995-2#2)(1995-3#3)(1995-8#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#10)(2008-12#4)(2008-5#2)(2008-7#4)(2008-9#2)(2009-4#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
This represents a##5##3##(1991-11#1)(1995-2#1)(2008-5#1)(2009-8#1)(2012-2#1)
This represents the first##2##4##(2008-10#1)(2013-8#1)
This represents##10##2##(1991-11#1)(1991-6#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-8#1)
This requirement##3##2##(1991-12#1)(2008-10#1)(2008-7#1)
This requires##7##2##(1996-3#1)(1997-4#1)(2008-11#2)(2008-12#1)(2008-8#2)
This research has##2##3##(1995-3#1)(2008-10#1)
This research is##2##3##(1990-12#2)
This research was##2##3##(2008-12#1)(2010-6#1)
This research##15##2##(1990-12#2)(1995-3#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-6#1)
This resistance##2##2##(2008-10#2)
This response was##2##3##(1990-6#1)(2008-11#1)
This response##5##2##(1990-6#1)(1995-12#1)(2008-11#1)(2009-8#1)(2010-4#1)
This result confirms the##2##4##(2008-8#2)
This result further##2##3##(1996-2#1)(2008-9#1)
This result implies that##4##4##(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
This result indicates that the##4##5##(1991-3#1)(1991-6#1)(2008-10#2)
This result indicates that##6##4##(1991-3#1)(1991-6#1)(2008-10#4)
This result is in contrast with the##2##7##(1992-12#1)(2008-10#1)
This result is in contrast##3##5##(1992-12#1)(2008-10#1)(2008-8#1)
This result is of##2##4##(1996-12#1)(2008-10#1)
This result is##9##3##(1992-12#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
This result may##3##3##(1994-5#1)(2008-10#1)(2008-3#1)
This result shows that##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
This result suggested that the##3##5##(2008-10#1)(2008-11#1)(2009-3#1)
This result suggested that##7##4##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-3#1)
This result suggests that##3##4##(2008-10#2)(2010-10#1)
This result supports the##2##4##(1997-1#1)(2008-8#1)
This result supports##3##3##(1997-1#1)(2008-8#2)
This result was not##2##4##(2008-10#1)(2008-9#1)
This result was##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
This result##66##2##(1990-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#18)(2008-11#6)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#8)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-8#1)
This resulted in the##2##4##(2008-10#1)(2008-11#1)
This resulted in##8##3##(1995-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)
This results in a##3##4##(1991-11#1)(1997-6#1)(2008-9#1)
This results in an##2##4##(1996-9#1)(2008-10#1)
This results in##9##3##(1991-11#1)(1996-9#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
This results##11##2##(1991-11#1)(1996-9#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#2)
This retrospective study compared the##2##5##(2009-3#1)(2012-3#1)
This retrospective study##5##3##(1995-3#1)(1996-1#1)(2009-3#1)(2011-2#1)(2012-3#1)
This retrospective##6##2##(1995-3#1)(1996-1#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
This revealed that##2##3##(1995-6#1)(2008-10#1)
This revealed##4##2##(1995-6#1)(2008-10#2)(2008-11#1)
This reveals##2##2##(2008-8#1)(2012-3#1)
This review addresses the##3##4##(2008-6#1)(2011-7#1)(2013-8#1)
This review addresses##4##3##(2008-6#1)(2008-8#1)(2011-7#1)(2013-8#1)
This review aims at providing##2##5##(2008-4#1)(2012-12#1)
This review aims at##3##4##(2008-4#1)(2012-12#1)(2013-8#1)
This review aims to summarize##3##5##(2008-11#1)(2013-1#2)
This review aims to##5##4##(2008-10#1)(2008-11#1)(2009-7#1)(2013-1#2)
This review aims##8##3##(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
This review article focuses on the##2##6##(2010-12#1)(2010-7#1)
This review article is a##2##5##(2012-2#2)
This review article##11##3##(2008-10#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#2)(2012-2#3)(2013-1#1)
This review assesses##2##3##(2008-10#1)(2010-5#1)
This review attempts to##2##4##(1997-8#1)(2008-11#1)
This review considers##2##3##(2008-10#1)(2008-11#1)
This review covers the##2##4##(2008-10#1)(2011-2#1)
This review covers##5##3##(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#2)
This review deals with##3##4##(2008-10#3)
This review demonstrates##2##3##(1997-6#1)(2010-11#1)
This review describes recent##4##4##(2008-10#3)(2011-2#1)
This review describes the##5##4##(2008-10#1)(2008-6#1)(2010-5#1)(2013-7#1)(2013-8#1)
This review describes##12##3##(2008-10#4)(2008-11#1)(2008-6#1)(2010-1#1)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#1)
This review details the##2##4##(1992-1#1)(2008-10#1)
This review discusses recent progress in the development of##2##9##(2011-2#1)(2011-3#1)
This review discusses recent##3##4##(2010-12#1)(2011-2#1)(2011-3#1)
This review discusses the##11##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-6#1)(2011-2#2)(2013-1#2)(2013-8#1)
This review discusses##22##3##(1993-3#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
This review examines the##2##4##(2010-7#1)(2010-9#1)
This review examines##5##3##(2008-10#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)
This review explores the##2##4##(2008-10#1)(2008-11#1)
This review focuses on the##8##5##(1991-7#1)(1994-1#1)(2008-11#1)(2009-10#1)(2010-7#1)(2012-3#2)(2013-1#1)
This review focuses on##13##4##(1991-7#1)(1994-1#1)(2006-6#1)(2008-1#1)(2008-11#1)(2009-10#1)(2010-7#1)(2012-2#1)(2012-3#4)(2013-1#1)
This review focuses##16##3##(1991-7#1)(1994-1#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-7#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
This review gives##2##3##(2010-11#1)(2012-2#1)
This review has##2##3##(2008-11#1)(2010-1#1)
This review highlights the##2##4##(2010-7#1)(2011-2#1)
This review highlights##3##3##(2010-7#2)(2011-2#1)
This review is focused on##3##5##(2010-10#1)(2011-2#1)(2012-2#1)
This review is##6##3##(2008-10#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
This review of##3##3##(1993-3#1)(1995-1#1)(2008-10#1)
This review presents a##3##4##(2010-7#1)(2011-2#1)(2011-3#1)
This review presents an##2##4##(2008-11#1)(2011-2#1)
This review presents the##3##4##(2008-10#1)(2011-2#1)(2011-7#1)
This review presents##9##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#3)(2011-3#1)(2011-7#1)
This review provides a##3##4##(2008-10#1)(2008-7#1)(2011-3#1)
This review provides an overview of the##4##7##(2008-12#1)(2009-1#1)(2012-3#1)(2013-1#1)
This review provides an##7##4##(2008-10#1)(2008-12#1)(2009-1#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
This review provides##13##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
This review shows##2##3##(2008-10#1)(2010-7#1)
This review summarises the##3##4##(2008-10#1)(2011-10#1)(2011-2#1)
This review summarises##6##3##(2008-10#1)(2008-11#1)(2011-10#1)(2011-2#2)(2012-2#1)
This review summarizes the current##2##5##(2008-11#1)(2008-7#1)
This review summarizes the##8##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#2)(2011-9#1)
This review summarizes##17##3##(2008-10#4)(2008-11#4)(2008-7#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#3)(2011-9#1)(2013-8#1)
This review will discuss the##3##5##(2008-8#1)(2008-9#1)(2012-2#1)
This review will discuss##7##4##(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
This review will examine the##2##5##(2008-10#1)(2012-2#1)
This review will focus on the##4##6##(1994-3#1)(2009-10#1)(2009-12#1)(2012-2#1)
This review will focus on##9##5##(1994-3#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)
This review will provide a##2##5##(2008-11#1)(2009-12#1)
This review will provide##3##4##(2008-11#1)(2009-12#1)(2009-4#1)
This review will summarize recent progress##2##6##(2008-1#1)(2011-2#1)
This review will##28##3##(1994-3#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)
This review##208##2##(1991-7#1)(1992-1#1)(1993-3#2)(1994-1#1)(1994-3#1)(1995-1#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-1#4)(2008-10#37)(2008-11#18)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#2)(2009-10#3)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-5#2)(2010-6#2)(2010-7#11)(2010-8#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#22)(2011-3#4)(2011-7#2)(2011-9#1)(2012-12#4)(2012-2#11)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#7)
This same##2##2##(1991-7#1)(2011-2#1)
This sampling##2##2##(2008-10#2)
This scheme##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
This second site was##2##4##(1995-6#1)(2011-2#1)
This second##5##2##(1994-5#1)(1995-6#1)(2008-10#2)(2011-2#1)
This section##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
This selection##3##2##(1996-6#1)(2008-10#1)(2010-5#1)
This sensing##3##2##(2008-10#3)
This sensitivity##3##2##(1990-2#1)(2008-10#1)(2008-7#1)
This sensor can be used##2##5##(2008-10#2)
This sensor exhibited##2##3##(2008-10#2)
This sensor is##2##3##(2008-10#1)(2008-2#1)
This sensor##12##2##(2008-10#11)(2008-2#1)
This sequence was##2##3##(2008-10#2)
This sequence##7##2##(1992-12#1)(1994-5#1)(1994-8#1)(2008-10#3)(2008-11#1)
This series of##2##3##(1991-12#1)(2008-9#1)
This series##5##2##(1991-12#1)(1991-2#1)(1996-3#1)(2008-9#1)(2009-8#1)
This set of##2##3##(2009-10#1)(2013-8#1)
This set##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
This shift##2##2##(2008-10#1)(2008-7#1)
This should##2##2##(1994-2#1)(1996-11#1)
This showed##2##2##(2008-11#1)(2010-7#1)
This shows that the##2##4##(1990-11#1)(1994-3#1)
This shows that##6##3##(1990-11#1)(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
This shows##8##2##(1990-11#1)(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
This sign is##2##3##(2012-12#1)(2013-1#1)
This sign was##2##3##(2013-7#2)
This sign##4##2##(2012-12#1)(2013-1#1)(2013-7#2)
This signal##2##2##(2008-10#1)(2008-7#1)
This significant##2##2##(1995-3#1)(2008-11#1)
This simple and##2##3##(1996-12#1)(2008-11#1)
This simple method##2##3##(2008-10#1)(2008-11#1)
This simple##9##2##(1992-12#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-9#1)
This situation##3##2##(1992-1#1)(2008-10#1)(2009-7#1)
This small##2##2##(2008-11#1)(2010-12#1)
This so-called##2##2##(2008-11#1)(2008-5#1)
This solution##4##2##(2008-10#3)(2008-3#1)
This source of##2##3##(2008-10#1)(2008-12#1)
This special issue##2##3##(2008-8#1)(2013-8#1)
This species##4##2##(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#1)
This state of affairs##2##4##(2008-11#1)(2011-2#1)
This statement##2##2##(2008-10#1)(2008-5#1)
This statistic##2##2##(1996-3#1)(2008-10#1)
This step##2##2##(1996-12#1)(2009-2#1)
This strain was##2##3##(2008-10#2)
This strain##3##2##(2008-10#3)
This strategy has##3##3##(1996-2#1)(2008-10#1)(2009-10#1)
This strategy is##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
This strategy was##2##3##(1993-8#1)(2008-10#1)
This strategy##19##2##(1992-6#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)
This strongly suggests that##2##4##(1993-6#1)(2008-10#1)
This structural##4##2##(1992-3#1)(1992-5#1)(1994-12#1)(2013-8#1)
This structure##2##2##(1992-5#1)(2008-12#1)
This study addresses the##2##4##(2008-9#1)(2009-4#1)
This study aimed to assess the##2##6##(2011-2#1)(2012-3#1)
This study aimed to develop a##2##6##(2008-10#1)(2010-1#1)
This study aimed to evaluate the quality of##2##8##(2008-11#1)(2012-3#1)
This study aimed to evaluate the##3##6##(2008-11#1)(2011-2#1)(2012-3#1)
This study aimed to evaluate##4##5##(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
This study aimed to examine the##2##6##(2012-2#1)(2013-1#1)
This study aimed to identify##3##5##(2011-2#1)(2012-3#1)(2012-8#1)
This study aimed to investigate the##3##6##(2008-10#1)(2012-3#2)
This study aimed to##21##4##(2008-10#3)(2008-11#2)(2010-1#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#5)(2012-8#1)(2013-1#2)
This study aimed##22##3##(2008-10#3)(2008-11#2)(2010-1#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#6)(2012-8#1)(2013-1#2)
This study aims at##2##4##(1994-6#1)(2009-11#1)
This study aims to evaluate##2##5##(2008-10#1)(2012-3#1)
This study aims to##7##4##(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
This study aims##9##3##(1994-6#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
This study also##7##3##(1991-12#1)(1992-12#1)(1994-8#1)(2008-10#3)(2008-5#1)
This study analyzed the accuracy of acute pain diagnoses after the implementation of a systematic evaluation of pain (study intervention)##2##20##(2013-1#2)
This study analyzed##4##3##(1995-12#1)(2013-1#3)
This study analyzes##3##3##(1995-2#1)(1996-3#2)
This study assessed the##6##4##(1993-3#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)
This study assessed##10##3##(1993-3#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-2#1)
This study assesses the##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
This study assesses##4##3##(1997-3#1)(2008-11#1)(2008-3#1)(2012-2#1)
This study attempted to##2##4##(1993-2#1)(2008-10#1)
This study attempts to##3##4##(2008-9#1)(2010-5#1)(2011-2#1)
This study characterized the##2##4##(2010-1#1)(2013-1#1)
This study characterized##3##3##(2008-10#1)(2010-1#1)(2013-1#1)
This study clearly##2##3##(2008-10#1)(2008-11#1)
This study compared the##6##4##(1993-1#1)(2009-3#1)(2010-1#1)(2011-2#2)(2013-1#1)
This study compared two##2##4##(2008-4#1)(2009-3#1)
This study compared##12##3##(1993-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#2)(2010-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
This study compares the##3##4##(1993-12#1)(1996-12#1)(1997-3#1)
This study compares##6##3##(1992-12#1)(1993-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2009-7#1)
This study concludes##2##3##(1995-12#1)(2013-1#1)
This study confirmed##2##3##(1993-2#1)(2011-2#1)
This study confirms that##2##4##(2008-10#2)
This study confirms the##2##4##(1995-2#1)(2008-10#1)
This study confirms##5##3##(1994-3#1)(1995-2#1)(2008-10#3)
This study deals with the##3##5##(2008-10#2)(2008-5#1)
This study deals with##4##4##(1995-12#1)(2008-10#2)(2008-5#1)
This study deals##5##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
This study demonstrated that the##2##5##(2011-2#2)
This study demonstrated that##7##4##(2008-10#1)(2008-12#1)(2010-9#1)(2011-2#4)
This study demonstrated##9##3##(2008-10#1)(2008-12#1)(2009-1#1)(2009-3#1)(2010-9#1)(2011-2#4)
This study demonstrates a##4##4##(1990-11#1)(1995-12#1)(1996-3#1)(2008-10#1)
This study demonstrates that##10##4##(1992-6#1)(1995-2#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
This study demonstrates the efficacy of##2##6##(2010-1#1)(2013-1#1)
This study demonstrates the##10##4##(1992-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
This study demonstrates##27##3##(1990-11#1)(1992-1#1)(1992-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#4)(2013-7#1)
This study describes a##3##4##(2008-10#3)
This study describes the development##2##5##(2008-10#1)(2008-6#1)
This study describes the##9##4##(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-6#1)(2010-5#1)(2013-1#1)
This study describes##19##3##(1991-12#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#6)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-6#1)(2013-1#2)
This study detected##2##3##(2008-12#1)(2012-7#1)
This study determined##2##3##(2010-6#1)(2013-1#1)
This study does not##2##4##(1992-12#1)(2008-9#1)
This study draws##2##3##(2009-12#1)(2012-2#1)
This study evaluated the##10##4##(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
This study evaluated##18##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)
This study evaluates the##5##4##(1993-3#1)(1996-2#1)(1997-2#1)(2010-2#1)(2013-8#1)
This study evaluates##7##3##(1993-3#1)(1996-2#1)(1997-2#1)(2008-11#1)(2010-11#1)(2010-2#1)(2013-8#1)
This study examined the effect of a##2##7##(1991-2#1)(2013-1#1)
This study examined the effect of##3##6##(1991-2#2)(2013-1#1)
This study examined the effects of##6##6##(1990-9#1)(1994-8#1)(2008-12#1)(2009-3#1)(2010-6#1)(2011-1#1)
This study examined the relationship between##3##6##(2009-11#1)(2010-9#1)(2011-2#1)
This study examined the##24##4##(1990-9#1)(1991-12#1)(1991-2#3)(1992-2#1)(1994-11#1)(1994-8#1)(1995-1#1)(2008-10#1)(2008-12#1)(2009-11#2)(2009-3#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
This study examined##40##3##(1990-9#1)(1991-12#1)(1991-2#3)(1992-2#1)(1993-1#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#1)
This study examines the relationship between##2##6##(1995-12#1)(1997-3#1)
This study examines the##14##4##(1992-12#1)(1994-6#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#2)(2012-3#1)
This study examines##24##3##(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#2)(2012-3#2)(2013-1#1)(2013-8#1)
This study explored the##6##4##(1994-3#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#1)
This study explores the##4##4##(1996-2#1)(1997-1#1)(2008-12#1)(2008-8#1)
This study explores##8##3##(1994-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-12#2)(2008-8#1)
This study extends previous##2##4##(1994-3#1)(2013-8#1)
This study extends##3##3##(1994-3#1)(2008-9#1)(2013-8#1)
This study focuses on the##2##5##(2008-10#1)(2008-11#1)
This study found that##2##4##(2008-11#1)(2009-9#1)
This study gave##2##3##(2008-10#1)(2008-11#1)
This study has been##2##4##(2008-10#1)(2011-2#1)
This study has shown that##2##5##(2008-7#1)(2010-12#1)
This study has##9##3##(1991-12#1)(1993-2#1)(1997-1#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-2#2)
This study highlighted the##2##4##(2008-1#1)(2011-2#1)
This study highlights the##3##4##(2008-5#1)(2010-4#1)(2011-2#1)
This study highlights##4##3##(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#1)
This study included##8##3##(1991-1#1)(1991-6#1)(1993-11#1)(1994-1#1)(2008-11#1)(2011-2#1)(2012-3#2)
This study indicates that##6##4##(1996-6#1)(2008-10#2)(2008-5#1)(2010-7#1)(2013-1#1)
This study indicates##7##3##(1996-6#1)(2008-10#3)(2008-5#1)(2010-7#1)(2013-1#1)
This study investigated the effect of##2##6##(2010-9#1)(2011-2#1)
This study investigated the effectiveness of##2##6##(1993-2#1)(2008-7#1)
This study investigated the possible##2##5##(1994-11#1)(2011-2#1)
This study investigated the##17##4##(1993-2#1)(1994-11#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-9#1)(2011-10#1)(2011-2#3)(2013-1#1)
This study investigated whether##4##4##(1994-8#1)(2008-6#1)(2009-10#1)(2012-2#1)
This study investigated##28##3##(1991-2#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2010-9#1)(2011-10#1)(2011-2#4)(2012-2#1)(2013-1#1)
This study investigates the effect of##2##6##(1996-12#1)(2008-11#1)
This study investigates the relationship##2##5##(2008-7#1)(2008-8#1)
This study investigates the##6##4##(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
This study investigates##8##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#2)
This study is a##2##4##(2010-6#1)(2011-2#1)
This study is an##3##4##(2009-8#1)(2011-1#1)(2013-1#1)
This study is the first to##3##6##(1993-1#1)(2008-11#1)(2011-2#1)
This study is the first##4##5##(1993-1#1)(2008-11#1)(2010-9#1)(2011-2#1)
This study is to##3##4##(2011-3#3)
This study is##21##3##(1992-1#1)(1993-1#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#3)(2012-3#1)(2013-1#2)
This study may##2##3##(2011-2#1)(2012-2#1)
This study measured the##2##4##(1995-1#1)(1996-2#1)
This study measured##4##3##(1995-1#1)(1996-2#1)(2008-11#1)(2008-9#1)
This study of##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
This study presents a##4##4##(2008-10#2)(2009-8#1)(2011-2#1)
This study presents##7##3##(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#2)(2013-1#1)
This study proved also that very important##2##7##(2007-11#2)
This study proved that##2##4##(2007-11#1)(2008-10#1)
This study proved##4##3##(2007-11#3)(2008-10#1)
This study provided##4##3##(2008-1#1)(2008-5#1)(2010-1#1)(2010-11#1)
This study provides a basis for##2##6##(2010-12#1)(2010-8#1)
This study provides a##3##4##(2008-10#1)(2010-12#1)(2010-8#1)
This study provides evidence for##2##5##(1994-8#1)(2013-8#1)
This study provides evidence##4##4##(1994-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
This study provides preliminary##2##4##(2008-12#1)(2011-2#1)
This study provides the first##2##5##(2008-10#2)
This study provides##18##3##(1994-8#1)(2008-10#8)(2008-12#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
This study reports a##2##4##(2008-10#1)(2008-11#1)
This study reports that##2##4##(1995-2#1)(1995-6#1)
This study reports the##7##4##(1997-7#1)(2008-10#3)(2008-11#1)(2012-7#1)(2013-1#1)
This study reports##13##3##(1991-2#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2012-7#1)(2013-1#1)
This study represents one of##2##5##(2008-10#1)(2008-8#1)
This study represents the first##2##5##(2008-10#1)(2008-9#1)
This study represents##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
This study revealed##3##3##(2008-12#2)(2012-2#1)
This study reveals that the##2##5##(2008-1#1)(2009-5#1)
This study reveals##4##3##(2008-1#1)(2008-10#1)(2009-5#1)(2013-1#1)
This study reviews the##2##4##(2012-2#2)
This study reviews##3##3##(1996-1#1)(2012-2#2)
This study showed that the##2##5##(2008-1#1)(2013-8#1)
This study showed that##8##4##(2008-1#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-8#2)
This study showed##10##3##(1992-12#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
This study shows that the##3##5##(2008-5#1)(2008-7#1)(2012-3#1)
This study shows that this##2##5##(2008-10#1)(2008-5#1)
This study shows that##16##4##(1990-8#1)(1991-12#1)(1992-12#1)(1993-1#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#2)
This study shows##19##3##(1990-8#1)(1991-12#1)(1992-12#1)(1993-1#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#2)
This study sought to investigate##2##5##(2008-11#1)(2008-5#1)
This study sought to##8##4##(2008-11#2)(2008-5#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-3#1)
This study suggests that the##4##5##(1991-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
This study suggests that##9##4##(1990-12#1)(1991-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
This study suggests##10##3##(1990-12#1)(1991-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
This study supports the use of##2##6##(2008-11#1)(2012-3#1)
This study supports the##3##4##(2008-11#1)(2008-7#1)(2012-3#1)
This study supports##5##3##(1996-2#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-3#1)
This study tested the hypothesis that##2##6##(1993-6#1)(1995-12#1)
This study tested##3##3##(1993-6#1)(1995-12#1)(2009-9#1)
This study tests##2##3##(1995-2#1)(2008-9#1)
This study used##6##3##(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
This study uses the##2##4##(2009-12#1)(2009-7#1)
This study uses##6##3##(1995-2#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)
This study was a##2##4##(2010-3#1)(2012-12#1)
This study was aimed at##2##5##(1994-8#1)(2011-2#1)
This study was aimed##3##4##(1994-8#1)(2011-2#1)(2012-2#1)
This study was based on##3##5##(2008-11#1)(2008-5#1)(2010-11#1)
This study was carried out to determine the##2##8##(1994-3#1)(2011-2#1)
This study was carried out to##6##6##(1994-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
This study was carried out##8##5##(1994-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
This study was conducted to evaluate##2##6##(2008-7#1)(2010-4#1)
This study was conducted to test##2##6##(2008-10#1)(2012-2#1)
This study was conducted to##11##5##(1990-12#1)(1995-1#1)(2008-10#5)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
This study was conducted##16##4##(1990-12#1)(1994-1#1)(1995-1#1)(2008-10#6)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
This study was designed to assess##2##6##(1994-3#1)(2011-2#1)
This study was designed to compare the##4##7##(1991-12#1)(1996-3#1)(2008-5#1)(2013-8#1)
This study was designed to evaluate the##2##7##(1995-8#1)(2011-2#1)
This study was designed to investigate the##4##7##(2008-10#1)(2011-2#3)
This study was designed to investigate##5##6##(2008-10#1)(2011-2#4)
This study was designed to##20##5##(1991-12#1)(1992-2#1)(1994-3#1)(1995-8#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#7)(2012-3#2)(2013-8#1)
This study was designed##21##4##(1991-12#1)(1992-2#1)(1994-3#1)(1995-8#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#7)(2012-3#2)(2013-1#1)(2013-8#1)
This study was initiated to##2##5##(2008-10#2)
This study was performed to##4##5##(2008-1#1)(2008-12#1)(2008-7#2)
This study was performed##5##4##(2008-1#1)(2008-12#1)(2008-7#2)(2009-7#1)
This study was to##3##4##(2009-1#1)(2009-9#1)(2013-1#1)
This study was undertaken to assess the##2##7##(1991-12#1)(2008-10#1)
This study was undertaken to compare##2##6##(2008-5#1)(2011-2#1)
This study was undertaken to##9##5##(1991-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
This study was##76##3##(1990-12#1)(1991-12#2)(1992-2#1)(1994-1#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-6#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#5)(2008-5#3)(2008-7#5)(2009-1#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#2)(2011-2#12)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
This study will##3##3##(1994-3#1)(1996-3#1)(2008-5#1)
This study##643##2##(1990-11#1)(1990-12#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#7)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#6)(1992-2#2)(1992-6#1)(1993-1#5)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#3)(1994-8#8)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#10)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#3)(1996-2#6)(1996-3#7)(1996-6#3)(1997-1#2)(1997-2#3)(1997-3#6)(1997-7#1)(1997-8#2)(2007-11#3)(2008-1#9)(2008-10#101)(2008-11#39)(2008-12#23)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#19)(2008-8#8)(2008-9#19)(2009-1#3)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#7)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#6)(2010-1#8)(2010-10#7)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#5)(2010-7#3)(2010-8#6)(2010-9#5)(2011-1#5)(2011-10#1)(2011-2#60)(2011-3#4)(2012-12#2)(2012-2#22)(2012-3#20)(2012-7#2)(2012-8#1)(2013-1#44)(2013-7#2)(2013-8#14)
This study's##2##2##(2010-2#1)(2012-2#1)
This substance##2##2##(1993-3#1)(2008-11#1)
This substitution##2##2##(1990-12#1)(2008-10#1)
This suggested that##6##3##(2008-10#4)(2008-9#1)(2012-2#1)
This suggested##8##2##(1991-3#1)(2008-10#4)(2008-9#1)(2012-2#2)
This suggests a potential##2##4##(1996-2#1)(2013-7#1)
This suggests a##3##3##(1996-2#1)(2008-10#1)(2013-7#1)
This suggests that natural##2##4##(2008-11#1)(2008-8#1)
This suggests that the##12##4##(1990-5#1)(1993-12#1)(1993-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
This suggests that##47##3##(1990-12#1)(1990-5#2)(1991-2#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#2)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#1)
This suggests the##2##3##(2008-10#1)(2013-8#1)
This suggests##58##2##(1990-12#1)(1990-5#2)(1991-2#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-2#2)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#2)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
This summary##2##2##(1991-1#1)(2008-10#1)
This supports##2##2##(1992-10#1)(2008-10#1)
This survey was##4##3##(1992-1#1)(1993-3#1)(2008-10#1)(2008-7#1)
This survey##7##2##(1992-1#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)
This survival##2##2##(1990-6#1)(1996-12#1)
This susceptibility##2##2##(1991-12#1)(2007-8#1)
This symposium##2##2##(2008-5#1)(2010-7#1)
This syndrome##2##2##(1991-3#1)(2013-8#1)
This system allows##2##3##(1990-5#1)(2008-11#1)
This system can##2##3##(2010-6#1)(2010-8#1)
This system has##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
This system is##2##3##(1993-9#1)(2008-12#1)
This system was applied##2##4##(2008-10#2)
This system was found to give compact spots for##2##9##(2008-10#2)
This system was##7##3##(1990-11#1)(2008-10#6)
This system##28##2##(1990-11#1)(1990-5#1)(1992-1#1)(1993-9#1)(1995-5#1)(1996-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-6#2)(2010-7#1)(2010-8#2)(2013-1#1)
This systematic review##3##3##(2013-1#3)
This systematic##4##2##(1990-8#1)(2013-1#3)
This team##2##2##(1992-5#1)(2013-1#1)
This technique allows##5##3##(2008-10#4)(2008-7#1)
This technique can##2##3##(2008-10#1)(2012-3#1)
This technique consists of##2##4##(1990-9#1)(2008-3#1)
This technique could be##2##4##(2008-10#1)(2008-11#1)
This technique has##2##3##(2008-3#1)(2008-9#1)
This technique is based on the##2##6##(2008-10#2)
This technique is based on##4##5##(2008-10#2)(2008-9#1)(2010-7#1)
This technique is##12##3##(1997-8#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-9#2)(2010-7#1)(2013-1#1)
This technique may##2##3##(2008-7#1)(2008-9#1)
This technique of monitoring the levels of endocrine-disruptors in##2##9##(2008-10#2)
This technique provides a##2##4##(2008-10#1)(2008-5#1)
This technique requires##2##3##(2009-5#1)(2011-2#1)
This technique was##5##3##(2008-10#4)(2012-2#1)
This technique##54##2##(1990-9#1)(1992-1#1)(1997-3#1)(1997-8#1)(2008-10#24)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#5)(2009-2#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
This technology##6##2##(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)
This tendency##3##2##(1995-11#1)(2008-10#1)(2008-7#1)
This test##5##2##(2008-10#2)(2008-4#1)(2008-5#1)(2013-1#1)
This theory##5##2##(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
This threshold##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
This time##2##2##(2008-11#1)(2010-6#1)
This tool##2##2##(2008-10#1)(2008-3#1)
This transformation##2##2##(1993-8#1)(1995-2#1)
This transient##2##2##(1994-5#1)(2008-11#1)
This translated into a##2##4##(2008-10#2)
This transport##2##2##(1990-2#1)(2009-8#1)
This treatment##3##2##(1994-2#1)(1996-12#1)(2012-12#1)
This trend##3##2##(1992-3#1)(1992-6#1)(1997-1#1)
This trial##3##2##(1996-12#1)(2013-1#1)(2013-8#1)
This type of##16##3##(1992-9#1)(1996-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
This type##17##2##(1991-11#1)(1992-9#1)(1996-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
This understanding##2##2##(2008-12#1)(2013-7#1)
This unique##3##2##(2008-6#1)(2011-1#1)(2012-3#1)
This unit addresses##2##3##(2008-4#1)(2008-9#1)
This unit briefly##2##3##(2008-4#1)(2008-9#1)
This unit contains protocols for##2##5##(2008-1#1)(2008-9#1)
This unit covers##5##3##(2008-4#3)(2008-9#2)
This unit demonstrates##2##3##(2008-4#2)
This unit describes a method for##5##6##(2008-4#1)(2008-9#4)
This unit describes a method to##2##6##(2008-4#1)(2008-9#1)
This unit describes a method##7##5##(2008-4#2)(2008-9#5)
This unit describes a##21##4##(2008-1#1)(2008-4#6)(2008-9#14)
This unit describes an##4##4##(2008-1#1)(2008-4#1)(2008-9#2)
This unit describes basic##2##4##(2008-4#1)(2008-9#1)
This unit describes in detail the##2##6##(2008-4#1)(2008-9#1)
This unit describes in detail##3##5##(2008-4#1)(2008-9#2)
This unit describes methods for preparation##2##6##(2008-1#1)(2008-9#1)
This unit describes methods for##7##5##(2008-1#1)(2008-4#5)(2008-9#1)
This unit describes methods##9##4##(2008-1#1)(2008-4#5)(2008-9#3)
This unit describes procedures for##5##5##(2008-4#2)(2008-9#3)
This unit describes protocols for the##2##6##(2008-4#2)
This unit describes protocols for##5##5##(2008-1#1)(2008-4#3)(2008-9#1)
This unit describes protocols##8##4##(2008-1#1)(2008-4#4)(2008-9#3)
This unit describes technical##2##4##(2008-9#2)
This unit describes the isolation of##2##6##(2008-4#1)(2008-9#1)
This unit describes the isolation##3##5##(2008-4#2)(2008-9#1)
This unit describes the preparation of##2##6##(2008-4#1)(2008-9#1)
This unit describes the purification of##2##6##(2008-1#1)(2008-4#1)
This unit describes the synthesis##3##5##(2008-4#3)
This unit describes the use of the##2##7##(2008-4#2)
This unit describes the use of##4##6##(2008-4#3)(2008-9#1)
This unit describes the##36##4##(2008-1#3)(2008-4#22)(2008-9#11)
This unit describes two##5##4##(2008-4#3)(2008-9#2)
This unit describes##113##3##(2008-1#7)(2008-4#56)(2008-9#50)
This unit details the##2##4##(2008-4#1)(2008-9#1)
This unit details##3##3##(2008-4#2)(2008-9#1)
This unit discusses the optics and other components of the fluorescence microscope##2##12##(2008-1#1)(2008-4#1)
This unit discusses the##6##4##(2008-1#1)(2008-4#2)(2008-9#3)
This unit discusses##9##3##(2008-1#1)(2008-4#4)(2008-9#4)
This unit focuses on the##2##5##(2008-4#2)
This unit focuses on##6##4##(2008-4#3)(2008-9#3)
This unit includes protocols for the##3##6##(2008-9#3)
This unit includes##4##3##(2008-9#4)
This unit is##2##3##(2008-4#2)
This unit offers a##2##4##(2008-4#2)
This unit offers##3##3##(2008-4#3)
This unit on##3##3##(2008-9#3)
This unit outlines##2##3##(2008-4#1)(2008-9#1)
This unit presents a protocol for##3##6##(2008-2#1)(2008-4#1)(2008-9#1)
This unit presents a protocol##4##5##(2008-2#1)(2008-4#2)(2008-9#1)
This unit presents a##11##4##(2008-2#1)(2008-4#4)(2008-9#6)
This unit presents an alternative to differential display that allows the quantification of transcripts##2##14##(2008-2#2)
This unit presents an overview of##2##6##(2008-4#1)(2008-9#1)
This unit presents an##4##4##(2008-2#2)(2008-4#1)(2008-9#1)
This unit presents methods##2##4##(2008-9#2)
This unit presents protocols for the##2##6##(2008-4#1)(2008-9#1)
This unit presents protocols for##7##5##(2008-4#1)(2008-9#6)
This unit presents protocols##8##4##(2008-4#1)(2008-9#7)
This unit presents the##4##4##(2008-4#1)(2008-9#3)
This unit presents two protocols for##2##6##(2008-9#2)
This unit presents two##3##4##(2008-2#1)(2008-9#2)
This unit presents##43##3##(2008-2#4)(2008-4#9)(2008-9#30)
This unit provides a general##2##5##(2008-4#2)
This unit provides a protocol##2##5##(2008-4#2)
This unit provides a set of protocols for introducing##2##9##(2008-4#2)
This unit provides a summary of some of the issues that researchers face when attempting to store purified proteins##2##19##(2008-4#2)
This unit provides a##13##4##(2008-4#10)(2008-9#3)
This unit provides an excellent##2##5##(2008-9#2)
This unit provides an overview of the field of synthetic peptides and proteins##2##13##(2008-4#2)
This unit provides an overview of##5##6##(2008-4#5)
This unit provides an##8##4##(2008-1#1)(2008-4#5)(2008-9#2)
This unit provides detailed##2##4##(2008-4#1)(2008-9#1)
This unit provides##31##3##(2008-1#1)(2008-4#21)(2008-9#9)
This unit reports##2##3##(2008-4#2)
This unit reviews the##2##4##(2008-4#2)
This unit reviews##5##3##(2008-4#4)(2008-9#1)
This unit summarizes the##2##4##(2008-4#1)(2008-9#1)
This unit summarizes##3##3##(2008-4#2)(2008-9#1)
This unit##263##2##(1997-4#1)(2008-1#11)(2008-2#5)(2008-3#1)(2008-4#122)(2008-9#123)
This unusual##3##2##(2008-11#1)(2008-7#1)(2013-7#1)
This value is##2##3##(1994-3#1)(2011-2#1)
This value##6##2##(1994-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
This variation in##2##3##(1994-5#1)(2008-10#1)
This variation##3##2##(1994-5#1)(2008-10#2)
This vector##2##2##(1993-8#1)(1993-9#1)
This view##3##2##(2009-10#1)(2010-3#1)(2013-1#1)
This virus has##2##3##(2008-10#1)(2008-9#1)
This virus##4##2##(2008-10#3)(2008-9#1)
This volume##2##2##(2008-11#1)(2009-5#1)
This was a cross-sectional descriptive##2##5##(2011-2#1)(2013-1#1)
This was a cross-sectional study##2##5##(2011-2#1)(2012-12#1)
This was a cross-sectional##4##4##(2011-2#2)(2012-12#1)(2013-1#1)
This was a descriptive##3##4##(2011-2#1)(2012-12#2)
This was a prospective##2##4##(2009-6#1)(2012-12#1)
This was a##17##3##(1991-12#1)(2008-11#1)(2009-6#1)(2011-2#6)(2012-12#6)(2013-1#2)
This was accomplished by##2##4##(1993-9#1)(2008-10#1)
This was accomplished##3##3##(1993-9#1)(2008-10#1)(2008-5#1)
This was achieved##3##3##(2008-10#2)(2008-11#1)
This was an##3##3##(1994-12#1)(2011-2#1)(2012-12#1)
This was attributed to##2##4##(2008-10#2)
This was based##2##3##(1994-12#1)(2011-3#1)
This was confirmed by##3##4##(1993-12#1)(1995-6#1)(2008-11#1)
This was confirmed##6##3##(1993-12#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-11#1)
This was corroborated by##2##4##(1997-3#1)(2008-10#1)
This was demonstrated by##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
This was done by##3##4##(2008-11#1)(2010-1#1)(2012-12#1)
This was done##5##3##(2008-10#1)(2008-11#1)(2010-1#1)(2012-12#2)
This was due to##2##4##(2008-9#1)(2011-2#1)
This was due##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
This was followed by##3##4##(2008-10#2)(2012-2#1)
This was in##4##3##(1997-2#1)(2008-10#1)(2008-11#2)
This was interpreted##2##3##(2008-10#1)(2012-7#1)
This was not##3##3##(1990-8#1)(1995-2#1)(2013-1#1)
This was particularly##5##3##(1994-12#1)(1994-2#1)(2008-10#3)
This was performed##2##3##(1997-6#1)(2008-10#1)
This was probably due to##2##5##(1996-6#1)(2008-11#1)
This was probably##3##3##(1994-8#1)(1996-6#1)(2008-11#1)
This was reflected in##3##4##(2008-5#1)(2009-8#1)(2010-8#1)
This was shown##2##3##(2008-10#1)(2008-7#1)
This was substantiated by##2##4##(1994-2#1)(2008-10#1)
This was successfully##2##3##(2008-10#1)(2010-5#1)
This was the first##2##4##(1992-5#1)(2013-8#1)
This was the##4##3##(1992-5#1)(2008-10#1)(2009-10#1)(2013-8#1)
This was then followed by##2##5##(2008-10#1)(2008-11#1)
This was treated##2##3##(1996-5#1)(2008-1#1)
This was##122##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#31)(2008-11#10)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-12#9)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#2)
This way##4##2##(2008-10#4)
This weak##3##2##(1990-2#1)(1995-12#1)(2008-10#1)
This week in science##5##4##(1990-11#1)(1990-8#1)(1994-9#1)(1995-3#1)(1995-6#1)
This weight##2##2##(1994-11#1)(2013-8#1)
This will allow the##2##4##(2008-10#1)(2009-7#1)
This will be illustrated##2##4##(2008-11#1)(2008-7#1)
This will be##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
This will require a##2##4##(1997-7#1)(2011-2#1)
This will##17##2##(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
This work deals with the##2##5##(2008-10#1)(2009-7#1)
This work demonstrates a##2##4##(1997-7#1)(2008-10#1)
This work demonstrates that##2##4##(1995-2#1)(2008-7#1)
This work demonstrates##4##3##(1995-2#1)(1997-7#1)(2008-10#1)(2008-7#1)
This work describes a##3##4##(2008-10#2)(2008-11#1)
This work describes the application of##2##6##(2008-10#2)
This work describes the##5##4##(2008-10#4)(2013-1#1)
This work describes##11##3##(2008-10#7)(2008-11#1)(2009-7#1)(2009-8#1)(2013-1#1)
This work focuses on##2##4##(2007-8#1)(2008-10#1)
This work has##5##3##(2008-10#3)(2008-11#1)(2009-8#1)
This work is an##2##4##(2008-10#2)
This work is the##2##4##(2008-10#2)
This work is##7##3##(2008-10#5)(2009-3#1)(2013-8#1)
This work presents a##5##4##(2008-10#5)
This work presents the##2##4##(2010-10#1)(2011-2#1)
This work presents##9##3##(2008-10#6)(2010-10#1)(2010-8#1)(2011-2#1)
This work proposes##2##3##(2008-10#2)
This work provides a##2##4##(2008-10#2)
This work provides##4##3##(2008-10#3)(2013-8#1)
This work reports a##2##4##(2008-10#2)
This work reports the##5##4##(2008-10#3)(2008-5#1)(2010-4#1)
This work reports##8##3##(2008-10#6)(2008-5#1)(2010-4#1)
This work suggests##2##3##(2008-8#1)(2012-2#1)
This work was##2##3##(1997-8#1)(2008-10#1)
This work##90##2##(1992-7#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-10#50)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
This would##8##2##(1994-12#1)(1994-8#1)(1995-3#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
This year##2##2##(2008-11#1)(2009-6#1)
This##6192##1##(1990-10#1)(1990-11#19)(1990-12#26)(1990-2#12)(1990-3#5)(1990-5#16)(1990-6#9)(1990-8#9)(1990-9#6)(1991-1#15)(1991-10#1)(1991-11#13)(1991-12#41)(1991-2#30)(1991-3#16)(1991-4#1)(1991-5#14)(1991-6#13)(1991-7#5)(1991-8#3)(1991-9#2)(1992-1#25)(1992-10#6)(1992-11#1)(1992-12#33)(1992-2#20)(1992-3#26)(1992-4#3)(1992-5#11)(1992-6#7)(1992-7#1)(1992-8#4)(1992-9#8)(1993-1#19)(1993-11#7)(1993-12#35)(1993-2#26)(1993-3#42)(1993-6#12)(1993-8#27)(1993-9#8)(1994-1#33)(1994-11#24)(1994-12#34)(1994-2#37)(1994-3#41)(1994-5#22)(1994-6#10)(1994-8#25)(1994-9#17)(1995-1#18)(1995-11#15)(1995-12#42)(1995-2#64)(1995-3#25)(1995-5#9)(1995-6#22)(1995-8#12)(1995-9#9)(1996-1#26)(1996-11#6)(1996-12#41)(1996-2#50)(1996-3#53)(1996-5#5)(1996-6#16)(1996-8#2)(1996-9#5)(1997-1#34)(1997-2#48)(1997-3#48)(1997-4#8)(1997-5#4)(1997-6#14)(1997-7#19)(1997-8#23)(2006-6#4)(2007-11#8)(2007-12#23)(2007-8#5)(2007-9#1)(2008-1#51)(2008-10#1399)(2008-11#472)(2008-12#169)(2008-2#27)(2008-3#98)(2008-4#194)(2008-5#135)(2008-6#33)(2008-7#169)(2008-8#125)(2008-9#299)(2009-1#12)(2009-10#39)(2009-11#9)(2009-12#25)(2009-2#3)(2009-3#19)(2009-4#10)(2009-5#20)(2009-6#18)(2009-7#30)(2009-8#50)(2009-9#17)(2010-1#28)(2010-10#32)(2010-11#29)(2010-12#29)(2010-2#6)(2010-3#14)(2010-4#19)(2010-5#24)(2010-6#25)(2010-7#48)(2010-8#34)(2010-9#17)(2011-1#35)(2011-10#3)(2011-2#286)(2011-3#19)(2011-7#8)(2011-8#1)(2011-9#2)(2012-12#38)(2012-2#139)(2012-3#121)(2012-5#3)(2012-7#4)(2012-8#1)(2012-9#1)(2013-1#214)(2013-7#14)(2013-8#95)
Thomas##10##1##(1991-5#1)(1992-4#1)(1993-12#1)(1994-3#1)(1995-12#2)(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)
Thominx neopulchra##2##2##(2011-2#2)
Thompson##5##1##(1995-12#1)(2008-12#1)(2011-2#2)(2013-1#1)
Thoracic Society##2##2##(2008-7#1)(2010-5#1)
Thoracic and##2##2##(2010-9#1)(2013-1#1)
Thoracic aortic##2##2##(2008-12#1)(2009-8#1)
Thoracic kidney is a rare##2##5##(2011-2#2)
Thoracic##14##1##(1990-12#1)(2008-12#2)(2008-7#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
Thorium colloid analysis##2##3##(2008-10#2)
Thorium##3##1##(2008-10#3)
Thorne##3##1##(1995-1#2)(2008-11#1)
Thorough##4##1##(1997-4#1)(2008-10#2)(2009-6#1)
Those are##2##2##(1992-11#1)(1997-8#1)
Those data##2##2##(1994-2#1)(2008-9#1)
Those in##2##2##(2008-7#1)(2013-1#1)
Those of the##3##3##(1993-12#1)(2008-10#2)
Those of##5##2##(1993-12#1)(1994-2#1)(2008-10#3)
Those results##2##2##(2008-5#1)(2008-8#1)
Those studies##2##2##(1996-12#1)(2008-10#1)
Those who##2##2##(1996-2#1)(2008-12#1)
Those with a##2##3##(1995-12#1)(2008-9#1)
Those with##4##2##(1994-12#1)(1995-12#1)(2008-10#1)(2008-9#1)
Those##44##1##(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#2)(1995-12#1)(1996-12#2)(1996-2#1)(1997-8#1)(2006-5#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#4)(2013-8#1)
Though the radial artery is##2##5##(2008-11#1)(2011-2#1)
Though the##10##2##(1992-3#1)(1994-5#1)(2008-10#2)(2008-11#3)(2009-7#1)(2011-2#1)(2013-8#1)
Though there##2##2##(2008-9#1)(2012-3#1)
Though this##4##2##(2008-1#1)(2011-2#2)(2012-3#1)
Though##33##1##(1991-7#1)(1992-3#2)(1994-11#1)(1994-5#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-8#2)
Thought Suppression Inventory##2##3##(2012-3#2)
Thought##3##1##(2012-3#3)
Thousand Oaks##2##2##(2008-12#2)
Thousands of##3##2##(2008-10#1)(2010-12#1)(2010-8#1)
Thousands##4##1##(2008-10#2)(2010-12#1)(2010-8#1)
Thr##9##1##(1991-3#1)(1991-9#1)(1993-3#1)(1993-8#3)(2008-2#1)(2008-8#1)(2012-2#1)
Thr)##2##1##(1993-8#2)
Thr-290##2##1##(2008-9#2)
Thr147##3##1##(2012-2#3)
Threats to##2##2##(2008-12#1)(2010-10#1)
Three Cases##2##2##(2011-2#1)(2013-1#1)
Three F(2) populations##2##3##(2008-10#2)
Three QTL on##3##3##(2008-10#3)
Three QTL##4##2##(2008-10#4)
Three alternate##2##2##(1993-12#1)(2008-9#1)
Three cases of##9##3##(1990-12#1)(1990-9#1)(1991-6#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2013-1#1)
Three cases##11##2##(1990-12#1)(1990-9#1)(1991-6#1)(1992-5#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-1#1)
Three categories##2##2##(1997-3#1)(2013-1#1)
Three children##3##2##(1991-2#1)(2008-10#1)(2008-9#1)
Three cultivars have##2##3##(2008-10#2)
Three cultivars##3##2##(2008-10#3)
Three days after##4##3##(2008-10#1)(2012-3#1)(2013-1#2)
Three days##5##2##(1995-12#1)(2008-10#1)(2012-3#1)(2013-1#2)
Three different methods for the##2##5##(2008-10#2)
Three different methods##3##3##(2008-10#3)
Three different##20##2##(1990-5#1)(1997-7#1)(2008-10#13)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-2#1)
Three digestion procedures##2##3##(2008-10#2)
Three examples##2##2##(1990-2#1)(2008-10#1)
Three experiments were carried out to##2##6##(2008-10#1)(2008-6#1)
Three experiments##3##2##(2008-10#2)(2008-6#1)
Three focus##2##2##(2008-11#1)(2012-3#1)
Three groups of animals were##2##5##(2006-6#1)(2008-11#1)
Three groups of##6##3##(2006-6#1)(2008-10#1)(2008-11#3)(2008-7#1)
Three groups##7##2##(2006-6#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-4#1)
Three hundred and##2##3##(1991-6#1)(1992-1#1)
Three hundred##7##2##(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(2008-10#2)(2012-3#1)
Three independent##2##2##(1997-7#1)(2008-10#1)
Three isolates of##3##3##(2008-10#3)
Three isolates##4##2##(2008-10#4)
Three levels of##3##3##(2008-10#3)
Three main##6##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)
Three methods of##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
Three methods##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
Three minor##2##2##(2008-10#1)(2013-1#1)
Three months after##3##3##(1991-6#1)(1992-12#1)(2008-12#1)
Three months##4##2##(1991-6#1)(1992-12#1)(2008-12#1)(2011-2#1)
Three new##4##2##(1997-9#1)(2008-10#1)(2009-8#1)(2011-2#1)
Three of the##10##3##(1990-6#1)(1991-6#1)(1993-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
Three of##14##2##(1990-6#1)(1991-3#1)(1991-6#1)(1993-12#1)(1995-6#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#2)
Three other##4##2##(1991-12#1)(2008-10#2)(2008-4#1)
Three out of##4##3##(1992-4#1)(1994-11#1)(1996-12#1)(2011-2#1)
Three patients died##2##3##(1994-3#1)(2013-8#1)
Three patients had##4##3##(1990-9#1)(1991-4#1)(1997-3#1)(2008-7#1)
Three patients were##2##3##(1997-8#1)(2008-5#1)
Three patients with##2##3##(1991-6#1)(2013-1#1)
Three patients##13##2##(1990-9#1)(1991-4#1)(1991-6#1)(1994-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
Three plant##2##2##(2008-11#1)(2008-8#1)
Three populations##2##2##(1997-2#1)(2008-10#1)
Three presidents##2##2##(1995-3#2)
Three putative##2##2##(1993-3#1)(2008-10#1)
Three recent legal cases##4##4##(2008-11#4)
Three recent##5##2##(2008-11#5)
Three regions##2##2##(1993-8#1)(1995-6#1)
Three sets of##2##3##(2008-10#2)
Three simple and sensitive visible spectrophotometric methods##2##7##(2008-10#2)
Three simple##4##2##(2008-10#4)
Three strategies##2##2##(2008-10#2)
Three types of##12##3##(2008-10#7)(2008-11#2)(2008-8#1)(2009-7#1)(2009-8#1)
Three types##13##2##(2008-10#7)(2008-11#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)
Three variables##2##2##(2008-10#2)
Three years##3##2##(1997-8#1)(2008-1#1)(2012-2#1)
Three##354##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#5)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#2)(1995-12#3)(1995-3#3)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#2)(1997-9#2)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#146)(2008-11#25)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#10)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#8)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#10)(2011-3#2)(2012-2#3)(2012-3#6)(2012-9#1)(2013-1#12)(2013-8#1)
Three-Dimensional##2##1##(1996-9#1)(2012-3#1)
Three-dimensional images of##2##3##(2008-3#1)(2012-3#1)
Three-dimensional structure of the##3##4##(1995-8#1)(2008-8#2)
Three-dimensional structure of##4##3##(1992-4#1)(1995-8#1)(2008-8#2)
Three-dimensional structure##5##2##(1992-4#1)(1995-8#1)(2008-8#3)
Three-dimensional visualization of##2##3##(2008-9#2)
Three-dimensional##32##1##(1990-12#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-8#1)(1995-12#1)(1995-8#1)(2007-12#1)(2008-11#7)(2008-3#6)(2008-8#3)(2008-9#2)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
Three-way##2##1##(2008-10#2)
Threshold bootstrap##2##2##(2008-10#2)
Threshold##8##1##(1995-2#1)(1996-9#1)(2008-10#4)(2008-3#1)(2010-7#1)
Thresholds##2##1##(2008-1#1)(2008-4#1)
Thrips setosus##2##2##(2008-10#2)
Thrips tabaci##3##2##(2008-10#3)
Thrips##14##1##(2008-10#14)
Thrombin##2##1##(1992-6#1)(2008-5#1)
Thromboangiitis obliterans##2##2##(1996-8#1)(1997-8#1)
Thrombocytopenia##3##1##(1991-8#1)(1997-3#1)(2013-1#1)
Thrombolysis and the general practitioner##2##5##(1990-3#2)
Thrombolysis and##3##2##(1990-3#2)(2008-8#1)
Thrombolysis##4##1##(1990-3#2)(2008-8#2)
Thrombolytic therapy##2##2##(1994-6#1)(2008-7#1)
Thrombolytic##4##1##(1994-6#1)(2008-11#1)(2008-7#2)
Thrombopoietin (TPO) is##2##3##(2008-8#2)
Thrombosis and##2##2##(1997-6#1)(1997-8#1)
Thrombosis##10##1##(1993-9#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-11#4)(2012-3#1)
Thrombotic##2##1##(2008-5#1)(2013-1#1)
Thromboxane##2##1##(1990-5#1)(1991-5#1)
Through a series of##2##4##(2008-10#1)(2010-8#1)
Through a##11##2##(1993-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)
Through the use of##3##4##(1994-3#2)(1994-5#1)
Through the##18##2##(1991-2#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
Through these##2##2##(2008-10#1)(2012-2#1)
Through##71##1##(1990-11#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2012-9#1)
Throughout the entire##2##3##(2011-2#1)(2012-9#1)
Throughout the##7##2##(1991-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-9#1)
Throughout this article##2##3##(2008-4#1)(2012-3#1)
Throughout this##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
Throughout##14##1##(1991-3#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#1)(2012-9#1)
Thurgau was##2##2##(1996-11#2)
Thurgau##10##1##(1996-11#10)
Thus a##8##2##(1994-11#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#1)
Thus far##2##2##(1996-5#1)(2010-6#1)
Thus the##26##2##(1992-12#1)(1992-9#1)(1994-11#3)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
Thus they##2##2##(1996-9#1)(2008-8#1)
Thus this##3##2##(1990-2#1)(2008-12#2)
Thus we##5##2##(1990-6#1)(1993-1#1)(1997-8#1)(2008-11#1)(2008-9#1)
Thus##593##1##(1990-11#1)(1990-12#2)(1990-2#5)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-3#6)(1992-4#1)(1992-6#3)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#4)(1994-11#6)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#5)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#7)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#4)(1996-12#2)(1996-2#9)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#5)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#154)(2008-11#45)(2008-12#6)(2008-3#4)(2008-4#5)(2008-5#15)(2008-6#1)(2008-7#19)(2008-8#22)(2008-9#16)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#3)(2009-7#3)(2009-8#12)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#22)(2011-3#3)(2012-12#6)(2012-2#11)(2012-3#14)(2012-5#1)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#5)
Thymic##4##1##(1993-12#1)(2008-8#1)(2011-2#1)(2013-7#1)
Thymus eriocalyx##3##2##(2008-12#3)
Thymus serpyllum L##2##3##(2012-2#2)
Thymus##14##1##(1995-12#1)(2008-10#2)(2008-11#3)(2008-12#5)(2012-2#2)(2012-3#1)
Thyroid disease##2##2##(2008-7#1)(2011-2#1)
Thyroid function##4##2##(2008-4#1)(2008-7#2)(2012-12#1)
Thyroid##22##1##(1991-5#1)(1994-8#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#3)
Thyrotropin-releasing##2##1##(1994-2#1)(2013-7#1)
ThzID1-M3 was##3##2##(2008-10#3)
ThzID1-M3##8##1##(2008-10#8)
Ti and##4##2##(2008-10#4)
Ti plasmid##3##2##(2008-10#3)
Ti##41##1##(2007-11#2)(2008-10#19)(2008-2#2)(2008-3#14)(2009-7#1)(2013-8#3)
Ti(IV)##10##1##(2008-10#10)
Ti-6 Al-4V##2##2##(2009-7#2)
Ti-6Al-4V##5##1##(2008-10#1)(2009-7#4)
Ti3+##2##1##(2008-3#2)
TiCl(3)##2##1##(2008-10#2)
TiNi alloy foams##2##3##(2009-7#2)
TiNi##4##1##(2009-7#4)
TiO _ 2 was found##3##5##(2008-5#3)
TiO _ 2##8##3##(2008-5#8)
TiO(2) and In(2)O(3)) and doped with noble metals (Au##2##9##(2008-10#2)
TiO(2) and##4##2##(2008-10#4)
TiO(2) as##2##2##(2008-10#2)
TiO(2) film##2##2##(2008-10#2)
TiO(2)##37##1##(2008-10#28)(2008-5#4)(2013-1#5)
TiO2##3##1##(2008-5#3)
Tibial##3##1##(1991-3#1)(2012-2#1)(2013-1#1)
Tick##2##1##(1997-7#1)(2013-1#1)
Ticks##2##1##(2012-2#1)(2013-8#1)
Ticlopidine##2##1##(1993-9#1)(1994-9#1)
Tid1##6##1##(2011-2#6)
Tierra Del Fuego##2##3##(2008-3#2)
Tift 23DB##2##2##(2008-10#2)
Tift##5##1##(2008-10#5)
Tifton##2##1##(2008-10#2)
Tikhonov##2##1##(2008-10#1)(2013-8#1)
Till Uwe Keil]##2##3##(1996-9#1)(1997-8#1)
Till##3##1##(1996-9#1)(1997-8#1)(2013-1#1)
Tillage and##2##2##(2008-10#2)
Tillage##6##1##(2008-10#6)
Tilletia controversa and T##3##4##(2008-10#3)
Tilletia indica##8##2##(2008-10#8)
Tilletia tritici##2##2##(2008-10#2)
Tilletia##17##1##(2008-10#17)
Tilt##4##1##(2008-11#1)(2008-3#2)(2013-1#1)
Tim##2##1##(2012-12#1)(2013-1#1)
Time 1##5##2##(2008-12#4)(2010-4#1)
Time 2##5##2##(2008-12#3)(2010-4#2)
Time course of##3##3##(1995-12#1)(1995-3#1)(2013-1#1)
Time course##5##2##(1993-8#1)(1995-12#1)(1995-3#1)(2009-6#1)(2013-1#1)
Time for##2##2##(2008-10#1)(2010-7#1)
Time of##2##2##(2008-10#2)
Time to get##2##3##(2008-11#1)(2013-8#1)
Time to##8##2##(1996-11#1)(2008-11#1)(2008-9#2)(2011-2#2)(2012-12#1)(2013-8#1)
Time trends##4##2##(2013-1#4)
Time##64##1##(1991-3#1)(1991-8#1)(1992-2#2)(1993-12#1)(1993-8#2)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#7)(2008-11#2)(2008-12#7)(2008-9#4)(2009-10#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#12)(2013-8#1)
Time-dependent##3##1##(1992-9#1)(1994-2#1)(1995-6#1)
Time-lapse##2##1##(1994-9#1)(2009-12#1)
Time-resolved##3##1##(1992-8#1)(2008-10#1)(2008-4#1)
Timely reporting##2##2##(2011-2#1)(2013-8#1)
Timely##7##1##(1994-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
Times##4##1##(1990-11#1)(1993-5#1)(1997-3#1)(2009-3#1)
Timing of surgery##2##3##(2011-2#2)
Timing of##10##2##(1991-6#1)(2007-11#1)(2008-10#3)(2008-4#1)(2009-10#1)(2010-6#1)(2011-2#2)
Timing##11##1##(1991-6#1)(2007-11#1)(2008-10#4)(2008-4#1)(2009-10#1)(2010-6#1)(2011-2#2)
Tin protein inhibits##2##3##(1997-3#2)
Tin protein##7##2##(1997-3#7)
Tin##9##1##(1997-3#7)(2008-10#2)
Tin(IV) was##2##2##(2008-10#2)
Tin(IV)##3##1##(2008-10#3)
Tinnitus is##2##2##(1996-6#1)(2010-7#1)
Tiopronin##2##1##(1994-5#2)
Tips##5##1##(1991-1#1)(1995-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
Tir##4##1##(2011-2#4)
Tiron##9##1##(1990-5#4)(2008-10#5)
Tissue culture##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
Tissue expansion##2##2##(1992-5#2)
Tissue samples##2##2##(2008-2#1)(2011-2#1)
Tissue##41##1##(1990-5#2)(1992-10#1)(1992-3#1)(1992-5#2)(1993-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-9#1)(2011-2#2)(2013-1#2)(2013-8#2)
Tissues in##2##2##(2008-10#2)
Tissues##6##1##(2008-10#5)(2009-8#1)
Titanium##5##1##(2008-10#4)(2008-5#1)
Titanium-nickel##2##1##(2009-7#2)
Tithonia diversifolia##2##2##(2008-10#2)
Title I of the Americans with Disabilities Act##2##8##(1993-3#1)(1994-2#1)
Title I of the##3##4##(1993-3#1)(1994-1#1)(1994-2#1)
Title III of the Americans with Disabilities Act##2##8##(1992-12#1)(1995-6#1)
Title III of the Americans##3##5##(1992-12#1)(1995-1#1)(1995-6#1)
Title III of##4##3##(1991-1#1)(1992-12#1)(1995-1#1)(1995-6#1)
Title V children with special health care needs##2##8##(1995-12#2)
Title V##3##2##(1995-12#3)
Title X##6##2##(1991-1#5)(1991-3#1)
Title##19##1##(1991-1#7)(1991-3#3)(1992-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#3)(1995-6#1)
Titrimetric##3##1##(2008-10#3)
Tl and##3##2##(2008-10#3)
Tl##21##1##(2008-10#20)(2010-5#1)
Tl(I) and Tl(III) were separated##2##5##(2008-10#2)
Tl(I) and Tl(III)##4##3##(2008-10#4)
Tl(I) and##6##2##(2008-10#6)
Tl(I) ions##2##2##(2008-10#2)
Tl(I)##10##1##(2008-10#10)
Tl(III)##7##1##(2008-10#7)
TlNO(3)##2##1##(2008-10#2)
Tm##9##1##(1993-8#1)(2007-12#3)(2008-10#2)(2008-2#3)
Tn3 transposase##2##2##(1996-12#2)
Tn3##5##1##(1996-12#5)
Tn4001##5##1##(1993-12#5)
Tn4001lac derivative##2##2##(1993-12#2)
Tn4001lac##3##1##(1993-12#3)
Tn5 insertion##2##2##(2008-10#2)
Tn5 mutant of##2##3##(2008-10#2)
Tn5##5##1##(2008-10#5)
TnI##3##1##(2010-12#3)
TnOA##2##1##(2008-10#2)
To a large extent##2##4##(1996-6#1)(1997-4#1)
To a##3##2##(1996-6#1)(1997-4#1)(2008-10#1)
To accelerate##2##2##(2008-10#1)(2008-11#1)
To accomplish this##4##3##(1992-12#1)(1995-12#1)(2008-10#1)(2008-5#1)
To accomplish##6##2##(1992-12#1)(1995-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
To account for##3##3##(1992-9#1)(2008-7#1)(2011-2#1)
To achieve a##2##3##(2008-11#1)(2012-2#1)
To achieve optimum##2##3##(2008-10#1)(2013-1#1)
To achieve this##4##3##(2006-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
To achieve##14##2##(1995-2#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
To address the issue of##2##5##(1996-12#1)(2010-10#1)
To address the##7##3##(1996-12#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
To address these##2##3##(2008-11#1)(2013-1#1)
To address this issue##5##4##(1997-2#1)(2008-10#1)(2008-11#3)
To address this question we##2##5##(1994-11#1)(2013-8#1)
To address this question##3##4##(1994-11#1)(2008-11#1)(2013-8#1)
To address this##14##3##(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
To address##26##2##(1992-10#1)(1993-12#1)(1994-11#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
To advance##2##2##(2008-11#1)(2010-10#1)
To aid##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
To analyze the##9##3##(1997-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
To analyze##11##2##(1994-12#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
To apply##2##2##(1995-5#1)(2012-2#1)
To ascertain the##2##3##(1996-12#1)(2011-2#1)
To ascertain whether##2##3##(1993-3#1)(2006-6#1)
To ascertain##4##2##(1993-3#1)(1996-12#1)(2006-6#1)(2011-2#1)
To assess the genetic##2##4##(2008-10#2)
To assess the technical efficiency##2##5##(2013-8#2)
To assess the##30##3##(1991-3#1)(1992-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
To assess whether##2##3##(1994-11#1)(2010-12#1)
To assess##43##2##(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#2)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
To assist##2##2##(2008-10#2)
To assure##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
To avoid possible##2##3##(2008-10#2)
To avoid the##2##3##(1996-3#1)(2008-10#1)
To avoid##15##2##(1996-1#1)(1996-3#1)(2008-10#7)(2008-11#2)(2010-3#1)(2011-2#2)(2012-12#1)
To be##12##2##(1993-3#1)(1995-9#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-3#1)(2013-1#1)
To better understand the mechanism##2##5##(1992-6#1)(2008-2#1)
To better understand the##11##4##(1992-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2010-10#1)(2010-12#1)(2012-2#1)
To better understand this##2##4##(2008-7#1)(2009-10#1)
To better understand##15##3##(1992-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2012-2#2)
To better##21##2##(1991-5#1)(1992-6#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)
To characterize the##10##3##(1991-5#2)(1996-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
To characterize this##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
To characterize##21##2##(1991-5#2)(1991-8#1)(1993-8#2)(1996-8#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
To check the accuracy of the proposed method##2##8##(2008-10#2)
To circumvent the difficulty of regeneration of##2##7##(2008-10#2)
To circumvent##3##2##(1997-8#1)(2008-10#2)
To clarify the serological relationship##2##5##(2008-10#2)
To clarify the##8##3##(1992-6#1)(1997-1#1)(1997-8#1)(2008-10#3)(2009-6#1)(2010-12#1)
To clarify##10##2##(1992-6#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#2)(2009-6#1)(2010-12#1)
To compare the outcome of##2##5##(2013-1#2)
To compare the results of##2##5##(1996-1#1)(2013-1#1)
To compare the##10##3##(1993-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#4)
To compare with##2##3##(2008-10#1)(2008-11#1)
To compare##13##2##(1993-1#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-1#1)(2013-1#4)(2013-8#1)
To compensate for the##2##4##(2011-2#1)(2012-3#1)
To comprehensively##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
To conclude##3##2##(1991-6#1)(2008-5#1)(2010-7#1)
To conduct##2##2##(2007-12#1)(2013-1#1)
To confirm the##2##3##(2008-5#1)(2011-2#1)
To confirm these##2##3##(1996-12#1)(2008-11#1)
To confirm##8##2##(1994-11#1)(1994-3#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
To construct##3##2##(2008-10#2)(2008-11#1)
To control##2##2##(1993-12#1)(1996-1#1)
To counter##2##2##(2008-5#1)(2010-4#1)
To create##3##2##(1994-2#1)(2008-3#1)(2012-3#1)
To date most##2##3##(2010-8#1)(2011-2#1)
To date the##2##3##(2010-7#1)(2013-8#1)
To date there##2##3##(1992-2#1)(2008-9#1)
To date##40##2##(1990-11#1)(1992-2#1)(1996-2#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-3#3)(2013-8#1)
To decrease##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
To define the role of##2##5##(2008-10#1)(2008-11#1)
To define the##5##3##(1992-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-1#1)
To define##7##2##(1992-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-1#1)
To delineate the##2##3##(1994-5#1)(1995-2#1)
To deliver##2##2##(2008-3#1)(2013-1#1)
To demonstrate the feasibility of the##2##6##(2008-10#2)
To demonstrate the feasibility of##3##5##(2008-10#3)
To demonstrate the##10##3##(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2013-1#1)
To depict the##2##3##(2010-12#1)(2012-3#1)
To describe the##10##3##(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
To describe##15##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
To detect the##2##3##(2008-10#1)(2008-11#1)
To detect##8##2##(2008-10#4)(2008-11#2)(2008-9#1)(2010-12#1)
To determine how##3##3##(1990-5#1)(2008-10#2)
To determine if the##3##4##(1994-6#1)(2008-10#2)
To determine if this##2##4##(1994-8#1)(2012-7#1)
To determine if##15##3##(1992-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-10#7)(2008-11#1)(2011-2#1)(2012-7#1)
To determine the effect of##5##5##(1995-12#1)(2008-10#2)(2008-12#1)(2008-8#1)
To determine the effects of##3##5##(1994-11#1)(2008-9#1)(2013-1#1)
To determine the incidence of##2##5##(2012-3#1)(2013-1#1)
To determine the##45##3##(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
To determine whether the##4##4##(1990-5#1)(1993-6#1)(2008-10#2)
To determine whether##16##3##(1990-5#1)(1993-11#1)(1993-6#1)(1995-3#1)(2008-10#5)(2008-11#2)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
To determine##93##2##(1990-5#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#3)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#30)(2008-11#7)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#8)(2013-8#4)
To develop a##2##3##(2008-10#1)(2008-11#1)
To develop##8##2##(1993-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2010-1#1)
To differentiate##3##2##(2008-10#3)
To discover##2##2##(2008-1#1)(2008-12#1)
To discuss##2##2##(2009-8#1)(2011-2#1)
To distinguish##2##2##(2008-4#1)(2010-11#1)
To do so##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
To do##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)
To ease##2##2##(1992-1#2)
To eliminate##4##2##(2008-10#3)(2011-2#1)
To elucidate the molecular mechanism##2##5##(2008-9#1)(2009-8#1)
To elucidate the molecular##3##4##(2008-10#1)(2008-9#1)(2009-8#1)
To elucidate the role of##3##5##(1990-2#1)(1991-5#1)(2013-7#1)
To elucidate the##14##3##(1990-2#1)(1991-5#1)(1992-6#1)(1993-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2013-7#1)
To elucidate##15##2##(1990-2#1)(1991-5#1)(1992-6#1)(1993-8#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2013-7#1)
To enable the##2##3##(1993-6#1)(1994-11#1)
To enable##5##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-12#1)(2010-10#1)
To enhance the##3##3##(2008-10#2)(2008-11#1)
To enhance##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
To ensure the##2##3##(2008-8#1)(2011-2#1)
To ensure##10##2##(1991-8#1)(1993-12#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
To establish a##4##3##(1997-2#1)(2008-1#1)(2008-10#1)(2011-3#1)
To establish##11##2##(1992-2#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-3#1)
To estimate the##2##3##(2008-11#1)(2012-12#1)
To estimate##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
To evaluate a##2##3##(2008-10#1)(2011-2#1)
To evaluate the effect of##4##5##(2008-1#1)(2008-10#2)(2008-9#1)
To evaluate the effectiveness of##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
To evaluate the effects of##2##5##(2008-10#1)(2012-3#1)
To evaluate the efficacy##3##4##(2008-10#3)
To evaluate the impact of##2##5##(1991-1#1)(2008-11#1)
To evaluate the possibility of##3##5##(1992-2#1)(1994-5#1)(2008-11#1)
To evaluate the prevalence of##3##5##(2007-8#1)(2012-2#1)(2013-1#1)
To evaluate the##47##3##(1991-1#1)(1992-2#1)(1993-8#1)(1994-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#1)
To evaluate##61##2##(1990-2#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#1)
To examine if##2##3##(2008-10#1)(2009-10#1)
To examine the consequences of##2##5##(1995-2#1)(2008-11#1)
To examine the expression of##2##5##(1993-8#1)(1995-2#1)
To examine the role of##2##5##(1995-2#1)(1997-7#1)
To examine the##24##3##(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-2#5)(1997-7#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
To examine this##2##3##(1993-1#1)(2008-11#1)
To examine whether or not the brain Epo protects the in vitro cultured neurons from glutamate-induced cell death##2##18##(2008-11#2)
To examine whether the##3##4##(2008-11#1)(2008-6#2)
To examine whether##10##3##(1993-8#1)(1994-8#1)(1997-6#1)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#1)
To examine##49##2##(1991-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-2#5)(1996-9#1)(1997-6#1)(1997-7#2)(2008-10#5)(2008-11#9)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)
To exclude the influence of##2##5##(2008-10#2)
To explain the##2##3##(1995-3#1)(2008-8#1)
To explain##4##2##(1995-3#1)(1997-3#1)(2008-8#1)(2012-2#1)
To explore the##8##3##(2008-10#1)(2008-9#2)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#2)
To explore this possibility##2##4##(2008-9#1)(2013-8#1)
To explore whether##2##3##(2008-10#1)(2008-11#1)
To explore##19##2##(2008-10#2)(2008-11#1)(2008-9#4)(2010-10#1)(2010-4#1)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#4)
To facilitate##7##2##(1996-3#1)(2008-10#4)(2009-10#1)(2013-1#1)
To find the relationship between the##2##6##(2013-8#2)
To find##4##2##(2010-7#1)(2011-3#1)(2013-8#2)
To follow the##3##3##(2008-10#3)
To fulfill this##2##3##(2008-10#2)
To further characterize the##5##4##(1996-12#1)(1997-7#1)(2008-10#3)
To further characterize##6##3##(1994-2#1)(1996-12#1)(1997-7#1)(2008-10#3)
To further elucidate##2##3##(2008-10#1)(2009-6#1)
To further explore##3##3##(1996-2#1)(2008-10#1)(2013-8#1)
To further investigate the##2##4##(2008-9#2)
To further investigate##4##3##(2008-10#1)(2008-9#2)(2010-3#1)
To further understand the##2##4##(2008-10#1)(2012-12#1)
To further understand##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
To further##28##2##(1992-3#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-9#1)(2008-10#8)(2008-11#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-3#2)(2012-12#1)(2013-8#2)
To gain a better understanding of##2##6##(1995-12#1)(2012-3#1)
To gain a better understanding##3##5##(1995-12#1)(2008-4#1)(2012-3#1)
To gain further insight into how##2##6##(2008-11#2)
To gain further insight into the##2##6##(1997-9#1)(2008-11#1)
To gain further insight into##4##5##(1997-9#1)(2008-11#3)
To gain insight into the mechanism by which##2##8##(1990-5#1)(2008-10#1)
To gain insight into the mechanism##3##6##(1990-5#1)(2008-10#2)
To gain insight into the##4##5##(1990-5#1)(2008-10#3)
To gain##15##2##(1990-5#1)(1993-6#1)(1995-12#2)(1997-9#1)(2008-10#3)(2008-11#3)(2008-4#1)(2010-10#1)(2010-12#1)(2012-3#1)
To generate##2##2##(1990-5#1)(2013-8#1)
To get more##2##3##(2008-10#1)(2008-5#1)
To get##5##2##(1994-1#1)(1995-2#1)(2008-10#2)(2008-5#1)
To give a##2##3##(1997-3#1)(2009-8#1)
To have##2##2##(1993-12#1)(2008-10#1)
To help##6##2##(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#2)(2013-8#1)
To identify the##7##3##(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-9#1)(2012-3#1)
To identify which##2##3##(1992-6#1)(2008-8#1)
To identify##26##2##(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#5)(2008-8#2)(2008-9#2)(2009-10#1)(2010-1#1)(2012-3#3)(2013-1#3)
To illuminate the function of EDRF1 in K562 cells##2##9##(2008-8#1)(2008-9#1)
To illuminate##3##2##(2008-6#1)(2008-8#1)(2008-9#1)
To illustrate the##2##3##(1995-2#1)(1997-3#1)
To illustrate this##2##3##(2008-10#2)
To illustrate##5##2##(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)
To impact##2##2##(1997-1#1)(2012-12#1)
To implement##3##2##(1993-1#1)(2011-2#1)(2013-1#1)
To improve the##10##3##(1996-11#1)(2008-10#7)(2008-11#1)(2010-7#1)
To improve##15##2##(1996-11#1)(1997-3#1)(2008-1#1)(2008-10#10)(2008-11#1)(2010-7#1)
To increase the##6##3##(2008-1#1)(2008-10#4)(2010-12#1)
To increase##8##2##(2008-1#1)(2008-10#5)(2010-12#1)(2013-1#1)
To induce##2##2##(2008-10#1)(2008-4#1)
To inform##2##2##(2009-5#1)(2010-8#1)
To insure##2##2##(1994-12#1)(2008-8#1)
To investigate further the##3##4##(1995-6#1)(1996-2#1)(2008-5#1)
To investigate the mechanism##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
To investigate the relationship between##2##5##(1993-8#1)(2008-9#1)
To investigate the relationship##3##4##(1990-8#1)(1993-8#1)(2008-9#1)
To investigate the role of##7##5##(1993-6#1)(1994-2#1)(1997-2#1)(2008-10#1)(2009-7#1)(2011-10#1)(2011-2#1)
To investigate the##35##3##(1990-8#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-11#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
To investigate this##4##3##(1997-7#1)(2008-5#2)(2013-8#1)
To investigate whether##6##3##(1990-5#1)(1995-6#1)(2008-11#1)(2008-8#2)(2013-8#1)
To investigate##60##2##(1990-5#1)(1990-8#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#2)(1997-8#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#4)(2008-9#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
To isolate the##2##3##(2008-10#1)(2008-8#1)
To isolate##7##2##(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
To know the##2##3##(2008-9#1)(2012-12#1)
To learn##2##2##(1991-1#1)(1997-3#1)
To make a distinction between##2##5##(2010-12#2)
To make a##4##3##(2008-10#1)(2009-11#1)(2010-12#2)
To make the##2##3##(2008-2#1)(2012-2#1)
To make##8##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-12#2)(2011-2#1)(2012-2#1)
To map##3##2##(1997-8#1)(2008-10#2)
To measure the##2##3##(2008-3#1)(2013-1#1)
To measure##7##2##(1996-2#1)(2008-10#1)(2008-3#1)(2009-9#1)(2013-1#2)(2013-8#1)
To meet the##2##3##(1994-12#1)(1996-12#1)
To minimize##2##2##(2008-9#1)(2012-12#1)
To mitigate the##2##3##(2008-3#1)(2011-2#1)
To molecularly##2##2##(1997-7#1)(2009-8#1)
To monitor##3##2##(1994-12#1)(1995-6#1)(2011-2#1)
To obtain more##2##3##(1996-11#1)(1997-8#1)
To obtain the##3##3##(1996-2#1)(2008-3#1)(2013-8#1)
To obtain##13##2##(1992-9#1)(1994-8#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-3#1)(2013-1#1)(2013-8#1)
To optimize##2##2##(2008-10#1)(2008-12#1)
To our knowledge this is the first##2##7##(2008-5#1)(2010-11#1)
To our knowledge this is the##3##6##(2008-5#1)(2010-11#1)(2013-1#1)
To our knowledge this##4##4##(2008-5#1)(2010-11#1)(2010-5#1)(2013-1#1)
To our knowledge##48##3##(1997-3#1)(1997-8#1)(2008-10#18)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2010-11#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#2)
To our##49##2##(1997-3#1)(1997-8#1)(2008-10#18)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2010-11#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#2)
To overcome the##3##3##(2008-6#1)(2009-12#1)(2012-3#1)
To overcome these##2##3##(1996-2#1)(2008-7#1)
To overcome this problem##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
To overcome this##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
To overcome##10##2##(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-3#1)
To perform a##2##3##(2012-3#1)(2013-1#1)
To perform##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
To pilot##2##2##(1994-3#2)
To predict##4##2##(1996-6#1)(1997-2#1)(2008-10#1)(2008-12#1)
To prevent##8##2##(1995-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
To produce##5##2##(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#1)
To promote##3##2##(1991-6#1)(2008-12#1)(2010-10#1)
To provide a##2##3##(2011-2#2)
To provide##7##2##(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-2#1)
To pursue##2##2##(1995-2#1)(2008-8#1)
To quantify the##2##3##(2008-10#1)(2012-3#1)
To reach these aims##2##4##(2010-8#1)(2012-2#1)
To reach##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
To realize##2##2##(1994-3#1)(2008-11#1)
To reduce the##3##3##(2008-10#2)(2008-9#1)
To reduce##8##2##(1993-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-12#1)(2011-1#1)
To remove##2##2##(2008-10#1)(2013-8#1)
To report a##3##3##(2009-1#1)(2012-3#1)(2013-1#1)
To report the##3##3##(2013-8#3)
To report##7##2##(1991-2#1)(2009-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
To retrospectively##2##2##(2011-1#1)(2012-2#1)
To reveal##2##2##(2008-6#1)(2013-1#1)
To review the##4##3##(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
To review##5##2##(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
To search for##2##3##(1997-2#1)(2008-10#1)
To show##3##2##(2008-10#1)(2008-5#2)
To simplify the##3##3##(1995-6#1)(1997-3#1)(2008-11#1)
To solve##3##2##(1992-9#1)(2008-5#1)(2013-8#1)
To study the effect of##5##5##(1996-3#1)(2008-10#3)(2008-9#1)
To study the effects of##2##5##(2008-10#1)(2011-3#1)
To study the function of##3##5##(1995-8#1)(2008-8#1)(2008-9#1)
To study the functions of##2##5##(1997-8#1)(2008-11#1)
To study the role of the##2##6##(1993-8#2)
To study the##30##3##(1991-6#1)(1991-9#1)(1993-8#2)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-12#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
To study this##3##3##(1997-7#1)(2009-12#1)(2013-1#1)
To study##36##2##(1991-6#1)(1991-9#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-12#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#3)
To supplement##2##2##(1997-4#1)(2013-1#1)
To support##3##2##(1993-3#1)(2008-11#1)(2008-12#1)
To take advantage of##2##4##(1991-5#1)(1993-12#1)
To take##3##2##(1991-5#1)(1993-12#1)(2008-11#1)
To test the hypothesis that##5##5##(1990-8#1)(1995-2#1)(2008-10#2)(2008-9#1)
To test the hypothesis##6##4##(1990-8#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-9#1)
To test the method##2##4##(2008-10#1)(2010-12#1)
To test the##17##3##(1990-8#1)(1993-6#1)(1994-8#1)(1995-2#1)(2008-10#8)(2008-3#1)(2008-8#2)(2008-9#1)(2010-12#1)
To test this hypothesis##5##4##(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-3#1)
To test this idea##2##4##(2008-7#1)(2011-1#1)
To test this##11##3##(1991-5#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#1)
To test whether##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
To test##36##2##(1990-8#1)(1991-5#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-12#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#2)(2012-7#1)
To the author's knowledge##2##4##(2008-10#1)(2008-2#1)
To the authors' knowledge##4##4##(2008-10#1)(2008-7#1)(2010-9#1)(2012-3#1)
To the best of our knowledge this is the##2##9##(2011-2#1)(2012-3#1)
To the best of our knowledge this##3##7##(2008-3#1)(2011-2#1)(2012-3#1)
To the best of our knowledge##12##6##(1994-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
To the best of##13##4##(1994-12#1)(2008-10#3)(2008-12#2)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
To the##23##2##(1994-12#1)(1995-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
To this end##21##3##(1993-11#1)(1996-2#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
To this purpose##2##3##(2008-10#2)
To this##25##2##(1992-2#1)(1993-11#1)(1996-2#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
To try to##2##3##(2008-10#1)(2011-2#1)
To understand how##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
To understand the function of##2##5##(1996-12#1)(2011-2#1)
To understand the mechanism of##2##5##(2008-10#1)(2008-11#1)
To understand the mechanisms##2##4##(2007-12#1)(2008-11#1)
To understand the##23##3##(1993-8#1)(1994-3#1)(1995-2#2)(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
To understand##35##2##(1991-3#1)(1993-8#1)(1994-3#1)(1995-2#2)(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-8#1)
To use##2##2##(2008-10#1)(2008-3#1)
To validate the##2##3##(2008-10#2)
To validate##6##2##(1992-9#1)(2008-10#3)(2008-3#1)(2009-10#1)
To verify##4##2##(1997-8#1)(2008-10#3)
To what extent##3##3##(1992-5#1)(2009-8#1)(2013-1#1)
To##1340##1##(1990-11#1)(1990-2#2)(1990-5#5)(1990-8#2)(1991-1#4)(1991-2#2)(1991-3#3)(1991-5#7)(1991-6#5)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#6)(1992-2#5)(1992-3#2)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#5)(1993-1#4)(1993-11#2)(1993-12#8)(1993-3#8)(1993-6#8)(1993-8#11)(1994-1#1)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#6)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#8)(1995-2#21)(1995-3#2)(1995-5#2)(1995-6#6)(1995-8#2)(1995-9#3)(1996-1#8)(1996-11#2)(1996-12#9)(1996-2#10)(1996-3#8)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#10)(1997-4#2)(1997-6#2)(1997-7#8)(1997-8#14)(1997-9#2)(2006-6#2)(2007-12#3)(2007-8#2)(2008-1#8)(2008-10#321)(2008-11#107)(2008-12#31)(2008-2#6)(2008-3#22)(2008-4#9)(2008-5#28)(2008-6#6)(2008-7#21)(2008-8#39)(2008-9#41)(2009-1#3)(2009-10#12)(2009-11#2)(2009-12#10)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#20)(2009-9#1)(2010-1#4)(2010-10#11)(2010-11#7)(2010-12#13)(2010-2#1)(2010-3#5)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#6)(2010-8#6)(2010-9#3)(2011-1#14)(2011-10#1)(2011-2#58)(2011-3#4)(2011-7#1)(2012-12#18)(2012-2#28)(2012-3#38)(2012-7#2)(2013-1#76)(2013-7#2)(2013-8#46)
ToCMoV##2##1##(2008-10#2)
ToCMoV-[BA-Se1] DNA-A##2##2##(2008-10#2)
ToCMoV-[BA-Se1]##3##1##(2008-10#3)
ToCV is##3##2##(2008-10#3)
ToCV##10##1##(2008-10#10)
ToLCBV##2##1##(2008-10#2)
ToLCGV-[Var] could##2##2##(2008-10#2)
ToLCGV-[Var] shares##3##2##(2008-10#3)
ToLCGV-[Var]##6##1##(2008-10#6)
ToLCJAV##3##1##(2008-10#3)
ToLCJV-Mld was##2##2##(2008-10#2)
ToLCNDV-Svr[Jes]##2##1##(2008-10#2)
ToLCNDV-[Lucknow]##2##1##(2008-10#2)
ToLCV is##3##2##(2008-10#3)
ToLCV##5##1##(2008-10#5)
ToLCVs##3##1##(2008-10#3)
ToM##4##1##(2008-12#4)
ToMoV##4##1##(2008-10#4)
Tobacco Plants##2##2##(2008-10#2)
Tobacco mosaic virus (TMV)##3##4##(2008-10#3)
Tobacco mosaic virus and##2##4##(2008-10#2)
Tobacco mosaic virus##7##3##(2008-10#7)
Tobacco plants##2##2##(2008-10#2)
Tobacco##33##1##(1996-1#1)(1997-1#1)(2008-10#25)(2008-8#2)(2008-9#1)(2009-6#1)(2011-1#2)
Tobamovirus##5##1##(2008-10#5)
Tobin##2##1##(1996-5#2)
Tocopherols are##2##2##(1992-9#1)(2008-5#1)
Tocopherols##3##1##(1992-9#2)(2008-5#1)
Today the##2##2##(1997-5#1)(2008-10#1)
Today there is##2##3##(2008-7#1)(2010-11#1)
Today this##2##2##(1997-6#1)(2009-6#1)
Today##29##1##(1991-2#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-7#1)(2011-2#2)(2011-4#1)(2012-12#2)(2012-2#1)(2013-8#1)
Today's##3##1##(1993-2#1)(2008-5#2)
Together our##2##2##(2008-11#1)(2010-3#1)
Together these results suggest that##2##5##(1990-2#1)(2008-8#1)
Together these studies##2##3##(1994-3#1)(2008-5#1)
Together these##4##2##(1990-2#1)(1994-3#1)(2008-5#1)(2008-8#1)
Together with the##5##3##(1993-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
Together with##11##2##(1991-6#1)(1992-6#1)(1993-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
Together##52##1##(1990-2#1)(1990-7#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#2)(1993-6#2)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)
Toiletry and Perfumery##2##3##(2008-5#2)
Tokyo Dental College##2##3##(2013-1#2)
Tokyo##5##1##(1994-12#1)(2008-2#1)(2008-6#1)(2013-1#2)
Tolerance limits for##3##3##(2008-10#3)
Tolerance of##7##2##(1993-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)
Tolerance to##2##2##(2008-10#2)
Tolerance was##2##2##(2008-10#2)
Tolerance##22##1##(1992-3#1)(1993-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2009-7#1)(2010-11#1)(2012-3#2)
Tolerant##2##1##(2008-10#2)
Toll-like receptor##2##2##(2008-10#1)(2012-3#1)
Toll-like##3##1##(2008-10#1)(2009-3#1)(2012-3#1)
Toluca##10##1##(2008-10#10)
Toluene##2##1##(2008-10#2)
Tom Yum herbs##2##3##(2011-2#2)
Tom##7##1##(1990-8#1)(1995-2#1)(2008-5#1)(2010-6#1)(2011-2#2)(2012-3#1)
Tom-6##3##1##(2008-10#3)
Tom40##5##1##(2012-2#5)
TomRSV##3##1##(2008-10#3)
Tomato Leaf##2##2##(2008-10#2)
Tomato Plants##2##2##(2008-10#2)
Tomato Race 3##2##3##(2008-10#2)
Tomato Resistance##2##2##(2008-10#2)
Tomato Spotted Wilt Tospovirus##2##4##(2008-10#2)
Tomato Spotted Wilt##4##3##(2008-10#4)
Tomato Yellow Leaf Curl Virus##2##5##(2008-10#2)
Tomato and Potato in the Del Fuerte Valley##2##8##(2008-10#2)
Tomato and Potato in##4##4##(2008-10#4)
Tomato and##5##2##(2008-10#5)
Tomato bushy stunt virus (TBSV)##3##5##(2008-10#3)
Tomato by##6##2##(2008-10#6)
Tomato chlorosis virus (ToCV)##2##4##(2008-10#2)
Tomato chlorosis virus##4##3##(2008-10#4)
Tomato chlorotic mottle virus##2##4##(2008-10#2)
Tomato in##4##2##(2008-10#4)
Tomato leaf curl Gujarat virus##3##5##(2008-10#3)
Tomato leaf curl Gujarat##4##4##(2008-10#4)
Tomato leaf curl Karnataka virus (ToLCKV)##2##6##(2008-10#2)
Tomato leaf curl Karnataka virus##3##5##(2008-10#3)
Tomato leaf curl New Delhi virus-Severe (ToLCNDV-Svr)##2##7##(2008-10#2)
Tomato leaf curl New Delhi virus-Severe##3##6##(2008-10#3)
Tomato leaf curl virus##2##4##(2008-10#2)
Tomato leaf curl##17##3##(2008-10#17)
Tomato leaf##19##2##(2008-10#19)
Tomato spotted wilt tospovirus (TSWV)##2##5##(2008-10#2)
Tomato spotted wilt virus (TSWV) and##3##6##(2008-10#3)
Tomato spotted wilt virus (TSWV)##14##5##(2008-10#14)
Tomato spotted wilt virus##26##4##(2008-10#26)
Tomato spotted wilt##29##3##(2008-10#29)
Tomato yellow leaf curl Sardinia virus (TYLCSV)##2##7##(2008-10#2)
Tomato yellow leaf curl Sardinia virus##4##6##(2008-10#4)
Tomato yellow leaf curl virus (TYLCV) and##2##7##(2008-10#2)
Tomato yellow leaf curl virus (TYLCV)##7##6##(2008-10#7)
Tomato yellow leaf curl virus##15##5##(2008-10#15)
Tomato yellow leaf curl##21##4##(2008-10#21)
Tomato##136##1##(2008-10#135)(2011-2#1)
Tomatoes##2##1##(2008-10#2)
Tomography##4##1##(2009-8#2)(2012-3#1)(2013-8#1)
Tomorrow's##2##1##(1991-1#1)(2012-2#1)
Tongan diabetes patients##2##3##(2008-1#2)
Tongan##4##1##(2008-1#4)
Tongans##5##1##(2008-1#5)
Too many##4##2##(2008-11#3)(2011-2#1)
Too often##2##2##(1993-12#1)(2008-11#1)
Too##8##1##(1993-12#1)(2008-11#4)(2008-8#1)(2009-6#1)(2011-2#1)
Tool for##3##2##(2008-10#2)(2008-11#1)
Tool##11##1##(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#3)(2009-4#1)(2013-1#1)(2013-8#1)
Toolbox##4##1##(2008-8#4)
Toolkit##3##1##(2008-3#2)(2009-12#1)
Tools to##2##2##(2008-10#2)
Tools##6##1##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
Top##6##1##(1990-12#1)(1991-2#2)(1997-8#1)(2008-10#1)(2011-2#1)
Topical sprays with##2##3##(2008-10#2)
Topical##14##1##(1993-8#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#1)
Topics include##2##2##(2008-4#1)(2009-6#1)
Topics##6##1##(2008-4#1)(2008-8#1)(2009-6#1)(2011-2#2)(2013-8#1)
Topo I##4##2##(1994-8#4)
Topo##7##1##(1994-8#7)
Topographic analysis of the##2##4##(2008-7#2)
Topography of##2##2##(1991-12#1)(2008-11#1)
Topography##3##1##(1991-12#1)(2008-11#2)
Topoisomerase I##3##2##(1990-7#2)(2008-11#1)
Topological##2##1##(1996-9#1)(2007-11#1)
Topper and Steptoe##2##3##(2008-10#2)
Tor Vergata##2##2##(2011-7#1)(2013-1#1)
Tor##6##1##(1992-5#2)(2011-7#1)(2012-3#2)(2013-1#1)
Torch##4##1##(2008-10#4)
Torenia fournieri##4##2##(2008-11#2)(2008-9#2)
Torenia##5##1##(2008-11#3)(2008-9#2)
Toronto Clearinghouse##4##2##(1996-3#4)
Toronto##29##1##(1991-1#1)(1991-12#1)(1991-2#4)(1992-3#2)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#5)(1996-3#6)(1997-3#2)(2008-10#1)(2008-11#2)(2011-2#1)
Torque##3##1##(1997-3#1)(2008-12#1)(2010-7#1)
Torr##2##1##(2008-3#2)
Torsion of##2##2##(2008-10#1)(2008-12#1)
Torsional##2##1##(2008-10#1)(2008-7#1)
Tosflex##2##1##(2008-10#2)
Tospovirus and##2##2##(2008-10#2)
Tospovirus##15##1##(2008-10#15)
Tospoviruses##2##1##(2008-10#2)
Total Knee Arthroplasty##3##3##(2013-1#3)
Total Synthesis of##3##3##(1996-5#2)(2008-8#1)
Total amount of##2##3##(2008-10#1)(2010-7#1)
Total and##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
Total anomalous pulmonary venous connection to##2##6##(2008-11#2)
Total arsenic##3##2##(2008-10#3)
Total bilirubin of##2##3##(2012-3#2)
Total cholesterol##2##2##(2008-10#1)(2009-7#1)
Total chromium was determined by##2##5##(2008-10#2)
Total chromium##4##2##(2008-10#4)
Total hip replacement is##2##4##(2009-4#1)(2010-10#1)
Total inorganic##2##2##(2008-10#2)
Total leaf##2##2##(2008-10#2)
Total mercury##2##2##(2008-10#2)
Total metal concentrations##2##3##(2008-10#2)
Total number of##2##3##(2008-11#1)(2011-2#1)
Total population size##2##3##(2008-10#2)
Total protein##2##2##(2008-10#1)(2013-1#1)
Total quality management in health care##2##6##(1994-12#1)(1994-2#1)
Total quality management##4##3##(1994-1#1)(1994-12#1)(1994-2#2)
Total removal of##3##3##(2008-7#3)
Total serum##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
Total##132##1##(1990-3#1)(1990-8#1)(1991-1#1)(1991-6#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#3)(1996-12#1)(1996-5#3)(2008-1#1)(2008-10#57)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-2#5)(2012-12#1)(2012-3#6)(2013-1#10)(2013-8#1)
Touch##2##1##(2008-10#1)(2012-2#1)
Toward a##5##2##(1991-1#1)(1996-2#1)(2008-8#1)(2011-2#1)(2012-3#1)
Toward an##3##2##(1993-2#1)(1997-3#1)(2011-2#1)
Toward this end##3##3##(1993-8#1)(1994-2#1)(2008-12#1)
Toward##27##1##(1991-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
Towards a##4##2##(1993-12#1)(2008-11#1)(2008-12#1)(2009-8#1)
Towards advanced chemical##2##3##(2008-10#2)
Towards the##2##2##(1994-11#1)(2010-5#1)
Towards##22##1##(1991-9#1)(1993-12#1)(1994-1#1)(1994-11#1)(2008-10#4)(2008-11#2)(2008-12#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
Tox(+)##4##1##(2008-10#4)
ToxA and##2##2##(2008-10#2)
ToxA##15##1##(2008-10#15)
ToxB##5##1##(2008-10#5)
Toxic##8##1##(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
Toxicity was##3##2##(1990-12#1)(1991-2#1)(2008-11#1)
Toxicity##13##1##(1990-12#1)(1990-2#1)(1991-2#1)(1991-6#1)(1992-2#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2010-7#1)
Toxicological##2##1##(2008-11#2)
Toxicology##10##1##(1995-11#1)(2008-10#4)(2008-9#2)(2009-8#1)(2011-2#2)
Toxin from##2##2##(2008-10#2)
Toxin##10##1##(2008-10#8)(2009-8#2)
Toxins##2##1##(2008-10#2)
Toxoplasma gondii antibodies##2##3##(2008-5#2)
Toxoplasma gondii##12##2##(1990-9#1)(1993-9#1)(1996-3#1)(2007-12#1)(2008-5#2)(2009-6#1)(2009-7#2)(2012-2#2)(2012-3#1)
Toxoplasmosis##2##1##(1995-9#1)(1996-3#1)
Toxoptera citricida##7##2##(2008-10#7)
Toyopearl##2##1##(2008-10#2)
Toyota Production System##5##3##(2012-2#5)
Toyota##7##1##(2012-2#5)(2013-8#2)
TrPs was##2##2##(2010-9#2)
TrPs were##2##2##(2010-9#2)
TrPs##10##1##(2010-9#10)
TraD##3##1##(1992-7#3)
Trace Elements in Serum##2##4##(2008-10#2)
Trace Elements in Urine##2##4##(2008-10#2)
Trace Elements in##7##3##(2008-10#7)
Trace Elements##8##2##(2008-10#8)
Trace amounts of##7##3##(2008-10#7)
Trace analysis of##4##3##(2008-10#4)
Trace concentrations of##2##3##(2008-11#1)(2008-3#1)
Trace element##2##2##(1993-2#1)(2008-10#1)
Trace enrichment of metal ions##2##5##(2008-10#2)
Trace enrichment##3##2##(2008-10#3)
Trace levels of##2##3##(2008-10#2)
Trace metal ions in##2##4##(2008-10#2)
Trace metal##3##2##(2008-10#3)
Trace metals##2##2##(2008-10#2)
Trace##46##1##(1993-2#1)(2008-10#40)(2008-11#1)(2008-3#3)(2009-8#1)
Tracer##2##1##(1994-3#1)(2012-2#1)
Tracheal and##2##2##(2010-7#2)
Tracheal##5##1##(1990-3#1)(2008-10#1)(2010-7#2)(2012-3#1)
Tracheostomy##4##1##(2008-6#2)(2012-2#2)
Tracing the##2##2##(2008-10#1)(2012-2#1)
Tracking##5##1##(1992-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-9#1)
Tract Infections##2##2##(2011-2#2)
Tract##5##1##(1992-2#1)(2011-2#3)(2013-8#1)
Trade##2##1##(2008-1#1)(2011-2#1)
Trade-offs##2##1##(2008-8#1)(2008-9#1)
Tradescantia zebrina leaves##2##3##(1994-11#2)
Traditional Chinese##3##2##(2008-10#3)
Traditional Uighur##3##2##(2009-5#3)
Traditional and##2##2##(1990-9#1)(2011-2#1)
Traditional methods of##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
Traditional##40##1##(1990-9#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-7#2)(2008-10#9)(2008-11#2)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#3)(2009-6#2)(2010-5#1)(2011-2#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
Traditionally##13##1##(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
Traffic##4##1##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
Trained##2##1##(1992-2#1)(2010-8#1)
Training Center##2##2##(2010-11#1)(2013-1#1)
Training Programs##2##2##(1992-1#1)(1992-12#1)
Training and##4##2##(1994-12#2)(2008-10#1)(2010-8#1)
Training for##2##2##(1996-8#1)(2012-2#1)
Training in##5##2##(1991-2#1)(1994-12#2)(2008-10#1)(2013-8#1)
Training##34##1##(1991-1#2)(1991-2#1)(1992-1#1)(1992-12#1)(1994-12#6)(1996-12#1)(1996-2#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-1#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
Traits##4##1##(2008-10#1)(2008-8#1)(2010-1#1)(2012-3#1)
Tramadol et de##3##3##(2013-1#3)
Tramadol et##5##2##(2013-1#5)
Tramadol##12##1##(2008-10#1)(2013-1#11)
Trametes versicolor##2##2##(2008-6#2)
Tranilast##3##1##(1995-11#2)(2008-5#1)
Trans-tamoxifen (1 muM)##2##3##(2008-11#2)
Trans-tympanic electric auditory brainstem response (TT-EABR)##2##6##(2008-9#2)
Transaction##3##1##(1994-12#2)(2012-12#1)
Transarterial##5##1##(1997-3#1)(1997-6#1)(2008-7#1)(2013-1#2)
Transbronchial##2##1##(2010-12#1)(2011-2#1)
Transcatheter closure of##2##3##(2008-11#2)
Transcatheter##3##1##(1997-8#1)(2008-11#2)
Transcervical##2##1##(2012-3#1)(2013-1#1)
Transcranial Magnetic Stimulation (rTMS)##2##4##(2008-12#1)(2011-2#1)
Transcranial magnetic stimulation (TMS)##2##4##(2010-7#2)
Transcranial magnetic stimulation##3##3##(2009-10#1)(2010-7#2)
Transcranial magnetic##4##2##(1996-6#1)(2009-10#1)(2010-7#2)
Transcranial##7##1##(1996-3#1)(1996-6#1)(2008-12#1)(2009-10#1)(2010-7#2)(2011-2#1)
Transcribed Spacer##7##2##(2008-10#6)(2012-2#1)
Transcribed##10##1##(2008-10#9)(2012-2#1)
Transcript levels##2##2##(2008-10#2)
Transcript##5##1##(1996-8#1)(2008-10#2)(2010-12#1)(2010-4#1)
Transcriptase##4##1##(2008-10#2)(2009-9#1)(2012-2#1)
Transcription factor##2##2##(1995-2#1)(2012-3#1)
Transcription in##2##2##(2008-11#1)(2012-3#1)
Transcription##12##1##(1994-3#2)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
Transcriptional activation##2##2##(1994-12#1)(2009-8#1)
Transcriptional regulation of##4##3##(1993-12#1)(1997-7#1)(2008-11#2)
Transcriptional##16##1##(1991-10#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-7#2)(2008-11#2)(2008-9#2)(2009-8#1)(2011-2#1)
Transcriptome analysis##2##2##(2010-6#1)(2011-2#1)
Transcriptome##6##1##(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
Transcripts of##3##2##(1993-2#1)(2008-10#2)
Transcripts##8##1##(1993-2#1)(2008-10#4)(2008-8#1)(2011-1#1)(2011-2#1)
Transcultural##2##1##(2008-11#2)
Transdermal##2##1##(2008-11#1)(2008-5#1)
Transepidermal##2##1##(2008-5#2)
Transfection of a##2##3##(2008-11#1)(2010-4#1)
Transfection of##9##2##(1993-12#1)(1993-8#1)(1997-1#1)(1997-2#1)(2008-11#3)(2008-9#1)(2010-4#1)
Transfection##13##1##(1992-6#1)(1993-12#1)(1993-8#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-11#5)(2008-9#1)(2010-4#1)
Transfer of##9##2##(1993-8#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2013-1#1)
Transfer##25##1##(1991-2#1)(1993-8#1)(1996-1#2)(1996-2#1)(1996-9#1)(1997-8#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#3)(2008-8#1)(2010-7#1)(2011-2#2)(2013-1#1)
Transferred##2##1##(1990-2#1)(2008-10#1)
Transferrin##5##1##(1993-11#3)(2008-11#2)
Transferring##2##1##(2008-11#1)(2008-12#1)
Transform##7##1##(2008-10#5)(2010-8#1)(2011-2#1)
Transformants of##3##2##(2008-10#3)
Transformants##9##1##(1991-9#1)(2008-10#7)(2011-2#1)
Transformation of##9##2##(1990-8#1)(1994-5#1)(1995-2#1)(1997-8#1)(2008-10#5)
Transformation##13##1##(1990-8#1)(1994-5#1)(1995-2#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-7#1)
Transformed with the##2##3##(2008-10#2)
Transformed##6##1##(1992-3#1)(1993-2#1)(1997-7#1)(2008-10#3)
Transformer##2##1##(2008-10#2)
Transforming growth factor beta##2##4##(1995-12#1)(1995-2#1)
Transforming growth factor##3##3##(1995-12#1)(1995-2#1)(1997-4#1)
Transforming growth##5##2##(1995-12#1)(1995-2#1)(1997-4#1)(2009-12#1)(2013-1#1)
Transforming##8##1##(1993-8#1)(1995-12#2)(1995-2#1)(1997-1#1)(1997-4#1)(2009-12#1)(2013-1#1)
Transfusion##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
Transgene##2##1##(1994-3#1)(2008-10#1)
Transgenesis in##2##2##(2012-3#2)
Transgenesis##3##1##(2008-11#1)(2012-3#2)
Transgenic Arabidopsis##2##2##(2008-10#2)
Transgenic Mouse##2##2##(2010-7#1)(2012-12#1)
Transgenic Nicotiana occidentalis##2##3##(2008-10#2)
Transgenic Nicotiana##3##2##(2008-10#3)
Transgenic plants##3##2##(1995-6#1)(1997-8#1)(2008-10#1)
Transgenic rabbits##2##2##(2008-11#1)(2008-12#1)
Transgenic soybean##2##2##(2008-10#2)
Transgenic tobacco plants##2##3##(2008-10#1)(2009-8#1)
Transgenic##32##1##(1995-6#1)(1997-8#1)(2008-10#22)(2008-11#2)(2008-12#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-10#1)(2012-12#1)
Transglutaminase##2##1##(1994-11#1)(2008-10#1)
Transgressive segregation##2##2##(2008-10#2)
Transient abnormal myelopoeisis##2##3##(2008-12#2)
Transient expression of##2##3##(2008-8#2)
Transient expression##6##2##(1993-8#1)(1994-11#1)(1995-6#1)(2008-11#1)(2008-8#2)
Transient gene expression in##2##4##(2008-11#2)
Transient gene expression##3##3##(2008-11#3)
Transient left ventricular##2##3##(2010-5#2)
Transient signals##2##2##(2008-10#2)
Transient transfection assays##2##3##(1993-6#1)(1995-8#1)
Transient transfection##4##2##(1993-6#1)(1995-8#1)(2008-11#1)(2011-2#1)
Transient visual##2##2##(2008-7#1)(2010-3#1)
Transient##31##1##(1991-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-12#1)(2010-3#1)(2010-5#2)(2011-2#1)
Transition in##2##2##(1996-9#1)(2008-3#1)
Transition##12##1##(1992-11#1)(1993-12#1)(1996-3#1)(1996-9#2)(1997-3#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-11#1)(2012-3#1)
Transitional funding##2##2##(1993-1#2)
Transitional##4##1##(1993-1#2)(2008-10#1)(2012-3#1)
Transitions##2##1##(2008-11#1)(2008-3#1)
Translating##2##1##(1996-3#1)(2009-11#1)
Translation##2##1##(2008-10#1)(2012-3#1)
Translational##3##1##(2010-10#1)(2010-5#1)(2011-2#1)
Translocation of the##2##3##(1995-2#1)(1997-7#1)
Translocation of##9##2##(1990-5#1)(1992-12#1)(1995-2#2)(1997-7#1)(2008-10#3)(2008-8#1)
Translocation##12##1##(1990-5#1)(1991-10#1)(1992-12#1)(1995-2#2)(1997-7#1)(2008-10#5)(2008-8#1)
Translocator Protein (TSPO) in##3##4##(2012-2#3)
Translocator Protein (TSPO)##9##3##(2012-2#9)
Translocator Protein##11##2##(2012-2#11)
Translocator##12##1##(2012-2#12)
Transmissible##3##1##(1997-5#1)(2008-10#1)(2008-11#1)
Transmission by##2##2##(2008-10#2)
Transmission electron microscopy was used to##3##6##(2007-12#1)(2008-10#1)(2008-5#1)
Transmission electron microscopy##10##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)
Transmission electron##12##2##(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#3)(2011-2#1)
Transmission from##2##2##(2008-10#1)(2013-1#1)
Transmission of##14##2##(1997-7#1)(2007-12#2)(2008-10#7)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Transmission to##2##2##(2008-10#2)
Transmission##52##1##(1997-7#1)(2007-12#4)(2008-10#31)(2008-11#1)(2008-3#2)(2008-5#2)(2008-9#3)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
Transmitted by##3##2##(2008-10#2)(2010-1#1)
Transmitted##7##1##(2008-10#2)(2008-3#1)(2010-1#1)(2011-2#2)(2013-1#1)
Transparent##2##1##(2008-10#2)
Transparent-scaled variant##2##2##(2008-5#2)
Transplant##7##1##(1991-2#1)(1994-3#1)(2008-9#1)(2010-12#2)(2012-2#1)(2013-1#1)
Transplantation in##2##2##(2012-12#1)(2012-3#1)
Transplantation of##6##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)
Transplantation##13##1##(1992-12#1)(1995-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)
Transplanted##2##1##(2008-7#1)(2008-8#1)
Transplants##2##1##(2008-9#1)(2013-1#1)
Transport of glutathione##2##3##(1990-2#2)
Transport of##14##2##(1990-2#3)(1990-9#1)(1993-8#1)(2008-10#6)(2009-10#1)(2011-2#1)(2012-2#1)
Transport##24##1##(1990-2#3)(1990-9#1)(1991-3#1)(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#9)(2008-11#1)(2009-10#2)(2010-4#1)(2011-2#2)(2012-2#1)
Transportation##3##1##(1995-6#1)(2013-1#2)
Transporter##2##1##(2008-11#1)(2011-2#1)
Transporting patients(3##2##2##(1991-2#2)
Transradial interventions##2##2##(2011-2#2)
Transradial percutaneous coronary interventions##2##4##(2011-2#2)
Transradial procedure failures can sometimes be due to##2##8##(2011-2#2)
Transradial##12##1##(2011-2#12)
Transrectal##3##1##(2011-2#2)(2013-1#1)
Transtheoretical##3##1##(2008-12#1)(2008-4#1)(2013-1#1)
Transthoracic##3##1##(2011-2#2)(2011-6#1)
Transvaginal##3##1##(1994-3#1)(1995-3#1)(1996-1#1)
Transverse myelitis##2##2##(2012-3#2)
Transverse##10##1##(1995-6#2)(1997-8#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-3#2)
Transversely##2##1##(2008-10#2)
Trap plants##2##2##(2008-10#2)
Trap##6##1##(2008-10#2)(2012-12#1)(2013-8#3)
Trastuzumab##3##1##(2012-12#1)(2012-3#1)(2013-1#1)
Trauma##13##1##(1990-3#1)(1990-9#1)(1992-1#1)(2008-12#3)(2009-4#2)(2010-1#1)(2011-2#3)(2013-8#1)
Traumatic Brain Injury##2##3##(2008-10#1)(2010-2#1)
Traumatic lumbar##2##2##(2008-12#2)
Traumatic##16##1##(2008-10#1)(2008-12#3)(2008-7#2)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Traumatology of##2##2##(2007-8#1)(2008-12#1)
Traumatology##6##1##(2007-8#1)(2008-12#1)(2009-4#1)(2012-12#1)(2013-1#2)
Treadmill##2##1##(2008-7#1)(2012-3#1)
Treat##2##1##(2008-11#1)(2012-3#1)
Treated by##2##2##(1995-11#1)(1997-6#1)
Treated mice##2##2##(1995-11#1)(2010-7#1)
Treated with##7##2##(1994-12#1)(1996-6#1)(2008-10#1)(2008-8#2)(2010-6#2)
Treated##14##1##(1994-12#1)(1995-11#2)(1996-3#1)(1996-6#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-8#2)(2010-6#2)(2010-7#1)
Treating##11##1##(1995-8#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-12#1)(2010-12#1)(2010-6#1)(2013-8#2)
Treatment and##6##2##(1990-9#1)(2008-10#1)(2008-3#1)(2009-9#1)(2011-2#2)
Treatment based on##2##3##(2008-11#1)(2011-3#1)
Treatment consisted of##5##3##(1990-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
Treatment for##4##2##(1992-5#1)(2008-6#1)(2012-3#2)
Treatment has##2##2##(1996-11#1)(2012-3#1)
Treatment in##2##2##(2008-11#1)(2012-3#1)
Treatment is##3##2##(1996-6#1)(2010-5#1)(2013-8#1)
Treatment of a##3##3##(1997-3#1)(1997-6#1)(2013-8#1)
Treatment of an##2##3##(1997-5#1)(2008-7#1)
Treatment of cells with##2##4##(2008-11#1)(2008-9#1)
Treatment of the##5##3##(1992-1#2)(1996-5#1)(1997-1#1)(2012-3#1)
Treatment of these##2##3##(1992-7#1)(1995-6#1)
Treatment of##89##2##(1990-2#1)(1990-6#1)(1992-1#2)(1992-7#2)(1992-8#1)(1993-11#1)(1995-11#1)(1995-2#1)(1995-6#3)(1996-5#5)(1997-1#2)(1997-3#2)(1997-5#2)(1997-6#1)(2008-10#14)(2008-11#4)(2008-12#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-10#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
Treatment options##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
Treatment planning##2##2##(2008-11#1)(2013-1#1)
Treatment was##10##2##(1992-12#1)(1994-8#1)(1996-3#1)(1997-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
Treatment with CoQ10##2##3##(2013-1#2)
Treatment with the##4##3##(1994-2#1)(2008-10#2)(2013-1#1)
Treatment with##49##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1996-6#1)(1997-4#1)(2008-10#13)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
Treatment##243##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#3)(1996-11#1)(1996-3#1)(1996-5#5)(1996-6#2)(1997-1#2)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2008-10#37)(2008-11#10)(2008-12#8)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#2)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#2)(2010-6#4)(2010-8#2)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#20)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#20)(2013-1#15)(2013-7#1)(2013-8#3)
Treatments included##3##2##(2008-10#3)
Treatments of##2##2##(1993-3#1)(2008-10#1)
Treatments that##2##2##(2008-10#1)(2008-5#1)
Treatments##11##1##(1993-3#1)(1995-11#1)(2008-10#6)(2008-12#1)(2008-5#2)
Tree##5##1##(1992-2#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)
TreeView##4##1##(2008-9#4)
Trees infected with##2##3##(2008-10#2)
Trees of##2##2##(2008-10#2)
Trees were##2##2##(2008-10#2)
Trees##18##1##(2008-10#16)(2009-10#1)(2010-8#1)
Treg quantification##2##2##(2013-8#2)
Treg subsets##3##2##(2013-8#3)
Treg##12##1##(2013-8#12)
Tregs##3##1##(2013-8#3)
Trend##2##1##(1991-2#1)(2012-3#1)
Trends Surveys##2##2##(1991-1#1)(1996-1#1)
Trends and##3##2##(1991-3#1)(1993-12#1)(2008-11#1)
Trends in radiology##2##3##(1991-1#1)(1996-1#1)
Trends in the##4##3##(1997-4#1)(2009-12#1)(2009-4#1)(2009-7#1)
Trends in##21##2##(1991-1#1)(1991-12#1)(1991-6#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-4#1)(2008-10#4)(2008-5#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
Trends##34##1##(1990-11#1)(1991-1#3)(1991-12#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1996-1#2)(1996-3#2)(1997-4#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#2)(2012-3#1)(2013-1#1)
Treponema##4##1##(1997-5#1)(2010-11#1)(2013-8#2)
Triage##2##1##(2009-4#1)(2013-1#1)
Trial in##2##2##(2009-10#1)(2010-12#1)
Trial##17##1##(1992-3#1)(1992-9#1)(1994-6#1)(1995-9#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#2)(2010-4#1)(2010-9#1)(2012-3#1)(2013-1#2)
Trialeurodes vaporariorum##2##2##(2008-10#2)
Trialists'##3##1##(1993-11#1)(1993-12#2)
Trials of##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
Trials##12##1##(2008-10#2)(2008-5#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-8#2)
Triangular##2##1##(2008-3#1)(2011-2#1)
Triassic##3##1##(1990-8#3)
Tribes##2##1##(1997-1#1)(2008-10#1)
Tribolium castaneum##4##2##(2008-12#2)(2008-9#1)(2012-2#1)
Trichinella infection##2##2##(1996-12#2)
Trichinella##5##1##(1990-12#2)(1996-12#3)
Trichloroethylene (TCE) is a##2##4##(2008-10#2)
Trichloroethylene##5##1##(2008-10#4)(2010-4#1)
Trichoderma and##3##2##(2008-10#3)
Trichoderma atroviride P1##2##3##(2008-10#2)
Trichoderma atroviride##4##2##(2008-10#4)
Trichoderma conidia##2##2##(2008-10#2)
Trichoderma hamatum 382 (T(382))##2##4##(2008-10#2)
Trichoderma hamatum 382##4##3##(2008-10#4)
Trichoderma hamatum strain##2##3##(2008-10#1)(2013-8#1)
Trichoderma hamatum##7##2##(2008-10#5)(2013-8#2)
Trichoderma harzianum (atroviride) P1##2##4##(2008-10#2)
Trichoderma harzianum Strain##2##3##(2008-10#2)
Trichoderma harzianum and##2##3##(2008-10#1)(2008-5#1)
Trichoderma harzianum in##2##3##(2008-10#2)
Trichoderma harzianum strain##3##3##(2008-10#3)
Trichoderma harzianum##21##2##(2008-10#20)(2008-5#1)
Trichoderma have been##2##3##(2008-10#2)
Trichoderma koningii##3##2##(2008-10#2)(2008-5#1)
Trichoderma reesei##6##2##(1993-8#2)(2008-10#1)(2008-9#2)(2011-2#1)
Trichoderma sp##6##2##(2008-10#5)(2008-5#1)
Trichoderma species##4##2##(2008-10#4)
Trichoderma spp##18##2##(2008-10#18)
Trichoderma strains##3##2##(2008-10#3)
Trichoderma stromaticum##2##2##(2008-10#2)
Trichoderma virens to##2##3##(2008-10#2)
Trichoderma virens##5##2##(2008-10#5)
Trichoderma viride##2##2##(2008-10#2)
Trichoderma##115##1##(1993-8#2)(2008-10#104)(2008-5#3)(2008-9#2)(2011-2#1)(2013-8#3)
Trichodiene##2##1##(2008-10#1)(2008-11#1)
Trichomonas##3##1##(1996-8#1)(2008-8#1)(2012-2#1)
Trichophyton mentagrophytes##6##2##(2008-5#5)(2012-3#1)
Trichophyton rubrum##6##2##(2008-5#6)
Trichophyton spp##4##2##(2011-2#4)
Trichophyton tonsurans##5##2##(2008-5#4)(2012-3#1)
Trichophyton##24##1##(2008-5#17)(2011-2#5)(2012-3#2)
Trichoplusia ni BTI-Tn-5B1-4##3##3##(2008-7#3)
Trichoplusia ni larvae##2##3##(1995-12#2)
Trichoplusia ni##11##2##(1990-8#1)(1995-12#2)(2008-11#4)(2008-7#4)
Trichoplusia##12##1##(1990-8#1)(1995-12#2)(2008-11#4)(2008-7#5)
Trichosporon cutaneum##2##2##(2008-10#1)(2008-5#1)
Trichosporon pullulans##2##2##(2008-10#2)
Trichosporon##4##1##(2008-10#3)(2008-5#1)
Trichostrongylus##5##1##(1996-12#5)
Trichovirus##5##1##(2008-10#5)
Trichuris##3##1##(1996-12#1)(2012-2#1)(2012-3#1)
Tricyclic##4##1##(1996-5#2)(2008-11#1)(2010-1#1)
Tridacna##3##1##(2008-5#3)
Trieste##2##1##(2008-10#2)
Trifluoroacetic acid was##2##3##(1997-2#1)(2008-10#1)
Trifolium (clover) species##2##3##(2011-2#2)
Trifolium polymorphum##2##2##(2011-2#2)
Trifolium##6##1##(2008-10#1)(2010-3#1)(2011-2#4)
Trigeminal##2##1##(1993-1#1)(2011-2#1)
Triggering##2##1##(1994-11#1)(2011-2#1)
Trimeresurus##3##1##(1993-3#1)(2008-6#2)
Trinidad and Tobago were##2##4##(2008-10#2)
Trinidad##5##1##(2008-10#4)(2008-8#1)
Triploid##2##1##(2008-5#1)(2010-5#1)
Tripterygium wilfordii##2##2##(2008-11#2)
Tris buffer##7##2##(1992-10#1)(2008-10#6)
Tris##15##1##(1992-10#2)(2008-10#13)
Tris(2##4##1##(2008-10#4)
Tris-HCl buffer at##2##3##(2008-10#2)
Tris-HCl buffer solution##2##3##(2008-10#2)
Tris-HCl buffer##6##2##(2008-10#6)
Tris-HCl##8##1##(1990-2#1)(2008-10#6)(2008-7#1)
Tris-boric acid##2##2##(2008-10#2)
Tris-buffer##2##1##(2008-10#2)
Tris/HCl##2##1##(2008-10#2)
Tristar)##3##1##(2008-10#3)
Tristeza##3##1##(2008-10#3)
Triterpenic derivatives##2##2##(2008-5#2)
Triticum isolate (pathogenic on wheat) of Magnaporthe##2##7##(2008-10#2)
Triticum isolate (pathogenic on wheat)##4##5##(2008-10#4)
Triticum isolate##5##2##(2008-10#5)
Triticum##6##1##(2008-10#6)
Triton X-100 and##7##3##(2008-10#7)
Triton X-100##28##2##(1994-3#1)(1997-8#1)(2008-10#23)(2008-7#1)(2008-8#1)(2012-2#1)
Triton X-114##4##2##(2008-10#4)
Triton X-I00##2##2##(2008-10#2)
Triton##38##1##(1994-3#1)(1997-8#1)(2008-10#33)(2008-7#1)(2008-8#1)(2012-2#1)
Triumph/I91-533-va##2##1##(2008-10#2)
Trolox C had no influence on##2##6##(2008-11#2)
Trolox C##8##2##(2008-11#8)
Trolox##15##1##(2008-10#6)(2008-11#9)
Tromsø University Hospital##2##3##(1991-9#2)
Tromsø##5##1##(1991-9#2)(1992-5#1)(1993-6#2)
Tropheryma##3##1##(1996-8#2)(2011-2#1)
Tropical Medicine##2##2##(2010-1#1)(2011-2#1)
Tropical##11##1##(2008-10#6)(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
Tropidurus semitaeniatus and##2##3##(2008-7#2)
Tropidurus##3##1##(2008-7#3)
Troponin I and cardiac enzymes##2##5##(2008-12#2)
Troponin I##7##2##(2008-12#6)(2011-2#1)
Trp residues of##2##3##(1990-5#1)(1994-5#1)
Trp residues##6##2##(1990-5#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#1)
Trp##15##1##(1990-5#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-5#3)(1995-11#1)(1995-2#2)(1995-3#1)(2008-10#3)(2008-11#1)
Trp-147##3##1##(2008-8#3)
Trp38##2##1##(1992-6#2)
Trp7##2##1##(1994-8#2)
True giant##2##2##(2008-12#1)(2013-1#1)
True##8##1##(1990-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
Trumpf##2##1##(2008-10#2)
Truncated##3##1##(1994-8#1)(1996-12#1)(2008-3#1)
Trust and##2##2##(2008-11#2)
Trust##12##1##(1994-12#1)(2008-11#9)(2008-7#1)(2013-8#1)
Trustees##2##1##(1992-2#1)(1993-5#1)
Trusts##5##1##(2008-11#5)
Truth##4##1##(1997-1#1)(2009-3#1)(2009-9#1)(2010-12#1)
Trx##4##1##(1991-6#2)(2009-3#2)
Trypan Blue dye##2##3##(2008-8#2)
Trypan Blue##3##2##(2008-11#1)(2008-8#2)
Trypan blue##2##2##(2008-11#2)
Trypan##5##1##(2008-11#3)(2008-8#2)
Trypanosoma brucei##6##2##(1993-9#2)(2009-7#3)(2011-2#1)
Trypanosomatidae##2##1##(2012-2#2)
Trypsin was##2##2##(1997-2#2)
Trypsin##6##1##(1997-2#2)(2008-10#1)(2008-11#1)(2008-8#2)
Ts##3##1##(2008-9#2)(2013-1#1)
Ts65Dn mice##4##2##(1997-2#4)
Ts65Dn mouse model of DS##2##5##(2012-2#2)
Ts65Dn mouse model of##3##4##(2012-2#3)
Ts65Dn mouse##4##2##(1997-2#1)(2012-2#3)
Ts65Dn##9##1##(1997-2#6)(2012-2#3)
Tsu-0##6##1##(2008-10#6)
Tsuda##2##1##(2008-11#2)
Tsukada##2##1##(2008-11#2)
Tsukuba and Chiba##3##3##(2008-10#3)
Tsukuba##6##1##(2008-10#6)
Tsx##5##1##(1990-11#5)
TtEST##2##1##(2011-1#2)
TuMV isolates with##2##3##(2008-10#2)
TuMV isolates##4##2##(2008-10#4)
TuMV##14##1##(2008-10#14)
Tube##4##1##(1991-12#1)(2008-10#2)(2012-2#1)
Tuber##2##1##(2008-10#2)
Tuberculosis (TB)##2##2##(2011-2#2)
Tuberculosis and##4##2##(2008-1#1)(2009-10#1)(2010-5#2)
Tuberculosis in##2##2##(1990-6#1)(1995-10#1)
Tuberculosis surveillance using a hidden markov model##2##7##(2013-1#2)
Tuberculosis##20##1##(1990-6#1)(1995-10#1)(1995-2#1)(1996-3#2)(1996-8#1)(2008-1#2)(2008-10#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#2)(2011-2#4)(2013-1#2)
Tuberculous##3##1##(2008-7#1)(2011-2#1)(2012-2#1)
Tubular##3##1##(1993-2#1)(2007-12#1)(2011-2#1)
Tubularized incised plate##2##3##(2008-10#2)
Tucson B1 and CVB1Nm strain##2##5##(2013-8#2)
Tucson##4##1##(1990-8#2)(2013-8#2)
Tukey's test (α=0##2##3##(2013-1#2)
Tukey's test##3##2##(2013-1#3)
Tukey's##5##1##(2008-10#1)(2009-3#1)(2013-1#3)
Tulasnein##2##1##(2008-11#2)
Tulipa##4##1##(2009-12#4)
Tumor Cells##2##2##(2008-11#1)(2013-8#1)
Tumor Growth##3##2##(2010-7#1)(2011-2#1)(2013-7#1)
Tumor Necrosis Factor-alpha##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
Tumor Necrosis##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
Tumor burden##2##2##(1992-2#2)
Tumor cell##3##2##(1995-2#1)(2008-5#1)(2009-10#1)
Tumor cells##3##2##(1992-2#1)(2010-12#1)(2011-2#1)
Tumor lysis syndrome (TLS)##2##4##(2008-7#2)
Tumor lysis syndrome##3##3##(2008-7#3)
Tumor markers##3##2##(1994-2#1)(1997-7#1)(2008-10#1)
Tumor necrosis factor (TNF)##2##4##(2008-9#1)(2011-2#1)
Tumor necrosis factor alpha##2##4##(1995-2#2)
Tumor necrosis factor##7##3##(1995-12#1)(1995-2#2)(2008-9#1)(2011-2#2)(2013-1#1)
Tumor necrosis##9##2##(1995-12#2)(1995-2#2)(2008-9#1)(2009-3#1)(2011-2#2)(2013-1#1)
Tumor##64##1##(1990-6#1)(1992-1#1)(1992-2#3)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#3)(1997-7#1)(2008-10#3)(2008-11#3)(2008-5#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#9)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
Tumor-associated##3##1##(1994-12#1)(2009-9#1)(2011-2#1)
Tumors##11##1##(1992-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#1)
Tumour##4##1##(2010-12#1)(2011-2#3)
Tumours##3##1##(1991-9#1)(1997-3#1)(2008-11#1)
Tunable##12##1##(1996-5#1)(2007-12#3)(2008-12#1)(2008-2#2)(2008-3#5)
Tuning##4##1##(2008-2#1)(2008-3#1)(2013-8#2)
Tunisia##7##1##(1992-5#1)(2007-8#2)(2008-10#1)(2009-1#1)(2009-5#1)(2013-8#1)
Tunisian##6##1##(2008-10#1)(2008-12#1)(2008-5#1)(2009-1#2)(2009-5#1)
Tunneling##4##1##(1990-11#1)(1996-9#3)
Turbidity##2##1##(2008-10#2)
Turbuhaler##4##1##(1992-3#3)(1996-2#1)
Turin##2##1##(2008-7#1)(2011-3#1)
Turkey by##2##2##(2008-10#2)
Turkey##27##1##(1995-12#1)(1997-5#3)(1997-8#2)(2008-10#10)(2008-11#1)(2008-12#1)(2009-8#2)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-8#2)
Turkey)##2##1##(2008-10#1)(2013-8#1)
Turkish adolescents##2##2##(2011-1#2)
Turkish boys##4##2##(2008-10#1)(2011-1#3)
Turkish men##2##2##(2010-10#2)
Turkish newborns##2##2##(2011-1#2)
Turkish patients with##2##3##(2009-12#1)(2011-2#1)
Turkish woman##2##2##(1997-5#2)
Turkish##33##1##(1995-12#1)(1996-11#2)(1997-5#3)(2008-10#1)(2008-7#1)(2009-12#2)(2010-10#2)(2010-11#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#11)(2011-10#1)(2011-2#3)(2013-8#1)
Turner syndrome##3##2##(2008-7#1)(2013-1#2)
Turner##4##1##(2008-7#1)(2009-10#1)(2013-1#2)
Turning##4##1##(1990-8#1)(1997-2#1)(1997-6#1)(2009-11#1)
Turnip mosaic virus (TuMV)##2##4##(2008-10#2)
Turnip mosaic virus##4##3##(2008-10#4)
Turnip yellow mosaic virus##2##4##(2008-10#2)
Turnip##6##1##(2008-10#6)
Turnover##4##1##(1992-1#1)(2007-12#1)(2008-8#1)(2011-2#1)
Tuscany##3##1##(2008-10#1)(2008-12#2)
Tutorial##9##1##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-3#1)
Tutotest##6##1##(2008-10#6)
Tutotest-C##2##1##(2008-10#2)
Tween 80##10##2##(2008-10#9)(2013-1#1)
Tween##11##1##(2008-10#10)(2013-1#1)
Tween-40##2##1##(2008-10#2)
Twelve healthy##2##2##(2013-1#1)(2013-8#1)
Twelve isolates of##2##3##(2008-10#2)
Twelve months after##2##3##(2008-11#1)(2012-12#1)
Twelve months##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
Twelve of the##3##3##(1992-6#1)(1997-3#1)(2008-10#1)
Twelve of##6##2##(1992-6#1)(1997-3#1)(2008-10#3)(2011-2#1)
Twelve patients##4##2##(1992-12#1)(1997-7#1)(2008-10#1)(2008-7#1)
Twelve##40##1##(1992-12#1)(1992-6#1)(1995-11#1)(1996-3#1)(1997-3#2)(1997-7#1)(2008-10#12)(2008-11#4)(2008-7#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#5)(2013-8#2)
Twenty children##2##2##(2008-9#1)(2010-9#1)
Twenty eight##2##2##(2008-12#1)(2013-1#1)
Twenty five##3##2##(1991-8#1)(1996-12#1)(2011-1#1)
Twenty patients with##2##3##(1992-12#1)(2013-1#1)
Twenty patients##6##2##(1992-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
Twenty percent of##2##3##(1995-3#1)(2008-10#1)
Twenty percent##3##2##(1995-3#1)(2008-10#2)
Twenty rats were##2##3##(1993-3#1)(2008-12#1)
Twenty two##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
Twenty##40##1##(1991-8#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-5#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
Twenty-eight patients##2##2##(2008-7#1)(2011-2#1)
Twenty-eight##8##1##(1995-1#1)(2008-12#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
Twenty-five##11##1##(1990-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
Twenty-four hours##3##2##(1991-11#1)(2008-6#1)(2010-8#1)
Twenty-four patients##2##2##(2008-10#1)(2009-11#1)
Twenty-four percent##3##2##(1991-12#1)(1994-2#1)(2010-7#1)
Twenty-four##15##1##(1991-11#1)(1991-12#1)(1993-12#1)(1994-2#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-7#1)(2010-8#1)(2012-3#1)
Twenty-nine##4##1##(1992-12#1)(1994-12#1)(2008-10#1)(2013-1#1)
Twenty-one patients##3##2##(2008-7#2)(2008-9#1)
Twenty-one##11##1##(1994-3#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#2)(2010-8#1)(2012-2#1)(2013-8#1)
Twenty-seven patients##5##2##(1990-2#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-12#1)
Twenty-seven##11##1##(1990-2#1)(1993-12#1)(1993-2#2)(1993-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-7#1)
Twenty-six##9##1##(1991-12#1)(2008-10#4)(2008-7#1)(2011-1#1)(2011-2#2)
Twenty-three patients##2##2##(1990-6#1)(1991-3#1)
Twenty-three##9##1##(1990-12#1)(1990-6#1)(1991-3#1)(1993-11#1)(1995-6#1)(2008-10#2)(2008-5#1)(2010-10#1)
Twenty-two patients##4##2##(1990-3#1)(1992-9#1)(2008-7#1)(2011-2#1)
Twenty-two##13##1##(1990-3#1)(1992-2#1)(1992-9#1)(1995-12#1)(1996-8#1)(2008-10#2)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#2)
Twig##2##1##(2008-10#2)
Twin 2##2##2##(2010-1#2)
Twin Cities##2##2##(1991-9#1)(2011-2#1)
Twin##7##1##(1991-9#1)(2010-1#3)(2010-8#1)(2011-2#1)(2013-1#1)
Two Cultivars of##2##3##(2008-10#2)
Two QTL##2##2##(2008-10#2)
Two QTLs##2##2##(2008-10#1)(2008-9#1)
Two Races of##2##3##(2008-10#2)
Two additional##4##2##(2010-10#1)(2010-12#1)(2012-3#2)
Two alternative##2##2##(1996-1#1)(2008-4#1)
Two biological##2##2##(2008-10#2)
Two case reports##2##3##(1990-9#1)(2012-3#1)
Two case##4##2##(1990-9#1)(2008-10#1)(2009-10#1)(2012-3#1)
Two cases of##11##3##(1990-5#1)(1991-3#2)(1992-2#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#2)
Two cell##2##2##(2008-11#1)(2008-7#1)
Two clinical##3##2##(1993-3#1)(1993-6#1)(2010-11#1)
Two clones##3##2##(2008-10#1)(2008-11#2)
Two consecutive##2##2##(2008-10#1)(2009-5#1)
Two days after##4##3##(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
Two days##5##2##(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
Two different approaches##2##3##(1991-6#1)(2008-10#1)
Two different methods##2##3##(2008-4#1)(2008-8#1)
Two different programs were##2##4##(2008-10#1)(2008-9#1)
Two different types of##2##4##(1996-2#1)(2009-2#1)
Two different##40##2##(1991-6#1)(1994-3#1)(1996-2#2)(1997-2#2)(2008-10#21)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#2)(2010-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
Two distinct##7##2##(1990-5#1)(1991-10#1)(1994-2#1)(1995-6#1)(2008-10#2)(2008-5#1)
Two enzyme##2##2##(1993-2#1)(2008-10#1)
Two experimental##2##2##(2008-10#1)(2008-4#1)
Two faces##2##2##(2008-11#1)(2010-11#1)
Two field##3##2##(2008-10#3)
Two flanking##2##2##(2008-10#2)
Two fluorescent##2##2##(1997-2#1)(2008-11#1)
Two forms of##2##3##(2008-10#1)(2010-5#1)
Two further##2##2##(2008-10#1)(2012-3#1)
Two genes##2##2##(1996-6#1)(2008-10#1)
Two genetically distinct##2##3##(2008-10#2)
Two groups of rats##2##4##(1990-5#1)(1996-12#1)
Two groups of##7##3##(1990-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
Two groups##9##2##(1990-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
Two highly##2##2##(2008-10#1)(2008-8#1)
Two histologically##2##2##(2008-10#1)(2012-3#1)
Two human##2##2##(1990-8#1)(2008-11#1)
Two hundred and##8##3##(1993-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)(2013-8#1)
Two hundred##16##2##(1992-2#1)(1993-12#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
Two identical##2##2##(2008-10#1)(2008-5#1)
Two important##6##2##(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#2)
Two independent reviewers assessed the strength of evidence using the GRADE criteria and disagreements were resolved by consensus##3##18##(2012-12#3)
Two independent##6##2##(2008-10#2)(2008-2#1)(2012-12#3)
Two isoforms of##2##3##(1996-12#1)(2008-6#1)
Two isolates were##2##3##(2008-10#2)
Two isolates##5##2##(2008-10#4)(2011-2#1)
Two kinds of##5##3##(2008-10#4)(2008-11#1)
Two lines##2##2##(2008-10#1)(2008-8#1)
Two main##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)
Two major##6##2##(1990-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
Two members of##2##3##(2008-10#1)(2009-9#1)
Two methods for the##2##4##(1992-11#1)(2008-10#1)
Two methods for##5##3##(1992-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
Two methods of##5##3##(2008-10#2)(2008-7#1)(2012-3#2)
Two methods were used##2##4##(2008-10#1)(2008-5#1)
Two methods were##3##3##(2008-10#2)(2008-5#1)
Two methods##16##2##(1992-11#1)(1993-9#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
Two models for##2##3##(2008-10#1)(2009-8#1)
Two models of##2##3##(1991-2#1)(1996-12#1)
Two models##7##2##(1991-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2009-8#1)
Two months after surgery##2##4##(2013-1#1)(2013-8#1)
Two months after##4##3##(2008-12#1)(2008-8#1)(2013-1#1)(2013-8#1)
Two months later##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
Two months##7##2##(2008-12#1)(2008-4#1)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
Two new##7##2##(1993-9#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-8#1)
Two novel##8##2##(1994-11#1)(1995-6#1)(2008-10#4)(2008-11#1)(2012-3#1)
Two of the most##2##4##(1997-2#1)(2008-10#1)
Two of the patients##2##4##(1993-3#1)(2012-3#1)
Two of the##24##3##(1991-12#1)(1991-5#1)(1993-3#1)(1994-3#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-3#2)
Two of them##2##3##(1991-11#1)(1995-12#1)
Two of these##6##3##(1990-9#1)(1997-3#1)(2008-10#2)(2008-9#1)(2013-1#1)
Two of##34##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#2)(1993-3#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#2)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#1)
Two oligonucleotide primers##3##3##(2008-10#2)(2008-5#1)
Two other##6##2##(1993-8#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-5#1)
Two out of##2##3##(1990-6#1)(1992-9#1)
Two pairs##2##2##(2008-10#1)(2008-9#1)
Two patients had##2##3##(1993-1#1)(2012-3#1)
Two patients underwent##2##3##(1990-6#1)(2008-9#1)
Two patients were##4##3##(1993-3#1)(2008-7#2)(2011-2#1)
Two patients with##4##3##(1990-9#1)(1992-5#1)(1993-6#1)(2008-7#1)
Two patients##23##2##(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-6#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-7#3)(2008-9#1)(2011-2#2)(2012-3#2)
Two percent##2##2##(2008-10#1)(2011-2#1)
Two procedures##2##2##(2008-10#2)
Two programs##2##2##(2008-10#2)
Two protein##2##2##(2008-10#1)(2008-8#1)
Two proteins##5##2##(1992-3#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-12#1)
Two recent developments##2##3##(2008-8#1)(2010-12#1)
Two recent##4##2##(2008-11#2)(2008-8#1)(2010-12#1)
Two regions##2##2##(1991-12#1)(1996-2#1)
Two representative##3##2##(2008-3#1)(2008-9#1)(2012-7#1)
Two sample##3##2##(1996-12#1)(2008-10#2)
Two samples##3##2##(1991-12#1)(1994-11#1)(2008-10#1)
Two sequential injection##2##3##(2008-10#2)
Two series of##2##3##(2008-11#1)(2008-12#1)
Two sets of##5##3##(1993-8#1)(1997-7#1)(2008-10#3)
Two simple##3##2##(2008-10#3)
Two species of##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
Two species##6##2##(2007-12#1)(2008-10#4)(2008-7#1)
Two specific##3##2##(1996-3#2)(2008-10#1)
Two strains of##3##3##(2008-10#3)
Two strains##5##2##(2008-10#4)(2009-6#1)
Two studies examined musculoskeletal injuries##2##5##(2013-1#2)
Two studies##4##2##(2008-12#1)(2013-1#2)(2013-8#1)
Two thirds of the##2##4##(1996-6#1)(1997-6#1)
Two topological indices for the##2##5##(2008-10#2)
Two types of##19##3##(1990-12#1)(1990-6#1)(1991-12#1)(1993-3#1)(1993-6#1)(1997-2#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#1)
Two types##20##2##(1990-12#1)(1990-6#1)(1991-12#1)(1993-3#1)(1993-6#1)(1996-9#1)(1997-2#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#1)
Two unknown##2##2##(2008-10#2)
Two weeks after##5##3##(1997-3#1)(2008-1#1)(2008-7#1)(2009-3#1)(2009-6#1)
Two weeks##7##2##(1997-3#1)(2008-1#1)(2008-7#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-3#1)
Two years##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
Two##729##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#6)(1990-6#3)(1990-8#1)(1990-9#4)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#3)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#4)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#5)(1993-6#6)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#5)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#3)(1995-8#1)(1996-1#4)(1996-12#12)(1996-2#5)(1996-3#3)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#7)(1997-6#2)(1997-7#3)(1997-8#3)(1997-9#1)(2007-12#2)(2008-1#2)(2008-10#287)(2008-11#30)(2008-12#12)(2008-2#3)(2008-3#14)(2008-4#9)(2008-5#18)(2008-6#5)(2008-7#16)(2008-8#21)(2008-9#19)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#8)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#29)(2012-12#6)(2012-2#5)(2012-3#20)(2012-7#1)(2013-1#20)(2013-8#8)
Two-Dimensional##4##1##(1996-9#2)(2008-11#1)(2008-3#1)
Two-Level##2##1##(1996-9#1)(2012-3#1)
Two-Photon##2##1##(1996-5#1)(2008-3#1)
Two-Wave Coupling in a##2##4##(2008-3#2)
Two-dimensional gel electrophoresis##3##3##(2008-4#2)(2011-3#1)
Two-dimensional##12##1##(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#2)(2011-3#1)
Two-photon##2##1##(2008-10#1)(2010-1#1)
Two-stage##4##1##(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
Two-thirds of the##5##3##(1991-12#1)(1994-3#1)(1996-1#1)(1997-8#1)(2008-11#1)
Two-thirds##6##1##(1991-12#1)(1994-3#1)(1996-1#1)(1997-8#1)(2008-11#1)(2013-1#1)
Two-way text paging##2##3##(2010-8#2)
Two-way##3##1##(2010-8#2)(2012-3#1)
TxA(2)##7##1##(2006-6#7)
TxD##4##1##(2008-10#4)
Ty1##4##1##(1995-9#4)
Ty3##5##1##(1997-7#5)
Tylenchulus semipenetrans##2##2##(2008-10#2)
Tymovirus##4##1##(2008-10#4)
Type 1 diabetes mellitus##2##4##(2010-12#1)(2011-1#1)
Type 1 diabetes##13##3##(1994-12#2)(2008-9#1)(2010-10#5)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#1)
Type 1##17##2##(1994-12#2)(1997-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#6)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#1)
Type 2 Diabetes Mellitus##2##4##(1994-12#1)(2008-3#1)
Type 2 Diabetes##3##3##(1994-12#1)(2008-3#1)(2013-1#1)
Type 2 diabetes mellitus##2##4##(2010-10#1)(2013-1#1)
Type 2 diabetes##13##3##(1994-12#2)(2008-1#3)(2008-9#1)(2009-12#1)(2010-10#3)(2012-3#1)(2012-5#1)(2013-1#1)
Type 2 diabetic patients##2##4##(2008-1#1)(2010-10#1)
Type 2 diabetic##3##3##(1994-12#1)(2008-1#1)(2010-10#1)
Type 2##25##2##(1994-12#4)(1997-1#1)(2008-1#5)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#4)(2012-3#2)(2012-5#1)(2013-1#3)
Type C Niemann-Pick disease##2##4##(1990-8#2)
Type I collagen mRNA##2##4##(1991-5#1)(1994-12#1)
Type I error rate is##2##5##(2012-2#2)
Type I error rate##5##4##(2012-2#5)
Type I##14##2##(1991-5#1)(1994-12#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#5)
Type II tracheal agenesis##2##4##(2012-3#2)
Type II##9##2##(1995-2#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#2)
Type III##3##2##(1996-6#1)(1997-8#2)
Type of##5##2##(1991-3#1)(2008-10#3)(2010-12#1)
Type##91##1##(1990-8#2)(1991-3#1)(1991-5#1)(1992-3#1)(1994-12#7)(1994-8#1)(1995-12#1)(1995-2#1)(1996-6#3)(1997-1#4)(1997-8#6)(2008-1#5)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2010-10#10)(2010-12#2)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#3)
Type-2 diabetic patients##2##3##(2012-2#2)
Type-2##3##1##(2012-2#3)
Types and##2##2##(2008-10#2)
Types of##4##2##(1993-12#1)(1996-12#1)(2008-10#2)
Types##8##1##(1993-12#1)(1996-12#1)(2008-10#5)(2008-7#1)
Typhi##4##1##(2012-3#4)
Typhimurium##5##1##(2008-10#2)(2008-11#2)(2011-2#1)
Typhlichthys##2##1##(2012-3#2)
Typhula spp##3##2##(2008-10#3)
Typhula##7##1##(2008-10#7)
Typical##14##1##(2008-10#11)(2009-11#1)(2009-9#1)(2011-2#1)
Typically##12##1##(1992-1#1)(1993-12#1)(1994-11#1)(2008-10#3)(2008-12#2)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#1)
Tyr residues##2##2##(1994-5#1)(2008-10#1)
Tyr##15##1##(1991-3#2)(1991-5#1)(1994-5#4)(2008-10#8)
Tyr-##5##1##(1991-5#5)
Tyr-Gly##2##1##(1991-3#2)
Tyr-Gly-Gly##3##1##(1991-3#2)(2008-10#1)
Tyr1##3##1##(1992-3#2)(1993-3#1)
Tyr1150##2##1##(1995-6#2)
Tyr83##3##1##(1990-5#3)
Tyramine##3##1##(2008-10#2)(2008-7#1)
Tyrode solution##2##2##(2008-12#2)
Tyrol##2##1##(2008-10#2)
Tyrosinase was##2##2##(2008-10#2)
Tyrosinase##4##1##(2008-10#3)(2008-5#1)
Tyrosine##3##1##(2008-9#1)(2009-8#1)(2013-1#1)
Tübingen##2##1##(2012-3#2)
Tükrös)##2##1##(2008-10#2)
U about the results##2##4##(2008-10#2)
U and B in waters by##2##6##(2008-10#2)
U and Pu##2##3##(2008-10#2)
U and##9##2##(2008-10#9)
U cm(-2) for##2##3##(2008-10#2)
U ml(-1) of##2##3##(2008-10#2)
U ml(-1)##9##2##(2008-10#6)(2008-11#3)
U ml-1 of beads##2##4##(1997-2#2)
U ml-1 of##3##3##(1997-2#3)
U ml-1##4##2##(1996-2#1)(1997-2#3)
U to##3##2##(2009-12#2)(2010-10#1)
U##306##1##(1990-10#1)(1990-11#2)(1990-6#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-1#4)(1992-12#3)(1992-2#2)(1992-3#4)(1992-9#1)(1993-1#5)(1993-12#1)(1993-2#5)(1993-3#3)(1993-8#1)(1994-1#6)(1994-11#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-12#7)(1995-2#1)(1995-3#3)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#4)(1996-3#4)(1996-5#4)(1996-6#3)(1997-1#5)(1997-2#6)(1997-3#1)(1997-6#2)(1997-7#1)(2008-1#1)(2008-10#134)(2008-11#7)(2008-12#9)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#2)(2009-5#1)(2009-7#9)(2010-10#2)(2010-12#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-9#1)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#5)(2013-8#4)
U(VI) and Th(IV) from##3##4##(2008-10#3)
U(VI) and Th(IV)##7##3##(2008-10#7)
U(VI) from##4##2##(2008-10#4)
U(VI) was found to be##2##5##(2008-10#2)
U(VI) was##3##2##(2008-10#3)
U(VI)##35##1##(2008-10#35)
U)##2##1##(1990-6#1)(2008-10#1)
U-50##5##1##(1997-2#5)
U-G units##4##2##(1997-3#4)
U-G##5##1##(1997-3#5)
U-LDL##2##1##(1991-5#2)
U-box proteins from the##2##4##(2009-10#2)
U-box proteins were##2##3##(2009-10#2)
U-box proteins##7##2##(2009-10#7)
U-box##10##1##(2009-10#10)
U-shaped reaction norms##2##3##(2008-8#2)
U-shaped##8##1##(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)
U/L##5##1##(2007-12#2)(2008-6#1)(2011-2#2)
U/g of##3##2##(2008-5#2)(2008-6#1)
U/l of##2##2##(2008-5#2)
U/l##3##1##(1990-2#1)(2008-5#2)
U/mg##9##1##(1990-12#2)(1994-6#2)(1995-8#5)
U/ml (0%) in##2##3##(1993-1#2)
U/ml of SOD##2##3##(2008-10#2)
U/ml##13##1##(1993-1#6)(1994-8#4)(2008-10#3)
U/ml)##2##1##(1994-8#1)(2008-10#1)
U2 RNAs##4##2##(1993-8#4)
U2 small nuclear##2##3##(1993-8#2)
U2 snRNPs##3##2##(1993-8#3)
U2##12##1##(1993-6#1)(1993-8#10)(2013-8#1)
U3##2##1##(2008-9#2)
U41##2##1##(2008-11#2)
U5##2##1##(2008-9#1)(2013-8#1)
U6##3##1##(2008-9#3)
U6atac##7##1##(2013-8#7)
U937 cells##8##2##(1993-6#1)(1995-3#1)(2008-10#1)(2012-12#4)(2012-2#1)
U937##17##1##(1990-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-3#5)(1995-6#1)(2008-10#2)(2012-12#4)(2012-2#1)
UA and##2##2##(2008-10#2)
UA is##2##2##(1994-8#1)(2008-10#1)
UA##13##1##(1994-8#3)(2008-10#10)
UAE and SPME##2##3##(2008-10#2)
UAE##3##1##(2008-10#3)
UC 27##2##2##(2008-10#2)
UC and##2##2##(2008-9#1)(2009-12#1)
UC was##3##2##(2008-9#1)(2011-2#2)
UC##19##1##(2008-10#3)(2008-11#1)(2008-9#6)(2009-12#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#4)
UCB units were##2##3##(2011-2#2)
UCBI##3##1##(2008-10#3)
UCOE vectors##2##2##(2008-11#2)
UCP2 and age (p&lt##2##4##(2008-10#2)
UCP2 and##4##2##(2008-10#4)
UCP3p and##2##2##(2008-10#2)
UCS is not##2##3##(2008-11#1)(2011-2#1)
UCS##10##1##(2008-11#8)(2011-2#2)
UCSs##5##1##(2011-2#5)
UDMA and##2##2##(2013-1#2)
UDMA##6##1##(2013-1#6)
UDP-glucuronosyltransferase##7##1##(1995-9#1)(2008-11#6)
UDPGTh1 and UDPGTh2##2##3##(2008-11#2)
UDPGTh1##3##1##(2008-11#3)
UDPGTh2 encoded a 529 amino acid protein with an amino terminus membrane-insertion signal peptide and a carboxyl terminus membrane-spanning region##2##20##(2008-11#2)
UDPGTh2##12##1##(2008-11#12)
UDPGTm1##2##1##(2008-11#2)
UER##3##1##(2008-5#1)(2011-2#2)
UES##3##1##(2013-8#3)
UFH##3##1##(2008-10#3)
UFL-AG-286 cells##3##2##(2008-11#3)
UFL-AG-286##4##1##(2008-11#4)
UG reflex##5##2##(1994-2#5)
UG-FNAB##6##1##(2012-3#6)
UGA##4##1##(2008-10#1)(2012-2#3)
UGT2B17 genotype##6##2##(2013-8#6)
UGT2B17##10##1##(2013-8#10)
UHMWPE cable##4##2##(2009-3#4)
UI and##2##2##(1997-3#1)(2010-10#1)
UI##3##1##(1997-3#1)(2008-10#1)(2010-10#1)
UK DURG##2##2##(2008-11#2)
UK Drug Utilization Research##2##4##(2008-11#2)
UK and##10##2##(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2010-4#1)
UK have##2##2##(2008-11#1)(2008-12#1)
UK in##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
UK registered##2##2##(2008-11#2)
UK##94##1##(1990-6#1)(1991-3#1)(1995-3#1)(1996-1#3)(1996-3#1)(2008-10#9)(2008-11#33)(2008-12#11)(2008-5#5)(2008-9#2)(2009-4#3)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#2)
UK)##5##1##(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)
UKCC##7##1##(2008-11#7)
UKM lecturers##2##2##(2008-10#2)
UKM##6##1##(2008-10#4)(2013-1#2)
UKPCD##2##1##(2008-11#2)
UL-VWFM##2##1##(2009-7#2)
UL9 gene##3##2##(1994-11#3)
UL9##7##1##(1994-11#7)
UM methods##2##2##(1997-2#2)
UM##3##1##(1997-2#3)
UMP synthase##4##2##(1993-2#4)
UMP synthases of##2##3##(1993-2#2)
UMP##7##1##(1993-2#7)
UMPS##2##1##(1993-2#2)
UN##7##1##(1990-2#1)(1994-9#1)(1996-5#2)(2008-10#3)
UNICEF##5##1##(1990-2#1)(2008-11#2)(2010-3#2)
UNITS 16D##2##2##(2008-9#2)
UNOTM##2##1##(2008-11#2)
UO(2)(2+) ion##2##2##(2008-10#2)
UO(2)(2+)##13##1##(2008-10#13)
UO(2)(II)##3##1##(2008-10#3)
UOx layers##2##2##(2008-10#2)
UOx##6##1##(2008-10#6)
UPDRS##3##1##(2008-7#3)
UPDRS-III score##2##2##(2008-7#2)
UPDRS-III##4##1##(2008-7#3)(2013-8#1)
UPLC system##2##2##(2008-10#2)
UPLC##9##1##(2008-10#9)
UR cells##2##2##(2008-11#2)
UR##4##1##(2008-11#4)
URA2##2##1##(1996-6#2)
URC##2##1##(1990-3#2)
URD##3##1##(2013-8#3)
US Dietary Guidelines##2##3##(2010-1#2)
US Food and Drug Administration (FDA)##5##6##(2008-9#2)(2012-12#2)(2013-1#1)
US Food and Drug Administration##8##5##(1995-8#1)(2008-9#2)(2012-12#3)(2012-3#1)(2013-1#1)
US Food and Drug##9##4##(1995-8#1)(2008-11#1)(2008-9#2)(2012-12#3)(2012-3#1)(2013-1#1)
US National##3##2##(2010-10#1)(2010-12#1)(2010-7#1)
US and##10##2##(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#3)(2011-2#2)(2012-12#1)
US can##3##2##(1994-12#1)(2010-12#1)(2012-2#1)
US examination##2##2##(2011-2#1)(2013-8#1)
US for##2##2##(2008-5#1)(2012-2#1)
US government##3##2##(2008-11#2)(2009-3#1)
US hospitals##2##2##(2008-11#2)
US imaging##2##2##(2010-12#1)(2013-1#1)
US in##4##2##(1994-6#1)(2010-12#2)(2012-2#1)
US is##2##2##(2008-1#1)(2008-5#1)
US##148##1##(1990-2#1)(1990-9#2)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#6)(1995-8#1)(1996-8#1)(1996-9#5)(1997-2#5)(1997-3#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#16)(2008-11#9)(2008-5#11)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#18)(2010-5#4)(2010-7#2)(2010-8#5)(2011-2#4)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#7)(2013-8#3)
US-02##2##1##(2008-10#2)
US-03##2##1##(2008-10#2)
US-1 and US-8 isolates##3##4##(2008-10#3)
US-1 and US-8##6##3##(2008-10#6)
US-1 and##8##2##(2008-10#8)
US-1 genotype##4##2##(2008-10#4)
US-1 isolate##2##2##(2008-10#2)
US-1 isolates##4##2##(2008-10#4)
US-1##32##1##(2008-10#32)
US-11 isolates##3##2##(2008-10#3)
US-11##8##1##(2008-10#8)
US-17##2##1##(2008-10#2)
US-6##5##1##(2008-10#5)
US-7 and US-8##3##3##(2008-10#3)
US-7##10##1##(2008-10#10)
US-8 and US-11##3##3##(2008-10#3)
US-8 and##5##2##(2008-10#5)
US-8 clonal##4##2##(2008-10#4)
US-8 genotype##6##2##(2008-10#6)
US-8 in##2##2##(2008-10#2)
US-8 isolates##9##2##(2008-10#9)
US-8##36##1##(2008-10#36)
US-8)##3##1##(2008-10#3)
US-SA##2##1##(2013-8#2)
US1 and##2##2##(2008-10#2)
US1##3##1##(2008-10#3)
US8##2##1##(2008-10#2)
USA 90 (1993) 2150-2154]##2##4##(1993-12#2)
USA and the##2##3##(2008-11#1)(2008-5#1)
USA and##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)
USA to##2##2##(2013-1#1)(2013-8#1)
USA##45##1##(1990-5#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-6#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-8#1)(2008-10#4)(2008-11#5)(2008-5#4)(2008-8#1)(2009-4#5)(2010-11#2)(2010-12#2)(2011-2#8)(2013-1#1)(2013-8#2)
USA)##13##1##(2008-10#2)(2008-12#1)(2008-5#6)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#1)
USC atrophy##3##2##(2010-12#3)
USC##5##1##(1992-12#1)(2010-12#4)
USEPA method 218##3##3##(2008-10#3)
USEPA##7##1##(2008-10#7)
USING##2##1##(2009-4#1)(2012-3#1)
USM and UKM##3##3##(2008-10#3)
USM##4##1##(2008-10#4)
USN and##2##2##(2008-10#2)
USP and##3##2##(1995-8#1)(2008-5#1)(2012-2#1)
USP units heparin/horn##2##3##(1992-1#2)
USP##13##1##(1992-1#2)(1995-8#2)(2008-10#4)(2008-5#1)(2012-2#4)
USSR##4##1##(1990-2#1)(1990-3#2)(1992-6#1)
UTI##6##1##(1994-3#1)(2008-7#2)(2011-2#2)(2012-3#1)
UTIs caused by MDR-Enterococcus##2##4##(2011-2#2)
UTIs caused by##3##3##(2011-2#3)
UTIs##4##1##(2008-10#1)(2011-2#3)
UTP activates##2##2##(1993-8#2)
UTP##13##1##(1993-8#8)(1995-11#1)(1995-8#2)(2008-11#2)
UTR and##2##2##(1993-12#1)(2008-8#1)
UTR##14##1##(1993-12#2)(1996-12#2)(2008-10#5)(2008-8#2)(2010-5#2)(2011-2#1)
UV absorbance detection##2##3##(2008-10#2)
UV absorbance##8##2##(2008-10#6)(2008-4#1)(2008-5#1)
UV absorption spectra of##2##4##(2008-10#2)
UV absorption##15##2##(2008-10#11)(2008-4#1)(2008-5#3)
UV and visible##2##3##(2008-10#1)(2009-12#1)
UV and##14##2##(2008-10#11)(2008-5#1)(2009-12#1)(2010-4#1)
UV assay of##2##3##(2008-10#2)
UV assay##3##2##(2008-10#3)
UV at##2##2##(2008-10#1)(2008-9#1)
UV damage##2##2##(2008-11#2)
UV detection at##9##3##(2008-10#7)(2008-5#2)
UV detection for##2##3##(1991-7#1)(1997-2#1)
UV detection was at##2##4##(2008-10#2)
UV detection was performed##2##4##(2008-10#2)
UV detection was##6##3##(2008-10#6)
UV detection##49##2##(1991-7#2)(1997-2#3)(2008-10#40)(2008-5#3)(2011-1#1)
UV detector is##2##3##(2008-10#2)
UV detector was used##2##4##(2008-10#2)
UV detector##12##2##(2008-10#12)
UV exposure##7##2##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#3)
UV filter in##2##3##(2008-5#2)
UV filter##5##2##(2008-5#5)
UV filters##4##2##(2008-5#4)
UV irradiated##2##2##(1994-8#2)
UV irradiation time##3##3##(2008-10#3)
UV irradiation to produce##2##4##(2008-10#2)
UV irradiation to##3##3##(2008-10#3)
UV irradiation##19##2##(1995-11#1)(2008-10#13)(2008-5#2)(2009-7#1)(2010-4#1)(2012-2#1)
UV lamp##5##2##(2008-10#5)
UV laser was##2##3##(2008-3#1)(2012-2#1)
UV laser##5##2##(2008-3#1)(2012-2#3)(2013-8#1)
UV light and##2##3##(2008-10#1)(2008-11#1)
UV light to##2##3##(2008-10#2)
UV light##22##2##(1997-3#1)(2008-10#12)(2008-11#4)(2008-5#3)(2008-7#1)(2009-11#1)
UV photo-oxidation##3##2##(2008-10#3)
UV photobleaching##4##2##(2008-2#4)
UV photoreduction##3##2##(2008-10#3)
UV protection##2##2##(2008-5#2)
UV radiation has##4##3##(2008-10#2)(2011-2#2)
UV radiation on##2##3##(2011-2#2)
UV radiation##31##2##(1993-3#2)(2008-10#13)(2008-3#2)(2008-5#4)(2010-4#1)(2011-2#8)(2013-8#1)
UV source##2##2##(2008-10#1)(2008-5#1)
UV spectra##4##2##(1996-5#1)(1997-2#1)(2008-10#1)(2008-3#1)
UV spectral##2##2##(2008-10#1)(2008-3#1)
UV spectrophotometric determination of##2##4##(2008-10#2)
UV spectrophotometric determination##3##3##(2008-10#3)
UV spectrophotometric##4##2##(2008-10#4)
UV spectrophotometry##8##2##(2008-10#8)
UV spectroscopic##3##2##(2008-10#3)
UV spectroscopy and##2##3##(2008-10#1)(2008-5#1)
UV spectrum##6##2##(2008-10#6)
UV##300##1##(1991-7#2)(1993-3#2)(1994-8#2)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#5)(1997-3#1)(2007-12#1)(2008-10#188)(2008-11#12)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#33)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#16)(2012-2#6)(2013-8#2)
UV- and##2##2##(2008-10#2)
UV-A light##2##2##(2008-11#2)
UV-A sun beds##3##3##(1991-6#3)
UV-A##10##1##(1991-6#6)(2008-11#3)(2011-2#1)
UV-B##4##1##(1991-6#2)(2011-2#1)(2013-1#1)
UV-C treatment##3##2##(2008-10#3)
UV-C##8##1##(2008-10#6)(2011-2#2)
UV-C-treated fruit##3##2##(2008-10#3)
UV-IP##2##1##(2008-5#2)
UV-VIS absorbance method##2##3##(2010-11#2)
UV-VIS absorbance##3##2##(2010-11#3)
UV-VIS##8##1##(2008-10#5)(2010-11#3)
UV-Vis absorption spectrometry##2##3##(2008-10#2)
UV-Vis absorption##3##2##(2008-10#3)
UV-Vis spectra of##2##3##(2008-10#2)
UV-Vis spectra##4##2##(2008-10#3)(2013-8#1)
UV-Vis spectrophotometer##2##2##(2008-10#2)
UV-Vis spectrophotometry##3##2##(2008-10#3)
UV-Vis spectroscopy##6##2##(2008-10#6)
UV-Vis##27##1##(2008-10#24)(2008-9#1)(2013-8#2)
UV-absorbing##3##1##(2008-10#1)(2008-5#2)
UV-blocking##4##1##(2008-5#4)
UV-damage recognition protein##2##3##(1993-3#2)
UV-exposure##2##1##(2009-4#1)(2011-2#1)
UV-filter##2##1##(2008-10#1)(2011-2#1)
UV-induced immunomodulation##2##2##(2008-10#2)
UV-induced##10##1##(2008-10#3)(2008-3#2)(2008-5#4)(2011-2#1)
UV-irradiation##2##1##(1997-3#1)(2008-10#1)
UV-light##4##1##(1991-6#2)(2007-12#1)(2008-9#1)
UV-spectrophotometric determination of##2##3##(2008-10#2)
UV-spectrophotometric##5##1##(2008-10#5)
UV-treated and preinoculated roots##2##4##(2008-10#2)
UV-treated##3##1##(2008-10#2)(2008-9#1)
UV-vis detection at##2##3##(2008-10#2)
UV-vis spectra of##3##3##(2008-10#2)(2009-3#1)
UV-vis spectra##4##2##(2008-10#3)(2009-3#1)
UV-vis spectrophotometric method for the##2##5##(2008-10#2)
UV-vis spectrophotometry##2##2##(2008-10#2)
UV-vis spectroscopy##5##2##(2008-10#4)(2009-3#1)
UV-vis##32##1##(2008-10#29)(2009-3#2)(2010-4#1)
UV-vis-NIR spectroscopy##2##2##(2008-10#2)
UV-vis-NIR##3##1##(2008-10#3)
UV-visible differential optical absorption spectroscopy##2##5##(2008-3#2)
UV-visible spectra##2##2##(1996-5#1)(2008-10#1)
UV-visible spectrophotometry##5##2##(2008-10#5)
UV-visible spectroscopy##3##2##(2008-10#2)(2009-10#1)
UV-visible##17##1##(1996-5#1)(2008-10#13)(2008-3#2)(2009-10#1)
UV/CD##3##1##(2008-10#3)
UV/UV-visible method##2##2##(2008-10#2)
UV/VIS##4##1##(2008-10#4)
UV/Vis##6##1##(2008-10#4)(2008-11#1)(2009-9#1)
UV/vis##3##1##(1992-8#1)(2008-10#2)
UVA filter##3##2##(2008-5#3)
UVA filters##2##2##(2008-5#2)
UVA protection in##2##3##(2008-5#2)
UVA protection##14##2##(2008-5#14)
UVA rays##2##2##(2008-5#2)
UVA##36##1##(1993-8#1)(2008-10#2)(2008-11#3)(2008-5#28)(2011-2#1)(2012-2#1)
UVA-filter##5##1##(2008-5#5)
UVA-induced##3##1##(2008-5#3)
UVA/UVB ratio and##2##3##(2008-5#2)
UVA/UVB ratio##6##2##(2008-5#6)
UVA/UVB##9##1##(2008-5#9)
UVB and UVA##4##3##(2008-5#4)
UVB and##5##2##(2008-5#4)(2010-4#1)
UVB exposure##3##2##(2008-10#3)
UVB radiation##5##2##(2008-10#1)(2008-11#4)
UVB##27##1##(2008-10#6)(2008-11#8)(2008-5#10)(2010-4#1)(2010-6#1)(2011-2#1)
UVB-absorbing sunscreens in##2##3##(2008-5#2)
UVB-induced##4##1##(2008-10#1)(2008-5#1)(2012-2#2)
UVC-induced##2##1##(2008-11#2)
UVC-irradiation##2##1##(2008-11#2)
UVR is a##2##3##(2011-2#2)
UVR##5##1##(2011-2#5)
UVS112##3##1##(1995-9#3)
Ub##4##1##(1993-6#2)(1994-11#1)(2008-4#1)
Uba1##4##1##(2008-9#4)
UbcH7##3##1##(2009-7#3)
Ubiquitin##7##1##(1992-12#1)(1994-11#4)(2009-10#1)(2011-3#1)
Ubiquitin-C-terminal hydrolase activity##2##3##(1994-11#2)
Ubiquitous##2##1##(1992-6#1)(2008-10#1)
Ubx##5##1##(2012-2#5)
Uganda and##2##2##(2008-10#2)
Uganda##12##1##(1993-3#1)(2008-10#7)(2008-8#2)(2010-4#1)(2013-1#1)
Ugandan##3##1##(2008-10#2)(2011-2#1)
Uighur Medicine##3##2##(2009-5#3)
Uighur##4##1##(2009-5#4)
Ulcerative Colitis##2##2##(2010-11#1)(2010-12#1)
Ulcerative##3##1##(2009-12#1)(2010-11#1)(2010-12#1)
Ullevål##3##1##(1990-9#1)(1991-9#1)(1995-2#1)
Ulocladium atrum and Gliocladium roseum##2##5##(2008-10#2)
Ulocladium atrum was##2##3##(2008-10#2)
Ulocladium atrum##10##2##(2008-10#10)
Ulocladium##12##1##(2008-10#11)(2013-1#1)
Ultimately##12##1##(1992-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#2)
Ultra Hybrid##3##2##(2008-10#3)
Ultra##5##1##(2008-10#5)
Ultra-pure##2##1##(2008-10#2)
Ultrafast##5##1##(1994-2#1)(1996-2#1)(2007-11#1)(2008-3#1)(2008-8#1)
Ultrafiltration##3##1##(1991-3#1)(2008-10#2)
Ultrahigh-resolution##2##1##(2007-12#2)
Ultrasensitive##2##1##(2008-10#1)(2008-3#1)
Ultrasonic slurry##2##2##(2008-10#2)
Ultrasonic##12##1##(1994-8#1)(1995-12#3)(2008-10#5)(2008-4#1)(2012-12#1)(2013-1#1)
Ultrasonographic##3##1##(2008-10#1)(2010-11#1)(2013-8#1)
Ultrasonography revealed##2##2##(1997-8#1)(2013-1#1)
Ultrasonography##6##1##(1993-2#1)(1996-8#1)(1997-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
Ultrasound and##2##2##(2008-10#1)(2008-12#1)
Ultrasound can be##2##3##(2011-2#2)
Ultrasound##18##1##(1990-11#1)(1992-11#1)(1993-8#1)(2008-10#3)(2008-12#1)(2010-8#1)(2011-2#4)(2011-5#1)(2011-6#1)(2012-2#1)(2013-1#3)
Ultrasound-assisted extraction##2##2##(2008-10#2)
Ultrasound-guided##4##1##(2008-8#1)(2012-2#2)(2012-3#1)
Ultrastructural Characteristics of##2##3##(2008-10#1)(2008-5#1)
Ultrastructural and Cytochemical Aspects of the##2##6##(2008-10#2)
Ultrastructural and Cytochemical##3##3##(2008-10#3)
Ultrastructural and cytochemical aspects of##2##5##(2008-10#1)(2008-7#1)
Ultrastructural and##7##2##(2008-10#5)(2008-7#2)
Ultrastructural investigations of##3##3##(2007-12#1)(2008-10#2)
Ultrastructural localization of##2##3##(2008-7#1)(2011-2#1)
Ultrastructural studies##3##2##(2008-10#2)(2008-12#1)
Ultrastructural##29##1##(1995-3#1)(2007-12#3)(2008-10#14)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#6)(2011-2#1)
Ultrastructure of the male##2##4##(2007-12#1)(2008-7#1)
Ultrastructure of the##6##3##(2007-12#2)(2008-10#2)(2008-7#2)
Ultrastructure of##11##2##(2007-12#4)(2008-10#2)(2008-11#1)(2008-7#4)
Ultrastructure##12##1##(2007-12#5)(2008-10#2)(2008-11#1)(2008-7#4)
Ultraviolet light##2##2##(2008-10#1)(2008-3#1)
Ultraviolet radiation##2##2##(2008-5#2)
Ultraviolet##7##1##(1996-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)
Ultraviolet-visible##3##1##(2008-10#3)
Ulysses##2##1##(1994-1#1)(2008-11#1)
Umbellularia##2##1##(2008-10#2)
Umbilical##6##1##(1991-8#1)(1994-3#2)(2008-10#1)(2008-11#1)(2009-8#1)
Uml(-1) The##2##2##(2008-10#2)
Uml(-1)##3##1##(2008-10#3)
Un##3##1##(2013-1#3)
Uncertainty in##3##2##(2008-10#1)(2010-10#2)
Uncertainty##10##1##(1990-8#1)(2008-10#2)(2008-3#2)(2009-5#1)(2010-10#3)(2012-12#1)
Uncinula necator##6##2##(2008-10#6)
Uncommon##2##1##(1997-8#1)(2012-2#1)
Uncontrolled##2##1##(2008-7#1)(2010-10#1)
Uncoupling##2##1##(2009-8#1)(2010-4#1)
Uncovering the complex relationship between pre-eclampsia##2##6##(2011-2#2)
Uncovering the##3##2##(2011-2#2)(2012-2#1)
Uncovering##4##1##(2011-2#2)(2012-2#2)
Under Greenhouse##2##2##(2008-10#2)
Under Medicare##2##2##(1991-1#2)
Under Option##2##2##(1995-1#2)
Under a##3##2##(1997-3#1)(2008-10#2)
Under all conditions##2##3##(1994-5#1)(1996-2#1)
Under all##4##2##(1994-5#1)(1996-12#1)(1996-2#1)(2008-10#1)
Under appropriate conditions##2##3##(2008-10#1)(2008-9#1)
Under both##2##2##(2008-10#2)
Under certain conditions##3##3##(2008-10#1)(2010-9#1)(2011-2#1)
Under certain##5##2##(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#2)
Under conditions##6##2##(1990-12#1)(1993-3#1)(2008-10#4)
Under constant##2##2##(2008-5#2)
Under controlled##2##2##(2008-10#1)(2012-8#1)
Under experimental conditions##2##3##(2008-10#1)(2008-5#1)
Under field conditions##5##3##(2008-10#4)(2008-9#1)
Under high##2##2##(2008-11#1)(2010-8#1)
Under identical conditions##2##3##(2008-10#1)(2010-7#1)
Under managed care##2##3##(1996-12#1)(1997-2#1)
Under normal##3##2##(1990-12#1)(2008-5#1)(2008-9#1)
Under optimal analytical##2##3##(2008-10#2)
Under optimal conditions the linear##2##5##(2008-10#2)
Under optimal conditions##15##3##(2008-10#15)
Under optimal##20##2##(2008-10#20)
Under optimised conditions##5##3##(2008-10#5)
Under optimized conditions##13##3##(2008-10#13)
Under optimized##16##2##(2008-10#16)
Under optimum conditions##11##3##(2008-10#11)
Under optimum##13##2##(2008-10#13)
Under proper experimental conditions##2##4##(2008-10#2)
Under selected conditions##2##3##(2008-10#2)
Under selected##3##2##(2008-10#3)
Under stoichiometric##2##2##(2008-11#2)
Under such conditions##3##3##(2008-8#1)(2009-12#1)(2013-8#1)
Under such##4##2##(2008-8#1)(2009-12#1)(2010-8#1)(2013-8#1)
Under suitable##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
Under the condition of##2##4##(2008-10#1)(2013-8#1)
Under the conditions employed##2##4##(2008-10#2)
Under the conditions of these drinking water studies##3##8##(2008-9#3)
Under the conditions of these##4##5##(2008-9#4)
Under the conditions of##6##4##(2008-9#5)(2010-7#1)
Under the conditions##10##3##(2008-10#4)(2008-9#5)(2010-7#1)
Under the experimental conditions##6##4##(1992-4#1)(2008-10#5)
Under the optimal conditions##15##4##(2008-10#15)
Under the optimal experimental conditions##4##5##(2008-10#4)
Under the optimal##22##3##(2008-10#22)
Under the optimised conditions##3##4##(2008-10#3)
Under the optimised##4##3##(2008-10#4)
Under the optimized conditions##12##4##(2008-10#11)(2008-12#1)
Under the optimized experimental conditions##2##5##(2008-10#2)
Under the optimized working conditions##2##5##(2008-10#2)
Under the optimized##20##3##(2008-10#19)(2008-12#1)
Under the optimum condition##3##4##(2008-10#3)
Under the optimum conditions##34##4##(2008-10#34)
Under the optimum experimental conditions##4##5##(2008-10#4)
Under the optimum##44##3##(2008-10#44)
Under the same conditions##3##4##(1993-8#1)(2008-11#1)(2011-2#1)
Under the same##5##3##(1993-8#1)(2008-10#1)(2008-11#2)(2011-2#1)
Under the selected conditions (i##2##5##(2008-10#2)
Under the selected conditions##5##4##(2008-10#5)
Under the selected##8##3##(2008-10#8)
Under the##145##2##(1991-8#1)(1992-4#1)(1993-3#1)(1993-8#2)(1994-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#115)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#6)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
Under these conditions the##4##4##(1993-3#1)(2008-10#3)
Under these conditions##28##3##(1991-3#1)(1992-3#1)(1993-3#1)(1993-8#1)(2008-10#21)(2008-11#1)(2008-7#1)(2011-2#1)
Under these##35##2##(1991-3#1)(1992-3#1)(1993-3#1)(1993-8#1)(1996-2#1)(1996-3#1)(2008-10#24)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
Under this##5##2##(1992-6#1)(2008-10#1)(2008-3#1)(2009-6#1)(2013-1#1)
Under those##2##2##(2008-10#2)
Under##367##1##(1990-12#2)(1991-1#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#3)(1993-8#3)(1994-1#1)(1994-11#1)(1994-5#1)(1995-1#2)(1995-12#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#253)(2008-11#15)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#12)(2009-12#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-2#4)(2012-2#2)(2012-8#1)(2013-1#4)(2013-8#5)
Undergraduate health administration education##2##4##(1991-1#2)
Undergraduate health administration##3##3##(1991-1#3)
Undergraduate##7##1##(1991-1#3)(2008-11#1)(2008-12#1)(2010-9#1)(2012-2#1)
Underlying##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
Understanding and##2##2##(2008-11#1)(2011-2#1)
Understanding how##7##2##(1995-2#1)(2008-10#1)(2009-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
Understanding of the##2##3##(1992-12#1)(2009-4#1)
Understanding of##4##2##(1992-12#1)(2008-9#1)(2009-4#1)(2012-3#1)
Understanding the mechanisms##2##3##(2008-7#1)(2008-9#1)
Understanding the specificity of##2##4##(2008-11#1)(2009-8#1)
Understanding the##27##2##(1995-6#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
Understanding these##3##2##(1993-12#1)(2010-11#1)(2011-2#1)
Understanding this##2##2##(2008-9#1)(2009-6#1)
Understanding##70##1##(1990-5#1)(1992-12#1)(1993-12#1)(1995-2#2)(1995-6#1)(1996-12#2)(2008-10#6)(2008-11#10)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-11#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
Underwent##3##1##(1994-12#1)(2008-10#1)(2008-11#1)
Underwriting psychiatric impairments##3##3##(1995-1#1)(1995-2#1)(1995-3#1)
Underwriting##6##1##(1992-1#1)(1992-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)
Undifferentiated##3##1##(1992-12#1)(2010-12#2)
Undoubtedly##2##1##(2008-5#1)(2009-9#1)
Une##3##1##(2009-10#1)(2013-1#2)
Uneven##2##1##(2008-10#1)(2012-2#1)
Unexpected##4##1##(1991-8#1)(1992-2#1)(1992-3#1)(2012-3#1)
Unexpectedly##15##1##(1990-5#1)(1991-10#1)(1992-2#1)(1993-2#1)(1994-8#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-8#1)
Unexplained##3##1##(1993-2#1)(2008-12#1)(2009-6#1)
Unfortunately##44##1##(1990-12#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
Unified Health System##2##3##(2012-3#2)
Unified##5##1##(2008-7#2)(2012-3#2)(2013-8#1)
Uniform##3##1##(1994-2#1)(2008-7#1)(2010-7#1)
Uniformity##2##1##(2008-10#2)
Unilamellar##2##1##(1991-5#1)(2008-10#1)
Unilateral and bilateral##2##3##(2008-7#2)
Unilateral##7##1##(1993-1#1)(1995-2#1)(1996-5#1)(2008-7#3)(2012-2#1)
Union and##4##2##(2008-10#3)(2008-12#1)
Union to##2##2##(2008-10#1)(2008-12#1)
Union##27##1##(1990-3#1)(1991-12#2)(1994-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-5#1)(2011-2#1)(2013-8#1)
Union's##2##1##(1990-3#1)(2008-10#1)
Unique to##2##2##(2011-2#1)(2012-2#1)
Unique##10##1##(1993-8#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-7#1)(2012-2#2)
Unit and##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
Unit directors##2##2##(1992-12#2)
Unit in the##2##3##(2008-10#1)(2010-10#1)
Unit in##3##2##(2008-10#1)(2010-10#1)(2012-3#1)
Unit of the Department##2##4##(1991-6#1)(1997-8#1)
Unit of the##3##3##(1991-6#1)(1996-8#1)(1997-8#1)
Unit of##4##2##(1991-6#1)(1996-8#1)(1997-8#1)(2011-2#1)
Unit##32##1##(1991-2#1)(1991-6#1)(1992-12#5)(1992-2#1)(1996-8#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#3)(2012-3#3)(2013-1#2)
United Arab Emirates##4##3##(2008-12#2)(2013-1#2)
United HealthCare##2##2##(1991-9#1)(1993-5#1)
United Kingdom Central Council for Nursing##4##6##(2008-11#4)
United Kingdom Central Council##5##4##(2008-11#5)
United Kingdom##47##2##(1991-2#1)(1991-3#1)(1991-8#2)(1992-1#1)(1994-12#2)(1995-1#2)(1995-2#1)(2008-10#11)(2008-11#13)(2008-12#5)(2008-9#3)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
United Nations##4##2##(1996-1#1)(2008-11#2)(2011-2#1)
United State##2##2##(2008-10#1)(2013-8#1)
United States and subsequently##2##4##(2008-10#2)
United States and##45##3##(1991-12#2)(1992-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#30)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
United States are##4##3##(1991-2#1)(1993-1#1)(2008-10#1)(2011-2#1)
United States has##5##3##(1995-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2009-3#1)
United States in 1989##2##4##(2008-10#2)
United States in##12##3##(1993-2#1)(1994-1#1)(1994-2#1)(1995-8#1)(2008-10#8)
United States is##3##3##(2008-10#2)(2013-1#1)
United States over the##2##4##(1993-3#1)(2008-5#1)
United States since##4##3##(1995-3#1)(2008-10#2)(2012-3#1)
United States was##3##3##(2008-10#3)
United States were characterized##2##4##(2008-10#2)
United States were##11##3##(2008-10#10)(2008-5#1)
United States##366##2##(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#6)(1991-2#1)(1991-3#3)(1991-8#3)(1992-12#2)(1992-6#1)(1992-9#2)(1993-1#4)(1993-12#2)(1993-2#6)(1993-3#7)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#6)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#169)(2008-11#12)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#5)(2009-7#2)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#4)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#18)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#12)(2013-8#6)
United##438##1##(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#4)(1991-8#5)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#2)(1993-1#4)(1993-12#3)(1993-2#7)(1993-3#8)(1993-5#1)(1994-1#1)(1994-12#5)(1994-2#3)(1994-3#1)(1995-1#4)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#6)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#184)(2008-11#29)(2008-12#11)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#3)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#5)(2009-7#2)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#4)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#20)(2012-12#7)(2012-2#7)(2012-3#8)(2013-1#14)(2013-8#8)
Units##9##1##(1995-12#1)(1996-5#1)(2008-11#3)(2008-7#1)(2012-3#1)(2013-1#2)
Univariate and multivariate##3##3##(2009-7#1)(2011-2#1)(2012-3#1)
Univariate and##4##2##(2009-7#1)(2011-2#2)(2012-3#1)
Univariate##5##1##(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
Universal health insurance##4##3##(1991-2#3)(1995-2#1)
Universal##12##1##(1991-12#1)(1991-2#3)(1994-2#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
Universita degli Studi di Genova##2##5##(2008-4#2)
Universitario##2##1##(2008-5#1)(2011-2#1)
Universiti Kebangsaan Malaysia##3##3##(2008-10#2)(2008-12#1)
Universiti Sains Malaysia##2##3##(2008-10#2)
Universiti##5##1##(2008-10#4)(2008-12#1)
Universities and##2##2##(2008-10#1)(2008-11#1)
Universities##5##1##(2008-10#1)(2008-11#3)(2013-1#1)
University Clinic##2##2##(1991-11#1)(2008-12#1)
University College##2##2##(2008-11#1)(2010-10#1)
University Hospital in##2##3##(1997-8#1)(2008-1#1)
University Hospital of the West Indies##3##6##(2011-2#3)
University Hospital of##5##3##(1996-11#1)(2008-10#1)(2011-2#3)
University Hospital##19##2##(1991-9#2)(1996-11#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2011-2#8)(2012-12#1)(2013-8#3)
University Medical Center##5##3##(1992-12#1)(1993-12#1)(1993-2#1)(1996-1#1)(1996-2#1)
University Medical School##2##3##(1991-6#1)(2008-5#1)
University Medical##7##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1996-1#1)(1996-2#1)(2008-5#1)
University Press##7##2##(1990-11#2)(1990-8#1)(2008-11#1)(2008-12#2)(2008-5#1)
University School of Medicine##2##4##(1991-3#1)(1996-9#1)
University Teaching Hospital##3##3##(2013-1#3)
University and NHS##2##3##(2008-11#2)
University and##3##2##(2008-11#2)(2010-5#1)
University hospital##2##2##(1995-12#1)(2013-1#1)
University hospitals##4##2##(1990-9#1)(2008-10#3)
University in##5##2##(1997-6#1)(2008-10#1)(2008-12#2)(2010-7#1)
University of Alberta##3##3##(1992-12#1)(1996-3#1)(1997-2#1)
University of British Columbia##2##4##(2008-12#1)(2013-8#1)
University of Chicago##2##3##(1990-11#1)(2008-5#1)
University of Durham##2##3##(2008-11#2)
University of Florida##2##3##(1992-1#2)
University of Guelph##3##3##(2013-8#3)
University of New##3##3##(1991-12#1)(1993-1#1)(1996-1#1)
University of Oslo##2##3##(1990-9#1)(1995-2#1)
University of Pittsburgh##2##3##(2008-5#2)
University of Rome##3##3##(1990-8#1)(2011-7#1)(2013-1#1)
University of Texas##3##3##(1990-11#2)(2011-2#1)
University of Vienna##2##3##(1995-11#1)(1996-3#1)
University of the Third Age##2##5##(2011-2#2)
University of the##4##3##(2010-1#1)(2011-2#3)
University of##107##2##(1990-11#4)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#2)(1992-12#2)(1993-1#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-1#3)(1996-3#2)(1997-2#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#17)(2008-12#10)(2008-3#1)(2008-5#4)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#7)(2011-7#1)(2012-2#1)(2013-1#6)(2013-8#10)
University##233##1##(1990-11#6)(1990-8#3)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#2)(1991-9#2)(1992-1#3)(1992-12#3)(1992-2#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#6)(1996-11#1)(1996-2#1)(1996-3#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#38)(2008-12#21)(2008-3#2)(2008-5#8)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#17)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#11)(2013-8#17)
University-based##2##1##(2008-11#1)(2008-9#1)
Unix##3##1##(2008-4#1)(2008-9#2)
Unknown##3##1##(2008-10#1)(2010-5#1)(2010-6#1)
Unlabelled##2##1##(2008-10#1)(2011-2#1)
Unless the##2##2##(1996-2#1)(2008-8#1)
Unless##6##1##(1996-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
Unlike conventional##2##2##(2008-3#1)(2012-12#1)
Unlike for##2##2##(2007-11#1)(2008-3#1)
Unlike in##2##2##(2008-8#1)(2009-10#1)
Unlike most other##2##3##(1991-10#1)(2008-10#1)
Unlike most##4##2##(1991-10#1)(1995-2#1)(2008-10#1)(2008-9#1)
Unlike other##13##2##(1996-12#2)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
Unlike previous##3##2##(1990-8#1)(2008-8#1)(2012-2#1)
Unlike the##15##2##(1990-11#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-6#2)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2009-7#1)(2013-8#1)
Unlike##65##1##(1990-11#1)(1990-8#1)(1991-10#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1995-2#1)(1995-6#2)(1996-12#3)(1996-2#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-10#18)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Unmasking##2##1##(1997-7#1)(2008-9#1)
Unoperated##2##1##(1993-3#1)(2012-3#1)
Unraveling##3##1##(2008-11#1)(2008-4#1)(2013-8#1)
Unravelling##2##1##(2008-11#2)
Unstable##5##1##(1992-8#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
Until now##9##2##(1990-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-3#1)
Until recently##13##2##(1992-9#1)(1993-9#1)(1994-6#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
Until the##5##2##(1994-12#1)(1995-2#1)(2008-7#1)(2009-7#1)(2011-2#1)
Until we##2##2##(1991-12#1)(1997-1#1)
Until##37##1##(1990-11#1)(1991-12#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#1)(2009-7#1)(2010-12#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
Untreated patients##2##2##(1996-11#1)(2011-2#1)
Untreated##4##1##(1996-11#1)(2009-7#1)(2010-11#1)(2011-2#1)
Unusual presentation##2##2##(2010-10#1)(2012-3#1)
Unusual##12##1##(1993-5#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#2)(2010-10#1)(2010-6#1)(2012-3#2)(2013-1#1)
Up to 1996##3##3##(1996-11#3)
Up to now##3##3##(1992-9#1)(1996-11#1)(2008-7#1)
Up to the##2##3##(2008-11#1)(2011-2#1)
Up to##29##2##(1992-9#1)(1996-1#2)(1996-11#4)(1996-3#1)(2008-10#13)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
Up##30##1##(1992-9#1)(1996-1#2)(1996-11#4)(1996-3#1)(2008-10#14)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
Up-Draft II##2##2##(1995-3#2)
Up-Draft##3##1##(1995-3#3)
Up-regulation of##4##2##(1990-11#1)(2009-6#1)(2010-4#2)
Up1##2##1##(2009-8#2)
Upconversion##2##1##(2008-3#2)
Update on the##2##3##(2008-2#1)(2009-4#1)
Update on##9##2##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)
Update##17##1##(1991-1#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
Updated##3##1##(1995-1#1)(2008-7#1)(2012-2#1)
Updates in##3##2##(2009-3#1)(2009-8#1)(2012-3#1)
Upon expression##2##2##(1991-9#1)(1995-11#1)
Upon publication##3##2##(2008-12#3)
Upon release##2##2##(1995-2#1)(2013-1#1)
Upon the##2##2##(2008-10#2)
Upon##50##1##(1990-11#1)(1990-2#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#1)(1996-5#1)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#1)(2008-7#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Upper Coast region##2##3##(2008-10#2)
Upper Coast##4##2##(2008-10#4)
Upper Silesia##2##2##(2008-10#2)
Upper extremity surgery in younger children under ultrasound-guided supraclavicular brachial plexus block##2##12##(2012-2#2)
Upper extremity##3##2##(2008-12#1)(2012-2#2)
Upper gastrointestinal##4##2##(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
Upper##22##1##(2007-12#1)(2008-10#8)(2008-12#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Uppsala##4##1##(2008-10#1)(2008-11#3)
Upregulation of##2##2##(2008-10#1)(2012-2#1)
Upstream##3##1##(2008-8#2)(2010-8#1)
Uptake and##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
Uptake of##2##2##(1992-3#1)(2008-5#1)
Uptake##10##1##(1992-12#1)(1992-3#2)(1993-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
Uranium dosed [Fe(-)U(+)]##2##3##(2013-1#2)
Uranium##7##1##(2008-10#4)(2013-1#3)
Uranium(VI)##2##1##(2008-10#2)
Urban##10##1##(1996-3#1)(1996-5#1)(2008-10#2)(2008-2#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
Urbana##5##1##(2008-10#5)
Urea##4##1##(1993-3#1)(2008-10#3)
Ureaplasma urealyticum##3##2##(2008-12#2)(2011-2#1)
Ureaplasma##5##1##(2008-12#2)(2011-2#2)(2012-3#1)
Urediniospores##2##1##(2008-10#2)
Ureteral##2##1##(2008-10#1)(2013-1#1)
Urethral##6##1##(1992-1#1)(1996-11#1)(2008-10#1)(2009-5#1)(2013-1#1)(2013-8#1)
Urgent##2##1##(2011-2#2)
Uric acid##4##2##(1994-6#1)(1997-2#1)(2008-5#2)
Urinary Bladder##2##2##(2008-10#1)(2013-1#1)
Urinary Tract##2##2##(2011-2#1)(2013-8#1)
Urinary bladder sonography##2##3##(2012-12#2)
Urinary levels of##2##3##(1990-2#1)(1992-3#1)
Urinary neopterin##2##2##(2008-10#2)
Urinary tract infection##3##3##(2008-7#2)(2012-3#1)
Urinary tract##4##2##(1993-2#1)(2008-7#2)(2012-3#1)
Urinary##27##1##(1990-2#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-5#1)(1997-8#1)(2008-10#6)(2008-5#2)(2008-7#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
Urine and serum neopterin concentrations##2##5##(1990-2#2)
Urine##12##1##(1990-2#3)(1991-12#2)(2008-10#6)(2009-6#1)
Urine)##2##1##(2008-10#2)
Urinoma##2##1##(2008-10#2)
Urm1##3##1##(2009-7#3)
Urmia##3##1##(2008-12#2)(2013-1#1)
Urodynamic##2##1##(2008-10#2)
Urology##5##1##(2008-10#3)(2008-8#1)(2011-2#1)
Uromyces appendiculatus##3##2##(2008-10#3)
Uromyces##5##1##(2008-10#5)
Ursodeoxycholic acid is##2##3##(1997-6#1)(2010-12#1)
Ursodeoxycholic acid##3##2##(1995-10#1)(1997-6#1)(2010-12#1)
Urtica dioica##5##2##(2008-10#1)(2008-12#4)
Uruguay##5##1##(1992-5#1)(2008-10#1)(2010-4#1)(2011-2#2)
Usability##2##1##(2010-4#1)(2012-2#1)
Usage##2##1##(2008-10#1)(2008-11#1)
Use Among##2##2##(2012-12#1)(2013-1#1)
Use and##5##2##(1991-1#1)(1991-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
Use in##2##2##(2008-10#2)
Use of Green Fluorescent##3##4##(2008-10#3)
Use of a##14##3##(1992-3#1)(1996-2#1)(2008-10#3)(2008-3#3)(2008-5#1)(2012-2#1)(2012-3#3)(2013-1#1)
Use of an##3##3##(2008-10#1)(2008-3#2)
Use of caffeine and nicotine##2##5##(2009-7#2)
Use of data from the EDP medical records in general practice]##2##11##(1994-6#2)
Use of the##20##3##(1991-1#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1996-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#2)(2010-3#1)(2013-1#2)
Use of these##3##3##(1992-2#1)(2008-10#1)(2011-2#1)
Use of this system##2##4##(2008-11#1)(2008-7#1)
Use of this##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
Use of ultrasound in##2##4##(1994-6#1)(2012-2#1)
Use of##178##2##(1990-12#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#4)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-6#3)(1994-8#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#47)(2008-11#12)(2008-12#5)(2008-2#1)(2008-3#11)(2008-4#8)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-3#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#8)(2013-1#9)(2013-8#2)
Use the##2##2##(1995-2#2)
Use##207##1##(1990-12#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#4)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-6#3)(1994-8#1)(1995-1#1)(1995-2#3)(1996-11#1)(1996-2#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#52)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#11)(2008-4#8)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#2)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-9#2)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#9)(2013-1#15)(2013-8#4)
Used##5##1##(2008-10#4)(2012-3#1)
Useful##6##1##(1990-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)
Usefulness of##4##2##(1996-6#1)(2008-10#2)(2009-12#1)
Usefulness##5##1##(1996-6#1)(2008-10#2)(2008-4#1)(2009-12#1)
User experience network##2##3##(2011-2#2)
User##3##1##(1991-3#1)(2011-2#2)
Users of##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
Users##11##1##(1991-3#1)(1993-3#1)(1994-12#1)(2008-11#1)(2008-6#1)(2008-9#2)(2011-2#2)(2013-1#1)(2013-8#1)
Uses##2##1##(2008-10#1)(2013-7#1)
Ushuaia##4##1##(2008-2#1)(2008-3#3)
Using 1##2##2##(1997-8#1)(2009-10#1)
Using DNA##4##2##(1991-2#1)(2008-10#2)(2009-6#1)
Using Northern blot analysis##2##4##(1996-12#1)(1997-2#1)
Using PCR##3##2##(1995-12#1)(2008-10#2)
Using Real-Time Polymerase Chain Reaction and##2##6##(2008-10#2)
Using Real-Time Polymerase Chain Reaction##3##5##(2008-10#3)
Using TaqMan##3##2##(2008-10#3)
Using a Genetic Cross Between Isolates from Wheat and Foxtail Millet##2##11##(2008-10#2)
Using a Real-Time Polymerase Chain Reaction Assay##2##7##(2008-10#2)
Using a calibration##2##3##(2008-10#2)
Using a case study##3##4##(1992-12#1)(1994-12#1)(1996-1#1)
Using a combination of##5##4##(1991-9#1)(2008-10#1)(2008-4#1)(2009-8#1)(2013-8#1)
Using a known##2##3##(2008-10#1)(2008-8#1)
Using a mathematical model##2##4##(2008-11#1)(2011-3#1)
Using a national sample##2##4##(1995-12#1)(2009-7#1)
Using a national##3##3##(1993-12#1)(1995-12#1)(2009-7#1)
Using a novel##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
Using a sample volume of##3##5##(2008-10#3)
Using a sample##5##3##(1992-12#1)(2008-10#3)(2009-5#1)
Using a simple##2##3##(2008-8#1)(2008-9#1)
Using a simulation##2##3##(2008-12#1)(2012-12#1)
Using a spatially##2##3##(2008-10#1)(2008-8#1)
Using a##139##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-9#2)(1994-12#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#36)(2008-11#8)(2008-12#10)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#4)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
Using an adapted##2##3##(2008-10#1)(2013-1#1)
Using an in vitro##2##4##(1990-2#1)(1995-6#1)
Using an individual-based##2##3##(2008-8#1)(2008-9#1)
Using an##26##2##(1990-2#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Using both##4##2##(1992-6#2)(2008-3#1)(2008-8#1)
Using cell##3##2##(1995-6#1)(2008-11#2)
Using confocal##2##2##(2009-8#1)(2010-10#1)
Using cyclic voltammetry (CV) and##2##5##(2008-10#2)
Using data from the##3##4##(1994-3#1)(2011-2#1)(2012-2#1)
Using data from two##2##4##(1992-2#1)(2008-8#1)
Using data from##13##3##(1992-2#1)(1993-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
Using data##14##2##(1992-2#1)(1993-1#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
Using differential##2##2##(1993-6#1)(2008-10#1)
Using domain##2##2##(2009-10#1)(2011-2#1)
Using electron##2##2##(2008-7#1)(2008-8#1)
Using evidence to teach##2##4##(1993-12#2)
Using evidence##4##2##(1993-12#4)
Using field data and computer simulation##2##6##(2008-10#2)
Using flow cytometric##2##3##(2008-11#1)(2012-3#1)
Using flow cytometry##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
Using flow##5##2##(2008-10#1)(2008-11#2)(2008-9#1)(2012-3#1)
Using gel##2##2##(1992-6#1)(1995-6#1)
Using health##2##2##(1992-12#1)(2009-3#1)
Using human##2##2##(2008-8#2)
Using immunohistochemistry##3##2##(2008-9#1)(2009-4#1)(2012-2#1)
Using in situ hybridization##2##4##(1995-12#1)(1997-3#1)
Using information##2##2##(1996-3#1)(2011-2#1)
Using linear##2##2##(2008-10#1)(2008-11#1)
Using modified##2##2##(2008-10#1)(2008-9#1)
Using molecular##2##2##(2007-12#1)(2008-10#1)
Using multiple##3##2##(1992-2#1)(2011-2#1)(2013-1#1)
Using nested##2##2##(2008-10#2)
Using our##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-8#1)
Using phage display##2##3##(2008-11#1)(2008-4#1)
Using protein##2##2##(1991-12#1)(2008-10#1)
Using purified##2##2##(2008-10#1)(2012-2#1)
Using real-time##2##2##(2010-5#2)
Using realistic##2##2##(2008-3#1)(2009-8#1)
Using reverse##2##2##(1995-12#1)(2008-10#1)
Using several##2##2##(1996-3#1)(2008-2#1)
Using single##2##2##(2008-8#1)(2013-1#1)
Using specific##3##2##(1992-7#1)(1993-6#1)(2008-10#1)
Using such##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
Using the computer##2##3##(1992-12#1)(1995-12#1)
Using the experimental conditions##2##4##(2008-10#2)
Using the full spectral capacity (six channels) of a real-time PCR instrument can simplify diagnostic laboratory screening and typing protocols for pandemic H1N1 influenza##2##24##(2011-2#2)
Using the genetic##2##3##(2008-10#1)(2008-9#1)
Using the highly sensitive##2##4##(1995-8#1)(2010-12#1)
Using the latter##2##3##(1992-2#1)(2006-6#1)
Using the method of##2##4##(2008-9#2)
Using the proposed method##2##4##(2008-10#2)
Using the same##3##3##(2008-10#2)(2009-10#1)
Using the selected conditions##2##4##(2008-10#2)
Using the##122##2##(1990-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2006-6#1)(2008-10#52)(2008-11#8)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#3)
Using these methods##2##3##(1992-9#1)(2008-4#1)
Using these techniques##2##3##(2008-7#1)(2009-12#1)
Using these##24##2##(1992-9#2)(1993-12#1)(1995-2#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
Using this approach an##2##4##(2008-10#1)(2008-7#1)
Using this approach##10##3##(1994-9#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-1#1)(2010-7#1)(2012-2#1)
Using this assay##2##3##(1991-9#1)(2008-5#1)
Using this method##8##3##(1994-11#1)(2008-10#2)(2008-11#3)(2008-2#1)(2010-10#1)
Using this system##3##3##(2008-11#3)
Using this technique##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
Using this##51##2##(1990-12#1)(1991-5#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-9#1)(1997-3#1)(2008-10#17)(2008-11#10)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-7#1)(2011-1#1)(2012-2#1)
Using two different##2##3##(1990-5#1)(2008-10#1)
Using two##4##2##(1990-5#1)(1991-7#1)(2008-10#1)(2008-9#1)
Using##792##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#4)(1991-12#3)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#3)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#11)(1993-2#4)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#5)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#5)(1995-3#2)(1995-6#6)(1995-8#3)(1996-1#4)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#5)(1996-6#1)(1996-9#2)(1997-1#5)(1997-2#13)(1997-3#4)(1997-5#1)(1997-7#2)(1997-8#3)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#239)(2008-11#61)(2008-12#17)(2008-2#5)(2008-3#6)(2008-4#8)(2008-5#12)(2008-6#3)(2008-7#14)(2008-8#36)(2008-9#31)(2009-10#6)(2009-11#2)(2009-12#3)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#10)(2010-1#5)(2010-10#7)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#23)(2011-3#1)(2011-7#1)(2012-12#7)(2012-2#19)(2012-3#13)(2013-1#19)(2013-3#1)(2013-8#12)
Ustilago hordei##6##2##(2008-10#6)
Ustilago maydis##9##2##(1996-6#2)(2008-10#4)(2009-8#2)(2010-7#1)
Ustilago spp##3##2##(2008-10#3)
Ustilago violacea##2##2##(1993-12#2)
Ustilago##28##1##(1993-12#2)(1996-6#4)(2008-10#17)(2008-5#2)(2009-8#2)(2010-7#1)
Usual##2##1##(1997-4#1)(2008-10#1)
Usually##17##1##(1993-6#1)(1994-6#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
Utah##6##1##(1996-1#1)(1996-2#1)(2008-10#2)(2008-3#2)
Uterine##5##1##(1991-2#1)(2008-10#1)(2011-2#2)(2013-1#1)
Utilisation of##2##2##(2008-7#1)(2013-1#1)
Utilisation##3##1##(2008-5#1)(2008-7#1)(2013-1#1)
Utility of the##2##3##(1991-1#1)(2012-3#1)
Utility of##8##2##(1991-1#1)(1995-5#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
Utilization Group##2##2##(1994-12#2)
Utilization Groups##5##2##(1993-12#1)(1993-2#1)(1994-12#2)(2008-7#1)
Utilization of##12##2##(1994-11#1)(1995-8#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2009-5#1)(2013-1#1)
Utilization##34##1##(1991-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#4)(1995-1#1)(1995-8#1)(1996-6#1)(1997-2#2)(2008-10#5)(2008-11#4)(2008-12#2)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#2)(2013-1#1)
Utilizing this##3##2##(2008-11#2)(2008-12#1)
Utilizing##20##1##(1992-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2013-8#1)
Utrogestan is##2##2##(2008-11#2)
Utrogestan##8##1##(2008-11#8)
Uttar##2##1##(1997-8#1)(2011-1#1)
Uyghur##2##1##(2011-2#2)
Uzbekistan##3##1##(2008-10#3)
V (for##4##2##(2009-9#4)
V (versus SCE)##2##3##(2008-10#2)
V (versus##5##2##(2008-10#5)
V (vs##19##2##(2008-10#19)
V and VI##5##3##(1990-5#1)(1994-2#1)(1997-2#1)(2007-12#1)(2012-2#1)
V and Zn##3##3##(2008-10#3)
V and the##3##3##(2008-10#3)
V and##22##2##(1990-5#1)(1991-9#1)(1994-2#2)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-2#1)
V as##2##2##(2008-10#2)
V at##3##2##(1990-5#1)(2008-10#1)(2010-12#1)
V cm(-1)##5##2##(2008-10#4)(2008-11#1)
V content decreased##2##3##(2011-2#2)
V content##6##2##(2011-2#6)
V for##3##2##(2008-10#3)
V in the presence of##2##5##(2008-10#2)
V in the##4##3##(2008-10#3)(2012-2#1)
V in##10##2##(2008-10#9)(2012-2#1)
V is##2##2##(2008-10#2)
V level##6##2##(2008-10#1)(2011-2#5)
V loss increased##2##3##(2011-2#2)
V loss##6##2##(2011-2#6)
V on##2##2##(2008-10#2)
V or##2##2##(2008-10#1)(2008-11#1)
V regions##3##2##(2008-4#3)
V to##4##2##(1994-9#1)(2008-11#2)(2008-4#1)
V using a##2##3##(2008-10#2)
V versus Ag/AgCl##7##3##(2008-10#7)
V versus SCE##4##3##(2008-10#4)
V versus##13##2##(2008-10#13)
V vs##16##2##(1991-9#1)(1996-5#1)(2008-10#14)
V was##6##2##(1991-9#2)(2008-10#4)
V were##4##2##(1990-9#1)(2006-6#1)(2008-10#1)(2010-1#1)
V with##4##2##(2008-10#3)(2008-3#1)
V##480##1##(1990-2#1)(1990-5#4)(1990-9#4)(1991-11#1)(1991-9#4)(1992-11#2)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-8#5)(2006-6#4)(2007-12#1)(2008-10#334)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#2)(2009-6#3)(2009-8#4)(2009-9#10)(2010-1#3)(2010-12#1)(2011-1#1)(2011-2#24)(2011-3#1)(2012-2#5)(2012-3#8)(2013-1#1)(2013-8#1)
V(2)O(5)##2##1##(2008-10#2)
V(5+)##2##1##(2008-10#2)
V(D)J recombination and##2##3##(1997-7#2)
V(D)J recombination reaction##2##3##(1997-7#2)
V(D)J recombination##14##2##(1996-2#2)(1997-7#9)(2013-1#3)
V(E)##3##1##(2008-10#3)
V(H)##3##1##(2008-10#1)(2008-11#2)
V(H)-gp130 and##3##2##(2008-11#3)
V(IV) and Co(II)##4##3##(2008-10#4)
V(IV) and##6##2##(2008-10#6)
V(IV) with##2##2##(2008-10#2)
V(IV)##21##1##(2008-10#21)
V(L)##3##1##(2008-10#1)(2008-11#2)
V(V) and Al(III)##3##3##(2008-10#3)
V(V) and Ti(IV)##2##3##(2008-10#2)
V(V) and V(IV) are##2##4##(2008-10#2)
V(V) and V(IV)##3##3##(2008-10#3)
V(V) and Zn##2##3##(2008-10#2)
V(V) and##15##2##(2008-10#15)
V(V) species##2##2##(2008-10#2)
V(V)##37##1##(2008-10#37)
V(c) that gives##2##3##(2008-10#2)
V(c) was##4##2##(2008-10#4)
V(c)##13##1##(2008-10#13)
V(eq)##3##1##(2008-10#3)
V(max) =##2##2##(2008-11#2)
V(max)##9##1##(2008-10#3)(2008-11#2)(2008-7#3)(2011-3#1)
V(t) andrhoV (alt)##4##3##(2008-9#4)
V) and##4##2##(1990-9#1)(1996-5#1)(2008-10#2)
V) of##2##2##(2008-10#2)
V) was##2##2##(2008-10#2)
V)##23##1##(1990-9#1)(1994-8#1)(1996-5#2)(2008-10#17)(2011-2#1)(2012-2#1)
V-FITC/PI staining##3##2##(2008-11#3)
V-PPase proteins##2##2##(2008-11#2)
V-PPase##5##1##(2008-11#5)
V-shaped##3##1##(2007-12#1)(2008-10#1)(2009-12#1)
V-type##2##1##(1993-6#1)(1994-6#1)
V/K##3##1##(1991-9#2)(1993-8#1)
V/cm##4##1##(2008-10#1)(2008-3#3)
V1 neurons##2##2##(2008-11#2)
V1##10##1##(1994-2#1)(1996-2#1)(2008-11#6)(2008-5#1)(2011-2#1)
V1-V3##2##1##(2008-12#1)(2013-1#1)
V108LRUH1##6##1##(2008-10#6)
V12##2##1##(2008-10#2)
V2##4##1##(1994-11#2)(2008-12#1)(2012-3#1)
V3 cells##2##2##(1996-2#2)
V3##6##1##(1993-1#1)(1995-5#1)(1996-2#2)(2008-10#1)(2008-12#1)
V3-VLPs##2##1##(1995-5#2)
V380M##2##1##(1997-7#2)
V4 and##2##2##(2008-10#1)(2011-2#1)
V4##5##1##(2008-10#1)(2008-11#2)(2011-2#2)
V6 regions##3##2##(2011-2#3)
V762##2##1##(2010-5#2)
V765##2##1##(2010-5#2)
V79 cells##3##2##(1997-3#3)
V79##4##1##(1997-3#3)(2011-1#1)
V8##7##1##(1990-5#2)(1992-3#1)(2008-10#4)
V94-5152##2##1##(2008-10#2)
VA and##2##2##(2011-2#2)
VA is##2##2##(2012-3#1)(2013-1#1)
VA medical centers##2##3##(1991-12#1)(2013-1#1)
VA##19##1##(1991-12#2)(1992-11#1)(1993-12#1)(1997-3#1)(2008-11#1)(2011-2#7)(2012-3#2)(2013-1#4)
VACVase was##2##2##(1995-6#2)
VACVase##4##1##(1995-6#4)
VAChT##2##1##(1996-12#2)
VAD##3##1##(2010-6#3)
VAF##2##1##(1992-9#2)
VAM plants##2##2##(2008-10#2)
VAM resistance##2##2##(2008-10#2)
VAM##7##1##(2008-10#7)
VAM7##2##1##(1996-6#2)
VAS##2##1##(2008-7#1)(2011-2#1)
VAS-I and VAS-U during##2##4##(2008-10#2)
VASobs##3##1##(2012-2#3)
VATER/VACTERL##2##1##(2008-8#2)
VB##2##1##(2008-10#1)(2013-1#1)
VBBO##4##1##(2008-11#4)
VBI##3##1##(2008-12#3)
VBP##2##1##(1992-9#2)
VC types##3##2##(2008-10#3)
VC##7##1##(2008-10#3)(2009-1#4)
VCA##2##1##(2008-3#2)
VCG 0035##2##2##(2008-10#2)
VCG 0083##2##2##(2008-10#2)
VCG 0094 isolates##3##3##(2008-10#3)
VCG 0094##6##2##(2008-10#6)
VCG diversity may##2##3##(2008-10#2)
VCG diversity##4##2##(2008-10#4)
VCG##48##1##(2008-10#47)(2010-8#1)
VCG1A##4##1##(2008-10#4)
VCG2A##4##1##(2008-10#4)
VCG2B isolates##2##2##(2008-10#2)
VCG2B##6##1##(2008-10#6)
VCG4##3##1##(2008-10#3)
VCGs US-01##2##2##(2008-10#2)
VCGs and##4##2##(2008-10#4)
VCGs of##2##2##(2008-10#2)
VCGs were identified among 74 and##2##6##(2008-10#2)
VCGs were identified##3##3##(2008-10#3)
VCGs##35##1##(2008-10#35)
VCO##5##1##(2013-1#5)
VCP##3##1##(1993-9#3)
VCR##5##1##(2012-2#5)
VCSEL's##2##1##(2008-3#2)
VCT##7##1##(2013-1#7)
VCUG##3##1##(2008-10#3)
VCZ at##3##2##(2008-10#3)
VCZ##7##1##(2008-10#7)
VDAC2##2##1##(2011-3#2)
VDD was##3##2##(2011-1#3)
VDD##6##1##(2011-1#6)
VDJ junctions##3##2##(1997-9#3)
VDJ##4##1##(1997-9#4)
VDR and##2##2##(1995-2#1)(1995-8#1)
VDR##7##1##(1995-2#4)(1995-8#1)(1997-7#1)(2013-1#1)
VDRE##3##1##(1995-8#2)(2012-12#1)
VDREs##2##1##(1995-8#2)
VDS##2##1##(1992-12#2)
VEGF Trap##3##2##(2013-8#3)
VEGF and##3##2##(2008-1#1)(2008-11#1)(2008-9#1)
VEGF expression in##3##3##(2008-9#2)(2010-12#1)
VEGF expression##8##2##(2008-9#3)(2009-8#4)(2010-12#1)
VEGF in##3##2##(2008-1#1)(2008-9#1)(2013-8#1)
VEGF protein##3##2##(2008-9#2)(2009-8#1)
VEGF secretion##2##2##(2013-8#2)
VEGF##39##1##(1994-11#1)(2008-1#2)(2008-11#2)(2008-8#2)(2008-9#11)(2009-8#8)(2010-12#1)(2013-8#12)
VEGF-A##2##1##(2013-1#2)
VEGF/VPF levels in the sera##2##5##(1994-3#2)
VEGF/VPF levels in##3##3##(1994-3#3)
VEGF/VPF##4##1##(1994-3#3)(2008-9#1)
VEP##3##1##(1990-9#1)(1996-2#2)
VER and##2##2##(2008-10#2)
VET##3##1##(2008-2#3)
VF##2##1##(2013-8#2)
VFA##2##1##(2008-10#2)
VFAs in##2##2##(2008-10#2)
VFAs were##2##2##(2008-10#2)
VFAs##6##1##(2008-10#6)
VFC##3##1##(1996-12#3)
VH##5##1##(1995-1#2)(1997-2#1)(1997-9#1)(2008-11#1)
VI and##3##2##(1994-2#1)(1997-2#1)(2013-1#1)
VI collagen##8##2##(1993-3#7)(2013-8#1)
VI of##5##2##(1990-5#1)(1991-3#1)(1997-6#3)
VI segment##2##2##(1991-6#1)(2013-1#1)
VI##42##1##(1990-5#1)(1991-3#1)(1991-6#1)(1993-3#7)(1994-2#5)(1995-11#1)(1995-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#5)(2007-12#2)(2008-10#7)(2008-5#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
VI) at##2##2##(2008-10#1)(2008-12#1)
VI)##12##1##(1994-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2012-3#1)
VIC##2##1##(2008-10#2)
VII and VIII##2##3##(2009-10#1)(2012-2#1)
VII and##3##2##(1991-6#1)(2009-10#1)(2012-2#1)
VII collagen##4##2##(1992-3#4)
VII##30##1##(1991-6#1)(1992-3#4)(1994-2#4)(1995-12#2)(1995-9#2)(1996-3#3)(1996-6#3)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#2)
VII) and Pb(II)##2##3##(2008-10#2)
VII) and##3##2##(1994-8#1)(2008-10#2)
VII)##5##1##(1994-8#1)(2008-10#4)
VII-VIII##2##1##(2009-10#1)(2012-3#1)
VIII and IX##4##3##(2008-10#1)(2011-2#3)
VIII and##8##2##(1994-8#1)(1995-2#1)(2008-10#2)(2011-2#3)(2012-2#1)
VIII##27##1##(1990-8#4)(1991-3#1)(1993-6#3)(1994-12#1)(1994-8#2)(1994-9#2)(1995-2#2)(1996-3#1)(2008-10#2)(2008-5#1)(2009-10#2)(2011-2#4)(2012-2#2)
VIII)##2##1##(1991-5#1)(1994-8#1)
VIP = PACAP-27##2##3##(1994-3#2)
VIP interview##3##2##(1994-1#1)(1994-2#1)(1995-2#1)
VIP##18##1##(1990-5#4)(1994-1#1)(1994-2#1)(1994-3#4)(1995-1#1)(1995-11#6)(1995-2#1)
VIP-receptor antagonist##2##2##(1995-11#2)
VIP-receptor##3##1##(1994-3#1)(1995-11#2)
VIP/NPY or VIP/C-PON IR##2##4##(1990-5#2)
VISION 2020##3##2##(2011-2#3)
VK210##2##1##(2012-12#2)
VKC##2##1##(2012-3#2)
VLA-4##2##1##(2008-5#2)
VLCAD##2##1##(1993-3#2)
VLDL and##2##2##(1995-6#1)(2012-2#1)
VLDL from##3##2##(1991-12#2)(1995-6#1)
VLDL receptor##10##2##(1995-6#10)
VLDL to##2##2##(1991-12#1)(1995-6#1)
VLDL was##2##2##(1991-12#1)(1995-6#1)
VLDL##30##1##(1991-12#10)(1995-6#16)(1995-8#1)(2008-3#1)(2012-2#1)(2013-1#1)
VLE##2##1##(2008-12#2)
VLM##2##1##(2012-2#2)
VLP preparations##3##2##(2008-10#3)
VLP##5##1##(2008-10#5)
VLPs carrying the##2##3##(1995-5#2)
VLPs carrying##3##2##(1995-5#3)
VM ratios for cyst##2##4##(2008-10#2)
VMT##8##1##(2013-1#8)
VNC##2##1##(2008-5#2)
VNO##2##1##(1994-2#2)
VO##3##1##(2008-11#2)(2011-2#1)
VO(2+) ions##2##2##(2008-10#2)
VO(2+)##9##1##(2008-10#9)
VO2max##7##1##(2012-2#3)(2013-1#4)
VO2max/kg##2##1##(2012-2#2)
VO613Y##2##1##(2008-10#2)
VOC##5##1##(2008-10#2)(2008-11#2)(2011-10#1)
VOCl(2) and NH(4)VO(3)##2##3##(2008-10#2)
VOCl(2)##4##1##(2008-10#4)
VOCs in soils##2##3##(2008-10#2)
VOCs in##5##2##(2008-10#5)
VOCs were##2##2##(2008-10#1)(2008-11#1)
VOCs##12##1##(2008-10#11)(2008-11#1)
VOHC##3##1##(2008-10#3)
VOX##3##1##(2008-10#3)
VP shunt in a patient with##2##6##(2008-7#2)
VP##3##1##(2008-5#1)(2008-7#2)
VP-16##3##1##(1992-12#3)
VP-SFM##3##1##(2008-11#3)
VP1 coding##3##2##(2013-8#3)
VP1 gene sequences##3##3##(2008-12#3)
VP1 gene##4##2##(1997-8#1)(2008-12#3)
VP1##12##1##(1997-8#3)(2008-12#3)(2013-8#6)
VP4/VP2##2##1##(2013-8#2)
VP6 mRNA##2##2##(2008-5#2)
VP6 protein##2##2##(2008-5#2)
VP6##5##1##(2008-5#5)
VPA (300 mg/kg##2##3##(2011-2#2)
VPA and PH##2##3##(2011-1#2)
VPA and##3##2##(2010-7#1)(2011-1#2)
VPA is##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
VPA treatment##2##2##(2008-7#1)(2011-2#1)
VPA##22##1##(2008-7#4)(2010-7#1)(2011-1#3)(2011-2#12)(2013-1#2)
VPD##3##1##(2008-10#3)
VPS##2##1##(1993-12#2)
VR can##2##2##(1992-3#1)(2009-11#1)
VR##6##1##(1992-3#2)(2009-11#3)(2013-1#1)
VR1-like protein##2##2##(2008-11#2)
VRCs##8##1##(2008-11#8)
VRN1##2##1##(2009-8#1)(2012-3#1)
VRN2##3##1##(2009-8#3)
VS cells##4##2##(2008-11#4)
VS##6##1##(2008-11#5)(2011-2#1)
VSCs##3##1##(2008-10#3)
VSG expression##2##2##(2011-2#2)
VSG##4##1##(2011-2#4)
VSGs##2##1##(2011-2#2)
VSMC and GMC##2##3##(2008-1#2)
VSMC##5##1##(1993-2#1)(2008-1#2)(2008-9#2)
VT##6##1##(1991-2#1)(2008-10#5)
VTA##3##1##(1996-12#2)(1996-5#1)
VTE after##2##2##(2012-3#2)
VTE##7##1##(2012-3#7)
VU##4##1##(1994-12#4)
VUMC##2##1##(1996-1#2)
VUR##4##1##(2008-10#4)
VV##3##1##(2008-10#3)
VVC##2##1##(2008-5#2)
VWA STR##3##2##(2008-12#3)
VWA##6##1##(2008-12#6)
Va##9##1##(1994-5#7)(1997-3#1)(2008-9#1)
Vaccination##6##1##(1990-3#1)(1995-3#1)(1996-1#1)(2008-5#1)(2013-1#2)
Vaccine in##2##2##(2012-3#1)(2013-1#1)
Vaccine strategies##2##2##(1995-5#2)
Vaccine##12##1##(1995-5#4)(1996-9#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Vaccines##6##1##(1995-5#1)(1996-12#2)(2008-11#1)(2008-8#1)(2013-1#1)
Vacuum##2##1##(1996-9#2)
Vaginal hysterectomy##5##2##(1994-2#2)(1995-1#1)(1995-12#2)
Vaginal##12##1##(1992-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(2008-12#1)(2009-2#1)(2011-2#2)(2011-5#1)
Vagus nerve stimulation##2##3##(2008-7#2)
Val##4##1##(1991-9#1)(1993-2#1)(1994-5#1)(2008-9#1)
Valencia (Spain)##3##2##(2008-10#3)
Valencia##8##1##(1996-2#1)(2008-10#7)
Validation and##3##2##(1997-3#1)(2010-10#1)(2012-3#1)
Validation of a high performance liquid chromatography##2##7##(2008-10#1)(2008-5#1)
Validation of a##6##3##(1995-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
Validation of an##2##3##(2008-10#1)(2012-12#1)
Validation of reducing-difference procedure##2##4##(2008-10#2)
Validation of the method according to the quality assurance standards##2##10##(2008-10#2)
Validation of the method##4##4##(2008-10#4)
Validation of the##11##3##(2008-10#9)(2011-2#1)(2012-2#1)
Validation of##31##2##(1995-12#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
Validation on##2##2##(2008-10#2)
Validation was carried out##2##4##(2008-10#2)
Validation was##3##2##(2008-10#3)
Validation##46##1##(1995-12#1)(1997-3#1)(2008-10#28)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
Validations##2##1##(2008-2#1)(2010-8#1)
Validity and reliability##2##3##(2010-10#1)(2013-1#1)
Validity of##2##2##(1995-12#1)(2013-1#1)
Validity##5##1##(1995-12#1)(2010-10#2)(2013-1#2)
Valley Regional##2##2##(1992-12#1)(2008-9#1)
Valley in##4##2##(2008-10#4)
Valley of California##2##3##(2008-10#2)
Valley of##6##2##(2008-10#6)
Valley##41##1##(1991-2#1)(1992-12#1)(1994-9#2)(2008-10#33)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Valley)##2##1##(2008-10#1)(2013-1#1)
Valleys##2##1##(2008-10#2)
Valproic##2##1##(2011-2#1)(2013-1#1)
Valsalva##6##1##(1994-3#1)(1997-5#3)(2012-2#1)(2012-3#1)
Valsalva's manoeuvre##2##2##(2008-9#2)
Value for##2##2##(2009-9#1)(2013-1#1)
Value of##6##2##(1996-6#1)(1997-5#1)(2011-6#1)(2012-3#1)(2013-1#2)
Value##10##1##(1996-6#1)(1997-5#1)(2008-10#2)(2009-9#1)(2011-6#1)(2012-3#1)(2013-1#3)
Values for##2##2##(2008-12#1)(2008-5#1)
Values of the##5##3##(2008-10#3)(2008-3#1)(2008-7#1)
Values of##14##2##(2008-10#10)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)
Values##19##1##(1995-12#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#2)(2012-3#1)
Valvular##2##1##(2008-11#1)(2010-12#1)
Van Handel##2##2##(2008-10#2)
Van##10##1##(1992-2#1)(1994-5#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-8#4)
Van't Hoff##3##2##(1997-2#1)(2008-10#2)
Vanadium##3##1##(2008-10#2)(2011-2#1)
Vanadium(IV)##3##1##(2008-10#3)
Vanadium(V)##3##1##(2008-10#3)
Vancomycin##2##1##(1991-3#1)(2010-6#1)
Vancouver Island##4##2##(2008-10#4)
Vancouver##10##1##(2008-10#4)(2008-12#2)(2011-2#2)(2013-8#2)
Vanderbilt University Medical Center##2##4##(1996-1#1)(1996-2#1)
Vanderbilt University##3##2##(1996-1#1)(1996-2#1)(2008-3#1)
Vanderbilt##4##1##(1996-1#2)(1996-2#1)(2008-3#1)
Vanuatu##2##1##(2008-1#2)
Vapour##3##1##(2008-10#2)(2008-5#1)
Varanasi##3##1##(2008-10#2)(2012-2#1)
Variability Within and Among##2##4##(2008-10#2)
Variability Within##3##2##(2008-10#3)
Variability in the##3##3##(2008-10#3)
Variability in##10##2##(1991-12#1)(2008-10#7)(2008-7#1)(2008-8#1)
Variability of##7##2##(1993-2#1)(2008-10#4)(2008-9#1)(2009-2#1)
Variability##26##1##(1990-11#1)(1991-12#1)(1993-2#1)(2008-10#18)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2013-8#1)
Variable##15##1##(1994-11#1)(1994-3#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-1#1)(2012-3#1)
Variables affecting the##3##3##(2008-10#3)
Variables##11##1##(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)
Varian##5##1##(2008-10#4)(2009-11#1)
Variance##2##1##(2008-10#1)(2009-1#1)
Variant##4##1##(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
Variants##6##1##(1994-12#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
Variation Among##3##2##(2008-10#3)
Variation and##3##2##(2008-10#3)
Variation at the##2##3##(2008-10#2)
Variation in Pathogenicity##2##3##(2008-10#2)
Variation in the##3##3##(1995-8#1)(2008-10#1)(2008-4#1)
Variation in##21##2##(1993-3#1)(1994-1#1)(1995-8#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-8#1)(2012-2#1)
Variation of##4##2##(2008-10#3)(2010-12#1)
Variation over the range of the standard curve was less than##2##11##(2008-10#2)
Variation##41##1##(1993-3#1)(1994-1#1)(1995-8#1)(2008-10#27)(2008-11#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
Variations in the##4##3##(1991-12#1)(2008-10#2)(2009-11#1)
Variations in##17##2##(1991-12#1)(1992-4#1)(1994-11#2)(1995-12#1)(1996-3#2)(1997-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-8#1)
Variations of##2##2##(2008-10#2)
Variations##20##1##(1991-12#1)(1992-4#1)(1994-11#2)(1995-12#1)(1996-3#3)(1997-2#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-8#1)
Varied levels of##2##3##(2008-10#1)(2008-11#1)
Varieties##4##1##(1994-1#1)(2008-10#3)
Variograms##2##1##(2008-10#2)
Various aspects of##2##3##(2008-10#2)
Various combinations of the##2##4##(2008-10#1)(2008-11#1)
Various conditions were optimized for practical application##2##7##(2008-10#2)
Various conditions##3##2##(2008-10#3)
Various experimental conditions##2##3##(2008-10#2)
Various factors##4##2##(1997-1#1)(2008-10#3)
Various imaging##2##2##(2010-7#1)(2011-2#1)
Various issues##2##2##(1990-6#1)(2011-2#1)
Various methods##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2009-5#1)
Various other##2##2##(2008-10#1)(2012-2#1)
Various parameters such as the effect of pH##5##8##(2008-10#5)
Various parameters such as##6##4##(2008-10#6)
Various parameters##13##2##(2008-10#13)
Various physio-chemical parameters##2##3##(2008-10#2)
Various physio-chemical##3##2##(2008-10#3)
Various procedures##2##2##(2009-9#1)(2010-7#1)
Various techniques of##2##3##(2012-3#1)(2013-8#1)
Various techniques##4##2##(2008-9#1)(2012-3#2)(2013-8#1)
Various types of##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
Various##116##1##(1990-6#1)(1991-7#1)(1992-5#1)(1993-1#1)(1993-8#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#54)(2008-11#8)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-7#3)(2011-2#3)(2012-2#5)(2012-3#6)(2013-8#3)
Varroa destructor##2##2##(2013-1#2)
Varroa##7##1##(2013-1#7)
Varunda##2##1##(2008-10#2)
Varying##4##1##(2008-10#2)(2008-11#1)(2011-1#1)
Vascular complications are##2##3##(2010-10#1)(2010-7#1)
Vascular endothelial cells##2##3##(1996-12#1)(2010-1#1)
Vascular endothelial growth factor (VEGF) is a##2##7##(1994-11#1)(2008-11#1)
Vascular endothelial growth factor (VEGF)##3##5##(1994-11#1)(2008-11#1)(2008-9#1)
Vascular endothelial growth##4##3##(1994-11#1)(1994-3#1)(2008-11#1)(2008-9#1)
Vascular endothelial##6##2##(1994-11#1)(1994-3#1)(1996-12#1)(2008-11#1)(2008-9#1)(2010-1#1)
Vascular smooth muscle cells##2##4##(1992-8#1)(2009-7#1)
Vascular##28##1##(1991-6#1)(1992-8#1)(1994-11#2)(1994-3#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-3#1)(2012-12#1)
Vasculitic##2##1##(2012-3#1)(2013-1#1)
Vasopressin##3##1##(1990-12#1)(1994-2#2)
Vasospasm##7##1##(1996-9#1)(1997-5#1)(2008-12#1)(2011-2#2)(2012-3#2)
Vb##3##1##(1991-11#3)
Vcyto##6##1##(1991-11#6)
Vector Circulifer##2##2##(2008-10#2)
Vector##24##1##(1997-7#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#1)
Vegard's law##2##2##(2008-10#2)
Vegetation##2##1##(2008-11#1)(2008-9#1)
Vegetative Compatibility Groups in##3##4##(2008-10#3)
Vegetative Compatibility Groups##5##3##(2008-10#5)
Vegetative Compatibility##9##2##(2008-10#9)
Vegetative compatibility##3##2##(2008-10#3)
Vegetative growth##2##2##(2008-10#1)(2008-8#1)
Vegetative indices calculated from##2##4##(2008-10#2)
Vegetative##17##1##(2008-10#16)(2008-8#1)
Veggie- CHO##2##2##(2008-11#2)
Veggie-CHO##3##1##(2008-11#3)
Vein of Galen##2##3##(1996-3#2)
Vein##5##1##(1996-3#2)(2008-12#2)(2013-1#1)
Veins##2##1##(2011-2#2)
Velocities for the synthesis of##2##5##(2009-8#2)
Velocities##3##1##(2008-8#1)(2009-8#2)
Venezuela##15##1##(1992-5#1)(2008-10#7)(2008-5#5)(2011-2#2)
Venezuelan crude##3##2##(2008-10#3)
Venezuelan patients with##2##3##(2009-10#1)(2011-2#1)
Venezuelan patients##3##2##(2009-10#1)(2011-2#2)
Venezuelan patients]##2##2##(2011-2#2)
Venezuelan##15##1##(2008-10#7)(2009-10#1)(2011-2#7)
Venice##4##1##(2008-11#3)(2011-2#1)
Venocuff##2##1##(2013-1#2)
Venous blood##2##2##(1991-6#1)(2013-1#1)
Venous thromboembolism##2##2##(2012-3#1)(2013-8#1)
Venous##10##1##(1990-3#1)(1991-6#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
Ventilation##2##1##(1996-12#1)(2010-7#1)
Ventilator##2##1##(1994-12#1)(2010-7#1)
Venturia inaequalis and##3##3##(2008-10#3)
Venturia inaequalis was##3##3##(2008-10#3)
Venturia inaequalis##27##2##(2008-10#27)
Venturia nashicola##5##2##(2008-10#5)
Venturia pirina##2##2##(2008-10#2)
Venturia species##2##2##(2008-10#2)
Venturia##40##1##(2008-10#40)
Venus flytrap##4##2##(2009-8#4)
Venus##7##1##(1991-5#2)(2008-11#1)(2009-8#4)
VeraBond##2##1##(2013-1#2)
Verbal##4##1##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
Verdelho##2##1##(2008-10#2)
Verification of##5##2##(1993-9#1)(2008-10#2)(2011-2#1)(2012-2#1)
Verification##8##1##(1993-9#1)(2008-10#3)(2008-3#2)(2011-2#1)(2012-2#1)
Verisyse##4##1##(2011-2#4)
Vermont##5##1##(1992-2#1)(1994-2#2)(2010-8#2)
Vermont's##3##1##(1994-2#1)(1997-1#2)
Vero and##4##2##(2008-11#3)(2008-8#1)
Vero cell##4##2##(2008-11#3)(2008-9#1)
Vero cells##12##2##(2008-11#9)(2008-9#2)(2011-2#1)
Vero##27##1##(1994-3#1)(2008-11#20)(2008-8#1)(2008-9#3)(2011-2#1)(2012-2#1)
Verrucous carcinoma##2##2##(2009-10#2)
Versatile##3##1##(1993-2#1)(2008-11#1)(2011-2#1)
Version##11##1##(1994-12#4)(1996-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-1#1)
Versus##3##1##(2012-3#2)(2013-1#1)
Vertebral##9##1##(1991-8#1)(2007-8#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
Vertebrate##2##1##(1995-12#1)(2012-3#1)
Vertical##9##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-11#1)(2010-5#1)(2011-2#2)
Verticillium dahliae and##2##3##(2008-10#1)(2008-12#1)
Verticillium dahliae by##2##3##(2008-10#2)
Verticillium dahliae in##3##3##(2008-10#3)
Verticillium dahliae isolates from##2##4##(2008-10#2)
Verticillium dahliae isolates##3##3##(2008-10#3)
Verticillium dahliae##34##2##(2008-10#32)(2008-12#2)
Verticillium isolates##2##2##(2008-10#2)
Verticillium lecanii and##2##3##(2008-10#2)
Verticillium lecanii##6##2##(2008-10#4)(2008-5#2)
Verticillium spp##4##2##(2008-10#4)
Verticillium wilt and##2##3##(2008-10#2)
Verticillium wilt development##3##3##(2008-10#3)
Verticillium wilt on cauliflower##2##4##(2008-10#2)
Verticillium wilt##16##2##(2008-10#16)
Verticillium##73##1##(2008-10#69)(2008-12#2)(2008-5#2)
Very few cases##2##3##(2012-12#1)(2013-1#1)
Very few##9##2##(1990-2#1)(1992-3#1)(2008-10#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
Very high##2##2##(1992-2#1)(2008-10#1)
Very little##3##2##(2008-1#1)(2008-10#1)(2009-8#1)
Very similar##2##2##(2008-10#1)(2008-11#1)
Very##26##1##(1990-2#1)(1991-10#1)(1992-2#1)(1992-3#1)(1995-6#1)(1996-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
Vesicles##2##1##(2008-10#1)(2008-11#1)
Vesicoureteral reflux (VUR) is##2##4##(2008-10#2)
Vesicoureteric reflux##2##2##(2008-1#1)(2008-10#1)
Vessel##2##1##(2010-9#1)(2012-5#1)
Vest-Agder##3##1##(1997-4#1)(1997-8#2)
Veterans Administration##3##2##(1991-12#1)(2009-11#1)(2012-12#1)
Veterans Affairs Medical Center##3##4##(1990-11#1)(1992-2#1)(1995-2#1)
Veterans Affairs##9##2##(1990-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(2008-6#1)(2009-11#1)(2011-2#1)(2013-1#1)
Veterans and##2##2##(2013-1#2)
Veterans who##2##2##(2013-1#2)
Veterans##25##1##(1990-11#1)(1991-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-5#1)(2008-6#1)(2008-7#2)(2009-11#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#8)
Veterinary College##5##2##(2013-8#5)
Veterinary Medicine##3##2##(2010-1#1)(2013-8#2)
Veterinary Sciences##2##2##(1996-12#1)(2011-2#1)
Veterinary manpower and 24-hour service##3##5##(1995-9#3)
Veterinary medical ethics##2##3##(2012-3#1)(2013-8#1)
Veterinary##25##1##(1991-8#1)(1992-2#1)(1995-9#4)(1996-12#2)(1997-7#1)(2008-11#1)(2010-1#2)(2011-2#2)(2012-3#1)(2013-8#10)
Vf resistance##2##2##(2008-10#2)
Vf##18##1##(2008-10#18)
Vg and##2##2##(2008-10#2)
Vg##17##1##(2008-10#17)
Via##3##1##(1994-9#1)(2012-3#1)(2013-1#1)
Viability in##2##2##(2008-10#1)(2008-11#1)
Viability of the adherent cells was determined by alamarBlue(R) assay after 2##2##12##(2008-11#2)
Viability of the##5##3##(1996-12#1)(2008-10#2)(2008-11#2)
Viability of##8##2##(1996-12#1)(2008-10#4)(2008-11#2)(2008-9#1)
Viability##14##1##(1996-12#1)(2008-10#7)(2008-11#3)(2008-9#1)(2010-11#1)(2012-3#1)
Viable##9##1##(2008-10#6)(2008-11#2)(2008-9#1)
Vibrational##6##1##(1992-11#1)(2008-10#2)(2008-3#3)
Vibrio anguillarum##2##2##(2011-2#2)
Vibrio cholerae##12##2##(1990-5#2)(1992-5#1)(1994-11#1)(2008-10#1)(2008-9#3)(2009-8#2)(2012-3#2)
Vibrio fischeri##8##2##(2008-10#7)(2013-8#1)
Vibrio splendidus and a V##2##5##(2009-6#2)
Vibrio##29##1##(1990-5#2)(1992-5#1)(1994-11#1)(1997-8#2)(2008-10#10)(2008-9#3)(2009-6#3)(2009-8#2)(2011-2#2)(2012-3#2)(2013-8#1)
Vice##4##1##(1994-1#1)(1995-2#1)(2008-8#1)(2009-5#1)
Vicente##2##1##(1993-3#1)(2012-12#1)
Vichada##3##1##(2012-12#3)
Vicia faba##10##2##(2008-10#4)(2008-8#6)
Vicia##11##1##(2008-10#5)(2008-8#6)
Vickers##3##1##(1995-3#1)(2009-7#1)(2011-2#1)
Victimization##2##1##(2010-1#1)(2013-1#1)
Victims##3##1##(1996-11#1)(2012-12#1)(2013-1#1)
Victor##2##1##(1993-2#1)(2008-10#1)
Victoria Harbor##3##2##(2010-5#3)
Victoria and##2##2##(2008-10#2)
Victoria blue derivatives##2##3##(2008-11#2)
Victoria blue##5##2##(2008-10#2)(2008-11#3)
Victoria##22##1##(1992-2#2)(1994-1#2)(2008-10#4)(2008-11#7)(2008-5#2)(2010-5#3)(2010-8#1)(2011-1#1)
Video##2##1##(2010-11#1)(2012-2#1)
Video-assisted hemithyroidectomy was##2##3##(2012-12#2)
Video-assisted##4##1##(2007-8#1)(2012-12#3)
Vienna##4##1##(1995-11#1)(1996-3#1)(2011-2#1)(2013-1#1)
Vietnam##5##1##(1993-2#1)(2008-10#1)(2009-7#1)(2010-10#1)(2010-3#1)
Vietnamese women was##2##3##(2010-3#2)
Vietnamese women##6##2##(2010-3#6)
Vietnamese##7##1##(1995-12#1)(2010-3#6)
View##4##1##(2008-4#3)(2008-9#1)
Viewed##2##1##(1993-12#1)(1994-5#1)
Viewer##3##1##(2008-4#1)(2008-5#2)
Viewing##4##1##(2008-11#1)(2008-4#1)(2009-12#1)(2010-7#1)
Views of##2##2##(2008-12#1)(2013-1#1)
Vigna radiata##3##2##(1995-2#1)(2008-12#2)
Vignette##2##1##(1994-9#1)(2012-3#1)
Vignettes##2##1##(1995-3#1)(1995-6#1)
Vigorous##2##1##(2008-7#1)(2011-2#1)
Village##3##1##(1994-1#1)(2008-6#2)
Vim DBS##5##2##(2012-3#5)
Vim##6##1##(2012-3#6)
Vinca##3##1##(2008-10#3)
Vinclozolin##2##1##(2008-10#2)
Vines inoculated##2##2##(2008-10#2)
Vines##4##1##(2008-10#3)(2013-1#1)
Vineyards##2##1##(2008-10#2)
Vinorelbine##3##1##(1994-8#3)
Vinyl##2##1##(1996-5#1)(2009-5#1)
Violence and##2##2##(1995-3#1)(2008-11#1)
Violence##12##1##(1991-12#2)(1995-3#1)(1996-12#1)(2008-1#1)(2008-11#2)(2009-12#1)(2010-11#1)(2012-12#2)(2013-1#1)
Vipera ammodytes##2##2##(1995-8#2)
ViraType##3##1##(1994-1#3)
Viral Accumulation##2##2##(2008-10#2)
Viral DNA##2##2##(2008-10#2)
Viral transformation of##2##3##(1997-7#1)(2008-4#1)
Viral##36##1##(1994-1#1)(1994-12#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#16)(2008-12#1)(2008-4#1)(2008-5#1)(2009-6#2)(2010-1#1)(2010-7#2)(2011-2#2)(2013-1#2)(2013-8#3)
Virgin##2##1##(2008-10#1)(2013-1#1)
Virginia##13##1##(1990-8#1)(1992-3#1)(1995-12#1)(1995-6#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#2)
Virginia's##3##1##(1997-2#1)(1997-6#2)
Virions were##2##2##(2008-10#2)
Virions##4##1##(2008-10#4)
Viroid interactions##2##2##(2008-10#2)
Virological##2##1##(2009-5#1)(2013-1#1)
Virosomes##2##1##(1990-2#2)
Virtual lesion extension##2##3##(2008-10#2)
Virtual##9##1##(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-11#1)(2011-2#1)(2011-7#1)
Virtually all##2##2##(1994-11#1)(1995-12#1)
Virtually every##2##2##(2008-4#1)(2008-9#1)
Virtually##6##1##(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
Virulence Diversity##2##2##(2008-10#2)
Virulence and Molecular##2##3##(2008-10#2)
Virulence and##6##2##(2008-10#6)
Virulence assays##2##2##(2008-10#2)
Virulence in##5##2##(2008-10#5)
Virulence of##4##2##(2008-10#4)
Virulence on##3##2##(2008-10#3)
Virulence to##2##2##(2008-10#2)
Virulence##36##1##(2008-10#35)(2011-1#1)
Virulences##2##1##(2008-10#2)
Virulent Strain of##2##3##(2008-10#2)
Virulent Strain##3##2##(2008-10#3)
Virulent##4##1##(2008-10#4)
Viruliferous##3##1##(2008-10#3)
Virus Accumulation##2##2##(2008-10#2)
Virus Infection##4##2##(2011-2#2)(2013-8#2)
Virus from##2##2##(1994-12#1)(2008-10#1)
Virus production##2##2##(2008-11#2)
Virus##63##1##(1990-2#1)(1994-12#1)(1995-12#1)(2008-1#1)(2008-10#34)(2008-11#12)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#3)
Virus-transfected strains##3##2##(2008-10#3)
Viruses in the##3##3##(2008-10#3)
Viruses##16##1##(1996-5#2)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#4)
Visceral##5##1##(2008-11#1)(2012-2#2)(2013-1#2)
Viscoelastic##2##1##(2009-3#1)(2009-7#1)
Viscum album&quot##4##2##(1993-2#4)
Visible and##2##2##(2008-10#2)
Visible##10##1##(1992-1#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-3#2)
Visitors##2##1##(1992-2#1)(2008-1#1)
Vista Hill##2##2##(1993-2#2)
Vistula##4##1##(2008-11#4)
Visual Analog##3##2##(2008-12#1)(2012-3#2)
Visual Analogue Scale##2##3##(1991-2#1)(2013-1#1)
Visual Commentary##5##2##(2008-8#5)
Visual acuity##2##2##(1991-2#1)(2008-7#1)
Visual inspection of##2##3##(2008-11#1)(2010-7#1)
Visual inspection##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
Visual test scales for##2##4##(2008-10#2)
Visual##33##1##(1990-8#1)(1991-2#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-7#3)(2008-8#7)(2008-9#1)(2010-7#1)(2012-3#4)(2013-1#2)(2013-8#1)
Visualization of##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2010-7#1)(2012-2#1)
Visualization##9##1##(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2012-2#1)(2013-1#2)
Visualizing##2##1##(2008-9#1)(2011-2#1)
Vit##4##1##(2008-11#1)(2013-1#3)
VitC##5##1##(2008-5#5)
Vital Capacity##2##2##(2011-2#2)
Vital capacity##2##2##(2012-3#2)
Vital##8##1##(1990-2#1)(1997-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
Vitality##2##1##(2008-10#1)(2013-1#1)
Vitamin A##3##2##(1992-6#1)(2008-5#1)(2009-8#1)
Vitamin B(12) from milk##2##4##(2008-10#2)
Vitamin B(12)##4##2##(2008-10#3)(2008-11#1)
Vitamin B12##2##2##(1993-12#1)(2010-1#1)
Vitamin B6 metabolism influences the##2##5##(2013-1#2)
Vitamin B6##3##2##(1992-9#1)(2013-1#2)
Vitamin C determination##2##3##(2008-10#2)
Vitamin C##14##2##(1992-9#1)(2008-10#9)(2008-5#2)(2010-7#1)(2012-2#1)
Vitamin D deficiency is associated with##2##6##(2011-2#1)(2012-3#1)
Vitamin D deficiency##4##3##(2011-2#1)(2012-2#2)(2012-3#1)
Vitamin D##13##2##(1994-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)
Vitamin D(2)##2##2##(2008-10#2)
Vitamin D(3) and 25-OH-D(3)##3##4##(2008-10#3)
Vitamin D(3) and##5##3##(2008-10#5)
Vitamin E and##2##3##(1992-9#2)
Vitamin E##11##2##(1991-12#1)(1992-9#5)(1994-5#1)(2008-10#3)(2008-5#1)
Vitamin d##2##2##(2011-1#1)(2012-2#1)
Vitamin##68##1##(1990-5#1)(1991-12#1)(1992-6#1)(1992-9#7)(1993-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(2008-10#27)(2008-11#2)(2008-5#5)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)
Vitamins##3##1##(1992-9#1)(2008-10#1)(2008-5#1)
Viterbi decoders##2##2##(2008-3#2)
Vitiligo##2##1##(2010-6#1)(2013-1#1)
Vitis vinifera L##2##3##(2009-8#2)
Vitis vinifera cultivars##2##3##(2008-10#2)
Vitis vinifera##10##2##(2008-10#8)(2009-8#2)
Vitis##13##1##(2008-10#11)(2009-8#2)
Vitronectin##2##1##(2008-11#2)
Vm and Km##2##3##(1991-9#2)
Vmax =##3##2##(1991-5#1)(1992-3#1)(1996-12#1)
Vmax by##2##2##(1994-8#2)
Vmax levels were##2##3##(1995-8#2)
Vmax levels##6##2##(1995-8#6)
Vmax of##8##2##(1991-5#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-6#2)
Vmax values for##2##3##(1990-10#1)(1994-6#1)
Vmax values##5##2##(1990-10#1)(1994-5#1)(1994-6#1)(1995-8#2)
Vmax was##2##2##(1991-5#1)(1993-6#1)
Vmax##29##1##(1990-10#1)(1990-2#1)(1990-5#1)(1991-5#3)(1992-3#2)(1993-6#2)(1993-8#1)(1994-5#3)(1994-6#3)(1994-8#3)(1995-8#8)(1996-12#1)
Vocal##3##1##(2008-11#2)(2008-9#1)
Vocational##2##1##(1991-8#1)(1992-3#1)
Vogelsang##3##1##(1995-12#3)
Voice of##2##2##(2008-12#1)(2010-4#1)
Voice##4##1##(1997-3#1)(2008-12#1)(2010-4#1)(2013-8#1)
Vol##4##1##(1990-11#1)(2008-11#2)(2008-5#1)
Volatile components##2##2##(2008-10#1)(2013-8#1)
Volatile##9##1##(2008-10#6)(2008-11#1)(2008-3#1)(2013-8#1)
Volatiles##2##1##(2008-10#2)
Volatilization##3##1##(2008-10#3)
Voltage##3##1##(1990-8#1)(1995-11#1)(2011-1#1)
Voltammetric and##2##2##(2008-10#2)
Voltammetric behavior of##4##3##(2008-10#4)
Voltammetric behavior##5##2##(2008-10#5)
Voltammetric behaviour##2##2##(2008-10#2)
Voltammetric determination of 4-nitrophenol at a##2##6##(2008-10#2)
Voltammetric determination of##18##3##(2008-10#18)
Voltammetric peak##2##2##(2008-10#2)
Voltammetric##41##1##(2008-10#41)
Voltammetry of##4##2##(2008-10#4)
Voltammetry##6##1##(2008-10#6)
Volume effects##3##2##(2009-7#3)
Volume overlap##2##2##(2009-2#2)
Volume##20##1##(1991-2#1)(1992-2#1)(1993-12#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-12#1)(2009-2#2)(2009-7#3)(2010-11#1)(2011-2#6)
Volumetric##3##1##(2008-10#1)(2011-2#1)(2011-7#1)
Voluntary##7##1##(1993-1#2)(1994-2#2)(2010-5#1)(2012-12#1)(2013-1#1)
Volunteer Administration##4##2##(1992-1#1)(1994-3#2)(1995-12#1)
Volunteer##11##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#3)(1993-2#1)(1994-3#2)(1995-12#2)
Volunteerism##2##1##(1991-2#1)(1992-3#1)
Volunteers and##2##2##(1992-12#1)(1993-12#1)
Volunteers are##2##2##(1993-2#1)(1994-12#1)
Volunteers were##2##2##(1992-3#1)(2013-1#1)
Volunteers##12##1##(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1996-12#1)(2010-8#1)(2013-1#1)
Volvulus##2##1##(1991-6#1)(2013-1#1)
Von##2##1##(1994-6#1)(2013-1#1)
Vortex##2##1##(1996-9#1)(2007-12#1)
Voting##2##1##(1996-5#1)(2010-8#1)
Vpr and Vpx in##2##4##(1997-3#2)
Vpr and Vpx##6##3##(1997-3#6)
Vpr##13##1##(1997-3#13)
Vpu##4##1##(2013-1#4)
Vpx of HIV-1##2##3##(1997-3#2)
Vpx##9##1##(1997-3#9)
Vrn-A1##2##1##(2012-3#2)
Vrn-B1 allele##2##2##(2012-3#2)
Vrn-B1 alleles##2##2##(2012-3#2)
Vrn-B1##6##1##(2012-3#6)
Vs##5##1##(2008-10#5)
Vtg##4##1##(2010-5#4)
Vulnerability to##2##2##(2010-1#1)(2012-3#1)
W (-1)##2##2##(2007-11#2)
W (VI)##7##2##(2008-10#7)
W = 0##2##3##(2008-9#2)
W and a##2##3##(2008-10#1)(2008-3#1)
W and##7##2##(2008-10#3)(2008-3#2)(2009-12#2)
W at##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
W in##2##2##(2008-9#2)
W microwave power##2##3##(2008-10#2)
W of##8##2##(2008-2#2)(2008-3#5)(2011-2#1)
W strains##2##2##(2008-10#2)
W was##2##2##(2008-10#1)(2008-3#1)
W##115##1##(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#2)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#48)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#17)(2008-5#2)(2008-9#4)(2009-12#2)(2009-8#1)(2010-5#3)(2010-7#2)(2011-2#3)
W(VI)##10##1##(2008-10#10)
W)##7##1##(1993-1#1)(2007-11#1)(2008-10#4)(2008-3#1)
W-7##3##1##(1996-2#2)(2008-8#1)
W-7976/Trenton##2##1##(2008-10#2)
W-7984/Opata 85##2##2##(2008-10#2)
W-CI##4##1##(2008-10#4)
W-Ir##3##1##(2008-10#3)
W-Rh permanent modifier was##2##4##(2008-10#2)
W-Rh permanent modifier##4##3##(2008-10#4)
W-Rh##7##1##(2008-10#7)
W-Ru##2##1##(2008-10#2)
W/O/W emulsions with low concentrations##2##5##(2008-5#2)
W/O/W multiple emulsions##2##3##(2008-5#2)
W/O/W multiple##3##2##(2008-5#3)
W/O/W##6##1##(2008-5#6)
W/m(2))##2##1##(2008-10#2)
W120F##2##1##(1995-2#2)
W19##2##1##(2008-8#2)
W2-6##2##1##(2008-10#2)
W22##3##1##(2012-3#3)
W260##5##1##(2008-10#5)
W276C##2##1##(1994-12#2)
W3110##2##1##(2008-7#2)
W370##5##1##(2008-10#5)
W370dsRNA##3##1##(2008-10#3)
W370dsRNA-containing strains##2##2##(2008-10#2)
W4##2##1##(2011-3#2)
W7##6##1##(1994-11#1)(1994-3#5)
WA##7##1##(2008-10#7)
WAC##2##1##(2008-10#2)
WAF##4##1##(2008-11#4)
WAG/Rij##3##1##(1990-2#3)
WAPH-1##2##1##(2008-10#2)
WB and PS##3##3##(1993-11#3)
WB and##5##2##(1993-11#3)(2008-10#2)
WB disease on pods and##2##5##(2008-10#2)
WB on pods##2##3##(2008-10#2)
WB on##4##2##(1993-11#1)(2008-10#3)
WB##21##1##(1993-11#7)(2008-10#10)(2008-12#1)(2008-4#1)(2008-5#1)(2010-1#1)
WBC count##2##2##(1991-2#1)(2011-2#1)
WBC##3##1##(1991-2#1)(2009-5#1)(2011-2#1)
WBI##5##1##(2011-2#5)
WBV##2##1##(2013-8#2)
WC##2##1##(2012-2#2)
WCC##2##1##(2010-8#2)
WCS##4##1##(1995-5#4)
WCS358 and RE8##2##3##(2008-10#2)
WCS358 on##2##2##(2008-10#2)
WCS358##13##1##(2008-10#13)
WCS374r##7##1##(2008-10#7)
WCS417r and##2##2##(2008-10#2)
WCS417r##5##1##(2008-10#5)
WCX resin##2##2##(2008-10#2)
WCX##4##1##(2008-10#4)
WD leading to##4##3##(2008-10#4)
WD was##2##2##(2008-10#1)(2010-12#1)
WD##16##1##(2008-10#13)(2008-8#2)(2010-12#1)
WEC##3##1##(1993-12#3)
WEP##5##1##(2008-11#5)
WFT##4##1##(2008-10#4)
WG##4##1##(2008-1#2)(2008-10#1)(2008-11#1)
WGA was##2##2##(2008-7#2)
WGA##7##1##(2008-7#6)(2008-8#1)
WGA-fed larvae was##2##3##(2008-7#2)
WGA-fed larvae##4##2##(2008-7#4)
WHHL##2##1##(1994-11#1)(1995-6#1)
WHITE##2##1##(2009-6#1)(2009-9#1)
WHO and##2##2##(1996-11#1)(2012-2#1)
WHO classification##2##2##(2008-9#1)(2011-2#1)
WHO criteria##2##2##(2008-11#1)(2011-1#1)
WHO is##2##2##(1993-3#1)(1994-9#1)
WHO##39##1##(1990-12#2)(1991-2#1)(1991-9#1)(1993-11#1)(1993-3#4)(1994-9#1)(1996-11#1)(1997-5#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
WHO)##2##1##(1997-3#2)
WHO-TEQ##4##1##(2008-10#4)
WHOQOL-BREF##3##1##(2011-2#3)
WI##2##1##(2010-11#1)(2010-3#1)
WI-38##3##1##(1995-8#3)
WI38##3##1##(1995-6#2)(2011-2#1)
WIC and AFDC##2##3##(1996-12#2)
WIC##3##1##(1996-12#3)
WILMA##2##1##(2008-10#2)
WIPK##6##1##(2009-8#6)
WITH##3##1##(2009-4#2)(2012-3#1)
WITHDRAWN##19##1##(2007-7#9)(2008-10#1)(2008-11#8)(2012-3#1)
WJC##2##1##(2010-12#2)
WJGS##2##1##(2010-12#2)
WJR##2##1##(2010-12#2)
WM##6##1##(1994-8#1)(2008-3#5)
WMS##2##1##(2008-3#1)(2008-7#1)
WMV##3##1##(2008-10#3)
WNIN/GR-Ob##2##1##(2012-3#2)
WNN model##4##2##(2008-10#4)
WNT pathway##2##2##(2013-1#2)
WNT##6##1##(1995-9#1)(2013-1#5)
WNV##3##1##(2009-10#2)(2010-8#1)
WO(3)-based mixed with different metal oxides (SnO(2)##2##7##(2008-10#2)
WO(3)-based mixed with##4##3##(2008-10#4)
WO(3)-based##6##1##(2008-10#6)
WORDS)##87##1##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-3#4)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#8)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#10)(1994-3#2)(1994-5#16)(1994-8#4)(1995-3#3)(1995-5#1)(1996-2#3)
WP2 strains##3##2##(2008-9#3)
WP2##4##1##(2008-9#4)
WPC##4##1##(2013-1#4)
WR302##3##1##(1993-9#3)
WRAP##8##1##(2008-11#8)
WRP-LC##4##1##(2008-10#4)
WRS 1906##2##2##(2008-10#2)
WRS##3##1##(2008-10#3)
WS presented##2##2##(2013-1#2)
WS##5##1##(1992-9#1)(2013-1#4)
WS-1##2##1##(2008-10#2)
WS3-10##4##1##(1992-9#4)
WSM1325 is##2##2##(2011-2#2)
WSM1325##3##1##(2011-2#3)
WSM2304##3##1##(2011-2#3)
WSMV cDNA##2##2##(2008-10#2)
WSMV##14##1##(2008-10#14)
WSMoV NP##2##2##(2008-10#2)
WSMoV##12##1##(2008-10#12)
WSS##2##1##(2013-1#2)
WSSMV##2##1##(2008-10#1)(2008-8#1)
WT Sham tissues##2##3##(2013-8#2)
WT and##3##2##(2008-9#1)(2012-3#1)(2013-8#1)
WT andfl ovules##2##3##(2008-8#2)
WT in##2##2##(2008-10#1)(2008-9#1)
WT mice##5##2##(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
WT##30##1##(1995-5#1)(1995-6#3)(2008-10#4)(2008-8#3)(2008-9#4)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#6)
WT-DOCA##2##1##(2013-8#2)
WT1##4##1##(1991-10#4)
WTA##4##1##(1995-6#4)
WTGs##3##1##(2008-10#3)
WTORS disuse and misuse##2##4##(2013-1#2)
WTORS##4##1##(2013-1#4)
WTP##3##1##(2008-10#3)
WTV##2##1##(2008-10#2)
WW domain##3##2##(2008-11#3)
WW domains##3##2##(2008-11#3)
WW##10##1##(2008-11#10)
WWP trees##2##2##(2008-10#2)
WWP##4##1##(2008-10#4)
WWTP##6##1##(2008-10#6)
WYMV##2##1##(2008-8#2)
Waardenburg syndrome##6##2##(2008-9#6)
Wackenheim line##3##2##(2012-12#3)
Waco bodies##2##2##(1995-11#2)
Waco##3##1##(1995-11#3)
Wadi Ara##2##2##(2008-6#2)
Waiting##5##1##(1991-11#4)(2012-3#1)
Waiànae##2##1##(2008-1#2)
Wake##3##1##(1992-1#1)(1993-9#1)(2008-11#1)
Wales##15##1##(1990-6#1)(1996-1#2)(2008-10#2)(2008-11#4)(2008-12#3)(2008-8#1)(2011-2#1)(2013-1#1)
Walking##4##1##(1997-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
Wall appositions##2##2##(2008-10#2)
Wall##8##1##(1994-9#1)(1995-1#1)(2008-10#5)(2013-8#1)
Wallerian degeneration##4##2##(1997-3#4)
Walp##2##1##(2008-12#2)
Walsh##3##1##(2008-11#3)
Walter and##2##2##(1995-12#1)(2008-10#1)
Walter##4##1##(1990-11#1)(1990-2#1)(1995-12#1)(2008-10#1)
Wangiella dermatitidis##2##2##(2008-5#2)
Want to##3##2##(1994-12#1)(1994-3#1)(2009-3#1)
War##17##1##(1992-12#2)(1996-1#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2010-1#2)(2011-2#1)(2011-4#2)(2013-1#1)(2013-8#1)
Ward##5##1##(1992-12#2)(1996-5#1)(2010-12#1)(2011-2#1)
Warner##2##1##(1995-6#1)(2013-1#1)
Wars##2##1##(1996-5#1)(2008-4#1)
Warsaw##3##1##(2007-8#1)(2008-10#1)(2013-1#1)
Washing##3##1##(1991-11#1)(1994-8#1)(2008-10#1)
Washington State##12##2##(1996-2#1)(1996-5#1)(1997-2#2)(2008-10#6)(2013-8#2)
Washington and##3##2##(1997-2#1)(2008-10#2)
Washington in the##2##3##(2008-10#2)
Washington in##3##2##(2008-10#3)
Washington state##3##2##(2008-10#3)
Washington##52##1##(1992-12#1)(1994-5#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#4)(1997-6#1)(2008-10#30)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
Waste Management##2##2##(2008-10#2)
Waste##7##1##(2008-10#4)(2008-12#1)(2010-5#1)(2013-1#1)
Wastewater##3##1##(2008-10#2)(2008-12#1)
Water Framework Directive##4##3##(2008-10#4)
Water and##3##2##(2008-10#2)(2008-12#1)
Water consumption by exposed mice was generally similar to that by control groups##2##13##(2008-9#2)
Water consumption by##4##3##(2008-9#4)
Water consumption##5##2##(2008-10#1)(2008-9#4)
Water in##3##2##(1996-9#1)(2008-10#2)
Water is##3##2##(2008-7#1)(2011-2#1)(2012-5#1)
Water stress##2##2##(2008-12#2)
Water vapor##2##2##(2008-10#1)(2008-3#1)
Water##60##1##(1993-1#1)(1996-9#2)(2008-10#32)(2008-11#3)(2008-12#6)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2011-2#4)(2012-5#1)(2013-8#1)
Water)##2##1##(2008-10#2)
Water-soluble##8##1##(2008-10#5)(2008-11#2)(2009-1#1)
Water-vapor##3##1##(2007-12#1)(2008-3#2)
Watermelon chlorotic stunt virus##2##4##(2008-10#2)
Watermelon mosaic virus##3##3##(2008-10#3)
Watermelon silver mottle virus (WSMoV)##4##5##(2008-10#4)
Watermelon silver mottle virus Serogroup##2##5##(2008-10#2)
Watermelon silver mottle virus##7##4##(2008-10#7)
Watermelon##17##1##(2008-10#17)
Waters Porapak(R) Sep-Park C(18) disk##2##5##(2008-10#2)
Waters##7##1##(2008-10#6)(2012-2#1)
Watson##2##1##(1990-5#1)(2008-12#1)
Watson-Crick base##2##2##(1994-5#1)(1995-6#1)
Wave 1##4##2##(2013-8#4)
Wave amplitudes##2##2##(1990-11#2)
Wave##12##1##(1990-11#2)(1996-9#1)(2008-11#4)(2013-8#5)
Waveguide##2##1##(2008-3#2)
Wavelength selection##2##2##(1991-2#1)(2008-10#1)
Wavelength##13##1##(1991-2#1)(1993-5#1)(2008-10#1)(2008-2#2)(2008-3#8)
Wavelength-Modulation##2##1##(2008-3#2)
Wavelength-modulation##2##1##(2008-2#1)(2008-3#1)
Wavelet##2##1##(2008-10#2)
Waves##2##1##(1996-9#2)
Way##4##1##(1996-5#1)(2011-2#1)(2012-2#2)
Ways to##2##2##(2008-11#1)(2010-8#1)
Ways##5##1##(1994-6#1)(2008-10#2)(2008-11#1)(2010-8#1)
We accept the##2##3##(2008-10#2)
We achieved a##2##3##(2008-3#1)(2008-9#1)
We achieved##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
We address the##5##3##(1995-5#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
We address##9##2##(1995-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#2)(2012-2#1)
We administered##2##2##(2008-11#1)(2012-12#1)
We advocate##4##2##(1991-6#1)(1997-8#1)(2009-7#1)(2013-1#1)
We agree with##2##3##(1991-6#1)(2008-10#1)
We aim to##2##3##(2011-2#2)
We aimed at##3##3##(2010-7#1)(2012-4#1)(2013-1#1)
We aimed to##5##3##(1997-4#1)(2011-1#1)(2012-3#2)(2013-1#1)
We aimed##8##2##(1997-4#1)(2010-7#1)(2011-1#1)(2012-3#2)(2012-4#1)(2013-1#2)
We also apply##2##3##(2008-11#1)(2013-8#1)
We also consider##2##3##(2008-11#1)(2012-2#1)
We also cover##2##3##(2010-4#1)(2012-2#1)
We also demonstrate that##4##4##(1995-8#1)(2008-11#1)(2008-8#2)
We also demonstrate the##2##4##(2008-11#1)(2008-2#1)
We also demonstrate##8##3##(1995-8#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-8#2)
We also demonstrated##2##3##(2008-10#1)(2008-3#1)
We also describe the##2##4##(1995-1#1)(2008-8#1)
We also describe##6##3##(1995-1#1)(2008-3#2)(2008-8#1)(2010-7#1)(2012-2#1)
We also detected##2##3##(2011-2#1)(2012-3#1)
We also determined the##2##4##(1993-8#1)(2008-11#1)
We also discuss our##2##4##(2008-12#1)(2008-8#1)
We also discuss the##8##4##(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-8#1)(2013-8#1)
We also discuss##21##3##(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
We also examine##2##3##(2008-11#1)(2012-2#1)
We also examined the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
We also examined##6##3##(1992-8#1)(2008-10#2)(2008-11#1)(2011-2#2)
We also explored the##2##4##(2008-10#1)(2008-8#1)
We also find a##2##4##(2008-10#1)(2009-7#1)
We also find that##2##4##(1995-11#1)(2011-2#1)
We also find##4##3##(1995-11#1)(2008-10#1)(2009-7#1)(2011-2#1)
We also found that the##3##5##(2008-11#1)(2008-5#1)(2012-2#1)
We also found that##15##4##(1994-11#1)(1994-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)
We also found##21##3##(1994-11#1)(1994-3#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
We also highlight##2##3##(2008-9#1)(2012-2#1)
We also investigate the##2##4##(2008-10#1)(2008-8#1)
We also investigated the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
We also investigated##5##3##(1992-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
We also measured##3##3##(1994-3#1)(2006-6#1)(2011-2#1)
We also observed that##3##4##(1995-6#1)(2008-11#1)(2012-3#1)
We also observed##5##3##(1993-3#1)(1995-6#1)(2008-11#2)(2012-3#1)
We also present a##2##4##(1991-11#1)(2008-2#1)
We also present##5##3##(1991-11#1)(1994-3#1)(2008-10#1)(2008-2#1)(2009-8#1)
We also provide##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
We also quantify##2##3##(2008-3#1)(2008-8#1)
We also report the##3##4##(1995-6#1)(2007-12#1)(2008-10#1)
We also report##5##3##(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)
We also review##2##3##(1994-12#1)(2008-12#1)
We also show how##3##4##(2008-8#2)(2013-1#1)
We also show that the##7##5##(1992-9#1)(2008-10#1)(2008-3#3)(2012-2#1)(2013-1#1)
We also show that##20##4##(1991-5#1)(1992-9#1)(1994-8#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-3#3)(2008-8#2)(2008-9#1)(2009-12#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
We also show##25##3##(1991-5#1)(1992-9#1)(1994-8#1)(1995-11#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
We also showed that##3##4##(1996-5#1)(2008-5#1)(2009-6#1)
We also showed##4##3##(1995-8#1)(1996-5#1)(2008-5#1)(2009-6#1)
We also studied the##2##4##(2008-11#1)(2012-3#1)
We also studied##3##3##(2008-11#1)(2008-8#1)(2012-3#1)
We also surveyed##2##3##(2009-8#1)(2012-3#1)
We also tested for##2##4##(1995-2#1)(2008-9#1)
We also tested the##2##4##(2008-3#1)(2008-9#1)
We also tested##4##3##(1995-2#1)(2008-3#1)(2008-9#2)
We also use##3##3##(1992-12#1)(2008-3#1)(2012-3#1)
We also##198##2##(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-5#2)(1997-2#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-12#2)(2008-10#22)(2008-11#19)(2008-12#3)(2008-2#7)(2008-3#15)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#19)(2008-9#10)(2009-1#1)(2009-10#3)(2009-12#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#5)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#8)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#3)
We analysed the##5##3##(1996-2#1)(2007-8#1)(2008-5#1)(2009-7#1)(2011-3#1)
We analysed##8##2##(1996-2#1)(2007-8#1)(2008-5#1)(2009-7#1)(2010-11#1)(2011-3#2)(2013-1#1)
We analyze a##2##3##(2008-3#1)(2008-8#1)
We analyze the##8##3##(1990-6#1)(2007-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2012-2#1)
We analyze##13##2##(1990-6#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#1)(2012-2#1)
We analyzed a##2##3##(2008-10#1)(2011-2#1)
We analyzed the results##2##4##(2008-1#1)(2011-2#1)
We analyzed the##11##3##(1994-11#1)(2008-1#1)(2008-10#2)(2009-8#1)(2011-2#4)(2012-3#1)(2013-1#1)
We analyzed##25##2##(1994-11#1)(1996-11#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2009-8#1)(2010-12#1)(2011-2#6)(2012-3#2)(2013-1#1)(2013-8#1)
We anticipate that##2##3##(2008-9#1)(2012-2#1)
We applied selected methods for the determination of total##2##9##(2008-10#2)
We applied the##4##3##(2008-10#2)(2008-5#1)(2012-12#1)
We applied this##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
We applied##12##2##(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
We apply the##4##3##(1995-12#1)(2008-3#1)(2008-8#1)(2009-8#1)
We apply##7##2##(1995-12#1)(2007-12#1)(2008-3#1)(2008-8#2)(2009-8#1)(2013-1#1)
We are presenting a##2##4##(2008-10#1)(2012-3#1)
We are presenting##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
We are reporting a case of##2##6##(2008-12#1)(2010-5#1)
We are reporting an##2##4##(1995-2#1)(2009-3#1)
We are reporting two cases of##2##6##(2010-2#1)(2013-8#1)
We are reporting##8##3##(1995-2#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2013-8#1)
We are##25##2##(1990-8#1)(1990-9#1)(1991-12#1)(1993-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-8#1)
We argue that a##2##4##(2008-12#1)(2008-8#1)
We argue that the##4##4##(1991-2#1)(1997-1#1)(2008-11#1)(2013-1#1)
We argue that##17##3##(1991-2#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-8#4)(2008-9#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
We argue##18##2##(1991-2#1)(1993-1#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-8#4)(2008-9#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
We asked##2##2##(2008-9#1)(2011-2#1)
We assessed immune function in##2##5##(2008-10#1)(2008-8#1)
We assessed the##8##3##(1991-5#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)(2010-9#1)
We assessed##20##2##(1991-5#1)(1993-12#1)(1995-2#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2013-1#3)
We assume that##4##3##(1996-2#1)(2008-3#1)(2008-9#2)
We assume##5##2##(1996-2#1)(2008-3#1)(2008-8#1)(2008-9#2)
We attempted to##6##3##(2008-11#3)(2008-6#1)(2009-6#1)(2013-8#1)
We attribute##2##2##(2008-11#1)(2008-9#1)
We begin##2##2##(2008-11#1)(2008-6#1)
We believe hospitals should remove these cords-which are supplied with equipment from a variety of medical device manufacturers-from service##2##19##(2011-1#1)(2011-2#1)
We believe that the##7##4##(2007-9#1)(2008-7#3)(2008-8#1)(2009-1#1)(2013-1#1)
We believe that this is##2##5##(2009-1#1)(2010-3#1)
We believe that this##3##4##(1992-2#1)(2009-1#1)(2010-3#1)
We believe that##27##3##(1990-3#2)(1991-1#1)(1991-12#1)(1992-2#1)(1995-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
We believe the##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
We believe this##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
We believe##41##2##(1990-3#2)(1991-1#1)(1991-12#3)(1992-2#1)(1994-8#1)(1995-2#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
We briefly##2##2##(2008-8#1)(2013-2#1)
We calculate the##2##3##(2007-12#1)(2008-2#1)
We calculated the##2##3##(1990-9#1)(2008-7#1)
We calculated##7##2##(1990-9#1)(1997-5#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)
We call##2##2##(2008-12#1)(2008-7#1)
We can also##3##3##(1995-9#2)(1997-3#1)
We can conclude that##2##4##(1994-8#1)(2011-2#1)
We can consider that for a direct measurement of the intensity of reflectance##2##13##(2008-10#2)
We can##11##2##(1992-2#1)(1994-8#1)(1995-9#2)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)
We cannot conclude##2##3##(2008-10#1)(2011-2#1)
We carried out a##4##4##(1994-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
We carried out##5##3##(1994-12#1)(2008-3#2)(2008-7#1)(2011-2#1)
We characterize the##2##3##(2009-5#1)(2012-2#1)
We characterize##4##2##(2007-12#1)(2008-11#1)(2009-5#1)(2012-2#1)
We characterized four##2##3##(1990-5#1)(2008-10#1)
We characterized the##3##3##(1992-8#1)(2008-11#1)(2009-8#1)
We characterized##8##2##(1990-11#1)(1990-5#1)(1992-8#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#1)
We chose##2##2##(2008-10#1)(2013-8#1)
We cloned and sequenced the##3##5##(1994-11#1)(1995-6#1)(1997-8#1)
We cloned the##2##3##(2008-8#1)(2008-9#1)
We cloned##5##2##(1994-11#1)(1995-6#1)(1997-8#1)(2008-8#1)(2008-9#1)
We collected##4##2##(2008-10#1)(2011-10#1)(2012-3#1)(2013-1#1)
We combine##3##2##(2008-3#2)(2008-6#1)
We combined##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
We compare the results##2##4##(2008-10#1)(2008-5#1)
We compare the##7##3##(1996-3#1)(1997-3#1)(2008-10#3)(2008-5#1)(2013-8#1)
We compare##15##2##(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#3)(2013-8#2)
We compared the effects of##2##5##(1991-12#1)(1995-12#1)
We compared the results##2##4##(2008-10#1)(2013-1#1)
We compared the##11##3##(1991-12#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
We compared##28##2##(1991-12#1)(1992-12#2)(1995-12#1)(1997-2#1)(2008-10#6)(2008-11#5)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2011-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
We conclude by discussing##2##4##(2008-8#1)(2012-2#1)
We conclude by##3##3##(2008-8#1)(2012-2#2)
We conclude from##2##3##(1991-8#1)(2008-10#1)
We conclude that D##2##4##(2008-10#1)(2008-8#1)
We conclude that a##4##4##(1997-7#1)(2008-11#1)(2008-9#2)
We conclude that although##2##4##(1992-2#1)(2013-1#1)
We conclude that in##6##4##(1994-5#1)(1995-10#1)(2008-11#3)(2008-5#1)
We conclude that it is##2##5##(2008-3#1)(2008-7#1)
We conclude that our##2##4##(1996-12#1)(2008-10#1)
We conclude that some##2##4##(1991-9#1)(2012-3#1)
We conclude that the most important##2##6##(2008-10#1)(2008-9#1)
We conclude that the use of##2##6##(2008-7#2)
We conclude that the##32##4##(1990-5#1)(1991-12#2)(1992-12#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)
We conclude that there are##2##5##(2008-10#1)(2008-9#1)
We conclude that these##2##4##(1997-2#1)(2008-10#1)
We conclude that##164##3##(1990-12#2)(1990-3#2)(1990-5#1)(1991-12#4)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#3)(1993-9#2)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-7#2)(1997-8#2)(2006-6#3)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#14)(2008-12#1)(2008-3#5)(2008-5#3)(2008-7#10)(2008-8#8)(2008-9#11)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
We conclude with##2##3##(2012-2#2)
We conclude##175##2##(1990-12#2)(1990-3#2)(1990-5#1)(1991-12#4)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#3)(1993-9#2)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-7#2)(1997-8#2)(2006-6#3)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#14)(2008-12#1)(2008-3#5)(2008-5#3)(2008-7#10)(2008-8#9)(2008-9#11)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#1)
We concluded that the##11##4##(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
We concluded that##24##3##(1991-12#1)(2008-10#6)(2008-11#3)(2008-5#2)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
We conducted a meta-analysis##2##4##(2008-4#1)(2008-9#1)
We conducted a quantitative##2##4##(2008-10#2)
We conducted a randomized##2##4##(2008-7#1)(2008-8#1)
We conducted a retrospective##2##4##(2012-2#1)(2012-3#1)
We conducted a##16##3##(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2012-2#1)(2012-3#2)(2013-1#2)
We conducted semistructured interviews with##2##5##(2010-8#1)(2013-1#1)
We conducted the##2##3##(2008-9#1)(2013-8#1)
We conducted##28##2##(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
We confirm the##2##3##(2008-3#1)(2008-9#1)
We confirm##5##2##(2008-3#1)(2008-9#2)(2012-3#1)(2013-1#1)
We confirmed the##3##3##(1992-6#1)(2008-10#1)(2012-3#1)
We confirmed##6##2##(1992-6#1)(1994-8#1)(2008-10#1)(2008-3#1)(2010-1#1)(2012-3#1)
We consider a##5##3##(1990-8#1)(2008-3#1)(2010-10#1)(2013-8#2)
We consider that##5##3##(1994-12#1)(2008-10#1)(2008-5#2)(2012-2#1)
We consider the##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-8#1)
We consider##24##2##(1990-8#1)(1994-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-8#3)
We considered##2##2##(2008-10#1)(2008-9#1)
We constructed a new##2##4##(1996-2#1)(2008-8#1)
We constructed a##6##3##(1991-6#1)(1996-2#1)(2008-10#1)(2008-8#1)(2010-1#1)(2012-3#1)
We constructed##9##2##(1991-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
We continue to##2##3##(1995-1#1)(2010-9#1)
We continue##3##2##(1995-1#1)(2008-6#1)(2010-9#1)
We could not find##2##4##(2012-3#1)(2013-8#1)
We could not##4##3##(1990-12#1)(2008-11#1)(2012-3#1)(2013-8#1)
We could##9##2##(1990-12#1)(1997-6#1)(2008-11#3)(2008-12#1)(2008-9#1)(2012-3#1)(2013-8#1)
We created##2##2##(1993-3#1)(2008-10#1)
We decided to##2##3##(2008-8#1)(2009-8#1)
We decided##3##2##(2008-8#1)(2009-8#1)(2011-2#1)
We define##4##2##(1997-3#2)(2011-2#1)(2013-8#1)
We defined##2##2##(1992-9#1)(2009-11#1)
We demonstrate a new##3##4##(2008-2#3)
We demonstrate a novel##2##4##(2007-11#1)(2007-12#1)
We demonstrate a##10##3##(2007-11#3)(2007-12#2)(2008-2#4)(2008-3#1)
We demonstrate for the first time##2##6##(2008-2#1)(2013-1#1)
We demonstrate here that##6##4##(1990-5#1)(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#2)
We demonstrate here##9##3##(1990-5#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#3)(2008-11#1)
We demonstrate that a##4##4##(1997-3#1)(2007-12#1)(2008-3#1)(2009-5#1)
We demonstrate that the##6##4##(1997-2#1)(2008-11#2)(2008-3#2)(2009-8#1)
We demonstrate that##27##3##(1992-3#1)(1993-12#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-11#4)(2008-2#1)(2008-3#5)(2008-8#3)(2009-5#1)(2009-8#2)(2010-10#1)(2012-3#3)(2013-8#1)
We demonstrate the use of##2##5##(2007-12#1)(2008-10#1)
We demonstrate the##15##3##(1990-8#1)(1995-8#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2012-2#1)
We demonstrate this##3##3##(2008-8#1)(2010-3#1)(2012-2#1)
We demonstrate what##2##3##(2007-12#1)(2008-3#1)
We demonstrate##84##2##(1990-5#1)(1990-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-11#6)(2007-12#8)(2008-10#6)(2008-11#8)(2008-2#7)(2008-3#15)(2008-5#1)(2008-6#3)(2008-8#4)(2009-11#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-3#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
We demonstrated that##5##3##(1990-5#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
We demonstrated##8##2##(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
We derive a##2##3##(2007-12#1)(2011-3#1)
We derive an##3##3##(2008-3#1)(2008-8#2)
We derive the##2##3##(1992-9#1)(2013-8#1)
We derive##12##2##(1992-9#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#4)(2011-3#1)(2013-8#1)
We derived##3##2##(1995-8#1)(2008-3#1)(2013-1#1)
We describe a case of a##5##6##(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
We describe a case of##13##5##(1990-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#1)
We describe a method for##2##5##(1991-11#1)(1993-8#1)
We describe a method that##2##5##(2008-3#2)
We describe a method to##2##5##(2008-10#1)(2008-3#1)
We describe a method##6##4##(1991-11#1)(1993-8#1)(2008-10#1)(2008-3#3)
We describe a novel##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2010-11#1)
We describe a patient with##4##5##(1990-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
We describe a patient##5##4##(1990-9#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
We describe a simple##3##4##(2008-3#1)(2008-6#1)(2010-7#1)
We describe a##67##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-12#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
We describe an unusual case of##2##6##(2011-2#1)(2013-1#1)
We describe an##7##3##(1991-6#1)(2008-10#3)(2011-2#2)(2013-1#1)
We describe here a new##2##5##(2008-10#2)
We describe here a##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
We describe here the##6##4##(1993-6#1)(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#1)
We describe here##12##3##(1993-6#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-10#1)(2010-5#1)(2010-8#1)
We describe how a##2##4##(1995-12#1)(2009-12#1)
We describe how##4##3##(1994-12#1)(1995-12#1)(2008-6#1)(2009-12#1)
We describe in this report##2##5##(2008-10#1)(2013-1#1)
We describe in this##4##4##(1995-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
We describe our experience##2##4##(1997-3#1)(2010-11#1)
We describe our##4##3##(1997-3#1)(2008-7#1)(2010-11#1)(2010-7#1)
We describe some##2##3##(2008-3#2)
We describe the case of an##2##6##(2008-7#1)(2011-2#1)
We describe the case of##3##5##(1990-8#1)(2008-7#1)(2011-2#1)
We describe the case##4##4##(1990-8#1)(1991-8#1)(2008-7#1)(2011-2#1)
We describe the clinical##4##4##(1991-8#1)(2008-7#1)(2009-5#1)(2012-12#1)
We describe the development of##3##5##(1996-11#1)(1996-12#1)(2008-2#1)
We describe the development##4##4##(1996-11#1)(1996-12#1)(2008-2#1)(2008-3#1)
We describe the isolation##2##4##(1993-12#1)(1994-8#1)
We describe the management of##2##5##(2010-7#1)(2010-8#1)
We describe the management##3##4##(1993-1#1)(2010-7#1)(2010-8#1)
We describe the##40##3##(1990-8#1)(1991-8#2)(1993-1#1)(1993-12#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-7#3)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
We describe two patients with##2##5##(1991-11#1)(2008-7#1)
We describe two##6##3##(1991-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2013-1#1)
We describe##163##2##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-6#1)(1991-8#2)(1992-12#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-3#4)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#8)(2008-2#7)(2008-3#25)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#3)
We described##2##2##(1991-8#1)(2012-12#1)
We designed a##2##3##(2007-12#1)(2013-1#1)
We designed##5##2##(2007-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
We detected the##4##3##(1993-3#2)(2008-10#1)(2008-8#1)
We detected##8##2##(1992-8#1)(1993-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
We determined that the##2##4##(2008-10#1)(2008-3#1)
We determined that##4##3##(2008-10#1)(2008-3#2)(2011-2#1)
We determined the##9##3##(1992-3#1)(1993-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#2)
We determined whether the##2##4##(1994-8#1)(2008-8#1)
We determined whether##5##3##(1994-8#1)(1995-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
We determined##18##2##(1992-3#1)(1993-12#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#2)
We develop a model##2##4##(2008-8#2)
We develop a##9##3##(2008-3#1)(2008-8#6)(2008-9#1)(2012-3#1)
We develop an##2##3##(2008-8#2)
We develop##16##2##(1994-9#1)(2008-3#3)(2008-8#9)(2008-9#2)(2012-3#1)
We developed a method##2##4##(2008-10#2)
We developed a novel##2##4##(2008-10#1)(2013-1#1)
We developed a##21##3##(1995-12#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
We developed an##5##3##(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
We developed and tested##2##4##(2008-10#2)
We developed##33##2##(1994-3#1)(1995-12#1)(1996-2#1)(1997-6#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
We diagnosed##3##2##(2009-1#1)(2011-2#2)
We did not detect any##2##5##(2008-10#1)(2008-7#1)
We did not detect##3##4##(2008-10#2)(2008-7#1)
We did not find a##2##5##(1990-3#1)(2008-7#1)
We did not find##5##4##(1990-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)
We did not##9##3##(1990-3#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)(2013-1#1)
We did##10##2##(1990-3#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)(2013-1#1)(2013-7#1)
We discovered a##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
We discovered##6##2##(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
We discuss a##2##3##(1997-2#1)(2009-6#1)
We discuss here##2##3##(2010-11#1)(2011-1#1)
We discuss how##3##3##(2008-11#1)(2013-8#2)
We discuss our##3##3##(2008-9#2)(2009-6#1)
We discuss the case of a##2##6##(1992-12#1)(2008-9#1)
We discuss the case of##3##5##(1991-2#1)(1992-12#1)(2008-9#1)
We discuss the implications of our##2##6##(2008-12#1)(2008-9#1)
We discuss the results##2##4##(2008-10#1)(2013-8#1)
We discuss the##39##3##(1990-9#2)(1991-2#1)(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
We discuss these##3##3##(2008-10#1)(2008-8#1)(2009-9#1)
We discuss this##3##3##(1990-9#1)(2008-8#1)(2009-6#1)
We discuss two##2##3##(2008-8#1)(2009-10#1)
We discuss whether##2##3##(1990-2#1)(2008-8#1)
We discuss##79##2##(1990-2#1)(1990-9#3)(1991-11#2)(1991-2#1)(1992-12#1)(1996-2#2)(1997-2#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#8)(2009-10#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-2#3)(2013-1#2)(2013-8#4)
We discussed the##4##3##(1995-8#1)(2008-8#1)(2008-9#1)(2013-1#1)
We discussed##5##2##(1995-8#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
We distinguish##2##2##(2008-8#1)(2012-2#1)
We do not##3##3##(1991-3#1)(1996-6#1)(2008-11#1)
We do##4##2##(1991-3#1)(1996-6#1)(2008-11#1)(2011-2#1)
We earlier##2##2##(2010-5#1)(2012-2#1)
We emphasize that##3##3##(1996-6#1)(2008-8#1)(2010-10#1)
We emphasize the importance of##3##5##(1991-9#1)(1997-8#1)(2008-10#1)
We emphasize the##4##3##(1991-9#1)(1997-8#1)(2008-10#1)(2013-1#1)
We emphasize##8##2##(1991-9#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#1)
We employed##3##2##(2008-10#1)(2008-11#1)(2009-4#1)
We encountered a##3##3##(2009-8#1)(2011-2#2)
We encountered##6##2##(1994-12#1)(1996-9#1)(2008-7#1)(2009-8#1)(2011-2#2)
We establish##2##2##(2007-11#1)(2008-3#1)
We established a##4##3##(2008-11#2)(2011-2#1)(2013-7#1)
We established##8##2##(2008-10#1)(2008-11#4)(2008-7#1)(2011-2#1)(2013-7#1)
We estimate that the##2##4##(1996-11#1)(2008-10#1)
We estimate the##3##3##(1992-12#1)(1994-2#1)(2008-2#1)
We estimate##7##2##(1992-12#1)(1994-2#1)(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
We estimated the##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2013-8#1)
We estimated##8##2##(2008-10#3)(2008-8#2)(2008-9#1)(2012-3#1)(2013-8#1)
We evaluate the##4##3##(2008-3#3)(2011-2#1)
We evaluate##8##2##(2008-3#3)(2008-6#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
We evaluated 22 patients with##2##5##(2008-1#1)(2011-2#1)
We evaluated both##2##3##(2010-7#1)(2012-3#1)
We evaluated the clinical##2##4##(2010-6#1)(2013-1#1)
We evaluated the role of##3##5##(1995-8#1)(2009-8#1)(2013-1#1)
We evaluated the##19##3##(1991-2#1)(1991-8#1)(1994-3#1)(1995-11#1)(1995-8#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
We evaluated##34##2##(1991-2#1)(1991-8#1)(1994-3#1)(1995-11#1)(1995-8#1)(1997-3#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#3)
We examine a##2##3##(1995-3#1)(2008-3#1)
We examine the##7##3##(1997-1#1)(2008-3#3)(2008-8#1)(2008-9#2)
We examine##14##2##(1995-3#1)(1997-1#1)(2008-3#5)(2008-4#1)(2008-8#2)(2008-9#3)(2012-2#1)
We examined how##3##3##(2008-10#2)(2013-8#1)
We examined the characteristics of##2##5##(1994-12#1)(2008-11#1)
We examined the correlation between##2##5##(1996-11#1)(2013-8#1)
We examined the effect of##7##5##(1992-8#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-9#1)
We examined the effects of##7##5##(1992-3#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)
We examined the effects##8##4##(1992-3#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
We examined the relationship between##4##5##(1995-2#1)(2008-10#1)(2008-11#1)(2010-1#1)
We examined the##44##3##(1990-12#1)(1991-1#1)(1991-2#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#2)(2007-12#1)(2008-10#9)(2008-11#6)(2008-12#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
We examined whether##5##3##(1997-3#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
We examined##70##2##(1990-12#1)(1991-1#1)(1991-2#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#14)(2008-11#9)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
We expect that##2##3##(2008-8#1)(2009-12#1)
We expect##6##2##(1996-11#1)(2008-8#1)(2009-12#1)(2010-6#1)(2011-2#2)
We experienced a case of##2##5##(2008-12#1)(2010-6#1)
We experienced a##3##3##(2008-12#1)(2010-6#1)(2011-2#1)
We experienced##4##2##(2008-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
We experimentally##4##2##(2008-2#1)(2008-3#1)(2008-8#2)
We explain the##2##3##(1997-3#1)(2009-6#1)
We explain##4##2##(1997-3#1)(2008-3#1)(2009-6#1)(2009-8#1)
We explore how##2##3##(2008-8#2)
We explore the##5##3##(1991-2#1)(2008-10#1)(2008-8#2)(2010-8#1)
We explore##8##2##(1991-2#1)(2008-10#1)(2008-8#4)(2010-8#1)(2011-1#1)
We explored the interaction##2##4##(2008-4#1)(2011-3#1)
We explored the##6##3##(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2011-3#1)
We explored##9##2##(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-3#1)
We exposed##2##2##(2008-10#1)(2008-11#1)
We expressed##2##2##(1994-11#1)(2008-10#1)
We extend the##3##3##(1994-9#1)(1997-2#1)(2011-2#1)
We extend##6##2##(1994-9#1)(1997-2#1)(2008-3#2)(2011-2#1)(2012-3#1)
We failed to##2##3##(2008-5#1)(2008-9#1)
We finally##2##2##(2011-1#1)(2012-3#1)
We find no##2##3##(2008-11#1)(2009-10#1)
We find that in this first year##2##7##(2013-1#2)
We find that the##9##4##(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2009-8#1)(2011-2#1)
We find that there##2##4##(1991-3#1)(2008-3#1)
We find that##38##3##(1991-12#1)(1991-3#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#9)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
We find the##2##3##(1994-9#1)(2008-3#1)
We find##51##2##(1991-12#1)(1991-3#1)(1992-4#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#6)(2008-5#3)(2008-8#10)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
We first describe##2##3##(2008-10#2)
We first##15##2##(1995-5#1)(1996-2#1)(2008-10#3)(2008-11#4)(2008-6#2)(2008-8#3)(2010-11#1)
We firstly##2##2##(2008-11#1)(2009-6#1)
We focus on the##5##4##(2008-10#1)(2008-3#2)(2013-8#2)
We focus on##6##3##(2008-10#1)(2008-3#2)(2013-8#3)
We formulate##2##2##(2008-6#1)(2011-2#1)
We found a##6##3##(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)
We found evidence##2##3##(2008-5#1)(2008-8#1)
We found high levels of##2##5##(1991-3#1)(2011-1#1)
We found it##2##3##(1995-2#1)(1997-3#1)
We found no statistically significant##2##5##(1994-3#1)(2011-2#1)
We found no##9##3##(1994-3#1)(1997-7#1)(2008-8#3)(2008-9#1)(2010-7#1)(2011-2#2)
We found that both##2##4##(2009-8#1)(2012-2#1)
We found that in the##2##5##(1993-8#1)(2008-10#1)
We found that in##3##4##(1993-8#1)(1995-6#1)(2008-10#1)
We found that the##21##4##(1990-12#1)(1992-12#1)(1994-11#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-8#2)(2012-3#1)
We found that this##4##4##(1997-1#1)(2008-8#1)(2009-10#1)(2012-2#1)
We found that##99##3##(1990-12#1)(1990-5#2)(1990-9#1)(1992-12#1)(1993-8#2)(1994-11#4)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#13)(2008-11#12)(2008-12#1)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#2)(2009-7#2)(2009-8#7)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-2#7)(2012-3#4)(2013-1#1)(2013-8#3)
We found the highest##2##4##(2008-10#2)
We found the##6##3##(1991-3#1)(2008-10#2)(2008-3#1)(2009-8#1)(2013-1#1)
We found##147##2##(1990-12#1)(1990-5#2)(1990-9#1)(1991-3#2)(1992-12#1)(1993-8#2)(1994-11#5)(1994-2#2)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-7#1)(2008-10#20)(2008-11#16)(2008-12#1)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#13)(2008-9#6)(2009-10#2)(2009-6#1)(2009-7#2)(2009-8#8)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#3)
We further demonstrate##2##3##(2008-10#1)(2013-8#1)
We further investigated the##3##4##(1997-1#1)(2008-10#1)(2008-11#1)
We further show that##3##4##(1994-8#1)(1995-2#1)(2008-11#1)
We further##21##2##(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-7#1)(2009-10#2)(2010-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
We generalize##3##2##(2008-3#1)(2008-8#1)(2009-12#1)
We generated a##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
We generated##7##2##(1993-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2013-1#1)
We give##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#2)
We had##2##2##(1994-12#1)(2010-8#1)
We have achieved##2##3##(2008-3#1)(2010-8#1)
We have addressed##2##3##(1994-6#1)(1995-11#1)
We have already##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
We have also demonstrated that##2##5##(2008-10#2)
We have also demonstrated##4##4##(2008-10#3)(2008-2#1)
We have also found that##2##5##(2008-9#1)(2013-8#1)
We have also##14##3##(1991-5#1)(1995-2#1)(1997-8#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-8#1)(2013-8#1)
We have analysed the##4##4##(1994-12#1)(1995-11#1)(1997-7#1)(2009-12#1)
We have analysed##5##3##(1994-12#1)(1995-11#1)(1997-7#2)(2009-12#1)
We have analyzed the##4##4##(1992-3#1)(1992-9#1)(1994-11#1)(2008-3#1)
We have analyzed##5##3##(1992-3#1)(1992-9#1)(1994-11#1)(1995-8#1)(2008-3#1)
We have applied##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
We have attempted##2##3##(1990-5#1)(1994-11#1)
We have been##3##3##(2008-10#2)(2008-3#1)
We have carried out##2##4##(1993-2#1)(2012-2#1)
We have characterized##6##3##(1996-12#1)(1997-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
We have chosen##2##3##(2009-5#1)(2009-7#1)
We have cloned a##4##4##(1991-7#1)(1993-2#1)(1995-6#1)(1997-7#1)
We have cloned and sequenced##3##5##(1991-6#1)(1993-9#1)(2008-10#1)
We have cloned the##2##4##(1991-9#1)(1995-6#1)
We have cloned##12##3##(1991-6#2)(1991-7#1)(1991-9#1)(1993-2#1)(1993-9#1)(1995-6#2)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#1)
We have compared##2##3##(2008-11#2)
We have completed##2##3##(1990-7#1)(1996-12#1)
We have confirmed##2##3##(2008-11#1)(2008-5#1)
We have constructed a##4##4##(1995-6#1)(2008-11#1)(2008-3#1)(2008-9#1)
We have constructed##9##3##(1993-12#1)(1993-2#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
We have demonstrated a##4##4##(1994-3#1)(1995-12#1)(2008-2#1)(2008-3#1)
We have demonstrated that the##3##5##(2008-10#1)(2008-7#1)(2012-3#1)
We have demonstrated that##8##4##(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
We have demonstrated the use of##2##6##(2008-3#2)
We have demonstrated the##4##4##(2007-12#1)(2008-3#2)(2010-8#1)
We have demonstrated##23##3##(1990-11#1)(1993-8#1)(1994-3#1)(1995-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#2)(2009-3#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)
We have designed and##2##4##(2008-3#2)
We have designed##4##3##(1995-5#1)(2008-3#3)
We have determined that##2##4##(1992-10#1)(1997-2#1)
We have determined the complete##2##5##(1993-2#1)(1995-9#1)
We have determined the##4##4##(1993-2#1)(1995-9#1)(2008-10#1)(2011-2#1)
We have determined##7##3##(1992-10#1)(1993-2#1)(1995-12#1)(1995-9#1)(1997-2#1)(2008-10#1)(2011-2#1)
We have developed a highly parallelized QM/MM implementation in the NAMD and OpenAtom simulation packages##2##15##(2013-1#2)
We have developed a method##2##5##(2008-5#1)(2008-7#1)
We have developed a new method for##2##7##(2008-10#1)(2008-2#1)
We have developed a new##5##5##(1991-12#1)(1995-8#1)(2008-10#2)(2008-2#1)
We have developed a novel##3##5##(2007-11#1)(2008-3#1)(2008-9#1)
We have developed a sensitive and##2##6##(1997-7#1)(2008-5#1)
We have developed a simple##4##5##(1994-11#1)(2008-11#2)(2008-3#1)
We have developed a stabilized##2##5##(2008-3#1)(2010-5#1)
We have developed a##43##4##(1991-12#1)(1993-2#1)(1994-11#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#5)(2008-7#3)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
We have developed an##6##4##(1993-8#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-3#1)
We have developed and##2##4##(2008-10#1)(2008-11#1)
We have developed##54##3##(1991-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#6)(2008-7#3)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
We have discovered##2##3##(2010-4#1)(2013-1#1)
We have employed##3##3##(1990-6#1)(1994-12#1)(2008-9#1)
We have established a new##2##5##(2008-11#1)(2008-9#1)
We have established a##5##4##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
We have established##7##3##(1994-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
We have evaluated the##5##4##(1994-1#1)(1995-11#1)(1996-12#1)(2008-10#2)
We have examined the##4##4##(1992-1#1)(1992-11#1)(1995-6#1)(2009-5#1)
We have examined##9##3##(1990-5#1)(1991-6#1)(1992-1#1)(1992-11#2)(1995-6#1)(2008-10#2)(2009-5#1)
We have exploited##2##3##(1992-4#1)(2008-8#1)
We have expressed##2##3##(1994-11#1)(1995-11#1)
We have extended##2##3##(1995-11#1)(2008-11#1)
We have found that##12##4##(1991-3#1)(1991-5#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-12#2)(2012-2#1)
We have found##17##3##(1991-3#1)(1991-5#1)(1992-9#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-8#1)(2009-12#2)(2009-8#1)(2012-2#1)(2012-3#1)
We have generated##3##3##(1993-12#1)(1995-6#1)(2008-10#1)
We have identified a##3##4##(1993-12#1)(1995-9#1)(2010-11#1)
We have identified and##2##4##(1995-2#1)(2008-10#1)
We have identified the##2##4##(1993-3#1)(2008-8#1)
We have identified##10##3##(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-9#1)(2008-10#2)(2008-8#1)(2010-11#1)
We have investigated how##2##4##(1996-2#1)(2009-8#1)
We have investigated the effect of##2##6##(1994-11#1)(2008-10#1)
We have investigated the effects##2##5##(1996-2#1)(1996-3#1)
We have investigated the influence of##2##6##(2008-11#2)
We have investigated the relationship##2##5##(1994-6#1)(1996-12#1)
We have investigated the use of##2##6##(2008-10#1)(2008-12#1)
We have investigated the##17##4##(1990-3#1)(1991-3#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-7#1)
We have investigated##22##3##(1990-3#1)(1991-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-2#3)(1996-3#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)
We have isolated a##2##4##(1993-12#1)(2008-11#1)
We have isolated##7##3##(1990-8#1)(1993-12#2)(1993-6#2)(2008-11#2)
We have learned##2##3##(2008-11#1)(2008-3#1)
We have made##2##3##(2008-10#1)(2009-8#1)
We have measured##3##3##(1991-5#2)(2008-3#1)
We have modified##2##3##(2008-11#1)(2008-2#1)
We have not##3##3##(2008-10#1)(2009-3#1)(2010-12#1)
We have now##6##3##(1992-3#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
We have observed that##4##4##(1996-2#1)(2008-11#1)(2010-5#1)(2013-1#1)
We have observed##5##3##(1996-2#1)(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#1)
We have obtained for##2##4##(2008-10#2)
We have obtained##4##3##(1993-8#1)(2008-10#2)(2008-3#1)
We have performed##4##3##(1990-2#1)(2008-3#1)(2010-5#1)(2011-2#1)
We have prepared##2##3##(1991-12#1)(2008-10#1)
We have previously constructed##2##4##(1995-6#1)(1996-12#1)
We have previously demonstrated that the##2##6##(1994-11#1)(2008-11#1)
We have previously demonstrated that##3##5##(1994-11#1)(2008-11#1)(2013-8#1)
We have previously demonstrated##5##4##(1993-11#1)(1994-11#1)(2008-11#1)(2013-1#1)(2013-8#1)
We have previously reported the##2##5##(1994-8#1)(2010-3#1)
We have previously reported##3##4##(1994-8#1)(1996-12#1)(2010-3#1)
We have previously shown that a##3##6##(1994-11#1)(2008-5#1)(2012-3#1)
We have previously shown that the##3##6##(1993-6#1)(2008-8#1)(2011-2#1)
We have previously shown that##12##5##(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
We have previously##30##3##(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-5#2)(2008-8#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
We have produced a##2##4##(1994-3#1)(2008-11#1)
We have produced##4##3##(1991-5#1)(1994-3#1)(1997-7#1)(2008-11#1)
We have purified##2##3##(1992-8#1)(1996-2#1)
We have recently demonstrated that the##3##6##(1994-2#1)(2009-8#2)
We have recently demonstrated##4##4##(1994-2#1)(2009-8#2)(2011-2#1)
We have recently described an##2##5##(1994-5#1)(2011-2#1)
We have recently proposed that##2##5##(2008-11#1)(2009-8#1)
We have recently proposed##3##4##(1995-12#1)(2008-11#1)(2009-8#1)
We have recently reported that##3##5##(1995-6#1)(2009-8#1)(2012-2#1)
We have recently reported##4##4##(1995-6#1)(2008-11#1)(2009-8#1)(2012-2#1)
We have recently shown that human##2##6##(1990-5#1)(1994-5#1)
We have recently shown that##8##5##(1990-5#1)(1994-5#1)(2008-1#1)(2009-8#4)(2011-2#1)
We have recently##29##3##(1990-5#1)(1991-5#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-11#4)(2009-8#9)(2011-2#4)(2012-2#1)
We have reconstituted this##2##4##(1992-12#1)(1995-12#1)
We have reported a##2##4##(1993-3#1)(2012-12#1)
We have reported that##2##4##(1995-11#1)(2008-10#1)
We have reported the##4##4##(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#1)
We have reported##8##3##(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(2008-10#2)(2008-11#1)(2012-12#1)
We have reviewed the##2##4##(1990-2#1)(1991-9#1)
We have sequenced##2##3##(1990-5#1)(2008-5#1)
We have shown that##9##4##(1996-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-8#1)
We have shown##12##3##(1996-5#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-8#1)
We have studied the effect of##3##6##(1994-11#1)(1995-6#1)(1997-7#1)
We have studied the effects of##2##6##(1994-8#1)(1995-12#1)
We have studied the##12##4##(1990-12#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)
We have studied##18##3##(1990-12#1)(1990-8#1)(1991-2#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-11#1)(2012-3#1)
We have synthesized##2##3##(2009-7#1)(2012-2#1)
We have tested the##2##4##(1995-2#1)(2008-11#1)
We have tested##3##3##(1995-2#1)(1997-1#1)(2008-11#1)
We have therefore##3##3##(1995-8#1)(2008-6#1)(2008-9#1)
We have undertaken##3##3##(1993-12#1)(1993-3#1)(2008-10#1)
We have used a##5##4##(1990-2#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
We have used the##2##4##(2008-10#1)(2008-3#1)
We have used this technique to##2##6##(2008-10#1)(2008-11#1)
We have used this##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
We have used##25##3##(1990-2#1)(1990-5#1)(1992-3#1)(1992-9#1)(1995-2#3)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
We have##487##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#7)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#10)(1993-2#6)(1993-3#4)(1993-6#7)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#9)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#3)(1995-11#8)(1995-12#6)(1995-2#11)(1995-5#2)(1995-6#8)(1995-8#3)(1995-9#2)(1996-12#8)(1996-2#10)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#10)(1997-8#3)(2006-6#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#59)(2008-11#52)(2008-12#2)(2008-2#7)(2008-3#33)(2008-5#15)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#8)(2009-1#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#15)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#8)(2013-1#5)(2013-8#5)
We here report the##2##4##(2011-2#1)(2013-1#1)
We here report##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
We here##9##2##(1996-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
We hereby present a patient with a##2##7##(2009-11#1)(2009-8#1)
We hereby report the case##2##5##(2013-1#2)
We hereby report##3##3##(2012-12#1)(2013-1#2)
We hereby##6##2##(2009-11#1)(2009-8#1)(2012-12#1)(2013-1#3)
We herein present##2##3##(2009-12#1)(2013-1#1)
We herein report##4##3##(1992-12#1)(1997-2#1)(2010-6#2)
We herein##9##2##(1992-12#1)(1997-2#1)(2009-12#1)(2010-6#2)(2011-2#1)(2013-1#1)(2013-8#2)
We highlight##2##2##(2008-8#1)(2011-2#1)
We hope that##4##3##(1993-11#1)(2008-10#2)(2013-1#1)
We hypothesize that the##2##4##(1997-3#1)(2009-8#1)
We hypothesize that##18##3##(1992-6#2)(1997-3#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#2)(2012-12#1)
We hypothesized that the##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
We hypothesized that##10##3##(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
We identified a##5##3##(1992-3#1)(2008-10#2)(2009-10#1)(2010-12#1)
We identified the##4##3##(1990-11#1)(1991-6#1)(1997-7#1)(2008-5#1)
We identified##17##2##(1990-11#1)(1991-2#1)(1991-6#1)(1992-3#1)(1994-12#1)(1997-7#1)(2008-10#3)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
We identify the##4##3##(1993-2#1)(2008-6#1)(2008-8#1)(2012-2#1)
We identify##11##2##(1993-2#1)(1994-1#1)(2007-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
We illustrate the##5##3##(1994-9#1)(1997-1#1)(2008-3#1)(2008-8#1)(2011-2#1)
We illustrate them##2##3##(2008-7#1)(2013-1#1)
We illustrate this##2##3##(2008-3#1)(2008-8#1)
We illustrate##10##2##(1994-9#1)(1997-1#1)(2008-3#2)(2008-7#2)(2008-8#2)(2011-2#1)(2013-1#1)
We included##2##2##(2008-10#1)(2013-1#1)
We infer##2##2##(1991-5#1)(1993-12#1)
We initiated##2##2##(2008-11#1)(2008-3#1)
We injected##2##2##(1995-12#1)(2010-1#1)
We inoculated##2##2##(2008-10#2)
We intend to##2##3##(2008-7#1)(2009-8#1)
We introduce a new##2##4##(2008-3#1)(2013-8#1)
We introduce a##5##3##(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-8#1)
We introduce##7##2##(2008-2#2)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
We introduced##2##2##(1993-3#1)(2008-8#1)
We investigate how##3##3##(2008-8#3)
We investigate the evolution of##2##5##(2008-8#1)(2008-9#1)
We investigate the influence of##2##5##(2007-11#1)(2008-2#1)
We investigate the##12##3##(1995-9#1)(2007-11#1)(2008-2#1)(2008-3#4)(2008-8#2)(2008-9#1)(2010-5#1)(2013-1#1)
We investigate theoretically##2##3##(2008-3#1)(2008-8#1)
We investigate##20##2##(1995-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-8#6)(2008-9#1)(2010-10#1)(2010-5#1)(2013-1#1)
We investigated by##2##3##(2006-6#1)(2010-7#1)
We investigated the effect of##2##5##(1994-8#1)(2008-11#1)
We investigated the effects of##4##5##(1993-8#1)(2008-10#1)(2008-12#1)(2010-11#1)
We investigated the expression pattern of##2##6##(2008-8#1)(2011-2#1)
We investigated the expression pattern##3##5##(2008-8#1)(2008-9#1)(2011-2#1)
We investigated the expression##4##4##(1996-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
We investigated the feasibility of##2##5##(1996-2#1)(2008-11#1)
We investigated the influence of##4##5##(1991-6#1)(1994-11#1)(2008-10#1)(2008-8#1)
We investigated the interaction##2##4##(2008-10#1)(2008-11#1)
We investigated the properties of##2##5##(2008-10#1)(2012-2#1)
We investigated the relationship between##2##5##(2008-10#2)
We investigated the relationship##3##4##(2008-10#2)(2008-5#1)
We investigated the role of##2##5##(1997-8#1)(2008-11#1)
We investigated the use of##2##5##(1997-3#1)(2008-10#1)
We investigated the##56##3##(1991-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-8#2)(2007-8#1)(2008-10#11)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-8#2)(2010-11#1)(2011-2#2)(2012-2#1)
We investigated this##3##3##(1990-11#1)(2008-4#1)(2009-10#1)
We investigated two##3##3##(2008-12#1)(2008-8#1)(2012-3#1)
We investigated whether##10##3##(1992-6#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-7#1)(2010-4#1)(2012-3#1)
We investigated##88##2##(1990-11#1)(1991-6#1)(1992-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-8#3)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#14)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-4#2)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#3)
We isolated a##2##3##(1995-6#1)(1997-4#1)
We isolated##10##2##(1991-7#1)(1993-3#1)(1993-8#2)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#2)
We know##3##2##(2008-9#1)(2012-3#1)(2013-1#1)
We list##2##2##(2011-1#1)(2013-8#1)
We live in##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
We locked##2##2##(2008-3#2)
We made##3##2##(2009-10#1)(2009-6#1)(2012-2#1)
We mainly##2##2##(2013-8#2)
We make##3##2##(1995-12#1)(1997-1#1)(2013-1#1)
We mapped the##2##3##(2008-7#1)(2012-3#1)
We mapped##4##2##(2008-10#1)(2008-7#1)(2012-3#2)
We measure##2##2##(2008-8#1)(2011-2#1)
We measured the##14##3##(1994-11#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-2#1)
We measured##26##2##(1990-11#1)(1994-11#1)(1995-8#1)(1996-12#1)(1996-3#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-2#4)
We model the##2##3##(2008-3#1)(2012-2#1)
We modeled the##4##3##(2008-10#1)(2008-3#2)(2008-8#1)
We monitored##2##2##(2008-11#1)(2008-8#1)
We must##2##2##(2009-10#1)(2012-3#1)
We need to##2##3##(1993-1#1)(2010-4#1)
We need##3##2##(1991-1#1)(1993-1#1)(2010-4#1)
We note that##2##3##(1994-9#1)(2008-11#1)
We note##3##2##(1994-9#1)(2008-11#1)(2008-9#1)
We noted##2##2##(1994-5#1)(2013-8#1)
We now have##3##3##(1990-9#1)(1993-3#1)(2008-3#1)
We now know##2##3##(1997-1#1)(2011-2#1)
We now present##2##3##(1991-5#1)(1997-7#1)
We now report on##2##4##(1990-8#1)(2008-10#1)
We now report that##2##4##(1990-2#1)(2009-10#1)
We now report the results of##2##6##(2008-10#2)
We now report the##4##4##(1993-12#1)(1994-11#1)(2008-10#2)
We now report##10##3##(1990-11#1)(1990-2#1)(1990-8#1)(1993-12#1)(1994-11#1)(2008-10#3)(2009-10#1)(2009-8#1)
We now##23##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1997-1#1)(1997-7#2)(2008-10#3)(2008-3#2)(2009-10#1)(2009-11#1)(2009-8#1)(2011-2#1)
We observe##2##2##(2008-6#1)(2009-8#1)
We observed a##8##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2013-8#1)
We observed an##2##3##(2008-3#1)(2011-2#1)
We observed that the##2##4##(2009-4#1)(2010-6#1)
We observed that##9##3##(1992-8#1)(1993-2#1)(1994-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-6#1)
We observed the##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
We observed##38##2##(1990-8#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-11#2)(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#1)
We obtain##2##2##(1992-9#1)(2008-3#1)
We obtained a##2##3##(1990-6#1)(2008-2#1)
We obtained evidence for##2##4##(1990-5#1)(2012-3#1)
We obtained three##2##3##(2008-11#1)(2009-3#1)
We obtained##18##2##(1990-5#1)(1990-6#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
We outline the##2##3##(2011-2#1)(2012-2#1)
We outline##4##2##(2008-8#1)(2011-2#1)(2012-2#2)
We parameterize##2##2##(2008-8#1)(2010-3#1)
We perform##2##2##(2008-3#1)(2010-12#1)
We performed a genome-wide##2##4##(2012-3#2)
We performed a retrospective##6##4##(2008-10#1)(2011-2#5)
We performed a##16##3##(1994-2#1)(2008-10#2)(2008-7#2)(2009-12#1)(2010-7#1)(2011-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
We performed the##3##3##(2008-12#1)(2008-3#1)(2011-2#1)
We performed two##2##3##(2008-11#2)
We performed##38##2##(1991-8#1)(1994-2#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
We point##2##2##(2012-3#1)(2013-8#1)
We postulate that defects in the human##2##7##(1994-12#2)
We postulate that the##2##4##(2008-11#1)(2008-5#1)
We postulate that##8##3##(1994-12#2)(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
We postulate##9##2##(1994-12#2)(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-8#1)
We predict that##3##3##(2008-10#1)(2008-8#2)
We predict##4##2##(2008-10#1)(2008-8#2)(2012-2#1)
We prepared##2##2##(1995-12#1)(2008-5#1)
We present a case in which##3##6##(2008-11#1)(2008-7#1)(2010-7#1)
We present a case of a##9##6##(2008-10#2)(2008-12#2)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
We present a case of bilateral##2##6##(2008-9#1)(2013-1#1)
We present a case of pulmonary##2##6##(2013-1#2)
We present a case of##35##5##(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#5)(2008-7#3)(2008-9#1)(2009-1#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
We present a case report##3##5##(1990-3#1)(2009-8#1)(2010-7#1)
We present a case##45##4##(1990-3#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#6)(2008-7#4)(2008-9#1)(2009-1#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#3)(2011-2#7)(2012-12#4)(2012-2#2)(2013-1#6)(2013-8#1)
We present a general##2##4##(1990-8#1)(2008-3#1)
We present a model for the##2##6##(2007-12#1)(2008-8#1)
We present a model to##2##5##(2008-2#1)(2008-8#1)
We present a model##5##4##(2007-12#1)(2008-2#1)(2008-8#2)(2008-9#1)
We present a new method##2##5##(2008-3#1)(2008-5#1)
We present a new##5##4##(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)
We present a novel##5##4##(1992-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)
We present a patient with##4##5##(2008-12#2)(2008-9#1)(2013-1#1)
We present a patient##5##4##(2008-12#2)(2008-9#1)(2011-1#1)(2013-1#1)
We present a rare case of##2##6##(2008-10#1)(2008-9#1)
We present a rare##3##4##(2008-10#1)(2008-9#1)(2010-12#1)
We present a retrospective##2##4##(2008-9#1)(2010-11#1)
We present a series of##2##5##(1990-9#1)(2008-11#1)
We present a simple model##2##5##(2008-7#1)(2008-9#1)
We present a simple##6##4##(2008-3#2)(2008-7#1)(2008-9#2)(2009-5#1)
We present a technique for##3##5##(2007-12#1)(2008-3#2)
We present a theoretical analysis of##2##6##(2007-11#1)(2008-3#1)
We present a theoretical analysis##3##5##(2007-11#1)(2008-3#2)
We present a theoretical##5##4##(2007-11#1)(2007-12#1)(2008-3#2)(2008-8#1)
We present a##122##3##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#1)(1994-6#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-12#4)(2008-10#9)(2008-11#4)(2008-12#9)(2008-2#2)(2008-3#17)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#7)(2009-1#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#3)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#3)
We present an##15##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)
We present and evaluate##2##4##(2008-3#1)(2008-9#1)
We present and##3##3##(2008-3#2)(2008-9#1)
We present both##2##3##(1994-9#1)(2008-3#1)
We present experimental evidence##2##4##(2008-3#2)
We present experimental results##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
We present experimental##8##3##(1995-3#1)(2007-12#2)(2008-2#1)(2008-3#4)
We present here a##8##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-6#1)(2010-8#1)(2011-1#1)
We present here the##4##4##(1993-12#1)(2008-10#1)(2009-7#1)(2013-1#1)
We present here##16##3##(1993-12#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
We present herein two synthetic strategies for accessing chiral polyamines##2##10##(2009-10#2)
We present herein##3##3##(2009-10#2)(2012-3#1)
We present numerical##2##3##(2008-11#1)(2008-2#1)
We present our##6##3##(2008-10#3)(2008-3#1)(2008-7#1)(2012-2#1)
We present results##3##3##(2008-2#1)(2008-3#2)
We present several##2##3##(1997-2#1)(2008-8#1)
We present six##2##3##(2008-9#1)(2012-2#1)
We present the case of a man who##2##8##(2008-11#1)(2008-8#1)
We present the case of a##9##6##(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#1)
We present the case of##12##5##(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-3#2)
We present the case##13##4##(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-3#2)(2013-1#1)
We present the first##2##4##(1993-2#1)(1993-3#1)
We present the results of our##2##6##(2007-12#1)(2008-3#1)
We present the results of##7##5##(1990-6#1)(1994-3#1)(2007-12#1)(2008-3#3)(2008-9#1)
We present the results##8##4##(1990-6#1)(1994-3#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-9#1)
We present the##36##3##(1990-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#8)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
We present two cases of##5##5##(2008-10#1)(2010-5#1)(2012-3#2)(2013-1#1)
We present two##8##3##(2008-10#2)(2009-8#1)(2010-5#1)(2012-3#2)(2013-1#2)
We present what is to our knowledge the first##3##9##(2007-12#1)(2008-2#2)
We present##265##2##(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#2)(1997-9#1)(2007-11#2)(2007-12#9)(2008-10#22)(2008-11#10)(2008-12#11)(2008-2#15)(2008-3#42)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#14)(2008-9#12)(2009-1#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#16)(2012-12#5)(2012-2#8)(2012-3#9)(2013-1#13)(2013-8#4)
We presented##2##2##(2012-3#2)
We presume##2##2##(2011-2#1)(2013-1#1)
We previously demonstrated that##6##4##(1990-12#1)(1993-3#1)(1996-2#1)(2010-11#1)(2011-2#1)(2012-2#1)
We previously described that an##2##5##(2008-10#2)
We previously developed##2##3##(2008-11#2)
We previously established##2##3##(2008-11#2)
We previously reported that##6##4##(1994-11#1)(1994-2#1)(2009-12#2)(2013-1#2)
We previously reported##7##3##(1992-6#1)(1994-11#1)(1994-2#1)(2009-12#2)(2013-1#2)
We previously showed that##3##4##(2006-6#1)(2011-2#1)(2012-3#1)
We previously##24##2##(1990-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1996-2#1)(2006-6#1)(2008-10#3)(2008-11#5)(2009-12#2)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
We propose a method for##3##5##(2008-10#2)(2008-3#1)
We propose a new approach to##2##6##(2008-3#1)(2008-6#1)
We propose a new approach##3##5##(2008-10#1)(2008-3#1)(2008-6#1)
We propose a new##7##4##(2008-10#2)(2008-3#3)(2008-6#1)(2013-1#1)
We propose a novel##4##4##(2008-2#1)(2008-3#1)(2010-10#2)
We propose a simple##2##4##(2009-2#1)(2013-1#1)
We propose a##32##3##(1993-6#1)(1995-2#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#7)(2008-6#2)(2008-7#2)(2009-2#1)(2010-10#2)(2010-12#1)(2012-3#1)(2013-1#3)
We propose an optical##2##4##(2008-2#1)(2008-3#1)
We propose an##5##3##(2008-2#1)(2008-3#1)(2009-6#1)(2012-2#2)
We propose that in##3##4##(1995-11#1)(2008-10#1)(2012-3#1)
We propose that the##15##4##(1991-5#1)(1994-3#1)(1995-12#1)(1995-2#2)(1997-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
We propose that these##3##4##(1995-2#1)(2008-11#2)
We propose that this##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
We propose that##42##3##(1990-2#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#4)(1996-2#2)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#2)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
We propose the use of##2##5##(2008-10#1)(2008-2#1)
We propose the##5##3##(2008-10#2)(2008-2#1)(2011-2#1)(2013-8#1)
We propose to##3##3##(2008-3#2)(2011-3#1)
We propose two##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
We propose##107##2##(1990-2#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#6)(1996-2#2)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#11)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#2)
We proposed##3##2##(2008-8#1)(2009-8#1)(2010-8#1)
We prospectively studied##3##3##(2008-7#3)
We prospectively##6##2##(1997-8#1)(2008-7#3)(2011-2#2)
We prove that##2##3##(2008-3#1)(2009-12#1)
We provide a##7##3##(1996-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
We provide an##3##3##(1992-9#1)(1996-3#1)(2008-9#1)
We provide evidence that##2##4##(1994-11#1)(2012-3#1)
We provide evidence##4##3##(1992-12#1)(1994-11#1)(2011-2#1)(2012-3#1)
We provide##19##2##(1992-12#1)(1992-9#1)(1994-11#1)(1996-12#1)(1996-3#2)(2008-11#1)(2008-3#3)(2008-6#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)
We purified the##3##3##(1992-12#1)(1995-6#1)(2012-2#1)
We quantified##5##2##(1996-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
We question the##2##3##(1992-3#1)(1995-5#1)
We question##3##2##(1992-3#1)(1995-5#1)(2008-9#1)
We randomized##2##2##(2013-1#2)
We recently discovered that the##2##5##(2011-2#2)
We recently mapped##2##3##(1994-12#1)(1996-8#1)
We recently observed that##2##4##(1990-5#1)(1997-7#1)
We recently reported that##2##4##(1995-2#1)(2009-8#1)
We recently##18##2##(1990-5#1)(1990-8#1)(1992-6#1)(1994-12#2)(1995-12#1)(1995-2#1)(1996-8#1)(1997-7#1)(2008-10#1)(2009-8#1)(2010-6#2)(2011-2#4)(2012-2#1)
We recommend that##5##3##(1993-3#1)(2008-10#2)(2010-8#1)(2013-1#1)
We recommend##10##2##(1993-3#1)(2008-10#3)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
We reconstruct##2##2##(2010-4#1)(2012-3#1)
We recorded##2##2##(2008-3#1)(2013-1#1)
We recovered##2##2##(2008-10#2)
We regard##2##2##(2008-10#1)(2012-3#1)
We reject the##2##3##(2008-10#2)
We report a 51-year-old##2##4##(2013-1#1)(2013-8#1)
We report a case of a female patient##2##8##(2012-12#2)
We report a case of a young##2##7##(2012-2#1)(2013-8#1)
We report a case of a##17##6##(1991-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
We report a case of acute##2##6##(2008-10#1)(2013-1#1)
We report a case of an##5##6##(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
We report a case of diffuse##2##6##(2009-1#1)(2011-2#1)
We report a case of primary##3##6##(2008-10#1)(2008-11#1)(2013-8#1)
We report a case of##79##5##(1990-12#1)(1990-6#1)(1991-11#1)(1992-2#2)(1994-12#1)(1994-8#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#12)(2008-5#2)(2008-7#4)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#3)
We report a case##86##4##(1990-12#1)(1990-6#1)(1991-11#1)(1992-2#3)(1994-12#1)(1994-8#1)(1995-10#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#13)(2008-5#2)(2008-7#4)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#3)
We report a further case##2##5##(2008-11#1)(2008-7#1)
We report a new##2##4##(2007-8#1)(2008-10#1)
We report a novel method##2##5##(2008-11#1)(2013-1#1)
We report a novel##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
We report a patient with a##2##6##(2012-2#1)(2012-3#1)
We report a patient with##5##5##(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
We report a patient##7##4##(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
We report a rare case of a##2##7##(2012-3#1)(2013-2#1)
We report a rare case of##9##6##(2008-12#3)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-2#1)
We report a rare##11##4##(2008-12#3)(2008-7#2)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-2#1)
We report a##136##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1992-2#3)(1994-12#2)(1994-8#1)(1995-10#1)(1997-6#1)(1997-8#1)(2007-8#2)(2008-10#11)(2008-11#5)(2008-12#18)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#10)(2008-8#1)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-12#7)(2012-2#5)(2012-3#6)(2013-1#15)(2013-2#1)(2013-8#8)
We report an unusual case of##5##6##(2008-10#2)(2012-2#1)(2013-1#2)
We report an##13##3##(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
We report complete NMR chemical shift assignments of##2##8##(2009-7#2)
We report for the first time##3##6##(1992-6#1)(1996-3#1)(2010-12#1)
We report here a##4##4##(1997-7#1)(2008-10#1)(2008-6#1)(2010-1#1)
We report here on a rare case of##2##8##(2010-6#1)(2012-3#1)
We report here on a##4##5##(2008-1#1)(2010-6#2)(2012-3#1)
We report here on the##2##5##(1993-12#1)(2008-10#1)
We report here on##6##4##(1993-12#1)(2008-1#1)(2008-10#1)(2010-6#2)(2012-3#1)
We report here that the##6##5##(1990-5#1)(1991-5#1)(1991-9#1)(1993-8#1)(1993-9#1)(1997-7#1)
We report here that##15##4##(1990-5#1)(1991-5#1)(1991-9#1)(1993-8#1)(1993-9#2)(1995-2#2)(1997-7#2)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
We report here the development of an##2##7##(2008-10#2)
We report here the development##3##5##(2008-10#2)(2011-8#1)
We report here the##12##4##(1993-12#1)(1993-2#1)(1993-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2009-3#1)(2009-7#1)(2011-2#1)(2011-8#1)
We report here##43##3##(1990-5#1)(1991-5#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-2#2)(1997-2#1)(1997-7#3)(1997-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-6#2)(2011-2#3)(2011-8#1)(2012-2#1)(2012-3#1)
We report herein##2##3##(2008-10#1)(2008-11#1)
We report on 2##2##4##(1992-12#1)(1996-11#1)
We report on a 4-year-old##2##5##(2008-10#1)(2013-1#1)
We report on a case of##2##6##(2007-9#1)(2013-1#1)
We report on a case##3##5##(2007-9#1)(2008-10#1)(2013-1#1)
We report on a patient##3##5##(1997-3#1)(2011-2#1)(2011-3#1)
We report on a##18##4##(1991-3#1)(1993-12#1)(1997-3#4)(1997-5#1)(2007-9#1)(2008-10#2)(2008-3#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
We report on an##4##4##(1993-12#1)(2007-12#1)(2008-3#2)
We report on the##10##4##(1993-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-12#1)
We report on##43##3##(1991-3#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-8#1)(1996-11#2)(1996-8#1)(1997-3#5)(1997-5#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#9)(2008-7#1)(2009-12#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
We report our experience with##2##5##(1995-3#1)(2008-11#1)
We report our experience##4##4##(1995-10#1)(1995-3#1)(2008-11#1)(2011-2#1)
We report that the##3##4##(1997-2#1)(2009-6#1)(2011-2#1)
We report that##11##3##(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-11#1)(2009-6#1)(2011-2#2)
We report the case of a newborn presenting with##2##9##(2008-10#2)
We report the case of a patient##4##7##(1993-6#1)(2011-2#1)(2013-1#2)
We report the case of a##27##6##(1993-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#3)(2009-1#1)(2010-5#2)(2010-6#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
We report the case of##33##5##(1990-6#1)(1993-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#4)(2009-1#1)(2010-12#1)(2010-5#2)(2010-6#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
We report the case##34##4##(1990-6#1)(1993-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#4)(2009-1#1)(2010-12#1)(2010-5#2)(2010-6#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)
We report the clinical##2##4##(2013-1#2)
We report the development##2##4##(1990-12#1)(2008-10#1)
We report the experimental##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
We report the first case of a##3##7##(2008-12#1)(2011-2#1)(2013-1#1)
We report the first case of##6##6##(2008-10#1)(2008-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
We report the first case##7##5##(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
We report the first##9##4##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
We report the identification of##3##5##(1993-6#2)(2012-3#1)
We report the isolation##2##4##(1997-7#1)(2008-8#1)
We report the results of##3##5##(1996-11#1)(2008-5#1)(2009-9#1)
We report the successful##2##4##(1994-6#1)(2008-7#1)
We report the use of the##3##6##(2007-12#1)(2010-5#1)(2011-2#1)
We report the use of##4##5##(2007-12#1)(2008-7#1)(2010-5#1)(2011-2#1)
We report the##89##3##(1990-12#1)(1990-6#1)(1992-12#1)(1993-11#1)(1993-6#4)(1993-9#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#7)(2008-8#1)(2009-1#1)(2009-5#2)(2009-7#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2011-2#10)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#11)(2013-7#1)
We report this case##2##4##(1996-3#1)(2008-12#1)
We report three cases##2##4##(2008-7#1)(2012-12#1)
We report three patients with##2##5##(2010-10#1)(2013-1#1)
We report three##4##3##(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
We report two cases of##8##5##(2007-8#1)(2008-10#2)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#2)
We report two cases##10##4##(2007-8#1)(2008-10#2)(2009-1#1)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#3)
We report two patients##3##4##(2008-1#1)(2008-7#1)(2013-1#1)
We report two##14##3##(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-1#1)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#4)
We report##392##2##(1990-12#3)(1990-3#2)(1990-5#1)(1990-6#2)(1991-11#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#2)(1992-2#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-2#4)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#4)(1996-3#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#6)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#36)(2008-11#14)(2008-12#22)(2008-2#4)(2008-3#15)(2008-5#5)(2008-6#1)(2008-7#23)(2008-8#2)(2008-9#2)(2009-1#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#9)(2009-8#1)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#3)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#28)(2011-3#1)(2011-8#1)(2012-12#11)(2012-2#8)(2012-3#14)(2013-1#36)(2013-2#1)(2013-7#1)(2013-8#9)
We reported a 28-year-old##2##4##(2013-1#2)
We reported previously that the##2##5##(1994-8#1)(2008-7#1)
We reported previously that##4##4##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
We reported previously##5##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
We reported that##2##3##(1992-12#1)(2010-6#1)
We reported##14##2##(1992-12#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#3)
We researched##2##2##(2008-10#2)
We retrospectively analysed##2##3##(1991-3#1)(2013-1#1)
We retrospectively analyzed the##2##4##(1993-2#1)(2012-12#1)
We retrospectively analyzed##4##3##(1993-2#1)(2012-12#1)(2012-3#2)
We retrospectively##10##2##(1991-3#1)(1993-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
We reveal that its genome size is##2##7##(2011-2#2)
We reveal##3##2##(2008-3#1)(2011-2#2)
We review different##2##3##(2012-3#1)(2013-1#1)
We review here##2##3##(2008-11#1)(2013-8#1)
We review the##13##3##(1991-6#1)(1993-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
We review##29##2##(1990-6#1)(1991-6#1)(1993-2#1)(1994-6#1)(1996-9#1)(1997-2#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
We reviewed published##2##3##(2008-7#1)(2012-3#1)
We reviewed studies##2##3##(2009-7#1)(2012-2#1)
We reviewed the clinical and##2##5##(1996-6#1)(1997-6#1)
We reviewed the##8##3##(1996-6#1)(1997-3#1)(1997-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
We reviewed##19##2##(1996-6#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
We revisit##2##2##(2008-3#1)(2009-11#1)
We sampled##2##2##(2008-10#2)
We screened##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
We searched##5##2##(1995-12#1)(1996-8#1)(2011-2#2)(2012-2#1)
We selected##6##2##(1992-9#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
We set out to##2##4##(2012-3#1)(2012-5#1)
We set##3##2##(2008-12#1)(2012-3#1)(2012-5#1)
We show by##2##3##(1994-11#1)(2008-3#1)
We show here that the##2##5##(1991-5#1)(1993-8#1)
We show here that this##2##5##(1997-3#1)(2008-10#1)
We show here that##7##4##(1990-12#1)(1991-5#1)(1993-8#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)
We show how these##2##4##(2008-3#1)(2008-8#1)
We show how to##3##4##(2008-3#2)(2008-6#1)
We show how##11##3##(1996-3#1)(2008-10#1)(2008-3#4)(2008-6#2)(2008-8#2)(2010-11#1)
We show that a##7##4##(2008-3#2)(2008-8#2)(2009-10#1)(2010-7#1)(2013-8#1)
We show that by##2##4##(2008-12#1)(2008-3#1)
We show that for##2##4##(2007-12#1)(2008-9#1)
We show that in##4##4##(1995-8#1)(2008-2#1)(2008-3#1)(2008-8#1)
We show that migration##2##4##(2008-8#1)(2013-8#1)
We show that spatial##3##4##(2008-10#1)(2008-8#2)
We show that the##34##4##(1990-5#1)(1992-2#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#11)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
We show that there##2##4##(2011-3#1)(2012-3#1)
We show that these##2##4##(1995-2#1)(1997-2#1)
We show that this##7##4##(1992-9#1)(2008-10#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
We show that with##3##4##(2008-6#1)(2008-8#1)(2013-1#1)
We show that##103##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#1)(1994-11#2)(1994-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(2007-11#1)(2007-12#4)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#24)(2008-5#1)(2008-6#1)(2008-8#14)(2008-9#3)(2009-10#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#6)
We show the##6##3##(1995-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-3#1)(2013-8#1)
We show##135##2##(1990-12#1)(1990-5#1)(1991-5#2)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-11#3)(1994-12#2)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#5)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#31)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#19)(2008-9#3)(2009-10#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#7)
We showed that after##2##4##(2008-11#2)
We showed that the##3##4##(2008-10#2)(2012-2#1)
We showed that##13##3##(1994-11#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-8#1)
We showed##14##2##(1994-11#1)(1997-6#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-8#1)
We solve##2##2##(2008-3#1)(2008-6#1)
We sought to determine##2##4##(2008-11#1)(2010-2#1)
We sought to##8##3##(2008-11#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
We specifically##2##2##(2008-11#1)(2012-2#1)
We speculate that in##2##4##(2008-10#1)(2011-2#1)
We speculate that the##2##4##(2008-10#2)
We speculate that##8##3##(1997-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
We speculate##9##2##(1997-2#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
We standardized##2##2##(2008-11#1)(2012-4#1)
We stress the##2##3##(1990-9#1)(2008-10#1)
We strongly##3##2##(1994-9#1)(1997-8#1)(2012-3#1)
We studied a##2##3##(2008-1#1)(2009-6#1)
We studied the changes##2##4##(2009-8#1)(2011-2#1)
We studied the effect of##11##5##(1990-8#1)(1994-11#2)(1997-8#1)(2008-10#3)(2008-11#3)(2008-7#1)
We studied the effects of##2##5##(2008-10#1)(2011-10#1)
We studied the effects##3##4##(1996-2#1)(2008-10#1)(2011-10#1)
We studied the##31##3##(1990-6#1)(1990-8#1)(1992-9#1)(1993-1#1)(1994-11#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#4)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
We studied##61##2##(1990-6#1)(1990-8#1)(1992-9#1)(1993-1#1)(1994-11#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#3)(2008-10#6)(2008-11#5)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#8)(2008-8#3)(2008-9#4)(2009-6#2)(2009-8#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#1)
We study a##2##3##(1995-5#1)(2008-8#1)
We study the##6##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#3)
We study##14##2##(1995-5#1)(2007-12#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#5)(2012-2#1)
We succeeded##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
We successfully##5##2##(1990-11#1)(2010-7#2)(2012-3#2)
We suggest a##3##3##(1992-6#1)(1995-2#1)(2008-3#1)
We suggest that the##11##4##(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2013-7#1)
We suggest that this##5##4##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)
We suggest that##43##3##(1992-3#1)(1993-11#1)(1993-2#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
We suggest##52##2##(1990-6#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-2#2)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
We summarize the##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
We summarize##4##2##(1997-2#1)(2008-10#1)(2010-12#1)(2011-2#1)
We surveyed##2##2##(1994-9#1)(2008-10#1)
We synthesized##2##2##(1994-8#1)(2009-10#1)
We test this hypothesis##2##4##(2008-10#1)(2009-7#1)
We test this##3##3##(1997-1#1)(2008-10#1)(2009-7#1)
We test##7##2##(1997-1#1)(1997-3#1)(2008-10#1)(2008-8#2)(2009-10#1)(2009-7#1)
We tested the hypothesis that the##2##6##(1995-8#1)(2008-10#1)
We tested the hypothesis that##4##5##(1995-8#1)(2008-10#3)
We tested the##9##3##(1995-8#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
We tested this##2##3##(2008-8#2)
We tested##21##2##(1995-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#3)(2012-3#2)(2013-1#1)
We then describe##3##3##(2008-11#1)(2010-12#1)(2012-2#1)
We then discuss the##2##4##(2008-11#1)(2008-9#1)
We then performed##2##3##(2011-2#1)(2012-3#1)
We then present##2##3##(2008-10#1)(2008-6#1)
We then show that the##3##5##(2008-3#1)(2010-3#1)(2013-8#1)
We then used##2##3##(1997-6#1)(2008-11#1)
We then##37##2##(1994-2#1)(1995-5#1)(1997-6#1)(2008-10#3)(2008-11#7)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
We therefore propose that##2##4##(1995-2#1)(1995-8#1)
We therefore studied##2##3##(1994-8#1)(2008-10#1)
We therefore suggest that##2##4##(1990-5#1)(2008-9#1)
We therefore##18##2##(1990-3#1)(1990-5#2)(1990-8#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#2)(2013-1#1)
We think##2##2##(1997-8#1)(2011-2#1)
We thus##6##2##(2008-11#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
We took##2##2##(2008-3#1)(2009-10#1)
We treated##2##2##(1991-6#1)(2011-2#1)
We use a##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2013-8#1)
We use an##3##3##(2008-2#1)(2008-9#1)(2013-8#1)
We use data from##2##4##(2011-2#1)(2013-1#1)
We use our##2##3##(2008-3#1)(2012-3#1)
We use the##10##3##(1994-9#1)(2007-12#1)(2008-3#4)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
We use this##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
We use##34##2##(1994-9#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
We used a novel##2##4##(2012-3#1)(2013-1#1)
We used a##24##3##(1990-8#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
We used an##3##3##(1993-12#1)(2011-1#1)(2012-2#1)
We used data from##2##4##(1995-12#1)(2008-11#1)
We used published##2##3##(2008-11#1)(2012-3#1)
We used the##11##3##(1990-7#1)(1994-1#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
We used this approach to##2##5##(2008-10#1)(2012-2#1)
We used this##5##3##(2008-10#1)(2008-3#1)(2012-2#2)(2013-1#1)
We used##94##2##(1990-12#1)(1990-7#1)(1990-8#1)(1993-12#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-6#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#8)(2008-9#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#5)(2012-3#6)(2013-1#6)(2013-8#1)
We utilized the##2##3##(1996-2#1)(2008-10#1)
We utilized##6##2##(1994-8#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
We validated the##2##3##(1997-2#1)(2009-12#1)
We validated##3##2##(1997-2#1)(2009-12#1)(2010-1#1)
We wanted to##3##3##(2008-11#1)(2010-12#1)(2011-2#1)
We were able to##7##4##(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2011-1#1)(2013-1#1)
We were also##2##3##(2008-1#1)(2008-12#1)
We were unable to##3##4##(1996-3#1)(2008-11#1)(2010-12#1)
We were##15##2##(1992-9#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
We will also##5##3##(1993-12#1)(2008-10#1)(2008-12#1)(2009-11#1)(2010-12#1)
We will continue to##2##4##(1997-8#1)(2013-8#1)
We will discuss##2##3##(2008-10#1)(2012-3#1)
We will review the##2##4##(1997-1#1)(2008-10#1)
We will review##3##3##(1995-1#1)(1997-1#1)(2008-10#1)
We will then##2##3##(1993-3#1)(2013-8#1)
We will##24##2##(1993-12#1)(1993-3#1)(1995-1#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#5)
We would like to##3##4##(2008-12#1)(2008-7#1)(2013-1#1)
We would##5##2##(1990-2#1)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
We##4450##1##(1990-11#9)(1990-12#13)(1990-2#8)(1990-3#10)(1990-5#19)(1990-6#9)(1990-7#2)(1990-8#13)(1990-9#13)(1991-1#4)(1991-11#8)(1991-12#17)(1991-2#10)(1991-3#10)(1991-5#17)(1991-6#15)(1991-7#3)(1991-8#7)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#19)(1992-2#8)(1992-3#15)(1992-4#2)(1992-5#1)(1992-6#12)(1992-8#8)(1992-9#18)(1993-1#5)(1993-11#8)(1993-12#28)(1993-2#14)(1993-3#21)(1993-6#17)(1993-8#18)(1993-9#10)(1994-1#4)(1994-11#41)(1994-12#30)(1994-2#8)(1994-3#17)(1994-5#11)(1994-6#7)(1994-8#20)(1994-9#12)(1995-1#4)(1995-10#3)(1995-11#15)(1995-12#25)(1995-2#41)(1995-3#5)(1995-5#10)(1995-6#20)(1995-8#20)(1995-9#7)(1996-11#9)(1996-12#24)(1996-2#29)(1996-3#13)(1996-5#5)(1996-6#12)(1996-8#4)(1996-9#5)(1997-1#21)(1997-2#31)(1997-3#37)(1997-4#5)(1997-5#2)(1997-6#7)(1997-7#27)(1997-8#22)(1997-9#3)(2006-6#8)(2007-11#21)(2007-12#55)(2007-8#7)(2007-9#4)(2008-1#15)(2008-10#520)(2008-11#318)(2008-12#82)(2008-2#83)(2008-3#346)(2008-4#7)(2008-5#76)(2008-6#42)(2008-7#155)(2008-8#259)(2008-9#139)(2009-1#14)(2009-10#36)(2009-11#11)(2009-12#22)(2009-2#1)(2009-3#8)(2009-4#10)(2009-5#11)(2009-6#23)(2009-7#26)(2009-8#69)(2009-9#8)(2010-1#14)(2010-10#15)(2010-11#20)(2010-12#30)(2010-2#5)(2010-3#15)(2010-4#12)(2010-5#19)(2010-6#23)(2010-7#34)(2010-8#25)(2010-9#9)(2011-1#23)(2011-10#3)(2011-2#226)(2011-3#12)(2011-8#1)(2012-12#41)(2012-2#126)(2012-3#160)(2012-4#2)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#182)(2013-2#2)(2013-7#6)(2013-8#108)
We'll##2##1##(2009-10#1)(2011-2#1)
We've established that##2##3##(2012-3#2)
We've##4##1##(2009-9#1)(2012-3#3)
Weak##4##1##(1994-8#1)(1997-8#1)(2008-12#1)(2012-2#1)
Weakly##3##1##(1996-9#1)(2009-8#1)(2011-2#1)
Weather##3##1##(2008-10#3)
Web at http##3##3##(1997-6#1)(1997-8#1)(2008-3#1)
Web of##3##2##(2011-2#1)(2013-1#2)
Web resource##2##2##(2008-11#1)(2008-9#1)
Web server##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
Web site##5##2##(2008-10#2)(2008-4#1)(2011-1#1)(2013-1#1)
Web sites was##2##3##(2011-1#2)
Web sites##4##2##(2009-5#1)(2011-1#3)
Web top 10##2##3##(2008-7#2)
Web##35##1##(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#5)(2009-5#1)(2011-1#4)(2011-2#1)(2013-1#4)
Web-based##6##1##(2008-12#2)(2010-10#1)(2010-8#1)(2013-1#2)
WebMILL##2##1##(2013-1#2)
Wechsler##2##1##(2008-10#1)(2008-7#1)
Weed Orobanche##2##2##(2008-10#2)
Weed##8##1##(2008-10#4)(2010-8#4)
Weeds in Central##2##3##(2008-10#2)
Weeds##3##1##(2008-10#3)
Week##5##1##(1991-2#1)(1991-5#1)(1995-3#1)(2008-11#1)(2012-3#1)
Weekly clinicopathological exercises##5##3##(1992-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-7#1)
Weekly##8##1##(1992-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-7#1)(2008-10#2)
Wegener's granulomatosis in##2##3##(2008-7#1)(2010-11#1)
Wegener's granulomatosis##6##2##(2008-1#1)(2008-7#1)(2010-11#3)(2012-3#1)
Wegener's##8##1##(2008-1#2)(2008-6#1)(2008-7#1)(2010-11#3)(2012-3#1)
Wei##2##1##(2008-11#1)(2010-7#1)
Weibull distribution##3##2##(2008-10#2)(2009-7#1)
Weibull distributions##2##2##(2009-11#1)(2011-2#1)
Weibull model##5##2##(1995-9#1)(2008-10#1)(2008-9#1)(2010-4#2)
Weibull##16##1##(1995-9#1)(2008-10#8)(2008-9#2)(2009-11#1)(2009-7#1)(2010-4#2)(2011-2#1)
Weight and##2##2##(2011-1#1)(2012-2#1)
Weight loss##2##2##(1993-2#1)(2008-4#1)
Weight##16##1##(1993-12#1)(1993-2#1)(1995-3#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Weighted##2##1##(2008-11#1)(2013-1#1)
Weights##2##1##(1991-12#1)(1992-12#1)
Weil osteotomy##3##2##(2010-11#3)
Welcome a New Resident&quot##2##4##(1992-1#2)
Welcome to the##2##3##(2008-10#2)
Welcome##4##1##(1992-1#2)(2008-10#2)
Welfare##14##1##(1990-12#1)(1991-3#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#2)(2013-8#3)
Well##5##1##(1994-3#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#1)
Well-Being##2##1##(2010-3#1)(2010-7#1)
Well-defined##4##1##(2008-10#3)(2008-12#1)
Wellcome##4##1##(1990-9#1)(2008-10#1)(2008-7#2)
Wellington##2##1##(2008-1#2)
Wellness##2##1##(1992-12#1)(2012-12#1)
Welsh onion##2##2##(2008-10#2)
Welsh##4##1##(2008-10#4)
Were the##2##2##(1991-2#1)(2009-10#1)
Were##4##1##(1991-2#1)(2009-10#1)(2009-8#1)(2013-1#1)
Werner syndrome##2##2##(1992-9#1)(2010-1#1)
Werner's syndrome is##2##3##(1994-12#2)
Werner's syndrome##6##2##(1994-12#6)
Wesley##2##1##(2008-12#2)
Wesley's##4##1##(2008-12#4)
West Africa##2##2##(2008-1#1)(2008-10#1)
West Bengal##4##2##(2008-10#1)(2010-10#1)(2011-1#2)
West Germany##2##2##(1990-3#1)(1997-8#1)
West Indies##5##2##(2008-7#1)(2011-2#4)
West Nile virus (WNV)##2##4##(2009-10#1)(2010-8#1)
West Nile virus##4##3##(2008-10#1)(2009-10#2)(2010-8#1)
West Nile##5##2##(2008-10#1)(2009-10#2)(2010-8#1)(2013-8#1)
West Virginia##2##2##(2008-10#1)(2008-4#1)
West##38##1##(1990-3#1)(1993-12#1)(1995-1#2)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2010-10#1)(2010-8#2)(2011-1#2)(2011-2#5)(2013-1#2)(2013-8#1)
West-Center region##2##2##(2008-10#2)
Westerbork##2##1##(2008-7#2)
Western Australia##17##2##(2008-10#12)(2008-11#2)(2010-3#3)
Western Australian##2##2##(1994-12#1)(2008-10#1)
Western Europe##5##2##(1997-1#1)(2008-1#1)(2008-10#1)(2011-2#2)
Western Hemisphere##4##2##(2008-10#4)
Western Pacific##2##2##(2008-3#1)(2008-6#1)
Western Pomerania##2##2##(2008-12#2)
Western United States##3##3##(2008-10#3)
Western Washington##2##2##(2008-10#2)
Western analysis of##2##3##(1995-6#1)(1995-8#1)
Western analysis##5##2##(1993-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-7#1)
Western and##2##2##(2008-10#1)(2012-2#1)
Western blot analyses##4##3##(1991-10#1)(1993-12#1)(1996-12#1)(2008-10#1)
Western blot analysis and##3##4##(1997-8#1)(2008-11#1)(2010-12#1)
Western blot analysis demonstrated##2##4##(2008-10#1)(2008-8#1)
Western blot analysis of##5##4##(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2011-2#1)
Western blot analysis revealed that both##2##6##(1996-2#1)(2009-3#1)
Western blot analysis revealed that##4##5##(1996-2#1)(2008-10#1)(2008-8#1)(2009-3#1)
Western blot analysis showed##4##4##(1997-7#1)(2008-11#2)(2011-2#1)
Western blot analysis##27##3##(1990-8#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#3)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-8#3)(2009-3#1)(2010-12#2)(2011-2#3)
Western blot and##8##3##(1994-5#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2013-8#1)
Western blot showed a##2##4##(2008-8#1)(2008-9#1)
Western blot##68##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-5#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#6)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#7)(2008-5#2)(2008-7#2)(2008-8#9)(2008-9#6)(2009-3#1)(2009-9#1)(2010-12#2)(2011-2#7)(2012-2#1)(2013-1#1)(2013-8#1)
Western blots and##2##3##(1995-6#1)(2008-10#1)
Western blots##8##2##(1993-12#1)(1995-12#3)(1995-6#1)(2008-10#2)(2008-9#1)
Western blotting also##2##3##(2008-8#1)(2008-9#1)
Western blotting of##3##3##(1994-11#1)(2008-11#1)(2008-9#1)
Western blotting with##3##3##(1997-1#1)(2008-8#1)(2010-12#1)
Western blotting##35##2##(1990-12#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-2#1)(2008-11#3)(2008-12#1)(2008-8#6)(2008-9#6)(2010-12#3)(2011-3#3)(2012-3#2)
Western countries has##2##3##(1992-1#1)(2012-2#1)
Western countries##10##2##(1990-6#2)(1992-1#1)(1995-11#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-2#2)(2012-3#1)
Western immunoblot##2##2##(1992-9#1)(2008-10#1)
Western medical ointments##2##3##(1997-2#2)
Western medicine##2##2##(2012-2#2)
Western moral theory##2##3##(2011-2#2)
Western society##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
Western white pine##2##3##(2008-10#2)
Western##217##1##(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-4#1)(1992-9#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#5)(1995-2#1)(1995-6#5)(1995-8#2)(1996-12#6)(1996-2#1)(1997-1#4)(1997-2#3)(1997-7#2)(1997-8#3)(2008-1#3)(2008-10#44)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#15)(2008-9#15)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-3#4)(2010-8#1)(2010-9#1)(2011-2#15)(2011-3#3)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#1)(2013-8#3)
Weston##3##1##(1994-2#1)(2008-10#2)
Wet##3##1##(2008-10#3)
Wetness Duration on Infection of##2##5##(2008-10#2)
Wetness Duration on##3##3##(2008-10#3)
Wetness##6##1##(2008-10#6)
Weymouth##3##1##(2008-10#3)
What Have##2##2##(2012-3#2)
What Is##2##2##(2012-3#2)
What a##4##2##(1993-1#1)(1997-3#1)(2008-11#1)(2010-3#1)
What affects##2##2##(1992-12#1)(1995-3#1)
What are the##11##3##(1992-11#1)(1993-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#1)(2012-3#1)
What are##15##2##(1992-11#1)(1993-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
What can be done to##2##5##(1992-11#1)(2008-10#1)
What can be##3##3##(1990-9#1)(1992-11#1)(2008-10#1)
What can we learn##2##4##(2009-8#1)(2011-2#1)
What can we##4##3##(1993-2#1)(2009-8#1)(2011-2#1)(2013-7#1)
What can##9##2##(1990-9#1)(1992-11#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-7#1)
What causes##2##2##(1995-8#1)(2008-9#1)
What do we##2##3##(1992-3#1)(1994-3#1)
What do##11##2##(1992-3#1)(1994-2#1)(1994-3#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
What evidence is available from##2##5##(2012-12#2)
What happens in##2##3##(2008-11#1)(2012-12#1)
What happens when the private sector plans hospital services for the NHS##5##12##(1997-5#5)
What happens when##6##3##(1997-5#5)(2008-11#1)
What happens##9##2##(1993-1#1)(1997-5#5)(2008-11#2)(2012-12#1)
What has##3##2##(1994-1#1)(1994-12#1)(2008-6#1)
What if I##2##3##(2008-4#1)(2008-8#1)
What is the future##2##4##(2008-11#2)
What is the purpose of launching World Journal of##2##9##(2010-12#2)
What is the purpose of launching##3##6##(2010-12#3)
What is the role of##4##5##(1993-11#1)(1995-12#1)(2008-11#1)(2012-2#1)
What is the##22##3##(1992-12#1)(1993-11#1)(1993-3#1)(1995-12#1)(1997-8#1)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#1)(2010-12#4)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
What is your diagnosis?##2##4##(1992-6#1)(2007-12#1)
What is##40##2##(1992-1#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#2)(1995-12#1)(1996-1#1)(1997-8#1)(2007-12#1)(2008-11#7)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2010-10#1)(2010-12#4)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#1)
What lessons have##2##3##(2008-10#2)
What should we##2##3##(1993-2#1)(2008-8#1)
What should##3##2##(1993-2#1)(1994-12#1)(2008-8#1)
What the##2##2##(1992-2#1)(2012-2#1)
What to do##2##3##(2009-9#1)(2010-12#1)
What##160##1##(1990-9#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#4)(1993-11#2)(1993-2#2)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#5)(1995-12#2)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#6)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-3#2)(1997-5#5)(1997-8#2)(2007-12#1)(2008-10#3)(2008-11#17)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#7)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#10)(2012-12#6)(2012-2#4)(2012-3#10)(2013-1#2)(2013-7#1)(2013-8#4)
What's hot##2##2##(2007-12#1)(2008-8#1)
What's in a name##2##4##(1993-1#1)(2008-5#1)
What's in a name?##2##4##(1992-12#1)(1993-9#1)
What's in a##4##3##(1992-12#1)(1993-1#1)(1993-9#1)(2008-5#1)
What's in##6##2##(1991-8#1)(1992-12#1)(1993-1#1)(1993-9#1)(2008-5#1)(2012-3#1)
What's next##2##2##(1993-5#1)(2009-1#1)
What's##20##1##(1990-11#1)(1990-8#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-5#1)(1993-9#1)(1995-1#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-1#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-3#2)
Whatever the##3##2##(1991-6#1)(1992-12#1)(2008-7#1)
Whatman 1PS paper and##2##4##(2008-10#2)
Whatman 1PS paper##3##3##(2008-10#3)
Whatman 1PS##5##2##(2008-10#5)
Whatman##6##1##(2008-10#6)
Wheat (Triticum aestivum)##3##3##(2008-10#3)
Wheat (Triticum##4##2##(2008-10#3)(2012-3#1)
Wheat Cultivars##4##2##(2008-10#4)
Wheat Fields##2##2##(2008-10#2)
Wheat Genotypes##2##2##(2008-10#2)
Wheat Leaf Rust##2##3##(2008-10#2)
Wheat Seedlings##3##2##(2008-10#3)
Wheat and##4##2##(2008-10#4)
Wheat by##3##2##(2008-10#3)
Wheat cultivars that##2##3##(2008-10#2)
Wheat genotypes##2##2##(2008-10#2)
Wheat leaf rust##2##3##(2008-10#2)
Wheat to##3##2##(2008-10#3)
Wheat was##2##2##(2008-10#2)
Wheat##84##1##(1991-12#1)(2008-10#79)(2008-12#1)(2008-8#1)(2012-3#1)(2013-8#1)
When RH decreased##2##3##(2008-10#2)
When a##28##2##(1990-12#1)(1990-2#2)(1991-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-8#1)(2008-10#10)(2008-11#2)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
When all##2##2##(1996-12#1)(2008-10#1)
When an##3##2##(1991-12#1)(2012-2#2)
When analyzed by##2##3##(1990-8#1)(2008-10#1)
When analyzing##2##2##(1995-2#1)(2008-10#1)
When and why##3##3##(1990-2#1)(1990-3#1)(1990-5#1)
When and##5##2##(1990-2#1)(1990-3#1)(1990-5#1)(1992-3#1)(2008-11#1)
When any of these##2##4##(2009-9#1)(2010-10#1)
When applied at##3##3##(2008-10#2)(2008-8#1)
When applied to the##4##4##(1990-12#1)(2008-10#2)(2008-11#1)
When applied to##12##3##(1990-12#1)(1997-8#1)(2008-10#9)(2008-11#1)
When applied##17##2##(1990-12#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-8#1)
When are##2##2##(1996-12#1)(2008-11#1)
When both##4##2##(1993-3#2)(2008-10#1)(2008-7#1)
When calcium##2##2##(1996-6#1)(2008-10#1)
When challenged##2##2##(2008-10#2)
When chicks were##2##3##(2008-6#2)
When combined with##4##3##(2008-2#2)(2012-2#1)(2013-1#1)
When combined##5##2##(2008-2#2)(2012-2#1)(2012-6#1)(2013-1#1)
When compared to the##3##4##(1990-12#1)(2008-10#1)(2010-8#1)
When compared to##8##3##(1990-11#1)(1990-12#1)(1991-5#1)(1997-2#1)(2008-10#3)(2010-8#1)
When compared with the##2##4##(2008-10#1)(2008-6#1)
When compared with##5##3##(2008-10#3)(2008-5#1)(2008-6#1)
When compared##13##2##(1990-11#1)(1990-12#1)(1991-5#1)(1997-2#1)(2008-10#6)(2008-5#1)(2008-6#1)(2010-8#1)
When comparing##2##2##(1997-6#1)(2008-10#1)
When considering##2##2##(1997-6#1)(2008-11#1)
When coupled with a##2##4##(2008-10#1)(2008-3#1)
When coupled with##3##3##(2008-10#2)(2008-3#1)
When coupled##4##2##(2008-10#3)(2008-3#1)
When cultured##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
When data##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
When developing##2##2##(2008-10#1)(2012-3#1)
When does##2##2##(2008-11#1)(2008-4#1)
When each##2##2##(1992-12#1)(2008-11#1)
When either##2##2##(2008-10#2)
When examined##2##2##(2008-8#1)(2011-1#1)
When expressed in##2##3##(1993-9#1)(2008-11#1)
When given a##2##3##(2008-10#2)
When given##3##2##(1992-12#1)(2008-10#2)
When goldfish were##2##3##(2008-6#2)
When grown##3##2##(2008-10#3)
When heads were inoculated at the##2##6##(2008-10#2)
When incubated##2##2##(1993-8#1)(2008-10#1)
When inoculated##4##2##(2008-10#4)
When iron##2##2##(2008-11#2)
When it comes to##3##4##(1994-12#1)(1996-3#1)(1997-6#1)
When it is##2##3##(2008-10#1)(2013-8#1)
When it##5##2##(1994-12#1)(1996-3#1)(1997-6#1)(2008-10#1)(2013-8#1)
When mixed with##2##3##(2008-10#2)
When one##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)
When only##3##2##(2008-10#2)(2008-8#1)
When patients##2##2##(1992-3#1)(2008-1#1)
When performed##2##2##(1992-3#1)(1993-11#1)
When plants were##3##3##(1995-2#1)(2008-10#2)
When plants##4##2##(1995-2#1)(2008-10#2)(2009-8#1)
When properly##2##2##(1994-3#1)(2008-7#1)
When rat##2##2##(1994-11#1)(2008-11#1)
When serum##2##2##(1991-8#1)(2008-9#1)
When soil was##2##3##(2008-10#2)
When such##3##2##(2008-11#1)(2013-1#2)
When tested against##2##3##(2008-10#2)
When tested in##2##3##(1994-11#1)(2008-10#1)
When tested on##2##3##(2008-10#2)
When tested##11##2##(1993-3#1)(1994-11#1)(2008-10#6)(2008-8#1)(2010-8#1)(2012-2#1)
When the analysis was##2##4##(1993-12#1)(2008-10#1)
When the cells were##3##4##(1992-6#1)(2008-11#2)
When the incubation##2##3##(2008-10#2)
When the initial##2##3##(2008-10#1)(2008-3#1)
When the inoculum density was##2##5##(2008-10#2)
When the larvae##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
When the number of subjects##2##5##(1995-9#2)
When the reaction##2##3##(2008-10#1)(2008-5#1)
When the sample##3##3##(2008-10#3)
When the two##2##3##(2008-10#1)(2008-5#1)
When the##152##2##(1990-3#1)(1990-5#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-8#3)(2008-10#51)(2008-11#17)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-6#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-7#1)(2013-1#3)(2013-8#1)
When there is no##2##4##(1990-2#1)(2008-3#1)
When there is##6##3##(1990-2#1)(1997-3#1)(2008-3#2)(2008-8#1)(2013-1#1)
When there##7##2##(1990-2#1)(1997-3#1)(2008-3#2)(2008-8#1)(2010-6#1)(2013-1#1)
When these cells were##2##4##(2008-11#1)(2010-1#1)
When these data were##2##4##(1991-12#1)(2008-9#1)
When these##10##2##(1991-12#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)
When they were##2##3##(2008-10#1)(2008-5#1)
When this##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
When total##2##2##(2008-10#1)(2008-11#1)
When two or more fluorochromes are measured simultaneously##2##8##(2008-9#2)
When two##3##2##(2008-10#1)(2008-9#2)
When used##2##2##(1990-5#1)(2008-11#1)
When using the##2##3##(2008-9#1)(2010-7#1)
When using##4##2##(2008-10#2)(2008-9#1)(2010-7#1)
When was the last time you##2##6##(1991-3#2)
When we##10##2##(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#2)
When whole##2##2##(1995-3#1)(2008-10#1)
When##704##1##(1990-11#1)(1990-12#6)(1990-2#4)(1990-3#2)(1990-5#5)(1990-8#3)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#7)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#9)(1993-6#3)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#4)(1995-9#3)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#4)(1996-5#4)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#6)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#248)(2008-11#63)(2008-12#8)(2008-2#5)(2008-3#16)(2008-4#3)(2008-5#15)(2008-6#8)(2008-7#14)(2008-8#40)(2008-9#20)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#4)(2011-1#2)(2011-10#1)(2011-2#17)(2011-3#2)(2012-12#2)(2012-2#8)(2012-3#6)(2012-6#1)(2012-7#1)(2013-1#15)(2013-8#6)
Whenever possible##3##2##(1993-11#1)(1993-6#1)(1994-2#1)
Where are##5##2##(1990-12#1)(1992-12#1)(1994-2#1)(2008-10#1)(2010-4#1)
Where asymmetry was indicated##2##4##(2008-10#2)
Where do we##2##3##(2008-11#1)(2012-12#1)
Where do##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
Where possible##3##2##(2011-2#1)(2012-2#2)
Where the##2##2##(1997-8#1)(2008-10#1)
Where##34##1##(1990-12#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-12#1)(1994-2#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-6#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
Where's the##3##2##(2008-12#2)(2012-2#1)
Whereas the##10##2##(1991-6#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)
Whereas their##2##2##(1996-2#1)(2008-10#1)
Whereas##45##1##(1990-2#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(2006-6#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
Whether a##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
Whether it##2##2##(2008-9#1)(2011-2#1)
Whether such##2##2##(2008-10#1)(2008-11#1)
Whether the##2##2##(2008-3#1)(2013-8#1)
Whether these##3##2##(1994-8#1)(2008-10#1)(2008-12#1)
Whether this##5##2##(1993-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)
Whether##28##1##(1991-2#1)(1993-1#1)(1994-12#1)(1994-8#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
Whey##3##1##(2008-11#1)(2008-7#1)(2012-2#1)
WhiA##6##1##(2012-2#6)
WhiG##3##1##(2012-2#3)
Which medications used in paediatric practice have demonstrated natural health product-drug interactions?##2##12##(2008-11#2)
Which species##2##2##(2008-8#2)
Which way##2##2##(2008-8#1)(2013-1#1)
Which##14##1##(1990-12#1)(1992-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
While a##7##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
While all##4##2##(1990-2#1)(2008-10#1)(2010-11#1)(2011-1#1)
While at##2##2##(2008-10#1)(2008-8#1)
While both##2##2##(2008-11#1)(2012-12#1)
While characterizing the##2##3##(1996-12#1)(2008-10#1)
While each##2##2##(1996-2#1)(2008-8#1)
While further research##2##3##(2008-11#2)
While in##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
While it has##2##3##(2008-4#1)(2012-2#1)
While it is##5##3##(1992-12#1)(1994-8#1)(2008-10#1)(2008-11#2)
While it##8##2##(1990-11#1)(1992-12#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2012-2#1)
While many##11##2##(1991-9#1)(1993-3#1)(1995-1#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#2)(2012-12#1)(2013-8#1)
While more than##2##3##(2009-4#2)
While more##3##2##(2009-4#2)(2009-7#1)
While most of us had courses in financial and operations management##2##11##(1994-1#2)
While most##4##2##(1994-1#3)(2011-1#1)
While no##3##2##(1995-11#1)(2008-7#1)(2013-1#1)
While not##2##2##(2008-4#1)(2008-9#1)
While previous studies have##2##4##(1995-12#1)(2010-8#1)
While previous##3##2##(1995-12#1)(2010-8#1)(2013-8#1)
While research##2##2##(2008-12#1)(2008-4#1)
While several of##2##3##(2008-10#1)(2012-2#1)
While several##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
While significant##2##2##(2008-11#1)(2009-12#1)
While some studies##2##3##(2008-12#1)(2009-12#1)
While some##11##2##(1991-3#2)(1992-12#1)(1993-1#1)(1993-3#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-12#1)(2013-1#1)
While the conceptual applications employed in this technology set are provided by way of illustration##2##15##(2010-8#2)
While the effects of##2##4##(1995-12#1)(2008-1#1)
While the major##2##3##(1997-1#1)(2008-4#1)
While the majority of##2##4##(1994-2#1)(2008-11#1)
While the use of##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
While the##78##2##(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-6#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#2)(1997-1#2)(1997-3#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-7#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
While there are##3##3##(1993-8#1)(2008-10#1)(2010-1#1)
While there is a##3##4##(1997-7#1)(2008-10#1)(2008-8#1)
While there is##6##3##(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)
While there was##2##3##(2008-12#1)(2008-9#1)
While there##15##2##(1993-8#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-11#1)(2012-2#1)
While these##6##2##(1995-1#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-11#1)(2009-10#1)
While this approach##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
While this##14##2##(1993-2#1)(1995-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#2)(2013-1#2)
While##326##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#4)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#4)(1996-2#2)(1997-1#5)(1997-3#1)(1997-7#5)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#51)(2008-11#31)(2008-12#13)(2008-2#1)(2008-4#8)(2008-5#7)(2008-6#4)(2008-7#9)(2008-8#9)(2008-9#8)(2009-10#5)(2009-11#1)(2009-12#3)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#6)(2010-1#6)(2010-10#3)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#4)(2010-8#6)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#8)(2012-2#10)(2012-3#2)(2013-1#12)(2013-8#8)
Whilst the##2##2##(2010-11#1)(2013-1#1)
Whilst there##2##2##(2012-2#1)(2013-1#1)
Whilst##12##1##(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-1#2)
Whipple##2##1##(1990-9#1)(2013-1#1)
Whipple's disease##3##2##(1996-8#2)(2009-5#1)
Whipple's##5##1##(1991-3#1)(1996-8#3)(2009-5#1)
White Deaf##2##2##(2011-2#2)
White House##3##2##(1994-12#1)(1995-12#1)(1995-6#1)
White Leghorn##2##2##(2008-10#1)(2008-12#1)
White Liqueur Wine##2##3##(2008-10#2)
White Liqueur##3##2##(2008-10#3)
White Pine (Pinus##2##3##(2008-10#2)
White Pine##3##2##(2008-10#3)
White faces##2##2##(2008-11#2)
White participants##4##2##(2008-11#3)(2012-2#1)
White targets##2##2##(2008-11#2)
White##53##1##(1994-12#1)(1995-12#2)(1995-6#3)(1996-5#1)(2008-10#21)(2008-11#9)(2008-12#2)(2008-3#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#3)(2012-2#3)(2013-8#2)
White-American Indian##2##2##(2013-8#2)
Whiteflies##2##1##(2008-10#2)
Whitefly##3##1##(2008-10#3)
Whites##6##1##(2010-10#4)(2012-12#1)(2012-2#1)
Whitman##3##1##(1996-5#3)
Who Underwent##2##2##(1994-12#1)(2008-11#1)
Who are##2##2##(1994-12#1)(2009-4#1)
Who should##3##2##(1993-11#1)(1994-12#1)(1994-9#1)
Who will##2##2##(1991-12#1)(1995-12#1)
Who##20##1##(1991-12#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-11#1)(2009-4#1)(2009-9#1)
Who's##3##1##(1992-11#1)(1993-1#1)(1997-6#1)
Whole Genome##2##2##(2008-7#1)(2012-3#1)
Whole blood##5##2##(2008-10#1)(2008-4#2)(2008-9#1)(2011-2#1)
Whole body##2##2##(2011-2#1)(2012-2#1)
Whole mount in situ hybridization##2##5##(1997-7#1)(2008-6#1)
Whole##20##1##(1997-7#1)(2008-10#4)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#2)
Whole-cell##5##1##(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
Whose##2##1##(1993-2#1)(1993-9#1)
Why do people##2##3##(1993-2#1)(2008-8#1)
Why do young##2##3##(2010-2#1)(2011-2#1)
Why do##13##2##(1991-12#1)(1993-2#1)(1995-3#1)(1996-3#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
Why don't we##2##3##(2008-11#1)(2013-8#1)
Why has##2##2##(1997-5#1)(2011-2#1)
Why the##3##2##(1991-3#2)(2008-10#1)
Why we##2##2##(1994-12#1)(2008-10#1)
Why##43##1##(1991-12#1)(1991-3#3)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
Wichita##4##1##(1996-1#3)(2008-10#1)
Wickbold decomposition method##3##3##(2008-10#3)
Wide resection of##2##3##(2008-9#2)
Wide##19##1##(1992-9#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#1)
Widespread##8##1##(1990-6#1)(1992-3#1)(1992-6#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-3#1)
Wiener##3##1##(2008-3#3)
Wigner##2##1##(1996-9#1)(2008-3#1)
Wiktor Dega##3##2##(2013-1#3)
Wilbur-Collins hypothesis##2##2##(2008-8#2)
Wilcoxon signed##3##2##(1997-8#1)(2008-10#1)(2010-6#1)
Wilcoxon statistic##2##2##(1996-3#2)
Wilcoxon test##3##2##(1996-3#2)(2013-1#1)
Wilcoxon##13##1##(1996-3#5)(1997-8#1)(2008-10#2)(2009-2#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
Wild Solanum##2##2##(2008-10#2)
Wild type##2##2##(2008-11#2)
Wild##16##1##(1994-12#1)(1995-9#1)(1996-3#1)(2008-10#9)(2008-11#2)(2012-12#2)
Wild-type##4##1##(2008-10#4)
Wildlife##2##1##(1996-3#1)(1997-7#1)
Wiley Periodicals##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
Wiley##105##1##(2008-11#37)(2008-7#36)(2008-9#2)(2011-2#10)(2012-2#7)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#7)
Wiley-Liss##17##1##(2011-2#17)
Wilkins##2##1##(2008-10#1)(2008-7#1)
Will the US##2##3##(2008-11#2)
Will the##4##2##(2008-11#3)(2013-7#1)
Will this##2##2##(2012-12#1)(2013-7#1)
Will##16##1##(1993-1#1)(1997-6#1)(2008-11#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2012-12#2)(2013-7#2)
Willamette Valley##2##2##(2008-10#2)
Willebrand##10##1##(1993-3#2)(1994-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-7#1)(2012-2#1)
William##7##1##(1991-3#1)(1994-12#1)(1995-3#1)(1995-6#1)(2008-10#2)(2010-3#1)
Williams and##3##2##(2008-10#2)(2008-7#1)
Williams syndrome are##2##3##(2008-11#2)
Williams syndrome##4##2##(2008-11#3)(2010-6#1)
Williams##18##1##(1992-1#1)(1993-8#1)(1996-2#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-8#1)(2010-6#1)(2012-12#1)
Williams's##2##1##(2008-8#2)
Willis##3##1##(1995-11#1)(2008-7#2)
Wilms tumor (WT)##2##3##(1991-10#1)(2013-1#1)
Wilms tumor##3##2##(1991-10#2)(2013-1#1)
Wilms' tumor##4##2##(1994-2#2)(2008-10#2)
Wilms' tumour##4##2##(2008-10#4)
Wilms'##8##1##(1994-2#2)(2008-10#6)
Wilson disease##2##2##(2012-2#2)
Wilson##9##1##(1991-8#2)(1992-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-3#1)(2012-2#2)
Wilt in##3##2##(2008-10#3)
Wilt##31##1##(2008-10#31)
Wind##2##1##(2008-10#1)(2012-2#1)
Wine##5##1##(2008-10#4)(2012-3#1)
Wine&quot##3##1##(2008-10#3)
Wines##2##1##(2008-10#2)
Winkler's##2##1##(2008-10#2)
Winter Garden##2##2##(2008-10#2)
Winter Wheat to##2##3##(2008-10#2)
Winter Wheat##8##2##(2008-10#8)
Winter##18##1##(1991-8#1)(2008-10#14)(2010-5#1)(2010-8#1)(2012-4#1)
Wire##2##1##(1996-6#1)(2011-2#1)
Wireless##2##1##(2010-2#1)(2013-1#1)
Wisconsin Card Sorting Test##2##4##(2008-7#1)(2013-8#1)
Wisconsin Card Sorting##4##3##(1995-5#1)(2008-11#1)(2008-7#1)(2013-8#1)
Wisconsin##26##1##(1991-12#2)(1994-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(2008-10#16)(2008-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
Wistar and Buffalo##2##3##(1993-12#2)
Wistar rats were##7##3##(1991-2#1)(2008-7#2)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
Wistar rats with##2##3##(1994-2#1)(2008-11#1)
Wistar rats##30##2##(1991-2#1)(1991-5#1)(1993-12#4)(1994-2#1)(1995-12#2)(1995-8#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-7#2)(2009-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
Wistar##39##1##(1990-2#2)(1991-2#1)(1991-5#1)(1993-12#6)(1994-2#1)(1995-12#2)(1995-8#2)(1996-3#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#3)(2009-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
Wistar-Kyoto rats##2##2##(1991-5#1)(1994-2#1)
With 1##2##2##(2008-10#2)
With Cancer##2##2##(2010-10#1)(2010-7#1)
With a high##2##3##(2008-10#1)(2008-9#1)
With a new##2##3##(2008-10#1)(2008-5#1)
With a sample##2##3##(2008-10#2)
With a sampling##2##3##(2008-10#2)
With a##49##2##(1990-3#1)(1991-2#1)(1992-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#3)
With all##2##2##(1992-2#1)(2008-9#1)
With an##9##2##(1992-12#1)(1992-3#1)(1994-5#1)(2008-12#2)(2008-3#2)(2012-3#1)(2013-1#1)
With appropriate##2##2##(2008-10#1)(2011-3#1)
With both##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
With constant##2##2##(2008-5#1)(2008-9#1)
With few exceptions##2##3##(2008-10#2)
With increasing##5##2##(1997-2#1)(2008-10#2)(2009-7#1)(2011-2#1)
With lower##2##2##(2008-10#1)(2012-2#1)
With modification##2##2##(2008-10#1)(2008-9#1)
With more##2##2##(2008-12#1)(2010-7#1)
With only##2##2##(1996-3#1)(2012-2#1)
With our##4##2##(1993-12#1)(2008-11#1)(2008-6#1)(2013-1#1)
With proper##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
With reference to the##2##4##(1991-8#1)(2008-11#1)
With regard to the##5##4##(1994-12#1)(2008-10#2)(2008-5#1)(2010-8#1)
With regard to##8##3##(1994-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-8#1)(2013-8#1)
With respect to the##2##4##(2008-10#1)(2011-1#1)
With respect to##11##3##(1991-2#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
With some##3##2##(1990-11#1)(2008-10#1)(2008-7#1)
With such##2##2##(1996-11#1)(2008-10#1)
With the addition of##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
With the advances in##2##4##(2008-6#1)(2012-2#1)
With the advent of##2##4##(1996-2#1)(2011-2#1)
With the aid of##2##4##(1991-6#1)(2008-10#1)
With the aim of##4##4##(1993-11#1)(2008-10#2)(2008-3#1)
With the aim##5##3##(1993-11#1)(2008-10#2)(2008-3#1)(2009-12#1)
With the combination of##2##4##(2008-8#1)(2012-2#1)
With the current##2##3##(2009-7#1)(2012-12#1)
With the developed##2##3##(2008-10#2)
With the development of##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
With the emergence of##2##4##(2008-10#1)(2011-9#1)
With the exception of one##4##5##(2008-10#3)(2008-5#1)
With the exception of the##4##5##(1996-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
With the exception of##14##4##(1995-8#1)(1996-11#1)(2008-10#6)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#2)
With the help of##2##4##(2008-8#2)
With the identification of##2##4##(2007-11#1)(2008-10#1)
With the improved method##2##4##(2008-10#2)
With the increase in##2##4##(2008-11#1)(2011-2#1)
With the increase##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
With the increased##3##3##(1996-3#1)(1997-3#1)(2009-12#1)
With the increasing##5##3##(1993-2#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
With the introduction of##3##4##(2008-11#1)(2008-7#1)(2010-12#1)
With the method##3##3##(1990-3#1)(2008-10#2)
With the optimal##2##3##(2008-10#1)(2013-1#1)
With the proposed##4##3##(2008-10#3)(2008-11#1)
With the purpose of##2##4##(1993-6#1)(2008-10#1)
With the rapid##2##3##(2008-10#1)(2012-2#1)
With the recent##4##3##(2008-10#1)(2008-7#1)(2009-11#1)(2010-12#1)
With the same##2##3##(2008-10#1)(2008-8#1)
With the use of##3##4##(1991-3#1)(2011-2#1)(2012-2#1)
With the##151##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#51)(2008-11#11)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
With these##13##2##(1991-2#1)(1992-3#1)(1995-1#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-10#1)(2013-1#1)
With this approach##3##3##(1996-3#1)(2012-2#2)
With this in mind##2##4##(1990-11#1)(2008-11#1)
With this method##6##3##(1990-2#1)(1993-8#1)(2008-10#3)(2008-8#1)
With this model##2##3##(2008-10#1)(2008-11#1)
With this report##2##3##(2010-12#1)(2012-3#1)
With this technique##7##3##(1993-8#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)(2012-3#1)
With this##50##2##(1990-11#1)(1990-2#1)(1993-8#2)(1994-12#1)(1994-8#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-10#20)(2008-11#5)(2008-3#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)
With training and##2##3##(2009-3#1)(2009-5#1)
With two##2##2##(2008-3#1)(2011-2#1)
With##485##1##(1990-11#4)(1990-2#2)(1990-3#2)(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-12#4)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#5)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-6#1)(1997-7#3)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#143)(2008-11#34)(2008-12#8)(2008-2#5)(2008-3#25)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#11)(2008-9#14)(2009-10#5)(2009-11#1)(2009-12#5)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-1#2)(2010-10#2)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#18)(2011-3#2)(2011-7#1)(2011-9#1)(2012-12#2)(2012-2#16)(2012-3#9)(2013-1#18)(2013-8#10)
Withdrawal##8##1##(1991-1#1)(2008-10#3)(2008-11#3)(2011-2#1)
Within Populations of##3##3##(2008-10#3)
Within a##8##2##(2008-10#3)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-7#1)
Within an##2##2##(2009-7#1)(2012-2#1)
Within and##3##2##(2008-10#3)
Within each##4##2##(1990-9#1)(1993-12#1)(2009-7#1)(2012-2#1)
Within the context of##2##4##(2008-11#1)(2008-12#1)
Within the limitations of this study##2##6##(2013-1#2)
Within the limitations of this##3##5##(2013-1#3)
Within the limitations of##4##4##(2011-2#1)(2013-1#3)
Within the##32##2##(1993-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#4)
Within these##3##2##(1997-4#1)(2010-1#1)(2011-2#1)
Within this framework##3##3##(1990-6#1)(1991-2#1)(2013-1#1)
Within this##10##2##(1990-6#1)(1991-2#1)(1991-6#1)(1995-2#1)(2008-10#1)(2008-11#3)(2010-9#1)(2013-1#1)
Within##102##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-12#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(2008-10#37)(2008-11#8)(2008-12#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-8#1)(2010-9#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)
Within-plant##2##1##(2008-10#1)(2009-8#1)
Without any##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
Without the##3##2##(1992-12#1)(1996-2#1)(2008-10#1)
Without these##2##2##(1994-2#1)(1994-8#1)
Without this##4##2##(1991-8#1)(1993-3#1)(2008-10#1)(2008-9#1)
Without##30##1##(1991-8#2)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#1)
Wittig##2##1##(1996-5#2)
WmCSV##3##1##(2008-10#3)
Wnt##4##1##(2008-10#1)(2013-1#2)(2013-8#1)
Wnt/beta-catenin signaling##2##2##(2009-8#2)
Wnt3a##2##1##(2009-8#2)
Woc##2##1##(2012-3#2)
Wolbachia are##3##2##(2008-8#1)(2008-9#2)
Wolbachia can##2##2##(2008-8#1)(2012-3#1)
Wolbachia differences##2##2##(2008-8#2)
Wolbachia pipientis##2##2##(2008-9#2)
Wolbachia transfection##2##2##(2008-9#2)
Wolbachia##29##1##(2008-10#1)(2008-8#13)(2008-9#12)(2012-3#3)
Wolbachia-infected females##2##2##(2012-3#2)
Wolf##4##1##(1990-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
Wollaston prism group##2##3##(2013-8#2)
Wollaston prism##3##2##(2013-8#3)
Wollaston##4##1##(2013-8#4)
Wolven Pole##3##2##(2008-10#3)
Women and men##2##3##(1995-9#1)(2008-12#1)
Women and##4##2##(1995-12#1)(1995-9#1)(2008-12#1)(2008-4#1)
Women in##3##2##(1991-2#1)(2009-9#1)(2012-2#1)
Women were##2##2##(1990-8#1)(2008-12#1)
Women who##3##2##(1995-3#1)(2009-5#1)(2012-3#1)
Women with##3##2##(1993-1#1)(1994-12#1)(2013-1#1)
Women##39##1##(1990-8#1)(1991-2#2)(1993-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-6#1)(2008-1#3)(2008-12#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
Women's Caucus is##2##3##(1996-5#2)
Women's Hospital##5##2##(1993-3#2)(1994-3#1)(2010-5#2)
Women's health needs have been a special focus of health care for more than a century##2##16##(1994-3#2)
Women's health##4##2##(1994-3#2)(1995-2#1)(1996-9#1)
Women's##21##1##(1993-12#1)(1993-3#2)(1994-3#3)(1995-2#1)(1996-5#2)(1996-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Wongan Hills##2##2##(2008-10#2)
Wood##10##1##(1993-2#1)(1996-12#1)(2008-10#4)(2008-9#1)(2012-5#1)(2013-1#2)
Woodall v##2##2##(1995-6#2)
Woodcock-Johnson##2##1##(2008-12#2)
Woody##2##1##(2008-10#1)(2012-7#1)
Work and##2##2##(2008-11#1)(2010-7#1)
Work with##2##2##(2008-10#2)
Work##12##1##(1992-3#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2009-12#1)(2010-7#3)
Work-based learning##2##2##(2008-11#2)
Workers Compensation cases##2##3##(1991-12#2)
Workers Compensation##3##2##(1991-12#3)
Workers of the world##2##4##(1994-1#2)
Workers##9##1##(1991-12#3)(1994-1#2)(1997-7#1)(2008-6#3)
Workers' compensation##2##2##(1995-1#2)
Workforce##6##1##(2008-11#2)(2010-10#1)(2010-11#1)(2012-12#1)(2012-2#1)
Working Group on the##2##4##(1993-5#1)(1996-6#1)
Working Group on##5##3##(1993-5#1)(1996-6#1)(2007-9#1)(2013-1#2)
Working Group##10##2##(1993-5#1)(1996-6#2)(1997-5#1)(2007-9#1)(2008-10#2)(2008-7#1)(2013-1#2)
Working Together##2##2##(2008-11#1)(2008-12#1)
Working and##2##2##(2008-11#2)
Working conditions##2##2##(2008-10#2)
Working in##2##2##(2008-10#2)
Working range##2##2##(2008-10#2)
Working together##2##2##(2008-6#1)(2013-1#1)
Working with an##2##3##(2008-11#1)(2008-9#1)
Working with##9##2##(1992-3#1)(1994-12#2)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#1)(2013-8#1)
Working##38##1##(1992-3#1)(1993-5#1)(1994-12#2)(1996-6#2)(1997-2#1)(1997-5#1)(2007-9#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-9#1)(2012-3#1)(2013-1#4)(2013-8#1)
Workplace##5##1##(2008-11#2)(2008-7#1)(2012-12#1)(2012-2#1)
Works##2##1##(2008-12#1)(2012-2#1)
Workshop for Early Career Investigators##2##5##(2012-2#2)
Workshop on##4##2##(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
Workshop##18##1##(1991-3#2)(2008-10#5)(2008-11#1)(2008-4#1)(2011-2#4)(2012-2#3)(2013-1#1)(2013-8#1)
Workshops##2##1##(2008-4#1)(2011-2#1)
Worland strains##3##2##(2008-10#3)
Worland##9##1##(2008-10#9)
World Allergy Organization##3##3##(2012-12#3)
World Bank##3##2##(1997-8#3)
World Congress##2##2##(2008-10#1)(2008-8#1)
World Health Day##2##3##(1995-3#2)
World Health Organization (WHO)##12##4##(1994-9#1)(1995-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#2)(2013-1#1)
World Health Organization has##2##4##(2008-1#1)(2011-2#1)
World Health Organization##35##3##(1990-11#1)(1991-9#1)(1992-1#1)(1993-11#2)(1994-9#2)(1995-3#1)(1996-9#1)(1997-6#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#6)(2011-7#1)(2012-12#2)(2013-1#3)
World Health##44##2##(1990-11#1)(1991-9#1)(1992-1#1)(1993-11#2)(1994-9#2)(1995-3#4)(1996-9#1)(1997-6#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#3)
World Journal of Gastrointestinal##3##4##(2010-12#3)
World Journal of##6##3##(2010-12#6)
World Leishmania spp##2##3##(2012-2#2)
World Organisation for Animal Health (OIE)##2##6##(2011-2#2)
World Organisation for Animal Health##4##5##(2011-2#4)
World War II##6##3##(1996-1#1)(1997-8#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
World War##14##2##(1996-1#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#1)(2011-4#2)(2013-1#1)(2013-8#1)
World Wide Web##6##3##(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#1)
World##124##1##(1990-11#3)(1991-5#1)(1991-9#1)(1992-1#1)(1993-11#3)(1993-3#1)(1994-1#1)(1994-12#1)(1994-9#2)(1995-3#5)(1996-1#1)(1996-2#2)(1996-9#1)(1997-5#1)(1997-6#3)(1997-8#5)(2008-1#2)(2008-10#20)(2008-11#7)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#5)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#11)(2011-3#1)(2011-4#2)(2011-7#1)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
World-Wide Web##2##2##(2008-3#1)(2008-4#1)
Worldwide##10##1##(1994-9#1)(1997-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2013-1#1)
Worm##2##1##(1996-12#1)(2012-2#1)
Wortmannin##3##1##(1994-11#1)(1995-8#1)(1996-2#1)
Wound Healing##2##2##(2008-10#1)(2013-1#1)
Wound##10##1##(1992-1#1)(1992-6#1)(2007-12#1)(2008-10#3)(2010-6#1)(2011-2#1)(2013-1#2)
Wounded##2##1##(2008-10#2)
Wounding##3##1##(2008-10#3)
Wright##3##1##(2008-8#1)(2008-9#1)(2012-2#1)
Wright's##2##1##(2008-9#1)(2012-2#1)
Writing for##3##2##(2008-11#3)
Writing##9##1##(1990-12#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2011-2#1)
Written##3##1##(2008-11#1)(2008-9#1)(2011-2#1)
Wuyujing-7 and CG-14 were##2##4##(2009-10#2)
Wuyujing-7##5##1##(2009-10#5)
Wx##2##1##(2008-9#2)
Wyeth-Ayerst##3##1##(2008-5#3)
Wyoming##2##1##(1994-1#1)(2008-10#1)
X 10(-6) M##3##3##(1996-2#3)
X 10(-7)##5##2##(1990-5#5)
X 10(-8)##2##2##(1990-5#1)(1996-2#1)
X and Y chromosome##2##4##(1990-3#1)(2008-7#1)
X and Y chromosomes##3##4##(1990-3#1)(2008-7#1)(2010-5#1)
X and Y##10##3##(1990-3#3)(2008-11#1)(2008-7#4)(2008-8#1)(2010-5#1)
X and##13##2##(1990-3#3)(1991-1#1)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#1)(2010-5#2)
X chromosome##11##2##(1991-6#1)(1994-11#1)(1996-12#2)(2008-11#2)(2008-4#3)(2008-8#1)(2010-5#1)
X chromosomes##4##2##(2008-12#1)(2008-4#2)(2013-1#1)
X in##2##2##(1994-8#1)(2008-10#1)
X is##3##2##(2008-12#1)(2008-7#2)
X linked##3##2##(2008-11#1)(2008-8#2)
X receptors##3##2##(1995-8#1)(2008-10#2)
X##329##1##(1990-3#4)(1990-5#7)(1990-6#1)(1991-1#5)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-10#1)(1993-12#5)(1993-2#1)(1993-6#9)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#3)(1995-9#2)(1996-12#2)(1996-2#5)(1996-6#2)(1996-9#1)(1997-3#1)(1997-8#1)(1997-9#1)(2008-10#207)(2008-11#10)(2008-12#9)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#10)(2008-8#5)(2008-9#1)(2009-7#1)(2010-5#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
X(+))X(3)(-)##2##1##(2008-10#2)
X- and##2##2##(1990-3#1)(2012-3#1)
X-##3##1##(1990-3#1)(1991-5#1)(2012-3#1)
X-100 and##9##2##(2008-10#9)
X-100 were##2##2##(2008-10#2)
X-100##36##1##(1994-3#1)(1997-8#1)(2008-10#30)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
X-100)##2##1##(2008-10#2)
X-8##4##1##(2008-10#1)(2008-12#3)
X-Ray##4##1##(2008-10#1)(2008-3#1)(2009-3#1)(2013-8#1)
X-box binding##2##2##(2011-2#2)
X-chromosomal short tandem##2##3##(2008-12#2)
X-chromosomal##5##1##(1994-11#1)(2008-12#4)
X-chromosome##5##1##(1990-8#1)(1994-11#1)(2008-12#3)
X-disease##2##1##(2008-10#2)
X-inactivation##2##1##(2008-11#1)(2008-4#1)
X-irradiation##2##1##(1994-2#1)(2011-2#1)
X-linked gene##2##2##(2008-11#1)(2012-2#1)
X-linked recessive##3##2##(2008-11#2)(2008-4#1)
X-linked##15##1##(1990-5#1)(1993-3#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
X-ray absorption fine structure spectroscopy##3##5##(2008-9#1)(2011-2#2)
X-ray absorption fine structure##5##4##(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#2)
X-ray absorption fine##6##3##(2008-10#2)(2008-9#1)(2010-11#1)(2011-2#2)
X-ray absorption spectroscopy (XAS)##2##4##(2008-10#1)(2010-11#1)
X-ray absorption##10##2##(2008-10#5)(2008-9#1)(2010-11#2)(2011-2#2)
X-ray analysis##4##2##(1996-5#2)(2008-10#1)(2008-5#1)
X-ray and nuclear medical examinations##2##5##(1997-8#2)
X-ray and##7##2##(1993-2#1)(1997-8#2)(2010-7#1)(2012-12#1)(2013-1#2)
X-ray cross correlation analysis##2##4##(2010-8#2)
X-ray crystal##2##2##(1996-5#2)
X-ray crystallography##5##2##(1992-4#1)(1996-5#1)(2008-10#2)(2008-4#1)
X-ray diffraction (XRD) and##5##4##(2008-10#5)
X-ray diffraction (XRD)##10##3##(2008-10#9)(2009-7#1)
X-ray diffraction analysis of the##2##5##(1992-11#1)(2011-2#1)
X-ray diffraction analysis##5##3##(1992-11#1)(2008-10#2)(2010-4#1)(2011-2#1)
X-ray diffraction and scattering##2##4##(2008-10#1)(2008-11#1)
X-ray diffraction and##12##3##(1994-5#1)(2008-10#6)(2008-11#3)(2008-5#2)
X-ray diffraction data##2##3##(1991-5#1)(2008-8#1)
X-ray diffraction for##2##3##(1996-5#1)(2008-5#1)
X-ray diffraction patterns##2##3##(1992-9#1)(2008-10#1)
X-ray diffraction spectrometry##2##3##(2008-10#2)
X-ray diffraction##47##2##(1991-5#1)(1992-11#1)(1992-9#1)(1994-5#1)(1996-5#1)(2008-10#24)(2008-11#3)(2008-5#6)(2008-8#1)(2008-9#1)(2009-7#2)(2010-4#2)(2010-5#1)(2011-2#1)(2013-8#1)
X-ray diffractometry##2##2##(2008-10#2)
X-ray energy dispersive spectroscopy##2##4##(2008-10#2)
X-ray energy##4##2##(1997-8#2)(2008-10#2)
X-ray film##5##2##(1991-12#2)(1993-6#1)(2008-4#1)(2008-7#1)
X-ray films##3##2##(1991-12#1)(2008-4#1)(2008-9#1)
X-ray fluorescence (EDXRF)##3##3##(2008-10#3)
X-ray fluorescence (XRF) analysis##4##4##(2008-10#3)(2008-5#1)
X-ray fluorescence (XRF)##5##3##(2008-10#4)(2008-5#1)
X-ray fluorescence spectrometry##7##3##(2008-10#7)
X-ray fluorescence spectroscopy##4##3##(2008-10#3)(2013-8#1)
X-ray fluorescence##37##2##(2008-10#31)(2008-5#3)(2013-8#3)
X-ray imaging##2##2##(2013-8#2)
X-ray lens##3##2##(2008-10#3)
X-ray microanalysis##6##2##(1995-8#1)(2008-10#4)(2013-1#1)
X-ray multispectrum imaging based on variable##2##6##(2013-8#2)
X-ray optics##2##2##(2008-10#2)
X-ray or##2##2##(1990-12#1)(1991-2#1)
X-ray photoelectron spectrometry and##2##4##(2008-10#2)
X-ray photoelectron spectroscopy (XPS)##4##4##(2008-10#4)
X-ray photoelectron spectroscopy##12##3##(1996-12#1)(2008-10#9)(2011-2#2)
X-ray photoelectron##17##2##(1996-12#1)(2008-10#14)(2011-2#2)
X-ray powder diffraction##2##3##(2008-10#1)(2011-3#1)
X-ray powder##3##2##(2008-10#1)(2011-3#1)(2013-8#1)
X-ray scattering##4##2##(2008-10#2)(2008-11#1)(2010-7#1)
X-ray source##2##2##(2008-10#1)(2011-2#1)
X-ray spectrometry##4##2##(2008-10#4)
X-ray structure##4##2##(1993-8#2)(1996-5#1)(2008-11#1)
X-ray##241##1##(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-8#1)(1996-12#1)(1996-5#8)(1997-3#1)(1997-8#4)(2008-1#1)(2008-10#116)(2008-11#6)(2008-4#4)(2008-5#10)(2008-7#4)(2008-8#1)(2008-9#6)(2009-7#2)(2009-9#1)(2010-11#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-2#12)(2011-3#1)(2012-12#1)(2013-1#5)(2013-8#14)
X-rays or##2##2##(2008-10#1)(2008-7#1)
X-rays##15##1##(1991-12#1)(1991-2#1)(1991-6#1)(1996-6#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
X1##2##1##(1997-7#2)
X2##3##1##(1993-2#1)(2008-1#1)(2009-8#1)
XACML which##2##2##(2010-8#2)
XACML##8##1##(2010-8#8)
XAD 8##2##2##(2008-10#2)
XAD##5##1##(2008-10#5)
XAD-1180-PV##2##1##(2008-10#2)
XAD-16 resin and##3##3##(2008-10#3)
XAD-16 resin##5##2##(2008-10#5)
XAD-16##15##1##(2008-10#15)
XAD-2 loaded with##3##3##(2008-10#3)
XAD-2 resin adsorption##2##3##(2008-10#2)
XAD-2 resin##17##2##(2008-10#17)
XAD-2##31##1##(2008-10#31)
XAD-4 and XAD-7##2##3##(2008-10#2)
XAD-4 columns##3##2##(2008-10#3)
XAD-4 resin##5##2##(2008-10#5)
XAD-4##23##1##(2008-10#23)
XAD-7##6##1##(2008-10#6)
XAD-8##7##1##(2008-10#7)
XANES and##2##2##(2008-10#1)(2010-4#1)
XANES spectra##2##2##(2008-10#2)
XANES##5##1##(2008-10#4)(2010-4#1)
XAS##2##1##(2010-11#1)(2012-2#1)
XBP1 gene##3##2##(2011-2#3)
XBP1##9##1##(2011-2#9)
XC##4##1##(2008-3#4)
XD##2##1##(2012-3#2)
XDLVO theory##2##2##(2013-1#2)
XDR-TB and##3##2##(2008-10#3)
XDR-TB##6##1##(2008-10#6)
XFGFR-1##4##1##(1993-6#4)
XGP##3##1##(2013-1#3)
XGal##2##1##(1993-12#1)(1993-9#1)
XI activation##2##2##(1991-9#2)
XI##12##1##(1991-9#8)(1993-9#1)(1996-3#1)(1996-6#2)
XII##3##1##(1991-9#1)(2008-10#1)(2011-2#1)
XIII##12##1##(1994-9#1)(1995-9#1)(2008-11#9)(2008-8#1)
XIV##9##1##(1991-1#1)(1995-9#2)(1996-3#4)(1996-6#1)(2008-10#1)
XN4 and##3##2##(2008-10#3)
XN4 x SP##3##3##(2008-10#3)
XN4 x##4##2##(2008-10#4)
XN4##11##1##(2008-10#11)
XO (L)##2##2##(2008-10#2)
XO##5##1##(2008-10#4)(2008-11#1)
XP##2##1##(2008-10#1)(2013-1#1)
XPS##6##1##(2008-10#6)
XRCC4 and##2##2##(1997-7#2)
XRCC4##7##1##(1997-7#7)
XRD and##5##2##(2008-10#4)(2013-8#1)
XRD##11##1##(2008-10#8)(2012-2#1)(2013-8#2)
XRF trans-rectal probe##2##3##(2008-10#2)
XRF##11##1##(2008-10#9)(2008-5#1)(2013-8#1)
XTT##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
XXIII##2##1##(2008-10#1)(2009-5#1)
XY##2##1##(1997-3#1)(2008-12#1)
XYLA##2##1##(2012-3#2)
Xa##10##1##(1991-3#2)(1994-5#5)(1994-8#1)(2008-11#1)(2008-5#1)
Xa10##5##1##(2008-10#5)
Xa21 gene##2##2##(2008-8#2)
Xa21 was##2##2##(2008-10#1)(2008-8#1)
Xa21##22##1##(2008-10#16)(2008-8#6)
Xa22(t) locus##3##2##(2008-10#3)
Xa22(t)##6##1##(2008-10#6)
Xa4##9##1##(2008-10#7)(2008-8#2)
XadA##2##1##(2008-10#2)
XadA-##2##1##(2008-10#2)
Xanthi##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
Xanthi-nc##2##1##(2008-10#2)
Xanthine oxidase##2##2##(2008-10#2)
Xanthoma disseminatum##2##2##(2012-3#2)
Xanthomonad-like bacteria associated with CBB in##2##6##(2008-10#2)
Xanthomonas albilineans##4##2##(2008-10#4)
Xanthomonas arboricola pv##2##3##(2008-10#2)
Xanthomonas axonopodis pv##21##3##(2008-10#21)
Xanthomonas axonopodis##22##2##(2008-10#22)
Xanthomonas campestris pv##38##3##(2008-10#37)(2009-6#1)
Xanthomonas campestris##40##2##(2008-10#38)(2009-6#1)(2012-2#1)
Xanthomonas isolates##2##2##(2008-10#2)
Xanthomonas oryzae pv##15##3##(2008-10#13)(2008-9#1)(2009-10#1)
Xanthomonas sp##2##2##(2009-6#2)
Xanthomonas spp##3##2##(2008-10#3)
Xanthomonas strains isolated from onion##2##5##(2008-10#2)
Xanthomonas strains isolated from##3##4##(2008-10#3)
Xanthomonas strains##8##2##(2008-10#8)
Xanthomonas translucens##6##2##(2008-10#6)
Xanthomonas##127##1##(2008-10#120)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#3)(2012-2#1)
Xanthosoma/Syngonium group##2##2##(2008-10#2)
Xavier##3##1##(1994-5#2)(2008-10#1)
XbaI##4##1##(1997-8#1)(2008-10#3)
Xca4##2##1##(2008-10#2)
XcmN##3##1##(2008-10#3)
Xemilofiban is##2##2##(2008-5#2)
Xemilofiban##5##1##(2008-5#5)
Xenon##2##1##(2008-10#1)(2008-3#1)
Xenopus embryos##2##2##(1993-3#2)
Xenopus fibroblast growth factor receptor-1##2##5##(1993-6#2)
Xenopus laevis (Daudin)##2##3##(2011-2#2)
Xenopus laevis egg##4##3##(1993-2#1)(1993-6#1)(2008-9#2)
Xenopus laevis##32##2##(1992-3#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#5)(1994-8#2)(1995-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#4)(2008-11#2)(2008-6#2)(2008-7#1)(2008-9#3)(2011-2#2)
Xenopus oocytes##13##2##(1990-7#2)(1994-11#1)(1994-12#1)(1995-11#7)(1995-2#1)(2008-5#1)
Xenopus##66##1##(1990-7#2)(1992-3#1)(1992-6#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#8)(1994-11#1)(1994-12#1)(1994-8#2)(1995-11#7)(1995-12#2)(1995-2#4)(1996-2#2)(1997-2#1)(1997-3#1)(1997-7#8)(1997-9#1)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2011-2#2)(2012-3#1)
Xenotransplantation##2##1##(2008-11#1)(2008-8#1)
Xenotropic##2##1##(1990-5#2)
Xgwm111##2##1##(2008-10#2)
Xgwm295##2##1##(2008-10#2)
Xgwm410##2##1##(2008-10#2)
Xian##2##1##(2008-10#2)
Xieyou 63##4##2##(2008-9#4)
Xieyou 9308##4##2##(2008-9#4)
Xieyou##8##1##(2008-9#8)
Xilingang granite##2##2##(2013-8#2)
Xilingang pluton##2##2##(2013-8#2)
Xilingang##5##1##(2013-8#5)
Xinjiang##2##1##(2008-9#1)(2009-5#1)
Xiphinema americanum##4##2##(2008-10#4)
Xiphinema index##3##2##(2008-10#3)
Xiphinema##7##1##(2008-10#7)
Xist##4##1##(1994-11#4)
Xmsx-1 and Xmsx-2B##2##3##(2008-6#2)
Xmsx-1##6##1##(2008-6#6)
Xmsx-2B##12##1##(2008-6#12)
Xoo##2##1##(2008-8#2)
Xp22##2##1##(1992-10#2)
Xpsr680 and##2##2##(2008-8#2)
Xq28##6##1##(1993-3#2)(2008-12#2)(2012-3#2)
Xray diffraction##2##2##(2013-8#2)
Xu-142##2##1##(2008-8#2)
XylS##7##1##(2011-1#7)
Xylella fastidiosa strains##3##3##(2008-10#3)
Xylella fastidiosa##27##2##(2008-10#27)
Xylene cyanol FF##3##3##(2008-10#3)
Xylene##4##1##(2008-10#4)
Xylenol orange##2##2##(2008-10#2)
Y (NPY)##4##2##(1990-5#1)(1996-12#1)(2008-8#1)(2009-8#1)
Y =##2##2##(2008-10#2)
Y and##5##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
Y chromosome##13##2##(1990-3#1)(1993-12#4)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#2)(2012-3#1)
Y chromosomes##8##2##(1990-3#2)(2008-12#2)(2008-7#1)(2008-8#1)(2010-5#2)
Y or##2##2##(2008-12#1)(2010-5#1)
Y sequence may##2##3##(1993-6#2)
Y sequence##7##2##(1993-6#7)
Y was##4##2##(2008-10#4)
Y with##3##2##(1995-11#1)(2008-10#2)
Y##112##1##(1990-11#1)(1990-3#4)(1990-5#2)(1991-12#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-12#4)(1993-6#7)(1993-8#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-8#1)(2008-10#29)(2008-11#4)(2008-12#7)(2008-3#1)(2008-4#1)(2008-7#12)(2008-8#9)(2008-9#4)(2009-11#1)(2009-8#1)(2010-5#3)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Y(3+)##3##1##(2008-10#3)
Y(III)##3##1##(2008-10#3)
Y(V)##2##1##(2008-7#2)
Y(t)##2##1##(1990-8#2)
Y)##2##1##(1993-6#1)(2008-7#1)
Y-CPApK##4##1##(2008-10#4)
Y-chromosome haplotype##2##2##(2008-8#2)
Y-chromosome##3##1##(2008-12#1)(2008-8#2)
Y-shaped##2##1##(2008-10#1)(2008-5#1)
Y-type##2##1##(2008-10#2)
Y17##3##1##(1997-3#3)
Y2-receptor##2##1##(1997-4#2)
Y55G TCS##2##2##(2008-10#2)
YAC 872B5##3##2##(1997-8#3)
YAC D142H8##2##2##(1997-8#2)
YAC F136C5##2##2##(1997-8#2)
YAC clone##3##2##(1996-12#1)(1997-8#1)(2008-8#1)
YAC clones##12##2##(1995-6#2)(1996-12#7)(1996-8#1)(1997-2#1)(1997-8#1)
YAC contigs at##2##3##(1995-6#2)
YAC contigs##3##2##(1995-6#3)
YAC libraries##2##2##(1995-6#1)(2008-4#1)
YAC##40##1##(1994-11#1)(1995-6#7)(1996-12#10)(1996-6#1)(1996-8#1)(1997-2#2)(1997-8#14)(2008-4#3)(2008-8#1)
YACs were##5##2##(1996-12#1)(1997-2#4)
YACs##12##1##(1996-12#2)(1997-2#8)(1997-8#1)(2008-4#1)
YAG (2##3##2##(1991-2#3)
YAG Laser##5##2##(2008-3#4)(2010-6#1)
YAG endometrial ablation##2##3##(1993-1#2)
YAG laser at##3##3##(1991-3#1)(2008-10#1)(2008-3#1)
YAG laser is##2##3##(2007-12#1)(2008-2#1)
YAG laser light##2##3##(2008-3#2)
YAG laser operating##2##3##(2008-10#2)
YAG laser photocoagulation##2##3##(1993-6#2)
YAG laser that##2##3##(2008-3#2)
YAG laser with a##3##4##(2008-10#1)(2008-2#2)
YAG laser with##4##3##(1991-2#1)(2008-10#1)(2008-2#2)
YAG laser##43##2##(1991-2#1)(1991-3#2)(1992-1#1)(1993-6#2)(1994-2#1)(1995-2#3)(2007-12#5)(2008-10#7)(2008-2#7)(2008-3#10)(2008-7#4)
YAG lasers with##2##3##(2008-3#2)
YAG lasers##5##2##(2008-2#1)(2008-3#4)
YAG microchip laser system for the detection of NO##2##9##(2008-3#2)
YAG microchip laser##4##3##(2008-2#2)(2008-3#2)
YAG rod with undoped ends##2##5##(2008-2#2)
YAG rod with##4##3##(2008-2#4)
YAG rod##8##2##(2008-2#8)
YAG rods##2##2##(2008-2#1)(2008-3#1)
YAG##91##1##(1991-2#4)(1991-3#2)(1992-1#1)(1993-1#2)(1993-6#2)(1994-2#1)(1995-2#3)(2007-12#8)(2008-10#7)(2008-2#26)(2008-3#29)(2008-7#5)(2010-6#1)
YAG)##2##1##(2008-2#1)(2008-3#1)
YAG-capsulotomy##3##1##(2011-2#3)
YAG-laser##3##1##(1991-9#3)
YAP+ frequency##2##2##(2008-9#2)
YAP+##5##1##(2008-9#5)
YAl(3)(BO(3))(4)##2##1##(2007-12#2)
YAlO(3)##2##1##(2008-3#2)
YBa2Cu3O7##3##1##(1990-12#1)(1993-5#1)(1994-2#1)
YBa2Cu3O7- delta##3##2##(1992-11#1)(1992-8#2)
YDVs##3##1##(2008-10#3)
YH439##6##1##(2008-11#6)
YK##3##1##(2008-10#3)
YK-4##2##1##(2008-11#2)
YLF laser##2##2##(2008-3#2)
YLF##7##1##(2008-3#7)
YM022##2##1##(1995-12#2)
YO-PRO-1##2##1##(2008-11#2)
YPA(4)##4##1##(2008-10#4)
YPD##2##1##(1993-9#1)(2011-1#1)
YPLH##2##1##(2013-1#2)
YRRM sequences##3##2##(1993-12#3)
YUF##5##1##(2008-11#5)
YVO(4) laser##6##2##(2007-11#2)(2008-3#4)
YVO(4)##8##1##(2007-11#2)(2007-12#1)(2008-3#5)
YY1##8##1##(2008-11#8)
YY3-36 concentrations##2##2##(2013-8#2)
Yag laser##2##2##(1992-1#1)(2008-10#1)
Yahoo Health##2##2##(2011-1#2)
Yahr stage##2##2##(2008-7#1)(2013-8#1)
Yahr##3##1##(2008-7#2)(2013-8#1)
Yale University##4##2##(1992-2#1)(1996-1#1)(1996-9#1)(2008-11#1)
Yale##6##1##(1992-2#1)(1996-1#1)(1996-9#3)(2008-11#1)
Yale-New Haven Hospital##2##3##(1996-2#1)(2013-8#1)
Yang##3##1##(1996-3#1)(2008-10#1)(2009-12#1)
Yb and iodine##2##3##(1997-8#2)
Yb and##4##2##(1997-8#2)(2008-10#2)
Yb##31##1##(1997-8#7)(2007-12#4)(2008-10#6)(2008-2#1)(2008-3#9)(2010-4#4)
Yb(3+)##5##1##(2008-10#1)(2008-2#1)(2008-3#2)(2010-4#1)
Yb(III)##2##1##(2008-10#2)
Year##6##1##(1990-8#1)(1992-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
Yearly##2##1##(1994-12#1)(2008-10#1)
Years of##2##2##(1995-11#1)(2011-3#1)
Years##7##1##(1995-11#2)(2008-10#2)(2008-12#1)(2011-1#1)(2011-3#1)
Yeast artificial chromosome (YAC) clones##2##5##(1996-12#1)(1997-8#1)
Yeast cells##2##2##(2008-10#1)(2011-2#1)
Yeast##12##1##(1993-12#1)(1995-5#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-3#1)
Yeasts##2##1##(2008-10#2)
Yeh##2##1##(1995-12#2)
Yellow Stripe Virus##2##3##(2008-10#2)
Yellow and##3##2##(1993-12#1)(2008-10#2)
Yellow##24##1##(1993-12#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-8#1)
Yellows Phytoplasma##2##2##(2008-10#2)
Yellows##4##1##(2008-10#4)
Yemen##7##1##(2010-6#7)
Yeq##2##1##(1990-8#2)
Yersinia enterocolitica##6##2##(1996-12#2)(2008-11#2)(2013-8#2)
Yersinia pestis##2##2##(2008-10#1)(2012-2#1)
Yersinia##13##1##(1996-12#5)(2008-10#1)(2008-11#2)(2012-2#2)(2013-8#3)
Yes##3##1##(1991-3#1)(1994-2#1)(2010-5#1)
Yet in##2##2##(1994-1#1)(2012-2#1)
Yet the##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
Yet##48##1##(1990-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
Yield Loss of##2##3##(2008-10#2)
Yield loss##2##2##(2008-10#2)
Yield losses due to##2##4##(2008-10#2)
Yield losses##3##2##(2008-10#3)
Yield##19##1##(2008-10#14)(2008-11#1)(2008-9#1)(2009-7#1)(2010-12#1)(2013-8#1)
Yields##2##1##(2008-10#1)(2008-11#1)
Yl##3##1##(1995-2#3)
Yoga on##2##2##(2012-2#2)
Yoga##3##1##(2012-2#3)
Yolo##3##1##(2008-10#3)
York##113##1##(1990-11#4)(1990-8#2)(1991-1#3)(1991-12#5)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-1#1)(1993-2#1)(1993-5#1)(1994-12#5)(1994-2#1)(1994-9#3)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#6)(1996-12#5)(1996-2#2)(1996-3#11)(1996-5#2)(1997-1#4)(2008-10#17)(2008-11#1)(2008-12#1)(2008-8#2)(2009-3#1)(2009-5#5)(2010-10#1)(2011-2#4)(2013-1#2)(2013-8#4)
Yorkshire##2##1##(2008-8#1)(2008-9#1)
Yoshida AH-130 ascites hepatoma##2##4##(1993-8#2)
Yoshida##3##1##(1993-8#3)
You can##2##2##(1997-3#1)(2008-9#1)
You##11##1##(1992-1#1)(1995-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(2008-11#2)(2008-9#1)(2012-12#1)(2012-3#1)
Young Adults##2##2##(2013-1#2)
Young adults##2##2##(2013-1#2)
Young children##2##2##(1994-12#1)(2008-12#1)
Young investigator##2##2##(2010-11#1)(2013-8#1)
Young people##2##2##(1997-5#1)(2013-1#1)
Young##28##1##(1990-5#1)(1994-12#1)(1997-5#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2009-12#3)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#8)(2013-8#2)
Young's Modulus##3##2##(2008-5#1)(2008-9#2)
Young's modulus change##2##3##(2009-5#2)
Young's modulus##14##2##(2008-5#4)(2009-11#1)(2009-5#2)(2009-7#6)(2010-8#1)
Young's relaxation modulus in the##2##5##(2009-7#2)
Young's relaxation modulus##6##3##(2009-7#6)
Young's##24##1##(2008-5#5)(2008-9#2)(2009-11#1)(2009-5#2)(2009-7#13)(2010-8#1)
Younger patients##3##2##(2009-9#1)(2010-12#1)(2011-2#1)
Younger##5##1##(2008-10#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#1)
Your##7##1##(1990-11#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-6#1)
Youth##12##1##(1990-12#1)(1994-2#1)(1997-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Youths##2##1##(2008-9#2)
YrCN19##2##1##(2008-10#2)
Yttrium##2##1##(2008-10#2)
Yunnan Province##4##2##(2008-8#2)(2008-9#1)(2013-8#1)
Yunnan and##2##2##(2008-8#1)(2008-9#1)
Yunnan##10##1##(2008-8#3)(2008-9#4)(2013-8#3)
Z = 4##2##3##(1992-12#1)(1996-5#1)
Z and##2##2##(2008-12#1)(2010-5#1)
Z is##2##2##(2008-3#1)(2009-12#1)
Z pinch##2##2##(1992-11#1)(2008-2#1)
Z##24##1##(1991-11#1)(1992-11#1)(1992-12#1)(1992-8#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#3)(2009-12#2)(2010-5#2)(2011-2#1)
Z-VAD-fmk##2##1##(2008-10#1)(2008-11#1)
Z-scores##3##1##(2008-10#3)
Z8 snoRNA gene##2##3##(2008-8#2)
Z8##3##1##(2008-8#3)
ZA##4##1##(2008-7#2)(2013-1#2)
ZAP-70##4##1##(2008-9#4)
ZAPM were##2##2##(2008-7#2)
ZAPM##7##1##(2008-7#7)
ZCFIA##4##1##(2008-10#4)
ZDV and##3##2##(2008-7#3)
ZDV##6##1##(2008-7#6)
ZEMAX##2##1##(2013-8#2)
ZEN and α-ZOL at##2##4##(2013-1#2)
ZEN and α-ZOL##4##3##(2013-1#4)
ZGMMV is##2##2##(2008-10#2)
ZGMMV##3##1##(2008-10#3)
ZIP##3##1##(2013-8#3)
ZIP1##2##1##(2008-9#2)
ZLRS##4##1##(1995-12#4)
ZM##2##1##(2008-12#2)
ZNF179##2##1##(1997-3#2)
ZO##2##1##(2013-1#2)
ZORBAX Eclipse##2##2##(2008-10#1)(2011-3#1)
ZP##7##1##(2008-8#1)(2013-1#6)
ZP3##3##1##(2008-4#3)
ZPT##6##1##(2008-10#2)(2008-5#4)
ZR-75-1##3##1##(1990-11#1)(1997-7#2)
ZYMV in##2##2##(2008-10#2)
ZYMV isolates##3##2##(2008-10#3)
ZYMV##13##1##(2008-10#13)
ZYQ8/JX17##2##1##(2008-8#2)
Zagreb##5##1##(2008-10#2)(2009-12#2)(2013-1#1)
Zaire##3##1##(1994-9#1)(1995-9#1)(1996-8#1)
Zambia##2##1##(1997-6#1)(2010-4#1)
Zea mays L##3##3##(2008-12#2)(2009-8#1)
Zea mays##9##2##(2008-10#4)(2008-11#1)(2008-12#2)(2009-8#1)(2012-3#1)
Zea##13##1##(1995-12#3)(2008-10#5)(2008-11#1)(2008-12#2)(2009-8#1)(2012-3#1)
Zealand##73##1##(1991-2#2)(1992-1#5)(1992-3#2)(1993-1#1)(1996-12#2)(2008-1#16)(2008-10#13)(2008-11#5)(2008-12#5)(2008-5#2)(2008-8#4)(2009-3#1)(2010-6#2)(2011-1#7)(2011-2#3)(2012-12#1)(2012-3#2)
Zeeman background correction##2##3##(2008-10#2)
Zeeman effect background corrector##2##4##(2008-10#2)
Zeeman effect background##4##3##(2008-10#4)
Zeeman effect##6##2##(2008-10#4)(2008-3#2)
Zeeman##17##1##(2008-10#11)(2008-2#2)(2008-3#4)
Zeeman-effect background correction##3##3##(2008-10#3)
Zeeman-effect background##4##2##(2008-10#4)
Zernike##2##1##(2008-3#2)
Zfx genes##2##2##(2008-8#2)
Zhan##2##1##(2008-10#2)
Zhejiang Province##3##2##(2008-10#2)(2008-9#1)
Zhejiang##4##1##(2008-10#2)(2008-9#2)
Zimbabwe##5##1##(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
Zinc and##2##2##(1994-6#1)(2012-2#1)
Zinc ion##2##2##(2008-10#2)
Zinc is##3##2##(2008-10#1)(2013-7#1)(2013-8#1)
Zinc was##3##2##(2008-10#2)(2008-11#1)
Zinc##22##1##(1993-2#1)(1994-6#1)(2008-10#10)(2008-11#2)(2009-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
Zincon##3##1##(2008-10#3)
Zingel asper##3##2##(2010-8#3)
Ziram and Zineb##3##3##(2008-10#3)
Ziram##6##1##(2008-10#6)
Zitazonium##2##1##(1993-2#2)
Zn and Cd##2##3##(1993-12#1)(2008-10#1)
Zn and Cu##2##3##(2008-10#2)
Zn and Ni##2##3##(2008-10#2)
Zn and Pb##2##3##(2008-10#1)(2011-2#1)
Zn and##15##2##(1993-12#1)(2008-10#13)(2011-2#1)
Zn by##5##2##(2008-10#5)
Zn complexes##3##2##(2008-10#3)
Zn concentration##2##2##(2008-10#1)(2013-8#1)
Zn concentrations##2##2##(2008-10#2)
Zn content##4##2##(2008-10#4)
Zn determination##3##2##(2008-10#3)
Zn for##2##2##(2012-2#2)
Zn homeostasis##2##2##(2010-11#1)(2012-2#1)
Zn in each##2##3##(2008-10#1)(2012-2#1)
Zn in##21##2##(2008-10#18)(2012-2#2)(2013-8#1)
Zn ions##2##2##(2008-10#1)(2013-7#1)
Zn is##2##2##(2012-2#1)(2013-8#1)
Zn levels##2##2##(2008-10#2)
Zn metabolism##3##2##(2012-2#3)
Zn species##2##2##(2008-10#2)
Zn to##2##2##(2008-10#1)(2010-11#1)
Zn was found##2##3##(2008-12#1)(2010-11#1)
Zn was##5##2##(2008-10#3)(2008-12#1)(2010-11#1)
Zn##231##1##(1993-12#8)(1993-2#2)(2008-10#183)(2008-11#1)(2008-12#2)(2008-5#2)(2010-11#6)(2011-2#1)(2012-2#15)(2013-7#1)(2013-8#10)
Zn(2+) and Cd(2+)##3##3##(2008-10#3)
Zn(2+) and Mn(2+)##2##3##(2008-10#2)
Zn(2+) and##9##2##(2008-10#9)
Zn(2+) based on the##2##4##(2008-10#2)
Zn(2+) concentration##2##2##(2008-10#2)
Zn(2+) in##5##2##(2008-10#5)
Zn(2+) on the##2##3##(2008-10#2)
Zn(2+)##62##1##(2008-10#55)(2008-5#3)(2010-11#2)(2011-2#1)(2012-2#1)
Zn(2+)-binding region##2##2##(1993-6#1)(1995-8#1)
Zn(II) and 0##2##3##(2008-10#2)
Zn(II) and Cd(II)##2##3##(2008-10#2)
Zn(II) and Pb(II)##5##3##(2008-10#5)
Zn(II) and##15##2##(2008-10#15)
Zn(II) has been##2##3##(2008-10#2)
Zn(II) in##6##2##(2008-10#5)(2010-11#1)
Zn(II) ions##4##2##(1992-3#2)(2008-10#2)
Zn(II) preconcentration##3##2##(2008-10#3)
Zn(II) was##2##2##(2008-10#2)
Zn(II) were found to be##2##5##(2008-10#2)
Zn(II) were##4##2##(2008-10#4)
Zn(II)##89##1##(1992-3#7)(2008-10#81)(2010-11#1)
Zn(ii)-NA##3##1##(2010-11#3)
Zn) in##4##2##(2008-10#4)
Zn)##12##1##(2008-10#12)
Zn-SOD and catalase##3##3##(1995-6#3)
Zn-SOD and##5##2##(1995-6#3)(1997-8#2)
Zn-SOD by H2O2##2##3##(1997-8#2)
Zn-SOD##9##1##(1995-6#3)(1997-8#6)
Zn-metallothioneins##5##1##(2008-10#5)
Zn-superoxide dismutase##2##2##(1997-8#2)
Zn2+##5##1##(1995-6#3)(1995-8#1)(1997-7#1)
ZnL##2##1##(2008-10#2)
ZnO and##2##2##(2008-10#1)(2008-5#1)
ZnO film##2##2##(2009-5#2)
ZnO thin films##2##3##(2008-10#2)
ZnO##16##1##(2008-10#7)(2008-5#4)(2009-5#4)(2010-7#1)
ZnO/chitosan composite##4##2##(2008-10#4)
ZnPTO shampoo##4##2##(2008-5#4)
ZnPTO##6##1##(2008-5#6)
ZnS QDs##2##2##(2008-10#2)
ZnS##5##1##(2008-10#4)(2008-3#1)
ZnS/MgF(2)##2##1##(2008-3#2)
ZnSO(4) in##2##2##(2008-10#2)
ZnSO(4)##8##1##(2008-10#8)
ZnSO₄##3##1##(2010-11#3)
Zoledronic##2##1##(2010-9#1)(2013-1#1)
Zoll M##2##2##(2010-9#2)
Zollinger-Ellison syndrome and##2##3##(1997-1#2)
Zone Diet##3##2##(2008-3#3)
Zone##5##1##(2008-10#1)(2008-3#3)(2012-3#1)
Zones of##3##2##(2008-10#2)(2008-5#1)
Zoo##4##1##(1996-12#3)(2008-5#1)
Zoospore##2##1##(2008-10#2)
Zorbax##5##1##(2008-10#5)
Zr in##2##2##(2008-10#2)
Zr is##2##2##(2008-10#2)
Zr was##2##2##(2008-10#2)
Zr##27##1##(2008-10#24)(2009-7#3)
Zr(IV) and Hf(IV)##6##3##(2008-10#6)
Zr(IV) porphyrins##2##2##(2008-10#2)
Zr(IV)##16##1##(2008-10#16)
Zr-Ir##2##1##(2008-10#2)
Zr-coating##2##1##(2008-10#2)
ZrO2##2##1##(2008-5#2)
Zucchini green mottle mosaic virus##2##5##(2008-10#2)
Zucchini yellow mosaic virus (ZYMV##2##5##(2008-10#2)
Zucchini yellow mosaic virus (ZYMV)##3##5##(2008-10#3)
Zucchini yellow mosaic virus##8##4##(2008-10#8)
Zucchini##12##1##(2008-10#12)
Zucker rat##2##2##(1996-12#2)
Zucker rats##4##2##(1994-11#1)(1996-12#3)
Zucker##10##1##(1994-11#3)(1996-12#5)(2008-4#2)
Zung-score##2##1##(2008-7#2)
Zurich and##2##2##(1996-11#1)(2013-1#1)
Zurich##10##1##(1996-11#9)(2013-1#1)
Zusanli##2##1##(2010-7#2)
Zymomonas mobilis under certain operating conditions##2##6##(2008-7#2)
Zymomonas mobilis##6##2##(1995-3#1)(2008-7#4)(2011-2#1)
Zymosan##2##1##(1994-6#1)(2008-12#1)
[ p##2##2##(2009-3#2)
[##6##1##(1992-6#1)(1997-7#2)(2009-3#2)(2012-12#1)
[&quot##8##1##(1992-5#1)(1993-11#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-6#1)(2010-6#1)(2013-1#1)
[(11)C]raclopride##2##1##(2013-8#2)
[(18)F]-fluorodeoxyglucose incorporation##6##2##(2008-11#6)
[(18)F]-fluorodeoxyglucose##8##1##(2008-11#8)
[(3)H]##2##1##(2008-11#1)(2008-8#1)
[(3)H]5-HT##3##1##(2008-7#3)
[(triisopropylsilyl)oxy]methyl##3##1##(2008-4#3)
[0##9##1##(1990-2#1)(2008-10#2)(2008-3#2)(2012-3#1)(2013-1#3)
[1##21##1##(1991-3#2)(1995-2#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2011-2#7)(2012-2#1)(2013-1#1)
[1-(2-pyridylazo)-2-naphthol]-naphthalene adsorbent##2##2##(2008-10#2)
[1-14C]pyruvate##2##1##(1991-3#2)
[111In-DTPA-D-Phe1]-octreotide##3##1##(1997-8#3)
[123I]iodobenzamide (IBZM)##2##2##(1996-12#2)
[125I]##2##1##(1992-6#1)(1995-11#1)
[125I]D-Trp6-LH-RH##3##1##(1993-1#3)
[125I]T-98 was##2##2##(1993-1#2)
[125I]T-98##5##1##(1993-1#5)
[125I]VIP##2##1##(1994-3#2)
[13C]formate##2##1##(1992-10#2)
[14C]##3##1##(1990-12#1)(1991-3#1)(1991-9#1)
[14C]-cholesterol##2##1##(1994-11#2)
[14C]TCDD##3##1##(1994-5#3)
[16-14C]ARM##2##1##(1994-8#2)
[180367]##3##1##(2008-5#3)
[182809]##3##1##(2008-5#3)
[18]##2##1##(2013-8#2)
[1]##13##1##(2008-10#3)(2008-11#1)(2008-5#3)(2010-7#1)(2011-2#5)
[2##23##1##(1992-10#1)(1992-3#2)(1992-5#1)(1994-5#1)(1995-12#2)(1995-5#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#3)(2009-4#1)(2010-4#1)(2011-2#3)(2012-12#1)
[2-13C]glycine and##2##2##(1992-10#2)
[22]##2##1##(2012-3#1)(2013-8#1)
[260590]##2##1##(2008-5#2)
[260592]##2##1##(2008-5#2)
[272638]##2##1##(2008-5#2)
[275922]##2##1##(2008-5#2)
[276895]##2##1##(2008-5#2)
[287131]##2##1##(2008-5#2)
[2]##3##1##(2008-7#1)(2011-2#2)
[3##3##1##(1996-5#1)(2008-5#1)(2013-8#1)
[3-13C]serine##3##1##(1992-10#3)
[32P]##2##1##(1992-9#1)(1994-8#1)
[35S]GTP gamma S binding##5##4##(1996-2#5)
[35S]sulfate##2##1##(1992-1#1)(1993-12#1)
[3H]-staurosporine##6##1##(1990-8#6)
[3H]5##2##1##(1995-11#2)
[3H]5-HT##6##1##(1994-2#6)
[3H]ACPC binding were##2##3##(1995-11#2)
[3H]ACPC##6##1##(1995-11#6)
[3H]CGP39653##2##1##(1996-2#2)
[3H]DHT##3##1##(1990-11#3)
[3H]GBR 12935##3##2##(1996-2#3)
[3H]Ins1##5##1##(1993-6#5)
[3H]R1881##3##1##(1990-11#3)
[3H]SR141716A##3##1##(1996-2#3)
[3H]T##3##1##(1990-11#3)
[3H]arachidonic acid-labelled##2##2##(1994-3#2)
[3H]arachidonic##3##1##(1994-3#2)(1997-1#1)
[3H]choline##2##1##(1991-5#1)(1997-2#1)
[3H]dichlorokynurenic acid##2##2##(1996-2#2)
[3H]dizocilpine binding##2##2##(1996-2#2)
[3H]dizocilpine##3##1##(1996-2#3)
[3H]dopamine uptake##2##2##(1996-2#2)
[3H]flunitrazepam binding##4##2##(1994-2#1)(1996-2#3)
[3H]flunitrazepam##6##1##(1994-2#1)(1996-2#5)
[3H]glycine##2##1##(1995-11#2)
[3H]imipramine binding##4##2##(1990-5#4)
[3H]inositol##4##1##(1991-12#1)(1993-6#1)(1997-1#2)
[3H]inositol-prelabeled##2##1##(1993-6#2)
[3H]leucine##3##1##(1993-12#3)
[3H]leukotriene D4##2##2##(1993-6#2)
[3H]leukotriene D4-specific binding##3##3##(1993-6#3)
[3H]leukotriene##5##1##(1993-6#5)
[3H]prazosin and##2##2##(1991-6#2)
[3H]prazosin##5##1##(1991-6#5)
[3H]thymidine incorporation##4##2##(1994-3#1)(1995-12#1)(1996-12#1)(1997-1#1)
[3H]thymidine##10##1##(1994-3#1)(1995-12#2)(1995-2#3)(1996-12#2)(1997-1#2)
[3]##2##1##(2011-2#1)(2012-3#1)
[4 + 2] cycloaddition##2##4##(1996-5#2)
[4##11##1##(1996-5#8)(2008-5#1)(2010-11#1)(2013-1#1)
[4Fe-4S]##2##1##(1993-8#2)
[4]##4##1##(2008-10#1)(2008-6#1)(2009-4#1)(2011-2#1)
[6]##3##1##(2008-10#1)(2009-12#1)(2009-4#1)
[7]##3##1##(2009-12#1)(2009-4#1)(2012-2#1)
[8]##2##1##(2008-7#1)(2012-2#1)
[95% CI##5##2##(2008-8#2)(2011-2#2)(2012-2#1)
[95% confidence interval 0##2##4##(1991-8#2)
[95% confidence interval##4##3##(1991-8#2)(2012-3#1)(2013-1#1)
[95%##9##1##(1991-8#2)(2008-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
[9]mercuracarborand-3##2##1##(2008-10#2)
[A case from practice##3##4##(1992-6#1)(1993-8#1)(1994-5#1)
[A case of severe##2##4##(1991-11#1)(1991-6#1)
[A case of##10##3##(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#1)(1993-2#1)(1996-11#2)(2008-11#2)(2013-8#1)
[A case report of##2##4##(2008-10#1)(2011-3#1)
[A case study of##3##4##(1990-12#1)(1990-2#1)(1991-2#1)
[A case##18##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-5#1)(1996-11#2)(2008-10#1)(2008-11#2)(2011-3#1)(2013-8#1)
[A health##2##2##(1990-6#1)(1996-2#1)
[A new##2##2##(1991-9#1)(1995-5#1)
[A pilot study of##2##4##(1990-2#1)(2009-8#1)
[A rare##3##2##(1992-5#1)(2009-5#1)(2012-2#1)
[A re-evaluation of the##2##4##(1993-11#1)(1993-2#1)
[A study on the##3##4##(1990-12#1)(1990-2#1)(1991-2#1)
[A##78##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1991-11#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-2#4)(1993-5#2)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#2)(1996-11#4)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#5)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2009-5#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#6)
[AIDS##2##1##(1992-11#1)(1996-3#1)
[About##2##1##(1995-11#1)(2012-3#1)
[Abstracts##2##1##(2010-1#1)(2010-3#1)
[Ac-D(2)-Nal1##2##1##(1994-8#2)
[Acetylsalicylic acid##3##2##(1990-9#1)(1994-6#1)(1995-11#1)
[Activity of##2##2##(1991-3#1)(2008-5#1)
[Acute respiratory##2##2##(1997-3#1)(2009-5#1)
[Acute##18##1##(1990-9#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-9#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#2)(2009-8#1)(2011-3#1)(2013-8#1)
[Adjuvant##3##1##(1991-9#1)(1993-2#1)(1997-8#1)
[Adult##2##1##(1992-2#1)(2007-8#1)
[Advances in the study of##2##5##(2011-3#2)
[Advances in##4##2##(2011-3#3)(2013-8#1)
[Adverse reactions##2##2##(1994-9#1)(1996-6#1)
[Adverse##3##1##(1994-9#1)(1996-6#1)(2012-3#1)
[Alarming##2##1##(1994-12#1)(1996-3#1)
[Alcohol and##3##2##(1990-6#1)(1995-5#1)(1996-8#1)
[Alcohol##6##1##(1990-6#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-8#1)
[Ambulatory##2##1##(1994-3#1)(1996-2#1)
[An analysis of the##4##4##(1993-5#2)(1997-5#1)(2013-8#1)
[An evaluation of##3##3##(1993-11#1)(1993-5#1)(1994-6#1)
[An overview##2##2##(2011-2#1)(2013-8#1)
[An##27##1##(1990-11#1)(1990-3#1)(1991-3#1)(1992-5#1)(1992-6#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-5#4)(1993-9#1)(1994-6#2)(1995-5#1)(1997-4#1)(1997-5#1)(2008-11#2)(2011-2#1)(2013-1#1)(2013-8#2)
[Analysis of the##4##3##(1994-5#1)(2012-3#3)
[Analysis of##14##2##(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(2011-1#1)(2012-3#6)(2013-8#3)
[Analysis##15##1##(1993-9#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(2011-1#1)(2012-3#6)(2013-8#3)
[Analyze##2##1##(2012-3#2)
[Antibiotic##2##1##(1991-3#1)(1992-6#1)
[Apo E##2##2##(1996-11#1)(1997-5#1)
[Appl##19##1##(2008-2#5)(2008-3#14)
[Application of##2##2##(1997-8#1)(2012-3#1)
[Are##3##1##(1993-11#1)(1994-6#1)(2009-5#1)
[Arterial##3##1##(1990-11#1)(1991-11#1)(1995-11#1)
[Aspects of##2##2##(1995-5#1)(1996-11#1)
[Assessment of##2##2##(1994-5#1)(2011-2#1)
[Assessment##3##1##(1992-6#1)(1994-5#1)(2011-2#1)
[Association##3##1##(1991-11#1)(2013-1#1)(2013-8#1)
[Attention deficit/hyperactivity##2##2##(1997-8#2)
[Autoimmune##2##1##(1997-5#1)(2009-5#1)
[Bajjalieh et al##2##3##(1993-12#2)
[Basic##2##1##(1994-6#1)(2011-2#1)
[Benign##2##1##(2009-5#1)(2010-12#1)
[Bilateral##2##1##(1997-8#1)(2013-1#1)
[Bladder##2##1##(2011-2#2)
[Blood##4##1##(1990-8#1)(1992-3#1)(1993-11#1)(1993-2#1)
[Bone density in##2##3##(1991-11#2)
[Bone density##3##2##(1991-11#3)
[Bone##6##1##(1991-11#5)(1996-11#1)
[Brazilian guidelines##2##2##(2008-10#2)
[Brazilian##3##1##(2008-10#2)(2012-3#1)
[Breast feeding##2##2##(1991-11#1)(1991-2#1)
[Breast##4##1##(1991-11#1)(1991-2#1)(1993-2#1)(1996-11#1)
[Breast-preserving surgery in breast##2##4##(1991-2#2)
[C##2##1##(2008-10#2)
[CI] =##3##2##(2010-10#1)(2011-2#2)
[CI]##8##1##(1993-12#1)(2010-10#1)(2010-4#3)(2011-2#3)
[Ca(2+)](i) increase##3##2##(2012-2#3)
[Ca(2+)](i)##12##1##(2008-9#5)(2009-12#2)(2012-2#5)
[Ca(2+)](o)##6##1##(2008-8#6)
[Ca++]i in##2##2##(1991-5#1)(1993-3#1)
[Ca++]i##8##1##(1991-5#4)(1993-3#4)
[Ca2+]##5##1##(1990-2#1)(1991-6#3)(1995-11#1)
[Ca2+]c by##2##2##(1991-12#1)(1995-8#1)
[Ca2+]c##9##1##(1991-12#6)(1995-8#3)
[Ca2+]i in##7##2##(1991-5#1)(1992-6#4)(1994-2#1)(1996-2#1)
[Ca2+]i increase with##2##3##(1996-2#2)
[Ca2+]i increase##3##2##(1996-2#3)
[Ca2+]i rise##2##2##(1994-5#1)(1995-11#1)
[Ca2+]i was##3##2##(1994-3#1)(1994-6#1)(1997-1#1)
[Ca2+]i##37##1##(1990-5#1)(1991-5#2)(1992-6#6)(1994-11#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#5)(1995-11#4)(1996-2#4)(1997-1#4)(2011-3#3)
[Can##4##1##(1993-11#1)(1993-2#2)(1997-8#1)
[Cancer of##2##2##(1990-9#1)(2013-1#1)
[Cancer##3##1##(1990-9#1)(1991-6#1)(2013-1#1)
[Cardiovascular screenings in Norwegian counties##2##5##(1991-6#2)
[Cardiovascular##4##1##(1991-6#2)(2008-10#1)(2010-12#1)
[Care for##3##2##(1991-2#1)(1993-2#1)(1997-5#1)
[Cataract surgery##2##2##(1993-3#2)
[Catheter treatment of##2##3##(1994-9#1)(1997-8#1)
[Causes of death in##2##4##(1995-5#1)(1996-11#1)
[Causes##3##1##(1991-3#1)(1995-5#1)(1996-11#1)
[Cerebral##3##1##(1990-3#1)(1997-4#1)(2009-5#1)
[Challenges##2##1##(2008-11#1)(2012-12#1)
[Change##2##1##(1995-2#1)(1996-11#1)
[Changes in the##3##3##(1997-3#2)(2011-2#1)
[Changes in##5##2##(1997-3#2)(1997-8#2)(2011-2#1)
[Changes of##3##2##(2010-12#3)
[Changes##8##1##(1997-3#2)(1997-8#2)(2010-12#3)(2011-2#1)
[Characteristics of##3##2##(1996-6#1)(2008-10#1)(2011-2#1)
[Characterization of##2##2##(2012-12#1)(2013-8#1)
[Childhood and juvenile ankylosing##2##4##(1993-11#2)
[Childhood##3##1##(1992-3#1)(1993-11#2)
[Children and##2##2##(1994-6#1)(2013-8#1)
[Children##4##1##(1990-12#1)(1994-6#1)(1997-2#1)(2013-8#1)
[Chinese##2##1##(2008-11#1)(2013-8#1)
[Chronic##10##1##(1990-3#1)(1993-5#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
[Classification##2##1##(1991-6#1)(2008-10#1)
[Clinical and##2##2##(2009-5#1)(2012-12#1)
[Clinical assessment of##2##3##(2010-6#1)(2012-3#1)
[Clinical##21##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#2)(1991-6#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-5#1)(2009-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#4)(2013-8#1)
[Co(phen)3]3+##2##1##(1990-5#2)
[Combination therapy##2##2##(1991-6#1)(2011-1#1)
[Combined##2##1##(2012-3#2)
[Common##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
[Comparative study of##4##3##(1996-11#1)(2009-1#1)(2009-8#1)(2013-8#1)
[Comparison of##4##2##(2011-1#1)(2012-3#2)(2013-1#1)
[Comparison##5##1##(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
[Compliance to therapy in daily##3##5##(1993-11#3)
[Complications of##3##2##(1990-5#1)(1996-3#1)(2011-1#1)
[Conflict of interest regarding clinical##2##5##(2011-3#2)
[Conflict of interest##4##3##(2011-3#4)
[Congenital##4##1##(1992-5#1)(1996-11#1)(2012-3#1)(2013-1#1)
[Conservative##2##1##(1993-6#1)(1997-2#1)
[Contribution to##2##2##(2008-5#1)(2011-3#1)
[Contribution##3##1##(1991-11#1)(2008-5#1)(2011-3#1)
[Control of##3##2##(1995-11#1)(1997-6#1)(2009-5#1)
[Coordination of##2##2##(1994-9#1)(1997-3#1)
[Correlation study##2##2##(2013-8#2)
[Correlation##4##1##(2013-1#1)(2013-8#3)
[Crib death##2##2##(1991-11#2)
[Cu(HIO(6))(2)](5-)##3##1##(2008-10#3)
[Current##8##1##(1991-11#1)(1993-2#1)(1993-6#1)(1997-4#1)(2008-1#1)(2008-5#1)(2011-3#1)(2013-8#1)
[Cutaneous##2##1##(1991-11#1)(2009-5#1)
[D-Ala2##4##1##(1995-6#1)(1996-2#3)
[D-Arg6]##2##1##(1994-8#2)
[D-Pen2##2##1##(1992-3#1)(1996-2#1)
[D-Trp6]LH-RH##2##1##(1993-1#2)
[D-hArg(Et2)6##2##1##(1994-8#2)
[D-hArg(Et2)6]##2##1##(1994-8#2)
[Delayed##2##1##(1994-6#1)(2013-1#1)
[Dental photograph##3##2##(1990-2#1)(1990-3#1)(1990-5#1)
[Dental##5##1##(1990-2#1)(1990-3#1)(1990-5#1)(1996-3#1)(2013-1#1)
[Department of Health##3##3##(2008-11#3)
[Dermatomyositis##2##1##(1991-3#1)(2013-1#1)
[Dermatophytes##2##1##(2008-5#2)
[Description of##2##2##(2008-5#1)(2013-1#1)
[Design and##2##2##(2012-3#2)
[Design##4##1##(2011-3#1)(2012-3#2)(2013-8#1)
[Detection of##3##2##(1990-6#1)(1996-6#1)(2013-1#1)
[Detection##5##1##(1990-6#1)(1996-6#2)(1997-2#1)(2013-1#1)
[Determination of##2##2##(1991-2#1)(2013-8#1)
[Development of##3##2##(1996-11#1)(2011-3#1)(2013-8#1)
[Diabetes mellitus in pregnancy]##2##4##(1996-11#2)
[Diabetes mellitus in##3##3##(1994-6#1)(1996-11#2)
[Diabetes##5##1##(1990-12#1)(1994-6#1)(1995-11#1)(1996-11#2)
[Diagnosis and##3##2##(1991-2#1)(1995-5#1)(2008-10#1)
[Diagnosis of##7##2##(1990-11#1)(1991-6#2)(1993-9#1)(1996-2#1)(1996-3#1)(2009-8#1)
[Diagnosis##13##1##(1990-11#1)(1991-2#1)(1991-6#2)(1993-2#1)(1993-9#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-4#2)(2008-10#1)(2009-8#1)
[Diagnostic criteria##2##2##(1991-9#1)(2008-11#1)
[Diagnostic peritoneal lavage in blunt abdominal##2##6##(1990-2#2)
[Diagnostic##9##1##(1990-11#1)(1990-2#2)(1990-9#1)(1991-9#1)(1997-3#1)(2008-11#1)(2011-2#1)(2011-6#1)
[Dialysis##3##1##(1994-5#1)(1995-5#2)
[Differential##2##1##(1997-8#1)(2013-8#1)
[Discussion##2##1##(2012-3#1)(2013-8#1)
[Do##2##1##(1995-5#1)(1996-6#1)
[Doctors##2##1##(1996-8#1)(2008-10#1)
[Does##6##1##(1990-11#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-4#1)
[Drug##3##1##(1994-9#1)(1997-8#1)(2011-3#1)
[Drugs##2##1##(1991-3#1)(1994-8#1)
[E##3##1##(2008-10#3)
[EC 1##4##2##(1996-6#1)(2008-10#3)
[EC 2##2##2##(1994-8#2)
[EC##7##1##(1994-8#2)(1996-2#1)(1996-6#1)(2008-10#3)
[EMIM][N(Tf)(2)]##2##1##(2008-10#2)
[Early##5##1##(1991-11#1)(1991-9#1)(1997-8#1)(2011-3#1)(2013-8#1)
[Effect of##24##2##(1992-11#1)(1994-6#1)(1996-11#1)(1996-3#1)(2008-5#1)(2010-12#5)(2011-1#1)(2011-2#1)(2011-3#4)(2013-8#8)
[Effective##2##1##(2011-3#1)(2012-3#1)
[Effectiveness of##3##2##(1997-2#1)(2009-5#1)(2009-8#1)
[Effects of##15##2##(1990-5#1)(1991-8#1)(2010-12#4)(2012-3#1)(2013-8#8)
[Effects##17##1##(1990-5#1)(1991-8#1)(1997-4#1)(2010-12#4)(2012-3#2)(2013-8#8)
[Efficacy of##4##2##(1991-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
[Elevated serum##2##2##(2012-2#2)
[Emergency##5##1##(1990-2#1)(1993-8#1)(1997-8#2)(2008-11#1)
[Endoscopic and##3##2##(1990-8#1)(1992-9#1)(2013-1#1)
[Endoscopic##7##1##(1990-11#1)(1990-8#1)(1991-3#1)(1992-6#1)(1992-9#1)(2013-1#2)
[Epidemiological##5##1##(2007-8#1)(2009-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
[Epidemiology of##2##2##(1990-3#1)(1993-9#1)
[Errata]##2##1##(2013-8#2)
[Erythema##2##1##(1992-5#1)(2009-1#1)
[Establish##2##1##(2012-3#1)(2013-8#1)
[Establishment and application of a##2##5##(2011-3#2)
[Establishment and application of##3##4##(2010-12#1)(2011-3#2)
[Ethical##2##1##(1993-6#1)(2011-3#1)
[Ethics and##2##2##(1993-6#1)(1997-4#1)
[Ethics##3##1##(1992-2#1)(1993-6#1)(1997-4#1)
[Euthanasia and assisted suicide by physicians in the home situation##2##10##(1991-8#2)
[Evaluating##2##1##(2011-2#1)(2012-12#1)
[Evaluation of a##2##3##(1996-11#1)(1996-6#1)
[Evaluation of the##11##3##(1991-3#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(2011-2#3)(2013-1#2)
[Evaluation of##24##2##(1990-6#1)(1990-9#1)(1991-3#2)(1992-5#1)(1995-3#2)(1996-11#2)(1996-2#1)(1996-6#2)(1997-3#1)(2008-10#1)(2010-6#1)(2011-2#4)(2011-3#1)(2013-1#2)(2013-8#2)
[Evaluation##25##1##(1990-6#1)(1990-9#1)(1991-3#2)(1992-5#1)(1995-3#2)(1996-11#2)(1996-2#1)(1996-6#2)(1997-3#1)(2008-10#1)(2010-6#1)(2011-2#4)(2011-3#1)(2013-1#3)(2013-8#2)
[Evolution of##4##2##(1995-11#1)(2009-1#1)(2013-1#2)
[Experience in##2##2##(1990-5#1)(1997-3#1)
[Experiential Learning##2##2##(2008-11#2)
[Experimental##3##1##(1993-6#1)(2010-12#1)(2012-3#1)
[Extraction##2##1##(2012-3#1)(2013-8#1)
[F (1##2##2##(2013-8#2)
[F##3##1##(2013-8#3)
[Factors associated with##3##3##(1993-5#1)(2010-6#1)(2013-8#1)
[Factors##6##1##(1993-5#1)(1993-9#1)(1996-3#1)(2010-6#1)(2012-12#1)(2013-8#1)
[Family##7##1##(1993-5#1)(1994-12#1)(1994-9#1)(1995-11#1)(1997-4#1)(2008-11#1)(2011-2#1)
[Fatal##2##1##(1991-11#1)(1996-8#1)
[Fe(-)U(+)]##3##1##(2013-1#3)
[Fe(CN)(6)](3-)-[Fe(CN)(6)](4-) potential buffer solution##2##4##(2008-10#2)
[Fe(CN)(6)](3-)-[Fe(CN)(6)](4-) potential buffer##3##3##(2008-10#3)
[Fe(CN)6]3- and##2##2##(1990-5#2)
[Fe(CN)6]4-##2##1##(1990-5#2)
[Fe(IV)(O)(N4Py)](2+)##2##1##(2012-12#2)
[First##2##1##(1990-9#1)(2012-3#1)
[Follow up##2##2##(1991-6#1)(1997-8#1)
[Follow-up of##2##2##(1991-6#1)(1993-11#1)
[Food##3##1##(1993-2#1)(1994-6#1)(1996-11#1)
[Formula##24##1##(2008-10#4)(2008-11#3)(2008-8#10)(2012-2#1)(2013-1#6)
[From##5##1##(1990-9#1)(1995-12#1)(1997-4#1)(2011-2#1)(2013-8#1)
[Functional##6##1##(1991-2#1)(1991-3#1)(1995-5#1)(2007-8#1)(2011-2#2)
[Future##3##1##(1996-3#1)(1997-5#1)(2011-3#1)
[Gardens of##2##2##(2010-6#2)
[Gardens##4##1##(2010-6#4)
[Gastric##3##1##(1990-5#1)(1990-9#1)(2013-1#1)
[Gastrointestinal##2##1##(2008-10#1)(2013-1#1)
[General##4##1##(1990-6#1)(1997-3#1)(2011-2#1)(2012-3#1)
[Genetic##2##1##(2013-1#1)(2013-8#1)
[Geriatrics in The Netherlands##2##4##(1996-11#2)
[Good##3##1##(1996-3#1)(1997-8#1)(2008-12#1)
[Growth hormone##2##2##(1993-2#1)(1996-11#1)
[Growth##3##1##(1993-2#1)(1996-11#1)(1997-2#1)
[Guidelines for##2##2##(1993-6#1)(1995-2#1)
[Guidelines##3##1##(1993-6#1)(1995-2#1)(2008-9#1)
[H(+)]##2##1##(2008-10#2)
[HIV##2##1##(1990-6#1)(1993-11#1)
[Health and##2##2##(1994-5#1)(1995-11#1)
[Health##10##1##(1990-6#1)(1993-11#1)(1993-5#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-5#1)(2012-3#1)
[Heart##3##1##(1990-2#1)(2008-10#1)(2013-1#1)
[Helicobacter pylori and##2##3##(1997-4#1)(2013-1#1)
[Helicobacter pylori##3##2##(1990-2#1)(1997-4#1)(2013-1#1)
[Hemodynamic##2##1##(1992-2#1)(1996-3#1)
[High##2##1##(1994-9#1)(1997-3#1)
[Hogg##2##1##(1994-5#2)
[Home nursing care (I)##2##4##(1991-2#2)
[Home##4##1##(1990-2#1)(1991-2#2)(1995-11#1)
[Hormonal##3##1##(1993-8#1)(1994-8#1)(2011-3#1)
[Hospital admission of nursing home patients##2##6##(1994-12#2)
[Hospital readmissions##2##2##(1997-5#2)
[Hospital##8##1##(1991-3#1)(1994-12#2)(1997-4#1)(1997-5#2)(2010-6#1)(2013-8#1)
[How can##2##2##(1992-5#1)(1993-11#1)
[How to evaluate##2##3##(1991-11#1)(1996-2#1)
[How to##5##2##(1991-11#1)(1992-2#1)(1993-6#1)(1996-2#1)(2011-3#1)
[How##11##1##(1990-6#1)(1991-11#2)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1996-11#1)(1996-2#1)(1997-4#1)(2011-3#1)
[Human##4##1##(1993-11#1)(1996-3#2)(2008-11#1)
[Hypertension in##3##2##(1990-12#1)(1997-4#1)(1997-5#1)
[Hypertension##4##1##(1990-12#1)(1993-11#1)(1997-4#1)(1997-5#1)
[Hypoglycemia##2##1##(1997-2#1)(1997-5#1)
[II]##3##1##(2008-10#3)
[I] and##4##2##(2008-10#4)
[I]##6##1##(2008-10#6)
[Idiopathic##3##1##(1991-11#1)(1992-2#1)(1996-11#1)
[Imaging##2##1##(1990-11#1)(2009-5#1)
[Immunological##2##1##(1996-11#1)(2013-1#1)
[Impact of##4##2##(1990-3#1)(2008-10#1)(2009-10#1)(2011-2#1)
[Importance of##5##2##(1991-3#1)(1994-9#2)(1997-4#1)(2008-10#1)
[Importance##6##1##(1991-3#1)(1994-9#2)(1997-4#1)(2008-10#1)(2011-2#1)
[Improvement in##2##2##(1996-3#1)(1997-4#1)
[In Process Citation]##43##3##(2008-10#2)(2008-11#4)(2008-7#4)(2008-8#8)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#15)(2012-3#1)(2013-1#5)
[In vitro##6##2##(1991-11#1)(1996-11#1)(2008-5#1)(2011-3#3)
[In##52##1##(1991-11#1)(1991-6#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#4)(2008-8#8)(2009-10#1)(2011-2#2)(2011-3#4)(2012-12#1)(2012-2#15)(2012-3#1)(2013-1#5)
[Includes supplementary material]##4##3##(2010-10#4)
[Increased##3##1##(1996-3#1)(1997-4#1)(2008-11#1)
[Indications and##2##2##(1990-3#1)(2011-3#1)
[Indications for##5##2##(1990-3#1)(1990-9#1)(1994-3#1)(1995-11#1)(1996-6#1)
[Indications##7##1##(1990-3#2)(1990-9#1)(1994-3#1)(1995-11#1)(1996-6#1)(2011-3#1)
[Infection##2##1##(1994-6#1)(1997-2#1)
[Infections##2##1##(1991-2#1)(1996-6#1)
[Infectious##2##1##(1996-3#1)(2009-5#1)
[Influence of##2##2##(2008-5#2)
[Information for##2##2##(1994-6#2)
[Inhibition of##3##2##(2010-12#2)(2011-3#1)
[Injuries##2##1##(1993-3#1)(1996-6#1)
[International##2##1##(1993-11#1)(2011-2#1)
[Interpretation of##2##2##(1993-9#1)(1995-11#1)
[Intestinal##3##1##(1992-5#1)(2009-5#1)(2012-3#1)
[Introduction of##2##2##(1992-5#1)(1993-11#1)
[Iron##2##1##(1990-11#1)(1994-6#1)
[Is primary care management possible from the hospital? The view of##2##11##(1994-6#2)
[Is the##3##2##(1990-3#1)(1991-9#1)(1997-4#1)
[Is there##2##2##(1991-8#1)(1995-12#1)
[Is##10##1##(1990-3#1)(1991-11#1)(1991-8#1)(1991-9#1)(1994-6#2)(1995-12#1)(1996-11#1)(1997-4#1)(1997-8#1)
[Ischemic##2##1##(1990-9#1)(1992-5#1)
[Isolated##7##1##(1992-9#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(2007-8#1)
[Isolation and##2##2##(2008-5#2)
[J##9##1##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)
[Job satisfaction##2##2##(2008-11#1)(2011-2#1)
[Kidney##3##1##(1994-5#1)(1997-4#1)(2013-8#1)
[L]/[M(+)]##3##1##(2008-10#3)
[Laparoscopic##4##1##(1996-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
[Large##2##1##(1991-2#1)(1993-6#1)
[Laser in##2##2##(1991-9#2)
[Laser##3##1##(1991-3#1)(1991-9#2)
[Lee-Huang##2##1##(1993-12#1)(1993-6#1)
[Leiomyoma of the##2##3##(1992-5#1)(1992-9#1)
[Leu31##3##1##(1997-4#3)
[Leu]- and [Met]enkephalin##3##3##(1991-3#3)
[Leu]enkephalin##2##1##(1991-3#2)
[Life##2##1##(1991-3#1)(1991-6#1)
[Local##2##1##(1990-11#1)(1991-6#1)
[Long-term outcome of##2##3##(2011-3#1)(2011-5#1)
[Long-term treatment##2##2##(1995-12#1)(2009-8#1)
[Long-term##4##1##(1995-12#1)(2009-8#1)(2011-3#1)(2011-5#1)
[Low##2##1##(1990-3#1)(2008-10#1)
[Lung##3##1##(1990-3#1)(1991-2#1)(2011-3#1)
[Magnetic resonance##2##2##(1991-11#1)(1997-4#1)
[Magnetic##3##1##(1990-11#1)(1991-11#1)(1997-4#1)
[Male##3##1##(1990-3#1)(1991-11#1)(2012-12#1)
[Malignant pleural mesothelioma in##2##4##(1995-2#1)(1997-5#1)
[Malignant##3##1##(1995-2#1)(1997-5#1)(2011-3#1)
[Management of##4##2##(2008-10#1)(2009-1#1)(2011-2#1)(2013-1#1)
[Maternity in adolescents##2##3##(1993-3#1)(1997-5#1)
[May##2##1##(1995-2#1)(1996-11#1)
[Medical##8##1##(1990-11#1)(1991-11#1)(1991-2#1)(1993-2#1)(1993-6#1)(1997-4#1)(2011-3#1)(2012-3#1)
[Medicine##2##1##(1997-5#1)(2013-1#1)
[Mem##4##1##(2007-12#4)
[Mental##2##1##(1996-11#1)(1997-5#1)
[Met]enkephalin##4##1##(1991-3#4)
[Methadone##2##1##(1991-11#1)(1992-5#1)
[Modern##2##1##(1996-3#1)(1996-9#1)
[Molecular characterization of##2##3##(2008-5#1)(2011-1#1)
[Molecular##3##1##(2008-5#1)(2011-1#1)(2013-1#1)
[More##3##1##(1991-2#1)(1996-6#1)(2008-6#1)
[Multiple sclerosis##2##2##(1996-3#1)(1996-8#1)
[Multiple##5##1##(1990-12#1)(1996-3#1)(1996-8#1)(2009-5#1)(2011-3#1)
[Myocardial##2##1##(1991-3#1)(2012-3#1)
[N##2##1##(1997-3#1)(2008-10#1)
[N-MePhe3##2##1##(1996-2#2)
[NaOH](T)##3##1##(2008-10#3)
[Natural##2##1##(1992-5#1)(2012-12#1)
[Neonatal##3##1##(2008-5#1)(2009-5#2)
[New##11##1##(1990-6#1)(1993-11#1)(1994-6#2)(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-3#1)(2012-3#1)(2013-1#1)
[News in##2##2##(1994-6#1)(2008-10#1)
[NiFe]hydrogenase-encoding structural genes##2##3##(1990-11#2)
[Nuclear medical##2##2##(1991-2#2)
[Nursing care for the adolescent (IV)##3##6##(1990-12#3)
[Nursing care##5##2##(1990-12#3)(2012-3#2)
[Nursing##11##1##(1990-12#4)(1990-2#2)(1993-3#1)(2008-11#1)(2012-3#3)
[Nutrition##2##1##(1991-6#1)(1993-9#1)
[Nutritional##2##1##(1990-3#1)(1995-5#1)
[OR##2##1##(2008-10#2)
[OR] =##2##2##(2010-10#1)(2011-2#1)
[OR]##3##1##(2010-10#1)(2011-2#2)
[Obstructive lung disease in##2##4##(1997-4#2)
[Obstructive##3##1##(1991-3#1)(1997-4#2)
[Occupational conditions##2##2##(1993-3#1)(1996-3#1)
[Occupational##6##1##(1992-5#1)(1993-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(2012-3#1)
[On the##2##2##(2008-5#2)
[On##3##1##(1990-3#1)(2008-5#2)
[Only##2##1##(1991-8#1)(1997-2#1)
[Oral##4##1##(1990-5#1)(1991-3#1)(1995-11#1)(2008-5#1)
[Osteoporosis##2##1##(1991-11#1)(1996-6#1)
[Our experience##3##2##(1990-3#1)(1990-9#1)(2011-2#1)
[P =##2##2##(2010-4#2)
[P##4##1##(2008-10#1)(2008-12#1)(2010-4#2)
[PER]##5##1##(2008-10#5)
[Palliative##2##1##(1996-8#1)(1997-2#1)
[Pancreas##2##1##(1991-9#1)(1995-2#1)
[Pancreatic##2##1##(1990-9#1)(2009-5#1)
[Parkinson disease##2##2##(1995-2#1)(2013-8#1)
[Pathogenesis of##2##2##(1991-2#1)(1996-9#1)
[Pathogenic##2##1##(2012-12#1)(2012-3#1)
[Patient##3##1##(1995-5#1)(1997-4#1)(2007-8#1)
[Patients##4##1##(1990-6#1)(1991-6#1)(1994-8#1)(1997-5#1)
[Perception of the##2##3##(1994-9#1)(1996-3#1)
[Perception of##4##2##(1994-9#1)(1996-3#1)(2008-11#1)(2013-1#1)
[Perception##5##1##(1994-9#1)(1996-3#1)(2008-11#1)(2009-10#1)(2013-1#1)
[Percutaneous treatment]##2##2##(1997-5#2)
[Percutaneous##4##1##(1991-9#1)(1997-5#2)(2008-12#1)
[Pharmacies' information##2##2##(1990-2#2)
[Physical activity and##2##3##(1993-2#1)(1995-5#1)
[Physical##3##1##(1993-2#1)(1995-5#1)(1997-6#1)
[Physiologic and pathologic age related changes in the##2##8##(1990-11#2)
[Practical##2##1##(1994-12#1)(1996-11#1)
[Pregnancy in##3##2##(1996-11#1)(2008-10#1)(2012-3#1)
[Premature##2##1##(1994-6#1)(2012-3#1)
[Prenatal##3##1##(1995-11#1)(2009-5#1)(2011-1#1)
[Preparation##3##1##(1991-3#1)(2008-5#1)(2010-12#1)
[Prevalence of##8##2##(1995-5#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-10#1)(2013-1#2)
[Prevention of##10##2##(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-2#1)(1995-5#1)(1996-9#1)(2011-3#1)(2012-3#1)
[Prevention##11##1##(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-2#1)(1995-5#1)(1996-9#1)(2011-3#1)(2012-3#1)(2013-8#1)
[Primary care##2##2##(1993-9#1)(1997-2#1)
[Primary pulmonary##2##2##(1997-5#1)(2009-5#1)
[Primary##15##1##(1990-11#1)(1990-3#1)(1991-2#1)(1992-9#1)(1993-6#1)(1993-9#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2009-5#2)(2011-2#1)(2013-1#1)
[Problems of##2##2##(1997-3#1)(1997-8#1)
[Problems##3##1##(1995-5#1)(1997-3#1)(1997-8#1)
[Procedures##2##1##(1990-2#1)(2011-3#1)
[Prognostic##3##1##(1992-2#1)(2009-1#1)(2013-1#1)
[Protective effect of##2##3##(2011-3#1)(2013-8#1)
[Psychological##2##1##(1991-3#1)(2008-11#1)
[Pulmonary##5##1##(1991-9#1)(2007-8#1)(2009-5#3)
[Quality assurance in##3##3##(1990-9#1)(1996-3#1)(1997-4#1)
[Quality assurance##4##2##(1990-9#1)(1996-3#1)(1997-4#1)(1997-8#1)
[Quality control of##2##3##(1993-6#1)(2011-3#1)
[Quality control##3##2##(1993-6#1)(2008-10#1)(2011-3#1)
[Quality of nursing##2##3##(1994-9#1)(2012-3#1)
[Quality of##3##2##(1994-9#1)(2012-3#1)(2013-8#1)
[Quality##12##1##(1990-9#1)(1992-5#1)(1993-6#1)(1994-9#1)(1996-3#1)(1997-4#1)(1997-8#2)(2008-10#1)(2011-3#1)(2012-3#1)(2013-8#1)
[Quantitative##2##1##(1991-11#1)(2011-3#1)
[Questionnaire##2##1##(2008-11#1)(2011-2#1)
[Radical##2##1##(1990-3#1)(1995-5#1)
[Rational##2##1##(1992-5#1)(1997-5#1)
[Recent advance in##2##3##(2013-8#2)
[Recent##5##1##(1991-3#1)(1997-2#1)(2011-3#1)(2013-8#2)
[Recurrent##2##1##(1994-3#1)(2009-5#1)
[Reduced##2##1##(1990-9#1)(1991-6#1)
[Rehabilitation##2##1##(1990-9#1)(1993-3#1)
[Report##2##1##(1990-12#1)(2008-10#1)
[Research on the##3##3##(2012-3#1)(2013-8#2)
[Research on##6##2##(2012-3#2)(2013-8#4)
[Research##8##1##(2012-3#4)(2013-8#4)
[Respiratory##3##1##(1996-11#1)(2008-1#1)(2008-5#1)
[Responsibility and##2##2##(1991-6#1)(2008-10#1)
[Results##2##1##(2013-1#1)(2013-8#1)
[Resuscitation of##2##2##(1994-6#1)(1996-6#1)
[Resuscitation##3##1##(1992-5#1)(1994-6#1)(1996-6#1)
[Review of##3##2##(1991-9#1)(1992-2#1)(1992-9#1)
[Rheumatoid arthritis##2##2##(1997-2#1)(2008-11#1)
[Risk factors for##2##3##(2008-1#1)(2013-1#1)
[Risk factors of##3##3##(1991-6#1)(1996-3#1)(2013-1#1)
[Risk factors##6##2##(1991-3#1)(1991-6#1)(1996-3#1)(2008-1#1)(2013-1#2)
[Risk##9##1##(1991-3#1)(1991-6#1)(1994-8#1)(1996-3#1)(1996-8#1)(2008-1#1)(2012-3#1)(2013-1#2)
[Role of mitochondrial##2##3##(2007-8#1)(2010-12#1)
[Role of the##3##3##(1995-11#2)(2011-2#1)
[Role of##9##2##(1995-11#2)(2007-8#1)(2008-10#1)(2010-12#2)(2011-2#1)(2012-3#2)
[Ru(bipy)(3)](2+)##2##1##(2008-10#2)
[Ru(bpy)(3)](2+)##4##1##(2008-10#3)(2010-7#1)
[S-(R*##3##1##(1993-8#3)
[Secondary##3##1##(1991-11#1)(1993-2#1)(1996-3#1)
[Self##3##1##(1994-6#1)(1997-3#1)(2008-10#1)
[Self-reported##2##1##(1996-6#1)(1997-4#1)
[Serum##2##1##(1993-2#1)(2008-11#1)
[Sexual abuse of##2##3##(1996-11#2)
[Sexual##3##1##(1995-11#1)(1996-11#2)
[Shibayama##2##1##(1993-8#2)
[Should##5##1##(1991-2#1)(1991-6#1)(1994-2#1)(1996-2#1)(1997-8#1)
[SiO(2)]/[Al(2)O(3)] ratio##3##2##(2008-10#3)
[Significance of##4##2##(1991-3#1)(1996-6#1)(1997-5#1)(2008-5#1)
[Simultaneous determination of##2##3##(2011-3#1)(2013-8#1)
[Sinusitis in##2##2##(1991-6#1)(1993-2#1)
[Small hospitals--future tasks and functions]##2##5##(1991-6#2)
[Small##3##1##(1991-6#2)(2010-11#1)
[Smoking and##2##2##(1990-6#1)(1991-9#1)
[Smoking##4##1##(1990-6#1)(1991-9#1)(1993-2#1)(1996-6#1)
[Solitary##2##1##(1991-3#1)(1994-5#1)
[Some##2##1##(2008-5#1)(2009-10#1)
[Special##2##1##(1993-6#1)(1996-6#1)
[Spectral##2##1##(2013-8#2)
[Spinal##2##1##(1991-3#1)(2012-3#1)
[Spontaneous##3##1##(1990-9#1)(1991-8#1)(2009-8#1)
[Statistical##2##1##(1991-3#1)(1997-4#1)
[Status##2##1##(2010-6#1)(2013-8#1)
[Strengthening##2##1##(1996-11#1)(2008-11#1)
[Stress##2##1##(1992-5#1)(1996-6#1)
[Study of##9##2##(1991-11#2)(1994-9#1)(1996-2#2)(1997-8#1)(2008-5#2)(2009-1#1)
[Study on chemical constituents of##3##5##(2012-3#1)(2013-8#2)
[Study on the chemical components of##2##6##(2013-8#2)
[Study on the chemical##3##4##(2013-8#3)
[Study on the##11##3##(1990-2#1)(1993-9#1)(2012-3#6)(2013-8#3)
[Study on##22##2##(1990-2#1)(1993-9#1)(2010-12#2)(2012-3#10)(2013-8#8)
[Study##32##1##(1990-2#1)(1990-9#1)(1991-11#2)(1993-9#1)(1994-9#1)(1996-2#2)(1997-8#1)(2008-5#2)(2009-1#1)(2010-12#2)(2012-3#10)(2013-8#8)
[Sudden infant death##2##3##(1990-11#1)(1991-11#1)
[Sudden infant##4##2##(1990-11#3)(1991-11#1)
[Sudden##5##1##(1990-11#3)(1991-11#1)(1994-9#1)
[Suicide##2##1##(1996-1#1)(2013-1#1)
[Surgery##2##1##(1990-2#1)(1995-5#1)
[Surgical treatment of##6##3##(1990-3#1)(1990-5#2)(1991-8#1)(1993-6#1)(2011-2#1)
[Surgical##9##1##(1990-3#1)(1990-5#2)(1991-11#1)(1991-3#1)(1991-8#1)(1993-6#2)(2011-2#1)
[Survey report on nursing education##2##5##(1990-2#1)(1991-2#1)
[Susceptibility to##2##2##(2008-5#1)(2012-12#1)
[Synchronous##2##1##(1991-6#1)(2009-5#1)
[Synthesis and##2##2##(2011-3#2)
[Systemic lupus erythematosus##2##3##(1992-5#1)(2009-5#1)
[The &quot##3##2##(1994-9#1)(1997-2#1)(2011-2#1)
[The HIV-epidemic among##2##3##(1996-11#2)
[The HIV-epidemic##3##2##(1996-11#3)
[The Norwegian##2##2##(1994-2#1)(1997-8#1)
[The age of##2##3##(1990-9#1)(1992-5#1)
[The application of##3##3##(1997-4#1)(2013-1#1)(2013-8#1)
[The application##4##2##(1997-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
[The companion##2##2##(1993-11#1)(1993-3#1)
[The concept of##4##3##(1991-2#1)(1993-3#1)(1993-6#1)(2013-1#1)
[The concept##5##2##(1990-5#1)(1991-2#1)(1993-3#1)(1993-6#1)(2013-1#1)
[The detection of##2##3##(1990-8#1)(2013-1#1)
[The diagnosis and treatment of##2##5##(1992-5#1)(1993-2#1)
[The diagnosis##3##2##(1992-5#1)(1993-2#1)(1993-5#1)
[The early detection of##2##4##(1993-11#1)(1993-3#1)
[The effect of##2##3##(1992-5#1)(2012-3#1)
[The effectiveness##2##2##(2008-1#1)(2013-8#1)
[The effects of##2##3##(2010-12#1)(2011-2#1)
[The epidemiology of##3##3##(1993-3#1)(1994-6#1)(2011-2#1)
[The evaluation of a##2##4##(1993-11#1)(1993-3#1)
[The evaluation of##4##3##(1993-11#1)(1993-3#1)(1997-4#1)(2013-1#1)
[The importance of##2##3##(1993-11#1)(2008-11#1)
[The incidence of##2##3##(1994-6#1)(2008-1#1)
[The introduction of##2##3##(1993-3#1)(1994-6#1)
[The medical##3##2##(1992-5#1)(1993-11#2)
[The physician's##2##2##(1990-2#1)(1991-6#1)
[The prestige of diseases and medical specialties]##2##7##(1991-11#1)(1991-6#1)
[The prevalence of##4##3##(1993-11#1)(1993-5#1)(2009-8#1)(2012-12#1)
[The protective##2##2##(2010-12#2)
[The protein##2##2##(1991-11#1)(1994-9#1)
[The research of##2##3##(2012-3#2)
[The risk of##2##3##(1994-9#1)(2011-2#1)
[The role of the##3##4##(1993-11#1)(2008-11#1)(2011-3#1)
[The role of##9##3##(1990-11#1)(1991-3#1)(1993-11#1)(1997-8#1)(2008-11#1)(2011-3#2)(2012-3#1)(2013-1#1)
[The significance of##2##3##(2008-11#1)(2013-8#1)
[The surgical treatment of##2##4##(1992-3#1)(1992-5#1)
[The surgical##4##2##(1992-3#3)(1992-5#1)
[The telephone##2##2##(1994-6#1)(1997-5#1)
[The treatment of##3##3##(1990-6#1)(1991-8#1)(1993-2#1)
[The use of##2##3##(1992-5#1)(1993-11#1)
[The validity of 6 indirect methods for assessing##2##8##(1997-4#1)(1997-5#1)
[The value of##3##3##(1991-3#1)(2013-1#1)(2013-8#1)
[The##235##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#5)(1991-11#2)(1991-2#5)(1991-3#7)(1991-6#4)(1991-8#2)(1991-9#1)(1992-3#8)(1992-5#7)(1993-11#12)(1993-2#5)(1993-3#14)(1993-5#4)(1993-6#2)(1993-8#1)(1993-9#4)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#11)(1994-8#1)(1994-9#4)(1995-11#2)(1995-5#3)(1996-11#5)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#4)(1997-8#3)(2007-8#1)(2008-1#2)(2008-11#7)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-12#6)(2010-6#3)(2011-2#6)(2011-3#9)(2012-12#2)(2012-3#12)(2013-1#17)(2013-8#12)
[Therapeutic##5##1##(1991-11#1)(1995-5#1)(1996-11#1)(1997-8#1)(2012-3#1)
[Therapy of##5##2##(1991-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-5#1)
[Therapy##7##1##(1991-11#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-2#1)
[This corrects the article DOI##2##5##(2010-9#1)(2012-2#1)
[This corrects the article on p##12##6##(2008-11#2)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
[This corrects the article##14##4##(2008-11#2)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
[Thoracoscopic lobectomy##2##2##(2011-2#2)
[Thrombocyte##3##1##(1990-12#1)(1994-9#1)(1996-6#1)
[Time course of##2##3##(2010-12#2)
[To the##2##2##(1993-2#1)(1994-12#1)
[To##7##1##(1991-2#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-5#1)(2010-12#1)
[Tobacco##2##1##(1993-9#1)(2009-5#1)
[Topical##3##1##(1990-9#1)(1991-3#1)(2008-5#1)
[Topics on reproductive health at the##2##6##(2008-11#2)
[Towards a##2##2##(1997-4#1)(1997-5#1)
[Training and professional profile of dentistry in the EEC##3##9##(1990-2#1)(1990-9#1)(1991-2#1)
[Training and professional profile of dentistry in the##4##8##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)
[Training##5##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1997-3#1)
[Transfusion medicine in##2##3##(2008-10#2)
[Transfusion##4##1##(1990-11#1)(1994-8#1)(2008-10#2)
[Traumatic##2##1##(1991-3#1)(2011-2#1)
[Treatment of hypertension in##2##4##(1994-6#1)(1996-6#1)
[Treatment of##21##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#2)(2011-1#1)(2013-8#4)
[Treatment##23##1##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#2)(2011-1#1)(2012-3#1)(2013-8#4)
[Triple##3##1##(1991-3#1)(1996-11#1)(2011-2#1)
[Tuberculosis##2##1##(1993-11#1)(1996-11#1)
[Tuberculous infection in##2##3##(1992-2#1)(1993-11#1)
[Tuberculous##3##1##(1992-2#1)(1993-11#1)(1997-5#1)
[Tumor##2##1##(1990-11#1)(1996-3#1)
[Two cases of##3##3##(1993-3#1)(1993-6#1)(2010-12#1)
[Type##2##1##(1991-11#1)(2011-2#1)
[Ulcerative##3##1##(1992-3#3)
[Ultrasonography##2##1##(1992-5#1)(1996-11#1)
[Use of##8##2##(1990-11#1)(1990-9#1)(1996-11#2)(1996-3#2)(2008-11#1)(2013-1#1)
[Usefulness of##3##2##(1996-11#2)(2012-3#1)
[Using##2##1##(2008-11#1)(2011-2#1)
[Vaccination##3##1##(1990-11#1)(1996-11#1)(1997-8#1)
[Vaccinations in##2##2##(1996-9#2)
[Vaccinations##3##1##(1994-5#1)(1996-9#2)
[Validation of##2##2##(1997-2#1)(2010-9#1)
[Variation in##3##2##(1995-12#1)(1996-6#1)(1996-8#1)
[Vascular##4##1##(1991-6#1)(2009-5#2)(2011-3#1)
[Ventricular##2##1##(1990-9#1)(1996-3#1)
[Virological##2##1##(2013-1#1)(2013-8#1)
[W##2##1##(2008-12#2)
[Waiting##2##1##(1991-11#2)
[We##3##1##(1990-12#1)(1990-2#1)(2009-10#1)
[What is the##3##3##(1991-2#1)(1993-11#1)(1997-2#1)
[What is your diagnosis?##2##4##(1993-11#1)(1994-5#1)
[What is your##3##3##(1993-11#1)(1993-8#1)(1994-5#1)
[What is##7##2##(1991-2#1)(1993-11#2)(1993-8#1)(1994-5#1)(1997-2#1)(2009-5#1)
[What##13##1##(1990-9#1)(1991-2#1)(1992-5#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-5#1)(1994-9#1)(1997-2#1)(1997-5#1)(2009-5#1)
[When##2##1##(1993-11#1)(1997-4#1)
[Where does##2##2##(1993-2#1)(1997-4#1)
[Where##4##1##(1993-11#1)(1993-2#1)(1993-3#1)(1997-4#1)
[Who should perform abortion counseling?]##3##5##(1995-11#3)
[Who should##4##2##(1994-5#1)(1995-11#3)
[Who##7##1##(1990-2#1)(1991-11#1)(1994-12#1)(1994-5#1)(1995-11#3)
[Whose##2##1##(1991-2#1)(1994-8#1)
[Why do##2##2##(1991-11#1)(1991-9#1)
[Why##5##1##(1991-11#1)(1991-9#1)(1994-2#1)(1995-2#1)(1997-3#1)
[Women##2##1##(1993-6#1)(2008-11#1)
[X##3##1##(1996-5#1)(2008-10#2)
[arrows##2##1##(1992-4#2)
[cAMP]i##4##1##(1991-3#4)
[cM])##2##1##(2008-10#2)
[corrected]##2##1##(1990-10#1)(1993-8#1)
[correction of##2##2##(1992-6#1)(1997-4#1)
[e##2##1##(2009-10#1)(2012-2#1)
[electric field##2##2##(2011-2#2)
[formula##2##1##(1992-12#1)(1995-6#1)
[i##4##1##(1991-5#1)(2008-10#1)(2010-3#1)(2010-7#1)
[ligand]/[metal cation]##2##2##(2008-10#2)
[n =##2##2##(2012-3#2)
[odds ratio##2##2##(2011-2#1)(2013-8#1)
[oxy/30%##2##1##(1992-8#2)
[sodium##2##1##(2008-10#1)(2008-5#1)
[standard##2##1##(2008-10#1)(2008-3#1)
[the##3##1##(1995-2#1)(2008-11#1)(2013-8#1)
[with##2##1##(1997-1#1)(2008-10#1)
]##134##1##(1990-9#1)(1991-3#2)(1993-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-5#46)(2008-7#5)(2009-5#1)(2009-6#1)(2009-8#16)(2010-1#1)(2010-11#4)(2010-12#1)(2010-9#1)(2011-2#19)(2011-3#9)(2012-2#2)(2012-3#1)(2013-1#11)
_ 2 and##4##3##(2008-5#4)
_ 2 stretching##2##3##(2008-5#2)
_ 2##19##2##(2008-5#19)
_ 50##6##2##(2008-5#6)
_##30##1##(2008-5#30)
a $1##2##2##(1996-5#1)(2008-5#1)
a $75##2##2##(1995-12#1)(1996-5#1)
a &quot##102##2##(1990-3#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1993-1#1)(1993-12#2)(1993-2#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1995-1#1)(1995-2#4)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#4)(2013-8#2)
a 'real'##2##2##(2012-3#1)(2013-1#1)
a 0##65##2##(1993-12#1)(1995-11#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#46)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#2)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
a 1 min##2##3##(2008-10#1)(2008-11#1)
a 1 mm##3##3##(2008-10#2)(2008-7#1)
a 1 x##2##3##(2008-3#1)(2011-2#1)
a 1##128##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-8#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#3)(1997-4#1)(1997-8#1)(2008-10#68)(2008-11#6)(2008-2#2)(2008-3#7)(2008-5#4)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-5#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
a 1%##2##2##(2008-9#1)(2013-1#1)
a 1-day##2##2##(2008-10#2)
a 1-h##2##2##(2008-10#1)(2008-3#1)
a 1-kHz repetition rate##2##4##(2008-3#2)
a 1-kHz##3##2##(2007-11#1)(2008-3#2)
a 1-mm-thick##3##2##(2007-12#1)(2008-3#2)
a 1-month##2##2##(2008-10#2)
a 1-mum##2##2##(2007-12#1)(2008-3#1)
a 1-nm##2##2##(2008-2#1)(2008-3#1)
a 1-year follow-up##2##3##(2012-5#1)(2013-8#1)
a 1-year period##5##3##(2008-11#2)(2008-5#1)(2011-2#1)(2013-8#1)
a 1-year##7##2##(2008-11#2)(2008-5#1)(2011-2#1)(2012-5#1)(2013-8#2)
a 1-year-old##3##2##(1997-8#1)(2008-10#1)(2012-3#1)
a 1-yr##2##2##(2008-8#1)(2010-10#1)
a 10 min##3##3##(1992-3#1)(2008-10#2)
a 10 ml##2##3##(2008-10#2)
a 10 years period##2##4##(1997-8#1)(2011-2#1)
a 10##23##2##(1991-6#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-8#1)(1996-3#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)
a 10%##5##2##(1997-3#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)
a 10-day##2##2##(2010-5#2)
a 10-fold increase in##3##4##(1990-6#1)(1992-3#1)(2010-1#1)
a 10-fold##4##2##(1990-6#1)(1992-3#1)(2008-10#1)(2010-1#1)
a 10-item##2##2##(2008-12#1)(2008-9#1)
a 10-month##2##2##(2008-10#1)(2008-7#1)
a 10-week##2##2##(2013-1#2)
a 10-year period##4##3##(1992-2#1)(1997-6#1)(2008-10#1)(2008-7#1)
a 10-year##9##2##(1991-2#1)(1992-2#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
a 10-year-old##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
a 100 l stirred tankbioreactor##2##5##(2008-11#2)
a 100##8##2##(1991-5#1)(2008-10#4)(2008-11#3)
a 100% increase##2##3##(1990-6#1)(2008-5#1)
a 100% of##2##3##(2008-10#1)(2008-5#1)
a 100% water mobile phase##4##5##(2008-10#4)
a 100%##16##2##(1990-11#1)(1990-6#1)(1990-8#1)(1994-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-5#2)(2013-1#1)
a 100-1000##2##2##(1996-12#1)(2008-10#1)
a 1000##2##2##(2008-10#2)
a 1000-fold##3##2##(1996-12#1)(2008-10#2)
a 106-residue##2##2##(1994-5#2)
a 10mul##2##2##(2008-10#2)
a 12##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
a 12-day##2##2##(2008-10#1)(2013-1#1)
a 12-h##4##2##(1994-8#1)(1995-11#1)(2008-10#2)
a 12-lead##2##2##(2009-10#1)(2010-1#1)
a 12-month period##5##3##(1992-1#1)(1994-9#1)(2008-10#1)(2008-12#1)(2010-4#1)
a 12-week##2##2##(2008-3#1)(2008-5#1)
a 12-year-old boy with diffuse##2##5##(2008-10#1)(2008-11#1)
a 12-year-old boy with##3##4##(2008-10#1)(2008-11#2)
a 12-year-old##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
a 120##3##2##(1993-12#1)(2008-10#2)
a 120s##2##2##(2008-10#2)
a 13##4##2##(1991-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
a 13% increase in##2##4##(2008-10#1)(2008-3#1)
a 13%##4##2##(2008-10#2)(2008-3#2)
a 13-year##2##2##(2008-3#1)(2012-2#1)
a 13-year-old boy##2##3##(2008-10#1)(2013-1#1)
a 13-year-old##3##2##(2007-9#1)(2008-10#1)(2013-1#1)
a 14##3##2##(1996-3#1)(2008-10#2)
a 14-kDa##2##2##(2008-10#2)
a 14-year-old girl##3##3##(2010-5#1)(2012-3#1)(2013-1#1)
a 14-year-old##4##2##(2008-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
a 15##8##2##(1993-2#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)
a 15%##3##2##(2008-10#3)
a 15-year-old boy##2##3##(2009-9#1)(2013-1#1)
a 15-year-old girl##2##3##(2010-5#1)(2013-8#1)
a 15-year-old##5##2##(2009-9#1)(2010-5#1)(2013-1#2)(2013-8#1)
a 150##4##2##(2008-10#3)(2008-11#1)
a 150-fold##2##2##(1993-8#1)(2008-10#1)
a 16##3##2##(2008-8#1)(2009-10#1)(2013-8#1)
a 16-year-old female##2##3##(2012-3#1)(2013-1#1)
a 16-year-old##5##2##(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
a 17##4##2##(1990-6#1)(1991-11#1)(2008-12#1)(2008-5#1)
a 170##2##2##(1993-3#1)(2008-10#1)
a 181-bp##2##2##(2008-10#1)(2012-3#1)
a 19##2##2##(1994-5#1)(2007-12#1)
a 1989##2##2##(1992-2#1)(1992-3#1)
a 1990##2##2##(1993-12#1)(1995-12#1)
a 1992##2##2##(1995-1#1)(2008-3#1)
a 2##45##2##(1990-11#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-6#1)(1995-9#1)(1996-5#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
a 2%##2##2##(1993-1#1)(2008-10#1)
a 2(4-1)##2##2##(2008-10#1)(2011-2#1)
a 2- to##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
a 2-##4##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
a 2-3 fold##2##3##(1992-7#1)(2008-11#1)
a 2-fold increase in the##2##5##(1993-3#1)(2010-1#1)
a 2-fold increase in##3##4##(1993-3#1)(1995-6#1)(2010-1#1)
a 2-fold##5##2##(1992-4#1)(1993-3#1)(1994-8#1)(1995-6#1)(2010-1#1)
a 2-min##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
a 2-month-old##3##2##(2008-10#1)(2010-6#2)
a 2-week interval##2##3##(2008-10#1)(2008-7#1)
a 2-week##9##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)(2013-1#1)
a 2-year period##4##3##(2008-10#3)(2012-5#1)
a 2-year##9##2##(1991-12#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-4#1)(2012-5#1)
a 2-year-old##2##2##(2008-10#1)(2011-2#1)
a 20 mM##3##3##(1997-2#1)(2008-10#2)
a 20 ml##3##3##(2008-10#3)
a 20 mul##2##3##(2008-10#2)
a 20##19##2##(1990-5#1)(1997-2#1)(2008-10#11)(2008-11#2)(2008-3#1)(2009-5#1)(2009-8#1)(2011-2#1)
a 20% increase in##3##4##(2008-5#1)(2011-2#1)(2013-8#1)
a 20%##9##2##(1992-4#1)(1994-5#1)(2008-10#1)(2008-5#3)(2008-7#1)(2011-2#1)(2013-8#1)
a 20-fold##3##2##(1990-8#1)(2008-10#2)
a 20-mul##3##2##(2008-10#3)
a 20-year##3##2##(1993-8#1)(2013-8#2)
a 20-year-old##3##2##(1994-11#1)(2008-9#1)(2010-6#1)
a 200##3##2##(2008-10#2)(2010-6#1)
a 200-fold##2##2##(2008-10#2)
a 200mul##2##2##(2008-10#2)
a 21##3##2##(1993-8#1)(1996-3#1)(2008-2#1)
a 22##5##2##(1992-12#1)(1994-11#1)(1994-8#1)(2008-11#1)(2008-9#1)
a 22-year-old female##2##3##(2008-7#1)(2011-2#1)
a 23##6##2##(1994-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)(2012-2#1)
a 23-kb##2##2##(1995-12#2)
a 23-year-old man##2##3##(1990-6#1)(1997-8#1)
a 23-year-old woman##3##3##(2008-7#1)(2010-12#1)(2013-8#1)
a 23-year-old##7##2##(1990-6#1)(1997-8#1)(2008-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
a 24 h##3##3##(1994-2#1)(1996-12#1)(2008-5#1)
a 24##5##2##(1994-2#1)(1995-9#1)(1996-12#1)(2008-5#1)(2009-4#1)
a 24-h##4##2##(2008-10#3)(2008-11#1)
a 24-hour##2##2##(1991-2#1)(1996-8#1)
a 25 kDa##2##3##(1992-8#2)
a 25##12##2##(1992-8#2)(2008-10#8)(2008-11#2)
a 25%##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
a 25-year##4##2##(1995-3#1)(1996-5#1)(2008-10#1)(2012-3#1)
a 250-fold##2##2##(1991-12#1)(2008-10#1)
a 26##2##2##(1992-4#1)(2008-10#1)
a 26-year-old##3##2##(1990-3#1)(1994-12#1)(2010-6#1)
a 27##3##2##(1990-11#1)(1990-2#1)(1996-8#1)
a 27-kDa##2##2##(1994-5#1)(2008-10#1)
a 27-year-old##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
a 28##2##2##(2011-2#1)(2013-1#1)
a 28-day##2##2##(2008-10#2)
a 28-year-old male##2##3##(2013-1#1)(2013-8#1)
a 28-year-old##6##2##(2008-12#2)(2013-1#3)(2013-8#1)
a 29##2##2##(1990-11#1)(1991-11#1)
a 29-amino-acid-long##2##2##(2008-10#2)
a 29-year-old male##3##3##(1990-3#1)(2008-12#1)(2010-7#1)
a 29-year-old##6##2##(1990-3#1)(2008-11#1)(2008-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
a 2mL##2##2##(2008-10#1)(2008-8#1)
a 2nd dose##2##3##(1995-8#2)
a 3##35##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
a 3%##3##2##(2008-10#3)
a 3' untranslated region##2##4##(1993-12#1)(1994-11#1)
a 3-4-fold##3##2##(1994-5#1)(1994-8#1)(2008-10#1)
a 3-D##3##2##(2008-11#2)(2008-3#1)
a 3-day AAP##2##3##(2008-10#2)
a 3-day##8##2##(2008-10#4)(2008-3#1)(2011-2#2)(2013-1#1)
a 3-fold increase in##2##4##(1990-7#1)(1994-8#1)
a 3-fold increase##3##3##(1990-7#1)(1994-12#1)(1994-8#1)
a 3-fold##5##2##(1990-7#1)(1994-12#1)(1994-8#2)(1995-8#1)
a 3-min##3##2##(2008-10#2)(2009-1#1)
a 3-month period##3##3##(1997-8#1)(2008-10#2)
a 3-month##4##2##(1997-8#1)(2008-10#2)(2010-9#1)
a 3-year period##7##3##(1993-12#1)(2008-10#4)(2008-9#1)(2012-2#1)
a 3-year##11##2##(1993-12#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-2#1)
a 3-year-old##2##2##(1994-2#1)(2012-3#1)
a 30 min##3##3##(1994-5#1)(2008-10#2)
a 30##13##2##(1990-9#1)(1994-5#1)(2008-10#7)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
a 30%##7##2##(2008-10#1)(2008-11#2)(2008-8#2)(2010-6#1)(2013-1#1)
a 30-day##2##2##(1990-8#1)(1995-2#1)
a 30-fold##2##2##(1995-11#1)(1995-3#1)
a 30-week cycling experiment in##2##5##(2008-10#2)
a 30-year period##2##3##(2008-10#1)(2008-7#1)
a 30-year-old male patient##2##4##(2010-5#1)(2013-1#1)
a 30-year-old##7##2##(1990-8#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
a 300##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
a 31##3##2##(1991-8#1)(2008-10#1)(2009-1#1)
a 31-year-old##2##2##(2011-2#1)(2012-3#1)
a 32-year-old female##3##3##(1995-12#1)(2013-1#2)
a 32-year-old man##3##3##(2009-1#1)(2010-6#1)(2012-3#1)
a 32-year-old##9##2##(1995-12#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-6#1)(2012-3#1)(2013-1#3)
a 33-kDa##3##2##(1992-9#1)(2008-10#2)
a 34##2##2##(1991-8#1)(1997-1#1)
a 35 kDa protein##2##4##(1996-6#1)(1997-8#1)
a 35##4##2##(1996-6#1)(1997-7#2)(1997-8#1)
a 35%##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
a 35-kDa##2##2##(1992-9#1)(1995-6#1)
a 350##2##2##(1995-12#1)(2008-10#1)
a 36-kDa##2##2##(1995-6#1)(2008-10#1)
a 37 degrees C##2##4##(2008-11#2)
a 37-amino acid##2##3##(1992-6#2)
a 37-year-old##4##2##(1991-3#1)(2008-12#1)(2008-7#1)(2013-1#1)
a 38-year-old##2##2##(1997-3#1)(2008-7#1)
a 39-year-old man##2##3##(1997-5#1)(2010-2#1)
a 39-year-old##3##2##(1997-5#1)(2010-2#1)(2013-1#1)
a 3D##5##2##(2007-12#1)(2008-3#1)(2008-9#1)(2011-2#2)
a 3sigma##2##2##(2008-10#2)
a 4##21##2##(1990-11#1)(1990-12#1)(1993-9#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2009-10#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
a 4%##2##2##(1991-8#1)(2008-10#1)
a 4-h##3##2##(2008-10#2)(2008-6#1)
a 4-week##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
a 4-year period##4##3##(1994-12#1)(2008-10#2)(2008-5#1)
a 4-year##11##2##(1993-12#1)(1994-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-6#1)(2012-3#1)
a 4-year-old##3##2##(2008-10#2)(2013-1#1)
a 40##7##2##(1994-11#1)(1996-12#1)(1996-6#2)(2008-10#3)
a 40%##2##2##(2008-11#1)(2012-2#1)
a 40-year-old woman##3##3##(2008-12#1)(2008-7#1)(2010-11#1)
a 40-year-old##5##2##(2008-12#2)(2008-7#2)(2010-11#1)
a 41-year-old female##2##3##(2008-12#1)(2012-3#1)
a 41-year-old##5##2##(2008-11#1)(2008-12#1)(2012-3#2)(2013-1#1)
a 43-year-old female##2##3##(2008-12#1)(2013-8#1)
a 43-year-old##4##2##(1991-6#1)(2008-12#1)(2008-9#1)(2013-8#1)
a 45-fold##2##2##(1994-5#1)(2011-2#1)
a 45-year-old male##2##3##(2008-11#1)(2010-6#1)
a 45-year-old##3##2##(2008-11#1)(2010-5#1)(2010-6#1)
a 450-kb##2##2##(1997-2#1)(2010-4#1)
a 46-year-old##4##2##(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
a 48%##2##2##(1990-5#1)(2008-11#1)
a 48-year-old man##2##3##(2013-1#2)
a 48-year-old##4##2##(2009-1#1)(2012-3#1)(2013-1#2)
a 4g enema##2##3##(2010-12#2)
a 5 min##2##3##(2008-10#2)
a 5 mm##3##3##(1991-12#1)(1993-3#1)(2013-1#1)
a 5 year##3##3##(1993-9#1)(2008-10#2)
a 5##26##2##(1991-12#1)(1993-3#1)(1993-9#1)(1995-11#1)(1996-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-6#1)(2010-7#1)(2011-2#2)(2013-1#1)
a 5% (v/v)##2##3##(2008-10#2)
a 5%##10##2##(1990-6#1)(2008-10#7)(2008-11#2)
a 5'##4##2##(1994-11#1)(1997-7#1)(1997-8#1)(2008-10#1)
a 5-fold##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
a 5-kb##2##2##(1993-2#1)(1997-7#1)
a 5-min##4##2##(2008-10#2)(2008-2#2)
a 5-ml##3##2##(2008-10#3)
a 5-mm##2##2##(2006-6#1)(2008-2#1)
a 5-year period##4##3##(1991-2#1)(1997-8#1)(2010-1#1)(2011-2#1)
a 5-year##9##2##(1991-2#1)(1997-8#1)(2008-10#2)(2008-7#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
a 5-year-old boy##2##3##(1990-6#1)(2013-1#1)
a 5-year-old##6##2##(1990-6#1)(2008-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
a 50##13##2##(2008-1#1)(2008-10#8)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
a 50% (v/v)##2##3##(2008-10#2)
a 50% competitive##2##3##(1993-3#1)(1995-8#1)
a 50% reduction##2##3##(2008-10#1)(2013-1#1)
a 50%##16##2##(1993-3#1)(1995-11#1)(1995-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
a 50-fold molar excess##2##4##(1990-11#2)
a 50-fold##3##2##(1990-11#2)(1994-8#1)
a 50-ha##2##2##(2008-8#1)(2008-9#1)
a 50-kDa##3##2##(1993-12#1)(1993-6#2)
a 50-year-old woman with a##2##5##(2011-2#1)(2012-12#1)
a 50-year-old##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
a 50/50##2##2##(1993-12#1)(2008-10#1)
a 500##5##2##(1990-9#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
a 51-kDa##2##2##(2008-10#2)
a 51-year-old##5##2##(1994-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
a 52-year-old male##2##3##(2011-2#1)(2013-1#1)
a 52-year-old##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
a 53##2##2##(2009-8#1)(2013-8#1)
a 53-kDa##2##2##(1993-8#1)(1995-9#1)
a 54##2##2##(2008-5#1)(2012-3#1)
a 54-year-old woman##2##3##(2013-1#2)
a 54-year-old##3##2##(2008-12#1)(2013-1#2)
a 57-year-old##3##2##(1997-8#1)(2010-5#1)(2011-2#1)
a 58-year-old patient##3##3##(1991-2#1)(2011-2#1)(2013-1#1)
a 59-year-old##3##2##(2009-8#1)(2012-12#1)(2013-8#1)
a 5x10(-4) M##3##3##(2008-10#3)
a 6##7##2##(1991-2#1)(1993-2#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
a 6-fold##2##2##(1993-6#1)(1995-11#1)
a 6-h##2##2##(2008-10#1)(2008-3#1)
a 6-month##8##2##(2008-10#1)(2008-11#1)(2010-10#1)(2010-12#1)(2012-12#2)(2013-1#2)
a 6-week##2##2##(2011-2#2)
a 6-year##4##2##(2008-10#2)(2013-1#2)
a 6-year-old##3##2##(2008-9#1)(2010-3#1)(2010-5#1)
a 60 kDa heat shock protein of Helicobacter pylori##2##9##(1996-12#2)
a 60 kDa##4##3##(1996-12#4)
a 60 s preconcentration time##3##5##(2008-10#3)
a 60##11##2##(1996-12#4)(2008-10#5)(2008-11#1)(2008-5#1)
a 60%##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
a 60-year-old woman##2##3##(2009-1#1)(2012-3#1)
a 60-year-old##4##2##(2008-7#1)(2009-1#1)(2012-3#1)(2013-1#1)
a 61-year-old##4##2##(1996-3#1)(2008-11#1)(2010-3#1)(2013-8#1)
a 62-year-old woman##3##3##(1991-11#1)(1994-6#1)(2008-10#1)
a 62-year-old##4##2##(1991-11#1)(1994-6#1)(2008-10#1)(2008-12#1)
a 63 years old##3##4##(1991-11#1)(2007-8#1)(2013-7#1)
a 63##4##2##(1991-11#1)(2007-8#1)(2010-12#1)(2013-7#1)
a 63-year-old woman##2##3##(2008-5#1)(2013-8#1)
a 63-year-old##3##2##(2008-5#1)(2012-12#1)(2013-8#1)
a 65%##2##2##(1991-8#1)(2008-10#1)
a 66-year-old man##2##3##(2009-1#1)(2012-12#1)
a 66-year-old woman##2##3##(1992-2#1)(2012-3#1)
a 66-year-old##5##2##(1992-2#1)(2009-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
a 67-year-old##3##2##(1991-8#1)(2008-7#1)(2013-1#1)
a 68-year-old##2##2##(2008-12#1)(2010-12#1)
a 69-year-old##2##2##(2008-7#1)(2010-6#1)
a 7##11##2##(1990-8#1)(1992-3#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#1)
a 7-day##2##2##(1992-12#1)(2008-10#1)
a 7-year##3##2##(1994-1#1)(2010-6#1)(2011-2#1)
a 70%##2##2##(2008-11#1)(2008-9#1)
a 70-80%##2##2##(1997-2#1)(2008-3#1)
a 70-year-old lady##2##3##(2008-12#1)(2013-1#1)
a 70-year-old woman with##2##4##(2011-2#1)(2012-3#1)
a 70-year-old woman##3##3##(1991-12#1)(2011-2#1)(2012-3#1)
a 70-year-old##7##2##(1991-12#1)(1992-2#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
a 72-h##2##2##(2008-10#2)
a 72-year-old female##2##3##(2011-2#1)(2012-12#1)
a 72-year-old woman who##2##4##(2007-8#1)(2008-7#1)
a 72-year-old woman##3##3##(2007-8#1)(2008-7#1)(2010-7#1)
a 72-year-old##7##2##(2007-8#1)(2008-12#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)
a 73##3##2##(1993-12#1)(1993-8#1)(1994-11#1)
a 74##2##2##(1992-10#1)(1996-3#1)
a 74%##2##2##(1991-8#1)(1994-12#1)
a 74-year-old woman##2##3##(2009-1#1)(2012-12#1)
a 74-year-old##3##2##(2009-1#1)(2011-2#1)(2012-12#1)
a 75%##2##2##(2008-10#1)(2008-11#1)
a 75-year-old##2##2##(1991-11#1)(2008-7#1)
a 78-kDa##2##2##(1993-12#2)
a 9##7##2##(1993-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
a 9-month##2##2##(1993-12#1)(2010-6#1)
a 9-point##2##2##(2010-12#2)
a 9-year-old boy##3##3##(1994-3#1)(2008-10#1)(2013-1#1)
a 90%##4##2##(2008-10#2)(2008-12#1)(2010-5#1)
a 91-year-old##2##2##(1996-5#1)(2008-11#1)
a 94-kDa##2##2##(2008-10#2)
a 95% confidence level with##2##5##(2008-10#2)
a 95% confidence level##8##4##(2008-10#8)
a 95% confidence##9##3##(1991-7#1)(2008-10#8)
a 95%##11##2##(1991-7#1)(2008-10#10)
a 96-well microtiter plate##2##4##(2008-10#1)(2008-9#1)
a 96-well##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
a 99 kDa##2##3##(1991-9#2)
a 99##4##2##(1991-9#2)(2008-10#2)
a =##5##2##(1992-11#1)(1992-12#1)(1992-9#1)(1996-5#1)(2008-8#1)
a AgGaSe(2) crystal##2##3##(2008-2#2)
a AgGaSe(2)##3##2##(2008-2#3)
a B##7##2##(1993-12#1)(2008-10#4)(2008-5#1)(2008-9#1)
a B-cell##2##2##(2008-10#1)(2009-8#1)
a BAC##3##2##(2008-4#1)(2008-9#1)(2012-3#1)
a BCL2 GR##3##3##(2009-8#3)
a BCL2##4##2##(2009-8#4)
a BMI greater than##2##4##(2008-1#2)
a Bachelor of Nursing degree##2##5##(2008-12#2)
a Bacillus##2##2##(1991-6#1)(2008-10#1)
a Bayesian##7##2##(1994-9#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2013-1#1)
a Biocontrol Agent##2##3##(2008-10#2)
a Biocontrol##3##2##(2008-10#3)
a BmNPV##2##2##(1997-3#2)
a Boeing##2##2##(1996-12#1)(2008-11#1)
a British##4##2##(1993-12#2)(2008-10#1)(2008-12#1)
a Broad##2##2##(2008-10#2)
a Broadband##2##2##(2008-3#2)
a C##9##2##(1994-12#1)(2008-10#7)(2008-8#1)
a C(18) column and##3##4##(2008-10#2)(2012-2#1)
a C(18) column##7##3##(2008-10#6)(2012-2#1)
a C(18)##16##2##(2008-10#14)(2009-8#1)(2012-2#1)
a C(8) column##2##3##(2008-10#2)
a C-18##5##2##(2008-10#5)
a C-shaped##2##2##(2011-2#2)
a C-terminal##13##2##(1991-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-6#2)(2009-9#1)(2012-2#1)
a C/EBP binding site##2##4##(1990-5#2)
a C1##2##2##(2008-10#2)
a C18 column##3##3##(2008-10#3)
a C18##5##2##(1993-11#1)(2008-10#3)(2011-3#1)
a C3 ketone##3##3##(1997-1#3)
a C3##4##2##(1997-1#3)(2008-10#1)
a CAAT box##2##3##(1993-6#2)
a CAAT##3##2##(1993-6#2)(1997-7#1)
a CC chemokine##2##3##(2010-5#2)
a CCD array##2##3##(2008-10#1)(2008-3#1)
a CCD camera##3##3##(2008-10#2)(2008-3#1)
a CCD##6##2##(2008-10#4)(2008-3#2)
a CCK-B receptor antagonist##2##4##(1995-12#2)
a CD##2##2##(1990-8#1)(2008-12#1)
a CD-ROM##2##2##(1993-1#1)(2008-11#1)
a CHIN##3##2##(1996-1#3)
a CHO cell line##5##4##(1990-8#1)(2008-11#3)(2011-2#1)
a CHO##6##2##(1990-8#1)(2008-11#4)(2011-2#1)
a CL##2##2##(2008-10#2)
a CL-HPLC##2##2##(2008-5#2)
a CNS##2##2##(2008-7#1)(2011-2#1)
a CO##3##2##(1992-3#1)(2008-2#1)(2008-3#1)
a CO(2) laser##2##3##(2008-3#2)
a CO(2)##5##2##(2008-11#1)(2008-3#4)
a CPP##2##2##(1993-6#1)(1994-2#1)
a CQI##2##2##(1995-12#1)(1996-1#1)
a CRDS##3##2##(2008-2#3)
a CSF##2##2##(1994-8#1)(2011-2#1)
a CT scan##3##3##(1990-12#1)(1990-6#1)(2013-1#1)
a CT##5##2##(1990-12#1)(1990-6#1)(1994-12#1)(1997-2#1)(2013-1#1)
a CWP##3##2##(2008-10#3)
a Ca(2+)##2##2##(2008-10#1)(2008-11#1)
a Ca(2+)-dependent##3##2##(1992-6#1)(1994-8#1)(1996-2#1)
a Ca2+##8##2##(1990-2#1)(1990-8#1)(1994-11#2)(1994-2#1)(1995-11#2)(1996-2#1)
a California##4##2##(1992-2#1)(1995-12#2)(2008-10#1)
a Canadian##9##2##(1992-12#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
a Catholic##2##2##(1993-12#1)(1994-1#1)
a Ce##2##2##(2008-3#1)(2011-2#1)
a Chinese hamster ovary (CHO) cell##2##6##(2008-11#1)(2008-7#1)
a Chinese hamster ovary##3##4##(2008-11#2)(2008-7#1)
a Chinese##13##2##(1991-6#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#5)(2013-8#1)
a Colletotrichum##2##2##(2008-10#2)
a Congressional##2##2##(2009-6#1)(2012-3#1)
a Conserved##2##2##(2008-10#1)(2012-2#1)
a Cr(4+)##3##2##(2007-12#1)(2008-2#2)
a Crataegus##2##2##(1992-5#1)(2008-10#1)
a Cs(+)-selective electrode##2##3##(2008-10#2)
a Cu electrode##2##3##(2008-10#2)
a Cys##2##2##(1993-11#1)(1994-12#1)
a DA##2##2##(2008-10#1)(2010-12#1)
a DDR2##2##2##(2012-2#2)
a DNA fragment containing the R##2##6##(1993-6#2)
a DNA fragment##6##3##(1993-6#2)(1993-8#1)(1996-6#1)(1997-2#1)(2008-10#1)
a DNA probe##2##3##(1990-5#1)(2008-10#1)
a DNA sequence##5##3##(1992-8#1)(1993-6#1)(2008-10#2)(2008-8#1)
a DNA##41##2##(1990-5#2)(1990-6#1)(1991-5#1)(1992-8#1)(1993-6#3)(1993-8#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-4#4)(2008-7#1)(2008-8#1)(2011-2#1)
a Difference curriculum##2##3##(2008-11#2)
a Difference##8##2##(2008-11#8)
a Diode-Pumped##2##2##(2008-3#2)
a Diploma in##4##3##(2008-11#3)(2013-1#1)
a Disordered##2##2##(1996-9#2)
a Distinct##3##2##(2008-10#3)
a Drosophila##4##2##(1993-2#1)(1996-12#1)(2008-8#1)(2008-9#1)
a European##5##2##(1994-12#1)(1996-6#1)(2008-10#2)(2011-2#1)
a FACS##2##2##(2008-11#1)(2008-4#1)
a FIA system##2##3##(2008-10#2)
a FIA##6##2##(2008-10#6)
a Fabry-Perot interferometer##4##3##(2008-3#4)
a Fabry-Perot##9##2##(2008-2#3)(2008-3#6)
a Fourier transform spectrometer##2##4##(2008-3#2)
a Fourier transform##3##3##(2008-10#1)(2008-3#2)
a Fourier##6##2##(2008-10#1)(2008-3#5)
a Fourier-transform infrared spectrometer##2##4##(2008-3#2)
a Fourier-transform infrared##3##3##(2008-3#3)
a Fourier-transform##4##2##(2008-3#4)
a French##5##2##(2008-3#1)(2008-7#2)(2010-6#1)(2011-2#1)
a Fusarium##5##2##(2008-10#5)
a G protein##6##3##(1993-6#1)(1993-9#1)(1994-3#1)(1995-8#1)(1997-7#2)
a G##9##2##(1993-6#1)(1993-9#1)(1994-3#1)(1995-6#2)(1995-8#2)(1997-7#2)
a GC##3##2##(2008-10#3)
a GFD##2##2##(2011-2#2)
a GFP reporter gene##2##4##(2008-10#2)
a GFP##3##2##(2008-10#3)
a GTP-binding protein##2##3##(1992-8#1)(1995-8#1)
a GaAs##2##2##(2008-2#1)(2008-3#1)
a Gaussian beam##3##3##(2008-3#3)
a Gaussian##11##2##(2008-2#1)(2008-3#9)(2012-3#1)
a Gene##4##2##(2008-10#4)
a German population##2##3##(2008-12#2)
a German##3##2##(2008-10#1)(2008-12#2)
a Gram-positive##5##2##(2011-2#4)(2012-3#1)
a HNO(3)##2##2##(2008-10#2)
a HPLC method##2##3##(2008-10#2)
a HPLC##5##2##(2008-10#5)
a He-Ne laser##2##3##(2008-3#2)
a Health Maintenance Organization##2##4##(2010-8#2)
a Health##5##2##(1991-2#2)(1994-12#1)(2010-8#2)
a Henyey-Greenstein phase function##2##4##(2008-3#2)
a Hg(II)##2##2##(2008-10#2)
a Hopf bifurcation##2##3##(2013-8#2)
a Human##2##2##(2008-11#2)
a Hypersensitive Response in##2##4##(2008-10#2)
a Hypersensitive Response##3##3##(2008-10#3)
a Japanese##5##2##(2008-10#3)(2010-10#1)(2013-1#1)
a K(i) of##2##3##(2008-11#2)
a KBD-affected diet##2##3##(2011-2#2)
a Km of##3##3##(1992-6#1)(1994-6#1)(2008-7#1)
a Km##6##2##(1991-12#1)(1992-3#1)(1992-6#1)(1994-6#2)(2008-7#1)
a Korean isolate##2##3##(2008-10#2)
a Korean##6##2##(1994-11#2)(2008-10#3)(2011-2#1)
a LED##2##2##(2008-10#1)(2008-3#1)
a LOD of##3##3##(2008-10#3)
a LOD##4##2##(2008-10#4)
a Lactobacillus##2##2##(2012-2#2)
a Lambertian##4##2##(2008-3#4)
a LiTaO(3)##2##2##(2008-2#1)(2008-3#1)
a Likert scale##2##3##(1991-2#1)(2008-9#1)
a Linear##2##2##(1996-9#1)(2008-11#1)
a Long##3##2##(2009-9#1)(2011-2#1)(2012-3#1)
a M##3##2##(2008-10#3)
a MADRS total score less or equal to##2##8##(2012-3#2)
a MADS-box gene##2##3##(2008-8#2)
a MEK##2##2##(1995-2#1)(1996-2#1)
a MEKK##2##2##(1995-2#2)
a MIG would##2##3##(1992-2#2)
a MIG##3##2##(1992-2#3)
a MOI of##3##3##(2008-11#3)
a MOI##4##2##(2008-11#4)
a Majocchi granuloma##4##3##(2012-3#4)
a Major Gene##2##3##(2008-10#2)
a Major##3##2##(2008-10#3)
a Markov##2##2##(2009-4#1)(2013-8#1)
a Med-El##2##2##(2008-9#2)
a Medicaid##3##2##(1991-2#1)(1995-1#1)(2009-6#1)
a Medicare##4##2##(1992-2#2)(1994-12#1)(1995-1#1)
a Mediterranean##2##2##(2008-10#2)
a Michaelis##2##2##(1993-8#1)(1994-5#1)
a Model for##2##3##(2008-11#1)(2012-12#1)
a Monte Carlo##2##3##(2008-3#1)(2009-11#1)
a Mycosphaerella teleomorph##2##3##(2008-10#2)
a Mycosphaerella##3##2##(2008-10#3)
a N(2)##2##2##(2008-10#1)(2008-3#1)
a NADP(+) -specific IDH##2##4##(2012-5#2)
a NADPH##2##2##(1995-8#1)(2009-8#1)
a NASA##2##2##(2008-2#1)(2008-3#1)
a NIR##2##2##(2008-10#2)
a NIST##2##2##(2008-10#2)
a Na+##2##2##(1997-8#2)
a NaOH##2##2##(2008-10#2)
a Nafion membrane##2##3##(2008-10#2)
a Nafion(R)/lead-ruthenium oxide pyrochlore chemically modified electrode##2##7##(2008-10#2)
a National Environmental Health Action Plan##2##6##(2008-1#2)
a National##3##2##(2008-1#3)
a Nd##14##2##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#7)
a Nernstian response for##10##4##(2008-10#10)
a Nernstian response to##2##4##(2008-10#2)
a Nernstian response##16##3##(2008-10#16)
a Nernstian slope of 19##2##5##(2008-10#2)
a Nernstian slope of 29##4##5##(2008-10#4)
a Nernstian slope of##16##4##(2008-10#16)
a Nernstian##35##2##(2008-10#35)
a New Subgroup##2##3##(2008-10#2)
a New Zealand##2##3##(1992-1#2)
a New##25##2##(1992-1#4)(1996-5#2)(2008-10#14)(2008-11#1)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
a Nigerian##4##2##(2012-12#3)(2013-1#1)
a Nordic Journal of Psychiatry##2##5##(2011-4#2)
a Nordic expert group##2##4##(1990-11#1)(2008-10#1)
a Nordic##6##2##(1990-11#1)(2008-10#2)(2011-4#3)
a North American##2##3##(1993-12#1)(2011-2#1)
a North##4##2##(1993-12#1)(2008-11#1)(2010-8#1)(2011-2#1)
a Novel##9##2##(1996-5#2)(2008-10#6)(2011-2#1)
a Nucleus##4##2##(2008-9#4)
a Nursing undergraduate##2##3##(2012-3#2)
a P##9##2##(1995-2#3)(2008-10#5)(2008-7#1)
a PBL##2##2##(2008-11#1)(2011-1#1)
a PC##2##2##(2008-10#1)(2010-9#1)
a PCMH##2##2##(2012-3#2)
a PCR product##2##3##(1993-12#1)(2008-10#1)
a PCR##8##2##(1990-8#1)(1993-12#1)(1997-2#1)(2008-10#4)(2008-8#1)
a PCR-amplified DNA fragment##2##4##(1993-12#1)(2008-10#1)
a PCR-amplified##3##2##(1993-12#1)(1997-4#1)(2008-10#1)
a PCR-based assay##2##3##(2008-10#1)(2008-4#1)
a PCR-based##4##2##(1995-11#1)(1997-8#1)(2008-10#1)(2008-4#1)
a PDMS##2##2##(2008-10#2)
a PEP##2##2##(2009-12#2)
a PFO##2##2##(2008-7#2)
a PKC inhibitor##2##3##(1995-11#1)(1997-1#1)
a PKC##3##2##(1995-11#1)(1997-1#2)
a PM##2##2##(1994-12#1)(2008-7#1)
a PPO##2##2##(1992-2#2)
a PR-5##2##2##(2008-10#2)
a PTFE membrane##3##3##(2008-10#3)
a PTFE##8##2##(2008-10#8)
a PVA##2##2##(2008-10#2)
a PVC##6##2##(2008-10#6)
a Pacific##3##2##(1995-11#1)(2008-1#2)
a Pediatric##2##2##(1993-9#1)(1995-11#1)
a Plackett-Burman design##2##3##(2008-10#2)
a Plackett-Burman##3##2##(2008-10#3)
a Possible##2##2##(2008-10#1)(2013-7#1)
a Potential##2##2##(2008-10#2)
a Prussian Blue##2##3##(2008-10#2)
a Pseudomonas putida##2##3##(2008-7#1)(2011-2#1)
a Pseudomonas##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
a Pt electrode##2##3##(2008-10#2)
a Pt##7##2##(2008-10#7)
a Putative##3##2##(2008-10#1)(2010-10#1)(2012-3#1)
a Q-switched diode-pumped Nd##2##4##(2008-3#2)
a QTL##2##2##(2008-10#2)
a R##22##2##(1997-2#1)(2008-10#21)
a RA##2##2##(2007-8#1)(2008-10#1)
a RAPD##2##2##(2008-10#2)
a Raman##4##2##(1992-4#1)(2007-12#1)(2008-10#2)
a Recombinant##2##2##(2008-10#2)
a Rev-dependent##2##2##(1995-2#1)(2011-3#1)
a Risk##2##2##(2011-2#1)(2013-1#1)
a S##2##2##(1996-6#1)(2008-10#1)
a SIA##2##2##(2008-10#2)
a SPE##2##2##(2008-10#2)
a SUN##2##2##(2008-9#2)
a Saturable Absorber##2##3##(2008-3#2)
a Scatchard##2##2##(1997-2#1)(2008-10#1)
a Schwann##2##2##(1995-2#1)(2008-7#1)
a Setaria isolate (pathogenic on foxtail millet)##2##7##(2008-10#2)
a Single##4##2##(1996-9#1)(2008-10#3)
a Small##4##2##(1997-3#1)(2008-10#1)(2008-5#1)(2009-10#1)
a Soil##2##2##(2008-10#2)
a South##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)
a Southeastern##3##2##(1995-6#1)(1996-1#1)(2012-2#1)
a Soxhlet##3##2##(2008-10#3)
a Species##2##2##(2008-10#2)
a Stokes##2##2##(1990-11#1)(2007-12#1)
a Strong##2##2##(1994-12#1)(2012-3#1)
a Support##2##2##(2008-4#1)(2010-8#1)
a Swedish##3##2##(1997-5#1)(2008-11#1)(2008-12#1)
a T cell##3##3##(1997-7#1)(2008-9#1)(2013-1#1)
a T##7##2##(1990-9#1)(1992-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
a T(m) of##2##3##(2011-1#2)
a T--&gt##2##2##(1994-11#2)
a T-cell lymphoma##2##3##(1991-12#1)(1995-1#1)
a T-cell##5##2##(1991-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(2009-1#1)
a T-dependent##2##2##(2008-10#2)
a T-flask##3##2##(2008-11#3)
a T7 RNA##2##3##(1993-8#1)(2008-10#1)
a TB##3##2##(1996-11#1)(1996-3#1)(2011-2#1)
a TBI##2##2##(2009-10#2)
a Teflon##2##2##(2008-10#2)
a Ti##3##2##(2008-10#1)(2008-3#2)
a Triticum isolate (pathogenic on wheat)##3##6##(2008-10#3)
a Triticum isolate##4##3##(2008-10#4)
a U##5##2##(1991-2#1)(1992-1#1)(2010-6#1)(2013-8#2)
a UV absorption##2##3##(2008-10#2)
a UV detector##5##3##(2008-10#5)
a UV irradiation##2##3##(1995-11#1)(2008-10#1)
a UV##13##2##(1995-11#1)(2008-10#11)(2008-11#1)
a University##2##2##(1995-12#1)(2008-12#1)
a V##3##2##(2009-6#2)(2013-1#1)
a VCG##2##2##(2008-10#2)
a Venezuelan oil##2##3##(2011-2#2)
a Vibrio##3##2##(2008-10#2)(2009-6#1)
a Virulent Strain##2##3##(2008-10#2)
a Web##3##2##(2008-11#1)(2008-9#2)
a Web-based##3##2##(2008-12#1)(2010-8#1)(2013-1#1)
a Workshop##2##2##(2008-10#2)
a World##2##2##(2008-10#1)(2008-4#1)
a Worldwide Collection of##3##4##(2008-10#3)
a Xenopus##2##2##(1993-2#1)(1995-2#1)
a YAC##3##2##(1996-12#1)(1996-6#1)(1997-8#1)
a Zea##2##2##(1995-12#1)(2012-3#1)
a and b##7##3##(1991-3#1)(1995-2#1)(2008-10#4)(2010-5#1)
a and##18##2##(1991-3#2)(1995-2#1)(1995-6#1)(1995-9#1)(1997-7#2)(2008-10#7)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#1)
a approximately##2##2##(2008-10#1)(2008-11#1)
a baby with##3##3##(1996-2#1)(2008-11#2)
a baby##7##2##(1992-2#1)(1996-2#1)(2008-11#3)(2008-5#1)(2011-2#1)
a baccalaureate##2##2##(2008-11#2)
a bachelor's degree##2##3##(1994-12#1)(2010-11#1)
a back pain##2##3##(1995-2#1)(2007-11#1)
a back##3##2##(1995-2#1)(1997-7#1)(2007-11#1)
a background electrolyte##2##3##(2008-10#2)
a background of##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
a background##7##2##(2008-10#5)(2008-11#1)(2008-8#1)
a backward##3##2##(1994-9#1)(2008-10#1)(2011-2#1)
a bacterial artificial chromosome##2##4##(2008-10#1)(2008-8#1)
a bacterial##13##2##(1990-11#1)(1995-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-8#1)
a bacterium##7##2##(1997-1#1)(2008-10#4)(2008-8#2)
a baculovirus expression system##3##4##(1992-10#1)(1993-6#1)(2008-11#1)
a baculovirus expression vector##3##4##(1993-6#1)(2008-11#2)
a baculovirus expression##6##3##(1992-10#1)(1993-6#2)(2008-11#3)
a baculovirus system##2##3##(1992-10#1)(1992-3#1)
a baculovirus##13##2##(1992-10#2)(1992-3#1)(1993-6#2)(2008-11#7)(2008-7#1)
a bad##8##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2012-3#1)
a badge##2##2##(2008-10#1)(2008-8#1)
a bafilomycin A1-sensitive##2##3##(1994-6#2)
a balance between##6##3##(1993-12#2)(2008-11#2)(2008-8#1)(2008-9#1)
a balance##8##2##(1993-12#2)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
a balanced##7##2##(1991-9#1)(1993-12#1)(1994-1#1)(1995-12#1)(2008-10#1)(2011-2#2)
a ball##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
a balloon##6##2##(1992-3#1)(1996-6#1)(2008-3#1)(2010-12#1)(2013-1#2)
a bamboo pulp##2##3##(2008-10#2)
a band of##3##3##(1991-12#1)(2008-10#1)(2013-1#1)
a band##5##2##(1991-12#1)(2008-10#3)(2013-1#1)
a bare##7##2##(1997-2#2)(2008-10#5)
a barley##5##2##(1995-6#1)(2008-10#3)(2008-8#1)
a barrier to##6##3##(1994-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
a barrier##11##2##(1990-6#1)(1994-11#1)(1994-3#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#2)
a basal medium##2##3##(2008-10#2)
a basal##6##2##(1992-8#1)(2008-10#2)(2008-6#1)(2013-1#2)
a base##7##2##(1993-8#2)(2008-10#2)(2008-5#2)(2009-1#1)
a baseline defined at##2##4##(2008-10#2)
a baseline established between##4##4##(2008-10#4)
a baseline##14##2##(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#10)(2008-6#1)
a basement membrane##2##3##(2008-7#1)(2011-2#1)
a basic principle##2##3##(1992-1#1)(2008-12#1)
a basic understanding of##2##4##(1997-1#1)(1997-7#1)
a basic##33##2##(1991-12#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-4#3)(2008-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
a basilar artery##3##3##(1997-6#1)(2011-2#2)
a basilar##4##2##(1997-6#2)(2011-2#2)
a basis for a##2##4##(1991-6#1)(2008-10#1)
a basis for constructing##2##4##(1997-6#1)(2010-8#1)
a basis for discussion##2##4##(2008-10#1)(2008-11#1)
a basis for future##2##4##(2008-10#1)(2010-12#1)
a basis for the development of##2##6##(2008-11#1)(2010-12#1)
a basis for the##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
a basis for##30##3##(1991-11#1)(1991-6#1)(1993-12#1)(1994-9#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#5)(2010-12#4)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
a basis in##2##3##(2008-9#1)(2010-7#1)
a basis##36##2##(1991-11#1)(1991-6#1)(1993-12#1)(1994-9#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#6)(2008-8#2)(2008-9#2)(2010-12#4)(2010-7#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
a batch culture##2##3##(2008-11#2)
a batch method##2##3##(2008-10#2)
a batch or##2##3##(2008-10#1)(2008-11#1)
a batch##15##2##(2008-10#9)(2008-11#3)(2008-7#3)
a battery of##3##3##(2008-11#1)(2009-10#2)
a bead##2##2##(2008-6#1)(2012-2#1)
a beam##3##2##(2008-3#3)
a bed of##2##3##(2008-10#2)
a bed##3##2##(1991-2#1)(2008-10#2)
a behavior##6##2##(1991-8#1)(1992-9#1)(2008-4#1)(2008-8#1)(2013-8#2)
a behavioral trait##2##3##(2008-8#1)(2008-9#1)
a behavioral##7##2##(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-8#1)
a benchmark##4##2##(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)
a benchmarking##2##2##(1996-1#1)(2008-11#1)
a beneficial effect of##3##4##(1992-12#1)(2013-1#2)
a beneficial effect on the##2##5##(1991-11#1)(2009-7#1)
a beneficial effect on##6##4##(1991-11#1)(2008-11#1)(2009-7#1)(2011-2#2)(2012-3#1)
a beneficial effect##9##3##(1991-11#1)(1992-12#1)(2008-11#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
a beneficial impact on##2##4##(2008-11#1)(2009-8#1)
a beneficial##17##2##(1991-11#1)(1991-3#1)(1991-6#1)(1992-12#1)(1997-1#1)(2008-11#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
a benefit##2##2##(2008-11#1)(2011-1#1)
a benign lesion##2##3##(1990-12#1)(2012-3#1)
a benign tumor##3##3##(2008-10#1)(2008-12#2)
a benign##21##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-4#1)(1994-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
a best##5##2##(2008-11#1)(2008-2#1)(2010-10#3)
a beta##3##2##(2008-10#2)(2010-6#1)
a beta-binomial distribution##3##3##(2008-10#3)
a beta-blocker##2##2##(1995-2#1)(2008-10#1)
a beta-cyclodextrin##2##2##(2008-10#2)
a beta-galactosidase##2##2##(1997-3#1)(2008-11#1)
a beta-lactam antibiotic##2##3##(2008-10#2)
a beta-tubulin##2##2##(2008-9#2)
a beta-turn##4##2##(1991-10#2)(1991-6#2)
a better appreciation of##3##4##(2008-10#1)(2008-8#1)(2009-3#1)
a better approach##2##3##(1991-2#1)(1996-1#1)
a better cue##2##3##(2013-8#2)
a better description of##2##4##(2008-9#1)(2012-2#1)
a better fit##2##3##(1995-12#1)(2008-10#1)
a better future##2##3##(1991-2#1)(2008-10#1)
a better insight##2##3##(2008-10#1)(2008-11#1)
a better knowledge of the##2##5##(1990-12#1)(1992-12#1)
a better outcome##3##3##(1992-9#1)(2008-11#1)(2008-7#1)
a better precision##2##3##(2008-10#2)
a better predictor of##2##4##(2010-8#1)(2012-3#1)
a better predictor##3##3##(1991-2#1)(2010-8#1)(2012-3#1)
a better prognosis##3##3##(1992-9#1)(1993-1#1)(1994-6#1)
a better quality of life##2##5##(1991-2#1)(2011-2#1)
a better response to##2##4##(1990-9#1)(1991-2#1)
a better selectivity for##2##4##(2008-10#2)
a better understanding of the role of##2##7##(1995-12#1)(2009-12#1)
a better understanding of the##24##5##(1990-11#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-9#1)(2011-2#3)(2013-8#1)
a better understanding of##35##4##(1990-11#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a better understanding##37##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a better working##3##3##(2008-10#1)(2012-3#2)
a better##123##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#5)(1991-6#1)(1992-12#1)(1992-9#2)(1993-1#1)(1994-1#1)(1994-2#1)(1994-6#2)(1995-12#2)(1995-3#1)(1996-1#1)(1997-2#2)(1997-3#1)(2007-8#1)(2008-10#31)(2008-11#13)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#10)(2011-7#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#4)
a bi-directional##2##2##(2008-10#1)(2010-8#1)
a bias in size##2##4##(2013-8#2)
a bias in##3##3##(1995-8#1)(2013-8#2)
a bias##7##2##(1995-8#1)(2008-3#1)(2013-1#2)(2013-8#3)
a biased##4##2##(2009-10#3)(2013-8#1)
a bibliographic revision##2##3##(2008-11#1)(2009-10#1)
a bibliographic##7##2##(1991-12#1)(2008-11#1)(2009-10#1)(2012-3#4)
a bidirectional##2##2##(2008-7#1)(2010-8#1)
a biennial##2##2##(2008-10#1)(2012-12#1)
a bifunctional toxin##2##3##(1990-8#2)
a bifunctional##6##2##(1990-8#2)(2008-10#2)(2008-4#1)(2011-1#1)
a bifurcated optical fiber##2##4##(2008-10#1)(2008-7#1)
a bifurcated##3##2##(2008-10#2)(2008-7#1)
a big diversity##2##3##(1997-8#2)
a big##6##2##(1994-3#1)(1997-8#2)(2008-10#1)(2009-10#1)(2013-1#1)
a bigger##3##2##(2008-10#1)(2009-10#2)
a bilateral increase##2##3##(1990-9#1)(1994-8#1)
a bilateral##9##2##(1990-9#2)(1994-12#1)(1994-8#1)(1996-2#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
a biliary##2##2##(1991-3#1)(1991-8#1)
a bill that##2##3##(1996-5#2)
a bill##3##2##(1995-6#1)(1996-5#2)
a billion##2##2##(1992-6#1)(2011-2#1)
a bimodal distribution##5##3##(2008-10#1)(2008-3#1)(2009-7#3)
a bimodal##8##2##(1993-6#1)(1996-12#1)(2008-10#2)(2008-3#1)(2009-7#3)
a binary##17##2##(1992-1#1)(1992-9#1)(1995-12#1)(2008-10#11)(2008-3#1)(2008-5#1)(2010-8#1)
a binding site for the##2##5##(1990-5#1)(2009-8#1)
a binding##11##2##(1990-12#1)(1990-5#1)(1992-6#1)(1994-5#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
a binomial##4##2##(2008-10#4)
a bioactive##7##2##(1995-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-3#1)(2012-2#1)
a bioassay##5##2##(2008-10#5)
a biochemical marker for##3##4##(1990-8#1)(2007-12#1)(2008-10#1)
a biochemical##11##2##(1990-5#1)(1990-8#1)(1992-10#1)(1992-7#1)(1992-9#1)(1993-8#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-4#1)
a biocontrol agent of##6##4##(2008-10#6)
a biocontrol agent##9##3##(2008-10#8)(2008-12#1)
a biocontrol fungus##2##3##(2008-10#2)
a biocontrol##14##2##(2008-10#13)(2008-12#1)
a biodegradable polymer##3##3##(2008-7#2)(2010-4#1)
a biogenic##2##2##(1997-1#1)(2008-3#1)
a biological assay##4##3##(1990-12#2)(1994-5#1)(2008-11#1)
a biological control agent for##3##5##(2008-10#3)
a biological control agent##4##4##(2008-10#4)
a biological tissue##2##3##(2007-12#1)(2009-10#1)
a biological##36##2##(1990-12#2)(1990-8#1)(1992-1#1)(1992-12#4)(1994-5#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
a biologically inactive##2##3##(2008-12#1)(2010-6#1)
a biologically##8##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)
a biomarker of##6##3##(2008-10#1)(2009-11#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
a biomarker##14##2##(2008-10#2)(2009-11#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-5#2)(2012-2#2)(2013-8#3)
a biomechanical##2##2##(2008-9#1)(2009-3#1)
a biomimetic##4##2##(1995-3#1)(2008-10#2)(2010-5#1)
a bioprocess##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
a biopsy for##3##3##(2012-2#3)
a biopsy##9##2##(1991-3#1)(2011-2#1)(2012-2#5)(2013-1#1)(2013-8#1)
a biopsychosocial model##2##3##(2008-4#1)(2009-9#1)
a bioreactor with##2##3##(2008-11#2)
a bioreactor##7##2##(2008-10#1)(2008-11#6)
a biosensor based on##2##4##(2008-10#2)
a biosensor for##2##3##(2008-10#2)
a biosensor method##2##3##(2008-10#2)
a biosensor##17##2##(2008-10#17)
a biotinylated polypyrrole##2##3##(2008-10#2)
a biotinylated##7##2##(1992-6#1)(1995-6#1)(2008-10#4)(2012-3#1)
a bipartite genome##2##3##(2008-10#2)
a bipartite##4##2##(1993-2#1)(2008-10#2)(2009-8#1)
a biphasic change##2##3##(1990-2#1)(2010-5#1)
a biphasic effect##2##3##(1994-3#1)(2012-4#1)
a biphasic pattern##2##3##(1993-11#1)(2008-1#1)
a biphasic##14##2##(1990-2#2)(1991-10#2)(1991-5#1)(1992-7#1)(1993-11#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-1#1)(2010-5#1)(2012-4#1)
a bipolar##2##2##(2009-10#1)(2013-1#1)
a bite by a tick##2##5##(1996-11#2)
a bivariate##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
a blank of##2##3##(2008-10#2)
a blank with the##2##4##(2008-10#2)
a blank##8##2##(2008-10#7)(2008-5#1)
a bleeding##2##2##(2008-7#1)(2013-1#1)
a blend of##2##3##(1993-1#1)(2009-8#1)
a blind##5##2##(1990-5#2)(1995-11#1)(1997-2#1)(2008-6#1)
a block of##2##3##(2008-10#2)
a block##5##2##(2008-10#3)(2008-12#1)(2010-2#1)
a blocking##4##2##(1990-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
a blood pressure##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
a blood##9##2##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)
a bloom##2##2##(1993-11#1)(2008-8#1)
a blue##8##2##(1990-2#1)(2008-10#6)(2008-7#1)
a blueprint for##5##3##(1994-12#2)(1995-1#1)(1995-12#1)(1997-3#1)
a blueprint##6##2##(1993-2#1)(1994-12#2)(1995-1#1)(1995-12#1)(1997-3#1)
a blunt##2##2##(1997-7#1)(2008-9#1)
a body mass index##2##4##(2008-11#2)
a body##7##2##(2008-10#2)(2008-11#2)(2009-8#1)(2011-2#1)(2013-8#1)
a bolus##2##2##(1993-1#1)(2011-2#1)
a bone graft##4##3##(1995-12#1)(2008-12#1)(2009-3#1)(2009-7#1)
a bone marrow stromal cell line##3##6##(2008-10#1)(2008-11#2)
a bone marrow##4##3##(2008-10#1)(2008-11#3)
a bone##11##2##(1995-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2013-1#1)
a booster dose##2##3##(1990-8#1)(2013-1#1)
a bootstrap confidence value of##2##5##(2008-10#2)
a borderline##2##2##(1997-3#1)(2008-12#1)
a boron##2##2##(2008-10#2)
a boron-doped diamond thin film##2##5##(2008-10#2)
a boron-doped diamond##3##3##(2008-10#3)
a botanical##2##2##(1993-11#1)(2013-8#1)
a bottleneck##2##2##(2008-10#1)(2008-11#1)
a bottom-up approach##2##3##(2011-2#1)(2012-2#1)
a boundary##4##2##(1995-6#1)(2008-10#1)(2008-4#1)(2010-10#1)
a bovine##6##2##(1991-5#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-6#1)
a boy##6##2##(1994-3#1)(1995-5#1)(1996-11#1)(2008-10#2)(2012-12#1)
a brain area##2##3##(2008-11#1)(2008-7#1)
a brain##10##2##(1991-11#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#1)(2011-3#1)(2013-8#2)
a branched##4##2##(1990-8#1)(1993-12#2)(2007-12#1)
a brand new##2##3##(2008-11#1)(2012-2#1)
a breakdown##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
a breast cancer screening##2##4##(2011-2#1)(2012-12#1)
a breast cancer##6##3##(1994-9#1)(1997-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
a breast screening##2##3##(1993-2#1)(2012-12#1)
a breast##12##2##(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
a bridge between the##2##4##(2008-10#1)(2012-3#1)
a bridge between##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
a bridge##10##2##(2008-10#6)(2008-11#2)(2011-2#1)(2012-3#1)
a brief but intensive##2##4##(2013-1#2)
a brief but##3##3##(2010-9#1)(2013-1#2)
a brief description of the##3##5##(1991-11#1)(2008-11#1)(2010-5#1)
a brief description of##5##4##(1991-11#1)(1996-2#1)(2008-11#1)(2008-8#1)(2010-5#1)
a brief discussion of the##2##5##(1990-5#1)(2008-11#1)
a brief discussion of##5##4##(1990-5#1)(2008-11#1)(2009-9#1)(2012-12#1)(2013-1#1)
a brief introduction to##3##4##(2008-7#1)(2009-9#1)(2012-2#1)
a brief introduction##4##3##(2008-7#1)(2009-9#1)(2010-8#1)(2012-2#1)
a brief overview of the##8##5##(1994-12#1)(1995-2#1)(2008-4#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#1)
a brief overview of##13##4##(1994-12#1)(1995-2#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
a brief overview##16##3##(1994-12#1)(1995-2#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
a brief review of the##4##5##(1990-12#1)(1993-6#1)(2009-5#1)(2010-8#1)
a brief review of##6##4##(1990-12#1)(1993-6#1)(2008-11#1)(2009-5#1)(2010-8#1)(2012-12#1)
a brief review##7##3##(1990-12#1)(1993-6#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-8#1)(2012-12#1)
a brief summary of the##2##5##(1997-3#1)(2012-2#1)
a brief##62##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-3#1)(2008-10#6)(2008-11#8)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#4)
a bright future##2##3##(1992-11#1)(2011-7#1)
a bright##7##2##(1991-5#1)(1992-11#1)(1995-2#1)(2008-3#2)(2008-8#1)(2011-7#1)
a broad maximum##2##3##(2008-10#2)
a broad pH range##2##4##(1991-5#1)(2006-6#1)
a broad perspective##2##3##(2008-10#1)(2011-2#1)
a broad range of pathogens##2##5##(2008-10#2)
a broad range of##38##4##(1995-2#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#13)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
a broad range##39##3##(1995-2#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#14)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
a broad spectrum of biological##2##5##(2008-10#1)(2010-4#1)
a broad spectrum of##17##4##(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
a broad variety of##2##4##(2008-9#1)(2009-10#1)
a broad##93##2##(1991-5#1)(1993-1#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-6#1)(2007-11#1)(2008-10#29)(2008-11#10)(2008-12#1)(2008-3#3)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#2)
a broad-area laser##2##3##(2008-3#2)
a broad-area##3##2##(2008-3#3)
a broad-spectrum##4##2##(2008-10#4)
a broadband##3##2##(2008-2#1)(2008-3#2)
a broader range##2##3##(2008-10#1)(2008-8#1)
a broader spectrum of##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
a broader understanding of##2##4##(2008-11#1)(2008-7#1)
a broader##23##2##(1993-2#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-7#1)(2013-1#3)
a broadly##3##2##(2008-3#1)(2009-12#1)(2011-9#1)
a broken##3##2##(2008-10#2)(2008-11#1)
a bromide##2##2##(2008-10#2)
a broth##2##2##(2008-10#1)(2008-12#1)
a brown##2##2##(2008-10#1)(2008-11#1)
a budget of##2##3##(1991-1#1)(1997-1#1)
a buffer##7##2##(2008-10#5)(2008-9#1)(2009-3#1)
a buffered solution##2##3##(2008-10#2)
a bulk acoustic wave##4##4##(2008-10#4)
a bulk acoustic##5##3##(2008-10#5)
a bulk of##2##3##(2010-1#1)(2010-10#1)
a bulk##13##2##(2008-10#10)(2008-3#1)(2010-1#1)(2010-10#1)
a bundle##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
a buoyant##3##2##(1996-12#1)(2008-10#2)
a burden##2##2##(2008-11#1)(2008-8#1)
a burst of##2##3##(1994-8#1)(2011-2#1)
a business##4##2##(1992-1#1)(1994-2#1)(2008-12#1)(2010-7#1)
a butterfly##2##2##(2008-8#1)(2013-1#1)
a buttock terotoma##2##3##(2012-12#2)
a by-product of##7##3##(1994-3#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)
a by-product##8##2##(1994-3#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)
a cDNA clone encoding##2##4##(1993-12#1)(1993-9#1)
a cDNA clone##4##3##(1993-12#1)(1993-9#1)(1995-8#1)(1997-7#1)
a cDNA coding for##3##4##(1991-9#1)(1995-2#1)(1996-2#1)
a cDNA encoding a##3##4##(1995-11#1)(1997-1#1)(2008-8#1)
a cDNA encoding human##4##4##(2008-8#4)
a cDNA encoding##14##3##(1993-12#1)(1993-3#2)(1994-11#2)(1995-11#1)(1997-1#1)(2008-5#1)(2008-6#1)(2008-8#5)
a cDNA library and##2##4##(2008-8#1)(2011-2#1)
a cDNA library derived from##2##5##(1992-9#1)(1993-6#1)
a cDNA library##8##3##(1992-9#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
a cDNA##44##2##(1990-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-6#2)(2008-8#7)(2008-9#3)(2011-2#1)
a cable##2##2##(2008-11#1)(2012-12#1)
a cadaver##2##2##(2008-10#1)(2008-12#1)
a cadre of##2##3##(1996-3#1)(2013-1#1)
a cage##2##2##(2010-5#2)
a calcified##2##2##(2008-10#1)(2013-8#1)
a calcium##10##2##(1990-2#1)(1990-5#1)(1991-6#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)
a calcium/calmodulin-dependent protein kinase II##2##5##(1996-2#1)(2008-8#1)
a calculated Mr of##2##4##(1990-11#1)(1990-5#1)
a calculated##10##2##(1990-11#1)(1990-5#1)(1993-3#1)(1993-9#1)(1995-6#1)(1996-6#1)(2008-10#3)(2009-12#1)
a calculator##3##2##(2008-11#3)
a calibrated##2##2##(1997-2#1)(2008-1#1)
a calibration curve by plotting the relative intensity of reflectance versus the##2##12##(2008-10#2)
a calibration curve by plotting the##3##6##(2008-10#3)
a calibration curve by##4##4##(2008-10#3)(2008-9#1)
a calibration curve##11##3##(2008-10#9)(2008-9#1)(2013-8#1)
a calibration graph##3##3##(2008-10#3)
a calibration model##3##3##(2008-10#3)
a calibration##28##2##(2008-10#26)(2008-9#1)(2013-8#1)
a call for an international coordinated effort in rice functional genomics##2##11##(2009-10#2)
a call for##3##3##(2009-10#2)(2011-1#1)
a call to##2##3##(1991-3#1)(2009-5#1)
a call##5##2##(1991-3#1)(2009-10#2)(2009-5#1)(2011-1#1)
a campus##2##2##(1991-2#1)(1996-12#1)
a canal##2##2##(2007-12#1)(2008-7#1)
a cancer treatment##2##3##(2008-11#1)(2011-2#1)
a cancer##8##2##(1995-9#1)(2008-10#1)(2008-11#2)(2010-5#1)(2010-8#1)(2011-2#2)
a candidate for##8##3##(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-9#1)(2012-2#1)
a candidate gene approach##2##4##(2008-10#1)(2009-10#1)
a candidate gene##5##3##(1992-3#1)(2008-10#1)(2009-10#2)(2012-3#1)
a candidate of##2##3##(1992-6#1)(2010-1#1)
a candidate tumor suppressor gene##2##5##(2008-9#1)(2009-9#1)
a candidate##30##2##(1992-3#1)(1992-6#1)(1993-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-9#2)(2010-1#1)(2011-3#1)(2012-2#1)(2012-3#2)
a canine model##3##3##(2009-8#3)
a canine##7##2##(1994-12#1)(2009-8#3)(2010-4#2)(2012-3#1)
a cannula##2##2##(2008-10#1)(2008-6#1)
a canonical##2##2##(1992-3#1)(2012-2#1)
a capacity of##4##3##(2008-10#4)
a capacity##6##2##(1990-5#1)(2008-10#4)(2008-8#1)
a capillary electrophoresis##4##3##(2008-10#4)
a capillary electrophoretic##2##3##(2008-10#2)
a capillary ion##2##3##(1997-2#1)(2008-10#1)
a capillary tube##2##3##(2008-2#2)
a capillary##25##2##(1997-2#3)(2008-10#17)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
a capstone course##2##3##(1993-1#2)
a car##2##2##(2008-10#1)(2008-11#1)
a carbohydrate##4##2##(1990-5#1)(2008-10#2)(2008-11#1)
a carbohydrate-binding##2##2##(2009-3#2)
a carbohydrate-restricted diet##4##3##(2008-3#4)
a carbon ceramic electrode##2##4##(2008-10#2)
a carbon electrode##3##3##(2008-10#3)
a carbon fiber##5##3##(2008-10#5)
a carbon paste electrode (CPE)##2##5##(2008-10#2)
a carbon paste electrode modified by##2##6##(2008-10#2)
a carbon paste electrode modified with organofunctionalized amorphous silica##2##9##(2008-10#2)
a carbon paste electrode modified with##8##6##(2008-10#8)
a carbon paste electrode modified##12##5##(2008-10#12)
a carbon paste electrode##20##4##(2008-10#20)
a carbon paste##23##3##(2008-10#23)
a carbon source##4##3##(2008-10#2)(2008-7#1)(2011-1#1)
a carbon##42##2##(1994-8#1)(2008-10#39)(2008-7#1)(2011-1#1)
a carboxylic##2##2##(2008-10#2)
a carcinogen##2##2##(1994-11#1)(2013-1#1)
a carcinogenic effect##2##3##(1995-11#1)(2008-10#1)
a carcinoid##3##2##(1990-2#1)(1992-5#1)(1997-1#1)
a carcinoma of the##2##4##(1997-8#2)
a carcinoma##4##2##(1990-9#1)(1992-2#1)(1997-8#2)
a card##2##2##(1996-2#1)(2008-11#1)
a cardiac##10##2##(1990-9#1)(2008-11#2)(2008-7#1)(2010-6#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a cardiovascular##3##2##(1993-3#1)(2009-10#1)(2010-6#1)
a care##2##2##(1995-12#1)(2008-11#1)
a career in##3##3##(1992-1#1)(1993-11#1)(1994-12#1)
a career##5##2##(1992-1#1)(1993-11#1)(1994-12#2)(2008-11#1)
a careful##10##2##(1991-6#1)(1992-9#1)(1993-11#1)(2008-7#1)(2009-7#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
a carefully##4##2##(1992-1#1)(2008-10#1)(2011-2#1)(2012-7#1)
a carotid artery reconstruction##2##4##(2008-7#2)
a carrier gas flow rate of##2##6##(2008-10#2)
a carrier gas##4##3##(2008-10#4)
a carrier of a##2##4##(1994-12#1)(1997-3#1)
a carrier of##4##3##(1994-12#1)(1997-3#1)(2008-10#1)(2008-8#1)
a carrier solution##3##3##(2008-10#3)
a carrier stream of##6##4##(2008-10#6)
a carrier stream##10##3##(2008-10#10)
a carrier##42##2##(1993-11#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-12#1)(1997-3#2)(2008-10#28)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)
a carrier-mediated##2##2##(1994-8#1)(2011-3#1)
a cascade of events##2##4##(1993-8#1)(2009-9#1)
a cascade of##3##3##(1993-8#1)(1994-6#1)(2009-9#1)
a cascade##5##2##(1993-8#1)(1994-6#1)(2008-6#1)(2008-7#1)(2009-9#1)
a case about]##2##3##(2013-1#2)
a case example##4##3##(1997-2#2)(2008-11#1)(2009-10#1)
a case for##4##3##(1994-1#1)(2008-1#1)(2008-7#1)(2010-9#1)
a case history of a##2##5##(1994-12#1)(2012-12#1)
a case in which the##2##5##(2012-12#1)(2013-8#1)
a case in which##7##4##(1992-2#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-8#1)
a case in##10##3##(1992-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a case involving a##2##4##(2009-9#1)(2010-8#1)
a case of a 16-year-old##2##5##(2012-3#1)(2013-1#1)
a case of a 72-year-old##2##5##(2008-12#1)(2010-6#1)
a case of a young##3##5##(2010-12#1)(2012-2#1)(2013-8#1)
a case of a##48##4##(1991-11#1)(1992-5#1)(1994-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-7#4)(2008-9#1)(2009-1#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#5)
a case of aggressive##2##4##(2007-8#1)(2011-2#1)
a case of an##9##4##(2007-8#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
a case of bilateral##4##4##(1994-12#1)(2008-9#1)(2010-5#1)(2013-1#1)
a case of cervical##2##4##(2012-3#2)
a case of chronic##3##4##(2008-11#1)(2011-2#2)
a case of congenital##3##4##(2008-12#1)(2010-11#1)(2012-3#1)
a case of cutaneous##3##4##(2008-10#1)(2010-11#1)(2010-6#1)
a case of giant##2##4##(2008-12#1)(2008-7#1)
a case of metastatic##2##4##(2010-6#1)(2011-2#1)
a case of painless##2##4##(2008-12#1)(2013-1#1)
a case of pneumocephalus##2##4##(2008-7#1)(2008-9#1)
a case of primary##9##4##(1990-2#1)(1991-6#1)(1992-2#1)(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-8#1)
a case of pulmonary##4##4##(2007-8#1)(2012-3#1)(2013-1#2)
a case of recurrent##2##4##(1993-1#1)(2008-11#1)
a case of severe##2##4##(2007-12#1)(2013-8#1)
a case of sigmoid##2##4##(2010-12#1)(2012-12#1)
a case of spontaneous##6##4##(1990-9#1)(1992-2#1)(2008-7#1)(2012-12#1)(2013-1#2)
a case of##247##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#4)(1991-8#1)(1992-2#3)(1992-5#2)(1992-9#2)(1993-1#1)(1993-3#1)(1994-12#2)(1994-6#1)(1994-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#9)(2008-12#25)(2008-5#3)(2008-7#12)(2008-8#1)(2008-9#4)(2009-1#4)(2009-11#2)(2009-12#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#5)(2010-3#5)(2010-5#2)(2010-6#9)(2010-7#2)(2010-8#2)(2011-1#7)(2011-2#25)(2012-12#14)(2012-2#6)(2012-3#13)(2013-1#24)(2013-8#9)
a case report and a review of literature##2##8##(2008-1#1)(2013-1#1)
a case report and a##3##5##(2008-1#1)(2013-1#2)
a case report and literature review##8##6##(2008-12#5)(2008-9#1)(2010-12#1)(2013-1#1)
a case report and review of the literature##8##8##(2008-10#1)(2008-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
a case report and review of##9##6##(2008-10#1)(2008-12#1)(2008-8#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
a case report and##21##4##(2008-1#1)(2008-10#1)(2008-12#6)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#6)
a case report of a##6##5##(2007-8#1)(2008-11#1)(2008-12#2)(2009-1#1)(2013-1#1)
a case report of an##2##5##(2008-12#1)(2013-1#1)
a case report of##11##4##(2007-8#1)(2008-11#1)(2008-12#3)(2009-1#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#2)
a case report##97##3##(1990-3#1)(1990-6#2)(1990-8#1)(1991-6#2)(1992-12#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#15)(2008-8#3)(2008-9#6)(2009-1#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#6)(2011-2#11)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#6)(2013-1#18)(2013-8#1)
a case report]##3##3##(2009-1#1)(2009-5#2)
a case series##6##3##(2008-12#2)(2009-6#1)(2010-9#1)(2012-2#2)
a case study from british columbia##2##6##(2009-3#2)
a case study from##3##4##(1995-3#1)(2009-3#2)
a case study in##4##4##(1995-3#1)(2008-11#2)(2010-10#1)
a case study of the##3##5##(1995-2#1)(2008-11#1)(2009-3#1)
a case study of##12##4##(1992-12#1)(1995-2#1)(1996-3#1)(1997-2#3)(2008-10#3)(2008-11#1)(2008-3#1)(2009-3#1)
a case study##45##3##(1991-2#2)(1992-12#2)(1993-1#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-3#1)(1997-2#4)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#8)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-3#3)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
a case that##6##3##(2008-10#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
a case with##9##3##(1991-6#1)(1992-5#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-1#1)(2011-1#1)(2012-3#1)
a case##463##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-6#7)(1991-8#1)(1992-12#4)(1992-2#4)(1992-5#3)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#4)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-3#1)(1996-9#2)(1997-2#6)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#23)(2008-11#22)(2008-12#49)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#15)(2008-8#5)(2008-9#13)(2009-1#6)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#7)(2010-5#3)(2010-6#10)(2010-7#6)(2010-8#3)(2010-9#3)(2011-1#14)(2011-2#39)(2011-3#1)(2012-12#21)(2012-2#11)(2012-3#22)(2013-1#49)(2013-8#14)
a case-control study##3##3##(1990-12#1)(1991-8#1)(2011-2#1)
a case-control##4##2##(1990-12#1)(1991-8#1)(2011-2#2)
a case]##4##2##(1990-9#1)(1991-6#1)(1996-2#1)(2013-1#1)
a casual##2##2##(2008-1#1)(2008-10#1)
a cat##4##2##(1992-5#1)(1993-12#1)(1995-1#1)(2012-3#1)
a catalyst for##3##3##(1995-2#1)(2008-10#2)
a catalyst##8##2##(1995-2#1)(2008-10#7)
a catalytic surface##2##3##(2008-10#2)
a catalytic##13##2##(2008-10#11)(2008-11#1)(2010-6#1)
a categorical##2##2##(2008-10#1)(2008-7#1)
a catheter##3##2##(2008-10#1)(2008-4#1)(2012-12#1)
a cathode##3##2##(2008-10#2)(2008-11#1)
a cathodic peak at##2##4##(2008-10#2)
a cathodic##4##2##(2008-10#4)
a cation exchange column##3##4##(2008-10#3)
a cation exchange##4##3##(2008-10#4)
a cation##6##2##(2008-10#6)
a cation-exchange##2##2##(2008-10#2)
a cationic dye##2##3##(2008-10#2)
a cationic gemini##2##3##(2008-10#2)
a cationic resin##2##3##(2008-10#2)
a cationic surfactant##9##3##(2008-10#9)
a cationic##29##2##(1995-8#1)(2008-10#27)(2009-12#1)
a causal agent of##2##4##(2008-10#2)
a causal agent##3##3##(2008-10#2)(2010-1#1)
a causal link##4##3##(2008-10#1)(2009-9#1)(2013-7#2)
a causal relationship##2##3##(1997-4#1)(2008-11#1)
a causal role in##2##4##(1990-5#1)(2008-10#1)
a causal##16##2##(1990-5#1)(1992-2#1)(1994-3#1)(1995-6#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-8#1)(2009-9#1)(2010-1#1)(2013-7#2)
a causative##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-5#1)(2013-1#1)
a cause for##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
a cause of##22##3##(1991-12#1)(1991-3#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-10#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)
a cause##26##2##(1991-12#1)(1991-3#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2010-10#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
a cautionary note##2##3##(2009-8#1)(2013-8#1)
a cavernous##2##2##(2008-10#1)(2012-3#1)
a cavity ringdown##2##3##(2008-2#1)(2008-3#1)
a cavity##5##2##(1996-5#1)(2008-2#1)(2008-3#2)(2008-7#1)
a ceiling##2##2##(1996-12#1)(2008-11#1)
a cell culture##4##3##(2008-11#4)
a cell death##2##3##(2008-10#1)(2008-5#1)
a cell density-dependent##3##3##(1993-8#2)(1995-2#1)
a cell is##2##3##(2008-2#1)(2008-7#1)
a cell line from##3##4##(1995-11#2)(2008-11#1)
a cell line##12##3##(1994-6#1)(1995-11#2)(1995-6#1)(2008-10#1)(2008-11#6)(2011-2#1)
a cell surface receptor##2##4##(1992-12#1)(1994-11#1)
a cell surface##4##3##(1992-12#1)(1994-11#1)(2008-10#1)(2008-11#1)
a cell type##2##3##(2008-11#1)(2008-7#1)
a cell wall##4##3##(2008-10#3)(2011-2#1)
a cell##79##2##(1991-8#1)(1992-12#2)(1993-8#3)(1994-11#2)(1994-6#1)(1995-11#3)(1995-2#1)(1995-6#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#15)(2008-11#23)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#7)(2009-5#1)(2010-12#1)(2011-2#4)(2013-1#1)
a cell-associated##2##2##(1990-2#1)(1992-10#1)
a cell-based##4##2##(1993-8#1)(2008-11#1)(2011-2#1)(2011-3#1)
a cell-cycle##3##2##(1993-9#1)(2008-11#1)(2008-9#1)
a cell-free system consisting of##2##5##(1991-5#1)(1993-8#1)
a cell-free system##9##3##(1990-5#2)(1991-5#1)(1993-8#2)(1995-6#1)(1996-2#1)(1997-7#2)
a cellular adhesion##2##3##(2008-11#2)
a cellular factor##2##3##(1995-2#1)(1995-6#1)
a cellular mechanism##2##3##(1997-2#1)(2009-8#1)
a cellular protein##2##3##(1997-1#1)(2008-11#1)
a cellular response##2##3##(2008-7#1)(2011-2#1)
a cellular##23##2##(1990-11#1)(1990-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
a cellulose##11##2##(1991-11#1)(2008-10#6)(2008-11#1)(2008-7#2)(2013-1#1)
a cement##2##2##(2008-10#2)
a cemented##2##2##(2009-7#1)(2013-1#1)
a center for##3##3##(1997-8#1)(2010-7#1)(2012-3#1)
a center##6##2##(1997-8#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-3#1)
a central action##2##3##(1996-12#1)(2011-2#1)
a central component##2##3##(2008-8#1)(2013-1#1)
a central composite design##8##4##(2008-10#8)
a central composite##9##3##(2008-10#8)(2008-11#1)
a central focus##2##3##(2008-11#1)(2012-2#1)
a central issue in##2##4##(2008-10#1)(2008-11#1)
a central role in determining the##2##6##(2008-8#1)(2009-10#1)
a central role in determining##3##5##(2008-8#1)(2009-10#1)(2013-1#1)
a central role in the##4##5##(1993-3#1)(1995-6#1)(1997-1#1)(2008-10#1)
a central role in##14##4##(1992-3#1)(1993-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-3#1)(2013-1#1)(2013-8#1)
a central role##19##3##(1991-5#1)(1992-3#1)(1993-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
a central theme##3##3##(2008-11#2)(2009-7#1)
a central##69##2##(1991-3#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#19)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
a centrifugal field##2##3##(2008-2#2)
a centrifugal##3##2##(2008-2#2)(2013-1#1)
a century ago##3##3##(1991-2#1)(1997-3#1)(2012-3#1)
a century##14##2##(1991-2#1)(1992-5#1)(1994-3#2)(1997-3#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2012-3#2)(2013-8#1)
a ceramic##2##2##(2008-10#2)
a cerebellar##3##2##(2009-1#1)(2012-2#1)(2012-3#1)
a cerebral infarction##5##3##(1997-5#4)(2011-2#1)
a cerebral##12##2##(1992-12#1)(1994-2#1)(1994-8#1)(1996-6#1)(1997-3#1)(1997-5#4)(2008-7#1)(2009-11#1)(2011-2#1)
a certain degree##3##3##(1990-11#1)(2008-10#1)(2008-12#1)
a certain extent##2##3##(2008-10#1)(2008-8#1)
a certain point##2##3##(2008-3#1)(2010-9#1)
a certain range##2##3##(2008-10#2)
a certain threshold##2##3##(1995-8#1)(2008-10#1)
a certain##45##2##(1990-11#1)(1991-8#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#6)(2008-9#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#3)(2012-3#1)
a certificate of##2##3##(1991-3#1)(1994-12#1)
a certificate##4##2##(1991-3#1)(1994-12#2)(2008-10#1)
a certified reference material of##3##5##(2008-10#3)
a certified reference material##10##4##(2008-10#10)
a certified reference##13##3##(2008-10#13)
a certified water##2##3##(2008-10#2)
a certified##19##2##(2008-10#19)
a cervical##10##2##(1992-5#1)(1996-6#1)(1997-6#1)(2009-10#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
a chair##2##2##(2010-4#1)(2013-8#1)
a challenge for the##6##4##(2008-11#2)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
a challenge for##11##3##(1992-1#1)(2008-11#2)(2009-6#1)(2009-7#1)(2010-5#2)(2012-12#1)(2012-3#1)(2013-8#2)
a challenge in##4##3##(1992-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
a challenge to the##2##4##(1992-1#1)(1995-6#1)
a challenge to##12##3##(1992-1#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#2)
a challenge##41##2##(1991-12#1)(1991-3#1)(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2009-6#1)(2009-7#1)(2010-5#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
a challenging problem##4##3##(2008-12#1)(2008-7#1)(2010-6#1)(2012-2#1)
a challenging task for##2##4##(2008-10#1)(2012-12#1)
a challenging task##7##3##(1996-1#1)(2008-10#3)(2008-5#1)(2009-12#1)(2012-12#1)
a challenging##23##2##(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
a chance for##2##3##(2008-8#1)(2011-2#1)
a chance to##3##3##(1997-3#1)(2008-12#1)(2013-8#1)
a chance##7##2##(1990-8#1)(1994-12#1)(1997-3#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
a change in diagnostic##2##4##(1991-9#1)(2008-11#1)
a change in practice##2##4##(2008-11#1)(2008-8#1)
a change in the##21##4##(1991-9#1)(1992-12#1)(1993-8#1)(1995-6#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#3)(2010-7#1)(2011-2#1)
a change in##50##3##(1990-11#1)(1991-2#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-3#1)(1993-8#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-10#15)(2008-11#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
a change may be##2##4##(2008-11#1)(2008-3#1)
a change of the##4##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
a change of##11##3##(1990-12#1)(1991-5#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#1)
a change##69##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-3#1)(1993-8#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#20)(2008-11#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2010-5#1)(2010-7#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
a changing environment##3##3##(1991-2#1)(1996-3#1)(2008-7#1)
a changing##7##2##(1991-2#1)(1992-11#1)(1993-12#1)(1996-3#1)(1997-3#1)(2008-7#1)(2012-7#1)
a channel##3##2##(1993-8#1)(1994-5#1)(2012-2#1)
a chaotic##3##2##(2008-10#2)(2008-9#1)
a chaperone##2##2##(2008-7#1)(2009-6#1)
a character##2##2##(2007-12#1)(2012-3#1)
a characteristic mass##3##3##(2008-10#3)
a characteristic of##6##3##(1990-11#1)(1991-8#1)(2007-12#1)(2008-10#2)(2008-12#1)
a characteristic##27##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-5#1)(1993-6#1)(1996-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-8#1)(2012-12#1)
a charge##5##2##(1995-11#1)(1996-5#1)(2008-10#3)
a charged membrane##2##3##(2008-7#2)
a charged##4##2##(1997-2#1)(2008-7#2)(2009-1#1)
a cheap##4##2##(1993-3#1)(2008-10#2)(2008-11#1)
a checklist##2##2##(1990-3#1)(1995-2#1)
a cheese##2##2##(2008-10#2)
a chelate with##2##3##(2008-10#2)
a chelate##5##2##(2008-10#5)
a chelating resin##5##3##(2008-10#5)
a chelating##14##2##(2008-10#14)
a chemical defense##2##3##(2008-10#1)(2008-8#1)
a chemical modifier##6##3##(2008-10#6)
a chemical reaction##3##3##(2008-10#2)(2008-7#1)
a chemical scoring and ranking##2##5##(2008-11#2)
a chemical sensor for##2##4##(2008-10#2)
a chemical sensor##3##3##(2008-10#3)
a chemical##35##2##(1991-9#1)(2008-10#19)(2008-11#5)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-9#1)(2012-2#1)
a chemically defined##2##3##(2008-11#1)(2008-5#1)
a chemically modified##4##3##(2008-10#4)
a chemically##7##2##(2008-10#5)(2008-11#1)(2008-5#1)
a chemiluminescence##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
a chemiluminescent##2##2##(2008-10#2)
a chemometric tool for##2##4##(2008-10#2)
a chemometric##3##2##(2008-10#3)
a chemometrical##2##2##(2008-10#2)
a chicken##4##2##(1997-9#1)(2008-10#1)(2008-11#2)
a chief##4##2##(1996-3#1)(2008-12#2)(2012-12#1)
a child who##3##3##(2009-9#1)(2010-6#1)(2011-2#1)
a child with a cochlear implant##2##6##(2008-9#2)
a child with##14##3##(1992-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#4)(2010-7#2)(2010-8#1)(2010-9#1)
a child##54##2##(1991-11#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-11#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-8#1)(2008-9#6)(2009-12#1)(2009-5#3)(2009-9#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#3)
a child's language##2##3##(2008-11#2)
a child's##15##2##(1992-2#1)(1994-3#1)(1995-1#1)(1997-6#1)(2008-11#3)(2008-12#1)(2008-9#1)(2009-9#3)(2011-1#1)(2011-2#1)(2012-3#1)
a children's hospital##2##3##(1991-1#1)(2008-11#1)
a children's##5##2##(1991-1#1)(1991-2#1)(1994-3#1)(1995-5#1)(2008-11#1)
a chimeric gene##3##3##(1993-12#1)(1994-5#2)
a chimeric##10##2##(1990-8#1)(1993-12#1)(1994-5#2)(1997-8#1)(2008-10#1)(2008-11#3)(2010-12#1)
a chip##5##2##(2008-10#5)
a chiral##11##2##(1996-5#1)(1997-2#1)(2008-10#9)
a chitinase##2##2##(2008-10#2)
a chloramphenicol##2##2##(1995-2#1)(1996-8#1)
a chlorate-resistant##2##2##(2008-10#2)
a chloride ion channel##2##4##(1995-12#1)(2011-3#1)
a chloride##4##2##(1995-12#1)(2008-10#1)(2008-9#1)(2011-3#1)
a choice of##2##3##(2008-9#2)
a choice##9##2##(2008-10#1)(2008-9#7)(2010-11#1)
a choosy##2##2##(2008-8#1)(2008-9#1)
a chromatographic separation##2##3##(2008-10#2)
a chromatographic##13##2##(2008-10#12)(2013-1#1)
a chromatomembrane cell##3##3##(2008-10#3)
a chromogenic##6##2##(2008-10#5)(2010-4#1)
a chromosomal##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)
a chromosome of size 4##2##5##(2011-2#2)
a chromosome##5##2##(1996-8#1)(2008-10#1)(2008-12#1)(2011-2#2)
a chromotropic acid##2##3##(2008-10#2)
a chronic disease##5##3##(1993-11#2)(1994-5#1)(1997-8#1)(2008-10#1)
a chronic illness##2##3##(2008-7#1)(2013-1#1)
a chronic inflammatory process##2##4##(2008-1#1)(2013-1#1)
a chronic inflammatory##7##3##(1994-5#1)(1997-8#1)(2008-1#1)(2009-10#1)(2012-3#1)(2013-1#2)
a chronic relapsing##2##3##(1991-2#1)(2009-7#1)
a chronic##40##2##(1990-3#1)(1991-2#1)(1992-5#1)(1993-11#2)(1993-9#1)(1994-5#3)(1995-12#1)(1997-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#4)
a chronically##3##2##(1992-12#1)(1997-8#1)(2013-1#1)
a circadian rhythm in##2##4##(1994-2#1)(2008-5#1)
a circadian rhythm##4##3##(1994-2#1)(1995-11#1)(2008-11#1)(2008-5#1)
a circadian##5##2##(1994-2#1)(1995-11#1)(2008-11#1)(2008-5#2)
a circle##2##2##(2008-8#1)(2011-2#1)
a circular##12##2##(1991-2#1)(2008-10#3)(2008-2#2)(2008-3#5)(2009-7#1)
a circulating hormone##2##3##(1991-5#1)(1992-6#1)
a circulatory flow injection method##2##5##(2008-10#2)
a cis-acting element##2##3##(1995-6#1)(2008-8#1)
a cis-acting##4##2##(1993-3#1)(1994-12#1)(1995-6#1)(2008-8#1)
a citrate synthase##2##3##(1997-4#2)
a citrus##2##2##(2008-10#2)
a clade##7##2##(2008-10#1)(2008-8#4)(2009-8#1)(2011-2#1)
a claim##2##2##(1992-9#1)(1995-12#1)
a class of##21##3##(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
a class##23##2##(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
a classic##6##2##(1996-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-7#1)
a classical least-squares##2##3##(2008-10#2)
a classical##28##2##(1990-10#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-5#1)(2008-10#9)(2008-11#2)(2008-5#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
a classification of##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
a classification system##3##3##(1993-1#1)(2008-12#2)
a classification##14##2##(1993-1#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
a clay##3##2##(2008-10#3)
a clean##7##2##(1997-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-2#1)
a clean-up method##2##3##(2008-10#2)
a clean-up##4##2##(2008-10#4)
a clear explanation##2##3##(2008-9#1)(2011-2#1)
a clear increase in##2##4##(1991-5#1)(2008-5#1)
a clear indication##2##3##(2008-10#1)(2008-9#1)
a clear relationship between##2##4##(2008-5#2)
a clear tendency towards##2##4##(1991-2#1)(1995-11#1)
a clear trend##2##3##(2008-12#1)(2010-7#1)
a clear understanding of the##2##5##(1997-1#1)(2010-3#1)
a clear understanding of##3##4##(1997-1#1)(2010-3#1)(2011-1#1)
a clear##57##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-2#1)(1991-5#1)(1993-3#1)(1993-8#1)(1995-11#1)(1997-1#1)(1997-3#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a clear-cut##5##2##(1995-2#1)(2008-10#2)(2008-8#1)(2013-1#1)
a clearer##5##2##(1991-1#1)(1996-3#1)(2008-10#1)(2008-6#1)(2008-9#1)
a clearly##2##2##(1995-12#1)(2008-10#1)
a climate##6##2##(1993-2#1)(2008-10#1)(2008-11#3)(2008-5#1)
a clinic##5##2##(1993-12#1)(1996-5#1)(1997-3#1)(2009-5#1)(2012-2#1)
a clinical and##5##3##(1994-12#1)(2008-5#1)(2011-2#2)(2012-12#1)
a clinical case of##2##4##(1990-5#1)(2013-1#1)
a clinical case##3##3##(1990-5#2)(2013-1#1)
a clinical case]##4##3##(1990-3#1)(1990-5#1)(1993-6#2)
a clinical condition characterized by##2##5##(2008-5#1)(2011-2#1)
a clinical condition##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
a clinical decision##2##3##(1991-1#1)(2008-4#1)
a clinical entity##3##3##(1991-6#1)(1996-11#1)(2008-12#1)
a clinical evaluation##2##3##(2008-1#1)(2008-5#1)
a clinical laboratory##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
a clinical model##2##3##(1997-2#2)
a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery##2##15##(2008-8#2)
a clinical pathology conference held by the##3##7##(2008-8#2)(2012-2#1)
a clinical pathway##3##3##(2008-3#2)(2012-3#1)
a clinical population of##2##4##(2010-2#1)(2012-2#1)
a clinical reality##2##3##(2010-10#1)(2011-2#1)
a clinical role##2##3##(2011-2#1)(2013-1#1)
a clinical setting##4##3##(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
a clinical study##6##3##(1990-5#2)(1992-12#1)(2008-10#1)(2008-11#1)(2009-12#1)
a clinical trial of##3##4##(1994-9#1)(2009-4#1)(2012-3#1)
a clinical trial##11##3##(1992-9#1)(1994-9#1)(1996-6#2)(2009-4#1)(2010-1#1)(2010-6#3)(2010-8#1)(2012-3#1)
a clinical##121##2##(1990-2#1)(1990-3#3)(1990-5#5)(1991-1#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-9#1)(1993-3#1)(1993-6#2)(1994-12#5)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-6#2)(1997-2#3)(1997-4#2)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#7)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#3)(2010-8#1)(2011-2#11)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#8)(2013-8#4)
a clinically relevant##2##3##(1996-2#1)(2008-8#1)
a clinically useful##4##3##(1990-9#1)(1991-12#1)(2008-12#1)(2008-7#1)
a clinically##16##2##(1990-9#1)(1991-12#1)(1993-12#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2012-4#1)
a clinico-pathologic##2##2##(1991-6#1)(1991-8#1)
a clonal population##3##3##(2008-10#3)
a clonal##8##2##(1996-2#1)(2008-10#4)(2008-9#1)(2009-8#1)(2010-1#1)
a clone##5##2##(1994-11#2)(1996-3#1)(1997-7#1)(2008-9#1)
a cloned##6##2##(1997-2#2)(2008-10#1)(2008-11#1)(2008-8#2)
a cloning##2##2##(1993-2#1)(1995-8#1)
a close association of##2##4##(2008-10#1)(2009-10#1)
a close association##3##3##(1993-1#1)(2008-10#1)(2009-10#1)
a close correlation between##3##4##(2008-10#2)(2008-12#1)
a close correlation##7##3##(1990-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)
a close relationship between the##2##5##(2008-10#1)(2008-8#1)
a close relationship between##6##4##(2008-10#3)(2008-8#1)(2009-9#1)(2011-2#1)
a close relationship##8##3##(2008-10#5)(2008-8#1)(2009-9#1)(2011-2#1)
a close relative##2##3##(2008-10#1)(2008-8#1)
a close##36##2##(1990-9#1)(1993-1#1)(1993-2#1)(1994-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-10#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2011-4#1)(2013-8#1)
a closed system##3##3##(2008-10#3)
a closed##13##2##(1993-3#1)(1994-12#1)(2008-10#8)(2008-3#1)(2008-9#1)(2013-1#1)
a closely related non-symbiotic clam##2##5##(2008-5#2)
a closer look##2##3##(2008-10#1)(2008-8#1)
a closer relationship with##3##4##(2008-10#1)(2008-8#2)
a closer relationship##4##3##(1994-1#1)(2008-10#1)(2008-8#2)
a closer##12##2##(1990-2#1)(1992-3#1)(1994-1#1)(1995-12#1)(2008-10#4)(2008-8#3)(2011-2#1)
a cloudy##2##2##(2008-10#2)
a cluster of genes##2##4##(1996-12#1)(2008-4#1)
a cluster of##15##3##(1992-4#2)(1996-12#2)(1996-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
a cluster##19##2##(1992-4#2)(1996-12#2)(1996-6#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
a co-culture system of##2##4##(2008-11#2)
a co-factor in##2##3##(2011-2#1)(2013-1#1)
a coalition of##3##3##(1994-12#1)(1996-3#1)(2008-8#1)
a coarse##4##2##(2008-10#1)(2008-11#1)(2009-7#1)(2012-3#1)
a coated cylinder##2##3##(2008-3#2)
a coated graphite##2##3##(2008-10#2)
a coated##4##2##(2008-10#2)(2008-3#2)
a coaxial##2##2##(1992-11#1)(2008-3#1)
a cobalt phthalocyanine modified##2##4##(2008-10#2)
a cobalt##3##2##(2008-10#3)
a cobalt-wire##2##2##(2008-10#2)
a cochlear implant##11##3##(2008-9#10)(2011-2#1)
a coculture##2##2##(2008-11#1)(2008-7#1)
a code##2##2##(1990-5#1)(1997-5#1)
a coding##3##2##(1997-7#1)(2008-10#1)(2009-3#1)
a codon##2##2##(2008-10#2)
a coefficient of variation of##3##5##(2008-10#3)
a coefficient of variation##4##4##(2008-10#4)
a coefficient of##7##3##(1990-2#1)(2008-10#6)
a cofactor in the##2##4##(1993-8#1)(1996-2#1)
a cofactor##3##2##(1993-8#1)(1996-2#1)(2012-2#1)
a cognitive##6##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-8#1)
a cognitive-behavioral##2##2##(2009-11#1)(2009-6#1)
a coherent set of##2##4##(1995-12#1)(2010-10#1)
a coherent##14##2##(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2010-10#1)(2012-2#2)(2013-1#1)
a cohort of##13##3##(1994-12#1)(1995-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
a cohort study##2##3##(2012-2#1)(2013-1#1)
a cohort##18##2##(1993-8#1)(1994-12#1)(1995-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
a coil##3##2##(1997-3#1)(2008-10#2)
a cold##10##2##(1994-9#1)(1995-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)
a collaborative effort to identify##2##5##(1995-11#2)
a collaborative effort##4##3##(1994-12#1)(1995-11#2)(1996-12#1)
a collaborative model##2##3##(1991-2#1)(2008-11#1)
a collaborative study##2##3##(1995-11#1)(2009-11#1)
a collaborative##23##2##(1991-2#2)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-11#3)(1996-1#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#1)(2009-11#1)(2011-9#1)
a collagen##2##2##(1994-8#1)(2009-7#1)
a collagenase##2##2##(1993-3#1)(2008-11#1)
a collection of P##2##4##(2008-10#2)
a collection of isolates##2##4##(2008-10#2)
a collection of##24##3##(1994-12#1)(1996-2#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
a collection##26##2##(1994-12#1)(1996-2#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
a collective##4##2##(1995-2#1)(2008-11#1)(2008-12#1)(2011-2#1)
a collector##2##2##(2008-10#2)
a college##4##2##(2008-11#2)(2008-5#1)(2011-1#1)
a college-based programme##2##3##(2012-3#2)
a collimated##3##2##(1996-2#1)(2008-3#2)
a colloid cyst of the third ventricle##2##7##(2008-7#2)
a colloid cyst##3##3##(2008-7#3)
a colloid##4##2##(2008-10#1)(2008-7#3)
a colloidal##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
a colon cancer##2##3##(2008-1#1)(2010-6#1)
a colony##6##2##(1992-1#1)(1994-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
a color##8##2##(1995-6#1)(2008-10#4)(2008-11#1)(2008-3#2)
a color-splitting##2##2##(2008-3#2)
a colored complex##5##3##(2008-10#5)
a colored##14##2##(1990-2#1)(2008-10#13)
a colorimetric assay##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
a colorimetric method##4##3##(2008-10#4)
a colorimetric##11##2##(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-12#1)
a colorless##4##2##(2008-10#3)(2009-10#1)
a coloured##3##2##(2008-10#3)
a colourless##3##2##(2008-10#3)
a column containing##4##3##(2008-10#4)
a column filled with##2##4##(2008-10#2)
a column of##4##3##(2008-10#3)(2008-4#1)
a column packed with##5##4##(2008-10#4)(2008-7#1)
a column temperature of##3##4##(2008-10#3)
a column##35##2##(2008-10#33)(2008-4#1)(2008-7#1)
a combination of a##6##4##(1997-4#1)(2008-10#3)(2008-11#1)(2009-10#1)
a combination of an##2##4##(2008-10#1)(2011-10#1)
a combination of analytical##2##4##(2008-8#2)
a combination of both##7##4##(2008-10#2)(2008-2#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
a combination of clinical##2##4##(2008-7#1)(2013-1#1)
a combination of decreased##2##4##(1991-7#1)(2008-11#1)
a combination of gel##2##4##(2008-11#1)(2008-8#1)
a combination of low pH and##2##6##(1994-8#2)
a combination of molecular##2##4##(1993-8#1)(2008-8#1)
a combination of monoclonal antibodies##2##5##(2008-10#1)(2008-4#1)
a combination of principal component analysis##2##6##(2008-10#2)
a combination of random##2##4##(2008-10#1)(2008-8#1)
a combination of the##16##4##(1992-3#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-6#1)(2013-8#1)
a combination of three##2##4##(2008-10#2)
a combination of two##3##4##(2008-10#2)(2008-2#1)
a combination of##166##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#2)(1993-12#3)(1993-8#2)(1994-3#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#46)(2008-11#10)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#5)(2010-1#3)(2010-10#1)(2010-11#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#1)(2012-6#1)(2012-9#1)(2013-1#2)(2013-8#4)
a combination with##3##3##(1990-8#1)(1992-11#1)(2008-10#1)
a combination##173##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#2)(1993-12#3)(1993-8#2)(1994-3#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#48)(2008-11#10)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#5)(2010-1#3)(2010-10#1)(2010-11#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#1)(2012-6#1)(2012-9#1)(2013-1#2)(2013-8#4)
a combinatorial##5##2##(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-2#1)
a combined approach##3##3##(1990-6#1)(2008-10#1)(2008-9#1)
a combined procedure##2##3##(2008-10#1)(2008-11#1)
a combined strategy##2##3##(2008-10#1)(2012-12#1)
a combined##39##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-9#3)(1994-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-8#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-2#1)
a combustion##2##2##(2008-10#2)
a commercial static mercury drop electrode##2##6##(2008-10#2)
a commercial##55##2##(1990-3#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1997-5#1)(2007-12#1)(2008-10#36)(2008-11#1)(2008-2#2)(2008-5#3)(2008-9#1)(2009-12#1)(2012-2#3)(2012-5#1)
a commercially available flow cell (Hellma 176-QS)##2##7##(2008-10#2)
a commercially available##21##3##(1991-12#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
a commercially##24##2##(1991-12#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
a commitment to##3##3##(1993-2#1)(1994-1#1)(1994-2#1)
a committed##3##2##(1995-6#2)(2008-11#1)
a committee was constituted by the University to look into these allegations##2##12##(2008-10#2)
a committee was##3##3##(2008-10#2)(2008-4#1)
a committee##4##2##(2008-10#2)(2008-4#1)(2012-12#1)
a common ancestor##2##3##(2008-10#1)(2012-3#1)
a common ancestral##2##3##(1997-9#1)(2008-10#1)
a common and##7##3##(2008-10#2)(2008-2#1)(2008-9#2)(2010-12#1)(2012-2#1)
a common cause of##7##4##(1997-3#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#2)(2013-1#1)
a common competitor##2##3##(2008-10#1)(2008-9#1)
a common conceptual definition and##4##5##(2013-1#4)
a common disease##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
a common evolutionary##2##3##(1990-5#1)(2013-8#1)
a common feature of##9##4##(1991-10#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-11#1)
a common feature##10##3##(1991-10#1)(1993-12#1)(1995-6#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-5#1)(2010-11#1)
a common finding in##4##4##(1996-6#1)(2008-7#1)(2009-8#1)(2012-2#1)
a common fixed point of##2##5##(2011-2#2)
a common intermediate##2##3##(1990-5#1)(1991-3#1)
a common mechanism for##2##4##(1995-12#1)(2009-8#1)
a common mechanism##5##3##(1994-5#1)(1995-12#1)(1996-12#1)(2008-4#1)(2009-8#1)
a common mutation in##2##4##(1990-8#1)(2008-7#1)
a common origin##3##3##(2008-8#1)(2008-9#1)(2010-12#1)
a common phenomenon##2##3##(2008-7#2)
a common problem in##5##4##(1993-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
a common problem##6##3##(1993-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)
a common property##2##3##(1994-11#1)(1996-12#1)
a common reason for##2##4##(2008-5#1)(2012-2#1)
a common spatial##2##3##(1993-8#1)(2008-3#1)
a common spectrofluorometer##6##3##(2008-10#6)
a common system##2##3##(2012-3#1)(2013-8#1)
a common target##2##3##(1991-9#2)
a common urologic##2##3##(1992-1#1)(2013-1#1)
a common##230##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-1#1)(1992-5#1)(1992-7#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#53)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#7)(2009-10#1)(2009-12#2)(2009-5#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#10)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#5)
a commonly used##5##3##(2008-10#2)(2010-7#1)(2012-12#1)(2012-2#1)
a commonly##9##2##(2008-10#3)(2008-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
a communication tool##3##3##(1996-1#2)(2008-11#1)
a communication##7##2##(1990-12#3)(1990-9#1)(1996-1#2)(2008-11#1)
a community health##2##3##(1996-1#1)(2008-1#1)
a community of research and practice##2##6##(2010-10#2)
a community of##5##3##(2008-12#1)(2008-8#1)(2009-6#1)(2010-10#2)
a community sample of##2##4##(1992-1#1)(2010-11#1)
a community sample##4##3##(1992-1#1)(2010-11#1)(2010-5#1)(2013-8#1)
a community with##2##3##(2008-1#1)(2008-8#1)
a community##40##2##(1991-1#1)(1991-2#1)(1992-1#1)(1993-1#1)(1996-1#2)(1996-11#1)(1996-3#3)(1997-1#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
a community-based approach##2##3##(1994-1#1)(1995-3#1)
a community-based program##3##3##(1992-1#1)(1994-12#1)(2013-1#1)
a community-based study##3##3##(2007-12#1)(2008-7#2)
a community-based##18##2##(1992-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1995-3#1)(2007-12#1)(2008-11#2)(2008-7#3)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#1)
a community-partnered##2##2##(2012-2#2)
a compact and portable##2##4##(2008-10#2)
a compact and##3##3##(2008-10#3)
a compact film##3##3##(2008-10#3)
a compact##19##2##(2008-10#10)(2008-2#1)(2008-3#7)(2008-4#1)
a companion##2##2##(1991-2#1)(1992-2#1)
a company##4##2##(1993-12#1)(2008-11#1)(2008-5#1)(2012-3#1)
a comparable##11##2##(1992-6#1)(1993-3#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#2)(2009-10#1)(2011-2#1)(2013-1#1)
a comparative analysis##4##3##(2008-8#1)(2008-9#2)(2012-3#1)
a comparative method##3##3##(2008-10#3)
a comparative study##7##3##(1990-9#1)(1995-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)
a comparative##29##2##(1990-9#1)(1991-12#1)(1994-1#2)(1995-12#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#2)(2010-4#1)(2010-8#1)(2012-3#1)
a comparatively##3##2##(1993-3#1)(2008-10#2)
a comparison between the##4##4##(1992-5#1)(2008-10#2)(2008-11#1)
a comparison between##11##3##(1990-2#1)(1992-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
a comparison is##2##3##(2008-10#2)
a comparison of results##2##4##(2008-10#1)(2008-11#1)
a comparison of the##6##4##(1992-2#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-9#1)
a comparison of two##2##4##(1994-9#1)(2008-3#1)
a comparison of##34##3##(1991-12#1)(1992-2#2)(1992-3#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#4)(2008-11#5)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-7#1)
a comparison was made##2##4##(2008-10#1)(2011-2#1)
a comparison with the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
a comparison with##12##3##(1991-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
a comparison##67##2##(1990-2#1)(1991-1#2)(1991-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#22)(2008-11#7)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#2)(2010-10#1)(2011-2#4)(2012-2#2)(2012-7#1)(2013-1#1)
a compartmental##3##2##(1992-9#1)(2008-7#1)(2010-10#1)
a compatible interaction##2##3##(2008-10#2)
a compatible##6##2##(2008-10#4)(2008-11#1)(2012-3#1)
a compensatory##3##2##(1994-5#1)(2008-10#2)
a competency-based##2##2##(2008-11#2)
a competent##2##2##(1996-1#1)(2008-5#1)
a competition experiment##2##3##(2008-10#1)(2008-8#1)
a competition##4##2##(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
a competitive advantage##2##3##(1994-2#1)(2008-11#1)
a competitive antagonist of the##2##5##(2008-11#1)(2012-3#1)
a competitive binding##2##3##(1992-3#1)(2008-10#1)
a competitive##26##2##(1991-3#1)(1991-9#2)(1992-3#2)(1993-3#1)(1993-8#1)(1994-2#1)(1997-1#1)(2008-10#12)(2008-11#2)(2008-4#1)(2008-7#1)(2012-3#1)
a compilation and##2##3##(1997-3#1)(2008-7#1)
a compilation##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
a complement to##5##3##(1996-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
a complement##6##2##(1996-3#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
a complementary DNA##2##3##(1991-5#1)(2008-4#1)
a complementary role##2##3##(2008-10#1)(2011-2#1)
a complementary##12##2##(1991-5#1)(1995-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
a complete absence of##2##4##(1993-12#1)(2008-10#1)
a complete list of##2##4##(1996-12#1)(2010-3#1)
a complete loss of##3##4##(1997-3#1)(2008-10#1)(2008-11#1)
a complete recovery##2##3##(2008-11#1)(2008-7#1)
a complete remission##2##3##(1991-6#1)(2012-3#1)
a complete separation of##2##4##(1997-2#1)(2008-10#1)
a complete##63##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-6#2)(1992-12#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-12#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#12)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-3#4)(2012-5#1)(2013-1#4)(2013-8#1)
a completely new##3##3##(2008-10#1)(2008-11#2)
a completely##9##2##(1990-11#1)(1996-9#1)(2008-10#3)(2008-11#3)(2012-3#1)
a complex and##5##3##(1992-3#1)(1997-3#1)(2008-10#2)(2010-12#1)
a complex formation reaction##2##4##(2008-10#2)
a complex formed##2##3##(2008-10#2)
a complex interaction between##3##4##(2010-12#1)(2010-8#1)(2013-1#1)
a complex interaction##5##3##(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
a complex matrix##3##3##(2008-10#2)(2009-10#1)
a complex mixture of proteins##2##5##(1996-12#1)(2008-4#1)
a complex mixture of##5##4##(1992-6#1)(1996-12#1)(2008-10#2)(2008-4#1)
a complex mixture##9##3##(1992-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-4#2)
a complex network of##2##4##(2008-6#1)(2009-8#1)
a complex network##3##3##(2008-6#1)(2009-8#1)(2010-8#1)
a complex of##14##3##(1992-9#1)(1995-8#1)(1997-1#1)(2008-10#9)(2008-4#2)
a complex pattern of##2##4##(1992-1#1)(2011-2#1)
a complex pattern##4##3##(1992-1#1)(1993-2#1)(2008-11#1)(2011-2#1)
a complex system##3##3##(1990-11#1)(2008-11#1)(2008-6#1)
a complex trait##2##3##(2008-4#1)(2012-3#1)
a complex web of##2##4##(2008-11#1)(2009-8#1)
a complex with##10##3##(1995-6#1)(2008-10#6)(2008-8#1)(2012-2#1)(2012-3#1)
a complex##145##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-12#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#40)(2008-11#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-8#7)(2010-10#1)(2010-12#2)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#2)
a complexing agent##3##3##(2008-10#3)
a complexing##6##2##(2008-10#6)
a complexity##2##2##(1991-6#1)(2008-10#1)
a complicated##7##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
a complication of##7##3##(1993-1#1)(1995-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
a complication rate##2##3##(2012-3#2)
a complication##12##2##(1993-1#1)(1995-10#1)(1995-12#1)(2008-10#2)(2008-7#2)(2008-9#1)(2012-2#1)(2012-3#3)
a component in##4##3##(1990-12#1)(1993-3#2)(2008-11#1)
a component of a##2##4##(2008-10#1)(2010-10#1)
a component of the Arp2/3 complex##2##6##(2012-2#2)
a component of the active##2##5##(1991-9#1)(1993-9#1)
a component of the##19##4##(1991-9#1)(1992-6#3)(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#2)(1997-7#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
a component of##34##3##(1991-9#1)(1992-6#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1997-7#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-10#1)(2011-10#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
a component##41##2##(1990-12#1)(1991-9#1)(1992-6#3)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1997-7#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-10#1)(2011-10#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
a composite B##2##3##(2008-10#2)
a composite graft##3##3##(2008-12#1)(2008-9#1)(2012-2#1)
a composite matrix##2##3##(2008-10#2)
a composite of##4##3##(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
a composite rod##3##3##(2008-2#3)
a composite##25##2##(1992-6#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#4)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2012-2#3)(2013-1#1)
a composition of##2##3##(2008-10#1)(2008-2#1)
a composition ratio of##2##4##(2008-10#2)
a composition##6##2##(2008-10#5)(2008-2#1)
a compound that##4##3##(1996-2#1)(2008-10#2)(2012-2#1)
a compound with##2##3##(2008-11#2)
a compound##18##2##(1991-5#1)(1996-2#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
a comprehensive and##2##3##(2008-10#1)(2008-7#1)
a comprehensive approach to##2##4##(1992-12#1)(2011-2#1)
a comprehensive assessment of##2##4##(2009-10#1)(2011-2#1)
a comprehensive assessment that##2##4##(2008-6#1)(2013-8#1)
a comprehensive assessment##4##3##(2008-6#1)(2009-10#1)(2011-2#1)(2013-8#1)
a comprehensive framework##2##3##(1995-12#1)(2008-11#1)
a comprehensive model for##2##4##(1992-9#2)
a comprehensive model of##2##4##(2010-5#1)(2010-8#1)
a comprehensive model##4##3##(1992-9#2)(2010-5#1)(2010-8#1)
a comprehensive overview of the##4##5##(1992-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
a comprehensive overview of##7##4##(1992-12#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a comprehensive overview##8##3##(1992-12#1)(2008-11#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a comprehensive review##2##3##(1997-2#1)(2012-2#1)
a comprehensive study of##2##4##(2008-10#1)(2009-3#1)
a comprehensive##80##2##(1991-1#1)(1991-2#1)(1992-12#3)(1992-2#2)(1992-9#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#3)(1995-3#2)(1995-5#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-6#2)(1997-7#1)(1997-8#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-4#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#4)
a compression##2##2##(2008-9#1)(2011-3#1)
a compressive##2##2##(1991-11#1)(2011-2#1)
a compromise##3##2##(2008-10#2)(2013-1#1)
a compromised Mlo pathway##2##4##(2008-10#2)
a compromised##4##2##(2008-10#3)(2008-9#1)
a computational model of##2##4##(2008-11#1)(2013-8#1)
a computational model##6##3##(2008-11#3)(2010-7#1)(2012-2#1)(2013-8#1)
a computational##9##2##(2008-10#2)(2008-11#3)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
a computationally##2##2##(2008-8#1)(2012-2#1)
a computer program##8##3##(1994-3#1)(1994-6#1)(1997-2#1)(1997-6#1)(2008-10#4)
a computer readable##2##3##(2008-10#1)(2008-4#1)
a computer##26##2##(1990-3#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#1)
a computer-based##2##2##(2008-10#1)(2008-12#1)
a computer-controlled environmental chamber##2##4##(2008-10#2)
a computer-controlled##3##2##(2008-10#3)
a computerised##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
a computerized medical##2##3##(1994-6#1)(2010-8#1)
a computerized##10##2##(1994-6#1)(1995-5#1)(1996-3#2)(2008-10#1)(2008-7#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
a concave##2##2##(2008-8#1)(2011-2#1)
a concentrated##5##2##(1990-5#1)(1991-11#1)(2008-10#2)(2008-7#1)
a concentration dependent##5##3##(1990-5#1)(1993-6#1)(2008-10#1)(2012-2#1)(2013-8#1)
a concentration gradient##3##3##(2008-10#2)(2012-2#1)
a concentration level of##5##4##(2008-10#4)(2009-8#1)
a concentration level##6##3##(2008-10#5)(2009-8#1)
a concentration limit of##2##4##(2008-10#2)
a concentration of 0##6##4##(2008-10#5)(2008-11#1)
a concentration of 1##9##4##(1995-11#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-5#1)
a concentration of 100##5##4##(1997-4#1)(2008-10#1)(2008-7#1)(2011-1#2)
a concentration of 2##3##4##(2008-10#2)(2008-5#1)
a concentration of 3 X 10(-7) M##2##7##(1990-5#2)
a concentration of 3##5##4##(1990-5#2)(2008-10#1)(2008-11#1)(2011-1#1)
a concentration of 4##2##4##(2008-10#2)
a concentration of 50##2##4##(2008-10#1)(2010-3#1)
a concentration of less than##2##5##(2008-10#1)(2008-5#1)
a concentration of##68##3##(1990-5#2)(1990-8#1)(1991-5#1)(1993-3#1)(1993-8#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#31)(2008-11#9)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-3#1)(2013-1#1)
a concentration range from##3##4##(2008-10#3)
a concentration range of 0##3##5##(2008-10#3)
a concentration range of 1##2##5##(2008-10#2)
a concentration range of##10##4##(2008-10#9)(2011-3#1)
a concentration range##15##3##(2008-10#14)(2011-3#1)
a concentration##115##2##(1990-5#3)(1990-8#1)(1991-5#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-6#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#63)(2008-11#10)(2008-12#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a concentration-dependent reduction in##2##4##(1992-1#1)(1993-12#1)
a concentration-dependent##22##2##(1990-5#2)(1991-6#1)(1992-1#1)(1992-6#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-11#3)(1997-4#2)(2008-10#1)(2008-11#1)(2009-3#1)
a concentric##2##2##(1997-8#1)(2008-8#1)
a concept of##3##3##(2008-7#1)(2010-8#1)(2012-2#1)
a concept##12##2##(1991-3#1)(1994-3#2)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-2#1)
a conceptual framework##3##3##(1992-3#1)(1993-2#1)(2010-8#1)
a conceptual##7##2##(1992-3#1)(1993-2#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-8#1)(2013-8#1)
a conceptually##2##2##(2011-2#1)(2013-1#1)
a concern for##2##3##(2008-9#1)(2011-1#1)
a concern##11##2##(1991-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
a concerted effort##3##3##(1991-1#1)(1991-3#1)(2012-2#1)
a concerted##4##2##(1991-1#1)(1991-3#1)(2008-10#1)(2012-2#1)
a concise overview##3##3##(2008-10#2)(2008-11#1)
a concise review##2##3##(2008-11#1)(2013-1#1)
a concise##6##2##(2008-10#2)(2008-11#2)(2008-7#1)(2013-1#1)
a conclusion##4##2##(1993-3#1)(1995-5#1)(2008-10#1)(2013-1#1)
a concomitant##13##2##(1991-8#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#2)(2013-8#1)
a concrete##2##2##(2008-11#1)(2010-1#1)
a concurrent cohort of##2##4##(2012-12#2)
a concurrent##4##2##(2010-10#1)(2011-10#1)(2012-12#2)
a condition for##2##3##(1994-12#1)(1997-5#1)
a condition in which##4##4##(2008-10#1)(2010-1#1)(2010-12#1)(2010-5#1)
a condition is##2##3##(2008-10#1)(2008-3#1)
a condition of##2##3##(1991-8#1)(2012-3#1)
a condition##19##2##(1991-8#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a conditional expression##2##3##(1997-3#1)(2013-1#1)
a conditional##3##2##(1997-3#1)(2008-9#1)(2013-1#1)
a conditioned##6##2##(1991-1#1)(1993-6#2)(1994-2#1)(1996-2#1)(2008-5#1)
a conditioning##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
a conducting polymer##3##3##(2008-10#3)
a conducting polypyrrole##2##3##(2008-10#2)
a conducting##9##2##(2007-12#1)(2008-10#6)(2012-2#1)(2013-1#1)
a conductive##3##2##(2008-10#3)
a conduit##2##2##(1992-8#1)(2013-1#1)
a conference##11##2##(1990-8#1)(1992-12#1)(1992-3#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#2)
a confidence interval for theta##2##5##(1996-3#2)
a confidence interval for##3##4##(1996-3#3)
a confidence interval of 95%##2##5##(2008-10#1)(2013-1#1)
a confidence interval##6##3##(1995-9#1)(1996-3#3)(2008-10#1)(2013-1#1)
a confidence##9##2##(1995-9#1)(1996-3#3)(2008-10#3)(2008-11#1)(2013-1#1)
a confirmatory##4##2##(2008-10#4)
a conflict##3##2##(2008-12#1)(2013-1#2)
a confluence##2##2##(2008-10#1)(2010-8#1)
a confocal laser scanning microscope##2##5##(2008-8#1)(2008-9#1)
a confocal##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
a conformational change##2##3##(1993-8#1)(2008-5#1)
a conformational epitope##3##3##(1995-2#1)(2009-8#1)(2012-2#1)
a conformational##8##2##(1993-3#1)(1993-8#1)(1995-2#1)(1995-8#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#1)
a confusing##3##2##(1991-3#1)(1997-1#1)(2008-10#1)
a congenital##7##2##(1996-11#1)(1997-8#3)(2008-7#1)(2010-3#1)(2012-3#1)
a conical##5##2##(2008-10#4)(2008-2#1)
a conidial suspension of P##2##5##(2008-10#2)
a conidial suspension of##3##4##(2008-10#3)
a conidial suspension##8##3##(2008-10#8)
a conjugate of##3##3##(2008-10#2)(2008-11#1)
a conjugate##5##2##(2008-10#4)(2008-11#1)
a conjugated##2##2##(2008-9#2)
a connecting##2##2##(1992-6#1)(2012-3#1)
a connection between##2##3##(1991-2#1)(2011-2#1)
a connection##5##2##(1991-2#1)(1996-6#1)(2008-6#1)(2010-8#1)(2011-2#1)
a consecutive series of##5##4##(1990-8#1)(1991-8#1)(2010-11#1)(2012-5#1)(2013-1#1)
a consecutive##7##2##(1990-12#1)(1990-8#1)(1991-8#1)(2010-11#1)(2012-2#1)(2012-5#1)(2013-1#1)
a consensus among##2##3##(2008-10#1)(2011-2#1)
a consensus sequence of##4##4##(1990-8#1)(1991-12#1)(2008-10#1)(2009-8#1)
a consensus sequence##6##3##(1990-8#1)(1991-12#1)(1993-9#1)(2008-10#2)(2009-8#1)
a consensus that##2##3##(1993-12#1)(1997-3#1)
a consensus##25##2##(1990-8#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-3#1)(2008-10#5)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#4)
a consent##2##2##(1995-12#1)(2012-3#1)
a consequence of a##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
a consequence of the##10##4##(1990-11#1)(1990-2#1)(1994-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
a consequence of this##2##4##(1997-8#1)(2008-11#1)
a consequence of##47##3##(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-6#2)(1993-8#1)(1994-3#1)(1994-5#1)(1997-8#1)(2008-10#14)(2008-11#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#4)
a consequence##77##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-6#2)(1993-8#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-8#1)(2008-10#25)(2008-11#8)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-5#1)(2013-1#5)(2013-8#1)
a consequent##4##2##(1995-12#1)(1995-5#1)(1997-6#1)(2008-10#1)
a conservative approach##2##3##(1990-9#1)(1996-6#1)
a conservative##8##2##(1990-9#1)(1991-12#1)(1994-5#1)(1996-6#1)(2008-8#1)(2011-7#1)(2013-1#2)
a conserved motif##2##3##(1995-6#1)(2008-8#1)
a conserved##13##2##(1991-6#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#2)(2011-2#2)
a considerable amount of##4##4##(1991-12#1)(2008-4#1)(2008-6#1)(2009-1#1)
a considerable amount##5##3##(1991-12#1)(2008-4#1)(2008-6#1)(2009-1#1)(2012-3#1)
a considerable degree##2##3##(1991-6#1)(2010-3#1)
a considerable heterogeneity##2##3##(2008-10#1)(2008-7#1)
a considerable improvement##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
a considerable reduction in##2##4##(2008-10#1)(2008-3#1)
a considerable reduction##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
a considerable variation##2##3##(1995-11#1)(2011-2#1)
a considerable##45##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1997-5#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#2)
a consideration of the##3##4##(1992-2#1)(1995-11#1)(2013-1#1)
a consideration of##6##3##(1992-2#1)(1995-11#1)(1996-6#1)(2008-11#1)(2009-7#1)(2013-1#1)
a consistent and##3##3##(2008-10#1)(2008-5#1)(2010-11#1)
a consistent increase##2##3##(1992-1#1)(2012-2#1)
a consistent pattern of##2##4##(2008-11#1)(2008-7#1)
a consistent pattern##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)
a consistent##25##2##(1991-1#1)(1992-1#1)(1993-3#1)(1994-2#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#2)(2011-2#1)(2012-2#3)(2013-1#3)
a consistently##2##2##(1993-3#1)(2008-10#1)
a consortium of##2##3##(1991-1#1)(2008-11#1)
a conspicuous##2##2##(2008-10#2)
a constant amount of##2##4##(2008-10#1)(2008-5#1)
a constant and##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
a constant current##2##3##(2008-10#2)
a constant ionic medium##3##4##(2008-10#3)
a constant ionic##4##3##(2008-10#4)
a constant level of##2##4##(2008-10#1)(2008-11#1)
a constant potential##3##3##(2008-10#3)
a constant rate##3##3##(2008-10#2)(2008-11#1)
a constant temperature##3##3##(2008-10#3)
a constant value for the##2##5##(2008-2#2)
a constant value##5##3##(2008-10#2)(2008-2#2)(2009-7#1)
a constant##66##2##(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-5#1)(1994-8#1)(2007-12#3)(2008-10#31)(2008-11#5)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
a constellation of##3##3##(2011-1#1)(2012-3#1)(2013-8#1)
a constituent of##2##3##(2008-10#1)(2008-11#1)
a constitutive expression##2##3##(2008-10#1)(2008-7#1)
a constitutive##3##2##(2008-10#2)(2008-7#1)
a constitutively##2##2##(1995-11#1)(2009-7#1)
a constraint##3##2##(2008-10#1)(2008-2#1)(2009-8#1)
a construct##5##2##(1993-2#1)(2008-10#2)(2008-12#1)(2010-10#1)
a construction##3##2##(1991-12#1)(1995-12#1)(2008-10#1)
a consumer guide on##2##4##(1996-2#2)
a consumer##7##2##(1993-1#1)(1994-1#1)(1996-2#2)(1997-3#1)(2008-11#2)
a contact lens##2##3##(2008-10#1)(2008-3#1)
a contact##7##2##(1994-5#1)(2008-10#3)(2008-3#1)(2009-1#1)(2009-7#1)
a contaminated##5##2##(2008-10#5)
a contamination##2##2##(2008-10#1)(2011-2#1)
a content analysis##2##3##(2008-11#2)
a content of##2##3##(2008-12#1)(2008-5#1)
a content##5##2##(2008-11#3)(2008-12#1)(2008-5#1)
a contentious##2##2##(2008-7#1)(2008-9#1)
a context of##4##3##(1991-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
a context##8##2##(1991-11#1)(1992-2#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
a contextual##2##2##(1996-2#1)(2010-10#1)
a contiguous gene##2##3##(1997-3#1)(2008-10#1)
a contiguous##3##2##(1997-3#1)(2008-10#1)(2010-6#1)
a continent##3##2##(2008-10#3)
a continued##6##2##(1991-6#1)(1997-5#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)
a continuing##6##2##(1991-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-2#1)
a continuous and##3##3##(1997-2#1)(2008-11#1)(2008-5#1)
a continuous filtration/dissolution system##2##4##(2008-10#2)
a continuous flow manifold##2##4##(2008-10#2)
a continuous flow of##2##4##(2008-10#2)
a continuous flow system was##2##5##(2008-10#2)
a continuous flow system##7##4##(2008-10#7)
a continuous flow##15##3##(2008-10#14)(2011-2#1)
a continuous monitoring of##2##4##(2008-10#1)(2011-2#1)
a continuous quality##2##3##(1993-3#1)(1994-3#1)
a continuous temperature##2##3##(1993-6#1)(2008-10#1)
a continuous wave##4##3##(1992-1#1)(1996-1#1)(2008-11#1)(2008-2#1)
a continuous##86##2##(1990-2#1)(1992-1#3)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#45)(2008-11#7)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2010-11#1)(2011-2#4)(2012-4#1)(2013-1#1)
a continuous-flow system##2##3##(2008-10#2)
a continuous-flow##4##2##(2008-10#4)
a continuous-wave laser##3##3##(2008-2#2)(2008-3#1)
a continuous-wave##11##2##(2008-2#4)(2008-3#7)
a continuously flowing##2##3##(2008-10#2)
a continuously##7##2##(2008-10#4)(2008-11#1)(2008-3#1)(2012-2#1)
a continuum of##7##3##(1992-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2011-2#1)
a continuum##10##2##(1992-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2011-2#1)
a contraceptive##2##2##(1996-9#1)(2013-1#1)
a contraindication##2##2##(2011-2#1)(2013-1#1)
a contralateral##2##2##(2008-7#1)(2008-9#1)
a contrast##2##2##(1992-3#1)(2008-5#1)
a contribution##3##2##(1993-12#1)(1996-11#1)(2010-7#1)
a control and##2##3##(2008-11#1)(2008-12#1)
a control condition##2##3##(2008-4#2)
a control group of##3##4##(2008-7#1)(2012-3#1)(2013-8#1)
a control group with##2##4##(1992-2#1)(2008-9#1)
a control group##23##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#2)(2013-8#2)
a control##63##2##(1991-1#1)(1991-12#1)(1991-2#2)(1992-2#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-5#1)(2008-10#10)(2008-11#7)(2008-12#5)(2008-4#2)(2008-5#5)(2008-7#1)(2008-9#3)(2009-12#2)(2009-3#1)(2009-8#1)(2010-6#1)(2010-9#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#3)
a controllable donor-acceptor nanohybrid##2##4##(2009-3#2)
a controlled##22##2##(1991-3#1)(1996-1#1)(1996-3#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#2)(2009-8#1)(2010-11#1)(2011-2#2)
a controller##2##2##(2008-10#2)
a controversial##3##2##(1990-3#1)(2008-10#1)(2008-11#1)
a controversy##2##2##(2008-8#1)(2012-12#1)
a convective##2##2##(1992-8#1)(2013-8#1)
a convenience sample of##5##4##(1993-3#1)(2008-12#1)(2009-5#1)(2010-6#1)(2010-8#1)
a convenience##6##2##(1993-3#1)(2008-12#1)(2009-5#1)(2010-6#1)(2010-8#1)(2013-8#1)
a convenient##17##2##(1990-8#1)(1994-6#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#3)(2010-4#1)(2011-2#1)
a conventional spectrophotometer##2##3##(2008-10#2)
a conventional##48##2##(1990-12#1)(1990-6#1)(1993-2#1)(1993-9#1)(1994-5#1)(2007-12#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-7#1)
a convergence##2##2##(1991-12#1)(1995-2#1)
a convicted##2##2##(1992-9#1)(1996-5#1)
a cooled##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
a cooperative##10##2##(1991-5#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)
a coordinated ambulatory care system##2##5##(1992-1#2)
a coordinated##6##2##(1992-1#2)(1995-1#1)(2008-12#1)(2011-2#1)(2012-12#1)
a copper##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
a copperised cadmium reductor column##2##5##(2008-10#2)
a copperised cadmium##3##3##(2008-10#3)
a copy of the##2##4##(2008-10#1)(2012-3#1)
a copy of##3##3##(1991-3#1)(2008-10#1)(2012-3#1)
a copy##4##2##(1991-3#1)(2008-10#2)(2012-3#1)
a core curriculum##3##3##(1992-1#1)(2012-2#2)
a core of##2##3##(1990-3#1)(2008-10#1)
a core##14##2##(1990-3#1)(1992-1#1)(1993-12#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-6#1)(2012-2#3)(2012-3#1)
a core-doped##2##2##(2008-2#2)
a corn##2##2##(2008-10#2)
a cornerstone##2##2##(1996-11#1)(2008-8#1)
a coronary stent##2##3##(2011-2#2)
a coronary##5##2##(2008-11#1)(2011-2#2)(2012-3#2)
a correct##10##2##(1991-3#1)(1991-6#2)(1992-9#1)(2008-10#1)(2008-3#1)(2010-9#1)(2012-12#1)(2013-1#2)
a correction factor##2##3##(2008-10#2)
a correction##7##2##(1995-9#1)(1997-4#1)(2008-10#3)(2008-3#1)(2013-1#1)
a corrective gene##2##3##(2008-11#2)
a corrective##3##2##(1994-8#1)(2008-11#2)
a correlation between the##7##4##(1990-2#1)(2008-10#1)(2008-9#2)(2011-2#1)(2013-1#2)
a correlation between##18##3##(1990-2#1)(1991-6#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#2)(2013-1#2)
a correlation coefficient (r)##2##4##(2008-10#2)
a correlation coefficient of 0##24##5##(2008-10#24)
a correlation coefficient of##26##4##(2008-10#26)
a correlation coefficient##32##3##(2008-10#31)(2008-8#1)
a correlation was##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
a correlation##63##2##(1990-12#1)(1990-2#1)(1991-6#1)(1994-12#1)(1994-8#1)(2008-10#43)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
a corresponding increase in##3##4##(1991-3#1)(1993-6#1)(2008-5#1)
a corresponding increase##4##3##(1991-3#1)(1993-6#1)(2008-5#1)(2011-2#1)
a corresponding##20##2##(1991-3#1)(1993-12#1)(1993-6#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
a cortical##4##2##(2008-7#1)(2010-7#2)(2011-2#1)
a cosmetic##9##2##(2008-10#1)(2008-5#7)(2011-2#1)
a cosmid clone##3##3##(1996-2#1)(1996-3#1)(2008-10#1)
a cosmid##6##2##(1993-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#1)
a cost effective##2##3##(2008-10#1)(2008-11#1)
a cost of##4##3##(1994-9#1)(2008-10#2)(2008-9#1)
a cost##15##2##(1993-1#1)(1994-3#1)(1994-9#1)(1995-12#1)(2008-10#3)(2008-11#3)(2008-8#2)(2008-9#3)
a cost-effective alternative to##2##4##(1991-1#1)(2008-10#1)
a cost-effective method##3##3##(1994-3#2)(2008-10#1)
a cost-effective##13##2##(1991-1#1)(1991-12#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#2)(1997-7#1)(2008-10#4)(2008-7#1)
a costly##2##2##(1991-12#1)(2008-9#1)
a cotton##2##2##(2008-10#1)(2008-9#1)
a coulometric##2##2##(2008-10#2)
a counter anion##2##3##(2008-10#2)
a counter##4##2##(2008-10#4)
a counting##3##2##(2009-8#1)(2013-8#2)
a country were to initiate a biological weapons##2##8##(1992-12#2)
a country were##4##3##(1992-12#3)(2011-2#1)
a country##8##2##(1992-12#3)(1997-6#1)(2008-10#3)(2011-2#1)
a county##4##2##(1990-11#1)(1991-3#2)(2008-12#1)
a couple of##4##3##(2008-10#2)(2009-12#1)(2012-2#1)
a coupled##4##2##(2008-10#2)(2008-3#2)
a coupler##2##2##(2008-2#1)(2008-8#1)
a coupling##4##2##(1993-3#1)(1993-8#1)(2008-2#1)(2008-3#1)
a course in##2##3##(1993-6#1)(2008-12#1)
a course of##4##3##(1993-11#1)(1997-2#1)(2011-2#2)
a course##10##2##(1992-3#1)(1993-11#1)(1993-6#1)(1994-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2011-2#2)(2013-8#1)
a court##3##2##(1990-11#1)(1995-12#1)(2008-11#1)
a covariate##3##2##(1994-8#1)(2009-12#1)(2013-8#1)
a cover crop##3##3##(2008-10#3)
a coverage factor k=2##2##4##(2008-10#2)
a covered stent##2##3##(2008-12#1)(2010-5#1)
a covered##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
a coverslip##2##2##(2008-7#1)(2008-9#1)
a cow##2##2##(1990-6#1)(1991-8#1)
a craniotomy##2##2##(2012-3#1)(2013-1#1)
a cream##3##2##(2008-5#3)
a creative##3##2##(1992-2#1)(2008-10#1)(2008-12#1)
a crime##4##2##(1997-7#1)(2008-10#2)(2008-12#1)
a criminal##2##2##(1991-2#1)(1994-3#1)
a crisis##6##2##(1993-12#1)(1996-3#1)(2008-12#1)(2009-6#2)(2010-8#1)
a criterion of##2##3##(1993-3#1)(1994-12#1)
a criterion##5##2##(1993-3#1)(1994-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
a critical amino acid for##2##5##(2008-11#1)(2008-8#1)
a critical and##2##3##(1997-2#1)(2009-9#1)
a critical component in##2##4##(2008-10#1)(2009-3#1)
a critical component##3##3##(2008-10#1)(2008-7#1)(2009-3#1)
a critical evaluation of the##2##5##(1990-9#1)(1995-3#1)
a critical evaluation of##3##4##(1990-9#1)(1995-3#1)(2013-8#1)
a critical factor##4##3##(1993-1#1)(1996-2#1)(2008-10#1)(2008-8#1)
a critical parameter in##2##4##(1991-2#1)(2008-5#1)
a critical parameter##3##3##(1991-2#1)(2008-5#1)(2010-7#1)
a critical review of the literature##2##6##(2008-11#1)(2012-3#1)
a critical review of the##4##5##(1993-3#1)(2008-11#1)(2012-2#1)(2012-3#1)
a critical review of##7##4##(1992-3#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
a critical review##9##3##(1992-3#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
a critical role in the regulation of##3##7##(1997-2#1)(2008-8#1)(2013-1#1)
a critical role in the##12##5##(1990-11#1)(1990-5#1)(1997-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
a critical role in##32##4##(1990-11#1)(1990-5#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#2)(1997-2#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
a critical role##37##3##(1990-11#1)(1990-5#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#2)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#6)(2008-5#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
a critical size##2##3##(1994-5#1)(2008-7#1)
a critical step in the##2##5##(1995-8#1)(2008-10#1)
a critical step##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
a critical threshold##3##3##(2008-8#2)(2010-10#1)
a critical##128##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#1)(1997-2#2)(2007-12#1)(2008-10#12)(2008-11#14)(2008-12#4)(2008-5#3)(2008-7#3)(2008-8#9)(2008-9#3)(2009-10#4)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#3)(2010-9#1)(2011-2#11)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
a crop##3##2##(2008-10#2)(2008-11#1)
a cropping##2##2##(2008-10#2)
a cross between cv##2##4##(2008-10#2)
a cross between##24##3##(2008-10#20)(2008-9#2)(2012-3#2)
a cross sectional##2##3##(2008-7#1)(2010-2#1)
a cross##35##2##(1997-3#1)(2008-10#25)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-3#2)
a cross-disciplinary##2##2##(2008-11#1)(2013-8#1)
a cross-linked##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
a cross-linker##2##2##(2008-10#1)(2010-4#1)
a cross-linking agent##3##3##(2008-10#3)
a cross-linking##4##2##(2008-10#3)(2008-4#1)
a cross-sectional study of##3##4##(1996-1#1)(2008-7#1)(2011-2#1)
a cross-sectional study##12##3##(1996-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-8#1)
a cross-sectional survey##4##3##(2008-11#2)(2008-9#2)
a cross-sectional##25##2##(1996-1#1)(1997-3#1)(1997-4#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#3)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#3)
a crosslink##2##2##(2008-10#1)(2010-11#1)
a crosslinked##5##2##(2008-10#3)(2008-11#1)(2010-6#1)
a crossover##2##2##(1993-11#1)(2008-7#1)
a crossroads##2##2##(1996-3#1)(1997-6#1)
a crosstalk between##3##3##(2011-2#1)(2012-2#2)
a crosstalk##5##2##(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#2)
a crucial decision##2##3##(2013-1#2)
a crucial factor##3##3##(2008-11#1)(2009-10#1)(2012-3#1)
a crucial parameter##2##3##(2008-7#1)(2008-8#1)
a crucial role in maintaining##2##5##(2008-7#1)(2012-2#1)
a crucial role in the pathogenesis of##2##7##(2008-1#1)(2011-2#1)
a crucial role in the##8##5##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
a crucial role in##18##4##(1993-8#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a crucial role##23##3##(1992-10#1)(1993-8#1)(1994-3#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a crucial##44##2##(1991-12#1)(1992-10#1)(1993-8#1)(1994-3#2)(1995-6#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a crude##6##2##(1996-12#1)(2008-10#4)(2008-7#1)
a crushed##2##2##(2008-10#2)
a cryogenic##3##2##(2008-10#3)
a crystal##2##2##(2008-2#1)(2013-8#1)
a crystalline##3##2##(1990-2#1)(2008-7#1)(2010-12#1)
a crystallographic##3##2##(1991-12#1)(1992-4#1)(1993-8#1)
a cubic##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)
a cuff##2##2##(1991-12#2)
a cultivar##2##2##(2008-10#2)
a cultivated##3##2##(2008-11#1)(2013-8#2)
a cultural##2##2##(2008-11#1)(2010-8#1)
a culturally diverse##2##3##(1997-2#1)(2008-7#1)
a culturally##4##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#1)
a culture of##3##3##(2008-11#2)(2013-8#1)
a culture system##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
a culture##15##2##(1995-3#1)(2008-10#2)(2008-11#7)(2008-7#2)(2008-8#2)(2013-8#1)
a cumulative##9##2##(2008-10#4)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
a curable##2##2##(1995-6#1)(2008-10#1)
a cure for##2##3##(1995-12#1)(2008-10#1)
a cure in##2##3##(2008-5#1)(2010-12#1)
a cure##5##2##(1995-12#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-3#1)
a current of##2##3##(2008-10#1)(2012-3#1)
a current##14##2##(1991-8#1)(1992-6#1)(1994-6#1)(1994-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
a currently##2##2##(2008-10#1)(2010-10#1)
a curriculum##5##2##(1993-1#2)(2008-12#3)
a curve##2##2##(1992-8#1)(2008-10#1)
a curved##2##2##(2008-3#1)(2009-5#1)
a custom##6##2##(1992-3#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#2)
a custom-made##2##2##(2008-10#2)
a customizable checklist##2##3##(2013-1#2)
a customizable##3##2##(2013-1#3)
a customized##2##2##(2008-10#1)(2008-5#1)
a cut-off value of##2##4##(1992-11#1)(1996-12#1)
a cutaneous##4##2##(1990-8#1)(2010-6#2)(2013-1#1)
a cuticle##2##2##(2007-12#1)(2008-7#1)
a cutoff point of##2##4##(2012-2#2)
a cutoff##3##2##(2011-3#1)(2012-2#2)
a cw laser##4##3##(2008-2#2)(2008-3#2)
a cw##11##2##(2007-11#1)(2008-2#6)(2008-3#4)
a cyanobacterial##2##2##(1994-6#2)
a cyanobacterium##3##2##(1995-6#1)(2008-8#2)
a cycle of##3##3##(1992-3#1)(2007-12#1)(2008-11#1)
a cycle##5##2##(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#1)
a cyclic##7##2##(1990-8#1)(1992-4#1)(1993-6#1)(1995-9#1)(2008-10#2)(2008-8#1)
a cycling##2##2##(2008-10#1)(2013-8#1)
a cyclooxygenase inhibitor##2##3##(1997-1#1)(2008-10#1)
a cylinder##2##2##(1991-12#1)(2007-12#1)
a cylindrical impactor in the spray chamber##2##7##(2008-10#2)
a cylindrical##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-7#1)
a cyst in the##2##4##(2008-12#1)(2010-12#1)
a cyst##4##2##(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
a cysteine##2##2##(1992-9#1)(2008-10#1)
a cysteine-rich##3##2##(1991-9#1)(1995-6#1)(1997-7#1)
a cystic##4##2##(1992-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
a cytochrome P450##2##3##(1992-8#1)(1994-5#1)
a cytokine##4##2##(1994-11#1)(1995-6#1)(2009-7#2)
a cytoplasmic##8##2##(1991-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
a cytosolic##2##2##(1996-2#1)(2013-1#1)
a cytotoxic##2##2##(2008-11#1)(2013-1#1)
a daily basis##3##3##(1991-12#1)(2008-10#1)(2008-7#1)
a daily dose of##2##4##(1990-11#1)(1990-2#1)
a daily##12##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#1)(1994-12#1)(1995-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-9#1)(2013-1#1)
a damaging disease of##2##4##(2008-10#1)(2010-1#1)
a damper##2##2##(1997-3#1)(2008-11#1)
a dark circle##2##3##(2008-3#2)
a dark##6##2##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)
a data collection##4##3##(1993-3#1)(1995-2#1)(2008-3#1)(2013-1#1)
a data set##4##3##(2008-10#3)(2008-8#1)
a data##13##2##(1993-12#1)(1993-3#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
a data-driven##3##2##(2010-10#1)(2011-8#1)(2013-8#1)
a database of##3##3##(1992-3#1)(2008-4#1)(2010-8#1)
a database system##2##3##(2008-10#1)(2008-7#1)
a database##18##2##(1992-3#3)(1994-12#1)(1995-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)
a dataset##2##2##(2008-12#1)(2013-1#1)
a daunting##2##2##(1995-3#1)(2008-9#1)
a day for##4##3##(1990-9#1)(1996-12#1)(1996-2#1)(2013-1#1)
a day##24##2##(1990-5#1)(1990-9#1)(1991-4#1)(1993-1#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
a day)##3##2##(1992-11#1)(2010-6#1)(2011-1#1)
a ddI- and/or d4T-containing antiretroviral drug regimen##3##7##(2008-11#3)
a de novo mutation##2##4##(1991-12#1)(1994-11#1)
a de novo##4##3##(1991-12#1)(1994-11#1)(2008-10#1)(2008-12#1)
a dearth of##5##3##(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)
a death response##2##3##(2008-7#2)
a debate##5##2##(1995-2#1)(1995-3#1)(2008-11#1)(2012-2#1)(2013-1#1)
a decade ago##3##3##(2009-3#1)(2012-2#2)
a decade of##5##3##(1993-1#1)(1994-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
a decade##17##2##(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-5#1)(1997-4#1)(2008-10#1)(2009-3#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#1)
a decay##2##2##(2008-10#2)
a decentralized##3##2##(1992-1#1)(1994-1#2)
a decision based##2##3##(2008-11#1)(2008-7#1)
a decision is##2##3##(1996-6#1)(2012-2#1)
a decision support##3##3##(2008-10#2)(2008-11#1)
a decision##14##2##(1994-1#2)(1996-2#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
a decision-making##2##2##(2008-10#1)(2009-10#1)
a decisive factor in the##3##5##(2008-1#1)(2011-2#1)(2013-1#1)
a decisive factor##4##3##(2008-1#1)(2011-2#1)(2013-1#2)
a decisive role in the##2##5##(2008-10#2)
a decisive role in##3##4##(2008-10#2)(2012-2#1)
a decisive##9##2##(1990-11#1)(2008-1#1)(2008-10#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
a decline in susceptibility##2##4##(2008-10#1)(2008-7#1)
a decline in the##4##4##(1991-7#1)(1996-12#1)(1997-2#1)(2008-9#1)
a decline in##13##3##(1991-7#1)(1992-12#1)(1993-12#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
a decline of##2##3##(1995-5#1)(2009-12#1)
a decline##21##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
a decomposition##2##2##(2008-10#1)(2008-8#1)
a deconvolution##2##2##(2008-10#1)(2008-3#1)
a decoy##2##2##(2008-10#1)(2008-11#1)
a decrease in cell##3##4##(1993-8#1)(2008-11#2)
a decrease in protein##2##4##(2011-2#2)
a decrease in pulmonary##2##4##(1991-6#1)(2008-12#1)
a decrease in the enzyme activity##2##6##(1994-8#1)(2008-10#1)
a decrease in the number of##4##6##(1993-8#1)(1997-3#1)(2008-10#1)(2008-5#1)
a decrease in the percentage of residents##2##7##(2011-2#2)
a decrease in the percentage of##3##6##(2008-10#1)(2011-2#2)
a decrease in the water content##2##6##(2008-10#1)(2008-5#1)
a decrease in the##48##4##(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-3#1)(1994-8#3)(1996-11#1)(1997-3#1)(1997-8#1)(2006-6#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#3)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#2)
a decrease in their##2##4##(2009-11#1)(2013-8#1)
a decrease in total##2##4##(2008-11#1)(2009-8#1)
a decrease in##126##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-6#2)(1992-8#2)(1993-1#2)(1993-12#1)(1993-8#3)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#3)(1995-12#2)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#9)(2008-12#4)(2008-3#2)(2008-5#5)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-9#1)(2011-2#8)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
a decrease of the##6##4##(1996-6#2)(2008-10#4)
a decrease of viability##2##4##(2008-11#2)
a decrease of##23##3##(1994-8#2)(1996-6#2)(2008-10#10)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-1#1)(2011-2#1)
a decrease##156##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-6#2)(1992-8#2)(1993-1#2)(1993-12#1)(1993-8#3)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#5)(1995-12#2)(1996-11#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#46)(2008-11#12)(2008-12#4)(2008-3#3)(2008-5#7)(2008-7#10)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#9)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
a decreased likelihood of##3##4##(2010-11#1)(2013-1#2)
a decreased maternal age effect##2##5##(1997-3#2)
a decreased number of##2##4##(1996-2#1)(2008-11#1)
a decreased response to##3##4##(1990-11#1)(2008-11#2)
a decreased risk of##3##4##(1996-9#1)(2010-1#1)(2011-2#1)
a decreased##30##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-6#1)(2008-10#4)(2008-11#6)(2008-5#2)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#2)(2013-1#2)
a dedicated##8##2##(1993-3#1)(1994-1#2)(2008-10#2)(2008-11#2)(2008-3#1)
a deduced protein##2##3##(1997-9#1)(2008-8#1)
a deduced##3##2##(1997-9#1)(2008-8#2)
a deep##8##2##(1990-8#1)(2008-11#1)(2008-7#2)(2009-3#1)(2011-2#2)(2013-1#1)
a deeper insight##2##3##(1993-8#1)(2008-10#1)
a deeper understanding of how##3##5##(2008-11#1)(2010-9#1)(2012-12#1)
a deeper understanding of##5##4##(2008-11#2)(2010-7#1)(2010-9#1)(2012-12#1)
a deeper##10##2##(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-3#1)(2010-7#1)(2010-9#1)(2012-12#1)
a deeply rooted##2##3##(1995-5#1)(2008-10#1)
a defect in the##6##4##(1990-5#2)(1994-11#1)(2008-12#1)(2011-1#1)(2013-8#1)
a defect in##11##3##(1990-5#2)(1994-11#1)(1994-12#1)(1995-2#1)(2008-12#1)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
a defect of a##2##4##(2013-1#2)
a defect of##3##3##(1995-6#1)(2013-1#2)
a defect##14##2##(1990-5#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(2008-12#1)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
a defective##10##2##(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
a defense response##2##3##(2008-10#2)
a defense##5##2##(1996-5#2)(2008-10#2)(2008-8#1)
a deficiency in the##4##4##(1993-3#1)(1996-8#1)(2008-9#1)(2013-1#1)
a deficiency in##7##3##(1993-3#1)(1996-12#1)(1996-8#1)(2008-9#1)(2013-1#3)
a deficiency of##3##3##(1991-7#2)(2011-2#1)
a deficiency##11##2##(1991-7#2)(1993-3#1)(1996-12#1)(1996-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#3)
a defined population##3##3##(1991-1#1)(1991-12#1)(1996-12#1)
a defined##22##2##(1991-1#1)(1991-12#1)(1992-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2009-6#2)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
a definite##9##2##(1995-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2013-8#1)
a definition of##4##3##(2008-10#1)(2008-11#1)(2013-1#2)
a definition##8##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
a definitive diagnosis was##2##4##(1993-6#1)(2011-2#1)
a definitive diagnosis##6##3##(1993-6#1)(1997-8#3)(2011-2#1)(2012-3#1)
a definitive##11##2##(1991-8#1)(1993-6#1)(1995-1#1)(1997-8#3)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a deformable model##2##3##(2009-12#1)(2012-3#1)
a degenerate##2##2##(2008-10#1)(2008-3#1)
a degree of##4##3##(1995-5#1)(2008-10#2)(2013-1#1)
a degree##8##2##(1991-2#1)(1992-1#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#1)
a delay in the##2##4##(1994-6#1)(2008-10#1)
a delay in##12##3##(1990-12#1)(1994-6#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#2)
a delay of##4##3##(1991-3#1)(2008-6#1)(2010-6#1)(2012-6#1)
a delay##27##2##(1990-12#1)(1991-3#1)(1994-6#1)(1994-8#1)(1997-4#1)(2008-10#7)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-6#1)(2012-7#1)
a delayed##11##2##(1991-6#1)(1993-3#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
a deleterious##3##2##(1992-9#1)(1997-5#1)(2008-4#1)
a deletion in##2##3##(1993-12#1)(1997-3#1)
a deletion mutant##2##3##(2008-10#1)(2008-8#1)
a deletion of##4##3##(1996-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
a deletion##13##2##(1993-11#1)(1993-12#1)(1994-12#1)(1996-6#1)(1997-3#3)(2008-10#3)(2008-8#1)(2008-9#1)(2011-1#1)
a delta##3##2##(1995-6#1)(1996-2#2)
a demand##3##2##(2008-3#1)(2008-7#1)(2012-3#1)
a demanding##3##2##(1991-2#1)(2008-9#2)
a demographic##3##2##(2008-8#1)(2008-9#1)(2010-8#1)
a demonstrable##2##2##(1994-12#1)(2008-5#1)
a demonstration of the##3##4##(1996-1#1)(2008-3#1)(2011-2#1)
a demonstration of##5##3##(1996-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
a demonstration##7##2##(1995-3#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
a denaturation##2##2##(1994-11#1)(2008-10#1)
a dense##8##2##(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-6#1)
a density of##3##3##(2008-10#1)(2008-11#2)
a density##5##2##(1997-3#1)(2008-10#2)(2008-11#2)
a density-dependent##2##2##(2008-10#1)(2008-8#1)
a dental home##2##3##(2011-2#2)
a dental office##2##3##(1994-12#1)(2008-4#1)
a dental##8##2##(1994-12#1)(2008-4#1)(2008-7#2)(2011-2#2)(2013-1#1)(2013-8#1)
a department of pulmonary medicine##2##5##(1995-2#1)(1997-4#1)
a department of##5##3##(1991-11#2)(1995-2#2)(1997-4#1)
a department##6##2##(1991-11#2)(1995-2#2)(1997-4#1)(2009-11#1)
a departmental portfolio##3##3##(2008-12#3)
a departmental##4##2##(1991-12#1)(2008-12#3)
a departure from##3##3##(2008-10#2)(2008-7#1)
a dependent virus##2##3##(2008-10#2)
a depression##2##2##(2007-12#1)(2013-8#1)
a depth of##5##3##(1990-11#1)(1993-1#1)(1996-2#1)(2008-10#2)
a depth##8##2##(1990-11#1)(1993-1#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)
a dequeened colony##2##3##(2008-6#2)
a derivative of a##2##4##(2008-11#1)(2011-1#1)
a derivative of##7##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-1#1)
a derivative##12##2##(1990-5#1)(1993-12#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-1#1)(2011-3#1)
a derivatization##2##2##(2008-10#2)
a dermal##3##2##(2008-5#3)
a dermoid cyst##2##3##(2011-2#2)
a description of the##10##4##(1990-12#1)(1992-1#1)(1994-2#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-7#1)(2013-1#1)
a description of##23##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#1)(1994-2#2)(1997-1#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-6#3)(2008-8#2)(2008-9#2)(2009-7#1)(2011-2#1)(2013-1#1)
a description##24##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#2)(1994-2#2)(1997-1#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-6#3)(2008-8#2)(2008-9#2)(2009-7#1)(2011-2#1)(2013-1#1)
a descriptive study##4##3##(1994-6#1)(2010-6#1)(2012-12#1)(2013-1#1)
a descriptive##19##2##(1991-1#1)(1992-3#1)(1994-1#1)(1994-6#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-10#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#2)
a design##6##2##(1992-12#1)(1994-2#1)(1996-12#1)(2008-3#1)(2009-4#1)(2012-3#1)
a desirable##7##2##(1992-1#1)(1997-2#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-2#1)
a desire to##2##3##(2009-4#1)(2013-1#1)
a desire##3##2##(2009-4#1)(2010-8#1)(2013-1#1)
a desired level of##2##4##(1992-9#1)(2008-10#1)
a desired##5##2##(1992-9#1)(2008-10#2)(2008-2#1)(2012-2#1)
a destabilizing effect on##2##4##(1993-8#1)(2008-8#1)
a destruction of##2##3##(2008-10#1)(2010-12#1)
a destructive disease of##5##4##(2008-10#5)
a destructive disease##7##3##(2008-10#7)
a destructive##9##2##(2008-10#7)(2013-1#1)(2013-8#1)
a detached##2##2##(2008-10#2)
a detailed account of the##2##5##(1992-2#1)(2009-12#1)
a detailed analysis of the##2##5##(2008-3#2)
a detailed analysis of##4##4##(1994-1#1)(2008-3#2)(2010-1#1)
a detailed and##2##3##(2011-2#1)(2013-8#1)
a detailed comparison between##2##4##(1994-5#1)(2008-2#1)
a detailed description of##2##4##(1996-1#1)(1996-6#1)
a detailed experimental investigation##2##4##(2008-2#1)(2008-3#1)
a detailed physical map of the region##2##7##(1997-8#2)
a detailed physical map of the##3##6##(1997-8#2)(2008-8#1)
a detailed physical##5##3##(1990-6#1)(1997-8#2)(2008-8#1)(2010-4#1)
a detailed study of##4##4##(2008-10#3)(2011-2#1)
a detailed study##5##3##(1991-12#1)(2008-10#3)(2011-2#1)
a detailed understanding of the##2##5##(2008-10#1)(2009-7#1)
a detailed understanding of##3##4##(2008-10#1)(2009-12#1)(2009-7#1)
a detailed##56##2##(1990-6#1)(1991-12#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-8#2)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
a detectable signal##3##3##(2008-10#1)(2008-9#2)
a detectable##4##2##(2008-10#2)(2008-9#2)
a detection limit (3sigma) of 0##5##6##(2008-10#5)
a detection limit (3sigma) of##7##5##(2008-10#7)
a detection limit for##2##4##(2008-10#2)
a detection limit of 0##72##5##(1992-11#1)(2007-12#1)(2008-10#68)(2008-11#1)(2010-4#1)
a detection limit of 1##37##5##(2008-10#36)(2008-2#1)
a detection limit of 10##3##5##(2008-10#2)(2008-11#1)
a detection limit of 10ppm##2##5##(2008-10#2)
a detection limit of 2##14##5##(2008-10#14)
a detection limit of 20##3##5##(2008-10#3)
a detection limit of 200##2##5##(2008-10#2)
a detection limit of 25##2##5##(2008-10#2)
a detection limit of 3##7##5##(2008-10#7)
a detection limit of 4##10##5##(2008-10#10)
a detection limit of 5##8##5##(2008-10#8)
a detection limit of 6##7##5##(2008-10#7)
a detection limit of 7##2##5##(2008-10#2)
a detection limit of 8##5##5##(2008-10#5)
a detection limit of 9##3##5##(2008-10#3)
a detection limit of##209##4##(1992-11#1)(2007-12#1)(2008-10#203)(2008-11#2)(2008-2#1)(2010-4#1)
a detection limit##236##3##(1992-11#1)(2007-12#1)(2008-10#230)(2008-11#2)(2008-2#1)(2010-4#1)
a detection of##3##3##(2008-10#3)
a detection range##2##3##(1992-12#1)(2008-10#1)
a detection sensitivity##2##3##(2008-10#1)(2008-3#1)
a detection##251##2##(1992-11#1)(1992-12#1)(1997-4#2)(2007-12#1)(2008-10#237)(2008-11#2)(2008-2#1)(2008-3#3)(2008-9#1)(2009-5#1)(2010-4#1)
a detector in##2##3##(2008-10#2)
a detector##16##2##(2008-10#13)(2008-2#2)(2008-3#1)
a detergent##2##2##(2008-4#1)(2012-2#1)
a deterioration in##2##3##(2008-7#2)
a deterioration##4##2##(1991-8#1)(2008-7#2)(2012-3#1)
a determinant##2##2##(1990-8#1)(2008-10#1)
a determination in the presence of##2##6##(2008-10#2)
a determination of##3##3##(1996-9#1)(2008-10#2)
a determination##6##2##(1996-9#1)(2008-10#4)(2010-10#1)
a deterministic##2##2##(2008-7#1)(2008-8#1)
a deterrent##2##2##(1994-5#1)(2008-10#1)
a detrimental effect on##3##4##(2008-10#1)(2008-7#1)(2010-1#1)
a detrimental effect##4##3##(2008-10#1)(2008-7#1)(2010-1#1)(2012-7#1)
a detrimental##7##2##(1996-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-1#1)(2012-7#1)
a devastating disease of##2##4##(2008-10#1)(2012-2#1)
a devastating disease##3##3##(2008-10#2)(2012-2#1)
a devastating##7##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
a developing country##5##3##(1994-9#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
a development of a##2##4##(2008-10#2)
a development of##3##3##(2008-10#2)(2008-5#1)
a development##5##2##(1993-1#1)(1994-3#1)(2008-10#2)(2008-5#1)
a developmental##6##2##(1997-9#1)(2008-11#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
a developmentally regulated##3##3##(1993-3#1)(2008-11#1)(2012-3#1)
a developmentally##4##2##(1993-3#1)(2008-11#2)(2012-3#1)
a deviation from##2##3##(2008-10#1)(2012-2#1)
a device##10##2##(1994-8#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-6#1)
a diabetic patient##2##3##(2012-3#1)(2013-1#1)
a diabetic##5##2##(1994-12#3)(2012-3#1)(2013-1#1)
a diabetogenic##2##2##(1995-2#1)(2008-11#1)
a diafiltration technique##2##3##(2008-10#2)
a diagnosis based##2##3##(2008-10#1)(2008-7#1)
a diagnosis of##33##3##(1991-11#2)(1991-8#1)(1997-3#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
a diagnosis##43##2##(1991-11#2)(1991-8#1)(1994-6#1)(1995-6#1)(1996-11#1)(1997-3#2)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
a diagnostic and therapeutic strategy##2##5##(2012-2#2)
a diagnostic and##3##3##(2010-12#1)(2012-2#2)
a diagnostic challenge##4##3##(2009-10#1)(2011-2#1)(2011-3#1)(2013-1#1)
a diagnostic dilemma##2##3##(2008-9#1)(2013-1#1)
a diagnostic##33##2##(1991-12#1)(1991-6#1)(1992-12#2)(1993-2#1)(1994-1#1)(1994-6#1)(1996-11#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#5)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#2)
a dialogue on##2##3##(1997-3#1)(2011-3#1)
a dialogue##4##2##(1997-3#1)(2011-3#1)(2013-1#1)(2013-8#1)
a dialyser##2##2##(2008-10#2)
a dialysis membrane##2##3##(2008-10#1)(2008-7#1)
a dialysis##9##2##(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#5)(2008-7#1)
a diameter of##7##3##(1990-8#1)(2007-12#1)(2008-10#3)(2008-7#1)(2013-1#1)
a diameter##12##2##(1990-8#1)(1994-2#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2013-1#1)
a diary##2##2##(2008-11#1)(2008-12#1)
a diastereoselective##2##2##(1996-5#2)
a diblock copolymer##2##3##(2008-10#1)(2008-12#1)
a diblock##3##2##(2008-10#1)(2008-12#2)
a dicistronic expression##2##3##(2008-7#2)
a dicistronic##4##2##(1997-8#1)(2008-11#1)(2008-7#2)
a dielectric##2##2##(2008-11#1)(2008-3#1)
a diet containing##2##3##(1991-12#1)(2008-11#1)
a diet##12##2##(1991-11#1)(1991-12#1)(1995-11#1)(1995-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-1#1)
a dietary supplement##2##3##(2008-10#2)
a dietary##3##2##(2008-10#2)(2011-2#1)
a dietitian##3##2##(1992-12#1)(1993-12#2)
a difference between the##3##4##(2008-3#1)(2008-7#1)(2009-7#1)
a difference between##4##3##(2008-3#1)(2008-7#1)(2009-7#1)(2010-11#1)
a difference in the##3##4##(1997-6#1)(2012-3#2)
a difference in##18##3##(1994-12#1)(1994-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#4)
a difference of##5##3##(1995-5#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-3#1)
a difference or##2##3##(1995-5#2)
a difference##43##2##(1994-12#1)(1994-5#2)(1995-5#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-3#5)
a difference?##2##2##(1997-3#1)(2013-1#1)
a different approach##4##3##(2008-11#2)(2008-7#1)(2012-3#1)
a different form##2##3##(2008-3#1)(2010-10#1)
a different genetic##2##3##(2008-10#2)
a different mechanism##2##3##(1991-5#1)(2008-8#1)
a different perspective##2##3##(2008-3#1)(2008-8#1)
a different profile##2##3##(1993-1#1)(2008-10#1)
a different risk are related##2##5##(2008-10#2)
a different set of##4##4##(1992-2#1)(2008-9#1)(2010-6#1)(2013-1#1)
a different species##3##3##(2008-10#2)(2008-4#1)
a different stimulus female##2##4##(1994-3#2)
a different way for##2##4##(2008-10#1)(2008-3#1)
a different way##3##3##(2008-10#2)(2008-3#1)
a different##105##2##(1990-12#2)(1990-5#1)(1991-5#1)(1992-2#4)(1993-1#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-12#2)(1995-2#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-1#1)(2008-10#33)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
a differential absorption coefficient of##2##5##(2008-2#2)
a differential diagnosis##2##3##(2008-10#1)(2013-1#1)
a differential##23##2##(1992-12#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#10)(2008-2#2)(2008-3#3)(2009-3#1)(2009-4#1)(2010-1#1)(2013-1#1)
a differentiation##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
a difficult problem##4##3##(2008-10#2)(2008-7#1)(2010-6#1)
a difficult task##4##3##(1990-9#1)(2008-5#1)(2008-7#1)(2008-9#1)
a difficult##14##2##(1990-9#1)(1994-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-5#1)(2010-6#1)
a difficulty in##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
a diffraction grating as a##2##5##(2007-12#2)
a diffraction grating##3##3##(2007-12#2)(2008-2#1)
a diffraction##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
a diffractive optical element##3##4##(2008-3#3)
a diffuse##14##2##(1990-6#1)(1991-11#1)(1995-11#1)(1995-12#1)(1997-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
a diffusible##4##2##(1994-12#3)(2008-10#1)
a diffusion##2##2##(2008-10#2)
a diffusive##3##2##(2008-10#2)(2008-2#1)
a digestion##2##2##(2008-10#2)
a digital image analysis##2##4##(2008-10#2)
a digital##11##2##(1992-6#1)(1993-2#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-1#1)(2013-1#1)(2013-8#1)
a dilatation##2##2##(1993-12#1)(2008-7#1)
a dilated hypokinetic cardiomyopathy##2##4##(2008-10#2)
a dilated##5##2##(1997-8#1)(2008-10#3)(2008-7#1)
a dilemma##3##2##(1994-1#1)(2008-11#1)(2008-3#1)
a diluent with##2##3##(2008-10#2)
a diluent##4##2##(2008-10#4)
a dilute##2##2##(2008-10#2)
a dilution factor of##2##4##(2008-10#2)
a dilution series of##2##4##(2008-10#2)
a dilution##8##2##(2008-10#5)(2008-7#2)(2012-3#1)
a dimension of##2##3##(1991-2#1)(2009-11#1)
a dimer##3##2##(1990-5#1)(1991-7#1)(2010-12#1)
a dimeric##8##2##(1992-3#1)(1993-8#1)(1994-11#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
a dimerization##2##2##(1996-5#1)(2013-8#1)
a diminished##2##2##(2008-10#1)(2012-2#1)
a diminution of##3##3##(2008-10#2)(2008-5#1)
a diode array detector##3##4##(2008-10#3)
a diode array spectrophotometer##2##4##(2008-10#2)
a diode array##6##3##(2008-10#5)(2008-2#1)
a diode laser##6##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
a diode##14##2##(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#3)
a diode-end-pumped##3##2##(2008-2#3)
a diode-pumped Nd##3##3##(2008-3#3)
a diode-pumped Yb##3##3##(2007-12#2)(2008-3#1)
a diode-pumped fiber-coupled##2##3##(2008-3#2)
a diode-pumped##12##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#8)
a diploid##3##2##(1993-3#1)(2008-12#1)(2009-12#1)
a dipole##2##2##(1997-6#1)(2007-12#1)
a direct action##4##3##(1990-11#1)(1991-6#1)(1992-6#1)(1994-8#1)
a direct comparison of the##2##5##(1992-3#1)(2008-5#1)
a direct comparison of##3##4##(1992-3#1)(2008-11#1)(2008-5#1)
a direct consequence of##2##4##(1994-5#1)(2008-11#1)
a direct consequence##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
a direct correlation between##3##4##(1994-5#1)(2008-11#1)(2011-1#1)
a direct detection##2##3##(2008-10#2)
a direct effect##2##3##(1991-3#1)(2008-8#1)
a direct electronic##2##3##(1994-5#2)
a direct impact on##3##4##(1993-2#1)(2008-7#1)(2009-10#1)
a direct interaction between##2##4##(1995-2#1)(2008-10#1)
a direct interaction with##2##4##(1995-8#1)(1997-2#1)
a direct interaction##4##3##(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#1)
a direct involvement of##2##4##(1995-8#1)(2008-11#1)
a direct link between##3##4##(1996-2#1)(2009-7#1)(2013-1#1)
a direct measure of the##2##5##(2008-10#1)(2008-3#1)
a direct measure of##4##4##(2008-10#2)(2008-3#1)(2013-1#1)
a direct measurement of the##4##5##(2008-10#2)(2008-3#2)
a direct method##3##3##(1990-5#1)(2008-10#2)
a direct potentiometric method##2##4##(2008-10#2)
a direct proof##3##3##(2009-10#1)(2009-12#2)
a direct relationship between##4##4##(1994-3#1)(2008-10#2)(2008-11#1)
a direct relationship##5##3##(1994-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
a direct visual##2##3##(2008-10#1)(2008-8#1)
a direct##108##2##(1990-11#2)(1990-5#3)(1991-3#1)(1991-6#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#5)(1994-8#2)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-10#28)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#2)(2009-12#2)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
a directed##2##2##(2008-11#1)(2011-2#1)
a direction##2##2##(2009-7#1)(2013-1#1)
a directly observed therapy##2##4##(1996-3#2)
a disability##2##2##(1991-11#1)(1995-12#1)
a disaster##2##2##(2008-11#1)(2010-8#1)
a discharge planner##2##3##(2010-11#2)
a discontinuous##4##2##(1996-2#1)(2008-10#2)(2008-7#1)
a discourse##2##2##(2010-10#1)(2013-8#1)
a discrepancy##2##2##(2008-2#1)(2011-2#1)
a discrete##7##2##(1993-8#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
a discriminant analysis##2##3##(1992-1#1)(2010-8#1)
a discussion about##2##3##(2008-10#1)(2008-11#1)
a discussion of how the##2##5##(2008-11#1)(2010-10#1)
a discussion of how##3##4##(2008-11#1)(2008-9#1)(2010-10#1)
a discussion of possible##2##4##(1991-2#1)(1995-12#1)
a discussion of the##18##4##(1992-9#1)(1993-2#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-9#2)(2009-12#1)(2010-5#1)(2010-9#1)(2012-2#1)
a discussion of##48##3##(1990-3#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-9#1)(1993-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-4#5)(2008-7#1)(2008-9#6)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#2)
a discussion on##6##3##(1996-3#1)(2008-1#1)(2008-11#4)
a discussion with##2##3##(2008-11#1)(2012-3#1)
a discussion##61##2##(1990-3#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-9#1)(1993-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-3#1)(1996-3#2)(1997-1#1)(1997-3#2)(2007-12#1)(2008-1#3)(2008-10#6)(2008-11#7)(2008-12#4)(2008-4#6)(2008-7#1)(2008-9#6)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
a disease complex##2##3##(2008-10#2)
a disease incidence##2##3##(2008-10#2)
a disease management strategy##2##4##(2008-10#1)(2013-1#1)
a disease management##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
a disease of the##2##4##(2008-11#1)(2008-5#1)
a disease of##9##3##(1991-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-7#1)
a disease that is##3##4##(2008-10#2)(2008-7#1)
a disease which##2##3##(1992-9#1)(1997-8#1)
a disease with##5##3##(1990-3#1)(1993-9#1)(2008-10#1)(2008-7#1)(2013-8#1)
a disease##51##2##(1990-3#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#23)(2008-11#3)(2008-5#1)(2008-7#3)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a disease-associated##2##2##(1996-12#1)(2008-10#1)
a dish##2##2##(2008-11#2)
a disintegrin and metalloprotease domain##2##5##(2008-8#1)(2008-9#1)
a disorder##5##2##(2008-1#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#1)
a disordered##2##2##(1990-12#1)(1993-5#1)
a disordering##2##2##(2008-10#1)(2008-11#1)
a dispersal-competition trade-off##2##3##(2008-8#2)
a dispersion of##3##3##(1997-2#1)(2008-3#2)
a dispersion##5##2##(1997-2#1)(2008-10#1)(2008-3#3)
a displaced##2##2##(2008-12#1)(2013-1#1)
a displacement of##2##3##(2008-10#1)(2010-12#1)
a displacement##3##2##(2008-10#2)(2010-12#1)
a display##2##2##(1995-2#1)(2012-2#1)
a disposable electrochemical DNA biosensor##5##5##(2008-10#5)
a disposable##11##2##(2008-10#10)(2008-5#1)
a disposition of##2##3##(2010-10#2)
a disposition##3##2##(1991-2#1)(2010-10#2)
a disproportionate share of##2##4##(1997-2#1)(2008-8#1)
a disproportionate##3##2##(1991-12#1)(1997-2#1)(2008-8#1)
a disrupted##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
a disruption of##2##3##(1995-9#1)(1996-12#1)
a dissecting aneurysm##2##3##(1997-5#1)(2008-7#1)
a dissection of the##2##4##(1992-10#1)(2008-9#1)
a dissection of##3##3##(1992-10#1)(2008-7#1)(2008-9#1)
a dissection##4##2##(1992-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
a dissociation##4##2##(1990-11#1)(1990-8#1)(2008-10#1)(2013-8#1)
a dissolved oxygen##4##3##(2008-10#4)
a distal##11##2##(1991-12#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-9#3)(2012-2#1)(2013-1#1)
a distance of 1##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
a distance of##14##3##(1992-1#1)(2008-10#9)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
a distance##22##2##(1992-1#1)(1997-3#1)(2008-10#12)(2008-12#2)(2008-3#1)(2008-8#2)(2008-9#1)(2010-10#1)(2013-1#1)
a distant##4##2##(1991-5#1)(2008-10#1)(2010-10#1)(2011-2#1)
a distended gallbladder containing##2##4##(2013-1#2)
a distinct begomovirus species with##2##5##(2008-10#2)
a distinct begomovirus species##3##4##(2008-10#3)
a distinct bipartite begomovirus##2##4##(2008-10#2)
a distinct entity##3##3##(2009-12#1)(2011-2#1)(2013-1#1)
a distinct position##2##3##(2008-9#1)(2012-3#1)
a distinct set of##2##4##(2008-11#1)(2011-2#1)
a distinct species##5##3##(2008-10#5)
a distinct subgroup##2##3##(2007-12#1)(2008-10#1)
a distinct##73##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-6#1)(1997-3#1)(2007-12#2)(2008-10#30)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a distinction between##6##3##(1990-5#1)(1991-3#1)(2010-12#2)(2013-8#2)
a distinction##10##2##(1990-5#1)(1991-2#1)(1991-3#1)(1992-9#1)(2008-11#1)(2008-9#1)(2010-12#2)(2013-8#2)
a distinctive##5##2##(1995-6#1)(2008-10#2)(2008-7#1)(2013-8#1)
a distributed##5##2##(2008-7#1)(2009-10#1)(2010-8#2)(2011-9#1)
a distribution of##2##3##(1997-2#1)(2008-10#1)
a distribution##4##2##(1997-2#1)(2008-10#2)(2009-11#1)
a district##2##2##(1990-3#1)(2008-10#1)
a disturbance of##2##3##(2008-10#1)(2008-7#1)
a disturbance##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
a divalent cation##2##3##(1997-3#1)(2008-6#1)
a divalent##4##2##(1990-5#1)(1997-3#1)(2008-10#1)(2008-6#1)
a divergent##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
a diverse array of##4##4##(2008-11#1)(2011-9#1)(2012-2#2)
a diverse group of##6##4##(2008-10#1)(2008-4#1)(2011-2#3)(2012-12#1)
a diverse range of##10##4##(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
a diverse set of##3##4##(2008-10#1)(2012-4#1)(2013-1#1)
a diverse##35##2##(1990-8#1)(1994-8#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-1#2)(2010-10#1)(2011-2#5)(2011-9#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#1)
a diversity of##6##3##(1994-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
a diversity##7##2##(1994-3#1)(2008-10#3)(2008-11#1)(2010-10#1)(2011-2#1)
a divided##2##2##(2008-10#2)
a doctor and##3##3##(1993-12#1)(1997-8#1)(2013-1#1)
a doctor##10##2##(1993-12#1)(1993-8#1)(1994-1#1)(1995-12#1)(1997-8#1)(2009-3#2)(2009-5#2)(2013-1#1)
a documented##3##2##(2008-10#2)(2008-11#1)
a dodecapeptide##2##2##(1992-12#1)(2008-10#1)
a dog##10##2##(1995-9#1)(1997-5#1)(2006-6#1)(2008-12#1)(2008-5#1)(2012-3#3)(2013-8#2)
a domain at the##2##4##(1997-8#2)
a domain which##2##3##(2008-11#2)
a domain##10##2##(1990-5#2)(1992-3#1)(1993-9#1)(1997-8#2)(2008-11#2)(2008-2#1)(2009-7#1)
a domestic microwave oven##6##4##(2008-10#6)
a domestic##7##2##(2008-10#6)(2011-2#1)
a dominant gene for resistance to##2##6##(2008-10#2)
a dominant gene##3##3##(2008-10#3)
a dominant role##2##3##(1992-1#1)(2008-2#1)
a dominant##23##2##(1992-1#1)(1992-3#1)(1993-11#1)(1995-5#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2013-1#1)
a dominant-negative##2##2##(2008-6#2)
a donor stream##3##3##(2008-10#3)
a donor##10##2##(1992-12#1)(1997-2#1)(2008-10#5)(2008-9#1)(2011-2#2)
a dopamine agonist##2##3##(2008-7#1)(2008-8#1)
a dopamine##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
a dopaminergic##2##2##(1990-8#1)(1996-5#1)
a dorsal##7##2##(2007-12#1)(2007-8#1)(2008-9#3)(2010-8#1)(2011-2#1)
a dosage of##3##3##(1990-9#1)(1994-2#1)(2008-9#1)
a dosage##4##2##(1990-9#1)(1994-2#1)(2008-10#1)(2008-9#1)
a dose of##27##3##(1990-9#1)(1991-2#1)(1991-6#1)(1994-3#2)(1994-8#3)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#2)(2013-1#2)
a dose range of##3##4##(1992-6#1)(1994-5#1)(2008-9#1)
a dose rate##2##3##(1990-6#1)(2009-11#1)
a dose##48##2##(1990-6#1)(1990-9#2)(1991-2#1)(1991-6#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-3#3)(1994-5#1)(1994-8#4)(1995-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
a dose- and time-dependent##5##4##(1996-2#1)(2008-11#2)(2011-2#2)
a dose- and##6##3##(1996-2#1)(2008-11#2)(2008-12#1)(2011-2#2)
a dose-dependent increase in##8##4##(1993-3#1)(1994-11#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-5#2)
a dose-dependent reduction in##2##4##(1992-12#1)(1997-2#1)
a dose-dependent reduction##3##3##(1992-12#2)(1997-2#1)
a dose-dependent##66##2##(1992-12#5)(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-8#4)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-5#4)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
a dose-related##9##2##(1994-2#1)(1995-11#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#1)
a dose-response relationship##4##3##(1990-8#1)(1993-9#1)(2008-8#1)(2011-2#1)
a dose-response study##2##3##(1994-8#2)
a dose-response##11##2##(1990-8#1)(1993-9#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
a dot##2##2##(2008-10#2)
a double mutant##2##3##(1995-6#1)(2008-7#1)
a double##28##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-9#1)(1995-6#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2011-2#2)(2013-1#1)
a double-blind randomized##3##3##(1991-3#1)(1994-6#1)(2012-12#1)
a double-blind##12##2##(1991-2#1)(1991-3#1)(1994-12#1)(1994-6#1)(1996-1#1)(2008-5#5)(2012-12#1)(2013-1#1)
a doubled haploid (DH) population##2##5##(2008-10#1)(2008-9#1)
a doubled haploid population##2##4##(2008-10#1)(2012-3#1)
a doubled haploid##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
a doubling of##2##3##(2008-10#1)(2008-11#1)
a doubling##5##2##(2008-10#1)(2008-11#4)
a down-regulation of##2##3##(2009-3#1)(2012-7#1)
a down-regulation##3##2##(2008-7#1)(2009-3#1)(2012-7#1)
a downstream##6##2##(1991-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
a dozen##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
a dramatic decrease in the##3##5##(1991-2#1)(1992-1#1)(2008-10#1)
a dramatic decrease in##8##4##(1990-3#1)(1991-2#1)(1992-1#1)(2007-12#1)(2008-10#3)(2012-3#1)
a dramatic improvement in##2##4##(1993-2#1)(1997-1#1)
a dramatic improvement##3##3##(1993-2#1)(1997-1#1)(2008-12#1)
a dramatic increase in reproductive potential##2##6##(2008-8#2)
a dramatic increase in the number of##2##7##(1994-12#1)(2008-10#1)
a dramatic increase in the##3##5##(1994-12#1)(2008-10#2)
a dramatic increase in##8##4##(1994-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2011-2#1)
a dramatic increase##10##3##(1994-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2011-2#2)
a dramatic reduction##3##3##(1995-2#1)(1996-6#1)(2013-1#1)
a dramatic reorganization##2##3##(2013-1#2)
a dramatic##33##2##(1990-3#1)(1991-2#1)(1992-1#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-1#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#3)
a drastic decrease##2##3##(1997-5#1)(2008-11#1)
a drastic reduction##2##3##(1994-12#1)(2008-10#1)
a drastic##9##2##(1994-12#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2011-1#1)
a drift##2##2##(2008-10#2)
a drinking water##2##3##(2008-10#1)(2008-9#1)
a drinking##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
a drop in the##2##4##(1996-2#1)(2008-11#1)
a drop in##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
a drop of##4##3##(1991-3#1)(2008-10#1)(2008-3#1)(2010-12#1)
a drop##8##2##(1991-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-12#1)
a droplet of##2##3##(2008-10#2)
a droplet##4##2##(2008-10#2)(2008-3#2)
a drug used##2##3##(1995-11#1)(2008-10#1)
a drug with##2##3##(2008-10#1)(2010-8#1)
a drug##30##2##(1990-2#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#3)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
a dry ashing##2##3##(2008-10#2)
a dry##15##2##(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)
a dry-room##2##2##(2008-10#2)
a dual effect##2##3##(1990-2#1)(1995-6#1)
a dual##20##2##(1990-2#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-3#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#2)(2011-2#1)(2012-2#2)(2013-8#1)
a dual-wavelength##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
a duplex##4##2##(1993-8#2)(2008-12#1)(2013-8#1)
a duplication of the##2##4##(1996-6#1)(2008-10#1)
a duplication##3##2##(1996-6#1)(1997-3#1)(2008-10#1)
a dural AVF##2##3##(1996-9#2)
a dural##5##2##(1996-9#3)(2008-7#1)(2012-12#1)
a duration of##7##3##(1993-1#1)(1997-8#1)(2008-10#1)(2008-7#2)(2008-9#1)(2013-8#1)
a duration that##2##3##(1993-1#1)(2013-1#1)
a duration##10##2##(1993-1#2)(1997-8#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
a dye##6##2##(1990-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-12#1)
a dynamic and##3##3##(2008-10#1)(2010-11#1)(2011-9#1)
a dynamic interfacial pressure##2##4##(2008-10#2)
a dynamic model##2##3##(2008-10#1)(2011-2#1)
a dynamic pH junction##3##4##(2008-10#3)
a dynamic range between##2##4##(2008-10#2)
a dynamic range from##3##4##(2008-10#3)
a dynamic range of##3##4##(2008-10#2)(2008-3#1)
a dynamic range##8##3##(2008-10#7)(2008-3#1)
a dynamic##42##2##(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-9#1)(2013-1#1)(2013-8#1)
a dysfunctional##2##2##(2008-10#1)(2012-2#1)
a dysregulated##4##2##(1992-12#1)(2009-12#1)(2011-2#2)
a eukaryotic##2##2##(1992-8#1)(2008-9#1)
a facile##4##2##(2008-10#2)(2009-11#1)(2011-2#1)
a facilitated##2##2##(1992-3#1)(2008-11#1)
a facilitative##2##2##(2008-11#2)
a facility##2##2##(1991-1#1)(1992-2#1)
a fact that##4##3##(1990-6#1)(1995-12#1)(2011-1#1)(2011-2#1)
a fact##5##2##(1990-6#1)(1995-12#1)(2008-6#1)(2011-1#1)(2011-2#1)
a factor of 1##3##4##(1992-6#1)(1995-11#1)(2008-10#1)
a factor of 10 since##2##5##(1992-3#2)
a factor of 10##5##4##(1992-3#3)(2008-10#1)(2008-5#1)
a factor of 10(4)##2##4##(1995-2#1)(2008-10#1)
a factor of 2 over a range from##2##8##(2008-10#2)
a factor of 2##7##4##(1992-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
a factor of 3##7##4##(1990-11#1)(2008-10#4)(2008-3#1)(2009-5#1)
a factor of 6##4##4##(1993-8#1)(2008-10#3)
a factor of three##2##4##(1995-12#1)(2008-10#1)
a factor of##49##3##(1990-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(2007-12#1)(2008-10#25)(2008-2#1)(2008-3#4)(2008-5#1)(2009-5#1)(2011-2#1)
a factor that##3##3##(2008-10#2)(2013-8#1)
a factor##68##2##(1990-11#1)(1990-2#1)(1990-8#3)(1991-3#1)(1991-5#1)(1992-12#2)(1992-3#3)(1992-6#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-8#1)
a factorial design to##2##4##(2008-10#2)
a factorial design##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
a factorial##8##2##(2008-10#5)(2008-11#1)(2009-10#1)(2010-4#1)
a facultatively sexual##2##3##(2008-10#2)
a failed##3##2##(2010-5#1)(2012-12#1)(2012-2#1)
a failure of##2##3##(1994-12#1)(2013-1#1)
a failure to##2##3##(1994-3#1)(2008-5#1)
a failure##7##2##(1994-12#1)(1994-3#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
a fair##3##2##(2008-10#1)(2009-10#1)(2013-1#1)
a fairly##11##2##(1992-12#1)(1994-1#1)(1996-6#1)(2008-10#4)(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#1)
a fall in##3##3##(1991-12#1)(1997-1#2)
a fall##7##2##(1991-12#1)(1997-1#2)(2008-7#2)(2013-1#2)
a false lumen##2##3##(1991-2#1)(2008-11#1)
a false##4##2##(1990-2#1)(1991-2#1)(2008-11#2)
a familial##8##2##(1990-12#1)(1991-2#1)(2008-4#1)(2008-7#4)(2012-12#1)
a familiar##4##2##(1994-8#1)(2008-11#1)(2009-10#1)(2013-1#1)
a family history of##5##4##(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
a family history##6##3##(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
a family of cysteine proteases##3##5##(2008-11#1)(2008-4#1)(2008-7#1)
a family of##36##3##(1992-3#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-8#2)(1996-2#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
a family with##2##3##(1997-8#1)(2008-7#1)
a family##58##2##(1992-3#3)(1993-1#2)(1993-12#1)(1993-6#1)(1994-5#2)(1995-12#2)(1995-2#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
a far##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
a farm##2##2##(2008-10#1)(2011-2#1)
a fascinating##2##2##(2009-10#1)(2010-8#1)
a fast and convenient method##2##5##(2008-10#1)(2008-11#1)
a fast and convenient##3##4##(2008-10#2)(2008-11#1)
a fast and reliable method##2##5##(2008-10#1)(2009-12#1)
a fast and reproducible##2##4##(2008-10#2)
a fast and sensitive##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
a fast and##20##3##(1995-3#1)(2008-10#12)(2008-11#2)(2008-7#1)(2008-9#3)(2009-12#1)
a fast atomization program##2##4##(2008-10#2)
a fast initial##2##3##(2008-11#1)(2012-2#1)
a fast potential response of##2##5##(2008-10#2)
a fast response time of approximately##3##6##(2008-10#3)
a fast response time of##15##5##(2008-10#15)
a fast response time##19##4##(2008-10#19)
a fast response##23##3##(2008-10#23)
a fast##76##2##(1994-5#1)(1994-6#1)(1995-3#1)(2008-10#56)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#3)(2009-12#1)(2011-7#1)(2012-2#2)(2012-3#1)
a faster##15##2##(1991-3#1)(1992-12#1)(1993-2#1)(1994-2#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)(2013-8#1)
a fatal outcome##2##3##(2008-12#1)(2013-8#1)
a fatal##5##2##(2008-12#1)(2008-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
a favorable##15##2##(1991-1#1)(1992-11#1)(1994-5#1)(1995-12#1)(2008-10#6)(2008-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
a favorite##2##2##(2008-10#1)(2008-4#1)
a favourable outcome##2##3##(2010-10#1)(2010-3#1)
a favourable##9##2##(1991-6#2)(1996-11#1)(1996-6#1)(1997-5#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-3#1)
a feasibility study##3##3##(2008-10#1)(2010-10#1)(2010-7#1)
a feasibility##5##2##(1994-8#1)(2008-10#2)(2010-10#1)(2010-7#1)
a feasible and##2##3##(1992-2#1)(2008-12#1)
a feasible##9##2##(1992-2#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-4#1)(2010-6#1)
a feature of the##2##4##(1997-8#1)(2011-2#1)
a feature of##5##3##(1996-2#1)(1997-7#1)(1997-8#1)(2008-11#1)(2011-2#1)
a feature##10##2##(1994-3#1)(1995-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
a featureless##2##2##(2008-8#1)(2009-5#1)
a fed-batch process##2##3##(2008-11#1)(2011-1#1)
a fed-batch##5##2##(2008-11#3)(2008-7#1)(2011-1#1)
a federal##2##2##(1994-3#1)(2008-11#1)
a federally##2##2##(2008-12#1)(2013-1#1)
a feed forward##2##3##(2008-10#1)(2008-11#1)
a feed##3##2##(2008-10#2)(2008-11#1)
a feedback##4##2##(1991-7#1)(1995-6#1)(2008-10#1)(2008-8#1)
a feeding##5##2##(1994-12#1)(2008-11#2)(2008-5#1)(2010-9#1)
a feeling of##2##3##(1990-11#1)(2008-1#1)
a female child##3##3##(2008-10#2)(2010-1#1)
a female patient affected by##2##5##(1992-12#1)(2010-7#1)
a female patient with##4##4##(1992-12#1)(2008-1#1)(2012-12#1)(2013-1#1)
a female patient##9##3##(1992-12#2)(2008-1#1)(2008-12#1)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
a female##23##2##(1990-3#1)(1992-12#2)(1994-2#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2012-12#2)(2012-3#3)(2013-1#2)
a feminist##2##2##(1996-1#1)(2008-10#1)
a fertile##2##2##(2008-12#1)(2012-2#1)
a fetal##4##2##(1990-2#1)(1993-3#1)(1994-8#1)(2008-11#1)
a fetus##2##2##(1990-5#1)(2012-3#1)
a fever##2##2##(2011-2#1)(2012-12#1)
a few bronchiolar/alveolar##2##3##(2008-9#2)
a few cases of##5##4##(1994-3#1)(1996-11#1)(2008-12#1)(2010-6#1)(2011-2#1)
a few cases##12##3##(1994-3#1)(1996-11#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
a few days##8##3##(1991-4#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)
a few examples of##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
a few examples##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
a few hours after##3##4##(1990-9#1)(2008-10#1)(2012-12#1)
a few hours##9##3##(1990-9#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
a few hundred##2##3##(2008-11#1)(2008-3#1)
a few large##2##3##(1994-3#1)(2008-5#1)
a few methods##2##3##(2008-4#1)(2010-6#1)
a few minutes##4##3##(2008-10#3)(2008-4#1)
a few minutes'##2##3##(2012-2#2)
a few nanometers##2##3##(2008-10#2)
a few notable##2##3##(1995-6#1)(2013-1#1)
a few of##4##3##(1990-2#1)(1992-3#1)(2008-8#1)(2011-2#1)
a few percent##4##3##(1992-6#1)(1997-7#1)(2008-3#2)
a few recent##2##3##(2008-10#1)(2013-1#1)
a few seconds of##2##4##(2008-10#1)(2008-3#1)
a few seconds##5##3##(1997-4#1)(2008-10#3)(2008-3#1)
a few selected##3##3##(2010-10#1)(2011-2#1)(2012-2#1)
a few short##2##3##(1993-6#1)(2008-5#1)
a few simple##2##3##(1994-1#1)(2010-7#1)
a few small##2##3##(1994-1#1)(2008-7#1)
a few studies##2##3##(2008-11#1)(2013-1#1)
a few such cases have currently been reported in the medical literature##2##12##(2010-6#2)
a few vacuoles##2##3##(2008-7#2)
a few weeks##5##3##(1996-11#1)(1996-5#1)(2008-10#3)
a few years ago##3##4##(1990-11#1)(1992-9#1)(2010-8#1)
a few years##5##3##(1990-11#1)(1991-6#1)(1992-9#1)(2010-8#1)(2013-1#1)
a few##212##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-6#2)(1994-1#2)(1994-12#1)(1994-3#3)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#3)(2008-10#61)(2008-11#10)(2008-12#6)(2008-3#8)(2008-4#3)(2008-5#3)(2008-7#7)(2008-8#5)(2008-9#6)(2009-10#1)(2009-9#2)(2010-10#3)(2010-4#2)(2010-5#1)(2010-6#6)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#12)(2012-12#2)(2012-2#5)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#11)(2013-8#1)
a fiber Bragg grating##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
a fiber grating##2##3##(2007-12#2)
a fiber laser##2##3##(2008-3#2)
a fiber optic liquid waveguide##2##5##(2008-10#2)
a fiber optic sensor##2##4##(2008-10#2)
a fiber optic##8##3##(2008-10#7)(2010-6#1)
a fiber ring semiconductor laser##2##5##(2008-2#2)
a fiber ring##3##3##(2008-2#2)(2008-3#1)
a fiber##21##2##(2007-12#4)(2008-10#7)(2008-2#4)(2008-3#5)(2010-6#1)
a fiber-coupled##3##2##(2007-12#1)(2008-3#2)
a fiber-optic##4##2##(2008-10#4)
a fibre##2##2##(2008-10#2)
a fibre-optic probe##2##3##(2008-10#2)
a fibrin##3##2##(1992-3#1)(1995-6#1)(2009-6#1)
a fibrinogen##2##2##(2008-10#2)
a fibroblast cell line##2##4##(1996-12#1)(2008-10#1)
a fibroblast##4##2##(1996-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
a fibroblast-like shape##2##3##(2008-11#2)
a fibroblast-like##4##2##(2008-11#4)
a fibrous##3##2##(2008-5#1)(2008-7#2)
a field experiment in##2##4##(2008-10#1)(2008-8#1)
a field experiment##8##3##(2008-10#5)(2008-8#3)
a field of##2##3##(2008-12#1)(2009-8#1)
a field plot##3##3##(2008-10#3)
a field population##2##3##(2008-10#2)
a field sample##2##3##(2008-10#2)
a field study##3##3##(2008-10#3)
a field survey##2##3##(2008-10#1)(2008-12#1)
a field trial in##2##4##(2008-10#2)
a field trial##6##3##(1990-6#1)(2008-10#5)
a field##55##2##(1990-6#1)(2007-12#1)(2008-10#41)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-5#1)(2012-12#1)
a field-widened Michelson interferometer##2##4##(2008-3#2)
a fifth of##2##3##(1996-11#1)(2011-2#1)
a fifth##4##2##(1996-11#1)(2008-6#1)(2010-3#1)(2011-2#1)
a fight##2##2##(2008-7#1)(2008-9#1)
a figure of##2##3##(2008-3#1)(2009-10#1)
a filamentous##2##2##(2008-11#1)(2012-3#1)
a film of##3##3##(2008-10#3)
a film##7##2##(2008-10#5)(2008-11#1)(2008-5#1)
a filter paper##2##3##(2008-10#2)
a filter##6##2##(1995-3#1)(2008-10#3)(2008-2#2)
a filtered##2##2##(2008-10#1)(2011-2#1)
a final diagnosis##2##3##(1991-6#1)(1994-6#1)
a final solution##2##3##(2008-10#2)
a final##23##2##(1991-3#1)(1991-6#1)(1993-3#1)(1994-6#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#3)(2010-10#1)(2011-2#1)(2012-9#1)(2013-1#1)(2013-8#1)
a finding of##2##3##(2011-1#1)(2013-1#1)
a finding that##5##3##(1994-8#1)(1997-2#1)(1997-3#1)(2008-8#1)(2010-10#1)
a finding which##2##3##(2010-7#1)(2011-1#1)
a finding##14##2##(1991-1#1)(1992-3#1)(1994-8#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2013-1#1)
a fine network##2##3##(2008-8#2)
a fine##7##2##(1994-3#1)(2008-10#2)(2008-3#1)(2008-8#2)(2011-2#1)
a finite##10##2##(2008-11#2)(2008-3#6)(2008-9#1)(2013-1#1)
a fire##4##2##(1993-12#1)(1994-12#1)(1996-12#1)(2008-10#1)
a firefly luciferase##2##3##(2008-10#2)
a firm##6##2##(1990-6#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
a first approach to##2##4##(2008-10#1)(2008-11#1)
a first attempt to##2##4##(2011-2#1)(2012-2#1)
a first choice##3##3##(1990-3#1)(1996-3#1)(2008-10#1)
a first step in##2##4##(1996-6#1)(1997-2#1)
a first step the##2##4##(2008-10#1)(2008-11#1)
a first step to##3##4##(1993-2#1)(2007-12#1)(2008-10#1)
a first step toward##5##4##(1997-7#1)(2008-10#1)(2009-7#1)(2010-12#1)(2012-3#1)
a first step##21##3##(1991-2#1)(1993-2#1)(1993-6#1)(1994-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-9#1)(2009-7#1)(2010-12#1)(2012-3#1)
a first##57##2##(1990-3#1)(1991-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#14)(2008-11#8)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#3)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
a first-line##7##2##(2008-10#2)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
a first-order rate##2##3##(1995-6#1)(2008-10#1)
a first-order##5##2##(1995-6#1)(2008-10#3)(2008-5#1)
a fish##5##2##(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
a fistula##4##2##(1991-8#1)(1996-9#1)(1997-3#1)(2012-12#1)
a fit##2##2##(2008-3#1)(2012-2#1)
a fitness function##2##3##(2008-10#1)(2010-10#1)
a fitness##3##2##(2008-10#1)(2008-8#1)(2010-10#1)
a five##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
a five-year period##4##3##(1991-12#1)(1991-6#1)(1992-1#1)(2008-12#1)
a five-year##8##2##(1991-12#1)(1991-6#1)(1992-1#1)(1993-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
a fixation##2##2##(2008-10#1)(2009-8#1)
a fixed amount of##3##4##(1991-5#2)(2008-10#1)
a fixed bed bioreactor##3##4##(2008-11#3)
a fixed bed##4##3##(2008-11#4)
a fixed concentration of##2##4##(2008-10#2)
a fixed number of##2##4##(1994-9#1)(2008-10#1)
a fixed parameter##2##3##(1997-2#1)(2008-9#1)
a fixed population of neurons##2##5##(1991-2#2)
a fixed time of 5 min##2##6##(2008-10#2)
a fixed time##4##3##(2008-10#4)
a fixed##50##2##(1990-9#1)(1991-1#1)(1991-2#2)(1991-5#2)(1991-6#1)(1993-8#1)(1994-2#1)(1994-9#2)(1996-11#1)(1996-12#1)(1996-3#3)(1997-2#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-12#1)(2012-3#1)
a fixed-bed##3##2##(2008-11#2)(2008-12#1)
a flame atomic absorption spectrometer##6##5##(2008-10#6)
a flame atomic absorption##7##4##(2008-10#7)
a flame ionization detector (FID)##2##5##(2008-10#2)
a flame ionization detector##4##4##(2008-10#3)(2008-11#1)
a flame##16##2##(2008-10#14)(2008-11#1)(2008-2#1)
a flash-lamp-pumped##3##2##(2008-2#2)(2008-3#1)
a flat##13##2##(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)
a flattening of##2##3##(1995-1#1)(2008-5#1)
a flavonol##2##2##(2008-10#2)
a flexible linker##2##3##(1994-5#1)(2009-7#1)
a flexible##17##2##(1992-1#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-7#1)(2013-1#1)
a flow analysis##2##3##(2008-10#2)
a flow cell##9##3##(2008-10#9)
a flow cytometer##9##3##(2006-6#1)(2008-9#8)
a flow cytometric##5##3##(2006-6#2)(2008-7#1)(2010-1#1)(2011-2#1)
a flow injection (FI) system##6##5##(2008-10#6)
a flow injection (FI)##7##4##(2008-10#7)
a flow injection analysis (FIA) system##4##6##(2008-10#4)
a flow injection analysis system##2##5##(2008-10#2)
a flow injection analysis##10##4##(2008-10#9)(2008-9#1)
a flow injection approach##3##4##(2008-10#3)
a flow injection on-line##2##4##(2008-10#2)
a flow injection system and##3##5##(2008-10#3)
a flow injection system coupled to##2##6##(2008-10#2)
a flow injection system coupled##3##5##(2008-10#3)
a flow injection system for the determination of##3##8##(2008-10#3)
a flow injection system for the##4##6##(2008-10#4)
a flow injection system is##2##5##(2008-10#2)
a flow injection system with##6##5##(2008-10#6)
a flow injection system##29##4##(2008-10#29)
a flow injection##62##3##(2008-10#61)(2008-9#1)
a flow manifold##2##3##(2008-10#2)
a flow of##4##3##(2008-10#3)(2012-2#1)
a flow program##2##3##(2008-10#2)
a flow rate of 1 ml min(-1)##2##7##(2008-10#2)
a flow rate of 1##11##5##(2008-10#11)
a flow rate of 2##5##5##(2008-10#5)
a flow rate of##35##4##(1996-12#1)(2008-10#34)
a flow rate##38##3##(1996-12#1)(2008-10#37)
a flow system##10##3##(2008-10#10)
a flow through cell##2##4##(2008-10#2)
a flow##160##2##(1995-2#1)(1996-12#1)(2006-6#3)(2008-10#141)(2008-3#1)(2008-7#1)(2008-9#9)(2010-1#1)(2011-2#1)(2012-2#1)
a flow-cell##3##2##(2008-10#3)
a flow-continuous##2##2##(2008-10#2)
a flow-injection system with##3##4##(2008-10#3)
a flow-injection system##11##3##(2008-10#11)
a flow-injection##15##2##(2008-10#15)
a flow-rate of 1##3##4##(2008-10#2)(2008-5#1)
a flow-rate of##4##3##(2008-10#3)(2008-5#1)
a flow-through bulk optode##2##4##(2008-10#2)
a flow-through cell##4##3##(2008-10#3)(2013-1#1)
a flow-through type##4##3##(2008-10#4)
a flow-through##25##2##(2008-10#24)(2013-1#1)
a flow-type chemiluminescence##2##3##(2008-10#2)
a flower##2##2##(2008-8#1)(2009-6#1)
a flowing##9##2##(2008-10#8)(2008-9#1)
a fluctuating##2##2##(2008-10#1)(2008-8#1)
a fluid lamellar signal is##2##5##(1994-5#2)
a fluid##5##2##(1994-5#2)(2008-3#1)(2008-9#1)(2011-2#1)
a fluorescein##3##2##(2008-10#3)
a fluorescence##12##2##(1994-5#1)(1997-3#1)(2008-10#9)(2008-4#1)
a fluorescence-based##2##2##(2008-10#1)(2008-9#1)
a fluorescent##28##2##(1990-2#2)(1994-12#1)(2008-10#19)(2008-11#3)(2008-7#1)(2010-4#1)(2010-5#1)
a fluoride ion-selective electrode##3##4##(2008-10#3)
a fluoride##4##2##(2008-10#4)
a fluoride-selective##3##2##(2008-10#3)
a fluorimetric##5##2##(2008-10#5)
a fluorochrome##2##2##(2008-11#1)(2008-9#1)
a fluorogenic##2##2##(2008-10#2)
a fluorometric##2##2##(2008-10#2)
a fluorometric-enzymatic method based on##2##5##(2008-10#2)
a fluorometric-enzymatic method##3##3##(2008-10#3)
a fluoroquinolone##2##2##(2008-10#1)(2011-2#1)
a fluorous##2##2##(2010-4#2)
a flux##2##2##(2008-10#1)(2008-7#1)
a focal##10##2##(1992-6#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
a focus group##2##3##(2008-11#2)
a focus of##5##3##(1991-1#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
a focus on recent##2##4##(2008-10#1)(2011-2#1)
a focus on the##6##4##(1995-12#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-10#1)(2013-1#1)
a focus on##24##3##(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
a focus##34##2##(1991-1#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-2#3)(2013-1#3)(2013-8#1)
a focused continuous-wave##2##3##(2008-3#2)
a focused laser beam##2##4##(2008-2#1)(2008-3#1)
a focused microwave digestor##2##4##(2008-10#2)
a focused microwave oven##2##4##(2008-10#2)
a focused microwave##5##3##(2008-10#5)
a focused##11##2##(1996-3#1)(2008-10#5)(2008-2#1)(2008-3#4)
a follicular##2##2##(2008-12#1)(2012-3#1)
a follow up of##3##4##(2007-8#1)(2013-1#1)(2013-8#1)
a follow-up of the##2##4##(1993-6#1)(2008-10#1)
a follow-up of##4##3##(1990-6#1)(1991-6#1)(1993-6#1)(2008-10#1)
a follow-up##15##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-11#1)(1993-6#1)(1994-6#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
a food##13##2##(1993-11#1)(1993-3#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#2)(2012-2#2)
a force##3##2##(1991-3#1)(1994-1#1)(2012-2#1)
a forearm##2##2##(2008-5#1)(2008-9#1)
a forecasting system for carpogenic germination##2##6##(2008-10#2)
a forecasting system##3##3##(2008-10#3)
a foreign body##4##3##(1990-3#1)(2011-2#2)(2013-1#1)
a foreign gene##4##3##(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#1)
a foreign##10##2##(1990-3#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#2)(2013-1#1)
a foreign-body##2##2##(2011-2#1)(2012-12#1)
a forensic##2##2##(2008-10#2)
a forgotten##2##2##(2008-11#2)
a form of##17##3##(1990-8#1)(1991-12#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
a form that##3##3##(1991-5#1)(1992-8#1)(1996-12#1)
a form##21##2##(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
a formal policy for##2##4##(1991-1#2)
a formal##11##2##(1991-1#2)(1994-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)
a formation##2##2##(2008-10#1)(2008-5#1)
a former industrial sludge basin##2##5##(2008-11#2)
a former##5##2##(2008-10#2)(2008-11#3)
a formerly##2##2##(2008-5#1)(2008-8#1)
a formidable challenge##2##3##(1991-2#1)(2008-8#1)
a formula for##3##3##(1992-9#1)(2008-5#1)(2008-8#1)
a formula##4##2##(1992-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
a formulation##5##2##(1995-5#1)(2008-10#2)(2008-5#1)(2012-2#1)
a fornix##2##2##(2008-10#1)(2011-2#1)
a fortuitous##2##2##(2008-11#1)(2008-3#1)
a forum for##2##3##(1995-3#1)(1996-1#1)
a forum to##2##3##(2008-10#1)(2008-11#1)
a forum##4##2##(1995-3#1)(1996-1#1)(2008-10#1)(2008-11#1)
a forward##2##2##(2008-11#1)(2008-3#1)
a foundation for the##2##4##(1995-12#1)(2008-10#1)
a foundation for##9##3##(1995-12#1)(1996-1#1)(1996-2#1)(2008-10#3)(2008-11#1)(2009-5#1)(2010-10#1)
a foundation##11##2##(1995-12#1)(1996-1#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-10#1)
a founder effect##3##3##(2008-10#3)
a founder population##2##3##(2008-10#1)(2008-8#1)
a founder##5##2##(2008-10#4)(2008-8#1)
a four##5##2##(2008-10#1)(2008-11#2)(2012-5#2)
a four-channel##2##2##(2008-10#1)(2008-3#1)
a four-color##2##2##(2008-9#2)
a four-helix##2##2##(1990-5#1)(1994-3#1)
a four-part##2##2##(2008-9#1)(2012-3#1)
a four-year##2##2##(1995-3#1)(1997-8#1)
a fourth##8##2##(1990-7#1)(1993-3#2)(2008-10#5)
a fourth-order##2##2##(2008-2#1)(2008-6#1)
a fraction of the##7##4##(1995-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
a fraction of##10##3##(1995-6#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-8#1)(2012-2#1)
a fraction##11##2##(1991-5#1)(1995-6#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-8#1)(2012-2#1)
a fractional effective dose (FED)##2##5##(1996-12#2)
a fractionation##2##2##(2008-10#1)(2008-7#1)
a fracture of##2##3##(2008-12#1)(2013-1#1)
a fracture##4##2##(2008-11#1)(2008-12#1)(2013-1#2)
a fractured##2##2##(1990-3#1)(2011-2#1)
a fragment of##5##3##(1992-12#1)(1996-3#1)(2008-12#1)(2010-4#1)(2013-8#1)
a fragment##9##2##(1992-12#1)(1992-6#1)(1993-3#1)(1996-3#1)(2008-10#2)(2008-12#1)(2010-4#1)(2013-8#1)
a fragmented##2##2##(2008-8#1)(2012-3#1)
a frame##3##2##(1992-2#1)(2008-3#1)(2008-7#1)
a frame-by-frame##2##2##(2011-2#2)
a frameshift##2##2##(2008-9#1)(2010-4#1)
a framework for examining##2##4##(1992-2#1)(2010-10#1)
a framework for sample-based graphics##2##5##(2008-6#2)
a framework for the##3##4##(1993-3#1)(2008-10#1)(2012-12#1)
a framework for##26##3##(1991-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1995-12#1)(1995-2#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#2)(2010-10#1)(2010-11#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
a framework in##2##3##(1994-3#1)(2008-10#1)
a framework to##2##3##(2008-11#1)(2012-2#1)
a framework##36##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#2)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-6#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
a free fat##3##3##(1997-3#2)(2011-2#1)
a free flap##2##3##(2012-12#2)
a free radical##2##3##(1995-8#1)(2008-10#1)
a free##20##2##(1990-9#1)(1991-3#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-3#2)(2008-10#2)(2009-8#1)(2010-6#1)(2011-2#3)(2012-12#3)
a free-knot spline shape function##2##5##(1995-9#2)
a free-living##5##2##(1992-9#1)(1995-5#1)(2008-7#1)(2011-2#2)
a freely##2##2##(2007-12#1)(2011-3#1)
a frequency of##13##3##(1995-3#1)(2008-10#8)(2008-11#2)(2011-2#1)(2013-1#1)
a frequency##17##2##(1993-12#1)(1995-3#1)(2008-10#9)(2008-11#3)(2008-2#1)(2011-2#1)(2013-1#1)
a frequent cause of##3##4##(1990-9#1)(2008-7#1)(2013-1#1)
a frequent target##2##3##(2008-11#1)(2008-9#1)
a frequent##19##2##(1990-9#1)(1993-12#1)(1993-3#1)(1995-10#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#2)
a frequently used##3##3##(2008-5#1)(2012-12#1)(2013-8#1)
a frequently##4##2##(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
a fresh##5##2##(1997-3#1)(1997-6#1)(2008-10#1)(2010-3#1)(2012-3#1)
a freshly##2##2##(1992-6#1)(1993-3#1)
a frontal##2##2##(2008-10#1)(2008-7#1)
a full agonist##3##3##(1992-8#1)(1995-11#1)(2009-8#1)
a full factorial design##2##4##(2008-10#2)
a full length##4##3##(1991-5#2)(1991-9#1)(2008-9#1)
a full recovery##4##3##(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
a full##37##2##(1991-5#2)(1991-9#1)(1992-8#1)(1993-2#1)(1995-11#1)(1995-12#2)(1995-6#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
a full-length cDNA clone of##2##5##(1997-3#1)(2008-10#1)
a full-length cDNA clone##3##4##(1997-3#1)(2008-10#2)
a full-length cDNA##8##3##(1991-9#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-6#1)(2008-8#1)
a full-length functional##2##3##(1993-12#1)(1995-2#1)
a full-length infectious clone of##2##5##(2008-10#1)(2008-9#1)
a full-length infectious clone##3##4##(2008-10#1)(2008-9#2)
a full-length##19##2##(1991-7#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#5)
a full-time##2##2##(1994-2#1)(1996-3#1)
a fully automated##4##3##(2008-10#3)(2008-11#1)
a fully developed##2##3##(2008-7#1)(2009-8#1)
a fully##24##2##(1993-1#1)(1996-1#1)(1996-3#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#1)
a fully-supervised learning##2##3##(2010-7#2)
a fulminating##2##2##(2008-12#1)(2011-2#1)
a fumigated##2##2##(2008-10#2)
a function for##2##3##(2008-11#1)(2012-2#1)
a function in the##2##4##(2008-10#2)
a function of both the##3##5##(2008-10#2)(2008-7#1)
a function of both##8##4##(1994-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#1)(2013-8#1)
a function of disease##2##4##(2008-10#2)
a function of incidence##2##4##(2008-10#2)
a function of pH##14##4##(1990-5#1)(1996-12#1)(2008-10#12)
a function of the degree of##2##6##(1991-5#1)(2008-3#1)
a function of the local##2##5##(2008-9#1)(2009-12#1)
a function of the rate of##2##6##(2008-10#1)(2008-11#1)
a function of the specific energy dissipation##2##7##(2008-7#2)
a function of the##60##4##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-3#2)(1994-12#1)(1994-5#1)(1995-9#1)(1996-11#1)(1996-3#2)(2007-12#1)(2008-10#19)(2008-11#2)(2008-3#10)(2008-5#6)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2012-2#1)
a function of time##16##4##(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2010-4#1)(2010-7#1)
a function of##227##3##(1990-10#1)(1990-12#1)(1990-5#2)(1991-1#2)(1991-11#2)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-9#1)(1994-12#1)(1994-2#1)(1994-5#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-7#1)(2007-12#2)(2008-10#96)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#24)(2008-4#2)(2008-5#13)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#2)
a function##242##2##(1990-10#1)(1990-12#1)(1990-5#3)(1991-1#2)(1991-11#2)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-9#1)(1994-12#1)(1994-2#1)(1994-5#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-7#1)(2007-12#2)(2008-10#103)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#25)(2008-4#2)(2008-5#13)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#2)(2010-7#1)(2012-2#3)(2012-4#1)(2013-1#1)(2013-8#2)
a functional analysis of##2##4##(2008-11#1)(2011-3#1)
a functional coupling##2##3##(1994-6#1)(1995-6#1)
a functional form##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
a functional group##2##3##(2008-10#1)(2008-11#1)
a functional ingredient##2##3##(2008-5#1)(2010-4#1)
a functional receptor##2##3##(1993-2#1)(1993-8#1)
a functional role##5##3##(1995-11#1)(1995-12#1)(1997-7#1)(2008-11#1)(2009-1#1)
a functional##62##2##(1991-5#2)(1991-6#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-7#3)(1997-8#1)(2008-10#9)(2008-11#9)(2008-4#2)(2008-5#3)(2008-8#1)(2009-1#2)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#3)(2011-3#1)(2013-1#3)
a functionalized##3##2##(2008-10#3)
a functionally redundant role##2##4##(2009-10#2)
a functionally##8##2##(1990-5#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-4#2)(2009-10#2)
a functioning##2##2##(1995-2#1)(2008-1#1)
a fundamental activity of##2##4##(1995-12#1)(2008-9#1)
a fundamental aspect of##2##4##(2008-12#1)(2008-9#1)
a fundamental biological##2##3##(2008-11#1)(2008-8#1)
a fundamental role in##3##4##(2008-8#2)(2013-7#1)
a fundamental tool for##2##4##(2008-4#1)(2011-2#1)
a fundamental##37##2##(1991-1#1)(1991-3#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#6)(2008-9#3)(2009-6#2)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
a fungal##11##2##(1995-3#1)(2008-10#6)(2008-5#1)(2008-9#1)(2011-2#1)(2012-6#1)
a fungicide##7##2##(2008-10#7)
a fungus##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
a fur mutation##2##3##(2009-6#2)
a furnace##2##2##(2008-10#2)
a further decrease##2##3##(1991-6#1)(1994-3#1)
a further increase in##2##4##(2008-5#1)(2013-8#1)
a further step##3##3##(1995-2#1)(1997-3#1)(2008-10#1)
a further##35##2##(1991-2#1)(1991-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-3#1)(2006-6#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-12#1)(2011-2#2)(2013-8#2)
a fused-silica##3##2##(1997-2#1)(2007-11#1)(2008-5#1)
a fusion gene##2##3##(1996-12#1)(2010-5#1)
a fusion protein##9##3##(1990-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-9#1)
a fusion##14##2##(1990-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-11#1)(1996-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-5#1)(2012-3#1)
a future##12##2##(1990-6#1)(1992-3#1)(1994-2#1)(1997-4#1)(2008-10#3)(2008-11#3)(2012-2#1)(2012-9#1)
a fuzzy##2##2##(2010-8#1)(2011-2#1)
a gain of##2##3##(2012-3#1)(2013-8#1)
a galvanic detector##2##3##(2008-10#2)
a galvanic##4##2##(2008-10#4)
a ganglion##3##2##(2008-9#3)
a gap in the##2##4##(1991-1#1)(2010-3#1)
a gap in##4##3##(1991-1#1)(2008-11#1)(2008-8#1)(2010-3#1)
a gap##7##2##(1991-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-3#1)(2012-2#1)
a gas chromatograph##5##3##(2008-10#4)(2008-11#1)
a gas chromatographic##2##3##(2008-10#2)
a gas##17##2##(1996-2#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)
a gas-filled hollow waveguide##2##4##(2007-11#2)
a gas-liquid separator##3##3##(2008-10#3)
a gas-liquid##4##2##(2008-10#4)
a gas-permeable##4##2##(2008-10#3)(2008-7#1)
a gaseous##3##2##(2008-10#3)
a gastric##4##2##(1993-12#1)(1996-11#1)(2008-12#1)(2008-9#1)
a gastrointestinal##3##2##(1996-3#1)(2012-12#1)(2012-3#1)
a gel##5##2##(1993-6#1)(2008-10#2)(2008-7#1)(2011-2#1)
a gelatin##2##2##(2008-11#1)(2012-12#1)
a gender##3##2##(1993-6#1)(2009-10#1)(2010-12#1)
a gene and##2##3##(2008-4#2)
a gene encoding the##2##4##(1993-6#1)(1996-6#1)
a gene encoding##6##3##(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-6#1)
a gene family##3##3##(1993-12#1)(2008-8#2)
a gene for##2##3##(2008-10#2)
a gene in##3##3##(1990-5#1)(1997-3#1)(2008-10#1)
a gene involved in##2##4##(2008-8#1)(2008-9#1)
a gene of interest##3##4##(1996-6#2)(2008-9#1)
a gene product##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
a gene that encodes a##3##5##(1993-2#1)(2008-10#2)
a gene that encodes##4##4##(1993-2#1)(2008-10#3)
a gene that##5##3##(1993-2#1)(2008-10#3)(2011-2#1)
a gene therapy##2##3##(1994-5#1)(1995-2#1)
a gene##72##2##(1990-11#1)(1990-5#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#2)(1995-2#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-3#2)(1996-6#5)(1997-3#5)(1997-6#1)(1997-7#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#6)(2008-8#5)(2008-9#3)(2009-8#1)(2010-10#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
a gene-for-gene interaction##2##3##(2008-10#2)
a gene-for-gene model##2##3##(2008-10#2)
a gene-for-gene relationship##4##3##(2008-10#4)
a gene-for-gene##10##2##(2008-10#10)
a gene-specific##2##2##(1997-7#1)(2008-9#1)
a general anaesthetic##3##3##(1994-3#2)(1996-11#1)
a general and##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
a general decline in##2##4##(2008-10#1)(2012-2#1)
a general discussion##2##3##(2008-4#1)(2011-2#1)
a general disease model##2##4##(2008-10#2)
a general framework for##2##4##(2008-10#1)(2010-11#1)
a general framework##3##3##(2008-10#1)(2008-4#1)(2010-11#1)
a general introduction to##3##4##(1997-3#1)(2008-4#2)
a general lack of##2##4##(1991-12#1)(2008-11#1)
a general method##2##3##(2008-10#1)(2008-9#1)
a general model##2##3##(1995-6#1)(2008-8#1)
a general overview of the##2##5##(2008-11#1)(2011-3#1)
a general overview of##5##4##(2008-11#2)(2008-4#1)(2008-7#1)(2011-3#1)
a general phenomenon in##2##4##(2008-10#2)
a general phenomenon##3##3##(1997-3#1)(2008-10#2)
a general population##5##3##(1991-1#1)(1997-1#1)(2008-11#3)
a general practice out of hours cooperative##2##7##(1997-5#2)
a general practitioner##4##3##(1996-11#1)(1996-8#1)(2009-3#1)(2010-1#1)
a general principle##2##3##(2009-8#2)
a general procedure##2##3##(1990-8#1)(2008-4#1)
a general quantitative framework for##2##5##(2009-5#2)
a general relationship between##3##4##(2008-10#2)(2008-9#1)
a general##131##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#13)(2008-3#3)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#5)
a generalist##6##2##(2008-8#3)(2008-9#2)(2011-10#1)
a generalization of##2##3##(2008-10#1)(2008-4#1)
a generalization##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
a generalized stress##2##3##(2008-7#1)(2009-10#1)
a generalized##18##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#2)(2012-12#1)
a generally##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
a generation##2##2##(1993-11#1)(2008-12#1)
a generic drug of##2##4##(2013-8#2)
a generic model##2##3##(2008-11#1)(2008-6#1)
a generic##12##2##(1992-9#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2010-10#2)(2013-8#3)
a genetic approach to##2##4##(1993-12#1)(1995-2#1)
a genetic basis##3##3##(2008-11#2)(2008-9#1)
a genetic component##2##3##(2008-7#1)(2008-8#1)
a genetic disorder##2##3##(2008-2#1)(2013-1#1)
a genetic distance of 2##2##5##(2008-10#1)(2008-9#1)
a genetic distance of##3##4##(2008-10#2)(2008-9#1)
a genetic linkage map of##2##5##(1996-8#1)(2008-10#1)
a genetic linkage map##4##4##(1996-8#1)(2008-10#2)(2012-3#1)
a genetic marker##3##3##(1993-8#1)(1994-12#1)(2008-5#1)
a genetic predisposition##2##3##(2011-2#1)(2012-2#1)
a genetic structure##3##3##(2008-10#3)
a genetic##48##2##(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-8#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
a genetically diverse##3##3##(2008-10#2)(2012-3#1)
a genetically engineered##3##3##(1995-2#1)(1997-2#1)(2008-11#1)
a genetically##16##2##(1990-2#1)(1995-2#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-4#1)(2009-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
a genital##2##2##(1997-8#1)(2008-10#1)
a genome##6##2##(1997-3#1)(1997-8#1)(2008-10#2)(2009-12#1)(2011-2#1)
a genome-wide##11##2##(2008-9#2)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#5)(2013-1#1)
a genomic DNA library##2##4##(1991-9#1)(1993-2#1)
a genomic##15##2##(1990-5#1)(1991-5#1)(1991-9#2)(1993-2#2)(1993-6#1)(2008-10#8)
a genotype##3##2##(2008-10#2)(2012-3#1)
a gentle##2##2##(2008-10#1)(2008-5#1)
a gentleman##2##2##(2013-1#2)
a genus of##2##3##(2008-10#1)(2008-9#1)
a genus##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
a geographic##3##2##(2008-10#3)
a geographical##2##2##(2008-10#2)
a geographically##2##2##(2008-7#1)(2012-3#1)
a geometric##2##2##(2008-10#1)(2008-2#1)
a geriatric assessment unit##2##4##(1992-12#1)(1992-2#1)
a geriatric##6##2##(1990-3#1)(1992-12#2)(1992-2#1)(2008-7#1)(2011-2#1)
a germ plasm##2##3##(2008-10#2)
a germ##3##2##(2008-10#3)
a giant leap towards personalized medicine##2##6##(2010-4#2)
a giant##20##2##(1991-11#1)(1993-6#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#2)(2010-6#2)(2011-2#3)(2012-12#1)(2013-1#3)
a given compound##3##3##(1991-5#1)(1993-12#1)(2008-10#1)
a given concentration##2##3##(1991-12#1)(2008-10#1)
a given hospital##2##3##(1992-2#2)
a given host##3##3##(2008-10#3)
a given level of##2##4##(2008-8#2)
a given number of##2##4##(1992-9#1)(2008-8#1)
a given person##2##3##(2008-11#1)(2010-6#1)
a given protein##2##3##(2008-11#1)(2009-12#1)
a given set of##2##4##(2008-7#1)(2011-3#1)
a given species##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
a given value of##3##4##(2008-10#2)(2008-5#1)
a given##116##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-9#2)(1993-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-9#1)(2008-1#1)(2008-10#34)(2008-11#10)(2008-12#2)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#10)(2008-9#9)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#2)
a glass column##3##3##(2008-10#3)
a glass electrode as the indicator electrode##2##7##(2008-10#2)
a glass electrode as##3##4##(2008-10#3)
a glass electrode##8##3##(2008-10#8)
a glass##32##2##(1991-12#1)(1995-3#1)(2008-10#25)(2008-3#2)(2008-5#1)(2008-9#1)(2012-2#1)
a glassy carbon (GC) electrode##4##5##(2008-10#4)
a glassy carbon electrode and##3##5##(2008-10#3)
a glassy carbon electrode at##3##5##(2008-10#3)
a glassy carbon electrode in##2##5##(2008-10#2)
a glassy carbon electrode is##2##5##(1990-12#1)(2008-10#1)
a glassy carbon electrode modified with##3##6##(2008-10#3)
a glassy carbon electrode modified##4##5##(2008-10#4)
a glassy carbon electrode surface##3##5##(2008-10#3)
a glassy carbon electrode##39##4##(1990-12#1)(2008-10#38)
a glassy carbon##47##3##(1990-12#1)(2008-10#46)
a glassy##49##2##(1990-12#1)(2008-10#47)(2010-4#1)
a global clinical##2##3##(2008-10#1)(2011-2#1)
a global health problem##2##4##(2008-10#1)(2012-12#1)
a global perspective##2##3##(1993-1#1)(2011-2#1)
a global strategy##2##3##(1994-9#1)(1997-7#1)
a global##38##2##(1993-1#1)(1993-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-12#3)(2013-1#1)(2013-8#2)
a globally##2##2##(1990-8#1)(2008-4#1)
a glove##2##2##(2008-11#1)(2012-2#1)
a glucose biosensor##2##3##(2008-10#2)
a glucose##13##2##(1995-11#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2010-8#1)
a glutamic acid##3##3##(1993-8#1)(2008-10#2)
a glutamine##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
a glutathione##2##2##(1995-6#2)
a gluten-free diet##5##3##(1991-2#3)(2011-2#2)
a glycine##2##2##(1995-2#1)(2008-10#1)
a glycolipid sorting defect in hepatocarcinogenesis##2##6##(1990-5#2)
a glycopeptide##2##2##(1990-5#1)(2008-8#1)
a glycoprotein##7##2##(1990-5#1)(1991-9#1)(1993-11#1)(1994-8#1)(2008-10#1)(2008-11#2)
a glycosylated##3##2##(1992-10#2)(1993-6#1)
a gnotobiotic system##2##3##(2008-10#2)
a go##2##2##(2008-7#1)(2013-8#1)
a goat##3##2##(1990-3#1)(1997-5#1)(2008-11#1)
a gold electrode modified with decanethiol##2##6##(2008-10#2)
a gold electrode modified with##4##5##(2008-10#4)
a gold electrode##7##3##(2008-10#7)
a gold standard in##2##4##(2011-2#1)(2012-12#1)
a gold standard##3##3##(2008-12#1)(2011-2#1)(2012-12#1)
a gold##22##2##(1991-7#1)(2008-10#18)(2008-12#1)(2011-2#1)(2012-12#1)
a goniometer##2##2##(2008-12#1)(2009-1#1)
a good abstract##2##3##(2008-12#1)(2009-4#1)
a good accuracy##2##3##(2008-10#2)
a good agreement between the##3##5##(2008-10#3)
a good agreement between##4##4##(2008-10#4)
a good agreement with the##5##5##(2008-10#5)
a good agreement with##7##4##(2008-10#7)
a good agreement##16##3##(2008-10#15)(2008-11#1)
a good alternative to##4##4##(1994-9#1)(2008-10#2)(2010-4#1)
a good alternative##6##3##(1994-9#1)(2008-10#3)(2010-4#1)(2013-1#1)
a good approximation of##2##4##(2008-10#1)(2008-2#1)
a good candidate for##6##4##(1992-6#1)(1993-9#1)(1996-12#1)(2008-10#2)(2008-11#1)
a good candidate##10##3##(1992-6#1)(1993-9#1)(1996-12#1)(2008-10#3)(2008-11#2)(2010-5#1)(2013-8#1)
a good clinical outcome##2##4##(2007-8#1)(2013-1#1)
a good clinical##6##3##(2007-8#2)(2008-7#1)(2013-1#2)(2013-8#1)
a good comparability##2##3##(2008-10#2)
a good correlation between the##3##5##(2008-10#2)(2008-5#1)
a good correlation was found between the##2##7##(1997-6#1)(2008-10#1)
a good correlation was##3##4##(1994-6#1)(1997-6#1)(2008-10#1)
a good correlation##9##3##(1994-6#1)(1997-6#1)(2008-10#6)(2008-5#1)
a good cosmetic##2##3##(2012-12#1)(2013-8#1)
a good deal of##2##4##(1994-3#1)(2011-2#1)
a good diagnostic##2##3##(2008-10#1)(2008-11#1)
a good discriminating ability towards##3##5##(2008-10#3)
a good electrode##2##3##(2008-10#2)
a good estimate of the##2##5##(2008-10#1)(2008-5#1)
a good estimate##3##3##(2008-10#2)(2008-5#1)
a good estimation of the##2##5##(1995-9#1)(2008-10#1)
a good fit to##2##4##(1994-8#1)(2008-10#1)
a good fit##5##3##(1993-1#1)(1994-8#1)(2008-10#1)(2008-3#1)(2009-3#1)
a good functional##2##3##(2007-8#1)(2008-7#1)
a good histocompatibility##2##3##(2012-3#2)
a good indicator of the##2##5##(2008-10#2)
a good indicator of##4##4##(2008-10#3)(2008-12#1)
a good linear relationship with the##2##6##(2008-10#2)
a good linear##5##3##(2008-10#5)
a good linearity##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
a good match##2##3##(2008-3#1)(2012-2#1)
a good model to study##2##5##(2008-10#1)(2008-11#1)
a good model##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-6#1)
a good neurological##2##3##(1997-6#1)(2008-7#1)
a good option for##3##4##(2009-3#1)(2011-2#1)(2013-1#1)
a good option##4##3##(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
a good outcome for##2##4##(2008-7#1)(2009-12#1)
a good outcome##3##3##(2008-7#1)(2009-12#1)(2013-8#1)
a good precision (R##2##4##(2008-10#2)
a good precision##6##3##(2008-10#6)
a good predictor of##4##4##(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
a good predictor##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
a good prognosis##5##3##(1991-8#1)(1992-5#1)(2008-10#1)(2012-3#2)
a good quality of life##3##5##(1992-11#1)(1996-3#1)(2012-3#1)
a good recovery##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
a good reproducibility##5##3##(2008-10#5)
a good response for##2##4##(2008-10#2)
a good response##5##3##(1992-12#1)(2008-10#3)(2012-3#1)
a good security program##2##4##(1991-1#2)
a good selectivity for##4##4##(2008-10#4)
a good selectivity##6##3##(2008-10#6)
a good separation of##2##4##(2008-10#2)
a good separation##3##3##(2008-10#3)
a good source##2##3##(2008-10#1)(2008-11#1)
a good stability##3##3##(2008-10#3)
a good substrate for the##2##5##(1991-5#1)(2008-10#1)
a good substrate for##3##4##(1991-5#1)(1994-11#1)(2008-10#1)
a good target for##2##4##(2008-10#1)(2008-9#1)
a good tool to##2##4##(2008-1#1)(2008-7#1)
a good tool##3##3##(2008-1#1)(2008-7#1)(2009-8#1)
a good yield##2##3##(2008-10#1)(2008-11#1)
a good##266##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-8#3)(2008-1#2)(2008-10#113)(2008-11#18)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#3)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#9)(2011-3#2)(2012-12#3)(2012-2#3)(2012-3#6)(2012-7#1)(2013-1#11)(2013-8#6)
a grade##2##2##(1991-2#1)(1991-6#1)
a graded##3##2##(1993-6#1)(2008-5#2)
a gradient flow##4##3##(2008-10#3)(2008-4#1)
a gradient in##2##3##(2008-9#2)
a gradient##11##2##(2008-10#7)(2008-4#2)(2008-9#2)
a gradual decline in responding##2##5##(1993-6#2)
a gradual decline in##3##4##(1993-6#2)(2012-7#1)
a gradual decline##4##3##(1993-6#2)(2008-10#1)(2012-7#1)
a gradual decrease in the##2##5##(2008-10#1)(2008-11#1)
a gradual decrease in##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
a gradual increase in the##2##5##(1994-8#1)(2008-10#1)
a gradual increase in##4##4##(1994-11#1)(1994-8#1)(2008-10#2)
a gradual increase of osmotic pressure##3##6##(2008-11#3)
a gradual increase##7##3##(1994-11#1)(1994-8#1)(2008-10#2)(2008-11#3)
a gradual##23##2##(1993-6#2)(1994-11#1)(1994-8#1)(1997-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#2)(2012-7#1)
a graduate nurse##2##3##(2008-11#2)
a graduate##6##2##(1996-1#2)(2008-11#2)(2013-1#2)
a graft##5##2##(1993-1#1)(1995-12#1)(2010-3#1)(2011-3#1)(2012-2#1)
a grafted##2##2##(2008-10#1)(2009-5#1)
a grandchild##3##2##(2010-9#3)
a grant##2##2##(1995-3#1)(1996-1#1)
a granulomatous##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
a graphic##2##2##(2008-9#2)
a graphical design##2##3##(2011-2#2)
a graphical##8##2##(2008-6#1)(2008-9#1)(2010-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
a graphite atomizer##2##3##(2008-10#2)
a graphite furnace atomic absorption##3##5##(2008-10#3)
a graphite furnace##6##3##(2008-10#6)
a graphite##13##2##(2008-10#13)
a grating##3##2##(2008-2#2)(2008-3#1)
a great challenge##2##3##(2010-12#1)(2011-2#1)
a great deal in##2##4##(1991-1#1)(1991-2#1)
a great deal of work##2##5##(1991-1#1)(2008-10#1)
a great deal of##15##4##(1991-1#1)(1992-9#1)(1994-2#1)(1994-9#1)(1996-11#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
a great deal##20##3##(1991-1#2)(1991-2#1)(1992-9#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
a great diversity of##2##4##(2009-10#1)(2009-7#1)
a great effect on the##2##5##(2008-10#2)
a great effect##3##3##(2008-10#2)(2008-3#1)
a great improvement##3##3##(2008-10#3)
a great influence on##3##4##(1992-6#1)(2008-10#1)(2008-3#1)
a great influence##4##3##(1992-6#1)(2008-10#1)(2008-3#1)(2013-1#1)
a great need for##2##4##(1994-9#1)(2008-10#1)
a great need##4##3##(1994-9#1)(2008-10#2)(2013-1#1)
a great number of##3##4##(2008-12#1)(2008-9#1)(2012-3#1)
a great potential for##2##4##(1997-8#1)(2008-11#1)
a great potential in##2##4##(2008-11#1)(2008-6#1)
a great potential##4##3##(1997-8#1)(2008-11#2)(2008-6#1)
a great variety of##2##4##(1993-11#1)(1997-6#1)
a great##78##2##(1990-12#2)(1991-1#2)(1991-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-9#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-6#2)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#20)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
a greater (P &lt##2##4##(2008-10#2)
a greater (P##3##3##(2008-10#2)(2010-12#1)
a greater contribution##2##3##(1994-11#1)(2008-5#1)
a greater degree of##2##4##(1991-2#1)(2009-8#1)
a greater degree##6##3##(1991-2#1)(1991-6#1)(1993-11#1)(1995-11#1)(2008-10#1)(2009-8#1)
a greater emphasis on##3##4##(1996-3#1)(2008-11#1)(2012-3#1)
a greater emphasis##4##3##(1996-3#1)(2008-11#2)(2012-3#1)
a greater frequency of##3##4##(2008-10#1)(2008-5#1)(2010-11#1)
a greater impact on##3##4##(2008-10#1)(2013-1#2)
a greater impact##4##3##(2008-10#1)(2008-9#1)(2013-1#2)
a greater increase in##4##4##(1991-3#1)(2008-12#1)(2009-11#1)(2011-10#1)
a greater influence on##2##4##(1991-8#1)(2008-4#1)
a greater likelihood of##2##4##(1995-2#1)(2012-12#1)
a greater number of##12##4##(1992-9#1)(1993-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)
a greater proportion of##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)
a greater risk of##2##4##(2008-10#1)(2008-11#1)
a greater risk##4##3##(1996-11#1)(2008-10#1)(2008-11#1)(2010-6#1)
a greater stability##2##3##(2008-10#2)
a greater understanding of the##3##5##(2008-10#1)(2008-11#1)(2008-9#1)
a greater understanding of these##2##5##(2008-10#1)(2008-7#1)
a greater understanding of##7##4##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
a greater understanding##8##3##(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
a greater variety of##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
a greater##126##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1994-1#1)(1994-11#2)(1994-8#1)(1995-11#3)(1995-2#2)(1996-11#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-6#1)(2008-10#24)(2008-11#11)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-4#1)(2013-1#5)(2013-8#1)
a greatly enhanced##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
a greatly##6##2##(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)
a green fluorescent protein (GFP)##3##5##(2008-10#3)
a green fluorescent protein##6##4##(2008-10#5)(2008-8#1)
a green##13##2##(1995-9#1)(2008-10#9)(2008-11#1)(2008-8#1)(2012-2#1)
a greenhouse experiment##2##3##(2008-10#2)
a greenhouse or##2##3##(2008-10#2)
a greenhouse##15##2##(2008-10#15)
a gross##2##2##(1990-5#1)(2009-2#1)
a ground##2##2##(2008-10#2)
a ground-based##2##2##(2008-3#2)
a grounded theory##3##3##(2008-12#2)(2012-3#1)
a grounded##4##2##(2008-12#2)(2012-3#1)(2013-8#1)
a group has##2##3##(2009-12#2)
a group of 7##2##4##(1994-2#1)(2011-2#1)
a group of adult##2##4##(2008-9#2)
a group of isolates##2##4##(2008-10#2)
a group of patients##3##4##(1990-5#1)(2009-4#1)(2010-12#1)
a group of physicians##2##4##(1992-2#1)(2010-1#1)
a group of student##2##4##(2008-11#2)
a group of sulfonamide##2##4##(2009-3#2)
a group of uninsured low-income adults in Oregon was selected by lottery to be given the chance to apply for Medicaid##2##21##(2013-1#2)
a group of young##2##4##(2009-10#1)(2013-8#1)
a group of##110##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-5#1)(1996-6#1)(1996-9#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#12)(2008-12#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#2)
a group that##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
a group to##3##3##(1994-3#2)(2010-4#1)
a group with##2##3##(1994-6#1)(2012-3#1)
a group##140##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#2)(1993-1#2)(1993-11#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-9#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#13)(2008-12#5)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#10)(2009-10#2)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#7)(2013-8#2)
a growing body of data##2##5##(2008-7#1)(2008-8#1)
a growing body of literature##3##5##(2008-12#1)(2009-4#1)(2012-3#1)
a growing body of research##2##5##(2009-5#1)(2013-8#1)
a growing body of##10##4##(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
a growing drop##2##3##(2008-10#2)
a growing interest in##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
a growing number of##6##4##(1995-12#1)(1995-2#1)(2007-12#1)(2008-4#1)(2011-2#2)
a growing population##3##3##(1997-6#2)(2008-9#1)
a growing season##4##3##(2008-10#4)
a growing##53##2##(1994-3#1)(1995-12#1)(1995-2#2)(1996-1#2)(1997-6#2)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
a growth chamber at##3##4##(2008-10#3)
a growth chamber##10##3##(2008-10#10)
a growth rate of##2##4##(1990-6#1)(2008-7#1)
a growth##27##2##(1990-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#12)(2008-11#3)(2008-5#1)(2008-7#1)(2010-1#1)(2012-2#1)(2013-1#1)
a guide for##5##3##(1991-12#1)(1991-2#1)(1996-2#1)(2011-2#1)(2012-2#1)
a guide to##5##3##(1990-8#1)(1993-12#1)(2009-10#1)(2011-2#2)
a guide##20##2##(1990-8#1)(1991-12#1)(1991-2#1)(1993-12#1)(1995-2#1)(1996-2#3)(1996-3#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-2#1)
a guideline for the##2##4##(2008-11#1)(2012-3#1)
a guideline for##4##3##(2008-11#1)(2008-3#1)(2008-6#1)(2012-3#1)
a guideline##5##2##(2008-11#1)(2008-3#2)(2008-6#1)(2012-3#1)
a gut##2##2##(2008-10#1)(2012-2#1)
a habitat##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
a hair dye##3##3##(2008-10#1)(2012-3#2)
a hairpin##2##2##(1992-3#1)(1997-7#1)
a half of##4##3##(2008-7#1)(2011-2#1)(2013-1#2)
a half##17##2##(1992-5#1)(1992-6#1)(1993-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#3)
a hallmark feature of##2##4##(2008-11#1)(2013-8#1)
a hallmark of##6##3##(1991-2#1)(2008-11#2)(2008-9#1)(2012-2#1)(2013-1#1)
a hallmark##10##2##(1991-2#1)(2008-11#4)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
a halo##2##2##(2011-2#1)(2012-2#1)
a hand##2##2##(2008-9#1)(2009-3#1)
a hand-held calculator##2##3##(2008-11#2)
a hand-held##6##2##(2008-10#3)(2008-11#2)(2012-2#1)
a handful of##2##3##(2010-7#1)(2011-3#1)
a handheld##4##2##(2008-10#2)(2011-7#1)(2013-1#1)
a hanging mercury drop electrode (HMDE)##7##6##(2008-10#7)
a hanging mercury drop electrode##23##5##(2008-10#23)
a hanging##25##2##(2008-10#23)(2008-11#1)(2008-8#1)
a haploid strain of##2##4##(1994-6#1)(1996-6#1)
a haploid##3##2##(1994-6#1)(1996-6#1)(2008-10#1)
a hard##3##2##(1993-3#1)(2008-8#1)(2010-6#1)
a hazardous##2##2##(1995-12#1)(2008-8#1)
a head injury##2##3##(2008-12#1)(2012-3#1)
a head##4##2##(2008-12#2)(2012-3#2)
a headspace##3##2##(2008-10#2)(2009-8#1)
a health administration curriculum##3##4##(1993-1#1)(1996-1#1)(1996-2#1)
a health administration##4##3##(1993-1#2)(1996-1#1)(1996-2#1)
a health care organization##3##4##(1994-1#1)(1994-12#1)(1995-12#1)
a health care transaction##2##4##(2008-11#2)
a health care##18##3##(1991-1#2)(1991-3#1)(1993-1#1)(1994-1#3)(1994-12#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2013-1#1)
a health center##2##3##(1993-3#1)(1996-3#1)
a health center]##10##3##(1991-11#1)(1993-3#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)
a health education##2##3##(1991-6#1)(2013-1#1)
a health insurance organization##2##4##(1994-2#2)
a health maintenance organization (HMO)##3##5##(1993-1#1)(1994-12#1)(1994-3#1)
a health maintenance organization##4##4##(1992-2#1)(1993-1#1)(1994-12#1)(1994-3#1)
a health##59##2##(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-2#1)(1993-1#4)(1993-3#3)(1993-5#1)(1993-9#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#4)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
a healthcare facility##2##3##(1993-12#1)(1994-12#1)
a healthcare##8##2##(1993-12#2)(1993-2#2)(1994-12#1)(1995-12#1)(1996-12#2)
a healthier##2##2##(2008-11#1)(2013-1#1)
a healthy diet##4##3##(2008-3#1)(2011-1#2)(2011-2#1)
a healthy man##2##3##(2010-1#1)(2013-8#1)
a healthy sample##2##3##(2010-2#1)(2013-8#1)
a healthy weight##2##3##(2011-2#2)
a healthy##33##2##(1991-1#1)(1991-2#2)(1992-3#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#1)(2010-1#2)(2010-2#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-3#1)(2013-7#1)(2013-8#2)
a heart attack##3##3##(2008-11#1)(2008-3#1)(2009-5#1)
a heart##4##2##(1993-3#1)(2008-11#1)(2008-3#1)(2009-5#1)
a heated##5##2##(1993-6#1)(2008-10#2)(2008-3#2)
a heating cycle##3##3##(2008-10#3)
a heating##5##2##(2008-10#5)
a heavily##2##2##(1990-8#1)(2010-5#1)
a heavy atom##2##3##(2008-10#2)
a heavy##7##2##(1993-3#2)(1996-12#1)(2008-10#4)
a height of##3##3##(2008-10#2)(2012-2#1)
a heightened##2##2##(1995-12#1)(2011-2#1)
a helicase##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
a hematopoietic##3##2##(2008-11#1)(2009-7#1)(2013-1#1)
a hepatitis B virus##2##4##(1994-11#1)(2013-8#1)
a hepatitis##3##2##(1994-11#1)(2013-8#2)
a herbal medicine##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
a herbicide##2##2##(2008-10#1)(2010-1#1)
a hereditary##3##2##(1994-12#2)(2006-6#1)
a heretofore##2##2##(1995-8#1)(2008-8#1)
a heritable##3##2##(2008-8#2)(2012-3#1)
a heritage of##2##3##(1993-3#1)(2012-2#1)
a hermaphroditic##2##2##(2008-8#1)(2008-9#1)
a heterobifunctional##2##2##(2008-10#1)(2008-7#1)
a heterodimer##3##2##(1993-3#1)(1995-6#1)(2011-2#1)
a heterodimeric##2##2##(1993-9#1)(2008-11#1)
a heterogeneous family##2##3##(1995-11#1)(2008-10#1)
a heterogeneous group of##8##4##(1991-11#1)(1997-5#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#2)
a heterogeneous group##10##3##(1991-11#1)(1997-5#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
a heterogeneous population of##2##4##(1991-12#1)(2008-11#1)
a heterogeneous population##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
a heterogeneous##35##2##(1991-11#1)(1991-12#1)(1995-11#1)(1995-2#1)(1997-5#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#4)(2009-8#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
a heterogenous##3##2##(1991-11#1)(2008-9#1)(2011-2#1)
a heterologous promoter##3##3##(1996-12#1)(1997-3#2)
a heterologous##9##2##(1994-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-5#1)
a heteromeric##2##2##(1991-5#1)(1995-2#1)
a heterozygous##5##2##(2008-10#3)(2008-4#1)(2012-3#1)
a heuristic##2##2##(2008-10#1)(2013-1#1)
a hexagonal column##2##3##(2008-3#2)
a hexagonal##6##2##(1995-6#1)(2008-3#5)
a hexane##2##2##(2008-10#1)(2008-7#1)
a hierarchical##6##2##(1991-6#1)(2008-6#2)(2009-12#1)(2011-2#1)(2013-8#1)
a hierarchy of##3##3##(2008-10#1)(2008-11#1)(2009-10#1)
a hierarchy##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2013-1#1)
a high affinity for the##4##5##(1992-11#1)(1994-11#1)(1995-11#1)(2008-6#1)
a high affinity for##6##4##(1992-11#1)(1994-11#1)(1995-11#1)(2008-10#2)(2008-6#1)
a high affinity##12##3##(1990-8#1)(1992-11#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
a high amount of##4##4##(2008-10#3)(2013-1#1)
a high background##2##3##(1994-12#1)(2008-10#1)
a high basal##2##3##(1994-11#2)
a high capacity##3##3##(2008-10#2)(2010-6#1)
a high catalytic activity##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
a high cell viability##2##4##(2008-11#2)
a high cleaning calcium carbonate system and 1450 ppm fluoride##2##10##(2011-2#2)
a high cleaning calcium carbonate system##3##6##(2011-2#3)
a high concentration of##8##4##(1994-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
a high concentration##9##3##(1994-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2009-12#1)
a high content of##2##4##(1996-2#1)(2010-4#1)
a high correlation between##4##4##(2008-10#2)(2008-9#2)
a high correlation coefficient##2##4##(2011-2#1)(2011-3#1)
a high correlation##9##3##(2008-10#3)(2008-9#2)(2010-8#1)(2011-2#2)(2011-3#1)
a high degree of accuracy##3##5##(2008-12#1)(2008-3#1)(2013-1#1)
a high degree of genetic diversity##4##6##(2008-10#4)
a high degree of genetic##6##5##(2008-10#5)(2008-8#1)
a high degree of homology to##3##6##(1992-8#1)(1993-2#1)(2008-10#1)
a high degree of homology##5##5##(1992-8#1)(1993-2#1)(1994-11#1)(1997-1#1)(2008-10#1)
a high degree of host specificity##2##6##(2008-10#2)
a high degree of sensitivity and selectivity##2##7##(2008-10#2)
a high degree of sensitivity##3##5##(2008-10#3)
a high degree of sequence homology##2##6##(1993-3#1)(2008-10#1)
a high degree of similarity##5##5##(1993-2#2)(1993-9#1)(2008-10#2)
a high degree of##64##4##(1990-11#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-12#1)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
a high degree##66##3##(1990-11#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
a high density of##3##4##(2008-10#1)(2008-3#1)(2010-7#1)
a high density##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)
a high disease incidence##2##4##(2008-10#2)
a high dose of##2##4##(2008-12#1)(2013-8#1)
a high dose##3##3##(2008-12#1)(2008-7#1)(2013-8#1)
a high drop-out rate##2##4##(1990-2#1)(2008-7#1)
a high enzyme activity##2##4##(1993-3#1)(1994-11#1)
a high frequency of##4##4##(1997-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
a high frequency##8##3##(1993-8#1)(1997-5#1)(2008-10#3)(2008-11#1)(2012-2#1)(2012-3#1)
a high incidence of##7##4##(1994-12#1)(1997-1#1)(1997-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
a high index of suspicion and##2##6##(2010-7#1)(2011-2#1)
a high index of suspicion##7##5##(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#3)(2013-8#1)
a high level of genetic##2##5##(2008-10#2)
a high level of homogeneity##2##5##(2008-10#1)(2012-3#1)
a high level of resistance to##2##6##(2008-10#2)
a high level of resistance##3##5##(2008-10#3)
a high level of##37##4##(1991-6#1)(1993-6#1)(1994-8#1)(1995-11#2)(1996-12#1)(1997-8#1)(2008-10#17)(2008-11#5)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
a high level##46##3##(1991-6#1)(1993-6#2)(1994-8#1)(1995-11#2)(1996-12#1)(1997-8#1)(2008-10#18)(2008-11#9)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)
a high local recurrence rate##2##5##(1997-7#1)(2010-3#1)
a high local##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2010-3#1)
a high molar##2##3##(1990-12#1)(2008-10#1)
a high molecular weight complex##2##5##(1995-6#1)(2008-12#1)
a high molecular weight##6##4##(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-12#1)
a high molecular##7##3##(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-12#1)
a high mortality rate##5##4##(2008-12#2)(2010-12#1)(2010-7#1)(2011-2#1)
a high number of##5##4##(2008-10#2)(2008-7#2)(2011-1#1)
a high numerical aperture##3##4##(2007-12#1)(2008-3#1)(2009-12#1)
a high percentage of##6##4##(1991-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
a high percentage##7##3##(1991-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-3#1)
a high performance liquid##4##4##(2008-10#2)(2008-5#2)
a high performance nebulizer##2##4##(2008-10#2)
a high performance runner##2##4##(2011-2#2)
a high performance##10##3##(2008-10#5)(2008-5#2)(2011-2#3)
a high polyunsaturated fatty acid content##2##6##(2008-5#2)
a high pressure##2##3##(2008-10#2)
a high prevalence of##12##4##(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
a high prevalence##13##3##(1990-6#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
a high priority for##3##4##(2008-11#1)(2013-1#2)
a high priority##5##3##(1994-2#1)(2008-1#1)(2008-11#1)(2013-1#2)
a high probability of##3##4##(1997-8#1)(2008-11#1)(2013-1#1)
a high probability##5##3##(1990-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
a high proportion of the##2##5##(1995-9#1)(2008-10#1)
a high proportion of##9##4##(1995-3#1)(1995-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)
a high proportion##11##3##(1992-12#1)(1995-3#1)(1995-9#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)
a high quality##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
a high rate of##9##4##(1991-6#1)(1991-9#1)(1994-1#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-12#1)
a high rate##10##3##(1991-6#1)(1991-9#1)(1994-1#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-12#1)
a high recurrence rate##2##4##(2011-2#1)(2013-1#1)
a high resolution##3##3##(2008-10#2)(2008-3#1)
a high response##3##3##(1991-12#1)(1991-8#1)(2008-10#1)
a high risk of##14##4##(1990-3#1)(1992-6#1)(1994-9#2)(1995-5#1)(1997-6#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
a high risk##19##3##(1990-3#1)(1991-6#1)(1992-6#1)(1994-5#1)(1994-9#2)(1995-5#1)(1997-6#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)
a high salt##2##3##(2008-10#1)(2008-11#1)
a high selectivity for##2##4##(2008-10#2)
a high selectivity##4##3##(2008-10#4)
a high sensitivity is##2##4##(2008-10#2)
a high sensitivity##8##3##(1992-11#1)(2008-10#5)(2008-3#1)(2012-2#1)
a high specific##2##3##(1994-11#1)(2008-5#1)
a high spectral##2##3##(2008-10#1)(2008-3#1)
a high stability##2##3##(1990-5#1)(2011-1#1)
a high success rate##4##4##(1994-12#1)(1996-11#1)(1997-4#1)(2012-12#1)
a high temperature##4##3##(1991-5#1)(2008-10#2)(2011-2#1)
a high throughput##8##3##(2008-10#6)(2008-11#1)(2012-3#1)
a high titer##2##3##(2012-2#1)(2013-1#1)
a high volume of##2##4##(2008-11#1)(2013-1#1)
a high volume##5##3##(1991-3#1)(1992-2#1)(2008-11#2)(2013-1#1)
a high yield##3##3##(1990-3#1)(2008-11#1)(2008-5#1)
a high##516##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#6)(1994-12#3)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#4)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#141)(2008-11#44)(2008-12#15)(2008-3#13)(2008-4#4)(2008-5#17)(2008-6#5)(2008-7#11)(2008-8#12)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-7#4)(2010-1#3)(2010-11#8)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#26)(2011-3#2)(2012-12#5)(2012-2#10)(2012-3#7)(2012-6#1)(2013-1#15)(2013-8#6)
a high- or##2##3##(2013-8#2)
a high-##3##2##(2012-3#1)(2013-8#2)
a high-affinity##4##2##(1993-6#1)(1996-12#1)(2008-10#1)(2012-2#1)
a high-birefringence##2##2##(2008-3#2)
a high-dose##2##2##(1990-9#1)(2010-11#1)
a high-efficiency sample introduction system##2##5##(2008-10#2)
a high-finesse##2##2##(2008-3#2)
a high-flow##2##2##(2008-10#2)
a high-frequency##2##2##(2008-9#1)(2012-2#1)
a high-grade##2##2##(1997-1#1)(2011-2#1)
a high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
a high-performance##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
a high-poverty urban neighborhood##2##4##(2010-9#2)
a high-power##3##2##(2008-3#3)
a high-reflectance##2##2##(2008-2#2)
a high-resolution##8##2##(2008-10#2)(2008-3#4)(2012-3#2)
a high-risk##9##2##(1991-6#1)(1992-3#1)(1996-3#2)(2008-11#2)(2009-5#1)(2012-2#1)(2013-1#1)
a high-speed##3##2##(2008-2#1)(2011-2#1)(2012-3#1)
a high-temperature##3##2##(1990-12#1)(2008-10#1)(2009-8#1)
a high-throughput##4##2##(2008-11#1)(2010-11#1)(2011-3#1)(2012-3#1)
a higher affinity##2##3##(1992-6#1)(1993-8#1)
a higher average##2##3##(2008-11#2)
a higher cell##2##3##(2008-11#2)
a higher concentration of##3##4##(2008-11#3)
a higher concentration##7##3##(2008-10#3)(2008-11#4)
a higher degree of##3##4##(1996-3#1)(2008-10#1)(2008-11#1)
a higher degree##4##3##(1991-6#1)(1996-3#1)(2008-10#1)(2008-11#1)
a higher dose##3##3##(1990-2#1)(1991-6#1)(1991-7#1)
a higher education diploma in nursing communication module##2##8##(2008-11#2)
a higher education##3##3##(1994-2#1)(2008-11#2)
a higher frequency of##4##4##(1997-8#1)(2008-11#1)(2009-8#1)(2011-2#1)
a higher frequency##5##3##(1997-8#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
a higher growth rate and##2##5##(1990-8#1)(2008-11#1)
a higher incidence of cyst rupture##2##6##(1996-3#2)
a higher incidence of##10##4##(1990-5#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
a higher incidence##11##3##(1990-5#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#1)
a higher initial##2##3##(2008-10#1)(2009-7#1)
a higher intensity of##3##4##(1995-12#1)(2008-7#1)(2013-1#1)
a higher intensity##4##3##(1995-12#1)(2008-7#1)(2013-1#2)
a higher ion##2##3##(2008-10#1)(2008-7#1)
a higher level of functioning##2##5##(1997-8#2)
a higher level of##11##4##(1994-3#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-5#1)(2009-10#1)(2012-2#1)
a higher level##15##3##(1994-3#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-6#1)(2012-2#1)
a higher mean##2##3##(1991-12#1)(2008-7#1)
a higher molecular weight##2##4##(1991-5#1)(2008-10#1)
a higher morbidity##2##3##(1993-6#1)(2009-12#1)
a higher mortality rate than##2##5##(1995-3#1)(2011-2#1)
a higher mortality##3##3##(1995-3#1)(2011-2#2)
a higher percent##3##3##(1995-12#1)(2008-10#1)(2008-6#1)
a higher percentage of##4##4##(1993-6#1)(1996-6#1)(2009-10#1)(2013-8#1)
a higher prevalence of##5##4##(1996-12#1)(2008-12#1)(2011-2#2)(2012-3#1)
a higher proportion of##9##4##(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-3#1)
a higher rate of##4##4##(1997-8#1)(2008-11#1)(2012-12#2)
a higher rate##10##3##(1990-8#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-11#3)(2012-12#2)
a higher resolution##2##3##(2008-10#1)(2012-2#1)
a higher risk for##2##4##(2008-8#1)(2011-2#1)
a higher risk of##12##4##(1995-2#1)(1996-11#1)(1996-9#1)(2008-12#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2013-1#2)(2013-8#1)
a higher risk##16##3##(1995-2#1)(1996-11#1)(1996-9#1)(2008-12#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2011-2#1)(2013-1#2)(2013-8#1)
a higher sensitivity##4##3##(2008-10#1)(2008-4#1)(2011-2#2)
a higher specific##2##3##(2008-11#1)(2011-2#1)
a higher than##2##3##(2008-10#1)(2008-11#1)
a higher value of##2##4##(2008-10#1)(2008-3#1)
a higher value##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
a higher##217##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-6#1)(1993-6#3)(1993-8#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#6)(2006-6#1)(2008-10#44)(2008-11#31)(2008-12#7)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#12)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#15)(2012-12#2)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#6)(2013-8#5)
a higher-order Gaussian beam##2##4##(2008-2#2)
a higher-order##3##2##(2008-11#1)(2008-2#2)
a highly acceptable##2##3##(1994-12#1)(2008-11#1)
a highly aggregated state##2##4##(1997-2#2)
a highly asymmetrical##2##3##(1991-2#1)(1993-3#1)
a highly charged##2##3##(1991-12#1)(1995-6#1)
a highly complex##3##3##(2009-5#1)(2009-6#1)(2010-7#1)
a highly conserved region##2##4##(1994-11#1)(2008-10#1)
a highly conserved##19##3##(1991-12#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-2#1)(1995-2#1)(1997-4#1)(1997-9#1)(2008-10#4)(2008-8#1)(2009-7#1)(2009-8#1)(2010-8#2)
a highly consistent##2##3##(1994-2#1)(1995-3#1)
a highly destructive##2##3##(2008-10#2)
a highly diverse##2##3##(2008-10#1)(2008-9#1)
a highly dynamic##2##3##(2009-6#1)(2010-8#1)
a highly effective##4##3##(1995-3#1)(2008-10#1)(2011-2#1)(2012-3#1)
a highly efficient##6##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
a highly homologous##2##3##(1995-8#1)(1997-7#1)
a highly promising##2##3##(1997-6#1)(2008-10#1)
a highly purified##3##3##(1996-3#1)(2008-2#1)(2008-7#1)
a highly reactive##2##3##(2008-10#1)(2008-11#1)
a highly reproducible##3##3##(2008-10#2)(2008-5#1)
a highly resistant##3##3##(2008-10#3)
a highly selective and sensitive##3##5##(2008-10#1)(2008-12#2)
a highly selective##7##3##(2008-10#5)(2008-12#2)
a highly sensitive and##4##4##(1994-11#1)(2008-10#3)
a highly sensitive detection##3##4##(2008-10#3)
a highly sensitive method##2##4##(2008-10#2)
a highly sensitive##22##3##(1994-11#1)(2008-10#14)(2008-2#2)(2009-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
a highly significant difference##2##4##(1994-3#1)(2008-5#1)
a highly significant##6##3##(1993-2#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-8#2)
a highly specialized##2##3##(1997-4#1)(2008-10#1)
a highly specific##3##3##(1995-12#1)(1997-3#1)(2008-10#1)
a highly stable##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
a highly susceptible##5##3##(2008-10#5)
a highly variable##2##3##(1997-3#1)(2008-10#1)
a highly virulent isolate##2##4##(2008-10#2)
a highly virulent##3##3##(2008-10#3)
a highly##169##2##(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-9#1)(2008-10#60)(2008-11#6)(2008-12#6)(2008-2#3)(2008-3#6)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
a hippocampal##2##2##(1993-6#1)(1997-2#1)
a histidine tag##2##3##(2008-10#2)
a histidine##3##2##(2008-10#3)
a histochemical##2##2##(2008-7#1)(2009-7#1)
a histologic diagnosis##2##3##(1992-12#1)(1995-3#1)
a histological##4##2##(1996-6#1)(2007-8#1)(2008-10#1)(2008-7#1)
a histopathologic##3##2##(1990-8#1)(1997-1#1)(2008-5#1)
a historical##10##2##(1991-8#1)(1993-11#1)(1996-1#1)(2008-3#1)(2009-10#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
a history of a##2##4##(1996-3#1)(2012-3#1)
a history of depression##2##4##(2010-4#1)(2013-8#1)
a history of previous##4##4##(1991-3#1)(2008-10#1)(2008-11#1)(2010-6#1)
a history of sexual##2##4##(2008-12#1)(2009-9#1)
a history of stroke##2##4##(1996-11#1)(2007-7#1)
a history of sudden##2##4##(2008-12#1)(2008-5#1)
a history of venous##2##4##(2010-6#1)(2010-7#1)
a history of##77##3##(1990-3#1)(1991-3#1)(1992-6#1)(1993-3#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-5#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#5)
a history##79##2##(1990-3#1)(1991-3#1)(1992-6#1)(1993-3#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-5#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#6)
a hitherto undescribed##3##3##(1995-6#1)(2008-10#1)(2011-1#1)
a hitherto##9##2##(1995-6#2)(2008-10#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
a holding coil##4##3##(2008-10#4)
a holding##5##2##(2008-10#4)(2008-8#1)
a holiday in##2##3##(1995-12#1)(1996-11#1)
a holistic approach##3##3##(1991-2#1)(2008-11#2)
a holistic##6##2##(1991-2#1)(2008-11#2)(2008-12#1)(2012-12#1)(2013-8#1)
a hollow fiber##8##3##(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)
a hollow needle##2##3##(2008-10#2)
a hollow waveguide##3##3##(2007-12#2)(2008-7#1)
a hollow##17##2##(1993-6#1)(1995-10#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#2)(2013-1#1)
a hollow-fiber##3##2##(1995-3#1)(2008-7#2)
a holographic##2##2##(2008-3#2)
a home made##3##3##(2008-10#2)(2008-11#1)
a home##10##2##(1991-11#1)(1993-1#1)(1993-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)
a home-made flow cell##2##4##(2008-10#2)
a home-made flow##3##3##(2008-10#3)
a home-made##11##2##(2008-10#10)(2008-7#1)
a homeobox gene##2##3##(1993-2#1)(2008-8#1)
a homodimeric##2##2##(1992-6#1)(2008-11#1)
a homogeneous PS##2##3##(2008-10#2)
a homogeneous group##2##3##(1996-12#1)(2008-10#1)
a homogeneous lesion##2##3##(1990-9#1)(2008-7#1)
a homogeneous population##2##3##(1995-2#1)(2008-9#1)
a homogeneous##28##2##(1990-11#1)(1990-9#1)(1991-11#1)(1995-2#1)(1996-12#1)(2008-10#14)(2008-2#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2012-2#1)
a homogenous##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
a homolog of##2##3##(2008-10#1)(2009-7#1)
a homologous sequence##2##3##(1995-8#1)(1996-6#1)
a homologous##7##2##(1990-11#1)(1990-5#1)(1995-8#1)(1996-6#1)(1996-9#1)(2008-7#1)(2013-8#1)
a homologue of the##2##4##(1997-7#1)(2007-12#1)
a homologue of##6##3##(1993-2#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2009-9#1)
a homozygous deletion##2##3##(1997-2#1)(2011-1#1)
a homozygous##6##2##(1994-11#1)(1997-2#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
a horizontal##3##2##(2008-10#2)(2008-3#1)
a hormetic##2##2##(2008-7#2)
a hormonal##3##2##(1995-11#1)(1995-8#1)(2008-5#1)
a horse##2##2##(1996-3#1)(2008-9#1)
a horseradish peroxidase (HRP)##2##4##(2008-10#2)
a horseradish peroxidase##3##3##(2008-10#3)
a hospital archives##2##3##(1992-1#2)
a hospital based study##2##4##(2012-3#2)
a hospital based##5##3##(1991-2#1)(2010-11#1)(2012-3#2)(2013-8#1)
a hospital is##2##3##(1993-12#1)(1994-3#1)
a hospital laboratory##2##3##(1994-12#1)(1997-3#1)
a hospital system##2##3##(1993-12#1)(1996-3#1)
a hospital to reduce##2##4##(1991-12#1)(1991-3#1)
a hospital to##4##3##(1991-12#1)(1991-2#1)(1991-3#1)(2008-11#1)
a hospital##42##2##(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#2)(1992-2#2)(1993-12#3)(1993-2#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-11#1)(1996-3#4)(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#5)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
a hospital's##3##2##(1993-12#1)(1994-12#2)
a hospital-based managed mental##2##4##(1991-3#2)
a hospital-based##5##2##(1990-8#1)(1991-3#2)(1994-1#2)
a host factor##2##3##(2008-10#2)
a host for##2##3##(2008-10#1)(2008-3#1)
a host genotype##2##3##(2008-10#2)
a host of##8##3##(2008-10#3)(2008-11#2)(2008-9#1)(2011-1#1)(2013-7#1)
a host plant##2##3##(2008-10#1)(2011-2#1)
a host##32##2##(1991-2#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-8#7)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
a host-selective toxin##2##3##(2008-10#2)
a host-specific##2##2##(2008-10#2)
a hot##7##2##(2008-10#4)(2008-5#1)(2009-10#1)(2011-2#1)
a household##2##2##(2008-10#1)(2010-5#1)
a housekeeping##2##2##(1995-6#2)
a huge##12##2##(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
a human alpha-1##2##3##(1995-2#2)
a human bone marrow##2##4##(2008-11#2)
a human breast##2##3##(1990-11#1)(1995-10#1)
a human cDNA##2##3##(1991-5#1)(1991-6#1)
a human cervical cancer cell line##2##6##(2008-11#1)(2010-12#1)
a human fetal brain cDNA library##2##6##(1996-2#1)(2008-8#1)
a human liver##3##3##(1991-5#1)(1993-3#1)(1994-11#1)
a human lung##3##3##(1991-5#1)(1997-2#1)(2008-11#1)
a human pathogen##2##3##(1995-2#1)(2007-12#1)
a human placenta cDNA library##2##5##(1994-11#1)(2008-8#1)
a human prostatic carcinoma cell strain##2##6##(1991-2#2)
a human tRNA gene##2##4##(1997-7#2)
a human testis##2##3##(1990-2#1)(2008-9#1)
a human##102##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1991-2#2)(1991-5#3)(1991-6#3)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#1)(1994-11#6)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#4)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#2)(1997-7#2)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#15)(2008-4#1)(2008-5#3)(2008-8#7)(2008-9#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#5)(2013-1#1)
a humanized monoclonal antibody (MAb)##2##5##(2008-5#1)(2008-7#1)
a humanized##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
a humid##2##2##(2008-10#2)
a hundred years##2##3##(1997-2#1)(2008-2#1)
a hundred##4##2##(1993-12#1)(1997-2#1)(2008-2#1)(2011-2#1)
a hunt##2##2##(2008-9#2)
a hybrid PBL curriculum##3##4##(2008-10#3)
a hybrid artificial liver##4##4##(2008-11#4)
a hybrid between##2##3##(1994-5#1)(2008-10#1)
a hybrid of##2##3##(1993-1#1)(2008-10#1)
a hybrid##26##2##(1993-1#1)(1994-5#1)(1997-5#1)(2007-12#1)(2008-10#11)(2008-11#5)(2008-3#3)(2008-4#1)(2012-12#1)(2012-3#1)
a hybridization##3##2##(1992-10#1)(2008-10#2)
a hybridoma##4##2##(2008-11#4)
a hydrazone##3##2##(1997-1#1)(2008-10#1)(2010-4#1)
a hydride generation##3##3##(2008-10#3)
a hydrodynamic##2##2##(2008-10#2)
a hydrogel##3##2##(2008-5#3)
a hydrogen bond forming ligand##2##5##(2008-10#2)
a hydrogen bond##5##3##(1993-1#1)(2008-10#2)(2010-7#2)
a hydrogen peroxide##3##3##(2008-10#3)
a hydrogen##11##2##(1991-3#1)(1993-1#1)(1995-11#1)(2008-10#6)(2010-7#2)
a hydrogen/entrained air flame##2##4##(2008-10#2)
a hydrolysis##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
a hydrophilic##4##2##(2008-10#3)(2008-7#1)
a hydrophobic##10##2##(1993-6#1)(1994-3#1)(1997-7#1)(2008-10#5)(2008-4#1)(2008-8#1)
a hydroponic##2##2##(2008-10#2)
a hydrothermal##2##2##(2008-6#1)(2009-11#1)
a hydroxyl group##3##3##(2008-10#1)(2008-11#2)
a hygromycin##2##2##(2008-10#1)(2011-1#1)
a hyperbolic##4##2##(2008-10#2)(2008-3#2)
a hyperphosphorylated##2##2##(1996-12#1)(1996-2#1)
a hypersensitive reaction##2##3##(2008-10#2)
a hypersensitive response##3##3##(2008-10#3)
a hypersensitive##5##2##(2008-10#5)
a hypersensitivity##2##2##(1996-12#1)(2008-8#1)
a hypertensive##4##2##(1993-11#1)(2008-7#1)(2010-4#2)
a hyperthermophilic##3##2##(2008-7#1)(2011-2#2)
a hypothesis about##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a hypothesis that##2##3##(2008-11#1)(2012-3#1)
a hypothesis##9##2##(1995-5#1)(2008-10#2)(2008-11#2)(2008-7#2)(2011-2#1)(2012-3#1)
a hypothesized##2##2##(2008-10#1)(2008-12#1)
a hypothetical protein##3##3##(1995-9#1)(1996-3#1)(1997-2#1)
a hypothetical##12##2##(1990-11#1)(1992-2#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-8#2)(2009-10#1)(2012-2#1)(2013-1#1)
a hypotonic##5##2##(1990-2#4)(2008-11#1)
a hypovirulence-associated##2##2##(2008-10#2)
a in##4##2##(1996-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
a internal##2##2##(2008-10#2)
a jellyfish sting##2##3##(2012-3#2)
a jellyfish##3##2##(2012-3#3)
a jet ring cell##2##4##(2008-10#2)
a jet ring##3##3##(2008-10#3)
a jet##6##2##(1994-12#1)(1996-3#1)(2008-10#3)(2013-1#1)
a job##6##2##(1990-2#1)(1991-2#1)(1991-3#1)(1993-1#1)(2008-9#1)(2013-8#1)
a joint venture##3##3##(1994-3#2)(2008-5#1)
a joint##9##2##(1991-2#1)(1994-3#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
a jury's##2##2##(1995-12#1)(1995-6#1)
a just##2##2##(1993-11#1)(2008-6#1)
a juvenile##4##2##(1995-11#1)(1997-6#1)(2008-8#1)(2013-1#1)
a kappa-opioid##2##2##(1997-2#2)
a key component in##3##4##(2008-11#2)(2013-8#1)
a key component##4##3##(2008-10#1)(2008-11#2)(2013-8#1)
a key enzyme of##2##4##(1992-8#1)(1993-6#1)
a key enzyme##7##3##(1990-2#1)(1992-8#1)(1993-6#1)(1995-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
a key factor for##2##4##(2008-10#1)(2008-9#1)
a key factor in the biocontrol activity of##2##8##(2008-10#2)
a key factor in the##4##5##(2008-10#2)(2013-1#1)(2013-8#1)
a key factor in##10##4##(1996-1#1)(2008-10#3)(2008-11#1)(2008-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
a key factor##13##3##(1996-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
a key intermediate in the synthesis of##2##7##(1992-12#1)(2011-1#1)
a key intermediate##3##3##(1992-12#1)(1996-5#1)(2011-1#1)
a key issue##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
a key mechanism##2##3##(2008-10#1)(2012-2#1)
a key molecule##2##3##(2008-11#1)(2008-7#1)
a key player in the##2##5##(1994-12#1)(2011-2#1)
a key protein##2##3##(2008-8#1)(2009-8#1)
a key regulator of##3##4##(1994-12#1)(2008-11#1)(2012-2#1)
a key regulatory##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
a key role in the development of##3##7##(2008-1#1)(2008-11#1)(2010-11#1)
a key role in the pathogenesis of##3##7##(2009-8#1)(2011-1#1)(2013-1#1)
a key role in the##22##5##(1991-5#1)(1995-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#2)
a key role in##37##4##(1991-5#1)(1994-2#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-8#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#4)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
a key role of##2##4##(2009-8#1)(2013-1#1)
a key role##43##3##(1991-5#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-5#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#1)(2011-1#4)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
a key step in##4##4##(1990-5#1)(1994-11#1)(2008-11#1)(2011-2#1)
a key step##6##3##(1990-5#1)(1994-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
a key to##3##3##(1994-12#1)(2008-8#2)
a key##140##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#2)(1995-11#2)(1995-2#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-1#3)(2008-10#19)(2008-11#15)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#7)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#3)
a keyword##2##2##(2010-12#1)(2011-2#1)
a kidney transplant##3##3##(2008-5#1)(2010-12#2)
a kidney##5##2##(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#2)
a kind of##7##3##(2008-10#4)(2008-3#1)(2008-8#1)(2009-3#1)
a kinetic model##2##3##(1996-2#1)(2008-7#1)
a kinetic study##2##3##(2008-10#1)(2012-2#1)
a kinetic##11##2##(1991-3#1)(1995-2#1)(1996-2#1)(2008-10#6)(2008-7#1)(2012-2#1)
a kinship##2##2##(2008-12#2)
a kit##3##2##(1996-2#1)(2008-5#1)(2012-2#1)
a knee##6##2##(2008-8#1)(2013-1#5)
a knotted reactor##3##3##(2008-10#3)
a knotted##7##2##(2008-10#7)
a knowledge of the##2##4##(1997-4#1)(2008-9#1)
a knowledge of##3##3##(1996-12#1)(1997-4#1)(2008-9#1)
a known amount of##2##4##(2008-10#1)(2008-12#1)
a known and##2##3##(1991-1#1)(2008-10#1)
a known cause of##2##4##(2008-4#1)(2012-12#1)
a known##46##2##(1991-1#1)(1991-5#2)(1993-6#1)(1995-6#1)(1995-8#1)(1997-5#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-7#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
a lab-made##2##2##(2008-10#2)
a lab-on-valve (LOV)##2##3##(2008-10#2)
a label-free detection##2##3##(2008-10#2)
a label-free##3##2##(2008-10#3)
a labeled##5##2##(1993-11#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
a labeling##3##2##(1996-5#1)(2008-10#2)
a laboratory colony of##2##4##(1996-6#1)(2010-4#1)
a laboratory population of##2##4##(2008-10#2)
a laboratory population##3##3##(2008-10#3)
a laboratory strain##4##3##(1996-12#1)(2011-2#2)(2012-3#1)
a laboratory##32##2##(1993-2#2)(1994-6#1)(1996-12#1)(1996-6#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-8#1)
a laboratory-made##5##2##(2008-10#5)
a lack of a##2##4##(2008-12#1)(2011-2#1)
a lack of adequate##2##4##(2010-6#1)(2011-3#1)
a lack of consensus##4##4##(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
a lack of knowledge##2##4##(2008-11#1)(2009-6#1)
a lack of##65##3##(1994-1#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#11)(2008-12#7)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-6#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
a lacunar##2##2##(2009-10#2)
a lag##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
a lake##4##2##(2008-10#2)(2008-8#1)(2010-8#1)
a lambda##5##2##(1993-2#1)(1993-6#1)(1993-8#1)(1997-7#1)(2008-11#1)
a laminar##6##2##(2008-11#1)(2008-3#4)(2008-7#1)
a laminin##2##2##(2008-10#1)(2008-11#1)
a language##2##2##(2008-11#2)
a laparoscopic##2##2##(2011-2#1)(2012-12#1)
a laparotomy##5##2##(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(2008-12#1)
a large AVM##2##3##(2008-7#2)
a large academic##2##3##(1995-3#1)(2008-11#1)
a large amount of##12##4##(2007-12#2)(2008-10#6)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)
a large amount##13##3##(2007-12#2)(2008-10#6)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
a large and diverse##2##4##(2008-10#1)(2008-11#1)
a large and##8##3##(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-2#1)
a large angular##2##3##(2008-2#1)(2008-3#1)
a large animal##2##3##(2008-4#1)(2012-12#1)
a large area##4##3##(1992-5#1)(2008-10#1)(2008-11#1)(2009-11#1)
a large automated database of computerized##2##6##(2008-11#2)
a large bandwidth##2##3##(2008-3#2)
a large body of evidence##2##5##(1992-3#1)(2008-10#1)
a large body of##6##4##(1992-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#2)
a large cohort of##2##4##(2009-8#1)(2011-2#1)
a large cohort##3##3##(2009-8#1)(2011-2#2)
a large collection of##2##4##(2008-10#1)(2013-1#1)
a large cystic##2##3##(1990-6#1)(2011-2#1)
a large data##2##3##(1994-3#1)(2008-9#1)
a large degree##3##3##(2008-10#2)(2008-9#1)
a large excess of##4##4##(1991-11#1)(1995-2#1)(2008-10#2)
a large extent##7##3##(1996-6#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
a large family of##2##4##(2008-9#1)(2009-8#1)
a large group of##6##4##(2008-10#2)(2008-12#1)(2009-10#1)(2011-2#1)(2012-3#1)
a large group##7##3##(2008-10#2)(2008-12#2)(2009-10#1)(2011-2#1)(2012-3#1)
a large hospital##2##3##(2010-8#1)(2012-2#1)
a large impact on##2##4##(1991-3#1)(1994-12#1)
a large impact upon##2##4##(2008-10#1)(2013-1#1)
a large impact##4##3##(1991-3#1)(1994-12#1)(2008-10#1)(2013-1#1)
a large increase in fluorescence intensity##2##6##(2008-10#2)
a large increase in##4##4##(1990-11#1)(1995-6#1)(2008-10#2)
a large increase##5##3##(1990-11#1)(1995-6#1)(2008-10#3)
a large mass##3##3##(2008-11#2)(2011-2#1)
a large municipal public health agency##2##6##(2010-8#2)
a large municipal##3##3##(1991-12#1)(2010-8#2)
a large network of##2##4##(2008-8#1)(2008-9#1)
a large number of anions##4##5##(2008-10#4)
a large number of different##4##5##(1994-2#1)(1995-5#1)(2008-9#1)(2013-1#1)
a large number of genes##3##5##(1996-12#1)(1996-6#1)(2011-1#1)
a large number of patients##4##5##(1993-11#2)(1996-3#1)(2010-12#1)
a large number of samples##8##5##(2008-10#4)(2008-11#2)(2008-9#1)(2010-11#1)
a large number of##88##4##(1990-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(2008-10#32)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
a large number##89##3##(1990-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(2008-10#33)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
a large part of the##2##5##(2008-5#1)(2008-8#1)
a large part of##3##4##(1993-2#1)(2008-5#1)(2008-8#1)
a large percentage of##4##4##(2008-10#1)(2012-12#1)(2012-2#2)
a large pool of##2##4##(1997-7#1)(2010-11#1)
a large population of##4##4##(1994-8#1)(1997-3#1)(2008-10#1)(2011-2#1)
a large population##6##3##(1994-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
a large proportion of the##4##5##(2008-10#2)(2010-10#1)(2013-8#1)
a large proportion of##11##4##(1990-3#1)(1992-12#2)(1996-2#1)(2007-12#1)(2008-10#3)(2010-10#1)(2011-2#1)(2013-8#1)
a large range of##5##4##(2008-10#3)(2008-3#1)(2008-4#1)
a large sample of##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
a large sample##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
a large scale##10##3##(1994-6#1)(2008-10#4)(2008-11#3)(2009-12#1)(2012-2#1)
a large series of##2##4##(2008-10#1)(2008-5#1)
a large set of##5##4##(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2013-8#1)
a large surface area##2##4##(2008-10#1)(2008-11#1)
a large urban##2##3##(1992-1#1)(1992-12#1)
a large vacuole##2##3##(2008-6#1)(2009-12#1)
a large variability##2##3##(1997-3#1)(2008-11#1)
a large variety of##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
a large volume of##5##4##(1995-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
a large volume##9##3##(1995-3#1)(2008-10#6)(2008-11#1)(2008-8#1)
a large##415##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-3#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-3#2)(1992-5#2)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#113)(2008-11#30)(2008-12#9)(2008-2#4)(2008-3#14)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#9)(2008-9#12)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#4)(2011-1#3)(2011-2#24)(2012-12#3)(2012-2#13)(2012-3#12)(2013-1#12)(2013-8#4)
a large-scale comparison of##2##4##(2008-10#1)(2012-3#1)
a large-scale##13##2##(1993-2#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-1#1)(2012-3#1)(2013-1#1)
a largely##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
a larger amount of##2##4##(2008-10#2)
a larger collection of##2##4##(1993-12#1)(2008-10#1)
a larger fraction of##2##4##(1991-11#1)(2013-8#1)
a larger number of patients##2##5##(1992-2#1)(2008-10#1)
a larger number of##4##4##(1992-2#1)(2008-10#3)
a larger proportion of##2##4##(1990-6#1)(2008-1#1)
a larger sample##2##3##(2008-12#1)(2010-7#1)
a larger study##6##3##(2008-11#2)(2008-12#1)(2008-8#1)(2009-12#1)(2010-7#1)
a larger surface area##2##4##(1994-9#1)(2008-7#1)
a larger##63##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#18)(2008-11#6)(2008-12#3)(2008-3#1)(2008-7#3)(2008-8#3)(2009-10#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-7#3)(2011-2#2)(2012-2#1)(2013-8#2)
a larval##3##2##(2009-6#1)(2010-8#1)(2011-2#1)
a laser diode for##2##4##(2008-3#2)
a laser diode##6##3##(2008-2#1)(2008-3#5)
a laser guide star##2##4##(2008-3#2)
a laser##28##2##(1993-2#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#16)(2008-9#2)(2009-12#1)(2009-7#1)(2012-3#1)(2013-8#1)
a laser-diode##2##2##(2008-3#2)
a last resort##2##3##(2008-8#1)(2010-10#1)
a lasting##2##2##(2008-12#1)(2008-7#1)
a late##6##2##(1992-9#1)(1996-6#1)(2008-11#1)(2010-11#2)(2012-2#1)
a latent variable##2##3##(2008-12#1)(2010-11#1)
a latent##4##2##(1995-6#1)(2008-12#1)(2009-11#1)(2010-11#1)
a later age##2##3##(1995-8#1)(1996-9#1)
a later##13##2##(1991-12#1)(1993-11#1)(1995-6#1)(1995-8#1)(1996-9#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-1#2)
a lateral##12##2##(1991-2#1)(1991-3#1)(2007-12#2)(2008-10#2)(2008-7#1)(2009-1#3)(2009-10#1)(2013-1#1)
a latissimus dorsi##2##3##(1992-9#1)(1994-12#1)
a layer of##10##3##(2008-10#8)(2008-3#1)(2008-5#1)
a layer##13##2##(1992-9#2)(2008-10#9)(2008-3#1)(2008-5#1)
a layered spheroid##2##3##(2008-3#2)
a lead##5##2##(1996-2#1)(2008-10#4)
a leader##4##2##(1991-9#1)(1993-12#1)(1993-6#1)(1994-1#1)
a leading cause of disability##2##5##(2010-3#1)(2013-1#1)
a leading cause of##13##4##(1993-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
a leading##17##2##(1993-3#1)(1994-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#1)
a leaf in##2##3##(2008-10#2)
a leaf spot##2##3##(2008-10#2)
a leaf##14##2##(1997-7#1)(2008-10#12)(2013-8#1)
a learning curve##2##3##(2011-2#1)(2012-2#1)
a learning##18##2##(1994-8#1)(1997-6#1)(2008-10#1)(2008-11#11)(2008-12#1)(2009-5#1)(2011-2#1)(2012-2#1)
a learning-based model##2##3##(2008-8#2)
a learning-based##3##2##(2008-8#3)
a least-squares method##3##3##(2008-3#3)
a least-squares##5##2##(2008-2#1)(2008-3#4)
a leave-on lotion##3##3##(2008-5#3)
a leave-on##6##2##(2008-5#6)
a lectin##6##2##(1990-5#3)(1993-6#1)(2008-10#1)(2008-11#1)
a lecturer##3##2##(2008-11#1)(2008-12#2)
a left lateral##3##3##(1992-9#1)(2008-7#1)(2012-3#1)
a left lower##3##3##(2008-1#2)(2008-7#1)
a left pleural effusion##2##4##(1991-12#1)(2013-1#1)
a left##23##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-9#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-7#4)(2009-8#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
a left-sided##2##2##(1997-7#1)(2010-5#1)
a leftward relaxation of the spatial##2##6##(2009-10#2)
a legacy of##2##3##(2008-10#1)(2013-1#1)
a legacy##4##2##(1992-3#1)(2008-10#2)(2013-1#1)
a legal##3##2##(1997-3#1)(2008-11#1)(2013-8#1)
a legitimate##2##2##(2008-6#1)(2010-12#1)
a length of##7##3##(1992-12#1)(1992-9#1)(1994-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-3#1)
a lengthy##4##2##(1992-12#1)(1992-2#1)(1996-1#1)(2008-10#1)
a lens##4##2##(2008-10#2)(2008-3#2)
a lesion in the##3##4##(2007-8#1)(2008-10#1)(2009-11#1)
a lesion with##2##3##(1996-3#1)(2010-7#1)
a lesion##19##2##(1990-5#1)(1990-9#1)(1991-6#1)(1996-2#1)(1996-3#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-7#1)(2011-2#1)(2013-1#2)
a less sensitive##2##3##(2008-10#1)(2011-2#1)
a less than##4##3##(1990-2#1)(1995-11#1)(2008-3#2)
a less##36##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-11#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#1)(2011-2#3)(2013-1#5)(2013-8#1)
a lesser degree##10##3##(1991-12#1)(1994-6#1)(1994-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
a lesser effect##3##3##(1997-1#1)(2008-10#1)(2012-12#1)
a lesser##54##2##(1991-12#2)(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-9#1)(2008-10#17)(2008-11#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-12#2)(2012-2#1)
a lesson##2##2##(2008-8#1)(2010-1#1)
a lethal##7##2##(1993-3#1)(1993-9#1)(1995-2#1)(1995-5#1)(2008-12#1)(2010-7#1)(2012-2#1)
a lethality of##2##3##(1997-8#2)
a letter##4##2##(1996-2#1)(2008-5#1)(2008-9#2)
a leucine##2##2##(1993-8#1)(2008-9#1)
a level below##2##3##(1991-6#1)(2008-7#1)
a level of 4##2##4##(1990-8#1)(2008-10#1)
a level of##14##3##(1990-8#1)(1991-3#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2009-3#1)
a level similar to##2##4##(2008-10#2)
a level that##4##3##(2008-10#1)(2008-12#2)(2009-3#1)
a level##37##2##(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1996-2#1)(1997-3#1)(2008-10#14)(2008-11#6)(2008-12#3)(2008-3#2)(2008-7#1)(2009-3#2)(2010-7#1)(2012-3#1)(2013-1#1)
a library of##3##3##(1990-5#1)(1995-6#1)(2008-10#1)
a library##5##2##(1990-5#1)(1991-9#1)(1995-6#1)(2008-10#1)(2011-1#1)
a licensed##3##2##(1991-3#2)(2011-2#1)
a lidar##2##2##(2008-2#2)
a life history##2##3##(2008-8#2)
a life of##3##3##(1993-12#1)(2008-12#2)
a life table approach##2##4##(2011-2#2)
a life table##3##3##(2008-9#1)(2011-2#2)
a life##10##2##(1993-12#1)(2008-12#2)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#3)
a life-history trait##2##3##(2008-8#1)(2008-9#1)
a life-history##3##2##(2008-8#2)(2008-9#1)
a life-threatening complication of##3##4##(2008-12#1)(2010-10#1)(2011-2#1)
a life-threatening complication##4##3##(2008-12#1)(2010-10#1)(2011-2#1)(2011-3#1)
a life-threatening##10##2##(1993-2#1)(2008-11#2)(2008-12#1)(2010-10#1)(2011-2#3)(2011-3#2)
a lifetime##2##2##(1994-9#1)(2008-10#1)
a ligand##20##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-9#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)
a light emitting diode##2##4##(1991-2#1)(2008-10#1)
a light source##5##3##(2007-12#1)(2008-10#3)(2012-3#1)
a light##22##2##(1991-2#1)(1992-3#1)(1994-2#1)(1996-6#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-3#3)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#2)
a likelihood##4##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-6#1)
a likely##7##2##(1990-3#1)(1991-9#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
a limit of detection (3sigma) of 1##2##7##(2008-10#2)
a limit of detection (LOD) of##2##6##(2008-10#2)
a limit of detection (LOD)##4##5##(2008-10#4)
a limit of detection (S/N=2) of##2##6##(2008-10#2)
a limit of detection of 1##3##6##(2008-10#3)
a limit of detection of##16##5##(2008-10#16)
a limit of detection##35##4##(2008-10#35)
a limit of quantification##2##4##(2008-10#2)
a limit of##38##3##(2008-10#38)
a limit on##3##3##(1993-12#2)(2007-12#1)
a limit to##2##3##(2008-9#1)(2010-8#1)
a limit##43##2##(1993-12#2)(2007-12#1)(2008-10#38)(2008-9#1)(2010-8#1)
a limited amount of##4##4##(1993-12#1)(2008-5#1)(2009-12#1)(2011-2#1)
a limited capacity##2##3##(1994-2#1)(2008-10#1)
a limited effect##2##3##(1990-6#1)(2008-6#1)
a limited geographic##2##3##(2008-10#1)(2008-8#1)
a limited involvement##2##3##(2007-12#1)(2008-12#1)
a limited number of genes##2##5##(2008-6#1)(2009-8#1)
a limited number of##15##4##(1993-9#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a limited range of##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
a limited range##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
a limited role in##2##4##(2008-10#2)
a limited role##4##3##(1995-10#1)(2008-10#2)(2011-2#1)
a limited set of##3##4##(2008-11#1)(2009-11#1)(2011-2#1)
a limited##65##2##(1990-6#1)(1991-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-8#1)(1995-10#1)(1995-11#1)(1997-1#1)(1997-7#1)(2007-12#2)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#1)(2013-1#1)
a limiting factor for##2##4##(2008-10#1)(2008-11#1)
a limiting factor in##2##4##(1996-3#1)(2008-10#1)
a limiting factor##6##3##(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#2)
a limiting step##2##3##(1994-11#2)
a limiting##10##2##(1994-11#2)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-8#2)
a line between##2##3##(1995-8#1)(1996-11#1)
a line of##4##3##(1993-6#1)(2008-10#1)(2008-9#1)(2012-12#1)
a line##13##2##(1993-6#1)(1995-8#1)(1996-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
a lineage##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
a linear calibration curve##3##4##(2008-10#3)
a linear calibration graph was obtained##3##6##(2008-10#3)
a linear calibration plot of##2##5##(2008-10#2)
a linear calibration plot##4##4##(2008-10#4)
a linear calibration range##4##4##(2008-10#4)
a linear calibration##15##3##(2008-10#15)
a linear combination of##3##4##(2008-10#2)(2010-2#1)
a linear concentration range of 1##2##6##(2008-10#2)
a linear concentration range of##4##5##(2008-10#4)
a linear correlation between the##2##5##(2008-10#2)
a linear correlation##6##3##(1993-1#1)(2008-10#5)
a linear dependence##2##3##(2008-10#2)
a linear determination range of 0##2##6##(2008-10#2)
a linear determination range##3##4##(2008-10#3)
a linear dynamic range between##3##5##(2008-10#3)
a linear dynamic range from 0##3##6##(2008-10#3)
a linear dynamic range from##6##5##(2008-10#6)
a linear dynamic range of##3##5##(2008-10#3)
a linear dynamic range##13##4##(2008-10#13)
a linear dynamic##14##3##(2008-10#14)
a linear function of the##2##5##(2008-10#2)
a linear function of##4##4##(2008-10#3)(2008-8#1)
a linear function##5##3##(2008-10#4)(2008-8#1)
a linear increase in##3##4##(2008-12#1)(2008-7#2)
a linear increase##4##3##(2008-11#1)(2008-12#1)(2008-7#2)
a linear model##2##3##(2008-10#1)(2008-3#1)
a linear potential##2##3##(2008-10#2)
a linear range between 0##3##5##(2008-10#3)
a linear range between 1##3##5##(2008-10#3)
a linear range between##9##4##(2008-10#9)
a linear range from##4##4##(2008-10#4)
a linear range of 0##3##5##(2008-10#3)
a linear range of 5##2##5##(2008-10#2)
a linear range of##15##4##(1991-2#1)(2008-10#14)
a linear range up to##2##5##(2008-10#2)
a linear range##32##3##(1991-2#1)(2008-10#31)
a linear regression model##2##4##(1995-9#1)(2008-10#1)
a linear regression##5##3##(1995-9#1)(2008-10#3)(2013-8#1)
a linear relation##2##3##(2008-10#2)
a linear relationship between peak height and##2##7##(2008-10#2)
a linear relationship between the##5##5##(2008-10#3)(2008-11#1)(2011-2#1)
a linear relationship between##12##4##(2008-10#10)(2008-11#1)(2011-2#1)
a linear relationship was obtained between the##2##7##(2008-10#2)
a linear relationship with the##3##5##(2008-10#3)
a linear relationship with##4##4##(2008-10#4)
a linear relationship##21##3##(2008-10#19)(2008-11#1)(2011-2#1)
a linear response for both drugs over the concentration range##2##10##(2008-10#2)
a linear response for##7##4##(2008-10#7)
a linear response from##2##4##(2008-10#2)
a linear response in the##3##5##(2008-10#3)
a linear response over a##3##5##(2008-10#2)(2010-3#1)
a linear response over the concentration range##2##7##(2008-10#2)
a linear response over the##4##5##(2008-10#4)
a linear response over##7##4##(2008-10#6)(2010-3#1)
a linear response range##2##4##(2008-10#2)
a linear response to##6##4##(2008-10#6)
a linear response with a##3##5##(2008-10#3)
a linear response with##5##4##(2008-10#5)
a linear response##37##3##(2008-10#35)(2008-2#1)(2010-3#1)
a linear##195##2##(1990-11#1)(1991-11#1)(1991-2#1)(1993-1#1)(1995-12#1)(1995-9#1)(2007-11#2)(2008-10#161)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#4)(2008-8#3)(2008-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#3)(2013-8#2)
a linearity##5##2##(2008-10#5)
a linewidth of##2##3##(2008-3#2)
a linewidth##3##2##(2008-3#3)
a link between the##2##4##(1994-8#1)(2008-11#1)
a link between##9##3##(1993-12#1)(1994-11#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-9#1)
a linkage map##3##3##(2008-10#2)(2010-8#1)
a linkage##7##2##(1991-2#1)(2008-10#3)(2008-9#2)(2010-8#1)
a linked##2##2##(1991-6#1)(1993-11#1)
a lipase##2##2##(2008-5#1)(2011-1#1)
a lipid extract##2##3##(1991-5#1)(2008-10#1)
a lipid membrane##2##3##(1994-11#2)
a lipid peroxidation##2##3##(1994-5#1)(2008-10#1)
a lipid##12##2##(1990-5#1)(1991-5#1)(1994-11#2)(1994-5#1)(2008-10#2)(2008-11#2)(2009-8#1)(2009-9#1)(2011-2#1)
a lipidic##2##2##(2007-12#1)(2008-10#1)
a lipophilic acrylate resin##2##4##(2008-10#2)
a lipophilic##10##2##(2008-10#9)(2008-4#1)
a lipstick##2##2##(2008-5#2)
a liquid chromatographic##2##3##(2008-10#2)
a liquid membrane containing##2##4##(2008-10#2)
a liquid membrane##5##3##(2008-10#5)
a liquid soap##2##3##(2008-10#1)(2008-5#1)
a liquid##30##2##(1996-1#2)(1996-2#1)(2008-10#20)(2008-3#5)(2008-5#1)(2008-9#1)
a liquid's complex refractive index##2##5##(2008-3#2)
a liquid's##3##2##(2008-3#3)
a liquid-core##2##2##(2008-10#2)
a liquid-core-waveguide##2##2##(2008-10#2)
a liquid-liquid extraction procedure##2##4##(2008-10#2)
a liquid-liquid extraction##4##3##(2008-10#4)
a liquid-liquid##5##2##(2008-10#5)
a liquid-nitrogen-cooled##2##2##(2008-10#1)(2008-2#1)
a list of##8##3##(1991-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-12#1)(2011-1#1)
a literature review and##2##4##(2009-8#1)(2012-3#1)
a literature review of the##3##5##(2008-11#1)(2008-8#1)(2010-6#1)
a literature review##18##3##(1991-1#1)(1991-6#1)(1993-6#1)(1996-12#1)(1996-3#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
a literature review]##2##3##(1991-3#1)(2013-1#1)
a literature##25##2##(1991-1#2)(1991-3#1)(1991-6#1)(1993-6#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#4)(2008-8#2)(2009-4#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
a lithium##5##2##(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
a little difference##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
a little effect##3##3##(2008-10#2)(2008-11#1)
a little while##2##3##(2011-2#1)(2012-2#1)
a little##25##2##(1991-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-2#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-9#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
a live##9##2##(1995-9#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-6#1)(2011-2#2)
a liver##4##2##(2008-11#2)(2012-2#1)(2013-8#1)
a load##2##2##(2008-10#2)
a loaded##3##2##(2012-3#1)(2013-1#2)
a loading time of##2##4##(2008-10#2)
a loading##3##2##(2008-10#2)(2012-12#1)
a loamy##2##2##(2008-10#1)(2008-11#1)
a lobe##2##2##(2009-8#2)
a local accumulation of##2##4##(2008-10#1)(2008-8#1)
a local anesthetic##4##3##(1993-1#3)(1994-2#1)
a local area##4##3##(2008-10#4)
a local scale##2##3##(2008-10#1)(2008-8#1)
a local##55##2##(1990-11#1)(1992-12#1)(1992-5#1)(1993-1#3)(1993-6#2)(1994-11#1)(1994-2#2)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
a locality##2##2##(2008-11#1)(2008-5#1)
a localized form##2##3##(2012-12#1)(2013-1#1)
a localized##5##2##(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
a locally##2##2##(1997-8#1)(2010-3#1)
a location##2##2##(1993-1#1)(2008-10#1)
a lock-in amplifier##2##3##(2007-11#1)(2008-10#1)
a locus##4##2##(1996-2#1)(1996-5#1)(2008-8#1)(2009-10#1)
a logarithmic##8##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#1)
a logical##7##2##(1992-2#1)(1993-2#1)(2008-10#1)(2008-5#1)(2008-9#2)(2013-8#1)
a logistic regression analysis##2##4##(2008-10#2)
a logistic regression model##3##4##(2008-10#1)(2008-11#1)(2009-5#1)
a logistic regression##5##3##(2008-10#3)(2008-11#1)(2009-5#1)
a logistic##8##2##(2008-10#5)(2008-11#1)(2009-5#1)(2012-2#1)
a long 3' untranslated##2##4##(1993-8#1)(1996-12#1)
a long exposure to##2##4##(2008-8#1)(2011-2#1)
a long fiber##2##3##(2007-12#1)(2008-3#1)
a long history of##4##4##(1997-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
a long history##7##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#2)(2013-8#1)
a long period##7##3##(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#1)
a long term##6##3##(1990-2#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)
a long way in##2##4##(2008-10#1)(2010-7#1)
a long way to##2##4##(1991-2#1)(2008-11#1)
a long way##7##3##(1991-1#1)(1991-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-7#1)
a long##96##2##(1990-2#1)(1990-5#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-3#2)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#8)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#6)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
a long-lasting##3##2##(1991-2#1)(2008-10#1)(2010-1#1)
a long-lived##2##2##(2008-10#1)(2008-8#1)
a long-period##2##2##(2008-3#2)
a long-standing##2##2##(2008-8#1)(2013-8#1)
a long-term care##2##3##(1994-12#1)(2009-3#1)
a long-term##30##2##(1991-3#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
a longer delay##2##3##(1990-12#1)(1994-3#1)
a longer duration of##2##4##(2008-11#1)(2012-5#1)
a longer duration##4##3##(2008-11#1)(2012-3#1)(2012-5#1)(2013-1#1)
a longer follow-up##2##3##(1990-12#1)(1993-11#1)
a longer period of time##3##5##(2008-1#1)(2010-12#1)(2013-1#1)
a longer period of##4##4##(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
a longer period##5##3##(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
a longer time##4##3##(1991-3#1)(2008-10#2)(2008-5#1)
a longer##35##2##(1990-12#2)(1990-9#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)(2011-2#5)(2012-3#1)(2012-5#1)(2013-1#2)
a longitudinal study of##4##4##(1990-2#1)(2009-8#1)(2010-10#1)(2011-2#1)
a longitudinal study##9##3##(1990-2#1)(1996-9#1)(2008-11#2)(2009-11#1)(2009-8#1)(2010-10#1)(2011-2#2)
a longitudinal##17##2##(1990-2#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
a longtime##2##2##(1995-6#1)(2008-11#1)
a look at##2##3##(1994-2#1)(1994-3#1)
a look##5##2##(1991-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(2009-10#1)
a loop##4##2##(1992-4#1)(2008-11#1)(2008-12#2)
a loss in##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
a loss of##24##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-3#1)(1994-8#1)(1996-12#2)(1997-3#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#2)
a loss##31##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-8#1)(1996-12#2)(1997-3#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#3)
a lost##2##2##(1994-9#1)(1995-6#1)
a lot of attention##2##4##(2008-10#1)(2013-1#1)
a lot of##13##3##(1994-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#2)(2010-7#1)(2012-2#1)(2013-1#1)
a lot##16##2##(1994-2#1)(1994-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-9#3)(2010-7#1)(2012-2#1)(2013-1#1)
a low but##2##3##(1996-8#1)(2008-10#1)
a low cell##2##3##(1991-8#1)(2010-11#1)
a low complication rate##3##4##(1993-12#1)(1993-6#1)(2013-1#1)
a low concentration of##4##4##(1993-1#1)(2008-10#2)(2008-11#1)
a low concentration##5##3##(1993-1#1)(2008-10#3)(2008-11#1)
a low cost##4##3##(1997-2#1)(2008-10#2)(2008-11#1)
a low degree of##4##4##(1990-12#1)(1991-6#1)(1996-3#1)(2011-2#1)
a low detection limit (0##2##5##(2008-10#2)
a low detection limit of 0##3##6##(2008-10#3)
a low detection limit of##5##5##(2008-10#5)
a low detection limit##10##4##(2008-10#10)
a low dose##2##3##(2008-7#2)
a low frequency of##2##4##(2008-7#1)(2012-3#1)
a low frequency##4##3##(1993-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
a low incidence of serious##2##5##(1995-5#1)(2011-2#1)
a low incidence of##7##4##(1990-6#1)(1993-11#1)(1995-5#1)(2008-5#1)(2008-8#1)(2011-2#2)
a low incidence##9##3##(1990-6#1)(1993-11#1)(1995-5#1)(1996-3#1)(1997-1#1)(2008-5#1)(2008-8#1)(2011-2#2)
a low initial##2##3##(2008-10#1)(2009-7#1)
a low inoculum##2##3##(2008-10#2)
a low level of##15##4##(2008-1#1)(2008-10#9)(2008-11#3)(2011-10#1)(2013-1#1)
a low level##25##3##(1990-3#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-9#1)(2011-10#1)(2013-1#1)
a low molecular weight##3##4##(1993-8#1)(2008-10#1)(2009-4#1)
a low molecular##4##3##(1993-8#1)(1995-6#1)(2008-10#1)(2009-4#1)
a low or##4##3##(1995-12#1)(2008-10#2)(2008-8#1)
a low percentage##2##3##(2008-5#1)(2008-7#1)
a low productivity##2##3##(2008-11#2)
a low rate of##4##4##(1993-6#1)(1994-1#1)(2008-10#1)(2009-12#1)
a low sensitivity##4##3##(1992-3#1)(2008-8#2)(2012-12#1)
a low solubility##2##3##(2008-10#2)
a low speed##2##3##(1992-3#1)(2008-7#1)
a low temperature##6##3##(2008-10#5)(2008-11#1)
a low value##2##3##(2008-10#1)(2009-7#1)
a low##187##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#4)(1993-8#2)(1994-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-3#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#69)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#4)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-10#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
a low-cost##10##2##(2008-10#8)(2008-11#1)(2010-5#1)
a low-glycemic load##2##3##(2008-3#2)
a low-grade##2##2##(1997-8#1)(2011-2#1)
a low-income##3##2##(1993-3#1)(1995-3#1)(1997-2#1)
a low-molecular-weight##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
a low-noise##2##2##(2008-1#1)(2008-10#1)
a low-power##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
a low-resolution##2##2##(2008-10#1)(2008-3#1)
a low-risk##3##2##(1993-1#1)(2008-12#1)(2012-2#1)
a lower Km##2##3##(1993-8#1)(1995-6#1)
a lower concentration##3##3##(1996-2#1)(2008-11#2)
a lower court's##3##3##(1995-6#2)(1996-5#1)
a lower detection limit of 0##3##6##(2008-10#2)(2008-11#1)
a lower detection limit of 1##2##6##(2008-10#2)
a lower detection limit of##5##5##(2008-10#4)(2008-11#1)
a lower detection limit##8##4##(2008-10#7)(2008-11#1)
a lower dose##2##3##(2008-1#1)(2008-10#1)
a lower frequency of##2##4##(1991-3#1)(2012-3#1)
a lower frequency##3##3##(1991-3#1)(2008-10#1)(2012-3#1)
a lower incidence of##4##4##(1990-8#1)(1992-3#1)(2008-10#1)(2011-2#1)
a lower level of##5##4##(2008-10#2)(2009-12#1)(2010-11#1)(2013-8#1)
a lower level##6##3##(1990-3#1)(2008-10#2)(2009-12#1)(2010-11#1)(2013-8#1)
a lower limit of##3##4##(1991-5#1)(2008-10#2)
a lower number of##4##4##(2008-10#1)(2012-3#1)(2012-5#1)(2013-1#1)
a lower one##2##3##(1990-9#1)(2009-5#1)
a lower rate of complications##2##5##(2013-1#2)
a lower rate of##4##4##(2011-2#1)(2012-12#1)(2013-1#2)
a lower sensitivity##2##3##(1991-6#1)(2008-10#1)
a lower total##2##3##(2008-11#1)(2013-8#1)
a lower##117##2##(1990-12#2)(1990-3#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-2#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#12)(2008-12#2)(2008-7#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#2)(2009-9#1)(2010-11#2)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#2)(2013-1#5)(2013-8#4)
a lowering of##2##3##(2008-10#1)(2008-5#1)
a lowest##2##2##(2008-10#2)
a luciferase reporter##2##3##(1995-6#1)(2011-2#1)
a luciferase##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
a lumbar##3##2##(1991-11#1)(1997-4#1)(2012-2#1)
a luminescence##2##2##(2008-10#2)
a luminescent##2##2##(2008-10#2)
a lung##4##2##(1994-5#1)(1997-2#2)(2008-11#1)
a lysosomal aspartyl protease##2##4##(1994-5#1)(1995-8#1)
a lysosomal##5##2##(1990-5#1)(1992-10#2)(1994-5#1)(1995-8#1)
a lytic##2##2##(2008-11#1)(2012-12#1)
a macro segmented flow##2##4##(2008-10#2)
a macro##3##2##(2008-10#2)(2012-2#1)
a macrocyclic##2##2##(2008-10#2)
a macroporous##4##2##(2008-10#3)(2008-11#1)
a macroscopic##5##2##(1995-3#1)(2008-7#1)(2009-7#1)(2012-2#2)
a magnet##3##2##(1990-12#2)(2008-10#1)
a magnetic field##2##3##(2008-8#1)(2010-9#1)
a magnetic##10##2##(1990-12#1)(1993-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2010-9#1)
a main##16##2##(1992-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#1)(2012-6#1)(2013-1#1)
a mainstay of##2##3##(2008-12#1)(2010-1#1)
a mainstay##3##2##(2008-12#1)(2010-1#1)(2013-1#1)
a maize##6##2##(1994-6#1)(2008-10#3)(2008-8#2)
a major abdominal##2##3##(2009-12#2)
a major cause of death##2##5##(2010-12#1)(2012-3#1)
a major cause of morbidity and mortality##3##7##(2008-11#1)(2008-12#1)(2009-12#1)
a major cause of morbidity##5##5##(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)
a major cause of persistent##2##5##(2010-12#1)(2013-1#1)
a major cause of the##2##5##(1990-6#1)(2008-10#1)
a major cause of##22##4##(1990-6#1)(1991-12#1)(1991-6#1)(1995-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
a major cause##23##3##(1990-6#1)(1991-12#1)(1991-6#1)(1995-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
a major challenge to##3##4##(2008-10#1)(2010-1#1)(2012-3#1)
a major challenge##4##3##(1991-1#1)(2008-10#1)(2010-1#1)(2012-3#1)
a major clinical##2##3##(2010-12#1)(2012-3#1)
a major component in##4##4##(1992-6#1)(2008-11#2)(2008-12#1)
a major component of the##7##5##(1990-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)
a major component of##13##4##(1990-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-4#1)
a major component##18##3##(1990-9#1)(1992-6#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2009-4#1)
a major concern in##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
a major concern##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
a major constituent of##2##4##(1990-8#1)(1992-12#1)
a major constraint on##2##4##(2008-10#2)
a major constraint##3##3##(2008-10#3)
a major contribution to##2##4##(2008-10#2)
a major contributor to the##2##5##(1994-8#1)(2008-1#1)
a major contributor to##4##4##(1994-8#1)(2008-1#1)(2011-9#1)(2012-12#1)
a major determinant of##2##4##(2008-10#2)
a major determinant##3##3##(1994-11#1)(2008-10#2)
a major disease of##3##4##(2008-10#3)
a major disease##6##3##(2008-10#6)
a major economic##3##3##(1992-6#1)(2008-10#2)
a major effect on the##2##5##(2008-9#1)(2013-1#1)
a major factor in##3##4##(1992-1#1)(1996-3#1)(2008-10#1)
a major factor##6##3##(1992-1#1)(1994-5#1)(1996-3#1)(2008-10#2)(2008-8#1)
a major focus of##2##4##(2008-7#1)(2011-2#1)
a major gene for resistance##2##5##(2008-10#2)
a major gene##9##3##(2008-10#7)(2008-8#2)
a major health problem in the##2##6##(2010-8#1)(2013-8#1)
a major health problem in##3##5##(2010-8#1)(2013-1#1)(2013-8#1)
a major health problem##5##4##(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
a major impact on##6##4##(1993-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-12#1)
a major issue##2##3##(1991-2#1)(2008-10#1)
a major limitation##2##3##(2008-11#1)(2012-3#1)
a major mechanism##3##3##(2008-11#1)(2008-4#2)
a major membrane##2##3##(2007-12#1)(2008-10#1)
a major part of the##5##5##(1994-1#2)(1997-4#1)(2008-10#2)
a major part##7##3##(1993-9#1)(1994-1#2)(1997-4#1)(2008-10#2)(2011-2#1)
a major pathogen of##2##4##(2008-10#2)
a major player in##2##4##(2010-11#1)(2010-12#1)
a major portion of##2##4##(2008-10#1)(2008-11#1)
a major problem in##4##4##(1991-9#1)(1997-1#1)(2008-10#1)(2008-11#1)
a major problem##7##3##(1991-9#1)(1997-1#1)(2008-10#2)(2008-11#2)(2010-10#1)
a major process change##2##4##(1993-2#1)(1995-2#1)
a major protein component with a molecular mass of##2##9##(2008-10#2)
a major public health problem##2##5##(2011-2#1)(2012-3#1)
a major public health##6##4##(2008-11#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
a major quantitative trait locus (QTL)##3##6##(2008-10#3)
a major quantitative trait locus##4##5##(2008-10#4)
a major resistance##2##3##(2008-10#1)(2012-2#1)
a major risk factor for##2##5##(1997-8#1)(2012-12#1)
a major risk factor##3##4##(1990-6#1)(1997-8#1)(2012-12#1)
a major role in determining the##2##6##(2008-10#1)(2008-6#1)
a major role in regulating##2##5##(2009-8#1)(2012-3#1)
a major role in the regulation of##2##7##(1991-6#1)(1995-8#1)
a major role in the##11##5##(1991-6#1)(1992-10#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-8#1)(2008-11#1)(2009-1#1)(2009-7#1)
a major role in##30##4##(1991-6#1)(1992-10#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
a major role##35##3##(1991-6#1)(1992-10#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
a major social##2##3##(2008-11#1)(2008-6#1)
a major source of##6##4##(1994-2#1)(2008-10#2)(2008-11#1)(2010-7#1)(2013-1#1)
a major step forward in##2##5##(2008-5#1)(2009-3#1)
a major storage##2##3##(1991-5#1)(2010-11#1)
a major success##2##3##(2008-10#2)
a major target##2##3##(2008-11#1)(2009-11#1)
a major threat to##3##4##(2008-10#1)(2011-2#1)(2011-3#1)
a major##320##2##(1990-11#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#4)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-6#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-7#2)(1997-8#6)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#76)(2008-11#28)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#5)(2009-1#1)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#13)(2011-3#2)(2011-9#1)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#12)(2013-8#1)
a majority of the##7##4##(1991-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(2008-9#1)(2010-12#2)
a majority of##18##3##(1990-3#1)(1991-12#1)(1994-2#2)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-3#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-12#2)(2011-2#1)(2012-2#1)
a majority##19##2##(1990-3#1)(1991-12#1)(1994-2#2)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-3#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-12#2)(2011-2#1)(2012-2#2)
a malaria##2##2##(1995-5#1)(2012-12#1)
a male predominance##2##3##(1994-12#1)(2008-1#1)
a male with##2##3##(2008-11#1)(2012-12#1)
a male##16##2##(1991-6#1)(1994-12#1)(1994-2#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#2)(2010-7#1)(2011-2#2)(2012-12#2)
a malignant disease##2##3##(1993-2#1)(2008-11#1)
a malignant tumor##2##3##(1990-5#1)(2008-12#1)
a malignant##10##2##(1990-5#1)(1991-8#1)(1993-2#1)(1994-8#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-1#1)
a mammalian cell line##2##4##(2008-11#1)(2008-8#1)
a mammalian genomic##2##3##(1991-6#1)(1993-2#1)
a mammalian##7##2##(1991-6#1)(1993-2#1)(1994-8#1)(1997-7#2)(2008-11#1)(2008-8#1)
a man who##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
a man##8##2##(1995-12#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#2)
a managed care environment##2##4##(1996-12#1)(1996-2#1)
a managed care##6##3##(1994-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)
a managed##10##2##(1991-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-3#1)
a management information system##3##4##(1992-3#2)(1996-12#1)
a management##8##2##(1992-12#1)(1992-3#2)(1993-1#1)(1994-2#1)(1996-12#1)(2008-10#2)
a manager##2##2##(2012-3#2)
a mandate##2##2##(1996-3#1)(2011-2#1)
a mandatory##3##2##(1994-12#1)(2008-10#2)
a manganese##2##2##(1993-8#1)(1996-6#1)
a manifestation of##2##3##(2008-11#1)(2013-8#1)
a manner similar to##7##4##(1991-5#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-3#1)
a manner##30##2##(1991-12#1)(1991-5#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-11#1)(1995-5#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-9#2)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
a manual##10##2##(1991-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2012-2#1)
a map of##2##3##(2008-12#1)(2008-7#1)
a mapping##2##2##(2008-10#1)(2008-6#1)
a marginal effect on##2##4##(1990-12#1)(1990-2#1)
a marginal increase of##2##4##(2008-9#2)
a marginal##6##2##(1990-12#1)(1990-2#1)(1990-6#1)(1995-11#1)(2008-9#2)
a marine##9##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#3)(2011-2#1)
a marked but##2##3##(1996-12#1)(2010-6#1)
a marked decrease in the##3##5##(1994-3#1)(1994-8#1)(1997-7#1)
a marked decrease in##6##4##(1993-2#1)(1994-3#1)(1994-8#1)(1997-7#1)(2008-7#1)(2013-8#1)
a marked decrease##7##3##(1993-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-7#1)(2013-8#1)
a marked difference in the##2##5##(2008-10#1)(2008-11#1)
a marked difference##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
a marked enhancement of the##2##5##(2008-10#2)
a marked enhancement##3##3##(2008-10#2)(2012-2#1)
a marked impact on##2##4##(2012-12#1)(2013-1#1)
a marked improvement##2##3##(1990-12#1)(2008-10#1)
a marked increase in##8##4##(1990-11#1)(1990-5#1)(1992-8#1)(1994-8#1)(1997-3#1)(1997-7#1)(2010-12#1)(2013-1#1)
a marked increase##9##3##(1990-11#1)(1990-5#1)(1992-8#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(2010-12#1)(2013-1#1)
a marked predilection for##2##4##(2009-5#1)(2013-1#1)
a marked reduction in##8##4##(1992-3#1)(1993-8#1)(1996-12#1)(2007-12#1)(2008-10#2)(2010-10#1)(2012-2#1)
a marked##58##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-12#2)(2008-10#8)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
a markedly##4##2##(1992-8#1)(1995-8#1)(1996-12#1)(2010-6#1)
a marker for the##2##4##(1995-6#1)(2008-10#1)
a marker for##13##3##(1990-5#1)(1994-2#1)(1995-1#1)(1995-6#2)(1996-6#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)
a marker of the##3##4##(1992-6#1)(1997-6#1)(2009-12#1)
a marker of##19##3##(1990-7#1)(1992-6#1)(1993-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-12#1)(2011-2#4)(2012-2#1)(2012-3#2)(2012-9#1)
a marker##39##2##(1990-5#1)(1990-7#1)(1992-6#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-6#2)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#5)(2012-2#1)(2012-3#2)(2012-9#1)
a market##4##2##(1991-3#1)(1992-11#1)(1996-1#1)(2008-10#1)
a marketing plan##4##3##(1994-3#2)(1995-1#1)(2010-7#1)
a masking agent##7##3##(2008-10#7)
a masking##8##2##(2008-10#7)(2008-5#1)
a mass in the left lower##2##6##(2010-11#2)
a mass in the##3##4##(2008-7#1)(2010-11#2)
a mass loss##2##3##(2008-10#2)
a mass of##6##3##(1992-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-12#1)
a mass spectrometer##7##3##(2008-10#5)(2008-3#1)(2010-6#1)
a mass spectrometry##2##3##(2008-10#2)
a mass##38##2##(1992-6#1)(1995-11#4)(1996-3#2)(2008-1#1)(2008-10#16)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-8#1)
a massive##11##2##(1992-1#1)(1992-2#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-3#1)(2012-3#1)
a master switch##2##3##(2008-5#1)(2013-8#1)
a master##3##2##(2008-5#1)(2013-1#1)(2013-8#1)
a master-oscillator##2##2##(2008-3#2)
a mastocytosis-like disease in mice##2##5##(2011-2#2)
a mastoid fascial flap##2##4##(2009-1#2)
a mastoidectomy##2##2##(2008-7#2)
a match##2##2##(2008-3#1)(2008-9#1)
a matched##6##2##(1992-12#1)(1993-8#2)(1997-1#1)(2013-1#1)(2013-8#1)
a mate##3##2##(2008-8#2)(2008-9#1)
a material or product is##2##5##(1996-12#2)
a material##10##2##(1990-11#1)(1996-12#2)(2008-10#2)(2008-3#1)(2008-5#2)(2009-7#1)(2010-7#1)
a maternal##2##2##(2009-7#1)(2010-6#1)
a mathematical model of the##2##5##(2008-7#1)(2008-9#1)
a mathematical model of##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
a mathematical model that##2##4##(2008-10#1)(2008-11#1)
a mathematical model to yield deconvolution##2##6##(2008-10#2)
a mathematical model to##5##4##(1991-11#1)(1997-1#1)(2008-10#2)(2008-5#1)
a mathematical model was##2##4##(2008-10#1)(2013-8#1)
a mathematical model##25##3##(1991-11#1)(1992-2#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-5#2)(2008-7#2)(2008-9#2)(2011-3#2)(2013-8#2)
a mathematical##31##2##(1991-11#1)(1992-2#1)(1997-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#4)(2011-3#2)(2013-8#2)
a mating##2##2##(2008-9#2)
a matrix effect is detected##2##5##(2008-10#2)
a matrix effect##3##3##(2008-10#3)
a matrix of##5##3##(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)
a matrix##18##2##(1992-10#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
a matter of debate##3##4##(1997-5#1)(2008-7#1)(2010-11#1)
a matter of fact##2##4##(2008-7#1)(2013-1#1)
a matter of##19##3##(1991-3#1)(1993-12#1)(1995-11#1)(1997-5#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2013-1#2)(2013-8#1)
a matter##21##2##(1991-3#1)(1993-12#1)(1995-11#1)(1997-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2013-1#2)(2013-8#2)
a maturation##3##2##(2008-10#1)(2008-5#2)
a mature protein##2##3##(1992-3#1)(2008-10#1)
a mature##14##2##(1990-12#1)(1992-3#1)(1993-12#1)(2008-10#4)(2008-9#1)(2011-3#2)(2012-3#2)(2013-1#1)(2013-8#1)
a maximal level##3##3##(1991-9#1)(1997-7#1)(2008-10#1)
a maximal viable cell density of##2##6##(2008-11#2)
a maximal viable cell density##3##5##(2008-11#3)
a maximal viable cell##4##4##(2008-11#3)(2008-7#1)
a maximal##17##2##(1991-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1995-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#2)
a maximum absorption peak at##3##5##(2008-10#3)
a maximum at##8##3##(1993-3#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-8#1)(2013-1#1)(2013-8#1)
a maximum average of##3##4##(1996-12#3)
a maximum average##5##3##(1996-12#3)(2008-2#1)(2008-3#1)
a maximum during##2##3##(2008-10#1)(2012-2#1)
a maximum in the##4##4##(2008-10#3)(2008-11#1)
a maximum in##8##3##(1997-8#1)(2008-10#6)(2008-11#1)
a maximum number##2##3##(2008-10#1)(2008-3#1)
a maximum of 2##2##4##(2008-10#1)(2008-11#1)
a maximum of##17##3##(1990-3#1)(1990-5#2)(1991-6#1)(1992-9#1)(1994-5#1)(1995-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-9#1)
a maximum value##2##3##(2008-10#1)(2008-5#1)
a maximum##92##2##(1990-3#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-5#1)(1995-2#2)(1996-12#3)(1996-2#2)(1997-1#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#37)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#2)(2009-9#1)(2012-2#1)(2013-1#2)(2013-8#2)
a mean age of##17##4##(1994-12#1)(1995-10#1)(1996-2#1)(1997-3#3)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
a mean age##18##3##(1994-12#1)(1995-10#1)(1996-2#1)(1997-3#3)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
a mean duration of##6##4##(2008-1#3)(2008-7#2)(2012-2#1)
a mean duration##7##3##(2008-1#3)(2008-7#3)(2012-2#1)
a mean follow-up of 1##2##5##(1996-6#1)(2013-1#1)
a mean follow-up of 23##2##5##(1994-2#1)(2008-10#1)
a mean follow-up of##7##4##(1990-6#1)(1994-12#1)(1994-2#1)(1996-6#1)(2008-10#1)(2009-10#1)(2013-1#1)
a mean free##2##3##(2008-10#1)(2008-3#1)
a mean height of##2##4##(2008-1#1)(2009-1#1)
a mean level of disease reduction of##3##7##(2008-10#3)
a mean of 1##2##4##(1990-6#1)(2010-6#1)
a mean of 4##3##4##(2008-1#1)(2009-4#1)(2010-6#1)
a mean of##12##3##(1990-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-6#2)(2012-2#1)
a mean peak##2##3##(1990-6#1)(2008-10#1)
a mean period of##3##4##(2008-1#2)(2008-7#1)
a mean recovery of 99##2##5##(2008-10#2)
a mean relative##4##3##(2008-10#4)
a mean standard##2##3##(2008-10#2)
a mean survival##2##3##(1990-2#1)(2008-7#1)
a mean total##2##3##(1991-11#1)(2008-7#1)
a mean weight##2##3##(2008-1#1)(2013-8#1)
a mean##113##2##(1990-2#1)(1990-3#1)(1990-6#3)(1991-11#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#3)(2007-8#2)(2008-1#10)(2008-10#31)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#9)(2008-9#4)(2009-1#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
a meaningful##6##2##(1995-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)
a means for##4##3##(1996-2#1)(1997-8#1)(2008-10#1)(2009-3#1)
a means of assessing##2##4##(2008-11#1)(2010-11#1)
a means of understanding##3##4##(1990-5#1)(2008-11#1)(2009-12#1)
a means of##37##3##(1990-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1996-1#1)(1996-3#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
a means to##22##3##(1991-2#1)(1995-1#1)(1997-1#1)(1997-2#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-2#2)(2013-1#1)
a means##64##2##(1990-5#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#13)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#2)
a measurable##6##2##(1994-1#1)(1995-12#1)(1995-2#1)(1996-6#1)(2008-10#1)(2011-2#1)
a measure for##2##3##(2008-6#1)(2009-6#1)
a measure of health##2##4##(1996-1#1)(2008-11#1)
a measure of its##2##4##(2008-10#1)(2008-11#1)
a measure of severity##2##4##(1994-12#2)
a measure of the##12##4##(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2009-12#1)(2012-3#1)
a measure of##54##3##(1990-2#1)(1990-8#1)(1991-3#2)(1994-11#1)(1994-12#3)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#2)(2009-3#1)(2009-7#1)(2010-1#2)(2010-10#1)(2011-2#1)(2012-2#3)(2012-3#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-8#2)
a measure to##3##3##(2008-10#2)(2008-6#1)
a measure##62##2##(1990-2#1)(1990-8#1)(1991-3#2)(1994-11#1)(1994-12#3)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#12)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2011-2#2)(2012-2#4)(2012-3#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-8#3)
a measurement of the##2##4##(2008-3#2)
a measurement of##3##3##(2008-11#1)(2008-3#2)
a measurement##7##2##(2008-10#4)(2008-11#1)(2008-3#2)
a measuring cell##2##3##(2008-10#2)
a measuring##3##2##(2008-10#3)
a mechanical model##2##3##(2009-7#1)(2013-1#1)
a mechanical valve##2##3##(2008-8#1)(2013-1#1)
a mechanical##15##2##(1992-9#2)(1995-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2013-1#3)(2013-8#1)
a mechanically##4##2##(1994-6#1)(1996-3#1)(2008-10#1)(2012-2#1)
a mechanism by which##3##4##(1993-3#1)(1995-12#1)(1995-9#1)
a mechanism for##13##3##(1995-8#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#4)(2008-3#2)(2009-5#1)(2009-8#1)(2013-1#1)
a mechanism involving##2##3##(1991-12#1)(1992-6#1)
a mechanism of##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
a mechanism other than##2##4##(2008-7#1)(2008-9#1)
a mechanism that can##2##4##(1991-9#1)(2010-4#1)
a mechanism that##3##3##(1991-9#1)(1995-8#1)(2010-4#1)
a mechanism whereby##2##3##(1990-8#1)(2008-9#1)
a mechanism##37##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-3#1)(1995-12#2)(1995-2#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-3#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
a mechanism-based classification##2##3##(2008-12#1)(2008-7#1)
a mechanism-based##3##2##(2008-12#2)(2008-7#1)
a mechanistic##9##2##(1993-1#1)(2008-10#2)(2008-8#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
a medial##7##2##(1995-2#1)(1996-2#1)(2007-12#1)(2008-9#1)(2010-11#1)(2012-12#2)
a median follow-up of##4##4##(1990-12#2)(1990-6#1)(1992-12#1)
a median follow-up##5##3##(1990-12#2)(1990-6#1)(1990-8#1)(1992-12#1)
a median followup of##2##4##(1991-8#1)(2012-3#1)
a median of##11##3##(1997-2#1)(2008-10#3)(2008-7#2)(2010-12#1)(2012-2#1)(2013-1#3)
a median survival##3##3##(1990-9#1)(2008-10#1)(2010-12#1)
a median##35##2##(1990-12#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#6)
a mediastinal##4##2##(1990-12#1)(2010-12#2)(2011-2#1)
a mediating##3##2##(1992-3#1)(1995-2#1)(2008-10#1)
a mediator of the##2##4##(2008-11#1)(2010-1#1)
a mediator of##5##3##(1995-2#2)(2008-11#2)(2010-1#1)
a mediator##15##2##(1995-2#2)(2008-10#8)(2008-11#2)(2009-10#1)(2010-1#1)(2011-2#1)
a medical and##2##3##(1994-12#1)(2011-2#1)
a medical center##2##3##(1991-3#1)(2007-9#1)
a medical condition##3##3##(1994-3#1)(1996-5#1)(2012-2#1)
a medical emergency##2##3##(2010-12#1)(2010-8#1)
a medical geographic##2##3##(2013-8#2)
a medical manpower plan##2##4##(1991-2#2)
a medical service##2##3##(2008-3#2)
a medical treatment##2##3##(2011-2#1)(2012-3#1)
a medical##39##2##(1990-6#1)(1991-2#3)(1991-3#2)(1992-2#2)(1994-12#3)(1994-3#1)(1994-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-9#1)(2008-3#2)(2008-6#1)(2009-11#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
a medication##2##2##(2009-7#1)(2010-8#1)
a medicinal##3##2##(1994-11#1)(2008-11#2)
a medium containing##7##3##(2008-10#5)(2008-11#1)(2008-9#1)
a medium##22##2##(1991-3#1)(1994-12#1)(1997-4#1)(2008-10#13)(2008-11#3)(2008-3#1)(2008-9#1)(2009-8#1)
a meeting##2##2##(2008-7#1)(2011-2#1)
a member of a##9##4##(1992-3#1)(1993-2#2)(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-12#1)
a member of the RING finger##2##6##(1997-3#2)
a member of the family##14##5##(1996-12#1)(2008-10#1)(2011-2#12)
a member of the genus Potyvirus##4##6##(2008-10#4)
a member of the genus##15##5##(2008-10#8)(2011-2#7)
a member of the immunoglobulin##2##5##(1996-12#1)(2008-7#1)
a member of the low density lipoprotein (LDL) receptor family##2##10##(1995-8#2)
a member of the newly##2##5##(2008-10#1)(2008-5#1)
a member of the##57##4##(1992-12#1)(1993-3#1)(1994-11#1)(1995-2#3)(1995-6#1)(1995-8#3)(1996-12#3)(1997-3#2)(1997-7#2)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#23)
a member of##72##3##(1991-3#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-11#1)(1995-2#3)(1995-6#1)(1995-8#4)(1996-12#4)(1997-3#2)(1997-7#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#23)
a member##73##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-11#1)(1995-2#3)(1995-6#1)(1995-8#4)(1996-12#4)(1997-3#2)(1997-7#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#24)
a membrane composition of##2##4##(2008-10#2)
a membrane filter##2##3##(2008-10#2)
a membrane of##2##3##(2008-10#1)(2012-2#1)
a membrane surface##2##3##(2008-10#1)(2008-11#1)
a membrane##31##2##(1990-5#1)(1991-5#1)(1991-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(2008-10#19)(2008-11#1)(2008-4#1)(2009-5#1)(2009-8#1)(2012-2#1)
a membrane-associated##2##2##(1991-10#1)(1994-11#1)
a membrane-bound##4##2##(1991-2#1)(1992-8#1)(1993-9#1)(1995-12#1)
a membrane-permeable##3##2##(1994-2#1)(1995-8#1)(2008-8#1)
a membranous##2##2##(2007-12#1)(2010-3#1)
a memory##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
a meningioma##2##2##(2008-7#1)(2011-2#1)
a mental health##4##3##(1992-2#1)(1994-1#1)(1997-4#1)(2008-11#1)
a mental##8##2##(1992-2#1)(1994-1#1)(1995-12#1)(1997-4#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-10#1)
a mentally##2##2##(1993-1#1)(2008-12#1)
a mentor##6##2##(2008-11#5)(2008-7#1)
a mercury electrode##9##3##(1990-5#1)(2008-10#8)
a mercury##15##2##(1990-5#2)(2008-10#13)
a mere##2##2##(2009-9#1)(2013-1#1)
a merely##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
a merging##2##2##(2008-10#2)
a mesophilic cellulase##2##3##(2008-9#2)
a mesoporous##3##2##(2008-10#2)(2009-11#1)
a message##2##2##(1997-6#1)(2010-1#1)
a meta-analysis of the##2##4##(1997-7#1)(2008-10#1)
a meta-analysis of##11##3##(1991-10#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
a meta-analysis##18##2##(1991-10#1)(1996-3#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
a metabolic##11##2##(2008-10#2)(2008-11#6)(2008-3#2)(2008-7#1)
a metabolically##3##2##(2008-10#2)(2008-7#1)
a metabolite of##3##3##(1996-12#1)(2008-10#1)(2009-12#1)
a metabolite##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2009-12#1)
a metabotropic glutamate receptor##2##4##(1995-12#2)
a metabotropic glutamate##3##3##(1995-12#2)(2008-11#1)
a metal ion##3##3##(2008-10#3)
a metal##10##2##(1993-5#1)(2008-10#8)(2008-2#1)
a metallic alloy##2##3##(1991-9#1)(2008-7#1)
a metallic##6##2##(1991-9#1)(2008-10#2)(2008-7#1)(2012-2#2)
a metalloenzyme##2##2##(1991-5#1)(1995-8#1)
a metapopulation of the American pika##2##6##(2008-9#2)
a metapopulation of##3##3##(2008-8#1)(2008-9#2)
a metapopulation with##2##3##(2008-8#1)(2008-9#1)
a metapopulation##11##2##(2008-10#1)(2008-8#6)(2008-9#4)
a metastasis##2##2##(1997-1#1)(2013-1#1)
a metastatic##6##2##(1990-12#2)(1990-2#1)(2008-4#1)(2010-11#1)(2013-1#1)
a methanol##2##2##(2008-10#2)
a methanol-water##2##2##(2008-10#2)
a method based on##5##4##(1994-9#1)(2008-10#3)(2008-5#1)
a method for amplifying DNA enzymatically by the##2##8##(2008-4#1)(2008-9#1)
a method for calculating##2##4##(2008-10#1)(2008-3#1)
a method for detecting##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
a method for estimating##2##4##(1994-12#1)(2013-1#1)
a method for monitoring##2##4##(2008-10#1)(2008-11#1)
a method for the determination of##5##6##(2008-10#5)
a method for the simultaneous determination of##2##7##(2008-10#2)
a method for the simultaneous##3##5##(2008-10#3)
a method for the##18##4##(1997-2#2)(2008-10#10)(2008-11#2)(2008-5#1)(2008-9#2)(2010-8#1)
a method for##71##3##(1991-11#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-3#2)(1997-2#2)(2007-11#1)(2008-10#26)(2008-11#5)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#6)(2009-3#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-4#1)(2013-1#2)
a method is described for##4##5##(1992-8#1)(2008-11#1)(2008-4#2)
a method is presented for##2##5##(2008-10#2)
a method is##8##3##(1992-8#1)(2008-10#3)(2008-11#1)(2008-4#3)
a method of data##2##4##(2008-3#1)(2009-10#1)
a method of##31##3##(1992-9#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#1)(2009-10#2)(2010-3#1)(2010-6#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)
a method that##11##3##(1990-12#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-2#1)
a method to correct for the##2##6##(2008-11#1)(2008-3#1)
a method to evaluate the##2##5##(2008-10#1)(2008-9#1)
a method to evaluate##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
a method to measure##3##4##(1997-7#1)(2008-4#1)(2008-7#1)
a method to reproducibly immortalize human T cells by##2##9##(2008-11#2)
a method to##28##3##(1992-9#1)(1995-5#1)(1997-7#1)(2008-10#3)(2008-11#5)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2013-8#1)
a method using##2##3##(1993-2#1)(2008-9#1)
a method was developed for##2##5##(2008-10#2)
a method was##5##3##(1990-8#1)(2008-10#4)
a method which##3##3##(1990-12#1)(1994-8#1)(2008-10#1)
a method with##2##3##(1993-12#1)(2008-10#1)
a method##183##2##(1990-12#2)(1990-8#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#57)(2008-11#18)(2008-12#3)(2008-2#3)(2008-3#12)(2008-4#14)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#9)(2009-10#3)(2009-12#1)(2009-3#1)(2009-8#2)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#5)(2011-7#1)(2012-12#2)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#1)
a methodological##2##2##(2008-10#1)(2008-11#1)
a methodology for the##3##4##(2008-10#2)(2008-11#1)
a methodology for##5##3##(1992-1#1)(2008-10#3)(2008-11#1)
a methodology to##4##3##(2008-10#3)(2011-2#1)
a methodology##15##2##(1992-1#1)(1993-2#1)(1995-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2011-2#1)
a methyl group##3##3##(1995-11#1)(2008-10#1)(2013-8#1)
a methyl##6##2##(1994-8#1)(1995-11#1)(2008-10#3)(2013-8#1)
a meticulous##2##2##(2008-10#2)
a metric##3##2##(2008-6#1)(2009-10#1)(2010-11#1)
a mica substrate##2##3##(2008-10#2)
a micellar medium of##2##4##(2008-10#2)
a micellar medium##5##3##(2008-10#5)
a micellar##8##2##(2008-10#7)(2009-8#1)
a micro##4##2##(1997-3#1)(2008-10#3)
a micro-FIA system##2##3##(2008-10#2)
a micro-column##4##2##(2008-10#4)
a micro-optical##2##2##(2008-3#2)
a micro-volume##2##2##(2008-10#2)
a microarray##2##2##(2008-7#1)(2011-2#1)
a microbial sensor##2##3##(2008-10#2)
a microbial##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
a microcarrier culture##2##3##(2008-11#2)
a microcatheter##2##2##(2008-7#2)
a microchannel##2##2##(2008-10#2)
a microcloning library##2##3##(2008-9#2)
a microcolumn containing##2##3##(2008-10#2)
a microcolumn of##3##3##(2008-10#3)
a microcolumn packed with##5##4##(2008-10#5)
a microcolumn##11##2##(2008-10#11)
a microcomputer##5##2##(2008-10#5)
a microdeletion of##2##3##(1993-11#1)(1997-3#1)
a microdialysis probe##5##3##(1993-6#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-7#1)
a microenvironment##2##2##(1990-5#2)
a microfabricated##5##2##(2007-11#1)(2008-10#4)
a microlens array and a zigzag grating##2##7##(2007-11#2)
a microlens array##3##3##(2007-11#2)(2008-3#1)
a micromachined##2##2##(2008-10#1)(2008-2#1)
a microplate##2##2##(2008-11#1)(2010-6#1)
a micropump##3##2##(2008-10#3)
a microscope##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
a microscopic##5##2##(2008-5#2)(2009-7#1)(2012-2#2)
a microtiter plate##2##3##(2008-1#1)(2008-10#1)
a microtiter##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
a microtubule-dependent##2##2##(1994-12#2)
a microwave oven and##2##4##(2008-10#2)
a microwave oven##6##3##(2008-10#6)
a microwave##13##2##(2008-10#11)(2008-2#1)(2008-3#1)
a midcarpal injection of lidocaine##3##5##(2008-9#3)
a middle##8##2##(1995-2#1)(1996-9#1)(2008-10#1)(2008-9#1)(2010-1#1)(2010-11#1)(2012-12#1)(2013-8#1)
a midline##2##2##(2007-12#1)(2011-2#1)
a migration##6##2##(1992-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)
a mild but##2##3##(1997-3#1)(2012-12#1)
a mild##20##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
a milk##2##2##(2008-10#2)
a mineral matrix##2##3##(2008-10#2)
a mineral water derived from##2##5##(2008-11#2)
a mineral##5##2##(2008-10#2)(2008-11#2)(2008-7#1)
a mini##2##2##(2008-10#1)(2008-7#1)
a mini-column containing##2##3##(2008-10#2)
a mini-column packed with##3##4##(2008-10#3)
a mini-column##11##2##(2008-10#11)
a mini-gene system##2##3##(1993-8#2)
a miniature mass spectrometer##2##4##(2010-7#2)
a miniature##6##2##(2008-10#2)(2008-3#1)(2010-7#2)(2011-2#1)
a miniaturized##2##2##(2008-10#2)
a minicolumn filled with##2##4##(2008-10#2)
a minicolumn packed with a##2##5##(2008-10#2)
a minicolumn packed with silica gel modified with##2##8##(2008-10#2)
a minicolumn packed with##7##4##(2008-10#7)
a minicolumn##19##2##(2008-10#19)
a minimal effect on##2##4##(2008-10#1)(2013-1#1)
a minimal medium containing##2##4##(2008-10#2)
a minimal medium##4##3##(2008-10#4)
a minimal##27##2##(1994-12#1)(1995-2#2)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#2)
a minimally invasive approach to anterior cranial vault##2##8##(2011-2#2)
a minimally invasive approach##3##4##(2011-2#3)
a minimally invasive technique##2##4##(2011-2#1)(2012-2#1)
a minimally invasive##8##3##(2011-2#4)(2012-2#1)(2013-1#3)
a minimally##9##2##(2010-9#1)(2011-2#4)(2012-2#1)(2013-1#3)
a minimum amount of##2##4##(1997-8#1)(2008-10#1)
a minimum during##2##3##(1992-12#1)(2008-10#1)
a minimum number of##2##4##(2008-10#2)
a minimum of 12##2##4##(2008-10#2)
a minimum of 3##2##4##(1994-8#1)(2008-9#1)
a minimum of##12##3##(1992-3#1)(1993-12#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
a minimum size##2##3##(1990-8#1)(1993-6#1)
a minimum##45##2##(1990-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2012-12#1)(2012-3#1)(2013-1#2)
a ministry of##2##3##(1992-2#1)(1993-12#1)
a minor component of##2##4##(2008-10#2)
a minor effect on##2##4##(2008-10#1)(2008-3#1)
a minor effect##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
a minor impact on##2##4##(2011-1#1)(2013-8#1)
a minor pontic stroke resulted in transient hemiparesis in the case with dehiscent dura around the petrous##2##17##(2011-2#2)
a minor portion of##2##4##(1995-9#1)(2008-10#1)
a minor role in##4##4##(1992-10#1)(2008-10#2)(2008-9#1)
a minor role##7##3##(1992-10#1)(2008-10#5)(2008-9#1)
a minor##40##2##(1990-2#1)(1991-11#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-9#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#2)(2011-2#4)(2013-8#1)
a minority of patients##2##4##(2006-6#1)(2011-2#1)
a minority of the##2##4##(2008-10#1)(2013-1#1)
a minority of##7##3##(1997-4#1)(2006-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
a minority##12##2##(1992-3#1)(1997-3#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
a minute##5##2##(2008-10#3)(2008-11#1)(2009-8#1)
a mirror##8##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#2)(2013-8#2)
a misleading##2##2##(2008-6#1)(2010-5#1)
a mismatch between##2##3##(1996-1#1)(2008-3#1)
a missed##2##2##(1996-11#1)(2012-12#1)
a missense mutation in the##2##5##(1996-2#1)(2008-8#1)
a missense mutation##5##3##(1996-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)
a missing link##2##3##(2009-8#2)
a missing##3##2##(2008-8#1)(2009-8#2)
a mission##2##2##(2008-11#1)(2008-6#1)
a misunderstanding of the##2##4##(1995-1#1)(2012-12#1)
a misunderstanding##3##2##(1995-1#1)(2009-10#1)(2012-12#1)
a mitochondrial (mt)##2##3##(1993-12#1)(2008-12#1)
a mitochondrial DNA##2##3##(2008-10#1)(2010-11#1)
a mitochondrial enzyme##2##3##(1995-6#1)(2009-8#1)
a mitochondrial##10##2##(1993-12#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#1)
a mixed effects##2##3##(2008-11#2)
a mixed infection##3##3##(2008-10#2)(2008-5#1)
a mixed meal##3##3##(1994-12#2)(2012-3#1)
a mixed population##2##3##(1992-6#1)(2008-10#1)
a mixed solution containing##2##4##(2008-10#2)
a mixed solution##3##3##(2008-10#3)
a mixed##35##2##(1992-6#1)(1994-12#2)(2008-10#22)(2008-11#2)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
a mixing chamber##2##3##(2008-10#2)
a mixing##6##2##(2008-10#6)
a mixture and##2##3##(2008-10#2)
a mixture containing##5##3##(2008-10#5)
a mixture of 1##2##4##(2008-10#2)
a mixture of 10##2##4##(2008-10#2)
a mixture of 5##2##4##(2008-10#2)
a mixture of a##2##4##(1990-9#1)(2008-10#1)
a mixture of amino acids##3##5##(2008-10#3)
a mixture of free##2##4##(2008-10#2)
a mixture of nitric##3##4##(2008-10#3)
a mixture of the two##2##5##(2008-10#1)(2008-9#1)
a mixture of the##9##4##(1996-3#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)
a mixture of trace##2##4##(2008-10#2)
a mixture of##112##3##(1990-12#2)(1990-9#2)(1992-11#1)(1992-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#85)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)
a mixture with##2##3##(2008-10#1)(2008-9#1)
a mixture##134##2##(1990-12#3)(1990-9#2)(1992-11#1)(1992-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#104)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
a mobile epidermoid tumour in the lumbar##2##7##(2008-7#2)
a mobile phase consisting of##2##5##(2008-10#2)
a mobile phase constituted##2##4##(2008-10#1)(2008-5#1)
a mobile phase containing##3##4##(2008-10#3)
a mobile phase of##6##4##(2008-10#6)
a mobile phase with##2##4##(2008-10#1)(2008-11#1)
a mobile phase##21##3##(2008-10#19)(2008-11#1)(2008-5#1)
a mobile##29##2##(1995-6#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-5#2)(2008-7#2)(2013-1#1)
a mock security department drill##2##5##(1993-12#2)
a mock##4##2##(1993-12#2)(2008-8#1)(2010-7#1)
a mode##2##2##(2008-1#1)(2008-3#1)
a mode-locked##4##2##(2007-12#1)(2008-3#3)
a model based##2##3##(2008-10#1)(2009-10#1)
a model compound##3##3##(1993-8#1)(1995-12#1)(2008-10#1)
a model for Down syndrome##2##5##(1997-2#2)
a model for health##2##4##(2010-8#2)
a model for predicting##2##4##(2008-10#1)(2008-11#1)
a model for the##14##4##(1993-8#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)
a model for##58##3##(1990-5#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-12#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#2)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-8#2)(2010-8#4)(2011-2#2)(2012-2#1)(2012-3#1)
a model in the##2##4##(2008-11#1)(2008-3#1)
a model in vitro##2##4##(1993-3#1)(2008-11#1)
a model in which the##5##5##(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)
a model in which##10##4##(1995-2#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-7#2)
a model in##15##3##(1993-3#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-7#2)(2010-8#1)
a model incorporating##2##3##(2008-3#1)(2013-8#1)
a model of neural##2##4##(2008-11#1)(2010-1#1)
a model of the##5##4##(1990-8#1)(1992-1#1)(1993-12#1)(2008-11#1)(2009-5#1)
a model of##29##3##(1990-8#1)(1991-5#1)(1992-1#1)(1993-12#1)(1995-1#1)(1996-1#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-8#2)(2008-9#3)(2009-5#2)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a model organism##2##3##(2009-9#1)(2011-2#1)
a model plant##2##3##(1996-12#1)(2008-9#1)
a model protein##3##3##(1997-8#2)(2008-11#1)
a model secreted##2##3##(2008-11#1)(2008-7#1)
a model system for the##2##5##(2011-1#1)(2012-3#1)
a model system for##6##4##(1992-6#1)(2008-10#3)(2011-1#1)(2012-3#1)
a model system to##2##4##(2008-10#2)
a model system##28##3##(1992-6#1)(1994-8#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
a model that included##2##4##(2008-10#1)(2013-1#1)
a model that##12##3##(1992-9#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
a model to study the##2##5##(1994-5#1)(2008-8#1)
a model to study##3##4##(1994-5#1)(2008-10#1)(2008-8#1)
a model to##8##3##(1994-5#1)(2008-10#2)(2008-2#1)(2008-8#2)(2011-10#1)(2013-1#1)
a model using##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
a model was##3##3##(2008-10#1)(2008-7#2)
a model where##4##3##(1995-2#1)(2008-10#1)(2008-8#1)(2009-8#1)
a model which##2##3##(2008-10#1)(2011-2#1)
a model with##3##3##(1995-9#1)(2008-9#1)(2009-7#1)
a model##248##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#7)(1995-5#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-8#4)(2007-12#2)(2008-1#2)(2008-10#69)(2008-11#18)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#16)(2008-9#15)(2009-10#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-2#1)(2010-8#5)(2011-1#1)(2011-10#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#4)
a moderate level of##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
a moderate level##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
a moderate or##3##3##(1994-2#1)(2009-4#1)(2010-1#1)
a moderate##23##2##(1991-2#1)(1992-12#1)(1993-6#1)(1994-2#1)(1997-4#2)(1997-6#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-8#1)(2009-4#1)(2010-1#1)(2010-6#1)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
a moderately high##2##3##(2008-11#1)(2011-2#1)
a moderately resistant cultivar resulted in##2##6##(2008-10#2)
a moderately resistant##4##3##(2008-10#4)
a moderately##11##2##(1990-8#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)
a modern##10##2##(1990-2#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#2)(2011-2#1)(2013-8#1)
a modest but##2##3##(2008-10#1)(2011-2#1)
a modest increase in##2##4##(1997-3#1)(2008-9#1)
a modest##11##2##(1991-12#1)(1994-5#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#1)
a modification in the##3##4##(2008-10#3)
a modification of the method##2##5##(2008-10#1)(2008-11#1)
a modification of the##12##4##(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#2)(2010-7#1)(2012-2#1)
a modification of##14##3##(2008-10#4)(2008-11#4)(2008-5#1)(2008-7#2)(2010-7#1)(2012-2#1)(2013-8#1)
a modification##20##2##(1992-12#1)(1995-6#1)(2008-10#8)(2008-11#4)(2008-5#1)(2008-7#2)(2010-7#1)(2012-2#1)(2013-8#1)
a modified form of##3##4##(2008-10#1)(2009-10#1)(2013-1#1)
a modified form##4##3##(2008-10#2)(2009-10#1)(2013-1#1)
a modified method of##2##4##(1996-3#1)(2013-1#1)
a modified method##3##3##(1996-3#1)(2008-9#1)(2013-1#1)
a modified radical mastoidectomy##2##4##(2008-9#2)
a modified radical##3##3##(1994-12#1)(2008-9#2)
a modified version of the##4##5##(2008-10#1)(2008-4#2)(2009-4#1)
a modified version of##6##4##(2008-10#2)(2008-4#2)(2009-10#1)(2009-4#1)
a modified##75##2##(1991-12#1)(1992-4#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-10#29)(2008-11#3)(2008-12#4)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#3)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
a modifier##6##2##(2008-10#6)
a modular##2##2##(1995-2#1)(2012-3#1)
a modulated laser beam##2##4##(2008-3#2)
a modulated##5##2##(1996-2#1)(2008-10#1)(2008-3#2)(2008-5#1)
a modulation of##2##3##(1994-3#1)(2012-12#1)
a modulation##5##2##(1994-3#1)(2008-3#1)(2009-8#1)(2012-12#1)(2013-8#1)
a modulator of##2##3##(1990-12#1)(1995-12#1)
a modulatory##3##2##(1993-6#1)(2008-5#1)(2013-8#1)
a module of study##2##4##(2008-11#2)
a module##4##2##(2008-11#3)(2008-9#1)
a moisture##2##2##(2009-8#1)(2010-4#1)
a molar ratio of##4##4##(1992-12#1)(1993-6#1)(2008-10#2)
a molar ratio##7##3##(1992-12#2)(1993-6#1)(2008-10#4)
a molar##13##2##(1992-12#2)(1993-6#1)(2008-10#8)(2011-2#1)(2013-1#1)
a mole##2##2##(2008-10#2)
a molecular analysis of##2##4##(2008-10#1)(2013-1#1)
a molecular diagnostic##2##3##(2008-10#1)(2011-2#1)
a molecular level##3##3##(2010-9#2)(2013-1#1)
a molecular marker for##3##4##(2008-10#2)(2013-8#1)
a molecular marker##4##3##(2008-10#3)(2013-8#1)
a molecular mass of 35 kDa was##2##7##(2008-10#2)
a molecular mass of##17##4##(1993-6#2)(1994-11#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-10#9)(2008-11#1)(2013-1#1)
a molecular mass##19##3##(1993-6#2)(1994-11#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-10#11)(2008-11#1)(2013-1#1)
a molecular mechanism##3##3##(1997-3#1)(2008-10#1)(2009-8#1)
a molecular perspective##2##3##(2008-4#1)(2008-6#1)
a molecular tweezer-type##2##3##(2008-10#2)
a molecular weight of about##2##5##(1991-5#1)(2010-3#1)
a molecular weight of##9##4##(1990-11#1)(1991-5#1)(1992-8#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
a molecular weight##12##3##(1990-11#1)(1991-5#1)(1992-8#1)(1993-12#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-3#1)(2011-2#1)
a molecular##72##2##(1990-11#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#25)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-3#1)(2010-9#2)(2011-2#3)(2013-1#3)(2013-8#1)
a molecularly imprinted polymer (MIP)##2##5##(2008-10#2)
a molecularly imprinted polymer##3##4##(2008-10#3)
a molecularly##4##2##(1997-2#1)(2008-10#3)
a molecule of##3##3##(2008-10#2)(2008-7#1)
a molecule##8##2##(1991-5#2)(1994-5#1)(2008-10#3)(2008-7#1)(2010-7#1)
a monitor##2##2##(2008-7#1)(2012-3#1)
a monitoring##7##2##(1994-6#1)(2008-10#4)(2008-11#1)(2008-5#1)
a monkey##2##2##(2008-10#1)(2008-5#1)
a monoclonal antibody against the##3##5##(1992-3#1)(1993-8#1)(1993-9#1)
a monoclonal antibody against##5##4##(1992-11#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-12#1)
a monoclonal antibody specific for the##2##6##(1990-12#1)(1995-2#1)
a monoclonal antibody specific for##3##5##(1990-12#1)(1995-2#1)(2008-10#1)
a monoclonal antibody specific##4##4##(1990-12#1)(1995-2#1)(2008-10#2)
a monoclonal antibody to the##2##5##(1996-2#1)(1997-3#1)
a monoclonal antibody to##6##4##(1992-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)
a monoclonal antibody##25##3##(1990-11#1)(1990-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#2)(1993-9#1)(1995-12#2)(1995-2#2)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-8#1)(2011-2#1)
a monoclonal##33##2##(1990-11#1)(1990-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#3)(1993-9#1)(1995-12#2)(1995-2#3)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-5#4)(2008-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
a monocyclic##2##2##(2008-10#1)(2011-2#1)
a monocyte##2##2##(2008-11#1)(2012-2#1)
a monolayer in the##2##4##(1992-9#1)(2008-5#1)
a monolayer of##6##3##(1995-2#1)(2008-10#2)(2008-8#1)(2009-3#1)(2009-5#1)
a monolayer##10##2##(1992-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-5#1)
a monomer##7##2##(1990-5#1)(1993-8#1)(1994-11#1)(1995-8#1)(2008-11#2)(2008-2#1)
a monomeric##4##2##(1995-11#1)(1995-2#1)(1997-6#1)(2008-11#1)
a monomolecular##4##2##(2008-10#3)(2012-2#1)
a mononuclear precursor of##2##4##(1991-11#2)
a monophyletic clade##2##3##(2008-10#2)
a monophyletic group##3##3##(2008-6#1)(2010-10#1)(2010-8#1)
a monophyletic lineage##2##3##(2008-10#2)
a monophyletic##7##2##(2008-10#4)(2008-6#1)(2010-10#1)(2010-8#1)
a monosaccharide##2##2##(2008-11#1)(2010-11#1)
a monotonically##2##2##(2008-8#2)
a month after##2##3##(2008-10#1)(2008-5#1)
a month##10##2##(1991-9#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-7#1)(2013-1#1)
a monthly##3##2##(1993-3#1)(2008-12#1)(2011-2#1)
a mood disorder##2##3##(2008-11#2)
a mood##3##2##(2008-11#2)(2012-2#1)
a moral##5##2##(2008-11#3)(2010-10#1)(2012-2#1)
a more accurate and##2##4##(2008-10#1)(2008-9#1)
a more accurate estimate of##2##5##(1990-3#1)(2008-11#1)
a more accurate##10##3##(1990-3#1)(1991-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-2#2)(2012-3#1)
a more affordable##2##3##(1994-2#1)(2008-10#1)
a more aggressive##2##3##(1990-3#1)(2013-1#1)
a more appropriate##6##3##(2008-10#3)(2008-11#2)(2008-8#1)
a more attractive##2##3##(1994-12#1)(2008-11#1)
a more collaborative##2##3##(2008-11#1)(2009-3#1)
a more complete picture##2##4##(2009-8#2)
a more complete understanding of the##2##6##(1996-12#1)(2008-4#1)
a more complete understanding of##3##5##(1996-12#1)(2008-10#1)(2008-4#1)
a more complete##7##3##(1996-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-8#2)
a more complex##5##3##(1996-11#1)(2008-10#1)(2008-11#2)(2009-8#1)
a more comprehensive##2##3##(2008-11#1)(2008-7#1)
a more convenient##2##3##(2008-10#2)
a more detailed examination of##2##5##(1997-8#1)(2008-7#1)
a more detailed##8##3##(1992-9#1)(1996-3#1)(1997-8#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
a more diversified##2##3##(2011-2#2)
a more effective##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
a more efficient##6##3##(1990-11#1)(1993-2#1)(2008-10#3)(2008-11#1)
a more expensive##2##3##(1991-3#1)(1993-12#1)
a more explicit##2##3##(2008-8#1)(2012-3#1)
a more favorable##3##3##(1990-8#1)(2008-10#1)(2013-1#1)
a more favourable##2##3##(2008-7#1)(2010-10#1)
a more female-biased##2##3##(2008-8#1)(2008-9#1)
a more flexible##2##3##(2008-10#1)(2008-11#1)
a more functional##2##3##(2010-8#1)(2011-2#1)
a more fundamental##2##3##(1993-6#1)(2009-4#1)
a more general##2##3##(1991-6#1)(1995-8#1)
a more global level##2##4##(2009-10#1)(2013-1#1)
a more highly##2##3##(1995-2#1)(1997-1#1)
a more holistic##3##3##(2008-11#1)(2009-8#1)(2010-8#1)
a more hydrophilic##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a more important role in##2##5##(1994-8#1)(2008-10#1)
a more important##5##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
a more physiological##2##3##(1994-12#2)
a more polar metabolite##2##4##(1991-5#2)
a more positive##4##3##(2008-10#1)(2008-12#1)(2013-1#2)
a more potent##7##3##(1991-5#1)(1993-8#2)(1994-11#1)(1995-11#1)(2008-5#1)(2012-3#1)
a more practical##3##3##(2008-10#2)(2010-5#1)
a more precise##4##3##(1994-12#1)(1994-5#1)(2008-7#1)(2009-6#1)
a more pronounced##2##3##(2008-10#1)(2013-1#1)
a more rapid##4##3##(1992-1#1)(2008-10#1)(2008-12#1)(2008-9#1)
a more rapidly##2##3##(2008-5#1)(2010-6#1)
a more realistic##3##3##(1995-11#1)(1996-2#1)(2008-3#1)
a more recent##2##3##(2009-7#1)(2012-12#1)
a more reliable##5##3##(1993-12#1)(2008-10#4)
a more rigid##2##3##(2008-4#1)(2008-5#1)
a more rigorous##2##3##(2008-2#1)(2010-5#1)
a more selective##2##3##(2008-11#1)(2008-5#1)
a more sensitive and##2##4##(2008-10#2)
a more severe##3##3##(1991-8#1)(1997-2#1)(2008-8#1)
a more sophisticated##2##3##(1991-3#1)(2013-1#1)
a more specific##5##3##(2008-10#2)(2008-9#1)(2013-1#1)(2013-8#1)
a more stable##4##3##(1994-11#1)(2008-10#3)
a more suitable##2##3##(2010-8#1)(2013-1#1)
a more systematic##2##3##(2013-1#2)
a more targeted approach to the##2##6##(1991-2#1)(2008-7#1)
a more##259##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-1#3)(1997-2#3)(1997-8#5)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#50)(2008-11#30)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#7)(2008-7#9)(2008-8#7)(2008-9#7)(2009-10#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#2)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#14)(2013-8#2)
a morphologic##3##2##(2011-2#1)(2012-3#2)
a morphometric##2##2##(2010-8#1)(2012-3#1)
a mosaic##3##2##(1997-3#1)(2008-10#1)(2012-2#1)
a most##6##2##(2008-10#2)(2008-5#2)(2008-9#1)(2013-1#1)
a mother and##2##3##(2008-7#1)(2012-3#1)
a mother##4##2##(1995-1#1)(2008-7#1)(2008-9#1)(2012-3#1)
a motif##2##2##(1993-12#1)(1993-9#1)
a motion##3##2##(1995-12#1)(1995-6#1)(2008-3#1)
a motivational approach##2##3##(2008-4#1)(2008-6#1)
a motivational##4##2##(2008-12#1)(2008-4#2)(2008-6#1)
a motor##4##2##(1990-12#1)(2009-4#1)(2010-1#1)(2013-1#1)
a mouse mammary tumour cell line##2##6##(2008-11#2)
a mouse model of##2##4##(2009-6#1)(2012-12#1)
a mouse model##6##3##(1994-5#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
a mouse monoclonal antibody##2##4##(1996-12#1)(2008-7#1)
a mouse##26##2##(1990-8#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#3)(1996-12#2)(1997-7#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
a movement protein##2##3##(2008-10#2)
a movement##8##2##(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2010-5#1)(2013-8#2)
a moving boundary##2##3##(2008-7#2)
a moving object##2##3##(2008-3#1)(2011-2#1)
a moving target##4##3##(2008-11#3)(2009-8#1)
a moving##13##2##(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#2)(2010-6#1)(2010-9#1)(2011-2#1)
a much broader context##2##4##(2010-1#1)(2010-3#1)
a much broader##3##3##(1992-10#1)(2010-1#1)(2010-3#1)
a much faster##2##3##(1992-12#1)(2008-7#1)
a much greater impact on##2##5##(1992-1#1)(2012-5#1)
a much greater##7##3##(1992-1#1)(1993-8#2)(1995-2#1)(1997-5#1)(2008-7#1)(2012-5#1)
a much higher##4##3##(1994-6#1)(2008-10#2)(2008-9#1)
a much longer##2##3##(1994-3#1)(2008-11#1)
a much lower concentration##2##4##(2008-10#1)(2012-2#1)
a much lower##6##3##(2008-10#5)(2012-2#1)
a much more##9##3##(1992-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-4#1)(2012-2#2)
a much stronger##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)
a much##50##2##(1990-11#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-5#1)(2008-10#14)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-5#1)(2013-8#2)
a mucosal prolapse occupying##2##4##(2013-1#2)
a mucosal prolapse##3##3##(2013-1#3)
a mucosal##5##2##(1991-12#1)(1995-2#1)(2013-1#3)
a multi##4##2##(1997-2#1)(2008-11#1)(2009-4#1)(2013-1#1)
a multi-analyte##3##2##(2008-10#2)(2013-1#1)
a multi-center##2##2##(2008-11#1)(2010-11#1)
a multi-channel##2##2##(2008-10#2)
a multi-faceted##3##2##(2008-12#1)(2008-6#1)(2013-8#1)
a multi-gene##2##2##(1996-3#1)(2008-10#1)
a multi-institutional health##2##3##(1993-12#1)(1994-2#1)
a multi-institutional##3##2##(1993-12#1)(1994-2#2)
a multi-level##2##2##(2009-10#1)(2012-2#1)
a multi-method##2##2##(2008-11#2)
a multi-professional##2##2##(2008-11#2)
a multi-site##4##2##(1995-3#3)(2013-1#1)
a multi-state##3##2##(1995-9#1)(2009-4#1)(2013-1#1)
a multi-step process##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a multi-subunit##2##2##(1994-3#1)(2008-11#1)
a multicellular##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
a multicenter randomized trial comparing##2##5##(1993-1#2)
a multicenter##7##2##(1990-12#1)(1993-1#2)(2008-6#1)(2009-10#1)(2010-11#1)(2013-1#1)
a multicentre##4##2##(1996-3#1)(2013-1#3)
a multichannel##4##2##(2008-10#3)(2008-9#1)
a multicopy plasmid##3##3##(1990-11#1)(1993-9#1)(1997-3#1)
a multicopy##4##2##(1990-11#1)(1993-9#1)(1995-6#1)(1997-3#1)
a multicultural##2##2##(1995-3#1)(2013-8#1)
a multicystic##2##2##(2008-10#1)(2011-2#1)
a multidimensional##10##2##(1992-12#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-2#1)(2012-2#1)(2012-3#1)
a multidisciplinary approach to management##2##5##(2008-7#1)(2011-2#1)
a multidisciplinary approach to##4##4##(1996-1#1)(2008-7#2)(2011-2#1)
a multidisciplinary approach##7##3##(1996-1#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#2)
a multidisciplinary international##4##3##(2010-12#4)
a multidisciplinary team##6##3##(1990-6#1)(1997-2#1)(2008-7#1)(2009-8#1)(2013-1#2)
a multidisciplinary##31##2##(1990-6#1)(1994-1#1)(1996-1#2)(1996-11#1)(1997-2#1)(2008-11#1)(2008-7#3)(2009-8#1)(2010-12#6)(2010-5#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#6)(2013-8#2)
a multidrug resistance##2##3##(1996-8#1)(2008-11#1)
a multifaceted##3##2##(2008-10#1)(2009-9#1)(2011-2#1)
a multifactorial##2##2##(2008-10#1)(2013-1#1)
a multifunctional column##2##3##(2008-10#2)
a multifunctional##13##2##(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#1)(2010-5#1)(2011-2#4)
a multigene family of##2##4##(1995-2#1)(1996-12#1)
a multigene family##5##3##(1993-6#1)(1994-11#2)(1995-2#1)(1996-12#1)
a multigene##6##2##(1993-6#1)(1994-11#2)(1995-2#1)(1996-12#2)
a multilayer##5##2##(2008-10#3)(2008-2#1)(2008-5#1)
a multilayered##3##2##(2008-10#2)(2009-9#1)
a multimeric##2##2##(1990-5#1)(2008-10#1)
a multimodality##2##2##(1991-2#1)(1994-6#1)
a multimode fiber##3##3##(2008-10#1)(2008-3#2)
a multimode laser##4##3##(1992-11#1)(2008-3#3)
a multimode phase retarder plastic optical fiber##2##7##(2010-4#2)
a multimode##11##2##(1992-11#1)(2007-11#1)(2008-10#1)(2008-3#6)(2010-4#2)
a multinational##2##2##(1994-2#1)(2011-8#1)
a multiple regression analysis##2##4##(2008-5#1)(2010-11#1)
a multiple##11##2##(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2010-11#1)(2012-3#1)
a multiplex##7##2##(2008-10#5)(2008-9#1)(2010-4#1)
a multiplexed capillary electrophoresis##2##4##(2008-10#2)
a multiplicity of##5##3##(1997-8#1)(2008-11#3)(2010-9#1)
a multiprotein complex##2##3##(1993-12#1)(2010-5#1)
a multiresolution##2##2##(2008-6#2)
a multiscale##2##2##(2009-7#1)(2013-1#1)
a multisensor system##2##3##(2008-10#2)
a multispecialty group##3##3##(1996-1#2)(2008-11#1)
a multispecialty##5##2##(1995-2#1)(1996-1#2)(2008-11#2)
a multistage##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
a multistep process##2##3##(2008-10#1)(2008-12#1)
a multistep##5##2##(2008-10#3)(2008-12#1)(2011-2#1)
a multisyringe flow injection system##2##5##(2008-10#2)
a multisyringe##4##2##(2008-10#4)
a multisystem disease##2##3##(1997-8#1)(2012-3#1)
a multisystem##4##2##(1997-8#1)(2008-9#1)(2012-3#2)
a multitude of##11##3##(1992-12#1)(1992-5#1)(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a multivariate analysis of##2##4##(2008-7#1)(2013-1#1)
a multivariate analysis##5##3##(1993-1#1)(2008-7#1)(2013-1#3)
a multivariate##21##2##(1991-3#1)(1993-1#1)(1993-12#1)(2008-10#9)(2008-7#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-3#1)(2013-1#3)
a multiwavelength##2##2##(2008-10#1)(2008-3#1)
a murine model of##5##4##(2008-4#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
a murine model##6##3##(2008-11#1)(2008-4#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
a murine##23##2##(1993-6#1)(1994-5#1)(1995-6#2)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#9)(2008-4#2)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
a muscle##5##2##(2009-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
a musical##4##2##(2012-12#2)(2013-1#1)(2013-8#1)
a must##4##2##(1995-11#1)(1996-11#1)(2008-7#1)(2010-8#1)
a mutant of##6##3##(1993-12#1)(2008-10#3)(2008-11#1)(2008-9#1)
a mutant##18##2##(1990-5#1)(1991-2#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)
a mutation in the##9##4##(1991-12#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-3#1)
a mutation in##11##3##(1991-12#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#2)(2012-3#1)(2013-1#1)
a mutation that##3##3##(1997-7#1)(2009-8#1)(2012-3#1)
a mutation##23##2##(1991-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-3#2)(1997-7#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#3)(2013-1#2)
a mutualist##3##2##(2008-8#2)(2008-9#1)
a mutualistic##2##2##(2008-10#1)(2008-8#1)
a mutually##3##2##(1996-1#1)(2008-9#1)(2009-4#1)
a mycoparasite##3##2##(2008-10#3)
a myeloid##3##2##(1991-9#1)(2010-11#1)(2013-8#1)
a myocardial infarction##2##3##(2008-11#1)(2010-7#1)
a myriad of##8##3##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)
a mystery##5##2##(1996-12#1)(2008-5#1)(2008-7#3)
a myxoid##2##2##(2008-11#1)(2013-1#1)
a nanostructured##2##2##(2008-10#2)
a narrative##2##2##(2010-8#1)(2013-1#1)
a narrow range##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
a narrow##19##2##(1994-2#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#1)
a narrow-band##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a narrow-bore##2##2##(2008-4#1)(2008-5#1)
a narrowing##2##2##(1994-2#1)(2008-10#1)
a nascent##3##2##(1990-5#1)(1994-1#1)(1995-2#1)
a nation-wide##2##2##(1990-9#1)(1994-12#1)
a national crisis##2##3##(2009-5#1)(2011-2#1)
a national health care##3##4##(1994-2#1)(1995-12#2)
a national health##6##3##(1994-12#1)(1994-2#1)(1995-12#2)(2008-1#2)
a national level##2##3##(1994-2#1)(1995-12#1)
a national network of##2##4##(1991-1#1)(2008-7#1)
a national perspective##2##3##(1997-2#2)
a national priority##2##3##(2009-5#1)(2011-3#1)
a national probability sample of##2##5##(1996-2#1)(2012-12#1)
a national public health surveillance system##2##6##(1997-3#2)
a national sample##3##3##(1993-12#1)(1995-12#1)(2009-7#1)
a national strategy##2##3##(1993-12#1)(2007-8#1)
a national survey of##3##4##(1993-12#1)(1993-3#1)(1994-2#1)
a national survey##4##3##(1993-12#1)(1993-3#1)(1994-2#1)(2012-2#1)
a national telephone##2##3##(1995-6#1)(2008-11#1)
a national##53##2##(1991-1#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#3)(1995-12#4)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#3)(1997-3#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#2)(2009-5#2)(2009-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a nationally representative sample of##3##5##(1993-1#1)(2012-2#1)(2013-8#1)
a nationally representative sample##4##4##(1993-1#1)(2010-6#1)(2012-2#1)(2013-8#1)
a nationally representative##7##3##(1993-1#1)(1997-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-8#1)
a nationally##10##2##(1992-12#1)(1993-1#1)(1994-3#2)(1997-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-8#1)
a nationwide##9##2##(1991-11#2)(1992-12#1)(1997-1#2)(2008-6#1)(2009-8#1)(2012-2#1)(2013-8#1)
a native protein with##2##4##(1993-8#2)
a native protein##3##3##(1993-8#2)(1997-7#1)
a native##8##2##(1990-2#1)(1991-6#1)(1993-8#2)(1994-8#1)(1997-7#1)(2008-10#2)
a natural experiment##2##3##(1992-2#1)(1997-3#1)
a natural population of song sparrows (Melospiza melodia)##2##8##(2008-9#2)
a natural population of##3##4##(2008-9#3)
a natural population##5##3##(2008-12#1)(2008-8#1)(2008-9#3)
a natural product##2##3##(2008-5#1)(2011-2#1)
a natural system##3##3##(2008-9#3)
a natural##58##2##(1990-5#1)(1990-6#1)(1991-2#2)(1992-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#6)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
a naturally occurring##8##3##(1993-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)
a naturally##11##2##(1993-11#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#2)
a near Nernstian##2##3##(2008-10#2)
a near infrared absorbing dye##2##5##(2008-10#2)
a near infrared##3##3##(2008-10#3)
a near neutral##2##3##(2011-2#1)(2012-3#1)
a near##13##2##(2008-10#6)(2008-7#1)(2009-7#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
a near-Nernstian response##3##3##(2008-10#3)
a near-Nernstian##6##2##(2008-10#6)
a near-field##2##2##(2007-12#1)(2009-5#1)
a near-infrared##6##2##(2008-10#3)(2008-3#2)(2008-5#1)
a nearby##2##2##(2007-12#1)(2008-10#1)
a nearly##10##2##(1991-3#1)(1994-2#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-1#1)(2011-3#1)
a nebulizer##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
a necessary and sufficient##2##4##(1992-9#1)(1993-8#1)
a necessary and##3##3##(1992-9#1)(1993-8#1)(2009-8#1)
a necessary condition for the##2##5##(2008-8#1)(2009-8#1)
a necessary condition##3##3##(2008-12#1)(2008-8#1)(2009-8#1)
a necessary step##3##3##(1993-8#1)(1994-1#1)(2012-2#1)
a necessary##16##2##(1991-7#1)(1992-1#1)(1992-9#1)(1993-8#2)(1994-1#1)(1997-1#2)(2008-11#1)(2008-12#1)(2008-8#2)(2009-8#2)(2010-4#1)(2012-2#1)
a necessity##3##2##(2008-11#1)(2008-7#1)(2011-3#1)
a necrosis##2##2##(2008-10#2)
a necrotic##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
a necrotrophic##4##2##(2008-10#4)
a need for a##7##4##(1994-1#2)(1997-6#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#1)
a need for better##2##4##(2011-1#1)(2013-1#1)
a need for further##3##4##(2010-10#2)(2010-4#1)
a need for more##3##4##(1995-2#1)(2008-10#1)(2008-12#1)
a need for precise and accurate methods that allow trace##2##10##(2008-10#2)
a need for##49##3##(1993-1#1)(1993-12#1)(1994-1#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#3)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#3)(2013-1#6)(2013-8#1)
a need in##2##3##(2008-10#1)(2013-8#1)
a need to develop##6##4##(2008-10#2)(2008-5#1)(2011-1#1)(2012-2#2)
a need to##34##3##(1991-3#2)(1992-12#1)(1993-12#2)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
a need##88##2##(1991-3#2)(1992-12#1)(1993-1#1)(1993-12#3)(1994-1#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#3)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#4)(2008-6#1)(2008-9#4)(2009-12#2)(2009-4#1)(2009-8#1)(2010-10#3)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#3)
a needs assessment##2##3##(1994-3#1)(2011-2#1)
a negative attitude##2##3##(1992-2#1)(2010-12#1)
a negative correlation between the##2##5##(2010-12#1)(2011-2#1)
a negative correlation between##4##4##(2008-8#2)(2010-12#1)(2011-2#1)
a negative correlation with##2##4##(1991-11#1)(2011-2#1)
a negative correlation##8##3##(1991-11#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-2#2)(2012-3#1)
a negative effect on##9##4##(1991-2#1)(1992-5#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)
a negative effect##11##3##(1991-2#1)(1992-5#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
a negative feedback mechanism##2##4##(2010-10#2)
a negative feedback##5##3##(1990-8#1)(2009-7#1)(2009-8#1)(2010-10#2)
a negative impact on the##2##5##(2008-12#1)(2011-7#1)
a negative impact on##6##4##(1992-1#1)(1992-3#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-7#1)
a negative impact##7##3##(1992-1#2)(1992-3#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-7#1)
a negative linear##2##3##(2008-10#1)(2008-11#1)
a negative potential (-1##2##4##(2008-10#2)
a negative prognosis##2##3##(1991-6#1)(2008-10#1)
a negative regulator of##4##4##(2009-10#1)(2009-6#1)(2010-5#1)(2013-1#1)
a negative relationship between##3##4##(1996-3#1)(2008-8#2)
a negative##74##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-5#1)(1994-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-5#1)(2010-7#2)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
a negatively charged surface##2##4##(1991-9#1)(2008-11#1)
a neglected##5##2##(1991-6#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
a negligible risk##2##3##(2008-10#1)(2009-10#1)
a negligible##6##2##(2008-10#3)(2008-3#2)(2009-10#1)
a negotiated##2##2##(1995-2#1)(2008-12#1)
a neighborhood##2##2##(1996-12#1)(2008-1#1)
a neighboring##2##2##(2008-8#1)(2012-3#1)
a neighbouring##3##2##(1993-9#1)(1995-8#1)(1997-3#1)
a nematode##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
a neoadjuvant##2##2##(2012-3#2)
a neodymium magnet##2##3##(2008-10#2)
a neoplasm##2##2##(1992-2#1)(2008-12#1)
a neoplastic##3##2##(1992-3#1)(2008-4#1)(2011-2#1)
a nervous system##2##3##(2008-4#1)(2009-8#1)
a nested PCR##2##3##(2008-10#1)(2008-11#1)
a nested case-control study##2##4##(2008-8#1)(2010-6#1)
a nested polymerase chain reaction (PCR)##3##6##(2008-10#2)(2011-2#1)
a nested polymerase chain reaction##4##5##(2008-10#3)(2011-2#1)
a nested##11##2##(2008-10#7)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)
a net analyte##2##3##(2008-10#2)
a net##7##2##(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-5#1)
a network model of the entorhinal cortex layer II with##2##10##(2008-11#2)
a network model of##3##4##(2008-11#3)
a network of##11##3##(1990-12#1)(1990-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
a network##23##2##(1990-12#2)(1990-5#1)(1996-3#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-8#1)
a neural network model##2##4##(2008-11#1)(2008-8#1)
a neural network##5##3##(2008-10#1)(2008-11#2)(2008-8#1)(2013-8#1)
a neural system##2##3##(1993-6#2)
a neural##13##2##(1993-6#2)(1995-2#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
a neurobiological##2##2##(2008-11#1)(2008-4#1)
a neuroendocrine##2##2##(2008-10#1)(2008-12#1)
a neurogenic##2##2##(2008-12#1)(2008-9#1)
a neurological deficit was noted in##2##6##(2011-2#2)
a neurological deficit##3##3##(1996-8#1)(2011-2#2)
a neurological##10##2##(1996-8#1)(1997-6#1)(2008-11#1)(2008-7#2)(2010-8#1)(2011-2#2)(2013-1#2)
a neuron##2##2##(1996-12#1)(2008-4#1)
a neuronal##4##2##(1996-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
a neuropathic pain##2##3##(2008-9#1)(2011-2#1)
a neuropeptide##4##2##(1992-6#1)(1994-11#1)(1996-2#1)(2008-5#1)
a neuroprotective##4##2##(2008-11#4)
a neurotoxin##2##2##(2008-5#1)(2008-7#1)
a neutral carrier##5##3##(2008-10#5)
a neutral face##2##3##(2008-11#1)(2009-4#1)
a neutral neurotoxin##2##3##(2008-9#2)
a neutral##25##2##(1994-8#2)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#2)(2009-4#1)(2012-9#1)
a new Ca(2+)-dependent phospholipid-binding protein##2##5##(2008-9#2)
a new agent for##2##4##(1994-9#1)(2008-5#1)
a new algorithm##2##3##(2008-10#1)(2012-12#1)
a new analytical methodology##2##4##(2008-10#2)
a new analytical##6##3##(2007-12#1)(2008-10#5)
a new and different##2##4##(1991-6#1)(2008-11#1)
a new and distinct##2##4##(2008-10#2)
a new and more##2##4##(1994-1#1)(2011-1#1)
a new and simple##2##4##(1996-5#1)(2012-2#1)
a new and##17##3##(1991-6#1)(1994-1#1)(1996-5#1)(2008-10#3)(2008-11#4)(2008-6#1)(2009-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
a new approach for the##4##5##(2008-10#3)(2008-3#1)
a new approach for##8##4##(2008-10#5)(2008-3#1)(2009-7#1)(2012-2#1)
a new approach to the##3##5##(2008-3#1)(2010-5#1)(2012-3#1)
a new approach to##10##4##(1992-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-5#1)(2012-3#2)(2013-8#1)
a new approach##27##3##(1992-1#1)(1996-2#1)(1996-5#1)(1997-6#1)(2008-10#8)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-5#1)(2012-2#2)(2012-3#2)(2013-8#1)
a new aspect of##2##4##(1993-8#1)(1994-3#1)
a new assay##4##3##(1991-12#1)(2008-10#3)
a new basis for##2##4##(1996-2#1)(2008-7#1)
a new calibration##3##3##(2008-10#2)(2008-6#1)
a new capillary electrophoresis (CE)##2##5##(2008-10#2)
a new case of##2##4##(2007-8#1)(2008-7#1)
a new case##4##3##(1991-11#1)(2007-8#1)(2008-7#1)(2009-1#1)
a new cell##2##3##(2008-10#1)(2008-11#1)
a new centrally acting muscle relaxant##3##6##(1992-3#2)(1996-2#1)
a new challenge for##2##4##(2008-10#1)(2008-11#1)
a new challenge##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
a new chelating##3##3##(2008-10#3)
a new chromogenic reagent##3##4##(2008-10#3)
a new chromogenic##4##3##(1996-5#1)(2008-10#3)
a new class of##17##4##(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-9#1)(2009-10#1)(2011-3#1)(2013-1#1)
a new classification of##2##4##(1991-1#1)(2008-7#1)
a new classification##3##3##(1991-1#1)(1997-8#1)(2008-7#1)
a new concept in##2##4##(1991-12#1)(2010-7#1)
a new concept of##3##4##(2008-8#1)(2009-5#1)(2012-2#1)
a new concept presented here on how to handle gloves with pinholes##2##12##(2012-2#2)
a new concept##10##3##(1991-12#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-2#3)
a new desensitizing dentifrice containing 8##3##6##(2011-2#3)
a new device##3##3##(2008-3#2)(2008-5#1)
a new disease##2##3##(2008-10#2)
a new drug##4##3##(1993-2#1)(1995-1#1)(2008-10#1)(2009-10#1)
a new equol-rich##2##3##(2010-1#2)
a new era for##2##4##(1993-12#1)(2011-2#1)
a new era in##3##4##(1991-8#1)(2008-11#1)(2009-5#1)
a new era of##4##4##(2008-6#1)(2008-9#2)(2011-7#1)
a new era##11##3##(1991-8#1)(1993-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2011-2#1)(2011-7#1)
a new experimental##2##3##(2008-10#1)(2008-11#1)
a new expression##2##3##(2008-3#1)(2008-8#1)
a new family of##4##4##(1991-9#1)(1993-2#1)(2008-3#1)(2012-2#1)
a new family##6##3##(1991-9#1)(1993-2#1)(1995-5#1)(2008-3#1)(2012-2#1)(2013-8#1)
a new field##2##3##(2008-10#1)(2008-12#1)
a new flow##3##3##(1995-9#1)(2008-10#2)
a new fluorescence##2##3##(2008-10#2)
a new formulation##2##3##(2007-12#1)(2010-12#1)
a new gene family##2##4##(2008-8#1)(2008-9#1)
a new gene##7##3##(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)
a new generation of##3##4##(2008-10#2)(2008-12#1)
a new genus##2##3##(2008-10#1)(2008-12#1)
a new graphical##2##3##(2008-10#1)(2009-7#1)
a new group of##2##4##(1997-3#1)(2008-10#1)
a new host##4##3##(2008-10#1)(2011-2#1)(2012-2#2)
a new image##2##3##(1992-1#1)(2008-3#1)
a new insight##2##3##(1997-2#1)(2013-8#1)
a new instrument##2##3##(1992-3#1)(1997-1#1)
a new isoform##2##3##(1992-3#1)(1993-6#1)
a new kind of##5##4##(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#2)
a new level of##4##4##(1993-12#1)(1994-2#1)(1997-3#1)(2008-11#1)
a new lipophilic tetrathiafulvalene-tetracyanoquinodimethane##2##4##(2008-10#2)
a new location##3##3##(1994-3#2)(2008-10#1)
a new look##2##3##(1993-2#1)(2008-8#1)
a new material##2##3##(2008-10#2)
a new mechanism##2##3##(2008-9#1)(2012-3#1)
a new medical##2##3##(1992-2#1)(2013-1#1)
a new member of the genus Mitovirus##2##7##(2008-10#2)
a new member of the genus##5##6##(2008-10#5)
a new member of the##7##5##(1995-12#1)(2008-10#5)(2009-3#1)
a new member of##10##4##(1995-12#1)(2008-10#5)(2008-8#2)(2008-9#1)(2009-3#1)
a new method called##2##4##(2008-10#1)(2008-5#1)
a new method for the determination of##3##7##(2008-10#3)
a new method for the##6##5##(2008-10#6)
a new method for##16##4##(2008-10#12)(2008-2#1)(2008-3#1)(2012-2#2)
a new method is##2##4##(2008-10#2)
a new method of##4##4##(1990-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
a new method to##5##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
a new method##36##3##(1990-2#1)(1991-12#1)(1996-3#1)(2008-10#18)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-9#1)(2011-3#1)(2012-2#3)
a new microcalorimetric method##2##4##(2008-10#2)
a new model for##2##4##(2008-5#1)(2010-11#1)
a new model of##3##4##(1996-3#1)(1997-4#1)(2009-8#1)
a new model##8##3##(1990-8#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-11#1)(2012-3#1)
a new national##3##3##(1994-9#1)(1997-2#1)(2008-3#1)
a new one##2##3##(1992-9#1)(2008-11#1)
a new opportunity to##2##4##(2008-10#2)
a new opportunity##3##3##(2008-10#2)(2008-2#1)
a new orientation program##2##4##(1996-1#2)
a new paradigm for##4##4##(2008-4#1)(2009-12#1)(2010-4#1)(2013-1#1)
a new paradigm##5##3##(2008-4#1)(2009-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
a new perspective##2##3##(1994-1#1)(2008-1#1)
a new philosophy##2##3##(1996-1#1)(2009-4#1)
a new phytoplasma##2##3##(2008-10#2)
a new picture##2##3##(2008-2#1)(2008-8#1)
a new population##2##3##(2008-10#1)(2013-8#1)
a new possibility##2##3##(1991-2#1)(2008-11#1)
a new potential##2##3##(2008-8#1)(2011-2#1)
a new procedure for the##2##5##(2008-10#1)(2008-12#1)
a new procedure for##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
a new procedure##8##3##(1992-3#1)(2008-10#5)(2008-12#1)(2011-2#1)
a new process##2##3##(1993-12#1)(2011-2#1)
a new product##2##3##(1992-2#1)(2008-5#1)
a new quantitative##2##3##(2008-10#2)
a new reagent##2##3##(2008-10#2)
a new regimen##2##3##(1990-12#1)(2012-3#1)
a new research##2##3##(2008-11#2)
a new response##3##3##(1993-6#2)(2008-11#1)
a new risk##2##3##(2009-7#1)(2011-2#1)
a new route to##3##4##(1991-1#1)(2008-5#2)
a new sample##3##3##(2008-10#2)(2012-2#1)
a new sensitive and selective##2##5##(2008-10#2)
a new set of##4##4##(1993-2#1)(1996-3#1)(2008-12#1)(2013-1#1)
a new simple##2##3##(2008-10#1)(2008-2#1)
a new solution to##2##4##(2008-10#1)(2008-11#1)
a new source of##3##4##(2008-10#2)(2012-2#1)
a new source##4##3##(2008-10#3)(2012-2#1)
a new species##8##3##(2008-10#7)(2010-3#1)
a new spectrofluorimetric method for the determination of##2##8##(2008-10#2)
a new spectrophotometric##2##3##(2008-10#2)
a new strain of##2##4##(2008-10#1)(2012-2#1)
a new strategy for##2##4##(2008-10#1)(2011-2#1)
a new strategy##5##3##(1993-9#1)(2008-10#2)(2008-8#1)(2011-2#1)
a new subcloning-less method for generating nested deletions##2##8##(1995-8#2)
a new suture technique for fascial closure##2##7##(1991-2#2)
a new system##3##3##(1991-1#1)(1995-12#1)(2008-9#1)
a new target for##3##4##(2008-9#1)(2012-12#1)(2013-1#1)
a new target##4##3##(2008-9#1)(2011-3#1)(2012-12#1)(2013-1#1)
a new technique for##5##4##(1990-3#1)(1991-12#1)(1991-3#1)(1991-9#1)(2008-10#1)
a new technique##16##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
a new technology##3##3##(1994-1#1)(2008-10#2)
a new test##2##3##(2008-5#1)(2008-9#1)
a new therapeutic##5##3##(1991-3#1)(1993-11#1)(1994-6#1)(1997-8#1)(2013-8#1)
a new tool for##3##4##(1993-3#1)(1996-12#1)(2008-3#1)
a new tool in##2##4##(2009-10#1)(2013-1#1)
a new tool to##2##4##(1996-12#1)(2008-11#1)
a new tool##8##3##(1993-3#1)(1996-12#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2013-1#1)
a new toothpaste##2##3##(2011-2#2)
a new treatment##3##3##(1995-9#1)(2011-2#1)(2013-1#1)
a new trial##4##3##(1992-2#1)(1996-6#3)
a new type of##12##4##(1992-6#1)(2008-10#7)(2008-8#2)(2012-2#1)(2012-3#1)
a new type##13##3##(1992-6#1)(2008-10#8)(2008-8#2)(2012-2#1)(2012-3#1)
a new understanding of##2##4##(2008-11#1)(2009-5#1)
a new way of##4##4##(2008-10#2)(2008-9#1)(2012-2#1)
a new way to##2##4##(1991-2#1)(2008-9#1)
a new way##7##3##(1991-2#1)(2008-10#2)(2008-8#1)(2008-9#2)(2012-2#1)
a new##823##2##(1990-11#1)(1990-12#6)(1990-2#2)(1990-3#2)(1990-8#2)(1990-9#1)(1991-1#6)(1991-11#1)(1991-12#8)(1991-2#6)(1991-3#4)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#4)(1992-12#2)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#6)(1993-3#2)(1993-6#6)(1993-8#1)(1993-9#1)(1994-1#4)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#6)(1995-8#2)(1995-9#3)(1996-1#6)(1996-11#1)(1996-12#5)(1996-2#10)(1996-3#5)(1996-5#5)(1996-6#5)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#5)(1997-9#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#260)(2008-11#45)(2008-12#13)(2008-2#15)(2008-3#21)(2008-4#5)(2008-5#30)(2008-6#10)(2008-7#5)(2008-8#27)(2008-9#23)(2009-1#1)(2009-10#5)(2009-12#3)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#7)(2009-8#5)(2010-1#3)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#29)(2011-3#6)(2011-7#2)(2012-12#6)(2012-2#30)(2012-3#15)(2013-1#12)(2013-8#13)
a newborn screening##2##3##(2010-8#2)
a newborn with##2##3##(2011-1#1)(2012-3#1)
a newborn##16##2##(1991-12#2)(1993-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2009-12#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
a newer##2##2##(1995-6#1)(2011-2#1)
a newly described species##2##4##(2008-10#2)
a newly described##7##3##(1990-5#1)(2008-10#5)(2011-2#1)
a newly developed method##2##4##(2008-10#2)
a newly developed##12##3##(1994-11#2)(1994-12#1)(2008-10#8)(2008-11#1)
a newly discovered##6##3##(1992-8#1)(2007-11#1)(2008-10#3)(2009-7#1)
a newly identified##3##3##(2008-10#2)(2008-7#1)
a newly isolated strain##2##4##(1994-12#1)(2011-2#1)
a newly isolated##3##3##(1994-12#1)(2011-2#1)(2013-1#1)
a newly prescribed antihypertensive##2##4##(2008-11#2)
a newly synthesized##6##3##(1995-11#1)(2008-10#5)
a newly##51##2##(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-12#2)(1995-11#1)(1995-2#1)(2007-11#1)(2008-10#27)(2008-11#3)(2008-7#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-5#1)(2013-1#1)
a newsletter##2##2##(1994-12#1)(1995-1#1)
a niche##2##2##(2008-11#1)(2008-8#1)
a nickel phthalocyanine complex##2##4##(2008-10#2)
a nickel##6##2##(2008-10#6)
a nine##2##2##(1991-11#1)(2008-10#1)
a nitrate##2##2##(2008-10#2)
a nitric acid##2##3##(2008-10#2)
a nitric oxide##3##3##(2008-5#1)(2008-7#1)(2010-1#1)
a nitric##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2010-1#1)
a nitrite concentration##3##3##(2008-10#3)
a nitrogen flow##3##3##(2008-10#2)(2008-2#1)
a nitrogen##7##2##(1994-8#1)(1995-9#1)(2008-10#3)(2008-2#1)(2011-2#1)
a nodular##2##2##(1996-12#1)(2010-3#1)
a nodule##3##2##(2008-12#1)(2012-12#1)(2012-3#1)
a noise level of##2##4##(2008-10#1)(2009-5#1)
a noise level##3##3##(2008-10#1)(2009-5#1)(2011-2#1)
a nominal##6##2##(1995-9#1)(1997-8#1)(2008-10#4)
a non##7##2##(1991-11#1)(2008-10#4)(2009-1#1)(2013-1#1)
a non-adhesive##2##2##(2008-11#1)(2008-7#1)
a non-clinical##2##2##(2008-1#2)
a non-contact##3##2##(2009-7#1)(2010-12#1)(2013-1#1)
a non-destructive##2##2##(2008-9#1)(2012-2#1)
a non-detachable balloon##3##3##(1997-3#3)
a non-displaced hip fracture##2##4##(2008-12#2)
a non-displaced##3##2##(2008-12#2)(2013-1#1)
a non-functioning##2##2##(2012-2#1)(2013-1#1)
a non-host-specific##2##2##(2008-10#2)
a non-invasive##6##2##(1997-2#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
a non-ionic surfactant##2##3##(2008-10#2)
a non-ionic##4##2##(1997-7#1)(2008-10#2)(2008-5#1)
a non-linear method##3##3##(2008-10#3)
a non-linear##10##2##(2008-10#4)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-8#1)(2013-8#1)
a non-mammalian##2##2##(1995-11#1)(2013-8#1)
a non-negligible##3##2##(1994-2#1)(2011-2#1)(2012-2#1)
a non-parametric##2##2##(1995-12#1)(2008-10#1)
a non-physiological##2##2##(1993-6#1)(2009-1#1)
a non-polar##5##2##(2008-10#5)
a non-receptor##2##2##(1992-6#1)(1995-8#1)
a non-selective##3##2##(1996-12#1)(1997-7#1)(2008-7#1)
a non-specific##6##2##(1992-12#1)(1997-8#2)(2008-10#1)(2008-7#1)(2010-12#1)
a non-toxic##3##2##(2008-10#2)(2008-5#1)
a noncompetitive##3##2##(1991-5#1)(1994-11#1)(2008-10#1)
a noncomposite##2##2##(2008-2#2)
a nondestructive##3##2##(2008-10#1)(2008-3#2)
a nonessential##2##2##(1994-5#1)(2009-8#1)
a nonfunctional##3##2##(1991-5#1)(1997-8#1)(2008-10#1)
a nonhost##2##2##(2008-10#2)
a noninvasive##11##2##(1993-1#1)(1993-11#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
a nonionic surfactant##2##3##(2008-10#1)(2008-5#1)
a nonionic##3##2##(2008-10#2)(2008-5#1)
a nonlinear least-squares##2##3##(2008-10#1)(2008-3#1)
a nonlinear medium##3##3##(2007-12#1)(2008-3#2)
a nonlinear optical crystal##3##4##(2007-11#1)(2008-3#2)
a nonlinear response##2##3##(2008-2#1)(2008-3#1)
a nonlinear##18##2##(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#7)(2008-6#1)
a nonmammalian enzyme##2##3##(1994-5#2)
a nonpathogenic isolate##2##3##(2008-10#2)
a nonpathogenic##6##2##(2008-10#6)
a nonpolar##2##2##(1991-2#1)(1995-2#1)
a nonprofit##3##2##(1994-1#1)(1994-3#1)(1995-12#1)
a nonrandom##3##2##(2008-10#2)(2008-8#1)
a nonsteroidal anti-inflammatory drug##2##4##(1997-4#1)(2008-11#1)
a nonstructural##2##2##(2008-10#2)
a normal ano-genital examination##2##4##(2010-4#2)
a normal component of##4##4##(2008-10#2)(2008-11#2)
a normal distribution##2##3##(2008-10#2)
a normal population##2##3##(1990-6#1)(1995-2#1)
a normal##57##2##(1990-11#1)(1990-6#1)(1991-5#1)(1992-9#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-4#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
a north##3##2##(2008-10#1)(2008-12#2)
a northern##2##2##(1990-6#1)(2008-10#1)
a nose##2##2##(2008-1#1)(2008-4#1)
a not negligible##2##3##(1990-6#1)(2009-10#1)
a notable##3##2##(1995-11#1)(2008-11#1)(2012-3#1)
a note of##2##3##(1991-3#1)(2012-2#1)
a note##5##2##(1991-3#1)(1992-1#1)(1995-6#1)(2012-2#1)(2013-1#1)
a noticeable##3##2##(2008-5#2)(2010-4#1)
a novel and##10##3##(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
a novel antihypertensive##2##3##(2008-10#1)(2010-4#1)
a novel approach for##5##4##(2008-10#1)(2010-10#1)(2013-1#3)
a novel approach is##2##4##(2008-10#1)(2008-7#1)
a novel approach to the##3##5##(1991-11#1)(1991-5#1)(2009-7#1)
a novel approach to##5##4##(1991-11#1)(1991-5#1)(2008-10#2)(2009-7#1)
a novel approach##16##3##(1991-11#1)(1991-5#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2012-3#1)(2013-1#3)
a novel assay##2##3##(2008-10#1)(2008-11#1)
a novel cDNA##3##3##(1994-11#1)(1995-6#1)(2008-4#1)
a novel cell##3##3##(1994-11#1)(2008-11#2)
a novel chemiluminescence##2##3##(2008-10#2)
a novel class of##8##4##(1991-5#1)(1994-3#1)(1994-6#1)(2008-10#3)(2010-11#1)(2012-2#1)
a novel computational##2##3##(2010-10#1)(2013-1#1)
a novel design##2##3##(1997-1#1)(2008-2#1)
a novel determinant of##2##4##(2011-2#1)(2013-1#1)
a novel device##2##3##(2007-11#1)(2008-10#1)
a novel electrochemical##2##3##(2008-10#2)
a novel family of##2##4##(2008-11#1)(2008-6#1)
a novel fiber##2##3##(2008-10#2)
a novel framework##2##3##(2008-11#1)(2012-3#1)
a novel functional##3##3##(2008-10#2)(2009-10#1)
a novel gene##6##3##(1995-8#1)(1997-7#1)(2008-10#1)(2008-8#2)(2008-9#1)
a novel human gene##3##4##(1996-2#1)(1997-7#1)(1997-8#1)
a novel human##7##3##(1990-8#2)(1992-9#1)(1996-2#1)(1997-7#1)(1997-8#2)
a novel inhibitor##2##3##(2008-8#1)(2011-2#1)
a novel mechanism of##3##4##(1994-3#1)(2008-11#1)(2009-7#1)
a novel mechanism##5##3##(1994-3#1)(2008-11#1)(2009-7#1)(2010-11#1)(2013-8#1)
a novel member of the##5##5##(1994-11#1)(1995-12#1)(2008-10#2)(2013-1#1)
a novel member of##6##4##(1994-11#1)(1995-12#1)(2008-10#2)(2008-9#1)(2013-1#1)
a novel method for the determination of##2##7##(2008-10#2)
a novel method for the##4##5##(2008-10#4)
a novel method for##8##4##(1994-11#1)(2008-10#4)(2008-5#1)(2011-7#1)(2012-2#1)
a novel method of##4##4##(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
a novel method##18##3##(1994-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-7#1)(2012-2#2)(2013-1#2)
a novel model##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
a novel post-transcriptional##2##3##(2008-9#1)(2013-8#1)
a novel probe for##2##4##(1995-11#1)(2008-8#1)
a novel protein##3##3##(1990-5#1)(1993-9#1)(2008-4#1)
a novel role##2##3##(1995-12#1)(2008-1#1)
a novel signaling##3##3##(1993-12#1)(2008-10#1)(2009-8#1)
a novel strategy##3##3##(1992-3#1)(2008-7#1)(2010-5#1)
a novel target for##3##4##(1997-1#1)(2009-6#1)(2013-8#1)
a novel technique for##3##4##(2008-10#1)(2009-6#1)(2011-2#1)
a novel technique##5##3##(2008-10#2)(2009-6#1)(2011-2#1)(2012-2#1)
a novel therapeutic target##2##4##(2012-2#2)
a novel therapeutic##3##3##(2010-6#1)(2012-2#2)
a novel tool##3##3##(2008-10#3)
a novel transcription factor##2##4##(1991-9#1)(2009-8#1)
a novel type of##2##4##(1990-5#1)(2008-11#1)
a novel type##3##3##(1990-5#2)(2008-11#1)
a novel way##2##3##(2008-7#1)(2013-1#1)
a novel##386##2##(1990-5#5)(1990-8#2)(1991-11#1)(1991-3#1)(1991-5#4)(1991-9#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#8)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#3)(1995-6#3)(1995-8#4)(1996-12#1)(1996-2#6)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-7#4)(1997-8#3)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#112)(2008-11#30)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#19)(2008-9#12)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#5)(2009-7#5)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#7)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#16)(2012-3#9)(2013-1#18)(2013-8#5)
a novice##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
a nuclear localization signal##2##4##(1994-11#2)
a nuclear localization##3##3##(1994-11#2)(1995-2#1)
a nuclear magnetic resonance##2##4##(1991-5#1)(1992-4#1)
a nuclear receptor##2##3##(1996-12#1)(2008-9#1)
a nuclear##24##2##(1990-5#1)(1991-5#1)(1992-4#1)(1994-11#2)(1994-6#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
a nucleic acid##2##3##(2008-10#1)(2008-4#1)
a nucleotide identity greater than 98%##2##6##(2008-10#2)
a nucleotide identity##3##3##(2008-10#3)
a nucleotide sequence##2##3##(2008-8#1)(2008-9#1)
a nucleotide##13##2##(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-8#1)(2008-9#1)(2011-3#1)(2013-8#1)
a null hypothesis of##2##4##(1995-9#2)
a null##3##2##(1995-9#2)(2008-10#1)
a number of advantages over##5##5##(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)
a number of advantages##8##4##(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#1)
a number of attractive properties##2##5##(2008-10#1)(2008-6#1)
a number of autoimmune diseases##2##5##(1992-5#1)(2008-10#1)
a number of biochemical##2##4##(2008-10#1)(2008-12#1)
a number of biological##2##4##(1996-6#1)(2008-10#1)
a number of biotic and abiotic stresses##2##7##(2010-10#2)
a number of broad##2##4##(2008-12#1)(2011-2#1)
a number of cell##2##4##(1995-6#1)(2008-11#1)
a number of clinical##3##4##(2008-3#1)(2009-3#1)(2010-12#1)
a number of commercially available##2##5##(2008-10#1)(2008-9#1)
a number of different diseases##2##5##(2008-10#2)
a number of different##16##4##(1991-5#1)(1992-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2009-9#1)(2010-5#1)(2013-8#1)
a number of disadvantages##2##4##(1991-3#1)(1993-6#1)
a number of diseases##2##4##(2008-9#1)(2009-5#1)
a number of drugs##2##4##(2009-12#1)(2012-3#1)
a number of dysfunction syndromes which will have predictable consequences##2##10##(2008-12#2)
a number of experimental##2##4##(1995-6#1)(2012-12#1)
a number of factors##7##4##(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
a number of genes##3##4##(1996-12#2)(2008-11#1)
a number of groups##2##4##(2008-11#1)(2009-1#1)
a number of human##2##4##(2008-11#1)(2008-4#1)
a number of important##5##4##(1992-9#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-2#1)
a number of issues##4##4##(1995-3#1)(2008-11#2)(2013-1#1)
a number of key##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
a number of new##2##4##(2008-10#1)(2008-11#1)
a number of nuclear##2##4##(1997-2#1)(2011-2#1)
a number of other##12##4##(1991-3#1)(1991-6#1)(1992-12#1)(1992-4#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
a number of pitfalls##2##4##(2008-7#1)(2011-2#1)
a number of possible##6##4##(1991-3#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-9#1)
a number of potentially##2##4##(2008-9#1)(2011-3#1)
a number of practical##2##4##(2008-11#1)(2008-9#1)
a number of problems##2##4##(1995-12#1)(2008-11#1)
a number of proteins##2##4##(2008-11#1)(2010-12#1)
a number of psychiatric disorders##2##5##(2012-2#1)(2013-1#1)
a number of recent studies##2##5##(2009-8#1)(2011-2#1)
a number of recommendations##3##4##(2008-11#2)(2008-9#1)
a number of samples##2##4##(2008-10#2)
a number of significant##2##4##(2008-11#1)(2008-9#1)
a number of small##2##4##(2007-12#1)(2008-10#1)
a number of sources##2##4##(1993-12#1)(2008-12#1)
a number of species##2##4##(1993-2#2)
a number of strategies##2##4##(1997-2#1)(2008-11#1)
a number of studies have##2##5##(2008-11#1)(2008-9#1)
a number of studies##6##4##(1997-1#1)(2008-11#1)(2008-7#3)(2008-9#1)
a number of test##2##4##(2008-10#2)
a number of the##2##4##(2008-11#1)(2008-7#1)
a number of these##2##4##(2008-10#2)
a number of tissues including##2##5##(2008-11#2)
a number of variables##2##4##(2008-10#1)(2008-9#1)
a number of viruses##2##4##(1995-9#1)(2013-1#1)
a number of wards used no measurement instruments at all##2##10##(2013-1#2)
a number of wards##3##4##(2008-7#1)(2013-1#2)
a number of years##2##4##(1992-1#1)(1993-3#1)
a number of##381##3##(1990-5#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-5#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#5)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#4)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#83)(2008-11#51)(2008-12#15)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#14)(2008-8#7)(2008-9#13)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#4)(2010-12#5)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#13)(2013-8#4)
a number##382##2##(1990-5#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-5#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#5)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#4)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#83)(2008-11#51)(2008-12#15)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#14)(2008-8#7)(2008-9#13)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#4)(2010-12#5)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#13)(2013-8#4)
a numeric##2##2##(1995-12#1)(2008-12#1)
a numerical model##2##3##(2007-12#1)(2008-10#1)
a numerical simulation##2##3##(2007-12#1)(2008-3#1)
a numerical solution##3##3##(1992-9#2)(2009-10#1)
a numerical##12##2##(1992-9#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2009-10#1)(2013-8#1)
a nurse and##2##3##(2008-11#1)(2010-7#1)
a nurse##7##2##(1992-3#1)(2008-11#4)(2010-7#1)(2011-1#1)
a nursery##2##2##(2008-10#2)
a nursing home for the blind##2##6##(2008-7#2)
a nursing home##8##3##(1994-2#1)(1995-2#1)(2008-7#2)(2010-10#4)
a nursing##21##2##(1992-2#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-11#8)(2008-5#1)(2008-7#3)(2010-10#4)(2012-3#1)
a nutrient##5##2##(2008-11#1)(2008-12#1)(2008-7#2)(2013-8#1)
a nutrient-rich##2##2##(2008-10#2)
a nutrition##2##2##(1992-12#1)(2012-12#1)
a nutritional##2##2##(2008-10#1)(2012-2#1)
a nutritionally##2##2##(2008-10#1)(2008-11#1)
a nylon membrane##2##3##(1995-6#1)(2008-10#1)
a one step##2##3##(2008-11#1)(2010-11#1)
a one year##4##3##(1996-2#1)(2008-12#1)(2008-7#1)(2013-8#1)
a one##14##2##(1994-8#1)(1995-10#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)(2013-8#1)
a one-dimensional##2##2##(2008-3#2)
a one-pot##2##2##(1996-5#1)(2008-10#1)
a one-step##2##2##(2008-10#1)(2008-3#1)
a one-to-one##2##2##(1996-12#1)(2008-10#1)
a one-way##4##2##(1993-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
a one-year##3##2##(1990-2#1)(1995-2#1)(1997-1#1)
a p53-independent##2##2##(1995-6#2)
a pH 2##3##3##(2008-10#3)
a pH 4##2##3##(2008-10#2)
a pH 5##2##3##(1990-12#1)(2008-10#1)
a pH dependent##2##3##(2008-10#1)(2009-12#1)
a pH of##7##3##(2008-10#7)
a pH optimum##2##3##(1994-5#1)(2008-9#1)
a pH range of 3##4##5##(2008-10#4)
a pH range of 5##2##5##(2008-10#2)
a pH range of 6##2##5##(2008-10#1)(2008-7#1)
a pH range of##15##4##(1991-9#1)(2008-10#12)(2008-7#1)(2012-2#1)
a pH range##21##3##(1991-9#1)(2008-10#18)(2008-7#1)(2012-2#1)
a pH sensitive##2##3##(2008-10#1)(2009-12#1)
a pH##60##2##(1990-12#1)(1991-9#2)(1993-8#1)(1994-5#1)(1994-8#1)(2008-10#47)(2008-11#1)(2008-7#2)(2008-9#1)(2009-12#2)(2012-2#1)
a pH-ISFET##2##2##(2008-10#2)
a pH-gradient##2##2##(1990-5#1)(2008-10#1)
a pH-metric##2##2##(2008-10#2)
a package of##2##3##(1993-3#1)(1995-6#1)
a package##3##2##(1993-3#1)(1994-8#1)(1995-6#1)
a packed bed##3##3##(2008-11#3)
a packed##8##2##(2008-10#4)(2008-11#3)(2008-7#1)
a paediatric##5##2##(2008-11#3)(2008-9#1)(2011-2#1)
a pain##5##2##(1996-12#1)(2008-11#1)(2008-4#1)(2009-12#2)
a painful##2##2##(1996-5#1)(2008-11#1)
a painless##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
a pair of LEDs##2##4##(2008-10#2)
a pair of##33##3##(1990-11#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-2#1)(2010-4#1)(2010-8#1)(2012-3#3)
a paired##5##2##(1993-6#1)(1996-3#1)(2008-10#2)(2010-10#1)
a palliative care unit##2##4##(2010-2#1)(2011-2#1)
a palliative care##3##3##(2008-12#1)(2010-2#1)(2011-2#1)
a palliative operation##3##3##(1990-9#3)
a palliative##7##2##(1990-9#3)(1997-3#1)(2008-12#1)(2010-2#1)(2011-2#1)
a pallidal stimulator##2##3##(2008-7#2)
a palpable mass in##2##4##(2010-3#1)(2013-1#1)
a palpable mass##4##3##(2010-3#1)(2013-1#3)
a palpable##7##2##(1990-9#1)(2010-3#1)(2011-2#1)(2013-1#4)
a pandemic##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
a panel discussion on the##2##5##(2008-6#1)(2013-1#1)
a panel discussion##3##3##(2008-6#2)(2013-1#1)
a panel of monoclonal antibodies##3##5##(1990-12#1)(1991-2#1)(1993-1#1)
a panel of##21##3##(1990-12#1)(1991-2#1)(1993-1#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-6#2)(2008-10#3)(2008-11#2)(2008-5#2)(2010-12#1)(2010-5#1)(2010-9#1)(2012-3#2)(2013-1#1)
a panel##25##2##(1990-12#1)(1991-2#1)(1993-1#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-6#2)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#2)(2010-12#1)(2010-5#1)(2010-9#1)(2012-3#2)(2013-1#2)
a panoramic##2##2##(2008-6#1)(2012-3#1)
a paper industry##2##3##(2008-10#2)
a paper##4##2##(2008-10#2)(2008-12#1)(2012-2#1)
a paracrine##5##2##(1995-12#1)(1995-8#1)(2008-4#1)(2013-1#1)(2013-8#1)
a paradigm for##2##3##(2011-2#1)(2013-8#1)
a paradigm of##2##3##(2008-11#2)
a paradigm shift in##2##4##(2008-11#2)
a paradigm shift##6##3##(2008-11#2)(2008-7#1)(2010-1#2)(2010-4#1)
a paradigm shift-Part##2##3##(2008-12#2)
a paradigm##14##2##(2008-11#4)(2008-12#2)(2008-7#1)(2009-8#1)(2010-1#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
a paradox##2##2##(2008-11#2)
a parallel comparison of##2##4##(2008-10#1)(2008-11#1)
a parallel increase in##3##4##(1994-11#1)(1994-3#1)(1995-2#1)
a parallel##16##2##(1991-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
a parameter for##3##3##(2008-5#1)(2008-7#2)
a parameter##10##2##(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#2)(2013-8#1)
a parametric##4##2##(1991-2#1)(2007-12#2)(2008-10#1)
a parasite of##2##3##(2008-10#2)
a parasite that##2##3##(2008-9#2)
a parasite##8##2##(1997-7#1)(2008-10#2)(2008-8#2)(2008-9#3)
a parasitic##6##2##(1996-6#1)(2008-10#2)(2008-8#1)(2010-11#1)(2011-2#1)
a parent in##2##3##(2008-11#1)(2010-5#1)
a parent##8##2##(1991-2#1)(1994-2#1)(2008-11#2)(2008-8#1)(2010-5#1)(2010-8#1)(2012-3#1)
a parish nurse faculty practice##2##5##(2008-12#2)
a parish##3##2##(1991-12#1)(2008-12#2)
a parking##2##2##(1992-12#1)(2008-10#1)
a part in##3##3##(1997-1#1)(2011-2#1)(2013-8#1)
a part of the##32##4##(1990-12#1)(1991-6#1)(1992-1#1)(1994-8#1)(1995-12#2)(1996-2#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#12)
a part of##54##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-1#1)(1994-8#1)(1995-12#3)(1996-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-6#1)(2010-8#1)(2011-2#12)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a part##60##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-1#1)(1994-8#1)(1995-12#3)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-6#1)(2010-8#1)(2011-2#13)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
a part-time##2##2##(2008-11#1)(2011-2#1)
a partial agonist##2##3##(1992-8#1)(1995-11#1)
a partial differential equation model##2##5##(2008-8#1)(2013-8#1)
a partial least squares (PLS)##2##5##(2008-10#2)
a partial least squares##3##4##(2008-10#3)
a partial least##4##3##(2008-10#4)
a partial least-squares##3##3##(2008-10#3)
a partial remission##2##3##(1991-6#1)(1991-8#1)
a partial response##4##3##(1990-12#1)(1990-2#1)(1992-12#1)(2010-12#1)
a partial##46##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#3)(1996-8#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#2)
a partially resistant cultivar##2##4##(2008-10#2)
a partially##8##2##(1991-12#1)(1996-5#1)(2008-10#5)(2010-10#1)
a participant##2##2##(1995-11#1)(2008-11#1)
a participatory##3##2##(1997-3#1)(2008-1#1)(2008-11#1)
a particle size##3##3##(2008-10#3)
a particle##7##2##(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)
a particles##2##2##(2008-8#2)
a particular chemical##2##3##(2008-12#1)(2008-9#1)
a particular developmental stage##2##4##(1993-9#1)(2008-8#1)
a particular gene##3##3##(1997-6#1)(2008-4#2)
a particular protein##3##3##(1993-8#1)(2008-1#1)(2008-4#1)
a particular region##2##3##(1994-2#1)(2012-12#1)
a particular set of##2##4##(2008-11#1)(2008-9#1)
a particular type of##4##4##(1991-8#1)(1993-6#1)(1994-12#1)(2012-3#1)
a particular##102##2##(1990-11#1)(1990-4#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#2)(1995-9#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#8)(2008-12#4)(2008-4#7)(2008-5#2)(2008-7#4)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
a particularly important role##2##4##(2008-11#1)(2011-2#1)
a particularly##13##2##(1992-2#1)(1993-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2010-4#1)(2011-2#2)(2012-2#1)
a partition##2##2##(2008-6#1)(2011-2#1)
a partner##6##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-5#1)(2008-8#1)(2012-2#1)
a partnership agreement##2##3##(1992-3#2)
a partnership between the##2##4##(1995-3#1)(1996-3#1)
a partnership between##3##3##(1995-3#1)(1996-3#2)
a partnership##8##2##(1992-3#2)(1995-3#1)(1996-3#2)(2008-11#1)(2008-12#2)
a passive sampler##3##3##(2008-10#2)(2008-11#1)
a passive##16##2##(2007-11#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#2)(2009-7#1)(2012-12#1)
a passively##2##2##(2008-2#1)(2008-3#1)
a past##6##2##(1995-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
a patchwork of##2##3##(1997-8#1)(2008-1#1)
a patchwork##3##2##(1995-6#1)(1997-8#1)(2008-1#1)
a patchy##3##2##(1991-11#1)(2008-8#1)(2008-9#1)
a patent ductus arteriosus##2##4##(1997-8#1)(2010-10#1)
a patent foramen ovale (PFO)##2##5##(2008-7#1)(2011-2#1)
a patent foramen ovale##4##4##(2008-7#2)(2009-10#1)(2011-2#1)
a patent##8##2##(1997-8#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-10#1)(2011-2#2)
a paternal##2##2##(1996-12#1)(2010-8#1)
a path##2##2##(2008-3#1)(2008-6#1)
a pathogen is##3##3##(2008-10#2)(2011-2#1)
a pathogen of##3##3##(2008-10#3)
a pathogen##20##2##(2008-10#16)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
a pathogen's##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
a pathogenetic##2##2##(1991-3#1)(2010-11#1)
a pathogenic##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
a pathogenicity##2##2##(2008-10#2)
a pathologic##2##2##(1992-9#1)(2012-3#1)
a pathological##6##2##(1990-6#3)(2008-12#1)(2011-2#1)(2011-3#1)
a pathology##5##2##(1991-2#1)(1996-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
a pathophysiologic##2##2##(2008-10#1)(2008-3#1)
a pathway distinct from##2##4##(1993-8#1)(1994-11#1)
a pathway to##2##3##(2008-6#1)(2013-1#1)
a pathway##9##2##(1993-8#1)(1994-11#1)(1995-6#1)(1995-8#2)(2008-11#1)(2008-6#1)(2011-3#1)(2013-1#1)
a patient affected by##2##4##(1990-3#1)(1993-6#1)
a patient affected##3##3##(1990-3#1)(1993-6#2)
a patient classification system##3##4##(1994-3#2)(1995-2#1)
a patient diagnosed##2##3##(2008-12#1)(2011-2#1)
a patient from##2##3##(2010-8#1)(2013-1#1)
a patient in whom##2##4##(1993-2#1)(2008-7#1)
a patient is##3##3##(1992-9#1)(1996-9#1)(2012-2#1)
a patient lacking##2##3##(1993-6#1)(1995-6#1)
a patient of##2##3##(1990-12#1)(2013-1#1)
a patient on##2##3##(2008-5#1)(2010-5#1)
a patient presenting with##3##4##(2008-12#2)(2011-2#1)
a patient presenting##5##3##(2008-12#2)(2010-5#1)(2011-2#1)(2012-3#1)
a patient treated##3##3##(1991-11#1)(1996-3#1)(2008-10#1)
a patient who developed##6##4##(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
a patient who had##2##4##(1991-3#1)(2011-1#1)
a patient who presented with##2##5##(2010-8#1)(2011-2#1)
a patient who underwent##2##4##(2007-8#1)(2013-1#1)
a patient who##14##3##(1990-9#1)(1991-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
a patient with AIDS##4##4##(2008-10#1)(2008-11#3)
a patient with HIV##2##4##(1995-12#1)(2010-12#1)
a patient with a short##2##5##(1991-12#1)(2012-2#1)
a patient with a##17##4##(1991-12#1)(1994-12#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-3#1)(2012-2#1)(2012-3#4)
a patient with an##3##4##(2008-7#1)(2008-9#1)(2009-11#1)
a patient with chronic##5##4##(1991-11#1)(2008-12#2)(2011-2#1)(2013-1#1)
a patient with end-stage renal disease##2##6##(2008-1#2)
a patient with end-stage renal##3##5##(2008-1#2)(2013-1#1)
a patient with malignant##2##4##(2011-3#1)(2013-7#1)
a patient with##128##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#3)(2008-11#9)(2008-12#13)(2008-7#9)(2008-8#2)(2008-9#3)(2009-11#3)(2009-4#1)(2009-6#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#12)(2011-3#1)(2012-2#1)(2012-3#17)(2013-1#9)(2013-7#2)(2013-8#2)
a patient##202##2##(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#2)(1993-2#1)(1993-6#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#10)(2008-12#17)(2008-4#1)(2008-5#1)(2008-7#13)(2008-8#3)(2008-9#5)(2009-11#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#18)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#19)(2013-1#13)(2013-7#2)(2013-8#3)
a patient's clinical##2##3##(2009-5#1)(2012-3#1)
a patient's risk##2##3##(2008-10#1)(2012-3#1)
a patient's view of##2##4##(1991-1#1)(2008-8#1)
a patient's##26##2##(1991-1#2)(1991-12#2)(1991-2#2)(1993-12#3)(1994-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#2)(2012-3#3)(2013-1#1)
a patient-based##2##2##(1993-12#1)(2011-2#1)
a pattern of##5##3##(1995-6#1)(2008-10#1)(2008-9#1)(2010-6#1)(2013-1#1)
a pattern similar to##3##4##(1996-12#1)(2008-10#2)
a pattern that##2##3##(2008-1#1)(2008-10#1)
a pattern##16##2##(1992-3#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
a paucity of##7##3##(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a payment model##2##3##(1993-12#1)(1994-3#1)
a payment##3##2##(1993-12#1)(1993-3#1)(1994-3#1)
a peak at##2##3##(2008-10#2)
a peak in##3##3##(1996-12#1)(2007-11#1)(2008-11#1)
a peak##17##2##(1992-3#1)(1996-12#2)(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#4)(2012-12#1)(2013-8#1)
a peanut allergen##2##3##(2008-10#1)(2008-11#1)
a pedagogical##2##2##(2008-11#1)(2008-12#1)
a pediatric##8##2##(1991-11#1)(1992-2#1)(1993-2#1)(1995-11#1)(1995-12#1)(2010-11#1)(2011-2#2)
a pelvic##3##2##(1991-2#1)(2008-12#1)(2013-1#1)
a penetrating##2##2##(2010-12#1)(2013-1#1)
a penetration##2##2##(1996-1#1)(2008-10#1)
a pepper##3##2##(2008-10#3)
a peptide fragment##3##3##(1992-6#1)(1994-11#1)(1997-8#1)
a peptide inhibitor##2##3##(2008-11#1)(2009-6#1)
a peptide of##5##3##(1995-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
a peptide##24##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2012-2#1)
a per cell##2##3##(2008-4#1)(2008-7#1)
a per##7##2##(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)
a perceived##2##2##(1995-1#1)(2013-1#1)
a percentage of##12##3##(1996-2#1)(2008-10#3)(2008-11#4)(2010-8#2)(2011-7#1)(2013-1#1)
a perception##2##2##(1992-2#1)(2012-12#1)
a perchlorate##2##2##(2008-10#2)
a percutaneous technique##2##3##(2012-3#2)
a percutaneous##6##2##(2008-4#1)(2010-6#1)(2012-2#2)(2012-3#2)
a perennial canker##2##3##(2008-10#2)
a perennial##5##2##(2008-10#3)(2008-12#1)(2012-7#1)
a perfect match to the##2##5##(1996-6#1)(1996-8#1)
a perfect##6##2##(1996-6#1)(1996-8#1)(2007-11#1)(2008-3#2)(2008-7#1)
a perfectly##2##2##(2008-3#1)(2008-8#1)
a performance##4##2##(2008-10#2)(2010-12#1)(2013-1#1)
a perfusion bioreactor##2##3##(2008-11#2)
a perfusion cultivation of a recombinant##2##6##(2008-11#2)
a perfusion##8##2##(2008-10#2)(2008-11#6)
a period of 10##3##4##(1997-2#1)(2008-11#1)(2013-8#1)
a period of 14 days##2##5##(1990-9#1)(2008-10#1)
a period of 15 years##2##5##(1990-8#1)(1992-12#1)
a period of 2 years##2##5##(2008-10#1)(2008-7#1)
a period of 24 h##4##5##(1997-2#1)(2008-10#2)(2010-11#1)
a period of 3 months with good reproducibility##2##8##(2008-10#2)
a period of 3##3##4##(2008-10#3)
a period of 30##3##4##(1994-8#1)(1997-8#1)(2008-10#1)
a period of 4##3##4##(1991-3#1)(2008-10#2)
a period of 5 months##3##5##(1991-2#1)(2008-10#2)
a period of 5##5##4##(1991-2#1)(1997-2#1)(2008-10#2)(2008-7#1)
a period of 6 months##2##5##(2008-10#2)
a period of 6##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
a period of approximately 8 months##2##6##(1991-2#1)(2008-11#1)
a period of at least##2##5##(1990-12#2)
a period of five##2##4##(1995-1#1)(1997-5#1)
a period of four months##2##5##(1997-5#1)(2011-2#1)
a period of four##3##4##(1991-6#1)(1997-5#1)(2011-2#1)
a period of one month##3##5##(1993-6#1)(2008-10#2)
a period of one##4##4##(1993-6#1)(2008-10#2)(2008-3#1)
a period of six##2##4##(1990-12#1)(1991-2#1)
a period of time##6##4##(1990-8#1)(2008-11#5)
a period of two##4##4##(1991-12#1)(2008-10#1)(2008-8#1)(2009-11#1)
a period of##87##3##(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-1#1)(1995-5#1)(1996-6#1)(1997-2#3)(1997-5#2)(1997-8#3)(2008-10#27)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-11#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
a period##92##2##(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-1#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-2#3)(1997-5#2)(1997-8#3)(2008-10#27)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-8#1)
a periodic cycle##2##3##(2008-10#2)
a periodic##3##2##(2008-10#2)(2008-3#1)
a periodically##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
a peripheral##7##2##(1996-12#1)(2008-4#1)(2008-7#2)(2010-5#1)(2011-2#2)
a peristaltic pump##6##3##(2008-10#5)(2008-11#1)
a peristaltic##7##2##(2008-10#6)(2008-11#1)
a peritoneal##2##2##(1991-8#1)(2011-2#1)
a permanent chemical##4##3##(2008-10#4)
a permanent##20##2##(1992-5#1)(1994-3#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)
a permeable membrane##2##3##(2006-6#1)(2008-11#1)
a permis une##2##3##(2013-1#2)
a permis##3##2##(2013-1#3)
a permissive##3##2##(2008-7#1)(2008-9#1)(2012-12#1)
a peroxidase##2##2##(1994-5#1)(2008-10#1)
a persistent##16##2##(1990-11#1)(1991-12#1)(1991-6#1)(1996-12#1)(1996-3#1)(2008-10#7)(2008-12#1)(2010-4#1)(2010-7#1)(2013-1#1)
a persistently##2##2##(1997-8#1)(2011-1#1)
a person with##3##3##(2010-5#1)(2010-8#1)(2011-3#1)
a person##12##2##(1992-9#1)(1994-2#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)
a person's##4##2##(1991-6#1)(2010-5#1)(2011-2#1)(2013-8#1)
a personal computer##6##3##(1997-2#1)(2008-10#4)(2008-11#1)
a personal perspective##2##3##(2008-12#1)(2013-1#1)
a personal reflection on##2##4##(1996-12#1)(2008-11#1)
a personal##28##2##(1990-2#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-7#1)(2011-2#3)(2013-1#1)
a personalized##2##2##(2008-6#1)(2010-12#1)
a perspective of##3##3##(1994-3#1)(2010-5#1)(2010-7#1)
a perspective on##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
a perspective##8##2##(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)
a perturbation of##2##3##(1994-8#1)(2009-8#1)
a perturbation##3##2##(1994-8#1)(2008-3#1)(2009-8#1)
a pervasive##3##2##(1995-2#1)(2008-12#1)(2009-8#1)
a pesticide##2##2##(2008-10#2)
a petrous##2##2##(2010-3#2)
a pharmacodynamic##4##2##(2008-5#2)(2008-7#1)(2011-2#1)
a pharmacokinetic##4##2##(2008-10#1)(2010-11#1)(2013-1#1)(2013-8#1)
a pharmacological treatment##2##3##(2008-1#1)(2012-3#1)
a pharmacological##4##2##(1990-9#1)(2008-1#1)(2012-3#2)
a pharmacy##3##2##(1993-11#1)(1993-3#1)(2013-1#1)
a phase II##3##3##(1991-2#1)(1994-2#1)(1995-10#1)
a phase of##3##3##(2008-3#1)(2012-2#1)(2012-9#1)
a phase separation##2##3##(2008-10#2)
a phase##14##2##(1991-2#1)(1994-2#1)(1995-10#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#3)(2009-11#1)(2011-2#1)(2012-2#1)(2012-9#1)
a phase-only##3##2##(2008-3#3)
a phenolic##2##2##(2008-5#1)(2012-2#1)
a phenomenological##6##2##(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-9#1)
a phenomenon known as##2##4##(2008-10#1)(2011-2#1)
a phenomenon that##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
a phenomenon##15##2##(1994-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#2)(2013-7#1)
a phenotype that##2##3##(2007-12#1)(2012-3#1)
a phenotype##6##2##(1992-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-3#1)
a phenotypic assay##2##3##(2008-10#2)
a phenotypic##6##2##(2008-10#4)(2008-8#1)(2008-9#1)
a phenyl group##2##3##(2008-10#2)
a phenyl##4##2##(1996-5#1)(2008-10#3)
a phloem-limited##2##2##(2008-10#2)
a phosphate buffer at##2##4##(2008-10#2)
a phosphate buffer##7##3##(2008-10#7)
a phosphate##10##2##(1993-8#1)(2008-10#9)
a phospholipase##2##2##(1993-3#1)(1994-3#1)
a phospholipid##3##2##(1990-5#1)(1992-11#1)(2008-11#1)
a phosphor##3##2##(2008-10#2)(2008-4#1)
a photo-diode##5##2##(2008-10#5)
a photoacoustic##2##2##(2008-10#1)(2008-3#1)
a photochemical reaction##3##3##(2008-10#3)
a photodetector##2##2##(2008-10#1)(2008-3#1)
a photodiode array detector##5##4##(2008-10#5)
a photodiode array##6##3##(2008-10#6)
a photodiode##9##2##(2008-10#9)
a photographic##8##2##(2008-10#8)
a photometric##4##2##(2008-10#4)
a photomultiplier tube##2##3##(2008-10#1)(2008-7#1)
a photomultiplier##3##2##(2008-10#2)(2008-7#1)
a photon counting##2##3##(2008-10#1)(2013-1#1)
a photon##5##2##(2007-12#2)(2008-10#2)(2013-1#1)
a photon-counting##2##2##(2008-10#1)(2008-3#1)
a photonic##2##2##(2007-12#1)(2008-3#1)
a photorefractive GaP crystal##2##4##(2007-11#2)
a photorefractive##8##2##(2007-11#2)(2008-3#6)
a photosensitive##2##2##(2008-10#1)(2008-2#1)
a photosensitivity disorder##2##3##(2008-5#1)(2010-6#1)
a phylogenetic tree##7##3##(1991-5#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-10#1)
a phylogenetic##13##2##(1991-5#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#3)(2009-10#1)(2012-3#1)
a phylogenetically##2##2##(2008-10#2)
a phylogenomic##3##2##(2009-10#1)(2012-3#2)
a phylogeny##2##2##(2008-10#1)(2008-9#1)
a physical activity##2##3##(2008-11#1)(2012-12#1)
a physical examination##2##3##(1990-6#1)(2012-3#1)
a physical map of the##2##5##(2008-10#1)(2011-2#1)
a physical stimulus##2##3##(1996-12#1)(1997-2#1)
a physical therapy##2##3##(2008-12#2)
a physical##18##2##(1990-6#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2009-10#1)(2011-2#1)(2012-12#2)(2012-3#1)
a physician and##3##3##(1995-6#1)(2010-1#1)(2012-3#1)
a physician##18##2##(1990-6#1)(1991-1#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#2)(2012-3#1)(2013-1#1)
a physician's##3##2##(1990-11#1)(1994-1#1)(1997-2#1)
a physiologic role in##2##4##(1993-8#1)(1995-2#1)
a physiologic role##3##3##(1993-8#1)(1995-2#1)(2008-4#1)
a physiologic##5##2##(1993-8#1)(1994-11#1)(1995-2#1)(2008-4#1)(2011-2#1)
a physiological role for##2##4##(1993-8#1)(1994-11#1)
a physiological role in##3##4##(1994-8#1)(1997-4#1)(2009-8#1)
a physiological role##6##3##(1993-8#1)(1994-11#1)(1994-8#1)(1997-4#1)(2008-5#1)(2009-8#1)
a physiological##15##2##(1991-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
a physiotherapist##2##2##(2009-3#1)(2013-1#1)
a phytoalexin##2##2##(2008-10#2)
a phytoplasma##2##2##(2008-10#2)
a picrate##2##2##(2008-10#2)
a pictorial essay##2##3##(2012-2#2)
a pictorial review##5##3##(2011-2#1)(2012-2#4)
a pictorial##8##2##(2009-9#1)(2011-2#1)(2012-2#6)
a picture of##3##3##(1995-9#1)(2008-11#1)(2009-8#1)
a picture##4##2##(1995-9#1)(2008-11#1)(2009-8#1)(2012-3#1)
a piece of##8##3##(1993-6#1)(1997-3#3)(2008-11#1)(2012-2#1)(2013-1#2)
a piezoelectric crystal##2##3##(2008-10#2)
a piezoelectric quartz crystal is##2##5##(2008-10#2)
a piezoelectric quartz##3##3##(2008-10#3)
a piezoelectric transducer##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
a piezoelectric##15##2##(1990-8#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2009-5#2)
a pig##3##2##(1996-2#1)(2010-12#1)(2011-2#1)
a piloleiomyoma##2##2##(2010-6#2)
a pilot project that##2##4##(2008-11#1)(2010-11#1)
a pilot project##7##3##(1993-3#1)(1994-1#1)(2008-11#3)(2008-12#1)(2010-11#1)
a pilot study of relationships in a graduate population##2##9##(2013-1#2)
a pilot study of##6##4##(1990-6#1)(1993-3#1)(2008-11#1)(2010-9#1)(2013-1#2)
a pilot study to##2##4##(2008-12#1)(2009-12#1)
a pilot study##32##3##(1990-3#1)(1990-6#1)(1990-8#2)(1991-2#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-8#1)(2008-11#2)(2008-12#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#1)(2013-1#3)
a pilot##54##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#3)(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#6)(2008-12#7)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#1)(2011-3#1)(2011-9#1)(2013-1#3)
a pineal germinoma##2##3##(2008-7#2)
a pineal##3##2##(2008-7#3)
a pinhole##2##2##(2008-3#1)(2012-2#1)
a pink colored##2##3##(2008-10#2)
a pink##5##2##(2008-10#5)
a pioneer of##2##3##(2008-10#1)(2009-1#1)
a pioneer##4##2##(1991-5#1)(2008-10#1)(2008-9#1)(2009-1#1)
a pioneering effort by the Health Care Financing Administration (HCFA) to measure interstate border crossing for services used by##2##19##(1995-12#1)(1997-3#1)
a pitfall##2##2##(2009-6#1)(2011-2#1)
a pituitary##3##2##(1991-6#1)(1993-11#1)(1996-2#1)
a pivotal role in the##5##5##(1994-2#1)(1995-2#1)(1997-8#1)(2008-11#1)(2012-2#1)
a pivotal role in##16##4##(1994-12#1)(1994-2#1)(1995-2#1)(1997-7#1)(1997-8#2)(2008-11#2)(2008-6#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#2)
a pivotal role##21##3##(1992-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-7#1)(1997-8#2)(2008-11#2)(2008-6#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
a pivotal##24##2##(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-7#1)(1997-8#2)(2008-11#2)(2008-6#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#2)
a place for##4##3##(1995-1#1)(2008-11#2)(2008-9#1)
a place##7##2##(1993-12#1)(1993-3#1)(1995-1#1)(2008-11#2)(2008-9#2)
a placement##2##2##(2008-11#1)(2008-12#1)
a plain##2##2##(2008-10#2)
a plan for##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
a plan of##2##3##(1991-1#1)(2008-11#1)
a plan to##2##3##(1992-1#1)(2008-11#1)
a plan##12##2##(1991-1#2)(1991-3#1)(1992-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-7#1)(2011-2#1)
a planar##5##2##(1990-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
a plane wave##2##3##(2008-3#2)
a plane##9##2##(2008-2#2)(2008-3#5)(2008-6#1)(2009-11#1)
a plane-parallel medium##2##3##(2008-2#1)(2008-3#1)
a plane-parallel##3##2##(2008-2#1)(2008-3#2)
a planned##3##2##(1990-3#1)(2008-11#1)(2011-2#1)
a plant RNA##2##3##(2008-10#2)
a plant host##2##3##(2008-10#2)
a plant virus##2##3##(2008-10#2)
a plant##33##2##(1991-6#1)(1993-2#1)(1993-8#1)(1995-2#1)(2008-10#19)(2008-12#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#2)(2010-11#1)(2011-2#1)
a plant-pathogenic##2##2##(2008-10#2)
a plantation##2##2##(2008-10#2)
a planting##2##2##(2008-10#2)
a plasma membrane##4##3##(1990-5#2)(1995-2#1)(2009-7#1)
a plasma##9##2##(1990-5#2)(1991-9#1)(1995-2#1)(2008-11#1)(2009-10#1)(2009-7#1)(2012-2#2)
a plasmid encoding##3##3##(1991-3#1)(2010-11#1)(2010-6#1)
a plasmid vector##4##3##(1994-12#1)(2008-10#2)(2010-8#1)
a plasmid##15##2##(1990-8#1)(1991-3#1)(1993-12#1)(1994-12#1)(1995-2#2)(1997-6#1)(2008-10#3)(2008-11#2)(2010-11#1)(2010-6#1)(2010-8#1)
a plastic##6##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#2)
a plasticized poly(vinyl chloride) membrane##3##5##(2008-10#3)
a plasticized poly(vinyl chloride)##5##4##(2008-10#5)
a plasticized##10##2##(2008-10#10)
a plasticizer##3##2##(2008-10#3)
a plate with##2##3##(2007-12#1)(2008-3#1)
a plate##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
a plateau at##2##3##(2011-2#1)(2012-2#1)
a plateau##10##2##(1990-12#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
a platform for##11##3##(2008-1#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-2#1)
a platform##13##2##(2008-1#1)(2008-10#2)(2008-11#2)(2010-10#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-2#2)
a platinum electrode##6##3##(2008-10#6)
a platinum##14##2##(2008-10#14)
a plausible mechanism##2##3##(2008-10#1)(2008-3#1)
a plausible##10##2##(1990-8#1)(1992-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-6#1)(2012-2#1)(2013-1#1)
a plethora of##6##3##(2008-10#1)(2008-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2013-1#1)
a plug flow##2##3##(2008-7#2)
a plug of##2##3##(2008-10#1)(2013-1#1)
a plug##7##2##(2008-10#2)(2008-7#2)(2011-2#1)(2013-1#2)
a point in time##2##4##(2008-11#1)(2008-9#1)
a point in##3##3##(1997-6#1)(2008-11#1)(2008-9#1)
a point mutation in the##2##5##(1992-8#1)(2008-10#1)
a point mutation of the##2##5##(1994-12#1)(1995-8#1)
a point mutation##6##3##(1991-2#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-8#1)(2008-10#1)
a point##16##2##(1991-2#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-8#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-9#1)(2011-2#1)
a point-diffraction##2##2##(2008-3#2)
a points##2##2##(1991-6#1)(2011-2#1)
a polar##9##2##(1995-2#1)(2008-10#5)(2008-3#1)(2008-5#2)
a polarization##2##2##(2007-12#1)(2008-3#1)
a polarized laser beam##3##4##(2008-2#1)(2008-3#2)
a polarized##4##2##(1991-12#1)(2008-2#1)(2008-3#2)
a polarizing beam splitter##3##4##(2008-10#1)(2008-3#2)
a police##2##2##(1992-2#1)(2012-3#1)
a policy##8##2##(1990-2#1)(1993-3#2)(1996-2#1)(1996-3#2)(2008-1#1)(2010-4#1)
a political##3##2##(1994-2#1)(2008-1#1)(2008-11#1)
a poly(A) tail##3##3##(2008-10#3)
a polyacrylamide-coated tube at neutral pH##2##6##(2008-10#2)
a polyadenylation##2##2##(1991-9#1)(2010-4#1)
a polyamine##3##2##(1990-12#1)(1991-5#1)(2008-10#1)
a polyamine-deficient##2##2##(2009-6#2)
a polyaniline##2##2##(2008-10#2)
a polycarbonate##4##2##(2008-10#3)(2008-3#1)
a polyclonal antibody##2##3##(1993-12#1)(2008-10#1)
a polyclonal antiserum against##3##4##(1997-1#1)(2008-10#2)
a polyclonal antiserum##4##3##(1997-1#1)(2008-10#3)
a polyclonal##10##2##(1992-6#1)(1993-12#1)(1997-1#2)(2008-10#5)(2008-5#1)
a polyester##2##2##(2008-11#2)
a polyether type polyurethane foam##2##5##(2008-10#2)
a polyethylene##2##2##(2008-10#1)(2012-3#1)
a polygonal##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
a polyherbal formulation##2##3##(2013-1#2)
a polymer matrix and##2##4##(2008-10#1)(2008-7#1)
a polymer matrix##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
a polymer##13##2##(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2012-2#1)
a polymerase chain reaction##5##4##(1993-9#1)(1996-12#1)(2008-10#3)
a polymerase chain##10##3##(1993-9#1)(1996-12#1)(2008-10#6)(2011-2#1)(2012-2#1)
a polymerase##12##2##(1990-5#1)(1993-9#1)(1996-12#1)(2008-10#7)(2011-2#1)(2012-2#1)
a polymeric##10##2##(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)
a polymorphism for##2##3##(2008-12#1)(2008-9#1)
a polymorphism##5##2##(2008-12#3)(2008-9#1)(2012-12#1)
a polypeptide of approximately##3##4##(1996-2#1)(1997-7#1)(2008-10#1)
a polypeptide of##10##3##(1990-11#1)(1990-5#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-8#1)
a polypeptide with##2##3##(1995-9#1)(2008-10#1)
a polypeptide##21##2##(1990-11#1)(1990-5#1)(1995-2#3)(1995-6#2)(1995-9#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-8#5)(2010-7#1)
a polyphasic approach##2##3##(2008-10#1)(2010-3#1)
a polyphenolic##2##2##(2008-11#1)(2011-2#1)
a polypoid##2##2##(2008-11#1)(2010-2#1)
a polypropylene vessel##2##3##(2008-10#2)
a polypropylene##3##2##(2008-10#2)(2008-12#1)
a polyprotein##2##2##(2008-8#2)
a polypyrrole (PPy)##2##3##(2008-10#2)
a polypyrrole##5##2##(2008-10#5)
a polystyrene matrix##2##3##(1996-12#1)(2008-11#1)
a polystyrene##3##2##(1996-12#1)(2008-11#2)
a polystyrene-based##2##2##(2008-11#2)
a polystyrene-divinylbenzene##2##2##(1997-2#1)(2008-10#1)
a polyurethane foam##3##3##(2008-10#2)(2008-11#1)
a polyurethane##6##2##(2008-10#4)(2008-11#1)(2009-7#1)
a polyvinyl alcohol##3##3##(2008-10#2)(2008-2#1)
a polyvinyl##5##2##(2008-10#3)(2008-2#1)(2013-1#1)
a pool of##8##3##(1993-2#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)
a poor compliance##2##3##(1993-11#2)
a poor prognosis##15##3##(1990-8#1)(1991-6#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
a poor response##3##3##(2008-10#2)(2010-6#1)
a poor substrate for##3##4##(1991-5#1)(1994-11#1)(1997-3#1)
a poor##36##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-11#4)(1994-11#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a poorly differentiated##2##3##(1990-2#1)(1990-3#1)
a poorly understood##2##3##(2008-12#1)(2012-3#1)
a poorly##6##2##(1990-2#1)(1990-3#1)(1995-6#1)(2008-12#1)(2012-3#1)(2013-1#1)
a popular##11##2##(1994-3#1)(1996-3#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2009-4#1)
a population from##2##3##(2008-10#2)
a population genetic##2##3##(2008-10#1)(2008-12#1)
a population in the##2##4##(2008-8#1)(2012-3#1)
a population in##3##3##(2008-8#2)(2012-3#1)
a population of 1##2##4##(1997-3#1)(1997-6#1)
a population of cells##2##4##(2008-9#1)(2010-10#1)
a population of plants##2##4##(2008-10#2)
a population of##41##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-8#1)(2008-9#3)(2010-10#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
a population sample##3##3##(1992-2#1)(2008-12#2)
a population that##2##3##(1996-2#1)(2008-8#1)
a population##91##2##(1990-12#1)(1990-3#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#3)(2008-7#1)(2008-8#11)(2008-9#6)(2009-3#1)(2010-10#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-3#4)(2013-1#1)(2013-8#4)
a population's##2##2##(1997-7#1)(2008-8#1)
a population-based sample of##3##4##(2008-7#2)(2012-2#1)
a population-based study##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
a population-based##13##2##(1991-6#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-7#3)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
a porcine##3##2##(1991-6#1)(2008-11#1)(2009-7#1)
a pore##5##2##(1994-5#1)(2008-10#3)(2008-11#1)
a porous##13##2##(2008-1#1)(2008-10#7)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#1)(2012-4#1)
a port city##2##3##(1997-6#2)
a port##5##2##(1997-1#1)(1997-6#2)(2007-11#1)(2008-10#1)
a portable forceplate##2##3##(2009-1#2)
a portable##13##2##(1996-2#1)(1997-4#1)(2008-10#8)(2009-1#2)(2009-10#1)
a portion of the##15##4##(1991-3#1)(1992-3#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-8#1)
a portion of##19##3##(1991-3#1)(1992-3#2)(1993-9#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-7#2)(2008-8#1)
a portion##21##2##(1991-3#1)(1992-3#2)(1993-9#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-7#2)(2008-8#1)(2010-5#1)
a position equivalent to##2##4##(1990-5#1)(2008-5#1)
a position in##2##3##(2008-10#1)(2008-8#1)
a position sensitive detector (PSD)##2##5##(2008-10#2)
a position##16##2##(1990-5#1)(1993-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
a positional##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
a positive allosteric##2##3##(1995-11#2)
a positive and##3##3##(1992-3#1)(1994-5#1)(2008-11#1)
a positive association between##4##4##(1990-8#1)(1993-12#1)(2010-6#1)(2013-1#1)
a positive correlation between the##3##5##(2008-10#1)(2011-1#1)(2011-2#1)
a positive correlation of##2##4##(1995-9#1)(2008-10#1)
a positive correlation with the##2##5##(1991-11#1)(2008-12#1)
a positive correlation with##3##4##(1991-11#1)(2008-12#1)(2013-1#1)
a positive correlation##9##3##(1991-11#1)(1995-9#1)(2008-10#2)(2008-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
a positive discography##4##3##(2012-12#4)
a positive effect on the##2##5##(2008-12#1)(2013-1#1)
a positive effect on##8##4##(1990-9#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
a positive effect##10##3##(1990-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
a positive electric##2##3##(1997-6#1)(2008-5#1)
a positive emotional##3##3##(2008-5#1)(2010-10#2)
a positive family history##2##4##(1997-6#1)(2011-2#1)
a positive impact on the##4##5##(1995-5#1)(2008-11#1)(2008-12#1)(2013-8#1)
a positive impact on##5##4##(1995-5#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
a positive influence on the##2##5##(2008-7#1)(2013-8#1)
a positive influence on##3##4##(2008-11#1)(2008-7#1)(2013-8#1)
a positive influence##4##3##(2008-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
a positive response in##2##4##(2008-10#2)
a positive role in##2##4##(1993-6#1)(2011-2#1)
a positive role##3##3##(1993-6#1)(1995-2#1)(2011-2#1)
a positive##120##2##(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#2)(1997-2#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#7)(2008-12#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#11)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
a positively charged##4##3##(1990-5#1)(2008-11#3)
a positively##5##2##(1990-5#1)(2008-11#4)
a possibility of##4##3##(1995-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
a possibility to##2##3##(2008-10#1)(2011-2#1)
a possibility##12##2##(1995-12#1)(1997-3#1)(2008-10#3)(2008-11#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
a possible &quot##2##3##(1994-11#1)(2009-3#1)
a possible approach##2##3##(2008-10#1)(2011-2#1)
a possible association of##2##4##(1997-3#1)(2011-2#1)
a possible association##3##3##(1997-3#1)(2011-2#1)(2013-1#1)
a possible candidate##2##3##(1996-12#1)(2008-11#1)
a possible cause##7##3##(1992-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
a possible explanation for the##3##5##(1992-3#1)(1997-1#1)(2008-10#1)
a possible explanation##4##3##(1992-3#1)(1993-1#1)(1997-1#1)(2008-10#1)
a possible involvement of##5##4##(1996-12#1)(1997-2#2)(2008-10#1)(2008-11#1)
a possible means of##2##4##(2008-10#1)(2013-1#1)
a possible means##3##3##(2008-10#2)(2013-1#1)
a possible mechanism for the##2##5##(2008-10#1)(2010-6#1)
a possible mechanism for##3##4##(2008-10#1)(2010-6#1)(2011-2#1)
a possible mechanism of##2##4##(1993-6#1)(2008-10#1)
a possible mechanism##8##3##(1993-6#2)(2008-10#3)(2008-3#1)(2010-6#1)(2011-2#1)
a possible member of the##2##5##(2008-10#1)(2009-9#1)
a possible model##2##3##(2009-10#1)(2012-2#1)
a possible new##2##3##(2008-10#1)(2008-11#1)
a possible role for this##2##5##(1991-1#1)(1994-8#1)
a possible role for##6##4##(1991-1#1)(1993-12#1)(1994-8#1)(2008-10#2)(2011-2#1)
a possible role in the##2##5##(1996-3#1)(2008-7#1)
a possible role in##3##4##(1993-12#1)(1996-3#1)(2008-7#1)
a possible role of##2##4##(1992-6#1)(1993-6#1)
a possible role##11##3##(1991-1#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-8#1)(1996-3#1)(2008-10#2)(2008-7#1)(2011-2#1)
a possible##122##2##(1990-11#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-8#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#2)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#1)(2011-2#11)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#1)
a post##2##2##(2008-10#1)(2012-3#1)
a post-acute##2##2##(1995-3#1)(2008-10#1)
a post-hoc##2##2##(2012-2#1)(2012-3#1)
a post-registration##2##2##(2008-11#2)
a post-transcriptional##4##2##(1992-1#2)(2008-10#1)(2010-11#1)
a postal##2##2##(1997-8#1)(2011-1#1)
a posterior urethral valve##2##4##(2011-2#2)
a posterior##13##2##(1991-6#1)(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#3)(2011-2#2)(2012-12#3)(2012-3#1)
a postharvest##4##2##(2008-10#4)
a postinfection##2##2##(2008-10#2)
a postnatal##2##2##(2009-3#1)(2012-12#1)
a postoperative hemorrhage##3##3##(1991-8#1)(2013-1#2)
a postoperative##4##2##(1991-8#1)(2012-2#1)(2013-1#2)
a postpartum checkup##3##3##(2013-1#3)
a postpartum##4##2##(1996-8#1)(2013-1#3)
a postsynaptic##2##2##(1996-12#1)(2009-9#1)
a posttranslational##2##2##(1993-12#1)(2010-4#1)
a potassium##4##2##(1992-3#1)(2008-10#2)(2011-2#1)
a potato##4##2##(2008-10#2)(2008-12#1)(2009-6#1)
a potent and selective##3##4##(1990-8#1)(1992-8#1)(1994-2#1)
a potent and##5##3##(1990-8#1)(1992-8#1)(1994-11#1)(1994-2#1)(1996-2#1)
a potent angiogenic factor##2##4##(1994-11#1)(1994-12#1)
a potent inducer of##6##4##(1990-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(2008-11#1)(2011-2#1)
a potent inhibitor of protein kinase##2##6##(1996-12#2)
a potent inhibitor of protein##3##5##(1994-11#1)(1996-12#2)
a potent inhibitor of##14##4##(1990-5#1)(1992-12#1)(1993-8#1)(1994-11#3)(1995-2#1)(1996-12#2)(1997-1#1)(1997-4#2)(2008-11#1)(2011-2#1)
a potent stimulator of##2##4##(1995-12#1)(2008-6#1)
a potent##79##2##(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-8#4)(1994-11#6)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
a potential alternative##3##3##(1996-1#1)(2008-10#2)
a potential application of##2##4##(2008-10#2)
a potential application##3##3##(2008-10#3)
a potential for##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
a potential inoculum source for##2##5##(2008-10#2)
a potential mechanism##4##3##(1990-8#1)(2008-10#2)(2012-2#1)
a potential method##2##3##(2008-10#2)
a potential new##2##3##(2008-11#1)(2011-2#1)
a potential of##9##3##(2008-10#8)(2012-2#1)
a potential protective##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2009-11#1)
a potential role for##6##4##(1992-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2013-1#1)
a potential role in##3##4##(1995-12#1)(2009-6#1)(2011-2#1)
a potential role##11##3##(1992-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2009-6#2)(2011-2#1)(2013-1#2)
a potential solution##2##3##(1992-12#1)(2008-8#1)
a potential source for##2##4##(2011-2#1)(2012-2#1)
a potential source of error##2##5##(2008-10#2)
a potential source of##4##4##(2008-10#4)
a potential source##6##3##(2008-10#4)(2011-2#1)(2012-2#1)
a potential target for##5##4##(1995-9#1)(2008-10#1)(2011-2#1)(2012-2#2)
a potential target##6##3##(1995-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#2)
a potential therapeutic##5##3##(2011-2#2)(2012-2#2)(2013-7#1)
a potential threat##2##3##(2008-10#1)(2011-2#1)
a potential to##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
a potential tool for##4##4##(2008-10#4)
a potential##166##2##(1990-12#1)(1990-8#1)(1991-7#1)(1992-12#1)(1992-3#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-6#2)(1997-8#1)(2008-1#2)(2008-10#54)(2008-11#9)(2008-12#1)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#3)(2009-7#2)(2010-12#1)(2010-4#1)(2011-2#12)(2012-12#1)(2012-2#12)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
a potentially fatal##3##3##(2009-11#1)(2011-2#1)(2012-3#1)
a potentially important##2##3##(1995-2#1)(2008-11#1)
a potentially increased##2##3##(1996-6#1)(2013-1#1)
a potentially serious##3##3##(2010-1#1)(2010-8#1)(2011-2#1)
a potentially useful##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
a potentially##29##2##(1993-2#1)(1995-2#1)(1996-1#1)(1996-6#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
a potentiation of##2##3##(1993-6#1)(2008-10#1)
a potentiometric method##2##3##(2008-10#2)
a potentiometric sensor##8##3##(2008-10#8)
a potentiometric##23##2##(2008-10#23)
a potentized homeopathic drug##2##4##(2008-10#2)
a potyvirus##3##2##(2008-10#2)(2008-9#1)
a powder##2##2##(2008-5#1)(2012-2#1)
a powdery mildew resistance gene in##2##6##(2008-10#2)
a power function##3##3##(1995-8#1)(2008-6#1)(2008-7#1)
a power of##4##3##(1991-3#1)(2008-10#2)(2008-8#1)
a power##15##2##(1991-3#1)(1992-9#1)(1995-8#1)(2007-12#2)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-8#1)(2013-1#1)
a power-law relationship##2##3##(2008-10#1)(2008-5#1)
a power-law##3##2##(2008-10#2)(2008-5#1)
a powerful alternative for##2##4##(2008-10#1)(2008-3#1)
a powerful analytical tool for##2##5##(2008-10#1)(2008-7#1)
a powerful analytical tool##4##4##(2008-10#3)(2008-7#1)
a powerful and##3##3##(2008-11#1)(2008-4#1)(2010-12#1)
a powerful method for##2##4##(1993-8#1)(1995-2#1)
a powerful new##2##3##(2008-10#2)
a powerful tool for the##6##5##(2008-10#4)(2008-4#1)(2008-8#1)
a powerful tool for##19##4##(1997-3#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#2)(2008-8#2)(2009-12#1)
a powerful tool in##5##4##(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2013-8#1)
a powerful tool to investigate##2##5##(2008-7#1)(2012-3#1)
a powerful tool to##4##4##(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
a powerful tool##30##3##(1993-2#1)(1997-3#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
a powerful##74##2##(1991-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-2#2)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#16)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
a practical and##4##3##(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)
a practical approach for##2##4##(1990-5#1)(2012-2#1)
a practical approach to##2##4##(2008-5#1)(2010-12#1)
a practical approach##4##3##(1990-5#1)(2008-5#1)(2010-12#1)(2012-2#1)
a practical review##2##3##(2008-10#1)(2008-12#1)
a practical way##2##3##(2012-3#1)(2013-1#1)
a practical##44##2##(1990-5#1)(1991-2#1)(1993-3#1)(1994-2#1)(1997-2#2)(2008-10#4)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-3#1)(2009-7#1)(2010-12#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#2)
a practice placement##2##3##(2008-11#2)
a practice##8##2##(1991-3#1)(2008-11#5)(2008-9#2)
a practitioner##4##2##(1997-4#2)(2008-11#2)
a practitioner's##4##2##(1990-9#1)(1991-1#1)(1996-3#1)(2008-11#1)
a pragmatic##4##2##(2008-11#1)(2010-1#1)(2011-2#1)(2012-3#1)
a pre- and##2##3##(1994-1#1)(2008-12#1)
a pre-concentration factor##2##3##(2008-10#2)
a pre-concentration##4##2##(2008-10#4)
a pre-determined##2##2##(1995-6#1)(1995-9#1)
a pre-existing##4##2##(1997-8#1)(2008-7#1)(2010-12#1)(2013-8#1)
a pre-registration##4##2##(2008-11#4)
a pre-treatment##2##2##(1992-9#1)(2008-10#1)
a preadapted##2##2##(2008-11#2)
a precipitate of##2##3##(2008-10#2)
a precipitate##6##2##(2008-10#5)(2008-2#1)
a precipitation##2##2##(2008-10#2)
a precipitation/dissolution##3##2##(2008-10#3)
a precise diagnosis##2##3##(1992-5#1)(2012-3#1)
a precise##10##2##(1992-5#1)(1997-2#1)(1997-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-3#1)(2012-3#1)
a precisely##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
a precision of 1##5##4##(2008-10#5)
a precision of 2##3##4##(2008-10#3)
a precision of##13##3##(2008-10#11)(2008-3#2)
a precision##30##2##(2008-10#25)(2008-3#5)
a preclinical##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
a preconcentration column##3##3##(2008-10#3)
a preconcentration factor of##3##4##(2008-10#3)
a preconcentration factor##4##3##(2008-10#4)
a preconcentration step##5##3##(2008-10#5)
a preconcentration time of 3min##2##5##(2008-10#2)
a preconcentration time of 90s##3##5##(2008-10#3)
a preconcentration time of##13##4##(2008-10#13)
a preconcentration##27##2##(2008-10#27)
a precursor for##2##3##(1993-12#1)(1997-2#1)
a precursor of##5##3##(1993-2#1)(1994-5#1)(1997-2#1)(2008-11#1)(2011-2#1)
a precursor to the##2##4##(1992-6#1)(2009-8#1)
a precursor##12##2##(1990-8#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-5#1)(1997-2#2)(2008-11#1)(2008-6#1)(2009-8#1)(2011-2#1)
a predator##7##2##(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#1)(2012-3#1)
a predefined##3##2##(1993-1#1)(2008-10#1)(2012-12#1)
a predetermined##3##2##(1993-12#1)(1996-3#1)(2008-3#1)
a predictable##4##2##(1993-3#1)(1995-3#1)(1997-1#1)(2011-7#1)
a predicted molecular##2##3##(2008-10#2)
a predicted##8##2##(1990-12#1)(1991-9#1)(1992-8#1)(1994-6#1)(1997-7#1)(2008-10#2)(2011-2#1)
a prediction of##2##3##(1992-3#1)(1993-2#1)
a prediction##4##2##(1992-3#1)(1993-2#1)(2008-10#2)
a predictive marker for##2##4##(2010-12#2)
a predictive model##5##3##(2008-11#1)(2008-5#1)(2009-3#1)(2010-7#1)(2010-8#1)
a predictive##16##2##(1993-2#1)(1993-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-7#2)(2010-8#1)(2013-8#1)
a predictor for##3##3##(2010-10#1)(2013-1#2)
a predictor of the##2##4##(2008-10#1)(2012-3#1)
a predictor of##12##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
a predictor##15##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
a predisposition to##2##3##(2010-12#1)(2011-2#1)
a predominance of##3##3##(1993-1#1)(2007-8#1)(2013-8#1)
a predominant##10##2##(1993-3#1)(1993-8#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)
a predominantly##5##2##(1990-9#1)(1992-9#1)(2008-5#1)(2008-8#1)(2011-2#1)
a preferable##2##2##(1994-12#1)(2008-11#1)
a preference for##4##3##(1995-6#1)(2008-11#3)
a preferential##2##2##(2008-10#1)(2013-1#1)
a preferred##3##2##(1997-2#1)(1997-3#1)(2008-3#1)
a pregnancy##6##2##(1995-8#1)(1996-8#1)(2009-3#1)(2012-3#1)(2013-1#2)
a pregnant woman##4##3##(1990-6#1)(1991-9#1)(1997-7#1)(2008-7#1)
a pregnant##9##2##(1990-6#1)(1991-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#2)(2009-6#1)(2013-1#1)
a preliminary evaluation##3##3##(1993-1#1)(2008-10#1)(2008-12#1)
a preliminary investigation##3##3##(1990-6#1)(2008-10#1)(2010-3#1)
a preliminary report##2##3##(1994-3#1)(2008-10#1)
a preliminary study##9##3##(2008-10#2)(2008-11#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
a preliminary##36##2##(1990-6#1)(1991-12#1)(1992-2#1)(1993-1#1)(1994-3#1)(1995-11#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
a premature infant##2##3##(2007-12#1)(2011-2#1)
a premature##4##2##(1991-1#1)(2007-12#1)(2011-2#2)
a premise##2##2##(1992-3#1)(1996-9#1)
a prenatal##2##2##(1991-12#1)(2008-11#1)
a preoperative diagnosis of##2##4##(1991-3#1)(2008-7#1)
a preoperative diagnosis##3##3##(1991-3#1)(2008-7#2)
a preoperative##9##2##(1990-11#1)(1990-9#1)(1991-3#1)(1993-1#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-3#1)
a preparation that##2##3##(2009-9#2)
a preparation##5##2##(1992-6#1)(2008-10#1)(2008-7#1)(2009-9#2)
a preplated##2##2##(2008-10#2)
a preprocessing##3##2##(2008-10#2)(2008-6#1)
a prerequisite for##13##3##(1990-2#1)(1991-11#1)(1991-8#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-2#1)
a prerequisite to##3##3##(1990-5#1)(1995-6#1)(2008-11#1)
a prerequisite##16##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-8#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-2#1)
a prescription drug##2##3##(2013-8#2)
a prescription for##2##3##(1991-3#1)(2009-6#1)
a prescription##8##2##(1991-3#1)(1993-1#1)(1994-6#1)(1995-1#1)(2008-11#1)(2009-6#1)(2013-8#2)
a presentation of##3##3##(1996-3#1)(2008-10#1)(2011-2#1)
a presentation##6##2##(1995-12#1)(1996-3#1)(2008-10#2)(2011-2#1)(2013-8#1)
a preservative##4##2##(2008-5#3)(2011-2#1)
a preset##2##2##(2008-10#2)
a prespecified##2##2##(1995-5#1)(2008-7#1)
a pressing need##2##3##(1995-1#1)(2008-12#1)
a pressing##3##2##(1995-1#1)(2008-11#1)(2008-12#1)
a pressure of##2##3##(2008-10#2)
a pressure##5##2##(2008-10#3)(2008-8#1)(2009-10#1)
a pressurized##2##2##(2008-10#2)
a presumptive##3##2##(1993-8#1)(2008-10#1)(2008-7#1)
a presynaptic##3##2##(1990-12#1)(1995-6#1)(1997-2#1)
a pretreatment##3##2##(2008-10#3)
a prevalence of##6##3##(1990-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)
a prevalence rate of##2##4##(2008-1#1)(2013-8#1)
a prevalence##8##2##(1990-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
a prevalent##4##2##(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
a prevention program for##2##4##(1995-3#1)(2008-12#1)
a prevention program##3##3##(1990-3#1)(1995-3#1)(2008-12#1)
a prevention##7##2##(1990-3#1)(1991-6#2)(1995-3#1)(2008-11#1)(2008-12#1)(2008-7#1)
a preventive effect on the##2##5##(2008-10#1)(2008-11#1)
a preventive effect on##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
a preventive##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2009-8#1)
a previous manuscript##2##3##(2008-10#1)(2008-5#1)
a previous paper##4##3##(2008-10#3)(2008-2#1)
a previous report##2##3##(1990-4#1)(1990-5#1)
a previous study of##2##4##(2008-10#2)
a previous study##14##3##(1991-2#1)(1994-8#1)(1995-12#1)(1997-2#1)(2008-10#6)(2008-9#1)(2011-2#2)(2013-1#1)
a previous work##3##3##(2009-6#1)(2010-10#1)(2010-4#1)
a previous##62##2##(1990-4#1)(1990-5#1)(1991-2#2)(1994-8#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#4)(2009-6#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
a previously described##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
a previously healthy##3##3##(2009-8#3)
a previously published##5##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)
a previously reported##9##3##(1994-11#1)(2008-10#5)(2008-3#1)(2012-2#1)(2012-3#1)
a previously undescribed##3##3##(2008-10#2)(2012-3#1)
a previously unknown##4##3##(1995-2#1)(2008-10#1)(2012-12#1)(2012-3#1)
a previously unrecognized##4##3##(1995-2#1)(2008-10#3)
a previously unsuspected##2##3##(1994-3#1)(2012-3#1)
a previously##56##2##(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-3#2)(1995-2#2)(1997-3#1)(1997-7#1)(2008-10#21)(2008-11#2)(2008-3#2)(2008-5#2)(2008-9#1)(2009-8#3)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#6)
a prey##2##2##(2008-9#1)(2010-8#1)
a primary care clinic##2##4##(1993-12#1)(1996-3#1)
a primary care setting##2##4##(2008-4#1)(2010-2#1)
a primary care##9##3##(1993-12#1)(1994-6#1)(1996-11#1)(1996-3#1)(1997-5#2)(2008-11#1)(2008-4#1)(2010-2#1)
a primary defense barrier##2##4##(1997-2#2)
a primary diagnostic##2##3##(1990-6#1)(2008-2#1)
a primary factor##2##3##(2008-10#2)
a primary role in##2##4##(2008-10#1)(2009-3#1)
a primary source of##3##4##(1995-1#1)(2008-10#2)
a primary##77##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
a primer for##2##3##(2008-11#1)(2010-1#1)
a primer on the schemes and the tools to fight health care fraud##2##13##(1993-12#2)
a primer on the##3##4##(1993-12#2)(2013-1#1)
a primer pair##3##3##(2008-10#3)
a primer##10##2##(1993-12#3)(1993-3#1)(2008-10#3)(2008-11#1)(2010-1#1)(2013-1#1)
a principal component analysis (PCA)##2##5##(2008-10#2)
a principal component analysis##5##4##(2008-10#3)(2010-8#1)(2013-8#1)
a principal component of##2##4##(1995-2#1)(1995-6#1)
a principal component##8##3##(1995-2#1)(1995-6#1)(2008-10#4)(2010-8#1)(2013-8#1)
a principal##14##2##(1992-12#1)(1994-1#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
a prior low dose##2##4##(2008-7#2)
a prior##16##2##(1997-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-5#2)(2010-6#2)(2012-3#1)
a priori information##2##3##(2008-3#2)
a priori knowledge##2##3##(2008-3#2)
a priori##21##2##(1997-6#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
a priority in##4##3##(1993-11#1)(1996-12#1)(2008-11#1)(2008-9#1)
a priority##12##2##(1993-11#1)(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-10#1)(2013-1#4)
a prison practice##2##3##(1992-2#2)
a private laboratory##3##3##(1994-12#1)(1997-4#2)
a private##11##2##(1991-2#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-4#2)(1997-5#1)(2010-5#1)
a pro-apoptotic##2##2##(2010-3#1)(2013-1#1)
a proactive##2##2##(1991-12#1)(2008-10#1)
a probabilistic framework##2##3##(2009-12#1)(2009-7#1)
a probabilistic##3##2##(2008-7#1)(2009-12#1)(2009-7#1)
a probability distribution##2##3##(2008-10#2)
a probability sample of##2##4##(2008-12#1)(2011-2#1)
a probability##7##2##(2008-10#3)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
a probable##4##2##(2008-10#1)(2008-7#1)(2009-11#1)(2013-1#1)
a probe containing##2##3##(1991-2#1)(2008-10#1)
a probe for the##2##4##(1990-8#1)(1995-11#1)
a probe for##4##3##(1990-8#1)(1995-11#1)(1997-3#1)(2008-10#1)
a probe##36##2##(1990-8#1)(1991-2#1)(1991-6#2)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-6#3)(1997-1#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-8#5)(2013-1#1)
a probit model##2##3##(2008-10#1)(2011-2#1)
a problem and##2##3##(1994-12#1)(1995-9#1)
a problem for##4##3##(1991-2#1)(2008-10#2)(2011-2#1)
a problem in the##3##4##(1997-1#1)(2008-11#1)(2013-8#1)
a problem in##5##3##(1997-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-8#1)
a problem of##7##3##(1995-11#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)
a problem that##2##3##(2008-11#1)(2009-5#1)
a problem with##4##3##(1995-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
a problem##37##2##(1991-2#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-9#1)(1996-5#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
a problem-based learning##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
a procedure for the##4##4##(2008-10#2)(2008-3#1)(2010-6#1)
a procedure for##15##3##(1992-8#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-6#1)(2013-1#1)
a procedure in which##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
a procedure is##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
a procedure similar to##2##4##(2008-10#1)(2008-5#1)
a procedure that##4##3##(2008-10#3)(2011-2#1)
a procedure to measure##2##4##(2008-10#1)(2012-2#1)
a procedure to##4##3##(2008-10#3)(2012-2#1)
a procedure##38##2##(1992-8#1)(1996-3#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
a process called##2##3##(2008-7#1)(2013-8#1)
a process development##2##3##(2008-11#2)
a process for##3##3##(1993-1#1)(1994-1#1)(2008-11#1)
a process known as##2##4##(2012-2#1)(2012-3#1)
a process of##8##3##(1995-8#1)(2008-11#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
a process that eliminates##2##4##(2008-10#1)(2008-12#1)
a process that involves##2##4##(2008-10#1)(2011-2#1)
a process that was##2##4##(2008-10#1)(2009-3#1)
a process that##9##3##(1994-2#1)(2008-10#4)(2008-12#1)(2009-3#1)(2011-2#2)
a process to##3##3##(1992-12#1)(2008-3#1)(2011-2#1)
a process which##2##3##(2008-5#1)(2011-2#1)
a process##50##2##(1992-12#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
a processing##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
a product may##2##3##(2008-5#2)
a product of the##4##4##(1990-2#1)(1995-2#1)(1995-6#1)(2009-10#1)
a product of##12##3##(1990-11#1)(1990-2#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-10#1)
a product##28##2##(1990-11#1)(1990-2#1)(1991-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#9)(2008-12#1)(2008-5#8)(2008-7#1)(2008-9#1)(2009-10#1)
a product's##2##2##(2012-2#1)(2013-1#1)
a production process##2##3##(2008-11#1)(2012-2#1)
a production##7##2##(2008-11#6)(2012-2#1)
a productive way to##2##4##(1992-12#1)(1993-2#1)
a productive##4##2##(1992-12#1)(1993-2#1)(1995-3#1)(2013-1#1)
a productivity##4##2##(2008-11#1)(2008-8#1)(2008-9#2)
a profession##4##2##(2008-12#2)(2008-5#1)(2012-2#1)
a professional and human service##2##5##(2011-2#2)
a professional and##3##3##(1994-1#1)(2011-2#2)
a professional##12##2##(1991-6#1)(1992-3#1)(1994-1#2)(1996-12#1)(1997-1#1)(2008-11#1)(2008-12#2)(2011-2#2)(2012-2#1)
a proficient mentor##2##3##(2008-7#2)
a profile of##7##3##(1991-12#1)(1991-2#1)(1992-3#1)(1995-2#2)(1997-3#1)(2013-1#1)
a profile##8##2##(1991-12#1)(1991-2#1)(1992-3#1)(1995-2#2)(1997-3#1)(2009-10#1)(2013-1#1)
a profound effect on the##2##5##(2008-10#1)(2010-6#1)
a profound effect on##3##4##(2008-10#1)(2010-4#1)(2010-6#1)
a profound influence on##3##4##(2008-11#2)(2010-7#1)
a profound##10##2##(2008-10#1)(2008-11#2)(2008-7#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2013-7#1)
a progeny##3##2##(2008-10#3)
a prognosis of##2##3##(1996-6#1)(2008-10#1)
a prognostic indicator##3##3##(1993-11#1)(1994-12#1)(2008-7#1)
a prognostic##7##2##(1993-11#1)(1994-12#1)(1995-9#2)(2007-8#1)(2008-7#1)(2011-2#1)
a program based##2##3##(2008-10#1)(2013-8#1)
a program for##5##3##(1995-3#1)(2008-10#1)(2008-12#2)(2008-4#1)
a program of preventive##3##4##(1993-11#1)(1993-2#1)(1993-3#1)
a program of research##2##4##(2008-11#1)(2012-3#1)
a program of##11##3##(1991-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-2#1)(1996-6#1)(2008-11#1)(2012-3#1)
a program that##3##3##(2008-4#1)(2008-7#1)(2012-3#1)
a program to##2##3##(1997-1#1)(2012-12#1)
a program written in##2##4##(2008-10#2)
a program written##3##3##(2008-10#3)
a program##34##2##(1991-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-4#2)(2008-7#2)(2012-12#2)(2012-3#2)(2013-8#1)
a programme##3##2##(1993-6#1)(2008-10#1)(2010-10#1)
a programmed##4##2##(2008-10#4)
a progression##2##2##(1991-12#1)(2008-5#1)
a progressive decline##2##3##(2013-1#1)(2013-7#1)
a progressive decrease##2##3##(1991-2#1)(1995-8#1)
a progressive increase in the##3##5##(1995-2#1)(2008-11#1)(2010-10#1)
a progressive increase in##4##4##(1995-2#1)(2008-11#1)(2010-10#1)(2011-1#1)
a progressive increase##5##3##(1995-2#1)(2008-11#1)(2009-10#1)(2010-10#1)(2011-1#1)
a progressive neurological##2##3##(2008-4#1)(2013-8#1)
a progressive reduction##2##3##(2008-10#2)
a progressive##36##2##(1990-12#1)(1991-2#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
a proinflammatory response##2##3##(2012-3#2)
a proinflammatory##4##2##(1995-12#1)(2008-12#1)(2012-3#2)
a project##9##2##(1995-2#1)(2008-10#1)(2008-12#4)(2009-10#1)(2010-8#1)(2013-1#1)
a prokaryote##2##2##(2008-10#2)
a proliferation of##7##3##(1997-7#1)(2008-11#1)(2009-1#1)(2010-12#1)(2010-6#3)
a proliferation##8##2##(1997-7#1)(2008-11#1)(2008-5#1)(2009-1#1)(2010-12#1)(2010-6#3)
a proliferative##5##2##(1990-12#1)(1994-12#1)(1995-11#2)(2013-1#1)
a proline##3##2##(1991-12#1)(1994-3#1)(1994-5#1)
a prolongation of##4##3##(2008-11#1)(2008-7#1)(2013-1#2)
a prolonged period of##2##4##(2008-9#2)
a prolonged period##4##3##(2008-7#2)(2008-9#2)
a prolonged##14##2##(1992-3#1)(1993-8#1)(1994-2#1)(1997-5#1)(2008-11#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-6#1)(2011-2#2)
a prominent feature of##2##4##(1990-5#1)(1997-3#1)
a prominent feature##4##3##(1990-5#1)(1994-11#2)(1997-3#1)
a prominent position##2##3##(2008-9#1)(2009-8#1)
a prominent role in##4##4##(1990-5#1)(1992-6#1)(2008-10#1)(2008-11#1)
a prominent role##5##3##(1990-5#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
a prominent##20##2##(1990-5#2)(1992-6#1)(1994-11#2)(1996-12#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
a promising alternative to##2##4##(2008-10#1)(2010-8#1)
a promising approach for the##2##5##(2012-2#2)
a promising approach for##3##4##(2008-10#1)(2012-2#2)
a promising approach to##2##4##(2009-10#1)(2010-5#1)
a promising approach##8##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2012-2#2)
a promising drug##2##3##(2008-8#1)(2011-3#1)
a promising means##2##3##(1997-3#1)(2009-10#1)
a promising novel##2##3##(2010-11#1)(2011-7#1)
a promising target for##2##4##(2009-6#1)(2011-2#1)
a promising technique for##3##4##(1990-11#1)(1991-9#1)(2008-10#1)
a promising therapeutic##2##3##(2009-8#1)(2013-1#1)
a promising tool for##3##4##(2008-10#3)
a promising tool##4##3##(2008-10#4)
a promising##65##2##(1990-11#1)(1991-9#2)(1992-12#1)(1995-10#1)(1997-3#1)(2008-10#18)(2008-11#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#2)
a promoter of##2##3##(1996-6#1)(2008-9#1)
a promoter##11##2##(1990-12#2)(1991-6#1)(1993-12#1)(1995-9#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
a prompt##4##2##(1991-12#1)(1991-8#1)(2008-11#1)(2013-1#1)
a pronounced effect##2##3##(2008-11#1)(2008-5#1)
a pronounced increase##2##3##(1997-7#1)(2008-7#1)
a pronounced##9##2##(1990-5#1)(1992-9#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
a propensity##2##2##(2008-10#1)(2008-9#1)
a proper##19##2##(1990-2#1)(1991-11#1)(1991-6#1)(1996-11#2)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
a properly##3##2##(1996-3#1)(2008-3#1)(2012-3#1)
a property of##3##3##(1994-8#1)(1995-8#1)(2009-10#1)
a property##5##2##(1991-5#1)(1994-8#1)(1995-8#1)(2008-10#1)(2009-10#1)
a prophylactic##3##2##(1990-12#1)(2008-5#1)(2011-2#1)
a proportion of the##2##4##(2008-10#2)
a proportion of##8##3##(2007-12#1)(2008-10#6)(2011-2#1)
a proportion##10##2##(2007-12#1)(2008-10#8)(2011-2#1)
a proportional##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
a proposal for a##2##4##(1994-6#1)(2011-2#1)
a proposal to##2##3##(1995-5#1)(2008-5#1)
a proposal##5##2##(1991-5#1)(1994-6#1)(1995-5#1)(2008-5#1)(2011-2#1)
a proposed mechanism for##2##4##(2008-10#1)(2008-3#1)
a proposed model for##2##4##(2010-8#2)
a proposed model##4##3##(2008-10#1)(2009-9#1)(2010-8#2)
a proposed##18##2##(1991-12#1)(1993-1#1)(1995-1#1)(1996-5#1)(1997-7#1)(2008-10#5)(2008-3#3)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#2)
a proprietary##3##2##(1992-12#1)(1993-3#1)(2008-10#1)
a prospective cohort##2##3##(2013-1#2)
a prospective mentor##2##3##(2008-7#2)
a prospective observational study##2##4##(2008-3#1)(2013-8#1)
a prospective payment system (PPS)##2##5##(1992-2#1)(1994-3#1)
a prospective payment system for ambulatory surgery##2##7##(1991-1#2)
a prospective payment system##8##4##(1991-1#3)(1992-12#1)(1992-2#1)(1994-3#2)(1995-2#1)
a prospective payment##9##3##(1991-1#3)(1992-12#1)(1992-2#1)(1994-3#3)(1995-2#1)
a prospective randomized##2##3##(1993-9#1)(2012-3#1)
a prospective study of##4##4##(1990-2#1)(1995-2#1)(2008-7#1)(2012-12#1)
a prospective study##7##3##(1990-11#1)(1990-2#1)(1995-2#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
a prospective##50##2##(1990-11#1)(1990-2#1)(1991-1#3)(1991-3#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#5)(1995-2#2)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#1)
a prospectively##2##2##(1995-3#1)(2012-3#1)
a prosthesis##2##2##(2009-4#1)(2010-8#1)
a prosthetic##3##2##(2012-12#1)(2013-1#2)
a protease##2##2##(1995-6#1)(2008-6#1)
a protection##2##2##(2008-10#1)(2008-12#1)
a protective effect of##2##4##(2011-1#1)(2012-12#1)
a protective effect on the##2##5##(2008-12#1)(2008-9#1)
a protective effect on##4##4##(1992-12#1)(2008-12#1)(2008-7#1)(2008-9#1)
a protective effect##13##3##(1992-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
a protective factor for##3##4##(2009-12#1)(2011-2#1)(2013-8#1)
a protective factor##5##3##(1995-12#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-8#1)
a protective medium##2##3##(2008-10#2)
a protective role##4##3##(1996-12#1)(1997-2#1)(2010-11#1)(2011-2#1)
a protective##32##2##(1992-1#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#3)
a protein consisting of##2##4##(1995-8#1)(2008-9#1)
a protein inhibitor of##2##4##(1994-6#1)(2008-7#1)
a protein involved in##2##4##(2011-2#1)(2012-2#1)
a protein kinase C (PKC)##2##5##(1994-11#1)(1997-1#1)
a protein kinase C##4##4##(1994-11#1)(1996-6#1)(1997-1#1)(2008-11#1)
a protein kinase inhibitor##3##4##(1990-12#2)(1995-2#1)
a protein kinase##13##3##(1990-12#2)(1993-12#1)(1993-2#1)(1994-11#2)(1995-11#1)(1995-2#2)(1996-6#1)(1997-1#1)(2008-11#1)(2009-7#1)
a protein of##38##3##(1990-11#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#4)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#4)(1997-7#3)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-5#1)
a protein or##3##3##(1995-5#1)(2008-4#1)(2008-9#1)
a protein precursor##2##3##(1993-12#2)
a protein that##4##3##(1993-12#1)(1995-12#1)(1995-2#1)(2008-8#1)
a protein tyrosine phosphatase##2##4##(1995-9#1)(2009-7#1)
a protein with an##2##4##(1995-5#1)(2010-4#1)
a protein with##12##3##(1994-6#1)(1995-5#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-8#3)(2009-10#1)(2010-4#1)(2011-2#1)
a protein##134##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-9#3)(1993-12#6)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#7)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#3)(1995-9#1)(1996-12#1)(1996-6#5)(1997-1#1)(1997-7#4)(2008-1#1)(2008-10#19)(2008-11#8)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#11)(2009-10#1)(2009-7#3)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
a protein-free medium##4##3##(2008-11#4)
a protein-free##6##2##(1993-12#2)(2008-11#4)
a proteinaceous##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
a proteinase##2##2##(2008-10#1)(2008-11#1)
a protocol for##16##3##(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#4)(2008-9#3)(2012-12#1)
a protocol in which##3##4##(1993-11#1)(2008-4#2)
a protocol is##3##3##(2008-4#2)(2008-9#1)
a protocol that##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
a protocol##33##2##(1993-11#1)(1996-2#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#2)(2008-4#10)(2008-5#3)(2008-9#5)(2012-12#2)
a proton from##2##3##(1992-10#1)(2008-10#1)
a proton gradient##2##3##(1990-2#1)(1995-2#1)
a proton##7##2##(1990-2#2)(1992-10#1)(1995-2#1)(2008-10#3)
a protonation constants determination##2##4##(2008-10#2)
a prototype##13##2##(1991-9#1)(1992-3#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)
a protracted##3##2##(2008-10#2)(2008-12#1)
a proven##4##2##(1992-11#1)(1997-2#1)(2008-12#1)(2008-5#1)
a province##3##2##(1992-1#1)(1993-2#1)(2009-6#1)
a proximal##4##2##(1997-3#1)(1997-8#1)(2009-3#1)(2010-3#1)
a proxy##4##2##(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)
a pseudo##2##2##(2008-10#2)
a psychiatric hospital##3##3##(1991-2#1)(1993-2#2)
a psychiatric patient##2##3##(1996-12#1)(1997-8#1)
a psychiatric ward##2##3##(2011-2#1)(2012-3#1)
a psychiatric##15##2##(1991-2#2)(1993-12#1)(1993-2#2)(1995-1#1)(1996-12#1)(1996-8#1)(1997-8#1)(2008-12#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-3#2)
a psychoanalytical##3##2##(1991-2#1)(2008-12#1)(2010-6#1)
a psychologist##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
a psychophysical##2##2##(2008-10#1)(2013-8#1)
a psychosocial##3##2##(1991-1#1)(1992-3#1)(2008-10#1)
a psychotherapeutic##3##2##(2010-9#1)(2012-3#1)(2013-1#1)
a psychotic disorder##2##3##(2008-4#2)
a public health care##3##4##(1991-3#1)(1994-9#2)
a public health problem in##2##5##(2008-11#1)(2012-12#1)
a public health problem##5##4##(2008-11#1)(2009-5#1)(2010-9#1)(2012-12#1)(2013-1#1)
a public health##16##3##(1991-3#2)(1994-9#2)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#1)(2009-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
a public##31##2##(1991-3#2)(1993-1#2)(1993-5#1)(1994-9#2)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#3)
a publicity plan##2##3##(1992-12#2)
a publicly##2##2##(1992-2#1)(1994-2#1)
a published##3##2##(1996-3#1)(2008-10#2)
a pulmonary##3##2##(1990-6#1)(1996-3#1)(2008-9#1)
a pulsatile##2##2##(1997-2#2)
a pulse quality factor##2##4##(2007-11#2)
a pulse width of##3##4##(2007-12#2)(2008-3#1)
a pulse width##4##3##(2007-12#2)(2008-3#2)
a pulse##12##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)
a pulsed Nd##3##3##(2008-10#2)(2008-2#1)
a pulsed flow##2##3##(2008-10#2)
a pulsed laser##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
a pulsed optical parametric oscillator##2##5##(2008-3#2)
a pulsed quench-flow apparatus##2##4##(1990-2#2)
a pulsed##24##2##(1990-2#2)(1992-1#2)(1995-12#1)(2008-10#7)(2008-2#3)(2008-3#7)(2008-7#1)(2012-2#1)
a pure amount effect##2##4##(2008-8#2)
a pure culture##2##3##(2008-7#1)(2010-4#1)
a pure##14##2##(1994-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-4#1)(2013-8#1)
a purge-and-trap##3##2##(2008-10#3)
a purification##2##2##(2008-11#1)(2008-4#1)
a purified##3##2##(1991-5#1)(1997-8#1)(2011-2#1)
a purpose to##2##3##(2008-10#1)(2012-2#1)
a purpose##4##2##(2008-10#2)(2012-2#2)
a purposive sample of##2##4##(2008-12#1)(2010-10#1)
a putative binding site for the##2##6##(1993-12#1)(1993-3#1)
a putative member of the##2##5##(1995-8#1)(2008-10#1)
a putative new##3##3##(1994-8#1)(1997-8#1)(2011-2#1)
a putative protein kinase##2##4##(1991-7#1)(2008-10#1)
a putative protein of##2##4##(2008-10#1)(2010-5#1)
a putative protein##4##3##(1991-7#1)(2008-10#2)(2010-5#1)
a putative role##2##3##(1990-11#1)(2009-8#1)
a putative##55##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-6#2)(1997-4#1)(1997-7#3)(1997-8#2)(2008-10#12)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-8#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
a pyruvate##2##2##(1990-5#1)(2008-10#1)
a quadrat##4##2##(2008-10#3)(2008-8#1)
a quadratic##8##2##(2007-11#1)(2008-10#5)(2008-3#1)(2013-8#1)
a quadrivalent##2##2##(2013-1#2)
a quadrupole##4##2##(2008-10#4)
a qualitative and quantitative##2##4##(2008-11#1)(2013-1#1)
a qualitative and##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
a qualitative descriptive study exploring##2##5##(2008-11#1)(2013-8#1)
a qualitative descriptive##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
a qualitative evaluation##2##3##(2008-1#1)(2008-11#1)
a qualitative research methodology##2##4##(1995-3#1)(2008-11#1)
a qualitative study of the##2##5##(2008-12#1)(2008-9#1)
a qualitative study##9##3##(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
a qualitative##40##2##(1994-11#1)(1995-3#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
a quality control##4##3##(1994-12#1)(2008-10#3)
a quality improvement culture##2##4##(2009-3#2)
a quality improvement tool##2##4##(1997-1#2)
a quality improvement##8##3##(1993-3#2)(1994-12#1)(1997-1#2)(1997-3#1)(2009-3#2)
a quality planning##2##3##(1993-12#2)
a quality##23##2##(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#2)(1994-12#3)(1997-1#2)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2009-3#2)(2009-5#1)(2010-9#1)
a quantification limit of##2##4##(2008-10#2)
a quantitation limit##2##3##(2008-10#2)
a quantitative approach##3##3##(2008-10#2)(2008-9#1)
a quantitative description of##2##4##(1996-1#1)(1997-6#1)
a quantitative descriptive analysis (QDA)##2##5##(2008-10#1)(2011-2#1)
a quantitative descriptive##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
a quantitative measure of the##2##5##(2008-4#1)(2010-10#1)
a quantitative measure of##3##4##(1996-6#1)(2008-4#1)(2010-10#1)
a quantitative method##2##3##(2008-10#1)(2012-2#1)
a quantitative model##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
a quantitative trait locus##2##4##(2008-10#1)(2010-4#1)
a quantitative trait##7##3##(2008-10#1)(2008-8#3)(2008-9#1)(2010-4#1)(2012-3#1)
a quantitative##50##2##(1993-1#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-6#1)(2008-10#17)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#5)(2010-10#1)(2010-4#2)(2010-7#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
a quantum##4##2##(1990-12#1)(1993-5#1)(2008-10#1)(2008-3#1)
a quarter of the##2##4##(2007-11#1)(2008-3#1)
a quarter of##4##3##(1992-3#1)(1992-6#1)(2007-11#1)(2008-3#1)
a quarter##5##2##(1992-3#1)(1992-6#2)(2007-11#1)(2008-3#1)
a quartz crystal microbalance##4##4##(2008-10#4)
a quartz crystal##8##3##(2008-10#6)(2009-5#2)
a quartz##18##2##(2007-12#1)(2008-10#13)(2008-5#1)(2008-7#1)(2009-5#2)
a quasi-experimental##3##2##(1995-1#1)(1996-3#1)(2008-11#1)
a quaternary ammonium##2##3##(2008-10#2)
a quaternary##3##2##(2008-10#3)
a quenching##2##2##(2008-10#2)
a query##3##2##(2008-10#1)(2008-9#2)
a question of##2##3##(1993-12#1)(2008-9#1)
a question##4##2##(1991-1#1)(1993-12#1)(2008-11#1)(2008-9#1)
a questionnaire that##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
a questionnaire to##2##3##(1992-12#1)(2012-12#1)
a questionnaire##32##2##(1990-6#1)(1991-6#1)(1992-1#2)(1992-12#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-5#1)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#2)(2010-1#2)(2010-10#2)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
a quick and##5##3##(1990-8#1)(2008-10#3)(2009-8#1)
a quick##13##2##(1990-8#1)(1990-9#1)(2008-10#10)(2009-8#1)
a quiescent##2##2##(1997-3#1)(2008-10#1)
a quite large##2##3##(2008-10#1)(2013-8#1)
a quite##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
a rabbit##8##2##(1991-10#1)(1993-6#1)(2008-10#3)(2009-3#2)(2012-3#1)
a race 2 isolate##3##4##(2008-10#3)
a race##4##2##(2008-10#4)
a radial artery perforator##2##4##(2008-9#2)
a radial laser array##2##4##(2008-2#2)
a radial##8##2##(1993-6#1)(2008-10#1)(2008-2#2)(2008-9#2)(2011-2#1)(2013-1#1)
a radially symmetric##2##3##(1994-2#1)(2008-3#1)
a radiation##5##2##(1997-8#1)(2008-11#3)(2008-7#1)
a radical operation##3##3##(1990-3#1)(1990-9#1)(1993-11#1)
a radical vulvar##2##3##(1992-3#2)
a radical##12##2##(1990-3#1)(1990-9#1)(1992-3#2)(1993-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#3)(2013-8#1)
a radioactive##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
a radiolabeled##3##2##(1993-8#2)(1996-3#1)
a radioligand##2##2##(1990-11#1)(1994-8#1)
a radiologic##3##2##(1994-1#1)(2008-10#1)(2011-2#1)
a radiologist##3##2##(2011-2#1)(2013-1#2)
a radiosensitizer##3##2##(1990-6#1)(1991-2#1)(2008-9#1)
a radius of##2##3##(2008-10#2)
a rain##4##2##(2008-10#4)
a rainbow##2##2##(2008-3#1)(2008-5#1)
a raised##2##2##(1997-4#1)(2011-2#1)
a ramified##2##2##(2007-12#1)(2008-12#1)
a ramp-hold-fire##2##2##(2008-3#2)
a random coil##2##3##(1996-2#1)(2008-7#1)
a random digit##2##3##(2012-12#1)(2013-1#1)
a random distribution##3##3##(1995-9#1)(2008-12#1)(2008-3#1)
a random pattern##2##3##(1995-1#1)(2008-10#1)
a random sample of 1##2##5##(1993-2#1)(1996-6#1)
a random sample of##16##4##(1991-3#1)(1992-12#1)(1993-2#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-3#1)
a random sample##19##3##(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-3#2)
a random##52##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-9#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
a randomised controlled##2##3##(2010-5#1)(2013-1#1)
a randomised##5##2##(1990-2#1)(2010-5#1)(2011-3#1)(2013-1#2)
a randomized clinical trial##2##4##(1996-6#1)(2012-12#1)
a randomized complete block design##4##5##(2008-10#4)
a randomized control##2##3##(2010-7#1)(2013-8#1)
a randomized controlled study##2##4##(2008-12#1)(2008-8#1)
a randomized controlled trial of##2##5##(2008-8#1)(2013-1#1)
a randomized controlled trial##6##4##(1997-2#1)(2008-8#3)(2009-12#1)(2013-1#1)
a randomized controlled##11##3##(1997-2#1)(2008-12#1)(2008-8#4)(2009-12#1)(2010-7#1)(2013-1#3)
a randomized trial comparing##2##4##(1993-11#1)(1995-12#1)
a randomized trial in##2##4##(1992-12#1)(1994-8#1)
a randomized trial##9##3##(1992-12#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-4#2)(2012-2#1)(2012-3#1)
a randomized##43##2##(1991-8#2)(1992-12#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-2#2)(2008-10#8)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#5)(2009-12#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
a randomly selected sample of##2##5##(1994-12#1)(2012-12#1)
a randomly##5##2##(1991-6#1)(1994-12#1)(2008-3#2)(2012-12#1)
a range between##2##3##(2008-10#2)
a range from 0 to##2##5##(2010-4#1)(2013-1#1)
a range from 0##4##4##(2008-10#2)(2010-4#1)(2013-1#1)
a range from##7##3##(1995-3#1)(2008-10#4)(2010-4#1)(2013-1#1)
a range of 0##8##4##(1993-12#1)(2008-10#4)(2008-11#1)(2011-2#1)(2013-1#1)
a range of densities##2##4##(1997-3#1)(2008-10#1)
a range of different##2##4##(2008-11#1)(2009-6#1)
a range of environments##2##4##(2011-2#2)
a range of frequencies##2##4##(2008-10#1)(2013-8#1)
a range of host plants##2##5##(2008-10#2)
a range of inoculum##3##4##(2008-10#3)
a range of other##2##4##(2008-10#2)
a range of physical and##2##5##(1994-5#1)(2008-10#1)
a range of simple organic##2##5##(2008-10#2)
a range of temperatures##5##4##(2008-10#3)(2008-4#1)(2008-8#1)
a range of winter barley cultivars##2##6##(2008-10#2)
a range of##170##3##(1990-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#1)(2008-1#2)(2008-10#67)(2008-11#15)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#8)(2012-8#1)(2013-1#7)(2013-8#3)
a range##185##2##(1990-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#1)(2008-1#2)(2008-10#75)(2008-11#15)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#8)(2012-8#1)(2013-1#8)(2013-8#3)
a rank##2##2##(1992-9#1)(1994-8#1)
a rapeseed protein hydrolysate##2##4##(2008-11#2)
a rapid analysis of##2##4##(2008-10#1)(2008-11#1)
a rapid and accurate##3##4##(2008-10#2)(2010-5#1)
a rapid and efficient approach for##2##6##(1991-12#1)(2008-10#1)
a rapid and efficient##4##4##(1991-12#1)(2008-10#3)
a rapid and sensitive method for the##2##7##(2008-10#1)(2010-4#1)
a rapid and sensitive method for##3##6##(2008-10#2)(2010-4#1)
a rapid and sensitive method##4##5##(2008-10#2)(2010-4#1)(2011-2#1)
a rapid and sensitive##8##4##(1993-8#1)(2008-10#5)(2010-4#1)(2011-2#1)
a rapid and simple method##2##5##(2008-10#1)(2008-12#1)
a rapid and simple##8##4##(2008-10#6)(2008-11#1)(2008-12#1)
a rapid and transient rise in##2##6##(1992-6#1)(1997-1#1)
a rapid and transient##3##4##(1992-6#1)(1996-2#1)(1997-1#1)
a rapid and##36##3##(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-8#1)(1994-11#1)(1996-2#1)(1997-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-4#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)
a rapid decline in##3##4##(2008-8#1)(2010-1#1)(2010-12#1)
a rapid decline##4##3##(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#1)
a rapid diagnostic##2##3##(2008-10#2)
a rapid increase in the##3##5##(1990-6#1)(1995-6#1)(2008-10#1)
a rapid increase in##5##4##(1990-6#1)(1995-6#1)(1997-1#1)(2008-10#2)
a rapid increase##6##3##(1990-6#1)(1995-6#1)(1997-1#1)(2008-10#2)(2013-1#1)
a rapid inhibition of##2##4##(1992-3#1)(2008-5#1)
a rapid method for the##2##5##(2008-10#2)
a rapid method for##4##4##(2008-10#3)(2008-11#1)
a rapid method##5##3##(2008-10#3)(2008-11#2)
a rapid return to##2##4##(1991-6#1)(2008-10#1)
a rapid technique##2##3##(2008-10#2)
a rapid##124##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#2)(1997-1#3)(2008-10#62)(2008-11#11)(2008-12#2)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a rapidly changing##5##3##(1991-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(2008-10#1)
a rapidly enlarging##3##3##(1997-6#1)(2008-12#1)(2009-3#1)
a rapidly evolving##2##3##(1994-12#1)(2008-2#1)
a rapidly expanding field##2##4##(1994-9#1)(2008-5#1)
a rapidly expanding##3##3##(1994-9#1)(2008-5#1)(2008-9#1)
a rapidly growing##4##3##(1993-2#1)(1994-8#1)(2008-12#1)(2010-10#1)
a rapidly##23##2##(1991-12#1)(1992-1#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2013-8#1)
a rare acute##2##3##(1995-11#1)(2013-1#1)
a rare and lethal##2##4##(2011-2#1)(2012-2#1)
a rare and##8##3##(1993-6#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a rare association with##2##4##(2012-2#2)
a rare case of a##3##5##(2008-11#1)(2012-3#1)(2013-2#1)
a rare case of primary##2##5##(1991-12#1)(2009-8#1)
a rare case of##26##4##(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-2#1)
a rare case report##2##4##(2012-3#1)(2013-8#1)
a rare case##30##3##(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-2#1)(2013-8#1)
a rare cause of##8##4##(2008-12#2)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a rare clinical entity##3##4##(2009-2#1)(2012-2#1)(2013-1#1)
a rare clinical##4##3##(2008-10#1)(2009-2#1)(2012-2#1)(2013-1#1)
a rare complication occurring##2##4##(2009-11#1)(2012-3#1)
a rare complication of##14##4##(1990-5#1)(2008-7#1)(2009-1#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)
a rare complication##18##3##(1990-5#1)(2008-12#2)(2008-7#1)(2009-1#1)(2009-11#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)
a rare disease##12##3##(1992-12#1)(1993-6#2)(1996-3#1)(1997-5#1)(1997-7#1)(2008-12#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
a rare disorder##4##3##(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
a rare entity##11##3##(2008-10#3)(2008-11#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)
a rare event##5##3##(2008-1#1)(2008-10#2)(2009-9#1)(2011-2#1)
a rare form of##2##4##(2008-10#1)(2011-2#1)
a rare form##3##3##(1994-5#1)(2008-10#1)(2011-2#1)
a rare group of##2##4##(2010-12#1)(2011-2#1)
a rare occurrence##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
a rare phenomenon##3##3##(2008-10#2)(2011-2#1)
a rare presentation##4##3##(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
a rare subtype##4##3##(2008-12#1)(2009-12#1)(2011-2#1)(2012-3#1)
a rare tumor##3##3##(2012-3#1)(2013-1#2)
a rare variant of##4##4##(1990-6#1)(2008-12#1)(2009-10#1)(2013-1#1)
a rare variant##5##3##(1990-6#1)(2008-11#1)(2008-12#1)(2009-10#1)(2013-1#1)
a rare##225##2##(1990-12#2)(1990-5#3)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#3)(1992-9#1)(1993-3#1)(1993-6#3)(1994-5#1)(1995-11#2)(1996-12#1)(1996-3#3)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#8)(2008-12#13)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#2)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#27)(2012-12#8)(2012-2#10)(2012-3#16)(2013-1#25)(2013-2#1)(2013-7#2)(2013-8#4)
a rat EFIA cDNA##2##4##(1993-2#2)
a rat ascites##4##3##(2008-11#4)
a rat genomic library##2##4##(1993-12#1)(1993-8#1)
a rat liver##2##3##(1995-2#1)(1995-6#1)
a rat pheochromocytoma cell line##2##5##(1993-8#1)(1994-11#1)
a rat##40##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-8#2)(1994-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#3)(2006-6#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
a rate constant##4##3##(2008-10#1)(2008-7#2)(2009-8#1)
a rate##30##2##(1990-9#1)(1991-9#1)(1992-12#1)(1993-8#2)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#15)(2008-11#2)(2008-7#3)(2009-11#1)(2009-8#1)
a rate-limiting enzyme##2##3##(2008-11#1)(2008-5#1)
a rate-limiting##3##2##(1991-9#1)(2008-11#1)(2008-5#1)
a rather high##3##3##(2008-10#2)(2008-8#1)
a rather##14##2##(1993-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
a ratio of 1##4##4##(1995-2#1)(2008-10#2)(2013-1#1)
a ratio of##11##3##(1991-12#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#3)(2009-6#1)(2013-1#1)
a ratio##12##2##(1991-12#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#3)(2009-6#1)(2012-3#1)(2013-1#1)
a rational approach to##3##4##(1996-3#1)(2009-5#1)(2011-2#1)
a rational approach##4##3##(1996-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
a rational target for##2##4##(2011-3#1)(2012-2#1)
a rational##12##2##(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
a rationale for the##2##4##(2008-11#1)(2013-8#1)
a rationale for##3##3##(1992-4#1)(2008-11#1)(2013-8#1)
a raw##2##2##(2008-10#1)(2008-5#1)
a ray optics##2##3##(2008-3#2)
a ray-tracing##3##2##(2008-3#3)
a re-infarction##3##2##(2009-6#3)
a reaction coil##5##3##(2008-10#5)
a reaction that##2##3##(2008-4#1)(2009-6#1)
a reaction##19##2##(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#12)(2008-4#1)(2009-6#1)(2009-8#2)
a reactive##4##2##(1992-12#1)(2008-11#1)(2013-1#2)
a reactor##5##2##(2008-10#4)(2008-11#1)
a readily available##2##3##(2010-7#1)(2013-1#1)
a readily##3##2##(1995-2#1)(2010-7#1)(2013-1#1)
a reading##3##2##(1997-2#1)(2008-11#1)(2010-7#1)
a ready source of##3##4##(2008-10#1)(2010-12#1)(2013-1#1)
a reagent consumption of##2##4##(2008-10#2)
a reagent for##3##3##(2008-10#2)(2008-9#1)
a reagent##14##2##(2008-10#13)(2008-9#1)
a reagent-injection flow injection##2##4##(2008-10#2)
a reagentless##2##2##(2008-10#2)
a real##12##2##(1993-3#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)
a real-time PCR instrument##3##4##(2008-10#1)(2011-2#2)
a real-time PCR##5##3##(2008-10#2)(2010-6#1)(2011-2#2)
a real-time quantitative##3##3##(2008-10#2)(2008-11#1)
a real-time##16##2##(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#2)
a realistic##8##2##(1990-8#1)(1992-9#1)(1993-2#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)
a reality for##2##3##(1994-12#1)(1995-2#1)
a reality in##2##3##(2008-10#1)(2013-8#1)
a reality within##2##3##(2008-10#1)(2008-9#1)
a reality##9##2##(1993-3#1)(1994-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2013-8#1)
a rearrangement##2##2##(1990-6#1)(1997-3#1)
a reason for##2##3##(1991-12#1)(2008-10#1)
a reasonable correlation between##2##4##(1991-9#1)(1992-6#1)
a reasonable##18##2##(1991-1#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#5)(2008-11#2)(2008-4#1)(2009-10#1)
a reasonably short##2##3##(2008-10#1)(2008-2#1)
a reasonably##4##2##(1992-2#1)(1993-12#1)(2008-10#1)(2008-2#1)
a receiver##2##2##(2008-10#1)(2013-1#1)
a recent case##3##3##(1990-9#2)(2008-9#1)
a recent history of##2##4##(2008-11#1)(2013-1#1)
a recent paper##5##3##(2008-10#1)(2008-2#1)(2009-8#3)
a recent study##15##3##(1990-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#3)(2013-1#1)
a recent survey of##4##4##(1994-3#1)(1995-1#1)(1995-2#1)(2008-6#1)
a recent survey##6##3##(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(2008-6#1)
a recent trend of##2##4##(2008-11#1)(2009-12#1)
a recent trend##3##3##(2008-11#1)(2008-4#1)(2009-12#1)
a recent##69##2##(1990-11#1)(1990-6#2)(1990-9#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#6)(2010-12#2)(2010-4#1)(2010-6#2)(2011-2#6)(2013-1#2)(2013-8#1)
a recently described##6##3##(1991-7#1)(2008-10#1)(2008-11#2)(2009-6#1)(2012-2#1)
a recently developed chemometric##2##4##(2008-10#2)
a recently developed##7##3##(1995-11#2)(2008-10#4)(2012-3#1)
a recently introduced##2##3##(2008-10#2)
a recently proposed##4##3##(2008-10#2)(2008-7#2)
a recently reported##2##3##(1992-8#1)(2008-8#1)
a recently synthesized Schiff's base##2##5##(2008-10#2)
a recently synthesized mercapto compound##2##5##(2008-10#2)
a recently synthesized##8##3##(2008-10#8)
a recently##41##2##(1990-3#1)(1991-11#1)(1991-7#1)(1992-8#1)(1993-2#1)(1995-11#2)(1995-12#1)(1997-1#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
a receptive##2##2##(2008-11#1)(2012-3#1)
a receptor in##2##3##(1992-10#1)(2008-11#1)
a receptor mediated##2##3##(1991-5#1)(1994-8#1)
a receptor protein##2##3##(1997-7#1)(2008-10#1)
a receptor##15##2##(1991-5#1)(1992-10#1)(1993-8#2)(1994-5#2)(1994-8#1)(1995-2#2)(1995-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2012-2#1)
a receptor-dependent##2##2##(1995-8#1)(2013-1#1)
a recessive gene##3##3##(2008-10#3)
a recessive##6##2##(1994-12#2)(2008-10#3)(2011-2#1)
a reciprocal regulatory loop##2##4##(2011-2#2)
a reciprocal##9##2##(1993-3#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)
a recirculating##2##2##(2008-10#2)
a recognition##4##2##(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)
a recognized##5##2##(2008-4#1)(2008-5#1)(2009-7#1)(2012-3#2)
a recombinant CHO cell line##4##5##(2008-11#4)
a recombinant baculovirus##7##3##(1992-3#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
a recombinant cutinase##2##3##(1995-3#1)(2008-7#1)
a recombinant human##2##3##(2008-11#2)
a recombinant inbred line population##2##5##(2008-10#2)
a recombinant inbred##3##3##(2008-10#3)
a recombinant protein##2##3##(2008-11#2)
a recombinant vector##2##3##(2008-9#1)(2011-2#1)
a recombinant virus##2##3##(2008-10#2)
a recombinant##57##2##(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1997-2#1)(2008-10#11)(2008-11#18)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-3#1)(2010-4#1)(2010-6#1)(2011-2#4)
a recommendation##2##2##(1996-11#1)(2009-8#1)
a recommended##4##2##(1996-2#1)(2008-10#2)(2012-2#1)
a reconstituted system##2##3##(1996-3#1)(2010-12#1)
a reconstituted##5##2##(1996-3#1)(2008-5#2)(2010-12#1)(2011-2#1)
a reconstitution##2##2##(1991-5#1)(2008-7#1)
a reconstructed##2##2##(2008-5#2)
a reconstructive##2##2##(1992-3#1)(2012-12#1)
a record##2##2##(2009-6#1)(2011-1#1)
a recovery period##2##3##(2012-2#1)(2013-8#1)
a recovery study##2##3##(2008-10#2)
a recovery test##2##3##(2008-10#2)
a recovery##20##2##(1995-12#1)(2008-10#14)(2008-5#2)(2012-2#2)(2013-8#1)
a rectal##4##2##(1990-9#1)(2009-12#2)(2013-8#1)
a rectangular##5##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
a recurrence##2##2##(2008-8#1)(2013-1#1)
a recurrent neural network##4##4##(2008-11#4)
a recurrent problem in##2##4##(1990-6#1)(2011-2#1)
a recurrent##11##2##(1990-6#1)(1992-11#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
a recycle batch##3##3##(2008-11#1)(2008-7#2)
a red LED as##2##4##(2008-10#2)
a red complex##4##3##(2008-10#4)
a red shift##2##3##(2008-10#2)
a red##23##2##(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2013-1#3)
a red-violet##2##2##(2008-10#2)
a redesigned##2##2##(1997-2#1)(2011-2#1)
a redesigning##2##2##(1992-3#1)(1997-2#1)
a redox electrode##3##3##(2008-10#3)
a redox mediator##2##3##(2008-10#2)
a redox reaction##3##3##(2008-10#3)
a redox##13##2##(2008-10#12)(2008-11#1)
a reduced barrier function##2##4##(2008-5#2)
a reduced growth##2##3##(2008-10#1)(2008-11#1)
a reduced level##3##3##(2008-5#1)(2010-1#1)(2012-12#1)
a reduced rate of##2##4##(2008-10#1)(2008-9#1)
a reduced##37##2##(1990-11#1)(1991-7#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#4)(2008-7#7)(2008-9#2)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-5#1)
a reducing agent##5##3##(2008-10#5)
a reducing##8##2##(2008-10#7)(2008-11#1)
a reduction in drug##2##4##(1992-12#1)(2008-11#1)
a reduction in lesion##2##4##(2008-10#2)
a reduction in serum##2##4##(2008-5#1)(2013-8#1)
a reduction in the number of##5##6##(1995-12#1)(2008-10#3)(2010-8#1)
a reduction in the##23##4##(1990-5#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-9#3)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
a reduction in their##2##4##(1990-5#1)(2009-10#1)
a reduction in##84##3##(1990-11#2)(1990-12#1)(1990-5#3)(1991-7#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#19)(2008-11#5)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#2)(2009-9#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#9)
a reduction of disease##2##4##(2008-10#2)
a reduction of the##8##4##(1992-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
a reduction of##31##3##(1990-12#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#3)(2009-7#1)(2010-7#1)(2011-2#2)(2013-1#2)
a reduction or##2##3##(1991-12#1)(2008-5#1)
a reduction##125##2##(1990-11#2)(1990-12#2)(1990-5#3)(1991-12#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(2008-10#32)(2008-11#10)(2008-3#6)(2008-5#3)(2008-7#7)(2008-8#2)(2008-9#6)(2009-10#2)(2009-7#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#9)
a redundant##2##2##(1991-5#1)(2013-1#1)
a reevaluation##2##2##(1992-1#1)(2009-6#1)
a reexamination of##2##3##(1993-8#1)(1994-12#1)
a reference electrode##5##3##(2008-10#4)(2008-9#1)
a reference material##6##3##(2008-10#6)
a reference method##7##3##(2008-10#7)
a reference procedure##2##3##(2008-10#2)
a reference range##2##3##(1990-2#1)(1993-2#1)
a reference strain##2##3##(2008-10#2)
a reference##56##2##(1990-2#1)(1992-3#1)(1993-2#1)(1996-12#1)(2008-10#38)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#1)(2008-9#1)(2009-10#1)(2012-3#1)
a referral coordinator##2##3##(2013-1#2)
a referral##7##2##(1994-1#2)(1994-6#2)(2008-12#1)(2013-1#2)
a refined##2##2##(2008-10#1)(2008-11#1)
a reflection of the##2##4##(1991-5#1)(2008-10#1)
a reflection of##3##3##(1991-5#1)(2008-10#1)(2012-3#1)
a reflection##4##2##(1991-5#1)(2007-12#1)(2008-10#1)(2012-3#1)
a reflective process##2##3##(2008-11#2)
a reflective##7##2##(2007-12#1)(2008-10#2)(2008-11#4)
a reformed health##2##3##(1995-1#1)(1995-12#1)
a refuge##4##2##(1993-6#2)(2009-5#2)
a regenerable##2##2##(2008-10#2)
a regime of##2##3##(2008-11#1)(2008-12#1)
a regimen of##2##3##(1992-9#1)(2008-5#1)
a region at the##2##4##(1993-12#1)(2008-10#1)
a region in the##2##4##(1995-6#1)(2008-11#1)
a region in##3##3##(1993-8#1)(1995-6#1)(2008-11#1)
a region of the##5##4##(1993-12#1)(1993-9#1)(1995-6#1)(1996-12#1)(2008-10#1)
a region of##21##3##(1990-2#1)(1990-5#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-7#1)
a region with##2##3##(2008-10#1)(2008-3#1)
a region##45##2##(1990-2#1)(1990-5#1)(1991-5#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-7#1)(2013-8#2)
a regional scale##2##3##(2008-10#2)
a regional##13##2##(1993-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-9#1)(2012-2#1)
a regression model##2##3##(2008-10#2)
a regression##6##2##(2008-10#5)(2008-11#1)
a regular grid##2##3##(2008-10#1)(2008-6#1)
a regular surface##2##3##(2007-12#1)(2008-3#1)
a regular##23##2##(1990-9#1)(1991-12#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#3)(2009-3#1)(2011-2#4)
a regularization scheme##2##3##(2008-3#2)
a regulated##3##2##(1995-6#1)(2008-10#2)
a regulation##2##2##(2009-8#1)(2013-8#1)
a regulator of##6##3##(1991-9#1)(1995-12#1)(1995-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
a regulator##7##2##(1991-12#1)(1991-9#1)(1995-12#1)(1995-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
a regulatory role in the##2##5##(1993-3#1)(2008-2#1)
a regulatory role##4##3##(1993-3#1)(1993-8#1)(1995-2#1)(2008-2#1)
a regulatory##18##2##(1993-3#1)(1993-8#1)(1993-9#1)(1995-2#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#2)(2009-9#1)(2010-11#1)(2011-2#1)
a rehabilitation##4##2##(1995-3#1)(2008-7#1)(2010-10#1)(2013-1#1)
a rehabilitative programme##2##3##(2008-10#2)
a relapse of##2##3##(2013-1#1)(2013-8#1)
a relapse##6##2##(1993-2#1)(2009-7#1)(2009-9#1)(2013-1#2)(2013-8#1)
a related##8##2##(1992-9#1)(1993-12#1)(1994-11#1)(2008-10#3)(2008-6#1)(2008-8#1)
a relation between the##3##4##(1991-11#1)(2008-10#1)(2008-11#1)
a relation between##5##3##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
a relational database##2##3##(2008-4#2)
a relationship between the##4##4##(1992-2#1)(2008-10#2)(2010-9#1)
a relationship between##21##3##(1991-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1994-11#1)(1995-12#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#6)
a relationship for##2##3##(2008-11#1)(2008-5#1)
a relationship was##2##3##(1991-2#1)(2008-10#1)
a relationship##31##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-7#1)(1993-11#1)(1994-11#1)(1995-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#6)
a relative accuracy error of 0##2##6##(2008-10#2)
a relative accuracy error of##3##5##(2008-10#3)
a relative dearth of##2##4##(2008-11#1)(2012-2#1)
a relative deviation of 1##2##5##(2008-10#1)(2008-2#1)
a relative deviation##3##3##(2008-10#2)(2008-2#1)
a relative error of##5##4##(2008-10#5)
a relative error##6##3##(2008-10#6)
a relative lack of##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
a relative molecular mass of##5##5##(1991-12#2)(1993-8#1)(2008-11#2)
a relative risk of##3##4##(1994-9#2)(2013-1#1)
a relative standard deviation (R##9##5##(2008-10#9)
a relative standard deviation (RSD) of##3##6##(2008-10#3)
a relative standard deviation between##2##5##(2008-10#2)
a relative standard deviation of 0##4##6##(2008-10#4)
a relative standard deviation of 1##14##6##(2008-10#14)
a relative standard deviation of 2##7##6##(2008-10#7)
a relative standard deviation of 3##3##6##(2008-10#3)
a relative standard deviation of 4##3##6##(2008-10#3)
a relative standard deviation of approximately##2##6##(2008-10#2)
a relative standard deviation of less than 0##3##8##(2008-10#3)
a relative standard deviation of less than##7##7##(2008-10#7)
a relative standard deviation of##51##5##(2008-10#51)
a relative standard deviation##73##4##(2008-10#73)
a relative standard##74##3##(2008-10#73)(2008-2#1)
a relative##128##2##(1991-12#3)(1991-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-9#2)(1995-3#1)(1996-11#1)(2008-10#96)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
a relatively benign##2##3##(2011-2#1)(2012-3#1)
a relatively broad##2##3##(2008-10#1)(2011-2#1)
a relatively common##5##3##(2008-7#1)(2009-6#1)(2011-2#2)(2012-3#1)
a relatively consistent##2##3##(2008-10#1)(2008-11#1)
a relatively fast##3##3##(2008-10#2)(2011-2#1)
a relatively frequent##3##3##(1991-12#1)(2010-5#1)(2013-1#1)
a relatively high concentration##2##4##(1997-2#1)(2008-8#1)
a relatively high##8##3##(1994-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
a relatively higher##3##3##(1990-3#1)(1994-6#1)(1994-8#1)
a relatively large##5##3##(1990-8#1)(1991-5#1)(2008-10#1)(2008-9#1)(2013-8#1)
a relatively low##9##3##(1993-2#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2012-2#1)
a relatively narrow##2##3##(2008-10#1)(2008-5#1)
a relatively new##11##3##(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)
a relatively rare##5##3##(1991-12#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
a relatively short time##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
a relatively short##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
a relatively simple and##2##4##(1990-11#1)(2006-6#1)
a relatively simple##5##3##(1990-11#1)(1993-12#1)(2006-6#1)(2007-11#1)(2009-8#1)
a relatively small effect##2##4##(2008-10#1)(2008-8#1)
a relatively small number of##2##5##(1996-3#1)(2008-3#1)
a relatively small##11##3##(1995-11#1)(1996-3#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-8#1)(2009-7#1)
a relatively stable##2##3##(1991-12#1)(1994-6#1)
a relatively wide##5##3##(2008-10#4)(2008-2#1)
a relatively##125##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-5#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-9#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-6#1)(1997-7#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-10#34)(2008-11#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#7)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
a relaxed##2##2##(1995-6#1)(2010-12#1)
a release of##3##3##(1990-8#1)(1994-3#1)(2008-10#1)
a relevant##5##2##(1990-8#1)(1993-3#1)(2009-6#1)(2011-2#1)(2012-3#1)
a reliability##2##2##(2008-10#1)(2009-12#1)
a reliable and##14##3##(1990-12#1)(1992-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#2)
a reliable determination of##2##4##(2008-10#2)
a reliable estimate of##2##4##(2008-12#1)(2008-8#1)
a reliable indicator of##2##4##(1991-12#1)(2013-7#1)
a reliable means of##2##4##(2008-10#1)(2011-7#1)
a reliable method##2##3##(2008-10#1)(2011-2#1)
a reliable source of##2##4##(2008-10#1)(2008-4#1)
a reliable tool to##2##4##(2008-5#1)(2010-12#1)
a reliable##54##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-12#1)(1994-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
a relict##2##2##(2008-6#1)(2009-6#1)
a remarkable decrease in##2##4##(2008-1#1)(2008-11#1)
a remarkable decrease##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
a remarkable example of##2##4##(2009-6#1)(2012-2#1)
a remarkable increase in the##2##5##(1991-2#1)(2012-3#1)
a remarkable increase of##3##4##(2008-7#1)(2008-8#1)(2008-9#1)
a remarkable increase##5##3##(1991-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
a remarkable##30##2##(1991-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)
a remarkably##2##2##(2008-10#1)(2008-8#1)
a remedy##2##2##(1994-12#1)(2008-11#1)
a remission##3##2##(1995-11#1)(2008-3#1)(2009-11#1)
a remnant of##2##3##(2008-10#1)(2009-6#1)
a remote##8##2##(1992-1#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
a renal##6##2##(1995-2#1)(1995-5#1)(2008-11#2)(2008-12#1)(2012-12#1)
a renewable##2##2##(2008-10#1)(2013-1#1)
a renewed emphasis on##2##4##(1996-12#1)(1996-3#1)
a renewed interest in##2##4##(2011-2#1)(2013-8#1)
a renewed##7##2##(1991-2#1)(1995-1#1)(1996-12#1)(1996-3#1)(2008-12#1)(2011-2#1)(2013-8#1)
a repeat of##2##3##(2008-10#1)(2013-8#1)
a repeat##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
a repeatability of 2##2##4##(2008-10#2)
a repeatability##4##2##(2008-10#4)
a repeated batch process##2##4##(2008-11#1)(2008-7#1)
a repeated measures design##2##4##(1993-3#1)(2008-10#1)
a repeated##7##2##(1993-3#1)(2008-10#3)(2008-11#2)(2008-7#1)
a repeating##2##2##(2008-7#1)(2008-9#1)
a repetition rate of##4##4##(2007-12#1)(2008-3#3)
a repetition rate##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
a repetitive##5##2##(1991-12#1)(2008-10#3)(2008-11#1)
a replacement for##5##3##(1992-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
a replacement of##3##3##(1992-8#1)(2008-10#1)(2008-4#1)
a replacement##10##2##(1991-12#1)(1992-3#1)(1992-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#1)
a replication##3##2##(1992-3#1)(1994-11#1)(2011-2#1)
a report of a##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
a report of four##2##4##(1991-12#1)(2011-2#1)
a report of the##2##4##(1996-9#1)(2012-3#1)
a report of two cases##2##5##(2011-2#1)(2013-8#1)
a report of##14##3##(1991-12#1)(1996-9#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a report on the##2##4##(1990-9#1)(2008-10#1)
a report on##5##3##(1990-9#2)(1993-2#1)(2008-10#1)(2008-8#1)
a report##25##2##(1990-9#2)(1991-12#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-9#1)(1997-2#2)(2008-10#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
a reported##5##2##(1994-9#1)(2008-10#2)(2010-8#1)(2011-2#1)
a reporter gene##8##3##(1991-5#1)(1992-3#1)(1994-5#2)(1995-8#1)(2008-11#1)(2008-8#1)(2010-10#1)
a reporter##24##2##(1991-5#1)(1992-3#1)(1992-6#1)(1994-5#2)(1995-2#1)(1995-8#1)(1996-3#2)(1997-8#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-10#1)(2011-1#1)
a representation of##3##3##(2008-10#1)(2009-10#1)(2009-6#1)
a representative example##2##3##(2008-10#1)(2008-9#1)
a representative of a##2##4##(2011-2#2)
a representative of the##3##4##(2008-10#1)(2011-2#2)
a representative of##5##3##(2008-10#1)(2011-2#4)
a representative sample of##2##4##(1991-12#1)(2009-7#1)
a representative##31##2##(1991-12#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#4)(2009-5#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-2#2)
a repressor of##2##3##(1991-10#1)(2011-2#1)
a repressor##4##2##(1991-10#1)(2008-9#1)(2010-4#1)(2011-2#1)
a reproducible and precise##2##4##(1996-2#1)(2008-3#1)
a reproducible##9##2##(1991-3#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
a requirement for##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
a requirement##6##2##(1993-3#1)(2008-10#2)(2008-11#2)(2008-7#1)
a research agenda##3##3##(1994-12#1)(2008-12#2)
a research field##2##3##(2008-7#1)(2010-11#1)
a research nurse##2##3##(2008-11#2)
a research program to##2##4##(2008-10#1)(2012-3#1)
a research project that##2##4##(1991-9#1)(2010-10#1)
a research project##4##3##(1991-6#1)(1991-9#1)(2010-10#2)
a research study##2##3##(2008-4#1)(2013-1#1)
a research##33##2##(1990-3#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#3)(2008-4#1)(2008-7#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a reservoir##6##2##(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#3)
a residency program##3##3##(1994-12#2)(1995-1#1)
a residency##4##2##(1993-12#1)(1994-12#2)(1995-1#1)
a residual##9##2##(1993-2#1)(1994-2#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)
a resin##6##2##(1990-5#1)(2008-10#4)(2013-1#1)
a resistance gene##3##3##(2008-10#3)
a resistance##9##2##(2008-10#6)(2008-8#1)(2010-1#1)(2013-1#1)
a resistance-breaking##2##2##(2008-10#2)
a resistant and susceptible##2##4##(2008-10#2)
a resistant cultivar##4##3##(2008-10#4)
a resistant##16##2##(2008-10#16)
a resolution of##5##3##(2008-10#3)(2008-3#2)
a resolution to##2##3##(1992-9#1)(1997-2#1)
a resolution##8##2##(1992-9#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#2)
a resonance##5##2##(1990-8#1)(2008-10#2)(2008-3#1)(2010-7#1)
a resource for##6##3##(1994-9#1)(1995-9#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-3#1)
a resource##12##2##(1994-9#1)(1995-12#1)(1995-9#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#2)(2010-5#1)(2010-8#1)(2012-3#1)
a response rate of##3##4##(1992-2#1)(2008-11#1)(2011-2#1)
a response that##3##3##(1993-8#1)(2007-11#1)(2011-2#1)
a response time of##11##4##(2008-10#11)
a response time##13##3##(2008-10#13)
a response to##14##3##(1990-2#1)(2008-10#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
a response##49##2##(1990-2#1)(1992-1#1)(1992-2#1)(1993-8#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#2)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
a resting##2##2##(1996-2#1)(2008-12#1)
a restricted##13##2##(1990-8#1)(1993-12#1)(1994-2#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-8#2)(2012-2#1)(2012-3#1)
a restriction enzyme##5##3##(1993-9#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)
a restriction fragment length polymorphism##2##5##(2008-10#2)
a restriction of##2##3##(2008-10#2)
a restriction##11##2##(1993-9#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-4#1)
a restrictive##2##2##(2010-2#1)(2010-4#1)
a restructured environment##2##3##(1994-3#1)(1996-3#1)
a restructured##6##2##(1994-12#1)(1994-3#1)(1996-1#1)(1996-3#3)
a restructuring program is##2##4##(1993-3#1)(1995-1#1)
a restructuring##4##2##(1993-3#1)(1995-1#1)(1996-1#1)(1996-3#1)
a result it##2##3##(2008-10#1)(2013-8#1)
a result of a##15##4##(1991-11#1)(1994-1#2)(1995-6#3)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)
a result of an##5##4##(1994-2#1)(1996-6#1)(2008-5#1)(2013-1#2)
a result of the rapid##2##5##(1993-8#1)(1994-9#1)
a result of the##49##4##(1991-12#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-11#1)(1996-9#1)(1997-2#1)(2008-10#19)(2008-11#6)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#3)(2013-1#3)
a result of this##9##4##(1991-12#1)(1995-9#1)(2008-11#2)(2008-3#1)(2010-3#1)(2010-5#2)(2013-1#1)
a result of##196##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#4)(1992-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-1#2)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#2)(2008-10#43)(2008-11#22)(2008-12#4)(2008-3#6)(2008-5#6)(2008-7#6)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#3)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#4)
a result that is##2##4##(2008-10#2)
a result we##3##3##(1997-7#1)(2008-8#1)(2008-9#1)
a result##298##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#4)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-3#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-5#1)(1997-7#2)(1997-8#2)(2007-12#2)(2007-8#2)(2008-10#66)(2008-11#31)(2008-12#7)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#8)(2008-7#6)(2008-8#10)(2008-9#11)(2009-10#1)(2009-11#2)(2009-12#3)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#12)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#14)(2013-7#2)(2013-8#7)
a resurgence in the##2##4##(2008-11#1)(2009-12#1)
a resurgence of interest in##2##5##(1997-7#1)(2013-1#1)
a resurgence of##3##3##(1997-7#1)(2008-12#1)(2013-1#1)
a resurgence##5##2##(1997-7#1)(2008-11#1)(2008-12#1)(2009-12#1)(2013-1#1)
a retained##3##2##(2008-12#2)(2012-2#1)
a retardation##2##2##(1995-6#1)(2008-5#1)
a retrospective analysis of##5##4##(1990-9#1)(1993-9#1)(1996-11#1)(2010-7#1)(2011-2#1)
a retrospective analysis##8##3##(1990-9#1)(1993-9#1)(1996-11#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#2)
a retrospective and prospective##2##4##(1992-12#1)(2008-8#1)
a retrospective case series##2##4##(2011-2#1)(2013-7#1)
a retrospective case##3##3##(2008-9#1)(2011-2#1)(2013-7#1)
a retrospective chart review of##3##5##(2008-10#1)(2008-3#1)(2013-1#1)
a retrospective cohort study##2##4##(2010-10#1)(2012-3#1)
a retrospective cohort##4##3##(2008-9#1)(2010-10#1)(2012-3#1)(2013-8#1)
a retrospective multicenter study##2##4##(2010-6#1)(2012-2#1)
a retrospective review of##6##4##(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
a retrospective review##8##3##(1996-1#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
a retrospective study of the##2##5##(2011-2#1)(2012-3#1)
a retrospective study of##6##4##(1993-11#1)(1995-5#1)(2010-11#1)(2011-2#2)(2012-3#1)
a retrospective study##14##3##(1993-11#1)(1993-8#1)(1995-5#1)(1996-11#1)(1996-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-3#2)(2013-1#1)
a retrospective##59##2##(1990-12#1)(1990-9#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
a retrovirus##2##2##(1994-5#1)(2008-11#1)
a return to the##2##4##(2008-7#1)(2012-3#1)
a return to##5##3##(1994-12#1)(1997-3#1)(2008-12#1)(2008-7#1)(2012-3#1)
a return##6##2##(1994-12#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
a reversal##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
a reverse fragment to a cDNA encoding human 6A8 alpha-mannosidase##3##10##(2008-8#3)
a reverse##11##2##(1996-3#1)(2008-10#5)(2008-8#3)(2008-9#2)
a reversed phase##3##3##(2008-10#2)(2008-5#1)
a reversed##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
a reversed-phase C18 column with##2##5##(2008-10#2)
a reversed-phase C18##3##3##(2008-10#3)
a reversed-phase HPLC##2##3##(2008-10#2)
a reversed-phase##11##2##(2008-10#11)
a reversible redox##3##3##(2008-10#3)
a reversible##17##2##(1990-2#1)(1992-6#1)(1996-12#1)(1996-3#1)(1996-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#3)(2011-2#1)(2013-1#1)
a review and##5##3##(1994-8#1)(2008-11#2)(2012-3#1)(2013-1#1)
a review of current##2##4##(2008-11#1)(2008-4#1)
a review of literature##4##4##(1992-5#1)(1993-6#1)(2008-1#1)(2013-1#1)
a review of the current literature##2##6##(2010-12#1)(2011-2#1)
a review of the current##5##5##(2008-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2011-7#1)
a review of the evidence##2##5##(1996-12#1)(2013-1#1)
a review of the literature and##5##6##(1990-3#1)(1991-1#1)(1991-3#1)(2006-5#1)(2013-1#1)
a review of the literature on the##3##7##(2008-11#1)(2009-6#1)(2013-1#1)
a review of the literature on this##2##7##(1993-6#1)(2008-5#1)
a review of the literature on##5##6##(1993-6#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
a review of the literature##38##5##(1990-3#1)(1991-1#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-5#1)(1993-6#1)(1995-11#1)(2006-5#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#5)
a review of the##67##4##(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-5#1)(1992-9#1)(1993-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#8)
a review of their##2##4##(1993-2#1)(2008-11#1)
a review of##106##3##(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1995-11#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#11)(2008-11#11)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#6)(2011-7#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#12)
a review##147##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#2)(1992-1#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-5#1)(2007-11#1)(2008-1#3)(2008-10#27)(2008-11#14)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#6)(2011-7#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#16)(2013-7#1)
a revised model##2##3##(1991-9#1)(2008-10#1)
a revised##7##2##(1991-9#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)
a revolution in##2##3##(1997-8#1)(2008-5#1)
a revolution of##2##3##(2008-10#1)(2011-1#1)
a revolution##5##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
a revolutionary##3##2##(2008-7#1)(2009-6#1)(2010-7#1)
a reward##3##2##(1991-3#1)(2008-4#1)(2009-8#1)
a rewarding##2##2##(1993-3#1)(1995-12#1)
a rhabdomyosarcoma of the left ventricle##2##6##(2013-1#2)
a rhythm##2##2##(2008-5#1)(2008-6#1)
a ribosomal protein##3##3##(1991-7#1)(1996-6#1)(2013-8#1)
a ribosomal##6##2##(1991-7#1)(1996-6#1)(2008-10#3)(2013-8#1)
a ribosome binding##2##3##(2008-10#1)(2010-6#1)
a ribosome##3##2##(1991-9#1)(2008-10#1)(2010-6#1)
a ribozyme##3##2##(1993-9#1)(1995-3#1)(2008-11#1)
a rice BAC clone containing##2##5##(2008-8#2)
a rice cDNA##2##3##(2008-10#1)(2008-9#1)
a rice genomic##2##3##(1996-12#1)(2008-8#1)
a rice##13##2##(1996-12#1)(2008-10#2)(2008-8#5)(2008-9#4)(2009-10#1)
a rich and##2##3##(2008-12#1)(2008-3#1)
a rich##16##2##(1993-1#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
a right to##5##3##(1994-8#1)(1995-12#3)(2008-12#1)
a right##13##2##(1993-3#1)(1994-8#1)(1995-12#3)(1995-8#1)(1997-6#1)(2008-1#1)(2008-12#2)(2008-7#1)(2012-3#1)(2013-8#1)
a right-sided##2##2##(2008-11#1)(2010-7#1)
a rigid##10##2##(1991-2#1)(1992-1#1)(1996-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-10#2)
a rigorous##13##2##(1991-2#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2012-2#1)
a ring cavity##2##3##(2008-3#2)
a ring##7##2##(1993-1#1)(1996-2#1)(2008-10#2)(2008-3#3)
a ringing##2##2##(2011-1#2)
a rise in body##3##4##(1992-3#1)(2008-5#2)
a rise in the##3##4##(2008-10#2)(2010-3#1)
a rise in##12##3##(1992-3#1)(1994-12#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-3#1)(2013-8#1)
a rise of##2##3##(1990-2#1)(2008-10#1)
a rise##15##2##(1990-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2010-3#1)(2013-8#1)
a risk analysis##2##3##(2012-2#2)
a risk factor for development of##2##6##(1997-3#1)(2011-2#1)
a risk factor for##21##4##(1990-8#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
a risk factor##23##3##(1990-8#1)(1992-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
a risk for##2##3##(2008-10#1)(2008-12#1)
a risk management program##2##4##(1993-2#1)(2013-1#1)
a risk management##4##3##(1993-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
a risk of##10##3##(1992-6#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
a risk to##2##3##(2011-2#1)(2013-8#1)
a risk##53##2##(1990-8#1)(1992-3#1)(1992-6#1)(1993-2#1)(1996-6#1)(1997-1#2)(1997-3#2)(1997-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#2)(2010-5#2)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
a river##3##2##(2008-10#2)(2008-8#1)
a road map##3##3##(1992-2#2)(2010-12#1)
a road##5##2##(1992-2#2)(1997-2#1)(2010-12#1)(2012-2#1)
a robust and##2##3##(2008-10#1)(2013-1#1)
a robust method##5##3##(2008-1#1)(2008-10#3)(2008-2#1)
a robust##24##2##(1992-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-9#1)(2009-9#1)(2010-1#2)(2010-10#1)(2012-2#2)(2013-1#3)
a rock-solid foundation##2##3##(1993-1#1)(1996-1#1)
a role for neurotrophins in##2##5##(1995-8#1)(1996-12#1)
a role for the##2##4##(1994-9#1)(2009-10#1)
a role for these##2##4##(1990-3#1)(1997-8#1)
a role for this##2##4##(1997-1#1)(2008-5#1)
a role for##41##3##(1990-3#1)(1990-5#2)(1990-6#1)(1992-6#1)(1992-7#1)(1993-12#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-8#1)(1997-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-6#2)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
a role in host defense##2##5##(2008-10#1)(2009-10#1)
a role in maintaining##2##4##(1994-11#1)(2009-10#1)
a role in mediating##3##4##(1996-2#1)(1996-5#1)(2011-2#1)
a role in public##2##4##(1996-2#1)(2008-11#1)
a role in resistance##4##4##(1992-7#1)(2008-10#3)
a role in the development of##6##6##(1994-12#1)(2009-1#1)(2010-12#1)(2011-10#1)(2011-2#1)(2013-8#1)
a role in the development##7##5##(1994-12#1)(1996-2#1)(2009-1#1)(2010-12#1)(2011-10#1)(2011-2#1)(2013-8#1)
a role in the diagnosis of##2##6##(2008-11#1)(2009-11#1)
a role in the diagnosis##3##5##(2008-11#1)(2009-11#1)(2012-2#1)
a role in the evolution of##2##6##(2008-8#1)(2013-1#1)
a role in the process of##2##6##(1993-11#1)(1997-7#1)
a role in the##56##4##(1990-11#1)(1990-5#2)(1991-1#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
a role in##156##3##(1990-11#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#4)(1992-6#4)(1992-7#1)(1993-11#1)(1993-3#2)(1994-1#1)(1994-11#4)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#5)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#3)(2007-12#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#8)(2008-8#2)(2008-9#2)(2009-1#3)(2009-10#4)(2009-11#1)(2009-4#1)(2009-6#2)(2009-7#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#2)(2011-10#2)(2011-2#9)(2012-12#1)(2012-2#10)(2012-3#3)(2012-7#1)(2013-1#3)(2013-8#7)
a role of the##5##4##(1992-6#2)(1997-1#1)(2008-11#1)(2010-4#1)
a role of##14##3##(1992-6#2)(1993-6#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
a role##230##2##(1990-11#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#4)(1992-6#7)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#5)(1994-12#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-6#2)(1995-8#3)(1995-9#2)(1996-12#4)(1996-2#6)(1996-3#1)(1996-5#1)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#2)(1997-9#1)(2007-12#1)(2008-10#29)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#2)(2009-1#3)(2009-10#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#5)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-10#2)(2011-2#14)(2012-12#1)(2012-2#12)(2012-3#4)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#8)
a room-temperature##2##2##(2008-2#1)(2008-3#1)
a root##5##2##(2008-10#4)(2011-2#1)
a root-dip##2##2##(2008-10#2)
a rotary evaporator##2##3##(2008-10#2)
a rotary##4##2##(2008-10#4)
a rotating bioreactor##2##3##(2008-10#2)
a rotating disk##4##3##(2008-10#3)(2008-3#1)
a rotating##17##2##(1990-12#2)(1994-2#1)(2008-10#10)(2008-3#2)(2008-8#1)(2010-12#1)
a rotation##4##2##(2008-11#1)(2008-8#1)(2011-2#2)
a rough estimate of##2##4##(1994-9#1)(2008-11#1)
a rough##3##2##(1994-9#1)(2008-11#1)(2011-2#1)
a roughly##2##2##(2008-10#2)
a round##6##2##(1993-11#1)(1993-6#1)(2008-10#2)(2012-2#1)(2013-1#1)
a route for##2##3##(1993-6#1)(2008-10#1)
a route to the##2##4##(1994-9#1)(2008-11#1)
a route to##3##3##(1994-9#1)(2008-11#1)(2008-8#1)
a route##5##2##(1993-6#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
a routine EEG##3##3##(2008-7#3)
a routine laboratory##3##3##(1990-2#1)(1994-1#1)(2008-10#1)
a routine procedure##2##3##(2008-9#1)(2011-1#1)
a routine##25##2##(1990-2#1)(1991-1#1)(1991-6#2)(1992-3#1)(1993-2#1)(1994-1#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-1#1)(2008-10#6)(2008-3#1)(2008-7#4)(2008-9#1)(2011-1#1)(2013-1#1)
a row##2##2##(2007-12#1)(2008-10#1)
a rsd##2##2##(2008-10#2)
a rudimentary##2##2##(2008-10#1)(2010-7#1)
a rule##8##2##(1991-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
a run##2##2##(2008-10#2)
a running##3##2##(1993-3#1)(2008-10#2)
a rupture of the##2##4##(2008-10#1)(2008-7#1)
a rupture of##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
a rupture##4##2##(1994-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
a ruptured aneurysm##2##3##(1997-8#1)(2013-8#1)
a ruptured dissecting aneurysm##2##4##(2008-7#2)
a ruptured##6##2##(1995-12#1)(1997-8#1)(2008-7#3)(2013-8#1)
a rural community##6##3##(1994-1#1)(2008-11#1)(2009-10#1)(2010-6#2)(2012-2#1)
a rural health##2##3##(1993-3#1)(1997-3#1)
a rural##18##2##(1991-1#1)(1992-2#1)(1993-3#1)(1993-5#2)(1994-1#1)(1994-2#1)(1994-6#1)(1997-3#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-4#1)(2010-6#2)(2011-2#2)(2012-2#1)
a rust##2##2##(2008-10#2)
a rye-vetch green manure##2##4##(2008-10#2)
a sacral##2##2##(2008-10#1)(2008-7#1)
a safe and effective alternative to##2##6##(1995-8#1)(2008-11#1)
a safe and effective alternative##3##5##(1995-8#1)(2008-11#1)(2011-2#1)
a safe and effective##9##4##(1990-8#1)(1993-12#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
a safe and##20##3##(1990-11#1)(1990-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a safe##39##2##(1990-11#2)(1990-8#1)(1991-12#1)(1991-3#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a safeguard##2##2##(1994-9#1)(2011-2#1)
a safer##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
a safety##2##2##(2008-11#1)(2010-11#1)
a salient##2##2##(1995-3#1)(2010-5#1)
a salivary##2##2##(2007-12#1)(2008-10#1)
a salt of##2##3##(2008-10#1)(2012-2#1)
a salt##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
a salvage##2##2##(1992-2#1)(2011-2#1)
a samarium-cobalt magnet##2##3##(2008-10#2)
a same##4##2##(2008-10#3)(2009-8#1)
a sample and##2##3##(2008-10#2)
a sample containing##6##3##(2008-10#6)
a sample diluted##2##3##(2008-10#2)
a sample flow rate of 1##3##6##(2008-10#3)
a sample flow rate of##5##5##(2008-10#5)
a sample flow##6##3##(2008-10#6)
a sample frequency of##10##4##(2008-10#10)
a sample from a first settlement of##2##7##(2008-10#2)
a sample group of##2##4##(1993-11#1)(2008-10#1)
a sample injection valve##2##4##(2008-10#2)
a sample injection volume of##3##5##(2008-10#3)
a sample injection##6##3##(2008-10#6)
a sample introduction##3##3##(2008-10#3)
a sample is##3##3##(2008-10#3)
a sample loading##2##3##(2008-10#2)
a sample loop of##2##4##(2008-10#2)
a sample of 15##2##4##(1991-2#1)(2010-11#1)
a sample of 2##3##4##(1992-12#1)(1993-12#1)(2008-4#1)
a sample of 5##2##4##(2008-10#2)
a sample of##75##3##(1990-8#1)(1991-2#2)(1992-12#1)(1993-12#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-4#1)(2008-10#16)(2008-11#7)(2008-12#7)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#4)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
a sample plan##2##3##(1993-3#1)(2008-10#1)
a sample size##3##3##(1994-9#1)(1995-5#1)(2012-2#1)
a sample solution was##2##4##(2008-10#2)
a sample solution##4##3##(2008-10#4)
a sample throughput of##11##4##(2008-10#11)
a sample throughput##12##3##(2008-10#12)
a sample volume of 100 ml##2##6##(2008-10#2)
a sample volume of 100##3##5##(2008-10#3)
a sample volume of 50##2##5##(2008-10#2)
a sample volume of##16##4##(2008-10#16)
a sample volume##17##3##(2008-10#17)
a sample with##2##3##(1991-12#1)(2008-10#1)
a sample##207##2##(1990-8#1)(1991-12#1)(1991-2#2)(1992-12#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#130)(2008-11#7)(2008-12#8)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#4)(2010-8#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
a sampling bout##2##3##(2008-10#2)
a sampling flow rate of##2##5##(2008-10#2)
a sampling frequency of 40 samples per hour##2##8##(2008-10#2)
a sampling frequency of##24##4##(2008-10#22)(2010-9#1)(2013-1#1)
a sampling frequency##25##3##(2008-10#23)(2010-9#1)(2013-1#1)
a sampling rate of 15##2##5##(2008-10#2)
a sampling rate of 60##3##5##(2008-10#3)
a sampling rate of##19##4##(2008-10#19)
a sampling volume of##3##4##(2008-10#3)
a sampling##64##2##(1996-3#1)(2008-10#59)(2008-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
a sandwich type##2##3##(2008-10#2)
a sandwich##5##2##(2008-10#5)
a sandwich-type##2##2##(2008-10#2)
a sapphire##2##2##(2008-2#1)(2008-3#1)
a satellite##6##2##(1994-1#2)(2008-10#2)(2008-12#1)(2008-3#1)
a satisfactory##16##2##(1993-11#1)(1995-5#1)(1996-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
a saturable absorber##3##3##(2008-3#3)
a saturable##6##2##(1990-8#1)(1992-3#1)(2008-3#4)
a saturated solution of##2##4##(2008-10#2)
a saturated##3##2##(2008-10#2)(2008-3#1)
a saturating concentration of##2##4##(1990-10#1)(1993-6#1)
a saturating##3##2##(1990-10#1)(1993-6#1)(2008-8#1)
a saturation##2##2##(2008-10#2)
a scaffold for##2##3##(2008-8#1)(2011-2#1)
a scaffold##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
a scaffold-free##2##2##(2011-2#2)
a scaffolding##2##2##(1993-2#1)(2009-12#1)
a scale larger than##2##4##(2008-10#2)
a scale of 0 to##4##5##(2008-10#1)(2010-6#1)(2010-7#1)(2010-8#1)
a scale of##10##3##(2008-10#3)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#2)
a scale##16##2##(1995-8#1)(2008-10#5)(2008-7#1)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#4)
a scan rate of 100 mV s(-1)##2##7##(2008-10#2)
a scan rate of##4##4##(2008-10#4)
a scan##6##2##(2008-10#5)(2013-1#1)
a scanning electron microscope##3##4##(2008-10#2)(2008-3#1)
a scanning##6##2##(2007-12#1)(2008-10#2)(2008-3#3)
a scattering medium##2##3##(2008-2#1)(2008-3#1)
a scattering##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
a scavenger of##2##3##(1995-2#1)(2008-11#1)
a scenario of##4##3##(2008-10#4)
a scenario##6##2##(2008-10#4)(2008-12#1)(2011-3#1)
a scheduled##2##2##(1994-3#1)(2013-1#1)
a scheme for##2##3##(1991-5#1)(2008-10#1)
a scheme##4##2##(1991-5#1)(1995-11#1)(2008-10#2)
a school of##2##3##(2008-12#1)(2008-2#1)
a school##7##2##(1990-2#1)(1991-12#1)(1994-1#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
a school-based##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
a schwannoma##2##2##(2008-7#1)(2011-2#1)
a scid mouse##2##3##(1995-2#2)
a science##2##2##(2008-10#1)(2010-10#1)
a scientific##9##2##(1992-12#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2012-12#1)
a scientist##2##2##(2008-12#1)(2008-4#1)
a sclerosing agent##2##3##(1990-9#1)(1997-8#1)
a score of##3##3##(1992-1#1)(1997-5#1)(2008-5#1)
a score##5##2##(1992-1#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
a scoring matrix##2##3##(2008-9#2)
a scoring##5##2##(2007-8#1)(2008-11#1)(2008-9#2)(2011-3#1)
a screen for##4##3##(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
a screen of approximately##2##4##(2008-11#1)(2008-9#1)
a screen##6##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)
a screen-printed carbon electrode##2##4##(2008-10#2)
a screen-printed electrode##2##3##(2008-10#2)
a screen-printed##5##2##(2008-10#5)
a screening program for##2##4##(1991-6#2)
a screening tool for##4##4##(1993-12#1)(2008-10#1)(2010-9#1)(2013-1#1)
a screening tool##5##3##(1992-12#1)(1993-12#1)(2008-10#1)(2010-9#1)(2013-1#1)
a screening##23##2##(1991-6#3)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-12#2)(1996-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2010-9#2)(2011-3#1)(2013-1#1)
a screw and##2##3##(2009-10#1)(2011-2#1)
a screw##3##2##(2009-10#1)(2011-2#1)(2012-3#1)
a seamless##3##2##(2008-11#3)
a search for the##4##4##(1995-12#1)(1996-8#1)(2008-10#1)(2010-3#1)
a search for##10##3##(1992-1#1)(1995-12#1)(1996-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
a search##15##2##(1992-1#1)(1994-2#1)(1995-12#2)(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
a searchable##2##2##(2008-7#1)(2008-9#1)
a season##4##2##(1991-12#1)(2008-10#3)
a seasonal##3##2##(2008-10#1)(2008-9#1)(2012-5#1)
a seawater sample##2##3##(2008-10#2)
a second antibody##2##3##(2008-10#1)(2008-11#1)
a second cluster##2##3##(2008-10#2)
a second derivative##2##3##(2008-10#2)
a second dose##2##3##(2008-7#2)
a second exhaustive##2##3##(2013-1#2)
a second group##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
a second independent##2##3##(1991-12#1)(1995-6#1)
a second messenger##2##3##(1992-3#1)(1995-11#1)
a second order##2##3##(2008-10#1)(2008-5#1)
a second prey##2##3##(2008-8#2)
a second set of##3##4##(1993-12#1)(2008-10#1)(2013-1#1)
a second step##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
a second study##2##3##(1991-3#1)(2008-10#1)
a second time by##2##4##(1992-12#1)(2008-10#1)
a second time##3##3##(1992-12#1)(1996-12#1)(2008-10#1)
a second unknown##2##3##(1990-11#1)(2008-10#1)
a second##148##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-12#2)(1993-2#3)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#3)(1996-1#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-3#4)(1997-4#1)(1997-7#4)(2007-12#2)(2008-1#1)(2008-10#41)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
a second-line##3##2##(1992-12#2)(2010-12#1)
a second-order polynomial##2##3##(2008-10#2)
a second-order reaction##2##3##(1993-8#1)(2008-10#1)
a second-order##7##2##(1993-8#1)(1994-5#1)(2008-10#4)(2008-3#1)
a secondary operation for cubital tunnel syndrome##2##7##(2008-9#2)
a secondary role in##2##4##(2008-2#1)(2008-7#1)
a secondary sexual##2##3##(2008-9#2)
a secondary##23##2##(1990-11#1)(1990-9#1)(1992-12#1)(1993-8#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#4)(2009-8#1)(2011-2#3)(2012-2#1)
a secreted##6##2##(2008-11#3)(2009-8#2)(2010-11#1)
a secretory##4##2##(1990-12#1)(1993-12#1)(1995-11#1)(2008-1#1)
a section of the##3##4##(1996-5#1)(2008-10#1)(2008-3#1)
a section of##6##3##(1992-12#1)(1996-5#1)(2008-10#3)(2008-3#1)
a section on##4##3##(1991-2#1)(1992-2#1)(1997-2#1)(2012-2#1)
a section##10##2##(1991-2#1)(1992-12#1)(1992-2#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-3#1)(2012-2#1)
a secure##3##2##(1996-9#1)(2008-10#1)(2008-8#1)
a security##3##2##(1993-2#1)(1994-12#1)(2008-9#1)
a sediment##3##2##(2008-10#3)
a seed bank##3##3##(2008-8#3)
a seed lot with##2##4##(2008-10#2)
a seed lot##3##3##(2008-10#3)
a seed##13##2##(1994-11#2)(2008-10#7)(2008-8#4)
a seemingly##4##2##(1990-12#1)(2008-7#1)(2011-2#2)
a segment of the women's market began seeking changes in the health care system##2##14##(1994-3#2)
a segment of##4##3##(1994-3#2)(2008-10#1)(2009-10#1)
a segment##7##2##(1992-4#1)(1994-3#2)(2008-10#1)(2008-9#1)(2009-10#1)(2012-3#1)
a segmental##3##2##(2007-12#2)(2009-10#1)
a segregating population##4##3##(2008-10#3)(2012-3#1)
a select group of##2##4##(1995-3#1)(2009-3#1)
a select##3##2##(1995-3#1)(2009-3#1)(2012-12#1)
a selectable marker##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
a selected group of##4##4##(1990-9#1)(1994-6#1)(2008-10#1)(2013-1#1)
a selected range of mobile-wireless infrastructure##2##6##(2010-8#2)
a selected##15##2##(1990-9#1)(1994-6#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-8#2)(2013-1#1)(2013-8#1)
a selection marker##3##3##(1997-4#1)(2008-11#2)
a selection of representatives of Metro Toronto##2##7##(1994-1#2)
a selection of##8##3##(1994-1#2)(2008-10#2)(2008-11#3)(2008-9#1)
a selection response##2##3##(2008-8#2)
a selection##17##2##(1994-1#2)(1996-3#1)(1997-4#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-8#2)(2008-9#1)
a selective advantage##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
a selective and##3##3##(1995-11#1)(2008-10#2)
a selective fluorescence quenching agent for##2##6##(2008-10#2)
a selective fluorescence quenching##3##4##(2008-10#3)
a selective medium and##2##4##(2008-10#2)
a selective medium##7##3##(2008-10#7)
a selective pressure##2##3##(2008-9#1)(2013-1#1)
a selective probe for##2##4##(1994-8#2)
a selective quencher##2##3##(2008-10#2)
a selective##59##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)
a selectivity##2##2##(2008-10#2)
a self monitoring blood pressure device##3##6##(2008-10#3)
a self##5##2##(2008-10#4)(2008-11#1)
a self-assembled monolayer (SAM) of##2##5##(2008-10#2)
a self-assembled monolayer##5##3##(2008-10#4)(2008-8#1)
a self-assembled##8##2##(2008-10#7)(2008-8#1)
a self-assessment##4##2##(1995-3#1)(2008-11#1)(2008-9#1)(2012-2#1)
a self-directed learning##2##3##(2008-11#1)(2008-12#1)
a self-limiting##2##2##(1992-2#1)(2012-3#1)
a self-renewing##2##2##(1995-11#1)(2013-1#1)
a semantic differential##2##3##(1991-2#1)(1993-2#1)
a semester##2##2##(2009-3#1)(2011-2#1)
a semi-continuous##2##2##(2008-10#1)(2008-7#1)
a semi-empirical##2##2##(1992-4#1)(1994-12#1)
a semi-quantitative##2##2##(2008-10#1)(2011-2#1)
a semi-supervised learning##3##3##(2010-7#3)
a semiconductor laser##3##3##(2008-10#2)(2008-3#1)
a semiconductor##6##2##(2008-10#2)(2008-3#4)
a seminar##2##2##(1990-2#1)(2008-12#1)
a semiparametric model##2##3##(1996-2#1)(2010-11#1)
a semiparametric##3##2##(1996-2#1)(2010-11#1)(2010-5#1)
a semipermeable membrane##2##3##(2008-11#1)(2008-7#1)
a semipermeable##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
a semiquantitative##3##2##(1993-12#1)(2008-7#1)(2013-8#1)
a semiselective medium##2##3##(2008-10#2)
a semiselective##4##2##(2008-10#4)
a semistructured##3##2##(2010-9#1)(2011-1#1)(2011-2#1)
a sense of##11##3##(1992-1#1)(1993-12#1)(2008-11#3)(2008-12#2)(2008-4#1)(2009-10#1)(2009-8#1)(2013-8#1)
a sense##12##2##(1992-1#1)(1993-12#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2013-8#1)
a sensing##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
a sensitive absorption peak at##3##5##(2008-10#3)
a sensitive adsorptive##2##3##(2008-10#2)
a sensitive and convenient##3##4##(2008-10#3)
a sensitive and reliable##3##4##(1997-7#1)(2008-10#2)
a sensitive and simple method for##2##6##(2008-10#2)
a sensitive and specific##4##4##(1996-12#1)(1997-7#1)(2011-2#1)(2011-3#1)
a sensitive and##17##3##(1994-11#1)(1996-12#1)(1997-7#2)(2008-10#10)(2008-5#1)(2011-2#1)(2011-3#1)
a sensitive assay for##2##4##(2008-10#1)(2008-7#1)
a sensitive assay##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
a sensitive indicator strain in##2##5##(2008-10#2)
a sensitive indicator##3##3##(2008-10#2)(2008-7#1)
a sensitive means##2##3##(1992-6#1)(2008-10#1)
a sensitive method for the##2##5##(1993-2#1)(2008-10#1)
a sensitive method for##3##4##(1993-2#1)(2008-10#2)
a sensitive second##2##3##(2008-10#2)
a sensitive spectrophotometric##2##3##(2008-10#2)
a sensitive technique##2##3##(1996-12#1)(2008-10#1)
a sensitive tool for##2##4##(2008-10#1)(2012-2#1)
a sensitive voltammetric##2##3##(2008-10#2)
a sensitive##79##2##(1990-2#1)(1990-6#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-12#2)(1997-7#2)(2008-10#55)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
a sensitivity enhancement of##2##4##(2008-10#2)
a sensitivity of##16##3##(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#9)(2008-3#1)(2012-3#1)
a sensitivity##26##2##(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#15)(2008-12#2)(2008-3#3)(2012-3#1)
a sensor of##3##3##(2008-2#1)(2008-9#1)(2009-8#1)
a sensor##14##2##(2008-10#8)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
a sensory##6##2##(2007-12#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
a sentence##2##2##(1997-8#1)(2007-12#1)
a sentinel##3##2##(1991-12#1)(2008-9#2)
a separate species##2##3##(2008-10#2)
a separate##33##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-3#1)(2008-10#14)(2008-12#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
a separation length of##2##4##(2008-10#2)
a separation of the##2##4##(2008-10#1)(2011-2#1)
a separation of##5##3##(2008-10#3)(2011-2#2)
a separation voltage of##6##4##(2008-10#6)
a separation##19##2##(1995-5#1)(2008-10#15)(2010-7#1)(2011-2#2)
a septate bicornuate uterus##2##4##(2013-1#2)
a sequel##2##2##(2008-7#1)(2012-3#1)
a sequence of##13##3##(1990-11#1)(1993-12#1)(1995-6#1)(1996-2#1)(2008-10#5)(2008-3#1)(2009-6#1)(2011-2#1)(2013-8#1)
a sequence on the##2##4##(1995-2#1)(2008-9#1)
a sequence##30##2##(1990-11#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
a sequential extraction procedure##2##4##(2008-10#2)
a sequential extraction##4##3##(2008-10#4)
a sequential injection analysis system##4##5##(2008-10#4)
a sequential injection analysis##8##4##(2008-10#8)
a sequential injection system for##2##5##(2008-10#2)
a sequential injection system##7##4##(2008-10#7)
a sequential injection##23##3##(2008-10#23)
a sequential##36##2##(2008-10#35)(2008-8#1)
a series of 10##2##4##(2008-10#2)
a series of 20##2##4##(2008-7#2)
a series of alternating##2##4##(2008-2#2)
a series of compounds##2##4##(1991-5#1)(2010-11#1)
a series of d##2##4##(2008-10#2)
a series of different##2##4##(2008-10#1)(2011-4#1)
a series of events##2##4##(1992-8#1)(2008-10#1)
a series of executive function tasks##2##6##(2013-8#2)
a series of five##2##4##(1994-5#1)(2012-2#1)
a series of four##4##4##(2008-10#1)(2008-12#1)(2008-4#2)
a series of indicators##2##4##(1995-12#1)(2008-8#1)
a series of new##2##4##(2008-8#1)(2012-3#1)
a series of similar##2##4##(2008-8#1)(2011-2#1)
a series of surface##2##4##(2007-12#1)(2008-10#1)
a series of##191##3##(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-5#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-6#2)(2006-6#1)(2007-12#1)(2008-10#55)(2008-11#14)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#8)(2009-12#2)(2009-4#1)(2009-7#3)(2010-1#2)(2010-11#1)(2010-5#1)(2010-8#2)(2011-2#7)(2011-4#2)(2012-2#7)(2012-3#3)(2013-1#1)(2013-8#3)
a series##196##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-5#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-6#2)(2006-6#1)(2007-12#1)(2008-10#55)(2008-11#14)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#8)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#3)(2010-1#2)(2010-11#2)(2010-5#1)(2010-8#2)(2011-2#7)(2011-4#2)(2012-2#7)(2012-3#3)(2013-1#2)(2013-8#3)
a serine protease##3##3##(1992-6#1)(1995-3#1)(2008-11#1)
a serine##5##2##(1992-6#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#1)
a serine/threonine kinase##2##3##(2008-9#1)(2009-8#1)
a serine/threonine##3##2##(1996-2#1)(2008-9#1)(2009-8#1)
a serious and##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
a serious complication##4##3##(2010-5#2)(2011-2#1)(2013-1#1)
a serious disease of##8##4##(2008-10#8)
a serious disease##10##3##(2008-10#9)(2011-2#1)
a serious health problem##2##4##(1991-6#1)(2013-1#1)
a serious problem for##2##4##(2008-11#1)(2012-12#1)
a serious problem in##4##4##(2008-7#1)(2012-3#1)(2013-1#2)
a serious problem##10##3##(1997-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
a serious public health problem##2##5##(2008-12#1)(2012-12#1)
a serious public health##3##4##(2008-12#1)(2011-2#1)(2012-12#1)
a serious threat##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
a serious##64##2##(1990-11#1)(1991-1#1)(1991-6#2)(1996-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-6#1)(2011-2#8)(2012-12#3)(2012-3#2)(2013-1#5)(2013-8#1)
a serosal##2##2##(2008-1#1)(2008-12#1)
a serum and##2##3##(2008-10#1)(2008-11#1)
a serum##11##2##(2008-10#2)(2008-11#4)(2011-2#1)(2012-3#1)(2013-8#3)
a serum-free medium##7##3##(1990-11#1)(2008-11#6)
a serum-free suspension##2##3##(2008-11#2)
a serum-free##16##2##(1990-11#1)(2008-11#13)(2008-7#2)
a service##7##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-6#1)(2008-2#1)
a session##2##2##(2008-6#1)(2010-1#1)
a set of 20##2##4##(2008-10#1)(2008-8#1)
a set of criteria##3##4##(2008-3#1)(2008-6#1)(2008-7#1)
a set of molecular##2##4##(2008-10#2)
a set of primers##2##4##(1995-8#1)(2008-5#1)
a set of simple rules for##2##6##(2008-2#1)(2011-2#1)
a set of simple##3##4##(2008-2#1)(2008-8#1)(2011-2#1)
a set of specific##2##4##(2008-10#2)
a set of suprathreshold tests##2##5##(2008-9#2)
a set of three##2##4##(2008-10#2)
a set of three-way solenoid valves assembled to implement##2##9##(2008-10#2)
a set of three-way solenoid valves##4##6##(2008-10#4)
a set of##132##3##(1991-2#1)(1993-9#1)(1994-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-6#2)(2008-1#1)(2008-10#55)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#3)(2010-8#2)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
a set##134##2##(1991-2#1)(1993-9#1)(1994-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-6#2)(2008-1#1)(2008-10#55)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-8#2)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#4)
a setting for##2##3##(1994-12#1)(2013-8#1)
a setting##6##2##(1992-1#1)(1993-1#1)(1994-12#1)(2009-6#1)(2013-1#1)(2013-8#1)
a seven##3##2##(1996-6#1)(2008-12#1)(2012-2#1)
a seven-year period##3##3##(1996-12#1)(2011-3#2)
a several-fold##2##2##(1991-6#1)(2008-7#1)
a severalfold increase in##2##4##(1995-2#1)(2008-7#1)
a severe disease of##2##4##(2008-10#1)(2011-2#1)
a severe disease##5##3##(2008-10#4)(2011-2#1)
a severe preeclampsia##2##3##(2008-11#1)(2009-1#1)
a severe##31##2##(1992-5#1)(1993-6#2)(1994-8#1)(1996-1#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
a severely##3##2##(2008-10#1)(2010-10#1)(2012-12#1)
a severity##3##2##(1994-9#1)(1995-2#1)(2009-4#1)
a sex##4##2##(2008-10#1)(2008-8#1)(2010-6#1)(2010-8#1)
a sexual##6##2##(1996-3#1)(2008-10#1)(2008-8#2)(2013-1#1)(2013-8#1)
a sexually dimorphic##3##3##(1992-3#3)
a sexually##4##2##(1992-3#3)(2008-10#1)
a shake-flask##2##2##(2008-11#1)(2008-12#1)
a shallow##3##2##(1991-2#1)(2008-10#1)(2013-8#1)
a shampoo##6##2##(2008-10#1)(2008-5#5)
a shared##5##2##(1993-12#1)(2007-12#1)(2008-11#2)(2008-2#1)
a sharp decline##2##3##(2008-11#1)(2009-6#1)
a sharp rise in##2##4##(1992-1#1)(2010-12#1)
a sharp rise##3##3##(1992-1#1)(2008-10#1)(2010-12#1)
a sharp##17##2##(1991-3#1)(1992-1#1)(1992-10#1)(1993-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2009-6#1)(2010-12#1)
a sharply##2##2##(2010-6#1)(2011-2#1)
a shear##5##2##(2008-11#3)(2010-1#1)(2013-1#1)
a sheep##4##2##(1996-12#1)(1997-3#1)(2011-2#2)
a shield##2##2##(2008-11#1)(2009-11#1)
a shift from##7##3##(1993-1#2)(1993-12#1)(2007-12#1)(2008-9#1)(2009-12#1)(2010-12#1)
a shift in the##6##4##(1991-3#1)(1993-8#1)(1994-11#1)(2008-10#3)
a shift in##10##3##(1991-3#1)(1993-8#1)(1994-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)
a shift of##3##3##(1991-12#1)(1994-5#1)(2008-10#1)
a shift to##3##3##(1994-5#1)(2010-11#1)(2010-12#1)
a shift toward##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
a shift##28##2##(1991-12#1)(1991-3#1)(1993-1#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#2)(1996-2#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-2#1)
a shock##2##2##(1996-2#1)(2013-1#1)
a shoot##2##2##(2008-10#2)
a short arm##2##3##(2008-9#2)
a short description of the##2##5##(2007-12#1)(2008-10#1)
a short length of##2##4##(2007-12#1)(2008-10#1)
a short peptide##2##3##(1995-2#1)(2012-12#1)
a short period of time to##2##6##(1996-3#1)(2013-1#1)
a short period of time##7##5##(1993-3#1)(1995-5#1)(1996-3#1)(2008-11#2)(2010-11#1)(2013-1#1)
a short period of##12##4##(1993-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-11#1)(2013-1#3)
a short period##17##3##(1990-8#1)(1993-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
a short response time##3##4##(2008-10#3)
a short review##2##3##(2009-3#1)(2012-12#1)
a short time##8##3##(1991-3#1)(1995-11#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-7#1)
a short##91##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#2)(1992-12#1)(1993-2#2)(1993-3#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-9#1)(2007-12#3)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#5)(2009-3#1)(2010-11#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#5)(2013-8#1)
a short-lived##3##2##(1991-2#1)(2012-12#1)(2012-3#1)
a short-term##7##2##(1990-2#1)(1995-12#1)(1997-8#1)(2008-11#2)(2012-3#1)(2013-1#1)
a shortage of##8##3##(1991-2#1)(1993-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-8#1)
a shortage##9##2##(1991-2#1)(1993-2#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-8#1)
a shortened##6##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)
a shorter analysis time than##2##5##(2008-10#2)
a shorter analysis time##3##4##(2008-10#3)
a shorter duration##2##3##(2008-8#1)(2008-9#1)
a shorter time##4##3##(1996-2#1)(1996-3#1)(2008-9#1)(2011-2#1)
a shorter##25##2##(1990-8#1)(1992-3#2)(1993-11#1)(1995-2#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2010-11#1)(2011-2#1)(2013-1#2)
a shoulder##4##2##(2008-10#4)
a shutdown##2##2##(1995-2#1)(1996-12#1)
a shuttle##2##2##(2008-11#1)(2008-4#1)
a side##5##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
a sigma##2##2##(1995-2#1)(1995-6#1)
a sigmoid##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
a sigmoidal##2##2##(2008-10#2)
a sign of##6##3##(1990-12#1)(1996-3#1)(2008-10#1)(2009-10#1)(2013-1#1)(2013-8#1)
a sign##7##2##(1990-12#1)(1996-3#1)(2008-10#1)(2009-10#1)(2010-6#1)(2013-1#1)(2013-8#1)
a signal at##2##3##(2008-3#2)
a signal for##4##3##(2008-10#1)(2008-11#2)(2009-8#1)
a signal in##2##3##(2008-11#1)(2008-2#1)
a signal of##2##3##(2008-11#1)(2008-5#1)
a signal peptidase##2##3##(1991-10#1)(1993-12#1)
a signal peptide and##2##4##(2008-4#1)(2010-6#1)
a signal peptide##5##3##(1993-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-6#1)
a signal to potential conspecific brood##2##6##(2008-8#2)
a signal to##3##3##(2008-10#1)(2008-8#2)
a signal transduction pathway##2##4##(1994-11#1)(2008-10#1)
a signal##37##2##(1991-10#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#4)(2009-8#1)(2010-6#1)(2010-8#1)
a signal-anchor##3##2##(1991-10#3)
a signal-to-noise ratio (S/N) of 3##2##6##(2008-10#2)
a signal-to-noise ratio of 3##7##5##(2008-10#6)(2008-3#1)
a signal-to-noise ratio of##11##4##(2008-10#9)(2008-3#2)
a signal-to-noise ratio##13##3##(2008-10#11)(2008-3#2)
a signal-to-noise##15##2##(2008-10#12)(2008-3#3)
a signaling##3##2##(2009-6#1)(2012-2#1)(2013-1#1)
a significance##2##2##(2008-10#1)(2012-2#1)
a significant (P &lt##5##4##(1993-12#1)(2008-10#2)(2012-2#2)
a significant (P = 0##2##5##(2008-10#1)(2008-8#1)
a significant (P##7##3##(1993-12#1)(2008-10#3)(2008-8#1)(2012-2#2)
a significant advance in##2##4##(1997-7#1)(2011-2#1)
a significant advantage over##2##4##(2008-10#2)
a significant advantage##3##3##(2008-10#2)(2009-1#1)
a significant amount of##5##4##(1991-2#1)(1997-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
a significant and##8##3##(1994-6#1)(2008-10#2)(2008-12#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
a significant association between##4##4##(2008-10#1)(2009-6#1)(2011-2#2)
a significant association with##2##4##(1992-2#1)(2012-2#1)
a significant association##8##3##(1990-8#1)(1992-2#1)(2008-10#2)(2009-6#1)(2011-2#2)(2012-2#1)
a significant cause of##2##4##(2008-11#1)(2012-3#1)
a significant change in the##5##5##(1991-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
a significant change in##10##4##(1991-2#1)(1993-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)(2011-2#1)
a significant component of the##2##5##(2008-10#1)(2008-12#1)
a significant contribution to##5##4##(1992-12#1)(1994-12#1)(2008-11#2)(2013-1#1)
a significant contribution##6##3##(1992-12#1)(1994-12#1)(2008-11#2)(2013-1#1)(2013-8#1)
a significant correlation between##5##4##(1990-5#1)(2008-10#1)(2008-12#1)(2010-4#1)(2013-8#1)
a significant correlation was##3##4##(2008-10#2)(2011-2#1)
a significant correlation##11##3##(1990-5#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#2)(2013-8#1)
a significant decrease in both##2##5##(1996-2#1)(1997-1#1)
a significant decrease in the##4##5##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
a significant decrease in##29##4##(1991-6#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#3)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
a significant decrease of the##5##5##(1992-6#1)(2008-1#1)(2008-10#2)(2008-11#1)
a significant decrease of##8##4##(1992-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2009-6#1)(2012-3#1)
a significant decrease##40##3##(1991-6#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-5#3)(2009-11#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
a significant degree of##2##4##(1990-5#1)(2011-2#1)
a significant degree##4##3##(1990-5#1)(2008-11#1)(2008-4#1)(2011-2#1)
a significant difference between the##4##5##(1992-2#1)(2008-7#1)(2009-7#1)(2011-2#1)
a significant difference between##8##4##(1992-2#1)(1995-5#1)(1995-8#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#2)
a significant difference in the##3##5##(2008-10#1)(2009-3#1)(2013-1#1)
a significant difference in##8##4##(1990-12#1)(2008-10#2)(2008-9#1)(2009-3#1)(2012-3#1)(2012-6#1)(2013-1#1)
a significant difference##20##3##(1990-12#1)(1992-2#1)(1993-3#1)(1995-5#1)(1995-8#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#1)
a significant diminution in##2##4##(2008-10#2)
a significant effect in##2##4##(1991-8#1)(2008-11#1)
a significant effect of##4##4##(1996-12#1)(2006-6#1)(2008-10#1)(2010-7#1)
a significant effect on both##2##5##(1995-12#1)(2008-10#1)
a significant effect on the##11##5##(1991-6#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
a significant effect on##24##4##(1990-6#2)(1991-6#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
a significant effect##35##3##(1990-6#2)(1991-6#1)(1991-8#1)(1992-12#1)(1995-12#1)(1996-12#2)(1996-2#1)(2006-6#1)(2007-11#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
a significant enhancement of the##3##5##(2008-10#3)
a significant enhancement of##4##4##(2008-10#3)(2008-5#1)
a significant enhancement##6##3##(2008-10#4)(2008-12#1)(2008-5#1)
a significant fall in##4##4##(1990-5#1)(2008-5#1)(2008-7#1)(2010-8#1)
a significant fraction##3##3##(1994-2#2)(1997-6#1)
a significant gene##2##3##(2008-6#1)(2010-5#1)
a significant health##3##3##(2008-12#1)(2009-8#1)(2011-1#1)
a significant impact on the##6##5##(2008-1#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#1)
a significant impact on##14##4##(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
a significant improvement in the##2##5##(2008-11#1)(2013-1#1)
a significant improvement in##10##4##(1990-2#2)(1991-8#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#3)
a significant improvement of the##2##5##(2008-10#2)
a significant improvement of##5##4##(2008-10#3)(2008-11#1)(2013-1#1)
a significant improvement over##2##4##(1994-1#1)(2010-5#1)
a significant improvement##17##3##(1990-2#2)(1991-8#1)(1994-1#1)(2008-10#5)(2008-11#2)(2010-5#1)(2012-2#1)(2013-1#4)
a significant increase (p&lt##2##4##(2008-11#1)(2013-1#1)
a significant increase in the levels of##2##7##(1994-2#1)(2008-12#1)
a significant increase in the##13##5##(1993-1#1)(1994-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
a significant increase in##38##4##(1992-12#1)(1993-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
a significant increase of##10##4##(1990-9#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2012-2#1)
a significant increase##56##3##(1990-9#1)(1992-12#1)(1993-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#2)(1997-1#2)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
a significant influence on the##2##5##(2008-5#1)(2011-2#1)
a significant influence on##7##4##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
a significant inhibition##2##3##(1994-8#1)(2008-7#1)
a significant interaction between##2##4##(2008-11#1)(2012-4#1)
a significant issue##2##3##(2008-12#1)(2008-7#1)
a significant loss##2##3##(1994-5#1)(2008-12#1)
a significant negative correlation##5##4##(1994-2#1)(2008-10#2)(2011-2#1)(2012-6#1)
a significant negative##6##3##(1994-2#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-6#1)
a significant number of##6##4##(1990-5#1)(1996-1#1)(2008-5#1)(2010-10#1)(2011-2#1)(2011-3#1)
a significant number##7##3##(1990-5#1)(1993-8#1)(1996-1#1)(2008-5#1)(2010-10#1)(2011-2#1)(2011-3#1)
a significant overall##2##3##(1993-3#1)(1994-12#1)
a significant portion of the##2##5##(1997-6#1)(2008-10#1)
a significant portion of##9##4##(1997-6#1)(2008-10#2)(2008-11#2)(2012-3#3)(2013-1#1)
a significant portion##10##3##(1997-6#1)(2008-10#2)(2008-11#2)(2009-10#1)(2012-3#3)(2013-1#1)
a significant positive correlation between##2##5##(2008-11#1)(2008-8#1)
a significant positive correlation##3##4##(1991-12#1)(2008-11#1)(2008-8#1)
a significant positive relationship between##2##5##(2008-10#1)(2010-11#1)
a significant positive##9##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-11#1)(2011-1#1)(2012-2#1)
a significant predictor of##4##4##(1991-3#1)(1996-3#1)(2012-3#1)(2013-1#1)
a significant predictor##5##3##(1991-3#1)(1996-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
a significant problem in##3##4##(1996-12#1)(2008-11#1)(2010-11#1)
a significant problem##6##3##(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-11#1)
a significant proportion of the##5##5##(1993-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
a significant proportion of##13##4##(1993-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
a significant public health problem##2##5##(1997-1#1)(1997-3#1)
a significant public health##3##4##(1997-1#1)(1997-3#1)(2008-11#1)
a significant reduction in the##6##5##(1991-3#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-7#1)(2010-6#1)
a significant reduction in##18##4##(1991-3#1)(1993-1#1)(1994-6#1)(1996-1#1)(1996-2#1)(2008-10#7)(2008-3#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-10#1)(2013-1#1)
a significant reduction of the symptom and medication score##2##9##(2011-2#2)
a significant reduction of the symptom and##3##7##(2011-2#3)
a significant reduction of the##4##5##(1992-1#1)(2011-2#3)
a significant reduction of##16##4##(1992-1#1)(1993-3#1)(1996-12#1)(2008-10#5)(2008-3#1)(2008-6#1)(2011-10#1)(2011-2#3)(2012-2#2)
a significant reduction##35##3##(1991-3#1)(1992-1#1)(1993-1#2)(1993-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#12)(2008-3#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-10#2)(2011-2#3)(2012-2#2)(2013-1#1)
a significant relationship between##4##4##(1995-2#1)(1997-8#2)(2008-10#1)
a significant relationship##5##3##(1995-2#1)(1997-8#2)(2008-10#1)(2011-2#1)
a significant rise in##6##4##(1996-3#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-8#1)
a significant rise##7##3##(1996-3#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
a significant risk factor for##6##5##(1997-3#1)(2008-2#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
a significant risk of##2##4##(2012-2#1)(2013-1#1)
a significant risk##8##3##(1997-3#1)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
a significant role for##3##4##(1993-12#1)(2008-10#1)(2008-7#1)
a significant role in the##6##5##(1995-6#1)(2008-10#1)(2008-4#1)(2012-2#2)(2013-1#1)
a significant role in##23##4##(1995-2#1)(1995-6#1)(2008-10#5)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
a significant role##28##3##(1993-12#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
a significant##551##2##(1990-12#1)(1990-2#3)(1990-5#7)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#3)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#3)(1992-6#1)(1992-9#1)(1993-1#5)(1993-12#2)(1993-3#5)(1993-6#1)(1993-8#4)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#3)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#4)(1996-12#6)(1996-2#4)(1996-3#3)(1996-5#1)(1996-6#2)(1997-1#6)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#3)(2006-6#1)(2007-11#2)(2008-1#3)(2008-10#117)(2008-11#47)(2008-12#16)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#13)(2008-6#4)(2008-7#15)(2008-8#9)(2008-9#6)(2009-1#2)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#8)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#4)(2011-10#3)(2011-2#34)(2011-3#1)(2012-12#1)(2012-2#23)(2012-3#14)(2012-4#1)(2012-5#2)(2012-6#2)(2013-1#29)(2013-7#2)(2013-8#9)
a significantly (P &lt##2##4##(2008-10#2)
a significantly better##3##3##(2008-10#2)(2008-7#1)
a significantly greater degree of##2##5##(1994-11#1)(2008-10#1)
a significantly greater##6##3##(1994-11#1)(1997-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-8#1)
a significantly higher level of##3##5##(1991-5#1)(2008-10#2)
a significantly higher number of##2##5##(2009-8#1)(2013-1#1)
a significantly higher percentage of##5##5##(1991-2#1)(2008-10#3)(2008-5#1)
a significantly higher prevalence of##2##5##(2009-12#1)(2011-1#1)
a significantly higher proportion of##2##5##(2008-2#1)(2011-2#1)
a significantly higher##29##3##(1991-2#1)(1991-5#1)(1996-8#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)
a significantly increased##4##3##(2008-1#1)(2008-9#2)(2011-2#1)
a significantly larger##5##3##(1992-3#1)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
a significantly lower level of##2##5##(1997-3#1)(2008-11#1)
a significantly lower##10##3##(1991-11#1)(1992-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
a significantly more##3##3##(1994-5#1)(2008-10#1)(2008-3#1)
a significantly##71##2##(1991-11#1)(1991-2#2)(1991-5#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-8#1)(1997-3#1)(1997-9#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#2)
a silent##2##2##(1993-3#1)(1994-12#1)
a silica gel##3##3##(2008-10#2)(2008-5#1)
a silica##11##2##(2008-10#10)(2008-5#1)
a silicon##7##2##(2008-10#4)(2008-3#3)
a silicone##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
a silver electrode##3##3##(2008-10#3)
a silver##4##2##(2008-10#3)(2008-3#1)
a silver/silver chloride##3##3##(2008-10#3)
a similar action##2##3##(2010-11#1)(2013-7#1)
a similar change##2##3##(1990-3#1)(1994-3#1)
a similar concentration##2##3##(2008-10#1)(2008-12#1)
a similar degree##5##3##(1992-3#1)(1996-2#1)(2008-10#2)(2008-11#1)
a similar effect##3##3##(1991-5#1)(1996-12#1)(2008-10#1)
a similar light##2##3##(2008-11#1)(2008-9#1)
a similar manner to the##2##5##(1997-2#1)(2008-11#1)
a similar manner##7##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-8#1)
a similar mechanism##2##3##(2008-7#1)(2009-10#1)
a similar pattern of##4##4##(1994-8#1)(1996-12#1)(1997-2#1)(2011-2#1)
a similar pattern##8##3##(1990-12#1)(1990-8#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2011-2#2)
a similar potency to##2##4##(1994-8#1)(2008-5#1)
a similar potency##4##3##(1993-8#2)(1994-8#1)(2008-5#1)
a similar project##2##3##(1994-1#1)(2008-11#1)
a similar range##2##3##(2008-11#1)(2009-5#1)
a similar safety profile to##2##5##(1996-1#1)(2012-3#1)
a similar set of##2##4##(2009-8#1)(2013-1#1)
a similar survey##2##3##(1994-1#1)(1994-3#1)
a similar time course to that##2##6##(1995-2#1)(2013-1#1)
a similar##158##2##(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#4)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#2)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#11)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
a similarity in the##2##4##(2008-10#2)
a similarity in##5##3##(1993-8#1)(2008-10#2)(2008-8#1)(2013-8#1)
a similarity##7##2##(1993-8#1)(1995-5#1)(2008-10#3)(2008-8#1)(2013-8#1)
a similarly##3##2##(1992-10#1)(2008-8#1)(2011-2#1)
a simple algorithm for##2##4##(2010-7#1)(2013-1#1)
a simple analytical##2##3##(2008-10#2)
a simple and efficient##4##4##(2008-10#2)(2008-9#1)(2009-5#1)
a simple and fast##5##4##(2008-10#3)(2008-5#1)(2008-6#1)
a simple and general##2##4##(2008-4#1)(2008-8#1)
a simple and inexpensive##2##4##(1991-6#1)(2008-10#1)
a simple and rapid method##3##5##(2008-10#2)(2008-5#1)
a simple and rapid##5##4##(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
a simple and reliable method##2##5##(2008-10#1)(2008-9#1)
a simple and scaleable##2##4##(2008-11#1)(2008-8#1)
a simple and sensitive method##2##5##(1991-3#1)(2008-10#1)
a simple and sensitive##3##4##(1991-3#1)(2008-10#1)(2008-9#1)
a simple and##43##3##(1991-3#1)(1991-6#1)(2007-12#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-5#1)(2012-2#1)
a simple diffusion##2##3##(2008-9#1)(2009-12#1)
a simple dilution##2##3##(2008-10#2)
a simple genetic circuit##2##4##(2008-11#2)
a simple genetic##3##3##(2008-11#2)(2008-5#1)
a simple growth##2##3##(2008-7#1)(2008-9#1)
a simple mathematical##2##3##(2008-3#1)(2009-8#1)
a simple method for the##2##5##(2008-10#1)(2008-2#1)
a simple method for##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
a simple method to##3##4##(1997-7#1)(2008-10#2)
a simple method##11##3##(1997-7#1)(2008-10#7)(2008-2#1)(2008-3#2)
a simple model for##2##4##(1992-9#1)(2008-10#1)
a simple model of##5##4##(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)
a simple model to##2##4##(2008-10#1)(2008-9#1)
a simple model##14##3##(1992-4#1)(1992-9#1)(2008-10#4)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)
a simple procedure##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
a simple protocol##2##3##(2008-10#1)(2008-9#1)
a simple relationship##2##3##(2008-10#1)(2008-3#1)
a simple rule##2##3##(1992-12#1)(2008-8#1)
a simple sequence##2##3##(1992-6#1)(1996-5#1)
a simple simulation model##2##4##(2008-8#1)(2008-9#1)
a simple stepwise pattern##2##4##(2008-10#2)
a simple system##2##3##(2008-10#1)(2008-5#1)
a simple technique##3##3##(1994-3#1)(2008-3#1)(2009-2#1)
a simple version of##2##4##(1992-12#1)(2008-8#1)
a simple way to##7##4##(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)
a simple yet##3##3##(1995-12#1)(2008-11#1)(2008-6#1)
a simple##300##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#1)(1992-12#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#123)(2008-11#22)(2008-12#2)(2008-2#4)(2008-3#24)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#11)(2008-8#14)(2008-9#17)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#3)(2011-2#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#4)(2013-8#3)
a simpler##7##2##(2008-10#5)(2008-3#1)(2011-2#1)
a simplified pulsed##2##3##(2008-10#2)
a simplified##8##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#2)(2013-1#1)
a simulated Class I restoration##2##5##(2013-1#2)
a simulated ward exercise##3##4##(2008-11#2)(2008-12#1)
a simulated##18##2##(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#4)(2008-8#1)(2009-4#1)(2009-7#1)(2012-3#1)(2013-1#3)
a simulation model##3##3##(2008-8#2)(2012-12#1)
a simulation study##6##3##(1992-9#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
a simulation##15##2##(1992-9#1)(1995-9#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2012-12#1)(2012-2#1)
a simultaneous determination##3##3##(2008-10#3)
a simultaneous##17##2##(1992-3#1)(1992-5#1)(1995-11#1)(1996-2#1)(2007-11#1)(2008-10#10)(2008-7#1)(2010-11#1)
a single (or##2##3##(2008-10#2)
a single 1##3##3##(2008-10#2)(2008-5#1)
a single DNA##2##3##(2008-10#1)(2008-12#1)
a single PCR##2##3##(2008-11#2)
a single aggregate##2##3##(2008-3#2)
a single amino acid substitution##2##5##(1991-12#1)(2008-10#1)
a single amino acid##3##4##(1991-12#1)(1995-2#1)(2008-10#1)
a single application of iprodione##2##5##(2008-10#2)
a single application of propiconazole##2##5##(2008-10#2)
a single application of##4##4##(2008-10#4)
a single band at##2##4##(1995-11#1)(2008-10#1)
a single band of##2##4##(1991-9#1)(1994-11#1)
a single band##8##3##(1991-9#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-11#2)(2008-10#1)
a single base##3##3##(1993-3#1)(2006-6#1)(2008-10#1)
a single bead string reactor##2##5##(2008-10#2)
a single bead##3##3##(2008-10#2)(2008-11#1)
a single carbon##2##3##(2008-10#1)(2008-8#1)
a single case##2##3##(2013-1#2)
a single cell##5##3##(1997-7#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)
a single channel##7##3##(1994-12#1)(1996-2#1)(2008-10#2)(2009-8#1)(2011-3#2)
a single chromatographic run##2##4##(2008-10#2)
a single clinical lacunar syndrome##2##5##(2009-10#2)
a single clinical##3##3##(2008-11#1)(2009-10#2)
a single clonal lineage##2##4##(2008-10#2)
a single colony-forming unit##2##4##(1993-12#2)
a single control##2##3##(2008-10#1)(2013-1#1)
a single copy gene and##2##5##(2008-8#1)(2009-10#1)
a single copy gene##4##4##(2008-5#1)(2008-8#2)(2009-10#1)
a single copy of##3##4##(1993-3#1)(2008-11#1)(2008-8#1)
a single copy##13##3##(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-10#1)
a single daily dose of##2##5##(1990-11#2)
a single daily dose##3##4##(1990-11#2)(1991-11#1)
a single day##3##3##(2008-12#1)(2010-10#2)
a single device##2##3##(2011-2#1)(2011-7#1)
a single disease##2##3##(2008-5#1)(2013-8#1)
a single dominant allele##2##4##(2008-10#2)
a single dominant gene##11##4##(2008-10#11)
a single dominant locus##5##4##(2008-10#5)
a single dominant##19##3##(2008-10#19)
a single dose of 2##2##5##(1992-12#1)(1997-5#1)
a single dose of##5##4##(1990-6#1)(1992-12#1)(1995-11#1)(1997-5#1)(2012-2#1)
a single dose##8##3##(1990-6#1)(1992-12#2)(1995-11#1)(1997-5#1)(2006-6#1)(2008-12#1)(2012-2#1)
a single experiment##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
a single fiber##2##3##(2007-12#1)(2008-10#1)
a single field##3##3##(2008-10#3)
a single gall##3##3##(2008-10#3)
a single gel##2##3##(2008-11#1)(2010-3#1)
a single gene control of avirulence##2##6##(2008-10#2)
a single gene##17##3##(1993-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#12)(2008-8#1)
a single genotype##3##3##(2008-10#3)
a single hospital##2##3##(2007-12#1)(2011-2#1)
a single host##3##3##(2008-10#3)
a single individual##2##3##(2008-10#1)(2013-1#1)
a single injection of##2##4##(2008-10#2)
a single injection##4##3##(1997-3#1)(2008-10#2)(2010-8#1)
a single institution##2##3##(2011-2#2)
a single intraperitoneal injection of##2##5##(1992-12#1)(1994-5#1)
a single intraperitoneal##4##3##(1992-12#1)(1994-5#2)(1994-8#1)
a single isolate in##2##4##(2008-10#2)
a single isolate##4##3##(2008-10#4)
a single large##3##3##(1993-12#1)(2008-1#1)(2008-11#1)
a single laser##3##3##(2008-3#3)
a single layer##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
a single left##3##3##(2008-1#1)(2013-1#1)(2013-2#1)
a single lick##3##3##(2008-11#3)
a single locus##4##3##(2008-10#3)(2008-8#1)
a single longitudinal##2##3##(2008-3#1)(2009-11#1)
a single low##2##3##(1995-8#1)(2008-7#1)
a single major##4##3##(2008-10#4)
a single mass##2##3##(1992-1#1)(2010-6#1)
a single membrane##2##3##(2008-10#2)
a single molecule##2##3##(1992-3#1)(2010-7#1)
a single mutant##3##3##(1995-6#1)(2011-2#1)(2013-8#1)
a single neuron##2##3##(1996-12#1)(2008-10#1)
a single nucleotide difference in the##2##6##(1996-12#1)(2008-10#1)
a single nucleotide##3##3##(1996-12#1)(2008-10#2)
a single one##3##3##(1990-8#1)(1993-8#1)(2008-11#1)
a single open reading frame##4##5##(1990-5#1)(1997-7#1)(2008-10#2)
a single or##2##3##(1996-9#1)(2008-2#1)
a single oral##2##3##(2008-10#2)
a single origin##3##3##(1994-3#2)(2008-10#1)
a single parameter##2##3##(1994-9#1)(2008-10#1)
a single particle##5##3##(1990-12#1)(2008-10#3)(2008-3#1)
a single pass of##2##4##(2008-10#1)(2008-2#1)
a single pass##3##3##(2008-10#2)(2008-2#1)
a single patient##4##3##(1990-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
a single peak##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
a single point##6##3##(1995-12#1)(2008-10#4)(2008-6#1)
a single polypeptide##3##3##(1995-6#1)(2008-11#1)(2010-5#1)
a single population##2##3##(2008-10#1)(2011-2#1)
a single product##2##3##(2008-10#1)(2008-11#1)
a single protein##2##3##(2009-6#1)(2009-9#1)
a single pulsed##3##3##(2008-10#1)(2008-9#2)
a single quantitative trait##2##4##(2008-10#2)
a single reaction##4##3##(2008-10#1)(2008-9#1)(2010-4#1)(2012-2#1)
a single recessive gene##5##4##(2008-10#4)(2008-9#1)
a single recessive##7##3##(2008-10#6)(2008-9#1)
a single resistance gene##4##4##(2008-10#4)
a single resource##2##3##(2008-9#2)
a single response##2##3##(2008-10#2)
a single run##2##3##(2008-10#2)
a single sample##5##3##(2008-10#4)(2008-6#1)
a single site of##2##4##(1996-6#1)(2008-10#1)
a single site##6##3##(1996-6#1)(2008-10#3)(2008-11#1)(2008-7#1)
a single small##2##3##(1990-2#1)(1993-2#1)
a single source##2##3##(1992-1#1)(2008-10#1)
a single species##6##3##(1993-12#1)(2008-10#4)(2011-2#1)
a single spray with C##2##5##(2008-10#2)
a single spray##3##3##(2008-10#3)
a single step##10##3##(1993-6#1)(1995-11#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2013-8#1)
a single strain##3##3##(2008-10#1)(2009-6#1)(2012-3#1)
a single subject##2##3##(2013-1#1)(2013-8#1)
a single surgeon##2##3##(2013-1#2)
a single test##2##3##(2008-10#1)(2009-12#1)
a single time point##3##4##(1995-12#1)(2011-2#1)(2012-3#1)
a single transcript##3##3##(1996-6#2)(2008-11#1)
a single transmembrane region##2##4##(1993-2#1)(2009-8#1)
a single trophic level##3##4##(2008-9#3)
a single tube##3##3##(1992-3#1)(2008-10#2)
a single two-electron irreversible##2##4##(2008-10#2)
a single well##2##3##(2008-10#1)(2008-9#1)
a single well-defined##2##3##(2008-10#2)
a single##686##2##(1990-11#4)(1990-12#3)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-6#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#5)(1992-3#4)(1992-4#1)(1992-8#2)(1993-1#1)(1993-12#5)(1993-2#6)(1993-3#2)(1993-6#4)(1993-8#4)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#8)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#6)(1995-2#8)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#3)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#7)(2008-1#2)(2008-10#269)(2008-11#33)(2008-12#12)(2008-2#6)(2008-3#26)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#10)(2008-8#23)(2008-9#25)(2009-10#7)(2009-11#2)(2009-12#4)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#25)(2011-3#3)(2011-7#1)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#15)(2013-2#1)(2013-7#1)(2013-8#8)
a single-chain##3##2##(1992-6#1)(2008-10#1)(2008-8#1)
a single-copy gene##5##3##(1993-12#1)(1993-6#1)(1993-9#1)(1996-6#1)(2008-8#1)
a single-copy##6##2##(1993-12#1)(1993-6#1)(1993-9#1)(1995-6#1)(1996-6#1)(2008-8#1)
a single-dose##2##2##(2008-10#1)(2011-2#1)
a single-frequency##2##2##(2008-2#1)(2008-3#1)
a single-group##2##2##(1993-1#1)(2013-1#1)
a single-mode##3##2##(2008-2#1)(2008-3#2)
a single-nucleotide##2##2##(2008-10#1)(2010-4#1)
a single-step##3##2##(2008-10#3)
a single-stranded##4##2##(1993-8#1)(1997-7#1)(2008-10#1)(2008-4#1)
a singly##2##2##(2007-12#1)(2011-2#1)
a sink##3##2##(2008-11#1)(2008-8#2)
a sinusoidal##2##2##(2008-10#1)(2008-3#1)
a sister##2##2##(1996-6#1)(2008-10#1)
a site of##2##3##(2012-2#1)(2013-7#1)
a site##18##2##(1991-11#1)(1991-2#1)(1992-6#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
a site-directed##3##2##(1993-8#1)(1995-6#1)(1997-3#1)
a situation that##3##3##(2008-8#1)(2009-3#1)(2009-7#1)
a situation##10##2##(1992-3#1)(1997-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-4#1)(2012-2#1)
a six##4##2##(1990-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
a six-component##2##2##(2008-10#2)
a six-month period##2##3##(1996-11#1)(1997-3#1)
a six-port##3##2##(2008-10#3)
a size of##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
a size##8##2##(1991-2#1)(1995-3#1)(1997-3#1)(2008-10#3)(2008-8#1)(2010-8#1)
a sizeable##2##2##(1996-3#1)(2010-12#1)
a skeletal##3##2##(1995-6#1)(2011-2#1)(2013-1#1)
a skilled and##2##3##(1997-3#1)(2008-10#1)
a skin##13##2##(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#2)
a slab waveguide##2##3##(2007-12#2)
a slab##4##2##(2007-12#2)(2008-10#2)
a slight decrease in##3##4##(1994-12#1)(2008-10#1)(2011-2#1)
a slight decrease##4##3##(1994-12#1)(2008-10#2)(2011-2#1)
a slight increase in the##2##5##(1991-12#1)(2008-10#1)
a slight increase in##6##4##(1991-12#1)(1991-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
a slight increase##10##3##(1991-12#1)(1991-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
a slight##34##2##(1991-12#1)(1991-6#2)(1991-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
a slightly better##3##3##(2008-10#2)(2013-1#1)
a slightly higher risk of developing PD##2##7##(2008-8#2)
a slightly higher##5##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#2)
a slightly increased##2##3##(2012-3#1)(2012-5#1)
a slightly lesser##2##3##(2008-10#1)(2010-3#1)
a slightly tender##2##3##(1993-8#1)(2013-8#1)
a slightly##27##2##(1991-12#1)(1993-8#1)(1995-3#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#2)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
a slope efficiency of##5##4##(2007-12#2)(2008-2#2)(2008-3#1)
a slope of -0##3##4##(1996-2#1)(2008-10#2)
a slope of 0##2##4##(2008-10#2)
a slope of 55##2##4##(2008-10#2)
a slope of about##2##4##(2008-10#2)
a slope of##37##3##(1996-2#2)(2008-10#35)
a slope##46##2##(1996-2#2)(2007-12#2)(2008-10#39)(2008-2#2)(2008-3#1)
a slow and##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
a slow rate of##3##4##(1997-1#1)(2008-10#1)(2008-7#1)
a slow##16##2##(1991-8#1)(1994-6#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-7#3)(2011-2#1)(2012-12#1)(2012-3#1)
a slow-growing##2##2##(2010-3#2)
a slower##6##2##(2008-10#4)(2012-12#1)(2012-2#1)
a slowing of##4##3##(1991-11#1)(1994-3#1)(2008-11#1)(2008-7#1)
a slowing##6##2##(1991-11#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-7#1)(2012-2#1)
a slowly growing##2##3##(1997-2#1)(2011-2#1)
a slowly progressive##2##3##(2012-3#2)
a slowly##5##2##(1996-2#1)(1997-2#1)(2011-2#1)(2012-3#2)
a slurry of##2##3##(2008-10#2)
a slurry##4##2##(2008-10#2)(2008-3#2)
a small amount of##12##4##(1991-9#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-9#1)(2013-8#1)
a small and##2##3##(1992-3#1)(2007-12#1)
a small benefit##2##3##(1991-7#1)(1997-8#1)
a small but significant##4##4##(1991-6#1)(1994-2#1)(1995-8#1)(2008-11#1)
a small but##6##3##(1991-6#1)(1992-2#1)(1994-2#1)(1995-8#1)(1996-5#1)(2008-11#1)
a small column##4##3##(2008-10#4)
a small decrease##2##3##(2008-10#2)
a small effect on##2##4##(1995-3#2)
a small effect##3##3##(1995-3#2)(2010-4#1)
a small fraction of##5##4##(1991-12#1)(1994-5#1)(1997-6#1)(2008-10#1)(2013-1#1)
a small geographical##2##3##(2008-10#1)(2012-3#1)
a small group of##2##4##(2008-10#1)(2013-1#1)
a small increase in##3##4##(1990-12#1)(1997-8#1)(2008-7#1)
a small increase##4##3##(1990-12#1)(1997-8#1)(2008-7#1)(2008-9#1)
a small molecule##4##3##(2008-10#1)(2008-4#2)(2013-1#1)
a small nuclear##2##3##(1996-3#1)(1997-3#1)
a small number of cases##3##5##(1994-9#1)(2008-7#1)(2010-12#1)
a small number of##20##4##(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1994-9#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)
a small number##22##3##(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1994-9#1)(1997-6#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)
a small omphalocele##2##3##(2008-10#2)
a small open##2##3##(2008-9#1)(2013-7#1)
a small percent##2##3##(1990-2#1)(2008-5#1)
a small percentage of##4##4##(1991-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
a small percentage##5##3##(1991-3#1)(1992-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
a small population of##3##4##(1991-12#1)(2008-10#1)(2008-7#1)
a small population##4##3##(1991-12#1)(2008-10#1)(2008-7#2)
a small portion of##2##4##(2008-4#1)(2010-3#1)
a small proportion of the total##2##6##(1994-8#1)(2008-10#1)
a small proportion of the##6##5##(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
a small proportion of##10##4##(1994-8#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
a small proportion##12##3##(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
a small role in##2##4##(2008-8#1)(2011-1#1)
a small sample size##2##4##(2008-10#1)(2012-12#1)
a small sample##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2012-12#1)
a small subset of patients##2##5##(1995-5#1)(1997-1#1)
a small subset of##3##4##(1995-5#1)(1997-1#1)(1997-7#1)
a small vessel##2##3##(2011-2#1)(2013-8#1)
a small volume of an##2##5##(2008-10#2)
a small volume of nitric acid##2##6##(2008-10#2)
a small volume of##10##4##(2008-10#10)
a small volume##11##3##(2008-10#11)
a small##223##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#1)(1991-12#5)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-9#1)(1993-2#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#4)(2008-10#59)(2008-11#15)(2008-12#4)(2008-3#8)(2008-4#4)(2008-5#5)(2008-7#9)(2008-8#3)(2008-9#10)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
a small-diameter##2##2##(2008-3#1)(2010-1#1)
a smaller##28##2##(1992-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
a smoker##3##2##(1996-3#1)(2013-1#2)
a smoking##3##2##(1993-1#1)(1996-1#1)(2007-12#1)
a smooth muscle protein##2##4##(1992-9#2)
a smooth muscle##3##3##(1992-9#2)(2008-11#1)
a smooth surface##2##3##(2008-10#1)(2008-8#1)
a smooth##14##2##(1992-9#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)
a snap bean##2##3##(2008-10#2)
a snap##3##2##(2008-10#3)
a so-called##2##2##(2008-10#1)(2008-9#1)
a social context##2##3##(1993-1#1)(2009-6#1)
a social##13##2##(1992-2#1)(1993-1#1)(1994-12#1)(2008-11#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2013-1#1)
a society##3##2##(1991-3#1)(1994-9#1)(2011-1#1)
a sodium##12##2##(1990-6#1)(2008-10#9)(2008-3#1)(2008-5#1)
a soft##6##2##(1991-2#1)(1992-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
a software##7##2##(1994-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
a soil with##2##3##(2008-10#2)
a soil##17##2##(2008-10#16)(2008-9#1)
a soilborne pathogen causing##2##4##(2008-10#2)
a soilborne pathogen##3##3##(2008-10#3)
a soilborne##5##2##(2008-10#5)
a sol-gel##8##2##(2008-10#8)
a solid catalyst##5##3##(2008-10#5)
a solid foundation for##3##4##(2008-9#2)(2010-9#1)
a solid phase extraction (SPE) procedure##2##6##(2008-10#2)
a solid phase extraction (SPE)##4##5##(2008-10#4)
a solid phase extraction##7##4##(2008-10#7)
a solid phase##17##3##(2008-10#15)(2008-11#1)(2008-7#1)
a solid sensing##2##3##(2008-10#2)
a solid sorbent##2##3##(2008-10#2)
a solid support##10##3##(2008-10#8)(2008-4#1)(2009-12#1)
a solid surface##2##3##(2008-10#2)
a solid##64##2##(1994-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#44)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2010-3#1)(2010-9#1)(2012-2#2)(2013-1#2)
a solid-phase extraction (SPE)##3##4##(2008-10#3)
a solid-phase extraction##6##3##(1997-2#1)(2008-10#5)
a solid-phase##15##2##(1997-2#2)(2008-10#13)
a solid-state##5##2##(1992-1#1)(2008-10#3)(2008-2#1)
a solitary kidney##2##3##(2012-12#2)
a solitary##10##2##(1991-9#1)(2008-7#1)(2008-9#1)(2010-6#2)(2011-2#1)(2012-12#4)
a solubility##2##2##(2008-10#1)(2013-1#1)
a solubilizing##2##2##(2008-10#1)(2013-1#1)
a soluble substrate##2##3##(2008-7#2)
a soluble##16##2##(1990-10#1)(1991-10#1)(1993-8#1)(1994-8#1)(2008-10#5)(2008-11#2)(2008-7#3)(2012-2#2)
a solution containing 0##3##4##(2008-10#3)
a solution containing 2##2##4##(2008-10#2)
a solution containing##19##3##(2008-10#19)
a solution of 2##2##4##(2008-10#2)
a solution of the##4##4##(2008-10#4)
a solution of##22##3##(2008-10#20)(2008-11#1)(2008-2#1)
a solution to the##3##4##(2008-1#1)(2008-12#1)(2010-7#1)
a solution to##7##3##(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-7#1)
a solution with##2##3##(2008-10#2)
a solution##65##2##(1990-5#1)(1992-9#1)(1994-12#1)(2008-1#1)(2008-10#47)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#2)(2010-7#1)(2011-2#1)
a solvent extraction##4##3##(2008-10#4)
a solvent of##2##3##(2008-10#2)
a solvent##14##2##(1994-8#1)(2008-10#12)(2008-5#1)
a somewhat different##2##3##(2008-10#1)(2010-6#1)
a somewhat##7##2##(2008-10#3)(2008-8#1)(2009-10#1)(2010-1#1)(2010-6#1)
a sorbent##4##2##(2008-10#4)
a sorption capacity of 1##2##5##(2008-10#2)
a sound##3##2##(1996-3#1)(1997-2#1)(2011-2#1)
a source for##2##3##(2008-10#1)(2011-3#1)
a source of inoculum for##2##5##(2008-10#2)
a source of inoculum##3##4##(2008-10#3)
a source of significant##2##4##(2008-6#1)(2008-7#1)
a source of the##2##4##(1996-5#1)(2008-10#1)
a source of vitamins##2##4##(2010-1#1)(2013-1#1)
a source of##45##3##(1991-2#1)(1992-1#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-6#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
a source##51##2##(1991-2#1)(1992-1#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
a source-sink system##2##3##(2008-8#1)(2008-9#1)
a source-sink##4##2##(2008-8#3)(2008-9#1)
a space-dependent rate equation##2##4##(2008-3#2)
a spacer device##4##3##(1996-1#2)(1996-2#2)
a spacer##13##2##(1996-1#3)(1996-2#2)(2007-11#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)
a spark##2##2##(2008-10#2)
a spatial gradient##2##3##(2008-8#2)
a spatial resolution of##3##4##(2007-12#1)(2008-3#1)(2008-5#1)
a spatial task##3##3##(1994-8#3)
a spatial##28##2##(1993-3#2)(1993-6#1)(1994-3#1)(1994-8#3)(1995-5#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2011-3#1)(2013-8#4)
a spatially explicit##5##3##(2008-10#1)(2008-8#3)(2008-9#1)
a spatially uniform##4##3##(2008-2#1)(2008-3#2)(2008-9#1)
a spatially##21##2##(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#6)(2008-9#3)(2009-8#1)(2011-2#1)
a spatio-temporal##2##2##(2008-11#1)(2013-8#1)
a spatiotemporal##2##2##(2008-10#1)(2008-3#1)
a speaker##3##2##(2008-2#1)(2009-10#2)
a speaker's##2##2##(2008-2#1)(2009-10#1)
a special case of##3##4##(2008-3#1)(2008-8#2)
a special case##5##3##(2008-3#2)(2008-8#3)
a special class of##2##4##(2009-4#1)(2013-8#1)
a special custom made##2##4##(2013-1#2)
a special focus##4##3##(1994-3#2)(2009-7#1)(2011-2#1)
a special interest##3##3##(2008-10#2)(2011-1#1)
a special sample treatment##2##4##(2008-10#2)
a special##62##2##(1990-6#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
a specialised##2##2##(2007-12#1)(2011-3#1)
a specialist education programme##2##4##(2010-10#2)
a specialist education##3##3##(2010-10#3)
a specialist in##2##3##(1992-2#1)(1995-6#1)
a specialist##12##2##(1992-1#1)(1992-2#2)(1992-5#1)(1993-12#1)(1995-6#1)(2010-10#3)(2011-2#1)(2013-1#1)(2013-8#1)
a specialized##9##2##(1995-5#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
a specially designed##9##3##(1994-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#1)(2010-3#1)
a specially##10##2##(1994-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-3#1)
a specialty##2##2##(1992-3#1)(1997-4#1)
a species previously##2##3##(1993-8#1)(2008-10#1)
a species specific##2##3##(2008-10#2)
a species##23##2##(1992-10#1)(1993-8#1)(1994-5#1)(1995-12#1)(2008-10#6)(2008-8#8)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#2)
a species'##3##2##(2008-8#2)(2008-9#1)
a species-specific##3##2##(2008-10#2)(2009-8#1)
a specific DNA##3##3##(1997-2#1)(2008-10#2)
a specific GABA(A)##2##3##(2008-7#1)(2008-9#1)
a specific activity of##2##4##(1991-12#1)(1994-5#1)
a specific analyte##2##3##(2008-4#1)(2009-3#1)
a specific and##5##3##(1990-2#1)(1994-8#1)(1996-11#1)(2008-10#1)(2013-1#1)
a specific antagonist of the##3##5##(1994-8#1)(2008-7#2)
a specific antibody##2##3##(1997-1#1)(2012-2#1)
a specific biological activity##2##4##(1990-12#1)(2011-2#1)
a specific chemical##2##3##(2008-10#1)(2010-7#1)
a specific diagnosis##3##3##(1996-6#1)(2012-2#2)
a specific drug##2##3##(2008-11#1)(2013-8#1)
a specific growth rate##2##4##(2008-7#1)(2011-2#1)
a specific inhibitor of the##2##5##(1993-3#1)(1994-6#1)
a specific inhibitor of##7##4##(1990-5#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-7#1)
a specific monoclonal antibody##2##4##(1993-8#1)(2008-10#1)
a specific polyclonal##2##3##(2008-10#2)
a specific region##3##3##(1993-9#1)(2011-2#1)(2013-8#1)
a specific response##2##3##(1990-5#1)(2008-10#1)
a specific role##2##3##(2008-11#1)(2013-1#1)
a specific situation##2##3##(2009-11#1)(2010-12#1)
a specific##201##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#5)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#7)(1995-11#3)(1995-12#3)(1995-2#2)(1995-6#3)(1995-8#2)(1995-9#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-7#3)(1997-8#1)(2007-12#2)(2008-10#34)(2008-11#16)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#8)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#4)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-2#7)(2013-1#9)(2013-8#4)
a specificity of 82##2##4##(1997-8#1)(2012-3#1)
a specificity of##4##3##(1992-3#1)(1995-11#1)(1997-8#1)(2012-3#1)
a specified period of time##2##5##(2008-10#1)(2008-11#1)
a specified time##2##3##(2008-10#1)(2008-12#1)
a specified##12##2##(1990-2#1)(1992-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2012-3#1)
a specimen##4##2##(2009-7#1)(2010-6#1)(2012-2#2)
a spectral resolution of##2##4##(1991-5#1)(2008-3#1)
a spectral##8##2##(1991-5#1)(2008-10#1)(2008-3#4)(2008-5#1)(2013-8#1)
a spectrofluorimetric method for the determination of##2##7##(2008-10#2)
a spectrometric##2##2##(2008-10#2)
a spectrophotometer and a##2##4##(2008-10#1)(2008-3#1)
a spectrophotometer##6##2##(2008-10#5)(2008-3#1)
a spectrophotometric method based on##2##5##(2008-10#2)
a spectrophotometric method for##3##4##(2008-10#3)
a spectrophotometric method to determine the##2##6##(2008-10#2)
a spectrophotometric method##14##3##(1996-12#1)(2008-10#13)
a spectrophotometric reference method##3##4##(2008-10#3)
a spectrophotometric##24##2##(1996-12#1)(2008-10#23)
a spectroscopic##4##2##(2008-3#3)(2010-4#1)
a spectrum of##9##3##(2008-10#3)(2010-10#1)(2012-2#3)(2013-1#2)
a spectrum##12##2##(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2012-2#3)(2013-1#2)
a speed of##2##3##(2008-10#1)(2013-1#1)
a sphere##2##2##(2008-2#1)(2008-3#1)
a spherical interference filter and a##2##6##(2008-3#2)
a spherical##13##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#2)(2009-7#2)(2010-11#1)(2012-2#1)(2013-1#1)
a spike##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
a spiked##3##2##(2008-10#3)
a spiking##2##2##(2008-10#1)(2008-11#1)
a spin coating##2##3##(2008-10#2)
a spin##3##2##(2008-10#2)(2008-11#1)
a spinal epidural##2##3##(2008-7#2)
a spinal##8##2##(1994-2#1)(2008-7#4)(2011-2#1)(2013-1#2)
a spindle cell##2##3##(2008-10#1)(2010-12#1)
a spinfilter##2##2##(2008-11#2)
a spinner flask##3##3##(2008-11#3)
a spinner##4##2##(2008-11#4)
a spiral##4##2##(2008-10#2)(2009-1#1)(2012-2#1)
a spirit##2##2##(1996-1#1)(2012-3#1)
a spiritual##2##2##(1997-2#1)(2011-1#1)
a spirometer##2##2##(2009-11#1)(2012-3#1)
a spiroplasma##2##2##(2008-10#2)
a splicing##2##2##(1993-12#1)(1995-6#1)
a split##2##2##(2008-12#1)(2008-2#1)
a split-mouth design##3##3##(2012-12#1)(2013-1#2)
a split-mouth##4##2##(2012-12#1)(2013-1#3)
a spontaneous##11##2##(1991-2#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#2)
a sporadic##2##2##(2008-5#1)(2012-2#1)
a spore suspension of##2##4##(2008-10#2)
a spore suspension##5##3##(2008-10#5)
a spore##6##2##(2008-10#6)
a sport-related concussion##2##3##(2010-1#2)
a spot##2##2##(2008-10#2)
a spouse##4##2##(1994-2#1)(1995-2#1)(1996-11#1)(2012-12#1)
a spray##5##2##(1992-2#1)(2008-10#3)(2008-5#1)
a spreading panicle##2##3##(2009-10#2)
a spreading##4##2##(1990-12#1)(2009-10#2)(2011-2#1)
a spreadsheet##2##2##(1993-1#1)(2008-11#1)
a squamous cell carcinoma##3##4##(1991-8#1)(2008-9#1)(2010-5#1)
a square wave##3##3##(2008-10#2)(2011-2#1)
a square##7##2##(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#2)
a square-wave (SW) potential-time##2##4##(2008-10#2)
a square-wave##5##2##(2008-10#5)
a stabilized##3##2##(2008-3#1)(2010-5#2)
a stabilizing##2##2##(1993-8#1)(2008-9#1)
a stable and##2##3##(2008-11#1)(2008-4#1)
a stable complex##2##3##(2008-10#2)
a stable environment##2##3##(1997-7#1)(2008-4#1)
a stable equilibrium where##2##4##(2008-8#2)
a stable equilibrium##4##3##(2008-8#3)(2008-9#1)
a stable stem cell population##2##5##(2010-7#2)
a stable stem##3##3##(2010-7#2)(2011-2#1)
a stable##56##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1993-8#2)(1993-9#1)(1994-5#2)(1995-8#1)(1996-12#1)(1997-7#2)(2008-10#14)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
a staff##2##2##(1992-3#1)(2008-11#1)
a stage##4##2##(1995-2#1)(1997-7#1)(2008-8#1)(2009-10#1)
a stage-specific##2##2##(1995-12#1)(2012-2#1)
a staged##5##2##(1993-12#1)(2009-4#2)(2010-11#1)(2013-1#1)
a staging##2##2##(1994-12#1)(2008-1#1)
a stagnant##2##2##(2008-10#1)(2008-5#1)
a stainless steel##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
a staminate##2##2##(2012-3#2)
a stand-alone##2##2##(2010-8#1)(2011-1#1)
a standard approach##2##3##(2008-10#1)(2013-1#1)
a standard compound##2##3##(2008-10#2)
a standard deviation##5##3##(2008-10#2)(2008-3#1)(2009-2#1)(2013-1#1)
a standard dose of##2##4##(1990-6#1)(2008-7#1)
a standard error of##3##4##(2008-10#3)
a standard method##4##3##(2008-10#3)(2012-2#1)
a standard questionnaire##2##3##(2008-7#1)(2009-5#1)
a standard reference material and##2##5##(2008-10#2)
a standard reference material##6##4##(2008-10#6)
a standard reference##10##3##(2008-10#10)
a standard set of##2##4##(2008-10#1)(2012-2#1)
a standard solution of##2##4##(2008-10#2)
a standard solution##6##3##(2008-10#6)
a standard stirred##2##3##(2008-11#2)
a standard tool##2##3##(2008-11#1)(2008-9#1)
a standard##130##2##(1990-6#1)(1991-12#2)(1992-1#1)(1992-12#2)(1992-9#1)(1994-12#1)(1994-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-8#1)(1997-8#1)(2008-10#63)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#7)
a standardised##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
a standardized questionnaire##2##3##(1996-11#1)(2008-11#1)
a standardized##24##2##(1993-2#1)(1996-11#1)(1997-5#1)(2008-10#5)(2008-11#3)(2008-12#4)(2008-5#2)(2009-11#1)(2009-9#1)(2010-1#1)(2010-3#1)(2013-1#2)(2013-8#1)
a standing##2##2##(2008-2#1)(2013-1#1)
a starting point for positional##2##5##(2008-10#2)
a starting point for##5##4##(2008-10#3)(2008-8#1)(2010-11#1)
a starting point##9##3##(1996-2#1)(1996-3#1)(1996-5#1)(2008-10#4)(2008-8#1)(2010-11#1)
a starting##11##2##(1993-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-11#1)
a state health agency##2##4##(1997-1#1)(1997-2#1)
a state of##7##3##(1995-3#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
a state##19##2##(1990-11#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
a state-of-the-art##4##2##(1992-2#1)(1996-1#1)(2010-5#1)(2012-12#1)
a statement of the##2##4##(2007-9#2)
a statement##4##2##(1996-3#1)(2007-9#2)(2008-12#1)
a statewide survey##2##3##(1994-12#1)(1997-1#1)
a statewide##8##2##(1994-12#1)(1995-12#2)(1996-1#1)(1996-3#2)(1997-1#1)(2008-9#1)
a static mercury drop electrode##3##5##(2008-10#3)
a static##9##2##(2008-10#7)(2008-6#1)(2008-7#1)
a stationary phase at##2##4##(2008-10#1)(2008-11#1)
a stationary phase##5##3##(2008-10#4)(2008-11#1)
a stationary##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#2)
a statistic##2##2##(1992-9#1)(1996-3#1)
a statistical method##2##3##(2008-5#1)(2008-9#1)
a statistical model##3##3##(2008-10#1)(2008-11#1)(2010-1#1)
a statistical study##2##3##(2008-1#1)(2008-6#1)
a statistical##27##2##(1990-12#2)(1992-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-9#2)(2010-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a statistically significant difference between the two##2##7##(2008-12#2)
a statistically significant difference between##4##5##(2007-12#1)(2008-12#2)(2010-12#1)
a statistically significant difference##7##4##(2007-12#1)(2008-12#2)(2010-12#1)(2013-1#2)(2013-8#1)
a statistically significant effect##2##4##(2008-10#1)(2008-7#1)
a statistically significant improvement##2##4##(2008-12#1)(2013-1#1)
a statistically significant increase in##2##5##(2009-8#2)
a statistically significant increase##3##4##(2009-8#2)(2013-1#1)
a statistically significant negative correlation##2##5##(2011-2#1)(2013-1#1)
a statistically significant reduction##3##4##(1992-9#1)(1996-1#1)(2013-1#1)
a statistically significant##27##3##(1992-9#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#1)(2009-8#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
a statistically##34##2##(1992-9#1)(1993-6#1)(1996-1#1)(1996-3#1)(1997-5#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#9)(2013-8#1)
a status report##2##3##(1996-12#1)(2009-4#1)
a stay##2##2##(1992-12#1)(1997-6#1)
a steady increase in##3##4##(2008-12#1)(2009-7#1)(2013-8#1)
a steady potential##2##3##(2008-10#2)
a steady state##4##3##(2008-10#2)(2008-7#1)(2010-11#1)
a steady##16##2##(1994-3#1)(1994-8#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-7#1)(2013-1#1)(2013-8#1)
a steady-state##4##2##(1991-7#1)(2008-10#3)
a steam generator tube rupture##2##5##(2009-10#2)
a steam##4##2##(2008-10#2)(2009-10#2)
a steep dispersal gradient##2##4##(2008-10#2)
a steep##5##2##(1995-12#1)(2008-10#3)(2008-11#1)
a stem##4##2##(2008-10#2)(2013-1#1)(2013-8#1)
a stem-loop structure##2##3##(1997-6#1)(2008-10#1)
a stem-loop##3##2##(1997-6#1)(2008-10#2)
a step in##2##3##(2008-3#1)(2008-9#1)
a step toward##4##3##(1991-12#1)(1995-2#1)(1997-2#1)(1997-3#1)
a step towards##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
a step##18##2##(1991-12#1)(1992-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)
a step-by-step method##2##3##(2008-11#2)
a step-by-step process##2##3##(1992-1#1)(1994-2#1)
a step-by-step##9##2##(1992-1#1)(1994-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-2#1)(2011-2#1)
a stepwise##7##2##(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#2)
a sterile##5##2##(1994-12#1)(2008-10#1)(2008-12#1)(2012-2#2)
a steroid##2##2##(1996-11#1)(1997-1#1)
a still##4##2##(1992-3#1)(2008-10#3)
a stimulating##2##2##(2008-11#1)(2010-7#1)
a stimulation index##2##3##(2008-10#1)(2008-5#1)
a stimulation of##3##3##(1994-5#1)(2008-11#1)(2008-5#1)
a stimulation##7##2##(1993-8#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#3)
a stimulatory effect on##2##4##(1993-12#1)(1994-2#1)
a stimulus##5##2##(1993-1#1)(2008-11#3)(2008-7#1)
a stirred tank reactor##2##4##(2008-7#2)
a stirred tank##6##3##(2008-11#3)(2008-7#3)
a stirred##9##2##(2008-10#1)(2008-11#4)(2008-7#4)
a stochastic model##2##3##(2008-10#1)(2008-9#1)
a stochastic##11##2##(2008-10#1)(2008-8#4)(2008-9#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)
a stoichiometric##2##2##(1993-9#1)(2008-11#1)
a stomach##2##2##(2008-10#1)(2012-3#1)
a stop codon##2##3##(1995-2#1)(2008-4#1)
a stop##3##2##(1995-2#1)(1996-11#1)(2008-4#1)
a storage capacity##2##3##(2008-3#2)
a storage##5##2##(2008-10#2)(2008-3#2)(2013-1#1)
a store##2##2##(1996-5#1)(2008-9#1)
a straight line##4##3##(1991-5#1)(2008-10#3)
a straight##7##2##(1991-5#1)(2008-10#3)(2008-9#2)(2013-1#1)
a straightforward##9##2##(1996-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2011-1#1)(2011-2#1)
a strain of##10##3##(1993-12#1)(2008-10#4)(2008-6#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-8#1)
a strain##20##2##(1992-10#1)(1993-12#1)(1993-9#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2012-2#1)(2013-8#1)
a strain-based##2##2##(2013-1#2)
a strain-specific##2##2##(2008-10#2)
a strategic weapon##3##3##(1995-2#1)(1996-2#2)
a strategic##11##2##(1991-2#1)(1992-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(2008-11#1)(2013-1#1)
a strategy for##13##3##(1994-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
a strategy is##2##3##(2008-10#1)(2012-12#1)
a strategy of##2##3##(2008-8#1)(2012-2#1)
a strategy to prevent the##2##5##(2008-1#2)
a strategy to prevent##3##4##(2008-1#2)(2013-8#1)
a strategy to##12##3##(1993-1#1)(1996-12#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
a strategy##39##2##(1993-1#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
a stratified##7##2##(1993-3#1)(1995-9#1)(1997-3#1)(2008-11#1)(2008-2#2)(2010-3#1)
a streak camera and a grating monochromator##2##7##(2008-2#2)
a stream of##11##3##(2007-12#1)(2008-10#9)(2008-11#1)
a stream##12##2##(2007-12#1)(2008-10#10)(2008-11#1)
a stress##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2009-11#1)
a stress-inducible##2##2##(1997-7#1)(2009-6#1)
a stress-related##2##2##(2008-10#2)
a stretch of##3##3##(1993-6#1)(1996-3#1)(1997-3#1)
a strict##11##2##(1991-1#1)(1991-5#1)(1992-9#1)(1996-6#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#2)
a strictly clonal##2##3##(2008-10#2)
a strictly##8##2##(1993-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
a stricture##2##2##(2013-1#1)(2013-7#1)
a striking difference##2##3##(2008-10#1)(2008-11#1)
a striking increase in##2##4##(1992-8#1)(2008-10#1)
a striking##10##2##(1991-5#1)(1992-8#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-7#1)(2008-10#3)(2008-11#1)
a stroke##9##2##(1996-11#1)(2007-9#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#1)
a strokectomy##2##2##(2012-3#2)
a strong acid##5##3##(1990-6#1)(2008-10#4)
a strong and##2##3##(1994-2#1)(2008-10#1)
a strong antibody response##2##4##(1995-12#1)(2009-6#1)
a strong association between##2##4##(1990-8#1)(2008-8#1)
a strong association with##2##4##(2010-5#1)(2011-2#1)
a strong association##4##3##(1990-8#1)(2008-8#1)(2010-5#1)(2011-2#1)
a strong base##2##3##(2008-10#2)
a strong bias##2##3##(1995-5#1)(1996-2#1)
a strong candidate##2##3##(2008-10#1)(2013-7#1)
a strong correlation (r = 0##2##6##(2008-10#1)(2008-11#1)
a strong correlation between##5##4##(1991-6#1)(1994-6#1)(1997-1#1)(2008-10#1)(2011-2#1)
a strong correlation with the##3##5##(2008-10#1)(2008-3#1)(2008-9#1)
a strong correlation##12##3##(1991-6#1)(1994-6#1)(1994-8#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
a strong dependence##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
a strong effect on##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
a strong effect##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2013-8#1)
a strong fluorescence##2##3##(2008-10#2)
a strong increase in##3##4##(1991-9#1)(2008-10#1)(2008-7#1)
a strong influence on the##3##5##(2008-10#2)(2012-8#1)
a strong influence on##5##4##(2008-10#2)(2008-9#1)(2011-2#1)(2012-8#1)
a strong influence##6##3##(2008-10#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-8#1)
a strong inhibitory effect##2##4##(1994-11#1)(2008-10#1)
a strong interaction##2##3##(2008-10#1)(2008-11#1)
a strong linkage##2##3##(1997-8#1)(2008-12#1)
a strong negative effect on##2##5##(1994-3#1)(2009-8#1)
a strong negative##4##3##(1994-12#1)(1994-3#1)(2009-8#1)(2010-6#1)
a strong positive correlation##2##4##(2008-11#1)(2010-8#1)
a strong positive##4##3##(1994-3#1)(2008-11#1)(2008-8#1)(2010-8#1)
a strong predictor of##3##4##(2007-12#1)(2008-9#1)(2012-2#1)
a strong relationship##2##3##(2008-10#1)(2008-9#1)
a strong##174##2##(1990-11#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#2)(1996-6#2)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#53)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#6)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#3)
a stronger effect on##2##4##(2008-4#1)(2008-8#1)
a stronger positive##2##3##(2009-7#1)(2010-10#1)
a stronger preference for feminine characteristics##2##6##(2012-3#2)
a stronger##21##2##(1991-12#1)(1994-12#1)(1996-1#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
a strongly absorbing##2##3##(2008-3#2)
a strongly acidic##2##3##(2008-10#2)
a strongly targeted agent##2##4##(2013-8#2)
a strongly##17##2##(1995-8#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-9#4)(2013-8#2)
a structural rationale for##2##4##(1993-8#2)
a structural##17##2##(1993-8#2)(1994-5#2)(1995-2#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
a structurally##4##2##(1995-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
a structure consisting of##2##4##(2007-12#1)(2008-11#1)
a structure for##2##3##(1996-2#1)(2013-1#1)
a structure in##2##3##(1995-6#1)(2009-7#1)
a structure similar to that of##2##6##(2008-5#1)(2008-6#1)
a structure similar to##3##4##(1990-11#1)(2008-5#1)(2008-6#1)
a structure that##3##3##(2007-12#1)(2009-10#1)(2013-1#1)
a structure##17##2##(1990-11#1)(1991-5#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-2#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#2)
a structured questionnaire##3##3##(2008-11#1)(2013-1#1)(2013-7#1)
a structured##10##2##(1995-1#1)(2008-11#2)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
a student##3##2##(2008-11#1)(2008-12#2)
a student's##2##2##(2008-11#2)
a study by##2##3##(2008-10#2)
a study of its##2##4##(1992-3#1)(2008-10#1)
a study of the##12##4##(1993-3#1)(1995-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-8#1)
a study of##51##3##(1990-5#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#1)(1996-3#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-9#1)(2012-3#2)(2013-1#1)
a study on the##4##4##(2008-10#1)(2008-11#2)(2012-3#1)
a study on##10##3##(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#3)(2012-3#2)(2013-1#1)(2013-8#1)
a study that##3##3##(2008-11#1)(2009-11#1)(2011-2#1)
a study to##3##3##(2008-10#2)(2009-6#1)
a study was conducted##2##4##(2008-10#1)(2012-2#1)
a study was made##2##4##(1990-2#1)(2008-3#1)
a study was##5##3##(1990-2#1)(2008-10#2)(2008-3#1)(2012-2#1)
a study which##2##3##(1996-1#1)(2008-11#1)
a study with##4##3##(1996-11#1)(2008-5#1)(2009-7#1)(2010-7#1)
a study##105##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#24)(2008-11#10)(2008-12#2)(2008-3#2)(2008-5#6)(2008-7#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-9#2)(2011-2#2)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#1)
a sub##2##2##(2007-8#1)(2013-1#1)
a sub-Nernstian##2##2##(2008-10#2)
a sub-regional##2##2##(2008-11#2)
a sub-sample of##6##3##(2008-10#2)(2008-12#1)(2010-8#1)(2013-1#2)
a sub-sample was collected in##2##5##(2008-10#2)
a sub-sample was##3##3##(2008-10#3)
a sub-sample##9##2##(2008-10#5)(2008-12#1)(2010-8#1)(2013-1#2)
a subacute##2##2##(1993-6#1)(2008-12#1)
a subarachnoid##4##2##(1996-9#1)(2008-7#1)(2012-3#1)(2013-8#1)
a subcellular##2##2##(1995-2#1)(2008-4#1)
a subchorionic hemorrhage##2##3##(2009-6#2)
a subcortical##2##2##(1996-3#1)(2008-7#1)
a subcutaneous##9##2##(1991-1#1)(1994-2#1)(1995-12#1)(1995-5#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
a subgroup of##5##3##(1993-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2011-2#1)
a subgroup within the##2##4##(2008-10#2)
a subgroup##11##2##(1993-1#1)(1997-7#1)(2007-12#1)(2008-10#7)(2011-2#1)
a subject of discussion##2##4##(2008-10#1)(2010-11#1)
a subject of##4##3##(2008-10#2)(2008-2#1)(2010-11#1)
a subject with##3##3##(1992-9#1)(1995-8#2)
a subject##16##2##(1991-1#1)(1991-3#1)(1992-9#1)(1995-6#1)(1995-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2010-11#1)(2010-8#2)(2012-3#1)
a subject's##2##2##(2008-4#2)
a subjective##8##2##(1991-11#1)(1991-12#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
a submerged##2##2##(1994-3#1)(2008-7#1)
a submicroscopic deletion of 22q11##2##5##(1997-3#2)
a submicroscopic deletion##3##3##(1997-3#2)(2012-12#1)
a suboptimal##2##2##(1991-6#1)(2008-5#1)
a subpopulation of##5##3##(2008-11#2)(2008-7#1)(2011-2#1)(2012-3#1)
a subpopulation##6##2##(2008-11#3)(2008-7#1)(2011-2#1)(2012-3#1)
a subsample of##3##3##(2008-10#2)(2008-4#1)
a subsequent##24##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1992-5#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(2008-10#8)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)
a subset of AG-2##2##4##(2008-10#2)
a subset of the##9##4##(2008-10#2)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
a subset of##46##3##(1990-8#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-8#2)(1997-1#1)(2008-10#13)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#1)
a subset##49##2##(1990-8#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-8#2)(1997-1#1)(2008-10#14)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#1)
a subsidiary of##2##3##(1990-2#1)(2008-5#1)
a substance##3##2##(2008-11#1)(2008-4#1)(2008-6#1)
a substantial amount of##2##4##(1995-1#1)(1997-3#1)
a substantial enhancement of the##2##5##(1997-3#1)(2008-10#1)
a substantial improvement in the##2##5##(2007-12#1)(2008-10#1)
a substantial increase in the number of##2##7##(1992-2#1)(2008-10#1)
a substantial increase in the##3##5##(1992-2#1)(2008-10#1)(2011-2#1)
a substantial increase in##6##4##(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
a substantial increase of##3##4##(1991-6#1)(2008-10#2)
a substantial increase##9##3##(1991-6#1)(1992-2#1)(1994-12#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-1#1)
a substantial number of##2##4##(1992-2#1)(2008-6#1)
a substantial part of##2##4##(1995-1#1)(2011-2#1)
a substantial part##3##3##(1995-1#1)(2008-11#1)(2011-2#1)
a substantial problem for##3##4##(1991-12#1)(1997-7#1)(2008-7#1)
a substantial proportion of##4##4##(1991-9#1)(2010-1#1)(2010-12#1)(2013-1#1)
a substantial proportion##5##3##(1991-9#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
a substantial reduction##2##3##(1991-8#1)(2008-10#1)
a substantial##53##2##(1991-12#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-1#3)(1996-12#1)(1997-3#2)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#1)
a substitute for##5##3##(1991-1#1)(1995-3#1)(2008-3#1)(2008-5#1)(2013-1#1)
a substitute##6##2##(1991-1#1)(1995-3#1)(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
a substitution of a##2##4##(1993-8#1)(2011-2#1)
a substitution of##4##3##(1993-8#1)(1994-11#2)(2011-2#1)
a substitution##7##2##(1993-8#1)(1994-11#2)(1996-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
a substrate for the##3##4##(1991-5#1)(2008-10#2)
a substrate for##12##3##(1991-5#1)(1992-7#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#3)(2009-3#1)(2009-9#1)
a substrate##35##2##(1990-9#2)(1991-5#1)(1992-6#1)(1992-7#2)(1993-3#1)(1993-8#3)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-2#1)
a subtotal##2##2##(1990-6#1)(2010-12#1)
a subtype of##4##3##(1997-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
a subungual metastasis##2##3##(2008-9#2)
a subungual##4##2##(2008-9#2)(2010-6#2)
a subunit of the##2##4##(1995-6#1)(2008-10#1)
a subunit of##3##3##(1993-12#1)(1995-6#1)(2008-10#1)
a subunit##4##2##(1993-12#1)(1995-2#1)(1995-6#1)(2008-10#1)
a success##4##2##(1994-9#1)(1997-2#1)(2008-10#1)(2013-8#1)
a successful outcome##3##3##(1991-9#1)(2008-12#1)(2012-2#1)
a successful##34##2##(1991-2#1)(1991-9#1)(1993-2#1)(1993-3#1)(1995-3#1)(1996-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#4)(2010-10#1)(2010-5#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
a succession of##2##3##(2008-10#2)
a sucrose solution##2##3##(1996-2#1)(2008-10#1)
a sucrose##3##2##(1996-2#1)(2008-10#2)
a sudden and##2##3##(2008-12#1)(2011-2#1)
a sudden onset of##2##4##(2007-12#1)(2009-12#1)
a sudden##7##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#1)
a sufficient amount of##2##4##(1993-2#1)(2008-10#1)
a sufficient number of##3##4##(2008-10#2)(2008-11#1)
a sufficient##16##2##(1992-9#1)(1993-2#1)(1994-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-8#1)
a sufficiently negative##2##3##(2008-10#2)
a sufficiently##4##2##(1997-6#1)(2008-10#3)
a sugar##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
a suggestion that##2##3##(1995-12#1)(2010-12#1)
a suggestion##3##2##(1995-12#1)(2008-1#1)(2010-12#1)
a suicide attempt##3##3##(1992-1#1)(2010-7#1)(2013-1#1)
a suitable alternative to##3##4##(1993-1#1)(1996-1#1)(2008-10#1)
a suitable alternative##7##3##(1993-1#1)(1996-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
a suitable instrumental##2##3##(2008-10#2)
a suitable ligand##2##3##(2008-10#2)
a suitable material for##2##4##(2008-10#2)
a suitable method for##3##4##(2008-10#3)
a suitable method##6##3##(2008-10#5)(2008-5#1)
a suitable model to##2##4##(1995-12#1)(2008-5#1)
a suitable model##5##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#2)
a suitable pH##2##3##(2008-10#2)
a suitable starting point for##2##5##(2008-11#2)
a suitable technique to##2##4##(2008-10#1)(2009-12#1)
a suitable tool for##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
a suitable tool##4##3##(1993-6#1)(2008-10#2)(2008-8#1)
a suitable vehicle for##2##4##(2008-5#2)
a suitable vehicle##3##3##(2008-5#3)
a suitable##89##2##(1990-2#1)(1991-10#1)(1993-1#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-6#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#42)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#11)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-5#1)
a suite of##8##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2012-3#1)(2013-1#1)
a sulfhydryl reagent##2##3##(1995-8#2)
a sulphate##2##2##(2008-10#1)(2008-7#1)
a sulphuric##2##2##(2008-10#2)
a summary of recent##2##4##(1991-2#1)(2011-2#1)
a summary of the##17##4##(1991-3#2)(1992-3#1)(1993-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-12#2)(2010-11#1)(2011-2#1)(2011-3#1)(2011-7#1)(2013-1#1)
a summary of##24##3##(1991-2#1)(1991-3#2)(1992-3#1)(1993-1#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-4#4)(2008-7#1)(2009-10#2)(2009-12#2)(2010-11#1)(2011-2#2)(2011-3#1)(2011-7#1)(2013-1#1)
a summary##30##2##(1991-2#1)(1991-3#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(2008-10#2)(2008-3#1)(2008-4#4)(2008-7#1)(2009-10#2)(2009-12#2)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2011-7#1)(2013-1#2)
a summation test##4##3##(2008-5#4)
a summation##5##2##(2008-5#4)(2013-1#1)
a sunscreen##4##2##(2008-10#1)(2008-5#3)
a super##3##2##(2008-10#2)(2012-2#1)
a superconducting##2##2##(1992-8#1)(2010-7#1)
a superfamily of##3##3##(1993-12#1)(2008-11#1)(2010-5#1)
a superficial##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
a superhigh-yield rice##2##3##(2008-9#2)
a superior competitor##2##3##(2008-8#2)
a superior##15##2##(1995-5#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#3)(2009-12#1)(2011-2#2)(2012-3#1)(2012-9#1)(2013-1#1)
a supernumerary##2##2##(2008-3#1)(2010-3#1)
a superoxide##2##2##(1995-8#1)(2008-5#1)
a superposition of##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
a supervised##3##2##(2008-10#2)(2008-11#1)
a supplement to##3##3##(1990-9#1)(1991-6#1)(1994-6#1)
a supplement##4##2##(1990-9#1)(1991-6#1)(1994-6#1)(2008-11#1)
a supplementation##2##2##(2010-1#1)(2013-1#1)
a supplier##2##2##(1994-12#1)(1994-3#1)
a support protocol##2##3##(2008-4#2)
a support##10##2##(2008-10#4)(2008-11#1)(2008-4#2)(2010-5#1)(2011-2#2)
a supported housing project##2##4##(1993-1#2)
a supported liquid membrane##3##4##(2008-10#3)
a supported##7##2##(1993-1#2)(2008-10#5)
a supporting electrolyte##3##3##(2008-10#3)
a supporting##4##2##(2008-10#4)
a supportive##4##2##(1992-3#1)(1994-6#1)(2010-9#1)(2013-1#1)
a suppression of##2##3##(1994-8#1)(2008-11#1)
a suppressive effect##2##3##(2008-11#1)(2012-12#1)
a surface plasmon resonance (SPR) biosensor##3##6##(2008-10#1)(2008-11#1)(2008-4#1)
a surface plasmon resonance (SPR)##4##5##(2008-10#2)(2008-11#1)(2008-4#1)
a surface plasmon resonance biosensor##2##5##(2008-10#2)
a surface plasmon resonance##8##4##(2008-10#6)(2008-11#1)(2008-4#1)
a surface tension##3##3##(2008-10#2)(2008-3#1)
a surface##29##2##(2008-10#16)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-6#1)(2010-7#1)(2013-8#1)
a surface-renewable##2##2##(2008-10#2)
a surfactant##8##2##(2008-10#3)(2008-5#3)(2009-10#1)(2013-1#1)
a surgical procedure##2##3##(2008-7#1)(2008-9#1)
a surgical series##2##3##(1990-6#2)
a surgical##17##2##(1990-6#2)(1995-11#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#3)
a surgically##2##2##(2008-7#1)(2010-6#1)
a surprising##3##2##(2008-11#2)(2013-1#1)
a surprisingly high##2##3##(2008-9#1)(2011-2#1)
a surprisingly##5##2##(1995-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
a surrogate for##4##3##(2010-11#1)(2011-2#2)(2013-8#1)
a surrogate##10##2##(1995-1#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-2#2)(2013-8#1)
a surveillance and##2##3##(1990-3#2)
a surveillance##3##2##(1990-3#2)(1996-3#1)
a survey conducted##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
a survey for##2##3##(1991-5#1)(1994-3#1)
a survey in##2##3##(1991-6#1)(2008-11#1)
a survey of the##2##4##(1997-3#1)(2008-11#1)
a survey of##26##3##(1991-1#1)(1991-3#1)(1991-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
a survey questionnaire##2##3##(1991-8#1)(1993-12#1)
a survey##53##2##(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-3#1)(1993-12#3)(1993-6#1)(1994-12#1)(1994-3#2)(1994-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a survival benefit##2##3##(2010-8#1)(2011-3#1)
a survival##6##2##(1994-3#1)(1996-12#1)(2008-6#1)(2009-8#1)(2010-8#1)(2011-3#1)
a susceptibility factor for##2##4##(2008-8#2)
a susceptible cultivar of##3##4##(2008-10#3)
a susceptible cultivar##12##3##(2008-10#12)
a susceptible host##3##3##(2008-10#3)
a susceptible##33##2##(2008-10#33)
a suspect##2##2##(2008-12#1)(2013-1#1)
a suspected##2##2##(1991-3#1)(2008-3#1)
a suspension containing##3##3##(2008-10#2)(2008-5#1)
a suspension culture##3##3##(2008-11#3)
a suspension of##5##3##(2008-10#3)(2008-12#1)(2008-7#1)
a suspension##12##2##(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)
a suspicion of##2##3##(1994-12#1)(2011-2#1)
a sustainable##6##2##(2008-10#2)(2010-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
a sustained##13##2##(1991-2#1)(1992-6#1)(1994-11#1)(1994-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)(2012-2#1)(2012-3#1)
a swelling##2##2##(1991-6#1)(2011-2#1)
a swine model##2##3##(2008-11#1)(2009-10#1)
a switch##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
a swollen##2##2##(1997-5#1)(2008-5#1)
a symbiosis of##2##3##(1996-2#1)(2009-6#1)
a symbiotic##2##2##(2010-4#1)(2011-2#1)
a symposium##5##2##(1992-2#1)(1992-3#1)(1994-3#1)(2008-12#1)(2013-1#1)
a symptom##2##2##(1990-12#1)(1994-6#1)
a symptomatic patient##2##3##(2008-10#1)(2011-2#1)
a symptomatic##8##2##(2008-10#2)(2008-11#1)(2011-2#3)(2012-3#1)(2013-1#1)
a symptomless##2##2##(2008-10#2)
a synchronous##2##2##(1993-8#1)(2009-6#1)
a synchronously pumped optical parametric oscillator##2##6##(2007-11#1)(2008-3#1)
a syndrome##8##2##(2008-11#2)(2008-7#3)(2008-8#1)(2009-10#1)(2011-2#1)
a synergistic effect on##2##4##(2008-11#2)
a synergistic effect##7##3##(2008-10#2)(2008-11#4)(2008-5#1)
a synergistic##15##2##(1990-2#1)(1992-10#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-5#1)(2009-7#1)(2010-8#1)
a synthesis of##2##3##(2008-10#2)
a synthesis##3##2##(1993-12#1)(2008-10#2)
a synthesized##4##2##(2008-10#3)(2010-5#1)
a synthetic peptide of##2##4##(1995-6#1)(2008-11#1)
a synthetic peptide##6##3##(1992-7#1)(1993-3#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)
a synthetic sample##3##3##(2008-10#3)
a synthetic solution##2##3##(2008-10#2)
a synthetic##49##2##(1990-7#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#25)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)(2011-2#1)
a syringe pump##3##3##(2008-10#3)
a syringe##11##2##(2008-10#10)(2008-11#1)
a system for targeted##2##4##(1997-7#1)(2008-9#1)
a system for##8##3##(1991-2#1)(1992-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
a system in##2##3##(1991-3#1)(2008-10#1)
a system is##3##3##(1992-3#1)(1994-5#1)(2008-10#1)
a system of##25##3##(1991-2#1)(1992-3#1)(1993-3#1)(1994-6#1)(1995-2#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#3)
a system that##3##3##(1993-12#1)(2008-10#1)(2008-12#1)
a system with##3##3##(1990-11#1)(2008-10#1)(2008-2#1)
a system##66##2##(1990-11#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#3)(1993-12#2)(1993-3#3)(1993-8#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#2)(2013-8#4)
a systematic approach to##4##4##(1995-12#1)(2006-5#1)(2012-2#1)(2013-1#1)
a systematic approach##8##3##(1995-12#1)(1996-2#1)(2006-5#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-1#1)
a systematic literature review##2##4##(2008-11#1)(2013-8#1)
a systematic literature##3##3##(2008-11#1)(2013-1#1)(2013-8#1)
a systematic review and meta-analysis##2##5##(2010-10#1)(2013-8#1)
a systematic review comparing##2##4##(2012-12#2)
a systematic review of##2##4##(2009-3#1)(2011-2#1)
a systematic review to evaluate##2##5##(2008-10#1)(2013-1#1)
a systematic review##17##3##(2008-10#1)(2009-1#1)(2009-12#1)(2009-3#1)(2010-10#1)(2011-2#4)(2011-7#1)(2012-12#3)(2013-1#2)(2013-8#2)
a systematic study of##2##4##(2008-2#1)(2010-6#1)
a systematic study##4##3##(2008-12#1)(2008-2#1)(2008-5#1)(2010-6#1)
a systematic way##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
a systematic##60##2##(1992-2#1)(1994-12#1)(1995-12#1)(1996-2#2)(2006-5#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#5)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#7)(2013-8#5)
a systemic disease##6##3##(1997-8#2)(2008-8#1)(2011-2#1)(2013-8#2)
a systemic inflammatory response##4##4##(2008-10#2)(2010-5#1)(2012-3#1)
a systemic inflammatory##5##3##(2008-10#2)(2010-5#1)(2012-2#1)(2012-3#1)
a systemic##26##2##(1990-6#1)(1992-12#1)(1994-9#1)(1995-11#1)(1995-9#1)(1997-8#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a systems approach to##2##4##(1994-2#1)(1995-12#1)
a systems approach##4##3##(1994-2#1)(1995-1#1)(1995-12#1)(2010-5#1)
a t(14##3##2##(2009-8#3)
a table that##2##3##(1996-3#1)(2008-6#1)
a table##5##2##(1996-1#1)(1996-3#1)(2008-12#1)(2008-4#1)(2008-6#1)
a taboo##2##2##(1993-6#1)(1996-6#1)
a tactile##2##2##(2008-5#1)(2009-8#1)
a tail##2##2##(2008-10#1)(2011-2#1)
a talar body fracture##2##4##(2010-5#2)
a tandem insertion of a Ty1##2##6##(1995-9#2)
a tandem##7##2##(1991-6#1)(1995-6#1)(1995-9#2)(1996-5#1)(2008-10#1)(2008-7#1)
a tank##2##2##(2008-6#1)(2008-8#1)
a tap water##2##3##(2008-10#2)
a target adolescent)##2##3##(2009-7#2)
a target for##13##3##(1992-6#1)(1995-5#1)(1996-1#1)(1997-7#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#3)(2011-3#1)(2013-1#2)
a target of##5##3##(1993-8#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)
a target protein##2##3##(2008-10#1)(2008-11#1)
a target weight##5##3##(2013-1#5)
a target##44##2##(1992-6#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-1#1)(1997-7#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#2)(2010-11#1)(2011-1#1)(2011-2#5)(2011-3#1)(2013-1#7)(2013-8#1)
a targeted disruption of the mouse##2##6##(1994-12#2)
a targeted##9##2##(1993-9#2)(1994-12#2)(1994-9#1)(1996-2#1)(2010-10#1)(2012-12#1)(2013-8#1)
a task involving##2##3##(1995-2#1)(2008-11#1)
a task##6##2##(1993-6#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
a tautomeric mixture##2##3##(2008-10#2)
a taxonomic##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
a tea-bag formulation of cryptolepis sanguinolenta root##2##7##(2011-2#2)
a teaching and learning##5##4##(2008-11#4)(2008-12#1)
a teaching and##6##3##(2008-11#4)(2008-12#2)
a teaching file test##2##4##(1990-2#2)
a teaching hospital in##2##4##(2008-10#1)(2009-1#1)
a teaching hospital##8##3##(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-5#1)(2012-3#2)
a teaching method##5##3##(2008-11#4)(2008-12#1)
a teaching module##2##3##(1996-1#2)
a teaching strategy##4##3##(2008-11#1)(2008-12#3)
a teaching##31##2##(1990-2#2)(1994-2#1)(1995-12#1)(1996-1#2)(1997-2#1)(2008-10#1)(2008-11#11)(2008-12#8)(2009-1#1)(2009-5#1)(2012-3#2)
a team approach##2##3##(1994-12#2)
a team of##6##3##(1996-1#2)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)
a team##15##2##(1994-12#3)(1994-2#1)(1995-2#1)(1996-1#2)(1997-4#1)(2008-11#2)(2008-12#2)(2009-6#1)(2010-7#1)(2011-2#1)
a team-based##2##2##(1993-12#1)(1997-2#1)
a technical report##2##3##(2011-2#1)(2012-3#1)
a technical##7##2##(1992-9#1)(1993-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#1)
a technically##3##2##(1993-11#1)(1993-3#1)(2012-3#1)
a technique for the##4##4##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
a technique for##16##3##(1996-2#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2013-1#2)
a technique of##4##3##(2008-10#2)(2009-8#1)(2013-1#1)
a technique that combines##2##4##(2008-10#1)(2008-3#1)
a technique that##6##3##(1995-12#1)(2008-10#1)(2008-3#4)
a technique to##6##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2011-3#1)
a technique used to##2##4##(2008-10#1)(2008-7#1)
a technique used##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
a technique using##2##3##(1992-12#2)
a technique which##2##3##(1993-9#1)(2010-12#1)
a technique##48##2##(1992-12#2)(1993-9#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)
a technology that##2##3##(1992-11#1)(2012-3#1)
a technology##5##2##(1992-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
a tedious##3##2##(2008-10#3)
a teicoplanin##2##2##(2008-10#2)
a teleomorph##2##2##(2008-10#1)(2010-3#1)
a teleost##2##2##(1997-9#1)(2008-7#1)
a telephone##2##2##(1995-3#1)(2008-9#1)
a temperature of 38##2##4##(2008-10#1)(2008-11#1)
a temperature of 50 degrees C##2##6##(2008-10#2)
a temperature of##17##3##(2008-10#11)(2008-11#2)(2008-12#1)(2008-7#1)(2009-7#1)(2013-1#1)
a temperature optimum##2##3##(1991-5#1)(2008-10#1)
a temperature range from##2##4##(2008-10#1)(2008-3#1)
a temperature range##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
a temperature##33##2##(1991-5#1)(1993-8#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-7#1)(2013-1#1)
a temperature-sensitive mutant##2##3##(1995-2#1)(1995-6#1)
a temperature-sensitive##6##2##(1993-9#1)(1995-2#1)(1995-6#1)(1995-9#1)(1997-8#1)(2008-8#1)
a template and##2##3##(1993-12#1)(2008-11#1)
a template for##5##3##(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#2)
a template##11##2##(1992-6#1)(1993-12#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-10#1)
a temporal resolution of##2##4##(2008-10#1)(2008-11#1)
a temporal##9##2##(2006-6#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-9#1)(2013-1#1)
a temporally##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
a temporary##10##2##(1992-5#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-2#1)(2013-1#1)
a ten##2##2##(1990-2#1)(2008-11#1)
a tendency for##2##3##(1991-2#1)(2008-2#1)
a tendency to##11##3##(1991-1#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
a tendency##17##2##(1991-1#1)(1991-2#1)(1993-3#1)(1993-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-2#1)
a tentative model for##2##4##(1992-9#1)(1994-5#1)
a tentative##4##2##(1992-9#1)(1994-5#1)(1996-2#1)(1996-5#1)
a term##7##2##(1996-12#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#2)
a terminal##7##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#2)
a termination##2##2##(1992-6#1)(2013-8#1)
a ternary complex##6##3##(1994-5#3)(2008-10#3)
a ternary mixture of##2##4##(2008-10#2)
a ternary##9##2##(1994-5#3)(2008-10#6)
a terrestrial##2##2##(1990-5#1)(2008-7#1)
a terrorist##2##2##(1996-12#1)(2008-9#1)
a tertiary care hospital in##3##5##(2008-11#2)(2013-8#1)
a tertiary care hospital##8##4##(1997-3#1)(2008-11#2)(2010-11#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
a tertiary care##14##3##(1997-3#1)(2008-11#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
a tertiary##21##2##(1997-3#1)(2008-10#2)(2008-11#2)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
a test of##7##3##(1992-7#1)(1993-3#1)(1994-2#1)(2008-10#1)(2008-8#1)(2010-7#1)(2012-2#1)
a test pattern##2##3##(2008-3#2)
a test sample##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
a test set of##2##4##(2008-10#1)(2009-3#1)
a test set##5##3##(2008-10#4)(2009-3#1)
a test using##2##3##(2008-8#2)
a test##49##2##(1992-12#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-2#1)(2007-12#1)(2008-10#15)(2008-11#8)(2008-12#2)(2008-3#6)(2008-5#1)(2008-8#5)(2009-3#1)(2010-7#1)(2012-2#2)(2013-1#2)
a tetracycline##3##2##(2008-10#2)(2008-7#1)
a tetracycline-repressible##2##2##(2008-11#1)(2008-7#1)
a thematic analysis##2##3##(2008-11#2)
a thematic content analysis##2##4##(2008-11#1)(2009-3#1)
a thematic##5##2##(2008-11#3)(2009-3#1)(2011-1#1)
a theoretical analysis##5##3##(2007-11#1)(2008-3#4)
a theoretical investigation of the##2##5##(2007-12#1)(2008-9#1)
a theoretical investigation##3##3##(1996-12#1)(2007-12#1)(2008-9#1)
a theoretical model##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
a theoretical study##2##3##(2008-3#1)(2008-8#1)
a theoretical##37##2##(1995-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-3#9)(2008-5#2)(2008-8#7)(2008-9#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
a theory##2##2##(1992-3#1)(2008-3#1)
a theory-based##2##2##(2013-1#2)
a therapeutic agent##3##3##(2007-11#1)(2008-6#1)(2012-2#1)
a therapeutic cure##2##3##(2010-6#1)(2011-2#1)
a therapeutic effect##2##3##(1992-3#1)(2008-9#1)
a therapeutic option in patients##2##5##(2010-12#2)
a therapeutic protein##2##3##(2008-11#2)
a therapeutic strategy for##2##4##(2010-7#1)(2011-2#1)
a therapeutic strategy##3##3##(2010-7#1)(2011-2#1)(2012-2#1)
a therapeutic target for the treatment of##2##7##(2008-1#1)(2013-1#1)
a therapeutic target for##3##4##(2008-1#1)(2010-11#1)(2013-1#1)
a therapeutic target##4##3##(2008-1#1)(2008-11#1)(2010-11#1)(2013-1#1)
a therapeutic##30##2##(1991-12#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-11#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#2)(2008-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
a therapy for##2##3##(1994-5#1)(2012-2#1)
a therapy in##2##3##(2009-10#1)(2010-7#1)
a therapy##5##2##(1994-5#1)(2008-6#1)(2009-10#1)(2010-7#1)(2012-2#1)
a thermal##5##2##(1993-8#1)(2008-10#1)(2008-3#2)(2008-4#1)
a thermoactive##2##2##(1991-5#2)
a thermodynamic##5##2##(1993-8#1)(2008-10#4)
a thermogenic nutritional supplement##3##4##(2013-8#3)
a thermogenic##4##2##(1994-2#1)(2013-8#3)
a thermostatic##2##2##(2008-10#2)
a theta rhythm##3##3##(2008-11#3)
a theta##4##2##(2008-11#4)
a thick##4##2##(2007-12#1)(2008-3#2)(2011-2#1)
a thickening of the##2##4##(2008-5#1)(2012-2#1)
a thicker##2##2##(2008-5#1)(2010-10#1)
a thickness of##2##3##(2007-12#1)(2011-2#1)
a thickness##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
a thin film of chlorogenic acid##3##6##(2008-10#3)
a thin film of##5##4##(2008-10#5)
a thin film##11##3##(2008-10#10)(2008-3#1)
a thin layer##3##3##(2008-10#3)
a thin##39##2##(1994-11#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-11#2)(2009-9#1)(2011-2#1)(2012-2#1)
a thinner##2##2##(2008-10#1)(2013-1#1)
a third class##2##3##(1990-3#1)(2010-6#1)
a third component##2##3##(1994-5#1)(2008-10#1)
a third of##3##3##(2008-10#1)(2010-8#1)(2011-1#1)
a third type##2##3##(2010-12#1)(2011-2#1)
a third##37##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
a third-generation cephalosporin##2##3##(2011-2#2)
a third-line 'rescue' option##2##4##(2010-12#2)
a thoracic##3##2##(1997-6#1)(2011-2#2)
a thorough analysis of the##2##5##(2008-3#1)(2008-5#1)
a thorough history##2##3##(2006-5#1)(2010-7#1)
a thorough understanding of##4##4##(2008-10#1)(2008-4#2)(2008-7#1)
a thorough##16##2##(1990-9#1)(1992-12#1)(1994-2#1)(2006-5#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-7#1)(2012-3#1)
a thousand times##2##3##(1990-12#1)(2008-10#1)
a thousand##4##2##(1990-12#1)(2008-10#2)(2013-1#1)
a threat to the##2##4##(1992-1#1)(2008-10#1)
a threat to##5##3##(1992-1#1)(2008-10#2)(2008-11#1)(2010-1#1)
a three year period##2##4##(2008-5#1)(2012-3#1)
a three year##4##3##(2008-11#2)(2008-5#1)(2012-3#1)
a three##14##2##(1990-11#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#2)(2012-3#1)
a three-banded pattern with##2##4##(2008-10#2)
a three-component##2##2##(2008-10#2)
a three-dimensional (3D)##2##3##(2008-11#1)(2012-2#1)
a three-dimensional hexagonal ice column##2##5##(2008-3#2)
a three-dimensional tissue construct from human dental##2##7##(2013-1#2)
a three-dimensional tissue construct from##3##5##(2013-1#3)
a three-dimensional##25##2##(1991-11#1)(1996-2#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-5#1)(2008-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)
a three-generation##3##2##(2008-10#3)
a three-hole##2##2##(2008-10#2)
a three-level##3##2##(1994-3#1)(2007-12#1)(2011-2#1)
a three-step##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
a three-way##4##2##(2008-10#3)(2013-1#1)
a three-year##7##2##(1994-3#1)(1995-12#1)(1996-3#1)(2008-11#3)(2012-2#1)
a threefold increase##2##3##(2008-10#2)
a threefold##5##2##(2008-10#3)(2010-1#1)(2011-1#1)
a threshold concentration of##2##4##(1995-11#1)(2008-10#1)
a threshold concentration##4##3##(1990-8#1)(1992-9#1)(1995-11#1)(2008-10#1)
a threshold effect for##2##4##(2010-1#2)
a threshold of##3##3##(2008-10#2)(2013-1#1)
a threshold value##3##3##(2008-10#3)
a threshold##30##2##(1990-8#1)(1992-9#1)(1995-11#1)(1995-8#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-8#4)(2009-7#1)(2009-8#1)(2010-1#2)(2012-2#2)(2013-1#1)
a thrombin##2##2##(1990-5#1)(2006-6#1)
a thrombus##3##2##(1997-6#1)(2008-7#2)
a throughput of##6##3##(2008-10#6)
a tick##5##2##(1996-11#2)(2013-8#3)
a tight##5##2##(1994-8#1)(1995-2#1)(2008-11#1)(2008-9#1)(2009-8#1)
a tightly regulated##3##3##(1995-2#1)(2012-2#2)
a tillage##2##2##(2008-10#2)
a time and##3##3##(1994-11#1)(1996-12#1)(2008-11#1)
a time course of##2##4##(2008-10#1)(2008-11#1)
a time course##3##3##(2008-10#1)(2008-11#2)
a time for##3##3##(1994-3#1)(2008-10#2)
a time of rapid change##2##5##(1997-3#1)(2013-1#1)
a time of##10##3##(1990-3#1)(1993-12#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2013-1#1)
a time series of##3##4##(1992-9#1)(2008-11#1)(2012-3#1)
a time to##3##3##(1993-12#2)(2012-12#1)
a time when the##2##4##(1997-2#1)(2008-9#1)
a time when##10##3##(1993-12#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-9#1)(2010-1#1)
a time##66##2##(1990-3#1)(1992-9#1)(1993-12#4)(1994-11#1)(1994-3#2)(1996-12#2)(1997-2#3)(1997-3#2)(1997-7#1)(2008-10#18)(2008-11#11)(2008-3#3)(2008-7#3)(2008-9#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#2)
a time- and dose-dependent##4##4##(1991-5#1)(1992-8#1)(1995-8#1)(2010-1#1)
a time- and voltage-dependent##2##4##(1993-3#2)
a time- and##10##3##(1991-5#1)(1992-8#1)(1993-11#1)(1993-3#2)(1995-8#1)(1997-1#2)(2008-9#1)(2010-1#1)
a time-based flow method##2##4##(2008-10#2)
a time-based##6##2##(2008-10#6)
a time-consuming##2##2##(2008-10#1)(2009-8#1)
a time-dependent##15##2##(1990-6#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-11#3)(2008-8#1)(2008-9#2)(2012-12#1)
a time-domain##2##2##(2007-12#1)(2008-3#1)
a time-of-flight mass##2##3##(2008-10#1)(2008-3#1)
a time-resolved##3##2##(2008-10#3)
a timely##10##2##(1991-6#1)(1994-12#1)(1994-2#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-12#1)(2010-11#1)
a timing##2##2##(1995-12#1)(2008-10#1)
a tiny##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
a tip##2##2##(1995-12#1)(2008-11#1)
a tissue##7##2##(1993-11#2)(2008-10#2)(2008-5#1)(2008-9#1)(2010-7#1)
a tissue-specific##3##2##(1995-2#1)(1997-7#1)(2008-12#1)
a titanium##2##2##(2008-10#1)(2008-7#1)
a titer exceeding##2##3##(2008-10#2)
a title##2##2##(2011-2#2)
a titrant##7##2##(2008-10#7)
a titration##3##2##(2008-10#3)
a to##2##2##(1997-7#1)(2008-10#1)
a tobacco##2##2##(2008-10#1)(2008-4#1)
a tolerance##2##2##(2008-10#1)(2013-1#1)
a tomato##5##2##(2008-10#5)
a tonsillectomy##3##2##(1995-11#1)(2013-1#2)
a tool for##21##3##(1990-8#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-3#1)
a tool to study##4##4##(1995-12#1)(1996-6#1)(2010-6#1)(2010-8#1)
a tool to##20##3##(1990-7#1)(1995-12#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-6#2)(2010-8#1)(2010-9#1)(2013-1#1)
a tool##46##2##(1990-7#1)(1990-8#1)(1994-12#1)(1995-12#1)(1996-6#1)(1997-6#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2010-11#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-3#1)(2013-1#2)
a topic##2##2##(2008-10#1)(2008-11#1)
a topoisomerase##2##2##(1993-8#1)(1995-6#1)
a total amount##2##3##(2008-10#1)(2008-11#1)
a total dose of##3##4##(1991-2#2)(1992-11#1)
a total length of##4##4##(1997-2#2)(2013-8#2)
a total of 10##3##4##(2008-10#2)(2008-11#1)
a total of 100##2##4##(1995-2#1)(2013-1#1)
a total of 102##2##4##(1990-6#1)(2013-1#1)
a total of 104##2##4##(1994-2#1)(1997-3#1)
a total of 11##2##4##(1993-8#1)(2008-10#1)
a total of 12##2##4##(2008-12#1)(2009-12#1)
a total of 19##3##4##(1991-11#1)(2008-5#1)(2011-2#1)
a total of 2##2##4##(2008-10#1)(2011-2#1)
a total of 20##3##4##(1990-8#1)(1995-6#1)(2008-12#1)
a total of 3##2##4##(1996-6#1)(2008-10#1)
a total of 4##2##4##(1994-2#1)(2008-12#1)
a total of 6##2##4##(2008-12#2)
a total of 72##2##4##(1996-8#1)(2008-10#1)
a total of 8##2##4##(1993-6#1)(2013-7#1)
a total of eight##2##4##(1994-5#1)(2008-12#1)
a total of##101##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-2#3)(1994-5#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-11#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#7)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#9)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
a total quality##2##3##(1994-2#1)(1995-3#1)
a total time of##2##4##(2008-10#2)
a total time##4##3##(1994-3#1)(2008-10#3)
a total##153##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-2#5)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#41)(2008-11#7)(2008-12#7)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#5)
a totally##2##2##(1996-11#1)(2008-10#1)
a toxic effect of##2##4##(1991-8#1)(2008-8#1)
a toxic##9##2##(1990-5#1)(1991-8#1)(1993-12#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
a toxin that##2##3##(2008-10#1)(2008-5#1)
a toxin##6##2##(1992-9#1)(1997-2#1)(2008-10#3)(2008-5#1)
a trace amount of##4##4##(2008-10#3)(2008-8#1)
a trace##12##2##(2008-10#4)(2008-3#1)(2008-5#6)(2008-8#1)
a tracer##6##2##(1990-5#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
a track##2##2##(1997-2#1)(2007-12#1)
a trade-off between##9##3##(2008-10#1)(2008-8#5)(2008-9#2)(2012-2#1)
a trade-off##12##2##(2008-10#2)(2008-8#5)(2008-9#2)(2010-10#1)(2012-2#1)(2013-1#1)
a tradition of##2##3##(1991-2#1)(2011-2#1)
a traditional open##2##3##(1997-8#1)(2008-10#1)
a traditional##21##2##(1991-12#1)(1992-12#1)(1994-9#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-9#2)(2010-7#1)(2013-1#1)
a train##2##2##(1997-2#1)(2007-12#1)
a trained##2##2##(1997-4#1)(2008-10#1)
a training program##3##3##(1991-12#1)(2008-7#2)
a training set##3##3##(1995-9#1)(2008-10#2)
a training##12##2##(1991-12#1)(1995-9#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#2)
a trait that##2##3##(2008-8#1)(2012-3#1)
a trait##4##2##(2008-8#2)(2010-1#1)(2012-3#1)
a trans-acting##2##2##(1993-12#1)(2008-9#1)
a transcript map##2##3##(1996-8#1)(1997-2#1)
a transcript of##3##3##(1991-6#1)(1996-6#1)(2010-7#1)
a transcript##6##2##(1991-6#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2010-7#1)
a transcription factor that##2##4##(1994-11#1)(2013-1#1)
a transcription factor##10##3##(1993-12#1)(1994-11#1)(2008-11#2)(2009-8#1)(2010-5#1)(2011-2#3)(2013-1#1)
a transcription##13##2##(1993-12#2)(1994-11#1)(1997-2#1)(2008-11#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#3)(2013-1#1)
a transcriptional activator##3##3##(1997-3#1)(2008-11#1)(2008-9#1)
a transcriptional##12##2##(1991-10#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#2)
a transducer of the##2##4##(1995-2#1)(2008-9#1)
a transducer##4##2##(1995-2#1)(2008-10#2)(2008-9#1)
a transfection##2##2##(2008-11#2)
a transfer of##3##3##(2007-12#1)(2008-10#2)
a transformation##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
a transfusion##2##2##(1995-6#1)(1996-9#1)
a transgene##3##2##(1995-2#1)(2008-11#2)
a transgenic mouse model##2##4##(1995-6#1)(2010-8#1)
a transgenic mouse##3##3##(1994-3#1)(1995-6#1)(2010-8#1)
a transgenic##11##2##(1994-3#1)(1995-2#1)(1995-6#1)(2008-10#5)(2009-8#1)(2010-8#1)(2012-3#1)
a transient increase in the##2##5##(1993-3#1)(2010-12#1)
a transient increase in##5##4##(1993-3#1)(1995-8#1)(1996-12#1)(2010-12#1)(2012-3#1)
a transient##25##2##(1993-1#1)(1993-3#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(2008-10#5)(2008-11#3)(2010-12#1)(2012-3#2)(2013-1#1)
a transition from##2##3##(1991-1#1)(1996-2#1)
a transition##12##2##(1991-1#1)(1991-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-1#1)(2012-12#1)
a transition-state##2##2##(1995-2#1)(2008-5#1)
a transitional##2##2##(1993-2#1)(2009-10#1)
a transitory##3##2##(1990-9#1)(2008-10#1)(2008-11#1)
a translation##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-8#1)(2012-3#1)
a translational##3##2##(2008-10#1)(2010-10#1)(2010-8#1)
a translocation##3##2##(1996-6#1)(2008-10#2)
a transmastoid##3##2##(2011-2#3)
a transmembrane H+ gradient##2##4##(1994-6#2)
a transmembrane glycoprotein##2##3##(1992-12#1)(1996-12#1)
a transmembrane transporter##2##3##(1993-12#2)
a transmembrane##10##2##(1992-12#1)(1993-12#3)(1994-6#2)(1995-6#1)(1996-12#1)(2008-11#1)(2008-8#1)
a transmission##6##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)
a transmitter##3##2##(1992-6#1)(2008-3#1)(2008-7#1)
a transparent##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)
a transport##2##2##(1990-2#1)(2008-11#1)
a transposable##2##2##(2008-10#1)(2010-8#1)
a transradial##2##2##(2011-2#2)
a transverse incision in##2##4##(1992-2#1)(2011-2#1)
a transverse##4##2##(1992-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
a transversely heated graphite##4##4##(2008-10#4)
a transversely##5##2##(2008-10#5)
a traumatic##8##2##(1994-12#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
a treatable##2##2##(2008-1#1)(2010-1#1)
a treatment approach##2##3##(2008-6#1)(2008-7#1)
a treatment for##9##3##(2008-11#2)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#3)(2013-1#1)
a treatment group receiving videotape training in##2##7##(1991-1#2)
a treatment group##3##3##(1991-1#2)(1996-11#1)
a treatment option for##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
a treatment option##4##3##(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
a treatment strategy##2##3##(2008-7#1)(2010-12#1)
a treatment##36##2##(1991-1#2)(1991-8#1)(1996-11#1)(1996-5#2)(1997-5#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-1#1)(2010-12#2)(2010-7#1)(2011-2#5)(2012-3#2)(2013-1#3)(2013-8#2)
a tree species##2##3##(2008-9#1)(2012-6#1)
a tree##10##2##(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#2)(2012-6#1)
a tremendous##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
a trend of decreasing##2##4##(2008-10#1)(2008-11#1)
a trend of##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a trend toward##8##3##(1992-9#1)(1995-11#1)(1996-11#1)(1997-3#1)(2008-10#2)(2009-3#1)(2011-2#1)
a trend towards an##2##4##(2008-10#1)(2008-7#1)
a trend towards improvement##2##4##(2009-3#2)
a trend towards##8##3##(1990-6#1)(2008-10#1)(2008-7#2)(2009-3#2)(2010-11#1)(2010-3#1)
a trend##25##2##(1990-2#1)(1990-6#1)(1992-9#1)(1995-11#1)(1996-11#1)(1996-6#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#3)(2009-3#3)(2010-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
a tri-colour##2##2##(2008-10#2)
a trial to##2##3##(1995-9#1)(2008-10#1)
a trial##17##2##(1990-11#1)(1992-3#1)(1995-12#1)(1995-5#1)(1995-9#3)(1996-6#3)(2008-10#3)(2008-3#1)(2008-8#1)(2010-8#1)(2012-2#1)
a triangular waveform##2##3##(2008-10#2)
a triangular##5##2##(2008-10#3)(2008-3#1)(2010-6#1)
a trigger##4##2##(2008-11#2)(2011-2#1)(2012-12#1)
a tripartite##3##2##(1991-5#1)(2008-12#1)(2009-8#1)
a triple##3##2##(1993-8#1)(2008-10#1)(2008-3#1)
a trivalent candidate##2##3##(2008-9#2)
a tropical##5##2##(2008-10#2)(2008-9#1)(2012-3#1)(2013-8#1)
a true##12##2##(1992-12#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-6#1)(2011-2#2)
a truly##3##2##(2013-1#1)(2013-7#1)(2013-8#1)
a truncated cDNA##2##3##(1990-7#1)(1993-8#1)
a truncated form of##2##4##(2008-11#1)(2008-9#1)
a truncated##8##2##(1990-7#1)(1993-8#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
a trustee##2##2##(1993-1#1)(1994-1#1)
a tryptophan##2##2##(1991-5#1)(2011-2#1)
a tsunami##2##2##(1990-11#1)(2013-1#1)
a tube##5##2##(1990-12#1)(2008-10#3)(2008-3#1)
a tuberculosis##2##2##(1996-3#1)(1997-2#1)
a tubular##7##2##(1996-2#1)(2008-10#2)(2008-7#1)(2009-1#2)(2013-1#1)
a tumor cell##2##3##(2009-12#1)(2009-3#1)
a tumor marker##3##3##(1993-1#2)(2009-4#1)
a tumor necrosis factor##2##4##(2012-3#2)
a tumor necrosis##3##3##(2012-3#2)(2013-1#1)
a tumor suppressor gene##3##4##(2008-9#1)(2011-2#1)(2013-1#1)
a tumor suppressor##7##3##(1995-6#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#1)
a tumor##35##2##(1990-12#1)(1992-12#1)(1993-1#2)(1994-11#2)(1994-12#2)(1995-1#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
a tumor-associated##2##2##(1994-5#1)(2008-11#1)
a tumour in##2##3##(2008-7#1)(2013-1#1)
a tumour##6##2##(2008-2#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
a tunable fiber ring depolarizer##2##5##(2008-3#2)
a tunable single-frequency##2##3##(2008-3#2)
a tunable##12##2##(2008-2#1)(2008-3#10)(2009-8#1)
a tungsten coil##4##3##(2008-10#4)
a tungsten wire##4##3##(2008-10#4)
a tungsten##13##2##(2008-10#13)
a tuning##2##2##(2007-12#1)(2008-3#1)
a tunnel diode can be##2##5##(2008-3#2)
a tunnel diode##4##3##(2008-3#4)
a tunnel##5##2##(2008-3#4)(2009-10#1)
a turbid medium##3##3##(2008-3#3)
a twelve-year-old##2##2##(1995-12#1)(2007-8#1)
a twin##4##2##(1990-6#1)(2008-12#1)(2009-6#1)(2011-2#1)
a two year##2##3##(1991-9#1)(2010-8#1)
a two##14##2##(1990-3#1)(1991-9#1)(1992-10#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-3#1)
a two- or##2##3##(2008-3#1)(2008-7#1)
a two-color##2##2##(1997-3#1)(2008-3#1)
a two-dimensional laminar counterflow burner (Tsuji burner) with a 60-mm line-of-sight path length##2##13##(2008-2#1)(2008-3#1)
a two-dimensional##10##2##(1991-9#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)
a two-electron##2##2##(2008-10#2)
a two-generation##2##2##(2008-10#1)(2010-1#1)
a two-level##2##2##(2008-10#1)(2008-7#1)
a two-part##2##2##(1994-3#1)(2012-3#1)
a two-phase##2##2##(2008-10#1)(2008-12#1)
a two-photon##2##2##(2008-3#2)
a two-site##2##2##(2009-7#1)(2013-8#1)
a two-stage procedure##2##3##(2008-10#1)(2013-1#1)
a two-stage##10##2##(1991-12#1)(2008-10#2)(2008-11#4)(2011-2#1)(2013-1#2)
a two-state transition##2##3##(1992-10#1)(1993-8#1)
a two-state##3##2##(1992-10#1)(1993-8#1)(1994-5#1)
a two-step##12##2##(1990-2#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-9#2)(2012-3#1)
a two-wavelength lidar##2##3##(2008-2#1)(2008-3#1)
a two-wavelength##3##2##(2008-2#1)(2008-3#2)
a two-way##3##2##(1991-2#1)(2008-9#1)(2010-8#1)
a two-week##2##2##(1990-11#1)(2008-10#1)
a two-year##3##2##(1991-1#1)(2008-12#1)(2011-2#1)
a twofold increase##2##3##(1996-12#1)(2008-7#1)
a twofold##3##2##(1996-12#1)(2008-7#1)(2009-8#1)
a type 1##2##3##(1992-3#1)(1993-6#1)
a type A##2##3##(1994-2#1)(1995-2#1)
a type C##2##3##(1992-3#1)(2008-4#1)
a type I##3##3##(2008-2#2)(2012-3#1)
a type II##4##3##(1991-10#1)(2008-2#1)(2008-5#1)(2009-7#1)
a type III secretion##2##4##(2008-10#1)(2008-9#1)
a type of##9##3##(1995-5#1)(1996-3#1)(2008-10#2)(2008-4#2)(2008-9#1)(2011-1#1)(2012-12#1)
a type##33##2##(1991-10#1)(1991-5#1)(1992-3#2)(1993-6#1)(1994-2#2)(1995-2#1)(1995-5#1)(1996-3#1)(2008-10#6)(2008-2#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
a typical case##2##3##(1994-12#1)(2008-1#1)
a typical feature of##3##4##(1997-6#1)(2008-10#1)(2008-8#1)
a typical lifetime##2##3##(2011-2#2)
a typical##58##2##(1990-3#1)(1993-8#1)(1994-12#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#4)(2009-5#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-2#8)(2012-2#3)(2013-8#2)
a tyrosinase##3##2##(2008-10#3)
a tyrosine phosphatase##2##3##(1994-11#1)(1995-2#1)
a tyrosine##5##2##(1992-1#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)
a ubiquitous##8##2##(1992-10#1)(1993-12#1)(1993-9#1)(2008-10#2)(2009-8#1)(2013-1#1)(2013-8#1)
a ubiquitously expressed##2##3##(1995-8#1)(2009-8#1)
a unidimensional##2##2##(2010-2#1)(2012-2#1)
a unified approach to##2##4##(2008-3#1)(2010-11#1)
a unified##9##2##(1992-1#1)(1993-12#1)(1997-3#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
a uniform and##2##3##(2008-4#1)(2008-9#1)
a uniform##18##2##(1994-12#1)(1994-2#1)(1996-2#2)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-3#1)
a unifying model##2##3##(1993-12#1)(2008-11#1)
a unifying##4##2##(1993-12#1)(2008-11#3)
a unilateral##6##2##(1995-2#1)(1996-2#1)(2008-11#1)(2008-7#2)(2011-2#1)
a unique AFLP##2##3##(2008-10#2)
a unique approach to##2##4##(1996-3#1)(2009-8#1)
a unique clinical##2##3##(2011-2#1)(2013-8#1)
a unique evolutionary##2##3##(2008-10#1)(2012-2#1)
a unique fingerprint##2##3##(1996-12#1)(2008-10#1)
a unique form of##2##4##(2012-2#1)(2013-7#1)
a unique group##2##3##(2008-10#2)
a unique haplotype##2##3##(2008-10#1)(2012-3#1)
a unique macronutrient composition##2##4##(2008-3#2)
a unique marker##2##3##(1993-8#1)(2012-12#1)
a unique mechanism##2##3##(1995-8#1)(2009-8#1)
a unique member of the##2##5##(1993-2#1)(2008-11#1)
a unique opportunity to##4##4##(2008-12#1)(2009-6#1)(2012-3#1)(2013-8#1)
a unique opportunity##5##3##(1991-2#1)(2008-12#1)(2009-6#1)(2012-3#1)(2013-8#1)
a unique platform##2##3##(2008-7#1)(2012-3#1)
a unique sequence##2##3##(1993-12#1)(2012-2#1)
a unique system##2##3##(2008-5#1)(2009-8#1)
a unique view into##2##4##(2008-4#1)(2011-7#1)
a unique##138##2##(1991-11#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-8#4)(1994-1#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#25)(2008-11#11)(2008-12#1)(2008-3#6)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#3)(2009-10#1)(2009-6#2)(2009-8#5)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
a uniquely##2##2##(2008-11#1)(2013-8#1)
a united##2##2##(2008-8#1)(2009-10#1)
a univariate or##2##3##(2008-10#2)
a univariate##5##2##(1991-2#1)(2008-10#3)(2009-4#1)
a universal health##2##3##(1991-2#1)(2007-12#1)
a universal##13##2##(1991-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-6#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
a university and##3##3##(1996-1#1)(2008-11#1)(2010-10#1)
a university hospital##3##3##(2009-1#1)(2010-8#1)(2012-3#1)
a university##14##2##(1994-12#1)(1995-11#1)(1996-1#1)(2008-11#3)(2008-12#1)(2009-1#1)(2010-1#1)(2010-10#2)(2010-8#1)(2012-3#2)
a urachal remnant##2##3##(2008-10#2)
a ureteral stent##2##3##(2008-10#1)(2013-1#1)
a urinary tract infection##2##4##(1994-2#1)(2008-7#1)
a urinary##4##2##(1991-12#1)(1994-2#1)(2008-7#1)(2012-12#1)
a used##3##2##(2008-10#3)
a useful addition to##2##4##(2008-10#1)(2012-3#1)
a useful adjunct##2##3##(2008-9#1)(2010-11#1)
a useful alternative##2##3##(2008-10#1)(2012-3#1)
a useful and##4##3##(1993-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
a useful approach for##2##4##(1995-8#1)(2008-10#1)
a useful biomarker##3##3##(2009-11#1)(2009-6#1)(2010-1#1)
a useful exercise##2##3##(2008-11#1)(2009-4#1)
a useful experimental model for##2##5##(1994-3#1)(2008-10#1)
a useful framework##2##3##(2008-11#1)(2009-4#1)
a useful guide##2##3##(2008-10#1)(2008-11#1)
a useful in##2##3##(2008-11#2)
a useful marker for##2##4##(2008-4#1)(2011-2#1)
a useful marker##3##3##(2008-4#1)(2010-5#1)(2011-2#1)
a useful means for##2##4##(2008-10#1)(2008-9#1)
a useful means##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
a useful method for##2##4##(1990-12#1)(2008-11#1)
a useful method##3##3##(1990-12#1)(2008-11#1)(2010-6#1)
a useful model for##3##4##(1990-5#1)(1995-12#1)(2008-10#1)
a useful model##4##3##(1990-5#1)(1990-8#1)(1995-12#1)(2008-10#1)
a useful parameter to##2##4##(1992-12#1)(2010-7#1)
a useful resource##2##3##(1992-3#1)(2008-9#1)
a useful screening tool##2##4##(2008-10#1)(2009-10#1)
a useful technique for##3##4##(2008-9#2)(2013-8#1)
a useful technique##4##3##(2008-9#2)(2010-7#1)(2013-8#1)
a useful test##2##3##(1991-3#1)(1995-5#1)
a useful tool for the##4##5##(1990-2#1)(1992-12#1)(2008-10#2)
a useful tool for##13##4##(1990-2#1)(1991-3#1)(1992-12#1)(1995-11#2)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
a useful tool in##9##4##(1991-11#1)(1996-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)
a useful tool to##7##4##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)
a useful tool##29##3##(1990-2#1)(1991-11#1)(1991-3#1)(1992-12#1)(1995-11#2)(1996-9#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-3#1)
a useful tumor marker##2##4##(1990-8#1)(2011-2#1)
a useful##131##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-3#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-12#3)(1993-3#2)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#28)(2008-11#14)(2008-4#6)(2008-5#3)(2008-7#4)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-2#10)(2012-3#4)(2013-1#1)(2013-8#1)
a user can##2##3##(2008-4#1)(2008-6#1)
a user##7##2##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
a user-defined##3##2##(2008-10#2)(2013-1#1)
a using##2##2##(2008-10#2)
a usual source of care##2##5##(1995-12#1)(2008-10#1)
a usual source of##4##4##(1995-12#1)(2008-10#3)
a usual source##5##3##(1995-12#2)(2008-10#3)
a usual##6##2##(1995-12#2)(2008-10#3)(2008-6#1)
a vaccine against##3##3##(1997-7#1)(2009-6#1)(2010-1#1)
a vaccine##18##2##(1990-11#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-5#2)(1997-7#2)(2008-11#3)(2009-6#2)(2010-1#1)(2011-2#3)(2012-3#1)
a vacuum##7##2##(1994-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
a vaginal##4##2##(1990-2#1)(1992-1#1)(1992-12#1)(1996-9#1)
a valid alternative to the##2##5##(1990-2#1)(2008-7#1)
a valid alternative to##4##4##(1990-2#1)(1992-5#1)(1995-3#1)(2008-7#1)
a valid alternative##8##3##(1990-2#1)(1992-5#1)(1995-3#1)(2008-10#3)(2008-7#2)
a valid and##2##3##(1993-2#1)(2008-5#1)
a valid##27##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#6)(2008-5#1)(2008-7#3)(2010-12#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
a validated##6##2##(2008-10#1)(2008-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-12#1)
a validation set##3##3##(1995-9#1)(2008-10#2)
a validation##7##2##(1995-9#1)(2008-10#4)(2008-5#1)(2013-1#1)
a valuable resource for##2##4##(2008-12#1)(2012-3#1)
a valuable source for##2##4##(2008-10#1)(2008-9#1)
a valuable source of##2##4##(2010-7#1)(2012-3#1)
a valuable source##4##3##(2008-10#1)(2008-9#1)(2010-7#1)(2012-3#1)
a valuable tool for##10##4##(1991-6#1)(1993-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-11#1)
a valuable tool in##2##4##(2008-10#1)(2008-11#1)
a valuable tool to##4##4##(1997-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
a valuable tool##17##3##(1991-6#1)(1993-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-11#2)(2011-2#1)
a valuable way##2##3##(2008-11#1)(2008-3#1)
a valuable##52##2##(1990-2#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#2)(2009-12#1)(2010-11#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)
a value comparable##2##3##(2008-10#1)(2008-3#1)
a value of 0##4##4##(2008-10#1)(2008-11#2)(2008-3#1)
a value of##8##3##(2008-10#3)(2008-11#3)(2008-3#2)
a value##19##2##(1990-10#1)(1991-5#1)(1992-12#1)(1993-3#1)(1996-1#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-5#1)(2009-12#1)(2011-1#1)
a values##3##2##(1994-1#2)(2010-4#1)
a van##2##2##(1992-10#1)(2008-10#1)
a vaporization temperature of##2##4##(2008-10#2)
a variable degree of##3##4##(2011-2#2)(2012-3#1)
a variable degree##4##3##(1997-3#1)(2011-2#2)(2012-3#1)
a variable factor##2##3##(1997-3#1)(2008-10#1)
a variable number of##2##4##(2008-10#1)(2008-11#1)
a variable##21##2##(1993-6#1)(1997-3#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#2)(2012-3#1)
a variant of the##3##4##(2008-10#2)(2010-7#1)
a variant of##8##3##(1992-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)
a variant##9##2##(1992-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-7#1)
a variation coefficient of##2##4##(2008-10#2)
a variation of the##5##4##(2008-10#2)(2008-3#1)(2009-7#1)(2010-8#1)
a variation##7##2##(2008-10#4)(2008-3#1)(2009-7#1)(2010-8#1)
a varied##2##2##(2008-10#1)(2012-2#1)
a variety of adverse##2##4##(2008-10#1)(2008-2#1)
a variety of alternative##2##4##(1996-1#1)(1996-6#1)
a variety of applications##6##4##(1996-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)
a variety of approaches##2##4##(2010-11#1)(2010-8#1)
a variety of behavioral##2##4##(2008-4#1)(2008-8#1)
a variety of biological samples##2##5##(2008-10#1)(2008-4#1)
a variety of biological##5##4##(2008-10#3)(2008-4#1)(2011-2#1)
a variety of cancers##2##4##(2008-12#1)(2013-8#1)
a variety of causes##2##4##(2008-6#1)(2011-2#1)
a variety of cells##5##4##(1992-7#1)(1995-6#1)(2008-10#1)(2009-3#1)(2012-2#1)
a variety of cellular##2##4##(2008-11#1)(2008-7#1)
a variety of clinical and##2##5##(1992-9#1)(2011-1#1)
a variety of clinical##5##4##(1992-9#1)(2008-11#3)(2011-1#1)
a variety of compounds##3##4##(2008-10#2)(2009-4#1)
a variety of conditions##2##4##(1990-2#1)(2008-6#1)
a variety of data##2##4##(1991-3#1)(1996-2#1)
a variety of different##4##4##(2008-10#2)(2010-4#1)(2012-2#1)
a variety of disease##2##4##(2008-10#1)(2008-4#1)
a variety of diseases##4##4##(2008-10#1)(2011-2#2)(2012-3#1)
a variety of drugs##2##4##(1990-11#1)(2008-11#1)
a variety of environmental##2##4##(2008-10#2)
a variety of fields##2##4##(2010-1#1)(2011-8#1)
a variety of forms##2##4##(1997-3#1)(2008-6#1)
a variety of heterologous##2##4##(1995-5#1)(1996-12#1)
a variety of human cancers##2##5##(2008-8#1)(2013-1#1)
a variety of human##3##4##(2008-8#1)(2011-2#1)(2013-1#1)
a variety of matrices##2##4##(2008-10#2)
a variety of medical##4##4##(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
a variety of mutations##2##4##(2008-4#2)
a variety of novel##2##4##(2008-10#1)(2008-11#1)
a variety of organisms##2##4##(2008-7#1)(2012-3#1)
a variety of other##7##4##(1993-12#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
a variety of patient##2##4##(2008-11#1)(2008-12#1)
a variety of physiological##2##4##(2008-4#1)(2008-5#1)
a variety of reasons##3##4##(1993-6#1)(1995-12#1)(2008-9#1)
a variety of sample##2##4##(2008-10#1)(2008-3#1)
a variety of techniques to##2##5##(1991-3#1)(1995-5#1)
a variety of techniques##5##4##(1991-3#1)(1994-1#1)(1995-5#1)(2010-3#1)(2012-2#1)
a variety of viral##2##4##(2008-11#1)(2011-2#1)
a variety of##343##3##(1990-11#2)(1990-2#1)(1991-12#2)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#4)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#4)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#57)(2008-11#30)(2008-12#8)(2008-2#2)(2008-3#5)(2008-4#16)(2008-5#5)(2008-6#6)(2008-7#9)(2008-8#10)(2008-9#16)(2009-10#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-2#1)(2010-3#1)(2010-4#5)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#18)(2011-3#1)(2011-8#1)(2012-12#1)(2012-2#10)(2012-3#10)(2013-1#4)(2013-8#10)
a variety##344##2##(1990-11#2)(1990-2#1)(1991-12#2)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#4)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#4)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#57)(2008-11#31)(2008-12#8)(2008-2#2)(2008-3#5)(2008-4#16)(2008-5#5)(2008-6#6)(2008-7#9)(2008-8#10)(2008-9#16)(2009-10#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-2#1)(2010-3#1)(2010-4#5)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#18)(2011-3#1)(2011-8#1)(2012-12#1)(2012-2#10)(2012-3#10)(2013-1#4)(2013-8#10)
a vascular disruption sequence##2##4##(1997-3#2)
a vascular tumor##2##3##(2007-8#1)(2009-1#1)
a vascular##14##2##(1990-12#1)(1996-11#1)(1997-3#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)
a vasoactive##2##2##(1991-6#1)(2011-2#1)
a vast##2##2##(1995-8#1)(1997-1#1)
a vector for##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
a vector##16##2##(2008-10#7)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
a vectorial##2##2##(1997-6#1)(2009-10#1)
a vegetative##2##2##(2008-10#1)(2008-11#1)
a vehicle for##2##3##(1991-2#1)(1994-1#1)
a vehicle##8##2##(1991-2#1)(1994-1#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-5#2)
a vein of Galen malformation##3##5##(1996-6#3)
a vein of##4##3##(1996-6#4)
a venous##2##2##(1994-9#1)(1997-6#1)
a ventral##3##2##(1994-12#1)(2007-12#2)
a ventricular septal defect##2##4##(2012-12#2)
a versatile##7##2##(1992-3#1)(2008-10#4)(2008-4#1)(2013-8#1)
a vertebral artery##2##3##(1996-9#1)(2008-7#1)
a vertebrate##2##2##(1993-12#1)(1994-12#1)
a vertex##3##2##(2008-6#3)
a vertical resolution of##2##4##(2008-3#2)
a vertical##6##2##(2008-10#2)(2008-11#1)(2008-3#3)
a vertically##2##2##(2008-3#2)
a very attractive##2##3##(1992-12#1)(2008-10#1)
a very close##2##3##(2008-10#1)(2013-1#1)
a very complex##7##3##(1992-9#2)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
a very different##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
a very effective##2##3##(1992-9#1)(2012-2#1)
a very efficient##3##3##(2008-11#1)(2008-8#1)(2010-10#1)
a very fast##4##3##(1990-2#1)(2008-10#3)
a very good agreement##2##4##(2008-10#2)
a very good##17##3##(1997-1#1)(2007-8#1)(2008-10#13)(2011-3#2)
a very high degree of##3##5##(1994-2#1)(2008-11#1)(2012-6#1)
a very high mortality rate##2##5##(1996-3#1)(2013-1#1)
a very high##18##3##(1990-12#1)(1994-2#1)(1996-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
a very important role in##3##5##(1990-9#1)(2008-9#1)(2009-2#1)
a very important role##4##4##(1990-9#1)(2008-11#1)(2008-9#1)(2009-2#1)
a very important step in##2##5##(2008-11#1)(2008-5#1)
a very important##15##3##(1990-9#1)(1991-2#1)(1991-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
a very inexpensive##2##3##(2008-10#2)
a very large##5##3##(1992-1#1)(1996-12#1)(2008-1#1)(2008-3#1)(2010-1#1)
a very limited##6##3##(2008-10#4)(2008-11#1)(2008-5#1)
a very long##3##3##(1997-7#1)(2008-3#1)(2009-12#1)
a very low rate of##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
a very low##18##3##(1990-3#1)(1990-5#1)(1991-11#1)(1992-9#1)(1993-12#1)(1995-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2010-11#1)(2011-2#2)(2013-1#1)
a very modest##3##3##(1994-12#1)(2008-1#1)(2009-4#1)
a very poor##2##3##(1991-11#1)(1992-3#1)
a very powerful tool##2##4##(2008-10#2)
a very powerful##3##3##(2008-10#2)(2008-7#1)
a very promising##5##3##(1996-3#1)(2008-10#1)(2008-8#1)(2010-7#2)
a very rare case of##2##5##(2011-2#2)
a very rare entity##2##4##(2010-11#1)(2013-1#1)
a very rare location##2##4##(1996-9#1)(2012-12#1)
a very rare occurrence##3##4##(2008-12#2)(2011-2#1)
a very rare##15##3##(1992-2#1)(1996-9#1)(1997-5#1)(1997-8#1)(2008-12#2)(2010-11#1)(2010-6#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
a very sensitive##5##3##(2008-10#4)(2012-3#1)
a very severe##2##3##(1996-12#1)(2008-8#1)
a very short time##2##4##(2008-10#1)(2008-11#1)
a very short##4##3##(2008-10#3)(2008-11#1)
a very significant##2##3##(1990-8#1)(1997-2#1)
a very similar##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
a very simple##3##3##(2008-10#3)
a very small volume##2##4##(2008-10#2)
a very small##9##3##(1993-3#1)(1995-5#1)(2008-10#5)(2008-11#1)(2010-5#1)
a very stable##3##3##(1990-12#1)(2008-10#2)
a very strong##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
a very successful##2##3##(1993-1#1)(2008-8#1)
a very uncommon##2##3##(2008-7#1)(2012-2#1)
a very useful tool##2##4##(1990-11#1)(1991-2#1)
a very useful##6##3##(1990-11#1)(1991-2#1)(1997-8#1)(2008-10#1)(2008-11#2)
a very wide##6##3##(1992-12#1)(1995-3#1)(2008-10#3)(2010-7#1)
a very##242##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#4)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-3#3)(1995-5#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#80)(2008-11#17)(2008-12#3)(2008-3#5)(2008-5#6)(2008-7#3)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-2#10)(2011-3#2)(2012-12#3)(2012-2#5)(2012-3#4)(2012-6#1)(2013-1#8)(2013-8#3)
a vested interest in##2##4##(1994-2#1)(2008-12#1)
a viable alternative##3##3##(1992-2#1)(2008-10#2)
a viable and##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
a viable option for##2##4##(2009-10#1)(2011-2#1)
a viable option##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
a viable solution##2##3##(1993-1#1)(2010-11#1)
a viable strategy for##2##4##(2008-8#1)(2013-1#1)
a viable technique##2##3##(2008-10#1)(2008-11#1)
a viable##36##2##(1991-2#1)(1992-2#1)(1993-1#1)(1996-3#1)(2008-10#12)(2008-11#5)(2008-8#2)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#5)
a vicious cycle##2##3##(2010-5#1)(2012-2#1)
a victim of##2##3##(2008-10#1)(2009-5#1)
a video##3##2##(1993-12#1)(2008-3#1)(2013-1#1)
a videotape of##2##3##(1994-3#1)(2009-7#1)
a view from##3##3##(1991-1#1)(1994-1#1)(2009-6#1)
a view of the##2##4##(1993-11#1)(2008-10#1)
a view of##5##3##(1993-11#1)(1994-12#1)(1996-1#1)(2008-10#1)(2011-2#1)
a view to##9##3##(1991-3#1)(1991-6#1)(1997-4#1)(2008-10#4)(2008-11#2)
a view##18##2##(1991-1#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-6#1)(2011-2#1)
a violation of##2##3##(1995-6#1)(2012-2#1)
a violent##2##2##(1996-5#1)(1997-7#1)
a violet##3##2##(2008-10#3)
a viral##9##2##(1992-9#1)(1995-5#1)(1996-11#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-5#1)
a virion##2##2##(1993-12#2)
a virtual camera##2##3##(2008-6#2)
a virtual learning environment##3##4##(2008-12#3)
a virtual lesion##2##3##(2008-10#2)
a virtual reality##3##3##(2008-11#1)(2011-7#2)
a virtual##15##2##(2008-10#3)(2008-11#1)(2008-12#3)(2008-6#3)(2008-9#1)(2011-7#2)(2013-8#2)
a virtually##2##2##(2008-11#1)(2009-10#1)
a virulence##5##2##(1996-12#1)(2008-10#4)
a virulent##3##2##(2008-10#2)(2008-9#1)
a virus associated with##2##4##(2008-10#2)
a virus exit process##2##4##(1997-1#2)
a virus##21##2##(1997-1#2)(2008-10#12)(2008-11#5)(2008-5#1)(2011-2#1)
a visible##6##2##(2008-10#3)(2008-11#1)(2008-2#1)(2012-12#1)
a visual analog scale##2##4##(2009-3#1)(2013-1#1)
a visual cue##3##3##(2008-8#2)(2010-5#1)
a visual##30##2##(1991-2#4)(1996-2#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
a vital part of##2##4##(1993-2#1)(2008-11#1)
a vital role in##3##4##(2010-8#1)(2011-2#1)(2013-1#1)
a vital role##4##3##(2008-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
a vital##13##2##(1993-2#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
a vitamin##3##2##(1990-3#1)(2008-10#2)
a vitellogenin##2##2##(1995-2#1)(2010-5#1)
a volar##3##2##(2008-9#3)
a volatile##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
a voltage##3##2##(1990-8#1)(2008-10#1)(2010-10#1)
a voltammetric method##2##3##(2008-10#2)
a voltammetric##8##2##(2008-10#8)
a voltammogram##2##2##(2008-10#2)
a volume greater than 10 ml##2##6##(2008-10#2)
a volume of##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
a volume##9##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-8#1)
a volumetric##2##2##(2008-1#1)(2008-6#1)
a voluntary##7##2##(1990-6#1)(1994-3#1)(1996-3#1)(2008-11#2)(2009-11#1)(2012-12#1)
a volunteer##6##2##(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-5#1)
a vulnerable##4##2##(2007-8#1)(2009-4#1)(2010-9#1)(2012-2#1)
a waiting##3##2##(1991-11#1)(1993-2#1)(2008-10#1)
a wall##2##2##(2008-10#1)(2011-2#1)
a wall-jet cell##2##3##(2008-10#2)
a wall-jet configuration##2##3##(2008-10#2)
a wall-jet##8##2##(2008-10#8)
a warm and##2##3##(2011-2#1)(2012-6#1)
a warm##4##2##(2008-10#1)(2011-2#1)(2012-4#1)(2012-6#1)
a warning##2##2##(1996-5#1)(2012-2#1)
a waste##4##2##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
a water bath##4##3##(2008-10#4)
a water carrier stream##3##4##(2008-10#3)
a water droplet##2##3##(2008-10#1)(2008-11#1)
a water mist##2##3##(1991-2#2)
a water mobile phase##4##4##(2008-10#4)
a water sample matrix##2##4##(2008-10#2)
a water sample##6##3##(2008-10#6)
a water soluble polymer##2##4##(2008-10#2)
a water soluble##3##3##(2008-10#3)
a water##34##2##(1991-2#2)(2008-10#28)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
a water-soluble Vitamin E##2##4##(2008-10#2)
a water-soluble polymer##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
a water-soluble##9##2##(1990-8#1)(1991-3#1)(2008-10#5)(2008-7#1)(2012-2#1)
a wavelength of 1##5##4##(2008-2#2)(2008-3#3)
a wavelength of approximately##2##4##(2008-2#1)(2008-3#1)
a wavelength of##13##3##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#6)
a wavelength##21##2##(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#12)
a wax-encased peat pot containing##2##5##(2008-10#2)
a way for##2##3##(2008-10#1)(2011-2#1)
a way forward##2##3##(2008-11#1)(2009-10#1)
a way of##7##3##(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-11#1)(2012-12#1)
a way that it could##2##5##(2008-11#1)(2008-3#1)
a way that it##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
a way that the##5##4##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
a way that##26##3##(1990-12#1)(1991-2#1)(1991-5#1)(1997-5#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2011-2#1)(2013-8#1)
a way to##14##3##(1993-3#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#3)(2010-11#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
a way##56##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-2#1)(1996-2#1)(1997-5#2)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
a weak correlation##3##3##(2008-10#2)(2009-5#1)
a weak homology##2##3##(1992-3#1)(1995-6#1)
a weak##38##2##(1990-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1994-11#1)(1994-3#2)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#1)
a weakening##3##2##(1996-6#1)(2008-10#2)
a weakly##9##2##(1995-8#1)(2008-10#5)(2008-11#1)(2009-5#1)(2010-3#1)
a wealth of##7##3##(1996-2#1)(1997-7#2)(2008-10#1)(2008-11#2)(2010-7#1)
a web##2##2##(2008-7#1)(2008-9#1)
a web-based##7##2##(2008-10#2)(2010-10#3)(2011-3#1)(2012-3#1)
a website##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
a week after##2##3##(2008-6#1)(2013-1#1)
a week for 4 weeks##2##5##(2008-10#2)
a week for##12##3##(1991-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2010-1#1)(2010-4#1)(2011-2#1)
a week of##2##3##(2008-11#1)(2011-2#1)
a week##29##2##(1991-3#1)(1993-6#1)(1995-6#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
a weekly##3##2##(1994-8#2)(2008-10#1)
a weight##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
a weighted##2##2##(2012-3#2)
a welcome##2##2##(1991-1#1)(2009-6#1)
a well defined##3##3##(1990-9#1)(2008-10#1)(2011-2#1)
a well developed##3##3##(1994-12#1)(2008-7#1)(2009-9#1)
a well established##6##3##(1992-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
a well known##8##3##(1993-11#1)(1993-8#1)(1994-5#1)(1997-5#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-11#1)
a well of##2##3##(2008-11#1)(2008-7#1)
a well validated##2##3##(2008-10#1)(2013-1#1)
a well##36##2##(1990-9#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-5#1)(1996-12#1)(1997-3#2)(1997-5#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
a well-characterized##5##2##(1992-1#1)(1996-12#1)(2008-9#1)(2010-6#1)(2011-2#1)
a well-defined##17##2##(1997-3#1)(1997-5#1)(2008-10#10)(2008-3#1)(2009-12#1)(2010-10#1)(2012-12#1)(2013-8#1)
a well-described##2##2##(2008-10#1)(2011-3#1)
a well-developed##3##2##(2008-10#1)(2008-7#1)(2009-7#1)
a well-differentiated##2##2##(2008-11#1)(2013-1#1)
a well-established technique##2##3##(2008-3#1)(2010-7#1)
a well-established##7##2##(1996-2#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-7#1)(2013-1#1)
a well-known##8##2##(1991-3#1)(1993-3#1)(2008-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
a well-ordered and##2##3##(1993-8#1)(2008-10#1)
a wet##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
a wheat powdery mildew population##2##5##(2008-10#2)
a wheat##10##2##(2008-10#10)
a white##6##2##(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
a whitefly-transmitted geminivirus##3##3##(2008-10#3)
a whole cell##4##3##(1990-11#1)(1991-12#1)(2008-10#1)(2008-11#1)
a whole genome##2##3##(2008-7#2)
a whole new##2##3##(2008-10#1)(2008-9#1)
a whole range of##2##4##(2008-5#1)(2013-8#1)
a whole##48##2##(1990-11#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a whole-cell##2##2##(1994-11#1)(2011-1#1)
a whole-genome##2##2##(2008-7#2)
a wide array of##5##4##(2008-10#3)(2008-8#1)(2013-1#1)
a wide concentration range from##2##5##(2008-10#2)
a wide concentration range##27##4##(1993-8#1)(2008-10#26)
a wide distribution##3##3##(1996-12#1)(2008-5#1)(2008-9#1)
a wide dynamic range##2##4##(2008-10#2)
a wide geographic##2##3##(2007-12#1)(2008-10#1)
a wide geographical##2##3##(2008-10#1)(2012-5#1)
a wide linear range and##2##5##(2008-10#2)
a wide linear range##5##4##(2008-10#5)
a wide pH range##9##4##(1993-8#1)(2008-10#8)
a wide pH##10##3##(1993-8#1)(2008-10#9)
a wide range of applications##2##5##(2008-10#1)(2010-12#1)
a wide range of clinical##2##5##(1990-2#1)(2008-11#1)
a wide range of concentrations##4##5##(2008-10#4)
a wide range of conditions##4##5##(2008-10#3)(2009-7#1)
a wide range of diseases##3##5##(1992-11#1)(2008-10#1)(2011-2#1)
a wide range of environmental##2##5##(2008-10#1)(2009-9#1)
a wide range of functions##2##5##(1992-1#1)(2008-11#1)
a wide range of human##2##5##(2009-8#1)(2012-3#1)
a wide range of organisms##2##5##(1995-2#1)(2008-10#1)
a wide range of pH##5##5##(2008-10#4)(2013-1#1)
a wide range of parameter values##3##6##(2008-8#2)(2008-9#1)
a wide range of parameters##2##5##(2008-8#1)(2008-9#1)
a wide range of physiological##3##5##(1991-2#1)(2008-11#1)(2011-2#1)
a wide range of plant##2##5##(2008-10#2)
a wide range of temperature##2##5##(2008-10#2)
a wide range of wavelengths##2##5##(2008-10#1)(2008-3#1)
a wide range of##121##4##(1990-11#1)(1990-2#1)(1991-2#1)(1992-1#1)(1992-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#2)(2007-11#1)(2008-10#49)(2008-11#14)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
a wide range##123##3##(1990-11#1)(1990-2#1)(1991-2#1)(1992-1#1)(1992-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#2)(2007-11#1)(2008-10#51)(2008-11#14)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
a wide spectrum of##9##4##(1993-3#1)(1997-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#2)(2013-1#1)
a wide variation in the##2##5##(2008-10#1)(2010-1#1)
a wide variation in##5##4##(1997-3#1)(2008-10#1)(2009-7#1)(2010-1#1)(2012-3#1)
a wide variety of cell##2##5##(1996-2#1)(2008-11#1)
a wide variety of human##2##5##(2011-2#2)
a wide variety of organisms##2##5##(2008-11#1)(2008-2#1)
a wide variety of other cations##3##6##(2008-10#3)
a wide variety of other##10##5##(2008-10#9)(2011-3#1)
a wide variety of plants##2##5##(2008-10#1)(2009-8#1)
a wide variety of##68##4##(1990-2#1)(1992-3#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-8#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#4)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-8#1)
a wide##294##2##(1990-11#1)(1990-2#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-8#3)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#131)(2008-11#20)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#11)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#12)(2011-3#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#5)(2013-8#3)
a widely accepted##2##3##(2008-10#1)(2008-11#1)
a widely used herbicide##2##4##(1995-8#1)(2008-10#1)
a widely used##14##3##(1991-5#1)(1993-1#1)(1995-8#1)(2008-10#5)(2008-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a widely##21##2##(1991-5#1)(1993-1#1)(1995-8#1)(2008-10#6)(2008-11#4)(2008-4#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
a wider range of##3##4##(1994-12#1)(2008-10#1)(2008-12#1)
a wider range##4##3##(1994-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
a wider##22##2##(1993-12#1)(1994-1#1)(1994-12#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2013-8#2)
a widespread disease##3##3##(2008-10#3)
a widespread environmental##2##3##(2008-10#2)
a widespread##13##2##(1996-12#1)(2008-10#8)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
a wild##3##2##(1994-2#1)(2008-11#1)(2013-8#1)
a wild-type##10##2##(2008-10#6)(2008-11#1)(2010-10#1)(2011-1#1)(2012-2#1)
a window for##2##3##(2009-8#1)(2012-2#1)
a window of opportunity for##2##5##(2008-3#1)(2013-1#1)
a window##7##2##(1993-9#1)(2008-1#1)(2008-3#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
a wire##2##2##(2008-11#2)
a wireless telephone##2##3##(2010-2#2)
a wireless##3##2##(2008-12#1)(2010-2#2)
a wish##2##2##(1993-3#1)(2012-3#1)
a woman aged##3##3##(1990-6#1)(1991-3#1)(1995-12#1)
a woman in##2##3##(1991-12#1)(2012-2#1)
a woman who hemorrhages 24 hours post tonsillectomy##2##7##(2013-1#2)
a woman who##4##3##(1995-12#1)(2010-12#1)(2013-1#2)
a woman with##4##3##(1995-12#1)(1997-3#1)(2008-4#1)(2013-1#1)
a woman##15##2##(1990-6#1)(1991-12#1)(1991-3#1)(1995-12#3)(1995-6#1)(1997-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
a woman's prenatal alcohol use##2##5##(2008-11#2)
a woman's##6##2##(1995-1#1)(1997-7#1)(2008-11#2)(2008-4#1)(2013-1#1)
a women's health center in an academic health##4##8##(1994-3#4)
a women's health center##6##4##(1994-3#6)
a word##3##2##(1995-2#1)(2008-8#1)(2011-3#1)
a work hardening##2##3##(2008-4#1)(2009-7#1)
a work rehabilitation center##2##4##(1993-1#2)
a work##8##2##(1993-1#2)(1996-1#1)(1996-3#1)(2008-4#1)(2009-7#2)(2013-1#1)
a worker##2##2##(1995-12#1)(1996-5#1)
a working electrode##7##3##(2008-10#7)
a working hypothesis##3##3##(2008-12#2)(2013-8#1)
a working plan for##2##4##(1994-1#2)
a working potential##2##3##(2008-10#2)
a working range##4##3##(2008-10#4)
a working##26##2##(1993-8#1)(1994-1#2)(1996-2#1)(2008-10#19)(2008-12#2)(2013-8#1)
a workplace##3##2##(2008-12#1)(2012-2#1)(2013-8#1)
a workshop##9##2##(1990-11#1)(1992-12#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#2)
a worldwide collection of##4##4##(2008-10#4)
a worldwide##13##2##(1994-1#1)(2008-10#8)(2008-5#2)(2011-1#1)(2012-2#1)
a worse prognosis in##2##4##(1990-8#1)(2011-2#1)
a worse prognosis##7##3##(1990-12#1)(1990-8#2)(1991-8#1)(2008-10#1)(2011-2#2)
a worsening##3##2##(1991-8#1)(1996-9#1)(2013-1#1)
a wound##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
a written##4##2##(1993-3#1)(1996-3#1)(2008-7#1)(2013-1#1)
a xenograft##2##2##(2008-8#1)(2011-2#1)
a year after##2##3##(2010-1#1)(2012-3#1)
a year with a##2##4##(1994-9#1)(2008-10#1)
a year##28##2##(1990-8#1)(1991-2#1)(1992-5#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-4#1)(2008-10#7)(2008-5#1)(2008-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-8#3)
a year)##2##2##(1997-8#1)(2008-11#1)
a yeast (Pichia guilermondii) and a bacterium (Bacillus mycoides)##2##9##(2008-10#2)
a yeast of##2##3##(1996-12#1)(2008-5#1)
a yeast##18##2##(1991-5#1)(1993-9#3)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-9#2)(2010-10#1)(2012-3#1)
a yellow pigment##2##3##(2008-10#1)(2008-11#1)
a yellow##11##2##(2008-10#9)(2008-11#1)(2013-1#1)
a yet##3##2##(1997-8#1)(2008-10#1)(2008-5#1)
a yield##3##2##(1994-6#1)(2008-10#2)
a young adult##2##3##(1990-3#1)(2008-12#1)
a young child##5##3##(1993-3#1)(1996-2#2)(2008-9#2)
a young female patient##2##4##(2012-12#1)(2013-8#1)
a young female##7##3##(2008-12#3)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
a young male with##2##4##(1996-3#1)(2012-2#1)
a young male##4##3##(1996-3#1)(2008-11#1)(2010-7#1)(2012-2#1)
a young man##2##3##(2012-3#1)(2013-1#1)
a young woman with##3##4##(1991-3#1)(2010-12#1)(2011-2#1)
a young woman##6##3##(1991-3#1)(1992-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
a young##41##2##(1990-3#1)(1991-3#1)(1992-12#1)(1993-3#2)(1994-9#1)(1995-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-5#1)(2008-11#1)(2008-12#4)(2008-4#1)(2008-7#1)(2008-9#2)(2010-10#2)(2010-12#1)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
a younger##5##2##(1994-8#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)
a youth development intervention##2##4##(2013-1#2)
a youth##4##2##(2010-11#1)(2010-5#1)(2013-1#2)
a zero##4##2##(2008-10#3)(2008-8#1)
a zigzag##6##2##(2007-11#2)(2008-10#3)(2008-11#1)
a zinc##4##2##(1991-10#1)(2008-10#1)(2008-5#1)(2009-8#1)
a zone of##3##3##(1993-12#1)(2008-10#2)
a zoonosis##2##2##(2008-5#1)(2011-2#1)
a zoonotic##2##2##(2008-10#1)(2011-2#1)
a été##8##2##(2011-2#2)(2013-1#6)
a##54189##1##(1990-10#9)(1990-11#143)(1990-12#166)(1990-2#134)(1990-3#97)(1990-4#4)(1990-5#225)(1990-6#106)(1990-7#14)(1990-8#150)(1990-9#105)(1991-1#101)(1991-10#26)(1991-11#109)(1991-12#243)(1991-2#246)(1991-3#195)(1991-4#4)(1991-5#157)(1991-6#185)(1991-7#28)(1991-8#85)(1991-9#100)(1992-1#130)(1992-10#36)(1992-11#44)(1992-12#240)(1992-2#156)(1992-3#242)(1992-4#24)(1992-5#43)(1992-6#142)(1992-7#16)(1992-8#62)(1992-9#146)(1993-1#153)(1993-11#84)(1993-12#348)(1993-2#216)(1993-3#255)(1993-5#15)(1993-6#221)(1993-8#274)(1993-9#98)(1994-1#123)(1994-11#222)(1994-12#319)(1994-2#216)(1994-3#242)(1994-5#201)(1994-6#100)(1994-8#219)(1994-9#80)(1995-1#77)(1995-10#14)(1995-11#201)(1995-12#335)(1995-2#391)(1995-3#136)(1995-5#116)(1995-6#294)(1995-8#182)(1995-9#95)(1996-1#156)(1996-11#92)(1996-12#314)(1996-2#300)(1996-3#295)(1996-5#139)(1996-6#173)(1996-8#50)(1996-9#61)(1997-1#210)(1997-2#304)(1997-3#314)(1997-4#106)(1997-5#76)(1997-6#126)(1997-7#215)(1997-8#250)(1997-9#16)(2006-5#3)(2006-6#33)(2007-11#100)(2007-12#353)(2007-7#1)(2007-8#51)(2007-9#12)(2008-1#242)(2008-10#15792)(2008-11#3739)(2008-12#1065)(2008-2#442)(2008-3#1672)(2008-4#535)(2008-5#1148)(2008-6#327)(2008-7#1455)(2008-8#1364)(2008-9#1402)(2009-1#91)(2009-10#327)(2009-11#116)(2009-12#184)(2009-2#12)(2009-3#145)(2009-4#91)(2009-5#130)(2009-6#176)(2009-7#219)(2009-8#434)(2009-9#108)(2010-1#200)(2010-10#266)(2010-11#225)(2010-12#297)(2010-2#48)(2010-3#115)(2010-4#167)(2010-5#210)(2010-6#244)(2010-7#238)(2010-8#253)(2010-9#91)(2011-1#254)(2011-10#17)(2011-2#2132)(2011-3#130)(2011-4#7)(2011-6#1)(2011-7#30)(2011-8#3)(2011-9#9)(2012-12#420)(2012-2#999)(2012-3#966)(2012-4#12)(2012-5#32)(2012-6#12)(2012-7#17)(2012-8#5)(2012-9#11)(2013-1#1779)(2013-2#3)(2013-3#1)(2013-7#59)(2013-8#830)
a&quot##3##1##(1995-2#2)(2008-10#1)
a( *)##3##2##(2010-4#3)
a(w) = 0##6##3##(2008-7#6)
a(w)##9##1##(2008-10#2)(2008-5#1)(2008-7#6)
a) the##4##2##(1990-6#1)(1991-6#1)(2008-7#1)(2012-2#1)
a)##13##1##(1990-6#1)(1991-6#1)(1993-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-1#2)(2012-2#2)
a1##2##1##(2008-5#2)
a2##2##1##(2008-10#1)(2008-4#1)
a3 and##2##2##(1995-6#1)(1997-7#1)
a3##4##1##(1995-6#1)(1997-7#1)(2008-10#1)(2008-8#1)
aFGF and/or bFGF##2##3##(1991-12#2)
aFGF##8##1##(1990-8#2)(1991-12#2)(1997-7#4)
aI3 alpha##3##2##(1995-6#3)
aMCI##4##1##(2011-2#4)
aOR =##3##1##(2013-1#3)
aVR##3##1##(2010-1#3)
a[actin]##2##1##(1993-8#2)
aa in##2##2##(1993-12#1)(1993-2#1)
aa replacements##2##2##(1991-6#1)(1991-9#1)
aa sequence of CelS##2##4##(1990-5#2)
aa sequence of##4##3##(1990-11#1)(1990-5#2)(1993-12#1)
aa sequence shows##2##3##(1993-2#2)
aa sequence##16##2##(1990-11#2)(1990-5#2)(1991-6#1)(1993-12#4)(1993-2#3)(1993-6#3)(2008-10#1)
aa sequences of##4##3##(1990-11#1)(1993-12#1)(1993-6#1)(1997-7#1)
aa sequences##6##2##(1990-11#1)(1993-12#2)(1993-6#2)(1997-7#1)
aa which may be##2##4##(1991-6#1)(1993-12#1)
aa with##2##2##(1990-11#1)(1993-9#1)
aa##59##1##(1990-11#6)(1990-12#1)(1990-5#2)(1991-6#7)(1991-9#2)(1993-12#13)(1993-2#6)(1993-6#7)(1993-9#1)(1995-12#2)(1996-6#1)(1997-7#2)(1997-9#2)(2008-10#3)(2010-5#3)(2013-8#1)
aaRSs##2##1##(2012-2#2)
ab initio##7##2##(1991-5#1)(1996-5#3)(2008-10#1)(2010-7#1)(2011-3#1)
abandon their##3##2##(1996-6#1)(2008-9#2)
abandon##4##1##(1993-9#1)(1996-6#1)(2008-9#2)
abandoned##8##1##(1991-1#2)(2008-10#2)(2008-11#1)(2008-9#2)(2012-3#1)
abandoned?##2##1##(2008-11#1)(2012-3#1)
abandoning the##2##2##(1991-3#1)(2008-5#1)
abandoning##6##1##(1990-6#1)(1991-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
abappressorium##4##1##(2008-10#4)
abasic site##2##2##(1991-3#1)(2008-10#1)
abatement of##2##2##(1990-2#1)(2011-2#1)
abatement##7##1##(1990-2#1)(1991-12#4)(2008-10#1)(2011-2#1)
abattoir##3##1##(2011-2#3)
abbreviated##3##1##(1995-12#1)(2008-10#2)
abbreviations##3##1##(1992-3#1)(2008-9#2)
abdomen and##6##2##(1995-10#1)(1997-5#1)(2009-8#1)(2011-2#1)(2012-2#2)
abdomen in##2##2##(1992-9#1)(2008-11#1)
abdomen was##4##2##(1993-6#1)(1997-3#1)(2011-2#1)(2013-8#1)
abdomen were##3##2##(1997-8#1)(2011-2#2)
abdomen##47##1##(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-9#2)(1993-6#1)(1995-10#1)(1995-3#3)(1997-3#2)(1997-5#2)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-6#2)(2011-2#7)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
abdominal CT##3##2##(1991-6#1)(2008-12#1)(2012-3#1)
abdominal adipose tissue##2##3##(2008-4#2)
abdominal and presternal##2##3##(2011-2#2)
abdominal and thoracic##3##3##(1993-12#2)(2012-3#1)
abdominal and vaginal##3##3##(1993-12#3)
abdominal and##12##2##(1993-12#6)(1995-3#1)(2008-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
abdominal aorta and/or renal arteries##2##5##(1997-8#2)
abdominal aorta##8##2##(1997-8#5)(2010-11#1)(2013-3#2)
abdominal aortic aneurysm (AAA)##3##4##(2009-7#1)(2010-12#1)(2010-7#1)
abdominal aortic aneurysm##10##3##(1992-5#4)(2009-7#1)(2010-12#1)(2010-7#2)(2011-2#1)(2011-3#1)
abdominal aortic##14##2##(1992-5#5)(1997-8#1)(2009-7#1)(2010-12#2)(2010-7#2)(2011-2#1)(2011-3#1)(2013-8#1)
abdominal area##2##2##(2013-1#2)
abdominal catheters##2##2##(2011-2#2)
abdominal cavity##5##2##(1991-12#1)(1991-2#1)(1993-6#1)(2011-2#1)(2013-1#1)
abdominal complaints##2##2##(1993-6#1)(1997-8#1)
abdominal discomfort##2##2##(2008-12#1)(2011-2#1)
abdominal disease##2##2##(1993-6#1)(2011-2#1)
abdominal distension##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
abdominal examination##2##2##(1993-6#1)(1997-3#1)
abdominal fat graft##2##3##(2011-2#2)
abdominal fat weight##2##3##(2008-12#1)(2008-8#1)
abdominal fat##10##2##(2008-11#2)(2008-12#2)(2008-8#4)(2011-2#2)
abdominal ganglia##2##2##(1994-2#1)(2007-12#1)
abdominal ganglion##2##2##(1994-2#1)(2008-4#1)
abdominal hysterectomy and##3##3##(1993-12#2)(2013-1#1)
abdominal hysterectomy with bilateral##2##4##(2008-10#1)(2013-1#1)
abdominal hysterectomy##17##2##(1991-12#2)(1991-3#1)(1993-12#2)(1993-3#1)(1994-2#2)(1995-12#1)(1995-3#1)(2008-10#1)(2010-3#2)(2013-1#3)(2013-8#1)
abdominal injuries]##2##2##(1990-2#2)
abdominal obesity##2##2##(2008-11#1)(2013-1#1)
abdominal open surgery##3##3##(2011-2#3)
abdominal or##3##2##(1992-2#1)(1993-2#1)(1993-3#1)
abdominal organ##2##2##(1993-6#1)(2009-3#1)
abdominal organs##2##2##(2010-8#1)(2011-2#1)
abdominal pain and##8##3##(1991-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2009-8#1)(2010-12#1)(2013-1#1)
abdominal pain associated##3##3##(1995-2#2)(2010-1#1)
abdominal pain in##5##3##(1992-5#2)(1997-5#1)(2009-8#1)(2011-2#1)
abdominal pain##54##2##(1990-11#1)(1990-9#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-5#2)(1992-9#1)(1993-6#2)(1995-2#2)(1995-3#1)(1997-5#2)(1997-7#1)(1997-8#3)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-12#2)(2011-2#7)(2012-12#2)(2012-3#3)(2013-1#5)
abdominal pains##2##2##(2008-10#2)
abdominal segments##2##2##(2007-12#2)
abdominal sepsis##2##2##(2008-5#1)(2009-8#1)
abdominal surgery##6##2##(1993-2#1)(1995-3#1)(2010-4#2)(2010-8#1)(2011-2#1)
abdominal surgical emergencies in##3##4##(2011-2#2)(2012-12#1)
abdominal surgical emergencies##4##3##(2011-2#3)(2012-12#1)
abdominal surgical##5##2##(2011-2#4)(2012-12#1)
abdominal symptoms##2##2##(2008-12#1)(2013-1#1)
abdominal tergites of##2##3##(2007-12#2)
abdominal tergites##3##2##(2007-12#3)
abdominal trauma##6##2##(1990-2#2)(2008-10#1)(2010-1#2)(2010-12#1)
abdominal ultrasonography and##2##3##(2009-8#1)(2011-1#1)
abdominal ultrasound##7##2##(1997-8#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
abdominal viscera##3##2##(1991-2#1)(2010-6#1)(2012-3#1)
abdominal wall portion of the##2##5##(2011-2#2)
abdominal wall##19##2##(1991-1#2)(1991-12#1)(1995-3#2)(1996-3#1)(2008-11#1)(2008-12#2)(2009-9#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)
abdominal##283##1##(1990-11#1)(1990-2#6)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#6)(1991-2#2)(1991-3#6)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#2)(1992-5#7)(1992-9#1)(1993-12#9)(1993-2#2)(1993-3#2)(1993-6#8)(1994-2#7)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#6)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#14)(2007-12#11)(2008-10#12)(2008-11#10)(2008-12#10)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#33)(2011-3#3)(2012-12#6)(2012-2#8)(2012-3#9)(2013-1#19)(2013-3#2)(2013-8#2)
abdominoscrotal hydrocele##2##2##(2008-10#2)
abducens nerve schwannoma##2##3##(2012-3#2)
abducens nerve##4##2##(2012-3#4)
abducens##5##1##(2012-3#5)
abduction and##2##2##(1990-2#1)(2011-2#1)
abduction##16##1##(1990-2#1)(1993-12#1)(1993-2#1)(1996-12#2)(2009-11#1)(2010-7#3)(2011-2#1)(2012-3#1)(2013-1#5)
abductive##3##1##(2009-11#3)
aberrant bands##2##2##(1991-12#2)
aberrant chromosome##3##2##(2008-11#1)(2009-12#1)(2012-3#1)
aberrant hyperproliferation in##2##3##(1995-9#2)
aberrant hyperproliferation##4##2##(1995-9#4)
aberrant splicing##2##2##(1996-2#1)(2008-8#1)
aberrant##40##1##(1991-12#2)(1991-9#1)(1993-2#1)(1993-8#1)(1995-6#1)(1995-9#5)(1996-2#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
aberration of##2##2##(2008-3#2)
aberration##13##1##(2008-10#1)(2008-2#2)(2008-3#7)(2008-7#1)(2009-5#1)(2013-8#1)
aberrations (CAs)##2##2##(2008-11#1)(2010-1#1)
aberrations and##5##2##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#2)
aberrations are##2##2##(2010-11#1)(2013-8#1)
aberrations in the##2##3##(1995-8#1)(2008-9#1)
aberrations in##7##2##(1993-1#1)(1995-8#1)(2008-9#3)(2010-1#1)(2012-3#1)
aberrations##35##1##(1991-12#1)(1993-1#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-3#5)(2008-7#1)(2008-9#5)(2010-1#5)(2010-11#1)(2011-2#3)(2012-3#1)(2013-8#4)
abietina and##2##2##(2008-10#2)
abietina epidemic##2##2##(2008-10#2)
abietina var##6##2##(2008-10#6)
abietina##20##1##(2008-10#20)
abilities and the##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
abilities and##10##2##(1994-6#1)(1994-8#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)(2012-3#1)
abilities are##4##2##(2010-10#1)(2010-2#3)
abilities at##2##2##(2008-9#1)(2011-2#1)
abilities in##6##2##(1994-8#1)(1997-2#1)(2008-9#1)(2011-1#3)
abilities is##3##2##(2008-7#1)(2010-2#1)(2011-1#1)
abilities of the##2##3##(1992-8#1)(2009-8#1)
abilities of##17##2##(1992-8#1)(1993-3#1)(1995-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
abilities to inhibit##3##3##(1993-8#1)(2008-10#1)(2009-12#1)
abilities to stimulate##3##3##(1992-10#1)(1994-8#1)(2009-12#1)
abilities to##24##2##(1992-10#1)(1993-8#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-8#1)(2008-9#2)(2009-12#3)(2009-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
abilities##96##1##(1990-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#15)(2008-11#11)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#6)(2009-12#4)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#6)(2011-1#4)(2011-2#5)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#3)
ability after##2##2##(2008-7#1)(2013-1#1)
ability and usefulness of##2##4##(1995-12#1)(2008-10#1)
ability and##32##2##(1991-6#1)(1991-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(2008-10#10)(2008-11#4)(2008-5#2)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
ability are##3##2##(2008-3#1)(2008-8#2)
ability as##2##2##(1992-2#1)(1992-9#1)
ability at##2##2##(1995-8#1)(2008-10#1)
ability depends on##2##3##(1990-11#1)(2008-6#1)
ability for the##3##3##(2008-10#3)
ability for##10##2##(2008-10#8)(2008-7#1)(2013-8#1)
ability in the##2##3##(2008-10#1)(2012-3#1)
ability in##15##2##(1994-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#3)(2009-8#2)(2011-8#1)(2012-3#1)(2013-1#1)
ability is##7##2##(1997-1#1)(2006-6#1)(2008-10#2)(2008-8#2)(2008-9#1)
ability of C##6##3##(2008-10#4)(2008-8#1)(2011-1#1)
ability of Phytophthora infestans##2##4##(2008-10#2)
ability of Ras to##2##4##(1996-2#2)
ability of a##11##3##(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
ability of cells to##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
ability of cells##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
ability of health##2##3##(1995-2#1)(2008-11#1)
ability of human##2##3##(2008-11#1)(2008-5#1)
ability of low##3##3##(1995-11#1)(1995-12#1)(2008-7#1)
ability of some##3##3##(2008-10#3)
ability of the new##4##4##(2008-10#2)(2008-3#1)(2009-5#1)
ability of the solvent##2##4##(2008-10#2)
ability of the##70##3##(1992-7#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-10#33)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#2)
ability of these##9##3##(1992-12#1)(1992-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#3)
ability of this##5##3##(1990-2#1)(1992-12#1)(1995-5#1)(2008-10#1)(2008-5#1)
ability of##280##2##(1990-11#1)(1990-2#3)(1990-5#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-8#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-5#3)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#112)(2008-11#19)(2008-12#6)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#9)(2008-9#11)(2009-1#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#3)
ability on##5##2##(2008-10#3)(2008-9#1)(2013-8#1)
ability or##3##2##(2008-10#1)(2008-8#2)
ability than##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
ability that##3##2##(1990-11#1)(1995-1#1)(2008-5#1)
ability to act as##3##4##(1990-11#1)(1995-2#1)(2008-10#1)
ability to act##4##3##(1990-11#1)(1995-2#1)(2008-10#2)
ability to activate##2##3##(1993-8#1)(1996-3#1)
ability to adhere to##2##4##(2008-12#1)(2008-9#1)
ability to affect##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
ability to apply##3##3##(1996-3#1)(1997-3#1)(2008-11#1)
ability to be transmitted##2##4##(2008-10#1)(2008-7#1)
ability to be##9##3##(1994-5#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
ability to bind##3##3##(1990-5#1)(1994-12#1)(2008-10#1)
ability to block##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
ability to carry out##2##4##(1990-2#1)(1995-5#1)
ability to cause disease on##2##5##(2008-10#2)
ability to cause##8##3##(1995-6#1)(2008-10#5)(2008-9#1)(2009-6#1)
ability to change##2##3##(2011-1#1)(2011-2#1)
ability to colonize##2##3##(2008-10#2)
ability to communicate##5##3##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
ability to compete##3##3##(1993-3#1)(2008-8#1)(2013-7#1)
ability to control##3##3##(2008-10#1)(2008-11#1)(2010-11#1)
ability to create##4##3##(1995-5#1)(2008-11#1)(2012-12#1)(2012-3#1)
ability to deal##2##3##(1995-2#1)(2008-12#1)
ability to decrease the##2##4##(2008-10#1)(2008-8#1)
ability to degrade##5##3##(2008-10#3)(2011-2#2)
ability to deliver##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
ability to detect##11##3##(1991-3#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-9#1)(2010-4#1)(2012-2#2)
ability to determine##4##3##(2008-10#1)(2009-8#1)(2013-1#2)
ability to differentiate into##3##4##(2008-9#2)(2012-4#1)
ability to differentiate##7##3##(1990-5#1)(1991-12#1)(2008-11#1)(2008-9#2)(2012-4#1)(2012-5#1)
ability to discriminate##5##3##(1993-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)
ability to distinguish##3##3##(2008-10#1)(2008-9#2)
ability to elevate##2##3##(1992-8#1)(1993-6#1)
ability to entrap##2##3##(2008-10#1)(2008-11#1)
ability to explain##2##3##(1991-12#1)(1992-12#1)
ability to express##2##3##(1996-12#1)(2012-2#1)
ability to extract##4##3##(2008-10#3)(2009-8#1)
ability to fall##2##3##(1990-5#1)(2008-3#1)
ability to form H-bonds##4##4##(1992-10#4)
ability to form##9##3##(1992-10#4)(1995-5#1)(2008-10#3)(2008-3#1)
ability to generate##3##3##(2008-7#1)(2008-9#1)(2010-7#1)
ability to grow at##2##4##(2008-10#1)(2011-2#1)
ability to grow in##4##4##(2008-10#2)(2008-11#1)(2010-4#1)
ability to grow##9##3##(2008-10#4)(2008-11#1)(2008-8#1)(2010-4#1)(2011-2#2)
ability to handle a large##2##5##(2008-10#1)(2008-11#1)
ability to handle a##3##4##(2008-10#1)(2008-11#2)
ability to handle##5##3##(2008-10#1)(2008-11#2)(2008-4#2)
ability to have##2##3##(2010-1#1)(2011-2#1)
ability to hydrolyze##2##3##(1993-8#1)(2008-10#1)
ability to identify the##3##4##(1997-2#1)(2008-6#1)(2012-12#1)
ability to identify##10##3##(1991-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-12#1)
ability to improve##2##3##(2008-5#2)
ability to induce resistance##3##4##(2008-10#3)
ability to induce systemic resistance##3##5##(2008-10#3)
ability to induce##20##3##(1994-5#1)(1996-2#1)(2006-6#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
ability to infect rice##2##4##(2008-10#2)
ability to infect##6##3##(2008-10#6)
ability to inhibit the##4##4##(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
ability to inhibit##9##3##(1990-4#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)
ability to interact with##3##4##(1993-3#1)(2008-9#1)(2012-3#1)
ability to isolate##2##3##(1993-9#1)(2008-10#1)
ability to localize##2##3##(1994-9#1)(2011-2#1)
ability to maintain##3##3##(2008-8#1)(2012-3#1)(2013-7#1)
ability to make##7##3##(2008-5#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-8#1)
ability to modulate##2##3##(1994-11#1)(2010-1#1)
ability to multiply in##2##4##(1995-2#1)(2008-10#1)
ability to multiply##4##3##(1995-2#1)(2008-10#2)(2009-8#1)
ability to obtain##2##3##(1997-2#1)(2008-3#1)
ability to pay##2##3##(1994-2#2)
ability to penetrate the##2##4##(1997-1#1)(2008-8#1)
ability to penetrate##4##3##(1997-1#1)(2008-10#2)(2008-8#1)
ability to perform##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
ability to predict##5##3##(2008-10#1)(2008-2#1)(2009-4#1)(2010-1#1)(2010-7#1)
ability to prevent##3##3##(1992-10#1)(1994-8#1)(2008-10#1)
ability to produce##20##3##(1991-12#1)(1991-2#1)(1996-2#1)(1996-3#1)(2008-10#12)(2011-2#2)(2012-2#1)(2013-1#1)
ability to proliferate and heterogeneity##2##5##(2008-11#2)
ability to proliferate##4##3##(2008-11#4)
ability to protect##2##3##(2008-12#1)(2008-5#1)
ability to provide##2##3##(2008-6#1)(2011-2#1)
ability to rapidly##2##3##(2008-10#1)(2008-9#1)
ability to recognize##6##3##(1991-2#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-2#1)
ability to reduce##4##3##(1991-2#1)(1993-11#1)(2008-10#2)
ability to reject##2##3##(2008-3#1)(2008-9#1)
ability to respond to the##2##5##(1995-1#1)(1997-3#1)
ability to respond to##5##4##(1991-12#1)(1995-1#1)(1997-3#1)(2008-8#1)(2010-8#1)
ability to sequester##2##3##(2008-10#1)(2010-6#1)
ability to serve as##3##4##(1992-9#1)(2008-10#2)
ability to spread##2##3##(2008-10#1)(2011-2#1)
ability to stimulate##4##3##(1992-7#1)(1996-12#1)(2008-10#1)(2011-1#1)
ability to successfully##2##3##(2008-12#1)(2008-9#1)
ability to support##2##3##(2009-10#1)(2010-5#1)
ability to suppress##2##3##(1993-2#1)(2008-10#1)
ability to survive##3##3##(2008-8#1)(2011-2#2)
ability to synthesize##3##3##(1990-5#1)(2008-9#1)(2013-1#1)
ability to take##2##3##(2008-11#1)(2008-9#1)
ability to transmit##8##3##(2008-10#8)
ability to trigger##2##3##(2008-10#1)(2008-11#1)
ability to understand and##2##4##(2010-11#1)(2010-7#1)
ability to understand##6##3##(1992-3#1)(1993-1#1)(1995-5#1)(2010-11#1)(2010-7#1)(2012-12#1)
ability to use##4##3##(1997-3#1)(2008-10#1)(2008-9#1)(2009-3#1)
ability to utilize##3##3##(1995-2#1)(1997-1#1)(2011-1#1)
ability to##494##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#5)(1990-8#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#5)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#5)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#5)(1995-12#3)(1995-2#8)(1995-3#1)(1995-5#5)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#4)(1997-1#3)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#133)(2008-11#39)(2008-12#10)(2008-2#2)(2008-3#7)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#7)(2008-8#13)(2008-9#23)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#4)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#7)(2010-8#2)(2011-1#4)(2011-2#25)(2011-7#2)(2012-12#3)(2012-2#14)(2012-3#6)(2012-4#1)(2012-5#2)(2013-1#15)(2013-7#3)(2013-8#3)
ability towards##7##2##(2008-10#6)(2008-11#1)
ability was##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
ability were##2##2##(2008-10#1)(2010-8#1)
ability##962##1##(1990-11#5)(1990-12#1)(1990-2#5)(1990-4#1)(1990-5#6)(1990-6#1)(1990-8#1)(1991-12#6)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#6)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#2)(1993-8#7)(1993-9#1)(1994-11#5)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#5)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#4)(1995-11#9)(1995-12#5)(1995-2#12)(1995-3#1)(1995-5#8)(1995-6#1)(1995-8#5)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#6)(1997-1#6)(1997-2#3)(1997-3#6)(1997-6#2)(1997-7#3)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#305)(2008-11#74)(2008-12#19)(2008-2#3)(2008-3#12)(2008-4#11)(2008-5#24)(2008-6#8)(2008-7#18)(2008-8#45)(2008-9#56)(2009-1#1)(2009-10#2)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#5)(2009-7#3)(2009-8#8)(2009-9#4)(2010-1#5)(2010-10#4)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#7)(2010-8#3)(2011-1#8)(2011-2#35)(2011-7#2)(2011-8#1)(2012-12#5)(2012-2#20)(2012-3#12)(2012-4#1)(2012-5#2)(2013-1#26)(2013-7#4)(2013-8#8)
abiotic agents##3##2##(2008-10#2)(2011-2#1)
abiotic and biotic stress##2##4##(2009-10#1)(2009-6#1)
abiotic and biotic##5##3##(2008-10#3)(2009-10#1)(2009-6#1)
abiotic factors##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
abiotic stress##3##2##(2008-10#1)(2009-10#2)
abiotic stresses##5##2##(2008-10#2)(2008-8#1)(2010-10#2)
abiotic suppression##3##2##(2008-10#3)
abiotic##29##1##(2008-10#16)(2008-8#3)(2008-9#1)(2009-10#3)(2009-6#1)(2010-10#2)(2011-2#2)(2013-8#1)
ablate##5##1##(1991-2#1)(1994-3#1)(1995-2#1)(2008-3#1)(2013-1#1)
ablated by##2##2##(1997-1#1)(2008-3#1)
ablated in##2##2##(2008-10#1)(2008-11#1)
ablated to##2##2##(1991-2#1)(1993-2#1)
ablated##12##1##(1991-2#2)(1993-2#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2013-1#2)
ablating##2##1##(2008-10#1)(2011-2#1)
ablation (LA)##2##2##(2008-10#2)
ablation and division##3##3##(2011-2#3)
ablation and##8##2##(1994-2#1)(2008-10#1)(2011-2#5)(2013-1#1)
ablation by##2##2##(1997-8#1)(2008-11#1)
ablation for##4##2##(2008-10#2)(2008-3#1)(2010-12#1)
ablation has##2##2##(2008-3#1)(2011-2#1)
ablation in##4##2##(2008-10#3)(2012-3#1)
ablation inductively coupled plasma mass spectrometry (LA-ICP-MS)##2##7##(2010-11#2)
ablation inductively coupled plasma mass spectrometry##4##6##(2008-10#2)(2010-11#2)
ablation inductively coupled plasma##6##4##(2008-10#4)(2010-11#2)
ablation is##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
ablation lesions##2##2##(2010-6#2)
ablation of the##5##3##(1991-2#1)(1991-3#1)(1994-8#1)(2008-10#2)
ablation of untolerated##3##3##(2009-10#3)
ablation of##19##2##(1990-11#1)(1991-2#1)(1991-3#2)(1993-1#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#2)(2009-10#5)(2010-6#1)(2012-12#1)(2013-1#1)
ablation rates##2##2##(2008-10#2)
ablation showed##2##2##(2008-10#2)
ablation therapies##2##2##(2010-12#2)
ablation therapy##3##2##(2008-7#1)(2010-12#2)
ablation were##2##2##(1991-2#1)(2010-12#1)
ablation##112##1##(1990-11#1)(1991-2#2)(1991-3#2)(1993-1#4)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-1#4)(1997-8#4)(2008-10#33)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#7)(2008-7#5)(2008-9#1)(2009-10#5)(2009-5#1)(2010-11#2)(2010-12#9)(2010-6#3)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
ablation-inductively coupled##3##2##(2008-10#3)
ablative##7##1##(1993-11#1)(1994-2#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-12#2)
able to access##2##3##(2008-11#1)(2010-8#1)
able to achieve##6##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2012-2#1)
able to acquire##2##3##(1994-3#2)
able to adhere to##2##4##(1996-12#1)(2008-9#1)
able to adhere##3##3##(1996-12#1)(2008-9#1)(2011-2#1)
able to alter##2##3##(2008-11#1)(2010-5#1)
able to amplify##2##3##(2008-10#2)
able to analyse##2##3##(2008-10#2)
able to assess the##2##4##(2008-12#1)(2008-5#1)
able to associate##2##3##(1993-6#1)(1993-9#1)
able to be applied##2##4##(2008-10#1)(2008-11#1)
able to be##8##3##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
able to bind to##5##4##(1993-8#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)
able to bind##9##3##(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#2)(1997-7#1)(2008-10#2)(2011-2#1)
able to bud##2##3##(2008-10#2)
able to cause##3##3##(2006-6#1)(2008-10#1)(2011-2#1)
able to change the##2##4##(2008-10#2)
able to control##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
able to cope##2##3##(1996-8#1)(1997-8#1)
able to cross the##2##4##(2008-10#1)(2011-2#1)
able to deliver##2##3##(2010-10#2)
able to demonstrate##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
able to detect as little as 10##2##7##(2008-10#1)(2013-1#1)
able to detect as little as##3##6##(2008-10#2)(2013-1#1)
able to detect##13##3##(2008-10#6)(2008-11#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
able to determine##2##3##(1993-8#1)(2008-10#1)
able to develop##2##3##(1992-3#1)(2013-1#1)
able to differentiate the role of##2##6##(2008-10#2)
able to differentiate##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
able to direct##2##3##(1990-2#1)(1991-6#1)
able to directly##2##3##(1992-9#1)(2008-11#1)
able to discriminate##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
able to displace##2##3##(2008-8#2)
able to distinguish between##2##4##(2008-10#1)(2013-8#1)
able to distinguish##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
able to effectively##2##3##(2008-11#1)(2011-3#1)
able to employ##2##3##(2008-3#1)(2012-12#1)
able to enhance the ECL##2##5##(2008-10#2)
able to enhance##4##3##(1990-2#1)(2008-10#3)
able to establish a##2##4##(1995-5#1)(2008-11#1)
able to estimate the##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
able to explain the##2##4##(2008-10#1)(2008-11#1)
able to find##2##3##(2008-10#1)(2012-12#1)
able to form secondary##2##4##(2008-10#1)(2008-4#1)
able to form##6##3##(1990-2#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-8#2)
able to generate##6##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)
able to grow in##3##4##(2008-11#2)(2008-7#1)
able to grow on##2##4##(2008-10#2)
able to grow under##2##4##(2008-11#2)
able to grow##9##3##(2008-10#3)(2008-11#4)(2008-7#1)(2011-2#1)
able to handle##2##3##(2008-10#1)(2008-4#1)
able to identify a##2##4##(1997-7#1)(2011-2#1)
able to identify the##2##4##(2008-10#1)(2008-5#1)
able to identify##7##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
able to improve##2##3##(2008-5#1)(2008-8#1)
able to increase the##2##4##(2008-5#1)(2009-7#1)
able to increase##5##3##(1991-3#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-7#1)
able to induce resistance in##2##5##(2008-10#2)
able to induce##13##3##(1991-5#1)(1995-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-9#2)(2009-12#1)
able to infect##6##3##(2008-10#6)
able to inhibit##2##3##(1995-11#1)(2010-4#1)
able to isolate##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
able to maintain##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
able to make##5##3##(1992-2#1)(1996-3#1)(1997-3#1)(2008-12#1)(2008-9#1)
able to manipulate##3##3##(2008-12#1)(2009-8#1)(2012-2#1)
able to meet##2##3##(2008-11#2)
able to modify##2##3##(1995-12#1)(2008-12#1)
able to modulate##3##3##(2008-4#1)(2008-5#1)(2012-2#1)
able to monitor##2##3##(2008-10#2)
able to obtain##6##3##(1992-2#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
able to offer##4##3##(1991-3#1)(1992-3#1)(2008-11#1)(2011-3#1)
able to overcome##3##3##(2008-10#1)(2008-8#2)
able to perceive##2##3##(2008-7#2)
able to perform##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
able to predict the##2##4##(2008-5#1)(2012-12#1)
able to predict##5##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
able to produce a##2##4##(1991-3#1)(2008-10#1)
able to produce the##2##4##(2008-10#1)(2008-5#1)
able to produce##10##3##(1991-12#1)(1991-3#1)(1996-11#1)(2008-10#2)(2008-5#2)(2008-8#2)(2011-2#1)
able to proliferate##2##3##(2008-11#2)
able to promote the formation of##2##6##(1995-2#2)
able to promote##4##3##(1995-2#2)(2008-10#1)(2008-9#1)
able to provide##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2013-8#1)
able to reap##2##3##(2008-10#1)(2008-11#1)
able to recognize##6##3##(1995-8#1)(2008-11#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
able to reduce##6##3##(1991-3#1)(1992-9#1)(2008-10#2)(2012-2#1)(2012-3#1)
able to regulate##2##3##(2009-8#1)(2011-2#1)
able to repair##2##3##(2008-10#1)(2010-1#1)
able to reproduce##6##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2013-8#1)
able to rescue the defective##2##5##(2008-10#1)(2008-11#1)
able to rescue the##3##4##(1993-9#1)(2008-10#1)(2008-11#1)
able to reveal##2##3##(2008-10#2)
able to save##2##3##(1996-12#1)(2010-8#1)
able to select the##2##4##(1993-11#1)(2009-12#1)
able to select##3##3##(1993-11#1)(2008-8#1)(2009-12#1)
able to show that##3##4##(2008-12#1)(2009-10#1)(2011-1#1)
able to show##5##3##(2008-12#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#1)
able to significantly##4##3##(1994-11#1)(2008-10#2)(2008-11#1)
able to specifically##3##3##(2008-10#2)(2011-2#1)
able to stimulate the##4##4##(1993-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
able to stimulate transcription##2##4##(1993-8#1)(1994-2#1)
able to stimulate##10##3##(1993-8#2)(1994-2#1)(2008-11#2)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
able to support the##3##4##(2008-10#2)(2008-11#1)
able to support##6##3##(2008-10#3)(2008-11#2)(2008-7#1)
able to suppress##2##3##(1995-12#1)(2008-10#1)
able to tolerate a##2##4##(1993-2#1)(2008-11#1)
able to transfer##2##3##(1997-8#1)(2008-11#1)
able to transmit##4##3##(2008-10#4)
able to trigger##2##3##(1994-8#1)(2013-8#1)
able to undergo##3##3##(1993-8#2)(2010-5#1)
able to use##4##3##(1993-11#1)(2008-10#1)(2008-7#1)(2009-7#1)
able to##478##2##(1990-2#3)(1991-1#1)(1991-12#2)(1991-3#5)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#8)(1993-9#2)(1994-11#2)(1994-2#3)(1994-3#3)(1994-5#4)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-5#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-8#1)(1997-2#3)(1997-3#3)(1997-7#2)(1997-8#2)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#120)(2008-11#58)(2008-12#15)(2008-3#7)(2008-4#3)(2008-5#21)(2008-6#1)(2008-7#13)(2008-8#17)(2008-9#17)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-5#1)(2009-7#3)(2009-8#7)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#2)(2011-2#17)(2011-3#4)(2011-7#2)(2012-12#3)(2012-2#11)(2012-3#6)(2012-6#1)(2013-1#13)(2013-8#9)
able##485##1##(1990-11#1)(1990-2#3)(1991-1#1)(1991-12#2)(1991-3#5)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#8)(1993-9#2)(1994-11#2)(1994-2#3)(1994-3#3)(1994-5#4)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-5#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-8#1)(1997-2#3)(1997-3#3)(1997-7#2)(1997-8#2)(2006-6#1)(2007-12#2)(2007-9#1)(2008-10#120)(2008-11#62)(2008-12#15)(2008-3#7)(2008-4#3)(2008-5#21)(2008-6#1)(2008-7#13)(2008-8#17)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-5#1)(2009-7#3)(2009-8#7)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#2)(2011-2#17)(2011-3#4)(2011-7#2)(2012-12#3)(2012-2#11)(2012-3#6)(2012-6#1)(2013-1#13)(2013-8#9)
abnormal EABR recordings##2##3##(2008-9#2)
abnormal cells##2##2##(2011-2#1)(2012-3#1)
abnormal cytology##3##2##(2012-12#3)
abnormal development of the##2##4##(2012-2#1)(2013-1#1)
abnormal development of##3##3##(2012-2#2)(2013-1#1)
abnormal findings##2##2##(2008-7#1)(2012-2#1)
abnormal in##5##2##(1991-12#1)(1997-3#1)(2008-12#1)(2009-11#1)(2013-1#1)
abnormal joint torque coupling##3##4##(2010-7#3)
abnormal levels##2##2##(1997-2#2)
abnormal results##4##2##(1994-12#1)(2007-11#1)(2012-3#1)(2013-1#1)
abnormal tissue##3##2##(1992-1#1)(2008-6#1)(2008-7#1)
abnormal uterine bleeding##2##3##(1991-2#1)(1995-3#1)
abnormal##169##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-9#1)(1993-11#7)(1994-1#1)(1994-12#3)(1994-3#3)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#2)(1997-3#4)(1997-7#3)(1997-8#1)(2006-5#1)(2007-11#1)(2008-10#11)(2008-11#7)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-1#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#5)(2011-1#1)(2011-2#12)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#9)(2013-8#4)
abnormal&quot##2##1##(2010-1#1)(2010-12#1)
abnormalities and##22##2##(1990-5#1)(1990-8#1)(1991-12#1)(1993-2#1)(1995-5#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#2)
abnormalities are##2##2##(1997-3#1)(2008-4#1)
abnormalities associated with##2##3##(2011-2#1)(2012-3#1)
abnormalities in hypertensive##2##3##(2008-12#1)(2009-1#1)
abnormalities in the##7##3##(1991-6#1)(1993-6#1)(2008-11#2)(2008-9#1)(2009-10#1)(2013-1#1)
abnormalities in##26##2##(1990-11#1)(1990-2#1)(1991-12#2)(1991-6#2)(1993-6#1)(1994-1#1)(1994-5#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
abnormalities include##3##2##(1991-12#1)(1997-3#1)(2009-11#1)
abnormalities is##3##2##(2011-1#1)(2012-2#1)(2013-1#1)
abnormalities may be##2##3##(1995-5#1)(2008-6#1)
abnormalities may##3##2##(1995-5#1)(2008-5#1)(2008-6#1)
abnormalities of the##6##3##(1996-2#1)(1997-1#1)(1997-8#1)(2008-9#2)(2011-2#1)
abnormalities of##11##2##(1991-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-8#1)(2008-5#1)(2008-9#3)(2011-2#1)(2013-1#1)
abnormalities on chest X-ray consistent with##2##6##(1991-12#2)
abnormalities on##3##2##(1991-12#2)(2011-2#1)
abnormalities such as##2##3##(2008-7#1)(2010-1#1)
abnormalities were##5##2##(1993-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
abnormalities with##3##2##(1994-11#1)(1997-3#1)(2008-8#1)
abnormalities##168##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#12)(1991-3#1)(1991-6#3)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-5#3)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-3#13)(1997-8#3)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#3)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#2)(2010-1#5)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#12)(2011-7#2)(2012-12#2)(2012-2#9)(2012-3#8)(2013-1#7)
abnormality and##2##2##(1992-3#1)(2008-12#1)
abnormality in the##2##3##(2008-2#1)(2008-4#1)
abnormality in##4##2##(2008-12#1)(2008-2#1)(2008-4#2)
abnormality of##2##2##(1993-3#1)(2012-2#1)
abnormality on##2##2##(1991-12#1)(2010-6#1)
abnormality##32##1##(1990-6#1)(1991-11#1)(1991-12#3)(1992-12#1)(1992-3#1)(1993-3#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)
abnormally high##2##2##(1997-1#1)(2009-8#1)
abnormally##13##1##(1994-8#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-5#1)(2008-10#2)(2008-8#1)(2008-9#2)(2009-8#1)(2012-3#1)(2013-1#1)
abolish the##2##2##(1992-12#1)(2008-10#1)
abolished at##2##2##(1990-5#1)(1994-5#1)
abolished both##3##2##(1994-6#1)(1997-1#1)(1997-2#1)
abolished by the##3##3##(1995-11#1)(1997-4#1)(2013-1#1)
abolished by##12##2##(1990-2#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
abolished in the##3##3##(1990-5#1)(1996-12#1)(1997-7#1)
abolished in##7##2##(1990-5#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#2)
abolished the##13##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#2)(1992-3#2)(1993-6#1)(1994-6#1)(1996-2#2)(1997-2#1)(1997-4#1)
abolished this##2##2##(1991-1#1)(1995-11#1)
abolished when##2##2##(1993-8#1)(2008-8#1)
abolished##66##1##(1990-2#1)(1990-3#1)(1990-5#4)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#2)(1992-3#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#3)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#2)
abolishes the##3##2##(1991-7#1)(1995-11#1)(1995-6#1)
abolishes##10##1##(1991-5#1)(1991-7#1)(1992-3#1)(1994-11#1)(1995-11#3)(1995-2#2)(1995-6#1)
abolishing##2##1##(1997-4#1)(2008-10#1)
abolition of##3##2##(1994-11#1)(2012-2#1)(2013-1#1)
abolition##4##1##(1994-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
aboriginal##2##1##(1996-12#2)
aborted##6##1##(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
abortion after##2##2##(1995-8#1)(2008-11#1)
abortion and##6##2##(1994-9#1)(2008-11#5)
abortion be##2##2##(2008-11#1)(2011-2#1)
abortion in##5##2##(2008-11#3)(2013-1#1)(2013-8#1)
abortion is##3##2##(1990-3#1)(1990-9#1)(2008-11#1)
abortion law and practice in Northern Ireland##2##7##(2013-8#2)
abortion law and##3##3##(2013-8#3)
abortion law##4##2##(2008-11#1)(2013-8#3)
abortion of##5##2##(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-1#1)
abortion safe and legal##2##4##(2008-11#2)
abortion services##2##2##(1991-1#1)(1996-5#1)
abortion to##2##2##(1991-1#1)(1994-9#1)
abortion was performed##2##3##(1994-3#1)(2012-3#1)
abortion was##4##2##(1994-3#1)(1995-8#1)(2012-3#2)
abortion without##2##2##(1997-6#1)(2011-2#1)
abortion##82##1##(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#4)(1991-2#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#3)(1994-9#2)(1995-11#3)(1995-8#3)(1996-5#2)(1997-6#2)(1997-7#2)(2008-1#1)(2008-10#4)(2008-11#18)(2008-8#8)(2008-9#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-2#7)(2012-3#4)(2013-1#1)(2013-8#4)
abortion]##3##1##(1991-3#2)(2008-11#1)
abortions and##6##2##(1997-4#1)(2008-11#3)(2011-1#1)(2013-1#1)
abortions at military facilities##3##4##(1996-5#3)
abortions at overseas military hospitals##2##5##(1995-6#2)
abortions at##5##2##(1995-6#2)(1996-5#3)
abortions except##2##2##(1995-6#1)(1996-5#1)
abortions in##4##2##(1995-6#1)(1996-11#2)(2013-1#1)
abortions or##2##2##(2008-11#1)(2013-1#1)
abortions##36##1##(1991-3#2)(1995-6#4)(1995-8#3)(1996-11#3)(1996-5#5)(1997-2#1)(1997-4#1)(1997-5#1)(2008-11#7)(2011-1#1)(2012-3#1)(2013-1#7)
abortive##2##1##(1991-5#1)(2008-10#1)
aborts##2##1##(1994-3#1)(2008-11#1)
abortus strain 2308##3##3##(1996-12#3)
abortus##5##1##(1996-12#3)(2011-2#2)
abounds##2##1##(2011-2#1)(2012-3#1)
about &quot##6##2##(1994-3#1)(2009-10#2)(2010-8#1)(2013-1#1)(2013-8#1)
about 0##31##2##(1990-10#1)(1992-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-10#22)(2008-8#1)(2009-5#1)
about 1 month##2##3##(2008-10#2)
about 1##28##2##(1990-12#1)(1992-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
about 1%##3##2##(1996-12#1)(2008-5#1)(2010-1#1)
about 1/3##2##2##(1991-12#1)(1991-6#1)
about 10 kb##2##3##(1993-2#1)(2008-10#1)
about 10 mug##2##3##(2008-10#2)
about 10 s and##3##4##(2008-10#3)
about 10 times##2##3##(2008-10#1)(2012-3#1)
about 10##20##2##(1990-11#1)(1993-2#1)(2008-10#15)(2010-2#1)(2012-12#1)(2012-3#1)
about 10% of the##2##4##(2008-10#1)(2012-3#1)
about 10% of##4##3##(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
about 10%##8##2##(1993-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-8#1)
about 10(3)##2##2##(2008-10#2)
about 100 times##2##3##(2008-10#2)
about 100##9##2##(1991-5#1)(1995-11#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-7#1)
about 100%##2##2##(2008-10#2)
about 1000##3##2##(1993-2#1)(2007-12#1)(2008-7#1)
about 12##3##2##(1994-11#1)(2008-7#1)(2010-12#1)
about 13-fold##2##2##(2008-11#1)(2012-3#1)
about 130##3##2##(1994-8#1)(1996-6#1)(2013-1#1)
about 14% of##2##3##(1992-6#1)(1992-8#1)
about 15 years##2##3##(1997-5#1)(2008-10#1)
about 15##7##2##(1992-9#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
about 15%##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
about 150##3##2##(1996-3#1)(2008-8#1)(2010-8#1)
about 15s##2##2##(2008-10#2)
about 16##2##2##(2007-12#1)(2008-10#1)
about 18##2##2##(1997-6#1)(2008-8#1)
about 2 kb##2##3##(1991-6#1)(2008-9#1)
about 2##26##2##(1991-6#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-8#1)(2008-10#10)(2008-11#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)
about 2% of##2##3##(1990-2#1)(1997-8#1)
about 2-fold##2##2##(1990-5#1)(2008-11#1)
about 20 min##2##3##(2008-10#2)
about 20##13##2##(1991-1#1)(1993-3#1)(1994-11#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)
about 20% of patients##3##4##(1996-5#1)(2008-7#1)(2013-1#1)
about 20% of the##2##4##(1991-8#1)(1997-2#1)
about 20% of##8##3##(1991-8#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#1)(2011-3#1)(2013-1#2)
about 20%##13##2##(1991-5#1)(1991-8#1)(1992-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#1)(2011-3#1)(2013-1#2)
about 200 mV##2##3##(2008-10#2)
about 200##3##2##(2008-10#2)(2008-12#1)
about 200mV##2##2##(2008-10#2)
about 21##2##2##(1992-6#1)(2010-10#1)
about 23##2##2##(1992-6#1)(2008-11#1)
about 24##3##2##(2008-10#2)(2008-11#1)
about 25##5##2##(2008-10#3)(2013-1#2)
about 25% of the##4##4##(1993-8#1)(1994-8#1)(2008-10#2)
about 25%##5##2##(1993-8#1)(1994-8#1)(2008-10#2)(2008-7#1)
about 250 times##2##3##(1990-11#1)(2008-8#1)
about 250##5##2##(1990-11#1)(1992-2#1)(1993-1#1)(1993-2#1)(2008-8#1)
about 27%##2##2##(2010-12#1)(2013-8#1)
about 3 times higher##2##4##(2008-11#1)(2011-2#1)
about 3 times##4##3##(1994-5#1)(2008-11#1)(2008-8#1)(2011-2#1)
about 3##15##2##(1994-11#1)(1994-5#1)(1996-2#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)
about 3% of##2##3##(1990-12#1)(1997-3#1)
about 3%##6##2##(1990-12#1)(1997-3#1)(2008-10#4)
about 3-fold in##2##3##(1990-5#1)(2012-3#1)
about 3-fold##5##2##(1990-11#1)(1990-5#1)(1995-8#1)(2008-11#1)(2012-3#1)
about 30 min##3##3##(2008-10#3)
about 30##12##2##(1990-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-10#7)(2009-9#1)
about 30% of##2##3##(1992-6#1)(1992-8#1)
about 30%##6##2##(1992-6#1)(1992-8#1)(1993-2#1)(1995-6#1)(2008-10#1)(2008-6#1)
about 300##3##2##(2008-10#3)
about 30min##2##2##(2008-10#2)
about 33%##2##2##(2008-10#1)(2008-11#1)
about 35##6##2##(1991-5#2)(2008-10#1)(2008-9#1)(2010-10#1)(2012-12#1)
about 4##12##2##(1995-8#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
about 4%##2##2##(2008-10#1)(2010-12#1)
about 40 years ago##2##4##(2008-10#1)(2008-5#1)
about 40##6##2##(1990-2#1)(2008-10#3)(2008-11#1)(2008-5#1)
about 40% of##6##3##(1994-8#1)(1996-6#1)(1997-3#1)(2008-5#1)(2010-8#1)(2011-3#1)
about 40%##10##2##(1991-8#1)(1994-8#2)(1996-6#1)(1997-3#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-3#2)
about 400##4##2##(2007-12#1)(2008-10#2)(2012-12#1)
about 45##2##2##(2008-10#1)(2012-12#1)
about 47%##2##2##(1996-12#1)(2008-11#1)
about 5 min##2##3##(2008-10#2)
about 5##13##2##(1990-2#1)(2008-10#8)(2008-11#1)(2008-8#3)
about 5% of the##2##4##(1995-2#2)
about 5% of##3##3##(1995-2#2)(1997-2#1)
about 5%##5##2##(1991-5#1)(1995-2#2)(1997-2#1)(2008-10#1)
about 5-fold##2##2##(2008-11#2)
about 50 years##2##3##(2010-6#1)(2011-2#1)
about 50##14##2##(1995-12#1)(2008-10#5)(2008-12#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#2)
about 50% of##7##3##(1990-12#1)(1994-11#1)(2008-10#2)(2010-8#1)(2011-2#1)(2012-12#1)
about 50%##21##2##(1990-11#1)(1990-12#2)(1993-3#1)(1994-11#1)(1996-6#1)(2008-10#6)(2008-11#2)(2008-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
about 50%)##3##2##(2009-8#3)
about 6##4##2##(1990-5#1)(1995-2#1)(2008-10#1)(2008-7#1)
about 6%##3##2##(2008-10#2)(2013-1#1)
about 60 samples##3##3##(2008-10#3)
about 60##6##2##(1993-3#1)(2008-10#4)(2013-8#1)
about 60%##2##2##(1993-12#1)(2008-10#1)
about 65% of##2##3##(2008-10#2)
about 65%##3##2##(1993-12#1)(2008-10#2)
about 7##5##2##(1992-2#1)(1996-6#1)(2008-10#2)(2008-7#1)
about 70##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
about 70% of##2##3##(1991-5#1)(1996-12#1)
about 70%##4##2##(1990-12#1)(1991-5#1)(1996-12#1)(2008-8#1)
about 75##2##2##(2008-11#1)(2010-8#1)
about 75%##2##2##(2008-10#1)(2013-8#1)
about 8 weeks##2##3##(2008-10#2)
about 8##4##2##(2008-10#3)(2013-1#1)
about 80 percent of##2##4##(1992-12#1)(1994-2#1)
about 80##3##2##(1992-12#1)(1992-2#1)(1994-2#1)
about 80% of the##5##4##(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2013-1#1)
about 80%##6##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2013-1#1)
about 9##5##2##(1992-9#1)(2008-10#3)(2009-11#1)
about 90 degrees##2##3##(1993-8#2)
about 90##4##2##(1990-2#1)(1993-8#2)(2008-10#1)
about 90% of the##2##4##(1997-6#1)(2008-10#1)
about 90% of##4##3##(1997-6#1)(2008-10#2)(2010-12#1)
about 90%##8##2##(1991-2#1)(1994-11#1)(1996-11#1)(1997-6#1)(2008-10#3)(2010-12#1)
about AIDS in the##2##4##(1997-6#1)(2012-3#1)
about AIDS in##3##3##(1997-6#1)(2012-3#2)
about AIDS##9##2##(1992-12#1)(1992-2#3)(1995-12#1)(1997-6#2)(2012-3#2)
about GAP##2##2##(2013-1#2)
about HIV##6##2##(1995-6#1)(1996-5#2)(1997-6#1)(2009-5#2)
about HIV/AIDS##3##2##(2008-10#3)
about Y##2##2##(2008-7#2)
about a dozen##2##3##(2008-11#1)(2013-1#1)
about a half of##2##4##(2008-7#1)(2011-2#1)
about a third##2##3##(2010-8#1)(2012-3#1)
about a##30##2##(1990-3#1)(1990-5#2)(1992-4#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
about abortion##2##2##(2008-11#1)(2010-11#1)
about adverse effects##2##3##(1996-9#1)(2011-2#1)
about adverse##3##2##(1995-11#1)(1996-9#1)(2011-2#1)
about alcohol##2##2##(2008-1#1)(2010-11#1)
about all##2##2##(2008-5#1)(2011-2#1)
about an##6##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2012-3#1)
about and##4##2##(1991-12#1)(1992-3#1)(1997-3#1)(2009-10#1)
about any##2##2##(2008-11#1)(2010-3#1)
about as##2##2##(1992-12#1)(2012-2#1)
about becoming##2##2##(1995-6#1)(2013-1#1)
about being##2##2##(1996-5#1)(2010-10#1)
about bullying##2##2##(2008-12#2)
about cancer##5##2##(1992-2#1)(1997-3#1)(2009-12#1)(2012-12#1)(2013-1#1)
about changes in##2##3##(2008-1#1)(2012-3#1)
about clinical##2##2##(1996-6#1)(2011-2#1)
about control##2##2##(1994-3#1)(2010-8#1)
about dengue##2##2##(2011-2#1)(2012-12#1)
about developmental coordination disorder##2##4##(2008-11#2)
about different##3##2##(1996-11#1)(2010-8#1)(2011-3#1)
about dynamic##2##2##(2008-10#1)(2008-9#1)
about eightfold##2##2##(1995-2#1)(2008-10#1)
about emotionally challenging situations##2##4##(2008-11#2)
about evolutionary##2##2##(2008-8#1)(2010-5#1)
about four times##2##3##(2007-12#1)(2011-1#1)
about four##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
about future##4##2##(1995-3#2)(2008-7#1)(2011-1#1)
about half of the##3##4##(1990-2#1)(2009-3#1)(2010-5#1)
about half of##4##3##(1990-2#1)(2009-3#1)(2010-5#1)(2013-8#1)
about half##9##2##(1990-2#1)(1995-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-5#1)(2013-1#1)(2013-8#1)
about health care reform##2##4##(1995-12#1)(1996-3#1)
about health care##5##3##(1993-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-11#1)
about health problems##2##3##(2008-7#1)(2011-2#1)
about health##10##2##(1993-12#1)(1993-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
about herb and supplement use##2##5##(2008-10#2)
about herbal##2##2##(2008-10#1)(2008-8#1)
about his##3##2##(1996-5#3)
about how they##2##3##(1995-2#1)(1997-1#1)
about how to prevent##2##4##(1990-9#1)(1997-1#1)
about how to##8##3##(1990-9#1)(1992-3#1)(1996-5#1)(1997-1#1)(2008-11#1)(2010-11#1)(2010-8#1)(2013-8#1)
about how##30##2##(1990-9#1)(1992-12#1)(1992-3#1)(1995-2#1)(1996-5#1)(1997-1#2)(1997-3#1)(2008-10#2)(2008-11#5)(2008-7#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
about important##2##2##(1997-2#1)(2008-7#1)
about in##2##2##(2008-12#1)(2012-2#1)
about influenza disease and##2##4##(2012-3#2)
about influenza##3##2##(2012-3#3)
about it##4##2##(2008-11#2)(2012-2#1)(2013-1#1)
about its##11##2##(1992-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#3)
about key##2##2##(1994-1#1)(2011-2#1)
about long-term care##2##3##(1991-3#1)(1997-3#1)
about management##2##2##(1994-2#1)(1995-1#1)
about mechanisms##2##2##(1991-1#1)(2011-2#1)
about medical##2##2##(1991-2#1)(2008-11#1)
about microbial##2##2##(2008-10#1)(2011-1#1)
about mutation rates##2##3##(2008-10#1)(2008-12#1)
about mutation##3##2##(2008-10#1)(2008-12#2)
about nanotechnology##2##2##(2010-12#2)
about new##2##2##(1996-9#1)(2011-2#1)
about older##3##2##(2010-10#1)(2010-2#1)(2012-12#1)
about one entry every##2##4##(2008-10#2)
about one fifth of##2##4##(1990-11#1)(2008-8#1)
about one month##2##3##(2008-10#1)(2008-11#1)
about one##8##2##(1990-11#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
about one-third##4##2##(1990-8#1)(1996-9#1)(2008-1#1)(2009-4#1)
about other##2##2##(2008-11#1)(2010-12#1)
about pain##2##2##(1992-3#1)(2012-2#1)
about patients and##2##3##(1997-1#1)(2010-8#1)
about patients##4##2##(1990-3#1)(1997-1#1)(2010-3#1)(2010-8#1)
about physical activity and##3##4##(2009-6#2)(2013-1#1)
about physical activity##4##3##(2009-6#3)(2013-1#1)
about physical and##2##3##(1990-6#1)(1991-8#1)
about physical##7##2##(1990-6#1)(1991-8#1)(2009-6#3)(2010-2#1)(2013-1#1)
about possible##4##2##(1990-5#1)(1996-8#1)(2011-2#1)(2013-1#1)
about potential##2##2##(1996-1#1)(2010-11#1)
about practice##2##2##(1997-1#1)(2008-11#1)
about prostate##2##2##(2008-11#1)(2009-5#1)
about protective role of exercise against##2##6##(2013-1#2)
about quality of##2##3##(1993-1#1)(1994-2#1)
about quality##4##2##(1993-1#1)(1993-3#2)(1994-2#1)
about rheumatoid arthritis##2##3##(2012-3#1)(2013-8#1)
about safe##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
about salt##2##2##(2009-8#1)(2013-1#1)
about sexual concerns##2##3##(2008-7#2)
about sexual##3##2##(1996-11#1)(2008-7#2)
about sexuality with##2##3##(2009-5#1)(2013-1#1)
about six##2##2##(1991-11#1)(1995-1#1)
about some##2##2##(1997-4#1)(2008-10#1)
about survival##2##2##(2008-11#1)(2012-12#1)
about ten##2##2##(2008-10#1)(2009-5#1)
about the &quot##2##3##(1993-3#1)(2008-10#1)
about the advantages##2##3##(2008-12#1)(2013-8#1)
about the appropriateness of##2##4##(2008-12#1)(2008-9#1)
about the availability of##2##4##(2008-9#1)(2010-8#1)
about the benefits##2##3##(1992-2#1)(1997-2#1)
about the best##2##3##(1995-2#1)(2008-10#1)
about the biology of##2##4##(2008-10#1)(2008-4#1)
about the clinical##2##3##(1991-2#1)(2008-12#1)
about the costs##3##3##(1992-1#1)(2008-11#1)(2010-9#1)
about the current##3##3##(1991-6#1)(2008-9#1)(2010-10#1)
about the disease##3##3##(1992-3#1)(1997-8#1)(2012-3#1)
about the effect of##5##4##(2008-12#2)(2008-9#1)(2012-2#1)(2013-8#1)
about the effectiveness of##2##4##(1996-6#1)(2007-12#1)
about the effects of##9##4##(1991-5#1)(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-2#1)
about the effects##10##3##(1990-2#1)(1991-5#1)(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-2#1)
about the efficacy##2##3##(1993-12#1)(2012-2#1)
about the etiology and management of orofacial clefts##3##8##(2009-10#3)
about the eventual##2##3##(1994-12#1)(2008-10#1)
about the evolution of##2##4##(2008-10#1)(2008-8#1)
about the existence##2##3##(1990-5#1)(2011-2#1)
about the factors##2##3##(1996-11#1)(2010-10#1)
about the future##2##3##(1992-3#1)(2012-2#1)
about the general##2##3##(1991-2#1)(2010-1#1)
about the growth and##2##4##(2008-10#1)(2008-11#1)
about the health##3##3##(1992-3#1)(1997-3#1)(2008-10#1)
about the impact of##4##4##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)
about the importance of##2##4##(2008-11#2)
about the incidence of##2##4##(2011-2#1)(2012-2#1)
about the long-term##2##3##(2008-11#1)(2012-2#1)
about the management of##2##4##(1993-12#1)(2013-1#1)
about the mechanism##2##3##(2008-10#1)(2011-2#1)
about the mechanisms##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
about the molecular##2##3##(2008-4#1)(2012-2#1)
about the most##2##3##(2008-10#2)
about the natural##3##3##(1992-9#1)(1994-9#1)(2008-7#1)
about the nature and##2##4##(1991-2#1)(2011-2#1)
about the nature of the##2##5##(1992-12#1)(2012-2#1)
about the nature of##5##4##(1992-12#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-2#1)
about the nature##7##3##(1991-2#1)(1992-12#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
about the optimal##2##3##(2008-7#1)(2013-8#1)
about the origin of the##2##5##(2008-7#1)(2009-8#1)
about the origin of##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
about the patient's##2##3##(1991-1#1)(1993-11#1)
about the possibility of##3##4##(1992-12#1)(2008-11#1)(2011-2#1)
about the potential##4##3##(2008-10#2)(2011-1#1)(2012-2#1)
about the practical##2##3##(2008-10#1)(2008-11#1)
about the precise##2##3##(2008-9#1)(2011-2#1)
about the presence##2##3##(2008-12#1)(2012-12#1)
about the process of##2##4##(2012-3#2)
about the prognosis##2##3##(2012-2#1)(2012-3#1)
about the psychosocial needs of##2##5##(1991-2#1)(2008-9#1)
about the purpose##2##3##(1991-6#1)(2008-11#1)
about the relationship of##2##4##(2008-10#1)(2012-2#1)
about the relationship##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
about the relationships between##2##4##(1992-3#1)(2008-8#1)
about the results##3##3##(2008-10#3)
about the risk of##2##4##(1995-6#1)(2008-8#1)
about the risk##3##3##(1995-6#1)(2008-8#1)(2012-2#1)
about the role of##3##4##(1992-12#1)(2008-11#1)(2008-8#1)
about the role##5##3##(1992-12#1)(2008-11#2)(2008-8#1)(2013-8#1)
about the same##5##3##(2008-10#2)(2008-11#1)(2010-11#1)(2013-8#1)
about the source of##2##4##(1992-3#1)(1994-5#1)
about the strength of##2##4##(1997-1#1)(2012-3#1)
about the structure##2##3##(2008-10#1)(2010-11#1)
about the time##3##3##(1992-5#1)(1993-3#1)(1995-12#1)
about the underlying##2##3##(2008-10#1)(2008-12#1)
about the use of the##2##5##(1992-5#1)(2013-8#1)
about the use of##7##4##(1992-5#1)(2008-5#1)(2009-10#1)(2011-10#1)(2013-1#1)(2013-8#2)
about the value of##3##4##(2008-12#1)(2008-3#1)(2008-8#1)
about the##437##2##(1990-11#1)(1990-2#5)(1990-3#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-1#3)(1991-2#5)(1991-5#2)(1991-6#4)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#3)(1992-3#7)(1992-5#3)(1992-9#1)(1993-11#2)(1993-12#5)(1993-3#4)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#5)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#2)(1997-7#3)(1997-8#2)(2007-12#5)(2008-1#2)(2008-10#69)(2008-11#38)(2008-12#16)(2008-2#1)(2008-3#10)(2008-4#5)(2008-5#4)(2008-7#6)(2008-8#10)(2008-9#14)(2009-10#10)(2009-11#2)(2009-12#3)(2009-5#5)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#8)(2010-11#7)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#5)(2010-9#3)(2011-1#2)(2011-10#1)(2011-2#21)(2011-3#2)(2012-12#3)(2012-2#24)(2012-3#14)(2013-1#10)(2013-8#14)
about their experiences##2##3##(2008-11#1)(2009-9#1)
about their knowledge##2##3##(1996-6#1)(2012-12#1)
about their relative##2##3##(2008-8#1)(2010-10#1)
about their sexual##2##3##(2008-11#1)(2009-5#1)
about their##56##2##(1990-11#1)(1991-2#3)(1992-1#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-1#3)(1995-2#3)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-5#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
about them##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
about these##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
about this phenomenon##2##3##(2008-11#1)(2012-3#1)
about this##14##2##(1993-12#2)(1994-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)
about those##2##2##(1997-3#1)(2008-11#1)
about three cases]##2##3##(2009-1#1)(2009-5#1)
about three orders of magnitude##3##5##(2008-10#3)
about three times##4##3##(1990-12#1)(1996-2#1)(1997-2#1)(2008-10#1)
about three##12##2##(1990-12#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-8#1)(2009-1#1)(2009-5#2)
about to##4##2##(1991-2#1)(1992-9#1)(2008-5#1)(2010-4#1)
about treatment##2##2##(1995-2#1)(2009-8#1)
about twice as##3##3##(2008-11#3)
about twice the##2##3##(2007-12#1)(2008-5#1)
about twice##5##2##(2007-12#1)(2008-11#3)(2008-5#1)
about two orders of magnitude##4##5##(1990-11#1)(2008-10#3)
about two##11##2##(1990-11#1)(1993-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
about using##2##2##(1997-6#1)(2008-3#1)
about what is##2##3##(2008-1#1)(2008-11#1)
about what the##2##3##(1990-2#1)(1991-2#1)
about what they##2##3##(1996-11#1)(2009-5#1)
about what##12##2##(1990-2#1)(1991-2#1)(1996-11#1)(1997-1#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-5#1)(2009-9#1)(2013-1#2)
about whether##9##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
about which##6##2##(1994-8#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-11#1)
about work-based learning##2##3##(2008-11#2)
about##1834##1##(1990-10#1)(1990-11#11)(1990-12#6)(1990-2#18)(1990-3#4)(1990-5#16)(1990-6#6)(1990-8#2)(1990-9#4)(1991-1#8)(1991-11#3)(1991-12#6)(1991-2#16)(1991-3#5)(1991-5#11)(1991-6#8)(1991-8#4)(1992-1#6)(1992-11#1)(1992-12#11)(1992-2#13)(1992-3#15)(1992-4#1)(1992-5#5)(1992-6#8)(1992-8#4)(1992-9#4)(1993-1#4)(1993-11#6)(1993-12#18)(1993-2#8)(1993-3#16)(1993-6#1)(1993-8#7)(1994-1#6)(1994-11#7)(1994-12#7)(1994-2#8)(1994-3#8)(1994-5#7)(1994-8#12)(1994-9#4)(1995-1#9)(1995-11#3)(1995-12#16)(1995-2#14)(1995-3#4)(1995-5#3)(1995-6#9)(1995-8#3)(1996-1#3)(1996-11#9)(1996-12#11)(1996-2#8)(1996-3#9)(1996-5#13)(1996-6#10)(1996-8#3)(1996-9#3)(1997-1#9)(1997-2#9)(1997-3#16)(1997-4#3)(1997-5#2)(1997-6#11)(1997-7#6)(1997-8#8)(2007-11#1)(2007-12#19)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#370)(2008-11#160)(2008-12#36)(2008-2#3)(2008-3#19)(2008-4#16)(2008-5#22)(2008-6#9)(2008-7#43)(2008-8#56)(2008-9#38)(2009-1#2)(2009-10#17)(2009-11#4)(2009-12#8)(2009-3#4)(2009-4#4)(2009-5#19)(2009-6#6)(2009-7#5)(2009-8#19)(2009-9#10)(2010-1#9)(2010-10#32)(2010-11#13)(2010-12#12)(2010-2#3)(2010-3#8)(2010-4#6)(2010-5#7)(2010-6#4)(2010-7#3)(2010-8#21)(2010-9#7)(2011-1#11)(2011-10#1)(2011-2#73)(2011-3#9)(2012-12#20)(2012-2#45)(2012-3#40)(2013-1#58)(2013-7#1)(2013-8#39)
above 0##8##2##(1990-5#1)(1994-6#1)(2008-10#3)(2008-11#2)(2008-5#1)
above 1##3##2##(2008-10#2)(2008-9#1)
above 10 mg##2##3##(2008-11#1)(2008-9#1)
above 10##5##2##(1993-6#1)(1997-1#1)(2008-11#1)(2008-9#1)(2009-8#1)
above 2##2##2##(1990-6#1)(2008-1#1)
above 250##2##2##(1996-8#1)(2008-10#1)
above 4##2##2##(2008-7#1)(2009-5#1)
above 50##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
above 70%##2##2##(2008-5#1)(2008-9#1)
above 80##2##2##(2008-10#1)(2012-12#1)
above 80%##2##2##(1994-9#1)(1997-8#1)
above 90%##2##2##(2008-10#1)(2008-8#1)
above T(g)##2##2##(1995-3#1)(2010-4#1)
above a critical##2##3##(2008-10#1)(2010-10#1)
above a threshold##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
above a##10##2##(1990-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-10#1)
above all##9##2##(1990-9#1)(1992-9#1)(1995-5#2)(1996-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
above an##2##2##(2008-10#1)(2008-3#1)
above and##8##2##(2008-10#3)(2008-3#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
above average##2##2##(1994-1#1)(2013-1#1)
above baseline##2##2##(2007-11#1)(2011-2#1)
above chance##2##2##(2008-5#1)(2008-9#1)
above compounds##2##2##(1991-6#1)(2008-10#1)
above control##2##2##(1995-12#1)(1995-2#1)
above control)##2##2##(1995-2#1)(2008-10#1)
above information##2##2##(2008-6#1)(2009-11#1)
above is##2##2##(1996-1#1)(2008-10#1)
above mentioned metal ions were##2##5##(2008-10#2)
above mentioned##23##2##(1990-9#1)(1996-2#1)(1996-3#1)(2008-10#13)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
above method##2##2##(1990-12#1)(1997-2#1)
above normal##5##2##(1992-3#1)(1996-3#1)(2008-1#1)(2008-10#1)(2012-2#1)
above results##8##2##(1994-8#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-8#1)(2012-2#1)
above suggest##2##2##(2008-10#1)(2008-8#1)
above system##2##2##(2008-10#2)
above that of##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
above that##9##2##(1994-5#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
above the burner##3##3##(2008-10#1)(2008-3#2)
above the cloud##2##3##(2008-10#1)(2008-2#1)
above the critical##2##3##(2008-10#1)(2008-7#1)
above the ground##3##3##(2008-10#2)(2008-3#1)
above the level##2##3##(2008-11#2)
above the limit of quantification##2##5##(2008-5#2)
above the maximum##3##3##(2008-10#3)
above the source##2##3##(2008-10#2)
above the surface of the##2##5##(2008-10#2)
above the threshold for##2##4##(2008-10#1)(2008-3#1)
above the threshold##4##3##(2008-10#2)(2008-3#1)(2009-5#1)
above the values##2##3##(1990-2#1)(2008-10#1)
above the##71##2##(1990-2#1)(1990-9#1)(1991-11#1)(1992-9#1)(1993-12#2)(1994-2#1)(1995-3#1)(2008-1#1)(2008-10#35)(2008-11#3)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
above their##2##2##(2008-10#1)(2012-2#1)
above this##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
above threshold##2##2##(2008-3#2)
above two years##2##3##(1994-9#1)(1996-8#1)
above two##5##2##(1991-5#1)(1994-9#1)(1995-11#1)(1996-8#1)(2008-4#1)
above was##4##2##(1995-12#1)(2008-10#1)(2008-9#2)
above wheat##2##2##(2008-10#2)
above which the##3##3##(2008-10#1)(2008-8#2)
above which##5##2##(2008-10#2)(2008-8#3)
above##385##1##(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#6)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#3)(1993-12#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-2#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#4)(1996-8#3)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#138)(2008-11#17)(2008-12#7)(2008-2#4)(2008-3#20)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#12)(2008-8#17)(2008-9#11)(2009-10#2)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#13)(2011-3#3)(2012-12#2)(2012-2#10)(2012-3#7)(2013-1#4)(2013-8#6)
above-ground##2##1##(2009-10#1)(2010-11#1)
above-mentioned indexes were##2##3##(2011-3#2)
above-mentioned##14##1##(1997-8#2)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2011-2#1)(2011-3#2)
aboveground plant parts##2##3##(2008-10#1)(2008-8#1)
aboveground tissues##2##2##(2008-10#2)
aboveground##7##1##(2008-10#6)(2008-8#1)
abrasion of##3##2##(2008-10#2)(2008-5#1)
abrasion##6##1##(2008-10#2)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
abrasive immobilization of multiwall carbon nanotubes##2##6##(2008-10#2)
abrasive##4##1##(2008-10#4)
abrasives##3##1##(2008-5#3)
abridged##4##1##(1994-1#1)(2008-11#1)(2008-12#1)(2010-11#1)
abrin##4##1##(1994-5#4)
abroad##11##1##(1991-2#1)(1992-9#1)(1994-1#1)(1995-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-12#1)(2010-7#1)(2012-12#1)(2012-2#1)
abrogate##3##1##(2008-11#1)(2008-8#1)(2011-2#1)
abrogated the##5##2##(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#1)(2011-2#1)
abrogated##11##1##(1992-6#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
abrogates##3##1##(2010-3#1)(2010-5#1)(2013-1#1)
abrupt decrease of##2##3##(2008-10#1)(2008-11#1)
abrupt##11##1##(1991-1#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)
abruptly##7##1##(1993-12#1)(1994-8#1)(2008-10#2)(2008-8#2)(2013-8#1)
abscess and##4##2##(1994-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
abscess caused by##3##3##(1991-3#1)(2013-8#2)
abscess formation##2##2##(1995-9#1)(2008-9#1)
abscess in##3##2##(1990-3#1)(2008-12#1)(2012-3#1)
abscess##38##1##(1990-3#2)(1991-3#2)(1991-6#1)(1994-12#1)(1995-10#1)(1995-9#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#3)(2012-3#8)(2013-1#2)(2013-8#5)
abscess)##2##1##(1991-3#1)(2008-12#1)
abscesses and fistulas##3##3##(1997-8#3)
abscesses and##4##2##(1997-8#3)(2008-12#1)
abscesses##13##1##(1990-3#1)(1991-8#1)(1997-8#4)(2008-12#1)(2010-12#1)(2012-2#1)(2013-8#4)
abscisic acid (ABA)##2##3##(2009-6#1)(2009-8#1)
abscisic acid##5##2##(2008-10#2)(2008-8#1)(2009-6#1)(2009-8#1)
abscission step##2##2##(2009-8#2)
abscission##3##1##(2008-10#1)(2009-8#2)
absence and in##2##3##(2008-10#2)
absence and##13##2##(1994-11#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-5#1)
absence in##2##2##(2008-10#1)(2008-11#1)
absence of SDS##2##3##(1990-11#1)(2008-10#1)
absence of a##30##3##(1990-5#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#2)
absence of acute##2##3##(1991-1#1)(1994-12#1)
absence of added##3##3##(1994-8#1)(1997-1#1)(2008-10#1)
absence of an##5##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)
absence of antibodies against##2##4##(1993-3#1)(2011-2#1)
absence of any##16##3##(1991-3#1)(1991-8#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-9#2)(2009-10#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
absence of compensatory##2##3##(1994-8#1)(2012-3#1)
absence of disease##3##3##(2008-10#2)(2013-1#1)
absence of extracellular##2##3##(1990-5#1)(1991-6#1)
absence of glutamine##3##3##(2008-11#3)
absence of insects##2##3##(2008-8#2)
absence of interferences##2##3##(2008-10#2)
absence of isthmus##2##3##(2013-1#2)
absence of light##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2009-8#1)
absence of matrix##2##3##(2008-10#2)
absence of other herbivores##2##4##(2008-8#2)
absence of other##7##3##(1991-12#1)(2008-4#2)(2008-8#3)(2013-1#1)
absence of reducing agent##2##4##(1995-11#2)
absence of serum##5##3##(2008-11#5)
absence of significant##2##3##(2008-10#1)(2008-11#1)
absence of such##6##3##(1991-12#1)(1991-2#1)(1994-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
absence of symptoms##5##3##(1990-6#3)(1991-6#1)(2008-10#1)
absence of the##45##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-8#1)(1997-3#2)(2007-12#1)(2008-10#14)(2008-11#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
absence of these##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2009-10#1)
absence of##485##2##(1990-11#6)(1990-2#2)(1990-5#5)(1990-6#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#8)(1993-6#5)(1993-8#7)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#1)(1994-8#4)(1995-11#5)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#6)(1995-8#6)(1996-11#2)(1996-12#1)(1996-2#3)(1996-5#2)(1997-1#1)(1997-3#5)(1997-6#1)(1997-7#2)(1997-8#6)(2007-12#5)(2007-8#1)(2008-10#123)(2008-11#44)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#13)(2008-8#28)(2008-9#16)(2009-1#1)(2009-10#6)(2009-11#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#23)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#14)(2013-7#1)(2013-8#4)
absence##523##1##(1990-11#6)(1990-2#3)(1990-5#5)(1990-6#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#8)(1993-6#5)(1993-8#8)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#1)(1994-8#5)(1995-11#5)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#6)(1995-8#8)(1996-11#2)(1996-12#1)(1996-2#3)(1996-5#2)(1997-1#1)(1997-3#5)(1997-6#1)(1997-7#3)(1997-8#6)(2007-12#5)(2007-8#1)(2008-10#134)(2008-11#50)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#16)(2008-8#29)(2008-9#17)(2009-1#1)(2009-10#6)(2009-11#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#26)(2012-12#4)(2012-2#7)(2012-3#7)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#6)
absence)##2##1##(2008-10#1)(2011-2#1)
absent from the##4##3##(1994-11#1)(2008-9#1)(2009-4#1)(2009-6#1)
absent from##11##2##(1993-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2012-2#1)
absent in the##6##3##(1993-2#1)(1994-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
absent in##25##2##(1990-12#1)(1990-2#1)(1990-3#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-10#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
absent or present##2##3##(2008-10#2)
absent or##7##2##(1992-9#1)(2008-10#3)(2010-6#1)(2013-1#2)
absent##92##1##(1990-12#1)(1990-2#2)(1990-3#1)(1991-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-6#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#1)(1997-3#3)(1997-8#2)(2008-10#20)(2008-11#4)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-4#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
absenteeism and##3##2##(1995-6#1)(1996-1#1)(2012-3#1)
absenteeism##6##1##(1992-12#1)(1995-6#1)(1996-1#1)(1997-2#1)(2012-12#1)(2012-3#1)
absidiomycosis in##2##2##(2008-5#2)
absolute EC50/IC50##4##2##(2012-2#4)
absolute and relative measures##2##4##(1990-2#1)(2008-10#1)
absolute and relative##4##3##(1990-2#1)(2008-10#2)(2008-7#1)
absolute and##6##2##(1990-2#1)(2008-10#3)(2008-7#1)(2012-3#1)
absolute bioavailability##2##2##(2010-11#1)(2012-2#1)
absolute cell counts##2##3##(2008-10#1)(2008-9#1)
absolute cell##4##2##(2008-10#1)(2008-9#3)
absolute concentration##3##2##(2008-10#2)(2008-3#1)
absolute configuration##2##2##(2008-10#1)(2008-11#1)
absolute contraindications##2##2##(2011-3#1)(2013-1#1)
absolute detection limit##4##3##(2008-10#4)
absolute detection limits##2##3##(2008-10#2)
absolute detection##6##2##(2008-10#6)
absolute difference##2##2##(2008-3#1)(2008-8#1)
absolute error##2##2##(2008-10#1)(2008-11#1)
absolute humidity##3##2##(1992-2#1)(2008-10#2)
absolute leukocyte##2##2##(2008-9#2)
absolute levels##2##2##(1991-2#1)(1993-12#1)
absolute minimum##2##2##(2008-8#1)(2009-12#1)
absolute number of##5##3##(1991-3#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
absolute number##7##2##(1991-3#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-1#1)
absolute numbers##5##2##(1991-3#1)(1995-12#2)(2008-10#1)(2013-8#1)
absolute requirement for##2##3##(2007-12#1)(2008-10#1)
absolute requirement##6##2##(1992-1#1)(1995-8#1)(2007-12#1)(2008-10#3)
absolute risk##2##2##(2008-9#1)(2013-1#1)
absolute value of##2##3##(2008-2#1)(2012-2#1)
absolute value##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
absolute values of##5##3##(1994-8#1)(2008-3#2)(2008-8#2)
absolute values##7##2##(1994-6#1)(1994-8#1)(2008-2#1)(2008-3#2)(2008-8#2)
absolute##143##1##(1990-2#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#2)(1992-6#3)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#2)(1994-8#3)(1995-12#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#40)(2008-11#3)(2008-2#2)(2008-3#13)(2008-5#3)(2008-7#2)(2008-8#9)(2008-9#12)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#2)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#1)
absolutely##8##1##(1992-9#1)(1993-1#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-3#3)
absolutes and##2##2##(2008-5#2)
absorb at the##2##3##(2008-10#2)
absorb the##3##2##(2008-3#2)(2009-10#1)
absorb##12##1##(1991-5#1)(1991-6#1)(1996-12#1)(2008-10#3)(2008-3#3)(2008-9#1)(2009-10#1)(2011-1#1)
absorbable suture##3##2##(1991-1#2)(1992-1#1)
absorbable##7##1##(1991-1#2)(1992-1#1)(1992-2#1)(1996-6#1)(2008-10#1)(2008-9#1)
absorbance and fluorescence##5##3##(2008-10#3)(2008-12#1)(2008-8#1)
absorbance and the##3##3##(2008-10#3)
absorbance and##13##2##(2008-10#11)(2008-12#1)(2008-8#1)
absorbance as##2##2##(2008-10#2)
absorbance at the##2##3##(2008-10#2)
absorbance at##27##2##(2008-10#25)(2008-11#1)(2011-2#1)
absorbance band##4##2##(2008-10#4)
absorbance bands##2##2##(2008-10#2)
absorbance by##2##2##(2008-10#2)
absorbance change##2##2##(2008-10#2)
absorbance data##5##2##(1993-3#1)(2008-10#4)
absorbance decrease##2##2##(2008-10#2)
absorbance detection at##3##3##(2008-10#3)
absorbance detection is##2##3##(2008-10#1)(2010-7#1)
absorbance detection##12##2##(2008-10#10)(2010-7#2)
absorbance detector##6##2##(2008-10#6)
absorbance for the##2##3##(2008-10#2)
absorbance for##5##2##(2008-10#5)
absorbance intensity of##2##3##(2008-10#2)
absorbance intensity##5##2##(2008-10#4)(2008-8#1)
absorbance is##8##2##(2008-10#7)(2008-3#1)
absorbance maxima##3##2##(2008-10#3)
absorbance maximum##2##2##(2008-10#2)
absorbance measurement##2##2##(2008-10#2)
absorbance measurements##8##2##(2008-10#8)
absorbance method##3##2##(2008-9#1)(2010-11#2)
absorbance mode##3##2##(2008-10#3)
absorbance of 0##5##3##(2008-10#5)
absorbance of MB##3##3##(2008-10#3)
absorbance of the acceptor stream##2##5##(2008-10#2)
absorbance of the blue##2##4##(2008-10#2)
absorbance of the coloured##2##4##(2008-10#2)
absorbance of the complex##2##4##(2008-10#2)
absorbance of the dye##3##4##(2008-10#3)
absorbance of the extracted complex##2##5##(2008-10#2)
absorbance of the formed##3##4##(2008-10#3)
absorbance of the purple##2##4##(2008-10#2)
absorbance of the##40##3##(2008-10#39)(2008-3#1)
absorbance of##67##2##(2008-10#65)(2008-3#2)
absorbance peaks##2##2##(2008-10#2)
absorbance signal##2##2##(2008-10#2)
absorbance signals##2##2##(2008-10#2)
absorbance spectra##2##2##(1995-2#1)(2008-10#1)
absorbance spectroscopy##4##2##(2008-10#3)(2010-11#1)
absorbance spectrum##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
absorbance to##2##2##(2008-10#2)
absorbance unit##2##2##(2008-10#2)
absorbance units##2##2##(2008-10#2)
absorbance values##8##2##(2008-10#8)
absorbance versus concentration##2##3##(2008-10#2)
absorbance versus##9##2##(2008-10#9)
absorbance was measured at 610 nm##2##6##(1990-2#1)(2008-10#1)
absorbance was measured at##5##4##(1990-2#1)(2008-10#4)
absorbance was##8##2##(1990-2#1)(2008-10#6)(2008-3#1)
absorbance were##2##2##(2008-10#2)
absorbance##283##1##(1990-2#1)(1993-3#1)(1993-8#1)(1995-2#1)(2008-10#254)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#4)(2010-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
absorbance)##2##1##(2007-12#1)(2008-5#1)
absorbances at##4##2##(2008-10#3)(2008-3#1)
absorbances of the##2##3##(2008-10#1)(2008-5#1)
absorbances##15##1##(2008-10#12)(2008-3#2)(2008-5#1)
absorbed at##2##2##(2008-10#1)(2008-7#1)
absorbed by the gas##2##4##(2008-3#2)
absorbed by the##7##3##(1995-12#1)(2008-10#1)(2008-3#4)(2013-1#1)
absorbed by##11##2##(1995-12#1)(1997-7#1)(2008-10#2)(2008-3#4)(2008-8#1)(2010-12#1)(2013-1#1)
absorbed dose##2##2##(1993-9#1)(2008-10#1)
absorbed doses##2##2##(1991-5#1)(2009-11#1)
absorbed in##6##2##(2008-10#5)(2009-8#1)
absorbed on##4##2##(1992-12#1)(2008-10#2)(2008-8#1)
absorbed power##3##2##(1992-3#1)(2008-2#2)
absorbed pump power##3##3##(2008-2#1)(2008-3#2)
absorbed pump##4##2##(2008-2#1)(2008-3#3)
absorbed quantitatively on##2##3##(2008-10#2)
absorbed##53##1##(1990-6#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-9#1)(1995-12#1)(1996-1#1)(1997-7#1)(2007-12#2)(2008-10#20)(2008-2#4)(2008-3#8)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-12#1)(2012-2#3)(2013-1#1)
absorbent##4##1##(2007-12#1)(2008-10#3)
absorbents##3##1##(2008-10#3)
absorber##10##1##(2007-12#1)(2008-3#9)
absorbers##2##1##(2008-3#1)(2010-7#1)
absorbing features##2##2##(2008-3#2)
absorbing inhomogeneities##4##2##(2008-3#4)
absorbing medium##2##2##(2008-3#2)
absorbing solution##10##2##(2008-10#9)(2008-3#1)
absorbing species##2##2##(2008-3#2)
absorbing##44##1##(1995-9#1)(2008-10#20)(2008-11#1)(2008-3#20)(2011-2#2)
absorbs at##2##2##(2008-10#2)
absorbs the##2##2##(2008-3#1)(2008-7#1)
absorbs##4##1##(2008-10#2)(2008-3#1)(2008-7#1)
absorptiometrically##2##1##(2008-10#2)
absorptiometry (DXA) scan##2##3##(2008-10#1)(2010-1#1)
absorptiometry (DXA)##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
absorptiometry in##2##2##(1991-11#1)(2008-8#1)
absorptiometry of the lumbar spine##2##5##(1991-11#2)
absorptiometry##12##1##(1991-11#6)(2008-10#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)
absorption and emission spectra##2##4##(2008-10#1)(2009-10#1)
absorption and emission spectrometry##3##4##(2008-10#3)
absorption and emission##9##3##(2008-10#8)(2009-10#1)
absorption and evaporation of##2##4##(2008-5#2)
absorption and fluorescence##3##3##(2008-10#2)(2010-4#1)
absorption and scattering##3##3##(2008-3#1)(2008-7#1)(2009-12#1)
absorption and stability##2##3##(2011-2#2)
absorption and##37##2##(1990-11#1)(1992-1#1)(1992-8#1)(2008-10#15)(2008-2#2)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)
absorption are##2##2##(1992-3#1)(2008-10#1)
absorption at##8##2##(2008-10#7)(2008-9#1)
absorption band##5##2##(2008-10#3)(2008-3#2)
absorption bands at##3##3##(2008-10#3)
absorption bands in the##3##4##(1996-5#1)(2008-10#2)
absorption bands of the##3##4##(2008-10#2)(2008-3#1)
absorption bands##12##2##(1991-5#1)(1992-4#1)(1996-5#1)(2008-10#8)(2008-3#1)
absorption by##10##2##(1992-8#1)(2007-11#1)(2008-2#2)(2008-3#5)(2008-7#1)
absorption can##2##2##(2008-3#2)
absorption cell##3##2##(2008-10#2)(2008-3#1)
absorption coefficient in##2##3##(2008-2#1)(2008-3#1)
absorption coefficient is##2##3##(2008-3#2)
absorption coefficient of the##2##4##(2008-10#1)(2008-3#1)
absorption coefficient of##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
absorption coefficient##31##2##(2008-10#7)(2008-2#6)(2008-3#15)(2008-5#1)(2012-2#2)
absorption coefficients of##2##3##(2008-3#2)
absorption coefficients##4##2##(2008-3#4)
absorption cross section of##2##4##(2007-12#1)(2008-3#1)
absorption cross section##8##3##(2007-12#1)(2008-3#7)
absorption cross sections##2##3##(2008-3#2)
absorption cross##10##2##(2007-12#1)(2008-3#9)
absorption cross-sections##2##2##(2008-11#2)
absorption detection##4##2##(2008-10#4)
absorption detector##2##2##(2008-10#2)
absorption efficiencies##2##2##(2008-3#2)
absorption efficiency##7##2##(2008-10#2)(2008-3#5)
absorption features##4##2##(2008-3#3)(2012-12#1)
absorption for##3##2##(1992-3#1)(1994-5#1)(2008-10#1)
absorption from##3##2##(1997-1#1)(2008-10#1)(2008-5#1)
absorption gas imaging##2##3##(2008-3#2)
absorption in the ultraviolet##2##4##(2008-10#2)
absorption in the##8##3##(1992-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2011-7#1)
absorption in##18##2##(1992-11#2)(1992-12#1)(1992-3#2)(2008-10#6)(2008-11#2)(2008-3#3)(2008-9#1)(2011-7#1)
absorption into the##3##3##(1992-3#1)(2008-10#1)(2008-3#1)
absorption into##4##2##(1992-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
absorption is described##3##3##(2008-10#3)
absorption is##12##2##(2008-10#5)(2008-2#1)(2008-3#4)(2008-8#1)(2012-2#1)
absorption lidar##18##2##(2007-12#1)(2008-2#2)(2008-3#15)
absorption limit of##2##3##(2008-3#2)
absorption line##3##2##(2008-2#2)(2008-3#1)
absorption lines##2##2##(2008-3#2)
absorption maxima at##2##3##(2008-10#1)(2008-11#1)
absorption maxima##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
absorption maximum at##13##3##(2008-10#12)(2008-8#1)
absorption maximum of##4##3##(2008-10#2)(2008-8#2)
absorption maximum##21##2##(1994-5#2)(2008-10#16)(2008-8#3)
absorption measurements of##3##3##(2008-3#3)
absorption measurements##6##2##(2008-10#2)(2008-3#4)
absorption near##2##2##(2008-10#1)(2008-3#1)
absorption occurred##3##2##(2008-2#1)(2008-3#2)
absorption of 2##2##3##(2008-3#2)
absorption of Hct##3##3##(2011-3#3)
absorption of a##2##3##(2008-10#2)
absorption of the##9##3##(1997-4#1)(2008-10#5)(2008-11#1)(2008-3#2)
absorption of##60##2##(1992-12#1)(1994-2#1)(1994-8#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#18)(2008-5#4)(2008-7#1)(2008-9#1)(2011-3#8)(2012-2#2)(2013-1#1)
absorption on##3##2##(2008-3#3)
absorption or##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
absorption peak at##7##3##(2008-10#6)(2013-8#1)
absorption peak of##2##3##(2008-10#1)(2008-8#1)
absorption peak##10##2##(2008-10#7)(2008-3#1)(2008-8#1)(2013-8#1)
absorption peaks##2##2##(2008-8#1)(2009-5#1)
absorption profile##2##2##(2008-11#1)(2008-2#1)
absorption profiles##3##2##(2008-10#2)(2008-2#1)
absorption properties of##2##3##(2008-10#1)(2008-3#1)
absorption properties##3##2##(2008-10#1)(2008-3#2)
absorption signal##4##2##(2008-10#3)(2008-3#1)
absorption spectra and##2##3##(2008-10#2)
absorption spectra by##3##3##(2008-3#3)
absorption spectra in the##4##4##(2008-10#4)
absorption spectra of aqueous##2##4##(2008-10#2)
absorption spectra of the##8##4##(2008-10#6)(2008-3#1)(2008-9#1)
absorption spectra of##19##3##(2008-10#14)(2008-3#2)(2008-9#3)
absorption spectra##47##2##(2008-10#30)(2008-3#14)(2008-9#3)
absorption spectrometer##21##2##(2008-10#20)(2008-3#1)
absorption spectrometric determination of ultra trace amounts of##2##8##(2008-10#2)
absorption spectrometric determination of##20##4##(2008-10#20)
absorption spectrometric determination##22##3##(2008-10#22)
absorption spectrometric procedure##3##3##(2008-10#3)
absorption spectrometric##46##2##(2008-10#46)
absorption spectrometry (AAS)##14##3##(2008-10#14)
absorption spectrometry (ETAAS) is described##3##5##(2008-10#3)
absorption spectrometry (ETAAS) is##5##4##(2008-10#5)
absorption spectrometry (ETAAS)##33##3##(2008-10#33)
absorption spectrometry (GFAAS)##25##3##(2008-10#25)
absorption spectrometry (HGAAS)##4##3##(2008-10#4)
absorption spectrometry and##7##3##(2008-10#7)
absorption spectrometry as##5##3##(2008-10#5)
absorption spectrometry for the determination of##2##6##(2008-10#2)
absorption spectrometry for##7##3##(2008-10#7)
absorption spectrometry method##3##3##(2008-10#3)
absorption spectrometry using a##3##4##(2008-10#3)
absorption spectrometry using##14##3##(2008-10#14)
absorption spectrometry with##13##3##(2008-10#13)
absorption spectrometry##425##2##(1991-12#1)(1995-11#1)(2008-10#421)(2008-5#1)(2011-2#1)
absorption spectrophotometric##6##2##(1991-2#1)(2008-10#5)
absorption spectrophotometry##23##2##(2008-10#23)
absorption spectroscopy (XAS)##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
absorption spectroscopy and##3##3##(1994-11#1)(1994-3#1)(2010-4#1)
absorption spectroscopy at##2##3##(2008-10#1)(2008-3#1)
absorption spectroscopy in##2##3##(2008-10#1)(2008-3#1)
absorption spectroscopy of##2##3##(2008-10#1)(2008-3#1)
absorption spectroscopy with##2##3##(2008-3#2)
absorption spectroscopy##39##2##(1994-11#1)(1994-3#1)(1996-3#1)(2008-10#18)(2008-3#14)(2008-9#1)(2010-11#1)(2010-4#1)(2012-2#1)
absorption spectrum of the##3##4##(2008-10#2)(2008-8#1)
absorption spectrum of##6##3##(1993-8#1)(2008-10#2)(2008-3#2)(2008-8#1)
absorption spectrum##15##2##(1993-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#3)
absorption studies##2##2##(2008-5#2)
absorption was##6##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
absorption wavelength of##3##3##(2008-10#2)(2008-2#1)
absorption wavelength##7##2##(2008-10#5)(2008-2#1)(2008-3#1)
absorption with##3##2##(2008-3#2)(2008-7#1)
absorption##1150##1##(1990-11#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#5)(1992-4#1)(1992-8#2)(1993-1#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#5)(1994-8#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#6)(2008-10#769)(2008-11#15)(2008-12#3)(2008-2#29)(2008-3#191)(2008-4#1)(2008-5#23)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#9)(2009-10#1)(2009-12#1)(2009-5#2)(2010-11#2)(2010-4#3)(2010-7#2)(2011-2#6)(2011-3#9)(2011-7#1)(2012-12#1)(2012-2#11)(2013-1#3)(2013-8#1)
absorption)##2##1##(2008-10#1)(2008-7#1)
absorption-based##2##1##(2008-10#2)
absorptions of##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
absorptions##5##1##(2007-11#1)(2008-10#2)(2008-3#2)
absorptivities##13##1##(2008-10#13)
absorptivity and##11##2##(2008-10#10)(2008-5#1)
absorptivity at##2##2##(2008-10#2)
absorptivity in##2##2##(2008-10#2)
absorptivity of the##8##3##(2008-10#8)
absorptivity of##18##2##(2008-10#18)
absorptivity##68##1##(2008-10#67)(2008-5#1)
abstinence during##2##2##(2013-8#2)
abstinence##20##1##(1991-1#2)(1995-11#1)(2008-6#1)(2009-5#3)(2009-7#3)(2010-11#4)(2010-2#2)(2013-1#2)(2013-8#2)
abstinent##5##1##(1995-11#1)(2013-1#1)(2013-8#3)
abstract and full text##2##4##(2013-1#2)
abstract and##3##2##(2011-2#1)(2013-1#2)
abstract are##2##2##(2010-4#2)
abstract is##5##2##(2009-4#3)(2010-4#2)
abstract##37##1##(1990-5#2)(1991-12#1)(1991-2#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-12#5)(2008-5#2)(2008-6#1)(2009-4#7)(2009-6#1)(2009-7#1)(2010-4#7)(2011-2#3)(2013-1#3)
abstracted independently by##2##3##(2009-9#1)(2010-2#1)
abstracted##6##1##(2008-10#2)(2008-3#1)(2009-9#1)(2010-2#1)(2010-8#1)
abstraction by##2##2##(1993-8#1)(1996-5#1)
abstraction from##2##2##(1991-3#1)(1996-5#1)
abstraction##9##1##(1991-3#1)(1993-8#1)(1996-5#2)(2008-10#1)(2008-11#2)(2008-2#1)(2009-12#1)
abstracts and##3##2##(1992-2#1)(1996-12#1)(2010-12#1)
abstracts##9##1##(1992-1#1)(1992-2#1)(1993-12#1)(1996-12#1)(2008-12#2)(2010-12#1)(2010-4#1)(2013-8#1)
abundance and##16##2##(1992-4#1)(1997-4#1)(2008-10#5)(2008-8#3)(2012-2#1)(2012-3#1)(2012-6#4)
abundance in##10##2##(1992-6#1)(2008-10#3)(2008-8#2)(2011-2#1)(2012-2#2)(2012-7#1)
abundance of C##3##3##(2012-6#3)
abundance of##48##2##(1990-12#1)(1991-5#1)(1992-3#1)(1992-7#1)(1994-11#2)(1994-2#3)(1994-6#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#1)(2009-6#1)(2009-8#1)(2010-8#2)(2012-2#1)(2012-6#3)
abundance or##4##2##(1994-5#2)(2008-10#1)(2008-9#1)
abundance patterns##3##2##(2008-8#3)
abundance were##3##2##(1995-2#1)(2008-10#2)
abundance##143##1##(1990-12#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1994-11#2)(1994-2#3)(1994-5#2)(1994-6#1)(1995-2#2)(1995-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(2008-1#1)(2008-10#33)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#26)(2008-9#12)(2009-10#1)(2009-6#1)(2009-8#2)(2010-5#1)(2010-8#5)(2011-2#2)(2012-12#1)(2012-2#7)(2012-3#7)(2012-6#7)(2012-7#1)(2013-8#2)
abundances of##7##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)
abundances were##2##2##(2008-8#1)(2012-3#1)
abundances##26##1##(1994-2#1)(2008-10#4)(2008-3#1)(2008-8#12)(2008-9#5)(2012-2#1)(2012-3#2)
abundant (LEA) proteins##2##3##(2008-10#1)(2012-7#1)
abundant and##12##2##(1992-9#1)(1995-2#1)(2008-10#1)(2008-9#1)(2009-7#2)(2010-11#1)(2010-4#1)(2012-2#2)(2013-1#2)
abundant expression##2##2##(1995-2#1)(1996-2#1)
abundant in the##7##3##(1996-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-10#1)
abundant in##22##2##(1990-12#1)(1990-5#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#2)(2012-2#1)
abundant protein in##3##3##(1997-4#1)(2011-2#1)(2013-8#1)
abundant protein##6##2##(1991-5#1)(1992-3#1)(1996-8#1)(1997-4#1)(2011-2#1)(2013-8#1)
abundant proteins##2##2##(1997-6#1)(2008-10#1)
abundant##140##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#3)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1995-12#1)(1995-2#5)(1996-12#2)(1996-2#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#5)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#5)(2013-8#1)
abundantly expressed##3##2##(1994-11#2)(2008-5#1)
abundantly in##2##2##(1994-11#1)(2008-10#1)
abundantly##16##1##(1991-5#1)(1994-11#3)(1996-12#1)(2008-10#8)(2008-5#2)(2009-10#1)
abuse among##2##2##(1990-2#1)(2009-10#1)
abuse and dependence##2##3##(1992-1#1)(2008-8#1)
abuse and##22##2##(1992-1#1)(1993-12#1)(1994-2#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-5#2)(2009-7#1)(2009-9#3)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
abuse are##3##2##(2008-10#1)(2009-7#1)(2009-9#1)
abuse at##2##2##(1991-1#1)(1992-2#1)
abuse by##4##2##(1990-8#1)(1991-1#1)(1992-1#1)(2008-11#1)
abuse in methadone##2##3##(1991-1#1)(2008-10#1)
abuse in pregnancy##2##3##(1994-3#1)(2008-11#1)
abuse in##10##2##(1991-1#2)(1992-1#1)(1994-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2013-1#2)
abuse is a##6##3##(1996-11#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2013-8#1)
abuse is##9##2##(1992-1#1)(1996-11#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#2)(2013-8#1)
abuse liability##3##2##(1991-1#3)
abuse of boys##2##3##(1996-11#2)
abuse of human rights##2##4##(1995-11#2)
abuse of##14##2##(1991-1#1)(1992-1#1)(1995-11#2)(1995-5#2)(1996-11#4)(1996-2#1)(2009-12#1)(2009-9#1)(2010-7#1)
abuse or dependence##2##3##(1992-1#1)(2008-11#1)
abuse or##4##2##(1992-1#1)(2008-11#1)(2010-4#1)(2010-7#1)
abuse potential##2##2##(2009-7#1)(2012-3#1)
abuse prevention##3##2##(1991-1#1)(1995-12#1)(2008-6#1)
abuse services##2##2##(1991-2#1)(1996-12#1)
abuse treatment and##4##3##(2008-6#3)(2010-6#1)
abuse treatment##13##2##(1991-1#1)(2008-6#8)(2010-11#3)(2010-6#1)
abuse was##2##2##(1995-5#1)(1997-2#1)
abuse with##2##2##(1996-11#1)(2008-10#1)
abuse##223##1##(1990-2#4)(1990-8#1)(1991-1#22)(1991-2#4)(1992-1#13)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#7)(1996-1#2)(1996-11#8)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#4)(1997-2#3)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#10)(2008-11#7)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#19)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#10)(2009-9#18)(2010-10#6)(2010-11#3)(2010-4#5)(2010-6#1)(2010-7#4)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#9)
abuse)##2##1##(2010-11#1)(2012-3#1)
abuse?##2##1##(2008-4#1)(2010-7#1)
abuse]##3##1##(1990-2#1)(1995-5#2)
abused and neglected child##3##4##(1995-5#3)
abused and neglected##5##3##(1995-5#5)
abused and##6##2##(1995-5#6)
abused child##3##2##(1995-5#3)
abused##19##1##(1990-11#1)(1991-1#1)(1992-3#1)(1995-5#10)(1996-11#1)(2008-10#1)(2009-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
abuser##4##1##(1990-3#1)(1991-1#1)(1996-11#1)(2008-12#1)
abusers##12##1##(1990-2#1)(1991-1#7)(2008-12#1)(2008-6#2)(2013-1#1)
abuses##2##1##(1993-3#1)(1997-3#1)
abusing##3##1##(1991-1#1)(1996-5#2)
abutment##4##1##(2013-1#4)
abutments##6##1##(2008-11#1)(2013-1#5)
abzyme##2##1##(1995-3#2)
ac impedance spectroscopy##2##3##(2008-10#2)
ac impedance##4##2##(2008-10#4)
ac##10##1##(1990-12#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)
acacia##5##1##(2008-10#1)(2008-5#4)
academia and##3##2##(2008-5#2)(2012-3#1)
academia##12##1##(1993-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#1)(2010-7#1)(2012-2#1)(2012-3#1)
academic achievement and##2##3##(2009-7#1)(2010-1#1)
academic achievement##14##2##(2008-11#1)(2009-7#2)(2010-1#9)(2012-2#2)
academic adjustment##4##2##(2008-12#1)(2010-1#3)
academic and##5##2##(2008-12#3)(2008-5#1)(2009-4#1)
academic background##2##2##(1991-2#1)(1996-3#1)
academic buoyancy##6##2##(2008-12#6)
academic center##2##2##(2008-10#1)(2012-3#1)
academic clinical##2##2##(2009-4#2)
academic development##2##2##(2008-12#1)(2011-2#1)
academic dishonesty##3##2##(2008-12#3)
academic engagement##7##2##(2008-12#7)
academic failure##2##2##(2008-11#2)
academic hospital##2##2##(2008-11#1)(2010-8#1)
academic institution##2##2##(1992-1#1)(2008-11#1)
academic institutions##5##2##(1996-1#1)(2009-12#1)(2009-4#1)(2012-2#1)(2013-8#1)
academic knowledge##2##2##(1996-3#2)
academic medical center##3##3##(1992-2#1)(2008-3#1)(2010-12#1)
academic medical centers##6##3##(1994-12#1)(1995-3#1)(1996-1#3)(2011-2#1)
academic medical##11##2##(1991-1#2)(1992-2#1)(1994-12#1)(1995-3#1)(1996-1#3)(2008-3#1)(2010-12#1)(2011-2#1)
academic outcomes##3##2##(2008-12#1)(2009-7#1)(2011-1#1)
academic performance and##3##3##(2008-11#1)(2013-8#2)
academic performance##13##2##(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#1)(2013-8#9)
academic programs##2##2##(1993-1#1)(2008-11#1)
academic reputation and##2##3##(1996-1#2)
academic self-competence##2##2##(2009-7#2)
academic setting##3##2##(1992-1#1)(2008-11#1)(2010-1#1)
academic staff##3##2##(2008-11#2)(2008-12#1)
academic##166##1##(1990-2#2)(1991-1#2)(1991-2#1)(1991-8#1)(1992-1#2)(1992-2#1)(1993-1#2)(1993-6#2)(1994-12#3)(1994-3#4)(1995-2#1)(1995-3#2)(1996-1#9)(1996-2#1)(1996-3#3)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#7)(2008-11#28)(2008-12#33)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#4)(2009-7#8)(2010-1#13)(2010-12#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#12)
academically##4##1##(2008-11#1)(2008-12#1)(2010-1#2)
academicians##2##1##(1996-1#1)(1996-3#1)
academics and##3##2##(1993-12#1)(1995-12#1)(2008-11#1)
academics##9##1##(1993-12#1)(1995-12#1)(2008-11#5)(2008-12#1)(2009-7#1)
acalculous cholecystitis in##2##3##(1991-6#2)
acanthosis nigricans##2##2##(2008-4#1)(2012-12#1)
acarbose##10##1##(1994-12#9)(2010-11#1)
acaricide##2##1##(1997-5#1)(1997-7#1)
accelerate the development of##3##4##(2008-10#3)
accelerate the##23##2##(1994-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-5#1)(2010-8#1)
accelerate##35##1##(1994-8#1)(1995-2#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-3#1)
accelerated ageing processes##2##3##(2008-10#2)
accelerated ageing##3##2##(2008-10#3)
accelerated and##2##2##(1994-3#1)(2008-10#1)
accelerated atherosclerosis and##2##3##(2008-1#1)(2008-8#1)
accelerated atherosclerosis##3##2##(2008-1#1)(2008-3#1)(2008-8#1)
accelerated by##5##2##(2008-10#1)(2008-11#1)(2012-3#2)(2013-8#1)
accelerated in the presence of##3##5##(2008-10#1)(2008-11#1)(2008-9#1)
accelerated in##6##2##(1993-12#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-9#1)
accelerated solvent extraction (ASE)##3##4##(2008-10#3)
accelerated solvent extraction##5##3##(2008-10#5)
accelerated solvent##6##2##(2008-10#6)
accelerated stability under centrifugation##2##4##(2008-5#2)
accelerated the development##2##3##(2008-10#1)(2013-1#1)
accelerated the##13##2##(1992-3#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
accelerated##86##1##(1990-9#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#4)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
accelerates the##5##2##(2008-10#1)(2008-11#3)(2011-3#1)
accelerates##12##1##(1993-3#1)(1994-5#1)(2008-10#2)(2008-11#4)(2008-6#1)(2009-3#1)(2011-3#1)(2013-8#1)
accelerating effect##4##2##(2008-10#3)(2008-11#1)
accelerating the##4##2##(1995-2#1)(2008-10#1)(2010-10#1)(2011-1#1)
accelerating##24##1##(1991-1#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
acceleration c##2##2##(2010-8#2)
acceleration feedback control of##3##4##(2013-1#3)
acceleration feedback##4##2##(2013-1#4)
acceleration in##2##2##(2013-8#2)
acceleration of the##2##3##(2008-10#1)(2008-11#1)
acceleration of##9##2##(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
acceleration was##2##2##(2013-1#2)
acceleration##32##1##(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#3)(2013-1#9)(2013-8#4)
accelerator##9##1##(1990-12#1)(1992-12#1)(1993-9#1)(2008-2#1)(2009-11#4)(2010-11#1)
accelerometers##2##1##(2013-1#2)
accentuate##2##1##(2008-10#1)(2011-2#1)
accentuated by##3##2##(1992-12#1)(2008-10#1)(2013-1#1)
accentuated in##2##2##(1991-2#1)(2009-10#1)
accentuated##7##1##(1991-2#1)(1992-12#1)(2008-10#1)(2008-7#2)(2009-10#1)(2013-1#1)
accentuation of ethanol-induced motor impairment by##2##6##(1997-2#2)
accentuation of##4##2##(1997-2#4)
accentuation##6##1##(1997-2#6)
accept a##2##2##(2008-8#2)
accept the##8##2##(1992-3#1)(1994-9#1)(1995-11#1)(1996-6#1)(2008-10#3)(2008-11#1)
accept##27##1##(1990-6#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-2#1)(1994-9#1)(1995-11#2)(1995-5#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2010-8#1)
acceptability and representativeness of##2##4##(2009-11#2)
acceptability and representativeness##3##3##(2009-11#3)
acceptability and##5##2##(2009-11#3)(2010-10#1)(2013-1#1)
acceptability of##8##2##(1994-2#1)(1995-1#1)(2008-8#2)(2009-11#1)(2011-2#1)(2013-1#2)
acceptability##24##1##(1992-1#1)(1992-12#2)(1994-2#1)(1995-1#1)(1997-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#4)(2010-10#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#3)
acceptable (10##2##2##(1991-8#2)
acceptable accuracy##3##2##(2008-10#3)
acceptable agreement with##2##3##(2008-10#2)
acceptable agreement##3##2##(2008-10#3)
acceptable and##6##2##(1994-2#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
acceptable for the##2##3##(1994-3#1)(2008-8#1)
acceptable for##8##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
acceptable in##2##2##(1996-3#1)(2008-10#1)
acceptable levels##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
acceptable limits##3##2##(2008-10#2)(2012-3#1)
acceptable means of##2##3##(1996-12#1)(1996-3#1)
acceptable practices##2##2##(2010-11#2)
acceptable range##5##2##(2008-10#4)(2008-11#1)
acceptable recoveries##3##2##(1997-2#1)(2008-10#2)
acceptable results##4##2##(2008-10#2)(2011-3#1)(2012-12#1)
acceptable sensory##2##2##(2010-7#1)(2011-2#1)
acceptable to##4##2##(1990-11#1)(1995-5#1)(2008-7#1)(2009-11#1)
acceptable treatment##2##2##(2008-11#1)(2013-1#1)
acceptable value##2##2##(2008-9#1)(2012-2#1)
acceptable##129##1##(1990-11#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-5#1)(1996-12#2)(1996-3#3)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#45)(2008-11#9)(2008-12#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-3#1)(2010-7#3)(2010-8#2)(2011-10#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
acceptance and##6##2##(1992-3#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-7#1)(2010-1#1)
acceptance limits##2##2##(2008-10#2)
acceptance of the##3##3##(1993-11#2)(2008-12#1)
acceptance of##14##2##(1990-6#1)(1993-11#2)(1993-12#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)
acceptance or##2##2##(2008-10#1)(2008-4#1)
acceptance##48##1##(1990-6#1)(1991-1#1)(1991-2#1)(1992-3#1)(1993-11#3)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-1#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-8#1)
accepted as a##6##3##(1990-9#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
accepted as the##3##3##(1993-12#1)(2008-11#1)(2008-9#1)
accepted as##13##2##(1990-9#1)(1993-12#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2011-1#2)(2013-1#1)
accepted at##2##2##(2008-11#1)(2012-2#1)
accepted by##13##2##(1990-6#1)(1991-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
accepted criteria##2##2##(1993-8#1)(1997-8#1)
accepted for##2##2##(2008-10#1)(2008-12#1)
accepted in##4##2##(2008-10#3)(2008-6#1)
accepted method##2##2##(2008-11#1)(2008-5#1)
accepted that##19##2##(1991-1#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-5#2)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#3)(2013-8#1)
accepted to##4##2##(1990-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
accepted##121##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#3)(1992-12#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#2)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#14)(2008-12#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#3)
accepting the##2##2##(1997-6#1)(2008-10#1)
accepting##10##1##(1993-11#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)
acceptor in##3##2##(1991-5#1)(1995-2#1)(2008-10#1)
acceptor is##2##2##(2008-10#1)(2010-7#1)
acceptor solution##3##2##(2008-10#3)
acceptor stream of##3##3##(2008-10#3)
acceptor stream##16##2##(2008-10#16)
acceptor was##2##2##(2008-10#2)
acceptor##56##1##(1991-5#1)(1992-10#1)(1993-11#1)(1994-5#2)(1995-2#1)(1995-6#1)(1996-5#2)(1997-3#1)(1997-4#1)(2008-10#37)(2008-11#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#2)(2011-2#1)
acceptor)##2##1##(2008-10#2)
acceptors and donors##2##3##(1992-12#1)(2008-10#1)
acceptors with##2##2##(1994-5#1)(2008-12#1)
acceptors##13##1##(1992-12#2)(1994-5#2)(2008-10#5)(2008-12#1)(2009-9#1)(2010-7#2)
accepts##2##1##(1991-3#1)(2013-1#1)
access a##2##2##(1995-2#1)(1996-2#1)
access and capacity issues##3##4##(1995-1#3)
access and capacity##4##3##(1995-1#4)
access and quality of care##2##5##(1997-2#1)(2012-2#1)
access and quality##7##3##(1995-12#2)(1997-2#4)(2012-2#1)
access and satisfaction##2##3##(1995-12#2)
access and use of##2##4##(2010-8#1)(2013-1#1)
access and utilization##2##3##(1994-1#1)(1994-2#1)
access and##25##2##(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#4)(1995-12#4)(1996-5#1)(1997-2#4)(2008-11#3)(2010-8#3)(2012-2#1)(2013-1#1)
access can##3##2##(2011-2#3)
access control##3##2##(2010-8#3)
access for coronary##2##3##(2008-11#1)(2011-2#1)
access for##11##2##(1991-6#2)(1994-2#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2011-2#3)(2013-8#1)
access from the##2##3##(1995-12#1)(2011-2#1)
access in##7##2##(1997-2#2)(2008-12#1)(2009-5#1)(2011-2#2)(2013-1#1)
access is##5##2##(1991-12#1)(1994-2#1)(1995-12#1)(2011-2#1)(2012-2#1)
access management##2##2##(1994-2#2)
access of##8##2##(1993-8#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-4#1)(2009-8#1)(2011-2#1)
access period of##2##3##(2008-10#2)
access period##8##2##(2008-10#8)
access periods##5##2##(2008-10#5)
access retroperitoneoscopic adrenalectomy##3##3##(2012-12#3)
access retroperitoneoscopic##5##2##(2012-12#5)
access route##2##2##(1990-9#1)(2011-2#1)
access services##2##2##(1995-2#1)(2010-8#1)
access site complications##5##3##(2011-2#5)
access site##8##2##(2011-2#8)
access technique##2##2##(2008-11#1)(2011-2#1)
access the##5##2##(1996-1#1)(2008-1#1)(2008-10#2)(2010-5#1)
access through a##2##3##(2007-9#1)(2008-7#1)
access to a doctor or clinic##2##6##(2009-5#2)
access to a range of##2##5##(2008-11#2)
access to a##9##3##(1991-12#1)(1993-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-5#2)
access to and experiences##2##4##(1997-3#1)(2008-12#1)
access to and use of##2##5##(1994-12#1)(2008-12#1)
access to and##7##3##(1994-1#1)(1994-12#1)(1997-3#2)(2008-1#1)(2008-12#2)
access to care for Medicare beneficiaries##2##6##(1992-12#1)(1995-12#1)
access to care for##4##4##(1992-12#1)(1995-12#1)(1997-2#1)(2013-8#1)
access to care##13##3##(1992-12#1)(1994-1#1)(1995-12#5)(1996-3#3)(1997-2#1)(1997-4#1)(2013-8#1)
access to emergency##2##3##(1997-8#1)(2008-6#1)
access to health care##7##4##(1994-2#2)(1995-12#2)(2008-11#2)(2012-2#1)
access to health services##3##4##(1992-2#2)(2008-11#1)
access to health##11##3##(1992-2#2)(1994-2#2)(1995-12#2)(2008-11#3)(2008-6#1)(2012-2#1)
access to hospice care by##2##5##(1993-12#2)
access to hospice care##3##4##(1993-12#3)
access to kidney transplantation##2##4##(1995-12#2)
access to learning resources##2##4##(2008-11#2)
access to learning##3##3##(2008-11#3)
access to medical care##2##4##(1996-5#1)(1997-3#1)
access to nursing homes##2##4##(1994-12#1)(1995-1#1)
access to services and##2##4##(1993-1#1)(1997-5#1)
access to services##4##3##(1993-1#1)(1994-1#1)(1997-5#1)(2009-6#1)
access to specialty##2##3##(1994-3#1)(1997-2#1)
access to the process##2##4##(2012-2#2)
access to the##27##3##(1990-2#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-4#1)(1993-6#1)(1994-5#1)(1996-2#1)(1997-6#1)(2007-12#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
access to treatment##2##3##(2008-10#1)(2013-1#1)
access to universal##2##3##(2008-11#2)
access to##169##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#2)(1992-12#3)(1992-2#3)(1992-4#2)(1993-1#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#1)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#14)(1996-2#2)(1996-3#5)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-12#1)(2007-9#2)(2008-1#3)(2008-10#12)(2008-11#22)(2008-12#7)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#2)(2009-6#2)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#3)
access##371##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#3)(1991-1#1)(1991-12#3)(1991-3#3)(1991-6#2)(1992-12#5)(1992-2#5)(1992-4#2)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#7)(1993-6#1)(1993-8#1)(1994-1#7)(1994-12#3)(1994-2#10)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#7)(1995-12#25)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#4)(1996-3#5)(1996-5#2)(1997-1#2)(1997-2#13)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-12#1)(2007-9#3)(2008-1#5)(2008-10#35)(2008-11#36)(2008-12#16)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#6)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#7)(2011-1#1)(2011-2#42)(2011-3#2)(2012-12#10)(2012-2#10)(2012-3#4)(2013-1#13)(2013-8#4)
accessed by##4##2##(1991-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
accessed##15##1##(1991-12#1)(1991-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)
accesses to##2##2##(2008-10#1)(2008-3#1)
accesses##4##1##(1992-2#1)(2008-10#1)(2008-3#1)(2009-5#1)
accessibility and##2##2##(1994-6#1)(1996-1#1)
accessibility in##2##2##(2012-2#1)(2012-3#1)
accessibility of the##3##3##(2008-10#2)(2012-3#1)
accessibility of##10##2##(1993-12#1)(1995-8#1)(2008-10#3)(2008-11#1)(2012-2#2)(2012-3#2)
accessibility to the##2##3##(1991-5#1)(2008-7#1)
accessibility to##3##2##(1991-5#1)(1992-3#1)(2008-7#1)
accessibility##32##1##(1990-2#1)(1991-5#1)(1992-1#2)(1992-3#1)(1993-12#3)(1994-6#1)(1995-8#1)(1996-1#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-7#1)(2009-3#2)(2009-5#1)(2012-2#4)(2012-3#3)
accessible and##5##2##(1993-11#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
accessible surface##2##2##(1997-2#1)(2008-11#1)
accessible through the##2##3##(2008-10#1)(2012-3#1)
accessible through##3##2##(1991-12#1)(2008-10#1)(2012-3#1)
accessible to the##5##3##(2008-10#2)(2008-7#1)(2013-1#1)(2013-8#1)
accessible to##14##2##(1990-2#1)(1993-11#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
accessible transit vehicles##2##3##(2013-1#2)
accessible via##2##2##(1997-2#1)(2008-2#1)
accessible##62##1##(1990-11#1)(1990-2#1)(1991-12#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#2)(1995-1#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-2#4)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#1)(2010-12#1)(2010-7#3)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
accessing the##4##2##(1996-5#1)(2008-12#1)(2012-12#1)(2012-3#1)
accessing##15##1##(1996-5#1)(1997-2#1)(1997-3#1)(2008-11#3)(2008-12#2)(2008-4#1)(2009-10#2)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
accession number##5##2##(1996-8#1)(2008-10#1)(2008-8#2)(2008-9#1)
accession were##2##2##(2008-10#2)
accession##22##1##(1996-8#1)(2008-10#16)(2008-8#2)(2008-9#1)(2012-3#2)
accessions CIho 14300##2##3##(2008-10#2)
accessions CIho##3##2##(2008-10#3)
accessions from the U##2##4##(2008-10#2)
accessions from the##3##3##(2008-10#3)
accessions from##4##2##(2008-10#4)
accessions of##4##2##(2008-10#4)
accessions was##3##2##(2008-10#3)
accessions were susceptible##2##3##(2008-10#2)
accessions were##7##2##(2008-10#7)
accessions##49##1##(2008-10#47)(2012-3#2)
accessories for##2##2##(1995-2#1)(2013-8#1)
accessories##4##1##(1995-2#1)(2008-9#2)(2013-8#1)
accessory bodies##2##2##(2008-7#2)
accessory cells##2##2##(1995-2#1)(2008-11#1)
accessory channel##2##2##(2013-1#2)
accessory genome##2##2##(2011-2#2)
accessory glands ofAllacma##2##3##(2008-7#2)
accessory glands##6##2##(2007-12#2)(2008-7#4)
accessory metatarsal located between the left fourth and fifth metatarsals##2##10##(2010-3#2)
accessory metatarsal##3##2##(2010-3#3)
accessory muscle##2##2##(2012-2#2)
accessory nerve##7##2##(2008-7#6)(2008-9#1)
accessory nuclei##3##2##(2007-12#2)(2008-7#1)
accessory pathway was##4##3##(1993-2#1)(2008-11#3)
accessory pathway##10##2##(1993-2#1)(2008-11#9)
accessory plantaris muscles##2##3##(2012-2#2)
accessory plantaris##4##2##(2012-2#4)
accessory protein##4##2##(1997-3#3)(2011-1#1)
accessory proteins##2##2##(2009-9#1)(2012-2#1)
accessory salivary glands##2##3##(2008-10#2)
accessory sex##2##2##(1991-5#1)(2008-10#1)
accessory##67##1##(1991-5#1)(1992-3#1)(1993-2#1)(1995-2#3)(1997-3#4)(2007-12#7)(2008-10#6)(2008-11#10)(2008-7#13)(2008-9#2)(2009-10#1)(2009-9#1)(2010-3#3)(2011-1#1)(2011-2#3)(2012-2#7)(2013-1#3)
accident and emergency##2##3##(1991-3#1)(2011-2#1)
accident and##5##2##(1991-3#1)(1997-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
accident databases##2##2##(2009-10#2)
accident or##2##2##(2008-12#1)(2008-7#1)
accident prevention##2##2##(1995-1#1)(2008-11#1)
accident risk##3##2##(2008-11#1)(2010-7#2)
accident##43##1##(1990-5#1)(1990-9#3)(1991-12#2)(1991-3#1)(1994-2#1)(1995-1#1)(1995-11#3)(1995-12#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-4#1)(2008-7#2)(2009-10#8)(2009-4#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
accidental and##2##2##(2008-10#1)(2008-11#1)
accidental ingestion of##2##3##(2007-12#1)(2011-2#1)
accidental injuries##2##2##(2008-11#2)
accidental or##2##2##(1992-2#1)(2008-10#1)
accidental pollution##2##2##(1994-3#1)(2008-11#1)
accidental##37##1##(1992-2#1)(1994-3#1)(1995-11#3)(1995-2#1)(1996-8#1)(2007-12#1)(2008-10#5)(2008-11#13)(2008-12#1)(2008-9#3)(2009-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
accidentally##4##1##(1991-3#1)(1991-6#2)(2008-9#1)
accidents and##5##2##(1990-6#1)(1991-3#1)(2008-11#1)(2009-10#1)(2011-2#1)
accidents in the##2##3##(1996-12#1)(2009-10#1)
accidents in##4##2##(1990-9#1)(1996-12#1)(2009-10#2)
accidents were##2##2##(2008-11#1)(2009-10#1)
accidents##40##1##(1990-6#2)(1990-9#3)(1991-3#3)(1996-11#1)(1996-12#2)(1996-2#2)(2008-11#3)(2008-7#2)(2009-10#14)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)
acclimated to tomato##2##3##(2008-8#2)
acclimated to##3##2##(2008-7#1)(2008-8#2)
acclimated##4##1##(2008-7#1)(2008-8#2)(2011-2#1)
acclimation of##3##2##(2008-7#1)(2012-5#2)
acclimation##14##1##(2008-12#1)(2008-7#5)(2008-8#2)(2012-5#3)(2012-9#1)(2013-8#2)
accommodate a##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
accommodate the##6##2##(1994-3#2)(2009-8#1)(2011-3#1)(2013-8#2)
accommodate##39##1##(1992-1#1)(1992-2#1)(1992-3#1)(1993-8#2)(1994-1#1)(1994-3#3)(1995-6#2)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#2)(2010-11#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#2)
accommodated in the##2##3##(2008-8#1)(2010-3#1)
accommodated##12##1##(1997-3#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
accommodating##3##1##(1996-5#1)(2008-11#2)
accommodation of##3##2##(1990-3#1)(1995-12#1)(2008-10#1)
accommodation##10##1##(1990-3#2)(1995-12#1)(1995-6#3)(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
accommodations##4##1##(1992-12#1)(1993-3#1)(1995-12#1)(2008-9#1)
accompagnée##2##1##(2011-2#1)(2013-1#1)
accompanied by a decrease in the##2##6##(1991-5#1)(2008-10#1)
accompanied by a decrease in##5##5##(1991-5#1)(1992-8#1)(1994-3#1)(2008-10#1)(2009-7#1)
accompanied by a##28##3##(1991-5#1)(1992-8#1)(1994-11#2)(1994-3#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#3)(2013-8#1)
accompanied by an increase in the##3##6##(1992-6#1)(2008-10#1)(2011-2#1)
accompanied by an increase in##6##5##(1992-6#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
accompanied by an##12##3##(1992-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
accompanied by changes in##4##4##(1993-8#1)(1995-3#1)(2008-9#1)(2010-4#1)
accompanied by considerable##2##3##(2007-12#1)(2008-10#1)
accompanied by diabetic ketoacidosis##2##4##(2011-1#2)
accompanied by diabetic##3##3##(2011-1#2)(2012-12#1)
accompanied by direct##2##3##(2008-11#2)
accompanied by enhanced##2##3##(2011-1#2)
accompanied by increased##4##3##(1992-12#1)(1994-3#1)(2008-8#1)(2012-2#1)
accompanied by multiple##2##3##(2008-11#1)(2008-8#1)
accompanied by the development of##2##5##(2010-3#1)(2012-3#1)
accompanied by the formation of##2##5##(1994-3#1)(2009-8#1)
accompanied by the##10##3##(1994-3#1)(2008-10#2)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
accompanied by##141##2##(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#3)(2008-10#23)(2008-11#13)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#7)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#5)
accompanied with a##2##3##(1997-1#1)(2011-2#1)
accompanied with##12##2##(1995-8#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)
accompanied##159##1##(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#2)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#3)(2008-10#29)(2008-11#15)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#7)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#5)
accompanies the##4##2##(1993-6#1)(1995-2#1)(2008-10#1)(2008-12#1)
accompanies##10##1##(1991-6#1)(1993-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-7#1)
accompany the##2##2##(2008-4#1)(2008-7#1)
accompany##10##1##(1990-3#1)(1994-5#1)(1994-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-2#1)
accompanying paper##4##2##(1995-11#1)(1995-2#1)(2008-3#2)
accompanying the##4##2##(1990-11#1)(1997-3#1)(2008-10#2)
accompanying##41##1##(1990-11#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-1#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-7#1)
accomplish the##4##2##(2008-10#3)(2013-1#1)
accomplish this##7##2##(1992-12#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)
accomplish##22##1##(1991-1#1)(1992-1#1)(1992-12#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#6)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#2)
accomplished by a##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
accomplished by using##5##3##(2008-10#5)
accomplished by##46##2##(1990-9#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-5#2)(1997-6#1)(2008-10#20)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#3)(2011-2#2)(2012-3#1)
accomplished in a##2##3##(2008-2#1)(2008-3#1)
accomplished in less than##2##4##(2008-10#2)
accomplished in##10##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-3#1)
accomplished using a##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
accomplished using##14##2##(1993-2#1)(2008-10#10)(2008-11#1)(2008-5#2)
accomplished via##2##2##(1993-3#1)(2008-10#1)
accomplished with a##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
accomplished with low##2##3##(1995-1#1)(2008-10#1)
accomplished with the##2##3##(2008-10#1)(2008-11#1)
accomplished with##14##2##(1992-2#1)(1995-1#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)
accomplished##113##1##(1990-9#1)(1991-2#1)(1991-6#1)(1992-2#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-6#1)(2007-11#1)(2008-10#55)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-4#2)(2011-2#4)(2012-3#2)
accomplishing this##2##2##(1991-3#1)(2008-9#1)
accomplishing##6##1##(1991-3#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
accomplishments and##5##2##(1995-12#1)(1997-2#1)(2008-4#3)
accomplishments##8##1##(1991-1#1)(1995-12#2)(1997-2#2)(2008-4#3)
accord with##9##2##(1991-6#1)(1991-9#3)(1992-6#1)(2008-10#1)(2008-9#3)
accord##11##1##(1991-6#1)(1991-9#3)(1992-6#1)(1993-3#1)(2008-10#1)(2008-9#3)(2012-2#1)
accordance to the##2##3##(2008-11#1)(2013-1#1)
accordance with the##24##3##(1993-8#2)(1994-8#1)(1995-11#1)(1996-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
accordance with##42##2##(1990-3#2)(1990-5#1)(1993-8#2)(1994-8#1)(1995-11#1)(1996-11#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
accordance##46##1##(1990-3#2)(1990-5#1)(1993-8#2)(1994-8#1)(1995-11#1)(1996-11#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#3)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
accorded##4##1##(1994-9#1)(1995-1#1)(2009-12#1)(2013-8#1)
according the##2##2##(1991-3#1)(2010-8#1)
according to CD127##2##3##(2013-1#2)
according to DSM-IV##2##3##(1997-8#1)(2008-7#1)
according to a protocol##2##4##(1993-11#1)(2012-12#1)
according to a split-mouth design##2##5##(2013-1#2)
according to a##27##3##(1993-11#1)(1993-12#1)(1993-6#1)(1996-8#1)(1997-6#1)(2008-10#7)(2008-5#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#4)
according to age##4##3##(1992-12#1)(2008-7#1)(2008-9#1)(2009-9#1)
according to an##4##3##(2008-10#3)(2013-1#1)
according to clinical##2##3##(2008-5#1)(2013-1#1)
according to different##2##3##(1994-5#1)(2013-1#1)
according to disease##2##3##(1994-9#1)(2008-7#1)
according to four##2##3##(2009-1#1)(2013-8#1)
according to genotype##2##3##(2008-10#1)(2008-8#1)
according to guidelines##2##3##(1996-11#1)(2008-8#1)
according to internal##2##3##(2008-11#2)
according to its##2##3##(2008-10#1)(2008-8#1)
according to one##2##3##(1992-5#1)(2008-9#1)
according to risk##2##3##(2010-8#2)
according to species##2##3##(1991-3#1)(2008-8#1)
according to specific##2##3##(2008-11#1)(2011-7#1)
according to standard##5##3##(1990-12#1)(1997-2#1)(2008-12#1)(2008-7#1)(2010-11#1)
according to the WHO##2##4##(1990-12#1)(2008-10#1)
according to the age##2##4##(2008-10#1)(2012-3#1)
according to the amount##2##4##(1994-9#1)(2008-10#1)
according to the classification##2##4##(1990-3#1)(2011-2#1)
according to the compound##2##4##(2008-10#2)
according to the degree of##2##5##(2008-1#1)(2008-10#1)
according to the different##2##4##(2008-7#1)(2009-10#1)
according to the equation##2##4##(2008-10#2)
according to the extent of##2##5##(2008-10#2)
according to the latest##2##4##(1991-6#1)(1997-8#1)
according to the levels##2##4##(2008-10#1)(2010-8#1)
according to the location##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
according to the manufacturer's instructions##2##5##(1994-1#1)(2009-7#1)
according to the metal##2##4##(2008-10#2)
according to the method of##2##5##(1997-7#1)(2008-10#1)
according to the method used##2##5##(2008-10#1)(2013-1#1)
according to the method##4##4##(1997-7#1)(2008-10#2)(2013-1#1)
according to the modified##2##4##(1990-8#1)(2010-10#1)
according to the nature of##2##5##(2008-4#1)(2013-1#1)
according to the patient's##2##4##(2008-3#1)(2010-8#1)
according to the presence##2##4##(2008-7#1)(2010-6#1)
according to the schedule##2##4##(1991-6#1)(2013-1#1)
according to the sensitivity##2##4##(1995-11#1)(2008-10#1)
according to the severity##3##4##(1990-12#1)(2008-6#1)(2013-1#1)
according to the type of##5##5##(1993-11#1)(1993-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
according to the##190##3##(1990-12#3)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-12#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2008-1#1)(2008-10#73)(2008-11#4)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#10)(2013-1#7)(2013-8#3)
according to their age##3##4##(1990-8#1)(1994-3#1)(2011-2#1)
according to their isoelectric##2##4##(2008-12#1)(2008-4#1)
according to their metal content##2##5##(2008-10#2)
according to their mineral content##4##5##(2008-10#4)
according to their##52##3##(1990-8#1)(1990-9#1)(1991-6#1)(1993-1#1)(1993-12#1)(1994-3#1)(2008-10#20)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-3#3)(2013-1#3)
according to this##5##3##(1991-12#1)(1991-3#1)(1997-8#1)(2008-10#1)(2008-2#1)
according to time##2##3##(2008-5#2)
according to traditional##2##3##(2008-10#1)(2013-8#1)
according to treatment##2##3##(2010-12#1)(2011-2#1)
according to type of##2##4##(2010-6#1)(2011-2#1)
according to whether##2##3##(1990-6#1)(2013-1#1)
according to which the##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
according to which##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
according to##459##2##(1990-11#1)(1990-12#4)(1990-3#2)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#7)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#8)(2008-1#1)(2008-10#146)(2008-11#16)(2008-12#10)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#19)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#8)(2009-1#2)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#25)(2011-3#2)(2011-7#2)(2012-12#3)(2012-2#2)(2012-3#16)(2013-1#27)(2013-7#1)(2013-8#7)
according with the##2##3##(2008-10#2)
according with##3##2##(1993-2#1)(2008-10#2)
according##466##1##(1990-11#1)(1990-12#4)(1990-3#2)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#7)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#8)(2008-1#1)(2008-10#148)(2008-11#16)(2008-12#10)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#19)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#8)(2009-1#2)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#6)(2011-1#2)(2011-2#25)(2011-3#2)(2011-7#2)(2012-12#3)(2012-2#2)(2012-3#16)(2013-1#29)(2013-7#1)(2013-8#7)
accordingly##18##1##(1991-11#1)(1993-12#1)(1995-1#1)(1997-8#1)(2008-10#6)(2008-12#2)(2008-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2013-1#1)
account all##4##2##(1996-5#1)(2008-1#1)(2008-10#1)(2008-3#1)
account can##2##2##(2007-12#1)(2009-10#1)
account for a significant proportion of##2##6##(1993-3#1)(2010-12#1)
account for a##4##3##(1993-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
account for about##2##3##(1997-6#1)(2008-10#1)
account for any##2##3##(2008-3#1)(2008-9#1)
account for approximately 80 percent of##2##6##(1992-12#1)(2009-9#1)
account for approximately##4##3##(1992-12#1)(2008-12#1)(2009-9#1)(2011-2#1)
account for differences in##3##4##(1991-3#1)(2008-11#1)(2012-2#1)
account for more than##3##4##(1991-12#1)(1994-6#1)(1995-1#1)
account for most##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
account for multiple light scattering in##2##6##(2008-3#2)
account for multiple##3##3##(2008-3#3)
account for some of##3##4##(1991-12#1)(2008-4#1)(2008-8#1)
account for the influence of##2##5##(2008-10#1)(2011-2#1)
account for the majority of##2##5##(1996-3#1)(2008-7#1)
account for the reduced##2##4##(1991-11#1)(1996-12#1)
account for the##53##3##(1990-12#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-3#1)(1994-8#1)(1996-12#2)(1996-3#2)(1996-5#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
account for their##2##3##(1992-12#1)(2010-11#1)
account for these##2##3##(1991-11#1)(2008-5#1)
account for this##2##3##(1997-3#1)(2008-8#1)
account for trends in##2##4##(1992-9#1)(1996-3#1)
account for##128##2##(1990-12#2)(1990-6#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#3)(1992-3#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#23)(2008-11#8)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#11)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
account is##3##2##(1994-3#1)(1997-7#1)(2013-8#1)
account of a##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
account of the existing detection protocols for##2##7##(2008-10#2)
account of the##21##3##(1990-3#1)(1992-2#1)(1992-5#1)(1995-2#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-1#1)(2010-7#1)
account of##38##2##(1990-12#2)(1990-3#1)(1990-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#2)
account the##43##2##(1990-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-5#2)(1996-1#1)(1997-2#1)(2008-10#15)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#2)(2011-3#1)(2012-3#1)
account##313##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-12#7)(2008-1#1)(2008-10#71)(2008-11#25)(2008-12#5)(2008-2#2)(2008-3#21)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#15)(2008-9#4)(2009-10#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#18)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#7)
accountability and##5##2##(1993-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(2009-6#1)
accountability for##5##2##(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-6#1)
accountability systems##2##2##(1996-12#1)(2012-2#1)
accountability##26##1##(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#1)(2008-11#2)(2008-6#2)(2008-9#1)(2009-6#1)(2012-2#2)(2013-8#1)
accountable##7##1##(1993-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-11#2)
accountants##3##1##(1993-1#1)(1994-1#2)
accounted for 24##2##3##(2008-10#1)(2010-11#1)
accounted for 85% of##2##4##(1990-8#1)(2008-10#1)
accounted for a##5##3##(2008-10#4)(2008-9#1)
accounted for all##2##3##(1991-12#1)(2008-10#1)
accounted for an##3##3##(1991-2#1)(2008-12#1)(2010-5#1)
accounted for by electrode discrimination ability##2##6##(2008-9#2)
accounted for by##13##3##(1990-10#1)(1990-5#1)(1994-3#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-9#2)(2009-5#1)(2011-2#1)
accounted for greater than##2##4##(1990-5#1)(1994-8#1)
accounted for in the##2##4##(2008-3#1)(2009-5#1)
accounted for in##5##3##(2008-3#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-6#1)
accounted for less than##2##4##(1993-2#1)(2008-10#1)
accounted for more than 70% of the##2##7##(2008-10#1)(2008-8#1)
accounted for only##3##3##(1992-5#1)(1997-7#1)(2010-5#1)
accounted for over##2##3##(1994-3#1)(1997-2#1)
accounted for the largest##2##4##(2008-10#2)
accounted for the##8##3##(1993-3#1)(2008-10#6)(2013-8#1)
accounted for using##2##3##(2008-10#2)
accounted for##95##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#3)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-8#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#32)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-5#2)(2010-11#2)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
accounted##96##1##(1990-10#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#3)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-8#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#32)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-5#2)(2010-11#2)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
accounting for approximately 20% of##2##5##(1995-6#1)(2013-1#1)
accounting for approximately##6##3##(1995-6#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
accounting for the free energy contribution from solvent relaxation##2##9##(2013-1#2)
accounting for the##11##3##(1993-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-1#1)(2009-4#1)(2011-3#1)(2012-2#1)(2013-1#2)
accounting for##47##2##(1992-3#1)(1992-9#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#2)
accounting on##2##2##(1993-2#1)(2008-11#1)
accounting rules##2##2##(1992-3#1)(1997-3#1)
accounting##59##1##(1992-3#2)(1992-9#1)(1993-1#1)(1993-2#4)(1993-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
accounts for 0##2##3##(1991-6#2)
accounts for 90% of##2##4##(1991-3#1)(2008-12#1)
accounts for a##4##3##(1992-12#1)(1993-3#1)(2010-3#1)(2013-8#1)
accounts for about##2##3##(2008-10#1)(2008-9#1)
accounts for approximately##4##3##(2009-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
accounts for only##2##3##(2009-8#1)(2012-12#1)
accounts for the invariant and dominant property##2##7##(2012-2#2)
accounts for the##18##3##(1991-8#1)(1992-10#2)(1992-12#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-2#2)(2013-8#1)
accounts for##56##2##(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#2)(1992-12#2)(1992-9#1)(1993-3#1)(1993-6#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#4)
accounts of##8##2##(1995-1#1)(2008-10#1)(2008-12#1)(2010-2#1)(2010-3#2)(2011-1#1)(2013-8#1)
accounts##82##1##(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#2)(1992-12#2)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#5)
accreditation as an##2##3##(1992-1#1)(1995-3#1)
accreditation as##3##2##(1992-1#1)(1995-3#2)
accreditation in##2##2##(1995-3#2)
accreditation##20##1##(1992-1#2)(1993-2#3)(1994-12#1)(1995-1#1)(1995-3#6)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-2#2)
accredited schools of public health##2##5##(1997-3#2)
accredited##10##1##(1994-12#2)(1997-3#3)(2008-11#3)(2011-2#2)
accrediting agencies##2##2##(1995-3#1)(2011-2#1)
accrediting local##2##2##(1997-2#2)
accrediting##5##1##(1995-3#2)(1997-2#2)(2011-2#1)
accretive##2##1##(2008-5#2)
accrual to##2##2##(2008-11#1)(2010-10#1)
accrual##5##1##(2008-11#1)(2010-10#2)(2013-1#2)
accrued##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
acculturation##10##1##(2009-7#6)(2012-2#4)
accumbens (NAc)##2##2##(2008-7#1)(2009-8#1)
accumbens##40##1##(1993-6#18)(1994-2#4)(1994-3#2)(1994-8#4)(1995-2#2)(1996-12#2)(1996-5#2)(1997-3#3)(2008-7#2)(2009-8#1)
accumulate and##2##2##(2008-11#1)(2008-9#1)
accumulate in the##8##3##(1992-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-2#1)
accumulate in##15##2##(1992-12#1)(1994-8#1)(2008-10#4)(2008-11#5)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#1)
accumulate##55##1##(1991-12#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-2#1)(1996-6#1)(2008-10#20)(2008-11#7)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#1)
accumulated after##3##2##(2008-10#3)
accumulated and the##3##3##(2008-10#3)
accumulated at##5##2##(2008-10#5)
accumulated by##5##2##(1990-5#1)(1997-1#1)(2008-10#2)(2008-8#1)
accumulated during##2##2##(2008-6#1)(2011-2#1)
accumulated high levels of phytoene##2##5##(1995-2#2)
accumulated high levels of##3##4##(1995-2#3)
accumulated in a##2##3##(1995-8#1)(2008-10#1)
accumulated in the##8##3##(1990-12#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2012-8#1)
accumulated in##23##2##(1990-12#1)(1994-3#1)(1995-8#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2012-8#1)
accumulated more##5##2##(2008-10#4)(2008-12#1)
accumulated on a##2##3##(2008-10#2)
accumulated on the##3##3##(1991-11#1)(2008-10#2)
accumulated on##5##2##(1991-11#1)(2008-10#4)
accumulated over the##2##3##(2008-2#1)(2008-9#1)
accumulated over##3##2##(1994-3#1)(2008-2#1)(2008-9#1)
accumulated rainfall##2##2##(2008-10#2)
accumulated that##2##2##(2008-1#1)(2009-8#1)
accumulated the##2##2##(1992-3#1)(2008-10#1)
accumulated to a##2##3##(2008-10#1)(2008-7#1)
accumulated to##5##2##(1992-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
accumulated##139##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1992-3#3)(1993-12#3)(1993-6#1)(1993-8#1)(1994-3#4)(1994-6#1)(1995-2#3)(1995-8#1)(1997-1#4)(1997-3#1)(2008-1#1)(2008-10#61)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
accumulates as##2##2##(1993-9#1)(2008-10#1)
accumulates in the##2##3##(1995-6#1)(2008-3#1)
accumulates in##3##2##(1995-6#1)(2008-10#1)(2008-3#1)
accumulates##15##1##(1993-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#2)(2013-8#1)
accumulating evidence##2##2##(2008-7#1)(2009-8#1)
accumulating in the##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
accumulating##19##1##(2008-10#7)(2008-11#3)(2008-7#2)(2009-8#1)(2011-2#4)(2012-3#1)(2013-1#1)
accumulation after##2##2##(2008-10#2)
accumulation and antagonistic##2##3##(2008-12#1)(2008-9#1)
accumulation and voltammetric##2##3##(2008-10#2)
accumulation and##32##2##(1990-2#2)(1990-8#1)(1991-5#1)(1994-11#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-8#1)
accumulation at +0##2##3##(2008-10#2)
accumulation at the##2##3##(2008-10#2)
accumulation at##8##2##(1997-1#1)(2008-10#6)(2011-2#1)
accumulation by##4##2##(1990-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
accumulation can##2##2##(1996-12#1)(2008-10#1)
accumulation during the early##2##4##(2008-10#2)
accumulation during##8##2##(2008-10#6)(2008-7#1)(2011-2#1)
accumulation in a##4##3##(2008-10#3)(2008-9#1)
accumulation in grain and##2##4##(2008-10#2)
accumulation in grain##5##3##(2008-10#5)
accumulation in the##7##3##(1994-11#1)(2008-10#2)(2008-12#1)(2009-12#1)(2012-7#1)(2013-8#1)
accumulation in##55##2##(1990-12#1)(1994-11#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-10#32)(2008-11#1)(2008-12#2)(2008-9#2)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-4#1)(2012-7#1)(2012-8#1)(2013-8#2)
accumulation induced by##4##3##(1991-6#2)(1994-11#1)(1997-1#1)
accumulation is a##2##3##(1994-11#1)(2008-8#1)
accumulation is the##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
accumulation is##7##2##(1994-11#1)(2008-10#2)(2008-8#2)(2011-2#1)(2012-3#1)
accumulation occurred in resistant##2##4##(1994-8#1)(2008-10#1)
accumulation occurred in##3##3##(1994-8#1)(2008-10#2)
accumulation of Cr(3+)##2##3##(2008-10#2)
accumulation of PRms##2##3##(2008-10#2)
accumulation of a##5##3##(1995-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
accumulation of ammonia##3##3##(2008-10#2)(2008-11#1)
accumulation of cells in##2##4##(2008-11#1)(2008-9#1)
accumulation of cells##3##3##(1995-2#1)(2008-11#1)(2008-9#1)
accumulation of defense##2##3##(2008-10#1)(2011-2#1)
accumulation of genetic##2##3##(2011-2#2)
accumulation of inositol##3##3##(1993-6#2)(1997-1#1)
accumulation of intracellular##2##3##(2008-7#1)(2008-9#1)
accumulation of labeled IP4 or##2##5##(1997-1#2)
accumulation of labeled IP4##5##4##(1997-1#5)
accumulation of labeled inositol mono-##2##5##(1997-1#2)
accumulation of labeled##7##3##(1997-1#7)
accumulation of long chain##2##4##(1995-6#2)
accumulation of metal ions##2##4##(2008-10#2)
accumulation of p53##3##3##(1997-7#3)
accumulation of phenolic compounds##2##4##(2008-10#2)
accumulation of the complex##2##4##(2008-10#2)
accumulation of the##21##3##(1997-7#1)(2008-10#16)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
accumulation of zinc##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
accumulation of##207##2##(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-6#9)(1995-8#1)(1996-11#1)(1997-1#9)(1997-2#1)(1997-3#1)(1997-7#6)(1997-8#1)(2008-1#1)(2008-10#83)(2008-11#12)(2008-12#6)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
accumulation ofcells in##2##3##(2008-11#2)
accumulation on##2##2##(2008-10#1)(2008-7#1)
accumulation or##2##2##(2008-10#2)
accumulation period##3##2##(2008-10#3)
accumulation potential and time##2##4##(2008-10#2)
accumulation potential and##5##3##(2008-10#5)
accumulation potential of -0##7##4##(2008-10#7)
accumulation potential of##9##3##(2008-10#9)
accumulation potential##24##2##(2008-10#24)
accumulation step##2##2##(2008-10#2)
accumulation time and potential##3##4##(2008-10#3)
accumulation time of 60 s##2##5##(2008-10#2)
accumulation time of##7##3##(2008-10#7)
accumulation time##30##2##(2008-10#30)
accumulation under##3##2##(2008-6#1)(2008-8#2)
accumulation was detected##2##3##(2008-10#2)
accumulation was##22##2##(1994-5#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-7#4)(2008-8#1)
accumulation were##2##2##(1997-2#1)(2008-7#1)
accumulation with##2##2##(2008-10#2)
accumulation within##2##2##(1991-12#1)(2012-2#1)
accumulation##538##1##(1990-12#1)(1990-2#3)(1990-5#4)(1990-8#4)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-6#2)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#9)(1994-12#1)(1994-2#2)(1994-5#7)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-6#11)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1997-1#16)(1997-2#3)(1997-3#2)(1997-7#6)(1997-8#1)(2008-1#2)(2008-10#278)(2008-11#29)(2008-12#12)(2008-5#1)(2008-6#2)(2008-7#20)(2008-8#15)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#15)(2012-2#5)(2012-3#7)(2012-4#3)(2012-7#1)(2012-8#2)(2013-1#8)(2013-8#5)
accumulation)##2##1##(2008-10#2)
accumulations in##2##2##(1997-3#1)(2013-1#1)
accumulations of##4##2##(1997-1#1)(1997-3#1)(2008-10#1)(2008-7#1)
accumulations##8##1##(1997-1#1)(1997-3#2)(2008-10#3)(2008-7#1)(2013-1#1)
accumulator##2##1##(2009-8#2)
accuracies of##6##2##(2008-10#3)(2008-3#1)(2012-2#1)(2013-1#1)
accuracies##9##1##(2008-10#5)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
accuracy (mean##2##2##(2008-10#1)(2011-2#1)
accuracy 82##2##2##(2010-7#2)
accuracy and precision for##3##4##(2008-10#2)(2008-3#1)
accuracy and precision of the determination##2##6##(2008-10#2)
accuracy and precision of the##5##5##(2008-10#5)
accuracy and precision of##11##4##(2008-10#11)
accuracy and precision was##2##4##(2008-10#2)
accuracy and precision were##3##4##(2008-10#2)(2011-3#1)
accuracy and precision##47##3##(2008-10#44)(2008-3#2)(2011-3#1)
accuracy and reduce##2##3##(1997-2#1)(2012-3#1)
accuracy and reproducibility##4##3##(2008-10#3)(2008-9#1)
accuracy and robustness##2##3##(2008-10#1)(2008-6#1)
accuracy and the precision##2##4##(2008-10#2)
accuracy and the reproducibility of the##2##6##(2008-10#1)(2010-7#1)
accuracy and the##8##3##(1990-2#1)(2008-10#5)(2010-7#1)(2010-8#1)
accuracy and##88##2##(1990-2#1)(1991-3#1)(1997-2#1)(1997-7#1)(2008-10#65)(2008-11#1)(2008-12#1)(2008-3#5)(2008-6#1)(2008-9#1)(2009-12#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-3#2)
accuracy are##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
accuracy as##4##2##(1997-6#1)(2008-10#1)(2013-1#2)
accuracy by use of a##2##5##(2008-3#2)
accuracy by##7##2##(1995-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
accuracy can be obtained##2##4##(2008-10#2)
accuracy can##3##2##(2008-10#2)(2008-8#1)
accuracy for the determination of##2##5##(2008-10#2)
accuracy for the##3##3##(2008-10#3)
accuracy for##11##2##(1992-2#1)(1994-12#1)(2008-10#6)(2008-3#1)(2012-3#2)
accuracy from##2##2##(2008-10#2)
accuracy has##2##2##(2008-10#1)(2008-7#1)
accuracy in a given##2##4##(2008-3#1)(2012-3#1)
accuracy in the##5##3##(1990-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2009-10#1)
accuracy in##18##2##(1990-5#1)(1991-2#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-12#1)(2012-3#1)
accuracy is##7##2##(2008-10#1)(2008-3#3)(2008-6#1)(2013-1#2)
accuracy of a##4##3##(1992-3#1)(2008-7#1)(2010-11#1)(2013-1#1)
accuracy of an##2##3##(2008-10#1)(2012-2#1)
accuracy of analysis##2##3##(2008-10#2)
accuracy of better than##3##4##(2008-10#1)(2008-3#2)
accuracy of the analysis##3##4##(2008-10#2)(2012-2#1)
accuracy of the analytical##2##4##(2008-10#2)
accuracy of the determination of##2##5##(2008-10#2)
accuracy of the determinations##2##4##(2008-10#2)
accuracy of the developed method##8##5##(2008-10#8)
accuracy of the developed##13##4##(2008-10#13)
accuracy of the method##20##4##(2008-10#20)
accuracy of the methods##3##4##(2008-10#3)
accuracy of the procedure was##2##5##(2008-10#2)
accuracy of the procedure##3##4##(2008-10#2)(2010-5#1)
accuracy of the proposed method##10##5##(2008-10#10)
accuracy of the proposed procedure was##2##6##(2008-10#2)
accuracy of the proposed procedure##3##5##(2008-10#3)
accuracy of the proposed##15##4##(2008-10#15)
accuracy of the results##4##4##(2008-10#3)(2008-3#1)
accuracy of the technique##6##4##(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-12#1)
accuracy of the##110##3##(1992-2#1)(1993-1#1)(1993-5#1)(1995-11#1)(1996-6#1)(2007-12#1)(2008-10#80)(2008-11#1)(2008-2#1)(2008-3#11)(2008-6#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#2)
accuracy of this##4##3##(2008-3#1)(2008-6#1)(2013-1#2)
accuracy of##218##2##(1990-9#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-11#1)(1996-6#1)(1997-6#1)(2007-12#2)(2008-10#115)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#22)(2008-5#1)(2008-6#6)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#3)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#8)(2013-8#3)
accuracy on##2##2##(1993-3#1)(2008-10#1)
accuracy only improved in the moderate category##2##7##(2013-1#2)
accuracy or##3##2##(2008-11#2)(2008-8#1)
accuracy over the##3##3##(2008-10#1)(2008-6#1)(2010-8#1)
accuracy over##4##2##(2008-10#2)(2008-6#1)(2010-8#1)
accuracy profiles##2##2##(2008-10#2)
accuracy study##2##2##(2008-12#1)(2013-8#1)
accuracy than##4##2##(2008-10#3)(2008-9#1)
accuracy that##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
accuracy the##2##2##(2008-10#1)(2008-7#1)
accuracy to##2##2##(2010-8#1)(2011-2#1)
accuracy using##2##2##(2008-10#2)
accuracy was accessed by##2##4##(2008-10#1)(2008-7#1)
accuracy was assessed by##2##4##(2008-10#2)
accuracy was assessed through recovery##4##5##(2008-10#4)
accuracy was assessed##7##3##(2008-10#7)
accuracy was evaluated by##2##4##(2008-10#2)
accuracy was evaluated##3##3##(2008-10#3)
accuracy was studied##2##3##(2008-10#2)
accuracy was##34##2##(1990-6#1)(1997-8#1)(2008-10#27)(2008-6#2)(2008-7#1)(2009-4#1)(2010-7#1)
accuracy were##4##2##(2008-10#3)(2012-12#1)
accuracy with which##2##3##(2009-11#1)(2011-2#1)
accuracy with##6##2##(2008-10#1)(2008-3#3)(2009-11#1)(2011-2#1)
accuracy within##2##2##(2008-10#1)(2013-8#1)
accuracy##585##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#324)(2008-11#9)(2008-12#7)(2008-2#3)(2008-3#48)(2008-4#2)(2008-5#2)(2008-6#14)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#4)(2009-4#1)(2009-5#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#2)(2010-7#11)(2010-8#9)(2010-9#2)(2011-1#2)(2011-2#17)(2011-3#5)(2011-7#1)(2012-12#6)(2012-2#12)(2012-3#10)(2013-1#20)(2013-8#7)
accurate analysis of the##2##4##(2008-10#2)
accurate analysis of##4##3##(2008-10#3)(2008-2#1)
accurate and precise analytical##3##4##(2008-10#3)
accurate and precise determination of##3##5##(2008-10#3)
accurate and precise results##2##4##(2008-10#2)
accurate and precise##20##3##(2008-10#18)(2010-7#1)(2012-2#1)
accurate and rapid##2##3##(2008-10#1)(2008-9#1)
accurate and reliable##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
accurate and reproducible##4##3##(2008-10#3)(2009-1#1)
accurate and sensitive##2##3##(2010-1#1)(2011-3#1)
accurate and##54##2##(1991-3#1)(1992-3#1)(2008-10#37)(2008-11#3)(2008-9#2)(2009-1#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-2#2)(2013-8#1)
accurate as##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
accurate assessment of the##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
accurate assessment of##6##3##(2008-10#4)(2008-9#1)(2013-1#1)
accurate blood##2##2##(2010-8#1)(2013-8#1)
accurate control of##2##3##(2008-10#2)
accurate control##3##2##(2008-10#3)
accurate data##2##2##(2008-10#1)(2010-3#1)
accurate detection##3##2##(2008-10#3)
accurate determination of the##4##4##(1990-12#1)(2008-10#1)(2008-12#1)(2008-3#1)
accurate determination of##13##3##(1990-12#2)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-9#1)
accurate diagnosis and##2##3##(2008-7#1)(2010-1#1)
accurate diagnosis of##3##3##(1994-1#1)(2010-10#1)(2010-8#1)
accurate diagnosis##11##2##(1991-11#1)(1992-3#1)(1994-1#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
accurate diagnostic##2##2##(1991-6#1)(2011-2#1)
accurate estimates##3##2##(2008-10#1)(2010-2#1)(2010-4#1)
accurate for##2##2##(2008-10#1)(2010-12#1)
accurate identification of##7##3##(1990-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2012-2#3)
accurate identification##8##2##(1990-11#1)(1994-3#1)(2008-10#1)(2008-12#2)(2012-2#3)
accurate in predicting##2##3##(2008-1#1)(2008-10#1)
accurate in##7##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-7#1)
accurate information on the##4##4##(1992-9#1)(1993-12#1)(1994-6#2)
accurate information##5##2##(1992-9#1)(1993-12#1)(1994-6#2)(2010-6#1)
accurate knowledge##2##2##(2010-3#1)(2012-2#1)
accurate mass measurements##2##3##(2008-10#1)(2011-2#1)
accurate mass##3##2##(2008-10#1)(2011-2#2)
accurate measurement of the##3##4##(1994-9#1)(2008-3#2)
accurate measurement of##5##3##(1994-9#1)(2008-10#2)(2008-3#2)
accurate measurement##6##2##(1994-9#1)(2008-10#3)(2008-3#2)
accurate measurements##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
accurate method for the determination##2##5##(2008-10#2)
accurate method for the##5##4##(2008-10#5)
accurate method for##6##3##(2008-10#5)(2008-3#1)
accurate method##12##2##(2008-10#11)(2008-3#1)
accurate molecular##2##2##(1995-3#1)(1997-2#1)
accurate organism identification and##2##4##(2013-1#2)
accurate prediction of##3##3##(2008-10#2)(2008-11#1)
accurate predictions##3##2##(2008-10#3)
accurate quantification##3##2##(2008-10#3)
accurate quantitative##2##2##(2008-10#1)(2013-1#1)
accurate results as##2##3##(1990-3#1)(2008-10#1)
accurate results for##2##3##(2008-10#2)
accurate results in##2##3##(2008-10#1)(2012-3#1)
accurate results were obtained##2##4##(2008-10#2)
accurate results were##3##3##(2008-10#3)
accurate results##24##2##(1990-3#1)(2008-10#20)(2008-3#1)(2008-9#1)(2012-3#1)
accurate risk assessments##2##3##(2008-10#1)(2008-5#1)
accurate risk##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
accurate than the##3##3##(2008-10#3)
accurate than##10##2##(2008-10#6)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
accurate##366##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-6#1)(1990-8#2)(1991-11#2)(1991-3#2)(1991-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-6#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1997-2#3)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#164)(2008-11#14)(2008-12#4)(2008-2#5)(2008-3#19)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#12)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-2#15)(2012-3#6)(2013-1#8)(2013-8#6)
accurately and##6##2##(2008-10#2)(2008-6#1)(2012-3#1)(2013-1#2)
accurately capture the##2##3##(2008-3#1)(2013-8#1)
accurately define the##2##3##(1994-6#1)(2010-1#1)
accurately detect##2##2##(2009-10#1)(2010-11#1)
accurately determined##4##2##(2008-10#3)(2008-3#1)
accurately identified##2##2##(1997-8#1)(2010-7#1)
accurately identify##2##2##(1997-8#1)(2008-10#1)
accurately in the##2##3##(2008-10#1)(2008-3#1)
accurately in##4##2##(1995-6#1)(2008-10#2)(2008-3#1)
accurately is##2##2##(2008-10#1)(2008-11#1)
accurately measure the##2##3##(2008-10#2)
accurately modeled##2##2##(2008-3#2)
accurately predict##8##2##(1991-12#1)(1992-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
accurately predicted##3##2##(2008-5#1)(2008-7#1)(2010-8#1)
accurately reflected##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
accurately than##4##2##(1993-12#1)(1997-1#1)(2008-10#1)(2012-4#1)
accurately the##4##2##(2008-11#1)(2008-5#2)(2011-3#1)
accurately with##2##2##(2008-10#2)
accurately##104##1##(1990-12#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#3)(2008-10#33)(2008-11#3)(2008-12#2)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#2)
accustomed to##2##2##(1995-2#1)(2008-9#1)
accustomed##3##1##(1993-11#1)(1995-2#1)(2008-9#1)
acellular dermis##4##2##(2008-9#4)
acellular pertussis vaccines##2##3##(1997-8#2)
acellular pertussis##4##2##(1995-5#1)(1997-8#2)(2013-1#1)
acellular vaccines##2##2##(1997-8#2)
acellular##18##1##(1995-5#1)(1997-8#4)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#1)(2010-3#1)(2010-7#1)(2012-2#2)(2013-1#2)
acenaphthene##2##1##(2008-10#2)
acenaphthylene##3##1##(2008-10#3)
acepromazine##2##1##(2012-3#1)(2013-8#1)
acervuli##2##1##(2008-10#2)
acetabular##4##1##(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
acetaldehyde and##3##2##(1994-5#1)(2008-2#1)(2009-8#1)
acetaldehyde on##2##2##(1994-5#1)(2008-10#1)
acetaldehyde##17##1##(1994-5#7)(2008-10#2)(2008-11#4)(2008-2#3)(2009-8#1)
acetamide##2##1##(1994-8#1)(2008-10#1)
acetaminophen and p-aminophenol##2##3##(2008-10#2)
acetaminophen and##7##2##(2008-10#6)(2008-11#1)
acetaminophen in##5##2##(2008-10#5)
acetaminophen##31##1##(2008-10#25)(2008-11#2)(2010-9#2)(2013-1#2)
acetate and formate##3##3##(2008-10#2)(2011-1#1)
acetate and the##2##3##(2008-10#1)(2008-7#1)
acetate and##20##2##(2008-10#17)(2008-5#1)(2008-7#1)(2011-1#1)
acetate as the##4##3##(2008-10#3)(2008-5#1)
acetate as##7##2##(1997-7#1)(2008-10#5)(2008-5#1)
acetate buffer (0##4##3##(2008-10#4)
acetate buffer (pH 4##2##4##(2008-10#2)
acetate buffer (pH 5##5##4##(2008-10#5)
acetate buffer (pH##12##3##(2008-10#12)
acetate buffer at pH 4##3##5##(2008-10#3)
acetate buffer at pH 6##2##5##(2008-10#2)
acetate buffer at pH##7##4##(2008-10#7)
acetate buffer at##9##3##(2008-10#9)
acetate buffer concentration##2##3##(2008-10#2)
acetate buffer medium##2##3##(2008-10#2)
acetate buffer pH 5##2##4##(2008-10#2)
acetate buffer pH##3##3##(2008-10#3)
acetate buffer solution##3##3##(2008-10#3)
acetate buffer##55##2##(1997-2#1)(2008-10#51)(2009-10#3)
acetate concentration##2##2##(2008-7#2)
acetate counter-ion##2##2##(1997-2#2)
acetate electrophoresis##2##2##(2008-10#2)
acetate enrichment##2##2##(2008-7#2)
acetate ester synthesis##2##3##(2011-1#2)
acetate followed by##2##3##(1996-5#1)(2008-10#1)
acetate for##5##2##(2008-10#2)(2008-11#3)
acetate in##2##2##(2008-10#2)
acetate ion##3##2##(1997-2#2)(2008-10#1)
acetate ions##4##2##(2008-10#4)
acetate is##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
acetate kinase##2##2##(2008-6#2)
acetate or##3##2##(2008-10#2)(2008-7#1)
acetate showed##2##2##(2008-10#1)(2008-11#1)
acetate solution##2##2##(2008-10#2)
acetate to##2##2##(2008-10#1)(2008-11#1)
acetate utilization##2##2##(2008-7#2)
acetate was##4##2##(2008-11#1)(2008-7#3)
acetate with##2##2##(1993-1#1)(2008-10#1)
acetate##239##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-9#1)(1993-1#4)(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#3)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#7)(1997-7#1)(2006-6#1)(2008-10#151)(2008-11#11)(2008-12#3)(2008-5#7)(2008-6#4)(2008-7#16)(2008-8#1)(2009-10#3)(2010-12#1)(2011-1#5)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
acetate)##3##1##(1994-11#1)(2008-10#2)
acetic acid (0##2##3##(2008-10#2)
acetic acid (2##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
acetic acid and##10##3##(1990-6#1)(1994-11#1)(2008-10#6)(2008-11#1)(2008-8#1)
acetic acid as the##2##4##(2008-10#2)
acetic acid as##3##3##(2008-10#3)
acetic acid in acetic anhydride##2##5##(2008-10#2)
acetic acid in##3##3##(2008-10#3)
acetic acid is##2##3##(2008-10#1)(2008-11#1)
acetic acid solution##4##3##(2008-10#4)
acetic acid to##2##3##(2008-10#2)
acetic acid with##3##3##(2008-10#2)(2008-5#1)
acetic acid##71##2##(1990-6#1)(1991-5#2)(1994-11#1)(1994-8#2)(2008-10#55)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#2)(2009-8#1)(2013-1#1)
acetic acid)##2##2##(2008-10#2)
acetic acid-sodium acetate buffer##5##4##(2008-10#5)
acetic acid/sodium acetate buffer##3##4##(2008-10#3)
acetic acids##2##2##(2008-10#2)
acetic anhydride##5##2##(2008-10#4)(2008-11#1)
acetic##97##1##(1990-6#1)(1991-5#3)(1994-11#1)(1994-8#2)(2008-10#79)(2008-11#4)(2008-12#2)(2008-5#1)(2008-8#2)(2009-8#1)(2013-1#1)
acetiphilus##3##1##(2011-2#3)
acetoin production##2##2##(2013-1#2)
acetoin##8##1##(2008-6#1)(2013-1#7)
acetone and##11##2##(2008-10#9)(2008-11#1)(2008-9#1)
acetone extract of the lichen Ramalina farinacea and its (+)-usnic acid##2##11##(2008-11#2)
acetone extract##3##2##(2008-11#3)
acetone in##3##2##(2008-10#2)(2008-5#1)
acetone was##2##2##(2008-10#1)(2013-8#1)
acetone##46##1##(1996-5#1)(2008-10#34)(2008-11#4)(2008-5#2)(2008-7#1)(2008-9#1)(2013-8#3)
acetone)##3##1##(2008-10#2)(2013-8#1)
acetone-hexane (1##2##2##(2008-10#2)
acetone-soluble##2##1##(2008-10#2)
acetonide##7##1##(1990-11#3)(2008-10#1)(2010-12#2)(2011-2#1)
acetonitrile (ACN)##2##2##(2008-10#2)
acetonitrile and water##3##3##(2008-10#3)
acetonitrile and##14##2##(2008-10#14)
acetonitrile as##4##2##(2008-10#4)
acetonitrile containing##3##2##(2008-10#2)(2008-7#1)
acetonitrile gradient##2##2##(2008-10#2)
acetonitrile in the mobile##2##4##(2008-10#2)
acetonitrile in the##4##3##(2008-10#4)
acetonitrile in##6##2##(2008-10#6)
acetonitrile was##2##2##(2008-10#2)
acetonitrile were##2##2##(2008-10#2)
acetonitrile##95##1##(1992-6#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#88)(2008-5#1)(2008-7#1)(2009-8#1)
acetonitrile+water##2##1##(2008-10#2)
acetonitrile-phosphate buffer##5##2##(2008-10#5)
acetonitrile-water (70##2##2##(2008-10#2)
acetonitrile-water mixed solvents##2##3##(2008-10#2)
acetonitrile-water mixtures##6##2##(2008-10#6)
acetonitrile-water##18##1##(2008-10#18)
acetonitrile/water##5##1##(2008-10#4)(2011-1#1)
acetoxy##3##1##(1996-5#2)(2008-11#1)
acetyl cholinesterase##2##2##(2013-1#2)
acetyl transferase##4##2##(1994-11#1)(1994-6#1)(1996-12#1)(1997-7#1)
acetyl xylan esterase##3##3##(2011-1#3)
acetyl##18##1##(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-5#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#4)(2013-1#2)
acetyl-CoA##3##1##(1992-9#2)(1995-6#1)
acetylacetonate##2##1##(2008-10#1)(2008-2#1)
acetylacetone and##2##2##(2008-10#2)
acetylacetone##4##1##(2008-10#3)(2008-11#1)
acetylated##9##1##(2008-10#3)(2008-11#1)(2009-8#1)(2011-1#2)(2011-2#2)
acetylation and methylation##2##3##(2009-4#1)(2011-9#1)
acetylation##11##1##(1996-5#1)(2008-10#6)(2009-10#2)(2009-4#1)(2011-9#1)
acetylcholine (ACh)##5##2##(1996-5#1)(2008-8#2)(2009-8#1)(2012-3#1)
acetylcholine and##4##2##(1990-5#1)(1997-1#1)(2008-8#1)(2013-1#1)
acetylcholine are##2##2##(1994-8#1)(1995-11#1)
acetylcholine esterase##4##2##(2008-10#2)(2008-11#1)(2011-1#1)
acetylcholine in##6##2##(1994-8#4)(1996-12#1)(2008-10#1)
acetylcholine levels##4##2##(1992-8#2)(1994-8#2)
acetylcholine receptor (AChR)##3##3##(1997-5#1)(2009-8#2)
acetylcholine receptor##16##2##(1994-5#2)(1995-11#1)(1996-12#1)(1997-5#1)(2008-8#7)(2009-11#1)(2009-8#2)(2010-8#1)
acetylcholine receptors##5##2##(1995-11#3)(2013-1#1)(2013-8#1)
acetylcholine regulating stomatal movement##2##4##(2008-8#2)
acetylcholine release##3##2##(1992-3#1)(1997-2#1)(2013-8#1)
acetylcholine to##2##2##(2008-8#1)(2011-2#1)
acetylcholine was##2##2##(2008-10#1)(2013-8#1)
acetylcholine##76##1##(1990-5#1)(1992-3#2)(1992-6#1)(1992-8#2)(1994-5#3)(1994-8#7)(1995-11#8)(1996-12#7)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#15)(2009-11#1)(2009-8#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
acetylcholinesterase (AChE) in##2##3##(1990-5#1)(1994-5#1)
acetylcholinesterase (AChE)##6##2##(1990-5#1)(1994-5#1)(2008-10#1)(2008-11#2)(2009-8#1)
acetylcholinesterase activity of the rat pheochromocytoma cell line PC12##2##9##(2008-11#2)
acetylcholinesterase activity of the rat##3##5##(2008-11#3)
acetylcholinesterase activity##5##2##(1992-8#1)(2008-11#4)
acetylcholinesterase and butyrylcholinesterase##2##3##(2008-10#1)(2008-7#1)
acetylcholinesterase inhibition##2##2##(1992-8#1)(2008-10#1)
acetylcholinesterase##33##1##(1990-5#2)(1992-8#4)(1994-5#1)(1994-8#7)(2008-10#9)(2008-11#6)(2008-7#2)(2009-8#1)(2012-2#1)
acetylene##4##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
acetylene-air flame##2##2##(2008-10#1)(2008-3#1)
acetylenic##2##1##(1996-5#2)
acetylisoniazid##2##1##(2008-10#2)
acetylsalicylhydroxamic acid##2##2##(2008-10#2)
acetylsalicylic acid (ASA)##4##3##(2008-10#4)
acetylsalicylic acid and##2##3##(2008-10#2)
acetylsalicylic acid by##2##3##(2008-10#2)
acetylsalicylic acid##21##2##(1990-12#2)(1990-9#1)(1991-2#1)(1993-11#1)(2008-10#16)
acetylsalicylic##22##1##(1990-12#2)(1990-9#1)(1991-2#1)(1993-11#1)(1994-9#1)(2008-10#16)
acetyltransferase (ChAT)##2##2##(1991-9#1)(1993-3#1)
acetyltransferase reporter##3##2##(1994-11#1)(1995-2#1)(1995-6#1)
acetyltransferase##19##1##(1991-9#2)(1992-3#1)(1992-6#2)(1993-3#2)(1993-8#1)(1994-11#1)(1995-2#2)(1995-6#1)(1996-12#3)(1996-2#1)(1997-8#1)(2008-4#1)(2008-7#1)
acetyltransferases##2##1##(1992-6#2)
achalasia##7##1##(1990-12#2)(1992-9#3)(2013-1#2)
achenes##4##1##(2008-10#4)
achievable at the##2##3##(1993-1#1)(2010-6#1)
achievable by##2##2##(2008-10#1)(2008-3#1)
achievable for##2##2##(2008-10#1)(2008-11#1)
achievable goal for##2##3##(2008-10#1)(2008-11#1)
achievable goal##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
achievable with##2##2##(2008-10#1)(2008-3#1)
achievable##22##1##(1992-2#1)(1993-1#1)(1994-2#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#3)(2008-7#1)(2010-6#1)(2010-7#1)(2012-3#1)
achieve a##31##2##(1992-3#3)(1992-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(2008-10#6)(2008-11#6)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
achieve an##9##2##(1996-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)
achieve better##4##2##(1992-9#1)(1997-8#1)(2008-10#1)(2013-1#1)
achieve clinical cure##2##3##(1992-6#1)(2010-5#1)
achieve early detection of##3##4##(1990-8#1)(2008-10#1)(2009-4#1)
achieve greater##4##2##(1993-1#1)(1997-1#1)(2008-11#1)(2008-3#1)
achieve high sensitivity##2##3##(2008-10#1)(2013-1#1)
achieve high##8##2##(1990-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
achieve improved##3##2##(1996-2#1)(1997-2#1)(2013-1#1)
achieve meaningful##2##2##(1993-3#1)(2012-3#1)
achieve more##3##2##(1992-3#1)(2008-7#1)(2010-11#1)
achieve successful##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
achieve than##2##2##(2008-11#1)(2010-8#1)
achieve the desired##2##3##(2008-10#1)(2009-8#1)
achieve the goals##2##3##(1996-2#1)(2008-11#1)
achieve the##31##2##(1990-11#1)(1990-3#1)(1993-1#2)(1993-6#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
achieve this goal##2##3##(2006-6#1)(2008-12#1)
achieve this##9##2##(1991-2#1)(1991-3#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
achieve##235##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-2#2)(1992-3#5)(1992-6#1)(1992-9#2)(1993-1#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#3)(1996-5#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#28)(2008-12#7)(2008-2#6)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#5)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-2#7)(2012-3#5)(2013-1#14)(2013-8#5)
achieved a complete##2##3##(1990-12#1)(1991-6#1)
achieved a good##2##3##(1992-12#1)(2008-7#1)
achieved a##21##2##(1990-12#1)(1991-6#1)(1992-12#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
achieved after the##4##3##(1991-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
achieved after##13##2##(1991-12#1)(1991-8#1)(1993-1#1)(1995-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
achieved an##6##2##(1992-5#1)(2008-2#1)(2008-3#2)(2012-3#1)(2013-1#1)
achieved and maintained##2##3##(2008-11#2)
achieved and##10##2##(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)
achieved are##2##2##(2008-10#1)(2008-11#1)
achieved as##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
achieved at a##6##3##(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)
achieved at the expense of##2##5##(1995-12#1)(2011-1#1)
achieved at the##3##3##(1995-12#1)(2008-10#1)(2011-1#1)
achieved at##22##2##(1992-6#1)(1995-12#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)
achieved between##2##2##(2008-10#2)
achieved by a combination of##2##5##(2008-10#1)(2008-11#1)
achieved by a##6##3##(1996-5#2)(2008-10#2)(2008-11#1)(2008-3#1)
achieved by applying##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
achieved by both##2##3##(2008-10#1)(2011-2#1)
achieved by either##2##3##(2008-10#1)(2008-3#1)
achieved by electron beam irradiation##2##5##(1991-6#1)(1994-11#1)
achieved by first##2##3##(2008-10#2)
achieved by gentle##2##3##(2008-10#2)
achieved by sampling##2##3##(2008-10#2)
achieved by the addition of##2##5##(2008-10#2)
achieved by the##23##3##(1991-6#1)(1992-1#1)(1993-6#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2013-1#1)
achieved by this##3##3##(1990-2#1)(2008-10#2)
achieved by using a##4##4##(2008-10#4)
achieved by using##15##3##(2008-10#12)(2008-12#1)(2011-2#2)
achieved by##152##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-6#1)(1997-7#1)(2008-10#85)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
achieved complete##5##2##(1990-12#1)(1990-8#1)(1997-8#1)(2008-10#1)(2009-12#1)
achieved during the##4##3##(1991-2#1)(2008-10#2)(2012-12#1)
achieved enrichment factors (EF)##2##4##(2008-10#2)
achieved experimentally##2##2##(2008-3#2)
achieved for a##2##3##(2007-12#1)(2008-10#1)
achieved for both##4##3##(2008-10#3)(2009-3#1)
achieved for determination of##2##4##(2008-10#2)
achieved for the determination of##2##5##(2008-10#2)
achieved for the##6##3##(2008-10#6)
achieved for##34##2##(1994-1#2)(2007-12#2)(2008-10#28)(2009-3#1)(2013-1#1)
achieved from the##2##3##(2008-11#1)(2010-7#1)
achieved from##9##2##(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-7#1)(2013-1#1)
achieved fusion##2##2##(2008-8#2)
achieved higher##2##2##(2008-11#1)(2008-9#1)
achieved in a##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
achieved in all cases##2##4##(2008-9#1)(2009-3#1)
achieved in all##4##3##(1997-8#1)(2008-10#1)(2008-9#1)(2009-3#1)
achieved in batch##2##3##(2008-11#2)
achieved in less than##4##4##(2008-10#4)
achieved in only##2##3##(2008-10#1)(2008-7#1)
achieved in the presence of##2##5##(2008-10#1)(2008-11#1)
achieved in the##10##3##(1992-9#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
achieved in##67##2##(1990-6#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
achieved is##2##2##(2008-10#1)(2008-3#1)
achieved on the##5##3##(1993-1#1)(2008-10#3)(2008-11#1)
achieved on##13##2##(1993-1#1)(2008-10#10)(2008-11#1)(2013-1#1)
achieved only##5##2##(1992-2#1)(1993-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
achieved over##4##2##(1990-2#1)(2008-10#1)(2010-10#1)(2013-8#1)
achieved partial##2##2##(1990-6#1)(2008-10#1)
achieved the##9##2##(1992-9#1)(1995-2#1)(1995-3#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
achieved through a##3##3##(1994-3#1)(2008-5#1)(2010-3#1)
achieved through the##4##3##(1994-9#1)(2008-10#2)(2008-9#1)
achieved through##20##2##(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-5#2)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-7#1)
achieved to##3##2##(1991-3#1)(2008-10#1)(2012-12#1)
achieved under##5##2##(1991-12#1)(2008-10#2)(2008-11#1)(2010-1#1)
achieved using a##9##3##(1992-9#1)(2008-10#6)(2008-12#1)(2008-5#1)
achieved using the##6##3##(1990-12#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-4#1)
achieved using##37##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-9#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-4#1)(2011-3#1)
achieved was##5##2##(2008-10#4)(2008-11#1)
achieved were##5##2##(2008-10#5)
achieved when the##5##3##(2008-10#4)(2008-11#1)
achieved when##19##2##(1994-2#1)(1995-6#1)(2006-6#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
achieved with a##13##3##(2007-11#2)(2008-10#8)(2008-3#1)(2011-2#1)(2012-12#1)
achieved with the proposed##2##4##(2008-10#2)
achieved with the##15##3##(1991-9#1)(1993-2#1)(1995-3#1)(2008-10#9)(2008-3#2)(2011-2#1)
achieved with this##2##3##(1997-8#1)(2010-7#1)
achieved with##72##2##(1991-3#1)(1991-9#1)(1993-2#1)(1994-3#1)(1995-3#1)(1997-8#1)(2007-11#2)(2008-10#36)(2008-11#2)(2008-12#1)(2008-3#6)(2008-5#2)(2008-7#4)(2009-4#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)
achieved within##7##2##(2008-10#7)
achieved without any##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
achieved without##10##2##(1995-12#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
achieved##812##1##(1990-12#4)(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#6)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#4)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-9#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#7)(2006-6#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#413)(2008-11#48)(2008-12#14)(2008-2#6)(2008-3#34)(2008-4#1)(2008-5#14)(2008-6#3)(2008-7#21)(2008-8#12)(2008-9#12)(2009-1#1)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#5)(2010-8#2)(2011-1#2)(2011-2#25)(2011-3#1)(2011-4#1)(2012-12#6)(2012-2#8)(2012-3#7)(2012-7#1)(2013-1#16)(2013-7#1)(2013-8#5)
achievement and##4##2##(1994-1#1)(2009-7#1)(2010-1#1)(2010-7#1)
achievement gap##3##2##(2008-12#3)
achievement in##2##2##(2010-10#1)(2010-5#1)
achievement motivation##2##2##(2009-7#2)
achievement of a##3##3##(1994-3#1)(1996-2#1)(2012-3#1)
achievement of##18##2##(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-7#2)(2012-2#1)(2012-3#1)(2013-1#1)
achievement outcomes##3##2##(2008-12#1)(2009-7#1)(2010-7#1)
achievement##61##1##(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-12#9)(2008-5#1)(2008-7#1)(2009-12#3)(2009-7#8)(2010-1#13)(2010-10#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
achievements and##3##2##(1993-12#2)(2008-11#1)
achievements in##4##2##(2008-10#1)(2008-11#1)(2012-3#2)
achievements of##5##2##(1995-1#1)(2008-10#1)(2008-12#2)(2008-7#1)
achievements##22##1##(1993-12#2)(1994-3#1)(1995-1#1)(1996-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-7#1)(2009-5#2)(2011-2#1)(2012-3#3)
achieves a##3##2##(2008-10#2)(2010-12#1)
achieves the same##2##3##(2009-6#1)(2012-3#1)
achieves the##6##2##(2008-10#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
achieves##18##1##(1990-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-2#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-3#3)(2013-8#1)
achieving a more##3##3##(1990-6#1)(1991-6#1)(2008-4#1)
achieving a##17##2##(1990-6#1)(1991-6#1)(1992-12#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2013-1#3)
achieving an##2##2##(2008-2#1)(2011-2#1)
achieving good##2##2##(2011-2#2)
achieving high##2##2##(2008-10#1)(2013-1#1)
achieving the##10##2##(1990-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
achieving this##3##2##(1992-12#1)(2008-3#1)(2010-10#1)
achieving##77##1##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-12#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-8#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
achiral##2##1##(2008-10#2)
achromatic##3##1##(2008-3#3)
acibenzolar-S-methyl (ASM)##2##2##(2008-10#2)
acibenzolar-S-methyl##4##1##(2008-10#4)
acid (0##6##2##(2008-10#6)
acid (1##3##2##(2008-10#3)
acid (1)##2##2##(1990-11#1)(2008-10#1)
acid (10##2##2##(1993-6#1)(2008-10#1)
acid (11##2##2##(2008-12#1)(2013-1#1)
acid (12-HETE)##2##2##(1992-8#1)(1994-8#1)
acid (2##17##2##(1993-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-8#1)
acid (2)##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
acid (3##2##2##(2008-10#1)(2008-11#1)
acid (3)##2##2##(2008-10#1)(2008-11#1)
acid (5##2##2##(1995-11#1)(2008-11#1)
acid (5-HIAA)##4##2##(1992-1#1)(1993-1#1)(2008-10#2)
acid (75##2##2##(2008-10#1)(2008-5#1)
acid (AA)##22##2##(1992-12#2)(1993-3#1)(1993-8#1)(1997-2#1)(2008-10#15)(2008-11#1)(2008-5#1)
acid (ABA)##3##2##(2008-10#1)(2009-6#1)(2009-8#1)
acid (AP-5)##2##2##(1997-2#1)(2008-11#1)
acid (ASA)##5##2##(2008-10#5)
acid (ATRA)##2##2##(2008-9#1)(2011-2#1)
acid (BA)##2##2##(2008-10#2)
acid (BABA)##3##2##(2008-10#2)(2009-6#1)
acid (BCA)##2##2##(2008-10#2)
acid (C16##2##2##(2011-1#2)
acid (C18##3##2##(1996-6#2)(2008-11#1)
acid (CA)##5##2##(2008-10#3)(2011-2#1)(2012-12#1)
acid (CAA)##2##2##(2008-10#1)(2008-11#1)
acid (CAS##2##2##(2008-5#1)(2008-9#1)
acid (DCA)##2##2##(2008-10#2)
acid (DEHPA)##2##2##(2008-10#2)
acid (DHAA)##2##2##(1993-3#1)(1997-2#1)
acid (DMA)##8##2##(2008-10#8)
acid (DMSA)##3##2##(1992-12#1)(2008-8#1)(2013-1#1)
acid (DOPAC)##4##2##(1992-1#1)(1994-2#1)(2008-10#2)
acid (DPA)##3##2##(2008-10#2)(2011-2#1)
acid (DTPA)##4##2##(2008-10#3)(2008-5#1)
acid (EA)##2##2##(2008-10#1)(2008-5#1)
acid (EDTA) and##2##3##(2008-10#1)(2008-5#1)
acid (EDTA)##10##2##(2008-10#6)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
acid (FA) in##2##3##(2009-8#1)(2013-1#1)
acid (FA)##4##2##(1992-2#1)(2008-6#1)(2009-8#1)(2013-1#1)
acid (GA)##4##2##(2008-10#3)(2008-9#1)
acid (GABA)##7##2##(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
acid (HA)##6##2##(2008-10#5)(2010-10#1)
acid (HSA)##2##2##(2008-10#1)(2011-2#1)
acid (LTA)##2##2##(1995-6#1)(1996-12#1)
acid (MA)##2##2##(1996-12#1)(2008-10#1)
acid (MAA)##3##2##(2008-10#3)
acid (MPA)##2##2##(2008-10#2)
acid (NA) and##3##3##(2008-10#2)(2011-1#1)
acid (NA)##5##2##(2008-10#4)(2011-1#1)
acid (NAA)##3##2##(2008-10#2)(2008-12#1)
acid (P=0##2##2##(2008-10#2)
acid (RA)##7##2##(1990-6#1)(1994-11#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-5#2)
acid (SA) and##3##3##(2008-10#2)(2009-8#1)
acid (SA) is##3##3##(2008-10#2)(2011-2#1)
acid (SA)##14##2##(2008-10#10)(2008-12#1)(2009-8#2)(2011-2#1)
acid (TFA) and##2##3##(2008-10#1)(2008-7#1)
acid (TFA)##3##2##(2008-10#2)(2008-7#1)
acid (VPA)##5##2##(2008-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
acid (ZA)##2##2##(2008-7#1)(2013-1#1)
acid (aa) polypeptide##2##3##(1990-5#1)(1993-2#1)
acid (aa) protein##2##3##(1993-9#1)(1997-7#1)
acid (aa)##19##2##(1990-5#1)(1991-6#2)(1993-12#2)(1993-2#2)(1993-6#5)(1993-9#2)(1994-8#1)(1997-7#2)(2008-10#1)(2010-5#1)
acid (pH 2##2##3##(1994-8#1)(2008-10#1)
acid (pH##4##2##(1994-8#1)(2008-10#3)
acid (vitamin C)##3##3##(1992-9#1)(2008-10#1)(2008-5#1)
acid (vitamin##4##2##(1992-9#1)(2008-10#2)(2008-5#1)
acid 244##2##2##(1990-10#2)
acid A##2##2##(2011-3#1)(2012-2#1)
acid B##2##2##(2008-10#2)
acid N-hydroxysuccinimidyl ester)-4##2##3##(2008-10#2)
acid N-oxide##2##2##(2008-10#2)
acid S-methyl ester (BTH)##2##4##(2008-10#2)
acid a##2##2##(1994-5#1)(2008-10#1)
acid addition##2##2##(2008-10#1)(2008-11#1)
acid alone##4##2##(1993-12#1)(1997-3#1)(2008-10#2)
acid amide##2##2##(1992-11#1)(2008-5#1)
acid amides of phenolic benzylamines##2##5##(2008-5#2)
acid amides of##3##3##(2008-5#3)
acid amides##4##2##(1992-11#1)(2008-5#3)
acid analysis in##2##3##(1995-3#1)(2008-10#1)
acid analysis##24##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-3#2)(1995-6#1)(2008-10#8)(2008-4#2)(2008-9#2)
acid and 0##6##3##(2008-10#5)(2011-2#1)
acid and 1##2##3##(2008-10#2)
acid and 2##3##3##(2008-10#3)
acid and a##8##3##(1992-6#1)(2008-10#7)
acid and alkali##3##3##(2008-10#3)
acid and amino##2##3##(2008-10#1)(2013-8#1)
acid and ammonium##2##3##(2008-10#2)
acid and caffeine##2##3##(2008-10#2)
acid and calcium##2##3##(2008-10#1)(2009-6#1)
acid and catecholamines##2##3##(2008-10#2)
acid and chlorogenic acid##2##4##(2008-10#2)
acid and coenzyme##2##3##(1993-8#1)(2008-10#1)
acid and dehydroascorbic acid##2##4##(1993-3#1)(2008-10#1)
acid and hydrogen peroxide##5##4##(2008-10#5)
acid and its application##2##4##(2008-10#2)
acid and its##13##3##(1993-11#3)(1993-8#1)(1994-5#1)(2008-10#7)(2008-11#1)
acid and p-coumaric acid##2##4##(2008-10#1)(2008-11#1)
acid and permanganate##3##3##(2008-10#3)
acid and sodium tetrahydroborate##3##4##(2008-10#3)
acid and sodium##5##3##(2008-10#5)
acid and sorbic acid##4##4##(2008-10#4)
acid and syringic acid##3##4##(2011-1#3)
acid and the##12##3##(1993-8#1)(2008-10#8)(2008-9#1)(2010-3#1)(2013-1#1)
acid and their##2##3##(2008-10#2)
acid and##243##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-2#1)(1993-3#3)(1993-8#5)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#169)(2008-11#7)(2008-12#1)(2008-5#8)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#4)(2010-11#1)(2010-3#3)(2010-4#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
acid and/or##3##2##(2008-10#3)
acid anhydrides##4##2##(1994-3#1)(1995-11#3)
acid are described##2##3##(2008-10#2)
acid are##10##2##(1993-11#1)(2008-10#8)(2008-11#1)
acid as a##9##3##(2008-10#9)
acid as an##4##3##(2008-10#4)
acid as the catalyst##2##4##(2008-10#1)(2008-5#1)
acid as the##7##3##(2008-10#4)(2008-11#1)(2008-5#2)
acid as well as##3##4##(2008-10#3)
acid as##44##2##(1995-11#1)(2008-10#39)(2008-11#1)(2008-5#2)(2010-1#1)
acid at 80 degrees C##2##5##(2008-10#2)
acid at pH##2##3##(2008-10#2)
acid at position##5##3##(1994-3#1)(1997-3#1)(2008-10#3)
acid at the##2##3##(1994-5#1)(2008-10#1)
acid at##26##2##(1990-9#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-3#1)(2008-10#20)
acid based on##5##3##(2008-10#5)
acid binding protein##6##3##(1991-9#1)(1994-8#2)(2008-8#2)(2009-8#1)
acid binding##8##2##(1991-9#1)(1994-8#2)(1996-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
acid biosynthesis in##3##3##(1995-6#1)(1997-2#2)
acid biosynthesis##8##2##(1992-8#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#2)(2008-9#2)
acid bomb and conventional wet digestion methods##3##7##(2008-10#3)
acid bomb##4##2##(2008-10#4)
acid buffer solution##4##3##(1993-8#1)(2008-10#3)
acid buffer##12##2##(1993-8#1)(2008-10#11)
acid but##3##2##(1997-3#1)(2008-10#2)
acid by a##2##3##(1992-8#1)(2008-10#1)
acid by hydrogen peroxide##3##4##(1994-5#1)(2008-10#2)
acid by partial##2##3##(2008-10#2)
acid by the##5##3##(2008-10#5)
acid by##35##2##(1990-10#1)(1991-9#1)(1992-8#1)(1994-5#1)(2008-10#28)(2008-12#1)(2008-7#1)(2011-2#1)
acid can be##3##3##(2008-10#3)
acid can##4##2##(1990-8#1)(2008-10#3)
acid cation-exchange resin##2##3##(2008-10#2)
acid chain##4##2##(1993-8#3)(2011-2#1)
acid chains of##2##3##(1993-8#1)(1994-11#1)
acid chains##4##2##(1993-8#1)(1994-11#1)(1997-2#1)(2008-5#1)
acid chloride##2##2##(2008-10#2)
acid citrate dextrose##2##3##(2011-2#2)
acid column##2##2##(1997-2#1)(2008-10#1)
acid compared to##2##3##(1994-11#1)(1995-11#1)
acid complex##5##2##(2008-10#5)
acid composition and##2##3##(1990-8#1)(2008-10#1)
acid composition of the##9##4##(1990-5#1)(1990-8#1)(1991-12#2)(1992-9#1)(1993-8#1)(2008-9#2)(2010-4#1)
acid composition of##15##3##(1990-5#2)(1990-8#1)(1991-12#4)(1992-12#1)(1992-9#1)(1993-8#1)(2008-11#1)(2008-9#2)(2010-4#1)(2011-1#1)
acid composition##28##2##(1990-5#2)(1990-8#2)(1991-12#5)(1991-9#1)(1992-12#2)(1992-7#1)(1992-9#2)(1993-8#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-9#2)(2010-4#1)(2011-1#3)
acid compounds##2##2##(2008-10#2)
acid concentration and temperature##2##4##(2008-10#2)
acid concentration and##4##3##(2008-10#4)
acid concentration between##2##3##(2008-10#2)
acid concentration in the##2##4##(2008-10#2)
acid concentration in##3##3##(2008-10#3)
acid concentration is##2##3##(2008-10#2)
acid concentration of##2##3##(2008-10#2)
acid concentration##34##2##(2008-10#32)(2010-1#1)(2013-1#1)
acid concentrations and##2##3##(2008-10#1)(2008-12#1)
acid concentrations##8##2##(1990-12#2)(1994-12#1)(2008-10#4)(2008-12#1)
acid conjugate##2##2##(1990-8#2)
acid consumption##2##2##(1990-8#1)(2008-11#1)
acid containing##2##2##(2008-10#1)(2008-5#1)
acid content in##9##3##(2008-10#6)(2008-11#1)(2008-12#1)(2013-1#1)
acid content of##3##3##(1990-5#1)(2008-11#1)(2010-4#1)
acid content##19##2##(1990-5#1)(1994-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#3)(2010-4#2)(2013-1#1)
acid contents of##2##3##(2008-10#2)
acid could be##3##3##(2008-10#3)
acid could##5##2##(2008-10#5)
acid decarboxylase##2##2##(1997-3#1)(2013-8#1)
acid derivatives as##2##3##(1992-12#1)(2013-1#1)
acid derivatives##16##2##(1991-5#1)(1992-12#2)(2008-10#9)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
acid derived##4##2##(1994-3#1)(2008-10#1)(2010-4#2)
acid detection##3##2##(2008-10#2)(2013-8#1)
acid determination in##3##3##(2008-10#3)
acid determination##8##2##(2008-10#8)
acid diacylester##2##2##(2008-10#2)
acid did not affect##2##4##(2008-10#1)(2008-6#1)
acid did not##5##3##(1995-11#1)(2008-10#2)(2008-6#1)(2013-1#1)
acid digested samples##2##3##(2008-10#2)
acid digested##7##2##(2008-10#7)
acid digestion and##3##3##(2008-10#3)
acid digestion for##3##3##(2008-10#3)
acid digestion of##2##3##(2008-10#2)
acid digestion procedure##2##3##(2008-10#2)
acid digestion##18##2##(2008-10#17)(2011-2#1)
acid digests of##4##3##(1990-8#2)(2008-10#2)
acid dimethyl ester##2##3##(1996-5#2)
acid directly##2##2##(2008-10#2)
acid disodium salt##2##3##(2008-10#2)
acid dissociation constants##7##3##(2008-10#7)
acid dissociation##8##2##(1990-5#1)(2008-10#7)
acid dissolution of##4##3##(2008-10#4)
acid dissolution##6##2##(2008-10#6)
acid due to##2##3##(2008-10#2)
acid esters of##2##3##(1995-6#1)(2008-11#1)
acid esters##6##2##(1994-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#1)
acid etching##2##2##(2009-7#2)
acid ethyl ester##8##3##(1992-6#4)(1995-3#1)(2008-10#1)(2009-8#1)(2011-1#1)
acid ethyl##9##2##(1992-6#4)(1995-3#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)
acid excretion and##2##3##(1993-12#1)(2008-10#1)
acid extraction##3##2##(2008-10#2)(2008-9#1)
acid extracts from##5##3##(1996-12#1)(2008-10#4)
acid extracts##8##2##(1991-7#1)(1996-12#1)(2008-10#6)
acid followed by##2##3##(2008-10#2)
acid for the##5##3##(1990-12#1)(1991-12#1)(2008-10#2)(2008-8#1)
acid for##22##2##(1990-12#1)(1991-12#1)(1995-11#1)(1995-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#5)
acid form##2##2##(2008-10#2)
acid from the##2##3##(1990-12#1)(1991-5#1)
acid from##10##2##(1990-12#1)(1991-5#1)(2008-10#5)(2011-2#1)(2012-3#1)(2013-1#1)
acid functional groups)##2##3##(2008-10#2)
acid functional##3##2##(2008-10#3)
acid gastro-oesophageal reflux##3##3##(1996-3#3)
acid gave##2##2##(1996-5#1)(2008-11#1)
acid glycoprotein##2##2##(1990-2#1)(2008-10#1)
acid groups##2##2##(2008-10#1)(2010-4#1)
acid had a##2##3##(2008-5#2)
acid had##3##2##(2008-10#1)(2008-5#2)
acid has been studied##2##4##(2008-10#2)
acid has been##8##3##(2008-10#8)
acid has##12##2##(1993-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2011-2#1)
acid herbicide##2##2##(2008-10#2)
acid herbicides##2##2##(2008-10#2)
acid hydrolases##2##2##(1992-12#2)
acid hydrolysis##8##2##(1992-12#1)(1994-11#2)(2008-10#4)(2008-5#1)
acid immobilised onto glycidoxypropyl-modified Fractosil 1000)##2##6##(1997-2#2)
acid in a##8##3##(2008-10#7)(2013-1#1)
acid in acidic medium##3##4##(2008-10#3)
acid in acidic##4##3##(2008-10#4)
acid in aqueous##4##3##(2008-10#4)
acid in fruit juices##3##4##(2008-10#3)
acid in human urine##5##4##(1997-2#1)(2008-10#4)
acid in human##6##3##(1997-2#1)(2008-10#5)
acid in pharmaceutical formulations##5##4##(2008-10#5)
acid in pharmaceutical##7##3##(2008-10#7)
acid in pharmaceuticals##4##3##(2008-10#4)
acid in plasma##2##3##(1992-9#1)(2008-10#1)
acid in platelets##2##3##(1991-12#1)(1992-12#1)
acid in the##25##3##(1990-5#1)(1990-9#1)(1992-2#1)(1997-2#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-9#4)(2012-2#1)(2013-1#1)
acid in urine and##2##4##(2008-10#2)
acid in urine##5##3##(2008-10#5)
acid in various##2##3##(2008-10#2)
acid in##153##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-9#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-2#3)(2007-11#1)(2008-10#110)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#7)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
acid increases##3##2##(1993-3#1)(1993-8#2)
acid induced##2##2##(2008-10#1)(2011-2#1)
acid induces##2##2##(2008-10#1)(2009-6#1)
acid inhibited##3##2##(1994-11#1)(1994-6#1)(2013-1#1)
acid inhibits##3##2##(1990-12#2)(2008-10#1)
acid interactions##2##2##(1993-6#1)(2008-8#1)
acid into the##2##3##(2008-10#1)(2011-3#1)
acid into##3##2##(2008-10#1)(2008-5#1)(2011-3#1)
acid invertase was##2##3##(2008-9#2)
acid invertase##9##2##(2008-9#9)
acid is a potent##2##4##(1992-8#1)(1993-8#1)
acid is the##4##3##(2008-10#2)(2008-9#1)(2010-12#1)
acid is used##3##3##(2008-10#2)(2008-11#1)
acid is##39##2##(1990-9#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-5#2)(1997-1#1)(1997-6#1)(2008-10#20)(2008-11#3)(2008-5#3)(2008-9#2)(2010-12#1)(2012-2#1)
acid lactase##2##2##(1991-12#2)
acid leaching with##2##3##(2008-10#2)
acid leaching##4##2##(2008-10#4)
acid lesions##4##2##(1993-6#2)(1994-3#1)(1995-12#1)
acid level##4##2##(1991-9#1)(1994-11#1)(2008-8#1)(2013-1#1)
acid levels and##2##3##(2008-10#1)(2012-2#1)
acid levels in##4##3##(1990-12#1)(1993-1#1)(1993-3#1)(1995-12#1)
acid levels##12##2##(1990-12#2)(1993-1#1)(1993-3#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-7#1)(2010-1#1)(2012-2#1)(2013-1#1)
acid liberation induced by##2##4##(1994-3#1)(1995-11#1)
acid liberation##7##2##(1994-3#3)(1995-11#3)(1997-1#1)
acid may be##4##3##(1992-9#1)(1995-11#1)(1996-5#1)(2008-10#1)
acid may##6##2##(1992-9#1)(1995-11#1)(1996-5#1)(2008-10#2)(2008-11#1)
acid media was##3##3##(2008-10#3)
acid media##18##2##(2008-10#18)
acid medium and##4##3##(2008-10#4)
acid medium##41##2##(1993-9#1)(2008-10#40)
acid metabolism in##2##3##(1990-9#1)(1995-2#1)
acid metabolism##9##2##(1990-9#1)(1994-8#3)(1995-2#1)(2008-11#3)(2012-2#1)
acid method##3##2##(1992-11#1)(2008-10#2)
acid methyl ester (FAME)##3##4##(2008-10#2)(2009-3#1)
acid methyl ester##8##3##(2008-10#5)(2008-11#1)(2008-7#1)(2009-3#1)
acid methyl##15##2##(1997-2#1)(2008-10#9)(2008-11#1)(2008-7#2)(2009-3#1)(2009-8#1)
acid mine drainage (AMD)##2##4##(2008-10#2)
acid mine drainage##3##3##(2008-10#3)
acid mine##4##2##(2008-10#4)
acid mixture and##2##3##(2008-10#2)
acid mixture of##2##3##(2008-10#2)
acid mixture##10##2##(2008-10#10)
acid mixtures##4##2##(2008-10#4)
acid modified##4##2##(2008-10#4)
acid moiety##3##2##(2008-10#3)
acid monolayer##3##2##(2008-10#3)
acid nucleus basalis##2##3##(1991-9#2)
acid nucleus##3##2##(1991-9#2)(1993-6#1)
acid number determination##3##3##(2008-10#3)
acid of##9##2##(1994-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
acid on the chemiluminescence##2##4##(2008-10#2)
acid on the viscosity##3##4##(1994-11#2)(2008-5#1)
acid on the##14##3##(1990-5#1)(1994-11#2)(2008-10#9)(2008-11#1)(2008-5#1)
acid on##31##2##(1990-10#1)(1990-5#1)(1990-8#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-8#1)(2008-10#10)(2008-11#3)(2008-5#3)(2010-12#1)(2011-2#3)(2012-2#1)
acid or##20##2##(1991-2#1)(1994-11#1)(1997-2#1)(2008-10#13)(2008-11#1)(2008-5#2)(2008-9#1)
acid oxidase##3##2##(2008-10#3)
acid oxidation##8##2##(1993-3#1)(1994-5#1)(1995-2#1)(2008-1#2)(2008-10#2)(2009-8#1)
acid peptide in##2##3##(1992-6#1)(2008-11#1)
acid peptide##4##2##(1992-6#2)(2008-10#1)(2008-11#1)
acid per##3##2##(1990-9#1)(2008-10#2)
acid phosphatase activity in##2##4##(2008-11#1)(2008-7#1)
acid phosphatase in##2##3##(1995-3#1)(2008-12#1)
acid phosphatase##10##2##(1990-9#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#3)(2013-1#1)
acid photo-oxidation assay##2##3##(2008-5#2)
acid polymers are##2##3##(2008-5#2)
acid polymers##5##2##(2008-5#5)
acid polypeptide##2##2##(1991-9#1)(1995-2#1)
acid preparation##4##2##(2008-10#1)(2013-1#3)
acid pretreatment on cadmium toxicity in##2##6##(1993-12#2)
acid pretreatment##6##2##(1993-12#5)(2013-1#1)
acid probes##3##2##(2008-10#1)(2008-9#2)
acid production and##2##3##(1994-3#1)(2008-10#1)
acid production by the##2##4##(2008-10#2)
acid production by##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
acid production in##2##3##(2008-10#1)(2013-1#1)
acid production##20##2##(1993-3#1)(1994-3#1)(2008-10#8)(2008-5#3)(2008-7#3)(2010-3#1)(2012-2#1)(2013-1#2)
acid profile##4##2##(2008-5#1)(2010-11#1)(2011-2#2)
acid profiles##13##2##(1991-12#1)(2008-10#9)(2010-11#1)(2010-4#1)(2011-2#1)
acid protein##6##2##(1991-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)
acid proteins##2##2##(1995-8#1)(2008-9#1)
acid pump inhibitor##2##3##(1996-3#2)
acid rain on##2##3##(2008-10#2)
acid rain##6##2##(2008-10#6)
acid reaction##3##2##(2008-10#3)
acid reactive substances##6##3##(1992-3#2)(1993-2#1)(2008-10#2)(2011-2#1)
acid reactive##8##2##(1992-3#2)(1993-2#1)(2008-10#3)(2010-5#1)(2011-2#1)
acid reacts with##2##3##(1994-5#2)
acid receptor##3##2##(1991-9#1)(1995-2#1)(2012-2#1)
acid reduced##2##2##(2008-10#2)
acid reduces##2##2##(1990-12#1)(2008-10#1)
acid region of##2##3##(1994-5#1)(1995-6#1)
acid region##3##2##(1994-5#1)(1995-6#1)(2008-10#1)
acid release and##2##3##(1991-12#1)(1997-1#1)
acid release##7##2##(1991-12#3)(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
acid released from the##2##4##(2008-11#1)(2008-5#1)
acid released##4##2##(2008-11#1)(2008-5#3)
acid repression##2##2##(1996-3#2)
acid residue##6##2##(1992-8#1)(1993-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
acid residues in##9##3##(1993-8#1)(1994-5#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-9#2)(2012-3#1)
acid residues while##2##3##(1990-5#1)(1994-11#1)
acid residues##46##2##(1990-5#2)(1990-8#1)(1991-5#2)(1992-6#1)(1993-3#2)(1993-8#2)(1994-11#3)(1994-5#1)(1995-6#5)(1995-8#2)(1997-4#2)(1997-7#1)(1997-8#2)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#5)(2008-9#5)(2009-8#1)(2011-2#1)(2012-3#1)
acid resulted in a##2##4##(1992-8#1)(2013-1#1)
acid resulted in##3##3##(1992-8#1)(2008-5#1)(2013-1#1)
acid revealed##2##2##(2008-10#1)(2008-7#1)
acid samples##4##2##(2008-10#2)(2008-4#2)
acid secretion and##3##3##(1992-6#1)(1997-1#2)
acid secretion in the##2##4##(1993-12#2)
acid secretion in##4##3##(1992-6#1)(1993-12#3)
acid secretion is##3##3##(1997-1#3)
acid secretion##22##2##(1990-9#1)(1992-6#3)(1993-12#3)(1997-1#14)(2008-10#1)
acid self-assembled##2##2##(2008-10#2)
acid sequence analysis##3##3##(1990-2#1)(1994-11#1)(1994-5#1)
acid sequence data##3##3##(1991-10#1)(1991-9#1)(2008-10#1)
acid sequence differences##2##3##(2008-10#1)(2008-9#1)
acid sequence of the##15##4##(1990-5#2)(1991-12#1)(1992-8#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1996-12#3)(2008-10#1)(2008-11#1)(2008-6#1)
acid sequence of##31##3##(1990-5#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#1)(1995-2#1)(1995-6#2)(1996-12#4)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
acid sequence##124##2##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#5)(1995-8#2)(1996-12#8)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#23)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#5)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
acid sequences by##2##3##(2008-9#1)(2012-2#1)
acid sequences of the##12##4##(1993-12#2)(1995-5#1)(1996-8#1)(2008-10#7)(2008-5#1)
acid sequences of##28##3##(1991-10#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-8#2)(1997-2#1)(1997-8#1)(2008-10#10)(2008-5#1)(2008-8#1)(2011-2#1)
acid sequences##65##2##(1990-5#1)(1991-10#1)(1991-5#2)(1992-10#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#6)(1994-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
acid showed##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
acid signal##3##2##(1992-3#1)(1994-11#1)(2008-10#1)
acid soil##2##2##(2008-10#2)
acid soils##3##2##(2008-10#2)(2009-8#1)
acid solution and##3##3##(2008-10#3)
acid solution as##2##3##(2008-10#2)
acid solution containing##2##3##(2008-10#2)
acid solution to##2##3##(2008-10#2)
acid solution##34##2##(1996-2#1)(2008-10#33)
acid solutions##11##2##(1992-12#1)(2008-10#10)
acid structure##5##2##(2008-4#4)(2010-11#1)
acid substitution##11##2##(1991-12#1)(1991-7#1)(1993-12#1)(1994-11#1)(2006-6#1)(2008-10#4)(2008-8#1)(2011-3#1)
acid supplementation##2##2##(1992-9#1)(2008-11#1)
acid supplements##2##2##(1992-9#2)
acid synthase##3##2##(1995-2#2)(2009-8#1)
acid synthesis##7##2##(1992-4#1)(1992-8#2)(1995-6#2)(2012-2#1)(2013-1#1)
acid than##2##2##(1994-11#1)(2008-10#1)
acid that##2##2##(2008-10#2)
acid there was##2##3##(2008-5#1)(2011-2#1)
acid through##2##2##(1994-3#1)(2008-10#1)
acid to be##2##3##(1994-8#1)(2008-11#1)
acid to form##3##3##(2008-10#3)
acid to the##5##3##(1996-5#1)(2008-10#3)(2009-6#1)
acid to##36##2##(1993-9#1)(1994-5#1)(1994-8#1)(1996-5#1)(2008-10#27)(2008-11#1)(2008-5#2)(2008-9#1)(2009-6#1)
acid transport##5##2##(1990-12#2)(1991-9#2)(1994-8#1)
acid treated##2##2##(2008-8#1)(2013-1#1)
acid treatment##8##2##(1996-5#1)(2008-10#5)(2008-8#2)
acid under##3##2##(2008-10#2)(2010-7#1)
acid units##2##2##(2008-10#2)
acid uptake##3##2##(1995-11#2)(2008-11#1)
acid urease##3##2##(2008-10#3)
acid using a##3##3##(2008-10#3)
acid using an##2##3##(2008-10#2)
acid using##11##2##(2008-10#11)
acid values in##4##3##(2008-10#4)
acid vapor partial digestion##2##4##(2008-10#2)
acid vapor##5##2##(2008-10#5)
acid variations##2##2##(2008-5#2)
acid volume##3##2##(2008-10#3)
acid was achieved##2##3##(2008-10#2)
acid was added to the##3##5##(2008-10#3)
acid was added to##5##4##(2008-10#5)
acid was also##3##3##(2008-10#2)(2008-9#1)
acid was determined by##2##4##(2008-7#1)(2012-3#1)
acid was developed##2##3##(2008-10#2)
acid was found to be the##2##6##(2009-3#1)(2011-2#1)
acid was found to be##4##5##(1991-5#1)(2008-11#1)(2009-3#1)(2011-2#1)
acid was found to##6##4##(1991-5#1)(2008-10#2)(2008-11#1)(2009-3#1)(2011-2#1)
acid was found##7##3##(1991-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)
acid was made##2##3##(2008-10#2)
acid was not##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
acid was selected##3##3##(2008-10#2)(2008-5#1)
acid was studied##2##3##(2008-10#2)
acid was used for the##2##5##(2008-10#2)
acid was used for##5##4##(1997-2#2)(2008-10#3)
acid was used##7##3##(1997-2#2)(2008-10#5)
acid was verified##2##3##(2008-10#2)
acid was##83##2##(1991-5#3)(1994-6#2)(1997-2#2)(2008-10#52)(2008-11#4)(2008-5#4)(2008-7#1)(2008-9#5)(2009-3#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
acid were also##2##3##(1990-5#1)(2013-1#1)
acid were determined by##2##4##(2008-10#2)
acid were determined##4##3##(2008-10#4)
acid were found to##2##4##(1990-10#1)(2013-1#1)
acid were found##4##3##(1990-10#1)(2008-11#2)(2013-1#1)
acid were investigated##2##3##(2008-10#2)
acid were the##2##3##(2008-11#1)(2010-4#1)
acid were used##2##3##(2008-10#2)
acid were##35##2##(1990-10#1)(1990-5#3)(1994-5#1)(1994-6#1)(2008-10#21)(2008-11#4)(2010-4#1)(2013-1#2)(2013-8#1)
acid when##3##2##(2008-10#3)
acid which is##2##3##(2008-10#1)(2008-11#1)
acid which##5##2##(2008-10#3)(2008-11#1)(2009-6#1)
acid with a##8##3##(2008-10#7)(2012-2#1)
acid with alkaline##3##3##(2008-10#3)
acid with the##3##3##(2008-10#3)
acid with##35##2##(2008-10#28)(2008-11#1)(2008-5#2)(2010-7#1)(2012-2#2)(2012-3#1)
acid without##4##2##(2008-10#3)(2013-1#1)
acid##3585##1##(1990-10#5)(1990-11#3)(1990-12#17)(1990-2#5)(1990-3#3)(1990-5#26)(1990-6#5)(1990-7#4)(1990-8#18)(1990-9#7)(1991-10#2)(1991-11#1)(1991-12#24)(1991-2#1)(1991-3#3)(1991-5#17)(1991-6#5)(1991-7#2)(1991-9#17)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#17)(1992-2#2)(1992-3#15)(1992-4#7)(1992-6#18)(1992-7#2)(1992-8#13)(1992-9#14)(1993-1#7)(1993-11#6)(1993-12#23)(1993-2#7)(1993-3#22)(1993-6#12)(1993-8#43)(1993-9#10)(1994-11#41)(1994-12#3)(1994-2#2)(1994-3#16)(1994-5#32)(1994-6#11)(1994-8#28)(1995-10#1)(1995-11#39)(1995-12#9)(1995-2#11)(1995-3#6)(1995-5#1)(1995-6#29)(1995-8#12)(1995-9#2)(1996-11#1)(1996-12#15)(1996-2#6)(1996-3#13)(1996-5#15)(1996-6#9)(1996-8#2)(1996-9#1)(1997-1#26)(1997-2#29)(1997-3#10)(1997-4#7)(1997-6#2)(1997-7#8)(1997-8#12)(1997-9#7)(2006-6#2)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#1970)(2008-11#148)(2008-12#18)(2008-3#5)(2008-4#25)(2008-5#124)(2008-6#10)(2008-7#37)(2008-8#50)(2008-9#70)(2009-10#1)(2009-3#3)(2009-6#13)(2009-7#8)(2009-8#19)(2009-9#1)(2010-1#10)(2010-10#2)(2010-11#5)(2010-12#4)(2010-3#7)(2010-4#16)(2010-5#4)(2010-6#2)(2010-7#6)(2011-1#22)(2011-10#3)(2011-2#59)(2011-3#6)(2012-12#5)(2012-2#33)(2012-3#13)(2012-9#3)(2013-1#63)(2013-8#15)
acid&gt##4##1##(2008-10#4)
acid) (PLGA)##2##2##(2009-7#2)
acid) and##15##2##(1995-11#1)(2008-10#14)
acid) as a##2##3##(2008-10#2)
acid) as##3##2##(2008-10#3)
acid) in##5##2##(2008-10#5)
acid) was##2##2##(2008-10#1)(2008-7#1)
acid) were##3##2##(2008-10#3)
acid)##92##1##(1990-10#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-11#4)(1995-6#1)(2008-10#68)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-7#3)(2010-4#3)(2012-12#1)(2013-1#1)
acid- and##2##2##(1994-11#1)(1997-1#1)
acid- or##2##2##(2008-10#1)(2008-11#1)
acid-##6##1##(1994-11#1)(1997-1#1)(2008-10#2)(2008-11#2)
acid-NaOH (pH##2##2##(2008-10#2)
acid-ammonium##2##1##(1990-10#1)(2008-10#1)
acid-assisted##4##1##(2008-10#2)(2013-1#2)
acid-base balance##2##2##(2010-7#1)(2012-3#1)
acid-base behavior##4##2##(2008-10#4)
acid-base catalysis##2##2##(1993-8#1)(2008-10#1)
acid-base equilibria in##2##3##(2008-10#2)
acid-base equilibria of##3##3##(2008-10#3)
acid-base equilibria##8##2##(2008-10#8)
acid-base indicator##2##2##(2008-10#2)
acid-base indicators##3##2##(2008-10#3)
acid-base properties of the##2##4##(2008-10#2)
acid-base properties of##3##3##(2008-10#3)
acid-base properties##7##2##(2008-10#7)
acid-base systems##2##2##(2008-10#2)
acid-base titration##4##2##(2008-10#4)
acid-base##47##1##(1993-8#2)(2008-10#42)(2010-7#1)(2011-2#1)(2012-3#1)
acid-based##6##1##(2008-12#1)(2008-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
acid-binding protein##4##2##(1994-8#2)(2013-1#2)
acid-binding##9##1##(1993-2#1)(1994-8#2)(2008-10#1)(2008-8#3)(2013-1#2)
acid-catalyzed##2##1##(1996-5#1)(2008-10#1)
acid-coated##3##1##(2008-10#1)(2008-11#2)
acid-dependent##3##1##(2008-10#2)(2009-6#1)
acid-digested##4##1##(2008-10#4)
acid-digestion##3##1##(2008-10#3)
acid-extractable##3##1##(2008-10#3)
acid-fast##3##1##(1996-12#1)(2008-11#1)(2010-8#1)
acid-imbedded##3##1##(2008-10#3)
acid-induced##2##1##(1997-7#1)(2008-7#1)
acid-matched##2##1##(2008-10#2)
acid-resistant##2##1##(1996-2#1)(2008-10#1)
acid-rich##2##1##(1994-11#1)(2008-8#1)
acid-sodium acetate##6##2##(2008-10#6)
acid-sodium##7##1##(2008-10#7)
acid-soluble##3##1##(1996-8#1)(1997-2#2)
acid-volatile##2##1##(2008-10#2)
acid-washed PM 1648 instilled mice##2##5##(2008-10#2)
acid-washed PM 1648 instilled##3##4##(2008-10#3)
acid-washed PM 1648##5##3##(2008-10#5)
acid/base##2##1##(2008-10#2)
acid]##3##1##(1994-9#1)(2008-10#2)
acidic Fc-fusion##2##2##(2011-2#2)
acidic amino acids##2##3##(1990-7#1)(2008-5#1)
acidic and alkaline##2##3##(2008-10#2)
acidic and basic##7##3##(2008-10#6)(2012-3#1)
acidic and calcareous soils##2##4##(2012-6#2)
acidic and neutral##2##3##(2008-10#2)
acidic and##16##2##(1991-6#1)(2008-10#11)(2012-12#1)(2012-3#1)(2012-6#2)
acidic aqueous##2##2##(2008-10#2)
acidic buffer##2##2##(2008-10#2)
acidic carrier##3##2##(2008-10#3)
acidic cation exchanger##2##3##(2008-10#2)
acidic compounds##2##2##(2008-10#2)
acidic conditions##14##2##(1990-8#1)(1995-8#1)(1996-5#1)(2008-10#11)
acidic domain##2##2##(1993-2#1)(1995-6#1)
acidic exchange##2##2##(2008-10#2)
acidic fibroblast growth factor##3##4##(1990-8#2)(1997-7#1)
acidic groups##3##2##(2008-10#3)
acidic hydrolysis of##3##3##(2008-10#3)
acidic hydrolysis##5##2##(1997-2#2)(2008-10#3)
acidic lipids in the##2##4##(1994-5#2)
acidic media has been##2##4##(2008-10#2)
acidic media##19##2##(1995-8#1)(2008-10#17)(2010-6#1)
acidic medium and##3##3##(2008-10#3)
acidic medium is##2##3##(2008-10#2)
acidic medium to form a##4##5##(2008-10#4)
acidic medium to form##7##4##(2008-10#7)
acidic medium##39##2##(2008-10#38)(2008-8#1)
acidic metabolites were##2##3##(2008-10#2)
acidic methanol##2##2##(1990-9#1)(2008-10#1)
acidic or##3##2##(2008-10#2)(2008-11#1)
acidic pH##8##2##(1991-5#1)(1994-5#1)(2008-10#5)(2008-11#1)
acidic potassium permanganate chemiluminescence##2##4##(2008-10#2)
acidic potassium permanganate##8##3##(2008-10#8)
acidic protease##3##2##(1993-12#3)
acidic protein##8##2##(1990-7#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-1#1)
acidic recognition site##2##3##(1994-5#2)
acidic residues##3##2##(1992-7#1)(1994-5#1)(1995-6#1)
acidic resins##4##2##(2008-10#4)
acidic silica column##2##3##(2008-10#2)
acidic soil##6##2##(2008-10#1)(2008-12#1)(2012-6#2)(2012-9#2)
acidic solution (pH##2##3##(2008-10#2)
acidic solution##18##2##(2008-10#16)(2008-11#1)(2008-5#1)
acidic solutions##4##2##(2008-10#4)
acidic waste solutions##2##3##(2008-10#2)
acidic waste##3##2##(2008-10#3)
acidic##280##1##(1990-10#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#3)(1992-7#1)(1993-12#3)(1993-2#1)(1994-5#10)(1994-6#2)(1995-6#3)(1995-8#2)(1996-5#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#2)(2006-6#3)(2008-10#200)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#4)(2012-9#2)
acidification and##2##2##(1990-2#1)(2008-10#1)
acidification gradient##3##2##(2012-3#3)
acidification in##2##2##(2008-10#1)(2008-7#1)
acidification of the samples##2##4##(2008-10#2)
acidification of the##5##3##(2008-10#4)(2008-9#1)
acidification##25##1##(1990-2#1)(1995-8#1)(2008-10#18)(2008-7#1)(2008-9#1)(2012-3#3)
acidified samples##3##2##(2008-10#3)
acidified urine##2##2##(2008-10#2)
acidified water##2##2##(2008-10#2)
acidified with 0##3##3##(2008-10#3)
acidified with##5##2##(2008-10#5)
acidified##29##1##(2008-10#28)(2011-2#1)
acidifying##3##1##(1993-8#1)(2008-10#2)
acidities##5##1##(2008-10#5)
acidity and##5##2##(2008-10#5)
acidity as##2##2##(2008-10#2)
acidity constants of##6##3##(2008-10#6)
acidity constants##8##2##(2008-10#8)
acidity of the##8##3##(2008-10#7)(2013-1#1)
acidity of##11##2##(2008-10#10)(2013-1#1)
acidity##61##1##(1996-9#1)(2008-10#55)(2008-5#1)(2011-2#2)(2013-1#2)
acidobasic##2##1##(2008-10#2)
acidocaldarius##3##1##(1990-2#3)
acidophilus LA-1##2##2##(2008-5#2)
acidophilus##9##1##(2008-5#6)(2012-2#2)(2013-1#1)
acidosis and##3##2##(1990-3#2)(2008-5#1)
acidosis##19##1##(1990-3#2)(1990-5#2)(1991-11#1)(1994-2#1)(1994-3#3)(1996-11#1)(1996-3#1)(2008-1#2)(2008-3#1)(2008-5#3)(2008-8#1)(2010-1#1)
acidotic crises##2##2##(1994-3#2)
acidotic##4##1##(1990-6#1)(1994-3#2)(2012-12#1)
acids (HA)##4##2##(2008-10#4)
acids (HAs)##3##2##(2008-10#3)
acids 5##2##2##(1996-5#1)(2008-10#1)
acids accounted for##2##3##(1990-5#1)(2010-11#1)
acids analysis and##2##3##(2008-10#1)(2008-8#1)
acids analyzed##2##2##(2008-10#1)(2008-11#1)
acids and bases##3##3##(2008-10#3)
acids and for##2##3##(2008-10#2)
acids and has##2##3##(1992-8#1)(2008-9#1)
acids and other##2##3##(2008-10#2)
acids and sterols##2##3##(2008-10#2)
acids and the determination of##2##5##(2008-10#2)
acids and the##3##3##(1991-12#1)(2008-10#2)
acids and their##5##3##(1997-2#1)(2008-10#3)(2008-9#1)
acids and then##2##3##(2008-10#2)
acids and##80##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-8#1)(2008-10#48)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
acids are extracted in##2##4##(2008-10#2)
acids are important##2##3##(2008-5#1)(2011-1#1)
acids are prepared##2##3##(1992-11#1)(2008-10#1)
acids are##16##2##(1992-11#1)(1993-2#1)(1994-6#1)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-2#1)
acids as well as##2##4##(2008-10#2)
acids as##7##2##(2008-10#5)(2011-1#1)(2012-2#1)
acids at##11##2##(1992-9#1)(1996-5#1)(2008-10#7)(2008-9#2)
acids based on##2##3##(2008-10#2)
acids based##3##2##(1991-7#1)(2008-10#2)
acids but not##2##3##(2008-10#1)(2011-2#1)
acids but##3##2##(2008-10#2)(2011-2#1)
acids by a##2##3##(2008-10#1)(2011-1#1)
acids by gas##2##3##(2008-10#2)
acids by##19##2##(1994-5#1)(1994-8#1)(1995-3#2)(2008-10#13)(2011-1#1)(2011-2#1)
acids can##2##2##(2008-10#2)
acids could be##2##3##(1995-3#1)(2008-10#1)
acids extracted from##2##3##(2008-10#2)
acids for##5##2##(1990-12#4)(2008-10#1)
acids found in##2##3##(2008-10#2)
acids from an##2##3##(2008-10#2)
acids from different##2##3##(2008-10#1)(2009-8#1)
acids from the##5##3##(1991-5#1)(1992-9#1)(1994-8#1)(2008-10#2)
acids from##24##2##(1991-12#1)(1991-5#1)(1992-9#1)(1994-8#2)(2008-10#15)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#1)
acids has been developed##2##4##(1992-11#1)(2008-10#1)
acids has been##3##3##(1992-11#1)(2008-10#2)
acids has##4##2##(1992-11#1)(1996-6#1)(2008-10#2)
acids have been carried out in##2##6##(2008-10#2)
acids have been##7##3##(1992-11#1)(2008-10#4)(2008-9#1)(2010-1#1)
acids having##2##2##(2008-10#1)(2013-1#1)
acids in N##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
acids in a##2##3##(2008-10#2)
acids in betaine##2##3##(2008-10#2)
acids in dilute aqueous##2##4##(2008-10#2)
acids in plasma##3##3##(1991-12#2)(1992-3#1)
acids in serum##4##3##(1993-2#3)(2008-10#1)
acids in the##20##3##(1990-5#1)(1990-6#1)(1991-12#1)(1995-11#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-8#1)(2010-4#2)(2012-2#2)
acids in##89##2##(1990-5#1)(1990-6#1)(1991-12#4)(1991-6#1)(1991-7#1)(1992-3#2)(1993-2#3)(1995-11#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-2#3)(1997-3#1)(2008-10#45)(2008-11#5)(2008-5#3)(2008-8#2)(2008-9#3)(2010-12#1)(2010-4#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
acids into##4##2##(1992-3#2)(2008-10#1)(2008-9#1)
acids is the##2##3##(1991-12#1)(1992-8#1)
acids is##7##2##(1991-12#1)(1992-8#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-9#1)
acids it##2##2##(1997-6#1)(2008-10#1)
acids like##2##2##(2008-10#2)
acids metabolism by VO 208##2##5##(2008-11#2)
acids mixture##2##2##(1994-6#1)(2008-10#1)
acids of the##4##3##(1992-6#1)(2008-11#1)(2008-7#1)(2008-9#1)
acids of##17##2##(1991-5#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-5#1)
acids on##7##2##(1995-12#1)(2008-10#4)(2008-11#2)
acids or##5##2##(1992-9#1)(1993-8#1)(2008-10#3)
acids play##2##2##(1992-11#1)(2008-11#1)
acids present in##2##3##(2008-5#1)(2013-8#1)
acids released by##2##3##(2008-10#2)
acids released##3##2##(1991-12#1)(2008-10#2)
acids resulted in##2##3##(2008-10#1)(2008-11#1)
acids significantly##2##2##(2008-11#2)
acids solutions##3##2##(2008-10#3)
acids that##8##2##(1992-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
acids to##8##2##(1992-8#1)(1997-4#1)(2008-10#2)(2008-11#2)(2012-2#2)
acids together with##2##3##(2008-10#1)(2008-11#1)
acids using##7##2##(2008-10#6)(2011-1#1)
acids was##18##2##(1994-8#1)(2008-10#15)(2008-11#2)
acids were determined##2##3##(2008-10#2)
acids were extracted##2##3##(1993-2#1)(2012-2#1)
acids were found##3##3##(2008-10#1)(2008-11#2)
acids were incubated with##2##4##(1994-8#2)
acids were studied##2##3##(2008-10#2)
acids were the##2##3##(2008-10#1)(2009-8#1)
acids were##37##2##(1990-12#1)(1990-7#1)(1991-12#1)(1993-2#4)(1994-8#3)(1997-2#1)(2008-10#15)(2008-11#3)(2008-5#3)(2008-7#1)(2009-8#2)(2010-4#1)(2012-2#1)
acids when##2##2##(1997-6#1)(2011-1#1)
acids which are##2##3##(1995-12#1)(2011-1#1)
acids which##8##2##(1993-6#1)(1993-8#1)(1995-12#2)(1996-12#1)(2011-1#2)(2013-1#1)
acids with the##3##3##(2008-10#3)
acids with##25##2##(1991-7#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-5#1)(1996-6#2)(2008-10#14)(2008-4#1)(2008-8#1)(2010-5#1)(2012-2#1)
acids##902##1##(1990-11#2)(1990-12#8)(1990-2#1)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#12)(1991-3#1)(1991-5#4)(1991-6#3)(1991-7#5)(1991-8#1)(1991-9#2)(1992-11#7)(1992-12#5)(1992-3#10)(1992-6#2)(1992-8#4)(1992-9#5)(1993-12#5)(1993-2#13)(1993-3#2)(1993-6#3)(1993-8#9)(1993-9#2)(1994-11#8)(1994-12#2)(1994-3#1)(1994-5#6)(1994-6#2)(1994-8#10)(1995-11#8)(1995-12#9)(1995-2#5)(1995-3#5)(1995-6#9)(1995-8#3)(1995-9#4)(1996-12#3)(1996-3#8)(1996-5#8)(1996-6#5)(1997-2#7)(1997-3#1)(1997-4#3)(1997-6#5)(1997-7#3)(1997-8#1)(2008-1#1)(2008-10#435)(2008-11#49)(2008-12#1)(2008-4#10)(2008-5#26)(2008-6#2)(2008-7#6)(2008-8#19)(2008-9#24)(2009-6#1)(2009-8#6)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#10)(2010-5#4)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#12)(2011-2#12)(2012-2#11)(2012-3#3)(2013-1#14)(2013-8#8)
acids) and##5##2##(1991-7#1)(1995-6#1)(2008-10#1)(2008-8#2)
acids) of##3##2##(1990-8#1)(2008-10#2)
acids)##34##1##(1990-8#1)(1991-7#1)(1992-3#2)(1995-6#1)(1997-9#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-8#6)(2008-9#2)(2009-10#1)(2011-2#2)(2011-3#1)(2013-1#2)
aciduria##2##1##(1994-3#2)
acinar cell##2##2##(1992-8#1)(2008-7#1)
acinar cells##5##2##(1991-5#1)(1992-8#1)(2008-7#1)(2009-7#2)
acinar##8##1##(1991-5#1)(1992-8#2)(1994-8#1)(2008-7#2)(2009-7#2)
acini and chief cells##3##4##(1994-8#3)
acini and##6##2##(1994-8#6)
acini##12##1##(1994-8#7)(1995-11#1)(2007-12#4)
acinus##2##1##(2007-12#2)
acitretin##2##1##(2007-11#2)
acknowledge and##2##2##(1995-11#1)(2008-12#1)
acknowledge that##3##2##(2008-11#2)(2010-11#1)
acknowledge##9##1##(1994-12#1)(1995-11#1)(1995-12#1)(2008-11#3)(2008-12#2)(2010-11#1)
acknowledged and##3##2##(1994-12#1)(2008-12#1)(2012-2#1)
acknowledged by##3##2##(1994-1#1)(2008-11#1)(2012-3#1)
acknowledged in the literature##3##4##(2008-11#3)
acknowledged that##2##2##(2008-1#1)(2008-11#1)
acknowledged the##2##2##(1991-6#1)(2011-1#1)
acknowledged##21##1##(1991-6#1)(1992-1#1)(1994-1#1)(1994-12#1)(1997-5#1)(2008-1#1)(2008-11#7)(2008-12#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
acknowledgement of the##2##3##(1997-7#1)(2008-11#1)
acknowledges the##2##2##(2008-11#1)(2009-12#1)
acknowledges##4##1##(1992-1#1)(2008-11#1)(2008-12#1)(2009-12#1)
acknowledging the##3##2##(1991-2#1)(2008-11#1)(2010-11#1)
aclacinomycin##2##1##(1994-5#2)
aclada subgroups##2##2##(2008-10#2)
aclada##5##1##(2008-10#5)
acne##7##1##(1997-8#3)(2008-10#1)(2008-5#1)(2011-2#2)
acorn##9##1##(1990-5#4)(1993-6#1)(2008-10#1)(2008-9#3)
acoustic neuroma##5##2##(2008-7#2)(2011-2#3)
acoustic startle response##2##3##(1996-2#1)(1996-5#1)
acoustic wave DNA biosensor##2##4##(2008-10#2)
acoustic wave devices##2##3##(2008-10#1)(2009-3#1)
acoustic wave sensor##3##3##(2008-10#3)
acoustic wave sensors##2##3##(2008-10#1)(2009-3#1)
acoustic wave##29##2##(2007-12#3)(2008-10#21)(2009-3#4)(2009-5#1)
acoustic##54##1##(1993-5#1)(1996-2#3)(1996-5#1)(1996-6#1)(2007-12#3)(2008-10#25)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-3#4)(2009-5#3)(2010-12#1)(2011-1#2)(2011-2#3)(2013-1#1)
acoustical##2##1##(1991-12#1)(2008-8#1)
acoustics##5##1##(2008-3#4)(2011-1#1)
acousto-optic modulator##2##2##(2008-2#1)(2013-8#1)
acousto-optic tunable##5##2##(2008-10#4)(2008-3#1)
acousto-optic##10##1##(2008-10#6)(2008-2#1)(2008-3#2)(2013-8#1)
acpP##2##1##(1992-4#2)
acquainted with##2##2##(1994-12#1)(2011-2#1)
acquire a##9##2##(1992-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
acquire an##2##2##(2008-11#1)(2009-9#1)
acquire different##2##2##(1990-12#1)(2013-8#1)
acquire the infection during##2##4##(1990-9#2)
acquire the##9##2##(1990-9#2)(1995-2#1)(1996-1#1)(2008-10#3)(2008-4#1)(2012-2#1)
acquire##52##1##(1990-12#1)(1990-9#2)(1992-12#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-1#2)(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
acquired HIV infection##2##3##(1996-11#2)
acquired HIV##3##2##(1996-11#3)
acquired PMWaV##2##2##(2008-10#2)
acquired TSWV##2##2##(2008-10#2)
acquired a##3##2##(1993-6#1)(2008-11#1)(2011-2#1)
acquired and transmitted by##3##4##(2008-10#3)
acquired and transmitted##4##3##(2008-10#4)
acquired and##9##2##(1991-6#1)(1993-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-6#1)
acquired at##4##2##(1995-5#1)(2008-10#2)(2008-5#1)
acquired by accumulating##2##3##(2008-10#2)
acquired by the##3##3##(1997-3#1)(2008-10#1)(2008-3#1)
acquired by##13##2##(1995-3#1)(1997-3#1)(2008-10#7)(2008-3#2)(2009-6#1)(2012-3#1)
acquired cystic kidney disease##3##4##(2011-2#3)
acquired during the##3##3##(1990-9#1)(2008-10#1)(2011-2#1)
acquired for##2##2##(2008-10#2)
acquired form of angioedema##2##4##(2013-1#2)
acquired from a##2##3##(2008-2#1)(2011-7#1)
acquired from##6##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)(2011-7#1)
acquired heart disease##2##3##(2009-12#1)(2012-2#1)
acquired heart##3##2##(2009-12#1)(2012-2#2)
acquired images##2##2##(2008-10#1)(2009-7#1)
acquired immunity##2##2##(1997-3#1)(2008-8#1)
acquired immunodeficiency syndrome (AIDS) patients##2##5##(1996-2#1)(1997-8#1)
acquired immunodeficiency syndrome (AIDS)##13##4##(1990-6#1)(1991-12#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-3#2)(1997-8#1)(2011-3#1)
acquired immunodeficiency syndrome##23##3##(1990-6#1)(1991-12#3)(1991-9#1)(1993-1#2)(1993-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-3#2)(1997-8#1)(2008-12#1)(2008-2#2)(2011-3#1)(2013-1#1)
acquired immunodeficiency##24##2##(1990-6#1)(1991-12#3)(1991-9#1)(1993-1#2)(1993-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-3#2)(1997-8#1)(2008-12#1)(2008-2#2)(2011-2#1)(2011-3#1)(2013-1#1)
acquired in a continuous mode##2##5##(2008-10#2)
acquired in a##3##3##(2008-10#3)
acquired in the##4##3##(1997-1#1)(2008-10#2)(2008-2#1)
acquired in##13##2##(1995-3#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
acquired resistance (SAR)##6##3##(2008-10#5)(2011-10#1)
acquired resistance in##3##3##(2008-10#3)
acquired resistance##18##2##(2008-10#13)(2008-11#2)(2010-5#1)(2011-10#1)(2011-2#1)
acquired the ability to##2##4##(1995-2#1)(2008-10#1)
acquired the##4##2##(1995-2#1)(1996-11#1)(2008-10#2)
acquired through##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
acquired using##4##2##(2008-10#2)(2008-6#1)(2012-3#1)
acquired with an##2##3##(2008-3#2)
acquired with##5##2##(2008-10#1)(2008-3#4)
acquired##206##1##(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#3)(1991-6#2)(1991-9#1)(1992-5#1)(1993-1#3)(1993-12#2)(1993-6#3)(1994-3#1)(1994-5#3)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#5)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#4)(1997-8#1)(2007-12#3)(2008-10#65)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#2)(2009-3#6)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#13)(2011-3#2)(2011-7#1)(2012-2#5)(2012-3#5)(2013-1#6)
acquires a##2##2##(1995-2#1)(1996-2#1)
acquires##7##1##(1992-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
acquiring a##3##2##(2008-3#1)(2008-9#1)(2010-6#1)
acquiring the##2##2##(2008-10#1)(2008-3#1)
acquiring##17##1##(1993-1#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#3)(2010-6#1)(2012-2#1)(2013-1#1)
acquisition access feeding##2##3##(2008-10#2)
acquisition access period##4##3##(2008-10#4)
acquisition access periods (AAPs)##3##4##(2008-10#3)
acquisition access periods##4##3##(2008-10#4)
acquisition access##10##2##(2008-10#10)
acquisition and in##2##3##(1992-12#1)(1994-8#1)
acquisition and retention of##2##4##(1991-2#1)(2012-2#1)
acquisition and retention##4##3##(1991-2#1)(2012-2#3)
acquisition and transmission##3##3##(2008-10#3)
acquisition and##24##2##(1991-2#2)(1992-12#1)(1994-8#1)(1996-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-9#1)(2012-2#3)
acquisition as##3##2##(1991-6#1)(2008-5#1)(2011-2#1)
acquisition by##5##2##(2008-10#4)(2009-8#1)
acquisition decisions##2##2##(1994-12#2)
acquisition in Canadian hospitals##2##4##(1994-12#2)
acquisition in##7##2##(1991-1#1)(1994-12#2)(2008-11#1)(2008-8#1)(2011-2#2)
acquisition is##2##2##(2008-8#1)(2008-9#1)
acquisition of a new response##2##5##(1993-6#2)
acquisition of a##4##3##(1993-6#3)(2008-8#1)
acquisition of food##2##3##(1991-2#1)(2008-9#1)
acquisition of hypovirulence##2##3##(2008-9#2)
acquisition of knowledge##3##3##(2008-12#2)(2011-2#1)
acquisition of the CPP##2##4##(1993-6#2)
acquisition of the##5##3##(1991-2#1)(1993-6#2)(2008-8#1)(2009-3#1)
acquisition of##53##2##(1991-2#3)(1992-2#1)(1993-3#1)(1993-6#5)(1994-8#2)(1995-8#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#7)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#3)(2013-1#1)
acquisition or##3##2##(1993-6#1)(1994-8#1)(1996-1#1)
acquisition rate##2##2##(2008-10#1)(2008-8#1)
acquisition rather than##2##3##(2008-11#1)(2008-4#1)
acquisition time##2##2##(2008-3#1)(2012-12#1)
acquisition to##2##2##(2008-5#2)
acquisition trials##2##2##(1993-3#1)(2008-5#1)
acquisition was##2##2##(2010-6#1)(2011-7#1)
acquisition when##2##2##(2008-10#1)(2008-8#1)
acquisition##176##1##(1991-1#1)(1991-2#6)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#3)(1993-6#7)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#6)(1995-11#1)(1995-8#1)(1996-1#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#47)(2008-11#18)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#10)(2008-7#1)(2008-8#10)(2008-9#11)(2009-3#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-7#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)
acquisitions##4##1##(2008-11#3)(2008-12#1)
acral melanoma##3##2##(2010-6#3)
acral##6##1##(2008-9#1)(2010-6#4)(2012-3#1)
acridan-based##2##1##(2008-10#2)
acridine orange (AO) and##2##4##(2008-10#1)(2008-9#1)
acridine orange (AO)##5##3##(2008-10#2)(2008-12#2)(2008-9#1)
acridine orange and##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
acridine orange##15##2##(1990-6#3)(1991-11#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#4)
acridine##16##1##(1990-6#3)(1991-11#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#4)
acridinium##2##1##(1992-9#1)(2008-10#1)
acrivastine##7##1##(2008-10#7)
acrocentric##3##1##(1993-12#2)(2008-12#1)
acronym##4##1##(1996-12#1)(2008-3#2)(2011-2#1)
acronyms##2##1##(2012-3#2)
acropetal##2##1##(2008-10#2)
acrophase##3##1##(2008-11#3)
acrosomal complex##4##2##(2007-12#4)
acrosomal##10##1##(1994-8#3)(2007-12#6)(2008-8#1)
acrosome and the##2##3##(2008-7#2)
acrosome and##4##2##(2008-7#4)
acrosome biogenesis##3##2##(2012-2#3)
acrosome of##3##2##(1995-6#1)(2008-7#2)
acrosome reaction and##2##3##(2008-8#2)
acrosome reaction##11##2##(2008-8#9)(2013-1#2)
acrosome##28##1##(1995-6#1)(2008-7#9)(2008-8#11)(2012-2#5)(2013-1#2)
across Canada##7##2##(1995-2#1)(2008-11#2)(2008-12#1)(2012-12#2)(2013-1#1)
across North America##3##3##(1995-1#1)(2008-11#1)(2011-9#1)
across a broad##3##3##(2008-5#1)(2008-8#2)
across a number of##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
across a wide##4##3##(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)
across a##30##2##(1990-8#1)(1994-12#1)(1994-5#1)(1996-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-7#1)(2009-8#2)(2012-3#2)(2013-1#2)
across all age groups##2##4##(2008-11#1)(2010-7#1)
across all four##2##3##(2008-11#1)(2008-12#1)
across all treatments##2##3##(2013-1#2)
across all##20##2##(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2009-1#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-1#3)
across an##2##2##(1995-2#1)(2012-3#1)
across areas##2##2##(1991-3#1)(2008-10#1)
across both##3##2##(1994-3#1)(2008-10#1)(2012-2#1)
across conditions##2##2##(2008-11#1)(2008-5#1)
across countries##4##2##(1993-2#2)(2012-2#1)(2013-8#1)
across cultures##2##2##(2013-8#2)
across days##6##2##(2008-12#6)
across different organisms##2##3##(2008-8#2)
across different##17##2##(1993-12#1)(1994-12#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#3)(2009-7#1)(2010-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
across disciplines##2##2##(2008-11#2)
across diverse HIV-1 subtypes##2##4##(2013-1#2)
across diverse##5##2##(1990-8#1)(2008-8#1)(2012-2#1)(2013-1#2)
across ethnic groups##2##3##(2008-1#1)(2012-2#1)
across four##2##2##(1994-2#1)(2013-8#1)
across gender##2##2##(2010-1#2)
across geographic areas##2##3##(1992-12#1)(2012-3#1)
across groups##2##2##(2008-9#1)(2011-2#1)
across habitats##2##2##(2008-9#2)
across many##2##2##(2008-11#1)(2012-2#1)
across multiple##8##2##(2008-10#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-8#1)
across other##2##2##(2008-10#1)(2008-5#1)
across provider##2##2##(1994-12#1)(1995-2#1)
across seasons##2##2##(2008-10#1)(2009-7#1)
across sectors##2##2##(1991-2#1)(2009-4#1)
across several##5##2##(1993-2#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-10#1)
across sites##2##2##(1991-3#1)(2008-10#1)
across six##2##2##(2012-2#1)(2013-8#1)
across specialties and##2##3##(1994-1#2)
across species##13##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2012-2#3)(2012-3#2)
across states##2##2##(1996-2#1)(2008-10#1)
across studies##2##2##(2008-11#1)(2012-12#1)
across the United States##3##4##(1995-8#1)(1997-1#1)(2008-10#1)
across the WAN##2##3##(2010-3#2)
across the cell membrane##3##4##(1990-5#1)(1993-11#1)(2012-2#1)
across the country##5##3##(1994-1#1)(1994-3#1)(1995-6#1)(1996-1#1)(1997-2#1)
across the course of##2##4##(2008-12#1)(2012-2#1)
across the cytoplasmic membrane##3##4##(1991-10#2)(1991-5#1)
across the entire##6##3##(1997-3#1)(2008-10#1)(2009-7#1)(2009-9#2)(2013-3#1)
across the globe##3##3##(2008-10#1)(2009-6#1)(2012-2#1)
across the inner##2##3##(1990-2#1)(2008-11#1)
across the landscape##2##3##(2008-10#1)(2008-8#1)
across the lifespan##4##3##(2008-9#2)(2009-5#1)(2010-7#1)
across the membrane##3##3##(1991-5#1)(1993-8#1)(2008-7#1)
across the mitochondrial##2##3##(1990-2#1)(2008-8#1)
across the nuclear envelope##3##4##(2011-2#3)
across the nuclear##4##3##(1995-2#1)(2011-2#3)
across the range of##2##4##(1994-8#1)(2008-12#1)
across the region##2##3##(1997-9#1)(2008-10#1)
across the three##4##3##(1991-3#1)(1991-9#1)(2008-12#1)(2012-2#1)
across the two##2##3##(1993-2#1)(2011-2#1)
across the various##2##3##(2009-9#1)(2013-8#1)
across the##165##2##(1990-2#3)(1990-5#1)(1991-10#3)(1991-3#1)(1991-5#6)(1991-9#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-6#1)(1997-9#2)(2007-12#1)(2008-10#24)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#2)(2010-3#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#8)(2012-2#9)(2012-3#4)(2012-6#1)(2013-1#7)(2013-3#1)(2013-8#3)
across these##2##2##(1995-2#1)(1995-3#1)
across three##3##2##(1995-1#1)(2008-10#2)
across thresholds##2##2##(2008-4#2)
across time##5##2##(2008-12#1)(2009-11#1)(2009-7#2)(2011-2#1)
across trials##5##2##(2008-10#4)(2008-12#1)
across two environments##2##3##(2008-10#2)
across two##6##2##(1994-5#1)(2008-10#2)(2008-6#1)(2010-7#1)(2012-5#1)
across western and central New York##2##6##(2008-10#2)
across##492##1##(1990-2#3)(1990-5#1)(1990-8#2)(1991-10#3)(1991-2#1)(1991-3#4)(1991-5#6)(1991-9#1)(1992-12#4)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#4)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#4)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-9#2)(2007-12#3)(2008-1#2)(2008-10#92)(2008-11#35)(2008-12#17)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#25)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#11)(2009-8#9)(2009-9#4)(2010-1#4)(2010-10#4)(2010-11#1)(2010-12#2)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#8)(2010-8#3)(2011-1#2)(2011-2#12)(2011-9#1)(2012-12#7)(2012-2#26)(2012-3#25)(2012-5#1)(2012-6#2)(2013-1#26)(2013-3#1)(2013-8#11)
across-row##4##1##(2008-10#4)
acrylamide##8##1##(1990-5#1)(1991-7#1)(2008-10#4)(2008-2#1)(2009-10#1)
acrylate and##3##2##(1996-5#1)(2008-10#1)(2008-12#1)
acrylate##8##1##(1996-5#1)(2008-10#5)(2008-12#2)
acrylate)##2##1##(1995-3#1)(2008-12#1)
acrylic acid##4##2##(2008-10#1)(2008-5#3)
acrylic and sulphonic polyanions##2##4##(2008-10#2)
acrylic glue##5##2##(1997-3#3)(1997-6#2)
acrylic microspheres##2##2##(2008-10#2)
acrylic##21##1##(1997-3#3)(1997-6#2)(2008-10#7)(2008-5#4)(2011-2#1)(2013-1#4)
acrylodan##3##1##(1994-5#2)(2008-8#1)
act antagonistically to##2##3##(2008-7#1)(2010-1#1)
act antagonistically##3##2##(2008-7#1)(2010-1#1)(2012-3#1)
act as a##26##3##(1990-5#1)(1993-8#1)(1994-8#1)(1995-2#2)(1996-12#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-1#1)
act as an##6##3##(1990-2#1)(1995-6#1)(2008-11#3)(2008-9#1)
act as biocontrol agents##2##4##(2008-10#2)
act as both##4##3##(1994-3#1)(2008-10#2)(2012-2#1)
act as ecological generalists##2##4##(2008-9#2)
act as the##2##3##(1992-10#1)(2008-11#1)
act as##84##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-10#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#4)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#1)(1997-7#2)(2008-10#18)(2008-11#10)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#3)
act at the##2##3##(1990-5#1)(2008-6#1)
act at##4##2##(1990-5#1)(2008-10#1)(2008-5#1)(2008-6#1)
act both as##2##3##(2008-11#1)(2008-5#1)
act both##4##2##(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
act by##4##2##(1993-8#1)(1993-9#1)(1995-2#1)(2010-7#1)
act differently##2##2##(2008-10#1)(2008-9#1)
act in a##4##3##(1990-5#1)(2008-8#1)(2010-5#1)(2010-6#1)
act in concert##2##3##(2009-10#1)(2011-2#1)
act in the same##2##4##(2008-8#1)(2009-10#1)
act in##11##2##(1990-5#1)(2008-10#1)(2008-8#3)(2009-10#2)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)
act is##2##2##(1994-1#1)(2012-3#1)
act like a##2##3##(2008-10#1)(2008-9#1)
act like##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
act of##8##2##(1994-2#1)(1997-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2013-1#1)
act on the##8##3##(1990-5#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2013-7#1)
act on##15##2##(1990-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-7#1)
act synergistically with##4##3##(2006-6#1)(2008-10#2)(2008-8#1)
act through the same##2##4##(1995-12#1)(2010-10#1)
act through##3##2##(1995-11#1)(1995-12#1)(2010-10#1)
act to prevent##2##3##(2008-11#1)(2013-7#1)
act to##9##2##(1993-12#1)(1994-11#1)(1995-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-7#1)
act together##2##2##(1991-2#1)(1993-6#1)
act##189##1##(1990-11#1)(1990-2#1)(1990-5#4)(1991-2#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-7#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#30)(2008-11#15)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#13)(2008-9#8)(2009-10#6)(2009-3#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-5#1)(2010-6#3)(2010-7#2)(2011-2#3)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#4)
acted as a##12##3##(1995-11#1)(1995-2#1)(2008-10#5)(2008-5#1)(2010-1#2)(2013-1#2)
acted as an activator for the##3##6##(2008-10#3)
acted as an activator##4##4##(2008-10#3)(2011-2#1)
acted as an##6##3##(1991-5#1)(2008-10#4)(2011-2#1)
acted as##25##2##(1991-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#12)(2008-5#1)(2010-1#2)(2011-2#1)(2012-2#1)(2013-1#3)
acted in##2##2##(1994-3#1)(2008-8#1)
acted on##2##2##(2008-5#2)
acted synergistically to##2##3##(1991-12#1)(1993-6#1)
acted##41##1##(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#14)(2008-11#1)(2008-5#3)(2008-8#1)(2009-10#1)(2010-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
acteoside##2##1##(2008-10#2)
actin and spectrin##2##3##(1996-12#2)
actin and##14##2##(1990-2#2)(1990-5#1)(1991-5#1)(1992-9#1)(1996-12#2)(2008-11#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
actin binding##3##2##(1994-5#1)(2009-7#1)(2011-2#1)
actin concentration##3##2##(1992-3#1)(1993-8#2)
actin cytoskeleton is##2##3##(2008-11#1)(2011-2#1)
actin cytoskeleton may##2##3##(2008-11#1)(2008-9#1)
actin cytoskeleton##17##2##(1996-12#2)(1996-2#1)(1997-7#1)(2008-11#6)(2008-9#3)(2009-5#1)(2009-7#2)(2011-2#1)
actin dynamics in##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
actin dynamics##5##2##(2008-11#1)(2012-2#3)(2013-8#1)
actin filament bundles at##3##4##(2012-2#3)
actin filament bundles##4##3##(2012-2#4)
actin filament##12##2##(1991-5#1)(1996-12#1)(2009-12#1)(2009-8#1)(2009-9#2)(2011-2#1)(2012-2#5)
actin filaments and##3##3##(1993-8#3)
actin filaments##19##2##(1993-6#2)(1993-8#3)(1993-9#1)(2008-11#4)(2008-7#1)(2008-9#4)(2009-9#3)(2012-2#1)
actin gene##4##2##(2008-10#2)(2010-5#2)
actin in the##3##3##(1992-4#1)(1996-12#1)(2011-2#1)
actin in##9##2##(1992-4#1)(1993-3#1)(1994-5#2)(1994-6#1)(1996-12#1)(2008-1#1)(2011-2#2)
actin is##3##2##(1993-8#2)(2008-9#1)
actin nucleation##2##2##(2012-2#2)
actin patches have also been##2##5##(2008-11#2)
actin promoter##2##2##(2010-5#1)(2012-3#1)
actin regulatory proteins##2##3##(2012-2#2)
actin was##5##2##(1991-5#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-12#1)
actin were##3##2##(1991-5#1)(1994-8#1)(2011-2#1)
actin with##2##2##(1994-5#1)(2011-2#1)
actin##177##1##(1990-2#6)(1990-5#2)(1991-5#11)(1991-6#1)(1992-3#5)(1992-4#4)(1992-9#1)(1993-3#3)(1993-6#2)(1993-8#10)(1993-9#1)(1994-12#2)(1994-5#6)(1994-6#2)(1994-8#1)(1996-12#7)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#33)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#14)(2009-12#2)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#5)(2010-12#1)(2010-5#5)(2011-2#13)(2012-2#21)(2012-3#1)(2013-8#2)
actin-binding peptide##2##2##(1993-8#2)
actin-binding proteins##5##2##(1993-8#1)(2009-9#1)(2011-2#1)(2012-2#2)
actin-binding site##3##2##(1993-8#2)(2011-2#1)
actin-binding##19##1##(1990-5#1)(1993-8#7)(1994-5#1)(2009-7#2)(2009-9#1)(2011-2#4)(2012-2#3)
acting as a platform##4##4##(2010-12#3)(2012-2#1)
acting as a##14##3##(1991-3#1)(1992-6#1)(1993-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#3)(2011-1#1)(2012-2#2)
acting as an##2##3##(2008-5#1)(2012-2#1)
acting as##29##2##(1990-11#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-2#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#3)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)
acting at##2##2##(1992-8#1)(2008-7#1)
acting in the##3##3##(1997-8#1)(2010-4#1)(2012-3#1)
acting in##5##2##(1995-3#1)(1997-8#1)(2010-4#1)(2012-3#2)
acting on these##2##3##(2009-12#1)(2012-3#1)
acting on##14##2##(1994-8#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-10#1)(2009-12#1)(2010-10#1)(2012-3#2)(2013-1#1)
acting through a##2##3##(1992-1#1)(1995-2#1)
acting through##4##2##(1992-1#1)(1995-2#1)(1995-8#1)(2008-4#1)
acting upon the##2##3##(2007-12#1)(2008-10#1)
acting upon##3##2##(1994-11#1)(2007-12#1)(2008-10#1)
acting##78##1##(1990-11#1)(1991-3#1)(1992-1#2)(1992-3#3)(1992-6#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-8#2)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#2)
actinic##4##1##(2008-5#2)(2011-2#2)
actinides and lanthanides##3##3##(2008-10#3)
actinides and##5##2##(2008-10#5)
actinides##8##1##(2008-10#8)
actinobacterial strains##2##2##(2012-2#2)
actinobacterial##7##1##(2011-2#4)(2012-2#3)
actinomyces##2##1##(2008-1#1)(2013-8#1)
actinomycete##4##1##(2008-10#4)
actinomycetes##11##1##(2008-10#9)(2009-6#1)(2010-12#1)
actinomycin D and##2##3##(1991-5#1)(2008-11#1)
actinomycin D##10##2##(1991-5#1)(1992-1#1)(1994-8#1)(1995-12#1)(2008-11#6)
actinomycosis##8##1##(1992-2#1)(2008-1#3)(2010-12#2)(2013-8#2)
actinophylla##3##1##(2008-10#3)
action against##5##2##(2008-10#2)(2008-7#1)(2013-7#1)(2013-8#1)
action aimed##2##2##(1991-6#1)(2008-11#1)
action and##18##2##(1991-2#2)(1993-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
action as##4##2##(2008-6#1)(2011-2#3)
action at##4##2##(1991-2#1)(1991-6#1)(1994-11#1)(2008-11#1)
action by the##2##3##(1997-2#1)(2009-11#1)
action by##6##2##(1991-1#1)(1992-6#1)(1997-2#1)(2008-10#1)(2009-11#1)(2012-2#1)
action coping##2##2##(2009-7#2)
action could##3##2##(1996-2#1)(2008-10#1)(2012-3#1)
action for##7##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#2)
action in rodents##2##3##(1990-3#1)(2008-7#1)
action in the##5##3##(1990-5#1)(1992-12#1)(1996-1#1)(1996-12#1)(2013-8#1)
action in this##3##3##(1990-11#1)(1996-12#1)(2008-5#1)
action in vitro##2##3##(1997-4#2)
action in##25##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1992-12#1)(1992-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
action is##13##2##(1990-12#1)(1990-5#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2013-1#2)
action mechanisms##2##2##(1994-11#1)(2008-11#1)
action model##2##2##(2008-11#1)(2008-7#1)
action of CGRP##2##3##(1992-6#2)
action of EA##2##3##(1995-12#2)
action of a##8##3##(1997-4#1)(2008-10#3)(2008-3#2)(2008-5#1)(2010-3#1)
action of acupuncture was##2##4##(1995-12#2)
action of acupuncture##4##3##(1995-12#3)(2008-10#1)
action of adenosine##3##3##(1996-2#3)
action of an##2##3##(1990-2#1)(2008-11#1)
action of antiestrogens##2##3##(2008-11#2)
action of cannabidiol##2##3##(2010-10#2)
action of central ET-1##2##4##(1994-11#2)
action of multiple##2##3##(1994-12#1)(2012-3#1)
action of phospholipids on the##2##5##(1995-8#2)
action of retinoic acid##2##4##(1990-6#2)
action of the Isabella volatiles##2##5##(2008-10#2)
action of the drug##5##4##(1990-11#2)(1991-10#1)(1994-8#1)(2008-10#1)
action of the##30##3##(1990-11#2)(1990-5#1)(1991-10#1)(1992-3#2)(1994-5#1)(1994-8#2)(1997-1#1)(1997-7#1)(2008-10#10)(2008-11#3)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
action of these compounds##2##4##(1994-2#1)(1994-8#1)
action of these##7##3##(1994-2#1)(1994-8#1)(2008-10#3)(2008-11#2)
action of this##5##3##(1994-3#1)(1996-3#1)(1997-2#2)(2008-10#1)
action of##208##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#2)(1991-10#1)(1991-5#2)(1991-8#1)(1992-3#3)(1992-6#5)(1993-3#1)(1993-8#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#3)(1994-8#5)(1995-12#8)(1995-6#2)(1995-8#3)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#6)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#45)(2008-11#28)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#1)
action on the##10##3##(1990-5#1)(1992-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#2)(2012-12#1)
action on tumor##2##3##(2013-7#1)(2013-8#1)
action on##26##2##(1990-5#1)(1991-6#1)(1992-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2010-1#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-12#1)(2013-7#1)(2013-8#1)
action plan##6##2##(1991-3#1)(1995-12#1)(2011-1#3)(2011-2#1)
action potential amplitude##2##3##(2008-4#2)
action potential firing##2##3##(1996-2#1)(2013-8#1)
action potential of the##3##4##(2008-11#3)
action potential of##4##3##(2008-11#4)
action potential##17##2##(1992-3#1)(1996-2#1)(1997-7#1)(2008-11#5)(2008-4#4)(2008-5#1)(2009-8#1)(2012-3#1)(2013-8#2)
action potentials in the##3##4##(1992-12#1)(2008-11#1)(2009-12#1)
action potentials that##3##3##(1990-5#1)(2008-11#1)(2009-12#1)
action potentials##15##2##(1990-5#1)(1992-12#1)(2008-11#7)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-8#1)
action research approach##3##3##(2008-1#1)(2008-11#1)(2008-12#1)
action research##13##2##(1991-2#1)(1995-3#3)(2008-1#1)(2008-11#6)(2008-12#1)(2009-1#1)
action should be##2##3##(2008-10#1)(2013-8#1)
action steps##2##2##(1993-1#1)(1994-12#1)
action taken to reduce##2##4##(1992-2#1)(1993-1#1)
action that##4##2##(1993-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
action therapy##2##2##(2008-6#2)
action threshold##3##2##(2008-4#3)
action to be taken##2##4##(2008-10#1)(2012-2#1)
action to##5##2##(2008-10#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
action via##2##2##(1997-4#1)(2008-11#1)
action was##9##2##(1993-3#1)(1995-2#1)(2008-10#5)(2008-5#1)(2008-9#1)
action were##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
action##589##1##(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#6)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#6)(1991-3#2)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#8)(1992-8#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#4)(1993-8#3)(1994-11#8)(1994-12#4)(1994-2#3)(1994-3#7)(1994-5#4)(1994-6#1)(1994-8#12)(1995-11#4)(1995-12#12)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#4)(1995-8#4)(1996-1#1)(1996-12#5)(1996-2#13)(1996-3#3)(1996-5#3)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#6)(1997-7#2)(2007-11#2)(2008-1#2)(2008-10#93)(2008-11#79)(2008-12#3)(2008-3#3)(2008-4#14)(2008-5#23)(2008-6#7)(2008-7#16)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#4)(2009-5#1)(2009-7#5)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#5)(2010-7#4)(2010-8#3)(2011-1#5)(2011-2#28)(2011-3#5)(2012-12#3)(2012-2#17)(2012-3#7)(2013-1#13)(2013-7#5)(2013-8#9)
action&quot##2##1##(1991-3#1)(2008-11#1)
action)##3##1##(2008-10#1)(2008-4#2)
actionable##4##1##(1996-3#1)(1997-1#1)(2008-8#1)(2010-8#1)
actions and##6##2##(1992-6#1)(1996-1#1)(1997-3#1)(2008-11#1)(2009-10#1)(2010-6#1)
actions are##3##2##(2011-2#1)(2012-2#1)(2013-7#1)
actions for##3##2##(1993-2#1)(1996-11#1)(2008-11#1)
actions in the##3##3##(1996-2#1)(2009-7#1)(2012-3#1)
actions in##6##2##(1993-6#1)(1996-2#1)(1997-2#1)(2009-7#1)(2010-6#1)(2012-3#1)
actions of PTPase##2##3##(2008-8#2)
actions of the##5##3##(1990-8#1)(1992-6#1)(1994-12#1)(1994-8#1)(2008-11#1)
actions of these##2##3##(1995-12#1)(2009-12#1)
actions of##55##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-6#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(2008-10#7)(2008-11#9)(2008-4#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-8#1)
actions on##7##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-6#1)(1994-2#1)(1997-4#1)(2012-12#1)
actions related to the##2##4##(2008-10#1)(2008-11#1)
actions taken##2##2##(2008-10#1)(2010-8#1)
actions that have been taken##2##5##(1996-1#1)(2012-3#1)
actions that##8##2##(1993-12#1)(1993-3#1)(1995-1#1)(1996-1#1)(2008-11#1)(2008-7#1)(2009-12#1)(2012-3#1)
actions to##6##2##(1997-4#1)(2008-11#1)(2008-4#3)(2011-1#1)
actions##157##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#4)(1992-7#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-6#3)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-5#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#2)(2007-12#1)(2008-10#10)(2008-11#23)(2008-12#1)(2008-4#9)(2008-5#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#5)
actions)##2##1##(2008-4#1)(2013-8#1)
activable##2##1##(1995-6#1)(2008-8#1)
activate BPlg##2##2##(1993-8#2)
activate and##2##2##(1997-3#1)(2009-8#1)
activate protein kinase C##2##4##(1992-8#1)(2008-11#1)
activate the ORL-1 receptor##2##4##(2008-11#2)
activate the transcription##2##3##(1997-7#1)(2008-11#1)
activate the##25##2##(1990-5#1)(1990-9#1)(1991-5#1)(1992-4#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-5#1)(2009-8#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-3#1)
activate##101##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#3)(1994-11#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#2)(1996-2#4)(1996-3#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-7#3)(2006-6#2)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#9)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
activated B cells##7##3##(1991-3#2)(1995-6#3)(2012-3#1)(2013-1#1)
activated T cells##4##3##(1997-7#1)(1997-8#1)(2009-6#1)(2010-5#1)
activated T##6##2##(1995-12#1)(1997-7#1)(1997-8#1)(2008-9#1)(2009-6#1)(2010-5#1)
activated alumina in##2##3##(2008-10#2)
activated alumina##4##2##(2008-10#4)
activated and##2##2##(2008-4#1)(2009-7#1)
activated at##2##2##(1992-12#1)(2008-10#1)
activated both##2##2##(1993-11#1)(1993-8#1)
activated by Ca2+##2##3##(1995-6#2)
activated by a##2##3##(2008-10#1)(2008-9#1)
activated by glutaraldehyde##2##3##(2008-10#2)
activated by interaction with##2##4##(1993-8#1)(1995-6#1)
activated by phorbol##2##3##(2008-11#2)
activated by the##11##3##(1991-2#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#2)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)
activated by##80##2##(1990-2#2)(1990-8#2)(1990-9#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-6#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#2)(1994-5#3)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#5)(1996-12#7)(1996-2#2)(1997-2#1)(2008-10#7)(2008-11#10)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
activated carbon (AC) at pH##3##5##(2008-10#3)
activated carbon (AC)##5##3##(2008-10#5)
activated carbon and##6##3##(2008-10#6)
activated carbon column##5##3##(2008-10#5)
activated carbon for##2##3##(2008-10#2)
activated carbon was##2##3##(2008-10#2)
activated carbon##40##2##(1992-5#1)(2008-10#39)
activated cells##3##2##(1994-2#1)(2008-10#1)(2008-4#1)
activated charcoal as##2##3##(2008-10#2)
activated charcoal##7##2##(2008-10#7)
activated complement##2##2##(1993-3#1)(2008-9#1)
activated during##3##2##(2008-10#1)(2008-11#2)
activated ester##2##2##(2008-10#1)(2008-4#1)
activated homopolymers##2##2##(2009-10#2)
activated human##6##2##(1994-11#1)(1994-5#1)(1995-12#2)(2008-11#1)(2008-7#1)
activated in a##2##3##(1991-5#1)(2008-9#1)
activated in the##4##3##(1996-2#2)(1996-3#1)(2008-10#1)
activated in vitro by##2##4##(1991-9#1)(1995-12#1)
activated in##20##2##(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
activated killer##3##2##(1991-8#1)(1992-2#1)(2008-11#1)
activated kinase##2##2##(2009-7#1)(2011-2#1)
activated lymphocytes##4##2##(1997-5#1)(2008-4#2)(2008-7#1)
activated macrophages and##2##3##(2008-4#1)(2009-12#1)
activated macrophages may##2##3##(1994-5#1)(2008-11#1)
activated macrophages##6##2##(1994-5#2)(2008-11#2)(2008-4#1)(2009-12#1)
activated partial thromboplastin##2##3##(2008-10#1)(2008-9#1)
activated partial##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
activated platelets##4##2##(2006-6#1)(2008-1#1)(2010-3#2)
activated polycarbonate surface##2##3##(2008-10#2)
activated polycarbonate##4##2##(2008-10#4)
activated protein C##2##3##(1997-3#1)(2011-2#1)
activated protein kinase##2##3##(1993-8#1)(1994-11#1)
activated protein##5##2##(1993-8#1)(1994-11#1)(1996-2#1)(1997-3#1)(2011-2#1)
activated receptor##2##2##(1996-12#1)(1996-2#1)
activated sludge##2##2##(2008-6#1)(2011-2#1)
activated the##9##2##(1993-8#1)(1995-2#1)(2008-10#2)(2008-11#3)(2009-8#1)(2013-1#1)
activated when##5##2##(1995-2#1)(1995-8#1)(2008-10#2)(2010-5#1)
activated with##4##2##(1993-8#1)(2008-10#3)
activated##348##1##(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#5)(1990-9#1)(1991-2#4)(1991-3#4)(1991-5#3)(1991-8#1)(1991-9#5)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1993-11#2)(1993-3#5)(1993-6#3)(1993-8#9)(1994-11#5)(1994-12#1)(1994-2#1)(1994-5#7)(1994-8#2)(1995-12#6)(1995-2#6)(1995-6#12)(1995-8#2)(1996-12#10)(1996-2#11)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#7)(1997-8#2)(2006-6#1)(2008-1#2)(2008-10#92)(2008-11#34)(2008-3#1)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#10)(2009-1#1)(2009-10#4)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-1#1)(2010-11#2)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
activates PI 3-kinase##2##3##(1994-11#1)(2008-11#1)
activates a##5##2##(1992-1#1)(1993-3#1)(2008-10#1)(2009-1#1)(2010-1#1)
activates phospholipase##3##2##(1993-3#1)(1993-8#1)(1997-1#1)
activates the##7##2##(1993-8#1)(1995-2#1)(1995-6#1)(1997-3#1)(2007-11#1)(2011-2#1)(2013-8#1)
activates transcription of##3##3##(1992-8#1)(1995-2#1)(2008-9#1)
activates transcription##5##2##(1991-10#1)(1992-8#1)(1995-2#1)(2008-9#2)
activates##56##1##(1990-8#1)(1991-10#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-8#2)(1995-11#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-11#4)(2008-5#1)(2008-6#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#2)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
activating a##2##2##(2008-10#1)(2008-3#1)
activating and##3##2##(2008-10#2)(2008-4#1)
activating autoantibodies##2##2##(2010-4#2)
activating effect##4##2##(1990-5#1)(1994-8#2)(2008-10#1)
activating factor##3##2##(1991-9#1)(1993-6#2)
activating group##3##2##(1994-11#3)
activating mutations in the##2##4##(2009-4#1)(2013-1#1)
activating mutations in##3##3##(2009-4#2)(2013-1#1)
activating protein##2##2##(1990-5#1)(2013-1#1)
activating signals##2##2##(1994-11#1)(2009-8#1)
activating the transcription of##2##4##(2008-9#1)(2011-1#1)
activating the transcription##3##3##(2008-9#2)(2011-1#1)
activating the##11##2##(1994-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-1#1)
activating transcription factor##2##3##(2009-3#1)(2011-2#1)
activating transcription factor-2 (ATF-2)##2##4##(1997-2#2)
activating transcription##4##2##(1997-2#2)(2009-3#1)(2011-2#1)
activating##77##1##(1990-2#1)(1990-5#2)(1991-5#1)(1991-9#1)(1992-10#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#6)(1994-8#3)(1995-11#1)(1995-12#1)(1996-3#1)(1997-2#2)(2008-10#8)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#3)(2013-8#2)
activation analysis##5##2##(2008-10#4)(2009-6#1)
activation and DNA##2##3##(1997-1#1)(2011-2#1)
activation and contributes to the##2##5##(1994-3#1)(1995-2#1)
activation and gene##3##3##(2008-11#2)(2008-9#1)
activation and proliferation of##2##4##(1997-3#1)(2008-9#1)
activation and that##3##3##(1992-6#1)(1996-2#1)(2008-10#1)
activation and the##2##3##(1993-8#1)(2012-2#1)
activation and##48##2##(1990-2#1)(1992-10#1)(1992-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-11#2)(1995-2#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-3#1)(2006-6#2)(2007-12#1)(2008-10#4)(2008-11#5)(2008-4#2)(2008-9#3)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
activation as##2##2##(2006-6#1)(2008-11#1)
activation at##3##2##(2008-10#1)(2013-1#2)
activation by all three Brn-3 factors##2##6##(1996-12#2)
activation by the##2##3##(1993-2#1)(1993-8#1)
activation by##27##2##(1990-5#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#3)(1996-12#2)(1997-5#1)(2006-6#2)(2008-10#2)(2008-11#2)(2008-9#1)(2013-8#1)
activation can be##2##3##(2008-4#2)
activation domain##3##2##(1995-6#1)(2008-8#2)
activation during experience predicted##2##4##(2008-11#2)
activation during##11##2##(1994-3#1)(1996-2#2)(1997-4#1)(2008-11#6)(2008-9#1)
activation energies of##2##3##(2008-11#1)(2008-9#1)
activation energies##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
activation energy for##6##3##(1992-3#1)(2008-10#4)(2012-2#1)
activation energy of##2##3##(1990-2#1)(1991-5#1)
activation energy was##4##3##(1992-3#1)(2008-10#3)
activation energy##22##2##(1990-2#2)(1991-5#1)(1992-3#2)(1993-8#1)(2008-10#11)(2008-4#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)
activation events##2##2##(1992-8#1)(2008-9#1)
activation for##3##2##(1996-2#1)(2008-8#1)(2013-1#1)
activation function##3##2##(2008-9#1)(2010-8#2)
activation in a##4##3##(1991-9#1)(1995-11#1)(1996-6#1)(2008-7#1)
activation in response to##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
activation in the##11##3##(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-5#1)(2010-5#1)(2013-8#1)
activation in##43##2##(1991-9#1)(1992-12#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#12)(2008-5#3)(2008-7#2)(2009-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
activation induced by##5##3##(1990-2#1)(1990-5#1)(1995-6#1)(1995-8#1)(2008-8#1)
activation induced##6##2##(1990-2#1)(1990-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-8#1)
activation is a##2##3##(2008-11#1)(2009-6#1)
activation is required for##2##4##(1994-11#1)(1997-7#1)
activation is required##3##3##(1994-11#1)(1997-7#1)(2007-12#1)
activation is##13##2##(1994-11#3)(1995-8#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-11#2)(2009-6#1)(2010-7#1)(2012-12#1)(2012-2#1)
activation may provide##2##3##(1995-8#1)(2009-6#1)
activation may##4##2##(1995-8#2)(2009-6#1)(2013-7#1)
activation motif##3##2##(1997-3#3)
activation occurred##3##2##(1990-8#1)(1997-3#2)
activation occurs##2##2##(1994-2#1)(2008-11#1)
activation of Akt and ERK1/2##2##5##(2010-1#2)
activation of G-protein##2##3##(1996-2#1)(2012-2#1)
activation of HIV-1 precursors##2##4##(2011-3#2)
activation of HIV-1##3##3##(2011-3#3)
activation of K+##2##3##(1994-3#2)
activation of MAP kinase##3##4##(1993-8#2)(1995-8#1)
activation of MAPKs##3##3##(1995-6#2)(2009-8#1)
activation of NADPH oxidase in a cell-free system##2##8##(1990-5#1)(1993-8#1)
activation of NADPH oxidase##5##4##(1990-5#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-6#1)
activation of NFκB##3##3##(2011-2#3)
activation of PKC##2##3##(1992-12#1)(2008-8#1)
activation of RII beta-type##2##4##(1994-8#2)
activation of STATs 1 and 3 in##2##7##(2012-3#2)
activation of T cells##2##4##(2007-12#1)(2009-6#1)
activation of T##3##3##(1994-3#1)(2007-12#1)(2009-6#1)
activation of a##13##3##(1992-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
activation of both##4##3##(1993-8#1)(1994-11#1)(1996-2#1)(2012-3#1)
activation of c-Myc##2##3##(1994-9#2)
activation of cell##2##3##(2008-11#1)(2012-12#1)
activation of cellular##2##3##(2012-3#2)
activation of either##3##3##(1995-2#1)(1996-2#2)
activation of entanglement##2##3##(2012-2#2)
activation of glucocorticoid##2##3##(1996-12#1)(2009-6#1)
activation of microglia in denervated neuropil##2##6##(1997-3#2)
activation of p72syk##3##3##(1992-6#3)
activation of pancreatic##2##3##(2013-1#1)(2013-7#1)
activation of phospholipase A2 and D##2##6##(1996-2#2)
activation of phospholipase C and##2##5##(2008-11#2)
activation of phospholipase##5##3##(1996-2#2)(1997-2#1)(2008-11#2)
activation of platelets by##2##4##(1992-12#1)(2006-6#1)
activation of platelets##3##3##(1992-12#1)(2006-6#2)
activation of protein kinase C in##2##6##(1997-1#1)(2008-11#1)
activation of protein kinase C##10##5##(1990-8#1)(1993-6#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-11#3)(2008-8#1)(2008-9#1)
activation of protein##13##3##(1990-8#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)
activation of quiescent##3##3##(1993-12#1)(2008-10#2)
activation of the MAPK cascade##2##5##(1995-2#1)(2009-8#1)
activation of the enzyme##4##4##(1992-6#1)(1993-6#1)(2008-10#1)(2008-7#1)
activation of the kinase##2##4##(1990-12#1)(2013-8#1)
activation of the mitogen-activated##2##4##(1995-2#1)(2008-7#1)
activation of the right hemisphere##2##5##(1996-2#2)
activation of the right##3##4##(1996-2#2)(2008-11#1)
activation of the##79##3##(1990-12#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-3#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#4)(1995-6#2)(1995-8#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-2#4)(1997-3#2)(1997-7#2)(2008-10#3)(2008-11#6)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#4)(2013-1#2)(2013-8#1)
activation of various##4##3##(2008-11#1)(2008-2#1)(2010-12#1)(2010-7#1)
activation of β-catenin##2##3##(2013-1#2)
activation of##322##2##(1990-12#1)(1990-5#5)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#5)(1992-4#1)(1992-6#5)(1992-8#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#5)(1993-8#7)(1993-9#1)(1994-11#8)(1994-12#1)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#5)(1994-8#5)(1994-9#2)(1995-11#5)(1995-12#1)(1995-2#11)(1995-6#10)(1995-8#6)(1996-12#6)(1996-2#20)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#1)(1997-7#4)(1997-8#1)(2006-6#4)(2007-12#1)(2008-10#17)(2008-11#20)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#7)(2008-8#7)(2008-9#2)(2009-10#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#6)(2009-7#3)(2009-8#8)(2010-1#4)(2010-10#2)(2010-12#3)(2010-7#3)(2011-1#1)(2011-2#10)(2011-3#5)(2012-12#1)(2012-2#11)(2012-3#11)(2013-1#11)(2013-7#1)(2013-8#2)
activation on the##2##3##(2008-10#1)(2009-8#1)
activation on##3##2##(1994-11#1)(2008-10#1)(2009-8#1)
activation or##5##2##(1992-3#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
activation parameters##3##2##(2008-10#3)
activation pattern##2##2##(1996-12#1)(2012-2#1)
activation patterns of##2##3##(1996-12#1)(2013-8#1)
activation patterns##4##2##(1996-12#1)(2008-11#1)(2008-9#1)(2013-8#1)
activation process##2##2##(1993-6#2)
activation products##2##2##(1993-11#1)(2008-10#1)
activation response##2##2##(1995-5#1)(1997-6#1)
activation state##3##2##(1995-6#1)(2008-9#1)(2010-12#1)
activation status##2##2##(2008-11#1)(2008-9#1)
activation test##3##2##(2008-10#1)(2012-3#2)
activation theory of stress (CATS)##2##5##(2010-4#2)
activation using the##2##3##(1993-3#1)(1994-3#1)
activation was determined##2##3##(2008-10#1)(2012-3#1)
activation was##16##2##(1990-2#1)(1990-5#1)(1992-4#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)(2012-3#2)
activation with glutaraldehyde##2##3##(2008-10#2)
activation with##8##2##(1993-6#2)(1995-12#1)(2008-10#2)(2008-4#1)(2009-11#1)(2009-8#1)
activation##801##1##(1990-12#1)(1990-2#5)(1990-5#11)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#3)(1991-7#1)(1991-9#3)(1992-10#1)(1992-12#6)(1992-3#4)(1992-4#3)(1992-6#9)(1992-8#6)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-6#10)(1993-8#15)(1993-9#3)(1994-11#22)(1994-12#2)(1994-2#8)(1994-3#12)(1994-5#3)(1994-6#14)(1994-8#5)(1994-9#3)(1995-11#14)(1995-12#7)(1995-2#17)(1995-5#3)(1995-6#29)(1995-8#20)(1996-12#15)(1996-2#33)(1996-5#2)(1996-6#2)(1997-1#5)(1997-2#8)(1997-3#11)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#1)(2006-6#12)(2007-12#3)(2008-1#1)(2008-10#69)(2008-11#68)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#17)(2008-5#13)(2008-6#1)(2008-7#12)(2008-8#12)(2008-9#29)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#6)(2009-4#1)(2009-5#1)(2009-6#13)(2009-7#4)(2009-8#15)(2009-9#1)(2010-1#4)(2010-10#2)(2010-12#6)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#7)(2010-8#3)(2011-1#5)(2011-2#20)(2011-3#5)(2012-12#3)(2012-2#24)(2012-3#27)(2012-9#1)(2013-1#23)(2013-7#3)(2013-8#11)
activation&quot##2##1##(1993-8#1)(2013-8#1)
activation-induced apoptosis in##2##3##(2008-10#2)
activation-induced apoptosis##5##2##(2008-10#5)
activation-induced##6##1##(2008-10#5)(2013-1#1)
activation-resistant conformation##2##2##(1995-6#2)
activations of##2##2##(2010-7#1)(2013-1#1)
activations##4##1##(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#1)
activator (tPA)##3##2##(2008-11#1)(2008-8#1)(2010-3#1)
activator activity in MCF-7 cells##4##5##(2008-11#4)
activator activity in##5##3##(2008-11#4)(2010-3#1)
activator activity##8##2##(1990-11#1)(2008-11#6)(2010-3#1)
activator and##3##2##(1993-12#1)(1995-6#1)(2006-6#1)
activator for the catalysis of##2##5##(2008-10#2)
activator for the##5##3##(1995-2#1)(2008-10#4)
activator for##10##2##(1993-6#1)(1995-2#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
activator function##2##2##(2008-11#1)(2013-1#1)
activator in##3##2##(1995-6#1)(2008-10#1)(2008-7#1)
activator inhibitor##2##2##(1992-7#1)(2011-2#1)
activator inhibitor-1##5##2##(1995-8#2)(1997-1#1)(2011-2#2)
activator of the##2##3##(1990-2#1)(2011-2#1)
activator of##16##2##(1990-2#3)(1991-5#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
activator phorbol 12-myristate 13-acetate (PMA)##2##5##(1995-11#1)(1997-1#1)
activator protein##3##2##(1990-11#1)(1994-3#1)(2010-4#1)
activator protein-1 and nuclear factor kappa B activity##2##8##(1994-6#2)
activator protein-1##4##2##(1994-6#4)
activator##123##1##(1990-11#2)(1990-2#3)(1990-8#1)(1991-5#3)(1992-7#1)(1992-8#2)(1993-12#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#3)(1994-5#2)(1994-6#4)(1995-11#4)(1995-2#1)(1995-6#4)(1995-8#3)(1996-3#1)(1997-1#3)(1997-3#1)(2006-6#1)(2007-9#1)(2008-10#13)(2008-11#20)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-3#2)(2010-4#3)(2011-2#5)(2012-3#6)(2013-1#2)(2013-8#1)
activator)##3##1##(1994-5#1)(2008-10#1)(2008-11#1)
activators and##3##2##(1992-6#1)(1994-12#1)(2008-9#1)
activators in##2##2##(1993-12#1)(1994-5#1)
activators of##7##2##(1996-2#3)(2008-1#1)(2011-2#2)(2012-3#1)
activators or##2##2##(1996-2#1)(2008-9#1)
activators##33##1##(1990-11#1)(1992-6#2)(1993-12#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#3)(1995-11#3)(1995-6#1)(1996-2#5)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#3)(2010-1#1)(2011-2#2)(2012-3#1)
active DNA##3##2##(1990-7#2)(2008-7#1)
active ERK##2##2##(2013-1#2)
active Gus##2##2##(1993-8#2)
active HB-EGF##2##2##(1997-1#2)
active Mu##2##2##(2012-3#2)
active TrPs##4##2##(2010-9#4)
active abduction##3##2##(2013-1#3)
active against HIV##2##3##(1990-8#1)(1991-3#1)
active against##19##2##(1990-8#1)(1991-3#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#4)(2011-2#3)
active agents##2##2##(2008-11#1)(2008-7#1)
active analogues##2##2##(1991-5#1)(2008-8#1)
active and inactive##6##3##(1992-6#1)(1994-12#1)(1995-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
active and passive##4##3##(2008-10#2)(2008-4#1)(2009-8#1)
active and##26##2##(1991-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-6#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-4#1)(2012-2#2)(2013-1#3)
active antiretroviral therapy (HAART)##6##4##(2008-11#1)(2009-7#1)(2010-5#1)(2011-2#2)(2011-3#1)
active antiretroviral therapy##8##3##(2008-10#1)(2008-11#1)(2009-7#1)(2010-5#1)(2011-2#3)(2011-3#1)
active area##3##2##(2008-10#2)(2008-4#1)
active as##5##2##(1992-10#1)(1995-11#1)(2008-10#1)(2008-7#2)
active at##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
active bleeding##3##2##(1991-6#1)(2013-1#2)
active cells##3##2##(2008-10#2)(2008-11#1)
active cellular##2##2##(2008-10#1)(2013-1#1)
active component of##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
active component##4##2##(1995-12#1)(2008-10#2)(2008-11#1)
active components and##2##3##(2008-10#2)
active components of##3##3##(2008-10#3)
active components##12##2##(2008-10#9)(2008-11#1)(2011-3#1)(2013-1#1)
active compound##6##2##(1997-8#1)(2008-10#4)(2008-5#1)
active compounds##10##2##(1994-11#1)(2008-10#5)(2008-11#2)(2010-7#1)(2011-3#1)
active conformation##2##2##(2008-8#2)
active coping##2##2##(2008-4#2)
active cosmetic##2##2##(2008-5#2)
active disease##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
active dots##2##2##(2009-11#2)
active drug##2##2##(1993-11#1)(1996-1#1)
active during##3##2##(2008-10#2)(2012-2#1)
active element in the##2##4##(2008-11#1)(2010-5#1)
active enzyme##4##2##(1991-7#1)(1993-8#1)(1994-11#1)(1994-5#1)
active enzymes##3##2##(1992-3#1)(1995-6#1)(1997-7#1)
active estrogen##2##2##(2008-11#2)
active euthanasia##2##2##(1990-6#1)(1991-2#1)
active for##4##2##(1995-2#1)(2008-10#2)(2012-3#1)
active form of the##2##4##(1990-10#1)(1994-11#1)
active form of##6##3##(1990-10#1)(1991-9#1)(1993-8#1)(1994-11#1)(1996-12#1)(2013-1#1)
active form##9##2##(1990-10#1)(1990-2#2)(1991-9#1)(1992-6#1)(1993-8#1)(1994-11#1)(1996-12#1)(2013-1#1)
active fraction##2##2##(1991-12#1)(2008-10#1)
active fractions##2##2##(1991-12#1)(2008-10#1)
active gene##2##2##(1995-6#1)(2010-10#1)
active genes in##2##3##(1996-2#1)(1997-8#1)
active group##3##2##(2008-10#2)(2013-1#1)
active groups##2##2##(2008-10#2)
active growth##3##2##(2008-7#3)
active histidase##2##2##(1994-5#2)
active in the##10##3##(1993-12#1)(1993-6#2)(1995-11#1)(1995-8#1)(1996-2#2)(2008-11#1)(2008-12#1)(2013-1#1)
active in this field##2##4##(2008-12#2)
active in##30##2##(1990-2#1)(1992-12#2)(1993-12#1)(1993-6#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#4)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#4)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
active ingredient to##2##3##(2008-5#2)
active ingredient##16##2##(2008-10#1)(2008-11#2)(2008-5#12)(2012-2#1)
active ingredients and excipients##2##4##(2008-10#2)
active ingredients are##3##3##(2008-5#2)(2012-12#1)
active ingredients in cough-cold##2##4##(2008-10#2)
active ingredients in##6##3##(2008-10#4)(2010-9#2)
active ingredients##16##2##(2008-10#6)(2008-11#1)(2008-5#5)(2010-9#3)(2012-12#1)
active interfacing##2##2##(2008-10#2)
active intermediates##2##2##(1993-8#1)(1996-5#1)
active interventions##2##2##(1991-12#1)(2013-1#1)
active involvement##2##2##(2008-10#1)(2008-11#1)
active knee extension range of motion##2##6##(2008-12#2)
active life##2##2##(1991-11#1)(1993-12#1)
active lifestyle##3##2##(2009-8#1)(2012-3#2)
active male##2##2##(1995-12#1)(2008-4#1)
active management##2##2##(2009-7#1)(2011-3#1)
active material##5##2##(1994-6#1)(2008-10#2)(2008-3#1)(2008-5#1)
active matter##2##2##(2008-5#2)
active matter'##2##2##(2008-5#2)
active medical conditions##2##3##(2010-1#2)
active medium##2##2##(2008-3#2)
active metabolite of##4##3##(1992-1#1)(1992-3#1)(1995-2#1)(2008-7#1)
active metabolite##5##2##(1992-1#1)(1992-3#1)(1995-2#1)(2008-7#1)(2008-8#1)
active metabolites##4##2##(2008-10#2)(2008-7#2)
active molecule##4##2##(2008-10#1)(2008-5#2)(2009-6#1)
active mutants##2##2##(1992-9#2)
active nanostructures##5##2##(2010-12#5)
active new##2##2##(2010-5#1)(2012-3#1)
active on HIV-1 integrase##2##4##(2011-3#2)
active on HIV-1##3##3##(2011-3#3)
active on##7##2##(1990-8#1)(2008-10#2)(2009-6#1)(2011-3#3)
active or##3##2##(1990-5#1)(2008-4#1)(2011-3#1)
active over a##2##3##(1991-5#1)(2012-2#1)
active oxygen species (AOS)##2##4##(2008-10#2)
active oxygen species##4##3##(1995-8#1)(2008-10#3)
active oxygen##6##2##(1994-5#1)(1995-8#1)(2008-10#3)(2008-8#1)
active packaging##4##2##(2010-5#1)(2010-7#3)
active participants in##2##3##(1997-3#1)(2008-11#1)
active participation of the##2##4##(2008-10#1)(2009-9#1)
active participation of##5##3##(1991-3#1)(1993-3#1)(2008-10#1)(2009-9#1)(2010-1#1)
active participation##7##2##(1991-3#1)(1993-3#1)(1996-12#1)(2008-10#1)(2009-9#1)(2010-1#1)(2013-1#1)
active peptide##2##2##(1993-3#1)(2008-10#1)
active peptides##4##2##(1994-3#1)(1995-3#1)(2008-5#2)
active period##2##2##(2008-10#1)(2012-2#1)
active pixel##2##2##(2008-10#2)
active pocket##2##2##(2008-8#2)
active principle##4##2##(2008-10#4)
active principles of##2##3##(2008-10#1)(2008-11#1)
active principles##7##2##(2008-10#5)(2008-11#1)(2012-2#1)
active process##2##2##(1992-7#1)(2010-10#1)
active product##2##2##(1992-6#1)(2008-10#1)
active protease##2##2##(1993-12#1)(2008-4#1)
active pulmonary##2##2##(1990-12#1)(2010-5#1)
active radiation##3##2##(2008-10#3)
active range of motion##2##4##(2008-12#2)
active range of##3##3##(2008-12#3)
active recombinant human##3##3##(1990-8#1)(1995-6#1)(2008-11#1)
active recombinant##6##2##(1990-8#1)(1994-11#1)(1995-6#1)(2008-11#2)(2010-5#1)
active role##5##2##(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
active sampling##4##2##(2008-10#4)
active segment##2##2##(2008-2#2)
active site of the enzyme##3##5##(1990-9#1)(1992-4#1)(1994-5#1)
active site of##18##3##(1990-2#1)(1990-9#1)(1991-5#2)(1992-4#1)(1992-6#1)(1993-9#1)(1994-5#7)(1994-8#1)(1995-6#1)(1995-8#1)(2008-8#1)
active site##53##2##(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-3#2)(1991-5#3)(1992-3#1)(1992-4#3)(1992-6#4)(1992-7#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-5#12)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#7)(1995-8#2)(1996-8#1)(1997-6#1)(2008-5#1)(2008-8#2)(2010-11#1)
active sites and##2##3##(2008-10#1)(2008-9#1)
active sites of##3##3##(2008-10#1)(2012-12#2)
active sites##10##2##(2008-10#5)(2008-4#1)(2008-9#1)(2010-7#1)(2012-12#2)
active solid##2##2##(2008-10#2)
active species##4##2##(1990-5#1)(1993-6#1)(1994-5#1)(2008-10#1)
active stage of the##2##4##(2012-3#1)(2013-1#1)
active state##3##2##(1990-8#1)(2008-11#1)(2012-3#1)
active substance content##2##3##(2008-10#2)
active substance##6##2##(1990-5#1)(2008-10#4)(2008-11#1)
active substances in##2##3##(2008-10#2)
active substances##6##2##(2008-10#4)(2008-11#1)(2008-5#1)
active surface##2##2##(2008-10#2)
active surveillance to##2##3##(2010-11#1)(2011-2#1)
active surveillance##9##2##(2009-5#1)(2010-10#2)(2010-11#1)(2011-2#2)(2012-12#3)
active than the##2##3##(1990-11#1)(1992-6#1)
active than##6##2##(1990-11#1)(1992-10#1)(1992-6#1)(1994-8#1)(1995-8#1)(2011-2#1)
active transport##5##2##(1990-9#1)(1994-8#1)(1997-7#1)(2011-2#1)(2011-3#1)
active treatment##3##2##(1991-1#1)(2008-3#1)(2009-6#1)
active tuberculosis##3##2##(1996-3#1)(2008-10#1)(2008-5#1)
active vitamin D3##2##3##(1991-5#2)
active when##4##2##(1995-8#1)(2008-10#1)(2010-9#1)(2013-8#1)
active zones##2##2##(1997-7#2)
active##867##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#2)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#4)(1991-5#9)(1991-6#4)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-12#7)(1992-2#3)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#11)(1992-7#2)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#12)(1993-8#13)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#20)(1994-6#2)(1994-8#5)(1995-11#5)(1995-12#3)(1995-2#7)(1995-3#3)(1995-6#18)(1995-8#8)(1996-1#1)(1996-12#5)(1996-2#7)(1996-3#4)(1996-5#5)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#8)(1997-8#7)(1997-9#1)(2008-1#5)(2008-10#177)(2008-11#56)(2008-12#14)(2008-2#4)(2008-3#13)(2008-4#17)(2008-5#48)(2008-7#21)(2008-8#18)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#8)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#16)(2010-3#4)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#7)(2010-8#3)(2010-9#9)(2011-1#4)(2011-10#1)(2011-2#20)(2011-3#10)(2011-4#1)(2012-12#7)(2012-2#13)(2012-3#24)(2013-1#37)(2013-7#2)(2013-8#5)
active-site##7##1##(1991-9#1)(1992-12#1)(1994-5#2)(1995-2#1)(1995-6#1)(2008-4#1)
active-site-modified##2##1##(1994-5#2)
actively growing mycelium##2##3##(1997-1#1)(2008-10#1)
actively growing##4##2##(1994-5#1)(1997-1#1)(2008-10#1)(2008-9#1)
actively involved in the##2##4##(1996-12#1)(2011-2#1)
actively involved in##4##3##(1996-12#1)(2008-11#1)(2009-7#1)(2011-2#1)
actively involved##6##2##(1994-8#1)(1996-12#1)(2008-11#2)(2009-7#1)(2011-2#1)
actively participate in##2##3##(2008-11#1)(2011-2#1)
actively participates in##2##3##(2008-12#1)(2008-7#1)
actively transcribed##2##2##(1993-12#1)(1993-2#1)
actively with##2##2##(1997-8#1)(2008-10#1)
actively##69##1##(1990-2#1)(1990-5#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
actives##3##1##(2008-5#3)
activin A in##2##3##(1995-8#1)(2012-12#1)
activin A induced a##2##4##(1995-8#2)
activin A##16##2##(1992-6#5)(1995-8#9)(2009-10#1)(2012-12#1)
activin levels##2##2##(1992-6#2)
activin##25##1##(1992-6#14)(1995-8#9)(2009-10#1)(2012-12#1)
activin-A cDNA##2##2##(1994-11#2)
activin-A##6##1##(1994-11#6)
activism##4##1##(1996-1#1)(2008-1#1)(2009-5#2)
activists##4##1##(1995-6#3)(2011-2#1)
activities against several##2##3##(2008-10#1)(2011-3#1)
activities against##14##2##(1993-3#1)(2008-10#2)(2008-11#3)(2008-12#2)(2010-6#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-8#1)
activities and the##3##3##(1991-12#1)(2008-10#1)(2008-8#1)
activities and##34##2##(1991-12#1)(1992-1#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-12#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#2)(2009-7#2)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#1)(2013-1#1)(2013-8#1)
activities are##15##2##(1991-9#1)(1992-6#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#4)(2013-1#1)
activities as well as the##2##5##(1992-8#1)(2008-11#1)
activities as##5##2##(1992-8#1)(2008-11#1)(2009-11#1)(2012-12#1)(2013-1#1)
activities associated with the##2##4##(1990-2#1)(1997-2#1)
activities associated with##4##3##(1990-2#1)(1997-2#1)(2008-11#1)(2013-1#1)
activities at##2##2##(1993-3#1)(2013-1#1)
activities between##2##2##(2008-9#1)(2010-12#1)
activities but##2##2##(1997-3#1)(2011-2#1)
activities by##4##2##(2008-11#1)(2008-12#1)(2009-1#1)(2011-3#1)
activities can be##5##3##(1994-8#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-2#1)
activities can##6##2##(1992-12#1)(1994-8#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-2#1)
activities did not##2##3##(2011-10#1)(2011-2#1)
activities during##2##2##(1994-9#1)(2008-11#1)
activities exhibited##3##2##(1994-11#1)(2011-3#1)(2013-1#1)
activities expressed##2##2##(1992-3#1)(1994-11#1)
activities for##4##2##(1994-8#1)(1995-12#1)(2008-11#1)(2012-12#1)
activities from##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
activities have been##2##3##(1997-7#1)(2008-4#1)
activities have##3##2##(1997-7#1)(2008-4#1)(2011-1#1)
activities in a##3##3##(1994-12#1)(1995-6#1)(2013-8#1)
activities in rat##2##3##(1994-6#1)(2008-10#1)
activities in the##9##3##(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(2008-12#1)(2008-7#1)(2012-3#2)(2013-1#1)
activities in trypanosomatid parasites of plants##2##6##(2008-10#2)
activities in vitro##3##3##(1993-8#1)(2008-10#1)(2011-3#1)
activities in##68##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#1)(2011-2#2)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
activities may be##2##3##(1991-2#1)(2008-5#1)
activities of a##3##3##(2008-11#1)(2008-5#1)(2009-3#1)
activities of beta-1##2##3##(2008-10#2)
activities of both the##2##4##(2008-10#1)(2008-11#1)
activities of both##5##3##(1992-6#1)(2008-10#2)(2008-11#1)(2008-7#1)
activities of daily living (ADL)##3##5##(1995-2#1)(2011-2#1)(2012-2#1)
activities of daily living and##2##5##(1991-12#1)(2011-2#1)
activities of daily living##11##4##(1991-12#1)(1993-3#1)(1995-2#1)(2008-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
activities of daily##12##3##(1991-12#1)(1993-3#1)(1995-2#1)(2008-7#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)
activities of different##2##3##(2008-10#2)
activities of key metabolic enzymes##2##5##(1994-8#1)(2008-11#1)
activities of key##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
activities of the DGN##2##4##(2012-2#2)
activities of the crude##2##4##(2008-12#1)(2013-1#1)
activities of the quality assurance system##2##6##(2012-12#2)
activities of the##29##3##(1990-7#1)(1991-12#1)(1992-1#1)(1992-2#2)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-9#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
activities of these enzymes##2##4##(1994-8#1)(2008-10#1)
activities of these##8##3##(1991-5#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
activities of this##2##3##(1994-5#1)(2008-11#1)
activities of two##2##3##(2008-10#1)(2008-11#1)
activities of zeaxanthins##2##3##(2008-11#2)
activities of##161##2##(1990-11#1)(1990-3#2)(1990-7#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#3)(1992-6#3)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-5#4)(1994-8#4)(1995-11#3)(1995-2#1)(1995-5#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#25)(2008-11#20)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#6)(2009-12#1)(2009-3#1)(2009-8#1)(2010-5#2)(2011-2#10)(2011-3#4)(2012-12#4)(2012-2#5)(2012-3#2)(2012-6#2)(2013-1#10)(2013-8#3)
activities on the organization's bottom line##2##6##(2008-9#2)
activities on##8##2##(1995-8#1)(1997-3#1)(2008-9#3)(2011-3#3)
activities over the##2##3##(1993-2#1)(2013-1#1)
activities related to##2##3##(2008-5#1)(2011-10#1)
activities such as##5##3##(1992-12#1)(2008-5#1)(2009-5#1)(2011-2#1)(2011-3#1)
activities than##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
activities that are##2##3##(1994-2#1)(2008-7#1)
activities that can##2##3##(2008-7#1)(2012-2#1)
activities that have##2##3##(1996-1#1)(2008-10#1)
activities that were##2##3##(1991-9#1)(2012-12#1)
activities that##16##2##(1991-9#1)(1994-2#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
activities to##9##2##(1992-3#1)(1993-1#1)(1996-6#1)(1997-3#1)(2009-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
activities undertaken by##2##3##(1993-9#1)(2013-1#1)
activities using##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
activities was##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
activities were also##2##3##(2011-10#1)(2011-2#1)
activities were determined##2##3##(1994-11#1)(1994-8#1)
activities were found##2##3##(2008-10#2)
activities were inhibited by##2##4##(1994-3#1)(2008-11#1)
activities were measured##3##3##(1992-6#1)(2008-5#1)(2008-7#1)
activities were significantly##3##3##(1995-11#1)(2008-10#2)
activities were##44##2##(1990-5#1)(1992-2#1)(1992-3#2)(1992-6#4)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-7#1)(2006-6#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#2)(2011-10#1)(2011-2#2)(2012-2#2)(2013-1#2)
activities which##2##2##(1990-9#1)(2010-10#1)
activities with##8##2##(1992-10#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#2)(2011-1#1)(2013-1#1)
activities within the##2##3##(2008-11#1)(2010-8#1)
activities##733##1##(1990-10#2)(1990-11#4)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#12)(1991-2#8)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#7)(1992-10#1)(1992-12#4)(1992-2#4)(1992-3#6)(1992-6#14)(1992-8#2)(1993-1#4)(1993-11#1)(1993-12#7)(1993-2#8)(1993-3#5)(1993-6#2)(1993-8#6)(1993-9#1)(1994-1#3)(1994-11#9)(1994-12#3)(1994-2#2)(1994-3#7)(1994-5#5)(1994-6#1)(1994-8#8)(1994-9#1)(1995-11#6)(1995-12#7)(1995-2#9)(1995-3#6)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#2)(1996-12#2)(1996-2#6)(1996-3#2)(1996-6#1)(1997-1#3)(1997-2#4)(1997-3#14)(1997-4#1)(1997-5#1)(1997-7#5)(1997-8#1)(1997-9#1)(2006-6#1)(2008-1#1)(2008-10#90)(2008-11#85)(2008-12#17)(2008-2#1)(2008-4#3)(2008-5#24)(2008-6#3)(2008-7#16)(2008-8#5)(2008-9#22)(2009-1#2)(2009-11#1)(2009-12#5)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#8)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#6)(2010-6#1)(2010-8#9)(2011-1#7)(2011-10#3)(2011-2#39)(2011-3#23)(2012-12#15)(2012-2#24)(2012-3#6)(2012-6#2)(2012-9#1)(2013-1#43)(2013-7#1)(2013-8#9)
activities)##3##1##(2008-5#1)(2010-2#1)(2010-4#1)
activity (0##4##2##(1993-11#1)(1993-8#1)(1994-8#1)(1997-2#1)
activity (IC _ 50##2##4##(2008-5#2)
activity (i##2##2##(1992-3#1)(2008-5#1)
activity (p &lt##3##3##(2008-11#1)(2009-5#1)(2013-1#1)
activity after 2##2##3##(2008-10#1)(2008-6#1)
activity after##12##2##(1992-9#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2010-11#1)(2012-3#1)(2013-8#1)
activity against F##3##3##(2008-10#2)(2011-10#1)
activity against a broad spectrum of##2##6##(2008-10#1)(2008-5#1)
activity against a##4##3##(2008-10#1)(2008-5#2)(2013-8#1)
activity against human##3##3##(1997-7#1)(2008-11#1)(2010-2#1)
activity against solid##2##3##(2008-11#1)(2008-5#1)
activity against the##9##3##(2008-10#3)(2008-11#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
activity against##51##2##(1992-12#1)(1992-6#2)(1994-11#1)(1994-8#1)(1997-7#1)(2008-10#13)(2008-11#11)(2008-12#1)(2008-5#5)(2008-9#1)(2009-6#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
activity along the##2##3##(2008-9#1)(2011-2#1)
activity along##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
activity alterations##2##2##(2008-7#1)(2011-3#1)
activity among the##2##3##(2008-10#2)
activity among##8##2##(1990-2#1)(2008-10#2)(2008-4#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
activity and ADH##3##3##(1997-8#3)
activity and DNA##2##3##(1990-11#1)(2008-7#1)
activity and a##5##3##(1997-8#1)(2008-10#2)(2008-7#1)(2013-1#1)
activity and body##2##3##(2008-11#1)(2008-8#1)
activity and cell##2##3##(2008-1#1)(2009-9#1)
activity and chemical##2##3##(2008-12#1)(2009-10#1)
activity and expression of##2##4##(2008-11#1)(2010-12#1)
activity and expression##3##3##(2008-11#2)(2010-12#1)
activity and growth##2##3##(2008-5#1)(2008-9#1)
activity and health##3##3##(1995-5#1)(2010-1#1)(2013-1#1)
activity and high##2##3##(2008-10#1)(2008-5#1)
activity and higher##2##3##(2008-10#1)(2013-1#1)
activity and is##4##3##(1993-3#1)(1995-6#1)(2008-5#1)(2008-9#1)
activity and its inhibition by manganese (II) chloride##2##8##(2008-7#2)
activity and its##6##3##(1991-12#1)(1994-11#1)(2008-10#1)(2008-7#2)(2008-8#1)
activity and mRNA##3##3##(1994-11#1)(1995-6#2)
activity and osteocalcin##2##3##(2012-4#2)
activity and phosphorylation##2##3##(1994-11#1)(1995-6#1)
activity and stability##4##3##(1994-11#2)(1995-3#1)(2008-10#1)
activity and subsequent##2##3##(2008-11#1)(2013-8#1)
activity and that##5##3##(1993-8#1)(1995-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
activity and the##24##3##(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-6#2)(2008-10#6)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
activity and to##2##3##(1990-8#1)(2008-10#1)
activity and##219##2##(1990-11#3)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#6)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-6#2)(1997-7#2)(1997-8#6)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#31)(2008-11#22)(2008-12#3)(2008-4#3)(2008-5#10)(2008-7#10)(2008-8#5)(2008-9#4)(2009-10#2)(2009-5#1)(2009-6#4)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-7#3)(2010-9#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-4#2)(2013-1#11)(2013-8#3)
activity are##9##2##(1995-12#2)(2008-10#4)(2008-9#1)(2009-8#1)(2009-9#1)
activity as a##6##3##(1990-10#1)(1990-8#1)(1994-11#1)(2008-10#2)(2011-2#1)
activity as determined##2##3##(1993-3#1)(2008-11#1)
activity as well as##4##4##(1992-6#1)(1992-8#1)(2008-10#1)(2009-3#1)
activity as well##6##3##(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(2008-10#1)(2009-3#1)
activity as##25##2##(1990-10#1)(1990-8#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#1)(2009-3#1)(2010-9#1)(2011-2#1)(2013-8#1)
activity assay of##2##3##(2008-10#1)(2009-10#1)
activity assay##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
activity at a##2##3##(2008-7#1)(2011-2#1)
activity at concentrations##2##3##(2008-10#1)(2008-11#1)
activity at low pH##2##4##(1990-5#1)(2008-10#1)
activity at pH##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
activity at the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
activity at##28##2##(1990-5#1)(1991-12#1)(1993-1#1)(1994-5#1)(1995-11#1)(2008-10#6)(2008-11#4)(2008-7#3)(2008-8#1)(2010-11#1)(2010-3#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
activity before##2##2##(1991-6#1)(2013-8#1)
activity between##4##2##(1996-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
activity but a##2##3##(1993-6#1)(2008-10#1)
activity but not##2##3##(1991-5#1)(1993-8#1)
activity but##9##2##(1991-5#2)(1992-6#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)
activity by the##5##3##(1993-12#1)(1995-8#1)(1997-1#1)(2008-10#1)(2009-9#1)
activity by using##2##3##(2008-10#1)(2008-8#1)
activity by##34##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#5)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
activity can be##6##3##(2008-10#2)(2009-8#1)(2011-2#3)
activity can##10##2##(1997-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#3)
activity cannot be##2##3##(1994-8#1)(2008-11#1)
activity changes##2##2##(1991-6#1)(2010-11#1)
activity coefficient##2##2##(2008-10#2)
activity coefficients of##3##3##(2008-10#3)
activity coefficients##9##2##(2008-10#7)(2008-5#1)(2008-7#1)
activity comparable to##2##3##(1990-5#1)(1993-1#1)
activity compared to##3##3##(1996-12#1)(2009-8#1)(2013-1#1)
activity compared with##3##3##(2008-10#2)(2008-7#1)
activity compared##6##2##(1996-12#1)(2008-10#2)(2008-7#1)(2009-8#1)(2013-1#1)
activity correlated with##3##3##(1991-6#1)(1994-11#1)(2009-9#1)
activity correlated##4##2##(1991-6#1)(1994-11#1)(2006-6#1)(2009-9#1)
activity could be##3##3##(1992-9#1)(1995-11#1)(2008-10#1)
activity could##5##2##(1992-9#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)
activity counseling##6##2##(2008-4#6)
activity decreased significantly with age##2##5##(1990-3#2)
activity decreased##5##2##(1990-3#2)(1991-12#1)(1993-12#1)(2008-7#1)
activity depends on##2##3##(1995-2#1)(2008-12#1)
activity detected in##2##3##(2008-10#2)
activity did not##2##3##(1995-6#1)(2008-10#1)
activity driven by##2##3##(1996-3#1)(2008-10#1)
activity due to hypopnoea##2##4##(2010-8#2)
activity due to##4##3##(1993-6#1)(2010-8#2)(2011-1#1)
activity during a##2##3##(2008-4#1)(2012-12#1)
activity during aging##2##3##(2008-7#1)(2011-2#1)
activity during the##5##3##(2008-11#1)(2008-7#2)(2010-8#1)(2013-8#1)
activity during##21##2##(1992-10#1)(1997-2#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#4)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#2)
activity equivalent to##2##3##(1991-6#1)(1993-8#1)
activity exhibited by##2##3##(1994-8#1)(2008-12#1)
activity exhibited##3##2##(1994-8#1)(2008-10#1)(2008-12#1)
activity expressed by##3##3##(2008-10#2)(2011-1#1)
activity expressed##5##2##(1994-11#1)(2008-10#2)(2008-8#1)(2011-1#1)
activity following##2##2##(2008-11#1)(2008-8#1)
activity for at least##2##4##(2008-10#2)
activity for oxidation of##2##4##(2008-10#2)
activity for several##2##3##(2008-10#2)
activity for the##7##3##(1993-1#1)(1997-2#1)(2008-10#3)(2008-12#1)(2009-11#1)
activity for##26##2##(1993-1#1)(1993-6#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-3#1)(2011-2#2)(2013-1#1)
activity from the##3##3##(1995-12#1)(1997-1#1)(2008-9#1)
activity from##12##2##(1991-5#1)(1992-6#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#1)
activity has a##2##3##(2008-7#1)(2013-1#1)
activity has been shown to be##2##6##(1993-11#1)(1994-8#1)
activity has been shown to##3##5##(1993-11#1)(1993-2#1)(1994-8#1)
activity has been##9##3##(1993-11#1)(1993-2#1)(1994-2#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-8#1)
activity has##17##2##(1993-11#1)(1993-2#1)(1994-2#1)(1994-8#1)(1996-1#1)(2008-10#2)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#2)
activity have been##5##3##(1997-9#1)(2008-10#1)(2009-8#1)(2010-4#1)(2010-5#1)
activity have##8##2##(1997-9#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-4#1)(2010-5#1)(2013-1#2)
activity in HeLa##2##3##(2008-9#1)(2010-3#1)
activity in PC12 cells##2##4##(2008-11#2)
activity in a##13##3##(1992-7#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2013-8#1)
activity in both##5##3##(1997-4#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-11#1)
activity in brain##2##3##(1993-8#1)(2008-11#1)
activity in cells##2##3##(1995-6#1)(2008-11#1)
activity in comparison##2##3##(1992-8#1)(2008-7#1)
activity in control and nucleus basalis-lesioned rats##2##7##(1991-12#2)
activity in culture##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
activity in erythrocytes##2##3##(1993-6#1)(2008-10#1)
activity in general##2##3##(1990-6#1)(2008-7#1)
activity in human##3##3##(2008-11#1)(2010-11#1)(2010-5#1)
activity in mammalian cells##3##4##(1993-6#1)(2008-11#2)
activity in mice##3##3##(2008-5#2)(2010-2#1)
activity in milk##3##3##(2008-10#2)(2013-1#1)
activity in mouse##3##3##(1992-5#1)(1992-6#2)
activity in patients##2##3##(1992-12#1)(2013-1#1)
activity in rat##4##3##(1990-11#1)(1993-8#1)(1995-11#1)(2008-12#1)
activity in rats##4##3##(1994-8#1)(2008-12#2)(2013-8#1)
activity in real##2##3##(2008-10#1)(2011-1#1)
activity in response to##3##4##(1994-11#1)(2008-11#2)
activity in the first##2##4##(2008-10#1)(2008-11#1)
activity in the liver##3##4##(1995-2#1)(2008-6#2)
activity in the presence of##5##5##(1990-7#1)(1990-8#1)(1994-5#1)(1995-8#1)(2011-2#1)
activity in the range##2##4##(2008-10#1)(2008-8#1)
activity in the roots##2##4##(2008-10#1)(2008-12#1)
activity in the##79##3##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#4)(1996-3#1)(2008-10#10)(2008-11#13)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2009-3#1)(2010-11#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
activity in this##4##3##(1993-3#1)(1996-12#1)(1996-2#1)(2008-10#1)
activity in transgenic##2##3##(1995-2#1)(1995-6#1)
activity in vitro and in##2##5##(2008-10#1)(2010-11#1)
activity in vitro##18##3##(1990-5#1)(1992-8#1)(1994-5#1)(1994-8#1)(1996-5#3)(2008-10#5)(2008-11#3)(2008-9#1)(2010-11#1)(2012-2#1)
activity in vivo##4##3##(1990-11#1)(1993-8#1)(2006-6#1)(2008-9#1)
activity in##330##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#4)(1993-1#2)(1993-12#4)(1993-3#5)(1993-6#3)(1993-8#9)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#4)(1995-11#4)(1995-12#5)(1995-2#6)(1995-5#1)(1995-6#4)(1995-8#5)(1996-12#1)(1996-2#8)(1996-3#2)(1996-5#3)(1997-2#1)(1997-4#1)(2006-6#1)(2008-10#47)(2008-11#49)(2008-12#8)(2008-4#8)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#9)(2009-3#1)(2009-6#3)(2009-8#2)(2010-10#2)(2010-11#6)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#12)
activity increased##10##2##(1991-12#1)(1992-3#1)(1993-12#1)(2008-11#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-11#1)
activity indicated that##2##3##(2008-9#1)(2011-3#1)
activity indicates that##2##3##(1993-8#1)(1997-3#1)
activity induced by##2##3##(1994-3#1)(1997-4#1)
activity into##2##2##(2008-1#1)(2008-11#1)
activity is a##3##3##(1992-10#1)(2008-11#1)(2008-9#1)
activity is associated with##2##4##(1994-11#1)(1995-6#1)
activity is determined by##2##4##(2008-4#1)(2012-3#1)
activity is measured##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
activity is modulated by##2##4##(2008-5#1)(2011-1#1)
activity is not altered##2##4##(1997-2#1)(2008-11#1)
activity is not##5##3##(1992-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
activity is present##2##3##(1993-8#1)(2013-8#1)
activity is regulated by##2##4##(2008-4#1)(2009-8#1)
activity is required for##3##4##(1992-10#1)(1997-1#1)(2008-11#1)
activity is##69##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-3#3)(1993-8#1)(1994-11#2)(1995-12#1)(1995-5#1)(1995-6#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#9)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#3)
activity level##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
activity levels and##2##3##(2008-10#1)(2008-11#1)
activity levels during##2##3##(2008-10#1)(2012-2#1)
activity levels were##2##3##(1996-12#1)(2012-12#1)
activity levels##12##2##(1996-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-9#1)(2012-12#2)(2012-2#1)(2013-8#1)
activity limitations##4##2##(2009-5#3)(2011-3#1)
activity markedly##2##2##(1994-11#1)(1995-6#1)
activity may reflect the##2##4##(2008-11#1)(2009-10#1)
activity may##12##2##(1992-10#1)(1992-9#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)
activity measured in##2##3##(1994-8#1)(2008-10#1)
activity might be##2##3##(1995-8#1)(2008-8#1)
activity more##2##2##(1994-8#1)(2008-11#1)
activity needed##2##2##(1997-6#1)(2008-10#1)
activity nor##2##2##(2008-11#1)(2008-8#1)
activity occurred at##2##3##(1994-9#1)(2008-10#1)
activity of 1-4 was##2##4##(2013-1#2)
activity of 2##2##3##(2008-10#1)(2013-1#1)
activity of 27##2##3##(1994-5#1)(2013-1#1)
activity of AP-1##2##3##(1996-2#2)
activity of C##3##3##(2008-10#2)(2012-6#1)
activity of LDH was##2##4##(2008-11#2)
activity of PKC was##2##4##(2008-11#1)(2008-8#1)
activity of Pseudomonas fluorescens B5##2##5##(2008-10#2)
activity of Pseudomonas fluorescens##3##4##(2008-10#3)
activity of a single channel##2##5##(2011-3#2)
activity of a##17##3##(1990-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2009-6#1)(2009-8#1)(2011-3#2)(2012-3#1)
activity of acid phosphatase##2##4##(1995-3#1)(2008-7#1)
activity of acid##3##3##(1995-3#1)(2008-7#1)(2008-9#1)
activity of alanine##2##3##(2008-10#1)(2008-12#1)
activity of alcohol dehydrogenase##2##4##(1992-11#1)(2008-11#1)
activity of an##4##3##(1993-2#1)(1997-1#1)(2008-10#2)
activity of antimicrobial agents##3##4##(2008-7#3)
activity of both##3##3##(2008-10#2)(2008-11#1)
activity of brain##2##3##(1994-8#1)(2008-7#1)
activity of cyclic##2##3##(1993-8#1)(1996-12#1)
activity of cytochrome P450SCC##2##4##(1997-2#2)
activity of cytochrome##3##3##(1997-2#2)(2008-11#1)
activity of cytosolic NADPH-dependent T3 binding##2##6##(1991-5#2)
activity of cytosolic##4##3##(1990-5#1)(1991-5#3)
activity of different##3##3##(2008-12#1)(2012-2#2)
activity of each##2##3##(1994-5#1)(2008-5#1)
activity of electrolyte##2##3##(2008-10#2)
activity of enzyme##2##3##(2008-10#1)(2012-2#1)
activity of enzymes##2##3##(2011-1#1)(2012-2#1)
activity of ethanol##2##3##(2008-11#1)(2012-2#1)
activity of exoglycosidases##2##3##(2009-8#2)
activity of human##7##3##(1990-12#3)(1993-8#1)(2008-5#2)(2008-9#1)
activity of its##2##3##(2008-5#1)(2009-3#1)
activity of lysosomal##2##3##(1991-7#1)(2006-6#1)
activity of novel##2##3##(1992-3#1)(2008-8#1)
activity of other##2##3##(2008-10#1)(2013-7#1)
activity of phospholipase##5##3##(1993-3#1)(1994-11#1)(1994-5#2)(2011-2#1)
activity of plasma##2##3##(2009-7#1)(2013-1#1)
activity of protein##2##3##(1997-8#1)(2008-11#1)
activity of proteins##2##3##(2008-10#1)(2008-11#1)
activity of purified##3##3##(1995-6#1)(2008-11#1)(2008-8#1)
activity of rat##3##3##(2008-10#1)(2008-11#2)
activity of recombinant glycoprotein##2##4##(2008-7#2)
activity of recombinant##6##3##(1991-3#1)(1995-12#1)(2008-10#1)(2008-7#2)(2011-2#1)
activity of recombined single chain insulin##2##6##(2008-9#2)
activity of reconstituted F(0)##2##4##(2008-8#2)
activity of selected##2##3##(2008-5#2)
activity of seminal##2##3##(1990-5#1)(1994-3#1)
activity of soil##2##3##(2008-11#2)
activity of some##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
activity of the acetone extract##2##5##(2008-11#2)
activity of the brain##3##4##(2008-11#1)(2008-7#1)(2010-8#1)
activity of the cells##2##4##(2008-10#1)(2008-11#1)
activity of the compost##2##4##(2008-10#2)
activity of the drug##2##4##(1991-3#1)(2010-12#1)
activity of the enzyme in##2##5##(1996-2#1)(2008-10#1)
activity of the enzyme##9##4##(1991-12#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-9#1)(2009-6#1)
activity of the essential oils##2##5##(2008-10#1)(2008-11#1)
activity of the immobilized enzyme##2##5##(2008-10#2)
activity of the intact##2##4##(1995-2#1)(2008-10#1)
activity of the most##2##4##(1991-6#1)(1994-8#1)
activity of the pathogen##2##4##(2008-10#2)
activity of the rat neuronal cell line PC12##3##8##(2008-11#3)
activity of the rat##7##4##(1990-5#2)(2008-11#5)
activity of the transformants##2##4##(2008-10#1)(2008-8#1)
activity of the##154##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-8#3)(1994-11#2)(1994-2#3)(1994-6#2)(1994-8#3)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#21)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-3#3)(2009-6#2)(2009-8#2)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#3)(2011-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
activity of these enzymes##3##4##(2008-10#2)(2008-11#1)
activity of these##10##3##(1994-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2009-8#1)
activity of this##10##3##(1990-5#1)(1992-6#2)(1993-6#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-3#1)
activity of three##2##3##(2008-10#1)(2011-2#1)
activity of two##2##3##(2008-10#1)(2008-11#1)
activity of type##2##3##(1994-5#1)(2008-8#1)
activity of various##3##3##(1994-12#1)(1994-8#1)(2008-9#1)
activity of wild-type##3##3##(1995-6#1)(1995-8#1)(2008-9#1)
activity of yeast##2##3##(1992-3#1)(2008-10#1)
activity of##667##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#10)(1990-6#1)(1990-8#5)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#3)(1991-5#9)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#6)(1993-6#2)(1993-8#8)(1994-11#9)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#9)(1994-6#4)(1994-8#11)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#8)(1995-3#4)(1995-5#4)(1995-6#7)(1995-8#4)(1996-12#2)(1996-2#10)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#5)(2006-6#3)(2007-12#1)(2008-1#3)(2008-10#139)(2008-11#78)(2008-12#12)(2008-4#1)(2008-5#27)(2008-6#4)(2008-7#16)(2008-8#26)(2008-9#30)(2009-10#2)(2009-3#5)(2009-4#2)(2009-6#3)(2009-7#2)(2009-8#10)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-6#3)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#10)(2011-3#8)(2012-12#1)(2012-2#9)(2012-3#10)(2012-6#1)(2013-1#26)(2013-7#2)(2013-8#3)
activity on organic##2##3##(2008-10#2)
activity on the##3##3##(1993-8#1)(2008-9#1)(2010-9#1)
activity on##25##2##(1990-5#1)(1991-5#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
activity only##4##2##(1995-12#1)(2008-11#1)(2009-6#1)(2010-11#1)
activity or##6##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
activity over##4##2##(1994-5#1)(2008-11#1)(2009-9#1)(2011-3#1)
activity participation and##2##3##(2009-3#1)(2009-6#1)
activity participation##3##2##(2009-3#1)(2009-6#1)(2012-2#1)
activity patterns##2##2##(2012-12#1)(2012-2#1)
activity peaked##2##2##(1993-8#1)(2011-1#1)
activity plays##2##2##(1995-8#1)(2010-10#1)
activity profiles##2##2##(2008-10#1)(2012-12#1)
activity ratios##2##2##(1994-8#1)(2008-10#1)
activity regulate##2##2##(1996-2#1)(2009-8#1)
activity related to##2##3##(2008-11#2)
activity related##3##2##(2008-11#2)(2012-2#1)
activity relationship##2##2##(2008-10#1)(2013-1#1)
activity remained##4##2##(1990-5#1)(1995-8#1)(2008-10#1)(2008-11#1)
activity revealed##2##2##(1995-11#1)(2008-10#1)
activity score##2##2##(2011-2#1)(2013-1#1)
activity seen##2##2##(1994-11#1)(2008-12#1)
activity showed a##2##3##(1994-8#1)(2008-8#1)
activity showed that##2##3##(2008-10#1)(2012-2#1)
activity showed##6##2##(1994-8#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)
activity significantly##2##2##(1992-12#1)(2008-6#1)
activity similar to that##2##4##(1993-6#1)(2008-7#1)
activity stimulated by##2##3##(1994-6#1)(1995-8#1)
activity testing##2##2##(1993-6#1)(2010-6#1)
activity than that of##3##4##(2008-10#2)(2008-5#1)
activity than the##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
activity than##22##2##(1990-12#1)(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#3)(2010-11#1)(2013-1#1)(2013-8#3)
activity that was##2##3##(1992-8#1)(2008-10#1)
activity that##17##2##(1992-8#1)(1993-3#1)(1994-12#1)(1994-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
activity through the##2##3##(2008-5#1)(2008-7#1)
activity through##5##2##(1994-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
activity to an extent##2##4##(1995-2#1)(2008-11#1)
activity to the reduction of##2##5##(2008-10#2)
activity to the##3##3##(1996-2#1)(2008-10#2)
activity to##27##2##(1990-3#1)(1992-8#1)(1993-8#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#4)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
activity together##2##2##(2009-6#1)(2011-2#1)
activity toward the##4##3##(1995-6#1)(2008-10#2)(2008-11#1)
activity toward##15##2##(1993-8#1)(1994-11#2)(1995-6#2)(2008-10#9)(2008-11#1)
activity towards the oxidation of##4##5##(2008-10#4)
activity towards the oxidation##5##4##(2008-10#5)
activity towards the##6##3##(2008-10#6)
activity towards##11##2##(1991-9#1)(1994-8#1)(2008-10#6)(2009-12#1)(2011-1#2)
activity under the same##2##4##(1991-5#1)(1993-6#1)
activity under##4##2##(1991-5#1)(1993-6#1)(1993-8#1)(1997-3#1)
activity up to##2##3##(1997-2#1)(2008-10#1)
activity using##4##2##(1994-2#1)(2008-10#3)
activity was also##6##3##(1990-5#1)(1993-12#1)(1993-2#1)(1994-11#1)(2008-10#1)(2008-7#1)
activity was assessed##2##3##(2008-10#1)(2008-5#1)
activity was at##2##3##(2008-6#1)(2008-7#1)
activity was characterized##2##3##(1992-12#1)(2012-3#1)
activity was confirmed by##2##4##(1995-12#1)(1995-6#1)
activity was confirmed##3##3##(1995-12#1)(1995-6#1)(2010-3#1)
activity was decreased##2##3##(2008-10#1)(2008-8#1)
activity was detected in##2##4##(2008-10#2)
activity was detected##9##3##(1991-12#1)(1992-9#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-7#2)
activity was determined##5##3##(1990-8#1)(1993-2#1)(2008-10#2)(2011-2#1)
activity was developed##2##3##(2008-10#1)(2010-7#1)
activity was due##2##3##(2008-10#1)(2008-7#1)
activity was evaluated by a##2##5##(2011-2#1)(2013-1#1)
activity was evaluated by##3##4##(1994-8#1)(2011-2#1)(2013-1#1)
activity was evaluated##4##3##(1994-8#1)(2011-2#2)(2013-1#1)
activity was found to be increased##2##6##(1990-2#1)(1997-3#1)
activity was found to be significantly##2##6##(2008-10#1)(2008-7#1)
activity was found to be##6##5##(1990-2#1)(1997-3#1)(2008-10#3)(2008-7#1)
activity was found to##7##4##(1990-2#1)(1994-2#1)(1997-3#1)(2008-10#3)(2008-7#1)
activity was found##8##3##(1990-2#1)(1994-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
activity was higher##2##3##(1997-8#1)(2011-2#1)
activity was induced##3##3##(1994-6#1)(2008-10#2)
activity was inhibited by##7##4##(1991-5#1)(1993-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2012-2#1)
activity was inversely##2##3##(1990-8#1)(1993-8#1)
activity was investigated in##2##4##(1996-2#1)(2008-5#1)
activity was investigated##3##3##(1994-8#1)(1996-2#1)(2008-5#1)
activity was measured in##3##4##(1990-3#1)(1991-2#1)(2008-10#1)
activity was measured##7##3##(1990-3#1)(1991-12#1)(1991-2#1)(2008-10#2)(2010-11#1)(2013-1#1)
activity was not required for##2##5##(1992-10#1)(2007-12#1)
activity was not##7##3##(1992-10#1)(1993-3#1)(1997-1#1)(2007-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
activity was observed at##4##4##(1995-8#1)(2008-11#1)(2008-6#1)(2012-2#1)
activity was observed in##2##4##(2008-10#1)(2010-4#1)
activity was observed##12##3##(1995-8#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#1)(2010-4#1)(2012-2#1)
activity was obtained##2##3##(1991-6#1)(1997-2#1)
activity was positively correlated with##2##5##(2008-10#1)(2011-2#1)
activity was quantified##3##3##(2006-6#1)(2008-10#1)(2011-2#1)
activity was recorded for the##2##5##(2008-10#1)(2013-8#1)
activity was recorded##3##3##(1994-2#1)(2008-10#1)(2013-8#1)
activity was retained##2##3##(1990-5#1)(1997-8#1)
activity was seen in##4##4##(1991-12#1)(1992-6#1)(1995-11#1)(1997-3#1)
activity was seen##5##3##(1991-12#1)(1992-6#1)(1995-11#1)(1997-3#1)(2008-10#1)
activity was significantly higher##2##4##(1990-11#1)(2008-11#1)
activity was significantly##5##3##(1990-11#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
activity was studied##2##3##(1991-12#1)(1994-6#1)
activity was unaffected by##2##4##(1995-11#1)(1995-12#1)
activity was unaffected##3##3##(1993-12#1)(1995-11#1)(1995-12#1)
activity was##185##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#2)(1991-12#6)(1991-2#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#5)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#7)(1994-2#2)(1994-6#2)(1994-8#2)(1995-11#3)(1995-12#2)(1995-6#3)(1995-8#3)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#3)(2006-6#1)(2007-12#1)(2008-10#40)(2008-11#13)(2008-12#1)(2008-5#7)(2008-6#4)(2008-7#9)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#7)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#2)
activity well##2##2##(1992-2#1)(2008-10#1)
activity were detected##2##3##(2008-10#1)(2010-10#1)
activity were increased in##2##4##(1991-12#1)(2008-10#1)
activity were investigated and##2##4##(2009-3#1)(2013-1#1)
activity were investigated in##2##4##(1990-5#1)(1994-3#1)
activity were investigated##6##3##(1990-5#1)(1994-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2013-1#1)
activity were observed##2##3##(2008-10#2)
activity were##37##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-8#1)(1994-3#2)(1994-8#2)(1995-11#2)(1995-8#1)(2008-10#13)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
activity when assayed in##2##4##(1990-10#1)(1995-2#1)
activity when##9##2##(1990-10#1)(1992-10#1)(1993-3#1)(1995-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-8#1)
activity which##4##2##(1992-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
activity while##2##2##(2008-8#1)(2010-1#1)
activity with EC50 values of##2##5##(2008-11#2)
activity with an##3##3##(1992-1#1)(2008-11#1)(2008-12#1)
activity with the##4##3##(1996-2#1)(2008-10#1)(2008-11#2)
activity with##29##2##(1990-2#1)(1992-1#1)(1992-6#1)(1992-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#8)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-3#2)
activity within##4##2##(1995-2#1)(2008-11#1)(2008-12#1)(2010-11#1)
activity without##4##2##(1992-3#2)(2008-10#2)
activity would##4##2##(1991-2#1)(1994-11#1)(2008-11#1)(2013-1#1)
activity##3173##1##(1990-10#3)(1990-11#17)(1990-12#15)(1990-2#13)(1990-3#6)(1990-5#28)(1990-6#6)(1990-7#1)(1990-8#14)(1990-9#6)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#31)(1991-2#14)(1991-3#7)(1991-5#34)(1991-6#16)(1991-7#5)(1991-8#3)(1991-9#5)(1992-1#4)(1992-10#8)(1992-11#4)(1992-12#20)(1992-2#4)(1992-3#24)(1992-4#2)(1992-5#4)(1992-6#33)(1992-7#4)(1992-8#16)(1992-9#8)(1993-1#11)(1993-11#11)(1993-12#21)(1993-2#13)(1993-3#24)(1993-6#19)(1993-8#51)(1993-9#5)(1994-11#56)(1994-12#8)(1994-2#15)(1994-3#17)(1994-5#28)(1994-6#13)(1994-8#46)(1994-9#4)(1995-11#22)(1995-12#30)(1995-2#40)(1995-3#8)(1995-5#9)(1995-6#46)(1995-8#34)(1995-9#2)(1996-1#3)(1996-12#12)(1996-2#34)(1996-3#8)(1996-5#3)(1996-6#1)(1997-1#21)(1997-2#22)(1997-3#8)(1997-4#6)(1997-6#7)(1997-7#10)(1997-8#21)(1997-9#1)(2006-6#12)(2007-11#3)(2007-12#6)(2008-1#6)(2008-10#571)(2008-11#361)(2008-12#44)(2008-3#3)(2008-4#41)(2008-5#118)(2008-6#20)(2008-7#98)(2008-8#74)(2008-9#69)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#6)(2009-3#20)(2009-4#2)(2009-5#9)(2009-6#23)(2009-7#6)(2009-8#29)(2009-9#14)(2010-1#7)(2010-10#15)(2010-11#26)(2010-12#16)(2010-2#6)(2010-3#10)(2010-4#3)(2010-5#4)(2010-6#9)(2010-7#9)(2010-8#13)(2010-9#11)(2011-1#23)(2011-10#3)(2011-2#92)(2011-3#22)(2011-7#1)(2012-12#22)(2012-2#61)(2012-3#29)(2012-4#2)(2012-6#2)(2013-1#110)(2013-7#6)(2013-8#73)
activity) and##4##2##(1991-9#1)(1992-3#1)(2008-5#1)(2011-2#1)
activity)##16##1##(1991-9#1)(1992-3#3)(1993-8#2)(1994-5#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
activity-dependent synaptic##2##2##(1997-7#1)(2012-2#1)
activity-dependent##8##1##(1996-2#1)(1997-7#1)(2008-1#2)(2009-8#2)(2012-2#1)(2013-8#1)
activity-related##2##1##(2009-10#1)(2012-2#1)
activity-response curves##2##2##(2008-5#2)
actor##6##1##(2008-11#2)(2008-8#1)(2013-8#3)
actors##8##1##(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-1#2)(2011-2#2)
acts as a potent##2##4##(1990-2#1)(1996-2#1)
acts as a weak ionophore##2##5##(1994-3#2)
acts as a##36##3##(1990-2#1)(1992-4#1)(1992-8#1)(1994-3#2)(1995-11#1)(1995-2#2)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
acts as an##8##3##(2008-10#4)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
acts as the##4##3##(1994-5#1)(2008-10#2)(2008-5#1)
acts as##55##2##(1990-2#1)(1992-4#1)(1992-8#1)(1994-3#3)(1994-5#1)(1995-11#1)(1995-2#2)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#14)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
acts at##3##2##(1994-8#1)(2006-6#1)(2013-1#1)
acts by##3##2##(1993-3#1)(2008-10#1)(2009-7#1)
acts in an##2##3##(1993-3#1)(2011-2#1)
acts in parallel to##2##4##(2008-9#1)(2009-8#1)
acts in the##2##3##(2008-8#1)(2011-2#1)
acts in##8##2##(1993-3#1)(1997-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)
acts on##6##2##(1991-5#1)(1991-6#1)(1992-3#1)(1993-9#1)(1995-11#1)(2008-8#1)
acts to##4##2##(1993-12#1)(2008-6#2)(2009-8#1)
acts##96##1##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-4#1)(2006-6#1)(2008-10#16)(2008-11#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
actual and potential##2##3##(2008-12#1)(2009-4#1)
actual and##3##2##(2008-12#1)(2009-4#1)(2011-3#1)
actual clinical##2##2##(1992-3#1)(2008-7#1)
actual data##2##2##(1992-2#1)(2008-10#1)
actual exercise##5##2##(1992-12#5)
actual health##3##2##(1991-12#1)(1992-2#1)(2008-11#1)
actual mechanism of##2##3##(2008-10#1)(2008-11#1)
actual mechanism##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
actual or potential##3##3##(2012-12#1)(2013-1#2)
actual or##4##2##(2008-11#1)(2012-12#1)(2013-1#2)
actual patients##2##2##(2008-11#1)(2012-12#1)
actual practice##4##2##(1992-1#1)(1993-2#1)(1997-8#1)(2010-7#1)
actual samples##4##2##(2008-10#4)
actual use##6##2##(1992-3#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-5#1)
actual weight##3##2##(1991-2#1)(1996-8#1)(2008-12#1)
actual##157##1##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#7)(1992-2#3)(1992-3#3)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#41)(2008-11#13)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-7#3)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#1)
actually be##2##2##(2008-11#1)(2011-2#1)
actually increase##2##2##(2008-2#1)(2008-8#1)
actually increases##2##2##(2008-8#1)(2011-2#1)
actually measured##2##2##(2008-7#1)(2013-8#1)
actually occurred##2##2##(2008-9#1)(2011-1#1)
actually promote##2##2##(1991-9#1)(1996-1#1)
actually reduce##4##2##(2008-7#2)(2010-3#1)(2011-3#1)
actually##73##1##(1990-12#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-3#1)(1997-7#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2013-1#3)(2013-8#3)
actuarial RFS##2##2##(2011-2#2)
actuarial overall survival was##2##4##(1991-8#2)
actuarial overall survival##3##3##(1991-8#2)(1994-12#1)
actuarial survival##4##2##(1991-6#1)(1996-11#1)(2008-10#1)(2011-3#1)
actuarial##15##1##(1990-6#1)(1991-6#1)(1991-8#3)(1992-2#1)(1993-3#1)(1994-12#1)(1996-11#1)(2008-10#1)(2011-2#4)(2011-3#1)
actuated##4##1##(1992-3#1)(1996-2#1)(2008-10#1)(2009-5#1)
actuation behavior##2##2##(2010-4#2)
actuation##7##1##(2008-10#1)(2009-5#1)(2010-4#5)
acuformis has##2##2##(2008-10#2)
acuformis in Washington##2##3##(2008-10#2)
acuformis in##3##2##(2008-10#3)
acuformis##13##1##(2008-10#13)
acuity and colour vision##2##4##(2008-7#2)
acuity and##3##2##(2008-7#2)(2013-1#1)
acuity of##5##2##(2010-10#1)(2011-2#3)(2013-7#1)
acuity was##2##2##(1991-2#1)(2011-2#1)
acuity##31##1##(1991-2#1)(1993-12#1)(1996-1#2)(2008-7#2)(2010-10#2)(2010-9#2)(2011-2#15)(2013-1#4)(2013-7#1)(2013-8#1)
acuminata##4##1##(1994-1#2)(2013-1#1)(2013-8#1)
acupoint##2##1##(2008-9#1)(2013-1#1)
acupoints of HM##2##3##(2008-9#2)
acupoints of##6##2##(2008-9#5)(2010-7#1)
acupoints##9##1##(2008-9#5)(2010-7#2)(2013-1#2)
acupuncture and moxibustion##5##3##(2008-10#5)
acupuncture and##7##2##(2008-10#5)(2011-2#1)(2013-1#1)
acupuncture meridians##2##2##(2010-7#2)
acupuncture needle##2##2##(2008-10#1)(2008-8#1)
acupuncture or moxibustion##2##3##(2008-10#2)
acupuncture to##2##2##(2008-10#2)
acupuncture treatment##3##2##(2010-6#1)(2010-7#1)(2013-1#1)
acupuncture##45##1##(1995-12#4)(2008-10#23)(2008-11#2)(2008-8#2)(2010-6#5)(2010-7#4)(2011-2#1)(2013-1#3)(2013-8#1)
acupuncturists##2##1##(2008-10#2)
acus##2##1##(2012-2#2)
acutatum and C##3##3##(2008-10#3)
acutatum and the##2##3##(2008-10#2)
acutatum and##7##2##(2008-10#7)
acutatum by##2##2##(2008-10#2)
acutatum conidia##2##2##(2008-10#2)
acutatum from strawberry##4##3##(2008-10#4)
acutatum from##8##2##(2008-10#8)
acutatum isolates##4##2##(2008-10#4)
acutatum on##6##2##(2008-10#6)
acutatum populations##2##2##(2008-10#2)
acutatum was##4##2##(2008-10#4)
acutatum were##4##2##(2008-10#4)
acutatum##81##1##(2008-10#81)
acutatum-##2##1##(2008-10#2)
acutatum-M##3##1##(2008-10#3)
acutatum-O##3##1##(2008-10#3)
acutatum-specific##3##1##(2008-10#3)
acute (&lt##2##2##(2008-8#1)(2011-2#1)
acute EBV infection##2##3##(2008-5#1)(2011-2#1)
acute EBV##3##2##(2008-5#1)(2011-2#2)
acute EtOH treatment##2##3##(2008-10#2)
acute EtOH##6##2##(2008-10#6)
acute PE##6##2##(2011-2#6)
acute abdomen due to##2##4##(2009-9#1)(2012-2#1)
acute abdomen##6##2##(1997-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
acute abdominal pain##2##3##(2008-12#1)(2009-8#1)
acute abdominal##4##2##(2008-12#2)(2009-8#1)(2011-2#1)
acute administration of##2##3##(2008-10#1)(2013-8#1)
acute and chronic effects##2##4##(1994-5#1)(2008-5#1)
acute and chronic health##2##4##(2008-7#1)(2012-12#1)
acute and chronic models of##2##5##(2008-12#2)
acute and chronic##29##3##(1991-9#3)(1992-3#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)(2009-12#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#4)
acute and long-term##2##3##(2012-3#1)(2013-7#1)
acute and persistent##2##3##(2010-1#1)(2010-12#1)
acute and preventive##2##3##(1995-11#1)(2008-9#1)
acute and##40##2##(1991-1#1)(1991-9#3)(1992-3#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
acute angle##2##2##(2008-2#1)(2013-1#1)
acute aortic##2##2##(2010-12#1)(2013-1#1)
acute appendicitis##4##2##(1993-6#2)(1997-8#1)(2008-12#1)
acute asthma##6##2##(1992-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-8#2)
acute bacterial##6##2##(1991-3#2)(2008-10#3)(2010-12#1)
acute biliary pancreatitis##2##3##(2007-8#2)
acute biliary##3##2##(1992-9#1)(2007-8#2)
acute bleeding##2##2##(2010-12#1)(2011-2#1)
acute care hospitals##9##3##(1992-2#1)(1993-12#1)(1994-3#1)(1997-1#1)(2008-11#3)(2010-10#1)(2010-8#1)
acute care psychiatric##2##3##(1992-3#2)
acute care##27##2##(1991-12#1)(1992-2#2)(1992-3#2)(1993-12#2)(1994-2#1)(1994-3#2)(1996-2#1)(1997-1#3)(2008-11#4)(2010-10#3)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2013-1#2)
acute cellular rejection (ACR)##2##4##(2008-10#2)
acute cerebellar ataxia##2##3##(2011-2#2)
acute cerebral##2##2##(2009-11#1)(2013-8#1)
acute chest##2##2##(2011-2#1)(2013-1#1)
acute cholangitis and##2##3##(1997-8#1)(2013-1#1)
acute cholangitis due to##2##4##(2013-1#2)
acute cholangitis##5##2##(1997-8#1)(2013-1#4)
acute cholecystitis##4##2##(1990-9#1)(1997-8#3)
acute compartment syndrome##2##3##(2009-1#2)
acute complications##4##2##(1992-9#1)(1994-6#2)(2013-7#1)
acute conditions##2##2##(1990-12#1)(1991-6#1)
acute coronary syndrome as##2##4##(2008-3#2)
acute coronary syndrome in the##4##5##(2008-3#3)(2008-7#1)
acute coronary syndrome##25##3##(2008-11#7)(2008-3#10)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#4)(2012-2#1)
acute coronary syndromes##23##3##(2008-11#1)(2008-3#13)(2009-10#3)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#3)
acute coronary##50##2##(2008-11#8)(2008-3#23)(2008-7#1)(2009-10#5)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#7)(2012-2#1)(2013-8#1)
acute disease##6##2##(1994-6#1)(1997-8#3)(2008-9#1)(2009-10#1)
acute dystonia in##2##3##(2012-12#2)
acute dystonia##3##2##(2012-12#3)
acute emesis##2##2##(2010-12#2)
acute encephalitis##2##2##(2008-12#1)(2011-2#1)
acute episode of##3##3##(2010-10#1)(2010-3#1)(2012-12#1)
acute episode##4##2##(1991-8#1)(2010-10#1)(2010-3#1)(2012-12#1)
acute exacerbation of chronic##2##4##(1997-4#1)(2008-10#1)
acute exacerbations of chronic bronchitis##2##5##(1996-11#1)(2008-7#1)
acute exacerbations of chronic##3##4##(1996-11#1)(2007-12#1)(2008-7#1)
acute exacerbations##4##2##(1996-11#1)(2007-12#1)(2008-7#1)(2010-5#1)
acute exercise stress##2##3##(2008-10#2)
acute exposure##2##2##(1990-6#1)(1994-5#1)
acute flaccid paralysis##3##3##(2010-8#3)
acute gastroenteritis##2##2##(1996-6#1)(2013-8#1)
acute glomerulonephritis##3##2##(1997-5#1)(2011-2#2)
acute gonococcal salpingitis##2##3##(1994-2#2)
acute hepatic##2##2##(1991-11#1)(2009-7#1)
acute hepatitis##5##2##(1991-8#1)(1995-2#1)(1996-3#2)(2010-8#1)
acute hospital stroke units##3##4##(2011-1#3)
acute hospital##5##2##(1994-12#1)(2008-11#1)(2011-1#3)
acute hospitalization##3##2##(2011-2#3)
acute iatrogenic water intoxication##2##4##(1995-11#2)
acute illness episodes##2##3##(2010-2#2)
acute illness##7##2##(2008-11#1)(2009-10#1)(2010-2#5)
acute increase in##2##3##(1994-8#1)(1995-2#1)
acute increase##3##2##(1994-8#1)(1995-2#1)(2010-10#1)
acute infection of##2##3##(1990-9#1)(2009-4#1)
acute infection##3##2##(1990-9#1)(2009-4#2)
acute infections##3##2##(1990-12#1)(2008-7#1)(2013-8#1)
acute infectious disease##2##3##(2008-7#2)
acute infectious##3##2##(1990-2#1)(2008-7#2)
acute inpatient##2##2##(1992-1#1)(1992-12#1)
acute intestinal##2##2##(1990-3#1)(2012-2#1)
acute intracranial hypertension##2##3##(2008-7#2)
acute intracranial##3##2##(2008-7#2)(2011-2#1)
acute intraperitoneal##2##2##(1996-2#1)(2011-2#1)
acute ischaemic##3##2##(2008-7#1)(2009-11#1)(2011-2#1)
acute ischemic stroke##8##3##(2008-10#1)(2009-11#2)(2009-6#1)(2012-12#4)
acute ischemic##9##2##(2008-10#1)(2009-11#2)(2009-6#1)(2011-2#1)(2012-12#4)
acute kidney injury##3##3##(2013-1#1)(2013-8#2)
acute kidney##4##2##(2012-3#1)(2013-1#1)(2013-8#2)
acute leukemia##12##2##(1997-7#2)(2008-11#1)(2008-9#3)(2011-2#4)(2012-3#1)(2013-1#1)
acute liver failure##2##3##(2010-12#1)(2013-1#1)
acute lung injury##2##3##(2008-12#1)(2010-10#1)
acute lung##3##2##(2008-12#1)(2010-10#1)(2012-3#1)
acute lymphoblastic leukaemia (ALL)##3##4##(2008-12#1)(2010-11#1)(2011-2#1)
acute lymphoblastic leukaemia##9##3##(2008-12#4)(2008-7#2)(2010-11#2)(2011-2#1)
acute lymphoblastic leukemia (ALL)##2##4##(2010-6#1)(2011-2#1)
acute lymphoblastic leukemia##8##3##(2008-10#1)(2008-11#4)(2008-9#1)(2010-6#1)(2011-2#1)
acute lymphoblastic##18##2##(2008-10#1)(2008-11#4)(2008-12#5)(2008-7#2)(2008-9#1)(2010-11#2)(2010-6#1)(2011-2#2)
acute medical##4##2##(1991-6#1)(2010-5#1)(2010-7#2)
acute megakaryoblastic leukaemia##2##3##(2008-12#1)(2009-12#1)
acute monoblastic leukemia 5##2##4##(2011-2#2)
acute monoblastic leukemia##3##3##(2011-2#3)
acute myelocytic leukemia##2##3##(1991-2#2)
acute myelogenous leukaemia##2##3##(2006-6#2)
acute myelogenous leukemia##2##3##(2008-4#1)(2008-7#1)
acute myelogenous##4##2##(2006-6#2)(2008-4#1)(2008-7#1)
acute myeloid leukaemia##4##3##(2009-3#2)(2011-2#1)(2011-3#1)
acute myeloid leukemia (AML)##4##4##(2010-1#1)(2011-2#2)(2012-12#1)
acute myeloid leukemia in a##2##5##(1990-8#2)
acute myeloid leukemia or##2##4##(2010-11#1)(2011-2#1)
acute myeloid leukemia##14##3##(1990-8#2)(1994-5#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-1#2)(2010-11#1)(2011-2#4)(2012-12#1)
acute myeloid##20##2##(1990-8#2)(1994-5#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-3#2)(2010-1#2)(2010-11#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#1)
acute myocardial infarction (AMI) and##2##5##(2008-5#1)(2010-12#1)
acute myocardial infarction (AMI)##10##4##(1990-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-11#1)(2010-12#1)
acute myocardial infarction and##5##4##(1995-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
acute myocardial infarction in##2##4##(2008-11#1)(2013-1#1)
acute myocardial infarction with##2##4##(1990-9#1)(2010-5#1)
acute myocardial infarction##46##3##(1990-12#1)(1990-9#3)(1992-3#2)(1992-9#2)(1993-12#3)(1994-12#1)(1995-12#4)(1995-2#1)(1995-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#7)(2008-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
acute myocardial infarction]##3##3##(1990-12#1)(1994-6#1)(2008-10#1)
acute myocardial##53##2##(1990-12#2)(1990-9#3)(1991-3#1)(1992-3#2)(1992-9#2)(1993-12#3)(1994-12#1)(1994-6#1)(1995-12#4)(1995-2#1)(1995-8#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#7)(2008-5#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
acute necrosis##2##2##(1996-11#1)(2008-5#1)
acute non-lymphoid leukemia##2##3##(1991-2#1)(1992-12#1)
acute onset of##6##3##(1997-3#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
acute or chronic##6##3##(1991-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
acute or##10##2##(1991-3#1)(1992-9#1)(1993-12#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
acute pain was diagnosed more often##2##6##(2013-1#2)
acute pain##6##2##(2013-1#6)
acute pancreatitis and the##2##4##(2008-3#1)(2013-1#1)
acute pancreatitis##20##2##(1990-3#2)(1997-8#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#3)(2012-12#2)(2013-1#9)
acute patellar tendinopathy after##2##4##(2013-1#2)
acute patients##2##2##(2008-10#1)(2008-11#1)
acute phase##16##2##(1992-9#1)(1993-12#1)(1994-6#2)(1997-5#6)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#2)
acute promyelocytic leukemia (APL)##2##4##(1991-9#1)(2008-8#1)
acute promyelocytic leukemia##3##3##(1991-9#2)(2008-8#1)
acute psychiatric##2##2##(1992-2#1)(2013-1#1)
acute pulmonary embolism##4##3##(2010-10#1)(2011-2#3)
acute pulmonary##7##2##(1991-11#1)(2008-10#1)(2009-1#1)(2010-10#1)(2011-2#3)
acute pyelonephritis##4##2##(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
acute rejection##6##2##(1991-11#1)(1993-2#2)(2008-10#1)(2011-3#1)(2012-2#1)
acute renal failure##4##3##(2008-1#1)(2008-11#1)(2012-3#1)(2013-8#1)
acute renal##6##2##(2008-1#1)(2008-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
acute respiratory distress syndrome##2##4##(2010-12#1)(2012-12#1)
acute respiratory infections in##3##4##(2010-4#1)(2013-8#2)
acute respiratory##14##2##(1993-5#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#4)(2013-8#3)
acute restraint stress##2##3##(1994-2#2)
acute sinusitis##2##2##(1991-6#1)(2011-2#1)
acute stage##6##2##(1990-12#1)(1990-9#1)(1997-3#1)(2008-12#1)(2008-7#1)(2009-11#1)
acute stress##3##2##(2012-3#1)(2013-8#2)
acute stroke##11##2##(2007-9#2)(2008-8#4)(2009-11#2)(2011-1#2)(2013-8#1)
acute thrombosis in##2##3##(2006-6#2)
acute thrombosis##4##2##(2006-6#2)(2011-2#2)
acute toxicity##7##2##(1996-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2011-2#1)
acute treatment##4##2##(1992-11#1)(1994-5#1)(2008-9#1)(2012-3#1)
acute uncomplicated##2##2##(2011-2#2)
acute viral##2##2##(2007-12#1)(2011-2#1)
acute##802##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#4)(1990-5#5)(1990-6#3)(1990-8#2)(1990-9#10)(1991-1#4)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#5)(1991-3#6)(1991-6#6)(1991-8#4)(1991-9#6)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#10)(1992-6#2)(1992-9#7)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#5)(1993-8#2)(1994-11#7)(1994-12#2)(1994-2#8)(1994-3#3)(1994-5#4)(1994-6#10)(1994-8#2)(1994-9#5)(1995-11#4)(1995-12#7)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#6)(1996-3#4)(1996-6#1)(1996-8#2)(1997-1#6)(1997-2#2)(1997-3#6)(1997-4#1)(1997-5#9)(1997-7#2)(1997-8#10)(2006-6#5)(2007-11#1)(2007-12#3)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#40)(2008-11#45)(2008-12#21)(2008-2#1)(2008-3#32)(2008-4#3)(2008-5#12)(2008-6#1)(2008-7#26)(2008-8#12)(2008-9#10)(2009-1#5)(2009-10#8)(2009-11#9)(2009-12#4)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#9)(2009-9#2)(2010-1#6)(2010-10#11)(2010-11#6)(2010-12#14)(2010-2#7)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#5)(2011-1#5)(2011-2#87)(2011-3#2)(2012-12#21)(2012-2#12)(2012-3#17)(2012-5#1)(2013-1#56)(2013-7#3)(2013-8#24)
acute- and##2##2##(1993-12#1)(1996-1#1)
acutely compensated##4##2##(1991-2#4)
acutely lethal##3##2##(1997-3#3)
acutely or chronically##2##3##(1992-9#1)(1996-12#1)
acutely or##3##2##(1992-9#1)(1996-12#1)(2008-10#1)
acutely##21##1##(1991-2#4)(1991-5#1)(1992-9#1)(1994-11#2)(1994-8#1)(1995-12#1)(1996-12#1)(1997-3#3)(2008-10#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-8#1)
acyclic carbonyl##2##2##(1990-9#2)
acyclic polyether##2##2##(2008-10#2)
acyclic polyethers with lipophilic amide##2##5##(2008-10#2)
acyclic##13##1##(1990-9#3)(1994-8#1)(1996-5#3)(2008-10#5)(2008-11#1)
acyclovir##9##1##(1991-12#1)(1994-3#1)(1994-8#1)(1995-6#5)(2011-2#1)
acyl chain length##5##3##(1993-8#2)(1994-5#3)
acyl chain##8##2##(1993-8#4)(1994-5#3)(1997-2#1)
acyl chains of##2##3##(2008-10#1)(2008-11#1)
acyl chains##7##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#2)
acyl donor##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
acyl transfer##2##2##(1991-12#1)(2008-10#1)
acyl##35##1##(1990-12#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-4#2)(1993-8#4)(1994-5#3)(1996-5#1)(1997-2#4)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
acyl-ACP##3##1##(1995-6#3)
acyl-CoA dehydrogenase##3##2##(1990-8#2)(1993-3#1)
acyl-CoA esters##4##2##(1994-8#4)
acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate##2##7##(1990-5#2)
acyl-CoA##16##1##(1990-5#3)(1990-8#2)(1993-3#2)(1994-8#9)
acyl-CoA-binding protein##2##2##(1994-8#2)
acyl-CoAs##4##1##(1990-5#1)(1992-8#2)(1994-8#1)
acyl-acyl carrier##2##2##(1995-6#2)
acyl-homoserine##2##1##(2008-9#2)
acylated##3##1##(1995-3#1)(1996-5#2)
acylation of##3##2##(1990-5#2)(1993-8#1)
acylation##5##1##(1990-12#1)(1990-5#2)(1993-8#1)(1997-4#1)
acylcarnitines##2##1##(1991-12#1)(2012-2#1)
acylcoenzyme A##2##2##(1994-8#2)
acyltransferase##13##1##(1990-5#3)(1991-12#1)(1993-6#2)(1993-8#2)(1994-8#3)(1995-6#1)(1997-2#1)
ad hoc##5##2##(1992-3#1)(1993-12#1)(1997-3#1)(2008-10#1)(2011-9#1)
ad lib##2##2##(1993-8#1)(2008-9#1)
ad libitum##7##2##(2008-10#2)(2008-11#2)(2008-7#1)(2013-1#1)(2013-8#1)
ad##15##1##(1992-3#1)(1993-12#1)(1993-8#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-9#1)(2013-1#1)(2013-8#1)
adFNDI##3##1##(2008-4#3)
adalimumab##4##1##(2010-12#3)(2011-2#1)
adamantinoma##4##1##(2010-11#4)
adanine dinucleotide##2##2##(2008-10#2)
adapt the##7##2##(1993-12#1)(2008-10#2)(2008-3#1)(2008-8#2)(2013-1#1)
adapt their##4##2##(2008-11#2)(2011-1#1)(2012-3#1)
adapt to changing##2##3##(1991-1#1)(2009-6#1)
adapt to new##2##3##(2008-10#1)(2010-4#1)
adapt to the##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2012-6#1)
adapt to##19##2##(1990-8#1)(1991-1#1)(1992-5#1)(1996-1#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-8#3)(2009-6#1)(2009-9#1)(2010-4#1)(2012-2#1)(2012-6#1)
adapt##39##1##(1990-8#1)(1991-1#1)(1992-5#1)(1993-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#6)(2008-11#6)(2008-3#1)(2008-6#1)(2008-8#5)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#2)(2011-1#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)
adaptability and##2##2##(2008-10#1)(2008-9#1)
adaptability##4##1##(1994-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
adaptable to##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
adaptable##6##1##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)
adaptation and##12##2##(1994-2#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2013-1#2)
adaptation difficulties##2##2##(2012-2#2)
adaptation for##3##2##(1990-8#1)(1993-9#1)(2008-8#1)
adaptation in the##2##3##(1995-5#1)(2008-5#1)
adaptation in##10##2##(1992-5#1)(1995-5#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-3#1)(2012-7#1)
adaptation into##2##2##(2013-1#2)
adaptation is##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
adaptation may##2##2##(2008-11#1)(2009-8#1)
adaptation occurred##2##2##(1997-7#1)(2008-8#1)
adaptation of a##2##3##(1990-12#1)(2008-9#1)
adaptation of the##11##3##(1996-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)
adaptation of##29##2##(1990-12#1)(1992-2#1)(1994-8#1)(1996-11#1)(1997-2#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#3)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
adaptation procedure##3##2##(2008-11#3)
adaptation process##2##2##(2008-11#1)(2013-1#1)
adaptation programmes##2##2##(2008-11#2)
adaptation should##2##2##(2008-10#1)(2008-8#1)
adaptation to a##5##3##(1990-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-6#1)
adaptation to different##2##3##(2008-10#1)(2008-9#1)
adaptation to increased##2##3##(1994-8#1)(2009-1#1)
adaptation to low temperature##2##4##(2011-1#2)
adaptation to stress##3##3##(2008-10#1)(2012-3#2)
adaptation to the##5##3##(1991-1#1)(1995-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
adaptation to their##2##3##(2009-6#1)(2011-2#1)
adaptation to##43##2##(1990-2#1)(1991-1#1)(1994-8#1)(1995-2#1)(1997-6#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-2#1)(2012-3#2)(2012-6#1)(2012-7#2)(2013-1#1)(2013-8#2)
adaptation##160##1##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#22)(2008-11#23)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#13)(2008-9#7)(2009-1#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#6)(2012-6#1)(2012-7#4)(2013-1#10)(2013-8#5)
adaptationist##2##1##(2008-8#2)
adaptations in##5##2##(2008-8#1)(2009-8#1)(2010-8#1)(2013-8#2)
adaptations may##2##2##(2009-8#2)
adaptations of##3##2##(2008-4#1)(2008-6#1)(2009-1#1)
adaptations that##2##2##(2010-5#1)(2013-8#1)
adaptations to the##2##3##(2008-10#1)(2010-8#1)
adaptations to##6##2##(1992-1#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)
adaptations##34##1##(1992-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#5)(2010-5#2)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#4)
adapted and non-adapted##2##3##(2008-11#2)
adapted and##3##2##(2008-11#3)
adapted cells##3##2##(2008-10#1)(2008-11#2)
adapted for use##2##3##(1990-2#1)(2008-4#1)
adapted for##12##2##(1990-12#1)(1990-2#1)(1994-12#1)(1994-3#1)(1997-6#1)(2008-10#5)(2008-4#2)
adapted from##4##2##(1994-2#1)(2008-12#1)(2012-2#1)(2012-3#1)
adapted method##2##2##(2008-10#1)(2010-2#1)
adapted strain was##2##3##(2013-8#2)
adapted strain##4##2##(2013-8#4)
adapted to a##5##3##(2008-10#4)(2008-9#1)
adapted to any##2##3##(1993-2#1)(2008-10#1)
adapted to bread wheat##2##4##(2008-10#2)
adapted to grow##2##3##(2008-11#2)
adapted to the##17##3##(1995-1#1)(1995-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2009-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-8#1)
adapted to##80##2##(1990-5#1)(1991-5#1)(1993-2#1)(1995-1#1)(1995-11#1)(2007-12#1)(2008-10#22)(2008-11#15)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-8#1)
adapted##142##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-1#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#32)(2008-11#27)(2008-12#6)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#7)(2009-10#2)(2009-12#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-7#2)(2011-2#2)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#2)(2013-8#6)
adapter protein##2##2##(2008-6#1)(2009-7#1)
adapter##5##1##(1995-8#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
adapting the##4##2##(1995-12#1)(1997-2#1)(2008-11#1)(2008-3#1)
adapting to##3##2##(1992-2#1)(2009-8#1)(2010-7#1)
adapting##15##1##(1992-1#1)(1992-2#1)(1995-12#1)(1996-2#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-8#1)(2010-7#1)(2012-2#2)
adaption##2##1##(1995-11#1)(2013-8#1)
adaptive and##3##2##(1997-2#1)(2008-7#1)(2013-1#1)
adaptive behavior##2##2##(2008-8#2)
adaptive changes in##2##3##(1990-12#1)(2009-7#1)
adaptive changes##3##2##(1990-12#1)(2009-7#1)(2013-1#1)
adaptive controller##2##2##(1997-2#2)
adaptive deme formation##4##3##(2008-9#4)
adaptive diversification##2##2##(2008-8#2)
adaptive evolution##5##2##(2008-8#3)(2011-1#2)
adaptive functions##2##2##(2009-8#2)
adaptive immune responses against##2##4##(2009-3#1)(2012-12#1)
adaptive immune responses##6##3##(2008-10#1)(2009-3#1)(2010-10#1)(2012-12#1)(2013-8#2)
adaptive immune##9##2##(2008-1#1)(2008-10#2)(2009-10#1)(2009-3#1)(2010-10#1)(2012-12#1)(2013-8#2)
adaptive immunity##4##2##(1995-5#1)(1996-12#1)(2008-5#1)(2008-6#1)
adaptive interferometer##2##2##(2007-11#2)
adaptive mechanism##2##2##(2009-8#1)(2011-1#1)
adaptive mechanisms##2##2##(2010-4#1)(2012-3#1)
adaptive mutations##5##2##(2008-9#5)
adaptive optics##2##2##(1990-8#1)(2008-3#1)
adaptive pattern##2##2##(2008-10#1)(2008-4#1)
adaptive plasticity##2##2##(2008-8#2)
adaptive radiation in##3##3##(2008-8#3)
adaptive radiation##5##2##(2008-8#5)
adaptive response in##2##3##(2008-7#2)
adaptive response##11##2##(2008-7#8)(2010-12#1)(2011-1#1)(2013-1#1)
adaptive responses to##2##3##(1994-2#1)(1996-12#1)
adaptive responses##8##2##(1994-2#1)(1996-12#2)(2008-7#3)(2011-2#1)(2013-8#1)
adaptive testing##3##2##(2010-2#3)
adaptive traits##2##2##(2008-8#1)(2008-9#1)
adaptive two-band algorithm##2##3##(2008-3#2)
adaptive value of floral integration##2##5##(2009-8#2)
adaptive value of##3##3##(2008-8#1)(2009-8#2)
adaptive value##4##2##(2008-8#1)(2009-8#3)
adaptive##152##1##(1990-12#1)(1990-8#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-12#3)(1997-2#3)(2007-11#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#14)(2008-8#24)(2008-9#17)(2009-10#1)(2009-11#2)(2009-3#1)(2009-7#1)(2009-8#6)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-4#3)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#8)
adaptively important genes##2##3##(2008-8#2)
adaptively##6##1##(2008-10#1)(2008-8#4)(2010-12#1)
adaptor protein##5##2##(1997-7#1)(2008-6#1)(2013-1#3)
adaptor##10##1##(1997-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-6#1)(2013-1#3)
adaptors and##2##2##(1995-11#1)(2013-1#1)
adaptors##3##1##(1995-11#1)(2008-2#1)(2013-1#1)
adapts##3##1##(1993-12#1)(2008-8#1)(2011-2#1)
adaxial surface##2##2##(2008-10#2)
add a##4##2##(1997-3#1)(2008-12#1)(2008-3#1)(2012-2#1)
add to previous##2##3##(2008-3#1)(2008-9#1)
add to the##3##3##(2008-12#1)(2008-7#1)(2009-10#1)
add to##6##2##(1992-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)
add up##2##2##(1990-11#1)(1997-6#1)
add##32##1##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
add-drop##2##1##(2008-3#2)
add-on devices##4##2##(1996-2#2)(1997-1#2)
add-on##6##1##(1996-2#2)(1997-1#2)(2008-10#1)(2009-10#1)
added a##2##2##(2008-10#1)(2008-11#1)
added advantage##2##2##(2008-4#1)(2008-9#1)
added amount##2##2##(2008-10#2)
added an##2##2##(1997-1#1)(2008-12#1)
added and##6##2##(2008-10#5)(2008-9#1)
added as an##2##3##(2008-10#2)
added as##6##2##(1994-12#1)(2008-10#3)(2008-11#2)
added at 1##2##3##(2008-10#2)
added at##6##2##(2008-10#4)(2008-7#1)(2008-8#1)
added benefit##2##2##(2008-8#2)
added directly##2##2##(1993-8#1)(2008-10#1)
added extracellularly##2##2##(1993-6#1)(2008-6#1)
added flexibility in##2##3##(1995-6#1)(2008-11#1)
added for##3##2##(1992-1#1)(2008-9#1)(2012-3#1)
added in the##8##3##(1997-8#1)(2007-11#2)(2008-10#3)(2012-12#1)(2013-1#1)
added in vitro##2##3##(1995-2#1)(2008-11#1)
added in##17##2##(1995-2#1)(1997-8#1)(2007-11#3)(2008-10#9)(2008-11#1)(2012-12#1)(2013-1#1)
added or##2##2##(1996-3#1)(2008-10#1)
added surfactant##2##2##(2008-10#2)
added to a##8##3##(1991-5#1)(2008-10#5)(2008-11#1)(2008-7#1)
added to an##3##3##(1997-2#1)(2008-10#2)
added to form##2##3##(2008-10#1)(2008-12#1)
added to samples##3##3##(1990-2#1)(2008-10#2)
added to soil##7##3##(2008-10#7)
added to the culture##3##4##(2008-11#3)
added to the medium##4##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
added to the sample solution##3##5##(2008-10#3)
added to the sample##6##4##(2008-10#6)
added to the samples##5##4##(2008-10#5)
added to the soil##2##4##(2008-10#2)
added to the solution##6##4##(2008-10#6)
added to the upper##2##4##(1992-6#1)(2008-11#1)
added to the water##2##4##(2008-10#2)
added to the wine##2##4##(2008-10#2)
added to the##96##3##(1991-3#2)(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-8#1)(1996-1#2)(1996-12#1)(2008-10#55)(2008-11#16)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-1#1)(2009-6#1)(2011-2#1)
added to this##3##3##(2008-10#2)(2011-2#1)
added to various##2##3##(1995-11#1)(2013-7#1)
added to##184##2##(1990-11#1)(1990-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1992-12#2)(1992-6#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#102)(2008-11#23)(2008-12#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#5)(2012-2#2)(2013-1#2)(2013-7#1)
added together with##2##3##(2008-11#2)
added up to##2##3##(1992-10#1)(2008-9#1)
added was##4##2##(2008-10#2)(2008-11#1)(2010-3#1)
added with##2##2##(2007-12#1)(2008-11#1)
added zinc##2##2##(1994-5#2)
added##385##1##(1990-11#3)(1990-2#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#5)(1993-8#4)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#4)(1994-8#1)(1995-11#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#4)(1997-2#1)(1997-8#4)(2007-11#3)(2007-12#1)(2008-10#182)(2008-11#44)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#11)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-3#2)(2010-4#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
addendum we discuss##2##3##(2009-8#2)
addendum we##5##2##(2009-8#5)
addendum##10##1##(2009-8#9)(2011-2#1)
addicted to##2##2##(1993-11#1)(2011-2#1)
addicted##3##1##(1993-11#1)(2011-2#2)
addiction and##4##2##(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
addiction as##2##2##(2008-6#1)(2011-2#1)
addiction is##2##2##(2009-7#2)
addiction##34##1##(1991-1#3)(1993-3#1)(1996-11#1)(1997-5#1)(2008-11#2)(2008-5#1)(2008-6#8)(2009-7#5)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
addiction?##2##1##(2009-7#1)(2011-2#1)
addictions##4##1##(1992-12#1)(1994-12#1)(2008-6#1)(2013-8#1)
addictive component##2##2##(2008-11#1)(2013-1#1)
addictive##7##1##(1990-11#1)(1993-6#1)(1995-6#1)(2008-11#1)(2008-6#1)(2009-4#1)(2013-1#1)
addicts##9##1##(1991-1#4)(1993-2#1)(1993-3#1)(1996-11#1)(2008-10#1)(2012-12#1)
adding 0##5##2##(2008-10#2)(2008-11#3)
adding 1##2##2##(2008-11#2)
adding Triton##2##2##(2008-10#2)
adding a##9##2##(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)
adding an##4##2##(2008-10#3)(2010-7#1)
adding any##2##2##(2008-10#2)
adding appropriate##2##2##(2008-10#2)
adding the##13##2##(1994-3#1)(2008-10#8)(2008-11#4)
adding to the##2##3##(2008-10#1)(2008-11#1)
adding##123##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-1#2)(1996-6#1)(1997-1#1)(1997-8#1)(2008-10#63)(2008-11#19)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#2)(2010-7#2)(2011-2#3)(2012-2#2)(2013-1#2)
addition and removal##2##3##(2008-11#1)(2008-2#1)
addition and##11##2##(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)
addition as##2##2##(2008-10#2)
addition for##2##2##(2008-11#1)(2009-10#1)
addition in the##2##3##(2008-10#1)(2008-6#1)
addition in##3##2##(2008-10#2)(2008-6#1)
addition into the##2##3##(2008-10#1)(2008-11#1)
addition is##3##2##(1995-2#1)(2008-10#2)
addition line##6##2##(2008-10#4)(2008-8#2)
addition lines##2##2##(2008-10#2)
addition method and##5##3##(2008-10#5)
addition method was##6##3##(2008-10#6)
addition method##60##2##(2008-10#60)
addition of 0##3##3##(2008-10#3)
addition of 1##2##3##(1991-5#1)(2008-10#1)
addition of 10##2##3##(2008-10#1)(2008-11#1)
addition of 20##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
addition of 200 muM SA##2##5##(2008-10#2)
addition of BSA##2##3##(1995-12#1)(2008-10#1)
addition of DS salt##2##4##(2008-5#2)
addition of HGF##4##3##(2008-11#4)
addition of Mg(2+)##2##3##(2008-10#2)
addition of NaCl##2##3##(2008-10#1)(2008-11#1)
addition of a mixture##2##4##(2008-10#2)
addition of a##24##3##(1993-1#1)(1996-5#1)(1997-7#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)(2013-1#1)
addition of an##8##3##(1992-9#1)(2008-10#4)(2008-8#2)(2011-2#1)
addition of chitin to##2##4##(2008-10#2)
addition of dexamethasone##2##3##(2008-11#2)
addition of different##2##3##(2008-10#2)
addition of either##4##3##(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#1)
addition of enzyme##2##3##(2008-10#2)
addition of excess##2##3##(2008-10#2)
addition of glucose##3##3##(2008-10#2)(2008-7#1)
addition of glycerol##2##3##(2008-10#1)(2008-11#1)
addition of human##2##3##(1994-3#1)(1997-7#1)
addition of potassium##2##3##(2008-10#1)(2008-7#1)
addition of proteins##3##3##(2008-10#3)
addition of salt##4##3##(2008-10#4)
addition of salts##2##3##(2008-10#1)(2009-8#1)
addition of several##2##3##(2008-10#1)(2008-11#1)
addition of sodium##5##3##(2008-10#4)(2011-2#1)
addition of the enzyme##2##4##(1992-12#1)(2008-10#1)
addition of the##32##3##(1990-8#2)(1991-5#1)(1992-12#1)(1995-1#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#9)(2008-11#7)(2008-5#2)(2008-8#1)(2010-4#1)
addition of these##2##3##(2008-10#1)(2013-1#1)
addition of triethylamine##2##3##(2008-7#2)
addition of two##2##3##(2008-11#1)(2008-7#1)
addition of water##3##3##(2008-10#2)(2009-8#1)
addition of##372##2##(1990-5#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#5)(1994-11#1)(1994-3#1)(1994-5#2)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#5)(1997-1#4)(1997-2#1)(1997-7#3)(1997-8#3)(2007-11#1)(2007-12#1)(2008-10#164)(2008-11#52)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#11)(2008-7#10)(2008-8#9)(2008-9#3)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#1)(2010-10#1)(2010-11#2)(2010-4#7)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#4)(2012-4#1)(2013-1#7)
addition on##2##2##(2008-10#1)(2008-11#1)
addition or##3##2##(2008-11#1)(2009-8#2)
addition reactions##3##2##(2008-10#2)(2008-8#1)
addition the##4##2##(1993-6#1)(2007-12#1)(2008-10#1)(2010-6#1)
addition to a##11##3##(1990-2#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)
addition to being##3##3##(1991-11#1)(2008-10#1)(2012-2#1)
addition to binding##2##3##(2008-11#1)(2008-9#1)
addition to clinical##2##3##(1995-5#1)(2008-10#1)
addition to direct##2##3##(2008-11#1)(2012-3#1)
addition to discussing the##2##4##(1993-2#1)(2008-4#1)
addition to its##11##3##(1993-12#1)(1993-8#1)(1995-11#1)(1997-3#1)(1997-6#2)(2008-10#2)(2008-4#1)(2008-5#1)(2010-7#1)
addition to reducing the##2##4##(1995-5#1)(2008-10#1)
addition to reducing##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
addition to the##83##3##(1990-5#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#16)(2008-11#7)(2008-12#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
addition to their##6##3##(1994-8#1)(1997-1#1)(2008-10#3)(2009-1#1)
addition to##278##2##(1990-2#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#2)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#4)(1997-6#4)(1997-8#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#62)(2008-11#23)(2008-12#8)(2008-2#2)(2008-3#5)(2008-4#10)(2008-5#8)(2008-6#2)(2008-7#11)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#2)(2009-2#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#12)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#2)
addition with##2##2##(2008-10#2)
addition##1567##1##(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#8)(1990-6#1)(1990-7#1)(1990-8#9)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#6)(1991-3#2)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#7)(1992-2#7)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#9)(1993-2#3)(1993-3#5)(1993-6#5)(1993-8#12)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#8)(1994-6#2)(1994-8#6)(1995-1#2)(1995-11#10)(1995-12#9)(1995-2#18)(1995-3#1)(1995-5#4)(1995-6#15)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#13)(1996-2#9)(1996-3#4)(1996-5#8)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#13)(1997-2#7)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#9)(1997-9#2)(2007-11#1)(2007-12#10)(2007-8#1)(2008-1#7)(2008-10#555)(2008-11#148)(2008-12#19)(2008-2#7)(2008-3#20)(2008-4#21)(2008-5#39)(2008-6#10)(2008-7#47)(2008-8#41)(2008-9#39)(2009-1#3)(2009-10#8)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-5#4)(2009-6#4)(2009-7#12)(2009-8#19)(2009-9#3)(2010-1#4)(2010-10#9)(2010-11#5)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#11)(2010-5#3)(2010-6#5)(2010-7#8)(2010-8#4)(2010-9#3)(2011-1#5)(2011-10#2)(2011-2#50)(2011-3#1)(2012-12#4)(2012-2#28)(2012-3#22)(2012-4#2)(2013-1#31)(2013-7#1)(2013-8#15)
addition/recovery##2##1##(2008-10#2)
additional &quot##2##2##(1991-3#1)(2013-8#1)
additional QTL##3##2##(2008-10#2)(2012-3#1)
additional UVB filters##2##3##(2008-5#2)
additional advantage##4##2##(2008-10#4)
additional analysis of##2##3##(2008-10#1)(2009-1#1)
additional applications of##2##3##(2008-10#2)
additional benefit##4##2##(1991-12#1)(1994-3#1)(2008-10#1)(2013-1#1)
additional case of##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
additional cases of##2##3##(2011-2#1)(2012-3#1)
additional cases##3##2##(1990-6#1)(2011-2#1)(2012-3#1)
additional clinical information##2##3##(1991-3#1)(1997-8#1)
additional contribution##2##2##(2008-10#1)(2010-4#1)
additional control##2##2##(2008-10#1)(2010-12#1)
additional data on##2##3##(1991-3#1)(2011-2#1)
additional data##6##2##(1991-3#1)(1993-8#1)(1996-3#1)(2009-8#2)(2011-2#1)
additional diagnostic##3##2##(1990-3#1)(1990-9#1)(1995-1#1)
additional evidence for##6##3##(1992-3#2)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
additional evidence that##2##3##(2006-6#1)(2009-8#1)
additional evidence##10##2##(1992-3#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)(2013-1#1)
additional experimental##2##2##(2008-10#2)
additional factors##4##2##(1996-2#1)(2008-10#1)(2008-11#2)
additional findings##2##2##(1997-3#1)(2011-2#1)
additional funding##2##2##(2008-10#1)(2013-1#1)
additional genes##3##2##(2008-10#2)(2008-7#1)
additional groups##4##2##(2008-10#1)(2008-9#3)
additional health##2##2##(2008-10#1)(2008-11#1)
additional information about##2##3##(1996-5#1)(2010-12#1)
additional information for##2##3##(1996-11#1)(2008-10#1)
additional information on the##4##4##(2008-10#2)(2008-7#1)(2013-1#1)
additional information on##5##3##(2008-10#3)(2008-7#1)(2013-1#1)
additional information to##2##3##(2008-4#1)(2011-2#1)
additional information##17##2##(1993-2#1)(1996-11#1)(1996-5#1)(2008-10#6)(2008-4#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
additional inoculum##2##2##(2008-10#2)
additional inputs##2##2##(1992-2#1)(2009-10#1)
additional insight into##3##3##(1991-10#1)(2009-8#1)(2012-3#1)
additional investigations##2##2##(1992-5#2)
additional layers##2##2##(2008-10#1)(2008-9#1)
additional mechanism##3##2##(1992-12#1)(2008-10#1)(2013-1#1)
additional modifications##2##2##(1991-12#1)(2011-2#1)
additional month##2##2##(1996-2#1)(2008-10#1)
additional motifs##2##2##(1997-7#1)(2008-5#1)
additional mutant##2##2##(1995-6#1)(2008-10#1)
additional nutritional##2##2##(2010-11#1)(2010-6#1)
additional peak corresponding to##2##4##(2008-10#2)
additional peak##3##2##(2008-10#3)
additional preconcentration##2##2##(2008-10#2)
additional procedures##2##2##(2011-2#2)
additional properties##2##2##(2009-3#1)(2013-1#1)
additional reduction##2##2##(2008-10#2)
additional research##3##2##(2008-6#1)(2009-8#1)(2010-10#1)
additional resources##2##2##(2008-10#1)(2008-8#1)
additional risk factors such as##2##5##(2008-11#2)
additional risk##3##2##(2008-11#2)(2011-2#1)
additional role##2##2##(1994-11#2)
additional slow##2##2##(2009-8#2)
additional sources##2##2##(1991-3#1)(2008-11#1)
additional steps##2##2##(2008-10#2)
additional strains##2##2##(2008-10#1)(2012-3#1)
additional studies##3##2##(2008-10#2)(2012-12#1)
additional support to##4##3##(1992-7#1)(2008-11#1)(2008-12#1)(2013-1#1)
additional support##5##2##(1992-7#1)(2008-11#1)(2008-12#1)(2013-1#2)
additional therapeutic##2##2##(2009-7#1)(2012-2#1)
additional therapy##2##2##(1990-11#1)(1997-8#1)
additional to##3##2##(1990-9#1)(2008-9#2)
additional tools##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
additional training##2##2##(1990-2#1)(2008-1#1)
additional use of##2##3##(1997-7#1)(2008-10#1)
additional##479##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#6)(1991-5#1)(1991-6#3)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-7#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-8#3)(1994-11#3)(1994-3#5)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#4)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#148)(2008-11#27)(2008-12#5)(2008-2#6)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#18)(2009-1#2)(2009-10#5)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#11)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#21)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#12)(2013-1#23)(2013-8#5)
additionally##22##1##(1993-12#1)(1995-5#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#2)(2012-12#1)(2012-3#2)
additions of##7##2##(1993-8#1)(2008-10#4)(2008-7#2)
additions were##2##2##(2008-10#2)
additions##47##1##(1993-8#1)(1996-5#1)(1997-7#1)(2008-10#39)(2008-7#3)(2008-8#1)(2012-2#1)
additive and##8##2##(1990-2#1)(1994-9#1)(2008-10#6)
additive effect##6##2##(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#2)(2011-2#1)
additive effects on##4##3##(2007-11#1)(2008-10#3)
additive effects##10##2##(2007-11#1)(2008-10#7)(2008-11#1)(2008-9#1)
additive for##2##2##(2008-10#1)(2008-11#1)
additive gene##3##2##(2008-10#2)(2009-5#1)
additive genetic##5##2##(2008-10#1)(2008-8#4)
additive in the##3##3##(2008-10#3)
additive in##7##2##(1990-5#1)(2008-10#5)(2011-2#1)
additive of##2##2##(2008-10#2)
additive on##3##2##(2008-10#3)
additive or##3##2##(1991-8#1)(2008-10#1)(2013-8#1)
additive to##3##2##(1990-2#1)(1990-3#1)(2008-10#1)
additive when##2##2##(1991-5#1)(2008-10#1)
additive##113##1##(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#1)(2007-11#1)(2008-10#64)(2008-11#6)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#7)(2008-9#1)(2009-5#1)(2011-2#5)(2013-8#2)
additively##5##1##(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)
additives and##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
additives are##2##2##(2008-10#2)
additives for##2##2##(2008-11#2)
additives in##7##2##(2008-10#5)(2010-9#2)
additives to##3##2##(2008-10#2)(2008-11#1)
additives##49##1##(1990-3#3)(1994-3#1)(2008-10#29)(2008-11#11)(2008-5#1)(2010-7#1)(2010-9#2)(2011-2#1)
additivity of##3##2##(2008-10#2)(2013-8#1)
additivity was##2##2##(1995-11#1)(2008-10#1)
additivity##8##1##(1992-12#1)(1992-3#1)(1995-11#1)(2008-10#4)(2013-8#1)
address a range of##2##4##(2008-10#1)(2008-12#1)
address any##2##2##(2008-11#2)
address gaps in##2##3##(2010-3#1)(2012-12#1)
address how##2##2##(1995-5#1)(2010-3#1)
address issues of##2##3##(1997-3#1)(2012-3#1)
address issues##5##2##(1997-3#1)(2008-1#1)(2008-12#1)(2010-5#1)(2012-3#1)
address questions##4##2##(1991-1#1)(1992-10#1)(2008-7#1)(2009-5#1)
address several##2##2##(2012-3#2)
address specific##4##2##(1992-1#1)(2008-12#1)(2012-2#1)(2013-1#1)
address the issue##4##3##(1992-1#1)(1996-12#1)(2010-10#1)(2013-1#1)
address the major##2##3##(1993-1#1)(2013-8#1)
address the need for##2##4##(2008-7#1)(2011-2#1)
address the possibility that##2##4##(2008-10#1)(2008-9#1)
address the problem of##2##4##(1997-1#1)(2007-12#1)
address the problem##4##3##(1997-1#1)(1997-3#1)(2007-12#1)(2012-12#1)
address the question##3##3##(1991-12#1)(2008-12#1)(2008-8#1)
address the##61##2##(1991-1#1)(1991-12#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
address these issues##3##3##(2008-11#2)(2013-1#1)
address these problems##2##3##(2008-10#1)(2008-12#1)
address these##14##2##(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#1)(2011-10#1)(2013-1#2)
address this concern##2##3##(2008-8#1)(2011-2#1)
address this deficit##2##3##(2008-9#1)(2013-1#1)
address this issue##11##3##(1993-1#1)(1995-8#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#5)(2012-3#1)
address this problem##3##3##(2009-3#1)(2010-10#1)(2011-2#1)
address this question##6##3##(1994-11#1)(2008-11#2)(2008-8#2)(2013-8#1)
address this##40##2##(1993-1#1)(1994-11#2)(1995-8#1)(1996-1#1)(1997-2#2)(2008-10#1)(2008-11#10)(2008-12#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
address what##2##2##(1996-6#1)(2008-11#1)
address whether##2##2##(1993-12#1)(2009-12#1)
address##201##1##(1990-11#1)(1991-1#2)(1991-12#1)(1992-1#3)(1992-10#1)(1992-3#2)(1993-1#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#6)(2007-12#1)(2008-1#2)(2008-10#14)(2008-11#29)(2008-12#13)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#4)(2011-1#1)(2011-10#2)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#11)(2013-8#6)
addressed and##4##2##(1992-2#1)(1994-1#2)(2008-9#1)
addressed are##3##2##(2008-11#2)(2011-2#1)
addressed at the##2##3##(2008-10#1)(2013-8#1)
addressed before##3##2##(2010-10#1)(2011-2#1)(2013-1#1)
addressed by a##2##3##(1996-1#1)(2012-3#1)
addressed by this##2##3##(1996-2#1)(2013-1#1)
addressed by##13##2##(1994-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-9#1)(2012-2#3)(2012-3#1)(2013-1#1)
addressed during##2##2##(1991-1#1)(2012-2#1)
addressed here##2##2##(2008-10#2)
addressed how##2##2##(2008-6#1)(2008-9#1)
addressed in the##5##3##(1992-9#1)(1994-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
addressed in this##2##3##(1993-1#1)(2012-2#1)
addressed in##14##2##(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#1)(1997-2#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
addressed the##5##2##(1994-6#1)(1994-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
addressed these##2##2##(1995-12#1)(2013-1#1)
addressed this##2##2##(1995-11#1)(2008-9#1)
addressed to the##3##3##(1996-11#1)(2009-7#1)(2011-2#1)
addressed to##11##2##(1992-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
addressed with##2##2##(2008-10#1)(2008-8#1)
addressed##121##1##(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-3#1)(2008-1#2)(2008-10#19)(2008-11#7)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#8)(2009-12#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-2#9)(2012-3#2)(2013-1#7)(2013-8#1)
addresses all##3##2##(2008-1#1)(2008-4#1)(2013-1#1)
addresses an##2##2##(1995-12#1)(2008-10#1)
addresses some##3##2##(1991-12#1)(2008-11#1)(2008-4#1)
addresses the challenges##2##3##(1994-3#1)(2008-12#1)
addresses the issue of##2##4##(1993-1#1)(2008-9#1)
addresses the issues##2##3##(2008-11#1)(2012-2#1)
addresses the question of##2##4##(2008-9#1)(2009-12#1)
addresses the##29##2##(1992-1#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-3#2)(1996-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-6#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
addresses these issues##2##3##(1992-9#1)(2009-10#1)
addresses this##2##2##(2008-4#1)(2008-9#1)
addresses##63##1##(1991-12#2)(1992-1#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-1#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#6)(2009-10#2)(2009-12#1)(2009-4#1)(2010-1#1)(2011-7#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
addressing cultural##2##2##(1995-1#1)(2008-12#1)
addressing many of##2##3##(1993-2#1)(2008-9#1)
addressing the##20##2##(1992-12#1)(1993-12#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-1#2)(2008-11#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
addressing these issues##2##3##(1997-2#1)(2008-12#1)
addressing these##5##2##(1997-1#1)(1997-2#1)(2008-10#1)(2008-12#2)
addressing this##3##2##(1993-1#1)(2008-10#1)(2010-10#1)
addressing##62##1##(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-9#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#5)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#6)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2010-10#2)(2010-6#1)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#6)
adds to the##5##3##(2009-12#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-3#1)
adds to##8##2##(1996-1#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
adds##16##1##(1994-3#1)(1996-1#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
adduct formation in##2##3##(1993-8#1)(1994-5#1)
adduct formation##11##2##(1993-8#3)(1994-5#1)(1995-9#1)(2008-10#4)(2008-11#1)(2011-2#1)
adduct ions##3##2##(2008-10#3)
adduct levels##4##2##(2008-12#4)
adduct of##2##2##(1991-5#1)(2008-8#1)
adduct##41##1##(1991-5#4)(1991-9#1)(1992-8#1)(1993-8#4)(1994-5#1)(1995-6#1)(1995-9#1)(1996-5#3)(2008-10#17)(2008-11#1)(2008-12#4)(2008-8#2)(2011-2#1)
adducted##3##1##(1993-8#3)
adducts and##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
adducts by##2##2##(1992-6#1)(2008-10#1)
adducts in##4##2##(1993-8#1)(2008-12#2)(2012-12#1)
adducts of##3##2##(1992-12#1)(1994-11#1)(2008-10#1)
adducts with##2##2##(2008-10#2)
adducts##33##1##(1991-5#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-11#1)(1996-5#4)(2008-10#6)(2008-11#2)(2008-12#7)(2008-8#1)(2010-7#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
adductus##4##1##(2012-2#3)(2012-3#1)
adefovir refractory patients##3##3##(2013-1#3)
adefovir##10##1##(2009-8#2)(2013-1#8)
adefovir-resistant HBV mutants##2##3##(2013-1#2)
adefovir-resistant##6##1##(2013-1#6)
adenine and##2##2##(1993-1#1)(2008-10#1)
adenine dinucleotide (NADH)##2##3##(2008-10#1)(2013-1#1)
adenine dinucleotide phosphate##4##3##(1992-12#2)(2011-2#2)
adenine dinucleotide##10##2##(1992-12#3)(2008-10#3)(2011-2#3)(2013-1#1)
adenine in##3##2##(2008-10#3)
adenine nucleotide##2##2##(2008-11#1)(2012-2#1)
adenine nucleotides##4##2##(1996-6#1)(2008-7#3)
adenine units##2##2##(2008-10#2)
adenine##37##1##(1990-10#1)(1990-2#1)(1992-12#3)(1993-1#2)(1994-5#1)(1996-6#1)(1996-8#1)(2008-10#14)(2008-11#3)(2008-7#3)(2008-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
adenines and 2##2##3##(1992-4#2)
adenines##4##1##(1992-4#2)(1996-3#1)(2008-10#1)
adeno-associated virus (AAV)##2##3##(2008-8#1)(2011-3#1)
adeno-associated virus (rAAV)##2##3##(2008-8#1)(2008-9#1)
adeno-associated virus vector##3##3##(1992-12#1)(2008-8#1)(2008-9#1)
adeno-associated virus##13##2##(1992-12#3)(1993-2#2)(2008-11#1)(2008-8#3)(2008-9#3)(2011-3#1)
adeno-associated##16##1##(1992-12#3)(1993-2#2)(2008-11#1)(2008-8#3)(2008-9#6)(2011-3#1)
adenocarcinoma and##6##2##(1990-2#1)(1991-12#1)(1995-3#1)(1997-8#1)(2008-11#1)(2008-12#1)
adenocarcinoma cell line##3##3##(1997-1#1)(2008-11#2)
adenocarcinoma cells##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
adenocarcinoma in a##2##3##(1991-8#1)(2008-1#1)
adenocarcinoma in##3##2##(1991-8#1)(2008-1#1)(2010-7#1)
adenocarcinoma is##2##2##(2008-12#1)(2008-9#1)
adenocarcinoma of the ovary##3##4##(1993-2#1)(2013-1#2)
adenocarcinoma of the pancreas##2##4##(1990-9#1)(2012-3#1)
adenocarcinoma of the##11##3##(1990-6#2)(1990-9#1)(1991-8#1)(1993-2#1)(2008-1#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
adenocarcinoma of##13##2##(1990-6#3)(1990-9#1)(1991-8#1)(1993-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
adenocarcinoma tumor##2##2##(1990-12#1)(2008-11#1)
adenocarcinoma with##3##2##(1992-2#2)(2011-2#1)
adenocarcinoma##81##1##(1990-12#1)(1990-2#2)(1990-6#5)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#3)(1992-2#2)(1993-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-8#1)(2008-1#8)(2008-10#1)(2008-11#8)(2008-12#5)(2008-4#1)(2008-9#7)(2009-1#1)(2009-12#2)(2009-5#1)(2010-11#1)(2010-6#2)(2010-7#2)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
adenocarcinoma)##4##1##(1994-8#1)(2008-11#3)
adenocarcinomas##6##1##(1990-2#1)(1995-3#1)(2008-11#1)(2010-6#1)(2010-7#1)(2012-2#1)
adenoid cystic carcinoma##2##3##(2013-8#2)
adenoma and CRC tissues##2##4##(2010-12#2)
adenoma and##7##2##(1996-9#1)(2008-12#1)(2008-5#1)(2010-12#4)
adenoma in##3##2##(1990-6#1)(2008-9#1)(2013-8#1)
adenoma is##2##2##(2008-10#2)
adenoma of the##3##3##(2008-10#2)(2009-1#1)
adenoma of##4##2##(1990-11#1)(2008-10#2)(2009-1#1)
adenoma was##2##2##(2008-9#1)(2011-2#1)
adenoma##45##1##(1990-11#4)(1990-6#1)(1990-9#1)(1992-5#1)(1996-11#1)(1996-9#1)(2008-10#9)(2008-12#2)(2008-5#1)(2008-9#2)(2009-1#2)(2009-12#2)(2009-6#1)(2009-8#2)(2010-12#8)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
adenomas and a##2##3##(2008-5#1)(2011-2#1)
adenomas and in##2##3##(1990-11#1)(2008-5#1)
adenomas and##14##2##(1990-11#4)(2008-5#3)(2009-12#4)(2011-2#3)
adenomas in##2##2##(2008-10#1)(2008-9#1)
adenomas of the##2##3##(2008-12#1)(2011-2#1)
adenomas or##2##2##(2012-3#2)
adenomas were##2##2##(1990-12#1)(2008-9#1)
adenomas##52##1##(1990-11#4)(1990-12#4)(1992-5#2)(1993-12#2)(1995-9#1)(1996-11#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#4)(2009-1#2)(2009-12#5)(2011-2#8)(2012-3#3)(2013-1#4)
adenomatoid odontogenic tumor##2##3##(2013-1#2)
adenomatoid odontogenic##3##2##(2013-1#3)
adenomatous polyposis##9##2##(2009-12#7)(2011-2#1)(2012-3#1)
adenomatous##13##1##(2008-1#2)(2008-10#1)(2009-12#8)(2011-2#1)(2012-3#1)
adenopathies##3##1##(2008-1#1)(2008-7#1)(2013-1#1)
adenopathy##2##1##(1995-1#2)
adenoregulin##10##1##(1993-3#6)(1994-5#4)
adenosine 3'##3##2##(1994-11#1)(1994-2#1)(1995-8#1)
adenosine A1 receptor##2##3##(1997-1#2)
adenosine A1##8##2##(1993-6#2)(1997-1#6)
adenosine analogues##3##2##(1994-8#2)(1995-8#1)
adenosine and guanosine##2##3##(2008-4#2)
adenosine and##4##2##(1995-8#1)(2008-10#1)(2008-4#2)
adenosine deaminase gene##2##3##(1995-9#2)
adenosine deaminase##7##2##(1991-3#1)(1992-12#2)(1993-12#1)(1995-9#2)(2008-10#1)
adenosine diphosphate and epinephrine##2##4##(1997-6#2)
adenosine diphosphate##4##2##(1993-6#1)(1997-6#2)(2006-6#1)
adenosine from spinal cord synaptosomes##2##5##(1996-2#2)
adenosine from the spinal cord##2##5##(1996-2#2)
adenosine from##4##2##(1996-2#4)
adenosine in##3##2##(1993-6#1)(1996-2#1)(2008-7#1)
adenosine kinase (ADK)##2##3##(2009-8#2)
adenosine modulation of Fc##2##4##(1994-6#2)
adenosine or##3##2##(1994-6#2)(1995-8#1)
adenosine receptor##8##2##(1993-3#2)(1993-6#1)(1994-5#2)(1995-8#3)
adenosine receptors##3##2##(1993-6#1)(1995-8#1)(2008-5#1)
adenosine release##2##2##(1996-2#2)
adenosine triphosphate##2##2##(1997-6#1)(2009-8#1)
adenosine##101##1##(1990-5#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#2)(1993-6#10)(1994-11#4)(1994-2#1)(1994-5#2)(1994-6#5)(1994-8#7)(1995-11#2)(1995-8#12)(1995-9#2)(1996-2#11)(1997-1#6)(1997-2#3)(1997-6#3)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#5)(2008-5#3)(2008-7#4)(2009-3#1)(2009-8#5)(2010-1#1)(2011-2#1)
adenosine)##2##1##(1997-1#1)(2008-11#1)
adenosine-3'##2##1##(1991-10#1)(1993-6#1)
adenosinergic modulation and##2##3##(1997-2#2)
adenosinergic modulation of ethanol-induced motor incoordination##2##6##(1997-2#2)
adenosinergic modulation of##3##3##(1997-2#3)
adenosinergic modulation##5##2##(1997-2#5)
adenosis##4##1##(1994-12#4)
adenoviral infection##2##2##(2008-11#2)
adenoviral vector carrying##3##3##(2010-1#3)
adenoviral vector##5##2##(2008-11#1)(2008-8#1)(2010-1#3)
adenoviral vectors##7##2##(1995-2#2)(1997-1#1)(2007-11#1)(2008-11#3)
adenoviral##18##1##(1995-2#2)(1997-1#1)(2007-11#1)(2008-11#10)(2008-8#1)(2010-1#3)
adenovirus major late promoter##2##4##(1997-3#1)(2008-11#1)
adenovirus production##4##2##(2008-11#4)
adenovirus recombinants##2##2##(1997-3#1)(2008-11#1)
adenovirus replication##3##2##(2008-11#3)
adenovirus type 9##2##3##(1992-9#2)
adenovirus type##3##2##(1992-9#2)(1995-2#1)
adenovirus vaccine##2##2##(2011-2#2)
adenovirus vector##5##2##(2008-11#2)(2008-9#1)(2010-1#2)
adenovirus vectors for##2##3##(2008-11#2)
adenovirus##64##1##(1992-9#4)(1993-2#1)(1995-2#2)(1997-1#1)(1997-3#3)(1997-8#1)(2008-11#20)(2008-8#4)(2008-9#2)(2010-1#5)(2011-2#8)(2011-3#3)(2012-3#3)(2013-8#7)
adenovirus-mediated##3##1##(2008-8#1)(2010-1#2)
adenoviruses##8##1##(1992-9#1)(1995-2#1)(1997-3#1)(2008-11#3)(2008-8#1)(2013-8#1)
adenylate cyclase activity in coronary vascular smooth muscle cells##2##9##(1990-8#2)
adenylate cyclase activity##5##3##(1990-8#4)(1992-6#1)
adenylate cyclase##13##2##(1990-8#5)(1992-6#1)(1993-6#2)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#1)(2010-1#1)
adenylate cyclase-activating##2##2##(1995-11#2)
adenylate##21##1##(1990-8#5)(1992-6#1)(1993-6#2)(1993-8#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-1#1)
adenylosuccinate synthetase##3##2##(1995-6#3)
adenylyl cyclase in##2##3##(1997-1#2)
adenylyl cyclase signal transduction##2##4##(1995-11#2)
adenylyl cyclase##16##2##(1993-6#1)(1994-3#1)(1995-11#6)(1995-8#1)(1997-1#3)(1997-2#1)(2008-9#2)(2009-8#1)
adenylyl##18##1##(1993-6#1)(1994-3#1)(1995-11#6)(1995-8#1)(1997-1#3)(1997-2#2)(2008-9#3)(2009-8#1)
adequacy and##2##2##(1991-2#1)(2011-2#1)
adequacy as##2##2##(1992-9#1)(2011-2#1)
adequacy of##19##2##(1990-11#1)(1991-1#1)(1992-12#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-3#3)(2008-11#2)(2008-5#2)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#2)
adequacy scores##4##2##(1993-1#4)
adequacy##34##1##(1990-11#1)(1991-1#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-1#4)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#3)(2007-9#1)(2008-11#2)(2008-5#2)(2009-10#2)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)
adequate amounts##3##2##(1995-8#1)(2011-2#1)(2012-2#1)
adequate analgesia##2##2##(2008-7#1)(2011-2#1)
adequate and##2##2##(1991-8#1)(2012-12#1)
adequate bone##2##2##(2012-12#1)(2013-1#1)
adequate choice of##2##3##(2008-10#1)(2008-11#1)
adequate control##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
adequate diagnosis##2##2##(2009-8#1)(2012-12#1)
adequate evidence##2##2##(1993-3#1)(2008-10#1)
adequate exposure##2##2##(1992-1#1)(2011-2#1)
adequate for the determination of##3##5##(2008-10#3)
adequate for the##6##3##(2008-10#6)
adequate for##25##2##(1991-1#1)(1991-12#2)(1991-6#1)(1992-1#1)(1995-9#1)(1997-8#2)(2008-10#14)(2008-11#1)(2008-9#1)(2011-2#1)
adequate funding##2##2##(1995-3#1)(2008-11#1)
adequate in##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
adequate information about the##2##4##(2011-2#1)(2012-2#1)
adequate information##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
adequate maintenance##2##2##(1990-9#1)(1993-9#1)
adequate management##2##2##(1992-2#1)(2013-1#1)
adequate multidisciplinary##2##2##(1993-11#1)(2009-1#1)
adequate performance##2##2##(1996-1#1)(2010-7#1)
adequate preparation##4##2##(1993-6#1)(2008-12#3)
adequate safety and##2##3##(1996-1#1)(2013-1#1)
adequate sensitivity##5##2##(1993-6#1)(2008-1#1)(2008-10#2)(2008-6#1)
adequate shelf life##2##3##(2008-10#2)
adequate support##2##2##(1991-2#1)(2008-12#1)
adequate to##9##2##(1992-12#1)(2008-10#5)(2008-11#1)(2011-2#1)(2013-1#1)
adequate training##2##2##(2008-11#1)(2013-1#1)
adequate treatment##5##2##(1990-9#1)(2008-11#2)(2011-3#1)(2013-1#1)
adequate tutorial support##2##3##(2008-11#2)
adequate##237##1##(1990-11#1)(1990-2#2)(1990-6#2)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-6#2)(1991-8#1)(1992-1#3)(1992-12#5)(1992-2#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-5#2)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#5)(2007-11#3)(2008-1#1)(2008-10#54)(2008-11#23)(2008-12#6)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-6#4)(2010-7#1)(2011-2#17)(2011-3#2)(2012-12#8)(2012-2#8)(2012-3#1)(2012-5#1)(2013-1#12)(2013-8#3)
adequately address##2##2##(1997-3#1)(2010-5#1)
adequately examined##2##2##(2012-2#1)(2012-3#1)
adequately##64##1##(1990-11#2)(1990-12#1)(1990-3#1)(1991-12#1)(1993-11#1)(1994-8#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#3)
adhere and##2##2##(2008-11#1)(2008-5#1)
adhere to the##5##3##(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)
adhere to##20##2##(1992-3#1)(1995-9#1)(1996-12#2)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#4)(2011-2#1)
adhere##25##1##(1990-2#1)(1992-3#1)(1995-9#1)(1996-12#2)(1996-3#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#4)(2011-2#2)
adhered to the##3##3##(2008-10#2)(2011-2#1)
adhered to##7##2##(2008-10#4)(2008-11#2)(2011-2#1)
adhered##10##1##(1996-12#1)(2008-10#5)(2008-11#2)(2008-9#1)(2011-2#1)
adherence and##6##2##(1991-5#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
adherence improvement strategies##2##3##(1994-3#2)
adherence inhibition##2##2##(1991-12#2)
adherence of##11##2##(1991-7#1)(2008-10#4)(2008-11#1)(2008-5#2)(2013-8#3)
adherence to a##2##3##(1996-11#1)(2011-2#1)
adherence to epithelial cells##2##4##(2008-10#1)(2008-5#1)
adherence to epithelial##3##3##(2008-10#1)(2008-5#2)
adherence to infection##2##3##(2011-2#2)
adherence to the##5##3##(1995-2#1)(1996-2#1)(2008-12#1)(2008-3#1)(2009-4#1)
adherence to their##2##3##(1994-3#1)(2008-8#1)
adherence to##34##2##(1991-3#1)(1994-3#2)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
adherence was##4##2##(2008-11#1)(2013-8#3)
adherence were##2##2##(2008-10#1)(2008-4#1)
adherence with##2##2##(1997-7#1)(2010-9#1)
adherence##95##1##(1991-12#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-9#1)(1994-3#6)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-7#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#6)(2010-12#1)(2010-9#2)(2011-2#8)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#8)
adherens junction (AJ)##2##3##(2009-10#1)(2012-2#1)
adherens##3##1##(2009-10#2)(2012-2#1)
adherent and nonadherent##2##3##(2008-10#2)
adherent and##4##2##(2008-10#2)(2008-11#2)
adherent cells was##3##3##(2008-10#1)(2008-11#2)
adherent cells##14##2##(2008-10#1)(2008-11#8)(2008-9#1)(2010-10#2)(2011-2#1)(2012-4#1)
adherent cultures##2##2##(2008-11#1)(2008-4#1)
adherent placenta##3##2##(1995-12#2)(2013-1#1)
adherent to the##2##3##(2008-7#1)(2010-12#1)
adherent to##3##2##(2008-12#1)(2008-7#1)(2010-12#1)
adherent##41##1##(1990-8#1)(1991-3#1)(1991-7#1)(1994-3#2)(1994-6#1)(1995-12#2)(2008-10#7)(2008-11#14)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#2)(2010-12#1)(2011-2#2)(2012-3#1)(2012-4#1)(2013-1#1)
adherente##2##1##(2008-5#2)
adherently##2##1##(2008-11#2)
adheres to the##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
adhering to the##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
adhering to##6##2##(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)
adhering##9##1##(2008-10#3)(2008-11#3)(2008-12#1)(2011-2#2)
adhesin families##2##2##(2011-1#2)
adhesin##6##1##(1996-12#1)(2008-10#2)(2009-6#1)(2011-1#2)
adhesins and##2##2##(1995-2#1)(2006-6#1)
adhesins##7##1##(1995-2#1)(1996-12#1)(2006-6#1)(2008-10#2)(2011-1#2)
adhesiolysis for##2##2##(1993-1#1)(1993-3#1)
adhesiolysis##10##1##(1991-3#4)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(2011-2#1)(2012-12#1)
adhesion and spreading##2##3##(2008-9#2)
adhesion and##24##2##(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-5#2)(2008-7#1)(2008-9#4)(2009-10#1)(2009-6#1)(2010-6#1)(2012-2#3)
adhesion are##2##2##(2008-10#1)(2013-1#1)
adhesion assay##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
adhesion behavior##2##2##(1990-8#1)(1995-8#1)
adhesion culture##2##2##(2008-11#2)
adhesion force and##2##3##(2008-11#2)
adhesion force##4##2##(2008-10#1)(2008-11#3)
adhesion formation and reproductive outcome##2##5##(1992-3#2)
adhesion formation and##4##3##(1991-1#1)(1992-1#1)(1992-3#2)
adhesion formation in##2##3##(1992-2#1)(1995-12#1)
adhesion formation##13##2##(1991-1#2)(1992-1#3)(1992-2#1)(1992-3#5)(1995-12#2)
adhesion in the##2##3##(1995-8#1)(2008-10#1)
adhesion molecule##6##2##(1995-2#2)(1996-12#1)(2008-11#1)(2008-5#1)(2009-9#1)
adhesion molecule-1##3##2##(2009-10#1)(2010-1#1)(2012-2#1)
adhesion molecules##7##2##(1996-12#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
adhesion of bacteria to##2##4##(2006-6#1)(2013-8#1)
adhesion of the##3##3##(2006-6#1)(2008-10#1)(2012-2#1)
adhesion of##14##2##(1990-9#1)(1996-12#1)(1997-8#1)(2006-6#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2012-2#2)(2013-1#1)(2013-8#1)
adhesion on##3##2##(2008-11#2)(2011-2#1)
adhesion onto##2##2##(1996-12#1)(2010-1#1)
adhesion properties##5##2##(2008-10#4)(2008-5#1)
adhesion rates##4##2##(2008-11#4)
adhesion reformation##3##2##(1992-1#3)
adhesion tension##3##2##(1997-1#2)(2008-5#1)
adhesion to the##6##3##(1994-6#1)(2008-11#2)(2009-10#1)(2011-1#1)(2012-3#1)
adhesion to##21##2##(1990-8#2)(1994-6#1)(1994-9#1)(1995-2#2)(1995-6#1)(2008-10#2)(2008-11#3)(2009-10#2)(2009-3#2)(2011-1#2)(2012-2#2)(2012-3#1)
adhesion was##2##2##(2008-11#1)(2013-1#1)
adhesion##191##1##(1990-2#1)(1990-8#3)(1990-9#1)(1991-1#2)(1992-1#6)(1992-2#1)(1992-3#5)(1993-3#1)(1993-6#3)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#5)(1995-6#1)(1995-8#5)(1996-12#6)(1997-1#2)(1997-8#1)(2006-6#5)(2007-12#1)(2008-1#2)(2008-10#18)(2008-11#34)(2008-12#1)(2008-3#1)(2008-5#11)(2008-7#8)(2008-9#9)(2009-10#5)(2009-12#2)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#13)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
adhesionculture##2##1##(2008-11#2)
adhesions can be##2##3##(1991-3#1)(1995-2#1)
adhesions##20##1##(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#4)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#4)(1996-1#2)(2008-10#1)(2008-7#2)
adhesive AH109A cells##3##3##(2008-11#3)
adhesive cells##4##2##(2008-11#2)(2008-9#2)
adhesive failures##2##2##(2013-1#2)
adhesive papillae##3##2##(2008-5#3)
adhesive properties##2##2##(1990-8#1)(2011-1#1)
adhesive##34##1##(1990-8#1)(1991-3#1)(1993-1#1)(1994-9#2)(1995-2#1)(2008-10#3)(2008-11#5)(2008-5#5)(2008-7#2)(2008-9#3)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#7)
adhesiveness##4##1##(1994-11#1)(1996-6#1)(1997-1#1)(2011-2#1)
adhesives##2##1##(2008-10#1)(2011-2#1)
adiabatic##8##1##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)
adipate##2##1##(2008-10#2)
adipic##3##1##(2008-10#3)
adipocyte differentiation##3##2##(1994-12#2)(2008-11#1)
adipocyte specific##2##2##(2011-2#2)
adipocyte##15##1##(1994-11#2)(1994-12#3)(2008-11#6)(2011-2#4)
adipocytes and##5##2##(1994-8#1)(1995-8#2)(2008-11#1)(2012-4#1)
adipocytes from##2##2##(1993-6#1)(2011-2#1)
adipocytes with the##2##3##(1993-8#1)(1994-8#1)
adipocytes with##3##2##(1993-8#1)(1994-8#1)(2011-2#1)
adipocytes##46##1##(1990-11#2)(1993-6#3)(1993-8#2)(1994-8#2)(1995-8#4)(1997-1#2)(2008-11#8)(2008-8#3)(2008-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#10)(2012-4#2)(2012-5#1)(2013-1#1)
adipocytes)##2##1##(1994-8#2)
adipocytokines##3##1##(2010-10#3)
adipogenesis and osteogenesis##2##3##(2008-11#2)
adipogenesis and##3##2##(2008-11#2)(2010-10#1)
adipogenesis in##2##2##(1994-12#1)(2008-11#1)
adipogenesis of##2##2##(2008-11#2)
adipogenesis##15##1##(1994-12#1)(2008-11#11)(2010-10#1)(2011-2#1)(2012-2#1)
adipogenic transcriptional factors##2##3##(2008-5#2)
adipogenic transcriptional##3##2##(2008-5#2)(2012-2#1)
adipogenic##12##1##(2008-11#3)(2008-4#1)(2008-5#2)(2012-2#5)(2013-1#1)
adipokines##2##1##(2008-5#1)(2013-1#1)
adiponectin and##3##2##(2011-1#1)(2013-1#2)
adiponectin level##2##2##(2011-1#1)(2013-1#1)
adiponectin levels##6##2##(2011-1#4)(2013-1#2)
adiponectin##14##1##(2011-1#7)(2013-1#7)
adipose and##2##2##(1990-11#1)(2010-6#1)
adipose cells##4##2##(1990-11#3)(2008-10#1)
adipose precursor cells##4##3##(1990-11#3)(1993-6#1)
adipose tissue and##3##3##(1995-6#1)(2008-1#1)(2008-11#1)
adipose tissue development##2##3##(1993-6#1)(2011-2#1)
adipose tissue in##2##3##(2008-11#1)(2008-4#1)
adipose tissue mass##2##3##(2012-2#2)
adipose tissue to the##2##4##(2008-6#1)(2011-2#1)
adipose tissue##33##2##(1993-6#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-4#2)(2008-5#2)(2008-6#1)(2009-10#1)(2010-6#3)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)
adipose tissues##2##2##(2008-11#1)(2008-9#1)
adipose##49##1##(1990-11#7)(1993-6#2)(1994-12#2)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-6#4)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)
adipose-derived stem cells##5##3##(2009-11#1)(2012-3#1)(2012-4#1)(2012-5#2)
adipose-derived##6##1##(2009-11#1)(2012-3#1)(2012-4#2)(2012-5#2)
adiposity and##3##2##(1996-11#1)(2012-2#1)(2012-5#1)
adiposity##16##1##(1996-11#1)(2010-6#2)(2012-2#12)(2012-5#1)
adjacency##2##1##(1996-3#1)(2008-8#1)
adjacent anatomic##2##2##(2012-3#1)(2013-1#1)
adjacent cells##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2011-2#1)
adjacent mesophyll cells##2##3##(2008-10#1)(2012-2#1)
adjacent nonexposed##2##2##(2008-10#2)
adjacent peaks##2##2##(2008-10#2)
adjacent plants##3##2##(2008-10#3)
adjacent proteins in##2##3##(2010-12#1)(2011-3#1)
adjacent proteins##3##2##(2010-12#1)(2011-3#2)
adjacent segment disease (ASD)##2##4##(2012-12#1)(2012-3#1)
adjacent segment disease##4##3##(2012-12#2)(2012-3#2)
adjacent segment##6##2##(2012-12#3)(2012-3#3)
adjacent tissues##2##2##(1990-5#1)(2010-12#1)
adjacent to a##3##3##(1996-5#1)(2008-10#1)(2012-3#1)
adjacent to leaf##2##3##(2008-10#2)
adjacent to the##16##3##(1993-8#1)(1994-5#1)(1995-6#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
adjacent to##41##2##(1993-8#1)(1994-5#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#22)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#1)
adjacent trees##8##2##(2008-10#8)
adjacent##167##1##(1990-11#1)(1990-5#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#3)(1995-6#2)(1995-8#2)(1996-2#1)(1996-5#3)(1997-3#2)(1997-7#4)(2007-12#4)(2008-10#63)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#4)(2009-3#2)(2009-8#3)(2009-9#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#2)(2012-12#9)(2012-2#3)(2012-3#7)(2013-1#5)(2013-8#2)
adjective##5##1##(1993-2#1)(2008-11#4)
adjoining##5##1##(1990-3#1)(2008-10#3)(2013-1#1)
adjudin##7##1##(2012-2#7)
adjunct in##2##2##(1993-1#1)(1997-8#1)
adjunct therapies##2##2##(2008-11#1)(2011-2#1)
adjunct therapy with levodopa##2##4##(2008-7#2)
adjunct therapy with##3##3##(2008-7#3)
adjunct therapy##5##2##(2008-7#5)
adjunct to the##2##3##(1994-3#1)(2013-1#1)
adjunct to##9##2##(1993-3#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
adjunct treatment##2##2##(2008-11#2)
adjunct##24##1##(1993-1#1)(1993-3#1)(1994-3#1)(1996-1#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#6)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
adjunctive therapies##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
adjunctive therapy in##3##3##(1994-12#1)(2011-2#2)
adjunctive therapy##5##2##(1994-12#1)(2011-10#1)(2011-2#3)
adjunctive treatment for##2##3##(2009-9#1)(2013-8#1)
adjunctive treatment##4##2##(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
adjunctive##25##1##(1992-12#1)(1994-12#1)(1995-5#1)(1996-3#1)(1997-8#1)(2008-4#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#7)(2013-1#5)(2013-8#1)
adjuncts to##4##2##(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#1)
adjust expenditures##2##2##(1992-12#2)
adjust for##6##2##(1990-8#1)(1991-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(2008-2#1)
adjust payments##2##2##(1995-2#1)(1997-1#1)
adjust the##10##2##(1991-12#1)(2008-10#3)(2008-3#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-3#1)
adjust their intentions##2##3##(2009-12#2)
adjust their##4##2##(2009-12#2)(2009-6#1)(2012-5#1)
adjust to##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
adjust##37##1##(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1992-12#2)(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#2)(1997-1#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#3)(2009-6#1)(2010-8#1)(2011-3#1)(2012-5#1)
adjustable##11##1##(2008-10#6)(2008-11#1)(2012-12#4)
adjusted average per capita cost (AAPCC) formula##2##7##(1993-3#2)
adjusted average per capita cost (AAPCC)##3##6##(1991-3#1)(1993-3#2)
adjusted average per capita##4##4##(1991-3#1)(1993-3#2)(1996-3#1)
adjusted by the##3##3##(2008-3#1)(2010-5#1)(2013-8#1)
adjusted by##10##2##(2007-12#1)(2008-10#6)(2008-3#1)(2010-5#1)(2013-8#1)
adjusted for age##3##3##(2008-11#1)(2011-2#2)
adjusted for##14##2##(1993-3#1)(1995-2#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2010-6#2)(2011-2#3)
adjusted odds ratios##2##3##(2008-11#1)(2013-1#1)
adjusted sedentary behavior indicators for physical activity##2##7##(2013-1#2)
adjusted to pH 2##2##4##(2008-10#2)
adjusted to pH 3##3##4##(2008-10#3)
adjusted to pH 4##2##4##(2008-10#2)
adjusted to pH 6##2##4##(2008-10#1)(2008-7#1)
adjusted to pH##12##3##(2008-10#11)(2008-7#1)
adjusted to the##3##3##(2008-10#2)(2008-11#1)
adjusted to##33##2##(1992-12#1)(1992-2#1)(2008-10#27)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
adjusted with##10##2##(2008-10#8)(2008-5#1)(2012-2#1)
adjusted##105##1##(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#4)(1994-12#1)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#50)(2008-11#7)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
adjusters for##3##2##(1993-3#1)(1994-3#2)
adjusters##4##1##(1993-3#2)(1994-3#2)
adjusting for age##4##3##(2008-11#1)(2008-3#1)(2012-3#1)(2013-8#1)
adjusting for other##5##3##(1992-12#1)(1995-12#1)(2009-6#1)(2012-2#1)(2012-5#1)
adjusting for potential confounders##2##4##(2013-1#2)
adjusting for potential##3##3##(2010-11#1)(2013-1#2)
adjusting for relevant##2##3##(2010-6#1)(2013-1#1)
adjusting for the##2##3##(1995-12#1)(2012-3#1)
adjusting for##28##2##(1992-12#1)(1993-12#2)(1994-2#1)(1995-12#2)(1995-2#1)(1995-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#2)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#2)(2013-1#4)(2013-8#1)
adjusting the level of##2##4##(2008-11#1)(2012-2#1)
adjusting the pH##2##3##(2008-10#1)(2013-1#1)
adjusting the##13##2##(1990-2#1)(1995-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
adjusting##53##1##(1990-2#1)(1991-1#1)(1992-12#2)(1993-12#3)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1997-1#1)(1997-2#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#2)(2012-12#1)(2012-2#2)(2012-3#3)(2012-5#2)(2013-1#6)(2013-8#1)
adjustment and##7##2##(1995-2#1)(1997-3#1)(2008-12#1)(2009-11#1)(2010-2#1)(2012-7#1)(2013-1#1)
adjustment are##2##2##(1994-1#1)(2012-7#1)
adjustment by##2##2##(1990-12#1)(1997-1#1)
adjustment difficulties##2##2##(2013-8#2)
adjustment disorders##2##2##(2010-5#1)(2013-8#1)
adjustment for a##2##3##(1991-8#1)(1994-3#1)
adjustment for confounding##2##3##(1992-9#1)(2010-1#1)
adjustment for potential confounding##2##4##(2008-4#1)(2010-1#1)
adjustment for##22##2##(1991-1#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-12#1)(1997-1#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
adjustment formula##2##2##(1992-12#2)
adjustment in the##2##3##(1992-12#1)(2010-7#1)
adjustment in##7##2##(1992-12#1)(1995-2#1)(1997-6#1)(2010-1#2)(2010-7#2)
adjustment is##4##2##(1993-11#1)(1995-2#1)(2008-7#1)(2009-12#1)
adjustment of the##9##3##(1992-2#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)
adjustment of##19##2##(1991-6#1)(1992-2#1)(1992-3#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-3#1)
adjustment than##2##2##(2009-7#2)
adjustment to##4##2##(1992-2#1)(2008-10#1)(2008-7#1)(2010-2#1)
adjustment##124##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#3)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#6)(1992-2#4)(1992-3#1)(1992-9#2)(1993-11#1)(1994-1#1)(1994-3#1)(1995-12#2)(1995-2#8)(1995-3#2)(1996-3#1)(1997-1#4)(1997-3#2)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#3)(2009-11#4)(2009-12#1)(2009-7#5)(2010-1#6)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-7#2)(2013-1#3)(2013-8#5)
adjustments and##3##2##(1991-3#1)(1995-12#1)(2010-7#1)
adjustments are##3##2##(1991-1#1)(1991-12#1)(2008-1#1)
adjustments can##2##2##(2010-7#1)(2011-2#1)
adjustments for##4##2##(1992-12#1)(1995-5#1)(2008-10#1)(2009-6#1)
adjustments have been made##2##4##(1992-12#1)(2008-10#1)
adjustments in##3##2##(1993-1#1)(2010-7#1)(2013-8#1)
adjustments of the##2##3##(2008-10#1)(2012-3#1)
adjustments to the##4##3##(1991-3#1)(1996-1#1)(2008-9#2)
adjustments to##6##2##(1991-1#1)(1991-3#1)(1996-1#1)(2008-6#1)(2008-9#2)
adjustments##39##1##(1991-1#3)(1991-12#1)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-12#1)(2008-1#5)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-7#3)(2011-2#1)(2012-3#1)(2013-8#1)
adjusts##4##1##(1994-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
adjuvant arthritis##2##2##(2013-1#1)(2013-8#1)
adjuvant chemotherapy##9##2##(1993-11#1)(2008-10#3)(2011-2#4)(2013-1#1)
adjuvant for##2##2##(1995-2#1)(2011-2#1)
adjuvant in##2##2##(1990-2#1)(2009-1#1)
adjuvant radiation##3##2##(1992-12#2)(2011-2#1)
adjuvant radiotherapy##3##2##(1992-12#3)
adjuvant systemic##2##2##(1993-1#1)(1996-11#1)
adjuvant therapies##4##2##(1993-11#1)(2008-11#1)(2009-7#1)(2011-2#1)
adjuvant therapy of##4##3##(1993-11#2)(1993-2#1)(2010-7#1)
adjuvant therapy##14##2##(1993-1#1)(1993-11#3)(1993-2#2)(1994-12#1)(1994-2#1)(1997-7#2)(2008-10#1)(2010-7#1)(2012-3#1)(2013-1#1)
adjuvant treatment with##2##3##(2010-6#1)(2012-3#1)
adjuvant treatment##5##2##(1990-9#1)(1993-11#1)(2010-6#1)(2012-3#2)
adjuvant##83##1##(1990-12#1)(1990-2#2)(1990-9#2)(1992-12#5)(1993-1#2)(1993-11#6)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#4)(1995-2#1)(1995-5#6)(1996-11#1)(1996-12#1)(1997-2#2)(1997-5#1)(1997-7#3)(2007-8#1)(2008-10#8)(2008-11#5)(2008-4#1)(2009-1#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#10)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
adjuvants are##2##2##(1995-5#1)(1996-2#1)
adjuvants for##3##2##(1995-5#2)(1996-12#1)
adjuvants##19##1##(1990-11#1)(1995-2#2)(1995-5#10)(1996-12#1)(1996-2#1)(1997-5#1)(2008-10#2)(2012-2#1)
administer##16##1##(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
administered N2O##2##2##(1993-1#2)
administered a##3##2##(1992-12#1)(1994-5#1)(2011-2#1)
administered and the##2##3##(1991-2#1)(2008-12#1)
administered antimicrobial##2##2##(2008-10#1)(2012-3#1)
administered as a##2##3##(1991-11#1)(2010-11#1)
administered as##5##2##(1991-11#1)(1997-5#1)(2010-11#1)(2010-7#1)(2013-8#1)
administered at a dose of##2##5##(1991-2#1)(2008-3#1)
administered at a##4##3##(1991-2#1)(1994-2#1)(1996-3#1)(2008-3#1)
administered at the dose of##2##5##(1990-9#1)(2011-2#1)
administered at the##4##3##(1990-9#1)(2008-12#1)(2010-8#1)(2011-2#1)
administered at##11##2##(1990-11#1)(1990-9#1)(1991-2#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
administered before##2##2##(1992-12#1)(2011-2#1)
administered by##7##2##(1991-8#1)(1993-6#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#2)
administered during the##4##3##(1993-12#1)(1996-6#1)(2008-1#1)(2008-10#1)
administered during##5##2##(1993-12#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#1)
administered every##3##2##(1992-2#1)(2010-12#1)(2011-2#1)
administered for##3##2##(1995-11#1)(2011-2#1)(2013-1#1)
administered i##2##2##(1997-2#1)(2010-8#1)
administered in an##2##3##(2008-5#1)(2013-1#1)
administered in the##4##3##(1991-6#1)(2009-9#1)(2013-1#1)(2013-7#1)
administered in##16##2##(1991-2#1)(1991-6#1)(1992-9#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-7#2)
administered intraperitoneally##2##2##(1990-5#1)(1992-12#1)
administered intravenously##4##2##(2008-1#2)(2008-10#1)(2008-11#1)
administered once##2##2##(1990-5#1)(1991-11#1)
administered orally at##2##3##(2008-5#1)(2013-1#1)
administered orally to##2##3##(1991-5#1)(2008-10#1)
administered orally##5##2##(1991-5#1)(2008-10#2)(2008-5#1)(2013-1#1)
administered over a##2##3##(1994-1#1)(2008-12#1)
administered perioperatively##2##2##(2011-2#1)(2012-3#1)
administered postoperatively##2##2##(1990-8#1)(2013-8#1)
administered the##6##2##(1994-5#1)(2008-11#2)(2008-9#2)(2009-11#1)
administered to adrenal-intact rats##2##4##(1994-2#2)
administered to all patients##2##4##(2008-3#1)(2008-7#1)
administered to the##2##3##(2010-8#1)(2013-1#1)
administered to##36##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1994-2#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
administered with##7##2##(1995-5#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-7#1)
administered##243##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#4)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#6)(1994-5#4)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#5)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-6#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-8#1)(2007-11#3)(2007-8#2)(2008-1#4)(2008-10#20)(2008-11#13)(2008-12#8)(2008-3#4)(2008-4#2)(2008-5#7)(2008-7#6)(2008-8#1)(2008-9#7)(2009-11#2)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#4)(2010-5#3)(2010-7#7)(2010-8#3)(2011-1#1)(2011-2#18)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#6)
administering the##2##2##(2008-4#1)(2010-8#1)
administering##16##1##(1993-6#1)(1994-9#1)(1995-5#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)
administrated##15##1##(1993-2#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2011-3#1)(2012-3#6)(2013-1#1)
administrating##3##1##(2008-9#1)(2012-12#1)(2012-3#1)
administration (0##2##2##(1991-10#1)(2006-6#1)
administration also##3##2##(1991-1#1)(1994-5#1)(2011-2#1)
administration and health##2##3##(1991-12#1)(1992-1#1)
administration and##14##2##(1991-12#1)(1991-2#1)(1992-1#1)(1993-11#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
administration are##2##2##(1992-1#1)(1993-2#1)
administration at the##2##3##(1995-6#1)(1997-3#1)
administration by##2##2##(2008-11#1)(2010-6#1)
administration caused##3##2##(2008-10#1)(2009-8#1)(2010-5#1)
administration during##2##2##(1993-2#1)(1994-3#1)
administration education for##2##3##(1992-3#1)(1996-3#1)
administration education in##3##3##(1991-1#1)(1996-3#1)(1997-3#1)
administration education programs##4##3##(1992-2#1)(1993-2#2)(1996-3#1)
administration education##25##2##(1991-1#3)(1991-2#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-2#4)(1994-2#1)(1996-2#1)(1996-3#5)(1997-2#1)(1997-3#4)(2009-8#1)
administration has##2##2##(1991-6#1)(1996-3#1)
administration in the##4##3##(1992-3#1)(1994-1#1)(2008-1#1)(2008-11#1)
administration in##16##2##(1992-1#2)(1992-3#1)(1994-1#1)(1994-2#2)(1994-8#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-7#1)
administration is##3##2##(1997-1#1)(2008-5#1)(2011-2#1)
administration led to##2##3##(1992-12#1)(1993-11#1)
administration of 0##4##3##(1994-3#1)(1994-8#1)(1997-8#1)(2008-10#1)
administration of 1##2##3##(1991-5#1)(2008-10#1)
administration of 2##2##3##(1992-3#1)(1993-12#1)
administration of AMD3100##2##3##(2008-7#2)
administration of DKT##3##3##(2011-2#3)
administration of EtOH##2##3##(2008-10#2)
administration of L-carnitine##2##3##(1991-12#2)
administration of RS extract##3##4##(2008-11#3)
administration of a single##2##4##(1990-6#1)(2008-10#1)
administration of a##11##3##(1990-6#1)(1994-3#1)(1994-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
administration of an##2##3##(2008-11#1)(2012-2#1)
administration of antimicrobial##2##3##(2011-2#1)(2013-1#1)
administration of dieldrin##2##3##(2008-10#2)
administration of diisopropylcarbodiimide##2##3##(2008-9#2)
administration of high##2##3##(1991-11#1)(1996-8#1)
administration of intravenous##2##3##(2008-12#1)(2013-1#1)
administration of medication##2##3##(1996-8#1)(2008-5#1)
administration of oral##2##3##(1991-12#1)(2013-1#1)
administration of proanthocyanidins##2##3##(2011-2#2)
administration of psychotropic##2##3##(1996-9#2)
administration of the##20##3##(1991-1#1)(1992-9#2)(1993-1#1)(1993-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#2)(2013-1#1)
administration of these agents##2##4##(2008-3#1)(2011-2#1)
administration of this##3##3##(1994-8#1)(1995-11#1)(2009-8#1)
administration of##208##2##(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#3)(1993-1#2)(1993-12#1)(1993-6#1)(1994-2#6)(1994-3#2)(1994-6#4)(1994-8#8)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#1)(1996-6#3)(1996-8#3)(1996-9#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2007-11#2)(2008-10#21)(2008-11#16)(2008-12#6)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#4)(2009-7#1)(2009-8#5)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#19)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#2)
administration on the##3##3##(1991-4#1)(1994-2#1)(1996-3#1)
administration on##4##2##(1991-4#1)(1994-2#1)(1996-3#1)(2007-8#1)
administration programs must##3##3##(1991-1#1)(1997-2#2)
administration programs##14##2##(1991-1#1)(1992-3#1)(1993-1#2)(1993-2#2)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#4)
administration students##5##2##(1992-3#1)(1996-1#3)(2009-8#1)
administration to##8##2##(1991-1#1)(1992-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
administration via##2##2##(1994-9#1)(2007-8#1)
administration was##9##2##(1991-1#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#1)(2011-2#1)(2012-2#1)
administration were##3##2##(1993-1#1)(2011-2#2)
administration with the##2##3##(1993-11#1)(1993-3#1)
administration with##4##2##(1993-11#1)(1993-3#1)(2008-10#2)
administration##508##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#16)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#10)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#1)(1992-1#6)(1992-12#5)(1992-2#2)(1992-3#11)(1992-6#3)(1992-9#3)(1993-1#12)(1993-11#6)(1993-12#2)(1993-2#12)(1993-3#3)(1993-6#1)(1994-1#4)(1994-12#2)(1994-2#15)(1994-3#6)(1994-5#4)(1994-6#4)(1994-8#10)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#13)(1996-11#3)(1996-12#8)(1996-2#19)(1996-3#15)(1996-6#9)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#8)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2006-5#1)(2006-6#2)(2007-11#4)(2007-8#2)(2008-1#3)(2008-10#33)(2008-11#28)(2008-12#11)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#9)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#31)(2011-3#1)(2012-12#6)(2012-2#12)(2012-3#3)(2013-1#20)(2013-7#2)(2013-8#4)
administration's##3##1##(1991-1#2)(1995-12#1)
administrations of##2##2##(1993-12#1)(2012-2#1)
administrations##5##1##(1992-11#1)(1992-2#1)(1993-12#1)(2008-11#1)(2012-2#1)
administrative and##3##2##(1997-2#1)(2008-10#1)(2011-2#1)
administrative capacity##2##2##(1997-3#2)
administrative costs##4##2##(1991-3#1)(1994-2#1)(1995-6#1)(2012-2#1)
administrative data##5##2##(1993-12#1)(1995-2#2)(1995-3#1)(1997-2#1)
administrative fellowship##2##2##(1993-2#2)
administrative fellowships##2##2##(1993-2#2)
administrative leaders##2##2##(1996-3#1)(2010-8#1)
administrative support##2##2##(1992-1#1)(1995-2#1)
administrative##68##1##(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-9#1)(1992-1#4)(1992-2#1)(1993-12#1)(1993-2#5)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-3#3)(1996-5#1)(1997-2#2)(1997-3#3)(2008-10#1)(2008-11#3)(2008-12#1)(2010-8#3)(2011-2#4)(2012-2#2)(2012-3#5)(2013-1#1)
administrator##14##1##(1992-1#1)(1992-2#2)(1993-1#1)(1993-3#1)(1994-1#3)(1994-2#4)(1994-3#1)(1995-6#1)
administrators and physicians##3##3##(1992-2#1)(1995-12#1)(1997-1#1)
administrators and##9##2##(1992-2#3)(1993-12#1)(1994-2#1)(1995-12#1)(1997-1#2)(2008-12#1)
administrators are##3##2##(1991-2#1)(1995-1#1)(1995-2#1)
administrators for##2##2##(1994-2#1)(1997-3#1)
administrators have##2##2##(1991-1#1)(1996-12#1)
administrators in##4##2##(1992-3#2)(1993-1#2)
administrators is##2##2##(1994-2#1)(2009-6#1)
administrators to##3##2##(1991-1#1)(1993-1#1)(1995-2#1)
administrators who##2##2##(1994-1#1)(2009-6#1)
administrators##65##1##(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-2#8)(1992-3#3)(1993-1#4)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#4)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#3)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#2)(2008-11#1)(2008-12#2)(2009-4#1)(2009-6#2)(2009-8#3)(2013-8#1)
administrators'##3##1##(1991-2#1)(1991-3#1)(2009-6#1)
admission and discharge##2##3##(1991-2#1)(1992-1#1)
admission and##9##2##(1991-12#1)(1991-2#3)(1992-1#1)(2008-7#1)(2009-4#1)(2011-2#2)
admission electrocardiogram##2##2##(2008-3#2)
admission for##2##2##(1992-2#1)(2012-3#1)
admission into##2##2##(1994-3#1)(1995-2#1)
admission of nursing home##3##4##(1994-12#3)
admission of##6##2##(1991-2#2)(1994-12#3)(2008-10#1)
admission process##3##2##(1997-2#3)
admission rates for##2##3##(1994-12#1)(2008-11#1)
admission rates##3##2##(1994-12#1)(1996-3#1)(2008-11#1)
admission test##3##2##(1994-3#3)
admission to a##2##3##(1990-3#1)(1994-2#1)
admission to hospital##2##3##(1991-11#1)(1995-5#1)
admission to the hospital##3##4##(1990-9#1)(1992-3#1)(2011-2#1)
admission to the##9##3##(1990-9#1)(1992-3#1)(1993-3#1)(1994-1#1)(2008-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
admission to##17##2##(1990-3#1)(1990-9#1)(1991-11#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-5#1)(2007-8#1)(2008-3#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
admission were##3##2##(1994-12#1)(2007-8#1)(2012-3#1)
admission##101##1##(1990-3#1)(1990-6#1)(1990-9#3)(1991-11#2)(1991-12#3)(1991-2#5)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-12#6)(1994-2#1)(1994-3#6)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#4)(2007-8#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#5)(2008-7#5)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#3)(2011-2#11)(2012-12#1)(2012-3#7)(2013-1#8)(2013-8#2)
admissions and##4##2##(1991-11#1)(1992-1#1)(1996-3#1)(2011-1#1)
admissions in##3##2##(1993-1#1)(1997-4#1)(2011-2#1)
admissions to##5##2##(1991-1#1)(1992-12#2)(1997-2#1)(2010-11#1)
admissions##28##1##(1990-11#2)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#1)(1993-1#1)(1993-12#1)(1994-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(2008-1#1)(2008-11#3)(2010-11#1)(2011-1#1)(2011-2#1)
admit##6##1##(1991-12#1)(1992-6#1)(1994-3#1)(1996-11#1)(2008-11#1)(2009-12#1)
admitted for##10##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-6#1)(2006-5#1)(2008-10#1)(2009-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
admitted in our##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
admitted in##11##2##(1994-3#1)(2011-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
admitted patients##5##2##(1991-1#2)(1997-3#1)(2008-11#1)(2013-1#1)
admitted that##2##2##(1995-5#1)(2013-8#1)
admitted to a##4##3##(1993-12#1)(2008-3#1)(2010-11#1)(2011-2#1)
admitted to an intensive care unit##2##6##(1991-11#1)(2012-12#1)
admitted to an##4##3##(1991-11#1)(2012-12#2)(2013-1#1)
admitted to having##2##3##(2008-10#1)(2008-7#1)
admitted to hospital with##2##4##(2008-7#1)(2011-2#1)
admitted to hospital##5##3##(1990-9#1)(2008-7#1)(2011-2#2)(2012-12#1)
admitted to nursing homes and##2##5##(1994-12#1)(1994-2#1)
admitted to our department##3##4##(1997-8#1)(2008-12#1)(2011-2#1)
admitted to our hospital because of##2##6##(2008-7#1)(2012-2#1)
admitted to our hospital##6##4##(1991-12#1)(1993-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
admitted to our##13##3##(1991-12#1)(1993-6#1)(1994-12#1)(1997-8#1)(2008-12#2)(2008-3#2)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
admitted to the coronary##2##4##(2008-3#1)(2012-3#1)
admitted to the emergency##3##4##(2011-2#2)(2013-1#1)
admitted to the hospital##7##4##(1993-6#1)(1995-2#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
admitted to the##20##3##(1991-2#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-4#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
admitted to##61##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1995-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#5)(2008-7#4)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#11)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#1)
admitted with##9##2##(1990-12#1)(1997-5#1)(1997-8#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#2)(2013-8#1)
admitted##109##1##(1990-12#2)(1990-3#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-8#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#3)(2006-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#6)(2008-7#5)(2009-1#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#14)(2012-12#5)(2012-2#1)(2012-3#10)(2013-1#12)(2013-7#1)(2013-8#4)
admitting##2##1##(2008-7#1)(2009-12#1)
admixture of##6##2##(1997-8#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#2)
admixture##10##1##(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2010-6#1)(2011-2#2)
admixtures on the##2##3##(2008-10#2)
admixtures upon the##2##3##(2008-10#2)
admixtures##11##1##(2008-10#11)
adnexal cystic masses##2##3##(1991-2#2)
adnexal masses##2##2##(1996-3#1)(2013-1#1)
adnexal##9##1##(1991-2#2)(1996-3#3)(2012-2#1)(2013-1#2)(2013-8#1)
adnexectomy##6##1##(1993-2#1)(1996-3#3)(2007-8#1)(2008-10#1)
adolescence and##3##2##(1997-7#1)(2008-11#2)
adolescence are##3##2##(2008-11#1)(2009-7#2)
adolescence for##2##2##(2009-7#2)
adolescence##51##1##(1990-12#1)(1990-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-7#1)(1997-8#1)(2008-11#12)(2008-4#2)(2009-12#2)(2009-7#14)(2009-8#1)(2010-1#2)(2010-10#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
adolescent AN##2##2##(2013-1#2)
adolescent and##2##2##(2012-12#2)
adolescent anorexia nervosa##2##3##(2013-1#2)
adolescent barriers##2##2##(2010-11#2)
adolescent boys##3##2##(2009-5#2)(2013-1#1)
adolescent cannabis##3##2##(2009-7#1)(2013-8#2)
adolescent depression##2##2##(2008-11#1)(2010-7#1)
adolescent females##2##2##(2008-11#1)(2009-10#1)
adolescent girls with eating disorders##2##5##(2008-11#2)
adolescent girls with##3##3##(2008-11#2)(2013-1#1)
adolescent girls##18##2##(1991-11#1)(2008-1#4)(2008-11#2)(2008-4#1)(2009-10#1)(2010-10#1)(2013-1#8)
adolescent girls'##3##2##(2010-10#1)(2013-1#2)
adolescent health care##2##3##(2008-8#2)
adolescent health##5##2##(2008-11#1)(2008-8#4)
adolescent inpatient##4##2##(1992-3#2)(1993-1#2)
adolescent invulnerability##2##2##(2010-7#2)
adolescent males##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
adolescent mental health##2##3##(2008-11#1)(2013-1#1)
adolescent mothers##6##2##(1993-3#1)(1995-1#1)(2013-1#4)
adolescent patients##3##2##(1991-2#1)(2008-8#1)(2010-11#1)
adolescent popularity##3##2##(2010-1#2)(2013-1#1)
adolescent population##2##2##(2009-7#1)(2013-8#1)
adolescent psychiatric##3##2##(1991-2#1)(1993-2#1)(2008-11#1)
adolescent smoking cessation##3##3##(2009-7#3)
adolescent smoking##5##2##(2009-7#3)(2013-1#2)
adolescent students##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
adolescent substance abuse##2##3##(1991-2#1)(2008-6#1)
adolescent substance##3##2##(1991-1#1)(1991-2#1)(2008-6#1)
adolescent time use##2##3##(2013-1#2)
adolescent weight##3##2##(2013-1#3)
adolescent##142##1##(1990-12#7)(1990-6#1)(1991-1#2)(1991-11#1)(1991-2#3)(1992-1#2)(1992-3#2)(1993-1#2)(1993-2#1)(1993-3#1)(1995-1#4)(1996-1#1)(2008-1#6)(2008-10#1)(2008-11#14)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#5)(2009-10#2)(2009-5#6)(2009-7#10)(2010-1#2)(2010-10#2)(2010-11#3)(2010-7#6)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#35)(2013-8#7)
adolescent's##3##1##(2009-7#1)(2011-1#2)
adolescent-being##2##1##(2012-3#2)
adolescents (M##2##2##(2009-7#1)(2010-1#1)
adolescents (aged##2##2##(2013-1#2)
adolescents (e##2##2##(2008-11#1)(2009-7#1)
adolescents aged##3##2##(1990-9#1)(1997-6#1)(2009-7#1)
adolescents and adults##6##3##(1993-1#1)(1996-2#1)(1997-8#1)(2008-11#1)(2013-1#2)
adolescents and to##2##3##(2013-1#2)
adolescents and young adults##4##4##(2008-11#1)(2008-12#1)(2009-10#1)(2010-4#1)
adolescents and young##5##3##(2008-11#2)(2008-12#1)(2009-10#1)(2010-4#1)
adolescents and##23##2##(1993-1#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-4#1)(2013-1#8)
adolescents are##5##2##(2008-11#2)(2008-3#1)(2009-6#1)(2013-1#1)
adolescents as##3##2##(2009-7#1)(2011-1#1)(2011-2#1)
adolescents at##2##2##(1993-3#1)(1996-1#1)
adolescents for##2##2##(1992-1#1)(2008-6#1)
adolescents from##3##2##(2010-9#2)(2013-1#1)
adolescents have##2##2##(2010-11#1)(2013-1#1)
adolescents hospitalized for##2##3##(2013-1#2)
adolescents in a##2##3##(1993-2#1)(1997-3#1)
adolescents in the United States##2##5##(2010-7#1)(2012-12#1)
adolescents in the##9##3##(1993-3#1)(1997-5#1)(2008-3#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
adolescents in##21##2##(1993-2#1)(1993-3#1)(1996-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-7#2)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
adolescents is##4##2##(2008-11#2)(2008-8#1)(2013-1#1)
adolescents living in##2##3##(2010-9#1)(2011-1#1)
adolescents living##3##2##(2010-9#1)(2011-1#1)(2013-1#1)
adolescents of color##3##3##(2009-7#3)
adolescents of##5##2##(2009-7#3)(2012-2#1)(2013-1#1)
adolescents on##2##2##(1996-6#1)(2013-1#1)
adolescents regarding##2##2##(2013-1#2)
adolescents reported##3##2##(1993-3#1)(2010-11#1)(2010-9#1)
adolescents were##4##2##(1990-2#1)(2008-11#1)(2010-1#1)(2012-3#1)
adolescents who##10##2##(2008-11#2)(2009-7#4)(2009-9#1)(2011-2#1)(2012-2#2)
adolescents whose parents##2##3##(2008-11#1)(2010-11#1)
adolescents with cancer##3##3##(1993-3#1)(2010-11#2)
adolescents with cochlear implants##2##4##(2012-2#2)
adolescents with low##3##3##(2010-1#1)(2011-1#2)
adolescents with##22##2##(1993-3#3)(1995-12#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-1#3)(2010-11#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
adolescents##266##1##(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#3)(1991-2#6)(1992-1#3)(1992-3#1)(1993-1#2)(1993-2#3)(1993-3#9)(1994-8#1)(1995-12#5)(1996-1#2)(1996-2#1)(1996-6#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#3)(2008-1#2)(2008-10#2)(2008-11#32)(2008-12#5)(2008-3#2)(2008-4#4)(2008-6#5)(2008-8#6)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#30)(2009-8#1)(2009-9#1)(2010-1#12)(2010-10#1)(2010-11#10)(2010-4#1)(2010-6#1)(2010-7#3)(2010-9#8)(2011-1#12)(2011-2#9)(2012-12#2)(2012-2#15)(2012-3#4)(2013-1#38)(2013-8#7)
adolescents' conduct problems##3##3##(2009-7#3)
adolescents'##16##1##(2009-7#9)(2010-1#3)(2010-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
adolescents]##5##1##(1990-9#1)(1996-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
adopt a##8##2##(1994-2#1)(2008-10#2)(2008-11#4)(2012-3#1)
adopt in##2##2##(1992-9#1)(1994-5#1)
adopt the##5##2##(1990-2#2)(1995-6#1)(2008-10#1)(2008-12#1)
adopt##43##1##(1990-2#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-1#2)(1997-6#1)(2008-10#5)(2008-11#8)(2008-12#3)(2009-3#1)(2009-5#2)(2010-11#3)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
adopted a##8##2##(1996-1#1)(1996-5#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)
adopted and the##2##3##(1992-1#1)(2008-10#1)
adopted and##4##2##(1992-1#1)(2008-10#1)(2008-8#2)
adopted as a##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
adopted as the##4##3##(2008-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
adopted as##10##2##(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)
adopted by the##3##3##(1995-12#1)(2012-2#1)(2012-3#1)
adopted by##14##2##(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#3)(2012-3#1)
adopted for the##6##3##(2008-10#4)(2013-1#2)
adopted for##11##2##(1995-5#1)(2008-10#6)(2010-8#1)(2011-2#1)(2013-1#2)
adopted from##2##2##(2008-10#1)(2013-1#1)
adopted in the##2##3##(1993-3#1)(2008-10#1)
adopted in##13##2##(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#6)
adopted is##2##2##(1991-2#1)(2008-10#1)
adopted the##4##2##(1995-6#1)(2008-3#1)(2008-9#1)(2010-11#1)
adopted to##10##2##(2008-10#3)(2008-2#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2012-3#2)
adopted##123##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#29)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#12)(2013-8#1)
adopting a##7##2##(1990-2#1)(1991-3#1)(1994-1#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-1#1)
adopting more##2##2##(2008-8#1)(2011-2#1)
adopting the##2##2##(1994-1#1)(2010-2#1)
adopting##18##1##(1990-2#2)(1991-3#1)(1994-1#2)(1994-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
adoption and##4##2##(2009-11#2)(2010-8#1)(2013-1#1)
adoption by##2##2##(1991-12#1)(1994-12#1)
adoption of a##4##3##(1995-1#1)(1995-9#1)(2008-10#2)
adoption of evidence-based postoperative pain assessment practices##2##7##(2010-11#2)
adoption of the Medicare fee schedule##2##6##(1993-3#1)(1994-1#1)
adoption of the three##3##4##(2010-11#3)
adoption of the##14##3##(1991-2#1)(1993-3#1)(1994-1#2)(1996-3#1)(1997-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-11#3)(2011-2#1)(2012-3#1)
adoption of these##2##3##(2008-10#1)(2010-8#1)
adoption of##43##2##(1991-12#2)(1991-2#1)(1993-3#1)(1994-1#2)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-11#6)(2010-3#1)(2010-8#3)(2011-2#3)(2012-2#1)(2012-3#2)
adoption process##3##2##(2013-1#3)
adoption to##2##2##(2008-5#1)(2008-9#1)
adoption##73##1##(1991-1#1)(1991-12#3)(1991-2#1)(1993-3#3)(1994-1#2)(1994-12#2)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#5)(2009-11#4)(2010-11#6)(2010-3#1)(2010-8#8)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#6)
adoptions##2##1##(2008-5#2)
adoptive T-cell##2##2##(2010-11#2)
adoptive immunotherapy##2##2##(1990-12#1)(2011-2#1)
adoptive transfer of##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
adoptive transfer##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
adoptive##14##1##(1990-12#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#3)(2010-11#2)(2011-2#3)(2013-1#1)
adoptively##2##1##(2008-9#1)(2012-2#1)
adopts a##4##2##(1991-5#1)(1993-8#1)(2008-5#1)(2012-2#1)
adopts##11##1##(1991-5#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-5#1)(2010-5#1)(2012-2#1)
adrenal adenoma##3##2##(2011-2#3)
adrenal adenomas and##3##3##(1990-11#3)
adrenal adenomas##4##2##(1990-11#3)(2011-2#1)
adrenal cells##2##2##(1991-3#2)
adrenal chromaffin cells##5##3##(1992-6#2)(1994-5#2)(1995-11#1)
adrenal cortex mitochondria##2##3##(1990-11#2)
adrenal cortex##11##2##(1990-11#3)(1990-5#2)(1991-5#1)(1996-12#1)(1997-5#1)(2008-4#1)(2011-1#1)(2011-2#1)
adrenal gland and##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
adrenal gland##16##2##(1990-5#2)(1991-6#1)(1993-12#1)(1996-12#2)(2008-11#1)(2008-12#1)(2011-2#6)(2012-12#1)(2013-1#1)
adrenal glands##5##2##(2011-2#3)(2013-1#2)
adrenal hyperplasia (CAH)##2##3##(2008-4#1)(2010-2#1)
adrenal hyperplasia##6##2##(1990-11#1)(2008-4#2)(2010-2#2)(2012-3#1)
adrenal insufficiency##2##2##(1990-12#1)(2012-3#1)
adrenal medulla##6##2##(1990-5#2)(1996-12#2)(2008-11#2)
adrenal steroidogenesis##2##2##(1991-3#1)(1995-12#1)
adrenal##91##1##(1990-11#9)(1990-12#1)(1990-5#7)(1990-6#1)(1991-3#3)(1991-5#4)(1991-6#2)(1992-12#1)(1992-6#2)(1993-12#1)(1993-3#2)(1994-5#2)(1994-8#3)(1995-11#1)(1995-12#3)(1996-12#5)(1997-5#1)(2008-11#5)(2008-12#1)(2008-4#4)(2009-9#1)(2010-2#2)(2011-1#2)(2011-2#14)(2012-12#2)(2012-3#5)(2013-1#7)
adrenalectomized##2##1##(1994-2#2)
adrenalectomy and##4##2##(2011-2#1)(2012-12#3)
adrenalectomy##14##1##(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#10)
adrenalin##2##1##(2013-1#2)
adrenaline and##2##2##(1994-9#1)(1997-3#1)
adrenaline in##2##2##(2008-10#1)(2013-1#1)
adrenaline is##2##2##(1997-3#1)(2008-11#1)
adrenaline##13##1##(1994-2#1)(1994-9#1)(1997-3#2)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
adrenals##4##1##(1994-8#1)(2008-4#1)(2010-7#1)(2012-2#1)
adrenergic and##2##2##(1996-2#1)(2008-11#1)
adrenergic receptor##2##2##(2008-10#1)(2010-6#1)
adrenergic##15##1##(1990-5#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-12#2)(2010-6#1)
adrenoceptor##2##1##(1995-11#1)(1996-2#1)
adrenocortical carcinoma##2##2##(1995-12#1)(1997-5#1)
adrenocortical secretion##2##2##(2008-11#2)
adrenocortical##5##1##(1995-12#2)(1997-5#1)(2008-11#2)
adrenocorticotropic hormone (ACTH)##5##3##(1992-8#1)(1994-2#1)(1996-12#1)(2011-1#1)(2011-2#1)
adrenocorticotropic hormone##8##2##(1992-8#1)(1994-2#1)(1996-12#1)(2008-4#2)(2011-1#1)(2011-2#2)
adrenoleukodystrophy##3##1##(1993-3#2)(1995-2#1)
adriamycin (ADR)##4##2##(1990-2#1)(1993-12#1)(2008-10#1)(2011-3#1)
adriamycin plus etoposide##2##3##(1993-8#2)
adriamycin plus##3##2##(1993-8#3)
adriamycin##23##1##(1990-2#3)(1991-5#1)(1991-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#6)(1997-7#1)(2008-10#6)(2011-3#1)
adriamycinol##2##1##(2008-10#2)
adriamycinone##2##1##(2008-10#2)
adriblastina and##2##2##(2008-10#2)
adriblastina##10##1##(2008-10#10)
ads##2##1##(1990-11#1)(1997-1#1)
adsorb##6##1##(2008-10#6)
adsorbate##3##1##(2008-10#3)
adsorbates##3##1##(1992-11#1)(2008-10#2)
adsorbed and##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
adsorbed at the mercury electrode##4##5##(2008-10#4)
adsorbed at##5##2##(2008-10#4)(2008-7#1)
adsorbed by##3##2##(2008-10#3)
adsorbed complex##3##2##(2008-10#3)
adsorbed compounds##2##2##(2008-10#2)
adsorbed electroactive##2##2##(2008-10#2)
adsorbed in##3##2##(1994-5#1)(2008-10#2)
adsorbed metal##2##2##(2008-10#2)
adsorbed on Whatman 1PS filter paper##2##6##(2008-10#2)
adsorbed on a small column packed with##3##7##(2008-10#3)
adsorbed on a##5##3##(2008-10#5)
adsorbed on silica##2##3##(2008-10#1)(2008-11#1)
adsorbed on the column##3##4##(2008-10#3)
adsorbed on the electrode##2##4##(2008-10#2)
adsorbed on the mercury electrode##2##5##(2008-10#2)
adsorbed on the surface of a##2##6##(2008-10#2)
adsorbed on the surface of the##2##6##(2008-10#2)
adsorbed on the surface of##5##5##(2008-10#5)
adsorbed on the##17##3##(2008-10#15)(2008-11#1)(2008-7#1)
adsorbed on##42##2##(1991-5#1)(2008-10#38)(2008-11#2)(2008-7#1)
adsorbed onto a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
adsorbed onto the##2##3##(2008-10#2)
adsorbed onto##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
adsorbed species##3##2##(2008-10#3)
adsorbed to##3##2##(1990-5#1)(1997-2#1)(2008-10#1)
adsorbed was obtained##2##3##(2008-10#2)
adsorbed##122##1##(1990-12#1)(1990-5#1)(1991-5#1)(1994-5#1)(1995-2#1)(1997-2#2)(2008-10#103)(2008-11#4)(2008-5#2)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
adsorbent and##4##2##(2008-10#4)
adsorbent for##4##2##(2008-10#4)
adsorbent packed in a column and determined similarly##4##8##(2008-10#4)
adsorbent surface##3##2##(2008-10#3)
adsorbent with##2##2##(2008-10#2)
adsorbent##41##1##(2008-10#40)(2013-1#1)
adsorbents for preconcentration##2##3##(2008-10#2)
adsorbents were##2##2##(1997-2#1)(2008-10#1)
adsorbents##22##1##(1997-2#8)(2008-10#14)
adsorbing##10##1##(2008-10#8)(2008-11#1)(2008-9#1)
adsorbs##2##1##(2008-10#1)(2008-5#1)
adsorption and##10##2##(2008-10#7)(2008-7#2)(2011-2#1)
adsorption at##2##2##(2008-10#2)
adsorption behaviour##3##2##(1997-2#3)
adsorption by##2##2##(2008-10#1)(2008-7#1)
adsorption capacities are##2##3##(2008-10#2)
adsorption capacities of##2##3##(2008-10#2)
adsorption capacities##6##2##(2008-10#5)(2013-1#1)
adsorption capacity of the##4##4##(2008-10#3)(2011-2#1)
adsorption capacity of##7##3##(2008-10#6)(2011-2#1)
adsorption capacity##8##2##(2008-10#7)(2011-2#1)
adsorption cathodic stripping##3##3##(2008-10#3)
adsorption cathodic##4##2##(2008-10#4)
adsorption characteristics##2##2##(2008-10#2)
adsorption coefficient##2##2##(2008-10#2)
adsorption coefficients##2##2##(2008-10#2)
adsorption collection of##2##3##(2008-10#2)
adsorption collection##3##2##(2008-10#3)
adsorption constant##3##2##(2008-10#3)
adsorption equilibrium##3##2##(2008-10#3)
adsorption for##3##2##(2008-10#2)(2013-1#1)
adsorption from##9##2##(2008-10#9)
adsorption is##2##2##(1990-2#1)(2008-10#1)
adsorption isotherm##3##2##(2008-10#3)
adsorption isotherms##4##2##(2008-10#3)(2011-2#1)
adsorption kinetics##2##2##(2008-10#2)
adsorption maximum at##2##3##(2008-10#2)
adsorption of fluoxetine##2##3##(2008-10#2)
adsorption of heavy metal ions##4##5##(2008-10#4)
adsorption of heavy metal##6##4##(2008-10#5)(2013-1#1)
adsorption of silver##2##3##(2008-10#2)
adsorption of the##8##3##(2008-10#8)
adsorption of##77##2##(1990-2#1)(2008-10#74)(2013-1#2)
adsorption on a##2##3##(2008-10#2)
adsorption on the electrode surface##2##5##(2008-10#2)
adsorption on the surface of the##3##6##(2008-10#3)
adsorption on the##7##3##(2008-10#7)
adsorption on##16##2##(1994-2#1)(2008-10#15)
adsorption onto##3##2##(2008-10#3)
adsorption preconcentration##3##2##(2008-10#3)
adsorption process##3##2##(2008-10#3)
adsorption properties of the##2##4##(2008-10#2)
adsorption properties of##4##3##(2008-10#4)
adsorption properties##7##2##(2008-10#7)
adsorption sites##3##2##(2008-10#3)
adsorption to##3##2##(2008-10#3)
adsorption was studied##2##3##(2008-10#1)(2013-1#1)
adsorption was##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
adsorption##264##1##(1990-2#3)(1992-5#1)(1994-2#1)(1997-2#5)(2008-10#236)(2008-12#1)(2008-7#6)(2010-7#1)(2011-2#4)(2013-1#6)
adsorption-desorption##6##1##(2008-10#4)(2008-5#1)(2009-11#1)
adsorptions##2##1##(2008-10#2)
adsorptive accumulation of the##3##4##(2008-10#3)
adsorptive accumulation of##6##3##(2008-10#6)
adsorptive accumulation##9##2##(2008-10#9)
adsorptive cathodic stripping voltammetric procedure was developed for the##2##9##(2008-10#2)
adsorptive cathodic stripping voltammetric procedure was##3##6##(2008-10#3)
adsorptive cathodic stripping voltammetry using##2##5##(2008-10#2)
adsorptive cathodic stripping voltammetry##9##4##(2008-10#9)
adsorptive cathodic stripping voltammogram of##2##5##(2008-10#2)
adsorptive cathodic stripping##14##3##(2008-10#14)
adsorptive polarographic##4##2##(2008-10#4)
adsorptive preconcentration##3##2##(2008-10#3)
adsorptive stripping voltammetric determination of##3##5##(2008-10#3)
adsorptive stripping voltammetric measurements of##2##5##(2008-10#2)
adsorptive stripping voltammetric##10##3##(2008-10#10)
adsorptive stripping voltammetry (AdSV)##2##4##(2008-10#2)
adsorptive stripping voltammetry on a##2##5##(2008-10#2)
adsorptive stripping voltammetry on##3##4##(2008-10#3)
adsorptive stripping voltammetry with a##2##5##(2008-10#2)
adsorptive stripping voltammetry##36##3##(2008-10#36)
adsorptive stripping##56##2##(2008-10#56)
adsorptive transfer##2##2##(2008-10#2)
adsorptive voltammetric##3##2##(2008-10#3)
adsorptive voltammetry##4##2##(2008-10#4)
adsorptive##112##1##(2008-10#111)(2008-11#1)
adsorptive-catalytic stripping##3##2##(2008-10#3)
adsorptivity##2##1##(2008-10#2)
adult Anopheles##2##2##(2012-12#2)
adult DRG##2##2##(1996-12#2)
adult Diploptera punctata males##2##4##(1995-11#2)
adult Drosophila melanogaster##2##3##(1997-7#1)(2008-8#1)
adult Drosophila##3##2##(1997-7#1)(2008-8#1)(2008-9#1)
adult Nucleus##2##2##(2008-9#2)
adult Sprague-Dawley##2##2##(2008-10#1)(2008-7#1)
adult T cell leukemia##2##4##(2008-11#1)(2008-4#1)
adult Wistar rats were##2##4##(1991-2#1)(2008-7#1)
adult Wistar rats##3##3##(1991-2#1)(2008-11#1)(2008-7#1)
adult age group##2##3##(2010-12#1)(2013-7#1)
adult age##3##2##(1990-3#1)(2010-12#1)(2013-7#1)
adult alveolar##2##2##(1994-3#2)
adult and child##2##3##(1991-12#1)(2008-11#1)
adult and embryonic##2##3##(2007-12#1)(2008-11#1)
adult and neonatal##2##3##(1997-2#1)(2008-5#1)
adult and##16##2##(1991-12#2)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-10#1)(2013-7#2)
adult animals##2##2##(1997-9#1)(2008-7#1)
adult asthma##3##2##(1996-1#2)(2012-12#1)
adult behavior##3##2##(1993-12#1)(2009-7#2)
adult birds##2##2##(1996-8#1)(2011-2#1)
adult bone marrow##2##3##(2008-10#1)(2009-10#1)
adult brain##3##2##(1996-12#1)(2008-1#1)(2008-7#1)
adult branch##2##2##(2008-11#2)
adult cardiac##2##2##(2008-12#1)(2013-1#1)
adult cardiomyocytes##3##2##(2008-7#3)
adult child##4##2##(1994-12#1)(1995-2#1)(2010-4#1)(2010-9#1)
adult cirrhotics##4##2##(2012-3#4)
adult cochlear implant recipients and normal-hearing adults##2##7##(2008-9#2)
adult cochlear implant users with##2##5##(2008-9#2)
adult cochlear implant users##4##4##(2008-9#4)
adult cochlear implant##6##3##(2008-9#6)
adult cochlear##8##2##(2008-9#8)
adult day care##4##3##(1992-3#1)(1994-3#2)(1997-2#1)
adult day centers##2##3##(1994-2#2)
adult day##6##2##(1992-3#1)(1994-2#2)(1994-3#2)(1997-2#1)
adult depression##2##2##(2008-11#1)(2010-7#1)
adult fecundity##3##2##(2008-11#3)
adult female##5##2##(1990-11#1)(2007-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
adult females##4##2##(1991-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
adult fish##2##2##(2009-7#2)
adult group##2##2##(1995-3#1)(2008-8#1)
adult hamster##2##2##(1996-2#2)
adult height##2##2##(2007-11#1)(2013-1#1)
adult hepatocytes##3##2##(2008-11#2)(2012-2#1)
adult horses##2##2##(2013-8#2)
adult household dogs##2##3##(2012-3#2)
adult human##5##2##(1991-7#1)(1994-2#1)(1997-8#1)(2008-9#1)(2010-8#1)
adult illiterates##3##2##(2009-9#3)
adult inbreeding depression##2##3##(2008-9#2)
adult influences##2##2##(2009-7#2)
adult insects##2##2##(2008-10#2)
adult life##14##2##(1995-12#4)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-8#2)(2010-11#1)(2011-2#1)(2013-1#1)
adult liver##2##2##(1994-3#1)(2013-1#1)
adult livers##2##2##(2013-1#2)
adult lung##3##2##(1994-11#2)(2013-1#1)
adult male Wistar##2##3##(2008-11#1)(2008-12#1)
adult male and female##2##4##(2008-10#1)(2008-11#1)
adult male rats##2##3##(1992-12#1)(1994-8#1)
adult male##10##2##(1992-12#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)
adult males and females##2##4##(2007-12#1)(2008-12#1)
adult males##10##2##(1991-12#2)(1994-8#1)(1996-12#1)(2007-12#2)(2008-12#1)(2008-9#1)(2010-4#1)(2010-7#1)
adult mammalian##2##2##(2008-11#1)(2009-10#1)
adult meadow voles##2##3##(1994-8#2)
adult men who had been##2##5##(1996-11#1)(1996-6#1)
adult men who##3##3##(1996-11#1)(1996-6#1)(2008-3#1)
adult men##4##2##(1992-9#1)(1996-11#1)(1996-6#1)(2008-3#1)
adult mice##7##2##(1993-3#1)(1994-11#1)(2008-4#1)(2008-9#2)(2012-2#1)(2012-3#1)
adult mites##4##2##(2007-12#4)
adult mouse neocortex##2##3##(2008-11#2)
adult mouse##11##2##(1990-12#2)(1995-2#2)(1997-7#2)(2008-11#4)(2012-2#1)
adult neural##3##2##(2008-11#1)(2008-9#1)(2013-7#1)
adult neurogenesis##4##2##(2008-11#1)(2008-7#2)(2012-2#1)
adult nursing##2##2##(2008-11#2)
adult offspring##2##2##(1991-1#1)(2008-10#1)
adult onset##2##2##(2008-7#1)(2013-8#1)
adult or##3##2##(2008-10#1)(2008-11#2)
adult pancreas##3##2##(2008-1#1)(2013-7#2)
adult patient##4##2##(2008-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
adult patients in##2##3##(2009-4#1)(2013-1#1)
adult patients who##2##3##(2012-3#2)
adult patients with##6##3##(1992-12#1)(1997-8#1)(2008-1#1)(2008-9#1)(2010-10#1)(2011-2#1)
adult patients##22##2##(1991-4#1)(1992-12#1)(1995-2#1)(1996-6#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#2)(2009-4#1)(2010-10#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
adult plant resistance to stripe rust##2##6##(2008-10#2)
adult plant resistance to##3##4##(2008-10#3)
adult plant resistance##5##3##(2008-10#5)
adult plant##10##2##(2008-10#10)
adult plants of##3##3##(2008-10#3)
adult plants##7##2##(2008-10#6)(2008-8#1)
adult population a##2##3##(2010-7#1)(2013-1#1)
adult population in##2##3##(2008-11#1)(2012-12#1)
adult population##15##2##(1996-6#1)(1997-2#1)(1997-4#1)(2008-11#2)(2008-8#4)(2010-7#1)(2012-12#2)(2013-1#3)
adult psychiatric##3##2##(1993-2#2)(1996-11#1)
adult rat cerebral cortex##2##4##(1996-12#1)(2008-11#1)
adult rat hepatocytes##4##3##(1993-8#2)(1995-8#2)
adult rat##18##2##(1991-12#1)(1993-8#2)(1994-2#1)(1995-8#2)(1996-12#6)(1997-3#2)(2008-11#2)(2009-10#1)(2012-2#1)
adult rats##14##2##(1990-5#1)(1991-12#1)(1992-12#3)(1994-2#2)(1997-1#1)(1997-2#1)(2008-11#1)(2008-7#1)(2013-7#3)
adult respiratory##2##2##(1992-2#1)(1993-2#1)
adult roles##2##2##(2009-7#2)
adult skeletal muscle##2##3##(1991-12#1)(2008-11#1)
adult smokers##2##2##(2010-2#1)(2013-1#1)
adult stage##7##2##(1990-3#2)(2008-10#4)(2013-1#1)
adult stages##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
adult stem cells##2##3##(2008-11#1)(2008-9#1)
adult stem##3##2##(2008-11#1)(2008-9#1)(2013-7#1)
adult students##2##2##(1996-1#1)(1996-2#1)
adult subjects##2##2##(2008-9#2)
adult testes##2##2##(2009-10#1)(2012-2#1)
adult thrips##4##2##(2008-10#4)
adult tissues such as##2##4##(2008-6#1)(2008-9#1)
adult tissues##8##2##(1993-6#1)(1993-8#1)(1994-11#1)(1997-7#2)(2008-6#1)(2008-9#1)(2009-12#1)
adult users of the##2##4##(2008-9#2)
adult users##3##2##(2008-9#3)
adult viability##2##2##(2008-8#2)
adult women in##3##3##(2012-2#1)(2013-1#2)
adult women##5##2##(2008-10#1)(2012-2#2)(2013-1#2)
adult zebrafish##2##2##(2008-10#1)(2009-5#1)
adult##596##1##(1990-11#1)(1990-12#3)(1990-3#4)(1990-5#7)(1991-1#1)(1991-11#1)(1991-12#8)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#5)(1992-2#3)(1992-3#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#5)(1993-8#3)(1994-1#1)(1994-11#7)(1994-12#2)(1994-2#10)(1994-3#9)(1994-8#6)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#4)(1996-11#2)(1996-12#18)(1996-2#8)(1996-3#2)(1996-5#1)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#4)(1997-9#2)(2007-11#1)(2007-12#11)(2007-8#1)(2008-1#5)(2008-10#61)(2008-11#41)(2008-12#14)(2008-3#2)(2008-4#4)(2008-5#13)(2008-6#2)(2008-7#18)(2008-8#22)(2008-9#44)(2009-1#1)(2009-10#4)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#10)(2009-8#4)(2009-9#5)(2010-10#3)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#9)(2010-8#4)(2010-9#1)(2011-2#13)(2012-12#9)(2012-2#17)(2012-3#21)(2013-1#29)(2013-7#12)(2013-8#6)
adult-onset##2##1##(2008-7#2)
adult-plant leaf##2##2##(2008-10#2)
adult-plant resistance##2##2##(2008-10#2)
adult-plant##9##1##(2008-10#9)
adulterated##2##1##(2008-10#2)
adulteration of##3##2##(2008-10#1)(2008-8#1)(2010-4#1)
adulteration##8##1##(2008-10#6)(2008-8#1)(2010-4#1)
adulthood##53##1##(1992-2#2)(1993-3#2)(1994-8#1)(1995-12#1)(1996-6#1)(1996-9#2)(1997-7#1)(1997-8#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#4)(2008-4#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#4)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)
adults (0-1 day)##2##3##(1997-8#2)
adults (n =##2##3##(2009-7#1)(2010-8#1)
adults aged##2##2##(2011-2#1)(2012-12#1)
adults and a##2##3##(2008-8#1)(2009-11#1)
adults and children##5##3##(1996-2#2)(2008-12#1)(2008-9#1)(2012-2#1)
adults and larvae##2##3##(2008-10#1)(2008-8#1)
adults and##22##2##(1996-2#2)(1997-8#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2011-2#4)(2012-2#1)(2013-8#3)
adults are##7##2##(1992-1#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
adults at##2##2##(2008-12#1)(2008-9#1)
adults can##2##2##(2008-10#1)(2013-7#1)
adults decreased with##2##3##(2008-10#2)
adults differs##2##2##(2008-10#1)(2008-7#1)
adults for##2##2##(2008-11#1)(2008-9#1)
adults from##2##2##(2010-2#1)(2012-2#1)
adults had##3##2##(1990-3#1)(2008-9#1)(2012-12#1)
adults have##5##2##(2008-9#3)(2010-5#1)(2013-1#1)
adults in Australia##2##3##(2012-12#1)(2013-8#1)
adults in a##2##3##(2008-9#1)(2012-12#1)
adults in the United States##2##5##(2010-10#1)(2013-1#1)
adults in the##4##3##(2008-10#1)(2008-12#1)(2010-10#1)(2013-1#1)
adults in##24##2##(1991-11#1)(1995-5#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#1)
adults is not##2##3##(1997-8#1)(2008-11#1)
adults is##6##2##(1995-5#1)(1996-11#2)(1997-8#1)(2008-11#1)(2013-7#1)
adults living in the##2##4##(2008-5#1)(2011-2#1)
adults living##3##2##(2008-5#2)(2011-2#1)
adults of the##5##3##(1991-11#1)(2007-12#1)(2008-9#1)(2010-8#1)(2013-8#1)
adults of##7##2##(1991-11#1)(2007-12#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-8#1)
adults on##4##2##(1997-4#1)(2008-10#1)(2010-7#2)
adults or##2##2##(2008-9#2)
adults over##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
adults participated in a##2##4##(2008-7#1)(2013-8#1)
adults that##3##2##(1994-8#1)(1996-11#1)(2008-8#1)
adults to##5##2##(2008-1#1)(2008-11#1)(2008-9#2)(2011-2#1)
adults using a##3##3##(2013-1#2)(2013-8#1)
adults using##6##2##(2008-11#1)(2008-9#2)(2013-1#2)(2013-8#1)
adults was##4##2##(1990-12#1)(1996-11#1)(1996-8#1)(2010-8#1)
adults were##11##2##(1994-8#1)(2008-12#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
adults who were##3##3##(1996-11#1)(2012-12#2)
adults who##6##2##(1996-11#1)(2008-10#1)(2009-10#1)(2012-12#2)(2013-8#1)
adults with RHD##2##3##(2012-3#2)
adults with a##4##3##(1997-4#1)(2008-7#1)(2008-9#1)(2010-7#1)
adults with cancer##3##3##(2008-11#1)(2010-11#1)(2012-2#1)
adults with chronic nonmalignant pain##2##5##(2010-3#2)
adults with developmental dyslexia##2##4##(2012-2#2)
adults with##51##2##(1990-3#1)(1991-8#1)(1992-1#1)(1992-5#1)(1997-4#2)(1997-8#1)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-9#1)(2010-11#4)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#6)(2012-3#6)(2013-1#4)(2013-8#1)
adults##405##1##(1990-11#1)(1990-12#1)(1990-3#2)(1991-1#1)(1991-11#3)(1991-12#3)(1991-4#1)(1991-8#1)(1992-1#4)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1993-1#1)(1993-12#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-8#1)(1996-11#8)(1996-2#7)(1996-8#1)(1997-1#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#12)(2007-11#1)(2007-12#6)(2008-1#4)(2008-10#22)(2008-11#24)(2008-12#19)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#12)(2008-8#12)(2008-9#42)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#7)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#24)(2012-12#11)(2012-2#17)(2012-3#14)(2013-1#32)(2013-7#4)(2013-8#17)
adults' expectations##2##2##(2009-7#2)
adults'##8##1##(2008-12#1)(2009-12#1)(2009-7#4)(2010-10#2)
adults)##3##1##(1995-3#1)(2008-9#1)(2009-9#1)
adults]##4##1##(1994-12#1)(1996-11#1)(1997-8#1)(2008-10#1)
advance directive decision making##2##4##(2008-12#2)
advance directive##3##2##(1994-1#1)(2008-12#2)
advance directives##2##2##(1994-1#2)
advance for##2##2##(2008-8#1)(2010-12#1)
advance in the##4##3##(1996-6#1)(1997-7#1)(2008-11#1)(2012-12#1)
advance in this##2##3##(2009-5#1)(2010-10#1)
advance in##14##2##(1996-6#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
advance information for##2##3##(2008-7#2)
advance information##3##2##(2008-7#3)
advance knowledge of##2##3##(2008-10#1)(2010-8#1)
advance of the##3##3##(2008-10#2)(2012-7#1)
advance of##7##2##(2008-10#3)(2008-5#1)(2008-7#1)(2012-6#1)(2012-7#1)
advance our##3##2##(2009-4#1)(2010-5#1)(2013-1#1)
advance the##5##2##(1994-12#1)(2008-11#2)(2012-2#1)(2013-1#1)
advance##64##1##(1991-1#1)(1991-12#1)(1992-12#1)(1994-1#3)(1994-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#7)(2008-11#7)(2008-12#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#5)(2012-6#1)(2012-7#1)(2013-1#2)(2013-8#2)
advanced CHF##3##2##(2009-10#3)
advanced HIV disease##3##3##(2013-1#3)
advanced RCC##2##2##(2013-1#2)
advanced age##5##2##(1994-2#1)(1997-3#1)(2008-7#2)(2011-3#1)
advanced analytical##2##2##(2008-11#1)(2010-7#1)
advanced and##5##2##(1991-8#1)(1995-10#1)(2011-1#1)(2011-2#2)
advanced backcross##2##2##(2008-10#1)(2013-8#1)
advanced breast cancer and##2##4##(1991-6#1)(1991-8#1)
advanced breast cancer patients##3##4##(1994-8#2)(1997-7#1)
advanced breast cancer##21##3##(1991-6#3)(1991-8#6)(1992-2#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-8#4)(1997-7#2)
advanced breast##24##2##(1991-6#3)(1991-8#6)(1992-2#2)(1992-5#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-8#4)(1997-7#2)(2011-2#1)(2013-8#1)
advanced by##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
advanced cancer patients##6##3##(2010-2#3)(2013-8#3)
advanced cancer##13##2##(1992-5#1)(2008-2#2)(2008-7#3)(2010-2#3)(2012-3#1)(2013-8#3)
advanced chronic##2##2##(2008-1#1)(2009-10#1)
advanced colorectal cancer##6##3##(1990-12#2)(1991-3#1)(1992-2#2)(1994-2#1)
advanced disease##6##2##(1990-8#1)(1991-3#1)(1992-3#1)(1997-7#1)(2008-9#1)(2010-7#1)
advanced glycation end products##3##4##(2008-1#1)(2008-7#1)(2010-10#1)
advanced head and neck cancer##3##5##(1990-12#1)(1990-6#1)(1993-9#1)
advanced head and neck##5##4##(1990-12#2)(1990-6#2)(1993-9#1)
advanced hilar##2##2##(2013-1#2)
advanced imaging##3##2##(1994-3#1)(2008-3#1)(2013-1#1)
advanced in##4##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
advanced into the##2##3##(2008-11#1)(2013-1#1)
advanced into##3##2##(2008-11#1)(2013-1#2)
advanced lung cancer##3##3##(2010-2#3)
advanced maternal age##2##3##(2012-3#2)
advanced non-small cell lung cancer##2##5##(1994-12#1)(2008-10#1)
advanced our##2##2##(2008-11#1)(2009-3#1)
advanced ovarian cancer##3##3##(1991-8#2)(2013-8#1)
advanced ovarian##4##2##(1991-8#2)(1993-2#1)(2013-8#1)
advanced oxidation process##3##3##(2008-10#3)
advanced practice nurses##3##3##(2008-12#2)(2012-3#1)
advanced practice##4##2##(2008-12#2)(2008-8#1)(2012-3#1)
advanced proliferations##2##2##(2011-2#2)
advanced renal cancer##2##3##(1991-6#1)(2008-5#1)
advanced renal##3##2##(1991-6#1)(2008-5#1)(2013-1#1)
advanced squamous cell carcinoma of the##2##6##(1992-3#1)(2007-11#1)
advanced stage##9##2##(1991-6#1)(1991-8#1)(1995-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-7#1)
advanced stages of##8##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
advanced stages##12##2##(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
advanced study courses##2##3##(1994-12#2)
advanced the##2##2##(1993-8#1)(2008-10#1)
advanced through the##2##3##(2010-4#1)(2011-1#1)
advanced to##5##2##(1996-1#1)(2008-11#1)(2008-7#1)(2010-4#1)(2013-8#1)
advanced##266##1##(1990-11#1)(1990-12#8)(1990-2#1)(1990-3#2)(1990-6#5)(1990-8#2)(1991-12#1)(1991-3#3)(1991-6#6)(1991-7#1)(1991-8#10)(1991-9#1)(1992-12#1)(1992-2#5)(1992-3#4)(1992-5#4)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#6)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#5)(1995-10#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#5)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#5)(2008-10#20)(2008-11#11)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#5)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#6)(2010-3#2)(2010-4#2)(2010-7#4)(2010-9#1)(2011-1#2)(2011-2#18)(2011-3#5)(2012-12#2)(2012-2#3)(2012-3#9)(2013-1#13)(2013-7#1)(2013-8#9)
advancement for##2##2##(1996-1#1)(2008-10#1)
advancement in##3##2##(2008-10#2)(2011-2#1)
advancement of knowledge##2##3##(2008-10#1)(2010-6#1)
advancement of##12##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-3#1)
advancement##24##1##(1994-12#1)(1995-12#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
advancements in the##2##3##(2008-10#1)(2013-1#1)
advancements in##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
advancements##5##1##(2008-10#1)(2009-6#2)(2011-2#1)(2013-1#1)
advances and##6##2##(2008-11#1)(2008-12#1)(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
advances have been made in the##2##6##(1990-9#1)(2011-2#1)
advances have been made in##6##5##(1990-9#1)(2008-11#2)(2008-9#1)(2011-1#1)(2011-2#1)
advances have been##7##3##(1990-9#1)(2008-11#2)(2008-9#1)(2011-1#1)(2011-2#2)
advances have##10##2##(1990-9#1)(1991-2#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#2)
advances in both##3##3##(2008-10#1)(2009-10#1)(2010-7#1)
advances in cancer##2##3##(1997-1#1)(2009-4#1)
advances in chemical##2##3##(2009-7#2)
advances in genetic##2##3##(2008-7#2)
advances in molecular biology have##2##5##(2009-1#1)(2012-3#1)
advances in molecular biology##3##4##(2008-9#1)(2009-1#1)(2012-3#1)
advances in molecular##4##3##(2008-10#1)(2008-9#1)(2009-1#1)(2012-3#1)
advances in our understanding of the##2##6##(2008-10#1)(2008-5#1)
advances in our##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
advances in systems##2##3##(2011-2#1)(2013-8#1)
advances in techniques##2##3##(2008-9#1)(2009-12#1)
advances in the basic neurosciences##2##5##(2008-4#2)
advances in the treatment of##6##5##(1996-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
advances in the understanding##2##4##(2009-3#1)(2011-2#1)
advances in the##31##3##(1990-11#1)(1992-2#1)(1995-5#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
advances in these##2##3##(2010-7#1)(2011-2#1)
advances in this field##2##4##(2008-5#1)(2013-8#1)
advances in this##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
advances in understanding the##3##4##(2010-12#1)(2011-1#1)(2012-2#1)
advances in##119##2##(1990-11#1)(1990-9#1)(1992-1#1)(1992-2#1)(1993-1#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#10)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#1)(2011-1#1)(2011-2#10)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#8)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#5)
advances into##2##2##(2008-11#1)(2012-2#1)
advances of##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
advances that have##2##3##(2008-10#1)(2008-11#1)
advances that##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
advances the##2##2##(2008-5#1)(2008-6#1)
advances will##2##2##(2011-10#1)(2012-2#1)
advances##183##1##(1990-11#2)(1990-9#3)(1991-2#1)(1992-1#1)(1992-2#1)(1993-1#3)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#16)(2008-11#19)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#17)(2011-3#1)(2011-7#3)(2012-12#1)(2012-2#11)(2012-3#6)(2013-1#5)(2013-7#3)(2013-8#6)
advancing the##6##2##(1993-3#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)
advancing##18##1##(1993-3#2)(1996-12#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#2)(2011-3#1)(2012-2#2)(2012-3#1)
advantage and##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
advantage for the##3##3##(1992-3#1)(2008-10#1)(2012-3#1)
advantage for##10##2##(1990-11#1)(1992-3#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-1#1)(2012-3#1)
advantage in##6##2##(1990-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
advantage is that the##2##4##(2008-10#1)(2008-9#1)
advantage is that##3##3##(2008-10#2)(2008-9#1)
advantage is##7##2##(2008-10#3)(2008-3#1)(2008-9#1)(2010-12#1)(2012-7#1)
advantage of a##7##3##(1997-3#1)(2008-10#3)(2008-3#1)(2012-3#1)(2013-1#1)
advantage of its##2##3##(2008-10#1)(2009-10#1)
advantage of recent##2##3##(2008-11#1)(2009-4#1)
advantage of the ability of##2##5##(2008-10#1)(2008-5#1)
advantage of the proposed##3##4##(2008-10#3)
advantage of the##28##3##(1994-3#1)(1995-3#2)(1997-3#1)(2008-10#15)(2008-12#1)(2008-3#5)(2008-5#1)(2008-8#1)(2010-7#1)
advantage of this method is##3##5##(2007-12#1)(2008-10#2)
advantage of this new##2##4##(2008-10#2)
advantage of this##12##3##(1993-12#2)(1996-2#1)(2007-12#1)(2008-10#8)
advantage of using an##2##4##(2008-10#1)(2008-2#1)
advantage of using##6##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)
advantage of##132##2##(1990-11#2)(1991-1#1)(1991-3#1)(1991-5#1)(1993-12#2)(1994-3#2)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#2)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#54)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#3)
advantage over other##3##3##(2008-10#2)(2009-1#1)
advantage over the##2##3##(2008-10#2)
advantage over##13##2##(1994-12#1)(1994-2#3)(1994-3#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-1#1)
advantage that##8##2##(1992-3#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)
advantage to##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
advantage was##3##2##(2008-10#1)(2008-7#2)
advantage##213##1##(1990-11#3)(1990-12#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#3)(1994-3#3)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#3)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#76)(2008-11#13)(2008-12#1)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#11)(2009-1#3)(2009-10#2)(2009-4#2)(2009-8#1)(2010-1#1)(2010-12#4)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#3)
advantage&quot##2##1##(1996-1#1)(2008-10#1)
advantageous because##3##2##(1997-6#1)(2008-10#1)(2008-9#1)
advantageous for##7##2##(1995-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
advantageous in##7##2##(1997-7#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
advantageous over##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
advantageous to##4##2##(2008-10#3)(2008-4#1)
advantageous##48##1##(1995-12#2)(1995-5#1)(1997-6#1)(1997-7#1)(2008-10#18)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
advantageously used for##2##3##(2008-10#2)
advantageously##4##1##(2008-10#3)(2008-5#1)
advantages and disadvantages of both##2##5##(1991-1#1)(2008-10#1)
advantages and disadvantages of each##4##5##(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
advantages and disadvantages of##15##4##(1991-1#1)(1993-3#1)(1997-2#1)(2008-10#5)(2008-4#1)(2009-5#2)(2009-7#1)(2010-3#1)(2011-2#1)(2013-8#1)
advantages and disadvantages##23##3##(1991-1#1)(1993-3#1)(1997-2#1)(2008-10#8)(2008-12#1)(2008-4#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
advantages and drawbacks of##5##4##(2008-10#3)(2008-3#1)(2012-12#1)
advantages and drawbacks##7##3##(2008-10#4)(2008-3#1)(2009-12#1)(2012-12#1)
advantages and limitations are##3##4##(2008-10#2)(2008-3#1)
advantages and limitations of the##3##5##(2008-10#2)(2008-9#1)
advantages and limitations of##7##4##(2008-10#4)(2008-4#1)(2008-9#1)(2012-3#1)
advantages and limitations##15##3##(1992-3#1)(1994-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-9#2)(2012-2#1)(2012-3#1)
advantages and##53##2##(1991-1#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1997-2#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-9#2)(2009-12#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
advantages are##3##2##(1995-2#1)(2008-10#2)
advantages as##2##2##(2008-10#1)(2008-11#1)
advantages compared to other##2##4##(2007-8#1)(2012-3#1)
advantages compared to##3##3##(2007-8#1)(2008-5#1)(2012-3#1)
advantages compared with##2##3##(2008-10#1)(2008-8#1)
advantages compared##5##2##(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
advantages for##5##2##(1993-1#1)(1993-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
advantages have##2##2##(2008-10#1)(2012-2#1)
advantages in this##2##3##(2008-10#1)(2008-11#1)
advantages in##8##2##(1993-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
advantages include##2##2##(2008-10#1)(2011-7#1)
advantages of a##3##3##(1994-3#1)(1997-1#1)(2008-3#1)
advantages of being##4##3##(2007-12#1)(2008-10#2)(2010-12#1)
advantages of high##2##3##(1992-11#1)(2008-10#1)
advantages of low resistance##3##4##(2008-10#3)
advantages of such##2##3##(2008-10#1)(2010-11#1)
advantages of the present##2##4##(2008-10#2)
advantages of the##22##3##(1994-9#1)(1996-3#1)(1997-2#1)(2008-10#13)(2008-12#1)(2008-3#3)(2008-4#1)(2010-6#1)
advantages of this method include##2##5##(1994-8#1)(2008-10#1)
advantages of this##15##3##(1993-1#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#6)(2008-11#2)(2011-2#2)(2012-3#1)
advantages of##115##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#55)(2008-11#4)(2008-12#1)(2008-3#7)(2008-4#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-7#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
advantages over conventional##6##3##(2008-10#5)(2011-2#1)
advantages over existing##2##3##(2008-10#1)(2008-2#1)
advantages over other##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
advantages over the##10##3##(1993-3#1)(1994-1#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#2)
advantages over traditional##4##3##(1993-3#1)(2008-10#1)(2008-9#2)
advantages over##35##2##(1993-3#3)(1994-1#1)(1997-1#1)(2007-11#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#3)(2011-2#3)(2012-2#1)(2012-3#1)
advantages such as##3##3##(2008-10#3)
advantages to the##2##3##(1990-5#1)(1997-2#1)
advantages to##5##2##(1990-5#1)(1997-2#1)(2008-9#1)(2013-1#2)
advantages which##2##2##(1992-3#1)(2010-5#1)
advantages with##3##2##(2008-11#1)(2009-1#1)(2012-12#1)
advantages##291##1##(1990-12#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-2#2)(1996-1#2)(1996-11#1)(1996-3#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#129)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#7)(2008-5#1)(2008-7#6)(2008-8#8)(2008-9#9)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-2#10)(2011-3#1)(2011-7#2)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#5)(2013-8#1)
advection##2##1##(2008-9#2)
advent of new##2##3##(2010-7#1)(2013-1#1)
advent of the##3##3##(1994-12#1)(1996-11#1)(2008-10#1)
advent of##28##2##(1994-12#1)(1996-11#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
advent##29##1##(1994-12#1)(1996-11#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
adventitia and##2##2##(1997-8#1)(2008-11#1)
adventitia##9##1##(1991-8#1)(1993-8#1)(1997-3#1)(1997-8#4)(2008-11#1)(2008-7#1)
adventitial and##2##2##(1992-12#1)(2010-4#1)
adventitial##7##1##(1992-12#1)(1997-1#1)(1997-8#3)(2010-4#2)
adventitious agents##2##2##(2008-11#2)
adventitious roots##3##2##(2008-10#1)(2008-9#2)
adventitious shoots##2##2##(2008-12#2)
adventitious##12##1##(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-9#3)(2013-1#1)
adventure##2##1##(2008-10#1)(2012-2#1)
adverse cardiovascular##2##2##(2009-1#1)(2013-8#1)
adverse changes##2##2##(1991-1#1)(1992-11#1)
adverse conditions is##2##3##(2008-10#1)(2008-11#1)
adverse consequences##6##2##(1991-2#1)(1992-2#2)(1993-3#1)(2008-11#2)
adverse drug events##2##3##(2011-2#1)(2011-3#1)
adverse drug reactions (ADRs)##3##4##(2008-11#1)(2011-2#2)
adverse drug reactions and##4##4##(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
adverse drug reactions in##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
adverse drug reactions is##2##4##(2013-8#2)
adverse drug reactions were##2##4##(2011-2#2)
adverse drug reactions##23##3##(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#4)(2011-2#11)(2013-8#5)
adverse drug##26##2##(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#5)(2011-2#12)(2011-3#1)(2013-8#5)
adverse effect in##2##3##(1995-3#1)(2008-11#1)
adverse effect of the##3##4##(1991-1#1)(2008-11#1)(2008-7#1)
adverse effect of##10##3##(1991-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-4#1)(2012-3#1)(2013-1#1)
adverse effect on the##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
adverse effect on##8##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
adverse effect profile##3##3##(1996-3#1)(2008-8#1)(2011-2#1)
adverse effect##28##2##(1991-1#1)(1992-4#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
adverse effects and##4##3##(1991-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
adverse effects of drugs##2##4##(1996-6#2)
adverse effects of##17##3##(1996-6#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
adverse effects on growth rate##2##5##(2007-11#2)
adverse effects on the ecological balance of the healthy##2##9##(2012-3#2)
adverse effects on the##6##4##(1996-9#1)(2008-10#1)(2008-5#1)(2012-3#3)
adverse effects on##13##3##(1994-12#1)(1996-9#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#3)
adverse effects were##3##3##(1993-1#1)(1996-3#1)(1997-7#1)
adverse effects with##2##3##(2008-7#1)(2013-1#1)
adverse effects##65##2##(1991-1#1)(1992-3#1)(1993-1#1)(1994-12#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#1)
adverse effects]##2##2##(1993-6#1)(1995-5#1)
adverse event profile##4##3##(1996-8#1)(2007-11#1)(2009-7#1)(2012-3#1)
adverse event was##2##3##(2008-5#1)(2013-1#1)
adverse event##13##2##(1996-8#1)(2007-11#1)(2008-11#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
adverse events and##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
adverse events in##8##3##(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
adverse events may##2##3##(2008-8#2)
adverse events of##2##3##(2008-11#1)(2011-2#1)
adverse events related to##2##4##(2008-11#1)(2008-5#1)
adverse events that are##2##4##(2008-7#1)(2010-12#1)
adverse events were##4##3##(1996-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
adverse events##57##2##(1996-1#1)(1996-11#1)(2007-11#2)(2008-10#5)(2008-11#14)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#10)(2009-12#1)(2009-7#1)(2010-12#6)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#4)
adverse experiences##2##2##(2008-10#1)(2013-1#1)
adverse health effects##5##3##(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
adverse health##7##2##(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#2)(2013-1#2)
adverse immune effects in##2##4##(2008-10#2)
adverse immune effects##3##3##(2008-10#3)
adverse impact##2##2##(2008-7#1)(2011-1#1)
adverse outcomes##4##2##(2008-11#2)(2009-9#1)(2013-1#1)
adverse pregnancy outcome##2##3##(2008-11#1)(2011-1#1)
adverse pregnancy##4##2##(2007-12#1)(2008-11#2)(2011-1#1)
adverse reaction##5##2##(2008-1#1)(2008-11#1)(2010-11#1)(2013-1#1)(2013-8#1)
adverse reactions and##2##3##(1997-1#1)(2008-5#1)
adverse reactions to##2##3##(1995-11#1)(2008-11#1)
adverse reactions##16##2##(1992-3#1)(1995-11#1)(1996-8#1)(1997-1#1)(1997-7#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#2)(2008-8#1)(2010-6#1)(2013-8#1)
adverse respiratory outcomes at 15 months##2##6##(2010-6#2)
adverse respiratory outcomes##3##3##(2010-6#3)
adverse respiratory##4##2##(2008-11#1)(2010-6#3)
adverse selection##2##2##(1996-3#1)(1997-3#1)
adverse##290##1##(1990-9#1)(1991-1#3)(1991-2#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-4#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-3#4)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#4)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#57)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#12)(2008-8#18)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#28)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#10)(2013-1#18)(2013-8#9)
adversely affect the##4##3##(1990-6#1)(2008-10#1)(2008-4#1)(2010-9#1)
adversely affect##11##2##(1990-6#1)(1991-1#1)(1993-2#2)(2008-10#2)(2008-4#1)(2009-5#1)(2010-11#1)(2010-9#1)(2012-12#1)
adversely affected by##6##3##(1992-2#1)(2008-11#1)(2008-6#1)(2009-10#1)(2012-4#1)(2013-8#1)
adversely affected##8##2##(1992-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-10#1)(2012-4#1)(2013-8#1)
adversely affects##2##2##(1994-2#1)(2008-10#1)
adversely effect##2##2##(1995-2#1)(2010-4#1)
adversely##26##1##(1990-6#1)(1991-1#1)(1992-2#1)(1993-2#2)(1994-2#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-4#1)(2013-8#1)
advertised##3##1##(1990-6#3)
advertisements##4##1##(1997-6#1)(2008-11#1)(2008-8#1)(2009-4#1)
advertising campaign##3##2##(1995-1#1)(1995-5#1)(1997-6#1)
advertising##6##1##(1990-2#1)(1995-1#1)(1995-5#1)(1997-6#2)(2011-1#1)
advice and##7##2##(1990-3#1)(1992-2#1)(1996-3#1)(1996-6#1)(2008-12#1)(2008-9#1)(2012-2#1)
advice by##3##2##(1996-8#1)(2011-2#2)
advice in##2##2##(1993-1#1)(2008-11#1)
advice on##3##2##(1991-12#1)(1997-8#1)(2008-11#1)
advice regarding##3##2##(2008-11#2)(2008-7#1)
advice to the##3##3##(1991-6#1)(2008-12#1)(2013-8#1)
advice to##4##2##(1991-6#1)(2008-12#1)(2009-9#1)(2013-8#1)
advice##36##1##(1990-3#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-12#1)(1995-1#1)(1995-6#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-2#3)(2012-2#1)(2013-8#1)
advisable to##4##2##(1996-6#1)(2008-12#1)(2013-1#2)
advisable##10##1##(1990-9#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#3)
advised about the##2##3##(1994-3#1)(2008-10#1)
advised to##12##2##(1996-11#1)(1997-4#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
advised##26##1##(1991-6#1)(1994-3#1)(1996-11#2)(1997-4#2)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
adviser##2##1##(1994-5#1)(1996-8#1)
advises##3##1##(1993-3#1)(1994-12#1)(2008-8#1)
advising##4##1##(1993-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
advisors to##2##2##(1995-12#1)(2008-11#1)
advisors##11##1##(1995-12#3)(1997-2#2)(2008-11#4)(2011-2#1)(2012-2#1)
advisory committee##2##2##(1996-2#1)(1996-3#1)
advisory##10##1##(1991-9#1)(1993-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(2008-11#1)(2008-5#2)(2013-1#1)
advocacy and##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
advocacy for##2##2##(1994-3#1)(2013-1#1)
advocacy groups##2##2##(1995-6#1)(2012-2#1)
advocacy in##2##2##(2009-12#1)(2012-3#1)
advocacy of##2##2##(2010-2#1)(2012-2#1)
advocacy##26##1##(1994-12#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-1#2)(2008-10#2)(2008-11#3)(2008-4#1)(2009-12#8)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
advocate a more##2##3##(1995-5#1)(1997-8#1)
advocate and##2##2##(2008-11#1)(2010-1#1)
advocate for##3##2##(2009-5#1)(2009-7#1)(2013-1#1)
advocate the##2##2##(1990-9#1)(2012-3#1)
advocate##27##1##(1990-9#1)(1991-6#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
advocated as a##3##3##(1991-12#1)(2008-11#1)(2010-2#1)
advocated as##6##2##(1991-12#1)(1997-5#1)(2008-11#2)(2008-7#1)(2010-2#1)
advocated by##4##2##(1990-9#1)(1993-12#1)(2008-11#2)
advocated that##3##2##(1992-3#1)(1997-7#1)(2008-8#1)
advocated to##3##2##(1991-3#1)(1991-6#1)(2012-2#1)
advocated##28##1##(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#5)(2008-4#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
advocates of##2##2##(1992-1#1)(2013-8#1)
advocates##11##1##(1991-1#1)(1992-1#3)(1992-2#1)(2008-11#2)(2008-12#1)(2009-7#1)(2010-6#1)(2013-8#1)
advocating the##2##2##(2008-10#1)(2008-11#1)
advocating##7##1##(1991-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
aecial##2##1##(2008-10#2)
aeciospores##4##1##(2008-10#4)
aedeagi##3##1##(2008-8#3)
aequorin##2##1##(1990-8#2)
aerated##4##1##(2008-10#4)
aeration and##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
aeration##12##1##(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#3)(2010-11#3)(2012-2#1)
aerial diseases##2##2##(2008-10#2)
aerial dissemination##2##2##(2008-10#2)
aerial growth##2##2##(2008-10#1)(2012-2#1)
aerial hyphae##2##2##(2008-8#1)(2012-2#1)
aerial oxidation##2##2##(2008-10#2)
aerial parts of the##2##4##(2008-10#1)(2008-12#1)
aerial parts of##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
aerial parts##6##2##(2008-10#3)(2008-11#2)(2008-12#1)
aerial##27##1##(1997-7#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-8#2)(2012-2#2)
aero-optic linking equation to a##2##5##(2008-3#2)
aero-optic linking equation##3##3##(2008-3#3)
aeroallergens in##2##2##(2008-5#1)(2013-1#1)
aeroallergens##5##1##(2008-5#4)(2013-1#1)
aerobic and anaerobic##2##3##(2013-8#2)
aerobic and##5##2##(2013-1#3)(2013-8#2)
aerobic bacteria in##2##3##(2008-5#1)(2011-1#1)
aerobic bacteria##6##2##(1991-3#1)(2008-10#2)(2008-5#1)(2011-1#2)
aerobic conditions##4##2##(1993-8#1)(2008-10#3)
aerobic coryneform##4##2##(2008-5#4)
aerobic coryneforms##3##2##(2008-5#3)
aerobic endospore-forming bacteria##4##3##(2008-10#4)
aerobic fitness level##3##3##(2013-8#3)
aerobic fitness##4##2##(2012-2#1)(2013-8#3)
aerobic metabolism##2##2##(2008-11#1)(2008-7#1)
aerobic or##2##2##(1996-12#1)(2013-1#1)
aerobic training group##2##3##(2013-1#2)
aerobic training##5##2##(2013-1#5)
aerobic##62##1##(1991-3#1)(1993-8#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#8)(2008-6#1)(2008-7#2)(2009-1#2)(2010-12#1)(2011-1#3)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#14)(2013-8#8)
aerobiological##2##1##(2008-5#1)(2010-5#1)
aerodigestive tract##2##2##(1992-9#1)(2009-5#1)
aerodigestive##3##1##(1992-9#2)(2009-5#1)
aerodynamic diameter##6##2##(1992-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)
aerodynamic##15##1##(1992-2#1)(1992-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-3#4)
aeromedical##2##1##(2012-3#2)
aerosol administration##2##2##(1996-3#1)(1997-1#1)
aerosol and##8##2##(1991-1#1)(1992-3#1)(1995-3#1)(2008-10#2)(2008-3#3)
aerosol backscatter measurements##2##3##(2008-2#1)(2008-3#1)
aerosol backscatter##6##2##(2008-2#3)(2008-3#3)
aerosol bolus dispersion##3##3##(1997-2#3)
aerosol bolus##5##2##(1997-1#2)(1997-2#3)
aerosol by##5##2##(1993-2#1)(1995-3#1)(2008-10#3)
aerosol containment##3##2##(2008-9#3)
aerosol could be##2##3##(1994-12#2)
aerosol defense sprays##2##3##(2008-10#2)
aerosol delivery of##2##3##(1997-1#2)
aerosol delivery system##2##3##(1992-3#2)
aerosol delivery systems##3##3##(1992-3#1)(1995-3#1)(1997-1#1)
aerosol delivery##11##2##(1992-3#5)(1994-12#1)(1995-3#2)(1997-1#3)
aerosol deposition##2##2##(2008-10#1)(2008-11#1)
aerosol extinction and##3##3##(2008-3#3)
aerosol extinction coefficient spectra##2##4##(2008-3#2)
aerosol extinction coefficient##3##3##(2008-3#3)
aerosol extinction##10##2##(2008-2#1)(2008-3#9)
aerosol generation and##2##3##(1992-3#1)(2008-10#1)
aerosol generation##3##2##(1992-3#1)(1995-3#1)(2008-10#1)
aerosol in##2##2##(1995-3#1)(1996-3#1)
aerosol inhaled&quot##4##2##(1992-3#4)
aerosol mass##2##2##(1996-3#1)(2008-11#1)
aerosol monitoring##2##2##(2008-3#1)(2008-5#1)
aerosol optical##4##2##(2008-2#1)(2008-3#3)
aerosol particles in##2##3##(1994-12#1)(2008-10#1)
aerosol particles with##2##3##(1996-2#1)(2008-3#1)
aerosol particles##11##2##(1994-12#1)(1996-1#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)
aerosol properties##2##2##(2008-3#2)
aerosol remote sensing over land##2##5##(2008-3#2)
aerosol research##2##2##(1994-1#1)(2008-10#1)
aerosol samples##5##2##(2008-10#4)(2008-3#1)
aerosol size distributions##3##3##(2008-3#3)
aerosol size##5##2##(2008-3#5)
aerosol systems##2##2##(1992-3#2)
aerosol therapy##3##2##(1992-3#1)(1994-12#1)(1997-1#1)
aerosol was##3##2##(1992-2#1)(1994-12#2)
aerosol##200##1##(1990-5#2)(1991-1#3)(1992-2#2)(1992-3#22)(1993-2#2)(1994-1#3)(1994-12#8)(1994-2#1)(1995-2#1)(1995-3#10)(1996-1#2)(1996-2#6)(1996-3#10)(1997-1#12)(1997-2#4)(2008-10#28)(2008-11#8)(2008-2#8)(2008-3#58)(2008-5#3)(2008-7#1)(2008-9#5)(2013-1#1)
aerosol's##2##1##(2008-3#2)
aerosol-derived airway morphometry##5##3##(1996-2#2)(1997-2#3)
aerosol-soot mixtures##3##2##(2008-3#3)
aerosol-volume##2##1##(2008-3#2)
aerosolization of##3##2##(1993-2#3)
aerosolization##4##1##(1993-2#4)
aerosolized##9##1##(1992-2#1)(1993-2#1)(1994-12#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#1)
aerosols and##7##2##(1996-1#1)(1997-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
aerosols at##2##2##(2008-3#2)
aerosols by##3##2##(1992-2#1)(1992-3#1)(2008-10#1)
aerosols can be##2##3##(2008-10#1)(2008-3#1)
aerosols in the##5##3##(1992-3#1)(1995-3#1)(1997-1#1)(2008-3#1)(2013-1#1)
aerosols in##11##2##(1992-3#3)(1995-3#1)(1997-1#1)(2008-10#2)(2008-3#2)(2013-1#2)
aerosols is##2##2##(2008-11#1)(2008-3#1)
aerosols of##3##2##(1996-1#2)(1997-1#1)
aerosols produced by jet##2##4##(1991-1#1)(1995-3#1)
aerosols to##4##2##(1994-12#2)(1996-1#1)(1997-2#1)
aerosols were##4##2##(1992-2#1)(1994-12#1)(1996-1#1)(2008-3#1)
aerosols with the##3##3##(1997-1#1)(2008-3#2)
aerosols with##5##2##(1997-1#1)(2008-2#1)(2008-3#3)
aerosols##93##1##(1991-1#1)(1992-2#4)(1992-3#8)(1994-12#3)(1995-3#2)(1996-1#9)(1996-2#1)(1996-3#1)(1997-1#7)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-2#6)(2008-3#27)(2008-7#1)(2008-9#3)(2012-2#1)(2013-1#4)
aeruginosa KM110##2##2##(2012-2#2)
aeruginosa lasR mutant containing a plasmid with lasR under the control of##2##12##(1995-2#2)
aeruginosa##49##1##(1991-3#1)(1995-2#8)(2008-10#8)(2008-11#1)(2008-7#4)(2009-6#7)(2011-2#4)(2012-2#13)(2013-1#2)(2013-8#1)
aesculetin##3##1##(2008-10#3)
aesculin and##4##2##(2008-10#4)
aesthetascs and##3##2##(2007-12#3)
aesthetascs##4##1##(2007-12#4)
aesthetic mate preferences##2##3##(2008-9#2)
aesthetic preferences##2##2##(2008-9#2)
aesthetic##13##1##(1990-9#1)(1992-9#1)(2008-5#1)(2008-6#1)(2008-9#5)(2010-6#1)(2012-3#1)(2013-1#2)
aestivum##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
aestivum)##14##1##(2008-10#11)(2008-11#1)(2008-12#1)(2008-9#1)
aestivum-Ag##2##1##(2008-8#2)
aetiological agent##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
aetiological##8##1##(1991-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
aetiologies and##2##2##(2008-12#1)(2012-2#1)
aetiologies##7##1##(1995-10#2)(2008-12#1)(2008-9#1)(2010-10#1)(2012-2#2)
aetiology and##7##2##(1991-6#1)(1997-1#1)(2008-12#2)(2008-7#1)(2010-12#1)(2012-2#1)
aetiology of cardiac##2##3##(2008-10#1)(2011-2#1)
aetiology of##18##2##(1992-5#1)(1997-1#1)(1997-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-2#1)
aetiology##37##1##(1991-6#1)(1992-5#3)(1993-6#2)(1996-3#1)(1997-1#2)(1997-8#2)(2008-10#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#5)(2012-2#4)
afarensis##3##1##(1994-3#3)
affairs##5##1##(1992-1#1)(1997-2#1)(2008-11#2)(2011-2#1)
affect a large proportion of the##2##6##(2010-10#1)(2013-8#1)
affect a##7##2##(2008-10#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2013-7#1)(2013-8#1)
affect and##3##2##(2009-11#1)(2010-1#1)(2011-2#1)
affect bacterial##3##2##(2008-10#2)(2012-2#1)
affect behavior##2##2##(1993-12#1)(2008-11#1)
affect bone##2##2##(1991-11#1)(2011-2#1)
affect both##2##2##(1994-9#1)(2011-2#1)
affect brain##2##2##(2012-12#1)(2013-1#1)
affect cell growth##3##3##(1995-6#1)(2008-11#1)(2011-2#1)
affect cell##5##2##(1995-6#1)(1996-12#1)(2008-11#1)(2009-7#1)(2011-2#1)
affect cellular##2##2##(1991-5#1)(2008-10#1)
affect each##2##2##(2008-8#1)(2009-10#1)
affect fitness##2##2##(2008-8#2)
affect growth rate##3##3##(1996-3#1)(2007-11#2)
affect growth##5##2##(1996-3#1)(2007-11#2)(2008-10#1)(2011-1#1)
affect health##2##2##(2009-3#1)(2013-1#1)
affect host##2##2##(2008-10#1)(2012-3#1)
affect maximum##2##2##(2008-10#1)(2008-11#1)
affect on##2##2##(2008-10#1)(2008-12#1)
affect overall##2##2##(2008-7#1)(2012-2#1)
affect patient##3##2##(1993-2#1)(2010-11#1)(2010-3#1)
affect regulation##3##2##(2009-11#1)(2013-1#2)
affect sexual trait expression##2##4##(2012-3#2)
affect sexual trait##3##3##(2012-3#3)
affect sexual##5##2##(1993-8#1)(2008-7#1)(2012-3#3)
affect social##2##2##(2008-11#1)(2008-8#1)
affect the ability of##3##4##(2008-10#2)(2008-8#1)
affect the ability##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
affect the accuracy of##2##4##(2008-10#2)
affect the accuracy##3##3##(2008-10#3)
affect the activity of##2##4##(1990-5#1)(1992-3#1)
affect the association##2##3##(2008-12#1)(2009-8#1)
affect the care##2##3##(1991-3#1)(1995-2#1)
affect the choice of##2##4##(1993-1#1)(2008-10#1)
affect the course of##2##4##(1997-6#1)(2012-3#1)
affect the development of##2##4##(1991-8#1)(2008-11#1)
affect the evolution of##2##4##(2008-8#2)
affect the expression of##3##4##(1995-2#1)(2008-8#2)
affect the expression##4##3##(1995-2#1)(2008-6#1)(2008-8#2)
affect the extraction##2##3##(2008-10#2)
affect the fluorescence##2##3##(1994-5#1)(2008-9#1)
affect the level of##2##4##(2008-10#1)(2008-8#1)
affect the maximum##2##3##(2008-10#1)(2008-11#1)
affect the measurement##2##3##(2008-8#1)(2012-2#1)
affect the outcome of##2##4##(1993-11#1)(2008-5#1)
affect the overall##3##3##(1991-2#1)(1991-3#1)(2011-2#1)
affect the performance of##6##4##(2008-10#4)(2008-2#2)
affect the performance##7##3##(2008-10#4)(2008-2#2)(2009-8#1)
affect the quality of life##2##5##(2008-12#1)(2008-5#1)
affect the quality of##4##4##(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)
affect the relative intensity of sexual selection##2##7##(2008-8#2)
affect the response of##2##4##(2008-10#1)(2008-4#1)
affect the response##4##3##(2008-10#1)(2008-11#2)(2008-4#1)
affect the responses##2##3##(1990-11#1)(1990-5#1)
affect the sensitivity##2##3##(2008-10#2)
affect the size of##2##4##(1991-2#1)(2008-10#1)
affect the size##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
affect the spatial##2##3##(2008-10#1)(2008-8#1)
affect the survival of##3##4##(2008-10#2)(2009-10#1)
affect the virus##2##3##(2008-10#1)(2008-11#1)
affect the##237##2##(1990-11#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1993-1#1)(1993-11#2)(1993-8#2)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#67)(2008-11#19)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#18)(2008-9#6)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-2#6)(2012-2#6)(2012-3#6)(2012-5#1)(2013-1#5)
affect their##10##2##(1993-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-2#1)(2013-1#1)
affect this##5##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
affect your##2##2##(1993-2#1)(2008-10#1)
affect##516##1##(1990-11#2)(1990-3#1)(1990-5#3)(1990-6#1)(1991-1#3)(1991-11#1)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-8#4)(1994-9#1)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#6)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#2)(2007-11#2)(2008-1#1)(2008-10#115)(2008-11#45)(2008-12#7)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#11)(2008-8#35)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#6)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#10)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#7)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#3)(2011-1#4)(2011-2#22)(2012-12#6)(2012-2#20)(2012-3#16)(2012-5#2)(2013-1#16)(2013-7#1)(2013-8#6)
affected (P##2##2##(1991-9#1)(2012-2#1)
affected all##2##2##(2008-11#1)(2011-2#1)
affected and##3##2##(2008-11#1)(2010-7#1)(2011-2#1)
affected areas##5##2##(1993-3#1)(2010-1#1)(2011-2#3)
affected both by##2##3##(2007-11#1)(2008-10#1)
affected both the##3##3##(1996-2#1)(2008-10#2)
affected both##7##2##(1996-2#1)(2007-11#1)(2008-10#5)
affected by &quot##2##3##(1993-2#1)(1993-3#1)
affected by a##6##3##(1990-8#1)(1994-11#1)(1997-8#1)(2008-11#1)(2008-9#1)(2013-1#1)
affected by an##4##3##(1990-3#1)(1995-5#1)(2009-6#1)(2012-3#1)
affected by both##2##3##(2008-10#2)
affected by changes in##3##4##(2008-10#2)(2011-2#1)
affected by competition##2##3##(2008-8#1)(2009-10#1)
affected by different##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
affected by environmental##2##3##(2008-10#1)(2013-1#1)
affected by increased metabolic load##2##5##(2008-11#2)
affected by increased##3##3##(2008-10#1)(2008-11#2)
affected by interferences##2##3##(2008-10#2)
affected by matrix##2##3##(2008-10#2)
affected by peri-implantitis##3##3##(2013-1#3)
affected by soil##2##3##(2008-10#1)(2013-8#1)
affected by such experiences##2##4##(1992-2#1)(2008-11#1)
affected by such##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
affected by temperature##5##3##(2008-10#5)
affected by the C-domain of##2##5##(2008-9#2)
affected by the amount of##2##5##(2008-10#2)
affected by the change##2##4##(1992-1#1)(2008-3#1)
affected by the concentration of##2##5##(1990-6#1)(2008-10#1)
affected by the degree of##2##5##(2008-10#2)
affected by the disease##3##4##(2008-10#3)
affected by the matrix and##2##5##(2008-10#2)
affected by the matrix##4##4##(2008-10#3)(2010-11#1)
affected by the presence of other##3##6##(2008-10#3)
affected by the presence of##8##5##(1995-12#1)(2008-10#5)(2008-11#2)
affected by the##67##3##(1990-11#2)(1990-6#1)(1991-12#1)(1992-1#1)(1992-3#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-8#1)(2008-10#33)(2008-11#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#4)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
affected by these##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
affected by this##3##3##(1990-9#1)(1994-11#1)(2013-8#1)
affected by##272##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#4)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-2#2)(1993-3#3)(1993-6#3)(1994-11#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-8#3)(2008-10#93)(2008-11#24)(2008-12#7)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#11)(2009-10#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#3)(2010-7#1)(2010-8#2)(2011-10#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2012-7#1)(2013-1#13)(2013-8#5)
affected countries##2##2##(2011-2#2)
affected during##3##2##(2011-2#2)(2012-3#1)
affected in their##2##3##(2008-10#2)
affected in##14##2##(1992-3#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-12#1)(2008-9#1)(2011-2#1)(2012-9#1)
affected individual##2##2##(1997-3#1)(2008-7#1)
affected individuals##5##2##(1990-12#1)(1996-12#1)(1997-3#2)(2009-6#1)
affected mainly##5##2##(2008-10#4)(2013-1#1)
affected members of##3##3##(1995-8#1)(1997-7#1)(1997-8#1)
affected members##4##2##(1995-8#1)(1997-7#1)(1997-8#1)(2008-7#1)
affected more##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
affected muscle##2##2##(2013-1#2)
affected neither in##2##3##(1992-1#1)(2008-10#1)
affected neither##5##2##(1992-1#1)(2008-10#2)(2008-7#1)(2010-11#1)
affected patients##5##2##(2008-1#1)(2008-11#1)(2008-7#2)(2009-8#1)
affected pregnancies##2##2##(2008-1#1)(2010-11#1)
affected production##2##2##(1997-3#1)(2008-10#1)
affected sibpair##3##2##(2008-9#3)
affected significantly (P &lt##3##4##(1996-6#1)(2008-10#2)
affected significantly by##2##3##(2008-10#1)(2008-9#1)
affected significantly##6##2##(1996-6#1)(2008-10#3)(2008-9#1)(2011-2#1)
affected than##2##2##(2008-10#1)(2008-11#1)
affected the expected##2##3##(2008-10#1)(2008-9#1)
affected the expression##2##3##(2008-10#1)(2008-8#1)
affected the relationship between##2##4##(2008-10#2)
affected the relative##2##3##(2008-10#2)
affected the##55##2##(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-5#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#2)(2011-10#1)(2011-2#3)(2012-2#1)(2012-5#1)(2013-1#3)
affected their##2##2##(1993-3#1)(2012-12#1)
affected tissues and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
affected tissues##4##2##(2008-10#1)(2011-2#1)(2012-12#2)
affected when##3##2##(2008-10#2)(2008-7#1)
affected with a##2##3##(1992-2#1)(1993-6#1)
affected with##6##2##(1992-2#1)(1993-6#2)(2008-5#1)(2011-3#1)(2012-2#1)
affected women##2##2##(2008-1#1)(2010-11#1)
affected##622##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#5)(1993-2#2)(1993-3#9)(1993-6#5)(1993-8#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-12#4)(1996-2#4)(1996-3#2)(1996-6#3)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#5)(2007-11#1)(2007-8#1)(2008-1#6)(2008-10#191)(2008-11#43)(2008-12#12)(2008-3#5)(2008-4#4)(2008-5#20)(2008-6#2)(2008-7#15)(2008-8#13)(2008-9#19)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#9)(2010-12#2)(2010-2#3)(2010-4#3)(2010-7#2)(2010-8#4)(2011-1#2)(2011-10#2)(2011-2#40)(2011-3#1)(2012-12#5)(2012-2#9)(2012-3#8)(2012-4#1)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#25)(2013-8#7)
affecting a##5##2##(2008-10#4)(2011-2#1)
affecting both crops##2##3##(2008-10#2)
affecting both the##2##3##(2008-10#1)(2010-5#1)
affecting both##7##2##(1993-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-5#1)
affecting cell growth##2##3##(2008-11#2)
affecting cell##3##2##(2008-11#3)
affecting children and##2##3##(2013-1#2)
affecting disease##2##2##(2008-10#1)(2012-2#1)
affecting in particular##2##3##(1997-8#1)(2008-5#1)
affecting intracellular##2##2##(1995-8#1)(2008-6#1)
affecting its##2##2##(2012-3#2)
affecting men##2##2##(2008-5#2)
affecting research##2##2##(2008-11#2)
affecting the binding of##3##4##(1993-3#1)(1994-6#1)(2008-10#1)
affecting the cell##2##3##(2008-11#2)
affecting the chemiluminescence##2##3##(2008-10#2)
affecting the enzymatic hydrolysis##2##4##(2008-10#2)
affecting the extraction efficiency##2##4##(2008-10#2)
affecting the extraction##3##3##(2008-10#3)
affecting the mandibular##2##3##(2011-2#1)(2013-1#1)
affecting the progression of##2##4##(1994-5#1)(2011-2#1)
affecting the reaction##2##3##(2008-10#2)
affecting the response##2##3##(2008-10#2)
affecting the sensitivity of the##2##5##(2008-10#2)
affecting the sensitivity of##3##4##(2008-10#3)
affecting the separation##2##3##(2008-10#2)
affecting the##128##2##(1991-11#2)(1991-12#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-3#2)(1993-6#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-3#2)(1997-8#2)(2008-1#3)(2008-10#65)(2008-11#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-3#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-3#4)(2013-1#6)(2013-8#1)
affecting their##4##2##(1997-3#1)(2008-10#2)(2008-8#1)
affecting these##2##2##(1995-1#1)(2011-2#1)
affecting this##2##2##(2008-10#1)(2011-2#1)
affecting##278##1##(1990-12#1)(1990-6#1)(1991-11#2)(1991-12#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#4)(1994-3#3)(1994-5#3)(1994-6#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#4)(2008-1#5)(2008-10#107)(2008-11#11)(2008-12#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#6)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#14)(2012-12#2)(2012-2#6)(2012-3#10)(2013-1#14)(2013-7#1)(2013-8#3)
affection of the##3##3##(1991-11#1)(1991-6#2)
affection##9##1##(1990-3#1)(1991-11#1)(1991-6#2)(2007-8#1)(2008-12#2)(2010-11#1)(2013-1#1)
affections from##2##2##(2013-1#2)
affections##4##1##(1990-3#1)(2008-10#1)(2013-1#2)
affective and##2##2##(2008-11#1)(2012-2#1)
affective disorders##3##2##(1991-11#1)(1996-12#1)(2013-1#1)
affective fronto-limbic circuitry##2##3##(2013-8#2)
affective state and##2##3##(2008-4#1)(2013-1#1)
affective symptoms##3##2##(2013-8#3)
affective##35##1##(1991-11#1)(1991-2#1)(1993-12#1)(1993-6#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-1#4)(2008-11#5)(2008-12#1)(2008-4#1)(2008-8#1)(2010-1#1)(2010-6#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#8)
affects approximately##3##2##(2009-9#1)(2012-12#1)(2012-3#1)
affects both the##2##3##(2008-3#1)(2009-8#1)
affects both##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
affects brain##2##2##(2009-12#1)(2013-1#1)
affects control##2##2##(2008-10#1)(2008-8#1)
affects how##2##2##(1993-3#1)(2008-11#1)
affects its##2##2##(2008-10#1)(2008-8#1)
affects mainly##2##2##(1997-8#1)(2007-12#1)
affects many##4##2##(2008-10#2)(2010-4#1)(2012-3#1)
affects patient##2##2##(1991-3#1)(2011-2#1)
affects patients##2##2##(2009-8#1)(2011-2#1)
affects plant##2##2##(2009-8#2)
affects several##2##2##(1995-2#1)(2008-10#1)
affects sexual##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
affects the development##2##3##(2012-12#1)(2012-3#1)
affects the expression of the##2##5##(1997-8#1)(2008-9#1)
affects the expression of##3##4##(1997-8#1)(2008-9#2)
affects the##58##2##(1990-12#2)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#3)(1994-9#1)(1995-3#1)(1995-9#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-3#1)(2008-8#5)(2008-9#4)(2009-2#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#3)
affects their##2##2##(2008-10#1)(2012-2#1)
affects##182##1##(1990-12#3)(1990-8#1)(1991-3#2)(1992-12#1)(1992-3#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#3)(2007-12#3)(2008-1#1)(2008-10#25)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#4)(2008-7#3)(2008-8#18)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#18)(2012-12#2)(2012-2#10)(2012-3#10)(2012-6#1)(2013-1#6)(2013-8#4)
afferent fibers##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
afferent fibres##2##2##(1996-2#1)(1997-3#1)
afferent neurons##5##2##(1995-12#2)(1996-12#1)(1997-3#1)(2008-12#1)
afferent pathways##2##2##(1995-3#1)(2008-5#1)
afferent signals##2##2##(2008-11#2)
afferent##30##1##(1990-5#1)(1992-6#2)(1995-12#4)(1995-3#1)(1996-12#1)(1996-2#2)(1997-3#6)(1997-4#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
afferents are##2##2##(1997-3#2)
afferents of the##3##3##(1997-2#2)(1997-3#1)
afferents##20##1##(1991-2#1)(1992-6#2)(1993-6#1)(1994-3#1)(1994-8#1)(1997-2#7)(1997-3#5)(2008-11#1)(2013-8#1)
affiliated hospitals##2##2##(1995-1#1)(2010-12#1)
affiliated with##4##2##(2007-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
affiliated##9##1##(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
affiliation of the##3##3##(2008-12#2)(2009-6#1)
affiliation of##5##2##(1993-12#1)(2008-12#2)(2008-9#1)(2009-6#1)
affiliation##17##1##(1990-9#1)(1993-12#5)(1996-1#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)
affiliations and##2##2##(1993-12#1)(2008-12#1)
affiliations##5##1##(1990-11#1)(1993-12#1)(1996-3#1)(2008-10#1)(2008-12#1)
affiliative##2##1##(1996-3#1)(2008-11#1)
affinities and##2##2##(1995-11#1)(2010-7#1)
affinities for the##2##3##(1990-11#1)(1990-12#1)
affinities for##8##2##(1990-11#2)(1990-12#1)(1991-5#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)
affinities of the##2##3##(2008-10#1)(2009-12#1)
affinities of##11##2##(1990-11#2)(1991-9#1)(1993-6#1)(1993-8#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#1)
affinities to##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
affinities##37##1##(1990-11#4)(1990-12#1)(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#4)(1994-2#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#2)(2008-10#6)(2008-11#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)
affinity (Kd = 0##5##4##(1994-8#4)(1995-12#1)
affinity (Kd =##7##3##(1994-8#4)(1995-11#1)(1995-12#1)(1996-2#1)
affinity (Kd##9##2##(1990-11#2)(1994-8#4)(1995-11#1)(1995-12#1)(1996-2#1)
affinity adsorbents##2##2##(1997-2#2)
affinity and high##2##3##(1993-1#1)(1993-8#1)
affinity and selectivity##2##3##(2008-10#1)(2012-2#1)
affinity and total binding##2##4##(1993-6#2)
affinity and##21##2##(1993-1#4)(1993-6#2)(1993-8#1)(1994-5#2)(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#2)(2011-2#1)(2012-2#2)
affinity between the##2##3##(2008-10#1)(2009-3#1)
affinity between##5##2##(2008-10#3)(2009-3#1)(2012-2#1)
affinity binding##6##2##(1993-1#2)(1994-8#1)(1997-4#2)(2009-12#1)
affinity by##3##2##(1993-8#2)(2012-2#1)
affinity chromatography also##2##3##(1995-6#1)(2008-10#1)
affinity chromatography and##5##3##(1991-9#1)(1992-6#1)(1997-2#1)(2008-8#2)
affinity chromatography on a##2##4##(1997-2#1)(2008-4#1)
affinity chromatography on##6##3##(1993-8#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-4#1)(2009-9#1)
affinity chromatography was used to##2##5##(1997-7#1)(2008-9#1)
affinity chromatography with##3##3##(2008-10#2)(2008-11#1)
affinity chromatography##45##2##(1990-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#3)(1995-8#1)(1996-12#3)(1997-2#3)(1997-7#1)(2008-10#7)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#5)(2009-3#1)(2009-9#1)(2011-2#1)
affinity column##3##2##(1991-5#1)(1992-9#1)(1995-2#1)
affinity columns##2##2##(1994-11#1)(2008-10#1)
affinity constant of##4##3##(2008-10#4)
affinity constant##11##2##(1991-5#1)(2008-10#9)(2008-11#1)
affinity for ATP##2##3##(1993-6#2)
affinity for Blue Sepharose##2##4##(1990-12#1)(1997-1#1)
affinity for alkali##3##3##(2008-10#3)
affinity for the protein##2##4##(1995-2#1)(2008-10#1)
affinity for the##20##3##(1992-11#1)(1994-11#3)(1994-8#1)(1995-11#4)(1995-2#1)(2008-10#6)(2008-11#1)(2008-6#1)(2009-7#1)(2010-10#1)
affinity for##72##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-6#3)(1993-6#2)(1993-8#1)(1994-11#4)(1994-5#2)(1994-8#1)(1995-11#6)(1995-2#3)(1995-6#3)(1996-12#1)(1996-2#1)(1997-1#2)(2008-10#22)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
affinity impurities##2##2##(2008-7#2)
affinity in a##2##3##(1992-3#1)(2008-10#1)
affinity in##3##2##(1992-3#1)(1995-8#1)(2008-10#1)
affinity labeled##2##2##(1995-11#2)
affinity labelled##2##2##(1990-11#2)
affinity matrix##5##2##(1994-8#2)(2008-4#3)
affinity maturation##2##2##(2008-8#2)
affinity of an##2##3##(1990-8#1)(1993-8#1)
affinity of the##12##3##(1991-12#1)(1993-6#1)(1993-8#2)(1994-5#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-1#1)
affinity of these##2##3##(2008-10#1)(2008-11#1)
affinity of##41##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#2)(1993-6#2)(1993-8#4)(1994-5#3)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-1#1)(2011-2#1)
affinity purification##4##2##(1993-8#1)(2008-10#1)(2008-4#2)
affinity purified##2##2##(1990-8#1)(2010-3#1)
affinity selection##3##2##(2008-1#2)(2008-4#1)
affinity site (Kd =##2##4##(1996-2#2)
affinity site##3##2##(1995-11#1)(1996-2#2)
affinity sites##2##2##(1995-11#1)(1995-6#1)
affinity support##3##2##(1993-8#3)
affinity than##3##2##(1995-11#1)(1995-6#2)
affinity to the##2##3##(1996-12#1)(1997-3#1)
affinity to##15##2##(1990-5#2)(1993-8#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-3#3)(2008-10#6)
affinity towards##2##2##(1992-6#1)(2008-10#1)
affinity was##4##2##(1992-10#1)(2008-10#1)(2008-8#2)
affinity with##3##2##(2008-10#1)(2008-5#1)(2009-6#1)
affinity##369##1##(1990-11#10)(1990-12#4)(1990-2#3)(1990-5#2)(1990-8#5)(1991-12#4)(1991-5#5)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#9)(1992-9#1)(1993-1#7)(1993-3#1)(1993-6#12)(1993-8#16)(1994-11#7)(1994-5#9)(1994-8#10)(1995-11#18)(1995-12#1)(1995-2#8)(1995-6#14)(1995-8#7)(1996-1#1)(1996-12#6)(1996-2#7)(1996-3#1)(1997-1#4)(1997-2#9)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#3)(2008-10#68)(2008-11#16)(2008-12#1)(2008-4#14)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#14)(2008-9#7)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#4)(2012-2#9)(2013-1#2)(2013-7#1)
affinity-purified##5##1##(1990-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2010-3#1)
affirm that##2##2##(1991-8#1)(2012-2#1)
affirm##5##1##(1991-12#1)(1991-8#1)(1996-3#1)(2012-2#2)
affirmed a lower court's##2##4##(1995-6#2)
affirmed##4##1##(1995-12#1)(1995-6#2)(2008-9#1)
affirms##2##1##(1992-6#1)(1993-12#1)
affixed##2##1##(2008-4#1)(2012-3#1)
afflicted##2##1##(1991-6#1)(1995-12#1)
affluence##2##1##(2008-1#1)(2013-1#1)
affluent##4##1##(1997-2#1)(1997-7#1)(2008-11#1)(2010-9#1)
afford a##3##2##(1991-2#1)(2008-10#1)(2012-12#1)
afford not to##2##3##(1991-2#1)(1994-2#1)
afford the##3##2##(1997-6#1)(2008-11#2)
afford to##2##2##(1993-12#1)(1994-2#1)
afford##21##1##(1991-2#2)(1993-12#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-5#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-11#5)(2009-12#1)(2009-8#1)(2012-12#1)(2012-3#1)
affordability##3##1##(1995-3#1)(2009-3#1)(2012-2#1)
affordable and##3##2##(2008-11#1)(2008-7#1)(2009-6#1)
affordable housing##2##2##(2008-11#2)
affordable to##2##2##(1991-3#1)(1995-6#1)
affordable##15##1##(1991-3#2)(1994-2#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-11#5)(2008-7#1)(2009-6#1)(2010-5#1)(2010-8#1)
afforded a##2##2##(2008-10#1)(2012-12#1)
afforded by the##5##3##(1996-1#1)(1996-12#1)(2008-10#3)
afforded by##10##2##(1996-1#1)(1996-12#1)(2008-10#5)(2008-5#3)
afforded the corresponding##2##3##(1996-5#2)
afforded the##6##2##(1996-5#4)(2008-11#1)(2013-1#1)
afforded##31##1##(1992-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#6)(1997-4#1)(2008-10#12)(2008-11#1)(2008-5#3)(2009-6#1)(2010-6#1)(2012-12#1)(2013-1#1)
affording##5##1##(1992-8#1)(1996-5#2)(2008-10#1)(2008-11#1)
affords##14##1##(1991-6#1)(1992-3#1)(1996-5#2)(2008-10#5)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#2)
afimbrial mutants##2##2##(2008-10#2)
afimbrial##4##1##(2008-10#4)
aflatoxin M1##8##2##(2008-12#2)(2013-1#6)
aflatoxin accumulation in grain##2##4##(2008-10#2)
aflatoxin accumulation##8##2##(2008-10#8)
aflatoxin biosynthesis##2##2##(2008-10#2)
aflatoxin concentration in grain##2##4##(2008-10#2)
aflatoxin concentration##3##2##(2008-10#3)
aflatoxin contamination in the##2##4##(2008-10#2)
aflatoxin contamination in##3##3##(2008-10#3)
aflatoxin contamination of##2##3##(2008-10#2)
aflatoxin contamination##9##2##(2008-10#9)
aflatoxin content of##2##3##(2008-10#2)
aflatoxin content##6##2##(2008-10#6)
aflatoxin in maize##3##3##(2008-10#3)
aflatoxin in##6##2##(2008-10#6)
aflatoxin production and##4##3##(2008-10#4)
aflatoxin production in corn (Zea##2##5##(2008-10#2)
aflatoxin production in##5##3##(2008-10#5)
aflatoxin production##15##2##(2008-10#15)
aflatoxin values##2##2##(2008-10#2)
aflatoxin when##2##2##(2008-10#2)
aflatoxin##70##1##(2008-10#62)(2008-12#2)(2013-1#6)
aflatoxins##7##1##(2008-10#5)(2008-12#1)(2010-7#1)
aforementioned##15##1##(1991-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
afraid to##3##2##(1992-9#1)(1995-12#1)(1995-2#1)
african american##2##2##(2009-5#1)(2011-1#1)
african##3##1##(1991-11#1)(2009-5#1)(2011-1#1)
africana##6##1##(2008-10#5)(2012-5#1)
after 1 day##2##3##(2008-10#1)(2008-11#1)
after 1 h##5##3##(1996-2#2)(1997-2#1)(2008-10#1)(2008-5#1)
after 1 month##2##3##(2008-10#2)
after 1 week##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
after 1 year##4##3##(1994-2#1)(2008-10#1)(2010-8#1)(2013-1#1)
after 1##21##2##(1990-12#1)(1994-2#1)(1996-2#2)(1997-2#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#2)(2010-8#1)(2011-2#1)(2013-1#1)
after 1-2##2##2##(2008-11#1)(2008-7#1)
after 10 days##5##3##(1992-12#1)(1995-2#1)(1995-3#1)(2008-10#1)(2010-5#1)
after 10 min##3##3##(2006-6#1)(2008-10#1)(2008-5#1)
after 10 years of##2##4##(1997-5#1)(2010-3#1)
after 10##13##2##(1991-1#1)(1992-12#1)(1995-2#1)(1995-3#1)(1997-5#1)(2006-6#1)(2008-10#4)(2008-5#1)(2010-3#1)(2010-5#1)
after 100##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
after 11 weeks##2##3##(1992-8#1)(2008-10#1)
after 11##3##2##(1992-8#1)(2008-10#2)
after 12 h##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
after 12 hrs##2##3##(1991-3#1)(2008-12#1)
after 12 months##2##3##(1993-1#1)(2012-2#1)
after 12##12##2##(1991-3#1)(1993-1#2)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
after 14 days##3##3##(2008-11#2)(2009-7#1)
after 14 months##2##3##(1991-8#1)(2008-7#1)
after 14 nmol##2##3##(1991-9#2)
after 14##7##2##(1991-8#1)(1991-9#2)(2008-11#2)(2008-7#1)(2009-7#1)
after 15 days##2##3##(2008-10#1)(2008-11#1)
after 15 days' culture##2##4##(2008-11#2)
after 15 min of sitting##2##5##(2010-3#2)
after 15 min of##4##4##(1996-12#1)(2010-3#2)(2011-2#1)
after 15 min##7##3##(1992-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-3#2)(2011-2#1)
after 15##13##2##(1992-8#1)(1996-12#1)(2008-10#3)(2008-11#4)(2010-3#2)(2011-2#2)
after 16##3##2##(1995-12#1)(2008-11#1)(2011-2#1)
after 1992##2##2##(1990-6#1)(1991-3#1)
after 2 and 4##2##4##(1991-6#1)(2008-10#1)
after 2 and##3##3##(1991-6#1)(2008-10#1)(2012-2#1)
after 2 h of##2##4##(1994-8#1)(2008-10#1)
after 2 h##3##3##(1994-8#1)(2008-10#1)(2008-6#1)
after 2 hr##3##3##(1993-8#1)(2008-11#1)(2008-6#1)
after 2 months of##2##4##(1996-12#1)(2008-12#1)
after 2 months##3##3##(1996-12#1)(2008-12#2)
after 2 to##3##3##(1991-8#1)(2008-10#2)
after 2 weeks##8##3##(1997-8#1)(2008-10#5)(2008-11#2)
after 2##32##2##(1991-6#1)(1991-8#1)(1993-8#1)(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#10)(2008-11#6)(2008-12#4)(2008-6#2)(2009-12#1)(2012-2#2)(2013-1#1)
after 2-3 years##2##2##(2013-8#2)
after 20##3##2##(2008-10#2)(2011-2#1)
after 23 days of##2##4##(2008-10#1)(2011-3#1)
after 24 h of##2##4##(1996-12#1)(2008-10#1)
after 24 h##9##3##(1990-12#1)(1996-12#1)(1996-2#1)(2008-10#5)(2013-1#1)
after 24 hours##2##3##(1993-6#1)(2008-5#1)
after 24 hrs##2##3##(2008-12#1)(2010-11#1)
after 24 months of##2##4##(1990-3#1)(1991-12#1)
after 24 months##3##3##(1990-3#1)(1991-12#1)(2008-4#1)
after 24 weeks##3##3##(2008-10#1)(2009-8#2)
after 24##22##2##(1990-12#1)(1990-3#1)(1991-12#1)(1993-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-8#2)(2010-11#1)(2013-1#1)
after 25##3##2##(1993-2#1)(2007-12#1)(2008-11#1)
after 27##2##2##(2008-10#1)(2012-3#1)
after 28##2##2##(1990-6#1)(2008-10#1)
after 3 and##2##3##(2008-10#2)
after 3 days##4##3##(1994-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
after 3 months##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
after 3 years of no tillage##2##6##(2008-10#2)
after 3 years of##3##4##(2008-10#2)(2008-9#1)
after 3##20##2##(1994-11#1)(1994-3#1)(2008-10#11)(2008-12#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
after 30 days##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
after 30 min of##3##4##(2008-10#2)(2008-7#1)
after 30 min##4##3##(1994-8#1)(2008-10#2)(2008-7#1)
after 30##11##2##(1994-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
after 30min##3##2##(2007-12#1)(2008-10#2)
after 35##2##2##(2008-10#1)(2012-3#1)
after 3h of##2##3##(2008-10#2)
after 3h##3##2##(2008-10#3)
after 3 weeks of storage##2##4##(2013-1#2)
after 4 days##2##3##(1990-2#1)(1995-2#1)
after 4 h##2##3##(1995-12#1)(2008-9#1)
after 4 weeks##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
after 4##13##2##(1990-2#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
after 40##3##2##(2008-10#2)(2008-11#1)
after 48 h of##3##4##(1996-2#1)(2008-11#1)(2008-8#1)
after 48 h##9##3##(1995-3#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-8#1)
after 48##13##2##(1991-3#1)(1995-3#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)
after 5 days##5##3##(2008-10#2)(2008-11#1)(2010-12#1)(2010-5#1)
after 5 months of##2##4##(1994-8#1)(2008-10#1)
after 5##11##2##(1990-12#1)(1994-12#1)(1994-8#1)(2008-10#4)(2008-11#2)(2010-12#1)(2010-5#1)
after 6 h##2##3##(1993-8#1)(2008-10#1)
after 6 hours##2##3##(1994-11#1)(2011-2#1)
after 6 hr##3##3##(2008-6#3)
after 6 months in##2##4##(1990-6#1)(2011-2#1)
after 6 months of life##2##5##(2008-10#2)
after 6 months of##3##4##(2007-11#1)(2008-10#2)
after 6 months##9##3##(1990-6#1)(2007-11#1)(2008-10#3)(2011-2#2)(2012-3#1)(2013-1#1)
after 6##23##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-11#1)(1993-8#1)(1994-11#1)(1995-8#1)(2007-11#1)(2008-10#4)(2008-6#3)(2011-2#4)(2012-3#1)(2013-1#3)
after 60 min##3##3##(1995-2#1)(1997-8#1)(2008-10#1)
after 60 s##2##3##(2008-10#2)
after 60##5##2##(1995-2#1)(1997-8#1)(2008-10#3)
after 7 days##5##3##(1990-2#1)(1995-3#1)(1995-8#1)(2008-11#1)(2009-8#1)
after 7##7##2##(1990-2#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#2)(2009-8#1)
after 72 h of##4##4##(1995-8#1)(2008-11#2)(2011-2#1)
after 72 h##6##3##(1995-8#1)(2008-10#2)(2008-11#2)(2011-2#1)
after 72##8##2##(1995-8#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-1#2)
after 8 h of##2##4##(2008-10#1)(2008-11#1)
after 8 months##3##3##(1990-6#1)(2008-10#1)(2010-3#1)
after 8 weeks of##2##4##(2013-1#2)
after 8 weeks##3##3##(2012-3#1)(2013-1#2)
after 8##9##2##(1990-6#1)(2008-10#3)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#2)
after 9 days##2##3##(2008-10#1)(2008-11#1)
after 9##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
after 90 min##2##3##(1992-6#1)(2008-10#1)
after 90##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
after 96##2##2##(1994-11#1)(2008-10#1)
after AAPs of##2##3##(2008-10#2)
after AMI##3##2##(1990-12#2)(1992-3#1)
after AuTM injection##4##3##(1994-5#4)
after B##3##2##(2008-10#3)
after DEX exposure##3##3##(1995-12#3)
after DEX##4##2##(1995-12#4)
after HL##3##2##(1991-2#3)
after HPLC##2##2##(1990-5#1)(1992-12#1)
after HT##2##2##(1996-3#1)(2008-8#1)
after IA (P = 0##3##5##(2011-2#3)
after IL-2 injection##2##3##(1991-6#2)
after IL-2##3##2##(1991-6#3)
after IV##2##2##(1997-8#1)(2011-2#1)
after January 2008##2##3##(2012-12#2)
after KB##2##2##(1991-12#2)
after LPS injection##2##3##(1997-2#1)(2008-10#1)
after LPS##3##2##(1997-2#1)(2008-10#1)(2008-12#1)
after LTP induction##2##3##(1997-2#1)(2008-7#1)
after Li+##2##2##(1996-12#2)
after MCAO##2##2##(1997-2#1)(2011-2#1)
after MCT administration##2##3##(1994-5#2)
after PTA##2##2##(2008-7#2)
after PTCA##2##2##(1992-9#2)
after Surgery##2##2##(1994-12#1)(2013-8#1)
after TCDD##3##2##(1992-12#1)(2008-10#2)
after TKR##2##2##(2008-8#2)
after UV##3##2##(2008-10#3)
after World War II##2##4##(1996-1#1)(2013-1#1)
after a 3-day##2##3##(2008-10#1)(2011-2#1)
after a brief##2##3##(1992-12#1)(2008-11#1)
after a coronary artery bypass grafting##2##6##(2012-3#2)
after a failed##2##3##(2010-5#1)(2012-12#1)
after a few##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
after a fixed time##2##4##(2008-10#2)
after a fixed##3##3##(1994-9#1)(2008-10#2)
after a follow-up##2##3##(1990-6#1)(2008-7#1)
after a free##2##3##(2010-6#1)(2012-12#1)
after a healthy subject has taken tablets##2##7##(2008-10#2)
after a knee##2##3##(2013-1#2)
after a local##2##3##(1995-3#1)(1997-7#1)
after a long##4##3##(1991-1#1)(1992-12#1)(1992-3#1)(2008-11#1)
after a longer##3##3##(1990-9#1)(1994-3#1)(2011-2#1)
after a mean duration of##2##5##(2008-7#2)
after a mean##3##3##(1990-6#1)(2008-7#2)
after a median##2##3##(1990-6#1)(2010-12#1)
after a new chemotherapy combination##2##5##(1992-2#2)
after a pre-reduction##2##3##(2008-10#2)
after a previous##2##3##(2008-10#2)
after a proper##2##3##(2008-10#2)
after a short period of##3##5##(1997-2#1)(2013-1#2)
after a short##6##3##(1997-2#1)(1997-5#1)(2008-10#2)(2013-1#2)
after a similar##2##3##(1995-5#1)(1996-5#1)
after a single##12##3##(1990-11#1)(1994-5#1)(1995-12#3)(1996-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)
after a standard kindling stimulus##2##5##(1992-12#2)
after a subcutaneous##2##3##(1995-12#1)(2008-8#1)
after a traumatic##2##3##(2008-10#1)(2011-2#1)
after a##167##2##(1990-11#2)(1990-6#3)(1990-9#3)(1991-1#1)(1991-11#2)(1992-12#4)(1992-2#2)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#38)(2008-11#10)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#8)(2012-12#4)(2012-3#5)(2012-8#1)(2013-1#10)
after abdominal##2##2##(2008-10#1)(2013-1#1)
after about##2##2##(2008-11#1)(2008-5#1)
after acid digestion##3##3##(2008-10#3)
after acid##5##2##(2008-10#5)
after activation of##2##3##(2006-6#1)(2008-10#1)
after activation##6##2##(2006-6#1)(2008-10#2)(2008-11#2)(2009-8#1)
after acute and chronic##2##4##(1992-3#1)(2008-10#1)
after acute coronary syndrome##2##4##(2009-10#1)(2010-4#1)
after acute myocardial infarction##2##4##(1990-9#1)(1995-8#1)
after acute##9##2##(1990-9#1)(1992-3#1)(1993-12#1)(1995-8#1)(1996-11#1)(2008-10#1)(2009-10#1)(2010-4#1)(2013-8#1)
after adding##2##2##(2008-10#1)(2008-11#1)
after addition of##7##3##(1990-5#1)(1993-8#2)(2008-10#3)(2013-1#1)
after addition##8##2##(1990-5#1)(1993-8#2)(2008-10#3)(2008-11#1)(2013-1#1)
after adjusting for age##2##4##(2008-11#1)(2008-3#1)
after adjusting for other##3##4##(1992-12#1)(1995-12#1)(2012-5#1)
after adjusting for##12##3##(1992-12#1)(1993-12#2)(1995-12#1)(2008-11#1)(2008-3#1)(2010-6#1)(2012-12#1)(2012-5#2)(2013-1#2)
after adjustment for##2##3##(1991-8#1)(2008-11#1)
after adjustment##4##2##(1990-12#1)(1990-8#1)(1991-8#1)(2008-11#1)
after administration of DKT##2##4##(2011-2#2)
after administration of##11##3##(1990-5#1)(1993-12#1)(1996-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)
after administration was##2##3##(2008-10#1)(2012-2#1)
after administration##17##2##(1990-5#1)(1993-12#1)(1996-1#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#1)
after admission##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
after adsorption##4##2##(2008-10#4)
after adsorptive preconcentration##2##3##(2008-10#2)
after adult##2##2##(2008-10#2)
after aerosol##2##2##(1997-1#2)
after agitation##2##2##(2008-5#2)
after all##3##2##(1991-12#1)(1993-2#1)(2008-10#1)
after allergen challenge##2##3##(1994-11#2)
after an AMI##3##3##(2009-6#3)
after an acute myocardial##2##4##(1991-3#1)(2008-10#1)
after an acute##3##3##(1991-3#1)(2008-10#1)(2013-1#1)
after an average##2##3##(1994-3#1)(2009-3#1)
after an episode of##4##4##(2012-3#1)(2013-1#3)
after an initial##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
after an intense##2##3##(2011-2#1)(2013-1#1)
after an ischemic stroke##2##4##(2009-11#2)
after an overnight##2##3##(2008-10#2)
after an##41##2##(1991-3#1)(1994-3#2)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-9#2)(2009-11#2)(2009-3#1)(2009-6#3)(2011-2#5)(2012-3#2)(2013-1#7)
after analysing##2##2##(2008-10#2)
after analysis##2##2##(2007-8#1)(2008-10#1)
after angioplasty##2##2##(1997-8#2)
after ankle arthroscopy##2##3##(2010-7#2)
after anterior cruciate ligament reconstruction##2##5##(2008-11#2)
after anthesis##8##2##(2008-10#5)(2008-11#2)(2008-9#1)
after antigen encounter##2##3##(2013-1#2)
after antitubercular##2##2##(2008-7#1)(2012-12#1)
after any##2##2##(1992-5#1)(2011-1#1)
after appendectomy##2##2##(1991-8#1)(2008-10#1)
after application of a##4##4##(2008-10#2)(2008-5#2)
after application of##9##3##(2008-10#5)(2008-11#1)(2008-5#2)(2013-1#1)
after application##14##2##(2008-10#9)(2008-11#1)(2008-5#3)(2013-1#1)
after applying the##3##3##(2008-10#3)
after applying##4##2##(2008-10#4)
after appropriate##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
after approximately 3##3##3##(1997-5#1)(2008-10#1)(2008-7#1)
after approximately##5##2##(1997-5#1)(2008-10#3)(2008-7#1)
after around 10##2##3##(2008-10#1)(2010-1#1)
after artificial##2##2##(2008-10#2)
after at least##3##3##(1991-8#1)(1993-2#1)(1995-2#1)
after attachment##2##2##(2008-11#2)
after bacterial challenge##2##3##(2010-5#2)
after bacterial##4##2##(2008-10#2)(2010-5#2)
after balloon##2##2##(1997-8#1)(2008-12#1)
after beginning##2##2##(1991-8#1)(2010-11#1)
after being exposed to##2##4##(2008-10#1)(2008-9#1)
after being##23##2##(1994-8#1)(1995-2#1)(1995-5#1)(1996-6#1)(2008-10#5)(2008-11#4)(2008-6#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2011-2#1)
after bilateral##4##2##(1990-5#2)(1996-2#1)(2013-8#1)
after birth##20##2##(1991-11#1)(1993-12#1)(1995-12#4)(1995-2#1)(1995-8#1)(1996-3#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#3)(2012-3#3)
after birth) and##2##3##(1994-8#1)(1995-12#1)
after birth)##3##2##(1994-8#1)(1995-12#2)
after bleaching##2##2##(2008-5#2)
after bloom##3##2##(2008-10#3)
after blunt abdominal trauma##2##4##(1990-2#1)(2008-10#1)
after blunt##5##2##(1990-2#1)(1990-9#2)(2008-10#1)(2008-7#1)
after bone marrow transplantation##2##4##(1993-2#1)(1997-7#1)
after bone marrow##3##3##(1993-2#1)(1997-7#1)(2013-8#1)
after breast cancer##2##3##(1996-11#1)(2008-4#1)
after breast##4##2##(1994-12#1)(1996-11#1)(2008-4#1)(2009-1#1)
after brief##3##2##(1995-2#1)(2012-3#2)
after budbreak##3##2##(2008-10#3)
after burial##2##2##(2008-10#2)
after calcium##2##2##(1991-11#1)(1996-11#1)
after cancer##3##2##(2008-7#2)(2008-8#1)
after capsaicin##2##2##(1992-6#1)(2008-11#1)
after cardiac surgery in##2##4##(2012-2#2)
after cardiac surgery##5##3##(2012-2#2)(2012-3#2)(2013-1#1)
after cardiac##7##2##(1994-3#1)(2010-11#1)(2012-2#2)(2012-3#2)(2013-1#1)
after cardiopulmonary##2##2##(1995-11#1)(2011-2#1)
after careful##4##2##(1990-3#1)(1996-5#1)(2013-1#1)(2013-8#1)
after castration##3##2##(1991-5#1)(1993-8#1)(1995-2#1)
after catheter##2##2##(1990-11#1)(2012-12#1)
after cation-exchange##2##2##(2008-10#2)
after cauliflower##3##2##(2008-10#3)
after cell##4##2##(2008-10#1)(2008-11#2)(2012-3#1)
after cellular exposure to##2##4##(1990-11#1)(1994-11#1)
after centrifugation##3##2##(2008-10#2)(2008-5#1)
after cesarean##2##2##(1995-12#1)(2012-12#1)
after chemotherapy and##2##3##(1992-7#1)(2008-10#1)
after chemotherapy##6##2##(1992-7#1)(1993-11#1)(2008-10#3)(2008-7#1)
after chronic##2##2##(1994-6#1)(2008-7#1)
after clinical##2##2##(2008-1#1)(2008-11#1)
after cloning##2##2##(2008-10#1)(2008-9#1)
after closed reduction##2##3##(2011-2#2)
after closed##3##2##(2011-2#2)(2012-3#1)
after cloud point extraction##4##4##(2008-10#4)
after coating##2##2##(1995-2#1)(2008-10#1)
after cochlear implantation##5##3##(2008-9#5)
after cochlear##6##2##(2008-9#6)
after cold##2##2##(2013-8#2)
after collection##3##2##(2008-10#3)
after combination##2##2##(1997-5#1)(2008-5#1)
after combined training##2##3##(2013-8#2)
after combined treatment##2##3##(2010-12#1)(2013-1#1)
after combined##4##2##(2010-12#1)(2013-1#1)(2013-8#2)
after complete##2##2##(1990-8#1)(2008-10#1)
after completely##2##2##(1991-2#1)(2008-10#1)
after completion of##5##3##(1991-6#2)(2008-10#1)(2008-7#1)(2013-1#1)
after complexation##4##2##(2008-10#4)
after conclusion of the##2##4##(1997-3#1)(2013-1#1)
after conditioning##2##2##(1994-8#1)(2008-7#1)
after considerable##2##2##(1991-2#1)(2008-11#1)
after contact with##3##3##(2008-10#2)(2009-6#1)
after contact##4##2##(2008-10#3)(2009-6#1)
after contrast##2##2##(1997-8#1)(2011-2#1)
after controlling for demographic##3##4##(2012-3#1)(2013-1#2)
after controlling for##11##3##(1994-2#1)(1997-2#1)(2008-11#1)(2009-10#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
after conversion to##2##3##(2008-10#2)
after conversion##4##2##(2008-10#4)
after coronary##5##2##(1992-5#1)(1992-9#1)(2008-8#1)(2011-2#2)
after correction for##2##3##(2011-2#2)
after correction##4##2##(2008-10#2)(2011-2#2)
after cranial surgery##2##3##(2011-2#1)(2012-3#1)
after cultivation##2##2##(1995-12#1)(2008-12#1)
after culture for##2##3##(2008-10#1)(2008-9#1)
after culture##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
after day##2##2##(2008-10#1)(2008-9#1)
after death##2##2##(2008-12#1)(2012-3#1)
after delivery##7##2##(1994-3#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-6#1)(2012-3#1)
after depletion of protein kinase C##2##6##(1990-12#2)
after deposition on##2##3##(2008-10#1)(2012-2#1)
after derivatization##3##2##(2008-10#2)(2008-11#1)
after diagnosis of##2##3##(1995-2#1)(2012-3#1)
after diagnosis##9##2##(1991-6#1)(1995-2#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
after diazepam injection##2##3##(2013-1#2)
after different##6##2##(1992-2#1)(1994-5#1)(2008-10#3)(2008-11#1)
after digestion with##3##3##(2008-10#3)
after digestion##9##2##(2008-10#8)(2008-11#1)
after dilation##2##2##(1993-6#2)
after dilution of the##2##4##(2008-10#2)
after dilution of##3##3##(2008-10#3)
after direct irradiation with ultraviolet light##2##6##(2008-10#2)
after direct##4##2##(2008-10#2)(2008-8#2)
after discharge from the##2##4##(2010-10#1)(2012-12#1)
after discharge##8##2##(1995-11#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#2)
after discontinuation of the##2##4##(2008-7#1)(2011-2#1)
after discontinuation of##4##3##(2008-7#1)(2008-8#1)(2011-2#2)
after discontinuing levamisole##2##3##(2008-1#2)
after discontinuing##3##2##(2008-1#3)
after dissection of##2##3##(2008-12#1)(2008-9#1)
after dissolution##5##2##(2008-10#5)
after doses of 0##2##4##(2010-11#1)(2013-8#1)
after doses##3##2##(2010-11#1)(2013-8#2)
after drug administration##2##3##(2008-11#1)(2012-2#1)
after drug injection##2##3##(1994-2#1)(2013-8#1)
after drug##7##2##(1994-2#2)(1995-12#1)(1996-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
after dry##2##2##(1990-8#1)(2008-5#1)
after each##20##2##(1993-6#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
after early planned operation##2##4##(1997-8#2)
after eating##2##2##(1993-6#1)(2008-10#1)
after effects##2##2##(2008-8#1)(2010-11#1)
after either##3##2##(1995-5#2)(2008-7#1)
after ejaculation##3##2##(1992-12#2)(1997-6#1)
after elective##3##2##(1997-8#1)(2012-3#1)(2013-1#1)
after embolisation was##2##3##(1996-6#1)(1997-3#1)
after embolisation##9##2##(1995-11#2)(1996-3#2)(1996-6#2)(1997-3#2)(1997-6#1)
after emergence##3##2##(2008-10#3)
after emergency##2##2##(1992-5#1)(1997-8#1)
after endoluminal##2##2##(2011-2#1)(2013-8#1)
after endoscopic sphincterotomy##2##3##(1990-2#1)(2007-8#1)
after endoscopic##3##2##(1990-2#1)(2007-8#1)(2013-1#1)
after endovascular abdominal aneurysm repair##2##5##(2010-12#1)(2011-3#1)
after endovascular treatment##3##3##(1995-11#1)(1996-3#1)(2013-1#1)
after endovascular##7##2##(1995-11#1)(1996-3#2)(2010-12#1)(2011-3#2)(2013-1#1)
after enrichment##2##2##(2008-10#1)(2008-5#1)
after enzymatic##3##2##(2008-10#2)(2009-12#1)
after equilibrating##2##2##(2008-10#2)
after establishment of##2##3##(1995-6#1)(1996-6#1)
after every##2##2##(2008-10#1)(2008-11#1)
after excision of the##2##4##(2010-5#1)(2011-2#1)
after excision of##3##3##(1990-3#1)(2010-5#1)(2011-2#1)
after exercise##2##2##(2013-1#1)(2013-8#1)
after exogenous##2##2##(2008-10#1)(2008-7#1)
after exposure for##2##3##(1992-6#1)(2008-10#1)
after exposure of##3##3##(1994-11#1)(2008-10#1)(2010-11#1)
after exposure to a##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
after exposure to an##2##4##(2008-10#1)(2008-4#1)
after exposure to different##2##4##(1996-12#1)(2013-1#1)
after exposure to soil at##2##5##(2008-10#2)
after exposure to##24##3##(1992-12#1)(1992-6#1)(1996-12#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2013-1#2)
after exposure##35##2##(1992-12#1)(1992-6#3)(1994-11#1)(1996-12#1)(1996-8#2)(2007-11#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2013-1#2)
after external fixation##3##3##(2009-4#3)
after extracorporeal shockwave lithotripsy##2##4##(2013-1#2)
after extraction##4##2##(2008-10#4)
after extrusion##2##2##(2008-9#1)(2012-2#1)
after fatigue##2##2##(2013-8#2)
after feeding##2##2##(2008-10#1)(2008-11#1)
after few##3##2##(2009-7#1)(2012-2#1)(2013-8#1)
after filtration##2##2##(2008-10#2)
after first##2##2##(2008-10#1)(2013-8#1)
after five years##2##3##(2011-2#2)
after five##3##2##(2008-12#1)(2011-2#2)
after fixation##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
after floods##2##2##(2013-8#2)
after following##2##2##(2011-2#1)(2013-8#1)
after four weeks of##2##4##(2013-1#2)
after four##7##2##(1993-8#1)(2008-10#1)(2008-11#2)(2013-1#3)
after freezing and thawing##3##4##(2008-11#2)(2008-5#1)
after freezing and##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
after fruit set##4##3##(2008-10#4)
after fruit##5##2##(2008-10#5)
after full##2##2##(2008-12#1)(2013-1#1)
after further##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
after garlic oil treatment##2##4##(2008-9#2)
after gastroenteric surgery or##2##4##(1991-8#2)
after germination##2##2##(2008-10#1)(2008-8#1)
after grafting##2##2##(1991-2#1)(1997-2#1)
after growing##2##2##(2008-10#2)
after growth##4##2##(1997-1#1)(2008-10#1)(2009-11#1)(2012-2#1)
after hCG##2##2##(2008-5#1)(2008-9#1)
after harvest##8##2##(2008-10#8)
after having been##2##3##(2008-11#1)(2013-1#1)
after having##7##2##(1990-3#2)(1994-9#1)(1997-3#1)(2008-11#1)(2008-5#1)(2013-1#1)
after he##3##2##(1995-6#1)(1996-5#1)(2008-12#1)
after head injury##2##3##(1991-12#1)(2008-7#1)
after head##5##2##(1991-12#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-1#1)
after heading and##3##3##(2008-9#3)
after heading##5##2##(2008-9#5)
after heads emerged##2##3##(2008-10#2)
after headspace##2##2##(2008-10#2)
after heat shock##3##3##(1994-8#1)(1997-7#1)(2012-3#1)
after heat##5##2##(1990-12#1)(1994-8#1)(1997-7#1)(2012-2#1)(2012-3#1)
after heating at##5##3##(1994-8#1)(2008-10#1)(2008-2#1)(2011-2#2)
after heating to##2##3##(2008-10#2)
after heating##11##2##(1994-8#1)(2008-10#3)(2008-2#2)(2010-4#1)(2011-2#3)(2012-2#1)
after hematopoietic stem cell transplantation##2##5##(1997-8#1)(2010-11#1)
after her##2##2##(1991-11#1)(2013-1#1)
after high pressure homogenization##2##4##(2008-7#2)
after high##3##2##(2008-7#2)(2010-9#1)
after hip##4##2##(2008-8#3)(2009-3#1)
after his##6##2##(1997-6#1)(1997-8#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-3#1)
after histamine##4##2##(1996-1#1)(2008-12#3)
after hybridization##3##2##(2008-9#3)
after i##5##2##(1991-1#1)(1991-8#1)(1994-2#1)(1996-12#1)(2008-11#1)
after imipramine administration in all three strains##2##7##(1994-2#2)
after immunization with##4##3##(1995-12#2)(1995-5#1)(2008-7#1)
after immunization##8##2##(1990-12#1)(1995-12#2)(1995-5#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-7#1)
after implant placement##3##3##(2013-1#3)
after implantation of a##4##4##(2008-11#1)(2008-7#2)(2011-2#1)
after implantation of##5##3##(2008-11#2)(2008-7#2)(2011-2#1)
after implantation##15##2##(1990-8#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#6)(2011-2#1)
after implementation of##2##3##(1991-3#1)(1995-12#1)
after implementation##3##2##(1991-3#1)(1995-12#1)(1997-2#1)
after in vitro fertilization##2##4##(2008-9#1)(2013-1#1)
after in vitro##3##3##(1990-2#1)(2008-9#1)(2013-1#1)
after in vivo initiation with paracetamol##2##6##(1995-11#2)
after in##6##2##(1990-2#1)(1995-11#2)(2008-10#1)(2008-9#1)(2013-1#1)
after incorporation##2##2##(2008-5#1)(2010-11#1)
after incubation for##4##3##(1996-2#1)(2008-10#1)(2010-6#1)(2012-12#1)
after incubation of##6##3##(1990-12#3)(1990-8#1)(1994-8#2)
after incubation with the##2##4##(1993-8#1)(2008-11#1)
after incubation with##7##3##(1991-3#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
after incubation##19##2##(1990-12#3)(1990-8#1)(1991-3#1)(1993-8#1)(1994-8#3)(1996-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-11#1)(2010-6#1)(2012-12#1)
after induction CCRT##2##3##(2008-10#2)
after induction chemotherapy##2##3##(1990-6#1)(2008-10#1)
after induction##8##2##(1990-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-11#1)
after infection and##2##3##(2008-10#1)(2008-11#1)
after infection by##2##3##(2008-10#1)(2009-10#1)
after infection with##5##3##(1996-12#1)(2008-10#2)(2008-9#1)(2011-10#1)
after infection##13##2##(1996-12#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-10#2)(2010-7#1)(2011-10#1)
after informed consent##2##3##(2008-5#1)(2012-3#1)
after ingesting##3##2##(2008-10#1)(2008-12#1)(2010-6#1)
after ingestion of##2##3##(2008-10#1)(2010-6#1)
after ingestion##3##2##(2008-10#2)(2010-6#1)
after inhibition##2##2##(1992-9#1)(2008-7#1)
after initial diagnosis##2##3##(2008-7#1)(2011-2#1)
after initial loading##2##3##(2013-1#2)
after initial##16##2##(1992-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-1#1)(2009-3#1)(2011-2#2)(2013-1#2)
after initiation of PD+HD therapy##2##5##(2011-2#2)
after initiation of##7##3##(1996-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)
after injection of a##2##4##(1990-6#1)(2008-12#1)
after injection of beta-AP(1-40)##2##4##(2008-8#2)
after injection of##10##3##(1990-5#1)(1990-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)
after injection##22##2##(1990-5#1)(1990-6#1)(1993-1#1)(1993-11#1)(1994-8#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-5#2)(2010-7#1)(2011-2#1)(2013-1#1)
after injections of##3##3##(1991-12#1)(1995-2#1)(1996-5#1)
after injections##4##2##(1991-12#1)(1995-2#1)(1996-5#1)(2013-8#1)
after injury##11##2##(2008-7#2)(2008-8#1)(2012-3#5)(2013-1#3)
after inoculation and##7##3##(2008-10#7)
after inoculation but##2##3##(2008-10#2)
after inoculation in##2##3##(2008-10#2)
after inoculation of##4##3##(2008-10#4)
after inoculation on##4##3##(2008-10#4)
after inoculation time##2##3##(2008-5#2)
after inoculation was##2##3##(2008-10#2)
after inoculation with the pathogen##4##5##(2008-10#4)
after inoculation with the##6##4##(1991-3#1)(2008-10#5)
after inoculation with##11##3##(1991-3#1)(2008-10#10)
after inoculation##116##2##(1991-3#1)(1993-8#1)(1995-2#1)(2008-10#105)(2008-11#2)(2008-5#4)(2008-8#2)
after intake##3##2##(1993-8#1)(2009-11#1)(2009-9#1)
after intercourse##2##2##(2008-12#2)
after intermittent##2##2##(1993-2#1)(2008-10#1)
after intervention##3##2##(2012-3#1)(2013-1#2)
after intracerebroventricular injection of##2##4##(1997-2#1)(2008-8#1)
after intracerebroventricular##3##2##(1992-3#1)(1997-2#1)(2008-8#1)
after intrathecal injection of fluorescein##3##5##(2008-12#3)
after intravenous injection of##3##4##(1992-12#1)(1994-5#1)(2013-8#1)
after intravenous injection##4##3##(1992-12#1)(1993-11#1)(1994-5#1)(2013-8#1)
after intravenous##6##2##(1992-12#1)(1993-11#1)(1994-5#1)(2010-10#1)(2012-3#1)(2013-8#1)
after intraventricular injection##3##3##(1991-12#3)
after intraventricular##4##2##(1991-12#4)
after introduction of##2##3##(1994-8#1)(2008-11#1)
after irradiation with##2##3##(2008-11#1)(2008-5#1)
after irradiation##7##2##(1995-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
after ischemia##2##2##(1990-5#2)
after islet##3##2##(2010-11#3)
after isolation##6##2##(1995-8#1)(1996-12#1)(2008-11#2)(2008-12#1)(2010-11#1)
after it was first##2##4##(2008-10#2)
after it was##4##3##(1990-3#1)(2008-10#3)
after it##5##2##(1990-3#1)(2008-10#4)
after its administration##2##3##(2007-8#1)(2008-10#1)
after its conclusion##2##3##(1992-2#2)
after its preconcentration onto##2##4##(2008-10#2)
after its preconcentration##3##3##(2008-10#3)
after its treatment##2##3##(2008-10#1)(2008-12#1)
after its##24##2##(1990-5#1)(1991-2#1)(1992-2#2)(2007-8#2)(2008-10#16)(2008-12#1)(2011-2#1)
after ketamine injection##3##3##(2013-1#3)
after kidney##4##2##(1995-2#1)(2008-10#1)(2012-12#2)
after labor##2##2##(2008-9#1)(2011-2#1)
after laparoscopic cholecistectomy##2##3##(2011-2#2)
after laparoscopic cholecystectomy##6##3##(2008-12#3)(2008-8#1)(2011-2#1)(2012-3#1)
after laparoscopic##18##2##(1992-2#1)(2008-12#4)(2008-8#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-3#1)
after laparoscopy##3##2##(1995-3#3)
after laser treatment##2##3##(1990-11#1)(1993-6#1)
after laser##5##2##(1990-11#1)(1991-2#1)(1993-6#2)(2012-2#1)
after last##2##2##(2008-10#1)(2011-2#1)
after leaving the##2##3##(1997-6#1)(2009-5#1)
after light initiation##5##3##(2008-10#5)
after liver transplantation##3##3##(1993-2#1)(1994-6#1)(2011-2#1)
after liver##5##2##(1993-2#1)(1994-6#1)(2008-11#1)(2011-2#1)(2012-3#1)
after load##2##2##(2012-2#2)
after loading##2##2##(2008-10#1)(2010-5#1)
after local##4##2##(1993-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
after long##3##2##(1991-12#1)(2008-10#2)
after long-term treatment##2##3##(1997-5#1)(2010-5#1)
after long-term##7##2##(1991-11#1)(1994-2#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-5#1)
after lung transplantation##4##3##(2012-2#4)
after major##3##2##(1996-3#1)(2009-6#2)
after mass##2##2##(1990-6#1)(2008-10#1)
after maturity##2##2##(2008-9#2)
after mechanical##2##2##(2008-10#1)(2013-1#1)
after membrane##2##2##(2008-10#2)
after meniscus repair and anterior cruciate ligament reconstruction##2##8##(2013-1#2)
after menopause##2##2##(2008-7#1)(2010-12#1)
after microinjection of##2##3##(1994-8#1)(1997-2#1)
after microwave##3##2##(2008-10#2)(2011-2#1)
after microwave-assisted digestion##2##3##(2008-10#2)
after microwave-assisted##5##2##(2008-10#5)
after mild##2##2##(1994-11#1)(2008-5#1)
after mixing##6##2##(1990-2#1)(2008-10#5)
after more than##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
after multiple##5##2##(1996-11#2)(2010-12#1)(2011-2#1)(2013-1#1)
after mutations##2##2##(2008-1#1)(2011-2#1)
after myotomy##2##2##(1990-12#1)(1992-9#1)
after nephrectomy##4##2##(2011-2#4)
after nickel##2##2##(2008-10#2)
after nine extinction trials##3##4##(2008-5#3)
after nine months##2##3##(2011-2#1)(2013-1#1)
after nine##5##2##(2008-5#3)(2011-2#1)(2013-1#1)
after normal delivery##3##3##(1991-3#1)(1992-12#1)(2011-2#1)
after normal##5##2##(1991-3#1)(1992-12#1)(1997-2#1)(2008-10#1)(2011-2#1)
after on-line hydrolysis##2##3##(2008-10#2)
after on-line##6##2##(2008-10#6)
after one and##2##3##(2008-10#1)(2008-7#1)
after one month##2##3##(2011-1#1)(2013-1#1)
after one year##3##3##(1991-11#1)(1995-1#1)(2007-11#1)
after one##10##2##(1991-11#1)(1991-6#1)(1995-1#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-1#1)(2013-1#1)
after one-step##2##2##(1993-6#1)(2008-10#1)
after only 2##2##3##(1993-6#1)(2008-10#1)
after only##7##2##(1993-6#1)(2008-10#5)(2008-11#1)
after onset of symptoms##2##4##(2008-10#1)(2009-9#1)
after onset of##4##3##(2008-10#1)(2008-7#1)(2009-11#1)(2009-9#1)
after operation##13##2##(1990-2#1)(1993-11#1)(1993-2#1)(1997-3#1)(2008-12#2)(2008-9#2)(2010-7#1)(2011-2#3)(2012-3#1)
after or##2##2##(1990-8#1)(1990-9#1)
after oral administration of##4##4##(1996-6#1)(2008-10#2)(2008-11#1)
after oral administration##6##3##(1996-2#1)(1996-6#1)(2008-10#2)(2008-11#2)
after oral intubation of##3##4##(2008-11#3)
after oral##14##2##(1990-2#1)(1992-9#1)(1993-12#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-11#5)(2008-5#1)(2012-3#1)
after orthotopic liver transplantation##2##4##(1993-2#1)(2011-2#1)
after osteochondral##2##2##(2011-2#2)
after ovarian surgery##3##3##(1992-3#3)
after oxidation of##3##3##(2008-10#3)
after partial##3##2##(1996-2#1)(2008-7#2)
after participating in##2##3##(2011-2#1)(2013-1#1)
after passage##2##2##(2008-10#1)(2008-9#1)
after passing through##2##3##(2008-10#2)
after percutaneous##2##2##(1990-2#1)(2012-12#1)
after placement of##2##3##(1990-5#1)(2008-10#1)
after placement##3##2##(1990-5#1)(2008-10#2)
after planting##14##2##(2008-10#14)
after platelet##2##2##(2006-6#2)
after plating##2##2##(1992-6#1)(2008-9#1)
after pollination##8##2##(2008-10#4)(2008-11#3)(2008-9#1)
after polyadenylation##3##2##(1994-11#3)
after polymerase chain reaction##2##4##(2008-10#1)(2013-1#1)
after post-column##2##2##(2008-10#2)
after pre-concentration in##2##3##(2008-10#2)
after pre-concentration##5##2##(2008-10#5)
after precolumn##2##2##(1990-12#1)(2008-10#1)
after preconcentration of its##3##4##(2008-10#3)
after preconcentration of##6##3##(2008-10#6)
after preconcentration on##3##3##(2008-10#3)
after preconcentration using##3##3##(2008-10#3)
after preconcentration with the ion pair of##2##7##(2008-10#2)
after preconcentration##22##2##(2008-10#22)
after presentation##2##2##(2008-7#1)(2012-12#1)
after pretreatment with##3##3##(2008-10#2)(2008-11#1)
after pretreatment##4##2##(1991-12#1)(2008-10#2)(2008-11#1)
after previous##4##2##(1997-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
after primary ocular infection##2##4##(2012-3#2)
after primary surgery##2##3##(1990-6#1)(2008-9#1)
after primary##8##2##(1990-6#1)(1993-1#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-3#3)
after prolonged##6##2##(1990-9#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
after prostatic massage##2##3##(1991-2#2)
after puberty##5##2##(1990-5#2)(1991-2#1)(2008-5#1)(2012-3#1)
after purification of the##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
after purification##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)
after rTMS##2##2##(2011-2#2)
after radiation therapy##7##3##(1993-8#5)(1993-9#1)(2008-7#1)
after radical prostatectomy##2##3##(2010-10#1)(2011-2#1)
after radical##4##2##(1990-9#1)(1992-12#1)(2010-10#1)(2011-2#1)
after radiotherapy of##2##3##(2008-7#1)(2012-12#1)
after radiotherapy##5##2##(1990-6#1)(1992-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
after rapid##3##2##(2008-7#2)(2011-2#1)
after reaction with##2##3##(2008-10#2)
after receiving##3##2##(1991-2#1)(2008-7#2)
after recording##2##2##(2008-3#1)(2009-5#1)
after reduction of##4##3##(2008-10#4)
after reduction to##2##3##(2008-10#2)
after reduction##7##2##(2008-10#7)
after release##3##2##(2009-11#2)(2010-3#1)
after removal of hemodialysis indwelling catheters##2##6##(2008-1#2)
after removal of the##3##4##(1990-10#1)(2008-10#1)(2011-2#1)
after removal of##9##3##(1990-10#1)(1990-5#1)(1990-6#1)(1994-3#1)(2008-1#2)(2008-10#2)(2011-2#1)
after removing the##3##3##(2008-10#2)(2008-5#1)
after renal transplantation##3##3##(1992-12#1)(2011-2#1)(2012-12#1)
after renal##4##2##(1992-12#1)(2011-2#2)(2012-12#1)
after repeated##5##2##(1990-2#1)(2008-10#2)(2008-6#1)(2013-8#1)
after reperfusion##4##2##(1992-9#1)(2011-2#3)
after resection of the##3##4##(2008-7#1)(2011-2#1)(2011-3#1)
after resection##6##2##(2007-8#1)(2008-7#3)(2011-2#1)(2011-3#1)
after resuscitation##2##2##(1990-12#1)(2012-3#1)
after revision surgery##2##3##(2012-3#2)
after routine dental implant surgery##2##5##(2013-1#2)
after routine##3##2##(2011-2#1)(2013-1#2)
after ruling out##2##3##(2011-2#1)(2012-12#1)
after rupture of##2##3##(2008-7#1)(2011-2#1)
after salvage##2##2##(1990-6#1)(2012-3#1)
after sample collection##3##3##(2008-10#3)
after sample digestion##2##3##(2008-10#2)
after sample injection##2##3##(1995-3#1)(2008-10#1)
after sample##8##2##(1995-3#1)(2008-10#7)
after sampling##3##2##(2008-10#3)
after scab inoculation of##2##4##(2008-10#2)
after scab inoculation##3##3##(2008-10#3)
after screening##3##2##(1992-5#1)(1993-12#1)(2011-2#1)
after seeding##2##2##(2008-10#2)
after separation by##4##3##(1990-12#1)(2008-10#2)(2008-11#1)
after separation from##2##3##(2008-10#2)
after separation of##2##3##(2008-10#2)
after separation on##2##3##(2008-10#2)
after separation with##2##3##(2008-10#2)
after separation##12##2##(1990-12#1)(2008-10#10)(2008-11#1)
after sequential##3##2##(2008-10#2)(2012-3#1)
after serial##2##2##(2008-10#1)(2008-11#1)
after settlement##2##2##(2010-8#2)
after seven##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
after several years##2##3##(2008-9#1)(2012-3#1)
after several##5##2##(1994-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-3#1)
after severe##2##2##(2008-10#1)(2012-3#1)
after sexting##2##2##(2013-1#2)
after short##3##2##(1995-11#1)(2008-10#2)
after simple##2##2##(1996-5#1)(2008-10#1)
after single##3##2##(1996-1#1)(2008-6#1)(2011-3#1)
after six months##3##3##(1993-3#1)(2008-11#1)(2008-9#1)
after skin##2##2##(2008-5#1)(2012-12#1)
after sodium dodecyl##2##3##(2008-10#1)(2008-11#1)
after sodium##4##2##(2008-10#3)(2008-11#1)
after soil##2##2##(2008-10#2)
after solid phase##2##3##(2008-10#2)
after solid-phase extraction using##2##4##(2008-10#2)
after solubilization by##2##3##(2008-11#2)
after solubilization##3##2##(1994-5#1)(2008-11#2)
after some##4##2##(1991-11#1)(1996-11#1)(2008-10#2)
after sorption on##2##3##(2008-10#2)
after sorption##3##2##(2008-10#3)
after specific in vitro challenge was##2##6##(2013-1#2)
after specific##3##2##(2010-12#1)(2013-1#2)
after spraying##3##2##(2008-10#3)
after staining the##2##3##(2008-10#1)(2008-11#1)
after staining with##3##3##(2008-10#1)(2008-7#1)(2009-12#1)
after staining##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)
after standard##2##2##(2008-10#1)(2012-3#1)
after start of##2##3##(1991-6#1)(1992-5#1)
after start-up##2##2##(1991-3#2)
after starting the##2##3##(1997-8#1)(2008-10#1)
after starting treatment with##2##4##(2011-2#1)(2012-3#1)
after starting##7##2##(1991-11#1)(1997-8#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-3#1)
after stimulation of##3##3##(1991-3#1)(1995-6#1)(1995-8#1)
after stimulation with##5##3##(1994-3#1)(1997-2#1)(1997-6#1)(2008-11#1)(2009-12#1)
after stimulation##16##2##(1991-3#2)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-11#2)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
after stopping##2##2##(2009-8#1)(2010-2#1)
after stroke##9##2##(2007-9#1)(2008-11#1)(2008-7#4)(2009-10#1)(2009-11#1)(2011-2#1)
after subsequent##2##2##(1997-8#1)(2008-10#1)
after successful closed reduction##2##4##(2013-7#2)
after successful##9##2##(1993-12#1)(1996-3#1)(1996-9#1)(2008-10#1)(2009-5#1)(2011-3#1)(2012-3#1)(2013-7#2)
after successive additions of##2##4##(1993-8#1)(2008-10#1)
after such a##2##3##(1994-2#1)(2008-10#1)
after such an##2##3##(2008-7#1)(2012-12#1)
after such##4##2##(1994-2#1)(2008-10#1)(2008-7#1)(2012-12#1)
after sulfo-SMCC modification##2##3##(2008-10#2)
after sunrise##4##2##(2008-10#4)
after surgery and##7##3##(1991-6#1)(1993-3#2)(1997-4#1)(1997-5#1)(2012-12#1)(2012-2#1)
after surgery in##2##3##(2008-7#1)(2011-2#1)
after surgery was##3##3##(1994-12#1)(2010-10#1)(2011-2#1)
after surgery with##2##3##(2008-12#1)(2008-7#1)
after surgery##71##2##(1990-6#2)(1990-9#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-3#3)(1994-12#5)(1994-8#1)(1995-3#2)(1997-3#1)(1997-4#2)(1997-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#8)(2008-9#1)(2009-1#2)(2010-10#3)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#10)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
after surgical intervention##2##3##(1990-2#1)(2008-7#1)
after surgical resection##4##3##(1991-12#1)(2011-2#2)(2013-1#1)
after surgical treatment of##2##4##(1991-6#1)(2013-1#1)
after surgical treatment##7##3##(1991-2#1)(1991-6#1)(1995-2#1)(2009-1#1)(2011-2#1)(2013-1#2)
after surgical##18##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(2008-7#1)(2009-1#1)(2011-2#3)(2013-1#4)
after switching##2##2##(2008-7#1)(2009-11#1)
after ten##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
after that##3##2##(1990-2#1)(2008-10#2)
after the 'stop' cue##2##4##(2008-11#2)
after the 1st##3##3##(1995-8#2)(2009-12#1)
after the 20 and 50##2##5##(2008-10#2)
after the DB exercise##2##4##(2012-2#2)
after the addition of##7##4##(1992-12#1)(1993-8#1)(2008-10#5)
after the administration of the##2##5##(1996-6#1)(2013-1#1)
after the administration of##3##4##(1994-8#1)(1996-6#1)(2013-1#1)
after the age of##2##4##(1994-6#1)(2011-2#1)
after the appearance of##2##4##(2008-10#2)
after the application of##3##4##(1996-12#1)(2008-11#1)(2013-1#1)
after the care##2##3##(1997-8#2)
after the completion of##2##4##(1991-8#1)(2008-10#1)
after the complication##2##3##(1997-3#1)(2012-12#1)
after the death of a##4##5##(2008-11#1)(2009-5#2)(2010-9#1)
after the death of##5##4##(1995-11#1)(2008-11#1)(2009-5#2)(2010-9#1)
after the delivery##2##3##(2008-7#1)(2012-3#1)
after the development of##2##4##(2008-10#1)(2008-7#1)
after the diagnosis of##2##4##(2009-8#1)(2010-6#1)
after the diagnosis##3##3##(2009-8#1)(2010-6#1)(2012-12#1)
after the discovery of##3##4##(2008-10#1)(2008-12#1)(2008-2#1)
after the discovery##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2010-5#1)
after the dose##2##3##(2008-6#2)
after the end of the##2##5##(1995-6#1)(2013-8#1)
after the end of##6##4##(1995-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
after the event##4##3##(1991-3#1)(2013-8#3)
after the exposure to##2##4##(1996-2#1)(2008-10#1)
after the exposure##3##3##(1996-2#1)(2008-10#2)
after the first examination##2##4##(2008-5#1)(2008-7#1)
after the first harvest##2##4##(2008-10#2)
after the first passage##2##4##(2008-10#2)
after the first year of##2##5##(1990-11#1)(2013-1#1)
after the first##24##3##(1990-11#1)(1990-12#1)(1991-3#1)(1991-6#2)(1994-9#1)(1996-9#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
after the imaginal molt##2##4##(2008-6#2)
after the imaginal##3##3##(1995-11#1)(2008-6#2)
after the immunization##2##3##(1990-12#1)(1993-2#1)
after the implementation of##4##4##(1997-8#1)(2007-12#1)(2013-1#2)
after the incubation of cells with##2##6##(2008-11#2)
after the incubation##3##3##(2008-11#3)
after the induction of##5##4##(1991-5#1)(2008-11#2)(2012-2#1)(2013-1#1)
after the initial operation##4##4##(2011-2#3)(2012-3#1)
after the initial##17##3##(1990-9#1)(1995-1#1)(2008-10#4)(2009-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
after the initiation of##4##4##(1992-1#1)(2008-10#1)(2009-7#1)(2010-5#1)
after the injection of##3##4##(1994-5#1)(1994-8#1)(2008-10#1)
after the injection##7##3##(1990-5#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
after the intervention were##2##4##(2008-12#2)
after the intervention##5##3##(2008-12#4)(2012-12#1)
after the introduction of the##2##5##(2008-11#1)(2008-7#1)
after the introduction of##6##4##(1994-12#1)(1996-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-7#1)
after the last##9##3##(1994-5#1)(1996-1#1)(1996-12#2)(2008-10#1)(2008-7#1)(2010-12#2)(2012-7#1)
after the on-line wavelet transform##2##5##(2008-10#2)
after the onset of symptoms##2##5##(2008-7#1)(2010-10#1)
after the onset of##10##4##(1994-12#1)(2007-12#1)(2008-7#3)(2010-10#1)(2012-5#1)(2013-1#3)
after the operation##20##3##(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1994-3#2)(2006-6#2)(2008-10#1)(2008-7#3)(2010-10#1)(2011-2#4)(2012-3#1)(2013-1#2)
after the oral administration of##2##5##(2008-11#1)(2010-10#1)
after the oral##3##3##(2008-11#1)(2008-6#1)(2010-10#1)
after the patient##2##3##(1997-5#1)(2008-11#1)
after the procedure and##2##4##(2008-10#1)(2008-11#1)
after the procedure##11##3##(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#2)
after the process of##2##4##(2008-12#1)(2013-8#1)
after the removal of##2##4##(1990-6#1)(2011-2#1)
after the return##2##3##(1990-9#1)(2010-12#1)
after the same##2##3##(2008-5#1)(2009-10#1)
after the second##6##3##(1996-12#2)(2008-10#2)(2010-3#1)(2013-1#1)
after the start of##2##4##(2008-10#1)(2008-7#1)
after the storm##2##3##(2011-2#2)
after the surgery##5##3##(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
after the surgical procedure##2##4##(2011-2#2)
after the surgical##3##3##(2011-2#3)
after the tenth##2##3##(1996-2#1)(2012-12#1)
after the transfer##2##3##(2008-10#1)(2008-12#1)
after the trauma##2##3##(2008-10#1)(2010-1#1)
after the treatment of##2##4##(2008-8#2)
after the treatment##7##3##(1995-11#1)(1997-8#1)(2007-11#1)(2008-8#2)(2010-12#1)(2013-1#1)
after the use of a hair dye##2##7##(2012-3#2)
after the use of##4##4##(2008-5#1)(2010-1#1)(2012-3#2)
after the withdrawal of serum##2##5##(1996-2#2)
after the withdrawal of##3##4##(1996-2#2)(2008-5#1)
after the##453##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#1)(1990-9#6)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#7)(1996-2#6)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#6)(2006-6#2)(2007-11#1)(2007-12#2)(2008-10#81)(2008-11#29)(2008-12#12)(2008-2#1)(2008-3#5)(2008-5#7)(2008-6#11)(2008-7#19)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#31)(2011-3#1)(2012-12#4)(2012-2#11)(2012-3#9)(2012-5#1)(2012-7#1)(2013-1#33)(2013-8#14)
after their##16##2##(1993-3#1)(1996-3#1)(2006-6#1)(2008-10#6)(2008-2#1)(2008-8#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
after therapy##4##2##(1996-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
after they had received mandibular##2##5##(2013-1#2)
after they had##4##3##(1995-9#1)(2008-8#1)(2013-1#2)
after they have been##2##4##(1990-11#1)(2009-7#1)
after they have##3##3##(1990-11#1)(2008-1#1)(2009-7#1)
after they were##2##3##(2008-1#1)(2008-10#1)
after they##17##2##(1990-11#1)(1992-2#1)(1995-6#1)(1995-9#1)(1997-3#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-5#1)(2013-1#2)
after this##3##2##(2008-3#1)(2010-3#1)(2012-2#1)
after thorough##2##2##(2012-2#1)(2012-3#1)
after three days##2##3##(2008-5#1)(2010-12#1)
after three months##2##3##(1993-3#1)(2008-5#1)
after three weeks##2##3##(2008-5#2)
after three years of##2##4##(1995-1#2)
after three##11##2##(1993-3#1)(1995-1#2)(2008-10#1)(2008-5#6)(2010-12#1)
after thrombin stimulation##2##3##(1992-12#1)(1993-8#1)
after topical##2##2##(2008-12#1)(2008-5#1)
after total hip replacement##5##4##(2010-10#4)(2013-1#1)
after total hip##7##3##(2010-10#4)(2013-1#3)
after total##10##2##(1990-9#1)(2007-8#1)(2008-10#1)(2010-10#4)(2013-1#3)
after training##2##2##(2013-1#2)
after transection##3##2##(1996-12#2)(2012-3#1)
after transfection with a##2##4##(2008-11#1)(2008-8#1)
after transfection##6##2##(1995-2#1)(1995-6#1)(2008-11#3)(2008-8#1)
after transfer##3##2##(2008-11#1)(2008-9#1)(2012-4#1)
after transient##2##2##(1996-12#1)(2012-3#1)
after transplantation##14##2##(1994-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)
after trauma to##2##3##(2013-1#2)
after trauma##6##2##(2007-8#1)(2012-3#1)(2013-1#3)(2013-8#1)
after traumatic brain injury##2##4##(2008-7#1)(2013-8#1)
after traumatic##4##2##(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
after treatment and##2##3##(2008-10#1)(2012-2#1)
after treatment for##3##3##(1991-6#1)(2010-11#1)(2013-1#1)
after treatment had##2##3##(1997-4#1)(2008-7#1)
after treatment of the##3##4##(1991-11#1)(1995-12#1)(2008-11#1)
after treatment of##7##3##(1991-11#1)(1995-12#2)(1997-5#1)(2008-11#2)(2008-7#1)
after treatment or##2##3##(1992-1#1)(2011-1#1)
after treatment was##3##3##(1990-12#1)(1991-9#1)(1993-8#1)
after treatment were##2##3##(2013-1#2)
after treatment with 3##2##4##(1992-12#1)(1993-8#1)
after treatment with the##2##4##(2008-7#1)(2012-3#1)
after treatment with##18##3##(1990-12#2)(1992-12#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-6#1)(2008-10#3)(2008-7#1)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-3#2)(2013-1#1)
after treatment##77##2##(1990-10#3)(1990-12#3)(1991-11#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#2)(1993-11#1)(1993-8#2)(1994-12#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#2)(1996-6#2)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-7#4)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#11)
after treatment)##2##2##(1994-8#1)(2008-10#1)
after two broccoli##2##3##(2008-10#2)
after two months of##2##4##(2013-1#2)
after two years##2##3##(1990-11#1)(1996-3#1)
after two##16##2##(1990-11#2)(1993-12#1)(1994-2#1)(1995-5#1)(1996-3#1)(1997-8#1)(2008-10#3)(2008-5#1)(2010-12#2)(2010-7#1)(2013-1#2)
after undergoing##4##2##(1996-9#1)(2008-7#1)(2011-2#1)(2013-8#1)
after unilateral##3##2##(1994-3#1)(1994-8#1)(1997-3#1)
after using##2##2##(2011-2#1)(2013-1#1)
after vaccination##3##2##(1994-8#1)(1995-5#1)(2008-9#1)
after valve##2##2##(1997-5#1)(2008-10#1)
after washing##2##2##(2008-5#2)
after water##3##2##(2008-10#2)(2008-5#1)
after weaning is##3##3##(2013-1#3)
after weaning##4##2##(1996-12#1)(2013-1#3)
after wet##2##2##(1990-8#1)(2008-10#1)
after which the##3##3##(1991-12#1)(2008-10#1)(2009-3#1)
after which##15##2##(1991-12#1)(1991-2#1)(1992-2#1)(1993-6#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-8#1)(2012-3#1)(2013-8#1)
after wide##2##2##(1992-2#1)(1994-12#1)
after wounding##2##2##(2008-10#2)
after xylose administration##2##3##(1996-6#2)
after##3937##1##(1990-10#4)(1990-11#10)(1990-12#28)(1990-2#20)(1990-3#8)(1990-5#25)(1990-6#22)(1990-8#9)(1990-9#20)(1991-1#5)(1991-11#12)(1991-12#22)(1991-2#24)(1991-3#23)(1991-5#5)(1991-6#19)(1991-8#16)(1991-9#8)(1992-1#6)(1992-10#2)(1992-11#1)(1992-12#26)(1992-2#12)(1992-3#11)(1992-4#1)(1992-5#8)(1992-6#12)(1992-7#2)(1992-8#4)(1992-9#11)(1993-1#14)(1993-11#10)(1993-12#15)(1993-2#14)(1993-3#13)(1993-6#16)(1993-8#22)(1993-9#3)(1994-1#6)(1994-11#14)(1994-12#24)(1994-2#17)(1994-3#23)(1994-5#22)(1994-6#6)(1994-8#31)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#23)(1995-12#37)(1995-2#29)(1995-3#13)(1995-5#10)(1995-6#15)(1995-8#15)(1995-9#6)(1996-1#12)(1996-11#11)(1996-12#34)(1996-2#23)(1996-3#12)(1996-5#11)(1996-6#21)(1996-8#5)(1996-9#7)(1997-1#8)(1997-2#21)(1997-3#19)(1997-4#10)(1997-5#13)(1997-6#6)(1997-7#4)(1997-8#29)(2006-6#9)(2007-11#7)(2007-12#6)(2007-8#9)(2007-9#1)(2008-1#15)(2008-10#1059)(2008-11#214)(2008-12#86)(2008-2#6)(2008-3#17)(2008-4#6)(2008-5#79)(2008-6#30)(2008-7#141)(2008-8#71)(2008-9#96)(2009-1#9)(2009-10#13)(2009-11#13)(2009-12#9)(2009-3#10)(2009-4#5)(2009-5#7)(2009-6#12)(2009-7#12)(2009-8#9)(2009-9#4)(2010-1#11)(2010-10#16)(2010-11#28)(2010-12#25)(2010-2#1)(2010-3#15)(2010-4#9)(2010-5#17)(2010-6#19)(2010-7#17)(2010-8#12)(2010-9#5)(2011-1#15)(2011-10#2)(2011-2#207)(2011-3#13)(2011-5#1)(2012-12#53)(2012-2#59)(2012-3#118)(2012-4#2)(2012-5#5)(2012-7#2)(2012-8#1)(2013-1#226)(2013-7#3)(2013-8#70)
after-effects of##2##2##(1991-6#1)(1995-11#1)
after-school program##2##2##(2012-12#1)(2013-1#1)
after-school##3##1##(2012-12#2)(2013-1#1)
afterdischarge##2##1##(1992-3#1)(1994-2#1)
afterglow##2##1##(2008-3#2)
afterload of##2##2##(2008-8#1)(2012-3#1)
afterload##4##1##(2008-7#1)(2008-8#1)(2009-10#1)(2012-3#1)
afternoon and##2##2##(2007-12#1)(2012-6#1)
afternoon##8##1##(1993-12#1)(1994-3#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-6#1)(2013-8#1)
afterpulses##2##1##(2008-3#2)
afterward##3##1##(1995-6#1)(2008-8#1)(2011-2#1)
afterwards##12##1##(1990-6#1)(1994-12#1)(2008-10#5)(2008-11#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
afterxenotransplantation##2##1##(2008-11#2)
again 4##3##2##(1990-2#1)(1993-12#1)(2013-1#1)
again after##2##2##(1993-6#1)(2013-1#1)
again at the end of the##2##6##(2008-10#1)(2008-12#1)
again at##5##2##(1991-2#1)(2008-10#2)(2008-12#1)(2011-2#1)
again by##2##2##(1994-3#1)(2008-10#1)
again following##2##2##(2011-2#1)(2013-1#1)
again for##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
again in the##4##3##(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
again in##9##2##(1996-2#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)
again suggested##2##2##(2008-10#1)(2008-6#1)
again the##2##2##(1992-6#1)(2008-8#1)
again to##4##2##(1991-11#1)(1997-3#1)(2008-10#2)
again with##4##2##(1994-12#1)(2008-10#3)
again##91##1##(1990-2#1)(1990-3#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-6#1)(1993-12#1)(1993-6#3)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#25)(2008-11#2)(2008-12#4)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#3)(2010-1#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#7)
against 16##2##2##(2008-10#1)(2012-2#1)
against A##4##2##(2008-10#3)(2008-5#1)
against AIDS##2##2##(1990-11#1)(1995-1#1)
against Alzheimer's disease##2##3##(2008-7#1)(2011-3#1)
against Aspergillus##2##2##(2008-10#1)(2008-5#1)
against B##4##2##(2008-10#4)
against Botrytis##2##2##(2008-10#2)
against C##6##2##(1995-12#1)(2008-10#3)(2008-5#2)
against Calif/09##2##2##(2011-2#2)
against Candida##2##2##(2008-11#1)(2013-1#1)
against EDTA as well as##2##5##(2008-10#2)
against EDTA##5##2##(2008-10#5)
against F##4##2##(2008-10#3)(2011-10#1)
against Gram-negative##2##2##(2008-10#1)(2008-7#1)
against H##2##2##(2008-10#2)
against HGF was##2##3##(2008-9#2)
against HIV and##2##3##(1991-3#1)(1995-5#1)
against HIV##3##2##(1990-8#1)(1991-3#1)(1995-5#1)
against HIV-1 replicative enzymes##2##4##(2011-3#2)
against HIV-1##5##2##(2011-3#5)
against Haemophilus influenzae type b##2##5##(1995-5#2)
against Haemophilus influenzae type##3##4##(1995-5#2)(2008-11#1)
against Helicobacter pylori##2##3##(2008-10#2)
against Helicobacter##3##2##(1991-2#1)(2008-10#2)
against Heterodera schachtii##2##3##(2008-10#1)(2008-12#1)
against Hib disease##2##3##(1995-5#2)
against M##3##2##(2008-10#2)(2008-11#1)
against P##7##2##(1992-6#1)(2008-10#6)
against PVX##2##2##(2008-10#2)
against Phytophthora infestans##2##3##(2008-10#2)
against Phytophthora##3##2##(2008-10#3)
against Pseudomonas##2##2##(2008-10#1)(2012-2#1)
against Pythium ultimum##2##3##(2008-10#2)
against Rhizoctonia##2##2##(2008-10#2)
against S##2##2##(2008-10#1)(2013-8#1)
against Staphylococcus aureus##2##3##(2008-12#2)
against Streptococcus pneumoniae##3##3##(1995-5#1)(2011-2#2)
against Streptococcus##4##2##(1995-5#1)(2009-6#1)(2011-2#2)
against W-CI##3##2##(2008-10#3)
against a blank##2##3##(2008-10#2)
against a broad range of##2##5##(2008-10#1)(2009-6#1)
against a broad spectrum of##3##5##(1994-5#1)(2008-10#1)(2008-5#1)
against a broad##5##3##(1994-5#1)(2008-10#2)(2008-5#1)(2009-6#1)
against a database##2##3##(2008-4#1)(2008-9#1)
against a human##2##3##(1995-6#1)(2008-11#1)
against a panel of##2##4##(2008-10#1)(2012-3#1)
against a range of##2##4##(2008-10#2)
against a synthetic peptide##2##4##(1995-6#1)(2008-10#1)
against a##51##2##(1991-5#1)(1993-9#1)(1994-5#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-12#2)(2007-12#1)(2008-10#21)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
against addition of an##2##4##(2008-8#2)
against agricultural##2##2##(2008-9#1)(2010-1#1)
against alcohol##2##2##(1994-5#1)(2009-8#1)
against all three##2##3##(2008-10#1)(2008-8#1)
against all##7##2##(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
against an##14##2##(1990-5#1)(1990-8#1)(1992-12#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)
against another##2##2##(2008-10#1)(2012-3#1)
against anthracnose##2##2##(2008-10#2)
against any##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
against apoptosis##2##2##(2008-11#1)(2012-3#1)
against aqueous standards##3##3##(2008-10#3)
against aqueous##4##2##(2008-10#4)
against bacteria and##2##3##(2008-5#2)
against bacteria##3##2##(2008-5#3)
against bacterial speck##3##3##(2008-10#3)
against bacterial##7##2##(1992-5#1)(2008-10#5)(2012-12#1)
against benzo[a]pyrene##2##2##(2008-10#2)
against blood##2##2##(1993-1#1)(1995-6#1)
against blue mold##2##3##(2008-10#2)
against both UVB and UVA##2##5##(2008-5#2)
against both##14##2##(1992-6#2)(1995-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#3)(2010-1#1)(2011-2#1)(2011-3#1)
against bovine##3##2##(1994-5#1)(1995-5#1)(1995-9#1)
against breast cancer##2##3##(1994-8#1)(1997-7#1)
against burnout##3##2##(2010-2#3)
against cancer##6##2##(1994-2#1)(2008-11#3)(2011-2#1)(2013-1#1)
against cell death##2##3##(1997-9#1)(2011-9#1)
against cell##3##2##(1997-9#1)(2008-11#1)(2011-9#1)
against chemical##2##2##(2010-7#2)
against chemically##2##2##(2008-10#2)
against children and adolescents##2##4##(2012-3#2)
against children##5##2##(1993-2#1)(1994-3#1)(2012-3#3)
against chloroquine-resistant malaria##3##3##(1992-6#3)
against cisplatin##2##2##(1990-12#1)(1993-2#1)
against clinical##2##2##(1995-5#1)(2008-5#1)
against cognitive##2##2##(2008-7#1)(2009-6#1)
against colon##2##2##(1993-11#1)(2008-11#1)
against complete proteins (MbSA and ex MbSA)##2##7##(2011-2#2)
against coptisine##2##2##(2008-11#2)
against crocin##2##2##(2008-11#2)
against disease##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
against diseases##3##2##(2009-8#1)(2012-2#2)
against dopaminergic and nondopaminergic neurons##2##5##(2008-7#2)
against dopaminergic neurons##4##3##(2008-7#4)
against dopaminergic##6##2##(2008-7#6)
against drugs##2##2##(2008-8#1)(2013-8#1)
against each##2##2##(2008-8#1)(2011-2#1)
against either##3##2##(2008-10#2)(2011-2#1)
against environmental stress##2##3##(2008-10#2)
against ethanol-induced##3##2##(1992-6#1)(2009-8#1)(2012-3#1)
against experimental##2##2##(1995-5#1)(2013-1#1)
against exploitation##2##2##(2012-3#2)
against five##2##2##(1990-12#1)(2008-6#1)
against foreign##6##2##(1992-12#1)(2008-8#4)(2012-2#1)
against free##2##2##(2008-10#1)(2008-11#1)
against fungal pathogens##3##3##(2008-10#2)(2011-2#1)
against fungal##5##2##(2008-10#4)(2011-2#1)
against further##2##2##(1994-3#1)(2008-7#1)
against future##2##2##(2008-7#2)
against glutamate neurotoxicity##2##3##(2008-7#2)
against glutamate##4##2##(1993-8#1)(2008-7#3)
against gray leaf spot##2##4##(2008-10#2)
against heartwater##3##2##(1996-12#1)(2010-1#2)
against hepatitis B##2##3##(1997-8#1)(2013-1#1)
against high##2##2##(2010-4#1)(2012-4#1)
against hospital##2##2##(1993-12#1)(1997-2#1)
against human##11##2##(1990-6#1)(1991-5#1)(1996-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)
against inactivation by##2##3##(1991-5#1)(1995-11#1)
against infection by##4##3##(2008-10#3)(2008-9#1)
against infection##8##2##(2008-10#4)(2008-9#2)(2009-6#1)(2011-2#1)
against infectious##3##2##(1995-12#1)(2008-4#1)(2011-2#1)
against isolates##2##2##(2008-10#2)
against its##2##2##(1991-7#1)(1994-3#1)
against known resistors##2##3##(2008-10#2)
against known##3##2##(2008-10#2)(2008-9#1)
against late blight##5##3##(2008-10#4)(2009-6#1)
against late##7##2##(2007-12#1)(2008-10#4)(2009-6#1)(2010-11#1)
against lethal##2##2##(1995-2#1)(2009-6#1)
against many##3##2##(2008-10#2)(2010-8#1)
against medical##2##2##(1996-3#1)(2011-2#1)
against microbial##2##2##(2008-11#1)(2008-7#1)
against most##3##2##(1990-8#1)(2010-12#1)(2011-2#1)
against mouse##2##2##(2008-11#1)(2008-9#1)
against multiple cucumber pathogens##2##4##(2008-10#2)
against multiple##4##2##(2008-10#4)
against one##3##2##(1990-5#1)(1990-8#1)(2008-10#1)
against organisms causing serious infections in##2##6##(2008-7#2)
against oropharyngeal and##2##3##(2008-5#2)
against oropharyngeal##3##2##(2008-5#3)
against other##10##2##(1993-1#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#1)(2011-2#1)
against oxidative stress##2##3##(2008-10#1)(2008-5#1)
against oxidative##5##2##(2008-10#1)(2008-5#1)(2009-8#2)(2013-7#1)
against pH##2##2##(2008-10#2)
against partially##2##2##(1990-11#1)(2008-3#1)
against pathogen invasion##2##3##(2008-10#1)(2008-9#1)
against pathogen##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2013-8#1)
against pathogenic##2##2##(2008-10#1)(2009-6#1)
against pathogens and##2##3##(2008-10#1)(2009-6#1)
against pathogens##6##2##(2008-10#2)(2008-6#1)(2009-6#1)(2011-10#1)(2012-2#1)
against plant pathogens##2##3##(2008-10#2)
against plant##4##2##(2008-10#4)
against postharvest##4##2##(2008-10#4)
against potential##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
against powdery mildew##5##3##(2008-10#5)
against protein##2##2##(1990-12#1)(2008-10#1)
against radiation-induced##2##2##(2008-7#2)
against rat##2##2##(1995-12#1)(2008-11#1)
against rust##2##2##(2008-10#2)
against several human cancer cell lines##2##6##(2010-6#1)(2011-3#1)
against several human##3##3##(2008-10#1)(2010-6#1)(2011-3#1)
against several##12##2##(1990-9#1)(2008-10#3)(2008-11#1)(2010-6#1)(2010-8#1)(2011-3#3)(2013-1#1)(2013-8#1)
against six##2##2##(1990-12#1)(2008-11#1)
against smoking##2##2##(1993-2#1)(2008-1#1)
against solid##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
against soluble antigens##2##3##(1997-9#1)(2008-11#1)
against some##2##2##(2012-2#1)(2013-1#1)
against stresses##2##2##(1991-5#1)(2008-10#1)
against such##2##2##(2008-6#1)(2008-8#1)
against surface antigens from##2##4##(2008-10#2)
against synthetic##3##2##(1994-11#1)(1996-12#1)(2008-5#1)
against target##2##2##(1997-5#1)(2008-11#1)
against the C-terminal##2##3##(1993-8#1)(1996-12#1)
against the bacteria##2##3##(2008-5#1)(2010-6#1)
against the benefit of##2##4##(1997-8#1)(2008-8#1)
against the challenges##2##3##(2008-9#1)(2013-8#1)
against the coat proteins##2##4##(2008-10#2)
against the cytotoxic##2##3##(1992-7#1)(2008-11#1)
against the development of##5##4##(1991-2#1)(1991-6#1)(1995-12#1)(2008-8#1)(2009-6#1)
against the disease##3##3##(2008-10#2)(2011-2#1)
against the enzymes##2##3##(1997-3#1)(2008-11#1)
against the fungal pathogen Magnaporthe grisea##2##6##(2008-10#2)
against the human##2##3##(2008-11#1)(2011-1#1)
against the major##2##3##(2008-10#1)(2008-11#1)
against the other##3##3##(2008-10#3)
against the pathogen##4##3##(2008-10#3)(2011-2#1)
against the renal toxicity##2##4##(1994-5#2)
against the role of##2##4##(2008-7#2)
against the tumor spheroid##2##4##(2008-11#2)
against the union##2##3##(1995-12#2)
against the virus##2##3##(1997-5#1)(2013-8#1)
against the##196##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-2#3)(1991-5#2)(1991-6#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-2#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#6)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#2)(1997-7#3)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#47)(2008-11#20)(2008-12#2)(2008-3#2)(2008-5#5)(2008-7#4)(2008-8#9)(2008-9#7)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#4)(2013-8#3)
against their##2##2##(2008-11#1)(2009-8#1)
against them##2##2##(2008-10#1)(2009-3#1)
against these##9##2##(1990-5#1)(1993-8#1)(2008-10#4)(2008-11#1)(2009-12#1)(2013-1#1)
against this##11##2##(1990-2#1)(1993-2#1)(1995-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2009-1#1)(2012-2#2)
against three##4##2##(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
against topoisomerase##2##2##(1993-8#2)
against tuberculosis##3##2##(1995-2#2)(2011-2#1)
against tumor necrosis##2##3##(2010-12#1)(2012-2#1)
against tumor##4##2##(2008-11#2)(2010-12#1)(2012-2#1)
against two##4##2##(1992-9#1)(2008-10#2)(2011-2#1)
against type 2 diabetes##2##4##(2012-2#2)
against type##3##2##(2008-8#1)(2012-2#2)
against typical##3##2##(1995-5#2)(2008-10#1)
against various pathogenic##2##3##(1993-3#1)(2012-2#1)
against various##13##2##(1991-2#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-11#3)(2011-2#1)(2012-2#1)
against violence##2##2##(2013-1#2)
against vitellin cleavage products##2##4##(2007-12#2)
against which##4##2##(1995-5#1)(2008-10#1)(2008-5#1)(2008-8#1)
against women##2##2##(1990-2#1)(1995-12#1)
against##1262##1##(1990-11#4)(1990-12#4)(1990-2#4)(1990-5#7)(1990-6#3)(1990-8#7)(1990-9#3)(1991-12#1)(1991-2#6)(1991-3#1)(1991-5#8)(1991-6#8)(1991-7#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#4)(1992-6#13)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#6)(1993-2#7)(1993-3#8)(1993-5#1)(1993-6#1)(1993-8#8)(1993-9#4)(1994-1#1)(1994-11#5)(1994-2#4)(1994-3#7)(1994-5#9)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#24)(1995-2#8)(1995-3#2)(1995-5#21)(1995-6#11)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#16)(1996-2#4)(1996-3#4)(1996-5#5)(1996-6#3)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#7)(1997-6#1)(1997-7#9)(1997-8#4)(1997-9#2)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#328)(2008-11#115)(2008-12#17)(2008-3#5)(2008-4#7)(2008-5#61)(2008-6#7)(2008-7#42)(2008-8#42)(2008-9#32)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#6)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#13)(2009-8#11)(2010-1#8)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-10#2)(2011-2#58)(2011-3#12)(2011-9#1)(2012-12#3)(2012-2#33)(2012-3#22)(2012-4#1)(2013-1#37)(2013-7#4)(2013-8#15)
aganglionic megacolon##2##2##(1994-12#2)
agar amended with##2##3##(2008-10#2)
agar and##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
agar at##3##2##(2008-10#1)(2008-5#2)
agar concentration##2##2##(2012-2#2)
agar culture##2##2##(2008-10#1)(2008-9#1)
agar diffusion test##2##3##(2008-10#1)(2008-5#1)
agar dilution method##3##3##(2008-10#2)(2012-3#1)
agar dilution##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)
agar medium##12##2##(1993-12#2)(1993-8#1)(2008-10#8)(2011-2#1)
agar or##3##2##(2008-10#3)
agar plate##3##2##(2008-10#3)
agar plates##10##2##(2008-10#5)(2008-7#2)(2010-6#3)
agar plating##2##2##(2008-10#2)
agar was##3##2##(2008-10#3)
agar were##3##2##(2008-10#2)(2008-12#1)
agar##125##1##(1990-5#1)(1990-6#1)(1993-12#4)(1993-8#1)(1995-2#2)(2008-10#80)(2008-11#4)(2008-12#4)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2010-6#5)(2011-2#1)(2012-2#6)(2012-3#1)
agarobiose oligomers##3##2##(2008-10#3)
agarobiose##4##1##(2008-10#4)
agarose gel electrophoresis##7##3##(1991-5#2)(1993-8#1)(1995-8#1)(2008-10#3)
agarose gel was##5##3##(2008-10#5)
agarose gel##18##2##(1991-5#2)(1992-3#1)(1993-8#1)(1995-8#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-9#2)
agarose gels##2##2##(2008-10#2)
agarose immobilised insulin receptors##2##4##(1993-8#2)
agarose##38##1##(1991-5#2)(1992-3#1)(1993-8#8)(1995-8#1)(1997-3#1)(2008-10#16)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)
agarose-based anion exchanger (Q-Sepharose)##2##4##(2008-10#2)
agarose-based##4##1##(2008-10#4)
agate-grinding##2##1##(2009-12#2)
agave species##2##2##(2009-8#2)
agave##5##1##(2008-10#1)(2009-8#4)
age &lt##2##2##(2008-10#1)(2011-2#1)
age (OR =##2##3##(1994-12#1)(2010-11#1)
age (P &lt##3##3##(1993-2#1)(2011-2#1)(2012-3#1)
age (P##6##2##(1991-9#1)(1993-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
age (p&lt##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
age (r = -0##2##4##(1995-8#2)
age (r =##3##3##(1995-8#2)(2010-4#1)
age 11##2##2##(2010-1#1)(2011-2#1)
age 18 to##2##3##(1996-2#1)(2013-1#1)
age 18##4##2##(1996-2#1)(1997-3#1)(2010-6#1)(2013-1#1)
age 2##2##2##(1995-12#1)(2013-1#1)
age 29##2##2##(1997-3#1)(2008-11#1)
age 30##2##2##(1991-6#1)(2008-12#1)
age 34##2##2##(1993-11#1)(2008-12#1)
age 35##4##2##(1990-6#1)(1991-3#1)(1997-4#2)
age 38##2##2##(1997-3#2)
age 45##2##2##(1994-3#1)(1994-6#1)
age 50##3##2##(1990-6#1)(1994-3#2)
age 6##2##2##(1994-9#1)(2008-10#1)
age 60##2##2##(2009-9#1)(2012-3#1)
age 65##3##2##(1993-1#1)(1994-6#1)(2008-11#1)
age 80##2##2##(2008-7#1)(2012-12#1)
age = 13##2##3##(2009-7#1)(2010-1#1)
age =##9##2##(2008-7#1)(2009-1#1)(2009-7#2)(2010-1#4)(2010-8#1)
age after##2##2##(2008-6#1)(2013-1#1)
age amphorae##2##2##(2008-10#2)
age and ICH volume##2##4##(2012-3#2)
age and ICH##3##3##(2012-3#3)
age and education##3##3##(1990-2#1)(2009-8#1)(2010-1#1)
age and gender##5##3##(1994-3#1)(2008-11#1)(2010-4#1)(2010-9#1)(2012-2#1)
age and leaf age##2##4##(2008-10#2)
age and quantified smoking##2##4##(2008-10#2)
age and sex matched##2##4##(2009-8#1)(2012-2#1)
age and sex of##2##4##(1991-8#2)
age and sex##14##3##(1991-11#1)(1991-8#2)(2008-11#1)(2008-12#2)(2008-7#3)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
age and size##4##3##(2008-8#4)
age and the##8##3##(1992-2#2)(1992-5#1)(1993-12#1)(1995-9#1)(1997-8#1)(2008-7#1)(2008-9#1)
age and##102##2##(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-8#2)(1992-2#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#10)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-4#2)(2010-9#2)(2011-1#2)(2011-2#7)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#2)
age are##3##2##(2006-5#1)(2008-8#1)(2012-3#1)
age as a##2##3##(2008-11#1)(2008-12#1)
age as##7##2##(1990-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
age at bilateral implantation##2##4##(2012-2#2)
age at diagnosis was##2##4##(2008-7#1)(2011-2#1)
age at diagnosis##6##3##(1990-12#1)(1990-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
age at disease onset##2##4##(2012-12#1)(2013-8#1)
age at first birth##2##4##(2009-5#2)
age at first egg##2##4##(2008-12#2)
age at first intercourse was##2##5##(1990-9#2)
age at first intercourse##5##4##(1990-9#5)
age at first##13##3##(1990-9#5)(1991-6#1)(1995-12#1)(2008-12#3)(2008-8#1)(2009-5#2)
age at implant##2##3##(2008-9#2)
age at implantation was##2##4##(2008-9#2)
age at implantation##3##3##(2008-9#3)
age at inoculation##5##3##(2008-10#5)
age at maturity and fertility##2##5##(2008-8#2)
age at maturity##3##3##(2008-8#3)
age at onset##2##3##(2008-7#1)(2011-2#1)
age at peak BMD##3##4##(2010-3#3)
age at sexual maturity##2##4##(2008-8#2)
age at the time of##4##5##(2008-10#1)(2008-9#2)(2012-2#1)
age at the##5##3##(2008-10#1)(2008-11#1)(2008-9#2)(2012-2#1)
age at which the##2##4##(1993-3#1)(2008-10#1)
age at which##6##3##(1991-8#2)(1993-3#1)(2008-10#1)(2008-8#1)(2009-5#1)
age at##67##2##(1990-12#1)(1990-8#1)(1990-9#5)(1991-6#1)(1991-8#2)(1993-3#1)(1994-6#1)(1995-12#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-7#2)(2008-8#10)(2008-9#7)(2009-3#2)(2009-5#3)(2010-10#1)(2010-3#3)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#1)
age average##3##2##(2008-5#1)(2011-2#2)
age but##2##2##(2008-7#1)(2008-8#1)
age can be##2##3##(2008-8#1)(2010-12#1)
age children##3##2##(1995-12#1)(2007-12#1)(2008-3#1)
age differences##4##2##(1993-1#1)(2008-5#1)(2013-1#1)(2013-8#1)
age distribution of the##2##4##(1990-6#1)(1997-8#1)
age distribution of##3##3##(1990-6#1)(1997-8#1)(2009-7#1)
age distribution##5##2##(1990-6#1)(1996-3#1)(1997-4#1)(1997-8#1)(2009-7#1)
age for the##3##3##(1990-8#1)(2007-12#1)(2008-11#1)
age for##7##2##(1990-8#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
age from##9##2##(1990-8#1)(1994-2#1)(1994-5#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
age group 16-19##2##3##(1990-2#1)(2012-2#1)
age group and##4##3##(1990-2#1)(1991-2#1)(1994-12#1)(2009-12#1)
age group of##4##3##(1991-2#1)(2008-11#2)(2008-7#1)
age group remains##2##3##(1997-1#1)(2012-3#1)
age group were##3##3##(1991-8#1)(1995-12#1)(2008-7#1)
age group##57##2##(1990-12#1)(1990-2#2)(1990-6#2)(1991-2#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-9#2)(1993-11#2)(1994-12#4)(1994-9#1)(1995-12#1)(1996-11#2)(1996-9#2)(1997-1#4)(1997-3#1)(2008-11#3)(2008-12#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#2)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#8)(2013-1#1)(2013-7#1)
age groups and##2##3##(1996-9#1)(2010-7#1)
age groups of##5##3##(1993-9#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
age groups##42##2##(1990-6#2)(1991-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#9)(2008-9#2)(2009-10#1)(2009-7#1)(2010-7#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)
age had a significant##2##4##(2008-10#2)
age had##3##2##(2008-10#3)
age in both##2##3##(2008-7#1)(2012-2#1)
age in the##8##3##(1990-11#1)(1990-8#1)(1991-11#1)(1996-11#1)(1996-2#1)(2008-7#3)
age in##28##2##(1990-11#1)(1990-3#4)(1990-8#1)(1991-1#1)(1991-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#6)(2010-6#1)(2010-8#1)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#1)
age increased##2##2##(1997-4#1)(2008-10#1)
age is a##2##3##(2009-12#1)(2013-7#1)
age is associated with##2##4##(2009-12#1)(2013-7#1)
age is##14##2##(1990-11#2)(1991-12#1)(1991-6#1)(1992-5#1)(1995-8#2)(2008-10#1)(2008-7#1)(2009-12#2)(2012-12#1)(2013-7#2)
age less than##2##3##(1991-2#1)(1997-8#1)
age may be##2##3##(2006-5#1)(2008-7#1)
age may##3##2##(1997-3#1)(2006-5#1)(2008-7#1)
age of 10##3##3##(2008-5#1)(2008-9#1)(2011-1#1)
age of 11##2##3##(2010-1#1)(2011-1#1)
age of 2##2##3##(1997-3#2)
age of 3##5##3##(1994-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
age of 30##4##3##(1991-8#1)(1997-3#1)(2008-11#1)(2009-10#1)
age of 32##2##3##(2008-1#1)(2008-7#1)
age of 34 years##2##4##(2008-7#1)(2008-9#1)
age of 40 years##3##4##(2008-5#2)(2008-9#1)
age of 40##7##3##(2008-5#2)(2008-7#1)(2008-9#1)(2012-3#3)
age of 41##2##3##(1994-12#1)(2012-3#1)
age of 42##2##3##(1992-5#1)(2008-12#1)
age of 50##7##3##(1994-12#2)(2007-8#1)(2008-5#2)(2009-8#1)(2011-2#1)
age of 6##4##3##(1997-3#1)(2008-7#1)(2013-1#1)(2013-7#1)
age of 62##2##3##(1992-9#1)(2013-1#1)
age of 65##2##3##(2010-8#1)(2011-2#1)
age of 8##2##3##(2008-1#1)(2013-1#1)
age of a##6##3##(1996-3#1)(2008-10#3)(2008-8#1)(2008-9#1)
age of chicks from##2##4##(2008-5#1)(2008-8#1)
age of initial##2##3##(1994-8#1)(1996-12#1)
age of internationalism##2##3##(1992-5#2)
age of onset##8##3##(1995-8#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2011-2#1)
age of patients with##2##4##(2008-9#1)(2012-12#1)
age of patients##4##3##(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
age of the patient##3##4##(1990-9#1)(2008-7#1)(2012-3#1)
age of the patients was##10##5##(1991-8#1)(1993-2#1)(1997-8#1)(2008-1#2)(2008-11#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-3#1)
age of the patients##12##4##(1991-8#1)(1993-2#1)(1997-8#1)(2008-1#2)(2008-11#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
age of the##30##3##(1990-6#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-2#1)(1994-11#1)(1997-6#2)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
age of these patients##2##4##(2012-3#1)(2013-1#1)
age of two##2##3##(1990-9#1)(1993-11#1)
age of##182##2##(1990-12#2)(1990-6#2)(1990-9#3)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-5#3)(1992-9#1)(1993-11#1)(1993-2#2)(1994-11#1)(1994-12#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-3#7)(1997-6#2)(1997-7#1)(1997-8#3)(2007-8#3)(2008-1#5)(2008-10#15)(2008-11#5)(2008-12#1)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#7)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-3#2)(2010-6#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#9)(2013-1#12)(2013-7#2)(2013-8#2)
age old##2##2##(1990-3#1)(2008-11#1)
age on infection##3##3##(2008-10#3)
age on the##3##3##(1990-3#1)(2008-9#1)(2011-2#1)
age on##16##2##(1990-3#1)(1995-8#1)(2008-10#6)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#2)
age or##7##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(2008-7#1)(2010-11#1)
age range 18-84 years##2##4##(2013-1#2)
age range##12##2##(1994-12#2)(2008-11#1)(2008-7#5)(2011-2#2)(2013-1#2)
age ranges##3##2##(1994-12#1)(2012-12#1)(2013-1#1)
age related changes in##3##4##(1990-11#2)(2011-2#1)
age related changes##5##3##(1990-11#2)(2008-12#1)(2011-2#2)
age related##11##2##(1990-11#2)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#6)
age spots##3##2##(2008-5#2)(2011-2#1)
age structure##2##2##(2013-8#2)
age than##2##2##(2008-7#1)(2008-9#1)
age to##4##2##(1991-7#1)(2008-12#1)(2011-2#1)(2012-12#1)
age was 33##2##3##(2010-1#1)(2012-3#1)
age was 48##2##3##(2008-9#1)(2011-2#1)
age was 66##2##3##(2008-3#1)(2008-7#1)
age was##38##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1993-11#1)(1993-12#1)(1995-8#1)(1997-8#1)(2008-12#2)(2008-3#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-3#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)
age were##9##2##(1995-12#1)(1995-8#1)(1996-1#1)(1996-3#1)(2008-10#3)(2012-12#1)(2012-3#1)
age when##3##2##(2008-8#1)(2009-7#1)(2010-1#1)
age while##3##2##(1997-7#1)(2010-11#1)(2012-3#1)
age with##6##2##(1994-6#1)(1994-9#1)(1997-3#1)(2011-2#1)(2013-1#2)
age##1284##1##(1990-11#11)(1990-12#6)(1990-2#7)(1990-3#14)(1990-5#2)(1990-6#13)(1990-8#8)(1990-9#9)(1991-1#2)(1991-11#8)(1991-12#7)(1991-2#8)(1991-3#5)(1991-6#20)(1991-7#2)(1991-8#9)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#5)(1992-5#5)(1992-6#1)(1992-9#4)(1993-1#4)(1993-11#7)(1993-12#9)(1993-2#6)(1993-3#5)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#14)(1994-2#4)(1994-3#8)(1994-5#1)(1994-6#11)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#11)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#18)(1995-9#1)(1996-1#1)(1996-11#5)(1996-12#1)(1996-2#7)(1996-3#14)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#7)(1997-1#5)(1997-2#2)(1997-3#25)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#11)(2006-5#4)(2007-12#4)(2007-8#4)(2008-1#9)(2008-10#98)(2008-11#48)(2008-12#31)(2008-3#5)(2008-4#1)(2008-5#31)(2008-6#5)(2008-7#114)(2008-8#38)(2008-9#38)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#8)(2009-3#4)(2009-5#7)(2009-6#2)(2009-7#8)(2009-8#9)(2009-9#6)(2010-1#14)(2010-10#4)(2010-11#6)(2010-12#3)(2010-2#2)(2010-3#8)(2010-4#4)(2010-5#1)(2010-6#7)(2010-7#3)(2010-8#14)(2010-9#5)(2011-1#14)(2011-2#114)(2011-3#5)(2011-7#2)(2012-12#25)(2012-2#22)(2012-3#64)(2012-5#1)(2013-1#68)(2013-3#3)(2013-7#7)(2013-8#29)
age)##8##1##(2008-10#2)(2008-11#1)(2008-7#3)(2010-10#1)(2012-12#1)
age- and sex-matched##4##3##(2008-7#3)(2011-2#1)
age- and##8##2##(1991-12#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-7#3)(2011-2#1)
age-adjusted mortality##2##2##(2012-3#2)
age-adjusted##8##1##(1997-7#1)(2008-10#2)(2012-12#1)(2012-3#3)(2013-1#1)
age-appropriate##4##1##(1992-1#1)(2009-11#1)(2011-1#1)(2011-2#1)
age-associated diseases##2##2##(2008-7#2)
age-associated##5##1##(2008-7#4)(2013-7#1)
age-dependent decrease##2##2##(1993-12#1)(2008-7#1)
age-dependent##5##1##(1993-12#1)(1995-8#2)(2008-7#1)(2010-8#1)
age-group##2##1##(2011-9#1)(2012-3#1)
age-groups##2##1##(1992-2#1)(1993-12#1)
age-matched control subjects##2##3##(1995-5#1)(2008-7#1)
age-matched control##3##2##(1995-5#1)(2008-10#1)(2008-7#1)
age-matched controls##4##2##(2008-11#1)(2008-7#3)
age-matched healthy controls##2##3##(1996-11#1)(2008-7#1)
age-matched healthy##3##2##(1996-11#1)(2008-7#1)(2010-12#1)
age-matched normal##2##2##(1993-1#1)(2008-7#1)
age-matched##21##1##(1993-1#1)(1995-5#1)(1996-11#1)(2008-10#3)(2008-11#2)(2008-7#8)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
age-related changes in the##5##4##(1990-3#1)(2008-11#1)(2008-5#1)(2008-7#2)
age-related changes in##9##3##(1990-3#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-5#2)(2008-7#3)
age-related changes##11##2##(1990-3#1)(1991-12#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-5#2)(2008-7#4)
age-related cognitive decline##2##3##(2008-6#1)(2009-8#1)
age-related cognitive##3##2##(2008-6#1)(2009-8#1)(2012-3#1)
age-related decline##2##2##(2008-11#1)(2008-7#1)
age-related decrease in##2##3##(1990-3#1)(1995-8#1)
age-related differences in##2##3##(2008-11#2)
age-related differences##3##2##(2008-11#2)(2008-7#1)
age-related increase##2##2##(1996-2#1)(2008-5#1)
age-related macular degeneration (AMD)##4##4##(2011-2#2)(2011-7#1)(2013-1#1)
age-related macular degeneration##10##3##(2010-8#1)(2011-2#6)(2011-7#2)(2013-1#1)
age-related macular##11##2##(2010-8#1)(2011-2#7)(2011-7#2)(2013-1#1)
age-related##57##1##(1990-11#1)(1990-3#2)(1991-12#1)(1993-1#1)(1995-6#3)(1995-8#3)(1996-11#1)(1996-2#2)(1997-4#1)(2008-10#2)(2008-11#6)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#8)(2011-7#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
age-specific death rates##2##3##(1997-2#1)(1997-7#1)
age-specific incidence##2##2##(1991-2#1)(1994-12#1)
age-specific mortality##2##2##(1995-8#1)(2008-8#1)
age-specific rates##2##2##(1991-6#1)(1992-2#1)
age-specific##18##1##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-12#2)(1995-8#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
age-standardized##2##1##(1991-6#1)(1992-2#1)
age-structured##2##1##(1995-5#1)(2011-3#1)
age?##3##1##(1992-11#1)(2010-10#1)(2012-2#1)
aged &lt##3##2##(2012-12#1)(2013-1#2)
aged 1##2##2##(1993-12#1)(2011-2#1)
aged 10##3##2##(2008-9#1)(2011-1#1)(2013-1#1)
aged 12##2##2##(1994-6#1)(2011-2#1)
aged 12-17##2##2##(2008-9#1)(2010-11#1)
aged 12-18 years##2##3##(1997-6#1)(2012-2#1)
aged 15 years or over##2##5##(1994-6#2)
aged 16 to##3##3##(1990-6#1)(2013-1#1)(2013-8#1)
aged 18 to##5##3##(1992-1#2)(2008-1#1)(2013-1#2)
aged 18 years##2##3##(2010-1#1)(2013-1#1)
aged 18##8##2##(1992-1#2)(1997-8#1)(2008-1#1)(2010-1#1)(2013-1#3)
aged 20 to##2##3##(2011-2#1)(2013-8#1)
aged 21-40 years##2##3##(2009-10#1)(2011-2#1)
aged 22##2##2##(2008-10#1)(2011-2#1)
aged 24 to##2##3##(1991-4#1)(2013-1#1)
aged 35-74##2##2##(2008-10#1)(2011-2#1)
aged 40##2##2##(1995-12#1)(2009-5#1)
aged 40-42 in##2##3##(1991-6#2)
aged 40-42##6##2##(1991-6#6)
aged 44##2##2##(1990-12#1)(1996-11#1)
aged 45##2##2##(2012-12#1)(2013-8#1)
aged 50##3##2##(1995-12#1)(2012-12#2)
aged 6##2##2##(1996-3#1)(2012-12#1)
aged 60 years or##2##4##(1992-5#1)(1996-6#1)
aged 60##4##2##(1992-5#1)(1996-6#1)(2011-2#1)(2013-8#1)
aged 65##3##2##(1990-12#1)(2008-11#1)(2010-10#1)
aged 70 years and over##2##5##(2008-7#2)
aged 70 years##3##3##(2008-7#3)
aged 70##4##2##(2008-7#3)(2013-1#1)
aged 85 years##2##3##(2008-7#1)(2012-12#1)
aged Medicare beneficiaries##3##3##(1993-12#2)(1997-2#1)
aged Medicare##5##2##(1991-1#1)(1993-12#3)(1997-2#1)
aged and disabled Medicare beneficiaries##2##5##(1991-2#1)(1991-3#1)
aged and disabled Medicare##3##4##(1991-2#1)(1991-3#1)(1997-1#1)
aged and palliative care policies##2##5##(2010-10#2)
aged and##7##2##(1990-6#1)(1991-2#1)(1991-3#1)(1997-1#1)(2008-10#1)(2010-10#2)
aged as##2##2##(1990-5#1)(1995-12#1)
aged between 4 and##2##4##(2008-9#1)(2013-1#1)
aged between 6##2##3##(2008-5#1)(2011-1#1)
aged between##23##2##(1990-9#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#3)
aged care in##2##3##(2010-10#2)
aged care##12##2##(2008-11#1)(2010-10#11)
aged from##4##2##(1991-9#1)(1996-12#1)(2010-11#1)(2011-2#1)
aged in##3##2##(1991-1#1)(1994-1#1)(2008-10#1)
aged individuals##2##2##(2009-1#1)(2013-1#1)
aged less than##3##3##(1990-3#1)(1994-12#1)(2012-12#1)
aged less##4##2##(1990-3#1)(1994-12#1)(2010-6#1)(2012-12#1)
aged over 60##2##3##(1990-6#1)(2012-3#1)
aged over 65##2##3##(1992-9#1)(2012-12#1)
aged over##7##2##(1990-6#1)(1992-9#1)(1994-2#1)(2008-10#1)(2012-12#1)(2012-3#2)
aged people##3##2##(1990-3#1)(2012-3#1)(2013-1#1)
aged persons##3##2##(1991-12#1)(1991-3#1)(1994-12#1)
aged population##3##2##(1996-3#1)(2008-7#2)
aged rat##3##2##(1990-5#1)(1992-12#1)(1994-2#1)
aged rats##6##2##(1990-5#1)(1992-12#2)(1995-8#1)(2008-7#2)
aged under##2##2##(2008-9#1)(2013-8#1)
aged##283##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#5)(1990-6#6)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#7)(1991-9#1)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-6#3)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#6)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2008-1#3)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#22)(2008-9#7)(2009-1#1)(2009-10#2)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#15)(2010-11#3)(2010-12#1)(2010-3#4)(2010-6#4)(2010-7#2)(2011-1#4)(2011-2#19)(2012-12#11)(2012-2#8)(2012-3#7)(2013-1#22)(2013-3#1)(2013-7#3)(2013-8#6)
aged-care##8##1##(2010-10#8)
ageing and the##2##3##(2008-10#2)
ageing and##10##2##(1992-11#1)(1995-3#1)(2008-10#3)(2008-5#2)(2009-10#2)(2012-2#1)
ageing in##2##2##(1990-5#1)(2008-5#1)
ageing is##4##2##(2008-10#1)(2008-5#3)
ageing of the##3##3##(1991-11#1)(2008-10#2)
ageing of##6##2##(1990-3#1)(1990-5#1)(1991-11#1)(2008-10#3)
ageing period##2##2##(2008-10#2)
ageing process##5##2##(1992-11#1)(2008-10#2)(2008-5#1)(2008-7#1)
ageing##68##1##(1990-3#2)(1990-5#2)(1991-11#1)(1992-11#2)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#18)(2008-11#4)(2008-5#20)(2008-7#3)(2009-10#4)(2009-8#1)(2010-10#2)(2012-2#2)(2013-1#1)(2013-7#3)
agencies and their patients##2##4##(1995-3#2)
agencies and##7##2##(1991-3#1)(1995-3#2)(1996-1#1)(1997-2#1)(1997-3#2)
agencies are in##2##3##(1994-1#1)(1996-3#1)
agencies are##3##2##(1994-1#1)(1996-3#1)(2011-2#1)
agencies at##2##2##(1996-3#1)(2010-12#1)
agencies have##3##2##(1996-2#1)(1997-1#2)
agencies in##9##2##(1992-3#1)(1994-2#1)(1995-12#2)(1995-3#3)(1997-3#1)(2008-10#1)
agencies such as the##3##4##(2008-1#1)(2008-8#1)(2012-2#1)
agencies to##10##2##(1995-12#2)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#1)(2009-3#2)
agencies with##2##2##(1995-3#2)
agencies##99##1##(1991-12#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#6)(1995-3#10)(1996-1#8)(1996-12#1)(1996-2#5)(1996-3#4)(1997-1#7)(1997-2#5)(1997-3#9)(2008-1#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
agency and##2##2##(2008-11#1)(2009-5#1)
agency relationship##2##2##(1993-12#1)(1997-1#1)
agency setting##4##2##(1996-2#4)
agency was##2##2##(2008-11#1)(2012-12#1)
agency##47##1##(1991-12#2)(1991-3#2)(1992-8#1)(1993-1#2)(1993-12#1)(1994-1#1)(1994-3#1)(1995-3#4)(1995-6#3)(1996-2#5)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#6)(2008-11#5)(2009-3#1)(2009-5#1)(2010-8#2)(2012-12#1)(2012-2#2)(2012-3#1)
agenda for##5##2##(1997-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
agenda of##2##2##(2008-10#1)(2008-12#1)
agenda to##2##2##(1991-1#1)(2008-11#1)
agenda##24##1##(1991-1#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-3#1)(1997-1#3)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#4)(2009-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
agendas of##3##2##(1995-3#1)(1997-2#1)(2009-3#1)
agendas##6##1##(1995-3#1)(1997-2#2)(2008-12#2)(2009-3#1)
agenesis of the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
agenesis##10##1##(1993-1#2)(2008-10#3)(2008-11#1)(2011-2#1)(2012-3#3)
agent (sodium##2##2##(2008-10#1)(2008-11#1)
agent Pseudomonas fluorescens##2##3##(2008-10#2)
agent against##3##2##(1993-2#1)(1997-5#1)(2008-12#1)
agent and its##2##3##(2008-10#1)(2008-11#1)
agent and the##2##3##(2008-10#2)
agent and##20##2##(1990-9#1)(1991-2#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)
agent can be##2##3##(2008-10#1)(2010-12#1)
agent can##3##2##(2008-10#1)(2010-12#2)
agent capable of##2##3##(2008-5#2)
agent database##2##2##(2010-5#2)
agent during##2##2##(2008-10#1)(2009-12#1)
agent for further##2##3##(1994-9#1)(2008-10#1)
agent for the##13##3##(1996-5#1)(2008-10#9)(2008-12#1)(2012-2#2)
agent for##36##2##(1991-3#1)(1994-9#1)(1996-5#1)(2008-1#1)(2008-10#21)(2008-12#1)(2008-5#3)(2008-7#2)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
agent from##3##2##(1994-11#1)(2008-10#2)
agent has been##3##3##(2008-10#2)(2008-5#1)
agent has##9##2##(2008-10#5)(2008-12#1)(2008-5#1)(2010-10#1)(2013-8#1)
agent in the##5##3##(1991-6#1)(1997-1#1)(2008-11#2)(2008-5#1)
agent in##25##2##(1991-5#1)(1991-6#2)(1993-3#1)(1994-8#2)(1997-1#1)(2007-11#1)(2008-10#8)(2008-11#4)(2008-5#3)(2008-6#1)(2010-11#1)
agent into the##2##3##(1997-8#1)(2010-4#1)
agent is a potent##2##4##(1993-3#1)(1995-8#1)
agent is##10##2##(1993-3#1)(1994-8#1)(1995-8#1)(2008-10#5)(2010-5#1)(2011-2#1)
agent may##2##2##(2008-5#1)(2008-9#1)
agent of Fusarium##4##3##(2008-10#4)
agent of Lyme##2##3##(1992-3#1)(2011-2#1)
agent of bacterial##4##3##(2008-10#3)(2009-6#1)
agent of citrus##2##3##(2008-10#2)
agent of grape##2##3##(2008-10#2)
agent of the##4##3##(2008-10#4)
agent of white##3##3##(2008-10#3)
agent of##131##2##(1990-5#1)(1992-3#1)(1992-8#1)(1997-4#1)(1997-5#1)(2008-10#104)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-6#1)(2011-10#1)(2011-2#6)(2012-2#2)(2013-1#4)(2013-8#1)
agent on the##2##3##(1996-3#1)(2008-10#1)
agent on##4##2##(1996-3#1)(2008-10#3)
agent or##3##2##(2007-11#1)(2009-6#1)(2011-2#1)
agent should##2##2##(1991-12#1)(2008-10#1)
agent sodium##2##2##(2008-10#2)
agent that##9##2##(1992-9#1)(1993-6#2)(1995-2#1)(1996-5#1)(2008-10#4)
agent to##8##2##(2008-10#4)(2008-5#2)(2009-12#1)(2011-2#1)
agent under##4##2##(1996-5#1)(2008-10#2)(2008-5#1)
agent was##13##2##(1990-10#1)(1991-3#1)(2008-10#8)(2008-5#1)(2010-8#1)(2012-3#1)
agent were##2##2##(1991-3#1)(2008-10#1)
agent which##2##2##(1992-12#1)(2008-11#1)
agent with a##2##3##(2010-7#1)(2013-7#1)
agent with##6##2##(1993-1#1)(2008-10#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-7#1)
agent##560##1##(1990-10#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#8)(1991-5#3)(1991-6#2)(1992-12#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#2)(1993-3#4)(1993-6#2)(1994-11#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#4)(1996-12#1)(1996-3#3)(1996-5#3)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#3)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#305)(2008-11#28)(2008-12#9)(2008-4#2)(2008-5#27)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-12#2)(2009-3#1)(2009-6#3)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#19)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#7)
agent) and##2##2##(2008-10#2)
agent)##8##1##(1997-2#1)(2008-10#7)
agent-based models##3##2##(2010-5#2)(2013-8#1)
agent-based##5##1##(2008-8#1)(2010-5#2)(2013-8#2)
agents active##3##2##(1996-2#2)(2011-2#1)
agents against##11##2##(1992-6#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)
agents alone##2##2##(1994-6#1)(1995-2#1)
agents and##27##2##(1992-12#1)(1992-4#1)(1995-8#1)(1996-11#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
agents are the most##2##4##(1991-3#1)(2008-11#1)
agents are the##3##3##(1991-3#1)(1993-9#1)(2008-11#1)
agents are##19##2##(1991-3#1)(1993-8#1)(1993-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-9#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#2)
agents as##2##2##(2008-10#1)(2010-5#1)
agents at##3##2##(1992-3#1)(1992-9#1)(2008-10#1)
agents based on##2##3##(2008-5#1)(2013-1#1)
agents by##3##2##(2008-11#2)(2010-9#1)
agents can##3##2##(2008-8#1)(2010-6#1)(2012-12#1)
agents could be##2##3##(1990-12#1)(2008-10#1)
agents currently##2##2##(2008-5#1)(2009-6#1)
agents did##2##2##(2008-10#2)
agents due to##2##3##(2008-7#1)(2012-3#1)
agents elicit##2##2##(1991-5#1)(1994-11#1)
agents for the management of##3##5##(2009-12#1)(2011-2#1)(2013-1#1)
agents for the treatment of##3##5##(2009-12#1)(2009-6#1)(2011-2#1)
agents for the treatment##4##4##(2009-12#1)(2009-6#1)(2010-1#1)(2011-2#1)
agents for the##8##3##(2009-12#2)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#1)
agents for treating##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
agents for treatment of##2##4##(2010-6#1)(2011-2#1)
agents for##30##2##(1991-1#1)(1992-12#1)(1994-11#1)(2008-10#10)(2008-2#1)(2008-9#1)(2009-12#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-3#1)(2013-1#2)
agents has been##3##3##(2008-10#3)
agents has##7##2##(2008-10#5)(2010-6#1)(2011-2#1)
agents have been used##2##4##(2009-1#1)(2013-1#1)
agents have been##6##3##(2008-7#1)(2009-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
agents have##10##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-1#3)
agents in reducing##2##3##(2008-8#1)(2013-1#1)
agents in the treatment of##2##5##(1990-5#1)(2008-8#1)
agents in the##6##3##(1990-5#1)(1991-1#1)(1995-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
agents in##36##2##(1990-5#1)(1991-1#1)(1991-11#1)(1992-12#1)(1995-11#1)(1995-8#1)(1997-3#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
agents include##2##2##(2012-3#2)
agents including##4##2##(1997-8#1)(2008-5#1)(2008-8#2)
agents induce##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
agents into the##2##3##(1997-1#1)(2008-11#1)
agents into##3##2##(1997-1#1)(2008-11#1)(2008-5#1)
agents involved##2##2##(2008-10#1)(2012-3#1)
agents is##10##2##(1992-12#2)(1997-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2013-1#1)
agents like##2##2##(1997-6#1)(2008-11#1)
agents may also cause##2##4##(2011-2#2)
agents may##7##2##(1992-12#1)(2008-10#3)(2010-6#1)(2011-2#2)
agents of the##2##3##(2008-10#1)(2011-2#1)
agents of##23##2##(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#4)
agents on##8##2##(1994-5#1)(1994-8#2)(1996-8#1)(2008-7#1)(2012-2#1)(2013-1#2)
agents or##6##2##(1997-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
agents should##4##2##(1991-6#1)(1996-3#1)(2008-11#1)(2011-2#1)
agents showed##2##2##(1996-2#1)(2011-2#1)
agents studied##2##2##(1997-1#1)(2008-10#1)
agents such as sodium##2##4##(2008-10#1)(2008-11#1)
agents such as##10##3##(1990-11#1)(1992-9#1)(1993-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
agents that cause##2##3##(2008-10#1)(2012-12#1)
agents that##18##2##(1993-11#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-5#1)(2010-7#2)(2012-12#1)
agents to be##3##3##(1995-2#1)(1996-9#1)(2008-10#1)
agents to treat##2##3##(2008-1#1)(2008-4#1)
agents to##12##2##(1995-2#1)(1996-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-12#1)(2010-5#2)
agents used##2##2##(2008-12#1)(2008-7#1)
agents was studied##2##3##(1991-3#1)(2008-10#1)
agents was##4##2##(1991-3#1)(1995-12#1)(2008-10#1)(2012-2#1)
agents were found to##2##4##(2008-11#1)(2013-1#1)
agents were lower##2##3##(2008-10#1)(2008-12#1)
agents were tested##3##3##(1990-5#1)(1993-8#1)(2008-7#1)
agents were##18##2##(1990-5#2)(1993-8#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#3)(2013-1#1)
agents when##2##2##(2008-10#1)(2008-5#1)
agents which have##2##3##(1997-7#1)(2009-1#1)
agents which##8##2##(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-12#1)
agents with##12##2##(1991-8#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-8#1)
agents##661##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#10)(1992-3#3)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#2)(1993-3#2)(1993-8#4)(1993-9#1)(1994-11#3)(1994-5#4)(1994-6#2)(1994-8#2)(1995-11#6)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#7)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#2)(1996-8#1)(1996-9#2)(1997-1#10)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#156)(2008-11#53)(2008-12#10)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#46)(2008-7#38)(2008-8#20)(2008-9#9)(2009-1#6)(2009-10#1)(2009-12#10)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-4#3)(2010-5#10)(2010-6#5)(2010-7#11)(2010-9#6)(2011-2#33)(2011-3#2)(2012-12#5)(2012-2#13)(2012-3#19)(2013-1#31)(2013-8#9)
agents)##5##1##(1994-8#1)(1996-12#1)(1997-5#1)(2011-1#1)(2011-2#1)
agents]##2##1##(1990-11#1)(1990-3#1)
ages 3##2##2##(1995-1#1)(2010-2#1)
ages 6##2##2##(1991-8#1)(2009-7#1)
ages at##2##2##(1993-2#1)(2008-9#1)
ages of##10##2##(1990-2#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
ages ranging##2##2##(2008-1#1)(2008-10#1)
ages studied##4##2##(1995-12#2)(1996-12#2)
ages to##3##2##(2008-7#3)
ages were##2##2##(2008-12#1)(2008-9#1)
ages##89##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#3)(1996-2#2)(1997-3#1)(1997-7#1)(1997-9#1)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#4)(2008-5#3)(2008-7#4)(2008-9#6)(2009-3#1)(2009-7#4)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
agglomerans strain##5##2##(2008-10#5)
agglomerans was##2##2##(2008-10#2)
agglomerans##28##1##(2008-10#28)
agglomerates##2##1##(2008-5#2)
agglutination test##5##2##(1990-12#1)(1996-12#2)(2011-2#1)(2012-2#1)
agglutination##8##1##(1990-12#2)(1996-12#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
agglutinin or##3##2##(1994-8#1)(1995-11#1)(2008-11#1)
agglutinin were##2##2##(1995-11#1)(2008-7#1)
agglutinin##26##1##(1991-12#1)(1992-6#3)(1994-11#3)(1994-8#3)(1995-11#8)(2008-10#2)(2008-11#3)(2008-7#3)
aggravate##2##1##(1992-9#1)(2011-2#1)
aggravated by##6##2##(1990-3#1)(1994-12#1)(1995-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
aggravated##9##1##(1990-3#1)(1991-12#1)(1994-12#1)(1995-10#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
aggravating##3##1##(2008-12#1)(2012-12#1)(2012-2#1)
aggravation of##4##2##(2008-10#2)(2008-7#1)(2013-8#1)
aggravation##7##1##(1993-8#1)(2008-10#4)(2008-7#1)(2013-8#1)
aggrecan core protein##2##3##(1992-1#2)
aggrecan mRNA##5##2##(1992-1#1)(2008-11#4)
aggrecan proteoglycan##2##2##(1992-1#2)
aggrecan##14##1##(1992-1#9)(2008-11#5)
aggregans type strain##2##3##(2011-2#2)
aggregans##4##1##(2011-2#4)
aggregata##5##1##(2008-8#3)(2008-9#2)
aggregate analysis##2##2##(2008-12#1)(2012-12#1)
aggregate and##3##2##(1995-8#1)(2008-11#1)(2008-8#1)
aggregate formation##2##2##(2008-10#2)
aggregate in the##2##3##(2008-10#1)(2008-7#1)
aggregate in##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
aggregate is##2##2##(2008-10#1)(2008-3#1)
aggregate level##2##2##(1996-3#1)(2011-9#1)
aggregate of spheres##2##3##(2008-3#2)
aggregate of##4##2##(1995-3#2)(2008-3#2)
aggregate particles##2##2##(2008-2#2)
aggregate size##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
aggregate was##2##2##(2008-11#2)
aggregate##63##1##(1991-1#1)(1992-1#1)(1992-2#2)(1994-5#3)(1995-3#2)(1995-8#1)(1996-3#1)(2008-1#1)(2008-10#14)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#2)(2013-1#2)
aggregated as##2##2##(2008-10#2)
aggregated in##3##2##(1996-12#1)(2008-10#2)
aggregated or##2##2##(1993-6#1)(2008-10#1)
aggregated pattern of distribution##3##4##(2008-10#3)
aggregated patterns of disease##3##4##(2008-10#3)
aggregated patterns##4##2##(2008-10#4)
aggregated spatial pattern##2##3##(2008-10#2)
aggregated##52##1##(1990-12#1)(1991-12#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#2)(2008-10#28)(2008-5#2)(2008-6#1)(2008-8#2)(2009-10#2)(2011-2#4)(2011-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
aggregates and##3##2##(2008-10#2)(2008-11#1)
aggregates as##2##2##(2008-10#1)(2008-11#1)
aggregates at##2##2##(2008-10#2)
aggregates containing##2##2##(2007-12#1)(2008-11#1)
aggregates from##2##2##(1992-12#1)(2008-10#1)
aggregates in the##5##3##(1994-5#1)(2008-10#2)(2008-11#2)
aggregates in##9##2##(1994-5#1)(2008-10#3)(2008-11#5)
aggregates is##2##2##(2008-2#1)(2008-9#1)
aggregates of bacteria##2##3##(2008-10#1)(2008-3#1)
aggregates of##13##2##(1996-1#1)(2008-10#8)(2008-3#3)(2011-2#1)
aggregates on##2##2##(2008-10#2)
aggregates were##3##2##(2008-10#3)
aggregates##86##1##(1990-11#1)(1991-6#1)(1992-12#1)(1993-11#1)(1994-5#1)(1996-1#1)(2007-12#3)(2008-1#1)(2008-10#39)(2008-11#19)(2008-2#1)(2008-3#9)(2008-5#2)(2008-9#2)(2010-4#1)(2011-2#2)(2013-8#1)
aggregating the##2##2##(1993-8#1)(2010-3#1)
aggregating##4##1##(1990-12#1)(1993-8#1)(2008-11#1)(2010-3#1)
aggregation and the##2##3##(2008-5#1)(2008-8#1)
aggregation and##15##2##(1990-12#4)(1990-8#1)(1991-12#1)(1992-4#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)
aggregation at##3##2##(2008-10#1)(2008-8#2)
aggregation by##2##2##(2008-5#1)(2008-8#1)
aggregation can##2##2##(2008-10#1)(2013-8#1)
aggregation in the##2##3##(2008-10#1)(2010-8#1)
aggregation in##16##2##(1991-2#1)(1992-4#1)(1994-5#1)(1997-2#1)(2006-6#4)(2008-10#4)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
aggregation induced by##2##3##(1990-12#1)(1997-6#1)
aggregation of CSD-symptomatic trees for##2##5##(2008-10#2)
aggregation of infected##3##3##(2008-10#3)
aggregation of teicoplanin##2##3##(2008-10#2)
aggregation of the##4##3##(1994-11#1)(2008-10#2)(2010-4#1)
aggregation of##34##2##(1990-5#1)(1994-11#2)(1994-5#2)(2008-10#22)(2008-9#2)(2009-8#1)(2010-4#2)(2010-6#1)(2013-1#1)
aggregation over##2##2##(2008-10#2)
aggregation techniques##2##2##(2008-8#1)(2010-3#1)
aggregation territories and##2##3##(2009-8#2)
aggregation was##8##2##(1990-5#1)(1991-12#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-7#2)
aggregation within##2##2##(2008-8#2)
aggregation##173##1##(1990-12#5)(1990-5#7)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1992-12#1)(1992-4#2)(1992-9#2)(1993-3#1)(1993-8#2)(1994-11#2)(1994-5#4)(1994-8#2)(1995-8#1)(1996-12#1)(1997-2#3)(1997-4#1)(1997-6#1)(2006-6#12)(2007-12#2)(2008-10#52)(2008-11#9)(2008-3#1)(2008-4#2)(2008-5#8)(2008-7#5)(2008-8#15)(2008-9#3)(2009-11#1)(2009-8#4)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#3)(2013-1#5)(2013-8#3)
aggregations are##2##2##(2008-10#1)(2008-8#1)
aggregations of##2##2##(2008-10#1)(2008-7#1)
aggregations##6##1##(2008-10#3)(2008-7#1)(2008-8#2)
aggression and##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
aggression in Drosophila##2##3##(2008-10#2)
aggression in##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)
aggression of##2##2##(1990-3#1)(2008-10#1)
aggression##42##1##(1990-3#1)(1995-5#1)(1997-7#1)(2008-10#7)(2008-11#9)(2008-12#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#4)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#3)(2012-2#1)(2012-3#3)(2013-1#1)
aggressive and##6##2##(1990-2#1)(1995-2#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-12#1)
aggressive approach to##2##3##(2008-11#1)(2012-3#1)
aggressive bark beetle##2##3##(2008-10#2)
aggressive behavior in##2##3##(2008-11#2)
aggressive behavior##9##2##(1997-8#1)(2008-11#5)(2008-12#1)(2008-8#1)(2013-1#1)
aggressive behaviour##6##2##(1993-2#2)(1994-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
aggressive behaviours##4##2##(2008-7#1)(2011-2#3)
aggressive biologic##2##2##(1993-3#1)(2008-11#1)
aggressive clinical##2##2##(2008-9#1)(2012-3#1)
aggressive course##2##2##(2008-7#1)(2013-7#1)
aggressive forms of##3##3##(2010-12#1)(2011-2#2)
aggressive in##2##2##(2008-10#1)(2013-1#1)
aggressive individuals##2##2##(2008-8#2)
aggressive infection##2##2##(1993-3#2)
aggressive interactions##9##2##(2008-8#8)(2008-9#1)
aggressive isolates##3##2##(2008-10#3)
aggressive management##4##2##(2010-9#1)(2011-2#1)(2013-1#2)
aggressive melanoma cells##3##3##(2009-3#3)
aggressive melanoma##4##2##(2009-3#4)
aggressive on both##2##3##(2008-10#2)
aggressive on##6##2##(2008-10#6)
aggressive or##2##2##(2008-10#1)(2009-6#1)
aggressive phenotype##3##2##(2008-12#1)(2009-9#1)(2012-2#1)
aggressive strain##2##2##(2008-10#2)
aggressive strains showed##2##3##(2008-10#2)
aggressive surgical management##2##3##(1997-5#1)(2008-12#1)
aggressive surgical resection##2##3##(2008-7#2)
aggressive surgical##8##2##(1990-12#1)(1990-9#1)(1997-5#1)(2008-12#1)(2008-7#3)(2012-3#1)
aggressive than those##2##3##(2008-10#2)
aggressive than##4##2##(2008-10#4)
aggressive therapeutic##2##2##(1990-3#1)(2008-11#1)
aggressive therapy##2##2##(2008-11#1)(2009-8#1)
aggressive to##4##2##(2008-10#4)
aggressive treatment##4##2##(2010-7#1)(2012-3#2)(2013-1#1)
aggressive tumor##3##2##(2009-3#2)(2010-6#1)
aggressive tumour of##2##3##(2008-10#2)
aggressive variants##2##2##(2008-10#2)
aggressive##179##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1992-12#1)(1993-11#1)(1993-2#3)(1993-3#3)(1994-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-8#3)(2008-1#2)(2008-10#44)(2008-11#12)(2008-12#6)(2008-4#1)(2008-7#10)(2008-8#12)(2008-9#4)(2009-10#1)(2009-3#6)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#9)(2013-1#12)(2013-7#1)
aggressively##5##1##(1991-12#1)(1996-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
aggressiveness and##4##2##(2008-10#4)
aggressiveness of isolates of##2##4##(2008-10#2)
aggressiveness of the US-8##2##4##(2008-10#2)
aggressiveness of the lesion##2##4##(1994-6#1)(2008-2#1)
aggressiveness of the##5##3##(1991-2#1)(1994-6#1)(2008-10#2)(2008-2#1)
aggressiveness of##15##2##(1991-2#1)(1994-6#1)(2008-10#11)(2008-2#1)(2012-3#1)
aggressiveness on potato##2##3##(2008-10#2)
aggressiveness on the##2##3##(1995-5#1)(2008-10#1)
aggressiveness on##8##2##(1995-5#1)(2008-10#7)
aggressiveness to##5##2##(1991-6#1)(2008-10#4)
aggressiveness was##4##2##(2008-10#4)
aggressiveness were##2##2##(2008-10#2)
aggressiveness##60##1##(1991-2#1)(1991-6#1)(1994-6#1)(1995-5#1)(2008-10#53)(2008-2#1)(2012-3#2)
aggressivum f##3##2##(2008-10#3)
aggressivum##4##1##(2008-10#4)
aging and##13##2##(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-6#1)(2008-11#1)(2008-7#4)(2010-12#1)(2012-2#1)(2012-3#1)
aging brain##2##2##(1994-8#1)(1996-11#1)
aging changes##2##2##(2008-7#1)(2011-2#1)
aging has##2##2##(1993-1#1)(2011-2#1)
aging in the##2##3##(2008-7#2)
aging in##10##2##(1995-3#1)(2008-7#5)(2008-9#2)(2011-2#1)(2012-2#1)
aging is##5##2##(2008-7#2)(2008-9#3)
aging males##2##2##(2008-12#1)(2009-5#1)
aging mice##4##2##(1993-12#2)(2013-7#2)
aging of the population##3##4##(1992-1#1)(1996-3#1)(2013-8#1)
aging of the##4##3##(1992-1#1)(1996-3#1)(2009-5#1)(2013-8#1)
aging of##10##2##(1990-3#2)(1992-1#2)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2009-5#1)(2013-8#1)
aging on the##3##3##(2008-7#2)(2010-12#1)
aging on##6##2##(2008-5#1)(2008-7#4)(2010-12#1)
aging population##5##2##(1995-1#1)(1996-8#1)(2007-12#1)(2008-12#1)(2009-3#1)
aging processes is##2##3##(1990-3#1)(2008-7#1)
aging processes##6##2##(1990-3#1)(2008-10#3)(2008-7#1)(2013-7#1)
aging rat##2##2##(1994-8#1)(2008-7#1)
aging##191##1##(1990-3#9)(1991-1#1)(1991-12#1)(1991-3#2)(1992-1#2)(1992-12#1)(1992-5#1)(1992-9#2)(1993-1#3)(1993-12#4)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-8#2)(1995-1#1)(1995-3#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#5)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#4)(2008-12#2)(2008-5#3)(2008-7#37)(2008-8#2)(2008-9#11)(2009-3#1)(2009-5#2)(2009-8#4)(2009-9#2)(2010-1#6)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#17)(2012-2#8)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#8)(2013-8#2)
aging)##2##1##(2010-1#1)(2010-3#1)
aging-related##5##1##(2008-9#2)(2013-1#1)(2013-7#2)
aging?##2##1##(1992-11#1)(2011-2#1)
agitated##5##1##(2008-11#4)(2009-6#1)
agitation and##5##2##(2008-10#3)(2008-11#1)(2009-6#1)
agitation intensities##2##2##(2008-11#1)(2008-7#1)
agitation rates##2##2##(2008-11#1)(2010-11#1)
agitation speed##3##2##(2011-2#1)(2013-1#2)
agitation speeds favored##2##3##(2013-1#2)
agitation system##2##2##(2008-11#2)
agitation##36##1##(2008-10#7)(2008-11#13)(2008-5#2)(2008-7#2)(2009-6#1)(2010-11#2)(2011-2#4)(2013-1#5)
aglycon transfer##3##2##(2008-12#3)
aglycon##5##1##(1994-5#2)(2008-12#3)
aglycone##6##1##(2008-10#1)(2008-11#4)(2012-2#1)
ago and##3##2##(1997-3#1)(2010-8#1)(2012-3#1)
ago but##2##2##(2008-10#2)
ago for##2##2##(2008-9#1)(2010-12#1)
ago that##3##2##(2009-3#1)(2009-8#1)(2013-8#1)
ago##74##1##(1990-11#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-3#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#2)(2009-8#3)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
agonist acting##2##2##(1992-8#1)(2008-7#1)
agonist activity of##2##3##(1997-7#1)(2008-11#1)
agonist activity##4##2##(1992-2#1)(1997-7#1)(2008-11#1)(2011-3#1)
agonist and##4##2##(1995-8#1)(1997-2#1)(2008-4#1)(2013-8#1)
agonist is##3##2##(1996-2#1)(2009-8#1)(2010-7#1)
agonist of##2##2##(1994-8#1)(2008-9#1)
agonist or antagonist##2##3##(1991-6#1)(1997-4#1)
agonist##86##1##(1991-6#1)(1992-10#1)(1992-2#2)(1992-8#2)(1993-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-11#12)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#8)(1997-1#1)(1997-2#6)(1997-4#4)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-7#1)(2009-8#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#2)
agonist)##2##1##(1995-12#1)(1997-1#1)
agonist-induced##3##1##(1990-12#1)(1995-11#1)(1996-2#1)
agonistic and##3##2##(2008-10#2)(2008-8#1)
agonistic##6##1##(1990-11#1)(2008-10#2)(2008-8#2)(2008-9#1)
agonists and antagonists##4##3##(1993-1#1)(2008-4#1)(2008-5#1)(2009-7#1)
agonists and##7##2##(1993-1#1)(1993-12#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-8#1)
agonists are of##2##3##(2009-8#2)
agonists are##4##2##(1993-9#1)(2008-7#1)(2009-8#2)
agonists for##2##2##(1996-2#2)
agonists in##3##2##(1994-11#1)(1996-2#1)(2008-4#1)
agonists may##3##2##(2009-12#3)
agonists on##2##2##(1995-12#1)(2013-1#1)
agonists to##5##2##(1993-3#1)(1994-5#2)(2006-6#1)(2012-12#1)
agonists with##2##2##(1995-12#1)(1997-1#1)
agonists##81##1##(1990-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-5#2)(1995-11#5)(1995-12#5)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#5)(1997-1#1)(1997-4#1)(2006-6#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#8)(2009-3#2)(2009-6#4)(2009-7#1)(2009-8#4)(2010-12#3)(2012-12#1)(2012-2#1)(2013-1#1)
agoraphobia##3##1##(1990-11#1)(2012-2#2)
agranular##5##1##(1992-9#1)(1994-2#1)(2008-5#2)(2008-7#1)
agree fairly well with data obtained##2##6##(2008-10#2)
agree in##2##2##(1992-2#1)(2008-10#1)
agree on##2##2##(2008-8#1)(2011-10#1)
agree that##2##2##(2009-5#1)(2010-11#1)
agree to##2##2##(1993-12#1)(2013-1#1)
agree well with the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
agree well with those obtained by##2##6##(2008-10#2)
agree well with##10##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
agree with measurements##2##3##(2008-3#2)
agree with that##2##3##(2008-10#1)(2008-3#1)
agree with the certified##2##4##(2008-10#2)
agree with the##7##3##(1990-2#1)(2008-10#5)(2013-8#1)
agree with those obtained by means of a##2##8##(2008-10#2)
agree with those obtained by##6##5##(2008-10#5)(2008-11#1)
agree with those obtained##7##4##(2008-10#6)(2008-11#1)
agree with those of##2##4##(2008-10#2)
agree with those##9##3##(2008-10#8)(2008-11#1)
agree with##30##2##(1990-2#1)(1991-6#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#2)(2010-3#1)(2013-8#1)
agree##58##1##(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-12#1)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-10#1)(2013-1#1)(2013-8#1)
agreed that the##2##3##(2008-10#1)(2009-8#1)
agreed that##7##2##(1992-3#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2009-8#1)
agreed to participate in##2##4##(1995-6#1)(2010-6#1)
agreed to participate##3##3##(1990-2#1)(1995-6#1)(2010-6#1)
agreed to pay##2##3##(1995-12#2)
agreed to##11##2##(1990-2#1)(1991-9#1)(1992-12#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-3#1)(2008-3#1)(2010-6#1)(2011-1#1)
agreed upon by##2##3##(2009-9#1)(2011-2#1)
agreed upon##3##2##(1992-3#1)(2009-9#1)(2011-2#1)
agreed very well with##2##4##(2008-10#2)
agreed well with the certified##2##5##(2008-10#2)
agreed well with the##5##4##(2008-10#5)
agreed well with those obtained by the##2##7##(2008-10#2)
agreed well with those##3##4##(2008-10#3)
agreed well with##14##3##(2008-10#11)(2008-3#1)(2009-7#1)(2010-10#1)
agreed well##16##2##(2008-10#13)(2008-3#1)(2009-7#1)(2010-10#1)
agreed with the reference##2##4##(2008-10#2)
agreed with the##10##3##(1995-6#1)(2008-10#8)(2012-12#1)
agreed with those obtained by##3##5##(2008-10#3)
agreed with those##6##3##(2008-10#6)
agreed with##23##2##(1995-6#1)(1996-5#1)(2008-10#17)(2008-3#2)(2011-2#1)(2012-12#1)
agreed##69##1##(1990-2#1)(1991-9#1)(1992-12#1)(1992-3#2)(1995-1#1)(1995-12#3)(1995-6#3)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#39)(2008-11#1)(2008-3#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
agreed-upon##2##1##(2011-2#1)(2012-2#1)
agreeing that##2##2##(1995-12#1)(2011-2#1)
agreeing with##4##2##(1993-9#1)(2008-10#2)(2008-7#1)
agreeing##8##1##(1993-9#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-7#1)(2011-2#2)
agreement about##2##2##(2008-12#1)(2011-2#1)
agreement and##3##2##(1994-3#1)(2008-10#2)
agreement between calculated and##2##4##(2008-3#2)
agreement between measured and calculated values of##2##7##(2008-3#2)
agreement between measured and##3##4##(2008-10#1)(2008-3#2)
agreement between results##2##3##(2008-10#2)
agreement between the model##2##4##(2008-7#1)(2011-2#1)
agreement between the proposed##3##4##(2008-10#3)
agreement between the results obtained by the proposed##2##8##(2008-10#2)
agreement between the results##3##4##(2008-10#3)
agreement between the two##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
agreement between the##24##3##(1995-5#1)(2008-10#16)(2008-3#3)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
agreement between##49##2##(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#28)(2008-3#8)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
agreement for##6##2##(1994-3#1)(1995-1#2)(2008-2#1)(2009-1#1)(2012-2#1)
agreement in the##2##3##(1993-3#1)(2008-3#1)
agreement in##4##2##(1993-3#1)(2008-10#1)(2008-3#1)(2009-9#1)
agreement is obtained##2##3##(2008-10#2)
agreement is##4##2##(2008-10#3)(2008-3#1)
agreement of##7##2##(2008-10#3)(2008-11#1)(2008-3#1)(2009-1#1)(2010-12#1)
agreement on diagnosis and recommendations##2##5##(1995-1#2)
agreement on the##7##3##(1993-12#1)(1997-5#1)(2008-12#1)(2008-9#2)(2011-2#1)(2012-2#1)
agreement on##14##2##(1993-12#2)(1995-1#2)(1997-5#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)
agreement that##3##2##(2008-11#1)(2008-4#1)(2012-12#1)
agreement was found between##6##4##(2007-11#1)(2008-10#5)
agreement was observed between##3##4##(2008-10#3)
agreement was obtained##5##3##(2008-10#5)
agreement was##19##2##(2007-11#1)(2008-10#17)(2008-3#1)
agreement when##3##2##(2008-10#2)(2008-11#1)
agreement with a##5##3##(1992-12#1)(2008-10#3)(2008-3#1)
agreement with certified values##11##4##(2008-10#11)
agreement with certified##14##3##(2008-10#14)
agreement with data##3##3##(2008-10#2)(2008-8#1)
agreement with our previous##2##4##(1990-5#1)(1995-12#1)
agreement with previous studies##3##4##(1995-11#1)(2008-10#1)(2009-8#1)
agreement with previous##10##3##(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-8#1)
agreement with recent##2##3##(2006-6#1)(2008-3#1)
agreement with results obtained by##2##5##(2008-10#2)
agreement with results##3##3##(2008-10#3)
agreement with that##4##3##(2008-10#4)
agreement with the certified value was obtained for##2##8##(2008-10#2)
agreement with the certified value##10##5##(2008-10#10)
agreement with the certified values##14##5##(2008-10#14)
agreement with the certified##26##4##(2008-10#26)
agreement with the data##2##4##(2008-10#1)(2008-8#1)
agreement with the experimental results##3##5##(2008-2#1)(2011-2#1)(2013-8#1)
agreement with the experimental##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
agreement with the literature##4##4##(1990-3#1)(1993-3#1)(2008-10#2)
agreement with the reference##3##4##(2008-10#3)
agreement with the results##3##4##(2008-10#2)(2013-1#1)
agreement with the theoretical##3##4##(2008-10#1)(2008-3#2)
agreement with the values obtained by a##2##7##(2008-10#2)
agreement with the##96##3##(1990-3#1)(1990-8#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#2)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#63)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#6)(2013-8#1)
agreement with those given by##2##5##(2008-10#2)
agreement with those obtained by a##4##6##(2008-10#4)
agreement with those obtained by the##7##6##(2008-10#7)
agreement with those obtained by using the##2##7##(2008-10#2)
agreement with those obtained by using##3##6##(2008-10#3)
agreement with those obtained by##25##5##(2008-10#25)
agreement with those obtained from##2##5##(2008-10#1)(2008-5#1)
agreement with those obtained using##3##5##(2008-10#3)
agreement with those obtained with##3##5##(2008-10#2)(2008-3#1)
agreement with those obtained##34##4##(2008-10#32)(2008-3#1)(2008-5#1)
agreement with those of the##3##5##(1992-1#1)(2008-10#2)
agreement with those of##5##4##(1992-1#1)(2008-10#3)(2008-3#1)
agreement with those##49##3##(1992-1#1)(2008-10#45)(2008-3#2)(2008-5#1)
agreement with##230##2##(1990-3#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1997-2#1)(2006-6#1)(2007-11#3)(2008-10#157)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#17)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#9)(2013-8#1)
agreement within##2##2##(1993-1#1)(2008-10#1)
agreement##410##1##(1990-3#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#3)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-3#2)(1994-5#2)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#2)(1997-2#2)(1997-5#1)(2006-6#1)(2007-11#4)(2008-10#243)(2008-11#8)(2008-12#8)(2008-2#6)(2008-3#38)(2008-4#1)(2008-5#11)(2008-7#5)(2008-8#6)(2008-9#4)(2009-1#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#2)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#1)
agreements were##2##2##(2008-10#2)
agreements with the##2##3##(2008-10#1)(2008-5#1)
agreements with##4##2##(1991-2#1)(2008-10#2)(2008-5#1)
agreements##13##1##(1991-2#2)(1994-1#1)(1997-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
agrees well with that##2##4##(1996-5#1)(2008-3#1)
agrees well with the calculated##2##5##(2008-10#1)(2008-3#1)
agrees well with the##4##4##(2008-10#2)(2008-3#2)
agrees well with##7##3##(1996-5#1)(2007-11#1)(2008-10#2)(2008-3#3)
agrees with##2##2##(1993-8#1)(2008-3#1)
agrees##10##1##(1993-8#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-3#4)
agricultural and nonagricultural environments##2##4##(2008-10#2)
agricultural and##5##2##(2008-10#4)(2008-11#1)
agricultural areas##2##2##(2008-10#1)(2013-1#1)
agricultural chemicals##2##2##(2008-10#2)
agricultural environments with##2##3##(2008-10#2)
agricultural environments##3##2##(2008-10#2)(2012-2#1)
agricultural fields##4##2##(2008-10#3)(2012-2#1)
agricultural landscape##2##2##(2013-1#2)
agricultural practice is replaced##2##4##(2008-11#2)
agricultural practice##6##2##(2008-10#2)(2008-11#2)(2013-1#2)
agricultural practices and##2##3##(2008-11#1)(2008-7#1)
agricultural practices##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
agricultural soils##4##2##(1995-3#1)(2008-10#3)
agricultural systems##5##2##(2008-10#1)(2008-12#1)(2008-8#2)(2010-7#1)
agricultural workers##2##2##(2008-11#2)
agricultural##90##1##(1991-6#2)(1995-3#1)(1996-3#1)(2008-10#50)(2008-11#9)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#3)(2010-10#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#5)(2013-8#1)
agriculturally##2##1##(2008-10#1)(2009-10#1)
agriculture can be##2##3##(2008-11#1)(2013-8#1)
agriculture in the##2##3##(2008-11#1)(2010-7#1)
agriculture in##3##2##(2008-11#1)(2010-7#2)
agriculture is##3##2##(2008-11#1)(2010-7#2)
agriculture##37##1##(1990-2#1)(1990-6#1)(1991-6#1)(1997-2#1)(2008-10#10)(2008-11#10)(2008-8#1)(2010-1#1)(2010-4#1)(2010-7#6)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
agrochemical pest control##2##3##(2008-11#2)
agrochemical##5##1##(1997-7#1)(2008-10#2)(2008-11#2)
agrochemicals##3##1##(2008-10#2)(2010-7#1)
agrocin 84##5##2##(2008-10#5)
agrocin##8##1##(2008-10#8)
agroecological zones##2##2##(2008-10#2)
agroecological##4##1##(2008-10#3)(2013-8#1)
agroecosystem##3##1##(2008-10#3)
agroinoculated##2##1##(2008-10#2)
agroinoculation##5##1##(2008-10#5)
agronomic crops##3##2##(2008-10#3)
agronomic practices##2##2##(2008-10#2)
agronomic traits##4##2##(2008-9#3)(2013-8#1)
agronomic##16##1##(2008-10#10)(2008-9#3)(2009-10#1)(2012-3#1)(2013-8#1)
agronomically important pathogen##2##3##(1992-8#1)(2008-10#1)
agronomically##4##1##(1992-8#1)(1996-12#1)(2008-10#2)
agrostis##3##1##(2008-10#3)
ahODN-Cu(I)##3##1##(2008-10#3)
ahead of the##3##3##(2008-10#1)(2008-7#1)(2010-11#1)
ahead of##6##2##(1990-6#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-2#1)
ahead on##2##2##(1993-5#1)(2011-2#1)
ahead##21##1##(1990-6#1)(1991-1#1)(1992-2#1)(1993-5#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
ahigh##2##1##(2008-11#2)
aid fitting##2##2##(2008-9#1)(2013-1#1)
aid for##6##2##(1992-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-7#1)
aid in diagnosis##2##3##(1991-11#1)(1997-5#1)
aid in the development of##6##5##(2008-11#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
aid in the study of the##2##6##(1991-9#1)(2008-10#1)
aid in the study of##3##5##(1991-9#1)(2008-10#1)(2012-2#1)
aid in the##17##3##(1991-9#1)(1992-3#1)(1994-6#1)(1996-9#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
aid in##33##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1994-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-9#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
aid of##32##2##(1990-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1994-11#1)(1997-6#1)(2008-10#21)(2008-11#2)(2008-3#1)(2008-5#1)(2013-1#1)
aid the development of more##2##5##(2008-5#1)(2009-12#1)
aid the development of##3##4##(2008-5#1)(2008-9#1)(2009-12#1)
aid the##10##2##(1992-9#1)(1994-3#1)(1995-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)
aid to the##2##3##(2009-12#1)(2012-3#1)
aid to##9##2##(1993-3#1)(1996-12#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
aid##141##1##(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#6)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#35)(2008-11#11)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#5)(2009-12#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
aide##3##1##(1991-12#1)(1994-2#1)(1994-3#1)
aided by a##2##3##(2008-12#1)(2008-7#1)
aided by##5##2##(1992-9#1)(1996-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
aided condition????##2##2##(2012-2#2)
aided pre-reduction of##2##3##(2008-10#2)
aided##18##1##(1992-9#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-2#4)(2013-1#1)(2013-8#1)
aides##2##1##(1991-1#1)(1995-2#1)
aiding in the##3##3##(2008-11#1)(2010-5#1)(2013-8#1)
aiding in##4##2##(2008-11#1)(2010-5#2)(2013-8#1)
aiding the##2##2##(2008-9#1)(2011-2#1)
aiding##10##1##(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-8#1)
aids and##2##2##(2009-7#1)(2011-2#1)
aids for##3##2##(1991-2#1)(2008-2#1)(2009-7#1)
aids in##5##2##(1990-2#1)(1991-2#1)(1993-12#1)(2011-2#2)
aids##28##1##(1990-12#1)(1990-2#1)(1991-2#4)(1993-11#2)(1993-12#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#2)(2010-11#1)(2011-2#4)(2012-2#2)
ailments##4##1##(2008-10#2)(2008-7#1)(2013-8#1)
aim at##4##2##(1992-9#1)(1996-3#1)(2011-2#2)
aim for##2##2##(2008-7#1)(2012-3#1)
aim is to improve##2##4##(1991-12#1)(2008-11#1)
aim is to provide##2##4##(2008-11#2)
aim is to##15##3##(1991-12#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-9#1)(2011-3#1)(2012-12#1)(2012-2#1)
aim of determining##2##3##(1995-2#1)(1996-11#1)
aim of our investigation was to##4##6##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
aim of our study was to determine the##2##8##(2011-2#1)(2012-6#1)
aim of our study was to##12##6##(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-6#1)(2013-1#3)
aim of our study was##13##5##(1990-5#1)(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-6#1)(2013-1#3)
aim of our study##16##4##(1990-5#1)(2008-11#1)(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-3#1)(2012-6#1)(2013-1#3)
aim of our##23##3##(1990-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)
aim of reducing##2##3##(2008-11#1)(2008-3#1)
aim of surgery##2##3##(2008-7#2)
aim of the present study was to analyze##2##8##(1995-8#1)(2011-2#1)
aim of the present study was to determine##3##8##(2008-10#1)(2008-12#1)(2011-1#1)
aim of the present study was to investigate the##4##9##(2008-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
aim of the present study was to investigate##7##8##(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
aim of the present study was to##34##7##(1992-2#1)(1993-1#1)(1995-2#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-5#3)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
aim of the present study was##35##6##(1992-2#1)(1993-1#1)(1995-2#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-5#3)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
aim of the present study##43##5##(1992-2#1)(1993-1#1)(1995-2#1)(1995-8#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-5#5)(2009-10#1)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#1)
aim of the present work was to develop##2##8##(2008-10#1)(2011-1#1)
aim of the present work was to##5##7##(1993-11#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
aim of the present work##8##5##(1993-11#1)(1997-2#1)(2008-10#2)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
aim of the present##54##4##(1992-2#1)(1993-1#1)(1993-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-5#6)(2009-10#1)(2009-12#1)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#7)(2013-8#1)
aim of the study was to compare##5##7##(1990-2#1)(1997-8#1)(2008-11#1)(2013-1#2)
aim of the study was to##31##6##(1990-2#1)(1993-2#1)(1994-12#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-11#4)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
aim of the study was##34##5##(1990-2#1)(1993-2#1)(1994-12#1)(1996-6#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-11#4)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#5)
aim of the study##42##4##(1990-2#1)(1993-2#1)(1994-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#2)(2008-11#4)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#6)
aim of the##109##3##(1990-2#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#2)(2008-10#13)(2008-11#9)(2008-12#8)(2008-5#9)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#15)(2013-8#1)
aim of this paper##17##4##(1994-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#2)(2009-8#2)(2010-8#1)(2011-2#4)(2013-1#3)
aim of this review##8##4##(2008-10#1)(2008-11#1)(2008-8#2)(2009-11#1)(2010-5#1)(2011-3#1)(2013-1#1)
aim of this study is to##16##6##(2008-10#4)(2008-11#2)(2010-12#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
aim of this study is##17##5##(2007-8#1)(2008-10#4)(2008-11#2)(2010-12#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
aim of this study was to compare the##2##8##(2008-12#1)(2008-7#1)
aim of this study was to compare##4##7##(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
aim of this study was to determine the##10##8##(2008-5#3)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-3#1)
aim of this study was to determine##15##7##(2008-10#1)(2008-5#3)(2008-9#1)(2009-6#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-3#1)
aim of this study was to examine the##6##8##(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
aim of this study was to examine##7##7##(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
aim of this study was to explore##4##7##(2008-11#1)(2008-12#2)(2012-3#1)
aim of this study was to identify the##2##8##(2008-1#1)(2010-10#1)
aim of this study was to identify##3##7##(2008-1#1)(2010-10#1)(2011-2#1)
aim of this study was to##104##6##(1994-8#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#11)(2008-12#6)(2008-5#14)(2008-7#7)(2008-9#4)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#14)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#13)(2013-3#1)(2013-8#1)
aim of this study was##106##5##(1994-1#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#11)(2008-12#6)(2008-5#14)(2008-7#7)(2008-9#4)(2009-2#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#14)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#13)(2013-3#1)(2013-8#1)
aim of this study##126##4##(1990-11#1)(1991-6#1)(1994-1#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#14)(2008-12#6)(2008-5#14)(2008-7#7)(2008-9#4)(2009-2#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#14)(2013-3#1)(2013-8#2)
aim of this work is to##7##6##(2008-10#5)(2012-2#1)(2013-1#1)
aim of this work is##9##5##(2008-10#7)(2012-2#1)(2013-1#1)
aim of this work##25##4##(1997-2#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-5#7)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
aim of this##222##3##(1990-11#1)(1991-6#1)(1991-9#1)(1994-1#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#4)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#30)(2008-11#19)(2008-12#8)(2008-5#24)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#30)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#9)(2012-3#6)(2013-1#24)(2013-3#1)(2013-8#2)
aim of using##2##3##(2008-10#1)(2008-11#1)
aim of##399##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-6#1)(1991-9#1)(1992-2#2)(1993-1#1)(1993-11#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#3)(1997-8#5)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#53)(2008-11#35)(2008-12#20)(2008-3#1)(2008-5#35)(2008-7#14)(2008-8#3)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#8)(2010-11#2)(2010-12#3)(2010-3#4)(2010-4#1)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#41)(2011-3#3)(2011-7#2)(2012-12#3)(2012-2#14)(2012-3#14)(2012-5#1)(2012-6#1)(2013-1#44)(2013-3#1)(2013-8#4)
aim to describe the##2##4##(2010-11#1)(2011-2#1)
aim to evaluate the##2##4##(2012-3#1)(2013-1#1)
aim to improve##2##3##(2008-10#1)(2013-8#1)
aim to##28##2##(1990-9#1)(1992-6#1)(1996-1#1)(1997-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#2)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
aim was to assess the##4##5##(2008-9#2)(2012-8#1)(2013-1#1)
aim was to determine the##2##5##(2011-2#1)(2013-1#1)
aim was to investigate##3##4##(2010-6#1)(2011-2#2)
aim was to##26##3##(1990-5#1)(1991-11#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
aim was##27##2##(1990-5#1)(1991-11#1)(1996-2#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
aim##484##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#5)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#67)(2008-11#46)(2008-12#20)(2008-2#1)(2008-3#4)(2008-5#38)(2008-7#15)(2008-8#4)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#8)(2010-11#4)(2010-12#3)(2010-3#4)(2010-4#1)(2010-5#5)(2010-6#5)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#7)(2011-2#52)(2011-3#4)(2011-7#2)(2012-12#5)(2012-2#17)(2012-3#17)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#49)(2013-3#1)(2013-8#5)
aimed at assessing##2##3##(2008-5#1)(2008-7#1)
aimed at characterizing the##2##4##(1995-2#1)(2008-10#1)
aimed at characterizing##3##3##(1994-2#1)(1995-2#1)(2008-10#1)
aimed at controlling##2##3##(2009-12#1)(2010-11#1)
aimed at defining##2##3##(1991-5#1)(2008-11#1)
aimed at determining##2##3##(1994-8#1)(2008-5#1)
aimed at developing##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
aimed at evaluating the##2##4##(2008-10#1)(2012-4#1)
aimed at evaluating##3##3##(2008-10#1)(2011-2#1)(2012-4#1)
aimed at improving##2##3##(2008-11#1)(2012-2#1)
aimed at investigating##3##3##(2009-1#1)(2012-3#1)(2013-8#1)
aimed at optimizing##2##3##(2008-11#1)(2010-12#1)
aimed at preventing##3##3##(1996-1#1)(2012-2#1)(2013-1#1)
aimed at reducing##3##3##(2008-2#1)(2008-8#1)(2011-2#1)
aimed at the##10##3##(1993-6#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)
aimed at understanding##4##3##(1995-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
aimed at##105##2##(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2008-10#10)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#5)(2013-8#4)
aimed to analyze the##2##4##(2012-3#1)(2013-1#1)
aimed to assess##5##3##(1991-6#1)(1997-4#1)(2011-2#1)(2011-8#1)(2012-3#1)
aimed to compare the##2##4##(2010-1#1)(2012-3#1)
aimed to describe##4##3##(2008-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
aimed to determine the##2##4##(2012-3#1)(2013-8#1)
aimed to evaluate the##5##4##(2008-11#1)(2011-1#1)(2011-2#2)(2012-3#1)
aimed to evaluate##6##3##(2008-11#1)(2011-1#2)(2011-2#2)(2012-3#1)
aimed to identify the##4##4##(2009-8#1)(2012-3#3)
aimed to identify##7##3##(2009-8#1)(2011-2#1)(2012-3#4)(2012-8#1)
aimed to improve##2##3##(1991-6#1)(2008-3#1)
aimed to investigate the##6##4##(2008-10#1)(2012-3#4)(2013-8#1)
aimed to the##2##3##(2008-10#1)(2009-10#1)
aimed to##71##2##(1991-6#2)(1992-2#1)(1997-4#1)(2008-10#4)(2008-11#7)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-7#1)(2011-1#3)(2011-2#4)(2011-3#1)(2011-8#1)(2012-12#1)(2012-2#3)(2012-3#19)(2012-6#1)(2012-8#1)(2013-1#4)(2013-8#2)
aimed##180##1##(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2008-10#16)(2008-11#16)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#1)(2010-7#3)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#2)(2011-8#1)(2012-12#1)(2012-2#7)(2012-3#22)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#9)(2013-8#6)
aiming at a##2##3##(2008-10#1)(2012-12#1)
aiming at evaluating the##2##4##(2008-5#2)
aiming at the##3##3##(2008-10#2)(2012-2#1)
aiming at##16##2##(1996-6#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
aiming to achieve##2##3##(2009-4#1)(2010-11#1)
aiming to provide##2##3##(2008-10#1)(2013-1#1)
aiming to##20##2##(2008-10#3)(2008-11#3)(2008-5#4)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
aiming##38##1##(1996-6#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-5#6)(2008-7#1)(2009-4#2)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
aims and##3##2##(1993-11#1)(2008-12#1)(2010-1#1)
aims at##13##2##(1991-2#1)(1994-6#1)(1996-11#1)(2008-11#2)(2008-4#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-11#1)(2012-12#1)(2013-8#2)
aims is##2##2##(2008-11#1)(2008-9#1)
aims of this study were##11##5##(2008-10#2)(2008-11#1)(2008-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-1#2)
aims of this study##12##4##(2008-10#2)(2008-11#1)(2008-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
aims of this##13##3##(1990-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
aims of##28##2##(1990-11#1)(1992-12#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
aims to assess##3##3##(2008-10#1)(2010-6#1)(2013-8#1)
aims to clarify##2##3##(1990-12#1)(2008-10#1)
aims to evaluate the##2##4##(2008-10#1)(2012-3#1)
aims to evaluate##4##3##(2008-10#2)(2012-3#2)
aims to further##2##3##(2008-11#1)(2008-7#1)
aims to highlight the##2##4##(2011-1#1)(2011-2#1)
aims to improve##2##3##(1993-9#1)(2011-3#1)
aims to provide a##2##4##(2008-7#1)(2012-2#1)
aims to provide an##2##4##(2008-10#2)
aims to provide##7##3##(2008-10#2)(2008-11#3)(2008-7#1)(2012-2#1)
aims to review the##2##4##(1993-3#1)(2008-8#1)
aims to##53##2##(1990-12#1)(1993-3#1)(1993-9#1)(1996-3#1)(2008-10#6)(2008-11#10)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
aims##110##1##(1990-11#1)(1990-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1996-11#1)(1996-3#2)(1997-7#1)(2008-1#1)(2008-10#12)(2008-11#16)(2008-12#7)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#7)(2013-8#4)
ainsi##2##1##(2008-11#1)(2013-1#1)
air and its##2##3##(2008-10#2)
air and surface##2##3##(1996-12#1)(2008-10#1)
air and the##2##3##(2008-10#1)(2009-7#1)
air and water sensitive##2##4##(2008-10#2)
air and##16##2##(1991-12#1)(1996-12#1)(1996-2#1)(2008-10#10)(2009-7#1)(2010-4#1)(2010-7#1)
air are##2##2##(2008-3#2)
air as##4##2##(1995-3#1)(2008-10#3)
air at##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#2)
air atmosphere##2##2##(2008-10#2)
air bubbles##2##2##(2008-10#2)
air by##10##2##(2008-10#9)(2008-3#1)
air can##2##2##(1991-12#1)(1994-9#1)
air cell##2##2##(2008-12#1)(2008-7#1)
air currents##2##2##(2008-10#2)
air drying##7##2##(2008-10#5)(2008-5#2)
air embolism##6##2##(1991-3#1)(2008-7#4)(2011-2#1)
air flow rate##3##3##(1995-3#2)(2008-10#1)
air flow##8##2##(1993-2#1)(1995-3#3)(2008-10#3)(2008-3#1)
air from##2##2##(2008-10#1)(2008-3#1)
air has##2##2##(2008-10#1)(2012-7#1)
air in the##2##3##(1997-4#1)(2008-10#1)
air in##5##2##(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-5#1)
air into##2##2##(2008-10#2)
air is##7##2##(1993-1#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-3#2)
air jet##3##2##(1993-2#1)(1994-12#1)(2008-3#1)
air of##6##2##(2008-10#4)(2008-11#2)
air on##2##2##(2008-10#2)
air optical breakdown##3##3##(2008-2#3)
air or water##2##3##(2008-7#1)(2008-8#1)
air or##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
air over a##2##3##(2007-12#1)(2008-2#1)
air particulate matter##3##3##(2008-10#2)(2008-11#1)
air particulate matters##4##3##(2008-10#4)
air particulate##7##2##(2008-10#6)(2008-11#1)
air pollutant (NO(2))##2##3##(2008-10#2)
air pollutant##4##2##(2008-10#2)(2008-11#2)
air pollutants in##2##3##(1996-3#1)(2008-11#1)
air pollutants##13##2##(1996-3#2)(2008-10#2)(2008-11#9)
air pollution and##4##3##(1997-1#1)(2008-11#3)
air pollution##16##2##(1991-3#1)(1994-9#1)(1997-1#4)(2008-11#10)
air pressure cell##2##3##(2008-10#2)
air pressure cells##2##3##(2008-10#2)
air pressure##5##2##(2008-10#4)(2009-10#1)
air purification##2##2##(2008-9#2)
air quality in##2##3##(2008-11#1)(2011-2#1)
air quality management##4##3##(2008-11#4)
air quality##16##2##(1993-2#1)(2008-11#13)(2010-5#1)(2011-2#1)
air sample matrix##3##3##(2008-10#3)
air sample necessary for the measurement was##2##7##(2008-10#2)
air sample##11##2##(2008-10#11)
air samples was preconcentrated in##2##5##(2008-10#2)
air samples was##3##3##(2008-10#3)
air samples were##3##3##(2008-10#3)
air samples##15##2##(2008-10#15)
air sampling##5##2##(2008-10#4)(2013-1#1)
air segments##2##2##(2008-10#2)
air temperature and sunlight intensity##2##5##(2008-6#2)
air temperature and##4##3##(2008-10#2)(2008-6#2)
air temperature was##4##3##(2008-10#1)(2008-6#3)
air temperature##11##2##(2008-10#5)(2008-6#5)(2012-6#1)
air temperatures##3##2##(2008-10#2)(2008-3#1)
air to##4##2##(1993-3#1)(2008-10#1)(2008-11#2)
air traffic##3##2##(2008-11#1)(2008-3#1)(2010-3#1)
air travel##5##2##(2010-3#1)(2010-5#4)
air travellers##2##2##(2010-5#2)
air velocity (vg)##2##3##(1995-3#2)
air velocity##3##2##(1995-3#3)
air volumetric flow rate##2##4##(1995-3#2)
air warming (+1##2##3##(2012-5#1)(2012-6#1)
air warming##16##2##(2012-5#4)(2012-6#8)(2012-9#4)
air was preconcentrated in a##2##5##(2008-10#2)
air was##8##2##(1995-3#1)(2008-10#7)
air were##2##2##(2008-10#1)(2008-11#1)
air with variable humidity content##2##5##(2008-10#2)
air with##7##2##(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)
air##421##1##(1990-3#1)(1991-12#3)(1991-3#5)(1992-1#1)(1992-12#1)(1993-1#2)(1993-2#4)(1993-3#4)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#12)(1995-5#1)(1996-12#6)(1996-2#2)(1996-3#7)(1997-1#5)(1997-4#1)(2007-12#1)(2008-10#188)(2008-11#53)(2008-12#5)(2008-2#7)(2008-3#21)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#10)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#9)(2010-7#2)(2011-2#5)(2012-2#3)(2012-3#3)(2012-5#4)(2012-6#9)(2012-7#1)(2012-9#5)(2013-1#5)(2013-7#1)
air)##2##1##(1996-12#1)(2008-5#1)
air-##2##1##(2008-10#1)(2008-3#1)
air-acetylene flame##3##2##(2008-10#3)
air-acetylene##4##1##(2008-10#4)
air-dried##2##1##(2008-10#1)(2011-2#1)
air-dust samples##2##2##(2008-10#2)
air-dust##5##1##(2008-10#5)
air-liquid##8##1##(2008-1#1)(2008-10#3)(2008-5#4)
air-quality##2##1##(1993-2#1)(2008-3#1)
air-sea temperature##3##2##(2008-3#3)
air-water interface##3##2##(1994-5#1)(2008-10#2)
air/water interface##2##2##(2008-10#2)
air/water##3##1##(2008-10#3)
airag##2##1##(2013-1#2)
airborne and##2##2##(2008-2#1)(2008-3#1)
airborne ascospores##3##2##(2008-10#3)
airborne carbamates in##3##3##(2008-10#3)
airborne conidia##3##2##(2008-10#3)
airborne dust##3##2##(2008-10#2)(2008-11#1)
airborne inoculum##2##2##(2008-10#2)
airborne lidar##2##2##(2008-3#2)
airborne multispectral scanners##2##3##(2008-10#2)
airborne particulate matter (PM)##2##4##(2008-10#1)(2009-7#1)
airborne particulate matter collected on filters##2##6##(2008-10#2)
airborne particulate matter##13##3##(2008-10#12)(2009-7#1)
airborne particulate##15##2##(2008-10#13)(2008-11#1)(2009-7#1)
airborne particulates##2##2##(2008-10#2)
airborne pollen##2##2##(2012-7#2)
airborne propagules##2##2##(2008-10#2)
airborne spores##3##2##(2008-10#3)
airborne##71##1##(1991-12#1)(1994-3#1)(2008-10#47)(2008-11#3)(2008-2#3)(2008-3#12)(2009-7#1)(2009-8#1)(2012-7#2)
aircraft and##3##2##(1996-12#1)(2008-11#1)(2008-3#1)
aircraft cabin##6##2##(1996-12#6)
aircraft##22##1##(1996-12#10)(2008-10#1)(2008-11#1)(2008-3#10)
aircraft-target##3##1##(2008-3#3)
airflow obstruction##2##2##(1992-3#1)(2008-7#1)
airflow rate##2##2##(1996-2#1)(1996-3#1)
airflow##9##1##(1992-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-5#1)(2008-7#1)
airlift reactors##4##2##(2008-7#4)
airline##4##1##(2008-10#1)(2010-3#2)(2010-5#1)
airport##2##1##(2008-10#1)(2008-12#1)
airspace##3##1##(1996-2#3)
airspaces##5##1##(1996-2#3)(1997-2#1)(2008-10#1)
airway and##4##2##(1992-2#1)(1992-3#1)(1997-1#1)(1997-2#1)
airway blood flow##2##3##(1997-1#2)
airway deposition##2##2##(1996-12#2)
airway dimension##2##2##(2008-11#2)
airway dimensions for##2##3##(2008-11#2)
airway dimensions##3##2##(2008-11#3)
airway disease##4##2##(1993-2#1)(1997-1#1)(2010-5#2)
airway epithelial cells##5##3##(1991-5#1)(1994-11#3)(2010-5#1)
airway epithelial##8##2##(1991-5#3)(1994-11#3)(1995-11#1)(2010-5#1)
airway epithelium##3##2##(1995-11#1)(1997-2#2)
airway gas exchange##2##3##(1997-1#2)
airway geometry##2##2##(1992-3#1)(2008-11#1)
airway have been##2##3##(2008-10#1)(2013-1#1)
airway hyperresponsiveness##3##2##(1993-9#1)(1997-1#1)(2008-10#1)
airway inflammation##6##2##(1992-5#1)(2009-1#1)(2010-1#1)(2010-5#2)(2012-12#1)
airway management##3##2##(2010-7#1)(2011-2#2)
airway obstruction##7##2##(2008-10#1)(2008-11#2)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
airway resistance##3##2##(1994-6#1)(2011-2#1)(2012-3#1)
airway retention of##2##3##(1995-12#2)
airway retention##6##2##(1995-12#6)
airway sealing pressure##4##3##(2010-7#4)
airway sensitization potential##3##3##(2008-10#3)
airway smooth muscle##3##3##(1996-1#1)(1997-1#1)(2010-1#1)
airway##139##1##(1990-6#1)(1991-5#3)(1992-2#5)(1992-3#3)(1992-5#2)(1993-2#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-6#3)(1995-11#2)(1995-12#6)(1996-1#4)(1996-12#6)(1996-2#2)(1997-1#17)(1997-2#7)(1997-4#1)(2008-10#11)(2008-11#10)(2008-12#4)(2008-7#1)(2009-1#2)(2010-1#4)(2010-12#1)(2010-5#6)(2010-7#11)(2011-1#1)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#3)
airways and##6##2##(1994-12#1)(1994-5#1)(1996-12#1)(1996-6#1)(2009-1#1)(2013-1#1)
airways obstruction##5##2##(1995-12#1)(2008-7#4)
airways of the lung##3##4##(1991-12#1)(1997-1#1)(2008-10#1)
airways of the##4##3##(1991-12#1)(1997-1#2)(2008-10#1)
airways of##8##2##(1991-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#2)(2008-10#1)
airways##54##1##(1991-12#3)(1991-6#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-1#1)(1994-12#2)(1994-2#2)(1994-5#2)(1995-12#1)(1996-12#1)(1996-6#1)(1997-1#13)(1997-2#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#5)(2009-1#1)(2010-1#1)(2010-7#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
ajoene##3##1##(2008-5#3)
akajimensis is##2##2##(2011-2#2)
akajimensis##4##1##(2011-2#4)
akathisia##3##1##(2008-7#3)
akinesia##4##1##(1991-3#1)(2008-7#2)(2012-2#1)
akinetic##2##1##(2008-7#1)(2013-1#1)
akratic##2##1##(2008-10#2)
al##229##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#9)(1993-3#2)(1993-6#2)(1993-8#6)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#5)(1995-8#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#18)(2008-11#35)(2008-12#7)(2008-3#2)(2008-5#10)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#29)(2012-12#1)(2012-3#5)(2013-1#8)(2013-8#3)
alachlor##7##1##(1993-12#2)(2008-10#5)
alane decomposition##3##2##(2010-4#3)
alane was##2##2##(2010-4#2)
alane##8##1##(2008-8#1)(2010-4#7)
alanine aminotransferase (ALT)##5##3##(2008-10#1)(2009-8#1)(2012-3#2)(2013-8#1)
alanine aminotransferase level##2##3##(2007-12#1)(2013-8#1)
alanine aminotransferase##11##2##(1993-2#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-8#2)(2012-3#2)(2013-8#2)
alanine and aspartate##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
alanine at##2##2##(1993-8#1)(2008-10#1)
alanine is##2##2##(1997-1#1)(2008-10#1)
alanine or##2##2##(1994-11#1)(1994-3#1)
alanine production##3##2##(2008-11#1)(2008-7#2)
alanine transaminase##2##2##(2008-11#2)
alanine##54##1##(1990-2#1)(1993-2#1)(1993-8#3)(1994-11#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-6#2)(1997-1#2)(1997-8#2)(2007-12#1)(2008-10#14)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-8#2)(2010-5#1)(2012-3#2)(2013-8#2)
alantolactone##2##1##(2008-10#2)
alanyl aminopeptidase##2##2##(1990-2#2)
alanyl##3##1##(1990-2#2)(1995-6#1)
alanyl- and threonyl-tRNA synthetases##2##4##(2012-2#2)
alarm cues##2##2##(2010-8#2)
alarm sensor##2##2##(2008-10#2)
alarm##13##1##(1995-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
alarming##4##1##(1995-6#1)(1996-1#1)(2013-1#2)
alarms##3##1##(1994-8#1)(2011-2#2)
alba##8##1##(2008-10#1)(2008-5#1)(2008-8#2)(2011-3#4)
albedo and##2##2##(2008-2#2)
albedo of a##2##3##(2008-2#1)(2008-3#1)
albedo of##6##2##(2008-2#1)(2008-3#5)
albedo##21##1##(2008-2#9)(2008-3#12)
albeit not##2##2##(2008-10#2)
albeit##18##1##(1991-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-3#3)(2013-8#1)
albendazole was##3##2##(2008-10#2)(2010-11#1)
albendazole##8##1##(1995-12#1)(1996-12#2)(2008-10#3)(2010-11#1)(2011-2#1)
albicans PKC1 gene##2##3##(1996-6#2)
albicans and##5##2##(2008-11#1)(2008-5#4)
albicans biofilm##3##2##(2013-1#3)
albicans cells##6##2##(1996-6#1)(2008-5#5)
albicans hyphal growth##2##3##(2009-8#2)
albicans in the##2##3##(2008-11#1)(2008-5#1)
albicans in##6##2##(2008-11#2)(2008-5#4)
albicans is##2##2##(1996-12#1)(2008-5#1)
albicans isolates##2##2##(2008-5#1)(2012-3#1)
albicans strains isolated from##2##4##(2008-5#2)
albicans strains##3##2##(2008-5#3)
albicans##81##1##(1992-8#1)(1996-12#2)(1996-3#2)(1996-6#5)(2006-6#1)(2008-11#5)(2008-5#46)(2009-8#3)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#8)
albicidin##2##1##(2008-10#2)
albicinctus and##2##2##(2008-10#2)
albilineans could be##2##3##(2008-10#2)
albilineans##9##1##(2008-10#9)
albinism##5##1##(2008-6#5)
albino and pigmented medaka##3##4##(2008-11#3)
albino medaka were##2##3##(2008-11#2)
albino mice##2##2##(2010-1#2)
albino rat##3##2##(1994-8#2)(2008-10#1)
albino rats were##3##3##(1994-8#1)(2008-10#1)(2012-2#1)
albino rats##4##2##(1994-8#1)(2008-10#1)(2012-2#2)
albino strain##2##2##(2008-10#2)
albino wistar rats##2##3##(2008-12#2)
albino##21##1##(1994-8#3)(2008-10#6)(2008-11#6)(2008-12#2)(2010-1#2)(2012-2#2)
albitarsis##2##1##(2012-12#2)
albite##2##1##(2013-8#2)
albo-atrum from##2##2##(2008-10#2)
albo-atrum##8##1##(2008-10#8)
album&quot##5##1##(1993-2#5)
albumin and hemoglobin##2##3##(2008-1#1)(2008-7#1)
albumin and the##2##3##(1993-12#1)(2008-10#1)
albumin and##24##2##(1993-12#1)(1995-2#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-7#2)(2011-2#1)
albumin as the##3##3##(1991-12#2)(2008-10#1)
albumin as##7##2##(1990-12#1)(1991-12#2)(2008-10#2)(2008-11#1)(2009-9#1)
albumin by##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
albumin concentration##7##2##(1992-9#5)(1993-8#1)(2008-10#1)
albumin excretion##4##2##(1997-8#1)(2013-1#3)
albumin for##2##2##(2008-7#1)(2013-1#1)
albumin globule##2##2##(2008-10#2)
albumin in##6##2##(2008-10#1)(2008-11#1)(2008-7#3)(2009-6#1)
albumin is##2##2##(1995-2#2)
albumin levels##2##2##(2008-10#1)(2009-6#1)
albumin molecule##2##2##(2008-10#2)
albumin on##2##2##(1993-8#1)(1995-12#1)
albumin production ability##2##3##(2008-11#2)
albumin production##3##2##(2008-11#3)
albumin secretion##9##2##(2008-11#7)(2013-1#2)
albumin to creatinine ratio##2##4##(2013-1#2)
albumin using##2##2##(2008-10#2)
albumin variants##2##2##(1991-12#2)
albumin##206##1##(1990-11#2)(1990-12#5)(1990-2#2)(1990-8#3)(1991-12#7)(1992-9#5)(1993-12#1)(1993-2#1)(1993-8#5)(1994-8#5)(1995-11#1)(1995-12#4)(1995-2#6)(1995-5#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-10#88)(2008-11#28)(2008-3#2)(2008-5#4)(2008-7#9)(2008-9#1)(2009-6#2)(2009-9#1)(2011-2#7)(2013-1#9)(2013-8#1)
albumin)##3##1##(2008-10#2)(2008-9#1)
albumin/creatinine ratio##2##2##(1992-9#2)
albumins were detected##2##3##(1991-12#1)(2008-5#1)
albumins were##3##2##(1991-12#1)(2008-5#2)
albumins##7##1##(1991-12#2)(1995-2#1)(2008-5#4)
albuminuria##6##1##(1992-9#3)(1993-12#1)(1994-8#1)(2008-10#1)
albus##4##1##(2008-10#1)(2008-12#1)(2011-2#2)
albuterol##2##1##(1997-2#1)(2008-8#1)
alcian blue concentration##2##3##(2008-10#2)
alcian blue##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
alcohol (PVA)##3##2##(2008-10#2)(2012-3#1)
alcohol abuse##13##2##(1990-2#3)(1992-12#1)(1996-6#1)(1997-2#2)(2008-11#2)(2009-7#2)(2011-2#1)(2013-1#1)
alcohol and drug dependent patients##2##5##(1992-12#2)
alcohol and drug##5##3##(1990-2#1)(1992-12#3)(2010-9#1)
alcohol and the##4##3##(1991-1#2)(2008-10#1)(2008-5#1)
alcohol and tobacco in##2##4##(2008-1#2)
alcohol and tobacco##4##3##(1994-12#1)(2008-1#3)
alcohol and##21##2##(1990-2#1)(1991-1#2)(1992-12#3)(1994-12#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-5#4)(2008-8#1)(2010-9#1)(2012-12#1)
alcohol as##3##2##(1997-8#1)(2008-1#1)(2008-10#1)
alcohol by##3##2##(1994-5#1)(2008-10#2)
alcohol concentration##3##2##(2008-10#3)
alcohol consumption and##2##3##(2008-11#1)(2009-7#1)
alcohol consumption in##2##3##(1995-11#1)(2008-7#1)
alcohol consumption##19##2##(1990-8#2)(1990-9#1)(1992-9#1)(1995-11#2)(1996-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#2)(2009-7#3)(2011-2#1)
alcohol consumption]##2##2##(1997-2#2)
alcohol dehydrogenase (ADH)##2##3##(1997-8#1)(2008-11#1)
alcohol dehydrogenase in##2##3##(1990-5#1)(1994-8#1)
alcohol dehydrogenase inactivated hepatocytes##2##4##(1994-8#2)
alcohol dehydrogenase##20##2##(1990-5#1)(1991-10#2)(1992-11#1)(1994-6#1)(1994-8#3)(1997-8#2)(2008-10#3)(2008-11#2)(2008-5#3)(2011-2#1)(2013-8#1)
alcohol dependence##3##2##(2008-10#1)(2009-10#1)(2010-1#1)
alcohol drinking behaviour##2##3##(2009-7#2)
alcohol drinking##6##2##(1990-2#1)(1997-6#1)(2009-7#2)(2010-5#1)(2013-8#1)
alcohol during##2##2##(2012-12#2)
alcohol eluates##2##2##(2008-10#2)
alcohol exposure##2##2##(2008-11#2)
alcohol in the##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
alcohol in##7##2##(1991-1#1)(2008-10#3)(2008-5#2)(2008-7#1)
alcohol into##2##2##(1997-8#1)(2012-12#1)
alcohol is##4##2##(1992-12#1)(1995-11#1)(2008-10#2)
alcohol or aldehyde##3##3##(1994-8#1)(2010-7#2)
alcohol or##7##2##(1992-12#1)(1993-3#1)(1994-8#1)(2010-7#3)(2013-1#1)
alcohol oxidase##8##2##(1994-11#1)(1995-9#1)(1997-7#1)(2008-10#4)(2008-7#1)
alcohol policies##2##2##(2008-1#1)(2008-11#1)
alcohol problems##5##2##(1993-12#1)(2008-11#4)
alcohol related##2##2##(2008-1#1)(2012-3#1)
alcohol sample##3##2##(2008-10#3)
alcohol samples##3##2##(2008-10#3)
alcohol screening##2##2##(2008-11#2)
alcohol through##2##2##(2008-7#1)(2009-12#1)
alcohol to##2##2##(1990-2#1)(2009-8#1)
alcohol use and##6##3##(2008-11#3)(2008-12#2)(2010-7#1)
alcohol use disorder##2##3##(2013-8#2)
alcohol use disorders##4##3##(2011-2#1)(2012-3#3)
alcohol use in##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
alcohol use##38##2##(1992-12#1)(2008-11#12)(2008-12#4)(2009-11#1)(2009-7#1)(2009-8#1)(2010-7#3)(2010-9#3)(2011-2#1)(2012-12#1)(2012-3#3)(2013-8#7)
alcohol was##2##2##(2008-10#1)(2009-10#1)
alcohol##315##1##(1990-2#8)(1990-5#2)(1990-8#3)(1990-9#2)(1991-1#4)(1991-10#2)(1991-9#5)(1992-11#1)(1992-12#7)(1992-3#2)(1992-7#1)(1992-9#2)(1993-12#2)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#4)(1995-10#1)(1995-11#3)(1995-9#1)(1996-1#3)(1996-12#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#5)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#7)(2007-12#1)(2008-1#9)(2008-10#71)(2008-11#40)(2008-12#7)(2008-2#1)(2008-4#1)(2008-5#16)(2008-7#7)(2008-8#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-7#11)(2009-8#5)(2010-1#2)(2010-11#2)(2010-5#1)(2010-7#7)(2010-9#4)(2011-1#1)(2011-2#5)(2012-12#8)(2012-3#8)(2013-1#4)(2013-8#13)
alcohol)##11##1##(1997-8#2)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)
alcohol-related problems##5##2##(1995-11#1)(2008-11#1)(2008-12#3)
alcohol-related##8##1##(1992-12#1)(1994-2#1)(1995-11#1)(2008-11#1)(2008-12#3)(2008-7#1)
alcoholic beverage##3##2##(1995-2#1)(2008-10#2)
alcoholic beverages##11##2##(1991-9#1)(2008-10#8)(2011-1#2)
alcoholic chronic pancreatitis##5##3##(2009-7#5)
alcoholic group##2##2##(2008-10#2)
alcoholic hepatitis##2##2##(2009-7#2)
alcoholic liver##3##2##(2008-8#1)(2009-7#1)(2010-12#1)
alcoholic patients##2##2##(1996-11#1)(2009-7#1)
alcoholic patients]##2##2##(1995-11#1)(2008-10#1)
alcoholic##49##1##(1990-5#1)(1990-8#1)(1991-1#1)(1991-9#2)(1995-11#2)(1995-2#1)(1996-11#1)(1997-1#1)(2007-8#2)(2008-10#21)(2008-12#1)(2008-8#1)(2009-7#9)(2010-12#1)(2011-1#3)(2013-1#1)
alcoholics##5##1##(1993-2#1)(1995-11#2)(2008-10#1)(2008-11#1)
alcoholism and tuberculosis##3##3##(2011-2#3)
alcoholism and##5##2##(1995-12#1)(1996-1#1)(2011-2#3)
alcoholism treatment##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
alcoholism##28##1##(1991-1#2)(1991-12#1)(1993-12#2)(1993-2#4)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#3)(2012-12#1)
alcohols and##6##2##(2008-10#4)(2008-3#1)(2008-7#1)
alcohols in##2##2##(1990-5#1)(1995-3#1)
alcohols is##3##2##(1996-5#1)(2008-10#2)
alcohols with##3##2##(1996-5#1)(2008-10#2)
alcohols##42##1##(1990-5#3)(1992-7#1)(1995-3#1)(1996-5#2)(1997-2#1)(1997-8#1)(2008-10#20)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#2)(2009-8#4)(2010-7#2)
alcuronium##3##1##(1995-11#3)
aldehyde dehydrogenase (ALDH)##2##3##(1994-5#1)(2008-11#1)
aldehyde dehydrogenase##6##2##(1994-5#1)(1994-8#2)(2008-10#2)(2008-11#1)
aldehyde##25##1##(1991-5#1)(1994-11#1)(1994-5#1)(1994-8#3)(1996-5#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-7#3)
aldehydes and##3##2##(1996-5#2)(2008-10#1)
aldehydes condense##2##2##(1996-5#2)
aldehydes in##2##2##(2008-10#1)(2008-8#1)
aldehydes using##2##2##(2008-10#2)
aldehydes##27##1##(1996-5#8)(2008-10#11)(2008-7#2)(2008-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#1)
alder##3##1##(2008-10#1)(2008-12#1)(2012-3#1)
aldicarb sulfoxide##2##2##(2008-10#2)
aldicarb##6##1##(2008-10#6)
aldo-1 was##2##2##(1990-5#2)
aldolase##2##1##(2008-10#1)(2012-2#1)
aldose reductase and sorbitol dehydrogenase##2##5##(1996-2#2)
aldose reductase##5##2##(1994-8#1)(1996-2#3)(2009-11#1)
aldose##6##1##(1994-8#1)(1996-2#3)(2008-10#1)(2009-11#1)
aldosterone synthase##4##2##(1990-5#3)(2008-4#1)
aldosterone##9##1##(1990-5#4)(1991-12#1)(2008-4#4)
aldosterone-producing adrenal adenomas and##2##4##(1990-11#2)
aldosterone-producing##3##1##(1990-11#3)
aldotetrofuranoses##2##1##(1990-9#2)
alemtuzumab for##2##2##(2008-7#1)(2009-12#1)
alemtuzumab##8##1##(2008-12#3)(2008-7#1)(2009-12#4)
alendronate and##3##2##(2008-11#3)
alendronate in##2##2##(2008-10#2)
alendronate use##2##2##(2008-11#2)
alendronate users##4##2##(2008-11#4)
alendronate##26##1##(2008-10#9)(2008-11#15)(2008-7#1)(2010-3#1)
aleophilum##3##1##(2008-10#3)
alert the##4##2##(1992-2#1)(2008-12#1)(2008-9#1)(2012-12#1)
alert##16##1##(1991-12#1)(1992-2#1)(1996-2#2)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-12#1)
alerted to the##2##3##(2008-7#1)(2010-8#1)
alerting##4##1##(2007-12#1)(2011-2#2)(2012-2#1)
alertness related training##2##3##(2013-8#2)
alertness related##3##2##(2013-8#3)
alertness##6##1##(1990-12#1)(2013-8#5)
alerts##2##1##(2008-10#1)(2011-2#1)
aleurone##6##1##(2008-10#3)(2008-8#3)
alexia##3##1##(2010-7#3)
alexithymia##5##1##(2008-11#5)
alfa##3##1##(2008-7#2)(2009-9#1)
alfalfa (Medicago sativa L##3##4##(2008-11#2)(2012-3#1)
alfalfa (Medicago sativa)##2##3##(2008-10#2)
alfalfa (Medicago##5##2##(2008-10#2)(2008-11#2)(2012-3#1)
alfalfa and##3##2##(2008-10#3)
alfalfa biomass##4##2##(2008-10#4)
alfalfa leaves##3##2##(2008-10#3)
alfalfa plants##2##2##(2008-10#2)
alfalfa populations##4##2##(2008-10#3)(2012-3#1)
alfalfa rust##2##2##(2008-10#2)
alfalfa stem##2##2##(2008-11#2)
alfalfa witches'-broom##3##2##(2008-10#3)
alfalfa##54##1##(2008-10#43)(2008-11#5)(2008-8#3)(2010-4#1)(2012-3#2)
alga##25##1##(2008-10#12)(2008-11#6)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-3#1)
algae and##4##2##(2008-8#2)(2009-6#1)(2012-2#1)
algae collected##3##2##(2008-10#3)
algae extracts##2##2##(2008-11#1)(2010-7#1)
algae from##3##2##(2007-12#1)(2008-11#2)
algae samples##3##2##(2008-10#2)(2008-11#1)
algae##43##1##(2007-12#1)(2008-10#18)(2008-11#7)(2008-5#1)(2008-7#2)(2008-8#7)(2009-10#1)(2009-4#1)(2009-6#1)(2010-7#2)(2011-10#1)(2012-2#1)
algal##11##1##(2008-10#4)(2008-11#1)(2008-12#1)(2009-6#1)(2009-8#4)
alginate microspheres##3##2##(2008-7#3)
alginate pellet##2##2##(2008-10#2)
alginate pellets##4##2##(2008-10#4)
alginate with snail##2##3##(2008-11#2)
alginate with##3##2##(2008-11#3)
alginate##30##1##(2008-10#8)(2008-11#8)(2008-5#1)(2008-7#3)(2011-2#8)(2012-2#1)(2013-1#1)
alginate/poly-L##4##1##(2008-11#4)
alginates##3##1##(2008-10#3)
alginolyticus is##2##2##(1997-8#2)
alginolyticus##6##1##(1997-8#6)
algorithm (GA)##2##2##(2008-10#1)(2008-3#1)
algorithm and##7##2##(2008-10#2)(2008-12#1)(2008-3#3)(2008-8#1)
algorithm based on##4##3##(2008-10#3)(2008-6#1)
algorithm based##5##2##(2008-10#4)(2008-6#1)
algorithm by##3##2##(2011-3#2)(2012-3#1)
algorithm for the##7##3##(2008-10#1)(2009-12#1)(2009-4#1)(2011-10#1)(2011-3#1)(2013-1#2)
algorithm for##27##2##(1993-8#1)(2008-10#5)(2008-3#4)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-7#2)(2011-10#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#5)(2013-8#1)
algorithm has been##3##3##(2008-10#2)(2008-3#1)
algorithm in order##2##3##(2008-3#1)(2010-8#1)
algorithm in##9##2##(2008-10#1)(2008-3#1)(2009-12#1)(2010-8#2)(2012-12#1)(2012-2#2)(2013-1#1)
algorithm is applied##2##3##(2008-10#1)(2010-8#1)
algorithm is based on the##2##5##(2008-10#1)(2011-3#1)
algorithm is based on##3##4##(2008-10#1)(2008-3#1)(2011-3#1)
algorithm is compared##2##3##(2008-6#1)(2010-8#1)
algorithm is demonstrated##2##3##(2008-3#2)
algorithm is developed##2##3##(2008-3#1)(2013-1#1)
algorithm is proposed for##2##4##(2008-10#1)(2008-3#1)
algorithm is proposed##3##3##(2008-10#2)(2008-3#1)
algorithm is used to##3##4##(2008-3#3)
algorithm is##32##2##(2008-10#9)(2008-2#1)(2008-3#10)(2008-6#4)(2010-8#2)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#2)
algorithm of##4##2##(2008-10#2)(2013-1#1)(2013-8#1)
algorithm that##6##2##(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-3#1)(2013-8#1)
algorithm to make##2##3##(2011-3#1)(2013-1#1)
algorithm to##12##2##(2007-11#1)(2008-10#2)(2008-3#4)(2008-6#2)(2011-3#1)(2013-1#2)
algorithm used##2##2##(2008-10#1)(2008-2#1)
algorithm was applied##2##3##(2008-10#1)(2008-3#1)
algorithm was developed##2##3##(1994-2#1)(2008-12#1)
algorithm was employed to##2##4##(2008-10#2)
algorithm was used to##3##4##(2008-10#3)
algorithm was used##4##3##(2008-10#4)
algorithm was##13##2##(1994-2#1)(2008-10#9)(2008-12#1)(2008-3#2)
algorithm were##3##2##(2008-10#3)
algorithm which##2##2##(2008-9#1)(2009-10#1)
algorithm with##6##2##(2008-10#2)(2008-3#2)(2010-12#1)(2013-8#1)
algorithm##216##1##(1992-12#1)(1993-8#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-10#61)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#46)(2008-6#21)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#6)(2009-4#3)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#3)(2010-8#7)(2011-10#1)(2011-2#2)(2011-3#6)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#11)(2013-8#8)
algorithm's##2##1##(2008-3#1)(2008-8#1)
algorithmic##3##1##(1991-12#2)(2008-10#1)
algorithms and##5##2##(2008-10#1)(2008-3#2)(2008-9#1)(2013-1#1)
algorithms are##6##2##(2008-3#3)(2008-6#1)(2010-9#1)(2013-1#1)
algorithms can##2##2##(2008-3#2)
algorithms for##16##2##(2008-1#1)(2008-10#1)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
algorithms is##3##2##(2008-3#3)
algorithms may##2##2##(2008-9#1)(2012-2#1)
algorithms of##2##2##(2008-10#1)(2012-3#1)
algorithms show##2##2##(2008-3#2)
algorithms that have##2##3##(2008-3#1)(2008-6#1)
algorithms that use##2##3##(2008-3#2)
algorithms that##6##2##(2008-3#5)(2008-6#1)
algorithms used to##2##3##(2008-3#2)
algorithms used##3##2##(2008-3#2)(2008-4#1)
algorithms utilize##2##2##(2008-3#2)
algorithms##92##1##(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#33)(2008-4#2)(2008-6#10)(2008-7#2)(2008-9#5)(2009-10#2)(2009-12#3)(2010-10#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
algorithms)##2##1##(2008-10#1)(2010-12#1)
alia##2##1##(1990-12#1)(2008-11#1)
alien additional line##2##3##(2008-9#2)
alien##4##1##(2008-10#1)(2008-8#1)(2008-9#2)
align to##2##2##(2008-11#1)(2012-3#1)
align##10##1##(1996-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
aligned on##2##2##(1995-6#1)(2008-6#1)
aligned with the##2##3##(2008-10#1)(2009-9#1)
aligned with##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2009-9#1)(2011-2#1)
aligned##32##1##(1991-5#1)(1995-3#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#7)
aligning forces for quality initiative##4##5##(2013-1#4)
aligning forces##5##2##(2013-1#5)
aligning##10##1##(2008-3#1)(2008-4#3)(2011-2#1)(2013-1#5)
alignment and adjustment##3##3##(2008-4#3)
alignment and##8##2##(2008-10#1)(2008-3#1)(2008-4#3)(2013-1#3)
alignment at##2##2##(2008-4#1)(2011-2#1)
alignment between##2##2##(2008-10#1)(2013-1#1)
alignment for##2##2##(1997-7#1)(2013-1#1)
alignment layer##4##2##(2008-10#4)
alignment of nucleotide##2##3##(2008-10#1)(2008-9#1)
alignment of the##5##3##(1992-9#1)(1993-12#1)(1994-2#1)(2008-10#2)
alignment of##16##2##(1991-3#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-5#1)(1997-8#1)(1997-9#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-9#1)
alignment perturbations##2##2##(2013-1#2)
alignment##87##1##(1991-3#2)(1992-9#1)(1993-12#2)(1994-2#1)(1994-5#1)(1997-7#1)(1997-8#1)(1997-9#2)(2007-12#1)(2008-10#18)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#7)(2008-7#1)(2008-8#1)(2008-9#6)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#20)
alignments that##2##2##(2008-9#1)(2011-3#1)
alignments##16##1##(2008-10#1)(2008-4#3)(2008-9#5)(2010-4#1)(2011-3#4)(2013-1#1)(2013-8#1)
aligns##2##1##(1994-3#1)(1997-3#1)
alike to##2##2##(2008-10#1)(2008-11#1)
alike##10##1##(1991-2#1)(1994-3#1)(1994-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)
alimentary tract##2##2##(2009-9#1)(2011-2#1)
alimentary##6##1##(2008-10#3)(2008-5#1)(2009-9#1)(2011-2#1)
alimentation##2##1##(2008-12#2)
aliphatic alcohols is##2##3##(2008-10#2)
aliphatic alcohols##6##2##(1990-5#1)(2008-10#5)
aliphatic amines at##2##3##(2008-10#2)
aliphatic amines in##4##3##(2008-10#4)
aliphatic amines##14##2##(2008-10#14)
aliphatic and aromatic##3##3##(1996-5#1)(2008-10#2)
aliphatic and##4##2##(1996-5#1)(2008-10#3)
aliphatic hydrocarbons##4##2##(2008-11#4)
aliphatic nitriles##2##2##(2012-3#2)
aliphatic##48##1##(1990-5#1)(1994-8#2)(1995-9#1)(1996-5#7)(2008-10#27)(2008-11#5)(2008-4#1)(2012-3#4)
aliquot and##2##2##(2008-10#2)
aliquot mixed with##2##3##(2008-10#2)
aliquot of a##2##3##(2008-10#1)(2008-11#1)
aliquot of the##6##3##(2008-10#6)
aliquot of##14##2##(2008-10#13)(2008-11#1)
aliquot##24##1##(2008-10#21)(2008-11#1)(2008-12#1)(2008-8#1)
aliquot)##2##1##(2008-10#1)(2009-6#1)
aliquots of this##2##3##(2008-10#2)
aliquots of##4##2##(2008-10#3)(2008-11#1)
aliquots##13##1##(1992-1#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-5#1)
alive and disease free at##2##5##(1991-8#1)(1992-5#1)
alive and well##2##3##(1994-12#1)(2008-6#1)
alive and##9##2##(1991-6#1)(1991-8#2)(1992-5#1)(1994-12#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)
alive at##6##2##(1991-8#1)(1992-9#1)(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
alive for##2##2##(1991-2#1)(2008-10#1)
alive today##2##2##(1990-9#1)(2013-8#1)
alive with##2##2##(2011-2#1)(2012-12#1)
alive without##2##2##(1990-2#1)(2010-1#1)
alive##44##1##(1990-2#1)(1990-6#2)(1990-9#3)(1991-2#1)(1991-6#1)(1991-8#3)(1992-5#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-5#1)(1995-2#1)(1996-12#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#2)(2010-1#1)(2010-9#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-8#1)
alizarin red S##2##3##(2008-10#2)
alizarin##5##1##(2008-10#5)
alk1##3##1##(1991-9#3)
alk2##3##1##(1991-9#3)
alkali aluminosilicate glasses##2##3##(2008-3#2)
alkali and alkaline earth metal cations is##2##7##(2008-10#2)
alkali and alkaline earth metal cations##4##6##(2008-10#4)
alkali and alkaline earth metal ions##3##6##(2008-10#3)
alkali and alkaline earth metal##9##5##(2008-10#9)
alkali and alkaline earth metals and##2##6##(2008-10#2)
alkali and alkaline earth##13##4##(2008-10#13)
alkali and alkaline earths##2##4##(2008-10#2)
alkali and alkaline##16##3##(2008-10#16)
alkali and##17##2##(2008-10#17)
alkali earth##2##2##(2008-10#2)
alkali light chain##2##3##(1993-9#2)
alkali metal cations##4##3##(2008-10#4)
alkali metal ion##2##3##(2008-10#2)
alkali metal ions##6##3##(2008-10#6)
alkali metal picrates##6##3##(2008-10#6)
alkali metal##26##2##(2008-10#23)(2008-2#2)(2012-2#1)
alkali metals and##2##3##(2008-10#2)
alkali metals##3##2##(2008-10#3)
alkali or##3##2##(2008-10#3)
alkali##90##1##(1993-9#2)(1994-3#1)(2008-10#79)(2008-2#2)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#2)
alkali-labile##2##1##(1991-3#2)
alkaline and alkaline-earth metals##2##4##(2008-10#2)
alkaline and alkaline-earth##3##3##(2008-10#3)
alkaline and transition metal ions##2##5##(2008-10#2)
alkaline and transition##3##3##(2008-10#3)
alkaline and##9##2##(1990-11#1)(2008-10#7)(2009-7#1)
alkaline aqueous solution##2##3##(1992-3#1)(2008-10#1)
alkaline buffer solution##2##3##(2008-10#2)
alkaline cations##2##2##(2008-10#2)
alkaline conditions (pH##2##3##(1991-7#1)(2008-10#1)
alkaline conditions##11##2##(1991-7#1)(1995-8#1)(1996-5#2)(2008-10#5)(2008-11#1)(2008-6#1)
alkaline earth and other transition metal cations##2##7##(2008-10#2)
alkaline earth and##7##3##(2008-10#6)(2010-11#1)
alkaline earth metal cations##6##4##(2008-10#6)
alkaline earth metal ions##5##4##(2008-10#5)
alkaline earth metal##15##3##(2008-10#15)
alkaline earth metals##8##3##(2008-10#8)
alkaline earth##50##2##(2008-10#49)(2010-11#1)
alkaline elution##3##2##(1993-12#2)(1994-8#1)
alkaline fusion and##2##3##(2008-10#2)
alkaline hydrolysis and##2##3##(1991-12#1)(2008-11#1)
alkaline hydrolysis of##2##3##(2008-10#2)
alkaline hydrolysis##7##2##(1991-12#1)(2008-10#5)(2008-11#1)
alkaline hydrothermal conversion of the##2##5##(2008-10#2)
alkaline hydrothermal conversion of##3##4##(2008-10#3)
alkaline media##9##2##(1995-8#1)(2008-10#8)
alkaline medium was##2##3##(2008-10#2)
alkaline medium##30##2##(2008-10#30)
alkaline metal##2##2##(2008-10#2)
alkaline metals##3##2##(2008-10#3)
alkaline pH##7##2##(2008-10#4)(2008-11#2)(2008-9#1)
alkaline phosphatase (ALP) activity##2##4##(2008-10#1)(2008-11#1)
alkaline phosphatase (ALP)##9##3##(2008-10#2)(2008-11#3)(2011-1#2)(2012-3#1)(2013-1#1)
alkaline phosphatase (AP)##3##3##(2008-10#2)(2008-11#1)
alkaline phosphatase (SEAP)##4##3##(2008-11#2)(2008-7#1)(2011-2#1)
alkaline phosphatase activity and##2##4##(2008-10#1)(2012-4#1)
alkaline phosphatase activity##8##3##(2008-10#3)(2008-11#4)(2012-4#1)
alkaline phosphatase and##4##3##(1993-3#1)(2008-10#2)(2013-1#1)
alkaline phosphatase as##3##3##(1995-11#1)(1995-2#1)(2008-11#1)
alkaline phosphatase in##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
alkaline phosphatase##68##2##(1990-12#2)(1991-10#4)(1991-12#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1995-11#1)(1995-2#2)(2008-10#20)(2008-11#14)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#1)
alkaline protease##2##2##(2008-11#1)(2008-5#1)
alkaline solution##13##2##(2008-10#13)
alkaline solutions##5##2##(2008-10#5)
alkaline treatment of the##2##4##(1991-10#1)(2008-10#1)
alkaline##287##1##(1990-11#2)(1990-12#2)(1991-10#5)(1991-12#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-8#3)(1995-11#1)(1995-2#2)(1995-8#2)(1996-5#2)(2008-10#190)(2008-11#22)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#9)(2009-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2012-4#2)(2013-1#5)(2013-8#3)
alkaline-earth metals##5##2##(2008-10#5)
alkaline-earth##6##1##(2008-10#6)
alkalinisation##2##1##(1991-12#1)(2013-1#1)
alkalinity##5##1##(2008-10#1)(2013-1#1)(2013-8#3)
alkalinization##3##1##(2008-10#1)(2013-8#2)
alkalinized##2##1##(2008-10#1)(2011-3#1)
alkaloid salts##3##2##(2008-10#3)
alkaloid which##2##2##(1994-8#1)(2008-7#1)
alkaloid##24##1##(1993-8#2)(1994-8#3)(1995-11#2)(1997-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2011-3#2)(2012-2#1)(2013-8#1)
alkaloids and##3##2##(2008-10#1)(2011-3#1)(2013-8#1)
alkaloids in##3##2##(2008-10#2)(2008-11#1)
alkaloids were separated##2##3##(2008-10#2)
alkaloids were##7##2##(2008-10#7)
alkaloids##31##1##(1995-12#1)(2008-10#19)(2008-11#1)(2010-7#1)(2011-3#4)(2012-3#1)(2013-8#4)
alkalosis##2##1##(1996-6#1)(1997-8#1)
alkane##3##1##(1991-9#2)(1996-3#1)
alkane-inducible##3##1##(1991-9#2)(1993-12#1)
alkavinone is##2##2##(1994-5#2)
alkavinone##4##1##(1994-5#4)
alkene 4##3##2##(1996-5#3)
alkene##6##1##(1996-5#6)
alkenes##2##1##(2009-8#1)(2012-3#1)
alkoxyl##2##1##(1996-5#1)(2008-10#1)
alkoxyresorufin O-dealkylation##2##2##(1994-8#2)
alkoxyresorufin##3##1##(1994-8#2)(2008-11#1)
alkoxyresorufins##2##1##(1994-8#2)
alkyl alcohols##3##2##(2009-8#3)
alkyl chain of##2##3##(1995-11#1)(2008-10#1)
alkyl chain##7##2##(1995-11#1)(2008-10#4)(2008-5#2)
alkyl chains of##2##3##(2008-5#2)
alkyl chains##5##2##(2008-10#1)(2008-5#3)(2011-2#1)
alkyl esters##2##2##(1995-2#1)(2008-7#1)
alkyl ether##2##2##(2008-10#1)(2008-5#1)
alkyl groups##3##2##(2008-10#1)(2008-11#2)
alkyl##42##1##(1995-11#2)(1995-2#1)(1996-5#1)(2008-10#16)(2008-11#2)(2008-5#10)(2008-7#1)(2009-8#4)(2009-9#1)(2011-2#1)(2012-2#3)
alkyl-diol silica (ADS) precolumn##2##4##(2008-10#2)
alkyl-diol##3##1##(2008-10#3)
alkylammonium cations over##2##3##(2008-10#2)
alkylammonium cations##4##2##(2008-10#4)
alkylammonium##5##1##(2008-10#5)
alkylating agent##2##2##(1995-8#1)(2010-12#1)
alkylating agents##7##2##(1995-8#1)(2008-11#5)(2008-5#1)
alkylating##15##1##(1995-8#2)(1996-3#1)(1997-2#1)(2008-11#7)(2008-5#1)(2010-11#2)(2010-12#1)
alkylation##3##1##(1994-5#1)(2008-11#1)(2010-7#1)
alkyldibenzylamines as neutral carriers##2##4##(2008-10#2)
alkylic##2##1##(2008-10#2)
alkylphenols and pesticides were##2##4##(2008-10#2)
alkylphenols and pesticides##3##3##(2008-10#3)
alkylphenols for##2##2##(2008-11#2)
alkylphenols in##6##2##(2008-10#5)(2008-11#1)
alkylphenols##14##1##(2008-10#10)(2008-11#4)
alkylresorcinol##2##1##(2008-11#2)
alkylresorcinols##6##1##(2008-11#6)
alkyltrimethylammonium cations##2##2##(2008-10#2)
alkyltrimethylammonium surfactants##2##2##(2008-10#2)
alkyltrimethylammonium##4##1##(2008-10#4)
alkyne##3##1##(2009-12#1)(2010-7#2)
all &quot##5##2##(1993-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2011-2#1)
all 10##6##2##(1991-1#1)(2008-10#3)(2008-9#1)(2011-2#1)
all 11 isolates that were##2##5##(2008-10#2)
all 12##2##2##(2009-10#1)(2011-1#1)
all 13##2##2##(2008-10#2)
all 14##2##2##(1996-12#1)(2008-10#1)
all 15##4##2##(2008-10#2)(2008-12#1)(2010-12#1)
all 24##4##2##(2008-10#1)(2008-7#2)(2010-1#1)
all 25##2##2##(2011-2#1)(2012-3#1)
all 3 years##2##3##(2008-10#2)
all 3##6##2##(1996-11#1)(2008-10#3)(2009-3#1)(2013-1#1)
all 4##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
all 45##2##2##(1996-3#1)(2008-10#1)
all 5##3##2##(1990-6#1)(1994-11#1)(2009-1#1)
all 6##2##2##(1995-6#1)(2012-2#1)
all 7##3##2##(1991-2#1)(1995-8#1)(2008-6#1)
all 8##2##2##(2008-11#1)(2008-8#1)
all AhR ligands##2##3##(2008-10#2)
all Avr loci##2##3##(2008-10#2)
all C##4##2##(2008-10#2)(2008-5#2)
all CMV##2##2##(2008-10#2)
all ED##2##2##(2008-11#1)(2011-9#1)
all European##2##2##(2008-10#2)
all F##2##2##(2008-10#2)
all HIV-infected##2##2##(2009-12#1)(2011-2#1)
all Medicaid##3##2##(1991-1#1)(1991-9#1)(1995-2#1)
all T##2##2##(2008-10#1)(2008-4#1)
all TB##2##2##(2011-2#2)
all Trichoderma##2##2##(2008-10#2)
all U##2##2##(1992-2#1)(1997-2#1)
all VA##2##2##(1991-12#1)(1993-12#1)
all abilities are intentional##2##4##(2010-2#2)
all adult patients##2##3##(2008-5#2)
all adult##3##2##(1993-6#1)(2008-5#2)
all age groups##5##3##(1996-9#1)(2008-11#1)(2009-10#1)(2010-7#1)(2013-1#1)
all age##6##2##(1996-9#1)(2008-11#1)(2009-10#1)(2010-7#1)(2013-1#2)
all ages##10##2##(1991-3#1)(1992-3#1)(1993-1#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
all amino acids##2##3##(1990-12#2)
all analyses##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
all analytes##6##2##(2008-10#6)
all animals##6##2##(1991-12#1)(1994-3#1)(1995-11#2)(2008-12#1)(2008-9#1)
all appear to##2##3##(2008-10#1)(2008-8#1)
all are##2##2##(2008-10#2)
all areas of##7##3##(1993-12#1)(1996-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-7#2)
all articles that##2##3##(2012-12#2)
all aspects of the##2##4##(1996-1#1)(2008-10#1)
all aspects of##7##3##(1996-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)
all associated##3##2##(2008-9#1)(2009-10#1)(2012-3#1)
all at once##3##3##(1995-2#1)(2011-1#1)(2011-2#1)
all at##6##2##(1992-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
all available data##3##3##(2010-11#1)(2011-2#2)
all available reference##2##3##(2008-10#1)(2012-3#1)
all available##12##2##(1991-6#1)(1992-3#1)(1992-9#1)(1996-2#1)(2007-9#1)(2008-10#1)(2009-4#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
all basic##2##2##(2008-4#1)(2008-8#1)
all be considered##2##3##(1994-12#1)(2012-12#1)
all be##4##2##(1992-3#1)(1994-12#1)(2008-8#1)(2012-12#1)
all below##5##2##(2008-10#5)
all beta##2##2##(1991-10#1)(1993-6#1)
all biological##2##2##(2010-11#1)(2013-1#1)
all brain regions##2##3##(1993-8#1)(2008-11#1)
all brain##3##2##(1993-8#1)(2008-11#1)(2012-2#1)
all but one case##3##4##(2008-10#1)(2008-6#1)(2009-10#1)
all but one of the##2##5##(2008-10#2)
all but one##11##3##(1990-12#2)(1997-2#1)(2008-10#3)(2008-4#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-1#1)
all but the##4##3##(1997-3#1)(2008-10#2)(2008-12#1)
all but two##5##3##(1993-2#2)(2008-10#2)(2012-3#1)
all but##26##2##(1990-12#2)(1992-3#1)(1993-2#2)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
all by##2##2##(1990-2#1)(1990-9#1)
all cases and##4##3##(1990-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
all cases except##2##3##(1991-8#1)(2008-12#1)
all cases in##2##3##(2009-8#1)(2013-1#1)
all cases of##8##3##(1990-12#1)(2008-10#3)(2008-12#1)(2010-12#1)(2010-6#1)(2011-2#1)
all cases the##8##3##(1993-8#1)(1996-5#1)(2008-10#2)(2008-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
all cases were##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
all cases##106##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-8#1)(1993-12#2)(1993-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#36)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#7)
all categories of##3##3##(1992-3#1)(2008-7#1)(2013-8#1)
all categories##4##2##(1992-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
all cell lines examined##2##4##(1995-12#1)(2008-11#1)
all cell lines##3##3##(1992-4#1)(1995-12#1)(2008-11#1)
all cell types##3##3##(1995-12#1)(2008-11#1)(2009-12#1)
all cell##8##2##(1992-4#1)(1995-12#2)(2008-11#4)(2009-12#1)
all cells##5##2##(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
all cellular##3##2##(1994-5#1)(2008-10#1)(2008-7#1)
all children in the##2##4##(1994-9#1)(1995-3#1)
all children in##3##3##(1991-8#1)(1994-9#1)(1995-3#1)
all children##9##2##(1991-8#1)(1991-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(2008-11#1)(2011-1#1)(2012-2#1)
all classes##2##2##(1992-12#1)(2008-4#1)
all clinic##2##2##(2011-2#1)(2011-3#1)
all clinical##2##2##(2008-11#1)(2011-2#1)
all coexisting##2##2##(2008-10#2)
all combinations##3##2##(2008-10#2)(2008-9#1)
all common##2##2##(2008-10#2)
all components of##2##3##(1996-3#1)(2008-10#1)
all components##4##2##(1996-3#1)(2008-10#3)
all compounds with##2##3##(2008-10#2)
all compounds##11##2##(2008-10#9)(2010-6#1)(2012-2#1)
all concentration levels##2##3##(2008-10#2)
all concentration##3##2##(2008-10#3)
all concentrations studied##2##3##(1994-8#1)(2008-10#1)
all concentrations##4##2##(1994-8#1)(2008-10#2)(2008-11#1)
all conditions of##2##3##(2008-3#1)(2008-9#1)
all conditions##12##2##(1990-8#1)(1994-5#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)(2010-4#1)(2012-2#1)
all consistent with##2##3##(2008-10#1)(2008-11#1)
all constituents##2##2##(2008-10#2)
all contribute to##2##3##(2009-8#1)(2012-2#1)
all control##2##2##(1997-8#1)(2009-8#1)
all countries##4##2##(1994-12#1)(1997-1#1)(1997-8#1)(2009-6#1)
all cultivars##11##2##(2008-10#9)(2009-8#1)(2011-2#1)
all cultures##4##2##(1990-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
all data sets##5##3##(2008-10#4)(2008-9#1)
all data##9##2##(1990-3#1)(1993-8#1)(2008-10#5)(2008-7#1)(2008-9#1)
all developmental stages##4##3##(2008-10#1)(2008-8#2)(2011-2#1)
all developmental##5##2##(1995-12#1)(2008-10#1)(2008-8#2)(2011-2#1)
all diagnosed##3##2##(1997-3#1)(2009-9#1)(2012-12#1)
all different##2##2##(1991-12#1)(2008-12#1)
all disciplines##2##2##(1993-3#1)(1995-5#1)
all dosed groups of##3##4##(2008-9#3)
all doses studied##2##3##(2008-11#2)
all doses##7##2##(1993-6#1)(2008-11#3)(2008-12#2)(2008-7#1)
all dyslipidemic drugs##2##3##(2010-2#2)
all eight strains##2##3##(2008-10#2)
all eight##7##2##(1996-12#1)(2008-10#4)(2010-10#1)(2012-3#1)
all electrodes##2##2##(2008-10#1)(2008-9#1)
all elements##11##2##(2008-10#9)(2011-2#2)
all enrollees##2##2##(1995-3#1)(1996-2#1)
all environments##2##2##(2008-10#2)
all events##2##2##(2008-10#2)
all examined tissues##2##3##(2009-8#2)
all exhibited a##2##3##(2008-10#1)(2011-2#1)
all existing##2##2##(2008-10#1)(2012-2#1)
all experimental groups##2##3##(1991-2#1)(2008-12#1)
all experimental##5##2##(1991-2#1)(1996-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
all experiments##6##2##(2008-10#4)(2008-7#2)
all exposed groups##3##3##(2008-9#3)
all exposed##4##2##(2008-7#1)(2008-9#3)
all faculty members##2##3##(1992-1#1)(2008-12#1)
all families##3##2##(2008-10#2)(2008-11#1)
all family##2##2##(1990-12#2)
all fatty acids##2##3##(2008-11#1)(2009-8#1)
all field##2##2##(1993-9#1)(2008-10#1)
all fields##2##2##(1992-3#1)(2008-10#1)
all five differentials##2##3##(2008-10#2)
all five patients##2##3##(2009-12#1)(2013-1#1)
all five##25##2##(1990-12#1)(1990-3#1)(1992-6#1)(1993-12#1)(2008-10#13)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
all foreign ions studied do not interfere with determination##2##9##(2008-10#2)
all foreign ions studied do not interfere with##3##8##(2008-10#3)
all forms of##5##3##(1991-12#1)(1995-6#1)(2008-10#1)(2011-2#2)
all four branches of nursing##2##5##(2008-11#2)
all four cases##3##3##(1996-12#1)(2007-11#1)(2008-10#1)
all four limbs##3##3##(2008-7#1)(2010-8#1)(2011-2#1)
all four##39##2##(1991-2#1)(1991-9#1)(1993-6#2)(1993-8#1)(1995-11#1)(1995-6#1)(1996-12#2)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
all fungal##2##2##(2008-10#2)
all future##3##2##(1996-6#1)(2008-11#1)(2008-12#1)
all genotypes##5##2##(2008-10#5)
all geographic regions##2##3##(2008-10#1)(2011-10#1)
all geographic##3##2##(2008-10#2)(2011-10#1)
all group members##2##3##(2008-8#1)(2008-9#1)
all groups of##2##3##(1994-11#1)(2013-1#1)
all groups##14##2##(1990-9#1)(1992-2#1)(1993-3#1)(1994-11#1)(1995-3#1)(2008-10#3)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#3)
all growth##3##2##(2008-10#3)
all had##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
all have##7##2##(1993-3#1)(1997-2#1)(2008-10#3)(2008-12#1)(2010-6#1)
all health and social care##2##5##(2008-11#2)
all health##5##2##(1996-3#2)(2008-11#2)(2008-12#1)
all higher##3##2##(1995-2#1)(2007-12#1)(2010-11#1)
all highly##2##2##(2008-10#1)(2011-2#1)
all hospital employees##2##3##(1993-3#1)(1994-12#1)
all hospital##4##2##(1992-12#1)(1993-3#1)(1994-12#1)(2012-2#1)
all hospitals##6##2##(1990-6#1)(1991-9#1)(1992-12#1)(1995-1#1)(2012-2#1)(2013-1#1)
all host##3##2##(2008-10#2)(2008-9#1)
all hosts of##2##3##(2008-10#2)
all hosts##4##2##(2008-10#4)
all human##8##2##(1992-6#1)(1993-8#2)(1995-6#1)(2008-9#1)(2009-4#1)(2011-3#1)(2013-1#1)
all important##4##2##(1996-1#1)(1996-3#1)(2010-11#1)(2012-2#1)
all in##10##2##(1992-9#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2013-1#1)
all including##2##2##(1990-12#1)(1994-8#1)
all individuals and##2##3##(2008-11#1)(2012-2#1)
all individuals are##2##3##(2008-10#1)(2008-8#1)
all individuals##9##2##(1996-1#1)(2008-10#2)(2008-11#3)(2008-8#2)(2012-2#1)
all induced##2##2##(2008-10#1)(2011-10#1)
all injection analysis##2##3##(2008-10#2)
all instances##10##2##(1990-11#1)(1991-12#1)(1995-5#1)(1996-2#1)(2008-10#6)
all interventions##2##2##(2012-2#1)(2013-1#1)
all investigated compounds##2##3##(2008-10#2)
all investigated##4##2##(2008-10#4)
all isolated##2##2##(2008-10#1)(2008-12#1)
all isolates in##2##3##(2008-10#2)
all isolates of the##2##4##(2008-10#2)
all isolates of##6##3##(1996-12#1)(2008-10#5)
all isolates tested##4##3##(2008-10#4)
all isolates were##3##3##(2008-10#3)
all isolates##30##2##(1996-12#1)(2008-10#29)
all its##4##2##(1997-2#1)(2008-10#1)(2008-4#1)(2009-10#1)
all key##2##2##(1993-3#1)(2009-11#1)
all kinds of##5##3##(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
all kinds##6##2##(1992-2#1)(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
all known##9##2##(1994-5#1)(1996-12#1)(1997-9#2)(2008-10#2)(2008-2#1)(2011-2#1)(2011-3#1)
all laboratories##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
all leaf##4##2##(2008-10#4)
all letters##3##2##(1997-2#1)(2012-2#1)(2013-8#1)
all levels of##9##3##(1992-12#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#1)
all levels##16##2##(1992-12#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2010-1#1)
all lineages##2##2##(2008-10#1)(2008-9#1)
all locations##5##2##(2008-10#4)(2013-8#1)
all loci except##2##3##(2008-10#1)(2008-11#1)
all loci##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
all lung##3##2##(1993-8#1)(2009-1#1)(2011-3#1)
all major##13##2##(1992-3#1)(1992-6#1)(1995-11#1)(1997-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2011-7#1)
all mammalian cells##2##3##(1992-12#1)(2013-7#1)
all mammalian##4##2##(1992-12#1)(1993-12#1)(2008-11#1)(2013-7#1)
all markers##2##2##(1997-8#1)(2008-12#1)
all materials##7##2##(2008-3#1)(2013-1#6)
all matrix elements##2##3##(2008-10#2)
all measures##2##2##(1991-1#1)(2008-6#1)
all mechanisms of dispersal were##2##5##(2008-10#2)
all medical##4##2##(1993-11#1)(1995-12#1)(2008-11#1)(2011-2#1)
all member##2##2##(1992-2#1)(2008-11#1)
all members of the##5##4##(2008-10#3)(2008-11#1)(2013-8#1)
all members of##6##3##(2006-6#1)(2008-10#3)(2008-11#1)(2013-8#1)
all members##7##2##(2006-6#1)(2008-10#3)(2008-11#2)(2013-8#1)
all metal ions##2##3##(2008-10#2)
all metal##3##2##(2008-10#3)
all metals##2##2##(2008-10#1)(2012-3#1)
all methods##3##2##(2008-10#2)(2008-6#1)
all mice##2##2##(2008-10#1)(2008-12#1)
all model##2##2##(2009-12#1)(2012-3#1)
all mouse genotypes##2##3##(2013-8#2)
all mouse##3##2##(1995-6#1)(2013-8#2)
all mutants##2##2##(1995-2#1)(2008-10#1)
all natural##2##2##(1997-6#1)(2013-8#1)
all necessary##2##2##(2008-10#1)(2012-2#1)
all neurons##2##2##(1993-12#1)(1994-2#1)
all new##2##2##(2008-10#1)(2010-6#1)
all newly##3##2##(2008-10#2)(2012-2#1)
all nine##2##2##(2008-10#2)
all nurses##2##2##(1990-2#1)(2008-12#1)
all of its##3##3##(1994-9#1)(1997-3#1)(2010-9#1)
all of our##3##3##(1997-3#1)(2008-7#1)(2008-8#1)
all of the above parameters##2##5##(1994-5#1)(2008-8#1)
all of the above##3##4##(1994-5#1)(2008-8#1)(2011-2#1)
all of the isolates##2##4##(2008-10#2)
all of the major##2##4##(2008-12#1)(2008-4#1)
all of the other##2##4##(1992-2#1)(2008-10#1)
all of the##70##3##(1990-7#1)(1990-8#1)(1992-2#2)(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-7#2)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#1)
all of them are##2##4##(1996-9#1)(2008-9#1)
all of them##17##3##(1993-8#1)(1994-9#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-6#1)(2008-10#4)(2008-8#1)(2008-9#3)(2011-2#1)(2012-12#1)
all of these areas##2##4##(1994-8#1)(1997-2#1)
all of these functions##2##4##(1995-6#1)(2013-1#1)
all of these##18##3##(1991-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-11#1)(2009-8#1)(2013-1#1)(2013-7#1)
all of which are##4##4##(1991-1#1)(1997-1#1)(2008-11#1)(2008-8#1)
all of which produce a##2##5##(2008-11#1)(2008-7#1)
all of which were##3##4##(1994-12#1)(1997-3#1)(2008-10#1)
all of which##17##3##(1991-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-9#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
all of whom had##2##4##(2008-9#1)(2009-5#1)
all of whom##4##3##(1991-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
all of##140##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-7#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#39)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#6)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-7#2)(2010-9#1)(2011-2#4)(2012-12#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
all on a##2##3##(1995-5#1)(2008-8#1)
all or most of##2##4##(1996-3#1)(2008-10#1)
all or##5##2##(1994-1#1)(1996-3#1)(2008-10#2)(2010-5#1)
all organic##2##2##(2008-10#2)
all other cases##2##3##(2007-8#1)(2008-11#1)
all other elements##3##3##(2008-10#2)(2008-3#1)
all other factors##2##3##(1995-12#1)(2012-3#1)
all other populations##2##3##(2008-10#1)(2008-9#1)
all other##50##2##(1993-2#1)(1994-1#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-4#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
all others##3##2##(2008-10#2)(2008-9#1)
all outcomes##2##2##(2008-8#1)(2010-12#1)
all over Egypt##2##3##(2008-10#2)
all over the world##12##4##(1992-5#1)(1994-9#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#1)
all over the##19##3##(1992-5#1)(1994-9#1)(1996-2#1)(1996-6#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
all over##21##2##(1992-5#1)(1994-9#1)(1996-2#1)(1996-6#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
all pH values##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
all pH##4##2##(1993-8#1)(2008-10#2)(2008-3#1)
all pairs of##2##3##(2008-10#2)
all parameters##4##2##(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
all participants##6##2##(2008-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
all parts of the##3##4##(1997-8#1)(2008-10#1)(2008-9#1)
all parts of##4##3##(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
all pathogenic strains##2##3##(2008-10#2)
all pathogenic##4##2##(2008-10#4)
all patient##2##2##(2008-12#1)(2012-3#1)
all patients and##2##3##(1993-3#1)(2007-8#1)
all patients except##2##3##(1997-8#1)(2008-3#1)
all patients in##2##3##(1990-3#1)(2010-7#1)
all patients received##2##3##(1990-6#1)(1997-7#1)
all patients was##2##3##(1997-4#1)(2011-2#1)
all patients who##2##3##(1997-4#1)(2008-5#1)
all patients with##15##3##(1992-12#1)(1992-5#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
all patients##75##2##(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-3#1)(1995-1#1)(1995-5#1)(1996-6#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#12)(2012-12#1)(2012-3#2)(2013-1#8)
all people##3##2##(1995-12#1)(1996-2#1)(2008-11#1)
all pesticides##2##2##(2008-10#2)
all phases of the##4##4##(2008-11#2)(2008-8#1)(2012-3#1)
all phases of##7##3##(1992-1#1)(1992-2#1)(2008-11#2)(2008-8#1)(2012-3#1)(2013-7#1)
all phases##10##2##(1992-1#1)(1992-2#1)(2008-10#1)(2008-11#3)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
all photosynthetic##2##2##(2008-11#1)(2011-2#1)
all physical##2##2##(1995-3#1)(2008-10#1)
all plant species##3##3##(2008-10#3)
all plant##5##2##(2008-10#4)(2008-11#1)
all plants##5##2##(2008-10#5)
all plots within the quadrat sizes tested##2##7##(2008-10#2)
all plots##5##2##(2008-10#5)
all populations to##2##3##(2008-10#1)(2008-9#1)
all populations##13##2##(2008-10#9)(2008-5#1)(2008-9#1)(2013-8#2)
all positive##3##2##(1990-11#1)(2009-12#1)(2009-3#1)
all possible combinations of##2##4##(2008-10#1)(2008-12#1)
all possible combinations##3##3##(2008-10#2)(2008-12#1)
all possible##13##2##(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)
all potential##2##2##(2008-10#1)(2011-2#1)
all predicted##2##2##(2008-10#1)(2008-3#1)
all pregnant women in##2##4##(1990-6#1)(1994-6#1)
all pregnant women##4##3##(1990-6#1)(1991-11#1)(1994-6#1)(1995-6#1)
all premature infants##2##3##(1996-11#1)(2008-9#1)
all previous##5##2##(1994-11#1)(2008-11#1)(2011-2#2)(2011-3#1)
all previously##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
all profiles##2##2##(2008-10#2)
all providers##2##2##(1997-2#2)
all public##2##2##(1996-1#1)(1997-3#1)
all quadrat sizes##2##3##(2008-10#2)
all races of##2##3##(2008-10#2)
all races##7##2##(1992-2#1)(1995-12#1)(2008-10#5)
all randomized##2##2##(2010-2#2)
all rats##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
all red##2##2##(1995-6#1)(1997-6#1)
all regions##5##2##(1994-3#1)(1994-5#1)(2008-10#3)
all relevant factors##2##3##(1996-1#1)(2008-11#1)
all relevant##6##2##(1993-12#1)(1996-1#1)(2008-11#1)(2008-8#1)(2013-1#2)
all reported##2##2##(1992-6#1)(2008-10#1)
all required##2##2##(1990-5#1)(2008-5#1)
all requirements##2##2##(2008-7#1)(2013-1#1)
all resistant##2##2##(2008-10#2)
all respondents##3##2##(1990-6#1)(1993-3#1)(2009-5#1)
all results##2##2##(2008-10#1)(2011-2#1)
all root##2##2##(2008-10#2)
all samples at##2##3##(2008-12#1)(2011-2#1)
all samples##20##2##(1991-11#1)(2008-10#14)(2008-12#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-2#1)
all sampling dates##3##3##(2008-10#2)(2013-8#1)
all sampling##4##2##(2008-10#2)(2013-8#2)
all scales##2##2##(2008-6#1)(2012-3#1)
all segments##2##2##(1997-1#1)(2008-10#1)
all sequenced##2##2##(2008-10#1)(2013-8#1)
all sequences##3##2##(1997-8#1)(2008-10#2)
all services##3##2##(1994-1#1)(1996-1#1)(1997-3#1)
all seven##2##2##(2008-10#1)(2008-5#1)
all showed##3##2##(2008-10#2)(2008-7#1)
all significant##2##2##(1991-11#1)(2008-10#1)
all significantly##4##2##(2008-10#4)
all sites and##2##3##(2008-10#2)
all sites of##2##3##(2008-10#1)(2012-2#1)
all sites##10##2##(2008-10#9)(2012-2#1)
all situations##3##2##(2008-11#1)(2010-8#1)(2011-2#1)
all six##9##2##(1992-6#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)
all sources of##2##3##(2008-10#1)(2010-1#1)
all species and##2##3##(1993-12#1)(2012-6#1)
all species##18##2##(1993-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-5#1)(2012-6#1)(2012-8#1)
all specimens##3##2##(2007-12#1)(2009-7#1)(2013-1#1)
all stages of##6##3##(1997-8#1)(2008-10#2)(2010-6#1)(2011-2#2)
all stages##8##2##(1997-8#1)(2008-10#3)(2008-9#1)(2010-6#1)(2011-2#2)
all stakeholders##2##2##(2008-12#1)(2013-8#1)
all states##4##2##(1991-1#1)(2008-10#3)
all steps of the analytical procedure##2##6##(2008-10#2)
all steps of the##4##4##(2008-10#3)(2010-7#1)
all steps##6##2##(2008-10#4)(2008-4#1)(2010-7#1)
all strains tested##2##3##(2008-10#1)(2008-5#1)
all strains##14##2##(2008-10#11)(2008-5#2)(2008-7#1)
all structures##2##2##(2011-2#1)(2013-1#1)
all studied##2##2##(2008-10#1)(2013-8#1)
all studies##4##2##(1994-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
all subjects##10##2##(1990-9#1)(1992-6#1)(2008-6#1)(2008-7#4)(2011-2#2)(2013-1#1)
all subpopulations##2##2##(2008-10#1)(2008-8#1)
all substances##2##2##(2008-10#2)
all successful##2##2##(1992-12#1)(1997-1#1)
all such##2##2##(1991-11#1)(2009-10#1)
all suspected##2##2##(2008-9#1)(2010-10#1)
all symptomatic##2##2##(2008-10#2)
all symptoms of##2##3##(2008-10#1)(2011-2#1)
all symptoms##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
all taxa##2##2##(2008-10#2)
all team members##2##3##(1993-12#1)(2008-3#1)
all temperature regimes##2##3##(2008-10#2)
all test##5##2##(1995-8#1)(1997-2#1)(2008-10#2)(2008-5#1)
all tested isolates##3##3##(2008-10#3)
all tested species##2##3##(2008-10#2)
all tested##16##2##(1990-12#1)(1996-8#1)(2008-10#12)(2008-12#1)(2013-1#1)
all tests##5##2##(1994-8#1)(2008-10#4)
all the analytes##4##3##(2008-10#4)
all the animals were##2##4##(2008-7#1)(2011-2#1)
all the animals##3##3##(2008-7#2)(2011-2#1)
all the arsenic##2##3##(2008-10#2)
all the available##3##3##(1997-7#1)(2008-10#1)(2008-4#1)
all the binding sites in the##2##6##(2011-3#2)
all the cases##6##3##(1990-6#1)(2008-10#3)(2010-7#1)(2012-12#1)
all the components of##2##4##(2008-10#1)(2010-1#1)
all the components##3##3##(2008-10#2)(2010-1#1)
all the compounds investigated##2##4##(2008-10#1)(2008-11#1)
all the compounds##7##3##(1994-11#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-7#1)
all the considered##3##3##(1992-2#1)(2008-10#2)
all the data##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
all the different##2##3##(1996-5#1)(2008-10#1)
all the elements##5##3##(2008-10#5)
all the factors##2##3##(1993-12#1)(2011-2#1)
all the four##5##3##(1990-11#1)(2008-10#4)
all the groups##4##3##(1994-8#1)(2008-5#1)(2008-8#1)(2010-1#1)
all the infected##2##3##(2008-5#1)(2011-2#1)
all the information##3##3##(1990-11#1)(2008-11#1)(2009-10#1)
all the isolates##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
all the major##2##3##(1997-7#1)(2008-9#1)
all the metal##3##3##(2008-10#3)
all the methods##4##3##(1995-5#1)(2008-10#2)(2008-9#1)
all the more##4##3##(1991-3#1)(1992-3#1)(2008-10#1)(2010-1#1)
all the necessary##2##3##(2008-10#2)
all the nine##2##3##(2008-10#1)(2011-1#1)
all the other##7##3##(1991-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-8#1)
all the parameters##7##3##(1992-2#1)(1992-3#1)(2008-10#1)(2008-12#3)(2008-7#1)
all the patients##7##3##(1990-6#1)(1990-9#1)(2008-7#1)(2010-7#4)
all the possible##2##3##(2011-2#1)(2012-3#1)
all the relevant##2##3##(1996-12#1)(2008-8#1)
all the samples##9##3##(2008-10#5)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
all the sites##2##3##(2008-10#2)
all the six metal ions##2##5##(2008-10#2)
all the strains sensitive to##2##5##(2008-10#2)
all the strains##4##3##(1993-12#1)(2008-10#3)
all the studied##4##3##(2008-10#3)(2011-2#1)
all the subregions##2##3##(2008-3#2)
all the three##10##3##(2008-10#5)(2008-11#1)(2008-7#1)(2012-2#2)(2013-1#1)
all the time##3##3##(1994-6#1)(2009-4#1)(2011-3#1)
all the tissues##3##3##(1995-8#1)(2008-5#1)(2009-7#1)
all the tumors##3##3##(2013-1#3)
all the##340##2##(1990-11#2)(1990-6#3)(1990-9#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#3)(1995-9#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#132)(2008-11#10)(2008-12#7)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#9)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#5)(2011-1#2)(2011-10#2)(2011-2#13)(2011-3#6)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#13)(2013-8#1)
all their##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
all these metal ions##3##4##(2008-10#3)
all these##39##2##(1990-8#1)(1991-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
all those##4##2##(1992-6#1)(1993-11#1)(1994-2#1)(2008-12#1)
all three agents together##2##4##(2008-10#2)
all three agents##4##3##(2008-10#4)
all three cases##2##3##(2008-10#1)(2008-7#1)
all three domains##2##3##(2008-7#1)(2010-11#1)
all three factors in##2##4##(2008-10#1)(2008-8#1)
all three fibre types##2##4##(2011-2#2)
all three genes##2##3##(1995-12#1)(2011-2#1)
all three groups##2##3##(1997-3#1)(2008-10#1)
all three isolates##2##3##(2008-10#2)
all three measures##2##3##(2008-4#1)(2010-11#1)
all three media##2##3##(2008-10#2)
all three methods##3##3##(1991-3#1)(2008-10#1)(2008-12#1)
all three of these##2##4##(2008-10#1)(2008-4#1)
all three of##4##3##(1991-5#1)(2008-10#2)(2008-4#1)
all three operationalizations##2##3##(1997-1#2)
all three populations##2##3##(2008-10#2)
all three regions##2##3##(1990-5#1)(2008-10#1)
all three sites##2##3##(1992-3#1)(2010-5#1)
all three soils##3##3##(2008-10#3)
all three species##4##3##(2008-10#1)(2008-11#1)(2011-3#1)(2012-8#1)
all three strains##5##3##(1994-2#2)(2008-10#2)(2008-11#1)
all three types of##2##4##(2008-10#1)(2008-8#1)
all three##143##2##(1990-5#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-3#2)(1993-2#1)(1993-8#1)(1994-2#2)(1994-5#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-6#1)(1997-1#2)(1997-3#2)(1997-6#1)(2008-10#61)(2008-11#7)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#7)(2008-9#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-5#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2012-8#1)
all through##2##2##(2008-10#1)(2008-9#1)
all time periods##3##3##(2008-10#1)(2008-7#1)(2009-11#1)
all time##4##2##(2008-10#1)(2008-7#1)(2009-11#1)(2013-8#1)
all times##3##2##(1990-12#1)(1993-6#1)(2010-10#1)
all tissues examined##2##3##(1993-3#1)(2008-12#1)
all tissues##6##2##(1990-11#1)(1993-3#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-2#1)
all together##2##2##(2008-5#1)(2011-2#1)
all too##2##2##(1996-12#1)(2011-2#1)
all traffic##2##2##(1990-6#1)(2011-2#1)
all treated##2##2##(2008-4#1)(2012-2#1)
all treatment##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
all treatments##9##2##(1995-3#1)(2008-10#5)(2011-2#1)(2013-1#2)
all trials##2##2##(2008-10#2)
all tropical##2##2##(2008-10#1)(2008-8#1)
all tumors##3##2##(1990-12#1)(1990-2#1)(1990-9#1)
all tumours##2##2##(1995-2#1)(2011-2#1)
all type##2##2##(2008-10#2)
all types of##16##3##(1990-12#1)(1992-3#1)(1996-9#1)(2008-10#4)(2008-11#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
all types##18##2##(1990-12#1)(1992-3#1)(1994-12#1)(1996-9#1)(2008-10#4)(2008-11#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
all virulences were significantly associated##2##5##(2008-10#2)
all water##2##2##(2008-10#2)
all were##16##2##(1991-12#1)(1993-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2010-1#1)(2011-7#1)
all with a##2##3##(2008-11#1)(2009-8#1)
all with##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
all women##3##2##(1990-6#1)(1991-2#1)(2011-2#1)
all work hours##2##3##(1993-1#2)
all year##2##2##(2008-11#1)(2008-5#1)
all years##4##2##(2008-10#4)
all zones##2##2##(2008-10#1)(2008-9#1)
all##3154##1##(1990-11#10)(1990-12#17)(1990-2#9)(1990-3#9)(1990-5#7)(1990-6#14)(1990-7#1)(1990-8#5)(1990-9#13)(1991-1#7)(1991-10#3)(1991-11#9)(1991-12#17)(1991-2#14)(1991-3#10)(1991-5#6)(1991-6#5)(1991-7#1)(1991-8#5)(1991-9#7)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#12)(1992-2#18)(1992-3#17)(1992-4#1)(1992-5#3)(1992-6#18)(1992-7#1)(1992-9#4)(1993-1#5)(1993-11#5)(1993-12#33)(1993-2#12)(1993-3#10)(1993-6#10)(1993-8#20)(1993-9#2)(1994-1#8)(1994-11#8)(1994-12#11)(1994-2#10)(1994-3#11)(1994-5#13)(1994-6#3)(1994-8#10)(1994-9#9)(1995-1#10)(1995-11#10)(1995-12#20)(1995-2#17)(1995-3#14)(1995-5#9)(1995-6#15)(1995-8#10)(1995-9#3)(1996-1#14)(1996-11#8)(1996-12#38)(1996-2#13)(1996-3#12)(1996-5#5)(1996-6#8)(1996-8#4)(1996-9#5)(1997-1#10)(1997-2#21)(1997-3#21)(1997-4#7)(1997-5#3)(1997-6#6)(1997-7#12)(1997-8#20)(1997-9#5)(2006-6#3)(2007-11#4)(2007-12#20)(2007-8#5)(2007-9#1)(2008-1#13)(2008-10#1086)(2008-11#154)(2008-12#64)(2008-2#7)(2008-3#37)(2008-4#22)(2008-5#51)(2008-6#16)(2008-7#78)(2008-8#79)(2008-9#78)(2009-1#3)(2009-10#15)(2009-11#4)(2009-12#13)(2009-2#2)(2009-3#7)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#24)(2009-9#2)(2010-1#14)(2010-10#10)(2010-11#10)(2010-12#14)(2010-2#7)(2010-3#6)(2010-4#8)(2010-5#7)(2010-6#11)(2010-7#15)(2010-8#18)(2010-9#3)(2011-1#11)(2011-10#4)(2011-2#155)(2011-3#16)(2011-7#3)(2011-9#1)(2012-12#20)(2012-2#64)(2012-3#45)(2012-4#1)(2012-5#1)(2012-6#3)(2012-8#2)(2013-1#107)(2013-7#4)(2013-8#40)
all)##2##1##(2008-11#1)(2008-12#1)
all-cause mortality in##3##3##(2008-7#1)(2010-1#1)(2011-2#1)
all-cause mortality risk and##2##4##(2013-8#2)
all-cause mortality##14##2##(1993-12#2)(2008-7#4)(2010-1#1)(2010-2#3)(2011-1#1)(2011-2#1)(2013-8#2)
all-cause##16##1##(1993-12#2)(2008-7#4)(2009-10#1)(2010-1#1)(2010-2#3)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
all-payer##4##1##(1992-2#1)(1994-12#3)
all-site##2##1##(2010-1#2)
all-solid-state electrodes##3##2##(2008-10#3)
all-solid-state laser##3##2##(2008-3#3)
all-solid-state potassium-selective electrode##2##3##(2008-10#2)
all-solid-state##18##1##(2008-10#13)(2008-2#1)(2008-3#4)
all-stage resistance##2##2##(2008-10#2)
all-trans isomers##3##2##(1991-5#3)
all-trans retinoic acid##6##3##(2008-5#2)(2008-8#1)(2011-2#2)(2013-1#1)
all-trans##10##1##(1991-5#3)(1992-9#1)(2008-5#2)(2008-8#1)(2011-2#2)(2013-1#1)
all-trans-retinoic acid##3##2##(1994-6#2)(2008-9#1)
allantoic fluid samples from##2##4##(2008-5#2)
allantoic##3##1##(2008-10#1)(2008-5#2)
allantoin and betaine##2##3##(2008-10#2)
allay##4##1##(1995-2#1)(2008-12#1)(2008-7#1)(2009-7#1)
allegations##6##1##(1992-12#1)(1995-12#1)(2008-10#4)
alleged that##2##2##(1995-12#1)(1995-6#1)
alleged##6##1##(1995-12#1)(1995-6#1)(1996-5#1)(2008-10#3)
allegedly##4##1##(1994-1#2)(1995-12#1)(2009-6#1)
alleging##2##1##(1995-11#1)(1995-12#1)
allele 1##2##2##(1993-3#2)
allele 4##4##2##(1993-3#3)(2008-12#1)
allele and##2##2##(1993-6#1)(2008-10#1)
allele at##4##2##(2008-10#3)(2008-8#1)
allele conferring##2##2##(2008-10#2)
allele frequencies in##2##3##(1995-12#1)(2008-10#1)
allele frequencies##14##2##(1995-12#1)(1997-8#1)(2008-10#7)(2008-12#3)(2008-8#1)(2010-4#1)
allele frequency##6##2##(1995-12#3)(2008-12#2)(2008-9#1)
allele from the high##2##4##(2008-10#1)(2008-2#1)
allele from##3##2##(2008-10#2)(2008-2#1)
allele had##4##2##(1995-2#1)(2008-10#1)(2008-12#2)
allele has been##2##3##(1995-12#1)(2012-2#1)
allele in##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
allele is##2##2##(2009-8#1)(2010-12#1)
allele of##7##2##(1993-3#1)(1995-9#1)(1997-4#2)(2009-6#1)(2011-2#1)(2012-3#1)
allele on##4##2##(1993-2#3)(2008-10#1)
allele richness##2##2##(2008-10#1)(2013-8#1)
allele specific##2##2##(2008-8#1)(2012-3#1)
allele that##4##2##(1993-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
allele was found##3##3##(1993-11#1)(2010-12#1)(2011-2#1)
allele was##10##2##(1993-11#1)(2008-10#4)(2010-12#2)(2011-2#3)
allele were##3##2##(1994-11#1)(2008-10#1)(2011-2#1)
allele##141##1##(1991-5#1)(1993-11#1)(1993-2#3)(1993-3#7)(1993-6#3)(1994-11#3)(1994-12#2)(1995-12#8)(1995-2#1)(1995-9#1)(1997-3#1)(1997-4#2)(1997-8#3)(1997-9#2)(2008-10#50)(2008-12#10)(2008-2#1)(2008-8#4)(2008-9#8)(2009-6#1)(2009-8#1)(2010-12#4)(2010-4#1)(2010-6#1)(2011-2#7)(2012-2#3)(2012-3#11)(2013-8#1)
allele-specific PCR##2##2##(1995-12#1)(2013-1#1)
allele-specific expression##2##2##(1993-2#1)(1997-7#1)
allele-specific##6##1##(1993-2#2)(1995-12#1)(1997-7#1)(2008-9#1)(2013-1#1)
alleles and##7##2##(1993-2#1)(2008-10#1)(2008-12#2)(2008-8#1)(2012-3#2)
alleles are##4##2##(1995-12#1)(1997-3#1)(2008-9#1)(2011-2#1)
alleles at##6##2##(2008-10#4)(2011-2#2)
alleles for##3##2##(2008-10#2)(2009-10#1)
alleles from##3##2##(2008-10#3)
alleles in the##5##3##(1997-3#1)(1997-8#1)(2008-11#1)(2008-9#1)(2012-3#1)
alleles in##13##2##(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#2)
alleles of##8##2##(2008-10#2)(2008-9#4)(2012-3#1)(2013-1#1)
alleles on##2##2##(1994-12#1)(2008-10#1)
alleles per##5##2##(2008-10#2)(2012-3#1)(2013-8#2)
alleles that##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
alleles were detected##2##3##(2008-10#2)
alleles were observed##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
alleles were shared by AI##2##5##(2008-10#2)
alleles were unique to only##2##5##(2008-10#2)
alleles were##11##2##(2008-10#7)(2008-12#1)(2008-8#2)(2013-8#1)
alleles with PIC and HET values of 0##2##8##(2008-12#2)
alleles with##4##2##(1997-8#1)(2008-12#3)
alleles##141##1##(1990-8#1)(1991-11#1)(1993-2#1)(1993-6#3)(1994-12#1)(1995-12#3)(1995-5#1)(1995-6#1)(1997-3#8)(1997-8#6)(1997-9#1)(2008-10#55)(2008-11#2)(2008-12#10)(2008-4#1)(2008-8#5)(2008-9#11)(2009-10#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#16)(2012-5#1)(2013-1#1)(2013-8#3)
alleles)##3##1##(1997-8#1)(2008-10#2)
allelic differences in##2##3##(1993-6#1)(2008-2#1)
allelic discrimination##3##2##(2008-10#3)
allelic diversity##2##2##(2008-10#2)
allelic effects##2##2##(2008-8#2)
allelic frequencies##2##2##(2008-9#1)(2009-8#1)
allelic imbalance##2##2##(2012-3#2)
allelic relationship of##2##3##(2008-10#2)
allelic relationships of##2##3##(2008-10#2)
allelic to##2##2##(2008-10#2)
allelic variation at##2##3##(2008-10#1)(2012-3#1)
allelic variation##3##2##(2008-10#1)(2012-3#2)
allelic##38##1##(1993-6#1)(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-12#1)(2012-3#6)(2013-8#1)
allelism##2##1##(2008-10#2)
allene##2##1##(1996-5#1)(2010-3#1)
allergen Phl p 1##2##4##(2012-2#2)
allergen as a##2##3##(2008-10#2)
allergen binding##2##2##(2008-10#2)
allergen concentrations##2##2##(2008-10#1)(2012-12#1)
allergen in##2##2##(2008-10#2)
allergen##31##1##(1994-11#2)(1995-5#1)(2008-10#13)(2008-11#6)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-2#4)
allergen-specific IgE in##2##3##(2008-10#1)(2008-11#1)
allergen-specific IgE##6##2##(2008-10#4)(2008-11#2)
allergen-specific##7##1##(2008-10#5)(2008-11#2)
allergenic##9##1##(2008-11#7)(2008-4#1)(2009-10#1)
allergens and##5##2##(1993-3#1)(1997-2#1)(2011-2#3)
allergens are##3##2##(1991-3#1)(2008-5#1)(2009-10#1)
allergens in##4##2##(1990-3#2)(2009-10#1)(2013-1#1)
allergens were##2##2##(2009-10#1)(2013-1#1)
allergens##39##1##(1990-3#3)(1991-3#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#3)(2009-10#4)(2011-2#15)(2012-2#1)(2013-1#7)
allergic conjunctivitis##2##2##(1991-2#1)(2012-3#1)
allergic contact dermatitis##4##3##(2008-5#3)(2012-3#1)
allergic disease##3##2##(2008-11#2)(2010-6#1)
allergic diseases##6##2##(1994-6#3)(2009-6#1)(2010-5#1)(2012-12#1)
allergic history of patients##2##4##(2011-2#2)
allergic history of##3##3##(2011-2#3)
allergic history##4##2##(2011-2#4)
allergic patients##2##2##(2013-1#2)
allergic reaction##3##2##(1991-1#1)(1993-6#1)(2008-11#1)
allergic reactions in##2##3##(2008-11#1)(2008-12#1)
allergic reactions##6##2##(1994-11#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
allergic rhinitis (AR) and asthma##2##5##(2008-7#1)(2012-12#1)
allergic rhinitis (AR)##3##3##(2008-7#1)(2012-12#2)
allergic rhinitis##13##2##(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#6)(2012-3#1)(2013-1#1)
allergic to all##3##3##(2011-2#3)
allergic to##4##2##(1996-11#1)(2011-2#3)
allergic##77##1##(1990-3#2)(1991-1#1)(1991-2#2)(1991-3#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#5)(1996-11#1)(1997-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#3)(2009-6#2)(2010-1#1)(2010-5#2)(2010-6#5)(2011-2#13)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#4)
allergies##7##1##(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
allergy and clinical immunology##3##4##(2012-12#3)
allergy and##4##2##(2012-12#3)(2013-1#1)
allergy or##3##2##(2008-10#1)(2008-7#2)
allergy reaction evaluation system##4##4##(2008-11#4)
allergy##28##1##(1990-8#1)(1991-8#1)(2008-10#2)(2008-11#7)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#4)(2013-1#5)
alleviate pain in##2##3##(1995-12#1)(2008-11#1)
alleviate the symptoms of##2##4##(2011-3#1)(2012-2#1)
alleviate the symptoms##3##3##(2011-3#2)(2012-2#1)
alleviate the##10##2##(1992-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
alleviate##20##1##(1990-5#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-3#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
alleviated by##3##2##(1991-12#1)(1996-3#1)(2008-10#1)
alleviated##7##1##(1991-12#1)(1996-3#1)(2008-10#3)(2008-7#1)(2009-8#1)
alleviates##3##1##(2008-12#1)(2012-9#1)(2013-8#1)
alleviating##7##1##(1993-9#1)(2008-10#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
alleviation of symptoms##3##3##(1993-11#1)(2008-7#1)(2009-7#1)
alleviation of##5##2##(1993-11#1)(1993-2#1)(2008-7#1)(2009-7#1)(2011-2#1)
alleviation##6##1##(1993-11#1)(1993-2#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-2#1)
alliance stakeholders##2##2##(2013-1#2)
alliance##16##1##(1993-1#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-4#2)(2008-6#1)(2013-1#9)
alliances are##3##2##(1997-2#1)(2013-1#2)
alliances had##2##2##(2013-1#2)
alliances have##3##2##(2013-1#3)
alliances##36##1##(1991-1#1)(1993-5#1)(1996-1#1)(1997-2#3)(2008-4#2)(2013-1#28)
alliances'##4##1##(2013-1#4)
allied with##2##2##(2008-10#1)(2008-6#1)
allied##6##1##(1996-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-6#1)
alligator gar##4##2##(2008-7#4)
alligator##5##1##(2008-7#4)(2008-8#1)
allii urediniospores and##2##3##(2008-10#2)
allii##11##1##(2008-10#11)
allis shad##3##2##(2008-12#3)
allo-deposition##2##1##(2008-10#2)
alloantibodies##2##1##(2008-9#1)(2010-11#1)
allocate##5##1##(1992-12#1)(1993-2#1)(2008-10#1)(2008-8#2)
allocated for##2##2##(1990-2#1)(2008-10#1)
allocated into##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
allocated to the##2##3##(2008-8#1)(2008-9#1)
allocated to##15##2##(1991-8#1)(2008-10#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
allocated##24##1##(1990-2#1)(1991-8#1)(1993-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#6)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-10#1)(2012-3#2)(2013-1#1)
allocating##4##1##(1995-12#1)(1995-2#1)(2008-11#1)(2009-3#1)
allocation and##4##2##(2008-8#2)(2008-9#2)
allocation are##2##2##(2008-12#1)(2008-8#1)
allocation concealment##2##2##(2008-10#2)
allocation in##3##2##(2008-8#2)(2008-9#1)
allocation of resources to##2##4##(2008-9#2)
allocation of resources##3##3##(2008-8#1)(2008-9#2)
allocation of##14##2##(1991-6#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-8#4)(2008-9#4)(2010-4#1)
allocation theory##3##2##(2008-8#1)(2008-9#2)
allocation to the##2##3##(1995-6#1)(2008-9#1)
allocation to##7##2##(1995-6#1)(2008-8#5)(2008-9#1)
allocation##73##1##(1991-6#1)(1992-1#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#2)(1997-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-8#32)(2008-9#15)(2009-6#1)(2010-4#1)(2011-2#1)(2011-3#3)(2013-8#3)
allochthonous inputs##6##2##(2008-9#6)
allodynia and##3##2##(2008-9#2)(2011-2#1)
allodynia##14##1##(1996-12#1)(2008-9#9)(2011-2#4)
allogeneic and##2##2##(2008-11#1)(2013-1#1)
allogeneic##16##1##(1994-5#1)(1995-2#1)(1996-9#1)(2008-11#5)(2008-7#1)(2010-11#1)(2011-2#4)(2012-3#1)(2013-1#1)
allogenic##4##1##(2009-3#2)(2010-6#1)(2012-3#1)
allograft and autograft PCL reconstruction##2##5##(2013-1#2)
allograft and autograft##4##3##(2010-3#1)(2012-3#1)(2013-1#2)
allograft dysfunction##2##2##(2008-5#1)(2011-3#1)
allograft fixation##4##2##(2009-3#4)
allograft for##2##2##(2011-2#1)(2012-2#1)
allograft in##3##2##(2012-12#1)(2012-3#2)
allograft recipients##3##2##(2008-10#2)(2008-5#1)
allograft rejection##2##2##(2008-10#1)(2008-5#1)
allograft tricortical iliac crest##2##4##(2009-10#2)
allograft##53##1##(1996-3#1)(2008-10#8)(2008-5#3)(2008-7#1)(2009-10#4)(2009-3#6)(2010-10#3)(2010-3#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#10)(2013-1#3)
allografts and##2##2##(1996-3#1)(2009-3#1)
allografts have a##2##3##(2008-7#1)(2012-3#1)
allografts have##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
allografts in##3##2##(1996-3#1)(2012-2#2)
allografts##16##1##(1996-3#4)(2008-10#1)(2008-7#1)(2009-3#3)(2011-3#1)(2012-2#3)(2012-3#3)
alloimmunization##4##1##(1991-11#2)(1991-3#1)(2011-2#1)
allometric relationships##3##2##(2008-8#2)(2010-8#1)
allometric##8##1##(2008-8#4)(2009-5#3)(2010-8#1)
allometry##5##1##(1993-12#2)(2008-9#3)
allopatric and##2##2##(2008-8#2)
allopatric##4##1##(2008-10#1)(2008-8#3)
allopatry were##2##2##(2008-10#2)
allopatry##6##1##(2008-10#6)
alloplasm##2##1##(2008-8#2)
alloplasmic wheat##3##2##(2008-8#3)
alloplastic##5##1##(2010-6#1)(2012-3#4)
allopurinol##7##1##(2008-10#6)(2008-7#1)
allorecognition##3##1##(2012-3#3)
allostatic load##3##2##(2010-12#3)
allosteric effects##2##2##(1991-10#1)(2012-2#1)
allosteric interaction##7##2##(1995-11#7)
allosteric##18##1##(1991-10#1)(1991-5#1)(1993-8#1)(1994-11#1)(1995-11#10)(2008-4#1)(2009-5#1)(2012-2#2)
allosterically##3##1##(1995-11#2)(2012-2#1)
allotransplant##2##1##(2008-10#2)
allotypes##2##1##(1997-8#2)
allow a higher##2##3##(1991-6#1)(2008-7#1)
allow a##15##2##(1991-6#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2011-7#1)
allow accurate##2##2##(2008-10#1)(2012-2#1)
allow an##4##2##(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#1)
allow analysis of##2##3##(1992-3#1)(1995-6#1)
allow better##2##2##(1995-3#1)(2009-1#1)
allow comparison##2##2##(2008-10#2)
allow effective##2##2##(2008-10#1)(2008-7#1)
allow efficient##2##2##(2008-11#1)(2013-1#1)
allow exploration of##2##3##(2008-12#1)(2009-12#1)
allow for a##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
allow for appropriate##2##3##(1997-3#1)(2008-10#1)
allow for more##3##3##(1992-3#1)(2008-10#2)
allow for the##16##3##(1992-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2012-3#1)(2013-1#1)(2013-8#2)
allow for##54##2##(1992-11#1)(1992-3#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
allow future##2##2##(1991-11#1)(2008-7#1)
allow greater##4##2##(1994-2#1)(2008-11#1)(2011-2#2)
allow identification of##2##3##(2008-5#1)(2012-2#1)
allow improved##2##2##(1997-8#1)(2008-1#1)
allow individuals to##2##3##(1996-5#1)(2010-4#1)
allow its##2##2##(2008-10#2)
allow more##2##2##(2008-10#1)(2013-8#1)
allow one to estimate the##2##5##(2008-3#1)(2009-8#1)
allow one to##9##3##(1997-2#1)(2008-1#1)(2008-10#4)(2008-3#2)(2009-8#1)
allow only determination of##2##4##(2008-10#2)
allow patients to##2##3##(2008-8#1)(2010-6#1)
allow rapid##3##2##(2008-9#1)(2010-5#1)(2011-2#1)
allow researchers to##2##3##(2009-8#1)(2010-4#1)
allow some##3##2##(1991-1#1)(1995-6#1)(2008-9#1)
allow the determination of##6##4##(2008-10#6)
allow the development of##2##4##(2008-10#1)(2008-5#1)
allow the formation of##2##4##(1992-9#1)(1993-12#1)
allow the simultaneous##2##3##(2008-10#2)
allow the use of##3##4##(2008-10#3)
allow the##69##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-2#1)(1997-6#1)(2008-10#27)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
allow their##4##2##(2008-10#3)(2008-11#1)
allow them to become##2##4##(1997-3#1)(2010-9#1)
allow them to##5##3##(1995-2#1)(1997-3#1)(2008-10#2)(2010-9#1)
allow this##2##2##(1992-9#1)(2009-8#1)
allow to##6##2##(1990-5#1)(2008-10#3)(2008-11#1)(2012-12#1)
allow two##2##2##(2008-9#1)(2009-6#1)
allow us to differentiate##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
allow us to##18##3##(1993-2#1)(1995-5#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-4#1)
allow##346##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-5#4)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#4)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#5)(2008-10#95)(2008-11#19)(2008-12#4)(2008-2#2)(2008-3#9)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#16)(2008-9#13)(2009-1#1)(2009-10#5)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#12)(2011-7#1)(2012-12#1)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#7)(2013-8#6)
allowable##4##1##(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)
allowance##4##1##(1992-9#1)(2008-10#2)(2008-8#1)
allowances##2##1##(2010-6#1)(2013-8#1)
allowed a##23##2##(1995-6#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-10#12)(2008-11#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
allowed an##2##2##(2008-10#1)(2008-5#1)
allowed at##3##2##(1997-8#1)(2008-10#2)
allowed both##2##2##(2008-10#2)
allowed calculations of##2##3##(2008-10#2)
allowed charges##3##2##(1992-1#1)(1994-2#2)
allowed complete##3##2##(2008-10#2)(2013-1#1)
allowed detection of the##2##4##(2008-10#1)(2008-5#1)
allowed detection of##3##3##(2008-10#2)(2008-5#1)
allowed determination of##3##3##(2008-10#2)(2008-11#1)
allowed determination##4##2##(2008-10#3)(2008-11#1)
allowed differentiation of##2##3##(2008-10#2)
allowed discrimination between##3##3##(1996-12#1)(2008-10#2)
allowed discrimination##5##2##(1996-12#1)(2008-10#4)
allowed efficient##2##2##(2008-11#2)
allowed for an##2##3##(2008-10#1)(2008-8#1)
allowed for the##12##3##(2008-10#6)(2008-11#1)(2008-12#2)(2009-7#1)(2013-1#2)
allowed for##23##2##(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-7#2)(2012-12#1)(2013-1#2)
allowed identification of##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
allowed that##2##2##(2008-10#2)
allowed the design of##2##4##(2008-10#2)
allowed the detection of##6##4##(1997-3#1)(1997-6#1)(2008-10#3)(2010-4#1)
allowed the determination of##16##4##(2008-10#15)(2008-11#1)
allowed the determination##17##3##(2008-10#16)(2008-11#1)
allowed the discrimination between##2##4##(2008-10#2)
allowed the estimation of the##2##5##(2008-8#1)(2009-10#1)
allowed the estimation of##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
allowed the formation of##2##4##(1996-5#1)(2008-10#1)
allowed the generation of##3##4##(1995-12#1)(1996-6#1)(2008-11#1)
allowed the identification of the three genotypic classes##2##8##(2008-10#2)
allowed the identification of##5##4##(2008-10#5)
allowed the identification##6##3##(2008-10#5)(2009-8#1)
allowed the preparation of##2##4##(1996-5#1)(2008-4#1)
allowed the rapid##2##3##(1993-2#1)(2009-7#1)
allowed the sample##2##3##(2008-10#2)
allowed the use of##4##4##(2008-10#3)(2008-11#1)
allowed the##95##2##(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-12#2)(1995-8#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#60)(2008-11#6)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
allowed to be##3##3##(1995-1#1)(2008-10#1)(2008-9#1)
allowed to dry##3##3##(2008-10#3)
allowed to interact with DMSO solutions of##2##7##(2008-10#2)
allowed to interact##3##3##(1993-6#1)(2008-10#2)
allowed to obtain a##2##4##(2008-10#2)
allowed to obtain##3##3##(2008-10#3)
allowed to react##2##3##(2008-10#2)
allowed to##43##2##(1990-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1996-12#1)(1997-2#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-3#2)(2008-8#3)(2008-9#2)(2010-12#1)(2012-3#1)
allowed us to determine the##3##5##(2008-10#3)
allowed us to determine##6##4##(1996-12#1)(2008-10#4)(2009-8#1)
allowed us to distinguish##2##4##(2008-10#1)(2011-10#1)
allowed us to identify##2##4##(1995-6#1)(2008-10#1)
allowed us to measure the##2##5##(1993-8#1)(2010-7#1)
allowed us to study the##2##5##(1993-2#1)(2008-10#1)
allowed us to test the##2##5##(2008-8#2)
allowed us to test##3##4##(2008-8#3)
allowed us to##52##3##(1990-2#1)(1993-2#1)(1993-8#4)(1995-6#2)(1996-12#2)(1997-8#1)(1997-9#1)(2008-10#20)(2008-11#1)(2008-3#2)(2008-5#5)(2008-8#5)(2009-10#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-10#1)(2011-2#1)
allowed##376##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#2)(1993-8#4)(1994-11#2)(1994-2#2)(1994-6#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#2)(1997-9#1)(2007-12#2)(2007-8#1)(2008-10#185)(2008-11#25)(2008-12#4)(2008-3#5)(2008-4#2)(2008-5#8)(2008-7#7)(2008-8#13)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#3)(2009-5#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#2)(2011-10#1)(2011-2#13)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#1)
allowing a more##2##3##(1994-12#1)(2008-10#1)
allowing a##15##2##(1994-12#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)(2013-1#1)
allowing accurate##2##2##(1990-12#1)(2008-11#1)
allowing an##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
allowing analytical##2##2##(2008-10#1)(2008-9#1)
allowing animals to##2##3##(2008-11#1)(2008-8#1)
allowing easy##2##2##(2008-10#1)(2008-11#1)
allowing for a##2##3##(2008-10#1)(2008-11#1)
allowing for the##4##3##(1990-5#1)(2008-10#2)(2010-8#1)
allowing for##23##2##(1990-5#1)(1993-11#1)(1994-12#1)(1996-11#1)(2008-10#8)(2008-11#2)(2008-3#4)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
allowing full##2##2##(1990-9#1)(2008-3#1)
allowing high##2##2##(2008-4#1)(2013-1#1)
allowing it to##4##3##(2007-12#1)(2008-10#2)(2008-6#1)
allowing its##2##2##(2008-6#1)(2011-1#1)
allowing more##2##2##(1991-3#1)(2012-2#1)
allowing one to##2##3##(2008-10#1)(2008-11#1)
allowing patients to##2##3##(2011-1#1)(2012-2#1)
allowing prediction of##2##3##(1995-11#1)(1996-6#1)
allowing substituted consent##2##3##(1995-2#2)
allowing the detection of##2##4##(2008-10#2)
allowing the determination of the##3##5##(2008-10#3)
allowing the determination of##6##4##(2008-10#6)
allowing the direct##2##3##(2008-10#2)
allowing the evaluation of##2##4##(1995-5#1)(2008-5#1)
allowing the simultaneous##2##3##(2008-10#2)
allowing the user to##2##4##(2008-6#1)(2008-9#1)
allowing the##41##2##(1990-12#1)(1992-12#1)(1995-5#1)(2008-10#19)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#1)
allowing their##3##2##(2008-10#2)(2011-2#1)
allowing them to##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
allowing to##6##2##(1996-11#1)(2008-10#4)(2011-2#1)
allowing us to##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
allowing##206##1##(1990-12#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-12#2)(2008-10#71)(2008-11#13)(2008-12#1)(2008-3#11)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#9)(2008-9#9)(2009-10#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-12#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#4)
allows a direct##2##3##(1992-3#1)(2008-3#1)
allows a good##2##3##(2008-10#2)
allows a more##2##3##(2008-10#1)(2008-3#1)
allows a##34##2##(1990-12#1)(1992-10#1)(1992-3#2)(1995-11#1)(1996-6#1)(1997-6#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2013-8#1)
allows an easy##2##3##(2008-10#1)(2011-1#1)
allows an##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2011-1#1)
allows better##2##2##(2010-12#1)(2013-1#1)
allows both##3##2##(2008-10#1)(2008-5#1)(2009-6#1)
allows complete##2##2##(2008-10#1)(2008-11#1)
allows determination of the##2##4##(2008-10#2)
allows determination of##5##3##(2008-10#5)
allows determining##2##2##(2008-10#2)
allows easy##3##2##(1993-9#1)(1997-3#1)(2013-8#1)
allows estimation of the##2##4##(1992-12#2)
allows flexibility##2##2##(2008-11#1)(2010-10#1)
allows for a##8##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-3#1)
allows for efficient##2##3##(2008-11#1)(2008-3#1)
allows for more##2##3##(2008-4#2)
allows for rapid##3##3##(2008-11#2)(2011-2#1)
allows for the direct##2##4##(2008-10#2)
allows for the possibility##2##4##(1991-5#1)(2008-8#1)
allows for the##15##3##(1991-5#1)(1996-5#1)(2008-10#8)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-9#1)
allows for##62##2##(1991-5#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#7)(2008-12#2)(2008-3#4)(2008-4#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
allows formation of a##2##4##(1995-2#2)
allows information##2##2##(2008-10#2)
allows its determination##2##3##(2008-10#2)
allows its##3##2##(2008-10#3)
allows measurement of##2##3##(2008-10#1)(2008-4#1)
allows more precise##2##3##(2008-9#1)(2011-7#1)
allows one to##12##3##(2007-12#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)
allows one##13##2##(2007-12#1)(2008-10#7)(2008-3#1)(2008-9#2)(2010-7#1)(2011-2#1)
allows only##2##2##(1997-8#1)(2008-10#1)
allows patients to##2##3##(1991-12#1)(2008-8#1)
allows precise##3##2##(1995-1#1)(2008-10#2)
allows quantitation of##2##3##(2008-10#2)
allows quantitation##3##2##(2008-10#3)
allows quantitative##2##2##(1991-5#1)(2008-10#1)
allows rapid##5##2##(2008-10#1)(2008-11#2)(2008-9#2)
allows sensitive##2##2##(2008-10#1)(2013-1#1)
allows simultaneous##4##2##(1996-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
allows the accurate##2##3##(2008-10#1)(2008-3#1)
allows the analysis of##4##4##(2008-10#4)
allows the application of##2##4##(2008-10#1)(2011-1#1)
allows the calculation of##2##4##(2008-10#1)(2010-12#1)
allows the detection of##3##4##(2008-10#2)(2010-11#1)
allows the determination of 0##4##5##(2008-10#4)
allows the determination of the##2##5##(2008-10#1)(2010-10#1)
allows the determination of##23##4##(2008-10#22)(2010-10#1)
allows the determination##24##3##(2008-10#23)(2010-10#1)
allows the direct determination of##3##5##(1991-12#1)(2008-10#2)
allows the direct##5##3##(1991-12#1)(2008-10#4)
allows the evaluation of##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
allows the isolation of##2##4##(2008-10#2)
allows the measurement of##2##4##(2008-10#2)
allows the patient to##2##4##(1993-12#1)(2013-8#1)
allows the possibility##2##3##(2008-10#1)(2009-12#1)
allows the separation of##2##4##(2008-10#2)
allows the separation##3##3##(2008-10#3)
allows the simultaneous determination of##5##5##(2008-10#5)
allows the simultaneous##8##3##(2008-10#6)(2008-11#1)(2008-3#1)
allows the use of##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
allows the user to##2##4##(2008-3#1)(2008-6#1)
allows the##126##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1996-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#67)(2008-11#7)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#4)
allows their determination##2##3##(2008-10#1)(2009-8#1)
allows them to##3##3##(1990-2#1)(2008-11#1)(2008-8#1)
allows to detect##2##3##(1997-6#1)(2008-10#1)
allows to determine##2##3##(2008-10#2)
allows to predict the##2##4##(2007-8#1)(2008-10#1)
allows to##22##2##(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#2)
allows us to calculate the##2##5##(2008-7#1)(2008-8#1)
allows us to determine##2##4##(2008-10#1)(2009-8#1)
allows us to##26##3##(1990-2#1)(1992-6#1)(1995-5#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#3)(2010-5#2)(2010-7#1)(2012-3#3)
allows users to##3##3##(2008-12#1)(2008-9#1)(2011-3#1)
allows##480##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-9#2)(1996-1#2)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(1997-8#3)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#180)(2008-11#32)(2008-12#10)(2008-2#7)(2008-3#27)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#19)(2009-1#1)(2009-10#1)(2009-12#4)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#8)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#3)(2011-7#3)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#8)(2013-8#10)
alloxan-induced##6##1##(2008-11#5)(2012-12#1)
alloy and##7##2##(2008-10#6)(2012-2#1)
alloy electrode##3##2##(2008-10#3)
alloy electrodes##2##2##(2008-10#2)
alloy foams##3##2##(2009-7#3)
alloy is##3##2##(2009-7#3)
alloy samples with satisfactory results##3##5##(2008-10#3)
alloy samples##13##2##(2008-10#13)
alloy were##2##2##(2009-7#1)(2012-2#1)
alloy with##3##2##(2008-10#2)(2009-7#1)
alloy##81##1##(1991-9#1)(1993-9#1)(2008-10#48)(2008-7#1)(2009-11#1)(2009-7#16)(2012-2#8)(2013-1#3)(2013-8#2)
alloy)##3##1##(2008-10#3)
alloying##2##1##(1993-5#1)(2009-7#1)
alloys and biological samples##3##4##(2008-10#3)
alloys and biological##4##3##(2008-10#4)
alloys and environmental samples after##2##5##(2008-10#2)
alloys and environmental samples##5##4##(2008-10#5)
alloys and##14##2##(2008-10#14)
alloys by hydride generation atomic absorption spectrometry##2##7##(2008-10#2)
alloys by##6##2##(2008-10#6)
alloys for##2##2##(2008-10#2)
alloys is##2##2##(2008-10#2)
alloys using##3##2##(2008-10#3)
alloys was##2##2##(2008-10#1)(2009-7#1)
alloys with##3##2##(2008-10#1)(2013-1#2)
alloys##68##1##(1995-3#1)(2007-11#1)(2008-10#55)(2009-7#6)(2013-1#5)
allozyme analysis##3##2##(2008-10#3)
allozyme genotype##6##2##(2008-10#6)
allozyme##14##1##(2008-10#13)(2008-9#1)
allozymes##5##1##(2008-10#5)
allura red in##2##3##(2008-10#2)
allura red##3##2##(2008-10#3)
allyl##3##1##(1992-12#1)(1996-5#1)(2008-10#1)
allylamine antimycotics##2##2##(2008-8#2)
allylamine##3##1##(1996-5#1)(2008-8#2)
allylamines##2##1##(1996-5#2)
allylic alcohols##3##2##(1996-5#1)(2008-8#1)(2010-7#1)
allylic esters##3##2##(1996-5#3)
allylic##8##1##(1994-11#1)(1996-5#5)(2008-8#1)(2010-7#1)
alm1##3##1##(2008-10#3)
almond (Prunus dulcis)##2##3##(2008-10#2)
almond and peach isolates##2##4##(2008-10#2)
almond and peach##3##3##(2008-10#3)
almond and##7##2##(2008-10#7)
almond anthracnose##2##2##(2008-10#2)
almond isolates from##2##3##(2008-10#2)
almond isolates##4##2##(2008-10#4)
almond leaves##2##2##(2008-10#2)
almond##36##1##(1992-12#1)(2008-10#33)(2008-11#2)
almost 100%##4##2##(1992-8#1)(2008-10#2)(2008-2#1)
almost 20 years##2##3##(2008-10#1)(2008-12#1)
almost 50##2##2##(1997-5#1)(2009-4#1)
almost 50%##4##2##(2008-10#3)(2008-11#1)
almost a factor of##2##4##(1992-3#1)(2008-10#1)
almost a##5##2##(1992-3#1)(2008-10#3)(2008-5#1)
almost all of them##3##4##(1996-9#1)(2008-8#1)(2008-9#1)
almost all of##5##3##(1996-9#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-3#1)
almost all the##2##3##(1990-6#1)(2008-12#1)
almost all##38##2##(1990-6#1)(1991-1#1)(1991-12#1)(1993-1#1)(1993-6#1)(1993-8#1)(1995-3#1)(1996-9#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
almost always##10##2##(1992-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#1)
almost any##2##2##(2008-9#1)(2012-2#1)
almost at the##2##3##(1993-3#1)(2008-10#1)
almost certainly##4##2##(1992-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
almost complete##12##2##(1990-2#1)(1994-11#1)(1995-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-7#2)
almost completed##2##2##(1993-3#1)(2008-8#1)
almost completely##13##2##(1992-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#3)
almost constant##8##2##(2008-10#4)(2008-11#2)(2008-5#1)(2009-8#1)
almost entirely##2##2##(2008-10#1)(2008-12#1)
almost equal##4##2##(1997-3#2)(2008-10#1)(2012-3#1)
almost equally in##2##3##(2008-10#2)
almost equally##7##2##(1992-12#1)(1992-4#1)(1994-2#1)(1994-5#1)(2008-10#3)
almost every##7##2##(1993-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2010-6#1)
almost exclusively in##2##3##(2008-10#2)
almost exclusively on##5##3##(1993-3#1)(1997-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
almost exclusively to##2##3##(1992-2#1)(2012-2#1)
almost exclusively##13##2##(1992-2#1)(1993-3#1)(1997-6#1)(2008-10#3)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-8#2)
almost fully##2##2##(1995-8#1)(2008-7#1)
almost half##4##2##(1996-3#1)(1997-8#1)(2008-12#2)
almost identical to##4##3##(1995-2#1)(1995-9#1)(2009-8#1)(2010-7#1)
almost identical##10##2##(1995-2#2)(1995-9#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#1)
almost identically##2##2##(1990-2#1)(1993-8#1)
almost immediate##2##2##(1990-5#1)(1992-12#1)
almost independent of the##2##4##(2008-11#1)(2008-2#1)
almost independent of##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
almost invariably##4##2##(1997-7#1)(2008-7#1)(2010-11#1)(2012-3#1)
almost no##7##2##(1990-11#1)(1991-1#1)(2008-10#4)(2010-8#1)
almost none##2##2##(1994-9#1)(2008-11#1)
almost normal##3##2##(1994-3#1)(1995-8#1)(2012-3#1)
almost normally##2##2##(1992-11#1)(2008-7#1)
almost not##2##2##(2008-10#2)
almost one##6##2##(1997-7#1)(2008-10#1)(2008-11#2)(2009-12#1)(2012-3#1)
almost quantitative##2##2##(1992-12#1)(2008-10#1)
almost reached##2##2##(2008-11#1)(2013-1#1)
almost similar to##2##3##(2008-10#1)(2008-12#1)
almost similar##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)
almost simultaneously##2##2##(2008-5#1)(2008-9#1)
almost the same as that of the##2##7##(2008-2#1)(2008-5#1)
almost the same as the##2##5##(1995-12#1)(2008-10#1)
almost the same as##5##4##(1995-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
almost the same##10##3##(1995-12#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)
almost the##12##2##(1995-12#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)
almost three##2##2##(1995-2#1)(2008-10#1)
almost to##2##2##(1991-2#1)(2008-9#1)
almost totally##4##2##(1990-5#1)(2008-10#3)
almost twice as##2##3##(2011-2#1)(2012-2#1)
almost twice the##2##3##(1997-6#1)(2008-10#1)
almost twice##6##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
almost unchanged##2##2##(2008-11#1)(2008-7#1)
almost universal##2##2##(2009-4#1)(2012-2#1)
almost##293##1##(1990-11#1)(1990-2#2)(1990-5#2)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#4)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#4)(2007-12#1)(2008-1#1)(2008-10#84)(2008-11#19)(2008-12#11)(2008-2#3)(2008-5#9)(2008-7#7)(2008-8#8)(2008-9#10)(2009-12#1)(2009-4#2)(2009-7#2)(2009-8#7)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-2#11)(2012-2#9)(2012-3#8)(2013-1#5)(2013-8#3)
alone (p##3##2##(1994-1#1)(2008-10#1)(2008-3#1)
alone after##2##2##(1994-11#1)(2008-10#1)
alone also##2##2##(2008-10#1)(2008-12#1)
alone and in combination to##2##5##(2008-10#2)
alone and in combination with##3##5##(1990-2#1)(1991-1#1)(2009-8#1)
alone and in combination##6##4##(1990-2#1)(1991-1#1)(2008-10#2)(2008-5#1)(2009-8#1)
alone and in##9##3##(1990-2#1)(1991-1#1)(1994-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-8#1)
alone and increased##2##3##(2009-7#1)(2012-4#1)
alone and##28##2##(1990-2#1)(1991-1#1)(1991-2#1)(1993-8#1)(1994-12#1)(1997-7#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2012-4#1)(2013-8#1)
alone are##3##2##(1995-5#2)(2009-10#1)
alone as##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
alone at##3##2##(1993-8#1)(1995-12#1)(2008-11#1)
alone by the##2##3##(1994-9#1)(1996-2#1)
alone can##2##2##(2008-11#1)(2011-2#1)
alone cannot##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
alone caused##3##2##(1993-8#1)(1994-5#1)(2008-10#1)
alone consistently##2##2##(2008-10#2)
alone decreased##2##2##(1993-12#1)(1994-5#1)
alone did not have##2##4##(2008-11#1)(2008-9#1)
alone did not induce##2##4##(1996-12#1)(2008-10#1)
alone did not##7##3##(1993-8#1)(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
alone do not##2##3##(2008-10#1)(2008-5#1)
alone does not##3##3##(1990-6#1)(1997-7#1)(2008-9#1)
alone for##3##2##(1994-6#1)(2008-10#1)(2013-1#1)
alone had no##2##3##(1993-6#1)(1994-11#1)
alone had##3##2##(1990-6#1)(1993-6#1)(1994-11#1)
alone has##3##2##(1994-6#1)(2008-10#1)(2008-7#1)
alone have##2##2##(1993-12#1)(2013-8#1)
alone in the##5##3##(1991-1#1)(2008-10#1)(2008-8#1)(2013-1#2)
alone in##18##2##(1990-6#1)(1991-1#1)(1991-8#1)(1994-11#1)(1995-2#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#2)(2010-12#1)(2012-3#1)(2013-1#2)
alone is essential##2##3##(1992-6#1)(2008-10#1)
alone is not sufficient to##2##5##(1996-12#1)(2008-5#1)
alone is not sufficient##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
alone is not##5##3##(1991-3#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
alone is##12##2##(1991-3#1)(1992-6#1)(1996-12#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
alone may be##2##3##(1991-2#1)(2012-3#1)
alone may##5##2##(1991-2#1)(1994-3#2)(2010-11#1)(2012-3#1)
alone or by##2##3##(1995-2#1)(2010-3#1)
alone or combined with##2##4##(2007-11#1)(2011-2#1)
alone or combined##4##3##(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
alone or in combination with other##2##6##(1995-2#1)(2008-11#1)
alone or in combination with##10##5##(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
alone or in combination##15##4##(1993-6#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
alone or in the presence of##2##6##(1993-8#1)(1995-8#1)
alone or in the##3##4##(1993-8#1)(1995-8#1)(2011-2#1)
alone or in##23##3##(1993-11#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
alone or the##4##3##(2008-10#3)(2009-6#1)
alone or with##3##3##(2009-2#1)(2009-9#1)(2012-3#1)
alone or##48##2##(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-2#2)(1995-8#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#16)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)
alone produced a##2##3##(1994-11#1)(2010-6#1)
alone produced##3##2##(1994-11#1)(2008-7#1)(2010-6#1)
alone resulted in##2##3##(1995-12#1)(2008-11#1)
alone showed no significant##2##4##(1993-8#1)(2008-12#1)
alone showed##4##2##(1993-8#1)(1994-5#1)(2008-11#1)(2008-12#1)
alone the##2##2##(2008-10#1)(2008-8#1)
alone to##2##2##(2008-1#1)(2008-6#1)
alone under the##2##3##(2008-10#1)(2011-2#1)
alone versus##2##2##(2011-2#1)(2012-3#1)
alone was##11##2##(1993-9#1)(1994-1#1)(1995-5#1)(1997-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
alone were##4##2##(1990-12#2)(1997-1#1)(2013-8#1)
alone with##2##2##(2008-7#2)
alone##401##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#4)(1990-8#2)(1991-1#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-11#3)(1993-12#4)(1993-3#1)(1993-6#4)(1993-8#7)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#6)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#9)(1995-5#6)(1995-8#5)(1996-12#5)(1996-2#1)(1997-1#5)(1997-2#6)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#102)(2008-11#25)(2008-12#6)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#8)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#2)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-5#1)(2010-6#1)(2011-10#1)(2011-2#22)(2011-3#1)(2012-2#6)(2012-3#9)(2012-4#1)(2012-6#1)(2013-1#16)(2013-7#1)(2013-8#6)
alone)##2##1##(1994-5#1)(2008-9#1)
along a certain##2##3##(2008-10#1)(2008-11#1)
along a productivity gradient##3##4##(2008-8#1)(2008-9#2)
along a##19##2##(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2013-1#1)
along an acidification gradient##2##4##(2012-3#2)
along an##5##2##(2009-10#1)(2009-5#1)(2012-3#2)(2012-6#1)
along its##3##2##(2008-11#1)(2008-3#2)
along lines##2##2##(2008-11#1)(2010-10#1)
along other##2##2##(2008-11#1)(2008-9#1)
along similar lines##2##3##(1992-1#1)(1995-3#1)
along the anterior##4##3##(2007-12#1)(2011-2#1)(2012-2#1)(2013-2#1)
along the course of##2##4##(2011-2#2)
along the curvature##2##3##(2009-2#2)
along the entire length of the##2##6##(1997-4#1)(2009-7#1)
along the entire##3##3##(1997-4#1)(2009-7#1)(2009-8#1)
along the inner##2##3##(2008-11#1)(2008-9#1)
along the length of the##3##5##(1997-1#1)(2008-3#1)(2008-7#1)
along the length of##4##4##(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
along the line##2##3##(2008-3#2)
along the longitudinal##3##3##(2008-9#2)(2009-7#1)
along the meridian##3##3##(2008-9#3)
along the molecule##2##3##(1992-9#2)
along the reaction##2##3##(2008-10#2)
along the routes##2##3##(2011-2#2)
along the study##2##3##(2008-12#1)(2013-8#1)
along the symbiotic##2##3##(2008-11#2)
along the way##4##3##(1996-3#1)(2008-12#1)(2008-4#1)(2010-10#1)
along the whole##2##3##(1990-5#1)(2008-3#1)
along the##120##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-4#1)(1992-9#3)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#26)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#4)(2008-9#8)(2009-10#1)(2009-2#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#1)(2013-2#1)(2013-8#4)
along their##2##2##(2008-5#1)(2012-2#1)
along these##2##2##(1992-12#1)(2011-2#1)
along this##2##2##(1991-3#1)(2008-10#1)
along two##2##2##(1996-2#1)(2009-10#1)
along which##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2010-10#1)
along with a detection limit of 0##2##7##(2008-10#2)
along with a review of the##3##6##(2008-7#1)(2011-2#1)(2013-1#1)
along with a##23##3##(1991-2#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
along with an##2##3##(2008-10#1)(2011-2#1)
along with growth##2##3##(2010-10#1)(2012-3#1)
along with increased##2##3##(1996-2#1)(2008-7#1)
along with its##7##3##(2008-10#2)(2008-11#1)(2008-12#1)(2010-6#1)(2010-8#1)(2011-2#1)
along with low##2##3##(2008-10#1)(2012-3#1)
along with one##2##3##(2008-10#2)
along with other##8##3##(1996-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#1)
along with that of##2##4##(2012-12#1)(2013-1#1)
along with the results of##2##5##(2008-10#1)(2013-8#1)
along with the##54##3##(1991-3#1)(1991-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-8#2)(1996-12#2)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
along with their##2##3##(2008-11#1)(2009-12#1)
along with those##3##3##(1993-8#1)(2008-2#1)(2012-2#1)
along with three other##2##4##(2008-10#1)(2011-2#1)
along with tillage information##2##4##(2008-10#2)
along with##228##2##(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-6#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#65)(2008-11#10)(2008-12#8)(2008-2#3)(2008-3#5)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#6)(2010-7#3)(2010-8#3)(2011-2#14)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#2)
along##436##1##(1990-11#1)(1990-12#1)(1990-5#3)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#3)(1992-12#1)(1992-4#1)(1992-6#3)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-7#1)(2007-11#2)(2007-12#5)(2008-10#108)(2008-11#27)(2008-12#13)(2008-2#4)(2008-3#22)(2008-4#10)(2008-5#11)(2008-6#1)(2008-7#11)(2008-8#15)(2008-9#19)(2009-10#5)(2009-12#2)(2009-2#3)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#6)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#6)(2010-7#5)(2010-8#6)(2011-1#1)(2011-2#25)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#10)(2012-3#11)(2012-5#1)(2012-6#1)(2013-1#15)(2013-2#1)(2013-7#1)(2013-8#7)
alongside the##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
alongside##7##1##(2008-10#2)(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
alongwith a##2##2##(2010-8#1)(2013-8#1)
alopecia areata##3##2##(2010-6#2)(2011-2#1)
alopecia at##2##2##(2008-10#1)(2012-3#1)
alopecia##21##1##(1991-6#1)(1992-2#1)(1996-10#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-6#7)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
aloud##3##1##(1995-2#1)(2008-9#2)
alpha 1 (I) and alpha 2 (I) collagen##2##8##(1991-5#2)
alpha 1 (I)##5##3##(1991-5#4)(1994-12#1)
alpha 1 and##2##3##(1995-11#1)(1995-2#1)
alpha 1 beta 2 gamma##2##5##(1995-11#2)
alpha 1 beta##5##3##(1993-8#3)(1995-11#2)
alpha 1##25##2##(1990-12#2)(1991-5#4)(1992-12#1)(1992-4#1)(1993-8#3)(1993-9#2)(1994-12#5)(1995-11#4)(1995-2#1)(1996-2#1)(2008-12#1)
alpha 1-PI cDNA##3##3##(1990-8#3)
alpha 1-PI##4##2##(1990-8#4)
alpha 1-acid glycoprotein##2##3##(1991-12#2)
alpha 1-adrenoceptor##3##2##(1995-11#3)
alpha 1-adrenoceptors##3##2##(1991-6#2)(1995-11#1)
alpha 1-antitrypsin##2##2##(1993-2#1)(1994-3#1)
alpha 1Deltag(nu =0) +##2##4##(2008-3#2)
alpha 1Deltag(nu##3##2##(2008-3#3)
alpha 2 (I) collagen##3##4##(1991-5#2)(1992-8#1)
alpha 2##6##2##(1991-5#2)(1992-8#1)(1993-8#2)(1995-2#1)
alpha 2(I)##4##2##(1990-5#1)(1991-5#3)
alpha 2--&gt##11##2##(1994-11#10)(1994-5#1)
alpha 2-adrenoceptors##2##2##(1990-5#1)(1991-6#1)
alpha 3 beta 2##4##4##(1995-11#4)
alpha 3 beta 4 and alpha 4 beta 2##2##9##(1995-11#2)
alpha 3 beta 4##5##4##(1992-4#1)(1995-11#4)
alpha 3 beta##10##3##(1992-4#1)(1995-11#8)(1995-6#1)
alpha 4 beta 2 gamma 2L##3##6##(1995-11#3)
alpha 4 beta 2 nicotinic receptor-mediated inward##2##7##(1995-11#2)
alpha 4 beta 2##6##4##(1995-11#6)
alpha 4 beta 4 octamer##2##5##(1991-10#2)
alpha 4 beta##8##3##(1991-10#2)(1995-11#6)
alpha 4 subunit##2##3##(1995-11#2)
alpha 4##11##2##(1991-10#2)(1995-11#9)
alpha 5 beta 3 gamma 2##2##6##(1995-11#2)
alpha 5 beta 3 gamma 3##3##6##(1995-11#3)
alpha 5 beta 3 gamma##7##5##(1995-11#7)
alpha 5 beta##8##3##(1992-2#1)(1995-11#7)
alpha 5##9##2##(1992-2#2)(1995-11#7)
alpha 7 cDNA##3##3##(1996-12#3)
alpha 7 genotype##2##3##(1996-12#2)
alpha 7 homopolymer##2##3##(2010-8#2)
alpha 7 subunit##2##3##(1996-12#2)
alpha 7##13##2##(1996-12#10)(2010-8#3)
alpha = 0##5##3##(2008-10#3)(2013-1#2)
alpha =##7##2##(1992-11#1)(2008-10#3)(2009-11#1)(2013-1#2)
alpha AGA##3##2##(1993-12#3)
alpha Amy3 expression##2##3##(1994-11#2)
alpha Amy3 mRNA##3##3##(1994-11#3)
alpha Amy3##9##2##(1994-11#9)
alpha BFV-4 and alpha BFV-5 inhibited the##2##7##(1994-5#2)
alpha BFV-4##3##2##(1994-5#3)
alpha BFV-5##3##2##(1994-5#3)
alpha and beta estimates##2##4##(2008-10#2)
alpha and beta subunits##10##4##(1990-8#1)(1991-10#2)(1991-7#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1995-11#1)
alpha and beta##27##3##(1990-8#2)(1991-10#3)(1991-7#2)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#2)(1994-11#5)(1994-6#1)(1995-11#1)(1995-6#2)(2008-10#2)(2008-8#2)(2008-9#1)
alpha and gamma are##2##4##(2008-6#2)
alpha and gamma##6##3##(2008-6#5)(2008-8#1)
alpha and the##2##3##(1995-6#2)
alpha and##60##2##(1990-12#1)(1990-8#3)(1991-10#3)(1991-7#2)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#5)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#6)(1996-12#1)(2008-10#4)(2008-11#1)(2008-6#5)(2008-8#5)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)
alpha as##2##2##(1995-11#1)(2009-12#1)
alpha at##2##2##(1995-6#2)
alpha beta##2##2##(1993-8#1)(1995-5#1)
alpha but not##2##3##(1994-8#1)(2008-11#1)
alpha chain##4##2##(1997-5#1)(1997-8#1)(1997-9#2)
alpha counter##2##2##(2008-10#2)
alpha fetoprotein##2##2##(2008-10#1)(2013-7#1)
alpha gene encodes##2##3##(1993-3#1)(1993-6#1)
alpha gene##7##2##(1993-12#2)(1993-3#4)(1993-6#1)
alpha has been##2##3##(1995-6#1)(1997-5#1)
alpha helices##2##2##(1991-12#1)(2008-10#1)
alpha in##3##2##(1991-7#1)(1996-12#1)(1997-5#1)
alpha is##5##2##(1993-6#1)(1995-2#1)(2008-7#1)(2009-12#2)
alpha isoform##2##2##(1994-8#1)(1995-2#1)
alpha mRNA in##2##3##(1993-3#1)(2008-12#1)
alpha monomer##2##2##(2008-7#2)
alpha of##2##2##(1995-6#1)(2013-1#1)
alpha on##3##2##(1994-8#1)(1995-6#1)(1997-5#1)
alpha or##3##2##(1994-2#1)(1997-1#1)(2008-8#1)
alpha phase##4##2##(2009-7#4)
alpha polypeptides##2##2##(1994-5#1)(1995-6#1)
alpha s2-CasA##2##2##(1993-6#2)
alpha s2-CasD##2##2##(1993-6#2)
alpha satellite DNA##2##3##(1997-6#2)
alpha satellite##4##2##(1997-6#3)(2008-7#1)
alpha subunit and##2##3##(1992-9#1)(1995-8#1)
alpha subunit in transcriptional##2##4##(1995-6#2)
alpha subunit in##4##3##(1995-6#2)(1995-8#1)(1997-7#1)
alpha subunit of##9##3##(1991-12#1)(1994-12#1)(1994-2#1)(1995-2#2)(1995-8#1)(1996-12#1)(2008-7#1)(2012-2#1)
alpha subunit##31##2##(1990-12#1)(1991-12#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-2#2)(1995-6#4)(1995-8#9)(1996-12#1)(1997-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
alpha subunits and##2##3##(1995-11#1)(1995-6#1)
alpha subunits##6##2##(1992-2#1)(1995-11#1)(1995-6#4)
alpha to##2##2##(1996-5#1)(2010-10#1)
alpha was##5##2##(1992-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(2010-1#1)
alpha were##2##2##(1992-11#1)(1996-12#1)
alpha with##2##2##(1991-9#1)(1992-9#1)
alpha##535##1##(1990-11#9)(1990-12#5)(1990-2#4)(1990-5#5)(1990-8#11)(1991-10#5)(1991-12#5)(1991-5#15)(1991-6#4)(1991-7#3)(1991-9#3)(1992-10#3)(1992-11#5)(1992-12#3)(1992-2#3)(1992-4#4)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#5)(1993-12#16)(1993-2#3)(1993-3#10)(1993-5#2)(1993-6#13)(1993-8#19)(1993-9#4)(1994-11#25)(1994-12#7)(1994-2#9)(1994-3#2)(1994-5#19)(1994-6#4)(1994-8#8)(1995-11#52)(1995-2#14)(1995-5#1)(1995-6#40)(1995-8#14)(1995-9#1)(1996-12#19)(1996-2#2)(1996-5#5)(1996-8#1)(1997-1#8)(1997-2#1)(1997-4#5)(1997-5#5)(1997-6#3)(1997-7#1)(1997-8#1)(1997-9#2)(2008-1#1)(2008-10#27)(2008-11#13)(2008-12#3)(2008-3#5)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#13)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#6)(2009-7#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
alpha(1)##2##1##(2008-10#2)
alpha) and##3##2##(1991-9#1)(1994-5#1)(1995-6#1)
alpha) by##2##2##(1992-9#1)(1993-8#1)
alpha) has##2##2##(1992-9#1)(1997-5#1)
alpha) or##2##2##(1994-8#1)(1997-1#1)
alpha)##21##1##(1991-9#1)(1992-9#6)(1993-12#1)(1993-8#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-1#2)(1997-5#1)(2008-10#1)
alpha- and LH beta-subunit##2##4##(1996-2#2)
alpha- and beta- myosin heavy chain gene expression##3##8##(1992-3#3)
alpha- and beta- myosin heavy chain gene##4##7##(1992-3#4)
alpha- and beta- myosin heavy chain##6##6##(1992-3#6)
alpha- and beta-CGRP##5##3##(1992-6#5)
alpha- and beta-relaxation##2##3##(1995-3#2)
alpha- and beta-subunits of##2##4##(1990-2#1)(1991-3#1)
alpha- and beta-subunits##3##3##(1990-2#1)(1991-3#2)
alpha- and lutropin##2##3##(1996-2#2)
alpha- and##33##2##(1990-2#1)(1990-9#1)(1991-3#2)(1991-7#1)(1992-3#6)(1992-6#6)(1995-3#2)(1996-2#4)(2008-10#9)(2008-12#1)
alpha-##46##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-3#6)(1992-6#6)(1994-2#1)(1994-5#1)(1995-3#2)(1996-12#1)(1996-2#4)(2008-10#16)(2008-12#1)
alpha-1##7##1##(1990-2#1)(1995-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
alpha-2##4##1##(1990-2#1)(2008-10#1)(2008-7#1)(2010-7#1)
alpha-2b interferon##3##2##(1990-6#2)(1992-2#1)
alpha-2b##5##1##(1990-6#2)(1992-2#2)(2013-1#1)
alpha-308##4##1##(1995-12#4)
alpha-Amylase##2##1##(2008-10#2)
alpha-CD did not##2##3##(2008-10#2)
alpha-CD##7##1##(2008-10#7)
alpha-CGRP##5##1##(1992-6#5)
alpha-D-mannopyranoside##2##1##(1992-12#2)
alpha-GP##4##1##(2008-10#4)
alpha-IFN##2##1##(2008-7#2)
alpha-LA##6##1##(2008-7#6)
alpha-MSH##6##1##(1995-2#5)(2008-6#1)
alpha-Si##3##1##(2008-10#3)
alpha-Tocopherol##2##1##(1991-2#1)(2008-11#1)
alpha-Tomatine##2##1##(2008-10#2)
alpha-[PMo(12)O(40)](3-) complex was##2##3##(2008-10#2)
alpha-[PMo(12)O(40)](3-) complex##3##2##(2008-10#3)
alpha-[PMo(12)O(40)](3-)##5##1##(2008-10#5)
alpha-acetolactic acid##2##2##(2008-6#2)
alpha-actin labelled##2##2##(2008-11#2)
alpha-actin##3##1##(1993-8#1)(2008-11#2)
alpha-actinin from chicken gizzard##2##4##(1993-8#2)
alpha-actinin##7##1##(1993-8#6)(2010-6#1)
alpha-adrenergic##3##1##(1994-2#1)(1994-3#1)(2008-10#1)
alpha-amidating enzyme##2##2##(2008-11#2)
alpha-amino-3-hydroxy-5-methyl-4-isoxazole##2##1##(1995-11#1)(1995-2#1)
alpha-aminoisobutyric acid uptake##2##3##(1995-11#2)
alpha-amylase activity##2##2##(2008-8#1)(2013-1#1)
alpha-amylase and##5##2##(1990-3#2)(2008-10#2)(2008-8#1)
alpha-amylase by##2##2##(1992-12#1)(2008-10#1)
alpha-amylase gene##8##2##(1994-11#1)(2008-10#1)(2008-8#6)
alpha-amylase was##2##2##(1990-3#1)(2008-10#1)
alpha-amylase##39##1##(1990-3#7)(1990-9#2)(1992-12#2)(1994-11#2)(2008-10#10)(2008-8#13)(2009-8#1)(2013-1#2)
alpha-amylase-deficient mutant##2##2##(2008-10#2)
alpha-bungarotoxin binding and sensitivity to nicotine-induced##2##6##(1996-12#2)
alpha-bungarotoxin binding##5##2##(1996-12#5)
alpha-bungarotoxin receptor levels##2##3##(1996-12#2)
alpha-bungarotoxin##9##1##(1996-12#8)(2008-8#1)
alpha-carbon hydroxylation##3##2##(1990-6#2)(1993-11#1)
alpha-chain##4##1##(1990-5#1)(1995-6#2)(1997-7#1)
alpha-chains##2##1##(1990-8#2)
alpha-cholest-8(14)-en-15-one##3##1##(1992-3#2)(1993-6#1)
alpha-chymotrypsin##5##1##(1996-12#2)(2008-10#1)(2008-7#2)
alpha-cyclodextrin (CD) and##2##3##(2008-10#2)
alpha-cyclodextrin##5##1##(1997-2#1)(2008-10#4)
alpha-diimine ligands##2##2##(2008-10#2)
alpha-dimer##2##1##(1995-6#2)
alpha-endosulfan##2##1##(2008-10#2)
alpha-erythro-2-pentulofuranose (0##2##2##(1990-9#2)
alpha-fetoprotein (AFP)##3##2##(1990-9#1)(2008-8#1)(2011-1#1)
alpha-fetoprotein##5##1##(1990-9#2)(2008-8#2)(2011-1#1)
alpha-globin mRNA##3##2##(2008-6#1)(2008-8#1)(2008-9#1)
alpha-glucosidase gene from Aspergillus niger##2##5##(1997-2#2)
alpha-glucosidase##9##1##(1995-3#1)(1997-2#3)(2007-12#3)(2008-6#1)(2011-3#1)
alpha-glycerophosphate##3##1##(2008-10#3)
alpha-granules##2##1##(1990-5#1)(2010-3#1)
alpha-helical character##2##2##(1995-2#2)
alpha-helical conformation##3##2##(1994-5#2)(1995-2#1)
alpha-helical protein##2##2##(1993-8#1)(1994-5#1)
alpha-helical structure##2##2##(1995-2#1)(2012-2#1)
alpha-helical##20##1##(1991-12#1)(1993-8#1)(1994-3#1)(1994-5#5)(1995-11#1)(1995-2#5)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
alpha-helices and connecting peptides can be##2##6##(2008-10#2)
alpha-helices and connecting peptides##3##4##(2008-10#3)
alpha-helices and##6##2##(1991-6#1)(2008-10#5)
alpha-helices##9##1##(1991-6#1)(1992-9#1)(1995-12#1)(1995-2#1)(2008-10#5)
alpha-helicity##2##1##(1990-5#1)(1995-11#1)
alpha-helix and##2##2##(2008-9#2)
alpha-helix##11##1##(1993-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-8#1)(2008-9#3)
alpha-hydroxy acid##2##2##(2008-5#2)
alpha-hydroxy acids##3##2##(2008-5#3)
alpha-hydroxy##6##1##(1992-12#1)(2008-5#5)
alpha-hydroxyisobutyric acid (HIBA)##2##3##(2008-10#2)
alpha-hydroxylation##4##1##(1993-11#1)(1995-12#1)(1995-9#2)
alpha-interferon##3##1##(1992-2#1)(2008-7#1)(2011-1#1)
alpha-ketoglutarate (AKG)##2##2##(2007-8#2)
alpha-ketoglutarate##7##1##(2007-8#4)(2008-11#1)(2008-8#2)
alpha-ketoisocaproic acid (KIC)##2##3##(2008-11#2)
alpha-ketoisocaproic acid##3##2##(2008-11#3)
alpha-lactalbumin##7##1##(1994-11#1)(2008-10#3)(2008-7#3)
alpha-linolenic acid##2##2##(2008-10#1)(2010-4#1)
alpha-mannosidase##4##1##(2008-8#4)
alpha-melanocyte-stimulating hormone##2##2##(1996-2#1)(2009-8#1)
alpha-meso##3##1##(1994-5#3)
alpha-naphtholphthalein in poly(isobutyl methacrylate)##2##4##(2008-10#2)
alpha-naphtholphthalein in##4##2##(2008-10#4)
alpha-peptide##2##1##(1991-3#2)
alpha-pinene##6##1##(2008-10#2)(2008-12#2)(2008-3#2)
alpha-sarcin##2##1##(1993-2#2)
alpha-subunit##12##1##(1990-4#1)(1990-5#2)(1991-3#4)(1995-2#1)(1995-6#1)(1996-12#2)(2012-2#1)
alpha-subunits of##2##2##(1990-4#1)(1995-6#1)
alpha-subunits##4##1##(1990-4#2)(1995-6#2)
alpha-synuclein##3##1##(2008-7#3)
alpha-tocopherol and##2##2##(2008-10#1)(2008-5#1)
alpha-tocopherol content in oxidized LDL##2##5##(2009-8#2)
alpha-tocopherol content in##3##3##(1991-12#1)(2009-8#2)
alpha-tocopherol in##2##2##(1991-12#1)(2008-10#1)
alpha-tocopherol##28##1##(1991-12#10)(1992-9#2)(1996-2#5)(2008-10#3)(2008-5#2)(2009-8#6)
alpha-tomatine##5##1##(2008-10#5)
alpha-toxin protein##2##2##(2010-6#2)
alpha-toxin##13##1##(2008-9#1)(2010-6#12)
alpha-trifluoromethyl-beta-alanyl##2##1##(1994-8#2)
alpha-type##2##1##(1994-8#1)(1997-1#1)
alpha/alpha' subunits##2##2##(1992-6#2)
alpha/alpha'##5##1##(1992-6#5)
alpha/beta##4##1##(1993-8#1)(1995-6#1)(1996-2#1)(1996-5#1)
alpha1##4##1##(1997-7#1)(2008-11#1)(2008-7#2)
alpha1c/86D##2##1##(2008-8#2)
alpha2##16##1##(1997-7#2)(2008-11#12)(2008-3#1)(2008-7#1)
alpha2(I) collagen##2##2##(1997-7#2)
alpha2(I)##3##1##(1997-7#3)
alpha2-adrenergic##2##1##(1997-4#2)
alpha2M##5##1##(2008-11#5)
alpha2M/K692##2##1##(2008-11#2)
alpha2M/K696##2##1##(2008-11#2)
alpha3##2##1##(2008-11#2)
alpha5##2##1##(2008-11#2)
alphabet##3##1##(2008-4#1)(2009-12#1)(2013-8#1)
alphabeta##2##1##(2008-4#1)(2008-8#1)
alphacalcidol##3##1##(2008-1#3)
alphanumeric pagers##2##2##(2010-8#2)
alphanumeric paging system##2##3##(2010-8#2)
alphanumeric paging##4##2##(2010-8#4)
alphanumeric##8##1##(2010-8#8)
alpine##3##1##(2009-5#2)(2010-6#1)
already applied##2##2##(2008-10#2)
already at##3##2##(1990-9#1)(2008-5#1)(2013-1#1)
already be found##2##3##(1996-1#1)(2008-7#1)
already be##5##2##(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
already been reported##2##3##(1993-8#1)(2013-8#1)
already been##28##2##(1990-12#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-2#2)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
already demonstrated##2##2##(1993-3#1)(2008-9#1)
already established##6##2##(1996-2#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
already evident##2##2##(1994-8#1)(2008-1#1)
already existing##2##2##(2008-11#1)(2013-7#1)
already formed##2##2##(2013-1#2)
already found##2##2##(1990-6#1)(2008-10#1)
already had##3##2##(1991-9#1)(1996-6#1)(2010-12#1)
already have##5##2##(1993-3#2)(1995-12#1)(1996-2#1)(1996-3#1)
already in clinical##2##3##(2009-7#1)(2012-2#1)
already in##8##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-1#1)(2012-2#1)(2013-8#1)
already influenced##2##2##(1993-11#1)(2011-2#1)
already known##3##2##(2008-12#1)(2011-2#2)
already on the##2##3##(1990-12#1)(1994-3#1)
already on##6##2##(1990-12#1)(1993-1#1)(1994-3#1)(2008-10#1)(2008-3#1)(2009-8#1)
already present in##2##3##(2007-12#1)(2011-2#1)
already present##5##2##(2007-12#1)(2008-4#1)(2008-9#1)(2011-2#2)
already proven##2##2##(2009-10#1)(2012-12#1)
already used##2##2##(2008-10#1)(2012-3#1)
already using##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
already within##2##2##(1994-3#1)(2013-8#1)
already##170##1##(1990-12#4)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-3#3)(1993-8#1)(1994-1#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#4)(1996-3#3)(1996-6#1)(1997-4#1)(1997-6#2)(2006-6#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#22)(2008-11#23)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#13)(2012-12#3)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#4)
also P##2##2##(2008-10#1)(2008-12#1)
also a##50##2##(1990-11#1)(1991-6#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-4#1)(2012-12#1)(2012-2#2)(2012-3#1)
also able to##6##3##(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)
also able##7##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)
also accelerated##2##2##(1993-12#1)(2008-11#1)
also accompanied by##2##3##(2008-10#1)(2008-8#1)
also accumulated##2##2##(1993-8#1)(1995-2#1)
also achieved##7##2##(2008-10#7)
also acquired##2##2##(1993-6#1)(2008-11#1)
also active##2##2##(1993-6#1)(1994-5#1)
also acts##2##2##(1991-6#1)(2013-1#1)
also added to##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
also addressed##7##2##(2008-10#2)(2008-12#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
also addresses the##2##3##(2008-9#1)(2009-10#1)
also admitted##2##2##(1991-2#1)(2010-6#1)
also affect the##8##3##(1990-5#1)(1991-3#1)(1996-2#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
also affect##13##2##(1990-5#1)(1991-3#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
also affected by the##3##4##(1990-6#1)(2008-10#2)
also affected by##6##3##(1990-6#1)(1994-11#1)(2008-10#3)(2011-2#1)
also affected the##4##3##(1993-8#1)(2008-10#2)(2008-8#1)
also affected##20##2##(1990-6#1)(1991-11#1)(1992-5#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(2008-10#8)(2008-11#2)(2008-8#1)(2009-12#1)(2011-2#1)
also affects##5##2##(1995-12#1)(2008-10#2)(2012-2#1)(2013-1#1)
also after##3##2##(2006-6#1)(2008-1#1)(2013-8#1)
also agreed##2##2##(2008-10#1)(2008-11#1)
also aid##2##2##(2008-11#2)
also allow us to##2##4##(2008-11#1)(2010-4#1)
also allow##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
also allowed for##2##3##(2008-10#1)(2008-8#1)
also allowed##10##2##(1996-5#1)(1996-6#1)(2008-10#6)(2008-8#1)(2008-9#1)
also allows a##3##3##(1990-12#1)(1996-6#1)(2008-12#1)
also allows for##2##3##(2008-10#1)(2009-4#1)
also allows##8##2##(1990-12#1)(1991-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-12#1)(2011-2#1)
also alter the##2##3##(1994-6#1)(2008-10#1)
also altered##2##2##(1992-7#1)(1994-3#1)
also an important##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
also an increase in the##3##5##(2007-12#1)(2008-12#1)(2011-2#1)
also an##18##2##(1995-3#1)(1996-8#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
also analysed##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
also analyzed in##3##3##(1997-6#1)(2008-11#1)(2011-2#1)
also analyzed using##2##3##(2008-10#2)
also analyzed##14##2##(1992-2#1)(1994-12#1)(1997-6#2)(2008-10#6)(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#1)
also analyzes##2##2##(1997-3#1)(2010-1#1)
also apparent that##2##3##(2008-12#1)(2011-1#1)
also apparent##4##2##(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)
also appeared to be a##2##5##(1995-11#1)(1995-12#1)
also appeared to be##4##4##(1995-11#1)(1995-12#1)(2008-11#1)(2012-2#1)
also appeared to##5##3##(1995-11#1)(1995-12#1)(2008-11#2)(2012-2#1)
also appeared##6##2##(1995-11#1)(1995-12#1)(2008-11#3)(2012-2#1)
also appears to be##2##4##(2008-10#1)(2008-11#1)
also appears to##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
also applicable for##2##3##(1993-9#1)(2008-10#1)
also applicable to##6##3##(2008-10#1)(2008-11#2)(2008-4#3)
also applicable##8##2##(1993-9#1)(2008-10#2)(2008-11#2)(2008-4#3)
also applied for the##2##4##(2008-10#2)
also applied to##8##3##(2008-10#8)
also applied##15##2##(2008-10#15)
also applies to##5##3##(1992-5#1)(1996-10#1)(2008-4#1)(2008-8#1)(2010-3#1)
also apply to##3##3##(2008-10#1)(2008-4#2)
also apply##5##2##(2008-10#1)(2008-11#1)(2008-4#2)(2013-8#1)
also are##4##2##(1990-12#1)(1992-12#1)(2008-10#2)
also as a##3##3##(2008-10#2)(2008-9#1)
also as##9##2##(1993-2#1)(2008-10#6)(2008-6#1)(2008-9#1)
also asked##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2010-12#1)
also assayed##2##2##(2008-10#1)(2009-10#1)
also assessed##13##2##(1991-8#1)(1994-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-2#1)(2013-1#1)
also assist in##5##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
also associated with an##4##4##(1993-11#1)(2011-2#1)(2013-1#2)
also associated with##26##3##(1990-9#1)(1991-12#1)(1993-11#1)(1996-12#2)(1997-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#5)
also associated##28##2##(1990-9#1)(1991-12#1)(1993-11#1)(1996-12#2)(1997-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#5)
also at the##2##3##(2008-10#2)
also at##11##2##(1990-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-8#1)(2012-3#1)
also available##4##2##(1991-12#1)(1991-3#1)(1996-2#1)(2008-7#1)
also based on##2##3##(1993-11#1)(2008-10#1)
also be a##7##3##(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-6#1)
also be applicable##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
also be applied to monitor##2##5##(1992-3#1)(2010-5#1)
also be applied to##8##4##(1992-3#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)
also be applied##9##3##(1992-3#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)
also be calculated##2##3##(2008-5#1)(2008-7#1)
also be considered as a##2##5##(2008-10#1)(2011-1#1)
also be considered##8##3##(1992-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#2)
also be detected##6##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
also be found##2##3##(2009-9#1)(2010-3#1)
also be influenced by##2##4##(2008-8#1)(2011-2#1)
also be influenced##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
also be inhibited by##2##4##(1995-2#1)(2008-8#1)
also be involved##4##3##(1997-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
also be measured##3##3##(2008-10#1)(2008-8#1)(2010-7#1)
also be observed in the##2##5##(1996-12#1)(2013-7#1)
also be seen##2##3##(2008-10#1)(2008-12#1)
also be the cause of a##2##6##(2008-4#1)(2011-2#1)
also be used for##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
also be used to detect##2##5##(2008-10#1)(2008-4#1)
also be used to determine the##2##6##(1990-12#1)(2008-9#1)
also be used to determine##3##5##(1990-12#1)(2008-10#1)(2008-9#1)
also be used to##14##4##(1990-12#1)(1996-2#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
also be used##24##3##(1990-12#1)(1992-2#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
also be useful for##2##4##(2008-3#1)(2012-12#1)
also be useful##4##3##(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
also be utilized##2##3##(1990-12#1)(2009-10#1)
also be##183##2##(1990-12#3)(1990-9#1)(1991-12#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#2)(1997-3#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#43)(2008-11#9)(2008-12#3)(2008-3#5)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
also became##2##2##(2008-10#1)(2011-1#1)
also because##3##2##(1993-1#1)(1997-1#1)(2008-4#1)
also becomes a##2##3##(2008-11#1)(2013-7#1)
also becoming##3##2##(2008-11#2)(2008-12#1)
also been analyzed##2##3##(1995-6#1)(2012-3#1)
also been compared with##2##4##(2008-10#2)
also been compared##3##3##(2008-10#3)
also been demonstrated##3##3##(2007-11#1)(2008-5#1)(2011-2#1)
also been determined by##2##4##(2008-10#2)
also been determined##4##3##(2008-10#3)(2009-8#1)
also been developed##3##3##(1993-3#1)(2008-10#2)
also been discussed##4##3##(2008-10#4)
also been estimated##2##3##(2008-10#1)(2011-2#1)
also been found##4##3##(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
also been implicated in##3##4##(2009-8#1)(2011-2#1)(2013-8#1)
also been introduced##2##3##(2010-12#1)(2012-2#1)
also been investigated##8##3##(2008-10#5)(2008-3#1)(2010-1#1)(2011-2#1)
also been linked##2##3##(2013-1#2)
also been observed in##3##4##(1994-3#1)(2008-10#1)(2008-11#1)
also been observed##7##3##(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#1)
also been performed##3##3##(2008-10#3)
also been reported to##2##4##(2008-5#1)(2013-8#1)
also been reported##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-8#1)
also been shown to contribute to##2##6##(2008-9#1)(2012-12#1)
also been shown to##11##4##(1993-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-7#1)(2012-12#1)
also been shown##14##3##(1993-8#1)(1994-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-7#1)(2012-12#1)
also been studied##10##3##(2008-10#7)(2008-6#1)(2010-5#1)(2012-2#1)
also been tested##2##3##(2008-10#2)
also been used as##3##4##(2008-10#3)
also been used to##2##4##(2009-10#1)(2013-1#1)
also been used##9##3##(1994-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-10#1)(2013-1#1)
also been##157##2##(1992-2#1)(1993-3#1)(1993-8#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#3)(1995-6#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-7#1)(1997-9#1)(2007-11#1)(2008-10#58)(2008-11#17)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#3)
also beneficial changes in##2##4##(2013-1#2)
also beneficial##3##2##(2008-12#1)(2013-1#2)
also between##2##2##(2008-10#1)(2008-12#1)
also binds a##2##3##(1995-8#2)
also binds to##2##3##(1994-11#1)(1997-7#1)
also binds##6##2##(1994-11#1)(1995-2#1)(1995-8#2)(1997-7#1)(2008-6#1)
also bound to##2##3##(1993-3#1)(2008-11#1)
also briefly##2##2##(2008-11#2)
also by##20##2##(1990-8#2)(1991-2#1)(1992-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(2008-10#8)(2008-11#2)(2008-8#1)(2011-2#2)
also calculated##9##2##(1994-8#1)(1996-3#1)(2008-10#4)(2010-6#1)(2011-2#2)
also called##11##2##(2008-10#2)(2008-12#1)(2008-5#3)(2008-9#2)(2009-10#2)(2013-1#1)
also can be##4##3##(2008-10#3)(2010-8#1)
also can##11##2##(1991-12#1)(1995-12#1)(2008-10#5)(2008-7#1)(2009-9#1)(2010-8#1)(2012-3#1)
also capable of##4##3##(2008-10#3)(2008-6#1)
also capable##5##2##(2008-10#3)(2008-6#1)(2011-2#1)
also carried out for##2##4##(2008-10#1)(2008-11#1)
also carried out##14##3##(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-5#1)
also carried##16##2##(1995-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-5#1)
also cause##9##2##(2006-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#4)
also caused a significant##2##4##(1993-1#1)(2009-8#1)
also caused a##3##3##(1993-1#1)(1994-8#1)(2009-8#1)
also caused##8##2##(1993-1#1)(1994-8#1)(1997-1#1)(2008-11#2)(2008-5#2)(2009-8#1)
also causes an##2##3##(2008-10#2)
also causes##6##2##(1993-11#1)(2008-10#4)(2010-4#1)
also characterized by a##2##4##(2008-5#1)(2013-8#1)
also characterized by##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
also characterized##7##2##(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
also checked##2##2##(2008-10#1)(2012-2#1)
also clarify##2##2##(1997-1#1)(1997-9#1)
also collected##3##2##(2008-10#2)(2012-12#1)
also comments##2##2##(1994-6#1)(2008-10#1)
also common##3##2##(1997-1#1)(1997-3#1)(1997-8#1)
also commonly##2##2##(2008-11#1)(2008-8#1)
also compared the##2##3##(1996-3#1)(2008-11#1)
also compared with the##2##4##(2008-2#2)
also compared with##6##3##(2008-10#3)(2008-2#2)(2011-10#1)
also compared##11##2##(1994-8#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2011-10#1)(2012-12#1)
also completed measures of##2##4##(2008-11#1)(2010-11#1)
also completed##4##2##(2008-11#1)(2008-7#1)(2010-11#1)(2013-8#1)
also completely##2##2##(1994-6#1)(2013-8#1)
also conclude that##2##3##(2008-8#1)(2008-9#1)
also concluded that##2##3##(1991-6#1)(2013-1#1)
also conducted##6##2##(2008-3#2)(2008-5#1)(2013-1#2)(2013-8#1)
also confirmed by the results of##2##6##(1997-4#1)(2008-10#1)
also confirmed by##4##3##(1997-4#1)(2008-10#3)
also confirmed that the##2##4##(2008-11#1)(2008-8#1)
also confirmed that##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
also confirmed##10##2##(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
also conserved##2##2##(1992-3#1)(2010-4#1)
also consider##6##2##(2008-11#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-2#2)
also considered in##2##3##(2008-10#1)(2008-8#1)
also considered##13##2##(1995-12#1)(2008-10#8)(2008-8#1)(2008-9#2)(2011-2#1)
also considers##6##2##(2008-10#1)(2008-11#2)(2008-8#1)(2010-12#1)(2012-2#1)
also consistent with##6##3##(1990-5#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
also contain##6##2##(1991-12#1)(1993-6#1)(2007-12#1)(2008-11#1)(2008-7#1)(2013-1#1)
also contained a##3##3##(2007-12#1)(2008-10#2)
also contained an##3##3##(1993-12#1)(2008-10#2)
also contained##14##2##(1992-6#1)(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-8#1)(2011-2#1)
also containing##2##2##(1990-5#1)(2008-10#1)
also contains a##3##3##(1991-12#1)(1993-3#1)(1995-9#1)
also contains##10##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-9#1)(2008-9#3)(2012-2#1)
also contribute to the##5##4##(1993-2#1)(2010-5#1)(2012-2#3)
also contribute to these##2##4##(1990-11#1)(1991-3#1)
also contribute to##15##3##(1990-11#1)(1991-3#1)(1993-2#1)(1995-2#1)(2008-10#5)(2008-7#1)(2010-5#1)(2012-2#3)(2013-1#1)
also contributed to##2##3##(2008-10#1)(2008-8#1)
also contributes to##3##3##(1992-3#1)(2008-10#2)
also controlled##4##2##(1991-3#1)(1997-3#1)(2008-10#2)
also correctly##2##2##(1995-12#1)(2008-7#1)
also correlated##3##2##(2008-10#3)
also could##3##2##(2008-10#2)(2008-8#1)
also covered##3##2##(1991-1#1)(2011-2#1)(2012-2#1)
also critical##2##2##(2011-2#1)(2013-7#1)
also critically##3##2##(2008-10#2)(2008-12#1)
also deals with##2##3##(1991-6#1)(1995-11#1)
also declined##2##2##(1990-6#1)(2008-7#1)
also decrease##2##2##(1997-1#1)(2011-2#1)
also decreased by##3##3##(1995-2#1)(1996-11#1)(2008-10#1)
also decreased the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
also decreased##9##2##(1990-5#1)(1994-2#1)(1995-2#1)(1996-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
also decreases##2##2##(2008-9#1)(2013-8#1)
also defined##3##2##(1990-11#1)(2009-10#1)(2009-8#1)
also demonstrate a##4##3##(1993-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
also demonstrate that the##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
also demonstrate that##7##3##(1992-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2013-1#1)
also demonstrate the effects of##2##5##(2008-3#1)(2011-2#1)
also demonstrate the utility of##2##5##(2008-5#1)(2012-2#1)
also demonstrate the##7##3##(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)
also demonstrate##23##2##(1992-3#1)(1993-12#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
also demonstrated in the##3##4##(1991-10#1)(1991-5#1)(2008-10#1)
also demonstrated in##6##3##(1991-10#1)(1991-5#1)(2008-10#3)(2008-5#1)
also demonstrated that the##4##4##(2008-10#2)(2008-8#1)(2010-3#1)
also demonstrated that##10##3##(1997-1#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)
also demonstrated##38##2##(1990-5#1)(1991-10#1)(1991-5#1)(1994-3#1)(1995-6#1)(1996-1#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
also demonstrates that##7##3##(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
also demonstrates##9##2##(1995-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
also depend on##2##3##(1992-3#1)(2008-8#1)
also depended on the##2##4##(1997-1#1)(2008-9#1)
also dependent on##2##3##(2008-10#1)(2008-5#1)
also depends##2##2##(2008-10#2)
also derived##3##2##(2008-2#1)(2008-3#2)
also describe a##2##3##(1994-3#1)(2012-2#1)
also describe##9##2##(1994-3#1)(1995-1#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
also described the##2##3##(2008-10#1)(2012-3#1)
also described##27##2##(1992-1#1)(1994-2#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-4#3)(2008-9#1)(2009-9#1)(2010-11#1)(2012-3#2)(2013-1#2)
also describes the##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
also describes##9##2##(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
also detected in the##8##4##(1993-3#1)(1996-12#2)(2008-10#2)(2008-8#1)(2009-12#1)(2010-5#1)
also detected in##16##3##(1993-3#1)(1996-12#4)(2008-10#6)(2008-5#1)(2008-8#1)(2009-12#1)(2010-5#1)(2012-2#1)
also detected##37##2##(1993-3#1)(1994-11#1)(1996-12#4)(1996-2#1)(1997-2#1)(2006-6#1)(2008-10#19)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
also determined by##4##3##(1992-9#1)(2008-10#3)
also determined##34##2##(1992-9#1)(1993-8#1)(2008-10#24)(2008-11#3)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
also determines##2##2##(1991-12#1)(2011-2#1)
also develop##2##2##(2008-10#1)(2011-2#1)
also developed a##3##3##(1992-12#1)(2008-10#1)(2008-8#1)
also developed for##4##3##(2008-10#4)
also developed to##4##3##(1992-3#1)(2008-10#3)
also developed##16##2##(1992-12#1)(1992-3#1)(2008-10#11)(2008-3#1)(2008-8#1)(2011-2#1)
also diagnosed##2##2##(2011-2#2)
also did not##5##3##(1990-7#1)(1994-2#1)(1995-2#1)(2008-11#2)
also differ in##2##3##(1995-12#1)(2008-8#1)
also differ##5##2##(1995-12#1)(1996-12#1)(2008-11#1)(2008-8#2)
also differed##3##2##(2008-10#2)(2008-12#1)
also different##3##2##(2008-10#1)(2008-7#2)
also directly##2##2##(2011-2#2)
also discuss a##2##3##(2008-3#1)(2013-8#1)
also discuss the##13##3##(1992-5#1)(1993-12#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-8#2)(2010-7#1)(2013-8#1)
also discuss##29##2##(1992-5#1)(1993-12#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-8#3)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
also discussed in this paper##2##5##(2008-10#1)(2008-11#1)
also discussed in this##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
also discussed in##8##3##(2008-10#5)(2008-11#1)(2008-6#1)(2010-7#1)
also discussed##94##2##(1991-12#1)(1991-2#1)(1991-8#1)(1993-3#1)(1995-2#1)(1995-3#2)(2007-12#1)(2008-10#41)(2008-11#4)(2008-3#4)(2008-4#4)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#4)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-7#3)(2010-8#1)(2011-3#2)(2011-7#2)(2012-12#1)(2012-2#1)(2013-8#3)
also discusses how to##2##4##(2008-4#2)
also discusses the##3##3##(1990-6#1)(2009-10#1)(2013-1#1)
also discusses##13##2##(1990-6#1)(1991-12#1)(1996-9#1)(2008-1#1)(2008-4#4)(2009-10#1)(2009-5#1)(2013-1#1)(2013-8#2)
also display##2##2##(2008-10#1)(2013-1#1)
also displayed##3##2##(1990-6#1)(1993-12#1)(2009-10#1)
also displays##2##2##(1990-5#1)(1995-2#1)
also do not##2##3##(2008-10#2)
also do##3##2##(1992-11#1)(2008-10#2)
also done##3##2##(1992-6#1)(2008-5#2)
also effective against##2##3##(1997-4#1)(2008-10#1)
also effective in reducing##2##4##(1990-5#1)(2008-3#1)
also effective in##4##3##(1990-5#1)(1994-8#1)(2008-11#1)(2008-3#1)
also effective##7##2##(1990-5#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
also effectively##4##2##(1994-1#1)(2008-10#2)(2009-7#1)
also elicited a##2##3##(2008-10#2)
also eliminated##2##2##(2008-10#1)(2008-11#1)
also elucidated##2##2##(2008-10#2)
also emphasized the##2##3##(1990-3#1)(1991-6#1)
also emphasizes##2##2##(2009-8#1)(2013-1#1)
also employed to##2##3##(1993-8#1)(2008-10#1)
also employed##4##2##(1993-8#1)(1997-3#1)(2008-10#1)(2009-3#1)
also enhance##2##2##(2008-5#1)(2008-8#1)
also enhanced the##4##3##(1994-11#2)(1995-6#1)(2008-11#1)
also enhanced##12##2##(1994-11#2)(1994-8#1)(1995-11#1)(1995-6#1)(1997-4#1)(2008-10#3)(2008-11#3)
also enhances##2##2##(2008-10#1)(2013-1#1)
also essential for##3##3##(1995-6#1)(2008-11#1)(2008-7#1)
also essential##6##2##(1995-6#1)(1997-1#1)(2008-11#1)(2008-7#2)(2010-7#1)
also evaluated##32##2##(1990-9#1)(1997-8#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-3#1)
also evidence##5##2##(2008-11#2)(2008-9#1)(2010-5#1)(2013-1#1)
also evidenced##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
also evident at##2##3##(2008-5#1)(2013-1#1)
also evident##9##2##(1990-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2013-1#1)
also evolve##2##2##(2008-10#1)(2008-6#1)
also evolved##3##2##(1997-3#1)(2008-8#1)(2010-6#1)
also examine##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
also examined and##2##3##(1994-11#1)(2008-10#1)
also examined for the##2##4##(2008-10#1)(2009-12#1)
also examined for##3##3##(2008-10#2)(2009-12#1)
also examined in the##3##4##(1993-1#1)(1997-8#1)(2008-10#1)
also examined in##4##3##(1993-1#1)(1997-8#1)(2008-10#1)(2011-2#1)
also examined protein kinase C (PKC)##2##6##(1992-8#1)(2008-11#1)
also examined the##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
also examined##44##2##(1991-3#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-11#1)(1995-11#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#20)(2008-11#5)(2008-12#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#3)
also excellent##2##2##(2008-11#1)(2012-3#1)
also exhibit##6##2##(1997-2#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)
also exhibited a##2##3##(2008-10#1)(2011-2#1)
also exhibited##13##2##(1990-5#2)(1992-9#1)(1994-5#1)(2008-10#8)(2011-2#1)
also exhibits##2##2##(2008-10#1)(2008-11#1)
also exists##6##2##(1991-3#1)(1994-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
also explain##2##2##(2008-10#1)(2013-8#1)
also explore##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
also explored##9##2##(1992-1#1)(1992-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-9#1)
also explores##2##2##(1996-3#1)(2008-10#1)
also exposed to##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
also exposed##4##2##(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
also expressed in##4##3##(1995-11#1)(1995-2#1)(2008-8#1)(2008-9#1)
also expressed##8##2##(1992-9#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)
also facilitate the##3##3##(2008-9#1)(2010-10#1)(2012-3#1)
also facilitate##5##2##(2008-9#1)(2009-11#1)(2010-10#1)(2012-3#2)
also failed to##3##3##(1994-5#1)(2008-5#1)(2009-9#1)
also favored##2##2##(1990-8#1)(2008-8#1)
also features a##2##3##(2008-10#1)(2008-9#1)
also find that##3##3##(1995-11#1)(2008-3#1)(2011-2#1)
also find##5##2##(1995-11#1)(2008-10#1)(2008-3#1)(2009-7#1)(2011-2#1)
also focus on##2##3##(2008-10#1)(2008-2#1)
also followed during the##2##4##(2008-10#2)
also followed##3##2##(1994-5#1)(2008-10#2)
also for other##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
also for the##3##3##(1997-8#1)(2013-1#1)(2013-8#1)
also for##30##2##(1991-2#1)(1991-6#1)(1993-3#1)(1993-8#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-7#3)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
also formed##4##2##(1997-3#1)(2008-10#2)(2008-12#1)
also found for the##3##4##(1995-6#1)(2008-10#2)
also found for##5##3##(1995-6#1)(2008-10#3)(2008-3#1)
also found in the##2##4##(2008-10#1)(2008-11#1)
also found in##15##3##(1994-5#1)(1995-9#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-3#1)
also found no##2##3##(2008-11#1)(2013-1#1)
also found that the addition of##2##6##(2008-10#1)(2008-5#1)
also found that the##10##4##(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)
also found that##32##3##(1994-11#1)(1994-3#1)(1995-2#1)(1996-5#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
also found the##2##3##(1990-12#1)(2010-7#1)
also found to be##9##4##(1992-12#1)(1996-3#1)(1997-1#1)(2008-10#2)(2009-10#1)(2012-2#3)
also found to##18##3##(1990-5#1)(1992-12#1)(1995-6#1)(1996-3#2)(1997-1#2)(2008-10#3)(2008-11#1)(2009-10#1)(2009-12#1)(2011-2#2)(2012-2#3)
also found##102##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#2)(1994-11#2)(1994-3#2)(1994-5#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#30)(2008-11#6)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
also from##7##2##(1994-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
also fully##2##2##(2008-10#1)(2008-11#1)
also functions##2##2##(2008-11#1)(2009-7#1)
also gave##6##2##(2008-10#4)(2008-2#1)(2008-5#1)
also generates##3##2##(1993-2#1)(1995-2#1)(2008-10#1)
also give##2##2##(2008-5#1)(2008-8#1)
also given##9##2##(1992-9#1)(2008-10#4)(2008-11#1)(2008-4#2)(2011-2#1)
also gives##4##2##(1990-2#1)(1994-3#1)(1995-6#1)(2008-10#1)
also greater##4##2##(1993-8#1)(1995-1#1)(2008-10#2)
also greatly##2##2##(2008-10#1)(2008-8#1)
also had a significant##2##4##(2008-10#1)(2011-10#1)
also had a##7##3##(1991-5#1)(1995-2#1)(1996-8#1)(2008-10#2)(2009-4#1)(2011-10#1)
also had an##2##3##(2008-10#1)(2009-1#1)
also had reduced##2##3##(2008-7#1)(2008-9#1)
also had the##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
also had##29##2##(1991-5#1)(1992-8#1)(1993-3#1)(1995-2#2)(1996-8#1)(1997-3#2)(2008-10#9)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#2)(2009-4#1)(2010-4#1)(2011-10#1)(2012-7#1)(2013-1#1)
also has a##8##3##(1990-5#1)(1992-3#1)(1992-9#1)(1995-2#1)(1996-6#1)(2008-4#1)(2008-9#1)(2009-3#1)
also has an##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
also has been##4##3##(2008-10#1)(2008-9#1)(2009-6#1)(2011-3#1)
also has the##3##3##(1990-7#1)(2008-10#1)(2013-1#1)
also has##23##2##(1990-5#1)(1990-7#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-2#1)(1996-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#3)(2009-3#1)(2009-6#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
also have a role##2##4##(2008-5#1)(2011-2#1)
also have a##6##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
also have an##4##3##(1995-6#1)(2008-10#1)(2008-5#1)(2012-3#1)
also have demonstrated that##2##4##(2008-10#1)(2013-1#1)
also have significant##2##3##(2008-6#1)(2013-1#1)
also have##34##2##(1991-3#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-8#1)(2008-9#2)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
also help to##2##3##(2008-9#1)(2009-10#1)
also help##6##2##(1994-12#1)(2008-8#1)(2008-9#2)(2009-10#2)
also helpful##2##2##(1994-12#1)(2011-1#1)
also high##2##2##(2009-10#1)(2012-3#1)
also higher##5##2##(1994-6#1)(2008-10#1)(2008-8#1)(2010-6#1)(2013-1#1)
also highest##2##2##(2008-11#1)(2009-7#1)
also highlight the##2##3##(2008-1#1)(2012-2#1)
also highlight##3##2##(2008-1#1)(2008-9#1)(2012-2#1)
also highlighted the##2##3##(2008-11#2)
also highlighted##5##2##(2008-10#1)(2008-11#2)(2010-1#1)(2013-1#1)
also highlights the importance of##2##5##(2007-12#1)(2009-3#1)
also highlights the##3##3##(2007-12#1)(2009-3#1)(2011-2#1)
also highlights##7##2##(1997-2#1)(2007-12#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-7#1)
also highly##7##2##(1990-2#1)(1991-2#1)(1995-2#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
also identified as##2##3##(1995-9#1)(2008-1#1)
also identified in the##2##4##(2008-10#1)(2009-6#1)
also identified in##3##3##(2008-10#2)(2009-6#1)
also identified the##3##3##(2008-10#3)
also identified##22##2##(1993-6#1)(1995-2#1)(1995-9#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
also identifies##2##2##(1997-1#1)(2010-10#1)
also identify##2##2##(2008-11#1)(2013-8#1)
also illustrated##2##2##(1994-2#1)(2008-12#1)
also implemented##2##2##(2010-8#1)(2012-3#1)
also implicated##4##2##(1994-9#1)(1996-11#1)(2008-10#1)(2010-10#1)
also important in##2##3##(2008-6#1)(2008-9#1)
also important##13##2##(1992-3#1)(1993-6#1)(1994-5#1)(1995-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)
also improved the##2##3##(2008-10#1)(2008-11#1)
also improved##8##2##(1996-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
also improves the selectivities##2##4##(2008-10#2)
also improves the##4##3##(2008-10#3)(2008-12#1)
also in a##3##3##(2008-10#3)
also in other##3##3##(1997-6#1)(2008-11#1)(2012-2#1)
also in our##2##3##(1995-5#1)(2008-5#1)
also in preventing##2##3##(1992-12#1)(2008-11#1)
also in the presence of##4##5##(2008-10#4)
also in the##23##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-6#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#4)(2009-3#1)(2010-3#1)(2011-2#2)(2012-3#1)
also in##88##2##(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-6#2)(1993-6#1)(1994-11#2)(1994-8#1)(1995-5#2)(1995-6#1)(1996-2#1)(1997-1#2)(1997-6#1)(1997-8#3)(2008-10#20)(2008-11#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#1)
also include##5##2##(1996-2#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
also included in the study##2##5##(2008-10#1)(2008-5#1)
also included in the##4##4##(1996-3#1)(2008-10#2)(2008-5#1)
also included##28##2##(1991-1#1)(1993-1#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-8#1)
also includes a##2##3##(1996-3#1)(2007-11#1)
also includes##8##2##(1992-12#1)(1993-9#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-9#1)
also increase the##2##3##(2008-9#1)(2013-1#1)
also increase##5##2##(1991-8#1)(1994-5#1)(1995-12#1)(2008-9#1)(2013-1#1)
also increased in the##2##4##(1996-11#1)(1996-12#1)
also increased linearly##2##3##(2008-10#1)(2008-11#1)
also increased the##10##3##(1993-6#2)(1995-8#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-8#1)
also increased##39##2##(1991-12#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-3#1)(2006-6#1)(2008-10#6)(2008-11#5)(2008-8#2)(2008-9#3)(2009-7#1)(2011-1#1)(2011-2#2)
also increases the##3##3##(1994-5#1)(1995-11#1)(2011-2#1)
also increases with##2##3##(1995-3#1)(2008-10#1)
also increases##6##2##(1994-5#1)(1995-11#1)(1995-3#1)(2008-10#2)(2011-2#1)
also increasing the##2##3##(2008-10#1)(2008-7#1)
also increasing##5##2##(1995-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
also indicate that the##3##4##(1993-6#1)(1996-2#1)(2008-3#1)
also indicate that##10##3##(1993-6#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)
also indicate the##2##3##(2008-10#1)(2013-1#1)
also indicate##15##2##(1993-6#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
also indicated a##2##3##(2008-10#1)(2011-1#1)
also indicated that the##6##4##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#2)
also indicated that##12##3##(1991-6#1)(2008-10#5)(2008-12#1)(2008-8#2)(2008-9#2)(2010-8#1)
also indicated the##2##3##(2008-10#1)(2011-2#1)
also indicated##19##2##(1991-6#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
also indicates that the##2##4##(1992-9#1)(2008-10#1)
also indicates##4##2##(1992-9#1)(2008-10#1)(2008-12#1)(2008-9#1)
also indicating##2##2##(2008-10#2)
also induce##4##2##(1995-5#1)(2008-7#1)(2008-8#1)(2011-10#1)
also induced an##2##3##(1991-12#1)(2008-12#1)
also induced by##4##3##(1991-5#1)(1993-8#1)(1997-7#1)(2008-11#1)
also induced##11##2##(1991-12#1)(1991-5#1)(1993-8#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-12#1)
also induces##2##2##(1997-4#1)(2008-11#1)
also infected##2##2##(2008-10#2)
also influence the##5##3##(1997-1#1)(2006-6#1)(2008-11#1)(2008-6#1)(2010-6#1)
also influence##8##2##(1997-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-6#1)
also influenced by the##2##4##(1994-5#1)(2009-6#1)
also influences##2##2##(1990-8#1)(2008-7#1)
also inhibited by##10##3##(1990-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
also inhibited the##7##3##(1995-11#1)(1995-2#1)(2008-10#3)(2008-11#2)
also inhibited##29##2##(1990-5#1)(1993-6#1)(1993-8#1)(1994-8#3)(1995-11#2)(1995-2#1)(1995-8#1)(1996-2#1)(2006-6#2)(2008-10#4)(2008-11#4)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
also inhibits##5##2##(1991-6#2)(1997-4#1)(1997-7#1)(2008-8#1)
also introduce##2##2##(1995-9#1)(2008-7#1)
also introduced##2##2##(2010-1#1)(2012-3#1)
also introduces##2##2##(1994-12#1)(2010-8#1)
also investigate the##4##3##(2008-10#1)(2008-8#2)(2012-2#1)
also investigate##6##2##(2008-10#1)(2008-6#1)(2008-8#3)(2012-2#1)
also investigated and##5##3##(2008-10#3)(2008-12#1)(2008-3#1)
also investigated by##3##3##(2008-10#3)
also investigated for##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
also investigated in##2##3##(1992-6#1)(2008-10#1)
also investigated the##6##3##(1994-6#1)(2008-10#3)(2008-3#1)(2008-5#1)
also investigated##74##2##(1992-3#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-10#48)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#3)(2010-4#1)(2011-3#1)
also involve##6##2##(1997-3#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)
also involved in the##5##4##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
also involved in##9##3##(1996-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-3#2)(2013-8#1)
also involved##13##2##(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-2#2)(2012-3#2)(2013-8#1)
also involves##2##2##(1993-6#1)(2008-5#1)
also is##5##2##(1996-2#1)(2008-10#4)
also isolated##5##2##(1993-2#1)(1993-6#2)(2008-10#1)(2008-5#1)
also it##3##2##(1995-1#1)(2008-10#1)(2008-12#1)
also its##4##2##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
also itself##2##2##(1991-6#1)(2012-3#1)
also known as &quot##2##4##(2009-5#1)(2010-4#1)
also known as##27##3##(1993-12#1)(1995-6#1)(1996-2#2)(2008-10#5)(2008-11#1)(2008-9#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
also known to##3##3##(1990-5#1)(2008-11#1)(2012-2#1)
also known##31##2##(1990-5#1)(1993-12#1)(1995-6#1)(1996-2#2)(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#2)
also laid##2##2##(1997-5#1)(2008-10#1)
also largely##3##2##(2008-1#1)(2010-12#1)(2013-1#1)
also lead to##4##3##(2008-8#1)(2010-10#1)(2013-8#2)
also leads to##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
also led to a##2##4##(2008-3#1)(2011-10#1)
also led to##6##3##(1991-10#1)(2008-10#3)(2008-3#1)(2011-10#1)
also less##3##2##(2008-10#2)(2011-2#1)
also likely to##2##3##(2008-5#1)(2008-7#1)
also likely##3##2##(2008-5#1)(2008-7#1)(2009-8#1)
also limited##2##2##(2008-9#1)(2012-2#1)
also lists##2##2##(1997-2#1)(2008-4#1)
also looks at##2##3##(1991-1#1)(2008-1#1)
also lower in##2##3##(2009-7#1)(2013-1#1)
also lower##3##2##(2008-9#1)(2009-7#1)(2013-1#1)
also made to##2##3##(2009-5#1)(2011-2#1)
also made##8##2##(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
also maintained##2##2##(2008-10#1)(2012-2#1)
also make##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
also makes it##4##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#1)
also makes the##2##3##(2008-10#1)(2008-8#1)
also makes##7##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2013-1#1)
also marked##2##2##(1994-5#1)(2012-3#1)
also markedly##2##2##(1997-1#1)(2008-11#1)
also may be##4##3##(1991-5#1)(2008-10#2)(2010-7#1)
also may##12##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-7#1)(2013-1#2)
also measured and##2##3##(2008-10#1)(2011-2#1)
also measured using##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
also measured##30##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1997-3#1)(2006-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#2)
also mentioned##2##2##(2011-2#1)(2012-3#1)
also modified##2##2##(2008-10#1)(2008-9#1)
also monitored##2##2##(1990-12#1)(2008-10#1)
also more##8##2##(1991-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#1)(2009-11#1)
also necessary##3##2##(2008-5#1)(2008-9#1)(2009-8#1)
also need to be##2##4##(2012-2#1)(2013-1#1)
also need to##5##3##(1997-1#1)(2008-12#1)(2012-2#1)(2013-1#2)
also no##6##2##(2008-10#1)(2008-8#2)(2009-10#1)(2009-3#1)(2011-2#1)
also normalized##2##2##(2011-2#2)
also not##10##2##(1993-6#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
also noted##9##2##(1990-3#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-8#1)(2010-7#2)(2013-1#1)
also noticed that##2##3##(2008-5#1)(2011-2#1)
also noticed##5##2##(1997-8#1)(2008-12#1)(2008-5#1)(2011-2#2)
also observed for##3##3##(1992-6#1)(1997-3#1)(2008-9#1)
also observed in the##8##4##(1991-12#1)(1995-6#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)
also observed in##21##3##(1991-12#1)(1991-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
also observed that##8##3##(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-3#1)
also observed within##3##3##(1991-12#1)(2008-10#2)
also observed##65##2##(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-5#2)(1995-12#2)(1995-6#2)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#18)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
also obtained from##5##3##(1992-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
also obtained##16##2##(1992-12#1)(1994-11#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#2)
also occur in##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
also occur through##3##3##(1995-6#1)(2008-10#2)
also occur##13##2##(1995-6#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2013-7#1)
also occurred##4##2##(2007-12#1)(2008-10#2)(2008-9#1)
also occurs in##2##3##(2007-12#1)(2008-7#1)
also occurs##3##2##(2007-12#1)(2008-7#1)(2012-2#1)
also of interest to##2##4##(1993-11#1)(2008-10#1)
also of interest##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
also of the##9##3##(1993-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)
also of##19##2##(1990-2#1)(1993-11#1)(1993-2#1)(1993-6#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#4)(2012-3#1)
also offered##2##2##(1997-4#1)(2008-12#1)
also offers##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
also on its##4##3##(1991-2#2)(2008-10#1)(2008-5#1)
also on the##3##3##(1995-11#1)(2008-10#1)(2010-12#1)
also on##14##2##(1991-2#2)(1995-11#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
also optimized for##2##3##(2008-10#2)
also optimized##4##2##(2008-10#4)
also other##3##2##(2008-5#1)(2010-8#1)(2013-1#1)
also outline##2##2##(1991-3#1)(2010-12#1)
also partially##2##2##(1996-5#1)(2008-11#1)
also participate in##2##3##(2011-1#1)(2011-2#1)
also participated in##3##3##(2008-11#2)(2010-4#1)
also penetrated##2##2##(2008-10#2)
also perceived##2##2##(2009-7#1)(2012-3#1)
also performed in##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
also performed##23##2##(1991-5#1)(1994-5#2)(1994-8#1)(1996-1#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
also permits the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
also permits##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
also placed##2##2##(2008-11#1)(2010-3#1)
also play a role in the##3##6##(1995-8#1)(1997-3#1)(2009-1#1)
also play a role##4##4##(1995-8#1)(1997-3#1)(2009-1#1)(2009-10#1)
also play a##7##3##(1995-8#1)(1997-3#1)(2008-7#1)(2009-1#1)(2009-10#1)(2011-1#1)(2011-2#1)
also play an important role in the##3##7##(1996-3#1)(2008-10#2)
also play an important role in##5##6##(1994-11#1)(1996-3#1)(2008-10#2)(2008-2#1)
also play an##6##3##(1994-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
also play##13##2##(1994-11#1)(1995-8#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-10#1)(2011-1#1)(2011-2#1)
also played##5##2##(1990-9#1)(1995-5#1)(2008-1#1)(2008-11#1)(2012-2#1)
also plays a##2##3##(1993-9#1)(1997-8#1)
also possess a##2##3##(2008-10#1)(2010-5#1)
also possess the##2##3##(2008-9#2)
also possess##8##2##(1993-12#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-9#2)(2010-5#1)
also possible in##2##3##(2008-11#1)(2008-9#1)
also possible to##7##3##(1997-4#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)
also possible##11##2##(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)
also potent##2##2##(1991-9#1)(2013-8#1)
also potentially##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
also potentiated##3##2##(1990-5#1)(1990-7#1)(1997-4#1)
also predict##2##2##(1997-6#1)(2008-8#1)
also predicted##3##2##(1997-6#1)(1997-8#1)(2008-8#1)
also predicts##3##2##(1995-6#1)(2008-3#1)(2008-8#1)
also prepared##3##2##(1992-12#1)(1993-8#1)(2008-10#1)
also present an##2##3##(2008-10#1)(2010-1#1)
also present as##2##3##(2008-10#1)(2013-1#1)
also present in the##4##4##(1990-5#1)(1994-9#1)(2007-12#1)(2008-10#1)
also present in##12##3##(1990-5#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-7#1)
also present##28##2##(1990-5#1)(1991-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
also presented for the##2##4##(1993-8#1)(2008-10#1)
also presented for##3##3##(1991-2#1)(1993-8#1)(2008-10#1)
also presented in##3##3##(2008-10#3)
also presented that##3##3##(1993-6#1)(1995-6#1)(2008-4#1)
also presented##43##2##(1991-2#1)(1993-6#1)(1993-8#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#19)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
also presents an##2##3##(1995-9#1)(2008-12#1)
also presents##6##2##(1991-3#1)(1995-9#1)(1996-1#1)(2008-12#1)(2008-9#1)(2010-11#1)
also prevent the##2##3##(2008-10#1)(2008-8#1)
also prevent##6##2##(1993-2#1)(2008-10#1)(2008-8#2)(2009-8#1)(2013-1#1)
also prevented the##2##3##(1991-7#1)(2008-11#1)
also prevented##6##2##(1991-12#1)(1991-7#1)(1994-2#1)(1994-8#1)(1997-1#1)(2008-11#1)
also produce##4##2##(1993-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
also produced by##2##3##(1995-12#1)(2008-11#1)
also produced##11##2##(1990-10#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#1)
also produces an##2##3##(1995-3#1)(2008-10#1)
also produces##6##2##(1995-3#1)(2008-10#3)(2008-7#1)(2008-9#1)
also promote##2##2##(2008-11#2)
also promotes##3##2##(1990-5#1)(2008-7#1)(2009-10#1)
also proposed##14##2##(1994-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2009-11#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
also proposes##2##2##(1991-12#1)(2008-10#1)
also protect against##2##3##(1991-6#1)(1994-3#1)
also protect##3##2##(1991-6#1)(1994-3#1)(2011-2#1)
also proved to be##2##4##(2008-10#2)
also proved useful in##2##4##(1992-9#1)(2008-10#1)
also proved useful##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
also proved##6##2##(1992-9#1)(2008-10#3)(2008-11#1)(2012-3#1)
also provide a##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
also provide an##4##3##(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
also provide insight into##2##4##(2009-8#2)
also provide##19##2##(1992-3#1)(1993-3#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-8#2)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
also provided for##5##3##(2007-9#1)(2008-4#3)(2010-10#1)
also provided support##2##3##(2008-12#1)(2010-4#1)
also provided##25##2##(1995-2#1)(2007-9#1)(2008-10#4)(2008-12#3)(2008-2#1)(2008-4#8)(2008-5#1)(2008-9#2)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#1)
also provides a conceptual##2##4##(2008-8#1)(2013-8#1)
also provides a##11##3##(1992-9#1)(1993-3#1)(1997-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
also provides an##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
also provides##22##2##(1992-9#1)(1993-3#1)(1995-12#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
also purified##2##2##(2008-8#1)(2009-8#1)
also quantify##3##2##(1996-3#1)(2008-3#1)(2008-8#1)
also rapidly##2##2##(1994-3#1)(2008-11#1)
also rated##2##2##(2010-12#1)(2012-2#1)
also reacted##2##2##(1994-3#1)(2008-10#1)
also receive##2##2##(1996-2#1)(2008-7#1)
also received##2##2##(2008-7#1)(2010-11#1)
also recently##2##2##(1994-11#1)(2010-11#1)
also recommended##2##2##(2008-12#1)(2013-1#1)
also reduce the##2##3##(1994-9#1)(1996-11#1)
also reduce##9##2##(1994-9#1)(1996-11#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
also reduced in##2##3##(1990-12#1)(2008-10#1)
also reduced the##6##3##(1991-5#1)(2008-10#3)(2008-11#1)(2011-1#1)
also reduced##15##2##(1990-12#1)(1991-5#1)(1996-2#1)(2008-10#10)(2008-11#1)(2011-1#1)
also reflect##2##2##(2008-11#1)(2008-8#1)
also reflected##3##2##(1991-12#1)(2008-10#2)
also registered##3##2##(1993-2#1)(1996-12#1)(2008-5#1)
also regulates##2##2##(2008-4#1)(2012-3#1)
also related to##2##3##(2008-10#1)(2008-7#1)
also relatively high##2##3##(1991-6#1)(2010-6#1)
also relatively##4##2##(1991-6#1)(1995-6#1)(2007-12#1)(2010-6#1)
also release##2##2##(2008-10#1)(2008-8#1)
also released##4##2##(1994-8#1)(1997-1#1)(2008-10#2)
also remains##3##2##(1996-2#1)(1997-3#1)(2012-12#1)
also remarkably##2##2##(2008-10#2)
also removes##2##2##(2008-10#1)(2011-2#1)
also report##8##2##(1990-11#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
also reported by others##2##4##(1993-8#1)(2011-2#1)
also reported for##2##3##(1993-1#1)(2011-2#1)
also reported##22##2##(1990-5#1)(1991-5#1)(1992-9#1)(1993-1#2)(1993-8#1)(2008-10#9)(2008-11#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
also require##4##2##(2008-11#1)(2009-8#1)(2012-2#1)(2013-8#1)
also required for the##2##4##(2010-11#1)(2013-7#1)
also required for##4##3##(1995-2#1)(2008-10#1)(2010-11#1)(2013-7#1)
also required##9##2##(1992-6#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-6#1)(2010-11#1)(2010-9#1)(2013-7#1)
also requires##2##2##(1996-12#1)(2008-11#1)
also resistant to##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
also resistant##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
also respond##2##2##(1993-11#1)(2008-4#1)
also responded to##4##3##(1991-2#1)(1992-12#1)(1992-6#1)(2008-8#1)
also responsible for##5##3##(1990-8#1)(1996-1#1)(2008-10#2)(2010-5#1)
also result from##2##3##(2007-12#1)(2008-7#1)
also result in a##2##4##(2008-11#1)(2013-1#1)
also result in##4##3##(2008-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
also result##6##2##(2007-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
also resulted in a##2##4##(2008-10#1)(2008-7#1)
also resulted in##11##3##(1990-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)
also results in##3##3##(1991-2#1)(2008-9#1)(2011-2#1)
also reveal##4##2##(2008-10#2)(2010-2#1)(2011-2#1)
also revealed an##2##3##(2008-8#1)(2012-2#1)
also revealed that##6##3##(1993-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
also revealed the presence of a##2##6##(2008-10#1)(2013-1#1)
also revealed the##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
also revealed##18##2##(1991-1#1)(1992-3#1)(1993-2#1)(2008-10#4)(2008-12#2)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
also reveals##3##2##(1993-2#1)(2009-12#1)(2012-3#1)
also reversed##2##2##(2007-11#1)(2008-10#1)
also review the##2##3##(1990-2#1)(1994-12#1)
also review##4##2##(1990-2#1)(1994-12#1)(2008-12#1)(2008-8#1)
also reviewed##9##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
also reviews the##3##3##(1991-2#1)(1995-2#1)(2008-2#1)
also reviews various##2##3##(1991-12#1)(2013-1#1)
also reviews##5##2##(1991-12#1)(1991-2#1)(1995-2#1)(2008-2#1)(2013-1#1)
also seems##2##2##(1990-2#1)(2011-2#1)
also seen in the##3##4##(1991-10#1)(1996-12#1)(2008-7#1)
also seen in##7##3##(1991-10#1)(1991-11#1)(1995-11#1)(1996-12#1)(2008-7#1)(2009-12#1)(2009-9#1)
also seen##10##2##(1991-10#1)(1991-11#1)(1994-6#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-7#1)(2009-12#1)(2009-9#1)
also separated##3##2##(2008-10#2)(2008-9#1)
also sequenced##4##2##(1993-6#1)(1995-12#1)(2008-10#1)(2008-12#1)
also serve as##6##3##(1995-3#1)(2008-6#1)(2010-8#4)
also serve##8##2##(1990-11#1)(1995-3#1)(2008-11#1)(2008-6#1)(2010-8#4)
also served as a##2##4##(2008-10#1)(2013-1#1)
also served as##3##3##(2008-10#2)(2013-1#1)
also served to##2##3##(2008-1#1)(2008-10#1)
also served##6##2##(2008-1#1)(2008-10#3)(2008-11#1)(2013-1#1)
also serves to##3##3##(1994-2#1)(2008-3#1)(2013-1#1)
also serves##4##2##(1994-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
also share##2##2##(1992-3#1)(2009-10#1)
also shared##2##2##(1993-2#1)(2008-10#1)
also show a##2##3##(1991-3#1)(1992-5#1)
also show major##2##3##(1991-3#1)(1997-2#1)
also show that the##10##4##(1992-9#1)(2008-10#1)(2008-12#1)(2008-3#3)(2012-2#1)(2012-3#1)(2013-1#2)
also show that##30##3##(1991-12#1)(1991-5#1)(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#1)(1997-7#1)(1997-9#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
also show##42##2##(1991-12#1)(1991-3#2)(1991-5#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-7#1)(1997-9#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#2)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
also showed a##9##3##(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#2)(2011-3#1)(2012-2#1)
also showed significantly##2##3##(2008-10#1)(2013-1#1)
also showed that the##6##4##(1990-12#1)(2008-10#3)(2008-7#1)(2008-8#1)
also showed that this##2##4##(2008-5#2)
also showed that##16##3##(1990-12#1)(1992-9#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)
also showed the##2##3##(2008-10#1)(2009-8#1)
also showed##60##2##(1990-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
also showing##2##2##(1991-10#1)(2012-2#1)
also shown that the##2##4##(2008-10#1)(2008-3#1)
also shown that##9##3##(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-7#1)
also shown to be##7##4##(1991-5#1)(1992-3#1)(2008-10#1)(2010-5#2)(2010-7#1)(2012-3#1)
also shown to##16##3##(1991-10#1)(1991-5#2)(1992-3#1)(1992-6#1)(1995-2#1)(1996-6#1)(2008-10#3)(2008-7#1)(2010-5#2)(2010-7#1)(2012-2#1)(2012-3#1)
also shown##32##2##(1991-10#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-11#1)(1995-2#1)(1996-6#1)(2007-11#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-7#1)(2012-2#1)(2012-3#2)
also shows a strong##2##4##(2008-3#1)(2008-8#1)
also shows a##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
also shows that the##2##4##(2008-10#1)(2010-7#1)
also shows that##5##3##(2008-10#1)(2008-11#1)(2010-7#1)(2010-8#1)(2011-2#1)
also shows##16##2##(1991-10#1)(1992-1#1)(1992-3#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-6#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)
also significant##4##2##(1995-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
also significantly changed##2##3##(2008-10#1)(2009-8#1)
also significantly decreased##2##3##(1993-3#1)(1994-8#1)
also significantly higher in##2##4##(2009-6#1)(2011-2#1)
also significantly higher##4##3##(2008-9#1)(2009-6#1)(2011-2#2)
also significantly increased##2##3##(1991-5#1)(1995-9#1)
also significantly reduced##3##3##(2008-10#2)(2013-1#1)
also significantly##20##2##(1990-8#1)(1991-5#1)(1993-3#1)(1994-8#2)(1995-9#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#3)(2013-1#1)
also similar to##3##3##(1994-6#1)(2008-10#1)(2008-8#1)
also similar##7##2##(1994-6#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-1#1)
also some characteristic##2##3##(2008-10#1)(2008-7#1)
also some##8##2##(1990-2#1)(1991-6#1)(1995-3#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)
also sometimes##3##2##(1994-12#1)(2008-9#1)(2013-1#1)
also sought to##2##3##(1996-12#1)(2008-10#1)
also stated that##2##3##(1995-6#1)(2008-1#1)
also stimulate##3##2##(1991-5#1)(2008-10#1)(2008-8#1)
also stimulated##7##2##(1990-4#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-11#2)
also stimulates##2##2##(2009-10#1)(2012-3#1)
also stressed##3##2##(2008-10#1)(2008-4#1)(2009-4#1)
also strongly##7##2##(1992-3#1)(1995-5#1)(2008-11#3)(2008-5#1)(2013-8#1)
also studied by##2##3##(2008-10#2)
also studied for##4##3##(1993-12#1)(2008-10#3)
also studied using##3##3##(2008-10#2)(2009-3#1)
also studied##62##2##(1991-11#1)(1993-12#1)(1993-2#1)(1995-1#1)(1996-5#1)(2008-10#42)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
also subject to##2##3##(2008-11#1)(2010-6#1)
also subject##3##2##(2008-11#1)(2010-6#1)(2012-2#1)
also successfully detected##2##3##(2008-10#2)
also successfully##5##2##(2008-10#5)
also suggest that a##3##4##(2008-10#1)(2009-10#1)(2012-3#1)
also suggest that the##7##4##(1991-5#1)(1996-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
also suggest that##24##3##(1991-5#1)(1992-9#1)(1993-3#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#7)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
also suggest##26##2##(1990-8#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-3#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#7)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
also suggested that##8##3##(1994-11#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-9#1)
also suggested##14##2##(1994-11#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2009-9#1)(2010-5#1)(2012-2#1)
also suggestive of##3##3##(2007-11#1)(2009-8#1)(2010-8#1)
also suggests that##8##3##(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-3#1)
also suggests##9##2##(1996-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-3#1)
also suitable for##4##3##(2008-10#3)(2008-4#1)
also summarized##5##2##(1991-12#1)(1996-1#1)(2008-11#2)(2008-12#1)
also support the##3##3##(2008-9#1)(2010-4#1)(2012-3#1)
also support##4##2##(2008-4#1)(2008-9#1)(2010-4#1)(2012-3#1)
also supported by##5##3##(1994-12#1)(2008-1#1)(2008-10#2)(2008-7#1)
also supported the##3##3##(2008-10#1)(2010-10#1)(2011-1#1)
also supported##11##2##(1992-1#1)(1994-12#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)
also supports the##2##3##(2011-2#1)(2012-3#1)
also suppressed the##5##3##(1995-11#1)(1996-2#1)(2008-10#2)(2012-2#1)
also suppressed##14##2##(1991-3#1)(1991-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
also surveyed##3##2##(1996-12#1)(2009-8#1)(2012-3#1)
also suspected##3##2##(2008-10#2)(2013-1#1)
also take##2##2##(2008-11#1)(2013-8#1)
also tended to improve##2##4##(2013-1#2)
also tended to##4##3##(1994-12#1)(1995-1#1)(2013-1#2)
also termed##3##2##(2008-1#1)(2008-4#1)(2011-2#1)
also tested for##5##3##(1995-2#1)(2008-10#2)(2008-9#2)
also tested in a##2##4##(2008-11#2)
also tested in##6##3##(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#1)
also tested##26##2##(1993-3#1)(1995-2#2)(1997-7#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#4)(2009-12#1)(2010-1#1)(2013-1#1)
also that##9##2##(1994-6#1)(2007-11#2)(2008-10#3)(2008-11#1)(2010-4#1)(2011-10#1)
also the first##3##3##(2008-10#2)(2009-1#1)
also the most##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
also the timing of the##2##5##(2009-10#1)(2009-12#1)
also the##69##2##(1991-6#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#1)(2008-10#19)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-8#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)
also their##6##2##(1993-11#1)(1995-12#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
also those##2##2##(2006-6#1)(2009-3#1)
also to be##3##3##(1991-12#1)(2009-7#1)(2011-3#1)
also to introduce##2##3##(2008-4#1)(2010-3#1)
also to the##10##3##(1990-11#1)(1992-9#1)(1995-5#1)(2008-10#3)(2008-8#1)(2009-3#1)(2009-5#1)(2013-1#1)
also to##52##2##(1990-11#1)(1990-5#2)(1991-12#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-3#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#2)
also treated##2##2##(2008-10#1)(2008-5#1)
also try to##2##3##(1992-3#1)(2009-11#1)
also two##2##2##(2008-12#1)(2013-8#1)
also unable to##2##3##(1995-6#1)(2008-12#1)
also under development##2##3##(1991-12#1)(2008-10#1)
also under##4##2##(1990-11#1)(1991-12#1)(2008-10#1)(2008-11#1)
also undergo##2##2##(1995-6#1)(2009-10#1)
also underline##2##2##(2008-10#1)(2011-2#1)
also undertaken##3##2##(2008-10#2)(2012-3#1)
also underwent##2##2##(1990-11#1)(2011-2#1)
also use##4##2##(1992-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
also used as a##4##4##(1996-8#1)(2008-10#1)(2008-12#1)(2010-8#1)
also used as an##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
also used as##8##3##(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)
also used for comparison##2##4##(2008-10#1)(2010-8#1)
also used for the determination of##3##6##(2008-10#3)
also used for the##5##4##(2008-10#5)
also used for##13##3##(1994-3#1)(1996-3#1)(2008-10#10)(2010-8#1)
also used in the##2##4##(1995-6#1)(2008-10#1)
also used in##6##3##(1995-6#1)(2008-10#5)
also used to calculate##2##4##(2008-10#1)(2010-7#1)
also used to directly##2##4##(2008-10#1)(2008-7#1)
also used to follow##2##4##(2008-10#2)
also used to##21##3##(2008-10#14)(2008-3#3)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
also used##64##2##(1990-9#1)(1992-5#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(2008-10#37)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#2)(2011-2#1)
also useful in##4##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-4#1)
also useful to##2##3##(1997-1#1)(2012-3#1)
also useful##8##2##(1992-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
also validated the##2##3##(2008-5#2)
also validated##3##2##(2008-10#1)(2008-5#2)
also varied with##2##3##(1991-6#1)(2008-10#1)
also varied##4##2##(1991-6#1)(1995-2#1)(1995-3#1)(2008-10#1)
also varies##4##2##(1990-6#1)(1995-2#1)(2008-10#1)(2008-8#1)
also verified##5##2##(2008-10#3)(2008-9#2)
also very good##2##3##(2008-10#2)
also very##16##2##(1990-5#1)(1990-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#2)
also was assessed##2##3##(2008-10#2)
also was associated with##4##4##(2008-10#3)(2012-2#1)
also was correlated with##2##4##(2008-10#2)
also was detected##2##3##(2008-10#2)
also was found##4##3##(2008-10#4)
also was not##3##3##(1993-8#1)(1994-5#1)(2009-9#1)
also was present in##3##4##(2008-10#3)
also was reduced##2##3##(2008-10#2)
also was the most##2##4##(2008-10#2)
also was the##3##3##(2008-10#2)(2013-1#1)
also was used to##2##4##(2008-10#2)
also was##54##2##(1990-11#1)(1993-8#1)(1994-5#1)(2008-10#45)(2008-12#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
also weakly##4##2##(1995-12#1)(1997-8#1)(2008-4#1)(2008-9#1)
also well##5##2##(1990-3#1)(2008-10#1)(2008-3#1)(2009-12#2)
also were assessed##2##3##(2008-10#2)
also were compared##3##3##(2008-10#2)(2012-3#1)
also were consistent with##2##4##(2008-10#2)
also were detected##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
also were evaluated##2##3##(2008-10#2)
also were examined##2##3##(2008-10#1)(2008-12#1)
also were found##5##3##(2008-10#5)
also were observed##2##3##(2008-10#2)
also were tested##4##3##(2008-10#4)
also were used to##2##4##(2008-10#2)
also were##65##2##(1993-2#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(2008-10#57)(2008-12#1)(2008-8#1)(2012-3#1)
also when the##2##3##(1990-9#1)(2008-10#1)
also when##4##2##(1990-9#1)(2008-10#3)
also will##7##2##(1997-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-12#1)
also with##12##2##(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#2)(2009-8#1)(2010-3#1)(2012-12#1)
also worked##2##2##(2009-6#1)(2010-1#1)
also yielded##3##2##(1993-8#1)(2008-10#2)
also##4811##1##(1990-10#1)(1990-11#12)(1990-12#15)(1990-2#8)(1990-3#7)(1990-4#1)(1990-5#28)(1990-6#6)(1990-7#4)(1990-8#12)(1990-9#8)(1991-1#5)(1991-10#6)(1991-11#7)(1991-12#29)(1991-2#16)(1991-3#18)(1991-5#20)(1991-6#19)(1991-7#2)(1991-8#5)(1991-9#3)(1992-1#6)(1992-11#1)(1992-12#17)(1992-2#6)(1992-3#21)(1992-5#5)(1992-6#13)(1992-7#1)(1992-8#3)(1992-9#15)(1993-1#8)(1993-11#12)(1993-12#16)(1993-2#17)(1993-3#21)(1993-6#20)(1993-8#21)(1993-9#4)(1994-1#3)(1994-11#23)(1994-12#19)(1994-2#19)(1994-3#22)(1994-5#24)(1994-6#16)(1994-8#23)(1994-9#6)(1995-1#6)(1995-11#20)(1995-12#33)(1995-2#39)(1995-3#11)(1995-5#15)(1995-6#36)(1995-8#17)(1995-9#8)(1996-1#10)(1996-10#1)(1996-11#5)(1996-12#28)(1996-2#26)(1996-3#14)(1996-5#13)(1996-6#7)(1996-8#4)(1996-9#6)(1997-1#32)(1997-2#22)(1997-3#29)(1997-4#11)(1997-5#3)(1997-6#12)(1997-7#15)(1997-8#25)(1997-9#3)(2006-5#1)(2006-6#13)(2007-11#9)(2007-12#26)(2007-8#1)(2007-9#1)(2008-1#27)(2008-10#1410)(2008-11#318)(2008-12#95)(2008-2#29)(2008-3#91)(2008-4#84)(2008-5#123)(2008-6#42)(2008-7#128)(2008-8#173)(2008-9#160)(2009-1#9)(2009-10#40)(2009-11#8)(2009-12#29)(2009-2#1)(2009-3#12)(2009-4#5)(2009-5#9)(2009-6#10)(2009-7#19)(2009-8#55)(2009-9#10)(2010-1#17)(2010-10#17)(2010-11#14)(2010-12#27)(2010-2#5)(2010-3#12)(2010-4#20)(2010-5#22)(2010-6#14)(2010-7#30)(2010-8#28)(2010-9#6)(2011-1#25)(2011-10#5)(2011-2#187)(2011-3#13)(2011-4#1)(2011-7#3)(2012-12#17)(2012-2#101)(2012-3#74)(2012-5#1)(2012-7#1)(2013-1#133)(2013-7#8)(2013-8#47)
alter either##3##2##(1992-3#1)(1993-6#1)(1997-4#1)
alter immune function##2##3##(2008-10#1)(2008-11#1)
alter the evolutionary##2##3##(2008-8#1)(2012-3#1)
alter the expression of##2##4##(2008-5#1)(2009-12#1)
alter the intracellular##2##3##(1994-6#1)(2010-4#1)
alter the normal##2##3##(1994-6#1)(2013-1#1)
alter the physiology of##2##4##(2008-11#1)(2011-2#1)
alter the##74##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1995-11#2)(1995-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#10)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#8)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
alter this##2##2##(1991-3#1)(2008-8#1)
alter##132##1##(1990-2#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-11#3)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#21)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)
alteration and##2##2##(2008-11#1)(2011-2#1)
alteration in the##7##3##(1990-3#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
alteration in##26##2##(1990-12#1)(1990-3#1)(1993-8#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
alteration of consciousness##4##3##(2010-6#1)(2013-8#3)
alteration of host##2##3##(2008-10#1)(2009-8#1)
alteration of its##2##3##(1992-6#1)(1992-9#1)
alteration of the gut commensal##2##5##(2011-2#2)
alteration of the##17##3##(1993-8#1)(1994-5#1)(1996-12#1)(1996-9#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-5#2)(2011-2#2)(2013-1#1)
alteration of##56##2##(1990-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-12#4)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-6#1)(2008-10#12)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#2)(2013-8#3)
alteration that##2##2##(1992-12#1)(1997-8#1)
alteration##115##1##(1990-12#1)(1990-3#1)(1990-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#3)(1994-12#4)(1994-5#1)(1994-8#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-12#2)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2008-10#23)(2008-11#9)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#3)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#4)
alterations and##7##2##(1992-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
alterations are the##2##3##(2009-4#1)(2012-3#1)
alterations are##6##2##(2008-11#1)(2008-2#1)(2009-4#2)(2011-3#1)(2012-3#1)
alterations caused by##2##3##(2008-5#2)
alterations caused##3##2##(2008-5#2)(2008-8#1)
alterations in culture condition##2##4##(2008-11#2)
alterations in the expression of##3##5##(1996-12#1)(2013-8#2)
alterations in the##20##3##(1990-5#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#2)(2008-5#2)(2008-7#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-7#2)(2013-8#2)
alterations in##76##2##(1990-5#1)(1991-10#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-3#2)(1993-9#1)(1994-2#1)(1994-5#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#4)(1997-2#2)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#1)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#4)
alterations is##2##2##(1996-6#1)(2013-1#1)
alterations may##2##2##(2008-5#1)(2010-12#1)
alterations of the gonadal steroid##2##5##(2008-11#2)
alterations of the##10##3##(1993-3#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#1)(2011-3#1)
alterations of##30##2##(1990-12#1)(1991-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-6#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-9#2)(2009-4#1)(2009-6#3)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2013-8#1)
alterations that##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)
alterations to SC##2##3##(2008-5#2)
alterations to##5##2##(2008-5#3)(2008-7#1)(2012-3#1)
alterations were##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#1)
alterations which##4##2##(1996-12#1)(2008-7#1)(2009-6#1)(2012-2#1)
alterations##188##1##(1990-12#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-5#3)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#5)(1996-2#1)(1996-6#2)(1997-2#2)(1997-6#2)(1997-7#2)(2008-1#2)(2008-10#19)(2008-11#10)(2008-12#4)(2008-2#4)(2008-5#13)(2008-7#9)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#1)(2009-4#4)(2009-6#4)(2009-7#4)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#14)(2011-3#2)(2012-2#7)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#10)
alterations?##2##1##(1994-8#2)
altered after##2##2##(2009-11#1)(2012-12#1)
altered and##3##2##(1994-9#1)(2008-8#1)(2013-8#1)
altered behavioral##2##2##(2008-8#1)(2013-8#1)
altered bone##2##2##(2010-10#1)(2013-1#1)
altered by site-directed mutagenesis##2##4##(1992-1#2)
altered by the##3##3##(1990-2#1)(1996-12#1)(2008-11#1)
altered by##24##2##(1990-2#1)(1990-5#2)(1991-4#2)(1992-1#3)(1992-3#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-12#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)
altered cell line##2##3##(2008-11#2)
altered cell##3##2##(2008-11#3)
altered expression of##4##3##(1993-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
altered expression##5##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
altered formation of##2##3##(2008-10#1)(2008-7#1)
altered genes##2##2##(2008-10#1)(2008-8#1)
altered in either##2##3##(1996-12#1)(2008-10#1)
altered in the##3##3##(1997-2#1)(2008-8#1)(2009-6#1)
altered in##20##2##(1990-6#1)(1992-6#1)(1993-3#1)(1994-8#1)(1996-12#3)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
altered levels of##3##3##(1993-3#1)(1997-3#1)(2012-2#1)
altered mRNA##2##2##(1995-2#1)(2011-2#1)
altered mental status##2##3##(2012-12#1)(2013-1#1)
altered metabolism##2##2##(1992-9#1)(2009-8#1)
altered phenotype##2##2##(2008-10#1)(2008-11#1)
altered sensitivity##2##2##(2008-10#1)(2008-7#1)
altered sensorium##3##2##(2009-11#3)
altered target##2##2##(2008-4#1)(2008-5#1)
altered the expression of##3##4##(2008-10#1)(2008-11#2)
altered the pattern of##2##4##(1995-12#1)(1995-6#1)
altered the##15##2##(1995-12#1)(1995-6#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-9#1)
altered when##2##2##(1994-8#1)(2008-10#1)
altered with##2##2##(1993-1#1)(2013-8#1)
altered##234##1##(1990-2#1)(1990-5#6)(1990-6#1)(1990-8#1)(1991-10#2)(1991-4#2)(1991-5#2)(1992-1#5)(1992-12#1)(1992-3#3)(1992-6#2)(1992-7#2)(1992-9#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#3)(1994-11#2)(1994-3#2)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#2)(2006-6#1)(2008-1#2)(2008-10#40)(2008-11#19)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#9)(2009-1#5)(2009-11#5)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-12#3)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#8)
altering the##22##2##(1990-12#1)(1991-9#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
altering##32##1##(1990-12#2)(1991-9#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)
alternant PAHs studied##2##3##(2008-10#2)
alternant PAHs##5##2##(2008-10#5)
alternant and##2##2##(2008-10#2)
alternant##11##1##(2008-10#11)
alternaria##3##1##(2008-10#3)
alternata apple pathotype##3##3##(2008-10#3)
alternata in##3##2##(2008-10#3)
alternata pathotypes##2##2##(2008-10#2)
alternata##49##1##(2008-10#49)
alternate 5'##2##2##(1993-12#2)
alternate protocol describes##2##3##(2008-4#2)
alternate protocol##5##2##(2008-4#4)(2008-9#1)
alternate protocols##5##2##(2008-4#3)(2008-9#2)
alternate##47##1##(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-4#9)(2008-8#1)(2008-9#4)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
alternated dual task##3##3##(2012-2#3)
alternated with segments of the##2##5##(2008-10#2)
alternated with##4##2##(2008-10#3)(2012-3#1)
alternated##9##1##(2008-10#4)(2008-11#1)(2012-2#3)(2012-3#1)
alternately##2##1##(2008-10#1)(2008-9#1)
alternating high and low temperatures##2##5##(2008-10#2)
alternating layers of##3##3##(2008-10#3)
alternating least squares##2##3##(2008-10#2)
alternating rows of##2##3##(2008-10#2)
alternating trilinear decomposition##3##3##(2008-10#3)
alternating##36##1##(1991-5#1)(1994-5#1)(1995-6#1)(1996-2#1)(2008-10#17)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#2)(2012-3#1)
alternation and##2##2##(1991-2#1)(1994-8#1)
alternation in##3##2##(1994-8#2)(2007-11#1)
alternation task and##2##3##(1991-2#1)(2012-2#1)
alternation task##3##2##(1991-2#1)(2008-8#1)(2012-2#1)
alternation##13##1##(1991-2#3)(1994-8#6)(2007-11#2)(2008-8#1)(2012-2#1)
alternations of##4##2##(2008-10#1)(2011-2#1)(2011-3#2)
alternations##6##1##(1996-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#2)
alternative RNA processing##2##3##(1992-6#2)
alternative RNA##3##2##(1992-6#3)
alternative and##7##2##(1995-2#1)(2008-10#4)(2010-11#1)(2013-8#1)
alternative approach is##2##3##(2011-2#1)(2012-2#1)
alternative approach to##4##3##(1994-1#1)(2008-9#1)(2012-3#1)(2013-8#1)
alternative approach##14##2##(1990-12#1)(1994-1#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
alternative approaches##2##2##(2010-11#1)(2010-3#1)
alternative assays##2##2##(2008-5#1)(2012-2#1)
alternative configurations and##2##3##(1991-1#2)
alternative control measures##2##3##(2008-10#2)
alternative control##3##2##(2008-10#2)(2008-11#1)
alternative drug##2##2##(2010-6#1)(2013-1#1)
alternative explanation##4##2##(2008-10#1)(2008-7#2)(2008-9#1)
alternative for the##8##3##(2008-10#7)(2008-7#1)
alternative for treatment##2##3##(1991-2#1)(2008-8#1)
alternative for##23##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-2#1)(1994-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
alternative forms of##2##3##(1992-3#1)(2008-10#1)
alternative fumigants through drip irrigation systems##2##6##(2008-10#2)
alternative fumigants##4##2##(2008-10#4)
alternative health care##2##3##(1997-6#1)(2008-12#1)
alternative health##3##2##(1997-6#1)(2008-12#1)(2008-8#1)
alternative hypotheses##2##2##(2008-8#2)
alternative hypothesis##2##2##(2008-11#1)(2008-8#1)
alternative in##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
alternative is to##2##3##(1991-1#1)(2008-10#1)
alternative is##3##2##(1991-1#1)(1993-3#1)(2008-10#1)
alternative magnetic field is##2##4##(2008-8#2)
alternative medicine##8##2##(1994-9#1)(2008-10#4)(2009-5#1)(2009-6#2)
alternative method for the determination of##2##6##(2008-10#2)
alternative method for the##3##4##(2008-10#3)
alternative method for##4##3##(2008-10#4)
alternative method in##2##3##(2008-10#1)(2013-1#1)
alternative method of##5##3##(2008-10#3)(2008-4#1)(2010-12#1)
alternative method to##5##3##(2008-10#4)(2008-5#1)
alternative method##18##2##(2008-10#12)(2008-4#2)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
alternative methods that##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
alternative methods##11##2##(1990-9#1)(1992-12#1)(1993-3#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)
alternative model##3##2##(1993-12#2)(1997-7#1)
alternative models##6##2##(1993-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
alternative oxidase##4##2##(1991-5#1)(2008-9#2)(2009-8#1)
alternative pathway of##2##3##(2009-6#1)(2009-8#1)
alternative pathway##4##2##(1995-2#1)(2008-9#1)(2009-6#1)(2009-8#1)
alternative payment##2##2##(1993-1#1)(1993-12#1)
alternative phenotypes##3##2##(2008-8#2)(2010-1#1)
alternative procedure for##3##3##(2008-10#2)(2008-11#1)
alternative procedure##7##2##(2008-10#4)(2008-11#2)(2012-12#1)
alternative procedures are##2##3##(2008-4#1)(2008-9#1)
alternative procedures##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
alternative reproductive##2##2##(2010-8#2)
alternative route##2##2##(1992-12#1)(1997-1#1)
alternative routes##3##2##(1992-12#1)(1995-5#1)(2008-10#1)
alternative sample introduction##2##3##(2008-10#2)
alternative splicing and##2##3##(1993-2#1)(2008-11#1)
alternative splicing##15##2##(1992-6#1)(1993-2#1)(1993-8#3)(1995-12#2)(1995-6#1)(1995-8#1)(1997-7#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#2)
alternative stable equilibria##2##3##(2008-8#2)
alternative strategies for##2##3##(1992-2#1)(2008-11#1)
alternative strategies##3##2##(1992-2#1)(2008-11#1)(2008-7#1)
alternative strategy for##2##3##(2008-10#1)(2008-9#1)
alternative strategy##5##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
alternative surgical technique for##2##4##(2008-7#1)(2008-9#1)
alternative surgical##4##2##(2008-7#3)(2008-9#1)
alternative system for##2##3##(2008-10#1)(2010-7#1)
alternative system##4##2##(2008-10#1)(2010-7#1)(2010-8#1)(2013-1#1)
alternative technique for##3##3##(2008-10#2)(2013-8#1)
alternative technique##8##2##(1991-12#1)(2008-10#6)(2013-8#1)
alternative techniques##2##2##(1997-7#1)(2009-3#1)
alternative test##2##2##(2008-5#1)(2012-3#1)
alternative that##2##2##(2008-6#1)(2008-9#1)
alternative therapies##2##2##(1997-5#1)(2008-6#1)
alternative therapy##3##2##(1997-1#1)(2011-2#1)(2013-1#1)
alternative to an##3##3##(1996-1#1)(2008-10#1)(2008-4#1)
alternative to conventional##7##3##(1990-5#1)(2008-10#3)(2008-4#1)(2009-4#1)(2012-2#1)
alternative to existing##3##3##(2008-10#3)
alternative to open##2##3##(1997-8#1)(2008-10#1)
alternative to other##3##3##(1990-9#1)(2008-10#1)(2008-3#1)
alternative to pulpotomy##2##3##(2011-2#2)
alternative to standard##2##3##(2008-10#1)(2008-9#1)
alternative to surgery##3##3##(1991-8#1)(2008-10#1)(2008-11#1)
alternative to the classical##2##4##(2008-10#1)(2008-11#1)
alternative to the use of##2##5##(2008-10#1)(2012-2#1)
alternative to the##23##3##(1990-2#1)(1994-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
alternative to traditional##7##3##(1992-1#1)(1992-5#1)(1994-9#1)(2008-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
alternative to##128##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-1#1)(1994-12#1)(1994-2#2)(1994-9#4)(1995-3#2)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#2)(2008-10#41)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#7)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#2)
alternative treatments##3##2##(1996-6#1)(2008-11#1)(2008-8#1)
alternative ways of##3##3##(2010-11#2)(2011-2#1)
alternative ways to##3##3##(1994-2#1)(2010-11#1)(2011-1#1)
alternative ways##6##2##(1994-2#1)(2010-11#3)(2011-1#1)(2011-2#1)
alternative with##2##2##(2008-10#1)(2011-2#1)
alternative##543##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#3)(1991-1#5)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#6)(1992-2#5)(1992-3#5)(1992-5#1)(1992-6#5)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#5)(1993-5#2)(1993-6#3)(1993-8#4)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#7)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#4)(2007-12#2)(2008-1#1)(2008-10#153)(2008-11#26)(2008-12#11)(2008-2#4)(2008-3#6)(2008-4#12)(2008-5#12)(2008-6#5)(2008-7#18)(2008-8#22)(2008-9#27)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#7)(2010-12#5)(2010-3#1)(2010-4#2)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#18)(2012-12#5)(2012-2#14)(2012-3#10)(2013-1#16)(2013-7#1)(2013-8#4)
alternative?##2##1##(2010-9#1)(2011-2#1)
alternatively spliced##7##2##(1990-8#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-11#1)
alternatively used##2##2##(2008-10#2)
alternatively##27##1##(1990-8#2)(1991-12#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
alternatives and##2##2##(1992-3#1)(2008-11#1)
alternatives are##3##2##(1991-1#1)(1993-3#1)(2008-10#1)
alternatives currently##2##2##(2008-10#2)
alternatives for##6##2##(1992-3#1)(1994-3#1)(2008-10#4)
alternatives in the##2##3##(1993-6#1)(2013-1#1)
alternatives in##3##2##(1993-6#1)(1996-1#1)(2013-1#1)
alternatives such as##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
alternatives that##3##2##(1997-7#1)(2008-11#1)(2010-7#1)
alternatives to methyl bromide will##2##5##(2008-10#2)
alternatives to methyl bromide##4##4##(2008-10#4)
alternatives to the##2##3##(1991-1#1)(1997-1#1)
alternatives to##26##2##(1991-1#2)(1991-2#1)(1992-1#1)(1993-1#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(2008-10#10)(2008-11#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#1)
alternatives##66##1##(1990-11#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#3)(1996-3#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#2)(2007-8#1)(2008-10#20)(2008-11#4)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-2#1)(2013-1#1)(2013-8#1)
alters the interaction##2##3##(2011-2#2)
alters the##15##2##(1994-5#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#3)(2012-2#2)
alters##33##1##(1991-10#1)(1992-3#1)(1993-6#3)(1994-12#1)(1994-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2011-2#4)(2012-2#2)
although a decrease##2##3##(2008-10#1)(2008-11#1)
although a few##2##3##(2008-10#1)(2011-2#1)
although a low level of##2##5##(2008-10#1)(2011-10#1)
although a##20##2##(1991-10#1)(1997-3#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2011-10#1)(2011-2#2)(2013-1#1)
although additional##2##2##(1996-12#1)(2008-10#1)
although at a##2##3##(2008-10#1)(2008-3#1)
although at##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
although both##3##2##(1995-5#1)(2008-6#1)(2008-7#1)
although cell##2##2##(2008-11#1)(2012-5#1)
although consistent##2##2##(2008-10#1)(2008-5#1)
although data##2##2##(2008-10#1)(2009-6#1)
although different##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
although efficiency##2##2##(2008-10#1)(2008-11#1)
although further##4##2##(2008-11#2)(2008-5#1)(2009-6#1)
although high##4##2##(1995-6#1)(2008-10#3)
although in##7##2##(1990-3#1)(1992-6#1)(2008-10#2)(2010-3#1)(2011-2#1)(2013-8#1)
although it is##7##3##(1994-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-6#1)(2012-2#1)
although it may also##2##4##(2008-9#1)(2013-8#1)
although it was##2##3##(2008-10#1)(2010-4#1)
although it##20##2##(1991-6#1)(1994-6#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-9#2)(2009-10#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-8#1)
although its##5##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
although many##5##2##(1990-9#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
although maybe##2##2##(2008-11#1)(2012-3#1)
although mild##2##2##(1993-12#1)(1994-12#1)
although more##2##2##(1990-5#1)(2008-11#1)
although most##3##2##(1995-3#1)(2008-4#1)(2012-3#1)
although neither##2##2##(2008-5#1)(2011-2#1)
although no##4##2##(1990-5#1)(2008-10#2)(2008-11#1)
although none of##2##3##(1997-8#1)(2011-2#1)
although none##3##2##(1997-8#1)(2011-2#1)(2012-3#1)
although not always##2##3##(1997-7#1)(2006-5#1)
although not##8##2##(1990-8#1)(1995-5#1)(1997-7#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-7#1)
although one##3##2##(1991-12#1)(2008-11#1)(2008-5#1)
although other##8##2##(1997-3#1)(2008-10#5)(2008-11#1)(2008-4#1)
although previous studies##2##3##(1995-8#1)(1996-5#1)
although rare##2##2##(2010-1#1)(2013-7#1)
although reduction##2##2##(2008-10#2)
although significant##2##2##(2008-10#1)(2008-7#1)
although smaller##2##2##(1991-6#1)(2008-5#1)
although some berries##2##3##(2008-10#2)
although some of##2##3##(2007-12#1)(2008-10#1)
although some##13##2##(1992-2#1)(1993-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
although still##2##2##(1994-6#1)(2012-2#1)
although strain##2##2##(1996-12#1)(2008-10#1)
although such##3##2##(2008-3#1)(2008-9#1)(2009-6#1)
although the effect##2##3##(1993-6#1)(2009-12#1)
although the latter is##2##4##(1990-11#1)(2008-10#1)
although the latter##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
although the level of expression##2##5##(1996-12#1)(2012-2#1)
although the level of##3##4##(1996-12#1)(2008-10#1)(2012-2#1)
although the level##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
although the levels##2##3##(1995-6#1)(2008-10#1)
although the magnitude of the##2##5##(1990-12#1)(2008-8#1)
although the majority of##2##4##(2008-10#1)(2008-5#1)
although the majority##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
although the patients##2##3##(2008-10#1)(2009-10#1)
although the peak##2##3##(1996-2#1)(2010-3#1)
although the results##2##3##(2008-10#1)(2012-2#1)
although the total##2##3##(1997-5#1)(2008-10#1)
although the two##2##3##(1993-12#1)(1995-6#1)
although the##104##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#4)(1997-4#2)(1997-5#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#21)(2008-11#9)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#6)(2009-10#2)(2009-12#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
although their##3##2##(1994-8#1)(2008-11#1)(2008-7#1)
although there are##5##3##(1996-1#1)(1997-1#1)(1997-7#1)(2008-11#1)(2009-11#1)
although there is evidence##2##4##(2010-1#1)(2012-3#1)
although there is some##2##4##(2008-11#1)(2008-9#1)
although there is##6##3##(1994-5#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2012-3#1)
although there was a##3##4##(1994-8#1)(2008-10#1)(2008-12#1)
although there was##6##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2010-8#1)
although there were##4##3##(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
although there##22##2##(1994-5#1)(1994-8#1)(1996-1#1)(1997-1#2)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
although these##6##2##(1995-1#1)(1996-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
although they are##5##3##(1994-12#1)(1996-2#1)(2008-9#1)(2010-4#1)(2013-8#1)
although they##10##2##(1994-12#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2013-8#1)
although this effect##2##3##(2008-5#1)(2010-10#1)
although this has##2##3##(2006-5#1)(2013-8#1)
although this was##2##3##(2008-11#1)(2013-1#1)
although this##12##2##(1993-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
although two##2##2##(2008-10#2)
although we##3##2##(2008-10#3)
although with##4##2##(1991-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
although##474##1##(1990-11#2)(1990-12#2)(1990-3#3)(1990-5#3)(1990-6#2)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#1)(1993-1#2)(1993-12#3)(1993-3#3)(1993-6#3)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#6)(1995-8#2)(1996-1#2)(1996-12#10)(1996-2#4)(1996-3#3)(1996-5#5)(1997-1#3)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#3)(1997-9#1)(2006-5#2)(2006-6#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#114)(2008-11#43)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#8)(2008-5#26)(2008-6#3)(2008-7#13)(2008-8#10)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#6)(2010-1#2)(2010-10#4)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-10#1)(2011-2#21)(2012-12#5)(2012-2#10)(2012-3#8)(2012-5#1)(2013-1#13)(2013-7#1)(2013-8#8)
altitude in##2##2##(2008-8#1)(2009-5#1)
altitude of##2##2##(2008-3#2)
altitude range resolutions##2##3##(2008-2#2)
altitude range##4##2##(2008-2#3)(2008-3#1)
altitude##27##1##(2008-2#5)(2008-3#11)(2008-8#5)(2009-5#4)(2012-6#2)
altitudes of##2##2##(2008-3#2)
altitudes##9##1##(1991-5#1)(2008-2#1)(2008-3#5)(2008-8#1)(2009-5#1)
altitudinal gradient##3##2##(2008-8#2)(2012-6#1)
altitudinal##7##1##(2008-8#4)(2012-6#3)
altogether in##2##2##(2008-10#2)
altogether##8##1##(1990-2#1)(1994-3#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-10#1)
altruism in##2##2##(2008-8#1)(2012-3#1)
altruism##20##1##(1992-3#1)(1995-3#1)(2008-8#10)(2008-9#4)(2010-4#2)(2012-3#2)
altruistic##6##1##(1992-3#1)(1993-5#1)(2008-8#2)(2010-12#1)(2012-3#1)
altruists##2##1##(2008-8#1)(2012-3#1)
alumina microcolumns##2##2##(2008-10#2)
alumina paper##5##2##(2008-10#5)
alumina##24##1##(2008-10#21)(2008-3#2)(2008-7#1)
aluminate##6##1##(2008-10#6)
aluminium alloys##4##2##(2008-10#4)
aluminium and manganese##5##3##(2008-10#5)
aluminium and##11##2##(2008-10#11)
aluminium chloride with##4##3##(2008-10#4)
aluminium chloride##7##2##(2008-10#7)
aluminium in the##2##3##(2008-10#2)
aluminium in##8##2##(1992-3#2)(2008-10#6)
aluminium ion##4##2##(2008-10#4)
aluminium of##2##2##(1992-3#1)(2008-10#1)
aluminium salts##2##2##(2008-10#2)
aluminium was##2##2##(2008-10#2)
aluminium were##2##2##(2008-10#2)
aluminium##95##1##(1992-3#6)(1996-2#2)(2008-10#81)(2008-5#3)(2008-7#2)(2013-8#1)
aluminium-base##2##1##(2008-10#2)
aluminon##4##1##(2008-10#4)
aluminum (Al)##5##2##(1996-2#1)(2008-10#2)(2009-6#1)(2009-8#1)
aluminum alloy##4##2##(2008-10#2)(2013-8#2)
aluminum alloy)##2##2##(2008-10#2)
aluminum alloys##2##2##(2008-10#2)
aluminum and indium##2##3##(2008-10#2)
aluminum and##3##2##(2008-10#3)
aluminum hydride##2##2##(1996-5#1)(2008-10#1)
aluminum in new and used lubricating oils##2##7##(2008-10#2)
aluminum in##8##2##(2008-10#8)
aluminum ions##3##2##(1994-11#2)(2008-10#1)
aluminum nanoparticles##5##2##(2010-4#5)
aluminum oxide and##2##3##(2008-10#2)
aluminum phthalocyanine##7##2##(2008-10#7)
aluminum tetrasulfophthalocyanines at a##2##4##(2012-3#2)
aluminum tetrasulfophthalocyanines at##3##3##(2012-3#3)
aluminum tetrasulfophthalocyanines##8##2##(2012-3#8)
aluminum was##4##2##(2008-10#4)
aluminum##99##1##(1991-12#1)(1992-11#1)(1994-11#2)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#64)(2008-2#2)(2008-3#1)(2008-8#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-4#6)(2012-3#8)(2013-8#2)
aluminum(III)##2##1##(2008-10#2)
alumni association##2##2##(1996-1#2)
alumni##3##1##(1996-1#2)(2012-2#1)
alveolar damage##2##2##(1994-5#1)(2011-2#1)
alveolar epithelial cells##3##3##(1994-3#3)
alveolar epithelial##5##2##(1993-2#1)(1994-3#4)
alveolar epithelium##4##2##(1995-8#3)(2008-10#1)
alveolar haemorrhage##2##2##(2011-2#2)
alveolar macrophages##10##2##(1990-6#2)(1992-12#1)(1993-3#3)(1993-8#2)(1996-3#1)(2012-3#1)
alveolar microlithiasis##2##2##(2012-12#2)
alveolar type II##3##3##(1992-3#1)(1995-8#2)
alveolar type of##3##3##(2010-11#3)
alveolar type##6##2##(1992-3#1)(1995-8#2)(2010-11#3)
alveolar type-II cells##3##3##(1994-3#3)
alveolar type-II##4##2##(1994-11#1)(1994-3#3)
alveolar##61##1##(1990-2#2)(1990-6#2)(1992-12#2)(1992-3#1)(1992-6#1)(1993-2#2)(1993-3#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#7)(1994-5#1)(1995-12#1)(1995-8#5)(1996-2#2)(1996-3#1)(1997-1#2)(1997-3#1)(2008-10#2)(2008-12#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-7#5)(2011-2#4)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#2)
alveolarization##3##1##(2009-9#3)
alveoli##2##1##(2008-7#1)(2012-12#1)
always a challenge##2##3##(1991-3#1)(2008-11#1)
always a##5##2##(1991-3#1)(2008-10#2)(2008-11#1)(2008-6#1)
always appeared##2##2##(1993-12#1)(2008-10#1)
always associated with the##2##4##(2008-10#2)
always associated with##6##3##(1997-1#1)(2008-10#4)(2008-12#1)
always be kept in mind##2##5##(2011-2#1)(2012-2#1)
always be##20##2##(1990-2#1)(1991-2#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-5#1)(2009-1#1)(2010-10#1)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#1)
always been##12##2##(1991-12#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-12#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-3#1)(2012-7#1)
always below 2%##2##3##(2008-10#2)
always better##2##2##(2008-10#1)(2011-2#1)
always found##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
always have##2##2##(1994-3#1)(2008-4#1)
always higher in##2##3##(2010-8#1)(2013-8#1)
always higher##4##2##(2008-10#2)(2010-8#1)(2013-8#1)
always in##2##2##(1994-6#1)(2008-10#1)
always included##2##2##(1997-8#1)(2008-5#1)
always increase with##2##3##(2008-8#2)
always induced##2##2##(2008-10#2)
always lower than##2##3##(2008-10#2)
always observed##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
always present in##3##3##(2008-10#3)
always present##5##2##(2008-10#4)(2008-8#1)
always shows##2##2##(2008-10#2)
always the##3##2##(2008-10#2)(2008-11#1)
always to be##2##3##(1997-5#1)(2011-2#1)
always well##2##2##(1997-3#1)(2008-10#1)
always were associated with##2##4##(2008-10#2)
always were##3##2##(2008-10#3)
always with##2##2##(1995-1#1)(2006-6#1)
always##234##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#66)(2008-11#16)(2008-12#8)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#13)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#11)(2011-3#1)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#1)(2013-8#3)
am##8##1##(1990-3#1)(1992-3#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#2)
amacrine cells##4##2##(2008-9#4)
amalgam and##2##2##(2008-10#2)
amalgam electrodes##4##2##(2008-10#4)
amalgam system##2##2##(2008-10#2)
amalgam##18##1##(1990-9#3)(2008-10#14)(2010-1#1)
amalgam-alloy electrode##2##2##(2008-10#2)
amalgam-alloy##6##1##(2008-10#6)
amalgamation of##2##2##(2008-10#1)(2008-11#1)
amalgamation##8##1##(2008-10#4)(2008-11#1)(2008-9#3)
amalgams##3##1##(2008-10#3)
amantadine inhibits##2##2##(1992-3#2)
amantadine##13##1##(1992-3#4)(1996-2#1)(1997-2#3)(2011-10#2)(2011-2#3)
amara##2##1##(2008-10#2)
amaranth grain##7##2##(2008-11#7)
amaranth##13##1##(2008-10#3)(2008-11#10)
amaranticolor##3##1##(2008-10#3)
amarus##3##1##(2013-1#3)
amassed##2##1##(2008-9#1)(2011-10#1)
amastatin##2##1##(1994-8#1)(1995-6#1)
amastigote##3##1##(1991-11#1)(2012-2#2)
amateurs##2##1##(2010-1#1)(2011-2#1)
amaurosis##2##1##(2010-10#1)(2011-2#1)
amber##6##1##(2008-10#4)(2008-8#1)(2011-2#1)
amberlite XAD-2 resin##3##3##(2008-10#3)
amberlite XAD-2##4##2##(2008-10#4)
amberlite##6##1##(2008-10#6)
ambidextrous##2##1##(1997-2#2)
ambient CO(2)##4##2##(2008-10#4)
ambient air and##2##3##(2008-10#2)
ambient air as##2##3##(1995-3#1)(2008-10#1)
ambient air of Madrid (Spain)##2##5##(2008-10#1)(2008-11#1)
ambient air pollution##2##3##(2008-11#2)
ambient air##21##2##(1991-12#1)(1995-3#1)(2008-10#13)(2008-11#4)(2008-3#2)
ambient and##2##2##(2008-10#1)(2012-9#1)
ambient background##3##2##(2008-11#3)
ambient conditions##11##2##(1992-3#1)(1993-12#1)(1995-3#2)(2008-10#4)(2009-12#1)(2012-2#1)(2013-8#1)
ambient light##2##2##(2008-10#1)(2009-9#1)
ambient pH##3##2##(2008-10#3)
ambient temperature and##3##3##(2008-10#3)
ambient temperature##18##2##(1994-2#1)(1996-12#1)(2008-10#9)(2008-4#1)(2008-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-7#1)
ambient temperatures##2##2##(2008-10#2)
ambient##102##1##(1991-12#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-3#3)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#50)(2008-11#11)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-7#1)(2012-9#2)(2013-8#1)
ambigua##2##1##(2010-8#2)
ambiguities and##2##2##(2008-11#1)(2008-7#1)
ambiguities##6##1##(1990-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)
ambiguity in##2##2##(1992-4#1)(2008-12#1)
ambiguity of##2##2##(2008-12#2)
ambiguity##10##1##(1992-4#1)(2008-10#2)(2008-12#4)(2008-3#1)(2010-11#1)(2011-2#1)
ambiguous genitalia##3##2##(2008-10#3)
ambiguous nature of the##2##4##(2008-11#2)
ambiguous##21##1##(1993-6#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#7)(2011-3#1)
ambisense##5##1##(2008-10#5)
ambitious##4##1##(1992-2#1)(2008-12#1)(2008-9#1)(2013-1#1)
amblyopia##5##1##(2013-1#1)(2013-7#4)
ambroxol hydrochloride and doxycycline in##3##5##(2008-10#3)
ambroxol##6##1##(2008-10#6)
ambulance##2##1##(2007-9#2)
ambulation and##2##2##(2008-7#1)(2009-3#1)
ambulation##5##1##(1991-9#1)(1994-3#1)(2008-7#1)(2009-3#2)
ambulatorial##2##1##(1990-3#1)(2008-5#1)
ambulatory blood pressure monitoring##3##4##(2010-1#3)
ambulatory care for the##2##4##(1991-3#1)(1995-2#1)
ambulatory care for##3##3##(1991-3#1)(1991-6#1)(1995-2#1)
ambulatory care services##2##3##(1991-3#1)(1995-12#1)
ambulatory care##16##2##(1991-12#1)(1991-3#3)(1991-6#1)(1992-1#2)(1994-3#2)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#2)(2008-11#1)
ambulatory patients##2##2##(2011-2#1)(2013-1#1)
ambulatory services##2##2##(1995-2#1)(1996-2#1)
ambulatory setting##2##2##(2008-11#1)(2013-1#1)
ambulatory surgery##7##2##(1991-1#5)(1995-2#1)(1997-2#1)
ambulatory visit##2##2##(1991-1#1)(2013-1#1)
ambulatory##67##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#9)(1991-12#1)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#2)(1992-3#1)(1992-6#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-12#2)(1995-2#4)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-8#3)(2008-10#3)(2008-11#4)(2010-1#3)(2011-2#2)(2013-1#5)(2013-8#1)
ameliorate the##4##2##(1994-5#1)(1996-2#1)(2010-7#1)(2011-2#1)
ameliorate##9##1##(1994-5#1)(1996-2#1)(2008-11#2)(2008-7#2)(2010-7#1)(2011-2#2)
ameliorated by##4##2##(1993-12#1)(2008-1#1)(2008-7#1)(2011-1#1)
ameliorated the##2##2##(1994-5#1)(2008-10#1)
ameliorated##9##1##(1993-11#1)(1993-12#1)(1994-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)
ameliorates##6##1##(1995-6#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
ameliorating##2##1##(2008-7#1)(2009-6#1)
amelioration of##5##2##(1991-2#2)(1992-9#1)(2013-1#1)(2013-8#1)
amelioration was##2##2##(2008-10#2)
amelioration##10##1##(1991-2#2)(1992-9#1)(2008-10#3)(2012-2#1)(2013-1#1)(2013-8#2)
ameloblastic fibro-odontoma##2##2##(2007-12#1)(2013-1#1)
ameloblastoma##2##1##(2007-12#1)(2013-1#1)
amenability to##3##2##(2008-10#2)(2011-2#1)
amenability##4##1##(2008-10#2)(2011-2#2)
amenable to structural##2##3##(1997-7#1)(2008-4#1)
amenable to##23##2##(1996-5#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
amenable##26##1##(1996-5#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
amendable to##2##2##(2008-8#2)
amended soil##5##2##(2008-10#5)
amended with Al(2)(SO(4))(3)##2##3##(2008-10#2)
amended with compost##3##3##(2008-10#3)
amended with either##2##3##(2008-10#2)
amended with silicon##2##3##(2008-10#2)
amended with the##2##3##(2008-10#2)
amended with##38##2##(2008-10#38)
amended##51##1##(2008-10#49)(2008-12#1)(2010-3#1)
amending the soil##2##3##(2008-10#2)
amending##4##1##(2008-10#4)
amendment did not##2##3##(2008-10#2)
amendment of##6##2##(2008-10#6)
amendment solutions at##2##3##(2008-10#2)
amendment solutions##3##2##(2008-10#3)
amendment to##3##2##(1995-6#1)(1996-5#1)(2008-10#1)
amendment with##2##2##(2008-10#2)
amendment##34##1##(1995-6#2)(1996-5#1)(2008-10#28)(2009-11#2)(2011-1#1)
amendments can be##2##3##(2008-10#2)
amendments did not##2##3##(2008-10#2)
amendments on##3##2##(2008-10#3)
amendments to##3##2##(1992-2#1)(2008-10#2)
amendments##29##1##(1991-3#1)(1992-2#1)(2008-10#27)
amenorrhea##5##1##(1991-11#1)(1992-12#1)(2010-1#2)(2012-3#1)
america##8##1##(2008-10#7)(2009-6#1)
american phytopathological society##12##3##(2008-10#12)
american##24##1##(2008-10#13)(2008-3#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
americanum##6##1##(2008-10#6)
americium##3##1##(2008-10#3)
amidase##5##1##(1990-2#1)(1991-7#1)(2009-6#3)
amidation of the##2##3##(2008-10#1)(2011-2#1)
amidation##4##1##(1992-8#1)(2008-10#1)(2011-2#2)
amide I and##2##3##(2008-5#2)
amide I##3##2##(2008-5#3)
amide bond##2##2##(1994-11#1)(2008-12#1)
amide derivative##2##2##(2008-10#2)
amide nitrogen##2##2##(2008-10#1)(2008-5#1)
amide proton##2##2##(1992-4#1)(1994-5#1)
amide##41##1##(1990-4#2)(1990-7#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-5#2)(1995-11#1)(1996-5#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#6)(2011-2#1)(2013-7#1)
amides and##3##2##(2008-5#1)(2010-8#2)
amides##12##1##(1992-11#1)(1996-5#2)(1997-2#1)(2008-10#2)(2008-5#4)(2010-8#2)
amidines##4##1##(1995-11#4)
amido black diazoaminoazobenzene##2##3##(2008-10#2)
amidoximated orlon##2##2##(2008-10#2)
amidoximated##3##1##(2008-10#3)
amidoxime##3##1##(2008-10#3)
amidst##2##1##(2012-3#1)(2013-8#1)
amikacin##9##1##(1991-3#2)(2008-10#3)(2008-7#2)(2012-3#1)(2013-1#1)
amiloride in##3##2##(1991-5#1)(2008-10#2)
amiloride##11##1##(1991-5#5)(1991-6#1)(1992-3#1)(1995-8#1)(2008-10#3)
aminated polystyrene membrane##2##3##(2008-10#2)
amine and##4##2##(2008-10#4)
amine carcinogens by##2##3##(1992-6#1)(1997-2#1)
amine carcinogens##3##2##(1992-6#2)(1997-2#1)
amine containing dye)##2##3##(1990-6#2)
amine containing##3##2##(1990-6#3)
amine coupling##2##2##(2008-10#2)
amine derivatives##3##2##(2008-10#3)
amine group to##2##3##(2008-10#2)
amine group##9##2##(2008-10#9)
amine groups##5##2##(2008-10#5)
amine ligands##2##2##(2008-7#2)
amine##79##1##(1990-6#3)(1991-9#1)(1992-6#3)(1994-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#56)(2008-7#6)(2009-8#1)(2010-4#2)(2012-12#1)(2013-1#1)
amine)##4##1##(2008-10#4)
amine-reactive##2##1##(1995-5#1)(2008-9#1)
amine-type neutral##2##2##(2008-10#2)
amines and amino acids##2##4##(2008-10#2)
amines and their##2##3##(1992-6#1)(2008-7#1)
amines and##8##2##(1992-6#1)(2008-10#6)(2008-7#1)
amines are##3##2##(2008-10#2)(2008-7#1)
amines as##2##2##(1997-3#1)(2008-10#1)
amines by##2##2##(2008-10#2)
amines for##3##2##(1997-2#1)(2008-10#2)
amines have been##2##3##(2008-10#2)
amines in food##2##3##(2008-10#2)
amines in##10##2##(1996-5#1)(2008-10#8)(2008-7#1)
amines to##5##2##(1996-5#1)(2008-10#2)(2009-10#2)
amines using##2##2##(2008-10#2)
amines were##3##2##(2008-10#3)
amines with##4##2##(1996-5#1)(2008-10#3)
amines##99##1##(1992-6#4)(1993-9#1)(1996-5#8)(1997-2#5)(1997-3#1)(2008-10#69)(2008-7#5)(2008-8#1)(2009-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
amino Acid change in##2##4##(2008-10#2)
amino Acid##5##2##(2008-10#2)(2010-1#1)(2010-7#1)(2012-2#1)
amino N in##2##3##(2012-8#2)
amino N##3##2##(2012-8#3)
amino acid (aa) sequence##4##4##(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)
amino acid (aa) sequences##3##4##(1993-6#2)(1993-9#1)
amino acid (aa)##16##3##(1991-6#1)(1993-12#2)(1993-2#2)(1993-6#5)(1993-9#1)(1994-8#1)(1997-7#2)(2008-10#1)(2010-5#1)
amino acid N##3##3##(2012-9#3)
amino acid analysis and##3##4##(1990-8#1)(1995-3#1)(1995-6#1)
amino acid analysis##10##3##(1990-8#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-8#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-4#2)
amino acid and a##2##4##(1992-6#1)(2008-10#1)
amino acid and##6##3##(1992-6#1)(2008-10#5)
amino acid at##3##3##(2008-10#3)
amino acid change##5##3##(1995-2#1)(2008-10#2)(2008-5#1)(2012-3#1)
amino acid changes in the##2##5##(1993-8#1)(2013-1#1)
amino acid changes##8##3##(1993-8#1)(2008-10#3)(2008-5#2)(2008-8#1)(2013-1#1)
amino acid composition of the connecting peptide and##2##8##(2008-9#2)
amino acid composition of the##6##5##(1990-5#1)(1990-8#1)(1992-9#1)(1993-8#1)(2008-9#2)
amino acid composition of##7##4##(1990-5#2)(1990-8#1)(1992-9#1)(1993-8#1)(2008-9#2)
amino acid composition##12##3##(1990-5#2)(1990-8#2)(1991-9#1)(1992-7#1)(1992-9#2)(1993-8#1)(2008-10#1)(2008-9#2)
amino acid content in##2##4##(2008-11#1)(2008-12#1)
amino acid content##5##3##(1994-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)
amino acid derivatives##6##3##(2008-10#5)(2008-7#1)
amino acid differences##3##3##(1997-8#2)(2008-10#1)
amino acid exchanges##2##3##(1997-6#1)(2013-8#1)
amino acid for the##2##4##(1991-12#1)(2008-8#1)
amino acid for##3##3##(1991-12#1)(2008-11#1)(2008-8#1)
amino acid homology##2##3##(2008-10#1)(2008-9#1)
amino acid identities of##3##4##(2008-10#3)
amino acid identities##11##3##(2008-10#9)(2008-8#2)
amino acid identity to##2##4##(1996-6#1)(2008-10#1)
amino acid identity with##3##4##(1995-6#2)(1995-8#1)
amino acid identity##11##3##(1992-3#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-6#1)(2008-10#4)
amino acid in eukaryotes whose biosynthesis##2##6##(2012-2#2)
amino acid in##5##3##(2008-10#2)(2012-2#3)
amino acid infusion##2##3##(2010-7#2)
amino acid levels##6##3##(1990-12#2)(1995-8#1)(2008-10#2)(2010-1#1)
amino acid of##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
amino acid or DNA##3##4##(2008-10#3)
amino acid peptide##2##3##(2008-10#1)(2008-11#1)
amino acid pool##3##3##(1990-12#3)
amino acid positions##5##3##(1993-8#1)(1994-11#1)(1997-9#1)(2008-10#1)(2008-9#1)
amino acid preferring##2##3##(1994-5#2)
amino acid profile##2##3##(2011-2#2)
amino acid protein##4##3##(1991-9#1)(2008-11#2)(2008-5#1)
amino acid region##2##3##(1994-5#1)(2008-10#1)
amino acid repeat region##2##4##(2008-10#2)
amino acid repeats##2##3##(2008-10#1)(2008-6#1)
amino acid replacements##3##3##(1991-9#1)(1997-9#2)
amino acid residue##5##3##(1992-8#1)(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
amino acid residues and##3##4##(1991-5#1)(1992-6#1)(1997-8#1)
amino acid residues in the##5##5##(1994-5#1)(1995-6#2)(2008-9#2)
amino acid residues in##8##4##(1993-8#1)(1994-5#1)(1995-6#2)(2008-10#1)(2008-9#2)(2012-3#1)
amino acid residues of the##2##5##(1997-8#1)(2008-11#1)
amino acid residues of##4##4##(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
amino acid residues that are##2##5##(2008-10#2)
amino acid residues that##3##4##(1997-4#1)(2008-10#2)
amino acid residues with a##2##5##(1993-8#1)(1995-6#1)
amino acid residues with##3##4##(1993-8#1)(1995-6#1)(2008-8#1)
amino acid residues##42##3##(1990-5#2)(1990-8#1)(1991-5#1)(1992-6#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-5#1)(1995-6#5)(1995-8#2)(1997-4#2)(1997-7#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#5)(2008-9#5)(2009-8#1)(2011-2#1)(2012-3#1)
amino acid residues)##2##3##(1992-3#1)(2011-2#1)
amino acid sequence and##2##4##(1993-8#1)(2008-10#1)
amino acid sequence data##2##4##(1991-9#1)(2008-10#1)
amino acid sequence homology to##2##5##(1991-5#1)(1995-12#1)
amino acid sequence homology with##2##5##(1992-6#1)(2008-9#1)
amino acid sequence homology##4##4##(1991-5#1)(1992-6#1)(1995-12#1)(2008-9#1)
amino acid sequence identities##3##4##(1990-7#1)(1997-3#1)(2008-10#1)
amino acid sequence identity between##2##5##(1991-5#1)(2008-10#1)
amino acid sequence identity##5##4##(1991-5#1)(1993-8#1)(2008-10#2)(2010-5#1)
amino acid sequence in##2##4##(2008-9#1)(2013-8#1)
amino acid sequence is##3##4##(1993-3#1)(1996-6#1)(2008-10#1)
amino acid sequence of human##3##5##(1993-3#1)(1996-2#1)(2008-11#1)
amino acid sequence of the rat##2##6##(1992-8#1)(1996-12#1)
amino acid sequence of the##14##5##(1990-5#2)(1991-12#1)(1992-8#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1996-12#2)(2008-10#1)(2008-11#1)(2008-6#1)
amino acid sequence of##30##4##(1990-5#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#1)(1995-2#1)(1995-6#2)(1996-12#3)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
amino acid sequence revealed##3##4##(1997-4#1)(1997-7#1)(2008-10#1)
amino acid sequence showed##2##4##(1995-6#1)(1996-3#1)
amino acid sequence similarities##2##4##(1992-7#1)(2008-10#1)
amino acid sequence similarity##3##4##(1995-11#1)(2008-10#1)(2011-1#1)
amino acid sequence was determined##2##5##(1993-12#1)(1995-6#1)
amino acid sequence was##7##4##(1992-3#1)(1993-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
amino acid sequence with those of##2##6##(2008-10#2)
amino acid sequence##117##3##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#4)(1993-9#2)(1994-11#3)(1994-12#1)(1994-6#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#5)(1995-8#2)(1996-12#7)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#22)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#5)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
amino acid sequences are##3##4##(1992-10#1)(1997-7#1)(2008-8#1)
amino acid sequences between##2##4##(1994-11#1)(2008-10#1)
amino acid sequences for##2##4##(1991-5#1)(1997-8#1)
amino acid sequences in the##3##5##(1994-11#1)(2008-10#1)(2008-5#1)
amino acid sequences of the##10##5##(1993-12#2)(1996-8#1)(2008-10#6)(2008-5#1)
amino acid sequences of##24##4##(1991-10#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-8#2)(1997-2#1)(1997-8#1)(2008-10#9)(2008-5#1)(2008-8#1)
amino acid sequences were compared##2##5##(2008-10#1)(2013-8#1)
amino acid sequences were determined##2##5##(1994-11#1)(2008-8#1)
amino acid sequences were##4##4##(1994-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
amino acid sequences##56##3##(1990-5#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#6)(1994-12#1)(1995-9#1)(1996-8#2)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#16)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2010-5#1)(2012-2#1)(2013-8#1)
amino acid sequencing and##2##4##(1994-8#1)(1997-7#1)
amino acid sequencing##5##3##(1990-2#1)(1993-8#1)(1994-8#1)(1997-1#1)(1997-7#1)
amino acid similarities##2##3##(2008-10#1)(2008-8#1)
amino acid substitution at##2##4##(1993-12#1)(2006-6#1)
amino acid substitution in the##2##5##(2008-10#2)
amino acid substitution##10##3##(1991-12#1)(1993-12#1)(1994-11#1)(2006-6#1)(2008-10#4)(2008-8#1)(2011-3#1)
amino acid substitutions in the##2##5##(2008-10#1)(2013-8#1)
amino acid substitutions in##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
amino acid substitutions##14##3##(1992-4#1)(1994-5#1)(1995-6#1)(1997-8#1)(1997-9#2)(2008-10#2)(2008-4#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
amino acid transport##3##3##(1990-12#2)(1994-8#1)
amino acid with##2##3##(2008-10#1)(2010-7#1)
amino acid##500##2##(1990-12#8)(1990-2#2)(1990-5#7)(1990-7#3)(1990-8#8)(1991-10#1)(1991-11#1)(1991-12#5)(1991-5#5)(1991-6#3)(1991-9#6)(1992-10#2)(1992-11#2)(1992-12#1)(1992-3#5)(1992-4#2)(1992-6#6)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#1)(1993-12#8)(1993-2#5)(1993-3#7)(1993-6#6)(1993-8#12)(1993-9#4)(1994-11#15)(1994-12#2)(1994-5#9)(1994-6#1)(1994-8#5)(1995-11#5)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#15)(1995-8#8)(1995-9#1)(1996-12#7)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#7)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#8)(1997-8#9)(1997-9#7)(2006-6#1)(2007-12#1)(2008-10#115)(2008-11#19)(2008-12#1)(2008-4#5)(2008-5#10)(2008-6#5)(2008-7#3)(2008-8#24)(2008-9#18)(2009-7#1)(2009-8#3)(2010-1#3)(2010-11#2)(2010-4#3)(2010-5#3)(2010-7#4)(2011-1#2)(2011-2#8)(2011-3#1)(2012-2#7)(2012-3#3)(2012-9#3)(2013-1#4)(2013-8#8)
amino acids (aa) and##3##4##(1991-9#1)(1993-12#1)(1997-7#1)
amino acids (aa)##13##3##(1990-11#2)(1991-9#1)(1993-12#3)(1993-2#2)(1993-6#2)(1995-12#1)(1996-6#1)(1997-7#1)
amino acids 201-319##2##3##(1995-11#2)
amino acids also##3##3##(2008-8#2)(2011-1#1)
amino acids and##31##3##(1990-2#1)(1990-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1997-8#1)(2008-10#20)(2008-11#1)(2008-8#1)(2011-2#1)
amino acids are##3##3##(1993-2#1)(1994-6#1)(2008-10#1)
amino acids as##3##3##(2008-10#2)(2011-1#1)
amino acids at the##5##4##(1992-9#1)(2008-10#3)(2008-9#1)
amino acids at##8##3##(1992-9#1)(2008-10#5)(2008-9#2)
amino acids by##4##3##(1994-5#1)(2008-10#2)(2011-2#1)
amino acids compared with##2##4##(1995-9#1)(2010-4#1)
amino acids containing##2##3##(1993-2#1)(1994-3#1)
amino acids for##4##3##(1990-12#4)
amino acids from##2##3##(1992-9#1)(2008-10#1)
amino acids has##2##3##(1992-11#1)(1996-6#1)
amino acids have been##2##4##(2008-10#1)(2010-1#1)
amino acids highly homologous##2##4##(1993-12#1)(2008-9#1)
amino acids in N terminal##2##5##(2008-8#1)(2008-9#1)
amino acids in Sargassum fusiforme##2##5##(2008-10#2)
amino acids in flow systems##2##5##(2008-10#2)
amino acids in the##5##4##(1997-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
amino acids in##21##3##(1992-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-2#2)
amino acids long##3##3##(1993-3#1)(1995-2#1)(1996-12#1)
amino acids of the##2##4##(1992-6#1)(2008-11#1)
amino acids of##11##3##(1992-6#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)
amino acids on the##2##4##(2008-10#2)
amino acids on##4##3##(1995-12#1)(2008-10#2)(2008-11#1)
amino acids or##3##3##(1992-9#1)(1993-8#1)(2008-10#1)
amino acids produced##2##3##(2008-10#2)
amino acids that is##2##4##(1997-7#1)(2008-6#1)
amino acids that##7##3##(1992-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
amino acids to##3##3##(1997-4#1)(2008-10#1)(2012-2#1)
amino acids using##3##3##(2008-10#3)
amino acids was##3##3##(2008-10#3)
amino acids were##9##3##(1990-12#1)(1990-7#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-4#1)
amino acids which##5##3##(1993-6#1)(1993-8#1)(1995-12#2)(1996-12#1)
amino acids with a##4##4##(1994-11#1)(1996-6#1)(2008-10#1)(2008-8#1)
amino acids with the##2##4##(2008-10#2)
amino acids with##15##3##(1991-7#1)(1994-11#1)(1995-6#1)(1996-5#1)(1996-6#2)(2008-10#7)(2008-8#1)(2010-5#1)
amino acids##347##2##(1990-11#2)(1990-12#8)(1990-2#1)(1990-5#4)(1990-7#2)(1991-12#2)(1991-7#1)(1991-9#2)(1992-11#2)(1992-12#5)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#5)(1993-12#4)(1993-2#6)(1993-3#1)(1993-6#3)(1993-8#9)(1994-11#6)(1994-12#1)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#1)(1995-11#4)(1995-12#8)(1995-2#2)(1995-6#9)(1995-8#3)(1995-9#2)(1996-12#3)(1996-3#3)(1996-5#3)(1996-6#4)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2008-1#1)(2008-10#121)(2008-11#25)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#16)(2008-9#9)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#5)(2010-5#4)(2010-6#1)(2011-1#3)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
amino acids) and##3##3##(1995-6#1)(2008-8#2)
amino acids)##20##2##(1990-8#1)(1992-3#2)(1995-6#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#6)(2008-9#2)(2011-3#1)(2013-1#2)
amino aluminum phthalocyanine (TAAlPc)##2##4##(2008-10#2)
amino aluminum phthalocyanine##3##3##(2008-10#3)
amino and carboxyl##2##3##(1990-7#1)(1996-12#1)
amino and##4##2##(1990-7#1)(1996-12#1)(2008-10#2)
amino compounds in##4##3##(2008-10#1)(2012-8#3)
amino compounds##5##2##(2008-10#2)(2012-8#3)
amino group of the##3##4##(1992-3#1)(2008-10#2)
amino group of##7##3##(1990-5#1)(1992-3#2)(1995-6#1)(2008-10#3)
amino group##15##2##(1990-5#1)(1991-3#1)(1992-3#3)(1995-6#1)(2008-10#9)
amino groups and##3##3##(1997-2#1)(2008-10#2)
amino groups of##3##3##(2008-10#2)(2008-7#1)
amino groups on the##2##4##(1994-5#1)(2008-10#1)
amino groups##14##2##(1994-5#1)(1997-2#1)(2008-10#9)(2008-5#1)(2008-7#1)(2009-8#1)
amino nitrogen##2##2##(1996-5#1)(2012-8#1)
amino terminal##2##2##(1990-5#1)(1992-6#1)
amino terminus##11##2##(1991-10#1)(1995-2#1)(1996-12#2)(1997-8#1)(2008-10#2)(2008-11#4)
amino transferase##3##2##(1994-8#1)(2008-10#2)
amino##958##1##(1990-11#2)(1990-12#16)(1990-2#3)(1990-5#13)(1990-7#6)(1990-8#9)(1991-10#3)(1991-11#1)(1991-12#7)(1991-3#1)(1991-5#5)(1991-6#3)(1991-7#1)(1991-9#8)(1992-10#2)(1992-11#4)(1992-12#6)(1992-3#13)(1992-4#2)(1992-6#9)(1992-7#2)(1992-8#4)(1992-9#10)(1993-1#1)(1993-12#12)(1993-2#11)(1993-3#8)(1993-6#9)(1993-8#21)(1993-9#4)(1994-11#22)(1994-12#3)(1994-3#1)(1994-5#15)(1994-6#3)(1994-8#9)(1995-11#9)(1995-12#10)(1995-2#6)(1995-3#2)(1995-6#26)(1995-8#12)(1995-9#3)(1996-12#13)(1996-2#1)(1996-3#5)(1996-5#6)(1996-6#6)(1996-8#2)(1997-1#2)(1997-2#10)(1997-3#5)(1997-4#6)(1997-6#2)(1997-7#12)(1997-8#11)(1997-9#8)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#273)(2008-11#53)(2008-12#2)(2008-4#10)(2008-5#19)(2008-6#6)(2008-7#7)(2008-8#47)(2008-9#29)(2009-7#1)(2009-8#5)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#9)(2010-5#7)(2010-6#1)(2010-7#5)(2011-1#5)(2011-2#13)(2011-3#2)(2012-2#13)(2012-3#4)(2012-8#7)(2012-9#3)(2013-1#9)(2013-8#10)
amino- and##2##2##(1991-5#1)(2008-10#1)
amino-acid residues##3##2##(1994-3#2)(1995-8#1)
amino-acid sequence of multiple lectins##2##5##(1990-5#2)
amino-acid sequence of##4##3##(1990-5#4)
amino-acid sequence was##2##3##(1990-5#1)(1995-6#1)
amino-acid sequence##9##2##(1990-5#6)(1995-6#1)(1995-8#1)(2008-8#1)
amino-acid sequences##3##2##(1990-5#1)(1994-11#2)
amino-acid##20##1##(1990-5#8)(1994-11#2)(1994-3#3)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(2008-8#1)(2008-9#1)
amino-acids##3##1##(1995-6#1)(2008-12#1)(2013-1#1)
amino-alcohols##3##1##(2008-10#3)
amino-modified silica-coated magnetic nanoparticles##3##4##(2008-10#3)
amino-modified##4##1##(2008-10#4)
amino-terminal and##2##2##(1991-12#1)(1995-6#1)
amino-terminal sequence##6##2##(1990-2#2)(1990-5#1)(1991-9#1)(1992-9#1)(2008-10#1)
amino-terminal sequences##2##2##(1996-8#2)
amino-terminal##22##1##(1990-2#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-9#1)(1994-11#1)(1995-6#5)(1996-8#3)(1997-4#1)(1997-6#3)(1997-8#1)(2008-10#1)
amino-terminated##3##1##(2008-10#3)
aminoacid##6##1##(1992-9#5)(2008-10#1)
aminoacids##2##1##(2008-11#1)(2012-3#1)
aminoacyl-tRNA synthetase##2##2##(2012-2#2)
aminoacylase##2##1##(2008-5#2)
aminoacylated##2##1##(1997-3#1)(2012-2#1)
aminoacylation##8##1##(1993-8#1)(1997-3#4)(2008-8#1)(2012-2#2)
aminoacylproline hydrolase##4##2##(1992-3#4)
aminocaproic acid##4##2##(2008-10#3)(2008-7#1)
aminocaproic##5##1##(2008-10#4)(2008-7#1)
aminoglycoside##4##1##(1995-8#1)(2009-8#2)(2011-2#1)
aminoglycosides are trafficked##2##3##(2012-2#2)
aminoglycosides##10##1##(2008-12#1)(2008-7#1)(2009-8#5)(2012-2#3)
aminomethylbenzoic acid and##4##3##(2008-10#4)
aminomethylbenzoic acid##7##2##(2008-10#7)
aminomutase##2##1##(2008-9#2)
aminopeptidase (EC 3##4##3##(1990-2#4)
aminopeptidase N##3##2##(1995-8#2)(2008-11#1)
aminopeptidase activity##2##2##(1990-2#1)(2012-6#1)
aminopeptidase has##2##2##(1990-2#1)(1994-8#1)
aminopeptidase##23##1##(1990-2#9)(1991-3#1)(1992-3#2)(1994-2#1)(1994-8#3)(1995-6#1)(1995-8#2)(2008-11#1)(2012-2#2)(2012-6#1)
aminopeptidases##4##1##(1990-2#3)(2010-3#1)
aminophenols##3##1##(1994-5#1)(2008-10#2)
aminophospholipid exposure##3##2##(2006-6#3)
aminophylline##7##1##(2008-10#7)
aminopropyl##8##1##(2008-10#6)(2013-8#2)
aminopropyl-glass bead##3##2##(2008-10#3)
aminopropyl-glass##4##1##(2008-10#4)
aminosaccharides and##3##2##(1991-7#3)
aminosaccharides##4##1##(1991-7#4)
aminotransferase (ALT)##6##2##(2008-10#2)(2009-8#1)(2012-3#2)(2013-8#1)
aminotransferase##27##1##(1992-3#1)(1993-2#3)(1994-5#2)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-5#1)(2009-8#3)(2012-3#3)(2013-8#3)
aminotransferases##3##1##(1994-8#1)(2008-10#1)(2011-2#1)
amiodarone##5##1##(1993-6#3)(1994-8#1)(2008-11#1)
amipurimycin##2##1##(1996-5#2)
amitriptyline##3##1##(1990-11#1)(2008-10#2)
amitrole and atrazin-2-hydroxy##2##3##(2008-10#2)
amitrole with##3##2##(2008-10#3)
amitrole##11##1##(2008-10#11)
amlodipine besylate in##2##3##(2008-10#2)
amlodipine besylate##5##2##(2008-10#5)
amlodipine##9##1##(2008-10#6)(2012-12#2)(2012-3#1)
ammine-complexes of copper(II)##2##3##(2008-10#2)
ammine-complexes##4##1##(2008-10#4)
ammonia (NH(3))##2##2##(2008-10#2)
ammonia accumulation##2##2##(2008-11#1)(2008-7#1)
ammonia and##13##2##(2008-10#12)(2008-11#1)
ammonia buffer##3##2##(2008-10#3)
ammonia by##3##2##(2008-10#1)(2008-3#2)
ammonia concentration##2##2##(2008-11#1)(2008-3#1)
ammonia concentrations##3##2##(2008-11#1)(2008-3#2)
ammonia detection##2##2##(2008-10#1)(2008-3#1)
ammonia detoxification##2##2##(2008-11#2)
ammonia gas##2##2##(2008-10#1)(2008-4#1)
ammonia in##10##2##(2007-12#1)(2008-10#8)(2011-2#1)
ammonia is##3##2##(2008-10#3)
ammonia on##2##2##(1995-3#1)(2008-11#1)
ammonia was##6##2##(2008-10#2)(2008-11#4)
ammonia with hypobromite##2##3##(2008-10#2)
ammonia with##3##2##(2008-10#3)
ammonia##135##1##(1993-8#1)(1994-8#1)(1995-3#5)(2007-12#2)(2008-10#79)(2008-11#26)(2008-3#12)(2008-4#1)(2008-7#4)(2008-9#2)(2011-2#2)
ammonia-ammonium chloride buffer##2##3##(2008-10#2)
ammonia-lyase##2##1##(1994-5#2)
ammonia/ammonium chloride buffer##2##3##(2008-10#2)
ammonium acetate and##3##3##(2008-10#3)
ammonium acetate buffer##2##3##(2008-10#2)
ammonium acetate##17##2##(2008-10#16)(2012-3#1)
ammonium aluminium##2##2##(2008-10#2)
ammonium and nitrate##6##3##(2008-10#6)
ammonium and nitrite##2##3##(2008-10#2)
ammonium and phosphate##2##3##(2008-10#2)
ammonium and##16##2##(2008-10#15)(2008-9#1)
ammonium assimilation##3##2##(1997-1#3)
ammonium at##2##2##(2008-10#2)
ammonium bromide##8##2##(2008-10#8)
ammonium cations##3##2##(2008-10#3)
ammonium chloride##6##2##(2008-10#6)
ammonium concentration##3##2##(2008-10#3)
ammonium determination##2##2##(2008-10#2)
ammonium diethyl dithiophosphate##3##3##(2008-10#3)
ammonium diethyldithiophosphate##2##2##(2008-10#2)
ammonium dihydrogenphosphate##5##2##(2008-10#5)
ammonium hydroxide##2##2##(2008-10#1)(2008-4#1)
ammonium in the##2##3##(2008-10#2)
ammonium in##6##2##(2008-10#6)
ammonium ion and##2##3##(2008-10#2)
ammonium ion selective##2##3##(2008-10#2)
ammonium ion##13##2##(2008-10#12)(2008-11#1)
ammonium ions##8##2##(2008-10#6)(2008-11#2)
ammonium molybdate in##2##3##(2008-10#2)
ammonium molybdate to##2##3##(2008-10#2)
ammonium molybdate##12##2##(2008-10#12)
ammonium nitrate and##2##3##(2008-10#1)(2009-3#1)
ammonium nitrate##7##2##(1991-12#2)(2008-10#4)(2009-3#1)
ammonium oxalate solution##2##3##(2008-10#2)
ammonium pyrolidine##2##2##(2008-10#2)
ammonium pyrrolidine dithiocarbamate (APDC)##7##4##(2008-10#7)
ammonium pyrrolidine dithiocarbamate##8##3##(2008-10#8)
ammonium salt of##2##3##(2008-10#2)
ammonium salt##4##2##(2008-10#4)
ammonium salts##4##2##(2008-10#4)
ammonium selective##2##2##(2008-10#2)
ammonium sulfate and##2##3##(1992-12#1)(2008-10#1)
ammonium sulfate fractionation##2##3##(1991-12#1)(1994-8#1)
ammonium sulfate fractions##2##3##(2008-10#2)
ammonium sulfate precipitation and##6##4##(1991-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-4#1)
ammonium sulfate precipitation##9##3##(1991-9#1)(1992-8#1)(1994-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-4#1)
ammonium sulfate##22##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-8#2)(2010-4#1)
ammonium sulphate##2##2##(1990-5#1)(1995-9#1)
ammonium thiocyanate##5##2##(2008-10#3)(2008-12#2)
ammonium with##3##2##(2008-10#3)
ammonium##235##1##(1990-11#1)(1990-5#1)(1990-6#2)(1991-12#3)(1991-9#1)(1992-12#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-9#1)(1996-12#1)(1997-1#3)(2008-10#199)(2008-11#6)(2008-12#2)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
ammonium-sensitive##2##1##(2008-10#2)
ammunition##6##1##(1995-11#1)(2008-10#1)(2008-11#4)
amnesia and##2##2##(1996-9#1)(2008-7#1)
amnesia##5##1##(1994-8#2)(1996-9#1)(2008-7#1)(2012-3#1)
amnestic##3##1##(1994-8#1)(2008-7#1)(2011-2#1)
amniocenteses##4##1##(1996-3#1)(2012-3#3)
amniocentesis and##2##2##(1990-9#1)(2012-3#1)
amniocentesis##9##1##(1990-9#3)(2007-7#1)(2008-4#1)(2012-3#4)
amnion tissue##3##2##(1993-3#3)
amnion##5##1##(1990-11#1)(1993-1#1)(1993-3#3)
amnion-derived WISH cells##2##3##(1997-1#2)
amniotes##4##1##(1996-5#1)(1997-3#2)(2008-8#1)
amniotic fluid and##3##3##(1995-8#1)(2008-9#2)
amniotic fluid##9##2##(1990-9#3)(1992-12#1)(1995-8#3)(2008-9#2)
amniotic membrane##4##2##(1993-3#1)(2008-10#1)(2011-2#2)
amniotic##18##1##(1990-9#3)(1992-12#1)(1993-1#2)(1993-3#1)(1995-8#3)(2008-10#1)(2008-8#1)(2008-9#3)(2011-2#2)(2012-3#1)
amoebae##3##1##(2008-8#1)(2009-8#2)
amoebic liver abscess##3##3##(1995-10#1)(2012-2#2)
among 1##2##2##(2008-10#2)
among 2##3##2##(2008-10#3)
among 30##2##2##(2008-10#1)(2013-1#1)
among 36##2##2##(1994-11#1)(2008-5#1)
among Adults in##2##3##(2008-10#1)(2013-1#1)
among African American men##3##4##(2009-5#3)
among African Americans##3##3##(2010-10#1)(2010-4#2)
among African##6##2##(2009-5#3)(2010-10#1)(2010-4#2)
among African-Americans in the##2##4##(2010-6#1)(2013-8#1)
among American##2##2##(2008-8#1)(2011-2#1)
among B##3##2##(2008-10#2)(2012-2#1)
among C##3##2##(1993-9#2)(2008-10#1)
among Canadian##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
among Chilean adolescents]##2##3##(2013-1#1)(2013-8#1)
among Chilean##3##2##(2013-1#2)(2013-8#1)
among Chinese##2##2##(2008-8#1)(2011-2#1)
among European##2##2##(2008-10#2)
among HG 3##2##3##(2008-10#2)
among Hispanics##2##2##(1995-12#1)(2012-12#1)
among IVDUs##4##2##(1991-1#1)(1992-9#3)
among Japanese##2##2##(2009-7#1)(2012-12#1)
among Nepalese##2##2##(2012-3#2)
among North American##3##3##(1993-12#1)(2008-10#1)(2012-3#1)
among North##4##2##(1993-12#1)(1995-1#1)(2008-10#1)(2012-3#1)
among Norwegian##5##2##(1990-9#2)(1991-9#1)(1993-2#1)(1994-6#1)
among Pacific##3##2##(2008-1#2)(2012-2#1)
among Pacificans##4##2##(2008-1#4)
among Pennsylvania##2##2##(1992-1#1)(2008-10#1)
among Spanish##2##2##(2008-10#1)(2011-2#1)
among States##2##2##(1994-3#1)(1996-2#1)
among T##3##2##(2008-10#1)(2012-3#2)
among V##3##2##(2008-10#3)
among X##5##2##(2008-10#5)
among a group of##3##4##(2008-11#2)(2008-12#1)
among a##16##2##(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-7#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
among adolescent girls##2##3##(1991-11#1)(2013-1#1)
among adolescent##8##2##(1991-11#1)(2008-11#1)(2009-10#1)(2009-5#3)(2013-1#2)
among adolescents in##3##3##(1996-1#1)(2009-10#1)(2012-12#1)
among adolescents is##2##3##(2008-11#1)(2013-1#1)
among adolescents##16##2##(1996-1#1)(1996-6#1)(2008-11#4)(2009-10#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#5)
among adult##5##2##(2008-10#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-2#1)
among adults##4##2##(2008-11#1)(2008-9#1)(2010-10#1)(2013-8#1)
among all strains##3##3##(2008-10#3)
among all the##5##3##(2008-10#3)(2008-11#1)(2008-9#1)
among all##27##2##(1990-5#1)(1993-6#1)(1994-5#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-3#1)
among amino##2##2##(1997-2#1)(2008-10#1)
among an at random sample of family doctors in North Holland (n = 521)##2##14##(1991-8#2)
among an##3##2##(1991-8#2)(2010-1#1)
among and##2##2##(2008-10#1)(2010-10#1)
among athletes##2##2##(1996-6#1)(2010-7#1)
among bacterial##2##2##(1993-12#1)(2008-10#1)
among both##5##2##(1994-1#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)
among caregivers of##3##3##(1995-2#1)(2008-7#1)(2013-8#1)
among certain##2##2##(1990-12#1)(2010-1#1)
among children and adolescents##4##4##(2010-11#2)(2010-7#1)(2012-12#1)
among children and##6##3##(1991-6#1)(2010-11#2)(2010-7#1)(2011-1#1)(2012-12#1)
among children under##2##3##(2008-1#1)(2013-1#1)
among children who##3##3##(1994-6#2)(2009-7#1)
among children##21##2##(1991-11#1)(1991-6#1)(1991-8#1)(1994-6#3)(2008-1#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-1#1)(2010-11#2)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
among circumpolar indigenous individuals##2##4##(2013-1#2)
among clinical##3##2##(1997-8#1)(2010-7#1)(2012-2#1)
among clinicians##2##2##(1997-2#1)(2011-2#1)
among closely related##2##3##(2008-8#1)(2008-9#1)
among closely##3##2##(1991-10#1)(2008-8#1)(2008-9#1)
among common##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
among continents##2##2##(2008-10#2)
among countries##2##2##(1997-8#1)(2008-10#1)
among cultivars##3##2##(2008-10#3)
among different populations##2##3##(1997-8#1)(2011-2#1)
among different species##2##3##(1997-3#1)(2008-10#1)
among different##31##2##(1994-11#1)(1997-3#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#1)
among distinct##2##2##(2008-10#1)(2008-8#1)
among diverse##2##2##(1995-2#1)(2009-10#1)
among drug users in Norway##2##5##(1996-11#2)
among drug##3##2##(1996-11#3)
among eastern##2##2##(2008-10#1)(2008-8#1)
among eight##4##2##(1993-12#1)(2008-10#3)
among employees##2##2##(1990-2#1)(1991-12#1)
among environments##2##2##(2008-10#1)(2008-8#1)
among experiments##3##2##(2008-10#3)
among experts##3##2##(2011-10#1)(2011-2#1)(2013-1#1)
among factory##2##2##(2008-11#1)(2010-8#1)
among family members##2##3##(1990-12#1)(2009-11#1)
among female victims of child abuse##2##6##(2009-9#2)
among female##3##2##(2008-8#1)(2009-9#2)
among females in##2##3##(2008-8#1)(2013-1#1)
among females##4##2##(1991-1#1)(1994-6#1)(2008-8#1)(2013-1#1)
among fields within##3##3##(2008-10#3)
among fields##6##2##(2008-10#6)
among fishermen##2##2##(1993-11#2)
among five isolates##2##3##(2008-10#2)
among five##3##2##(2008-10#2)(2008-11#1)
among four##5##2##(1992-2#1)(2008-10#1)(2009-8#1)(2012-3#1)(2013-8#1)
among free-living animals##3##3##(2008-9#3)
among gay##2##2##(2008-12#1)(2009-5#1)
among genotypes##2##2##(2008-10#1)(2012-5#1)
among group##2##2##(2008-8#2)
among groups##6##2##(2008-10#2)(2009-1#1)(2010-1#1)(2010-7#1)(2013-1#1)
among health care professionals##2##4##(1992-12#1)(1992-3#1)
among health care providers##2##4##(1992-2#1)(1996-3#1)
among health care##6##3##(1992-12#1)(1992-2#1)(1992-3#1)(1994-1#1)(1996-3#1)(2008-11#1)
among health professionals and##2##4##(1993-2#1)(2012-3#1)
among health professionals##3##3##(1993-2#1)(2008-11#1)(2012-3#1)
among health##12##2##(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-11#2)(2012-3#1)
among healthy##4##2##(1990-2#1)(2008-10#3)
among high school students in the Tiko health district##2##9##(2013-1#2)
among high##3##2##(1995-1#1)(2013-1#2)
among homosexual men in##2##4##(1996-11#2)
among homosexual men##3##3##(1996-11#3)
among hospitalized##2##2##(2008-11#1)(2009-4#1)
among hospitals##5##2##(1992-11#1)(1993-12#1)(1994-1#1)(1994-3#1)(2010-8#1)
among host##2##2##(2008-10#2)
among human##3##2##(1995-12#1)(1997-8#1)(2008-11#1)
among hybrids##2##2##(2008-10#1)(2012-3#1)
among independent community dwelling older adults##2##6##(2008-12#2)
among individual##3##2##(2008-10#2)(2008-8#1)
among individuals and##2##3##(2008-11#1)(2008-12#1)
among individuals are##2##3##(2008-1#1)(2008-8#1)
among individuals with##4##3##(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
among individuals within##3##3##(2008-10#2)(2012-7#1)
among individuals##17##2##(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#4)(2009-4#1)(2010-8#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
among infants and##2##3##(1992-12#1)(2011-2#1)
among infants##3##2##(1992-12#2)(2011-2#1)
among infected plants##2##3##(2008-10#2)
among insects##2##2##(2007-12#1)(2010-4#1)
among intravenous drug users (IVDUs)##2##5##(1991-1#1)(1992-9#1)
among intravenous drug users##3##4##(1991-1#1)(1992-9#1)(2013-8#1)
among intravenous drug##4##3##(1991-1#1)(1992-9#1)(2013-8#2)
among isolates and##2##3##(2008-10#2)
among isolates for##2##3##(2008-10#2)
among isolates from different##2##4##(2008-10#2)
among isolates from##4##3##(2008-10#4)
among isolates in the##2##4##(2008-10#2)
among isolates in##3##3##(2008-10#3)
among isolates of either##2##4##(2008-10#2)
among isolates of##10##3##(1996-12#1)(2008-10#8)(2012-2#1)
among isolates sampled from##2##4##(2008-10#2)
among isolates within##5##3##(2008-10#5)
among isolates##43##2##(1996-12#1)(2008-10#41)(2012-2#1)
among juveniles##2##2##(2008-11#1)(2008-9#1)
among large##2##2##(2008-11#1)(2011-2#1)
among lesions##2##2##(2008-10#2)
among local##2##2##(1996-1#1)(2009-5#1)
among locations##6##2##(1993-6#1)(2008-10#5)
among loci##2##2##(2008-10#1)(2010-5#1)
among low##2##2##(1995-1#1)(2008-10#1)
among machinists##2##2##(1991-12#2)
among male physicians who##2##4##(2011-2#2)
among male##3##2##(2008-7#1)(2011-2#2)
among males and##3##3##(1994-12#1)(2008-8#1)(2009-5#1)
among males##7##2##(1994-12#1)(1994-6#1)(2008-8#2)(2009-5#1)(2013-1#1)(2013-8#1)
among many##6##2##(1991-3#1)(2008-10#1)(2008-9#2)(2010-12#2)
among medical specialties and systems of care##2##7##(1992-4#2)
among medical students in##3##4##(2011-2#1)(2013-1#1)(2013-7#1)
among medical##6##2##(1992-4#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
among members of##2##3##(2008-10#1)(2009-5#1)
among men##7##2##(1995-2#1)(1996-2#1)(2008-12#1)(2008-4#1)(2009-5#2)(2011-2#1)
among mothers##3##2##(2009-5#1)(2010-10#1)(2011-1#1)
among multiple sclerosis patients##2##4##(2010-2#1)(2012-12#1)
among muscles monitored with##2##4##(2012-2#2)
among neighboring##2##2##(1991-1#1)(2008-9#1)
among new users of meloxicam##2##5##(2008-11#2)
among newborns##2##2##(1991-3#2)
among nonrelatives##2##2##(2008-8#2)
among nurses in##2##3##(2008-7#1)(2012-3#1)
among nurses##4##2##(1990-2#1)(2008-11#1)(2008-7#1)(2012-3#1)
among nursing home residents##2##4##(1995-2#2)
among nursing home##3##3##(1995-2#2)(1997-2#1)
among nursing##7##2##(1995-2#2)(1996-3#2)(1997-2#1)(2008-11#1)(2008-12#1)
among obese##2##2##(2008-10#1)(2013-1#1)
among occupied patches##2##3##(2008-8#2)
among older adults##3##3##(1997-3#1)(2008-4#1)(2010-11#1)
among older people##2##3##(2012-12#1)(2013-1#1)
among older##9##2##(1994-3#2)(1997-3#1)(2008-4#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-12#1)(2013-1#1)
among other factors##2##3##(1994-9#1)(2012-2#1)
among other things##3##3##(1990-2#1)(1994-2#1)(2008-10#1)
among other##13##2##(1990-2#1)(1992-3#1)(1994-2#1)(1994-9#1)(2008-10#5)(2009-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
among others##9##2##(1991-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
among pairs of##3##3##(2008-10#3)
among parents##3##2##(1993-3#1)(1994-6#1)(2013-8#1)
among participants##2##2##(2008-11#1)(2013-8#1)
among patches##2##2##(2008-8#1)(2008-9#1)
among pathovars of##2##3##(2008-10#2)
among pathovars##3##2##(2008-10#3)
among patient populations##2##3##(1995-2#1)(2011-2#1)
among patient##3##2##(1995-2#1)(2008-4#1)(2011-2#1)
among patients with##10##3##(2008-12#1)(2008-7#1)(2009-1#1)(2009-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
among patients##25##2##(1991-2#1)(1991-5#1)(1993-2#1)(1994-12#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-1#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
among pea cultivars##2##3##(2008-10#2)
among people##3##2##(1990-11#1)(1997-1#1)(2012-3#1)
among persons aged 40-42##2##4##(1991-6#2)
among persons##8##2##(1991-6#2)(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#2)(1997-3#1)
among physicians##4##2##(1991-3#1)(2008-11#1)(2013-1#1)(2013-8#1)
among plant-associated##2##2##(2008-10#2)
among plants##2##2##(2008-8#1)(2008-9#1)
among polygynous than monogamous##2##4##(2008-9#2)
among polygynous##3##2##(2008-9#3)
among population##2##2##(2011-2#1)(2012-3#1)
among populations adapted to##2##4##(2012-3#2)
among populations from##2##3##(2008-10#1)(2008-8#1)
among populations of##2##3##(2008-10#2)
among populations that##2##3##(2008-10#1)(2008-8#1)
among populations was##2##3##(2008-10#2)
among populations within regions##2##4##(2008-10#2)
among populations##23##2##(2008-10#14)(2008-8#4)(2012-3#3)(2013-1#1)(2013-8#1)
among pregnant women in##3##4##(1990-6#1)(2013-1#1)(2013-8#1)
among pregnant women##5##3##(1990-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
among primary school children in##2##5##(2008-10#2)
among prisoners##2##2##(2008-12#2)
among providers##2##2##(1994-1#2)
among provinces##3##2##(2008-10#3)
among public health##2##3##(1995-12#1)(1997-1#1)
among public##3##2##(1992-1#1)(1995-12#1)(1997-1#1)
among raters##2##2##(2008-10#2)
among regions and##2##3##(2008-10#2)
among regions##9##2##(2008-10#9)
among residents of##2##3##(2008-10#1)(2013-1#1)
among residents##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
among rural##3##2##(2010-10#1)(2010-6#1)(2013-1#1)
among sampling##4##2##(2008-10#4)
among school children in##2##4##(2008-10#1)(2011-2#1)
among school children##3##3##(1991-9#1)(2008-10#1)(2011-2#1)
among school##5##2##(1991-12#1)(1991-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
among selected##2##2##(2008-10#2)
among seven##4##2##(1994-11#1)(1997-5#1)(2008-10#2)
among several##5##2##(1997-3#1)(2008-10#1)(2008-9#1)(2010-7#1)(2013-1#1)
among sexual##2##2##(2008-12#1)(2011-2#1)
among single##2##2##(2008-10#1)(2012-3#1)
among sites##2##2##(2008-10#1)(2008-8#1)
among six##5##2##(2008-10#3)(2008-9#2)
among social##3##2##(2008-8#1)(2010-1#1)(2012-3#1)
among species in##2##3##(2008-8#1)(2010-8#1)
among species##8##2##(1992-10#1)(1993-3#1)(1997-1#1)(2008-10#1)(2008-8#3)(2010-8#1)
among strain##2##2##(1994-8#1)(2008-10#1)
among strains from##3##3##(2008-10#3)
among strains of X##2##4##(2008-10#2)
among strains of##4##3##(2008-10#4)
among strains##23##2##(2008-10#21)(2008-2#1)(2008-5#1)
among students and##2##3##(2008-11#1)(2008-12#1)
among students##3##2##(2008-11#2)(2008-12#1)
among studies##2##2##(2008-4#1)(2008-7#1)
among subjects with##2##3##(1995-9#1)(2012-3#1)
among subjects##4##2##(1995-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
among subpopulations##4##2##(2008-10#4)
among taxa in##2##3##(2008-8#1)(2008-9#1)
among the 17##2##3##(2008-10#1)(2008-11#1)
among the biocontrol isolates##2##4##(2008-10#2)
among the cells##2##3##(2008-11#1)(2008-6#1)
among the different##8##3##(1990-9#1)(1996-12#1)(2008-10#3)(2008-9#1)(2009-10#1)(2013-8#1)
among the elderly##7##3##(1990-2#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-7#2)(2011-2#1)
among the five##2##3##(2008-10#2)
among the four##7##3##(1990-8#1)(2008-10#4)(2008-7#1)(2010-4#1)
among the general##2##3##(2008-11#1)(2012-3#1)
among the highest##2##3##(2008-12#1)(2010-1#1)
among the isolates that##2##4##(2008-10#2)
among the isolates##7##3##(2008-10#6)(2008-12#1)
among the key##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
among the lowest##2##3##(1996-1#1)(2009-10#1)
among the major##2##3##(1996-2#1)(2010-5#1)
among the most common##5##4##(2008-10#1)(2008-12#1)(2009-8#1)(2010-8#1)(2011-2#1)
among the most important##2##4##(1994-9#1)(2008-12#1)
among the most##17##3##(1994-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2009-10#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
among the nine##3##3##(1992-2#1)(2008-10#2)
among the other##2##3##(2008-10#2)
among the patients##3##3##(1997-8#1)(2008-10#1)(2012-3#1)
among the population of##2##4##(2011-2#1)(2013-8#1)
among the population##3##3##(1997-6#1)(2011-2#1)(2013-8#1)
among the populations##2##3##(2008-10#2)
among the potential##3##3##(2008-10#1)(2010-12#1)(2010-9#1)
among the primary##2##3##(1997-3#1)(2008-3#1)
among the range##2##3##(2008-8#2)
among the same##2##3##(2008-11#1)(2008-9#1)
among the sampled isolates##2##4##(2008-10#2)
among the ten##2##3##(2008-11#1)(2013-8#1)
among the tested##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
among the three groups##3##4##(1993-1#1)(2012-5#1)(2013-8#1)
among the three##18##3##(1993-1#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-3#1)(2012-5#1)(2013-8#2)
among the two##2##3##(2008-10#2)
among the various##4##3##(1990-7#1)(2008-10#3)
among the workers##2##3##(1996-3#1)(2009-12#1)
among the younger##2##3##(1997-5#1)(2008-10#1)
among the##308##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#3)(1997-9#1)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#99)(2008-11#14)(2008-12#11)(2008-3#2)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#6)(2009-10#3)(2009-12#4)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-2#5)(2012-3#7)(2012-5#1)(2013-1#8)(2013-8#12)
among their##4##2##(1995-1#1)(2008-11#1)(2008-4#1)(2013-8#1)
among them a##2##3##(1995-6#1)(2008-7#1)
among them were##2##3##(1991-12#1)(2008-10#1)
among them##18##2##(1990-6#1)(1991-12#1)(1992-3#1)(1993-2#1)(1995-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#2)
among themselves##4##2##(1992-1#1)(2006-6#1)(2008-10#2)
among these genes##2##3##(1997-8#1)(2008-8#1)
among these organs##2##3##(2008-11#1)(2011-2#1)
among these populations was low##2##5##(2008-10#1)(2013-1#1)
among these populations##4##3##(2008-10#3)(2013-1#1)
among these species##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
among these three groups##2##4##(2008-10#2)
among these three##4##3##(1994-12#1)(2008-10#3)
among these##44##2##(1992-3#1)(1993-12#1)(1994-12#2)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#3)
among this population##3##3##(2008-11#1)(2008-12#2)
among this##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
among those aged##2##3##(2010-3#1)(2011-2#1)
among those with##2##3##(1991-12#2)
among those##15##2##(1991-12#2)(1995-12#1)(1995-5#2)(1997-2#1)(2008-10#3)(2008-8#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
among three##5##2##(1997-3#1)(2008-10#2)(2008-8#1)(2010-7#1)
among time##2##2##(1992-2#1)(2013-1#1)
among tomato##2##2##(2008-10#2)
among total##2##2##(2008-11#1)(2008-9#1)
among treatments##2##2##(2008-10#2)
among two##4##2##(2008-10#3)(2008-8#1)
among users of##3##3##(1995-5#1)(2008-11#1)(2008-5#1)
among users##4##2##(1995-3#1)(1995-5#1)(2008-11#1)(2008-5#1)
among variables in##2##3##(2008-10#1)(2008-7#1)
among variables##3##2##(2008-10#2)(2008-7#1)
among various##6##2##(1996-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
among which the most##2##4##(1996-12#1)(2008-10#1)
among which the##3##3##(1996-12#1)(2008-10#1)(2010-12#1)
among which##13##2##(1995-12#1)(1996-12#1)(2008-10#4)(2009-8#1)(2010-12#2)(2011-2#1)(2011-3#2)(2013-1#1)
among women in##4##3##(1997-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
among women with##3##3##(1997-4#2)(2012-3#1)
among women##15##2##(1990-6#1)(1991-11#3)(1993-12#1)(1996-3#1)(1997-4#3)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
among workers##4##2##(1991-9#1)(1992-3#1)(2008-8#1)(2012-3#1)
among years##5##2##(2008-10#5)
among young adults##3##3##(2012-3#2)(2013-8#1)
among young people##3##3##(1990-3#1)(1997-6#1)(2012-2#1)
among young##14##2##(1990-3#1)(1990-6#1)(1991-3#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-3#1)(2012-2#1)(2012-3#2)(2013-8#2)
among younger##2##2##(1990-6#1)(1996-6#1)
among youth with disabilities or special health care needs##2##9##(2010-11#2)
among youth##6##2##(1997-6#1)(2008-11#1)(2009-7#1)(2010-11#2)(2012-2#1)
among##1819##1##(1990-11#1)(1990-12#2)(1990-2#10)(1990-3#5)(1990-5#1)(1990-6#7)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#8)(1991-10#2)(1991-11#5)(1991-12#18)(1991-2#6)(1991-3#9)(1991-5#6)(1991-6#6)(1991-8#7)(1991-9#6)(1992-1#5)(1992-10#3)(1992-11#3)(1992-12#7)(1992-2#7)(1992-3#10)(1992-4#3)(1992-6#4)(1992-9#4)(1993-1#5)(1993-11#3)(1993-12#8)(1993-2#10)(1993-3#3)(1993-6#4)(1993-9#3)(1994-1#5)(1994-11#5)(1994-12#11)(1994-2#2)(1994-3#9)(1994-5#3)(1994-6#10)(1994-8#1)(1994-9#4)(1995-1#9)(1995-11#3)(1995-12#14)(1995-2#9)(1995-3#4)(1995-5#6)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#6)(1996-11#7)(1996-12#7)(1996-2#5)(1996-3#12)(1996-5#2)(1996-6#7)(1996-8#4)(1997-1#3)(1997-2#5)(1997-3#12)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#9)(1997-9#2)(2006-6#2)(2007-11#1)(2007-12#7)(2008-1#19)(2008-10#548)(2008-11#91)(2008-12#45)(2008-2#4)(2008-3#6)(2008-4#11)(2008-5#20)(2008-6#7)(2008-7#27)(2008-8#80)(2008-9#56)(2009-1#2)(2009-10#8)(2009-11#8)(2009-12#10)(2009-3#1)(2009-4#5)(2009-5#20)(2009-6#4)(2009-7#9)(2009-8#8)(2009-9#2)(2010-1#12)(2010-10#9)(2010-11#10)(2010-12#14)(2010-2#5)(2010-3#5)(2010-4#5)(2010-5#7)(2010-6#6)(2010-7#12)(2010-8#11)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#68)(2011-3#5)(2012-12#12)(2012-2#43)(2012-3#59)(2012-5#2)(2012-6#2)(2012-7#2)(2013-1#83)(2013-7#1)(2013-8#52)
among-group##3##1##(2008-10#1)(2008-8#2)
amongst others##2##2##(2008-10#2)
amongst staff in##2##3##(2008-11#2)
amongst staff##3##2##(2008-11#2)(2010-10#1)
amongst the different##2##3##(2008-10#1)(2009-8#1)
amongst the five areas (P2##2##5##(1993-1#2)
amongst the##16##2##(1993-1#2)(1997-7#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-8#1)(2011-2#3)(2012-12#3)
amongst##58##1##(1993-1#2)(1995-10#1)(1997-7#1)(2007-12#3)(2008-1#4)(2008-10#9)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#2)(2010-10#1)(2010-3#1)(2011-2#7)(2012-12#6)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
amorphous aggregates##2##2##(2008-10#1)(2008-11#1)
amorphous content of the samples##2##5##(2008-10#2)
amorphous content of##5##3##(2008-10#5)
amorphous content##7##2##(2008-10#7)
amorphous fluoropolymer##3##2##(2008-10#2)(2012-2#1)
amorphous iron oxide##2##3##(2008-10#2)
amorphous iron##3##2##(2008-10#3)
amorphous material##3##2##(2008-10#3)
amorphous materials##2##2##(1995-3#1)(2008-7#1)
amorphous silica##3##2##(2008-10#3)
amorphous silicon##2##2##(2008-10#2)
amorphous##48##1##(1991-12#1)(1995-3#2)(2007-12#1)(2008-10#31)(2008-11#1)(2008-2#2)(2008-5#4)(2008-7#2)(2010-6#1)(2010-7#1)(2010-8#1)(2012-2#1)
amosite fibers##4##2##(1991-12#4)
amosite##7##1##(1991-12#7)
amount and##10##2##(1990-5#1)(1991-11#1)(1995-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)
amount at##3##2##(1990-12#1)(1996-12#1)(2008-7#1)
amount by##2##2##(2008-10#2)
amount for##2##2##(2008-10#1)(2008-5#1)
amount in##3##2##(2008-10#1)(2009-7#1)(2013-8#1)
amount is##3##2##(2008-10#2)(2012-2#1)
amount of 1##2##3##(2008-10#1)(2008-5#1)
amount of F-actin##2##3##(1991-5#1)(2008-7#1)
amount of HEG##2##3##(2008-10#2)
amount of HRP-SjAb bound##2##4##(2008-10#2)
amount of Hsp70##2##3##(1991-9#2)
amount of acid##3##3##(2008-10#2)(2008-9#1)
amount of adsorbent##4##3##(2008-10#4)
amount of alpha phase##2##4##(2009-7#2)
amount of ammonia##2##3##(2008-10#2)
amount of aromatase mRNA in##2##5##(1993-8#2)
amount of aromatase##3##3##(1993-8#3)
amount of arsenic##3##3##(2008-10#3)
amount of available##3##3##(2008-12#1)(2008-9#1)(2010-12#1)
amount of biological##2##3##(2008-10#1)(2009-12#1)
amount of blood##4##3##(1994-3#2)(1996-9#2)
amount of bone##2##3##(2008-11#1)(2013-1#1)
amount of bound##2##3##(1990-12#1)(2008-7#1)
amount of chromium##2##3##(2008-10#2)
amount of copper##2##3##(2008-10#2)
amount of data##8##3##(1995-5#1)(2008-10#3)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)
amount of disease##7##3##(2008-10#7)
amount of drug##2##3##(1997-2#1)(2008-10#1)
amount of dsDNA##3##3##(2008-10#3)
amount of eluent##6##3##(2008-10#6)
amount of energy available for##2##5##(2008-8#2)
amount of energy##9##3##(2008-10#1)(2008-8#3)(2008-9#3)(2013-1#2)
amount of enzyme##2##3##(2008-10#2)
amount of fat##2##3##(2008-4#1)(2012-3#1)
amount of formaldehyde in##3##4##(2008-10#3)
amount of hydrogen peroxide##2##4##(2008-10#2)
amount of information##6##3##(1997-3#1)(2008-10#2)(2008-7#3)
amount of intracellular##3##3##(2008-10#1)(2008-11#2)
amount of iron##3##3##(2008-10#3)
amount of lead##2##3##(2008-10#2)
amount of ligand##4##3##(2008-10#4)
amount of lipofuscin in##2##4##(1995-3#2)
amount of mRNA##2##3##(1996-2#1)(1996-6#1)
amount of manganese##2##3##(2008-10#2)
amount of material removed##2##4##(2008-10#2)
amount of material##4##3##(2008-10#4)
amount of methanol##2##3##(2008-10#2)
amount of neurofilament protein##2##4##(1996-12#2)
amount of nitrite##3##3##(2008-10#3)
amount of one##2##3##(2008-10#2)
amount of organic##2##3##(2008-10#2)
amount of pathogen DNA quantified##2##5##(2008-10#2)
amount of pathogen DNA##5##4##(2008-10#5)
amount of pathogen##6##3##(2008-10#6)
amount of radiation##2##3##(2008-7#1)(2013-1#1)
amount of reagents and##2##4##(2008-10#2)
amount of reagents##3##3##(2008-10#3)
amount of recombinant##2##3##(2008-10#1)(2008-11#1)
amount of research##2##3##(2009-1#1)(2011-2#1)
amount of reserpine##2##3##(2008-12#2)
amount of sample matrix##2##4##(2008-10#2)
amount of sample to be##2##5##(2008-10#2)
amount of sample##10##3##(2008-10#10)
amount of t-PA##2##3##(2008-11#2)
amount of tartaric acid##3##4##(2008-5#3)
amount of the variance in the##2##6##(1995-3#1)(2008-9#1)
amount of the##25##3##(1992-6#3)(1993-12#1)(1995-3#1)(1996-12#1)(1996-5#2)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)
amount of these##3##3##(1990-6#1)(2008-11#1)(2008-8#1)
amount of time##8##3##(1996-3#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-8#1)(2011-2#1)
amount of type I collagen##2##5##(2008-9#2)
amount of virus##2##3##(2008-10#2)
amount of water##2##3##(2008-10#2)
amount of yeast biomass##2##4##(2008-10#2)
amount of##560##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#7)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#3)(1996-9#4)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#5)(2008-10#286)(2008-11#42)(2008-12#10)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#12)(2008-8#12)(2008-9#21)(2009-1#1)(2009-10#1)(2009-12#2)(2009-7#5)(2009-8#6)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#5)(2011-2#13)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#5)
amount on the##2##3##(2008-10#2)
amount that is##2##3##(1993-3#1)(2009-5#1)
amount to##2##2##(1990-2#1)(1995-12#1)
amount was##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
amount were##2##2##(1993-8#1)(2008-10#1)
amount##665##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#7)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#6)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#3)(1996-5#3)(1996-6#3)(1996-9#4)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#5)(2008-10#324)(2008-11#47)(2008-12#14)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#18)(2008-6#6)(2008-7#16)(2008-8#19)(2008-9#21)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#6)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#6)(2011-10#1)(2011-2#13)(2011-3#1)(2012-2#5)(2012-3#5)(2013-1#12)(2013-8#9)
amount)##5##1##(1992-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
amounted to##6##2##(1991-12#1)(1991-2#1)(1996-5#1)(1997-6#1)(2008-10#1)(2012-12#1)
amounted##7##1##(1991-12#1)(1991-2#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-12#1)
amounting to##5##2##(1994-5#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
amounts and##6##2##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)
amounts by##5##2##(1991-2#1)(2008-10#1)(2008-7#1)(2011-1#2)
amounts for##2##2##(1995-6#1)(1995-8#1)
amounts found in##2##3##(2008-10#1)(2012-2#1)
amounts from##2##2##(2008-5#1)(2008-9#1)
amounts in the##3##3##(1993-6#1)(1995-2#1)(2008-6#1)
amounts in##8##2##(1993-6#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-6#2)
amounts of Cr(VI)##3##3##(2008-10#3)
amounts of DNA##3##3##(1995-5#1)(2008-10#1)(2008-12#1)
amounts of IAA##3##3##(2008-10#3)
amounts of NADH##3##3##(2008-10#3)
amounts of Pd##2##3##(2008-10#2)
amounts of Zn##2##3##(1993-12#1)(2008-10#1)
amounts of actin##2##3##(1991-5#2)
amounts of active##2##3##(1992-3#1)(2008-11#1)
amounts of aluminium##2##3##(2008-10#2)
amounts of an##2##3##(1990-5#1)(2008-11#1)
amounts of analytes##2##3##(2008-10#2)
amounts of antimony##2##3##(2008-10#2)
amounts of both##3##3##(2008-10#2)(2008-11#1)
amounts of cadmium in##3##4##(2008-10#3)
amounts of cadmium is##2##4##(2008-10#2)
amounts of cadmium##8##3##(2008-10#8)
amounts of chloride##2##3##(2008-10#2)
amounts of copper##9##3##(2008-10#9)
amounts of data##4##3##(1995-12#2)(2008-9#1)(2012-3#1)
amounts of different##2##3##(2008-10#2)
amounts of each##3##3##(2008-10#3)
amounts of food##2##3##(1993-6#1)(2013-1#1)
amounts of glutamic acid##2##4##(2008-10#1)(2011-2#1)
amounts of heavy metals in##2##5##(2008-10#2)
amounts of hydrogen##3##3##(2008-10#3)
amounts of iron in##2##4##(2008-10#2)
amounts of iron##6##3##(2008-10#6)
amounts of lead##5##3##(2008-10#5)
amounts of metal##3##3##(2008-10#2)(2010-11#1)
amounts of monoclonal##2##3##(2008-10#1)(2008-11#1)
amounts of nickel##2##3##(2008-10#2)
amounts of nitrate##3##3##(2008-10#3)
amounts of nucleic##4##3##(2008-10#4)
amounts of products##2##3##(1993-8#1)(2008-5#1)
amounts of protein##2##3##(1990-12#1)(2008-10#1)
amounts of radioactivity##2##3##(1990-12#1)(1991-12#1)
amounts of recombinant protein##2##4##(1994-11#1)(2008-11#1)
amounts of recombinant##3##3##(1994-11#1)(2008-11#2)
amounts of salbutamol##2##3##(2008-10#2)
amounts of sample##3##3##(2008-10#2)(2010-7#1)
amounts of selenium##3##3##(2008-10#3)
amounts of sodium##2##3##(2008-10#2)
amounts of sulfur##3##3##(2008-10#3)
amounts of target##2##3##(2008-10#2)
amounts of the##25##3##(1990-11#1)(1990-12#1)(1990-5#2)(1991-5#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-3#2)(2012-2#1)
amounts of these##5##3##(1990-11#1)(2008-10#3)(2008-12#1)
amounts of this##5##3##(1992-12#1)(2008-10#2)(2008-11#2)
amounts of total##2##3##(1994-11#1)(2009-12#1)
amounts of uranium(VI)##2##3##(2008-10#2)
amounts of volatile##2##3##(2008-10#1)(2009-8#1)
amounts of water##2##3##(2008-10#1)(2008-7#1)
amounts of zinc##4##3##(2008-10#4)
amounts of##438##2##(1990-11#3)(1990-12#4)(1990-2#1)(1990-5#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#7)(1992-10#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#3)(1996-5#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-12#1)(2008-10#269)(2008-11#29)(2008-12#6)(2008-3#4)(2008-4#3)(2008-5#14)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-4#2)(2010-7#2)(2011-2#6)(2011-3#2)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#5)(2013-8#1)
amounts or##3##2##(1993-9#1)(2008-10#1)(2008-11#1)
amounts to##9##2##(1994-5#1)(1996-2#1)(2008-10#3)(2008-11#3)(2012-2#1)
amounts up to##2##3##(2008-10#1)(2008-9#1)
amounts were##4##2##(1994-11#1)(2008-10#2)(2008-7#1)
amounts##524##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#8)(1992-10#1)(1992-12#3)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#5)(1994-2#1)(1994-3#2)(1994-5#4)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#4)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-12#1)(2008-10#300)(2008-11#39)(2008-12#8)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#18)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#2)(2012-2#6)(2012-3#2)(2012-8#1)(2013-1#5)(2013-8#1)
amounts)##3##1##(2011-2#3)
amoxicillin##2##1##(1996-11#1)(2010-12#1)
amoxycillin and##3##2##(2008-10#3)
amoxycillin##7##1##(1991-3#3)(2008-10#4)
amperometric ammonia sensor##2##3##(2008-10#2)
amperometric biosensor based on##8##4##(2008-10#8)
amperometric biosensor for hydrogen peroxide##3##5##(2008-10#3)
amperometric biosensor for screening##2##4##(2008-10#2)
amperometric biosensor for##8##3##(2008-10#8)
amperometric biosensor##24##2##(2008-10#24)
amperometric biosensors##5##2##(2008-10#5)
amperometric current-time##2##2##(2008-10#1)(2013-1#1)
amperometric detection (AD)##2##3##(2008-10#2)
amperometric detection at a##4##4##(2008-10#4)
amperometric detection at##9##3##(2008-10#9)
amperometric detection for##3##3##(2008-10#3)
amperometric detection of NADH##3##4##(2008-10#3)
amperometric detection of underivatized amino acids in anion-exchange chromatography##2##9##(2008-10#2)
amperometric detection of underivatized amino acids##4##6##(2008-10#4)
amperometric detection of##23##3##(2008-10#23)
amperometric detection on##2##3##(2008-10#2)
amperometric detection was##4##3##(2008-10#4)
amperometric detection with##3##3##(2008-10#3)
amperometric detection##78##2##(1991-7#2)(1992-1#1)(2008-10#75)
amperometric detector for microchip##2##4##(2008-10#2)
amperometric detector for the##4##4##(2008-10#4)
amperometric detector for##12##3##(2008-10#12)
amperometric detector##25##2##(2008-10#25)
amperometric detectors for##2##3##(2008-10#2)
amperometric determination of##7##3##(2008-10#7)
amperometric determination##8##2##(2008-10#8)
amperometric enzyme electrode for the##2##5##(2008-10#2)
amperometric enzyme##3##2##(2008-10#3)
amperometric glucose biosensors##2##3##(2008-10#2)
amperometric glucose sensor##3##3##(2008-10#3)
amperometric glucose##8##2##(2008-10#8)
amperometric immunosensor based on##2##4##(2008-10#2)
amperometric immunosensor for the##2##4##(2008-10#2)
amperometric immunosensor for##3##3##(2008-10#3)
amperometric immunosensor##6##2##(2008-10#6)
amperometric immunosensors##3##2##(2008-10#3)
amperometric measurements at##2##3##(2008-10#2)
amperometric measurements##4##2##(2008-10#3)(2009-10#1)
amperometric method##4##2##(2008-10#4)
amperometric monitoring of flowing streams##2##5##(2008-10#2)
amperometric pH-sensing##2##2##(2008-10#2)
amperometric response of the biosensor##2##5##(2008-10#2)
amperometric response of the##3##4##(2008-10#3)
amperometric response of##5##3##(2008-10#5)
amperometric response##13##2##(2008-10#13)
amperometric screen-printed##2##2##(2008-10#2)
amperometric selectivity##2##2##(2008-10#2)
amperometric sensor for the##2##4##(2008-10#2)
amperometric sensor for##6##3##(2008-10#6)
amperometric sensor##8##2##(2008-10#8)
amperometric sensors##3##2##(2008-10#3)
amperometric working##2##2##(2008-10#2)
amperometric##240##1##(1991-7#2)(1992-1#1)(2008-10#235)(2009-10#1)(2013-1#1)
amperometrically##7##1##(1995-3#1)(2008-10#6)
amperometry at a##2##3##(2008-10#2)
amperometry at the interface between two immiscible electrolyte solutions##2##9##(2008-10#2)
amperometry at##7##2##(2008-10#7)
amperometry with##2##2##(2008-10#2)
amperometry##25##1##(1991-7#1)(2008-10#24)
amphetamine (1##3##2##(1993-6#1)(1994-2#2)
amphetamine and##4##2##(1993-6#1)(1994-2#1)(2008-10#2)
amphetamine in rat's blood and brain##3##6##(2008-10#3)
amphetamine in##5##2##(1994-2#2)(2008-10#3)
amphetamine intravenous self-administration##2##3##(1993-6#2)
amphetamine##30##1##(1992-2#1)(1992-7#2)(1993-3#1)(1993-6#8)(1994-2#6)(1996-6#1)(2008-10#10)(2008-11#1)
amphetamine-induced##3##1##(1993-6#1)(1994-2#2)
amphetamines according to##2##3##(2008-10#2)
amphetamines from##2##2##(2008-10#2)
amphetamines##14##1##(1991-1#1)(2008-10#13)
amphibian##9##1##(1994-11#3)(1996-2#1)(1997-1#1)(1997-3#1)(2008-12#2)(2008-9#1)
amphibians##12##1##(1995-12#1)(1996-5#4)(1997-3#4)(1997-7#1)(2008-7#1)(2008-8#1)
amphiboles##2##1##(1991-12#2)
amphihaploids##2##1##(2008-10#2)
amphipathic##6##1##(1994-5#3)(1995-11#1)(2008-10#2)
amphipatic##2##1##(2011-2#2)
amphiphile##2##1##(2008-10#2)
amphiphiles##4##1##(2008-11#3)(2008-5#1)
amphiphilic character##2##2##(1994-5#2)
amphiphilic forms##3##2##(1990-5#3)
amphiphilic leader sequence##3##3##(1991-10#3)
amphiphilic leader##4##2##(1991-10#4)
amphiphilic peptides##2##2##(1994-11#2)
amphiphilic##21##1##(1990-5#3)(1991-10#7)(1994-11#2)(1994-5#3)(2008-10#3)(2008-5#1)(2012-2#2)
amphipod##2##1##(2008-10#1)(2008-6#1)
amphipods in##2##2##(2008-6#1)(2012-3#1)
amphoteric and##3##2##(2008-10#1)(2008-5#2)
amphoteric##8##1##(2008-10#6)(2008-5#2)
amphotericin B plus flucytosine##2##4##(2011-2#2)
amphotericin B##17##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#10)(2010-10#1)(2011-2#3)
amphotericin##18##1##(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#10)(2010-10#1)(2011-2#4)
amphotropic retroviruses##2##2##(1990-5#2)
amphotropic##5##1##(1990-5#4)(2008-11#1)
ampicillin and##5##2##(2008-10#4)(2012-3#1)
ampicillin##20##1##(1993-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-8#1)
ample opportunity##2##2##(2008-12#1)(2011-2#1)
ample##6##1##(1991-5#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
amplicon and##2##2##(2008-10#1)(2011-2#1)
amplicon##17##1##(2008-10#9)(2008-11#1)(2008-8#4)(2010-10#1)(2011-2#2)
amplicons with##2##2##(2008-10#2)
amplicons##12##1##(1995-12#1)(2008-10#9)(2008-9#1)(2011-2#1)
amplifiable DNA##2##2##(2008-10#1)(2009-8#1)
amplifiable##3##1##(2008-10#2)(2009-8#1)
amplification activity##2##2##(1991-6#2)
amplification and sequencing of##3##4##(1993-12#1)(2008-10#1)(2012-2#1)
amplification and sequencing##5##3##(1993-12#1)(2008-10#1)(2012-2#1)(2013-8#2)
amplification and the##6##3##(2008-10#3)(2008-3#2)(2011-2#1)
amplification and##16##2##(1990-6#1)(1993-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#2)(2012-2#1)(2013-8#2)
amplification by the##2##3##(2008-10#1)(2008-3#1)
amplification by##6##2##(1991-6#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-3#2)
amplification in the##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2011-3#1)
amplification in##8##2##(1994-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-3#1)(2013-8#1)
amplification kit##2##2##(2008-12#2)
amplification methods##4##2##(2008-10#1)(2008-9#1)(2010-6#1)(2010-7#1)
amplification of a##7##3##(1995-12#1)(2008-10#4)(2008-11#1)(2011-2#1)
amplification of cDNA##3##3##(1993-2#1)(2010-5#2)
amplification of genomic##2##3##(1997-7#1)(2008-10#1)
amplification of pre-parietal cells##2##4##(1995-6#2)
amplification of such##2##3##(2008-11#1)(2008-4#1)
amplification of the viral##3##4##(2008-10#2)(2008-9#1)
amplification of the##16##3##(1993-8#1)(1994-12#1)(2008-10#9)(2008-3#1)(2008-9#2)(2011-2#1)(2013-8#1)
amplification of##67##2##(1991-6#1)(1992-10#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#2)(1997-6#1)(1997-7#2)(2007-12#2)(2008-10#27)(2008-11#6)(2008-2#3)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#5)(2010-5#2)(2011-2#2)(2013-8#1)
amplification or##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
amplification product##2##2##(2008-10#2)
amplification products were##2##3##(2008-10#1)(2008-12#1)
amplification products##5##2##(2008-10#3)(2008-12#1)(2008-2#1)
amplification reactions##3##2##(1996-12#1)(1997-6#2)
amplification system##4##2##(2008-11#3)(2008-9#1)
amplification systems##2##2##(1997-6#1)(2008-2#1)
amplification techniques##2##2##(2008-4#1)(2009-12#1)
amplification using primers##2##3##(2008-10#1)(2008-8#1)
amplification was##5##2##(2008-10#3)(2008-5#1)(2010-4#1)
amplification with##6##2##(1996-8#1)(2008-10#4)(2009-6#1)
amplification##219##1##(1990-11#1)(1990-6#2)(1991-6#6)(1992-10#1)(1993-12#3)(1993-2#2)(1993-8#1)(1993-9#1)(1994-12#6)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#6)(1997-7#3)(2007-11#2)(2007-12#8)(2008-10#75)(2008-11#16)(2008-12#4)(2008-2#6)(2008-3#8)(2008-4#8)(2008-5#1)(2008-8#4)(2008-9#12)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
amplification)##3##1##(2008-11#2)(2012-12#1)
amplifications and##2##2##(2008-9#1)(2011-3#1)
amplifications in##2##2##(2008-11#1)(2013-8#1)
amplifications of##3##2##(1993-6#1)(2008-10#1)(2008-3#1)
amplifications##15##1##(1993-6#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-3#1)(2013-8#1)
amplified CHO##2##2##(2008-11#2)
amplified DNA from##3##3##(2008-10#3)
amplified DNA##9##2##(1993-12#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#4)(2011-2#1)
amplified PCR##2##2##(2008-10#2)
amplified a fragment##2##3##(2008-10#2)
amplified a product of##2##4##(2008-10#2)
amplified a single 1##2##4##(2008-10#2)
amplified a##14##2##(2008-10#14)
amplified and cloned##2##3##(2008-10#2)
amplified and labeled##2##3##(2008-10#1)(2008-4#1)
amplified and sequenced##6##3##(2008-10#4)(2008-12#1)(2013-8#1)
amplified and##14##2##(1992-6#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2013-8#1)
amplified by PCR and##5##4##(1995-8#1)(1997-8#1)(2008-10#2)(2008-8#1)
amplified by PCR##11##3##(1995-11#1)(1995-8#2)(1997-8#1)(2008-10#4)(2008-8#3)
amplified by polymerase chain reaction (PCR)##3##6##(2008-10#2)(2010-6#1)
amplified by polymerase chain reaction from##3##6##(2008-10#3)
amplified by polymerase chain reaction##10##5##(2008-10#9)(2010-6#1)
amplified by reverse##2##3##(1996-12#1)(2008-10#1)
amplified by the##7##3##(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-11#1)
amplified by##43##2##(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#5)(2010-5#1)(2010-6#1)
amplified detection of##2##3##(2008-10#2)
amplified enzyme-linked immunosorbent assay##2##4##(2008-10#2)
amplified fragment length polymorphism (AFLP) analysis##6##6##(2008-10#6)
amplified fragment length polymorphism (AFLP) and microsatellite markers##2##8##(2008-10#2)
amplified fragment length polymorphism (AFLP) and##7##6##(2008-10#7)
amplified fragment length polymorphism (AFLP) loci##2##6##(2008-10#2)
amplified fragment length polymorphism (AFLP) markers##8##6##(2008-10#8)
amplified fragment length polymorphism (AFLP)##36##5##(2008-10#36)
amplified fragment length polymorphism among##2##5##(1996-8#1)(2008-10#1)
amplified fragment length polymorphism analysis##3##5##(2008-10#3)
amplified fragment length polymorphism marker##4##5##(2008-10#4)
amplified fragment length polymorphism markers##4##5##(2008-10#4)
amplified fragment length polymorphism##61##4##(1996-8#1)(2008-10#59)(2011-2#1)
amplified fragment length polymorphisms (AFLPs)##2##5##(2008-10#2)
amplified fragment length polymorphisms##8##4##(2008-10#8)
amplified fragment length##69##3##(1996-8#1)(2008-10#67)(2011-2#1)
amplified fragment##70##2##(1996-8#2)(2008-10#67)(2011-2#1)
amplified fragments##5##2##(2008-10#3)(2008-8#1)(2012-2#1)
amplified from the##6##3##(1996-6#1)(2008-10#3)(2008-8#1)(2010-4#1)
amplified from##27##2##(1993-12#1)(1994-12#1)(1996-6#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-8#3)(2010-4#1)(2013-8#1)
amplified genes##4##2##(1995-12#1)(2008-11#3)
amplified in##7##2##(1990-6#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-7#1)(2010-1#1)
amplified microsatellites##3##2##(2008-10#3)
amplified only from##2##3##(2008-10#2)
amplified polymorphic DNA (RAPD) analyses##2##5##(2008-10#2)
amplified polymorphic DNA (RAPD) analysis##7##5##(2008-10#7)
amplified polymorphic DNA (RAPD) and##2##5##(2008-10#2)
amplified polymorphic DNA (RAPD) marker##2##5##(2008-10#2)
amplified polymorphic DNA (RAPD) markers and##2##6##(2008-10#2)
amplified polymorphic DNA (RAPD) markers##11##5##(1995-6#1)(2008-10#10)
amplified polymorphic DNA (RAPD)##40##4##(1995-6#1)(2008-10#39)
amplified polymorphic DNA and amplified fragment length polymorphism##2##8##(2008-10#2)
amplified polymorphic DNA and##4##4##(2008-10#4)
amplified polymorphic DNA markers##7##4##(2008-10#7)
amplified polymorphic DNA##65##3##(1995-6#1)(1997-8#1)(2008-10#63)
amplified polymorphic##66##2##(1995-6#1)(1997-8#1)(2008-10#64)
amplified polymorphism##3##2##(2008-10#3)
amplified porA##2##2##(1993-12#2)
amplified product was##2##3##(1996-8#1)(2008-10#1)
amplified products##5##2##(2008-10#3)(2011-2#1)(2012-2#1)
amplified ras oncogene##3##3##(2008-11#3)
amplified real samples##3##3##(2008-10#3)
amplified region (SCAR) marker##3##4##(2008-10#3)
amplified region (SCAR)##5##3##(2008-10#5)
amplified sample##2##2##(2008-10#2)
amplified spontaneous emission##2##3##(2008-2#1)(2008-3#1)
amplified systems##2##2##(2007-12#2)
amplified target DNA##2##3##(1993-12#1)(2008-10#1)
amplified the##4##2##(1993-6#1)(2008-10#2)(2008-11#1)
amplified three##2##2##(2008-10#1)(2008-11#1)
amplified using the##2##3##(2008-11#1)(2008-12#1)
amplified using##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#1)
amplified with the##2##3##(1996-8#1)(2008-10#1)
amplified with##6##2##(1996-8#1)(1997-8#1)(2008-10#4)
amplified##374##1##(1990-6#2)(1992-6#1)(1993-1#2)(1993-12#6)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-6#2)(1995-8#3)(1996-12#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(1997-9#1)(2007-12#5)(2008-10#261)(2008-11#24)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#10)(2008-9#2)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#10)(2012-2#4)(2013-8#3)
amplifier and##2##2##(2008-3#2)
amplifier as##2##2##(2008-10#1)(2008-3#1)
amplifier at##2##2##(2007-12#1)(2008-3#1)
amplifier with##2##2##(2008-3#2)
amplifier##40##1##(2007-11#7)(2007-12#6)(2008-10#9)(2008-2#6)(2008-3#11)(2009-7#1)
amplifiers##12##1##(1990-12#1)(2007-11#6)(2008-2#2)(2008-3#2)(2008-9#1)
amplifies the##2##2##(2008-10#1)(2013-8#1)
amplifies##5##1##(1990-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
amplify DNA from##3##3##(2008-10#3)
amplify DNA##6##2##(2008-10#5)(2009-6#1)
amplify a##7##2##(2008-10#5)(2008-9#1)(2009-8#1)
amplify sequences from##2##3##(2008-10#2)
amplify sequences##3##2##(1992-6#1)(2008-10#2)
amplify the##11##2##(1991-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
amplify##51##1##(1991-7#1)(1992-6#1)(1993-12#2)(1994-11#1)(1997-3#1)(2008-10#28)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
amplifying DNA##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
amplifying the##3##2##(1994-11#1)(2008-11#1)(2008-4#1)
amplifying##17##1##(1994-11#1)(1995-6#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#3)(2008-9#3)(2011-2#1)(2012-2#1)
amplimers##3##1##(2008-10#2)(2008-12#1)
amplitude and phase##5##3##(2008-3#4)(2012-2#1)
amplitude and the##3##3##(1996-2#2)(2008-10#1)
amplitude and##22##2##(1990-12#1)(1990-9#1)(1993-3#1)(1996-2#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)(2008-9#1)(2009-11#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-2#1)
amplitude distribution##2##2##(2007-12#1)(2008-2#1)
amplitude from##2##2##(2008-10#1)(2008-2#1)
amplitude in the##2##3##(1996-6#1)(2008-11#1)
amplitude in##3##2##(1996-6#1)(2008-11#1)(2008-2#1)
amplitude increased##3##2##(2008-10#1)(2009-3#2)
amplitude of 25##2##3##(2008-10#1)(2008-11#1)
amplitude of the##13##3##(1990-9#1)(1993-3#1)(1994-2#1)(1996-6#1)(1997-4#2)(2008-10#4)(2008-3#1)(2008-7#1)(2009-12#1)
amplitude of##28##2##(1990-5#1)(1990-9#1)(1993-3#1)(1994-2#1)(1995-11#1)(1996-6#1)(1997-4#3)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-5#1)
amplitude oscillations##3##2##(1994-11#1)(2008-10#2)
amplitude to##2##2##(1997-4#1)(2008-2#1)
amplitude was##2##2##(2008-7#1)(2013-8#1)
amplitude##123##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#2)(1993-3#2)(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#3)(1996-6#2)(1997-2#2)(1997-4#5)(2007-11#1)(2007-12#2)(2008-10#32)(2008-11#6)(2008-2#7)(2008-3#22)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-10#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-2#4)(2012-5#1)(2013-8#2)
amplitudes in the##2##3##(1990-11#1)(2008-10#1)
amplitudes of the##5##3##(1997-2#1)(2008-10#2)(2010-6#1)(2011-2#1)
amplitudes of##8##2##(1997-2#1)(2008-10#2)(2008-8#2)(2010-6#1)(2010-9#1)(2011-2#1)
amplitudes##20##1##(1990-11#2)(1991-9#1)(1995-2#1)(1996-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
amply##2##1##(1997-2#1)(2008-11#1)
amputated##4##1##(2008-9#2)(2009-1#1)(2010-6#1)
amputation in##2##2##(2008-9#1)(2011-2#1)
amputation of##2##2##(1995-2#1)(2008-8#1)
amputation##18##1##(1990-3#1)(1995-2#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#1)(2011-2#2)(2011-3#2)(2012-3#2)(2013-1#2)
amputations##2##1##(2009-12#1)(2011-2#1)
amputees##3##1##(2012-12#1)(2013-1#2)
amu##2##1##(2008-10#2)
amurensis##4##1##(1994-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
amygdala activity than light-skinned##2##4##(2008-11#2)
amygdala activity was observed##2##4##(2008-11#2)
amygdala activity##6##2##(2008-11#6)
amygdala and the##2##3##(1993-6#1)(1994-2#1)
amygdala and##8##2##(1993-6#4)(1994-2#1)(1997-2#1)(2008-11#2)
amygdala is##4##2##(1991-1#1)(1992-6#1)(2008-11#2)
amygdala lesions##4##2##(1993-6#4)
amygdala neurons##3##2##(1993-6#1)(1997-7#2)
amygdala or##3##2##(1990-5#1)(1993-6#1)(1996-12#1)
amygdala##84##1##(1990-5#2)(1991-1#3)(1991-10#3)(1992-1#1)(1992-12#1)(1992-6#3)(1993-6#25)(1994-2#5)(1996-12#3)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#2)(1997-7#4)(2008-11#22)(2009-10#3)(2013-8#2)
amygdala-kindled rats##5##2##(1992-3#2)(1994-2#2)(1996-12#1)
amygdala-kindled##6##1##(1992-3#2)(1994-2#2)(1996-12#2)
amygdali##3##1##(2008-10#3)
amygdaloid neurons##3##2##(2008-10#3)
amygdaloid##5##1##(1994-2#2)(2008-10#3)
amylase activity##4##2##(2008-10#4)
amylase level##2##2##(2011-2#1)(2013-1#1)
amylase##16##1##(2008-10#12)(2008-11#1)(2010-1#1)(2011-2#1)(2013-1#1)
amylin action##2##2##(2008-9#2)
amylin responsive protein##2##3##(2008-9#2)
amylin##9##1##(1992-6#1)(2008-9#8)
amyloid A##3##2##(2009-10#2)(2009-8#1)
amyloid and hyalin##2##3##(2013-7#2)
amyloid beta protein##3##3##(1994-11#1)(1995-12#2)
amyloid beta-protein##2##2##(1992-12#2)
amyloid deposition##4##2##(1991-1#1)(2008-5#1)(2010-4#1)(2013-8#1)
amyloid deposits##4##2##(1992-6#1)(1994-11#2)(2008-5#1)
amyloid plaques##3##2##(2008-5#3)
amyloid polypeptide##2##2##(1992-6#2)
amyloid precursor protein (APP)##2##4##(1993-8#1)(1995-12#1)
amyloid precursor protein##5##3##(1992-12#1)(1993-8#2)(1995-12#1)(2008-11#1)
amyloid precursor-like protein 2 (APLP2)##2##5##(1996-12#2)
amyloid protein##3##2##(1994-11#2)(2011-2#1)
amyloid##48##1##(1991-1#2)(1992-12#3)(1992-6#3)(1993-8#3)(1994-11#5)(1995-12#3)(1996-11#1)(1996-12#2)(1996-2#2)(2008-11#4)(2008-4#2)(2008-5#6)(2009-10#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
amyloidogenic conformer (A beta##2##4##(1996-2#2)
amyloidogenic conformer##3##2##(1996-2#3)
amyloidogenic##5##1##(1992-12#1)(1996-2#3)(2011-2#1)
amyloidosis in a##2##3##(2008-11#1)(2013-1#1)
amyloidosis in##3##2##(1996-11#1)(2008-11#1)(2013-1#1)
amyloidosis##26##1##(1992-8#2)(1996-11#1)(1997-5#1)(1997-8#1)(2008-11#2)(2009-5#1)(2010-5#1)(2010-6#2)(2011-2#10)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
amyloidosis)##2##1##(2011-2#1)(2012-2#1)
amyloliquefaciens##10##1##(1990-11#2)(1991-6#2)(2008-10#3)(2013-1#3)
amylolytic##3##1##(2008-10#1)(2008-8#2)
amylose tris-(3##3##2##(2008-10#3)
amylose##11##1##(1990-9#3)(1994-8#1)(1995-12#1)(2008-10#4)(2013-8#2)
amylovora and##7##2##(2008-10#6)(2008-8#1)
amylovora cells were##2##3##(2008-10#2)
amylovora in##3##2##(2008-10#3)
amylovora on##4##2##(2008-10#4)
amylovora strain##2##2##(2008-10#2)
amylovora was##4##2##(2008-10#4)
amylovora##48##1##(2008-10#47)(2008-8#1)
amyotrophic lateral sclerosis##8##3##(1993-9#1)(1996-5#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-7#1)(2013-1#2)
amyotrophic##9##1##(1993-9#1)(1996-5#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-7#1)(2013-1#3)
amyotrophy##3##1##(2008-7#3)
an &quot##24##2##(1990-3#1)(1990-9#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2012-12#1)(2013-8#1)
an 'orphan##2##2##(2010-10#2)
an 11##5##2##(1995-9#2)(1996-6#1)(2012-3#1)(2013-8#1)
an 11-year-old boy who presented with##2##6##(2011-2#1)(2013-1#1)
an 11-year-old boy##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
an 18##4##2##(1992-12#1)(2008-11#2)(2009-5#1)
an 18-month period##2##3##(2008-9#1)(2012-12#1)
an 18-month##5##2##(1996-5#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-12#1)
an 8##5##2##(1995-11#1)(2008-10#2)(2009-3#1)(2012-12#1)
an 8-day treatment for PDA##2##5##(2012-2#2)
an 8-day##4##2##(2009-8#1)(2012-2#3)
an 8-h day##2##3##(2008-10#1)(2010-10#1)
an 8-h##3##2##(2008-10#2)(2010-10#1)
an 8-week##4##2##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
an 8-year period##3##3##(1990-9#1)(2008-10#1)(2012-2#1)
an 8-year##6##2##(1990-9#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
an 8-year-old##2##2##(1996-5#1)(1997-3#1)
an 80 kDa##2##3##(1992-6#1)(2011-2#1)
an A##8##2##(1990-11#1)(1993-3#2)(2008-10#4)(2008-3#1)
an ACS##2##2##(2008-10#1)(2012-2#1)
an AIDS##8##2##(1990-6#1)(1992-9#2)(1993-3#1)(1995-6#1)(1996-5#2)(1997-6#1)
an AMI##4##2##(1995-2#1)(2009-6#3)
an ANN##3##2##(2008-10#3)
an AP##2##2##(2008-10#1)(2008-5#1)
an APD and##2##3##(2011-10#2)
an APD##3##2##(2011-10#3)
an ASP intervention##2##3##(2013-1#2)
an ASP##4##2##(2013-1#4)
an ATP##2##2##(1997-4#1)(2008-11#1)
an AVM in the##2##4##(2008-7#2)
an AVM##4##2##(2008-7#3)(2012-3#1)
an Active##3##2##(2008-10#2)(2009-10#1)
an Ad##2##2##(1990-3#1)(1997-3#1)
an African##2##2##(1991-5#1)(2010-8#1)
an Ag/AgCl reference electrode##2##4##(2008-10#2)
an Agrobacterium-mediated##2##2##(2008-10#1)(2008-8#1)
an Allee effect##3##3##(2008-10#2)(2008-8#1)
an Amberlite##2##2##(2008-10#2)
an Arabidopsis##5##2##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
an Asian##4##2##(2008-1#1)(2008-10#2)(2013-3#1)
an Australian perspective##2##3##(2008-10#1)(2008-11#1)
an Australian##9##2##(1996-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)
an E##5##2##(1996-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-9#1)
an EC(50)##3##2##(2008-10#2)(2012-2#1)
an EC50##2##2##(1995-12#1)(1996-12#1)
an EDTA##2##2##(2008-10#2)
an ELISA##8##2##(1991-3#1)(1992-12#1)(1995-2#1)(2008-10#3)(2008-12#2)
an Effective##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
an Emergency##2##2##(2012-3#1)(2013-1#1)
an English University##2##3##(2008-11#1)(2008-12#1)
an Escherichia coli##5##3##(1993-8#1)(1993-9#1)(1994-5#1)(1997-7#1)(2008-7#1)
an F(2) population of##3##4##(2008-10#3)
an F(2) population##6##3##(2008-10#5)(2008-9#1)
an FIA system##2##3##(2008-10#2)
an HIV##4##2##(1993-12#1)(1996-5#1)(2009-5#1)(2010-12#1)
an HIV-antibody test##2##3##(1996-5#2)
an HIV-positive##2##2##(1992-12#1)(1996-5#1)
an HMO##4##2##(1993-12#3)(1996-2#1)
an HPLC method##4##3##(2008-10#4)
an HPLC##11##2##(2008-10#10)(2008-4#1)
an HPV##2##2##(2008-11#2)
an ICP-MS##4##2##(2008-10#4)
an ICP-OES##2##2##(2008-10#2)
an IgM monoclonal##2##3##(2008-11#2)
an Indian context##2##3##(2013-1#2)
an Indian perspective##2##3##(2009-11#2)
an Indian##5##2##(2008-5#1)(2009-11#2)(2013-1#2)
an Interprofessional##3##2##(2008-11#2)(2008-12#1)
an Iranian##2##2##(2012-2#1)(2013-1#1)
an Irish##4##2##(1991-12#1)(2008-11#2)(2008-12#1)
an Italian##6##2##(1994-12#1)(2008-10#2)(2008-11#2)(2008-12#1)
an LC##2##2##(2008-10#2)
an LED##2##2##(2008-10#2)
an M##2##2##(1992-1#1)(2008-10#1)
an MDI with a spacer##2##5##(1996-1#2)
an MDI##7##2##(1996-1#5)(1997-1#2)
an MRI##2##2##(1992-3#1)(2012-12#1)
an N##3##2##(2008-10#3)
an N-linked glycosylation##2##3##(1994-11#1)(2008-11#1)
an N-terminal extension##2##3##(1991-6#2)
an N-terminal##11##2##(1991-10#1)(1991-6#2)(1993-12#2)(1995-8#1)(1997-4#1)(2008-10#2)(2009-6#1)(2012-2#1)
an NMR##2##2##(1991-5#1)(2008-10#1)
an O2##2##2##(1992-8#1)(2011-1#1)
an OAH##9##2##(2008-7#9)
an ODS##2##2##(2008-10#2)
an OF##2##2##(2008-10#2)
an OR##2##2##(2008-11#1)(2013-1#1)
an ORF##3##2##(1993-2#1)(1995-9#1)(1996-6#1)
an Objective Structured Clinical Examination (OSCE)##2##6##(2008-11#2)
an Ohio##2##2##(1995-12#2)
an Oryza##2##2##(2008-10#2)
an RGD-containing##2##2##(1994-11#1)(2009-7#1)
an RNA polymerase##2##3##(1994-3#1)(2008-7#1)
an RNA##11##2##(1991-5#1)(1994-3#1)(1995-2#1)(1997-6#2)(2008-4#4)(2008-7#1)(2010-4#1)
an RNase protection assay##2##4##(1993-6#1)(1997-7#1)
an RNase##3##2##(1993-6#1)(1995-8#1)(1997-7#1)
an RPE that corresponded to 70% of oxygen uptake reserve##2##10##(2013-8#2)
an RPE that corresponded to##3##5##(2013-8#3)
an RS##2##2##(1995-6#1)(2008-8#1)
an RSD##2##2##(2008-10#2)
an S##2##2##(2008-10#1)(2012-12#1)
an SIA system##2##3##(2008-10#2)
an SIA##4##2##(2008-10#4)
an SKM##2##2##(2011-2#2)
an SPE##2##2##(2008-10#2)
an SV40##2##2##(1993-12#1)(1995-6#1)
an UV-Vis##2##2##(2008-10#2)
an X##2##2##(2008-10#2)
an X-ray diffraction##2##3##(2008-9#1)(2010-5#1)
an X-ray lens##2##3##(2008-10#2)
an X-ray##5##2##(2008-10#3)(2008-9#1)(2010-5#1)
an abandoned##2##2##(2008-10#1)(2008-11#1)
an abdominal aortic aneurysm##2##4##(1992-5#1)(2010-7#1)
an abdominal##8##2##(1992-5#1)(1994-2#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
an aberrant##3##2##(2010-7#1)(2011-2#1)(2012-3#1)
an ability to##8##3##(1994-2#1)(1995-5#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-6#1)(2012-3#1)
an ability##10##2##(1990-11#1)(1994-2#1)(1995-5#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-6#2)(2012-3#1)
an abnormal thermogram##3##3##(1993-11#3)
an abnormal##21##2##(1993-11#3)(1994-1#1)(1994-3#1)(1996-2#1)(1997-3#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
an abnormality##2##2##(2008-2#1)(2008-6#1)
an abnormally##3##2##(1997-1#1)(2012-3#1)(2013-1#1)
an abortion##5##2##(1990-6#1)(1990-9#1)(1995-8#1)(1997-6#2)
an about##4##2##(1997-2#1)(2008-8#2)(2011-2#1)
an abridged##3##2##(1994-1#1)(2008-11#1)(2010-11#1)
an abscess##3##2##(1991-6#1)(2009-6#1)(2012-3#1)
an absence of##6##3##(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#1)(2010-7#1)
an absence##7##2##(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#1)(2010-7#1)(2013-8#1)
an absolute contraindication to the##2##5##(1994-8#1)(2011-2#1)
an absolute requirement##4##3##(1992-1#1)(2007-12#1)(2008-10#2)
an absolute##17##2##(1992-1#1)(1994-8#1)(1996-11#1)(2007-12#1)(2008-10#5)(2008-3#3)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
an absorbable##2##2##(1996-6#1)(2008-9#1)
an absorbance maxima at##2##4##(2008-10#2)
an absorbance##7##2##(2008-10#6)(2008-3#1)
an absorbed pump power of##2##5##(2008-2#1)(2008-3#1)
an absorbed##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
an absorbing solution##4##3##(2008-10#4)
an absorbing##7##2##(2008-10#5)(2008-3#2)
an absorption maximum at##7##4##(2008-10#7)
an absorption##13##2##(2008-10#10)(2008-2#1)(2008-3#2)
an abstract for##2##3##(2008-12#2)
an abstract##10##2##(1990-5#1)(2008-12#4)(2008-5#1)(2010-4#3)(2011-2#1)
an abundance of##6##3##(1992-3#1)(1992-7#1)(1995-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
an abundance##7##2##(1992-3#1)(1992-7#1)(1995-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
an abundant##5##2##(1991-5#1)(1992-8#1)(1995-2#1)(2008-4#1)(2010-4#1)
an academic medical library##2##4##(1991-1#2)
an academic medical##3##3##(1991-1#2)(2008-3#1)
an academic year##3##3##(2008-12#1)(2011-1#2)
an academic##19##2##(1991-1#2)(1992-1#2)(1994-3#4)(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
an accelerated##12##2##(1990-9#1)(1993-1#1)(1995-12#1)(2008-10#5)(2008-12#2)(2009-10#1)(2013-8#1)
an acceleration##2##2##(2008-3#1)(2013-8#1)
an acceptable airway##2##3##(2010-7#1)(2013-8#1)
an acceptable level of##3##4##(2008-10#3)
an acceptable level##5##3##(1991-2#1)(2008-10#3)(2009-8#1)
an acceptable range##3##3##(2008-10#3)
an acceptable##23##2##(1991-2#1)(1991-3#1)(1994-12#1)(1996-12#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-5#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
an accepted##7##2##(1996-2#1)(1997-4#1)(2006-6#1)(2008-12#1)(2008-9#1)(2010-11#1)(2013-8#1)
an acceptor stream containing##3##4##(2008-10#3)
an acceptor stream##5##3##(2008-10#5)
an acceptor##8##2##(1996-5#1)(2008-10#6)(2008-11#1)
an accessory plantaris muscle in##2##5##(2012-2#2)
an accessory##4##2##(1995-2#1)(2008-10#1)(2012-2#2)
an accidental duplication of an article that has already been published in##6##12##(2008-11#6)
an accidental duplication of an article that has already been published##7##11##(2008-11#6)(2012-3#1)
an accidental##8##2##(2008-11#6)(2012-3#1)(2013-1#1)
an accompanying paper##2##3##(1995-2#1)(2008-3#1)
an accompanying##5##2##(1991-12#1)(1995-2#1)(2008-11#1)(2008-3#1)(2012-2#1)
an account of a##2##4##(2008-10#1)(2008-11#1)
an account of the##5##4##(1995-2#1)(2008-10#2)(2008-12#2)
an account of##7##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#2)
an accumulation of##11##3##(1994-5#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-7#1)(2008-10#2)(2009-10#1)(2011-2#1)(2013-1#2)
an accumulation potential of -0##5##5##(2008-10#5)
an accumulation potential of##6##4##(2008-10#6)
an accumulation time of##3##4##(2008-10#3)
an accumulation time##4##3##(2008-10#4)
an accumulation##24##2##(1994-5#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-7#1)(2008-10#14)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#2)
an accuracy of##11##3##(2008-10#6)(2008-11#1)(2008-3#3)(2010-8#1)
an accuracy that is##2##4##(2008-2#1)(2008-9#1)
an accuracy##15##2##(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-9#1)(2010-8#1)
an accurate and##6##3##(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)(2012-2#1)
an accurate depiction of##2##4##(2008-9#1)(2012-2#1)
an accurate determination of the##2##5##(2008-10#1)(2008-12#1)
an accurate determination of##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
an accurate diagnosis##2##3##(1991-11#1)(2010-6#1)
an accurate##38##2##(1990-6#1)(1991-11#2)(1992-5#1)(1994-2#1)(1995-11#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#1)
an acetate buffer##4##3##(2008-10#4)
an acetate##5##2##(2008-10#4)(2008-7#1)
an acetic acid##2##3##(2008-10#2)
an acetic##3##2##(2008-10#3)
an acetonitrile-phosphate buffer##2##3##(2008-10#2)
an acid mixture##2##3##(2008-10#2)
an acid solution##3##3##(2008-10#3)
an acid##11##2##(2008-10#10)(2009-7#1)
an acidic solution and##2##4##(2008-10#2)
an acidic solution##3##3##(2008-10#3)
an acidic##29##2##(1994-5#3)(1994-6#1)(2008-10#23)(2008-11#1)(2011-2#1)
an acoustic##3##2##(2008-10#2)(2008-7#1)
an acousto-optic tunable filter##3##4##(2008-10#2)(2008-3#1)
an acousto-optic##4##2##(2008-10#2)(2008-3#2)
an acquired##2##2##(1996-11#1)(2013-1#1)
an acquisition access period##2##4##(2008-10#2)
an acquisition##4##2##(1993-6#1)(2008-10#2)(2008-3#1)
an acrosomal complex##2##3##(2007-12#2)
an acrosome##2##2##(2008-7#2)
an act of##2##3##(1997-3#1)(2009-10#1)
an actin##3##2##(2008-11#2)(2012-2#1)
an actin-binding##3##2##(1990-5#1)(1993-8#1)(2012-2#1)
an action of##2##3##(1994-2#1)(2013-1#1)
an action##10##2##(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-11#2)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
an activated carbon column##3##4##(2008-10#3)
an activated carbon##4##3##(2008-10#4)
an activated##8##2##(1991-2#1)(1995-8#1)(1997-3#1)(2008-10#4)(2009-8#1)
an activation of##4##3##(1992-6#1)(1997-2#1)(1997-8#1)(2010-1#1)
an activation##9##2##(1992-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-1#1)
an activator for##4##3##(2008-10#3)(2009-12#1)
an activator of##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
an activator##16##2##(1992-8#1)(1993-12#2)(1994-5#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
an active CDC28 gene##2##4##(1991-5#2)
an active and##2##3##(1995-6#1)(2008-9#1)
an active enzyme##2##3##(1991-7#1)(1994-5#1)
an active metabolite of##2##4##(1992-3#1)(2008-7#1)
an active molecule##2##3##(2008-10#1)(2008-5#1)
an active role in##3##4##(1996-3#1)(2008-10#1)(2013-1#1)
an active role##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
an active##63##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-6#3)(1996-12#1)(1996-3#1)(2008-10#13)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-7#1)
an actively mode-locked##2##3##(2007-12#1)(2008-2#1)
an activity##5##2##(1991-6#2)(1994-12#1)(2008-10#1)(2011-1#1)
an actual##5##2##(1991-12#1)(1993-3#1)(2008-11#1)(2008-5#1)(2008-6#1)
an acute abdomen##3##3##(1997-3#1)(2009-9#1)(2010-12#1)
an acute myocardial infarction##4##4##(1990-9#1)(2008-11#2)(2010-11#1)
an acute myocardial##6##3##(1990-9#1)(1991-3#1)(2008-10#1)(2008-11#2)(2010-11#1)
an acute onset of##3##4##(2008-11#1)(2009-3#1)(2012-12#1)
an acute##49##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1996-8#1)(1997-3#2)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
an acyl##2##2##(1997-2#1)(2008-10#1)
an ad libitum##2##3##(2008-10#1)(2013-8#1)
an ad##3##2##(1997-3#1)(2008-10#1)(2013-8#1)
an adaptation of##4##3##(2008-11#1)(2010-1#1)(2012-2#1)(2013-1#1)
an adaptation to##2##3##(2009-1#1)(2011-2#1)
an adaptation##9##2##(1990-8#1)(2008-11#3)(2009-1#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
an adaptive response to##2##4##(2008-7#2)
an adaptive response##3##3##(2008-7#3)
an adaptive##14##2##(2007-11#1)(2008-11#1)(2008-3#3)(2008-7#4)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
an added##5##2##(1991-3#1)(1992-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
an addition to the##2##4##(1991-2#1)(2008-12#1)
an addition##5##2##(1991-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
an additional 2##3##3##(1994-11#1)(1996-2#1)(2008-10#1)
an additional case of##2##4##(2009-3#1)(2013-1#1)
an additional criterion to##2##4##(2008-10#2)
an additional factor##3##3##(1992-6#1)(2008-10#1)(2012-3#1)
an additional source of##2##4##(2008-10#2)
an additional tool for##2##4##(2008-11#1)(2011-2#1)
an additional treatment##2##3##(2008-10#1)(2013-1#1)
an additional##91##2##(1990-11#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-6#1)(1993-3#2)(1994-11#2)(1995-11#2)(1996-11#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
an additive effect##3##3##(1994-8#1)(1995-2#1)(2008-10#1)
an additive##17##2##(1990-2#1)(1991-8#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)(2013-8#1)
an adenosine##3##2##(1993-6#1)(1995-8#1)(1995-9#1)
an adenovirus vector##2##3##(2008-11#1)(2010-1#1)
an adenovirus##4##2##(1992-9#2)(2008-11#1)(2010-1#1)
an adenovirus-mediated siRNA system##2##4##(2010-1#2)
an adequate explanation##2##3##(2008-10#1)(2009-5#1)
an adequate##28##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-3#1)(1994-9#1)(1996-2#2)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#2)(2013-8#1)
an adhesion##3##2##(2008-10#1)(2008-7#1)(2009-6#1)
an adjacent##5##2##(1990-5#1)(1993-8#1)(1993-9#1)(1997-7#1)(2010-4#1)
an adjunct to##4##3##(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
an adjunct##7##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-2#1)(2013-1#1)
an adjustment##3##2##(1992-2#2)(2008-10#1)
an adjuvant##6##2##(1990-2#2)(1995-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
an administrative##3##2##(1992-1#1)(1995-6#1)(2012-3#1)
an admixture of##4##3##(1997-8#1)(2008-10#1)(2010-6#1)(2011-2#1)
an adolescent##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
an adrenal##2##2##(1990-5#1)(1992-12#1)
an adsorption##2##2##(2008-10#2)
an adsorptive##2##2##(2008-10#2)
an adult child##2##3##(1994-12#1)(2010-4#1)
an adult individual##2##3##(2008-11#1)(2008-9#1)
an adult population##2##3##(1997-4#1)(2012-12#1)
an adult with##6##3##(1997-3#1)(2010-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
an adult##32##2##(1990-3#1)(1994-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#4)(2009-5#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
an advance of##2##3##(2012-6#1)(2012-7#1)
an advanced stage##4##3##(1991-6#1)(1991-8#1)(1997-4#1)(2008-1#1)
an advanced##13##2##(1991-6#1)(1991-8#1)(1994-12#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2012-3#1)(2013-8#1)
an advantage in##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
an advantage##5##2##(2008-10#2)(2008-11#2)(2008-8#1)
an advantageous##3##2##(2008-10#3)
an adverse effect of##2##4##(2008-10#1)(2008-7#1)
an adverse effect##6##3##(1995-3#1)(1997-2#1)(2008-10#2)(2008-7#1)(2012-2#1)
an adverse event##2##3##(2008-11#2)
an adverse##10##2##(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-4#1)(2009-6#1)(2012-2#1)
an advertising campaign##2##3##(1995-1#1)(1997-6#1)
an advisory##2##2##(1996-2#1)(1996-8#1)
an aerobic##3##2##(2011-2#2)(2013-1#1)
an aerodynamic##2##2##(1997-1#1)(2008-3#1)
an aerosol##6##2##(1992-3#1)(1995-3#1)(1996-3#1)(1997-1#1)(2008-3#2)
an affective##2##2##(1996-1#1)(2013-8#1)
an affinity for##3##3##(1993-8#1)(2009-7#1)(2010-10#1)
an affinity##8##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-7#1)(2010-10#1)(2012-2#1)
an agar medium##2##3##(2008-10#2)
an agar##5##2##(2008-10#5)
an age dependent##2##3##(1994-3#1)(2011-2#1)
an age##4##2##(1990-3#1)(1994-3#1)(2010-8#1)(2011-2#1)
an age-adjusted##2##2##(2012-12#1)(2013-1#1)
an age-related##3##2##(1995-8#1)(2008-7#2)
an aged care##2##3##(2008-11#1)(2010-10#1)
an aged##3##2##(1992-3#1)(2008-11#1)(2010-10#1)
an agency setting##3##3##(1996-2#3)
an agency##4##2##(1993-12#1)(1996-2#3)
an agent that##3##3##(1993-6#1)(1995-2#1)(2008-10#1)
an agent##7##2##(1993-6#1)(1995-2#1)(2008-10#2)(2008-5#2)(2011-2#1)
an agent-based##2##2##(2008-8#1)(2013-8#1)
an aggregate##3##2##(2008-11#1)(2008-3#2)
an aggregated pattern of distribution##2##5##(2008-10#2)
an aggregated##3##2##(2008-10#3)
an aggressive phenotype##2##3##(2008-12#1)(2009-9#1)
an aggressive surgical approach##3##4##(1990-12#1)(1990-9#1)(2012-3#1)
an aggressive##16##2##(1990-12#1)(1990-9#1)(1991-1#1)(1993-3#1)(1995-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)(2012-3#1)(2013-7#1)
an aging population and##2##4##(2007-12#1)(2009-3#1)
an aging population##3##3##(1995-1#1)(2007-12#1)(2009-3#1)
an aging##6##2##(1994-2#1)(1994-3#2)(1995-1#1)(2007-12#1)(2009-3#1)
an agricultural area##2##3##(2008-10#2)
an agricultural##4##2##(2008-10#4)
an agrocin 84-sensitive##2##3##(2008-10#2)
an agrocin##3##2##(2008-10#3)
an aid in the##3##4##(1991-9#1)(1994-6#1)(2008-4#1)
an aid in##6##3##(1991-11#1)(1991-12#1)(1991-9#1)(1994-6#1)(1997-8#1)(2008-4#1)
an aid to##4##3##(1993-3#1)(1996-12#1)(2008-12#1)(2010-4#1)
an aid##11##2##(1991-11#1)(1991-12#1)(1991-9#1)(1993-3#1)(1994-6#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-4#1)
an air##9##2##(1994-12#1)(1996-12#1)(2008-10#4)(2008-11#2)(2009-10#1)
an air-agitated##2##2##(2008-7#2)
an aircraft cabin##3##3##(1996-12#3)
an aircraft##5##2##(1996-12#3)(2008-3#2)
an alcoholic##2##2##(2008-10#1)(2013-1#1)
an aldehyde##3##2##(1994-5#1)(1994-8#1)(2009-12#1)
an aldose reductase inhibitor##2##4##(1994-8#1)(2009-11#1)
an algorithm for management##2##4##(2013-1#2)
an algorithm for the##3##4##(2009-4#1)(2011-10#1)(2013-1#1)
an algorithm for##7##3##(1993-8#1)(2008-3#1)(2009-4#1)(2011-10#1)(2013-1#3)
an algorithm##9##2##(1993-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-4#1)(2011-10#1)(2013-1#3)
an alignment##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
an aliquot of##2##3##(2008-10#2)
an aliquot##3##2##(2008-10#3)
an alkali##2##2##(1993-9#1)(2008-10#1)
an alkaline enzyme##3##3##(2008-9#3)
an alkaline medium is##2##4##(2008-10#2)
an alkaline medium##10##3##(2008-10#10)
an alkaline##30##2##(1993-6#1)(2008-10#24)(2008-11#1)(2008-9#4)
an alkylating##3##2##(1997-2#1)(2010-11#1)(2010-12#1)
an all##2##2##(1995-3#1)(2008-11#1)
an all-solid-state laser##2##3##(2008-3#2)
an all-solid-state##5##2##(2008-10#2)(2008-3#3)
an allele of the##3##4##(1995-9#1)(1997-4#1)(2012-3#1)
an allele of##4##3##(1995-9#1)(1997-4#2)(2012-3#1)
an allele##7##2##(1995-9#1)(1997-4#2)(2008-10#3)(2012-3#1)
an allergic reaction to the##2##5##(1991-1#1)(1993-6#1)
an alloy##2##2##(2008-10#2)
an almost equal##3##3##(1997-3#2)(2008-10#1)
an almost##11##2##(1993-8#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
an alpha##3##2##(1991-10#1)(1992-4#1)(2008-10#1)
an alpha-helical##4##2##(1991-12#1)(1994-3#1)(1995-6#1)(2012-2#1)
an already##4##2##(1990-8#1)(1995-2#1)(2013-1#2)
an alteration in the##2##4##(2010-12#1)(2012-2#1)
an alteration in##7##3##(1990-12#1)(1993-8#1)(1996-12#1)(1996-2#1)(2010-12#1)(2012-2#2)
an alteration of the##2##4##(1997-6#1)(2008-5#1)
an alteration of##4##3##(1993-6#1)(1995-12#1)(1997-6#1)(2008-5#1)
an alteration##11##2##(1990-12#1)(1993-6#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-6#1)(2008-5#1)(2010-12#1)(2012-2#2)
an altered##12##2##(1990-8#1)(1993-1#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
an alternate##7##2##(1993-12#1)(1994-9#1)(2008-10#1)(2008-4#1)(2013-1#3)
an alternating##2##2##(1994-5#1)(2008-11#1)
an alternative and effective##2##4##(2008-10#2)
an alternative and##6##3##(2008-10#4)(2010-11#1)(2013-8#1)
an alternative approach to##2##4##(2008-9#1)(2012-3#1)
an alternative approach##6##3##(1995-2#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
an alternative calibration##2##3##(2008-10#2)
an alternative explanation##2##3##(2008-7#1)(2008-9#1)
an alternative for##3##3##(1991-1#1)(2008-10#1)(2013-1#1)
an alternative host for##2##4##(2008-10#2)
an alternative method for##2##4##(2008-10#2)
an alternative method of##2##4##(2008-10#1)(2010-12#1)
an alternative method to##4##4##(2008-10#3)(2008-5#1)
an alternative method##10##3##(2008-10#7)(2008-5#1)(2008-9#1)(2010-12#1)
an alternative procedure##3##3##(2008-10#2)(2012-12#1)
an alternative source of##2##4##(2008-10#1)(2008-11#1)
an alternative strategy##2##3##(2008-11#1)(2008-9#1)
an alternative surgical approach##2##4##(2008-7#2)
an alternative surgical##3##3##(2008-7#2)(2008-9#1)
an alternative technique for##2##4##(2008-10#1)(2013-8#1)
an alternative technique##6##3##(1991-12#1)(2008-10#4)(2013-8#1)
an alternative to conventional##4##4##(2008-10#2)(2008-4#1)(2009-4#1)
an alternative to the traditional##2##5##(2008-10#1)(2012-3#1)
an alternative to the##13##4##(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
an alternative to traditional##4##4##(1992-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
an alternative to##65##3##(1990-9#1)(1991-3#1)(1992-1#1)(1994-2#2)(1994-9#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#2)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)
an alternative##168##2##(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#3)(1997-8#2)(2007-12#1)(2008-10#56)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#4)(2008-9#11)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
an aluminium##2##2##(2008-5#1)(2008-7#1)
an aluminum##6##2##(1991-12#1)(1992-11#1)(2008-10#1)(2008-3#1)(2009-8#2)
an alumni##2##2##(1996-1#1)(2012-2#1)
an ambitious##3##2##(1992-2#1)(2008-12#1)(2013-1#1)
an ambulatory##3##2##(1997-1#1)(2008-11#2)
an amendment to##2##3##(1995-6#1)(2008-10#1)
an amendment##3##2##(1995-6#1)(2008-10#2)
an amine##3##2##(2008-10#3)
an amino acid substitution##4##4##(1994-11#1)(2008-10#3)
an amino acid##11##3##(1991-6#1)(1992-7#1)(1994-11#1)(1997-7#1)(2007-12#1)(2008-10#6)
an amino group##3##3##(1992-3#1)(2008-10#2)
an amino##17##2##(1991-6#1)(1992-3#1)(1992-7#1)(1994-11#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)
an amino-terminal##2##2##(1990-5#1)(1995-6#1)
an aminopropyl##2##2##(2008-10#1)(2013-8#1)
an ammonia##2##2##(2008-10#2)
an ammonium sulfate##2##3##(1994-6#1)(1996-12#1)
an ammonium##7##2##(1994-6#1)(1996-12#1)(2008-10#5)
an amorphous material##2##3##(2008-10#2)
an amorphous metal hydroxide##2##4##(2008-5#2)
an amorphous##6##2##(2008-10#3)(2008-5#3)
an amount equal to##2##4##(1993-3#1)(1995-3#1)
an amount of##2##3##(1996-9#1)(2008-11#1)
an amount##5##2##(1993-3#1)(1995-3#1)(1996-9#1)(2008-11#1)(2008-5#1)
an amperometric biosensor based on##2##5##(2008-10#2)
an amperometric biosensor for the##2##5##(2008-10#2)
an amperometric biosensor##5##3##(2008-10#5)
an amperometric detector for flow injection analysis of##2##8##(2008-10#2)
an amperometric detector for flow injection analysis##3##7##(2008-10#3)
an amperometric detector for##7##4##(2008-10#7)
an amperometric detector##8##3##(2008-10#8)
an amperometric##23##2##(2008-10#23)
an amphipathic##2##2##(1994-5#1)(2008-10#1)
an ampicillin##2##2##(1993-8#1)(2011-2#1)
an amplification##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
an amplified##4##2##(2008-10#3)(2008-3#1)
an amplitude comparable with##2##4##(2008-3#2)
an amylose column##2##3##(1994-8#1)(1995-12#1)
an amylose##3##2##(1990-9#1)(1994-8#1)(1995-12#1)
an anaerobic##3##2##(2008-1#1)(2008-7#1)(2013-1#1)
an analog of##4##3##(1993-8#1)(1995-8#1)(2008-10#1)(2008-9#1)
an analog##5##2##(1993-8#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
an analogous##7##2##(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)
an analogue of##2##3##(1990-5#1)(2010-3#1)
an analogue##3##2##(1990-5#1)(2009-11#1)(2010-3#1)
an analogy##2##2##(1992-9#1)(2008-11#1)
an analysis of molecular variance##3##5##(2008-10#3)
an analysis of the cost##2##5##(2012-12#2)
an analysis of the##15##4##(1995-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)(2012-12#3)
an analysis of variance##2##4##(2008-10#2)
an analysis of##45##3##(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-8#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
an analysis taking##2##3##(1992-9#1)(2008-10#1)
an analysis time of##2##4##(2008-10#2)
an analysis##58##2##(1991-2#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-8#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
an analyst##2##2##(2008-10#2)
an analyte is##2##3##(2008-10#2)
an analyte##8##2##(2008-10#7)(2008-7#1)
an analytic##2##2##(2008-12#1)(2010-5#1)
an analytical curve##2##3##(2008-10#2)
an analytical frequency of 90##2##5##(2008-10#2)
an analytical frequency of##4##4##(2008-10#4)
an analytical method to##3##4##(1996-12#1)(2008-10#2)
an analytical method was##2##4##(2008-10#2)
an analytical method##11##3##(1996-12#1)(2008-10#10)
an analytical procedure##7##3##(1997-2#1)(2008-10#6)
an analytical protocol##2##3##(2008-10#2)
an analytical sequence##2##3##(2008-10#2)
an analytical solution##3##3##(2008-10#1)(2008-3#2)
an analytical system##2##3##(2008-10#1)(2008-9#1)
an analytical technique##2##3##(2009-12#1)(2012-2#1)
an analytical throughput of##6##4##(2008-10#6)
an analytical throughput##7##3##(2008-10#7)
an analytical tool##2##3##(2008-10#2)
an analytical##67##2##(1991-12#1)(1996-12#1)(1997-2#1)(2008-10#53)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#2)(2009-12#1)(2012-2#1)(2013-1#1)
an anamorphic external cavity##2##4##(2008-3#2)
an anatomical##4##2##(1996-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
an anatomically##2##2##(2013-1#2)
an ancestral condition##3##3##(2008-8#1)(2009-8#1)(2012-2#1)
an ancestral##7##2##(1990-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-2#1)
an anchored##2##2##(1997-7#1)(2008-10#1)
an ancient##9##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#2)(2011-2#1)(2013-8#1)
an androgen##3##2##(1990-11#2)(1991-5#1)
an anesthetic##6##2##(1990-5#3)(1993-1#1)(2010-1#1)(2011-1#1)
an aneurysm of the##2##4##(1991-6#1)(1997-8#1)
an aneurysm##9##2##(1991-6#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-7#1)(2011-2#1)(2013-8#1)
an aneurysmal##3##2##(1997-3#1)(2008-12#1)(2008-7#1)
an angiotensin##2##2##(2008-1#1)(2013-1#1)
an angle of##2##3##(2008-2#1)(2008-3#1)
an angle##6##2##(1992-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
an animal model of##8##4##(1993-12#1)(1995-2#1)(1996-8#1)(2008-11#1)(2008-4#1)(2008-6#2)(2010-1#1)
an animal model##17##3##(1993-12#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#2)(2010-1#1)(2010-6#1)(2011-2#1)
an animal shelter in##2##4##(2013-8#2)
an animal tissue##2##3##(2008-10#1)(2008-7#1)
an animal##28##2##(1993-12#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-8#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#2)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
an anion exchange column##3##4##(2008-10#3)
an anion exchange##5##3##(2008-10#5)
an anion exchanger##3##3##(2008-10#3)
an anion excluder##2##3##(2008-10#2)
an anion##11##2##(1996-12#1)(2008-10#10)
an anion-exchange column##5##3##(2008-10#5)
an anion-exchange resin##8##3##(2008-10#8)
an anion-exchange##14##2##(2008-10#14)
an anionic resin##2##3##(2008-10#2)
an anionic##10##2##(1994-5#1)(2008-10#9)
an ankle##3##2##(2008-12#1)(2010-3#1)(2012-3#1)
an annual##15##2##(1992-2#1)(1994-12#2)(1996-1#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2012-12#1)(2012-3#1)
an annular##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
an anodic peak was observed at##2##6##(2008-10#2)
an anodic##7##2##(2008-10#7)
an anomalous##3##2##(2008-10#1)(2009-11#1)(2012-3#1)
an anonymous##3##2##(1991-8#1)(1991-9#1)(2008-11#1)
an answer##2##2##(2009-12#1)(2011-2#1)
an antagonist of the##3##4##(1996-2#1)(2008-8#2)
an antagonist of##4##3##(1996-2#1)(1997-2#1)(2008-8#2)
an antagonist##10##2##(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-8#2)
an antagonistic effect##2##3##(2008-10#1)(2008-8#1)
an antagonistic sterile fungus StFCh1-1 in the rhizosphere condition##2##9##(2008-12#2)
an antagonistic##6##2##(2008-10#2)(2008-12#2)(2008-8#1)(2010-1#1)
an antennal##2##2##(1994-8#1)(2008-10#1)
an anterior communicating artery aneurysm##3##5##(1996-3#2)(2008-7#1)
an anterior##10##2##(1991-3#1)(1992-9#2)(1996-3#2)(2008-7#3)(2012-3#1)(2013-1#1)
an anterograde factor##2##3##(1995-2#2)
an anti-HIV##2##2##(1994-11#1)(2011-3#1)
an anti-Hofmeister selectivity pattern with high##2##6##(2008-10#2)
an anti-LAS monoclonal antibody##2##4##(2008-10#2)
an anti-aging##3##2##(1990-3#1)(2011-2#1)(2013-7#1)
an anti-inflammatory##5##2##(2008-10#1)(2008-11#1)(2008-3#3)
an antibacterial and antifungal material##2##5##(2008-10#2)
an antibacterial and antifungal##3##4##(2008-10#3)
an antibacterial##6##2##(1997-8#1)(2008-10#3)(2008-5#1)(2012-3#1)
an antibiotic treatment##2##3##(1997-4#1)(2008-11#1)
an antibiotic##6##2##(1996-6#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)
an antibody against##2##3##(1990-5#1)(2010-6#1)
an antibody raised against##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
an antibody to the##2##4##(2008-10#1)(2008-11#1)
an antibody to##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
an antibody##24##2##(1990-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(2008-10#8)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-6#1)
an anticoagulant##2##2##(2008-10#1)(2010-10#1)
an antigen##12##2##(1990-12#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-8#1)(2010-6#1)
an antigenic##2##2##(1996-12#1)(2008-5#1)
an antigenically##2##2##(1996-1#1)(2008-10#1)
an antimicrobial peptide##2##3##(2011-2#2)
an antimicrobial##3##2##(1994-3#1)(2011-2#2)
an antioxidant##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
an antipsychotic##4##2##(2008-11#1)(2011-10#1)(2012-3#2)
an antisense RNA##4##3##(1992-12#1)(1994-11#1)(1995-2#1)(2011-1#1)
an antisense##9##2##(1992-12#1)(1994-11#1)(1995-11#1)(1995-2#2)(1997-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
an antiseptic##2##2##(2008-10#2)
an antiserum raised against the##2##5##(1996-2#1)(2008-10#1)
an antiserum##6##2##(1993-3#1)(1996-12#1)(1996-2#1)(2008-10#3)
an anxiety disorder##3##3##(2008-4#1)(2010-5#1)(2013-8#1)
an anxiety##4##2##(1996-2#1)(2008-4#1)(2010-5#1)(2013-8#1)
an anxious attachment style##3##4##(2012-2#3)
an aortic##3##2##(1994-6#1)(2008-12#1)(2013-1#1)
an apolar##2##2##(2008-10#2)
an apparatus##2##2##(1991-5#1)(2008-10#1)
an apparent molecular mass of##2##5##(1993-8#1)(1997-2#1)
an apparent molecular mass##4##4##(1993-8#1)(1994-3#1)(1997-2#1)(2008-10#1)
an apparent molecular weight of##2##5##(1992-7#1)(1997-2#1)
an apparent molecular##7##3##(1992-7#1)(1993-8#1)(1994-3#1)(1997-2#2)(2008-10#2)
an apparent##39##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#3)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-7#1)(2008-9#1)(2010-1#1)
an apparently healthy##2##3##(2008-10#1)(2011-2#1)
an apparently##7##2##(1990-11#1)(1991-9#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
an appealing##3##2##(2008-10#2)(2008-8#1)
an applicant for##2##3##(1991-11#1)(1993-1#1)
an application for##2##3##(2009-3#1)(2013-1#1)
an application in##4##3##(1992-9#1)(2008-10#2)(2008-12#1)
an application of the##5##4##(1994-2#1)(1995-1#1)(2008-10#2)(2008-11#1)
an application of this##2##4##(2008-10#1)(2011-2#1)
an application of##9##3##(1992-2#1)(1994-2#1)(1995-1#1)(2008-10#4)(2008-11#1)(2011-2#1)
an application to##3##3##(2008-10#1)(2009-4#1)(2010-7#1)
an application##26##2##(1992-2#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
an applied potential of##5##4##(2008-10#5)
an applied potential##6##3##(2008-10#6)
an applied##11##2##(1992-2#1)(1993-1#1)(2008-10#8)(2008-7#1)
an appreciable##9##2##(1992-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-5#1)(2009-7#1)(2012-3#1)
an appreciation of the##3##4##(2008-4#1)(2013-8#2)
an appreciation##4##2##(1991-12#1)(2008-4#1)(2013-8#2)
an appressorium##5##2##(2008-10#5)
an approach for##10##3##(1991-3#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
an approach to analyzing##2##4##(2008-4#1)(2008-9#1)
an approach to##12##3##(1991-2#1)(1993-8#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-11#1)
an approach##32##2##(1991-2#1)(1991-3#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-2#2)(1995-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
an appropriate balance between##2##4##(1992-3#1)(2010-4#1)
an appropriate incubation##2##3##(1992-9#1)(2008-11#1)
an appropriate method##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
an appropriate outcome measure##2##4##(1995-5#1)(2013-1#1)
an appropriate tool##3##3##(2008-3#1)(2008-9#1)(2011-2#1)
an appropriate##57##2##(1992-3#2)(1992-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-8#2)(2008-10#20)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-9#5)(2009-12#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#4)(2013-1#3)(2013-8#1)
an appropriately##3##2##(1996-3#1)(2008-10#1)(2012-3#1)
an approx##2##2##(1990-8#1)(1993-12#1)
an approximate formula for the##2##5##(1992-9#1)(1995-9#1)
an approximate molecular weight of##2##5##(1990-12#1)(2008-8#1)
an approximate##9##2##(1990-12#1)(1992-9#1)(1995-9#2)(2008-10#2)(2008-6#1)(2008-8#1)(2012-2#1)
an approximately 1##2##3##(2008-10#2)
an approximately##15##2##(1992-9#1)(1995-11#1)(1995-2#4)(1995-6#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-6#1)
an aprotic##2##2##(2008-10#2)
an aquarium air pump##2##4##(2008-10#2)
an aquatic##3##2##(2008-10#3)
an aqueous phase##3##3##(2008-10#3)
an aqueous solution containing##3##4##(2008-10#2)(2011-2#1)
an aqueous solution of##3##4##(2008-10#3)
an aqueous solution##20##3##(2008-10#17)(2008-11#1)(2008-3#1)(2011-2#1)
an aqueous##51##2##(2007-11#1)(2008-10#43)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#2)
an arbitrary##10##2##(1997-2#1)(2007-12#1)(2008-3#7)(2008-6#1)
an area in which the##2##5##(2008-10#2)
an area in which##3##4##(2008-10#3)
an area of##14##3##(1991-11#2)(1996-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
an area that has##2##4##(1995-1#1)(2008-11#1)
an area that##5##3##(1995-1#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)
an area where##2##3##(2008-1#1)(2008-10#1)
an area##39##2##(1991-11#2)(1991-12#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-1#1)(1997-3#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#2)
an argon##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
an argument##2##2##(1991-6#1)(1995-12#1)
an array of micromechanical##2##4##(2008-3#2)
an array of non-specific##2##4##(2008-10#2)
an array of##26##3##(1992-12#1)(1995-1#1)(1996-1#1)(2008-10#10)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#2)
an array##29##2##(1992-12#1)(1995-1#1)(1996-1#1)(2008-10#12)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#2)
an array-based immunosorbent assay##2##4##(2008-10#2)
an arsenic##2##2##(2008-10#2)
an arterial autograft##2##3##(2006-6#2)
an arterial##6##2##(1990-11#1)(1991-3#1)(1993-9#1)(2006-6#2)(2008-10#1)
an arteriovenous fistula##2##3##(1996-9#1)(2008-1#1)
an arthrodesis##3##2##(2010-5#3)
an artificial mouth system##2##4##(2008-10#2)
an artificial neural network (ANN)##3##5##(2008-10#3)
an artificial neural network consisting of three layers of nodes was trained by applying a back-propagation learning rule##3##18##(2008-10#3)
an artificial neural network##9##4##(2008-10#7)(2008-8#1)(2010-8#1)
an artificial##27##2##(1992-12#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-8#2)(2011-2#4)
an artificially##3##2##(1996-3#1)(2008-11#1)(2008-8#1)
an artist##2##2##(2008-10#2)
an as yet##2##3##(2008-11#1)(2009-3#1)
an aspartic##2##2##(1991-9#1)(1993-8#1)
an aspartyl##2##2##(1994-5#1)(1995-6#1)
an aspect of##2##3##(2008-5#1)(2009-10#1)
an aspherical lens##2##3##(2008-2#2)
an assay for##4##3##(2008-10#2)(2008-4#1)(2010-4#1)
an assay of##2##3##(2008-10#1)(2008-6#1)
an assay##9##2##(1994-5#1)(1995-2#1)(2008-10#4)(2008-4#1)(2008-6#1)(2010-4#1)
an assertive##2##2##(2008-11#2)
an assessment of its##2##4##(2008-11#1)(2008-3#1)
an assessment of the##7##4##(1991-6#1)(1992-3#1)(1993-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)
an assessment of##16##3##(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#1)(1996-2#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2012-2#1)(2013-1#1)
an assessment tool##3##3##(2008-11#2)(2011-2#1)
an assessment##32##2##(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-11#1)(1996-2#3)(1997-6#1)(2008-11#11)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
an assistant##2##2##(1996-8#1)(2009-11#1)
an associate##3##2##(2008-10#1)(2009-7#1)(2010-5#1)
an associated##16##2##(1995-2#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-10#1)(2013-1#1)
an association between the##3##4##(1990-8#1)(2008-8#1)(2013-8#1)
an association between##19##3##(1990-8#1)(1996-11#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
an association constant for tetrol I-1##2##6##(2008-10#2)
an association constant##3##3##(1996-5#1)(2008-10#2)
an association of##4##3##(1990-3#1)(2006-5#1)(2008-10#1)(2011-2#1)
an association with##2##3##(1997-8#1)(2012-2#1)
an association##33##2##(1990-3#1)(1990-8#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-8#2)(2006-5#1)(2008-10#5)(2008-11#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
an associative##6##2##(2008-11#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#2)
an assumed##3##2##(2008-10#2)(2008-8#1)
an assumption##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
an aster yellows##3##3##(2008-10#3)
an asthma##2##2##(1997-1#1)(2010-8#1)
an astrocytic cell line##2##4##(1994-11#2)
an asymmetric distribution##2##3##(1994-2#1)(2012-2#1)
an asymmetric##9##2##(1992-11#1)(1992-3#1)(1993-3#1)(1994-2#1)(2008-10#3)(2010-7#1)(2012-2#1)
an asymptomatic##6##2##(1991-11#1)(1992-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2012-3#1)
an asymptotically stable##2##3##(2013-8#2)
an athlete##4##2##(2009-1#1)(2010-1#1)(2011-2#1)(2012-3#1)
an atmosphere of##4##3##(1997-3#1)(2008-12#1)(2008-5#1)(2013-1#1)
an atmosphere##5##2##(1991-12#1)(1997-3#1)(2008-12#1)(2008-5#1)(2013-1#1)
an atmospheric pressure##2##3##(2008-3#2)
an atmospheric##3##2##(2008-3#3)
an atmospheric-pressure##2##2##(2008-2#1)(2008-3#1)
an atomic absorption spectrometer##2##4##(2008-10#2)
an atomic absorption spectrometric##2##4##(2008-10#2)
an atomic absorption spectrophotometric method##2##5##(2008-10#2)
an atomic absorption##7##3##(2008-10#7)
an atomic##14##2##(1994-5#1)(2008-10#9)(2008-11#1)(2008-2#2)(2012-2#1)
an attempt at##2##3##(2008-12#1)(2013-8#1)
an attempt to develop##4##4##(2008-10#3)(2008-11#1)
an attempt to elucidate the##2##5##(1996-2#1)(1997-7#1)
an attempt to elucidate##3##4##(1996-2#1)(1997-7#1)(2008-9#1)
an attempt to identify##2##4##(2012-3#1)(2013-8#1)
an attempt to overcome##3##4##(1996-12#1)(1996-3#1)(2008-10#1)
an attempt to##46##3##(1991-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
an attempt was made to##2##5##(1990-6#1)(2012-2#1)
an attempt##52##2##(1990-6#1)(1991-2#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
an attenuation##2##2##(1996-5#1)(2008-10#1)
an attractive alternative to conventional##2##5##(2008-10#1)(2012-2#1)
an attractive alternative to##3##4##(2008-10#2)(2012-2#1)
an attractive alternative##9##3##(1997-8#1)(2008-10#5)(2008-11#2)(2012-2#1)
an attractive candidate##2##3##(2008-10#1)(2011-2#1)
an attractive model##2##3##(1996-12#1)(2012-3#1)
an attractive sink##2##3##(2008-8#2)
an attractive solution##2##3##(1995-2#1)(2008-11#1)
an attractive system for##2##4##(2007-12#1)(2008-11#1)
an attractive target for##5##4##(2008-11#2)(2009-4#1)(2011-2#1)(2013-1#1)
an attractive technique for the##2##5##(2008-10#1)(2010-9#1)
an attractive technique##4##3##(2008-10#3)(2010-9#1)
an attractive##39##2##(1995-2#1)(1996-12#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#7)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
an atypical##6##2##(1993-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
an audience##4##2##(2009-6#3)(2013-1#1)
an audio##2##2##(2008-11#1)(2013-1#1)
an audit##5##2##(1993-1#4)(1994-12#1)
an auditory##3##2##(2008-11#1)(2008-9#1)(2010-5#1)
an augmented##2##2##(2008-10#1)(2013-1#1)
an autocrine##4##2##(1990-2#1)(2008-11#1)(2008-4#1)(2009-8#1)
an autocrine/paracrine fashion##2##3##(1993-3#2)
an autoimmune disease and##2##4##(2008-1#1)(2008-11#1)
an autoimmune disease##4##3##(2008-1#1)(2008-11#1)(2009-8#1)(2010-12#1)
an autoimmune##9##2##(1990-12#1)(1996-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
an autologous##3##2##(1994-5#1)(2008-11#1)(2013-1#1)
an automated cell##2##3##(2008-11#2)
an automated flow injection##2##4##(2008-10#2)
an automated process##2##3##(2008-10#1)(2010-1#1)
an automated sample##2##3##(1997-6#1)(2008-10#1)
an automated system##2##3##(1991-12#1)(2008-10#1)
an automated##34##2##(1990-2#1)(1991-12#1)(1991-2#1)(1996-3#1)(1997-6#1)(2008-10#22)(2008-11#2)(2008-4#2)(2010-1#1)(2010-7#1)(2012-2#1)
an automatic injector##2##3##(2008-10#2)
an automatic##14##2##(1991-12#1)(2008-10#11)(2009-12#1)(2010-8#1)
an automation##2##2##(2008-10#2)
an autonomous##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
an autoregulatory##2##2##(1997-7#1)(2008-6#1)
an autosomal dominant disorder##5##4##(1997-3#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
an autosomal dominant##14##3##(1993-12#1)(1997-3#2)(1997-6#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-6#2)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
an autosomal recessive disorder##3##4##(2008-7#1)(2011-1#1)(2012-12#1)
an autosomal recessive##10##3##(1990-8#1)(1990-9#1)(1995-6#1)(2008-4#2)(2008-7#2)(2011-1#1)(2011-3#1)(2012-12#1)
an autosomal##26##2##(1990-8#1)(1990-9#1)(1993-12#1)(1995-6#1)(1997-3#2)(1997-6#1)(2008-12#3)(2008-4#3)(2008-7#4)(2010-6#2)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
an auxiliary##2##2##(1991-8#1)(2008-3#1)
an available##2##2##(2007-12#1)(2012-12#1)
an average age of##6##4##(1990-12#1)(1994-12#1)(2008-9#2)(2010-8#1)(2013-1#1)
an average age##8##3##(1990-12#1)(1994-12#1)(1997-3#1)(2008-9#2)(2010-8#1)(2013-1#2)
an average doubling time of##2##5##(2008-11#2)
an average follow-up of##3##4##(2008-8#1)(2009-3#1)(2011-2#1)
an average follow-up##4##3##(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)
an average genetic##2##3##(2008-10#2)
an average life##2##3##(1993-9#1)(1995-6#1)
an average of 0##4##4##(1990-12#1)(2008-10#2)(2008-8#1)
an average of 1##2##4##(1991-5#1)(2012-2#1)
an average of 2##2##4##(2008-3#1)(2012-2#1)
an average of 4##3##4##(2008-10#1)(2008-9#1)(2013-7#1)
an average of 5##4##4##(2008-10#3)(2008-3#1)
an average of 6##2##4##(1997-7#1)(2008-10#1)
an average of 7##2##4##(1993-3#1)(2009-3#1)
an average of 8 months##2##5##(1994-3#1)(2008-7#1)
an average of 8##3##4##(1994-3#1)(2008-7#1)(2009-3#1)
an average of a##2##4##(2011-2#2)
an average of##59##3##(1990-12#2)(1990-2#1)(1991-3#1)(1991-5#2)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#4)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#2)(2010-4#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-7#1)
an average power##2##3##(2007-12#1)(2008-3#1)
an average recovery of 97##2##5##(2008-10#2)
an average recovery of 99##2##5##(2008-10#2)
an average recovery of##7##4##(2008-10#7)
an average recovery##8##3##(2008-10#8)
an average relative##4##3##(2008-10#4)
an average roughness##2##3##(2012-2#2)
an average##152##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-3#1)(1991-5#2)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-9#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#41)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#10)(2009-10#1)(2009-3#3)(2009-5#1)(2010-10#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-2#8)(2012-2#7)(2013-1#5)(2013-7#1)(2013-8#2)
an aversive event##2##3##(2008-11#2)
an aversive##4##2##(2008-11#2)(2008-4#1)(2010-10#1)
an avian##3##2##(2008-8#1)(2011-2#1)(2013-8#1)
an avidin##2##2##(2008-10#1)(2011-2#1)
an avirulence locus##2##3##(2008-10#2)
an avirulence##3##2##(2008-10#3)
an awareness of the##2##4##(2008-12#1)(2008-7#1)
an azo##3##2##(2008-10#3)
an ear##2##2##(2008-10#1)(2012-3#1)
an earlier article##2##3##(1994-3#1)(2008-12#1)
an earlier stage of##2##4##(1997-7#1)(2010-1#1)
an earlier stage##3##3##(1992-3#1)(1997-7#1)(2010-1#1)
an earlier study##7##3##(1991-3#1)(1993-12#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-5#1)
an earlier work##2##3##(2008-10#2)
an earlier##29##2##(1991-3#1)(1992-3#2)(1993-12#1)(1994-3#2)(1995-3#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
an early and##3##3##(1992-5#1)(2009-8#1)(2011-2#1)
an early event##2##3##(1990-7#1)(1991-1#1)
an early intervention##2##3##(2011-3#1)(2013-1#1)
an early stage of##8##4##(2007-9#1)(2008-10#4)(2008-5#1)(2010-3#1)(2013-8#1)
an early stage##20##3##(1994-3#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
an early##66##2##(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-3#1)(1997-1#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#4)(2010-3#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
an easily##8##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-9#1)(2013-1#1)
an easy and##4##3##(2008-10#2)(2008-11#1)(2010-3#1)
an easy way to##2##4##(1997-2#1)(2008-10#1)
an easy way##3##3##(1997-2#1)(2008-10#2)
an easy##17##2##(1994-11#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-8#1)
an eccentric##2##2##(2008-3#1)(2013-1#1)
an echinocandin##2##2##(2008-10#1)(2011-2#1)
an ecological perspective##4##3##(2008-1#1)(2008-11#1)(2009-7#2)
an ecological##10##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#2)(2010-11#1)
an economic##7##2##(1991-3#1)(1997-2#1)(2008-10#4)(2012-2#1)
an economical and##3##3##(2008-10#2)(2008-4#1)
an economical##5##2##(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)
an economically important##3##3##(2008-10#3)
an economically##6##2##(2008-10#4)(2011-2#2)
an ectopic##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
an edge##2##2##(2008-6#1)(2008-9#1)
an education program##2##3##(2008-9#1)(2013-1#1)
an education##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
an educational intervention##3##3##(2008-8#2)(2008-9#1)
an educational program to##2##4##(1997-7#1)(2012-2#1)
an educational program##3##3##(1990-6#1)(1997-7#1)(2012-2#1)
an educational strategy##2##3##(2008-11#1)(2008-12#1)
an educational##15##2##(1990-12#1)(1990-6#1)(1997-3#1)(1997-7#1)(2008-11#4)(2008-12#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-2#1)
an effect in##2##3##(1996-12#1)(2008-9#1)
an effect of the##3##4##(1995-6#1)(2008-12#1)(2010-10#1)
an effect of##11##3##(1993-3#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-10#1)(2013-8#1)
an effect on the##6##4##(1992-9#1)(1996-11#1)(2008-10#2)(2008-12#1)(2012-2#1)
an effect on##13##3##(1992-9#1)(1994-8#2)(1995-12#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
an effect that is##2##4##(1993-3#1)(1994-6#1)
an effect that was##2##4##(1990-5#2)
an effect that##5##3##(1990-5#2)(1993-3#1)(1994-6#1)(2008-11#1)
an effect##36##2##(1990-5#2)(1992-9#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-4#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
an effective alternative to##3##4##(2008-10#1)(2008-9#1)(2010-8#1)
an effective alternative##4##3##(2008-10#1)(2008-9#1)(2010-8#1)(2013-8#1)
an effective and reliable##2##4##(2008-10#2)
an effective and##9##3##(1990-12#1)(1991-12#1)(2008-10#4)(2008-11#2)(2010-8#1)
an effective antioxidant##2##3##(2008-10#1)(2011-1#1)
an effective approach##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
an effective clinical##2##3##(2008-12#1)(2013-1#1)
an effective diagnostic##2##3##(1993-3#1)(2008-9#1)
an effective inhibitor of##2##4##(1992-9#1)(2008-11#1)
an effective intervention##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
an effective means for##2##4##(2008-10#2)
an effective means of##5##4##(1993-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
an effective means##8##3##(1993-11#1)(2008-10#5)(2008-5#1)(2012-2#1)
an effective method for##3##4##(1991-2#1)(2008-4#1)(2011-2#1)
an effective method of##4##4##(1991-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
an effective method to##3##4##(2008-10#1)(2011-3#1)(2013-1#1)
an effective method##12##3##(1991-2#1)(1991-7#1)(2008-10#4)(2008-12#1)(2008-4#1)(2011-2#2)(2011-3#1)(2013-1#1)
an effective microsymbiont of##2##4##(2011-2#2)
an effective on-line##2##3##(2008-10#1)(2008-7#1)
an effective sample size##3##4##(2008-10#3)
an effective strategy for improving##2##5##(2010-7#1)(2013-1#1)
an effective strategy for##5##4##(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#2)
an effective strategy##6##3##(2008-11#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
an effective technique##2##3##(2008-10#2)
an effective therapeutic##2##3##(2008-6#1)(2011-2#1)
an effective tool for the##2##5##(2008-10#1)(2008-11#1)
an effective tool for##3##4##(2008-10#1)(2008-11#2)
an effective tool in##2##4##(1996-3#1)(2008-10#1)
an effective tool to##5##4##(1994-3#1)(2008-10#1)(2010-10#1)(2013-7#1)(2013-8#1)
an effective tool##10##3##(1994-3#1)(1996-3#1)(2008-10#3)(2008-11#2)(2010-10#1)(2013-7#1)(2013-8#1)
an effective treatment for##3##4##(2008-7#1)(2012-3#2)
an effective treatment##5##3##(1997-6#1)(2008-7#1)(2011-2#1)(2012-3#2)
an effective vaccine##2##3##(1995-5#1)(2011-2#1)
an effective way to##5##4##(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
an effective##154##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-6#2)(2008-10#42)(2008-11#15)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#11)(2011-3#1)(2012-2#5)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#5)
an efficiency of##2##3##(2008-11#1)(2008-3#1)
an efficiency##6##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-5#1)
an efficient algorithm##2##3##(2012-2#1)(2013-8#1)
an efficient and cost-effective way##3##5##(1994-3#2)(2010-8#1)
an efficient and##8##3##(1994-2#1)(1994-3#2)(2008-10#1)(2008-11#2)(2010-8#1)(2012-3#1)
an efficient detection scheme##2##4##(2012-2#2)
an efficient inhibitor of##2##4##(1994-8#1)(2013-1#1)
an efficient means to##3##4##(1997-2#1)(2008-10#2)
an efficient means##4##3##(1997-2#1)(2008-10#3)
an efficient method##5##3##(1997-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
an efficient procedure for##2##4##(2008-10#1)(2008-11#1)
an efficient system for##2##4##(1993-8#1)(2008-11#1)
an efficient tool for##2##4##(2008-10#2)
an efficient way to##2##4##(2008-10#1)(2008-3#1)
an efficient way##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
an efficient##71##2##(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#18)(2008-11#8)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
an effort to better##3##4##(2008-10#1)(2009-9#1)(2010-9#1)
an effort to develop##3##4##(1995-2#1)(2008-10#2)
an effort to identify##3##4##(1993-2#1)(1997-1#1)(2008-11#1)
an effort to increase##2##4##(1997-3#1)(2008-8#1)
an effort to understand##2##4##(2008-5#1)(2009-9#1)
an effort to##32##3##(1990-11#1)(1992-3#1)(1993-2#1)(1994-3#2)(1995-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-9#2)(2010-9#2)(2011-2#1)(2012-12#1)(2012-3#4)
an effort##33##2##(1990-11#1)(1992-3#1)(1993-2#1)(1994-3#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-9#2)(2010-9#2)(2011-2#1)(2012-12#1)(2012-3#4)
an eight##2##2##(1994-2#1)(2008-10#1)
an eight-week##3##2##(1990-2#1)(2011-1#2)
an elastase-specific inhibitor##2##3##(1992-6#2)
an elastic stable intramedullary nail##2##5##(2011-2#2)
an elastic##5##2##(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#2)
an elderly population##5##3##(2008-7#3)(2012-12#2)
an elderly##11##2##(1994-12#1)(2008-6#1)(2008-7#6)(2010-7#1)(2012-12#2)
an elective##3##2##(1995-1#1)(2008-12#1)(2013-1#1)
an electric field##8##3##(1990-8#1)(1995-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)
an electric##11##2##(1990-8#1)(1995-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2009-12#1)
an electrical##8##2##(2008-10#5)(2008-9#1)(2009-3#1)(2009-8#1)
an electrically##2##2##(1995-2#1)(2008-3#1)
an electro-optically Q-switched##2##3##(2008-3#2)
an electroactive##10##2##(2008-10#10)
an electroanalytical##3##2##(2008-10#3)
an electrocardiogram##2##2##(2008-12#2)
an electrocatalytic##2##2##(2008-10#2)
an electrochemical active##2##3##(2008-10#2)
an electrochemical cell##2##3##(2008-10#2)
an electrochemical detector for##2##4##(2008-10#2)
an electrochemical detector##5##3##(2008-10#4)(2008-6#1)
an electrochemical##30##2##(2008-10#27)(2008-6#1)(2008-7#1)(2013-1#1)
an electrochemically##4##2##(2008-10#4)
an electrode composition##2##3##(2008-10#2)
an electrode surface##2##3##(2008-10#2)
an electrode##18##2##(1993-8#1)(1995-3#1)(2008-10#15)(2012-3#1)
an electrode/electrolyte interface##3##3##(2008-10#3)
an electrolyte##4##2##(2008-10#4)
an electromagnetic##2##2##(2008-2#1)(2011-2#1)
an electromyographic study##2##3##(1990-11#1)(1996-5#1)
an electron capture detector##4##4##(2008-10#4)
an electron capture##5##3##(2008-10#5)
an electron spin resonance (ESR)##2##5##(2008-10#2)
an electron transfer##3##3##(1996-3#1)(2008-10#2)
an electron##18##2##(1991-5#1)(1995-6#1)(1996-3#1)(1997-1#1)(2007-12#2)(2008-10#12)
an electronic health record##5##4##(2013-1#5)
an electronic medical##2##3##(2009-10#1)(2010-8#1)
an electronic nose##3##3##(2008-10#2)(2008-11#1)
an electronic##26##2##(1991-8#1)(1993-9#1)(1995-3#1)(1996-3#3)(2008-10#7)(2008-11#2)(2008-3#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#5)
an electroosmotic pump##2##3##(2008-10#2)
an electroosmotic##3##2##(2008-10#3)
an electrophoretic##5##2##(1992-8#1)(2008-10#3)(2008-4#1)
an electrophysiological##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
an electrostatic force##2##3##(2008-10#2)
an electrostatic interaction##4##3##(1996-5#1)(2008-10#3)
an electrostatic##8##2##(1996-5#1)(2008-10#6)(2008-4#1)
an electrothermal##2##2##(2008-10#2)
an element##7##2##(1991-3#1)(1992-12#1)(1992-6#1)(2008-10#4)
an elevated risk##2##3##(2009-10#1)(2013-1#1)
an elevated##16##2##(1990-5#1)(1991-7#1)(1994-5#1)(1996-12#1)(1997-5#2)(2008-10#2)(2008-3#1)(2009-10#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
an elevation in##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
an elevation of##3##3##(1990-2#1)(1995-8#1)(2011-2#1)
an elevation##6##2##(1990-2#1)(1990-6#1)(1995-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
an elicitor of systemic resistance##2##5##(2008-10#2)
an elicitor of##3##3##(2008-10#3)
an elicitor##4##2##(2008-10#4)
an elite##3##2##(2008-10#3)
an elliptic disk##2##3##(2008-2#2)
an elliptic##4##2##(2008-2#2)(2008-3#2)
an elliptical##2##2##(2007-11#1)(2008-7#1)
an elliptical-cross-section cylinder##2##3##(2008-3#2)
an eluent##2##2##(2008-10#2)
an embryo##3##2##(1993-2#1)(2008-11#1)(2012-3#1)
an embryonic##2##2##(2009-1#1)(2010-7#1)
an emergency department##3##3##(1994-8#1)(2008-3#2)
an emergency##15##2##(1991-3#1)(1992-8#1)(1994-8#1)(1996-1#1)(1996-6#1)(1997-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
an emerging and##2##3##(2010-10#1)(2013-1#1)
an emerging disease in##2##4##(2009-8#1)(2012-12#1)
an emerging technique##3##3##(2010-11#2)(2012-2#1)
an emerging##24##2##(1993-3#1)(2008-10#3)(2008-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
an emission wavelength of##5##4##(2008-10#5)
an emission wavelength##7##3##(2008-10#7)
an emission##11##2##(2008-10#10)(2008-3#1)
an emotional##3##2##(2008-11#2)(2008-7#1)
an emphasis on##10##3##(1992-12#1)(2008-11#2)(2009-3#1)(2010-3#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#2)
an emphasis placed on##2##4##(1997-3#1)(2008-11#1)
an emphasis##15##2##(1992-1#1)(1992-12#1)(1992-3#1)(1996-6#1)(1997-3#1)(2008-11#3)(2009-3#1)(2010-3#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#2)
an empirical example of##2##4##(2008-9#1)(2012-3#1)
an empirical example##3##3##(2008-9#1)(2012-2#1)(2012-3#1)
an empirical study##4##3##(1992-2#1)(1992-3#1)(2008-11#1)(2009-8#1)
an empirical##15##2##(1992-2#1)(1992-3#1)(1994-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-2#2)(2012-3#1)
an employee##10##2##(1991-3#2)(1992-1#1)(1993-1#1)(1994-2#5)(2012-3#1)
an empty##2##2##(2008-8#1)(2011-2#1)
an emulsion##4##2##(2008-10#2)(2008-5#2)
an encapsulated##2##2##(2008-11#2)
an enchondroma##2##2##(2008-9#1)(2010-3#1)
an encouraging##5##2##(1991-9#1)(1992-2#1)(2008-10#1)(2010-12#2)
an end user##2##3##(1991-12#1)(2008-9#1)
an end##9##2##(1991-11#1)(1991-12#1)(1991-2#1)(2008-10#3)(2008-6#1)(2008-9#1)(2013-8#1)
an end-column##2##2##(2008-10#2)
an end-stage renal##2##3##(2013-1#2)
an endangered##4##2##(1991-5#2)(2008-11#1)(2008-8#1)
an endemic area for##3##4##(2008-5#2)(2012-2#1)
an endemic region##2##3##(2008-10#1)(2012-3#1)
an endemic##11##2##(2008-10#2)(2008-5#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
an endochitinase##2##2##(2008-10#2)
an endogenous ligand for##2##4##(1996-12#2)
an endogenous ligand##3##3##(1990-5#1)(1996-12#2)
an endogenous##16##2##(1990-5#3)(1991-10#1)(1994-11#2)(1995-8#1)(1996-12#2)(1996-2#2)(2008-10#1)(2008-11#3)(2008-7#1)
an endometrial suction curette##2##4##(1992-12#2)
an endometrial##3##2##(1992-12#2)(2011-2#1)
an endopolygalacturonase##2##2##(2008-10#2)
an endoprotease##2##2##(1995-8#1)(2008-7#1)
an endorectal silicone catheter with a balloon in the extremity##2##10##(2013-1#2)
an endoscopic transsphenoidal approach##4##4##(2011-2#4)
an endoscopic##6##2##(2010-12#1)(2011-2#5)
an endothelial##4##2##(1995-2#1)(2008-11#2)(2010-11#1)
an endovascular##2##2##(2008-7#1)(2011-2#1)
an enduring##2##2##(1995-5#1)(2008-9#1)
an energy##7##2##(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-8#2)
an energy-dispersive X-ray spectrometer for a scanning electron microscope##2##9##(2008-10#2)
an engineered##3##2##(2009-7#2)(2012-2#1)
an engineering##2##2##(2008-11#2)
an enhanced expression of##2##4##(1990-2#1)(2008-11#1)
an enhanced##18##2##(1990-2#1)(1990-5#1)(1990-6#1)(1994-8#1)(1995-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2010-8#1)(2011-2#1)(2012-12#1)
an enhancement factor of##2##4##(2008-10#2)
an enhancement in##4##3##(1995-3#1)(2008-10#2)(2008-11#1)
an enhancement of the##5##4##(2008-10#4)(2008-11#1)
an enhancement of##6##3##(2008-10#5)(2008-11#1)
an enhancement##12##2##(1995-3#1)(2008-10#9)(2008-11#2)
an enhancer##3##2##(2008-10#2)(2012-3#1)
an enlarged##4##2##(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
an enormous##8##2##(1997-5#1)(2008-10#4)(2008-4#1)(2010-7#1)(2013-1#1)
an enriched##2##2##(1991-12#1)(2013-8#1)
an enrichment factor of##7##4##(2008-10#7)
an enrichment factor##8##3##(2008-10#8)
an enrichment of##3##3##(2008-10#2)(2008-11#1)
an enrichment##13##2##(2008-10#12)(2008-11#1)
an ensemble of##2##3##(1994-5#1)(2010-3#1)
an enterocyte##2##2##(1991-12#2)
an entire##7##2##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-7#1)(2013-1#1)
an entity##2##2##(1991-12#1)(2011-2#1)
an enumeration##2##2##(1996-3#1)(2013-8#1)
an environment in which##2##4##(1995-6#1)(2010-8#1)
an environment of##2##3##(2008-12#1)(2013-8#1)
an environment where##2##3##(1991-12#1)(2008-11#1)
an environment##17##2##(1991-12#1)(1994-12#1)(1995-6#1)(1997-3#1)(1997-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2010-11#1)(2010-8#1)(2013-8#2)
an environmental##11##2##(1991-12#3)(1997-7#1)(2008-10#5)(2008-9#1)(2013-8#1)
an environmentally##5##2##(2008-10#2)(2008-3#1)(2008-8#2)
an enzymatic reaction##2##3##(2008-10#1)(2009-5#1)
an enzymatic##14##2##(1992-11#1)(2008-10#11)(2009-5#1)(2012-2#1)
an enzymatically active##2##3##(1994-11#1)(1995-6#1)
an enzyme electrode##2##3##(2008-10#2)
an enzyme in##2##3##(2008-10#2)
an enzyme of the##2##4##(1994-8#1)(2010-12#1)
an enzyme of##5##3##(1992-1#1)(1994-11#1)(1994-8#1)(1997-2#1)(2010-12#1)
an enzyme that##4##3##(1992-3#1)(1993-12#1)(2008-10#1)(2009-8#1)
an enzyme##38##2##(1990-2#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#2)(2010-12#1)(2011-1#1)(2012-2#1)
an enzyme-linked immunosorbent assay (ELISA) for##4##6##(1994-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
an enzyme-linked immunosorbent assay (ELISA)##7##5##(1994-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#1)
an enzyme-linked immunosorbent assay##11##4##(1994-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2011-2#2)
an enzyme-linked##13##2##(1994-3#1)(2008-10#7)(2008-11#2)(2008-4#1)(2011-2#2)
an ephedra##2##2##(2008-10#2)
an epidemic of##2##3##(1993-12#1)(1996-11#1)
an epidemic##9##2##(1992-2#2)(1993-12#1)(1996-11#1)(2008-10#4)(2010-12#1)
an epidemiological##6##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
an epidural##2##2##(2011-2#1)(2012-3#1)
an episode of##11##3##(1994-3#1)(1997-8#1)(2008-7#2)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
an episode##12##2##(1994-3#1)(1997-8#1)(2008-7#2)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#4)
an epithelial##2##2##(1993-12#1)(2008-10#1)
an epitope##2##2##(1995-2#1)(1997-1#1)
an equal number of##4##4##(1991-7#1)(2010-1#1)(2012-2#1)(2013-1#1)
an equal volume of##3##4##(1992-6#1)(1997-2#1)(2011-2#1)
an equal##14##2##(1991-6#1)(1991-7#1)(1992-6#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
an equilibrium between the##3##4##(1992-11#1)(2008-10#2)
an equilibrium between##4##3##(1992-11#1)(2008-10#3)
an equilibrium##13##2##(1992-11#1)(1993-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)
an equimolar ratio of##2##4##(1990-8#1)(1994-5#1)
an equimolar##3##2##(1990-8#1)(1994-5#1)(2008-10#1)
an equivalent of##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
an equivalent##15##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#2)(2012-2#1)(2013-8#1)
an erbium-doped fiber amplifier##2##4##(2008-2#1)(2008-3#1)
an ergometer##2##2##(2008-9#2)
an erratic##2##2##(2008-10#1)(2013-1#1)
an error##6##2##(2008-10#5)(2008-11#1)
an erythropoietin##2##2##(2008-4#1)(2008-8#1)
an essential component in the##3##5##(2008-5#1)(2010-1#1)(2013-8#1)
an essential component in##4##4##(1990-5#1)(2008-5#1)(2010-1#1)(2013-8#1)
an essential component of the##3##5##(1991-6#1)(1997-3#1)(2012-2#1)
an essential component of##11##4##(1991-6#1)(1992-1#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#2)(2012-2#1)(2013-8#2)
an essential component##16##3##(1990-5#1)(1991-6#1)(1992-1#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-1#1)(2012-2#1)(2013-8#3)
an essential element##2##3##(2008-10#2)
an essential gene##2##3##(1993-12#1)(1996-6#1)
an essential nutrient##2##3##(2008-5#2)
an essential part of the treatment##2##6##(1992-1#1)(2011-2#1)
an essential resource for##3##4##(1996-2#1)(2008-8#1)(2008-9#1)
an essential role for##2##4##(1994-12#1)(1996-2#1)
an essential role in the##4##5##(1992-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
an essential role in##14##4##(1992-11#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2012-12#1)(2013-1#1)
an essential role##18##3##(1992-11#1)(1992-3#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2012-12#1)(2013-1#1)
an essential step##4##3##(1992-6#1)(1995-6#1)(2008-10#1)(2011-2#1)
an essential tool for##2##4##(1996-1#1)(2008-9#1)
an essential##91##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-6#3)(1996-1#1)(1996-2#2)(1996-6#1)(1997-3#2)(1997-7#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#6)(2013-1#4)(2013-8#6)
an essentially##2##2##(1992-9#1)(2008-10#1)
an established##26##2##(1991-1#1)(1992-9#2)(1997-7#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2011-2#5)(2011-3#2)(2013-1#1)
an estimate of developmental##2##4##(2008-8#2)
an estimate of the##8##4##(1996-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)
an estimate of##15##3##(1991-5#1)(1992-12#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#2)(2009-12#1)
an estimate##17##2##(1990-5#1)(1991-5#1)(1992-12#1)(1996-3#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#2)(2009-12#1)
an estimated 130##2##3##(1994-9#1)(2009-5#1)
an estimated##27##2##(1991-11#1)(1993-8#1)(1994-9#1)(1995-2#3)(1996-12#1)(1997-2#2)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-7#1)(2009-5#1)(2009-9#1)(2010-1#1)(2011-2#2)(2013-8#1)
an estimation of##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
an estimation##5##2##(2008-10#1)(2008-3#2)(2008-7#1)(2013-8#1)
an estrogen##2##2##(2008-10#1)(2008-6#1)
an estrogenic##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
an ethanolic##2##2##(2008-10#1)(2011-2#1)
an ether##2##2##(1994-8#1)(2008-10#1)
an ethical##5##2##(2008-11#2)(2008-12#1)(2008-7#1)(2010-11#1)
an ethnically diverse sample of##2##5##(2009-7#2)
an ethnically##3##2##(2008-1#1)(2009-7#2)
an ethnographic study##3##3##(1993-1#1)(2009-5#1)(2010-9#1)
an ethnographic##4##2##(1993-1#1)(2008-1#1)(2009-5#1)(2010-9#1)
an ethylene##3##2##(2008-10#3)
an etiology##2##2##(2008-4#1)(2012-3#1)
an evacuee's##2##2##(2011-2#2)
an evaluation for##2##3##(2008-10#1)(2011-1#1)
an evaluation of an##2##4##(2008-12#1)(2011-1#1)
an evaluation of the##9##4##(1994-1#1)(2008-10#3)(2008-11#3)(2010-6#1)(2012-3#1)
an evaluation of##27##3##(1990-6#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(2008-10#8)(2008-11#5)(2008-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
an evaluation study##2##3##(1994-1#1)(2008-11#1)
an evaluation##40##2##(1990-6#2)(1990-9#2)(1991-2#1)(1992-2#1)(1993-12#1)(1994-1#2)(1994-2#1)(1997-8#1)(2007-11#1)(2008-10#11)(2008-11#7)(2008-12#2)(2008-3#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-3#2)(2013-8#1)
an evaluative##2##2##(1992-3#1)(1993-1#1)
an evaporation##2##2##(2008-10#1)(2008-11#1)
an even distribution of##3##4##(1990-11#1)(2008-10#1)(2008-5#1)
an even greater##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
an even higher##2##3##(2008-11#1)(2008-3#1)
an even##15##2##(1990-11#1)(1993-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
an event##4##2##(1991-2#1)(1996-2#1)(2008-11#1)(2008-7#1)
an event-related##2##2##(1995-12#1)(2008-11#1)
an ever-increasing##2##2##(1997-2#1)(2008-12#1)
an evidence##4##2##(2008-10#3)(2011-10#1)
an evidence-based review##2##3##(2011-2#2)
an evidence-based##11##2##(1993-12#1)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#3)(2011-7#1)(2013-1#3)
an evident##5##2##(1990-2#1)(1992-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
an evolution##2##2##(1994-3#1)(1997-6#1)
an evolutionarily conserved##3##3##(1995-6#1)(1997-1#1)(1997-7#1)
an evolutionarily##5##2##(1995-6#1)(1997-1#1)(1997-7#1)(2008-9#1)(2010-1#1)
an evolutionary perspective##2##3##(2008-8#1)(2009-8#1)
an evolutionary##15##2##(2008-10#1)(2008-8#6)(2009-10#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#3)
an evolving##3##2##(1991-12#1)(1996-6#1)(2011-7#1)
an exact##12##2##(1995-1#1)(1995-6#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-3#1)
an exaggerated##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
an examination of the##4##4##(2008-10#2)(2008-11#1)(2011-1#1)
an examination of their##2##4##(1996-12#1)(1996-3#1)
an examination of##11##3##(1993-12#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#2)(2010-1#1)(2010-3#1)(2011-1#1)(2012-2#1)
an examination##12##2##(1993-12#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#3)(2010-1#1)(2010-3#1)(2011-1#1)(2012-2#1)
an example of an##2##4##(2007-9#1)(2008-11#1)
an example of how##2##4##(2008-7#1)(2010-12#1)
an example of its use##2##5##(1993-3#1)(2008-11#1)
an example of the##7##4##(1993-9#1)(1997-1#1)(2008-10#3)(2009-8#1)(2010-12#1)
an example of##25##3##(1992-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1997-1#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#2)
an example to##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
an example using##2##3##(1996-3#1)(2008-11#1)
an example##69##2##(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-9#2)(1996-3#1)(1997-1#1)(1997-8#1)(2007-9#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-8#2)
an exceedingly##2##2##(2008-11#1)(2011-2#1)
an excellent alternative to the##2##5##(2008-10#1)(2012-2#1)
an excellent alternative##3##3##(2008-10#1)(2010-6#1)(2012-2#1)
an excellent catalytic activity##2##4##(2008-10#2)
an excellent correlation between##3##4##(1992-2#1)(2008-10#1)(2008-5#1)
an excellent correlation##7##3##(1990-12#1)(1992-2#1)(2008-10#4)(2008-5#1)
an excellent electrocatalytic activity##2##4##(2008-10#2)
an excellent linear##2##3##(2008-10#2)
an excellent method##2##3##(2008-10#2)
an excellent sorbent##2##3##(2008-10#2)
an excellent tool for##3##4##(1997-6#1)(2008-10#2)
an excellent way to##2##4##(1991-2#1)(2008-12#1)
an excellent##72##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#36)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#7)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#4)
an exception to##2##3##(1995-12#1)(2012-3#1)
an exception##4##2##(1995-12#1)(2008-10#2)(2012-3#1)
an exceptional case of##2##4##(1997-8#1)(2013-1#1)
an exceptional##7##2##(1997-8#1)(2007-12#1)(2008-11#1)(2011-3#1)(2013-1#3)
an exceptionally##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
an excess of the##3##4##(2008-10#2)(2012-2#1)
an excess of##20##3##(1990-12#1)(1991-12#2)(1993-8#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-10#10)(2008-8#1)(2008-9#1)(2012-2#1)
an excess##22##2##(1990-12#1)(1991-12#2)(1993-8#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-10#10)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)
an exchange##2##2##(1996-5#1)(2008-10#1)
an excised##3##2##(2008-10#3)
an excision##2##2##(2009-3#1)(2013-1#1)
an excitation wavelength of##7##4##(1997-2#1)(2008-10#6)
an excitation wavelength##8##3##(1997-2#1)(2008-10#7)
an excitation##11##2##(1997-2#1)(2008-10#10)
an exciting new##2##3##(2008-4#1)(2008-9#1)
an exciting##7##2##(1992-9#1)(1995-12#1)(1996-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2012-12#1)
an exclusive##4##2##(1990-2#1)(2008-10#1)(2008-7#1)(2011-3#1)
an exemplary##2##2##(2008-11#1)(2011-2#1)
an exemption##2##2##(1995-2#1)(1996-1#1)
an exercise##3##2##(1995-11#1)(2008-11#1)(2010-4#1)
an exhaustive##3##2##(2008-10#1)(2008-4#1)(2010-10#1)
an existing##10##2##(1994-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2012-2#1)(2012-3#2)
an exo-beta-1##6##2##(1992-11#2)(2008-10#4)
an exogenous##6##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)
an expanded##10##2##(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#2)
an expanding##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
an expansion of the##2##4##(1997-4#1)(2013-1#1)
an expansion of##3##3##(1997-4#1)(2010-5#1)(2013-1#1)
an expansion##4##2##(1997-4#1)(2009-1#1)(2010-5#1)(2013-1#1)
an expansive##3##2##(2008-7#1)(2013-1#2)
an expectation##2##2##(2008-11#1)(2008-12#1)
an expected##2##2##(1995-9#1)(2009-3#1)
an experience of##2##3##(2008-12#1)(2013-1#1)
an experience##4##2##(2008-12#1)(2008-7#1)(2013-1#2)
an experienced##9##2##(1991-12#1)(1991-3#1)(1997-6#1)(2008-11#3)(2008-7#1)(2010-9#1)(2011-2#1)
an experiment in##2##3##(1994-6#1)(2008-7#1)
an experiment to##2##3##(1994-11#1)(2008-10#1)
an experiment using##2##3##(2008-3#2)
an experiment with##2##3##(1994-8#1)(2008-11#1)
an experiment##13##2##(1994-11#1)(1994-6#1)(1994-8#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-7#1)(2012-7#1)
an experimental Parkinsonian animal model##3##5##(2008-10#3)
an experimental analysis##2##3##(2008-2#1)(2008-7#1)
an experimental approach to##2##4##(1991-6#1)(2008-10#1)
an experimental approach##3##3##(1991-6#1)(2008-10#1)(2009-7#1)
an experimental demonstration of##2##4##(2007-12#2)
an experimental demonstration##3##3##(2007-11#1)(2007-12#2)
an experimental design##5##3##(2008-10#5)
an experimental group##2##3##(2008-12#1)(2010-6#1)
an experimental method##2##3##(2008-10#1)(2008-3#1)
an experimental model##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
an experimental research]##3##3##(2013-8#3)
an experimental study of the##2##5##(2008-2#1)(2008-3#1)
an experimental study of##3##4##(2008-12#1)(2008-2#1)(2008-3#1)
an experimental study##7##3##(1992-9#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
an experimental system for##2##4##(1993-2#1)(1996-2#1)
an experimental system##5##3##(1993-2#1)(1996-2#1)(2008-3#2)(2008-8#1)
an experimental test##2##3##(2008-11#1)(2008-9#1)
an experimental##67##2##(1991-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#23)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
an experimentally##3##2##(2008-3#1)(2010-1#1)(2010-8#1)
an expert in##3##3##(1994-12#1)(2008-11#1)(2013-1#1)
an expert##14##2##(1991-9#1)(1992-3#1)(1994-12#1)(2008-10#2)(2008-11#1)(2010-10#2)(2010-8#2)(2012-2#2)(2012-3#1)(2013-1#1)
an explanation for the##4##4##(1997-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
an explanation for##8##3##(1997-2#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-3#1)(2013-8#1)
an explanation of the##2##4##(2008-3#1)(2009-12#1)
an explanation##13##2##(1997-2#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
an explanatory##2##2##(2008-8#1)(2009-12#1)
an explicit##4##2##(2008-10#1)(2008-4#2)(2013-1#1)
an exploration of##4##3##(2008-11#2)(2008-12#2)
an exploratory framework for##2##4##(2012-3#2)
an exploratory study##5##3##(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
an exploratory survey##2##3##(1993-2#1)(1993-3#1)
an exploratory##17##2##(1991-8#2)(1993-2#2)(1993-3#1)(2008-10#1)(2008-12#1)(2009-5#2)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
an explosive##2##2##(2008-10#2)
an exponent of -0##2##4##(2008-7#2)
an exponential increase##2##3##(1995-9#1)(2012-2#1)
an exponential model##2##3##(2008-10#1)(2013-8#1)
an exponential##8##2##(1995-9#1)(2008-10#3)(2008-11#1)(2012-2#2)(2013-8#1)
an exposed##3##2##(1994-11#1)(1995-6#1)(2008-9#1)
an exposure time of##2##4##(2008-3#2)
an exposure to##2##3##(2009-12#1)(2013-1#1)
an exposure##5##2##(2008-3#2)(2008-8#1)(2009-12#1)(2013-1#1)
an expressed gene##2##3##(1995-9#1)(1997-8#1)
an expressed##3##2##(1995-9#1)(1997-8#1)(2012-3#1)
an expression for the##2##4##(2008-3#2)
an expression of##2##3##(2008-10#2)
an expression vector##4##3##(1993-8#1)(1997-8#1)(2008-8#1)(2010-5#1)
an expression##13##2##(1992-10#1)(1993-8#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)
an extended period of time##2##5##(1997-2#1)(2008-10#1)
an extended period of##3##4##(1997-2#1)(2008-10#1)(2011-2#1)
an extended period##6##3##(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#2)
an extended##21##2##(1992-4#1)(1992-8#1)(1993-3#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#1)
an extension of our previous work##2##6##(1997-2#1)(2008-10#1)
an extension of the##10##4##(1992-3#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)
an extension of##18##3##(1991-12#1)(1991-2#1)(1992-3#1)(1995-3#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)(2010-7#1)(2013-8#1)
an extension##22##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1995-3#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)(2010-7#1)(2013-8#2)
an extensive collection of##2##4##(2008-10#2)
an extensive review of the literature##2##6##(1995-1#1)(1996-12#1)
an extensive survey##2##3##(2008-10#2)
an extensive##23##2##(1990-8#1)(1992-4#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-1#1)(2013-1#1)
an extent that##3##3##(1990-11#1)(1994-6#1)(2008-10#1)
an extent##7##2##(1990-11#1)(1990-9#1)(1994-6#1)(1995-2#1)(2008-10#2)(2008-11#1)
an external##19##2##(1990-9#1)(1991-11#1)(1992-1#2)(1993-12#1)(1996-3#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)
an external-cavity diode laser##2##4##(2008-3#2)
an external-cavity##4##2##(2008-3#4)
an externally##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
an extinguished delay CS##2##4##(2008-5#2)
an extinguished trace CS##2##4##(2008-5#2)
an extinguished##4##2##(2008-5#4)
an extra##8##2##(1992-6#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-7#1)
an extracellular##8##2##(1995-6#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)
an extract from##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
an extract of##3##3##(1993-6#1)(2008-10#2)
an extract##7##2##(1993-2#1)(1993-6#1)(2008-10#3)(2008-11#1)(2008-5#1)
an extraction chromatographic##2##3##(2008-10#2)
an extraction medium##2##3##(2008-10#2)
an extraction##17##2##(1990-5#2)(2008-10#15)
an extraordinarily##4##2##(1990-8#1)(1992-3#1)(2008-10#1)(2010-5#1)
an extreme##10##2##(1992-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
an extremely high##3##3##(1994-8#1)(2008-10#2)
an extremely large##3##3##(1994-2#1)(2008-10#1)(2011-2#1)
an extremely rare##12##3##(2008-10#4)(2008-12#3)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#2)
an extremely valuable resource##2##4##(2008-11#1)(2012-2#1)
an extremely variable##2##3##(2008-9#1)(2011-2#1)
an extremely##35##2##(1993-6#1)(1994-2#1)(1994-8#1)(2008-10#11)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
an eye on##3##3##(1994-2#1)(2008-11#1)(2008-12#1)
an eye##6##2##(1993-3#1)(1994-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)
an fMRI##2##2##(2008-11#2)
an herbal##2##2##(2008-10#1)(2011-2#1)
an historical overview of##2##4##(2009-10#1)(2010-1#1)
an historical##5##2##(1995-3#1)(2008-11#1)(2009-10#1)(2010-1#2)
an homogeneous##2##2##(1994-5#1)(2008-11#1)
an hospital##2##2##(2008-10#1)(2008-11#1)
an hour##7##2##(1992-12#1)(1997-3#1)(2008-10#3)(2010-12#1)(2012-12#1)
an i##4##2##(1994-2#3)(1995-11#1)
an iatrogenic##3##2##(1991-6#1)(1993-1#1)(2008-12#1)
an ice##4##2##(2008-3#2)(2008-9#1)(2011-2#1)
an idea about##2##3##(2008-10#1)(2008-5#1)
an idea of##2##3##(2008-4#1)(2013-1#1)
an idea##8##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
an ideal setting##2##3##(1994-12#1)(2008-12#1)
an ideal tool##2##3##(2008-10#1)(2012-2#1)
an ideal##24##2##(1994-12#1)(1994-2#1)(1995-5#1)(1996-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-6#1)(2012-2#3)(2013-8#1)
an identical##11##2##(1995-6#2)(1995-8#1)(2007-9#1)(2008-10#3)(2008-8#1)(2009-3#1)(2010-11#1)(2010-7#1)
an idiopathic##2##2##(2008-10#1)(2010-6#1)
an iliac##2##2##(2008-11#1)(2012-3#1)
an illness##2##2##(1994-9#1)(2010-10#1)
an illustration##2##2##(1990-5#1)(2008-10#1)
an illustrative example of##2##4##(2008-10#1)(2011-2#1)
an illustrative example##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
an image of##3##3##(2008-1#1)(2008-3#1)(2008-4#1)
an image##11##2##(1991-1#1)(1991-6#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#2)
an imaginary##2##2##(2008-7#1)(2009-10#1)
an imaging spectrometer##2##3##(2007-12#1)(2013-8#1)
an imaging technique##2##3##(2007-12#1)(2010-12#1)
an imaging##11##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2010-12#1)(2012-2#1)(2013-8#1)
an imbalance between##4##3##(1993-2#1)(2008-10#2)(2008-7#1)
an imbalance in the##2##4##(1991-2#1)(1997-7#1)
an imbalance##6##2##(1991-2#1)(1993-2#1)(1997-7#1)(2008-10#2)(2008-7#1)
an iminodiacetate##2##2##(2008-10#2)
an immediate##11##2##(1990-11#1)(1991-12#1)(1991-6#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#2)
an immobilized cell##2##3##(1995-3#1)(2008-10#1)
an immobilized##9##2##(1990-5#1)(1995-3#1)(1996-12#1)(2008-10#5)(2008-11#1)
an immune response##4##3##(2008-10#3)(2008-11#1)
an immune##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2012-12#1)(2013-1#1)
an immunization##2##2##(1992-5#1)(1993-2#1)
an immunoaffinity column##4##3##(1992-3#1)(2008-10#2)(2008-11#1)
an immunoassay##4##2##(1991-12#1)(1992-11#1)(2008-10#2)
an immunocapture##2##2##(2008-10#2)
an immunocompetent patient##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
an immunocompetent##4##2##(1996-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
an immunogenic##2##2##(1996-12#1)(2008-10#1)
an immunoglobulin##4##2##(1990-12#1)(2008-10#1)(2008-4#2)
an immunohistochemical study##4##3##(1992-2#1)(1994-6#1)(1995-12#1)(2012-3#1)
an immunologically privileged##2##3##(2009-10#2)
an immunoreactor##2##2##(2008-10#2)
an immunosuppressive##3##2##(1990-5#1)(1994-3#1)(2008-10#1)
an impact on the##5##4##(2008-10#1)(2008-11#2)(2012-2#2)
an impact on##15##3##(1991-7#1)(1996-6#1)(2008-10#3)(2008-11#3)(2008-5#1)(2011-2#1)(2012-2#4)(2013-1#1)
an impact##18##2##(1991-7#1)(1996-6#1)(2008-10#3)(2008-11#4)(2008-5#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#2)
an impaired##2##2##(2008-7#1)(2011-2#1)
an impairment in##3##3##(2008-1#1)(2008-11#1)(2009-10#1)
an impairment##4##2##(1997-7#1)(2008-1#1)(2008-11#1)(2009-10#1)
an imperative##2##2##(1993-3#1)(2012-3#1)
an imperfect##2##2##(1993-12#1)(2012-3#1)
an impermeable##2##2##(1997-1#1)(2009-8#1)
an implant##5##2##(2008-9#3)(2013-1#2)
an implanted##2##2##(2008-7#1)(2008-9#1)
an implementation of##3##3##(2008-10#2)(2008-11#1)
an implementation##4##2##(1996-2#1)(2008-10#2)(2008-11#1)
an important addition to the##3##5##(2008-11#1)(2008-9#1)(2010-9#1)
an important advance in##2##4##(2008-9#2)
an important analytical##3##3##(2008-10#2)(2008-9#1)
an important and##5##3##(1993-1#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-7#1)
an important aspect of##5##4##(1997-4#1)(2008-10#2)(2008-8#1)(2012-2#1)
an important aspect##7##3##(1997-4#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-11#1)(2012-2#1)
an important biological##2##3##(1995-12#1)(2010-10#1)
an important cause of##10##4##(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#5)(2012-2#1)(2012-3#1)
an important challenge##3##3##(1997-2#1)(2008-5#1)(2010-6#1)
an important clinical##3##3##(1994-5#1)(2008-10#1)(2008-9#1)
an important component in the##3##5##(2008-4#2)(2008-5#1)
an important component of the##4##5##(1996-2#1)(2008-10#2)(2011-2#1)
an important component of##9##4##(1993-3#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#1)
an important component##12##3##(1993-3#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)
an important consideration in##2##4##(2008-10#1)(2013-1#1)
an important consideration##4##3##(1993-1#1)(2008-10#1)(2010-11#1)(2013-1#1)
an important contribution##2##3##(2008-9#1)(2010-7#1)
an important determinant of the##5##5##(1992-2#1)(1993-3#1)(1996-3#1)(1997-8#1)(2008-10#1)
an important determinant of##12##4##(1990-12#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
an important disease of##7##4##(2008-10#7)
an important disease##10##3##(2008-10#9)(2008-11#1)
an important element in##3##4##(1992-2#1)(2010-7#1)(2013-1#1)
an important factor for##3##4##(1992-10#1)(2011-3#1)(2013-7#1)
an important factor in the##3##5##(2008-3#1)(2008-5#1)(2012-2#1)
an important factor in##9##4##(1996-12#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-6#1)(2012-2#1)
an important factor to##2##4##(2008-10#1)(2008-11#1)
an important factor##21##3##(1992-10#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-11#1)(2009-8#1)(2010-6#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
an important feature of##5##4##(1992-4#1)(2008-11#1)(2009-4#1)(2011-2#1)(2013-1#1)
an important feature##6##3##(1992-4#1)(2008-11#1)(2009-4#1)(2011-2#2)(2013-1#1)
an important focus##2##3##(1992-2#1)(2009-12#1)
an important function##3##3##(1995-6#1)(2012-2#2)
an important impact##3##3##(2008-1#1)(2010-2#1)(2013-8#1)
an important influence on the##2##5##(2008-10#1)(2008-5#1)
an important influence on##3##4##(1990-12#1)(2008-10#1)(2008-5#1)
an important issue in##2##4##(2008-10#1)(2008-3#1)
an important issue##5##3##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
an important link##2##3##(2008-5#1)(2013-8#1)
an important means of##3##4##(1993-1#1)(2008-10#2)
an important mechanism of##7##4##(2008-10#3)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
an important mechanism##11##3##(1993-2#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
an important mediator##2##3##(1994-11#1)(2008-10#1)
an important parameter##3##3##(2008-10#1)(2008-8#1)(2010-11#1)
an important part of the##6##5##(1993-12#1)(1996-6#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
an important part of##14##4##(1993-12#1)(1993-3#1)(1995-2#1)(1996-6#1)(2008-11#2)(2008-4#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-7#1)
an important part##16##3##(1993-12#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-5#1)(1996-6#1)(2008-11#2)(2008-4#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-7#1)
an important pathological##2##3##(2008-5#1)(2010-10#1)
an important place in##2##4##(1992-5#1)(2008-11#1)
an important post-translational##2##3##(1993-3#1)(2009-7#1)
an important prerequisite##2##3##(2008-10#1)(2008-8#1)
an important question in##2##4##(2008-11#1)(2008-8#1)
an important question##3##3##(2008-11#2)(2008-8#1)
an important reduction##2##3##(1990-3#1)(1993-8#1)
an important regulator of##3##4##(1995-2#1)(1997-4#1)(2008-8#1)
an important regulatory mechanism##2##4##(1992-8#1)(1996-12#1)
an important regulatory##3##3##(1991-5#1)(1992-8#1)(1996-12#1)
an important role during##3##4##(2008-5#1)(2008-8#1)(2008-9#1)
an important role for the##3##5##(1995-2#1)(1997-6#1)(2012-2#1)
an important role for##8##4##(1995-2#2)(1997-1#1)(1997-6#1)(2008-10#2)(2012-2#1)(2012-3#1)
an important role in both##2##5##(2011-2#2)
an important role in cell##2##5##(2008-9#1)(2011-2#1)
an important role in controlling##4##5##(1997-1#1)(2008-10#1)(2008-9#1)(2009-11#1)
an important role in its##3##5##(2008-10#1)(2008-8#2)
an important role in structuring##2##5##(2008-8#1)(2010-8#1)
an important role in the development of##7##7##(2006-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
an important role in the development##8##6##(2006-6#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
an important role in the extraction process##2##7##(2008-10#2)
an important role in the regulation of##5##7##(1991-5#1)(1995-11#1)(1995-2#1)(2008-8#1)(2012-2#1)
an important role in the##70##5##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-3#1)
an important role in this##3##5##(1993-11#1)(2008-7#1)(2008-9#1)
an important role in tumor##4##5##(1994-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
an important role in##168##4##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#3)(1994-2#2)(1994-5#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-8#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#21)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#13)(2008-9#11)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#15)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#2)(2013-3#1)(2013-8#1)
an important role to play##4##5##(1992-3#1)(1993-12#1)(2008-11#1)(2012-12#1)
an important role to##5##4##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
an important role##196##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-8#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#26)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#14)(2008-9#12)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#15)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#6)(2012-7#1)(2013-1#2)(2013-3#1)(2013-8#1)
an important source##2##3##(2008-10#1)(2013-1#1)
an important step in the##2##5##(2009-7#1)(2009-8#1)
an important step in##4##4##(1996-2#1)(2008-11#1)(2009-7#1)(2009-8#1)
an important step##7##3##(1996-2#1)(2008-10#1)(2008-11#2)(2009-7#1)(2009-8#1)(2012-3#1)
an important structural role in##2##5##(1995-6#1)(2008-10#1)
an important structural role##3##4##(1995-6#1)(2008-10#1)(2009-8#1)
an important structural##5##3##(1995-6#1)(2008-10#1)(2008-9#1)(2009-7#1)(2009-8#1)
an important subject##2##3##(2008-11#1)(2008-9#1)
an important target for##4##4##(1995-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
an important target##5##3##(1995-2#1)(2008-5#1)(2012-2#2)(2013-8#1)
an important tool for##7##4##(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-7#1)(2012-2#1)(2013-8#1)
an important tool in the##4##5##(1992-2#1)(2008-10#1)(2010-12#1)(2013-8#1)
an important tool##14##3##(1992-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-8#2)
an important way##2##3##(1993-1#1)(2008-10#1)
an important##576##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#3)(1991-5#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#6)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-5#3)(1994-9#1)(1995-11#2)(1995-12#7)(1995-2#9)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#7)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#3)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#4)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#8)(2008-10#101)(2008-11#39)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#9)(2008-5#18)(2008-6#2)(2008-7#12)(2008-8#32)(2008-9#33)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#5)(2009-8#8)(2010-1#4)(2010-10#6)(2010-11#7)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#35)(2011-3#6)(2011-7#3)(2012-12#3)(2012-2#17)(2012-3#13)(2012-7#1)(2013-1#13)(2013-3#2)(2013-7#2)(2013-8#11)
an impression##2##2##(2008-11#2)
an impressive##2##2##(1992-1#1)(2010-11#1)
an improved detection limit of##2##5##(2008-10#2)
an improved method##2##3##(2008-5#1)(2012-3#1)
an improved##43##2##(1992-3#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
an improvement in the##7##4##(2008-10#4)(2011-2#2)(2013-1#1)
an improvement in##24##3##(1991-12#1)(1991-2#1)(1991-8#1)(1995-11#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#2)(2010-4#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)
an improvement of the##5##4##(2008-10#5)
an improvement of##8##3##(2008-10#6)(2008-11#1)(2012-3#1)
an improvement##35##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(1994-9#1)(1995-11#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-7#2)(2010-4#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#2)
an impurity##3##2##(2008-10#2)(2008-11#1)
an in situ##8##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-3#5)
an in vitro fertilization##2##4##(2012-3#1)(2013-1#1)
an in vitro immunization##3##4##(2008-11#3)
an in vitro model of vitamin D synthesis##2##8##(2008-10#2)
an in vitro model of##3##5##(2008-10#2)(2008-5#1)
an in vitro model system##2##5##(2008-11#2)
an in vitro model##8##4##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#3)
an in vitro skin equivalent model##2##6##(2008-5#2)
an in vitro study##2##4##(2011-2#1)(2013-1#1)
an in vitro system to##3##5##(1994-6#1)(2008-11#1)(2013-8#1)
an in vitro system##9##4##(1990-2#1)(1990-5#1)(1994-6#1)(1995-11#1)(1996-12#2)(2008-11#2)(2013-8#1)
an in vitro##51##3##(1990-12#2)(1990-2#1)(1990-5#1)(1991-8#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#12)(2008-12#3)(2008-5#7)(2008-7#1)(2009-7#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
an in vivo method##2##4##(1991-12#1)(2008-5#1)
an in vivo system##2##4##(1995-2#1)(1996-12#1)
an in vivo##13##3##(1990-11#1)(1991-12#1)(1994-11#1)(1995-2#2)(1996-12#1)(2008-12#1)(2008-5#4)(2009-12#2)
an in##74##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-12#4)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#13)(2008-12#4)(2008-3#5)(2008-5#11)(2008-7#1)(2009-12#2)(2009-7#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
an in-hospital support group for employee victims of violence##2##9##(1991-12#2)
an in-line##2##2##(2008-10#2)
an inability to##2##3##(1994-12#1)(2009-3#1)
an inactivated vaccine##2##3##(2008-5#2)
an inactivated##3##2##(2008-5#3)
an inactive odor##2##3##(2008-10#2)
an inactive##9##2##(1991-10#1)(1991-6#1)(1992-12#1)(1994-11#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
an inadequate##4##2##(1992-12#1)(2009-12#1)(2013-1#2)
an inappropriate##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
an inbred##2##2##(2008-10#1)(2012-3#1)
an incentive##2##2##(1992-1#1)(1994-3#1)
an incidence of##6##3##(1995-12#1)(1997-5#1)(2008-9#1)(2010-10#1)(2010-7#1)(2013-1#1)
an incidence##10##2##(1995-12#1)(1997-5#1)(2008-2#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2013-1#2)
an incident wavelength of##2##4##(2008-2#1)(2008-3#1)
an incident##7##2##(1993-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2013-1#1)
an incidental finding##6##3##(1992-5#1)(1992-9#1)(1995-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
an incidental renocolic fistula was##2##5##(2013-1#2)
an incidental##12##2##(1991-3#1)(1992-5#1)(1992-9#1)(1995-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#3)
an inclusion complex##2##3##(2008-10#2)
an incomplete##7##2##(1991-5#1)(1992-12#1)(1996-3#1)(2008-11#1)(2008-7#2)(2012-3#1)
an incorrect##4##2##(2008-11#1)(2008-2#1)(2010-10#1)(2011-2#1)
an increase in FN##2##4##(2012-2#2)
an increase in blood##2##4##(1996-3#1)(2008-10#1)
an increase in cell##3##4##(1995-11#1)(2008-11#1)(2013-8#1)
an increase in child##2##4##(2008-10#1)(2008-11#1)
an increase in cytosolic##2##4##(1992-4#1)(2008-7#1)
an increase in intracellular##3##4##(1991-5#1)(1995-11#1)(2008-11#1)
an increase in its##3##4##(1990-10#1)(1997-1#1)(2008-11#1)
an increase in sensitivity##2##4##(1991-6#1)(2008-10#1)
an increase in serum##2##4##(2008-10#1)(2009-6#1)
an increase in the activity of##3##6##(1994-5#1)(2008-11#2)
an increase in the amount of##5##6##(1992-6#2)(2008-11#1)(2008-9#1)(2009-8#1)
an increase in the fluorescence##2##5##(2008-10#2)
an increase in the incidence of##2##6##(2008-9#1)(2013-7#1)
an increase in the number and##2##6##(1997-2#1)(2010-12#1)
an increase in the number of##7##6##(1997-2#1)(1997-6#1)(2008-10#3)(2011-2#2)
an increase in the number##10##5##(1995-3#1)(1997-2#2)(1997-6#1)(2008-10#3)(2010-12#1)(2011-2#2)
an increase in the percentage of##2##6##(2011-2#2)
an increase in the range of##2##6##(2007-12#1)(2008-8#1)
an increase in the##79##4##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1992-6#2)(1993-11#1)(1994-5#2)(1995-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#17)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-8#2)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
an increase in total##2##4##(1992-11#1)(2008-9#1)
an increase in##227##3##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#4)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-3#4)(1994-5#3)(1994-8#1)(1995-11#3)(1995-12#2)(1995-3#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-6#1)(1997-1#4)(1997-2#4)(1997-6#1)(1997-7#3)(1997-8#3)(2007-12#3)(2008-1#1)(2008-10#44)(2008-11#23)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#8)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#3)(2012-9#2)(2013-1#4)(2013-7#1)(2013-8#7)
an increase of the order in the##2##7##(2008-10#2)
an increase of the##11##4##(1993-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2009-10#1)(2009-11#1)
an increase of##51##3##(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-2#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2010-2#1)(2011-10#1)(2011-2#1)(2012-5#1)(2013-1#3)
an increase to##3##3##(1994-2#1)(2008-11#1)(2008-5#1)
an increase##298##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#4)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#5)(1994-5#3)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#2)(1995-3#2)(1995-8#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#4)(1997-2#5)(1997-6#1)(1997-7#3)(1997-8#3)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#51)(2008-11#34)(2008-12#9)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#5)(2011-10#1)(2011-2#10)(2011-3#1)(2012-2#4)(2012-3#3)(2012-5#1)(2012-9#2)(2013-1#8)(2013-7#1)(2013-8#7)
an increased affinity for##2##4##(1991-12#1)(1995-6#1)
an increased amount of##4##4##(2008-10#3)(2008-7#1)
an increased expression of##2##4##(1997-2#1)(2008-11#1)
an increased frequency of##3##4##(1991-3#1)(1997-3#1)(2008-4#1)
an increased incidence of##3##4##(1994-5#1)(2008-10#1)(2013-7#1)
an increased likelihood of##7##4##(1995-2#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
an increased number of##3##4##(1990-12#1)(2008-10#1)(2009-10#1)
an increased production of##2##4##(2008-7#1)(2008-9#1)
an increased proportion of##3##4##(1994-3#1)(2008-11#1)(2008-9#1)
an increased rate of##4##4##(1990-2#1)(1994-8#1)(1995-6#1)(2008-10#1)
an increased rate##5##3##(1990-2#1)(1994-8#1)(1995-6#1)(2008-10#2)
an increased risk for##8##4##(1996-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
an increased risk of breast cancer##2##6##(1990-8#1)(1993-11#1)
an increased risk of##23##4##(1990-12#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-6#1)(2011-2#4)(2011-3#1)(2013-1#3)(2013-7#1)
an increased risk##33##3##(1990-12#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-11#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
an increased understanding##2##3##(1996-1#1)(2009-11#1)
an increased##140##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#4)(1991-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#2)(1995-2#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#17)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#10)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#8)(2013-7#2)
an increasing interest in##3##4##(2008-10#2)(2012-12#1)
an increasing interest##4##3##(2008-10#3)(2012-12#1)
an increasing need for##3##4##(2008-10#1)(2010-12#1)(2011-1#1)
an increasing number of patients##2##5##(1992-3#1)(1994-5#1)
an increasing number of##5##4##(1991-6#1)(1992-3#1)(1993-3#1)(1994-5#1)(2010-12#1)
an increasing population##2##3##(1991-3#1)(2008-11#1)
an increasing proportion of the##2##5##(2008-10#1)(2008-9#1)
an increasing proportion of##3##4##(1990-3#1)(2008-10#1)(2008-9#1)
an increasing role##2##3##(2010-12#1)(2011-2#1)
an increasing share of##3##4##(1991-2#1)(1993-11#1)(1996-2#1)
an increasing trend##3##3##(2008-12#1)(2009-4#1)(2009-6#1)
an increasing##49##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-5#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
an increasingly competitive##3##3##(1994-12#2)(2008-10#1)
an increasingly important role in##2##5##(2010-12#1)(2011-7#1)
an increasingly important##6##3##(2006-6#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-7#1)(2012-3#1)
an increasingly popular##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
an increasingly##24##2##(1993-12#1)(1994-12#2)(1995-2#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-7#1)(2012-3#2)(2013-1#2)
an increment of##2##3##(2008-10#1)(2008-5#1)
an incremental cycling test to exhaustion##2##6##(2011-2#2)
an incremental increase in##2##4##(1992-3#1)(2008-8#1)
an incremental##6##2##(1992-3#1)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
an incubation temperature##2##3##(2008-10#2)
an incubation##3##2##(2008-10#3)
an incubator##6##2##(2008-10#1)(2008-11#4)(2008-5#1)
an indefinite##2##2##(2008-12#1)(2008-4#1)
an independent method##2##3##(1995-5#1)(2008-10#1)
an independent risk factor for##4##5##(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
an independent risk factor##6##4##(1994-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
an independent risk##8##3##(1994-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
an independent scientific field##2##4##(1994-12#2)
an independent scientific##3##3##(1994-12#2)(2013-1#1)
an independent set of##2##4##(2008-10#1)(2012-3#1)
an independent##45##2##(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#6)(1994-3#2)(1994-8#1)(1995-5#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#3)
an index of##16##3##(1992-6#1)(1993-11#1)(1993-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2010-11#1)(2012-3#2)
an index##24##2##(1990-2#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#3)(2010-11#1)(2012-3#2)
an indication of the##5##4##(1990-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)
an indication of##10##3##(1990-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-8#1)
an indication that##4##3##(2008-10#2)(2008-11#1)(2010-3#1)
an indication##15##2##(1990-2#1)(1990-5#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-3#1)
an indicator electrode for potentiometric##2##5##(2008-10#2)
an indicator electrode for##3##4##(2008-10#3)
an indicator electrode##21##3##(2008-10#21)
an indicator for the##3##4##(2008-11#2)(2008-7#1)
an indicator for##8##3##(1995-2#2)(2008-11#3)(2008-12#2)(2008-7#1)
an indicator of a##2##4##(2008-10#2)
an indicator of the##4##4##(2008-10#3)(2013-7#1)
an indicator of##19##3##(1994-2#1)(2008-10#11)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-8#1)(2013-7#1)
an indicator##57##2##(1990-12#1)(1990-8#1)(1994-2#1)(1995-2#2)(1997-8#1)(2008-10#37)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)(2013-7#1)
an indirect ELISA##2##3##(1994-8#1)(2008-11#1)
an indirect competitive immunoassay##2##4##(2008-10#2)
an indirect competitive##4##3##(2008-10#4)
an indirect consequence of##2##4##(1997-3#1)(2008-8#1)
an indirect effect##2##3##(1994-8#1)(2011-2#1)
an indirect method of##2##4##(1993-11#1)(1993-3#1)
an indirect##25##2##(1992-12#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-8#2)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
an indispensable##7##2##(1991-5#2)(1994-2#1)(2008-10#2)(2010-1#1)(2012-3#1)
an individual has##2##3##(1996-3#1)(2008-11#1)
an individual plant##2##3##(2008-10#1)(2009-8#1)
an individual to##2##3##(2008-12#1)(2008-7#1)
an individual tree##2##3##(2008-10#2)
an individual with##4##3##(2009-10#1)(2011-1#2)(2013-1#1)
an individual##48##2##(1990-9#1)(1991-2#1)(1993-3#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-2#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2011-1#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
an individual's genetic##2##3##(2008-4#1)(2012-3#1)
an individual's##13##2##(1994-3#1)(1995-2#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
an individual-based model##2##3##(2008-8#1)(2008-9#1)
an individual-based##5##2##(2008-8#2)(2008-9#2)(2011-2#1)
an individualised##2##2##(2011-3#2)
an individualized##2##2##(2008-11#1)(2010-12#1)
an indolent##5##2##(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
an indoor##2##2##(2008-10#1)(2008-3#1)
an induced##3##2##(2008-10#2)(2009-12#1)
an inducible##2##2##(2008-10#1)(2008-12#1)
an induction of##3##3##(2008-10#2)(2008-11#1)
an induction##5##2##(1997-8#1)(2008-10#3)(2008-11#1)
an inductive##2##2##(2008-11#1)(2010-10#1)
an inductively coupled plasma##5##4##(2008-10#5)
an inductively coupled##7##3##(2008-10#7)
an industrial scale##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
an industrial##12##2##(1995-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)
an indwelling##3##2##(1993-2#1)(1997-2#1)(2008-11#1)
an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma##2##11##(1992-12#2)
an inefficient##2##2##(2008-5#1)(2011-2#1)
an inert##6##2##(2008-10#5)(2009-10#1)
an inexpensive##9##2##(2008-10#8)(2008-7#1)
an infant in##2##3##(2008-11#1)(2009-12#1)
an infant oral##2##3##(2011-2#2)
an infant who##2##3##(1991-2#1)(2008-5#1)
an infant with##3##3##(1997-3#1)(2012-2#1)(2012-3#1)
an infant##14##2##(1991-2#1)(1993-12#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#4)(2012-2#1)(2012-3#1)
an infected##6##2##(2008-10#2)(2011-3#3)(2013-1#1)
an infection control link nurse programme##2##6##(2008-11#2)
an infection of a##2##4##(2008-11#1)(2011-2#1)
an infection of the central nervous system##2##7##(2008-7#1)(2010-12#1)
an infection of##4##3##(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
an infection with##2##3##(2010-5#1)(2010-6#1)
an infection##16##2##(1992-9#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)
an infectious cDNA clone##2##4##(2008-10#2)
an infectious disease##3##3##(1990-12#1)(1991-8#1)(1997-3#1)
an infectious##11##2##(1990-12#1)(1991-8#1)(1997-3#1)(2008-10#5)(2009-1#1)(2011-2#2)
an inferior##3##2##(2008-8#1)(2011-2#2)
an infinite##7##2##(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)
an inflammatory##13##2##(1990-12#1)(1991-8#2)(1994-11#1)(1996-3#2)(2008-12#2)(2008-7#2)(2011-7#1)(2012-3#2)
an influence in##2##3##(2007-11#1)(2008-5#1)
an influence of##2##3##(2008-5#2)
an influence on the##4##4##(1991-1#1)(2008-10#1)(2008-11#1)(2009-1#1)
an influence on##6##3##(1991-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-1#1)(2011-2#1)
an influence##10##2##(1991-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2009-1#1)(2011-2#1)
an influential##4##2##(1992-3#1)(1993-12#1)(2008-11#1)(2008-5#1)
an influenza##2##2##(1996-6#1)(2009-6#1)
an influx of Ca2+##2##4##(1994-2#1)(1995-11#1)
an influx of##4##3##(1994-2#1)(1995-11#1)(1996-12#1)(2008-5#1)
an informal##2##2##(2009-9#1)(2011-2#1)
an information-theoretic##2##2##(2010-10#1)(2012-2#1)
an informed##2##2##(2008-12#1)(2008-7#1)
an infrared##3##2##(2008-2#1)(2008-3#2)
an infusion##2##2##(2010-7#1)(2011-2#1)
an inhalation##2##2##(1994-2#1)(2008-10#1)
an inherent##6##2##(1990-2#1)(2008-11#3)(2009-10#2)
an inherently##2##2##(1994-11#1)(1995-11#1)
an inherited##4##2##(1990-5#1)(1997-3#1)(2009-12#1)(2010-6#1)
an inhibiting effect##2##3##(1991-12#1)(2008-10#1)
an inhibition of the##3##4##(1990-8#1)(1991-5#1)(1992-3#1)
an inhibition of##8##3##(1990-11#1)(1990-8#2)(1991-3#1)(1991-5#1)(1992-3#1)(1994-3#1)(2008-10#1)
an inhibition##11##2##(1990-11#1)(1990-8#2)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-3#1)(2008-10#1)(2013-1#1)
an inhibitor of both##2##4##(2008-11#2)
an inhibitor of cyclooxygenase##2##4##(2008-11#2)
an inhibitor of lipoxygenase##2##4##(2008-11#2)
an inhibitor of protein kinase C##3##6##(1993-8#1)(1994-6#1)(2008-11#1)
an inhibitor of protein##4##4##(1992-8#1)(1993-8#1)(1994-6#1)(2008-11#1)
an inhibitor of the##3##4##(2008-7#1)(2009-8#1)(2009-9#1)
an inhibitor of##47##3##(1990-8#1)(1992-8#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#5)(1996-2#1)(1997-1#2)(1997-2#1)(2008-10#3)(2008-11#12)(2008-5#3)(2008-7#1)(2009-6#2)(2009-8#1)(2009-9#2)(2011-2#2)(2013-8#1)
an inhibitor##50##2##(1990-8#1)(1991-5#1)(1992-8#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#5)(1996-2#1)(1997-1#2)(1997-2#1)(2008-10#3)(2008-11#14)(2008-5#3)(2008-7#1)(2009-6#2)(2009-8#1)(2009-9#2)(2011-2#2)(2013-8#1)
an inhibitory effect of##2##4##(2011-2#2)
an inhibitory effect on the##2##5##(1992-5#1)(2008-10#1)
an inhibitory effect on##4##4##(1992-5#1)(1994-8#1)(1997-4#1)(2008-10#1)
an inhibitory effect##7##3##(1992-5#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#2)
an inhibitory##15##2##(1991-5#2)(1992-5#1)(1994-8#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
an inhomogeneous##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
an initial concentration of##2##4##(2008-10#1)(2011-2#1)
an initial decrease in##2##4##(2008-11#1)(2008-5#1)
an initial decrease##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
an initial step in##2##4##(2008-1#1)(2010-4#1)
an initial step##3##3##(2008-1#1)(2008-10#1)(2010-4#1)
an initial##60##2##(1991-6#1)(1992-1#2)(1994-1#1)(1994-3#1)(1994-5#1)(1995-3#2)(1995-8#1)(1996-12#2)(1997-2#2)(2007-11#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#3)
an initially##4##2##(1993-6#1)(2008-8#2)(2008-9#1)
an initiative##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
an initiator of##2##3##(1994-11#1)(2009-8#1)
an initiator##6##2##(1994-11#1)(1995-9#1)(1997-6#1)(2008-10#1)(2008-12#1)(2009-8#1)
an injectable##3##2##(2008-5#1)(2009-7#1)(2013-1#1)
an injected volume of##3##4##(2008-10#3)
an injected##5##2##(2008-10#5)
an injection of##3##3##(1993-1#1)(1997-2#1)(2011-2#1)
an injection valve##2##3##(2008-10#2)
an injection volume of 100##2##5##(2008-10#2)
an injection volume of##3##4##(2008-10#3)
an injection##9##2##(1993-1#1)(1994-9#1)(1997-2#1)(2008-10#5)(2011-2#1)
an injury to##2##3##(2008-12#1)(2013-1#1)
an injury##4##2##(1995-12#1)(2008-12#1)(2008-7#1)(2013-1#1)
an inner diameter of##2##4##(2007-12#2)
an inner##10##2##(1991-1#1)(1992-7#1)(1994-9#1)(2007-12#2)(2008-10#4)(2011-2#1)
an innovative and##2##3##(1997-2#1)(2008-10#1)
an innovative approach##3##3##(1992-1#1)(2008-10#1)(2008-12#1)
an innovative model##2##3##(1996-1#1)(2008-12#1)
an innovative##26##2##(1991-2#2)(1992-1#1)(1992-5#1)(1994-2#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-12#6)(2008-5#1)(2008-6#2)(2009-12#1)(2009-3#1)(2010-7#1)(2012-12#1)(2013-1#1)
an inorganic##6##2##(2008-10#3)(2008-5#1)(2008-8#1)(2010-6#1)
an inpatient##5##2##(1991-2#1)(1994-9#1)(1995-2#1)(1997-2#1)(2008-12#1)
an input price index##3##4##(1992-2#1)(1993-1#2)
an input##7##2##(1992-2#1)(1993-1#2)(2008-10#1)(2008-11#1)(2008-3#2)
an insect##6##2##(2008-10#3)(2008-7#3)
an insertion##4##2##(1993-12#1)(1993-6#1)(1997-8#1)(2013-1#1)
an insertional mutation in the##2##5##(1996-2#1)(2008-11#1)
an insertional mutation##3##3##(1993-9#1)(1996-2#1)(2008-11#1)
an insertional##5##2##(1993-9#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-9#1)
an inside##3##2##(1994-12#1)(1995-2#1)(2008-11#1)
an insight into the##4##4##(2008-10#2)(2008-11#1)(2010-6#1)
an insight into##8##3##(1995-12#1)(2008-10#2)(2008-11#2)(2009-10#1)(2010-12#1)(2010-6#1)
an insight##9##2##(1995-12#1)(2008-10#2)(2008-11#3)(2009-10#1)(2010-12#1)(2010-6#1)
an insignificant##2##2##(1990-2#1)(2008-7#1)
an insoluble##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
an instance of##2##3##(1993-6#2)
an institution##3##2##(1991-6#1)(1992-12#1)(2011-2#1)
an institutional##2##2##(1993-2#1)(2009-2#1)
an instructional##2##2##(1996-1#1)(2013-1#1)
an instrument for measuring##2##4##(2012-2#1)(2013-1#1)
an instrument for##4##3##(1994-3#1)(2010-6#1)(2012-2#1)(2013-1#1)
an instrument that is##2##4##(2008-10#1)(2008-3#1)
an instrument to##3##3##(1993-3#1)(1997-1#1)(2008-10#1)
an instrument##18##2##(1993-2#1)(1993-3#1)(1994-3#1)(1997-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
an instrumented##2##2##(2013-1#2)
an insufficient##4##2##(1997-8#1)(2008-10#1)(2008-9#1)(2010-9#1)
an insulin receptor##2##3##(1993-8#1)(2008-12#1)
an insulin##7##2##(1990-12#1)(1992-10#1)(1993-8#1)(1996-3#1)(2008-12#1)(2008-3#1)(2012-3#1)
an insurance perspective##3##3##(1993-12#2)(1994-2#1)
an insurance##5##2##(1991-12#1)(1993-1#1)(1993-12#2)(1994-2#1)
an intact##9##2##(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
an integral component of##2##4##(2008-10#1)(2012-2#1)
an integral component##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
an integral equation of the first kind##2##7##(2008-10#1)(2008-2#1)
an integral membrane protein from Mycobacterium tuberculosis##2##7##(2009-7#2)
an integral membrane protein##4##4##(2008-10#1)(2009-7#2)(2011-2#1)
an integral membrane##5##3##(1991-10#1)(2008-10#1)(2009-7#2)(2011-2#1)
an integral part of the##4##5##(1991-2#1)(1992-6#1)(1997-4#1)(2012-2#1)
an integral part of##15##4##(1991-2#1)(1992-1#1)(1992-6#1)(1994-12#1)(1994-6#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)
an integral part##16##3##(1991-2#1)(1992-1#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)
an integral role in the##3##5##(1992-2#1)(1993-3#1)(2008-11#1)
an integral role in##4##4##(1992-2#1)(1993-3#1)(2008-11#1)(2010-10#1)
an integral##35##2##(1991-10#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#4)(2013-1#1)
an integrated approach to health system reform##2##7##(1993-12#2)
an integrated approach to teaching clinical##2##6##(2008-11#2)
an integrated approach to##7##4##(1993-12#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)
an integrated approach##10##3##(1993-12#2)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)
an integrated component of##2##4##(2012-2#1)(2012-3#1)
an integrated delivery system##3##4##(1996-1#1)(1996-3#2)
an integrated delivery##5##3##(1996-1#1)(1996-3#3)(1997-1#1)
an integrated optical##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
an integrated pest management program##2##5##(2008-10#1)(2013-8#1)
an integrated pest management##3##4##(2008-10#2)(2013-8#1)
an integrated public##2##3##(1995-12#1)(2008-6#1)
an integrated system##3##3##(1995-12#1)(1997-1#1)(1997-3#1)
an integrated##72##2##(1990-5#1)(1992-3#1)(1993-12#2)(1994-12#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#2)(2007-9#1)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#3)
an integration##2##2##(1997-1#1)(2012-3#1)
an integrative approach to##2##4##(2008-8#2)
an integrative medicine##2##3##(2008-1#1)(2008-12#1)
an integrative##7##2##(1994-2#1)(2008-1#1)(2008-12#1)(2008-8#2)(2012-3#1)(2013-8#1)
an intended##2##2##(2008-5#1)(2012-3#1)
an intense burst of##2##4##(2008-10#1)(2008-5#1)
an intense##18##2##(1992-8#1)(1994-2#1)(1997-1#2)(2008-10#9)(2008-2#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
an intensified##2##2##(2008-10#1)(2008-3#1)
an intensity of##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
an intensity##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
an intensive care unit##3##4##(1991-11#1)(1992-2#1)(2012-12#1)
an intensive care##5##3##(1991-11#1)(1991-3#1)(1992-2#1)(2009-1#1)(2012-12#1)
an intensive fluorescence in ultraviolet region##2##6##(2008-10#2)
an intensive##14##2##(1990-12#1)(1991-11#1)(1991-3#1)(1992-2#1)(2008-10#5)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
an inter-laboratory study##3##3##(2008-10#3)
an interacting regulatory network##2##4##(2011-2#2)
an interacting##3##2##(2010-1#1)(2011-2#2)
an interaction between the##3##4##(1991-2#1)(2008-10#2)
an interaction between##7##3##(1991-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)
an interaction effect##4##3##(2008-4#1)(2013-1#1)(2013-8#2)
an interaction of##2##3##(1994-5#1)(2008-10#1)
an interaction with##3##3##(1992-6#1)(1996-2#1)(2008-8#1)
an interaction##22##2##(1991-2#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#2)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
an interactive information##2##3##(1995-2#2)
an interactive##8##2##(1994-1#1)(1995-2#2)(2008-11#1)(2008-12#2)(2008-6#1)(2010-6#1)
an interdigitated##2##2##(2008-10#2)
an interdisciplinary approach##3##3##(1997-8#1)(2008-4#1)(2013-1#1)
an interdisciplinary assessment##3##3##(1995-1#1)(2013-1#2)
an interdisciplinary##17##2##(1994-12#1)(1995-1#1)(1995-5#1)(1996-1#2)(1997-8#1)(2008-1#1)(2008-4#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
an interest in##3##3##(1995-1#1)(1995-2#1)(2008-11#1)
an interest##5##2##(1991-6#1)(1991-9#1)(1995-1#1)(1995-2#1)(2008-11#1)
an interesting alternative##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
an interesting case of##2##4##(2008-10#1)(2010-6#1)
an interesting case##4##3##(2008-10#1)(2010-11#1)(2010-6#1)(2013-1#1)
an interesting tool##2##3##(2008-10#1)(2008-11#1)
an interesting##32##2##(1992-5#1)(1994-6#1)(1996-1#1)(2007-11#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
an interface##3##2##(1993-8#1)(1996-2#1)(2010-10#1)
an interference study##2##3##(2008-10#2)
an interference##4##2##(1997-7#1)(2008-10#2)(2009-10#1)
an interfering##3##2##(2008-10#3)
an intergenic region##2##3##(2008-10#1)(2008-8#1)
an interim##5##2##(1992-12#1)(1992-8#1)(1995-3#1)(2012-2#2)
an intermediary##2##2##(1995-12#1)(2008-10#1)
an intermediate step##2##3##(2008-10#1)(2008-8#1)
an intermediate##21##2##(1990-3#1)(1990-5#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#4)(2011-2#1)(2013-1#1)
an internal coating of##2##4##(2008-10#2)
an internal positive control##3##4##(2008-10#3)
an internal quality##2##3##(2008-9#1)(2011-2#1)
an internal standard##20##3##(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#15)(2008-11#1)(2008-8#1)
an internal##40##2##(1993-12#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#24)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#1)
an international perspective##2##3##(2008-11#1)(2008-12#1)
an international##31##2##(1991-9#1)(1993-1#2)(1993-2#3)(1994-2#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-1#1)(1997-4#1)(2008-10#8)(2008-11#4)(2008-12#1)(2009-10#2)(2010-10#1)(2010-2#1)(2011-10#1)(2013-1#1)
an interpretation##2##2##(2008-10#1)(2008-3#1)
an interpretive##2##2##(2010-10#1)(2010-9#1)
an interruption of the##2##4##(1990-5#1)(2008-7#1)
an interspecific hybrid##2##3##(2008-10#1)(2011-2#1)
an interspecific##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
an interstitial##4##2##(1991-12#1)(2007-8#1)(2012-12#2)
an interval of##8##3##(1991-6#1)(1993-11#1)(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-5#1)
an interval##12##2##(1991-6#1)(1993-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#3)(2008-5#1)(2010-10#1)(2013-1#1)
an intervention##11##2##(1991-2#1)(1993-2#1)(1994-3#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)
an interview with##4##3##(1996-8#1)(2008-4#1)(2009-12#1)(2010-5#1)
an interview##6##2##(1996-8#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-5#1)(2010-7#1)
an interviewer-administered##2##2##(2008-11#1)(2010-11#1)
an intestinal##5##2##(2008-11#3)(2011-2#1)(2012-2#1)
an intimate other##2##3##(2008-11#2)
an intimate##5##2##(1992-2#1)(2008-11#3)(2012-2#1)
an intra-aortic balloon pump##2##4##(2013-1#2)
an intracavity##7##2##(2008-2#1)(2008-3#6)
an intracellular Ca(2+)##2##3##(2008-8#1)(2009-10#1)
an intracellular pathogen##2##3##(2009-8#1)(2011-2#1)
an intracellular protein##2##3##(2008-11#2)
an intracellular reporter##2##3##(2008-11#1)(2008-9#1)
an intracellular##24##2##(1990-8#1)(1996-12#1)(1996-2#2)(2008-10#3)(2008-11#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2011-2#1)(2013-1#3)
an intracerebral haemorrhage##2##3##(2008-7#2)
an intracerebral##4##2##(1992-12#1)(2008-12#1)(2008-7#2)
an intracranial##4##2##(1992-6#1)(2008-7#3)
an intramolecular##7##2##(1991-5#1)(1992-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-10#2)
an intramuscular##2##2##(1990-12#1)(1995-8#1)
an intraocular##2##2##(1990-11#1)(2009-12#1)
an intraoperative##4##2##(2008-10#2)(2010-7#1)(2012-3#1)
an intraperitoneal##2##2##(1994-8#1)(1997-2#1)
an intrathoracic##2##2##(1991-3#1)(2008-11#1)
an intrauterine##2##2##(2010-11#1)(2013-1#1)
an intravascular##3##2##(2008-11#1)(2008-4#1)(2010-8#1)
an intravenous##6##2##(1993-6#1)(2008-10#1)(2009-1#1)(2009-6#1)(2010-12#1)(2012-2#1)
an intriguing##2##2##(2008-11#1)(2011-2#1)
an intrinsic motivation##2##3##(2008-11#2)
an intrinsic##12##2##(1990-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-11#1)(2011-2#1)
an intrinsically##2##2##(2008-8#1)(2009-7#1)
an introduced isolate of Rhizoctonia solani##2##6##(2008-10#2)
an introduced##6##2##(2008-10#4)(2012-2#1)(2012-3#1)
an introduction to the##4##4##(1992-3#1)(1997-2#1)(2008-10#2)
an introduction to##7##3##(1992-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2012-12#1)
an introduction##11##2##(1992-3#1)(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
an introductory##2##2##(2008-11#2)
an intron##4##2##(1991-2#1)(1993-8#1)(1994-11#1)(1997-8#1)
an intronic##2##2##(1993-12#1)(2011-1#1)
an intuitive##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
an invaluable tool for##2##4##(2008-10#1)(2008-9#1)
an invaluable tool##5##3##(1996-1#1)(2008-10#1)(2008-9#3)
an invaluable##6##2##(1996-1#1)(2008-10#1)(2008-12#1)(2008-9#3)
an invasion##2##2##(2008-10#1)(2008-8#1)
an invasive procedure##2##3##(2012-2#2)
an invasive##9##2##(1994-12#2)(1997-1#1)(2008-12#1)(2010-11#1)(2010-12#1)(2012-2#2)(2013-1#1)
an inventory##2##2##(2008-7#1)(2013-1#1)
an inverse correlation between##2##4##(2011-2#1)(2012-12#1)
an inverse correlation was found##2##5##(1992-2#1)(2008-7#1)
an inverse correlation##4##3##(1992-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
an inverse relationship between##6##4##(1991-5#1)(2008-10#1)(2009-7#1)(2013-8#3)
an inverse relationship##7##3##(1991-5#1)(2008-10#1)(2008-7#1)(2009-7#1)(2013-8#3)
an inverse##22##2##(1991-5#2)(1992-2#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#3)
an inversion scheme##2##3##(2008-3#2)
an inversion##3##2##(2008-11#1)(2008-3#2)
an inverted##8##2##(1997-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-11#1)(2012-3#1)(2013-1#1)
an investigation into the##2##4##(2008-10#1)(2008-9#1)
an investigation of the##6##4##(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2011-1#1)
an investigation of##8##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-1#1)
an investigation on##4##3##(2008-10#3)(2008-7#1)
an investigation##18##2##(1995-6#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)
an involvement of##8##3##(1992-12#1)(2008-11#4)(2008-7#1)(2010-8#1)(2012-3#1)
an inward##2##2##(1993-3#1)(2008-8#1)
an inward-rectifying##2##2##(1994-12#2)
an ion associate##4##3##(2008-10#4)
an ion channel##2##3##(1994-8#1)(2008-11#1)
an ion exchange membrane##2##4##(2008-10#2)
an ion exchange resin##2##4##(2008-10#2)
an ion exchange##6##3##(2008-10#6)
an ion mobility spectrometer##3##4##(2008-10#3)
an ion mobility##4##3##(2008-10#4)
an ion pair##4##3##(2008-10#4)
an ion selective##2##3##(2008-10#2)
an ion trap mass spectrometer##2##5##(2008-10#2)
an ion trap##4##3##(2008-10#4)
an ion##36##2##(1994-8#1)(2008-10#34)(2008-11#1)
an ion-pair##4##2##(2008-10#4)
an ion-selective electrode##3##3##(2008-10#3)
an ion-selective##4##2##(2008-10#4)
an ionic strength##3##3##(2008-10#3)
an ionic##9##2##(1990-11#1)(2008-10#7)(2010-7#1)
an ionization buffer##2##3##(2008-10#2)
an ionization##3##2##(2008-10#3)
an ionophore##12##2##(2008-10#11)(2009-12#1)
an iron chelator##2##3##(2008-10#1)(2008-11#1)
an iron uptake system##2##4##(1996-8#1)(1997-7#1)
an iron##10##2##(1991-12#1)(1993-11#1)(1996-8#1)(1997-7#1)(2008-10#4)(2008-11#1)(2012-12#1)
an irradiated##2##2##(2008-10#1)(2008-12#1)
an irregular##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2010-1#1)(2011-2#1)
an irreversible##10##2##(1990-12#1)(1991-5#1)(1993-6#1)(2008-10#4)(2008-4#1)(2012-3#1)(2013-7#1)
an irritant##2##2##(1996-12#1)(2008-5#1)
an ischaemic##3##2##(1991-11#1)(1996-8#1)(2008-10#1)
an ischemic stroke##3##3##(2009-11#2)(2013-8#1)
an ischemic##7##2##(1990-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-11#2)(2013-8#1)
an isocratic elution with##2##4##(2008-10#2)
an isocratic##8##2##(2008-10#8)
an isoelectric point of 3##2##5##(2008-10#2)
an isoelectric point##5##3##(1995-12#1)(2008-10#4)
an isolate from##2##3##(2008-10#2)
an isolate of the##2##4##(2008-10#2)
an isolate of##9##3##(2008-10#8)(2008-5#1)
an isolate##15##2##(2008-10#14)(2008-5#1)
an isolated##20##2##(1992-3#1)(1994-5#1)(2008-10#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#6)
an isolation##3##2##(2008-12#1)(2008-3#2)
an isoleucine##5##2##(2008-10#5)
an isometric##2##2##(2008-10#1)(2013-8#1)
an isotropic##4##2##(2008-3#3)(2008-6#1)
an issue for##2##3##(2008-10#1)(2008-11#1)
an issue in##2##3##(1996-9#1)(2011-2#1)
an issue of##3##3##(2008-5#1)(2011-2#2)
an issue##12##2##(1996-3#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#3)
an italian cross-sectional study##2##4##(2013-1#2)
an item response##2##3##(2009-11#1)(2012-2#1)
an item##4##2##(2009-11#1)(2012-2#3)
an iterative technique##2##3##(2008-10#1)(2008-3#1)
an iterative##15##2##(1992-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2010-3#1)(2010-5#1)(2011-8#1)(2013-1#1)
an mRNA of##2##3##(1993-2#1)(1993-3#1)
an mRNA##6##2##(1993-2#1)(1993-3#1)(2008-11#1)(2011-2#2)(2012-3#1)
an o/w##2##2##(2008-5#2)
an oat##2##2##(2008-10#1)(2008-9#1)
an object of investigation##2##4##(2008-3#1)(2013-1#1)
an object of##3##3##(2008-3#1)(2012-3#1)(2013-1#1)
an object##13##2##(1996-2#2)(2008-11#4)(2008-3#3)(2008-6#2)(2012-3#1)(2013-1#1)
an objective method##2##3##(2010-8#1)(2011-2#1)
an objective##22##2##(1990-12#1)(1992-2#1)(1994-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-8#1)
an obligate biotrophic##2##3##(2010-3#2)
an obligate parasite##2##3##(2008-10#1)(2011-2#1)
an obligate##8##2##(2008-10#3)(2008-11#1)(2010-3#2)(2010-8#1)(2011-2#1)
an obligation in the##2##4##(1994-12#1)(2008-11#1)
an obligation##5##2##(1992-3#1)(1994-12#2)(2008-11#2)
an obligatory##3##2##(1993-11#1)(1996-5#1)(2013-1#1)
an observation##5##2##(1990-3#1)(1990-8#1)(2008-5#2)(2012-12#1)
an observational study##6##3##(1990-9#1)(1991-3#1)(1995-3#1)(1996-8#1)(2010-4#1)(2013-1#1)
an observational##9##2##(1990-9#1)(1991-3#1)(1995-3#1)(1996-3#1)(1996-8#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
an observed##2##2##(2008-10#1)(2008-3#1)
an obstacle to##3##3##(1996-3#1)(2008-12#1)(2009-10#1)
an obstacle##4##2##(1996-3#1)(2008-12#1)(2009-10#1)(2010-11#1)
an obstructive##2##2##(2008-10#1)(2013-1#1)
an occipital##2##2##(2008-7#1)(2011-2#1)
an occluded##2##2##(2008-12#1)(2008-5#1)
an occult##2##2##(1991-6#1)(2008-12#1)
an occupational##4##2##(1992-5#1)(2008-11#1)(2012-2#1)(2013-8#1)
an ocean sediment reference material##2##5##(2008-10#2)
an oceanographically based##2##3##(2008-9#2)
an octadecyl##2##2##(2008-10#2)
an octadecyl-bonded silica##2##3##(2008-10#2)
an odds##2##2##(2010-11#1)(2011-2#1)
an off-axis##2##2##(2008-3#2)
an offensive##5##2##(1992-12#4)(1997-4#1)
an office##5##2##(1991-1#3)(1993-1#1)(2008-10#1)
an office-based##3##2##(2013-1#3)
an official method##3##3##(2008-10#3)
an official##4##2##(2008-10#4)
an offline##2##2##(2010-8#1)(2013-8#1)
an offset point beacon##2##4##(2008-3#2)
an offset##4##2##(2008-3#2)(2008-6#1)(2013-1#1)
an often##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
an oil##5##2##(2008-10#3)(2008-11#1)(2012-2#1)
an oil-in-water##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
an oily##2##2##(2008-5#2)
an old##11##2##(1991-2#1)(1993-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-1#1)
an older##7##2##(1994-8#2)(2008-9#1)(2010-10#3)(2012-12#1)
an oligoclonal##2##2##(2008-11#1)(2011-2#1)
an oligodeoxyribonucleotide##2##2##(1993-12#1)(2008-4#1)
an oligonucleotide##4##2##(1993-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
an on-axis uniform circular beacon##2##5##(2008-3#2)
an on-chip##2##2##(2008-10#1)(2009-12#1)
an on-line microwave##2##3##(2008-10#2)
an on-line preconcentration system for copper##2##6##(2008-10#2)
an on-line preconcentration system for##5##5##(2008-10#5)
an on-line preconcentration system##6##4##(2008-10#6)
an on-line preconcentration##7##3##(2008-10#7)
an on-line system##4##3##(2008-10#4)
an on-line##40##2##(1992-11#1)(1995-12#1)(1997-2#1)(2008-10#36)(2008-11#1)
an oncolytic##2##2##(1995-2#1)(2013-1#1)
an ongoing challenge##3##3##(1996-3#1)(2008-7#1)(2011-2#1)
an ongoing process##2##3##(1997-2#1)(2008-7#1)
an ongoing##18##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#3)(2010-9#1)(2011-2#1)(2011-8#1)(2013-8#1)
an online##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
an onset of##2##3##(1993-1#1)(2008-5#1)
an onset##3##2##(1993-1#1)(1994-9#1)(2008-5#1)
an open circuit##2##3##(2008-10#1)(2010-12#1)
an open pyelolithotomy was performed and##2##6##(2008-10#2)
an open reading frame (ORF) of##2##6##(1991-9#1)(2008-10#1)
an open reading frame (ORF)##8##5##(1991-9#1)(1993-12#2)(1994-12#1)(1996-8#1)(2008-10#3)
an open reading frame encoding##5##5##(1990-5#1)(1995-6#1)(2008-10#1)(2008-5#1)(2012-3#1)
an open reading frame of 1##3##6##(1992-3#1)(1997-9#1)(2008-9#1)
an open reading frame of##14##5##(1992-3#1)(1993-2#2)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-3#1)(1997-2#1)(1997-9#1)(2008-8#1)(2008-9#1)
an open reading frame that##2##5##(1992-10#1)(2008-9#1)
an open reading frame##31##4##(1990-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-12#3)(1993-2#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#3)(1995-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-9#1)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#2)(2012-3#1)
an open source##2##3##(2009-12#2)
an open study##3##3##(1990-12#1)(1991-2#1)(1991-3#1)
an open tube##2##3##(2008-10#2)
an open urban area##2##4##(2008-10#1)(2008-11#1)
an open vessel##2##3##(2008-10#2)
an open##71##2##(1990-12#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1993-12#3)(1993-2#4)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#4)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-9#1)(2008-10#16)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#2)(2010-12#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
an open-angle mechanism##2##3##(2011-2#2)
an opening##2##2##(1994-12#1)(2008-9#1)
an operant paradigm##2##3##(2008-10#2)
an operant##3##2##(1993-6#1)(2008-10#2)
an operating##5##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
an operation for##2##3##(2008-9#1)(2011-2#1)
an operation##6##2##(1993-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
an operational definition##3##3##(2008-10#1)(2013-1#2)
an operational##6##2##(2008-10#2)(2008-3#2)(2013-1#2)
an operative##2##2##(1990-3#1)(2012-3#1)
an operator##4##2##(2008-10#2)(2008-5#2)
an opioid##3##2##(1996-12#1)(2008-11#1)(2008-7#1)
an opponent's##2##2##(2008-11#2)
an opportunistic##2##2##(2009-9#1)(2011-2#1)
an opportunity for more##2##4##(2008-10#1)(2008-11#1)
an opportunity for##8##3##(1993-2#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)
an opportunity to##22##3##(1994-2#1)(1995-12#2)(1997-3#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#1)(2010-8#1)(2012-3#1)(2013-1#3)
an opportunity##34##2##(1993-2#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-10#6)(2008-11#6)(2008-12#5)(2008-4#2)(2008-5#1)(2010-8#1)(2012-3#1)(2013-1#3)
an opposite effect##3##3##(1990-12#1)(1996-2#1)(2008-10#1)
an opposite##4##2##(1990-12#1)(1996-2#2)(2008-10#1)
an optical biosensor##4##3##(1995-12#1)(2008-10#3)
an optical coherence tomography##2##4##(2008-3#1)(2009-9#1)
an optical coupling##2##3##(2008-2#2)
an optical fiber##3##3##(2008-10#2)(2008-3#1)
an optical parametric oscillator (OPO)##2##5##(2007-12#1)(2008-10#1)
an optical pumping##2##3##(2008-3#2)
an optical sensor for##2##4##(1996-5#1)(2008-10#1)
an optical sensor##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
an optical trap##2##3##(2008-2#1)(2012-2#1)
an optical vortex trap##2##4##(2009-5#2)
an optical##64##2##(1992-11#1)(1994-3#2)(1995-12#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#18)(2008-2#7)(2008-3#20)(2008-4#1)(2008-5#1)(2009-5#3)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
an optically thick##3##3##(2008-10#1)(2008-3#2)
an optically##13##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#9)(2012-2#1)
an optimal growth rate at##2##5##(2008-10#2)
an optimal##31##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1996-3#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
an optimally##2##2##(2012-2#1)(2013-1#1)
an optimised##2##2##(2008-10#1)(2012-2#1)
an optimization##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
an optimized##8##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
an optimum calibration##2##3##(2008-10#2)
an optimum response at pH##2##5##(2008-10#2)
an optimum temperature##4##3##(2008-10#3)(2012-2#1)
an optimum##25##2##(1991-3#1)(1994-8#1)(2008-10#17)(2008-11#1)(2008-2#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
an optoelectronic device##2##3##(2008-3#2)
an optoelectronic##3##2##(2008-3#3)
an oral formulation##2##3##(2008-5#2)
an oral sustained release##2##4##(2008-11#1)(2012-2#1)
an oral##20##2##(1990-8#1)(1991-2#1)(1991-3#1)(1994-12#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#4)(2008-9#3)(2012-2#1)(2012-3#1)(2013-1#1)
an orange-red##2##2##(2008-10#2)
an orbiting##2##2##(2008-3#2)
an orchard##2##2##(2008-10#2)
an order of magnitude higher than##2##6##(1991-5#1)(2008-10#1)
an order of magnitude##15##4##(1991-5#1)(1993-8#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
an order of##17##3##(1991-5#1)(1993-8#1)(1994-3#2)(1995-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
an order##18##2##(1991-5#1)(1993-8#1)(1994-3#2)(1995-3#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
an ordered##5##2##(1994-3#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-11#1)
an ordinal##4##2##(2008-10#2)(2008-4#1)(2013-8#1)
an ordinary least squares##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
an ordinary##5##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
an organ##5##2##(1993-12#1)(1993-2#1)(2008-12#1)(2008-5#1)(2008-8#1)
an organic modifier##6##3##(2008-10#6)
an organic solvent##8##3##(1992-3#1)(2008-10#6)(2008-7#1)
an organic##32##2##(1992-3#1)(1995-12#1)(2008-10#27)(2008-11#1)(2008-5#1)(2008-7#1)
an organisation##2##2##(2008-12#1)(2008-6#1)
an organism and##2##3##(1990-8#2)
an organism##7##2##(1990-8#2)(1995-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
an organism's##5##2##(1995-12#1)(2008-4#1)(2008-7#1)(2008-8#2)
an organization##8##2##(1992-3#1)(1993-12#1)(1994-1#1)(1994-2#1)(1997-1#1)(2008-10#1)(2012-3#2)
an organization's##4##2##(1993-3#1)(1994-3#1)(1995-12#1)(2010-8#1)
an organizational##3##2##(1992-2#1)(1993-12#1)(2008-11#1)
an organized##4##2##(1993-3#1)(1994-3#1)(2012-12#1)(2012-3#1)
an organophosphorus##2##2##(2008-10#2)
an orientation##5##2##(1994-5#1)(1996-1#1)(1996-5#1)(2008-11#1)(2008-8#1)
an oriented##2##2##(2008-10#1)(2008-2#1)
an origin##2##2##(1992-2#1)(2008-10#1)
an original##8##2##(1993-11#1)(2007-12#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#1)
an orthogonal##2##2##(2008-10#1)(2008-2#1)
an orthophosphate calibration graph##2##4##(2008-10#2)
an orthophosphate##3##2##(2008-10#3)
an oscillatory##3##2##(2008-11#2)(2009-9#1)
an osmiophilic##2##2##(1997-2#1)(2008-10#1)
an osmotic##3##2##(2008-7#1)(2009-8#1)(2011-2#1)
an osseous##2##2##(2010-5#1)(2010-6#1)
an osteochondral##2##2##(2011-2#1)(2013-1#1)
an osteogenic##2##2##(2008-11#2)
an osteolytic lesion##2##3##(2008-12#2)
an osteoporotic##2##2##(1991-11#2)
an otherwise##7##2##(1994-9#1)(1995-1#1)(1997-3#1)(2007-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
an out-patient##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
an outbreak of##8##3##(1991-11#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-5#1)(2012-2#1)
an outbreak##10##2##(1991-11#1)(1996-2#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-5#1)(2012-2#1)
an outcome##2##2##(1995-12#1)(2008-8#1)
an outer membrane protein##2##4##(1990-11#1)(2008-5#1)
an outer##10##2##(1990-11#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
an outgroup##2##2##(2008-10#2)
an outlier##3##2##(1993-12#1)(1993-3#1)(2008-10#1)
an outline of the##4##4##(1992-12#1)(1997-8#1)(2008-6#1)(2013-1#1)
an outline of##6##3##(1992-12#1)(1997-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2013-1#1)
an outline##7##2##(1992-12#1)(1992-3#1)(1997-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2013-1#1)
an outlook##2##2##(2008-5#1)(2010-12#1)
an outpatient basis##6##3##(1993-6#1)(1994-2#1)(1995-2#1)(1996-3#1)(2008-11#1)(2013-1#1)
an outpatient study##2##3##(1993-2#2)
an outpatient##14##2##(1991-1#2)(1991-2#1)(1993-2#2)(1993-6#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-3#1)(2008-11#1)(2012-12#1)(2013-1#1)
an output power of##2##4##(2008-3#2)
an output##8##2##(2007-11#1)(2008-2#2)(2008-3#5)
an outstanding##3##2##(1991-3#1)(2011-2#2)
an outward##2##2##(1991-5#1)(2009-1#1)
an ovarian##2##2##(1990-10#1)(1996-3#1)
an ovariole##2##2##(2008-7#2)
an over##3##2##(2008-12#1)(2011-3#1)(2013-1#1)
an overall assessment##2##3##(2010-9#1)(2011-2#1)
an overall picture of##2##4##(2008-11#1)(2012-5#1)
an overall##48##2##(1991-3#1)(1991-9#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)
an overdose of vitamin pills##2##5##(2008-10#2)
an overestimation of##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
an overlooked##3##2##(1994-12#1)(1996-6#1)(2008-3#1)
an overnight##3##2##(2008-10#2)(2010-7#1)
an overproduction of##2##3##(2008-10#1)(2008-7#1)
an overriding second toe##2##4##(2010-11#2)
an overview about##2##3##(2010-10#1)(2013-1#1)
an overview and##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
an overview for##2##3##(1996-2#1)(2008-4#1)
an overview of computer simulation##2##5##(2008-4#2)
an overview of published##2##4##(1992-1#1)(2010-11#1)
an overview of the current##3##5##(2009-4#1)(2011-2#2)
an overview of the literature##2##5##(2009-1#1)(2012-2#1)
an overview of the most##3##5##(1991-6#1)(2010-11#1)(2010-9#1)
an overview of the##47##4##(1991-6#1)(1993-11#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#5)(2008-12#2)(2008-4#3)(2008-5#3)(2008-9#3)(2009-1#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#2)
an overview of their##3##4##(2008-5#1)(2011-1#1)(2013-1#1)
an overview of##87##3##(1991-1#2)(1991-2#1)(1991-6#1)(1992-1#2)(1993-11#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#2)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-4#11)(2008-5#4)(2008-9#3)(2009-1#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#4)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#1)
an overview on the##2##4##(2008-10#1)(2010-11#1)
an overview on##3##3##(2008-10#2)(2010-11#1)
an overview##111##2##(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-6#1)(1992-1#2)(1993-11#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#3)(2008-4#12)(2008-5#4)(2008-6#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#1)
an overwhelming##2##2##(1991-1#1)(2011-2#1)
an ovine##3##2##(1993-2#1)(2008-7#1)(2010-6#1)
an oxidant##5##2##(2008-10#5)
an oxidase##2##2##(2008-10#1)(2008-5#1)
an oxidative stress##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
an oxidative##5##2##(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)
an oxidized##3##2##(1995-2#1)(2008-10#2)
an oxidizing agent##3##3##(1996-5#1)(2008-10#2)
an oxidizing##4##2##(1996-5#1)(2008-10#3)
an oxygen electrode##2##3##(1995-3#1)(2008-10#1)
an oxygen##5##2##(1995-3#1)(2008-10#3)(2008-11#1)
an oxygen-permeable film##2##3##(2008-11#2)
an oxygen-rich##2##2##(2008-11#1)(2011-2#1)
an oxygen-sensitive##2##2##(1997-1#1)(2008-10#1)
an ozone hole##2##3##(1991-5#2)
an ozone##3##2##(1991-5#2)(2008-10#1)
an pI of##2##3##(2008-10#2)
an rDNA analysis##2##3##(2008-10#2)
an ubiquitous##2##2##(1990-12#1)(2008-8#1)
an ultra##2##2##(2008-10#1)(2010-1#1)
an ultrafiltration membrane with a##2##5##(2008-10#2)
an ultrafiltration##5##2##(1995-2#1)(1995-3#1)(2008-10#2)(2011-2#1)
an ultrashort pulse##2##3##(2007-12#1)(2008-3#1)
an ultrasonic##10##2##(1993-2#1)(2008-10#8)(2008-11#1)
an ultrasound##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)
an ultrasound-assisted##2##2##(2008-10#2)
an ultrastructural##2##2##(2008-10#1)(2008-7#1)
an unbalanced##3##2##(2008-10#2)(2008-2#1)
an unbiased##2##2##(2008-8#1)(2012-2#1)
an uncertainty of##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
an uncertainty##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
an unchanged##2##2##(2008-3#1)(2012-2#1)
an uncharacterized##2##2##(1996-6#1)(2008-11#1)
an uncoated##6##2##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
an uncommon case of##2##4##(1993-6#1)(2011-2#1)
an uncommon cause of##5##4##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#1)
an uncommon cause##6##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
an uncommon circumstance##2##3##(2011-2#2)
an uncommon##39##2##(1991-6#1)(1992-3#1)(1993-6#1)(2008-1#1)(2008-10#3)(2008-12#4)(2008-7#5)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-2#7)(2011-3#1)(2012-3#4)(2013-1#2)(2013-8#1)
an uncomplicated##2##2##(1996-9#1)(2009-8#1)
an unconditioned##2##2##(1996-2#1)(1997-7#1)
an unconjugated##2##2##(2008-9#1)(2013-1#1)
an undergraduate nursing##2##3##(2008-11#2)
an undergraduate programme##2##3##(2008-11#2)
an undergraduate##7##2##(2008-11#7)
an underlying condition##2##3##(2008-4#1)(2011-2#1)
an underlying##11##2##(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
an understanding of how the##2##5##(1993-1#1)(2009-12#1)
an understanding of how##5##4##(1993-1#1)(1994-1#1)(2008-9#1)(2009-12#1)(2009-6#1)
an understanding of the##10##4##(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-10#1)(2011-2#1)
an understanding of##31##3##(1992-9#1)(1993-1#2)(1994-1#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#1)(2009-6#1)(2010-10#1)(2011-10#1)(2011-2#1)
an understanding##33##2##(1992-9#1)(1993-1#2)(1994-1#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#1)(2009-6#1)(2010-10#1)(2011-10#1)(2011-2#1)(2013-1#1)
an undiagnosed##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
an undoped##2##2##(2008-10#1)(2008-2#1)
an undue##2##2##(1996-5#1)(1997-7#1)
an unequivocal##2##2##(2008-10#1)(2009-8#1)
an uneventful recovery##8##3##(1994-2#1)(1997-3#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
an uneventful##10##2##(1994-2#1)(1997-3#1)(2008-12#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
an unexpected##7##2##(1992-9#1)(2008-12#1)(2008-3#1)(2010-2#1)(2010-6#1)(2012-2#2)
an unfamiliar##2##2##(1994-8#1)(2008-4#1)
an unfavorable outcome##4##3##(2012-3#4)
an unfavorable##8##2##(1997-1#1)(2008-10#1)(2012-3#4)(2013-1#2)
an unfavourable##3##2##(1992-2#1)(2008-5#1)(2013-1#1)
an unidentified##9##2##(1992-2#1)(1997-1#1)(1997-8#1)(2008-10#6)
an unique##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
an unknown##21##2##(1994-9#1)(1996-9#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-8#1)
an unlikely##3##2##(1996-2#1)(2008-10#1)(2013-1#1)
an unmodified carbon paste electrode##2##5##(2008-10#2)
an unprecedented##2##2##(2008-4#1)(2008-5#1)
an unrecognized##3##2##(1993-2#1)(2011-2#1)(2012-2#1)
an unrelated##5##2##(1997-3#1)(2008-10#1)(2008-8#2)(2009-6#1)
an unstable resonator##2##3##(2008-2#1)(2008-3#1)
an unstable##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#2)(2013-1#1)
an unstructured##4##2##(2010-11#1)(2013-1#3)
an untreated##5##2##(1992-2#1)(2008-10#2)(2008-5#2)
an unusual case of a##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
an unusual case of##13##4##(1997-5#1)(2008-10#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
an unusual case##14##3##(1997-5#1)(2008-10#3)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
an unusual cause of##3##4##(2009-8#1)(2013-1#1)(2013-8#1)
an unusual cause##5##3##(2009-3#1)(2009-8#2)(2013-1#1)(2013-8#1)
an unusual complication of##2##4##(2009-9#1)(2011-2#1)
an unusual complication##3##3##(2008-7#1)(2009-9#1)(2011-2#1)
an unusual form of##2##4##(2009-6#1)(2012-2#1)
an unusual location for##2##4##(2008-10#1)(2011-2#1)
an unusual location##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
an unusual presentation##4##3##(1997-8#1)(2008-7#2)(2012-3#1)
an unusual##61##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-5#1)(1994-6#1)(1995-6#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-3#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#2)
an unusually##4##2##(1993-12#1)(1993-2#2)(1997-7#1)
an unweighted##2##2##(1991-12#1)(2008-10#1)
an up##2##2##(2008-11#1)(2011-2#1)
an up-regulation of##2##3##(1991-5#1)(2010-11#1)
an up-to-date##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
an update of##5##3##(1994-3#1)(2008-11#1)(2008-9#1)(2012-2#2)
an update on the current##2##5##(2011-1#1)(2013-1#1)
an update on the##3##4##(2011-1#1)(2012-12#1)(2013-1#1)
an update on##5##3##(1991-3#1)(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
an update##18##2##(1991-1#1)(1991-3#1)(1994-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#1)
an upper limit of##2##4##(1991-5#1)(2008-10#1)
an upper##7##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)
an urban area of##2##4##(2008-7#1)(2009-10#1)
an urban area##5##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)
an urban health##2##3##(1997-4#1)(2009-10#1)
an urban population##4##3##(1990-2#1)(1991-1#1)(2008-11#1)(2011-2#1)
an urban##21##2##(1990-2#1)(1991-1#1)(1994-1#1)(1996-3#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#3)(2011-2#1)(2013-1#2)(2013-8#1)
an urgent need to##3##4##(2008-1#1)(2008-11#1)(2010-5#1)
an urgent need##7##3##(2008-1#1)(2008-10#1)(2008-11#3)(2010-5#1)(2011-2#1)
an urgent##11##2##(2008-1#1)(2008-10#1)(2008-11#4)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
an##11844##1##(1990-10#3)(1990-11#27)(1990-12#42)(1990-2#32)(1990-3#18)(1990-5#42)(1990-6#22)(1990-7#3)(1990-8#29)(1990-9#22)(1991-1#28)(1991-10#6)(1991-11#25)(1991-12#67)(1991-2#44)(1991-3#43)(1991-4#2)(1991-5#43)(1991-6#38)(1991-7#8)(1991-8#19)(1991-9#20)(1992-1#32)(1992-10#8)(1992-11#14)(1992-12#55)(1992-2#47)(1992-3#57)(1992-4#5)(1992-5#13)(1992-6#24)(1992-7#5)(1992-8#21)(1992-9#35)(1993-1#45)(1993-11#19)(1993-12#73)(1993-2#48)(1993-3#69)(1993-5#2)(1993-6#34)(1993-8#48)(1993-9#16)(1994-1#14)(1994-11#45)(1994-12#63)(1994-2#65)(1994-3#65)(1994-5#51)(1994-6#21)(1994-8#45)(1994-9#19)(1995-1#17)(1995-11#29)(1995-12#63)(1995-2#96)(1995-3#30)(1995-5#21)(1995-6#69)(1995-8#41)(1995-9#20)(1996-1#32)(1996-10#1)(1996-11#16)(1996-12#72)(1996-2#75)(1996-3#66)(1996-5#50)(1996-6#26)(1996-8#15)(1996-9#12)(1997-1#57)(1997-2#79)(1997-3#62)(1997-4#28)(1997-5#12)(1997-6#27)(1997-7#46)(1997-8#63)(1997-9#3)(2006-5#1)(2006-6#7)(2007-11#19)(2007-12#69)(2007-7#1)(2007-8#7)(2007-9#4)(2008-1#49)(2008-10#3191)(2008-11#871)(2008-12#249)(2008-2#107)(2008-3#388)(2008-4#134)(2008-5#280)(2008-6#74)(2008-7#314)(2008-8#280)(2008-9#276)(2009-1#21)(2009-10#65)(2009-11#25)(2009-12#51)(2009-2#2)(2009-3#31)(2009-4#20)(2009-5#29)(2009-6#38)(2009-7#48)(2009-8#86)(2009-9#27)(2010-1#54)(2010-10#64)(2010-11#59)(2010-12#66)(2010-2#6)(2010-3#26)(2010-4#31)(2010-5#43)(2010-6#50)(2010-7#49)(2010-8#49)(2010-9#14)(2011-1#55)(2011-10#10)(2011-2#484)(2011-3#40)(2011-7#7)(2011-8#2)(2012-12#90)(2012-2#253)(2012-3#240)(2012-4#1)(2012-5#4)(2012-6#2)(2012-7#4)(2012-9#3)(2013-1#412)(2013-3#3)(2013-7#17)(2013-8#173)
ana##3##1##(2013-8#3)
anabolic agents##2##2##(2010-7#2)
anabolic compounds##2##2##(2008-10#2)
anabolic effect##2##2##(2007-8#1)(2013-1#1)
anabolic steroids in##2##3##(2008-10#2)
anabolic steroids##5##2##(1991-3#2)(2008-10#2)(2010-4#1)
anabolic##19##1##(1991-3#3)(1992-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-4#1)(2010-7#2)(2011-1#1)(2012-2#1)(2013-1#2)
anabolites##5##1##(2008-7#5)
anaemia and##3##2##(1994-6#1)(1995-5#1)(2008-5#1)
anaemia could##2##2##(1990-3#1)(2008-5#1)
anaemia virus##6##2##(2008-5#4)(2009-6#2)
anaemia##25##1##(1990-3#1)(1990-9#1)(1991-3#3)(1994-6#2)(1995-5#1)(2008-11#1)(2008-5#7)(2008-7#1)(2009-6#2)(2009-8#2)(2012-2#4)
anaemic##4##1##(1990-3#3)(2010-8#1)
anaerobes##2##1##(1996-6#1)(2011-2#1)
anaerobic and##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
anaerobic bacteria##6##2##(1991-2#1)(2011-1#5)
anaerobic bacterium##2##2##(1990-12#1)(2008-9#1)
anaerobic co-digestion##2##2##(2013-1#2)
anaerobic conditions##5##2##(1993-8#1)(2008-10#3)(2013-1#1)
anaerobic metabolism##2##2##(2010-11#1)(2012-12#1)
anaerobic##54##1##(1990-12#1)(1991-12#1)(1991-2#1)(1993-8#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#6)(2011-2#10)(2012-12#1)(2012-3#1)(2013-1#8)(2013-8#2)
anaerobiosis##4##1##(1996-12#1)(2008-10#1)(2008-6#2)
anaesthesia and##3##2##(2008-5#1)(2010-7#2)
anaesthesia for##4##2##(1990-6#1)(1996-6#1)(2007-8#2)
anaesthesia in##3##2##(1990-6#1)(1991-9#1)(2012-2#1)
anaesthesia management##3##2##(2010-7#3)
anaesthesia or##2##2##(2011-2#1)(2013-1#1)
anaesthesia to##2##2##(1995-5#1)(2008-12#1)
anaesthesia using##2##2##(2010-7#1)(2011-2#1)
anaesthesia was induced##2##3##(1996-6#1)(2010-7#1)
anaesthesia was##3##2##(1996-6#1)(2010-7#2)
anaesthesia were##2##2##(1996-6#1)(2010-7#1)
anaesthesia with propofol##2##3##(2011-2#2)
anaesthesia with##3##2##(2011-2#3)
anaesthesia##50##1##(1990-6#2)(1991-9#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-6#4)(1997-6#1)(2007-8#3)(2008-12#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-7#15)(2010-8#2)(2011-2#11)(2012-2#1)(2013-1#2)
anaesthesiologist##2##1##(2010-7#2)
anaesthesiology##4##1##(2008-1#1)(2009-5#2)(2010-7#1)
anaesthetic and##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
anaesthetic techniques##3##2##(1991-6#1)(1994-3#2)
anaesthetic vapours##2##2##(1991-6#2)
anaesthetic##22##1##(1991-6#4)(1994-3#4)(1995-3#1)(1996-11#1)(2008-10#1)(2010-7#7)(2011-1#1)(2011-2#2)(2013-1#1)
anaesthetics##4##1##(1991-6#1)(1994-3#1)(1995-11#1)(2010-7#1)
anaesthetised##2##1##(1995-9#1)(1996-6#1)
anaesthetized##3##1##(1996-5#1)(2011-2#2)
anagen##4##1##(2008-5#2)(2008-8#2)
anal anatomy and##2##3##(1997-8#2)
anal anatomy##3##2##(1997-8#3)
anal atresia##2##2##(2008-7#1)(2008-8#1)
anal canal##4##2##(2013-1#4)
anal cancer##3##2##(1991-6#3)
anal intercourse with##2##3##(2008-12#2)
anal intercourse##3##2##(2008-12#2)(2010-7#1)
anal##29##1##(1990-3#1)(1991-6#3)(1992-5#3)(1996-11#1)(1997-8#3)(2008-12#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#3)(2010-8#1)(2011-2#3)(2013-1#6)
analgesia (p=0##2##2##(2008-10#2)
analgesia and##9##2##(1996-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
analgesia during##2##2##(1991-6#1)(2012-3#1)
analgesia scores##2##2##(2008-10#2)
analgesia was##2##2##(1996-2#1)(2007-8#1)
analgesia with##2##2##(1993-1#1)(2012-3#1)
analgesia##38##1##(1991-6#1)(1992-2#1)(1993-1#2)(1993-2#1)(1996-12#1)(1996-2#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-7#3)(2009-12#2)(2010-1#1)(2011-2#3)(2012-12#2)(2012-3#6)(2013-1#2)(2013-8#3)
analgesia]##2##1##(2009-5#1)(2012-3#1)
analgesic activity and##2##3##(1992-3#1)(2008-12#1)
analgesic activity of##2##3##(2013-1#2)
analgesic activity##6##2##(1992-3#1)(2008-11#1)(2008-12#2)(2013-1#2)
analgesic and##5##2##(1995-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#1)
analgesic effect of##4##3##(1996-2#2)(2008-11#1)(2011-2#1)
analgesic effect##7##2##(1991-2#1)(1996-2#3)(2008-10#1)(2008-11#1)(2011-2#1)
analgesic effects##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
analgesic medications##2##2##(2010-6#1)(2011-2#1)
analgesic use##3##2##(1993-12#1)(2010-11#1)(2012-3#1)
analgesic##47##1##(1991-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1995-6#1)(1996-1#1)(1996-2#3)(1997-2#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-6#2)(2010-7#5)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#5)
analgesics and##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
analgesics for medically compromised patients undergoing oral surgery##2##8##(1993-1#2)
analgesics in the##2##3##(1991-8#1)(2011-2#1)
analgesics##22##1##(1991-6#1)(1991-8#1)(1993-1#2)(1996-11#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-11#1)(2009-12#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#4)
analgesics)##3##1##(2008-10#1)(2010-11#2)
analog K##2##2##(1994-8#2)
analog is##3##2##(1994-12#1)(1997-6#1)(2008-4#1)
analog of##11##2##(1993-8#2)(1995-11#2)(1995-8#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)
analog to the##2##3##(1993-8#1)(1994-12#1)
analog to##4##2##(1993-8#1)(1994-12#1)(2008-11#2)
analog##65##1##(1990-2#1)(1990-9#1)(1991-5#2)(1992-12#1)(1992-8#2)(1993-1#2)(1993-6#1)(1993-8#5)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#3)(1995-11#5)(1995-2#2)(1995-8#2)(1996-12#2)(1997-2#1)(1997-6#3)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
analogical##3##1##(2008-3#2)(2010-6#1)
analogies##2##1##(2008-10#1)(2012-3#1)
analogous systems##2##2##(1994-5#1)(2008-10#1)
analogous to that##4##3##(1991-5#2)(1994-11#1)(2010-10#1)
analogous to the##8##3##(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)
analogous to those##3##3##(1992-6#1)(1994-11#1)(2012-3#1)
analogous to##23##2##(1991-12#1)(1991-5#2)(1991-8#1)(1992-6#1)(1994-11#2)(1995-2#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
analogous##54##1##(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-6#1)(1994-11#2)(1994-5#3)(1995-2#1)(1995-9#1)(1996-5#2)(1996-8#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#3)(2011-2#1)(2012-3#1)
analogs J and K##2##4##(1994-8#2)
analogs are##2##2##(1994-5#1)(2008-8#1)
analogs by##2##2##(2008-10#2)
analogs have been##2##3##(2008-10#1)(2008-5#1)
analogs have##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
analogs in the##2##3##(1995-6#1)(2008-10#1)
analogs in##3##2##(1994-5#1)(1995-6#1)(2008-10#1)
analogs of GTP and##2##4##(1991-5#2)
analogs of the##4##3##(1990-5#1)(1992-8#1)(2008-10#1)(2008-4#1)
analogs of vitamin D##2##4##(1992-1#2)
analogs of##18##2##(1990-11#1)(1990-5#1)(1991-5#2)(1992-1#2)(1992-8#2)(1993-1#2)(1994-8#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
analogs on##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
analogs were synthesized##2##3##(2008-6#1)(2011-2#1)
analogs were##4##2##(1992-8#1)(1994-11#1)(2008-6#1)(2011-2#1)
analogs##78##1##(1990-11#1)(1990-5#2)(1991-3#1)(1991-5#2)(1992-1#2)(1992-8#3)(1993-1#3)(1993-6#1)(1993-8#4)(1994-11#3)(1994-5#6)(1994-6#1)(1994-8#6)(1995-2#2)(1995-6#3)(2008-10#16)(2008-11#6)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-12#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
analogue inhibited cholesterol esterification in##2##5##(1994-8#2)
analogue inhibited##3##2##(1994-8#2)(1995-2#1)
analogue of##5##2##(1990-2#1)(1990-5#1)(1992-8#1)(1994-8#1)(2010-3#1)
analogue to##2##2##(2008-5#1)(2011-1#1)
analogue##63##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#6)(1995-11#1)(1995-2#3)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#3)(2010-3#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
analogues (0-11 ns)##2##3##(1991-5#2)
analogues and##6##2##(1993-1#2)(1994-11#1)(2008-10#1)(2008-8#1)(2010-10#1)
analogues as##2##2##(1992-12#1)(1996-2#1)
analogues could##2##2##(2008-8#2)
analogues in##4##2##(1991-5#2)(1996-11#1)(2008-4#1)
analogues is##2##2##(1992-6#1)(2010-1#1)
analogues of the anticonvulsant##2##4##(1994-8#2)
analogues of the##3##3##(1994-8#2)(2011-2#1)
analogues of##11##2##(1994-8#3)(1995-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#3)
analogues was achieved##2##3##(1996-5#2)
analogues was##4##2##(1996-5#2)(2011-2#2)
analogues were##2##2##(1991-5#1)(2008-8#1)
analogues##74##1##(1990-12#1)(1991-3#1)(1991-5#7)(1992-11#1)(1992-12#2)(1992-6#1)(1993-1#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-8#11)(1995-11#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#3)(2008-10#6)(2008-11#3)(2008-4#4)(2008-8#4)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#9)(2012-3#1)(2013-1#1)(2013-8#1)
analogy to##8##2##(1996-2#1)(1997-6#2)(2008-10#1)(2008-11#2)(2008-8#1)(2009-6#1)
analogy with the##2##3##(1992-9#1)(2008-10#1)
analogy##17##1##(1992-9#1)(1994-2#1)(1996-2#1)(1997-3#1)(1997-6#2)(2008-10#7)(2008-11#2)(2008-8#1)(2009-6#1)
analyse and##2##2##(2008-11#1)(2011-2#1)
analyse the##24##2##(1990-9#1)(1991-3#1)(1992-5#1)(1993-2#1)(1993-6#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#2)(2012-5#2)
analyse their##2##2##(1993-9#1)(2008-5#1)
analyse##62##1##(1990-9#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2012-5#2)(2013-1#4)
analysed and discussed##2##3##(2008-10#1)(2010-11#1)
analysed and the##2##3##(2008-10#2)
analysed and##15##2##(1990-2#1)(1996-12#1)(2008-10#10)(2008-9#1)(2010-11#1)(2010-8#1)
analysed as a function of##2##5##(2008-10#2)
analysed as a##3##3##(2008-10#2)(2012-8#1)
analysed as##6##2##(1992-9#1)(2008-10#3)(2011-2#1)(2012-8#1)
analysed by gas##6##3##(1990-5#1)(2008-10#5)
analysed by inductively coupled plasma##2##5##(2008-10#2)
analysed by inductively coupled##3##4##(2008-10#3)
analysed by the##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
analysed by##55##2##(1990-5#2)(1991-8#2)(1993-6#1)(1993-9#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#29)(2008-11#7)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#2)
analysed elements##2##2##(2008-10#2)
analysed for their##2##3##(2008-10#1)(2008-12#1)
analysed for##24##2##(1995-8#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#2)(2011-2#2)(2012-6#1)(2012-9#1)
analysed in both##2##3##(2008-10#2)
analysed in order to##3##4##(2008-10#2)(2008-11#1)
analysed in terms of##2##4##(2008-10#2)
analysed in the##3##3##(1996-2#1)(2008-10#2)
analysed in##21##2##(1990-3#1)(1991-5#1)(1991-6#1)(1996-2#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#2)(2013-1#1)
analysed samples##5##2##(2008-10#4)(2010-4#1)
analysed the clinical##2##3##(1991-3#1)(2007-8#1)
analysed the##17##2##(1990-3#1)(1991-3#1)(1994-12#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-12#1)(2009-4#1)(2009-7#1)(2011-10#1)(2011-3#1)
analysed to provide##2##3##(2008-11#2)
analysed to##6##2##(1991-6#1)(1996-8#1)(2008-10#1)(2008-11#3)
analysed using a##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
analysed using the##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
analysed using##24##2##(1997-1#1)(2008-10#10)(2008-11#4)(2008-12#3)(2010-10#2)(2010-11#1)(2011-2#2)(2012-2#1)
analysed with##12##2##(2008-10#6)(2008-11#3)(2008-3#1)(2008-7#1)(2013-1#1)
analysed without prior##2##3##(2008-10#2)
analysed without##3##2##(2008-10#2)(2008-11#1)
analysed##285##1##(1990-2#1)(1990-3#3)(1990-5#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#5)(1992-5#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#4)(1997-8#2)(2007-11#2)(2007-8#2)(2008-10#117)(2008-11#28)(2008-12#12)(2008-3#1)(2008-5#11)(2008-7#6)(2008-8#2)(2008-9#6)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#4)(2010-11#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#11)(2011-3#2)(2012-12#2)(2012-2#5)(2012-6#1)(2012-8#1)(2012-9#1)(2013-1#9)
analyser for##5##2##(2008-10#5)
analyser##28##1##(1990-2#1)(1991-6#1)(2008-10#25)(2008-11#1)
analysers##10##1##(1990-2#1)(1994-9#1)(2008-10#8)
analyses and the##2##3##(2008-10#1)(2010-2#1)
analyses and##24##2##(1991-7#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-3#1)
analyses are needed##2##3##(1993-12#1)(1997-3#1)
analyses are performed##3##3##(1995-3#1)(2009-12#1)(2010-11#1)
analyses are presented##3##3##(1994-1#1)(2008-3#2)
analyses are required to##2##4##(2008-12#1)(2010-7#1)
analyses are##20##2##(1992-12#1)(1993-12#2)(1994-1#1)(1995-12#1)(1995-3#2)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-8#1)
analyses based on##4##3##(1996-3#1)(2008-10#1)(2008-12#1)(2011-1#1)
analyses be##2##2##(1996-12#1)(2008-10#1)
analyses between##4##2##(1991-12#1)(2008-10#2)(2008-12#1)
analyses by##5##2##(1997-7#1)(2008-10#2)(2008-11#1)(2013-1#1)
analyses can be##3##3##(2008-10#2)(2008-4#1)
analyses can##4##2##(2008-10#2)(2008-4#1)(2009-8#1)
analyses carried out##2##3##(2008-10#1)(2008-5#1)
analyses confirmed that##2##3##(2008-10#2)
analyses confirmed##4##2##(2008-10#4)
analyses demonstrate that##2##3##(1992-3#1)(1997-7#1)
analyses demonstrated that the##2##4##(2008-10#1)(2009-7#1)
analyses demonstrated that##7##3##(1995-1#1)(2008-10#4)(2009-7#1)(2011-2#1)
analyses demonstrated##8##2##(1993-3#1)(1995-1#1)(2008-10#4)(2009-7#1)(2011-2#1)
analyses detected##2##2##(1996-12#1)(2008-10#1)
analyses determined that##2##3##(2008-10#1)(2010-11#1)
analyses did##2##2##(2008-4#1)(2012-2#1)
analyses exhibited an##2##3##(2008-10#2)
analyses exhibited##3##2##(2008-10#3)
analyses for##4##2##(2008-10#4)
analyses gave##2##2##(2008-1#1)(2008-10#1)
analyses have been##2##3##(2007-12#1)(2008-10#1)
analyses have revealed##2##3##(2008-10#2)
analyses have shown that##2##4##(1994-11#1)(2012-2#1)
analyses have##7##2##(1994-11#1)(2007-12#1)(2008-10#3)(2010-10#1)(2012-2#1)
analyses identified four##2##3##(2008-10#2)
analyses identified##7##2##(2008-10#3)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)
analyses in the##2##3##(1991-12#1)(2008-8#1)
analyses in##12##2##(1990-11#1)(1991-12#2)(2008-10#5)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)
analyses include##2##2##(2008-10#1)(2011-2#1)
analyses included##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
analyses indicate that the##3##4##(1995-2#1)(2008-10#1)(2008-3#1)
analyses indicate that##4##3##(1995-2#1)(2008-10#2)(2008-3#1)
analyses indicate##5##2##(1995-2#1)(2008-10#2)(2008-3#1)(2009-8#1)
analyses indicated that the##7##4##(1992-3#1)(1993-6#1)(1997-8#1)(2008-10#3)(2008-9#1)
analyses indicated that##20##3##(1992-3#1)(1993-12#3)(1993-6#1)(1995-9#1)(1997-8#1)(2008-10#8)(2008-8#1)(2008-9#2)(2012-2#2)
analyses indicated##27##2##(1990-11#1)(1992-3#1)(1993-12#3)(1993-6#1)(1995-9#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-8#1)(2008-9#3)(2009-7#1)(2011-2#1)(2012-2#2)
analyses involving##2##2##(2008-10#1)(2011-2#1)
analyses is##5##2##(2008-10#2)(2008-3#1)(2008-4#1)(2009-8#1)
analyses of DNA sequences##2##4##(2008-10#2)
analyses of a##2##3##(2008-10#2)
analyses of both##2##3##(2008-10#2)
analyses of four##2##3##(2008-10#2)
analyses of gene##2##3##(2008-10#1)(2008-8#1)
analyses of sequences##2##3##(2008-10#2)
analyses of the beta-tubulin##2##4##(2008-10#2)
analyses of the internal transcribed spacer##2##6##(2008-10#2)
analyses of the##59##3##(1990-5#1)(1993-12#3)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#36)(2008-11#1)(2008-8#1)(2009-10#1)(2009-7#3)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
analyses of these##4##3##(1994-5#1)(1996-3#1)(2008-10#1)(2012-2#1)
analyses of three##2##3##(2008-10#2)
analyses of variance##4##3##(1993-2#1)(2008-12#1)(2008-4#1)(2009-11#1)
analyses of##193##2##(1990-5#2)(1990-8#1)(1991-12#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-5#3)(1995-6#2)(1996-3#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#116)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#3)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
analyses on##10##2##(2007-12#1)(2008-10#5)(2008-11#2)(2009-7#1)(2012-3#1)
analyses per h##2##3##(2008-10#2)
analyses per hour##2##3##(2008-10#2)
analyses per##4##2##(2008-10#4)
analyses performed with##2##3##(2008-10#2)
analyses performed##5##2##(2008-10#5)
analyses provided a##2##3##(2012-2#2)
analyses provided##4##2##(2008-11#1)(2008-2#1)(2012-2#2)
analyses reveal##2##2##(1993-3#1)(2012-3#1)
analyses revealed that the##6##4##(2008-10#3)(2008-11#1)(2008-12#1)(2010-3#1)
analyses revealed that##18##3##(1996-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#1)
analyses revealed the##2##3##(1995-12#1)(2008-10#1)
analyses revealed##32##2##(1990-11#1)(1993-11#1)(1995-12#1)(1996-8#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-2#2)
analyses show a significant##2##4##(1993-1#1)(2011-2#1)
analyses show that##6##3##(1992-3#1)(1994-11#1)(2008-10#2)(2008-12#1)(2010-11#1)
analyses show##8##2##(1992-3#1)(1993-1#1)(1994-11#1)(2008-10#2)(2008-12#1)(2010-11#1)(2011-2#1)
analyses showed significant##2##3##(2008-10#1)(2012-2#1)
analyses showed that the expression##2##5##(2008-10#1)(2008-6#1)
analyses showed that the##4##4##(1997-8#1)(2008-10#1)(2008-6#1)(2009-12#1)
analyses showed that##11##3##(1997-8#1)(2008-10#5)(2008-6#1)(2009-12#1)(2009-7#1)(2010-1#1)(2012-2#1)
analyses showed##15##2##(1997-8#1)(2008-10#7)(2008-6#1)(2009-12#1)(2009-7#1)(2010-1#1)(2012-2#2)(2013-1#1)
analyses strongly##2##2##(2008-10#2)
analyses suggest that##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
analyses suggest##7##2##(1991-12#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-9#2)
analyses suggested that##2##3##(2008-10#1)(2008-5#1)
analyses that##3##2##(1993-12#1)(1993-2#1)(1994-1#1)
analyses the##4##2##(2008-11#1)(2008-12#2)(2009-12#1)
analyses to determine##2##3##(2008-11#1)(2008-8#1)
analyses to examine##2##3##(2008-6#1)(2008-8#1)
analyses to##11##2##(1993-12#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2012-3#1)
analyses using a##2##3##(1993-8#1)(1997-7#1)
analyses using##10##2##(1993-8#1)(1995-6#1)(1997-7#1)(2008-10#5)(2012-3#1)(2013-1#1)
analyses was##4##2##(2008-10#3)(2011-2#1)
analyses were carried out by##3##5##(2008-10#2)(2008-5#1)
analyses were carried out##6##4##(1997-7#1)(2008-10#4)(2008-5#1)
analyses were conducted using##2##4##(1994-8#1)(2009-7#1)
analyses were conducted##4##3##(1994-8#1)(1996-12#1)(2009-7#1)(2010-8#1)
analyses were not##2##3##(1992-9#1)(2008-8#1)
analyses were performed on##5##4##(2008-10#3)(2010-3#1)(2013-1#1)
analyses were performed to##5##4##(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)
analyses were performed with##2##4##(2008-10#1)(2012-2#1)
analyses were performed##19##3##(1990-8#1)(1994-12#1)(1997-8#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
analyses were used to##5##4##(2008-10#2)(2008-7#1)(2010-4#1)(2013-8#1)
analyses were used##7##3##(2008-10#2)(2008-12#2)(2008-7#1)(2010-4#1)(2013-8#1)
analyses were##45##2##(1990-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
analyses which##2##2##(1995-12#1)(2008-10#1)
analyses with##11##2##(1994-9#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-5#1)(2009-12#1)(2013-1#2)(2013-8#1)
analyses##752##1##(1990-11#3)(1990-5#2)(1990-8#2)(1991-10#1)(1991-12#5)(1991-7#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#13)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#3)(1995-5#4)(1995-6#4)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-7#6)(1997-8#7)(2007-12#3)(2008-1#2)(2008-10#357)(2008-11#26)(2008-12#12)(2008-2#1)(2008-3#8)(2008-4#9)(2008-5#12)(2008-6#4)(2008-7#5)(2008-8#14)(2008-9#22)(2009-10#3)(2009-11#3)(2009-12#8)(2009-5#2)(2009-6#1)(2009-7#9)(2009-8#11)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#7)(2010-12#4)(2010-2#2)(2010-3#6)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#23)(2011-3#1)(2012-12#4)(2012-2#20)(2012-3#10)(2013-1#19)(2013-8#8)
analyses)##3##1##(2008-10#2)(2008-2#1)
analysing a##5##2##(1992-12#1)(2008-10#4)
analysing complex##2##2##(2008-10#2)
analysing several##4##2##(2008-10#4)
analysing the data##2##3##(1994-9#1)(2008-11#1)
analysing the##13##2##(1994-9#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#3)(2011-3#1)(2013-1#1)
analysing##61##1##(1992-12#1)(1992-9#1)(1994-3#1)(1994-9#3)(1995-12#1)(1996-9#1)(2008-10#35)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
analysis (BIA)##6##2##(2008-10#5)(2011-2#1)
analysis (BIS-FIA) system with spectrofluorimetric detection##2##6##(2008-10#2)
analysis (CFA)##3##2##(2008-10#3)
analysis (FIA) for the determination of##2##6##(2008-10#2)
analysis (FIA) for the##4##4##(2008-10#4)
analysis (FIA) method##2##3##(2008-10#2)
analysis (FIA) system##13##3##(2008-10#12)(2008-11#1)
analysis (FIA) technique##3##3##(2008-10#3)
analysis (FIA) was##2##3##(2008-10#2)
analysis (FIA)##51##2##(2008-10#50)(2008-11#1)
analysis (MRA)##2##2##(2008-10#2)
analysis (MSFIA)##3##2##(2008-10#3)
analysis (PCA) for the##2##4##(2008-10#2)
analysis (PCA) is a##2##4##(2008-10#1)(2010-7#1)
analysis (PCA) was##4##3##(2008-10#4)
analysis (PCA)##36##2##(2008-10#35)(2010-7#1)
analysis (PLS-DA)##2##2##(2008-10#2)
analysis (QDA)##4##2##(2008-10#3)(2011-2#1)
analysis (SFA)##4##2##(2008-10#4)
analysis (SIA) method##2##3##(2008-10#2)
analysis (SIA)##30##2##(2008-10#30)
analysis (TGA)##6##2##(2008-10#5)(2009-3#1)
analysis - a##2##3##(2008-10#1)(2010-10#1)
analysis -##5##2##(2008-10#4)(2010-10#1)
analysis a##4##2##(2008-10#3)(2008-11#1)
analysis according to##3##3##(2008-11#1)(2010-11#2)
analysis after##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
analysis allowed us to##3##4##(1997-9#1)(2008-10#1)(2008-5#1)
analysis allows##2##2##(1990-11#1)(2008-5#1)
analysis also##8##2##(1993-2#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
analysis and Southern##2##3##(1992-3#1)(2008-9#1)
analysis and a##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
analysis and artificial neural networks##5##5##(2008-10#5)
analysis and by##4##3##(1992-3#1)(1994-2#1)(2008-10#1)(2008-11#1)
analysis and canonical##2##3##(2008-10#2)
analysis and classification##2##3##(2008-10#1)(2012-12#1)
analysis and clustering analysis##2##4##(2008-5#2)
analysis and clustering##3##3##(2008-5#2)(2009-11#1)
analysis and confirmed##2##3##(1993-3#1)(2008-11#1)
analysis and environmental##3##3##(2008-10#3)
analysis and expression##3##3##(1993-2#1)(2008-8#1)(2008-9#1)
analysis and for##3##3##(2008-10#2)(2010-4#1)
analysis and identification of##2##4##(1993-12#1)(2008-10#1)
analysis and in situ hybridization##2##5##(1995-11#1)(2008-6#1)
analysis and in##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
analysis and interpretation##4##3##(1996-6#1)(2008-12#1)(2008-9#1)(2010-11#1)
analysis and its##2##3##(2008-10#1)(2010-5#1)
analysis and logistic regression##2##4##(2008-8#1)(2013-8#1)
analysis and purification##2##3##(2010-7#1)(2013-1#1)
analysis and review##5##3##(1991-12#1)(1992-3#1)(1993-12#2)(1995-2#1)
analysis and sorting of##2##4##(2008-9#2)
analysis and stepwise##2##3##(2008-10#2)
analysis and the##11##3##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
analysis and therefore##2##3##(2008-3#1)(2012-2#1)
analysis and to##3##3##(2008-10#2)(2008-9#1)
analysis and visualization##3##3##(2008-4#2)(2011-7#1)
analysis and##239##2##(1990-12#1)(1990-8#2)(1991-12#4)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#107)(2008-11#12)(2008-12#4)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#16)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#1)(2011-2#3)(2011-3#2)(2011-7#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
analysis approach##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
analysis are consistent with##2##4##(1995-6#1)(2010-12#1)
analysis are described##2##3##(2008-10#1)(2008-11#1)
analysis are discussed##4##3##(1996-6#1)(2008-10#2)(2011-2#1)
analysis are##25##2##(1994-9#1)(1995-6#1)(1996-6#1)(2008-10#16)(2008-11#2)(2008-4#1)(2010-11#1)(2010-12#1)(2011-2#1)
analysis as it##2##3##(2008-10#1)(2011-2#1)
analysis as well as##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
analysis as##13##2##(1995-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)
analysis at a##4##3##(2008-10#2)(2008-9#1)(2012-5#1)
analysis at the##2##3##(2008-10#2)
analysis at##11##2##(1997-2#1)(1997-4#1)(2008-10#6)(2008-9#1)(2011-1#1)(2012-5#1)
analysis based on a##2##4##(2008-10#1)(2008-3#1)
analysis based on the##2##4##(2008-10#2)
analysis based on##21##3##(1994-5#1)(1997-4#1)(2008-10#12)(2008-11#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-6#1)(2012-3#1)(2013-8#1)
analysis based##22##2##(1994-5#1)(1997-4#1)(2008-10#13)(2008-11#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-6#1)(2012-3#1)(2013-8#1)
analysis because##2##2##(2008-10#1)(2008-3#1)
analysis between##6##2##(2008-10#2)(2009-11#1)(2011-2#2)(2013-8#1)
analysis both##2##2##(2008-10#1)(2009-10#1)
analysis by ICP-OES##2##3##(2008-10#2)
analysis by capillary##2##3##(2008-10#2)
analysis by distance indices (SADIE)##3##5##(2008-10#3)
analysis by distance indices##4##4##(2008-10#4)
analysis by flow cytometry##2##4##(2008-11#1)(2008-9#1)
analysis by gas chromatography (GC)##2##5##(2008-10#2)
analysis by gas chromatography##3##4##(2008-10#3)
analysis by graphite furnace atomic absorption spectrometry##2##7##(2008-10#2)
analysis by means of##2##4##(2008-9#2)
analysis by the proposed##2##4##(2008-10#2)
analysis by the##5##3##(1995-8#1)(1996-6#1)(2008-10#3)
analysis by##67##2##(1993-6#1)(1993-9#1)(1995-8#1)(1996-6#1)(1997-1#2)(2008-10#45)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#6)(2010-4#1)(2010-6#1)(2013-8#1)
analysis can be used to##3##5##(1994-3#1)(1997-9#1)(2008-10#1)
analysis can be##10##3##(1994-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2013-1#1)
analysis can##15##2##(1994-3#1)(1995-12#1)(1995-3#1)(1997-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#1)
analysis carried##2##2##(2008-5#1)(2008-9#1)
analysis combined with##2##3##(2008-10#1)(2008-6#1)
analysis combined##3##2##(2008-10#2)(2008-6#1)
analysis confirmed that##8##3##(1992-9#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2011-1#1)
analysis confirmed the##6##3##(2008-10#3)(2009-12#1)(2009-9#1)(2010-7#1)
analysis confirmed##20##2##(1992-6#1)(1992-9#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-11#2)(2009-1#1)(2009-12#2)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
analysis confirms##2##2##(2008-2#1)(2011-2#1)
analysis could be##4##3##(2008-10#4)
analysis could##7##2##(2008-10#6)(2011-2#1)
analysis data##2##2##(2008-10#1)(2013-8#1)
analysis demonstrated a##2##3##(2008-9#1)(2013-1#1)
analysis demonstrated that the##6##4##(1994-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
analysis demonstrated that##12##3##(1994-11#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)
analysis demonstrated the##4##3##(1991-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
analysis demonstrated##22##2##(1991-6#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2011-2#1)(2012-2#1)(2013-1#1)
analysis described in##2##3##(1997-2#1)(2008-10#1)
analysis detected##3##2##(1993-2#1)(1997-7#1)(1997-9#1)
analysis did not##3##3##(2008-10#2)(2012-2#1)
analysis divided##2##2##(2008-10#2)
analysis during##2##2##(1997-3#1)(2012-2#1)
analysis employing##2##2##(2008-10#2)
analysis examines the##2##3##(1994-12#1)(1996-1#1)
analysis followed##2##2##(2008-10#1)(2008-12#1)
analysis following##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
analysis for a##2##3##(1997-3#1)(2008-11#1)
analysis for each##2##3##(2008-10#1)(2012-5#1)
analysis for human##2##3##(1993-2#1)(2010-12#1)
analysis for retrieval of##2##4##(2008-3#2)
analysis for the determination of##8##5##(2008-10#7)(2008-11#1)
analysis for the selection of##2##5##(2008-10#1)(2010-1#1)
analysis for the##17##3##(1991-12#1)(2008-10#12)(2008-11#1)(2008-9#1)(2010-1#1)(2010-11#1)
analysis for##66##2##(1991-12#1)(1993-2#1)(1996-1#1)(1997-3#1)(2008-10#39)(2008-11#5)(2008-3#5)(2008-9#5)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-3#1)(2012-5#1)(2013-1#2)
analysis found that##2##3##(2008-9#2)
analysis found##4##2##(1992-2#1)(2008-9#3)
analysis from##6##2##(1993-3#1)(2008-10#3)(2008-11#2)
analysis further##3##2##(2008-10#2)(2013-8#1)
analysis gave##2##2##(2008-10#2)
analysis grouped the##2##3##(2008-10#2)
analysis has been developed##2##4##(2008-10#2)
analysis has been made##2##4##(1992-6#1)(2008-10#1)
analysis has been used in##2##5##(1991-1#1)(2008-3#1)
analysis has been##10##3##(1991-1#1)(1992-6#1)(2008-10#6)(2008-3#2)
analysis has demonstrated##2##3##(1996-12#1)(2008-7#1)
analysis has identified##2##3##(1992-6#1)(2008-10#1)
analysis has revealed that##2##4##(1994-11#1)(1996-3#1)
analysis has shown that##3##4##(1992-2#1)(1994-11#1)(2008-11#1)
analysis has##23##2##(1991-1#1)(1992-2#1)(1992-6#2)(1994-11#2)(1996-12#1)(1996-3#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-7#1)(2012-2#1)
analysis have been##2##3##(2008-10#1)(2010-4#1)
analysis have##6##2##(1995-6#1)(2008-10#2)(2008-3#1)(2009-7#1)(2010-4#1)
analysis identified a##2##3##(1993-12#1)(2008-10#1)
analysis identified the##2##3##(2008-10#1)(2012-3#1)
analysis identified##15##2##(1990-4#1)(1991-12#2)(1993-12#1)(1997-3#1)(2008-10#8)(2012-3#1)(2013-1#1)
analysis in a##3##3##(2008-10#1)(2010-10#1)(2012-3#1)
analysis in addition##2##3##(2008-10#2)
analysis in an##2##3##(1990-11#1)(2008-10#1)
analysis in aqueous##2##3##(2008-10#2)
analysis in human blood##2##4##(1997-2#1)(2008-10#1)
analysis in human skin##2##4##(2008-10#2)
analysis in human##5##3##(1997-2#1)(2008-10#3)(2008-12#1)
analysis in order to##6##4##(2008-10#6)
analysis in plant##2##3##(2008-10#2)
analysis in the presence of##2##5##(1990-11#1)(2008-4#1)
analysis in the##14##3##(1990-11#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-12#1)
analysis in water##2##3##(2008-10#2)
analysis in which##3##3##(1993-8#1)(2009-11#1)(2009-12#1)
analysis in##108##2##(1990-11#2)(1991-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#65)(2008-11#5)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#6)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-3#1)
analysis including##2##2##(2008-11#1)(2011-2#1)
analysis increased##3##2##(2008-10#2)(2010-10#1)
analysis indicated a##3##3##(1990-6#1)(1993-3#1)(1995-3#1)
analysis indicated that BCMoV##2##4##(2008-10#2)
analysis indicated that a single##2##5##(2008-10#2)
analysis indicated that a##3##4##(2008-10#2)(2008-9#1)
analysis indicated that disease##2##4##(2008-10#2)
analysis indicated that the##14##4##(1990-2#1)(1993-3#1)(1993-8#1)(2008-10#8)(2008-8#1)(2008-9#1)(2010-7#1)
analysis indicated that these##2##4##(2008-10#1)(2010-12#1)
analysis indicated that##40##3##(1990-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1997-3#1)(2008-10#23)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#1)(2010-12#1)(2010-7#1)(2012-3#1)
analysis indicated the##2##3##(2008-10#2)
analysis indicated##51##2##(1990-2#1)(1990-6#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-8#1)(1995-3#1)(1997-3#1)(2008-10#27)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-8#1)
analysis indicates that the##3##4##(1996-2#1)(1997-7#1)(2010-7#1)
analysis indicates that##13##3##(1990-5#1)(1990-8#1)(1993-12#1)(1995-1#1)(1996-2#2)(1997-7#1)(2008-10#2)(2008-6#1)(2008-9#2)(2010-7#1)
analysis indicates the##2##3##(1992-10#1)(2008-10#1)
analysis indicates##16##2##(1990-5#1)(1990-8#1)(1992-10#1)(1993-12#1)(1995-1#1)(1996-2#2)(1997-7#1)(2008-10#4)(2008-6#1)(2008-9#2)(2010-7#1)
analysis instrument##2##2##(2008-10#2)
analysis into##2##2##(2008-1#1)(2013-1#1)
analysis is a##8##3##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
analysis is an important##2##4##(2008-4#1)(2009-8#1)
analysis is an##3##3##(2008-4#1)(2009-8#1)(2010-5#1)
analysis is based on a##2##5##(2008-11#1)(2008-9#1)
analysis is based upon##2##4##(1991-3#1)(1991-5#1)
analysis is based##5##3##(1991-3#1)(1991-5#1)(2008-11#1)(2008-9#1)(2010-11#1)
analysis is compared##2##3##(2008-10#2)
analysis is described##3##3##(2008-10#2)(2009-12#1)
analysis is illustrated by the##2##5##(2008-10#2)
analysis is illustrated by##3##4##(2008-10#3)
analysis is made of the##2##5##(2008-10#1)(2008-3#1)
analysis is made##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
analysis is not possible##2##4##(1997-3#1)(2008-4#1)
analysis is not##4##3##(1997-3#1)(2008-10#2)(2008-4#1)
analysis is performed##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
analysis is presented##3##3##(2008-10#2)(2013-8#1)
analysis is still##2##3##(2008-10#1)(2011-2#1)
analysis is that the##2##4##(2010-12#1)(2011-2#1)
analysis is the##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
analysis is used##2##3##(2008-4#1)(2010-6#1)
analysis is very##2##3##(2008-10#2)
analysis is##88##2##(1990-5#1)(1991-3#1)(1991-5#1)(1992-9#1)(1995-12#1)(1997-3#1)(1997-6#1)(2008-10#38)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
analysis manifold##3##2##(2008-10#3)
analysis may be##3##3##(2008-10#2)(2008-4#1)
analysis may##6##2##(1992-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-11#1)
analysis method for the determination of##3##6##(2008-10#3)
analysis method for##5##3##(2008-10#5)
analysis method is##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
analysis method##17##2##(1997-2#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
analysis methodology##4##2##(2008-10#3)(2008-7#1)
analysis methods for##2##3##(2008-10#2)
analysis methods##11##2##(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)
analysis mode##3##2##(2008-10#3)
analysis of 165##2##3##(2008-10#2)
analysis of 16S##3##3##(2008-10#3)
analysis of 2##2##3##(2008-10#2)
analysis of 20##2##3##(1997-8#1)(2008-10#1)
analysis of 30##2##3##(2008-10#2)
analysis of 41##2##3##(1990-8#1)(2008-10#1)
analysis of AFLP##2##3##(2008-10#2)
analysis of Allium##2##3##(2008-10#2)
analysis of As##2##3##(2008-10#2)
analysis of Cr##2##3##(2008-10#2)
analysis of DNA content and##3##5##(2008-9#3)
analysis of DNA##8##3##(2008-10#2)(2008-4#2)(2008-9#4)
analysis of HLA genes##2##4##(1997-8#2)
analysis of ITS2##2##3##(2008-10#2)
analysis of PCR##2##3##(2008-10#2)
analysis of PCR-amplified##2##3##(2008-10#2)
analysis of RAPD##3##3##(2008-10#3)
analysis of RNA##3##3##(2008-5#1)(2008-9#1)(2011-3#1)
analysis of SRM##2##3##(2008-10#2)
analysis of a certified##2##4##(2008-10#2)
analysis of a human##4##4##(1991-6#1)(1993-12#1)(1993-3#1)(2012-2#1)
analysis of a large number of##2##6##(2008-10#2)
analysis of a new##4##4##(1990-12#1)(1996-6#1)(2008-10#1)(2008-8#1)
analysis of a polymerase chain reaction-amplified region of##2##8##(2008-10#2)
analysis of a putative##2##4##(1995-12#1)(1997-4#1)
analysis of a set of##3##5##(2008-10#2)(2009-10#1)
analysis of a small##2##4##(1991-12#1)(2008-4#1)
analysis of a wide##2##4##(1997-2#1)(2008-10#1)
analysis of a##61##3##(1990-12#1)(1991-12#1)(1991-6#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#2)(1997-4#1)(1997-8#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#6)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)
analysis of adolescent##2##3##(2009-7#1)(2013-1#1)
analysis of adult mouse##2##4##(1995-2#1)(1997-7#1)
analysis of alcohol##2##3##(2008-10#2)
analysis of all##6##3##(1993-11#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
analysis of aluminium##2##3##(2008-10#2)
analysis of amino acids##2##4##(2008-10#1)(2008-11#1)
analysis of amino##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
analysis of ammonium and nitrate##2##5##(2008-10#2)
analysis of an##7##3##(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
analysis of ancient ceramics##2##4##(2008-10#2)
analysis of ancient##3##3##(2008-10#3)
analysis of antifouling agent Irgarol 1051 and its decyclopropylated degradation product in seawater##2##13##(2008-10#2)
analysis of antifouling##3##3##(2008-10#2)(2008-11#1)
analysis of archaeological##2##3##(2008-10#1)(2012-9#1)
analysis of aroma compounds##2##4##(2008-10#2)
analysis of aroma##3##3##(2008-10#3)
analysis of aromatic##3##3##(2008-10#3)
analysis of arsenic##4##3##(2008-10#4)
analysis of bacterial##3##3##(2008-10#2)(2008-7#1)
analysis of binary mixtures##2##4##(2008-10#2)
analysis of binary##3##3##(2008-10#3)
analysis of blood##3##3##(1994-12#1)(2008-9#1)(2013-1#1)
analysis of both##8##3##(1993-12#1)(1996-6#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
analysis of brain##2##3##(2008-7#1)(2010-12#1)
analysis of cDNA clones##6##4##(1995-8#2)(1996-2#2)(1997-2#2)
analysis of cDNA##7##3##(1995-8#2)(1996-2#2)(1997-2#2)(2008-8#1)
analysis of calcium##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
analysis of cancer##3##3##(1994-2#1)(2009-12#1)(2009-6#1)
analysis of carbamazepine##2##3##(2008-10#2)
analysis of cell##3##3##(2008-5#1)(2008-9#2)
analysis of cells##2##3##(2008-9#1)(2012-3#1)
analysis of cellular DNA content##2##5##(2008-9#2)
analysis of cellular##7##3##(2008-10#1)(2008-11#1)(2008-9#3)(2010-12#1)(2012-3#1)
analysis of certified reference material##5##5##(2008-10#5)
analysis of certified reference materials and by##2##7##(2008-10#2)
analysis of certified reference materials and##5##6##(2008-10#5)
analysis of certified reference materials##12##5##(2008-10#12)
analysis of certified reference##18##4##(2008-10#18)
analysis of certified##19##3##(2008-10#19)
analysis of changes in##2##4##(2007-12#1)(2011-2#1)
analysis of chromium##3##3##(2008-10#3)
analysis of clinical and##2##4##(2008-3#1)(2009-3#1)
analysis of clinical##4##3##(2008-1#1)(2008-3#1)(2009-3#1)(2013-8#1)
analysis of clopidogrel bisulphate##2##4##(2008-10#2)
analysis of commercial##2##3##(2008-10#2)
analysis of complex##6##3##(1993-9#1)(1997-2#1)(2008-10#2)(2010-5#1)(2012-3#1)
analysis of covariance showed##2##4##(2008-10#1)(2012-12#1)
analysis of covariance##5##3##(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
analysis of crosses between##2##4##(2008-10#2)
analysis of data collected##2##4##(2008-10#1)(2012-12#1)
analysis of data from##3##4##(2010-11#1)(2011-8#1)(2012-3#1)
analysis of data on##2##4##(1993-9#1)(2008-12#1)
analysis of data was##2##4##(2011-1#1)(2013-1#1)
analysis of data##17##3##(1992-3#1)(1993-9#1)(1995-12#1)(1997-2#1)(2008-10#5)(2008-12#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
analysis of diagnostic##2##3##(1991-6#1)(2012-12#1)
analysis of diazinon##2##3##(2008-10#2)
analysis of different##12##3##(2007-8#1)(2008-10#10)(2012-2#1)
analysis of dioxins in##2##4##(2008-10#2)
analysis of disease##2##3##(2008-10#2)
analysis of diversity##3##3##(2008-10#2)(2011-1#1)
analysis of drug##5##3##(1990-2#1)(1992-3#1)(1993-12#1)(2008-11#2)
analysis of each sample##2##4##(2008-10#2)
analysis of effects##2##3##(2008-10#1)(2012-2#1)
analysis of eight##3##3##(2008-10#3)
analysis of energy##2##3##(2008-10#1)(2008-3#1)
analysis of environmental samples##2##4##(2008-10#1)(2012-12#1)
analysis of environmental##4##3##(2008-10#3)(2012-12#1)
analysis of experimental##2##3##(1994-9#1)(2012-3#1)
analysis of explosives##3##3##(2008-10#3)
analysis of extracts##2##3##(2008-10#2)
analysis of fatty acid methyl esters##2##6##(2008-10#2)
analysis of fluorescence##2##3##(1994-5#1)(2008-10#1)
analysis of four##6##3##(1997-3#1)(2008-10#3)(2008-8#1)(2012-3#1)
analysis of full-length cDNA##2##4##(2008-10#1)(2008-8#1)
analysis of gamma##2##3##(2008-8#1)(2012-3#1)
analysis of gene expression##3##4##(2008-11#1)(2008-2#1)(2010-1#1)
analysis of gene##4##3##(2008-11#1)(2008-2#1)(2010-1#1)(2013-8#1)
analysis of genetic##2##3##(2008-10#2)
analysis of genomic clones##2##4##(1990-8#1)(1991-6#1)
analysis of genomic##3##3##(1990-8#1)(1991-6#1)(2008-10#1)
analysis of glass##8##3##(2008-10#8)
analysis of glucose##2##3##(2008-10#2)
analysis of healthcare##3##3##(2009-8#1)(2010-1#1)(2010-4#1)
analysis of high purity##2##4##(2008-10#2)
analysis of how##2##3##(1997-1#1)(2008-11#1)
analysis of human genomic DNA##2##5##(1993-6#1)(2008-9#1)
analysis of human##13##3##(1993-6#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-9#4)
analysis of in situ hybridization##2##5##(1995-2#1)(2010-1#1)
analysis of in situ##3##4##(1995-2#1)(2008-10#1)(2010-1#1)
analysis of individual##3##3##(2008-10#2)(2008-9#1)
analysis of inorganic arsenic##2##4##(2008-10#2)
analysis of installing dust control devices##2##6##(2009-12#2)
analysis of internal transcribed##2##4##(2008-10#2)
analysis of intracellular##2##3##(2008-4#1)(2008-9#1)
analysis of iron in##3##4##(2008-10#3)
analysis of isolates##4##3##(2008-10#3)(2008-7#1)
analysis of its##6##3##(1991-5#1)(1995-6#1)(2008-11#1)(2008-8#2)(2012-3#1)
analysis of large##2##3##(2008-10#1)(2008-4#1)
analysis of lead##2##3##(2008-10#2)
analysis of long##2##3##(1996-6#1)(2008-10#1)
analysis of lymphoid##2##3##(2008-10#1)(2008-5#1)
analysis of medical##3##3##(1993-3#1)(1994-6#1)(2009-6#1)
analysis of membrane##2##3##(1993-8#1)(2008-9#1)
analysis of mercury in Traditional Chinese Medicines##2##7##(2008-10#2)
analysis of microcystins##2##3##(2008-10#2)
analysis of mitochondrial DNA##2##4##(2008-4#1)(2013-8#1)
analysis of mitochondrial##3##3##(2008-4#1)(2008-9#1)(2013-8#1)
analysis of molecular variance indicated that##2##6##(2008-10#2)
analysis of molecular variance##8##4##(2008-10#8)
analysis of molecular##12##3##(2008-10#10)(2008-3#1)(2009-3#1)
analysis of morphine##2##3##(2008-10#2)
analysis of most##2##3##(2008-10#1)(2008-3#1)
analysis of multicomponent polycyclic aromatic##2##5##(2008-10#2)
analysis of multicomponent##3##3##(2008-10#3)
analysis of nevirapine##2##3##(2008-10#2)
analysis of nitrite##4##3##(2008-10#4)
analysis of nuclear DNA content##2##5##(1994-3#1)(2008-11#1)
analysis of nuclear##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
analysis of nucleic acid##2##4##(2008-10#1)(2008-4#1)
analysis of nucleic##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
analysis of nursing##2##3##(1997-2#1)(2008-12#1)
analysis of one##2##3##(2008-10#1)(2008-8#1)
analysis of ordinal data##3##4##(2008-10#3)
analysis of organic vapours in air##2##6##(2008-10#2)
analysis of organic##5##3##(2008-10#4)(2008-11#1)
analysis of organophosphorus pesticide residues##3##5##(2008-10#3)
analysis of organophosphorus##6##3##(2008-10#6)
analysis of other##3##3##(2008-10#3)
analysis of patients with##3##4##(2008-10#1)(2010-5#1)(2011-2#1)
analysis of patients##7##3##(1994-12#1)(2008-10#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
analysis of peptides##2##3##(2008-10#1)(2008-4#1)
analysis of peripheral blood##4##4##(2008-9#3)(2013-1#1)
analysis of pesticides##5##3##(2008-10#5)
analysis of pharmaceutical preparations##2##4##(2008-10#2)
analysis of pharmaceutical##5##3##(2008-10#5)
analysis of phenolic compounds##2##4##(2008-10#2)
analysis of phosphate in##2##4##(2008-10#2)
analysis of phosphate##3##3##(2008-10#3)
analysis of phosphorus##2##3##(2008-10#1)(2008-12#1)
analysis of plant##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
analysis of plants##2##3##(2008-10#2)
analysis of polybrominated diphenyl ethers##2##5##(2008-10#2)
analysis of polycyclic aromatic hydrocarbons (PAHs)##5##6##(2008-10#5)
analysis of polycyclic aromatic hydrocarbons by##2##6##(2008-10#2)
analysis of polycyclic aromatic hydrocarbons in##5##6##(2008-10#5)
analysis of polycyclic aromatic hydrocarbons##13##5##(2008-10#13)
analysis of population##2##3##(2008-10#1)(2008-12#1)
analysis of potassium##2##3##(2008-10#2)
analysis of protein##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
analysis of proteins##7##3##(1993-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#2)
analysis of protoberberine##2##3##(2008-10#2)
analysis of radiograms obtained from##2##5##(2007-8#2)
analysis of raw##2##3##(2008-10#1)(2010-4#1)
analysis of real samples##4##4##(2008-10#4)
analysis of real##8##3##(2008-10#7)(2008-2#1)
analysis of reference##2##3##(2008-10#2)
analysis of samples##3##3##(2008-10#2)(2008-4#1)
analysis of secondary data##2##4##(2012-12#1)(2013-1#1)
analysis of secondary##3##3##(1990-5#1)(2012-12#1)(2013-1#1)
analysis of several##7##3##(1995-6#1)(2008-10#3)(2008-4#1)(2009-10#1)(2009-6#1)
analysis of sibutramine and citalopram##2##5##(2012-3#2)
analysis of single##2##3##(2008-10#1)(2008-9#1)
analysis of small##4##3##(2008-10#3)(2008-4#1)
analysis of soils##2##3##(2008-10#2)
analysis of solid##4##3##(2008-10#4)
analysis of soluble##3##3##(2008-10#3)
analysis of some##16##3##(1994-11#1)(2008-10#14)(2008-7#1)
analysis of specific##3##3##(2008-10#2)(2008-4#1)
analysis of spiked samples##3##4##(2008-10#3)
analysis of spiked##5##3##(2008-10#5)
analysis of standard reference materials##3##5##(2008-10#3)
analysis of standard##4##3##(2008-10#3)(2012-2#1)
analysis of sterile##2##3##(2012-2#2)
analysis of such##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
analysis of synthetic##8##3##(2008-10#7)(2008-4#1)
analysis of terpenes##2##3##(2008-10#2)
analysis of the CP##3##4##(2008-10#3)
analysis of the DPH2##3##4##(1993-9#3)
analysis of the ITS regions##2##5##(2008-10#2)
analysis of the ITS##4##4##(2008-10#3)(2010-3#1)
analysis of the PCR products##2##5##(2008-10#2)
analysis of the PCR##3##4##(2008-10#3)
analysis of the active##2##4##(2008-10#2)
analysis of the binding##2##4##(1996-12#1)(2008-10#1)
analysis of the clinical##3##4##(1993-11#1)(1993-12#1)(1993-5#1)
analysis of the coat protein##2##5##(2008-10#2)
analysis of the combined##2##4##(1992-9#1)(2008-10#1)
analysis of the complete##3##4##(2008-10#3)
analysis of the contribution of##2##5##(2008-11#1)(2008-12#1)
analysis of the data##6##4##(1995-8#1)(2008-10#3)(2008-11#1)(2010-10#1)
analysis of the deduced amino acid##2##6##(1993-9#1)(2008-10#1)
analysis of the distribution of##2##5##(2008-10#2)
analysis of the effect of##4##5##(1991-6#1)(2008-3#2)(2013-1#1)
analysis of the efficiency##2##4##(2008-3#1)(2013-1#1)
analysis of the entire##2##4##(1997-6#1)(2008-10#1)
analysis of the experimental##2##4##(2008-10#1)(2008-5#1)
analysis of the expression##2##4##(1996-8#1)(2008-10#1)
analysis of the focus groups##2##5##(2012-3#2)
analysis of the following##2##4##(2008-10#1)(2008-12#1)
analysis of the genetic structure of##2##6##(2008-10#2)
analysis of the genome of the##4##6##(1995-8#1)(1996-6#2)(1997-3#1)
analysis of the genome of##5##5##(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)
analysis of the interaction of##2##5##(2008-10#2)
analysis of the interaction##3##4##(2008-10#3)
analysis of the internal transcribed spacer (ITS) region of##2##9##(2008-10#2)
analysis of the internal transcribed spacer (ITS)##3##7##(2008-10#3)
analysis of the internal transcribed spacer region##3##7##(2008-10#3)
analysis of the internal transcribed spacer##7##6##(2008-10#7)
analysis of the internal##8##4##(1992-3#1)(2008-10#7)
analysis of the interview transcripts##2##5##(1993-3#1)(2009-5#1)
analysis of the isolated##2##4##(1990-2#1)(2009-10#1)
analysis of the literature##2##4##(1992-9#1)(2008-7#1)
analysis of the population##2##4##(2008-10#2)
analysis of the presence of the##2##6##(2008-11#1)(2010-3#1)
analysis of the protein##2##4##(1994-11#1)(1997-4#1)
analysis of the proteome##2##4##(2008-4#1)(2009-6#1)
analysis of the quenching##2##4##(2008-10#2)
analysis of the rep-PCR##2##4##(2008-10#2)
analysis of the response##2##4##(2008-10#1)(2008-7#1)
analysis of the role of##2##5##(1997-5#1)(2013-8#1)
analysis of the samples##2##4##(2008-10#2)
analysis of the selected##2##4##(2008-10#1)(2012-2#1)
analysis of the spatial##4##4##(2008-10#2)(2008-9#2)
analysis of the surface##3##4##(2008-10#2)(2008-5#1)
analysis of the system##2##4##(2008-10#1)(2008-9#1)
analysis of the three##3##4##(1993-12#1)(1997-6#1)(2008-10#1)
analysis of the visual##2##4##(1995-5#1)(1995-8#1)
analysis of the##427##3##(1990-11#2)(1990-2#2)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#4)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#5)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#164)(2008-11#25)(2008-12#11)(2008-2#3)(2008-3#15)(2008-4#2)(2008-5#10)(2008-7#10)(2008-8#7)(2008-9#14)(2009-10#6)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#13)(2012-12#5)(2012-2#4)(2012-3#7)(2013-1#11)(2013-8#8)
analysis of their##11##3##(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#3)(2009-11#1)
analysis of these compounds##3##4##(2008-10#3)
analysis of these genes##2##4##(2008-10#1)(2008-11#1)
analysis of these sequences##2##4##(1993-6#1)(2008-10#1)
analysis of these##31##3##(1990-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-9#1)(1996-2#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-6#1)
analysis of this##17##3##(1993-2#1)(1997-9#1)(2008-10#10)(2008-11#1)(2009-10#1)(2011-3#2)(2012-3#1)
analysis of three##9##3##(1995-12#1)(2008-10#6)(2008-8#1)(2013-8#1)
analysis of total##7##3##(2008-10#7)
analysis of trace elements in##2##5##(2008-10#2)
analysis of trace elements##3##4##(2008-10#2)(2010-11#1)
analysis of trace heavy metals##2##5##(2008-10#2)
analysis of trace metals in estuarine waters##3##7##(2008-10#3)
analysis of trace metals in##5##5##(2008-10#5)
analysis of trace##18##3##(2008-10#17)(2010-11#1)
analysis of two standard reference materials##2##6##(2008-10#2)
analysis of two##16##3##(1993-2#1)(2008-10#10)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
analysis of ultra-trace##2##3##(2008-10#2)
analysis of uranium##2##3##(2008-10#2)
analysis of variance (ANOVA) and paired##2##6##(2009-2#1)(2012-2#1)
analysis of variance (ANOVA) and##4##5##(1995-2#1)(2008-10#1)(2009-2#1)(2012-2#1)
analysis of variance (ANOVA)##9##4##(1995-2#1)(2008-10#5)(2009-2#1)(2012-2#1)(2013-1#1)
analysis of variance showed that##2##5##(1993-2#1)(2013-1#1)
analysis of variance##26##3##(1991-2#1)(1992-2#1)(1993-2#1)(1995-2#1)(2008-10#13)(2008-7#1)(2009-2#1)(2009-7#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
analysis of various##4##3##(2008-10#3)(2008-7#1)
analysis of very##2##3##(2008-10#2)
analysis of viral##3##3##(2008-10#1)(2008-9#2)
analysis of volatile##3##3##(2008-10#3)
analysis of water and##2##4##(2008-10#2)
analysis of water samples##3##4##(2008-10#3)
analysis of water##5##3##(2008-10#5)
analysis of zinc##3##3##(2008-10#3)
analysis of##2029##2##(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#8)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#5)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#6)(1992-3#5)(1992-6#2)(1992-8#3)(1992-9#6)(1993-1#2)(1993-11#2)(1993-12#11)(1993-2#10)(1993-3#6)(1993-5#3)(1993-6#7)(1993-8#5)(1993-9#8)(1994-1#3)(1994-11#6)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#6)(1994-8#4)(1994-9#2)(1995-1#4)(1995-12#10)(1995-2#7)(1995-5#5)(1995-6#8)(1995-8#8)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#9)(1996-3#8)(1996-5#2)(1996-6#8)(1996-8#1)(1997-1#1)(1997-2#13)(1997-3#8)(1997-4#2)(1997-5#2)(1997-6#7)(1997-7#3)(1997-8#11)(1997-9#2)(2007-11#1)(2007-12#9)(2007-8#4)(2008-1#8)(2008-10#1059)(2008-11#83)(2008-12#20)(2008-2#14)(2008-3#35)(2008-4#31)(2008-5#22)(2008-6#4)(2008-7#28)(2008-8#41)(2008-9#81)(2009-1#1)(2009-10#15)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#4)(2009-5#4)(2009-6#5)(2009-7#6)(2009-8#8)(2009-9#1)(2010-1#9)(2010-10#3)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#6)(2010-6#6)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#5)(2011-2#39)(2011-3#4)(2011-5#1)(2011-8#1)(2012-12#16)(2012-2#25)(2012-3#34)(2012-9#1)(2013-1#38)(2013-8#19)
analysis offers##3##2##(2008-10#2)(2010-9#1)
analysis often##2##2##(2008-10#1)(2009-8#1)
analysis on a##2##3##(2008-4#1)(2011-2#1)
analysis on the##3##3##(1997-6#1)(2008-11#1)(2011-2#1)
analysis on##26##2##(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
analysis or##7##2##(1991-12#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-10#1)(2013-8#1)
analysis performed for the##2##4##(2008-10#2)
analysis performed##5##2##(2008-10#5)
analysis placed##4##2##(1995-9#1)(2008-10#3)
analysis predicts that the##2##4##(1997-8#1)(2010-10#1)
analysis predicts that##4##3##(1993-6#2)(1997-8#1)(2010-10#1)
analysis presented in this##3##4##(1993-3#1)(2013-1#2)
analysis procedure##7##2##(2008-10#5)(2008-9#2)
analysis procedures##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
analysis process##2##2##(2008-10#2)
analysis produced##3##2##(2008-10#3)
analysis proved##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
analysis proves that##2##3##(2008-10#1)(2008-9#1)
analysis provides##5##2##(1992-1#1)(1992-3#1)(2008-10#3)
analysis ranged from 0##2##4##(2008-10#2)
analysis rather##2##2##(2008-10#2)
analysis required##2##2##(2008-10#2)
analysis requires##2##2##(2008-10#1)(2008-12#1)
analysis resulted in##3##3##(2008-10#3)
analysis results##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
analysis revealed a single##2##4##(1995-2#1)(2009-9#1)
analysis revealed a##11##3##(1992-8#2)(1995-2#1)(1996-12#1)(2008-10#2)(2009-9#1)(2010-10#2)(2010-6#1)(2012-2#1)
analysis revealed an##5##3##(1993-3#1)(1995-2#1)(1997-7#1)(2008-10#1)(2010-1#1)
analysis revealed no##2##3##(1993-11#1)(2008-10#1)
analysis revealed that all##2##4##(1992-4#1)(2008-10#1)
analysis revealed that one##2##4##(1990-2#1)(2008-8#1)
analysis revealed that the gene##2##5##(1995-6#1)(2013-1#1)
analysis revealed that the##18##4##(1992-1#1)(1992-6#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-6#1)(2009-10#1)(2010-12#1)(2013-1#1)
analysis revealed that##60##3##(1990-2#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-2#1)(1997-7#2)(1997-8#1)(2008-10#16)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
analysis revealed the presence of a##2##6##(2008-8#1)(2011-2#1)
analysis revealed the presence of##5##5##(1994-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
analysis revealed the##7##3##(1994-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
analysis revealed##108##2##(1990-2#1)(1991-12#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-6#2)(1997-2#1)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#33)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
analysis reveals a##2##3##(1990-8#1)(2009-10#1)
analysis reveals that the##2##4##(2008-10#1)(2010-10#1)
analysis reveals that##7##3##(1990-8#1)(2008-10#3)(2009-6#1)(2010-10#1)(2012-12#1)
analysis reveals the presence of##2##5##(1995-12#1)(2008-11#1)
analysis reveals the##3##3##(1995-12#2)(2008-11#1)
analysis reveals##18##2##(1990-8#2)(1993-3#1)(1995-12#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
analysis scheme##2##2##(2008-3#1)(2009-10#1)
analysis separated##3##2##(2008-10#3)
analysis should##3##2##(2006-6#1)(2008-10#1)(2008-3#1)
analysis show that##2##3##(1997-1#1)(2008-12#1)
analysis show##4##2##(1997-1#1)(2008-10#2)(2008-12#1)
analysis showed a significant##3##4##(2008-10#1)(2010-1#1)(2010-4#1)
analysis showed a##11##3##(1992-12#1)(1993-6#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-1#2)(2010-12#1)(2010-4#1)
analysis showed an##2##3##(2008-8#1)(2012-2#1)
analysis showed low##2##3##(2011-1#1)(2013-8#1)
analysis showed no##4##3##(1990-11#1)(1993-2#1)(2008-11#1)(2012-3#1)
analysis showed significant##4##3##(2008-10#3)(2008-9#1)
analysis showed that after##2##4##(2008-9#1)(2009-3#1)
analysis showed that both##3##4##(2008-10#1)(2008-11#1)(2009-3#1)
analysis showed that the##32##4##(1990-11#1)(1990-5#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
analysis showed that this##2##4##(2008-11#1)(2008-8#1)
analysis showed that##89##3##(1990-11#1)(1990-5#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#3)(2008-1#1)(2008-10#25)(2008-11#9)(2008-12#3)(2008-7#2)(2008-8#11)(2008-9#6)(2009-10#1)(2009-3#2)(2009-6#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
analysis showed the presence of##3##5##(2008-10#2)(2008-5#1)
analysis showed the##5##3##(1995-8#1)(2008-10#3)(2008-5#1)
analysis showed##134##2##(1990-11#2)(1990-5#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-6#3)(1995-8#2)(1996-12#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#4)(2008-1#1)(2008-10#34)(2008-11#13)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#12)(2008-9#7)(2009-10#1)(2009-3#2)(2009-6#2)(2009-7#1)(2010-1#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
analysis shows a##2##3##(1995-3#1)(2011-2#1)
analysis shows four##2##3##(1991-6#1)(2008-10#1)
analysis shows that the##4##4##(1993-12#1)(1995-6#1)(2008-11#1)(2008-3#1)
analysis shows that##16##3##(1993-12#2)(1994-1#1)(1995-1#1)(1995-6#2)(1997-9#1)(2008-11#2)(2008-3#2)(2008-8#3)(2008-9#1)(2013-8#1)
analysis shows##24##2##(1991-6#1)(1993-12#2)(1994-1#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#2)(1997-9#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-8#4)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
analysis software##5##2##(1995-12#1)(2008-10#2)(2008-4#1)(2013-1#1)
analysis study##2##2##(2008-10#1)(2008-7#1)
analysis such as##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
analysis suggest that##2##3##(1993-2#1)(2008-9#1)
analysis suggest##3##2##(1993-2#1)(2008-10#1)(2008-9#1)
analysis suggested that the##3##4##(1993-8#1)(2008-10#1)(2008-11#1)
analysis suggested that this##2##4##(1993-6#1)(1997-2#1)
analysis suggested that##12##3##(1991-3#1)(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-9#2)
analysis suggested the##4##3##(1993-2#1)(2008-11#2)(2011-2#1)
analysis suggested##17##2##(1991-3#1)(1993-2#1)(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-9#2)(2011-2#1)
analysis suggests that the##4##4##(2008-8#3)(2011-2#1)
analysis suggests that##10##3##(1992-3#1)(1993-12#1)(1994-5#1)(1997-7#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-2#1)
analysis suggests the##2##3##(1993-8#1)(2010-5#1)
analysis suggests##12##2##(1992-3#1)(1993-12#1)(1993-8#1)(1994-5#1)(1997-7#1)(2008-11#1)(2008-8#3)(2008-9#1)(2010-5#1)(2011-2#1)
analysis supports##2##2##(2008-10#1)(2008-9#1)
analysis system (ByT-FAS)##4##3##(2008-10#4)
analysis system and##2##3##(2008-10#1)(2013-8#1)
analysis system employing##2##3##(2008-10#2)
analysis system for the##2##4##(2008-10#2)
analysis system for##8##3##(2008-10#7)(2012-3#1)
analysis system was##2##3##(2008-10#2)
analysis system with##5##3##(2008-10#5)
analysis system##45##2##(2008-10#38)(2008-11#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-8#1)
analysis systems##12##2##(2008-10#11)(2010-11#1)
analysis takes about##2##3##(2008-10#2)
analysis taking into account##2##4##(2008-10#1)(2008-7#1)
analysis taking##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
analysis technique was##2##3##(1996-1#1)(2008-10#1)
analysis technique##10##2##(1996-1#1)(2008-10#8)(2008-3#1)
analysis techniques are##3##3##(2008-10#2)(2008-3#1)
analysis techniques for##2##3##(2008-10#2)
analysis techniques such##2##3##(2008-10#1)(2008-5#1)
analysis techniques##16##2##(2008-10#13)(2008-3#1)(2008-5#1)(2009-8#1)
analysis that is##3##3##(1992-8#1)(1995-5#1)(2008-4#1)
analysis that##11##2##(1992-8#1)(1994-11#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
analysis the##6##2##(1991-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-9#1)
analysis through##2##2##(2008-10#1)(2008-4#1)
analysis time and the##2##4##(2008-10#2)
analysis time and##6##3##(2008-10#6)
analysis time for##3##3##(2008-10#3)
analysis time is##3##3##(2008-10#3)
analysis time of##3##3##(2008-10#3)
analysis time than##3##3##(2008-10#3)
analysis time was less than##2##5##(2008-10#2)
analysis time was##8##3##(2008-10#8)
analysis time##40##2##(2008-10#39)(2008-11#1)
analysis times##6##2##(2008-10#6)
analysis to determine the##2##4##(2008-10#1)(2008-2#1)
analysis to determine##4##3##(2008-10#2)(2008-2#1)(2013-1#1)
analysis to identify##3##3##(2008-6#1)(2008-9#1)(2012-3#1)
analysis to the##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
analysis to##49##2##(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
analysis tool##2##2##(2008-7#1)(2010-12#1)
analysis tools that are##2##4##(2009-10#1)(2011-3#1)
analysis tools that##3##3##(2009-10#1)(2011-3#1)(2013-1#1)
analysis tools##11##2##(1997-3#1)(2008-10#1)(2008-2#1)(2009-10#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
analysis used##3##2##(1997-3#1)(2008-10#1)(2009-5#1)
analysis using a##11##3##(1990-8#1)(2008-10#7)(2009-3#1)(2010-1#1)(2010-4#1)
analysis using an antibody##2##4##(2008-10#1)(2009-8#1)
analysis using an##6##3##(2008-10#1)(2008-11#2)(2009-8#1)(2013-1#2)
analysis using specific##2##3##(1995-11#1)(1995-12#1)
analysis using the##11##3##(1994-11#1)(2008-10#8)(2008-4#1)(2008-9#1)
analysis using##78##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#2)(1993-12#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-10#39)(2008-11#3)(2008-4#6)(2008-9#6)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#2)
analysis varied##2##2##(2008-10#2)
analysis via##2##2##(2008-10#1)(2013-8#1)
analysis was achieved by##2##4##(2008-10#2)
analysis was achieved##3##3##(2008-10#3)
analysis was applied to the data##2##6##(2008-10#1)(2011-2#1)
analysis was applied to the##3##5##(2008-10#2)(2011-2#1)
analysis was applied to##7##4##(2008-10#5)(2011-2#1)(2013-1#1)
analysis was applied##8##3##(2008-10#6)(2011-2#1)(2013-1#1)
analysis was based on##2##4##(2008-10#1)(2013-8#1)
analysis was carried out on##2##5##(2008-6#1)(2011-2#1)
analysis was carried out##9##4##(1993-11#1)(1995-12#1)(2008-10#3)(2008-6#1)(2009-3#1)(2011-2#2)
analysis was carried##10##3##(1993-11#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-6#1)(2009-3#1)(2011-2#2)
analysis was completed within##2##4##(2008-10#2)
analysis was completed##4##3##(2008-10#4)
analysis was conducted on##2##4##(2008-10#1)(2012-3#1)
analysis was conducted to##2##4##(2008-10#1)(2008-6#1)
analysis was conducted##8##3##(1991-1#1)(2008-10#3)(2008-6#1)(2012-3#2)(2013-1#1)
analysis was consistent with##2##4##(1994-5#1)(2008-8#1)
analysis was done by##2##4##(2008-10#2)
analysis was done to##2##4##(2011-2#1)(2013-8#1)
analysis was done##6##3##(1997-8#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
analysis was employed to##2##4##(2008-10#2)
analysis was employed##3##3##(2008-10#2)(2009-7#1)
analysis was extended to##2##4##(2008-10#1)(2010-12#1)
analysis was made for##2##4##(2008-10#1)(2011-2#1)
analysis was made##5##3##(1991-1#1)(1994-1#1)(2008-10#1)(2009-8#1)(2011-2#1)
analysis was performed after 15##2##5##(2008-11#1)(2011-2#1)
analysis was performed after##3##4##(1990-8#1)(2008-11#1)(2011-2#1)
analysis was performed and##2##4##(2008-11#2)
analysis was performed by##5##4##(2008-10#3)(2010-12#1)(2011-2#1)
analysis was performed in##5##4##(1996-12#1)(2008-10#2)(2008-12#1)(2013-1#1)
analysis was performed to determine the##4##6##(2008-10#2)(2008-7#1)(2011-2#1)
analysis was performed to##9##4##(2008-10#5)(2008-7#1)(2011-2#2)(2013-1#1)
analysis was performed using the##3##5##(2008-10#1)(2008-7#1)(2012-12#1)
analysis was performed using##10##4##(1995-6#1)(2008-10#2)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
analysis was performed##40##3##(1990-8#1)(1995-6#1)(1996-12#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-7#3)(2008-9#1)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#3)
analysis was restricted to##2##4##(1993-12#1)(2008-11#1)
analysis was tested##2##3##(2008-10#2)
analysis was then##2##3##(2008-10#1)(2011-2#1)
analysis was to##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
analysis was undertaken to##2##4##(1995-11#1)(2008-10#1)
analysis was undertaken##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
analysis was used to determine##5##5##(1993-8#1)(1995-6#1)(2008-10#3)
analysis was used to evaluate the##2##6##(2012-3#1)(2013-1#1)
analysis was used to identify##5##5##(2008-10#3)(2010-6#1)(2012-3#1)
analysis was used to measure##2##5##(2008-10#1)(2008-11#1)
analysis was used to quantify##2##5##(2010-1#1)(2010-12#1)
analysis was used to##22##4##(1993-8#1)(1995-6#1)(2008-10#10)(2008-11#2)(2008-12#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
analysis was used##25##3##(1993-8#1)(1995-6#1)(2008-10#12)(2008-11#2)(2008-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
analysis was##161##2##(1990-8#1)(1991-1#2)(1991-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-12#1)(1997-8#2)(2007-8#1)(2008-10#80)(2008-11#9)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-6#1)(2011-2#15)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#2)
analysis we have##2##3##(1995-9#1)(2008-3#1)
analysis we##9##2##(1991-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
analysis were applied to##2##4##(2008-10#2)
analysis were applied##3##3##(2008-10#3)
analysis were done##2##3##(2008-12#1)(2008-8#1)
analysis were performed##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
analysis were used to identify##2##5##(2010-2#1)(2011-2#1)
analysis were used to##5##4##(2008-10#2)(2009-4#1)(2010-2#1)(2011-2#1)
analysis were used##7##3##(2008-10#2)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-3#1)
analysis were##37##2##(1991-8#1)(2008-10#20)(2008-11#7)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
analysis when compared##2##3##(1997-7#1)(2008-10#1)
analysis when##3##2##(1997-7#1)(2008-10#1)(2010-4#1)
analysis which##3##2##(2008-3#1)(2008-4#1)(2008-9#1)
analysis while##2##2##(2008-10#1)(2008-5#1)
analysis will##3##2##(1991-12#1)(2008-10#1)(2009-10#1)
analysis with DNA##2##3##(2008-10#2)
analysis with a##6##3##(1990-5#1)(1993-8#1)(2008-10#4)
analysis with simultaneous live/dead discrimination using##2##6##(2008-4#2)
analysis with the##9##3##(1993-3#1)(1995-6#1)(2008-10#6)(2009-10#1)
analysis with##68##2##(1990-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#44)(2008-11#2)(2008-3#1)(2008-4#3)(2009-10#2)(2010-1#1)(2010-7#1)(2011-2#1)
analysis without any##2##3##(2008-10#2)
analysis without##3##2##(2008-10#3)
analysis yielded##2##2##(2008-12#1)(2010-9#1)
analysis##5479##1##(1990-11#8)(1990-12#7)(1990-2#8)(1990-3#2)(1990-4#2)(1990-5#10)(1990-6#4)(1990-8#13)(1990-9#2)(1991-1#4)(1991-12#25)(1991-2#9)(1991-3#7)(1991-5#4)(1991-6#9)(1991-8#6)(1991-9#2)(1992-1#6)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#12)(1992-3#14)(1992-4#1)(1992-6#10)(1992-8#6)(1992-9#14)(1993-1#4)(1993-11#5)(1993-12#35)(1993-2#23)(1993-3#18)(1993-5#3)(1993-6#15)(1993-8#14)(1993-9#12)(1994-1#6)(1994-11#16)(1994-12#17)(1994-2#5)(1994-3#8)(1994-5#11)(1994-6#8)(1994-8#8)(1994-9#7)(1995-1#7)(1995-11#5)(1995-12#32)(1995-2#15)(1995-3#6)(1995-5#10)(1995-6#23)(1995-8#16)(1995-9#4)(1996-1#7)(1996-11#4)(1996-12#17)(1996-2#18)(1996-3#13)(1996-5#4)(1996-6#17)(1996-8#2)(1997-1#7)(1997-2#31)(1997-3#25)(1997-4#6)(1997-5#2)(1997-6#13)(1997-7#15)(1997-8#27)(1997-9#9)(2006-6#3)(2007-11#1)(2007-12#16)(2007-8#6)(2008-1#12)(2008-10#2824)(2008-11#248)(2008-12#63)(2008-2#33)(2008-3#84)(2008-4#88)(2008-5#60)(2008-6#14)(2008-7#67)(2008-8#112)(2008-9#218)(2009-1#3)(2009-10#42)(2009-11#12)(2009-12#16)(2009-2#1)(2009-3#16)(2009-4#4)(2009-5#9)(2009-6#13)(2009-7#16)(2009-8#29)(2009-9#6)(2010-1#19)(2010-10#25)(2010-11#20)(2010-12#31)(2010-2#3)(2010-3#5)(2010-4#13)(2010-5#15)(2010-6#15)(2010-7#20)(2010-8#14)(2010-9#11)(2011-1#17)(2011-10#1)(2011-2#135)(2011-3#9)(2011-5#1)(2011-7#3)(2011-8#1)(2012-12#25)(2012-2#71)(2012-3#88)(2012-5#3)(2012-7#1)(2012-9#1)(2013-1#106)(2013-7#1)(2013-8#63)
analysis) have been##2##3##(2008-10#1)(2009-8#1)
analysis) of##2##2##(2008-10#1)(2012-12#1)
analysis)##19##1##(1992-2#4)(2008-10#11)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
analysis-based##2##1##(2008-3#1)(2008-5#1)
analysis-hydride generation-gas phase derivative molecular##2##5##(2008-10#2)
analysis-hydride##3##1##(2008-10#3)
analysis-mass spectrometry##3##2##(2008-10#3)
analysis]##7##1##(1990-8#1)(1993-11#1)(1994-9#1)(1996-2#1)(1996-6#1)(2012-3#1)(2013-8#1)
analyst##5##1##(2008-10#3)(2008-11#2)
analysts##5##1##(1991-2#1)(1992-11#1)(1996-2#1)(2008-10#2)
analyte absorbance##2##2##(2008-10#2)
analyte and##14##2##(2008-10#13)(2010-7#1)
analyte at##5##2##(2008-10#5)
analyte concentration and##2##3##(2008-10#2)
analyte concentration in the##3##4##(2008-10#3)
analyte concentration was##2##3##(2008-10#2)
analyte concentration##17##2##(2008-10#16)(2008-7#1)
analyte concentrations##8##2##(1997-2#1)(2008-10#6)(2008-7#1)
analyte determination##2##2##(2008-10#2)
analyte elements in##2##3##(2008-10#2)
analyte elements##8##2##(2008-10#8)
analyte extraction##4##2##(2008-10#4)
analyte from##6##2##(2008-10#5)(2008-7#1)
analyte in a##3##3##(2008-10#3)
analyte in the presence##2##4##(2008-10#2)
analyte in the##11##3##(2008-10#10)(2009-8#1)
analyte in##16##2##(2008-10#15)(2009-8#1)
analyte ions in##3##3##(2008-10#3)
analyte ions##7##2##(2008-10#7)
analyte is determined##2##3##(2008-10#2)
analyte is##13##2##(2008-10#12)(2008-4#1)
analyte loss##2##2##(2008-10#2)
analyte mass##3##2##(2008-10#3)
analyte on the##3##3##(2008-10#3)
analyte preconcentration##3##2##(2008-10#3)
analyte pulse width##3##3##(2008-10#3)
analyte pulse##6##2##(2008-10#6)
analyte recoveries##2##2##(2008-10#2)
analyte sample##2##2##(2008-10#2)
analyte signal (NAS)-based##2##3##(2008-10#2)
analyte signal##10##2##(2008-10#10)
analyte signal-based##2##2##(2008-10#2)
analyte solution was##2##3##(2008-10#2)
analyte solution##10##2##(2008-10#10)
analyte species##2##2##(2008-10#1)(2010-7#1)
analyte to be##2##3##(2008-10#2)
analyte to##6##2##(2008-10#6)
analyte transfer##2##2##(2008-10#2)
analyte was##11##2##(2008-10#11)
analyte were##2##2##(2008-10#2)
analyte with a##2##3##(2008-10#1)(2008-3#1)
analyte with##7##2##(2008-10#5)(2008-3#1)(2009-7#1)
analyte##289##1##(1997-2#3)(2008-10#267)(2008-3#1)(2008-4#3)(2008-7#7)(2009-3#1)(2009-7#1)(2009-8#2)(2010-7#2)(2010-9#1)(2012-12#1)
analytes and the##4##3##(2008-10#4)
analytes and##11##2##(2008-10#11)
analytes are in the range of 0##2##7##(2008-10#2)
analytes are in the range of##3##6##(2008-10#3)
analytes are quantitatively##2##3##(2008-10#2)
analytes are##19##2##(1992-11#1)(2008-10#18)
analytes as##3##2##(2008-10#3)
analytes by##3##2##(2008-10#3)
analytes can be##3##3##(2008-10#3)
analytes concentration in##2##3##(2008-10#2)
analytes could be well separated within 12 min in a 40 cm length capillary at the separation voltage of 12 kV in a 100 mmol l(-1) borate buffer (pH##2##29##(2008-10#2)
analytes could be##4##3##(2008-10#4)
analytes during##2##2##(1993-2#1)(2008-10#1)
analytes from##6##2##(1997-2#1)(2008-10#5)
analytes have been investigated##2##4##(2008-10#2)
analytes have been##5##3##(2008-10#5)
analytes in a##2##3##(2008-10#2)
analytes in both##2##3##(2008-10#2)
analytes in complex##2##3##(2008-10#2)
analytes in real##2##3##(2008-10#2)
analytes in the##8##3##(2008-10#8)
analytes in##32##2##(1997-2#1)(2008-10#29)(2008-4#2)
analytes investigated##2##2##(2008-10#2)
analytes is##4##2##(2008-10#4)
analytes of interest##5##3##(2008-10#5)
analytes of##6##2##(2008-10#6)
analytes on the##3##3##(2008-10#3)
analytes on##7##2##(2008-10#7)
analytes over##2##2##(2008-10#2)
analytes retained on the##2##4##(2008-10#2)
analytes retained on##3##3##(2008-10#3)
analytes retained##4##2##(2008-10#4)
analytes that##2##2##(2008-10#2)
analytes using##2##2##(2008-10#2)
analytes was##7##2##(2008-10#7)
analytes were also##2##3##(2008-10#2)
analytes were detected##3##3##(2008-10#3)
analytes were determined##4##3##(2008-10#4)
analytes were evaluated##2##3##(2008-10#2)
analytes were extracted##3##3##(2008-10#3)
analytes were obtained##2##3##(2008-10#2)
analytes were simultaneously##2##3##(2008-10#2)
analytes were then##4##3##(2008-10#4)
analytes were vaporized##2##3##(2008-10#2)
analytes were##46##2##(2008-10#46)
analytes with the##3##3##(2008-10#3)
analytes with##7##2##(2008-10#7)
analytes##305##1##(1992-11#1)(1993-2#1)(1997-2#4)(2008-10#292)(2008-12#1)(2008-4#3)(2009-3#1)(2010-5#1)(2010-7#1)
analytic framework##2##2##(1992-3#1)(2008-12#1)
analytic##29##1##(1990-8#1)(1992-3#2)(1995-2#2)(1996-2#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-9#1)(2010-1#1)(2010-5#2)(2011-2#2)(2012-2#2)(2013-1#3)
analytical and bioanalytical##2##3##(2008-10#2)
analytical and diagnostic potential of##2##5##(1997-6#2)
analytical and##26##2##(1994-8#1)(1997-6#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-8#2)(2011-2#1)(2012-2#2)
analytical application of##4##3##(2008-10#4)
analytical application##10##2##(2008-10#10)
analytical applications of##5##3##(2008-10#5)
analytical applications##15##2##(2008-10#14)(2010-7#1)
analytical approach to##2##3##(2008-10#2)
analytical approach##8##2##(1995-11#1)(2008-10#6)(2008-2#1)
analytical approaches##2##2##(2008-10#2)
analytical approximation##2##2##(2008-10#1)(2008-8#1)
analytical as well as##2##4##(2008-10#1)(2008-3#1)
analytical assay##2##2##(2008-10#2)
analytical assays##5##2##(2008-10#4)(2010-7#1)
analytical characteristic##2##2##(2008-10#2)
analytical characteristics have been##2##4##(2008-10#2)
analytical characteristics of the##6##4##(2008-10#6)
analytical characteristics of##9##3##(2008-10#9)
analytical characteristics such as##2##4##(2008-10#2)
analytical characteristics were obtained##2##4##(2008-10#2)
analytical characteristics were studied##3##4##(2008-10#3)
analytical characteristics were##5##3##(2008-10#5)
analytical characteristics##25##2##(2008-10#25)
analytical chemical##3##2##(2008-10#3)
analytical chemist##2##2##(2008-10#2)
analytical chemistry and##3##3##(2008-10#2)(2008-5#1)
analytical chemistry of##2##3##(2008-10#1)(2010-7#1)
analytical chemistry##35##2##(2008-10#24)(2008-11#1)(2008-5#1)(2010-7#9)
analytical chemists##3##2##(2008-10#2)(2010-11#1)
analytical column with##2##3##(2008-10#2)
analytical column##13##2##(2008-10#13)
analytical columns##3##2##(2008-10#3)
analytical concentration##2##2##(2008-10#2)
analytical conditions for the determination of##3##6##(2008-10#3)
analytical conditions for##4##3##(2008-10#4)
analytical conditions were##2##3##(2008-10#2)
analytical conditions##16##2##(2008-10#15)(2010-10#1)
analytical curve for##2##3##(2008-10#2)
analytical curve was linear##3##4##(2008-10#3)
analytical curve was##7##3##(2008-10#7)
analytical curve##16##2##(2008-10#16)
analytical curves##9##2##(2008-10#9)
analytical data for##2##3##(2008-10#2)
analytical data were##2##3##(2008-10#2)
analytical data##13##2##(1995-5#1)(2008-10#12)
analytical determination of##5##3##(2008-10#5)
analytical determination##8##2##(2008-10#8)
analytical determinations##4##2##(2008-10#4)
analytical development##5##2##(2008-10#1)(2010-12#1)(2010-7#1)(2012-2#2)
analytical errors##3##2##(2008-10#2)(2008-6#1)
analytical evaluation of##2##3##(2008-10#1)(2008-9#1)
analytical expression for the apparent infection rate##2##7##(2008-10#2)
analytical expression for the##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
analytical expression##5##2##(2007-11#1)(2008-10#2)(2008-3#2)
analytical expressions for the##2##4##(2008-3#1)(2008-8#1)
analytical features##5##2##(2008-10#5)
analytical figures of merit were##2##5##(2008-10#2)
analytical figures of merit##10##4##(2008-10#10)
analytical figures of merits##2##4##(2008-10#2)
analytical figures of##12##3##(2008-10#12)
analytical formula is##2##3##(2007-12#1)(2008-2#1)
analytical formula##3##2##(2007-12#1)(2008-2#2)
analytical frequency of##5##3##(2008-10#5)
analytical frequency was##3##3##(2008-10#3)
analytical frequency##10##2##(2008-10#10)
analytical grade##3##2##(2008-10#3)
analytical information##6##2##(1992-2#4)(2008-10#2)
analytical instrumentation##3##2##(2008-10#3)
analytical instruments##3##2##(2008-10#3)
analytical issues##2##2##(2008-6#1)(2008-9#1)
analytical laboratories##3##2##(2008-10#3)
analytical laboratory##2##2##(2008-10#2)
analytical lines##2##2##(2008-10#2)
analytical measurements##6##2##(2008-10#6)
analytical method based on##3##4##(2008-10#3)
analytical method for the determination of##13##6##(2008-10#13)
analytical method for the##17##4##(2008-10#17)
analytical method for##25##3##(1993-3#1)(2008-10#23)(2008-5#1)
analytical method is##7##3##(2008-10#6)(2012-3#1)
analytical method to##4##3##(1996-12#1)(2008-10#2)(2012-2#1)
analytical method using##2##3##(2008-10#2)
analytical method was##4##3##(2008-10#4)
analytical method##64##2##(1993-3#1)(1996-12#1)(2008-10#56)(2008-5#1)(2009-8#1)(2010-11#1)(2012-2#2)(2012-3#1)
analytical methodology##14##2##(1995-11#1)(2008-10#13)
analytical methods and##2##3##(2008-10#1)(2010-7#1)
analytical methods can be used##2##5##(1993-3#1)(2008-10#1)
analytical methods for the##3##4##(2008-10#3)
analytical methods for##9##3##(2008-10#9)
analytical methods in##2##3##(2008-9#1)(2010-9#1)
analytical methods to measure##2##4##(2008-9#1)(2010-5#1)
analytical methods to##3##3##(2008-11#1)(2008-9#1)(2010-5#1)
analytical methods used##2##3##(1996-12#1)(2008-10#1)
analytical methods which##2##3##(1990-2#1)(2008-10#1)
analytical methods##45##2##(1990-2#1)(1993-3#2)(1996-12#1)(2008-10#32)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-3#1)
analytical minimalism##3##2##(2008-10#3)
analytical model##3##2##(2008-10#1)(2008-8#2)
analytical parameter##3##2##(2008-10#3)
analytical parameters and##2##3##(2008-10#2)
analytical parameters have been##4##4##(2008-10#4)
analytical parameters of##3##3##(2008-10#3)
analytical parameters were##5##3##(2008-10#5)
analytical parameters##25##2##(2008-10#25)
analytical pathways##2##2##(2008-10#2)
analytical performance characteristics for##2##4##(2008-10#2)
analytical performance characteristics##4##3##(2008-10#4)
analytical performance for##4##3##(2008-10#3)(2008-6#1)
analytical performance of the method##3##5##(2008-10#3)
analytical performance of the proposed##3##5##(2008-10#3)
analytical performance of the##9##4##(2008-10#9)
analytical performance of##14##3##(2008-10#14)
analytical performance was evaluated with##2##5##(2008-10#2)
analytical performance was##3##3##(2008-10#3)
analytical performance##31##2##(2008-10#30)(2008-6#1)
analytical performances of a##2##4##(2008-10#2)
analytical performances of##5##3##(2008-10#5)
analytical performances##10##2##(2008-10#10)
analytical pervaporation##2##2##(2008-10#2)
analytical potential of##2##3##(2008-10#2)
analytical potential##3##2##(2008-10#3)
analytical precision##9##2##(2008-10#8)(2009-8#1)
analytical problems##5##2##(2008-10#2)(2010-11#1)(2010-7#2)
analytical procedure for the determination of##2##6##(2008-10#2)
analytical procedure for the simultaneous determination of##2##7##(2008-10#2)
analytical procedure for the##7##4##(2008-10#7)
analytical procedure for##8##3##(2008-10#8)
analytical procedure has been developed for##2##6##(2008-10#2)
analytical procedure is based on the##2##6##(2008-10#2)
analytical procedure to##2##3##(1997-2#1)(2008-10#1)
analytical procedure was developed for##2##5##(2008-10#2)
analytical procedure was developed##3##4##(2008-10#3)
analytical procedure was##8##3##(2008-10#8)
analytical procedure##42##2##(1997-2#1)(2008-10#41)
analytical procedures and##2##3##(2008-10#1)(2010-11#1)
analytical procedures for##2##3##(2008-10#2)
analytical procedures##14##2##(1992-3#1)(2008-10#10)(2008-11#1)(2008-9#1)(2010-11#1)
analytical process##3##2##(2008-10#2)(2008-11#1)
analytical properties of the##2##4##(2008-10#2)
analytical properties of##4##3##(2008-10#4)
analytical properties were##2##3##(2008-10#2)
analytical properties##7##2##(2008-10#7)
analytical protocol##4##2##(2008-10#3)(2010-11#1)
analytical purposes##7##2##(2008-10#5)(2010-7#1)(2011-2#1)
analytical range##4##2##(2008-10#4)
analytical reactions##2##2##(2008-10#1)(2010-7#1)
analytical reagent##3##2##(2008-10#2)(2008-9#1)
analytical reagents##5##2##(2008-10#5)
analytical recoveries were##2##3##(2008-10#2)
analytical recoveries##5##2##(2008-10#5)
analytical recovery were##2##3##(2008-10#2)
analytical recovery##3##2##(2008-10#3)
analytical response##6##2##(2008-10#6)
analytical result##2##2##(2008-10#2)
analytical results are##2##3##(2008-10#1)(2013-8#1)
analytical results for##4##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
analytical results obtained##6##3##(2008-10#6)
analytical results of##2##3##(2008-10#2)
analytical results were found to be##2##6##(2008-10#2)
analytical results were##6##3##(2008-10#6)
analytical results##27##2##(1997-2#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
analytical scale##2##2##(2008-10#1)(2011-1#1)
analytical scheme was##2##3##(2008-10#2)
analytical self-focus##2##2##(2010-10#2)
analytical sensitivity and##3##3##(2008-10#3)
analytical sensitivity of the##2##4##(2008-10#1)(2011-2#1)
analytical sensitivity##11##2##(2008-10#10)(2011-2#1)
analytical separation##3##2##(2008-10#3)
analytical sequence##3##2##(2008-10#3)
analytical signal in##2##3##(2008-10#2)
analytical signal is##3##3##(2008-10#3)
analytical signal of##3##3##(2008-10#3)
analytical signal to##3##3##(2008-10#3)
analytical signal##41##2##(2008-10#41)
analytical signals for##2##3##(2008-10#2)
analytical signals were##3##3##(2008-10#3)
analytical signals##17##2##(2007-11#2)(2008-10#14)(2008-3#1)
analytical solution for##2##3##(2008-3#2)
analytical solution##6##2##(2008-10#2)(2008-3#4)
analytical strategy##2##2##(2008-10#1)(2012-3#1)
analytical studies##3##2##(2008-10#2)(2008-5#1)
analytical study was##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
analytical study##5##2##(2008-10#2)(2011-2#1)(2013-1#2)
analytical support##2##2##(2008-10#2)
analytical system is##4##3##(2008-10#3)(2008-9#1)
analytical system was##2##3##(2008-10#2)
analytical system##16##2##(2008-10#12)(2008-9#1)(2010-7#2)(2013-8#1)
analytical systems to##2##3##(2008-10#2)
analytical systems##8##2##(2008-10#8)
analytical technique for##3##3##(2008-10#2)(2009-12#1)
analytical technique##13##2##(2008-10#11)(2009-12#1)(2012-2#1)
analytical techniques and##7##3##(2008-10#5)(2008-11#1)(2010-11#1)
analytical techniques are##2##3##(2008-10#1)(2010-11#1)
analytical techniques for the##2##4##(2008-10#2)
analytical techniques for##3##3##(2008-10#3)
analytical techniques##30##2##(2008-10#24)(2008-11#2)(2008-9#1)(2010-11#2)(2010-7#1)
analytical throughput of 20##2##4##(2008-10#2)
analytical throughput of##8##3##(2008-10#8)
analytical throughput##12##2##(2008-10#12)
analytical time##3##2##(2008-10#3)
analytical tool for the investigation of##2##6##(2008-10#1)(2008-7#1)
analytical tool for##4##3##(2008-10#3)(2008-7#1)
analytical tool in##2##3##(2008-10#1)(2008-9#1)
analytical tool##11##2##(2008-10#8)(2008-7#1)(2008-9#1)(2011-1#1)
analytical tools for##3##3##(2008-10#3)
analytical tools in##2##3##(2008-10#1)(2008-4#1)
analytical tools##9##2##(2008-10#7)(2008-4#1)(2010-9#1)
analytical ultracentrifugation##3##2##(1994-5#1)(1995-2#1)(2011-2#1)
analytical usefulness##3##2##(2008-10#3)
analytical utility of##4##3##(2008-10#4)
analytical utility##5##2##(2008-10#5)
analytical wavelengths##3##2##(2008-10#3)
analytical##1011##1##(1990-2#1)(1991-12#1)(1992-2#4)(1992-3#1)(1993-3#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-2#6)(1997-3#1)(1997-6#2)(2007-11#5)(2007-12#1)(2008-10#835)(2008-11#14)(2008-12#2)(2008-2#5)(2008-3#16)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#8)(2008-9#11)(2009-12#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#8)(2010-12#1)(2010-5#1)(2010-7#27)(2010-9#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#9)(2012-3#2)(2013-1#5)(2013-8#2)
analytically and numerically##2##3##(2007-12#1)(2011-2#1)
analytically and##3##2##(2007-12#1)(2008-8#1)(2011-2#1)
analytically the##2##2##(1996-2#1)(2008-3#1)
analytically##23##1##(1990-8#1)(1996-2#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
analytics##4##1##(1992-2#1)(1994-12#1)(2013-1#1)(2013-8#1)
analyze a##12##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#4)(2008-9#2)(2011-2#1)
analyze an##2##2##(2008-10#1)(2008-9#1)
analyze and##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
analyze cell##2##2##(2008-4#1)(2008-9#1)
analyze data##2##2##(1993-3#1)(1997-3#1)
analyze in detail the##3##4##(1991-6#1)(2012-3#1)(2013-1#1)
analyze in##5##2##(1991-6#1)(1995-5#1)(1997-3#1)(2012-3#1)(2013-1#1)
analyze molecular##2##2##(2008-10#1)(2008-4#1)
analyze the clinical##2##3##(2012-12#1)(2013-7#1)
analyze the data##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
analyze the differences in##2##4##(1996-3#1)(2010-9#1)
analyze the evolution of##2##4##(1993-3#1)(2008-9#1)
analyze the evolutionary##2##3##(2008-8#2)
analyze the factors##2##3##(2008-8#1)(2013-1#1)
analyze the genetic##2##3##(1997-8#1)(2011-2#1)
analyze the influence of##2##4##(2008-3#1)(2008-8#1)
analyze the possible##2##3##(1992-5#1)(2008-9#1)
analyze the results of##3##4##(1990-6#1)(2012-3#1)(2013-1#1)
analyze the results##4##3##(1990-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
analyze the##99##2##(1990-6#1)(1992-1#1)(1992-5#1)(1993-3#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#19)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#4)(2009-8#1)(2010-12#2)(2010-9#1)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
analyze these##2##2##(2009-12#1)(2009-8#1)
analyze this##2##2##(1994-12#1)(2009-10#1)
analyze trends in##2##3##(1994-12#1)(2009-10#1)
analyze##227##1##(1990-11#1)(1990-6#1)(1991-6#1)(1992-1#1)(1992-5#2)(1993-3#5)(1993-6#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-3#3)(1997-1#2)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-10#52)(2008-11#18)(2008-12#5)(2008-2#4)(2008-3#8)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#19)(2008-9#11)(2009-1#1)(2009-10#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#4)(2010-9#1)(2011-2#14)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#2)
analyzed 115##2##2##(2008-10#1)(2011-2#1)
analyzed DNA##2##2##(2008-10#2)
analyzed a##6##2##(1991-3#1)(1992-9#1)(1995-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
analyzed after##4##2##(2008-10#3)(2010-6#1)
analyzed and compared##3##3##(1996-11#1)(2012-3#1)(2013-1#1)
analyzed and the##8##3##(1997-8#1)(2008-10#6)(2008-4#1)
analyzed and##31##2##(1991-12#1)(1993-12#2)(1993-3#1)(1994-2#1)(1996-11#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
analyzed as a##3##3##(1992-1#1)(2008-10#1)(2010-7#1)
analyzed as##7##2##(1992-1#1)(2008-10#3)(2008-11#1)(2010-7#1)(2011-2#1)
analyzed at the##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
analyzed at##6##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
analyzed based on##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
analyzed by HPLC##3##3##(1993-11#1)(2008-10#1)(2009-8#1)
analyzed by PCR##2##3##(2008-12#1)(2009-8#1)
analyzed by SDS-PAGE and##2##4##(2008-4#1)(2008-8#1)
analyzed by SDS-PAGE##3##3##(2008-4#1)(2008-8#1)(2013-1#1)
analyzed by Southern##2##3##(2008-10#1)(2008-8#1)
analyzed by a##11##3##(1994-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-9#1)(2013-1#1)
analyzed by both##2##3##(2008-10#2)
analyzed by capillary electrophoresis##2##4##(2008-10#1)(2008-12#1)
analyzed by fitting##2##3##(2008-10#1)(2008-8#1)
analyzed by gas chromatography##3##4##(2008-10#2)(2008-9#1)
analyzed by gas##5##3##(2008-10#3)(2008-9#1)(2013-8#1)
analyzed by immunohistochemistry and##2##4##(2011-2#1)(2013-8#1)
analyzed by means of##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
analyzed by restriction##2##3##(2008-10#2)
analyzed by reverse phase##2##4##(1990-12#1)(2008-10#1)
analyzed by reverse##4##3##(1990-12#1)(1996-12#1)(2008-10#1)(2008-11#1)
analyzed by scanning electron microscopy##2##5##(2008-10#1)(2009-7#1)
analyzed by scanning##3##3##(2007-12#1)(2008-10#1)(2009-7#1)
analyzed by selected ion monitoring##2##5##(2008-10#2)
analyzed by the##18##3##(1990-5#1)(1997-2#1)(2008-10#12)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
analyzed by this method##2##4##(2008-10#2)
analyzed by this##5##3##(1993-12#1)(2008-10#4)
analyzed by use of##2##4##(2008-3#2)
analyzed by using the##5##4##(2008-10#4)(2010-7#1)
analyzed by using##8##3##(1997-7#1)(2008-10#6)(2010-7#1)
analyzed by##171##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1997-2#2)(1997-7#1)(2007-12#1)(2008-10#76)(2008-11#13)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#4)
analyzed data from the##2##4##(2010-12#1)(2010-6#1)
analyzed data from##3##3##(2010-12#1)(2010-6#1)(2012-2#1)
analyzed data##4##2##(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)
analyzed directly by##2##3##(2008-10#2)
analyzed during 1994##2##3##(2008-10#2)
analyzed during##6##2##(1993-9#1)(2008-10#3)(2008-11#1)(2008-3#1)
analyzed for a##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
analyzed for genetic##2##3##(2008-10#2)
analyzed for statistical significance##2##4##(2009-2#2)
analyzed for the expression of##2##5##(1996-12#1)(2008-10#1)
analyzed for the presence of##2##5##(2008-10#2)
analyzed for the##11##3##(1992-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2011-2#1)(2013-8#1)
analyzed for their##5##3##(1996-12#1)(1997-3#1)(2008-10#2)(2012-3#1)
analyzed for##69##2##(1990-5#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-3#2)(1993-1#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#35)(2008-11#4)(2008-3#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#2)(2012-5#1)(2013-8#2)
analyzed from##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
analyzed in a single##2##4##(2008-9#1)(2012-2#1)
analyzed in a##9##3##(1991-5#1)(1994-1#1)(2008-11#1)(2008-12#3)(2008-9#2)(2012-2#1)
analyzed in detail##3##3##(1995-12#1)(1995-8#1)(2008-10#1)
analyzed in more detail##2##4##(1995-6#1)(1997-5#1)
analyzed in order to##4##4##(1990-2#1)(1991-3#1)(2008-10#2)
analyzed in relation to##2##4##(1991-3#1)(1991-6#1)
analyzed in several##2##3##(2008-10#1)(2011-3#1)
analyzed in terms of##7##4##(1991-5#1)(1995-6#1)(1997-6#1)(2008-10#3)(2008-11#1)
analyzed in the##13##3##(1994-8#1)(1995-2#1)(1997-6#1)(2008-10#7)(2008-3#2)(2008-4#1)
analyzed in this study##2##4##(2008-7#1)(2011-2#1)
analyzed in this##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
analyzed in two##2##3##(2008-10#1)(2008-7#1)
analyzed in##68##2##(1990-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-5#1)(1997-6#2)(2008-10#19)(2008-11#4)(2008-12#4)(2008-3#2)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
analyzed included##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
analyzed ions##3##2##(2008-10#3)
analyzed its##2##2##(2008-9#2)
analyzed on the basis of the##2##6##(2008-3#1)(2009-4#1)
analyzed on the basis of##4##5##(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)
analyzed on##8##2##(2006-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-7#1)
analyzed over##2##2##(2008-10#1)(2012-2#1)
analyzed spatially##2##2##(2008-10#1)(2008-2#1)
analyzed statistically##3##2##(2008-10#1)(2013-1#2)
analyzed the effect of##2##4##(2010-5#1)(2013-1#1)
analyzed the effects of these##2##5##(2008-11#1)(2008-8#1)
analyzed the effects of##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
analyzed the role of##2##4##(1992-3#1)(2013-1#1)
analyzed the##48##2##(1990-9#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#7)
analyzed to demonstrate##2##3##(1997-1#1)(2008-10#1)
analyzed to determine the##5##4##(1995-1#1)(2008-10#2)(2008-3#1)(2013-1#1)
analyzed to determine##9##3##(1995-1#1)(1995-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2013-1#1)
analyzed to study the##2##4##(2008-10#1)(2008-8#1)
analyzed to##27##2##(1995-1#1)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-10#1)(2010-5#1)(2013-1#2)(2013-8#2)
analyzed two##2##2##(2008-10#1)(2010-7#1)
analyzed under##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
analyzed using a##7##3##(2008-10#5)(2012-3#1)(2013-1#1)
analyzed using modified##2##3##(2008-10#1)(2013-1#1)
analyzed using polymerase chain reaction##2##5##(2008-10#2)
analyzed using the##17##3##(1991-2#1)(1992-8#1)(2008-10#8)(2008-12#2)(2008-4#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
analyzed using##63##2##(1991-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-6#1)(2008-10#35)(2008-11#1)(2008-12#2)(2008-4#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
analyzed were##3##2##(2008-10#3)
analyzed whether##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
analyzed with a##4##3##(1997-2#1)(2008-11#1)(2008-3#1)(2012-2#1)
analyzed with both##2##3##(2008-10#2)
analyzed with the##6##3##(2008-10#5)(2011-1#1)
analyzed with##31##2##(1991-3#1)(1994-11#1)(1996-11#1)(1997-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
analyzed##864##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#6)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#4)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#4)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#3)(1995-12#6)(1995-2#6)(1995-6#4)(1995-8#4)(1996-1#2)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#1)(1996-8#2)(1997-1#3)(1997-2#7)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#4)(1997-9#1)(2006-6#1)(2007-12#7)(2008-1#3)(2008-10#336)(2008-11#45)(2008-12#18)(2008-2#8)(2008-3#27)(2008-4#9)(2008-5#8)(2008-6#3)(2008-7#11)(2008-8#23)(2008-9#21)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#3)(2011-2#33)(2011-3#2)(2011-7#1)(2011-9#1)(2012-12#4)(2012-2#11)(2012-3#31)(2012-5#1)(2013-1#42)(2013-8#22)
analyzer and##3##2##(1995-8#1)(2008-10#1)(2008-11#1)
analyzer based##2##2##(2008-10#2)
analyzer for##3##2##(2008-10#3)
analyzer with##3##2##(2008-10#3)
analyzer##28##1##(1995-8#1)(2008-10#22)(2008-11#1)(2010-7#3)(2013-1#1)
analyzers that##2##2##(2008-10#2)
analyzers##7##1##(2008-10#6)(2013-1#1)
analyzes a##3##2##(1991-3#1)(1992-12#1)(2008-8#1)
analyzes the##11##2##(1991-1#1)(1991-12#1)(1993-1#1)(1995-5#1)(1996-3#1)(2010-9#1)(2012-3#1)(2013-1#3)(2013-8#1)
analyzes##29##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
analyzing a series of seven replicates##3##6##(2008-10#3)
analyzing a##13##2##(2008-10#13)
analyzing and##3##2##(2008-4#1)(2008-8#2)
analyzing gene expression##2##3##(2008-4#2)
analyzing large##2##2##(2008-3#1)(2013-1#1)
analyzing molecular##2##2##(2008-4#1)(2012-2#1)
analyzing of##3##2##(1990-12#1)(2008-10#1)(2012-3#1)
analyzing real##3##2##(2008-10#3)
analyzing such##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
analyzing the##32##2##(1990-6#1)(1992-9#1)(1993-2#1)(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#5)(2008-7#2)(2008-9#3)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
analyzing their##3##2##(1993-8#1)(1997-3#1)(2008-10#1)
analyzing##145##1##(1990-12#1)(1990-6#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-2#3)(1997-3#2)(2008-1#1)(2008-10#67)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#14)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
anamnesis##5##1##(1990-9#1)(1991-3#1)(1992-5#1)(1992-9#1)(2011-2#1)
anamnestic##2##1##(1993-2#2)
anamorph and teleomorph##2##3##(2008-10#2)
anamorph genera##4##2##(2008-10#4)
anamorph##9##1##(2008-10#9)
anamorphic external cavity##3##3##(2008-3#3)
anamorphic##5##1##(2008-10#2)(2008-3#3)
anamorphs##3##1##(2008-10#2)(2010-3#1)
anaphase##3##1##(2008-11#2)(2011-2#1)
anaphases##2##1##(2008-11#2)
anaphylactic shock##4##2##(1991-8#1)(2011-2#3)
anaphylactic##7##1##(1991-8#1)(2009-6#1)(2010-1#2)(2011-2#3)
anaphylactoid reactions##2##2##(2008-8#2)
anaphylaxis in##2##2##(2013-1#2)
anaphylaxis##23##1##(1991-8#1)(1992-6#1)(1995-11#1)(2008-10#1)(2008-8#1)(2010-1#6)(2010-6#4)(2011-2#1)(2012-3#3)(2013-1#4)
anaplastic thyroid cancer##3##3##(2008-12#2)(2013-1#1)
anaplastic thyroid carcinoma##2##3##(2008-10#1)(2008-12#1)
anaplastic thyroid##5##2##(2008-10#1)(2008-12#3)(2013-1#1)
anaplastic##8##1##(2008-10#1)(2008-12#5)(2011-2#1)(2013-1#1)
anastomose with tester##2##3##(2008-10#2)
anastomosed with tester##2##3##(2008-10#2)
anastomosed with##3##2##(2008-10#3)
anastomosed##5##1##(1991-3#1)(2008-10#3)(2013-1#1)
anastomoses are performed##2##3##(2008-9#1)(2011-3#1)
anastomoses##9##1##(1991-6#1)(1997-1#1)(2008-9#3)(2011-3#2)(2012-2#1)(2013-1#1)
anastomosis group (AG)##2##3##(2008-10#2)
anastomosis group 1 (AG-1)##2##4##(2008-10#2)
anastomosis group##14##2##(2008-10#14)
anastomosis in##5##2##(1992-9#2)(1993-3#2)(2009-5#1)
anastomosis or##2##2##(1993-6#1)(2008-10#1)
anastomosis reaction##2##2##(2008-10#2)
anastomosis reactions##4##2##(2008-10#4)
anastomosis##56##1##(1990-9#2)(1991-11#1)(1991-3#4)(1991-6#1)(1992-9#3)(1993-3#6)(1993-6#1)(2007-8#3)(2008-10#28)(2008-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
anastomotic##3##1##(2006-6#1)(2010-12#1)(2013-1#1)
anatipestifer septicaemia##2##2##(2008-5#2)
anatipestifer##3##1##(2008-5#3)
anatomic and##3##2##(1994-12#1)(2011-7#1)(2012-3#1)
anatomic basis for##2##3##(2012-3#2)
anatomic characteristics##2##2##(2008-10#1)(2012-3#1)
anatomic limitations##2##2##(2011-7#1)(2013-1#1)
anatomic location##3##2##(1994-6#1)(2008-12#1)(2008-9#1)
anatomic relationships of the##2##4##(2012-3#2)
anatomic sites##3##2##(1994-1#1)(1997-7#1)(2012-3#1)
anatomic structures##5##2##(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
anatomic variations of##2##3##(2008-9#1)(2011-2#1)
anatomic variations##4##2##(1996-6#1)(2008-9#1)(2011-2#2)
anatomic##55##1##(1990-9#1)(1991-10#2)(1994-1#1)(1994-12#1)(1994-3#2)(1994-6#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-6#2)(2011-2#9)(2011-7#3)(2012-3#11)(2013-1#3)(2013-8#1)
anatomical and functional##2##3##(2012-12#1)(2013-1#1)
anatomical and physiological##5##3##(2008-11#1)(2008-5#1)(2013-1#3)
anatomical and##12##2##(2008-11#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#5)
anatomical barriers##2##2##(2008-10#1)(2011-2#1)
anatomical circumstances##2##2##(2011-2#2)
anatomical considerations##2##2##(2011-2#2)
anatomical details##2##2##(1991-6#1)(2012-3#1)
anatomical factors##2##2##(2008-10#2)
anatomical features of##2##3##(2012-2#1)(2013-1#1)
anatomical features##4##2##(1996-9#1)(2008-5#1)(2012-2#1)(2013-1#1)
anatomical landmarks and##2##3##(2010-6#1)(2012-12#1)
anatomical landmarks##3##2##(2008-9#1)(2010-6#1)(2012-12#1)
anatomical location##3##2##(2011-2#2)(2013-8#1)
anatomical models##3##2##(1991-12#3)
anatomical region##2##2##(2008-11#1)(2011-2#1)
anatomical structure##2##2##(2007-12#1)(2013-1#1)
anatomical variables of the##2##4##(2008-7#2)
anatomical variants##5##2##(1996-3#1)(2008-10#1)(2012-2#3)
anatomical variations##2##2##(1991-2#1)(2008-11#1)
anatomical##105##1##(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1993-3#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#2)(2007-12#1)(2008-10#7)(2008-11#8)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-2#17)(2012-12#2)(2012-2#9)(2012-3#1)(2012-5#3)(2013-1#9)(2013-8#2)
anatomically modern humans##2##3##(2010-5#2)
anatomically modern##4##2##(1994-3#2)(2010-5#2)
anatomically normal##2##2##(2013-1#2)
anatomically realistic##2##2##(2013-1#1)(2013-8#1)
anatomically reduced fracture##2##3##(2013-1#2)
anatomically reduced##3##2##(2013-1#3)
anatomically##16##1##(1994-3#2)(1994-5#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-5#2)(2013-1#7)(2013-8#1)
anatomo-pathological##3##1##(1990-9#1)(1991-6#1)(1993-3#1)
anatomopathological##3##1##(2008-5#2)(2011-2#1)
anatomy and function##2##3##(1993-6#1)(2013-1#1)
anatomy and physiology of the##2##5##(1997-1#1)(2010-9#1)
anatomy and physiology##4##3##(1997-1#1)(2008-9#1)(2010-9#1)(2011-2#1)
anatomy and##26##2##(1990-9#1)(1993-6#1)(1994-6#1)(1996-9#1)(1997-1#1)(1997-8#2)(2008-1#1)(2008-9#4)(2010-6#2)(2010-9#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
anatomy in##2##2##(1990-11#1)(2009-8#1)
anatomy is##2##2##(2012-2#1)(2013-1#1)
anatomy of the##9##3##(1990-11#1)(2008-10#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#2)
anatomy of this##3##3##(1994-3#1)(1996-9#1)(2010-11#1)
anatomy of##14##2##(1990-11#1)(1994-3#1)(1996-9#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#2)(2012-3#2)
anatomy was##2##2##(1994-3#1)(2012-2#1)
anatomy##77##1##(1990-11#2)(1990-3#1)(1990-8#1)(1990-9#1)(1993-11#1)(1993-6#2)(1994-3#2)(1994-6#1)(1996-9#3)(1997-1#1)(1997-8#3)(2008-1#1)(2008-10#4)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#7)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#2)(2011-2#10)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#6)(2013-8#2)
ancestor of##6##2##(1997-6#1)(2008-9#3)(2009-10#1)(2010-4#1)
ancestor with the##2##3##(2008-10#1)(2012-2#1)
ancestor with##3##2##(2008-10#2)(2012-2#1)
ancestor##22##1##(1993-3#1)(1997-6#1)(2008-10#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-6#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
ancestors of##4##2##(2009-6#3)(2009-8#1)
ancestors##7##1##(1994-9#1)(2008-12#1)(2008-9#1)(2009-6#3)(2009-8#1)
ancestral clone##2##2##(2008-8#2)
ancestral condition##4##2##(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)
ancestral node values##2##3##(2008-8#2)
ancestral node##3##2##(2008-8#3)
ancestral origin of##2##3##(2008-10#1)(2008-12#1)
ancestral origin##5##2##(2008-10#1)(2008-12#4)
ancestral##34##1##(1990-7#1)(1995-6#1)(1996-6#1)(1997-6#1)(1997-9#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-8#8)(2009-8#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
ancestry##4##1##(1990-2#1)(2008-12#1)(2008-5#1)(2012-3#1)
ancestry-informative##2##1##(2008-12#2)
anchor points##2##2##(2008-10#1)(2010-10#1)
anchor##16##1##(1991-2#1)(1994-12#2)(1994-8#2)(1995-2#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#5)(2009-10#1)(2010-10#1)
anchorage##3##1##(2008-11#3)
anchorage-dependent cells##7##2##(2008-11#7)
anchorage-dependent##14##1##(1994-3#1)(1997-1#2)(2008-11#11)
anchorage-independent##4##1##(1994-3#1)(1995-9#1)(1997-1#2)
anchored on the##2##3##(1996-5#1)(2008-10#1)
anchored on##4##2##(1990-2#1)(1996-5#1)(2008-10#2)
anchored to the plasma membrane##2##5##(1995-6#1)(1996-3#1)
anchored to the##8##3##(1991-10#1)(1995-6#1)(1996-3#2)(1997-3#1)(2008-12#1)(2008-7#1)(2010-4#1)
anchored to##10##2##(1991-10#1)(1995-6#1)(1996-3#2)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2012-2#1)
anchored##29##1##(1990-2#1)(1991-10#1)(1991-9#1)(1993-12#1)(1995-6#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-8#1)
anchoring junction##3##2##(2009-10#3)
anchoring junctions##3##2##(2009-10#3)
anchoring of the##3##3##(1997-6#1)(2012-2#1)(2013-8#1)
anchoring of##4##2##(1997-6#1)(2008-10#1)(2012-2#1)(2013-8#1)
anchoring##19##1##(1993-3#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-11#2)(2009-10#7)(2012-2#2)(2013-8#2)
anchors##3##1##(2008-7#1)(2008-8#1)(2008-9#1)
ancient and##4##2##(1991-2#1)(2008-10#3)
ancient duplication of##2##3##(1996-3#1)(2009-10#1)
ancient glass##3##2##(2008-10#3)
ancient##48##1##(1991-2#2)(1991-5#1)(1994-12#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-9#3)(2009-10#1)(2009-8#3)(2010-10#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
ancillary##13##1##(1992-1#1)(1994-6#1)(1995-1#1)(1996-1#2)(1997-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#2)(2011-7#1)
and % tail DNA##2##4##(2010-5#2)
and %##3##2##(2008-10#1)(2010-5#2)
and %K##2##2##(2008-10#2)
and &gt##18##2##(1994-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-10#8)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
and &lt##21##2##(1992-9#1)(1996-2#1)(2008-10#13)(2008-3#1)(2008-8#1)(2011-2#2)(2013-8#2)
and &quot##63##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-2#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#3)
and 'Erysimum' isolates##2##3##(2008-10#2)
and 'Orlando'##2##2##(2008-10#2)
and 'social'##3##2##(2008-11#3)
and (-)-epigallocatechin##2##2##(2008-11#2)
and (0##5##2##(2008-8#2)(2010-12#2)(2011-3#1)
and (1##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
and (1)H##2##2##(2008-10#1)(2012-2#1)
and (1)HNMR##2##2##(2008-10#2)
and (13)C NMR spectroscopic data##2##5##(2008-10#1)(2013-1#1)
and (13)C NMR spectroscopy##2##4##(2008-10#2)
and (13)C NMR##11##3##(2008-10#8)(2011-2#1)(2013-1#2)
and (13)C##13##2##(2008-10#8)(2008-4#1)(2009-7#1)(2011-2#1)(2013-1#2)
and (15)N##2##2##(1996-5#1)(2009-7#1)
and (2) a##3##3##(1997-3#1)(2008-4#1)(2013-8#1)
and (2) by##2##3##(2008-10#1)(2008-11#1)
and (2) continuous##2##3##(2008-10#2)
and (2) that the##2##4##(1991-2#2)
and (2) that##3##3##(1991-2#2)(2009-7#1)
and (2) the ratio of##2##5##(1991-1#1)(2008-3#1)
and (2) the##11##3##(1991-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-3#1)
and (2) to##5##3##(1993-12#1)(1994-1#1)(2010-8#1)(2013-1#2)
and (2)##58##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#2)(1992-3#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-3#3)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#3)(2009-7#2)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and (2)D at##2##3##(2008-10#2)
and (3##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
and (3) an##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
and (3) determine##2##3##(1994-12#1)(2013-1#1)
and (3) the##4##3##(1994-3#1)(1996-8#1)(2008-10#1)(2008-4#1)
and (3) to##4##3##(1992-12#1)(1995-12#1)(2008-4#1)(2009-1#1)
and (3)##44##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#2)(1994-12#2)(1994-3#2)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-3#1)(2008-10#3)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-6#1)(2009-7#2)(2010-1#1)(2012-2#1)(2012-3#2)(2013-1#4)
and (4##2##2##(2008-10#2)
and (4) the##5##3##(1991-2#1)(2008-11#2)(2008-12#1)(2010-6#1)
and (4)##24##2##(1991-2#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
and (5##3##2##(2008-10#3)
and (5) the##3##3##(1991-3#1)(2007-12#1)(2008-5#1)
and (5)##13##2##(1991-3#1)(1992-2#1)(1993-12#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-9#1)(2013-1#2)
and (6)##10##2##(1993-12#1)(1993-3#1)(1994-8#1)(1997-2#1)(2008-4#1)(2008-7#1)(2011-2#2)(2013-1#2)
and (68)Ga##2##2##(2010-6#2)
and (7)##3##2##(1997-3#1)(2009-6#1)(2013-1#1)
and (NH(4))(2)SO(4) mixture##2##3##(2008-10#2)
and (V)##3##2##(2008-10#3)
and (b) a##2##3##(1994-1#2)
and (b) determination##2##3##(2008-10#2)
and (b) in##2##3##(2008-10#1)(2008-11#1)
and (b) the##5##3##(1997-2#1)(2008-10#2)(2010-7#1)(2013-8#1)
and (b)##24##2##(1993-2#1)(1994-1#2)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#2)(2009-11#1)(2010-10#1)(2010-7#1)(2013-8#2)
and (c) a##2##3##(1991-1#1)(1994-1#1)
and (c) the##3##3##(1994-6#1)(2008-10#1)(2011-2#1)
and (c)##18##2##(1991-1#1)(1994-1#1)(1994-6#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
and (d)##12##2##(1991-12#1)(1991-3#1)(1993-3#1)(1993-9#1)(1994-1#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-4#2)(2009-9#1)(2010-7#1)
and (e)##7##2##(1992-1#1)(1992-2#1)(1997-8#2)(2008-11#1)(2008-2#1)(2012-2#1)
and (f) the##2##3##(1996-12#1)(2012-2#1)
and (f)##3##2##(1996-12#1)(2008-7#1)(2012-2#1)
and (for##2##2##(2010-3#1)(2013-8#1)
and (ii) a##2##3##(2008-10#1)(2012-5#1)
and (ii) the##14##3##(1993-8#1)(1994-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2009-12#1)(2013-1#1)
and (ii) to##3##3##(2008-10#2)(2011-2#1)
and (ii)##52##2##(1990-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#2)(2006-6#1)(2008-10#25)(2008-11#4)(2008-5#2)(2008-7#2)(2009-12#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-5#1)(2013-1#3)(2013-8#1)
and (iii) a##4##3##(2008-10#3)(2010-5#1)
and (iii) the##5##3##(2008-10#2)(2008-11#1)(2010-10#1)(2013-1#1)
and (iii) with##2##3##(1994-3#1)(2007-12#1)
and (iii)##40##2##(1994-3#2)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
and (iv) the##3##3##(1993-8#1)(2008-11#1)(2009-7#1)
and (iv)##18##2##(1993-8#1)(1996-6#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-1#1)
and (v)##5##2##(2008-10#4)(2008-5#1)
and +/-0##3##2##(2008-10#3)
and +/-1##2##2##(2008-10#2)
and +13##2##2##(1990-5#1)(2009-9#1)
and -##2##2##(1997-8#1)(2012-9#1)
and -0##15##2##(2008-10#14)(2008-7#1)
and -1##7##2##(2008-10#5)(2008-12#1)(2012-2#1)
and -10##4##2##(2008-10#3)(2008-4#1)
and -2##4##2##(2008-1#1)(2008-10#1)(2012-7#1)(2013-1#1)
and -2-4)##2##2##(2008-10#2)
and -3##5##2##(2008-10#4)(2008-9#1)
and -5##2##2##(1995-2#1)(2008-10#1)
and -7 MPa##2##3##(2008-10#2)
and -7##6##2##(2008-10#3)(2011-2#3)
and -9##2##2##(2008-4#1)(2013-7#1)
and -B##4##2##(1997-4#1)(2008-10#3)
and -II##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and -gamma##2##2##(2007-11#2)
and -independent##3##2##(1994-6#2)(1995-11#1)
and -negative##2##2##(2009-6#1)(2010-3#1)
and -phthalocyanines##2##2##(2008-10#2)
and -selectivity of##3##3##(2008-10#3)
and -selectivity##5##2##(2008-10#5)
and / or##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
and 0 degrees C (experiment##2##5##(2008-10#2)
and 0 to##3##3##(2008-10#2)(2008-5#1)
and 0##682##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#4)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#4)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#4)(1996-3#1)(1997-2#2)(1997-8#2)(2007-12#1)(2008-10#502)(2008-11#20)(2008-12#15)(2008-2#1)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#10)(2009-11#2)(2009-2#1)(2009-3#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#17)(2011-3#3)(2012-2#3)(2012-3#5)(2013-1#10)(2013-8#3)
and 0%##4##2##(1990-8#1)(2008-10#2)(2008-8#1)
and 0-0##2##2##(2008-10#1)(2008-2#1)
and 1 case of##2##4##(1994-12#1)(2012-3#1)
and 1 case##3##3##(1994-12#1)(2012-3#1)(2013-1#1)
and 1 for##2##3##(2008-10#2)
and 1 from##2##3##(2008-10#2)
and 1 in the##2##4##(1996-1#1)(2013-1#1)
and 1 microg##2##3##(2008-10#2)
and 1 ml of##2##4##(2008-10#2)
and 1 month after##2##4##(2008-10#1)(2013-8#1)
and 1 month##4##3##(1995-2#1)(2008-10#1)(2010-4#1)(2013-8#1)
and 1 muM##2##3##(2008-10#1)(2008-11#1)
and 1 mug##2##3##(2008-10#2)
and 1 nmol##3##3##(1997-2#3)
and 1 to##2##3##(1997-3#1)(2008-10#1)
and 1 with##3##3##(1994-3#1)(2008-7#1)(2010-3#1)
and 1 x 10(-4)moll(-1) triiodide##2##5##(2008-10#2)
and 1 x##4##3##(2008-10#4)
and 1 year##3##3##(1994-3#1)(1995-3#1)(2008-10#1)
and 1##460##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#3)(1991-6#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-6#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-8#4)(2008-10#294)(2008-11#13)(2008-12#8)(2008-2#2)(2008-3#7)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#10)(2013-8#2)
and 1%##11##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)
and 1-5%##2##2##(2008-10#2)
and 1-IC##3##2##(2008-10#3)
and 1-naphthalenacetamide##2##2##(2008-10#2)
and 1/2 years##3##3##(1990-6#3)
and 1/2##4##2##(1990-6#3)(2008-10#1)
and 10 at##2##3##(1995-11#1)(2008-12#1)
and 10 days##2##3##(2008-10#2)
and 10 for##3##3##(2008-10#3)
and 10 in##2##3##(2008-10#1)(2013-1#1)
and 10 m##2##3##(2008-10#2)
and 10 mM##4##3##(2008-10#3)(2008-11#1)
and 10 mg##3##3##(2008-10#1)(2011-1#1)(2011-3#1)
and 10 micrograms/ml##3##3##(1990-2#1)(1994-11#2)
and 10 microm##2##3##(2008-3#1)(2009-7#1)
and 10 min##4##3##(1997-2#1)(2008-10#2)(2013-1#1)
and 10 mm beyond the##2##5##(1995-2#2)
and 10 mm##3##3##(1995-2#2)(2008-10#1)
and 10 months##3##3##(2008-7#1)(2010-1#1)(2011-2#1)
and 10 mug##3##3##(2008-10#3)
and 10 ng##5##3##(2008-10#5)
and 10 pg##2##3##(2008-10#1)(2011-3#1)
and 10 samples##2##3##(1992-3#1)(2013-1#1)
and 10 were##3##3##(1993-1#1)(1996-5#1)(2008-10#1)
and 10 years##4##3##(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
and 10##168##2##(1990-2#2)(1991-10#1)(1991-6#2)(1991-8#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#2)(1996-2#2)(1996-5#2)(1996-9#1)(1997-2#4)(1997-3#2)(1997-8#1)(2007-8#1)(2008-10#73)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#8)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#1)
and 10% were##2##3##(2008-10#1)(2010-11#1)
and 10%##20##2##(1991-11#1)(1996-12#2)(2008-10#10)(2008-11#2)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
and 10(-3)-6x10(-2) M##2##3##(2008-10#2)
and 10(-4)##2##2##(2008-10#2)
and 10(-5)##3##2##(1997-4#1)(2008-10#2)
and 10(-6)##2##2##(1997-4#1)(2008-10#1)
and 10(-7)##3##2##(1990-11#1)(1996-2#1)(2008-10#1)
and 10(4)##2##2##(2008-10#2)
and 10(5)##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
and 10(6)##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
and 10(8)##2##2##(2008-10#1)(2008-9#1)
and 10)##3##2##(1995-8#1)(2013-1#1)(2013-8#1)
and 10-fold##2##2##(2008-10#1)(2008-11#1)
and 10-year##3##2##(1991-8#1)(1993-11#1)(2011-2#1)
and 100 degrees##2##3##(2008-5#1)(2009-3#1)
and 100 mg##3##3##(2008-10#2)(2008-5#1)
and 100 mug##2##3##(2008-10#2)
and 100 mul##2##3##(2008-10#2)
and 100 mum PDMS##2##4##(2008-10#2)
and 100 ng ml(-1)##2##4##(2008-10#2)
and 100 ng##3##3##(2008-10#3)
and 100##48##2##(1990-12#1)(1992-3#1)(1996-12#2)(1996-2#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2009-3#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-2#1)
and 100% for##2##3##(2008-10#1)(2013-1#1)
and 100% in the##2##4##(1990-2#1)(2012-12#1)
and 100% in##3##3##(1990-2#1)(2011-2#1)(2012-12#1)
and 100% of##3##3##(1996-1#1)(2011-2#1)(2012-3#1)
and 100% oxygen##2##3##(2008-10#2)
and 100% were##2##3##(1990-8#1)(2008-10#1)
and 100%##31##2##(1990-2#1)(1990-8#1)(1992-11#1)(1992-6#1)(1993-2#1)(1996-1#1)(1997-1#1)(2008-10#14)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
and 100%)##2##2##(2008-10#2)
and 1000 mg/kg##2##3##(2008-7#1)(2012-2#1)
and 1000##11##2##(1995-12#1)(2008-10#7)(2008-12#1)(2008-7#1)(2012-2#1)
and 100mM##2##2##(2008-10#1)(2011-2#1)
and 100ng##2##2##(2008-10#1)(2010-4#1)
and 101##4##2##(1990-9#1)(2008-10#2)(2012-2#1)
and 101%##2##2##(2008-10#2)
and 102##7##2##(1997-8#1)(2008-10#6)
and 103##7##2##(1996-12#1)(2008-10#4)(2012-12#1)(2012-2#1)
and 103% for##2##3##(2008-10#2)
and 103%##5##2##(2008-10#5)
and 104##5##2##(2008-10#4)(2012-3#1)
and 104%##2##2##(2008-10#2)
and 105##5##2##(1991-8#1)(1995-12#1)(2008-10#1)(2011-1#1)(2013-8#1)
and 105%##7##2##(2008-10#7)
and 106##3##2##(1994-11#1)(2008-10#2)
and 106%##5##2##(2008-10#5)
and 1064 nm##2##3##(2008-2#1)(2008-3#1)
and 107##6##2##(2008-10#4)(2008-9#1)(2011-1#1)
and 109%##2##2##(2008-10#2)
and 10mugl(-1)##2##2##(2008-10#2)
and 10th##4##2##(2009-8#1)(2012-3#1)(2013-1#2)
and 11 and##2##3##(1994-12#1)(2008-10#1)
and 11 weeks##2##3##(1991-2#1)(1995-8#1)
and 11 were##2##3##(1994-12#1)(2008-10#1)
and 11##57##2##(1990-11#2)(1991-2#1)(1991-3#1)(1991-9#1)(1993-8#1)(1994-12#3)(1994-3#1)(1995-8#1)(1996-12#4)(1996-2#1)(1997-3#1)(2008-10#16)(2008-12#4)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#4)
and 11% of##2##3##(1990-6#1)(2008-10#1)
and 11%##9##2##(1990-11#1)(1990-6#1)(2008-10#5)(2008-2#1)(2013-8#1)
and 110##2##2##(1995-8#1)(2008-10#1)
and 1100 degrees C##2##4##(2008-10#2)
and 114##2##2##(1995-6#1)(2012-2#1)
and 118##2##2##(1994-2#1)(2010-8#1)
and 12 as##2##3##(1996-12#1)(2008-10#1)
and 12 females##2##3##(2008-5#1)(2008-7#1)
and 12 healthy##2##3##(2008-11#2)
and 12 hr##3##3##(2008-5#1)(2008-6#2)
and 12 months after##3##4##(1997-1#1)(1997-6#1)(2013-1#1)
and 12 months##15##3##(1991-2#1)(1993-12#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#2)(2013-1#5)
and 12 to##2##3##(2008-10#1)(2008-4#1)
and 12 weeks##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
and 12 were##2##3##(2008-9#1)(2012-3#1)
and 12##87##2##(1991-2#2)(1991-6#2)(1993-1#1)(1993-12#1)(1995-8#1)(1996-12#6)(1996-5#2)(1997-1#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#26)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-10#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#8)
and 12%##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
and 120 degrees##2##3##(2013-1#2)
and 120 s##2##3##(2008-10#2)
and 120##13##2##(1995-12#1)(1995-2#2)(2008-1#1)(2008-10#6)(2008-8#1)(2013-1#2)
and 121##2##2##(1996-2#1)(2008-10#1)
and 122##2##2##(2008-10#1)(2010-10#1)
and 123##2##2##(1996-9#1)(2008-1#1)
and 124##4##2##(1993-12#1)(2011-2#1)(2013-1#2)
and 126##3##2##(1991-6#1)(1993-11#1)(2008-10#1)
and 129##2##2##(2008-10#1)(2008-9#1)
and 13 QTL##2##3##(2008-10#1)(2008-8#1)
and 13 patients##2##3##(1992-1#1)(1997-8#1)
and 13##42##2##(1991-5#1)(1992-1#1)(1993-11#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#3)(2008-9#1)(2011-10#1)(2011-2#4)(2012-3#1)(2013-1#2)
and 13%##5##2##(1990-6#1)(1996-12#1)(2008-10#2)(2008-7#1)
and 13-cis-retinoic acid##2##3##(1994-6#2)
and 130##5##2##(1995-8#1)(2008-10#2)(2008-5#1)(2010-1#1)
and 1300 degrees C##5##4##(2008-10#5)
and 131##3##2##(1991-12#1)(2008-9#1)(2010-6#1)
and 133##2##2##(2008-10#1)(2010-1#1)
and 135##3##2##(1991-8#1)(1997-8#1)(2008-12#1)
and 136##2##2##(2008-10#1)(2008-9#1)
and 138##3##2##(1994-11#1)(2008-10#1)(2012-3#1)
and 13C NMR##6##3##(1991-5#1)(1992-12#2)(1994-11#1)(2008-11#1)(2009-7#1)
and 13C##9##2##(1991-5#1)(1992-12#2)(1994-11#1)(2008-11#1)(2009-7#4)
and 13C(beta)##2##2##(2009-7#2)
and 14 days##6##3##(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
and 14 isolates of C##2##5##(2008-10#2)
and 14 new##2##3##(1995-9#1)(2008-10#1)
and 14 of##4##3##(2008-10#3)(2013-1#1)
and 14 years##2##3##(2013-1#2)
and 14##52##2##(1990-3#1)(1990-6#1)(1990-9#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-1#1)(1994-6#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2010-7#3)(2011-2#5)(2012-2#1)(2013-1#4)
and 14% of##2##3##(1990-12#1)(1994-12#1)
and 14%##9##2##(1990-12#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-10#4)(2010-6#1)
and 140##7##2##(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#3)
and 1400##3##2##(2008-10#2)(2008-3#1)
and 143##2##2##(2008-10#1)(2012-3#1)
and 1450 ppm fluoride##4##4##(2011-2#4)
and 1450##5##2##(2008-10#1)(2011-2#4)
and 148##2##2##(2008-10#1)(2008-9#1)
and 149##3##2##(1995-8#1)(2008-10#1)(2008-7#1)
and 14th##2##2##(1990-9#2)
and 15 days##2##3##(1995-2#1)(2008-10#1)
and 15 female##7##3##(2008-9#6)(2011-2#1)
and 15 females##3##3##(1991-12#2)(2008-7#1)
and 15 min of##2##4##(2008-10#2)
and 15 min on the##2##5##(1993-1#2)
and 15 min##5##3##(1993-1#2)(2008-10#2)(2008-12#1)
and 15 patients##2##3##(1991-12#1)(1994-3#1)
and 15 weeks post-capture##2##4##(2008-5#2)
and 15 weeks##3##3##(2008-5#2)(2012-3#1)
and 15##83##2##(1990-2#1)(1990-6#2)(1991-12#3)(1991-6#2)(1993-1#3)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-5#1)(2008-10#28)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#9)(2010-5#1)(2011-2#3)(2012-3#4)(2013-1#2)
and 15% of##5##3##(1991-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
and 15%##13##2##(1991-11#1)(1994-11#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2010-4#1)(2012-12#1)
and 15-fold##2##2##(1990-10#1)(2008-10#1)
and 150 mg/kg##2##3##(2008-10#2)
and 150##15##2##(1991-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1997-2#1)(2008-10#9)(2008-5#1)
and 153##2##2##(2008-10#1)(2011-3#1)
and 157##2##2##(2008-10#1)(2011-2#1)
and 15N NMR assignments of##3##5##(2009-7#3)
and 15N NMR assignments##4##4##(2009-7#4)
and 15N NMR##5##3##(1992-3#1)(2009-7#4)
and 15N assignment of the oxidized and reduced##2##8##(2009-7#2)
and 15N resonance assignment of the##3##6##(2009-7#3)
and 15N resonance assignment of##4##5##(2009-7#4)
and 15N resonance assignments of the##3##6##(2009-7#3)
and 15N resonance assignments of##6##5##(2009-7#6)
and 15N resonance assignments##7##4##(2009-7#7)
and 15N resonance##11##3##(2009-7#11)
and 15N resonances of the##2##5##(2009-7#2)
and 15N resonances##3##3##(1995-2#1)(2009-7#2)
and 15N##24##2##(1992-3#1)(1995-2#1)(2009-7#22)
and 15min of##2##3##(2008-10#2)
and 15th##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
and 16 cases##2##3##(1995-11#1)(2008-11#1)
and 16 h##3##3##(2008-10#2)(2008-11#1)
and 16 isolates##2##3##(2008-10#2)
and 16 patients##2##3##(1992-2#1)(2012-4#1)
and 16 to##3##3##(1996-12#1)(2008-11#1)(2008-8#1)
and 16 with##2##3##(2008-5#1)(2012-3#1)
and 16##50##2##(1990-2#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#5)(2008-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2012-4#1)
and 16%##6##2##(1990-3#1)(2008-10#3)(2011-2#1)(2013-1#1)
and 160##5##2##(1994-6#1)(1996-12#1)(2008-10#2)(2011-1#1)
and 17##37##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-8#1)(1993-11#1)(1996-12#2)(1997-2#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#4)(2010-11#1)(2011-2#1)(2013-8#1)
and 17%##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
and 172##2##2##(2008-10#1)(2008-7#1)
and 176##3##2##(2008-10#1)(2010-1#1)(2010-6#1)
and 18 in##3##3##(1990-5#1)(2008-11#2)
and 18 months of age##4##5##(1993-12#2)(2008-10#1)(2008-7#1)
and 18 months of##5##4##(1990-2#1)(1993-12#2)(2008-10#1)(2008-7#1)
and 18 months##9##3##(1990-2#1)(1993-1#1)(1993-12#2)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#1)
and 18 of##7##3##(1994-3#1)(2008-10#1)(2008-8#3)(2013-1#2)
and 18 patients##2##3##(2008-10#1)(2011-2#1)
and 18 weeks after##2##4##(2010-12#1)(2012-3#1)
and 18 weeks##4##3##(1993-3#1)(2010-12#2)(2012-3#1)
and 18 were##2##3##(1996-5#1)(2008-10#1)
and 18##55##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#1)(1993-1#1)(1993-12#2)(1993-3#2)(1994-11#1)(1994-3#1)(1996-11#1)(1996-5#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
and 18% of##2##3##(1991-8#1)(1993-11#1)
and 18%##4##2##(1991-8#1)(1993-11#1)(2008-10#1)(2013-8#1)
and 180##5##2##(1996-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
and 184##2##2##(1997-8#1)(2008-10#1)
and 187##2##2##(2009-10#1)(2011-2#1)
and 19 months after##2##4##(1990-5#1)(1994-12#1)
and 19 months##4##3##(1990-5#2)(1994-1#1)(1994-12#1)
and 19 of##2##3##(1995-12#1)(2008-10#1)
and 19##28##2##(1990-5#2)(1992-3#1)(1994-1#1)(1994-12#1)(1994-8#2)(1995-12#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#2)(2012-12#1)(2013-1#3)
and 19% of##2##3##(1997-2#1)(2008-10#1)
and 19%##6##2##(1997-2#1)(2008-10#3)(2009-5#1)(2011-2#1)
and 1900##2##2##(2008-3#1)(2011-2#1)
and 194##2##2##(1995-1#1)(2012-2#1)
and 1984##2##2##(1990-3#1)(1991-1#1)
and 1985##4##2##(1990-8#2)(1993-3#1)(1996-11#1)
and 1987##6##2##(1990-3#1)(1992-12#1)(1992-2#1)(1994-2#1)(2008-11#1)(2008-8#1)
and 1988##11##2##(1990-9#1)(1991-1#1)(1992-12#2)(1992-2#2)(1993-1#3)(1995-3#1)(1997-7#1)
and 1989##8##2##(1990-11#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-2#1)(1995-3#1)(2008-10#1)
and 1990##3##2##(1991-8#1)(1997-5#1)(2008-10#1)
and 1991##4##2##(1992-9#1)(1995-1#1)(1996-1#1)(2008-10#1)
and 1992##4##2##(1993-6#1)(1995-2#1)(2008-10#2)
and 1993##7##2##(1995-12#1)(2008-10#5)(2008-5#1)
and 1994##9##2##(1996-3#1)(1996-6#1)(2008-10#4)(2008-5#3)
and 1995 we##2##3##(1996-11#1)(2008-7#1)
and 1995##13##2##(1995-12#1)(1996-11#3)(1997-2#1)(1997-3#1)(2008-10#4)(2008-7#2)(2010-7#1)
and 1996 to 1997##2##4##(2008-10#2)
and 1996 to evaluate the##2##5##(2008-10#2)
and 1996 to##4##3##(2008-10#4)
and 1996##17##2##(1997-6#1)(1997-8#1)(2008-10#15)
and 1997##18##2##(1996-1#1)(2008-10#15)(2008-11#2)
and 1998##15##2##(2008-10#14)(2008-9#1)
and 1999##15##2##(2008-10#13)(2008-11#2)
and 1H##2##2##(1994-2#1)(2009-7#1)
and 1x10(-6)##2##2##(2008-10#2)
and 2 PR in grade##2##5##(1990-12#2)
and 2 are##2##3##(2008-10#1)(2008-7#1)
and 2 cases of##2##4##(1991-6#1)(2009-10#1)
and 2 days after##3##4##(2008-10#2)(2008-5#1)
and 2 from##2##3##(2008-10#1)(2011-2#1)
and 2 h after##2##4##(2008-10#2)
and 2 had##2##3##(1991-12#1)(1991-2#1)
and 2 mM##2##3##(1993-8#1)(2008-10#1)
and 2 mg##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
and 2 ml of##2##4##(2008-10#2)
and 2 ml##4##3##(2008-10#4)
and 2 months##5##3##(2008-10#2)(2009-3#2)(2013-1#1)
and 2 ng ml(-1) for##3##5##(2008-10#3)
and 2 of##7##3##(1992-4#1)(1994-12#1)(2008-10#5)
and 2 patients##5##3##(1991-8#2)(1996-3#1)(1997-3#1)(2008-7#1)
and 2 to##3##3##(1994-12#1)(2008-10#2)
and 2 were##10##3##(1990-2#1)(1994-2#1)(2008-10#4)(2008-11#3)(2008-12#1)
and 2##365##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-4#3)(1992-5#1)(1992-6#2)(1993-12#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-8#4)(1995-11#2)(1995-5#1)(1995-8#2)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#197)(2008-11#23)(2008-12#10)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#7)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#4)(2009-4#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#4)
and 2% at##2##3##(2008-11#1)(2008-3#1)
and 2%##11##2##(2008-10#8)(2008-11#1)(2008-3#1)(2013-1#1)
and 2) the##2##3##(1994-3#1)(1996-9#1)
and 2)##16##2##(1990-2#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##3##2##(2008-10#3)
and 2-4##2##2##(2008-11#1)(2012-12#1)
and 2-8##2##2##(2008-10#2)
and 2-HPbetaCD##2##2##(2008-11#2)
and 2-fold##2##2##(2008-11#1)(2013-1#1)
and 2-hydroxypropyl-beta-cyclodextrin##3##2##(2008-10#1)(2008-11#2)
and 2-mercaptoethanol##2##2##(1991-12#1)(1992-12#1)
and 2-mercaptosuccinic acid were##2##4##(1990-5#2)
and 2-mercaptosuccinic acid##3##3##(1990-5#3)
and 2-methyl-5-butyloxymethyl-8-quinolinol##2##2##(2008-10#2)
and 2-nitrophenyl octyl ether##2##4##(2008-10#2)
and 2-year post-implementation to obtain feedback from the acute care registered nurses (RNs)##2##13##(2013-1#2)
and 2-year##3##2##(2012-3#1)(2013-1#2)
and 20 control subjects##2##4##(1997-8#2)
and 20 days after##2##4##(1995-12#1)(2008-10#1)
and 20 days##3##3##(1995-12#1)(1997-3#1)(2008-10#1)
and 20 degrees C##4##4##(2008-10#4)
and 20 in##2##3##(2011-2#1)(2012-3#1)
and 20 ml of##2##4##(2008-10#2)
and 20 mug##2##3##(2008-11#2)
and 20 mul of##2##4##(2008-10#2)
and 20 mul##3##3##(2008-10#3)
and 20 ng ml(-1) for##2##5##(2008-10#2)
and 20 ng ml(-1)##3##4##(2008-10#3)
and 20 ng##5##3##(2008-10#5)
and 20 patients##2##3##(1992-2#1)(2011-2#1)
and 20 to##2##3##(2008-10#1)(2010-11#1)
and 20 were##3##3##(2008-7#1)(2011-2#2)
and 20##75##2##(1991-11#1)(1991-2#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-11#2)(1995-12#2)(1995-3#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-1#1)(2008-10#33)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)
and 20% for##2##3##(2008-10#1)(2009-3#1)
and 20%##11##2##(1993-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-3#1)(2010-4#1)(2010-6#1)(2013-1#1)
and 200 mg/kg##4##3##(2008-10#2)(2012-2#2)
and 200##18##2##(1991-12#1)(1992-3#1)(1995-6#1)(2008-10#9)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
and 2000 to##2##3##(2008-10#2)
and 2000##18##2##(1991-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2010-1#1)(2012-2#1)(2012-9#1)
and 2001##9##2##(2008-10#6)(2008-11#1)(2008-9#1)(2010-3#1)
and 2002##11##2##(2007-8#1)(2008-1#1)(2008-10#8)(2011-2#1)
and 2003 in##2##3##(2011-2#1)(2013-1#1)
and 2003##11##2##(2008-10#5)(2008-11#2)(2008-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
and 2004##10##2##(2008-10#5)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
and 2005##13##2##(2008-10#6)(2008-12#4)(2010-3#1)(2011-2#1)(2012-3#1)
and 2006##5##2##(2008-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-3#1)
and 2007##5##2##(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
and 2008 and##2##3##(2011-3#1)(2013-8#1)
and 2008##20##2##(2009-6#1)(2010-11#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#4)(2012-5#1)(2013-8#3)
and 2009##6##2##(2011-2#3)(2012-3#2)(2013-1#1)
and 2010##10##2##(1996-1#1)(2012-12#2)(2012-3#1)(2013-1#6)
and 2011##5##2##(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and 20th##2##2##(2008-6#1)(2012-3#1)
and 21 days after##2##4##(2008-10#2)
and 21 days##3##3##(1995-11#1)(2008-10#2)
and 21 degrees C##3##4##(2008-10#3)
and 21 in##3##3##(1992-12#1)(2010-1#1)(2010-5#1)
and 21##31##2##(1991-6#1)(1992-12#1)(1993-1#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#11)(2008-5#6)(2008-8#1)(2010-1#1)(2010-5#1)(2013-1#1)
and 21% with##2##3##(2008-3#1)(2011-3#1)
and 21%##3##2##(2008-10#1)(2008-3#1)(2011-3#1)
and 210 kDa)##2##3##(2008-11#2)
and 210##3##2##(2008-11#2)(2008-3#1)
and 22 degrees C##2##4##(2008-10#2)
and 22##31##2##(1991-6#2)(1991-8#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-3#1)(1996-8#1)(1997-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
and 22% of##3##3##(1994-8#1)(1997-2#1)(1997-8#1)
and 22%##5##2##(1994-8#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)
and 220##3##2##(2008-10#2)(2008-9#1)
and 223##2##2##(2008-10#2)
and 23 isolates of##2##4##(2008-10#2)
and 23 were##2##3##(1992-5#1)(2011-2#1)
and 23##29##2##(1990-2#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-11#1)(1995-9#1)(1996-5#3)(2008-10#6)(2008-11#2)(2008-12#3)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and 230##2##2##(2008-11#1)(2010-12#1)
and 2300 degrees C##3##4##(2008-10#3)
and 2300##4##2##(2008-10#4)
and 239##2##2##(1997-2#1)(2008-10#1)
and 24 degrees C##2##4##(2008-10#2)
and 24 h after##3##4##(1995-12#1)(2008-10#1)(2012-3#1)
and 24 h##7##3##(1990-12#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2012-3#1)
and 24 months##4##3##(1990-6#1)(1992-9#1)(1997-9#1)(2008-4#1)
and 24##36##2##(1990-12#1)(1990-5#2)(1990-6#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-8#1)(1994-8#1)(1995-12#2)(1995-8#1)(1997-9#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#2)
and 24%##3##2##(1990-6#1)(2008-10#2)
and 243##4##2##(2008-10#1)(2008-2#2)(2011-2#1)
and 24h urinary##2##3##(2011-2#2)
and 25 degrees C##12##4##(2008-10#10)(2008-7#1)(2009-7#1)
and 25 degrees##13##3##(2008-10#10)(2008-11#1)(2008-7#1)(2009-7#1)
and 25##44##2##(1993-12#1)(1993-2#1)(1994-2#1)(1994-8#1)(1997-8#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#1)
and 25%##9##2##(1990-2#1)(1991-8#1)(1996-12#1)(2008-10#4)(2011-2#1)(2013-8#1)
and 25-fold##2##2##(2006-6#1)(2008-10#1)
and 250##6##2##(2008-10#4)(2008-11#1)(2008-8#1)
and 2500 degrees C##2##4##(2008-10#2)
and 250mugl(-1)##2##2##(2008-10#2)
and 256 mg/kg##5##3##(2008-9#5)
and 256##6##2##(2008-9#5)(2013-1#1)
and 26##14##2##(1991-8#1)(1992-11#1)(1992-12#1)(1994-12#1)(2008-10#5)(2008-9#2)(2010-12#1)(2012-2#1)(2013-1#1)
and 26% of##2##3##(2008-10#1)(2008-11#1)
and 26%##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
and 266##2##2##(2008-11#1)(2012-2#1)
and 27##16##2##(1993-8#1)(1994-3#2)(1994-5#1)(1996-5#1)(2008-10#4)(2008-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and 27% of the##2##4##(1991-9#1)(1996-12#1)
and 27%##5##2##(1991-9#1)(1996-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
and 270##2##2##(2008-10#1)(2008-8#1)
and 28 days##2##3##(2008-10#2)
and 28 degrees C##4##4##(2008-10#2)(2008-11#1)(2010-1#1)
and 28##26##2##(1990-12#1)(1990-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-6#1)(1996-12#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-7#1)(2010-1#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#1)
and 28%##2##2##(2008-9#1)(2011-2#1)
and 285##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
and 288##2##2##(1991-12#1)(2012-12#1)
and 29 years##2##3##(2007-12#1)(2010-3#1)
and 29##20##2##(1990-2#1)(1991-1#1)(1993-12#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
and 29% at##2##3##(1991-9#1)(2011-3#1)
and 29%##5##2##(1991-9#1)(2008-10#2)(2008-8#1)(2011-3#1)
and 293 cells##2##3##(2008-11#2)
and 293##3##2##(2008-11#2)(2013-8#1)
and 294##3##2##(2008-3#2)(2011-2#1)
and 2971 cm(-1)##2##3##(2008-10#2)
and 2C##2##2##(1995-8#1)(2008-10#1)
and 2D NMR##4##3##(1994-5#1)(2010-2#1)(2010-6#1)(2013-1#1)
and 2D##6##2##(1993-8#1)(1994-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
and 2ngml(-1)##2##2##(2008-10#2)
and 3 M##2##3##(1991-7#1)(2008-10#1)
and 3 alpha##3##3##(1990-11#2)(1996-2#1)
and 3 and##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2009-11#1)
and 3 days##2##3##(2008-10#1)(2010-12#1)
and 3 had##4##3##(1994-3#1)(2008-10#1)(2011-2#2)
and 3 in the##2##4##(2008-10#1)(2011-2#1)
and 3 in##7##3##(1992-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#3)
and 3 months after##2##4##(1991-6#1)(2008-10#1)
and 3 months##8##3##(1991-6#1)(1993-12#3)(2008-10#1)(2011-2#2)(2013-1#1)
and 3 mug l(-1) for##2##5##(2008-10#2)
and 3 patients##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
and 3 weeks##2##3##(1994-5#1)(2011-2#1)
and 3 were##5##3##(1995-12#1)(2008-10#2)(2012-3#1)(2013-8#1)
and 3 with##3##3##(2008-11#1)(2008-7#2)
and 3 x##2##3##(1991-5#1)(2008-10#1)
and 3##250##2##(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-4#2)(1992-5#1)(1993-12#3)(1993-6#2)(1994-3#3)(1994-5#2)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#122)(2008-11#12)(2008-12#5)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#3)(2009-4#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#13)(2012-12#2)(2012-3#7)(2013-1#7)(2013-3#1)(2013-8#5)
and 3%##5##2##(1995-2#1)(2008-10#2)(2008-11#1)(2013-8#1)
and 3' UTR##2##3##(2008-10#1)(2008-8#1)
and 3' untranslated##2##3##(1993-2#1)(2008-10#1)
and 3'##17##2##(1993-2#1)(1996-6#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-8#4)(2010-5#2)
and 3'-NTR##2##2##(2008-10#2)
and 3'-end##2##2##(2008-10#2)
and 3'-terminal sequences of##2##4##(2008-10#1)(2008-9#1)
and 3'-terminal##3##2##(2008-10#2)(2008-9#1)
and 3)##17##2##(1990-2#1)(1991-2#1)(1993-1#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-8#1)
and 30 days##2##3##(2008-10#1)(2008-5#1)
and 30 degrees C##11##4##(2008-10#8)(2008-12#1)(2008-8#1)(2010-4#1)
and 30 degrees C) and##2##5##(2008-10#2)
and 30 degrees C)##3##4##(2008-10#3)
and 30 degrees##14##3##(2008-10#11)(2008-12#1)(2008-8#1)(2010-4#1)
and 30 min after##2##4##(1994-2#1)(2011-2#1)
and 30 min of##2##4##(2011-2#1)(2012-3#1)
and 30 min##8##3##(1993-1#2)(1994-2#1)(1994-3#1)(2008-10#1)(2011-2#2)(2012-3#1)
and 30 ng##2##3##(2008-10#2)
and 30 years##2##3##(2010-3#1)(2011-2#1)
and 30##77##2##(1990-2#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-12#5)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-7#3)(1997-8#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#1)
and 30% in##2##3##(2008-10#1)(2013-1#1)
and 30% of##2##3##(2008-3#1)(2012-2#1)
and 30%##12##2##(1995-11#1)(1995-3#1)(2008-10#7)(2008-3#1)(2012-2#1)(2013-1#1)
and 300 mg##2##3##(1991-3#1)(2011-2#1)
and 300##11##2##(1991-3#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)
and 3000##2##2##(1990-5#1)(1992-12#1)
and 300ngml(-1)##2##2##(2008-10#2)
and 301##2##2##(2008-10#2)
and 305##2##2##(2008-10#1)(2008-5#1)
and 31##14##2##(1991-3#1)(1991-8#2)(1993-8#1)(1994-1#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
and 31% of cationic arsenic##2##5##(2008-10#2)
and 31%##9##2##(1990-9#1)(1994-8#1)(2008-10#4)(2008-11#2)(2013-8#1)
and 31P##2##2##(1994-2#2)
and 32 +/-##2##3##(1996-2#1)(2008-10#1)
and 32 degrees C)##2##4##(2008-10#1)(2010-4#1)
and 32 degrees##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
and 32 microM phosphate ion##2##5##(2008-10#2)
and 32##22##2##(1991-12#1)(1994-12#1)(1994-5#1)(1996-2#1)(1996-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
and 32% of the##2##4##(2008-10#2)
and 32% of##3##3##(2008-10#2)(2008-5#1)
and 32%##4##2##(2008-10#3)(2008-5#1)
and 32%)##2##2##(2008-10#1)(2008-7#1)
and 320##2##2##(1992-6#1)(2011-2#1)
and 33##21##2##(1993-12#1)(1996-3#1)(1997-2#1)(2008-10#10)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
and 33%##4##2##(1990-3#1)(1991-2#1)(1994-8#1)(2008-5#1)
and 332##2##2##(2008-10#1)(2008-3#1)
and 336##3##2##(1990-11#1)(2008-10#1)(2013-1#1)
and 34##9##2##(1990-2#1)(1993-2#1)(1993-3#1)(1995-1#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)
and 34%##3##2##(2008-10#2)(2008-7#1)
and 340##2##2##(1994-5#1)(1996-6#1)
and 35 degrees C were established as providing the optimum##2##10##(2008-10#2)
and 35 degrees C were##4##5##(2008-10#4)
and 35 degrees C##10##4##(2008-10#8)(2008-2#1)(2009-8#1)
and 35 in##2##3##(2008-8#1)(2010-2#1)
and 35##28##2##(1990-3#1)(1990-6#1)(1994-3#1)(1996-5#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-2#1)
and 35% of the##2##4##(1997-2#1)(2008-10#1)
and 35%##3##2##(1997-2#1)(2008-10#2)
and 350##4##2##(1996-2#1)(2008-10#2)(2008-11#1)
and 357##2##2##(2008-10#1)(2011-2#1)
and 36 h##4##3##(1996-12#1)(2008-10#2)(2008-8#1)
and 36 isolates##2##3##(2008-10#2)
and 36##25##2##(1990-5#1)(1991-11#1)(1993-2#1)(1995-6#1)(1996-12#1)(1996-3#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#1)
and 36% of the##2##4##(2008-10#1)(2011-2#1)
and 36% of##4##3##(1991-8#1)(1993-8#1)(2008-10#1)(2011-2#1)
and 36%##8##2##(1990-2#1)(1991-8#1)(1993-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
and 360##2##2##(2008-10#1)(2008-5#1)
and 365##3##2##(2008-10#2)(2011-1#1)
and 37 degrees C were##2##5##(1992-3#1)(2008-10#1)
and 37 degrees C##10##4##(1991-9#1)(1992-3#1)(1993-8#1)(1996-12#1)(2008-10#3)(2008-5#3)
and 37 degrees##12##3##(1991-9#1)(1992-3#1)(1993-8#1)(1996-12#1)(2008-10#5)(2008-5#3)
and 37 of##2##3##(1994-1#1)(2008-10#1)
and 37##22##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-1#1)(1996-12#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-5#3)(2011-2#1)
and 37%##5##2##(1994-8#1)(1997-6#1)(2008-10#2)(2012-2#1)
and 38 ku##2##3##(2008-9#2)
and 38##17##2##(1990-3#1)(1991-8#1)(1992-5#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-10#6)(2008-9#2)(2013-1#1)
and 38% in##2##3##(2008-10#1)(2008-7#1)
and 38% of##2##3##(2008-7#1)(2008-9#1)
and 38%##10##2##(1997-3#1)(2008-10#4)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
and 39 weeks##2##3##(1996-11#1)(2008-9#1)
and 39##10##2##(1991-8#2)(1995-2#1)(1996-11#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-3#1)
and 39%##2##2##(2011-1#1)(2011-2#1)
and 394##2##2##(2008-10#1)(2012-3#1)
and 3D CT scan##2##4##(2010-3#2)
and 3D##8##2##(2008-11#1)(2010-12#2)(2010-3#2)(2010-8#2)(2012-3#1)
and 3b)##3##2##(1992-12#2)(2011-1#1)
and 3h##2##2##(2008-10#2)
and 4 h##5##3##(1994-12#1)(1995-11#1)(1996-12#1)(1997-2#1)(2013-1#1)
and 4 min##3##3##(2008-10#2)(2008-7#1)
and 4 months##3##3##(1991-6#1)(2008-10#1)(2013-1#1)
and 4 patients##3##3##(2008-7#2)(2012-3#1)
and 4 to##2##3##(2008-10#2)
and 4 weeks of##2##4##(2008-10#1)(2009-3#1)
and 4 weeks##7##3##(2008-10#3)(2008-11#2)(2009-3#2)
and 4 were##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
and 4##182##2##(1990-2#2)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#96)(2008-11#9)(2008-12#7)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-3#3)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#2)(2012-2#1)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
and 4% for##4##3##(2007-12#1)(2008-10#3)
and 4% of##2##3##(1996-1#1)(2008-10#1)
and 4%##8##2##(1996-1#1)(2007-12#1)(2008-10#6)
and 4) the##2##3##(1991-3#1)(1995-11#1)
and 4)##10##2##(1991-3#1)(1994-12#1)(1995-11#1)(2008-11#3)(2008-6#1)(2009-8#1)(2011-2#1)(2011-9#1)
and 4-aminoantipyrine##2##2##(2008-10#2)
and 4-ethyl##2##2##(2008-10#2)
and 4-hydroxynonenal##2##2##(2009-8#2)
and 40 degrees C##4##4##(2008-10#3)(2010-4#1)
and 40 healthy##2##3##(1991-8#1)(2008-12#1)
and 40 min##2##3##(2008-10#1)(2008-7#1)
and 40 samples##2##3##(2008-10#2)
and 40 times the##2##4##(1991-5#1)(1997-5#1)
and 40 years##2##3##(2012-3#2)
and 40##32##2##(1991-5#1)(1991-8#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-5#1)(2008-10#13)(2008-12#4)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#2)
and 40%##9##2##(1991-12#1)(1996-2#1)(2008-10#3)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
and 400 mOsm##2##3##(2008-11#2)
and 400##8##2##(1990-9#1)(1991-11#1)(1993-2#1)(2008-10#2)(2008-11#3)
and 41##5##2##(1991-6#1)(1993-2#1)(1995-12#1)(1997-8#1)(2008-10#1)
and 41%##4##2##(1991-8#1)(2008-10#1)(2008-9#1)(2012-3#1)
and 410##2##2##(1993-2#1)(1996-11#1)
and 42##10##2##(1990-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2013-1#2)
and 42%##3##2##(1993-12#1)(1993-2#1)(2008-10#1)
and 43##9##2##(1993-12#1)(1994-2#1)(1995-12#1)(2008-10#4)(2008-11#1)(2013-1#1)
and 43%##3##2##(1996-12#2)(2008-10#1)
and 430##2##2##(2008-10#1)(2008-11#1)
and 44##7##2##(1994-8#1)(1995-6#1)(1995-8#2)(2011-2#2)(2013-8#1)
and 44%##2##2##(2008-10#2)
and 45 degrees C##5##4##(2008-10#2)(2008-7#1)(2010-4#2)
and 45##21##2##(1992-2#1)(1993-1#1)(1994-12#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#3)(2010-4#2)(2013-1#3)
and 45%##4##2##(1990-8#1)(1992-12#1)(2008-10#1)(2013-1#1)
and 450 nm##2##3##(2008-10#1)(2008-11#1)
and 450##8##2##(1993-8#2)(1994-8#1)(2008-10#2)(2008-11#3)
and 45Ca uptake##2##3##(1993-3#2)
and 45Ca##3##2##(1993-3#3)
and 46##10##2##(2008-10#6)(2012-12#1)(2013-1#2)(2013-8#1)
and 46% of##2##3##(2008-10#2)
and 46%##3##2##(2008-10#2)(2008-7#1)
and 460 nm for##2##4##(2008-10#2)
and 469##2##2##(2008-11#2)
and 47##8##2##(1994-8#1)(2008-10#2)(2008-9#1)(2011-2#2)(2013-1#2)
and 47%##2##2##(2008-10#2)
and 48 h after##3##4##(2008-10#1)(2008-12#1)(2010-5#1)
and 48 h##7##3##(1995-12#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-5#1)
and 48##20##2##(1991-8#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#2)
and 48%##2##2##(1991-2#1)(2013-1#1)
and 480##2##2##(2008-10#1)(2010-4#1)
and 49##7##2##(1995-10#1)(1996-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
and 49%##2##2##(1994-8#1)(2008-10#1)
and 490nm##2##2##(2008-10#2)
and 4th##4##2##(1992-9#1)(1994-11#1)(2008-12#2)
and 5 and##5##3##(2008-10#4)(2009-12#1)
and 5 days per week##2##5##(2013-1#2)
and 5 days##5##3##(2008-10#1)(2008-7#1)(2013-1#3)
and 5 in the##3##4##(1992-2#1)(1997-6#1)(2008-5#1)
and 5 in##4##3##(1992-2#1)(1996-5#1)(1997-6#1)(2008-5#1)
and 5 kb)##2##3##(1995-6#1)(2008-10#1)
and 5 mM##3##3##(2008-10#3)
and 5 mg##2##3##(2008-10#2)
and 5 min after##2##4##(2008-12#1)(2012-3#1)
and 5 min of##2##4##(2008-10#2)
and 5 min##6##3##(2008-10#3)(2008-12#2)(2012-3#1)
and 5 ml##2##3##(2008-10#2)
and 5 on##2##3##(2008-10#2)
and 5 patients##2##3##(1994-12#1)(2008-7#1)
and 5 to##2##3##(2008-10#2)
and 5 weeks after##2##4##(2008-10#1)(2013-8#1)
and 5 weeks##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
and 5 were##5##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-5#1)(2010-9#1)
and 5 with##2##3##(1991-11#1)(2008-7#1)
and 5 wt##2##3##(2008-10#1)(2008-5#1)
and 5 x##4##3##(1991-5#1)(2008-10#2)(2008-7#1)
and 5 years##5##3##(1990-9#1)(2008-9#2)(2011-2#2)
and 5##215##2##(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-2#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-6#3)(1996-2#1)(1996-5#3)(1997-2#2)(1997-6#1)(1997-8#1)(2008-10#106)(2008-11#12)(2008-12#8)(2008-2#1)(2008-5#7)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#1)
and 5% for##2##3##(2008-10#2)
and 5% of##3##3##(2008-10#2)(2008-12#1)
and 5%##29##2##(1990-11#1)(1996-2#1)(1997-7#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#2)
and 5' flanking##3##3##(1991-5#1)(1993-12#1)(1994-11#1)
and 5'##4##2##(1991-5#1)(1993-12#1)(1994-11#2)
and 5'-fluorouracil##2##2##(1990-2#2)
and 5)##4##2##(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
and 5-10##2##2##(1990-12#1)(2008-10#1)
and 5-ASA##3##2##(2011-3#3)
and 5-HT transporter##2##3##(1994-2#2)
and 5-HT##6##2##(1990-5#1)(1994-2#4)(2008-7#1)
and 5-HT1E sites##3##3##(1994-2#3)
and 5-HT1E##6##2##(1994-2#6)
and 5-HTT315##3##2##(1996-12#3)
and 5-MTO##2##2##(1995-12#2)
and 5-fluorouracil##3##2##(1990-12#1)(1992-2#1)(1997-7#1)
and 5-year survival##2##3##(2010-12#1)(2011-3#1)
and 5-year##3##2##(2008-7#1)(2010-12#1)(2011-3#1)
and 50 degrees C##2##4##(1991-5#1)(2008-10#1)
and 50 mg##2##3##(2008-10#2)
and 50 mg/kg##3##3##(1996-2#1)(2008-10#1)(2010-1#1)
and 50 microM##3##3##(1990-12#1)(1994-3#1)(2010-6#1)
and 50 min##2##3##(2008-10#1)(2013-8#1)
and 50 ml L(-1))##2##4##(2008-12#2)
and 50 patients##2##3##(2011-2#2)
and 50 to##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
and 50##50##2##(1990-12#1)(1991-5#1)(1992-2#1)(1993-12#1)(1994-3#2)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-7#3)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and 50% of##2##3##(2008-9#1)(2013-1#1)
and 50%##19##2##(1990-12#1)(1992-3#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2011-2#1)(2013-1#3)
and 500 mug l(-1)##2##4##(2008-10#2)
and 500 mug##3##3##(2008-10#3)
and 500##16##2##(2008-10#12)(2008-11#2)(2008-9#1)(2012-12#1)
and 50mugl(-1)##2##2##(2008-10#2)
and 51##11##2##(2008-10#3)(2008-12#1)(2010-4#2)(2011-2#3)(2012-12#1)(2012-3#1)
and 51%##4##2##(2008-10#3)(2012-3#1)
and 512##2##2##(1996-2#1)(2008-10#1)
and 52##14##2##(1991-5#1)(1992-4#1)(1992-9#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-8#1)(2009-10#1)(2011-2#4)(2012-2#1)
and 52% were##2##3##(2008-10#1)(2010-1#1)
and 52%##7##2##(1990-12#1)(1991-2#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
and 520 nm##4##3##(2008-10#4)
and 520##5##2##(2008-10#4)(2008-8#1)
and 53##11##2##(1990-12#1)(1993-2#1)(1995-10#1)(1996-11#1)(2008-10#2)(2008-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
and 53% at##2##3##(2008-7#1)(2011-2#1)
and 53%##5##2##(1997-4#1)(2008-10#2)(2008-7#1)(2011-2#1)
and 54##10##2##(1994-8#1)(2008-10#5)(2008-11#2)(2011-2#1)(2013-1#1)
and 55 degrees C##3##4##(1990-5#1)(2008-10#2)
and 55##18##2##(1990-5#1)(1990-9#1)(1994-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#4)(2012-2#1)(2013-8#1)
and 55%##4##2##(1992-5#1)(1996-8#1)(2012-12#1)(2013-1#1)
and 56##12##2##(1990-12#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
and 56%##4##2##(2008-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
and 57##11##2##(1990-3#1)(1991-6#1)(1995-8#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#2)
and 57%##2##2##(1996-12#1)(2008-12#1)
and 58 kDa##3##3##(1995-12#1)(1996-12#2)
and 58##11##2##(1994-5#1)(1995-12#1)(1996-12#2)(2008-10#3)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
and 58% of the##3##4##(1991-9#1)(1993-8#1)(2013-1#1)
and 58%##7##2##(1991-9#1)(1993-1#1)(1993-8#1)(2008-10#2)(2012-3#1)(2013-1#1)
and 59##10##2##(1996-11#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-8#1)(2011-2#1)
and 59%##2##2##(1995-6#1)(2008-10#1)
and 5S##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
and 6 caused##2##3##(2008-10#2)
and 6 days##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
and 6 h##2##3##(2008-10#2)
and 6 have##2##3##(2008-4#1)(2008-7#1)
and 6 months after the##2##5##(2008-7#1)(2011-2#1)
and 6 months after##3##4##(2008-7#1)(2009-11#1)(2011-2#1)
and 6 months##12##3##(1993-12#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#2)(2011-2#1)(2013-1#1)
and 6 ng##2##3##(2008-10#2)
and 6 patients##2##3##(2008-7#1)(2010-2#1)
and 6 to 8##2##4##(2008-10#2)
and 6 weeks##4##3##(1994-3#1)(2008-10#2)(2011-2#1)
and 6 were##6##3##(2008-10#5)(2010-3#1)
and 6 with##3##3##(1991-3#1)(1994-12#1)(2011-2#1)
and 6 years##2##3##(2011-2#1)(2013-1#1)
and 6##151##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#77)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#2)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#6)
and 6%##11##2##(1995-10#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-7#2)
and 6)##5##2##(1990-2#1)(1992-4#1)(2008-10#2)(2008-4#1)
and 6-9 months following##2##4##(1995-2#2)
and 6-9##3##2##(1995-2#2)(2008-1#1)
and 6-methyl coumarin##2##3##(2008-11#2)
and 60 degrees C##2##4##(2008-10#1)(2008-5#1)
and 60 min##7##3##(1990-12#1)(1991-3#1)(1997-1#1)(2008-10#2)(2008-9#2)
and 60 months##2##3##(2012-12#1)(2013-1#1)
and 60##40##2##(1990-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-11#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#3)(2008-9#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
and 60% of##5##3##(1994-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-8#1)
and 60%##11##2##(1990-6#1)(1994-1#1)(1994-2#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-8#1)
and 60%fatigue##3##2##(2013-8#3)
and 600##6##2##(1996-3#1)(2008-10#3)(2010-8#1)(2012-2#1)
and 61##4##2##(1993-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
and 62##4##2##(1996-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
and 62%##3##2##(1992-3#1)(2008-10#2)
and 63##8##2##(1993-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#2)
and 63%##6##2##(1991-6#1)(1994-11#1)(2008-10#2)(2012-2#2)
and 64 years##2##3##(1991-1#1)(2011-2#1)
and 64##11##2##(1990-2#1)(1991-1#2)(1993-2#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#2)(2012-2#1)
and 64%##4##2##(1993-2#1)(2008-10#2)(2008-9#1)
and 65 years##3##3##(1997-4#1)(2010-3#2)
and 65##12##2##(1991-6#1)(1996-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#2)(2010-8#1)(2012-2#1)
and 65%##5##2##(2008-10#4)(2008-11#1)
and 66 kDa##2##3##(2008-11#1)(2008-5#1)
and 66##12##2##(1991-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
and 66%##3##2##(2008-10#2)(2013-7#1)
and 67##4##2##(1992-5#1)(2008-10#1)(2008-12#1)(2010-11#1)
and 67%##2##2##(1990-2#1)(1992-5#1)
and 68##7##2##(1995-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)(2013-8#1)
and 68%##7##2##(1993-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)(2013-1#1)
and 680##2##2##(2008-10#2)
and 69##4##2##(1992-4#1)(1997-5#1)(2008-12#1)(2011-3#1)
and 7 days##7##3##(1990-2#1)(1995-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
and 7 in##2##3##(2008-10#2)
and 7 months##2##3##(1994-3#1)(2008-7#1)
and 7 of the##2##4##(1994-5#1)(2008-10#1)
and 7 were##5##3##(1991-6#1)(1997-2#2)(2008-10#1)(2013-8#1)
and 7 with chronic##2##4##(1994-12#1)(2011-2#1)
and 7##123##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-5#1)(1997-2#4)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#61)(2008-11#3)(2008-12#3)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-10#1)(2011-2#6)(2012-2#1)(2013-1#8)(2013-8#2)
and 7% of##2##3##(1991-8#1)(2008-10#1)
and 7%##5##2##(1991-8#1)(2008-10#4)
and 7)##2##2##(1995-8#1)(2008-10#1)
and 7-hydroxymethylnalidixic acid##2##3##(2008-10#2)
and 70##15##2##(1993-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#2)
and 70% of##3##3##(1994-5#1)(2012-2#1)(2013-8#1)
and 70%##14##2##(1994-5#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-5#1)(2012-2#2)(2013-8#1)
and 700##4##2##(1994-8#1)(1995-2#1)(2008-10#2)
and 7000 infectious units/cell##2##4##(2008-11#2)
and 71##8##2##(1990-2#1)(1997-6#1)(2008-10#5)(2008-7#1)
and 71% of the##3##4##(2008-10#3)
and 71% of##4##3##(2008-10#3)(2008-9#1)
and 71%##7##2##(2008-10#3)(2008-12#1)(2008-9#2)(2013-1#1)
and 718##2##2##(2008-10#1)(2011-2#1)
and 72 h##4##3##(1995-11#1)(1996-12#1)(2008-10#1)(2008-12#1)
and 72##11##2##(1990-5#1)(1994-12#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-12#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and 72% of##2##3##(2008-10#1)(2013-1#1)
and 72%##5##2##(1996-6#1)(2008-10#1)(2009-4#1)(2012-12#1)(2013-1#1)
and 73##7##2##(1991-11#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
and 73%##3##2##(1994-2#1)(2008-8#1)(2009-10#1)
and 74 markers##3##3##(1996-12#3)
and 74##12##2##(1994-3#1)(1996-12#3)(1997-7#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#1)
and 74%##5##2##(1995-12#1)(1995-9#1)(2008-10#1)(2010-3#1)(2012-2#1)
and 740 nm##2##3##(2008-10#2)
and 75 %##2##3##(2008-8#1)(2012-12#1)
and 75 kDa##2##3##(1995-2#1)(2008-10#1)
and 75 ng##2##3##(2008-10#2)
and 75##17##2##(1993-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
and 75% with##2##3##(2008-10#2)
and 75%##8##2##(2008-10#3)(2008-8#1)(2009-10#1)(2009-6#1)(2010-7#1)(2013-1#1)
and 750##3##2##(2008-10#3)
and 76##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
and 76% for##2##3##(2008-10#1)(2011-2#1)
and 76%##4##2##(1996-9#1)(2008-10#2)(2011-2#1)
and 77##10##2##(1990-12#1)(1993-8#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-11#1)(2011-2#1)(2012-12#1)
and 77%##3##2##(1992-10#1)(2008-10#2)
and 78##12##2##(1990-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(2008-10#2)(2010-6#2)(2011-2#2)(2012-3#1)(2013-8#1)
and 79##11##2##(1991-12#1)(1997-8#1)(2008-10#4)(2008-9#1)(2009-9#1)(2010-7#1)(2012-12#1)(2013-1#1)
and 79%##2##2##(1995-11#1)(2013-8#1)
and 7DS##2##2##(2008-10#2)
and 7NSK2 induced##2##3##(2008-10#2)
and 7NSK2##3##2##(2008-10#3)
and 8 days##2##3##(1997-3#1)(2008-7#1)
and 8 degrees C##2##4##(2008-10#2)
and 8 h##2##3##(1996-12#1)(1996-2#1)
and 8 had##2##3##(2008-7#1)(2012-2#1)
and 8 mg l(-1)##2##4##(2008-10#2)
and 8 mg##4##3##(2008-10#2)(2008-12#2)
and 8 mug ml(-1) of##2##5##(2008-10#2)
and 8 mug##3##3##(2008-10#3)
and 8 of##3##3##(1991-2#1)(1993-8#1)(2012-2#1)
and 8 patients##3##3##(1990-12#1)(1991-11#1)(2010-3#1)
and 8 pg##2##3##(2008-10#1)(2011-3#1)
and 8 weeks##5##3##(1996-11#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-3#1)
and 8 with##2##3##(1992-2#1)(2008-10#1)
and 8 years##2##3##(1996-3#1)(2013-1#1)
and 8##133##2##(1990-12#2)(1990-5#2)(1990-8#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-2#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#4)(2007-11#1)(2008-10#55)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#3)(2009-3#1)(2009-7#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#1)
and 8% of the##2##4##(1990-5#1)(1993-12#1)
and 8% of##3##3##(1990-5#1)(1993-12#1)(2008-10#1)
and 8%##8##2##(1990-5#1)(1993-12#1)(1994-12#2)(2008-10#2)(2009-8#1)(2010-9#1)
and 8)##3##2##(1991-10#1)(1995-8#1)(2008-10#1)
and 8-hydroxyquinoline##2##2##(2008-10#2)
and 8-oxo-7##2##2##(2008-10#2)
and 80 to##2##3##(2008-10#2)
and 80 years##2##3##(1991-1#1)(2008-7#1)
and 80##22##2##(1991-1#1)(1993-3#1)(1995-12#1)(2008-10#11)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#4)
and 80% of##6##3##(1990-5#1)(1991-9#1)(2008-10#1)(2008-11#1)(2011-2#2)
and 80%##13##2##(1990-5#1)(1991-9#1)(1993-3#1)(1995-3#1)(1995-9#1)(2008-10#4)(2008-11#1)(2010-8#1)(2011-2#2)
and 80%)##2##2##(2008-10#1)(2013-8#1)
and 800 mg/L males and females at##2##7##(2008-9#2)
and 800 mg/L males and females##3##6##(2008-9#3)
and 800 mg/L males##4##4##(2008-9#4)
and 800 mg/L##8##3##(2008-9#8)
and 800 mg/kg##2##3##(2008-9#2)
and 800 nm##3##3##(2008-10#3)
and 800##16##2##(2008-10#5)(2008-11#1)(2008-9#10)
and 803##2##2##(1993-3#1)(2008-10#1)
and 81##12##2##(1997-4#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
and 81%##5##2##(2008-10#3)(2011-2#1)(2012-3#1)
and 82##10##2##(1991-6#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-8#1)(2012-2#1)
and 82% of##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
and 82%##5##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
and 83##4##2##(1994-2#1)(1996-9#1)(2008-10#1)(2012-12#1)
and 83%##3##2##(1992-6#1)(2008-10#1)(2011-2#1)
and 84##4##2##(2008-10#1)(2008-8#1)(2011-10#1)(2011-2#1)
and 84% of##3##3##(1991-5#1)(2008-10#1)(2011-2#1)
and 84%##4##2##(1991-5#1)(2007-8#1)(2008-10#1)(2011-2#1)
and 85 mum##2##3##(2008-10#2)
and 85##12##2##(1990-2#1)(1994-11#1)(1994-5#1)(2008-10#4)(2008-12#1)(2008-7#2)(2008-8#1)(2013-8#1)
and 85% of##3##3##(2008-10#3)
and 85%##10##2##(1991-8#1)(2008-10#8)(2008-3#1)
and 86##4##2##(2008-10#3)(2008-7#1)
and 86%##2##2##(2008-3#2)
and 87 were##2##3##(1994-3#1)(2008-1#1)
and 87##7##2##(1990-12#1)(1994-3#1)(2008-1#2)(2008-10#2)(2012-12#1)
and 87% of##2##3##(1994-2#1)(1997-3#1)
and 87%##4##2##(1994-11#1)(1994-2#1)(1995-8#1)(1997-3#1)
and 88##3##2##(2008-10#2)(2008-11#1)
and 88% of##2##3##(1993-11#1)(2010-7#1)
and 88%##4##2##(1993-11#1)(1993-2#1)(2010-7#1)(2011-2#1)
and 89##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
and 89%##5##2##(1995-12#1)(2008-10#3)(2008-7#1)
and 8b in CH(2)Cl(2) at -78 degrees C followed by##2##10##(1996-5#2)
and 8b in##3##3##(1996-5#3)
and 9 patients had##2##4##(1995-12#1)(2010-3#1)
and 9##61##2##(1990-3#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-3#1)(1995-12#3)(1996-12#4)(1997-7#1)(1997-8#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-6#1)(2008-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-3#3)(2013-1#2)
and 9%##2##2##(2008-10#2)
and 9)##3##2##(2008-10#2)(2008-11#1)
and 90 degrees C##2##4##(2008-10#1)(2008-12#1)
and 90 to##2##3##(2008-10#2)
and 90##16##2##(1992-3#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and 90%##6##2##(1991-6#1)(2008-10#3)(2008-7#1)(2012-2#1)
and 900##2##2##(2008-10#2)
and 91##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
and 92##8##2##(2008-10#3)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
and 92%##2##2##(2008-10#1)(2011-2#1)
and 93##5##2##(1994-12#1)(1997-1#1)(2008-10#1)(2008-12#1)(2010-1#1)
and 93%##4##2##(1995-2#1)(1996-9#1)(2008-10#1)(2008-8#1)
and 94##6##2##(1995-12#1)(1997-9#1)(2008-10#2)(2008-12#1)(2009-6#1)
and 94%##4##2##(1994-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
and 945##4##2##(1995-6#1)(2008-11#3)
and 95##18##2##(1990-2#1)(1992-3#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-11#1)(2011-2#4)(2013-1#1)(2013-8#2)
and 95% confidence intervals##2##4##(2011-2#2)
and 95% confidence##3##3##(2008-10#1)(2011-2#2)
and 95%##11##2##(2008-10#7)(2008-12#1)(2011-2#3)
and 96 h##4##3##(2008-10#1)(2008-12#2)(2008-8#1)
and 96##15##2##(1991-3#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-8#1)(2012-3#1)
and 96%##5##2##(1997-8#1)(2008-10#3)(2011-2#1)
and 97##10##2##(1992-3#1)(1996-11#1)(2008-10#7)(2008-9#1)
and 97%##5##2##(2008-10#3)(2008-3#1)(2012-2#1)
and 98##25##2##(1993-8#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
and 98%##4##2##(1993-6#1)(2008-10#2)(2008-11#1)
and 99##16##2##(2008-10#14)(2008-12#1)(2008-5#1)
and 99% of##2##3##(1995-3#1)(2008-10#1)
and 99%##6##2##(1995-3#1)(2008-10#5)
and A and##2##3##(1995-6#1)(2008-6#1)
and A beta##4##3##(1994-11#1)(1995-12#3)
and A##44##2##(1993-1#1)(1994-11#1)(1995-12#3)(1995-6#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-8#3)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#2)
and A+T-rich DNA analyses##3##4##(2008-10#3)
and A2 mating##2##3##(2008-10#2)
and A2##9##2##(1993-6#1)(2008-10#8)
and AA560##4##2##(1990-11#4)
and AAC were##2##3##(2008-10#2)
and AAC##3##2##(2008-10#3)
and AAL-TB##2##2##(2008-10#2)
and AAS##3##2##(2008-10#3)
and AB##2##2##(2008-10#2)
and AC##4##2##(2008-10#3)(2009-7#1)
and ACBP##4##2##(1994-8#4)
and ACC##3##2##(2010-7#1)(2011-10#1)(2011-2#1)
and ACD blood##6##3##(2011-2#6)
and ACT-toxin##2##2##(2008-10#2)
and AD##4##2##(2008-10#1)(2008-7#1)(2011-2#2)
and ADH##4##2##(1997-8#4)
and ADP##8##2##(1991-9#6)(2006-6#1)(2008-7#1)
and AF-toxins##2##2##(2008-10#2)
and AFLP Analyses##2##3##(2008-10#2)
and AFLP analyses##3##3##(2008-10#3)
and AFLP##10##2##(2008-10#10)
and AFS detection##3##3##(2008-10#3)
and AFS##5##2##(2008-10#5)
and AG-6 GV##2##3##(2008-10#2)
and AG-6##3##2##(2008-10#3)
and AG-8##2##2##(2008-10#2)
and AG-MIN##3##2##(2008-10#3)
and AH##2##2##(1995-1#1)(2009-7#1)
and AIDS##10##2##(1990-6#1)(1992-12#1)(1995-12#2)(1996-11#1)(1996-9#1)(1997-1#1)(2008-10#1)(2009-7#1)(2011-3#1)
and AII##5##2##(2008-10#5)
and ALP##4##2##(2008-11#3)(2012-3#1)
and AM1##2##2##(2008-10#1)(2008-11#1)
and AMBER##2##2##(1996-5#2)
and AML##3##2##(2006-6#1)(2010-1#1)(2011-2#1)
and AMP##5##2##(2008-10#2)(2008-8#3)
and AMPA##2##2##(2008-7#2)
and ANN##5##2##(2008-10#5)
and ANOVA##2##2##(1991-2#1)(2012-2#1)
and ANTA##4##2##(2008-11#4)
and AO##2##2##(2008-10#2)
and AP-PPG##2##2##(2008-4#2)
and API##2##2##(2008-10#2)
and APLP2 mRNA in##4##4##(1996-12#4)
and APLP2 mRNA##8##3##(1996-12#8)
and APLP2##9##2##(1996-12#9)
and ARG2(-/-) mice##2##3##(2013-8#2)
and AT-rich##2##2##(2008-12#1)(2008-8#1)
and ATP##11##2##(1991-5#1)(1993-6#1)(1993-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#2)
and ATP7B##3##2##(2012-2#3)
and AUC##2##2##(1994-12#1)(2008-11#1)
and Acinetobacter##2##2##(2012-2#1)(2013-8#1)
and Activation of##2##3##(2012-3#1)(2013-8#1)
and Activity##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
and Administration##2##2##(1991-12#1)(1992-1#1)
and Adolescent##4##2##(2008-11#2)(2010-1#2)
and Advance##2##2##(2008-8#2)
and Aelia##2##2##(2013-8#2)
and Afghanistan##3##2##(2012-2#1)(2013-1#2)
and Aflatoxin##2##2##(2008-10#1)(2013-1#1)
and African American men in##2##5##(2009-5#2)
and African American##4##3##(2008-12#1)(2009-5#2)(2012-3#1)
and African##6##2##(2008-12#2)(2009-10#1)(2009-5#2)(2012-3#1)
and Ag##2##2##(2008-10#1)(2010-11#1)
and Ag(+)##3##2##(2008-10#2)(2010-11#1)
and Ag(I)##4##2##(2008-10#4)
and Aggregation##2##2##(2008-10#2)
and Al were##2##3##(2008-10#2)
and Al##11##2##(2008-10#11)
and Al(3+)##4##2##(2008-10#4)
and Al(III)##6##2##(2008-10#6)
and Alizarin Red S##2##4##(2008-10#2)
and Alternaria alternata##2##3##(2008-10#2)
and Alternaria spp##2##3##(2013-1#2)
and Alternaria##6##2##(2008-10#4)(2013-1#2)
and Alzheimer's disease (AD)##2##4##(2008-7#1)(2009-10#1)
and Alzheimer's disease##4##3##(1992-12#1)(1996-12#1)(2008-7#1)(2009-10#1)
and Alzheimer's disease]##2##3##(1997-5#1)(2013-8#1)
and Alzheimer's##6##2##(1992-12#1)(1996-12#1)(1997-5#1)(2008-7#1)(2009-10#1)(2013-8#1)
and Amberlite XAD-7##2##3##(2008-10#2)
and Amberlite##4##2##(1992-12#1)(2008-10#3)
and American##7##2##(1991-1#1)(1991-2#1)(1996-6#1)(1997-8#1)(2008-11#1)(2010-11#1)(2013-8#1)
and Ammonium##2##2##(2008-10#1)(2008-11#1)
and Among##3##2##(2008-10#3)
and An##3##2##(2008-11#1)(2012-12#2)
and Andean isolates from##3##4##(2008-10#3)
and Ang II##2##3##(2008-1#2)
and Angiogenesis##2##2##(2008-11#1)(2010-1#1)
and Anglo##4##2##(2008-9#2)(2011-2#1)(2012-2#1)
and Aph3##3##2##(2008-10#3)
and Apoptotic##2##2##(2008-11#1)(2011-2#1)
and Apple##3##2##(2008-10#3)
and Application of##2##3##(2008-10#1)(2008-11#1)
and Application##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
and April##5##2##(1992-1#1)(2008-10#3)(2011-2#1)
and Arabidopsis thaliana##4##3##(1991-6#2)(2008-1#1)(2009-8#1)
and Arabidopsis##12##2##(1991-6#2)(2008-1#1)(2008-10#4)(2009-10#4)(2009-8#1)
and Arg##4##2##(1992-4#2)(2008-11#1)(2008-8#1)
and Arizona##3##2##(2008-10#1)(2011-2#2)
and Arp3##3##2##(2012-2#3)
and Arthus and delayed##2##4##(2008-7#2)
and Artificial Neural Networks##2##4##(2008-10#2)
and Aryl##2##2##(1996-5#1)(2010-8#1)
and As##4##2##(2008-10#4)
and As(III)##2##2##(2008-10#2)
and As(III+V)##2##2##(2008-10#2)
and As(V) in##10##3##(2008-10#10)
and As(V) were##4##3##(2008-10#4)
and As(V)##28##2##(2008-10#28)
and Asia##5##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)
and Asian##2##2##(1996-3#1)(2008-12#1)
and Aspergillus ear rots and##2##5##(2008-10#2)
and Aspergillus ear rots##3##4##(2008-10#3)
and Aspergillus ear##6##3##(2008-10#6)
and Aspergillus##12##2##(2008-10#7)(2008-5#3)(2009-6#1)(2012-3#1)
and Assessment##3##2##(2008-11#1)(2010-7#1)(2013-1#1)
and Attention##2##2##(2008-9#1)(2010-8#1)
and August##7##2##(1994-12#1)(2008-10#4)(2008-11#1)(2012-12#1)
and Australia##16##2##(1992-1#1)(1993-2#1)(1995-6#1)(2008-10#6)(2008-6#1)(2011-10#1)(2011-2#3)(2012-2#1)(2013-8#1)
and Australian##3##2##(2008-10#1)(2008-11#2)
and AvrTU##2##2##(2008-10#2)
and B cell##2##3##(1995-5#1)(2008-4#1)
and B in##3##3##(2008-10#3)
and B##110##2##(1990-5#2)(1990-9#1)(1992-5#1)(1993-11#1)(1994-5#2)(1995-2#1)(1995-5#1)(1997-2#9)(1997-7#1)(1997-8#4)(2008-10#56)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#6)(2012-8#1)(2013-8#3)
and B(12)##5##2##(2008-10#5)
and B(2)##2##2##(2008-10#2)
and B-cell##2##2##(1992-12#1)(2008-8#1)
and B-cells##2##2##(2008-10#2)
and B104##2##2##(1993-8#1)(2008-10#1)
and B4)##2##2##(2008-12#2)
and BALB/cByJ (mean##3##3##(2008-5#3)
and BAP##2##2##(2008-12#1)(2013-1#1)
and BAPP##2##2##(2008-2#2)
and BC(1)F(1) populations derived from##2##5##(2008-10#2)
and BC(1)F(1) populations##3##3##(2008-10#3)
and BCP(1)-selfed generations were##2##4##(2008-10#2)
and BCP(2)##3##2##(2008-10#3)
and BHK21##2##2##(2008-11#2)
and BHT##5##2##(1996-2#1)(2008-5#4)
and BI##2##2##(2008-10#1)(2012-3#1)
and BMI##7##2##(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)
and BRL 24924##4##3##(1990-5#4)
and BS##2##2##(2008-10#2)
and BSA##8##2##(2008-10#6)(2008-7#1)(2011-2#1)
and BUN##2##2##(1990-12#1)(1994-5#1)
and BV1##2##2##(2008-10#2)
and Ba(2+)##2##2##(2008-10#2)
and Ba)##2##2##(2008-10#2)
and Bacillus licheniformis##2##3##(2008-10#1)(2011-2#1)
and Bacillus subtilis##4##3##(1997-2#1)(2008-10#3)
and Bacillus##11##2##(1997-2#1)(2008-10#8)(2011-2#2)
and Bacteroides forsythus##3##3##(2008-12#3)
and Basic##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
and Bax##4##2##(2008-5#2)(2008-9#2)
and Bayer##2##2##(1996-5#1)(2008-3#1)
and Bayesian methods##3##3##(2008-10#2)(2010-4#1)
and Bayesian##9##2##(1994-9#1)(2008-10#6)(2010-11#1)(2010-4#1)
and Bean##3##2##(2008-10#3)
and Beer's law is obeyed in the range##2##8##(2008-10#2)
and Beer's law is obeyed##3##5##(2008-10#3)
and Beer's law##4##3##(2008-10#4)
and Bi in##5##3##(2008-10#5)
and Bi##11##2##(2008-10#11)
and Bim##3##2##(2013-1#3)
and Biocontrol##3##2##(2008-10#3)
and Biological Characterization of##5##4##(2008-10#5)
and Biological##8##2##(1994-12#1)(2008-10#7)
and Biostatistics##2##2##(2010-5#1)(2013-8#1)
and Birth##2##2##(2009-11#1)(2013-1#1)
and BisEMA##2##2##(2013-1#2)
and BisGMA##4##2##(2013-1#4)
and Blk##2##2##(1995-6#2)
and Blood Institute##2##3##(1992-12#1)(2013-1#1)
and BmNPV##2##2##(1997-3#1)(2008-11#1)
and Body Composition in##2##4##(2012-2#1)(2012-3#1)
and Botrytis cinerea##6##3##(2008-10#5)(2009-6#1)
and Botrytis##7##2##(2008-10#6)(2009-6#1)
and Bovine Parainfluenza type 3 virus##2##6##(2008-11#2)
and Box-Behnken##2##2##(2008-10#2)
and Brassica##3##2##(2008-10#1)(2011-1#1)(2011-10#1)
and Brazil##7##2##(1993-3#1)(2008-10#5)(2013-8#1)
and BrdU##2##2##(2007-12#1)(2008-9#1)
and Britain##3##2##(1990-6#1)(2008-10#1)(2008-8#1)
and British##2##2##(2008-10#1)(2008-5#1)
and Brome mosaic virus##2##4##(2008-10#2)
and Burkholderia##3##2##(2008-10#2)(2008-7#1)
and Burkitt lymphomas##2##3##(2009-8#2)
and C are##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
and C were##2##3##(2008-1#1)(2013-1#1)
and C##84##2##(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1995-6#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-1#1)(2010-12#5)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#2)
and C(18)##3##2##(2008-10#3)
and C)##3##2##(1995-6#1)(2008-10#2)
and C-banding##3##2##(2008-12#3)
and C-peptide##2##2##(1994-12#1)(2010-4#1)
and C-reactive protein##4##3##(1994-12#1)(2009-8#1)(2010-4#1)(2011-2#1)
and C-terminal##7##2##(1991-10#1)(1991-5#1)(1993-3#1)(1994-5#1)(1997-8#1)(2008-6#1)(2009-7#1)
and C1##3##2##(2008-10#2)(2013-1#1)
and C18##3##2##(1992-8#1)(2008-10#2)
and C2##5##2##(2008-10#2)(2008-12#1)(2012-3#1)(2013-1#1)
and C3 and C4 averaged##2##5##(2008-10#2)
and C3##5##2##(2008-10#2)(2013-1#3)
and C57##2##2##(1995-12#1)(2013-8#1)
and C57BL/6 mice##4##3##(1997-8#1)(2008-12#1)(2013-1#2)
and C6##4##2##(1992-6#2)(1993-6#1)(2013-1#1)
and C6-ceramide##2##2##(1995-12#1)(2011-2#1)
and C7##3##2##(2008-7#1)(2010-9#2)
and C77##4##2##(2008-10#4)
and CA##7##2##(1994-12#2)(1995-3#3)(2008-10#2)
and CA1##2##2##(1996-12#2)
and CA3 pyramidal##2##3##(1990-5#1)(2008-11#1)
and CA3##6##2##(1990-5#1)(1996-12#2)(2008-11#1)(2008-12#2)
and CAT##4##2##(1992-12#1)(1995-2#1)(2008-4#1)(2008-9#1)
and CCK-8##2##2##(1994-2#1)(2008-7#1)
and CD##5##2##(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
and CD11b##3##2##(1991-2#1)(2006-6#2)
and CD14##2##2##(2008-10#1)(2012-2#1)
and CD15 antigens##2##3##(1991-2#1)(2008-11#1)
and CD34(+) cells##2##3##(2008-8#2)
and CD4##3##2##(1990-12#1)(2008-8#1)(2012-12#1)
and CD4(+)##3##2##(2008-11#1)(2008-9#2)
and CD63##4##2##(1997-3#1)(2006-6#2)(2012-3#1)
and CD8##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
and CD8+##6##2##(1995-12#3)(1995-2#1)(1997-7#1)(2013-8#1)
and CD86##4##2##(2008-10#2)(2008-11#2)
and CDEA##2##2##(2008-10#2)
and CF##4##2##(2008-10#3)(2008-5#1)
and CFA##3##2##(2012-3#3)
and CGF-1##2##2##(1995-2#2)
and CGRP##4##2##(1992-6#2)(1997-3#2)
and CGRP-LI##2##2##(1994-8#2)
and CH _ 2##3##4##(2008-5#3)
and CHA0r##2##2##(2008-10#2)
and CHO cells##2##3##(2008-11#2)
and CHO##5##2##(2008-11#5)
and CHO-K1##3##2##(2008-11#3)
and CHS17##2##2##(2008-10#2)
and CI##2##2##(1996-2#1)(2008-8#1)
and CIho 10644##3##3##(2008-10#3)
and CK##2##2##(1994-12#1)(2008-11#1)
and CL##5##2##(2008-10#5)
and CLP##4##2##(2012-3#4)
and CMV##2##2##(2008-10#1)(2011-2#1)
and CN##3##2##(2008-9#2)(2011-2#1)
and CO##2##2##(1992-12#1)(2008-10#1)
and CO(2)##10##2##(2008-10#3)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)
and CO2##3##2##(1996-1#1)(1997-1#2)
and COMB##3##2##(1993-3#3)
and COMFORT-B##3##2##(2012-2#3)
and COONa groups##2##3##(1997-2#2)
and COPD##2##2##(1995-12#1)(2012-12#1)
and CP##7##2##(2008-10#6)(2011-2#1)
and CPB##2##2##(2008-11#1)(2012-3#1)
and CPT##3##2##(1994-8#2)(2007-12#1)
and CRC tissues##3##3##(2010-12#3)
and CRMs of##2##3##(1997-8#1)(2008-10#1)
and CRP##2##2##(2008-3#1)(2013-1#1)
and CRS##2##2##(2008-10#2)
and CS##2##2##(2008-10#2)
and CS-1##2##2##(2008-10#2)
and CSF##4##2##(1994-8#1)(2008-12#1)(2012-3#1)(2013-7#1)
and CT scan showed##2##4##(2013-1#2)
and CT scan##4##3##(2008-12#1)(2011-2#1)(2013-1#2)
and CT##17##2##(1996-6#1)(1997-3#1)(1997-8#1)(2008-12#1)(2008-7#2)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#3)
and CV##2##2##(2008-10#2)
and CVA4##3##2##(2013-8#3)
and CVd-III##2##2##(2008-10#2)
and CVd-IV##4##2##(2008-10#4)
and CXB H mice##2##4##(1994-5#2)
and CYP1A1##2##2##(1995-11#1)(2008-11#1)
and CYP2B1##3##2##(1994-8#3)
and Ca##5##2##(2008-10#1)(2008-5#1)(2009-6#2)(2009-8#1)
and Ca(2+) signaling##3##3##(2008-11#2)(2009-8#1)
and Ca(2+)##12##2##(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)
and Ca2+ in##2##3##(1994-5#1)(1997-1#1)
and Ca2+##11##2##(1991-5#1)(1994-11#1)(1994-5#1)(1995-6#4)(1996-2#2)(1997-1#1)(2009-10#1)
and CaCO(3)##2##2##(2013-1#2)
and CaCl(2)##3##2##(2008-10#3)
and CaMV##2##2##(2008-10#2)
and Campylobacter##2##2##(2007-12#1)(2008-10#1)
and Canada were##3##3##(2007-12#1)(2008-10#2)
and Canada##23##2##(1991-12#2)(1992-3#1)(1994-1#1)(1994-2#1)(2007-12#1)(2008-10#13)(2010-12#1)(2011-2#1)(2012-2#2)
and Canadian##6##2##(1993-12#1)(1993-3#1)(1996-3#1)(1997-2#1)(2008-10#1)(2013-8#1)
and Candida albicans##4##3##(2006-6#1)(2008-5#1)(2011-2#1)(2012-2#1)
and Candida glabrata##3##3##(2008-11#2)(2008-5#1)
and Candida spp##2##3##(2010-6#1)(2011-2#1)
and Candida##14##2##(1997-1#1)(2006-6#1)(2008-11#3)(2008-5#4)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
and Caribbean##2##2##(2008-11#1)(2010-10#1)
and Carnation Italian ringspot virus##2##5##(2008-10#2)
and Castleman disease##2##3##(2011-2#2)
and Caucasian populations##2##3##(2008-12#1)(2010-3#1)
and Caucasian##5##2##(2008-10#1)(2008-12#1)(2010-3#2)(2012-3#1)
and Caucasians##2##2##(2008-10#1)(2011-2#1)
and Cd in##3##3##(1990-5#1)(2008-10#2)
and Cd##19##2##(1990-5#1)(1993-12#1)(2008-10#17)
and Cd(2+)##12##2##(2008-10#11)(2008-11#1)
and Cd(II) were##2##3##(2008-10#2)
and Cd(II)##8##2##(2008-10#8)
and Cd)##3##2##(2008-10#3)
and CdL(2)##2##2##(2008-10#2)
and Ce##3##2##(2008-10#3)
and Ce(3+)##3##2##(2008-10#3)
and Ce(IV) in##2##3##(2008-10#2)
and Cell##3##2##(2008-10#2)(2008-11#1)
and Central##4##2##(1995-3#1)(2008-10#3)
and Cereal yellow dwarf virus-RPV##3##5##(2008-10#3)
and Cereal yellow dwarf##4##4##(2008-10#4)
and Cervical##4##2##(1997-1#3)(2008-12#1)
and Characterization of a##5##4##(2008-10#4)(2008-5#1)
and Characterization of##16##3##(2008-10#13)(2008-11#1)(2008-5#1)(2013-8#1)
and Charles##2##2##(2008-9#1)(2010-1#1)
and Chemical##2##2##(2008-10#1)(2013-8#1)
and Cherry##3##2##(2008-10#2)(2008-9#1)
and Chest##2##2##(2008-10#1)(2013-1#1)
and Chiba##4##2##(2008-10#4)
and Child Health##2##3##(1995-1#1)(2012-12#1)
and Child##4##2##(1995-1#1)(2010-6#2)(2012-12#1)
and Children##4##2##(1996-12#3)(2010-1#1)
and Chili veinal mottle virus##2##5##(2008-10#2)
and China##2##2##(2008-10#2)
and Chinese##9##2##(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
and Chlamydia##3##2##(2010-12#1)(2013-1#1)(2013-8#1)
and Cisplatin Followed by##2##4##(2008-10#2)
and Cisplatin##4##2##(2008-10#4)
and Cistanche##2##2##(2011-2#2)
and Citrus viroid##2##3##(2008-10#2)
and Citrus##5##2##(2008-10#5)
and Cl##3##2##(2008-9#3)
and Cladosporium##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
and Clare Vaughan##2##3##(1996-8#2)
and Class##2##2##(2008-11#2)
and Clinical##8##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
and ClustalX##2##2##(2008-9#2)
and Co##11##2##(2008-10#7)(2008-5#2)(2010-6#1)(2010-7#1)
and Co(II) were##3##3##(2008-10#3)
and Co(II)##21##2##(2008-10#21)
and Coast##4##2##(2008-10#1)(2011-2#2)(2012-3#1)
and Cochliobolus##2##2##(2008-10#2)
and Cochrane Database of Systematic Reviews##2##6##(2013-1#2)
and Cochrane databases##2##3##(2013-1#2)
and Cochrane##4##2##(2013-1#4)
and Cognitive##2##2##(2008-11#1)(2012-3#1)
and Cohen's kappa##2##3##(1997-8#1)(2010-1#1)
and Colletotrichum##3##2##(1997-4#1)(2008-10#2)
and Colocasia##2##2##(2008-10#2)
and Colombia##7##2##(2008-10#3)(2008-5#2)(2012-12#2)
and Colonization of##3##3##(2008-10#3)
and Common##3##2##(2008-10#3)
and Community Medicine##2##3##(1996-1#1)(1997-3#1)
and Community##5##2##(1991-1#1)(1993-5#1)(1996-1#1)(1997-3#1)(2010-10#1)
and Concanavalin##2##2##(1991-12#1)(1992-12#1)
and Conformations of##2##3##(1996-5#1)(2008-10#1)
and Control of##3##3##(1996-9#1)(2008-10#1)(2008-11#1)
and Control##6##2##(1996-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#1)
and Costa Rica##2##3##(1990-6#1)(2008-10#1)
and Cougarblight##4##2##(2008-10#4)
and CpG##2##2##(1991-6#1)(1995-8#1)
and Cr (III)##2##3##(2008-10#2)
and Cr and##2##3##(2008-10#1)(2008-11#1)
and Cr##20##2##(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)
and Cr(III) in the##2##4##(2008-10#2)
and Cr(III) in##4##3##(2008-10#4)
and Cr(III)##20##2##(2008-10#20)
and Cr(VI) species in##2##4##(2008-10#2)
and Cr(VI) species##3##3##(2008-10#3)
and Cr(VI)##22##2##(2008-10#22)
and Croatian##2##2##(2008-10#1)(2013-1#1)
and Crohn's disease##3##3##(1995-8#1)(2010-12#1)(2011-2#1)
and Crop##4##2##(2008-10#4)
and Crown##2##2##(2008-10#2)
and Cryptosporidium spp##3##3##(2012-12#3)
and Cryptosporidium##5##2##(2007-12#1)(2012-12#4)
and Csp I)##2##3##(1992-6#2)
and Cu and##2##3##(2008-10#2)
and Cu for##2##3##(2008-10#2)
and Cu in##4##3##(2008-10#4)
and Cu were##4##3##(2008-10#3)(2008-11#1)
and Cu##28##2##(2008-10#27)(2008-11#1)
and Cu(2+)##10##2##(2008-10#10)
and Cu(II) ions##2##3##(2008-10#2)
and Cu(II) were 0##2##4##(2008-10#2)
and Cu(II) were##3##3##(2008-10#3)
and Cu(II)##20##2##(2008-10#20)
and Cu)##3##2##(2008-10#3)
and Current##2##2##(2011-2#1)(2013-1#1)
and Cy3##2##2##(2008-10#1)(2010-12#1)
and Cypress##2##2##(2008-10#2)
and Cys##5##2##(1993-12#1)(1995-8#1)(2008-10#3)
and Cytochemical##4##2##(2008-10#4)
and D are##2##3##(1997-1#1)(2008-10#1)
and D were##2##3##(2013-1#2)
and D##45##2##(1991-5#1)(1993-2#1)(1995-6#6)(1996-2#2)(1997-1#4)(2008-10#15)(2008-11#4)(2008-12#1)(2008-6#3)(2009-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)
and D)##2##2##(2008-10#1)(2008-7#1)
and D-amino acid##2##3##(1995-11#1)(2008-10#1)
and D-amphetamine##3##2##(1993-3#3)
and D-proline##2##2##(2008-10#1)(2008-5#1)
and D-serine##2##2##(1995-11#1)(2012-2#1)
and D2 receptors##3##3##(1993-9#1)(2008-5#1)(2008-7#1)
and D2##4##2##(1993-9#1)(2008-5#1)(2008-7#1)(2013-8#1)
and D3##3##2##(1993-3#1)(1993-9#1)(2008-5#1)
and DA##11##2##(1994-2#1)(1996-12#4)(2008-10#6)
and DAD##2##2##(2011-2#2)
and DAI (Pearson r =##2##5##(2011-3#2)
and DBA/2 mice##2##3##(1993-12#1)(1996-12#1)
and DBP (p&lt##2##3##(2008-10#2)
and DBP##4##2##(2008-10#3)(2013-8#1)
and DEAE##2##2##(1992-12#1)(2008-10#1)
and DHA##3##2##(1994-8#1)(2008-11#1)(2010-1#1)
and DHAA##2##2##(1993-3#2)
and DMDS##2##2##(2008-10#2)
and DMSO##3##2##(2008-10#2)(2011-1#1)
and DNA binding##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
and DNA content##2##3##(2008-11#1)(2008-9#1)
and DNA damage##2##3##(2008-10#1)(2011-1#1)
and DNA end-joining##2##3##(2013-1#2)
and DNA fingerprint##2##3##(2008-10#2)
and DNA fingerprints were used to##2##6##(2008-10#2)
and DNA fingerprints##4##3##(2008-10#4)
and DNA polymorphism##2##3##(2008-10#2)
and DNA repair##4##3##(1993-12#1)(2008-11#1)(2008-9#1)(2011-2#1)
and DNA sequence analysis of##2##5##(2008-10#2)
and DNA sequence analysis##3##4##(1993-12#1)(2008-10#2)
and DNA sequence##4##3##(1993-12#1)(2008-10#3)
and DNA sequences##3##3##(2008-2#1)(2008-4#2)
and DNA sequencing of##3##4##(2008-10#2)(2008-8#1)
and DNA sequencing##7##3##(2008-10#5)(2008-8#2)
and DNA synthesis in##2##4##(1995-12#1)(1995-2#1)
and DNA synthesis##9##3##(1990-11#1)(1992-10#1)(1993-11#1)(1993-8#1)(1995-12#2)(1995-2#1)(1995-8#1)(1997-1#1)
and DNA##88##2##(1990-11#1)(1992-10#1)(1992-3#5)(1993-11#1)(1993-12#3)(1993-8#2)(1994-11#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#3)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#2)(2008-8#5)(2008-9#9)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-4#1)(2013-1#3)
and DNA-B##11##2##(2008-10#11)
and DNA-DNA##2##2##(2008-10#2)
and DNA-binding##2##2##(1997-7#1)(2012-2#1)
and DNA-nicking domains##2##3##(2008-10#2)
and DON##11##2##(2008-10#11)
and DR##2##2##(1997-8#1)(2011-2#1)
and DSC##3##2##(2008-5#1)(2009-7#1)(2011-3#1)
and DSM-IV##2##2##(1997-8#2)
and DT##5##2##(1995-11#4)(2013-1#1)
and DV##2##2##(1991-9#2)
and DVB/CAR/PDMS##2##2##(2008-10#2)
and Datura##2##2##(2008-10#2)
and David##2##2##(1990-8#1)(2008-11#1)
and De##2##2##(2010-4#1)(2012-2#1)
and December 1988##2##3##(1990-12#2)
and December 1994##4##3##(1994-9#1)(1995-3#1)(1996-2#1)(2008-11#1)
and December##15##2##(1990-12#2)(1991-8#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
and Department of##3##3##(1992-12#1)(2013-8#2)
and Detection of##4##3##(2008-10#4)
and Development of##5##3##(2008-10#5)
and Development##16##2##(1993-2#1)(1993-3#2)(1994-1#1)(1994-9#2)(1995-2#1)(2008-10#5)(2008-11#3)(2009-5#1)
and Discussion##2##2##(2007-8#1)(2010-12#1)
and Disease##3##2##(1996-2#1)(2008-10#2)
and Dispersal of Ascospores##2##4##(2008-10#2)
and Distribution of##2##3##(2008-10#2)
and Distribution##3##2##(2008-10#2)(2012-12#1)
and Dithizone##2##2##(2008-10#2)
and Diversity of##3##3##(2008-10#3)
and Doehlert##3##2##(2008-10#3)
and Drosophila melanogaster##2##3##(1993-12#1)(1995-6#1)
and Drosophila##4##2##(1993-12#1)(1995-6#1)(2008-9#2)
and Drug##35##2##(1995-8#1)(1996-5#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#2)(2010-6#2)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)
and E and##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2012-3#1)
and E were##3##3##(2008-10#2)(2011-2#1)
and E##46##2##(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#3)(2010-3#2)(2010-4#2)(2011-2#3)(2012-3#1)(2013-1#1)
and E2##7##2##(1990-11#1)(2008-10#2)(2008-11#2)(2008-8#2)
and E3##5##2##(2008-10#3)(2008-11#1)(2009-10#1)
and E7##5##2##(1995-2#4)(2008-9#1)
and EC##5##2##(2008-10#2)(2012-4#2)(2013-8#1)
and ECF bleaching sequences##2##4##(2008-6#2)
and ECS##2##2##(1996-12#2)
and EDTA as##2##3##(2008-10#2)
and EDTA##9##2##(1994-5#1)(1994-8#1)(2008-10#7)
and EGF receptor##2##3##(2008-6#1)(2013-7#1)
and EGF##11##2##(1991-12#6)(1994-3#1)(2008-6#3)(2013-7#1)
and EIA##2##2##(1990-9#1)(2008-10#1)
and ELISA##9##2##(1990-12#1)(2008-10#6)(2008-6#1)(2008-9#1)
and EMBASE##4##2##(1994-3#2)(2013-1#2)
and EMV##2##2##(2008-10#2)
and ENETS grading systems were not##2##6##(2011-2#2)
and ENRO##3##2##(2008-10#3)
and EPA##2##2##(1991-12#1)(2008-10#1)
and EPS I##3##3##(2008-10#3)
and ER##5##2##(1993-1#2)(1997-7#1)(2008-12#1)(2011-2#1)
and ESI-MS##2##2##(2008-10#2)
and East Chapman##3##3##(2008-10#3)
and East##4##2##(2008-10#3)(2008-12#1)
and EcoRI##2##2##(1992-3#1)(1993-12#1)
and Economic##2##2##(1994-3#1)(2008-10#1)
and Edman degradation##2##3##(1990-5#1)(2010-4#1)
and Effects of##3##3##(2008-10#2)(2012-2#1)
and Effects##4##2##(2008-10#3)(2012-2#1)
and Electron##2##2##(1996-9#1)(2008-10#1)
and Emergency##2##2##(2008-11#1)(2013-1#1)
and Emotional State##2##3##(2013-1#2)
and End Results (SEER)##2##4##(1997-3#1)(2012-3#1)
and End Results##3##3##(1997-3#1)(2012-3#2)
and English##9##2##(2008-11#1)(2008-5#1)(2009-7#3)(2011-2#4)
and Enhanced##2##2##(2013-1#1)(2013-7#1)
and Enterobacter cloacae##3##3##(2008-11#1)(2008-9#1)(2010-6#1)
and Environmental Factors##2##3##(2008-10#1)(2008-11#1)
and Environmental Sciences##2##3##(2008-10#2)
and Environmental##6##2##(2008-10#3)(2008-11#1)(2008-3#1)(2010-4#1)
and Erwinia##2##2##(2008-10#2)
and Escape##2##2##(2008-10#2)
and Escherichia coli genes##2##4##(1997-6#2)
and Escherichia coli##5##3##(1994-11#1)(1997-2#1)(1997-6#2)(2008-10#1)
and Escherichia##7##2##(1994-11#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-11#1)(2012-2#1)
and Ethibond suture as##2##4##(2012-3#2)
and Ethibond suture##3##3##(2012-3#3)
and Eu(3+)##3##2##(2008-10#3)
and Europe##12##2##(1994-3#1)(1995-3#1)(2008-10#7)(2009-4#2)(2012-12#1)
and European##8##2##(2008-1#1)(2008-10#2)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
and Euscelis incisus##2##3##(2008-10#2)
and Evaluation of##3##3##(2008-10#3)
and Evaluation##6##2##(2008-10#3)(2008-11#1)(2011-9#1)(2012-12#1)
and Evans##2##2##(1997-2#1)(2008-5#1)
and Experiment##2##2##(2008-11#1)(2008-6#1)
and Experimental##2##2##(1996-5#1)(2008-3#1)
and Express Five SFM##2##4##(2008-7#2)
and Expression of##6##3##(2008-10#5)(2008-6#1)
and F and##2##3##(2008-6#2)
and F##54##2##(2008-10#43)(2008-11#1)(2008-6#6)(2008-9#2)(2011-2#1)(2013-1#1)
and F(1)##7##2##(2008-10#5)(2008-8#1)(2013-1#1)
and F(2##3##2##(2008-10#3)
and F(2)##6##2##(2008-10#4)(2008-8#2)
and F(3) progeny##2##3##(2008-10#2)
and F(3)##7##2##(2008-10#7)
and F1##2##2##(1994-8#1)(2008-12#1)
and F2##7##2##(1996-12#1)(2008-10#4)(2008-12#2)
and F3##2##2##(2008-10#1)(2009-2#1)
and FBS##2##2##(1997-8#1)(2008-10#1)
and FCFP##2##2##(2011-2#2)
and FDA##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
and FGA##2##2##(2008-12#2)
and FGD type##2##3##(2011-1#2)
and FGF##2##2##(1997-1#2)
and FHB resistance##2##3##(2008-10#2)
and FHB##3##2##(2008-10#3)
and FI##5##2##(2008-10#5)
and FIA variables##2##3##(2008-10#2)
and FIA##4##2##(2008-10#4)
and FIR##2##2##(2010-8#2)
and FIS1B##4##2##(2009-10#4)
and FISH##4##2##(1997-3#1)(2008-9#1)(2009-8#1)(2012-3#1)
and FK506##2##2##(1991-9#2)
and FKBP-FK506##2##2##(1991-9#2)
and FN of##2##3##(2008-12#2)
and FP##2##2##(1996-1#1)(1996-2#1)
and FT-IR##3##2##(2008-10#2)(2013-8#1)
and FT-Raman##2##2##(2008-10#2)
and FT3##2##2##(2012-3#2)
and FTIR##3##2##(2008-10#3)
and FYY140-142GSA TCS##2##3##(2008-10#2)
and Factor##2##2##(1994-11#1)(2008-5#1)
and Faculty of Medicine##2##4##(2008-10#2)
and Family##3##2##(1990-6#1)(1996-3#1)(2009-9#1)
and Fatigue##2##2##(2008-7#1)(2010-7#1)
and FcgammaR/CR co-operation##2##3##(2008-10#2)
and Fe concentrations##2##3##(2008-10#2)
and Fe in##6##3##(2008-10#6)
and Fe were##3##3##(2008-10#3)
and Fe##25##2##(1996-2#1)(2008-10#22)(2008-12#1)(2013-1#1)
and Fe(2+)##2##2##(2008-10#2)
and Fe(3+) and##2##3##(2008-8#1)(2010-11#1)
and Fe(3+)##10##2##(2008-10#6)(2008-8#1)(2008-9#2)(2010-11#1)
and Fe(II)##14##2##(2008-10#14)
and Fe(III) can be determined in the##2##7##(2008-10#2)
and Fe(III) can be determined##3##5##(2008-10#3)
and Fe(III) can be##4##4##(2008-10#4)
and Fe(III) can##5##3##(2008-10#5)
and Fe(III) in##6##3##(2008-10#6)
and Fe(III) is##2##3##(2008-10#2)
and Fe(III) were##3##3##(2008-10#3)
and Fe(III)##36##2##(2008-10#35)(2010-4#1)
and FeSO(4)##2##2##(2008-10#1)(2008-11#1)
and February##2##2##(2008-7#1)(2012-12#1)
and Field Conditions##2##3##(2008-10#2)
and Field##3##2##(2008-10#3)
and Fisher's##4##2##(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
and Florida##6##2##(1994-3#1)(1996-5#2)(2008-10#2)(2011-1#1)
and Fo47##3##2##(2008-10#3)
and Fourier transform infrared (FTIR) spectrometric detection has been developed for the determination of##2##14##(2008-10#2)
and Fourier transform infrared (FTIR)##3##5##(2008-10#3)
and Fourier transform infrared spectrometry (FTIR)##2##6##(2008-10#2)
and Fourier transform infrared spectrometry##3##5##(1997-2#1)(2008-10#2)
and Fourier transform infrared spectroscopy##3##5##(2008-10#2)(2013-1#1)
and Fourier transform infrared##10##4##(1997-2#1)(2008-10#8)(2013-1#1)
and Fourier transform mid infrared spectroscopy##2##6##(2008-10#2)
and Fourier transform##12##3##(1997-2#1)(2008-10#10)(2013-1#1)
and France##5##2##(2008-10#4)(2011-2#1)
and Fruit##2##2##(2008-10#1)(2012-3#1)
and Function of##2##3##(2008-6#1)(2010-1#1)
and Function##3##2##(2008-6#1)(2009-4#1)(2010-1#1)
and Functional##5##2##(2008-4#1)(2008-7#1)(2011-8#1)(2012-12#1)(2012-2#1)
and Fusarium oxysporum f##2##4##(2008-10#2)
and Fusarium oxysporum##4##3##(2008-10#4)
and Fusarium spp##2##3##(2011-2#1)(2013-1#1)
and Fusarium wilt##2##3##(2008-10#2)
and Fusarium##19##2##(2008-10#16)(2010-7#1)(2011-2#1)(2013-1#1)
and Future##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
and Fuzzy##2##2##(2008-10#1)(2010-8#1)
and G proteins##2##3##(1993-9#1)(1995-11#1)
and G##16##2##(1993-9#1)(1995-11#1)(1995-8#2)(2008-10#5)(2008-11#1)(2008-6#1)(2008-9#1)(2010-7#2)(2011-1#1)(2011-2#1)
and G(2)/M phases##2##3##(2008-11#1)(2010-2#1)
and G2 phases of##2##4##(1994-3#1)(2008-9#1)
and G2##5##2##(1994-3#1)(1994-5#1)(1997-3#1)(2008-10#1)(2008-9#1)
and G3##2##2##(1995-6#1)(2013-1#1)
and G4##2##2##(2013-1#2)
and GABA##7##2##(1992-12#1)(1995-2#1)(1996-12#1)(1997-2#3)(2008-7#1)
and GABA(A) receptors##2##3##(2008-8#2)
and GABA(A)##3##2##(2008-8#3)
and GABAB##3##2##(1995-11#1)(2008-7#1)(2013-8#1)
and GABAergic interneurons##2##3##(2009-8#1)(2013-8#1)
and GABAergic##4##2##(1995-2#1)(2008-7#1)(2009-8#1)(2013-8#1)
and GART)##2##2##(1997-8#2)
and GATA##2##2##(2012-2#1)(2012-3#1)
and GBC mutants##2##3##(2008-10#2)
and GBMT##2##2##(1994-8#2)
and GBW##2##2##(2008-10#2)
and GC##2##2##(2013-1#2)
and GC-MS##9##2##(1997-1#1)(2008-10#6)(2008-11#1)(2012-2#1)
and GC/MS##8##2##(2008-10#4)(2008-11#2)(2008-12#2)
and GC/MS/MS##2##2##(2008-10#2)
and GDP##2##2##(1991-2#1)(1991-5#1)
and GE##2##2##(2013-1#2)
and GEPR-9##6##2##(1996-12#6)
and GFAAS determination##2##3##(2008-10#2)
and GFAAS##6##2##(2008-10#6)
and GH##11##2##(1991-9#1)(1994-8#5)(1995-8#1)(1996-2#2)(1997-2#1)(2010-5#1)
and GHPSAM##3##2##(2008-10#3)
and GIP(7-30)##2##2##(1997-4#2)
and GLP##3##2##(1995-8#3)
and GLP-1##2##2##(2011-2#1)(2012-3#1)
and GM-CSF##2##2##(2008-10#1)(2008-8#1)
and GM-CSF)##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
and GM4##2##2##(2008-10#2)
and GMP##3##2##(1992-8#1)(2008-11#1)(2012-2#1)
and GPDH##2##2##(2008-11#2)
and GR##4##2##(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)
and GRPR##3##2##(2010-6#3)
and GS##2##2##(2008-11#2)
and GSH##6##2##(1993-8#1)(2008-10#2)(2011-3#1)(2012-3#1)(2013-1#1)
and GST##2##2##(1990-2#1)(2011-10#1)
and GTP gamma##3##3##(1991-6#1)(1993-8#1)(1994-3#1)
and GTP##4##2##(1991-6#1)(1993-8#1)(1994-3#1)(1995-6#1)
and Gadd45##3##2##(2008-9#3)
and Gd(III)##2##2##(2008-10#2)
and Gen11 were##2##3##(2011-10#2)
and Gene##2##2##(2008-10#1)(2012-12#1)
and General##2##2##(1994-1#1)(2008-10#1)
and Genetic Analysis of##2##4##(2008-10#2)
and Genetic##8##2##(2008-10#8)
and Genome##2##2##(2008-10#1)(2012-3#1)
and Genomic##2##2##(2008-10#2)
and Genotype##2##2##(2008-10#2)
and Georgia##3##2##(1991-1#1)(2008-10#2)
and German measles##5##3##(2012-12#5)
and German##9##2##(1995-1#1)(2008-10#2)(2008-11#1)(2012-12#5)
and Giardia spp##2##3##(2012-12#2)
and Glenn counties##2##3##(2008-10#2)
and Gliocladium roseum##3##3##(2008-10#3)
and Golgi##3##2##(1994-11#1)(2008-5#1)(2009-8#1)
and Good##2##2##(2012-12#1)(2013-1#1)
and Graves' disease##2##3##(1990-6#1)(2012-3#1)
and Graves'##4##2##(1990-6#1)(1995-12#2)(2012-3#1)
and Great##2##2##(2008-10#1)(2013-8#1)
and Group 2##2##3##(1995-12#1)(2011-1#1)
and Group II##4##3##(1995-12#1)(2007-8#1)(2008-10#2)
and Group II's##2##3##(1993-2#2)
and Group##11##2##(1993-2#2)(1995-12#2)(2007-8#1)(2008-10#2)(2010-4#1)(2010-7#2)(2011-1#1)
and Growth of##3##3##(2008-10#3)
and Growth##5##2##(2008-10#4)(2012-2#1)
and H##13##2##(1993-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-9#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
and H'##2##2##(2008-8#2)
and H(+) in##2##3##(2008-10#2)
and H(+)##3##2##(2008-10#3)
and H(2)##3##2##(2008-10#1)(2010-4#2)
and H(2)O##6##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
and H(2)O(2) in##2##3##(2008-10#2)
and H(2)O(2) production##2##3##(2008-10#1)(2008-11#1)
and H(2)O(2) was##2##3##(2008-10#2)
and H(2)O(2)##20##2##(2008-10#17)(2008-11#1)(2009-8#1)(2010-7#1)
and H-point##2##2##(2008-10#2)
and H10##2##2##(1990-12#2)
and H2O##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
and H2O2##3##2##(1994-8#1)(1995-8#1)(2013-8#1)
and HA##2##2##(2008-10#1)(2010-10#1)
and HB##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
and HBV##3##2##(1995-2#1)(2008-8#1)(2009-5#1)
and HC##3##2##(2008-10#1)(2013-8#2)
and HC-toxin##2##2##(2008-10#2)
and HCB##2##2##(2008-10#1)(2008-11#1)
and HCC##2##2##(1993-2#1)(2013-8#1)
and HCV##2##2##(1991-8#1)(2008-10#1)
and HCl##9##2##(2008-10#8)(2009-10#1)
and HDL##2##2##(1991-2#1)(2008-6#1)
and HEC gel##2##3##(2008-5#2)
and HF with##2##3##(2008-10#2)
and HF##4##2##(2008-10#4)
and HFA227##2##2##(1996-1#2)
and HG##2##2##(1992-8#1)(2008-1#1)
and HGC (Pearson r =##2##5##(2011-3#2)
and HGC##3##2##(2011-3#3)
and HIIE##2##2##(2013-8#2)
and HIV in##3##3##(2008-10#1)(2011-2#2)
and HIV infection##3##3##(1990-2#1)(1992-12#1)(1993-11#1)
and HIV prevention##2##3##(2009-5#2)
and HIV sexual risk behavior##2##5##(2008-12#2)
and HIV##24##2##(1990-2#1)(1991-1#1)(1992-12#1)(1993-11#2)(1993-8#1)(1994-11#2)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-12#2)(2009-5#2)(2009-8#1)(2010-7#1)(2011-2#4)
and HIV-1 infection##2##3##(2008-11#1)(2008-2#1)
and HIV-1##6##2##(1991-9#2)(1997-3#1)(2008-11#1)(2008-2#2)
and HIV-2##3##2##(1992-6#1)(1994-11#1)(2011-2#1)
and HIV-infected##2##2##(2008-5#1)(2011-2#1)
and HIV/AIDS##2##2##(2009-10#1)(2010-10#1)
and HL-60##2##2##(1990-2#1)(2011-2#1)
and HLA class II##2##4##(1995-12#1)(1997-8#1)
and HLA##6##2##(1993-3#1)(1995-12#1)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#1)
and HLA-B51##2##2##(2008-8#2)
and HLA-Dr##2##2##(1990-12#2)
and HNO(3)##7##2##(2008-10#6)(2008-3#1)
and HNPP##2##2##(1997-3#2)
and HPLC determination of##3##4##(2008-10#2)(2008-5#1)
and HPLC methods for the##2##5##(2008-10#2)
and HPLC methods##4##3##(2008-10#3)(2011-2#1)
and HPLC##22##2##(1992-2#1)(2008-10#12)(2008-11#4)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#1)
and HPLC-UV##2##2##(2008-10#2)
and HPLC/diode-array UV##2##3##(2008-10#2)
and HPV##2##2##(2008-10#1)(2011-2#1)
and HR##3##2##(2008-10#1)(2008-11#2)
and HRP##7##2##(2008-10#3)(2012-4#4)
and HSA##4##2##(2008-10#4)
and HSP70##3##2##(1994-8#1)(2008-10#1)(2009-6#1)
and HUVEC##2##2##(2008-11#1)(2008-8#1)
and Haemophilus b conjugate##2##4##(1995-5#2)
and Haemophilus influenzae type b##2##5##(1995-3#1)(1995-5#1)
and Haemophilus##5##2##(1995-3#1)(1995-5#3)(2008-5#1)
and Hand##3##2##(2008-9#3)
and Harvard Medical School##2##4##(2008-4#1)(2010-5#1)
and Harvard##3##2##(2008-12#1)(2008-4#1)(2010-5#1)
and Hb &gt##2##3##(1996-12#2)
and Hb##3##2##(1996-12#2)(2008-10#1)
and He##2##2##(2008-8#1)(2010-7#1)
and HeLa##2##2##(2008-8#2)
and Health Care##3##3##(1994-12#1)(2008-11#2)
and Health##33##2##(1991-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#16)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
and Helicobacter##2##2##(1997-1#1)(2012-12#1)
and Hepatitis B##2##3##(2008-10#1)(2012-3#1)
and Hepatitis##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
and Heterodera glycines##4##3##(2008-10#4)
and Hf(IV)##7##2##(2008-10#7)
and Hg##9##2##(1990-5#4)(2006-6#1)(2008-10#4)
and Hg(2+)##10##2##(2008-10#10)
and Hg(II)##3##2##(2008-10#3)
and High##3##2##(1995-6#1)(2008-3#1)(2012-2#1)
and His-241##6##2##(1992-3#6)
and Hispanic##6##2##(1994-9#1)(2008-4#1)(2011-2#4)
and Hispanics##3##2##(1995-12#1)(2011-2#2)
and Hoechst 33342##2##3##(2008-7#1)(2008-9#1)
and Holstein##4##2##(2013-1#4)
and Holter##3##2##(1996-3#3)
and Hong Kong##2##3##(2008-5#2)
and Hospital##5##2##(1991-12#1)(1992-1#1)(1996-3#1)(2008-11#1)(2013-1#1)
and Hospitals##2##2##(1991-2#1)(1997-1#1)
and Host Specificity##2##3##(2008-10#2)
and Host##4##2##(2008-10#4)
and Hsp90##2##2##(1997-4#1)(2010-4#1)
and Human##11##2##(1993-12#2)(1994-1#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-7#1)(2012-2#1)
and Hx##4##2##(2008-10#4)
and HxfB##2##2##(2008-10#2)
and Hydrocote##2##2##(1995-3#2)
and I##18##2##(1992-3#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#3)
and I(-)##5##2##(2008-10#5)
and I=0##3##2##(2008-10#3)
and IBA##2##2##(2008-10#1)(2008-12#1)
and IBD were##2##3##(2008-12#2)
and IC-PCR##2##2##(2008-10#2)
and ICD-10##2##2##(2008-11#1)(2012-12#1)
and ICP##3##2##(2008-10#2)(2008-7#1)
and ICP-AES determination of##3##4##(2008-10#3)
and ICP-AES determination##4##3##(2008-10#4)
and ICP-AES##9##2##(2008-10#9)
and ICP-MS##4##2##(2008-10#4)
and ICP-OES##6##2##(2008-10#6)
and IFN##2##2##(1996-2#2)
and IFN-gamma##7##2##(1994-8#1)(2008-10#2)(2008-11#3)(2009-12#1)
and IFN-γ##4##2##(2010-11#1)(2011-2#2)(2012-2#1)
and IGF##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
and IGF-1##8##2##(1994-11#5)(1996-2#1)(2008-9#2)
and IGF-I mRNA##4##3##(2008-9#2)(2010-5#2)
and IGF-I signaling##2##3##(1997-1#1)(2008-6#1)
and IGF-I##18##2##(1992-4#1)(1996-2#2)(1997-1#1)(2008-6#1)(2008-8#2)(2008-9#4)(2010-5#5)(2012-3#2)
and II genes##2##3##(2008-10#2)
and II##54##2##(1993-3#1)(1995-12#5)(1995-6#2)(2006-6#1)(2008-10#31)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
and II)##7##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)
and III in##3##3##(2008-1#1)(2008-7#2)
and III##21##2##(1990-8#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
and III)##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
and IKDC scores##2##3##(2013-1#2)
and IKDC##5##2##(2013-1#5)
and IL-1 alpha##2##3##(1993-8#1)(1996-12#1)
and IL-1 beta##2##3##(1995-2#1)(1996-12#1)
and IL-1##7##2##(1990-5#2)(1993-8#1)(1995-2#1)(1996-12#3)
and IL-10##8##2##(1995-5#1)(2008-10#1)(2010-12#4)(2011-3#2)
and IL-12##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
and IL-1Ra##4##2##(1996-12#4)
and IL-2##6##2##(1991-6#1)(1995-5#1)(2008-11#1)(2008-7#2)(2008-8#1)
and IL-4##7##2##(2008-11#7)
and IL-5##2##2##(1994-11#1)(2010-12#1)
and IL-6 in##2##3##(1994-6#1)(2008-10#1)
and IL-6##12##2##(1994-6#2)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
and IL-7 gene##3##3##(1995-2#3)
and IL-8##3##2##(1996-12#2)(2008-10#1)
and IPC##2##2##(2010-1#1)(2013-8#1)
and IR spectra##3##3##(2008-10#2)(2013-8#1)
and IR##11##2##(2008-10#4)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#3)(2013-8#1)
and ISF-induced microsomes##2##3##(1994-8#2)
and ITS##6##2##(2008-10#5)(2010-3#1)
and ITS-2 regions##2##3##(2008-10#2)
and ITS1##2##2##(2008-10#2)
and ITS2##2##2##(2008-10#2)
and ITS2)##5##2##(2008-10#4)(2008-12#1)
and ITS4##2##2##(2008-10#2)
and IV of the##2##4##(1990-8#1)(1997-3#1)
and IV of##3##3##(1990-8#1)(1996-6#1)(1997-3#1)
and IV##21##2##(1990-8#1)(1991-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-6#2)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#4)(2009-10#1)(2011-2#2)(2012-3#1)(2013-8#2)
and IVD101 medium##3##3##(2008-11#3)
and IX##6##2##(1990-8#1)(1995-8#1)(2008-10#1)(2011-2#3)
and Identification of##6##3##(2008-10#6)
and Identification##7##2##(2008-10#6)(2008-5#1)
and IgA##4##2##(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
and IgE production##2##3##(2008-11#2)
and IgE##3##2##(1991-9#1)(2008-11#2)
and IgG##5##2##(1997-8#1)(2008-11#2)(2008-12#1)(2008-9#1)
and IgG1##3##2##(2008-10#3)
and IgG2##2##2##(1995-11#2)
and IgG3##2##2##(1993-6#1)(1996-12#1)
and IgM##4##2##(1990-12#1)(1994-3#1)(1996-12#1)(2008-10#1)
and Illinois##3##2##(1997-2#1)(2008-10#2)
and Image Analysis##2##3##(2008-10#2)
and Implications for##2##3##(2008-10#2)
and Improvement##2##2##(1996-6#1)(1997-2#1)
and In Planta##2##3##(2008-10#2)
and In##9##2##(1997-7#1)(2008-10#7)(2012-2#1)
and In(3+)##2##2##(2008-10#2)
and In(III)##4##2##(2008-10#4)
and InP##2##2##(2008-3#2)
and Increases##2##2##(2008-10#1)(2008-6#1)
and India##9##2##(2008-10#4)(2010-12#4)(2012-3#1)
and Induced##3##2##(2008-10#3)
and Infection of##3##3##(2008-10#3)
and Infection##4##2##(2008-10#4)
and Information##3##2##(1995-12#1)(1995-2#1)(2013-1#1)
and Internal Transcribed Spacer##2##4##(2008-10#2)
and Internal##3##2##(2008-10#2)(2008-3#1)
and International##2##2##(1995-1#1)(2008-10#1)
and Internet##2##2##(2008-11#1)(2008-12#1)
and Inula##2##2##(2008-10#1)(2008-5#1)
and Iowa##2##2##(2008-10#2)
and Ireland##6##2##(2008-10#2)(2008-12#1)(2008-9#2)(2009-5#1)
and Is##3##2##(2008-10#3)
and Islands (p = 0##2##5##(2011-2#2)
and Islands##6##2##(2011-2#6)
and Israel##7##2##(1996-2#1)(2008-10#5)(2008-11#1)
and Israeli##2##2##(2008-10#2)
and Italian##2##2##(2008-10#1)(2008-11#1)
and Italy##2##2##(2008-10#2)
and Its Effect on##2##4##(2008-10#2)
and Its Impact on##2##4##(2008-10#1)(2012-12#1)
and Its Relationship##2##3##(2008-10#2)
and Its Use##2##3##(2008-10#2)
and Its##23##2##(1990-11#1)(1996-5#1)(2008-10#17)(2008-6#1)(2012-12#1)(2013-1#1)(2013-7#1)
and J##2##2##(2008-10#1)(2008-11#1)
and JNK##2##2##(2012-2#2)
and January##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
and Japan##11##2##(2008-10#8)(2008-12#1)(2008-5#1)(2010-12#1)
and John##6##2##(1990-8#1)(2008-11#1)(2011-2#4)
and July 2008##2##3##(2011-2#2)
and July##8##2##(1994-12#1)(2008-10#2)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
and June##7##2##(1991-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#3)
and K##16##2##(1990-8#1)(1991-5#1)(1994-8#2)(2008-10#6)(2008-12#3)(2008-9#1)(2011-2#1)(2012-2#1)
and K(+) and##3##3##(2008-10#3)
and K(+) are##2##3##(2008-10#2)
and K(+)##13##2##(2008-10#11)(2008-7#1)(2013-8#1)
and K)##2##2##(2008-10#2)
and K+ currents##2##3##(1994-11#1)(1996-2#1)
and K+##6##2##(1994-11#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)
and K-ras##3##2##(1993-11#1)(2009-12#1)(2009-8#1)
and KC chemokine##2##3##(2008-10#2)
and KDR##2##2##(2008-9#2)
and KI##3##2##(2008-10#3)
and KMnO(4) in##2##3##(2008-10#2)
and KMnO(4)##3##2##(2008-10#3)
and Kashmir##3##2##(2011-2#2)(2013-8#1)
and Kim##3##2##(1991-12#2)(1997-8#1)
and Klebsiella##2##2##(2011-2#2)
and Klotz plot##2##3##(2008-10#2)
and Km##3##2##(1991-9#2)(1994-8#1)
and Kruskal-Wallis##2##2##(1994-2#1)(2013-1#1)
and Kyrgyzstan were##2##3##(2008-10#2)
and Kyrgyzstan##3##2##(2008-10#3)
and L##23##2##(1990-12#1)(1993-6#4)(1993-8#1)(2006-5#1)(2008-10#7)(2008-9#2)(2010-8#1)(2011-10#1)(2011-2#3)(2012-2#1)(2012-3#1)
and L)##2##2##(1995-12#1)(2008-10#1)
and L-683##2##2##(1993-8#2)
and L-FABP##3##2##(1994-8#1)(2013-1#2)
and L-arginine##2##2##(1993-8#1)(2010-12#1)
and L2##2##2##(2011-2#1)(2013-1#1)
and LA##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and LA4+##2##2##(2008-10#2)
and LAK cells##2##3##(1990-12#1)(1994-6#1)
and LAK##5##2##(1990-12#1)(1991-8#1)(1992-2#2)(1994-6#1)
and LDH##2##2##(2008-10#1)(2008-11#1)
and LDL cholesterol##4##3##(1992-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
and LDL##9##2##(1992-11#1)(1994-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
and LH receptor in the##2##5##(2008-8#2)
and LH receptor in##3##4##(2008-8#3)
and LH receptor##4##3##(2008-8#4)
and LH##9##2##(1995-11#1)(1996-2#3)(2008-8#4)(2013-8#1)
and LIF##2##2##(1996-2#1)(2008-8#1)
and LMH##2##2##(1993-12#2)
and LOD##3##2##(2008-10#3)
and LOQ##3##2##(2008-10#3)
and LPS##5##2##(1995-12#3)(1997-8#1)(2008-11#1)
and LS##2##2##(2008-7#1)(2012-3#1)
and LY294002##2##2##(1995-8#2)
and La##3##2##(2008-10#3)
and Laboratory##2##2##(2008-12#1)(2013-8#1)
and Lactobacillus##3##2##(1993-12#1)(2008-5#1)(2013-1#1)
and Langmuir##4##2##(2008-10#4)
and Lanzarote##2##2##(2008-10#2)
and Late##2##2##(2008-10#2)
and Latin America##2##3##(1993-1#1)(1993-3#1)
and Latin##3##2##(1993-1#1)(1993-3#1)(2008-10#1)
and Lauridromia intermedia##2##3##(2007-12#2)
and Learning##4##2##(2008-11#3)(2010-8#1)
and Ler##2##2##(2012-3#2)
and Lettuce##2##2##(2008-10#2)
and Lewisite##2##2##(2008-11#2)
and Leydig##2##2##(1992-12#1)(2009-10#1)
and Linear Discriminant Analysis##2##4##(2008-10#2)
and Listeria monocytogenes##2##3##(2008-10#2)
and Literature Review##4##3##(2011-2#3)(2012-3#1)
and Louisiana##3##2##(2008-10#2)(2013-8#1)
and Lowry##3##2##(2008-10#3)
and Lr26##2##2##(2008-10#2)
and Ltnβ##2##2##(2011-1#2)
and Lu(III)##2##2##(2008-10#2)
and Lu)##2##2##(2008-10#2)
and M##59##2##(1994-5#1)(1997-3#3)(2008-10#45)(2008-12#1)(2008-5#5)(2010-8#1)(2011-2#2)(2012-2#1)
and M19 were##2##3##(2008-10#2)
and M19##3##2##(2008-10#3)
and M2##5##2##(1992-10#2)(1992-8#1)(2007-12#1)(2010-4#1)
and MA##2##2##(2013-1#1)(2013-8#1)
and MALDI-TOF-MS##2##2##(2009-9#1)(2010-12#1)
and MAO##3##2##(2009-12#2)(2009-8#1)
and MAP##2##2##(1995-8#1)(2013-8#1)
and MCS##2##2##(2013-1#2)
and MDM2##2##2##(2011-2#2)
and MEDLINE databases for##2##4##(1994-3#1)(2013-1#1)
and MEDLINE##5##2##(1991-1#1)(1994-3#2)(2012-3#1)(2013-1#1)
and MESS-2##4##2##(2008-10#4)
and MG##3##2##(2008-10#3)
and MHC class II##2##4##(1995-12#1)(1997-8#1)
and MHC class##5##3##(1995-12#1)(1997-8#1)(2008-1#1)(2008-4#1)(2013-8#1)
and MHC##8##2##(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-4#1)(2013-8#1)
and MM##3##2##(2008-10#2)(2011-2#1)
and MMA##2##2##(1995-11#1)(2008-10#1)
and MMP-2 activity##3##3##(2011-2#3)
and MMP-2##5##2##(2008-11#1)(2011-2#4)
and MMP-9##9##2##(1993-3#1)(2012-3#8)
and MPhi##5##2##(2010-1#5)
and MR findings in##2##4##(1996-6#1)(2011-2#1)
and MR findings##3##3##(1996-6#1)(1997-8#1)(2011-2#1)
and MR for##2##3##(2012-2#2)
and MR##13##2##(1996-6#1)(1997-8#6)(2008-1#1)(2010-12#1)(2011-2#2)(2012-2#2)
and MRI findings##3##3##(2010-9#1)(2011-2#1)(2012-12#1)
and MRI##13##2##(1992-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
and MS##5##2##(2008-10#1)(2010-11#1)(2010-6#1)(2011-3#1)(2011-7#1)
and MS/MS##2##2##(2008-10#1)(2008-8#1)
and MTT##2##2##(2008-11#2)
and MVK##2##2##(1995-11#1)(1996-5#1)
and MaYMFV##2##2##(2008-10#2)
and Mages are##2##3##(2008-9#2)
and Magnaporthe grisea##2##3##(2008-10#2)
and Making a Difference##2##4##(2008-11#2)
and Malassezia furfur##2##3##(2008-5#2)
and Man-76##3##2##(2008-10#3)
and Management of##3##3##(2008-12#1)(2010-9#1)(2011-2#1)
and Management##8##2##(1997-2#1)(1997-4#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Mapping of##3##3##(2008-10#3)
and March##8##2##(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
and Maryland##3##2##(1997-2#1)(2008-10#2)
and Matric##2##2##(2008-10#2)
and May##8##2##(2008-10#7)(2012-2#1)
and MeHg(+)##4##2##(2008-10#4)
and Meckel's cave##2##3##(2011-2#2)
and Meckel's##3##2##(2011-2#3)
and Medicaid recipients##2##3##(1992-2#1)(1995-12#1)
and Medicaid##26##2##(1991-12#1)(1991-2#2)(1991-3#3)(1992-2#2)(1994-3#1)(1995-12#1)(1996-2#6)(1996-3#2)(1997-2#4)(1997-3#2)(2008-11#1)(2008-12#1)
and Medical##4##2##(1991-3#1)(1994-12#1)(1996-12#1)(2013-1#1)
and Medicare Part##3##3##(1996-2#2)(2010-5#1)
and Medicare##14##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(2010-5#1)
and Mediterranean##2##2##(2008-10#2)
and Medley PC##2##3##(2011-2#2)
and Meloidogyne##2##2##(2008-10#2)
and Memory##2##2##(2008-12#2)
and Meniere's disease##2##3##(2012-3#2)
and Mental Health##2##3##(2009-6#1)(2013-1#1)
and Mesoamerican groups##2##3##(2008-10#2)
and Metabolic Syndrome##2##3##(2008-3#1)(2013-1#1)
and Metabolic##4##2##(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
and Methods##45##2##(2008-10#6)(2010-7#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#24)(2013-8#8)
and Mexican##2##2##(2008-10#2)
and Mexico##5##2##(2008-10#5)
and Mg##8##2##(1991-5#2)(2008-10#6)
and Mg(2+) were##2##3##(2008-10#1)(2010-4#1)
and Mg(2+)##12##2##(2008-10#8)(2008-11#2)(2008-9#1)(2010-4#1)
and Mg(II) in##3##3##(2008-10#3)
and Mg(II)##4##2##(2008-10#4)
and Mg)##2##2##(2008-10#2)
and Mg2+##6##2##(1990-5#1)(1991-9#1)(1995-11#2)(1995-6#2)
and MiLV##2##2##(2008-10#2)
and Michigan##6##2##(1992-2#2)(1992-3#1)(1995-12#2)(2008-10#1)
and Microdochium nivale##2##3##(2008-10#2)
and Microsporum canis##2##3##(2008-5#2)
and Middle##2##2##(2008-10#2)
and Minnesota##4##2##(2008-10#4)
and Missouri##3##2##(2008-10#3)
and Mn in##3##3##(2008-10#3)
and Mn prior to their determination by##2##7##(2008-10#2)
and Mn##19##2##(2008-10#19)
and Mn(2+)##3##2##(2008-10#3)
and Mn(II)##6##2##(2008-10#6)
and Mo##6##2##(2008-10#6)
and Mo(VI)##3##2##(2008-10#3)
and Molecular Characterization of##5##4##(2008-10#4)(2012-2#1)
and Molecular Characterization##6##3##(2008-10#5)(2012-2#1)
and Molecular Mapping of a##3##5##(2008-10#3)
and Molecular Markers##2##3##(2008-10#2)
and Molecular##23##2##(1994-12#1)(1997-7#2)(2008-10#18)(2012-2#1)(2013-1#1)
and Morocco##2##2##(2008-10#2)
and Mycobacterium tuberculosis##2##3##(2011-2#1)(2012-2#1)
and Mycobacterium##5##2##(1996-11#1)(2007-12#2)(2011-2#1)(2012-2#1)
and Mycosphaerella##3##2##(2008-10#3)
and Mycotoxin##2##2##(2008-10#2)
and Müller##2##2##(2008-7#1)(2011-2#1)
and N##27##2##(1991-8#1)(1995-11#1)(1997-3#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#2)(2013-1#1)
and N(2) adsorption-desorption##3##3##(2008-10#3)
and N(2)##5##2##(2008-10#3)(2008-3#2)
and N-acetyl##2##2##(1991-12#1)(1994-11#1)
and N-acetylcysteine##2##2##(2008-10#2)
and N-chlorosuccinimide##2##2##(2008-10#2)
and N-terminal##3##2##(1990-8#1)(1994-11#1)(1995-2#1)
and N3##2##2##(1990-6#1)(2008-11#1)
and NA metabolism in hypothalamus##2##5##(2008-8#2)
and NA##5##2##(2008-11#3)(2008-8#2)
and NABP##2##2##(2008-9#2)
and NAD##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
and NADH in normal and cancer##3##6##(2008-10#3)
and NADH in##4##3##(2008-10#4)
and NADH were##2##3##(2008-10#1)(2008-8#1)
and NADH##13##2##(2008-10#6)(2008-5#1)(2008-8#1)(2009-9#2)(2013-1#3)
and NADPH##2##2##(2009-8#1)(2011-2#1)
and NC##5##2##(2008-10#3)(2008-11#2)
and ND##3##2##(2008-10#3)
and NF-kappaB##6##2##(2008-11#2)(2008-9#4)
and NF-κB##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
and NH(4)(+)##2##2##(2008-10#2)
and NIES##2##2##(2008-10#2)
and NIH/3T3 cells##2##3##(1991-5#2)
and NIST SRM##2##3##(2008-10#2)
and NIST##4##2##(2008-10#4)
and NK cell##4##3##(2008-10#1)(2008-4#1)(2013-1#2)
and NK cells##2##3##(2008-4#1)(2012-3#1)
and NK##6##2##(2008-10#1)(2008-4#2)(2012-3#1)(2013-1#2)
and NKA##2##2##(2008-8#2)
and NMDA receptors##4##3##(1995-11#2)(1997-2#2)
and NMDA##8##2##(1995-11#2)(1997-2#5)(2008-7#1)
and NMR##9##2##(1992-12#2)(1994-5#1)(1996-5#1)(2008-10#5)
and NMR)##2##2##(1991-6#1)(2008-11#1)
and NN##3##2##(1996-2#3)
and NO##10##2##(1992-3#2)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#3)
and NO(2)##5##2##(2008-10#2)(2008-3#2)(2012-2#1)
and NOK##2##2##(1995-2#1)(1997-4#1)
and NP##2##2##(2008-8#1)(2013-8#1)
and NPM-ALK##2##2##(2011-2#2)
and NPR1##2##2##(2008-10#1)(2011-2#1)
and NRT##3##2##(2008-9#3)
and NT##2##2##(2008-10#2)
and Na##8##2##(1997-6#1)(2008-10#4)(2008-8#1)(2008-9#2)
and Na(+)##5##2##(2008-10#4)(2012-7#1)
and Na+##2##2##(1992-8#1)(2008-12#1)
and NaBH(4)##3##2##(2008-10#3)
and NaCl at##2##3##(1993-3#1)(2008-10#1)
and NaCl##6##2##(1993-3#1)(2008-10#3)(2008-11#1)(2011-1#1)
and NaOH##2##2##(2008-10#2)
and NaSA##2##2##(2008-10#2)
and Nafion sensitized##2##3##(2008-10#2)
and Nafion##5##2##(2008-10#5)
and National##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
and Natural##2##2##(2008-10#2)
and Nbs1##2##2##(2011-2#2)
and Nd##2##2##(2008-10#1)(2012-2#1)
and Nd(III)##5##2##(2008-10#5)
and Nei's##3##2##(2008-10#3)
and Neisseria spp##2##3##(2011-2#2)
and Neisseria##3##2##(2010-12#1)(2011-2#2)
and Nernstian##2##2##(2008-10#2)
and Neuro-2a cells##2##3##(2008-11#2)
and Neutral##2##2##(2008-10#1)(2008-11#1)
and New Mexico##2##3##(1990-8#1)(2008-10#1)
and New World X##2##4##(2008-10#2)
and New World##4##3##(2008-10#3)(2008-8#1)
and New York##3##3##(1994-9#1)(1996-1#1)(2013-8#1)
and New Zealand##5##3##(2008-1#1)(2008-10#2)(2008-5#1)(2009-3#1)
and New##21##2##(1990-8#1)(1991-2#1)(1992-6#1)(1994-9#1)(1996-1#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-8#2)(2009-3#1)(2010-3#1)(2013-1#1)(2013-8#1)
and Newfoundland##3##2##(2008-10#3)
and Ni in##5##3##(2008-10#5)
and Ni were##7##3##(2008-10#7)
and Ni##29##2##(2008-10#28)(2008-11#1)
and Ni(II)##14##2##(2008-10#14)
and Nicotiana benthamiana plants##2##4##(2008-10#2)
and Nicotiana benthamiana##4##3##(2008-10#4)
and Nicotiana##6##2##(2008-10#6)
and NifA##2##2##(1993-12#1)(2008-9#1)
and Nigeria##2##2##(2008-10#2)
and Nile##2##2##(2008-10#1)(2008-5#1)
and North America##12##3##(2008-10#5)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#2)(2013-1#1)
and North Dakota##2##3##(2008-10#2)
and North##18##2##(1997-8#3)(2008-10#8)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#2)(2013-1#1)
and Northern blot analysis##3##4##(1995-6#1)(1996-12#1)(1997-8#1)
and Northern blot##5##3##(1992-3#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-8#1)
and Northern##7##2##(1992-3#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-8#1)
and Norway##4##2##(1990-11#2)(2008-10#2)
and November##4##2##(1991-2#1)(1996-12#1)(2011-2#1)(2013-1#1)
and Nurr1##2##2##(1995-12#2)
and Nursing##4##2##(1990-12#1)(1992-12#1)(2008-12#1)(2012-3#1)
and O##6##2##(1996-12#1)(1996-2#1)(2008-12#1)(2008-9#1)(2009-10#1)(2013-8#1)
and O(3)##4##2##(2008-11#1)(2008-3#3)
and O-linked##3##2##(1990-5#1)(1992-6#1)(2008-1#1)
and O157##2##2##(2012-2#2)
and O2##2##2##(1991-5#1)(2013-8#1)
and ODS##2##2##(2008-10#2)
and OH##4##2##(2008-3#4)
and OH-radical generation##2##3##(1993-8#2)
and OP##5##2##(2008-10#3)(2011-2#2)
and OPCs##2##2##(2008-7#1)(2012-4#1)
and OPZ19(1800)##2##2##(2008-10#2)
and OR##5##2##(2008-10#4)(2012-2#1)
and ORF4##2##2##(2008-10#2)
and OSCC##2##2##(2012-3#1)(2013-1#1)
and OT2##2##2##(2008-10#2)
and OY-NIM##3##2##(2008-10#3)
and Objectives##3##2##(1996-9#1)(2011-2#1)(2012-2#1)
and Occupational##2##2##(1991-12#1)(2008-11#1)
and October##6##2##(1995-12#1)(1996-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
and Ohio in##2##3##(2008-10#2)
and Ohio##7##2##(1997-1#1)(2008-10#6)
and Okrun##2##2##(2008-10#2)
and Oncidium orchid##2##3##(2008-10#2)
and Ontario##5##2##(1995-2#1)(2007-12#1)(2008-10#3)
and Oregon##8##2##(2008-10#8)
and Origin of Xanthomonas##2##4##(2008-10#2)
and Origin of##3##3##(2008-10#3)
and Other##13##2##(2008-10#6)(2011-2#6)(2013-1#1)
and Outcomes##2##2##(2011-2#1)(2012-3#1)
and Ox##2##2##(1993-6#1)(2008-10#1)
and P &lt##5##3##(1994-12#2)(1994-3#1)(2012-2#1)(2012-3#1)
and P = 0##5##4##(1991-12#1)(2008-10#3)(2013-1#1)
and P##98##2##(1991-12#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-8#1)(2008-10#74)(2008-12#4)(2008-4#1)(2009-6#1)(2010-3#4)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
and P(N)##2##2##(2012-7#2)
and P3##3##2##(2008-8#1)(2011-2#1)(2013-8#1)
and PA##4##2##(1995-8#2)(2008-10#1)(2013-1#1)
and PAH##2##2##(1995-11#1)(2008-10#1)
and PAL activities in UV-C-treated fruit##2##6##(2008-10#2)
and PAR2##5##2##(2008-7#1)(2009-8#4)
and PAS##2##2##(1992-11#1)(2012-3#1)
and PAUP*##2##2##(2008-4#1)(2008-9#1)
and PBB 77##2##3##(2008-10#2)
and PBB##3##2##(2008-10#3)
and PBDEs##3##2##(2008-10#3)
and PCA##4##2##(1997-3#1)(2008-10#2)(2008-7#1)
and PCB##2##2##(2008-10#1)(2008-11#1)
and PCBs##3##2##(2008-10#3)
and PCNA##2##2##(1995-6#1)(2011-2#1)
and PCP##2##2##(2008-10#1)(2009-3#1)
and PCR##16##2##(1992-6#1)(1993-12#1)(1994-1#3)(1995-12#1)(2008-10#8)(2008-11#1)(2008-12#1)
and PCR-based##3##2##(1997-2#2)(1997-8#1)
and PD##16##2##(1990-2#1)(2008-10#1)(2008-12#7)(2008-7#1)(2011-2#6)
and PDV##2##2##(2008-10#2)
and PEG##2##2##(2008-10#1)(2011-2#1)
and PF##2##2##(1990-12#1)(2011-2#1)
and PG##3##2##(2008-10#2)(2008-11#1)
and PGA-alginate methods##3##3##(2011-2#3)
and PGA-alginate##4##2##(2011-2#4)
and PGE2##2##2##(1993-12#1)(2008-5#1)
and PH##3##2##(2008-9#1)(2011-1#2)
and PHB##4##2##(2008-10#4)
and PI##12##2##(1996-1#1)(1996-6#1)(1997-3#1)(2008-10#6)(2008-8#1)(2009-3#2)
and PIC##2##2##(2010-3#1)(2011-2#1)
and PIP2##2##2##(1992-12#1)(1993-8#1)
and PKA##2##2##(1995-6#1)(1997-2#1)
and PKC##4##2##(1994-6#1)(1995-8#1)(1997-7#1)(2013-8#1)
and PKC-α##2##2##(2012-3#2)
and PLD##2##2##(1995-8#1)(2011-2#1)
and PLL1 are##3##3##(2009-8#3)
and PLS methods##3##3##(2008-10#3)
and PLS##4##2##(2008-10#4)
and PM3##4##2##(1996-5#1)(2008-10#2)(2008-11#1)
and PMA##3##2##(1993-6#1)(1995-6#1)(2008-11#1)
and PMA-induced##3##2##(1993-6#1)(1994-8#1)(1995-6#1)
and PMNL##4##2##(2006-6#2)(2010-1#2)
and PNS##4##2##(1995-12#1)(2008-7#2)(2011-2#1)
and PPO##2##2##(1996-2#1)(2008-10#1)
and PPY##2##2##(1997-6#2)
and PR##2##2##(2008-10#2)
and PRL##2##2##(1994-3#1)(2013-1#1)
and PS##7##2##(1993-11#3)(1995-12#1)(2008-10#2)(2008-8#1)
and PS-264##2##2##(2008-10#2)
and PTH##4##2##(1991-6#1)(1993-3#1)(2012-12#1)(2012-3#1)
and PV##2##2##(2008-10#1)(2010-5#1)
and PVC##3##2##(2008-10#3)
and Pacific##3##2##(1997-2#2)(2008-10#1)
and PainSmart infusion pumps##2##4##(2010-9#2)
and Pantoea##3##2##(2008-10#3)
and Paramphistomum eggs##2##3##(1996-12#2)
and Parkinson's disease##3##3##(1994-2#1)(2008-7#1)(2009-5#1)
and Parkinson's##4##2##(1994-2#1)(1996-2#1)(2008-7#1)(2009-5#1)
and Partial##4##2##(2008-10#4)
and Pathogenic Characterization of##2##4##(2008-10#2)
and Pathogenic##7##2##(2008-10#7)
and Pathogenicity of##3##3##(2008-10#3)
and Pathogenicity##4##2##(2008-10#4)
and Patterns of##2##3##(2008-10#2)
and Pb by##4##3##(2008-10#4)
and Pb determination##2##3##(2008-10#2)
and Pb in##15##3##(2008-10#14)(2011-2#1)
and Pb was##2##3##(2008-10#2)
and Pb were found to be 0##2##7##(2008-10#2)
and Pb were##4##3##(2008-10#4)
and Pb##51##2##(2008-10#50)(2011-2#1)
and Pb(2+)##10##2##(2008-10#10)
and Pb(II) as##2##3##(2008-10#2)
and Pb(II) by##2##3##(2008-10#2)
and Pb(II) in##2##3##(2008-10#2)
and Pb(II) ions by##2##4##(2008-10#1)(2013-1#1)
and Pb(II) ions##3##3##(2008-10#2)(2013-1#1)
and Pb(II) were##3##3##(2008-10#3)
and Pb(II)##30##2##(2008-10#28)(2013-1#2)
and Pd as##2##3##(2008-10#2)
and Pd from##2##3##(2008-10#2)
and Pd was##2##3##(2008-10#2)
and Pd##11##2##(2008-10#10)(2008-11#1)
and Pd(II)##4##2##(2008-10#4)
and Pd(IV)##2##2##(2008-10#2)
and Peer##2##2##(2010-9#1)(2013-1#1)
and Pej-SGP-IV##2##2##(2008-5#2)
and Penicillium expansum##2##3##(2008-10#2)
and Penicillium##4##2##(1993-12#1)(2008-10#3)
and Pepper golden mosaic virus##2##5##(2008-10#2)
and Persistence##2##2##(2008-10#1)(2013-1#1)
and Peyer's##2##2##(2008-11#1)(2009-9#1)
and PhIP##2##2##(1992-6#1)(1997-2#1)
and Phenotypic##2##2##(2008-10#2)
and Phomopsis##9##2##(2008-10#9)
and Phylogeny of##2##3##(2008-10#1)(2008-8#1)
and Physical##3##2##(2008-10#1)(2013-1#2)
and Physiological##2##2##(2008-10#1)(2013-1#1)
and Phytophthora sojae##2##3##(2008-10#2)
and Phytophthora##7##2##(2008-10#7)
and Pimelodus sp##2##3##(2008-12#2)
and Pioneer##2##2##(2008-10#2)
and Pleurotus##2##2##(2008-10#2)
and Poland##3##2##(1997-3#1)(2013-1#2)
and Polymerase Chain##3##3##(2008-10#3)
and Polyscias spp##2##3##(2008-10#2)
and Polyscias##3##2##(2008-10#3)
and Ponceau 4R by##3##4##(2008-10#3)
and Ponceau 4R##4##3##(2008-10#4)
and Population##3##2##(2008-10#2)(2013-8#1)
and Potato##5##2##(2008-10#5)
and Potential##2##2##(2008-10#2)
and Practice##6##2##(2008-11#6)
and Pratylenchus penetrans##2##3##(2008-10#2)
and Pratylenchus##3##2##(2008-10#3)
and Preventive Dentistry##2##3##(2013-1#2)
and Preventive##3##2##(1995-9#1)(2013-1#2)
and Production of##2##3##(2008-10#2)
and Prognostic##2##2##(2008-10#2)
and Proventil##2##2##(1992-2#2)
and Pseudomonas fluorescens##3##3##(2008-10#3)
and Pseudomonas putida##4##3##(2008-10#4)
and Pseudomonas syringae pv##2##4##(2008-10#2)
and Pseudomonas syringae##3##3##(2008-10#3)
and Pseudomonas##16##2##(2008-10#12)(2008-12#1)(2008-7#1)(2009-6#1)(2012-2#1)
and Pt##8##2##(2008-10#7)(2008-11#1)
and Pt(IV)##5##2##(2008-10#5)
and Pt) as##2##3##(2008-10#2)
and Pt)##4##2##(2008-10#4)
and PtMo##2##2##(2008-10#2)
and Ptr ToxC##2##3##(2008-10#2)
and Ptr##3##2##(2008-10#3)
and Public Health##3##3##(1995-12#1)(2010-12#1)(2011-2#1)
and Public##4##2##(1995-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
and Pv##2##2##(2013-8#2)
and Pyracantha spp##2##3##(2008-10#2)
and Pyracantha##4##2##(2008-10#4)
and Pyrenophora tritici-repentis##2##3##(2008-10#2)
and Pythium spp##3##3##(2008-10#3)
and Pythium##12##2##(2008-10#12)
and Q Sepharose ion exchange##2##5##(1991-5#1)(1997-1#1)
and Q##19##2##(1991-5#1)(1997-1#1)(2008-10#4)(2008-3#1)(2011-10#1)(2012-5#5)(2012-6#2)(2012-7#1)(2012-9#2)(2013-8#1)
and Q8r2-96)##2##2##(2008-10#2)
and QRS duration##2##3##(1992-6#1)(2008-10#1)
and QRS##3##2##(1992-6#1)(2008-10#1)(2012-12#1)
and QUADAS##3##2##(2008-12#3)
and Qigong##2##2##(2013-1#2)
and Quality of Life##3##4##(2008-10#1)(2012-2#1)(2012-3#1)
and Quality of##4##3##(2008-10#2)(2012-2#1)(2012-3#1)
and Quality##5##2##(2008-10#2)(2008-5#1)(2012-2#1)(2012-3#1)
and Quantification of##2##3##(2008-10#2)
and Quantification##3##2##(2008-10#3)
and Quercus##2##2##(2008-8#1)(2011-10#1)
and R wave##4##3##(1996-6#4)
and R##44##2##(1990-11#1)(1995-8#2)(1996-6#4)(1996-8#1)(2008-10#31)(2008-12#1)(2008-5#1)(2008-9#2)(2012-2#1)
and R2##4##2##(2008-10#1)(2010-3#3)
and RAPD analyses##2##3##(2008-10#2)
and RAPD grouping##2##3##(2008-10#2)
and RAPD##9##2##(2008-10#9)
and RDX##3##2##(2008-10#1)(2008-3#2)
and REE from##2##3##(2008-10#2)
and REE##4##2##(2008-10#4)
and REEs##2##2##(2008-10#1)(2008-9#1)
and RFLP##7##2##(2008-10#3)(2008-8#4)
and RG IV##2##3##(2008-10#2)
and RG##6##2##(2008-10#6)
and RI##5##2##(1996-6#1)(1997-3#2)(2008-10#1)(2013-8#1)
and RM##2##2##(1991-7#1)(2013-1#1)
and RMS of##2##3##(2008-10#2)
and RNA replication##2##3##(2013-1#2)
and RNA##26##2##(1996-12#1)(2008-10#6)(2008-4#2)(2008-9#7)(2009-10#2)(2009-5#2)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#2)
and RNA2##2##2##(2008-10#1)(2008-8#1)
and RNase##2##2##(2008-4#1)(2012-3#1)
and RP##2##2##(2008-10#1)(2013-1#1)
and RSD##2##2##(2008-10#2)
and RT##3##2##(1990-11#3)
and RT-PCR##5##2##(2008-10#2)(2010-12#1)(2010-5#1)(2011-3#1)
and RTS##2##2##(2011-2#2)
and Rac2##2##2##(1997-7#2)
and Radiation##2##2##(1994-12#1)(2008-2#1)
and Ralstonia solanacearum##2##3##(2008-10#2)
and Ralstonia##3##2##(2008-10#3)
and Raman spectra of##2##4##(2008-10#2)
and Raman spectra##3##3##(2008-10#3)
and Raman spectroscopy##5##3##(2008-10#4)(2013-8#1)
and Raman spectrum##2##3##(2008-10#1)(2013-8#1)
and Raman##19##2##(2008-10#10)(2008-3#2)(2009-12#1)(2010-10#3)(2013-8#3)
and Random Amplified Polymorphic DNA##2##5##(2008-10#2)
and Ras##3##2##(1996-2#1)(2013-8#2)
and Rasch##2##2##(2011-2#1)(2012-2#1)
and Rayleigh##2##2##(2008-3#2)
and Rcm 5##2##3##(2008-10#2)
and Reactive##2##2##(1995-11#1)(2008-10#1)
and Real##2##2##(1991-2#1)(2013-1#1)
and Recommendations##2##2##(2008-10#1)(2008-8#1)
and Reduced##2##2##(2008-10#2)
and Reduces##3##2##(2008-10#2)(2010-7#1)
and Related##9##2##(1996-5#1)(1997-2#1)(2008-10#4)(2008-9#1)(2013-1#2)
and Relationship with##2##3##(2008-10#2)
and Reproductive##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
and Research##6##2##(1992-8#1)(1993-12#1)(2010-11#1)(2012-2#1)(2013-1#2)
and Resistance in##2##3##(2008-10#2)
and Resistance##3##2##(2008-10#2)(2013-1#1)
and Resistant##3##2##(2008-10#3)
and Rev##3##2##(1993-2#2)(1993-8#1)
and Review of the Literature##3##5##(2011-2#1)(2012-3#1)(2013-1#1)
and Rg1##2##2##(1995-8#1)(2010-12#1)
and Rh(III)##4##2##(2008-10#4)
and Rhizoctonia solani##3##3##(2008-10#3)
and Rhizoctonia##5##2##(2008-10#5)
and Rhodamine##2##2##(2008-10#1)(2008-3#1)
and Rhopalosiphum padi##2##3##(2008-10#2)
and Rhy##2##2##(2011-3#2)
and Ridomil Gold EC##2##4##(2008-10#2)
and Ripley's##2##2##(2008-10#1)(2008-9#1)
and Risk Factors for##2##4##(2009-9#1)(2011-2#1)
and Risk Reduction##2##3##(2011-2#1)(2013-1#1)
and Risk of##2##3##(2008-10#1)(2013-8#1)
and Risk##7##2##(2008-10#1)(2009-4#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
and Role in##2##3##(2008-10#1)(2013-1#1)
and Roman low-avoidance##2##3##(1994-2#2)
and Romania##2##2##(2008-10#1)(2013-8#1)
and Root##3##2##(2008-10#3)
and Rough Lemon##2##3##(2008-10#2)
and Rph9##2##2##(2008-10#2)
and RsaI##2##2##(1995-12#1)(2008-10#1)
and Rsp3##4##2##(2008-10#4)
and Ru##4##2##(2008-10#4)
and Rx3##2##2##(2008-10#2)
and S were##2##3##(2008-1#1)(2013-1#1)
and S##59##2##(1996-8#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
and S)##3##2##(1990-5#1)(2008-10#2)
and S1##3##2##(1992-12#1)(1993-12#1)(2012-12#1)
and S6##2##2##(2008-10#1)(2013-1#1)
and SA##3##2##(1995-11#1)(2011-1#2)
and SAR##2##2##(2011-10#1)(2013-1#1)
and SB202190##2##2##(2011-2#2)
and SC##2##2##(2008-5#2)
and SC-791##4##2##(2008-10#4)
and SCLP##4##2##(2012-3#4)
and SD =##2##3##(1993-1#2)
and SD##3##2##(1993-1#2)(1996-12#1)
and SDF1-3'##2##2##(2008-9#2)
and SECV##2##2##(2008-10#2)
and SEM were##2##3##(2008-10#2)
and SEM##7##2##(1991-2#1)(2008-10#4)(2008-11#1)(2012-2#1)
and SF##2##2##(1994-8#2)
and SF-36##2##2##(2012-12#2)
and SIV##4##2##(1997-3#4)
and SL##2##2##(2008-11#1)(2013-1#1)
and SLCV-E##3##2##(2008-10#3)
and SLS##2##2##(2008-10#2)
and SM##3##2##(2012-2#1)(2013-1#2)
and SNAP-25##2##2##(1995-6#2)
and SNP treated KU812 cells##3##5##(2008-11#3)
and SNU##2##2##(2008-12#2)
and SO(2)##2##2##(2008-10#2)
and SO(4)(2-)##5##2##(2008-10#5)
and SOWG##2##2##(2008-10#2)
and SP##7##2##(2008-10#6)(2008-11#1)
and SPE##3##2##(2008-10#3)
and SPFMV##2##2##(2008-10#2)
and SPME##5##2##(2008-10#5)
and SRM##6##2##(2008-10#6)
and SS##4##2##(2011-2#2)(2013-8#2)
and SSCP##2##2##(2008-10#2)
and SSE##3##2##(2013-1#2)(2013-8#1)
and SSEA-1##2##2##(2008-11#2)
and SSR##2##2##(2008-10#2)
and ST-R##2##2##(2010-12#2)
and STI##3##2##(2008-10#1)(2008-12#2)
and SV40 transformation##2##3##(1995-12#1)(2008-11#1)
and SV40##3##2##(1993-8#1)(1995-12#1)(2008-11#1)
and SW##2##2##(2008-11#1)(2011-2#1)
and SWV##4##2##(2008-10#4)
and Saccharomyces cerevisiae##4##3##(1996-6#3)(2012-2#1)
and Safety##3##2##(1992-3#1)(1995-12#1)(2012-12#1)
and Safranine##4##2##(2008-10#4)
and Salmonella##5##2##(1990-5#1)(1997-3#1)(2010-4#2)(2011-1#1)
and San Diego##2##3##(2012-2#2)
and San##3##2##(2008-10#1)(2012-2#2)
and Sandell's sensitivity were found to be##3##7##(2008-10#3)
and Sandell's sensitivity##12##3##(2008-10#12)
and Sargassum##2##2##(2008-10#1)(2011-2#1)
and Satisfaction##2##2##(2008-10#1)(2008-11#1)
and Saururus chinensis (Lour##2##4##(2008-10#2)
and Savannah##3##2##(2008-10#3)
and Sb were##3##3##(2008-10#3)
and Sb##18##2##(2008-10#18)
and Sb(III)##2##2##(2008-10#2)
and Schefflera##2##2##(2008-10#2)
and Sclerotium rolfsii##4##3##(2008-10#4)
and ScrFI##2##2##(2008-10#2)
and Se in##5##3##(2008-10#5)
and Se speciation##3##3##(2008-10#3)
and Se were##3##3##(2008-10#3)
and Se##28##2##(2008-10#28)
and Se(IV)##5##2##(2008-10#5)
and Seeds##2##2##(2008-10#2)
and Selective##2##2##(2008-10#2)
and Sephadex##2##2##(1990-11#1)(2008-8#1)
and September##5##2##(1994-9#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-7#1)
and Septoria tritici##2##3##(2008-10#2)
and Septoria##4##2##(2008-10#4)
and Ser##4##2##(1991-3#1)(1997-7#1)(1997-8#1)(2008-10#1)
and Sertoli cells##2##3##(1995-6#1)(2009-10#1)
and Sexual##2##2##(2008-10#1)(2013-1#1)
and SgCV##2##2##(2008-10#2)
and Shigella##2##2##(2008-10#1)(2013-8#1)
and Si were##2##3##(2008-10#2)
and Si##6##2##(1993-1#1)(2008-10#5)
and Sida##2##2##(2008-10#2)
and Simple##2##2##(1996-5#1)(2008-11#1)
and Simulated##2##2##(2008-10#2)
and Simultaneous##2##2##(1995-5#1)(2008-10#1)
and Sm##3##2##(2008-10#3)
and SmaI##2##2##(1993-8#1)(2008-10#1)
and Smac/DIABLO##2##2##(2008-11#2)
and Sn in##2##3##(2008-10#2)
and Sn##5##2##(2008-10#5)
and Sn)##2##2##(2008-10#1)(2009-9#1)
and Social Services##2##3##(1994-1#1)(1995-3#1)
and Social##5##2##(1993-6#2)(1994-1#1)(1995-3#1)(2013-1#1)
and Sohag Cancer Center between##2##5##(2008-10#2)
and Soil##2##2##(2008-10#2)
and Soil-borne rye mosaic virus##2##5##(2008-8#2)
and Solanaceae##4##2##(2008-10#3)(2008-5#1)
and Somatization##2##2##(2012-5#2)
and South Africa##7##3##(2008-10#7)
and South America##7##3##(2008-10#6)(2011-2#1)
and South Carolina##3##3##(1996-1#1)(2008-10#2)
and South##28##2##(1992-2#2)(1995-3#1)(1996-1#1)(2008-10#18)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
and Southeast##2##2##(2008-10#1)(2008-11#1)
and Southern analysis##4##3##(1995-6#1)(2008-8#3)
and Southern blot analysis##2##4##(1993-12#1)(2008-10#1)
and Southern blot hybridization##2##4##(2008-10#1)(2008-9#1)
and Southern blot##6##3##(1993-12#1)(2008-10#4)(2008-9#1)
and Southern hybridization using##2##4##(1996-12#2)
and Southern hybridization##3##3##(1992-3#1)(1996-12#2)
and Southern##16##2##(1992-3#1)(1993-12#1)(1995-6#1)(1996-12#2)(2008-10#4)(2008-8#4)(2008-9#1)(2009-10#1)(2013-8#1)
and Soxhlet##3##2##(2008-10#3)
and Sp1##4##2##(1993-12#1)(1993-6#2)(1997-8#1)
and Spatial Patterns of##2##4##(2008-10#2)
and Spatial##5##2##(2008-10#5)
and Specific##2##2##(2008-10#2)
and Spiroplasma##2##2##(2008-10#2)
and Sports##2##2##(1996-8#1)(2010-1#1)
and Sporulation of##2##3##(2008-10#2)
and Sporulation##3##2##(2008-10#3)
and Spread of##3##3##(2008-10#3)
and Sr##2##2##(2008-10#2)
and Sr12##2##2##(2008-10#2)
and St##5##2##(1991-3#1)(2008-10#4)
and Stagonospora##3##2##(2008-10#3)
and Staphylococcus aureus##4##3##(1995-5#1)(2011-2#1)(2013-8#2)
and State##5##2##(1994-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-6#1)
and States##2##2##(1994-12#1)(1995-12#1)
and Stauffers Obersulzer##2##3##(2008-10#2)
and Stellaria media##2##3##(2008-10#1)(2008-7#1)
and Streptococcus##3##2##(1996-8#1)(1997-8#1)(2010-8#1)
and Structure##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
and Student's##2##2##(1990-9#1)(2013-1#1)
and Study##2##2##(2008-10#1)(2008-12#1)
and Sudan##3##2##(2009-7#1)(2013-1#2)
and Survival of##4##3##(2008-10#2)(2009-10#1)(2013-8#1)
and Susceptible##5##2##(2008-10#5)
and Sweden##5##2##(1990-11#2)(1991-2#1)(2010-4#1)(2011-4#1)
and Symptom##2##2##(2008-10#1)(2008-4#1)
and T antigen##3##3##(1993-8#3)
and T cell proliferation##3##4##(2008-11#1)(2012-3#2)
and T cell##8##3##(2008-11#1)(2008-4#3)(2012-3#2)(2013-1#2)
and T cells##9##3##(1995-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#2)(2011-2#1)
and T lymphocytes##4##3##(1994-3#1)(1997-8#1)(2008-4#1)(2011-2#1)
and T##73##2##(1991-6#1)(1993-8#3)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-8#2)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-3#4)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)
and T-cell receptor##4##3##(1994-3#1)(1997-7#1)(1997-9#1)(2008-10#1)
and T-cell##12##2##(1994-3#1)(1994-8#1)(1995-2#3)(1995-5#2)(1997-5#1)(1997-7#1)(1997-9#1)(2008-10#2)
and T-cells in##2##3##(1996-12#1)(2008-10#1)
and T-cells##3##2##(1996-12#1)(2008-10#2)
and T-lymphocytes##2##2##(2008-10#1)(2013-8#1)
and T1##2##2##(2008-10#1)(2011-2#1)
and T2##7##2##(1991-8#2)(1996-2#2)(2009-10#2)(2011-2#1)
and T2-weighted images##3##3##(1991-11#1)(1997-8#1)(2012-12#1)
and T2-weighted##5##2##(1991-11#1)(1997-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
and T3##9##2##(1990-3#2)(1990-6#1)(1991-8#1)(2008-10#2)(2008-7#1)(2011-1#2)
and T30##3##2##(2008-10#3)
and T36##2##2##(2008-10#2)
and T4##4##2##(1990-2#1)(1991-8#1)(2008-7#1)(2011-2#1)
and TA##4##2##(1997-8#1)(2008-10#3)
and TA1535##2##2##(2008-9#2)
and TB##7##2##(1993-5#1)(1997-2#1)(2008-10#1)(2009-12#1)(2012-3#2)(2013-8#1)
and TBARS##2##2##(2008-10#1)(2010-4#1)
and TBHQ##2##2##(2008-10#2)
and TBP##3##2##(2008-10#3)
and TBZ##4##2##(2008-10#1)(2011-10#3)
and TCE##2##2##(2008-10#1)(2010-4#1)
and TCF##2##2##(1994-11#2)
and TDeltaS(0)##4##2##(2008-10#4)
and TEE##2##2##(2008-10#1)(2011-2#1)
and TEGDMA##2##2##(2013-1#2)
and TETRASPORE##2##2##(2009-10#2)
and TGF-beta##4##2##(1995-2#1)(2008-1#1)(2008-11#2)
and TIMP##2##2##(1992-6#2)
and TIMP-1##5##2##(2008-1#1)(2008-5#3)(2008-9#1)
and TL2##3##2##(2008-10#3)
and TLR4##2##2##(2008-10#2)
and TM##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
and TMV##2##2##(2008-10#2)
and TNF##4##2##(1992-12#1)(1994-3#1)(2008-11#1)(2011-2#1)
and TNF-alpha##5##2##(1993-6#1)(1995-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
and TNFalpha##2##2##(2006-6#1)(2008-11#1)
and TNT was##2##3##(2008-10#2)
and TNT##4##2##(2008-10#4)
and TPA##2##2##(1995-12#1)(1996-12#1)
and TPC-1##2##2##(1993-8#2)
and TPO##2##2##(2008-8#2)
and TSH C##3##3##(1993-8#3)
and TSH levels##2##3##(2008-4#1)(2012-3#1)
and TSH##8##2##(1991-6#1)(1993-8#3)(1994-11#1)(2008-4#1)(2011-1#1)(2012-3#1)
and TSWV##2##2##(2008-10#2)
and TUNEL##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
and Taiwan##2##2##(2008-10#1)(2008-5#1)
and Tanzania##3##2##(1997-6#1)(2008-10#2)
and TaqMan##4##2##(2008-10#3)(2010-4#1)
and Tc##2##2##(1995-12#1)(2008-8#1)
and Te by##2##3##(2008-10#2)
and Te##4##2##(2008-10#4)
and Technical##2##2##(1997-5#1)(2010-8#1)
and Technology##7##2##(1990-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)
and Temperature on##2##3##(2008-10#2)
and Temperature##3##2##(2008-10#3)
and Temporal##2##2##(2008-10#2)
and Tennessee##2##2##(2008-10#2)
and Testing Programme##3##3##(2008-10#3)
and Testing##6##2##(2008-10#6)
and Texas##7##2##(2008-10#6)(2013-8#1)
and Th##2##2##(1995-12#1)(2008-10#1)
and Th(IV)##8##2##(2008-10#8)
and Th17##4##2##(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
and Th2##3##2##(2008-11#2)(2012-12#1)
and Thailand##5##2##(1996-9#3)(2008-10#2)
and The##6##2##(1993-12#1)(1994-2#1)(1995-1#1)(2010-5#1)(2010-7#1)(2012-3#1)
and Their##14##2##(1995-3#1)(2008-10#7)(2008-4#2)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
and Thermoanaerobacter tengcongensis##2##3##(2011-1#2)
and Thielaviopsis basicola on##2##4##(2008-10#2)
and Thr##2##2##(1991-9#1)(2008-2#1)
and Ti##4##2##(2008-10#1)(2008-3#1)(2013-8#2)
and Ti(IV) ions from solution samples##2##6##(2008-10#2)
and Ti(IV) ions##3##3##(2008-10#3)
and Ti(IV)##6##2##(2008-10#6)
and Ti)##4##2##(2008-10#4)
and TiO(2)##2##2##(2008-10#1)(2013-1#1)
and Tillage##2##2##(2008-10#2)
and Tissue##3##2##(1995-8#1)(2008-10#1)(2010-1#1)
and Title X##2##3##(1991-1#1)(1991-3#1)
and Tl##6##2##(2008-10#6)
and Tobacco mosaic virus##3##4##(2008-10#3)
and Tomato in##2##3##(2008-10#2)
and Tomato leaf curl##2##4##(2008-10#2)
and Tomato yellow leaf curl##3##5##(2008-10#3)
and Tomato##9##2##(2008-10#8)(2011-2#1)
and Total Problems##2##3##(2010-8#2)
and Total##3##2##(2010-8#2)(2011-2#1)
and Traumatology##4##2##(2007-8#1)(2009-4#1)(2013-1#2)
and Treatment##4##2##(2008-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
and Treponema##3##2##(2010-11#1)(2013-8#2)
and Trichoderma##5##2##(2008-10#4)(2008-5#1)
and Trichophyton mentagrophytes##2##3##(2008-5#2)
and Trichophyton##3##2##(2008-5#3)
and Trichoplusia ni BTI-TN-5B1-4##2##4##(2008-11#2)
and Trichoplusia ni##5##3##(2008-11#3)(2008-7#2)
and Trichoplusia##6##2##(2008-11#3)(2008-7#3)
and Triton X-100##5##3##(2008-10#5)
and Tropical##2##2##(2008-10#1)(2010-1#1)
and Trp##2##2##(1995-3#1)(2008-11#1)
and Tukey's test##2##3##(2013-1#2)
and Turkey##5##2##(2008-10#5)
and Type##5##2##(1997-8#1)(2008-8#2)(2008-9#2)
and Tyr##2##2##(2008-10#2)
and U##24##2##(1994-1#1)(2008-10#18)(2008-11#1)(2009-7#1)(2010-8#2)(2012-2#1)
and U937##2##2##(1995-3#1)(2012-12#1)
and UDPGTh2 were##2##3##(2008-11#2)
and UDPGTh2##3##2##(2008-11#3)
and UHMWPE cable##3##3##(2009-3#3)
and UI##2##2##(2008-10#1)(2010-10#1)
and UK##2##2##(2008-10#1)(2008-11#1)
and UO(2)(2+)##2##2##(2008-10#2)
and UO(2)(PBI)(2)##3##2##(2008-10#3)
and US-04##2##2##(2008-10#2)
and US-1##2##2##(2008-10#2)
and US-8 clonal lineages for##2##5##(2008-10#2)
and US-8 clonal lineages##3##4##(2008-10#3)
and US-8 isolates##4##3##(2008-10#4)
and US-8##12##2##(2008-10#12)
and US-8)##2##2##(2008-10#2)
and US14##2##2##(2008-10#2)
and USEPA##2##2##(2008-10#2)
and UTP##3##2##(1993-8#2)(1995-11#1)
and UV detection at##4##4##(2008-10#2)(2008-5#2)
and UV detection##10##3##(1997-2#1)(2008-10#5)(2008-5#3)(2011-1#1)
and UV irradiation##2##3##(2008-10#2)
and UV##25##2##(1994-8#1)(1997-2#2)(2008-10#15)(2008-5#4)(2010-7#1)(2011-1#1)(2011-2#1)
and UV-A##2##2##(1991-6#1)(2008-11#1)
and UV-VIS##2##2##(2008-10#2)
and UV-Vis##4##2##(2008-10#3)(2013-8#1)
and UV-vis##4##2##(2008-10#4)
and UV-visible spectrophotometry##2##3##(2008-10#2)
and UV-visible##5##2##(2008-10#5)
and UVA protection##2##3##(2008-5#2)
and UVA##8##2##(2008-10#1)(2008-5#7)
and UVB-tolerant##2##2##(2008-11#2)
and Ultrastructural##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
and University##2##2##(1993-2#1)(2008-11#1)
and Ustilago maydis##2##3##(1996-6#1)(2010-7#1)
and Ustilago##4##2##(1996-6#1)(2008-5#2)(2010-7#1)
and Utilization##3##2##(2008-10#2)(2008-11#1)
and V in##3##3##(2008-10#3)
and V loss##4##3##(2011-2#4)
and V##32##2##(1990-2#1)(1994-2#1)(2008-10#22)(2008-2#1)(2010-1#1)(2011-2#5)(2011-3#1)
and V(IV)##4##2##(2008-10#4)
and V(L)-gp130##2##2##(2008-11#2)
and V(max)##3##2##(2008-10#2)(2008-11#1)
and V3##2##2##(1996-2#1)(2008-12#1)
and V6 regions##2##3##(2011-2#2)
and V767 of 4##2##4##(2010-5#2)
and VCG4B##3##2##(2008-10#3)
and VI and a##2##4##(1994-2#1)(1997-2#1)
and VI##9##2##(1990-5#1)(1991-6#1)(1994-2#2)(1997-2#1)(2007-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
and VII##3##2##(2008-10#1)(2008-5#2)
and VIP##2##2##(1994-3#1)(1995-11#1)
and VP1##2##2##(2013-8#2)
and VPA##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
and VTA##2##2##(1996-12#1)(1996-5#1)
and Validation##2##2##(2008-10#1)(2012-3#1)
and Varroa##2##2##(2013-1#2)
and Vegetative Compatibility##2##3##(2008-10#2)
and Venturia inaequalis##3##3##(2008-10#3)
and Verticillium dahliae##4##3##(2008-10#4)
and Verticillium##6##2##(2008-10#6)
and Virulence of##2##3##(2008-10#2)
and Virulence##7##2##(2008-10#7)
and Vmax of##2##3##(1993-8#1)(1994-6#1)
and Vmax values of##3##4##(1994-5#1)(1995-8#2)
and Vmax##6##2##(1991-5#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-8#2)
and W##5##2##(1995-3#1)(2008-10#2)(2008-9#1)(2010-5#1)
and W(VI) with##2##3##(2008-10#2)
and W(VI)##4##2##(2008-10#4)
and W-7)##2##2##(1990-8#1)(2008-10#1)
and WBI##4##2##(2011-2#4)
and WIPK##2##2##(2009-8#2)
and WNA are##2##3##(2008-8#2)
and WNA##9##2##(2008-8#9)
and Water##2##2##(1996-9#1)(2008-10#1)
and Web##2##2##(2008-9#2)
and Welfare##5##2##(1996-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
and Welsh##2##2##(2008-10#2)
and West##2##2##(1990-3#1)(2011-2#1)
and Western Europe##3##3##(1997-1#1)(2008-1#1)(2011-2#1)
and Western blot analysis##4##4##(1996-12#1)(1996-2#1)(2008-8#1)(2011-2#1)
and Western blot##12##3##(1996-12#1)(1996-2#1)(2008-11#2)(2008-8#3)(2008-9#2)(2011-2#3)
and Western blotting analysis##2##4##(2008-11#1)(2008-8#1)
and Western blotting##7##3##(1993-8#1)(1994-8#1)(1995-8#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-3#1)
and Western##31##2##(1993-8#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-8#4)(2008-9#2)(2009-10#1)(2010-12#1)(2011-2#4)(2011-3#1)
and Wheat##3##2##(2008-10#3)
and White participants##2##3##(2008-11#1)(2012-2#1)
and White##9##2##(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#2)
and Wild##3##2##(2008-10#3)
and Wilt##2##2##(2008-10#2)
and Wisconsin##2##2##(2008-10#2)
and Within Populations of##2##4##(2008-10#2)
and Within##3##2##(2008-10#3)
and Worland##4##2##(2008-10#4)
and World##2##2##(1993-3#1)(2008-7#1)
and X##16##2##(1993-2#1)(1995-2#1)(1995-5#1)(2008-10#11)(2008-3#1)(2008-8#1)
and X-ray diffraction (XRD)##3##4##(2008-10#2)(2009-7#1)
and X-ray diffraction analysis##2##4##(2008-10#1)(2011-2#1)
and X-ray diffraction##9##3##(2008-10#5)(2008-5#2)(2009-7#1)(2011-2#1)
and X-ray photoelectron spectroscopy##5##4##(1996-12#1)(2008-10#4)
and X-ray photoelectron##6##3##(1996-12#1)(2008-10#5)
and X-ray##23##2##(1992-3#1)(1994-3#1)(1996-12#1)(1996-5#1)(2008-10#14)(2008-5#2)(2009-7#1)(2010-4#1)(2011-2#1)
and XN4##4##2##(2008-10#4)
and XO##2##2##(2008-10#1)(2008-11#1)
and XPS spectra##2##3##(2008-10#2)
and XPS##4##2##(2008-10#4)
and Xa21##5##2##(2008-10#4)(2008-8#1)
and Xanthomonas campestris##2##3##(2008-10#2)
and Xanthomonas##4##2##(2008-10#4)
and Xenopus##2##2##(1995-11#1)(1997-3#1)
and Y chromosomes##4##3##(1990-3#2)(2008-7#1)(2010-5#1)
and Y point##2##3##(2008-7#2)
and Y##20##2##(1990-11#1)(1990-3#4)(2008-10#2)(2008-11#3)(2008-7#6)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
and YAC 876D4##2##3##(1997-8#2)
and YAC##4##2##(1996-8#1)(1997-8#3)
and Yb##4##2##(1997-8#2)(2008-10#1)(2010-4#1)
and Yb(3+)##2##2##(2008-10#1)(2010-4#1)
and York##2##2##(1992-1#1)(2008-10#1)
and Young##2##2##(2008-6#1)(2009-12#1)
and Z##4##2##(1992-12#1)(2008-10#1)(2009-12#1)(2010-5#1)
and ZAPM##3##2##(2008-7#3)
and Zn as##2##3##(2008-10#2)
and Zn by##2##3##(2008-10#2)
and Zn determination##2##3##(2008-10#2)
and Zn from##2##3##(2008-10#2)
and Zn in##17##3##(2008-10#17)
and Zn were##6##3##(2008-10#6)
and Zn##69##2##(2008-10#69)
and Zn(2+) can be##2##4##(2008-10#2)
and Zn(2+) from aqueous environments##2##5##(2008-10#2)
and Zn(2+) in##2##3##(2008-10#2)
and Zn(2+)##18##2##(2008-10#15)(2008-5#2)(2010-11#1)
and Zn(II) from##2##3##(2008-10#2)
and Zn(II) in##2##3##(2008-10#2)
and Zn(II) using##2##3##(2008-10#2)
and Zn(II) were##2##3##(2008-10#2)
and Zn(II)##23##2##(2008-10#23)
and Zn) by##2##3##(2008-10#2)
and Zn) in##2##3##(2008-10#2)
and Zn)##10##2##(2008-10#10)
and Zr##4##2##(2008-10#4)
and [2##2##2##(1992-10#1)(1997-1#1)
and [3H]T##2##2##(1990-11#2)
and [D-Ala2##3##2##(1995-6#1)(1996-2#2)
and a &quot##2##3##(1994-3#1)(2009-4#1)
and a 0##3##3##(2008-10#2)(2009-11#1)
and a 1##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)
and a 2##2##3##(2007-12#1)(2008-10#1)
and a 2'-hydroxyl in##2##4##(1993-1#2)
and a 30%##2##3##(2008-8#1)(2013-1#1)
and a 4##2##3##(2008-10#2)
and a C-terminal##5##3##(1993-12#1)(1993-6#1)(2008-10#1)(2009-6#1)(2012-2#1)
and a CAAT##2##3##(1993-6#1)(1997-7#1)
and a CT##2##3##(1990-6#1)(1997-2#1)
and a DNA##2##3##(1996-12#1)(2008-10#1)
and a GUS##2##3##(2008-10#2)
and a R##5##3##(2008-10#5)
and a Vmax##2##3##(1992-3#1)(1994-6#1)
and a bacterium##3##3##(2008-10#3)
and a better##4##3##(2008-10#3)(2008-9#1)
and a bilateral##2##3##(1990-9#1)(1996-2#1)
and a buffer##2##3##(2008-10#1)(2008-9#1)
and a calibration##2##3##(2008-10#2)
and a candidate##2##3##(2009-9#1)(2012-2#1)
and a case##2##3##(1992-12#1)(2010-5#1)
and a cationic##3##3##(2008-10#3)
and a cell##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
and a central##3##3##(1997-7#1)(2008-10#2)
and a chest##2##3##(1990-6#1)(2010-12#1)
and a clearer##2##3##(2008-10#1)(2008-9#1)
and a clinical##3##3##(2008-1#1)(2008-7#1)(2012-3#1)
and a column temperature of##2##5##(2008-10#2)
and a combination of##2##4##(1991-9#1)(1994-3#1)
and a commercially available##4##4##(2008-10#3)(2008-3#1)
and a common##2##3##(2008-8#1)(2009-9#1)
and a comparison##5##3##(1991-1#1)(2008-10#3)(2008-3#1)
and a complete##4##3##(1996-1#1)(2008-10#1)(2008-8#1)(2010-3#1)
and a concentration of##2##4##(2008-10#1)(2008-12#1)
and a concentration##3##3##(2008-10#2)(2008-12#1)
and a concomitant##5##3##(1992-1#1)(1994-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
and a considerable##3##3##(1990-9#1)(2008-10#1)(2008-3#1)
and a consistent##3##3##(2008-10#1)(2012-2#2)
and a constant##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
and a control group##7##4##(1991-12#1)(1992-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)(2010-9#1)
and a control##11##3##(1991-12#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-6#1)(2010-9#1)(2013-1#1)
and a conventional##2##3##(2008-10#1)(2008-3#1)
and a cooled##3##3##(2008-10#2)(2008-2#1)
and a correlation coefficient of 0##2##6##(2008-10#2)
and a correlation coefficient##3##4##(2008-10#3)
and a correlation##6##3##(2008-10#5)(2008-7#1)
and a corresponding##6##3##(2008-10#4)(2009-11#1)(2013-1#1)
and a critical##2##3##(2008-11#1)(2009-10#1)
and a cytoplasmic##2##3##(1991-5#1)(2011-2#1)
and a dark##2##3##(1991-5#1)(2008-10#1)
and a decline in##2##4##(1993-12#1)(1996-12#1)
and a decrease in the##3##5##(2008-10#3)
and a decrease in##13##4##(1993-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-1#1)
and a decrease of##3##4##(2008-10#3)
and a decrease##16##3##(1993-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-1#1)
and a decreased##5##3##(1990-11#1)(1991-12#1)(1996-2#1)(1997-3#1)(2013-1#1)
and a delay##2##3##(1994-6#1)(2008-10#1)
and a deletion of##2##4##(2008-10#1)(2011-1#1)
and a description of the##2##5##(1990-12#1)(1994-2#1)
and a description##3##3##(1990-12#1)(1992-1#1)(1994-2#1)
and a detection limit (3sigma) of##2##6##(2008-10#2)
and a detection limit of 0##11##6##(2008-10#11)
and a detection limit of 1##8##6##(2008-10#8)
and a detection limit of 2##4##6##(2008-10#4)
and a detection limit of 20##2##6##(2008-10#2)
and a detection limit of 3##3##6##(2008-10#3)
and a detection limit of 4##2##6##(2008-10#2)
and a detection limit of 6##2##6##(2008-10#2)
and a detection limit of##41##5##(2008-10#41)
and a detection limit##45##4##(2008-10#45)
and a detection##46##3##(2008-10#45)(2009-5#1)
and a difference##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
and a different behaviour##2##4##(1992-2#1)(2008-10#1)
and a different##5##3##(1992-2#1)(1995-2#1)(2008-10#2)(2008-3#1)
and a digital##2##3##(1992-6#1)(2013-1#1)
and a diode array##2##4##(2008-10#2)
and a direct##2##3##(1995-2#1)(2008-11#1)
and a discussion of the##2##5##(2008-4#1)(2008-9#1)
and a discussion of##5##4##(1991-2#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
and a discussion##6##3##(1991-2#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
and a dissociation constant##2##4##(1990-8#1)(2008-10#1)
and a distal##3##3##(2008-9#2)(2012-2#1)
and a double##3##3##(1995-6#1)(1997-6#1)(2008-10#1)
and a drug##2##3##(2008-1#1)(2013-8#1)
and a duplex with##2##4##(1993-8#2)
and a dynamic##3##3##(2008-10#3)
and a family of##2##4##(1996-6#1)(2011-2#1)
and a family##3##3##(1996-6#1)(2008-7#1)(2011-2#1)
and a fast response##2##4##(2008-10#2)
and a fast##3##3##(2008-10#3)
and a few##8##3##(1994-12#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-9#1)
and a field##2##3##(2008-10#2)
and a final##6##3##(1993-3#1)(1994-6#1)(2008-11#1)(2008-7#1)(2012-9#1)(2013-1#1)
and a flow rate of 1##2##6##(2008-10#2)
and a flow rate of##4##5##(2008-10#4)
and a flow rate##6##4##(2008-10#6)
and a flow##7##3##(2008-10#7)
and a fluorescent##2##3##(2008-10#2)
and a formal##2##3##(1996-2#1)(2008-10#1)
and a framework for##2##4##(1991-12#1)(2010-4#1)
and a free##3##3##(2008-10#1)(2011-2#2)
and a functional##2##3##(2008-10#1)(2008-11#1)
and a further##7##3##(1991-6#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-7#1)(2011-2#2)
and a general##2##3##(1996-11#1)(1997-7#1)
and a generalized##3##3##(2008-10#1)(2009-10#2)
and a genetic##2##3##(1994-12#1)(2011-2#1)
and a genetically engineered##2##4##(1995-2#1)(2008-11#1)
and a glass##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
and a global##2##3##(1997-7#1)(2011-2#1)
and a good selectivity##2##4##(2008-10#2)
and a good##9##3##(1995-2#1)(1997-3#1)(1997-4#1)(2008-10#6)
and a greater number of##4##5##(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)
and a greater##8##3##(1992-3#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)
and a group of##5##4##(1992-2#1)(1994-11#1)(2008-10#1)(2008-9#1)(2010-12#1)
and a half years##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
and a half##9##3##(1992-5#1)(1993-2#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-11#1)(2010-6#1)
and a health##2##3##(2008-11#1)(2008-7#1)
and a high degree of##5##5##(1992-3#1)(1995-10#1)(2008-10#3)
and a high level of##3##5##(2008-11#2)(2010-3#1)
and a high proportion of##2##5##(1995-3#1)(1995-9#1)
and a high risk##3##4##(1991-6#1)(2008-4#2)
and a high##32##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-9#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#2)(2009-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#1)
and a higher##11##3##(1991-5#1)(1996-6#1)(1997-5#1)(2008-10#3)(2008-7#2)(2011-2#2)(2013-1#1)
and a highly selective##2##4##(2008-10#2)
and a highly susceptible##2##4##(2008-10#2)
and a highly##10##3##(1990-8#1)(1995-6#1)(2008-10#7)(2008-12#1)
and a history of##5##4##(2007-7#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
and a host of##2##4##(2008-9#1)(2011-1#1)
and a host##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
and a human##3##3##(1996-2#1)(2008-11#2)
and a laboratory strain##2##4##(2011-2#1)(2012-3#1)
and a lack of##4##4##(2008-10#1)(2008-12#2)(2009-6#1)
and a large number of##4##5##(1993-12#1)(2008-9#1)(2011-2#2)
and a large##16##3##(1993-12#1)(1995-8#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#1)
and a larger##5##3##(1990-6#1)(1995-2#1)(2008-10#1)(2008-7#1)(2010-7#1)
and a left##3##3##(1991-12#1)(2008-7#1)(2011-2#1)
and a less##10##3##(1991-6#1)(2008-10#5)(2008-3#1)(2011-2#1)(2013-1#2)
and a limit of detection between##2##6##(2008-10#2)
and a limit of detection##5##5##(2008-10#5)
and a limit of##6##4##(2008-10#6)
and a limited##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
and a linear dynamic range of##2##6##(2008-10#2)
and a linear dynamic range##3##5##(2008-10#3)
and a linear range of##3##5##(2008-10#3)
and a linear range##4##4##(2008-10#4)
and a linear##10##3##(2008-10#10)
and a liquid##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
and a literature review##2##4##(2009-4#1)(2011-2#1)
and a literature##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
and a local##4##3##(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
and a logarithmic##2##3##(2008-8#1)(2009-7#1)
and a long##6##3##(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)
and a low detection limit of 0##2##7##(2008-10#2)
and a low detection limit##4##5##(2008-10#4)
and a low##17##3##(1990-8#1)(1995-12#1)(2008-10#9)(2008-11#2)(2008-8#2)(2011-3#1)(2012-3#1)
and a lower detection limit##2##5##(2008-10#2)
and a lower incidence of##2##5##(1990-8#1)(2011-2#1)
and a lower number of##2##5##(2012-3#1)(2013-1#1)
and a lower##15##3##(1990-8#1)(1993-12#1)(1994-2#1)(2008-10#5)(2008-11#2)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
and a lung##2##3##(1994-5#1)(2008-11#1)
and a magnetic##2##3##(1990-12#1)(2008-7#1)
and a major##7##3##(1992-2#1)(1992-6#1)(2007-12#1)(2008-12#1)(2011-2#3)
and a majority of them##2##5##(1995-2#1)(2008-10#1)
and a majority of##3##4##(1994-3#1)(1995-2#1)(2008-10#1)
and a marked##3##3##(1992-8#1)(2008-10#1)(2012-2#1)
and a mass##2##3##(1996-3#1)(2008-10#1)
and a matched##2##3##(1993-8#1)(2013-8#1)
and a mathematical model##2##4##(1997-1#1)(2008-10#1)
and a maximum of##2##4##(1992-9#1)(2008-10#1)
and a maximum##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
and a mean##6##3##(1990-3#1)(1994-12#1)(2008-10#3)(2010-4#1)
and a measure of##2##4##(2012-3#2)
and a mechanical##2##3##(2009-4#1)(2013-1#1)
and a member of the##2##5##(1992-12#1)(2008-10#1)
and a method for##2##4##(2008-10#1)(2008-11#1)
and a method##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
and a mild##2##3##(2008-7#1)(2011-2#1)
and a minimum##2##3##(2008-10#1)(2008-9#1)
and a mixture of##4##4##(2008-10#4)
and a mobile phase##5##4##(2008-10#5)
and a model for##2##4##(1992-12#1)(2008-10#1)
and a model system##2##4##(2008-10#2)
and a model##5##3##(1992-12#1)(2008-10#3)(2008-9#1)
and a monoclonal antibody to##2##5##(1995-12#1)(1997-1#1)
and a monoclonal antibody##4##4##(1995-12#1)(1997-1#1)(2008-10#1)(2011-2#1)
and a more##8##3##(1990-3#1)(1993-6#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
and a mouse##2##3##(1996-12#1)(2008-8#1)
and a much##2##3##(1992-10#1)(2011-2#1)
and a mutant##2##3##(1995-12#1)(2010-10#1)
and a national##2##3##(1993-12#1)(2008-9#1)
and a nationwide##2##3##(1991-11#1)(2008-6#1)
and a negative##2##3##(1994-5#1)(2008-7#1)
and a neighbouring##2##3##(1993-9#1)(1995-8#1)
and a new##19##3##(1992-2#1)(1992-8#1)(1993-6#1)(1995-6#1)(1996-12#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
and a newly##3##3##(1992-9#1)(2008-10#2)
and a normal##2##3##(2008-10#1)(2013-1#1)
and a novel##6##3##(1997-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2012-2#1)
and a number of approaches have been##2##7##(2008-11#1)(2012-3#1)
and a number of other##7##5##(1991-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)
and a number of##17##4##(1991-3#1)(1995-5#1)(1996-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2012-3#1)(2013-1#1)
and a numerical##2##3##(2007-12#1)(2008-3#1)
and a p101##2##3##(1996-2#2)
and a pH##3##3##(2008-10#2)(2009-12#1)
and a pI of##3##4##(1992-8#1)(1995-6#1)(2008-10#1)
and a parallel##2##3##(1995-2#1)(2009-8#1)
and a part##2##3##(1990-3#1)(1991-6#1)
and a partial##4##3##(1990-5#1)(1994-11#1)(1995-2#1)(2013-8#1)
and a partially##2##3##(2008-10#2)
and a phosphate buffer##3##4##(2008-10#3)
and a photometric##2##3##(2008-10#2)
and a polar##2##3##(2008-10#1)(2008-5#1)
and a polyurethane##2##3##(2008-10#2)
and a poor##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
and a population##2##3##(1991-6#1)(2008-10#1)
and a portion of##2##4##(1997-2#1)(2008-10#1)
and a position##2##3##(2008-10#1)(2008-3#1)
and a positive##5##3##(1990-8#1)(1991-11#1)(2009-1#1)(2010-2#1)(2010-8#1)
and a possible##6##3##(1994-12#1)(1994-8#1)(1995-8#1)(2008-10#1)(2009-9#1)(2010-6#1)
and a potential of##2##4##(2008-10#2)
and a potential##8##3##(1991-7#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
and a powerful##2##3##(1991-3#1)(2013-1#1)
and a pre-reducing##2##3##(2008-10#2)
and a precision expressed as relative standard deviation##2##8##(2008-10#2)
and a precision##5##3##(2008-10#5)
and a predictive##2##3##(1993-2#1)(2009-3#1)
and a predictor of##2##4##(2008-8#1)(2010-10#1)
and a preliminary##2##3##(1992-2#1)(2008-8#1)
and a primary##5##3##(1990-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
and a private##2##3##(1991-9#1)(1997-2#1)
and a probe##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
and a protein##2##3##(2008-10#1)(2011-2#1)
and a pulmonary##2##3##(1990-6#1)(1996-3#1)
and a pulse width##2##4##(2008-3#2)
and a pulse##4##3##(2008-3#3)(2008-7#1)
and a putative##3##3##(1993-6#1)(1995-8#1)(1997-7#1)
and a qualitative##2##3##(2008-10#1)(2010-7#1)
and a range of##6##4##(1995-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
and a rapid##2##3##(1992-1#1)(2008-10#1)
and a ratio of##2##4##(1991-12#1)(1995-5#1)
and a reactor##2##3##(2008-10#2)
and a recent##2##3##(2008-4#1)(2013-1#1)
and a recently##4##3##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and a recombinant##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
and a recovery##2##3##(2008-10#1)(2008-5#1)
and a red##4##3##(2008-10#3)(2008-8#1)
and a reduced##4##3##(1991-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
and a reduction in the##2##5##(2008-9#1)(2013-1#1)
and a reduction in##9##4##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-3#1)(2013-1#1)(2013-8#2)
and a reduction of the##2##5##(2008-3#1)(2008-7#1)
and a reduction of##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
and a reduction##12##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-3#1)(2013-1#1)(2013-8#2)
and a reference##4##3##(1990-2#1)(2008-10#3)
and a related##2##3##(1993-12#1)(2008-6#1)
and a relative accuracy error of##2##6##(2008-10#2)
and a relative standard deviation (R##2##6##(2008-10#2)
and a relative standard deviation lower than##2##7##(2008-10#2)
and a relative standard deviation of 1##2##7##(2008-10#2)
and a relative standard deviation of 2##2##7##(2008-10#2)
and a relative standard deviation of##12##6##(2008-10#12)
and a relative standard deviation##19##5##(2008-10#19)
and a relative##24##3##(1994-9#1)(2008-10#23)
and a relatively##2##3##(1994-8#1)(2008-10#1)
and a requirement##2##3##(1993-3#1)(2008-10#1)
and a response##2##3##(2008-10#2)
and a retrospective##2##3##(1994-2#1)(2013-1#1)
and a review of the literature is##2##7##(1991-3#1)(2010-12#1)
and a review of the literature##6##6##(1991-3#1)(2008-10#1)(2009-6#1)(2010-12#1)(2013-1#2)
and a review of##10##4##(1991-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2013-1#3)
and a role for##2##4##(1993-12#1)(1997-8#1)
and a rotating##3##3##(2008-10#2)(2010-12#1)
and a sample frequency of##4##5##(2008-10#4)
and a sample measurement frequency of##3##6##(2008-10#3)
and a sample throughput of##4##5##(2008-10#4)
and a sample volume of##2##5##(2008-10#2)
and a sample##16##3##(2008-10#16)
and a sampling frequency of##6##5##(2008-10#6)
and a sampling frequency##7##4##(2008-10#7)
and a sampling rate of##2##5##(2008-10#2)
and a sampling##9##3##(2008-10#9)
and a search for##2##4##(2010-3#1)(2011-2#1)
and a second group##2##4##(1990-5#1)(2008-9#1)
and a second##19##3##(1990-12#1)(1990-5#1)(1991-3#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-11#1)(2012-3#1)
and a sensitive##2##3##(2008-10#2)
and a sensitivity##3##3##(1997-8#1)(2008-10#1)(2008-3#1)
and a separate##2##3##(1991-2#1)(2008-10#1)
and a sequential##3##3##(2008-10#3)
and a series of##6##4##(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)
and a set of##5##4##(1995-12#1)(1996-6#1)(2008-9#1)(2009-10#1)(2012-3#1)
and a short##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-12#1)
and a shorter##4##3##(1992-3#2)(1995-2#1)(1996-6#1)
and a significant decrease in##2##5##(1994-3#1)(1997-1#1)
and a significant increase in##3##5##(2008-10#2)(2010-1#1)
and a significant increase##4##4##(2008-10#2)(2009-8#1)(2010-1#1)
and a significant reduction of##3##5##(1993-3#1)(2008-10#1)(2012-2#1)
and a significant##13##3##(1993-3#1)(1994-3#1)(1994-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-2#1)
and a significantly##4##3##(1994-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
and a silver/silver chloride electrode##2##5##(2008-10#2)
and a simple##9##3##(2008-10#7)(2008-2#1)(2008-8#1)
and a single##13##3##(1991-10#1)(1993-2#1)(2008-1#1)(2008-10#7)(2008-3#2)(2012-2#1)
and a slight##5##3##(1991-12#1)(1993-12#1)(1997-2#1)(2008-10#2)
and a slope of 56##2##5##(2008-10#2)
and a slope of##6##4##(1996-2#2)(2008-10#4)
and a slope##7##3##(1996-2#2)(2008-10#4)(2008-2#1)
and a slowly##2##3##(1996-2#1)(2012-3#1)
and a small##8##3##(1991-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
and a software##2##3##(2008-5#1)(2012-3#1)
and a solution##2##3##(2008-11#1)(2008-9#1)
and a spatial##2##3##(2007-12#1)(2008-8#1)
and a specially designed furnace##2##5##(2008-10#2)
and a spectral##2##3##(2008-3#1)(2013-8#1)
and a standard error of cross validation of 0##2##9##(2008-10#2)
and a standard##6##3##(1991-12#1)(2008-10#3)(2008-11#1)(2012-2#1)
and a standardized##4##3##(1997-5#1)(2008-10#3)
and a state##3##3##(1995-6#1)(1996-3#1)(2008-11#1)
and a strong##5##3##(1994-3#1)(2007-12#1)(2008-10#2)(2008-5#1)
and a strongly##2##3##(2008-10#1)(2008-11#1)
and a study of##2##4##(2008-10#2)
and a sub-sample was##2##4##(2008-10#2)
and a subsequent##3##3##(1990-12#1)(1996-12#1)(2008-10#1)
and a subset of##5##4##(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#1)
and a summary of the##3##5##(2008-10#1)(2008-4#1)(2011-7#1)
and a surgical##2##3##(2008-11#1)(2008-7#1)
and a survey of##2##4##(2008-11#1)(2008-9#1)
and a susceptible cultivar##2##4##(2008-10#2)
and a susceptible##3##3##(2008-10#3)
and a synthesized polymer##2##4##(2008-10#2)
and a synthetic##4##3##(1990-7#1)(1997-3#1)(1997-8#1)(2008-10#1)
and a systematic##2##3##(2006-5#1)(2008-3#1)
and a temperature of##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
and a temperature##6##3##(1993-8#1)(2008-10#3)(2008-11#1)(2013-1#1)
and a test set##3##4##(2008-10#3)
and a test##7##3##(1994-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)
and a thickness##2##3##(2007-12#1)(2008-3#1)
and a third##6##3##(1990-5#1)(1993-12#1)(1994-5#1)(2008-10#2)(2008-11#1)
and a time##2##3##(2008-3#1)(2012-12#1)
and a total of##2##4##(1993-8#1)(2008-10#1)
and a total time##2##4##(2008-10#2)
and a total##10##3##(1990-5#1)(1993-8#1)(2008-10#7)(2013-8#1)
and a trade-off##2##3##(2008-10#1)(2008-8#1)
and a treatment##2##3##(2008-10#1)(2008-3#1)
and a tumor##2##3##(1992-12#1)(2008-10#1)
and a typical##2##3##(1995-8#1)(2008-10#1)
and a unique##3##3##(1994-5#1)(2008-3#1)(2012-3#1)
and a used##2##3##(2008-10#2)
and a useful##2##3##(1991-3#1)(2008-10#1)
and a validation##2##3##(1995-9#1)(2008-10#1)
and a value##2##3##(2008-10#1)(2011-1#1)
and a variable##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
and a variety of##10##4##(1992-11#1)(1992-3#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-1#1)
and a very low##2##4##(1991-11#1)(2013-1#1)
and a very##7##3##(1991-11#1)(1997-7#1)(2008-10#4)(2013-1#1)
and a virus##2##3##(2008-10#1)(2011-2#1)
and a weak##2##3##(1991-5#1)(2008-8#1)
and a well-defined##3##3##(2008-10#2)(2013-8#1)
and a wide##3##3##(2007-12#1)(2008-10#1)(2009-8#1)
and a work##2##3##(1996-1#1)(2009-7#1)
and a yeast##2##3##(2008-5#1)(2010-10#1)
and a##2055##2##(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#7)(1990-5#10)(1990-6#4)(1990-7#1)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#2)(1991-11#8)(1991-12#15)(1991-2#6)(1991-3#8)(1991-5#6)(1991-6#5)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#7)(1992-2#10)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#7)(1993-1#5)(1993-11#3)(1993-12#13)(1993-2#6)(1993-3#7)(1993-6#7)(1993-8#9)(1993-9#1)(1994-1#3)(1994-11#5)(1994-12#13)(1994-2#9)(1994-3#7)(1994-5#8)(1994-6#7)(1994-8#8)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#11)(1995-2#15)(1995-3#4)(1995-5#5)(1995-6#7)(1995-8#12)(1995-9#6)(1996-1#5)(1996-11#2)(1996-12#8)(1996-2#13)(1996-3#8)(1996-5#3)(1996-6#9)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#11)(1997-3#9)(1997-4#4)(1997-5#4)(1997-6#6)(1997-7#11)(1997-8#6)(2006-5#1)(2006-6#1)(2007-11#6)(2007-12#22)(2007-7#1)(2008-1#9)(2008-10#804)(2008-11#106)(2008-12#32)(2008-2#20)(2008-3#77)(2008-4#14)(2008-5#37)(2008-6#4)(2008-7#46)(2008-8#52)(2008-9#47)(2009-1#4)(2009-10#10)(2009-11#6)(2009-12#5)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#7)(2009-7#9)(2009-8#8)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#9)(2010-2#1)(2010-3#5)(2010-4#6)(2010-5#10)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#9)(2011-10#2)(2011-2#58)(2011-3#4)(2011-7#1)(2012-12#11)(2012-2#25)(2012-3#27)(2012-5#2)(2012-9#1)(2013-1#47)(2013-8#28)
and abdomen##2##2##(2010-6#1)(2011-2#1)
and abdominal fat##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
and abdominal hysterectomy##2##3##(1994-2#1)(2010-3#1)
and abdominal pain##7##3##(1991-9#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#3)
and abdominal##29##2##(1991-9#1)(1994-2#1)(1996-8#2)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#5)(2012-2#2)(2012-3#4)(2013-1#1)(2013-3#1)
and aberrant##3##2##(1995-9#1)(2008-12#1)(2011-2#1)
and aberration##2##2##(2008-3#2)
and abietic##2##2##(1997-2#2)
and abilities##3##2##(1993-1#1)(2008-12#1)(2013-1#1)
and ability to##11##3##(1991-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-4#1)(2013-1#1)
and ability##15##2##(1991-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-4#1)(2013-1#1)(2013-7#1)
and abiotic stresses##4##3##(2008-10#1)(2008-8#1)(2010-10#2)
and abiotic suppression##2##3##(2008-10#2)
and abiotic##9##2##(2008-10#5)(2008-8#2)(2010-10#2)
and able to##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
and abnormal##14##2##(1991-1#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
and abnormalities##3##2##(2008-9#1)(2009-10#1)(2011-7#1)
and abnormally##2##2##(1995-12#1)(2008-10#1)
and abolished##2##2##(1990-5#1)(1997-3#1)
and abolishes the##2##3##(1995-11#1)(1995-6#1)
and abortion##5##2##(1991-1#1)(1994-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
and about 70%##2##3##(1996-12#1)(2008-8#1)
and about##31##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-12#3)(1997-7#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
and above the##8##3##(1994-2#1)(1995-3#1)(2008-10#3)(2008-7#2)(2012-2#1)
and above##22##2##(1991-8#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-3#1)(1996-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#4)(2009-9#1)(2010-10#1)(2012-2#2)
and abroad##4##2##(1992-9#1)(1994-1#1)(1997-8#1)(2012-12#1)
and absence of##35##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1997-1#1)(2008-10#12)(2008-11#4)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
and absence##36##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1997-1#1)(2008-10#13)(2008-11#4)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
and absent from##2##3##(1996-12#1)(2009-6#1)
and absent##3##2##(1996-12#1)(2008-10#1)(2009-6#1)
and absolute detection limit##2##4##(2008-10#2)
and absolute detection##3##3##(2008-10#3)
and absolute numbers of##2##4##(1995-12#2)
and absolute##11##2##(1992-2#1)(1995-12#2)(2008-10#4)(2008-8#2)(2008-9#1)(2012-2#1)
and absorbance was measured at##3##5##(1990-2#1)(2008-10#2)
and absorbance##9##2##(1990-2#1)(2008-10#8)
and absorbing##4##2##(2008-3#4)
and absorption of##4##3##(2008-3#1)(2012-2#2)(2013-1#1)
and absorption spectra of##2##4##(2008-10#1)(2008-3#1)
and absorption spectra##3##3##(2008-10#1)(2008-3#2)
and absorption##20##2##(2008-10#2)(2008-2#1)(2008-3#10)(2008-5#2)(2008-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
and abundance of##2##3##(2008-1#1)(2012-2#1)
and abundance##3##2##(2008-1#1)(2008-8#1)(2012-2#1)
and abundant##4##2##(2008-10#1)(2010-1#1)(2011-3#1)(2013-1#1)
and abuse in##2##3##(2008-11#1)(2013-1#1)
and abuse of##3##3##(1991-1#1)(1995-5#1)(2009-12#1)
and abuse##20##2##(1991-1#7)(1992-3#1)(1993-1#2)(1993-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(2008-11#2)(2009-12#1)(2010-7#1)(2013-1#2)
and ac impedance##2##3##(2008-10#2)
and ac##3##2##(1990-12#1)(2008-10#2)
and academic achievement##4##3##(2010-1#3)(2012-2#1)
and academic adjustment##3##3##(2010-1#3)
and academic institutions##2##3##(2012-2#1)(2013-8#1)
and academic##24##2##(1993-1#1)(1996-3#1)(2008-11#4)(2008-12#6)(2008-7#1)(2010-1#6)(2012-2#3)(2013-8#2)
and academics##3##2##(2008-11#3)
and accelerate the##2##3##(2008-10#1)(2008-7#1)
and accelerate##4##2##(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
and accelerated##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
and accelerates##3##2##(2008-10#1)(2008-11#1)(2009-3#1)
and acceleration of##2##3##(2008-10#1)(2008-5#1)
and acceleration##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
and acceptability of##2##3##(1995-1#1)(2013-1#1)
and acceptability##5##2##(1992-1#1)(1995-1#1)(2008-11#1)(2012-3#1)(2013-1#1)
and acceptable to##2##3##(2008-7#1)(2009-11#1)
and acceptable##9##2##(2008-10#4)(2008-7#2)(2009-11#1)(2010-8#2)
and acceptance of##2##3##(1993-12#1)(1996-12#1)
and acceptance##4##2##(1993-12#1)(1996-12#1)(2008-11#2)
and accepted by##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
and accepted##5##2##(1997-2#1)(2008-10#2)(2010-4#1)(2012-2#1)
and acceptor##6##2##(2008-10#4)(2008-9#1)(2011-2#1)
and access to health services##2##5##(1992-2#1)(2008-11#1)
and access to health##3##4##(1992-2#1)(2008-11#2)
and access to the##2##4##(1991-1#1)(2012-2#1)
and access to##14##3##(1991-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#5)(2012-2#1)(2013-8#1)
and access##19##2##(1991-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#5)(2012-12#1)(2012-2#1)(2013-8#1)
and accessibility of health care##2##5##(2008-11#1)(2012-3#1)
and accessibility##5##2##(1992-1#1)(2008-11#2)(2009-5#1)(2012-3#1)
and accessible##4##2##(1990-11#1)(1995-1#1)(2008-11#1)(2013-8#1)
and accident##3##2##(1991-12#1)(2008-11#1)(2010-7#1)
and accidental##2##2##(1995-2#1)(2008-12#1)
and accompanied by##2##3##(2008-10#1)(2013-1#1)
and accompanying##2##2##(2008-5#1)(2010-12#1)
and according to##2##3##(1992-3#1)(2008-12#1)
and accordingly##2##2##(2008-12#1)(2009-8#1)
and account for##4##3##(1990-6#1)(1996-2#1)(2008-10#1)(2011-2#1)
and account##5##2##(1990-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
and accountability##4##2##(1995-3#1)(1996-2#1)(2008-9#1)(2013-8#1)
and accounted for##3##3##(1992-3#1)(1996-5#1)(2008-10#1)
and accounting for##2##3##(1995-6#1)(2012-12#1)
and accounts for##2##3##(2008-12#1)(2013-8#1)
and accounts##4##2##(1993-1#1)(2008-12#2)(2013-8#1)
and accreditation##2##2##(1997-3#1)(2008-11#1)
and accumulate##2##2##(2011-2#2)
and accumulated##8##2##(1994-3#1)(1995-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)
and accumulating in the##2##4##(2008-10#1)(2008-11#1)
and accumulation of##15##3##(1995-11#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
and accumulation potential##2##3##(2008-10#2)
and accumulation time##3##3##(2008-10#3)
and accumulation##27##2##(1995-11#1)(1997-7#1)(2008-10#20)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
and accuracy and##3##3##(2008-10#3)
and accuracy are##2##3##(2008-10#2)
and accuracy of the developed##2##5##(2008-10#2)
and accuracy of the##17##4##(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#1)(2010-8#1)
and accuracy of##33##3##(1991-3#1)(2007-12#1)(2008-10#19)(2008-11#3)(2008-3#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
and accuracy were##3##3##(2008-10#3)
and accuracy##70##2##(1991-3#1)(1997-2#1)(2007-12#1)(2008-10#49)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
and accurate detection of##2##4##(2008-10#2)
and accurate high performance##2##4##(2012-2#2)
and accurate method for the separation##2##6##(2008-10#2)
and accurate method for the##4##5##(2008-10#4)
and accurate method for##5##4##(2008-10#4)(2008-3#1)
and accurate method##7##3##(2008-10#6)(2008-3#1)
and accurate quantification of##2##4##(2008-10#2)
and accurate results##5##3##(2008-10#3)(2008-3#1)(2008-9#1)
and accurate##56##2##(1995-3#1)(2008-10#38)(2008-11#1)(2008-3#3)(2008-9#4)(2009-10#1)(2009-8#1)(2010-5#2)(2010-8#1)(2012-2#3)(2012-3#1)
and accurately##5##2##(1996-2#1)(2008-10#2)(2008-11#1)(2012-2#1)
and acemethacin##3##2##(2008-10#3)
and acetaminophen##4##2##(2008-10#4)
and acetate buffer##3##3##(2008-10#1)(2009-10#2)
and acetate ions##2##3##(2008-10#2)
and acetate##6##2##(2008-10#4)(2009-10#2)
and acetic acid##6##3##(2008-10#5)(2008-11#1)
and acetic##8##2##(2008-10#7)(2008-11#1)
and acetone and##3##3##(2008-10#3)
and acetone as##2##3##(2008-10#2)
and acetone##10##2##(1996-5#1)(2008-10#7)(2013-8#2)
and acetone)##2##2##(2008-10#1)(2013-8#1)
and acetonitrile##7##2##(2008-10#7)
and acetylcholine##2##2##(2009-11#1)(2011-1#1)
and acetylcholinesterase activity of the rat##2##6##(2008-11#2)
and acetylcholinesterase##4##2##(2008-11#2)(2008-7#1)(2009-8#1)
and acetylsalicylic acid##3##3##(2008-10#3)
and achievable##2##2##(1992-2#1)(2008-3#1)
and achieve##3##2##(1991-2#1)(2012-3#1)(2013-1#1)
and achieved##3##2##(1995-1#1)(2008-10#1)(2008-5#1)
and achievement of##2##3##(1997-2#1)(2012-3#1)
and achievement##4##2##(1993-12#1)(1997-2#1)(2008-12#1)(2012-3#1)
and achieves##3##2##(2010-12#1)(2010-5#1)(2013-8#1)
and achieving##4##2##(1994-9#1)(2008-4#1)(2009-12#1)(2011-2#1)
and acid##18##2##(1992-12#1)(1994-11#2)(1996-2#1)(2008-10#9)(2008-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
and acid-base##4##2##(2008-10#3)(2012-3#1)
and acidic##7##2##(2008-10#7)
and acidification##3##2##(2008-10#3)
and acidity##2##2##(2008-10#2)
and acne##2##2##(2008-5#1)(2011-2#1)
and acquired##9##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-3#2)(2012-2#2)
and acquisition of##4##3##(2007-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
and acquisition##5##2##(2007-12#1)(2008-5#1)(2008-9#1)(2011-7#1)(2012-3#1)
and acridine orange##4##3##(1990-6#3)(2008-10#1)
and across species##2##3##(1993-12#1)(2012-3#1)
and across the entire##3##4##(2008-10#1)(2009-7#1)(2013-3#1)
and across the##5##3##(2008-10#2)(2008-11#1)(2009-7#1)(2013-3#1)
and across##16##2##(1993-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#3)(2013-3#1)
and across-row##2##2##(2008-10#2)
and acrylamide##2##2##(1990-5#1)(2009-10#1)
and act as##2##3##(2009-8#1)(2012-2#1)
and act on##2##3##(1994-2#1)(2008-7#1)
and act##4##2##(1994-2#1)(2008-7#1)(2009-8#1)(2012-2#1)
and acted as##5##3##(1995-2#1)(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
and actin filaments##3##3##(1993-6#2)(2008-9#1)
and actin##10##2##(1990-5#1)(1993-6#2)(1994-8#1)(1996-12#1)(2008-1#1)(2008-9#2)(2011-2#1)(2012-2#1)
and acting##3##2##(1993-12#1)(1997-8#1)(2011-1#1)
and action##9##2##(1992-2#1)(1994-12#1)(1995-11#1)(1996-2#1)(2008-11#2)(2009-7#1)(2011-2#1)(2013-1#1)
and action)##2##2##(2008-4#2)
and actions that##2##3##(2009-12#1)(2012-3#1)
and actions##5##2##(1991-2#1)(1994-12#1)(2008-10#1)(2009-12#1)(2012-3#1)
and activate##3##2##(1991-5#1)(2008-10#1)(2009-8#1)
and activated charcoal##2##3##(2008-10#2)
and activated##11##2##(1990-6#1)(1993-3#1)(1997-7#1)(2008-10#4)(2008-6#1)(2008-8#1)(2010-1#1)(2013-1#1)
and activates the##2##3##(2011-2#1)(2013-8#1)
and activates##4##2##(1994-11#1)(2007-11#1)(2011-2#1)(2013-8#1)
and activating##3##2##(2009-3#1)(2012-2#1)(2013-8#1)
and activation energy was##2##4##(2008-10#2)
and activation of the##3##4##(1990-6#1)(1995-8#1)(2008-11#1)
and activation of##21##3##(1990-6#1)(1993-8#1)(1995-6#1)(1995-8#2)(1996-2#2)(1997-1#1)(2008-11#5)(2008-12#1)(2008-3#1)(2009-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
and activation##34##2##(1990-6#1)(1990-9#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-6#2)(1995-8#2)(1996-2#2)(1997-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2009-1#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)
and activator##4##2##(2008-8#1)(2012-3#3)
and active##24##2##(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#2)(2010-12#1)(2012-12#2)(2012-3#3)(2013-1#4)
and activities are##2##3##(1995-3#1)(1997-1#1)
and activities of##6##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)
and activities were##2##3##(1995-3#1)(2012-2#1)
and activities##17##2##(1993-2#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
and activity in##3##3##(1990-6#1)(2008-12#1)(2012-3#1)
and activity of SOD was##2##5##(2011-3#2)
and activity of a##2##4##(1995-3#1)(2011-3#1)
and activity of the##2##4##(1991-11#1)(2008-5#1)
and activity of##14##3##(1991-11#1)(1994-5#1)(1995-3#2)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-3#3)
and activity##31##2##(1990-11#1)(1990-6#1)(1991-11#1)(1994-3#1)(1994-5#1)(1995-3#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
and acts as a##2##4##(1995-11#1)(2009-8#1)
and acts as##3##3##(1995-11#1)(2008-10#1)(2009-8#1)
and acts##6##2##(1993-3#1)(1995-11#1)(2008-10#1)(2008-8#2)(2009-8#1)
and actual severity##4##3##(2008-10#4)
and actual##16##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1997-3#1)(2008-10#8)(2008-11#1)(2009-7#1)(2012-2#1)
and actually##3##2##(1995-6#1)(1996-3#1)(2008-5#1)
and acute coronary syndromes##2##4##(2008-11#1)(2011-2#1)
and acute glomerulonephritis##2##3##(2011-2#2)
and acute kidney##2##3##(2012-3#1)(2013-8#1)
and acute myeloid leukemia##2##4##(2010-1#2)
and acute myeloid##3##3##(2010-1#2)(2011-2#1)
and acute myocardial infarction##2##4##(2008-12#1)(2013-1#1)
and acute renal failure##2##4##(2008-1#1)(2013-8#1)
and acute renal##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
and acute##38##2##(1991-11#1)(1991-6#1)(1992-12#1)(1993-11#1)(1994-2#1)(1996-12#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#2)(2010-10#1)(2010-8#1)(2011-2#7)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#2)
and ad##2##2##(1993-8#1)(2011-9#1)
and adapt##5##2##(1995-9#1)(1996-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
and adaptation to##2##3##(2008-8#1)(2013-8#1)
and adaptation##5##2##(1991-6#1)(2008-8#1)(2010-1#1)(2010-4#1)(2013-8#1)
and adapted to##2##3##(2008-10#2)
and adapted##6##2##(1990-2#1)(1992-1#1)(2008-1#1)(2008-10#2)(2008-12#1)
and adaptive immunity##2##3##(2008-5#1)(2008-6#1)
and adaptive##11##2##(1994-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-8#2)(2013-8#1)
and add##3##2##(1990-5#1)(1992-12#1)(2008-9#1)
and added##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
and addictive##2##2##(1995-6#1)(2009-4#1)
and adding##7##2##(1996-1#1)(2008-10#4)(2008-4#1)(2008-8#1)
and addition of##6##3##(2008-10#3)(2008-11#1)(2008-4#1)(2009-8#1)
and addition##8##2##(2008-10#5)(2008-11#1)(2008-4#1)(2009-8#1)
and additional##17##2##(1991-3#1)(1995-6#1)(1996-2#1)(2008-10#6)(2008-11#5)(2008-9#1)(2009-10#1)(2010-6#1)
and additive##4##2##(1992-3#1)(2008-10#3)
and additives##2##2##(2008-10#2)
and address##3##2##(2008-11#1)(2008-3#1)(2010-9#1)
and addressed##2##2##(2008-12#1)(2008-7#1)
and addresses##3##2##(1992-2#1)(2008-11#1)(2008-12#1)
and addressing##2##2##(2012-3#1)(2013-1#1)
and adenine##2##2##(1990-10#1)(2008-10#1)
and adenocarcinoma##2##2##(1991-8#1)(2009-5#1)
and adenosine##7##2##(1993-6#1)(1994-11#1)(1995-11#1)(1995-8#2)(2008-11#1)(2008-5#1)
and adequacy of##3##3##(1994-12#1)(2010-11#1)(2012-3#1)
and adequacy##5##2##(1993-1#1)(1994-12#1)(2009-10#1)(2010-11#1)(2012-3#1)
and adequate##18##2##(1990-9#2)(2008-10#5)(2008-11#3)(2008-7#1)(2009-1#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)
and adherence to##3##3##(1996-11#1)(1996-3#1)(2012-3#1)
and adherence##9##2##(1992-9#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-7#1)(2012-3#2)(2013-1#1)
and adherent##2##2##(2008-11#1)(2008-7#1)
and adhesiolysis##2##2##(1993-1#1)(1993-12#1)
and adhesion properties of##2##4##(2008-10#2)
and adhesion##8##2##(1992-1#1)(1994-9#1)(2008-10#2)(2008-11#1)(2009-7#1)(2011-2#2)
and adhesive##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
and adipocytes##4##2##(1993-6#2)(2010-10#1)(2010-12#1)
and adipose tissue##3##3##(1995-6#1)(2010-6#1)(2012-3#1)
and adipose##4##2##(1990-11#1)(1995-6#1)(2010-6#1)(2012-3#1)
and adiposity##2##2##(2012-2#2)
and adjacent##13##2##(1991-3#1)(1995-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
and adjust##2##2##(1991-12#1)(2010-8#1)
and adjusted##2##2##(1992-2#1)(2008-10#1)
and adjusting the##2##3##(2008-10#1)(2013-1#1)
and adjusting##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
and adjustment for##2##3##(2010-1#2)
and adjustment of##2##3##(1992-3#1)(2008-4#1)
and adjustment##10##2##(1992-3#1)(2008-4#3)(2009-11#1)(2010-1#2)(2010-7#2)(2013-1#1)
and adjuvant chemotherapy##2##3##(2011-2#1)(2013-1#1)
and adjuvant radiation therapy##2##4##(1992-12#2)
and adjuvant therapies##2##3##(1993-11#1)(2008-11#1)
and adjuvant##12##2##(1990-12#1)(1990-9#1)(1992-12#2)(1993-11#1)(1996-11#1)(2008-11#2)(2011-2#2)(2011-3#1)(2013-1#1)
and administered##4##2##(1992-12#1)(1996-3#1)(2012-3#2)
and administration of cellular##2##4##(2013-1#2)
and administration of##6##3##(2011-2#1)(2012-3#1)(2013-1#4)
and administration##9##2##(1991-2#1)(1994-2#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#4)
and administrative##15##2##(1991-1#2)(1991-3#1)(1992-1#1)(1992-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-3#2)(2008-12#1)(2010-8#2)(2011-2#1)(2012-2#1)
and administrators##3##2##(1991-1#1)(1996-1#1)(1997-2#1)
and admission##3##2##(2008-3#2)(2012-3#1)
and admissions##2##2##(1991-11#1)(2011-2#1)
and adolescence##8##2##(1995-2#1)(1996-11#1)(2008-11#1)(2009-12#2)(2011-2#2)(2013-8#1)
and adolescent inpatient units##2##4##(1993-1#2)
and adolescent obesity##2##3##(2012-2#1)(2012-3#1)
and adolescent weight##2##3##(2013-1#2)
and adolescent##16##2##(1991-2#1)(1992-1#2)(1993-1#2)(1993-2#1)(2008-11#3)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#4)
and adolescents##59##2##(1990-6#1)(1991-2#5)(1992-1#1)(1993-1#1)(1994-8#1)(1995-12#2)(1997-8#1)(2008-1#1)(2008-11#7)(2008-3#2)(2008-4#1)(2008-8#4)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#5)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#1)
and adolescents'##2##2##(2009-7#1)(2012-3#1)
and adopted##2##2##(2008-11#1)(2008-8#1)
and adoption of the##2##4##(1991-2#1)(2008-3#1)
and adoption of##4##3##(1991-2#1)(1997-6#1)(2008-3#1)(2010-8#1)
and adrenaline##6##2##(1994-2#1)(1997-3#1)(1997-6#1)(2008-10#3)
and adrenals##2##2##(1994-8#1)(2010-7#1)
and adriamycin##5##2##(1991-5#1)(1993-1#1)(1993-8#3)
and adsorbed on##2##3##(2008-10#2)
and adsorbed##4##2##(2008-10#4)
and adsorption isotherms##2##3##(2008-10#2)
and adsorption##10##2##(1992-5#1)(2008-10#9)
and adsorptive stripping voltammetry##2##4##(2008-10#2)
and adsorptive stripping##4##3##(2008-10#4)
and adsorptive##8##2##(2008-10#8)
and adult patients##4##3##(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
and adult stages##2##3##(2008-10#1)(2008-9#1)
and adult##47##2##(1990-12#1)(1991-12#1)(1992-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-9#1)(2007-12#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#2)(2010-10#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)
and adulthood##3##2##(1996-9#1)(1997-7#1)(2008-11#1)
and adults (5-7 days)##2##4##(1997-8#2)
and adults were##2##3##(2008-12#1)(2011-2#1)
and adults with congenital##2##4##(1992-5#1)(2010-6#1)
and adults with##6##3##(1992-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)
and adults##37##2##(1992-2#1)(1992-5#1)(1993-1#1)(1995-5#1)(1996-2#2)(1997-1#1)(1997-7#1)(1997-8#4)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
and advance##2##2##(2008-10#1)(2008-11#1)
and advanced##8##2##(1991-3#2)(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#2)
and advances in##3##3##(1996-2#1)(1997-7#1)(2011-2#1)
and advances##6##2##(1996-2#1)(1997-7#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)
and advancing##2##2##(2008-11#1)(2008-8#1)
and advantages of##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
and adventitious##2##2##(2008-12#1)(2008-9#1)
and adverse drug reactions##3##4##(2008-10#1)(2011-2#2)
and adverse effects of##2##4##(2008-11#1)(2010-1#1)
and adverse events##2##3##(2008-11#1)(2011-2#1)
and adverse pregnancy##2##3##(2008-11#2)
and adverse##15##2##(1996-3#1)(2008-10#1)(2008-11#6)(2009-11#1)(2009-12#1)(2010-1#1)(2010-10#1)(2011-2#3)
and advice by##2##3##(1996-8#1)(2011-2#1)
and advice##3##2##(1996-8#1)(2011-2#2)
and advocated##2##2##(1994-12#1)(2010-1#1)
and aeration##3##2##(2008-11#2)(2012-2#1)
and aerobic##2##2##(2009-1#1)(2013-1#1)
and aerosol##7##2##(2008-10#2)(2008-2#1)(2008-3#4)
and aerosols##8##2##(1997-1#1)(2008-3#7)
and aesculetin in##2##3##(2008-10#2)
and aesthetic##3##2##(2008-6#1)(2012-3#1)(2013-1#1)
and affect the##2##3##(1994-8#1)(1997-2#1)
and affect##5##2##(1994-8#1)(1997-2#1)(2008-11#1)(2012-2#1)(2012-3#1)
and affected##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#1)
and affecting##2##2##(2008-10#1)(2013-1#1)
and affective##5##2##(1991-2#1)(2008-11#1)(2010-1#1)(2012-3#1)(2013-8#1)
and affects the##2##3##(1990-12#1)(2008-9#1)
and affects##9##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#2)(2012-12#1)(2012-3#1)
and affinities##2##2##(2008-10#1)(2011-2#1)
and affinity chromatography##2##3##(1997-2#1)(2009-9#1)
and affinity##6##2##(1990-11#1)(1995-11#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-9#1)
and affordable##3##2##(2008-11#1)(2010-5#1)(2010-8#1)
and afimbrial##2##2##(2008-10#2)
and aflatoxin accumulation##4##3##(2008-10#4)
and aflatoxin in maize##2##4##(2008-10#2)
and aflatoxin production##7##3##(2008-10#7)
and aflatoxin##17##2##(2008-10#17)
and after 1 year##2##4##(1994-2#1)(2013-1#1)
and after 15##2##3##(2008-10#1)(2011-2#1)
and after 3##2##3##(2008-10#1)(2011-2#1)
and after HA##2##3##(2013-8#2)
and after a##9##3##(1990-9#1)(1992-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-8#2)(2011-2#1)(2013-1#1)
and after cancer##2##3##(2008-7#2)
and after each##3##3##(1996-12#1)(2008-11#1)(2013-8#1)
and after exposure to##2##4##(2008-5#1)(2013-1#1)
and after exposure##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
and after implementation##2##3##(1995-12#1)(1997-2#1)
and after the##33##3##(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1995-6#2)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-12#4)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
and after treatment##6##3##(1990-12#1)(1993-11#1)(2007-8#1)(2008-7#1)(2011-1#1)(2013-1#1)
and after##171##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#2)(1997-6#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#30)(2008-11#4)(2008-12#8)(2008-3#1)(2008-5#7)(2008-7#5)(2008-9#5)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#14)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#7)(2012-4#1)(2012-5#1)(2013-1#11)(2013-8#6)
and afterwards##3##2##(1990-6#1)(2008-10#1)(2013-8#1)
and again 4 months later##2##5##(1993-12#1)(2013-1#1)
and again##10##2##(1990-3#1)(1991-2#1)(1993-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-1#2)
and against the##2##3##(1991-2#1)(1993-3#1)
and against##12##2##(1991-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#1)(1997-4#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
and agarose##2##2##(2008-10#1)(2008-5#1)
and age (P##2##3##(2011-2#1)(2012-3#1)
and age (p&lt##4##3##(2008-10#3)(2011-2#1)
and age at##5##3##(2008-8#1)(2010-3#2)(2012-2#1)(2013-1#1)
and age in##3##3##(1995-12#1)(2008-11#1)(2012-3#1)
and age of##3##3##(2010-8#1)(2012-3#1)(2013-1#1)
and age##38##2##(1991-1#1)(1991-6#1)(1993-1#1)(1995-12#1)(2008-10#4)(2008-11#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-3#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
and aged##5##2##(1990-5#1)(1991-12#1)(2008-10#1)(2008-5#1)(2010-10#1)
and ageing##5##2##(1990-3#2)(2008-5#2)(2013-7#1)
and agencies##3##2##(1994-8#1)(2012-2#1)(2012-3#1)
and agents##4##2##(1997-1#1)(1997-3#1)(2008-10#1)(2012-3#1)
and aggregate##5##2##(1991-1#1)(1994-5#1)(2008-2#1)(2011-2#2)
and aggregation##5##2##(1996-12#1)(2006-6#2)(2008-10#1)(2008-11#1)
and aggression##2##2##(2008-11#1)(2009-6#1)
and aggressive behavior##2##3##(2008-11#1)(2008-12#1)
and aggressive treatment##3##3##(2010-7#1)(2012-3#2)
and aggressive##16##2##(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
and aggressively##2##2##(2011-2#1)(2013-8#1)
and aggressiveness on##2##3##(1995-5#1)(2008-10#1)
and aggressiveness to tomato and potato##3##6##(2008-10#3)
and aggressiveness##7##2##(1995-5#1)(2008-10#6)
and aging##14##2##(1994-8#1)(2008-10#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
and agitation intensity##2##3##(2008-7#1)(2011-2#1)
and agitation##5##2##(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#2)
and agonist##2##2##(1992-2#1)(2008-8#1)
and agonists##2##2##(2006-6#1)(2009-8#1)
and agranular##2##2##(1992-9#1)(2008-7#1)
and agreed to##2##3##(1995-1#1)(2010-6#1)
and agreed##3##2##(1992-3#1)(1995-1#1)(2010-6#1)
and agreement##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
and agrees well with##2##4##(2007-11#1)(2008-3#1)
and agrees##3##2##(1993-8#1)(2007-11#1)(2008-3#1)
and agricultural entomology##2##3##(2010-1#2)
and agricultural products##2##3##(2008-10#2)
and agricultural##9##2##(1991-6#1)(2008-10#5)(2008-7#1)(2010-1#2)
and agriculture##5##2##(1991-6#1)(1997-2#1)(2008-11#1)(2010-7#1)(2013-8#1)
and agroinoculation##2##2##(2008-10#2)
and aid##4##2##(1993-1#1)(2008-1#1)(2008-12#1)(2011-2#1)
and aids in##2##3##(1991-2#1)(2011-2#1)
and aims##4##2##(2008-4#1)(2009-8#2)(2012-3#1)
and air travel##2##3##(2010-5#2)
and air warming##6##3##(2012-6#6)
and air##26##2##(1993-2#1)(1995-3#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#2)(2012-3#1)(2012-6#6)(2012-9#1)
and airborne##3##2##(2008-10#2)(2008-11#1)
and airway##2##2##(1997-1#1)(2010-5#1)
and alachlor##2##2##(2008-10#2)
and alanine##7##2##(1993-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
and albendazole was 0##2##4##(2008-10#2)
and albumin##12##2##(1991-12#1)(1993-8#1)(1994-8#1)(1997-8#1)(2008-10#1)(2008-11#2)(2009-6#2)(2011-2#3)
and alcian blue##2##3##(2008-11#1)(2008-5#1)
and alcohol consumption##2##3##(1990-8#1)(2008-10#1)
and alcohol content##2##3##(2008-10#2)
and alcohol use##3##3##(2009-8#1)(2010-9#1)(2013-8#1)
and alcohol##26##2##(1990-8#1)(1991-1#2)(1991-9#2)(1992-12#1)(1993-12#1)(1993-3#1)(1996-1#1)(1996-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#3)(2013-8#1)
and alcoholism##2##2##(1993-2#1)(2008-5#1)
and aldehyde dehydrogenase##3##3##(2008-10#2)(2008-11#1)
and aldosterone##2##2##(1990-5#1)(1991-12#1)
and alert##2##2##(1996-2#1)(2007-12#1)
and alertness related##2##3##(2013-8#2)
and alfalfa cv##2##3##(2008-10#2)
and alfalfa##5##2##(2008-10#5)
and algae##4##2##(2008-10#1)(2008-7#1)(2010-7#2)
and alginate##2##2##(2008-11#1)(2011-2#1)
and alginic acid##2##3##(2008-10#2)
and algorithms##2##2##(2010-7#1)(2011-2#1)
and align##2##2##(2008-5#1)(2013-1#1)
and alignment of##2##3##(2008-10#1)(2008-7#1)
and alignment##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
and aliphatic##4##2##(2008-10#3)(2012-3#1)
and alkali and alkaline earth cations##2##6##(2008-10#2)
and alkali##8##2##(2008-10#6)(2013-8#2)
and alkali-earth##2##2##(2008-10#2)
and alkaline conditions##2##3##(2008-11#1)(2008-6#1)
and alkaline earth metal##10##4##(2008-10#10)
and alkaline earth##16##3##(2008-10#16)
and alkaline medium##2##3##(2008-10#2)
and alkaline phosphatase (ALP)##2##4##(2008-11#1)(2011-1#1)
and alkaline phosphatase##9##3##(1993-2#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#1)(2013-1#1)
and alkaline##41##2##(1993-2#1)(1993-3#1)(1994-8#1)(1995-11#1)(2008-10#29)(2008-11#4)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
and alkaline-earth metals##3##3##(2008-10#3)
and alkaline-earth##4##2##(2008-10#4)
and alkylphenols in the##2##4##(2008-10#2)
and alkylphenols in##4##3##(2008-10#4)
and alkylthiols##2##2##(2008-10#2)
and all isolates##3##3##(2008-10#3)
and all its##2##3##(2008-10#1)(2008-4#1)
and all lambs##2##3##(1996-12#2)
and all of##2##3##(1994-5#1)(1996-12#1)
and all patients##2##3##(2008-11#1)(2010-7#1)
and all the##9##3##(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-2#1)(2011-3#2)(2013-1#1)
and all were##5##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
and all##76##2##(1990-6#1)(1991-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#4)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#35)(2008-11#3)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#2)(2009-2#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#2)
and all-cause mortality##3##3##(2010-2#2)(2011-1#1)
and all-trans retinoic acid##2##4##(2011-2#2)
and allele##2##2##(1993-3#1)(2008-10#1)
and allelic##4##2##(2008-10#3)(2012-3#1)
and allergens##3##2##(1991-3#1)(2008-10#1)(2011-2#1)
and allergic##4##2##(1991-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
and allergy##4##2##(2008-8#1)(2009-5#1)(2013-1#2)
and allocation##4##2##(1995-12#1)(2008-10#1)(2011-3#1)(2013-8#1)
and allograft fixation##3##3##(2009-3#3)
and allograft##7##2##(2009-3#3)(2010-10#3)(2012-3#1)
and allopurinol##2##2##(2008-10#1)(2008-7#1)
and allow a##2##3##(2008-7#1)(2011-7#1)
and allow for##3##3##(2008-10#2)(2011-1#1)
and allow the##3##3##(1992-9#1)(2008-8#1)(2008-9#1)
and allow##12##2##(1992-9#1)(1995-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
and allowed charges##2##3##(1992-1#1)(1994-2#1)
and allowed for the##3##4##(2008-10#2)(2008-12#1)
and allowed the determination of##2##5##(2008-10#2)
and allowed the##6##3##(2008-10#5)(2012-3#1)
and allowed to##5##3##(1994-11#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-8#1)
and allowed##24##2##(1992-1#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
and allowing##4##2##(2008-10#3)(2013-1#1)
and allows for##5##3##(1993-9#1)(2008-10#2)(2008-12#1)(2008-4#1)
and allows simultaneous##2##3##(2008-10#1)(2008-9#1)
and allows the determination of 0##2##6##(2008-10#2)
and allows the##9##3##(1993-12#1)(2008-10#5)(2010-11#1)(2010-12#1)(2013-8#1)
and allows##35##2##(1991-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
and alloy samples##3##3##(2008-10#3)
and alloy##5##2##(2008-10#5)
and alloys##4##2##(2008-10#4)
and almond##2##2##(2008-10#2)
and almost all of them##2##5##(1996-9#1)(2008-9#1)
and almost all##3##3##(1996-9#1)(2008-10#1)(2008-9#1)
and almost half##2##3##(1997-8#1)(2008-12#1)
and almost no interference##2##4##(2008-10#2)
and almost##19##2##(1992-12#2)(1996-9#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#2)
and along the##2##3##(2008-10#1)(2009-2#1)
and along##3##2##(2008-10#2)(2009-2#1)
and alopecia##2##2##(1997-7#1)(2008-10#1)
and alpha 1##2##3##(1992-12#1)(1995-11#1)
and alpha 2##3##3##(1991-5#2)(1995-2#1)
and alpha##18##2##(1991-5#2)(1991-6#1)(1992-12#1)(1992-6#1)(1994-5#2)(1995-11#7)(1995-2#1)(1995-9#1)(2008-10#1)(2008-8#1)
and alpha-1##2##2##(2008-10#1)(2008-7#1)
and alpha-tocopherol##2##2##(2008-10#2)
and alpha2##2##2##(2008-11#1)(2008-7#1)
and also a##2##3##(1996-11#1)(2008-10#1)
and also affect##2##3##(2008-5#1)(2010-12#1)
and also after##2##3##(2006-6#1)(2013-8#1)
and also allowed us to##2##5##(2008-10#2)
and also an##3##3##(2008-10#1)(2008-12#1)(2013-7#1)
and also as##2##3##(1993-2#1)(2008-10#1)
and also because##2##3##(1993-1#1)(2008-4#1)
and also by##10##3##(1990-8#2)(1995-12#1)(2008-10#6)(2011-2#1)
and also carried##2##3##(1995-6#1)(2010-1#1)
and also for##3##3##(2008-10#2)(2013-8#1)
and also found##2##3##(1990-12#1)(2008-11#1)
and also from##2##3##(2008-10#2)
and also highlights##2##3##(2011-2#1)(2013-7#1)
and also in a##2##4##(2008-10#2)
and also in the##4##4##(2008-10#2)(2008-7#1)(2011-2#1)
and also in##20##3##(1991-12#1)(1996-2#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
and also indicated that##2##4##(2008-10#1)(2008-8#1)
and also its##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and also of##2##3##(2008-10#1)(2012-3#1)
and also on##2##3##(2008-10#2)
and also provide##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
and also provides##2##3##(2008-11#1)(2013-1#1)
and also reduced##2##3##(2008-10#2)
and also show that##2##4##(1994-9#1)(2013-1#1)
and also suggest that the##2##5##(1991-5#1)(1996-5#1)
and also suggest##3##3##(1990-8#1)(1991-5#1)(1996-5#1)
and also the##12##3##(1995-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-7#1)(2010-8#1)
and also through##2##3##(2008-10#1)(2008-11#1)
and also to the selective determination of##2##7##(2008-10#2)
and also to the##3##4##(1990-11#1)(2008-10#2)
and also to##19##3##(1990-11#1)(1993-3#1)(1994-2#1)(1997-1#1)(2006-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2012-2#1)
and also used##2##3##(2008-10#1)(2008-12#1)
and also was##2##3##(2008-10#2)
and also when##2##3##(1990-9#1)(2008-10#1)
and also with##4##3##(2008-10#2)(2009-8#1)(2010-3#1)
and also within##2##3##(2006-6#1)(2008-10#1)
and also##243##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-8#3)(1997-9#1)(2006-6#4)(2008-1#1)(2008-10#70)(2008-11#10)(2008-12#10)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#4)(2009-10#3)(2009-7#2)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-2#8)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#5)
and alter##3##2##(2008-11#2)(2008-7#1)
and alteration of##5##3##(1994-12#1)(2008-10#2)(2010-6#1)(2011-1#1)
and alteration##6##2##(1994-12#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-1#1)
and altered the##2##3##(2008-10#1)(2008-11#1)
and altered##16##2##(1993-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2009-11#2)(2009-12#1)(2010-10#1)(2013-1#3)(2013-8#1)
and alternate##3##2##(1997-2#1)(2008-10#1)(2008-4#1)
and alternative##19##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-3#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#2)(2013-1#1)
and although##6##2##(1995-11#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-3#2)
and altitude##4##2##(2008-8#2)(2009-5#1)(2012-6#1)
and altruism##5##2##(2008-8#3)(2010-4#2)
and aluminium in##4##3##(1992-3#2)(2008-10#2)
and aluminium##9##2##(1992-3#3)(1996-2#1)(2008-10#5)
and aluminum##10##2##(1996-2#1)(2008-10#9)
and alveolar##6##2##(1994-12#1)(1994-5#1)(1997-1#1)(1997-3#1)(2010-7#1)(2012-3#1)
and always##5##2##(1997-1#1)(2006-6#1)(2008-10#2)(2008-12#1)
and ambulatory##2##2##(1997-1#1)(1997-2#1)
and amenability to##2##3##(2008-10#1)(2011-2#1)
and amended##2##2##(2008-10#2)
and americium##2##2##(2008-10#2)
and amide##2##2##(2008-5#2)
and amine end groups##2##4##(2008-10#2)
and amine##5##2##(1991-9#1)(2008-10#4)
and amines##2##2##(1996-5#1)(2008-10#1)
and amino acid composition of the##3##6##(1990-5#1)(1992-9#1)(2008-9#1)
and amino acid composition of##4##5##(1990-5#2)(1992-9#1)(2008-9#1)
and amino acid or DNA##2##5##(2008-10#2)
and amino acid sequence of##2##5##(1994-11#2)
and amino acid sequence##7##4##(1990-2#1)(1990-7#1)(1992-9#1)(1994-11#2)(1995-11#1)(2008-10#1)
and amino acid sequences##3##4##(1991-5#1)(1994-11#1)(2013-8#1)
and amino acid##27##3##(1990-2#1)(1990-5#2)(1990-7#1)(1991-5#1)(1992-9#2)(1993-3#1)(1993-8#2)(1994-11#3)(1995-11#1)(1995-8#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-9#2)(2013-8#3)
and amino acids##15##3##(2008-10#9)(2008-11#3)(2008-7#1)(2011-2#1)(2012-2#1)
and amino positions##2##3##(2008-4#2)
and amino##49##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-5#1)(1992-9#2)(1993-3#1)(1993-8#2)(1994-11#3)(1995-11#1)(1995-8#1)(1997-3#1)(2008-10#14)(2008-11#6)(2008-4#2)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#3)
and amino-acid##2##2##(1990-5#1)(1995-8#1)
and aminophenols##2##2##(1994-5#1)(2008-10#1)
and aminophospholipid exposure##2##3##(2006-6#2)
and aminopropyl sol-gel was##2##4##(2008-10#2)
and aminopropyl sol-gel##3##3##(2008-10#3)
and aminosaccharides and##2##3##(1991-7#2)
and ammonia##12##2##(2008-10#2)(2008-11#7)(2008-3#1)(2008-7#1)(2011-2#1)
and ammonium acetate##3##3##(2008-10#2)(2012-3#1)
and ammonium ions##4##3##(2008-10#3)(2008-11#1)
and ammonium molybdate##2##3##(2008-10#2)
and ammonium tetraphenylborate##3##3##(2008-10#3)
and ammonium##23##2##(2008-10#18)(2008-11#2)(2008-12#1)(2008-8#1)(2012-3#1)
and among fields##2##3##(2008-10#2)
and among isolates##2##3##(2008-10#2)
and among populations##2##3##(2008-10#2)
and among##32##2##(1994-6#1)(1995-1#1)(1997-1#1)(1997-3#2)(2008-10#16)(2008-11#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
and amorphous##4##2##(1995-3#1)(2008-10#2)(2008-2#1)
and amount of##7##3##(1994-8#1)(2008-10#4)(2011-2#1)(2012-3#1)
and amounts of##3##3##(2008-10#2)(2008-5#1)
and amounts##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
and amperometric##5##2##(2008-10#4)(2013-1#1)
and amphetamine##4##2##(1993-3#1)(1993-6#1)(1994-2#1)(2008-10#1)
and amphotericin B##4##3##(2008-5#4)
and ampicillin##2##2##(2008-10#1)(2013-8#1)
and amplification of##5##3##(1992-10#1)(1995-12#1)(2008-11#1)(2008-4#2)
and amplification##9##2##(1992-10#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-9#1)(2009-12#1)
and amplified by PCR using##2##5##(1995-11#1)(1995-8#1)
and amplified by##4##3##(1995-11#1)(1995-8#1)(2008-10#1)(2008-12#1)
and amplified fragment length polymorphism (AFLP) analyses##2##7##(2008-10#2)
and amplified fragment length polymorphism (AFLP)##7##6##(2008-10#7)
and amplified fragment length polymorphism##14##5##(2008-10#14)
and amplified fragment length polymorphisms##2##5##(2008-10#2)
and amplified fragment length##16##4##(2008-10#16)
and amplified with##2##3##(2008-10#2)
and amplified##29##2##(1995-11#1)(1995-8#1)(2008-10#23)(2008-11#2)(2008-12#1)(2010-1#1)
and amplitude##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)(2012-2#2)
and amygdala##6##2##(1992-12#1)(1993-6#1)(1994-2#1)(1997-2#1)(2009-10#2)
and amylase##3##2##(2008-10#2)(2008-11#1)
and an abdominal##2##3##(2010-10#1)(2013-1#1)
and an absorption##2##3##(2008-3#2)
and an accumulation##2##3##(1995-2#1)(2008-10#1)
and an accuracy of##2##4##(2008-10#1)(2008-3#1)
and an accurate##4##3##(1992-5#1)(2007-11#1)(2008-3#1)(2008-9#1)
and an acidic pH##2##4##(2008-10#1)(2008-11#1)
and an activated##2##3##(1991-2#1)(2008-10#1)
and an active##2##3##(2008-10#1)(2008-3#1)
and an additional##5##3##(1990-11#1)(1997-4#1)(2008-10#2)(2008-9#1)
and an adult##2##3##(2008-9#1)(2009-5#1)
and an altered##2##3##(2008-11#1)(2008-5#1)
and an alternative##3##3##(2007-12#1)(2008-10#2)
and an amperometric biosensor##2##4##(2008-10#2)
and an amperometric##3##3##(2008-10#3)
and an analysis of the##2##5##(2008-7#1)(2012-12#1)
and an analysis of##6##4##(1993-2#1)(1994-1#1)(2008-10#2)(2008-7#1)(2012-12#1)
and an analysis##8##3##(1993-2#1)(1994-1#1)(2008-10#4)(2008-7#1)(2012-12#1)
and an analytical throughput of##4##5##(2008-10#4)
and an analytical throughput##5##4##(2008-10#5)
and an analytical##7##3##(2008-10#6)(2013-1#1)
and an animal##2##3##(2008-10#1)(2008-11#1)
and an annual##3##3##(1994-12#1)(1996-1#1)(2008-6#1)
and an anodic##3##3##(2008-10#3)
and an antibody##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
and an antifungal##2##3##(2008-10#2)
and an application##2##3##(1996-8#1)(2009-4#1)
and an appropriate method##2##4##(2008-10#1)(2009-12#1)
and an appropriate##3##3##(2008-10#2)(2009-12#1)
and an approximately##2##3##(1995-2#2)
and an aqueous##2##3##(2008-10#2)
and an assessment of the##2##5##(1992-3#1)(2008-5#1)
and an assessment of##3##4##(1992-3#1)(2008-3#1)(2008-5#1)
and an associated##3##3##(1995-6#1)(2008-10#1)(2009-5#1)
and an automated##2##3##(1991-12#1)(1997-6#1)
and an average recovery of##2##5##(2008-10#2)
and an average resolution of##2##5##(2013-8#2)
and an average##9##3##(1994-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#2)
and an effective##2##3##(1995-3#1)(2008-10#1)
and an efficient##4##3##(2008-10#3)(2008-5#1)
and an elite##2##3##(2008-10#2)
and an emission wavelength of##3##5##(2008-10#3)
and an emission wavelength##4##4##(2008-10#4)
and an enhancement##2##3##(2008-10#2)
and an estimate of##2##4##(2008-3#1)(2008-6#1)
and an evaluation of##4##4##(1990-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
and an evaluation##5##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
and an even##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
and an example is##3##4##(1995-9#1)(2008-3#1)(2008-8#1)
and an example##4##3##(1992-1#1)(1995-9#1)(2008-3#1)(2008-8#1)
and an excellent##2##3##(2008-10#1)(2009-7#1)
and an experimental##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
and an exponential##2##3##(2008-10#1)(2013-8#1)
and an external##2##3##(1992-1#1)(2008-3#1)
and an idler##2##3##(2008-3#2)
and an important##2##3##(1990-3#1)(2008-5#1)
and an improved##4##3##(2008-10#1)(2008-3#2)(2012-12#1)
and an improvement in##2##4##(2008-10#1)(2008-11#1)
and an increase in the##7##5##(1990-12#1)(1991-12#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
and an increase in##22##4##(1990-12#1)(1991-12#1)(1992-4#1)(1994-3#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
and an increase##23##3##(1990-12#1)(1991-12#1)(1992-4#1)(1994-3#2)(1995-12#1)(1996-6#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
and an increased amount of##2##5##(2008-10#1)(2008-7#1)
and an increased##13##3##(1994-5#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#1)
and an increasing##2##3##(1991-6#1)(2011-2#1)
and an inhibitor of##2##4##(1995-8#1)(2013-8#1)
and an instrumental##2##3##(2008-3#1)(2011-1#1)
and an integrated##2##3##(1997-7#1)(2008-10#1)
and an intracellular##2##3##(2009-8#1)(2013-1#1)
and an ionic strength of 0##2##6##(2008-10#2)
and an ionic##3##3##(2008-10#3)
and an isolate##2##3##(2008-10#2)
and an iterative##2##3##(2008-3#1)(2013-1#1)
and an optical##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
and an organic solvent##2##4##(2008-10#1)(2008-7#1)
and an otherwise##2##3##(2007-12#1)(2013-1#1)
and an output##2##3##(2007-11#1)(2008-3#1)
and an overall##2##3##(1991-9#1)(2008-10#1)
and an unidentified##5##3##(1992-2#1)(2008-10#4)
and an unknown##3##3##(2008-9#1)(2011-2#1)(2013-8#1)
and an##469##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#5)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#6)(2007-11#3)(2007-12#5)(2008-1#2)(2008-10#147)(2008-11#21)(2008-12#9)(2008-2#5)(2008-3#32)(2008-4#3)(2008-5#16)(2008-6#3)(2008-7#11)(2008-8#11)(2008-9#12)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#18)(2011-3#3)(2012-12#3)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#18)(2013-8#11)
and anaerobic##3##2##(2012-12#1)(2013-8#2)
and anal##3##2##(1996-11#1)(2010-8#1)(2011-2#1)
and analgesic effects##2##3##(2010-7#1)(2013-1#1)
and analogues##2##2##(1992-12#1)(2008-10#1)
and analyse##4##2##(1992-5#1)(1993-9#1)(2008-11#1)(2013-1#1)
and analysed by##4##3##(1997-2#1)(2008-10#2)(2008-11#1)
and analysed for##3##3##(1995-8#1)(2008-5#1)(2008-9#1)
and analysed the##2##3##(2008-12#1)(2011-10#1)
and analysed using##4##3##(2008-10#1)(2008-11#2)(2008-12#1)
and analysed with content##2##4##(2008-11#1)(2013-1#1)
and analysed##28##2##(1991-6#1)(1995-8#2)(1996-3#1)(1997-2#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-5#2)(2008-8#1)(2008-9#1)(2011-10#1)(2013-1#2)
and analyses of##4##3##(1993-1#1)(2008-10#3)
and analyses##6##2##(1993-1#1)(1994-3#1)(2008-10#3)(2010-10#1)
and analysing##5##2##(1994-9#2)(2008-10#1)(2008-11#1)(2011-3#1)
and analysis by##2##3##(2008-10#1)(2008-11#1)
and analysis in##3##3##(1994-3#1)(1995-5#1)(2008-5#1)
and analysis of a##5##4##(1991-6#1)(1993-12#1)(1996-6#1)(2008-10#2)
and analysis of certified reference material##2##6##(2008-10#2)
and analysis of its##3##4##(2008-11#1)(2008-8#2)
and analysis of proteins modified by##3##6##(2008-2#2)(2008-4#1)
and analysis of proteins##4##4##(2008-2#2)(2008-4#1)(2008-9#1)
and analysis of the##6##4##(1993-12#1)(1993-9#1)(1996-3#1)(2008-11#1)(2008-12#2)
and analysis of##67##3##(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-12#2)(1993-3#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-9#1)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#4)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
and analysis procedure##2##3##(2008-10#1)(2008-9#1)
and analysis techniques##2##3##(2008-10#2)
and analysis time##4##3##(2008-10#4)
and analysis tools##3##3##(2009-10#1)(2011-3#1)(2012-3#1)
and analysis with##3##3##(1997-6#1)(1997-8#1)(2008-10#1)
and analysis##119##2##(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-8#1)(1997-9#1)(2008-1#3)(2008-10#29)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#7)(2008-9#6)(2009-10#3)(2009-3#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#4)
and analyte concentration##3##3##(2008-10#3)
and analyte##9##2##(2008-10#9)
and analytic##6##2##(1996-2#3)(2010-1#1)(2010-5#1)(2013-1#1)
and analytical application of##3##4##(2008-10#3)
and analytical application##4##3##(2008-10#4)
and analytical applications of##4##4##(2008-10#4)
and analytical applications##6##3##(2008-10#6)
and analytical development##3##3##(2010-12#1)(2012-2#2)
and analytical methods##3##3##(2008-10#1)(2008-5#1)(2011-3#1)
and analytical parameters of##2##4##(2008-10#2)
and analytical parameters were##3##4##(2008-10#3)
and analytical parameters##8##3##(2008-10#8)
and analytical performances##2##3##(2008-10#2)
and analytical sensitivity##3##3##(2008-10#3)
and analytical##50##2##(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#38)(2008-11#2)(2008-5#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-2#2)(2013-1#1)
and analytically##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
and analyze a##4##3##(2008-8#1)(2008-9#2)(2011-2#1)
and analyze the##5##3##(1992-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
and analyze##25##2##(1992-5#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#2)
and analyzed by HPLC##2##4##(1993-11#1)(2009-8#1)
and analyzed by the##3##4##(2008-10#2)(2012-3#1)
and analyzed by##20##3##(1993-11#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and analyzed for their##3##4##(1996-12#1)(1997-3#1)(2012-3#1)
and analyzed for##7##3##(1992-3#1)(1996-12#1)(1997-3#1)(2008-10#3)(2012-3#1)
and analyzed in##3##3##(2008-10#1)(2008-12#2)
and analyzed on##2##3##(2006-6#1)(2011-7#1)
and analyzed the##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
and analyzed their##2##3##(2008-11#2)
and analyzed to##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
and analyzed using##7##3##(2008-10#5)(2008-11#1)(2012-3#1)
and analyzed##76##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-7#1)(2011-2#2)(2011-7#1)(2011-9#1)(2012-3#3)(2013-1#2)(2013-8#2)
and analyzes##2##2##(2010-9#1)(2012-3#1)
and analyzing the##4##3##(1994-8#1)(2008-10#2)(2008-9#1)
and analyzing##12##2##(1993-8#1)(1994-8#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-4#2)(2008-9#1)(2012-3#1)(2013-1#1)
and anastomosed##2##2##(2008-10#1)(2013-1#1)
and anastomosis##2##2##(1991-6#1)(2010-12#1)
and anatomic##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
and anatomical##6##2##(1995-2#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)
and anchoring##4##2##(2009-10#4)
and ancient##3##2##(1995-3#1)(2008-10#1)(2008-12#1)
and and##4##2##(1995-12#1)(2012-12#1)(2013-1#2)
and androgen##6##2##(2008-4#3)(2011-1#2)(2012-12#1)
and anemia##4##2##(2008-10#2)(2010-6#1)(2012-2#1)
and anesthesia##4##2##(1993-1#1)(1993-12#1)(2012-3#2)
and aneuploidy##3##2##(2012-3#2)(2013-1#1)
and aneurysms##2##2##(2008-7#1)(2011-2#1)
and angelicin##2##2##(2008-11#2)
and anger##3##2##(2008-12#2)(2008-4#1)
and angiogenesis in##2##3##(2009-1#1)(2010-1#1)
and angiogenesis of##2##3##(2008-11#1)(2011-2#1)
and angiogenesis##8##2##(2008-11#3)(2009-1#1)(2010-1#1)(2010-3#1)(2011-2#2)
and angiogenic##2##2##(2008-1#1)(2008-7#1)
and angiographic##5##2##(1994-9#1)(1996-9#1)(1997-8#1)(2008-11#1)(2008-7#1)
and angioplasty##4##2##(1997-8#1)(2011-2#3)
and angiotensin II##4##3##(1996-2#3)(1996-6#1)
and angiotensin##8##2##(1991-3#1)(1994-3#3)(1996-2#3)(1996-6#1)
and angiotensinogen##2##2##(1995-6#1)(2008-10#1)
and angles##2##2##(1992-4#1)(2008-3#1)
and angular distribution of##3##4##(2008-10#2)(2008-3#1)
and angular distribution##5##3##(2008-10#4)(2008-3#1)
and angular##10##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-1#1)
and aniline##2##2##(2008-10#2)
and animal models##2##3##(2008-11#1)(2010-5#1)
and animal studies##3##3##(1995-9#1)(2008-11#1)(2012-12#1)
and animal##42##2##(1991-2#1)(1994-12#1)(1995-9#1)(1997-1#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)
and animals##18##2##(1993-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#3)
and anion exchange##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
and anion##8##2##(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)
and anion-exchange##2##2##(2008-10#2)
and anionic species##2##3##(2008-10#2)
and anionic surfactants##2##3##(2008-10#2)
and anionic##10##2##(1990-5#1)(1991-7#1)(2008-10#8)
and anions in##4##3##(2008-10#4)
and anions on the determination of##2##6##(2008-10#2)
and anions on the##3##4##(2008-10#3)
and anions on##5##3##(2008-10#5)
and anions were##3##3##(2008-10#3)
and anions##32##2##(2008-10#32)
and anisotropic##2##2##(2008-10#2)
and ankle##20##2##(2008-12#2)(2009-10#1)(2009-4#1)(2010-3#2)(2010-7#1)(2011-2#5)(2012-2#6)(2012-3#1)(2013-1#1)
and ankylosing spondylitis##3##3##(2010-12#2)(2012-3#1)
and ankylosis in##2##3##(2011-2#2)
and ankylosis##3##2##(2011-2#3)
and annotation##22##2##(2010-12#1)(2011-2#21)
and annual##3##2##(1997-2#1)(2008-10#1)(2009-11#1)
and anodic stripping voltammetry##4##4##(2008-10#4)
and anodic stripping##5##3##(2008-10#5)
and anodic##7##2##(2008-10#6)(2013-1#1)
and anomalous##3##2##(2007-11#1)(2008-12#1)(2012-2#1)
and anorexia##4##2##(1991-1#1)(1993-12#1)(2008-1#1)(2012-3#1)
and anorthite##2##2##(2013-8#2)
and another for##2##3##(1997-7#1)(2008-11#1)
and another had##2##3##(1990-3#1)(1991-12#1)
and another of##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
and another one for##2##4##(2008-11#1)(2011-2#1)
and another one##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
and another##41##2##(1990-2#1)(1990-3#2)(1991-12#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#1)
and answers##3##2##(1993-3#1)(2008-11#2)
and antagonistic activity##2##3##(2008-10#2)
and antagonistic##8##2##(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
and anterior to##2##3##(2008-7#1)(2011-2#1)
and anterior##10##2##(2008-11#2)(2008-7#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#4)
and anterolateral##4##2##(2010-5#1)(2010-7#1)(2011-2#2)
and anthracnose##4##2##(2008-10#4)
and anthropogenic##2##2##(2008-11#1)(2008-12#1)
and anthropometric##3##2##(1993-12#1)(2008-7#1)(2013-8#1)
and anthropometry##2##2##(2008-10#1)(2013-1#1)
and anti##5##2##(1990-6#1)(1996-5#1)(2008-5#1)(2010-1#1)(2012-2#1)
and anti-HIV##2##2##(2008-10#1)(2009-8#1)
and anti-IgE##2##2##(2008-11#1)(2012-12#1)
and anti-TNF-alpha##2##2##(1996-12#1)(2008-10#1)
and anti-TNP antibody##2##3##(2008-10#2)
and anti-angiogenic##2##2##(2008-11#1)(2013-1#1)
and anti-apoptotic##5##2##(2009-12#2)(2010-10#1)(2012-2#2)
and anti-cancer##2##2##(2008-11#1)(2010-7#1)
and anti-hyaluronidase##2##2##(2008-5#2)
and anti-inflammatory##3##2##(2008-10#2)(2013-7#1)
and anti-microsomal antibodies##2##3##(1991-8#1)(2008-7#1)
and anti-oxidation##2##2##(2010-12#1)(2011-3#1)
and anti-thrombotic##2##2##(2008-10#1)(2010-12#1)
and antibacterial activity of##2##4##(2008-12#1)(2008-5#1)
and antibacterial##3##2##(2008-12#1)(2008-5#2)
and antibiotic resistance##2##3##(1991-3#1)(2012-3#1)
and antibiotic susceptibility##3##3##(2007-12#1)(2008-12#1)(2012-3#1)
and antibiotic##9##2##(1991-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-9#1)(2012-3#2)
and antibiotics##5##2##(1991-3#1)(2008-4#1)(2010-12#1)(2010-6#1)(2012-12#1)
and antibodies##5##2##(1990-12#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-7#1)
and antibody production in##4##4##(2008-11#4)
and antibody production##8##3##(2008-11#8)
and antibody##15##2##(1995-5#1)(2008-10#2)(2008-11#10)(2013-8#2)
and anticancer##2##2##(2011-2#1)(2013-1#1)
and anticheater adaptations##2##3##(2008-8#2)
and anticipated##2##2##(1992-1#1)(1992-2#1)
and anticipatory##2##2##(1992-1#1)(2010-8#1)
and anticoagulant##4##2##(1996-6#1)(1996-8#1)(2008-8#1)(2013-1#1)
and anticonvulsant effects of NBQX##2##5##(1994-2#2)
and anticonvulsant##3##2##(1994-2#3)
and antidepressants##2##2##(2010-7#1)(2013-1#1)
and antifouling##2##2##(2008-10#2)
and antifungal activity##2##3##(2008-10#1)(2012-2#1)
and antifungal##10##2##(2007-8#1)(2008-10#6)(2008-5#1)(2011-2#1)(2012-2#1)
and antigen-presenting##2##2##(1995-5#1)(2008-8#1)
and antigens##2##2##(2008-10#1)(2008-4#1)
and antimicrobial evaluation of new##2##5##(2012-3#2)
and antimicrobial evaluation of##3##4##(2012-3#3)
and antimicrobial properties##2##3##(2013-1#2)
and antimicrobial susceptibility##2##3##(2013-1#2)
and antimicrobial##13##2##(1996-9#1)(2008-12#1)(2010-4#1)(2010-7#1)(2012-3#3)(2013-1#5)(2013-8#1)
and antimycotic activity##3##3##(2008-5#3)
and antimycotic##4##2##(2008-5#3)(2011-2#1)
and antioxidant activities##2##3##(2008-10#1)(2008-11#1)
and antioxidant potential##2##3##(2008-10#2)
and antioxidant##14##2##(1992-9#1)(2008-10#4)(2008-11#2)(2008-7#3)(2009-9#1)(2010-5#1)(2013-1#2)
and antioxidants##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#3)
and antiproliferative activity##2##3##(1997-1#1)(2008-8#1)
and antipsychotic##2##2##(2009-7#1)(2010-1#1)
and antisense oligodeoxynucleotides##2##3##(1992-6#1)(2008-11#1)
and antisense##10##2##(1992-6#1)(1993-3#1)(1994-11#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
and antithrombin##2##2##(2010-3#2)
and antithrombotic##2##2##(2008-5#1)(2013-8#1)
and antitumor##2##2##(2008-8#1)(2012-12#1)
and anus##2##2##(2010-4#1)(2011-2#1)
and anxieties of##2##3##(1991-3#1)(2011-2#1)
and anxieties##5##2##(1991-3#1)(2011-2#4)
and anxiety to##2##3##(2008-11#1)(2010-12#1)
and anxiety##12##2##(1993-2#1)(1995-1#3)(2008-11#3)(2008-7#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
and anxious##2##2##(1992-2#1)(2009-12#1)
and any##16##2##(1990-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
and aorta##2##2##(1994-11#1)(2008-10#1)
and aortic##4##2##(1993-3#1)(2008-10#1)(2011-2#2)
and apatite##3##2##(2008-10#1)(2009-7#2)
and apex##2##2##(2009-2#2)
and aphid##2##2##(2008-10#2)
and apical meristem explants##2##4##(2008-12#2)
and apical meristem##3##3##(2008-12#3)
and apical##7##2##(2008-12#3)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
and apolipoprotein##2##2##(1994-11#1)(2008-6#1)
and apoprotein(a)##2##2##(1994-11#2)
and apoptosis in##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
and apoptosis of##4##3##(1993-3#2)(2008-8#1)(2011-2#1)
and apoptosis was##4##3##(1995-2#2)(2011-2#1)(2011-3#1)
and apoptosis##44##2##(1993-2#1)(1993-3#3)(1995-2#5)(1995-8#1)(2008-10#1)(2008-11#9)(2008-8#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#4)
and apoptotic cells##4##3##(1995-2#3)(2008-9#1)
and apoptotic##10##2##(1995-2#4)(1996-2#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
and apothecia##5##2##(2008-10#5)
and apparent competition##2##3##(2008-8#1)(2008-9#1)
and apparent##9##2##(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)
and apparently##4##2##(2008-10#2)(2008-7#1)(2013-7#1)
and appear to be##3##4##(1995-2#1)(2008-7#1)(2008-8#1)
and appear to##4##3##(1995-2#1)(2008-7#1)(2008-8#2)
and appear##8##2##(1991-1#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-9#1)
and appearance##4##2##(2008-10#1)(2008-9#1)(2009-7#1)(2013-1#1)
and appeared as##2##3##(1990-5#1)(2008-10#1)
and appeared##7##2##(1990-5#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-6#1)(2008-8#1)
and appears to be##3##4##(1992-10#1)(1997-3#1)(2008-10#1)
and appears to##8##3##(1992-10#1)(1993-8#1)(1997-3#1)(2008-10#3)(2009-8#1)(2013-1#1)
and appears##11##2##(1991-12#1)(1992-10#1)(1993-8#1)(1997-3#1)(2008-10#3)(2008-11#1)(2009-8#1)(2012-2#1)(2013-1#1)
and apple##13##2##(2008-10#13)
and applicability of the##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
and applicability of##4##3##(2008-10#1)(2008-2#1)(2011-2#2)
and applicability to##4##3##(2008-10#3)(2008-3#1)
and applicability##10##2##(1991-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#3)
and applicable##2##2##(2008-10#1)(2008-11#1)
and application for##2##3##(2008-10#1)(2008-5#1)
and application in##2##3##(2008-10#2)
and application of a##11##4##(2008-10#6)(2008-11#2)(2008-5#1)(2011-3#2)
and application of an electrode##2##5##(2008-10#2)
and application of an##4##4##(1997-1#1)(2008-10#3)
and application of##46##3##(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-3#1)(1997-1#1)(1997-7#1)(2008-10#25)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-3#2)(2012-3#1)(2013-7#1)
and application to##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2012-3#1)
and application##65##2##(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#35)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#2)(2012-3#4)(2013-7#1)
and application-oriented factors##2##3##(2008-10#2)
and applications of the##2##4##(1996-3#1)(2008-10#1)
and applications of##12##3##(1993-3#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
and applications to##2##3##(1994-9#1)(2013-1#1)
and applications##38##2##(1992-12#1)(1993-3#2)(1994-2#2)(1994-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-4#2)(2008-9#3)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and applied as##2##3##(2008-10#1)(2012-5#1)
and applied for the determination of##5##6##(2008-10#5)
and applied for the##7##4##(2008-10#7)
and applied for##9##3##(2008-10#9)
and applied in##3##3##(2008-10#2)(2008-7#1)
and applied potential##3##3##(2008-10#3)
and applied the##2##3##(2008-10#2)
and applied to the determination of the##2##7##(2008-10#1)(2009-8#1)
and applied to the determination of##6##6##(2008-10#5)(2009-8#1)
and applied to the##14##4##(1994-12#1)(2008-10#10)(2008-3#1)(2008-5#1)(2009-8#1)
and applied to##28##3##(1994-12#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)
and applied voltage on##2##4##(2008-10#2)
and applied voltage##3##3##(2008-10#3)
and applied##60##2##(1994-12#1)(1995-3#1)(1996-2#1)(2008-10#45)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-5#1)
and applies##2##2##(1992-12#1)(2010-8#1)
and apply a##3##3##(2008-10#3)
and apply##8##2##(1991-1#1)(1997-2#1)(2008-10#4)(2012-12#1)(2012-2#1)
and applying##6##2##(1993-12#2)(2008-10#1)(2013-1#2)(2013-8#1)
and appraisal of the##2##4##(1991-1#1)(2013-8#1)
and appraisal of##3##3##(1991-1#1)(2007-8#1)(2013-8#1)
and appraise their##2##3##(1992-3#1)(2008-1#1)
and appraised##2##2##(2008-10#2)
and appreciation of##2##3##(2009-8#1)(2013-1#1)
and appreciation##3##2##(2009-8#2)(2013-1#1)
and appressoria##5##2##(2008-10#5)
and appressorial##2##2##(2008-10#2)
and appressorium formation were##2##4##(2008-10#2)
and appressorium formation##6##3##(2008-10#6)
and appressorium##7##2##(2008-10#6)(2009-8#1)
and approach##2##2##(1994-12#1)(2011-3#1)
and approached##3##2##(1993-1#1)(2008-10#2)
and approaches for##2##3##(1992-1#1)(1997-3#1)
and approaches to##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
and approaches##13##2##(1992-1#1)(1994-6#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and appropriate therapy##2##3##(2008-8#1)(2010-1#1)
and appropriate treatment##2##3##(2008-12#1)(2013-1#1)
and appropriate##26##2##(1990-8#1)(1991-12#1)(1993-3#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-1#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
and appropriately##2##2##(2011-10#1)(2013-8#1)
and appropriateness of##3##3##(2013-1#3)
and appropriateness##4##2##(1993-1#1)(2013-1#3)
and approval##3##2##(2009-5#1)(2012-12#2)
and approved##3##2##(1993-3#1)(2008-10#1)(2010-12#1)
and approximately 2##2##3##(1996-2#1)(2008-6#1)
and approximately 5##2##3##(2008-3#2)
and approximately half##2##3##(1993-1#1)(2012-3#1)
and approximately##29##2##(1992-4#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#2)(2012-3#1)
and aquatic##3##2##(1995-12#1)(2008-10#1)(2009-4#1)
and aqueous extract of##2##4##(2012-2#2)
and aqueous phases##2##3##(2008-10#2)
and aqueous##15##2##(2008-10#12)(2012-2#3)
and arachidonate##2##2##(1991-5#1)(2008-10#1)
and arachidonic acid##2##3##(1994-3#1)(2008-11#1)
and arbitrary orientation##2##3##(2008-2#1)(2008-3#1)
and arborescens species-groups##2##3##(2008-10#2)
and arbuscular mycorrhizal colonization##2##4##(2008-10#2)
and arbuscular##3##2##(2008-10#3)
and architectural##3##2##(2008-10#2)(2008-9#1)
and archived##2##2##(2008-9#1)(2011-2#1)
and arcus senilis were##2##4##(2008-7#2)
and are a##3##3##(1995-6#1)(2008-11#1)(2008-5#1)
and are able to##2##4##(1993-8#1)(2009-7#1)
and are almost##2##3##(2009-8#1)(2010-7#1)
and are also##3##3##(2008-10#1)(2009-8#1)(2012-3#1)
and are amenable to##2##4##(2008-11#1)(2012-2#1)
and are associated with##9##4##(1992-5#1)(1993-6#1)(1995-5#1)(2007-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and are based on the##2##5##(1992-2#1)(2008-4#1)
and are compared with the##2##5##(1991-2#1)(2008-3#1)
and are compared with##5##4##(1991-2#1)(2008-3#4)
and are compared##6##3##(1991-2#1)(1993-8#1)(2008-3#4)
and are consistent with the##3##5##(1990-10#1)(1993-6#1)(1995-2#1)
and are consistent with##5##4##(1990-10#1)(1993-6#1)(1995-2#1)(1996-12#1)(2008-4#1)
and are critical##2##3##(1995-8#1)(2008-11#1)
and are currently used##2##4##(2008-10#1)(2010-11#1)
and are currently##5##3##(2008-10#2)(2010-11#1)(2010-12#1)(2011-2#1)
and are derived##2##3##(2013-1#2)
and are difficult to detect##2##5##(2008-10#1)(2008-9#1)
and are discussed##4##3##(1995-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
and are essential for##4##4##(1992-3#1)(2008-4#1)(2009-8#1)(2011-2#1)
and are essential##5##3##(1992-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-7#1)
and are highly##2##3##(1990-8#1)(2008-11#1)
and are in##3##3##(1990-8#1)(1994-3#2)
and are insensitive to##2##4##(1994-5#1)(2008-5#1)
and are involved in##4##4##(1997-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and are known as##2##4##(2008-10#1)(2012-2#1)
and are known to be##2##5##(1992-6#1)(2008-11#1)
and are known##4##3##(1992-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
and are likely to##2##4##(2008-8#1)(2010-11#1)
and are likely##3##3##(2008-8#1)(2010-11#1)(2011-2#1)
and are more##3##3##(1995-11#1)(1996-5#1)(2008-5#1)
and are morphologically##2##3##(1995-2#1)(2007-12#1)
and are not##7##3##(1991-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)
and are now##2##3##(1991-12#1)(2008-12#1)
and are often##4##3##(1994-3#1)(1997-8#1)(2012-2#1)(2012-5#1)
and are particularly##2##3##(1996-12#1)(2008-10#1)
and are prevalent in##2##4##(2008-11#1)(2012-3#1)
and are produced by##3##4##(1995-11#1)(2008-10#1)(2010-11#1)
and are referred to as##2##5##(2008-10#2)
and are regarded as##2##4##(2009-6#1)(2010-5#1)
and are regarded##3##3##(1991-3#1)(2009-6#1)(2010-5#1)
and are required##2##3##(2009-10#2)
and are responsible for##2##4##(1992-10#1)(2009-8#1)
and are the two procedures comparable in terms of##2##9##(2012-12#2)
and are the##8##3##(1994-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-12#2)
and are there##2##3##(1994-3#1)(2010-12#1)
and are therefore likely to##2##5##(1991-6#1)(2011-2#1)
and are therefore##4##3##(1991-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
and are thus##4##3##(1992-3#1)(1996-5#1)(2008-4#1)(2009-12#1)
and are useful for##2##4##(1993-12#1)(2008-4#1)
and are useful##3##3##(1993-12#1)(2008-10#1)(2008-4#1)
and are usually##2##3##(1990-11#1)(1993-6#1)
and are very##2##3##(2008-11#1)(2010-10#1)
and are widely##2##3##(2008-9#2)
and are##258##2##(1990-10#1)(1990-11#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-6#5)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#5)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#4)(2006-6#1)(2007-12#2)(2008-1#4)(2008-10#39)(2008-11#20)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#6)(2009-10#4)(2009-12#5)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#18)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#5)(2012-5#2)(2013-1#3)(2013-7#1)(2013-8#4)
and area effects##2##3##(2008-8#1)(2008-9#1)
and area of##4##3##(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
and area under##2##3##(2008-12#1)(2008-7#1)
and area##14##2##(1995-8#2)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2012-9#1)
and areas of##2##3##(2008-11#1)(2008-12#1)
and areas##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
and arginine##5##2##(1996-2#1)(2008-10#3)(2012-3#1)
and argon##4##2##(2008-10#4)
and argue that##2##3##(1997-2#1)(2013-8#1)
and argue##3##2##(1997-1#1)(1997-2#1)(2013-8#1)
and arithmetic##2##2##(2008-11#1)(2008-8#1)
and arm##2##2##(2008-7#1)(2012-12#1)
and arms##2##2##(1996-3#1)(2011-2#1)
and aromatic##6##2##(1990-12#1)(1996-5#1)(2008-10#4)
and around the##5##3##(1996-12#1)(2008-5#1)(2009-5#1)(2013-1#2)
and around##13##2##(1990-6#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-5#1)(2013-1#2)
and arranged in a##2##4##(2011-2#1)(2013-8#1)
and arranged##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
and arrangement of##3##3##(1997-7#1)(2008-5#1)(2008-7#1)
and arrangement##5##2##(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#2)
and arrangements##2##2##(1991-3#1)(2008-8#1)
and arrest##4##2##(2008-10#1)(2008-7#1)(2010-7#1)(2013-8#1)
and arsenate##5##2##(2008-10#5)
and arsenazo(III)##2##2##(2008-10#2)
and arsenic species were##3##4##(2008-10#3)
and arsenic##7##2##(2008-10#5)(2008-11#1)(2013-1#1)
and arsenobetaine##2##2##(2008-10#2)
and art##2##2##(2009-10#1)(2011-2#1)
and arterial hypertension)##2##3##(2008-1#1)(2011-2#1)
and arterial smooth##2##3##(1997-4#2)
and arterial##10##2##(1991-11#2)(1992-6#1)(1997-4#2)(2008-1#1)(2008-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
and arthralgias##2##2##(1993-8#1)(2012-3#1)
and articular##3##2##(1991-11#1)(2008-7#1)(2013-1#1)
and articulate the##2##3##(2008-11#1)(2010-9#1)
and articulate##4##2##(1994-12#1)(2008-11#1)(2010-9#1)(2013-1#1)
and artificial neural network (ANN)##3##5##(2008-10#3)
and artificial neural network##5##4##(2008-10#5)
and artificial neural networks (ANN)##2##5##(2008-10#2)
and artificial neural networks (ANNs)##2##5##(2008-10#2)
and artificial neural networks##13##4##(1996-2#1)(2008-10#12)
and artificial neural##18##3##(1996-2#1)(2008-10#17)
and artificial##30##2##(1992-12#1)(1996-2#1)(2008-10#24)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
and artificially inoculated##2##3##(2008-10#2)
and artificially##5##2##(2008-10#5)
and arts##2##2##(2011-2#2)
and as a consequence##4##4##(2008-11#2)(2008-7#1)(2009-8#1)
and as a function of the##3##6##(2008-10#2)(2008-3#1)
and as a function of##4##5##(2008-10#3)(2008-3#1)
and as a result##9##4##(1990-12#1)(1997-2#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#2)
and as a##43##3##(1990-11#1)(1990-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-6#1)(1994-11#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
and as an indicator electrode in potentiometric titration of##2##9##(2008-10#2)
and as an indicator electrode in##3##6##(2008-10#3)
and as an##8##3##(1991-12#1)(1994-3#1)(2008-10#3)(2008-4#1)(2009-8#1)(2012-3#1)
and as it##2##3##(1996-2#1)(2011-2#1)
and as low as##2##4##(2008-10#2)
and as such##4##3##(1991-11#1)(2008-10#1)(2008-4#1)(2010-10#1)
and as the##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
and as##99##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#2)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#33)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#4)(2010-10#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#3)
and asbestos exposure##2##3##(1991-12#1)(2008-12#1)
and ascites##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
and ascorbate##3##2##(2008-10#2)(2013-8#1)
and ascorbic acid (AA)##2##4##(2008-10#2)
and ascorbic acid in##3##4##(2008-10#3)
and ascorbic acid##27##3##(1992-9#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#3)
and ascorbic##29##2##(1992-9#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#4)
and ascospore##2##2##(2008-10#2)
and ascospores##8##2##(2008-10#7)(2010-3#1)
and asexual##6##2##(2008-10#6)
and asked to##5##3##(1990-11#1)(1996-2#1)(2008-10#1)(2009-11#1)(2010-11#1)
and asked##9##2##(1990-11#1)(1993-12#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-11#1)(2012-12#1)
and asp##2##2##(1997-3#1)(2010-8#1)
and aspartate aminotransferase##2##3##(2008-12#1)(2009-8#1)
and aspartate##5##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)
and aspartic acid##4##3##(1994-8#1)(1997-8#1)(2008-10#1)(2011-2#1)
and aspects of##2##3##(1993-9#1)(2008-5#1)
and assay of##2##3##(2008-10#2)
and assay##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
and assayed for##5##3##(1990-5#1)(2008-10#2)(2008-4#1)(2008-8#1)
and assayed##7##2##(1990-5#1)(2008-10#4)(2008-4#1)(2008-8#1)
and assays##2##2##(2008-10#2)
and assembled##5##2##(1996-12#1)(1996-2#1)(2008-8#1)(2010-4#1)(2012-3#1)
and assembly is##2##3##(2008-10#1)(2008-4#1)
and assembly of##4##3##(1990-2#1)(1993-9#1)(1994-12#1)(2012-3#1)
and assembly##8##2##(1990-2#1)(1993-9#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
and assess the##7##3##(1990-11#1)(1992-2#1)(1993-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
and assess##18##2##(1990-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-3#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#3)
and assessed by##2##3##(2008-11#1)(2009-8#1)
and assessed for their##2##4##(2008-10#2)
and assessed for##7##3##(1995-12#1)(2008-10#6)
and assessed its##2##3##(2008-10#1)(2010-12#1)
and assessed the##3##3##(1994-1#1)(1997-6#1)(2008-10#1)
and assessed##21##2##(1994-1#1)(1995-12#1)(1997-6#1)(2008-10#9)(2008-11#2)(2008-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2013-1#3)
and assesses##2##2##(1997-3#1)(2008-12#1)
and assessing the##2##3##(2008-4#1)(2009-8#1)
and assessing##13##2##(1992-12#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-9#2)(2009-1#1)(2009-8#1)(2011-2#1)
and assessment of the##3##4##(2011-2#1)(2011-8#1)(2012-2#1)
and assessment of##15##3##(1991-3#1)(1995-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#2)(2011-8#1)(2012-2#1)(2013-1#1)
and assessment##28##2##(1991-12#1)(1991-3#1)(1995-5#1)(1997-3#3)(2008-10#4)(2008-11#7)(2008-12#2)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-8#1)(2012-2#1)(2013-1#1)
and assign##2##2##(2009-8#1)(2011-2#1)
and assigned##3##2##(1995-6#1)(1996-1#1)(2008-10#1)
and assignment##4##2##(1990-8#1)(1995-12#1)(1996-6#2)
and assimilate##2##2##(2008-10#1)(2013-8#1)
and assist the##2##3##(2009-8#1)(2009-9#1)
and assist##5##2##(1992-1#1)(2008-10#2)(2009-8#1)(2009-9#1)
and assisted living##2##3##(2008-12#2)
and assisted##5##2##(1991-8#2)(2008-12#2)(2012-2#1)
and assisting##2##2##(2008-10#2)
and associate##2##2##(2008-6#1)(2012-3#1)
and associated diagnoses##2##3##(2008-11#2)
and associated factors in##2##4##(2009-10#1)(2013-1#1)
and associated factors##5##3##(1996-2#1)(2008-10#1)(2009-10#1)(2013-1#2)
and associated risk factors in##2##5##(2012-2#1)(2013-8#1)
and associated risk factors##3##4##(2011-2#1)(2012-2#1)(2013-8#1)
and associated to##2##3##(1994-5#1)(2008-5#1)
and associated with##8##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
and associated##61##2##(1993-1#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-2#2)(1997-1#1)(2008-10#13)(2008-11#7)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
and association constant of##2##4##(2008-10#2)
and association constant##3##3##(2008-10#3)
and association mapping##2##3##(2012-3#2)
and association of##2##3##(1993-8#1)(2008-10#1)
and association with the##2##4##(2007-12#1)(2008-10#1)
and association with##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
and association##14##2##(1993-8#1)(2007-12#1)(2008-10#8)(2011-2#2)(2012-3#2)
and associations with##2##3##(2011-2#1)(2013-1#1)
and associations##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and assume##2##2##(1992-4#1)(2008-8#1)
and assumed##2##2##(2008-11#1)(2008-7#1)
and assuming##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
and assumptions##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
and assurance##4##2##(1996-1#1)(1996-12#1)(1997-1#1)(2008-10#1)
and assure##2##2##(1992-11#1)(2010-4#1)
and assuring the##2##3##(1995-3#1)(2008-10#1)
and assuring##4##2##(1995-3#1)(2008-10#2)(2008-11#1)
and aster##2##2##(2008-10#2)
and asthma (2##2##3##(2011-2#1)(2013-1#1)
and asthma are##2##3##(2011-2#1)(2012-12#1)
and asthma##12##2##(1995-2#1)(1997-1#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#2)(2013-1#3)
and astrocyte##3##2##(1992-12#1)(1996-12#1)(2008-7#1)
and astrocytes##9##2##(1994-2#1)(2008-11#1)(2008-7#7)
and asymmetric##10##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-8#6)
and asymptomatic plants##2##3##(2008-10#2)
and asymptomatic##4##2##(2008-10#3)(2013-1#1)
and at 1##2##3##(2008-10#1)(2008-7#1)
and at 25 degrees C##2##5##(2008-10#2)
and at 3##2##3##(2008-10#1)(2008-5#1)
and at 4##2##3##(2008-10#1)(2013-1#1)
and at 40 degrees C##2##5##(2008-5#2)
and at a##8##3##(1990-12#1)(1993-3#1)(2008-10#3)(2008-2#1)(2010-10#1)(2013-8#1)
and at all##2##3##(2008-10#2)
and at an##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
and at different##3##3##(2008-10#2)(2008-3#1)
and at each##2##3##(2008-10#1)(2011-10#1)
and at high concentrations##2##4##(1992-12#1)(2011-2#1)
and at high##4##3##(1992-12#1)(1992-4#1)(2008-10#1)(2011-2#1)
and at home##2##3##(1992-2#1)(2009-10#1)
and at least one##6##4##(1991-5#1)(1993-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
and at least##18##3##(1991-5#1)(1993-3#1)(1993-6#2)(1995-8#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
and at low##2##3##(1994-8#1)(2008-6#1)
and at lower##3##3##(1992-10#1)(1994-12#1)(2008-10#1)
and at the end of each##2##6##(2008-10#1)(2008-6#1)
and at the end of the##4##6##(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
and at the end of##6##5##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
and at the molecular##2##4##(1997-6#1)(2008-10#1)
and at the same time##11##5##(1990-11#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-8#1)(2010-12#1)(2010-7#2)(2013-1#1)
and at the same##12##4##(1990-11#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-12#1)(2010-7#2)(2013-1#1)
and at the##47##3##(1990-11#1)(1990-2#1)(1991-11#1)(1991-3#1)(1991-9#2)(1993-12#2)(1994-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and at three##2##3##(2011-2#1)(2013-8#1)
and at what stage##2##4##(2006-6#1)(2008-10#1)
and at what##4##3##(2006-6#1)(2008-10#1)(2008-11#1)(2009-7#1)
and at##178##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#64)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#6)
and atherosclerosis##11##2##(1997-8#1)(2008-11#4)(2008-7#3)(2011-2#2)(2012-2#1)
and atherosclerotic##2##2##(1991-9#1)(2008-4#1)
and atmospheric products##2##3##(2008-3#2)
and atmospheric##8##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-2#1)
and atomic absorption spectrometry##4##4##(2008-10#3)(2011-2#1)
and atomic absorption##6##3##(2008-10#5)(2011-2#1)
and atomic emission##2##3##(2008-10#2)
and atomic fluorescence spectrometry (AFS)##2##5##(2008-10#2)
and atomic fluorescence spectrometry##4##4##(2008-10#4)
and atomic fluorescence##6##3##(2008-10#6)
and atomic force microscopy##4##4##(2008-3#1)(2008-5#1)(2009-7#1)(2010-7#1)
and atomic force##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-7#1)
and atomic##23##2##(2008-10#17)(2008-3#2)(2008-5#1)(2009-7#1)(2010-7#1)(2011-2#1)
and atomisation##6##2##(2008-10#6)
and atomization curves##2##3##(2008-10#2)
and atomization temperatures of 1500 and##2##6##(2008-10#2)
and atomization temperatures of##4##4##(2008-10#4)
and atomization temperatures##14##3##(2008-10#14)
and atomization##25##2##(2008-10#25)
and atopic dermatitis##2##3##(2008-5#1)(2013-1#1)
and atopic##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
and atopy (p=0##2##3##(2008-10#2)
and atopy##9##2##(2008-10#7)(2010-6#2)
and atrazine were##2##3##(2008-10#2)
and atrazine##7##2##(2008-10#7)
and atrial fibrillation##2##3##(1996-3#1)(2008-10#1)
and atrial##5##2##(1994-11#1)(1994-8#1)(1996-3#1)(2008-10#1)(2010-4#1)
and atrogin-1 mRNA##2##3##(2013-1#2)
and atrophy##2##2##(1992-2#1)(2013-1#1)
and atropine##3##2##(1994-9#1)(2008-10#1)(2010-4#1)
and attached##3##2##(2008-10#1)(2008-11#2)
and attachment##4##2##(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
and attain##3##2##(2008-10#1)(2008-8#1)(2010-4#1)
and attempt##2##2##(2010-7#1)(2012-2#1)
and attempts to##3##3##(2008-12#1)(2008-4#1)(2010-10#1)
and attempts##5##2##(1992-12#1)(2008-12#1)(2008-4#1)(2010-10#1)(2011-2#1)
and attendance benefits##2##3##(1994-6#2)
and attendance##5##2##(1991-12#1)(1994-6#3)(2012-3#1)
and attendant##2##2##(2008-8#1)(2012-3#1)
and attention deficit##2##3##(1996-6#1)(2008-11#1)
and attention to##2##3##(1993-2#1)(2008-9#1)
and attention##8##2##(1993-2#1)(1996-6#1)(2008-11#2)(2008-9#1)(2009-8#1)(2013-8#2)
and attenuate the##2##3##(1995-1#1)(2013-8#1)
and attenuates##2##2##(2010-10#1)(2011-3#1)
and attenuation of##2##3##(2008-9#1)(2009-8#1)
and attenuation##3##2##(1997-2#1)(2008-9#1)(2009-8#1)
and attitude towards the##3##4##(1997-3#1)(2008-5#1)(2013-1#1)
and attitude##8##2##(1990-6#1)(1997-3#1)(2008-5#1)(2012-3#1)(2013-1#3)(2013-7#1)
and attitudes of psychiatric healthcare##2##5##(1991-2#2)
and attitudes of##9##3##(1991-2#2)(1996-6#1)(2008-1#1)(2008-11#1)(2010-3#1)(2011-2#2)(2012-3#1)
and attitudes toward##4##3##(1992-1#1)(1994-3#1)(2009-5#2)
and attitudes towards##3##3##(2008-11#1)(2010-3#1)(2013-1#1)
and attitudes##30##2##(1991-2#3)(1992-1#1)(1992-2#1)(1993-11#1)(1994-3#1)(1996-6#1)(2008-1#1)(2008-11#4)(2008-7#1)(2009-5#2)(2010-3#4)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)
and attractive##2##2##(2008-6#1)(2008-8#1)
and atypical##9##2##(1994-12#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-6#2)(2013-1#1)
and audit##3##2##(1991-8#1)(1996-8#1)(2013-1#1)
and auditing##2##2##(1994-2#1)(2010-5#1)
and auditory##2##2##(2008-8#1)(2013-1#1)
and augmented##2##2##(2008-11#1)(2008-7#1)
and authority##2##2##(1991-1#1)(1993-1#1)
and autism spectrum##2##3##(2010-7#1)(2012-12#1)
and autism##3##2##(1991-2#1)(2010-7#1)(2012-12#1)
and autoclaved mulberry leaves##2##4##(2008-10#2)
and autoclaved##3##2##(2008-10#3)
and autogeneic##2##2##(2013-1#2)
and autograft##5##2##(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#2)
and autohydrolysis##2##2##(1994-11#2)
and autoimmune disease##2##3##(2008-10#1)(2008-5#1)
and autoimmune diseases##2##3##(2013-1#1)(2013-8#1)
and autoimmune##9##2##(1990-11#1)(2008-10#2)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
and autoimmunity in##2##3##(2008-10#1)(2008-7#1)
and autoimmunity##5##2##(1993-3#1)(2008-10#2)(2008-4#1)(2008-7#1)
and autologous CTLs##2##3##(2008-11#2)
and autologous##3##2##(1994-5#1)(2008-11#2)
and automated method##2##3##(2008-10#2)
and automated##12##2##(1997-2#1)(2008-10#10)(2010-7#1)
and automatic##7##2##(2008-10#4)(2008-7#1)(2009-10#2)
and automation##5##2##(1992-11#1)(2008-10#4)
and autonomic##10##2##(1991-1#1)(1996-12#1)(2007-12#1)(2008-12#2)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
and autonomy##2##2##(1990-6#1)(1991-2#1)
and autophosphorylation##2##2##(1993-8#2)
and autoradiography##3##2##(1995-11#1)(2008-11#1)(2008-7#1)
and autosomal##3##2##(1997-8#1)(2008-11#1)(2012-3#1)
and autotransfusion##3##2##(1990-2#1)(1992-3#2)
and autumn##5##2##(2008-10#3)(2008-5#1)(2013-1#1)
and auxin##3##2##(2008-10#2)(2009-8#1)
and availability of##8##3##(1992-2#1)(1994-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2010-8#1)(2013-1#1)
and availability##10##2##(1992-2#1)(1994-1#1)(1996-2#1)(2008-10#3)(2008-11#2)(2010-8#1)(2013-1#1)
and available data##2##3##(2008-8#1)(2011-2#1)
and available##11##2##(1991-7#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
and average premiums paid by##2##5##(1996-3#2)
and average premiums##3##3##(1996-3#3)
and average##23##2##(1992-12#1)(1992-2#1)(1994-1#2)(1994-2#1)(1996-3#3)(2008-10#5)(2008-11#1)(2008-7#3)(2008-9#1)(2009-3#2)(2011-2#1)(2012-12#1)(2013-3#1)
and avian influenza##2##3##(2008-9#1)(2013-8#1)
and avian##5##2##(1990-5#1)(1997-1#1)(2008-8#1)(2008-9#1)(2013-8#1)
and avirulent populations##2##3##(2008-10#2)
and avirulent##5##2##(2008-10#5)
and avoid##11##2##(1993-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
and avoidance of##4##3##(1992-9#1)(1997-6#1)(2008-10#1)(2011-2#1)
and avoidant##2##2##(2008-11#1)(2009-5#1)
and avoided the##2##3##(2008-10#2)
and avoiding##7##2##(1991-1#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
and avoids the##5##3##(1990-3#1)(1991-3#1)(2008-10#2)(2008-8#1)
and avoids##9##2##(1990-3#1)(1991-3#1)(2008-10#5)(2008-8#1)(2008-9#1)
and awareness of##3##3##(2008-10#1)(2009-11#1)(2010-12#1)
and awareness##6##2##(1994-3#1)(2008-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2012-2#1)
and away##2##2##(2008-10#1)(2008-8#1)
and axial##6##2##(2008-2#1)(2008-9#1)(2010-1#2)(2011-2#1)(2013-8#1)
and axillary nerve##2##3##(2008-9#1)(2013-1#1)
and axillary##3##2##(2008-9#1)(2010-6#1)(2013-1#1)
and axonal##4##2##(1996-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
and axons##5##2##(1997-3#2)(2008-11#1)(2008-7#2)
and azomethene##2##2##(2008-10#2)
and b##8##2##(1991-3#1)(1995-2#1)(2008-10#4)(2010-5#1)(2011-2#1)
and b) the##2##3##(1993-1#1)(2012-2#1)
and b)##5##2##(1991-3#1)(1993-1#2)(2008-2#1)(2012-2#1)
and bFGF##2##2##(2008-11#1)(2010-8#1)
and bZIP##3##2##(2008-10#3)
and babies##2##2##(1994-6#1)(2009-11#1)
and back pain##5##3##(2008-12#2)(2009-7#1)(2012-2#1)(2013-1#1)
and back##16##2##(1995-3#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-7#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and backcross##4##2##(1996-12#2)(2008-10#2)
and backcrosses were##2##3##(2008-10#2)
and backcrosses##3##2##(2008-10#2)(2008-8#1)
and background absorption##3##3##(2008-10#3)
and background##10##2##(2008-10#7)(2008-11#1)(2008-3#1)(2010-2#1)
and backscattering##2##2##(2008-2#1)(2008-3#1)
and bacoside##2##2##(2012-2#2)
and bacteria were not##2##4##(2008-10#2)
and bacteria##12##2##(1990-2#1)(1992-11#1)(1993-12#1)(1994-5#1)(2008-10#5)(2008-7#1)(2008-8#1)(2011-1#1)
and bacterial multiplication##2##3##(2008-10#2)
and bacterial##12##2##(1992-5#1)(2008-10#6)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
and bacteriological##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
and bacteriophage##2##2##(1990-11#1)(1994-8#1)
and balance disorders in cancer patients##2##6##(2013-1#2)
and balance disorders in##3##4##(2013-1#3)
and balance disorders##4##3##(2008-7#1)(2013-1#3)
and balance##5##2##(2008-7#1)(2009-3#1)(2013-1#3)
and balanced##5##2##(1991-12#1)(1997-8#1)(2008-10#1)(2010-4#1)(2012-3#1)
and ball##4##2##(1996-1#1)(2011-2#3)
and band##5##2##(1995-2#1)(2008-10#4)
and bandwidth##4##2##(1994-8#1)(2007-12#1)(2008-3#2)
and bank##2##2##(2008-11#1)(2012-3#1)
and barely##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
and barium##3##2##(1994-12#1)(2008-10#1)(2008-7#1)
and bark##2##2##(2008-10#2)
and barley and##3##3##(1991-12#1)(2008-10#2)
and barley genotypes##2##3##(2008-10#2)
and barley##20##2##(1991-12#2)(2008-10#15)(2009-10#3)
and barriers to##3##3##(1996-2#1)(2008-11#2)
and barriers##6##2##(1992-8#1)(1996-2#1)(1997-3#1)(2008-11#2)(2009-12#1)
and basal ES##2##3##(2012-2#2)
and basal ganglia##2##3##(1996-12#1)(2008-7#1)
and basal##13##2##(1991-10#2)(1993-9#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#3)
and base composition##2##3##(1994-9#1)(2008-5#1)
and base##6##2##(1991-5#1)(1992-3#1)(1994-9#1)(2008-5#2)(2009-5#1)
and based on##4##3##(2008-10#3)(2009-8#1)
and baseline drift##2##3##(2008-10#2)
and baseline##9##2##(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)
and bases##6##2##(2008-10#5)(2008-9#1)
and basic fibroblast growth factor##5##5##(1995-11#2)(2008-11#3)
and basic media##2##3##(2008-10#2)
and basic research##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
and basic##27##2##(1992-1#1)(1993-2#1)(1995-11#2)(1997-7#1)(2008-10#12)(2008-11#5)(2008-3#1)(2008-8#1)(2009-12#1)(2011-7#1)(2012-3#1)
and basis##2##2##(2008-5#1)(2013-8#1)
and batch composition##2##3##(2011-2#2)
and batch##4##2##(2008-10#1)(2011-2#3)
and battering##2##2##(2009-5#2)
and bcl-2##6##2##(1993-3#2)(2008-10#1)(2008-11#3)
and be a##2##3##(1993-12#1)(2013-1#1)
and be capable of##2##4##(2008-10#1)(2008-11#1)
and be##20##2##(1990-2#1)(1991-3#1)(1993-12#1)(1995-2#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-8#3)(2010-10#2)(2010-7#1)(2012-3#1)(2013-1#1)
and bead injection##2##3##(2008-10#2)
and beam##5##2##(2008-3#5)
and bean##4##2##(1994-11#1)(2008-10#3)
and became##8##2##(1991-10#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2013-8#1)
and because it##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
and because of the##2##4##(1992-3#1)(2010-5#1)
and because of their##2##4##(2006-5#1)(2008-7#1)
and because of##5##3##(1990-2#1)(1992-3#1)(2006-5#1)(2008-7#1)(2010-5#1)
and because the##2##3##(2008-10#1)(2009-10#1)
and because##17##2##(1990-2#1)(1992-3#1)(1997-7#1)(2006-5#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
and become##4##2##(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
and becomes##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
and becoming##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
and bed##2##2##(1993-12#1)(2008-1#1)
and beds##2##2##(1996-3#1)(2008-10#1)
and beef##6##2##(1990-5#1)(2008-10#2)(2012-3#3)
and beet pseudo-yellows virus##2##4##(2008-10#2)
and before##3##2##(1992-6#1)(2008-11#2)
and began##3##2##(2008-10#1)(2010-11#1)(2010-8#1)
and begin##4##2##(2008-1#1)(2008-10#1)(2008-6#1)(2010-4#1)
and behavior and##2##3##(2011-2#1)(2013-8#1)
and behavior in##2##3##(2009-8#1)(2009-9#1)
and behavior of##3##3##(2008-11#1)(2008-8#1)(2012-12#1)
and behavior problems##3##3##(2009-9#1)(2010-11#2)
and behavior##29##2##(1993-3#1)(1997-6#1)(1997-8#1)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and behavioral enrichment##2##3##(2009-8#2)
and behavioral resistance##2##3##(2010-1#1)(2010-10#1)
and behavioral sciences##3##3##(1996-2#1)(2010-7#2)
and behavioral##28##2##(1992-6#1)(1994-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-2#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#4)(2010-1#3)(2010-10#1)(2010-7#2)(2012-3#1)(2013-1#3)(2013-8#1)
and behaviors##10##2##(1993-3#1)(2008-11#3)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2011-1#2)
and behaviour##8##2##(1990-11#1)(1991-2#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)
and behavioural factors##4##3##(2010-6#4)
and behavioural##14##2##(1991-6#1)(1992-2#1)(1994-8#1)(2008-1#1)(2008-11#2)(2008-9#1)(2010-6#4)(2011-2#1)(2013-8#2)
and behaviours##5##2##(2008-1#1)(2008-5#1)(2010-6#3)
and being##9##2##(1993-1#1)(1996-6#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-11#2)(2010-9#1)(2012-2#1)
and beliefs regarding##2##3##(1995-1#1)(2013-8#1)
and beliefs##8##2##(1994-12#1)(1995-1#1)(2008-12#4)(2008-9#1)(2013-8#1)
and believed to##2##3##(1997-2#1)(2008-10#1)
and belongs to##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
and below the##3##3##(1991-11#1)(2008-10#1)(2008-3#1)
and below##5##2##(1991-11#1)(2008-10#3)(2008-3#1)
and beneficial##3##2##(1991-3#1)(1996-1#1)(2008-11#1)
and benefit##3##2##(1991-3#1)(2008-9#2)
and benefits of this procedure##2##5##(2011-2#2)
and benefits of this##3##4##(2008-12#1)(2011-2#2)
and benefits of##14##3##(1991-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-12#2)(2011-2#2)
and benefits##19##2##(1991-2#1)(1994-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-12#2)(2011-2#2)
and benfotiamine##4##2##(2012-4#4)
and benign##5##2##(1992-5#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
and benomyl##5##2##(2008-10#5)
and benserazide##2##2##(2008-10#2)
and benzene##3##2##(1994-3#1)(2008-10#2)
and benzo(a)pyrene##2##2##(2008-10#2)
and benzo[a]pyrene##2##2##(1994-5#1)(2008-10#1)
and benzoic acid##3##3##(2008-10#3)
and benzothiadiazole##2##2##(2008-10#2)
and benzyl##3##2##(2008-10#2)(2013-1#1)
and benzyloxyresorufin##2##2##(1994-8#2)
and bereavement##4##2##(1991-2#1)(2008-12#2)(2012-3#1)
and berries##4##2##(2008-10#4)
and berry##3##2##(2008-10#3)
and beryllium##2##2##(2008-10#2)
and best##7##2##(2008-10#3)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
and bestatin##2##2##(1996-2#2)
and beta 2##2##3##(1992-9#1)(1995-11#1)
and beta 2-microglobulin##5##3##(1995-12#4)(1997-3#1)
and beta A4##3##3##(1991-6#3)
and beta and##3##3##(1994-11#1)(2008-8#2)
and beta##53##2##(1990-8#2)(1991-10#4)(1991-12#1)(1991-5#1)(1991-6#4)(1991-7#2)(1992-6#1)(1992-9#3)(1993-2#2)(1993-6#3)(1994-11#5)(1994-6#2)(1995-11#2)(1995-12#4)(1995-6#2)(1996-12#2)(1997-3#3)(2008-10#2)(2008-11#2)(2008-8#4)(2008-9#1)(2010-8#1)
and beta(2)##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
and beta-1##14##2##(1991-5#1)(1992-11#2)(1992-7#2)(2008-10#9)
and beta-CGRP##8##2##(1992-6#8)
and beta-actin mRNA##2##3##(1996-12#1)(1996-2#1)
and beta-actin##4##2##(1996-12#1)(1996-2#1)(2008-8#1)(2008-9#1)
and beta-blockers in##2##3##(1993-2#1)(2011-2#1)
and beta-blockers##6##2##(1993-2#1)(1994-12#1)(2008-10#2)(2011-2#2)
and beta-carotene##3##2##(1992-9#1)(2009-6#2)
and beta-cyclodextrin (beta-CD)##2##3##(2008-10#2)
and beta-cyclodextrin##5##2##(2008-10#5)
and beta-endorphin given##2##3##(1992-3#2)
and beta-endorphin##8##2##(1991-6#1)(1992-3#5)(2008-6#1)(2009-7#1)
and beta-galactosidase##4##2##(1990-5#1)(1993-8#1)(2008-10#1)(2008-11#1)
and beta-lactoglobulin##2##2##(2008-10#1)(2008-7#1)
and beta-naphthoflavone-induced##2##2##(1993-11#2)
and beta-naphthol##3##2##(2008-10#3)
and beta-sheet##2##2##(1991-6#1)(2008-9#1)
and beta-tubulin##4##2##(2008-10#4)
and better self-reported physical and mental health than the control group##2##11##(2013-1#2)
and better##29##2##(1990-2#1)(1991-1#1)(1994-1#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
and between 0##3##3##(2008-10#3)
and between 2 and##2##4##(2008-10#1)(2011-10#1)
and between 3##2##3##(2008-10#2)
and between assay##2##3##(1990-2#1)(2008-10#1)
and between days##4##3##(2008-10#2)(2010-12#2)
and between patients##2##3##(1997-2#1)(2008-7#1)
and between regions##2##3##(2008-10#1)(2013-8#1)
and between species##4##3##(2008-10#1)(2009-6#1)(2012-3#2)
and between the##13##3##(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)(2012-12#1)
and between##103##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1997-2#1)(1997-4#1)(2006-6#1)(2008-10#44)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-10#1)(2011-2#1)(2012-12#4)(2012-3#3)(2012-9#1)(2013-1#3)(2013-8#2)
and between-day##3##2##(1991-2#1)(2008-10#2)
and beverages##9##2##(2008-10#4)(2010-9#2)(2012-12#2)(2012-2#1)
and beyond##17##2##(1991-3#1)(1993-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
and bias##6##2##(1990-6#1)(2008-10#3)(2008-8#1)(2010-9#1)
and bibliographies of key articles##3##5##(2012-12#3)
and bigger##2##2##(2008-10#1)(2011-2#1)
and bilateral lesions of##2##4##(2008-7#2)
and bilateral##20##2##(1993-1#1)(1994-3#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-5#2)(2008-7#5)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#1)
and bilaterally##3##2##(1990-6#1)(2008-7#1)(2008-9#1)
and bile acid##2##3##(2008-10#2)
and bile##5##2##(1993-3#1)(2008-10#2)(2008-11#1)(2012-2#1)
and biliary##8##2##(1992-6#1)(1992-9#1)(2010-12#1)(2011-2#3)(2013-1#2)
and bilirubin##3##2##(1993-1#1)(2008-10#1)(2012-12#1)
and binary mixtures##2##3##(2008-10#1)(2008-7#1)
and binary##4##2##(2008-10#3)(2008-7#1)
and bind##3##2##(1996-2#1)(2008-9#1)(2011-1#1)
and binder##2##2##(2008-10#2)
and binding affinity##2##3##(1993-6#1)(2008-8#1)
and binding constant##2##3##(2008-10#2)
and binding of##3##3##(1994-11#1)(1997-2#1)(2008-10#1)
and binding pattern of##2##4##(2008-10#2)
and binding sites##4##3##(1993-6#1)(2008-10#1)(2008-7#2)
and binding to##2##3##(1995-2#1)(2008-11#1)
and binding##21##2##(1990-11#1)(1993-6#2)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#2)(2008-10#6)(2008-11#1)(2008-7#2)(2008-8#1)(2012-2#1)
and binds to##3##3##(1990-5#1)(2009-8#1)(2012-2#1)
and binge drinking##2##3##(2009-5#2)
and binomial##2##2##(2008-10#1)(2010-5#1)
and bioactivity##2##2##(2008-8#1)(2012-2#1)
and bioanalytical##4##2##(2008-10#2)(2010-11#1)(2011-2#1)
and bioassay##2##2##(2009-12#1)(2011-3#1)
and bioassays##2##2##(2008-10#1)(2012-12#1)
and biochemical changes##3##3##(1991-2#1)(2008-12#1)(2012-2#1)
and biochemical characterization of##3##4##(1991-2#1)(1991-9#1)(1993-8#1)
and biochemical characterization##4##3##(1991-2#1)(1991-9#1)(1993-8#1)(2008-10#1)
and biochemical effects of##2##4##(1992-3#1)(2010-1#1)
and biochemical effects##3##3##(1992-3#1)(2008-7#1)(2010-1#1)
and biochemical features##2##3##(2008-10#1)(2008-11#1)
and biochemical parameters##4##3##(2008-11#1)(2011-10#2)(2012-2#1)
and biochemical processes##3##3##(2009-8#2)(2013-8#1)
and biochemical properties##2##3##(2008-10#1)(2012-2#1)
and biochemical responses##2##3##(2011-10#1)(2012-6#1)
and biochemical##52##2##(1991-2#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-12#2)(1994-5#1)(1996-2#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-7#1)(2011-10#4)(2011-2#3)(2012-2#3)(2012-3#1)(2012-6#2)(2013-1#1)(2013-8#1)
and biochemically##4##2##(1995-2#1)(2008-10#1)(2011-1#1)(2012-3#1)
and biocompatibility##2##2##(2008-10#1)(2008-5#1)
and biocontrol activity##2##3##(2008-10#2)
and biocontrol##8##2##(2008-10#8)
and biocorrosion behaviors##2##3##(2012-2#2)
and biodegradation##2##2##(2008-11#1)(2008-7#1)
and biodiversity##2##2##(2011-2#1)(2012-2#1)
and bioengineering applications##2##3##(2008-3#1)(2009-12#1)
and bioengineering##3##2##(2008-3#1)(2009-12#2)
and bioethical##2##2##(2008-7#1)(2013-8#1)
and biofilm formation##3##3##(2007-12#1)(2008-7#2)
and biofilm##5##2##(2007-12#1)(2008-7#4)
and biogeography##2##2##(2008-6#1)(2008-8#1)
and bioinformatic##2##2##(2008-9#1)(2013-8#1)
and biologic##3##2##(1990-8#1)(1991-3#1)(2011-2#1)
and biological activity of##2##4##(1990-2#1)(2008-10#1)
and biological activity##6##3##(1990-2#1)(1991-5#1)(1993-8#1)(2008-10#1)(2008-11#1)(2010-9#1)
and biological and##2##3##(2008-11#1)(2013-1#1)
and biological assays##2##3##(2008-10#2)
and biological behavior##2##3##(2008-10#1)(2011-2#1)
and biological characteristics##4##3##(1990-9#1)(1997-2#1)(1997-8#1)(2008-10#1)
and biological characterization of##2##4##(1992-12#1)(2008-10#1)
and biological characterization##3##3##(1992-12#1)(2008-10#2)
and biological control##4##3##(1997-7#1)(2008-10#3)
and biological defense research##2##4##(1992-12#2)
and biological fluids using##3##4##(2008-10#3)
and biological fluids##18##3##(2008-10#18)
and biological function of##2##4##(2008-11#1)(2011-1#1)
and biological function##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
and biological parameters##2##3##(1993-6#1)(2008-7#1)
and biological profile##2##3##(1997-8#1)(2011-3#1)
and biological samples by##3##4##(2008-10#3)
and biological samples is##2##4##(2008-10#2)
and biological samples##28##3##(2008-10#27)(2010-6#1)
and biological systems##2##3##(1992-3#1)(2008-10#1)
and biological##139##2##(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-9#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#74)(2008-11#7)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#3)(2012-2#2)(2013-1#2)
and biologically##8##2##(1990-3#1)(1996-12#1)(1996-3#2)(1997-4#1)(2008-10#3)
and biologics##2##2##(2008-10#1)(2011-2#1)
and biology of##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
and biology##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
and biomarker##3##2##(2009-10#1)(2010-10#1)(2010-7#1)
and biomass##8##2##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)(2009-8#1)
and biomaterials##3##2##(2008-10#1)(2008-12#1)(2012-5#1)
and biomechanical##5##2##(1993-9#1)(2009-4#1)(2009-7#1)(2011-7#1)(2012-12#1)
and biomedical##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
and biophysical##4##2##(1996-12#1)(2008-4#1)(2008-5#1)(2009-12#1)
and biopsy was##2##3##(2009-1#1)(2012-2#1)
and biopsy##7##2##(2008-1#1)(2008-10#1)(2008-2#1)(2009-1#1)(2011-2#1)(2012-2#2)
and bioreactors##3##2##(2008-11#2)(2011-2#1)
and biorheological##2##2##(2008-9#2)
and biosensor##2##2##(2008-10#2)
and biosensors##3##2##(1995-3#1)(2008-10#1)(2010-7#1)
and biotech##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
and biotechnological applications##3##3##(2008-11#1)(2009-10#1)(2010-4#1)
and biotechnology##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)
and biotic##6##2##(2008-10#3)(2009-10#1)(2009-6#1)(2009-8#1)
and biotin-labeled##2##2##(2008-10#2)
and biotinylated##5##2##(2008-10#3)(2008-9#2)
and bipolar disorder##3##3##(2008-4#2)(2009-6#1)
and bipolar##9##2##(1995-3#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-6#1)(2010-6#1)(2012-3#1)
and bird##4##2##(2008-10#1)(2008-8#2)(2009-7#1)
and birefringent##2##2##(2007-12#1)(2008-3#1)
and birth defects##2##3##(2008-11#1)(2008-8#1)
and birth outcome##3##3##(1991-12#1)(1995-2#2)
and birth weight##3##3##(1992-2#1)(2008-11#1)(2012-12#1)
and birth##12##2##(1991-12#1)(1992-2#1)(1995-1#1)(1995-2#3)(2008-11#2)(2008-8#1)(2009-11#1)(2009-7#1)(2012-12#1)
and bisexual##10##2##(2008-12#10)
and bismuth from cobalt##2##4##(2008-10#2)
and bismuth from##3##3##(2008-10#3)
and bismuth were##3##3##(2008-10#3)
and bismuth##12##2##(2008-10#10)(2010-11#2)
and bisphenol##2##2##(2008-10#2)
and bitter gourd##2##3##(2013-8#2)
and bitter rot##3##3##(2008-10#3)
and bitter##5##2##(2008-10#3)(2013-8#2)
and bivariate##2##2##(1995-1#1)(2011-2#1)
and black tea##3##3##(2008-11#1)(2009-8#2)
and black teas##4##3##(2008-10#2)(2008-11#2)
and black##9##2##(2008-10#3)(2008-11#3)(2009-8#2)(2011-2#1)
and bladder agenesis##2##3##(2008-10#2)
and bladder cancer##2##3##(2008-11#1)(2013-8#1)
and bladder##14##2##(1990-8#1)(1993-8#1)(2008-10#4)(2008-11#1)(2009-11#3)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
and blank##4##2##(1990-5#1)(2008-10#3)
and blastocyst##4##2##(2008-5#1)(2008-9#2)(2012-3#1)
and blastospores##2##2##(2008-10#2)
and bleeding##8##2##(2008-10#1)(2008-4#1)(2008-8#1)(2009-3#2)(2011-2#1)(2012-12#1)(2013-8#1)
and blight##2##2##(2008-10#2)
and blindness##2##2##(2011-2#2)
and blocked##3##2##(1994-5#1)(2008-7#1)(2008-8#1)
and blocking##2##2##(2008-10#1)(2010-12#1)
and blocks the##2##3##(2008-7#1)(2008-8#1)
and blocks##3##2##(1995-2#1)(2008-7#1)(2008-8#1)
and blood chemistry##2##3##(2008-5#1)(2013-1#1)
and blood flow##2##3##(2008-12#1)(2013-1#1)
and blood gas##2##3##(1997-3#1)(2010-10#1)
and blood glucose concentrations##2##4##(1993-1#1)(2013-8#1)
and blood glucose##4##3##(1993-1#2)(2012-2#1)(2013-8#1)
and blood lactate##3##3##(2009-1#1)(2013-1#1)(2013-8#1)
and blood loss##2##3##(1992-2#1)(2012-3#1)
and blood plasma##3##3##(1995-12#1)(2008-10#2)
and blood pressure##8##3##(1992-12#1)(1992-9#2)(1994-3#1)(1996-2#1)(2008-7#1)(2013-8#2)
and blood samples were collected##2##5##(1990-12#1)(1997-2#1)
and blood samples were##4##4##(1990-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
and blood samples##10##3##(1990-12#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2009-12#1)(2013-1#2)
and blood transfusion##2##3##(1991-8#1)(2013-1#1)
and blood vessel##2##3##(1991-12#1)(2013-1#1)
and blood##64##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-1#2)(1993-11#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#5)
and blue and##2##3##(2008-10#1)(2008-3#1)
and blue light##2##3##(2008-3#1)(2011-2#1)
and blue##6##2##(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#1)
and board##2##2##(1992-3#1)(1994-12#1)
and body balance##2##3##(2008-12#2)
and body composition##2##3##(2008-11#1)(2012-2#1)
and body fat##3##3##(2008-7#1)(2009-7#1)(2013-8#1)
and body flexibility##3##3##(2010-12#3)
and body mass index (BMI)##5##5##(1994-12#1)(2008-10#1)(2010-1#1)(2011-1#1)(2011-2#1)
and body mass index##9##4##(1994-12#1)(2008-10#2)(2008-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)
and body mass##12##3##(1994-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-3#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)
and body of##3##3##(2008-9#1)(2010-6#1)(2013-1#1)
and body size##2##3##(1991-12#1)(2008-9#1)
and body weight##4##3##(1992-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
and body##50##2##(1991-1#2)(1991-12#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
and boiling##2##2##(1996-12#1)(2008-10#1)
and bombesin##2##2##(1994-3#1)(2010-6#1)
and bond##3##2##(1990-8#1)(2008-8#1)(2011-2#1)
and bonding strategies on the microshear bond strength of##2##9##(2013-1#2)
and bonding##3##2##(2013-1#3)
and bone graft##2##3##(2010-6#1)(2013-1#1)
and bone grafting##2##3##(2011-2#1)(2012-12#1)
and bone marrow transplantation##3##4##(2008-11#2)(2013-8#1)
and bone marrow##8##3##(1990-3#1)(2008-10#1)(2008-11#2)(2008-5#2)(2012-12#1)(2013-8#1)
and bone##45##2##(1990-3#1)(1991-5#2)(1993-11#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-11#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#4)(2011-2#5)(2012-12#4)(2013-1#1)(2013-8#2)
and books##2##2##(2008-10#1)(2013-8#1)
and borate buffer##2##3##(2008-10#2)
and borderline personality disorder##2##4##(2009-10#1)(2013-1#1)
and borderline##3##2##(2008-11#1)(2009-10#1)(2013-1#1)
and boric acid##3##3##(2008-10#3)
and boronic acid##2##3##(2008-10#2)
and botanical origin##2##3##(2008-10#2)
and both factors##2##3##(2008-8#1)(2008-9#1)
and both of##2##3##(2008-11#1)(2008-9#1)
and both species##3##3##(2008-10#2)(2008-8#1)
and both the##9##3##(1994-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#2)
and both were##3##3##(1995-8#1)(2008-10#2)
and both##54##2##(1991-5#1)(1991-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-3#2)(2008-10#13)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)
and bottled##3##2##(2008-10#3)
and bottom##4##2##(2008-10#2)(2013-1#2)
and bound to##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
and bound##6##2##(1991-5#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#2)
and bovine liver##2##3##(1992-12#1)(2008-10#1)
and bovine serum albumin (BSA)##6##5##(2008-10#5)(2008-11#1)
and bovine serum albumin##11##4##(2008-10#8)(2008-11#3)
and bovine##23##2##(1992-10#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-8#1)(2008-10#13)(2008-11#3)
and bowel resection##3##3##(2010-12#3)
and boys##5##2##(2009-10#1)(2009-5#1)(2010-10#1)(2013-8#2)
and brachial artery flow-mediated vasodilatation##3##5##(2008-11#3)
and bradycardia##3##2##(2008-12#1)(2008-7#2)
and brain MAO inhibitory activity##2##5##(1994-3#2)
and brain are##2##3##(2008-10#1)(2009-9#1)
and brain areas##2##3##(2008-11#1)(2013-8#1)
and brain function##2##3##(2008-7#1)(2009-7#1)
and brain stem##2##3##(1991-8#1)(1996-2#1)
and brain##49##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#4)(1996-2#2)(1997-8#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and brain-derived neurotrophic factor##2##4##(1997-2#2)
and brains##2##2##(1992-12#1)(2008-7#1)
and brainstem##3##2##(1991-10#1)(1996-12#1)(2012-3#1)
and branched##2##2##(2008-10#2)
and branching##4##2##(2008-10#1)(2008-7#2)(2012-2#1)
and bread##2##2##(2008-10#2)
and breakage##2##2##(2008-5#1)(2008-7#1)
and breakdown of##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
and breakdown##4##2##(1993-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
and breast cancer##9##3##(1990-6#1)(1990-8#1)(1993-11#1)(1996-3#2)(1997-8#1)(2008-7#1)(2010-1#1)(2012-12#1)
and breast##18##2##(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-6#2)(1996-3#2)(1997-8#2)(2008-5#1)(2008-7#1)(2010-1#1)(2012-12#1)
and breastfeeding in##2##3##(2010-12#1)(2012-2#1)
and breathing##2##2##(1994-12#1)(2012-2#1)
and bred##2##2##(2008-10#1)(2008-9#1)
and breeding##6##2##(2008-8#5)(2010-10#1)
and brefeldin##2##2##(2008-11#1)(2010-3#1)
and brief intervention##7##3##(2008-11#7)
and brief review of the literature##3##6##(2010-9#1)(2012-3#1)(2013-1#1)
and brief##12##2##(1992-1#1)(2008-11#8)(2010-9#1)(2012-3#1)(2013-1#1)
and briefly##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-1#1)
and brightness##2##2##(2013-8#2)
and bring##2##2##(1994-6#1)(2008-12#1)
and broad##9##2##(1991-12#1)(1992-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2013-1#1)
and broader##2##2##(2008-11#1)(2008-3#1)
and broccoli##2##2##(2008-10#1)(2008-12#1)
and bromate##2##2##(2008-10#2)
and bromegrass species##2##3##(2008-10#2)
and bromide##3##2##(2008-10#3)
and bromine##3##2##(2008-10#3)
and bromodeoxyuridine incorporation##2##3##(1996-12#1)(2007-12#1)
and brought##3##2##(1991-3#1)(2008-11#1)(2009-5#1)
and brown##3##2##(2008-10#3)
and budget##2##2##(1993-2#1)(2013-8#1)
and buffer##5##2##(2008-10#5)
and buffers##2##2##(2008-10#1)(2013-8#1)
and build##4##2##(1997-1#2)(2008-12#1)(2010-5#1)
and building##3##2##(1991-12#1)(1996-1#1)(2013-1#1)
and builds##2##2##(1997-3#1)(2011-2#1)
and built##4##2##(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#1)
and bulk##4##2##(1994-9#1)(2008-10#2)(2008-6#1)
and bulked##2##2##(2008-10#1)(2008-9#1)
and burnout##4##2##(1992-1#1)(1996-2#1)(2008-11#1)(2010-7#1)
and burns##2##2##(1991-6#1)(2008-10#1)
and burst##4##2##(1996-2#1)(2008-11#1)(2008-7#1)(2010-8#1)
and business##7##2##(1991-12#1)(1994-12#1)(1996-3#1)(2008-11#2)(2012-3#2)
and butanol##3##2##(2008-10#2)(2013-1#1)
and butyrate##2##2##(2008-11#2)
and by HPLC##2##3##(2008-10#2)
and by Western blotting##2##4##(1994-11#1)(1995-6#1)
and by Western##3##3##(1993-6#1)(1994-11#1)(1995-6#1)
and by a C##2##4##(2008-10#2)
and by a method##2##4##(2008-10#1)(2008-11#1)
and by a##23##3##(1990-5#1)(1991-8#1)(1996-5#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#2)(2010-7#1)(2013-1#1)
and by an##2##3##(2008-10#1)(2008-5#1)
and by analysis of##2##4##(2008-10#2)
and by comparing##2##3##(2008-10#2)
and by comparison with##2##4##(1994-5#1)(2008-10#1)
and by comparison##3##3##(1994-5#1)(2008-10#1)(2008-12#1)
and by determining the##2##4##(2008-10#1)(2008-11#1)
and by direct##2##3##(2008-6#1)(2012-3#1)
and by doing##2##3##(2008-7#1)(2012-2#1)
and by identifying##2##3##(1994-1#1)(1994-3#1)
and by including##2##3##(1993-8#1)(2008-10#1)
and by increasing##3##3##(2008-10#2)(2008-8#1)
and by inhibition of##2##4##(1994-2#1)(2008-10#1)
and by its##2##3##(2008-10#1)(2009-1#1)
and by means of##2##4##(2008-10#1)(2009-11#1)
and by measurement of##2##4##(1995-3#1)(2008-10#1)
and by measuring##2##3##(2008-10#2)
and by others##2##3##(1994-3#1)(2008-5#1)
and by our##2##3##(1997-3#1)(2010-8#1)
and by polymerase chain reaction (PCR)##3##6##(1996-12#1)(2008-10#2)
and by polymerase chain reaction##4##5##(1996-12#1)(2008-10#3)
and by providing##2##3##(1995-3#1)(2011-2#1)
and by recovery measurements on spiked samples##2##7##(2008-10#2)
and by recovery##3##3##(2008-10#3)
and by the##37##3##(1991-1#1)(1991-8#1)(1993-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#11)(2008-11#4)(2008-5#4)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and by their##3##3##(1993-3#1)(1997-3#1)(2008-5#1)
and by two##2##3##(2008-11#1)(2009-10#1)
and by using a##2##4##(1990-5#1)(2010-7#1)
and by using##4##3##(1990-5#1)(1995-3#1)(2008-10#1)(2010-7#1)
and by way of##2##4##(1993-3#1)(2008-10#1)
and by##303##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#3)(1991-5#3)(1991-8#2)(1992-12#2)(1992-3#3)(1992-5#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#5)(1994-9#2)(1995-11#3)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#100)(2008-11#22)(2008-12#3)(2008-2#1)(2008-3#6)(2008-5#12)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
and c##2##2##(2008-11#1)(2010-8#1)
and c)##3##2##(1991-6#2)(2012-2#1)
and c-Ha-ras##2##2##(1990-12#1)(1992-8#1)
and c-fos##3##2##(1997-3#2)(2008-9#1)
and c-jun##6##2##(1991-5#1)(1995-8#2)(1996-12#2)(2008-7#1)
and c-myc##4##2##(2008-5#3)(2008-8#1)
and cAMP##3##2##(1991-3#1)(1994-8#1)(1995-8#1)
and cDNA##7##2##(1993-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
and cGMP##2##2##(1993-8#1)(2009-10#1)
and ca##2##2##(2008-10#1)(2010-10#1)
and cadaveric##3##2##(2010-10#1)(2010-7#1)(2011-2#1)
and cadmium amalgam##2##3##(2008-10#2)
and cadmium in##5##3##(2008-10#4)(2008-12#1)
and cadmium ions were##2##4##(2008-10#2)
and cadmium ions##3##3##(2008-10#3)
and cadmium##23##2##(1994-6#1)(2008-10#21)(2008-12#1)
and cadmium(II) ions##2##3##(2008-10#2)
and cadmium(II) was##4##3##(2008-10#4)
and cadmium(II)##13##2##(2008-10#13)
and caffeine in##4##3##(1996-5#1)(2008-10#3)
and caffeine##10##2##(1996-5#1)(2008-10#5)(2009-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
and calcareous##3##2##(2012-6#3)
and calcification of##2##3##(1997-3#1)(2012-12#1)
and calcification##4##2##(1991-9#1)(1997-3#1)(2012-12#1)(2012-2#1)
and calcitonin gene-related peptide##3##4##(1997-1#1)(1997-3#2)
and calcitonin gene-related##4##3##(1997-1#1)(1997-3#3)
and calcitonin##7##2##(1992-6#1)(1997-1#1)(1997-3#3)(2008-4#2)
and calcium carbonate##5##3##(2008-10#2)(2008-7#1)(2011-2#2)
and calcium ions##2##3##(2008-10#2)
and calcium##35##2##(1990-11#1)(1990-5#1)(1991-6#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-12#1)(2008-1#2)(2008-10#13)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#3)
and calcium-dependent##2##2##(1990-5#1)(1994-5#1)
and calcium/calmodulin-dependent##2##2##(1990-8#1)(2008-10#1)
and calculate the##2##3##(1992-12#1)(2008-11#1)
and calculated values##3##3##(2008-10#1)(2008-3#2)
and calculated##12##2##(1991-11#1)(2008-10#4)(2008-2#1)(2008-3#4)(2009-3#1)(2012-2#1)
and calculation of##2##3##(2008-10#2)
and calculation##4##2##(2008-10#2)(2008-12#1)(2008-7#1)
and calculations##2##2##(1991-6#1)(2008-3#1)
and caldesmon##2##2##(1993-8#1)(1994-5#1)
and calf##3##2##(1992-6#1)(2008-12#1)(2012-2#1)
and calibration against aqueous##2##4##(2008-10#2)
and calibration against##3##3##(2008-10#3)
and calibration of##2##3##(2008-10#1)(2008-4#1)
and calibration solutions##2##3##(2008-10#2)
and calibration##11##2##(2008-10#9)(2008-2#1)(2008-4#1)
and callose##2##2##(2008-10#1)(2011-2#1)
and calls##2##2##(2008-10#1)(2010-11#1)
and calmodulin antagonists##2##3##(2008-10#2)
and calmodulin##5##2##(1990-5#1)(2008-10#2)(2008-8#1)(2010-3#1)
and calmodulin-dependent##2##2##(1991-9#1)(1993-6#1)
and caloric intake##2##3##(1991-1#1)(1991-12#1)
and calorimetric##2##2##(1997-2#1)(2008-10#1)
and calpain##2##2##(1994-5#2)
and calvaria##3##2##(2008-11#3)
and cambium##2##2##(2008-10#1)(2010-3#1)
and can also be adapted for##2##6##(1990-12#1)(2008-4#1)
and can also be desorbed with##2##6##(2008-10#2)
and can also be used##2##5##(2008-10#2)
and can also be##9##4##(1990-12#1)(1992-3#1)(2008-10#5)(2008-4#1)(2009-9#1)
and can also##11##3##(1990-12#1)(1991-6#1)(1992-3#1)(2008-10#5)(2008-4#1)(2009-9#1)(2013-1#1)
and can be a##2##4##(2010-4#1)(2013-1#1)
and can be accessed##2##4##(2008-10#1)(2009-2#1)
and can be applied satisfactorily for##2##6##(2008-10#2)
and can be applied##3##4##(2008-10#2)(2012-3#1)
and can be considered##3##4##(1992-11#1)(2008-11#1)(2011-2#1)
and can be controlled##2##4##(2008-11#1)(2010-4#1)
and can be detected by##2##5##(2008-10#1)(2009-6#1)
and can be detected##3##4##(1991-3#1)(2008-10#1)(2009-6#1)
and can be determined##2##4##(2008-10#1)(2008-11#1)
and can be distinguished##2##4##(2008-10#1)(2010-12#1)
and can be easily##3##4##(2008-10#2)(2008-7#1)
and can be extended to other##2##6##(2008-2#1)(2008-3#1)
and can be performed##4##4##(1991-3#1)(1992-3#1)(2010-5#1)(2012-3#1)
and can be readily##3##4##(2007-12#1)(2008-10#2)
and can be regenerated##2##4##(2008-10#2)
and can be treated##2##4##(2008-7#2)
and can be used as a##3##6##(2008-10#1)(2008-5#1)(2009-3#1)
and can be used as##4##5##(2008-10#2)(2008-5#1)(2009-3#1)
and can be used at##2##5##(2008-10#1)(2008-7#1)
and can be used for a period of##2##8##(2008-10#2)
and can be used for at least 2 months without##2##10##(2008-10#2)
and can be used for at least 3 months without any considerable divergence in potential##2##15##(2008-10#2)
and can be used for at least 3 months without any##4##11##(2008-10#4)
and can be used for at least##11##7##(2008-10#11)
and can be used for more than##2##7##(2008-10#2)
and can be used for the determination of##2##8##(2008-10#2)
and can be used for the##3##6##(2008-10#3)
and can be used for##23##5##(2007-12#1)(2008-10#21)(2013-1#1)
and can be used in a wide##2##7##(2008-10#2)
and can be used in the##2##6##(2008-10#2)
and can be used in##6##5##(2008-10#5)(2008-12#1)
and can be used over a period of##2##8##(2008-10#2)
and can be used over a##3##6##(2008-10#3)
and can be used to##13##5##(1996-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-3#1)
and can be used##51##4##(1996-2#1)(2007-12#1)(2008-10#38)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-3#1)(2013-1#1)
and can be useful##2##4##(2008-10#1)(2010-10#1)
and can be##140##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-5#1)(1996-2#1)(1997-7#1)(2007-12#3)(2008-10#69)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
and can evaluate##2##3##(2008-9#1)(2013-1#1)
and can even##2##3##(2008-5#1)(2008-8#1)
and can have##2##3##(2008-11#1)(2012-2#1)
and can help to##2##4##(2008-10#1)(2013-1#1)
and can help##3##3##(2008-10#2)(2013-1#1)
and can lead to##7##4##(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
and can provide##4##3##(1993-2#1)(2008-10#2)(2008-11#1)
and can result in##3##4##(2008-4#1)(2011-2#1)(2012-2#1)
and can stimulate##3##3##(1991-5#1)(2008-11#2)
and can therefore##2##3##(1995-11#1)(2008-10#1)
and can thus##2##3##(1995-8#1)(2008-11#1)
and can##236##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#3)(1993-2#3)(1993-3#2)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#89)(2008-11#21)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#6)
and canalicular##2##2##(2008-11#2)
and cancellous bone##2##3##(2011-2#1)(2013-1#1)
and cancer control##2##3##(1997-1#1)(2009-4#1)
and cancer mortality##4##3##(1990-8#1)(2010-1#2)(2010-11#1)
and cancer of the##3##4##(1991-11#1)(2008-11#2)
and cancer patients##2##3##(1994-3#1)(1994-6#1)
and cancer risk##3##3##(1990-8#2)(2008-11#1)
and cancer##50##2##(1990-8#3)(1991-11#1)(1991-8#1)(1992-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1996-11#1)(1997-1#2)(2008-1#1)(2008-10#7)(2008-11#6)(2008-2#1)(2008-7#1)(2009-12#1)(2009-4#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
and cancer-related##3##2##(2008-4#1)(2010-11#1)(2013-1#1)
and cancerous##3##2##(1990-6#1)(2008-11#1)(2008-5#1)
and canine adenovirus type-1##2##4##(2012-3#2)
and canine##4##2##(2008-10#1)(2011-2#1)(2012-3#2)
and canker##3##2##(2008-10#3)
and cannot be##4##3##(1996-6#1)(2008-4#1)(2009-8#1)(2013-1#1)
and cannot##5##2##(1996-6#1)(2008-10#1)(2008-4#1)(2009-8#1)(2013-1#1)
and canonical correlation analysis##2##4##(2008-10#2)
and canonical##3##2##(2008-10#3)
and canopy##4##2##(2008-10#3)(2008-9#1)
and canthaxanthin##2##2##(2013-8#2)
and capable of detecting##2##4##(2008-10#2)
and capable of##7##3##(1997-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-3#2)
and capacitance##4##2##(2008-10#2)(2008-11#2)
and capacitors##2##2##(2008-10#2)
and capacity##9##2##(1995-1#4)(2008-10#3)(2009-3#1)(2010-4#1)
and capillary electrophoresis##5##3##(2008-10#4)(2008-4#1)
and capillary##13##2##(2008-10#11)(2008-4#1)(2010-12#1)
and capsaicin##2##2##(2008-8#1)(2011-2#1)
and capsule##3##2##(2008-10#2)(2010-12#1)
and captive##3##2##(2008-8#2)(2008-9#1)
and captopril##4##2##(1994-5#3)(1996-2#1)
and carbachol##2##2##(2008-10#1)(2008-11#1)
and carbamate##5##2##(2008-10#5)
and carbamazepine##2##2##(2008-8#1)(2008-9#1)
and carboCys##2##2##(2008-10#2)
and carbohydrate##4##2##(1992-11#1)(2008-4#1)(2008-7#1)(2010-1#1)
and carbohydrates##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
and carbon dioxide production##4##4##(2008-11#4)
and carbon dioxide##7##3##(2008-11#7)
and carbon electrodes##2##3##(2008-10#2)
and carbon monoxide##3##3##(1990-5#1)(2008-10#1)(2008-11#1)
and carbon paste electrodes##2##4##(2008-10#2)
and carbon paste##3##3##(2008-10#3)
and carbon tetrachloride##2##3##(2008-10#1)(2009-8#1)
and carbon##29##2##(1990-5#1)(2008-10#13)(2008-11#9)(2008-7#2)(2009-8#1)(2010-7#1)(2012-12#1)(2012-5#1)
and carbonate##8##2##(2008-10#8)
and carbonyl group##2##3##(2008-10#1)(2011-3#1)
and carbonyl##4##2##(2008-10#2)(2009-7#1)(2011-3#1)
and carboplatin##6##2##(2008-10#5)(2008-7#1)
and carboxyl terminal##2##3##(1996-12#1)(2008-10#1)
and carboxyl##4##2##(1990-7#1)(1993-8#1)(1996-12#1)(2008-10#1)
and carboxyl-terminal##2##2##(1991-12#1)(1995-6#1)
and carboxylate##2##2##(1991-5#1)(2008-10#1)
and carboxypeptidase##5##2##(1993-8#5)
and carcass##2##2##(2013-1#2)
and carcinogenesis##10##2##(1993-11#1)(1993-12#1)(1995-11#1)(1995-9#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-6#2)
and carcinogenic##3##2##(2008-10#3)
and carcinogenicity studies##3##3##(2008-9#3)
and carcinogenicity##5##2##(2008-9#5)
and carcinoid##2##2##(1992-11#1)(2012-3#1)
and carcinoma of the##3##4##(1991-3#1)(1993-8#1)(2008-1#1)
and carcinoma##6##2##(1991-3#1)(1993-8#2)(1997-3#1)(2008-1#1)(2008-11#1)
and cardiac function##2##3##(1991-2#1)(2008-7#1)
and cardiac troponin I##2##4##(2008-10#2)
and cardiac##26##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1994-3#1)(1994-6#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-12#3)(2008-6#1)(2008-7#1)(2009-5#1)(2010-7#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)
and cardiovascular disease (CVD)##3##4##(2008-6#1)(2011-1#1)(2013-1#1)
and cardiovascular disease is##2##4##(2008-6#1)(2010-6#1)
and cardiovascular disease##14##3##(1992-9#1)(2008-11#1)(2008-3#1)(2008-6#5)(2009-6#1)(2010-6#2)(2011-1#1)(2013-1#1)(2013-8#1)
and cardiovascular diseases##2##3##(2008-10#1)(2010-10#1)
and cardiovascular effects##2##3##(1991-1#1)(2009-7#1)
and cardiovascular events##2##3##(2012-2#2)
and cardiovascular risk##6##3##(2008-1#2)(2008-7#1)(2010-12#1)(2011-2#2)
and cardiovascular##35##2##(1990-2#1)(1991-1#1)(1992-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#5)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#2)
and care for##2##3##(2008-10#1)(2010-5#1)
and care of##2##3##(2008-11#1)(2013-1#1)
and care##15##2##(1993-3#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-11#1)(2010-5#1)(2010-6#1)(2013-1#3)(2013-8#1)
and careful follow-up##3##3##(1993-3#1)(2008-11#1)(2008-9#1)
and careful##7##2##(1993-3#1)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#3)
and caregiving##2##2##(1994-3#1)(1995-1#1)
and carer##3##2##(2008-11#1)(2008-12#1)(2009-6#1)
and carers##6##2##(1997-8#1)(2008-12#1)(2009-6#4)
and caries-related##2##2##(2012-2#2)
and caring##2##2##(2008-11#1)(2008-5#1)
and carotenoid levels##2##3##(2008-10#2)
and carotenoid##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)
and carpal##2##2##(1997-3#1)(2008-9#1)
and carpel##2##2##(2008-8#2)
and carried out##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
and carried to the##2##4##(2008-10#2)
and carried##6##2##(1997-6#1)(2008-10#4)(2008-11#1)
and carrier##2##2##(2008-10#2)
and carriers##2##2##(2008-10#1)(2010-7#1)
and carry##3##2##(2008-10#1)(2009-9#1)(2013-1#1)
and carrying##2##2##(2008-10#1)(2008-11#1)
and cartilage##6##2##(1990-11#2)(1991-5#2)(2010-10#1)(2011-2#1)
and carvacrol##4##2##(2008-10#3)(2008-12#1)
and caryopsis##2##2##(2008-10#2)
and case management##3##3##(1991-12#1)(1995-3#1)(2010-6#1)
and case mix##2##3##(1992-12#1)(1994-1#1)
and case series##2##3##(2012-12#1)(2012-3#1)
and case studies##3##3##(1990-5#1)(1994-12#1)(2008-8#1)
and case##15##2##(1990-5#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1995-3#1)(1997-4#1)(2008-11#3)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
and case-mix##2##2##(1993-2#2)
and cases##2##2##(1993-12#1)(2008-7#1)
and cast iron samples##2##4##(2008-10#2)
and cast##7##2##(2008-10#3)(2008-11#2)(2009-7#1)(2013-1#1)
and casting methods##2##3##(2008-11#2)
and casting##3##2##(2008-11#2)(2008-7#1)
and cat##3##2##(1990-5#1)(1990-6#1)(2013-1#1)
and catalase##13##2##(1990-3#1)(1992-9#1)(1993-8#1)(1995-6#5)(1995-8#2)(2008-10#2)(2013-1#1)
and catalysis##4##2##(1991-5#1)(1993-8#1)(2008-10#1)(2008-8#1)
and catalysts##2##2##(2008-10#2)
and catalytic activity of the##2##5##(2008-10#1)(2009-3#1)
and catalytic activity of##4##4##(2008-10#2)(2009-3#2)
and catalytic properties##2##3##(2009-10#1)(2010-7#1)
and catalytic##17##2##(1992-4#2)(1992-7#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-11#1)(2009-10#1)(2009-3#2)(2010-7#1)
and catechin##2##2##(2008-11#1)(2009-8#1)
and catechol was##2##3##(2008-10#2)
and catechol##10##2##(2008-10#8)(2011-1#2)
and catecholamine##2##2##(1995-11#1)(2008-7#1)
and catecholamines##4##2##(2008-10#3)(2008-7#1)
and categorical variables##2##3##(2008-10#1)(2013-1#1)
and categorized as##3##3##(2008-10#2)(2009-3#1)
and categorized##5##2##(2008-10#2)(2009-3#1)(2012-3#1)(2013-1#1)
and category##2##2##(2011-2#1)(2012-2#1)
and cathepsin G##4##3##(1994-5#1)(2008-6#1)(2008-7#2)
and cathodic##5##2##(2008-10#5)
and cation exchange##5##3##(2008-10#5)
and cation##15##2##(1991-9#1)(1996-5#1)(2008-10#12)(2012-2#1)
and cation-selective##3##2##(2008-10#3)
and cationic surfactants##2##3##(2008-10#1)(2008-5#1)
and cationic##12##2##(1997-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-9#1)
and cations on the##2##4##(2008-10#2)
and cations##12##2##(2008-10#12)
and cats##2##2##(2008-8#1)(2012-3#1)
and cattle##5##2##(2010-1#1)(2010-4#2)(2011-2#2)
and cauda##2##2##(2008-12#2)
and cauliflower isolates##2##3##(2008-10#2)
and cauliflower##4##2##(2008-10#4)
and cause the##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
and cause##19##2##(1992-3#1)(1993-6#1)(1995-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#1)
and cause-specific survival##2##3##(2012-3#2)
and caused a##2##3##(1994-8#1)(2012-7#1)
and caused##16##2##(1990-3#1)(1991-2#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#7)(2008-12#1)(2008-9#1)(2011-2#1)(2012-7#1)
and causes of death##2##4##(2008-7#1)(2011-2#1)
and causes of##6##3##(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-12#1)
and causes##19##2##(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-7#2)(2008-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)
and causing##3##2##(2008-10#2)(2008-12#1)
and caution##2##2##(2008-10#1)(2008-11#1)
and cautions##2##2##(2008-10#1)(2008-9#1)
and caveats##2##2##(2012-3#1)(2013-1#1)
and cavitated caries##2##3##(2012-2#2)
and cefazolin sodium##2##3##(2008-10#2)
and cefazolin##3##2##(2008-10#2)(2008-12#1)
and ceftazidime##2##2##(2008-10#1)(2008-7#1)
and ceftriaxone##6##2##(1991-3#1)(2007-12#1)(2008-7#4)
and celecoxib##3##2##(2008-12#2)(2011-2#1)
and cell and##2##3##(2008-11#1)(2011-3#1)
and cell apoptosis##2##3##(2011-2#1)(2013-1#1)
and cell biological##3##3##(1995-3#1)(2011-2#1)(2012-2#1)
and cell biology##3##3##(1995-5#1)(2008-10#1)(2008-9#1)
and cell concentration##2##3##(2008-11#1)(2008-9#1)
and cell culture##4##3##(2008-4#1)(2008-9#1)(2012-2#1)(2013-1#1)
and cell cycle analysis##4##4##(2008-11#2)(2008-9#2)
and cell cycle##15##3##(1993-8#1)(1994-9#1)(2008-1#1)(2008-11#2)(2008-9#6)(2009-8#3)(2012-2#1)
and cell death##10##3##(2008-11#4)(2008-12#1)(2008-7#1)(2009-8#2)(2011-2#1)(2012-12#1)
and cell differentiation##2##3##(1995-8#1)(2011-2#1)
and cell division##4##3##(1991-2#1)(2009-5#1)(2010-5#1)(2012-3#1)
and cell growth in##2##4##(1996-2#1)(2008-11#1)
and cell growth##4##3##(1991-5#1)(1996-2#1)(2008-11#1)(2009-9#1)
and cell killing##2##3##(1995-8#2)
and cell line##2##3##(2008-11#1)(2011-2#1)
and cell lines derived from##2##5##(1993-8#1)(2008-11#1)
and cell lines##7##3##(1992-8#1)(1993-8#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-2#1)
and cell membranes##2##3##(1991-3#1)(2008-4#1)
and cell migration##2##3##(1992-6#1)(2011-2#1)
and cell number##2##3##(1992-8#1)(2008-11#1)
and cell polarity##2##3##(2012-2#2)
and cell proliferation in##3##4##(1995-11#2)(2012-2#1)
and cell proliferation##6##3##(1993-9#1)(1995-11#2)(2011-2#1)(2012-2#2)
and cell specific##2##3##(2008-11#2)
and cell therapy##2##3##(1994-6#1)(2008-11#1)
and cell viability of##3##4##(2008-11#2)(2010-10#1)
and cell viability was##2##4##(2008-11#1)(2009-9#1)
and cell viability##8##3##(2008-11#5)(2008-7#1)(2009-9#1)(2010-10#1)
and cell wall##5##3##(2008-10#3)(2008-8#1)(2009-10#1)
and cell##132##2##(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-8#2)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#11)(2008-11#33)(2008-12#1)(2008-4#3)(2008-7#3)(2008-8#3)(2008-9#13)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#5)(2009-9#2)(2010-10#1)(2010-5#1)(2011-2#9)(2011-3#3)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#3)
and cell-based##2##2##(2008-9#1)(2009-8#1)
and cell-cell##2##2##(1994-5#1)(2008-11#1)
and cell-free##2##2##(2008-11#1)(2008-5#1)
and cell-mediated##2##2##(2008-8#1)(2011-2#1)
and cells##15##2##(1992-9#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
and cellular DNA##2##3##(2008-11#1)(2008-9#1)
and cellular levels##2##3##(2008-4#2)
and cellular mechanisms##2##3##(2008-2#1)(2009-8#1)
and cellular responses##2##3##(1992-3#1)(2008-5#1)
and cellular##42##2##(1991-12#2)(1992-3#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1997-3#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
and cellulose were##2##3##(2008-10#2)
and cellulose##5##2##(2008-10#5)
and censored data##2##3##(1997-3#1)(2008-10#1)
and center##3##2##(2013-8#3)
and centractin##2##2##(1995-2#2)
and central composite designs##2##4##(2008-10#2)
and central disorders##2##3##(2013-1#2)
and central nervous system (CNS)##2##5##(2008-11#1)(2012-12#1)
and central nervous system##3##4##(2008-11#1)(2011-1#1)(2012-12#1)
and central nervous##4##3##(2008-11#1)(2010-1#1)(2011-1#1)(2012-12#1)
and central##25##2##(1992-1#1)(1992-12#1)(1997-4#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-7#2)(2009-5#1)(2010-1#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-7#1)
and centrifugation##2##2##(2008-10#2)
and centrifuged##2##2##(2008-10#1)(2008-9#1)
and centrin-3##2##2##(2008-9#2)
and ceramide##2##2##(2008-5#2)
and cereal##3##2##(2008-10#1)(2009-8#1)(2010-1#1)
and cerebellar ataxia##2##3##(2008-7#1)(2013-1#1)
and cerebellar##11##2##(1995-11#1)(1996-12#2)(1997-2#2)(2008-7#2)(2009-8#1)(2011-2#2)(2013-1#1)
and cerebellum##5##2##(1990-5#1)(1991-4#1)(1996-12#3)
and cerebral##11##2##(1990-3#2)(1990-9#1)(1993-6#1)(1995-11#1)(1996-11#1)(2008-7#1)(2011-2#3)(2012-3#1)
and cerebrospinal fluid##2##3##(1991-7#1)(1997-8#1)
and cerebrovascular complications##2##3##(2008-11#1)(2008-7#1)
and cerebrovascular##8##2##(1991-6#1)(1992-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
and certain##18##2##(1991-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)(2013-8#2)
and certification of##2##3##(2008-10#2)
and certification##4##2##(1991-1#1)(1994-12#1)(2008-10#2)
and certified samples##2##3##(2008-10#2)
and certified values in##3##4##(2008-10#3)
and certified values##5##3##(2008-10#5)
and certified##12##2##(2008-10#12)
and cervical cancer##6##3##(1990-8#2)(1997-1#1)(1997-2#1)(2011-3#1)(2012-12#1)
and cervical##14##2##(1990-8#2)(1991-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-10#1)(2010-9#1)(2011-3#1)(2012-12#1)
and cessation of##2##3##(1993-2#1)(2008-7#1)
and cessation##4##2##(1993-2#1)(1997-1#1)(2008-7#1)(2013-1#1)
and cetyl rhamnoside##2##3##(2008-5#2)
and cetyl##5##2##(2008-10#3)(2008-5#2)
and cetylpyridinium chloride##2##3##(2008-10#2)
and cetylpyridinium##4##2##(2008-10#4)
and cetyltrimethylammonium##3##2##(2008-10#3)
and chain##4##2##(1994-11#1)(2008-10#1)(2008-12#1)(2008-5#1)
and challenge##2##2##(1993-3#1)(1995-12#1)
and challenges faced##2##3##(2008-12#1)(2013-1#1)
and challenges facing##2##3##(1996-3#1)(2009-6#1)
and challenges for##3##3##(1995-5#1)(2010-8#1)(2013-1#1)
and challenges in##2##3##(2010-5#1)(2011-2#1)
and challenges of##5##3##(1997-2#1)(2008-12#2)(2008-5#1)(2010-7#1)
and challenges that##2##3##(2008-12#1)(2011-2#1)
and challenges##25##2##(1991-11#1)(1991-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-12#5)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
and challenging##4##2##(2008-11#1)(2008-12#1)(2011-7#1)(2013-8#1)
and chamigrenal##2##2##(2008-11#2)
and change in##10##3##(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)
and change##23##2##(1993-12#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-11#3)(2008-12#4)(2008-4#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#2)
and changed##2##2##(1993-12#1)(2008-10#1)
and changes in the surveillance definition of AIDS##2##8##(1992-9#2)
and changes in the##8##4##(1991-2#1)(1991-6#1)(1992-12#1)(1992-9#2)(2008-10#2)(2012-3#1)
and changes in##28##3##(1991-2#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#2)(1994-9#1)(1995-3#1)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-3#1)(2013-1#3)
and changes to##2##3##(2008-8#1)(2009-7#1)
and changes##37##2##(1991-2#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#2)(1994-9#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#2)(2011-2#4)(2012-3#1)(2013-1#3)
and changing the##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
and changing##9##2##(1991-3#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
and chaotic dynamics##2##3##(2008-11#1)(2008-8#1)
and chaotic##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
and chapters##2##2##(2008-11#1)(2008-4#1)
and character of##4##3##(1992-12#1)(2008-9#1)(2009-6#1)(2012-3#1)
and character##6##2##(1992-12#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2012-3#1)
and characterisation of the##2##4##(1993-12#1)(1993-2#1)
and characterisation of##6##3##(1990-11#1)(1993-12#1)(1993-2#1)(2008-10#3)
and characterisation##7##2##(1990-11#1)(1993-12#1)(1993-2#1)(2008-1#1)(2008-10#3)
and characterised by##2##3##(1997-1#1)(2008-10#1)
and characterised##8##2##(1993-2#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-7#1)
and characteristic##8##2##(1996-12#1)(1997-8#2)(2008-10#2)(2008-12#1)(2013-1#2)
and characteristics of a##3##4##(1993-3#1)(2008-10#2)
and characteristics of the##3##4##(1993-6#1)(2008-10#1)(2008-7#1)
and characteristics of##10##3##(1993-3#1)(1993-6#1)(1996-3#1)(2008-10#3)(2008-7#1)(2011-3#1)(2012-2#1)(2013-1#1)
and characteristics##12##2##(1993-3#1)(1993-6#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-7#1)(2011-3#1)(2012-2#1)(2013-1#1)
and characterization are##2##3##(2008-10#1)(2008-4#1)
and characterization of a cDNA##3##5##(1993-12#1)(1994-11#1)(2008-8#1)
and characterization of a human##4##5##(1991-2#1)(1991-5#1)(1992-3#1)(2008-8#1)
and characterization of a new##4##5##(2008-10#2)(2008-8#1)(2011-2#1)
and characterization of a novel##7##5##(1993-2#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
and characterization of a##37##4##(1990-2#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
and characterization of an##3##4##(1996-12#1)(1997-2#1)(2008-10#1)
and characterization of cDNAs##2##4##(1991-6#1)(1993-6#1)
and characterization of human##5##4##(1991-6#1)(1997-2#1)(2008-9#1)(2009-9#1)(2012-2#1)
and characterization of new##2##4##(1993-12#1)(2010-4#1)
and characterization of nonhuman primate##2##5##(2008-9#2)
and characterization of the##18##4##(1990-11#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-4#2)(2008-8#1)(2010-12#1)(2013-8#1)
and characterization of their##2##4##(2008-10#1)(2008-8#1)
and characterization of these##2##4##(2011-2#1)(2013-8#1)
and characterization of two##3##4##(1992-2#2)(1993-12#1)
and characterization of##144##3##(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-5#2)(1994-8#2)(1995-11#2)(1995-6#2)(1996-12#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#2)(2008-10#32)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#12)(2008-5#2)(2008-6#1)(2008-8#8)(2008-9#6)(2009-9#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#3)
and characterization##154##2##(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-5#2)(1994-8#2)(1995-11#2)(1995-6#2)(1996-12#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#2)(2008-10#35)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#13)(2008-5#2)(2008-6#1)(2008-8#9)(2008-9#6)(2009-9#2)(2010-11#2)(2010-12#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#1)(2013-8#3)
and characterize the##4##3##(2008-10#3)(2008-12#1)
and characterize##11##2##(1990-2#1)(1996-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)
and characterized a##6##3##(1991-2#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)
and characterized as the##2##4##(1991-5#1)(1995-2#1)
and characterized as##5##3##(1991-5#1)(1995-2#1)(2008-10#1)(2008-11#2)
and characterized by elemental analysis##3##5##(2008-10#3)
and characterized by##17##3##(1993-2#1)(1997-2#1)(2008-10#10)(2008-12#1)(2008-7#2)(2009-7#1)(2011-2#1)
and characterized for##4##3##(2008-10#3)(2013-8#1)
and characterized from##5##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#2)
and characterized in##3##3##(2008-10#1)(2009-9#1)(2013-1#1)
and characterized using##5##3##(1991-9#1)(2008-10#4)
and characterized with##2##3##(2008-10#2)
and characterized##88##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#3)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#3)(1996-12#2)(1997-2#1)(2008-10#35)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and characterizing##3##2##(1992-3#1)(1995-6#1)(2008-10#1)
and charge##7##2##(1992-8#1)(1993-6#1)(1997-2#1)(2008-10#3)(2012-2#1)
and charges##2##2##(1992-12#1)(1993-12#1)
and charity##2##2##(2008-11#2)
and cheap to##2##3##(2008-10#1)(2011-2#1)
and cheap##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
and cheaper than##2##3##(2008-10#2)
and cheaper##5##2##(1995-11#1)(2008-10#3)(2008-12#1)
and checks##2##2##(2008-10#1)(2008-11#1)
and cheese##2##2##(1990-8#1)(2008-10#1)
and chemical analysis##4##3##(2008-10#2)(2013-8#2)
and chemical characteristics of##3##4##(2008-10#1)(2010-4#2)
and chemical characteristics##5##3##(2008-10#2)(2009-8#1)(2010-4#2)
and chemical composition##2##3##(2008-10#1)(2009-7#1)
and chemical conditions##2##3##(2008-10#2)
and chemical environment##3##3##(2008-10#2)(2008-8#1)
and chemical orthogonality##2##3##(2009-3#2)
and chemical parameters##2##3##(2008-10#2)
and chemical properties##8##3##(1996-12#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#2)(2011-3#1)(2013-8#1)
and chemical seed##2##3##(2008-10#2)
and chemical variables affecting the##2##5##(2008-10#2)
and chemical variables##6##3##(2008-10#6)
and chemical##96##2##(1990-8#1)(1992-2#1)(1996-12#2)(1997-6#1)(2007-12#2)(2008-10#51)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#4)(2009-10#1)(2009-2#2)(2009-3#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-4#2)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#6)
and chemically modified beta-cyclodextrins##2##4##(2008-10#2)
and chemically##7##2##(1991-3#1)(2008-10#4)(2008-11#2)
and chemicals##5##2##(1991-12#1)(2008-10#2)(2008-7#1)(2010-12#1)
and chemiluminescence detection##5##3##(2008-10#5)
and chemiluminescence##11##2##(2008-10#11)
and chemiluminescent nitrogen detection##2##4##(1997-2#2)
and chemiluminescent##3##2##(1997-2#2)(2008-10#1)
and chemistry##3##2##(1992-11#1)(2008-10#1)(2010-11#1)
and chemokine##3##2##(2008-10#1)(2009-3#1)(2011-2#1)
and chemometric##7##2##(2008-10#7)
and chemometrics##2##2##(2008-10#2)
and chemoresistance and##2##3##(2009-4#1)(2013-1#1)
and chemotactic##2##2##(2008-10#2)
and chemotaxis##2##2##(1995-6#1)(2008-9#1)
and chemotherapy for##3##3##(1990-10#1)(2012-12#1)(2013-1#1)
and chemotherapy##20##2##(1990-10#1)(1990-8#3)(1993-2#1)(1993-9#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#1)
and cherry##2##2##(2008-10#2)
and chest X-ray##2##3##(1997-3#1)(2010-11#1)
and chest##6##2##(1991-2#1)(1997-3#1)(2008-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
and chewing##2##2##(2013-1#2)
and chi##2##2##(1991-3#2)
and chicken##8##2##(1991-3#1)(1993-6#1)(1994-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
and chief##5##2##(1994-8#3)(2013-1#2)
and child care##2##3##(1990-2#1)(2008-11#1)
and child development after##2##4##(1996-9#2)
and child health##5##3##(1991-3#1)(1995-12#2)(1996-12#1)(1997-2#1)
and child##25##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1994-6#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-6#1)(2008-11#4)(2008-12#2)(2009-11#1)(2010-6#1)(2011-2#1)
and childbirth##3##2##(1993-3#1)(1995-1#1)(1995-6#1)
and childhood##5##2##(1992-6#1)(2008-11#1)(2010-1#1)(2012-2#1)(2013-8#1)
and children in##4##3##(1990-2#1)(1995-1#1)(2008-6#1)(2009-9#1)
and children who##5##3##(1992-1#1)(1992-2#1)(2008-11#2)(2008-2#1)
and children with AIDS##2##4##(1995-6#2)
and children with##6##3##(1995-6#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)
and children##40##2##(1990-2#3)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-2#2)(1995-1#2)(1995-12#1)(1995-6#2)(1996-2#2)(1997-2#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and children's health##2##3##(2008-11#1)(2012-12#1)
and children's social competence and behavior problems##2##7##(2010-11#2)
and children's##22##2##(1990-6#2)(1991-12#1)(1993-12#1)(1994-6#5)(2008-11#1)(2008-12#2)(2008-6#1)(2009-10#1)(2010-1#2)(2010-11#2)(2011-2#2)(2012-12#1)(2012-2#1)
and chimeras##4##2##(1997-8#1)(2008-8#3)
and chimeric##2##2##(1990-8#1)(2008-11#1)
and chin##6##2##(2008-5#5)(2012-3#1)
and chiral##2##2##(2008-10#2)
and chitin##4##2##(2008-10#4)
and chitinase##2##2##(2008-10#2)
and chitinolytic##2##2##(2008-10#1)(2008-5#1)
and chitosan##7##2##(2008-10#4)(2008-5#3)
and chives##3##2##(2008-10#3)
and chlamydospores##4##2##(2008-10#4)
and chloramphenicol##2##2##(1995-6#1)(1997-7#1)
and chlorate in##4##3##(2008-10#4)
and chlorate##11##2##(2008-10#11)
and chlorfenvinphos##3##2##(2008-10#3)
and chloride ions##2##3##(2008-10#2)
and chloride##9##2##(2008-10#6)(2010-12#1)(2010-7#1)(2012-2#1)
and chlorinated hydrocarbons##3##3##(2008-10#3)
and chlorinated##4##2##(2008-10#4)
and chloroform##3##2##(2008-10#3)
and chlorogenic acid##3##3##(2008-10#3)
and chlorogenic##5##2##(2008-10#5)
and chlorophyll##3##2##(2008-12#2)(2008-9#1)
and chloropicrin##2##2##(2008-10#2)
and chloroplast##6##2##(1991-6#1)(1992-8#1)(1994-11#1)(2008-12#1)(2009-8#2)
and chloroquine##2##2##(1992-12#1)(1994-6#1)
and chlorosis in##2##3##(2008-10#2)
and chlorosis##4##2##(2008-10#4)
and chlorothalonil##2##2##(2008-10#2)
and chlorpyrifos##2##2##(2008-10#2)
and chlortetracycline##4##2##(2008-10#4)
and chocolate##3##2##(2008-10#3)
and choice##3##2##(1992-1#1)(2008-10#1)(2008-7#1)
and choice-offering were##2##3##(2008-4#2)
and cholesterol in##2##3##(2009-7#2)
and cholesterol levels##2##3##(1994-11#1)(2013-1#1)
and cholesterol##18##2##(1990-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-5#1)(2009-7#4)(2012-2#5)(2013-1#1)
and choline on-line##2##3##(2008-10#2)
and choline##5##2##(1991-5#1)(2008-10#3)(2008-7#1)
and cholinergic##6##2##(1992-8#1)(1996-2#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-12#1)
and chondrogenic##5##2##(2008-11#5)
and choosing friends##2##3##(2009-7#2)
and choroidal##3##2##(2010-1#1)(2011-7#1)(2013-1#1)
and chromatin structure##3##3##(1994-5#1)(2007-12#1)(2011-2#1)
and chromatin##8##2##(1992-12#1)(1994-5#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-2#3)
and chromatographed##2##2##(1997-2#1)(2008-10#1)
and chromatographic conditions were optimized##2##5##(2008-10#2)
and chromatographic conditions##3##3##(2008-10#3)
and chromatographic##8##2##(2008-10#8)
and chromatography##5##2##(1991-12#1)(2008-10#3)(2008-11#1)
and chromium in##8##3##(2008-10#8)
and chromium was##2##3##(2008-10#2)
and chromium##16##2##(2008-10#16)
and chromium(III)##3##2##(2008-10#3)
and chromium(VI) using##2##3##(2008-10#2)
and chromium(VI)##7##2##(2008-10#7)
and chromosomal mapping of##2##4##(1997-8#1)(2008-8#1)
and chromosomal##11##2##(1996-6#1)(1997-8#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-3#2)
and chromosome##11##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-8#2)(2011-2#1)(2013-8#1)
and chronic diseases in##2##4##(1997-8#1)(2008-7#1)
and chronic hepatitis C##2##4##(2011-2#1)(2013-8#1)
and chronic hepatitis##3##3##(2009-12#1)(2011-2#1)(2013-8#1)
and chronic inflammation##3##3##(2012-12#1)(2012-5#2)
and chronic inflammatory##2##3##(2008-10#1)(2012-3#1)
and chronic obstructive pulmonary disease (COPD)##3##6##(1992-3#1)(1995-12#1)(1996-1#1)
and chronic obstructive pulmonary disease##5##5##(1992-3#1)(1995-12#2)(1996-1#1)(2012-2#1)
and chronic periodontitis##2##3##(2013-1#2)
and chronic quis and ibo NB##2##6##(1991-9#2)
and chronic renal##3##3##(1997-2#1)(2008-1#1)(2011-2#1)
and chronic##73##2##(1991-9#5)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#3)(1996-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-6#1)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#4)(2013-1#7)(2013-8#1)
and chronoamperometry##4##2##(2008-10#4)
and chrysoeriol##2##2##(2010-6#2)
and chymotrypsin##3##2##(1990-2#1)(1990-5#1)(2008-10#1)
and cigarette##2##2##(1991-12#1)(2008-10#1)
and cinnamoyl##2##2##(2008-10#1)(2013-1#1)
and ciprofloxacin##6##2##(2008-10#4)(2008-7#2)
and circadian##4##2##(1995-2#1)(2008-11#1)(2009-7#2)
and circuit##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
and circular dichroism##3##3##(1992-1#1)(1992-6#1)(2008-10#1)
and circular##6##2##(1992-1#1)(1992-6#1)(2008-10#1)(2008-12#1)(2008-8#2)
and circulating##2##2##(1990-2#1)(2010-6#1)
and circumferential spinal fusion with instrumentation##2##6##(2008-8#2)
and circumferential##4##2##(2008-8#2)(2009-7#1)(2010-10#1)
and circumstantial##2##2##(2008-10#1)(2008-12#1)
and cis-resveratrol##3##2##(2008-10#3)
and cisplatin in##2##3##(1991-6#1)(1993-8#1)
and cisplatin##14##2##(1990-12#1)(1991-6#2)(1991-8#1)(1993-8#2)(1995-10#2)(2008-10#6)
and citalopram##4##2##(2012-2#1)(2012-3#3)
and citrate##2##2##(2008-10#1)(2011-2#1)
and citric acid##8##3##(2008-10#4)(2013-1#4)
and citric acids##3##3##(2008-10#2)(2008-5#1)
and citric##12##2##(2008-10#7)(2008-5#1)(2013-1#4)
and citrus##5##2##(2008-10#5)
and city##2##2##(1997-6#1)(2008-11#1)
and clarified##2##2##(2008-11#1)(2011-2#1)
and class 3 secretory##2##4##(2007-12#2)
and class 3##3##3##(2007-12#2)(2008-10#1)
and class 4##2##3##(2008-10#2)
and class II##5##3##(1995-5#1)(1997-8#2)(2008-4#1)(2008-9#1)
and class##16##2##(1992-3#1)(1992-7#1)(1995-5#1)(1997-8#2)(2007-12#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-5#1)
and classical dynamics##4##3##(2013-1#4)
and classical##7##2##(1993-8#1)(2008-10#2)(2013-1#4)
and classification of these##2##4##(2008-10#1)(2010-12#1)
and classification of wines##2##4##(2008-10#2)
and classification of##21##3##(1997-8#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
and classification##32##2##(1997-8#1)(2007-12#1)(2008-10#13)(2008-12#1)(2008-4#1)(2008-9#2)(2009-10#3)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
and classifications##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
and classified as##2##3##(2008-10#2)
and classified into##4##3##(1996-6#1)(1997-3#1)(2008-10#1)(2011-2#1)
and classified##10##2##(1996-6#1)(1997-3#1)(2008-10#5)(2008-11#1)(2009-9#1)(2011-2#1)
and classify##4##2##(2008-10#1)(2009-10#1)(2010-8#1)(2013-1#1)
and classifying##2##2##(1997-3#1)(2008-10#1)
and classroom##2##2##(2008-12#2)
and clay##3##2##(2008-10#3)
and clean up##2##3##(2008-10#2)
and clean##8##2##(2007-12#1)(2008-10#5)(2011-2#1)(2012-3#1)
and clean-up##7##2##(1996-6#1)(2008-10#6)
and cleaning##8##2##(2008-10#5)(2008-4#1)(2010-9#1)(2013-1#1)
and cleanliness##2##2##(2008-11#1)(2011-2#1)
and cleanroom##2##2##(2012-2#2)
and clear##7##2##(1991-3#1)(1991-8#1)(1994-2#1)(2008-10#1)(2010-11#1)(2011-2#2)
and clear-cell renal##2##3##(1995-10#1)(2008-10#1)
and clearance in##2##3##(2008-8#1)(2011-2#1)
and clearance##6##2##(1994-8#1)(1997-1#2)(2008-8#1)(2011-2#2)
and clearly##3##2##(2008-10#3)
and cleft##2##2##(1993-12#1)(2011-1#1)
and client##4##2##(1996-2#1)(2009-5#1)(2009-9#1)(2012-2#1)
and clients##5##2##(1992-12#1)(1996-2#2)(2008-11#1)(2013-8#1)
and climate##4##2##(2008-10#2)(2010-3#1)(2012-5#1)
and climatic##2##2##(2008-8#1)(2010-3#1)
and clinical application of##2##4##(2011-2#1)(2013-8#1)
and clinical application##4##3##(1990-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
and clinical applications##5##3##(1997-8#1)(2008-10#1)(2012-2#2)(2013-8#1)
and clinical aspects of##2##4##(1990-9#1)(2009-8#1)
and clinical aspects##6##3##(1990-5#1)(1990-9#1)(1991-3#1)(1997-1#1)(2009-8#1)(2013-1#1)
and clinical assessment of##2##4##(1995-5#1)(2011-2#1)
and clinical biochemistry##4##3##(1994-12#2)(2008-5#2)
and clinical characteristics of##2##4##(2008-7#1)(2013-1#1)
and clinical characteristics##4##3##(2008-7#1)(2011-2#2)(2013-1#1)
and clinical consequences##2##3##(2008-5#1)(2008-7#1)
and clinical course##2##3##(1994-6#1)(2013-8#1)
and clinical data##7##3##(2008-10#2)(2008-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and clinical evidence##2##3##(2008-7#1)(2011-2#1)
and clinical examination##3##3##(1991-6#1)(2008-12#1)(2009-12#1)
and clinical experience##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
and clinical features are##2##4##(1993-6#1)(2012-12#1)
and clinical features of##3##4##(2008-9#1)(2012-3#2)
and clinical features##9##3##(1992-12#1)(1993-6#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#3)
and clinical findings##2##3##(1993-2#1)(2012-12#1)
and clinical implications##8##3##(2008-12#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
and clinical importance of##2##4##(2008-5#1)(2008-6#1)
and clinical importance##3##3##(2008-5#1)(2008-6#2)
and clinical information##3##3##(1993-2#1)(2008-3#1)(2012-2#1)
and clinical laboratories##2##3##(2008-10#1)(2008-11#1)
and clinical literature##2##3##(2008-10#1)(2008-12#1)
and clinical management of##3##4##(2008-4#1)(2011-2#1)(2012-12#1)
and clinical management##5##3##(2008-4#2)(2011-2#2)(2012-12#1)
and clinical manifestations of##2##4##(2008-7#1)(2013-1#1)
and clinical manifestations##3##3##(1991-11#1)(2008-7#1)(2013-1#1)
and clinical outcome in##2##4##(1995-12#1)(2011-2#1)
and clinical outcome##5##3##(1995-12#1)(2006-6#1)(2011-2#2)(2012-12#1)
and clinical outcomes##5##3##(1997-3#1)(2008-11#1)(2009-7#1)(2010-2#1)(2011-2#1)
and clinical parameters##3##3##(2008-10#2)(2011-2#1)
and clinical placement##2##3##(2008-11#1)(2013-8#1)
and clinical practice##5##3##(2008-11#2)(2008-8#1)(2010-7#1)(2010-9#1)
and clinical profile##2##3##(2009-1#1)(2010-5#1)
and clinical reports##4##3##(2011-2#2)(2011-7#1)(2013-7#1)
and clinical research##8##3##(1995-5#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)
and clinical response##2##3##(1996-8#1)(2008-4#1)
and clinical results##6##3##(1991-3#1)(1993-11#1)(1997-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
and clinical sciences##2##3##(1994-12#2)
and clinical significance##2##3##(2013-1#2)
and clinical signs of##2##4##(1996-12#1)(2009-1#1)
and clinical signs##3##3##(1991-8#1)(1996-12#1)(2009-1#1)
and clinical skills##2##3##(1992-3#1)(2008-11#1)
and clinical spectrum##2##3##(2008-4#1)(2008-7#1)
and clinical studies have revealed##2##5##(1996-9#1)(2010-10#1)
and clinical studies have##3##4##(1992-2#1)(1996-9#1)(2010-10#1)
and clinical studies##13##3##(1992-2#1)(1993-6#1)(1996-9#1)(2008-10#1)(2008-11#2)(2009-7#3)(2010-10#1)(2010-5#1)(2012-2#1)(2012-5#1)
and clinical support##2##3##(2008-11#1)(2008-12#1)
and clinical symptoms##2##3##(1991-6#1)(2008-12#1)
and clinical trial##3##3##(2008-6#1)(2009-2#1)(2010-7#1)
and clinical trials##5##3##(1993-11#1)(1994-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
and clinical validation##2##3##(2010-5#1)(2012-2#1)
and clinical##247##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#2)(1994-12#8)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#2)(2006-6#1)(2007-12#1)(2008-10#13)(2008-11#21)(2008-12#12)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#1)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#19)(2011-7#2)(2012-12#10)(2012-2#10)(2012-3#8)(2012-5#1)(2013-1#17)(2013-7#1)(2013-8#8)
and clinically evaluated##2##3##(2008-11#1)(2011-3#1)
and clinically relevant##2##3##(2009-12#1)(2011-2#1)
and clinically significant##2##3##(2008-6#1)(2012-2#1)
and clinically##16##2##(1996-3#1)(2008-11#3)(2008-12#1)(2008-6#2)(2009-12#1)(2010-1#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#3)
and clinician##2##2##(2010-8#2)
and clinicians with##2##3##(2008-11#1)(2008-8#1)
and clinicians##13##2##(1992-2#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#1)
and cloacal##4##2##(1996-12#3)(2008-10#1)
and clofibrate##2##2##(1992-8#1)(2008-11#1)
and clonal##4##2##(1993-12#1)(2008-10#2)(2008-9#1)
and cloned into the plasmid vector##2##6##(1992-3#1)(2008-10#1)
and cloned into the##3##4##(1992-3#1)(1993-12#1)(2008-10#1)
and cloned into##6##3##(1992-3#1)(1993-12#1)(1997-8#1)(2008-10#2)(2008-8#1)
and cloned##20##2##(1992-10#1)(1992-3#1)(1993-12#1)(1993-6#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-8#3)(2008-9#1)(2009-8#2)
and cloning of##4##3##(2008-11#2)(2008-8#2)
and cloning##5##2##(2008-10#1)(2008-11#2)(2008-8#2)
and close friends##2##3##(2009-7#2)
and close to##3##3##(1996-6#1)(2008-2#1)(2013-8#1)
and close##6##2##(1996-6#1)(2008-12#1)(2008-2#1)(2009-7#2)(2013-8#1)
and closed eyes##2##3##(2010-9#2)
and closed##5##2##(1996-5#1)(2008-11#1)(2008-12#1)(2010-9#2)
and closed-loop##2##2##(2012-2#1)(2013-1#1)
and closely linked##2##3##(2008-10#1)(2008-12#1)
and closely related##3##3##(2008-10#1)(2008-9#1)(2010-10#1)
and closely##7##2##(1991-2#1)(1992-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-10#1)
and closer##2##2##(1991-6#1)(1993-12#1)
and clostridia##2##2##(2011-2#2)
and closure##2##2##(2008-10#1)(2009-8#1)
and clothing##2##2##(1990-3#1)(2011-1#1)
and cloud##2##2##(2008-10#1)(2008-3#1)
and cluster analysis were applied##2##5##(2008-10#2)
and cluster analysis##8##3##(2008-10#8)
and cluster in##2##3##(1993-8#1)(2008-6#1)
and cluster##14##2##(1993-8#1)(2008-10#10)(2008-6#1)(2013-1#2)
and clustered##2##2##(2008-10#1)(2010-12#1)
and clustering of##2##3##(2008-10#1)(2009-8#1)
and clustering##7##2##(2008-10#2)(2008-11#1)(2008-5#2)(2009-11#1)(2009-8#1)
and clusters##2##2##(2008-10#1)(2008-8#1)
and co-factor##2##2##(2008-10#2)
and co-suppression##2##2##(2008-9#2)
and coagulation##3##2##(1991-3#1)(1994-12#1)(2008-3#1)
and coal fly ash samples##2##5##(2008-10#2)
and coal fly##3##3##(2008-10#3)
and coal##7##2##(2008-10#7)
and coastal##4##2##(2008-10#3)(2013-1#1)
and coat protein genes##2##4##(2008-10#2)
and coat protein##5##3##(2008-10#5)
and coat##7##2##(1994-12#1)(2008-10#6)
and coated##7##2##(1997-1#1)(2008-10#6)
and coating##2##2##(2008-4#1)(2010-7#1)
and cobalt in##3##3##(2008-10#3)
and cobalt##10##2##(1993-12#1)(2008-10#9)
and cobalt(II) tetrasulfonated phthalocyanine##2##4##(2008-10#2)
and cobalt(II)##8##2##(2008-10#8)
and cocaine##3##2##(1991-1#1)(2009-7#1)(2013-8#1)
and cochlear##4##2##(2008-9#2)(2011-2#2)
and cocoamidopropyl betaine (CAPB)##2##4##(2008-10#1)(2008-5#1)
and coding##5##2##(1990-11#1)(1992-12#1)(1993-6#1)(1997-7#1)(2013-1#1)
and coefficients of variation##2##4##(2008-10#2)
and coefficients of##5##3##(2008-10#4)(2011-2#1)
and coefficients##7##2##(1996-5#1)(2008-10#4)(2008-3#1)(2011-2#1)
and coenzyme Q(10)##2##3##(2008-10#2)
and coenzyme##4##2##(1990-5#1)(1993-8#1)(2008-10#2)
and coexistence in##2##3##(2008-8#1)(2008-9#1)
and coexistence##4##2##(2008-8#3)(2008-9#1)
and coexisting##2##2##(2008-10#1)(2013-8#1)
and coffee##3##2##(2008-10#3)
and cognition##4##2##(2008-11#1)(2010-7#1)(2012-3#1)(2013-8#1)
and cognitive function##3##3##(2008-8#1)(2012-2#1)(2013-8#1)
and cognitive impairment##2##3##(2012-3#1)(2013-8#1)
and cognitive problems##2##3##(1995-3#1)(2008-8#1)
and cognitive status##3##3##(2008-7#2)(2012-3#1)
and cognitive##30##2##(1990-12#2)(1994-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-9#1)(2012-2#1)(2012-3#4)(2013-8#2)
and cognitive-emotional##2##2##(2008-11#1)(2012-12#1)
and coherence##3##2##(2008-10#1)(2008-3#2)
and cohort##3##2##(1994-2#1)(1996-3#2)
and coil##2##2##(2010-7#1)(2013-1#1)
and coincided with##2##3##(2008-8#1)(2011-2#1)
and cold allodynia##2##3##(2011-2#2)
and cold vapor atomic absorption##2##5##(2008-10#2)
and cold vapour##2##3##(2008-10#2)
and cold##9##2##(2008-10#5)(2010-3#1)(2011-2#2)(2013-8#1)
and collaboration between the##3##4##(1996-1#1)(2008-11#2)
and collaboration between##4##3##(1996-1#1)(1996-2#1)(2008-11#2)
and collaboration with##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
and collaboration##11##2##(1996-1#2)(1996-2#1)(2008-10#1)(2008-11#5)(2008-6#1)(2010-5#1)
and collaborative##10##2##(1994-1#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-12#1)(2011-3#1)(2011-9#1)(2012-2#2)
and collagen type I##2##4##(2008-5#2)
and collagen##18##2##(1993-12#1)(1994-8#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-5#7)(2008-7#1)(2009-7#1)(2012-2#1)
and collapse##2##2##(2008-10#1)(2012-2#1)
and collaterals##2##2##(1997-3#1)(2008-12#1)
and colleagues##8##2##(2008-11#2)(2008-12#1)(2008-5#2)(2009-10#1)(2010-11#1)(2010-5#1)
and collect##3##2##(2008-11#2)(2008-7#1)
and collected on the walls of a knotted coil##2##9##(2008-10#2)
and collected##4##2##(2008-10#3)(2008-11#1)
and collection of the##4##4##(2008-10#4)
and collection of##6##3##(2008-10#6)
and collection practices##2##3##(2008-11#2)
and collection##17##2##(1996-3#1)(2008-10#8)(2008-11#4)(2008-2#1)(2011-2#3)
and collective##2##2##(2011-3#1)(2012-2#1)
and college##4##2##(2008-11#1)(2010-1#1)(2010-7#1)(2011-2#1)
and colloidal##2##2##(2008-10#1)(2010-6#1)
and colon##6##2##(1991-12#1)(1994-11#1)(1994-2#1)(1997-7#1)(2008-5#1)(2012-2#1)
and colonies##2##2##(2008-8#2)
and colonization by##4##3##(2008-10#4)
and colonization of the##3##4##(2008-10#3)
and colonization of##9##3##(2008-10#8)(2013-1#1)
and colonization##18##2##(2008-10#13)(2008-8#4)(2013-1#1)
and colonize##2##2##(2008-10#1)(2011-2#1)
and colonized##6##2##(2008-10#6)
and colonizing##2##2##(2008-8#1)(2011-2#1)
and colony##7##2##(2008-10#5)(2008-8#1)(2013-8#1)
and colorectal cancer##3##3##(2008-5#1)(2010-6#1)(2011-2#1)
and colorectal cancers##2##3##(2010-6#2)
and colorectal##9##2##(1992-5#1)(1993-3#1)(1995-6#1)(2008-5#1)(2010-6#3)(2011-2#1)(2012-12#1)
and colorimetric##4##2##(1994-3#1)(2008-10#2)(2008-5#1)
and colour##7##2##(2008-10#3)(2008-7#2)(2008-8#1)(2011-1#1)
and column temperature##4##3##(2008-10#4)
and column##14##2##(2008-10#13)(2008-8#1)
and coma##2##2##(2009-8#1)(2012-12#1)
and combination of##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
and combination##6##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
and combinations of##7##3##(1993-1#1)(2008-10#2)(2008-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
and combinations##9##2##(1993-1#1)(1995-5#1)(2008-10#3)(2008-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
and combined filter/XAD-2##2##3##(2008-10#2)
and combined with the##3##4##(2008-3#1)(2009-7#1)(2010-4#1)
and combined with##4##3##(1996-3#1)(2008-3#1)(2009-7#1)(2010-4#1)
and combined##14##2##(1993-3#1)(1995-5#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-3#2)(2010-4#1)
and combines##2##2##(2008-10#1)(2008-9#1)
and combining##4##2##(2008-10#4)
and combustion##4##2##(2008-10#2)(2008-3#2)
and comet##6##2##(2010-8#6)
and comfort##2##2##(2013-1#2)
and comfortable##2##2##(2008-9#1)(2011-2#1)
and coming##2##2##(2008-11#1)(2013-1#1)
and comment on##2##3##(1993-12#1)(2008-1#1)
and comments on##2##3##(1996-1#1)(1997-2#1)
and comments##4##2##(1991-3#1)(1996-1#1)(1997-2#1)(2008-7#1)
and commercial drinking water##2##4##(2008-10#2)
and commercial drinking##3##3##(2008-10#3)
and commercial formulations##3##3##(2008-10#3)
and commercial##18##2##(2008-10#15)(2008-12#1)(2010-9#1)(2013-1#1)
and committees for##5##3##(2008-10#5)
and commodity##3##2##(2008-10#3)
and common bean##2##3##(2008-10#2)
and common people's##2##3##(2013-8#2)
and common rust##2##3##(2008-10#2)
and common wheat##2##3##(2008-10#1)(2008-8#1)
and common##34##2##(1995-1#1)(1995-2#1)(1996-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-8#2)
and communication in##2##3##(2008-11#1)(2008-4#1)
and communication of##2##3##(2008-11#1)(2009-5#1)
and communication skills##3##3##(2008-11#1)(2010-10#1)(2012-2#1)
and communication##21##2##(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
and communities in##2##3##(2008-11#2)
and communities##7##2##(1991-2#1)(2008-11#2)(2008-12#1)(2008-9#1)(2012-2#2)
and community health##5##3##(1990-9#1)(1992-2#1)(1996-1#1)(1996-11#1)(1997-3#1)
and community leaders##2##3##(1996-1#1)(2010-9#1)
and community levels##2##3##(1997-1#1)(2008-9#1)
and community pharmacists##2##3##(2011-1#2)
and community##36##2##(1990-9#1)(1991-1#2)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-5#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#1)
and community-based##5##2##(1992-3#1)(1993-1#1)(1994-2#1)(1996-2#1)(2008-7#1)
and community-level##3##2##(2008-9#1)(2009-6#2)
and comorbidities##3##2##(2008-7#1)(2011-2#2)
and compact##4##2##(2008-10#3)(2008-12#1)
and comparable to those obtained##2##5##(2008-10#2)
and comparable with##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
and comparable##10##2##(1993-1#1)(1994-6#1)(1995-3#1)(2008-10#4)(2008-5#1)(2009-6#1)(2013-1#1)
and comparative analysis##2##3##(1991-6#1)(2008-10#1)
and comparative##13##2##(1991-6#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-11#2)(2009-6#1)(2011-2#3)(2012-3#2)
and compare it with##2##4##(1996-11#1)(2008-11#1)
and compare it##3##3##(1996-11#1)(1997-3#1)(2008-11#1)
and compare the results with##2##5##(2008-3#1)(2008-8#1)
and compare the results##3##4##(1991-3#1)(2008-3#1)(2008-8#1)
and compare the##10##3##(1991-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#3)
and compare them##2##3##(2008-11#1)(2008-3#1)
and compare these with##2##4##(2008-3#1)(2011-1#1)
and compare these##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
and compare##27##2##(1991-3#1)(1995-9#1)(1996-11#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#5)
and compared for##3##3##(2008-10#2)(2013-1#1)
and compared in terms of##2##5##(2008-10#2)
and compared in##5##3##(1994-3#1)(2008-10#3)(2008-11#1)
and compared it with##3##4##(2008-11#1)(2008-3#1)(2008-5#1)
and compared the results##2##4##(2008-10#1)(2008-11#1)
and compared the##10##3##(1990-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)
and compared their##3##3##(1990-5#1)(1995-12#1)(2008-3#1)
and compared them to##2##4##(1991-1#1)(2009-8#1)
and compared them with##2##4##(1994-11#1)(2012-3#1)
and compared them##4##3##(1991-1#1)(1994-11#1)(2009-8#1)(2012-3#1)
and compared these##2##3##(2008-3#1)(2013-8#1)
and compared to the##14##4##(1990-11#1)(1990-5#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
and compared to##24##3##(1990-11#1)(1990-5#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-12#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
and compared with a control##2##5##(2008-10#1)(2013-1#1)
and compared with a##5##4##(2008-10#3)(2008-5#1)(2013-1#1)
and compared with data from##2##5##(1993-6#1)(2008-10#1)
and compared with each other##2##5##(2008-10#1)(2008-12#1)
and compared with that of##3##5##(2008-10#2)(2009-6#1)
and compared with that##4##4##(2008-10#2)(2008-7#1)(2009-6#1)
and compared with the results of##4##6##(1996-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
and compared with the##23##4##(1991-2#1)(1993-8#1)(1996-11#1)(1996-2#1)(2008-10#8)(2008-2#1)(2008-3#5)(2008-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
and compared with those of other##2##6##(2008-10#1)(2008-3#1)
and compared with those of the##2##6##(2008-10#1)(2008-3#1)
and compared with those of##10##5##(1993-11#1)(1996-3#1)(2008-10#5)(2008-3#2)(2011-2#1)
and compared with those##15##4##(1990-9#1)(1993-11#1)(1996-3#1)(2008-10#8)(2008-3#2)(2008-5#1)(2011-2#1)
and compared with##80##3##(1990-9#1)(1991-2#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#12)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
and compared##163##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-12#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-2#1)(2007-12#1)(2008-10#63)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#15)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
and compares these##2##3##(2008-10#1)(2008-11#1)
and compares##4##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
and comparing the results with##2##5##(2008-10#1)(2010-11#1)
and comparing the##8##3##(1996-3#1)(2008-10#4)(2008-8#1)(2009-5#1)(2010-11#1)
and comparing these##2##3##(2008-10#1)(2010-1#1)
and comparing##13##2##(1996-3#1)(2008-10#7)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2013-1#1)
and comparison of the##3##4##(1996-8#1)(2008-10#2)
and comparison of##11##3##(1996-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2009-7#1)(2010-9#1)
and comparison with that of##2##5##(1995-6#1)(2008-10#1)
and comparison with the##2##4##(1993-8#1)(1995-2#1)
and comparison with##13##3##(1993-8#1)(1995-2#2)(1995-6#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-5#1)
and comparison##28##2##(1991-9#1)(1993-8#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#3)(2009-5#1)(2009-7#1)(2010-9#1)
and comparisons between##2##3##(1991-11#1)(2011-2#1)
and comparisons of##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
and comparisons with##4##3##(1992-4#1)(1994-3#1)(1996-1#1)(2008-7#1)
and comparisons##12##2##(1991-11#1)(1991-3#1)(1992-4#1)(1994-3#1)(1995-2#2)(1996-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)
and compartmentalization of##5##3##(1994-8#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
and compatibility##2##2##(2008-10#1)(2011-2#1)
and compatible##2##2##(1992-3#1)(2008-10#1)
and compensation of##2##3##(1991-12#1)(2008-2#1)
and compensation##4##2##(1991-12#1)(1994-1#1)(1996-2#1)(2008-2#1)
and compensatory homeostasis##2##3##(2012-2#2)
and compensatory##5##2##(2009-7#1)(2012-2#3)(2013-1#1)
and compete##3##2##(1991-3#1)(1997-1#1)(2006-6#1)
and competence##9##2##(2008-11#7)(2013-1#2)
and competent##2##2##(2008-12#2)
and competing##2##2##(2008-9#1)(2011-2#1)
and competition over##2##3##(2009-10#1)(2010-1#1)
and competition##14##2##(1992-3#1)(1993-2#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#1)
and competitive enzyme-linked immunosorbent##2##4##(2011-2#2)
and competitive##13##2##(1991-3#1)(1993-12#1)(1997-1#1)(2008-10#6)(2008-8#2)(2011-2#2)
and complement fixation##2##3##(2008-1#1)(2008-5#1)
and complement##7##2##(1995-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
and complementary method to##2##4##(2008-10#2)
and complementary##6##2##(2008-10#3)(2008-6#2)(2008-9#1)
and complementation##3##2##(1996-2#1)(2008-8#1)(2008-9#1)
and complete absence##2##3##(1992-5#1)(2008-11#1)
and complete extraction of##2##4##(2008-10#2)
and complete information##2##3##(1994-2#1)(2011-3#1)
and complete occlusion of the fistula was##2##7##(1996-9#1)(1997-3#1)
and complete resolution of##2##4##(2010-9#1)(2012-3#1)
and complete##24##2##(1992-5#1)(1994-2#1)(1996-9#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#3)(2008-9#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-8#2)
and completed##7##2##(1991-11#1)(1992-12#1)(1995-1#1)(1997-3#1)(2008-11#2)(2012-3#1)
and completely##15##2##(1994-5#1)(1995-2#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2013-1#2)
and completion##2##2##(1994-12#1)(1996-3#1)
and complex formation##3##3##(2008-10#3)
and complex synthetic mixtures##2##4##(2008-10#2)
and complex##33##2##(1990-4#1)(1996-1#1)(1997-7#1)(2008-10#10)(2008-11#3)(2008-3#1)(2008-5#2)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)
and complexation properties of humic acids##2##6##(2008-10#2)
and complexation##7##2##(2008-10#7)
and complexes containing##2##3##(2008-11#2)
and complexes##4##2##(1995-6#1)(2008-10#1)(2008-11#2)
and complexing agents##4##3##(2008-10#4)
and complexing##5##2##(2008-10#5)
and complexity of##3##3##(2008-11#1)(2008-12#1)(2009-10#1)
and complexity##12##2##(1992-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2008-8#1)(2009-10#2)(2011-2#1)
and complexometric##3##2##(2008-10#3)
and compliance##2##2##(2008-7#1)(2010-5#1)
and complicated##4##2##(1991-3#1)(2008-3#1)(2011-2#2)
and complication rates##3##3##(1994-8#1)(2008-11#1)(2011-2#1)
and complication##4##2##(1994-8#1)(1995-1#1)(2008-11#1)(2011-2#1)
and complications associated with##2##4##(1990-11#1)(2008-11#1)
and complications of##6##3##(1993-2#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
and complications related to##2##4##(1990-5#1)(1997-3#1)
and complications were##3##3##(1991-1#1)(1995-12#1)(2013-1#1)
and complications##30##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#2)(2013-1#5)(2013-8#1)
and components##2##2##(2008-11#1)(2011-2#1)
and composite##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-2#1)
and composites##2##2##(1990-2#1)(2009-7#1)
and composition of the##6##4##(2008-10#4)(2008-11#1)(2008-9#1)
and composition of these##2##4##(2008-11#1)(2010-7#1)
and composition of##11##3##(2008-10#5)(2008-11#2)(2008-9#1)(2010-10#1)(2010-7#1)(2013-1#1)
and composition##20##2##(1997-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
and compositions##2##2##(2008-10#1)(2011-10#1)
and compost##2##2##(2008-10#2)
and composted##2##2##(2008-10#2)
and compound##2##2##(2008-10#1)(2011-2#1)
and compounds##6##2##(1993-3#1)(2008-10#5)
and comprehension##4##2##(2008-12#1)(2010-7#1)(2011-2#2)
and comprehensive##6##2##(1992-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
and compression##6##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-7#1)(2013-1#1)
and comprise##2##2##(2009-4#1)(2010-12#1)
and comprised##5##2##(2008-10#2)(2008-6#1)(2009-11#1)(2010-8#1)
and comprises##2##2##(1997-3#1)(2008-10#1)
and compromised##2##2##(2008-11#1)(2013-1#1)
and computation##2##2##(2008-10#1)(2008-3#1)
and computational analysis##2##3##(2012-2#2)
and computational##9##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#2)
and computed tomographic##5##3##(1993-6#1)(2008-7#1)(2009-10#1)(2010-9#1)(2013-1#1)
and computed tomography##5##3##(1991-3#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
and computed##11##2##(1991-3#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
and computer reconstruction##2##3##(2008-8#2)
and computer simulation##4##3##(2007-11#1)(2008-10#2)(2008-2#1)
and computer technologies##2##3##(2008-11#1)(2008-3#1)
and computer##15##2##(1993-3#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2012-3#1)
and computerized##3##2##(1991-2#1)(1992-9#1)(2013-1#1)
and concanavalin A##2##3##(1993-8#1)(1995-11#1)
and concentrate##3##2##(2008-10#2)(2010-4#1)
and concentrated by##2##3##(1992-11#1)(2012-2#1)
and concentrated##7##2##(1992-11#1)(1995-6#1)(2008-10#4)(2012-2#1)
and concentration camps##2##3##(2008-7#2)
and concentration of##26##3##(1995-3#1)(2008-10#21)(2011-2#2)(2011-3#1)(2013-1#1)
and concentration was##2##3##(2008-10#2)
and concentration with##3##3##(2008-10#3)
and concentration##55##2##(1990-2#1)(1991-2#1)(1991-5#1)(1995-3#1)(1996-3#1)(2008-10#35)(2008-3#2)(2008-7#3)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#1)
and concentration-dependent##5##2##(1993-11#1)(1996-12#1)(1997-1#2)(2008-9#1)
and concentrations and##2##3##(2008-10#1)(2008-3#1)
and concentrations of##10##3##(2008-10#6)(2008-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
and concentrations##18##2##(2008-10#12)(2008-12#1)(2008-3#2)(2008-8#1)(2009-8#1)(2013-1#1)
and concepts of##2##3##(2008-9#1)(2011-2#1)
and concepts##4##2##(1992-1#1)(1997-3#1)(2008-9#1)(2011-2#1)
and conceptual##6##2##(1990-12#1)(2008-11#1)(2008-8#1)(2009-7#1)(2012-12#1)(2012-3#1)
and concern about##3##3##(1990-6#1)(1991-3#1)(2011-2#1)
and concern##5##2##(1990-6#1)(1991-3#1)(1992-1#1)(2008-11#1)(2011-2#1)
and concerns about##3##3##(1994-2#1)(1996-9#1)(2010-8#1)
and concerns regarding##2##3##(2008-11#1)(2013-1#1)
and concerns##9##2##(1992-2#1)(1994-2#1)(1995-2#1)(1996-9#1)(2008-10#2)(2008-11#1)(2010-8#1)(2013-1#1)
and conclude by##2##3##(1996-2#1)(2011-2#1)
and conclude that the##3##4##(1990-9#1)(2008-10#1)(2009-9#1)
and conclude that there is a need for professional nursing consensus to define the term##2##15##(2013-1#2)
and conclude that##6##3##(1990-9#1)(2008-10#1)(2009-9#1)(2012-3#1)(2013-1#2)
and conclude with a discussion of##2##6##(1994-3#1)(2009-6#1)
and conclude##10##2##(1990-9#1)(1994-3#1)(1996-2#1)(2008-10#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
and conclusions of##2##3##(1993-3#1)(1994-2#1)
and conclusions##4##2##(1991-12#1)(1993-3#1)(1994-2#1)(1996-1#1)
and concomitant##7##2##(1995-10#1)(1996-2#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-8#1)
and concurrent##7##2##(1993-6#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
and condensation of##2##3##(1993-8#1)(2008-10#1)
and condensation##3##2##(1993-8#1)(2008-10#1)(2008-7#1)
and condensed##5##2##(1990-2#1)(1995-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
and condition of##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
and condition##7##2##(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and conditional##3##2##(1995-9#1)(2012-2#2)
and conditioned##3##2##(2008-10#2)(2009-8#1)
and conditioning of the##2##4##(2008-10#2)
and conditioning##4##2##(1995-5#1)(2008-10#3)
and conditions for##3##3##(2008-10#2)(2008-9#1)
and conditions of the##2##4##(1997-8#1)(2008-10#1)
and conditions of##5##3##(1990-2#1)(1992-12#1)(1995-12#1)(1997-8#1)(2008-10#1)
and conditions##15##2##(1990-2#1)(1992-12#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)
and conduct##5##2##(2008-11#1)(2008-12#1)(2009-7#1)(2012-12#1)(2012-3#1)
and conducted a##2##3##(2011-2#1)(2011-3#1)
and conducted by##2##3##(1993-3#2)
and conducted##6##2##(1993-3#2)(2010-10#1)(2011-2#1)(2011-3#1)(2013-1#1)
and conductimetric##2##2##(2008-10#2)
and conducting##2##2##(2008-11#1)(2010-4#1)
and conduction##2##2##(2007-8#1)(2010-7#1)
and conductive##2##2##(2008-10#2)
and cone biopsy##2##3##(1994-2#2)
and cone##3##2##(1994-2#2)(2008-10#1)
and confers##2##2##(1997-3#1)(2008-10#1)
and confidence in##5##3##(1996-1#1)(2008-11#2)(2010-8#2)
and confidence interval##2##3##(1996-3#1)(1997-3#1)
and confidence intervals##2##3##(2008-10#2)
and confidence##16##2##(1996-1#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#5)(2008-12#3)(2010-8#2)
and confident##2##2##(1997-3#1)(2008-11#1)
and configuration##2##2##(2008-10#1)(2013-1#1)
and confirm the##5##3##(2008-10#3)(2008-11#1)(2011-2#1)
and confirm##9##2##(2008-10#5)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)
and confirmation##3##2##(2008-10#3)
and confirmed by a##2##4##(1992-1#1)(2008-7#1)
and confirmed by the##2##4##(1990-3#1)(1991-5#1)
and confirmed by##16##3##(1990-3#1)(1991-5#1)(1992-1#1)(1993-3#1)(2008-10#6)(2008-7#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
and confirmed that##3##3##(2006-6#1)(2008-10#2)
and confirmed the##4##3##(1993-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
and confirmed with##2##3##(2008-11#1)(2010-12#1)
and confirmed##27##2##(1990-3#1)(1991-5#1)(1992-1#1)(1993-11#1)(1993-3#1)(2006-6#1)(2008-10#10)(2008-11#1)(2008-7#2)(2010-11#1)(2010-12#2)(2011-2#3)(2012-12#1)(2013-1#1)
and confirming##2##2##(1991-12#1)(2008-7#1)
and confirms the##3##3##(1991-3#1)(1991-6#1)(2009-8#1)
and confocal laser scanning microscopy##3##5##(2008-10#1)(2008-8#2)
and confocal##6##2##(2007-12#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-2#1)
and conformation of##2##3##(1997-2#1)(2008-10#1)
and conformational##7##2##(1993-3#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
and confusion##3##2##(2008-11#1)(2008-7#1)(2009-1#1)
and congenital heart disease##3##4##(2009-10#3)
and congenital heart##4##3##(1992-5#1)(2009-10#3)
and congenital malformations##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
and congenital##11##2##(1992-5#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-10#3)(2012-3#1)
and congregational support##2##3##(2010-2#2)
and conidia of##2##3##(2008-10#2)
and conidia production##3##3##(2008-10#3)
and conidia were##2##3##(2008-10#2)
and conidia##12##2##(2008-10#12)
and conidial##2##2##(2008-10#2)
and conifer##2##2##(2008-8#2)
and conjugate##2##2##(1996-5#1)(2008-10#1)
and conjugated bile acids##3##4##(1993-2#3)
and conjugated with##2##3##(2008-10#1)(2008-11#1)
and conjugated##10##2##(1992-3#1)(1993-2#3)(2008-10#2)(2008-11#2)(2008-4#2)
and conjunctiva##2##2##(2008-11#1)(2010-10#1)
and connected##2##2##(2008-10#1)(2008-7#1)
and connective tissue##2##3##(1993-2#1)(1996-2#1)
and connectivity##2##2##(1994-3#1)(2008-8#1)
and cons of##9##3##(1992-1#1)(1996-6#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and cons##13##2##(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and consecutive##2##2##(1996-5#1)(2012-2#1)
and consensus##3##2##(1997-2#1)(2008-7#1)(2009-5#1)
and consequences of the##2##4##(2008-11#2)
and consequences of##7##3##(2008-11#3)(2008-8#2)(2010-9#1)(2012-12#1)
and consequences##10##2##(1991-1#1)(2008-10#1)(2008-11#3)(2008-8#2)(2010-7#1)(2010-9#1)(2012-12#1)
and consequent##7##2##(1992-2#1)(1997-2#1)(2008-10#1)(2009-8#1)(2011-2#2)(2013-1#1)
and consequently it##2##3##(1995-5#1)(2008-10#1)
and consequently the##5##3##(1997-7#1)(2008-10#3)(2009-7#1)
and consequently their##2##3##(1992-3#1)(2008-10#1)
and consequently##36##2##(1992-3#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
and conservation##2##2##(2008-9#2)
and conservative surgery are the mainstay of therapy for##2##9##(2010-12#2)
and conservative##7##2##(2008-3#1)(2010-12#2)(2011-2#1)(2011-3#1)(2013-1#2)
and conserved region of##2##4##(2008-12#1)(2013-1#1)
and conserved##3##2##(2008-12#1)(2008-8#1)(2013-1#1)
and conserving the##2##3##(2008-10#1)(2008-11#1)
and consider the##4##3##(1996-3#1)(2008-11#1)(2010-4#1)(2010-5#1)
and consider##8##2##(1991-2#1)(1996-3#1)(2008-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
and consideration of##2##3##(2011-2#1)(2013-1#1)
and consideration##3##2##(1992-3#1)(2011-2#1)(2013-1#1)
and considerations of##2##3##(2008-10#1)(2008-11#1)
and considerations##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2009-6#1)
and considered for##2##3##(2006-5#1)(2012-2#1)
and considered##8##2##(1992-2#1)(2006-5#1)(2008-10#2)(2008-11#1)(2010-10#1)(2012-2#1)(2013-1#1)
and considering##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
and considers the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
and considers##6##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
and consisted of two##2##4##(2008-10#2)
and consisted of##12##3##(1990-5#1)(1991-2#1)(1992-3#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#3)
and consisted##16##2##(1990-3#1)(1990-5#1)(1991-2#1)(1992-3#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#3)(2012-2#1)
and consistency of the##3##4##(1995-5#1)(2008-10#1)(2008-11#1)
and consistency of##4##3##(1995-5#1)(2008-10#2)(2008-11#1)
and consistency##5##2##(1995-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
and consistent with the##2##4##(2008-10#2)
and consistent with##6##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
and consistent##15##2##(1990-5#1)(1994-2#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
and consistently##5##2##(2008-10#3)(2008-11#1)(2013-1#1)
and consists of five##2##4##(1991-6#1)(2008-6#1)
and consists of two##2##4##(2008-10#1)(2008-7#1)
and consists of##12##3##(1991-5#1)(1991-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#3)
and consists##13##2##(1991-5#1)(1991-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#3)
and consolidation##2##2##(2008-10#1)(2009-10#1)
and conspecific##3##2##(2008-10#1)(2008-8#2)
and constant current##2##3##(2008-10#1)(2010-1#1)
and constant##11##2##(1990-11#1)(1997-6#1)(2008-10#7)(2008-7#1)(2010-1#1)
and constitute a##2##3##(1994-9#1)(2011-2#1)
and constitute##5##2##(1990-6#1)(1994-3#1)(1994-9#1)(2008-10#1)(2011-2#1)
and constitutes the##2##3##(2008-10#1)(2008-8#1)
and constitutes##4##2##(2008-10#1)(2008-8#1)(2013-1#1)(2013-7#1)
and constitutive##9##2##(1992-12#4)(2006-6#2)(2008-8#3)
and constitutively##2##2##(1995-6#1)(2008-7#1)
and constraints##4##2##(2008-11#2)(2008-7#1)(2011-2#1)
and constricted##2##2##(1993-1#1)(2013-1#1)
and construct validity##2##3##(2009-12#1)(2010-7#1)
and construct##4##2##(2008-4#1)(2009-12#1)(2010-10#1)(2010-7#1)
and constructed##5##2##(1997-6#1)(2008-10#3)(2008-11#1)
and construction of##3##3##(2008-10#2)(2008-4#1)
and construction##4##2##(2008-10#2)(2008-4#1)(2011-2#1)
and consumer##4##2##(1993-12#1)(2007-12#1)(2011-2#1)(2013-1#1)
and consumers##6##2##(1995-1#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-5#1)(2010-9#1)
and consumption of##4##3##(2008-10#1)(2011-2#3)
and consumption##8##2##(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)(2011-2#3)
and consumptive##2##2##(2008-10#1)(2008-7#1)
and contact time of##2##4##(2008-10#2)
and contact time##4##3##(2008-10#3)(2011-1#1)
and contact##9##2##(1994-6#1)(2008-10#6)(2008-7#1)(2011-1#1)
and contain##7##2##(1993-12#1)(1993-6#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
and contained a##5##3##(1994-11#1)(1997-8#1)(2008-10#2)(2013-8#1)
and contained##18##2##(1994-11#1)(1996-12#2)(1997-7#1)(1997-8#2)(2008-10#8)(2008-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
and containing##6##2##(1995-2#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#1)
and contains a##4##3##(1990-11#1)(1993-3#1)(1996-2#1)(2008-8#1)
and contains four open reading frames##2##6##(2008-10#2)
and contains the##5##3##(1992-3#1)(1996-3#1)(1997-7#1)(2008-10#1)(2009-10#1)
and contains##18##2##(1990-11#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-8#3)(2009-10#1)(2009-8#1)
and contaminants##3##2##(1994-3#1)(2008-11#2)
and contaminated##4##2##(1990-10#1)(2008-10#1)(2008-11#2)
and contamination##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
and contemporary##5##2##(1995-3#1)(1996-1#1)(2008-10#2)(2012-2#1)
and content of physician performance##3##5##(2013-1#3)
and content of the##3##4##(1991-2#1)(2008-10#1)(2008-9#1)
and content of##10##3##(1991-2#1)(2008-10#3)(2008-9#1)(2012-8#2)(2013-1#3)
and content##15##2##(1991-2#1)(1993-12#1)(2008-10#4)(2008-9#1)(2009-8#1)(2012-2#1)(2012-8#2)(2013-1#4)
and contents of the##2##4##(1992-12#1)(2008-9#1)
and contents##4##2##(1992-12#1)(1995-9#1)(2008-10#1)(2008-9#1)
and context of##2##3##(2008-11#1)(2012-2#1)
and context##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
and contexts##2##2##(2008-11#1)(2008-12#1)
and contextual##8##2##(1993-12#2)(2008-11#3)(2010-10#1)(2011-2#1)(2013-1#1)
and continue to##5##3##(1997-1#1)(2008-11#4)
and continued for##2##3##(2008-10#1)(2011-3#1)
and continued to##3##3##(1995-6#1)(2008-10#2)
and continued with##2##3##(2013-1#1)(2013-8#1)
and continued##14##2##(1995-6#1)(2008-10#6)(2008-7#1)(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
and continues to##2##3##(1997-3#1)(2013-1#1)
and continues##5##2##(1997-3#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
and continuing education##4##3##(1993-3#1)(2008-12#2)(2010-8#1)
and continuing##13##2##(1992-2#1)(1993-3#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-8#1)(2010-8#1)
and continuity of care##2##4##(1994-3#1)(1996-3#1)
and continuity of##3##3##(1994-3#1)(1996-3#1)(2008-11#1)
and continuity##8##2##(1993-1#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-3#1)
and continuous ambulatory##2##3##(1995-2#1)(1997-8#1)
and continuous education##2##3##(1994-12#1)(2010-10#1)
and continuous flow/stopped-flow/continuous-flow processing##3##4##(2008-10#3)
and continuous##32##2##(1994-12#1)(1995-2#2)(1996-12#1)(1997-8#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-10#2)(2013-1#1)(2013-8#2)
and continuous-flow##2##2##(2008-10#1)(2008-7#1)
and continuously tunable##2##3##(2008-2#1)(2008-3#1)
and continuously##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
and contract##2##2##(1995-1#1)(2008-5#1)
and contractility##2##2##(2008-10#1)(2008-7#1)
and contraction of##2##3##(1995-2#1)(2010-1#1)
and contraction##3##2##(1993-8#1)(1995-2#1)(2010-1#1)
and contractual##3##2##(1991-12#1)(1991-2#1)(2008-11#1)
and contralateral##2##2##(1993-3#1)(2008-12#1)
and contrast the##2##3##(1994-1#1)(2008-9#1)
and contrast##9##2##(1994-1#1)(1997-1#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
and contrasts##2##2##(1994-2#1)(2008-8#1)
and contribute to the##4##4##(2008-10#2)(2008-11#1)(2013-8#1)
and contribute to##9##3##(1994-9#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-3#1)(2013-8#1)
and contribute##11##2##(1994-9#1)(1995-6#1)(2008-10#3)(2008-11#2)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
and contributed to the##2##4##(2008-12#1)(2011-2#1)
and contributed to##4##3##(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
and contributed##6##2##(1991-8#1)(1993-2#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
and contributes to##7##3##(1993-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(2009-4#1)(2009-8#1)(2013-8#1)
and contribution of##3##3##(1997-8#1)(2008-7#1)(2010-4#1)
and contribution##4##2##(1997-8#1)(2008-7#1)(2010-4#1)(2011-2#1)
and control animals##2##3##(1994-2#1)(2008-10#1)
and control group was##2##4##(2008-10#1)(2008-9#1)
and control group##5##3##(2008-10#1)(2008-9#2)(2010-10#1)(2011-2#1)
and control groups were##3##4##(1991-12#1)(2013-1#1)(2013-8#1)
and control groups##10##3##(1991-12#1)(1993-12#1)(1995-11#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and control in##2##3##(2008-9#1)(2010-5#1)
and control issues##2##3##(2008-11#1)(2011-2#1)
and control males##2##3##(2008-8#2)
and control measures##5##3##(1996-1#1)(2008-10#1)(2011-2#2)(2012-12#1)
and control mice##2##3##(1990-6#1)(1994-11#1)
and control of hypertension##2##4##(2008-11#2)
and control of the##4##4##(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
and control of##29##3##(1994-8#1)(1996-11#1)(2008-10#3)(2008-11#7)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#4)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)
and control over their##2##4##(1992-1#1)(1996-1#1)
and control plants##2##3##(2008-10#1)(2011-10#1)
and control rates##3##3##(2008-11#3)
and control rats##2##3##(1994-5#1)(2009-6#1)
and control subjects##7##3##(1991-12#1)(1992-12#1)(1995-5#2)(2008-12#1)(2011-2#1)(2012-3#1)
and control the##4##3##(1994-5#1)(1995-5#1)(2008-11#1)(2010-6#1)
and control##134##2##(1990-6#1)(1991-12#2)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#4)(2007-12#1)(2008-10#14)(2008-11#21)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#9)(2009-10#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-10#1)(2011-2#12)(2011-9#1)(2012-12#3)(2012-2#6)(2012-3#2)(2012-6#1)(2013-1#4)(2013-8#2)
and controlled by##2##3##(2008-10#1)(2008-5#1)
and controlled##21##2##(1996-3#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
and controlling the##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
and controlling##13##2##(1992-1#1)(1992-3#1)(2008-10#3)(2008-11#3)(2008-12#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
and controls on##3##3##(2010-8#1)(2013-1#2)
and controls were##2##3##(1991-7#1)(2011-2#1)
and controls##26##2##(1990-8#2)(1991-12#1)(1991-7#2)(1992-9#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-12#1)(2008-10#4)(2008-7#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
and controversial##2##2##(1994-9#1)(2010-12#1)
and controversies in the treatment of##2##6##(1991-8#1)(2010-11#1)
and controversies##3##2##(1991-8#1)(1994-12#1)(2010-11#1)
and convenience##3##2##(1991-3#1)(2011-2#1)(2012-12#1)
and convenient analysis##2##3##(2008-10#2)
and convenient assay for##2##4##(1994-11#1)(2008-4#1)
and convenient assay##3##3##(1994-11#1)(2008-4#1)(2008-5#1)
and convenient method for the##2##5##(1990-12#1)(2008-10#1)
and convenient method for##3##4##(1990-12#1)(2008-10#2)
and convenient method##5##3##(1990-12#1)(2008-10#3)(2008-11#1)
and convenient##21##2##(1990-12#1)(1994-11#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-5#1)(2013-8#1)
and conventional tillage treatments##2##4##(2008-10#2)
and conventional tillage##3##3##(2008-10#3)
and conventional wet digestion methods showed a good agreement##2##9##(2008-10#2)
and conventional wet digestion methods##4##5##(2008-10#4)
and conventional##24##2##(1990-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(2008-10#15)(2008-3#2)(2010-12#1)(2012-2#2)
and conversion of##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
and conversion##7##2##(1992-10#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-4#3)
and converted##2##2##(2008-10#1)(2008-6#1)
and convincing##2##2##(1990-11#1)(2008-10#1)
and cooked beef patties##3##4##(2010-4#3)
and cooked##4##2##(2010-4#4)
and cool##4##2##(2008-11#1)(2008-12#1)(2008-9#2)
and cooler##2##2##(2008-10#1)(2012-4#1)
and cooling##6##2##(2008-10#4)(2008-3#1)(2009-1#1)
and cooperation##4##2##(1993-12#1)(2008-11#1)(2008-8#2)
and cooperative breeding##3##3##(2008-8#3)
and cooperative##5##2##(1997-6#1)(2008-11#1)(2008-8#3)
and cooperativity##2##2##(2008-10#2)
and coordinated##5##2##(2008-10#2)(2008-11#1)(2010-11#1)(2010-8#1)
and coordination of care##2##4##(1995-12#1)(2008-11#1)
and coordination of##7##3##(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-10#1)(2013-1#1)
and coordination##12##2##(1994-3#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-1#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
and coping##10##2##(1991-12#1)(1995-1#2)(2008-11#3)(2010-11#1)(2012-2#3)
and copper and##2##3##(2008-10#2)
and copper based on the formation of their complexes with##2##10##(2008-10#2)
and copper by##3##3##(2008-10#3)
and copper in##7##3##(2008-10#7)
and copper solid amalgam electrodes##2##5##(2008-10#2)
and copper were##3##3##(2008-10#3)
and copper with##2##3##(2008-10#2)
and copper##50##2##(1990-8#2)(1992-3#1)(2008-10#46)(2013-7#1)
and copper(II) and##4##3##(2008-10#4)
and copper(II)##10##2##(2008-10#10)
and copy number##2##3##(2008-9#1)(2012-3#1)
and core biopsy##2##3##(2011-2#2)
and core##5##2##(1997-2#1)(2008-7#1)(2010-1#1)(2011-2#2)
and corn##5##2##(2008-10#5)
and cornea##2##2##(2008-3#1)(2011-3#1)
and coronal##5##2##(1995-5#1)(1997-8#1)(2008-10#1)(2013-1#2)
and coronary artery disease##2##4##(2008-11#1)(2008-7#1)
and coronary artery##5##3##(1997-8#1)(2008-11#2)(2008-7#1)(2010-12#1)
and coronary heart disease##6##4##(1993-2#2)(2008-11#3)(2012-3#1)
and coronary##18##2##(1993-2#2)(1994-11#1)(1995-2#1)(1996-8#1)(1997-8#2)(2008-11#5)(2008-7#2)(2010-12#1)(2010-9#1)(2012-3#1)(2013-1#1)
and corporate##4##2##(1993-1#2)(2008-10#1)(2008-11#1)
and corpus luteum##2##3##(2008-9#1)(2010-3#1)
and corpus##4##2##(1997-1#1)(1997-2#1)(2008-9#1)(2010-3#1)
and correct##7##2##(1993-9#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
and corrected##5##2##(2008-10#4)(2008-3#1)
and correction of##5##3##(2008-12#1)(2008-3#2)(2008-8#1)(2010-7#1)
and correction##6##2##(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-7#1)
and correctly##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
and correlate##2##2##(1993-8#1)(2011-2#1)
and correlated these##2##3##(1993-2#1)(2013-1#1)
and correlated to##3##3##(1990-9#1)(2008-10#2)
and correlated with##6##3##(1990-12#1)(1994-3#1)(1995-11#1)(1997-8#1)(2008-10#2)
and correlated##14##2##(1990-12#1)(1990-9#1)(1993-2#1)(1994-3#1)(1995-11#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
and correlates of##3##3##(2013-1#3)
and correlates with##2##3##(2008-11#1)(2013-1#1)
and correlates##8##2##(1992-9#1)(1993-3#1)(2008-11#1)(2010-2#1)(2013-1#4)
and correlation coefficient of##2##4##(2008-10#1)(2010-8#1)
and correlation coefficient##3##3##(2008-10#1)(2010-8#2)
and correlation with##4##3##(1994-11#1)(1996-8#1)(2008-1#1)(2011-2#1)
and correlation##9##2##(1994-11#1)(1995-3#1)(1996-8#1)(2008-1#1)(2008-10#2)(2010-8#2)(2011-2#1)
and correspond to##3##3##(1990-5#1)(1994-9#1)(2008-5#1)
and corresponded to a##2##4##(2008-10#2)
and corresponded to##3##3##(2008-10#2)(2012-3#1)
and corresponding##15##2##(1990-5#1)(1992-10#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-10#2)
and correspondingly##2##2##(1993-3#1)(2008-10#1)
and corresponds to##2##3##(1991-11#1)(1996-2#1)
and cortex##7##2##(1994-2#2)(1995-2#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
and cortical cells##5##3##(1996-12#1)(2008-10#3)(2008-9#1)
and cortical##21##2##(1990-5#1)(1991-10#3)(1991-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and corticosteroids##4##2##(1997-1#1)(2008-1#1)(2010-1#1)(2011-3#1)
and corticosterone##7##2##(1990-11#1)(1995-12#1)(1996-12#5)
and cortisol levels##2##3##(2008-6#2)
and cortisol were##2##3##(2008-6#1)(2011-2#1)
and cortisol##12##2##(1995-11#1)(2008-10#1)(2008-11#2)(2008-6#3)(2010-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
and cosmetic##10##2##(2008-11#1)(2008-5#7)(2012-12#1)(2013-1#1)
and cosmetics##3##2##(2008-10#1)(2008-5#2)
and cosmid##2##2##(1993-3#1)(1994-11#1)
and cost containment##4##3##(1991-12#1)(1994-1#1)(1995-2#1)(2008-11#1)
and cost effective in##2##4##(2008-11#1)(2011-2#1)
and cost effective##11##3##(1992-3#1)(1996-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2011-2#1)(2012-2#1)
and cost effectiveness##5##3##(1995-1#1)(2008-11#1)(2010-2#1)(2010-7#1)(2013-1#1)
and cost in##3##3##(2008-10#1)(2008-7#2)
and cost of care##4##4##(1992-3#1)(1996-1#1)(2008-11#1)(2012-2#1)
and cost of##12##3##(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-3#2)(1996-1#1)(2008-10#1)(2008-11#2)(2012-2#1)(2013-1#1)
and cost per HCC prevented##2##5##(2009-8#2)
and cost savings##3##3##(1997-2#1)(2008-10#1)(2013-1#1)
and cost##68##2##(1991-12#2)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#5)(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-8#3)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
and cost-benefit ratios##2##3##(2009-4#2)
and cost-benefit##3##2##(2008-7#1)(2009-4#2)
and cost-effective##17##2##(1992-2#1)(1994-3#2)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
and cost-effectiveness##7##2##(1994-9#1)(1995-2#2)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)
and cost-efficient##2##2##(1997-1#1)(2008-11#1)
and costly##6##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-12#1)
and costs associated with##2##4##(1997-2#2)
and costs in##3##3##(1994-6#1)(1995-2#1)(2009-11#1)
and costs of##9##3##(1990-12#1)(1993-1#1)(1995-1#1)(1995-12#1)(2008-10#2)(2008-11#1)(2009-4#1)(2011-2#1)
and costs vary##2##3##(1996-3#1)(2008-8#1)
and costs##34##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-8#4)(2009-11#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-12#1)
and cotton root##2##3##(2008-10#2)
and cotton##5##2##(2008-10#5)
and cotyledonary##3##2##(2008-12#2)(2013-8#1)
and cotyledons##2##2##(2008-10#2)
and cough##3##2##(1997-1#2)(2008-1#1)
and coughing##3##2##(1990-3#1)(1992-6#1)(1993-1#1)
and could be easily reused over##2##6##(2008-10#2)
and could be easily##3##4##(2008-10#2)(2008-12#1)
and could be explained by##3##5##(1993-1#1)(1995-12#1)(2008-11#1)
and could be used as a##3##6##(2008-10#1)(2011-2#1)(2013-8#1)
and could be used as##4##5##(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
and could be used for##3##5##(2008-10#2)(2008-11#1)
and could be used in a pH range of 2##4##10##(2008-10#4)
and could be used in a pH range of##5##9##(2008-10#5)
and could be used in the##2##6##(2008-10#2)
and could be used in##8##5##(2008-10#8)
and could be used to##2##5##(2008-10#1)(2008-11#1)
and could be used##19##4##(2008-10#12)(2008-11#2)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and could be##52##3##(1991-5#1)(1992-11#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-6#1)(1997-1#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
and could contribute to the##2##5##(1994-2#1)(2008-5#1)
and could detect##2##3##(2008-10#2)
and could lead to the##2##5##(2010-12#1)(2011-2#1)
and could lead to##4##4##(2008-10#1)(2010-10#1)(2010-12#1)(2011-2#1)
and could not be##4##4##(1994-8#1)(1997-3#1)(2008-10#2)
and could not##9##3##(1993-8#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-3#1)
and could serve as a##2##5##(2008-10#1)(2008-11#1)
and could serve as##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and could serve##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
and could therefore be##3##4##(1990-8#1)(2008-10#1)(2010-12#1)
and could therefore##4##3##(1990-8#1)(2008-10#2)(2010-12#1)
and could thus##2##3##(2008-11#1)(2008-5#1)
and could##106##2##(1990-8#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-8#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#41)(2008-11#11)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-9#1)(2011-2#9)(2013-1#3)(2013-8#3)
and counsel##2##2##(1997-6#1)(2008-10#1)
and counseling##4##2##(1991-6#1)(1993-1#1)(1997-4#1)(2010-12#1)
and counselling##2##2##(2008-11#1)(2013-8#1)
and counter##2##2##(2008-1#1)(2008-10#1)
and counteracted##2##2##(2008-10#1)(2013-1#1)
and counterpropagating##2##2##(2007-11#2)
and counting##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
and countries##2##2##(1990-11#1)(2010-10#1)
and county##3##2##(1997-5#1)(2008-11#1)(2009-7#1)
and couple##3##2##(2008-10#1)(2012-2#2)
and coupled gas chromatography-electroantennographic detection##2##5##(2008-10#2)
and coupled with##3##3##(1992-6#1)(2008-10#2)
and coupled##6##2##(1992-6#1)(2008-10#5)
and couples##2##2##(2008-11#1)(2009-7#1)
and coupling of##2##3##(1995-12#1)(2008-10#1)
and coupling##3##2##(1995-12#1)(2008-10#2)
and course of the##2##4##(1996-6#1)(2008-10#1)
and course##4##2##(1996-6#1)(1996-8#1)(2008-10#1)(2009-8#1)
and courses##2##2##(1991-2#1)(2013-1#1)
and cover##3##2##(1996-5#1)(1996-6#1)(2012-3#1)
and coverage##3##2##(1991-1#1)(2008-11#1)(2012-2#1)
and covered with##3##3##(2008-10#3)
and covered##6##2##(2008-10#5)(2008-5#1)
and covering##6##2##(1992-3#1)(1997-3#1)(2008-10#4)
and covers##2##2##(1995-2#1)(2008-10#1)
and coworkers##3##2##(1990-11#1)(1997-8#1)(2010-8#1)
and cowpea##2##2##(2008-10#2)
and cows##3##2##(1997-4#1)(2013-1#2)
and coxII##3##2##(2008-10#3)
and create a##2##3##(1996-1#1)(2008-7#1)
and create##6##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
and created##2##2##(2008-10#1)(2008-11#1)
and creates##3##2##(1992-12#1)(1997-6#1)(2009-5#1)
and creatine##2##2##(1990-11#1)(2011-2#1)
and creating##4##2##(1994-3#1)(1996-2#1)(2008-4#1)(2010-8#1)
and creatinine##11##2##(1995-11#2)(1997-2#1)(2008-10#7)(2008-7#1)
and creation of##2##3##(2010-9#1)(2013-1#1)
and creative##4##2##(1993-2#1)(1996-3#1)(2008-11#1)(2013-1#1)
and creep##3##2##(2009-9#3)
and criminal justice##2##3##(1996-1#1)(2008-6#1)
and criminal##4##2##(1996-1#1)(2008-6#2)(2013-8#1)
and criteria for##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
and criteria##5##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
and criterion##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
and critical thinking##2##3##(2008-11#1)(2008-12#1)
and critical##10##2##(2008-11#1)(2008-12#3)(2008-5#1)(2009-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
and critically##3##2##(2008-10#2)(2008-6#1)
and critiques of##2##3##(2008-11#1)(2012-3#1)
and critiquing##2##2##(2008-11#1)(2008-12#1)
and crop##5##2##(2008-10#4)(2012-3#1)
and cross##4##2##(2008-10#1)(2008-11#2)(2008-3#1)
and cross-clamping##2##2##(2012-3#2)
and cross-correlation##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
and cross-cultural##2##2##(2008-12#1)(2013-1#1)
and cross-linked##3##2##(1995-3#1)(2008-10#2)
and cross-linking##7##2##(2008-10#4)(2008-5#2)(2009-7#1)
and cross-polarization##2##2##(2008-10#1)(2008-3#1)
and cross-reactivity##2##2##(2008-10#1)(2009-12#1)
and cross-sectional##5##2##(1994-3#1)(2008-10#2)(2009-3#1)(2011-2#1)
and crown rot##3##3##(2008-10#3)
and crown##6##2##(2008-10#6)
and crystal##4##2##(2008-3#3)(2009-7#1)
and crystalline##4##2##(2008-10#4)
and crystallization##2##2##(2008-10#1)(2013-8#1)
and ctr-EGR-Xa##2##2##(1994-5#2)
and cubic##3##2##(1995-3#1)(2007-11#1)(2008-10#1)
and cucumber##2##2##(2008-10#2)
and cultivar of##2##3##(2008-10#2)
and cultivar##6##2##(2008-10#6)
and cultivars of##2##3##(2008-10#2)
and cultivars with##2##3##(2008-10#2)
and cultivars##9##2##(2008-10#8)(2008-8#1)
and cultivated##8##2##(2008-10#6)(2008-11#1)(2013-8#1)
and cultivation##3##2##(1997-7#1)(2008-11#2)
and cultural origin##3##3##(1991-11#1)(2011-2#1)(2012-2#1)
and cultural practices##2##3##(2008-1#1)(2008-10#1)
and cultural##29##2##(1990-3#1)(1991-11#1)(1993-11#1)(1995-12#1)(1995-5#1)(1996-9#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#2)(2009-10#3)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
and culturally sensitive##2##3##(2010-9#1)(2011-1#1)
and culturally##4##2##(2008-1#1)(2010-9#1)(2011-1#2)
and culture of##4##3##(2008-11#2)(2008-8#1)(2008-9#1)
and culture supernatant##2##3##(1992-12#1)(1993-9#1)
and culture##19##2##(1992-12#1)(1993-9#1)(1995-2#1)(2008-10#2)(2008-11#8)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
and culture-independent##2##2##(2008-10#1)(2012-2#1)
and cultured for##3##3##(1993-3#1)(1995-8#1)(2008-5#1)
and cultured in the presence of##2##6##(2008-4#1)(2011-3#1)
and cultured in##5##3##(1995-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-3#1)
and cultured on##2##3##(1993-3#1)(2008-10#1)
and cultured##18##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#2)(1995-8#3)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-3#1)(2012-4#1)(2012-5#1)(2013-1#1)
and cultures of##2##3##(1991-5#1)(2008-5#1)
and cultures were##2##3##(2008-5#2)
and cultures##9##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-5#4)(2013-8#1)
and culturing##3##2##(1992-5#1)(2008-4#1)(2008-8#1)
and cumbersome##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
and cumulative##10##2##(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#1)(2010-11#1)(2012-3#1)
and cure##4##2##(2008-10#1)(2008-7#2)(2008-8#1)
and curettage##4##2##(1992-12#1)(1993-12#1)(1995-3#1)(2009-4#1)
and current research##2##3##(1990-11#1)(2012-2#1)
and current use of##3##4##(2008-11#1)(2008-4#1)(2013-8#1)
and current##31##2##(1990-11#2)(1991-12#1)(1993-12#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-8#1)
and currently available##2##3##(2008-5#1)(2010-11#1)
and currently##4##2##(2008-10#1)(2008-5#1)(2010-11#1)(2012-3#1)
and curriculum##5##2##(1993-2#2)(1997-2#1)(2008-12#1)(2009-8#1)
and curve##2##2##(2008-10#2)
and customer##4##2##(1992-1#1)(1993-1#1)(1993-12#1)(2013-8#1)
and customizing##2##2##(2008-10#1)(2010-8#1)
and cutaneous lesions##2##3##(2008-5#2)
and cutaneous##6##2##(2008-5#4)(2008-8#1)(2011-2#1)
and cuticle##2##2##(2008-10#1)(2009-8#1)
and cv##3##2##(2008-10#2)(2008-9#1)
and cyanobacteria##2##2##(2009-4#1)(2011-2#1)
and cycle##2##2##(2009-10#1)(2010-4#1)
and cyclic AMP-dependent protein kinase##2##5##(1993-8#1)(1995-11#1)
and cyclic voltammetric##2##3##(2008-10#1)(2009-9#1)
and cyclic voltammetry (CV)##2##4##(2008-10#2)
and cyclic voltammetry##11##3##(2008-10#9)(2008-4#2)
and cyclic##25##2##(1990-5#1)(1993-8#1)(1994-11#1)(1995-11#1)(1996-5#1)(1997-1#1)(2008-10#11)(2008-4#2)(2009-10#1)(2009-7#2)(2009-9#1)(2010-4#2)
and cyclin##3##2##(1994-11#1)(1997-1#1)(2013-1#1)
and cyclin-dependent kinase 2##2##4##(2012-3#2)
and cyclin-dependent kinase##4##3##(1994-11#1)(2011-2#1)(2012-3#2)
and cyclo-1##3##2##(2008-10#3)
and cyclohexane##3##2##(2008-10#3)
and cyclohexanone##5##2##(2008-10#5)
and cycloheximide##3##2##(1991-5#1)(1993-12#1)(2008-10#1)
and cyclooxygenase##3##2##(2008-11#3)
and cyclophosphamide in##2##3##(1997-8#1)(2008-1#1)
and cyclophosphamide treatment##2##3##(1993-2#1)(2008-7#1)
and cyclophosphamide##7##2##(1991-8#1)(1993-2#2)(1997-8#1)(2008-1#1)(2008-7#1)(2012-3#1)
and cyclosporin##3##2##(2008-11#1)(2012-3#2)
and cylinders##2##2##(2008-3#2)
and cyst##6##2##(1996-3#1)(2008-10#3)(2012-2#2)
and cysteamine##2##2##(1995-8#2)
and cysteine##6##2##(2008-10#5)(2008-5#1)
and cystic##3##2##(1997-3#1)(2009-1#1)(2013-1#1)
and cystine##6##2##(2008-10#4)(2008-11#2)
and cysts##2##2##(2008-10#1)(2008-12#1)
and cytochalasin B##2##3##(2008-8#1)(2008-9#1)
and cytochemical##3##2##(2008-10#2)(2008-7#1)
and cytochrome##5##2##(1994-5#1)(2008-10#1)(2008-11#2)(2008-7#1)
and cytocompatibility of##2##3##(2009-7#1)(2013-8#1)
and cytokeratin 8##2##3##(2008-11#2)
and cytokine production in##4##4##(2008-10#2)(2008-4#1)(2010-12#1)
and cytokine production##10##3##(2008-10#3)(2008-11#1)(2008-4#1)(2009-6#1)(2010-12#2)(2012-2#1)(2013-8#1)
and cytokine secretion##2##3##(2008-10#1)(2008-4#1)
and cytokine##16##2##(1996-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2009-6#1)(2010-12#2)(2012-2#1)(2013-8#1)
and cytokines##10##2##(1994-3#1)(1996-2#2)(2008-11#1)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
and cytokinesis##3##2##(2009-9#1)(2011-1#1)(2013-1#1)
and cytological##9##2##(1994-5#1)(1997-2#1)(2008-10#3)(2010-12#1)(2011-10#1)(2011-2#1)(2012-12#1)
and cytology##2##2##(1994-1#1)(2011-2#1)
and cytoplasm##6##2##(1990-5#1)(1995-8#1)(1997-2#1)(2008-10#3)
and cytoplasmic##19##2##(1990-8#1)(1991-11#2)(1991-5#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
and cytoskeleton##2##2##(2008-11#1)(2009-9#1)
and cytosol##3##2##(1993-8#1)(2008-9#2)
and cytosolic##5##2##(1991-8#1)(1995-11#1)(1996-2#1)(1997-1#2)
and cytotoxic T cells##2##4##(2008-10#2)
and cytotoxic##10##2##(2008-10#2)(2008-11#2)(2009-12#1)(2009-9#1)(2010-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
and cytotoxicity##6##2##(1994-8#2)(1997-2#1)(2008-11#2)(2013-1#1)
and d##5##2##(1992-6#3)(2008-11#1)(2008-3#1)
and d)##2##2##(2008-12#1)(2008-7#1)
and daidzin are##2##3##(2008-11#2)
and daidzin##5##2##(2008-11#5)
and daily intake of pulses##2##5##(2008-10#2)
and daily##16##2##(1992-12#1)(1992-9#1)(1993-1#1)(1997-1#1)(2008-10#5)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#1)
and dairy products##2##3##(2008-10#1)(2011-2#1)
and dairy##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and damage##6##2##(1995-12#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-7#1)(2012-3#1)
and damping-off##3##2##(2008-10#3)
and dangerous##2##2##(2008-11#1)(2008-9#1)
and dark##8##2##(1991-5#2)(2008-10#4)(2011-2#1)(2013-7#1)
and data analysis##3##3##(1997-3#1)(2009-9#1)(2012-2#1)
and data capture##2##3##(2008-11#1)(2010-8#1)
and data collection##3##3##(1991-2#1)(1995-2#1)(2008-8#1)
and data from##3##3##(1995-5#1)(1996-3#1)(2008-7#1)
and data interpretation##4##3##(2008-4#1)(2008-9#1)(2011-2#2)
and data on##4##3##(1991-3#1)(2007-11#1)(2008-12#1)(2008-8#1)
and data processing##2##3##(2008-10#2)
and data##43##2##(1991-2#2)(1991-3#1)(1993-2#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
and databases##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-1#1)
and date of##2##3##(1996-3#1)(2012-12#1)
and date##4##2##(1996-3#1)(2011-2#2)(2012-12#1)
and daunomycin in##2##3##(2008-10#1)(2008-11#1)
and daunomycin##3##2##(2008-10#2)(2008-11#1)
and daunorubicin##2##2##(1991-2#1)(1993-11#1)
and day 10##2##3##(1994-2#2)
and day##7##2##(1991-1#1)(1994-2#2)(1995-12#1)(1996-3#1)(2008-10#1)(2008-7#1)
and day-to-day##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
and days to anthesis##3##4##(2008-10#3)
and days to##4##3##(2008-10#4)
and daytime functioning in##2##4##(2010-7#2)
and daytime##7##2##(2008-10#2)(2008-3#1)(2010-7#4)
and ddCTP##2##2##(1994-11#2)
and de novo##2##3##(1993-11#1)(1997-1#1)
and de##3##2##(1993-11#1)(1996-9#1)(1997-1#1)
and dead cells##2##3##(2008-11#1)(2008-8#1)
and dead##7##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#2)(2012-12#1)
and deaf##2##2##(2011-2#1)(2012-3#1)
and deafness##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
and dealing with the##2##4##(2008-10#2)
and dealing with##4##3##(1995-12#1)(2008-10#2)(2010-8#1)
and death in the##2##4##(1994-8#1)(2010-12#1)
and death in##4##3##(1994-8#1)(2008-11#2)(2010-12#1)
and death of microsclerotia##2##4##(2008-10#2)
and death of plants##2##4##(2008-10#2)
and death of##8##3##(1993-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2012-3#1)
and death##36##2##(1992-1#3)(1992-6#1)(1993-11#2)(1993-3#1)(1994-8#1)(1995-2#2)(1997-7#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#2)(2011-2#1)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
and deaths##8##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
and debate##4##2##(2008-11#2)(2008-12#1)(2013-8#1)
and debated##2##2##(2009-8#1)(2010-1#1)
and debriefing##2##2##(2008-11#1)(2008-8#1)
and decay##4##2##(2007-12#1)(2008-10#1)(2009-10#1)(2011-2#1)
and decision making##2##3##(1990-3#1)(2013-1#1)
and decision##6##2##(1990-3#1)(1994-2#1)(2008-10#2)(2009-7#1)(2013-1#1)
and decision-making##4##2##(2008-11#1)(2008-12#1)(2011-2#2)
and decisional##2##2##(2008-11#1)(2009-4#1)
and decisions about##2##3##(2008-1#1)(2010-12#1)
and decline over time##3##4##(2008-10#1)(2008-7#2)
and decline##6##2##(2008-10#1)(2008-11#1)(2008-7#2)(2011-2#1)(2013-8#1)
and declined rapidly##2##3##(1992-6#1)(2008-10#1)
and declined##8##2##(1990-5#1)(1990-6#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
and declines##2##2##(1994-3#1)(2008-8#1)
and declining##4##2##(1991-3#1)(1992-3#1)(1995-6#1)(2009-10#1)
and decontamination##2##2##(2008-10#1)(2008-9#1)
and decrease at##2##3##(1992-7#2)
and decrease in##4##3##(1993-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
and decrease of##6##3##(1993-1#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
and decrease the##3##3##(2008-10#1)(2009-7#1)(2012-3#1)
and decrease##29##2##(1992-7#2)(1993-1#1)(1993-3#1)(1996-12#1)(1996-3#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
and decreased expression of##2##4##(2011-2#2)
and decreased in##2##3##(1997-2#1)(2008-10#1)
and decreased significantly##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
and decreased the##5##3##(1993-6#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
and decreased with##2##3##(2008-10#1)(2013-3#1)
and decreased##59##2##(1991-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-2#3)(2008-10#12)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#5)(2013-3#1)
and decreases in##5##3##(1994-12#1)(1997-2#1)(2008-11#1)(2012-3#2)
and decreases the##2##3##(2008-10#1)(2008-7#1)
and decreases##16##2##(1993-2#1)(1994-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-3#2)
and decreasing the##2##3##(2008-11#1)(2011-2#1)
and decreasing##9##2##(2008-10#4)(2008-11#1)(2009-8#1)(2011-2#2)(2011-7#1)
and dedicated##2##2##(2011-2#1)(2011-3#1)
and deduced amino acid sequences of##2##6##(1993-12#1)(1993-2#1)
and deduced amino acid sequences##4##5##(1992-10#1)(1993-12#1)(1993-2#1)(1994-11#1)
and deduced amino acid##5##4##(1992-10#1)(1993-12#1)(1993-2#1)(1994-11#1)(2008-11#1)
and deduced##9##2##(1992-10#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#3)(2008-11#1)
and deep##13##2##(1995-3#1)(1996-6#1)(2008-10#1)(2008-8#1)(2009-1#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#5)
and deeper##3##2##(1995-3#1)(2008-9#1)(2011-7#1)
and defective##2##2##(1991-7#1)(2011-2#1)
and defects in##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
and defects##4##2##(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
and defense##5##2##(1991-3#1)(2008-9#3)(2010-10#1)
and defibrillators##3##2##(2009-10#2)(2010-6#1)
and deficiency##3##2##(1997-7#1)(2012-3#1)(2013-7#1)
and deficient##2##2##(1994-5#1)(2012-3#1)
and deficits in##2##3##(2008-11#1)(2013-1#1)
and deficits##3##2##(1997-6#1)(2008-11#1)(2013-1#1)
and define##2##2##(1996-3#1)(2008-9#1)
and defined as the##2##4##(2007-9#1)(2008-10#1)
and defined##7##2##(1991-1#1)(1991-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
and defines##3##2##(1996-3#1)(2008-12#1)(2013-1#1)
and defining##3##2##(1993-12#1)(1995-9#1)(2008-4#1)
and definitions##4##2##(1994-12#1)(1995-1#1)(1997-3#1)(2012-12#1)
and definitive treatment##3##3##(2008-9#1)(2010-12#1)(2011-2#1)
and definitive##5##2##(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
and deflations##2##2##(1992-9#2)
and degenerate##3##2##(2008-10#1)(2008-9#1)(2010-3#1)
and degeneration##2##2##(1997-5#1)(2011-2#1)
and degenerative and regenerative##2##4##(1994-5#2)
and degenerative diseases##3##3##(1992-9#1)(2010-3#1)(2012-2#1)
and degenerative joint##2##3##(2011-2#2)
and degenerative##10##2##(1992-9#1)(1994-5#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
and degradation of the##2##4##(2008-7#1)(2011-2#1)
and degradation of##8##3##(1995-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and degradation products##4##3##(2008-10#3)(2012-2#1)
and degradation##17##2##(1995-6#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
and degraded##4##2##(1995-2#1)(1995-6#2)(2008-8#1)
and degree of##14##3##(1996-11#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-2#1)
and degrees of##2##3##(2008-10#1)(2008-3#1)
and dehydroascorbic acid##3##3##(1993-3#2)(2008-10#1)
and delay in##2##3##(1994-3#1)(2013-1#1)
and delay##7##2##(1994-3#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
and delayed the##2##3##(1996-3#1)(2008-7#1)
and delayed##21##2##(1992-5#1)(1992-9#1)(1993-11#1)(1996-3#1)(1997-8#3)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#3)(2013-1#1)(2013-8#1)
and delays the##5##3##(1994-8#2)(2008-10#1)(2008-3#1)(2008-7#1)
and delays##7##2##(1994-8#2)(1997-2#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
and deletion##4##2##(1995-6#1)(1997-3#1)(2008-10#2)
and deletions of##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
and deletions##9##2##(1991-5#1)(1993-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
and delinquent behavior##3##3##(2008-11#1)(2009-7#2)
and deliver##7##2##(1993-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2013-8#1)
and delivered##3##2##(1997-2#1)(2008-10#2)
and delivering##5##2##(1992-3#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-9#1)
and delivers##2##2##(2012-2#2)
and delivery efficiency##2##3##(2008-10#2)
and delivery of##9##3##(1992-3#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-12#3)(2009-7#1)
and delivery systems##5##3##(1993-12#1)(1993-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
and delivery##27##2##(1992-2#2)(1992-3#2)(1993-12#1)(1993-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2013-8#1)
and delta subunit##2##3##(1996-12#2)
and delta##16##2##(1990-5#1)(1991-12#1)(1993-8#1)(1994-5#1)(1996-12#2)(1996-2#1)(2008-8#4)(2009-7#4)(2011-1#1)
and delta-opioid receptors##2##3##(1993-3#1)(1996-2#1)
and delta-opioid##3##2##(1992-3#1)(1993-3#1)(1996-2#1)
and deltamethrin##4##2##(2008-10#3)(2012-12#1)
and demand##4##2##(1991-1#1)(1992-1#1)(1992-3#1)(2011-2#1)
and demands##3##2##(2008-10#1)(2009-12#1)(2009-5#1)
and dementia in##2##3##(2008-7#1)(2013-1#1)
and dementia##8##2##(1991-3#1)(2008-6#1)(2008-7#3)(2009-8#1)(2012-12#1)(2013-1#1)
and demographic characteristics##2##3##(1992-12#1)(2008-7#1)
and demographic factors##2##3##(1993-2#1)(2012-12#1)
and demographic##11##2##(1990-12#1)(1992-12#1)(1993-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-12#2)
and demonstrate a##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
and demonstrate its##3##3##(2008-3#1)(2008-8#1)(2012-2#1)
and demonstrate that##5##3##(1995-2#1)(2007-12#1)(2008-7#1)(2010-5#1)(2013-1#1)
and demonstrate the association##2##4##(2013-1#2)
and demonstrate the##7##3##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
and demonstrate##21##2##(1992-4#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#3)
and demonstrated a##3##3##(2008-3#1)(2010-5#1)(2013-1#1)
and demonstrated that it is##2##5##(2008-10#1)(2008-11#1)
and demonstrated that the##2##4##(1994-8#1)(2008-10#1)
and demonstrated that##7##3##(1990-5#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-5#1)
and demonstrated to##2##3##(1993-6#1)(1997-7#1)
and demonstrated##26##2##(1990-5#1)(1993-11#1)(1993-6#1)(1994-8#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-3#4)(2008-5#1)(2009-10#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
and demonstrates how##2##3##(1995-1#1)(2008-4#1)
and demonstrates that##4##3##(1992-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
and demonstrates the##4##3##(2008-11#2)(2008-8#1)(2008-9#1)
and demonstrates##12##2##(1991-2#1)(1992-10#1)(1995-1#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)
and demonstrating##3##2##(1995-6#1)(2008-5#1)(2009-1#1)
and demonstration##2##2##(2008-1#1)(2008-10#1)
and denaturation##2##2##(2008-10#2)
and denatured##7##2##(1990-5#1)(1995-3#1)(2008-10#4)(2008-8#1)
and dendrites##2##2##(1997-3#1)(2007-12#1)
and dendritic branching points##2##4##(2008-10#2)
and dendritic##7##2##(1995-8#2)(2008-10#2)(2008-6#1)(2009-12#1)(2013-1#1)
and dengue##2##2##(2011-2#2)
and denial##2##2##(1990-6#1)(2008-4#1)
and dense##5##2##(1991-2#1)(2008-10#3)(2008-7#1)
and densities##3##2##(2008-2#1)(2008-9#1)(2010-6#1)
and density measurements##2##3##(2008-10#2)
and density##17##2##(1995-8#1)(2008-10#10)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)
and density-dependent##2##2##(2008-8#1)(2008-9#1)
and dental state##2##3##(2008-7#2)
and dental##15##2##(1994-12#1)(1994-3#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-7#2)(2011-7#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)
and dentate granule cells##2##4##(1990-5#2)
and dentate gyrus##2##3##(1994-2#1)(2008-11#1)
and dentate##6##2##(1990-5#2)(1991-10#1)(1994-2#1)(2008-11#1)(2008-7#1)
and dentin##5##2##(1990-2#1)(1991-2#1)(2008-7#1)(2012-12#2)
and dentofacial##2##2##(2012-12#1)(2013-1#1)
and deoxynivalenol (DON)##2##3##(2008-10#2)
and deoxynivalenol##6##2##(2008-10#6)
and depend on##4##3##(2008-10#1)(2008-5#1)(2011-3#1)(2013-8#1)
and dependence in##2##3##(1992-1#1)(2008-7#1)
and dependence##5##2##(1992-1#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)
and dependency##2##2##(2008-7#1)(2008-8#1)
and dependent on##2##3##(1993-1#1)(2010-12#1)
and dependent##3##2##(1993-1#1)(2008-10#1)(2010-12#1)
and depends on the##5##4##(1995-5#1)(1997-7#1)(2008-12#1)(2011-2#2)
and depends on##8##3##(1995-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#3)
and depletion of##2##3##(2013-1#2)
and depletion##5##2##(2008-10#2)(2008-11#1)(2013-1#2)
and deploying##2##2##(2008-10#1)(2010-11#1)
and depolarization##3##2##(2008-2#1)(2008-3#2)
and deposited on the##2##4##(2008-10#2)
and deposited on##3##3##(2008-10#3)
and deposited##4##2##(2008-10#4)
and deposition of##5##3##(1995-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
and deposition##9##2##(1995-3#1)(1996-2#1)(2008-10#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-1#2)
and depressed##4##2##(1995-5#1)(2008-10#1)(2008-7#1)(2009-11#1)
and depression and the##2##4##(2008-11#1)(2008-4#1)
and depression and##3##3##(2008-11#1)(2008-4#1)(2010-7#1)
and depression in##2##3##(2008-10#1)(2012-12#1)
and depression##30##2##(1992-3#1)(1995-5#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#3)(2008-7#1)(2009-11#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-2#2)(2010-7#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
and depression]##2##2##(1997-3#2)
and depressive symptoms##3##3##(2008-7#1)(2009-7#1)(2013-8#1)
and depressive##5##2##(1991-6#1)(2008-7#1)(2009-7#1)(2010-5#1)(2013-8#1)
and depth##6##2##(1993-12#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
and derivative spectrophotometric methods##2##4##(2008-10#2)
and derivative spectrophotometry##2##3##(2008-10#2)
and derivative##7##2##(2008-10#5)(2008-11#1)(2010-7#1)
and derivatives##4##2##(1993-1#2)(1994-5#1)(2008-11#1)
and derivatization with##2##3##(2008-10#1)(2008-11#1)
and derivatization##7##2##(2008-10#6)(2008-11#1)
and derivatized##3##2##(2008-10#2)(2011-3#1)
and derive a##2##3##(2008-8#1)(2008-9#1)
and derive##6##2##(2007-12#1)(2008-10#1)(2008-8#2)(2008-9#1)(2013-8#1)
and derived from##2##3##(2008-10#1)(2010-4#1)
and derived##3##2##(2008-10#2)(2010-4#1)
and dermal##4##2##(2008-5#3)(2008-9#1)
and dermatitis##3##2##(2008-5#2)(2011-2#1)
and dermatological##2##2##(2008-5#2)
and dermis##6##2##(1994-12#1)(1996-12#1)(2008-11#1)(2008-5#3)
and descending##3##2##(1997-8#1)(2012-2#1)(2013-1#1)
and describe an##2##3##(2008-11#1)(2011-2#1)
and describe how##4##3##(1993-2#1)(2008-10#1)(2008-6#1)(2008-9#1)
and describe the anatomy##2##4##(1990-8#1)(1996-9#1)
and describe the##10##3##(1990-8#1)(1993-2#1)(1996-9#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
and describe##20##2##(1990-8#1)(1993-2#2)(1994-3#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#3)(2013-1#1)
and described by##4##3##(1993-11#1)(1993-6#1)(2011-2#1)(2013-1#1)
and described##11##2##(1993-11#1)(1993-6#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
and describes how##4##3##(1997-2#1)(2008-11#1)(2008-4#1)(2009-12#1)
and describes the##11##3##(1991-11#1)(1992-1#1)(1994-1#1)(1997-2#1)(2008-10#1)(2008-12#2)(2008-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
and describes##25##2##(1991-11#1)(1991-12#1)(1992-1#2)(1994-1#1)(1996-12#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
and describing##3##2##(2008-10#1)(2008-9#1)(2010-10#1)
and description of the##2##4##(2008-10#2)
and description of##6##3##(2008-10#3)(2012-2#1)(2012-3#1)(2013-1#1)
and descriptive study##2##3##(2012-3#2)
and descriptive##6##2##(2008-11#2)(2008-12#1)(2012-12#1)(2012-3#2)
and deserves##2##2##(1991-6#1)(2010-12#1)
and design inputs##2##3##(2012-2#2)
and design of the##2##4##(2008-10#1)(2008-8#1)
and design of##8##3##(1997-3#1)(2008-10#2)(2008-3#2)(2008-8#2)(2012-3#1)
and design##15##2##(1997-3#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
and designated as##2##3##(2008-10#2)
and designated##7##2##(1991-7#1)(1995-11#1)(2008-10#4)(2008-9#1)
and designed##4##2##(1996-2#1)(2008-4#1)(2008-9#1)(2010-11#1)
and designing##5##2##(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
and desipramine in##2##3##(1990-5#1)(1991-1#1)
and desipramine##5##2##(1990-5#2)(1991-1#2)(2008-10#1)
and desired##2##2##(1995-2#1)(2008-10#1)
and desorbed##3##2##(2008-10#3)
and desorption##7##2##(1994-2#1)(2008-10#6)
and destruction of##6##3##(1990-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-12#1)(2013-1#1)
and destructive##5##2##(2008-10#4)(2013-1#1)
and detach at the end of a capillary tip##2##9##(2008-10#2)
and detached##5##2##(1994-2#1)(2008-10#4)
and detachment##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
and detailed unit presents##2##4##(2008-9#2)
and detailed##16##2##(1990-9#1)(1991-6#1)(1992-3#1)(1993-12#1)(1995-6#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-9#4)(2012-12#1)(2013-1#1)
and details##4##2##(1994-12#1)(2008-11#1)(2008-9#2)
and detect##3##2##(1993-3#1)(2012-2#1)(2012-3#1)
and detectable##3##2##(1995-6#1)(2008-10#1)(2008-7#1)
and detected at##6##3##(2008-10#6)
and detected by##8##3##(2008-10#8)
and detected the##4##3##(2008-10#2)(2008-9#1)(2013-8#1)
and detected using##4##3##(2008-10#3)(2008-4#1)
and detected##30##2##(1995-12#1)(2008-10#25)(2008-4#1)(2008-9#2)(2013-8#1)
and detecting##2##2##(2008-10#1)(2010-12#1)
and detection and##2##3##(2008-10#1)(2008-4#1)
and detection by##4##3##(2008-10#3)(2012-2#1)
and detection for##2##3##(2008-10#1)(2012-2#1)
and detection limit 0##4##4##(2008-10#4)
and detection limit of 0##2##5##(2008-10#2)
and detection limit of##8##4##(2008-10#8)
and detection limit was##3##4##(2008-10#3)
and detection limit were##3##4##(2008-10#3)
and detection limit##27##3##(2008-10#27)
and detection limits are##3##4##(1995-9#2)(2008-10#1)
and detection limits for linear homoscedastic assays##2##7##(1995-9#2)
and detection limits of 0##3##5##(2008-10#3)
and detection limits of##5##4##(2008-10#5)
and detection limits##18##3##(1995-9#4)(2008-10#13)(2013-1#1)
and detection methods##3##3##(2008-10#3)
and detection of a benzo[a]pyrene##2##5##(2008-10#2)
and detection of a##3##4##(2008-10#3)
and detection of the##2##4##(2008-10#2)
and detection of##37##3##(1992-11#1)(1994-6#1)(1995-2#1)(1997-2#1)(2008-10#26)(2008-4#2)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
and detection systems##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
and detection was##4##3##(2008-10#4)
and detection were##3##3##(2008-10#3)
and detection##130##2##(1992-11#1)(1994-6#1)(1995-2#1)(1995-9#4)(1996-8#1)(1997-2#1)(2008-10#105)(2008-12#1)(2008-4#3)(2008-6#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#3)
and detector were##2##3##(2008-10#2)
and detector##11##2##(1990-12#1)(2008-10#8)(2008-3#2)
and detects##2##2##(2008-10#1)(2009-5#1)
and deterioration of##3##3##(2008-10#1)(2010-1#1)(2010-3#1)
and determinants of##3##3##(1991-8#2)(2011-2#1)
and determination by flame atomic absorption spectrometry##6##7##(2008-10#6)
and determination by flow##2##4##(2008-10#2)
and determination by inductively coupled plasma optical emission spectrometry##2##9##(2008-10#2)
and determination by inductively coupled plasma##3##6##(2008-10#3)
and determination by inductively coupled##4##5##(2008-10#4)
and determination by##24##3##(2008-10#24)
and determination in aqueous medium##2##5##(2008-10#2)
and determination in##6##3##(2008-10#6)
and determination limits of##4##4##(2008-10#4)
and determination of Cr(III) and Cr(VI) in##2##7##(2008-10#2)
and determination of Cr(III)##3##4##(2008-10#3)
and determination of aloperine##2##4##(2008-10#2)
and determination of copper in##3##5##(2008-10#3)
and determination of copper##9##4##(2008-10#9)
and determination of inorganic##3##4##(2008-10#3)
and determination of l-tyrosine##2##4##(2008-10#2)
and determination of lead in##4##5##(2008-10#4)
and determination of lead##7##4##(2008-10#7)
and determination of metal ions##2##5##(2008-10#2)
and determination of metal##3##4##(2008-10#3)
and determination of nitroaniline##2##4##(2008-10#2)
and determination of terbinafine##2##4##(2008-10#2)
and determination of the pesticide##2##5##(2008-10#2)
and determination of the##7##4##(2008-10#4)(2008-5#1)(2009-5#1)(2013-1#1)
and determination of this##2##4##(2008-10#1)(2011-2#1)
and determination of trace amounts of##4##6##(2008-10#4)
and determination of trace##8##4##(2008-10#8)
and determination of two##3##4##(2008-10#3)
and determination of ultra trace amounts of##3##7##(2008-10#3)
and determination of##141##3##(1993-2#1)(1994-5#1)(2008-10#128)(2008-11#2)(2008-5#1)(2009-5#1)(2009-8#2)(2011-2#3)(2012-2#1)(2013-1#1)
and determination##192##2##(1992-5#1)(1993-2#1)(1994-5#1)(2008-10#178)(2008-11#2)(2008-5#1)(2009-5#1)(2009-8#2)(2011-2#3)(2012-2#1)(2013-1#1)
and determinations##2##2##(2008-10#2)
and determine the##5##3##(1994-3#1)(2008-10#4)
and determine whether##3##3##(2008-5#1)(2009-10#1)(2011-2#1)
and determine##18##2##(1994-3#1)(2008-10#12)(2008-5#2)(2009-10#1)(2011-2#1)(2012-3#1)
and determined by FAAS##2##4##(2008-10#2)
and determined by HPLC##2##4##(2008-10#1)(2009-8#1)
and determined by flame atomic absorption spectrometry (FAAS)##3##8##(2008-10#3)
and determined by flame atomic absorption spectrometry##4##7##(2008-10#4)
and determined by flame atomic absorption##5##6##(2008-10#5)
and determined by reversed-phase HPLC##2##5##(2008-10#2)
and determined by##22##3##(2008-10#20)(2009-8#1)(2013-1#1)
and determined in standard and##2##5##(2008-10#2)
and determined in##3##3##(2008-10#3)
and determined similarly##5##3##(2008-10#5)
and determined spectrophotometrically using##2##4##(2008-10#2)
and determined spectrophotometrically##6##3##(2008-10#6)
and determined the##6##3##(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-1#1)
and determined using##3##3##(2008-10#2)(2008-11#1)
and determined whether##2##3##(1993-3#1)(2011-2#1)
and determined with an##2##4##(2008-10#2)
and determined with##5##3##(2008-10#5)
and determined##65##2##(1993-3#1)(1995-8#1)(1997-4#1)(2008-10#53)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#2)(2013-1#1)
and determines##2##2##(2008-8#1)(2013-8#1)
and determining the##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
and determining##11##2##(1996-1#1)(1996-2#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-9#1)(2012-12#1)
and deterministic##2##2##(2008-10#2)
and detoxification of##2##3##(2008-10#1)(2011-1#1)
and detoxification##4##2##(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)
and detuning##2##2##(2008-3#2)
and develop##18##2##(1993-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
and developed a##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
and developed by##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
and developed for##2##3##(2008-10#2)
and developed in##2##3##(2008-1#1)(2008-11#1)
and developed##31##2##(1990-6#1)(1991-2#1)(1995-2#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
and developing countries##5##3##(1996-12#1)(2008-11#2)(2012-3#1)(2013-1#1)
and developing germ##2##3##(2008-10#1)(2012-2#1)
and developing##16##2##(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
and development and##4##3##(1994-3#1)(2008-10#1)(2009-6#1)(2010-8#1)
and development in##3##3##(1992-12#1)(1996-12#1)(2009-8#1)
and development issues##2##3##(1996-2#1)(2008-11#1)
and development of a##3##4##(2008-10#2)(2008-5#1)
and development of novel##2##4##(2010-8#1)(2011-3#1)
and development of the nervous system in the brine shrimp Artemia salina Linnaeus##2##13##(2007-12#2)
and development of the##7##4##(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
and development of##61##3##(1990-3#1)(1991-1#1)(1991-2#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#6)(2011-3#5)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
and development were##2##3##(2008-10#1)(2008-11#1)
and development##122##2##(1990-3#1)(1990-6#1)(1991-1#2)(1991-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#14)(2008-12#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#7)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-2#7)(2011-3#5)(2012-12#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
and developmental delay##2##3##(1997-3#2)
and developmental disabilities##2##3##(1993-3#1)(2010-10#1)
and developmental disorders##3##3##(2013-8#3)
and developmental##31##2##(1993-3#1)(1993-6#1)(1997-3#2)(1997-8#2)(2008-10#2)(2008-11#6)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
and developmentally##2##2##(2008-10#1)(2012-2#1)
and developments in##2##3##(2008-11#1)(2010-7#1)
and deviant##2##2##(2008-12#1)(2013-8#1)
and device##2##2##(2009-10#2)
and devices##5##2##(1995-3#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)
and dew##4##2##(2008-10#4)
and dexamethasone##5##2##(1990-11#1)(1990-3#1)(1995-11#1)(2008-10#2)
and dextransulphate##2##2##(2008-11#2)
and di-ortho methoxybenzoyl thiourea##2##4##(2008-10#2)
and diabetes mellitus##6##3##(1996-11#1)(2008-11#1)(2010-11#1)(2010-5#1)(2012-5#1)(2013-1#1)
and diabetes##18##2##(1996-11#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-9#1)(2010-10#1)(2010-11#2)(2010-5#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
and diabetes-extract group##2##3##(2008-12#2)
and diabetic nephropathy##2##3##(1991-11#1)(2008-1#1)
and diabetic retinopathy##3##3##(1995-9#1)(2008-5#1)(2011-2#1)
and diabetic##14##2##(1991-11#1)(1993-8#1)(1994-8#2)(1995-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
and diacylglycerol##2##2##(1994-11#1)(2008-10#1)
and diagnose##3##2##(1997-2#1)(2008-10#1)(2009-10#1)
and diagnoses##2##2##(1990-12#1)(1993-1#1)
and diagnosis are##2##3##(2008-9#1)(2011-2#1)
and diagnosis of pancreatic cancer]##2##5##(1990-11#1)(1990-9#1)
and diagnosis of the##2##4##(2010-10#1)(2012-3#1)
and diagnosis of##9##3##(1990-11#1)(1990-9#1)(1997-7#1)(2008-11#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
and diagnosis##14##2##(1990-11#1)(1990-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
and diagnostic accuracy of##2##4##(1995-11#1)(2008-12#1)
and diagnostic accuracy##3##3##(1995-11#1)(2008-12#1)(2012-3#1)
and diagnostic applications##2##3##(2008-11#1)(2010-12#1)
and diagnostic method##3##3##(2012-12#3)
and diagnostic potential of##3##4##(1997-6#2)(2013-8#1)
and diagnostic##32##2##(1990-9#2)(1991-11#2)(1991-12#1)(1991-8#1)(1993-11#1)(1995-11#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-10#2)(2010-12#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#2)(2013-8#2)
and dialysis treatment##2##3##(2008-1#1)(2011-2#1)
and dialysis##5##2##(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
and diameter and##2##3##(2008-10#1)(2008-12#1)
and diameter of##2##3##(2007-11#1)(2008-10#1)
and diameter##4##2##(2007-11#1)(2008-10#2)(2008-12#1)
and diaphragm##2##2##(1995-8#2)
and diarrhea##3##2##(1992-12#1)(2009-11#1)(2011-2#1)
and diarrhoea##2##2##(1997-8#1)(2011-2#1)
and diastolic arterial blood pressure##2##5##(2011-2#1)(2012-3#1)
and diastolic blood pressure (DBP)##2##5##(1992-12#1)(2008-10#1)
and diastolic blood pressure##9##4##(1992-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-7#1)(2011-1#1)
and diastolic blood##10##3##(1992-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-7#1)(2011-1#1)
and diastolic##21##2##(1991-2#1)(1992-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
and diazepam##3##2##(1990-6#1)(2012-3#1)(2013-1#1)
and diazinon##3##2##(2008-10#3)
and dibenzofurans##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
and dibutyl phthalate (DBP)##2##4##(2008-10#2)
and dibutyl phthalate##3##3##(2008-10#3)
and dichloroacetic##2##2##(2008-10#2)
and dichloromethane##6##2##(2008-10#4)(2008-11#2)
and dichloromethane-methanol##2##2##(2008-10#2)
and dichlorovos##3##2##(2008-10#3)
and diclofenac sodium##2##3##(2008-10#2)
and diclofenac##5##2##(1990-9#2)(2008-10#3)
and did not affect##3##4##(1995-11#1)(2008-10#2)
and did not amplify DNA##2##5##(2008-10#1)(2009-6#1)
and did not contain##2##4##(2008-10#1)(2011-2#1)
and did not correlate##2##4##(1993-3#1)(2008-10#1)
and did not differ##3##4##(1993-6#1)(2008-10#1)(2013-8#1)
and did not exceed##3##4##(2008-10#3)
and did not interfere with the##2##6##(1997-2#1)(2008-10#1)
and did not interfere with##4##5##(1991-5#1)(1997-2#1)(2008-10#2)
and did not produce##2##4##(2008-10#2)
and did not require##2##4##(2008-10#2)
and did not reveal##2##4##(2008-11#1)(2008-12#1)
and did not##45##3##(1990-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-1#1)(2013-8#1)
and did##46##2##(1990-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-1#1)(2013-8#1)
and die##2##2##(1996-5#1)(2008-10#1)
and died##8##2##(1993-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#2)
and dielectric##2##2##(2008-10#2)
and diesel fuel-like##2##3##(2008-10#2)
and diet breadth on##2##4##(2008-9#2)
and diet##8##2##(1990-9#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-9#2)(2012-12#1)(2013-1#1)
and dietary intake##2##3##(2010-9#1)(2011-2#1)
and dietary##10##2##(1992-2#1)(2008-10#1)(2008-4#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)
and differ from##3##3##(1990-5#1)(2009-9#1)(2011-2#1)
and differ in##2##3##(2008-5#1)(2012-2#1)
and differ##6##2##(1990-5#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
and difference##2##2##(2008-3#1)(2008-9#1)
and differences between the##4##4##(1994-6#1)(1995-1#1)(2008-10#1)(2008-11#1)
and differences between##11##3##(1993-1#1)(1994-6#1)(1995-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-3#1)(2010-10#1)(2011-2#1)
and differences in##10##3##(1992-2#1)(1993-2#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
and differences##31##2##(1991-3#1)(1991-8#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-5#1)(2013-1#2)
and different anions##2##3##(2008-10#2)
and different clinical##2##3##(1997-8#1)(2012-3#1)
and different from##3##3##(2008-10#1)(2011-3#1)(2013-8#1)
and different in##2##3##(2008-3#1)(2008-5#1)
and different treatment##2##3##(1990-2#1)(1993-8#1)
and different types##2##3##(2008-10#1)(2012-3#1)
and different##87##2##(1990-12#1)(1990-2#1)(1991-11#2)(1991-6#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-10#26)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#4)
and different-ethnic##2##2##(2009-7#2)
and differential access to##2##4##(1992-2#1)(1993-12#1)
and differential diagnosis of##2##4##(1996-11#1)(2013-1#1)
and differential pulse cathodic stripping voltammetry##2##6##(2008-10#2)
and differential pulse polarography##3##4##(2008-10#3)
and differential pulse voltammetric##2##4##(2008-10#2)
and differential pulse voltammetry (DPV)##3##5##(2008-10#3)
and differential pulse voltammetry##5##4##(2008-10#5)
and differential pulse##17##3##(2008-10#17)
and differential regulation##2##3##(1996-12#1)(2008-11#1)
and differential scanning calorimetry (DSC)##3##5##(1992-10#1)(2008-5#1)(2009-3#1)
and differential scanning calorimetry##4##4##(1992-10#1)(2008-5#2)(2009-3#1)
and differential scanning##5##3##(1992-10#1)(2008-10#1)(2008-5#2)(2009-3#1)
and differential##39##2##(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1996-11#1)(1996-12#1)(2007-12#1)(2008-10#23)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#2)(2013-1#1)
and differentiate between##2##3##(2008-10#1)(2011-2#1)
and differentiate into##3##3##(2008-11#1)(2008-4#1)(2009-10#1)
and differentiate these##2##3##(2008-10#1)(2008-11#1)
and differentiate##12##2##(1995-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2009-10#1)(2010-3#1)(2011-2#1)
and differentiated##8##2##(1994-11#1)(2008-10#3)(2008-11#2)(2009-10#1)(2011-2#1)
and differentiating##3##2##(1995-11#1)(2008-10#1)(2010-8#1)
and differentiation between##2##3##(2008-11#1)(2008-9#1)
and differentiation in##3##3##(1993-11#1)(1995-12#1)(2008-10#1)
and differentiation of murine##2##4##(2008-11#1)(2008-8#1)
and differentiation of the##7##4##(1991-7#1)(1995-11#1)(1995-8#1)(1997-7#1)(2008-10#1)(2009-8#1)(2011-2#1)
and differentiation of##28##3##(1991-6#1)(1991-7#1)(1993-3#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-7#2)(2008-10#8)(2008-11#6)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#2)
and differentiation were##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
and differentiation##72##2##(1991-6#2)(1991-7#1)(1993-11#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#3)(2008-10#9)(2008-11#19)(2008-5#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#2)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)
and difficult to##4##3##(1991-2#1)(2008-10#2)(2012-2#1)
and difficult##11##2##(1991-2#1)(1995-2#1)(2008-10#5)(2008-12#1)(2012-2#1)(2013-8#2)
and difficulties in##2##3##(1992-5#1)(2010-11#1)
and difficulties##8##2##(1992-5#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2010-11#1)(2011-1#1)
and difficulty in interpreting the##2##5##(2011-2#1)(2012-3#1)
and difficulty in##5##3##(1992-9#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and difficulty of##2##3##(2008-11#1)(2013-1#1)
and difficulty##8##2##(1992-9#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and diffraction##4##2##(2008-3#4)
and diffuse##9##2##(1991-12#2)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
and diffusion is##2##3##(2008-1#1)(2013-8#1)
and diffusion of##2##3##(2008-10#1)(2008-11#1)
and diffusion##19##2##(2008-1#1)(2008-10#7)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#4)
and diffusion-weighted##5##2##(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2013-8#1)
and digested with##3##3##(2008-10#3)
and digested##6##2##(2008-10#5)(2008-9#1)
and digestion##2##2##(2008-10#2)
and digestive##8##2##(1992-9#1)(1995-2#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)
and digital##7##2##(1997-3#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)
and dilatation of##3##3##(1994-9#1)(2008-7#2)
and dilatation##4##2##(1994-9#1)(2008-1#1)(2008-7#2)
and dilated##2##2##(1995-12#1)(2013-1#1)
and dill##4##2##(2008-10#4)
and diluted##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
and dilution of##2##3##(2008-10#2)
and dilution plating##2##3##(2008-10#2)
and dilution##5##2##(2008-10#5)
and dimension of the##2##4##(2008-7#2)
and dimensions of##2##3##(2008-10#2)
and dimer##4##2##(1995-8#1)(2008-10#3)
and dimethyl##6##2##(1991-7#1)(1996-5#1)(2008-10#3)(2011-2#1)
and dimethylarsinic acid (DMAA)##2##4##(2008-10#2)
and dimethylarsinic acid##5##3##(2008-10#5)
and dimethylarsinic##8##2##(2008-10#8)
and dimethylglyoxime##2##2##(2008-10#2)
and diminished##4##2##(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
and dioctyl##2##2##(2008-10#2)
and dioxin##2##2##(2008-10#2)
and dioxin-like PCBs in food##3##5##(2008-10#3)
and dioxin-like PCBs##5##3##(2008-10#5)
and dioxin-like compounds##2##3##(2008-10#2)
and dioxin-like##10##2##(2008-10#10)
and dioxins##2##2##(1994-3#1)(2008-11#1)
and dipeptide##2##2##(1996-3#1)(2008-10#1)
and diphenyl-mercury##3##2##(2008-10#3)
and diploma##2##2##(2008-12#2)
and diplopia##2##2##(2008-7#1)(2011-2#1)
and dipyridamole##4##2##(1994-5#2)(1995-8#2)
and direct detection##3##3##(2008-10#2)(2008-3#1)
and direct immersion solid-phase microextraction##2##5##(2008-10#2)
and direct measurement of the##3##5##(2008-10#3)
and direct##50##2##(1990-12#1)(1992-1#1)(1992-12#1)(2008-10#24)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#2)(2010-3#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and directed##5##2##(1997-3#1)(2006-6#1)(2008-10#3)
and direction of the##2##4##(2008-3#1)(2010-8#1)
and direction of##10##3##(1994-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-11#1)(2010-5#1)(2010-8#1)
and direction##13##2##(1994-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2009-11#1)(2009-6#1)(2010-5#1)(2010-8#1)(2013-1#1)
and directional##2##2##(2008-8#1)(2013-1#1)
and directions for future##2##4##(1995-2#1)(2011-2#1)
and directions##4##2##(1995-1#1)(1995-2#1)(2008-10#1)(2011-2#1)
and directly from##2##3##(2008-10#1)(2012-2#1)
and directly introduced into the graphite furnace##2##7##(2008-10#2)
and directly##15##2##(1994-5#1)(1996-3#1)(2008-10#7)(2008-3#2)(2008-7#1)(2010-1#1)(2012-2#1)(2012-3#1)
and disabilities##2##2##(2010-10#1)(2010-8#1)
and disability in##2##3##(1993-3#1)(2013-1#1)
and disability##15##2##(1991-12#1)(1992-12#1)(1993-3#1)(1995-11#1)(1996-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and disabled##5##2##(1991-2#1)(1991-3#1)(1995-3#1)(1997-1#1)(2008-11#1)
and disadvantages of each##5##4##(2008-10#2)(2008-4#1)(2011-2#1)(2013-8#1)
and disadvantages of the##4##4##(1992-3#1)(2008-10#2)(2009-5#1)
and disadvantages of##21##3##(1991-1#1)(1991-3#1)(1992-3#2)(1993-3#1)(1996-1#1)(1997-2#1)(2008-10#7)(2008-4#1)(2009-5#2)(2009-7#1)(2010-3#1)(2011-2#1)(2013-8#1)
and disadvantages##31##2##(1991-1#1)(1991-3#1)(1992-3#2)(1993-3#1)(1996-1#1)(1997-2#1)(2008-10#10)(2008-12#1)(2008-4#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and disappearance of##2##3##(2011-2#1)(2013-8#1)
and disappeared##2##2##(1995-12#1)(2008-5#1)
and disassembly of##2##3##(1994-12#1)(2011-2#1)
and disc diffusion##2##3##(2008-12#1)(2008-7#1)
and discharge##7##2##(1991-2#1)(1992-1#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)
and discharged##2##2##(2008-10#2)
and discharges##3##2##(1991-2#1)(1993-12#1)(2008-11#1)
and disclosure##3##2##(1995-3#1)(2008-1#1)(2008-10#1)
and discoloration##2##2##(2008-10#2)
and discomfort##4##2##(1992-3#1)(2008-12#3)
and discontinuous##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
and discourse##2##2##(2008-9#1)(2011-1#1)
and discovery##2##2##(2011-2#1)(2012-2#1)
and discrete##2##2##(1995-6#1)(2008-10#1)
and discriminant analysis##2##3##(2008-10#1)(2008-11#1)
and discriminant##4##2##(2008-10#2)(2008-11#1)(2009-11#1)
and discrimination against##2##3##(1995-12#1)(2010-10#1)
and discrimination of##2##3##(2008-10#2)
and discrimination power##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
and discrimination##14##2##(1995-12#1)(1996-3#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#2)
and discriminatory##2##2##(2008-11#2)
and discuss a##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
and discuss common##2##3##(2008-11#1)(2011-2#1)
and discuss current##3##3##(2010-7#1)(2010-9#1)(2012-2#1)
and discuss implications##2##3##(2008-9#1)(2009-7#1)
and discuss its##2##3##(2008-11#1)(2010-7#1)
and discuss the implications##2##4##(1995-2#1)(2010-5#1)
and discuss the most##2##4##(2009-10#1)(2010-7#1)
and discuss the possibility##2##4##(1991-5#1)(2009-5#1)
and discuss the potential##2##4##(2011-1#1)(2013-8#1)
and discuss the role of##2##5##(2008-7#1)(2011-2#1)
and discuss the##29##3##(1991-5#1)(1994-12#1)(1994-2#1)(1995-2#2)(1995-5#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
and discuss their implications for##3##5##(2008-8#1)(2009-5#1)(2011-2#1)
and discuss their##9##3##(1995-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
and discuss##66##2##(1991-2#1)(1991-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1995-5#3)(1997-2#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-5#2)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#10)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
and discussed for##2##3##(2008-10#1)(2008-3#1)
and discussed from##2##3##(2008-10#1)(2010-11#1)
and discussed in the light of##2##6##(2008-10#1)(2012-3#1)
and discussed in##6##3##(2008-10#4)(2008-11#1)(2012-3#1)
and discussed##52##2##(1990-9#1)(1995-1#1)(1995-11#1)(1996-2#1)(2008-10#30)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2009-11#1)(2009-3#1)(2010-1#1)(2010-11#1)(2012-3#1)(2013-1#1)
and discusses how##3##3##(1994-3#1)(2008-4#1)(2008-7#1)
and discusses some##2##3##(2008-11#1)(2008-9#1)
and discusses the importance of##3##5##(2008-11#2)(2011-2#1)
and discusses the##19##3##(1991-12#1)(1993-11#1)(1993-3#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-4#2)(2008-9#1)(2011-2#2)(2011-7#1)(2012-12#1)
and discusses their##2##3##(1996-3#1)(2008-11#1)
and discusses##37##2##(1991-12#1)(1993-11#1)(1993-3#2)(1994-3#1)(1996-3#1)(1997-3#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-9#5)(2011-2#3)(2011-7#1)(2012-12#1)(2012-3#1)
and discussing##2##2##(2008-10#1)(2012-2#1)
and discussion of the##2##4##(2008-11#1)(2008-8#1)
and discussion of##4##3##(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)
and discussion##7##2##(1991-6#1)(1997-3#1)(2008-11#3)(2008-7#1)(2008-8#1)
and disease and##2##3##(2008-10#2)
and disease control##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
and disease development##2##3##(2008-10#2)
and disease for##2##3##(1992-5#1)(2008-1#1)
and disease in##2##3##(1993-11#1)(2012-12#1)
and disease incidence at midstem elongation##2##6##(2008-10#2)
and disease incidence was##2##4##(2008-10#2)
and disease incidence##5##3##(2008-10#5)
and disease prevention##4##3##(1995-12#2)(2008-11#1)(2008-7#1)
and disease progression##3##3##(2009-7#1)(2010-1#1)(2010-11#1)
and disease resistance in##2##4##(1992-9#1)(2008-8#1)
and disease resistance##4##3##(1992-9#1)(2008-10#2)(2008-8#1)
and disease severity were##2##4##(2008-10#2)
and disease severity##10##3##(1994-9#1)(2008-10#7)(2008-7#1)(2010-12#1)
and disease states##2##3##(2008-10#1)(2010-10#1)
and disease surveillance##2##3##(1997-3#2)
and disease##94##2##(1990-8#1)(1991-8#1)(1992-5#2)(1992-9#1)(1993-11#2)(1993-12#1)(1994-9#1)(1995-12#2)(1995-5#2)(1997-1#1)(1997-3#3)(1997-7#1)(2006-5#1)(2008-1#1)(2008-10#36)(2008-11#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#2)
and disease-free survival##3##3##(2008-10#1)(2011-2#2)
and disease-free##4##2##(1994-2#1)(2008-10#1)(2011-2#2)
and disease-induced##2##2##(2008-10#2)
and disease-related##2##2##(2008-5#1)(2012-2#1)
and diseased##8##2##(2008-10#6)(2008-4#1)(2013-1#1)
and diseases are##2##3##(1997-7#1)(2008-1#1)
and diseases in##2##3##(1997-8#1)(2008-10#1)
and diseases##8##2##(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#2)(2013-7#2)
and disintegration##2##2##(1997-3#2)
and disordered eating##4##3##(2011-2#1)(2012-2#3)
and disorders##5##2##(1993-11#1)(1997-4#1)(2008-10#1)(2012-3#2)
and dispel##2##2##(2008-7#1)(2010-4#1)
and dispersal##8##2##(2008-10#1)(2008-8#6)(2008-9#1)
and dispersed##5##2##(1991-3#2)(2008-10#2)(2010-4#1)
and dispersion calculations##2##3##(2008-11#2)
and dispersion of##2##3##(2008-10#1)(2008-11#1)
and dispersion##6##2##(2008-10#2)(2008-11#3)(2008-3#1)
and displacement##3##2##(2008-3#1)(2008-9#1)(2009-3#1)
and display##3##2##(1994-5#1)(2008-10#1)(2010-10#1)
and displayed##2##2##(2008-10#2)
and displaying##2##2##(2008-10#2)
and displays a##3##3##(1991-5#1)(1995-6#1)(2008-10#1)
and displays##6##2##(1991-5#1)(1995-6#1)(2008-10#1)(2008-6#2)(2010-8#1)
and disposal of##2##3##(2008-10#2)
and disruptive##2##2##(2008-12#1)(2010-7#1)
and dissection are the##2##4##(2008-11#1)(2012-12#1)
and dissection##5##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
and disseminated##2##2##(2008-11#1)(2011-2#1)
and disseminating##4##2##(1993-12#1)(1997-3#2)(2010-8#1)
and dissemination is##2##3##(2008-7#2)
and dissemination of##4##3##(2008-10#3)(2008-11#1)
and dissemination##11##2##(1991-4#1)(1992-12#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-8#1)(2013-1#1)
and dissociation##7##2##(1991-5#1)(1993-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
and dissolution of the precipitate with##2##6##(2008-10#2)
and dissolution of the##3##4##(2008-10#2)(2008-11#1)
and dissolution studies##2##3##(2008-10#2)
and dissolution##9##2##(2008-10#5)(2008-11#1)(2012-2#3)
and dissolved in ammonium##2##4##(2008-10#2)
and dissolved in##3##3##(2008-10#3)
and dissolved oxygen##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
and dissolved##16##2##(2008-10#11)(2008-11#3)(2011-2#2)
and dissolving##2##2##(2008-10#1)(2008-12#1)
and distal tubal##2##3##(1993-1#2)
and distal tubular##2##3##(1995-11#2)
and distal##14##2##(1993-1#4)(1995-11#2)(1997-8#1)(2007-12#2)(2008-7#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
and distance of##2##3##(2008-10#1)(2010-5#1)
and distance##9##2##(2008-10#4)(2008-8#1)(2010-5#2)(2010-8#1)(2013-1#1)
and distances##2##2##(2008-10#2)
and distant metastases##2##3##(1996-10#1)(2012-3#1)
and distant metastasis##2##3##(2008-10#1)(2010-3#1)
and distant##9##2##(1990-12#1)(1991-6#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
and distensibility##4##2##(2013-3#4)
and distension##2##2##(2008-1#1)(2010-12#1)
and distinct from##3##3##(1992-6#1)(2008-10#2)
and distinct##13##2##(1992-6#1)(1997-2#1)(1997-4#1)(2008-10#7)(2008-11#1)(2011-1#1)(2013-1#1)
and distinctive##2##2##(1997-3#1)(2013-1#1)
and distinguish them##2##3##(2008-10#1)(2013-8#1)
and distinguish##6##2##(1993-12#1)(2008-10#2)(2009-8#1)(2011-2#1)(2013-8#1)
and distinguishable##2##2##(2008-10#1)(2008-11#1)
and distorted##2##2##(2008-10#1)(2012-2#1)
and distraction##2##2##(2010-10#2)
and distress##5##2##(2008-11#3)(2012-3#2)
and distributed##6##2##(1994-3#1)(2008-10#1)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)
and distribution analysis of##2##4##(2008-10#2)
and distribution analysis##3##3##(2008-10#3)
and distribution of species##2##4##(2008-8#2)
and distribution of the##6##4##(1991-3#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-8#1)(2011-2#1)
and distribution of wheat bugs##2##5##(2013-8#2)
and distribution of##39##3##(1990-12#1)(1990-5#1)(1991-3#1)(1992-12#2)(1993-11#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#6)(2008-5#1)(2008-8#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#2)
and distribution on the##2##4##(1991-2#1)(2008-8#1)
and distribution pattern of##3##4##(2007-12#2)(2009-6#1)
and distribution throughout the##2##4##(2008-10#1)(2009-8#1)
and distribution##61##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-11#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(2007-12#2)(2008-10#17)(2008-11#7)(2008-12#1)(2008-5#2)(2008-8#5)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
and distributional impacts of##2##4##(1994-2#2)
and distributions##2##2##(2008-10#1)(2011-2#1)
and district##2##2##(1990-3#1)(2013-1#1)
and disturbance##2##2##(2008-9#1)(2009-10#1)
and dityrosine##2##2##(2009-8#2)
and diuretics##2##2##(2008-1#1)(2013-1#1)
and diuron##3##2##(2008-10#3)
and divalent ions##2##3##(2008-10#1)(2011-2#1)
and divalent##6##2##(2008-10#4)(2011-2#2)
and divergence##3##2##(2012-3#3)
and divergent##3##2##(1992-12#1)(1994-6#1)(2008-10#1)
and diverse##12##2##(2008-1#1)(2008-10#6)(2008-11#2)(2011-2#1)(2012-3#1)(2013-8#1)
and diversity of the##3##4##(1997-9#1)(2012-2#2)
and diversity of##7##3##(1997-9#1)(2008-10#4)(2012-2#2)
and diversity##12##2##(1990-8#1)(1997-9#1)(2008-10#4)(2008-12#1)(2008-8#2)(2012-2#2)(2013-8#1)
and divided into##3##3##(1996-9#1)(2008-12#1)(2011-3#1)
and divided##5##2##(1991-1#1)(1996-9#1)(2008-12#1)(2010-1#1)(2011-3#1)
and division of##2##3##(2008-7#1)(2013-8#1)
and division##6##2##(2008-7#1)(2009-8#1)(2011-2#3)(2013-8#1)
and do not require##3##4##(2008-10#2)(2010-1#1)
and do not##19##3##(1991-1#1)(1992-9#1)(1993-3#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-4#1)(2008-7#2)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
and do##22##2##(1991-1#1)(1992-9#1)(1993-3#1)(1995-2#1)(1996-2#1)(1997-3#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
and docking##2##2##(1995-2#1)(2011-2#1)
and docosahexaenoic acid##2##3##(2010-1#1)(2013-1#1)
and docosahexaenoic##3##2##(2010-1#1)(2011-2#1)(2013-1#1)
and doctors##3##2##(1990-12#1)(1990-3#1)(2011-2#1)
and documentation are##2##3##(1992-2#1)(1996-3#1)
and documentation of##2##3##(1994-12#1)(2013-1#1)
and documentation##4##2##(1992-2#1)(1994-12#1)(1996-3#1)(2013-1#1)
and documents##3##2##(1994-3#2)(2011-2#1)
and does not cause##3##4##(2008-10#2)(2008-12#1)
and does not have a##2##5##(1992-2#1)(2008-10#1)
and does not need##2##4##(2008-10#1)(2008-3#1)
and does not occur in##2##5##(1995-6#1)(2008-11#1)
and does not produce##2##4##(2008-10#2)
and does not require the##2##5##(2008-4#1)(2011-2#1)
and does not require##9##4##(2008-10#3)(2008-3#1)(2008-4#2)(2009-6#1)(2011-2#1)(2012-2#1)
and does not##36##3##(1990-12#1)(1990-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-6#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
and does##40##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
and dog##2##2##(1992-10#1)(2008-10#1)
and dogs##6##2##(1992-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
and doing##2##2##(1994-1#1)(2008-10#1)
and domain##4##2##(1991-6#1)(1995-2#1)(2008-8#1)(2009-5#1)
and dome formation in##2##4##(1995-10#2)
and dome##3##2##(1995-10#2)(2009-2#1)
and domestic animals in##2##4##(1990-3#1)(2008-12#1)
and domestic animals##3##3##(1990-3#1)(2008-12#2)
and domestic##6##2##(1990-3#1)(2008-10#1)(2008-12#2)(2010-4#1)(2011-2#1)
and dominant##9##2##(1995-8#2)(2008-10#3)(2008-11#1)(2012-2#2)(2012-3#1)
and dominants##2##2##(2008-8#1)(2010-8#1)
and donors##3##2##(1992-12#1)(2008-10#1)(2010-12#1)
and dopamine (DA)##2##3##(2008-10#2)
and dopamine in##2##3##(1993-6#1)(2008-10#1)
and dopamine##13##2##(1993-6#3)(1995-12#1)(2008-10#6)(2008-7#1)(2011-1#1)(2012-3#1)
and dopaminergic##4##2##(1994-2#2)(2009-11#1)(2010-12#1)
and doped samples##2##3##(2008-10#2)
and doped##6##2##(2008-10#6)
and doping##2##2##(1990-8#1)(2009-11#1)
and dorsal paragigantocellularis##2##3##(1990-9#2)
and dorsal radioulnar ligaments##2##4##(2008-9#2)
and dorsal raphe##2##3##(1993-3#1)(1994-2#1)
and dorsal##9##2##(1990-9#2)(1993-3#2)(1994-2#1)(2008-10#1)(2008-9#2)(2012-3#1)
and dosage forms##3##3##(2008-10#3)
and dosage##7##2##(2008-10#3)(2008-5#2)(2008-6#1)(2011-2#1)
and dose dependently##2##3##(1994-2#1)(2012-3#1)
and dose##10##2##(1991-5#1)(1991-8#1)(1994-2#1)(1997-1#1)(2008-5#2)(2008-7#2)(2012-3#2)
and dose-dependent manner##2##3##(1994-11#1)(1995-8#1)
and dose-dependent##10##2##(1991-5#1)(1992-8#1)(1994-11#2)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(2010-1#1)
and dot blot##2##3##(2008-10#1)(2008-9#1)
and double stranded##2##3##(1990-5#1)(2008-10#1)
and double##14##2##(1990-5#1)(1991-9#2)(1996-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
and double-stranded RNA##2##3##(2008-10#1)(2008-9#1)
and double-stranded##5##2##(2008-10#3)(2008-9#2)
and down##6##2##(2008-11#3)(2011-2#2)(2013-8#1)
and down-regulation of##3##3##(1997-1#1)(2009-9#1)(2010-4#1)
and downregulation of##2##3##(2008-11#1)(2010-12#1)
and downstream##6##2##(1991-9#1)(2008-3#1)(2008-8#2)(2012-2#1)(2013-1#1)
and downy mildew##5##3##(2008-10#5)
and doxycycline##7##2##(2008-10#7)
and doxycycline)##2##2##(2008-10#1)(2012-3#1)
and dozens of##2##3##(2008-10#1)(2009-8#1)
and drainage of the##2##4##(2008-12#1)(2011-2#1)
and drainage##7##2##(2008-10#1)(2008-12#1)(2009-6#2)(2010-1#1)(2011-2#2)
and drained##2##2##(1996-9#1)(1997-8#1)
and dramatically##2##2##(1996-2#1)(2008-8#1)
and draw##3##2##(1990-2#1)(2008-11#1)(2010-12#1)
and drawbacks of##7##3##(2008-10#3)(2008-3#1)(2012-12#1)(2013-1#2)
and drawbacks##9##2##(2008-10#4)(2008-3#1)(2009-12#1)(2012-12#1)(2013-1#2)
and drawing##2##2##(2008-1#2)
and drawn##2##2##(1994-3#1)(1996-6#1)
and draws##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
and dreaming##2##2##(2013-8#2)
and dreams##2##2##(2008-12#1)(2013-1#1)
and drew##3##2##(1996-5#1)(2008-12#1)(2008-5#1)
and dried##2##2##(2008-10#2)
and drift in##2##3##(2008-10#2)
and drift##3##2##(2008-10#3)
and drinking water samples##2##4##(2008-10#2)
and drinking water##7##3##(1990-3#1)(2008-10#3)(2008-9#3)
and drinking##12##2##(1990-3#1)(2008-10#4)(2008-12#3)(2008-9#3)(2009-7#1)
and drip irrigation##2##3##(2008-10#2)
and drippy##2##2##(2008-10#2)
and drop##2##2##(2008-10#2)
and dropped to##2##3##(2008-10#1)(2008-8#1)
and drought##2##2##(2012-6#2)
and drug dependence##2##3##(2008-6#2)
and drug development##2##3##(2008-10#1)(2008-8#1)
and drug resistance##5##3##(2008-11#3)(2012-2#2)
and drug therapy##2##3##(2009-10#1)(2010-6#1)
and drug transport##2##3##(2008-11#2)
and drug treatment##2##3##(1992-12#1)(2009-12#1)
and drug use##4##3##(1996-6#2)(2009-11#1)(2010-9#1)
and drug##51##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-7#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-6#2)(2008-10#6)(2008-11#8)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2011-3#2)(2012-2#3)(2013-1#2)(2013-8#3)
and drugs##10##2##(1990-11#1)(1993-8#1)(1997-4#1)(1997-6#1)(2008-11#3)(2008-5#1)(2011-2#1)(2013-1#1)
and dry bean##3##3##(2008-10#3)
and dry heat treatment##2##4##(2008-10#2)
and dry heat##3##3##(2008-10#3)
and dry mass##2##3##(2008-10#1)(2008-7#1)
and dry matter##2##3##(2008-10#1)(2008-9#1)
and dry powder##2##3##(1997-2#1)(2007-11#1)
and dry weight of##2##4##(2008-10#2)
and dry weight##3##3##(2008-10#3)
and dry weights of leaves and roots were determined##2##9##(2008-10#2)
and dry weights of leaves and roots##3##7##(2008-10#3)
and dry##31##2##(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#20)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-3#2)(2012-6#1)
and drying##7##2##(2008-10#6)(2011-2#1)
and dsDNA##4##2##(2008-10#2)(2008-4#1)(2008-8#1)
and dsRNAs from##2##3##(2008-10#2)
and dual##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
and due to their##2##4##(2008-10#1)(2008-11#1)
and due to##5##3##(1990-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
and dumping##2##2##(1994-3#1)(2008-10#1)
and duplication of##2##3##(2008-7#1)(2011-2#1)
and durability of##2##3##(2008-10#1)(2013-1#1)
and durability##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
and durable##7##2##(1992-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
and dural##2##2##(2008-7#2)
and duration of stay##2##4##(1992-12#1)(2012-3#1)
and duration of the##2##4##(1990-12#1)(1996-2#1)
and duration of##24##3##(1990-12#1)(1992-12#2)(1992-3#1)(1993-1#1)(1994-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-3#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#3)
and duration##33##2##(1990-12#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#4)
and during a##3##3##(1994-2#1)(2011-2#1)(2013-1#1)
and during recovery from exercise in##2##6##(2013-8#2)
and during the course of a##2##6##(2008-10#2)
and during the stress##2##4##(2008-10#1)(2013-8#1)
and during the##14##3##(1991-6#1)(1992-12#2)(2008-10#7)(2008-11#1)(2013-1#2)(2013-8#1)
and during##32##2##(1990-5#1)(1991-6#1)(1992-12#3)(1993-1#2)(1994-2#1)(1994-3#1)(1995-12#1)(1996-6#1)(2008-10#9)(2008-11#2)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
and durum##2##2##(2008-10#2)
and dye##4##2##(1997-2#1)(2008-10#3)
and dying##4##2##(2008-9#1)(2010-1#1)(2011-2#2)
and dynamic changes##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
and dynamic##39##2##(1992-4#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
and dynamically##3##2##(1990-8#1)(2012-3#2)
and dynamics of a##2##4##(2008-12#1)(2008-8#1)
and dynamics of the##3##4##(1992-9#1)(2008-10#2)
and dynamics of##10##3##(1992-9#1)(1995-10#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
and dynamics##22##2##(1992-9#1)(1993-12#2)(1994-9#1)(1995-10#1)(1995-5#2)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
and dynein##4##2##(2012-2#4)
and dysfunction##4##2##(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
and dyslexia##2##2##(2008-12#2)
and dysplastic##2##2##(2012-3#1)(2013-1#1)
and dyspnea##4##2##(1993-6#1)(2008-12#1)(2010-6#1)(2013-8#1)
and each of the##3##4##(1990-8#1)(1996-12#1)(2008-10#1)
and each of##6##3##(1990-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
and each other##2##3##(1996-1#1)(2010-5#1)
and each##24##2##(1990-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-12#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
and ear##3##2##(2008-10#3)
and earlier##7##2##(1990-3#1)(1990-8#1)(2008-12#1)(2010-7#1)(2011-7#1)(2012-2#1)(2013-1#1)
and early HD individuals##2##4##(2011-8#2)
and early clinical##3##3##(1997-3#1)(2008-11#1)(2010-11#1)
and early decline##2##3##(2008-11#2)
and early detection##2##3##(1993-2#1)(2010-8#1)
and early diagnosis is##2##4##(2008-12#1)(2010-11#1)
and early embryonic##2##3##(2012-2#1)(2012-3#1)
and early embryos##2##3##(1993-6#1)(2012-3#1)
and early infancy##2##3##(1996-9#1)(2013-1#1)
and early intervention##2##3##(2007-11#1)(2011-2#1)
and early life##2##3##(2008-10#1)(2009-10#1)
and early postoperative##2##3##(2011-2#2)
and early spring##2##3##(2008-10#2)
and early treatment##2##3##(2008-6#1)(2010-11#1)
and early twentieth##3##3##(2008-10#1)(2010-1#2)
and early##79##2##(1990-6#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-1#5)(2010-11#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#8)(2011-3#1)(2011-8#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
and earnings in the private health sector##2##7##(1991-2#1)(1992-2#1)
and earnings in the private##3##5##(1991-1#1)(1991-2#1)(1992-2#1)
and ears##2##2##(2008-10#1)(2011-2#1)
and earthworms##2##2##(2008-10#2)
and ease in##2##3##(2008-10#1)(2008-12#1)
and ease of##9##3##(2008-10#4)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and ease##12##2##(2008-10#5)(2008-12#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
and easier to##3##3##(2008-10#1)(2008-4#1)(2009-1#1)
and easier##7##2##(2008-10#4)(2008-4#1)(2009-1#1)(2010-6#1)
and easily available##4##3##(2008-10#3)(2008-5#1)
and easily detected##2##3##(2008-10#1)(2010-6#1)
and easily##21##2##(1994-3#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-6#1)(2013-7#1)
and east##2##2##(2008-10#2)
and eastern##2##2##(2008-10#2)
and easy to use##4##4##(1991-9#1)(1997-3#1)(2008-11#1)(2008-3#1)
and easy to##13##3##(1991-9#1)(1997-3#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#2)(2010-7#1)(2011-2#1)
and easy##27##2##(1991-9#1)(1992-3#1)(1996-12#1)(1997-3#2)(2008-10#12)(2008-11#3)(2008-3#1)(2008-6#1)(2008-9#2)(2010-7#1)(2010-9#1)(2011-2#1)
and eating##2##2##(1993-6#1)(2011-7#1)
and echocardiographic##3##2##(1997-5#1)(2008-11#1)(2011-2#1)
and echocardiography##4##2##(2011-2#2)(2012-2#1)(2013-1#1)
and eco-friendly##2##2##(2008-10#2)
and ecological risk##2##3##(2008-10#1)(2008-8#1)
and ecological systems##2##3##(1995-5#1)(2013-8#1)
and ecological##16##2##(1992-11#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-8#4)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
and ecology and##2##3##(2008-8#1)(2008-9#1)
and ecology##6##2##(2008-10#3)(2008-8#1)(2008-9#2)
and economic benefits##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
and economic burden##2##3##(2007-12#1)(2009-8#1)
and economic consequences##4##3##(1995-1#1)(2008-10#1)(2010-4#1)(2012-2#1)
and economic impact##3##3##(1997-2#1)(2008-7#2)
and economic method##2##3##(2008-10#2)
and economic##42##2##(1991-1#1)(1991-3#1)(1992-12#1)(1994-2#1)(1994-9#1)(1995-1#2)(1997-2#1)(2007-12#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#1)
and economical differential pulse polarographic method has been developed for the determination of trace amount of##2##16##(2008-10#2)
and economical method##3##3##(2008-10#3)
and economical techniques for screening##2##5##(2008-10#2)
and economical##18##2##(1991-12#1)(1994-1#2)(1994-5#1)(2008-10#11)(2008-11#2)(2013-1#1)
and economics of health care finance##3##6##(1991-2#1)(1994-3#2)
and economics of##4##3##(1991-2#1)(1994-3#3)
and economics##5##2##(1991-2#1)(1994-3#3)(1994-8#1)
and economies of scale##2##4##(2010-5#1)(2012-2#1)
and ecotoxicological##2##2##(2008-10#1)(2008-11#1)
and ectopic##2##2##(1995-12#1)(2012-3#1)
and edema##2##2##(1994-9#1)(2011-7#1)
and edible##2##2##(2008-8#1)(2010-7#1)
and edited##2##2##(2008-11#1)(2010-1#1)
and editing##4##2##(2008-4#2)(2011-3#1)(2012-2#1)
and educate##2##2##(1994-1#1)(2008-11#1)
and educated##2##2##(2008-11#1)(2010-11#1)
and education in##3##3##(1994-12#1)(2008-11#1)(2008-12#1)
and education of##4##3##(1995-2#1)(1995-5#1)(2008-11#1)(2011-2#1)
and education##37##2##(1990-2#3)(1991-2#1)(1992-1#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#8)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#3)(2013-1#1)(2013-8#2)
and educational factors##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
and educational##17##2##(1991-6#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-11#4)(2008-12#2)(2009-11#1)(2009-5#1)(2011-2#1)(2012-2#4)
and educationalists##5##2##(2008-11#4)(2008-9#1)
and effect of##12##3##(1990-3#1)(1992-6#1)(1997-2#1)(2008-10#5)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)
and effect on##2##3##(1994-5#1)(2008-10#1)
and effect##14##2##(1990-3#1)(1992-6#1)(1994-5#1)(1997-2#1)(2008-10#6)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)
and effective at##2##3##(1990-5#1)(2010-10#1)
and effective clinical##2##3##(1995-5#1)(2008-12#1)
and effective in this##2##4##(2008-11#2)
and effective in##5##3##(2008-10#1)(2008-11#2)(2009-3#1)(2011-2#1)
and effective management##3##3##(2008-11#1)(2008-12#1)(2010-1#1)
and effective means##2##3##(1990-8#1)(2008-11#1)
and effective method for##3##4##(2008-10#1)(2009-6#1)(2010-3#1)
and effective method of##2##4##(1993-1#1)(1993-12#1)
and effective method to##2##4##(2008-10#1)(2008-5#1)
and effective method##8##3##(1993-1#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)(2010-3#1)
and effective output rates##2##4##(1995-3#2)
and effective technique for##2##4##(2008-3#1)(2009-8#1)
and effective technique##4##3##(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
and effective therapy##2##3##(1997-5#1)(2008-10#1)
and effective##96##2##(1990-5#1)(1990-8#1)(1992-2#1)(1992-6#1)(1993-1#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#4)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#11)(2008-12#5)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
and effectively##16##2##(1991-1#2)(1992-2#1)(1993-2#2)(1995-1#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-6#1)(2010-7#1)(2013-1#1)
and effectiveness of medigap PPOs##2##5##(1992-2#2)
and effectiveness of telemedicine##2##4##(1996-3#2)
and effectiveness of treatment##2##4##(2008-7#1)(2012-2#1)
and effectiveness of##17##3##(1992-12#1)(1992-2#3)(1992-5#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-3#2)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)
and effectiveness##26##2##(1992-12#1)(1992-2#3)(1992-5#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-3#2)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
and effector##4##2##(1990-12#1)(1994-5#1)(1997-8#1)(2013-8#1)
and effects of##14##3##(1992-3#1)(1994-2#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
and effects on##8##3##(1991-12#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-5#1)
and effects##24##2##(1991-12#1)(1992-3#1)(1993-8#1)(1994-2#1)(1995-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#2)
and efficacious##7##2##(1990-3#1)(1993-1#1)(1995-11#1)(1996-1#1)(2008-10#1)(2008-5#1)(2012-3#1)
and efficacy in##2##3##(1995-2#1)(2011-2#1)
and efficacy of the##5##4##(2008-10#1)(2008-11#2)(2010-8#1)(2011-2#1)
and efficacy of these##2##4##(2008-11#1)(2010-6#1)
and efficacy of##27##3##(1994-5#1)(1995-11#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-11#6)(2008-8#1)(2009-12#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
and efficacy##44##2##(1992-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#7)(2008-11#6)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#2)
and efficiency in##2##3##(1992-1#1)(2012-2#1)
and efficiency of##5##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)
and efficiency##19##2##(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#2)(1993-12#1)(1993-3#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
and efficient approach for##3##4##(1991-12#1)(2008-10#1)(2012-3#1)
and efficient method for##3##4##(2008-10#2)(2008-11#1)
and efficient technique##2##3##(2008-10#2)
and efficient tool##2##3##(2008-10#1)(2008-2#1)
and efficient way to##3##4##(2008-10#2)(2008-8#1)
and efficient##57##2##(1991-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-2#2)(2008-10#25)(2008-11#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
and efficiently##6##2##(1993-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-8#1)
and effluents of##2##3##(2008-10#1)(2008-11#1)
and effluents##3##2##(2008-10#2)(2008-11#1)
and efflux and##2##3##(1990-2#1)(2008-11#1)
and efflux##7##2##(1990-2#1)(1994-8#4)(2008-11#1)(2013-1#1)
and effort##4##2##(1994-3#1)(1996-3#1)(2008-10#1)(2008-12#1)
and efforts##4##2##(1993-1#1)(1995-12#1)(1997-3#1)(2012-2#1)
and egg##13##2##(1993-6#1)(2008-10#8)(2008-12#2)(2008-8#1)(2011-2#1)
and eggfish##5##2##(2010-8#5)
and eggs##7##2##(2008-10#5)(2010-8#1)(2011-2#1)
and egression##2##2##(2008-10#2)
and eight of##2##3##(1993-12#1)(2008-5#1)
and eight patients##2##3##(1993-1#1)(2011-2#1)
and eight##24##2##(1992-3#1)(1993-1#2)(1993-12#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-5#3)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)
and eighteen##2##2##(2008-10#1)(2008-7#1)
and either of##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
and either the##2##3##(2008-10#1)(2009-8#1)
and either##19##2##(1991-11#1)(1993-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
and ejected##2##2##(2008-10#2)
and elaboration##2##2##(1996-6#1)(2008-10#1)
and elastic fibers##2##3##(1992-12#1)(2012-2#1)
and elastic recoil##2##3##(1992-9#1)(2009-7#1)
and elastic##12##2##(1992-12#1)(1992-9#1)(2008-10#1)(2008-5#3)(2009-7#3)(2009-9#1)(2011-3#1)(2012-2#1)
and elasticity##4##2##(2008-5#3)(2008-9#1)
and elastin##2##2##(1991-9#1)(2008-5#1)
and elderly people##2##3##(1991-11#1)(1995-3#1)
and elderly##6##2##(1991-11#1)(1995-3#1)(2008-7#3)(2013-8#1)
and electrical isolation##2##3##(2008-11#1)(2010-6#1)
and electrical##7##2##(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-6#1)(2012-3#1)
and electrically##2##2##(2008-10#1)(2008-9#1)
and electroanalytical##2##2##(2008-10#1)(2010-7#1)
and electrocardiographic##3##2##(1991-12#1)(2008-12#1)(2008-7#1)
and electrocatalysis of##3##3##(2008-10#3)
and electrocatalysis##5##2##(2008-10#5)
and electrochemical behavior of##2##4##(2008-10#2)
and electrochemical impedance spectroscopy (EIS)##3##5##(2008-10#3)
and electrochemical impedance spectroscopy##4##4##(2008-10#4)
and electrochemical method##3##3##(2008-10#3)
and electrochemical methods##5##3##(2008-10#4)(2010-7#1)
and electrochemical properties##3##3##(1994-3#1)(1996-5#1)(2008-8#1)
and electrochemical techniques##2##3##(2008-10#2)
and electrochemical##33##2##(1994-3#1)(1996-5#1)(2008-10#24)(2008-8#1)(2009-9#1)(2010-7#2)(2012-12#1)(2012-2#2)
and electroconvulsive stimuli##2##3##(1996-12#2)
and electroconvulsive##3##2##(1996-12#2)(2008-7#1)
and electrode##5##2##(1990-8#1)(2008-10#3)(2008-12#1)
and electrodes##3##2##(2008-10#3)
and electrolysis##2##2##(2008-10#2)
and electrolyte leakage##4##3##(2008-10#2)(2008-12#2)
and electrolyte##6##2##(1991-2#1)(2008-10#3)(2008-12#2)
and electrolytes##5##2##(1991-6#1)(2008-10#3)(2011-2#1)
and electrolytic##2##2##(2008-10#1)(2009-10#1)
and electromagnetic##3##2##(1992-3#1)(1992-4#1)(2009-10#1)
and electron microscopic##4##3##(1990-8#1)(1995-6#1)(2008-7#1)(2011-2#1)
and electron microscopy##13##3##(1992-2#1)(1997-3#1)(2006-6#1)(2008-10#7)(2008-5#1)(2009-7#1)(2012-2#1)
and electron##32##2##(1990-8#1)(1992-2#1)(1994-5#1)(1995-6#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-7#2)(2011-2#2)(2012-2#2)(2012-5#1)
and electron-dense##2##2##(2007-12#1)(2008-10#1)
and electronic##14##2##(1991-5#1)(1992-10#2)(1992-8#1)(2008-10#3)(2008-7#1)(2009-11#2)(2009-3#1)(2009-7#1)(2010-7#1)(2012-2#1)
and electrophoresed##2##2##(1992-8#1)(2008-4#1)
and electrophysiological##5##2##(1992-6#1)(1992-9#1)(1993-2#1)(1997-3#1)(2012-3#1)
and electrophysiology##2##2##(2008-10#1)(2012-2#1)
and electrospray ionization mass##2##4##(2008-10#2)
and electrospray mass spectrometry detection##3##5##(2008-10#3)
and electrospray mass spectrometry##5##4##(1996-12#1)(2008-10#4)
and electrospray##10##2##(1996-12#1)(1997-2#1)(2008-10#7)(2011-1#1)
and electrostatic##6##2##(1994-12#1)(1997-2#1)(2008-4#1)(2008-7#2)(2010-12#1)
and electrosurgical loop##2##3##(1994-12#2)
and electrothermal atomic absorption spectrometry (ETAAS)##5##6##(2008-10#5)
and electrothermal atomic absorption spectrometry##12##5##(2008-10#12)
and electrothermal##13##2##(2008-10#13)
and elemental analysis##2##3##(2008-10#2)
and elemental carbon##2##3##(2008-10#2)
and elemental##9##2##(2008-10#8)(2008-12#1)
and elements##4##2##(2008-10#3)(2012-12#1)
and elevated##15##2##(1997-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#2)(2012-6#1)(2012-7#1)(2013-8#1)
and elevation of##4##3##(2008-10#2)(2008-7#1)(2009-8#1)
and eleven##2##2##(2010-6#1)(2013-7#1)
and elicitin##2##2##(2008-10#2)
and eliciting##2##2##(2008-12#1)(2013-1#1)
and eliminate##2##2##(1994-3#1)(2008-10#1)
and eliminated##6##2##(2008-10#3)(2008-11#2)(2012-2#1)
and eliminates the##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
and eliminates##4##2##(1994-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
and elimination of interferences##2##4##(2008-10#2)
and elimination of##5##3##(1996-5#1)(2008-10#4)
and elimination##9##2##(1996-5#1)(1997-2#1)(2008-10#5)(2008-11#1)(2009-8#1)
and elm##3##2##(2008-10#3)
and elongation##5##2##(1991-12#1)(1994-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
and elsewhere in##2##3##(2008-10#2)
and elsewhere##8##2##(1995-1#1)(1996-12#1)(2008-10#5)(2008-4#1)
and elucidate##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
and elucidation of##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
and eluent flow##2##3##(2008-10#2)
and eluent##16##2##(2008-10#16)
and eluted with a##2##4##(2008-10#1)(2008-4#1)
and eluted with##6##3##(2008-10#4)(2008-4#1)(2008-5#1)
and eluted##10##2##(2008-10#8)(2008-4#1)(2008-5#1)
and elution flow##2##3##(2008-10#2)
and elution on##2##3##(2008-10#2)
and elution solvents##2##3##(2008-10#2)
and elution steps##2##3##(2008-10#2)
and elution with##2##3##(2008-10#2)
and elution##24##2##(2008-10#24)
and embedded in paraffin##2##4##(2008-10#1)(2008-11#1)
and embodied##2##2##(2008-12#1)(2009-6#1)
and embolization##3##2##(2008-7#1)(2009-9#1)(2012-3#1)
and embryo##3##2##(1996-9#1)(2008-10#1)(2008-9#1)
and embryology##2##2##(1990-6#1)(2012-2#1)
and embryonic red blood##2##4##(1990-8#2)
and embryonic stem cells##2##4##(2008-11#1)(2009-3#1)
and embryonic stem##3##3##(2008-11#2)(2009-3#1)
and embryonic##7##2##(1990-8#2)(2007-12#1)(2008-11#2)(2009-3#2)
and embryos##4##2##(1990-5#1)(2008-4#2)(2009-7#1)
and emerged##2##2##(2008-10#1)(2013-1#1)
and emergence##4##2##(2008-10#3)(2009-4#1)
and emergency care##2##3##(1995-2#1)(2009-6#1)
and emergency##8##2##(1991-3#1)(1992-6#1)(1995-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
and emerging clinical##2##3##(2009-11#1)(2011-2#1)
and emerging##9##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-11#1)(2011-2#1)(2013-8#1)
and emission maxima##5##3##(2008-10#5)
and emission rate##2##3##(2011-10#2)
and emission slit##2##3##(2008-10#2)
and emission spectra of##3##4##(2008-9#2)(2009-10#1)
and emission spectra##5##3##(2008-10#2)(2008-9#2)(2009-10#1)
and emission wavelength##3##3##(1997-2#1)(2008-10#2)
and emission were##4##3##(2008-10#3)(2011-10#1)
and emission##50##2##(1997-2#1)(2008-1#1)(2008-10#40)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#1)(2011-10#3)
and emotion##3##2##(2008-11#3)
and emotional disorders##2##3##(1995-1#1)(1997-2#1)
and emotional responses##2##3##(2009-10#1)(2010-9#1)
and emotional##25##2##(1991-8#1)(1994-5#1)(1995-1#1)(1995-5#1)(1997-2#1)(2008-11#4)(2008-12#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#3)
and emotions##5##2##(1997-3#1)(2008-12#1)(2009-9#1)(2010-1#2)
and empathy##3##2##(1993-12#1)(1995-2#1)(2013-1#1)
and emphasize the importance of##2##5##(2009-10#1)(2011-1#1)
and emphasize the##6##3##(1996-3#1)(1997-1#1)(2008-10#1)(2009-10#1)(2011-1#1)(2012-2#1)
and emphasize##9##2##(1990-9#1)(1992-9#1)(1993-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2009-10#1)(2011-1#1)(2012-2#1)
and emphasized##2##2##(1991-6#1)(2008-11#1)
and emphasizes the##2##3##(1991-2#1)(2013-1#1)
and emphasizing##2##2##(1993-12#1)(2012-2#1)
and empirical results##2##3##(2008-10#1)(2008-8#1)
and empirical studies##2##3##(2013-1#2)
and empirical##14##2##(1992-9#1)(1993-3#1)(1995-11#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#2)
and employed for##2##3##(2008-10#1)(2008-11#1)
and employed##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
and employees##5##2##(1993-12#1)(1993-3#1)(1994-12#2)(2012-3#1)
and employers##2##2##(1993-2#1)(2010-10#1)
and employing##2##2##(1995-2#1)(2008-10#1)
and employment##9##2##(1991-12#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-9#1)(1996-3#1)(1997-2#1)(2011-2#1)
and empty##2##2##(1994-11#1)(2008-10#1)
and emulsified##2##2##(2008-10#2)
and emulsifying properties##2##3##(2010-4#2)
and emulsion stability##2##3##(2008-5#2)
and emulsion##3##2##(2008-4#1)(2008-5#2)
and enable the##3##3##(2009-11#1)(2011-2#2)
and enable##10##2##(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2011-2#3)(2013-1#1)
and enabled##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
and enables the##2##3##(2008-11#1)(2013-8#1)
and enables##7##2##(2008-10#4)(2008-11#1)(2008-7#1)(2013-8#1)
and enabling##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
and enamel##2##2##(1991-2#1)(2011-2#1)
and encoded##2##2##(2008-10#1)(2008-5#1)
and encodes a protein of##3##5##(1993-6#1)(1996-6#2)
and encodes a protein##4##4##(1993-6#1)(1996-6#2)(2008-10#1)
and encodes a##7##3##(1990-11#1)(1993-6#1)(1996-6#2)(1997-9#1)(2008-10#1)(2010-5#1)
and encoding##2##2##(1993-12#1)(2008-6#1)
and encourage##3##2##(2008-5#1)(2010-3#1)(2013-8#1)
and encouraged##2##2##(2008-11#1)(2009-6#1)
and encouraging##6##2##(2008-12#1)(2010-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
and end##5##2##(1992-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
and end-of-life##3##2##(2012-12#3)
and end-point##2##2##(2008-10#2)
and end-stage renal disease##2##4##(1994-12#1)(2008-10#1)
and end-stage##3##2##(1994-12#1)(2008-10#1)(2010-6#1)
and ending with##3##3##(1994-3#2)(2012-2#1)
and ending##4##2##(1994-3#2)(2008-10#1)(2012-2#1)
and endochitinase##2##2##(2008-10#2)
and endocrine##9##2##(1993-12#1)(1993-3#1)(2009-7#2)(2011-1#1)(2012-3#4)
and endocrinologic##3##2##(2008-10#1)(2008-11#2)
and endocrinological##2##2##(2008-4#1)(2012-2#1)
and endocrinologists in##2##3##(2011-2#2)
and endocrinologists##4##2##(2011-2#4)
and endocytosis to polarized growth##2##5##(2009-8#2)
and endocytosis##6##2##(2008-10#1)(2009-3#1)(2009-7#1)(2009-8#3)
and endodermal##2##2##(2008-7#1)(2010-11#1)
and endogenous substances##2##3##(2008-10#2)
and endogenous##13##2##(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-8#1)(2012-2#1)
and endometrial cancer##6##3##(2008-10#2)(2008-4#1)(2011-2#3)
and endometrial##12##2##(1995-3#2)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#6)
and endophytic##3##2##(2008-10#3)
and endorsement of##2##3##(1994-12#1)(2013-1#1)
and endoscopic##15##2##(1991-11#1)(1991-3#1)(1991-6#1)(1993-2#1)(1995-10#1)(1997-1#1)(2008-10#3)(2009-1#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2013-1#1)
and endoscopy##2##2##(1997-8#1)(2013-1#1)
and endothelial cells##7##3##(1991-5#1)(2009-3#2)(2011-2#1)(2012-12#1)(2013-8#2)
and endothelial progenitor cells##2##4##(2010-1#2)
and endothelial##13##2##(1991-5#1)(1996-12#1)(2008-12#1)(2009-3#2)(2010-1#2)(2011-2#1)(2012-12#1)(2012-4#1)(2013-8#3)
and endovascular##3##2##(1997-6#1)(2008-7#1)(2011-3#1)
and endrin##2##2##(2008-10#2)
and ends in##2##3##(1996-3#1)(2008-7#1)
and ends##5##2##(1995-3#1)(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#1)
and endurance training##2##3##(2010-12#1)(2013-8#1)
and endurance##3##2##(2010-12#1)(2011-2#1)(2013-8#1)
and energetic##4##2##(1990-8#1)(1993-8#1)(2008-11#1)(2008-9#1)
and energy expenditure##2##3##(2008-10#1)(2013-1#1)
and energy transfer##2##3##(1992-11#1)(2008-10#1)
and energy##32##2##(1991-5#1)(1992-11#1)(1992-3#1)(1993-3#1)(1996-11#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#4)(2009-8#1)(2010-8#1)(2012-2#4)(2013-1#3)(2013-8#1)
and enforce##2##2##(1993-3#1)(2008-10#1)
and engagement in##2##3##(2009-7#2)
and engagement##6##2##(2008-12#2)(2009-7#2)(2011-2#1)(2012-2#1)
and engineers##3##2##(2009-11#1)(2009-12#1)(2010-10#1)
and enhance patient##2##3##(1992-2#1)(2008-11#1)
and enhance the##3##3##(1997-7#1)(2012-2#2)
and enhance##17##2##(1992-2#1)(1993-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#2)
and enhanced by##2##3##(1990-2#1)(2008-10#1)
and enhanced formation of##2##4##(2008-11#1)(2013-1#1)
and enhanced the##2##3##(1993-8#1)(2008-9#1)
and enhanced##24##2##(1990-2#1)(1993-11#1)(1993-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
and enhancement of##3##3##(1997-1#1)(2008-11#2)
and enhancement##8##2##(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)
and enhancements##2##2##(2010-8#2)
and enhances the##3##3##(1996-2#1)(2008-11#1)(2011-2#1)
and enhances##6##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
and enhancing the##2##3##(1997-3#1)(2008-10#1)
and enhancing##13##2##(1995-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-4#1)
and enlarged##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
and enlargement of the##2##4##(1997-5#1)(1997-7#1)
and enrichment of##6##3##(1995-6#1)(2008-10#4)(2008-4#1)
and enrichment##9##2##(1995-6#1)(2008-10#7)(2008-4#1)
and enrollment##3##2##(1991-3#1)(1994-2#1)(2010-11#1)
and ensiling##2##2##(2008-10#2)
and ensuing##2##2##(2008-10#1)(2009-10#1)
and ensure##3##2##(2008-11#1)(2011-2#1)(2011-3#1)
and ensured##2##2##(2011-2#2)
and ensures##2##2##(1991-2#1)(2008-10#1)
and ensuring##2##2##(2008-11#1)(2008-7#1)
and entails##2##2##(2008-10#2)
and enter hair cells##2##4##(2009-8#1)(2012-2#1)
and enter the##2##3##(2011-2#1)(2011-3#1)
and enter##4##2##(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
and entered into##2##3##(2008-10#1)(2008-12#1)
and entering##3##2##(2007-12#1)(2008-10#1)(2010-9#1)
and entry##2##2##(1994-12#1)(2011-2#1)
and enumerating##3##2##(2008-10#2)(2008-9#1)
and enumeration of##7##3##(2008-10#1)(2008-9#5)(2010-1#1)
and env##3##2##(1994-12#1)(2008-9#2)
and environment##13##2##(1995-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-10#1)(2010-12#2)
and environmental conditions##5##3##(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)
and environmental exposure##2##3##(2008-12#1)(2010-1#1)
and environmental factors are##2##4##(2008-7#1)(2013-7#1)
and environmental factors in##2##4##(2008-11#1)(2011-1#1)
and environmental factors##16##3##(2008-10#3)(2008-11#3)(2008-7#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and environmental influences##3##3##(1995-2#1)(2008-10#1)(2008-12#1)
and environmental interactions of quantitative trait##2##6##(2008-10#2)
and environmental relationships##2##3##(2008-7#2)
and environmental samples##20##3##(2008-10#20)
and environmental stochasticity##2##3##(2008-9#2)
and environmental variables##2##3##(2008-10#2)
and environmental##97##2##(1991-10#1)(1991-12#1)(1995-2#1)(1997-3#1)(2008-10#45)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#5)(2008-9#4)(2009-11#1)(2009-12#3)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
and environmentally friendly##4##3##(2008-10#4)
and environmentally##9##2##(2008-10#7)(2012-2#2)
and enzymatic properties of##2##4##(1995-6#1)(2008-10#1)
and enzymatic##12##2##(1990-9#1)(1995-6#2)(1997-2#2)(1997-8#1)(2008-10#5)(2012-2#1)
and enzyme activity of##2##4##(2011-2#1)(2012-6#1)
and enzyme activity##7##3##(1994-11#1)(1995-2#1)(1996-12#2)(2009-8#1)(2011-2#1)(2012-6#1)
and enzyme##20##2##(1992-10#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(2008-10#8)(2009-8#1)(2010-3#1)(2011-10#1)(2011-2#2)(2012-6#1)
and enzyme-linked immunosorbent assay##3##4##(2008-10#3)
and enzyme-linked##4##2##(1995-11#1)(2008-10#3)
and enzymes##5##2##(2008-11#1)(2008-5#2)(2011-1#1)(2013-1#1)
and eosin##4##2##(2011-2#2)(2013-1#2)
and eosinophil##2##2##(2008-10#1)(2008-11#1)
and eosinophilic##6##2##(1991-12#2)(2008-11#2)(2010-6#1)(2013-1#1)
and eosinophils##4##2##(1992-12#1)(2008-11#1)(2010-6#1)(2013-8#1)
and epicotyls##2##2##(2008-10#1)(2008-8#1)
and epidemic##3##2##(2008-10#3)
and epidemics##5##2##(2008-10#2)(2011-2#2)(2013-8#1)
and epidemiologic##4##2##(1995-9#1)(1997-2#1)(1997-4#1)(2011-2#1)
and epidemiological characteristics##2##3##(2008-7#1)(2011-2#1)
and epidemiological studies##2##3##(1991-12#1)(2008-10#1)
and epidemiological##15##2##(1991-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and epidemiologically##3##2##(1995-12#1)(2011-2#1)(2012-3#1)
and epidemiology of##3##3##(2008-5#1)(2008-9#1)(2011-2#1)
and epidemiology##5##2##(1996-1#1)(2008-5#1)(2008-9#1)(2011-2#2)
and epidermal growth factor##3##4##(1991-7#1)(1995-8#1)(2008-8#1)
and epidermal##8##2##(1991-7#1)(1994-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
and epidermis##4##2##(1996-12#1)(2008-10#1)(2008-5#2)
and epidermoid cancer of cervix##3##5##(2013-1#3)
and epidural anesthesia##4##3##(2012-3#4)
and epidural##6##2##(2007-8#1)(2008-12#1)(2012-3#4)
and epigallocatechin gallate##2##3##(2008-10#1)(2008-11#1)
and epigenetic##6##2##(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
and epigenetically##2##2##(2008-10#1)(2012-3#1)
and epinephrine##5##2##(1997-6#2)(2008-10#2)(2013-1#1)
and epithelial cell##2##3##(1995-9#1)(2008-5#1)
and epithelial cells##6##3##(1990-11#1)(1991-11#2)(2007-11#1)(2008-11#1)(2013-1#1)
and epithelial membrane antigen##4##4##(1991-12#1)(1992-2#1)(1994-8#1)(2008-7#1)
and epithelial##14##2##(1990-11#1)(1991-11#2)(1991-12#1)(1992-2#1)(1994-5#1)(1994-8#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
and epsilon and##3##3##(2008-8#3)
and epsilon##12##2##(1990-8#1)(1995-12#1)(2008-10#1)(2008-8#9)
and equal##6##2##(1993-3#1)(1995-2#1)(2008-10#3)(2009-2#1)
and equally##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
and equations##2##2##(2008-10#1)(2013-8#1)
and equilibrated##2##2##(2008-10#1)(2008-11#1)
and equilibria##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
and equilibrium constants##2##3##(2008-10#1)(2008-4#1)
and equilibrium impairments##4##3##(2011-2#4)
and equilibrium studies##2##3##(2008-10#2)
and equilibrium##17##2##(1995-6#1)(2008-10#9)(2008-3#1)(2008-4#1)(2011-2#5)
and equipment and##2##3##(2008-1#1)(2008-11#1)
and equipment##8##2##(1991-1#1)(2008-1#2)(2008-11#1)(2008-7#2)(2010-4#1)(2012-3#1)
and equivalent##2##2##(2008-10#1)(2008-3#1)
and eradication##2##2##(2008-10#1)(2010-1#1)
and ergosterol##2##2##(2008-10#2)
and erratic##3##2##(1996-3#1)(2008-10#1)(2008-5#1)
and error##7##2##(2008-10#2)(2008-7#1)(2011-1#3)(2012-2#1)
and errors##3##2##(2008-10#2)(2008-3#1)
and erythema##3##2##(1991-11#1)(1991-6#1)(1997-8#1)
and erythrocyte fatty acids##2##4##(2013-8#2)
and erythrocyte##8##2##(1993-2#2)(2008-10#2)(2008-9#1)(2012-12#1)(2013-8#2)
and erythrocytes##3##2##(1991-12#1)(1993-2#2)
and erythroid##2##2##(1991-2#1)(2008-9#1)
and erythropoietin##2##2##(2008-11#1)(2011-2#1)
and escape##2##2##(2008-10#1)(2010-7#1)
and esophageal pH-metry##2##3##(1996-3#2)
and esophageal##9##2##(1990-8#1)(1996-3#2)(2008-12#1)(2008-5#2)(2010-6#1)(2010-7#1)(2013-1#1)
and esophagitis##2##2##(2011-2#2)
and esophagus##2##2##(1990-8#1)(2008-10#1)
and especially in the##2##4##(2009-10#1)(2011-7#1)
and especially in##4##3##(1992-2#1)(2008-10#1)(2009-10#1)(2011-7#1)
and especially of##2##3##(1996-3#1)(2013-1#1)
and especially the##4##3##(2008-10#1)(2008-12#1)(2008-9#2)
and especially##25##2##(1990-5#2)(1990-9#1)(1992-2#1)(1996-3#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#1)(2011-7#1)(2013-1#1)(2013-8#1)
and essential##10##2##(1990-12#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2012-2#2)(2013-1#2)
and essentially##2##2##(2008-10#1)(2008-5#1)
and establish the##3##3##(1994-5#1)(2010-9#1)(2011-2#1)
and establish##6##2##(1994-5#1)(1994-8#1)(2008-10#1)(2010-9#1)(2011-2#1)(2012-3#1)
and established##11##2##(1991-3#1)(1995-1#1)(1995-6#1)(2008-10#4)(2008-3#1)(2009-12#1)(2010-11#1)(2013-1#1)
and establishes the##2##3##(1992-9#1)(2008-7#1)
and establishes##4##2##(1992-9#1)(2008-10#1)(2008-7#1)(2010-11#1)
and establishing##4##2##(2008-10#1)(2011-2#2)(2013-8#1)
and establishment in##2##3##(2008-10#1)(2010-3#1)
and establishment of##7##3##(2008-10#3)(2008-11#1)(2009-1#1)(2010-3#1)(2012-3#1)
and establishment##9##2##(2008-10#4)(2008-11#1)(2009-1#1)(2010-3#2)(2012-3#1)
and esters##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
and estimate the##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
and estimate##5##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)
and estimated by##2##3##(2008-10#2)
and estimated spectrophotometrically##3##3##(2008-10#3)
and estimated the##2##3##(2008-9#1)(2012-3#1)
and estimated##17##2##(2008-10#14)(2008-9#2)(2012-3#1)
and estimates of##2##3##(2008-10#2)
and estimates##5##2##(1994-9#2)(2008-10#2)(2010-1#1)
and estimating either the##2##4##(2008-10#2)
and estimating##5##2##(1995-3#1)(2008-10#2)(2008-6#1)(2008-9#1)
and estimation of##9##3##(2008-10#8)(2009-11#1)
and estimation##10##2##(1995-9#1)(2008-10#8)(2009-11#1)
and estradiol##3##2##(1992-3#1)(2008-11#1)(2008-4#1)
and estrogen receptor##2##3##(1993-1#1)(1993-11#1)
and estrogen##7##2##(1993-1#3)(1993-11#1)(1993-6#1)(1994-2#1)(2008-11#1)
and estrone##2##2##(2008-10#2)
and etching##2##2##(2008-10#1)(2013-1#1)
and ethanol in##3##3##(2008-10#2)(2008-2#1)
and ethanol were##3##3##(2008-10#3)
and ethanol##25##2##(1990-2#1)(1991-1#2)(2008-10#17)(2008-2#2)(2008-7#1)(2011-1#1)(2012-2#1)
and ethanolamine##2##2##(2008-10#1)(2008-7#1)
and ether##2##2##(1994-2#1)(2008-10#1)
and ethical aspects of the##2##5##(1991-3#1)(2008-11#1)
and ethical aspects##3##3##(1991-3#1)(2008-11#1)(2012-12#1)
and ethical considerations##2##3##(1996-6#1)(2008-11#1)
and ethical issues##3##3##(1992-3#1)(2008-11#1)(2013-1#1)
and ethical##18##2##(1991-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1994-9#1)(1995-9#1)(1996-6#1)(2008-11#3)(2008-12#1)(2008-9#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
and ethics in##2##3##(1991-3#1)(1997-8#1)
and ethics##8##2##(1991-3#1)(1992-12#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-12#1)(2012-2#1)
and ethnic groups##3##3##(1992-2#1)(1997-1#1)(2011-2#1)
and ethnic##10##2##(1992-2#1)(1997-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-1#1)(2011-2#3)(2013-1#1)
and ethnicity##2##2##(2010-9#1)(2011-2#1)
and ethoxyresorufin##2##2##(1994-8#1)(2008-11#1)
and ethyl acetate##6##3##(2008-10#4)(2008-12#2)
and ethyl##13##2##(2008-10#11)(2008-12#2)
and ethylacetoacetate##2##2##(2008-10#1)(2008-11#1)
and ethylene glycol##2##3##(2008-10#2)
and ethylene production##2##3##(2008-10#1)(2011-2#1)
and ethylene##9##2##(2008-10#8)(2011-2#1)
and ethylenediaminetetraacetic acid (EDTA)##2##4##(2008-10#2)
and etiological##3##2##(1992-5#1)(2008-10#1)(2008-12#1)
and etiology of##3##3##(1994-6#1)(2008-4#1)(2012-3#1)
and etoposide##3##2##(1993-8#1)(1994-12#1)(2008-10#1)
and eukaryotes##4##2##(1992-12#1)(1996-12#1)(2011-2#1)(2012-3#1)
and eukaryotic##6##2##(1997-7#2)(2008-10#1)(2009-6#1)(2009-9#1)(2012-2#1)
and euthanasia##2##2##(1990-6#1)(2011-2#1)
and evacuation of##2##3##(1991-11#1)(2012-12#1)
and evacuation##3##2##(1991-11#1)(2008-7#1)(2012-12#1)
and evade##2##2##(2013-1#2)
and evaluate a##5##3##(2008-10#1)(2008-2#1)(2008-6#1)(2010-7#1)(2010-8#1)
and evaluate its##2##3##(2008-11#2)
and evaluate the##5##3##(1994-1#1)(1997-6#1)(2008-11#2)(2008-3#1)
and evaluate##22##2##(1994-1#1)(1996-1#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-7#1)(2010-8#1)(2013-1#1)
and evaluated as##3##3##(1993-1#1)(2008-10#2)
and evaluated by the##4##4##(1994-3#1)(2008-10#2)(2008-11#1)
and evaluated by##7##3##(1992-12#1)(1994-3#1)(2008-10#3)(2008-11#1)(2013-1#1)
and evaluated for the##2##4##(2008-10#2)
and evaluated for their##3##4##(1991-5#1)(2008-11#1)(2008-12#1)
and evaluated for##13##3##(1991-5#1)(1992-12#1)(2008-10#9)(2008-11#1)(2008-12#1)
and evaluated in##4##3##(1992-12#1)(2008-10#1)(2008-11#2)
and evaluated the##4##3##(1995-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
and evaluated with##2##3##(2008-10#1)(2008-12#1)
and evaluated within##2##3##(2008-10#1)(2008-11#1)
and evaluated##63##2##(1991-5#1)(1992-12#3)(1992-9#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-12#1)(2008-10#34)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-4#1)(2013-1#1)(2013-8#1)
and evaluates the##3##3##(1994-2#1)(1994-3#1)(1995-12#1)
and evaluates##4##2##(1994-2#1)(1994-3#1)(1995-12#1)(2008-10#1)
and evaluating a##2##3##(1991-12#1)(1995-3#1)
and evaluating the delivery of services under managed care##2##9##(1997-2#2)
and evaluating the##14##3##(1991-1#1)(1992-1#1)(1997-2#3)(2008-10#2)(2008-11#2)(2008-12#3)(2008-6#1)(2009-10#1)
and evaluating##23##2##(1991-1#1)(1991-12#1)(1992-1#1)(1995-3#1)(1996-2#1)(1997-2#3)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)
and evaluation in##2##3##(2008-10#1)(2008-12#1)
and evaluation of a##12##4##(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2012-2#1)
and evaluation of an##4##4##(2008-10#3)(2008-12#1)
and evaluation of the##4##4##(1991-1#1)(2007-11#1)(2008-11#1)(2008-7#1)
and evaluation of their##2##4##(1996-2#1)(2011-2#1)
and evaluation of##44##3##(1991-1#1)(1992-1#1)(1993-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-11#5)(2008-12#5)(2008-3#1)(2008-6#1)(2008-7#2)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and evaluation##56##2##(1991-1#1)(1992-1#1)(1993-11#1)(1994-6#1)(1995-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#16)(2008-11#6)(2008-12#8)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and evaluations##3##2##(1996-2#1)(2008-6#1)(2011-2#1)
and evanescent-wave##2##2##(2010-7#2)
and evaporation##4##2##(2008-10#2)(2008-5#2)
and evasion of##2##3##(2013-1#2)
and even death##4##3##(2007-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
and even distribution of##2##4##(2008-10#1)(2013-1#1)
and even distribution##3##3##(1996-2#1)(2008-10#1)(2013-1#1)
and even if##2##3##(2008-8#1)(2011-3#1)
and even in##2##3##(1997-8#1)(2008-9#1)
and even induced##2##3##(2008-5#1)(2008-9#1)
and even larger##2##3##(2008-10#1)(2008-9#1)
and even less##2##3##(2007-12#1)(2009-8#1)
and even more##2##3##(2008-5#1)(2013-8#1)
and even population##2##3##(2010-5#1)(2012-3#1)
and even the##4##3##(1997-1#1)(1997-7#1)(2008-7#1)(2011-2#1)
and even##75##2##(1992-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#7)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-5#1)(2009-8#4)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
and evening##2##2##(2007-12#1)(2008-10#1)
and evenness##2##2##(2008-10#2)
and events##5##2##(1993-2#1)(1997-3#1)(2008-10#1)(2009-11#1)(2010-5#1)
and eventual##8##2##(1990-5#2)(1992-12#1)(2008-10#2)(2008-2#1)(2012-2#2)
and eventually develop##2##3##(1991-1#1)(2008-7#1)
and eventually##15##2##(1991-1#1)(1994-2#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2013-7#1)(2013-8#1)
and every##4##2##(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)
and everyday##2##2##(2008-11#1)(2008-12#1)
and evidence for the##2##4##(2009-6#1)(2013-8#1)
and evidence for##7##3##(1995-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-6#1)(2013-8#1)
and evidence of##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
and evidence that##2##3##(1997-1#1)(2011-2#1)
and evidence##16##2##(1992-1#1)(1994-3#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
and evidence-based##2##2##(2008-11#1)(2013-8#1)
and evolution in##2##3##(1996-3#1)(2008-8#1)
and evolution of social##2##4##(2008-8#2)
and evolution of the##5##4##(1990-6#1)(1990-7#1)(2008-5#1)(2008-8#1)(2009-8#1)
and evolution of##27##3##(1990-6#1)(1990-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#8)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
and evolution##41##2##(1990-6#1)(1990-7#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
and evolutionarily##2##2##(2009-3#1)(2012-3#1)
and evolutionary biology##2##3##(2007-12#1)(2009-7#1)
and evolutionary processes##2##3##(1995-5#1)(2008-8#1)
and evolutionary##17##2##(1993-2#1)(1995-5#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-8#4)(2008-9#1)(2009-12#2)(2009-7#1)(2011-3#1)(2012-3#1)
and evolving##5##2##(1994-2#2)(2008-11#1)(2010-11#1)(2013-1#1)
and ex##8##2##(2008-10#1)(2008-11#4)(2008-7#1)(2011-2#2)
and exact##4##2##(1990-12#1)(1995-12#1)(2008-3#1)(2008-5#1)
and examination of##3##3##(1997-4#1)(2008-6#1)(2011-2#1)
and examination##8##2##(1991-6#1)(1996-2#1)(1997-4#1)(2008-11#1)(2008-12#2)(2008-6#1)(2011-2#1)
and examinations##3##2##(1990-12#1)(2008-11#1)(2008-12#1)
and examine its##2##3##(2011-2#1)(2013-1#1)
and examine the##6##3##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
and examine##16##2##(1992-12#1)(1993-12#1)(1995-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#2)(2011-2#4)(2013-1#2)
and examined by##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
and examined for##4##3##(2008-10#3)(2008-9#1)
and examined to##2##3##(2008-3#1)(2008-8#1)
and examined##16##2##(1991-10#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-3#1)(2013-8#1)
and examines##6##2##(2008-1#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-2#1)
and examining the##2##3##(1996-9#1)(2008-11#1)
and examining##3##2##(1996-9#1)(2008-11#1)(2008-7#1)
and example##2##2##(2008-10#1)(2008-3#1)
and examples are##2##3##(2008-11#1)(2008-3#1)
and examples##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
and exceed##2##2##(1994-2#1)(2008-12#1)
and excellent agreement##2##3##(2008-10#1)(2008-7#1)
and excellent stability##2##3##(2008-10#1)(2008-11#1)
and excellent##21##2##(1990-2#1)(1997-3#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
and exceptionally##2##2##(2007-8#1)(2013-8#1)
and excess body##2##3##(2011-2#1)(2012-2#1)
and excess##8##2##(1993-2#1)(1995-8#1)(1996-11#1)(2008-10#3)(2011-2#1)(2012-2#1)
and excessive##8##2##(2008-10#3)(2008-11#1)(2008-7#2)(2009-7#1)(2009-8#1)
and exchange of information##4##4##(1991-2#3)(1996-12#1)
and exchange##9##2##(1991-2#3)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#2)(2011-2#1)
and excipient##2##2##(2008-5#1)(2011-2#1)
and excipients in##2##3##(2008-10#2)
and excipients##4##2##(2008-10#4)
and excised##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
and excision of the##3##4##(1992-6#1)(2008-10#1)(2008-12#1)
and excisional biopsy##2##3##(2010-11#2)
and excitation emission##2##3##(2008-10#2)
and excitation wavelength##2##3##(2008-10#1)(2008-9#1)
and excitation##6##2##(2008-10#5)(2008-9#1)
and excited-state absorption##3##3##(2008-3#3)
and exciting##4##2##(1994-12#1)(2010-10#1)(2011-1#1)(2013-1#1)
and excluded##2##2##(2008-12#1)(2013-1#1)
and exclusion of##2##3##(1994-2#1)(2011-2#1)
and exclusion##7##2##(1994-2#1)(2008-11#1)(2011-2#2)(2012-12#1)(2013-1#2)
and exclusive##2##2##(1991-3#1)(2008-10#1)
and excretion of##2##3##(2008-11#1)(2012-2#1)
and excretion##4##2##(1993-12#1)(2008-11#1)(2011-2#1)(2012-2#1)
and execution of##5##3##(1992-3#1)(2008-11#3)(2013-1#1)
and execution##7##2##(1991-6#2)(1992-3#1)(2008-11#3)(2013-1#1)
and executive functions##2##3##(2008-2#1)(2009-10#1)
and executive##4##2##(1996-1#1)(2008-2#1)(2009-10#1)(2012-2#1)
and executives##2##2##(1996-3#1)(2008-11#1)
and exercise in##2##3##(1992-12#1)(2008-12#1)
and exercise tolerance##2##3##(2010-4#1)(2013-8#1)
and exercise##14##2##(1992-12#1)(1993-2#1)(2008-1#1)(2008-12#3)(2008-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#2)
and exerts##2##2##(2008-8#1)(2012-3#1)
and exhaustive##2##2##(2008-10#2)
and exhibit the##2##3##(2008-10#1)(2008-8#1)
and exhibit##8##2##(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)
and exhibited a##2##3##(2008-10#1)(2008-11#1)
and exhibited good reproducibility##2##4##(2008-10#2)
and exhibited good##5##3##(2008-10#4)(2010-4#1)
and exhibited##23##2##(1992-6#1)(1997-4#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)
and exhibits##5##2##(1994-5#1)(2008-10#3)(2009-7#1)
and existential##2##2##(1991-2#1)(2012-3#1)
and existing##3##2##(1997-2#1)(2011-2#1)(2013-8#1)
and exit##4##2##(1991-3#1)(1993-9#1)(2008-12#1)(2008-3#1)
and exocytosis of##2##3##(1995-2#1)(1997-7#1)
and exocytosis##4##2##(1995-2#1)(1997-7#1)(2008-11#1)(2009-8#1)
and exogenous factors##2##3##(2008-10#2)
and exogenous##8##2##(1992-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2012-12#1)(2012-2#1)
and exon##2##2##(1996-2#1)(2012-3#1)
and exotic##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
and expand the##2##3##(1994-2#1)(1996-12#1)
and expand##4##2##(1991-2#1)(1994-2#1)(1995-12#1)(1996-12#1)
and expanded in##2##3##(2009-6#1)(2011-2#1)
and expanded##9##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2011-3#1)
and expanding##4##2##(1996-3#2)(1997-2#1)(2008-11#1)
and expansion of##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
and expansion##7##2##(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)
and expect to##2##3##(2008-10#1)(2013-8#1)
and expectations of##2##3##(2008-11#1)(2011-1#1)
and expectations regarding##2##3##(1993-6#1)(2011-2#1)
and expectations##7##2##(1993-6#1)(1995-12#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-2#1)
and expected heterozygosity##2##3##(2013-8#2)
and expected##9##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-6#1)(2013-1#1)(2013-8#2)
and expenditure##4##2##(1991-2#1)(1992-1#1)(1993-3#1)(2012-2#1)
and expenditures for##2##3##(1991-12#1)(1994-12#1)
and expenditures##5##2##(1991-12#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-2#1)
and expensive##4##2##(1996-11#1)(2010-7#1)(2011-2#1)(2013-1#1)
and experience in##2##3##(2008-10#1)(2010-10#1)
and experience of##3##3##(1997-5#1)(2008-1#2)
and experience with##4##3##(1994-2#1)(1996-1#1)(2008-11#1)(2008-7#1)
and experience##23##2##(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-3#1)(2013-1#1)
and experienced nurses##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
and experienced##9##2##(1993-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)
and experiences of##5##3##(2008-1#2)(2008-12#3)
and experiences with##3##3##(1993-3#1)(1997-3#1)(2010-8#1)
and experiences##13##2##(1993-3#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-12#4)(2008-6#1)(2010-10#1)(2010-8#1)(2013-1#1)
and experiencing##3##2##(2007-12#1)(2009-12#1)(2012-3#1)
and experiential##2##2##(2008-1#1)(2009-8#1)
and experiment##7##2##(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)
and experimental data##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)(2010-10#1)
and experimental design##2##3##(2008-10#1)(2008-8#1)
and experimental evidence##2##3##(2008-8#1)(2011-2#1)
and experimental investigation of the##2##5##(2008-3#2)
and experimental results are presented##4##5##(2008-3#4)
and experimental results for##2##4##(2008-2#1)(2008-7#1)
and experimental results##11##3##(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#2)(2011-2#1)
and experimental spectra##2##3##(2008-3#2)
and experimental studies##3##3##(2008-8#1)(2009-7#1)(2010-12#1)
and experimental uncertainty##3##3##(2008-10#1)(2008-7#2)
and experimental validation##3##3##(2008-11#2)(2011-2#1)
and experimental##67##2##(1994-6#1)(1994-8#1)(1997-8#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-9#1)
and experimentally verified##2##3##(2008-10#1)(2008-7#1)
and experimentally##14##2##(1992-6#1)(1997-2#1)(2008-10#4)(2008-3#4)(2008-7#1)(2008-8#1)(2009-7#1)(2011-3#1)
and experiments with##2##3##(1991-3#1)(2008-11#1)
and experiments##11##2##(1991-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#2)(2012-3#1)(2013-8#1)
and expert opinion##2##3##(1996-2#1)(2012-3#1)
and expert opinions##2##3##(1995-5#1)(2011-2#1)
and expert##7##2##(1992-2#1)(1995-5#1)(1996-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
and expertise##3##2##(1995-11#1)(2011-9#1)(2012-2#1)
and experts##2##2##(2008-5#1)(2011-8#1)
and explain the##4##3##(2008-10#1)(2008-4#1)(2008-7#2)
and explain##6##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)
and explained more than##2##4##(2008-10#1)(2013-1#1)
and explained##16##2##(1993-12#1)(2008-10#11)(2008-8#1)(2010-10#1)(2010-2#1)(2013-1#1)
and explains how they##2##4##(1992-12#1)(2009-10#1)
and explains the##2##3##(2008-4#1)(2011-1#1)
and explains##5##2##(1992-12#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-1#1)
and exploration##2##2##(2008-8#1)(2010-7#1)
and exploratory factor analyses##2##4##(2009-11#1)(2010-11#1)
and exploratory##3##2##(2009-11#1)(2010-11#1)(2012-3#1)
and explore##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
and explored the##2##3##(1992-2#1)(2008-11#1)
and explored##8##2##(1992-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-11#1)(2010-9#1)
and explores the##2##3##(1996-2#1)(2010-5#1)
and explores##5##2##(1996-2#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-7#1)
and exploring##2##2##(2008-10#1)(2012-3#1)
and explosive##2##2##(2008-10#1)(2008-7#1)
and explosives##2##2##(2008-10#2)
and export##6##2##(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
and exposed in##2##3##(2006-6#1)(2008-11#1)
and exposed the##2##3##(1995-6#1)(2008-10#1)
and exposed to a##2##4##(2008-11#1)(2008-9#1)
and exposed to different##2##4##(2008-10#2)
and exposed to##11##3##(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
and exposed##19##2##(1993-9#1)(1995-6#1)(2006-6#1)(2008-10#9)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
and exposure periods##2##3##(2008-10#2)
and exposure time##3##3##(2008-10#3)
and exposure times on the##2##5##(2008-10#2)
and exposure times##3##3##(2008-10#2)(2012-2#1)
and exposure to a##2##4##(2010-10#1)(2010-11#1)
and exposure to##9##3##(1990-8#1)(1991-12#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2010-10#1)(2010-11#1)
and exposure##23##2##(1990-8#1)(1991-12#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-10#12)(2008-4#1)(2008-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2012-2#1)
and express##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
and expressed at##2##3##(1990-5#1)(1994-8#1)
and expressed in Escherichia coli##6##5##(1993-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-9#1)
and expressed in##13##3##(1990-11#1)(1991-5#1)(1993-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)
and expressed under the##2##4##(2008-10#1)(2008-8#1)
and expressed##29##2##(1990-11#1)(1990-5#1)(1991-5#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-4#3)(2008-8#3)(2008-9#1)
and expression analyses##2##3##(1996-8#1)(2010-5#1)
and expression analysis of##2##4##(2008-8#1)(2010-5#1)
and expression analysis##3##3##(2008-8#1)(2008-9#1)(2010-5#1)
and expression characterization of##2##4##(2008-8#1)(2008-9#1)
and expression in##4##3##(1990-8#1)(1991-5#1)(1993-2#1)(2008-8#1)
and expression level of##2##4##(1997-8#1)(2008-9#1)
and expression level##3##3##(1997-8#1)(2008-10#1)(2008-9#1)
and expression levels of##2##4##(2008-11#1)(2012-3#1)
and expression levels##4##3##(1993-6#1)(2008-11#2)(2012-3#1)
and expression of a##7##4##(1991-9#1)(1993-6#2)(1995-6#1)(1997-2#1)(2013-1#1)(2013-8#1)
and expression of co-stimulatory molecules##2##5##(2008-10#2)
and expression of foreign genes##2##5##(1995-5#1)(2008-11#1)
and expression of the##10##4##(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#2)(1996-12#1)(1997-7#1)(2008-11#2)(2008-5#1)
and expression of##48##3##(1990-5#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-6#2)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-7#2)(1997-8#2)(2007-11#1)(2008-10#3)(2008-11#8)(2008-5#1)(2008-8#2)(2008-9#5)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and expression pattern##2##3##(1997-7#2)
and expression patterns of##2##4##(1993-12#1)(2012-3#1)
and expression studies##2##3##(1996-6#1)(2008-8#1)
and expression systems##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
and expression##91##2##(1990-5#2)(1990-8#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-2#4)(1993-6#3)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-7#4)(1997-8#3)(1997-9#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#14)(2008-4#1)(2008-5#1)(2008-8#7)(2008-9#9)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
and expressive##4##2##(1996-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
and extend the##3##3##(2008-10#1)(2008-7#1)(2011-7#1)
and extend##7##2##(1994-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-1#1)(2011-2#1)(2011-7#1)
and extended from##2##3##(2008-11#1)(2008-7#1)
and extended into the##2##4##(1990-5#1)(2008-9#1)
and extended the##2##3##(1990-5#1)(2008-10#1)
and extended##18##2##(1990-5#2)(1990-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-1#1)(2010-5#1)(2010-7#1)
and extending to the##2##4##(2008-10#1)(2008-11#1)
and extending##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
and extends the##2##3##(2007-12#1)(2011-2#1)
and extends##5##2##(1993-6#1)(2007-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
and extension of##4##3##(1996-6#1)(2010-1#1)(2012-3#2)
and extension##10##2##(1991-6#1)(1996-6#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-1#1)(2011-2#1)(2012-3#2)
and extensive##16##2##(1991-5#1)(1992-2#1)(1993-2#1)(1995-1#1)(1995-5#1)(1996-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)
and extensively##3##2##(2008-5#1)(2009-9#1)(2010-5#1)
and extent of##19##3##(1990-12#1)(1991-12#1)(1992-6#2)(1994-11#1)(1995-12#1)(1996-6#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
and extent##22##2##(1990-12#1)(1991-12#1)(1992-6#2)(1994-11#1)(1995-12#1)(1996-6#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
and external calibration##2##3##(2008-10#2)
and external factors##3##3##(1991-2#1)(1991-6#1)(2009-10#1)
and external##32##2##(1991-2#1)(1991-6#1)(1992-12#2)(1996-1#3)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#2)(2009-6#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#3)
and externalizing##4##2##(1995-2#1)(2008-12#1)(2013-1#2)
and extinction##5##2##(1992-12#1)(2008-3#2)(2008-9#2)
and extra##2##2##(1994-8#1)(2013-8#1)
and extra-hepatic##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
and extracardiac##2##2##(2010-10#1)(2010-12#1)
and extracellular matrix##4##3##(2008-5#1)(2009-3#1)(2011-1#1)(2013-1#1)
and extracellular##9##2##(2008-10#2)(2008-5#2)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
and extractable organic halogens##2##4##(2008-10#2)
and extractant##3##2##(2008-10#3)
and extracted##6##2##(2008-10#4)(2008-3#1)(2010-7#1)
and extracting##2##2##(2008-10#1)(2012-3#1)
and extraction chromatographic##2##3##(2008-10#2)
and extraction chromatography##2##3##(2008-10#2)
and extraction efficiency##2##3##(2008-10#1)(2012-2#1)
and extraction of the##2##4##(2008-10#2)
and extraction of##4##3##(2008-10#4)
and extraction time were##2##4##(2008-10#2)
and extraction time##7##3##(2008-10#7)
and extraction time) were##2##4##(2008-10#2)
and extraction##30##2##(2008-10#28)(2011-2#1)(2012-2#1)
and extracts##7##2##(2008-10#6)(2012-3#1)
and extreme##6##2##(1990-6#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-7#1)
and extremely##3##2##(1997-3#1)(2008-5#1)(2010-6#1)
and extremities##2##2##(2010-6#1)(2012-2#1)
and extrinsic factors##2##3##(2008-11#1)(2010-7#1)
and extrinsic work values##3##4##(2010-10#3)
and extrinsic work##4##3##(1996-1#1)(2010-10#3)
and extrinsic##12##2##(1996-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-10#3)(2010-7#1)(2011-2#1)(2013-1#1)
and eye##7##2##(2007-12#1)(2008-10#1)(2008-11#2)(2010-1#1)(2011-7#1)(2013-1#1)
and eyes##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
and fabD##2##2##(1992-4#2)
and fabricated##5##2##(2008-10#3)(2008-3#2)
and fabrication of a##2##4##(2008-10#1)(2009-9#1)
and fabrication of##7##3##(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)
and face##6##2##(1994-1#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
and facial##8##2##(1996-5#1)(1997-5#1)(2008-5#1)(2008-9#2)(2011-2#2)(2012-3#1)
and facilitate the##3##3##(2008-10#1)(2010-5#1)(2010-7#1)
and facilitate##14##2##(1994-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#1)(2013-1#3)
and facilitated##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)
and facilitates the##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2013-1#1)
and facilitates##10##2##(1993-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)(2013-1#2)
and facilitating##4##2##(1995-8#1)(1997-3#1)(2008-11#2)
and facilitation in##2##3##(2008-12#1)(2010-8#1)
and facilities##3##2##(2009-3#2)(2009-8#1)
and facility##3##2##(1991-3#1)(1994-12#1)(1995-2#1)
and facing##2##2##(1993-3#1)(2010-7#1)
and factor structure##2##3##(2008-1#1)(2010-1#1)
and factor##6##2##(1991-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-1#1)(2012-12#1)
and factorial design study##2##4##(2008-10#2)
and factors associated with##4##4##(2007-11#1)(2013-1#2)(2013-8#1)
and factors influencing##2##3##(2008-11#1)(2008-12#1)
and factors predicting##2##3##(2008-10#1)(2013-7#1)
and factors that##4##3##(1993-1#1)(2008-10#1)(2008-8#1)(2009-12#1)
and factors##15##2##(1993-1#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and factory workers##3##3##(1991-12#1)(2008-11#2)
and faculty##5##2##(1996-1#2)(2008-11#1)(2008-12#2)
and faecal##2##2##(2008-10#1)(2008-5#1)
and fail to exhibit##2##4##(1994-11#2)
and fail to##4##3##(1990-8#1)(1994-11#2)(2013-1#1)
and failed to##3##3##(1996-6#1)(2008-7#1)(2012-2#1)
and failed##6##2##(1996-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-2#1)
and failure##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
and failures in##2##3##(1991-8#1)(2008-5#1)
and failures##4##2##(1990-11#1)(1991-8#1)(1994-3#1)(2008-5#1)
and fair to##2##3##(1997-8#2)
and fair##5##2##(1997-8#2)(2008-11#3)
and fairly##4##2##(2008-10#3)(2013-1#1)
and fall##7##2##(2008-10#7)
and false negative##2##3##(2008-1#1)(2011-2#1)
and false##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
and familial adenomatous polyposis##2##4##(2009-12#2)
and familial autosomal dominant##2##4##(1997-8#2)
and familial##7##2##(1997-8#2)(2009-12#2)(2010-6#1)(2012-3#2)
and familiarity with##2##3##(2009-5#1)(2012-2#1)
and families are##2##3##(2008-9#1)(2011-2#1)
and families in##3##3##(1992-3#1)(1997-1#2)
and families##24##2##(1990-12#1)(1991-12#3)(1991-2#1)(1992-2#1)(1992-3#1)(1994-1#1)(1997-1#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
and family doctors in the rest of the Netherlands (n = 521)##2##12##(1991-8#2)
and family doctors##3##3##(1991-8#2)(2008-11#1)
and family formation##2##3##(2008-8#1)(2009-10#1)
and family functioning##3##3##(2008-6#1)(2008-7#2)
and family members##2##3##(2008-6#1)(2008-7#1)
and family satisfaction##2##3##(1997-1#1)(2010-2#1)
and family##48##2##(1991-1#1)(1991-8#2)(1992-3#1)(1993-3#1)(1994-1#2)(1995-11#1)(1996-6#2)(1997-1#1)(1997-8#1)(2007-11#1)(2008-11#8)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-8#1)
and far away from ore body rock##2##7##(2013-8#2)
and far from##2##3##(1993-8#1)(2008-11#1)
and far##6##2##(1993-8#1)(2008-11#2)(2008-2#1)(2013-8#2)
and far-field##2##2##(2008-2#1)(2008-3#1)
and farmers##2##2##(1997-7#1)(2010-1#1)
and fast atom bombardment##2##4##(1995-3#1)(2008-10#1)
and fast food##2##3##(2011-2#2)
and fast method for the##4##5##(2008-10#4)
and fast method for##6##4##(2008-10#5)(2008-11#1)
and fast method has been developed for the##2##8##(2008-10#2)
and fast method##10##3##(2008-10#9)(2008-11#1)
and fast procedure for##2##4##(2008-10#1)(2008-6#1)
and fast procedure##3##3##(2008-10#2)(2008-6#1)
and fast response##5##3##(2007-11#1)(2008-10#4)
and fast spectrophotometric determination of##2##5##(2008-10#2)
and fast##47##2##(1995-3#1)(2007-11#1)(2008-10#38)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#4)
and faster##10##2##(1996-3#1)(2008-10#6)(2008-11#1)(2011-2#2)
and fasting##3##2##(2008-11#1)(2008-7#1)(2010-4#1)
and fat##9##2##(1994-5#1)(2008-10#2)(2008-3#2)(2010-4#1)(2010-6#1)(2012-12#1)(2013-7#1)
and fat-free##2##2##(2008-10#1)(2012-2#1)
and fatal injury##2##3##(2008-11#2)
and fatal##5##2##(1991-8#1)(2008-11#2)(2010-5#1)(2011-2#1)
and fate of##3##3##(2008-10#2)(2013-1#1)
and fatigue##9##2##(1991-6#1)(1996-8#1)(2009-5#1)(2010-6#3)(2011-2#2)(2012-2#1)
and fatty acid composition##2##4##(1991-12#1)(1992-12#1)
and fatty acid profiles##5##4##(2008-10#2)(2010-11#1)(2010-4#1)(2011-2#1)
and fatty acid##14##3##(1991-12#1)(1992-12#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-11#2)(2010-4#1)(2011-2#1)(2012-2#1)
and fatty acids##6##3##(1991-12#1)(2008-10#3)(2008-5#1)(2008-8#1)
and fatty##24##2##(1991-12#2)(1992-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
and favor##2##2##(1996-3#1)(2008-9#1)
and fear of##2##3##(1996-6#1)(2011-2#1)
and fear##5##2##(1996-6#1)(2008-11#2)(2011-2#2)
and fears##2##2##(2008-11#2)
and feasibility of##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
and feasibility##5##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
and feasible##5##2##(1991-2#1)(1995-2#1)(2008-10#2)(2012-3#1)
and feather quality##2##3##(2008-9#2)
and feather##5##2##(1992-2#1)(2008-5#2)(2008-9#2)
and feature##2##2##(2008-11#1)(2008-6#1)
and features of##4##3##(2008-10#1)(2008-3#1)(2009-11#1)(2012-2#1)
and features##9##2##(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
and fecal##5##2##(1991-3#1)(1994-5#1)(1996-12#1)(2011-2#2)
and feces##5##2##(1993-2#4)(1996-12#1)
and fed##5##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
and fed-batch cultures##5##3##(2008-11#5)
and fed-batch##15##2##(2008-11#9)(2008-7#2)(2011-2#3)(2013-1#1)
and federal health##3##3##(1996-1#1)(1996-3#1)(2009-5#1)
and federal##10##2##(1995-2#1)(1996-1#3)(1996-3#1)(1997-1#1)(1997-3#1)(2009-11#1)(2009-5#1)(2010-9#1)
and fee-for-service##5##2##(1991-3#1)(1993-12#1)(1994-2#1)(1995-3#1)(1997-2#1)
and feed##13##2##(1993-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#2)
and feedback##12##2##(1994-12#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-7#1)(2012-2#2)(2013-1#1)
and feeding##16##2##(1990-12#2)(2008-10#1)(2008-11#3)(2008-9#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#2)
and feel##2##2##(1992-3#1)(2008-5#1)
and feeling##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
and feelings about##3##3##(1992-3#1)(2009-6#2)
and feelings of##2##3##(1995-1#1)(2011-2#1)
and feelings##9##2##(1992-2#1)(1992-3#1)(1995-1#1)(2008-11#1)(2009-6#2)(2011-2#2)(2013-1#1)
and fees##2##2##(1990-9#1)(1995-12#1)
and fellowship##2##2##(1994-3#1)(2010-5#1)
and female Tg##7##3##(2008-9#7)
and female components##4##3##(2008-9#4)
and female fitness##2##3##(2008-8#1)(2008-9#1)
and female##85##2##(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-8#2)(1997-7#1)(2008-10#6)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#12)(2008-9#17)(2009-10#1)(2010-1#1)(2010-4#2)(2011-2#6)(2012-2#3)(2012-3#6)(2013-1#2)(2013-8#3)
and females in both studies##4##5##(2008-9#4)
and females in##6##3##(2008-9#5)(2012-3#1)
and females of##2##3##(2007-12#1)(2008-8#1)
and females##47##2##(1990-3#1)(1990-8#1)(1991-2#1)(1994-6#1)(1996-2#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#25)(2009-5#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and femoral neck BMD##2##4##(2010-1#1)(2011-2#1)
and femoral##4##2##(1991-11#1)(2008-4#1)(2010-1#1)(2011-2#1)
and fentanyl##4##2##(1993-1#2)(1996-6#2)
and fermentation##4##2##(2008-10#2)(2013-1#2)
and fermentative##4##2##(2008-7#2)(2011-2#2)
and ferricyanide##4##2##(2008-10#4)
and ferritin##4##2##(1994-11#2)(1996-2#1)(2008-10#1)
and ferroin##2##2##(2008-10#2)
and fertile##3##2##(2008-10#1)(2008-8#2)
and fertility##11##2##(1994-8#1)(1994-9#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-8#3)(2009-10#1)(2012-2#1)(2013-1#1)
and fertilization##2##2##(2007-12#1)(2008-11#1)
and ferulic acid and syringic acid##2##6##(2011-1#2)
and ferulic acid##4##3##(1994-5#2)(2011-1#2)
and ferulic acids##2##3##(1994-5#1)(2008-10#1)
and ferulic##6##2##(1994-5#3)(2008-10#1)(2011-1#2)
and fetal liver##2##3##(1990-5#1)(2008-4#1)
and fetal##15##2##(1990-5#1)(1992-6#1)(1994-3#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#2)(2012-3#2)(2013-1#3)
and fetus##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
and fever##9##2##(1995-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-4#1)(2010-12#1)(2013-1#1)
and few##12##2##(1991-11#1)(1991-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-3#2)(2009-8#1)(2013-1#1)
and fewer side##2##3##(1996-5#1)(2008-9#1)
and fewer##13##2##(1991-3#2)(1993-8#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-11#1)
and fiber##3##2##(2008-3#1)(2009-7#1)(2012-5#1)
and fibers##5##2##(1992-12#4)(2008-6#1)
and fibre##4##2##(2008-10#3)(2009-7#1)
and fibrillarin are two##2##4##(2008-8#2)
and fibrin##3##2##(1994-5#1)(2010-12#1)(2012-3#1)
and fibrinogen##8##2##(2006-6#4)(2008-10#1)(2008-7#2)(2011-2#1)
and fibrinolytic##2##2##(1994-5#1)(2013-1#1)
and fibroblast##4##2##(1990-5#1)(2008-12#1)(2012-3#1)(2013-1#1)
and fibroblasts##6##2##(1990-2#2)(1990-6#1)(1991-6#1)(1997-1#1)(1997-7#1)
and fibronectin##3##2##(1990-5#1)(1993-8#1)(2011-2#1)
and fibrosis##3##2##(2007-8#1)(2009-7#1)(2011-2#1)
and fibrous DNA##3##3##(2008-11#3)
and fibrous##6##2##(2008-11#3)(2008-7#1)(2009-7#1)(2010-12#1)
and field experiments were conducted to##2##6##(2008-10#2)
and field experiments##4##3##(2008-10#4)
and field studies##4##3##(2008-10#4)
and field trials##2##3##(2008-10#1)(2008-12#1)
and field##29##2##(1993-3#1)(2007-11#1)(2008-10#24)(2008-12#1)(2008-9#1)(2013-1#1)
and fields##3##2##(2008-10#2)(2010-10#1)
and fifth##11##2##(1997-3#2)(2008-10#4)(2010-11#2)(2010-3#2)(2012-3#1)
and filamentous##5##2##(1994-6#2)(1996-6#1)(2011-2#1)(2013-8#1)
and file##2##2##(1991-2#1)(2011-1#1)
and filled with##6##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
and filling##2##2##(1991-6#1)(2008-12#1)
and film thickness##2##3##(2008-10#2)
and films##2##2##(1993-5#1)(2010-5#1)
and filter##3##2##(2008-10#1)(2012-3#2)
and filtering##4##2##(1992-12#1)(2008-10#1)(2010-11#1)(2010-8#1)
and filters##2##2##(2008-11#1)(2008-9#1)
and filtrated##2##2##(2008-10#2)
and filtration##5##2##(1995-11#1)(2008-10#3)(2008-7#1)
and final product##2##3##(1996-5#1)(2008-11#1)
and final##24##2##(1991-8#1)(1993-12#1)(1996-5#1)(1996-9#1)(2008-10#10)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
and finally a##2##3##(2008-11#1)(2008-9#1)
and finally detected by##2##4##(2008-10#2)
and finally the##5##3##(1993-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
and finally##53##2##(1991-6#2)(1993-8#1)(1994-1#2)(1994-6#1)(1997-1#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#5)
and finance##4##2##(1993-3#1)(1994-2#1)(1997-3#1)(2008-11#1)
and financed##2##2##(1996-1#1)(1997-3#1)
and financial systems##2##3##(1996-1#1)(1997-3#1)
and financial##20##2##(1991-12#1)(1991-2#2)(1992-1#2)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-1#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-6#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
and financing of##5##3##(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1997-3#1)
and financing##10##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-2#1)(1995-2#2)(1997-3#1)
and find that the##4##4##(1993-6#1)(2008-11#1)(2008-2#1)(2008-3#1)
and find that##5##3##(1993-6#1)(1994-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
and find##10##2##(1990-11#1)(1991-1#1)(1993-6#1)(1994-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-2#1)
and finding##2##2##(1993-5#1)(2008-9#1)
and findings are##2##3##(1993-2#1)(2008-11#1)
and findings in##2##3##(1996-3#1)(2008-7#1)
and findings of##2##3##(2008-12#1)(2011-3#1)
and findings that##2##3##(2008-10#2)
and findings##11##2##(1993-2#1)(1995-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-3#1)(2012-2#1)
and fine##8##2##(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
and finger##2##2##(2008-7#1)(2009-3#1)
and finishing##2##2##(1990-3#1)(2008-4#1)
and fire##3##2##(1990-8#1)(1991-12#1)(2008-11#1)
and firing rate##2##3##(2008-11#1)(2008-7#1)
and firing##5##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
and firmness##2##2##(2008-10#1)(2008-5#1)
and first derivative##4##3##(2008-10#4)
and first##14##2##(1991-8#1)(1995-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#3)(2012-2#1)
and first-derivative##2##2##(2008-10#2)
and fiscal##3##2##(1992-1#1)(1995-3#1)(2008-6#1)
and fish samples##3##3##(2008-10#3)
and fish##14##2##(2008-10#9)(2008-11#1)(2008-12#2)(2008-8#2)
and fisheries##2##2##(2010-8#2)
and fission##3##2##(1995-6#1)(2008-10#1)(2009-8#1)
and fistula##3##2##(2008-7#1)(2009-1#2)
and fit##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
and fitness##8##2##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)
and fitting the##2##3##(2008-10#1)(2008-7#1)
and fitting##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
and five cell##2##3##(2008-11#1)(2012-2#1)
and five other##2##3##(2008-11#1)(2008-3#1)
and five variables##2##3##(2008-10#2)
and five##39##2##(1991-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-5#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-8#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
and fix##2##2##(1993-3#1)(2011-2#1)
and fixation of##2##3##(2012-2#1)(2013-1#1)
and fixation##8##2##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
and fixed cells##2##3##(2008-10#1)(2008-9#1)
and fixed on##5##3##(2008-10#4)(2010-8#1)
and fixed##18##2##(1994-5#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-9#2)(2010-5#1)(2010-8#1)(2013-8#1)
and flame atomic absorption spectrometry is presented##2##7##(2008-10#2)
and flame atomic absorption spectrometry were##2##6##(2008-10#2)
and flame atomic absorption spectrometry##13##5##(2008-10#13)
and flame atomic absorption##15##4##(2008-10#15)
and flame##18##2##(1997-3#1)(2008-10#17)
and flanking##3##2##(2008-10#1)(2008-8#2)
and flask##2##2##(2008-10#1)(2008-12#1)
and flattened##2##2##(2007-12#1)(2008-11#1)
and flavin##2##2##(2008-11#1)(2008-8#1)
and flexibility of##2##3##(2008-10#1)(2008-3#1)
and flexibility##7##2##(1990-4#1)(2008-10#4)(2008-3#1)(2012-3#1)
and flexible##10##2##(1992-3#1)(1993-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
and flexion##4##2##(2008-9#2)(2009-11#1)(2009-3#1)
and floating##2##2##(2008-11#1)(2012-3#1)
and floor##6##2##(1994-12#4)(1997-2#1)(2008-7#1)
and flow analysis##2##3##(2008-10#2)
and flow cytometric##3##3##(1993-8#1)(2008-10#1)(2008-9#1)
and flow cytometry##14##3##(1990-8#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#5)(2011-2#1)(2013-8#1)
and flow injection (FI)##2##4##(2008-10#2)
and flow injection analysis (FIA)##2##5##(2008-10#2)
and flow injection analysis##4##4##(2008-10#4)
and flow injection atomic##2##4##(2008-10#2)
and flow injection variables were##2##5##(2008-10#2)
and flow injection variables##3##4##(2008-10#3)
and flow injection##20##3##(2008-10#20)
and flow rate of the##2##5##(2008-10#2)
and flow rate of##3##4##(2008-10#3)
and flow rate##13##3##(2008-10#13)
and flow rates of##2##4##(2008-10#2)
and flow rates were##2##4##(2008-10#2)
and flow rates##5##3##(2008-10#4)(2008-11#1)
and flow variables##5##3##(2008-10#5)
and flow##74##2##(1990-8#1)(1993-8#1)(1997-1#1)(2006-6#1)(2008-10#56)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2011-2#1)(2013-8#1)
and flow-injection (FI) analysis##2##4##(2008-10#2)
and flow-injection (FI)##3##3##(2008-10#3)
and flow-injection methods##2##3##(2008-10#2)
and flow-injection##8##2##(2008-10#8)
and flow-rate##3##2##(2008-10#2)(2008-9#1)
and flowed through the##2##4##(2008-10#2)
and flower buds##2##3##(2008-10#2)
and flower##6##2##(1993-2#1)(2008-10#3)(2008-8#1)(2009-5#1)
and flowering stages##2##3##(2008-10#1)(2013-8#1)
and flowering time##2##3##(2009-8#1)(2012-3#1)
and flowering##7##2##(2008-10#3)(2009-8#1)(2010-5#1)(2012-3#1)(2013-8#1)
and fluctuating##4##2##(2008-9#2)(2010-4#1)(2012-3#1)
and fluid##6##2##(1991-12#1)(2008-10#2)(2010-1#1)(2011-2#1)(2012-2#1)
and fluorescein##3##2##(2008-10#2)(2011-2#1)
and fluorescence behavior of##3##4##(2008-10#3)
and fluorescence detection##4##3##(2008-10#4)
and fluorescence epi-illumination)##2##3##(2008-4#2)
and fluorescence in situ hybridization##2##5##(1993-12#1)(2008-9#1)
and fluorescence in##3##3##(1993-12#1)(2008-3#1)(2008-9#1)
and fluorescence intensity##2##3##(2008-10#2)
and fluorescence microscopy##6##3##(2008-10#2)(2008-5#1)(2008-9#3)
and fluorescence properties##2##3##(2008-8#1)(2010-4#1)
and fluorescence spectra##3##3##(2008-10#2)(2008-3#1)
and fluorescence##50##2##(1991-5#1)(1993-12#1)(1994-5#1)(1995-6#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#6)(2009-10#1)(2010-4#1)(2012-2#2)
and fluorescent detection##2##3##(2008-10#1)(2008-9#1)
and fluorescent dyes##2##3##(2008-3#1)(2008-7#1)
and fluorescent##14##2##(1991-5#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-9#3)(2009-7#1)(2011-2#1)(2012-3#1)
and fluoride using##2##3##(2008-10#2)
and fluoride##11##2##(1994-5#1)(1994-8#1)(2008-10#8)(2011-2#1)
and fluorimetric detection##5##3##(2008-10#5)
and fluorimetric methods##2##3##(2008-10#2)
and fluorimetric##9##2##(2008-10#9)
and fluorometric detection##2##3##(2008-10#2)
and fluoroquinolones##2##2##(2008-10#1)(2011-2#1)
and fluoroscopic control##2##3##(2011-2#2)
and fluvalinate in##2##3##(2008-10#2)
and fluvalinate##3##2##(2008-10#3)
and fluxes##2##2##(2008-10#1)(2008-11#1)
and fly##2##2##(1993-12#1)(2008-10#1)
and focal##7##2##(1996-12#1)(1996-6#1)(1996-9#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
and focus groups##3##3##(1997-3#1)(2008-11#1)(2010-10#1)
and focus of##2##3##(2008-11#1)(2009-6#1)
and focus on a##2##4##(2008-11#1)(2008-8#1)
and focus on##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)
and focus##12##2##(1997-3#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-10#2)
and focused##4##2##(1996-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
and focuses on##3##3##(1992-1#1)(2008-10#1)(2013-8#1)
and focuses##4##2##(1992-1#1)(1996-1#1)(2008-10#1)(2013-8#1)
and focusing##2##2##(2007-12#1)(2008-2#1)
and folate##2##2##(1992-9#2)
and foliar##5##2##(2008-10#4)(2011-10#1)
and folic acid##2##3##(2008-10#1)(2009-8#1)
and follicular##3##2##(1995-12#1)(2008-8#1)(2008-9#1)
and follow up##2##3##(2008-4#1)(2011-2#1)
and follow##4##2##(2008-4#2)(2010-1#1)(2011-2#1)
and follow-up of adolescents##2##4##(1990-6#1)(1993-3#1)
and follow-up of##9##3##(1990-6#1)(1993-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
and follow-up##26##2##(1990-6#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-3#2)(2008-11#4)(2008-6#1)(2008-7#2)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
and follow-up]##2##2##(1990-9#1)(2011-1#1)
and followed by an##2##4##(1996-5#1)(2013-8#1)
and followed by##7##3##(1996-2#1)(1996-5#1)(2008-10#2)(2008-7#1)(2013-1#1)(2013-8#1)
and followed the##2##3##(1995-6#1)(2012-12#1)
and followed up for##3##4##(2008-7#1)(2011-2#1)(2012-12#1)
and followed up##4##3##(2008-7#1)(2011-2#2)(2012-12#1)
and followed##17##2##(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-7#2)(2008-8#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
and following a##2##3##(1991-2#1)(2008-10#1)
and following the##4##3##(1996-9#1)(2008-10#3)
and following##18##2##(1990-11#1)(1991-2#1)(1994-2#1)(1996-9#1)(2008-10#7)(2008-11#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
and follows the##3##3##(1994-5#1)(1995-6#1)(2008-10#1)
and food and##2##3##(1991-2#1)(2008-10#1)
and food ingredients##2##3##(2011-2#2)
and food intake##2##3##(2008-7#1)(2011-2#1)
and food samples##3##3##(2008-10#3)
and food##35##2##(1991-2#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#3)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-2#4)(2013-8#2)
and foodborne##2##2##(2007-12#1)(2011-2#1)
and foods##4##2##(2008-10#4)
and foodstuffs##2##2##(2008-10#2)
and foot##4##2##(1994-8#1)(1997-8#1)(2011-2#1)(2012-2#1)
and for 10##2##3##(2008-10#2)
and for a##5##3##(2008-10#2)(2008-3#2)(2008-5#1)
and for analysis of##2##4##(2008-10#1)(2008-4#1)
and for analysis##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
and for determining##2##3##(2008-10#1)(2009-5#1)
and for different##3##3##(1993-12#1)(2008-10#1)(2010-2#1)
and for each##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
and for elucidating##2##3##(2009-10#1)(2009-8#1)
and for evaluation of##2##4##(1993-1#1)(2008-11#1)
and for every##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
and for its admixture with##2##5##(2008-10#2)
and for its##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
and for most of the##2##5##(2008-10#2)
and for one##2##3##(2008-10#2)
and for pathogenicity on##2##4##(2008-10#2)
and for patients##3##3##(1992-5#1)(2010-11#1)(2012-3#1)
and for preconcentration##2##3##(2008-10#2)
and for pyramiding##2##3##(2008-10#2)
and for reproducibility##2##3##(2008-10#2)
and for selected##2##3##(1995-12#1)(2011-3#1)
and for several##2##3##(2007-12#1)(2008-10#1)
and for some##3##3##(1995-12#1)(2007-8#1)(2013-1#1)
and for suppression of##2##4##(2008-10#2)
and for the control##2##4##(2010-4#1)(2011-2#1)
and for the determination of the##3##6##(2008-10#1)(2008-12#2)
and for the determination of##4##5##(2008-10#2)(2008-12#2)
and for the development of##2##5##(2008-3#1)(2012-12#1)
and for the evaluation##2##4##(2008-9#1)(2011-2#1)
and for the first time##2##5##(1997-2#1)(2011-2#1)
and for the maintenance of##2##5##(2008-8#1)(2009-3#1)
and for the presence of##2##5##(1991-3#1)(2011-2#1)
and for the##69##3##(1990-6#1)(1991-1#1)(1991-3#1)(1991-6#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#23)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#3)(2008-9#4)(2009-3#2)(2010-11#2)(2010-4#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#1)
and for their ability to##2##5##(1991-2#1)(2010-4#1)
and for their##8##3##(1991-2#1)(1995-2#1)(2008-10#4)(2009-1#1)(2010-4#1)
and for those who##2##4##(1994-2#1)(2013-1#1)
and for those##4##3##(1994-2#1)(2011-2#2)(2013-1#1)
and for three##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
and for total##3##3##(1991-2#1)(1994-9#1)(2008-10#1)
and for understanding the##2##4##(1996-12#1)(2008-3#1)
and for which##4##3##(2008-10#1)(2008-11#1)(2012-2#2)
and for##350##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#3)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#130)(2008-11#24)(2008-12#7)(2008-2#2)(2008-3#13)(2008-4#12)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#15)(2009-1#1)(2009-10#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#1)
and foraging##2##2##(2008-9#1)(2012-3#1)
and forbidden##2##2##(2007-12#1)(2008-11#1)
and foreign ions##4##3##(2008-10#4)
and foreign##11##2##(1995-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2009-8#1)(2012-3#1)
and foremost##3##2##(1990-11#1)(1995-11#1)(2013-8#1)
and forensic purposes##2##3##(2008-10#2)
and forensic##4##2##(2008-10#3)(2008-12#1)
and forest##7##2##(2008-10#3)(2008-8#1)(2008-9#2)(2012-5#1)
and form a##6##3##(2007-12#1)(2008-10#4)(2008-7#1)
and form the basis for##2##5##(1996-2#1)(2009-5#1)
and form the##3##3##(1996-2#1)(2008-7#1)(2009-5#1)
and form##16##2##(1996-2#1)(2007-12#2)(2008-10#6)(2008-5#2)(2008-7#2)(2009-5#2)(2009-8#1)
and formal##4##2##(2008-10#2)(2008-11#1)(2009-5#1)
and formaldehyde##2##2##(2008-10#2)
and formalize##2##2##(2008-10#1)(2008-9#1)
and formamide##2##2##(2008-10#2)
and formation constant of##2##4##(2008-10#2)
and formation constant##3##3##(2008-10#3)
and formation constants##2##3##(2008-10#2)
and formation of the##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
and formation of##12##3##(1991-11#1)(1994-3#1)(2008-10#3)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#1)
and formation##23##2##(1991-11#1)(1994-3#1)(2008-10#10)(2008-5#2)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
and formed##16##2##(1997-2#1)(1997-3#1)(2008-10#8)(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
and former##3##2##(1995-11#1)(1995-12#1)(2010-8#1)
and forming##3##2##(2008-10#3)
and forms a##5##3##(1994-9#1)(2008-10#2)(2010-11#1)(2010-12#1)
and forms an##2##3##(1992-11#1)(2008-5#1)
and forms##15##2##(1992-11#1)(1994-9#1)(1995-1#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
and formulation##3##2##(2008-10#3)
and formulations##2##2##(2008-10#1)(2008-5#1)
and forskolin##8##2##(1993-6#1)(1994-11#1)(1995-8#1)(1997-2#5)
and forskolin-stimulated adenylyl cyclase##2##4##(1995-11#1)(1997-1#1)
and forward##4##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
and fos##2##2##(2008-11#2)
and foster##2##2##(1997-2#1)(2008-12#1)
and fostering##2##2##(2008-11#1)(2011-3#1)
and foul##3##2##(2009-10#1)(2013-1#2)
and fouling##4##2##(2008-11#1)(2008-7#2)(2013-1#1)
and found a significant##2##4##(2008-11#1)(2008-5#1)
and found a##5##3##(1994-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
and found it to be##2##5##(1993-8#1)(2008-3#1)
and found no##3##3##(1995-2#1)(1995-3#1)(2009-10#1)
and found significant##2##3##(2008-5#1)(2013-1#1)
and found that it##3##4##(1996-3#1)(2008-10#1)(2008-5#1)
and found that the##10##4##(1991-5#1)(1994-11#1)(2008-10#3)(2008-11#2)(2009-8#1)(2011-2#1)(2012-3#1)
and found that there##2##4##(1996-12#1)(2012-3#1)
and found that##30##3##(1991-5#1)(1994-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#2)(1997-8#1)(2008-10#6)(2008-11#4)(2008-5#1)(2009-8#4)(2011-2#1)(2012-3#5)
and found to be 1##2##5##(2008-10#2)
and found to be accurate##2##5##(2008-10#2)
and found to be identical##2##5##(1996-12#1)(2008-11#1)
and found to be##22##4##(1992-3#1)(1993-9#1)(1994-2#1)(1996-12#1)(2008-10#14)(2008-11#2)(2011-2#1)(2012-3#1)
and found to encode##3##4##(1992-10#1)(1993-12#1)(1994-12#1)
and found to have##3##4##(1992-6#1)(1994-5#1)(2013-1#1)
and found to##41##3##(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#2)(2008-10#22)(2008-11#3)(2011-2#1)(2012-3#1)(2013-1#1)
and found##94##2##(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#3)(1995-3#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-8#2)(1997-8#1)(2008-10#31)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#3)(2008-9#3)(2009-10#1)(2009-8#5)(2011-1#1)(2011-2#3)(2012-3#7)(2013-1#2)(2013-8#1)
and foundation##2##2##(1997-1#1)(2008-5#1)
and four additional##2##3##(1995-6#1)(2008-10#1)
and four cases of##2##4##(1994-12#1)(2008-10#1)
and four different##2##3##(2008-10#2)
and four other##3##3##(2008-10#2)(2009-8#1)
and four patients##3##3##(1990-9#1)(1997-8#1)(2008-5#1)
and four selected##2##3##(2011-3#1)(2013-8#1)
and four were##3##3##(2008-10#1)(2009-3#1)(2010-1#1)
and four years##2##3##(1991-6#1)(2008-11#1)
and four##85##2##(1990-5#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-10#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-8#3)(1997-9#1)(2008-1#1)(2008-10#35)(2008-11#2)(2008-12#4)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-2#5)(2011-3#1)(2012-12#2)(2013-1#2)(2013-8#2)
and four-color##2##2##(2008-9#2)
and four-component##2##2##(2008-10#2)
and fourteen##2##2##(1995-12#1)(2008-5#1)
and fourth##6##2##(1990-8#1)(2008-10#4)(2013-1#1)
and foveal##3##2##(2011-7#1)(2013-1#2)
and fractionated by##2##3##(1991-12#1)(2008-10#1)
and fractionated##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2009-8#1)
and fractionation of##4##3##(1993-12#1)(2008-10#2)(2008-5#1)
and fractionation##5##2##(1993-12#1)(2008-10#3)(2008-5#1)
and fractions##2##2##(2008-11#1)(2008-5#1)
and fracture characteristics##2##3##(2008-8#1)(2009-7#1)
and fracture line##2##3##(2013-1#2)
and fracture risk##2##3##(2008-8#1)(2011-2#1)
and fracture toughness##3##3##(2009-7#3)
and fracture##13##2##(2008-8#2)(2009-7#6)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
and fragile##2##2##(1995-3#1)(2008-7#1)
and fragment##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
and fragments##2##2##(1997-6#1)(2008-8#1)
and frail##2##2##(1991-12#1)(1994-2#1)
and frame##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
and free energy##5##3##(2008-10#4)(2010-7#1)
and free fatty acid##2##4##(1994-5#1)(2008-11#1)
and free of##8##3##(1993-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-3#1)
and free radical##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
and free##41##2##(1992-9#1)(1993-8#1)(1994-5#2)(2008-10#12)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#6)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#2)(2013-3#1)
and free-radical##2##2##(1997-7#1)(2008-6#1)
and freezing-thawing##2##2##(2008-10#2)
and frequencies of##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
and frequencies##4##2##(1993-12#1)(2008-10#2)(2008-5#1)
and frequency of the##3##4##(1990-8#1)(2008-10#2)
and frequency of##20##3##(1990-8#1)(1990-9#2)(1993-2#1)(1995-12#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#2)(2012-2#1)
and frequency##28##2##(1990-8#1)(1990-9#2)(1993-2#1)(1995-12#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#3)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
and frequent##11##2##(1992-2#1)(1994-12#1)(1996-3#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
and frequently used##2##3##(1996-3#1)(2011-2#1)
and frequently##7##2##(1993-1#1)(1996-3#1)(1997-7#1)(2010-12#1)(2011-2#2)(2012-2#1)
and fresh##6##2##(1993-6#1)(2008-10#2)(2008-11#1)(2010-7#1)(2011-2#1)
and freshwater##5##2##(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-5#1)
and friction##3##2##(1994-9#1)(1997-3#2)
and from 0##13##3##(1996-2#1)(2008-10#9)(2008-5#1)(2013-8#2)
and from 1##4##3##(2008-10#4)
and from 100 to##2##4##(2008-10#2)
and from 100##3##3##(2008-10#2)(2011-2#1)
and from 2##4##3##(2008-10#4)
and from 20 to##2##4##(2008-10#2)
and from 20##3##3##(2008-10#3)
and from 3##2##3##(2008-10#2)
and from 30 to##2##4##(2008-10#1)(2009-7#1)
and from 4##2##3##(2008-10#2)
and from 5##3##3##(2008-10#3)
and from 92##3##3##(2008-10#3)
and from 95##2##3##(2008-10#2)
and from P##2##3##(2008-10#2)
and from a##4##3##(2008-10#1)(2008-3#2)(2008-9#1)
and from all##2##3##(1994-9#1)(2008-10#1)
and from highly mineralised water##2##5##(2008-10#2)
and from other##4##3##(2008-10#2)(2008-8#1)(2010-10#1)
and from soil##3##3##(2008-10#3)
and from the##25##3##(1991-5#1)(1992-1#1)(1994-9#1)(1996-6#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)
and from these##2##3##(2008-10#2)
and from two##2##3##(1994-6#1)(2008-11#1)
and from##181##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(2006-6#1)(2008-1#1)(2008-10#100)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#8)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
and frontal lobes##2##3##(1994-3#1)(1997-3#1)
and frontal##10##2##(1990-8#1)(1994-3#1)(1997-3#1)(2008-11#2)(2011-2#5)
and fructose##6##2##(1990-2#1)(1996-2#1)(1996-6#1)(2008-10#3)
and fruit juice samples##2##4##(2008-10#2)
and fruit juice##6##3##(2008-10#6)
and fruit russet severity##2##4##(2008-10#2)
and fruit with##2##3##(2008-10#2)
and fruit yield##3##3##(2008-10#3)
and fruit##41##2##(2008-10#39)(2008-8#1)(2011-2#1)
and fruiting##3##2##(2008-10#1)(2008-12#1)(2012-4#1)
and fruits of##2##3##(2008-10#1)(2008-12#1)
and fruits##4##2##(2008-10#3)(2008-12#1)
and frustration##4##2##(1993-5#1)(1994-3#1)(1997-3#1)(2009-9#1)
and fry survival##2##3##(2010-8#2)
and fry##6##2##(1992-6#2)(2008-6#2)(2010-8#2)
and fuel##2##2##(1990-8#1)(2008-7#1)
and fulfillment##2##2##(1995-1#1)(2008-10#1)
and full bloom##2##3##(2008-10#2)
and full##10##2##(1995-8#1)(2008-10#3)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#3)
and full-length##2##2##(1995-6#1)(2008-10#1)
and full-swing shots##2##3##(2011-2#2)
and full-swing##3##2##(2011-2#3)
and fully##4##2##(1996-2#1)(2008-12#1)(2009-12#1)(2010-7#1)
and fulvic acid##3##3##(2008-10#3)
and fulvic acids##4##3##(2008-10#4)
and fulvic##8##2##(2008-10#8)
and fumonisin contamination##3##3##(2008-10#3)
and fumonisin##6##2##(2008-10#5)(2013-1#1)
and function and##2##3##(2011-2#1)(2013-1#1)
and function are##3##3##(1991-1#1)(2008-11#1)(2008-9#1)
and function in##16##3##(1992-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-1#1)(2009-5#2)(2010-11#2)(2011-2#1)(2012-12#1)(2013-8#1)
and function of each##2##4##(1990-12#1)(2008-7#1)
and function of the##17##4##(1994-8#1)(1996-2#2)(1996-3#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-5#1)(2012-2#1)(2013-1#2)
and function of these##2##4##(2008-2#1)(2008-9#1)
and function of this##2##4##(1995-8#1)(2009-8#1)
and function of##51##3##(1990-12#1)(1992-11#1)(1993-1#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#3)(1996-3#1)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-2#4)(2013-1#2)(2013-8#1)
and function words##2##3##(1996-2#1)(2008-10#1)
and function##122##2##(1990-12#1)(1991-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#4)(1996-3#1)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#3)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#5)(2009-1#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#5)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
and functional ability##2##3##(2011-8#1)(2013-1#1)
and functional activity##4##3##(1994-5#1)(2008-8#3)
and functional alterations of##2##4##(1997-6#1)(2008-1#1)
and functional analysis of a##2##5##(2008-8#2)
and functional analysis of##7##4##(1997-7#1)(2008-10#1)(2008-4#2)(2008-8#2)(2008-9#1)
and functional analysis##8##3##(1993-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-8#2)(2008-9#1)
and functional aspects of##2##4##(1992-9#1)(1995-3#1)
and functional assessment##2##3##(2010-9#1)(2012-3#1)
and functional changes##2##3##(1994-12#1)(2012-3#1)
and functional characteristics of##3##4##(1991-3#1)(1995-3#1)(2011-2#1)
and functional characterization of##2##4##(2008-11#2)
and functional complementation##2##3##(2008-9#1)(2009-10#1)
and functional consequences##2##3##(2009-12#1)(2013-1#1)
and functional genomics##2##3##(2009-4#1)(2011-2#1)
and functional groups##2##3##(2008-10#1)(2008-7#1)
and functional magnetic resonance imaging##2##5##(1994-3#1)(2010-7#1)
and functional maturation##2##3##(2008-5#1)(2008-8#1)
and functional mechanism of tetrahydroisoquinoline##2##5##(2011-3#2)
and functional outcomes in##2##4##(2009-10#1)(2013-1#1)
and functional outcomes##6##3##(2009-10#1)(2012-12#2)(2013-1#3)
and functional performance##2##3##(2013-1#2)
and functional plasticity##2##3##(2008-1#1)(2008-7#1)
and functional properties of##4##4##(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
and functional properties##7##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#2)
and functional recovery##2##3##(1994-8#1)(2011-2#1)
and functional responses##2##3##(2008-9#1)(2010-1#1)
and functional results##5##3##(1991-9#1)(2008-10#1)(2008-9#1)(2013-1#2)
and functional studies##3##3##(1993-12#1)(2009-4#1)(2010-12#1)
and functional study##2##3##(1991-6#1)(2008-9#1)
and functional##134##2##(1990-6#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-9#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#3)(1995-6#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#8)(2008-2#4)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#12)(2008-9#6)(2009-10#6)(2009-12#1)(2009-4#2)(2010-1#2)(2010-12#2)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#5)(2011-3#2)(2011-7#1)(2011-8#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#12)(2013-8#2)
and functionality of##3##3##(2008-10#2)(2008-9#1)
and functionality##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
and functionalized##2##2##(2008-10#1)(2009-8#1)
and functionally##10##2##(1993-3#1)(1994-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
and functioning of##3##3##(2011-1#1)(2012-2#1)(2012-6#1)
and functioning##7##2##(1991-2#1)(2008-7#1)(2010-9#2)(2011-1#1)(2012-2#1)(2012-6#1)
and functions of##4##3##(2008-11#1)(2008-9#1)(2009-9#1)(2012-2#1)
and functions that##2##3##(2011-2#1)(2013-1#1)
and functions##12##2##(1990-11#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and fundamental##4##2##(2008-10#2)(2009-12#1)(2013-1#1)
and funding##5##2##(1995-3#1)(2008-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
and fungal growth##2##3##(2008-10#1)(2010-7#1)
and fungal infections##3##3##(2007-8#1)(2011-3#1)(2013-1#1)
and fungal##24##2##(2007-8#1)(2008-10#12)(2008-5#1)(2008-8#2)(2009-10#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
and fungi##15##2##(1994-9#1)(2006-5#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)
and fungicide##4##2##(2008-10#4)
and furafylline inhibition##2##3##(1994-8#2)
and furan##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
and further characterized##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
and further development##2##3##(2008-10#2)
and further research##2##3##(1993-12#1)(2012-2#1)
and further studies##2##3##(2008-10#1)(2008-5#1)
and further the##2##3##(1995-1#1)(2008-5#1)
and further##51##2##(1991-6#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-6#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#2)
and furthermore to##2##3##(2008-10#1)(2013-1#1)
and furthermore##3##2##(2008-10#2)(2013-1#1)
and fused to##2##3##(1994-8#1)(1996-6#1)
and fused with the##2##4##(2008-9#2)
and fused##5##2##(1994-8#1)(1996-6#1)(2008-8#1)(2008-9#2)
and fusing##2##2##(2008-10#1)(2011-3#1)
and fusion protein GST-IE86##2##4##(2008-9#2)
and fusion##16##2##(1993-9#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2012-12#7)(2012-3#1)
and fusions##2##2##(2008-8#1)(2012-3#1)
and future challenges##2##3##(2008-11#1)(2013-1#1)
and future developments##2##3##(2008-10#1)(2008-11#1)
and future directions of##2##4##(2008-10#1)(2008-12#1)
and future directions##12##3##(1991-2#1)(1992-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
and future of##6##3##(1993-3#1)(1996-11#1)(1996-3#1)(2008-10#1)(2010-7#1)(2010-8#1)
and future prospects for##2##4##(1997-6#1)(2008-11#1)
and future prospects##6##3##(1997-6#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-5#1)(2012-3#1)
and future research directions are##3##5##(1994-3#1)(2008-1#1)(2009-9#1)
and future research##6##3##(1992-12#1)(1994-3#1)(1996-6#1)(2008-1#1)(2009-9#1)(2013-1#1)
and future use##2##3##(2008-10#1)(2013-1#1)
and future##75##2##(1991-2#1)(1991-3#1)(1992-12#3)(1993-12#2)(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#5)
and fuzzy##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
and g were##2##3##(2008-10#2)
and g##4##2##(2008-10#2)(2008-2#2)
and gain insight into##2##4##(2008-10#1)(2012-3#1)
and gain##9##2##(1996-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
and gait disorders##2##3##(2013-1#2)
and gait##5##2##(2008-12#1)(2008-7#1)(2013-1#3)
and galactose##7##2##(1990-2#1)(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#3)
and gallbladder cancer##2##3##(2010-12#2)
and gallbladder size##2##3##(2011-2#2)
and gallbladder##5##2##(1994-2#1)(2010-12#2)(2011-2#2)
and gallic acid##2##3##(2008-10#1)(2008-6#1)
and gallic##3##2##(2008-10#2)(2008-6#1)
and galls##2##2##(2008-10#2)
and gametic phase equilibrium##2##4##(2008-10#1)(2012-3#1)
and gametic phase##3##3##(2008-10#2)(2012-3#1)
and gamma camera##2##3##(1994-2#1)(1996-2#1)
and gamma subunits##2##3##(1995-11#1)(2008-8#1)
and gamma##21##2##(1991-5#1)(1992-6#1)(1993-6#1)(1994-2#1)(1995-11#3)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#5)(2008-8#5)
and gamma-CD##3##2##(2008-10#3)
and gamma-aminobutyric acid##4##3##(1990-7#1)(1995-11#1)(1995-2#1)(1997-2#1)
and gamma-cyclodextrins##3##2##(2008-10#3)
and gamma2)##2##2##(2008-11#2)
and gap junction formation in##2##5##(1994-3#2)
and gap junction##4##3##(1994-3#2)(2012-2#2)
and gap junctions##2##3##(2009-10#1)(2012-2#1)
and gap##6##2##(1994-3#2)(2009-10#1)(2012-2#3)
and gas chromatographic##2##3##(2008-10#2)
and gas chromatography##6##3##(1993-1#1)(2008-10#5)
and gas chromatography-mass spectrometry (GC-MS)##4##5##(2008-10#4)
and gas chromatography-mass spectrometry##10##4##(2008-10#10)
and gas chromatography-mass##11##3##(2008-10#11)
and gas chromatography/electron capture##2##4##(2008-10#2)
and gas exchange##2##3##(1994-5#1)(2012-3#1)
and gas##30##2##(1993-1#1)(1994-5#1)(2008-10#24)(2008-11#1)(2008-9#1)(2010-7#1)(2012-3#1)
and gaseous##2##2##(1996-12#1)(2008-10#1)
and gasoline##2##2##(2008-10#1)(2008-3#1)
and gastric ulcer##4##3##(1992-11#2)(2008-12#1)(2011-2#1)
and gastric##19##2##(1992-11#3)(1994-8#3)(1995-2#1)(1997-1#1)(1997-4#1)(2008-11#3)(2008-12#2)(2008-5#1)(2010-12#1)(2011-2#3)
and gastroduodenal##3##2##(1997-1#1)(1997-4#1)(2012-12#1)
and gastrointestinal bleeding##3##3##(2009-8#1)(2012-2#1)(2012-3#1)
and gastrointestinal manifestations##2##3##(2008-11#1)(2011-2#1)
and gastrointestinal tract##4##3##(1997-8#2)(2008-1#1)(2012-2#1)
and gastrointestinal##19##2##(1990-2#2)(1991-6#1)(1996-11#1)(1997-8#2)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#2)(2009-8#1)(2011-2#3)(2012-2#2)(2012-3#1)
and gave a##2##3##(1996-1#1)(2008-10#1)
and gave##10##2##(1996-1#1)(1997-2#1)(2008-10#5)(2008-5#1)(2009-5#1)(2010-12#1)
and gel filtration chromatography##2##4##(1991-3#1)(2008-10#1)
and gel filtration##6##3##(1991-3#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
and gel permeation chromatography##2##4##(2008-10#2)
and gel##14##2##(1991-3#1)(1993-9#1)(1994-8#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2011-2#1)
and gel-filtration##2##2##(2008-10#1)(2010-4#1)
and gelatin##4##2##(2008-10#4)
and gender differences##3##3##(2008-11#1)(2011-1#2)
and gender in##2##3##(2011-2#1)(2012-2#1)
and gender on##3##3##(1994-3#1)(2008-7#1)(2010-4#1)
and gender##26##2##(1992-3#1)(1994-12#1)(1994-3#2)(2008-11#4)(2008-7#1)(2009-12#1)(2009-7#2)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)
and genders##2##2##(2011-1#1)(2011-2#1)
and gene diversity##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
and gene expression of##3##4##(2008-9#1)(2010-12#1)(2012-3#1)
and gene expression##12##3##(1993-6#1)(1996-2#1)(1997-7#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and gene flow##2##3##(2008-10#1)(2012-3#1)
and gene networks##2##3##(2010-5#1)(2012-2#1)
and gene therapy##2##3##(1994-5#1)(2008-4#1)
and gene transfer##2##3##(2008-11#1)(2008-8#1)
and gene##43##2##(1993-6#1)(1994-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-4#2)(2008-8#2)(2008-9#6)(2009-10#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-8#1)
and general characteristics was found to be statistically significant for##2##10##(1990-2#2)
and general hospitals##3##3##(1991-2#1)(1994-1#2)
and general practice##3##3##(1992-2#1)(2008-3#1)(2008-8#1)
and general self-esteem##2##3##(2009-7#2)
and general##43##2##(1990-2#2)(1990-5#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-1#3)(1994-12#1)(1994-3#2)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#3)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
and generalised##3##2##(2008-10#3)
and generalist##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
and generalized H-point standard additions##2##5##(2008-10#2)
and generalized##7##2##(2008-1#1)(2008-10#3)(2008-11#1)(2009-3#1)(2013-1#1)
and generally##10##2##(1990-11#1)(1992-3#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-6#1)
and generate##4##2##(1993-12#1)(2008-10#2)(2008-3#1)
and generated##2##2##(1997-8#1)(2009-9#1)
and generates##3##2##(1991-2#1)(1995-2#1)(2012-2#1)
and generating##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and generation of##2##3##(2008-4#1)(2011-2#1)
and generic##2##2##(2011-1#1)(2011-3#1)
and genes of##2##3##(2008-10#1)(2012-3#1)
and genes##5##2##(1996-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
and genetic analysis##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
and genetic characteristics of##2##4##(2011-2#1)(2013-8#1)
and genetic characteristics##3##3##(2011-2#1)(2013-8#2)
and genetic characterization of##2##4##(2008-10#1)(2012-2#1)
and genetic diversity of##2##4##(2008-10#2)
and genetic diversity##3##3##(2008-10#2)(2008-8#1)
and genetic exchange##2##3##(2008-8#1)(2013-8#1)
and genetic factors##5##3##(2008-7#1)(2008-9#1)(2009-8#2)(2013-1#1)
and genetic linkage##3##3##(1997-3#1)(2008-10#2)
and genetic manipulation##2##3##(2008-11#1)(2009-3#1)
and genetic mapping##2##3##(1996-8#1)(2008-4#1)
and genetic structure of##3##4##(2008-10#2)(2008-9#1)
and genetic variation of##2##4##(2011-10#1)(2012-2#1)
and genetic variation##5##3##(2008-10#3)(2011-10#1)(2012-2#1)
and genetic##74##2##(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-3#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-3#1)(2009-8#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#6)
and genetically distinct from##2##4##(2008-10#2)
and genetically##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
and genetics in##2##3##(1997-3#1)(2008-8#1)
and genetics of crown rust resistance in barley##2##8##(2008-10#2)
and genetics of##6##3##(2008-10#2)(2008-8#2)(2009-9#1)(2012-3#1)
and genetics##11##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#3)(2009-9#1)(2011-3#1)(2012-3#1)(2013-8#1)
and genital##2##2##(1993-3#1)(2008-12#1)
and genitalia##2##2##(2008-8#1)(2010-4#1)
and genome organization##2##3##(2008-10#1)(2008-8#1)
and genome##8##2##(2007-12#2)(2008-10#3)(2008-8#3)
and genome-based##2##2##(2008-10#1)(2011-1#1)
and genome-wide##5##2##(2009-4#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#1)
and genomic DNA##2##3##(1996-8#1)(2008-4#1)
and genomic##16##2##(1993-6#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-3#1)
and genomics##3##2##(2008-7#1)(2009-8#1)(2010-5#1)
and genotype##7##2##(2008-10#5)(2008-5#1)(2009-7#1)
and genotypes of##3##3##(2008-10#2)(2012-3#1)
and genotypes##6##2##(2008-10#4)(2009-10#1)(2012-3#1)
and genotypic diversity##2##3##(2008-10#2)
and genotypic##10##2##(2008-10#8)(2008-8#2)
and genotyping of##2##3##(2008-10#1)(2012-3#1)
and genotyping##4##2##(2008-10#1)(2008-2#1)(2012-3#2)
and gentle##2##2##(2008-10#1)(2008-9#1)
and geochemical##2##2##(2008-10#2)
and geographic areas##2##3##(1994-1#1)(1996-12#1)
and geographic distance##4##3##(2008-10#4)
and geographic distribution of##2##4##(2008-10#1)(2011-2#1)
and geographic distribution##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
and geographic origin##2##3##(2008-10#2)
and geographic##16##2##(1994-1#1)(1996-12#1)(2008-10#9)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
and geographical distribution of the##2##5##(1997-7#1)(2013-8#1)
and geographical origin##2##3##(2008-10#2)
and geographical##12##2##(1990-8#1)(1997-7#1)(2008-10#7)(2008-8#1)(2010-11#1)(2013-8#1)
and geographically##2##2##(2008-10#1)(2010-12#1)
and geological samples##2##3##(2008-10#2)
and geometric##2##2##(2008-10#1)(2008-6#1)
and geometry of##2##3##(1991-12#1)(1993-8#1)
and geometry##3##2##(1991-12#1)(1993-8#1)(2008-3#1)
and geostatistical##2##2##(2008-10#1)(2008-11#1)
and germ cell##3##3##(2009-10#2)(2009-7#1)
and germ tube growth of##4##5##(2008-10#4)
and germ tube##5##3##(2008-10#5)
and germ##12##2##(2008-10#6)(2009-10#5)(2009-7#1)
and germinate##3##2##(2008-10#3)
and germination of##2##3##(2008-10#2)
and germination were##2##3##(2008-10#2)
and germination##9##2##(1995-6#1)(2008-10#7)(2008-12#1)
and germline##2##2##(2008-11#1)(2013-8#1)
and gestational age##2##3##(2007-12#1)(2011-1#1)
and gestational##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
and get more##2##3##(1994-1#1)(1996-12#1)
and get##3##2##(1994-1#1)(1996-12#1)(2008-10#1)
and gfg transcripts##2##3##(1994-11#2)
and ghost talk##2##3##(2008-3#2)
and ghost##3##2##(2007-11#1)(2008-3#2)
and giant##6##2##(1992-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
and gills##3##2##(2008-12#2)(2008-7#1)
and give an overview of##2##5##(2010-11#1)(2010-9#1)
and give##13##2##(1993-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(2008-10#3)(2009-8#1)(2010-11#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
and given the##2##3##(2012-3#1)(2013-8#1)
and given##5##2##(1997-5#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
and gives a##5##3##(1991-11#1)(1997-2#1)(2008-10#2)(2008-4#1)
and gives rise to##2##4##(2008-10#1)(2008-5#1)
and gives the##2##3##(2008-10#1)(2008-11#1)
and gives##15##2##(1990-11#1)(1991-11#1)(1992-2#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)
and giving##2##2##(2008-10#1)(2008-11#1)
and glass beads##2##3##(2008-10#1)(2009-5#1)
and glass##9##2##(1995-3#1)(2008-10#3)(2008-3#2)(2009-5#1)(2010-8#1)(2012-2#1)
and glassy carbon##3##3##(2008-10#3)
and glia is##2##3##(2008-7#1)(2009-9#1)
and glial##4##2##(1994-2#1)(2008-11#1)(2008-5#1)(2008-7#1)
and glibenclamide##7##2##(1992-3#2)(1994-11#1)(1994-8#4)
and glioma risk##3##3##(2011-2#3)
and glioma##4##2##(1992-6#1)(2011-2#3)
and global ratings of energy##2##5##(2008-7#2)
and global##18##2##(1992-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#3)(2013-8#1)
and globoid cell leukodystrophy##2##4##(2008-11#2)
and globule compressibility##2##3##(2008-10#2)
and globulin##2##2##(2008-10#1)(2008-5#1)
and globus pallidus##2##3##(1996-12#1)(2008-7#1)
and glomerular##2##2##(2008-1#1)(2010-4#1)
and glomerulonephritis##3##2##(1996-3#1)(1997-8#1)(2013-8#1)
and gluC##2##2##(2008-10#2)
and glucagon##6##2##(1994-11#1)(1994-8#2)(2008-11#1)(2008-3#1)(2008-8#1)
and glucagon-like peptide-1##2##3##(2011-2#2)
and glucagon-like##3##2##(2011-2#2)(2012-3#1)
and glucocorticoid receptors##3##3##(1995-12#2)(2008-6#1)
and glucocorticoid##8##2##(1993-5#1)(1995-12#4)(2008-12#1)(2008-6#1)(2011-1#1)
and glucocorticoids##5##2##(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
and glucose and##3##3##(1994-5#2)(2010-8#1)
and glucose concentration##2##3##(2008-10#2)
and glucose concentrations##2##3##(1993-1#1)(2010-10#1)
and glucose in##2##3##(2008-10#1)(2008-9#1)
and glucose levels##5##3##(2008-10#3)(2008-11#1)(2012-5#1)
and glucose oxidase##6##3##(2008-10#6)
and glucose##51##2##(1993-1#2)(1994-5#3)(1994-8#3)(1997-6#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-3#1)(2008-5#1)(2008-9#3)(2010-10#1)(2010-8#1)(2012-3#1)(2012-4#1)(2012-5#4)(2013-1#1)
and glutamate dehydrogenase##2##3##(2008-10#1)(2008-11#1)
and glutamate##11##2##(1991-11#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2010-1#1)
and glutamatergic##3##2##(2008-7#3)
and glutamic##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
and glutamine concentration##2##3##(2008-11#2)
and glutamine synthetase##4##3##(2008-11#2)(2008-7#1)(2009-8#1)
and glutamine##26##2##(2008-11#22)(2008-7#3)(2009-8#1)
and glutamine)##2##2##(2008-11#2)
and glutaraldehyde##2##2##(2008-10#2)
and glutathione determination##2##3##(2008-10#2)
and glutathione disulfide##5##3##(2008-10#4)(2008-11#1)
and glutathione peroxidase##3##3##(1990-3#2)(1997-5#1)
and glutathione##23##2##(1990-3#2)(1993-8#1)(1997-5#1)(2008-10#15)(2008-11#2)(2008-7#1)(2010-5#1)
and glycemic control##2##3##(2009-8#1)(2011-2#1)
and glycemic load##2##3##(2008-1#1)(2013-8#1)
and glycemic##4##2##(2008-1#1)(2009-8#1)(2011-2#1)(2013-8#1)
and glyceraldehyde-3-phosphate dehydrogenase##2##3##(1992-6#1)(1995-11#1)
and glycerol which##2##3##(1995-11#2)
and glycerol##7##2##(1995-11#2)(2008-10#3)(2008-5#1)(2008-8#1)
and glycine##5##2##(1992-10#1)(1993-2#1)(1997-3#1)(2008-10#1)(2009-6#1)
and glycogen##4##2##(2008-10#3)(2010-7#1)
and glycolytic##5##2##(1994-3#1)(1994-8#1)(1997-1#3)
and glycophorin##2##2##(1992-11#1)(2008-9#1)
and glycosylated##2##2##(1992-6#1)(2008-11#1)
and glycosylation of##2##3##(2011-2#2)
and glycosylation##5##2##(2008-11#3)(2011-2#2)
and glycuronic acids##2##3##(1991-7#2)
and go##2##2##(1992-3#1)(1994-12#1)
and goal re-engagement##2##3##(2010-2#2)
and goals of##4##3##(1993-3#1)(1995-3#1)(2008-11#1)(2010-6#1)
and goals##6##2##(1991-12#1)(1993-3#1)(1995-3#1)(2008-11#1)(2010-6#1)(2010-7#1)
and goat##3##2##(1995-2#1)(2011-2#2)
and goes on to describe##2##5##(1994-3#1)(2008-9#1)
and gold##12##2##(2008-10#10)(2008-3#1)(2010-11#1)
and goldfish##3##2##(1997-7#1)(2008-12#2)
and gonadal##2##2##(2008-10#1)(2008-4#1)
and gonadotropin-releasing##2##2##(1996-2#2)
and gonads##2##2##(2008-11#1)(2008-4#1)
and good agreement was obtained with the##2##7##(2008-10#2)
and good agreement was obtained##3##5##(2008-10#3)
and good agreement##4##3##(2008-10#4)
and good correlation##2##3##(2008-10#2)
and good linearity##4##3##(2008-10#3)(2009-8#1)
and good long-term stability##2##4##(2008-10#2)
and good precision (RSD##2##4##(2008-10#2)
and good recoveries##3##3##(2008-10#3)
and good reproducibility##6##3##(2008-10#6)
and good results were obtained##2##5##(2008-10#2)
and good results##3##3##(2008-10#3)
and good selectivity for##2##4##(2008-10#2)
and good selectivity##5##3##(2008-10#4)(2010-11#1)
and good stability##2##3##(2008-10#1)(2008-5#1)
and good##65##2##(1992-2#1)(1993-6#1)(1994-1#2)(1997-8#1)(2008-10#43)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
and governance##4##2##(1991-1#1)(1995-12#2)(2013-8#1)
and government##9##2##(1991-12#2)(1992-12#1)(1994-2#1)(1995-6#1)(1997-2#2)(2008-10#1)(2012-12#1)
and governmental##6##2##(1993-3#1)(1996-12#1)(1997-3#1)(2008-10#1)(2009-4#1)(2011-2#1)
and governments##5##2##(1991-12#1)(1993-3#1)(1994-1#1)(1996-2#1)(2008-11#1)
and grade 4##2##3##(1991-8#2)
and grade##9##2##(1991-8#2)(2008-8#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
and graded-index POF's were##2##4##(2008-3#2)
and grading##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
and gradual##4##2##(1996-3#1)(2008-11#1)(2010-11#1)(2012-3#1)
and gradually became##2##3##(1997-8#1)(2008-9#1)
and gradually##5##2##(1997-8#1)(2007-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
and graduate##5##2##(1994-12#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-1#1)
and grain##5##2##(2008-10#5)
and grains##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
and granular##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
and granularity##3##2##(2011-2#3)
and granulocyte-macrophage colony-stimulating factor##2##4##(1995-6#1)(2008-11#1)
and granulocyte-macrophage##3##2##(1992-3#1)(1995-6#1)(2008-11#1)
and granulocytes##2##2##(2008-9#1)(2009-6#1)
and granulosa##3##2##(1995-8#2)(2008-12#1)
and grape##3##2##(2008-10#3)
and graphic##2##2##(2008-10#1)(2010-3#1)
and graphical##2##2##(2008-10#1)(2008-8#1)
and graphics##2##2##(2010-8#1)(2012-3#1)
and graphite furnace atomic absorption spectrometric determination of##2##8##(2008-10#2)
and graphite furnace atomic absorption spectrometry (GFAAS)##4##7##(2008-10#4)
and graphite furnace atomic absorption spectrometry##8##6##(2008-10#8)
and graphite furnace atomic absorption##11##5##(2008-10#11)
and graphite##13##2##(2008-10#13)
and grasping##2##2##(1996-2#1)(2012-2#1)
and grasses##5##2##(2008-10#3)(2008-8#1)(2013-1#1)
and gray MTA+10%CaO##2##3##(2013-1#2)
and gray leaf spot resistance##2##5##(2008-10#2)
and gray leaf spot##4##4##(2008-10#4)
and gray##11##2##(2008-10#7)(2008-6#1)(2011-2#1)(2013-1#2)
and grease##3##2##(2008-5#1)(2013-1#2)
and greater coverage##2##3##(1994-3#1)(2013-1#1)
and greater than##3##3##(1990-12#1)(1992-12#1)(2008-10#1)
and greater##33##2##(1990-12#1)(1992-12#2)(1994-3#1)(1996-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
and greatest##2##2##(2008-11#1)(2008-12#1)
and greatly##3##2##(1993-9#1)(2008-10#1)(2008-3#1)
and green coffee beans##3##4##(2008-10#3)
and green fluorescent protein##2##4##(2008-11#1)(2008-9#1)
and green##7##2##(2008-10#5)(2008-11#1)(2008-9#1)
and greenhouse conditions##2##3##(2008-10#2)
and greenhouse experiments##5##3##(2008-10#4)(2008-8#1)
and greenhouse studies##2##3##(2008-10#1)(2013-8#1)
and greenhouse##13##2##(2008-10#11)(2008-8#1)(2013-8#1)
and grew##8##2##(2008-10#5)(2008-11#2)(2012-3#1)
and grip##2##2##(2008-9#1)(2013-1#1)
and grooves##2##2##(1991-2#1)(2008-8#1)
and gross##6##2##(1994-5#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
and ground water##3##3##(2008-10#3)
and ground##9##2##(2008-10#5)(2008-3#1)(2008-8#1)(2009-7#1)(2010-12#1)
and grounded##2##2##(2008-11#2)
and groundwater##2##2##(2008-10#1)(2008-8#1)
and group II##3##3##(2008-10#2)(2010-1#1)
and group III##2##3##(2006-6#1)(2009-8#1)
and group##24##2##(1992-2#1)(1996-12#1)(1996-3#1)(2006-6#1)(2008-10#5)(2008-11#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and grouped into##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
and grouped##6##2##(2008-10#4)(2008-3#1)(2011-2#1)
and groups of##2##3##(1996-12#1)(2009-12#1)
and groups with##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
and groups##10##2##(1993-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#1)
and grow##4##2##(2008-11#1)(2009-8#1)(2011-2#2)
and growing##8##2##(1990-12#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-6#1)
and grown##4##2##(1995-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
and growth abnormalities##2##3##(2008-10#2)
and growth chamber##3##3##(2008-10#3)
and growth conditions on##2##4##(2008-7#1)(2011-2#1)
and growth conditions##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
and growth factor##4##3##(1995-11#1)(1995-8#1)(2008-11#1)(2008-7#1)
and growth factors##7##3##(1991-12#1)(1993-12#2)(1993-2#1)(2008-5#1)(2009-12#1)(2013-1#1)
and growth hormone deficiency##2##4##(2008-5#1)(2011-1#1)
and growth hormone##6##3##(1991-9#1)(1994-8#2)(1996-2#1)(2008-5#1)(2011-1#1)
and growth in##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
and growth of the##3##4##(2008-10#3)
and growth of these##2##4##(2008-1#1)(2008-10#1)
and growth of##26##3##(1990-6#1)(1996-2#1)(1997-3#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)
and growth on##2##3##(2008-10#2)
and growth only##2##3##(2009-10#1)(2012-3#1)
and growth rate##2##3##(2008-10#1)(2012-3#1)
and growth were##2##3##(2008-10#1)(2012-3#1)
and growth##95##2##(1990-6#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-8#3)(1995-11#1)(1995-8#1)(1996-2#3)(1997-3#3)(2008-1#2)(2008-10#29)(2008-11#11)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-9#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#3)(2012-5#2)(2012-9#1)(2013-1#2)(2013-8#1)
and guanine##3##2##(1995-11#1)(2008-10#2)
and guanosine##6##2##(1992-8#1)(1993-8#1)(1994-8#1)(2008-4#2)(2009-12#1)
and guarantee##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
and guidance##5##2##(1997-8#1)(2008-11#1)(2008-12#3)
and guide##4##2##(1996-3#1)(2008-10#1)(2009-12#1)(2010-6#1)
and guided##3##2##(1990-5#1)(2008-4#1)(2013-1#1)
and guidelines for##3##3##(1992-3#1)(2008-12#2)
and guidelines##9##2##(1992-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-4#1)(2010-12#1)
and guilt##2##2##(1996-11#1)(2009-10#1)
and guinea pig##2##3##(1992-3#1)(1992-6#1)
and guinea pigs##6##3##(1995-12#5)(2008-10#1)
and guinea##8##2##(1992-3#1)(1992-6#1)(1995-12#5)(2008-10#1)
and gum##2##2##(2012-2#2)
and gut##3##2##(1994-11#2)(2008-5#1)
and gynecologic##2##2##(1992-1#1)(2011-2#1)
and hCG levels##2##3##(2011-1#2)
and hCG##3##2##(2008-5#1)(2011-1#2)
and hIL-6##2##2##(2008-8#2)
and habitat##7##2##(2008-8#3)(2008-9#3)(2010-8#1)
and habits##2##2##(2008-5#1)(2011-2#1)
and had a higher##4##4##(1990-11#1)(1993-6#1)(2008-6#1)(2011-2#1)
and had a molecular mass of##2##6##(1995-6#1)(2008-10#1)
and had a significant##2##4##(1991-6#1)(2010-4#1)
and had a##24##3##(1990-11#1)(1991-6#1)(1991-8#1)(1993-2#1)(1993-6#2)(1995-6#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
and had an##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
and had been##3##3##(1994-12#1)(2008-10#1)(2009-3#1)
and had complete##2##3##(2008-7#1)(2010-5#1)
and had distinct##2##3##(2008-8#1)(2013-1#1)
and had less##4##3##(1995-3#1)(1996-2#1)(2008-10#2)
and had low##2##3##(2008-2#1)(2008-5#1)
and had more##5##3##(1993-12#1)(1995-1#1)(2008-12#1)(2008-7#1)(2013-8#1)
and had no further##2##4##(2008-5#1)(2011-2#1)
and had no##5##3##(1993-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)
and had not been##2##4##(2008-11#1)(2011-3#1)
and had not##4##3##(2008-11#1)(2008-7#1)(2009-1#1)(2011-3#1)
and had the highest##2##4##(2008-10#2)
and had the##3##3##(1997-2#1)(2008-10#2)
and had##97##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1993-12#2)(1993-2#1)(1993-6#2)(1994-12#4)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#21)(2008-11#4)(2008-12#5)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#5)(2011-3#1)(2013-1#3)(2013-8#2)
and haematuria##2##2##(2008-10#1)(2011-2#1)
and haemodynamic parameters##2##3##(2010-7#1)(2011-2#1)
and haemodynamic##4##2##(2008-3#1)(2009-5#1)(2010-7#1)(2011-2#1)
and haemolytic##2##2##(2011-2#1)(2013-1#1)
and hair samples##8##3##(2008-10#7)(2008-5#1)
and hair##18##2##(2008-10#8)(2008-12#1)(2008-5#5)(2008-8#1)(2008-9#2)(2012-2#1)
and half of##2##3##(1997-8#1)(2008-6#1)
and half years##2##3##(2010-11#2)
and half##8##2##(1997-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-11#2)(2010-5#1)(2011-1#1)
and half-strength##2##2##(2008-10#2)
and halophenols##3##2##(2008-10#3)
and hampered##2##2##(2010-8#1)(2011-2#1)
and hand massage##3##3##(2010-7#3)
and hand##9##2##(1997-3#2)(2008-9#1)(2010-7#3)(2011-2#3)
and handling of##3##3##(1990-2#1)(2008-11#1)(2008-9#1)
and handling##11##2##(1990-2#1)(1992-1#1)(1995-11#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-9#1)
and hands-on##3##2##(1994-12#1)(1994-6#1)(2009-2#1)
and haploid segregation analysis##2##4##(2008-10#2)
and haploid##4##2##(2008-10#3)(2012-3#1)
and happy##2##2##(1996-9#1)(2010-4#1)
and hard of hearing children and adolescents##2##7##(2011-2#2)
and hard of hearing##7##4##(2011-2#7)
and hard##11##2##(2008-10#2)(2011-2#9)
and hardness of##2##3##(2008-10#1)(2010-10#1)
and hardness##4##2##(2008-10#2)(2010-10#1)(2010-4#1)
and haricot##2##2##(2008-10#2)
and harm##2##2##(1995-9#1)(2008-11#1)
and harmful##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
and harmonic##2##2##(2008-3#2)
and harsh##3##2##(2008-8#1)(2009-7#1)(2010-11#1)
and harvest##3##2##(2008-10#1)(2008-11#2)
and harvested##3##2##(2008-10#3)
and has a##23##3##(1990-11#1)(1991-5#2)(1991-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-8#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-7#1)
and has also been##2##4##(2009-12#1)(2013-8#1)
and has also##4##3##(2008-10#1)(2009-12#1)(2010-1#1)(2013-8#1)
and has an##7##3##(1993-2#1)(1996-12#1)(1997-1#1)(1997-9#1)(2008-10#1)(2008-3#1)(2010-10#1)
and has become an##2##4##(2008-10#1)(2012-2#1)
and has become##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
and has been applied successfully to the##2##7##(2008-10#2)
and has been applied to the##2##6##(2008-10#2)
and has been applied to##3##5##(2008-10#2)(2008-9#1)
and has been applied##7##4##(2008-10#6)(2008-9#1)
and has been implicated in##3##5##(1992-10#1)(1996-12#1)(2012-2#1)
and has been shown to##4##5##(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
and has been successfully##3##4##(2008-10#3)
and has been used as##2##5##(2008-10#1)(2008-7#1)
and has been used##5##4##(1991-7#1)(2008-10#3)(2008-7#1)
and has been##50##3##(1991-7#1)(1992-10#1)(1993-11#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-7#3)(2008-9#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
and has facilitated the##2##4##(1996-1#1)(2008-10#1)
and has high##2##3##(1997-2#1)(2008-10#1)
and has led to##2##4##(1994-12#1)(2009-6#1)
and has low##2##3##(2008-10#2)
and has maintained##2##3##(1996-1#1)(2012-3#1)
and has not been##2##4##(1995-6#1)(2012-3#1)
and has not##4##3##(1995-6#1)(2012-3#1)(2013-1#2)
and has only##2##3##(2008-5#1)(2013-1#1)
and has produced##2##3##(1996-1#1)(2009-7#1)
and has provided##2##3##(1997-2#1)(2008-10#1)
and has recently been shown to##2##6##(1995-6#1)(2008-10#1)
and has recently##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
and has required##2##3##(2008-12#1)(2008-9#1)
and has since##2##3##(1996-11#1)(2010-1#1)
and has the advantage of##5##5##(1994-3#1)(2008-10#2)(2008-9#1)(2011-2#1)
and has the advantage##6##4##(1994-3#1)(2008-10#3)(2008-9#1)(2011-2#1)
and has the potential to##4##5##(2008-10#2)(2008-11#1)(2012-3#1)
and has the##13##3##(1994-12#1)(1994-3#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-9#2)(2011-2#1)(2012-3#1)
and has##169##2##(1990-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1994-12#3)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#3)(1997-1#3)(1997-2#2)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#1)(2007-8#1)(2008-10#52)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#6)(2009-12#1)(2009-6#3)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#1)
and haustoria##2##2##(2008-10#2)
and have a##16##3##(1991-2#1)(1991-3#1)(1994-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2010-4#1)(2010-7#1)(2011-2#2)(2013-8#1)
and have also been##2##4##(2010-1#1)(2010-5#1)
and have an increased##2##4##(2008-7#1)(2011-1#1)
and have an##5##3##(2008-11#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-7#1)
and have become##2##3##(2008-11#1)(2008-3#1)
and have been linked to##2##5##(2012-12#1)(2013-1#1)
and have been reported to##2##5##(1994-5#1)(2008-10#1)
and have been##14##3##(1993-2#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
and have found##2##3##(2008-11#1)(2011-3#1)
and have high##2##3##(2008-10#1)(2008-9#1)
and have identified##2##3##(1990-5#1)(1994-3#1)
and have important implications for##2##5##(2008-12#1)(2008-8#1)
and have important##3##3##(2008-12#1)(2008-8#1)(2010-11#1)
and have led to##2##4##(1993-8#1)(2013-1#1)
and have more##2##3##(1995-1#1)(2013-8#1)
and have not been##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and have not##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
and have proved##2##3##(1997-1#1)(2008-2#1)
and have shown##3##3##(2008-11#1)(2009-5#1)(2011-2#1)
and have the##3##3##(2008-10#1)(2013-1#2)
and have to be##2##4##(2008-10#1)(2011-2#1)
and have##113##2##(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-1#2)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#15)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#5)
and having a##4##3##(1995-8#1)(2008-12#2)(2011-2#1)
and having an##2##3##(1992-2#1)(2010-8#1)
and having##15##2##(1992-2#1)(1995-1#1)(1995-8#1)(1996-2#1)(2008-12#2)(2008-8#1)(2009-6#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-8#1)
and hazard##2##2##(1997-3#1)(2011-2#1)
and hazards##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
and he is##3##3##(1990-11#1)(2008-11#1)(2011-2#1)
and he was##2##3##(2008-12#1)(2011-1#1)
and he##11##2##(1990-11#2)(1997-3#1)(2008-11#1)(2008-12#3)(2011-1#2)(2011-2#2)
and head circumference##3##3##(2011-1#3)
and head##12##2##(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#3)(2013-8#2)
and headache in##2##3##(2008-7#1)(2013-8#1)
and headache##7##2##(2008-12#1)(2008-7#2)(2010-12#2)(2013-7#1)(2013-8#1)
and healing##5##2##(1992-6#1)(1997-6#1)(2008-11#1)(2008-12#1)(2013-1#1)
and health administration##4##3##(1991-2#1)(1992-3#1)(1994-3#1)(1997-3#1)
and health care delivery systems##2##5##(1993-12#1)(1995-1#1)
and health care delivery##5##4##(1993-12#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-12#1)
and health care planners##2##4##(1992-2#1)(1996-3#1)
and health care professionals##2##4##(1991-2#1)(2008-11#1)
and health care providers##4##4##(1991-12#1)(1995-6#1)(1997-2#1)(2013-8#1)
and health care reform##5##4##(1993-12#1)(1995-12#3)(1996-2#1)
and health care utilization##5##4##(1996-2#3)(1997-1#2)
and health care##41##3##(1991-12#2)(1991-2#1)(1992-2#1)(1993-12#3)(1994-1#2)(1994-12#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#2)(1997-2#1)(2008-11#5)(2008-12#2)(2008-7#2)(2009-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
and health characteristics##2##3##(1991-3#1)(2011-2#1)
and health delivery##2##3##(2008-11#1)(2011-2#1)
and health education##2##3##(1992-1#1)(2008-1#1)
and health information##3##3##(1993-3#1)(1996-11#1)(2008-7#1)
and health insurance coverage##2##4##(2008-11#1)(2011-2#1)
and health insurance##4##3##(1991-2#1)(1997-2#1)(2008-11#1)(2011-2#1)
and health of low-income adults using a randomized controlled design##2##10##(2013-1#2)
and health of##5##3##(2008-11#2)(2012-12#1)(2013-1#2)
and health outcomes##2##3##(1994-1#1)(2008-10#1)
and health policy##4##3##(1991-12#1)(1992-1#1)(1996-3#1)(2010-9#1)
and health professionals##4##3##(1992-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and health promotion##5##3##(1992-1#1)(1996-2#1)(2008-1#1)(2008-11#1)(2010-6#1)
and health reform##4##3##(1995-2#2)(1996-12#1)(1996-9#1)
and health service delivery##2##4##(1996-1#1)(2008-12#1)
and health service##3##3##(1996-1#1)(2008-12#1)(2011-1#1)
and health services##5##3##(1991-1#1)(1994-12#1)(1997-3#1)(2008-1#1)(2010-1#1)
and health status##2##3##(1994-3#1)(1996-3#1)
and health system##5##3##(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
and health systems##4##3##(1997-3#1)(2008-11#3)
and health##153##2##(1990-6#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#3)(1994-12#2)(1994-3#2)(1994-6#2)(1995-1#1)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#4)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#6)(2008-1#3)(2008-10#5)(2008-11#15)(2008-12#4)(2008-7#6)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#4)
and health-care##2##2##(1993-2#1)(2008-1#1)
and health-related quality of life in##2##6##(2009-3#1)(2013-8#1)
and health-related quality of life##3##5##(2009-3#1)(2012-12#1)(2013-8#1)
and health-related##4##2##(2009-3#1)(2010-9#1)(2012-12#1)(2013-8#1)
and health]##2##2##(1990-3#1)(1997-4#1)
and healthcare providers##3##3##(1997-5#1)(2008-11#1)(2013-8#1)
and healthcare##15##2##(1994-12#1)(1996-8#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-12#2)(2009-3#1)(2009-6#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
and healthy control##2##3##(1990-12#1)(2008-12#1)
and healthy controls##5##3##(1990-8#1)(1992-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
and healthy leaf area absorption##2##5##(2008-10#2)
and healthy peach seedlings##2##4##(2008-10#2)
and healthy subjects##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
and healthy women##2##3##(2010-9#1)(2013-1#1)
and healthy##31##2##(1990-12#1)(1990-8#1)(1992-12#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
and hearing and equilibrium impairments##3##5##(2011-2#3)
and hearing##7##2##(2008-9#1)(2011-2#4)(2012-2#2)
and heart disease##3##3##(2008-3#1)(2009-6#1)(2013-8#1)
and heart failure##5##3##(1993-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
and heart rate (HR)##3##4##(2008-11#2)(2013-8#1)
and heart rate##5##3##(1990-9#1)(2008-11#2)(2008-5#1)(2013-8#1)
and heart##32##2##(1990-2#1)(1990-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-3#2)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
and heat shock##4##3##(1990-11#1)(1993-8#1)(1997-4#1)(2008-11#1)
and heat##17##2##(1990-11#1)(1991-12#2)(1992-2#1)(1993-8#1)(1994-11#1)(1996-12#2)(1997-4#1)(2008-10#1)(2008-11#4)(2008-2#1)(2012-2#2)
and heated##6##2##(2008-10#4)(2010-9#2)
and heating##7##2##(1990-2#1)(2008-10#6)
and heavier##2##2##(2008-10#2)
and heavy metal ions##11##4##(2008-10#11)
and heavy metal##15##3##(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#2)
and heavy metals in##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
and heavy metals##4##3##(2008-10#1)(2008-11#1)(2008-12#2)
and heavy##26##2##(1993-3#1)(1993-8#1)(1994-6#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-7#2)
and height of##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
and height##6##2##(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
and held##2##2##(2008-5#1)(2012-2#1)
and help students##2##3##(2008-11#1)(2009-12#1)
and help to##5##3##(2008-11#2)(2009-7#1)(2009-8#1)(2013-1#1)
and help##17##2##(1996-1#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
and helped##3##2##(2008-12#1)(2010-8#1)(2011-2#1)
and helper##2##2##(2008-8#1)(2012-3#1)
and helping##5##2##(2008-11#2)(2008-8#1)(2010-7#1)(2011-2#1)
and helps to##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
and helps##6##2##(1997-6#1)(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
and hematocrit##4##2##(1993-2#1)(1996-3#1)(2008-1#1)(2008-8#1)
and hematologic##2##2##(1990-12#1)(1997-3#1)
and hematopoietic stem##2##3##(2008-11#1)(2012-12#1)
and hematuria##3##2##(2008-10#2)(2011-2#1)
and hemin##2##2##(2008-10#1)(2008-9#1)
and hemocoagulative##2##2##(2008-7#2)
and hemodynamic##6##2##(2008-10#1)(2011-2#3)(2011-3#1)(2013-8#1)
and hemoglobin were not significantly##2##5##(2011-2#1)(2013-1#1)
and hemoglobin were##4##3##(2008-1#1)(2009-12#1)(2011-2#1)(2013-1#1)
and hemoglobin##14##2##(1994-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-5#1)(2013-1#2)
and hemolymph of##3##3##(1995-11#1)(2008-10#2)
and hemolymph##4##2##(1995-11#2)(2008-10#2)
and hemolytic anemia##2##3##(1991-2#1)(1996-3#1)
and hemorrhagic##3##2##(2010-6#3)
and hemostasis##2##2##(1991-6#1)(2011-2#1)
and hence a##2##3##(1990-12#1)(2008-10#1)
and hence eliminated##2##3##(2008-10#2)
and hence it##4##3##(1997-1#1)(2008-10#3)
and hence the##7##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
and hence to the##3##4##(2008-10#2)(2008-3#1)
and hence to##4##3##(2008-10#3)(2008-3#1)
and hence were##2##3##(2008-10#1)(2013-8#1)
and hence##50##2##(1990-12#2)(1993-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-9#1)(2007-12#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#6)(2009-8#2)(2012-2#1)(2013-8#1)
and heparan sulfate##2##3##(1992-11#1)(1995-6#1)
and hepatic lipid profiles##2##4##(2008-10#2)
and hepatic##13##2##(1994-11#1)(1994-5#2)(1994-8#1)(2008-10#3)(2010-12#1)(2010-2#1)(2011-2#2)(2013-8#2)
and hepatitis B virus##2##4##(2008-10#1)(2009-5#1)
and hepatitis B##3##3##(1995-2#1)(2008-10#1)(2009-5#1)
and hepatitis C virus (HCV)##2##5##(2008-10#1)(2013-8#1)
and hepatitis C virus##4##4##(1996-9#1)(2008-10#2)(2013-8#1)
and hepatitis##9##2##(1995-2#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-6#1)(2009-5#1)(2013-8#1)
and hepatobiliary##2##2##(1990-3#1)(2012-3#1)
and hepatocyte##2##2##(2008-11#1)(2008-8#1)
and her condition##2##3##(1995-12#1)(2011-2#1)
and her##12##2##(1990-12#1)(1990-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1997-3#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
and her-2/neu protein markers##2##4##(2008-10#2)
and herbal##4##2##(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#1)
and herbarium##3##2##(2008-10#3)
and here we##3##3##(2008-11#1)(2009-7#1)(2010-12#1)
and here##6##2##(1994-11#1)(1995-11#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-12#1)
and hereditary##2##2##(2013-1#2)
and heritability of##2##3##(2008-10#1)(2008-8#1)
and heterogeneity of##2##3##(2008-10#1)(2009-7#1)
and heterogeneity##6##2##(2008-10#3)(2008-11#2)(2009-7#1)
and heterogeneous group of##2##4##(2012-2#1)(2012-3#1)
and heterogeneous##8##2##(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
and heteromeric receptors##2##3##(1995-11#2)
and heteromeric##4##2##(1995-11#4)
and heteronuclear##2##2##(1990-5#1)(1992-4#1)
and heterosexual##2##2##(1992-9#2)
and heterotic gene expression##2##4##(2009-10#2)
and hexadecanoic acid##3##3##(2008-12#1)(2008-5#2)
and hexane##2##2##(2008-10#2)
and hierarchical##2##2##(2008-10#1)(2010-7#1)
and high concentrations##2##3##(1990-5#1)(2008-11#1)
and high density lipoprotein##2##4##(1991-11#1)(2008-3#1)
and high density##3##3##(1991-11#1)(2008-10#1)(2008-3#1)
and high dose##4##3##(2007-11#1)(2008-11#1)(2008-7#1)(2010-11#1)
and high frequency##2##3##(1996-12#1)(2010-12#1)
and high genetic##2##3##(2008-8#1)(2013-8#1)
and high level##2##3##(2008-11#1)(2012-2#1)
and high levels of##3##4##(1996-12#1)(2008-10#1)(2008-9#1)
and high mortality##2##3##(1990-12#1)(1996-2#1)
and high pH##2##3##(1991-9#1)(2008-10#1)
and high performance liquid chromatographic##2##5##(2008-10#2)
and high performance liquid chromatography (HPLC)##2##6##(1997-2#1)(2008-10#1)
and high performance liquid chromatography##3##5##(1997-2#1)(1997-7#1)(2008-10#1)
and high performance liquid##6##4##(1990-5#1)(1997-2#1)(1997-7#1)(2008-10#3)
and high pulse##2##3##(2008-3#1)(2010-1#1)
and high quality##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
and high reproducibility##2##3##(2008-10#2)
and high resolution##3##3##(2008-10#3)
and high sample throughput##2##4##(2008-10#2)
and high school financial education##2##5##(2010-10#2)
and high school##3##3##(1990-6#1)(2010-10#2)
and high selectivity##6##3##(2008-10#6)
and high sensitivity##7##3##(2008-10#6)(2013-1#1)
and high temperature##2##3##(1995-6#1)(2008-8#1)
and high temperatures##2##3##(2008-10#2)
and high titer##2##3##(1991-8#1)(2008-11#1)
and high voltage##2##3##(1991-9#1)(2008-11#1)
and high##180##2##(1990-12#2)(1990-5#2)(1990-6#2)(1991-11#2)(1991-2#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#3)(1995-12#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#69)(2008-11#11)(2008-12#4)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#3)(2009-11#3)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#3)
and high)##2##2##(1992-3#1)(2012-3#1)
and high-density lipoprotein##3##3##(2008-12#1)(2008-6#1)(2013-8#1)
and high-density##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2013-8#1)
and high-dose##2##2##(1992-6#1)(1996-11#1)
and high-level##2##2##(1994-1#1)(2013-1#1)
and high-performance liquid chromatography##5##4##(1994-3#1)(1997-2#1)(2008-10#3)
and high-performance##7##2##(1994-3#1)(1997-2#1)(2008-10#3)(2011-2#2)
and high-quality##2##2##(2008-11#1)(2011-2#1)
and high-resolution##2##2##(2007-12#1)(2008-11#1)
and high-risk##2##2##(2008-6#1)(2013-1#1)
and high-sensitivity##3##2##(2008-10#1)(2011-2#1)(2012-5#1)
and high-throughput##2##2##(2008-10#1)(2013-8#1)
and higher concentrations##2##3##(1994-11#1)(2007-12#1)
and higher education institutions##2##4##(2008-12#2)
and higher education##6##3##(1991-1#2)(2008-12#4)
and higher for##2##3##(1995-1#1)(2008-10#1)
and higher level of##2##4##(2008-10#1)(2011-2#1)
and higher level##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
and higher levels of##3##4##(2008-10#2)(2008-8#1)
and higher order##2##3##(2008-11#2)
and higher than the##2##4##(2008-3#1)(2010-8#1)
and higher than##5##3##(1996-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)
and higher##73##2##(1991-1#2)(1992-11#1)(1992-3#2)(1992-9#1)(1993-1#1)(1994-11#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#9)(2008-12#5)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-7#2)(2010-4#1)(2010-8#2)(2011-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
and highest##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
and highlight the need for##2##5##(2008-9#1)(2013-1#1)
and highlight the role of##2##5##(2009-9#1)(2013-1#1)
and highlight the##11##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#2)
and highlight##18##2##(1992-12#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
and highlighted##2##2##(2008-11#1)(2011-2#1)
and highlighting##2##2##(2013-1#1)(2013-8#1)
and highlights the##7##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)(2013-8#1)
and highlights##15##2##(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
and highly effective##2##3##(1997-4#1)(2013-1#1)
and highly efficient##3##3##(1994-5#1)(2008-9#2)
and highly reproducible##3##3##(2008-10#2)(2011-2#1)
and highly selective##7##3##(2008-10#7)
and highly sensitive##9##3##(2008-10#7)(2008-11#1)(2009-12#1)
and highly significant##2##3##(2008-10#1)(2010-3#1)
and highly specific##4##3##(1997-2#1)(2008-10#2)(2008-5#1)
and highly##59##2##(1992-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#25)(2008-11#7)(2008-12#1)(2008-5#1)(2008-9#6)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
and hilar##2##2##(1996-1#1)(1997-8#1)
and hinder##3##2##(1995-3#1)(2008-10#2)
and hip circumference##2##3##(2011-2#2)
and hip##6##2##(1997-8#1)(2008-11#1)(2011-2#3)(2013-1#1)
and hippocampal##11##2##(1993-6#1)(1994-2#3)(1996-12#2)(2008-11#1)(2008-7#1)(2013-7#1)(2013-8#2)
and hippocampus and##2##3##(1994-2#1)(1997-2#1)
and hippocampus##10##2##(1993-3#1)(1993-6#1)(1994-2#2)(1996-12#1)(1996-2#1)(1997-2#2)(2013-8#2)
and his##27##2##(1990-11#1)(1991-6#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(2007-12#2)(2008-10#1)(2008-12#5)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
and his4##2##2##(2008-10#2)
and histochemical##5##2##(1991-1#1)(2007-12#2)(2008-10#1)(2008-7#1)
and histologic type##2##3##(1990-12#1)(1991-8#1)
and histologic##5##2##(1990-12#2)(1991-8#1)(2007-8#1)(2008-9#1)
and histological aspects##2##3##(2012-2#1)(2013-1#1)
and histological differentiation##2##3##(2008-9#1)(2011-2#1)
and histological examination##2##3##(2008-7#1)(2012-12#1)
and histological features of##2##4##(2008-7#1)(2012-3#1)
and histological features##5##3##(1991-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
and histological findings##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
and histological methods##2##3##(2007-12#1)(2008-4#1)
and histological##27##2##(1991-11#2)(1991-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
and histologically##3##2##(1995-2#1)(2010-12#1)(2011-2#1)
and histology##5##2##(2008-10#1)(2008-11#1)(2009-12#1)(2009-4#1)(2011-2#1)
and histone##3##2##(1990-5#1)(1994-11#1)(2009-4#1)
and histopathologic##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
and histopathological examination##3##3##(2012-2#1)(2013-1#2)
and histopathological findings in##2##4##(2011-2#1)(2013-1#1)
and histopathological findings##7##3##(2008-4#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#2)(2013-1#1)
and histopathological##17##2##(1991-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#3)
and histopathology of##2##3##(2008-10#1)(2012-12#1)
and histopathology study##2##3##(2008-5#2)
and histopathology##9##2##(2008-10#2)(2008-5#2)(2011-2#2)(2012-12#1)(2012-2#2)
and history of the##2##4##(2008-11#1)(2009-11#1)
and history of##8##3##(1996-3#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
and history##9##2##(1996-3#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
and hold##2##2##(2008-10#1)(2008-9#1)
and holding##2##2##(1997-1#1)(2008-10#1)
and holistic##2##2##(2008-11#1)(2009-8#1)
and home care##2##3##(1993-2#1)(1994-8#1)
and home##5##2##(1993-2#1)(1994-2#1)(1994-8#1)(1995-12#1)(2010-8#1)
and homeostasis##3##2##(1996-2#1)(2012-5#1)(2013-1#1)
and homicide##2##2##(1992-2#1)(2008-12#1)
and homocysteine##2##2##(1991-12#1)(2008-8#1)
and homogeneous##8##2##(1992-3#1)(2008-10#3)(2008-3#2)(2008-4#1)(2013-7#1)
and homogenized##2##2##(2008-10#2)
and homologous##4##2##(1991-12#1)(1994-8#1)(2008-4#1)(2008-9#1)
and homology##3##2##(1990-7#1)(2008-8#1)(2009-6#1)
and honesty in##2##3##(1995-5#1)(2008-9#1)
and honeydew##2##2##(2008-10#1)(2011-2#1)
and hope##3##2##(1993-2#1)(2008-11#1)(2008-12#1)
and horizontal##7##2##(1997-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-6#1)(2013-1#1)
and hormonal##11##2##(1994-12#2)(1995-11#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)(2013-1#1)(2013-7#2)
and hormone signals##2##3##(2009-8#2)
and hormone##6##2##(1993-6#1)(1996-2#1)(1997-1#1)(2009-8#3)
and hormones##4##2##(1995-11#1)(1997-1#1)(2008-11#1)(2009-10#1)
and horse##5##2##(1990-5#1)(2008-10#2)(2008-7#1)(2010-4#1)
and horse-radish peroxidase##5##3##(2008-10#5)
and horseradish peroxidase (HRP) were immobilized##2##6##(2008-10#2)
and horseradish peroxidase (HRP) were##3##5##(2008-10#3)
and horseradish peroxidase (HRP)##6##4##(2008-10#6)
and horseradish peroxidase##11##3##(2007-12#1)(2008-10#10)
and horticultural crops##2##3##(2008-10#2)
and horticultural##3##2##(2008-10#3)
and hospital care##2##3##(1993-3#1)(2013-1#1)
and hospital competition##2##3##(2008-11#2)
and hospital profitability##2##3##(2008-11#2)
and hospital##28##2##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(2008-11#9)(2012-2#1)(2012-3#2)(2013-1#2)
and hospitalization##2##2##(1995-2#1)(2008-11#1)
and hospitalizations##2##2##(2008-11#1)(2011-2#1)
and hospitals##13##2##(1991-3#1)(1992-11#1)(1992-3#1)(1993-1#1)(1994-1#2)(1994-12#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-3#1)(2013-1#1)(2013-8#1)
and host factors##3##3##(2008-10#1)(2008-9#1)(2010-6#1)
and host range##3##3##(2008-10#3)
and host resistance##6##3##(2008-10#4)(2008-8#2)
and host##30##2##(2008-10#19)(2008-8#5)(2008-9#2)(2010-1#1)(2010-6#1)(2011-2#2)
and hostility##4##2##(2008-4#3)(2010-7#1)
and hot##4##2##(1994-3#1)(2008-10#3)
and hot-spring water##2##3##(2008-10#2)
and hours##2##2##(2008-10#2)
and house finches##2##3##(2008-8#2)
and house##3##2##(2008-10#1)(2008-8#2)
and how a##2##3##(2011-1#1)(2011-2#1)
and how best to##2##4##(2009-9#1)(2013-1#1)
and how different##2##3##(1997-3#1)(2008-10#1)
and how it should be maintained as required to obtain maximum image-forming capacity and resolution##2##15##(2008-4#2)
and how it##8##3##(1992-2#1)(1993-3#1)(1995-12#1)(2008-4#2)(2008-7#1)(2009-7#1)(2013-8#1)
and how much##2##3##(1994-3#1)(2010-12#1)
and how rapidly##3##3##(1997-7#1)(2008-10#1)(2011-2#1)
and how the##5##3##(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#2)
and how their##3##3##(1991-1#1)(2008-10#1)(2009-8#1)
and how these relationships##2##4##(1996-2#1)(2008-8#1)
and how these##9##3##(1996-2#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2011-2#2)(2012-2#1)
and how they are##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
and how they can be##2##5##(1997-2#1)(2010-12#1)
and how they interact##2##4##(2008-8#1)(2010-5#1)
and how they##18##3##(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
and how this##10##3##(1996-6#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#2)
and how to relate##2##4##(1997-2#1)(2008-12#1)
and how to##18##3##(1992-2#1)(1993-3#1)(1994-1#1)(1995-2#1)(1997-2#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and how##128##2##(1991-1#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#2)(1996-1#2)(1996-2#2)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#5)(2008-3#2)(2008-4#7)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#5)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-11#2)(2010-12#4)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#13)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
and how?]##2##2##(1991-2#1)(1992-3#1)
and hs-CRP were##2##3##(2011-2#1)(2012-5#1)
and hs-CRP##4##2##(2011-2#3)(2012-5#1)
and human breast cancer##2##4##(2011-2#2)
and human cell lines##3##4##(1997-7#1)(2008-11#2)
and human cell##5##3##(1997-7#2)(2008-11#2)(2008-9#1)
and human fibroblasts##2##3##(1997-7#1)(2012-2#1)
and human hair##6##3##(2008-10#3)(2012-3#3)
and human health##3##3##(1994-3#1)(2008-11#1)(2011-1#1)
and human liver##3##3##(1991-5#1)(1995-2#1)(2008-11#1)
and human melanoma cell##3##4##(1992-2#2)(2008-8#1)
and human neutrophils##2##3##(1995-6#1)(1996-12#1)
and human rights##2##3##(2008-11#1)(2008-8#1)
and human sequences##2##3##(1993-6#1)(1994-11#1)
and human serum samples##5##4##(2008-10#5)
and human serum##16##3##(1997-2#1)(2008-10#15)
and human service##4##3##(1991-3#1)(1994-1#1)(2011-2#2)
and human skin##2##3##(2008-5#2)
and human studies##8##3##(1993-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-7#1)(2012-2#1)(2012-3#1)
and human tumor##4##3##(1994-12#1)(1994-5#2)(2008-11#1)
and human umbilical vein endothelial cells##3##6##(1994-8#1)(2008-9#1)(2010-3#1)
and human umbilical vein endothelial##4##5##(1994-8#1)(2008-11#1)(2008-9#1)(2010-3#1)
and human urine by##2##4##(2008-10#2)
and human urine samples##2##4##(2008-10#2)
and human urine##6##3##(2008-10#6)
and human volunteers##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
and human##177##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#1)(1991-10#3)(1991-3#1)(1991-5#1)(1991-6#3)(1992-2#2)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#6)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#3)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#3)(1996-12#2)(1996-5#2)(1997-2#2)(1997-6#1)(1997-7#5)(1997-8#1)(1997-9#1)(2007-7#1)(2008-10#36)(2008-11#14)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#6)(2009-10#1)(2009-7#3)(2010-3#2)(2010-6#2)(2011-1#1)(2011-2#7)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#1)(2013-8#1)
and humanistic psychology##3##3##(2010-6#3)
and humanistic##4##2##(2010-6#3)(2012-3#1)
and humans are##2##3##(2008-11#1)(2012-2#1)
and humans##20##2##(1992-6#1)(1993-2#1)(1994-12#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-9#1)(2011-2#2)(2012-2#2)
and humic acid##4##3##(2008-10#4)
and humic substances##3##3##(2008-10#3)
and humic##11##2##(2008-10#11)
and humidity##6##2##(1992-2#2)(2008-10#2)(2009-3#1)(2013-1#1)
and humoral immune responses##5##4##(1995-2#2)(2008-10#1)(2008-11#1)(2008-12#1)
and humoral immune##6##3##(1995-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
and humoral immunity in##2##4##(2008-10#1)(2012-3#1)
and humoral immunity##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
and humoral responses##3##3##(1991-12#2)(2008-10#1)
and humoral##12##2##(1991-12#2)(1995-2#2)(2008-10#3)(2008-11#1)(2008-12#1)(2012-2#2)(2012-3#1)
and hybrid linear##2##3##(2008-10#2)
and hybrid##15##2##(1992-6#1)(2008-10#8)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
and hybridization of##4##3##(1993-6#1)(2008-10#2)(2008-4#1)
and hybridization with##2##3##(2008-10#2)
and hybridization##11##2##(1993-6#1)(2008-10#7)(2008-4#3)
and hybridoma cells##3##3##(2008-11#3)
and hybridomas##2##2##(2008-11#2)
and hybrids##4##2##(2008-10#1)(2008-8#1)(2012-3#2)
and hydration##7##2##(1990-11#2)(1991-12#1)(1994-3#2)(2008-5#1)(2013-8#1)
and hydraulic conductance##3##3##(2009-8#3)
and hydrazine in##4##3##(2008-10#4)
and hydrazine##8##2##(2008-10#8)
and hydride generation atomic absorption spectrometry##2##6##(2008-10#2)
and hydride generation atomic##3##4##(2008-10#3)
and hydride generation##8##3##(2008-10#8)
and hydride##12##2##(2008-10#11)(2009-7#1)
and hydrocarbon##2##2##(2008-10#2)
and hydrocarbons##2##2##(1992-3#1)(2008-10#1)
and hydrocephalus##2##2##(2011-2#1)(2012-2#1)
and hydrochloric acid##8##3##(1997-2#1)(2008-10#7)
and hydrochloric acids##2##3##(2008-10#2)
and hydrochloric##10##2##(1997-2#1)(2008-10#9)
and hydrocortisone##4##2##(2008-10#1)(2008-11#1)(2011-2#2)
and hydrofluoric acids##5##3##(2008-10#5)
and hydrogen bonding##5##3##(2008-10#5)
and hydrogen ions##2##3##(2008-10#2)
and hydrogen peroxide (H(2)O(2))##2##4##(2008-10#2)
and hydrogen peroxide in the##2##5##(1994-8#1)(2008-10#1)
and hydrogen peroxide in##4##4##(1994-8#1)(2008-10#3)
and hydrogen peroxide##29##3##(1994-8#1)(1997-4#1)(2008-10#23)(2008-11#1)(2009-8#1)(2011-2#2)
and hydrogen sulfide##2##3##(2008-6#1)(2009-12#1)
and hydrogen##45##2##(1994-8#1)(1996-12#1)(1997-4#1)(2008-10#36)(2008-11#1)(2008-6#1)(2009-12#1)(2009-8#1)(2011-2#2)
and hydrolysis of##3##3##(1993-8#1)(1994-11#1)(2008-10#1)
and hydrolysis reactions##2##3##(2008-7#2)
and hydrolysis##9##2##(1993-8#1)(1994-11#1)(2008-10#3)(2008-5#1)(2008-7#3)
and hydrolytic##2##2##(1990-10#1)(2008-10#1)
and hydromorphone##2##2##(2008-7#1)(2012-3#1)
and hydrophilic##6##2##(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#2)
and hydrophobic interactions##2##3##(2008-10#1)(2008-5#1)
and hydrophobic##9##2##(1991-5#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-10#3)(2012-2#1)
and hydroquinone##3##2##(2008-10#3)
and hydrostatic pressure##2##3##(2008-10#1)(2008-3#1)
and hydroxyapatite##2##2##(2008-11#1)(2011-2#1)
and hydroxyl radical##2##3##(2008-10#1)(2008-5#1)
and hydroxyl##3##2##(2008-10#2)(2008-5#1)
and hydroxylamine hydrochloride##2##3##(2008-10#2)
and hydroxylamine##8##2##(1991-5#1)(1995-2#1)(1997-2#1)(2008-10#5)
and hygiene##2##2##(2007-12#1)(2013-1#1)
and hygienic##2##2##(2008-10#1)(2013-8#1)
and hygromycin resistance genes##2##4##(2008-10#2)
and hypercalcemia in##2##3##(1991-8#1)(2008-12#1)
and hypercalcemia##5##2##(1990-2#1)(1991-8#3)(2008-12#1)
and hypercholesteremic##3##2##(2008-10#3)
and hyperinsulinemia##2##2##(2008-3#1)(2008-7#1)
and hyperlipidaemia##2##2##(2008-11#1)(2011-2#1)
and hyperlipidemia##3##2##(1994-5#1)(2009-6#1)(2013-1#1)
and hyperplasia##4##2##(2008-10#1)(2008-9#2)(2010-11#1)
and hyperplastic##3##2##(1990-12#1)(1992-8#1)(2009-12#1)
and hyperprolactinemia##2##2##(2008-8#1)(2011-2#1)
and hypersensitivity##3##2##(1995-6#1)(2007-12#1)(2008-7#1)
and hypertension##14##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and hypertrophy of##2##3##(2008-10#1)(2008-8#1)
and hypertrophy##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
and hyphal growth##4##3##(2008-10#3)(2012-2#1)
and hyphal##5##2##(2008-10#4)(2012-2#1)
and hyphenated techniques##2##3##(2008-10#2)
and hypoglossal##3##2##(2011-2#2)(2013-1#1)
and hypophosphatemia##3##2##(1991-8#3)
and hypoplastic##2##2##(2011-1#1)(2013-8#1)
and hypospadias##2##2##(2008-10#2)
and hypotension##2##2##(1990-9#1)(2011-1#1)
and hypothalamic##2##2##(1996-12#1)(2012-3#1)
and hypothalamus##2##2##(1994-2#1)(1995-2#1)
and hypothesis##2##2##(2009-12#1)(2013-1#1)
and hypothetical##4##2##(1990-8#1)(1996-6#1)(2008-12#1)(2008-9#1)
and hypovirulent phenotype##2##3##(2008-10#2)
and hypoxanthine##3##2##(1994-8#1)(2008-10#2)
and hypoxic##2##2##(1997-1#1)(2008-10#1)
and iNOS##2##2##(2008-9#1)(2009-10#1)
and iatrogenic##2##2##(1990-9#1)(2012-3#1)
and ibuprofen##3##2##(1997-5#1)(2008-10#1)(2008-11#1)
and ideas##4##2##(1990-11#1)(2008-12#1)(2010-5#1)(2013-8#1)
and identification of Vibrio cholerae##2##5##(2008-9#2)
and identification of a##6##4##(1997-7#1)(2008-10#1)(2009-12#1)(2009-6#1)(2012-2#1)(2012-3#1)
and identification of its##2##4##(1995-8#1)(2008-5#1)
and identification of several##2##4##(1993-12#1)(2008-10#1)
and identification of the##3##4##(2008-10#2)(2008-11#1)
and identification of##47##3##(1990-5#1)(1993-12#1)(1995-2#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-3#1)(2012-2#2)(2012-3#1)
and identification##56##2##(1990-5#1)(1993-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#17)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-8#1)
and identified a##2##3##(2008-11#2)
and identified as##6##3##(2008-10#6)
and identified by using standard bacteriological methods##2##7##(2008-12#2)
and identified by##4##3##(2008-10#2)(2008-12#2)
and identified the##3##3##(1995-11#1)(2008-10#1)(2012-2#1)
and identified##40##2##(1993-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(1997-3#1)(2008-10#16)(2008-11#4)(2008-12#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#2)
and identifies some##2##3##(1996-1#1)(2010-7#1)
and identifies##8##2##(1993-1#1)(1994-1#1)(1995-8#1)(1996-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-7#1)
and identify a##2##3##(1991-12#1)(2008-10#1)
and identify the##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
and identify them as##2##4##(1995-12#1)(2012-3#1)
and identify##29##2##(1991-12#1)(1994-9#1)(1995-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#4)(2012-4#1)(2013-8#1)
and identifying the##2##3##(1997-2#1)(2008-10#1)
and identifying##8##2##(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
and identity of##3##3##(1993-8#1)(2007-12#1)(2008-10#1)
and identity##6##2##(1993-8#1)(2007-12#1)(2008-10#2)(2009-7#2)
and idiopathic##3##2##(1993-6#1)(2008-11#1)(2009-8#1)
and ie-2##2##2##(1997-3#2)
and if so##7##3##(1990-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2012-7#1)
and if the##4##3##(1997-2#1)(2008-4#1)(2008-8#2)
and if they##3##3##(1997-2#1)(2008-7#1)(2012-3#1)
and if##26##2##(1990-5#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-8#1)
and ifosphamide##4##2##(2008-10#4)
and ignored##2##2##(1995-11#1)(2008-10#1)
and ii)##4##2##(2008-10#1)(2008-12#1)(2009-8#1)(2009-9#1)
and iii)##2##2##(2012-2#2)
and ileal##2##2##(2009-12#2)
and ill-health in agriculture##2##4##(2008-11#2)
and ill-health in##4##3##(2008-11#4)
and ill-health##6##2##(2008-11#6)
and illness##6##2##(1993-3#1)(2008-11#1)(2010-10#1)(2010-2#2)(2010-6#1)
and illnesses##4##2##(1993-3#2)(1997-4#1)(2010-1#1)
and illustrate the##4##3##(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
and illustrate##9##2##(2008-10#1)(2008-4#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
and illustrated in##2##3##(2007-12#1)(2012-2#1)
and illustrated with##4##3##(2008-10#2)(2011-7#1)(2012-2#1)
and illustrated##9##2##(2007-12#1)(2008-10#4)(2011-7#1)(2012-2#2)(2013-1#1)
and illustrates how##2##3##(1991-2#1)(2007-12#1)
and illustrates the##3##3##(1992-12#1)(2008-1#1)(2008-10#1)
and illustrates##8##2##(1991-2#1)(1992-12#1)(1992-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-7#1)(2013-1#1)
and image analysis##3##3##(2008-10#2)(2010-10#1)
and image##15##2##(1995-6#2)(1997-8#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-9#2)(2010-10#1)(2011-2#2)
and images of##2##3##(2008-10#1)(2010-10#1)
and images##6##2##(2007-11#1)(2008-1#1)(2008-10#2)(2010-10#1)(2011-3#1)
and imaging features##3##3##(1997-8#1)(2009-4#1)(2012-2#1)
and imaging of##2##3##(2008-10#1)(2009-6#1)
and imaging##21##2##(1993-3#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#1)
and immature##2##2##(2008-10#2)
and immediate##6##2##(1993-11#1)(1994-9#1)(2008-11#1)(2010-12#1)(2011-2#2)
and immediately##6##2##(1996-2#1)(2008-3#1)(2012-2#1)(2013-1#3)
and immigration##5##2##(1990-3#1)(2008-10#2)(2008-12#1)(2008-8#1)
and immobilisation##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
and immobilised##2##2##(2008-10#2)
and immobilize##2##2##(2008-10#1)(2008-7#1)
and immobilized##5##2##(1990-2#1)(2008-10#2)(2008-7#2)
and immortalization of##3##3##(2008-2#3)
and immune cells##5##3##(2008-11#1)(2008-5#1)(2009-3#1)(2012-3#1)(2013-1#1)
and immune function in##2##4##(2010-1#1)(2011-2#1)
and immune function##3##3##(2008-8#1)(2010-1#1)(2011-2#1)
and immune response of##2##4##(2008-7#1)(2011-2#1)
and immune response##6##3##(1997-8#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
and immune responses##2##3##(1995-5#1)(2008-11#1)
and immune##28##2##(1995-5#1)(1996-12#1)(1997-8#3)(2006-6#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-1#1)(2011-2#3)(2012-3#3)(2013-1#3)(2013-7#1)
and immunity##2##2##(2008-12#1)(2008-8#1)
and immunization##4##2##(1995-12#1)(1995-5#1)(1996-12#2)
and immunoaffinity##3##2##(1993-9#2)(2008-10#1)
and immunoblot analysis##2##3##(1993-8#1)(2008-11#1)
and immunoblot##5##2##(1993-3#1)(1993-8#1)(2008-10#2)(2008-11#1)
and immunoblotting##9##2##(1991-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-2#1)
and immunocapture##2##2##(2008-10#2)
and immunochemical##3##2##(1993-8#1)(2008-10#1)(2013-1#1)
and immunocompromised patients##2##3##(1990-12#1)(2011-2#1)
and immunocytochemical##6##2##(1993-11#1)(1997-3#1)(2007-12#2)(2008-7#1)(2009-12#1)
and immunocytochemistry##3##2##(1997-7#1)(2008-11#1)(2009-12#1)
and immunofluorescence##3##2##(2008-5#1)(2011-2#2)
and immunogenic##2##2##(2013-1#2)
and immunogenicity of##4##3##(1994-8#1)(2007-11#1)(2008-10#1)(2013-1#1)
and immunogenicity##8##2##(1994-8#1)(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
and immunoglobulin A##2##3##(2010-4#2)
and immunoglobulin G##3##3##(2008-10#2)(2012-3#1)
and immunoglobulin M##2##3##(1994-3#1)(1995-2#1)
and immunoglobulin##9##2##(1994-3#1)(1995-2#1)(1997-5#1)(2008-10#2)(2010-4#2)(2012-3#1)(2013-7#1)
and immunoglobulins##2##2##(1990-12#1)(2008-7#1)
and immunohistochemical findings##2##3##(2009-3#1)(2013-8#1)
and immunohistochemical methods##2##3##(2008-7#1)(2011-2#1)
and immunohistochemical studies##2##3##(2008-12#1)(2011-2#1)
and immunohistochemical##17##2##(1990-8#1)(1991-6#1)(1992-3#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-3#1)(2011-2#3)(2012-3#2)(2013-8#2)
and immunohistochemistry of##2##3##(2008-10#1)(2008-5#1)
and immunohistochemistry##6##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#2)
and immunologic memory##2##3##(1995-5#1)(2012-3#1)
and immunologic##7##2##(1992-10#1)(1992-2#1)(1993-3#1)(1995-5#2)(2008-10#1)(2012-3#1)
and immunological presentation##2##3##(1990-2#1)(1995-5#1)
and immunological##10##2##(1990-2#1)(1991-1#1)(1992-6#1)(1994-5#1)(1995-5#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
and immunology##4##2##(1994-12#2)(2008-8#1)(2008-9#1)
and immunoperoxidase tests for the detection of antibodies to chicken anaemia agent##2##12##(1991-3#2)
and immunophenotype##2##2##(2008-11#1)(2009-8#1)
and immunophenotyping##3##2##(2008-12#1)(2008-9#2)
and immunoprecipitation##3##2##(1993-3#1)(2008-11#1)(2008-9#1)
and immunoregulation##2##2##(1991-2#1)(2011-3#1)
and immunostaining##2##2##(2008-10#1)(2008-11#1)
and immunosuppressive drugs##3##3##(2008-11#1)(2010-7#1)(2013-1#1)
and immunosuppressive##6##2##(2008-1#1)(2008-11#1)(2010-7#1)(2011-3#1)(2012-3#1)(2013-1#1)
and immunotherapy##2##2##(1993-11#1)(2011-2#1)
and immunotoxicity##3##2##(2008-10#2)(2008-4#1)
and impact of##5##3##(1990-6#1)(1996-1#1)(2008-12#1)(2009-8#1)(2010-11#1)
and impact on##7##3##(1992-12#1)(1996-11#1)(2008-10#1)(2008-7#2)(2010-8#1)(2012-3#1)
and impact##16##2##(1990-6#1)(1992-12#1)(1993-12#1)(1996-1#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)
and impacted##2##2##(1997-1#1)(2008-10#1)
and impaired growth##2##3##(1996-6#1)(2010-6#1)
and impaired##14##2##(1991-3#1)(1993-8#1)(1994-8#1)(1996-11#1)(1996-6#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-3#2)(2013-1#2)
and impairment of##4##3##(2008-10#1)(2008-7#2)(2012-6#1)
and impairment##6##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2012-6#1)
and impairs##2##2##(2010-6#1)(2013-8#1)
and impedance##2##2##(2008-9#1)(2011-2#1)
and implantation of##5##3##(1991-9#1)(2008-4#1)(2011-2#2)(2013-1#1)
and implanted##3##2##(2010-8#2)(2012-2#1)
and implement a##6##3##(1991-12#1)(1995-2#1)(1996-1#1)(2008-9#1)(2012-3#1)(2013-1#1)
and implement an##2##3##(1993-2#1)(2008-12#1)
and implement##20##2##(1991-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
and implementation of a##6##4##(1991-2#1)(1993-3#2)(1996-2#1)(2012-2#1)(2013-1#1)
and implementation of the##5##4##(1993-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
and implementation of these programs##2##5##(2011-3#1)(2013-1#1)
and implementation of these##3##4##(2008-10#1)(2011-3#1)(2013-1#1)
and implementation of##38##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-3#3)(1994-2#2)(1994-3#1)(1995-3#2)(1996-2#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)
and implementation##53##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#3)(1994-12#2)(1994-2#3)(1994-3#1)(1995-3#3)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
and implemented in##2##3##(2008-10#1)(2008-11#1)
and implemented##18##2##(1996-12#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
and implementing##14##2##(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(2008-11#2)(2008-12#1)(2009-12#1)(2010-8#2)(2011-1#1)(2012-2#1)
and implications are##2##3##(1992-3#1)(2010-5#1)
and implications for disease##2##4##(2008-10#2)
and implications for treatment and##2##5##(2008-6#1)(2009-12#1)
and implications for##15##3##(1992-9#1)(1994-2#1)(1997-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-9#1)(2011-1#4)(2013-1#1)
and implications of these##2##4##(2009-11#1)(2010-3#1)
and implications of##5##3##(2009-11#2)(2010-3#1)(2011-2#1)(2013-8#1)
and implications##29##2##(1992-3#1)(1992-9#1)(1994-2#1)(1996-2#2)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#1)(2013-1#2)(2013-8#1)
and implicit##2##2##(1991-5#1)(2009-9#1)
and implies##3##2##(1996-12#1)(2011-2#1)(2013-1#1)
and importance of##7##3##(1990-2#1)(1990-5#1)(2008-10#3)(2008-11#1)(2010-6#1)
and important##16##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
and improve health##2##3##(1997-2#1)(2013-1#1)
and improve the quality of##2##5##(1990-12#1)(2008-11#1)
and improve the##11##3##(1990-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2009-7#1)(2011-7#1)(2012-12#1)(2013-1#1)
and improve their##3##3##(2008-12#1)(2010-10#1)(2011-2#1)
and improve##46##2##(1990-12#1)(1991-3#1)(1993-3#1)(1994-1#3)(1995-1#1)(1996-1#1)(1996-2#1)(1997-2#2)(2008-10#6)(2008-11#2)(2008-12#4)(2008-2#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
and improved flexibility##2##3##(2008-10#2)
and improved in##3##3##(2008-10#1)(2008-7#2)
and improved patient##2##3##(1995-3#1)(2013-1#1)
and improved quality of##2##4##(1992-3#1)(2008-11#1)
and improved the##2##3##(1991-3#1)(1993-3#1)
and improved##43##2##(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-1#2)(1997-1#1)(1997-8#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#4)(2013-1#4)(2013-8#3)
and improvement in##5##3##(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
and improvement of grip strength were##2##6##(2008-9#2)
and improvement of##10##3##(1994-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#2)(2009-1#1)(2010-10#1)(2013-8#1)
and improvement##20##2##(1993-3#1)(1994-12#1)(1996-1#1)(1997-1#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#2)(2009-1#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#3)
and improvements in##6##3##(2008-10#2)(2008-7#1)(2008-9#1)(2010-10#1)(2012-2#1)
and improvements##10##2##(1994-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
and improves the##4##3##(1994-9#1)(2008-9#1)(2010-10#1)(2013-8#1)
and improves##10##2##(1994-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-11#1)(2013-8#2)
and improving the efficiency of the##2##6##(1992-2#1)(2010-8#1)
and improving the##8##3##(1992-2#1)(1996-2#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
and improving##22##2##(1992-1#1)(1992-12#1)(1992-2#1)(1996-2#3)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-8#3)(2011-2#2)(2012-2#2)(2013-8#1)
and impulse##2##2##(2008-4#1)(2012-3#1)
and in 0##2##3##(2008-10#2)
and in 1##4##3##(1991-3#1)(2008-10#2)(2013-1#1)
and in 2##3##3##(1992-5#1)(2007-11#1)(2010-2#1)
and in 25##2##3##(1993-12#1)(2008-7#1)
and in 3##5##3##(1990-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
and in 5##2##3##(1991-11#1)(2011-2#1)
and in 50##2##3##(1996-6#1)(2011-2#1)
and in 6##2##3##(1996-11#1)(2011-2#1)
and in 8 patients##3##4##(1996-3#1)(1997-8#1)(2013-1#1)
and in 800 mg/L males##2##5##(2008-9#2)
and in Canada##3##3##(2008-10#2)(2008-11#1)
and in a##34##3##(1990-2#2)(1991-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-6#1)(1996-6#1)(1997-5#1)(2008-10#13)(2008-12#1)(2008-7#2)(2009-8#3)(2012-3#1)(2013-8#2)
and in about##2##3##(2008-11#1)(2008-9#1)
and in addition##2##3##(1997-8#1)(2008-10#1)
and in adult life##2##4##(1995-12#1)(2009-8#1)
and in adult##4##3##(1995-12#1)(1997-7#1)(2007-12#1)(2009-8#1)
and in adults with##2##4##(1997-4#1)(2012-3#1)
and in adults##3##3##(1997-4#1)(2008-7#1)(2012-3#1)
and in agreement with##5##4##(2008-10#5)
and in all##11##3##(1993-6#1)(1996-11#1)(2008-10#3)(2008-9#2)(2009-7#1)(2011-2#2)(2012-12#1)
and in an##5##3##(1990-3#1)(1995-9#1)(2008-11#1)(2009-8#1)(2012-3#1)
and in another third##2##4##(1994-9#1)(2008-10#1)
and in aqueous##2##3##(2008-10#1)(2008-11#1)
and in artificial##2##3##(2008-10#2)
and in association with##3##4##(2007-12#1)(2008-10#2)
and in blood plasma##3##4##(2008-10#3)
and in blood##5##3##(2008-10#4)(2013-1#1)
and in both##4##3##(1993-8#1)(1996-5#1)(2008-10#1)(2008-12#1)
and in cases##2##3##(1991-8#1)(2011-2#1)
and in certain##2##3##(2008-3#1)(2008-7#1)
and in clarifying##2##3##(2010-12#1)(2011-2#1)
and in clinical##3##3##(1994-12#1)(2008-11#1)(2008-5#1)
and in combination to##3##4##(2008-10#3)
and in combination with nitrite##2##5##(1990-6#2)
and in combination with##8##4##(1990-2#1)(1990-6#2)(1991-1#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
and in combination##14##3##(1990-2#1)(1990-6#2)(1991-1#1)(2008-10#5)(2008-5#2)(2009-8#1)(2011-2#1)(2012-6#1)
and in commercial##3##3##(2008-10#3)
and in complex##2##3##(2008-10#1)(2009-7#1)
and in cortical##2##3##(2008-10#2)
and in culture##2##3##(2008-12#1)(2008-7#1)
and in determining##2##3##(1997-8#1)(2008-8#1)
and in different##6##3##(2008-10#5)(2008-8#1)
and in differentiating##3##3##(1994-11#1)(2012-2#2)
and in each##2##3##(2008-10#2)
and in females##3##3##(2008-8#1)(2011-2#2)
and in five##3##3##(1995-12#1)(2008-10#2)
and in four##4##3##(1990-9#1)(2008-10#2)(2008-8#1)
and in good##4##3##(1991-6#1)(1992-2#1)(1992-3#1)(2008-10#1)
and in health##2##3##(1997-1#1)(2012-3#1)
and in human##4##3##(1992-2#1)(1993-6#1)(1994-11#1)(2013-1#1)
and in implanted##2##3##(1996-12#1)(2008-8#1)
and in industrial##3##3##(2008-10#2)(2008-11#1)
and in inflammatory##2##3##(1993-3#1)(2013-1#1)
and in intrinsic##2##3##(2008-11#1)(2009-5#1)
and in its##4##3##(1994-11#1)(2008-10#1)(2009-12#1)(2012-2#1)
and in keeping with##2##4##(1995-1#1)(2008-10#1)
and in keeping##3##3##(1992-9#1)(1995-1#1)(2008-10#1)
and in many cases##3##4##(2008-10#2)(2013-1#1)
and in many##6##3##(1991-6#1)(1992-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
and in markets where blood or urine tests are not commonly used in underwriting##2##14##(1993-12#2)
and in matched##2##3##(1995-5#1)(2011-2#1)
and in mitotic##2##3##(2008-11#1)(2012-2#1)
and in more##2##3##(1994-6#1)(2008-10#1)
and in most##3##3##(1997-1#1)(1997-4#1)(2008-9#1)
and in mouse##3##3##(1995-6#1)(1997-7#1)(2008-9#1)
and in need of##2##4##(2010-9#1)(2011-2#1)
and in no case did the##2##6##(1991-8#1)(2008-9#1)
and in no case##3##4##(1991-3#1)(1991-8#1)(2008-9#1)
and in one of the##3##5##(1990-2#1)(1991-6#1)(2008-9#1)
and in one##9##3##(1990-2#1)(1990-3#1)(1991-6#1)(1994-9#1)(1996-9#1)(2008-10#2)(2008-9#1)(2011-1#1)
and in only##2##3##(2008-10#1)(2008-11#1)
and in order to##3##4##(2008-10#2)(2008-11#1)
and in other countries##2##4##(2008-5#2)
and in other##12##3##(1990-12#1)(1993-12#1)(1996-1#1)(1996-2#1)(2006-6#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-3#1)(2013-8#2)
and in our##2##3##(1993-2#1)(2012-3#1)
and in particular the##3##4##(2008-10#1)(2008-11#1)(2009-3#1)
and in particular##16##3##(1990-11#1)(1990-3#1)(1991-12#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-5#1)(2012-3#1)
and in patients with##7##4##(1991-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
and in patients##9##3##(1991-8#1)(2008-1#2)(2008-10#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
and in pharmaceutical formulations##3##4##(2008-10#3)
and in pharmaceutical##6##3##(2008-10#6)
and in phase##2##3##(2008-11#1)(2008-5#1)
and in planta##6##3##(2008-10#5)(2009-12#1)
and in presence of##2##4##(2008-10#1)(2008-11#1)
and in protoplast culture##2##4##(2008-8#2)
and in rats##2##3##(1996-5#1)(1997-2#1)
and in real##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
and in recognizing##2##3##(2008-10#1)(2012-2#1)
and in reducing##2##3##(1992-12#1)(2008-4#1)
and in relation to##3##4##(1991-6#1)(2008-10#1)(2010-6#1)
and in response to##6##4##(1994-3#1)(1995-6#1)(2008-1#1)(2008-7#2)(2012-3#1)
and in rural##2##3##(1994-1#1)(2012-12#1)
and in seedlings##2##3##(2008-10#2)
and in serum-free##2##3##(2008-11#1)(2008-7#1)
and in several##2##3##(1997-2#1)(2011-2#1)
and in silico##2##3##(2010-11#1)(2011-2#1)
and in situ hybridization have##2##5##(2008-6#1)(2009-7#1)
and in situ hybridization histochemistry##4##5##(1992-6#1)(1994-11#1)(1994-2#1)(1995-2#1)
and in situ hybridization of##2##5##(1996-12#2)
and in situ hybridization##17##4##(1991-5#2)(1992-6#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-12#3)(1997-1#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)
and in situ##34##3##(1991-5#2)(1992-6#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-12#4)(1997-1#1)(2008-10#12)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2012-3#1)(2013-7#1)
and in soil##2##3##(2008-10#1)(2011-2#1)
and in some cases##16##4##(1993-12#2)(1996-12#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
and in some instances##5##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
and in some##30##3##(1992-6#1)(1993-12#2)(1995-3#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
and in specific##2##3##(1997-4#1)(2008-10#1)
and in terms of##2##4##(1996-12#1)(2008-10#1)
and in that##2##3##(1990-11#1)(2008-10#1)
and in the United States##3##5##(1991-12#1)(1997-3#1)(2008-10#1)
and in the United##4##4##(1991-12#1)(1997-3#1)(2008-10#1)(2008-12#1)
and in the absence of##4##5##(1993-3#1)(1994-5#1)(2008-9#1)(2010-11#1)
and in the acrosome of##2##5##(2008-7#2)
and in the adult##2##4##(1994-2#1)(2008-11#1)
and in the case of##3##5##(2008-10#1)(2008-5#1)(2010-12#1)
and in the control group##2##5##(1994-12#2)
and in the development of##2##5##(2009-10#1)(2011-2#1)
and in the evaluation of##2##5##(1990-11#1)(2012-2#1)
and in the field##4##4##(2008-10#4)
and in the first##3##4##(1991-6#1)(2008-8#1)(2008-9#1)
and in the following##3##4##(1996-12#1)(2008-10#1)(2008-9#1)
and in the future##6##4##(1991-12#1)(1993-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-4#1)
and in the liver##2##4##(2008-12#1)(2013-7#1)
and in the other##2##4##(2008-10#2)
and in the presence of ascorbic acid##2##7##(2008-10#2)
and in the presence of the##3##6##(2008-10#3)
and in the presence of##16##5##(1993-11#1)(2008-10#14)(2011-2#1)
and in the range##3##4##(2008-10#3)
and in the remaining##2##4##(1991-3#1)(2010-3#1)
and in the salivary##2##4##(2008-10#2)
and in the second##2##4##(2008-10#1)(2013-1#1)
and in the third##3##4##(1993-12#1)(1993-3#1)(2013-1#1)
and in the treatment##2##4##(1992-12#1)(2008-10#1)
and in the##220##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-8#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#5)(1996-2#2)(1996-3#2)(1996-6#2)(1997-1#2)(1997-2#4)(1997-3#5)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#74)(2008-11#10)(2008-12#5)(2008-3#6)(2008-4#2)(2008-5#7)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
and in their##7##3##(1992-12#1)(1992-8#1)(2008-10#4)(2008-11#1)
and in this way##4##4##(1997-2#1)(2008-11#1)(2008-5#1)(2009-10#1)
and in this##6##3##(1997-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2013-1#1)(2013-8#1)
and in those of##2##4##(2008-10#2)
and in those who had##2##5##(2013-1#2)
and in those##10##3##(1990-8#2)(1991-2#1)(1994-12#1)(2008-10#3)(2013-1#2)(2013-8#1)
and in three cases##2##4##(1995-11#1)(2008-10#1)
and in three##3##3##(1995-11#1)(2008-10#2)
and in two##8##3##(1990-9#1)(1991-12#1)(1993-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-2#1)
and in various##4##3##(2008-10#3)(2008-5#1)
and in vitro antimicrobial##2##4##(2008-11#1)(2011-2#1)
and in vitro studies##5##4##(1992-9#1)(1994-8#1)(1995-9#1)(2009-1#1)(2013-1#1)
and in vitro transcription##2##4##(1994-8#1)(2008-4#1)
and in vitro##67##3##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#3)(1991-2#1)(1992-12#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-5#3)(1994-8#5)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-2#1)(2010-6#1)(2011-2#4)(2013-1#1)
and in vivo and##2##4##(2008-10#1)(2008-11#1)
and in vivo assays##3##4##(2008-10#2)(2011-2#1)
and in vivo methods##2##4##(2008-10#1)(2008-5#1)
and in vivo##89##3##(1990-2#1)(1991-2#1)(1992-6#1)(1993-1#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#13)(2008-11#10)(2008-3#1)(2008-4#1)(2008-5#15)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#2)(2010-11#2)(2010-6#1)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#1)(2013-1#6)(2013-8#2)
and in water##2##3##(2008-10#2)
and in what##2##3##(1994-3#1)(2008-11#1)
and in which##2##3##(2008-8#1)(2009-10#1)
and in whom the##2##4##(1992-3#1)(2011-2#1)
and in whom##3##3##(1992-3#1)(2010-6#1)(2011-2#1)
and in women##2##3##(2008-4#1)(2011-1#1)
and in##1213##2##(1990-11#6)(1990-12#3)(1990-2#12)(1990-3#5)(1990-5#3)(1990-6#3)(1990-8#6)(1990-9#6)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#13)(1991-2#4)(1991-3#7)(1991-5#2)(1991-6#6)(1991-8#3)(1991-9#1)(1992-1#2)(1992-12#7)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#2)(1992-9#5)(1993-1#3)(1993-11#2)(1993-12#13)(1993-2#6)(1993-3#4)(1993-5#1)(1993-6#5)(1993-8#7)(1993-9#1)(1994-1#2)(1994-11#6)(1994-12#9)(1994-2#9)(1994-3#6)(1994-5#6)(1994-6#3)(1994-8#8)(1994-9#4)(1995-1#1)(1995-11#10)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#5)(1995-6#5)(1995-8#3)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#15)(1996-2#8)(1996-3#3)(1996-5#2)(1996-6#9)(1996-8#1)(1996-9#1)(1997-1#9)(1997-2#8)(1997-3#11)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#8)(2006-6#2)(2007-11#5)(2007-12#7)(2007-8#1)(2008-1#9)(2008-10#350)(2008-11#74)(2008-12#18)(2008-2#4)(2008-3#15)(2008-4#11)(2008-5#44)(2008-6#3)(2008-7#33)(2008-8#27)(2008-9#32)(2009-1#2)(2009-10#8)(2009-12#8)(2009-3#3)(2009-5#2)(2009-6#3)(2009-7#7)(2009-8#14)(2009-9#2)(2010-1#4)(2010-11#6)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#6)(2010-7#4)(2010-9#2)(2011-1#7)(2011-2#50)(2011-3#3)(2011-7#1)(2012-12#5)(2012-2#9)(2012-3#23)(2012-6#1)(2012-8#1)(2013-1#32)(2013-7#3)(2013-8#14)
and in-situ##2##2##(2008-10#2)
and in-vitro##2##2##(1992-3#1)(2010-5#1)
and inability to##3##3##(1992-12#1)(2008-7#1)(2011-3#1)
and inactivation of##3##3##(1994-3#1)(1994-6#1)(2007-12#1)
and inactivation##7##2##(1992-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(2007-12#2)(2008-10#1)
and inadequate##6##2##(1997-1#1)(1997-3#1)(2008-12#1)(2010-3#1)(2010-9#1)(2013-1#1)
and inappropriate (1-3)##2##3##(2010-12#2)
and inappropriate##5##2##(1993-3#1)(1996-12#1)(2010-12#2)(2011-2#1)
and inbreeding##2##2##(2008-12#1)(2008-9#1)
and incentive##2##2##(1993-6#1)(1997-1#1)
and incidence in##2##3##(1991-3#1)(1993-2#1)
and incidence of infection##2##4##(2008-10#2)
and incidence of##18##3##(1990-6#1)(1991-3#1)(1992-12#1)(1997-3#1)(2008-10#7)(2009-5#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)
and incidence##28##2##(1990-6#1)(1991-3#3)(1992-12#1)(1993-2#1)(1997-3#1)(2008-10#10)(2008-11#1)(2009-5#1)(2010-6#1)(2011-2#4)(2012-3#3)(2013-1#1)
and incident##3##2##(2008-3#1)(2009-10#1)(2010-10#1)
and incidentally##2##2##(2011-2#1)(2013-1#1)
and include a##2##3##(1993-12#1)(2008-10#1)
and include the##4##3##(1992-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
and include##23##2##(1992-12#1)(1993-12#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-3#2)(2013-8#1)
and included in a##2##4##(2008-10#1)(2011-7#1)
and included in##4##3##(2008-10#2)(2011-7#1)(2012-2#1)
and included##17##2##(1990-12#1)(1990-5#1)(1991-6#1)(1993-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-7#1)(2011-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
and includes the##2##3##(1995-6#1)(2008-10#1)
and includes##18##2##(1993-2#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
and including the##2##3##(2008-1#1)(2008-10#1)
and including##5##2##(1997-3#1)(2008-1#1)(2008-10#2)(2009-4#1)
and inclusion##2##2##(2008-10#2)
and income##7##2##(1991-3#1)(1992-3#1)(1994-1#1)(1994-6#1)(2008-11#2)(2008-12#1)
and incompatible##2##2##(2008-10#2)
and incomplete##7##2##(1995-12#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
and inconclusive##2##2##(2012-2#2)
and inconsistency##2##2##(2008-10#1)(2010-2#1)
and inconsistent##4##2##(1996-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
and incorporate##3##2##(2008-10#1)(2008-12#1)(2010-1#1)
and incorporated into##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
and incorporated##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
and incorporates##2##2##(1993-12#1)(1993-3#1)
and incorporating##2##2##(2008-10#2)
and incorporation in##2##3##(2008-10#1)(2009-3#1)
and incorporation of##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
and incorporation##5##2##(1995-12#1)(2008-10#2)(2008-3#1)(2009-3#1)
and increase in the##2##4##(1992-6#1)(2012-2#1)
and increase in##6##3##(1992-6#2)(1997-1#1)(2008-10#1)(2012-2#2)
and increase its referral base##2##5##(1994-3#2)
and increase of##7##3##(1990-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
and increase the sensitivity of##2##5##(1997-3#1)(2008-10#1)
and increase the##14##3##(1993-2#1)(1994-2#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-11#4)(2008-5#1)(2011-2#2)(2013-8#1)
and increase##47##2##(1990-12#1)(1991-3#1)(1992-6#2)(1993-2#2)(1994-2#1)(1994-3#2)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
and increased catabolism of##2##4##(2008-6#2)
and increased exponentially with##2##4##(2008-10#2)
and increased from##2##3##(2008-10#1)(2009-7#1)
and increased in##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
and increased mortality##4##3##(1996-3#1)(2010-12#1)(2012-3#1)(2013-8#1)
and increased plant##2##3##(2008-10#1)(2008-8#1)
and increased significantly##2##3##(1996-2#1)(2008-9#1)
and increased specific##2##3##(2008-11#1)(2013-1#1)
and increased the percentage of##2##5##(1991-11#1)(1996-3#1)
and increased the##11##3##(1991-11#1)(1993-1#1)(1996-2#2)(1996-3#1)(2008-10#3)(2008-5#1)(2009-7#1)(2012-2#1)
and increased to##2##3##(2008-10#2)
and increased with increasing##2##4##(2008-10#1)(2010-8#1)
and increased with##10##3##(2008-10#4)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-3#1)
and increased##144##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#4)(1997-1#1)(2007-8#1)(2008-10#37)(2008-11#8)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#4)(2012-2#3)(2012-3#4)(2012-4#2)(2013-1#4)(2013-3#1)(2013-8#2)
and increases in CRP##2##4##(2008-8#2)
and increases in##6##3##(1990-12#1)(1991-2#1)(2008-10#2)(2008-8#2)
and increases the##6##3##(1996-2#1)(1997-1#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
and increases with##2##3##(2008-10#2)
and increases##24##2##(1990-12#2)(1991-2#1)(1993-8#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2011-2#2)(2013-1#1)
and increasing numbers of##2##4##(1993-3#1)(2013-1#1)
and increasing the##9##3##(1990-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2013-1#1)
and increasing##37##2##(1990-12#1)(1990-5#1)(1991-2#1)(1993-3#1)(1994-12#2)(1997-3#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2013-1#2)
and increasingly##2##2##(1995-2#1)(2006-6#1)
and incubated at 37 degrees C##2##6##(2008-10#1)(2008-11#1)
and incubated at##8##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)
and incubated in##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
and incubated##19##2##(1996-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#2)(2010-3#1)(2013-1#1)
and incubation period##2##3##(2008-10#2)
and incubation temperatures##2##3##(2008-10#1)(2008-5#1)
and incubation time of##3##4##(1996-2#2)(2008-10#1)
and incubation time##6##3##(1996-2#2)(2008-10#2)(2010-5#1)(2011-3#1)
and incubation##14##2##(1996-2#2)(2008-10#8)(2008-5#2)(2010-5#1)(2011-3#1)
and independence##2##2##(2011-2#1)(2012-3#1)
and independent contrasts##2##3##(2008-9#2)
and independent of##2##3##(2008-10#2)
and independent##18##2##(1991-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-9#1)(2008-10#5)(2008-7#2)(2008-9#2)(2010-8#1)(2012-2#1)(2012-3#1)
and independently##3##2##(1994-11#1)(2010-10#1)(2012-3#1)
and index##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
and indicate that the##2##4##(1990-11#1)(1992-4#1)
and indicate that##12##3##(1990-11#1)(1992-4#1)(1993-12#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-2#1)
and indicate##14##2##(1990-11#1)(1992-12#1)(1992-4#1)(1993-12#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
and indicated that##2##3##(2008-10#2)
and indicated the##3##3##(2008-12#1)(2008-6#1)(2008-8#1)
and indicated##7##2##(1994-11#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)
and indicates that the##4##4##(1993-2#2)(2008-3#1)(2010-8#1)
and indicates that##8##3##(1993-2#2)(1995-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-8#1)
and indicates##12##2##(1993-2#2)(1994-12#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
and indications for##2##3##(2009-10#1)(2010-12#1)
and indications##3##2##(2009-10#1)(2010-12#2)
and indicator##2##2##(2008-10#1)(2008-4#1)
and indicators of##2##3##(1991-12#1)(2012-12#1)
and indices of##3##3##(1992-9#2)(2013-1#1)
and indices##4##2##(1992-9#2)(2008-11#1)(2013-1#1)
and indigenous##2##2##(2008-8#1)(2008-9#1)
and indigo carmine##3##3##(1993-8#1)(2008-10#2)
and indirect PAD##3##3##(2008-10#3)
and indirect effects of##3##4##(1997-1#1)(2008-7#1)(2008-9#1)
and indirect effects##6##3##(1997-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)
and indirect methods##2##3##(2008-3#1)(2012-3#1)
and indirect##36##2##(1990-12#1)(1991-12#1)(1991-6#1)(1997-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-8#1)(2010-1#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
and indirectly##10##2##(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#3)(2012-3#2)
and indium##7##2##(2008-10#7)
and indium(III)##3##2##(2008-10#3)
and individual difference factors in##2##5##(2009-4#2)
and individual##25##2##(1991-1#1)(1991-12#1)(1992-7#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#2)
and individual-based##3##2##(2008-9#3)
and individual-level##3##2##(1994-9#1)(2008-8#1)(2010-7#1)
and individualized##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
and individually##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
and individuals are##2##3##(1994-2#1)(1997-8#1)
and individuals with##2##3##(2010-4#1)(2012-3#1)
and individuals##16##2##(1991-2#1)(1992-9#1)(1994-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and indole##2##2##(1994-8#1)(2008-10#1)
and indomethacin##3##2##(1990-11#1)(2008-11#2)
and indoor##3##2##(2013-1#3)
and induce##11##2##(1993-6#1)(1997-1#1)(1997-3#2)(1997-6#1)(2007-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-4#1)
and induced apoptosis##3##3##(2008-9#1)(2011-2#2)
and induced changes in##2##4##(2008-9#1)(2012-5#1)
and induced resistance##2##3##(2008-10#1)(2008-8#1)
and induced##29##2##(1992-8#1)(1995-12#1)(1997-7#1)(2008-10#6)(2008-11#5)(2008-7#1)(2008-8#3)(2008-9#3)(2010-1#1)(2011-2#3)(2012-5#1)(2013-1#2)(2013-8#1)
and induces apoptosis##2##3##(2011-2#1)(2013-1#1)
and induces##7##2##(1995-2#1)(2008-10#1)(2008-11#2)(2009-8#1)(2011-2#1)(2013-1#1)
and inducible##6##2##(1992-12#1)(1993-12#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-7#1)
and inducing##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
and induction of apoptosis##2##4##(2008-10#1)(2008-12#1)
and induction of##12##3##(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-3#1)(2011-2#2)(2013-1#1)
and induction##13##2##(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)
and inductively coupled plasma atomic emission##3##6##(2008-10#3)
and inductively coupled plasma mass spectrometry (ICP-MS)##4##7##(2008-10#4)
and inductively coupled plasma mass spectrometry##7##6##(2008-10#7)
and inductively coupled plasma mass##8##5##(2008-10#8)
and inductively coupled plasma##11##4##(2008-10#11)
and inductively coupled plasma-mass##2##4##(2008-10#2)
and inductively coupled##14##3##(2008-10#14)
and inductively##15##2##(2008-10#15)
and industrial waste water##2##4##(2008-10#2)
and industrial##24##2##(1993-3#1)(2008-10#19)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
and industry##8##2##(1991-12#1)(1992-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-8#1)
and inert##4##2##(2008-10#3)(2008-8#1)
and inexpensive##14##2##(1991-6#1)(2007-12#1)(2008-10#10)(2008-11#1)(2010-9#1)
and inexpensively##2##2##(1996-11#1)(2008-12#1)
and infancy##2##2##(2008-11#1)(2012-12#1)
and infant##15##2##(1991-12#1)(1993-3#1)(1994-3#1)(1995-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-9#1)
and infants##4##2##(1994-3#1)(1994-6#1)(1996-3#1)(2008-11#1)
and infected leaves##2##3##(2008-10#2)
and infected with##7##3##(1995-12#1)(2008-10#6)
and infected##23##2##(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#18)(2008-8#1)(2011-2#1)
and infection are##4##3##(1997-4#1)(2008-10#1)(2009-3#1)(2011-10#1)
and infection control##2##3##(2008-10#1)(2011-2#1)
and infection efficiency##2##3##(2008-10#2)
and infection frequency##3##3##(2008-10#3)
and infection in##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
and infection of##5##3##(2008-10#4)(2011-2#1)
and infection##42##2##(1997-4#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-5#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and infections##2##2##(2008-10#1)(2012-2#1)
and infectious##7##2##(2008-10#1)(2008-7#1)(2010-5#1)(2011-3#1)(2012-2#2)(2013-8#1)
and infectivity of##2##3##(2008-10#1)(2011-3#1)
and inferior##4##2##(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)
and infertility in##2##3##(2008-4#1)(2010-11#1)
and infertility##3##2##(2008-12#1)(2008-4#1)(2010-11#1)
and infested with##2##3##(2008-10#2)
and infested##5##2##(1996-12#1)(2008-10#4)
and infiltration of##4##3##(2008-10#1)(2010-1#3)
and infinite##2##2##(2008-11#1)(2008-3#1)
and inflammation and##3##3##(2008-9#1)(2010-5#1)(2012-12#1)
and inflammation##14##2##(2008-5#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)
and inflammatory response##3##3##(2008-8#1)(2008-9#1)(2010-11#1)
and inflammatory##16##2##(1991-2#1)(1991-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(1997-5#1)(1997-8#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#2)
and infliximab are##2##3##(2010-12#2)
and infliximab##4##2##(2010-12#4)
and influence of##4##3##(2008-10#3)(2008-11#1)
and influence the##3##3##(1992-9#1)(1997-1#1)(2008-10#1)
and influence##11##2##(1992-6#1)(1992-9#1)(1994-3#1)(1997-1#2)(2008-10#4)(2008-11#1)(2011-2#1)
and influences##2##2##(2008-11#1)(2013-1#1)
and influencing##2##2##(1992-6#1)(2008-10#1)
and influent##3##2##(2008-10#3)
and influenza##3##2##(1992-6#1)(1994-9#1)(1995-5#1)
and influx##2##2##(1991-5#1)(1992-12#1)
and inform##2##2##(2008-10#1)(2008-12#1)
and informal##6##2##(1992-12#2)(1996-3#1)(2008-11#1)(2008-12#1)(2010-8#1)
and information literacy##3##3##(2008-11#3)
and information systems##6##3##(1993-2#1)(1996-2#1)(1997-1#1)(1997-3#3)
and information technology##8##3##(1994-12#1)(2008-11#4)(2011-1#1)(2012-2#2)
and information##30##2##(1993-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-3#3)(2008-10#2)(2008-11#8)(2008-12#2)(2008-3#2)(2008-7#3)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#2)
and informed##6##2##(1991-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-11#1)
and infrared (IR)##2##3##(2008-10#1)(2008-5#1)
and infrared spectroscopy##2##3##(2008-10#1)(2012-2#1)
and infrared##9##2##(2008-10#5)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
and infrastructure##2##2##(1997-1#1)(2010-12#1)
and inguinal##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)
and inhalational##2##2##(2010-7#1)(2012-3#1)
and inhaled##3##2##(1997-1#1)(2010-10#2)
and inhaler use##2##3##(1996-1#1)(2010-6#1)
and inhaler##3##2##(1996-1#1)(2007-11#1)(2010-6#1)
and inherent##2##2##(1991-12#1)(2013-1#1)
and inheritance##2##2##(2008-10#1)(2011-2#1)
and inherited##2##2##(2008-11#1)(2012-3#1)
and inhibin##3##2##(2008-8#3)
and inhibit the##4##3##(1991-9#1)(2008-8#1)(2008-9#1)(2013-1#1)
and inhibit##12##2##(1991-9#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-10#1)(2013-1#1)
and inhibited by##4##3##(1990-12#1)(1994-6#1)(1994-8#1)(2008-10#1)
and inhibited cell##2##3##(1994-11#1)(2011-2#1)
and inhibited growth##2##3##(1990-6#1)(2008-10#1)
and inhibited the##3##3##(1991-6#1)(1997-6#1)(2008-8#1)
and inhibited##19##2##(1990-12#1)(1990-6#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-8#2)(2010-1#1)(2011-2#1)
and inhibiting##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)
and inhibition of##19##3##(1991-9#1)(1994-3#1)(1995-11#1)(1996-6#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-8#2)(2010-8#1)(2011-2#1)
and inhibition##24##2##(1990-11#1)(1991-9#1)(1994-3#1)(1995-11#1)(1996-6#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-4#1)(2008-8#2)(2010-8#1)(2011-2#1)(2013-8#1)
and inhibitors of the##2##4##(1994-3#1)(1994-8#1)
and inhibitors##7##2##(1991-5#1)(1994-3#1)(1994-8#2)(1995-8#1)(2006-6#1)(2008-5#1)
and inhibitory effects##2##3##(1995-11#1)(2008-10#1)
and inhibitory##12##2##(1992-6#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-8#1)(2010-4#1)
and inhibits the##3##3##(1994-5#1)(2008-9#1)(2011-2#1)
and inhibits##11##2##(1992-3#1)(1993-11#1)(1994-5#1)(1995-12#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)
and initial characterization of##3##4##(1991-5#1)(2008-4#1)(2008-9#1)
and initial rate##4##3##(2008-10#4)
and initial##24##2##(1991-5#1)(1997-1#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-3#1)(2010-9#1)(2012-12#1)(2013-1#1)
and initially##2##2##(1996-9#1)(2008-10#1)
and initiate##7##2##(1992-9#1)(1995-11#1)(2008-11#2)(2009-8#1)(2011-3#1)(2013-7#1)
and initiated##2##2##(1991-8#1)(2010-1#1)
and initiating##4##2##(2008-10#1)(2009-10#1)(2010-7#1)(2011-2#1)
and initiation of##7##3##(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-2#1)
and initiative##2##2##(1995-2#1)(1997-8#1)
and injected into##3##3##(1993-8#1)(1997-8#1)(2008-10#1)
and injected##6##2##(1991-12#1)(1993-8#1)(1997-8#1)(2008-10#3)
and injecting##2##2##(2008-10#2)
and injection of##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
and injection##7##2##(1997-8#1)(2008-10#4)(2011-2#1)(2013-1#1)
and injured##2##2##(2008-4#1)(2009-6#1)
and injuries##3##2##(1995-12#1)(2008-10#1)(2010-11#1)
and injury##7##2##(1990-5#2)(2008-10#1)(2008-11#2)(2008-12#1)(2010-9#1)
and inland##4##2##(2008-10#1)(2008-3#3)
and inner##7##2##(2008-10#2)(2008-11#1)(2009-6#1)(2011-2#2)(2013-8#1)
and innovation in health care##2##5##(1995-1#2)
and innovation##6##2##(1995-1#4)(2008-11#1)(2012-3#1)
and innovations##2##2##(1992-3#1)(1995-1#1)
and innovative ways##2##3##(1992-12#1)(1997-2#1)
and innovative##8##2##(1992-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(2010-11#3)(2012-2#1)
and innovativeness##2##2##(2010-11#2)
and inoculated with R##2##4##(2008-10#2)
and inoculated with##6##3##(2008-10#5)(2013-1#1)
and inoculated##12##2##(1990-8#1)(2008-10#10)(2013-1#1)
and inoculation of the##2##4##(2008-10#2)
and inoculation of##3##3##(2008-10#2)(2008-9#1)
and inoculation##10##2##(2008-10#9)(2008-9#1)
and inoculum densities##2##3##(2008-10#2)
and inoculum density of##3##4##(2008-10#3)
and inoculum density##4##3##(2008-10#4)
and inoculum##13##2##(2008-10#13)
and inorganic anions##8##3##(2008-10#8)
and inorganic ions##3##3##(2008-10#2)(2008-11#1)
and inorganic mercury##5##3##(2008-10#5)
and inorganic##33##2##(2008-10#27)(2008-11#3)(2009-7#1)(2010-4#1)(2011-2#1)
and inosine triphosphatase##2##3##(2013-1#2)
and inosine##3##2##(1992-3#1)(2013-1#2)
and inositol 1##2##3##(1995-2#1)(1997-8#1)
and inositol trisphosphate##3##3##(1990-8#1)(1991-12#1)(1995-2#1)
and inositol##8##2##(1990-8#1)(1991-12#1)(1993-6#1)(1995-2#2)(1997-8#1)(2008-10#1)(2008-11#1)
and inotropic support##2##3##(2010-5#1)(2013-1#1)
and inpatient##2##2##(1995-12#1)(1995-2#1)
and insect vectors##3##3##(2008-10#3)
and insect##10##2##(2008-10#9)(2008-8#1)
and insects##5##2##(2008-10#3)(2009-8#2)
and insensitive##3##2##(2008-10#3)
and inserted into##4##3##(1997-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
and inserted##8##2##(1990-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#2)
and inside##5##2##(2008-10#2)(2008-11#2)(2008-9#1)
and insights##2##2##(2008-11#2)
and insignificant##4##2##(1996-3#1)(2008-10#3)
and insoluble##9##2##(1990-5#1)(1994-11#2)(1996-1#1)(2008-10#4)(2008-4#1)
and instability of the##2##4##(1990-5#1)(1992-12#1)
and instability##7##2##(1990-5#1)(1992-12#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
and installing the##2##3##(1994-1#2)
and instead##5##2##(1992-2#1)(1995-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
and institutional##6##2##(1991-1#1)(1995-3#2)(2009-10#1)(2009-4#1)(2011-2#1)
and institutions##6##2##(1990-6#1)(1993-1#1)(1995-5#1)(2008-7#1)(2009-4#1)(2010-7#1)
and instruction##2##2##(2008-10#1)(2013-1#1)
and instrument##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
and instrumental parameters##2##3##(2008-10#2)
and instrumental variables##5##3##(2008-10#5)
and instrumental##19##2##(1990-3#1)(1990-6#1)(1991-3#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#1)
and instrumentation##8##2##(2008-10#4)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#1)
and instruments for##2##3##(2008-9#2)
and instruments##5##2##(2008-10#2)(2008-6#1)(2008-9#2)
and insufficient##6##2##(1990-2#1)(1991-6#1)(2008-10#1)(2009-10#2)(2011-3#1)
and insulin levels##2##3##(2010-8#1)(2013-1#1)
and insulin resistance in##2##4##(2008-9#1)(2013-1#1)
and insulin resistance##11##3##(2008-1#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#2)(2013-1#2)(2013-8#1)
and insulin sensitivity##9##3##(1994-12#4)(2008-1#2)(2010-10#1)(2012-3#2)
and insulin were##3##3##(1991-2#1)(2010-8#1)(2012-2#1)
and insulin##45##2##(1991-1#1)(1991-2#1)(1992-5#1)(1993-8#2)(1994-12#5)(1996-11#2)(2008-1#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#1)
and insulin-dependent diabetes##2##3##(1990-5#1)(1997-3#1)
and insulin-like growth factor##3##4##(1995-11#1)(2008-11#1)(2008-9#1)
and insulin-like growth factor-I##2##4##(1995-12#1)(2007-11#1)
and insulin-like growth##7##3##(1990-12#1)(1995-11#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-5#1)
and insulin-like##8##2##(1990-12#1)(1995-11#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
and insurance##3##2##(1992-12#1)(1997-2#1)(2012-12#1)
and intact rats##2##3##(1996-2#1)(2008-7#1)
and intact##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#2)
and integral##3##2##(2008-10#2)(2008-5#1)
and integrate##4##2##(2008-10#1)(2008-12#1)(2009-12#1)(2010-1#1)
and integrated health care systems##2##5##(1997-1#2)
and integrated health care##3##4##(1995-2#1)(1997-1#2)
and integrated##13##2##(1995-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2010-7#1)(2011-2#1)
and integrates##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
and integrating##2##2##(1993-1#1)(1997-3#1)
and integration of##6##3##(1992-12#1)(1994-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2012-3#1)
and integration##11##2##(1992-12#1)(1992-6#1)(1994-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2012-3#2)
and integrative##2##2##(2008-8#1)(2011-2#1)
and integrin α(v) β(3)##2##4##(2010-12#2)
and integrin##4##2##(2008-11#1)(2010-12#2)(2010-6#1)
and integrity of the##3##4##(1994-5#1)(2008-7#1)(2012-12#1)
and integrity of##4##3##(1994-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
and integrity##9##2##(1994-5#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
and intellectual##2##2##(2008-7#1)(2010-10#1)
and intellectually##3##2##(1995-1#1)(2009-8#1)(2013-1#1)
and intelligence##2##2##(2008-7#1)(2009-8#1)
and intended##2##2##(1993-3#1)(2008-11#1)
and intense##2##2##(2008-7#1)(2008-8#1)
and intensity of the##3##4##(1997-8#1)(2008-11#1)(2008-5#1)
and intensity of##11##3##(1991-2#3)(1993-1#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-8#1)
and intensity##23##2##(1991-2#4)(1992-12#1)(1993-1#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2010-11#1)(2013-8#1)
and intensive care##5##3##(1991-3#1)(2009-5#2)(2010-7#1)(2011-2#1)
and intensive##8##2##(1991-3#1)(1992-3#1)(1996-12#1)(2008-6#1)(2009-5#2)(2010-7#1)(2011-2#1)
and intent to use condoms##2##5##(2008-4#2)
and intentional##6##2##(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)
and intentions##2##2##(1991-3#2)
and inter-assay coefficients of variation were##2##6##(2008-10#2)
and inter-assay coefficients of variation##3##5##(1990-11#1)(2008-10#2)
and inter-assay##5##2##(1990-11#1)(2008-10#3)(2011-3#1)
and inter-day coefficients of variation##2##5##(2008-10#2)
and inter-day precision##3##3##(2008-10#2)(2011-3#1)
and inter-day##11##2##(2008-10#10)(2011-3#1)
and inter-professional##2##2##(2008-11#1)(2010-10#1)
and interact with##5##3##(1995-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)
and interact##6##2##(1995-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)
and interacting##4##2##(1996-3#1)(1997-6#1)(2008-11#1)(2008-4#1)
and interaction effects##2##3##(2008-10#1)(2008-2#1)
and interaction of##2##3##(2008-10#1)(2011-2#1)
and interaction with##5##3##(1990-8#1)(1995-8#1)(1997-1#1)(1997-8#1)(2008-10#1)
and interaction##15##2##(1990-8#1)(1995-8#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#1)
and interactions of##3##3##(1992-9#1)(2008-10#2)
and interactions with##2##3##(2008-10#2)
and interactions##12##2##(1991-2#1)(1992-9#1)(2008-10#8)(2008-5#1)(2008-8#1)
and interactive effects of##2##4##(2008-10#1)(2012-3#1)
and interactive##9##2##(2008-10#2)(2008-11#1)(2011-2#2)(2012-2#1)(2012-3#3)
and interacts##2##2##(2008-1#1)(2008-10#1)
and intercellular spaces##2##3##(2008-10#2)
and intercellular##4##2##(2008-10#3)(2008-9#1)
and intercept of##2##3##(2008-10#2)
and intercept##9##2##(2008-10#9)
and intercostal##2##2##(2011-2#2)
and interday##2##2##(2008-10#2)
and interdisciplinary##2##2##(2008-1#1)(2010-10#1)
and interest##4##2##(1991-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
and interesting##2##2##(1992-5#1)(2012-2#1)
and interests of the##2##4##(1997-1#1)(2012-12#1)
and interests of##4##3##(1995-2#1)(1997-1#1)(1997-3#1)(2012-12#1)
and interests##7##2##(1991-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
and interfacial tension##2##3##(1997-1#1)(2010-4#1)
and interfacial##7##2##(1997-1#1)(2008-10#3)(2008-7#1)(2010-4#2)
and interfere with the##2##4##(2008-3#1)(2008-9#1)
and interfere with##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
and interference free##2##3##(2008-10#2)
and interference of a number of metal ions on the determination of##4##12##(2008-10#4)
and interference of a##5##4##(2008-10#5)
and interference of##7##3##(2008-10#6)(2008-3#1)
and interference##13##2##(2008-10#12)(2008-3#1)
and interferences##6##2##(2008-10#6)
and interferes with##2##3##(2008-11#1)(2013-7#1)
and interfering ions on the recoveries of Cr(III)##2##8##(2008-10#2)
and interfering ions on the recovery of the analyte##2##9##(2008-10#2)
and interfering ions on the recovery of the analytes have been##2##11##(2008-10#2)
and interfering ions on the recovery of the##4##8##(2008-10#4)
and interfering ions on the##6##5##(2008-10#6)
and interfering ions##8##3##(2008-10#8)
and interfering with##2##3##(2010-12#1)(2011-2#1)
and interfering##11##2##(2008-10#9)(2010-12#1)(2011-2#1)
and interferon regulatory##2##3##(1994-11#1)(2012-3#1)
and interferon##3##2##(1994-11#1)(1995-12#1)(2012-3#1)
and interferon-alpha-2a##2##2##(1990-2#2)
and interferon-gamma##2##2##(1994-8#1)(2008-11#1)
and intergenic regions##2##3##(1996-3#1)(2008-4#1)
and intergenic##3##2##(1996-3#1)(1996-6#1)(2008-4#1)
and interleukin##5##2##(1995-2#1)(1996-12#2)(2008-11#1)(2011-2#1)
and interleukin-2 (IL-2)##2##3##(1995-12#1)(2008-5#1)
and interleukin-2##4##2##(1990-12#1)(1995-12#1)(2008-11#1)(2008-5#1)
and interleukin-4##2##2##(1997-1#1)(2008-11#1)
and interleukin-6 (IL-6)##2##3##(1996-12#1)(2008-10#1)
and interleukin-6 in##2##3##(2008-5#1)(2011-2#1)
and interleukin-6##6##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
and intermediate##21##2##(1991-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-9#2)(2011-2#3)(2012-2#1)(2012-3#2)
and intermittent##5##2##(2008-10#1)(2008-11#1)(2011-2#2)(2012-4#1)
and intermolecular##4##2##(1992-4#1)(1997-7#1)(2008-10#2)
and internal deletions in##2##4##(1995-6#1)(2011-2#1)
and internal standard##2##3##(2008-10#2)
and internal transcribed spacer (ITS)##2##5##(2008-10#2)
and internal transcribed spacer##4##4##(2008-10#4)
and internal transcribed##6##3##(2008-10#5)(2008-8#1)
and internal##28##2##(1993-12#1)(1995-6#2)(1996-2#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-4#2)(2008-8#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
and internalization of##2##3##(1994-8#1)(1997-1#1)
and internalization##4##2##(1994-8#1)(1995-6#1)(1997-1#1)(2008-9#1)
and international collaboration##2##3##(2008-10#1)(2010-1#1)
and international scientific##2##3##(2008-10#1)(2008-12#1)
and international##22##2##(1990-2#1)(1992-12#1)(1997-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and internationally##3##2##(1993-2#1)(2008-12#2)
and interpersonal##5##2##(1992-3#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-7#1)
and interpret##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
and interpretable##2##2##(1991-3#1)(2010-6#1)
and interpretation of the##6##4##(1996-11#1)(2008-10#3)(2008-7#1)(2009-12#1)
and interpretation of##13##3##(1996-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
and interpretation##20##2##(1996-11#1)(1996-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#2)
and interpretations of##2##3##(1991-11#1)(2008-8#1)
and interpreted##3##2##(2008-3#2)(2010-7#1)
and interpreting##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-3#1)
and intersections##2##2##(2008-10#1)(2008-5#1)
and interspecies transmission##2##3##(2013-8#2)
and interspecies##4##2##(1992-6#1)(2009-6#1)(2013-8#2)
and interspecific crosses##2##3##(2008-10#2)
and interspecific##4##2##(2008-10#3)(2008-9#1)
and interstitial##4##2##(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
and interval estimates##3##3##(1994-9#2)(2008-11#1)
and interval##4##2##(1994-9#2)(2008-11#1)(2009-7#1)
and intervention are##2##3##(2008-11#2)
and intervention in##3##3##(1990-9#1)(2008-11#1)(2010-10#1)
and intervention needs of##2##4##(2008-12#2)
and intervention studies##2##3##(2010-4#1)(2013-8#1)
and intervention##28##2##(1990-9#1)(1997-1#1)(2008-11#5)(2008-12#2)(2008-7#1)(2009-6#2)(2009-7#1)(2010-10#4)(2010-12#2)(2010-4#1)(2010-7#3)(2011-2#1)(2012-2#3)(2013-8#1)
and interventional##7##2##(1993-12#1)(1993-3#2)(2011-2#2)(2012-3#1)(2013-1#1)
and interventions and##2##3##(1994-3#1)(1996-2#1)
and interventions for##2##3##(1995-12#1)(2008-12#1)
and interventions that##3##3##(2008-11#1)(2013-1#2)
and interventions##16##2##(1994-3#1)(1995-12#1)(1996-2#1)(2008-11#2)(2008-12#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#6)
and intervertebral disc##2##3##(2009-12#1)(2010-3#1)
and intervertebral discs##5##3##(2007-8#5)
and intervertebral##7##2##(2007-8#5)(2009-12#1)(2010-3#1)
and interviews with##5##3##(1993-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2013-1#1)
and interviews##6##2##(1993-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2009-5#1)(2013-1#1)
and intestinal##12##2##(1991-8#1)(1996-12#1)(1997-8#2)(2008-5#2)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
and intestine##9##2##(1991-5#2)(1997-7#1)(1997-9#1)(2008-11#3)(2008-12#1)(2011-2#1)
and intimal##2##2##(2010-4#1)(2011-3#1)
and intimately##2##2##(1993-8#1)(2010-10#1)
and into the##4##3##(1995-3#1)(2008-10#1)(2008-6#1)(2009-5#1)
and into##9##2##(1994-1#1)(1995-3#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)
and intra##2##2##(2008-11#1)(2012-2#1)
and intra-day##2##2##(2008-10#2)
and intra-day)##2##2##(2008-10#2)
and intraabdominal##2##2##(1990-2#1)(1991-3#1)
and intracellular calcium concentration##2##4##(1995-2#1)(2008-8#1)
and intracellular calcium##4##3##(1995-2#1)(1996-2#1)(2008-7#1)(2008-8#1)
and intracellular ions in##2##4##(2010-4#2)
and intracellular localization##3##3##(1993-8#1)(1995-2#1)(2011-2#1)
and intracellular pH##4##3##(1994-2#1)(2008-10#1)(2010-8#2)
and intracellular signaling##2##3##(2009-8#1)(2012-2#1)
and intracellular transport of##2##4##(2011-2#1)(2013-1#1)
and intracellular##40##2##(1990-12#3)(1993-8#1)(1994-2#1)(1995-2#2)(1995-8#2)(1996-2#2)(1997-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#5)(2010-8#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
and intracellularly##3##2##(1997-3#1)(2008-10#2)
and intracranial##2##2##(2013-8#2)
and intramolecular##2##2##(1991-5#1)(1993-3#1)
and intraoperative digital subtraction angiography##2##5##(2008-7#2)
and intraoperative##8##2##(1992-9#2)(2008-7#2)(2011-2#1)(2012-3#2)(2013-8#1)
and intraspecific##5##2##(2008-10#2)(2008-8#3)
and intrauterine##7##2##(1990-11#1)(1994-12#1)(1996-11#1)(1996-3#1)(2008-11#1)(2010-3#1)(2012-3#1)
and intravenous##15##2##(1991-1#1)(1991-12#1)(1991-6#1)(1992-9#1)(1994-12#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-3#1)
and intravitreal##2##2##(2012-3#1)(2013-1#1)
and intriguing##2##2##(1994-12#1)(2008-7#1)
and intrinsic##10##2##(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#2)(2009-8#1)
and introduced directly into the##2##5##(2008-10#2)
and introduced into the##3##4##(2008-10#3)
and introduced into##7##3##(1993-12#1)(1997-6#1)(2008-10#4)(2008-8#1)
and introduced species##2##3##(2008-6#1)(2008-9#1)
and introduced##17##2##(1993-12#1)(1996-1#1)(1997-6#1)(2008-10#9)(2008-6#1)(2008-8#2)(2008-9#1)(2012-2#1)
and introduction of##2##3##(1994-5#1)(2008-11#1)
and introduction to staff was mainly supported by continuing education courses (92##2##12##(2013-1#2)
and introduction to##3##3##(2008-10#1)(2013-1#2)
and introduction##6##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#2)
and introgression##2##2##(2008-10#1)(2008-8#1)
and intron##2##2##(1993-2#1)(2008-8#1)
and intron/exon boundaries##2##3##(2008-11#1)(2008-4#1)
and introns##3##2##(1997-6#1)(2008-11#1)(2012-3#1)
and intubation##2##2##(1993-6#2)
and invade the##2##3##(2008-10#2)
and invade##3##2##(2008-10#2)(2008-9#1)
and invaded##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
and invasion assay##2##3##(2008-11#1)(2013-8#1)
and invasion in##2##3##(2012-3#1)(2013-8#1)
and invasion of hepatoma##3##4##(2008-11#2)(2013-8#1)
and invasion of the##2##4##(2008-11#1)(2011-2#1)
and invasion of##11##3##(2008-11#7)(2011-2#1)(2013-1#1)(2013-8#2)
and invasion##21##2##(2008-11#8)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#7)
and invasive growth##2##3##(1994-11#1)(2008-11#1)
and invasive##9##2##(1990-6#1)(1992-10#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-3#1)(2013-1#1)
and invasiveness##3##2##(1995-6#1)(2008-11#1)(2013-1#1)
and inventory##2##2##(1996-12#1)(2008-10#1)
and inverse##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
and inversely correlated with the##2##5##(1990-2#1)(2011-2#1)
and inversely##5##2##(1990-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
and inversion##3##2##(1996-5#1)(2008-9#1)(2010-3#1)
and invertebrate immunocytes##2##3##(1995-12#2)
and invertebrate##5##2##(1992-12#1)(1995-12#2)(1997-7#1)(2008-10#1)
and investigate the##2##3##(2008-6#1)(2008-9#1)
and investigate##8##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2012-3#1)(2013-1#1)
and investigated as a##2##4##(2008-10#1)(2010-7#1)
and investigated as##9##3##(2008-10#7)(2008-12#1)(2010-7#1)
and investigated its relationship##2##4##(2008-10#1)(2013-1#1)
and investigated its##4##3##(1993-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
and investigated the effect of##2##5##(2008-11#1)(2013-1#1)
and investigated the##4##3##(2008-10#1)(2008-11#1)(2010-6#1)(2013-1#1)
and investigated##26##2##(1993-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-6#1)(2010-7#1)(2013-1#2)
and investigates the##3##3##(1994-2#1)(2013-1#1)(2013-8#1)
and investigation of##2##3##(1990-11#1)(2008-10#1)
and investigation##5##2##(1990-11#1)(2008-10#1)(2009-10#1)(2011-3#1)(2012-2#1)
and investigational##2##2##(2008-12#1)(2009-12#1)
and invited##2##2##(2008-11#1)(2008-12#1)
and involve##2##2##(2008-11#1)(2008-12#1)
and involved in many##2##4##(2008-8#1)(2013-8#1)
and involved in##5##3##(1995-3#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
and involved only##2##3##(1993-8#1)(2008-10#1)
and involved##10##2##(1993-8#1)(1995-3#1)(2008-10#3)(2008-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
and involvement in the##2##4##(1990-6#1)(1997-3#1)
and involvement of##2##3##(1992-12#1)(1997-8#1)
and involvement##9##2##(1990-6#2)(1992-12#2)(1996-1#1)(1996-9#1)(1997-3#2)(1997-8#1)
and involves the##3##3##(1991-5#1)(2008-5#1)(2012-12#1)
and involves##9##2##(1991-5#1)(1995-12#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
and iodate in##2##3##(2008-10#2)
and iodate##6##2##(2008-10#6)
and iodide organification defect##2##4##(2011-1#2)
and iodide##16##2##(1990-2#1)(2008-10#13)(2011-1#2)
and iodine in##2##3##(1997-8#2)
and iodine##5##2##(1997-8#3)(2008-10#1)(2009-8#1)
and ion channels##2##3##(1993-9#1)(1995-2#1)
and ion chromatography##3##3##(2008-10#3)
and ion exchange##3##3##(1990-8#1)(2008-10#1)(2008-4#1)
and ion permeability##2##3##(2008-8#1)(2008-9#1)
and ion##20##2##(1990-8#1)(1993-9#1)(1995-2#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
and ion-depletion effect##2##3##(2008-10#2)
and ion-exchange chromatography (IEC)##2##4##(2008-10#1)(2008-12#1)
and ion-exchange chromatography##3##3##(1991-9#1)(2008-10#1)(2008-12#1)
and ion-exchange##4##2##(1991-9#1)(2008-10#2)(2008-12#1)
and ion-pair liquid chromatography-electrospray-tandem mass spectrometry##2##6##(2008-10#2)
and ion-pair##3##2##(2008-10#3)
and ionic strength of##6##4##(2008-10#6)
and ionic strength on##2##4##(2008-10#2)
and ionic strength##17##3##(1997-2#1)(2008-10#15)(2008-7#1)
and ionic strengths##3##3##(1995-2#1)(2008-10#2)
and ionic##24##2##(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#18)(2008-7#2)(2012-3#1)
and ionization##2##2##(2008-10#1)(2010-7#1)
and ionized##2##2##(2008-10#2)
and ionomycin in a dose-dependent manner##2##6##(1995-8#2)
and ionomycin##6##2##(1993-3#1)(1994-11#1)(1995-8#3)(2008-11#1)
and ipsilateral##4##2##(1996-12#1)(2008-12#1)(2008-8#1)(2011-2#1)
and iris##2##2##(2008-10#1)(2011-2#1)
and iron in mixtures##2##4##(2008-10#2)
and iron in##8##3##(1997-8#1)(2008-10#7)
and iron ions##2##3##(2008-10#2)
and iron were##3##3##(2008-10#3)
and iron##32##2##(1990-11#1)(1994-5#1)(1997-8#1)(2008-10#29)
and iron(II)##5##2##(2008-10#5)
and iron(III)##8##2##(2008-10#8)
and irradiated##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
and irradiation##2##2##(1992-12#1)(2008-10#1)
and irregular##2##2##(1991-2#1)(2008-11#1)
and irregularity in##2##3##(2008-11#1)(2008-9#1)
and irregularity##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
and irrelevant##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
and irreversible##6##2##(1990-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
and irreversibly##3##2##(2008-10#3)
and irrigation water##4##3##(2008-10#4)
and irrigation##9##2##(2008-10#8)(2013-8#1)
and is a component of##2##5##(2008-10#2)
and is a##27##3##(1993-12#1)(1993-9#1)(1996-3#1)(1997-2#2)(1997-4#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
and is able to##5##4##(1994-5#1)(2008-10#2)(2008-3#1)(2009-5#1)
and is also##2##3##(1994-5#1)(2008-10#1)
and is an##9##3##(1990-2#1)(1990-5#1)(1995-9#1)(2008-10#3)(2009-5#1)(2013-1#1)(2013-8#1)
and is applicable to the analysis of alloy samples##2##9##(2008-10#2)
and is applicable to the analysis of synthetic mixtures and alloys##2##11##(2008-10#2)
and is applicable to the analysis of##4##7##(2008-10#4)
and is applicable to the##5##5##(2008-10#5)
and is applicable to##6##4##(2008-10#6)
and is applicable##8##3##(2008-10#6)(2008-3#1)(2010-5#1)
and is applied to the##2##5##(2008-10#2)
and is applied to##5##4##(2008-10#2)(2008-3#2)(2008-7#1)
and is applied##6##3##(2008-10#3)(2008-3#2)(2008-7#1)
and is associated to##2##4##(2008-10#1)(2008-9#1)
and is associated with a##3##5##(2008-10#1)(2009-12#1)(2010-6#1)
and is associated with high##2##5##(2009-10#1)(2009-7#1)
and is associated with##9##4##(1995-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-6#1)(2012-3#1)(2013-1#1)
and is associated##11##3##(1995-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-6#1)(2012-3#1)(2013-1#1)
and is based on the##5##5##(1991-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
and is based on##9##4##(1991-1#1)(2008-10#4)(2008-11#2)(2013-1#2)
and is based##10##3##(1991-1#1)(1992-4#1)(2008-10#4)(2008-11#2)(2013-1#2)
and is believed to be##2##5##(2008-9#1)(2010-3#1)
and is believed to##3##4##(2008-5#1)(2008-9#1)(2010-3#1)
and is capable of##5##4##(1991-12#1)(1996-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
and is characterised clinically by##2##5##(1991-2#1)(1997-8#1)
and is characterized by##2##4##(2009-11#1)(2010-11#1)
and is comparable##2##3##(2008-10#1)(2008-11#1)
and is composed mainly of##2##5##(1994-5#1)(2010-8#1)
and is composed of##2##4##(2008-8#1)(2008-9#1)
and is composed##4##3##(1994-5#1)(2008-8#1)(2008-9#1)(2010-8#1)
and is considered to##2##4##(1996-12#1)(2008-5#1)
and is consistent with the##2##5##(2008-10#2)
and is consistent with##5##4##(1992-12#1)(1997-6#1)(2008-10#2)(2010-11#1)
and is continuing to##2##4##(2008-6#1)(2011-2#1)
and is currently##3##3##(1996-1#1)(2008-11#1)(2011-2#1)
and is designed to##2##4##(1991-12#1)(2008-10#1)
and is doing well##2##4##(2008-8#1)(2013-7#1)
and is easily##2##3##(1996-1#1)(2008-10#1)
and is especially useful##2##4##(1995-11#1)(2008-10#1)
and is especially##3##3##(1995-11#1)(2008-10#1)(2008-5#1)
and is essential for##2##4##(2008-5#1)(2011-2#1)
and is expected to##3##4##(2008-10#2)(2008-11#1)
and is expressed in##2##4##(1992-3#1)(2012-2#1)
and is expressed##5##3##(1992-3#1)(1993-2#1)(1994-11#1)(1995-12#1)(2012-2#1)
and is found to accurately and reliably include the free energy contributions of solvent relaxation to hydrolysis##2##17##(2013-1#2)
and is found to##3##4##(2008-10#1)(2013-1#2)
and is found##7##3##(1996-6#1)(2008-10#4)(2013-1#2)
and is frequently##3##3##(1992-9#1)(1997-4#1)(2008-5#1)
and is highly##5##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)
and is in##4##3##(2008-10#2)(2008-5#1)(2009-5#1)
and is independent of the concentration of##2##7##(2008-10#2)
and is influenced by##2##4##(2009-8#1)(2013-8#1)
and is involved in many##2##5##(2011-2#1)(2013-8#1)
and is involved in the##3##5##(2008-9#1)(2009-8#1)(2013-8#1)
and is involved in##10##4##(1995-8#1)(1996-2#1)(2008-11#1)(2008-9#2)(2009-8#1)(2011-2#2)(2013-8#2)
and is known for its##2##5##(2008-10#1)(2009-9#1)
and is known##4##3##(2008-10#1)(2008-11#1)(2009-9#1)(2010-7#1)
and is largely##3##3##(1994-5#1)(2008-7#1)(2010-11#1)
and is less##4##3##(2008-10#1)(2008-7#1)(2009-10#1)(2010-7#1)
and is limited to##2##4##(2008-3#1)(2013-1#1)
and is limited##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
and is located##5##3##(1992-9#1)(1993-12#1)(1993-9#1)(1997-7#1)(2008-12#1)
and is more##3##3##(2008-10#1)(2010-6#1)(2013-1#1)
and is most##2##3##(2009-8#1)(2011-1#1)
and is much##3##3##(1997-4#1)(1997-7#1)(2008-10#1)
and is not##12##3##(1996-12#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-10#1)(2011-2#3)(2013-1#1)
and is now##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
and is observed in##2##4##(2008-10#1)(2012-2#1)
and is of##5##3##(2008-11#1)(2008-12#2)(2011-2#1)(2013-1#1)
and is often##4##3##(2008-10#3)(2010-5#1)
and is one of the major##2##6##(2008-10#1)(2013-1#1)
and is one of the##3##5##(2008-1#1)(2008-10#1)(2013-1#1)
and is only a##2##4##(1994-6#1)(2008-11#1)
and is only##3##3##(1994-6#1)(2008-11#1)(2008-3#1)
and is partly##2##3##(1997-7#1)(2008-3#1)
and is possibly a##2##4##(1994-8#1)(1996-12#1)
and is potentially##2##3##(2008-7#1)(2012-3#1)
and is present in##2##4##(1995-2#1)(2008-10#1)
and is present##4##3##(1993-3#1)(1995-2#1)(2008-10#1)(2011-2#1)
and is presumed to##2##4##(1993-6#1)(2008-10#1)
and is probably an##2##4##(2008-10#1)(2011-2#1)
and is probably##5##3##(2008-10#3)(2008-8#1)(2011-2#1)
and is rapidly##2##3##(1994-9#1)(1996-12#1)
and is rarely##2##3##(1995-1#1)(2008-12#1)
and is regulated by##2##4##(2011-2#1)(2013-1#1)
and is related##2##3##(2008-10#2)
and is reproducible##2##3##(2008-10#2)
and is required for##4##4##(1997-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
and is responsible for the##2##5##(2009-7#1)(2012-2#1)
and is responsible for##7##4##(2008-10#2)(2008-12#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
and is sensitive to##2##4##(1997-2#1)(2009-11#1)
and is significantly##2##3##(1993-3#1)(2008-10#1)
and is similar to##4##4##(1996-3#1)(2008-3#1)(2008-8#1)(2009-10#1)
and is similar##6##3##(1992-2#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
and is sometimes##2##3##(1991-11#1)(2007-8#1)
and is specific for##2##4##(1995-2#1)(2008-10#1)
and is specifically##2##3##(1993-12#1)(2008-9#1)
and is stimulated by##2##4##(1992-6#1)(2008-5#1)
and is suitable for##8##4##(1996-1#1)(1996-12#1)(2008-10#5)(2008-2#1)
and is suitable##9##3##(1996-1#1)(1996-12#1)(2008-10#5)(2008-2#1)(2011-2#1)
and is surrounded by##2##4##(1993-9#1)(2008-7#1)
and is the most##3##4##(2007-8#1)(2013-1#1)(2013-8#1)
and is the only##4##4##(2007-12#1)(2008-10#3)
and is the preferred##2##4##(2008-9#1)(2010-7#1)
and is the##15##3##(1993-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
and is therefore##8##3##(1990-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
and is thus##4##3##(1992-12#1)(1996-6#1)(2008-10#1)(2008-7#1)
and is under the##2##4##(1993-6#1)(2012-12#1)
and is used##2##3##(2008-10#2)
and is useful##2##3##(2008-11#1)(2010-12#1)
and is usually##3##3##(1991-11#1)(2008-10#1)(2008-9#1)
and is very##3##3##(1992-8#1)(2008-10#1)(2012-2#1)
and is##499##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#2)(1992-1#1)(1992-10#2)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#3)(1996-12#5)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#4)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#129)(2008-11#22)(2008-12#12)(2008-2#5)(2008-3#14)(2008-4#1)(2008-5#13)(2008-6#2)(2008-7#12)(2008-8#11)(2008-9#16)(2009-10#5)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#7)(2010-8#3)(2011-1#2)(2011-2#30)(2012-12#7)(2012-2#11)(2012-3#6)(2013-1#20)(2013-7#1)(2013-8#7)
and ischemic heart disease##2##4##(2008-3#1)(2012-3#1)
and ischemic stroke##3##3##(2008-8#1)(2008-9#2)
and ischemic##7##2##(1993-6#1)(1995-5#1)(2008-3#1)(2008-8#1)(2008-9#2)(2012-3#1)
and iso-butylamine##2##2##(2008-10#2)
and isoalantolactone##2##2##(2008-10#2)
and isobutane##2##2##(2008-10#1)(2011-2#1)
and isobutyric acids##2##3##(2008-10#2)
and isoelectric focusing##2##3##(2008-11#1)(2010-7#1)
and isoelectric##3##2##(1993-3#1)(2008-11#1)(2010-7#1)
and isoflurane##3##2##(1991-6#1)(2010-7#1)(2012-3#1)
and isolate##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
and isolated##11##2##(1992-3#1)(1992-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)
and isolates from the##2##4##(2008-10#2)
and isolates from##7##3##(2008-10#7)
and isolates of##7##3##(2008-10#7)
and isolates##20##2##(2008-10#19)(2008-5#1)
and isolation frequency##2##3##(2008-10#2)
and isolation of the##2##4##(1996-12#1)(2008-2#1)
and isolation of##11##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2011-7#1)
and isolation##18##2##(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#1)(2010-7#1)(2011-7#1)
and isoleucine##2##2##(2008-10#2)
and isopropanol were##2##3##(1991-5#1)(2008-10#1)
and isopropanol##5##2##(1991-5#3)(2008-10#2)
and isotopic##3##2##(2008-10#2)(2008-7#1)
and isozyme patterns##2##3##(2008-10#1)(2008-11#1)
and isozyme##3##2##(2008-10#2)(2008-11#1)
and issues to be##2##4##(1993-2#1)(1994-12#1)
and issues##9##2##(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-5#1)(1997-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
and it allowed the##2##4##(1992-12#1)(2008-10#1)
and it also showed a##2##5##(2008-10#1)(2011-3#1)
and it also##4##3##(2008-10#2)(2008-7#1)(2011-3#1)
and it can be##10##4##(1993-3#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-7#1)(2010-6#1)
and it can##11##3##(1991-6#1)(1993-3#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-7#1)(2010-6#1)
and it could be##6##4##(2008-10#4)(2008-11#1)(2010-7#1)
and it could##7##3##(2008-10#5)(2008-11#1)(2010-7#1)
and it did not##2##4##(2008-10#2)
and it did##3##3##(2008-10#2)(2010-1#1)
and it has a##2##4##(2008-10#2)
and it has been proposed that##2##6##(1995-2#1)(2008-7#1)
and it has been##9##4##(1995-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2012-3#1)
and it has##16##3##(1995-2#1)(2008-10#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-3#1)
and it is a##5##4##(2008-5#1)(2008-6#1)(2008-7#1)(2011-3#1)(2012-3#1)
and it is also##4##4##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
and it is concluded##2##4##(1990-3#1)(2008-2#1)
and it is critical##2##4##(2008-11#1)(2013-1#1)
and it is estimated that##2##5##(2008-11#1)(2011-2#1)
and it is estimated##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
and it is found that the##2##6##(2008-10#1)(2009-7#1)
and it is important that##2##5##(1992-6#1)(1995-2#1)
and it is important##4##4##(1992-6#1)(1995-2#1)(2008-10#1)(2010-10#1)
and it is likely that this##3##6##(1992-12#1)(2007-12#1)(2008-10#1)
and it is likely that##6##5##(1992-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)
and it is necessary to##2##5##(1996-5#1)(2009-12#1)
and it is now##2##4##(2008-11#1)(2011-2#1)
and it is possible to##2##5##(2008-10#1)(2012-3#1)
and it is possible##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
and it is proposed that##2##5##(2008-10#1)(2012-12#1)
and it is shown that the##3##6##(1994-5#1)(2008-6#1)(2009-9#1)
and it is shown that##4##5##(1994-5#1)(2008-3#1)(2008-6#1)(2009-9#1)
and it is shown##5##4##(1994-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-9#1)
and it is still a##2##5##(2010-11#2)
and it is suggested that##3##5##(1991-2#1)(2008-11#1)(2008-8#1)
and it is suitable##2##4##(2008-10#1)(2010-12#1)
and it is susceptible##2##4##(2008-10#2)
and it is##95##3##(1990-12#1)(1990-3#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2007-12#3)(2008-10#28)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
and it may be##5##4##(1997-1#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
and it may##10##3##(1995-12#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)
and it might be##2##4##(1997-8#1)(2008-10#1)
and it must be##2##4##(1996-1#1)(2008-10#1)
and it offers##2##3##(2012-2#1)(2013-8#1)
and it remains##2##3##(1990-12#1)(2013-1#1)
and it seems##2##3##(2008-1#1)(2013-1#1)
and it should be##4##4##(2008-10#1)(2009-12#1)(2010-11#2)
and it should##5##3##(1996-6#1)(2008-10#1)(2009-12#1)(2010-11#2)
and it shows##4##3##(1990-12#1)(2008-10#2)(2008-8#1)
and it suggests that##2##4##(1990-2#1)(2008-10#1)
and it was applied to the##2##6##(2008-10#2)
and it was applied##3##4##(2008-10#3)
and it was concluded that##2##5##(1991-12#1)(2008-10#1)
and it was found that both##2##6##(2008-10#1)(2010-5#1)
and it was found that the##6##6##(2008-10#6)
and it was found that##13##5##(1990-12#1)(1992-3#1)(2008-10#9)(2010-5#2)
and it was found##16##4##(1990-12#1)(1992-3#1)(1994-11#1)(2008-10#10)(2010-5#2)(2011-2#1)
and it was not##4##4##(1990-6#1)(2008-10#2)(2008-9#1)
and it was possible to##2##5##(1993-8#1)(2008-10#1)
and it was shown that##3##5##(2008-10#2)(2008-3#1)
and it was successfully applied##2##5##(2008-10#2)
and it was##66##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#2)(2011-2#1)(2011-4#1)(2012-3#1)(2013-1#1)
and it##281##2##(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#103)(2008-11#13)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#4)(2011-4#1)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#6)(2013-8#3)
and it's##4##2##(2008-10#1)(2010-12#1)(2012-3#2)
and its 1##2##3##(2008-10#2)
and its Cu(2+) and Zn(2+) complexes##2##6##(2008-5#2)
and its ability to##7##4##(1991-6#1)(1994-5#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#2)
and its accuracy was##2##4##(2008-10#2)
and its active##2##3##(1993-8#1)(2013-1#1)
and its activity##3##3##(1995-6#1)(2008-10#1)(2008-12#1)
and its amperometric##2##3##(2008-10#2)
and its analogs##2##3##(2008-11#1)(2009-7#1)
and its analogue##3##3##(2008-11#2)(2010-3#1)
and its analogues##3##3##(1994-8#1)(2008-10#2)
and its analytical application##2##4##(2008-10#2)
and its analytical##6##3##(2008-10#6)
and its antagonists##2##3##(2008-8#2)
and its antibody##2##3##(2008-11#1)(2011-2#1)
and its apparent##2##3##(1993-2#1)(1994-12#1)
and its application as a##2##5##(2008-10#2)
and its application as##3##4##(2008-10#3)
and its application for determination of##2##6##(2008-10#2)
and its application for the determination of##2##7##(2008-10#2)
and its application for the##4##5##(2008-10#3)(2008-11#1)
and its application for##10##4##(2008-10#8)(2008-11#1)(2008-7#1)
and its application in analytical chemistry##2##6##(2008-10#2)
and its application in environmental##2##5##(2008-10#2)
and its application in the##3##5##(1993-2#1)(2008-10#2)
and its application in##16##4##(1993-2#1)(1995-3#1)(2008-10#12)(2011-2#1)(2013-8#1)
and its application to the determination of trace##2##8##(2008-10#2)
and its application to the determination of##7##7##(2008-10#7)
and its application to the##10##5##(2008-10#10)
and its application to water samples##2##6##(2008-10#2)
and its application to##36##4##(1990-5#1)(2008-10#29)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)
and its application##74##3##(1990-5#1)(1992-2#1)(1993-2#1)(1995-3#1)(2008-10#60)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
and its applications in##2##4##(2008-10#1)(2010-9#1)
and its applications##5##3##(2008-10#4)(2010-9#1)
and its associated factors##3##4##(2008-10#2)(2013-8#1)
and its associated##9##3##(2008-10#5)(2009-8#1)(2012-2#1)(2013-8#2)
and its association with##9##4##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
and its attendant##2##3##(2011-2#1)(2012-3#1)
and its binding##2##3##(2008-8#2)
and its biological##2##3##(1995-12#1)(2008-9#1)
and its branches##3##3##(1997-8#3)
and its catalytic activity##2##4##(1996-2#1)(2008-10#1)
and its catalytic##3##3##(1996-2#1)(2008-10#2)
and its characteristics##2##3##(1993-3#1)(2011-2#1)
and its characterization##2##3##(2008-11#2)
and its chemical##5##3##(2008-10#3)(2008-7#1)(2011-2#1)
and its clinical##2##3##(2011-2#1)(2012-3#1)
and its complex with##2##4##(2008-10#2)
and its complexes with##2##4##(2008-10#2)
and its complications##3##3##(2008-1#1)(2008-7#1)(2010-10#1)
and its components##6##3##(1991-2#1)(1997-1#1)(2008-10#2)(2008-7#1)(2008-9#1)
and its concentration was##2##4##(2008-10#2)
and its concentration##6##3##(2008-10#6)
and its conjugate were##2##4##(2008-10#2)
and its conjugate##3##3##(2008-10#3)
and its connections in##2##4##(2011-2#2)
and its connections##4##3##(1993-6#1)(2011-2#2)(2013-8#1)
and its consequences##8##3##(1996-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#2)(2013-8#1)
and its content##4##3##(1990-3#1)(2008-10#2)(2008-5#1)
and its conversion into##2##4##(1991-7#1)(2008-10#1)
and its correlation with##2##4##(2008-10#1)(2009-5#1)
and its correlation##3##3##(2008-10#2)(2009-5#1)
and its corresponding##3##3##(2008-10#2)(2008-6#1)
and its current##2##3##(1992-2#1)(2008-11#1)
and its degradation product##3##4##(2008-10#2)(2008-5#1)
and its degradation products##2##4##(2008-10#2)
and its degradation##5##3##(2008-10#4)(2008-5#1)
and its demonstrated##2##3##(2008-11#2)
and its dependence on##3##4##(2008-10#2)(2008-3#1)
and its derivatives are##3##4##(1993-11#1)(2008-8#1)(2008-9#1)
and its derivatives on##2##4##(2008-10#1)(2008-5#1)
and its derivatives with##2##4##(1993-11#1)(2008-11#1)
and its derivatives##23##3##(1993-11#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#3)(2013-1#1)
and its derivatives]##2##3##(1993-11#1)(2011-3#1)
and its detection limit##2##4##(2008-10#2)
and its detection##6##3##(2008-10#6)
and its determinants##2##3##(2008-1#1)(2010-3#1)
and its determination by##6##4##(2008-10#5)(2008-11#1)
and its determination in##2##4##(2008-10#2)
and its determination##11##3##(2008-10#10)(2008-11#1)
and its development##2##3##(2008-11#1)(2013-1#1)
and its dissociation##2##3##(2008-10#2)
and its dose##2##3##(2008-12#1)(2008-5#1)
and its downstream##2##3##(2012-2#1)(2013-1#1)
and its effect on##11##4##(1995-11#1)(2008-10#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
and its effect to##2##4##(2008-10#1)(2008-11#1)
and its effect was##2##4##(2008-10#2)
and its effect##17##3##(1995-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
and its effects on##5##4##(1994-5#1)(2008-10#1)(2008-9#1)(2009-10#1)(2012-3#1)
and its effects##6##3##(1994-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2012-3#1)
and its electrochemical##2##3##(2008-10#2)
and its environment##2##3##(1990-8#1)(2008-10#1)
and its environmental##2##3##(2008-10#1)(2011-2#1)
and its evolution##3##3##(2008-10#2)(2010-6#1)
and its expression in the##2##5##(1996-12#1)(1997-2#1)
and its expression in##5##4##(1996-12#1)(1997-2#2)(2008-8#2)
and its expression is##3##4##(1992-12#1)(1995-6#1)(2008-9#1)
and its expression##9##3##(1992-12#1)(1995-6#1)(1996-12#1)(1997-2#2)(2008-8#3)(2008-9#1)
and its flanking regions##3##4##(1990-11#1)(1990-8#1)(1993-8#1)
and its four##3##3##(2008-10#2)(2013-1#1)
and its function in regulating##2##5##(2008-8#1)(2008-9#1)
and its function##4##3##(2008-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
and its genetic##2##3##(2008-10#1)(2008-9#1)
and its homologues##2##3##(1995-6#1)(2008-10#1)
and its host##3##3##(1997-1#1)(2008-10#2)
and its immediate##2##3##(2008-2#1)(2008-9#1)
and its impact on the##4##5##(1996-1#1)(2008-11#1)(2012-12#1)(2013-1#1)
and its impact on##15##4##(1996-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-10#1)(2011-2#3)(2012-12#3)(2013-1#2)
and its impact##16##3##(1996-1#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-10#1)(2011-2#3)(2012-12#3)(2013-1#2)
and its implication on##3##4##(2008-10#1)(2008-11#2)
and its implication##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
and its implications for##4##4##(1992-9#1)(1993-8#1)(1995-2#1)(2012-2#1)
and its implications in##5##4##(1993-5#1)(2008-1#1)(2008-11#1)(2010-5#1)(2012-3#1)
and its implications##11##3##(1992-9#1)(1993-5#1)(1993-8#1)(1995-2#1)(2008-1#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
and its importance in##2##4##(1997-3#1)(2013-1#1)
and its importance##3##3##(1997-3#1)(2008-11#1)(2013-1#1)
and its influence on the##2##5##(1994-5#1)(2008-2#1)
and its influence on##5##4##(1994-5#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-8#1)
and its influence##6##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-9#1)(2013-8#1)
and its influential factors]##2##4##(2013-8#2)
and its inhibition by##3##4##(2008-11#1)(2008-7#2)
and its inhibition##4##3##(1997-2#1)(2008-11#1)(2008-7#2)
and its interaction with##4##4##(1997-1#1)(2008-10#3)
and its keto acid##2##4##(2008-11#2)
and its ligand##2##3##(1994-12#1)(2011-2#1)
and its limitations##2##3##(2008-10#1)(2008-12#1)
and its low##3##3##(2008-10#2)(2009-1#1)
and its mRNA##2##3##(1995-12#1)(2008-9#1)
and its main metabolite##7##4##(2008-10#7)
and its main##12##3##(1997-8#1)(2008-10#11)
and its major metabolite (AM1) in##2##6##(2008-10#2)
and its major transformation product##2##5##(2008-10#2)
and its major##8##3##(1997-8#1)(2008-10#6)(2013-8#1)
and its management in##2##4##(2008-5#1)(2008-7#1)
and its management##6##3##(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-3#1)
and its mechanism of##2##4##(2008-8#2)
and its mechanism##5##3##(2008-8#2)(2008-9#1)(2010-12#1)(2013-8#1)
and its medicinal preparation by capillary##2##6##(2008-10#2)
and its medicinal preparation##3##4##(2008-10#3)
and its medicinal##5##3##(2008-10#5)
and its metabolite in##2##4##(2008-10#2)
and its metabolite##8##3##(2008-10#7)(2009-6#1)
and its metabolites in##6##4##(2008-10#3)(2008-11#2)(2011-3#1)
and its metabolites were##2##4##(2008-11#1)(2008-7#1)
and its metabolites##17##3##(1993-3#1)(2008-10#10)(2008-11#4)(2008-7#1)(2011-3#1)
and its modulation by##3##4##(1990-3#2)(1993-2#1)
and its molecular##3##3##(2008-1#1)(2008-8#1)(2009-4#1)
and its mutant##2##3##(2008-8#2)
and its mutants##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
and its operation in##2##4##(2007-12#1)(2008-11#1)
and its oxidation products##2##4##(2008-10#1)(2008-11#1)
and its oxidation##3##3##(2008-10#2)(2008-11#1)
and its pH##3##3##(2008-10#3)
and its performance##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
and its pharmaceutical formulation##2##4##(2008-10#2)
and its pharmaceutical preparations##2##4##(2008-10#2)
and its pharmaceutical##4##3##(2008-10#4)
and its phosphorylated anabolites##2##4##(2008-7#2)
and its physicochemical properties##2##4##(2008-10#2)
and its physiological##3##3##(1994-3#1)(2007-8#1)(2008-5#1)
and its position##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
and its possible##5##3##(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)(2009-9#1)
and its potential application##2##4##(2011-2#1)(2013-1#1)
and its potential for##2##4##(2007-11#1)(2008-10#1)
and its potential##10##3##(1991-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#2)(2013-1#2)
and its preliminary##2##3##(2008-8#1)(2012-3#1)
and its prevention##4##3##(1997-2#1)(2009-5#1)(2012-12#1)(2013-7#1)
and its properties##2##3##(1991-12#1)(2008-10#1)
and its protection##2##3##(1994-8#1)(2008-5#1)
and its receptor in##3##4##(1991-7#1)(2008-11#1)(2013-7#1)
and its receptor##14##3##(1991-7#1)(1993-11#1)(1995-12#4)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2013-7#1)
and its recombinant##2##3##(1994-8#1)(2008-9#1)
and its regulatory##2##3##(2012-2#1)(2013-1#1)
and its related compounds##3##4##(2008-11#3)
and its related##10##3##(1992-6#1)(2008-11#3)(2008-8#3)(2010-6#1)(2011-3#1)(2012-2#1)
and its relation to the##4##5##(1992-3#1)(1993-5#1)(1997-6#1)(2013-8#1)
and its relation to##11##4##(1990-2#1)(1991-12#1)(1992-3#1)(1993-5#1)(1994-12#1)(1996-6#1)(1997-6#1)(2008-12#1)(2012-3#1)(2013-8#2)
and its relationship to the##2##5##(1995-12#1)(2008-10#1)
and its relationship to##6##4##(1992-12#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
and its relationship with cigarette##2##5##(2013-1#2)
and its relationship with the##3##5##(1995-12#1)(2008-10#1)(2012-12#1)
and its relationship with##8##4##(1991-12#1)(1995-12#1)(2008-10#2)(2012-12#2)(2013-1#2)
and its relationship##14##3##(1991-12#1)(1992-12#1)(1993-12#1)(1995-12#2)(2008-10#3)(2008-12#1)(2012-12#2)(2012-2#1)(2013-1#2)
and its relevance to##3##4##(2008-7#1)(2008-9#1)(2012-2#1)
and its resistance##2##3##(2008-10#1)(2008-3#1)
and its robustness##2##3##(2008-10#1)(2008-3#1)
and its role in the##3##5##(2008-12#1)(2008-8#2)
and its role in##9##4##(2008-1#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-4#1)(2011-2#2)(2012-2#1)
and its role##10##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-4#1)(2011-2#2)(2012-2#1)
and its sensitivity##2##3##(1992-6#1)(2008-3#1)
and its separation##2##3##(2008-10#2)
and its significance##2##3##(2009-4#1)(2010-6#1)
and its solution##2##3##(2008-10#2)
and its specific##4##3##(1990-2#1)(1990-5#1)(1992-12#1)(2008-11#1)
and its structure##2##3##(2008-10#1)(2011-2#1)
and its subsequent##6##3##(1994-11#2)(1997-6#1)(2008-10#3)
and its substrate##2##3##(2009-7#2)
and its subunits##2##3##(1990-5#1)(2008-10#1)
and its suitability for##2##4##(1995-11#1)(2008-10#1)
and its suppression by##4##4##(1993-8#1)(2008-10#1)(2008-11#1)(2009-9#1)
and its suppression##5##3##(1993-8#1)(2008-10#1)(2008-11#2)(2009-9#1)
and its surrounding##2##3##(2008-4#1)(2009-12#1)
and its synthetic##2##3##(1997-3#1)(2009-3#1)
and its therapeutic##2##3##(2008-11#1)(2008-7#1)
and its toxic metabolite##3##4##(2008-10#3)
and its transmission##2##3##(2008-10#1)(2010-1#1)
and its treatment with##2##4##(1994-5#1)(2008-11#1)
and its treatment##6##3##(1991-2#1)(1994-5#1)(2008-11#1)(2008-9#1)(2010-9#1)(2012-3#1)
and its two##2##3##(1991-2#1)(2008-10#1)
and its uncertainty##3##3##(2008-10#3)
and its underlying##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
and its use as##2##4##(2008-10#1)(2008-5#1)
and its use for##2##4##(2008-10#2)
and its use in the##2##5##(2008-10#2)
and its use in##4##4##(2008-10#4)
and its use is##3##4##(1995-11#1)(2008-11#1)(2010-2#1)
and its use##12##3##(1991-6#1)(1995-11#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-2#1)
and its withdrawal##2##3##(1996-12#2)
and its##1097##2##(1990-11#1)(1990-2#2)(1990-3#4)(1990-5#8)(1990-6#1)(1990-8#2)(1990-9#3)(1991-12#6)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#4)(1991-7#2)(1992-10#2)(1992-12#4)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#2)(1993-2#5)(1993-3#5)(1993-5#2)(1993-6#2)(1993-8#5)(1994-11#7)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#6)(1995-1#1)(1995-11#6)(1995-12#9)(1995-2#4)(1995-3#1)(1995-5#4)(1995-6#9)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#7)(1996-2#8)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#5)(2007-11#3)(2007-12#5)(2007-8#4)(2008-1#10)(2008-10#402)(2008-11#80)(2008-12#12)(2008-2#2)(2008-3#17)(2008-4#4)(2008-5#22)(2008-6#3)(2008-7#27)(2008-8#42)(2008-9#34)(2009-1#2)(2009-10#10)(2009-12#2)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#10)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#5)(2010-7#1)(2010-9#4)(2011-1#5)(2011-10#1)(2011-2#41)(2011-3#5)(2012-12#12)(2012-2#23)(2012-3#16)(2012-6#1)(2013-1#23)(2013-7#3)(2013-8#19)
and ivermectin##2##2##(1996-11#1)(2010-2#1)
and japonica##4##2##(2008-10#3)(2008-8#1)
and jasmonic acid##2##3##(2008-10#1)(2009-8#1)
and jasmonic##3##2##(2008-10#2)(2009-8#1)
and jatropha##3##2##(2009-3#3)
and jaundice##4##2##(1990-9#1)(2012-2#1)(2012-3#2)
and jaw##2##2##(1996-3#1)(2013-1#1)
and job satisfaction##2##3##(1992-1#1)(2008-9#1)
and job##5##2##(1991-3#1)(1992-1#1)(1993-3#1)(2008-9#1)(2010-11#1)
and joining of##2##3##(1997-7#2)
and joining##4##2##(1997-3#2)(1997-7#2)
and joint##8##2##(1992-6#1)(2008-10#1)(2008-11#2)(2009-1#1)(2011-2#2)(2012-2#1)
and journals##3##2##(2008-12#1)(2009-6#1)(2010-8#1)
and joy##2##2##(2009-10#1)(2013-1#1)
and judging##2##2##(1992-12#1)(1996-2#1)
and judgment##2##2##(1992-3#1)(2010-8#1)
and judicious##2##2##(2010-1#1)(2013-1#1)
and juice 0##2##3##(2008-10#2)
and juice##6##2##(2008-10#4)(2010-5#2)
and jumping##2##2##(1990-6#1)(1996-2#1)
and just##5##2##(1994-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
and justice##3##2##(1991-12#1)(1992-2#1)(1997-1#1)
and justicidin E##2##3##(1996-5#2)
and juvenile rheumatoid arthritis##2##4##(2012-3#2)
and juvenile##9##2##(1993-11#2)(2008-11#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#3)
and juveniles##2##2##(2010-8#2)
and k##2##2##(1992-9#1)(2008-5#1)
and kappa##3##2##(1995-6#1)(2009-8#1)(2013-8#1)
and kcat##2##2##(1994-5#1)(1995-8#1)
and kept##5##2##(1996-2#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#1)
and keratin##2##2##(2008-11#1)(2012-3#1)
and keratinocytes##2##2##(2008-5#1)(2012-3#1)
and kernel##7##2##(2008-10#7)
and ketoconazole##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
and key##8##2##(1991-3#1)(1993-1#1)(1996-1#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
and kidney of##2##3##(2008-5#2)
and kidney##34##2##(1990-11#1)(1990-12#1)(1990-3#6)(1991-5#1)(1991-8#2)(1993-12#2)(1994-11#2)(1994-5#1)(2008-10#4)(2008-11#1)(2008-5#4)(2008-9#3)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
and kidneys##4##2##(1991-6#1)(2008-5#1)(2012-3#2)
and kill##2##2##(2011-2#1)(2012-2#1)
and killed##3##2##(1990-3#1)(1993-12#1)(1996-12#1)
and kinase##2##2##(1994-11#1)(2009-8#1)
and kind of##3##3##(1994-6#2)(2008-10#1)
and kinematics##4##2##(2008-12#1)(2008-9#1)(2011-2#2)
and kinetic and##2##3##(1993-8#1)(2008-10#1)
and kinetic energy##2##3##(2008-10#2)
and kinetic parameters for##2##4##(1990-9#1)(1993-8#1)
and kinetic parameters##3##3##(1990-9#1)(1993-8#1)(2008-4#1)
and kinetic studies##2##3##(1993-8#1)(2008-11#1)
and kinetic##20##2##(1990-9#1)(1991-5#1)(1991-9#1)(1993-8#3)(1995-3#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
and kinetics of##8##3##(1990-2#1)(1994-5#1)(2008-10#4)(2012-2#1)(2013-1#1)
and kinetics##13##2##(1990-2#1)(1994-5#1)(1995-11#1)(2008-10#5)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and kinetin##2##2##(2008-10#1)(2013-1#1)
and knee flexion##2##3##(2011-2#1)(2013-1#1)
and knee joint##2##3##(1994-8#1)(2011-2#1)
and knee##7##2##(1994-8#1)(1995-5#1)(2009-3#1)(2011-2#2)(2013-1#2)
and knowledge about##4##3##(1997-1#1)(2008-11#1)(2009-7#1)(2011-2#1)
and knowledge of the##4##4##(1992-12#1)(2008-10#2)(2009-9#1)
and knowledge of##14##3##(1992-12#1)(1996-9#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
and knowledge##33##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-2#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)
and known##6##2##(1993-12#2)(1994-11#1)(1995-2#1)(2012-12#1)(2012-3#1)
and kringle##3##2##(1993-8#2)(1995-6#1)
and l-ascorbic acid##2##3##(2008-10#1)(2008-5#1)
and l-cystine##3##2##(2008-10#3)
and l-dopa##7##2##(2008-10#7)
and l-triiodothyronine (l-T(3))##2##3##(2008-10#2)
and labeled simultaneously##2##3##(2008-10#2)
and labeled with##2##3##(1996-2#1)(2008-4#1)
and labeled##5##2##(1990-12#1)(1996-2#1)(2008-10#2)(2008-4#1)
and labeling of##2##3##(2008-10#1)(2008-4#1)
and labeling##7##2##(2008-10#3)(2008-4#4)
and labor##7##2##(1990-5#1)(2008-10#2)(2011-2#1)(2012-3#3)
and laboratory analysis##2##3##(2008-10#1)(2012-2#1)
and laboratory data##2##3##(1991-3#1)(2011-2#1)
and laboratory evaluations##2##3##(2008-1#1)(2010-1#1)
and laboratory investigations were##2##4##(2008-11#1)(2011-2#1)
and laboratory investigations##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
and laboratory variables##3##3##(2011-1#2)(2011-2#1)
and laboratory##31##2##(1991-3#1)(1992-12#1)(1992-9#1)(1994-12#2)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2010-1#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)
and laborious##2##2##(2008-10#2)
and labour##2##2##(1990-11#1)(2007-12#1)
and lack of control##2##4##(1992-3#1)(2013-1#1)
and lack of##26##3##(1991-6#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
and lack##27##2##(1991-6#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-2#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
and lacked a##2##3##(1993-3#1)(1997-7#1)
and lacked##4##2##(1993-3#1)(1997-7#1)(2008-10#2)
and lacking##3##2##(1991-6#1)(1997-1#1)(2008-10#1)
and lacks##2##2##(1990-11#1)(2007-12#1)
and lactate dehydrogenase (LDH)##2##4##(1994-5#1)(2008-10#1)
and lactate##11##2##(1994-5#1)(2008-10#3)(2008-11#5)(2008-7#1)(2011-2#1)
and lactic acid##4##3##(2008-10#3)(2008-7#1)
and lactoferrin##2##2##(2008-10#2)
and lactose##6##2##(1990-2#2)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
and lag phase##2##3##(2011-2#2)
and lag##4##2##(2008-10#1)(2008-7#1)(2011-2#2)
and lag-2##2##2##(1994-12#2)
and lake water##4##3##(2008-10#4)
and lamb##2##2##(1991-12#1)(1997-2#1)
and lambda##5##2##(1995-6#1)(2008-10#2)(2008-8#1)(2009-3#1)
and lamellar##2##2##(2008-5#1)(2009-7#1)
and laminar##2##2##(1992-9#1)(2008-9#1)
and laminarinase##3##2##(2008-10#3)
and land##2##2##(1992-1#1)(2008-10#1)
and language development##2##3##(2008-11#1)(2008-9#1)
and language skills of##3##4##(2008-9#3)
and language##17##2##(1995-5#1)(2008-11#4)(2008-12#1)(2008-9#5)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
and lansoprazole##5##2##(2012-2#5)
and lanthanides##5##2##(2008-10#5)
and lanthanum##4##2##(2008-10#4)
and laparoscopic##4##2##(1993-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
and large amounts of##2##4##(1992-8#1)(2008-10#1)
and large numbers of##2##4##(1997-1#1)(2008-10#1)
and large##43##2##(1990-11#2)(1990-5#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#12)(2008-11#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#3)
and large-scale##6##2##(2008-11#3)(2008-9#1)(2009-6#1)(2012-2#1)
and large-volume##2##2##(2008-10#2)
and largely##4##2##(1996-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
and larger##8##2##(1990-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)
and larvae and##2##3##(2008-8#2)
and larvae##3##2##(2008-10#1)(2008-8#2)
and larval##3##2##(2008-9#1)(2010-8#1)(2012-3#1)
and laryngeal##4##2##(1990-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
and laser ablation##2##3##(2008-10#2)
and laser in##2##3##(1993-6#2)
and laser##19##2##(1991-9#1)(1993-12#1)(1993-6#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
and laser-induced##2##2##(2008-3#1)(2008-8#1)
and last##6##2##(1991-3#1)(1992-3#1)(1997-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
and lasted more than##2##4##(2008-9#2)
and lasted##5##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-9#2)
and lasting##6##2##(1992-9#1)(2011-2#4)(2013-1#1)
and lastly##3##2##(1990-8#1)(2008-10#1)(2011-10#1)
and late colonizers##2##3##(2008-5#2)
and late in##2##3##(2008-10#2)
and late phases##2##3##(2010-12#2)
and late season##2##3##(2008-10#2)
and late##36##2##(1993-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#3)(2008-9#1)(2010-12#2)(2010-8#1)(2013-1#1)(2013-8#2)
and late-season##2##2##(2008-10#1)(2011-2#1)
and late-stage myxomatous mitral valves from dogs##2##7##(2010-12#2)
and late-stage##3##2##(2010-12#3)
and latency in##2##3##(2008-10#2)
and latent period##3##3##(2008-10#3)
and latent##5##2##(1995-8#2)(2008-10#3)
and later also in##2##4##(2011-3#1)(2012-2#1)
and later appeared##2##3##(2008-10#1)(2008-7#1)
and later##24##2##(1997-7#1)(2008-10#9)(2008-11#3)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#4)
and lateral regions of##2##4##(1990-9#1)(1996-12#1)
and lateral##22##2##(1990-9#1)(1993-11#1)(1993-3#2)(1996-12#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
and law##2##2##(1991-2#1)(2008-1#1)
and layered##3##2##(2007-12#2)(2010-4#1)
and lead in marine sediment##2##5##(2008-10#2)
and lead in seawater##3##4##(2008-10#3)
and lead in##23##3##(2008-10#23)
and lead is##2##3##(2008-10#2)
and lead to a##3##4##(2008-10#2)(2008-7#1)
and lead to the##2##4##(2008-10#1)(2008-7#1)
and lead to##11##3##(1994-11#1)(1994-9#1)(1995-8#1)(1996-11#1)(2008-10#4)(2008-7#2)(2010-12#1)
and lead##62##2##(1993-3#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-11#1)(2008-10#52)(2008-11#2)(2008-7#2)(2010-12#1)
and lead(II) in##3##3##(2008-10#3)
and lead(II)##10##2##(2008-10#10)
and leadership in##2##3##(1994-2#2)
and leadership##7##2##(1991-2#1)(1992-2#1)(1994-2#2)(1996-1#2)(2008-10#1)
and leads to##13##3##(1991-3#1)(1995-8#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-12#1)(2010-4#2)(2013-1#1)
and leaf age on infection and lesion development of pecan scab##2##11##(2008-10#2)
and leaf age##5##3##(2008-10#5)
and leaf blight##4##3##(2008-10#4)
and leaf distortion##2##3##(2008-10#2)
and leaf rust##4##3##(2008-10#4)
and leaf spot development##2##4##(2008-10#2)
and leaf spot##5##3##(2008-10#5)
and leaf wetness duration##7##4##(2008-10#7)
and leaf wetness##10##3##(2008-10#10)
and leaf##47##2##(2008-10#44)(2008-8#2)(2012-6#1)
and leafhopper##2##2##(2008-10#2)
and lean mass##2##3##(2008-10#1)(2008-11#1)
and lean##5##2##(1996-12#3)(2008-10#1)(2008-11#1)
and learn##5##2##(1993-2#1)(2008-11#2)(2009-8#1)(2013-1#1)
and learners##2##2##(2008-11#1)(2011-2#1)
and learning and memory##2##4##(1993-12#1)(2012-2#1)
and learning disabilities##2##3##(2008-11#1)(2012-3#1)
and learning in##2##3##(1993-12#1)(1996-1#1)
and learning resources##2##3##(1996-2#1)(2008-12#1)
and learning##51##2##(1993-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#29)(2008-12#8)(2008-7#2)(2008-9#1)(2009-1#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
and least amount of eluent for elution of##3##8##(2008-10#3)
and least amount of eluent for##4##6##(2008-10#4)
and least amount of eluent##5##5##(2008-10#5)
and least amount of##7##4##(2008-10#7)
and least##13##2##(2008-10#11)(2008-8#1)(2009-11#1)
and leaves##20##2##(2008-10#10)(2008-11#1)(2008-12#4)(2008-8#1)(2012-2#1)(2012-7#1)(2013-8#2)
and leaving behind##2##3##(1997-7#1)(2008-12#1)
and leaving##3##2##(1997-7#1)(2008-12#1)(2011-2#1)
and lecturers##3##2##(2008-11#3)
and led to a##5##4##(1992-2#1)(1992-8#1)(1993-8#1)(2008-10#1)(2008-5#1)
and led to the##3##4##(2008-10#1)(2010-8#1)(2011-2#1)
and led to##11##3##(1992-2#1)(1992-8#1)(1993-8#1)(2008-10#3)(2008-5#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
and led##12##2##(1992-2#1)(1992-8#1)(1993-8#1)(2008-10#3)(2008-5#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-3#1)
and leek##3##2##(2008-10#3)
and left parietotemporal##2##3##(1995-2#2)
and left ventricular hypertrophy in patients with##2##7##(2008-12#1)(2012-12#1)
and left ventricular##7##3##(1995-11#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and left##33##2##(1990-3#1)(1990-8#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-2#2)(1996-2#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
and left-sided##2##2##(2008-12#1)(2011-2#1)
and leg##8##2##(2008-1#1)(2010-9#2)(2012-3#3)(2013-1#2)
and legal issues##5##3##(2008-11#4)(2008-12#1)
and legal##18##2##(1996-2#1)(1997-2#1)(2008-11#7)(2008-12#2)(2009-11#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
and leisure##3##2##(1996-11#1)(2012-12#2)
and lemma##3##2##(2008-8#1)(2008-9#2)
and length of hospital stay##3##5##(1991-12#2)(2011-2#1)
and length of stays are##2##5##(2010-8#2)
and length of the##6##4##(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
and length of##19##3##(1990-5#1)(1991-12#3)(1992-2#1)(1996-1#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
and length##26##2##(1990-5#1)(1991-12#3)(1992-2#2)(1996-1#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and lepidopteran##2##2##(2008-10#2)
and leptin##6##2##(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
and leptomeningeal##2##2##(2012-3#2)
and lesbian##3##2##(1995-6#1)(2008-12#2)
and lesbians##2##2##(1996-5#1)(2008-12#1)
and lesion development##3##3##(2008-10#3)
and lesion size##4##3##(2008-10#4)
and lesion##10##2##(1997-8#1)(2008-10#9)
and lesions##3##2##(1991-6#1)(1996-11#1)(2008-10#1)
and less frequently##5##3##(2008-10#1)(2008-4#1)(2011-2#2)(2012-2#1)
and less low##2##3##(1993-11#1)(2013-8#1)
and less than 1%##3##4##(2008-10#2)(2008-8#1)
and less than##8##3##(1991-2#1)(1997-3#1)(2008-10#4)(2008-8#1)(2012-2#1)
and less variability##2##3##(2008-10#2)
and less##65##2##(1991-2#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-2#2)(1995-12#1)(1997-3#1)(2008-10#14)(2008-11#1)(2008-12#5)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-2#3)(2012-3#3)(2012-5#1)(2012-9#1)(2013-8#4)
and lessons learned##2##3##(2008-11#1)(2008-8#1)
and lessons##3##2##(1996-2#1)(2008-11#1)(2008-8#1)
and lethality##4##2##(1996-12#2)(1997-8#1)(2011-2#1)
and letters##2##2##(1992-2#1)(1992-8#1)
and lettuce##5##2##(2008-10#5)
and leucine##3##2##(1991-12#1)(1997-8#1)(2008-12#1)
and leucocytosis##2##2##(1997-8#1)(2008-12#1)
and leukemia##3##2##(1995-11#1)(2010-8#1)(2011-2#1)
and leukemic##2##2##(2011-2#1)(2013-1#1)
and leukocyte##3##2##(1995-2#1)(2006-6#2)
and level of##16##3##(1991-3#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
and level##17##2##(1991-3#1)(1993-6#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
and levels in maize silage##2##5##(2008-10#2)
and levels of resistance##2##4##(2008-10#2)
and levels of##17##3##(1991-11#1)(1992-12#1)(1993-3#1)(1995-11#1)(1997-3#1)(2008-10#7)(2008-12#1)(2008-5#1)(2011-2#2)(2012-3#1)
and levels##21##2##(1991-11#1)(1992-12#1)(1993-3#1)(1994-1#1)(1995-11#1)(1997-3#1)(2008-10#10)(2008-12#1)(2008-5#1)(2011-2#2)(2012-3#1)
and leveraging##2##2##(2008-9#1)(2013-1#1)
and levo-norgestrel##2##2##(2008-10#2)
and levofloxacin##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)
and liability##3##2##(1992-3#1)(1994-1#1)(1994-2#1)
and lichen##3##2##(2009-6#1)(2011-2#2)
and lidocaine##3##2##(1993-1#1)(2008-10#2)
and life cycles##2##3##(2008-10#1)(2008-9#1)
and life events##2##3##(2008-11#1)(2009-12#1)
and life history##2##3##(2008-8#1)(2009-6#1)
and life table##2##3##(1991-3#1)(2008-12#1)
and life threatening##2##3##(2011-2#1)(2012-3#1)
and life##28##2##(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
and life-history traits##2##3##(2008-8#1)(2008-9#1)
and life-history##5##2##(2008-8#4)(2008-9#1)
and life-threatening##5##2##(1995-12#1)(1996-12#1)(2010-1#1)(2011-2#1)(2012-2#1)
and lifestyle##7##2##(1996-8#1)(2008-3#1)(2009-5#1)(2011-2#3)(2012-3#1)
and lifetime of the##5##4##(2008-10#5)
and lifetime of##7##3##(2008-10#6)(2008-9#1)
and lifetime##14##2##(2008-10#10)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)
and ligaments##2##2##(2008-10#1)(2013-1#1)
and ligand##7##2##(1994-11#1)(1997-7#1)(2008-10#3)(2008-12#1)(2009-10#1)
and light##25##2##(1994-11#1)(1994-5#2)(1997-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
and like##2##2##(1995-11#1)(2012-3#1)
and likely to##2##3##(2008-10#1)(2010-11#1)
and likely##10##2##(1992-8#1)(1994-5#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#1)
and limbs##4##2##(2008-5#1)(2012-12#3)
and limit of detection (LOD)##2##5##(2008-10#2)
and limit of detection for##2##5##(2008-10#2)
and limit of detection of the##3##6##(2008-10#3)
and limit of detection of##6##5##(2008-10#6)
and limit of detection##14##4##(2008-10#14)
and limit of detection)##2##4##(2008-10#2)
and limit of##20##3##(2008-10#19)(2012-2#1)
and limit the##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
and limit##24##2##(2008-10#19)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
and limitations are discussed##2##4##(1997-1#1)(2008-10#1)
and limitations are##4##3##(1997-1#1)(2008-10#2)(2008-3#1)
and limitations of each##2##4##(2008-10#1)(2008-4#1)
and limitations of the various##2##5##(2008-10#1)(2008-9#1)
and limitations of the##8##4##(2008-10#4)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
and limitations of these##2##4##(2008-11#1)(2012-3#1)
and limitations of this##2##4##(1993-1#1)(2008-8#1)
and limitations of##25##3##(1993-1#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#3)(2008-8#2)(2008-9#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
and limitations with##2##3##(2008-10#1)(2011-2#1)
and limitations##45##2##(1992-3#2)(1993-1#1)(1994-1#1)(1997-1#1)(1997-3#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#4)(2008-8#2)(2008-9#2)(2009-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2011-7#2)(2012-2#2)(2012-3#2)(2013-1#1)
and limited to##2##3##(2008-7#1)(2013-1#1)
and limited##24##2##(1992-11#1)(1993-11#1)(1996-12#1)(1996-3#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#2)
and limiting##2##2##(2008-11#1)(2008-7#1)
and limits of detection of##2##5##(2008-10#2)
and limits of detection##9##4##(2008-10#9)
and limits of quantification##2##4##(2008-10#2)
and limits of##13##3##(2008-10#12)(2012-2#1)
and limits##16##2##(1992-11#1)(1997-4#1)(2008-10#13)(2012-2#1)
and linalool##3##2##(2008-10#3)
and line##2##2##(1997-2#1)(2008-10#1)
and lineages##2##2##(2008-10#1)(2008-8#1)
and linear calibration##2##3##(2008-10#2)
and linear discriminant analysis##2##4##(2008-10#2)
and linear range##2##3##(2008-10#2)
and linear ranges of##3##4##(2008-10#2)(2008-4#1)
and linear ranges##4##3##(2008-10#3)(2008-4#1)
and linear regression##2##3##(1993-12#1)(2008-10#1)
and linear response##2##3##(2008-10#2)
and linear##28##2##(1990-5#1)(1993-12#1)(2008-10#21)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#1)
and linearity of##2##3##(1996-2#1)(2008-10#1)
and linearity were##2##3##(2008-10#2)
and linearity##8##2##(1996-2#1)(2008-10#7)
and linguistic##4##2##(1997-2#1)(2008-11#1)(2013-1#2)
and linguistics##2##2##(2008-9#1)(2013-1#1)
and link##3##2##(1997-3#1)(2008-11#2)
and linkage disequilibrium in##2##4##(2012-2#1)(2012-3#1)
and linkage disequilibrium##5##3##(1995-6#1)(2008-10#2)(2012-2#1)(2012-3#1)
and linkage##6##2##(1995-6#1)(2008-10#3)(2012-2#1)(2012-3#1)
and linked to##2##3##(1992-12#1)(2008-10#1)
and linking##6##2##(1994-9#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)
and lipid hydroperoxides##2##3##(2008-10#1)(2009-8#1)
and lipid metabolism##3##3##(1994-12#1)(2008-7#1)(2012-2#1)
and lipid peroxidation##8##3##(1993-8#1)(1994-8#1)(1996-2#2)(2008-10#2)(2008-12#1)(2008-5#1)
and lipid##40##2##(1991-12#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-2#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
and lipids##13##2##(1990-2#1)(1992-9#1)(1993-2#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#2)(2012-12#1)
and lipofuscin##2##2##(1992-12#1)(2008-7#1)
and lipophilic anions##2##3##(2008-10#2)
and lipophilic##4##2##(2008-10#4)
and lipoprotein lipase##2##3##(1995-6#1)(1996-11#1)
and lipoprotein metabolism##3##3##(2008-11#1)(2008-6#2)
and lipoprotein##10##2##(1992-2#1)(1995-2#1)(1995-6#1)(1996-11#1)(2008-11#1)(2008-3#1)(2008-6#3)(2012-2#1)
and liposomal##2##2##(2008-5#1)(2013-1#1)
and liposome##2##2##(2008-10#1)(2008-9#1)
and liposome-loaded##2##2##(1993-8#2)
and liposomes##2##2##(1990-2#1)(1994-5#1)
and liquid chromatography##7##3##(2008-10#6)(2011-2#1)
and liquid media##2##3##(2008-10#2)
and liquid sampling##2##3##(2008-10#2)
and liquid##25##2##(1991-9#1)(1995-3#1)(1995-6#1)(2008-10#20)(2008-8#1)(2011-2#1)
and liquid-liquid extraction##2##3##(2008-10#1)(2011-3#1)
and liquid-liquid##4##2##(2008-10#2)(2009-8#1)(2011-3#1)
and liquids##2##2##(2008-3#2)
and literature review##18##3##(2008-10#1)(2008-12#6)(2008-9#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
and literature review]##2##3##(1993-8#1)(2011-2#1)
and literature##25##2##(1993-8#1)(2008-10#2)(2008-12#6)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#5)(2011-3#1)(2012-3#1)(2013-1#4)(2013-8#2)
and lithium##2##2##(1996-5#1)(2008-10#1)
and litter##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
and little evidence##2##3##(2008-5#1)(2009-7#1)
and little##12##2##(1993-8#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-5#1)(2012-3#1)
and live##5##2##(1996-1#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
and liver cancer in##2##4##(2010-1#1)(2011-2#1)
and liver cirrhosis##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
and liver disease##2##3##(1991-8#1)(2009-8#1)
and liver of the##2##4##(1995-9#1)(2008-12#1)
and liver of##3##3##(1995-9#1)(2008-12#1)(2008-5#1)
and liver tissues##2##3##(2008-10#1)(2008-11#1)
and liver were##2##3##(2008-5#1)(2012-3#1)
and liver##52##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#2)(1991-8#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-5#3)(1994-8#1)(1995-9#1)(1996-12#2)(1997-1#2)(1997-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-8#3)(2010-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
and lives##2##2##(2008-11#1)(2009-3#1)
and living in##2##3##(1990-2#1)(2008-10#1)
and living##3##2##(1990-2#1)(2008-10#1)(2013-8#1)
and loading##2##2##(2008-10#2)
and lobster##2##2##(2008-10#2)
and local clays##2##3##(2008-10#2)
and local communities##2##3##(1996-2#1)(1996-3#1)
and local environmental##2##3##(2008-8#1)(2010-6#1)
and local health departments##2##4##(1996-1#1)(1997-3#1)
and local health##4##3##(1996-1#1)(1996-3#1)(1997-3#1)(2011-9#1)
and local##46##2##(1991-2#1)(1992-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#4)(1997-2#3)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#3)(2010-3#1)(2010-6#1)(2011-2#1)(2011-9#4)(2012-3#1)(2013-1#1)(2013-8#2)
and localization of##7##3##(1990-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-8#1)(2013-1#1)
and localization to##2##3##(1992-10#1)(2008-10#1)
and localization##14##2##(1990-3#1)(1992-10#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
and localize##2##2##(1990-11#1)(1991-6#1)
and localized##9##2##(1990-9#1)(1992-10#1)(1996-12#1)(2008-10#3)(2008-9#1)(2010-5#1)(2012-2#1)
and locally##4##2##(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#1)
and located on the##2##4##(2008-8#1)(2010-12#1)
and located##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)
and location in##2##3##(1995-12#1)(2011-2#1)
and location of##11##3##(1993-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#2)(2011-2#1)
and location##20##2##(1993-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#3)(2011-2#2)(2013-1#1)
and locations of##2##3##(2008-10#1)(2008-3#1)
and locations##5##2##(1995-1#1)(2008-10#3)(2008-3#1)
and loci##2##2##(2008-8#1)(2012-3#1)
and locomotion##3##2##(1991-2#1)(2008-11#1)(2008-9#1)
and locomotory##2##2##(1991-2#1)(2008-8#1)
and log##4##2##(2008-10#3)(2009-11#1)
and logarithm of##2##3##(2008-10#2)
and logistic regression##5##3##(2008-10#2)(2008-8#1)(2011-2#1)(2013-8#1)
and logistic##8##2##(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
and long term##8##3##(1993-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-3#1)(2013-1#2)
and long##21##2##(1993-1#1)(1994-1#1)(1995-6#1)(1996-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#3)
and long-distance movement of##2##4##(2008-10#2)
and long-distance##3##2##(2008-10#2)(2012-2#1)
and long-lasting##2##2##(1991-2#1)(2008-5#1)
and long-range##2##2##(2008-10#1)(2012-2#1)
and long-term care##5##3##(1991-1#1)(1991-3#2)(1997-3#1)(2009-4#1)
and long-term factors##2##3##(2008-1#2)
and long-term follow-up##3##3##(1991-2#1)(2008-11#1)(2008-7#1)
and long-term maintenance of##2##4##(2008-10#1)(2008-8#1)
and long-term outcomes##2##3##(2011-2#1)(2013-1#1)
and long-term results of##3##4##(1991-6#1)(2012-3#2)
and long-term results##4##3##(1991-6#2)(2012-3#2)
and long-term stability of##2##4##(2008-10#1)(2008-11#1)
and long-term stability##5##3##(2008-10#4)(2008-11#1)
and long-term treatment of##2##4##(2010-8#1)(2012-3#1)
and long-term##71##2##(1991-1#1)(1991-2#2)(1991-3#2)(1991-6#3)(1993-12#2)(1995-2#2)(1995-8#1)(1996-1#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#3)
and longer latent period in a##2##6##(2008-10#2)
and longer##12##2##(1991-1#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-8#1)(2012-3#1)(2013-8#1)
and longer-term##2##2##(1996-1#1)(2008-11#1)
and longevity##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-7#1)
and longitudinal##5##2##(1995-2#1)(2008-10#1)(2010-10#1)(2010-12#1)(2013-1#1)
and longitudinally##3##2##(2008-7#1)(2009-10#1)(2013-1#1)
and loop##3##2##(2008-8#1)(2011-3#1)(2013-8#1)
and loose##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
and lose##2##2##(2008-8#1)(2011-2#1)
and loss of the##4##4##(1993-8#1)(2008-5#2)(2011-2#1)
and loss of##20##3##(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-5#2)(2008-9#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-2#2)
and loss##25##2##(1993-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-2#2)
and losses##4##2##(1993-12#1)(2009-10#2)(2009-6#1)
and love##2##2##(2012-12#1)(2012-3#1)
and low affinity for##2##4##(1995-2#1)(1995-6#1)
and low affinity##5##3##(1990-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(2009-12#1)
and low anterior##2##3##(1990-9#1)(2008-12#1)
and low back pain##3##4##(1997-4#1)(2009-4#2)
and low back##5##3##(1997-4#1)(2008-12#2)(2009-4#2)
and low birth weight##6##4##(1991-12#2)(1994-3#1)(2008-10#1)(2013-1#2)
and low birth##7##3##(1991-12#2)(1994-3#1)(2008-10#1)(2012-3#1)(2013-1#2)
and low capacity##3##3##(1993-1#2)(1995-12#1)
and low cell##2##3##(1993-8#1)(2008-11#1)
and low cost##10##3##(2008-10#9)(2011-2#1)
and low density lipoprotein##3##4##(1991-11#1)(2008-7#1)(2008-8#1)
and low density##5##3##(1991-11#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
and low detection limit##2##4##(2008-10#2)
and low detection##4##3##(2008-10#4)
and low in polar lipids##2##5##(2008-11#2)
and low in##3##3##(2008-11#2)(2009-7#1)
and low ionic##2##3##(1990-11#1)(2008-7#1)
and low levels of##3##4##(1991-12#1)(2008-9#1)(2010-5#1)
and low limits of detection##2##5##(2008-10#2)
and low risk##2##3##(1994-3#1)(2012-3#1)
and low values of##2##4##(2008-10#2)
and low values##3##3##(2008-10#3)
and low##145##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#3)(1993-1#3)(1993-11#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-8#1)(2008-10#48)(2008-11#8)(2008-12#9)(2008-3#2)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#2)(2009-7#2)(2010-1#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#6)(2013-8#2)
and low-cost method for the##2##5##(2008-10#2)
and low-cost##9##2##(2008-10#9)
and low-density lipoprotein##2##3##(2008-10#1)(2008-12#1)
and low-income countries##2##3##(2008-8#1)(2012-2#1)
and lower body##2##3##(2010-1#1)(2012-2#1)
and lower costs##2##3##(2008-11#1)(2011-2#1)
and lower detection limits were##2##5##(2008-10#2)
and lower detection limits##5##4##(2008-10#5)
and lower extremity##4##3##(2008-12#1)(2012-3#1)(2013-1#2)
and lower for##2##3##(2008-10#1)(2011-7#1)
and lower levels of##3##4##(1991-1#1)(2009-7#1)(2011-2#1)
and lower parts##5##3##(2008-10#2)(2008-12#1)(2013-1#2)
and lower recovery##2##3##(2008-10#2)
and lower than##2##3##(2008-10#2)
and lower trapezius##2##3##(2010-9#2)
and lower##74##2##(1991-1#1)(1991-2#1)(1991-3#1)(1993-3#1)(1993-8#1)(2008-1#2)(2008-10#22)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#2)(2009-7#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-9#3)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
and lower-extremity##2##2##(2012-3#1)(2013-1#1)
and lowering of glucose-stimulated##2##4##(2008-11#2)
and lowest in the##2##4##(1996-12#1)(2008-10#1)
and lowest in##9##3##(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#3)(2009-7#2)(2013-8#1)
and lowest##17##2##(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-7#1)(2009-11#1)(2009-7#2)(2012-3#1)(2013-8#1)
and lumbar curvature##3##3##(2013-1#3)
and lumbar##11##2##(2008-7#1)(2008-8#5)(2011-2#2)(2013-1#3)
and luminance##2##2##(2008-3#1)(2008-8#1)
and luminescent##2##2##(2008-11#1)(2012-2#1)
and luminol##4##2##(2008-10#4)
and lung cancer in##2##4##(2008-8#1)(2013-1#1)
and lung cancer##10##3##(1991-12#1)(1991-2#1)(1996-3#2)(2008-8#1)(2009-12#1)(2013-1#4)
and lung##29##2##(1990-12#1)(1991-12#3)(1991-2#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-3#2)(1997-2#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
and lungs of##2##3##(1993-8#1)(2008-7#1)
and lungs##10##2##(1993-12#1)(1993-8#2)(1996-2#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2013-1#1)
and luteinizing hormone##2##3##(2008-8#1)(2011-1#1)
and luteolin##3##2##(2008-10#1)(2008-11#2)
and lymph node metastases##2##4##(1990-6#1)(2012-3#1)
and lymph node##7##3##(1990-6#2)(1995-1#1)(1996-9#1)(2008-5#1)(2010-6#1)(2012-3#1)
and lymph nodes##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
and lymph##10##2##(1990-6#2)(1995-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2010-6#1)(2012-3#1)
and lymphatic##4##2##(1990-9#1)(2008-9#2)(2010-7#1)
and lymphocyte##4##2##(1993-1#1)(1995-12#1)(1995-2#1)(2008-11#1)
and lymphocytes##7##2##(1991-2#1)(1991-5#1)(2008-11#2)(2008-5#1)(2009-12#1)(2010-6#1)
and lymphoid##7##2##(1997-1#1)(1997-7#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-1#1)
and lymphoma among young##2##4##(1990-3#1)(1991-3#1)
and lymphoma##10##2##(1990-3#1)(1991-3#1)(1992-3#3)(1994-5#1)(1996-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
and lyophilised##2##2##(2008-10#2)
and lysine##7##2##(1996-2#1)(2008-10#4)(2008-12#1)(2013-8#1)
and lysozyme##3##2##(1997-8#1)(2008-7#1)(2011-2#1)
and m##7##2##(2008-10#5)(2008-8#1)(2008-9#1)
and mAb##2##2##(2008-10#1)(2011-2#1)
and mGluR5##2##2##(1996-12#2)
and mRNA expression of##2##4##(2011-2#1)(2013-1#1)
and mRNA expression##3##3##(1994-11#1)(2011-2#1)(2013-1#1)
and mRNA in the##2##4##(1994-2#1)(1995-2#1)
and mRNA in##3##3##(1994-2#1)(1995-2#1)(2008-8#1)
and mRNA level##3##3##(1995-11#1)(1995-2#1)(2008-11#1)
and mRNA levels##3##3##(1993-3#1)(1995-6#1)(2010-1#1)
and mRNA##17##2##(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#5)(1995-6#2)(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
and mRNAs##2##2##(2008-10#1)(2009-6#1)
and machine##4##2##(2010-12#1)(2010-8#1)(2011-2#2)
and macrophage##4##2##(1991-5#1)(1995-3#1)(2008-10#2)
and macrophages##7##2##(1993-6#1)(1997-8#2)(2007-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
and macroscopic##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
and macular##5##2##(2008-10#1)(2011-2#2)(2013-1#2)
and made a##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
and made##12##2##(1994-2#1)(2008-10#5)(2008-11#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
and magnesium nitrate##2##3##(2008-10#2)
and magnesium were used as##2##5##(2008-10#2)
and magnesium were##3##3##(2008-10#3)
and magnesium##32##2##(1991-5#2)(1991-9#1)(1997-8#1)(2008-10#26)(2008-5#1)(2013-1#1)
and magnetic resonance angiography##2##4##(2008-12#1)(2008-7#1)
and magnetic resonance imaging in##2##5##(1990-12#1)(2012-12#1)
and magnetic resonance imaging##20##4##(1990-12#2)(2008-11#1)(2008-2#1)(2008-7#4)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-7#1)
and magnetic resonance##24##3##(1990-12#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#5)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#1)(2013-7#1)
and magnetic##28##2##(1990-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#5)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#1)(2013-7#1)
and magnitude of the##3##4##(2008-10#2)(2008-8#1)
and magnitude of##7##3##(1992-2#1)(1996-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-11#1)
and magnitudes of##2##3##(2008-10#1)(2010-3#1)
and magnolol##6##2##(2008-10#6)
and main##6##2##(1991-2#1)(2008-11#2)(2010-1#1)(2010-8#1)(2013-8#1)
and mainly##6##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)
and maintain a##2##3##(1990-5#1)(2008-8#1)
and maintain##12##2##(1990-5#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-9#1)(2012-2#1)(2013-1#1)
and maintained at##2##3##(2008-10#1)(2008-5#1)
and maintained for##2##3##(2008-8#1)(2008-9#1)
and maintained using##2##3##(2011-2#1)(2012-3#1)
and maintained with##4##3##(1996-6#1)(2010-7#3)
and maintained##23##2##(1993-12#1)(1993-6#1)(1996-6#1)(2008-10#2)(2008-11#6)(2008-5#1)(2008-8#2)(2008-9#2)(2010-4#1)(2010-7#3)(2011-2#1)(2012-3#2)
and maintaining a##2##3##(2011-2#1)(2012-6#1)
and maintaining the##3##3##(1992-1#1)(1994-12#1)(2008-8#1)
and maintaining##15##2##(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-6#1)
and maintains##3##2##(2008-8#1)(2010-12#1)(2010-8#1)
and maintenance are##2##3##(2008-7#1)(2009-8#1)
and maintenance of the##4##4##(1990-8#1)(1993-3#1)(2008-10#1)(2008-11#1)
and maintenance of##23##3##(1990-8#1)(1992-1#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#4)(2008-7#2)(2009-11#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and maintenance therapy with##2##4##(2011-2#1)(2011-3#1)
and maintenance##38##2##(1990-8#1)(1991-1#1)(1992-1#1)(1993-3#1)(1993-8#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#6)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and maize##14##2##(2008-10#7)(2008-8#2)(2008-9#2)(2009-10#3)
and major depression##4##3##(2011-2#4)
and major##17##2##(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2011-2#5)(2013-8#2)
and make recommendations##2##3##(2008-10#1)(2009-3#1)
and make##14##2##(1991-1#1)(1993-3#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-3#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
and makes recommendations for##3##4##(2008-11#1)(2012-12#1)(2012-2#1)
and makes##13##2##(1993-2#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#1)
and making death happen##3##4##(1991-2#3)
and making##8##2##(1991-2#3)(1993-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
and malachite green##3##3##(2008-10#1)(2010-5#2)
and malaria##3##2##(2010-1#2)(2012-2#1)
and malate##2##2##(2008-10#2)
and male fertility##6##3##(2008-8#1)(2009-10#2)(2012-2#3)
and male sexuals)##2##3##(2008-8#2)
and male##30##2##(1990-11#1)(1990-3#2)(1990-6#1)(1992-3#1)(1992-8#3)(1994-2#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-10#2)(2010-4#1)(2010-8#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
and males##9##2##(2008-5#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
and malignancies##2##2##(2011-2#1)(2011-3#1)
and malignancy##5##2##(1990-2#1)(2008-11#1)(2009-12#1)(2011-1#1)(2013-8#1)
and malignant disease##2##3##(1990-9#1)(2011-2#1)
and malignant glioma##2##3##(2008-8#2)
and malignant transformation##2##3##(2008-7#1)(2011-2#1)
and malignant##29##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-3#1)(1993-11#3)(1994-3#1)(1995-3#2)(1997-4#1)(1997-8#1)(2008-11#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
and malnutrition##5##2##(1993-12#1)(1993-9#1)(2008-11#1)(2010-9#1)(2012-2#1)
and malondialdehyde##2##2##(2008-7#1)(2009-8#1)
and malonic acid##2##3##(2008-10#2)
and malonic##4##2##(2008-10#4)
and mammalian cells##7##3##(1997-3#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
and mammalian target of rapamycin (mTOR)##2##6##(2008-7#1)(2013-1#1)
and mammalian##16##2##(1991-6#1)(1994-11#1)(1997-3#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2011-2#2)(2013-1#1)
and mammals##7##2##(1995-11#1)(2008-7#1)(2008-8#2)(2008-9#3)
and mammary gland are##2##4##(2012-2#2)
and mammary gland##4##3##(2008-9#1)(2012-2#3)
and mammary##7##2##(1992-9#1)(1995-12#1)(2008-11#1)(2008-9#1)(2012-2#3)
and man##2##2##(1994-11#1)(1997-7#1)
and manage the##4##3##(1996-3#1)(2008-11#1)(2011-2#1)(2013-7#1)
and manage##11##2##(1994-1#2)(1996-3#1)(2008-11#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and manageable##2##2##(2008-1#1)(2008-6#1)
and managed care organizations##2##4##(1995-2#1)(1996-1#1)
and managed care##7##3##(1991-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)
and managed##10##2##(1991-2#1)(1991-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
and management are##2##3##(2008-7#1)(2013-1#1)
and management development##2##3##(1992-1#1)(1994-1#1)
and management of a##5##4##(1991-12#1)(2008-11#1)(2008-12#2)(2008-6#1)
and management of patients with##3##5##(2008-4#1)(2011-2#1)(2013-1#1)
and management of this##2##4##(2008-12#1)(2011-2#1)
and management of##68##3##(1991-12#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-5#1)(2006-5#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-1#1)(2009-10#4)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#4)(2010-4#1)(2010-5#1)(2011-2#7)(2011-7#5)(2012-3#2)(2013-1#4)(2013-8#1)
and management strategies##2##3##(2008-11#1)(2010-7#1)
and management##151##2##(1990-9#1)(1991-12#1)(1991-3#3)(1992-1#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#2)(1995-10#1)(1995-12#1)(1996-1#2)(1996-3#2)(1997-2#2)(1997-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#11)(2008-12#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#4)(2009-12#3)(2009-4#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#4)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#14)(2011-7#5)(2012-2#2)(2012-3#6)(2013-1#9)(2013-8#1)
and managerial##3##2##(1994-12#2)(1994-3#1)
and managers in their##2##4##(1996-3#1)(1997-4#1)
and managers in##3##3##(1995-1#1)(1996-3#1)(1997-4#1)
and managers of##2##3##(1993-12#1)(1994-3#1)
and managers##15##2##(1992-2#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-1#1)(1996-2#2)(1996-3#1)(1997-1#3)(1997-4#1)(2008-11#1)(2010-8#1)
and managing##14##2##(1992-3#1)(1994-3#2)(1997-8#5)(2008-10#2)(2008-11#2)(2009-10#1)(2011-2#1)
and mandibular##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
and manganese determination##2##3##(2008-10#2)
and manganese in##6##3##(2008-10#6)
and manganese peroxidase##2##3##(2008-6#2)
and manganese##24##2##(2008-10#21)(2008-6#2)(2011-2#1)
and mango##4##2##(2008-10#4)
and manipulate the##2##3##(2008-10#1)(2008-4#1)
and manipulate##4##2##(2008-10#1)(2008-4#1)(2009-12#1)(2010-7#1)
and manipulated##2##2##(2009-12#1)(2010-9#1)
and manipulating##2##2##(2008-11#1)(2009-10#1)
and manipulation of##3##3##(2009-10#1)(2010-7#1)(2011-2#1)
and manipulation##4##2##(2008-12#1)(2009-10#1)(2010-7#1)(2011-2#1)
and mannitol in the##2##4##(2008-10#1)(2012-7#1)
and mannitol##4##2##(1993-8#1)(2008-10#2)(2012-7#1)
and manual##6##2##(2008-10#3)(2008-12#2)(2008-9#1)
and manufacturing process##2##3##(2008-10#1)(2008-11#1)
and manufacturing##3##2##(2008-10#2)(2008-11#1)
and many countries##2##3##(2008-10#2)
and many of the##2##4##(1997-1#1)(2008-8#1)
and many of them##2##4##(2008-10#1)(2009-10#1)
and many of these##2##4##(2008-10#1)(2010-11#1)
and many of##7##3##(1997-1#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)
and many other factors##2##4##(1991-12#1)(1996-3#1)
and many other##7##3##(1991-12#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-9#2)(2013-7#1)
and many others##2##3##(1991-3#1)(2009-4#1)
and many were##2##3##(1991-2#1)(2010-1#1)
and many##49##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-12#1)(1994-8#2)(1995-2#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and map##2##2##(1993-3#1)(2008-10#1)
and mapped##8##2##(1995-6#1)(1996-6#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-8#1)(2012-2#1)(2012-3#1)
and mapping of the##2##4##(1997-9#1)(2008-10#1)
and mapping of##7##3##(1996-6#1)(1997-9#2)(2008-10#2)(2008-8#1)(2008-9#1)
and mapping##12##2##(1996-6#1)(1997-9#2)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)(2013-8#1)
and maps##4##2##(1991-6#1)(1994-11#2)(2008-11#1)
and marginal##4##2##(1990-9#1)(2008-1#1)(2012-3#1)(2013-1#1)
and marginally##2##2##(1994-3#1)(2008-8#1)
and marijuana use##2##3##(2013-8#2)
and marijuana##4##2##(1991-4#1)(2012-12#1)(2013-8#2)
and marine##6##2##(2008-10#3)(2008-11#2)(2008-9#1)
and marital##4##2##(1991-6#1)(2011-2#2)(2012-2#1)
and marked##7##2##(1992-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
and marker##3##2##(2008-9#1)(2011-2#2)
and marker-assisted selection##2##3##(2008-10#1)(2012-3#1)
and markers of##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
and markers##7##2##(2008-10#4)(2008-3#1)(2008-7#1)(2013-1#1)
and market##6##2##(1992-3#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#2)
and marketing##2##2##(1993-2#1)(2008-1#1)
and masking##3##2##(2008-10#3)
and mass spectrometry##10##3##(1992-6#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-8#2)
and mass transfer##3##3##(2008-10#2)(2010-4#1)
and mass##31##2##(1992-6#1)(1993-2#1)(1994-11#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2010-4#1)(2010-7#1)
and massage for##2##3##(2008-10#1)(2013-1#1)
and massage##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
and massive##5##2##(1994-11#1)(2008-12#1)(2010-5#1)(2011-2#1)(2011-3#1)
and mastoid##2##2##(2008-7#1)(2013-7#1)
and mastoparan##5##2##(1994-11#4)(2008-10#1)
and matched##4##2##(1996-12#1)(2008-12#1)(2010-5#1)(2012-2#1)
and mate choice in##3##4##(2008-8#2)(2008-9#1)
and material from##2##3##(2008-10#2)
and material##9##2##(1991-8#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-7#1)(2012-2#1)
and materials##6##2##(1992-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2010-8#1)(2011-2#1)
and maternal depression##2##3##(2009-12#1)(2012-12#1)
and maternal##10##2##(1992-2#1)(1993-3#1)(1994-3#1)(1995-8#1)(2007-12#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2012-12#1)
and mathematical models##2##3##(2008-10#2)
and mathematical##4##2##(2008-10#2)(2008-6#1)(2009-8#1)
and mating success##2##3##(2008-8#1)(2012-3#1)
and mating systems of##2##4##(2012-2#2)
and mating type were##2##4##(2008-10#2)
and mating type##12##3##(2008-10#12)
and mating##23##2##(2008-10#12)(2008-11#1)(2008-12#2)(2008-8#3)(2008-9#2)(2012-2#2)(2012-3#1)
and matric potentials##2##3##(2008-10#2)
and matric##3##2##(2008-10#3)
and matrices##4##2##(1990-2#3)(2008-10#1)
and matrix effects are discussed##3##5##(2008-10#3)
and matrix effects for preconcentration were##2##6##(2008-10#2)
and matrix effects##8##3##(2008-10#8)
and matrix elimination##2##3##(2008-10#2)
and matrix##28##2##(1990-2#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)
and maturation of the##4##4##(1992-12#2)(2008-10#1)(2012-2#1)
and maturation of##9##3##(1992-12#2)(2008-10#2)(2008-11#1)(2009-6#2)(2010-4#1)(2012-2#1)
and maturation##17##2##(1992-12#2)(1995-6#1)(2008-10#2)(2008-11#2)(2009-12#1)(2009-6#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)
and mature##14##2##(1991-7#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#3)(2011-2#1)
and matured##2##2##(2008-10#2)
and maxillary##4##2##(2013-1#4)
and maxillofacial##9##2##(1993-1#2)(2008-7#6)(2011-2#1)
and maximal##5##2##(1990-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)
and maximizing the benefits to editorial board members##3##8##(2010-12#3)
and maximizing the##4##3##(1991-12#1)(2010-12#3)
and maximum likelihood##2##3##(2008-4#1)(2008-9#1)
and maximum temperatures##2##3##(2008-10#1)(2012-2#1)
and maximum##24##2##(1993-8#1)(1994-9#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
and may actually##2##3##(2008-8#1)(2011-3#1)
and may allow##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
and may also serve as a transformative model for emerging EMR/EHR requirements##2##12##(2010-8#2)
and may also##11##3##(1994-6#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-8#2)(2009-1#1)(2010-8#2)(2011-2#1)(2013-1#1)
and may assist##2##3##(2010-10#1)(2012-2#1)
and may be a useful##2##5##(2008-10#1)(2010-11#1)
and may be a##7##4##(1992-6#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-3#1)
and may be an##2##4##(1997-8#1)(2009-12#1)
and may be applied to##2##5##(2008-11#1)(2008-4#1)
and may be applied##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
and may be associated with##2##5##(2008-7#1)(2010-12#1)
and may be caused by##2##5##(1994-12#1)(2011-2#1)
and may be critical for##2##5##(2008-10#1)(2012-7#1)
and may be of##2##4##(2008-10#1)(2008-9#1)
and may be part of##2##5##(2008-10#1)(2008-9#1)
and may be related to##2##5##(2008-8#1)(2010-1#1)
and may be the##7##4##(1991-12#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-8#1)
and may be used as##2##5##(1990-11#1)(2008-11#1)
and may be used for the##3##6##(1990-11#1)(2008-10#1)(2008-12#1)
and may be used##6##4##(1990-11#2)(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
and may be useful in##2##5##(2008-10#2)
and may be##65##3##(1990-11#2)(1991-12#2)(1991-6#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-5#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
and may become##2##3##(2007-11#1)(2009-11#1)
and may benefit from##2##4##(2012-2#1)(2012-3#1)
and may compromise##2##3##(2008-10#1)(2013-1#1)
and may constitute##2##3##(1991-5#1)(2013-8#1)
and may contribute to the##2##5##(2008-12#1)(2008-9#1)
and may contribute to##6##4##(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)
and may depend on##2##4##(2008-12#1)(2008-9#1)
and may directly##2##3##(2006-6#1)(2008-10#1)
and may explain the##2##4##(2008-10#2)
and may have a##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
and may have##10##3##(1990-5#1)(1991-3#1)(1993-8#1)(1995-6#1)(2008-10#3)(2008-5#1)(2010-5#1)(2011-1#1)
and may help identify##2##4##(2010-10#1)(2011-2#1)
and may help##4##3##(1991-2#1)(2010-10#1)(2011-2#2)
and may include##2##3##(2008-9#1)(2010-4#1)
and may increase##3##3##(1996-6#1)(2008-11#1)(2013-1#1)
and may involve##2##3##(1992-12#1)(2013-1#1)
and may lead to##2##4##(2008-11#1)(2010-12#1)
and may not be##2##4##(2008-5#1)(2011-2#1)
and may now be##2##4##(2008-11#1)(2008-8#1)
and may play a role in##2##6##(1992-6#1)(2010-10#1)
and may play a##3##4##(1992-6#1)(1995-2#1)(2010-10#1)
and may play an important role in the##2##8##(1995-12#1)(2008-9#1)
and may play##5##3##(1992-6#1)(1995-12#1)(1995-2#1)(2008-9#1)(2010-10#1)
and may present##2##3##(2008-1#1)(2008-8#1)
and may provide a##2##4##(1994-11#1)(2009-8#1)
and may provide insight into##2##5##(2008-10#1)(2008-9#1)
and may provide##8##3##(1994-11#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)
and may represent a##5##4##(1994-11#1)(1997-7#1)(2008-10#2)(2013-8#1)
and may represent##6##3##(1994-11#1)(1997-6#1)(1997-7#1)(2008-10#2)(2013-8#1)
and may require a##2##4##(2008-11#1)(2009-8#1)
and may require##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
and may result in##2##4##(2008-3#1)(2013-8#1)
and may result##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
and may serve to##2##4##(1991-2#1)(2008-1#1)
and may suggest##2##3##(1990-3#1)(1991-12#1)
and may therefore be##2##4##(1990-11#1)(1993-2#1)
and may therefore##3##3##(1990-11#1)(1993-2#1)(2008-11#1)
and may thus##2##3##(2008-10#1)(2011-2#1)
and may##219##2##(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-2#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#3)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#2)(2007-11#2)(2008-1#3)(2008-10#41)(2008-11#10)(2008-12#6)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#12)(2008-9#16)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#5)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#6)
and mealybug##2##2##(2008-10#2)
and mean SRIF##2##3##(1997-2#2)
and mean incidence##2##3##(2008-10#2)
and mean##27##2##(1990-2#1)(1990-8#1)(1997-2#2)(1997-4#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
and meaning##3##2##(2008-12#1)(2013-1#2)
and meaningful##4##2##(2008-12#3)(2012-2#1)
and means of##2##3##(1990-2#1)(2008-3#1)
and means##4##2##(1990-2#1)(1995-5#2)(2008-3#1)
and measurable##2##2##(1994-2#1)(1996-2#1)
and measure the##2##3##(2008-11#1)(2011-2#1)
and measure##5##2##(2007-8#1)(2008-11#2)(2008-12#1)(2011-2#1)
and measured a##2##3##(2008-3#1)(2009-11#1)
and measured by the##4##4##(2008-10#4)
and measured by##12##3##(1991-2#1)(1994-5#1)(1995-11#1)(2008-10#7)(2008-11#1)(2008-5#1)
and measured in a##2##4##(1994-3#1)(2008-10#1)
and measured in##3##3##(1994-3#1)(2008-10#2)
and measured##31##2##(1991-2#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(2008-10#15)(2008-11#1)(2008-3#4)(2008-5#3)(2009-11#1)(2010-10#1)
and measurement of the##7##4##(2008-10#6)(2008-3#1)
and measurement of##17##3##(1992-3#1)(1993-2#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2011-2#1)
and measurement repeatability##2##3##(2008-10#2)
and measurement##28##2##(1992-3#1)(1993-2#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#3)
and measurements of##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)
and measurements##14##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2013-1#2)
and measures of##10##3##(1992-9#1)(1993-3#1)(1994-3#2)(2008-8#1)(2009-11#1)(2010-7#1)(2011-2#2)(2013-8#1)
and measures the##2##3##(2008-2#1)(2008-3#1)
and measures##22##2##(1990-12#1)(1991-3#2)(1992-9#1)(1993-3#1)(1994-3#2)(1994-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
and measuring the##8##3##(2008-10#5)(2008-4#1)(2008-5#2)
and measuring##15##2##(1993-12#1)(2008-10#7)(2008-4#1)(2008-5#3)(2008-8#2)(2012-2#1)
and meat products##4##3##(2008-10#2)(2010-4#1)(2012-12#1)
and meat##6##2##(2008-10#3)(2010-4#1)(2012-12#1)(2013-1#1)
and mebendazole##5##2##(2008-10#5)
and mechanical behavior of##2##4##(2009-7#2)
and mechanical properties of##6##4##(2007-8#2)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#1)
and mechanical properties##10##3##(1995-3#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#1)(2013-1#1)
and mechanical stability##2##3##(2008-10#1)(2008-11#1)
and mechanical##33##2##(1991-11#1)(1993-5#1)(1994-3#1)(1995-3#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#2)(2009-3#1)(2009-7#3)(2009-8#5)(2010-8#1)(2010-9#1)(2012-3#2)(2013-1#1)
and mechanically##4##2##(2008-10#2)(2008-7#1)(2009-7#1)
and mechanism of##9##3##(2008-10#3)(2010-1#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)
and mechanism##10##2##(2008-10#3)(2008-5#1)(2010-1#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)
and mechanisms of##4##3##(2008-10#2)(2009-7#1)(2012-12#1)
and mechanisms that##3##3##(1994-1#1)(2008-7#1)(2010-3#1)
and mechanisms##15##2##(1994-1#1)(1997-2#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-3#1)(2012-12#1)(2013-7#1)
and mechanistic##4##2##(2008-10#1)(2008-7#1)(2009-10#1)(2010-10#1)
and meclofenamic acids##2##3##(2008-10#2)
and media##4##2##(2009-5#1)(2009-7#1)(2012-2#1)(2013-8#1)
and medial prefrontal lesions on##2##5##(1993-3#2)
and medial prefrontal##3##3##(1993-3#2)(1993-6#1)
and medial##11##2##(1991-12#1)(1993-3#2)(1993-6#1)(1994-3#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-3#1)(2013-1#1)
and median##8##2##(1991-6#1)(1994-3#1)(1996-12#2)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)
and mediastinal##3##2##(2008-1#1)(2013-1#2)
and mediate the##2##3##(1994-5#1)(1995-2#1)
and mediate##4##2##(1994-5#1)(1995-2#1)(2013-1#1)(2013-8#1)
and mediated##4##2##(1991-3#1)(2008-10#3)
and mediates##4##2##(1995-2#2)(2008-8#1)(2008-9#1)
and mediator##2##2##(2008-10#1)(2009-10#1)
and mediators##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
and medical care##6##3##(1991-3#1)(1993-1#1)(1997-2#1)(2008-11#1)(2008-7#1)(2012-3#1)
and medical complications in##2##4##(2008-9#2)
and medical complications##3##3##(2008-9#3)
and medical doctors##2##3##(2008-1#1)(2011-2#1)
and medical management##5##3##(1997-3#1)(2008-4#1)(2010-6#1)(2011-3#1)(2013-1#1)
and medical services##2##3##(1991-3#1)(2012-3#1)
and medical students in##2##4##(2008-4#1)(2013-1#1)
and medical students to##2##4##(1992-2#1)(2008-11#1)
and medical students##10##3##(1992-2#1)(2008-11#5)(2008-12#2)(2008-4#1)(2013-1#1)
and medical##81##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-6#3)(1992-12#1)(1992-2#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#12)(2008-12#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-1#2)(2010-2#1)(2010-6#2)(2011-2#2)(2011-3#3)(2012-12#1)(2012-3#3)(2013-1#5)
and medically##4##2##(1991-3#1)(1992-3#1)(2008-8#1)(2009-6#1)
and medication##6##2##(1994-2#1)(2008-5#1)(2010-9#1)(2011-2#2)(2012-3#1)
and medicinal plants##2##3##(2008-10#1)(2011-3#1)
and medicinal##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2011-3#1)
and medicine##7##2##(2008-10#1)(2008-11#3)(2008-12#1)(2009-11#1)(2010-7#1)
and medium term##2##3##(2011-2#1)(2013-1#1)
and medium##9##2##(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2009-6#1)(2011-2#1)(2013-1#1)
and medium-sized##2##2##(1997-8#1)(2011-2#1)
and medium-term##3##2##(2010-11#1)(2011-2#2)
and medulla##5##2##(1997-2#4)(2007-12#1)
and medullary##2##2##(2008-10#1)(2009-3#1)
and meet##2##2##(1997-3#1)(2008-5#1)
and meeting##3##2##(1992-1#1)(1994-2#1)(1996-2#1)
and mefenamic##2##2##(2008-10#2)
and meiotic##4##2##(2008-7#3)(2009-10#1)
and melanogenic##2##2##(1995-2#2)
and melanoma##5##2##(2008-9#1)(2009-10#2)(2013-1#1)(2013-8#1)
and melatonin##4##2##(1995-12#1)(1996-2#1)(2008-10#1)(2011-2#1)
and melon##4##2##(2008-10#4)
and melting##2##2##(1992-1#1)(2008-10#1)
and member##2##2##(1995-6#1)(2012-2#1)
and members of##2##3##(1996-12#1)(2008-10#1)
and membership##2##2##(1993-1#1)(2008-10#1)
and membrane fractions##3##3##(1992-6#1)(1995-8#1)(2008-11#1)
and membrane lipid##2##3##(1995-8#1)(2008-8#1)
and membrane lipids##2##3##(1990-2#1)(2008-8#1)
and membrane potential##2##3##(1994-11#1)(2009-6#1)
and membrane transport##2##3##(2008-10#1)(2008-11#1)
and membrane##28##2##(1990-2#1)(1992-6#1)(1993-6#2)(1993-8#2)(1994-11#2)(1995-8#3)(2008-10#8)(2008-11#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)
and membranes##4##2##(1996-2#1)(2008-10#1)(2008-11#2)
and memory deficits##2##3##(2011-1#1)(2012-2#1)
and memory performance##2##3##(1994-8#1)(2008-12#1)
and memory##46##2##(1993-12#2)(1993-3#3)(1994-8#1)(1995-12#1)(2008-10#4)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#4)(2011-1#1)(2011-2#3)(2012-2#9)(2013-1#1)(2013-8#2)
and men were##2##3##(2008-12#1)(2008-5#1)
and men who##2##3##(1996-5#1)(2009-5#1)
and men##23##2##(1991-6#2)(1991-8#1)(1995-9#1)(1996-1#1)(1996-5#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#3)(2009-5#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#3)
and meningitis##5##2##(2009-12#4)(2009-6#1)
and menstrual##3##2##(2008-4#1)(2012-2#2)
and mental health disorders##4##4##(2013-8#4)
and mental health services##3##4##(1992-3#1)(2008-11#1)(2008-12#1)
and mental health##25##3##(1992-1#1)(1992-3#3)(1994-1#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-8#1)(2009-11#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#4)
and mental retardation##2##3##(1995-1#1)(1997-8#1)
and mental##44##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#3)(1993-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#2)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-8#1)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#4)
and mentioned##2##2##(1995-1#1)(2008-10#1)
and mentors##2##2##(2008-1#1)(2008-11#1)
and mercaptopicolinate##2##2##(1995-8#2)
and mercury in##4##3##(2008-10#4)
and mercury ions##7##3##(2008-10#7)
and mercury was##2##3##(2008-10#2)
and mercury##29##2##(1994-3#1)(2007-12#1)(2008-10#25)(2009-12#1)(2013-1#1)
and merging##2##2##(1995-2#1)(2010-10#1)
and merit##2##2##(1997-1#1)(2012-3#1)
and mesenteric##3##2##(1991-6#1)(1997-8#1)(2009-8#1)
and mesoderm##2##2##(2008-10#1)(2008-11#1)
and mesothelioma##5##2##(1991-12#4)(1995-12#1)
and met##3##2##(2008-10#1)(2008-12#1)(2010-10#1)
and meta-analyses are##2##3##(1996-6#1)(2013-1#1)
and meta-analyses in##2##3##(1993-12#1)(2013-1#1)
and meta-analyses##9##2##(1991-3#1)(1993-12#2)(1996-6#3)(2010-11#1)(2013-1#2)
and meta-analytic##2##2##(1996-6#1)(2008-11#1)
and metabolic activity##3##3##(2008-10#2)(2008-11#1)
and metabolic control##2##3##(1995-2#1)(2012-4#1)
and metabolic imaging##2##3##(2013-1#1)(2013-8#1)
and metabolic responses during supramaximal exercise##2##6##(2013-8#2)
and metabolic responses##4##3##(2008-10#1)(2008-3#1)(2013-8#2)
and metabolic stress##2##3##(2010-9#1)(2012-12#1)
and metabolic syndrome in##2##4##(2009-9#1)(2012-3#1)
and metabolic syndrome##6##3##(2008-3#2)(2009-9#1)(2012-3#1)(2013-1#2)
and metabolic##45##2##(1990-5#1)(1991-2#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#3)(2008-11#7)(2008-3#4)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#4)(2013-7#1)(2013-8#4)
and metabolism in the##3##4##(1991-12#1)(1997-2#1)(2008-3#1)
and metabolism of##11##3##(1993-11#1)(2008-11#6)(2008-5#1)(2008-8#1)(2010-5#1)(2011-3#1)
and metabolism##26##2##(1991-12#1)(1993-11#1)(1993-9#1)(1997-2#1)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-5#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
and metabolite concentrations##3##3##(1991-3#1)(2008-10#1)(2012-5#1)
and metabolite##5##2##(1991-3#1)(2008-10#1)(2008-11#1)(2012-5#2)
and metabolites##4##2##(2008-10#1)(2008-11#1)(2010-11#2)
and metabolized##2##2##(1990-6#1)(1992-3#1)
and metabolomic##2##2##(2008-11#1)(2012-12#1)
and metabolomics##2##2##(2011-2#1)(2012-2#1)
and metal ion##2##3##(2008-10#2)
and metal ions was##2##4##(2008-10#2)
and metal ions##6##3##(2008-10#6)
and metal##19##2##(1990-3#1)(2008-10#13)(2008-3#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
and metal-semiconductor-metal##2##2##(2008-3#2)
and metalaxyl##3##2##(2008-10#3)
and metallic##4##2##(1992-6#1)(1994-5#1)(2007-12#1)(2012-12#1)
and metalloprotease##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
and metalloproteinase##2##2##(1992-9#1)(2009-7#1)
and metallothionein turnover in##2##4##(2008-10#2)
and metallurgical##2##2##(2008-10#2)
and metamorphosis of##2##3##(1995-11#1)(1995-12#1)
and metapopulation##2##2##(2008-8#2)
and metastable reaction monitoring GC-MS-MS##2##5##(2008-10#2)
and metastases##3##2##(2008-11#1)(2009-3#1)(2013-1#1)
and metastasis in##2##3##(1994-12#1)(2011-2#1)
and metastasis of##4##3##(1994-12#1)(1996-10#1)(2011-2#1)(2013-1#1)
and metastasis to##2##3##(2010-6#1)(2012-3#1)
and metastasis##25##2##(1994-12#3)(1995-9#1)(1996-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#3)(2010-6#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and metastatic disease##2##3##(1997-5#1)(2008-1#1)
and metastatic progression##2##3##(2009-3#1)(2013-1#1)
and metastatic spread of##2##4##(1990-11#1)(2010-7#1)
and metastatic##14##2##(1990-11#1)(1990-8#1)(1997-5#2)(2008-1#1)(2008-11#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and methamphetamine##3##2##(2008-10#2)(2013-1#1)
and methane##6##2##(2008-11#1)(2008-2#4)(2008-3#1)
and methanol##12##2##(1990-2#1)(1993-11#1)(1996-5#1)(2008-10#9)
and methanol)##2##2##(2008-10#1)(2013-8#1)
and methocarbamol##2##2##(2008-10#2)
and method of##2##3##(2007-12#1)(2009-9#1)
and method##8##2##(1995-1#1)(2007-12#1)(2008-10#3)(2009-9#1)(2010-10#1)(2012-2#1)
and methodological##3##2##(2008-4#1)(2008-6#1)(2008-9#1)
and methodology##5##2##(1991-2#1)(1993-12#1)(2008-10#1)(2010-10#1)(2010-8#1)
and methods for##9##3##(1992-3#1)(1992-9#1)(1997-3#2)(2008-9#2)(2009-5#1)(2010-1#1)(2011-2#1)
and methods of##12##3##(1991-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1997-1#1)(1997-6#1)(2008-10#4)(2008-8#1)(2010-5#1)
and methods to##6##3##(1991-12#1)(1994-1#1)(1997-1#1)(2008-9#1)(2010-12#1)(2010-7#1)
and methods used to##3##4##(1991-2#1)(1993-2#1)(2008-3#1)
and methods used##4##3##(1991-2#1)(1993-2#1)(2008-3#1)(2008-9#1)
and methods##78##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1996-2#1)(1997-1#2)(1997-3#2)(1997-6#1)(2006-6#1)(2007-11#4)(2007-8#5)(2008-10#6)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-12#11)(2012-3#1)(2013-1#10)
and methotrexate (MTX)##2##3##(2008-10#1)(2012-3#1)
and methotrexate##5##2##(1991-8#1)(2008-10#2)(2012-3#2)
and methyl jasmonate##2##3##(2008-10#2)
and methyl mercury##4##3##(2008-10#4)
and methyl##15##2##(1990-9#1)(1992-12#1)(1994-8#2)(1996-5#1)(2008-10#10)
and methylated##3##2##(2008-10#3)
and methylation##4##2##(2008-10#1)(2008-11#1)(2009-4#1)(2011-9#1)
and methylene##2##2##(1997-1#1)(2008-10#1)
and methylglycol chitosan##2##3##(2008-10#2)
and methylmercuric chloride##2##3##(2008-7#2)
and methylmercury chloride##2##3##(2008-10#2)
and methylmercury##9##2##(2008-10#9)
and metoprolol##2##2##(1996-3#1)(2012-2#1)
and metribuzin##2##2##(2008-10#2)
and mice##15##2##(1991-1#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-4#6)(2008-7#1)(2008-9#1)(2012-2#1)
and micellar solutions##2##3##(2008-10#2)
and micellar##5##2##(2008-10#5)
and miconazole##2##2##(1991-5#2)
and micro##3##2##(2008-11#1)(2010-9#1)(2012-2#1)
and micro-vesiculation##2##2##(2006-6#2)
and microalbuminuria##2##2##(1995-11#1)(2013-1#1)
and microarray##2##2##(2008-4#1)(2012-2#1)
and microbial biomass##2##3##(2008-10#2)
and microbial##12##2##(2008-10#8)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
and microbiologic##2##2##(2011-2#2)
and microbiological##5##2##(2007-12#2)(2008-5#2)(2013-1#1)
and microcirculation##2##2##(1992-12#1)(2009-5#1)
and microglia##4##2##(2008-7#2)(2010-1#1)(2013-7#1)
and microinvasive##2##2##(2012-3#2)
and microleakage##2##2##(2013-1#2)
and micronuclei##2##2##(2008-9#1)(2010-1#1)
and microorganisms##4##2##(2008-10#2)(2008-11#1)(2010-7#1)
and microsatellite markers##5##3##(2008-10#4)(2013-8#1)
and microsatellite##6##2##(2008-10#5)(2013-8#1)
and microscopic examination##2##3##(2008-4#1)(2012-7#1)
and microscopic lesion scores##3##4##(2008-5#3)
and microscopic##14##2##(1991-6#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-7#1)(2012-7#1)
and microscopically##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
and microscopy##4##2##(2008-7#1)(2008-9#2)(2009-3#1)
and microsomal b5##3##3##(1992-6#3)
and microsomal##6##2##(1992-6#5)(1993-8#1)
and microstructure of##3##3##(2008-5#2)(2011-2#1)
and microsurgery for##2##3##(1993-1#1)(2008-7#1)
and microtubule##3##2##(1991-1#1)(2009-12#1)(2011-2#1)
and microvascular##3##2##(1990-9#1)(1994-8#1)(1997-1#1)
and microwave##4##2##(2008-10#3)(2008-3#1)
and microwave-assisted digestion##3##3##(2008-10#3)
and microwave-assisted##5##2##(2008-10#5)
and mid##3##2##(2008-10#1)(2008-11#2)
and mid-infrared spectroscopy##2##3##(2008-10#2)
and mid-infrared##3##2##(2008-10#3)
and midazolam##2##2##(1993-1#1)(1995-11#1)
and midbrain##3##2##(1996-12#1)(2008-6#1)(2013-7#1)
and middle##12##2##(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
and middle-aged##5##2##(2008-7#3)(2009-12#1)(2011-2#1)
and middle-income countries##4##3##(2008-10#3)(2010-11#1)
and middle-income##6##2##(1993-3#1)(2008-10#3)(2010-11#1)(2011-2#1)
and might also be##2##4##(1997-3#1)(2009-6#1)
and might be##6##3##(1991-9#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
and might play##2##3##(2008-7#1)(2011-2#1)
and might therefore be##2##4##(1991-12#1)(1993-12#1)
and might##22##2##(1991-12#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-7#3)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
and migraine without aura##3##4##(2008-9#3)
and migraine##5##2##(2008-9#4)(2012-3#1)
and migration from##2##3##(2011-2#1)(2013-1#1)
and migration in##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
and migration of##2##3##(2008-10#1)(2010-8#1)
and migration##23##2##(1990-8#1)(1992-3#1)(1994-1#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
and mild cognitive impairment##2##4##(2008-6#1)(2010-11#1)
and mild traumatic##2##3##(2009-8#1)(2010-1#1)
and mild##17##2##(1993-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-8#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
and mildly##2##2##(1997-2#1)(2010-3#1)
and military aerosol##2##3##(2008-3#2)
and military##4##2##(2008-11#1)(2008-12#1)(2008-3#2)
and milk samples##3##3##(2008-10#2)(2011-2#1)
and milk##13##2##(1991-2#1)(1992-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2011-2#2)
and mimic##3##2##(2008-10#2)(2012-12#1)
and mimicking##2##2##(2008-7#1)(2011-1#1)
and mindfulness##2##2##(2013-1#2)
and minds##2##2##(1991-3#1)(2008-7#1)
and mineral salts##2##3##(2008-10#1)(2008-7#1)
and mineral water##5##3##(2008-10#5)
and mineral waters##3##3##(2008-10#3)
and mineral##21##2##(2008-10#18)(2008-11#2)(2008-7#1)
and mineralization of##2##3##(2008-11#1)(2008-12#1)
and mineralization##7##2##(2008-10#1)(2008-11#2)(2008-12#1)(2009-7#2)(2011-1#1)
and mineralocorticoid##2##2##(1994-2#1)(1997-1#1)
and miniaturisation##2##2##(2008-10#1)(2008-12#1)
and miniaturization##3##2##(2008-10#2)(2010-11#1)
and miniaturized##2##2##(2008-10#1)(2013-1#1)
and minimal residual disease##2##4##(2008-10#1)(2011-2#1)
and minimal##8##2##(1993-3#1)(2008-10#2)(2008-3#1)(2010-10#1)(2011-2#1)(2013-8#2)
and minimal-scan fan-beam##2##3##(2008-3#2)
and minimal-scan##3##2##(2008-3#3)
and minimising##2##2##(2008-10#2)
and minimization of##3##3##(2008-10#2)(2008-11#1)
and minimize the##5##3##(1997-1#1)(2008-10#3)(2011-2#1)
and minimize##11##2##(1991-3#1)(1992-2#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
and minimizes##2##2##(2008-10#2)
and minimizing##3##2##(2008-4#1)(2008-6#1)(2010-11#1)
and minimum##14##2##(1992-9#1)(1997-3#1)(2008-10#8)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and minocycline##2##2##(2008-7#2)
and minor complications in carotid##2##5##(1990-9#2)
and minor complications##3##3##(1990-9#2)(2009-3#1)
and minor##19##2##(1990-9#2)(1991-8#1)(1993-12#1)(2008-10#10)(2008-4#1)(2009-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
and miscellaneous##5##2##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
and misconceptions##2##2##(2010-11#1)(2010-7#1)
and misleading##2##2##(1990-6#1)(2008-8#1)
and misoprostol##2##2##(1995-8#2)
and missed clinic##2##3##(1991-1#1)(1996-3#1)
and missed##3##2##(1991-1#1)(1996-3#1)(2008-10#1)
and mistakes##2##2##(1992-1#1)(2012-3#1)
and misuse##5##2##(1991-12#1)(2008-11#1)(2013-1#3)
and mite##2##2##(2008-11#1)(2008-8#1)
and mites##2##2##(2008-10#1)(2008-8#1)
and mitigate##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
and mitochondria are##2##3##(2009-10#1)(2009-12#1)
and mitochondria##7##2##(2008-7#1)(2009-10#5)(2009-12#1)
and mitochondrial DNA##4##3##(2008-10#4)
and mitochondrial isocitrate dehydrogenase subunit α##2##6##(2010-12#2)
and mitochondrial membrane potential##2##4##(2008-9#2)
and mitochondrial membrane##3##3##(2008-11#1)(2008-9#2)
and mitochondrial##29##2##(1991-5#4)(1992-10#2)(1993-2#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#9)(2008-11#2)(2008-9#3)(2010-12#2)(2012-2#2)(2013-1#1)
and mitosis##3##2##(1995-11#1)(2008-7#1)(2012-2#1)
and mitotic##3##2##(1993-9#1)(2011-2#1)(2012-3#1)
and mixed cultures##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
and mixed inflammatory##2##3##(2007-9#1)(2013-8#1)
and mixed pollination systems##2##4##(2009-8#2)
and mixed with a##2##4##(2008-10#1)(2008-8#1)
and mixed with##7##3##(1994-1#1)(2008-10#4)(2008-8#1)(2012-3#1)
and mixed##31##2##(1990-2#1)(1994-1#1)(1996-12#1)(1996-5#1)(2007-9#1)(2008-10#14)(2008-8#1)(2009-12#1)(2009-8#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
and mixing with##2##3##(2008-10#1)(2008-11#1)
and mixing##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#1)
and mixture##2##2##(2008-10#2)
and mixtures of##3##3##(2008-10#3)
and mixtures##9##2##(2008-10#9)
and mlt2##2##2##(2012-3#2)
and mobile##7##2##(1995-6#1)(2008-10#2)(2008-5#1)(2010-8#2)(2012-5#1)
and mobility of##3##3##(1995-12#1)(2008-10#2)
and mobility##7##2##(1995-12#1)(2008-10#3)(2011-2#1)(2013-1#2)
and mobilization of##2##3##(2008-12#1)(2009-6#1)
and modalities##3##2##(1993-11#1)(2008-4#1)(2011-2#1)
and mode of speech##2##4##(2011-1#2)
and mode of##6##3##(1992-9#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#2)
and mode##8##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-10#1)(2011-1#2)
and model##15##2##(1994-5#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
and modeling##6##2##(2008-10#1)(2008-4#1)(2008-7#3)(2013-8#1)
and models to##2##3##(2008-10#1)(2008-7#1)
and models##5##2##(1996-3#1)(2008-10#2)(2008-7#1)(2010-10#1)
and moderate deficiency in##2##4##(2011-1#2)
and moderate##13##2##(1991-11#1)(1997-8#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#2)(2013-1#1)
and moderately##5##2##(2007-12#1)(2008-10#3)(2008-8#1)
and modern##6##2##(1991-2#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-9#1)(2013-1#1)
and modification of##7##3##(1993-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-2#1)
and modification##12##2##(1992-3#1)(1993-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)
and modifications##2##2##(1990-8#1)(2008-10#1)
and modified with##2##3##(2008-10#2)
and modified##19##2##(1991-2#1)(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-7#2)(2009-7#1)(2012-12#1)
and modifier##5##2##(2008-10#5)
and modify##3##2##(1994-12#1)(1995-2#1)(2008-11#1)
and modulate##2##2##(1994-8#1)(2009-6#1)
and modulated##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
and modulates the##2##3##(2008-10#2)
and modulates##7##2##(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#2)(2010-10#1)
and modulation of##3##3##(2008-7#1)(2010-5#1)(2011-2#1)
and modulation##4##2##(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#1)
and moisture resistance##2##3##(2008-2#2)
and moisture##9##2##(1992-2#2)(1997-2#1)(2008-10#4)(2008-2#2)
and molar##4##2##(2008-10#4)
and mole##2##2##(2008-10#2)
and molecular analyses were##2##4##(2008-10#2)
and molecular analyses##5##3##(1997-7#1)(2008-10#4)
and molecular analysis##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
and molecular biology##4##3##(1997-1#1)(2008-4#1)(2008-9#2)
and molecular characterization of a##4##5##(1995-6#1)(2008-10#2)(2012-12#1)
and molecular characterization of##7##4##(1995-6#1)(2008-10#4)(2012-12#1)(2012-2#1)
and molecular cloning of the##3##5##(1992-9#1)(1994-11#1)(1997-7#1)
and molecular differences##2##3##(2008-10#1)(2013-1#1)
and molecular dynamics##4##3##(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
and molecular features of##2##4##(2011-2#2)
and molecular features##4##3##(2008-10#1)(2011-2#3)
and molecular forms of##2##4##(1991-5#2)
and molecular genetic##2##3##(2008-8#1)(2011-2#1)
and molecular levels##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
and molecular mapping##3##3##(2008-10#3)
and molecular markers were used to##2##6##(2008-10#2)
and molecular markers##3##3##(2008-10#3)
and molecular mechanisms##2##3##(2008-8#1)(2011-2#1)
and molecular modeling##4##3##(1992-4#1)(1994-5#2)(1996-5#1)
and molecular properties of##3##4##(1994-3#1)(2008-10#2)
and molecular studies##5##3##(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)
and molecular techniques##2##3##(2008-10#1)(2011-1#1)
and molecular variation of##2##4##(2008-10#2)
and molecular variation##3##3##(2008-10#3)
and molecular weight of##3##4##(2008-10#2)(2010-3#1)
and molecular weight##6##3##(1991-9#1)(2008-10#3)(2008-5#1)(2010-3#1)
and molecular##120##2##(1991-5#2)(1991-9#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-11#2)(1994-3#1)(1994-5#2)(1995-6#1)(1996-5#2)(1997-1#1)(1997-7#4)(2007-12#1)(2008-10#47)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-3#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#3)
and molecules##4##2##(2008-10#1)(2008-2#1)(2010-4#1)(2013-1#1)
and molybdate##2##2##(2008-10#2)
and molybdenum in##5##3##(2008-10#5)
and molybdenum##13##2##(2008-10#13)
and molybdenum(VI) in##3##3##(2008-10#3)
and molybdenum(VI)##6##2##(2008-10#6)
and momentum##2##2##(2008-10#2)
and money##3##2##(1995-2#1)(2008-8#1)(2011-2#1)
and monitor the##2##3##(1993-2#1)(2008-11#1)
and monitor##3##2##(1993-2#1)(2008-11#1)(2008-12#1)
and monitored at##2##3##(2008-10#2)
and monitored##6##2##(1995-12#1)(2008-10#3)(2008-6#1)(2011-3#1)
and monitoring of the##3##4##(2011-3#1)(2012-12#1)(2012-2#1)
and monitoring of##21##3##(1990-9#1)(1992-3#1)(1995-5#1)(1996-6#2)(1997-7#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
and monitoring the##10##3##(1997-7#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
and monitoring##51##2##(1990-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1995-5#1)(1996-2#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-7#2)(2006-6#1)(2007-11#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)
and monoclonal antibodies##5##3##(1992-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
and monoclonal antibody production##4##4##(2008-11#3)(2011-2#1)
and monoclonal antibody##8##3##(1990-2#1)(2008-11#6)(2011-2#1)
and monoclonal##15##2##(1990-2#1)(1992-6#1)(2008-11#7)(2008-4#2)(2008-5#2)(2011-2#1)(2012-3#1)
and monocyte chemoattractant protein-1##2##4##(2012-2#1)(2013-1#1)
and monocyte chemoattractant##3##3##(2010-6#1)(2012-2#1)(2013-1#1)
and monocyte##4##2##(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
and monocyte-derived cells##2##3##(2010-3#1)(2011-2#1)
and monocyte/macrophage##2##2##(1995-3#2)
and monocytes##6##2##(1990-5#2)(1992-12#1)(2006-6#1)(2008-9#2)
and monocytes/macrophages##2##2##(2010-1#2)
and monocytic##4##2##(1997-7#1)(2013-1#3)
and monomer##2##2##(2008-10#1)(2008-12#1)
and monomeric##2##2##(2008-5#1)(2008-7#1)
and monomethylarsonic acid (MMA) were##2##5##(2008-10#2)
and monomethylarsonic acid##5##3##(2008-10#5)
and mononuclear##2##2##(2008-10#1)(2009-10#1)
and mood##5##2##(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2011-2#1)
and mood-related##2##2##(2009-8#2)
and moral##4##2##(1994-9#1)(2008-11#2)(2008-12#1)
and morbidity##22##2##(1992-12#1)(1992-2#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-1#1)(2010-4#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and more accurate##2##3##(2008-3#1)(2010-6#1)
and more aggressive##2##3##(1997-8#1)(2008-9#1)
and more complex##3##3##(1997-2#1)(2008-10#1)(2010-4#1)
and more cost effective than##2##5##(2011-2#2)
and more effective##6##3##(1991-12#1)(1994-1#1)(2007-12#1)(2008-10#1)(2010-11#1)(2012-3#1)
and more efficient##2##3##(2008-10#1)(2011-7#1)
and more expensive##2##3##(2008-1#1)(2008-11#1)
and more frequent family meals and breakfast consumption##2##8##(2013-1#2)
and more frequent family meals##3##5##(2013-1#3)
and more frequent##6##3##(1996-3#1)(2007-12#1)(2007-8#1)(2013-1#3)
and more generally in##2##4##(2008-10#1)(2010-1#1)
and more generally##4##3##(2008-10#1)(2008-9#1)(2010-1#2)
and more important##2##3##(2008-10#1)(2011-1#1)
and more likely to be##2##5##(2008-9#1)(2009-5#1)
and more likely to##5##4##(1992-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)
and more likely##6##3##(1992-2#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-5#1)
and more of##3##3##(1994-1#1)(1994-2#1)(2011-2#1)
and more particularly##2##3##(2008-5#1)(2011-2#1)
and more precise##2##3##(2008-10#2)
and more realistic##2##3##(2008-5#1)(2013-8#1)
and more recently##8##3##(1994-5#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
and more reliable than##2##4##(2008-10#1)(2010-6#1)
and more reproducible##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
and more satisfied than##2##4##(2009-11#1)(2012-2#1)
and more stable##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
and more than half##2##4##(1994-12#1)(2010-8#1)
and more than##15##3##(1990-9#1)(1991-12#1)(1994-12#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-3#1)(2013-1#1)
and more variable##2##3##(1996-2#1)(2010-8#1)
and more##197##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#41)(2008-11#11)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#9)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-11#1)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#6)(2012-7#1)(2013-1#12)(2013-8#3)
and moreover##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
and morphine##4##2##(1994-2#1)(1996-2#2)(2009-7#1)
and morphological analysis of##2##4##(2008-9#1)(2012-3#1)
and morphological aspects of##2##4##(2008-7#1)(2009-8#1)
and morphological##22##2##(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2012-5#2)
and morphologically similar##2##3##(2008-10#1)(2008-8#1)
and morphologically##5##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#2)
and morphology of the##2##4##(2007-12#1)(2008-10#1)
and morphology of##9##3##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2009-3#1)(2009-7#1)
and morphology##15##2##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#1)(2009-3#2)(2009-7#1)(2009-8#1)(2011-2#1)
and morphometrical##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
and mortality after##2##3##(2012-2#1)(2013-1#1)
and mortality and##2##3##(2008-11#1)(2013-8#1)
and mortality can be##3##4##(1993-12#1)(2011-2#1)(2013-1#1)
and mortality for##2##3##(2011-2#1)(2012-3#1)
and mortality from##3##3##(1993-2#1)(2010-4#1)(2011-2#1)
and mortality in these##2##4##(2008-10#1)(2013-1#1)
and mortality in##14##3##(1993-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#2)(2011-2#1)(2011-3#1)(2013-1#2)
and mortality is##2##3##(2008-10#1)(2008-11#1)
and mortality of the##2##4##(2008-7#1)(2008-8#1)
and mortality of##6##3##(1992-11#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
and mortality risk##2##3##(2008-11#1)(2008-8#1)
and mortality was##3##3##(1997-3#1)(2008-11#1)(2011-2#1)
and mortality were##2##3##(1997-1#1)(2008-7#1)
and mortality##104##2##(1991-1#1)(1992-11#1)(1992-12#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#2)(1996-3#1)(1997-1#4)(1997-3#1)(1997-8#2)(2008-1#3)(2008-10#5)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#14)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#2)
and most importantly##2##3##(1997-2#1)(2013-8#1)
and most of the metal ions##2##6##(2008-10#2)
and most of the##6##4##(2008-10#5)(2013-8#1)
and most of them##5##4##(1990-11#1)(1992-12#1)(1993-2#1)(2008-5#1)(2010-8#1)
and most of##14##3##(1990-11#1)(1992-12#1)(1993-2#1)(2008-10#7)(2008-5#1)(2008-8#1)(2010-8#1)(2013-8#1)
and most##57##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-12#1)(1993-2#1)(1993-6#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-7#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-5#3)(2008-8#4)(2008-9#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-8#3)
and mostly of##2##3##(2009-8#1)(2009-9#1)
and mostly##4##2##(2008-11#1)(2009-8#1)(2009-9#1)(2010-8#1)
and mother##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
and mothers##2##2##(2009-10#1)(2009-12#1)
and motilin##2##2##(1994-11#2)
and motility##3##2##(1992-12#1)(2009-8#1)(2011-2#1)
and motion##2##2##(2008-10#1)(2012-12#1)
and motivate##2##2##(2008-11#1)(2008-12#1)
and motivated##2##2##(1994-3#1)(2013-1#1)
and motivation to##2##3##(2012-3#1)(2013-8#1)
and motivation##9##2##(1994-1#2)(1997-5#1)(2008-11#2)(2008-9#1)(2012-3#1)(2013-8#2)
and motor block##2##3##(2012-3#2)
and motor cortex##6##3##(1991-6#4)(2008-7#1)(2011-2#1)
and motor##29##2##(1990-5#1)(1991-6#4)(1992-3#1)(1993-3#1)(1993-6#1)(1994-2#2)(1996-5#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#4)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and motor-evoked##2##2##(2008-7#1)(2010-7#1)
and motoric##2##2##(1991-6#1)(1993-11#1)
and mouse gene nomenclature##2##4##(2008-4#2)
and mouse liver##3##3##(1991-8#2)(2008-8#1)
and mouse monoclonal antibodies (MAbs)##2##5##(2008-10#2)
and mouse##45##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-6#4)(1991-8#4)(1992-6#4)(1993-1#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-9#1)(2008-10#3)(2008-4#7)(2008-8#3)(2008-9#2)(2010-11#1)(2011-9#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
and mouth in##2##3##(2008-5#1)(2010-5#1)
and mouth##13##2##(2008-12#5)(2008-5#1)(2009-10#1)(2010-5#2)(2011-2#2)(2013-8#2)
and move##2##2##(2008-10#1)(2013-8#1)
and movement in##2##3##(2008-8#1)(2010-8#1)
and movement of##4##3##(2008-10#2)(2008-7#1)(2009-10#1)
and movement protein (MP)##2##4##(2008-10#1)(2008-9#1)
and movement protein##4##3##(1997-3#1)(2008-10#1)(2008-9#2)
and movement##20##2##(1993-6#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-7#1)(2010-8#1)(2013-8#1)
and mtSSU rDNA##3##3##(2008-10#3)
and mtSSU##4##2##(2008-10#4)
and mu##3##2##(2008-10#3)
and much greater than that##2##5##(2008-10#1)(2008-11#1)
and much less##2##3##(1993-2#1)(1994-11#1)
and much##14##2##(1991-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-11#1)(2008-10#3)(2008-11#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)
and mucinous##2##2##(1990-6#1)(2011-2#1)
and mucosal##4##2##(1992-6#1)(1995-5#1)(1997-1#1)(2012-2#1)
and mucus##2##2##(1996-1#1)(2008-4#1)
and multi-commutation##2##2##(2008-10#2)
and multiangle light scattering##2##4##(2011-2#2)
and multicentre##2##2##(1992-5#1)(2012-3#1)
and multicollinearity##2##2##(1994-12#1)(2008-10#1)
and multicommutation##3##2##(2008-10#3)
and multicomponent##3##2##(2008-10#3)
and multidimensional##3##2##(1994-1#1)(2008-10#1)(2012-2#1)
and multidisciplinary##2##2##(1993-3#1)(2012-3#1)
and multidrug resistance##4##3##(2008-11#3)(2011-2#1)
and multiemission scan##2##3##(2008-10#2)
and multifocal##2##2##(1994-5#1)(2011-2#1)
and multifunctional##2##2##(1995-2#1)(2010-7#1)
and multilevel##2##2##(2008-12#1)(2010-1#1)
and multilocus##3##2##(2008-10#2)(2011-2#1)
and multinucleated##2##2##(1991-11#1)(1991-12#1)
and multiphoton laser scanning microscopy##2##5##(2008-9#2)
and multiple linear regression##2##4##(2008-10#1)(2011-2#1)
and multiple logistic regression analysis##2##5##(2008-11#2)
and multiple sclerosis##4##3##(2010-12#2)(2011-7#1)(2013-1#1)
and multiple##45##2##(1991-12#1)(1991-3#1)(1992-10#1)(1992-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#3)(2009-12#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#5)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and multiple-pulse##3##2##(2008-3#3)
and multiple-stage##2##2##(2008-12#1)(2011-2#1)
and multiplex##4##2##(2008-10#3)(2011-2#1)
and multiplication##3##2##(2008-12#1)(2012-12#1)(2013-7#1)
and multiplies##2##2##(1994-12#1)(2008-10#1)
and multiply##3##2##(2008-10#3)
and multipolar##2##2##(1994-2#1)(2007-11#1)
and multisyringe##2##2##(2008-10#2)
and multivariate analyses##4##3##(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
and multivariate analysis were##2##4##(2012-3#1)(2013-1#1)
and multivariate analysis##5##3##(1991-8#1)(1995-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
and multivariate calibration##14##3##(2008-10#14)
and multivariate methods##3##3##(2008-10#2)(2008-11#1)
and multivariate statistical##3##3##(2008-10#2)(2012-3#1)
and multivariate##43##2##(1991-8#1)(1992-1#1)(1995-12#1)(2008-10#29)(2008-11#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
and multivitamin##2##2##(2008-10#2)
and multiwavelength##2##2##(2007-12#1)(2008-10#1)
and municipal##2##2##(2008-10#1)(2008-11#1)
and murine IL-10##2##3##(1993-8#2)
and murine##14##2##(1990-12#1)(1991-5#1)(1992-2#2)(1993-8#3)(1994-11#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
and muscarinic##2##2##(2010-4#1)(2012-3#1)
and muscle cells of##2##4##(1997-7#1)(2008-10#1)
and muscle cells##5##3##(1997-7#1)(2006-6#1)(2008-10#2)(2008-11#1)
and muscle strength##2##3##(2008-12#1)(2009-3#1)
and muscle##23##2##(1994-9#1)(1995-12#1)(1996-12#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2010-12#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
and muscles##5##2##(1993-12#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
and muscular##4##2##(1992-12#1)(1995-11#1)(1996-11#1)(2008-12#1)
and mussel##3##2##(2008-10#3)
and must be considered##2##4##(2012-3#1)(2013-8#1)
and must be##10##3##(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2012-3#1)(2013-8#3)
and must##13##2##(1995-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-3#1)(2012-3#1)(2013-1#1)(2013-8#3)
and mutagenic##2##2##(1997-2#1)(2008-10#1)
and mutant##18##2##(1991-6#1)(1992-4#1)(1993-8#1)(1995-6#1)(1997-3#2)(1997-7#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#5)
and mutants##2##2##(2008-9#1)(2009-10#1)
and mutated##2##2##(2008-9#2)
and mutation##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
and mutational##2##2##(2008-12#1)(2013-1#1)
and mutations in##2##3##(2011-1#1)(2011-2#1)
and mutations##4##2##(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
and mycelial compatibility##2##3##(2008-10#2)
and mycelial##4##2##(2008-10#4)
and mycelium##4##2##(2008-10#4)
and mycological##4##2##(2008-5#4)
and mycoparasitism##2##2##(2008-10#1)(2013-8#1)
and mycophenolate mofetil##2##3##(2010-12#1)(2012-3#1)
and mycophenolic acid##2##3##(1990-10#1)(2010-3#1)
and mycoses##2##2##(2011-2#2)
and mycotoxin accumulation in barley##2##5##(2008-10#2)
and mycotoxin accumulation in##3##4##(2008-10#3)
and mycotoxin accumulation##4##3##(2008-10#4)
and mycotoxin contamination##2##3##(2008-10#1)(2011-10#1)
and mycotoxin production##2##3##(2008-10#1)(2010-7#1)
and mycotoxin##9##2##(2008-10#7)(2010-7#1)(2011-10#1)
and myelin basic protein##3##4##(1994-6#1)(1996-6#1)(2008-8#1)
and myelodysplastic disorders##2##3##(1990-8#2)
and myelodysplastic##3##2##(1990-8#2)(2010-11#1)
and myeloid##2##2##(2008-10#1)(2008-11#1)
and myelosuppression##2##2##(1991-2#1)(2013-1#1)
and myocardial infarction##2##3##(1994-12#1)(2010-8#1)
and myocardial##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2010-8#1)
and myopia progression##2##3##(2010-1#2)
and myosin##4##2##(1991-5#1)(1992-9#1)(1995-12#1)(2012-3#1)
and mysteries##2##2##(2008-5#1)(2009-1#1)
and n##3##2##(2008-10#3)
and n-caproic acids##2##3##(2008-10#2)
and nafion chemically modified electrode##2##5##(2008-10#2)
and nalidixic acid##2##3##(2008-10#1)(2012-3#1)
and name##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
and named as##2##3##(1996-12#1)(2008-10#1)
and named##4##2##(1996-12#1)(1997-8#1)(2008-10#1)(2008-8#1)
and nanostructured##3##2##(2008-10#2)(2009-12#1)
and nanotechnology##4##2##(1994-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
and naphazoline##3##2##(2008-10#3)
and naphthalene##7##2##(2008-10#7)
and narrow##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
and nasal##3##2##(2010-6#1)(2012-3#2)
and national economic indicators##3##4##(1991-1#1)(1991-2#1)(1992-2#1)
and national##17##2##(1991-1#1)(1991-2#1)(1992-2#2)(1993-12#1)(1994-2#1)(1995-2#1)(1997-3#3)(2008-10#2)(2008-11#1)(2008-12#1)(2009-11#1)(2009-5#1)(2010-8#1)
and nationally##2##2##(1996-5#1)(2013-1#1)
and natural forests##2##3##(2008-10#1)(2012-2#1)
and natural history of##2##4##(2008-11#1)(2008-7#1)
and natural history##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
and natural killer (NK) cell activity were evaluated in##2##9##(2008-10#2)
and natural killer (NK)##3##4##(2008-10#2)(2012-3#1)
and natural killer cell##2##4##(2008-10#2)
and natural killer##6##3##(2008-10#4)(2012-3#1)(2013-1#1)
and natural selection##4##3##(2010-5#1)(2012-3#3)
and natural water samples##2##4##(2008-10#2)
and natural water##3##3##(2008-10#3)
and natural##49##2##(1991-1#1)(1993-12#1)(1994-12#1)(1996-3#1)(2008-10#25)(2008-11#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
and naturally occurring##2##3##(2008-10#2)
and naturally##6##2##(2008-10#6)
and nature of##7##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
and nature##8##2##(1993-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
and nausea and vomiting##2##4##(2008-10#2)
and nausea and##3##3##(2008-10#2)(2013-1#1)
and nausea##5##2##(2007-12#1)(2008-10#2)(2010-2#1)(2013-1#1)
and navigation##2##2##(2008-6#1)(2009-12#1)
and near infrared##2##3##(2008-10#2)
and near normal##2##3##(2008-11#1)(2010-5#1)
and near##10##2##(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#1)
and near-infrared##3##2##(2008-10#2)(2008-3#1)
and nearly all##3##3##(1990-9#1)(2008-10#1)(2012-2#1)
and nearly half##2##3##(1996-11#1)(2008-10#1)
and nearly##14##2##(1990-9#1)(1996-11#1)(1996-2#1)(2008-10#6)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#2)
and necessary##5##2##(1991-1#1)(1994-1#1)(1995-5#1)(1997-2#1)(2013-8#1)
and necessity##2##2##(1996-3#1)(2011-2#1)
and neck contrast-enhanced CT##4##4##(2013-1#4)
and neck contrast-enhanced##5##3##(2013-1#5)
and neck dissection##2##3##(2012-3#1)(2013-1#1)
and neck squamous cell##2##4##(1997-7#1)(2013-8#1)
and neck trauma##2##3##(2010-9#2)
and neck##71##2##(1990-12#5)(1990-6#5)(1992-5#1)(1993-9#4)(1994-6#1)(1995-6#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-6#2)(1997-7#2)(2007-11#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#5)(2008-7#1)(2009-11#1)(2010-4#3)(2010-6#1)(2010-9#2)(2011-2#9)(2012-2#1)(2012-3#1)(2013-1#11)(2013-8#2)
and necrosis of##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
and necrosis##9##2##(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)
and necrotic lesions##2##3##(2008-10#2)
and necrotic##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2013-8#1)
and need for##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
and need to be##2##4##(2008-10#1)(2010-11#1)
and need##9##2##(1991-12#1)(1991-2#1)(1992-6#2)(2008-10#1)(2008-11#1)(2010-11#1)(2010-12#1)(2013-1#1)
and needs of##4##3##(1991-3#1)(1992-1#1)(2008-6#1)(2010-11#1)
and needs to be##3##4##(1997-8#1)(2008-10#1)(2012-3#1)
and needs##16##2##(1991-3#1)(1992-1#1)(1994-3#2)(1995-1#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-6#2)(2009-5#1)(2010-11#2)(2012-3#1)
and negative attributional style##2##4##(2010-10#2)
and negative predictive value of##3##5##(2008-3#1)(2011-2#2)
and negative predictive value##6##4##(2008-10#1)(2008-3#1)(2011-2#4)
and negative predictive##8##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#4)
and negative religious coping##2##4##(2008-12#2)
and negative##62##2##(1990-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#10)(2008-12#2)(2008-3#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
and negatively correlated with##7##4##(2008-10#4)(2008-9#1)(2011-2#1)(2013-1#1)
and negatively with##4##3##(1991-12#1)(1994-6#1)(2008-10#1)(2008-11#1)
and negatively##20##2##(1991-12#2)(1992-9#1)(1994-6#1)(2008-10#6)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#2)(2013-1#2)(2013-7#1)
and neglect##4##2##(1995-5#1)(1996-2#1)(2012-2#1)(2012-3#1)
and neglected##7##2##(1995-5#5)(2009-4#1)(2012-3#1)
and negligible##2##2##(1996-12#1)(2008-10#1)
and neighborhood frequency##2##3##(2008-11#2)
and neighborhood##3##2##(2008-11#2)(2009-7#1)
and neighborhoods##2##2##(1997-5#1)(1997-6#1)
and neighboring##2##2##(1994-11#1)(2008-10#1)
and neither##5##2##(1993-11#1)(1994-11#1)(2008-10#3)
and nematicide##2##2##(2008-10#2)
and nematode##4##2##(2008-10#1)(2008-12#2)(2008-8#1)
and neonatal follow-up##2##3##(2008-11#2)
and neonatal intensive care##2##4##(1994-3#1)(2008-11#1)
and neonatal rats##2##3##(1997-2#1)(2008-7#1)
and neonatal##24##2##(1990-3#3)(1994-3#1)(1994-6#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-11#7)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
and neoplastic##6##2##(1991-8#1)(1992-3#1)(1995-12#1)(2009-3#1)(2011-2#1)(2013-7#1)
and neovascularization##2##2##(1992-3#1)(2010-9#1)
and nephropathy##3##2##(1997-5#1)(2008-1#1)(2011-2#1)
and nerve##8##2##(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
and nerves##3##2##(1995-12#1)(1996-3#1)(2012-3#1)
and nervous##2##2##(2008-10#1)(2009-7#1)
and nest##2##2##(2008-5#1)(2008-9#1)
and nested PCR##2##3##(2008-12#1)(2008-9#1)
and nested##3##2##(2008-12#1)(2008-9#1)(2013-8#1)
and net##2##2##(1993-1#1)(2012-2#1)
and network##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)
and neural##12##2##(1996-12#1)(2008-11#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2013-8#1)
and neuraminidase##2##2##(2008-9#1)(2011-2#1)
and neurite extension##3##3##(1996-12#1)(2008-11#2)
and neurite##5##2##(1996-12#2)(2008-11#3)
and neurobiological##2##2##(2008-12#1)(2013-8#1)
and neurochemical##6##2##(1993-6#1)(1997-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
and neurocognitive endophenotypes##2##3##(2010-1#2)
and neurocognitive##3##2##(2009-10#1)(2010-1#2)
and neurodegenerative disease##2##3##(2012-2#1)(2013-7#1)
and neurodegenerative##4##2##(1992-12#1)(2011-9#1)(2012-2#1)(2013-7#1)
and neuroendocrine##7##2##(1992-11#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
and neurogenic##5##2##(2008-11#3)(2008-5#1)(2013-7#1)
and neuroimaging##3##2##(2008-11#2)(2008-8#1)
and neurologic##4##2##(2008-7#1)(2010-1#1)(2012-3#2)
and neurological deficits##3##3##(1996-11#1)(2008-12#1)(2011-2#1)
and neurological##15##2##(1993-1#1)(1996-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
and neurologically##2##2##(2009-10#1)(2011-2#1)
and neuromedin N##3##3##(1994-8#1)(1996-2#2)
and neuromuscular disease##2##3##(2008-5#2)
and neuromuscular##3##2##(2008-5#2)(2012-3#1)
and neuron-specific enolase##2##3##(2011-2#2)
and neuronal networks##2##3##(1990-5#1)(2013-1#1)
and neuronal##13##2##(1990-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-10#3)(2013-1#1)
and neurons in##2##3##(1996-12#1)(2008-5#1)
and neurons##6##2##(1996-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)
and neuropathic##2##2##(2009-12#2)
and neuropathologic aspects##2##3##(2008-4#1)(2008-7#1)
and neuropathological##2##2##(1996-11#1)(2008-7#1)
and neuropeptide Y##4##3##(1990-5#1)(1994-8#1)(1995-11#1)(1997-1#1)
and neuropeptide##5##2##(1990-5#1)(1994-8#2)(1995-11#1)(1997-1#1)
and neuropeptides##2##2##(1995-11#1)(2008-7#1)
and neurophysiological##2##2##(2007-8#1)(2013-8#1)
and neuroprotection##2##2##(2009-6#1)(2013-8#1)
and neuroprotective##2##2##(2013-7#1)(2013-8#1)
and neuropsychological##4##2##(1994-6#1)(2008-10#1)(2008-7#1)(2010-12#1)
and neuroscience##2##2##(1997-6#1)(2008-11#1)
and neurotoxic##2##2##(1993-6#1)(2008-12#1)
and neurotransmitter##2##2##(1996-12#1)(2013-1#1)
and neurotransmitters##3##2##(1995-2#1)(2008-10#2)
and neurotrophic##2##2##(2013-1#1)(2013-7#1)
and neutral markers##2##3##(2008-10#1)(2012-3#1)
and neutral##15##2##(1990-5#2)(1996-5#1)(1997-8#1)(2008-10#6)(2010-9#1)(2011-2#1)(2012-3#3)
and neutropenia##2##2##(2008-11#1)(2013-1#1)
and neutrophil##2##2##(1994-5#1)(2008-10#1)
and neutrophils##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
and never##3##2##(1992-6#1)(2008-10#2)
and new and##2##3##(2008-3#1)(2012-2#1)
and new applications##2##3##(1992-11#1)(2012-2#1)
and new methylene blue##2##4##(2008-10#2)
and new surgical##2##3##(1993-6#1)(2011-2#1)
and new therapies##2##3##(2009-8#1)(2010-5#1)
and new##60##2##(1992-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#16)(2008-11#1)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
and newborn##5##2##(1993-3#1)(1994-5#1)(1996-2#1)(2010-11#2)
and newly emerged##2##3##(2008-10#2)
and newly##10##2##(1997-4#1)(2008-10#5)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
and news##2##2##(1991-2#1)(2010-8#1)
and next##2##2##(2008-4#1)(2011-2#1)
and nickel by flame atomic absorption##2##6##(2008-10#2)
and nickel by##6##3##(2008-10#4)(2008-12#2)
and nickel in brass##2##4##(2008-10#2)
and nickel in urine##2##4##(2008-10#2)
and nickel in##13##3##(2008-10#13)
and nickel were##4##3##(2008-10#4)
and nickel##40##2##(1996-12#2)(2008-10#34)(2008-12#3)(2009-12#1)
and nickel(II)##6##2##(2008-10#6)
and nicotinamide##3##2##(1994-8#1)(2008-10#1)(2008-8#1)
and nicotine##9##2##(1992-6#1)(2008-8#1)(2009-7#6)(2013-8#1)
and nicotinic acid##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
and nicotinic receptors##2##3##(1994-5#1)(1995-11#1)
and nicotinic##5##2##(1994-5#1)(1995-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
and night sweats##2##3##(1997-4#1)(2008-11#1)
and night##10##2##(1992-3#1)(1995-10#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#2)
and nine healthy##2##3##(2010-12#1)(2013-1#1)
and nine##20##2##(1990-11#1)(1992-5#1)(1993-2#1)(1993-3#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
and nioxime##2##2##(2008-10#2)
and nitrate ester explosives##2##4##(2008-10#2)
and nitrate in##12##3##(2008-10#12)
and nitrate removal##2##3##(2008-12#2)
and nitrate using##3##3##(2008-10#3)
and nitrate were##2##3##(2008-10#2)
and nitrate##43##2##(1994-5#1)(2008-10#38)(2008-12#3)(2008-7#1)
and nitrendipine##2##2##(1994-8#1)(2008-10#1)
and nitric oxide (NO)##3##4##(2008-10#1)(2008-7#1)(2009-10#1)
and nitric oxide##8##3##(2008-10#2)(2008-7#2)(2009-10#1)(2009-8#1)(2010-4#1)(2012-3#1)
and nitric##11##2##(2008-10#5)(2008-7#2)(2009-10#1)(2009-8#1)(2010-4#1)(2012-3#1)
and nitrite (NO(2)(-))##3##3##(2008-10#3)
and nitrite on##2##3##(1990-6#1)(2008-10#1)
and nitrite production##3##3##(1996-12#3)
and nitrite was##4##3##(1990-6#1)(2008-10#3)
and nitrite were##2##3##(1996-2#1)(2008-10#1)
and nitrite##31##2##(1990-6#4)(1993-8#2)(1996-12#3)(1996-2#1)(2008-10#21)
and nitrite/nitrate##3##2##(2008-10#2)(2010-5#1)
and nitrogen##24##2##(1996-12#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#2)(2012-3#1)
and nitrous oxide anaesthesia##2##4##(1996-6#2)
and nitrous oxide##4##3##(1991-6#1)(1996-6#3)
and nitrous##5##2##(1991-6#1)(1996-6#3)(2008-10#1)
and nivalenol (NIV)##2##3##(2008-10#2)
and no accumulation##2##3##(2008-11#2)
and no change in##4##4##(1991-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
and no chemical treatment##2##4##(2008-10#2)
and no correlation##2##3##(1990-2#1)(1992-2#1)
and no data##2##3##(2008-10#1)(2013-1#1)
and no difference##2##3##(1991-1#1)(2008-10#1)
and no effect##3##3##(2008-10#2)(2008-11#1)
and no evidence of##6##4##(1992-6#1)(1994-12#1)(2008-10#1)(2008-7#1)(2010-12#2)
and no evidence##8##3##(1992-6#1)(1994-12#1)(2008-10#2)(2008-7#1)(2010-12#2)(2012-3#1)
and no further##2##3##(2008-10#2)
and no implant failed##2##4##(2013-1#2)
and no mortality##2##3##(1996-3#1)(2008-7#1)
and no other relevant history##2##5##(2008-10#2)
and no other##5##3##(1990-12#1)(1991-12#1)(1997-7#1)(2008-10#2)
and no potential for decreasing in vivo phagocytosis by the intact murine immune system##2##14##(2008-10#2)
and no recurrence was##2##4##(2008-10#1)(2008-12#1)
and no significant difference at 95% confidence level##2##8##(2008-10#2)
and no significant differences##3##4##(2008-10#2)(2008-12#1)
and no significant##9##3##(1994-2#1)(2008-10#6)(2008-12#1)(2010-7#1)
and no specific##2##3##(2008-10#1)(2011-2#1)
and no such##2##3##(1992-9#1)(2010-6#1)
and no systematic errors were observed##2##6##(2008-10#2)
and no transmission##2##3##(2008-10#2)
and no##163##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#66)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#8)(2009-5#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#3)(2012-3#3)(2013-1#10)(2013-8#3)
and nodes##2##2##(2008-10#2)
and noise##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
and noisy##2##2##(2008-3#1)(2008-9#1)
and non##16##2##(1991-3#1)(1993-3#1)(1995-12#1)(1997-4#1)(2008-10#5)(2008-11#3)(2008-7#1)(2011-2#2)(2012-3#1)
and non-Hispanic Whites##2##3##(2010-10#2)
and non-Hispanic##3##2##(2010-10#2)(2010-12#1)
and non-alcoholic##3##2##(2008-10#1)(2013-1#2)
and non-aqueous media##2##3##(2008-10#2)
and non-aqueous##4##2##(2008-10#4)
and non-coding##4##2##(2007-12#1)(2010-7#1)(2011-2#1)(2012-5#1)
and non-conducting##3##2##(2008-10#1)(2008-7#2)
and non-demented##4##2##(1996-12#1)(2008-7#3)
and non-destructive##2##2##(2008-10#2)
and non-displaced southern##2##3##(2013-1#2)
and non-displaced##4##2##(1993-11#1)(2013-1#3)
and non-drinkers##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
and non-enzymatic##3##2##(2008-10#1)(2008-5#2)
and non-human##2##2##(1997-8#1)(2012-12#1)
and non-immunized##2##2##(2008-9#2)
and non-infected##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
and non-insulin-dependent##2##2##(2008-4#1)(2011-1#1)
and non-invasive measurements##2##3##(2008-5#2)
and non-invasive##8##2##(1996-2#1)(2006-6#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-8#1)
and non-involved##3##2##(2009-7#3)
and non-ionic surfactants##4##3##(2008-10#3)(2008-5#1)
and non-ionic##5##2##(2008-10#4)(2008-5#1)
and non-linear##3##2##(2008-10#2)(2008-11#1)
and non-medical##5##2##(1994-12#3)(2008-11#1)(2008-12#1)
and non-moral dilemmas##2##3##(2008-11#2)
and non-nucleoside reverse transcriptase##2##4##(2007-12#1)(2011-2#1)
and non-pathogenic##2##2##(2008-9#1)(2011-2#1)
and non-pharmacological##3##2##(1993-2#1)(2009-7#1)(2011-2#1)
and non-polar##3##2##(1994-3#1)(2008-10#2)
and non-selective##5##2##(2008-10#1)(2008-12#1)(2011-2#3)
and non-self-specific##2##2##(2013-8#2)
and non-smokers##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
and non-specific##4##2##(1990-11#1)(2008-10#3)
and non-sporulating bacterium##2##3##(2011-2#2)
and non-steroidal anti-inflammatory drugs##3##4##(2008-10#3)
and non-steroidal anti-inflammatory##4##3##(1991-8#1)(2008-10#3)
and non-steroidal##6##2##(1991-8#1)(1995-12#1)(2008-10#4)
and non-thrust##3##2##(2008-12#3)
and non-toxic##3##2##(1991-12#1)(1996-1#1)(2008-10#1)
and non-transgenic##2##2##(2008-12#2)
and non-treatment##2##2##(1990-2#1)(2008-10#1)
and non-use of##2##3##(1997-6#1)(2013-8#1)
and non-users##4##2##(2008-11#1)(2013-8#3)
and non-vaccinated##2##2##(2008-5#2)
and non-virulent##3##2##(2008-5#3)
and non-volatile##3##2##(2008-10#3)
and nonamended##2##2##(2008-10#2)
and noncitrus hosts were##2##4##(2008-10#2)
and noncitrus hosts##3##3##(2008-10#3)
and noncoding##4##2##(2008-10#1)(2008-4#2)(2008-9#1)
and nonconducting##2##2##(2008-10#2)
and nondiagnostic##3##2##(2008-11#3)
and none has##3##3##(1991-4#1)(1997-7#1)(2011-2#1)
and none of the##3##4##(1992-6#1)(2008-10#1)(2011-2#1)
and none of##5##3##(1992-6#1)(1995-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
and none##17##2##(1991-4#1)(1992-6#1)(1994-6#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#1)
and nonionic surfactants##2##3##(2008-10#1)(2008-5#1)
and nonlinear in##2##3##(2008-2#2)
and nonlinear waveguides induced by optical vortex solitons##2##8##(2007-12#2)
and nonlinear##10##2##(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#1)(2009-12#1)(2009-8#1)
and nonlinearity##2##2##(2008-2#1)(2008-9#1)
and nonpathogenic F##2##3##(2008-10#2)
and nonpathogenic##6##2##(2008-10#6)
and nonpathogens##3##2##(2008-10#3)
and nonselective##5##2##(2008-10#2)(2008-12#2)(2008-7#1)
and nonsmokers##3##2##(2008-10#2)(2012-12#1)
and nonspecific##2##2##(1991-12#1)(2008-10#1)
and nonsteroidal anti-inflammatory##2##3##(1997-1#1)(2008-10#1)
and nonsteroidal##3##2##(1997-1#1)(2008-10#1)(2009-12#1)
and nontransgenic##2##2##(2008-10#2)
and nonwords##2##2##(1990-8#1)(2008-11#1)
and nor##2##2##(2010-10#1)(2011-2#1)
and norepinephrine##3##2##(1993-1#1)(1995-11#1)(2012-3#1)
and normal cells##2##3##(2008-11#2)
and normal in##3##3##(1990-2#1)(2008-7#2)
and normal intelligence##2##3##(1997-3#2)
and normal plasma cells##2##4##(2010-12#2)
and normal saline##2##3##(2010-7#1)(2012-3#1)
and normal skin##3##3##(1992-8#1)(2008-5#2)
and normal tissue##2##3##(2008-7#1)(2009-10#1)
and normal##43##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-3#2)(2006-6#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#8)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
and normalization##2##2##(1996-9#1)(2009-10#1)
and normalized##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and normally##3##2##(1995-12#1)(2008-5#1)(2009-12#1)
and northern Sudanese women##2##4##(2013-1#2)
and northern blot analyses##2##4##(2008-10#2)
and northern blot##4##3##(2008-10#4)
and northern hybridization##2##3##(2008-10#2)
and northern##18##2##(2008-10#11)(2008-8#2)(2008-9#1)(2010-3#1)(2013-1#3)
and noscapine##3##2##(2008-10#3)
and not a##2##3##(2008-10#1)(2009-8#1)
and not as##2##3##(2008-10#1)(2008-5#1)
and not attributable to a##2##5##(2008-10#1)(2008-5#1)
and not by##2##3##(1993-3#1)(2008-9#1)
and not consistent##2##3##(2008-10#2)
and not due to##5##4##(1990-5#1)(1993-12#1)(1994-5#1)(1995-11#1)(2008-10#1)
and not from##2##3##(2008-10#1)(2008-5#1)
and not having##2##3##(2011-2#1)(2012-12#1)
and not in the##2##4##(1991-1#1)(2008-10#1)
and not in##4##3##(1991-1#1)(1997-2#1)(2008-10#2)
and not merely##2##3##(1990-8#1)(2012-3#1)
and not on the##2##4##(2008-5#1)(2008-9#1)
and not on##5##3##(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)
and not related to##2##4##(1995-11#1)(2008-10#1)
and not significantly different##2##4##(2008-10#2)
and not significantly##3##3##(2008-10#3)
and not so##2##3##(2008-5#1)(2011-2#1)
and not the##5##3##(1990-6#1)(1997-1#1)(1997-8#1)(2008-10#1)(2012-3#1)
and not to##3##3##(2008-10#2)(2010-12#1)
and not with##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
and not##93##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-5#1)(1995-11#2)(1995-12#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2008-10#38)(2008-11#3)(2008-3#1)(2008-5#5)(2008-6#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
and note##2##2##(2008-3#1)(2011-2#1)
and novel##13##2##(1993-6#1)(2008-10#3)(2008-3#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#2)(2011-2#1)(2013-8#1)
and now##8##2##(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#2)(2009-3#1)(2010-8#2)
and nuclear DNA##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
and nuclear factor##3##3##(1994-6#2)(2010-10#1)
and nuclear magnetic resonance##2##4##(1990-3#1)(2008-4#1)
and nuclear volume##2##3##(2008-7#1)(2010-8#1)
and nuclear##38##2##(1990-3#2)(1990-5#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#3)(1995-2#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-8#2)(2010-10#3)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
and nuclei##2##2##(1992-11#1)(2008-9#1)
and nucleic acid##2##3##(2008-10#1)(2008-11#1)
and nucleic acids##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
and nucleic##5##2##(2008-10#2)(2008-11#1)(2012-3#1)(2013-8#1)
and nucleocapsid##2##2##(1993-12#1)(2009-7#1)
and nucleoside##3##2##(2008-4#1)(2008-7#1)(2010-8#1)
and nucleotide sequence##2##3##(1997-6#1)(2008-10#1)
and nucleotide sequences of the##2##5##(1993-12#1)(2008-10#1)
and nucleotide sequences##4##3##(1991-5#1)(1993-12#1)(1997-3#1)(2008-10#1)
and nucleotide##10##2##(1991-5#1)(1993-12#2)(1995-12#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)
and nucleus accumbens##3##3##(1993-6#1)(1994-8#2)
and nucleus##7##2##(1991-12#2)(1993-6#1)(1994-8#2)(2008-11#1)(2009-10#1)
and number of factors##4##4##(2008-10#4)
and number of lesions##2##4##(2008-10#2)
and number of##38##3##(1990-8#1)(1992-3#2)(1993-1#1)(1993-3#1)(1996-2#1)(1997-1#1)(2008-10#16)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-1#2)
and number##42##2##(1990-8#1)(1991-5#1)(1992-3#2)(1993-1#1)(1993-3#1)(1996-2#1)(1997-1#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-1#2)
and numbers of##5##3##(1993-8#1)(1994-3#1)(2007-12#1)(2008-10#2)
and numbers##7##2##(1993-8#1)(1994-3#1)(2007-12#1)(2008-10#2)(2013-8#2)
and numeric##2##2##(2008-7#1)(2012-2#1)
and numerical results##5##3##(2008-3#5)
and numerical simulations##3##3##(2008-10#2)(2008-2#1)
and numerical##17##2##(2008-10#4)(2008-2#2)(2008-3#6)(2008-8#2)(2009-7#1)(2013-8#2)
and numerically##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
and numerous other##2##3##(2008-10#1)(2011-2#1)
and numerous##15##2##(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and nurse education##4##3##(2008-11#2)(2008-12#2)
and nurse##12##2##(1997-5#1)(2008-11#4)(2008-12#4)(2008-3#1)(2010-4#1)(2011-1#1)
and nurse's##4##2##(1993-2#1)(1995-1#1)(2010-10#2)
and nurses in##3##3##(1992-12#1)(2010-4#1)(2011-2#1)
and nurses who##2##3##(2008-12#1)(2009-11#1)
and nurses##15##2##(1991-2#1)(1992-12#1)(1993-2#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-12#2)(2010-3#1)(2010-4#1)(2011-2#1)
and nurses'##3##2##(1992-2#2)(2012-3#1)
and nursing home##3##3##(1992-3#1)(1993-12#1)(1994-2#1)
and nursing interventions for persons with post-op hemorrhage after tonsillectomy##2##10##(2013-1#2)
and nursing interventions of an adult with a postoperative hemorrhage##2##10##(2013-1#2)
and nursing interventions that guided nursing care during this emergency##2##10##(2013-1#2)
and nursing interventions##6##3##(2013-1#6)
and nursing##20##2##(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-6#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#6)
and nurturant##2##2##(1992-3#2)
and nurture##2##2##(1993-12#1)(2008-11#1)
and nutrient consumption##2##3##(2008-7#2)
and nutrient intake##4##3##(1994-12#1)(2010-6#3)
and nutrient##17##2##(1994-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-6#4)(2013-8#1)
and nutrients##5##2##(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
and nutrition##7##2##(1991-3#1)(1995-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
and nutritional##11##2##(2008-10#4)(2008-11#1)(2010-1#1)(2010-8#1)(2011-2#4)
and nutritive##2##2##(2008-10#2)
and o##2##2##(2008-10#2)
and o-nitrophenyl octyl ether##2##4##(2008-10#2)
and o-nitrophenyloctyl ether##2##3##(2008-10#2)
and o-nitrotoluene##2##2##(2008-10#2)
and o-phenylenediamine##3##2##(2008-10#3)
and oICH##2##2##(2012-3#2)
and oak##3##2##(2008-10#3)
and oat##5##2##(2008-10#3)(2011-2#2)
and obese patients##2##3##(2011-2#2)
and obese##8##2##(1993-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2011-2#3)(2012-2#1)
and obesity are##5##3##(2008-1#1)(2008-11#1)(2012-2#2)(2013-8#1)
and obesity in##2##3##(2011-2#2)
and obesity on##2##3##(2008-10#1)(2011-1#1)
and obesity##32##2##(2008-1#2)(2008-10#2)(2008-11#1)(2009-12#1)(2010-8#1)(2011-1#5)(2011-2#7)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#5)
and object##3##2##(1993-11#1)(2008-6#1)(2013-1#1)
and objective##12##2##(1990-12#1)(1990-3#1)(1992-9#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#2)
and objectives##11##2##(1991-12#1)(1994-12#2)(1996-3#2)(2008-7#1)(2009-8#1)(2010-10#3)(2011-2#1)
and objects##2##2##(2008-11#1)(2009-10#1)
and oblique##2##2##(2008-3#1)(2008-9#1)
and observation##2##2##(2013-1#1)(2013-8#1)
and observational##4##2##(2008-9#1)(2009-11#1)(2012-12#1)(2012-3#1)
and observations##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
and observe##2##2##(2008-11#1)(2011-3#1)
and observed values##3##3##(2008-10#3)
and observed##18##2##(1994-11#1)(1994-5#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-8#2)
and observers##2##2##(2008-10#1)(2009-10#1)
and observing##2##2##(2008-11#1)(2008-2#1)
and obtain##8##2##(2008-10#4)(2008-3#2)(2008-7#1)(2011-2#1)
and obtained##15##2##(1991-6#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#2)
and obtaining##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
and obvious##2##2##(1997-3#1)(2008-10#1)
and occasional##2##2##(1994-3#1)(1997-3#1)
and occasionally##10##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-11#1)(2012-2#2)(2013-1#1)
and occipital cortices##2##3##(1996-12#1)(2010-7#1)
and occipital##3##2##(1996-12#1)(2010-7#1)(2013-8#1)
and occlusion of the##2##4##(1991-8#1)(2008-7#1)
and occlusion of##3##3##(1991-8#1)(2008-10#1)(2008-7#1)
and occlusion##5##2##(1991-8#1)(2008-10#2)(2008-7#1)(2013-1#1)
and occlusivity##2##2##(2008-5#2)
and occupation##2##2##(1995-12#1)(2012-12#1)
and occupational health##2##3##(1990-6#1)(2011-1#1)
and occupational status##2##3##(1995-3#2)
and occupational therapy##3##3##(2008-11#2)(2010-9#1)
and occupational##21##2##(1990-6#1)(1990-8#1)(1994-2#1)(1995-3#2)(1997-1#1)(2008-11#4)(2009-12#3)(2010-11#2)(2010-9#3)(2011-1#1)(2013-1#1)(2013-8#1)
and occur##2##2##(2007-12#1)(2008-10#1)
and occurred##7##2##(1993-8#1)(1997-3#1)(2008-10#5)
and occurrence of##5##3##(2006-6#1)(2008-10#1)(2010-12#1)(2011-2#2)
and occurs in##2##3##(1996-8#1)(2008-12#1)
and occurs##7##2##(1992-10#1)(1994-8#1)(1996-8#1)(1997-7#1)(2008-12#1)(2008-6#1)(2008-7#1)
and ocean##2##2##(2008-2#1)(2008-9#1)
and octyl salicylate##3##3##(2008-5#3)
and octylphenol##3##2##(2008-10#2)(2008-11#1)
and ocular signs##2##3##(2013-1#2)
and ocular##5##2##(1990-3#1)(2007-11#1)(2008-11#1)(2013-1#2)
and odds##2##2##(2011-2#1)(2012-3#1)
and odontoglossum ringspot tobamovirus##2##4##(2008-10#2)
and odour##4##2##(1990-5#1)(2008-10#1)(2008-7#2)
and of 1##2##3##(2008-10#2)
and of a##5##3##(2008-10#4)(2008-8#1)
and of cancer##2##3##(1990-8#1)(2008-7#1)
and of different##3##3##(2008-10#3)
and of glucose##2##3##(1992-12#1)(2008-10#1)
and of health##2##3##(1993-11#1)(2012-3#1)
and of its derivatives##2##4##(2008-10#2)
and of its##7##3##(1990-6#1)(2008-10#5)(2009-12#1)
and of normal##2##3##(1993-1#1)(2008-11#1)
and of some##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
and of the##79##3##(1990-3#1)(1990-5#2)(1991-11#3)(1991-12#1)(1991-6#2)(1992-1#1)(1992-12#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-5#3)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#25)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
and of their##5##3##(1990-5#2)(1991-5#1)(2008-10#1)(2009-10#1)
and of these##6##3##(1991-2#1)(1993-1#1)(1996-1#1)(2008-9#1)(2009-12#1)(2012-2#1)
and of two##2##3##(2006-6#1)(2008-11#1)
and of wild-type##2##3##(1994-5#1)(1995-2#1)
and of##297##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#114)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#5)(2008-9#7)(2009-10#4)(2009-12#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#6)(2013-8#3)
and off##3##2##(2008-2#1)(2008-8#1)(2011-1#1)
and off-label##2##2##(2008-9#1)(2010-12#1)
and off-line preconcentration##2##3##(2008-10#2)
and off-line##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
and offer an##3##3##(2008-11#1)(2008-6#1)(2012-2#1)
and offer new##2##3##(2012-2#1)(2013-1#1)
and offer the##2##3##(2008-10#1)(2008-5#1)
and offer##19##2##(1991-12#1)(1992-12#1)(1996-3#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#3)(2013-1#2)
and offered##4##2##(2008-10#2)(2011-1#1)(2012-12#1)
and offering##2##2##(1995-1#1)(2012-2#1)
and offers a##3##3##(2008-11#1)(2009-8#1)(2010-7#1)
and offers an##2##3##(2010-9#1)(2012-3#1)
and offers some##3##3##(1991-2#1)(1993-1#1)(2008-9#1)
and offers##14##2##(1991-2#1)(1993-1#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
and official##2##2##(2008-10#1)(2013-1#1)
and offset##3##2##(2008-11#1)(2008-3#2)
and offspring##5##2##(1995-12#1)(1997-7#1)(2008-8#2)(2008-9#1)
and ofloxacin##5##2##(2008-10#5)
and often##33##2##(1990-7#1)(1991-3#1)(1992-9#2)(1994-8#1)(1997-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
and oil##7##2##(2008-10#1)(2008-3#1)(2008-5#5)
and okadaic acid##3##3##(1993-8#1)(1995-8#2)
and old##20##2##(1990-3#2)(1994-8#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#8)(2008-8#1)(2012-3#1)(2013-7#1)
and older adults##5##3##(2008-11#1)(2008-4#2)(2009-10#1)(2013-1#1)
and older age##2##3##(2008-5#1)(2013-8#1)
and older females##2##3##(2008-4#2)
and older##31##2##(1990-3#1)(1994-2#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#2)
and oldest##2##2##(2008-7#1)(2013-8#1)
and olfactory##6##2##(1993-6#1)(1996-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)
and oligonucleotide##2##2##(1996-6#1)(1997-7#1)
and oligonucleotides##2##2##(1997-7#1)(2008-4#1)
and oligotrophic##3##2##(2008-10#3)
and omentum##2##2##(2008-1#1)(2008-12#1)
and on a##9##3##(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
and on different##2##3##(2008-10#1)(2012-3#1)
and on factors that affect##2##5##(2006-6#1)(2008-10#1)
and on factors that##3##4##(2006-6#2)(2008-10#1)
and on human##2##3##(2008-11#1)(2008-5#1)
and on in vitro##2##4##(2008-10#1)(2008-8#1)
and on its##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
and on molecular##2##3##(2008-10#1)(2010-12#1)
and on the basis of##3##5##(1990-3#1)(2008-12#1)(2010-1#1)
and on the other##5##4##(1994-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
and on the perceived usefulness and appropriateness of each instrument##2##10##(2013-1#2)
and on the stability of##2##5##(1996-5#1)(2008-10#1)
and on the subsequent##3##4##(1994-8#1)(2008-10#2)
and on the surface of##2##5##(2008-10#2)
and on the surface##4##4##(2008-10#2)(2008-3#1)(2013-8#1)
and on the##74##3##(1990-3#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-5#1)(1994-1#3)(1994-3#1)(1994-8#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#1)(2007-12#1)(2008-10#22)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2010-1#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#1)
and on who##2##3##(1994-6#2)
and on##182##2##(1990-3#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-5#2)(1993-6#1)(1994-1#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-6#3)(2007-12#1)(2008-10#61)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#5)(2008-9#4)(2009-1#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#1)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#2)
and on-line##8##2##(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#1)
and oncology##3##2##(1991-2#1)(1994-3#1)(2008-11#1)
and one additional##2##3##(2008-10#1)(2010-12#1)
and one at##2##3##(2008-10#2)
and one case##3##3##(2008-7#1)(2008-9#2)
and one cultivar##2##3##(2008-10#2)
and one dominant##2##3##(2008-10#2)
and one each##2##3##(1995-12#1)(2008-10#1)
and one fistula##2##3##(1993-2#1)(1996-3#1)
and one for##7##3##(1997-8#1)(2008-10#2)(2008-6#1)(2008-9#2)(2009-3#1)
and one from##7##3##(2008-10#6)(2008-5#1)
and one had##3##3##(1997-5#1)(2008-7#1)(2012-3#1)
and one has##2##3##(1990-6#1)(2008-10#1)
and one in##3##3##(1996-3#1)(2008-10#1)(2008-8#1)
and one isolate of##3##4##(2008-10#3)
and one isolate##4##3##(2008-10#4)
and one line##2##3##(2008-10#2)
and one month##2##3##(1991-2#1)(2008-5#1)
and one of the two##2##5##(2008-10#1)(2009-10#1)
and one of the##10##4##(1996-2#1)(1997-2#1)(2008-10#4)(2008-8#1)(2009-10#1)(2013-1#2)
and one of them##3##4##(2008-10#2)(2008-9#1)
and one of##26##3##(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2012-2#1)(2013-1#2)
and one or more##2##4##(2008-10#2)
and one or##4##3##(1990-5#1)(2008-10#3)
and one patient with##2##4##(1990-12#1)(1996-9#1)
and one patient##7##3##(1990-12#1)(1996-9#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)
and one putative##2##3##(1993-3#1)(1993-6#1)
and one race of##3##4##(2008-10#3)
and one sample##2##3##(2008-10#2)
and one strain##2##3##(2008-10#2)
and one that##3##3##(1992-9#1)(1997-6#1)(2008-3#1)
and one third##2##3##(1990-9#1)(2010-8#1)
and one was##4##3##(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
and one with##7##3##(1991-11#1)(2008-11#1)(2008-5#1)(2008-9#3)(2012-2#1)
and one without##2##3##(2008-7#1)(2008-8#1)
and one year##4##3##(1991-11#2)(2008-10#1)(2012-12#1)
and one##252##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(1997-9#1)(2007-12#2)(2008-10#96)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#16)(2008-6#1)(2008-7#11)(2008-8#8)(2008-9#15)(2009-10#3)(2009-12#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)
and one-dimensional##3##2##(2008-3#2)(2008-5#1)
and one-half##2##2##(1993-3#1)(1995-1#1)
and one-way ANOVA##2##3##(2008-10#1)(2010-8#1)
and ongoing##8##2##(2008-1#1)(2008-10#1)(2008-12#2)(2011-4#1)(2012-2#1)(2013-1#2)
and online##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)
and only 10%##2##3##(1992-9#1)(1996-11#1)
and only 2%##2##3##(2008-7#1)(2008-9#1)
and only 5##2##3##(1993-8#1)(2008-7#1)
and only a few##6##4##(1995-12#1)(1997-8#1)(2008-11#1)(2010-6#1)(2013-1#2)
and only a##7##3##(1995-12#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-6#1)(2013-1#2)
and only after##2##3##(2008-10#1)(2008-7#1)
and only eight##2##3##(2008-1#1)(2008-7#1)
and only if##4##3##(2008-3#1)(2008-6#1)(2008-7#1)(2010-7#1)
and only in##6##3##(1990-6#1)(1992-12#1)(1993-8#1)(1996-12#1)(2008-8#1)(2008-9#1)
and only one##7##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
and only the second genome sequence##2##6##(2011-2#2)
and only the##5##3##(2008-10#1)(2011-2#4)
and only##95##2##(1990-12#1)(1990-2#1)(1990-6#3)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#2)(2009-8#2)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#7)(2011-9#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
and onset##2##2##(2008-12#1)(2012-3#1)
and open surgical intervention##2##4##(2013-8#2)
and open surgical##3##3##(2011-2#1)(2013-8#2)
and open##15##2##(1997-3#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
and open-ended##3##2##(2008-11#1)(2010-8#1)(2011-1#1)
and opened##3##2##(1991-8#1)(2008-7#1)(2008-8#1)
and operate##2##2##(2008-11#1)(2011-7#1)
and operated in the positive ion mode##2##7##(2011-3#2)
and operated##4##2##(2008-10#2)(2011-3#2)
and operating costs##2##3##(1991-12#1)(2008-2#1)
and operating expenses##2##3##(1992-2#1)(2008-11#1)
and operating##11##2##(1991-12#1)(1992-2#1)(1993-3#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)
and operation of##2##3##(2008-10#1)(2012-2#1)
and operation##9##2##(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)
and operational and storage stability##2##5##(2008-10#2)
and operational issues##2##3##(2008-10#1)(2008-11#1)
and operational lifetime of##2##4##(2008-10#2)
and operational##21##2##(1990-5#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-1#1)(1996-1#1)(1997-3#1)(2008-10#9)(2008-11#2)(2009-10#1)(2009-5#1)(2010-8#1)
and operations##7##2##(1992-3#1)(1993-3#1)(1994-1#2)(2008-10#1)(2008-11#1)(2010-10#1)
and operative##2##2##(2012-2#1)(2013-1#1)
and operator##3##2##(1992-12#2)(2008-10#1)
and operators##3##2##(1990-11#1)(2012-2#2)
and ophthalmologic##2##2##(2011-2#1)(2013-1#1)
and opiate##4##2##(1997-4#1)(2010-11#3)
and opioids##2##2##(1991-2#1)(2013-1#1)
and opportunities for##5##3##(1993-12#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
and opportunities in##2##3##(1996-3#1)(2013-1#1)
and opportunities that##2##3##(1994-3#1)(2008-5#1)
and opportunities to##2##3##(1993-2#1)(2010-4#1)
and opportunities##15##2##(1991-1#1)(1993-12#1)(1993-2#1)(1994-3#2)(1996-3#1)(2008-12#1)(2008-5#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and opportunity##6##2##(1994-12#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
and opposed-phase pulse sequence##2##4##(1997-8#2)
and opposed-phase##8##2##(1997-8#8)
and opposing##2##2##(2008-8#1)(2012-2#1)
and optic nerve##3##3##(2010-8#1)(2011-2#2)
and optic##5##2##(1995-12#1)(2008-7#1)(2010-8#1)(2011-2#2)
and optical properties of##2##4##(2008-3#2)
and optical##25##2##(2008-10#5)(2008-2#4)(2008-3#8)(2008-5#1)(2008-9#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and optically##4##2##(2008-10#2)(2008-3#1)(2009-7#1)
and optimal##9##2##(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-2#1)
and optimisation of##2##3##(2008-10#2)
and optimisation##4##2##(2008-10#3)(2010-11#1)
and optimised##7##2##(2008-10#7)
and optimism##3##2##(1995-12#1)(2010-7#2)
and optimization of a##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
and optimization of the##4##4##(2008-10#3)(2008-7#1)
and optimization of##12##3##(2008-10#6)(2008-3#2)(2008-7#2)(2011-2#1)(2012-2#1)
and optimization##16##2##(2008-10#8)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
and optimize##5##2##(2008-11#2)(2008-3#1)(2010-10#1)(2012-2#1)
and optimized for##3##3##(2008-10#2)(2008-3#1)
and optimized to##4##3##(2008-10#3)(2008-5#1)
and optimized##44##2##(1997-2#1)(2008-10#36)(2008-3#3)(2008-5#1)(2008-8#1)(2011-2#2)
and optimizes the##2##3##(2008-11#1)(2011-2#1)
and optimizing the##2##3##(2008-11#1)(2008-5#1)
and optimizing##6##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-10#1)
and optimum conditions##3##3##(2008-10#3)
and optimum##10##2##(2008-10#9)(2013-1#1)
and option costs##2##3##(2008-8#2)
and options for##4##3##(1993-12#1)(2008-3#1)(2010-5#1)(2011-3#1)
and options##9##2##(1991-3#1)(1993-12#1)(1997-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-3#1)
and optosensing##2##2##(2008-10#2)
and or##3##2##(2007-8#1)(2008-10#1)(2008-12#1)
and oral##21##2##(1994-12#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-8#1)(2009-12#1)(2010-12#4)(2010-6#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-7#1)
and orange juice##5##3##(2008-10#2)(2010-5#3)
and orange##7##2##(2008-10#3)(2008-3#1)(2010-5#3)
and orbital##3##2##(1992-2#2)(2013-1#1)
and order##5##2##(2008-12#1)(2008-2#1)(2010-9#1)(2013-8#2)
and ore samples##2##3##(2008-10#2)
and organ##9##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2010-7#2)(2013-1#1)
and organelles##3##2##(2008-5#1)(2008-8#1)(2010-4#1)
and organic arsenic##2##3##(2008-10#2)
and organic compounds##4##3##(2008-10#4)
and organic matter content##2##4##(2008-10#2)
and organic matter##4##3##(2008-10#4)
and organic mercury##4##3##(2008-10#4)
and organic solvent##7##3##(1990-5#2)(2008-10#4)(2010-11#1)
and organic solvents##3##3##(2008-10#3)
and organic##60##2##(1990-5#2)(1994-3#1)(1994-9#1)(2008-10#47)(2008-11#1)(2008-12#2)(2008-6#1)(2010-11#1)(2010-4#2)(2011-2#1)(2013-8#1)
and organic)##2##2##(2008-10#1)(2008-7#1)
and organisational support (OR = 1##2##4##(2011-2#2)
and organisations##4##2##(2008-11#2)(2008-7#1)(2011-2#1)
and organization##9##2##(1991-2#2)(1994-1#1)(1996-1#2)(2008-4#1)(2009-12#1)(2012-2#1)(2013-1#1)
and organizational structure##3##3##(1991-1#1)(2008-11#1)(2013-8#1)
and organizational##14##2##(1991-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-9#1)(2010-7#1)(2010-8#1)(2013-8#1)
and organizations##2##2##(1997-3#1)(2010-5#1)
and organized##6##2##(1991-1#1)(1991-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
and organizing##2##2##(2008-11#1)(2008-9#1)
and organotypic##3##2##(2008-4#1)(2009-9#2)
and organs##9##2##(2008-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
and orient in##2##3##(2009-8#2)
and orientation of##5##3##(1993-3#1)(1997-6#1)(2007-12#1)(2008-3#1)(2011-3#1)
and orientation##15##2##(1992-3#1)(1993-3#1)(1993-6#1)(1995-5#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-9#2)(2011-3#1)
and orientations##3##2##(1993-8#1)(2008-10#1)(2009-7#1)
and origin##2##2##(2008-10#2)
and original##4##2##(2008-10#1)(2008-12#2)(2011-1#1)
and originating from##2##3##(2008-10#1)(2012-3#1)
and origins of##2##3##(2008-10#1)(2008-11#1)
and origins##4##2##(2008-10#2)(2008-11#2)
and ornamental shapes##2##3##(2008-9#2)
and ornamental##3##2##(2008-10#1)(2008-9#2)
and ornithine##2##2##(1990-2#1)(2008-10#1)
and orthogonal##2##2##(2008-10#1)(2011-2#1)
and orthographic##3##2##(1991-2#2)(2013-8#1)
and orthopaedic##2##2##(1990-9#1)(2007-8#1)
and orthophosphate##2##2##(2008-10#2)
and oscillations##5##2##(1990-5#1)(1995-5#1)(2008-11#3)
and oscillatory##2##2##(2008-12#1)(2008-5#1)
and osmolality##3##2##(2008-11#3)
and osmotic##3##2##(2008-11#1)(2010-7#1)(2012-7#1)
and osteoarthritis##2##2##(1992-3#1)(2009-8#1)
and osteoblastic##2##2##(2008-11#2)
and osteochondral lesions##3##3##(2011-2#2)(2012-3#1)
and osteoclast##3##2##(2008-11#1)(2011-2#2)
and osteogenesis##3##2##(2008-11#3)
and osteoporosis##8##2##(1991-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-10#1)(2011-2#2)(2011-3#1)
and other AGs of R##2##5##(2008-10#2)
and other adverse##2##3##(2008-7#1)(2010-6#1)
and other agencies##2##3##(1996-2#1)(1997-2#1)
and other agents##2##3##(1996-3#1)(2008-8#1)
and other applications##2##3##(2008-10#1)(2008-4#1)
and other areas of##2##4##(2008-10#1)(2010-11#1)
and other aspects of##2##4##(1993-2#1)(2012-3#1)
and other biological##2##3##(2008-4#1)(2008-5#1)
and other biomolecules##2##3##(2008-10#2)
and other body##2##3##(1992-9#1)(1996-3#1)
and other cancers##3##3##(1993-1#1)(2008-11#1)(2008-7#1)
and other cardiac##2##3##(2010-6#1)(2012-2#1)
and other cardiovascular risk factors##2##5##(1996-8#1)(2010-4#1)
and other cardiovascular##3##3##(1996-8#1)(2008-6#1)(2010-4#1)
and other causes##2##3##(2008-10#1)(2009-8#1)
and other cells##4##3##(1990-9#1)(2008-4#1)(2009-12#1)(2013-8#1)
and other challenges facing##2##4##(1996-3#1)(2008-8#1)
and other chemical##2##3##(2008-10#1)(2008-11#1)
and other chronic##2##3##(1994-3#1)(2010-4#1)
and other clinical##3##3##(2008-5#1)(2010-12#2)
and other coexisting##2##3##(2008-10#1)(2013-1#1)
and other cognitive##2##3##(2009-10#1)(2009-8#1)
and other community##2##3##(1996-1#1)(2012-2#1)
and other complex##3##3##(2008-3#1)(2010-8#1)(2011-2#1)
and other components##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
and other compounds##3##3##(1991-5#1)(2008-10#2)
and other conditions##2##3##(1991-2#1)(2008-10#1)
and other countries##4##3##(1993-1#1)(2008-10#2)(2008-11#1)
and other critical##2##3##(1996-12#1)(2008-11#1)
and other cytokines##2##3##(1996-2#1)(2008-7#1)
and other data##2##3##(1991-1#1)(1997-2#1)
and other devices##2##3##(1991-3#2)
and other disorders##3##3##(1997-2#1)(2008-1#1)(2010-1#1)
and other drug use behaviors##2##5##(1996-1#2)
and other drug##3##3##(1996-1#2)(2012-12#1)
and other drugs##4##3##(1991-1#1)(2008-10#1)(2009-7#1)(2011-2#1)
and other effects##2##3##(1990-12#1)(1990-9#1)
and other environmental##5##3##(1991-12#1)(2008-5#1)(2008-7#2)(2010-5#1)
and other experimental##2##3##(1994-8#1)(2008-10#1)
and other factors##6##3##(1997-3#1)(2008-1#2)(2008-10#2)(2010-5#1)
and other family members are##2##5##(2011-2#1)(2012-12#1)
and other forms of##2##4##(2009-10#1)(2011-2#1)
and other genetic##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
and other governmental##2##3##(2008-11#2)
and other health care providers##2##5##(1993-1#1)(1994-12#1)
and other health care##5##4##(1993-1#1)(1994-12#1)(1996-12#1)(2008-11#1)(2012-12#1)
and other health##13##3##(1991-3#1)(1991-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-1#1)(2008-11#2)(2009-6#1)(2010-10#1)(2010-6#1)(2012-12#1)
and other heavy##2##3##(1995-2#1)(2008-10#1)
and other hosts##2##3##(2008-10#2)
and other important##3##3##(1992-2#1)(2010-7#1)(2012-4#1)
and other infections##2##3##(1995-5#1)(2013-1#1)
and other information##2##3##(1996-11#1)(2008-11#1)
and other inorganic##2##3##(2008-10#2)
and other issues##2##3##(1995-12#1)(1996-2#1)
and other key##2##3##(2008-10#1)(2012-2#1)
and other ligands##3##3##(1996-2#1)(2008-10#1)(2009-8#1)
and other medical##2##3##(1996-3#1)(2008-8#1)
and other members of the##2##5##(2008-10#1)(2011-2#1)
and other members of##3##4##(2008-10#2)(2011-2#1)
and other men who have sex with men##2##8##(2009-5#2)
and other metabolic parameters##2##4##(1994-12#1)(2013-1#1)
and other miscellaneous##2##3##(2008-10#2)
and other mu##2##3##(1995-6#1)(2008-10#1)
and other neurodegenerative diseases##2##4##(2008-5#1)(2010-5#1)
and other neurodegenerative##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
and other neurological##2##3##(2008-5#1)(2012-3#1)
and other new##2##3##(1994-3#1)(2008-11#1)
and other nutrients##2##3##(2008-11#1)(2012-3#1)
and other occupational diseases##2##4##(2009-12#2)
and other oral##2##3##(2008-5#1)(2013-8#1)
and other organelles##2##3##(2008-10#1)(2008-7#1)
and other organisms##2##3##(2008-10#1)(2008-8#1)
and other outcomes##2##3##(1995-2#1)(2008-12#1)
and other parameters of##2##4##(1992-9#1)(2008-10#1)
and other parameters##4##3##(1992-9#1)(2008-10#2)(2008-8#1)
and other pathogens##2##3##(1995-2#1)(2008-5#1)
and other patient##2##3##(1995-12#1)(2008-10#1)
and other physical##2##3##(1992-5#1)(2011-2#1)
and other phytopathogenic##2##3##(2008-10#2)
and other plant hosts##2##4##(2008-10#2)
and other plant##3##3##(2008-10#2)(2010-3#1)
and other plants##3##3##(2008-10#2)(2009-10#1)
and other potential##3##3##(1996-2#1)(2010-12#1)(2013-1#1)
and other procedures##4##3##(1991-2#1)(1995-1#1)(1995-12#1)(1997-7#1)
and other protein##2##3##(1995-2#1)(2008-11#1)
and other proteins##2##3##(2008-10#2)
and other providers##2##3##(1992-12#1)(1996-3#1)
and other reasons##2##3##(1992-2#1)(1993-1#1)
and other related##3##3##(1991-6#1)(2008-11#1)(2008-12#1)
and other relevant##2##3##(1994-3#1)(2008-9#1)
and other rheumatic conditions##2##4##(2011-2#2)
and other rheumatic##3##3##(1991-3#1)(2011-2#2)
and other sexually transmitted diseases##2##5##(1993-9#1)(1997-6#1)
and other sites##2##3##(1993-2#1)(2013-1#1)
and other small##3##3##(1990-12#1)(2008-10#2)
and other solvents##2##3##(2008-10#1)(2008-7#1)
and other sources of##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
and other sources##4##3##(1990-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
and other species##4##3##(1992-12#1)(2008-8#1)(2013-1#1)(2013-8#1)
and other staff##3##3##(1993-3#1)(2008-12#1)(2009-3#1)
and other stimuli##2##3##(2009-10#2)
and other studies##2##3##(1994-3#1)(2008-9#1)
and other substance##2##3##(1991-1#1)(2008-10#1)
and other substances##3##3##(1991-3#1)(1996-1#1)(2008-11#1)
and other systemic##2##3##(2012-3#1)(2013-1#1)
and other systems##2##3##(1996-1#1)(2008-9#1)
and other techniques##3##3##(1991-2#1)(2008-10#2)
and other tumors##2##3##(2008-11#1)(2010-12#1)
and other types of##3##4##(2008-4#1)(2010-1#1)(2012-2#1)
and other variables##4##3##(1991-6#1)(2008-10#2)(2013-1#1)
and other##624##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-8#1)(1990-9#2)(1991-1#4)(1991-12#6)(1991-2#4)(1991-3#7)(1991-5#4)(1991-6#4)(1992-12#5)(1992-2#4)(1992-5#1)(1992-6#1)(1992-9#4)(1993-1#8)(1993-12#3)(1993-2#5)(1993-3#7)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#6)(1994-5#4)(1994-8#4)(1995-1#4)(1995-12#5)(1995-2#9)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#8)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#7)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#5)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-1#9)(2008-10#156)(2008-11#46)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#8)(2008-5#12)(2008-6#3)(2008-7#18)(2008-8#19)(2008-9#12)(2009-10#8)(2009-12#4)(2009-3#3)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#5)(2010-1#5)(2010-10#3)(2010-11#1)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#8)(2011-1#2)(2011-2#25)(2011-3#1)(2012-12#8)(2012-2#6)(2012-3#7)(2012-4#1)(2013-1#22)(2013-8#6)
and others have##2##3##(2008-11#1)(2008-8#1)
and others in a##2##4##(1992-3#1)(1994-12#1)
and others in##3##3##(1992-3#1)(1994-12#1)(2008-11#1)
and others that##2##3##(2010-5#1)(2013-8#1)
and others to##2##3##(1993-3#1)(2009-10#1)
and others##41##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
and others)##2##2##(2008-10#1)(2008-3#1)
and otherwise##3##2##(1995-5#1)(2008-5#1)(2013-8#1)
and otitis media##2##3##(1991-3#1)(2008-7#1)
and otolaryngology##2##2##(2008-11#2)
and our present results##2##4##(1991-5#1)(1997-2#1)
and our results##2##3##(2008-10#1)(2011-2#1)
and our##20##2##(1991-5#1)(1994-6#1)(1995-5#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
and out of##6##3##(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#2)
and out##7##2##(1992-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#2)
and out-migration##2##2##(2011-2#2)
and outbreeding depression##2##3##(2008-8#2)
and outcome measures##3##3##(1994-2#1)(2008-11#1)(2013-1#1)
and outcome of##14##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
and outcome##33##2##(1991-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-7#4)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
and outcomes for the##2##4##(1994-12#1)(2010-6#1)
and outcomes for##5##3##(1994-12#1)(1996-2#1)(2008-12#1)(2010-6#1)(2012-12#1)
and outcomes management##2##3##(1994-3#1)(1997-3#1)
and outcomes of care##3##4##(1993-3#2)(1994-2#1)
and outcomes of##13##3##(1991-12#1)(1993-3#2)(1994-2#1)(2008-12#4)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
and outcomes were##2##3##(2008-10#1)(2009-9#1)
and outcomes##50##2##(1991-12#2)(1992-1#1)(1993-3#2)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#9)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#2)
and outdoor##16##2##(2008-10#12)(2008-11#1)(2010-5#3)
and outdoors##4##2##(2008-10#2)(2012-12#2)
and outer##8##2##(1991-10#1)(2008-10#5)(2011-2#1)(2013-8#1)
and outgrowth of##2##3##(2011-2#2)
and outgrowth##10##2##(2011-2#10)
and outline##5##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
and outlines the##4##3##(1993-12#1)(1997-1#1)(2008-11#1)(2008-4#1)
and outlines##8##2##(1993-12#1)(1997-1#2)(1997-2#1)(2008-11#2)(2008-4#1)(2009-5#1)
and outlook##2##2##(1996-2#1)(2008-11#1)
and outpatient services##2##3##(1992-1#1)(1995-2#1)
and outpatient##13##2##(1992-1#2)(1992-12#3)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#3)(2013-1#1)
and output power##2##3##(2008-2#1)(2008-3#1)
and output##9##2##(2008-10#6)(2008-2#2)(2008-3#1)
and outputs##4##2##(1992-2#2)(1996-2#1)(1996-3#1)
and outside the##5##3##(1997-2#1)(2008-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
and outside##10##2##(1991-1#1)(1993-1#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
and ovalbumin##8##2##(1995-2#1)(2008-10#5)(2008-11#2)
and ovarian cancer##7##3##(1991-3#1)(1997-7#4)(2008-10#1)(2013-1#1)
and ovarian##11##2##(1991-3#1)(1995-8#2)(1997-7#4)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
and ovary##4##2##(2008-10#2)(2009-7#1)(2010-5#1)
and over##22##2##(1992-2#1)(1993-3#1)(1997-1#1)(2008-10#9)(2008-12#3)(2008-7#3)(2008-8#2)(2012-2#1)(2012-3#1)
and overall health##3##3##(2008-7#3)
and overall impression (helpfulness)##2##4##(2010-8#2)
and overall survival was##2##4##(1992-12#1)(2012-3#1)
and overall survival were##2##4##(1990-12#1)(2012-3#1)
and overall survival##5##3##(1990-12#1)(1991-8#1)(1992-12#1)(2012-3#2)
and overall##21##2##(1990-12#1)(1991-8#1)(1992-12#1)(1997-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#3)(2010-12#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#1)(2013-8#1)
and overcome##3##2##(1991-2#1)(1994-12#2)
and overexpression##2##2##(2008-11#1)(2012-2#1)
and overlap##2##2##(1996-12#1)(2013-1#1)
and overlapping of##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
and overproduction of##2##3##(1997-7#1)(2013-8#1)
and overseas##2##2##(2008-1#1)(2008-11#1)
and overweight##4##2##(1991-12#2)(1995-5#1)(2011-2#1)
and oviduct##3##2##(2008-12#3)
and oxalate##5##2##(1992-9#1)(2008-10#4)
and oxendolone##2##2##(1990-11#2)
and oxidation index##2##3##(2013-8#2)
and oxidation of the##2##4##(2008-8#2)
and oxidation of##5##3##(2008-10#3)(2008-8#2)
and oxidation##15##2##(2008-10#9)(2008-3#1)(2008-8#3)(2013-8#2)
and oxidative damage##2##3##(2013-8#2)
and oxidative stress##8##3##(2008-10#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-3#1)(2012-2#2)(2013-8#1)
and oxidative##10##2##(2008-10#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-3#1)(2012-2#2)(2013-8#3)
and oxidized LDL##2##3##(1997-8#1)(2010-3#1)
and oxidized##9##2##(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-8#1)(2010-3#1)(2012-12#1)
and oxygen saturation##3##3##(2010-10#2)(2012-2#1)
and oxygen uptake##5##3##(2008-11#2)(2013-8#3)
and oxygen##33##2##(1994-5#1)(1996-12#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
and oxyhemoglobin##2##2##(1993-1#1)(2008-11#1)
and oxymatrine##2##2##(2008-10#2)
and ozone##2##2##(2007-8#1)(2008-10#1)
and p = 0##4##4##(2008-5#1)(2011-2#3)
and p =##5##3##(2008-10#1)(2008-5#1)(2011-2#3)
and p##7##2##(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#4)
and p-cresol##3##2##(1990-8#1)(1991-5#2)
and p-nitroaniline##3##2##(2008-10#3)
and p120##2##2##(1996-2#2)
and p21cip1##2##2##(2013-1#2)
and p27##2##2##(2011-2#2)
and p35##7##2##(1995-6#1)(1997-3#1)(2008-8#5)
and p38##4##2##(2010-1#1)(2011-2#2)(2012-2#1)
and p38)##2##2##(1996-2#1)(2009-6#1)
and p53 expression in##2##4##(2008-7#1)(2012-12#1)
and p53##8##2##(1995-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-12#1)
and pH 12##2##3##(2008-11#2)
and pH 5##3##3##(1994-5#1)(2008-10#2)
and pH 6##5##3##(1997-2#1)(2008-10#4)
and pH 7##3##3##(2008-10#2)(2008-5#1)
and pH are##2##3##(2008-10#2)
and pH dependent##2##3##(1993-12#1)(1994-11#1)
and pH for the##2##4##(2008-10#2)
and pH for##3##3##(2008-10#3)
and pH in##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
and pH measurements##2##3##(2008-10#2)
and pH of the##7##4##(2008-10#6)(2008-6#1)
and pH of##17##3##(2008-10#16)(2008-6#1)
and pH on the##2##4##(2008-10#1)(2008-5#1)
and pH on##4##3##(2008-10#3)(2008-5#1)
and pH optima##2##3##(1991-12#1)(2010-3#1)
and pH values##4##3##(2008-10#3)(2010-4#1)
and pH were##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
and pH##95##2##(1990-2#2)(1991-12#2)(1991-9#2)(1993-12#1)(1994-11#1)(1994-5#2)(1997-2#1)(2008-10#66)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#2)(2010-3#2)(2010-4#1)(2013-1#1)
and pH)##2##2##(2008-10#2)
and pI##2##2##(1990-5#1)(1994-8#1)
and pK(2)##2##2##(2008-10#2)
and pK(a) values##3##3##(2008-10#3)
and pK(a)##4##2##(2008-10#4)
and pKa2##2##2##(1990-5#1)(2008-10#1)
and pSmad##2##2##(2011-2#2)
and pack##2##2##(2008-10#1)(2008-5#1)
and packaging##5##2##(1993-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)
and packed column##2##3##(2008-10#2)
and packed in##2##3##(2008-10#2)
and packed##7##2##(2008-10#7)
and packinghouses##2##2##(2008-10#2)
and paediatric##2##2##(1990-3#1)(2008-11#1)
and paediatricians##2##2##(2008-11#1)(2008-7#1)
and pain for##2##3##(2010-9#1)(2012-12#1)
and pain in the##3##4##(1993-2#1)(2008-9#1)(2012-12#1)
and pain in##5##3##(1993-2#1)(1996-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
and pain thresholds to argon laser stimulation##2##7##(1993-1#2)
and pain##26##2##(1990-9#1)(1991-3#1)(1993-1#4)(1993-2#1)(1996-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
and painful##6##2##(2008-1#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-11#1)(2013-7#1)
and painting##4##2##(2008-10#4)
and paired##4##2##(2008-10#1)(2009-2#1)(2011-2#1)(2012-2#1)
and pairwise##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
and palladium from##2##3##(2008-10#2)
and palladium in##2##3##(2008-10#2)
and palladium on##2##3##(2008-10#2)
and palladium##15##2##(2008-10#15)
and palladium(II)##6##2##(2008-10#6)
and palliative care##5##3##(1992-2#1)(2010-10#3)(2012-12#1)
and palliative##6##2##(1992-2#1)(2010-10#3)(2012-12#1)(2013-8#1)
and pancreas##4##2##(1990-3#1)(1996-12#1)(2008-8#1)(2010-11#1)
and pancreatic##7##2##(1992-3#1)(1993-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2013-1#2)
and panning##2##2##(2008-6#1)(2008-9#1)
and paper##6##2##(1995-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-4#1)
and papilla formation##2##3##(2008-10#2)
and papillary##4##2##(1993-2#2)(2011-2#2)
and paraaortic node dissection##2##4##(1994-2#2)
and paracetamol by##2##3##(2008-10#2)
and paracetamol##6##2##(2008-10#6)
and paradigms##3##2##(2008-2#1)(2009-7#1)(2009-8#1)
and paraffin##4##2##(2008-10#4)
and parallel##7##2##(1994-11#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
and parameter##3##2##(2008-10#3)
and parameters##12##2##(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#3)
and parasite##7##2##(2008-8#5)(2010-8#1)(2012-3#1)
and parasites##5##2##(2008-8#1)(2009-6#2)(2012-3#1)(2013-1#1)
and parasitic##3##2##(1996-1#1)(2008-10#1)(2012-2#1)
and parasitoid##3##2##(2008-8#3)
and parasitoids##2##2##(2008-8#1)(2009-8#1)
and paraventricular##2##2##(1996-12#1)(2008-9#1)
and parenchymal##2##2##(1991-12#1)(1992-3#1)
and parenchymatous##2##2##(1992-2#1)(1997-2#1)
and parent PAHs##2##3##(2008-11#2)
and parent##10##2##(1993-8#1)(1994-3#1)(1995-2#2)(2008-11#4)(2010-8#1)(2011-2#1)
and parental investment per offspring##2##5##(2008-9#2)
and parental investment##3##3##(2008-8#1)(2008-9#2)
and parental##14##2##(1991-11#1)(1992-2#2)(1993-1#1)(1994-6#1)(2008-12#2)(2008-8#2)(2008-9#2)(2009-7#1)(2010-9#1)(2011-2#1)
and parenteral##4##2##(2006-5#1)(2008-12#1)(2008-5#1)(2010-6#1)
and parenting practices##2##3##(2008-11#1)(2009-7#1)
and parenting##9##2##(1992-12#1)(1995-2#1)(2008-11#2)(2009-11#1)(2009-12#1)(2009-7#2)(2010-1#1)
and parents##10##2##(1990-9#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#2)
and parietal cells##2##3##(1997-1#1)(2007-12#1)
and parietal##3##2##(1997-1#1)(2007-12#1)(2010-7#1)
and parity##2##2##(1990-6#1)(2008-3#1)
and part of the##5##4##(1990-5#1)(1991-12#1)(1993-6#1)(2008-10#1)(2008-11#1)
and part of##8##3##(1990-11#1)(1990-5#1)(1991-12#1)(1993-6#1)(2008-10#2)(2008-11#2)
and part##9##2##(1990-11#1)(1990-5#1)(1991-12#1)(1993-6#1)(2008-10#2)(2008-11#3)
and partial characterization of##3##4##(1992-6#1)(1993-3#1)(2008-10#1)
and partial characterization##4##3##(1990-5#1)(1992-6#1)(1993-3#1)(2008-10#1)
and partial degradation##2##3##(2008-7#1)(2009-7#1)
and partial least square##3##4##(2008-10#3)
and partial least squares (PLS)##4##5##(2008-10#4)
and partial least squares regression##3##5##(2008-10#3)
and partial least squares##11##4##(2008-10#11)
and partial least##15##3##(2008-10#15)
and partial least-squares##2##3##(2008-10#2)
and partial##48##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1995-11#1)(1995-5#2)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#1)
and partially overlapping##2##3##(2008-8#1)(2009-10#1)
and partially purified##4##3##(1994-11#1)(1996-6#1)(2008-10#2)
and partially##19##2##(1990-5#1)(1994-11#1)(1995-8#1)(1996-6#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-2#1)(2010-3#1)
and participant##5##2##(1997-1#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
and participants##2##2##(2008-11#1)(2013-8#1)
and participate in##2##3##(2010-10#1)(2011-2#1)
and participation by##2##3##(2008-10#2)
and participation in##8##3##(1990-6#1)(1990-9#1)(1993-12#1)(1996-2#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-2#1)
and participation of##2##3##(2008-10#1)(2012-2#1)
and participation##13##2##(1990-6#1)(1990-9#1)(1993-12#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
and particle size and##2##4##(2008-3#1)(2011-2#1)
and particle size##7##3##(1993-2#1)(1995-3#1)(2008-10#3)(2008-3#1)(2011-2#1)
and particle##10##2##(1993-2#1)(1995-3#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
and particles in##2##3##(2008-10#1)(2008-3#1)
and particles##6##2##(1996-12#1)(2008-10#4)(2008-3#1)
and particular##3##2##(1995-8#1)(2008-11#1)(2008-6#1)
and particularly in##3##3##(1990-9#1)(1997-8#1)(2009-9#1)
and particularly the##2##3##(2008-5#1)(2013-1#1)
and particularly##21##2##(1990-5#1)(1990-9#1)(1991-8#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-10#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
and particulate matter##2##3##(2008-10#1)(2008-3#1)
and particulate##3##2##(2008-10#2)(2008-3#1)
and particulates##4##2##(2008-10#3)(2008-11#1)
and partitioning##2##2##(1993-8#1)(1993-9#1)
and partly with##2##3##(1995-8#1)(2011-2#1)
and partly##5##2##(1992-2#1)(1995-8#1)(2010-4#1)(2011-2#2)
and partners in##2##3##(1997-3#1)(2010-4#1)
and parvovirus B19##2##3##(2012-3#1)(2013-1#1)
and passed through a##2##4##(2008-10#2)
and passed through the##3##4##(2008-10#3)
and passed through##5##3##(2008-10#5)
and passive##6##2##(2008-10#2)(2008-4#1)(2008-9#1)(2009-8#1)(2010-10#1)
and passively##2##2##(2008-3#2)
and past gene##2##3##(2008-8#1)(2012-3#1)
and past##3##2##(2008-8#1)(2010-9#1)(2012-3#1)
and pasture##2##2##(1996-12#2)
and patch area##2##3##(2008-8#2)
and patch extinction##2##3##(2008-8#2)
and patch##5##2##(2008-8#5)
and patches##3##2##(2008-12#1)(2010-6#2)
and patent ductus arteriosus##2##4##(2008-11#2)
and patent##5##2##(1996-9#1)(2008-11#2)(2010-12#1)(2011-2#1)
and paternal care is##2##4##(2008-8#1)(2008-9#1)
and paternal##4##2##(2008-12#1)(2008-8#1)(2008-9#2)
and paternity##2##2##(2008-12#1)(2008-9#1)
and path##2##2##(2008-11#1)(2008-3#1)
and pathogen evolution##3##3##(2008-10#2)(2011-10#1)
and pathogen population##3##3##(2008-10#3)
and pathogen populations from mixtures##2##5##(2008-10#2)
and pathogen##23##2##(2008-10#19)(2008-8#1)(2011-10#2)(2012-2#1)
and pathogen-induced##2##2##(2008-10#2)
and pathogenesis of##6##3##(1990-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
and pathogenesis##9##2##(1990-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#2)
and pathogenic##14##2##(2008-10#8)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#2)
and pathogenicity on##3##3##(2008-10#3)
and pathogenicity tests##4##3##(2008-10#4)
and pathogenicity##18##2##(2008-10#16)(2011-2#1)(2013-8#1)
and pathogens##4##2##(2008-10#3)(2008-9#1)
and pathologic changes##2##3##(1996-6#1)(2010-6#1)
and pathologic conditions##3##3##(1990-12#1)(1993-12#1)(1996-6#1)
and pathologic features of##3##4##(1990-6#1)(1991-8#1)(1992-2#1)
and pathologic features##4##3##(1990-6#1)(1991-8#1)(1992-2#1)(2012-3#1)
and pathologic findings##2##3##(1991-8#1)(1997-8#1)
and pathologic##16##2##(1990-11#2)(1990-12#1)(1990-6#1)(1991-8#2)(1992-2#1)(1993-12#1)(1993-2#1)(1996-6#2)(1997-8#1)(2008-9#1)(2010-6#2)(2012-3#1)
and pathological features of##4##4##(1991-12#1)(1991-6#1)(2010-11#1)(2010-6#1)
and pathological features##5##3##(1991-12#1)(1991-6#1)(2010-11#1)(2010-6#1)(2012-2#1)
and pathological##34##2##(1990-9#3)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1994-3#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#4)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
and pathologically##2##2##(2009-1#1)(2010-12#1)
and pathologists##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
and pathology of the##2##4##(1997-1#1)(2008-1#1)
and pathology##5##2##(1997-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-1#1)
and pathophysiological##4##2##(1996-9#1)(2009-12#1)(2010-9#1)(2011-1#1)
and pathophysiology of the##2##4##(2009-10#1)(2011-1#1)
and pathophysiology of these##2##4##(1992-9#1)(2008-7#1)
and pathophysiology of##7##3##(1992-9#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-6#1)(2010-9#1)(2011-1#1)
and pathophysiology##9##2##(1992-9#1)(1994-12#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-8#1)
and pathotypes##2##2##(2008-10#2)
and pathways involved in##2##4##(2008-11#1)(2012-3#1)
and pathways involved##3##3##(2008-11#1)(2010-6#1)(2012-3#1)
and pathways of##2##3##(2009-8#1)(2013-8#1)
and pathways##11##2##(2008-11#3)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-8#2)
and patient care##5##3##(1994-1#2)(1995-2#1)(2010-12#1)(2010-2#1)
and patient education##4##3##(1996-12#1)(1996-3#1)(2008-5#1)(2010-2#1)
and patient management##2##3##(2008-10#1)(2008-3#1)
and patient outcome##2##3##(2008-11#1)(2013-8#1)
and patient outcomes##2##3##(2009-8#1)(2011-2#1)
and patient satisfaction##10##3##(1990-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
and patient##55##2##(1990-3#1)(1992-12#1)(1992-3#2)(1993-11#3)(1993-3#1)(1994-1#2)(1995-2#3)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
and patient's##3##2##(2009-8#1)(2010-10#2)
and patient-related##2##2##(2009-12#1)(2013-1#1)
and patients have##2##3##(2008-10#1)(2013-1#1)
and patients in the##2##4##(1993-1#1)(2009-8#1)
and patients in##5##3##(1990-11#1)(1993-1#1)(1995-2#1)(2009-8#1)(2011-2#1)
and patients is##2##3##(1993-3#1)(1996-1#1)
and patients to##3##3##(1991-2#1)(1997-3#1)(2009-8#1)
and patients with##16##3##(1990-12#1)(1991-6#2)(1992-11#1)(1992-12#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)
and patients##66##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-2#2)(1996-1#4)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#3)(2010-11#1)(2010-12#2)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
and patients' social##2##3##(2011-2#2)
and patients'##9##2##(2008-11#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#3)(2012-3#1)(2013-8#1)
and pattern of##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
and pattern recognition##2##3##(2008-10#2)
and pattern##10##2##(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-7#1)(2012-2#1)(2013-1#1)
and patterns in##3##3##(1991-3#1)(1994-6#1)(2011-2#1)
and patterns of##8##3##(1991-1#1)(1991-2#1)(1992-5#1)(2008-10#3)(2008-11#1)(2012-3#1)
and patterns##13##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-5#1)(1994-6#1)(2008-10#3)(2008-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
and pay##2##2##(1993-3#1)(2008-11#1)
and payers##3##2##(1991-3#1)(1995-3#1)(1997-6#1)
and payment##6##2##(1991-1#1)(1992-2#1)(1994-12#1)(1996-2#1)(2008-11#1)(2011-1#1)
and payors##2##2##(1994-1#2)
and pea##5##2##(2008-10#5)
and peach##7##2##(2008-10#7)
and peak area##3##3##(2008-10#3)
and peak areas##3##3##(2008-10#3)
and peak current##3##3##(2008-10#3)
and peak height##6##3##(2008-10#6)
and peak inspiratory##2##3##(1994-2#1)(2012-2#1)
and peak to##2##3##(2008-10#1)(2008-11#1)
and peak##34##2##(1990-12#1)(1990-9#1)(1994-2#1)(1997-3#1)(2008-10#25)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
and peanut##3##2##(1994-8#1)(2008-10#2)
and pear##3##2##(2008-10#3)
and pedagogical##2##2##(2008-11#1)(2012-3#1)
and pediatric##4##2##(1996-12#1)(2008-10#1)(2011-2#2)
and pediatrics##2##2##(1994-12#1)(1996-9#1)
and pedicle##3##2##(2007-11#2)(2008-7#1)
and peer assessment has been##2##5##(2008-11#2)
and peer assessment##6##3##(2008-11#6)
and peer##15##2##(1994-12#1)(2008-11#7)(2009-12#1)(2011-2#1)(2013-1#5)
and peers##7##2##(1990-2#3)(1991-2#1)(2010-11#1)(2013-1#2)
and pelvic pain##3##3##(1992-1#2)(1994-3#1)
and pelvic##6##2##(1992-1#2)(1993-1#1)(1994-3#1)(2011-2#2)
and pelvis and##3##3##(1991-11#1)(2012-2#2)
and pelvis##10##2##(1991-11#1)(2008-12#5)(2010-1#1)(2011-2#1)(2012-2#2)
and penetrate##3##2##(1997-6#1)(2008-10#2)
and penetrating##2##2##(1990-12#1)(2010-10#1)
and penetration of the##2##4##(2008-10#1)(2008-8#1)
and penetration of##4##3##(2008-10#3)(2008-8#1)
and penetration##7##2##(2008-10#5)(2008-5#1)(2008-8#1)
and penile##3##2##(1994-1#1)(2008-10#1)(2011-1#1)
and pentachlorophenol (PCP)##2##3##(2008-10#2)
and pentachlorophenol##3##2##(2008-10#3)
and pentaerythritol tetranitrate##2##3##(2008-10#2)
and pentagalloylglucose##2##2##(2008-10#2)
and pentavalent##2##2##(2008-10#2)
and pentoxyresorufin##2##2##(1994-8#2)
and people in New Zealand##2##5##(1996-12#2)
and people with AIDS##2##4##(1995-12#2)
and people with##4##3##(1995-12#2)(1996-12#1)(2010-12#1)
and people##8##2##(1995-12#2)(1996-12#3)(2008-10#2)(2010-12#1)
and pepper##2##2##(2008-10#2)
and peptidase##4##2##(2008-10#3)(2008-9#1)
and peptide##6##2##(1995-2#2)(1995-5#2)(2010-7#1)(2013-8#1)
and peptides##8##2##(1990-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-3#1)
and peptone after preload##2##4##(1997-4#2)
and peptone after##3##3##(1997-4#3)
and peptone##6##2##(1997-4#4)(2008-10#1)(2012-2#1)
and per##4##2##(1991-2#1)(1991-6#1)(2008-10#1)(2008-12#1)
and perceived##16##2##(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#2)(2013-1#3)
and percent clay##2##3##(2008-10#2)
and percent##14##2##(1997-8#1)(2008-10#12)(2013-1#1)
and percentage of recovery##2##4##(2008-10#1)(2008-5#1)
and percentage of##8##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)
and percentage##11##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
and perception of##3##3##(1996-3#1)(2010-11#1)(2012-12#1)
and perception##5##2##(1996-3#1)(2010-11#1)(2011-1#2)(2012-12#1)
and perceptions of##12##3##(1995-2#1)(1995-3#1)(2008-11#1)(2009-11#2)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and perceptions##13##2##(1995-2#1)(1995-3#1)(2008-11#2)(2009-11#2)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and perceptual##4##2##(1992-12#1)(2008-5#2)(2008-9#1)
and perchlorate##3##2##(2008-10#3)
and perchloric acid##3##3##(2008-10#3)
and perchloric##4##2##(2008-10#4)
and percutaneous coronary intervention##2##4##(2008-11#1)(2011-2#1)
and percutaneous##3##2##(1990-8#1)(2008-11#1)(2011-2#1)
and perform##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
and performance in the##2##4##(1995-12#1)(1996-2#1)
and performance in##5##3##(1995-12#1)(1996-2#2)(2008-11#1)(2012-12#1)
and performance of a##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)
and performance of##14##3##(1991-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-1#1)(2013-8#1)
and performance on##2##3##(2008-8#1)(2012-2#1)
and performance##44##2##(1991-3#2)(1993-12#1)(1994-1#1)(1995-12#2)(1995-2#1)(1996-2#2)(1997-3#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and performed a##2##3##(2011-2#1)(2012-3#1)
and performed##13##2##(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2009-1#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
and performing a##2##3##(1994-12#1)(2008-10#1)
and performing##6##2##(1992-5#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
and performs##2##2##(1993-3#1)(2013-8#1)
and perfusion will##2##3##(2010-12#1)(2012-2#1)
and perfusion##8##2##(1997-1#1)(1997-8#1)(2008-11#2)(2010-12#1)(2010-2#1)(2010-9#1)(2012-2#1)
and perhaps other##2##3##(1991-2#1)(2008-8#1)
and perhaps##14##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(2006-6#1)(2008-10#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-5#1)(2012-3#1)
and periampullary##2##2##(1991-3#2)
and perinatal##5##2##(2009-10#1)(2009-7#1)(2010-4#1)(2013-1#1)(2013-8#1)
and perineum##3##2##(1993-1#2)(2008-10#1)
and period##3##2##(1992-3#1)(2008-10#1)(2008-2#1)
and periodic##4##2##(1995-10#1)(1996-11#1)(2008-10#1)(2012-2#1)
and periodicity of##2##3##(1996-2#1)(2008-4#1)
and periodontal disease##4##3##(1990-3#2)(2008-1#1)(2008-5#1)
and periodontal##5##2##(1990-3#2)(2008-1#1)(2008-5#1)(2013-1#1)
and perioperative##5##2##(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)
and peripancreatic##2##2##(2012-2#2)
and peripheral arterial##2##3##(1990-11#1)(1995-2#1)
and peripheral blood lymphocytes##4##4##(1990-5#1)(1991-12#1)(1994-3#1)(2008-9#1)
and peripheral blood##10##3##(1990-5#1)(1991-12#1)(1994-3#1)(2008-10#3)(2008-9#2)(2010-8#1)(2012-3#1)
and peripheral nerve##2##3##(1992-6#1)(2008-12#1)
and peripheral tissues##2##3##(1991-2#1)(1997-8#1)
and peripheral vascular##2##3##(2008-8#1)(2010-9#1)
and peripheral##44##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#4)(1997-8#2)(2007-12#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
and periphery##2##2##(1996-12#1)(2008-10#1)
and peristaltic##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
and peritoneal dialysis##5##3##(1994-5#1)(2008-10#4)
and peritoneal tuberculosis##2##3##(2013-1#2)
and peritoneal##10##2##(1991-12#2)(1994-5#1)(1997-4#1)(2008-10#4)(2013-1#2)
and peritoneum##2##2##(2008-5#2)
and perivascular infiltrating inflammatory cells##3##5##(2012-3#3)
and perivascular##4##2##(1995-12#1)(2012-3#3)
and periventricular##2##2##(2011-2#1)(2012-3#1)
and permanent morbidity was##3##4##(2008-7#3)
and permanent##14##2##(1996-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#3)
and permanganate##4##2##(2008-10#4)
and permeate##2##2##(2008-10#2)
and permeation##4##2##(2008-10#1)(2008-5#3)
and permit##5##2##(1993-12#1)(1995-5#1)(2008-10#2)(2008-9#1)
and permits the##2##3##(2008-10#2)
and permits##5##2##(2008-10#2)(2009-10#1)(2010-6#1)(2012-12#1)
and permitted the##2##3##(2008-10#2)
and permitted##3##2##(2008-10#2)(2012-2#1)
and peroxidase activities##2##3##(1994-5#1)(2008-10#1)
and peroxidase##10##2##(1991-2#1)(1994-5#2)(2008-10#7)
and peroxide##2##2##(2008-10#1)(2008-5#1)
and peroxynitrite##3##2##(2008-10#2)(2011-2#1)
and persistence of the##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
and persistence of##11##3##(1993-8#2)(1995-9#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#2)
and persistence##18##2##(1993-8#2)(1995-5#1)(1995-9#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)
and persistent##11##2##(1990-3#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2013-1#1)
and personal digital assistant##2##4##(2008-10#1)(2008-3#1)
and personal health care##2##4##(1996-1#1)(1997-3#1)
and personal##28##2##(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#2)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-3#1)(2009-11#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
and personality##4##2##(1990-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
and personalized##2##2##(2010-10#2)
and personnel##5##2##(1993-12#1)(1997-3#1)(2008-10#3)
and persons##2##2##(1990-11#1)(1994-9#1)
and perspective##2##2##(2008-4#1)(2012-12#1)
and perspectives##6##2##(2008-11#2)(2008-12#1)(2008-3#1)(2009-12#1)(2012-12#1)
and perturbed##3##2##(2008-10#2)(2013-1#1)
and pertussis##4##2##(1995-3#1)(1995-5#1)(1997-1#1)(2007-11#1)
and pervasive##2##2##(2009-11#1)(2012-2#1)
and pest##3##2##(2008-10#2)(2008-8#1)
and pesticides##5##2##(2008-10#4)(2009-8#1)
and petal##2##2##(2008-10#2)
and petioles##2##2##(2008-10#2)
and petroleum##2##2##(2008-10#1)(2008-11#1)
and phage##3##2##(1993-8#1)(1993-9#1)(2013-1#1)
and pharmaceutical dosage##2##3##(2008-10#2)
and pharmaceutical formulations##7##3##(2008-10#7)
and pharmaceutical industries##2##3##(2008-10#2)
and pharmaceutical preparations##5##3##(2008-10#5)
and pharmaceutical products##2##3##(2008-10#1)(2008-5#1)
and pharmaceutical samples##5##3##(2008-10#4)(2012-2#1)
and pharmaceutical##26##2##(1991-6#1)(2008-10#22)(2008-5#1)(2012-2#2)
and pharmaceuticals##8##2##(2008-10#8)
and pharmacist##2##2##(1994-12#1)(2013-1#1)
and pharmacists##2##2##(1994-12#1)(1995-2#1)
and pharmacodynamics of##2##3##(1991-1#1)(1991-2#1)
and pharmacokinetic characteristics##2##3##(2008-10#1)(2013-1#1)
and pharmacokinetic##4##2##(1990-6#1)(1993-12#1)(2008-10#1)(2013-1#1)
and pharmacokinetics of##2##3##(1996-1#1)(2008-11#1)
and pharmacokinetics##3##2##(1996-1#1)(2008-11#1)(2009-12#1)
and pharmacologic##3##2##(1993-1#1)(2008-4#1)(2008-7#1)
and pharmacological properties of##2##4##(1994-11#1)(1995-11#1)
and pharmacological##14##2##(1991-2#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-10#2)(2011-1#1)(2011-3#1)(2012-3#1)(2013-8#1)
and pharmacology##3##2##(1994-1#1)(1995-11#1)(2012-2#1)
and pharmacotherapy##3##2##(1991-2#1)(2008-4#1)(2013-1#1)
and pharmacy##5##2##(1991-1#1)(1993-3#1)(1994-12#1)(1997-2#1)(2009-6#1)
and pharynx##5##2##(1990-8#2)(1995-5#1)(1997-6#1)(2011-2#1)
and phase I trials in##2##5##(2008-5#2)
and phase II##2##3##(1995-12#1)(2008-5#1)
and phase##30##2##(1991-9#1)(1994-5#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#4)(2008-8#1)(2010-4#2)(2012-2#2)(2013-3#2)(2013-8#5)
and phenobarbital##2##2##(2008-10#2)
and phenol in##2##3##(2008-10#2)
and phenol##5##2##(2008-10#5)
and phenolic compounds##2##3##(2008-10#1)(2013-1#1)
and phenolic##3##2##(2008-10#2)(2013-1#1)
and phenols in##3##3##(2008-10#3)
and phenols##5##2##(2008-10#5)
and phenotype in##2##3##(2008-8#2)
and phenotype of arylsulfatase A##2##5##(1997-3#2)
and phenotype of##3##3##(1997-3#2)(2010-7#1)
and phenotype##8##2##(1997-3#2)(2008-10#1)(2008-8#2)(2009-6#1)(2010-7#1)(2012-3#1)
and phenotypes##4##2##(2008-11#1)(2010-4#2)(2010-7#1)
and phenotypic analyses##2##3##(1997-3#1)(2008-10#1)
and phenotypic information##2##3##(2008-10#1)(2008-5#1)
and phenotypic##17##2##(1992-2#1)(1993-2#1)(1997-3#1)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
and phenotypically##3##2##(2008-10#2)(2011-1#1)
and phenyl##2##2##(2008-10#2)
and phenylalanine (Phe)##2##3##(2008-10#1)(2013-1#1)
and phenylalanine##6##2##(1994-5#1)(1995-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
and phenylhydrazine##10##2##(2008-10#10)
and phenylmercury##5##2##(2008-10#5)
and phenylpropanoids##2##2##(2008-11#2)
and phenytoin##6##2##(2008-10#4)(2008-11#1)(2011-1#1)
and phi##2##2##(1991-11#1)(2008-10#1)
and philanthropic##2##2##(2008-8#1)(2009-4#1)
and philosophical##2##2##(2008-11#1)(2008-12#1)
and philosophy##2##2##(2008-11#1)(2008-12#1)
and phloem##6##2##(2008-10#2)(2012-8#4)
and phonological awareness skills##2##4##(2008-9#1)(2011-1#1)
and phonological awareness##7##3##(2008-12#3)(2008-9#1)(2011-1#2)(2011-2#1)
and phonological##8##2##(2008-12#3)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)
and phorbol ester##2##3##(1990-12#1)(1996-2#1)
and phorbol ester-stimulated##2##3##(1991-5#1)(1995-6#1)
and phorbol esters##2##3##(1996-2#1)(2008-11#1)
and phorbol##11##2##(1990-12#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-2#3)(2008-11#1)
and phosphatase activity##2##3##(1994-8#1)(2011-1#1)
and phosphate buffer##3##3##(2008-10#2)(2011-3#1)
and phosphate in##2##3##(2008-10#2)
and phosphate salts##2##3##(2011-2#2)
and phosphate were##2##3##(1996-6#1)(2008-10#1)
and phosphate##21##2##(1996-6#1)(2008-1#1)(2008-10#14)(2008-7#1)(2011-2#3)(2011-3#1)
and phosphatidylethanolamine##2##2##(2008-8#1)(2012-2#1)
and phosphodiesterase##2##2##(2010-10#2)
and phosphoglycerate mutase##3##3##(1993-3#1)(2010-12#2)
and phosphoinositide##3##2##(1996-2#2)(1997-1#1)
and phospholipase##4##2##(1994-6#2)(2008-5#1)(2011-2#1)
and phospholipid##6##2##(1992-11#1)(1993-8#1)(1994-3#1)(1995-6#1)(2009-10#1)(2012-2#1)
and phospholipids##5##2##(1991-12#1)(2008-10#1)(2008-11#2)(2011-2#1)
and phosphomolybdic acid##2##3##(2008-10#2)
and phosphoric##2##2##(2008-10#2)
and phosphorous##3##2##(2008-10#1)(2008-11#2)
and phosphorus in##2##3##(2013-1#1)(2013-8#1)
and phosphorus##7##2##(2008-10#5)(2013-1#1)(2013-8#1)
and phosphorylated##3##2##(1994-2#1)(1996-12#1)(1996-2#1)
and phosphorylation of##5##3##(1992-7#1)(1994-8#1)(1995-2#1)(2008-11#1)(2011-2#1)
and phosphorylation##10##2##(1992-6#1)(1992-7#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-11#1)(2011-2#1)(2013-1#2)
and photochemical##3##2##(1994-3#1)(2008-10#1)(2011-3#1)
and photocoagulation##2##2##(1993-1#1)(1993-6#1)
and photoluminescence##4##2##(2008-10#3)(2009-11#1)
and photometric##3##2##(2008-10#3)
and photosensitive##3##2##(1995-6#1)(2008-8#2)
and photostability##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
and photosynthetic##3##2##(1994-3#1)(2008-12#1)(2008-9#1)
and phthalic##4##2##(2008-10#4)
and phylloplane of creeping bentgrass##2##5##(2008-10#2)
and phylogenetic analyses of##2##4##(2008-10#2)
and phylogenetic analyses##4##3##(2008-10#2)(2013-8#2)
and phylogenetic analysis of##2##4##(1993-12#1)(2008-10#1)
and phylogenetic analysis suggested that##2##5##(2008-10#2)
and phylogenetic analysis##9##3##(1993-12#1)(2008-10#7)(2008-8#1)
and phylogenetic characterization of##2##4##(2008-10#2)
and phylogenetic relationships##5##3##(2008-10#4)(2009-10#1)
and phylogenetic significance of##2##4##(2010-3#1)(2013-1#1)
and phylogenetic##28##2##(1993-12#1)(2008-10#17)(2008-8#3)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and phylogeny##2##2##(2008-6#1)(2008-8#1)
and physical activity behaviors##2##4##(2012-2#1)(2013-1#1)
and physical activity on##2##4##(2010-9#1)(2013-8#1)
and physical activity##15##3##(1997-1#1)(2009-6#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
and physical and##2##3##(2010-11#1)(2013-1#1)
and physical changes##2##3##(2008-10#1)(2008-5#1)
and physical development##2##3##(2008-11#1)(2013-1#1)
and physical examination is##2##4##(1995-11#1)(2008-11#1)
and physical examination to##2##4##(2010-7#1)(2011-2#1)
and physical examination##11##3##(1991-12#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-7#1)(2011-2#3)(2013-8#1)
and physical exercise##2##3##(1996-11#1)(2008-7#1)
and physical function##2##3##(2011-2#1)(2013-1#1)
and physical functioning##2##3##(1995-3#1)(2013-1#1)
and physical health##4##3##(1996-9#1)(2009-5#1)(2010-3#1)(2012-2#1)
and physical mapping of##2##4##(2008-10#2)
and physical mapping##4##3##(1997-9#1)(2008-10#3)
and physical performance##2##3##(2009-3#1)(2010-2#1)
and physical properties##5##3##(1995-11#1)(2008-10#1)(2010-4#1)(2010-7#2)
and physical therapy##3##3##(1997-6#1)(2008-12#1)(2010-6#1)
and physical##90##2##(1991-12#1)(1992-2#1)(1993-1#1)(1995-11#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-9#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#5)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-2#5)(2012-12#1)(2012-2#6)(2013-1#9)(2013-8#4)
and physically##2##2##(1997-8#1)(2008-8#1)
and physician education##2##3##(1994-12#1)(1997-1#1)
and physician##17##2##(1992-1#3)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#2)(1996-12#2)(1996-3#1)(1997-1#1)(2008-11#2)(2008-8#1)(2009-12#1)(2012-3#1)
and physicians and##2##3##(1992-1#1)(2008-11#1)
and physicians can##2##3##(1991-3#1)(1996-1#1)
and physicians##14##2##(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-3#1)(1995-12#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-4#1)(2008-11#2)(2008-8#1)
and physicochemical characteristics##2##3##(2008-10#2)
and physicochemical properties of##2##4##(1993-1#1)(2008-10#1)
and physicochemical properties##3##3##(1993-1#1)(2008-10#1)(2011-2#1)
and physicochemical##7##2##(1993-1#1)(2008-10#4)(2010-7#1)(2011-2#1)
and physiologic##5##2##(1993-1#1)(1993-6#1)(1996-3#1)(2009-12#1)(2013-7#1)
and physiological processes##2##3##(2008-10#1)(2011-2#1)
and physiological role of##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
and physiological##37##2##(1992-3#1)(2008-10#6)(2008-11#3)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#2)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
and physiology of the##3##4##(1997-1#1)(2008-8#1)(2010-9#1)
and physiology of this##2##4##(2009-9#1)(2011-1#1)
and physiology of##7##3##(1997-1#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-9#1)(2011-1#1)
and physiology##13##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#2)
and physiology)##2##2##(2008-9#1)(2010-8#1)
and physiotherapists##2##2##(1991-2#1)(1996-6#1)
and phytotoxicity##2##2##(2008-10#1)(2011-1#1)
and pi-pi##2##2##(2008-10#1)(2009-11#1)
and pictorial##2##2##(2011-2#1)(2012-2#1)
and piezoelectric##2##2##(1992-3#1)(2008-10#1)
and pig##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
and pigment##2##2##(2008-8#1)(2010-10#1)
and pigmentary##2##2##(1994-12#1)(2013-1#1)
and pigmentation##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
and pilot##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
and pindolol##5##2##(2008-10#5)
and piperidine##2##2##(2008-10#2)
and piriform##2##2##(1996-12#1)(2013-1#1)
and pitfalls##4##2##(1994-6#1)(2008-9#1)(2012-2#2)
and pituitary##6##2##(1993-9#1)(1997-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-8#1)
and pk(a(2))=8##2##2##(2008-10#2)
and pk(a(2))=9##3##2##(2008-10#3)
and place##2##2##(1990-6#1)(1993-3#1)
and placebo##5##2##(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
and placed in a##3##4##(2008-10#3)
and placed in##10##3##(1996-11#1)(2008-10#6)(2008-12#1)(2009-5#1)(2009-9#1)
and placement##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
and placenta##4##2##(1990-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
and placental##6##2##(1990-4#1)(1995-6#1)(1995-8#1)(2008-9#3)
and plan##2##2##(1991-12#1)(1993-1#1)
and planning##8##2##(1992-12#1)(1994-1#2)(1994-2#2)(1996-2#1)(2008-11#1)(2008-12#1)
and plans##8##2##(1994-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-4#3)
and plant cells##4##3##(2008-11#2)(2008-8#1)(2009-8#1)
and plant death##2##3##(2008-10#2)
and plant disease##2##3##(2008-10#2)
and plant growth##4##3##(2008-10#3)(2008-12#1)
and plant kingdoms##2##3##(2008-11#1)(2008-8#1)
and plant samples##3##3##(2008-10#2)(2008-11#1)
and plant##54##2##(1992-3#1)(2008-10#29)(2008-11#5)(2008-12#2)(2008-8#7)(2008-9#3)(2009-6#2)(2009-8#3)(2011-2#1)(2013-8#1)
and planted with##2##3##(2008-10#1)(2008-12#1)
and planted##4##2##(2008-10#3)(2008-12#1)
and plants and is##2##4##(2008-10#1)(2013-8#1)
and plants were##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
and plants with##2##3##(2008-10#2)
and plants##18##2##(1997-3#1)(2008-10#10)(2008-12#1)(2008-8#3)(2008-9#1)(2011-10#1)(2013-8#1)
and plaque##4##2##(2008-1#1)(2009-1#1)(2010-12#1)(2012-2#1)
and plasma V level and V loss##2##7##(2011-2#2)
and plasma V level and##3##5##(2011-2#3)
and plasma V level##4##4##(2011-2#4)
and plasma and##2##3##(1994-8#1)(2008-10#1)
and plasma components##2##3##(1990-11#1)(2008-11#1)
and plasma membrane##4##3##(1993-1#1)(1993-3#1)(2008-10#1)(2013-1#1)
and plasma of##3##3##(2013-1#3)
and plasma##47##2##(1990-11#1)(1990-8#2)(1991-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#2)(1995-2#1)(1996-5#1)(1996-8#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#2)
and plasma)##2##2##(1992-3#1)(2008-10#1)
and plasmapheresis##2##2##(2012-3#1)(2013-8#1)
and plasminogen activator##3##3##(1992-7#1)(2008-11#2)
and plasminogen##4##2##(1992-7#1)(2008-11#2)(2013-8#1)
and plasmodium##2##2##(1994-11#2)
and plastic coverslips##2##3##(2008-10#2)
and plastic##4##2##(1990-3#1)(2008-10#3)
and plasticity##7##2##(1996-12#1)(1997-7#1)(2008-11#2)(2009-3#1)(2009-9#1)(2012-2#1)
and plasticizer##5##2##(2008-10#5)
and plated##3##2##(2008-10#1)(2008-11#2)
and platelet##10##2##(1990-5#1)(1991-12#1)(1992-12#1)(1994-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2012-12#2)
and platelets##7##2##(1992-12#1)(2006-6#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
and platinum##7##2##(2008-10#6)(2008-11#1)
and play a role in##3##5##(1997-7#2)(2008-10#1)
and play a significant role in##2##6##(2008-8#1)(2012-2#1)
and play a##8##3##(1997-7#2)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and play an essential role##2##5##(1992-11#1)(1997-7#1)
and play an##3##3##(1992-11#1)(1997-7#1)(2008-9#1)
and play important roles in##2##5##(1997-8#1)(2012-3#1)
and play important roles##3##4##(1997-8#1)(2010-12#1)(2012-3#1)
and play##17##2##(1992-11#1)(1997-7#3)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and playing surface##2##3##(1990-6#2)
and playing##4##2##(1990-6#2)(2010-8#1)(2012-12#1)
and plays a role in##2##5##(1997-2#1)(2012-2#1)
and plays a##4##3##(1995-8#1)(1997-2#1)(2011-2#1)(2012-2#1)
and plays an important role in the##3##7##(1990-9#1)(2008-11#1)(2010-10#1)
and plays an important role in##7##6##(1990-9#1)(1996-12#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#2)
and plays an important##8##4##(1990-9#1)(1996-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#2)
and plays##13##2##(1990-9#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#3)(2012-2#1)
and pleural##4##2##(1991-12#1)(2007-8#1)(2008-5#1)(2011-2#1)
and pleurisy##2##2##(2011-2#2)
and pneumolysin##3##2##(2008-10#3)
and pneumonia##3##2##(1992-2#1)(1994-6#1)(2008-1#1)
and pod##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
and pods##2##2##(2008-10#1)(2013-8#1)
and point to##2##3##(2008-11#1)(2012-12#1)
and point##9##2##(2008-10#2)(2008-11#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
and points out##3##3##(1995-2#1)(1997-5#1)(2008-6#1)
and points to##3##3##(1995-5#1)(2008-10#1)(2008-4#1)
and points##7##2##(1992-12#1)(1995-2#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-6#1)
and polar##4##2##(2008-10#3)(2008-5#1)
and polarimetric detectors##2##3##(2008-10#2)
and polarimetric##3##2##(2008-10#2)(2008-3#1)
and polarity##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
and polarization of##2##3##(2008-3#2)
and polarization##4##2##(2008-10#1)(2008-3#3)
and polarized##3##2##(2008-10#1)(2008-3#2)
and polarographic##3##2##(2008-10#3)
and police##2##2##(1992-2#1)(2008-7#1)
and policies##7##2##(1993-3#1)(1994-12#1)(1996-12#1)(2008-11#1)(2010-1#2)(2010-10#1)
and policy implications on##2##4##(1991-12#1)(2008-11#1)
and policy implications##4##3##(1991-12#2)(1996-1#1)(2008-11#1)
and policy makers##4##3##(1994-12#1)(1996-2#1)(2009-7#1)(2010-8#1)
and policy##19##2##(1991-1#3)(1991-12#2)(1991-2#1)(1993-1#1)(1993-11#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#1)(2009-3#1)(2009-7#1)(2010-8#1)(2012-2#2)
and policy-makers##3##2##(1995-3#1)(2008-11#1)(2013-1#1)
and policymakers##3##2##(1992-3#1)(2009-4#1)(2010-4#1)
and political##16##2##(1993-1#1)(1993-11#1)(1993-12#1)(1996-3#1)(1997-2#1)(2008-1#3)(2008-11#4)(2008-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
and politics##2##2##(2008-11#2)
and pollen tubes of Lilium davidii##2##6##(2008-8#2)
and pollen tubes##3##3##(2008-8#3)
and pollen##10##2##(2008-10#3)(2008-8#4)(2009-10#2)(2012-7#1)
and pollination and seed dispersal##2##5##(2008-9#2)
and pollination##4##2##(2008-10#1)(2008-9#2)(2009-6#1)
and pollutants##4##2##(2008-10#2)(2009-8#1)(2011-1#1)
and poly##2##2##(2008-10#1)(2009-7#1)
and poly(1##2##2##(2008-10#2)
and poly(2-acrylamido-2-methylpropane sulfonate)##2##3##(2008-10#2)
and poly(ethylene##3##2##(2008-10#2)(2013-1#1)
and poly-deoxyguanosine(11)##2##2##(2008-10#2)
and poly-drug users who used##2##5##(2013-8#2)
and poly-drug users##3##3##(2013-8#3)
and polyamine biosynthesis inhibitors##2##4##(2008-10#2)
and polyamine##3##2##(1993-9#1)(2008-10#2)
and polyandry in##2##3##(2008-9#2)
and polyaniline##3##2##(2008-10#3)
and polychlorinated biphenyls (PCBs) in##2##5##(2008-10#2)
and polychlorinated biphenyls##3##3##(2008-10#3)
and polychlorinated dibenzofurans##3##3##(2008-10#3)
and polychlorinated##7##2##(2008-10#7)
and polyclonal antibodies##4##3##(1990-5#2)(2008-1#1)(2008-10#1)
and polyclonal##5##2##(1990-5#2)(2008-1#1)(2008-10#1)(2008-5#1)
and polycystic##3##2##(1997-1#1)(2008-5#1)(2010-8#1)
and polymer##5##2##(2008-10#3)(2008-7#1)(2012-2#1)
and polymerase chain reaction (PCR) assays##2##6##(2008-10#2)
and polymerase chain reaction (PCR)##8##5##(1992-6#1)(1994-1#1)(2008-10#5)(2011-2#1)
and polymerase chain reaction and##2##5##(2008-10#1)(2011-2#1)
and polymerase chain reaction##13##4##(1992-6#1)(1994-1#1)(1995-12#1)(2008-10#8)(2011-2#2)
and polymerase chain reaction-restriction fragment length polymorphism##2##7##(2008-10#2)
and polymerase chain##17##3##(1992-6#2)(1994-1#1)(1995-12#1)(2008-10#11)(2011-2#2)
and polymeric##3##2##(2008-10#2)(2012-12#1)
and polymerization##4##2##(1993-8#1)(2008-10#2)(2012-2#1)
and polymorphic##5##2##(1992-6#2)(1995-6#1)(2008-10#1)(2009-10#1)
and polymorphisms##2##2##(2008-10#1)(2008-11#1)
and polymorphonuclear##2##2##(1992-12#1)(2008-7#1)
and polyparasitism##2##2##(2012-12#2)
and polyphenols##7##2##(2008-10#5)(2011-2#1)(2011-3#1)
and polyspermy##4##2##(2008-8#4)
and polystyrene##4##2##(2008-10#1)(2008-11#3)
and poor differentiation##2##3##(2011-2#1)(2012-3#1)
and poor##25##2##(1990-12#1)(1991-12#1)(1991-8#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-12#3)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and poorer##6##2##(1991-8#1)(1995-12#1)(1995-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
and poorly defined##2##3##(2008-11#1)(2010-8#1)
and poorly managed##2##3##(2008-10#2)
and poorly##5##2##(1994-1#1)(2008-10#2)(2008-11#1)(2010-8#1)
and popular##2##2##(2008-6#1)(2010-1#1)
and population biology##2##3##(2008-8#1)(2008-9#1)
and population densities of H##3##5##(2008-10#3)
and population densities##5##3##(2008-10#4)(2008-8#1)
and population density##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
and population differentiation##3##3##(2008-10#1)(2012-3#2)
and population dynamics of the##2##5##(2008-10#2)
and population dynamics##4##3##(2008-10#3)(2008-8#1)
and population genetic##2##3##(2008-8#1)(2008-9#1)
and population levels##2##3##(2008-10#1)(2010-5#1)
and population structure of##2##4##(2008-10#1)(2013-8#1)
and population structure##4##3##(2008-10#2)(2012-3#1)(2013-8#1)
and population##44##2##(1991-6#1)(1997-2#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-8#8)(2008-9#4)(2009-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#3)(2013-8#2)
and population-based##3##2##(1996-12#1)(1997-8#1)(2008-10#1)
and populations of##2##3##(2008-10#2)
and populations##7##2##(1996-2#1)(2008-10#4)(2008-8#1)(2010-8#1)
and pore size##4##3##(2008-10#2)(2008-7#1)(2009-11#1)
and pore##6##2##(2007-12#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-10#1)
and pork##3##2##(2008-10#2)(2010-4#1)
and porosity##3##2##(2009-7#1)(2010-7#1)(2010-9#1)
and porous##2##2##(2009-12#1)(2012-2#1)
and porphyrin##2##2##(2008-10#2)
and portability##3##2##(2008-10#2)(2009-12#1)
and portable##7##2##(2008-10#6)(2010-7#1)
and portal hypertension##4##3##(2009-8#3)(2010-10#1)
and portal##8##2##(1997-8#2)(2009-2#1)(2009-8#3)(2010-10#1)(2011-2#1)
and poses a##2##3##(1995-2#1)(2013-8#1)
and poses##4##2##(1995-2#1)(2008-11#1)(2012-12#1)(2013-8#1)
and position of the##4##4##(2008-10#1)(2009-10#1)(2010-12#1)(2011-2#1)
and position of##6##3##(1990-2#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)
and position##9##2##(1990-2#1)(2008-10#2)(2008-8#1)(2009-10#2)(2010-12#1)(2011-2#1)(2012-3#1)
and positional##2##2##(2008-10#1)(2008-2#1)
and positioned##3##2##(1994-2#1)(1997-9#1)(2008-10#1)
and positioning##4##2##(1997-4#1)(2008-7#1)(2009-10#1)(2012-3#1)
and positions of##2##3##(1997-6#1)(2008-10#1)
and positive and negative##3##4##(2009-11#1)(2013-1#2)
and positive controls##2##3##(2008-10#2)
and positive predictive##3##3##(1994-3#1)(2008-11#1)(2012-12#1)
and positive samples##2##3##(2008-1#1)(2008-10#1)
and positive##35##2##(1990-12#1)(1991-4#1)(1991-6#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
and positively charged##4##3##(1990-5#1)(2008-10#2)(2008-7#1)
and positively correlated with##7##4##(2008-10#6)(2011-2#1)
and positively##19##2##(1990-11#1)(1990-5#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
and posits##2##2##(2008-11#1)(2008-12#1)
and possesses##3##2##(1994-11#1)(2008-10#1)(2011-1#1)
and possibilities of##4##3##(1993-11#1)(1994-6#1)(2007-11#1)(2011-3#1)
and possibilities##6##2##(1993-11#1)(1994-6#1)(2007-11#1)(2008-10#2)(2011-3#1)
and possible contributing factors##2##4##(2008-11#1)(2011-2#1)
and possible future directions##2##4##(1996-12#1)(2008-11#1)
and possible future##3##3##(1996-12#1)(2008-11#1)(2011-7#1)
and possible mechanisms##2##3##(1991-1#1)(2008-8#1)
and possible solutions##3##3##(2009-6#1)(2010-6#1)(2011-1#1)
and possible treatment##2##3##(2008-7#2)
and possible##49##2##(1990-5#1)(1991-1#1)(1991-6#1)(1992-2#1)(1993-8#2)(1996-12#1)(1997-5#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
and possibly also##2##3##(1993-8#1)(1996-12#1)
and possibly for##2##3##(2013-1#1)(2013-8#1)
and possibly other##7##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)
and possibly the##2##3##(1992-12#1)(2010-7#1)
and possibly##35##2##(1990-5#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-6#1)(1993-8#1)(1995-2#1)(1996-12#3)(1996-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and post registration##3##3##(2008-11#2)(2008-12#1)
and post##11##2##(1995-9#1)(2008-11#3)(2008-12#1)(2008-7#1)(2010-8#1)(2010-9#1)(2011-3#1)(2013-1#1)(2013-8#1)
and post-column##3##2##(2008-10#3)
and post-genomic##2##2##(2009-9#1)(2012-3#1)
and post-operative##4##2##(1990-9#1)(2010-11#1)(2010-12#1)(2012-2#1)
and post-stage##2##2##(2013-8#2)
and post-test design##2##3##(1993-1#1)(1996-1#1)
and post-test##6##2##(1993-1#1)(1994-1#3)(1996-1#1)(1996-5#1)
and post-traumatic##3##2##(1990-9#1)(2012-3#1)(2013-8#1)
and post-treatment##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
and posterior cingulate##2##3##(2008-11#1)(2013-8#1)
and posterior interosseous neurectomy##2##4##(2008-9#2)
and posterior##35##2##(1990-12#1)(1993-1#1)(1993-12#1)(1995-2#1)(1997-3#1)(2007-12#2)(2008-11#2)(2008-12#4)(2008-7#2)(2008-8#6)(2008-9#2)(2010-4#1)(2010-6#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
and postexercise##2##2##(2013-8#2)
and postgraduate##5##2##(1994-12#2)(1997-5#1)(2008-11#1)(2013-8#1)
and postinfectious##2##2##(2008-10#1)(2010-12#1)
and postmenopausal patients##2##3##(1994-12#1)(1994-2#1)
and postmenopausal##3##2##(1994-12#1)(1994-2#1)(2008-11#1)
and postnatal##10##2##(1993-12#1)(1993-3#2)(1994-11#2)(1995-1#1)(1996-12#1)(2012-2#2)(2013-1#1)
and postoperative care##2##3##(2010-7#2)
and postoperative complications##2##3##(2008-9#1)(2011-3#1)
and postoperative treatment##2##3##(1990-12#1)(1992-9#1)
and postoperative##20##2##(1990-12#2)(1992-9#1)(1994-12#1)(1994-3#1)(2008-7#1)(2008-9#3)(2010-3#1)(2010-7#2)(2010-8#2)(2011-2#1)(2011-3#1)(2011-7#1)(2012-3#1)(2013-1#2)
and postoperatively##3##2##(2009-10#2)(2013-8#1)
and postpartum##5##2##(2008-10#1)(2008-8#1)(2008-9#3)
and postprandial plasma##2##3##(2011-1#1)(2012-3#1)
and postprandial##6##2##(2011-1#3)(2012-3#2)(2012-4#1)
and postsynaptic neurons##2##3##(2008-11#1)(2009-8#1)
and postsynaptic##5##2##(1990-12#1)(2008-11#1)(2009-8#1)(2009-9#2)
and posttraumatic stress##4##3##(2009-11#2)(2012-3#2)
and postural##3##2##(2008-12#1)(2008-7#1)(2010-12#1)
and postzygotic##2##2##(2012-3#2)
and potassium bromate in phosphoric acid medium##2##7##(2008-10#2)
and potassium bromate##5##3##(2008-10#4)(2008-9#1)
and potassium chloride##2##3##(2008-10#2)
and potassium concentrations##2##3##(1995-8#1)(2008-10#1)
and potassium gadolinium tungstate##2##4##(2008-10#2)
and potassium in##3##3##(2008-10#2)(2008-12#1)
and potassium nitrate##2##3##(2008-10#2)
and potassium##45##2##(1995-8#1)(1996-2#1)(2008-10#39)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
and potato##17##2##(2008-10#15)(2008-12#1)(2008-8#1)
and potatoes##2##2##(1990-8#1)(2008-10#1)
and potency##3##2##(1994-8#1)(1997-4#1)(2008-10#1)
and potent##7##2##(1992-6#1)(1993-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#1)
and potential application in##2##4##(2008-10#1)(2013-1#1)
and potential for##2##3##(2008-10#1)(2008-11#1)
and potential health##2##3##(2008-12#1)(2011-1#1)
and potential liability##2##3##(1991-12#1)(1993-2#1)
and potential of##5##3##(2008-10#2)(2008-11#1)(2010-7#1)(2011-2#1)
and potential pitfalls##2##3##(2008-4#1)(2012-2#1)
and potential pulse amplitude##2##4##(2008-10#2)
and potential solutions##2##3##(1996-12#1)(2010-6#1)
and potential uses of##2##4##(1996-3#1)(2010-5#1)
and potential##66##2##(1991-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#2)
and potentially interfering ions of##2##5##(2008-10#2)
and potentially toxic##2##3##(2008-10#1)(2008-7#1)
and potentially##33##2##(1993-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
and potentials on pH##2##4##(2008-10#2)
and potentials##3##2##(2008-10#3)
and potentiated##2##2##(2008-10#1)(2008-11#1)
and potentiates##2##2##(1997-4#1)(2010-12#1)
and potentiometric titration##3##3##(2008-10#3)
and potentiometric##7##2##(2008-10#7)
and potentiometry##3##2##(2008-10#3)
and potyviruses##2##2##(2008-10#2)
and powder inhalers##2##3##(1992-3#1)(1996-1#1)
and powder##6##2##(1992-3#1)(1996-1#1)(2008-10#2)(2009-7#1)(2010-4#1)
and power##10##2##(1994-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
and powerful##7##2##(2008-10#2)(2008-4#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
and practical aspects##2##3##(1991-12#1)(2008-11#1)
and practical considerations##2##3##(2008-1#1)(2008-11#1)
and practical field##2##3##(2008-10#1)(2008-3#1)
and practical issues regarding##2##4##(1996-6#1)(2008-10#1)
and practical training##3##3##(1994-12#3)
and practical##36##2##(1991-12#1)(1993-12#1)(1994-12#3)(1995-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#4)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)
and practically##4##2##(1993-11#1)(1997-6#1)(2008-10#2)
and practice are discussed##2##4##(2008-11#1)(2008-12#1)
and practice are##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
and practice can##2##3##(2008-11#1)(2011-2#1)
and practice guidelines##2##3##(1993-12#1)(2010-10#1)
and practice in##4##3##(2008-11#1)(2012-3#1)(2013-8#2)
and practice is##4##3##(2008-1#1)(2008-11#1)(2010-10#2)
and practice of cancer pain treatment##2##6##(1997-3#2)
and practice of##11##3##(1993-12#1)(1994-5#1)(1995-1#1)(1997-3#3)(2008-11#1)(2008-5#1)(2013-1#3)
and practice##80##2##(1990-3#1)(1990-8#1)(1991-3#1)(1992-3#1)(1993-12#3)(1994-1#1)(1994-5#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-2#1)(1997-3#4)(2008-1#2)(2008-10#1)(2008-11#18)(2008-12#10)(2008-4#2)(2008-5#2)(2008-8#1)(2010-10#12)(2011-2#3)(2012-3#2)(2013-1#7)(2013-8#2)
and practiced##2##2##(2009-10#1)(2013-1#1)
and practices in##2##3##(2008-11#1)(2011-2#1)
and practices of##3##3##(1990-6#1)(1990-8#1)(2012-2#1)
and practices that##2##3##(2008-5#1)(2010-7#1)
and practices##29##2##(1990-6#1)(1990-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
and practicing##2##2##(1996-1#1)(2008-12#1)
and practitioners to##4##3##(1996-1#1)(2008-11#1)(2010-11#1)(2010-9#1)
and practitioners##11##2##(1993-2#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2010-10#1)(2010-11#1)(2010-9#1)
and pre-concentration of##6##3##(2008-10#6)
and pre-concentration##7##2##(2008-10#7)
and precancerous##5##2##(2011-2#1)(2011-3#4)
and precipitated##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
and precipitation were##2##3##(2008-10#1)(2009-7#1)
and precipitation##8##2##(2008-10#4)(2008-3#1)(2008-8#1)(2009-7#1)(2013-1#1)
and precise analytical procedure##2##4##(2008-10#2)
and precise analytical##4##3##(2008-10#4)
and precise determination of uranium in concentrates and##2##8##(2008-10#2)
and precise determination of##4##4##(2008-10#4)
and precise results##3##3##(2008-10#3)
and precise spectrophotometric##3##3##(2008-10#3)
and precise##42##2##(1996-2#1)(2008-10#32)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
and precision and##2##3##(2008-10#1)(2009-8#1)
and precision associated with this##2##5##(2008-10#2)
and precision at the##2##4##(2008-10#2)
and precision for##4##3##(2008-10#3)(2008-3#1)
and precision in##4##3##(2008-10#4)
and precision of the method##3##5##(2008-10#3)
and precision of the##9##4##(2008-10#9)
and precision of##16##3##(2008-10#16)
and precision was##3##3##(2008-10#3)
and precision were##5##3##(2008-10#3)(2009-8#1)(2011-3#1)
and precision##73##2##(1990-2#1)(2008-10#67)(2008-3#2)(2009-8#2)(2011-3#1)
and precolumn##2##2##(1991-12#1)(2008-10#1)
and preconcentrate##2##2##(2008-10#2)
and preconcentrated##6##2##(2008-10#6)
and preconcentration for the##3##4##(2008-10#3)
and preconcentration of Cr(III) and Cr(VI)##2##6##(2008-10#2)
and preconcentration of U(VI)##2##4##(2008-10#2)
and preconcentration of inorganic##3##4##(2008-10#3)
and preconcentration of samples##2##4##(2008-10#2)
and preconcentration of trace##5##4##(2008-10#5)
and preconcentration of##34##3##(2008-10#34)
and preconcentration parameters##2##3##(2008-10#2)
and preconcentration time)##2##3##(2008-10#2)
and preconcentration##60##2##(2008-10#60)
and predation risk##2##3##(2008-9#1)(2012-3#1)
and predation##5##2##(2008-8#1)(2008-9#3)(2012-3#1)
and predator species##2##3##(2008-9#2)
and predator##5##2##(2008-8#2)(2008-9#2)(2012-3#1)
and predict the##5##3##(2008-10#1)(2008-6#1)(2010-1#1)(2010-7#1)(2011-3#1)
and predict##9##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)(2010-7#1)(2011-3#1)(2013-8#2)
and predictable##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
and predicted amino acid##2##4##(2008-10#1)(2008-9#1)
and predicted secondary##2##3##(1990-4#1)(1993-3#1)
and predicted the coding sequences of the corresponding genes##2##9##(1995-8#1)(1996-2#1)
and predicted the##3##3##(1995-8#1)(1996-2#1)(2008-8#1)
and predicted##17##2##(1990-4#1)(1993-3#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-8#4)(2008-9#1)(2011-2#1)
and predicting the##2##3##(2008-3#1)(2008-8#1)
and predicting##6##2##(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#1)(2013-1#1)
and prediction of##9##3##(1995-9#1)(2007-8#1)(2008-10#2)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
and prediction rates##2##3##(2008-10#2)
and prediction##21##2##(1994-12#1)(1995-9#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-8#1)(2009-12#1)(2010-12#2)(2010-7#1)(2011-2#1)(2013-1#2)
and predictions of##2##3##(2008-6#1)(2010-4#1)
and predictions##3##2##(2008-6#1)(2010-4#1)(2013-1#1)
and predictive factors of##2##4##(2008-10#1)(2010-7#1)
and predictive factors##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
and predictive##9##2##(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-7#1)(2011-2#2)(2013-8#1)
and predictors of##2##3##(1995-12#1)(2012-2#1)
and predictors##3##2##(1995-12#1)(2008-11#1)(2012-2#1)
and predicts##2##2##(2008-11#1)(2008-3#1)
and prednisolone##4##2##(1992-2#2)(2008-10#1)(2013-8#1)
and prednisone##3##2##(1990-12#1)(2008-12#1)(2010-12#1)
and predominant##3##2##(1990-5#2)(2011-2#1)
and preference tests##2##3##(2008-5#2)
and preference##3##2##(2008-5#2)(2008-8#1)
and preferences for##2##3##(2012-12#1)(2013-1#1)
and preferences##5##2##(2010-7#1)(2012-12#2)(2013-1#2)
and preferentially##4##2##(1993-3#1)(2008-3#1)(2009-10#1)(2012-2#1)
and preferred##3##2##(1994-1#1)(2008-10#1)(2011-10#1)
and prefrontal##3##2##(1994-2#1)(1997-2#2)
and pregnancy outcome##3##3##(1991-12#1)(1992-9#1)(2013-1#1)
and pregnancy##7##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-9#1)(1996-9#1)(2008-11#1)(2013-1#1)
and pregnancy]##2##2##(1992-5#1)(1996-11#1)
and pregnant women##4##3##(1995-12#1)(1995-2#2)(2013-8#1)
and preliminary results##2##3##(1991-3#1)(2009-12#1)
and preliminary validation##2##3##(2010-6#1)(2013-1#1)
and preliminary##18##2##(1991-2#1)(1991-3#1)(1992-11#1)(1993-3#1)(1993-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and premature##7##2##(2007-11#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
and prenatal##3##2##(2012-3#2)(2013-1#1)
and preoperative##3##2##(1991-2#1)(1994-12#1)(2011-2#1)
and preparation of a##3##4##(2008-11#1)(2008-4#1)(2009-3#1)
and preparation of human##2##4##(2008-9#2)
and preparation of##11##3##(1992-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#4)(2009-3#1)(2013-1#1)
and preparation##17##2##(1992-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-9#5)(2009-3#1)(2011-2#1)(2013-1#1)
and preparations##2##2##(2008-10#2)
and preparative##4##2##(1990-2#1)(1991-9#1)(2008-10#1)(2012-2#1)
and prepared##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
and preparing a##2##3##(2008-12#1)(2008-9#1)
and preparing##5##2##(2008-11#1)(2008-12#1)(2008-9#3)
and presbyacusis##2##2##(2008-7#2)
and presence of a##3##4##(1990-8#1)(2007-12#1)(2008-10#1)
and presence of##23##3##(1990-2#1)(1990-8#1)(1991-2#1)(1994-11#1)(1995-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
and presence##24##2##(1990-2#1)(1990-8#1)(1991-2#1)(1994-11#1)(1995-8#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
and present a##2##3##(2008-9#1)(2013-1#1)
and present as##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
and present experimental results##3##4##(2007-11#1)(2008-3#1)(2008-6#1)
and present the results of##2##5##(1996-1#1)(2011-2#1)
and present the results##3##4##(1996-1#1)(2008-7#1)(2011-2#1)
and present the##6##3##(1994-12#1)(1996-1#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
and present##29##2##(1993-3#1)(1994-12#2)(1995-12#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#4)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
and presentation of each epitope##2##5##(2008-8#2)
and presentation of##5##3##(1996-12#1)(2008-11#1)(2008-8#3)
and presentation##8##2##(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#4)(2010-7#1)
and presented evidence##2##3##(2008-10#1)(2008-11#1)
and presented in##2##3##(1994-2#1)(1995-1#1)
and presented with##2##3##(1996-6#1)(2011-2#1)
and presented##13##2##(1991-10#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
and presenting##5##2##(1992-3#1)(1997-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
and presents a##3##3##(1992-3#1)(1997-3#1)(2008-7#1)
and presents an##3##3##(1995-9#1)(1997-2#1)(2008-9#1)
and presents as a##2##4##(2008-7#1)(2009-12#1)
and presents the##5##3##(1991-2#1)(1993-1#1)(1997-2#1)(2010-5#1)(2013-8#1)
and presents##21##2##(1991-2#2)(1992-3#1)(1993-1#1)(1994-1#1)(1995-9#1)(1997-2#2)(1997-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
and preservation of##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
and preservation##7##2##(1993-12#1)(2008-10#1)(2008-11#2)(2010-9#1)(2011-2#2)
and preserve the##2##3##(1994-3#1)(2008-3#1)
and preserve##3##2##(1994-3#1)(2008-10#1)(2008-3#1)
and preserved with##2##3##(2008-10#2)
and preserved##7##2##(1991-2#1)(2008-10#3)(2008-6#1)(2010-5#1)(2011-1#1)
and preserves##2##2##(2008-7#1)(2012-3#1)
and preserving##2##2##(2008-10#1)(2008-11#1)
and pressure##18##2##(1990-5#1)(1991-3#1)(1992-8#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#1)(2012-2#1)
and pressures##4##2##(2008-10#3)(2008-3#1)
and presumably##2##2##(1992-12#1)(1996-12#1)
and preterm##4##2##(1994-3#2)(2012-3#1)(2013-8#1)
and pretreatment##3##2##(1993-9#1)(2008-10#1)(2008-7#1)
and prevails under##2##3##(2008-10#2)
and prevalence of##10##3##(1991-6#1)(1992-2#1)(1996-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
and prevalence##13##2##(1991-6#1)(1992-2#2)(1996-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#2)
and prevent their##2##3##(2008-9#1)(2013-8#1)
and prevent##10##2##(1991-1#1)(1991-2#1)(1993-12#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
and preventative##2##2##(2008-11#1)(2008-7#1)
and prevented the infection of the##2##6##(2010-10#2)
and prevented the##3##3##(2010-10#2)(2011-2#1)
and prevented##6##2##(1993-12#1)(2008-10#1)(2008-5#1)(2010-10#2)(2011-2#1)
and preventing the##3##3##(2008-10#2)(2008-7#1)
and preventing##9##2##(1992-12#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
and prevention efforts##3##3##(2008-11#1)(2009-5#1)(2012-2#1)
and prevention of cancer##2##4##(2009-4#2)
and prevention of dental##2##4##(2008-5#1)(2008-7#1)
and prevention of##17##3##(1991-2#1)(1991-3#1)(1993-2#1)(1996-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2009-4#2)(2010-5#1)(2011-2#1)
and prevention program##2##3##(1990-3#1)(1992-2#1)
and prevention programs##3##3##(1996-5#1)(2008-11#1)(2012-2#1)
and prevention strategies##2##3##(2009-5#1)(2011-2#1)
and prevention##43##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#2)(1993-2#1)(1993-6#1)(1996-2#2)(1996-5#1)(1996-8#1)(2008-10#2)(2008-11#6)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-1#2)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)
and preventive care##4##3##(2009-5#1)(2011-2#1)(2013-1#2)
and preventive strategies##2##3##(1993-11#1)(1996-12#1)
and preventive##15##2##(1991-2#1)(1993-11#1)(1993-2#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
and prevents##6##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2013-8#1)
and previous neurologic disease##2##4##(2008-7#2)
and previous##18##2##(1990-3#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-11#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-7#4)(2008-8#1)(2008-9#1)(2012-2#1)
and previously##10##2##(1994-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
and prey selection##3##3##(2010-8#3)
and prey##10##2##(2008-8#5)(2008-9#2)(2010-8#3)
and price indicators for the health care industry##3##8##(1995-12#1)(1997-2#1)(1997-3#1)
and price##11##2##(1991-12#1)(1994-12#3)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2012-2#2)(2013-1#1)
and pride##2##2##(2013-8#2)
and primarily##3##2##(2008-10#1)(2011-3#1)(2013-8#1)
and primary care physicians##2##4##(1996-11#1)(2008-9#1)
and primary care##8##3##(1993-12#1)(1996-11#1)(1996-3#1)(1997-2#2)(1997-5#1)(2008-6#1)(2008-9#1)
and primary human##3##3##(1994-5#1)(2008-11#1)(2009-12#1)
and primary structure of##2##4##(1991-6#1)(1995-3#1)
and primary##38##2##(1991-6#1)(1992-12#3)(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
and primers were designed##2##4##(2008-10#2)
and primers were##3##3##(2008-10#3)
and primers##5##2##(2008-10#5)
and primitive##2##2##(1993-8#1)(2013-8#1)
and primordial##3##2##(2008-12#1)(2010-5#1)(2013-1#1)
and principal component analysis (PCA)##2##5##(2008-10#2)
and principal component analysis##3##4##(2008-10#3)
and principal component regression (PCR)##5##5##(2008-10#5)
and principal component regression methods##2##5##(2008-10#2)
and principal component regression##9##4##(2008-10#9)
and principal component##12##3##(2008-10#12)
and principal##14##2##(2008-10#14)
and principles are##3##3##(1993-3#1)(2008-2#1)(2010-8#1)
and principles##4##2##(1993-3#1)(2008-11#1)(2008-2#1)(2010-8#1)
and prior to the##2##4##(2008-10#2)
and prior to##4##3##(1991-12#1)(2008-10#3)
and prior##8##2##(1991-12#1)(1996-12#1)(1997-4#1)(2008-10#3)(2009-8#1)(2010-2#1)
and priorities##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
and prioritization##3##2##(1996-1#1)(1996-2#1)(2010-8#1)
and prioritizing##2##2##(1994-12#1)(2008-11#1)
and priority##3##2##(1991-11#1)(1991-2#1)(1992-2#1)
and privacy##3##2##(1994-3#1)(1996-1#1)(2010-8#1)
and private sectors##3##3##(1996-2#2)(1997-3#1)
and private##23##2##(1991-3#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#3)(1996-3#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
and pro-apoptotic##4##2##(1995-6#1)(2009-12#1)(2010-10#1)(2013-1#1)
and pro-opiomelanocortin##2##2##(1992-10#1)(2009-8#1)
and probabilistic##2##2##(2008-10#2)
and probability of##3##3##(1990-5#1)(1993-1#1)(2008-10#1)
and probability##4##2##(1990-5#1)(1993-1#1)(2008-10#1)(2009-11#1)
and probable##3##2##(1992-4#1)(2008-7#1)(2013-8#1)
and probably also##4##3##(1992-6#1)(1993-11#1)(1997-3#1)(2011-2#1)
and probably the##2##3##(1991-12#1)(2013-1#1)
and probably##20##2##(1990-5#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-5#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#4)(2011-3#1)(2013-1#1)
and probe##6##2##(2008-10#4)(2008-3#1)(2008-9#1)
and probed##2##2##(2008-10#2)
and probes##3##2##(2008-10#2)(2008-9#1)
and probing##2##2##(2008-10#1)(2008-3#1)
and probiotics##6##2##(2009-12#1)(2010-12#1)(2011-2#3)(2013-1#1)
and problem##3##2##(1994-12#1)(1997-3#1)(2008-11#1)
and problematic##2##2##(2008-11#1)(2008-7#1)
and problems of##3##3##(1990-2#1)(1995-2#1)(2008-10#1)
and problems that##2##3##(2008-4#1)(2010-9#1)
and problems##14##2##(1990-2#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#2)(2010-9#1)(2011-1#1)
and problems]##2##2##(1992-5#1)(1993-11#1)
and procaine##2##2##(2008-10#2)
and procedural##3##2##(1996-2#1)(2008-12#1)(2012-2#1)
and procedure##3##2##(1995-3#1)(2008-10#2)
and procedures for##3##3##(2008-12#1)(2010-11#1)(2010-7#1)
and procedures of##2##3##(2008-12#1)(2011-3#1)
and procedures##16##2##(1990-3#1)(1992-3#1)(1994-1#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-12#3)(2008-9#2)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#1)(2011-3#1)
and process development##2##3##(2008-11#2)
and process of the##2##4##(2008-11#1)(2012-3#1)
and process of##4##3##(1994-12#1)(1996-3#1)(2008-11#1)(2012-3#1)
and process##15##2##(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-11#5)(2008-6#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
and processed##8##2##(1991-6#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and processes for##2##3##(2008-12#1)(2010-8#1)
and processes that##2##3##(1996-2#1)(2010-12#1)
and processes##20##2##(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#3)(2013-1#1)
and processing of##6##3##(1990-5#2)(1991-10#1)(1991-5#1)(2008-9#2)
and processing##14##2##(1990-5#2)(1991-10#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#1)
and produce##8##2##(1994-1#1)(2008-10#4)(2008-11#1)(2009-8#1)(2012-12#1)
and produced a##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
and produced by##2##3##(1992-3#1)(2011-2#1)
and produced significantly##2##3##(2008-10#1)(2013-1#1)
and produced##20##2##(1991-3#1)(1992-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-8#4)(2008-9#2)(2011-2#1)(2013-1#1)
and producers##2##2##(1996-2#2)
and produces a##4##3##(1993-12#1)(2008-10#3)
and produces##12##2##(1993-12#1)(1993-9#1)(1994-11#1)(2008-10#6)(2008-3#1)(2010-3#1)(2011-2#1)
and producing##3##2##(2008-10#3)
and product quality##2##3##(2008-11#1)(2013-1#1)
and product##18##2##(1992-1#1)(1994-12#1)(1994-5#1)(2008-10#3)(2008-11#5)(2008-5#2)(2008-7#2)(2010-7#1)(2012-2#1)(2013-1#1)
and product-related factors##2##3##(2008-10#1)(2011-2#1)
and production of a##4##4##(1993-8#1)(2008-10#2)(2008-11#1)
and production of interferon-beta##2##4##(2008-11#2)
and production of the##2##4##(2008-10#1)(2008-11#1)
and production of##28##3##(1993-8#1)(1994-11#2)(1995-5#1)(2008-10#6)(2008-11#10)(2008-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)
and production rates##2##3##(2008-11#2)
and production##43##2##(1992-12#1)(1993-8#1)(1994-11#2)(1994-3#2)(1995-5#1)(2008-10#7)(2008-11#18)(2008-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#3)
and productivity in##2##3##(2008-11#2)
and productivity of recombinant##2##4##(2008-11#2)
and productivity of##5##3##(2008-11#3)(2008-12#2)
and productivity##22##2##(1991-2#1)(1993-3#1)(2008-10#2)(2008-11#11)(2008-12#2)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)
and products of their photodegradation##2##5##(2008-10#2)
and products of##4##3##(1991-3#1)(1996-12#1)(2008-10#2)
and products##9##2##(1991-3#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#3)
and professional associations##2##3##(1996-12#1)(2008-12#1)
and professional development##4##3##(2008-11#2)(2008-12#1)(2010-10#1)
and professional issues##3##3##(1991-2#1)(2008-11#1)(2008-12#1)
and professional knowledge##2##3##(2008-11#1)(2010-10#1)
and professional learning##2##3##(2008-12#2)
and professional level##2##3##(1993-3#1)(2008-11#1)
and professional##47##2##(1990-2#4)(1990-3#1)(1990-9#1)(1991-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#2)(2008-11#16)(2008-12#9)(2008-4#1)(2010-10#2)(2011-2#2)(2012-2#1)(2013-1#2)
and professionalization of the field##2##5##(1994-3#2)
and professionals##7##2##(1992-3#2)(1996-8#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
and proficiency##2##2##(2008-4#1)(2011-2#1)
and profile of##2##3##(2008-9#1)(2011-2#1)
and profile##3##2##(2008-2#1)(2008-9#1)(2011-2#1)
and profiles##3##2##(1994-2#1)(2008-10#1)(2010-3#1)
and profit##2##2##(1995-3#1)(1997-2#1)
and profitability of##3##3##(1991-1#1)(1995-1#1)(2008-11#1)
and profitability##4##2##(1991-1#1)(1995-1#2)(2008-11#1)
and profits##4##2##(1991-3#2)(1997-2#1)(2008-11#1)
and progenitor cells of##2##4##(2008-9#1)(2011-2#1)
and progenitor cells##5##3##(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#1)
and progenitor##6##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)
and progeny isolates##2##3##(2008-10#2)
and progeny virus##2##3##(2008-10#2)
and progeny##6##2##(2008-10#6)
and progesterone receptors in##2##4##(1990-11#1)(1994-2#1)
and progesterone receptors##3##3##(1990-11#2)(1994-2#1)
and progesterone##12##2##(1990-11#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#1)(2013-8#1)
and prognosis of this##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
and prognosis of##12##3##(1995-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
and prognosis##27##2##(1990-12#2)(1991-2#1)(1991-8#1)(1993-11#1)(1995-9#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
and prognostic implications##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
and prognostic value##2##3##(2008-7#1)(2012-2#1)
and prognostic##21##2##(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-5#2)(2010-7#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#2)
and program evaluation##2##3##(1993-2#1)(1997-1#1)
and program payments##2##3##(1991-3#2)
and program##15##2##(1991-3#3)(1993-2#1)(1994-3#1)(1995-12#1)(1996-1#2)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2013-1#2)(2013-8#1)
and programmatic##2##2##(1997-3#1)(2012-2#1)
and programmed##3##2##(2008-10#2)(2008-4#1)
and programmes##2##2##(2008-11#1)(2008-9#1)
and programs to##2##3##(1996-1#1)(2008-11#1)
and programs##6##2##(1996-1#1)(1996-3#1)(1997-3#1)(2008-11#2)(2010-8#1)
and progress in##3##3##(1997-6#1)(2008-6#1)(2013-8#1)
and progress##5##2##(1997-6#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
and progresses##2##2##(2009-12#1)(2013-8#1)
and progressing##2##2##(1996-3#1)(2010-7#1)
and progression free survival (PFS)##2##5##(2008-10#2)
and progression of the##2##4##(1991-11#1)(2010-11#1)
and progression of these##2##4##(2011-2#1)(2013-1#1)
and progression of##13##3##(1991-11#1)(1993-9#1)(2008-10#1)(2010-10#1)(2010-11#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#3)
and progression rates##2##3##(2011-3#1)(2012-12#1)
and progression##22##2##(1991-11#1)(1993-9#1)(2008-10#4)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#4)(2011-3#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
and progressive disease##2##3##(1992-12#1)(2010-12#1)
and progressive##15##2##(1990-3#1)(1992-12#1)(1996-8#1)(1997-3#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#3)(2013-1#1)
and progressively##3##2##(1993-2#1)(1995-2#1)(2008-6#1)
and projection##2##2##(2008-10#1)(2008-7#1)
and projections##2##2##(1992-9#1)(1994-2#1)
and prokaryotic##4##2##(1994-12#1)(1996-2#1)(1997-4#1)(2011-2#1)
and prolactin##5##2##(1991-3#1)(1993-2#3)(1995-11#1)
and proliferate in##2##3##(2007-12#1)(2008-11#1)
and proliferating##4##2##(1992-6#1)(1993-11#1)(2008-11#1)(2011-2#1)
and proliferation and##2##3##(2008-11#1)(2008-5#1)
and proliferation in##3##3##(1993-8#1)(1996-12#1)(2013-8#1)
and proliferation kinetics of adapted##2##5##(2013-8#2)
and proliferation of mouse##2##4##(2008-9#2)
and proliferation of the##2##4##(1996-3#1)(2008-7#1)
and proliferation of##13##3##(1995-3#1)(1996-3#1)(1997-3#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-7#1)
and proliferation was##2##3##(1996-12#1)(2008-9#1)
and proliferation were##2##3##(2008-11#1)(2008-5#1)
and proliferation##36##2##(1992-8#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-12#2)(1996-3#2)(1997-3#1)(2006-6#1)(2008-11#7)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-7#1)(2013-8#3)
and proliferative##3##2##(2008-11#3)
and proline accumulation##2##3##(2008-12#2)
and proline##4##2##(2008-12#4)
and prolonged exposure to##2##4##(2008-10#2)
and prolonged in##2##3##(1997-3#1)(2008-10#1)
and prolonged##12##2##(1997-3#1)(2008-10#3)(2008-11#3)(2008-12#2)(2013-1#2)(2013-8#1)
and prolyl##2##2##(2008-5#1)(2013-1#1)
and promise##2##2##(1996-12#1)(2008-8#1)
and promising##2##2##(2008-4#1)(2010-12#1)
and promote a##2##3##(1993-1#1)(2008-10#1)
and promote##12##2##(1993-1#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
and promoted##3##2##(2008-11#1)(2008-12#2)
and promoter activity##2##3##(1997-8#1)(2010-11#1)
and promoter##5##2##(1997-8#1)(1997-9#1)(2008-9#1)(2009-8#1)(2010-11#1)
and promotes##7##2##(1997-8#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-2#1)
and promoting##3##2##(2008-11#1)(2009-6#1)(2012-2#1)
and promotion of##4##3##(1992-12#1)(1995-12#1)(1996-11#1)(2010-5#1)
and promotion##6##2##(1992-12#1)(1992-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(2010-5#1)
and prompt surgical decompression is##2##5##(2011-2#2)
and prompt##8##2##(2008-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
and pronounced##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
and propagated##2##2##(2008-10#1)(2008-11#1)
and propagation##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
and propagative##2##2##(2008-10#2)
and propamocarb##2##2##(2008-10#2)
and proper management of##2##4##(2010-6#1)(2013-1#1)
and proper management##3##3##(2010-11#1)(2010-6#1)(2013-1#1)
and proper treatment##4##3##(2011-1#1)(2011-2#1)(2013-8#2)
and proper##9##2##(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and properties of an##2##4##(2008-8#1)(2009-7#1)
and properties of concentration and separation of trace##2##8##(2008-10#2)
and properties of the##3##4##(1992-7#1)(1994-5#1)(2008-8#1)
and properties of##16##3##(1992-7#1)(1994-5#1)(1995-3#1)(2008-10#6)(2008-4#1)(2008-8#3)(2009-7#2)(2010-4#1)
and properties##19##2##(1992-7#1)(1994-5#1)(1995-3#1)(2008-10#7)(2008-4#1)(2008-8#3)(2009-7#4)(2010-4#1)
and property##2##2##(1992-2#1)(1996-12#1)
and prophylactic##2##2##(1993-3#1)(2008-7#1)
and prophylaxis of##2##3##(1991-8#1)(2010-6#1)
and prophylaxis##5##2##(1990-11#1)(1991-8#1)(1994-6#1)(2010-6#2)
and propidium##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
and proportion of##4##3##(2008-10#1)(2008-8#1)(2011-2#2)
and proportion##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#2)
and proportional to the##2##4##(2008-10#1)(2008-7#1)
and proportional##5##2##(1995-2#1)(2008-10#2)(2008-7#1)(2008-8#1)
and proposals for##5##3##(2008-11#4)(2013-1#1)
and propose a model##2##4##(2008-10#1)(2009-8#1)
and propose a##5##3##(2007-11#1)(2008-10#1)(2009-8#1)(2011-2#2)
and propose an##2##3##(2012-3#1)(2013-1#1)
and propose that##3##3##(1992-3#1)(1992-6#1)(2008-11#1)
and propose##15##2##(1990-11#1)(1992-3#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
and proposed as##2##3##(2008-12#1)(2009-10#1)
and proposed##7##2##(2008-10#1)(2008-12#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)
and proposes a##4##3##(1991-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
and proposes##6##2##(1991-6#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)
and propranolol in##2##3##(1993-5#1)(2008-10#1)
and propranolol##3##2##(1993-5#1)(1996-2#1)(2008-10#1)
and proprioceptive##2##2##(2009-1#1)(2013-1#1)
and prospective##8##2##(1991-9#1)(1992-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#2)
and prospectively##3##2##(1996-1#1)(2008-12#1)(2013-8#1)
and prospects for##4##3##(1992-3#1)(1994-5#1)(1995-1#1)(2011-2#1)
and prospects##10##2##(1992-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#2)(2011-7#1)
and prospects]##2##2##(1991-3#1)(1992-3#1)
and prostacyclin##2##2##(1994-5#1)(1996-2#1)
and prostaglandin E2##4##3##(1995-6#1)(1997-1#1)(2011-2#2)
and prostaglandin synthesis##2##3##(1997-1#2)
and prostaglandin##11##2##(1994-2#1)(1995-6#1)(1996-2#1)(1997-1#4)(2006-6#1)(2008-11#1)(2011-2#2)
and prostate cancer##5##3##(2008-7#2)(2011-2#2)(2012-3#1)
and prostate were not##2##4##(1992-12#1)(2011-2#1)
and prostate##12##2##(1992-12#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
and prosthesis##2##2##(1993-6#1)(2012-2#1)
and prosthetic groups##3##3##(2008-7#3)
and prosthetic##10##2##(1991-3#1)(2008-11#1)(2008-7#4)(2011-2#1)(2013-1#3)
and protease##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2011-3#1)
and protect the##3##3##(2008-10#1)(2008-11#1)(2010-6#1)
and protect##6##2##(2008-10#1)(2008-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
and protected the##2##3##(1996-3#1)(2008-11#1)
and protected##8##2##(1995-5#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-3#1)
and protecting the##3##3##(2008-11#1)(2010-4#1)(2012-3#1)
and protecting##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-3#1)
and protection against##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
and protection by##2##3##(1992-9#1)(2008-8#1)
and protection in##2##3##(1995-11#1)(1995-5#1)
and protection##11##2##(1992-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)
and protective factors##2##3##(2009-7#1)(2010-5#1)
and protective##10##2##(1995-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-2#1)(2010-5#1)
and protects it##2##3##(2008-5#2)
and protects##3##2##(2008-11#1)(2008-5#2)
and protein A##2##3##(1996-12#2)
and protein A-Sepharose##2##3##(2008-11#1)(2008-8#1)
and protein and##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
and protein binding##2##3##(2008-9#1)(2009-10#1)
and protein complexes##2##3##(2008-4#1)(2011-2#1)
and protein content##4##3##(2009-11#1)(2010-11#1)(2010-4#1)(2012-7#1)
and protein disulfide##2##3##(2009-8#1)(2012-2#1)
and protein expression is##2##4##(2008-11#1)(2013-1#1)
and protein expression of##3##4##(2008-11#1)(2008-8#1)(2012-2#1)
and protein expression##11##3##(2008-10#1)(2008-11#5)(2008-8#1)(2012-2#1)(2013-1#3)
and protein in##2##3##(1992-7#1)(1995-12#1)
and protein intake##2##3##(2013-8#2)
and protein interactions can be##2##5##(2008-4#1)(2011-2#1)
and protein kinase A##4##4##(1994-8#1)(1995-6#1)(1997-2#1)(2008-11#1)
and protein kinase B##2##4##(2008-3#2)
and protein kinase C activation##2##5##(1994-3#1)(1995-11#1)
and protein kinase C##9##4##(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(2008-10#1)(2008-11#3)
and protein kinase##17##3##(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-9#1)
and protein level##2##3##(1994-8#1)(2011-2#1)
and protein levels of##4##4##(2011-3#2)(2012-2#1)(2013-8#1)
and protein levels##9##3##(1993-6#1)(1997-7#1)(2008-9#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-8#2)
and protein metabolism##2##3##(2008-10#1)(2009-10#1)
and protein production##2##3##(2008-11#1)(2008-7#1)
and protein productivity##2##3##(2008-11#1)(2008-7#1)
and protein sequences##2##3##(2008-10#1)(2008-4#1)
and protein synthesis in##2##4##(1995-12#1)(2008-12#1)
and protein synthesis##5##3##(1991-5#1)(1995-12#2)(2008-12#1)(2012-2#1)
and protein transformations##2##3##(2013-1#2)
and protein were##5##3##(1993-3#1)(2008-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
and protein##128##2##(1990-2#1)(1990-5#2)(1991-5#3)(1992-12#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-7#2)(2008-10#9)(2008-11#23)(2008-12#1)(2008-3#2)(2008-4#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-4#1)(2010-7#1)(2011-2#7)(2011-3#3)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#6)(2013-8#4)
and protein-bound##7##2##(1991-12#2)(2008-10#5)
and protein-free##2##2##(2008-11#2)
and protein-protein##2##2##(2008-4#1)(2009-7#1)
and proteins in##4##3##(1991-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
and proteins of##4##3##(1991-6#1)(1991-8#1)(1997-4#1)(2011-2#1)
and proteins were##3##3##(1990-10#1)(2008-10#1)(2010-3#1)
and proteins which##2##3##(2008-11#1)(2008-5#1)
and proteins##41##2##(1990-10#1)(1991-6#2)(1991-8#2)(1995-2#1)(1996-1#1)(1997-4#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-11#2)(2010-3#1)(2010-7#2)(2011-2#2)
and proteoglycans##2##2##(1991-5#1)(1992-12#1)
and proteolysis##3##2##(2008-11#1)(2013-1#2)
and proteolytic activities##2##3##(2008-10#1)(2011-2#1)
and proteolytic##9##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
and proteome##2##2##(2008-11#1)(2011-2#1)
and proteomic##4##2##(2008-10#1)(2008-11#3)
and proteomics##4##2##(2008-11#2)(2010-7#1)(2011-3#1)
and protocols for##2##3##(2008-4#2)
and protocols##4##2##(2008-4#2)(2008-9#2)
and proton##5##2##(2008-10#3)(2009-8#1)(2011-2#1)
and protonated species##2##3##(2008-10#2)
and protonated##5##2##(1991-9#2)(2008-10#3)
and protoplast##2##2##(2008-10#1)(2008-8#1)
and protoplasts##3##2##(1997-3#1)(2008-8#1)(2008-9#1)
and protoporphyrin##2##2##(1991-5#1)(2012-2#1)
and protozoa##3##2##(1994-11#1)(2008-9#2)
and proved to be##3##4##(1994-12#1)(2008-10#1)(2012-2#1)
and proved to##4##3##(1994-12#1)(2008-10#2)(2012-2#1)
and proved##7##2##(1994-12#1)(2008-10#5)(2012-2#1)
and proven to##2##3##(1996-2#1)(2010-5#1)
and proven##4##2##(1994-2#1)(1996-2#1)(2010-5#1)(2011-7#1)
and provenances##3##2##(2012-5#2)(2012-9#1)
and provide a blueprint##2##4##(1993-2#1)(1994-12#1)
and provide a##15##3##(1991-1#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-10#1)(2012-3#2)(2013-8#1)
and provide accurate##2##3##(2010-8#1)(2013-8#1)
and provide an##2##3##(2010-10#1)(2011-7#1)
and provide clues##2##3##(1997-6#1)(2008-10#1)
and provide evidence##5##3##(1991-12#1)(1997-3#1)(1997-6#1)(2008-11#1)(2012-2#1)
and provide guidance##3##3##(1993-12#1)(1996-3#1)(2008-11#1)
and provide information##2##3##(2007-12#1)(2008-10#1)
and provide new##3##3##(1997-7#1)(2008-11#1)(2008-8#1)
and provide some##2##3##(2008-9#1)(2010-5#1)
and provide support to##2##4##(1994-12#1)(2013-8#1)
and provide the##3##3##(1995-9#1)(2008-11#1)(2011-2#1)
and provide useful##2##3##(2006-6#1)(2012-3#1)
and provide##68##2##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#2)(1995-3#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
and provided a##3##3##(2008-10#2)(2010-11#1)
and provided satisfactory results##2##4##(2008-10#2)
and provided##23##2##(1994-1#1)(1996-1#1)(1997-3#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
and provider##5##2##(1991-2#2)(1992-3#1)(1994-1#1)(2008-11#1)
and providers are##2##3##(1991-3#1)(1996-2#1)
and providers##15##2##(1991-3#1)(1993-12#1)(1994-1#3)(1994-12#2)(1996-2#1)(1997-1#1)(2008-4#1)(2009-6#1)(2013-1#4)
and provides a brief##3##4##(2008-11#1)(2008-9#1)(2010-5#1)
and provides a new##3##4##(2008-5#1)(2008-8#1)(2009-12#1)
and provides a review of the##2##6##(2010-12#1)(2011-7#1)
and provides a summary of##2##5##(1992-3#1)(2011-2#1)
and provides a##28##3##(1990-5#1)(1992-3#1)(1992-4#1)(1993-3#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-2#2)(2011-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
and provides an analysis##2##4##(2008-1#1)(2010-10#1)
and provides an excellent##2##4##(2008-10#1)(2008-9#1)
and provides an##7##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#1)
and provides background for the##2##5##(2008-9#1)(2012-12#1)
and provides further evidence for##2##5##(2008-10#1)(2008-7#1)
and provides further evidence##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
and provides further##4##3##(1994-2#1)(2008-10#2)(2008-7#1)
and provides good##2##3##(2011-2#1)(2012-12#1)
and provides information##2##3##(2008-10#1)(2008-9#1)
and provides new##2##3##(2008-10#2)
and provides the##2##3##(2008-10#1)(2008-11#1)
and provides##77##2##(1990-12#1)(1990-5#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-2#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#9)(2009-12#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-7#2)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#1)
and providing##7##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#2)(2013-8#1)
and provision of##4##3##(1995-2#1)(1997-3#1)(2008-10#1)(2009-5#1)
and provision##5##2##(1994-1#1)(1995-2#1)(1997-3#1)(2008-10#1)(2009-5#1)
and provoked##2##2##(2008-6#1)(2012-12#1)
and proximal tubular##2##3##(1994-5#2)
and proximal##10##2##(1991-9#1)(1994-3#1)(1994-5#2)(1997-2#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)
and proximity##2##2##(2008-9#2)
and pseudoephedrine##2##2##(2008-10#2)
and psychiatric disorders##3##3##(1991-1#1)(2008-11#1)(2008-12#1)
and psychiatric##13##2##(1991-1#1)(1991-2#1)(1996-1#1)(1997-5#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2012-3#1)(2013-1#2)
and psychiatrists##2##2##(1996-1#1)(2009-9#1)
and psychiatry##2##2##(1991-12#1)(1991-6#1)
and psychological adjustment##4##3##(1996-3#1)(2009-11#1)(2009-7#1)(2010-2#1)
and psychological and academic adjustment in##2##6##(2010-1#2)
and psychological distress##3##3##(2008-9#1)(2009-12#1)(2010-6#1)
and psychological invulnerability##3##3##(2010-7#3)
and psychological problems##2##3##(1993-6#1)(2009-11#1)
and psychological well-being##8##3##(1992-2#1)(2008-11#1)(2012-2#2)(2013-1#4)
and psychological##40##2##(1992-2#1)(1993-11#1)(1993-6#2)(1994-3#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-7#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#3)(2010-7#3)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#4)
and psychologists##4##2##(1990-6#1)(2008-12#2)(2010-12#1)
and psychomotor##2##2##(1994-6#1)(2008-11#1)
and psychophysical##3##2##(2008-11#1)(2008-9#2)
and psychosocial characteristics##2##3##(2011-2#1)(2013-1#1)
and psychosocial interventions##2##3##(1995-1#1)(2013-1#1)
and psychosocial##18##2##(1994-6#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-7#2)(2010-11#1)(2011-2#3)(2012-12#1)(2013-1#3)
and psychosomatic##3##2##(1990-2#1)(2008-4#1)(2012-2#1)
and psychotherapy##5##2##(1991-1#1)(2008-4#1)(2010-4#1)(2013-1#2)
and pubertal status##3##3##(2011-1#3)
and pubertal##4##2##(2011-1#4)
and public and##2##3##(1997-3#1)(2008-5#1)
and public health agencies##2##4##(1995-12#2)
and public health implications##2##4##(2010-8#1)(2011-2#1)
and public health issues##2##4##(1993-2#1)(1996-2#1)
and public health##25##3##(1993-2#1)(1995-12#2)(1996-1#2)(1996-2#2)(1996-6#1)(1997-2#2)(1997-3#6)(1997-4#1)(2008-1#2)(2008-10#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)
and public policy##3##3##(1991-1#1)(1996-12#1)(2008-12#1)
and public reporting of##2##4##(2013-1#2)
and public##46##2##(1991-1#2)(1992-9#1)(1993-2#1)(1994-1#1)(1995-12#3)(1996-1#3)(1996-12#2)(1996-2#2)(1996-6#2)(1997-2#2)(1997-3#7)(1997-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#3)(2013-1#2)
and publication of##2##3##(2008-10#2)
and publication##5##2##(1993-12#2)(2008-10#2)(2008-12#1)
and published in##2##3##(2008-10#1)(2012-2#1)
and publishing##2##2##(1993-12#1)(1994-12#1)
and puerperium##2##2##(1991-3#1)(2008-11#1)
and pulmonary arterial##3##3##(2008-11#2)(2011-3#1)
and pulmonary artery##4##3##(1993-12#1)(1995-2#1)(1997-8#2)
and pulmonary edema##3##3##(1994-8#2)(2011-2#1)
and pulmonary hypertension##3##3##(2010-12#1)(2011-3#1)(2012-12#1)
and pulmonary##28##2##(1992-12#1)(1993-12#1)(1993-8#2)(1994-5#1)(1994-8#2)(1995-2#1)(1997-8#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and pulp##5##2##(2008-10#3)(2009-12#1)(2013-1#1)
and pulse amplitude##2##3##(2008-10#2)
and pulse height##2##3##(2008-10#2)
and pulse##14##2##(1992-12#1)(2008-10#6)(2008-11#1)(2008-3#5)(2008-7#1)
and pulsed##4##2##(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#1)
and pulsed-field gel electrophoresis##3##4##(2008-10#3)
and pump##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)
and pumpkin##2##2##(2008-10#2)
and puncture##3##2##(2012-3#3)
and purchasers##2##2##(1996-2#2)
and pure##11##2##(2008-10#7)(2008-9#2)(2011-2#1)(2013-1#1)
and purge##2##2##(1995-6#1)(2008-10#1)
and purification of a##2##4##(2008-10#1)(2008-4#1)
and purification of active serine proteases and their variants from##2##10##(2008-4#2)
and purification of halophilic proteins##2##5##(2011-2#2)
and purification of human##2##4##(2008-11#1)(2008-8#1)
and purification of the##5##4##(1994-5#1)(1994-6#1)(2008-10#1)(2009-9#1)(2011-1#1)
and purification of##30##3##(1994-5#1)(1994-6#1)(1997-2#2)(2008-10#8)(2008-11#3)(2008-4#6)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
and purification steps##3##3##(2008-10#2)(2008-7#1)
and purification##43##2##(1994-5#1)(1994-6#1)(1997-2#2)(2008-10#14)(2008-11#3)(2008-4#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and purified by affinity chromatography##2##5##(1995-6#1)(2008-9#1)
and purified by##7##3##(1990-8#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-9#2)
and purified from##4##3##(2008-10#2)(2008-12#1)(2012-2#1)
and purified on##2##3##(1995-11#1)(2008-10#1)
and purified to homogeneity by##2##5##(1993-8#1)(2008-8#1)
and purified to homogeneity##3##4##(1993-8#1)(1995-2#1)(2008-8#1)
and purified to##4##3##(1993-8#1)(1995-2#2)(2008-8#1)
and purified##34##2##(1990-8#1)(1993-8#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#2)(1997-2#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#1)(2012-2#1)(2013-8#1)
and purify##6##2##(1993-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and purine nucleotides##2##3##(1996-8#1)(2008-10#1)
and purpose of##2##3##(1994-12#1)(1997-3#1)
and purpose##4##2##(1994-12#1)(1997-3#1)(2008-11#1)(2011-2#1)
and purulent##2##2##(1993-2#1)(2013-1#1)
and pustules##2##2##(2010-6#1)(2012-3#1)
and put in##2##3##(1992-12#1)(1995-2#1)
and put##6##2##(1992-12#1)(1994-1#2)(1995-2#1)(2008-10#1)(2008-5#1)
and putative##8##2##(2008-10#6)(2008-7#1)(2011-2#1)
and putrescine oxidase##2##3##(2008-10#2)
and puts##4##2##(2008-3#1)(2010-11#1)(2012-2#1)(2012-3#1)
and pyrazinamide##2##2##(2008-1#1)(2008-10#1)
and pyridoxine##3##2##(2008-10#3)
and pyridoxine) in pharmaceutical##2##4##(2008-10#2)
and pyrifenox##2##2##(2008-10#2)
and pyrogallol##4##2##(2008-10#4)
and pyrolysis##3##2##(2008-10#3)
and pyruvate carboxylase##2##3##(2008-11#2)
and pyruvate kinase##2##3##(1994-3#1)(1994-8#1)
and pyruvate stimulate the conversion of glucose to glycogen##2##9##(1995-8#2)
and pyruvate##10##2##(1994-3#1)(1994-8#1)(1995-8#2)(2008-10#3)(2008-11#2)(2008-7#1)
and p = 0##2##2##(2013-8#2)
and quadrat size##3##3##(2008-10#3)
and quadrat##4##2##(2008-10#4)
and quadratic discriminant##3##3##(1991-12#2)(2008-10#1)
and quadratic##7##2##(1991-12#3)(2008-10#3)(2008-8#1)
and quadriceps muscle strength in##2##5##(2011-2#2)
and qualitative analysis##2##3##(1994-2#1)(2010-10#1)
and qualitative data on##2##4##(1991-8#1)(2012-2#1)
and qualitative data##5##3##(1990-9#1)(1991-8#1)(2008-11#1)(2012-2#1)(2013-8#1)
and qualitative observation##2##3##(2012-2#2)
and qualitative##26##2##(1990-9#1)(1991-8#1)(1993-1#1)(1994-2#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-8#1)(2009-10#2)(2010-10#1)(2010-6#1)(2010-7#1)(2012-2#3)(2013-8#1)
and qualitatively##4##2##(1997-8#1)(2008-10#2)(2012-2#1)
and quality and##2##3##(1995-12#1)(2008-10#1)
and quality assessment##2##3##(2008-12#1)(2012-2#1)
and quality assurance programs##2##4##(1995-1#1)(2012-2#1)
and quality assurance##9##3##(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-6#1)(2012-2#2)
and quality control in##3##4##(1994-3#1)(2008-10#1)(2008-4#1)
and quality control##12##3##(1994-3#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#1)
and quality improvement##2##3##(1995-2#1)(2010-8#1)
and quality in##3##3##(1992-2#1)(1997-2#1)(2008-10#1)
and quality management##2##3##(1993-3#1)(1994-2#1)
and quality of care in##2##5##(1995-12#1)(2008-11#1)
and quality of care##11##4##(1993-12#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#3)(2008-11#1)(2012-2#1)(2012-3#1)
and quality of life among##2##5##(2009-12#1)(2009-5#1)
and quality of life in patients with##2##7##(2009-7#1)(2013-8#1)
and quality of life in##4##5##(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
and quality of life of##3##5##(2008-7#1)(2011-2#1)(2011-3#1)
and quality of life##23##4##(1996-11#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
and quality of the##2##4##(2007-8#1)(2008-3#1)
and quality of##55##3##(1990-11#1)(1990-2#1)(1991-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#3)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
and quality##110##2##(1990-11#1)(1990-2#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#4)(1995-2#4)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#6)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#2)
and quality-of-life##2##2##(2008-7#1)(2012-2#1)
and quantification have##2##3##(2008-10#1)(2010-7#1)
and quantification limits##12##3##(2008-10#12)
and quantification of the##4##4##(2008-10#2)(2010-9#1)(2011-2#1)
and quantification of##26##3##(1992-3#1)(2008-10#15)(2008-11#1)(2008-5#2)(2008-9#2)(2009-7#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
and quantification were##3##3##(2008-10#3)
and quantification##57##2##(1992-3#1)(2008-10#43)(2008-11#1)(2008-5#3)(2008-9#2)(2009-7#1)(2010-7#2)(2010-9#1)(2011-2#1)(2011-7#1)(2013-8#1)
and quantified by##7##3##(1991-12#1)(2008-10#4)(2008-11#1)(2008-12#1)
and quantified in##2##3##(1991-11#1)(2013-8#1)
and quantified on##2##3##(2008-10#1)(2008-5#1)
and quantified##19##2##(1991-11#1)(1991-12#2)(1994-6#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2013-8#1)
and quantify the##6##3##(2008-10#5)(2008-9#1)
and quantify##26##2##(1997-2#1)(2008-10#17)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#2)
and quantifying##6##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-1#2)
and quantitated using##2##3##(2008-10#1)(2008-7#1)
and quantitated##4##2##(2008-10#2)(2008-7#2)
and quantitating##2##2##(2008-4#1)(2008-9#1)
and quantitation of iodotyrosines and iodothyronines##2##6##(2008-10#2)
and quantitation of the##2##4##(2008-10#1)(2008-9#1)
and quantitation of##12##3##(1990-12#1)(1997-3#1)(2008-10#5)(2008-4#3)(2008-9#1)(2013-8#1)
and quantitation##21##2##(1990-12#1)(1997-3#1)(2008-10#14)(2008-4#3)(2008-9#1)(2013-8#1)
and quantitative analyses of##2##4##(2008-10#1)(2008-9#1)
and quantitative analyses##4##3##(2008-10#2)(2008-9#1)(2010-8#1)
and quantitative analysis of##12##4##(2008-10#9)(2008-5#2)(2012-3#1)
and quantitative analysis##17##3##(2008-10#12)(2008-5#2)(2010-11#1)(2011-2#1)(2012-3#1)
and quantitative assessment of##2##4##(2008-2#1)(2008-5#1)
and quantitative detection##2##3##(2008-10#2)
and quantitative determination of##5##4##(2008-10#2)(2008-5#3)
and quantitative determination was##2##4##(2008-10#1)(2008-5#1)
and quantitative determination##8##3##(2008-10#3)(2008-5#5)
and quantitative measurement of##2##4##(2008-5#1)(2008-9#1)
and quantitative resistance of bermudagrass genotypes##2##6##(2008-10#2)
and quantitative resistance##4##3##(2008-10#3)(2008-9#1)
and quantitative studies##2##3##(2008-9#1)(2012-2#1)
and quantitative##78##2##(1990-12#1)(1996-1#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#10)(2008-8#1)(2008-9#7)(2010-1#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
and quantitatively compared##2##3##(2008-10#1)(2008-11#1)
and quantitatively##16##2##(1991-5#1)(1996-12#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-7#1)(2012-2#1)
and quantities of##2##3##(2008-10#1)(2009-8#1)
and quantity of##6##3##(1997-6#1)(2008-10#1)(2008-11#1)(2011-10#1)(2012-12#1)(2012-2#1)
and quantity##7##2##(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2011-10#1)(2012-12#1)(2012-2#1)
and quantum chemistry##2##3##(2011-2#2)
and quantum##6##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#2)
and quarantine##4##2##(1996-11#1)(1996-8#1)(2008-10#1)(2008-12#1)
and quartz##4##2##(2008-10#3)(2008-5#1)
and quaternary ammonium##2##3##(2008-10#2)
and quaternary##4##2##(2008-10#4)
and quaternized##2##2##(2008-10#1)(2008-5#1)
and quenching##2##2##(1992-12#1)(2010-4#1)
and quercetin##8##2##(1994-8#1)(2008-10#5)(2008-9#2)
and question##3##2##(2009-10#1)(2009-6#1)(2010-12#1)
and questionnaires were##2##3##(2008-11#1)(2011-1#1)
and questionnaires##5##2##(1994-12#1)(2008-11#1)(2010-1#1)(2010-3#1)(2011-1#1)
and questions##5##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#1)
and queuing##2##2##(2008-8#1)(2008-9#1)
and quick##4##2##(1997-5#1)(2008-10#1)(2008-11#1)(2010-6#1)
and quickly##8##2##(1992-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-3#1)
and quinic acids##4##3##(2008-10#1)(2008-11#3)
and quinic##5##2##(2008-10#2)(2008-11#3)
and quinoline##2##2##(2008-10#1)(2008-7#1)
and quinolone##3##2##(2008-10#2)(2011-2#1)
and quinolones##5##2##(2008-10#4)(2011-2#1)
and quite##4##2##(1990-6#1)(2008-3#1)(2011-2#1)(2012-2#1)
and r = 0##6##4##(1991-2#2)(1991-8#1)(1995-11#2)(2008-10#1)
and r =##7##3##(1991-2#3)(1991-8#1)(1995-11#2)(2008-10#1)
and r##11##2##(1991-2#3)(1991-8#1)(1995-11#2)(2008-10#3)(2008-8#1)(2008-9#1)
and rRNA##4##2##(2008-10#1)(2008-8#2)(2011-2#1)
and rabbit##8##2##(1990-5#1)(1991-6#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-9#3)
and rabbits##4##2##(1990-11#3)(1994-8#1)
and race 2##3##3##(2008-10#3)
and race 6##3##3##(2008-10#3)
and race##17##2##(1995-12#1)(2008-10#15)(2008-8#1)
and races of F##2##4##(2008-10#2)
and races##3##2##(2008-10#3)
and radial##6##2##(2008-10#1)(2008-3#1)(2011-2#3)(2012-2#1)
and radiation therapy##5##3##(1993-2#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-9#1)
and radiation##19##2##(1992-7#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
and radiative##2##2##(1992-3#1)(2008-2#1)
and radical##3##2##(2008-12#1)(2008-7#1)(2010-11#1)
and radicular##2##2##(2011-2#1)(2012-2#1)
and radio##4##2##(1995-2#1)(1997-1#1)(1997-6#1)(2008-10#1)
and radiographic##10##2##(1997-8#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and radiographs were##2##3##(2008-8#1)(2012-2#1)
and radiologic##5##2##(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
and radiological examination##5##3##(1991-3#1)(1995-9#1)(2008-10#1)(2012-12#1)(2012-2#1)
and radiological findings##6##3##(2009-5#1)(2012-12#3)(2012-2#1)(2013-1#1)
and radiological investigations##2##3##(1990-12#1)(1991-11#1)
and radiological##29##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#2)(1991-3#1)(1995-9#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)
and radiologically##2##2##(2008-12#1)(2010-11#1)
and radiologists##4##2##(1993-3#1)(2008-12#1)(2008-7#1)(2012-2#1)
and radiology##2##2##(1993-1#1)(2009-6#1)
and radiopharmaceuticals##2##2##(2012-12#2)
and radiotherapy in the##2##4##(1993-9#1)(2011-2#1)
and radiotherapy in##4##3##(1993-2#1)(1993-9#1)(2007-8#1)(2011-2#1)
and radiotherapy##12##2##(1990-6#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-2#2)(1993-9#2)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
and radish##4##2##(2008-10#4)
and raffinose##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
and rain##4##2##(2008-10#4)
and rainfall##4##2##(2008-10#4)
and rainwater##3##2##(2008-10#3)
and raise questions about##2##4##(2008-8#1)(2012-2#1)
and raise the##2##3##(2008-9#1)(2012-2#1)
and raise##5##2##(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)
and raised##5##2##(1990-2#1)(1991-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
and raises the##2##3##(1995-12#1)(1995-2#1)
and raises##6##2##(1990-5#1)(1995-12#1)(1995-2#1)(2008-10#1)(2010-4#1)(2013-8#1)
and raising##5##2##(1991-7#1)(2008-11#1)(2010-11#1)(2010-5#1)(2012-3#1)
and random amplified polymorphic DNA (RAPD)##3##6##(2008-10#3)
and random amplified polymorphic DNA##4##5##(2008-10#4)
and random amplified##5##3##(2008-10#5)
and random##19##2##(1993-11#1)(1995-5#1)(2008-10#12)(2008-3#3)(2008-9#1)(2011-2#1)
and randomized##2##2##(1995-12#1)(2009-12#1)
and randomly##2##2##(2008-10#1)(2008-4#1)
and range of motion##2##4##(2008-12#1)(2013-1#1)
and range of##4##3##(2008-10#2)(2008-12#1)(2013-1#1)
and range##8##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#2)
and ranged from##4##3##(1990-6#1)(1992-11#1)(2008-10#2)
and ranged##5##2##(1990-6#1)(1992-11#1)(2008-10#3)
and ranges##2##2##(2008-10#1)(2008-7#1)
and ranitidine##4##2##(2008-10#2)(2008-11#2)
and rank##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
and ranked##2##2##(2008-10#1)(2008-8#1)
and ranking of##2##3##(1993-12#1)(2009-11#1)
and ranking##8##2##(1993-12#1)(2008-11#5)(2008-9#1)(2009-11#1)
and rapid analytical method is##2##5##(2008-10#2)
and rapid assay for##2##4##(2008-10#1)(2008-11#1)
and rapid determination of##2##4##(2008-10#2)
and rapid differential##2##3##(2008-10#2)
and rapid eye movement (REM) sleep##2##6##(2008-11#1)(2013-8#1)
and rapid growth##2##3##(1994-2#1)(2012-3#1)
and rapid method for detecting##2##5##(2008-10#2)
and rapid method for the determination of##4##7##(2008-10#4)
and rapid method for the##6##5##(2008-10#6)
and rapid method for##11##4##(2008-10#11)
and rapid method is##2##4##(2008-10#2)
and rapid method##17##3##(1994-11#1)(2008-10#15)(2008-5#1)
and rapid response##4##3##(1992-1#1)(2008-10#2)(2011-2#1)
and rapid separation##2##3##(2008-10#2)
and rapid spectrophotometric method is##2##5##(2008-10#2)
and rapid spectrophotometric method##3##4##(2008-10#3)
and rapid spectrophotometric##5##3##(2008-10#5)
and rapid##93##2##(1990-12#1)(1991-11#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-10#56)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#2)(2010-5#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and rapidity and##3##3##(1990-12#1)(2008-10#1)(2009-6#1)
and rapidity##7##2##(1990-12#1)(2008-10#5)(2009-6#1)
and rapidly changing##3##3##(1997-3#1)(2008-11#2)
and rapidly than##2##3##(2008-10#1)(2011-2#1)
and rapidly##23##2##(1992-8#1)(1993-12#1)(1994-11#1)(1995-2#1)(1997-3#1)(2008-10#10)(2008-11#3)(2008-3#2)(2009-12#1)(2011-2#2)
and rare earth elements##3##4##(2008-10#3)
and rare earth##5##3##(2008-10#5)
and rare##8##2##(2008-10#6)(2011-2#1)(2012-2#1)
and rarely in##2##3##(2008-5#1)(2013-1#1)
and rarely##7##2##(1991-2#1)(1997-3#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
and rat brain##4##3##(1993-6#1)(2008-10#3)
and rat liver microsomes##4##4##(1991-5#1)(1994-8#1)(2011-3#2)
and rat liver##8##3##(1991-5#1)(1992-10#1)(1993-12#1)(1994-3#1)(1994-8#2)(2011-3#2)
and rat##35##2##(1990-2#1)(1991-5#3)(1992-10#2)(1992-6#2)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1994-3#3)(1994-8#5)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2011-3#2)
and rate of growth of##2##5##(1996-3#1)(2011-2#1)
and rate of the##2##4##(1991-12#1)(2008-9#1)
and rate of##14##3##(1991-12#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
and rate parameters##2##3##(2008-10#1)(2008-11#1)
and rate their##2##3##(2008-7#1)(2010-4#1)
and rate##24##2##(1991-12#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#2)(2012-8#1)(2013-1#1)
and rates of death##2##4##(1991-12#1)(2013-1#1)
and rates of##6##3##(1991-12#1)(1992-2#1)(2008-10#2)(2009-7#1)(2013-1#1)
and rates##8##2##(1991-12#1)(1992-2#1)(2008-10#3)(2008-9#1)(2009-7#1)(2013-1#1)
and rating##2##2##(2008-10#2)
and ratings of##2##3##(1991-3#1)(2013-8#1)
and ratings##3##2##(1991-3#2)(2013-8#1)
and ratio##5##2##(1995-3#1)(2008-10#4)
and ratiometric##2##2##(2008-10#2)
and rational design##2##3##(2008-8#1)(2011-2#1)
and rational##6##2##(1992-5#1)(1994-8#1)(2008-8#1)(2011-2#2)(2011-3#1)
and rationale for##3##3##(1997-1#1)(2008-6#1)(2008-9#1)
and rationale##4##2##(1997-1#1)(2008-12#1)(2008-6#1)(2008-9#1)
and ratios##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
and rats##17##2##(1992-12#1)(1992-9#1)(1993-12#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-7#5)(2008-9#2)(2010-7#1)
and raw##2##2##(2008-10#1)(2011-2#1)
and re-association##2##2##(2008-12#2)
and re-dissolved in##2##3##(2008-10#1)(2008-5#1)
and re-establishment##2##2##(2008-1#1)(2008-11#1)
and reach##6##2##(1995-2#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#1)
and reached a maximum##4##4##(1993-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
and reached a##8##3##(1990-6#1)(1993-8#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-8#1)
and reached the##4##3##(1996-3#1)(2008-10#2)(2008-9#1)
and reached##17##2##(1990-6#1)(1993-8#1)(1995-11#1)(1995-6#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
and reaches the##2##3##(1997-1#1)(2008-5#1)
and reaches##3##2##(1993-8#1)(1997-1#1)(2008-5#1)
and reaching##2##2##(2008-10#1)(2008-9#1)
and react##2##2##(1993-3#1)(2013-7#1)
and reacted with the##3##4##(2008-10#3)
and reacted with##7##3##(2008-10#5)(2008-11#1)(2008-5#1)
and reacted##10##2##(2008-10#6)(2008-11#2)(2008-5#1)(2012-3#1)
and reaction mechanism##2##3##(2008-10#1)(2008-11#1)
and reaction of##2##3##(1996-5#1)(2008-10#1)
and reaction time##2##3##(2008-6#1)(2011-2#1)
and reaction##13##2##(1996-5#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
and reactive nitrogen species##2##4##(2009-8#1)(2011-2#1)
and reactive oxygen species##4##4##(2008-10#2)(2008-7#1)(2009-6#1)
and reactive##14##2##(2008-10#8)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#1)
and reactivity##5##2##(1992-5#1)(2008-10#1)(2010-6#1)(2012-12#1)(2012-2#1)
and reactor##3##2##(2008-10#2)(2008-11#1)
and reacts with the##2##4##(2008-10#2)
and reacts with##3##3##(2008-10#3)
and readers##4##2##(2008-10#1)(2010-12#3)
and readily##6##2##(1994-3#1)(2008-10#2)(2008-5#1)(2010-6#1)(2012-3#1)
and reading comprehension##3##3##(2008-12#1)(2011-2#2)
and reading scores##2##3##(2008-12#2)
and reading##10##2##(1993-2#1)(2008-12#5)(2008-5#1)(2011-2#2)(2012-2#1)
and reagent consumption##3##3##(2008-10#3)
and reagent volumes##3##3##(2008-10#3)
and reagent##20##2##(2008-10#20)
and reagents and##2##3##(2008-10#2)
and reagents##14##2##(2008-10#11)(2008-4#1)(2008-9#1)(2010-7#1)
and real data##2##3##(2008-10#2)
and real sample##2##3##(2008-10#2)
and real samples##12##3##(2008-10#11)(2008-5#1)
and real##29##2##(1991-6#1)(2008-10#25)(2008-5#1)(2008-8#2)
and real-time PCR##3##3##(2008-10#2)(2013-1#1)
and real-time polymerase chain reaction (PCR)##2##6##(2008-10#2)
and real-time polymerase chain##3##4##(2008-10#3)
and real-time##17##2##(2008-10#10)(2008-11#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
and realistic##2##2##(1991-2#1)(2008-5#1)
and reality##3##2##(1994-1#1)(1994-12#1)(1996-12#1)
and realization##2##2##(1995-1#1)(1995-3#1)
and really dangerous##2##3##(2012-3#2)
and really##4##2##(1992-2#1)(2012-3#2)(2013-1#1)
and reared##2##2##(2008-10#1)(2013-8#1)
and rearing##2##2##(1997-2#1)(2012-2#1)
and rearrangement##2##2##(2008-10#1)(2008-11#1)
and reason##2##2##(2008-8#1)(2010-11#1)
and reasonably##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
and reasoning##2##2##(2008-12#1)(2010-11#1)
and reasons for failure##2##4##(2012-12#1)(2013-1#1)
and reasons for##3##3##(1993-12#1)(2012-12#1)(2013-1#1)
and reasons##4##2##(1993-12#1)(2012-12#2)(2013-1#1)
and recall##3##2##(1991-10#1)(2008-11#1)(2011-2#1)
and receipt of##2##3##(2008-4#1)(2013-1#1)
and receive##5##2##(1994-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2013-1#1)
and received an##2##3##(1992-3#1)(2008-7#1)
and received##11##2##(1991-12#1)(1992-3#1)(1993-1#1)(1994-1#1)(1995-1#1)(1995-8#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
and receiver##6##2##(1995-5#1)(2008-10#1)(2008-3#3)(2008-9#1)
and receiving##4##2##(1994-3#1)(2007-8#1)(2008-1#1)(2010-10#1)
and recent advances##3##3##(2008-10#1)(2011-7#1)(2012-2#1)
and recent applications##2##3##(1994-9#1)(2010-9#1)
and recent##23##2##(1990-8#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-3#1)(1994-9#1)(2008-10#5)(2008-11#3)(2009-10#1)(2010-1#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
and recently##5##2##(1997-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
and receptacle area##2##3##(2008-10#2)
and reception##2##2##(2008-11#1)(2012-2#1)
and receptor binding assays##2##4##(1994-5#1)(1995-8#1)
and receptor##6##2##(1990-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-12#1)(2008-10#1)
and receptors for##2##3##(1990-11#1)(1996-12#1)
and receptors##6##2##(1990-11#1)(1992-6#1)(1996-12#1)(2012-12#1)(2013-8#2)
and recessive##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
and recipient##2##2##(2012-12#1)(2012-2#1)
and recognise the##2##3##(2011-2#2)
and recognise##3##2##(2008-8#1)(2011-2#2)
and recognition of##3##3##(1994-2#1)(2008-10#1)(2008-5#1)
and recognition##9##2##(1991-3#2)(1993-8#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)
and recognize the##2##3##(2008-10#1)(2011-2#1)
and recognize##6##2##(1993-12#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
and recognizing##2##2##(2008-4#1)(2011-2#1)
and recombinant human##2##3##(1992-8#1)(2008-11#1)
and recombinant inbred lines##2##4##(2008-10#2)
and recombinant protein expression##2##4##(2008-11#2)
and recombinant protein production##5##4##(2008-11#5)
and recombinant protein##8##3##(2008-11#7)(2008-7#1)
and recombinant##24##2##(1992-8#1)(1993-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#11)(2008-7#1)(2008-9#2)(2011-2#2)
and recombinases##2##2##(2008-11#1)(2012-3#1)
and recombination of##2##3##(1995-2#1)(2008-8#1)
and recombination##9##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#1)
and recommend##3##2##(1991-6#1)(1992-12#1)(2010-9#1)
and recommendations are made##2##4##(1992-12#1)(2008-11#1)
and recommendations are##5##3##(1992-12#1)(1997-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
and recommendations for the##2##4##(2008-9#1)(2012-2#1)
and recommendations for##8##3##(1995-1#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-2#1)
and recommendations##23##2##(1992-12#1)(1994-12#1)(1995-1#3)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-5#2)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#3)
and recommended##2##2##(2008-10#1)(2008-8#1)
and recommends##2##2##(1990-9#1)(2011-3#1)
and reconstituted##5##2##(1992-8#1)(1993-8#1)(2008-10#2)(2008-8#1)
and reconstitution##2##2##(1995-8#1)(2008-10#1)
and reconstructed##3##2##(1997-8#1)(2008-5#1)(2008-7#1)
and reconstruction of##2##3##(2008-7#1)(2012-3#1)
and reconstruction##9##2##(2008-3#1)(2008-6#1)(2008-7#2)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
and reconstructive surgery of##2##4##(1992-9#1)(2011-2#1)
and reconstructive surgery##4##3##(1992-9#1)(2008-11#2)(2011-2#1)
and reconstructive##5##2##(1992-9#2)(2008-11#2)(2011-2#1)
and record##2##2##(2008-12#1)(2012-3#1)
and recorded##3##2##(1990-9#1)(1996-5#1)(1997-3#1)
and recording##2##2##(2008-3#1)(2013-8#1)
and recovered from##2##3##(2008-10#2)
and recovered##10##2##(1996-11#1)(1996-6#1)(2008-10#5)(2008-9#1)(2011-2#1)(2012-3#1)
and recoveries between##2##3##(2008-10#2)
and recoveries of##3##3##(2008-10#2)(2008-7#1)
and recoveries##11##2##(1993-2#1)(2008-10#9)(2008-7#1)
and recovery from the pharmaceutical##2##5##(2008-10#2)
and recovery from##3##3##(1990-7#1)(2008-10#2)
and recovery is quantitative##2##4##(2008-10#2)
and recovery is##3##3##(2008-10#3)
and recovery of the##3##4##(2008-10#3)
and recovery of##21##3##(2008-10#17)(2008-11#3)(2012-12#1)
and recovery tests##2##3##(2008-10#2)
and recovery time##2##3##(2008-10#1)(2011-2#1)
and recovery to##2##3##(2008-10#1)(2012-2#1)
and recovery##57##2##(1990-7#1)(1993-2#1)(2008-10#42)(2008-11#4)(2008-7#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
and recreation##3##2##(1993-2#1)(1994-3#1)(2012-12#1)
and recruit##3##2##(2008-11#1)(2009-5#1)(2009-8#1)
and recruitment and retention##2##4##(1995-2#1)(2008-11#1)
and recruitment of##2##3##(2008-7#1)(2012-2#1)
and recruitment##7##2##(1995-2#1)(2008-11#2)(2008-7#1)(2012-2#3)
and rectal cancer##3##3##(1997-8#1)(2010-6#2)
and rectal##6##2##(1991-6#1)(1997-8#1)(2008-10#1)(2010-6#2)(2011-2#1)
and rectocele##3##2##(1994-3#1)(2011-2#2)
and rectum##6##2##(1991-2#1)(1991-6#3)(1992-5#1)(2008-11#1)
and recur after##2##3##(2011-2#1)(2013-1#1)
and recurrence##9##2##(1997-7#1)(2008-11#1)(2009-8#1)(2011-2#3)(2012-3#2)(2013-8#1)
and recurrent##14##2##(1990-9#1)(1991-3#2)(1991-6#4)(1994-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
and recursive##2##2##(1995-2#1)(2008-6#1)
and red blood cells##2##4##(2008-10#2)
and red wine##2##3##(2008-10#2)
and red##22##2##(1992-1#1)(1995-12#1)(2008-10#10)(2008-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)
and redesign##2##2##(1993-12#1)(1997-2#1)
and redox##9##2##(2008-10#6)(2008-11#1)(2008-7#1)(2012-2#1)
and reduce average##2##3##(1997-2#1)(2008-8#1)
and reduce the number of##3##5##(1997-5#1)(2008-10#1)(2011-2#1)
and reduce the##17##3##(1992-12#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#3)(2013-1#1)
and reduce##35##2##(1990-2#1)(1992-12#1)(1993-11#1)(1995-11#1)(1995-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)
and reduced disease severity##3##4##(2008-10#3)
and reduced disease##4##3##(2008-10#4)
and reduced glutathione (GSH)##2##4##(2008-10#2)
and reduced glutathione##5##3##(2008-10#3)(2012-2#2)
and reduced in##3##3##(2008-7#2)(2013-8#1)
and reduced morbidity##2##3##(2008-10#1)(2010-6#1)
and reduced root rot severity by##2##6##(2008-10#2)
and reduced survival##2##3##(1993-1#1)(2008-7#1)
and reduced the rate of##2##5##(1991-12#1)(2008-10#1)
and reduced the##17##3##(1991-12#1)(1994-8#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-9#1)(2010-11#1)(2013-1#1)
and reduced##93##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-8#2)(1995-2#1)(1996-2#2)(1996-6#1)(1997-3#1)(2008-10#39)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#4)(2012-6#1)(2013-1#3)(2013-8#1)
and reduces the##2##3##(1990-2#1)(1995-9#1)
and reduces##9##2##(1990-2#1)(1992-3#2)(1995-9#1)(1996-3#1)(2008-10#2)(2010-8#1)(2011-2#1)
and reducing costs##2##3##(1997-2#1)(2008-10#1)
and reducing the##2##3##(2008-10#2)
and reducing##24##2##(1990-6#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-2#1)(2008-10#11)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#3)
and reduction coil length##3##4##(2008-10#3)
and reduction in##5##3##(1995-3#1)(2008-10#3)(2008-7#1)
and reduction of the##2##4##(1995-5#1)(2008-10#1)
and reduction of##15##3##(1990-6#1)(1995-5#1)(1996-11#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-3#1)(2010-1#1)(2013-8#1)
and reduction##28##2##(1990-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-3#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-7#1)(2010-1#1)(2013-8#1)
and reductive##2##2##(2008-10#1)(2008-11#1)
and reengineering##2##2##(1995-3#2)
and reference memory##2##3##(2008-12#2)
and reference methods##3##3##(2008-10#3)
and reference strains##2##3##(2008-10#2)
and reference values##2##3##(2008-10#2)
and reference##26##2##(1997-1#1)(2008-10#17)(2008-12#2)(2008-3#2)(2012-12#3)(2012-2#1)
and references##2##2##(2008-10#1)(2008-8#1)
and referral to##2##3##(2008-11#1)(2009-8#1)
and referral##5##2##(1990-11#1)(1994-1#1)(1996-1#1)(2008-11#1)(2009-8#1)
and referred##3##2##(1994-6#1)(2008-10#1)(2010-9#1)
and refined by##2##3##(1992-12#1)(1992-4#1)
and refined to##2##3##(1993-8#1)(2008-11#1)
and refined using##2##3##(2008-11#1)(2008-8#1)
and refined##10##2##(1992-12#1)(1992-4#1)(1993-8#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2011-1#1)
and refinement##2##2##(1993-8#1)(2011-3#1)
and reflect##2##2##(1993-6#1)(2008-8#1)
and reflectance##7##2##(2008-10#4)(2008-3#3)
and reflected##2##2##(2008-11#1)(2009-9#1)
and reflecting##3##2##(2008-12#3)
and reflection##5##2##(2008-11#3)(2008-3#2)
and reflections on##2##3##(2008-11#1)(2012-2#1)
and reflective##4##2##(2008-11#4)
and reflects##2##2##(2008-12#1)(2008-3#1)
and reflux##2##2##(1992-11#1)(2011-2#1)
and refolding of the##2##4##(2008-4#1)(2008-8#1)
and refolding##4##2##(2008-10#1)(2008-4#2)(2008-8#1)
and refractive index##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
and refugee##2##2##(2008-11#1)(2011-2#1)
and regarding##2##2##(1990-3#1)(2008-4#1)
and regardless of##2##3##(1994-9#1)(2008-9#1)
and regenerated##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
and regenerating##2##2##(1990-5#1)(2010-5#1)
and regeneration of##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
and regeneration##13##2##(1993-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#1)(2012-2#1)(2013-1#1)
and regenerative medicine##5##3##(2008-11#1)(2009-7#1)(2010-3#1)(2012-5#2)
and regenerative##7##2##(1994-5#2)(2008-11#1)(2009-7#1)(2010-3#1)(2012-5#2)
and region of origin##2##4##(2008-10#2)
and region##4##2##(2008-10#2)(2011-2#1)(2011-9#1)
and regional##35##2##(1990-11#2)(1990-6#1)(1993-9#1)(1994-3#4)(1994-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-11#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-3#1)
and regions##4##2##(1990-4#1)(1995-5#1)(2008-10#1)(2013-8#1)
and registered##2##2##(2008-12#1)(2010-5#1)
and registries##3##2##(2009-10#1)(2011-2#1)(2012-12#1)
and regression analyses were##2##4##(2008-10#2)
and regression coefficient##2##3##(2008-10#2)
and regression of##2##3##(1995-9#1)(2008-12#1)
and regression tree##3##3##(2008-10#3)
and regression##12##2##(1995-9#1)(2008-10#10)(2008-12#1)
and regrowth##2##2##(2008-10#1)(2008-7#1)
and regular use of##2##4##(1990-9#1)(1991-9#1)
and regular##10##2##(1990-9#1)(1991-9#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-11#1)(2013-1#1)
and regularly##2##2##(1992-9#1)(1997-3#1)
and regulate the##3##3##(1991-11#1)(2008-11#1)(2010-1#1)
and regulate their##2##3##(2008-10#1)(2012-2#1)
and regulate##9##2##(1991-11#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-1#1)(2012-2#1)
and regulated expression of##2##4##(1992-6#1)(1993-9#1)
and regulated##6##2##(1992-6#1)(1993-9#1)(1994-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
and regulates the##2##3##(2011-2#1)(2012-2#1)
and regulates##4##2##(1995-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
and regulating cell##2##3##(2009-8#1)(2010-9#1)
and regulating##4##2##(2009-5#1)(2009-8#1)(2010-9#1)(2013-1#1)
and regulation by##2##3##(1995-11#1)(2008-11#1)
and regulation of glucose and glutamine metabolism##2##7##(2008-11#2)
and regulation of the##3##4##(1991-5#1)(1993-2#1)(1995-11#1)
and regulation of##15##3##(1991-5#1)(1993-2#1)(1995-11#1)(1997-1#1)(2008-11#2)(2008-5#1)(2008-8#4)(2010-11#1)(2011-1#1)(2013-1#2)
and regulation##25##2##(1991-5#1)(1993-2#1)(1995-11#2)(1995-6#1)(1997-1#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#2)(2010-11#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and regulators of##2##3##(2009-7#1)(2011-2#1)
and regulators##3##2##(2009-7#1)(2011-2#1)(2012-3#1)
and regulatory mechanisms##2##3##(2011-1#1)(2012-3#1)
and regulatory##19##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1995-6#1)(2008-10#1)(2008-11#7)(2008-2#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#1)
and rehabilitation of##2##3##(1995-2#1)(2012-3#1)
and rehabilitation##12##2##(1991-12#1)(1993-12#3)(1995-12#1)(1995-2#1)(1995-5#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
and rehabilitative##3##2##(2013-1#3)
and rehydration##2##2##(2008-10#1)(2011-1#1)
and reimbursement##7##2##(1991-12#2)(1992-11#1)(1995-3#2)(2007-12#1)(2008-11#1)
and reinforcement##3##2##(1991-1#1)(2008-11#1)(2008-9#1)
and reinforces the##2##3##(2008-10#1)(2011-2#1)
and rejected##3##2##(1995-12#2)(2008-10#1)
and rejection of##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
and rejection##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
and relapse##5##2##(1996-11#1)(2008-11#1)(2009-9#2)(2011-2#1)
and relapsing##2##2##(1991-2#1)(1995-12#1)
and relate them to##2##4##(2008-12#1)(2012-2#1)
and relate##5##2##(2008-10#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
and related aminothiols##2##3##(2008-10#2)
and related compounds in##3##4##(2008-10#3)
and related compounds on protein##3##5##(2008-11#3)
and related compounds##14##3##(2008-10#11)(2008-11#3)
and related disorders##10##3##(1992-6#2)(2008-11#1)(2008-12#5)(2008-3#1)(2012-2#1)
and related genera##2##3##(2008-10#1)(2008-5#1)
and related issues##2##3##(2008-5#1)(2009-9#1)
and related materials##2##3##(1994-3#1)(2009-12#1)
and related phenomena##2##3##(2008-3#2)
and related problems##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
and related research##2##3##(1996-2#1)(2008-10#1)
and related species##7##3##(2007-12#1)(2008-10#5)(2008-11#1)
and related to the##4##4##(2008-10#3)(2009-10#1)
and related to##9##3##(2008-10#4)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2012-7#1)
and related##123##2##(1990-3#1)(1991-2#2)(1992-2#2)(1992-6#2)(1992-9#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#39)(2008-11#11)(2008-12#8)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#4)(2008-9#5)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-3#4)(2012-12#3)(2012-2#1)(2012-3#2)(2012-7#1)(2013-8#1)
and relatedness##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)
and relates the##2##3##(1995-1#1)(2008-8#1)
and relates##3##2##(1995-1#1)(2008-8#1)(2008-9#1)
and relating##3##2##(1990-2#1)(2008-10#1)(2008-7#1)
and relational##5##2##(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-1#1)
and relations##2##2##(2013-1#2)
and relationship to##3##3##(2008-9#2)(2012-12#1)
and relationship##7##2##(2008-9#2)(2012-12#1)(2012-2#3)(2013-1#1)
and relationships between##2##3##(2008-11#1)(2008-9#1)
and relationships of##2##3##(1991-1#1)(2008-8#1)
and relationships##6##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
and relative abundance##3##3##(2008-10#1)(2008-8#2)
and relative head weight (0##2##5##(2008-10#2)
and relative humidity##11##3##(1995-3#1)(1996-12#1)(2008-10#8)(2013-1#1)
and relative standard deviation (R##2##5##(2008-10#2)
and relative standard deviation of +/-0##2##6##(2008-10#2)
and relative standard deviation of +/-1##2##6##(2008-10#2)
and relative standard deviation of##11##5##(2008-10#11)
and relative standard deviation was##3##5##(2008-10#3)
and relative standard deviation were##2##5##(2008-10#2)
and relative standard deviation##30##4##(2008-10#30)
and relative standard deviations for##2##5##(2008-10#2)
and relative standard deviations of##2##5##(2008-10#2)
and relative standard deviations were##5##5##(2008-10#5)
and relative standard deviations##11##4##(2008-10#11)
and relative standard##42##3##(2008-10#42)
and relative##88##2##(1990-2#1)(1992-3#1)(1995-3#1)(1995-9#1)(1996-12#3)(2008-10#68)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
and relatively effective##2##3##(2008-10#1)(2013-1#1)
and relatively inexpensive##3##3##(2008-10#3)
and relatively low##2##3##(2008-10#2)
and relatively##20##2##(1991-3#1)(1992-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-3#1)(2012-7#1)(2013-1#1)
and relatives##2##2##(1995-1#1)(2012-12#1)
and relaxation##7##2##(1991-12#1)(1992-12#1)(1994-5#1)(1995-3#1)(1997-4#2)(2011-2#1)
and relaxed##2##2##(2008-11#1)(2008-9#1)
and release from##2##3##(1995-11#1)(1996-12#1)
and release in##2##3##(2008-10#2)
and release of ascospores of Anisogramma anomala##2##7##(2008-10#2)
and release of the##3##4##(2008-10#3)
and release of##18##3##(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
and release the##3##3##(1992-6#1)(2008-7#1)(2010-4#1)
and release##42##2##(1992-6#1)(1993-8#2)(1995-11#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#2)
and released in##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
and released##12##2##(1991-12#1)(1992-6#1)(1993-6#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-10#1)(2011-10#1)(2011-2#1)
and relevance of##2##3##(2008-5#1)(2008-7#1)
and relevant information##2##3##(2008-6#1)(2013-8#1)
and relevant##13##2##(1990-11#1)(1990-8#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
and reliability of a##2##4##(1995-11#1)(2010-9#1)
and reliability of the##5##4##(1994-6#1)(2008-10#3)(2008-3#1)
and reliability of this##2##4##(2008-11#1)(2013-8#1)
and reliability of##14##3##(1994-6#1)(1995-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2010-9#1)(2011-3#1)(2013-1#1)(2013-8#1)
and reliability##19##2##(1994-6#1)(1995-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
and reliable analytical method##2##4##(2008-10#2)
and reliable analytical##5##3##(2008-10#5)
and reliable and##2##3##(2008-10#1)(2008-4#1)
and reliable detection of##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
and reliable detection##5##3##(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
and reliable method for the selective extraction and##2##8##(2008-10#2)
and reliable method for the##4##5##(2008-10#4)
and reliable method for##10##4##(1997-7#1)(2008-10#8)(2008-11#1)
and reliable method has been developed##2##6##(2008-10#2)
and reliable method of##2##4##(2008-10#1)(2008-9#1)
and reliable method was developed for##2##6##(2008-10#2)
and reliable method##18##3##(1997-7#1)(2008-10#14)(2008-11#1)(2008-9#1)(2009-12#1)
and reliable##70##2##(1990-8#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-7#2)(2008-10#41)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#3)
and reliably##5##2##(1992-1#1)(2008-10#1)(2012-2#1)(2013-1#2)
and reliance on##2##3##(2008-12#1)(2008-6#1)
and relies##2##2##(2008-11#1)(2008-8#1)
and relieve##3##2##(2007-11#1)(2008-11#1)(2012-3#1)
and religion are##3##3##(2008-12#1)(2010-10#1)(2013-1#1)
and religion##7##2##(2008-11#1)(2008-12#2)(2009-8#1)(2010-10#1)(2013-1#2)
and religious coping##3##3##(2008-12#1)(2009-11#2)
and religious##6##2##(1991-6#1)(2008-12#3)(2009-11#2)
and remain##4##2##(2008-10#3)(2008-9#1)
and remained##13##2##(1995-11#1)(1996-12#1)(2008-10#6)(2010-8#1)(2011-2#3)(2013-1#1)
and remains##5##2##(2008-10#2)(2008-3#1)(2011-2#1)(2013-8#1)
and remarkable stability##3##3##(1990-5#1)(2008-10#2)
and remarkable##4##2##(1990-5#1)(2008-10#2)(2008-7#1)
and reminder##2##2##(1996-2#1)(2010-8#1)
and remission of##2##3##(1994-12#1)(1995-10#1)
and remodeling of##2##3##(2009-7#2)
and remodeling##3##2##(2009-7#2)(2009-9#1)
and remote##6##2##(1990-5#1)(1993-6#1)(2008-10#2)(2008-3#1)(2010-9#1)
and removal of the##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
and removal of##12##3##(1997-4#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
and removal##16##2##(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
and remove infected##2##3##(2008-10#2)
and remove##4##2##(1994-12#1)(2008-10#2)(2009-12#1)
and removed##10##2##(1990-9#1)(2008-10#5)(2008-2#1)(2008-7#1)(2009-7#1)(2011-2#1)
and removing##5##2##(1991-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
and renal cell##4##3##(1994-3#1)(2009-4#1)(2011-2#2)
and renal or##2##3##(2008-10#1)(2008-8#1)
and renal toxicity of gold sodium thiomalate##2##7##(1994-5#2)
and renal toxicity of gold##3##5##(1994-5#3)
and renal##29##2##(1990-2#1)(1990-9#1)(1991-9#1)(1994-3#1)(1994-5#5)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
and rendering##2##2##(2008-6#2)
and renin##4##2##(1993-6#3)(2008-11#1)
and renovation of##3##3##(2008-11#1)(2012-3#2)
and rep-PCR##2##2##(2008-10#2)
and repair##14##2##(1994-3#1)(1994-9#2)(1996-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#2)(2013-1#1)
and repairing##2##2##(2008-5#1)(2012-5#1)
and repeat##3##2##(1996-1#1)(2008-11#1)(2008-12#1)
and repeatability of##3##3##(2008-10#2)(2008-5#1)
and repeatability##7##2##(2008-10#6)(2008-5#1)
and repeated##6##2##(1991-6#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
and reperfusion##3##2##(1996-2#1)(2010-1#2)
and repetition compulsion##2##3##(2009-11#2)
and repetitive extragenic palindromic (REP)##2##5##(2008-10#2)
and repetitive sequence-based polymerase chain reaction##2##6##(2008-10#2)
and repetitive##7##2##(2008-10#7)
and replaced by a##2##4##(1992-6#1)(2009-8#1)
and replaced by##4##3##(1992-6#1)(1996-11#1)(2008-5#1)(2009-8#1)
and replacement with##2##3##(1991-10#1)(2008-9#1)
and replacement##3##2##(1991-10#1)(2008-10#1)(2008-9#1)
and replacing##2##2##(2008-11#1)(2012-2#1)
and replicated##3##2##(2008-10#1)(2008-12#1)(2010-1#1)
and replication##3##2##(2008-7#1)(2011-2#2)
and report the##3##3##(1990-5#1)(1993-3#1)(2012-3#1)
and report##11##2##(1990-5#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-5#1)(1996-12#1)(2008-3#1)(2011-2#1)(2012-2#2)(2012-3#1)
and reported as##4##3##(1991-12#1)(2008-10#1)(2011-1#1)(2012-2#1)
and reported for the##2##4##(2008-10#1)(2012-2#1)
and reported in##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
and reported that##2##3##(2008-12#1)(2013-1#1)
and reported##23##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
and reporting of##3##3##(1991-11#1)(2008-4#1)(2008-7#1)
and reporting##9##2##(1991-11#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
and reports on##3##3##(1996-2#1)(2008-11#1)(2010-1#1)
and reports that##2##3##(2008-10#1)(2008-11#1)
and reports##8##2##(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-1#1)
and represent a##4##3##(1990-5#1)(2008-7#1)(2010-12#1)(2010-7#1)
and represent##9##2##(1990-5#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
and representation##2##2##(1995-12#1)(2008-8#1)
and representative of the##2##4##(2008-10#2)
and representative of##3##3##(1992-3#1)(2008-10#2)
and representative##4##2##(1992-3#1)(2008-10#3)
and representativeness of##3##3##(2008-4#1)(2009-11#2)
and representativeness##4##2##(2008-4#1)(2009-11#3)
and representatives of##2##3##(1991-6#1)(2008-10#1)
and representatives##3##2##(1991-6#1)(1996-1#1)(2008-10#1)
and represented##5##2##(1992-6#1)(1993-6#1)(2008-10#3)
and representing the##2##3##(2008-10#1)(2009-10#1)
and represents a possible##2##4##(2010-11#1)(2011-2#1)
and represents a##6##3##(1990-2#1)(1996-12#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-4#1)
and represents an##2##3##(2008-10#1)(2008-3#1)
and represents the##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
and represents##14##2##(1990-2#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-4#1)
and repressed##3##2##(2008-11#1)(2008-9#2)
and represses##2##2##(1994-12#1)(2012-2#1)
and reproducibility (R##2##3##(2008-10#2)
and reproducibility of the assay##2##5##(2008-10#1)(2013-8#1)
and reproducibility of the##7##4##(2008-10#4)(2008-12#1)(2009-2#1)(2013-8#1)
and reproducibility of##15##3##(2008-10#10)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-8#1)
and reproducibility studies##2##3##(2008-10#2)
and reproducibility were obtained##2##4##(2008-10#2)
and reproducibility were##3##3##(2008-10#3)
and reproducibility##53##2##(1992-11#1)(2008-10#44)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2013-8#1)
and reproducible (RSD 0##2##4##(2008-10#2)
and reproducible and##2##3##(2008-10#2)
and reproducible determination##2##3##(2008-10#2)
and reproducible in##2##3##(2008-7#1)(2009-1#1)
and reproducible method to##2##4##(1994-6#1)(2008-10#1)
and reproducible method##5##3##(1994-6#1)(2008-10#2)(2008-11#2)
and reproducible results##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
and reproducible##60##2##(1990-11#1)(1994-3#1)(1994-6#1)(1996-12#1)(2006-6#1)(2008-10#35)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-1#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and reproducibly##3##2##(2008-10#1)(2012-2#2)
and reproduction of##4##3##(2008-10#1)(2008-11#1)(2008-8#2)
and reproduction##13##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2010-4#1)(2010-5#1)
and reproductive function##2##3##(2008-4#2)
and reproductive health services##2##4##(2008-11#2)
and reproductive health##11##3##(1994-9#1)(2008-11#4)(2012-12#4)(2012-2#1)(2013-8#1)
and reproductive organs##2##3##(2008-12#1)(2010-1#1)
and reproductive success was##2##4##(2008-10#1)(2008-8#1)
and reproductive success##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
and reproductive##38##2##(1990-11#1)(1992-2#1)(1992-3#2)(1994-9#1)(1996-2#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-12#5)(2012-2#1)(2012-3#1)(2012-8#2)(2013-8#1)
and request##2##2##(1991-3#1)(2010-10#1)
and require a##2##3##(1996-3#1)(2008-10#1)
and require further##2##3##(2008-10#1)(2012-3#1)
and require##14##2##(1993-9#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-3#2)
and required only##2##3##(1990-2#1)(1991-3#1)
and required##13##2##(1990-2#1)(1991-3#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2012-3#1)
and requirements for##2##3##(1991-6#1)(2012-3#1)
and requirements##4##2##(1991-6#1)(1992-9#1)(2012-3#2)
and requires further##2##3##(2008-10#1)(2012-2#1)
and requires surgical##2##3##(1991-6#1)(2008-4#1)
and requires the##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
and requires##25##2##(1991-6#1)(1993-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and resampling##2##2##(2008-10#1)(2008-6#1)
and research are##2##3##(1991-2#1)(2008-11#1)
and research data##2##3##(1997-2#1)(2010-8#1)
and research implications##2##3##(1991-1#1)(2008-12#1)
and research in##8##3##(1991-6#1)(1993-11#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
and research into##2##3##(1991-2#1)(2009-1#1)
and research on the##2##4##(2008-10#1)(2008-5#1)
and research on##4##3##(2008-10#1)(2008-5#2)(2012-3#1)
and research studies##3##3##(2013-1#3)
and research##66##2##(1991-1#2)(1991-12#2)(1991-2#2)(1991-6#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-5#3)(2008-6#6)(2008-8#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)
and researchers##6##2##(2008-12#1)(2008-7#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#1)
and resected##2##2##(2008-10#1)(2013-1#1)
and resection##2##2##(2008-7#2)
and resembled the##2##3##(1994-5#1)(2008-11#1)
and reservoir##4##2##(1996-2#1)(2008-10#3)
and residence##4##2##(1991-6#1)(1992-3#1)(2008-10#2)
and resident##3##2##(1991-9#1)(2008-5#1)(2009-8#1)
and residential care##3##3##(1997-1#2)(2008-12#1)
and residential##5##2##(1991-1#1)(1997-1#2)(2008-12#1)(2011-2#1)
and residents##5##2##(1993-3#1)(1995-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
and residual##11##2##(1997-1#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-9#4)
and residue##3##2##(2008-10#3)
and residues from##2##3##(2008-10#1)(2008-5#1)
and residues##6##2##(1997-9#1)(2008-10#3)(2008-5#1)(2008-8#1)
and resin amount##3##3##(2008-10#3)
and resin##5##2##(2008-10#5)
and resistance to lodging##2##4##(2008-10#2)
and resistance to the##2##4##(2011-10#1)(2013-1#1)
and resistance to##25##3##(1991-3#1)(2008-10#14)(2008-8#2)(2008-9#1)(2009-9#1)(2011-10#1)(2011-2#2)(2013-1#3)
and resistance training##2##3##(2013-1#2)
and resistance was found##2##4##(2008-10#2)
and resistance was##4##3##(2008-10#4)
and resistance##50##2##(1991-3#1)(1996-6#1)(1997-4#1)(2008-10#28)(2008-5#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-9#1)(2011-10#2)(2011-2#2)(2012-3#1)(2013-1#7)
and resistant isolates##2##3##(2008-10#2)
and resistant to##6##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-10#1)
and resistant##36##2##(1992-12#1)(1994-8#1)(1996-12#1)(2008-10#26)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-10#1)
and resisted##2##2##(2009-5#1)(2013-1#1)
and resolution of the##2##4##(2008-10#1)(2008-3#1)
and resolution of##7##3##(1994-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2012-3#1)
and resolution##16##2##(1994-12#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#2)(2011-7#1)(2012-3#1)
and resolutions##3##2##(1994-1#2)(1995-3#1)
and resolve##2##2##(2008-10#1)(2011-2#1)
and resonance##5##2##(2008-10#2)(2009-9#1)(2010-3#1)(2013-8#1)
and resonant##2##2##(2008-3#2)
and resorcinol##3##2##(2008-10#3)
and resource allocation##2##3##(1992-1#1)(1995-2#1)
and resource##12##2##(1991-12#1)(1992-1#1)(1993-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and resources are##4##3##(2008-12#1)(2008-8#1)(2010-8#1)(2013-1#1)
and resources for##4##3##(1992-3#2)(1995-12#1)(1997-3#1)
and resources in##2##3##(1990-12#1)(1997-3#1)
and resources of##2##3##(1990-2#1)(2008-10#1)
and resources to##4##3##(2008-11#1)(2009-3#1)(2012-2#1)(2012-3#1)
and resources##29##2##(1990-12#1)(1990-2#1)(1992-3#2)(1994-1#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-3#3)(2008-10#1)(2008-11#4)(2008-12#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and respect##2##2##(1994-1#1)(1996-1#1)
and respective##4##2##(2008-10#3)(2013-8#1)
and respectively##2##2##(1994-2#1)(2008-1#1)
and respiratory failure##4##3##(2011-2#2)(2012-3#1)(2013-1#1)
and respiratory function##2##3##(2011-2#1)(2012-2#1)
and respiratory infections##2##3##(1997-6#1)(2010-6#1)
and respiratory outcomes##2##3##(2010-6#2)
and respiratory syncytial virus##2##4##(1995-5#1)(2008-11#1)
and respiratory##29##2##(1990-2#1)(1991-6#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-2#2)(1997-6#1)(2007-8#1)(2008-11#3)(2008-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#3)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#1)
and respond to##6##3##(1990-12#1)(1994-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
and respond##7##2##(1990-12#1)(1994-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
and responded##2##2##(1994-2#1)(1995-10#1)
and responding##3##2##(1992-2#1)(1994-2#1)(2009-9#1)
and response time of the electrode##2##6##(2008-10#2)
and response time of the##3##5##(2008-10#3)
and response time of##4##4##(2008-10#4)
and response time##6##3##(2008-10#5)(2008-6#1)
and response to##12##3##(1993-11#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
and response##36##2##(1993-11#1)(1993-6#1)(1994-12#1)(1994-8#1)(1996-12#2)(1997-2#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-6#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and responses to##5##3##(2008-10#1)(2008-12#1)(2008-6#1)(2010-4#1)(2012-2#1)
and responses##9##2##(1991-6#1)(1993-6#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-4#1)(2012-2#1)
and responsibilities of##3##3##(1992-12#1)(1994-1#1)(1997-2#1)
and responsibilities##7##2##(1992-12#1)(1994-1#1)(1995-12#1)(1997-2#1)(2008-11#1)(2010-5#1)(2013-1#1)
and responsibility##3##2##(2008-11#1)(2010-11#1)(2011-2#1)
and responsible##2##2##(2008-9#1)(2012-3#1)
and responsive##2##2##(2008-10#1)(2009-7#1)
and responsiveness to##3##3##(1990-12#1)(1993-2#1)(1994-2#1)
and responsiveness##4##2##(1990-12#1)(1993-2#1)(1994-11#1)(1994-2#1)
and rest##2##2##(1992-12#1)(1996-2#1)
and restenosis##3##2##(1992-9#2)(2008-11#1)
and resting##3##2##(1991-6#1)(2008-10#1)(2012-2#1)
and restoration of##5##3##(1995-3#1)(2008-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
and restoration##6##2##(1995-3#1)(2008-1#1)(2008-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
and restore##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
and restored##5##2##(1993-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
and restricted activity days##2##4##(2013-1#2)
and restricted to the##2##4##(2008-10#2)
and restricted to##3##3##(1991-12#1)(2008-10#2)
and restricted##9##2##(1991-12#1)(2008-10#4)(2008-9#1)(2011-2#1)(2013-1#2)
and restriction fragment length polymorphism (RFLP)##2##6##(2008-10#2)
and restriction fragment length polymorphism analysis of##2##7##(2008-10#2)
and restriction fragment length polymorphism##7##5##(2008-10#6)(2013-1#1)
and restriction fragment length polymorphisms##2##5##(2008-10#2)
and restriction fragment length##9##4##(2008-10#8)(2013-1#1)
and restriction##17##2##(1993-6#1)(1997-2#1)(2008-10#13)(2008-12#1)(2013-1#1)
and restrictive##2##2##(1991-12#1)(1997-3#1)
and result in##5##3##(1995-1#1)(1997-2#1)(2008-10#1)(2009-7#1)(2010-9#1)
and result##6##2##(1995-1#1)(1997-2#1)(2008-10#1)(2009-7#1)(2010-9#1)(2011-2#1)
and resultant##6##2##(1991-3#1)(2009-8#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
and resulted in a##2##4##(2008-10#2)
and resulted in increased##2##4##(1994-8#1)(1995-3#1)
and resulted in the##3##4##(1997-5#1)(2008-8#1)(2013-1#1)
and resulted in##16##3##(1991-8#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-5#1)(2008-10#7)(2008-8#1)(2011-2#1)(2013-1#2)
and resulting in##3##3##(2008-10#1)(2008-9#1)(2010-12#1)
and resulting##7##2##(1994-12#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-12#1)
and results are discussed##2##4##(1991-3#1)(2008-10#1)
and results are presented for##2##5##(1992-12#1)(2008-10#1)
and results are presented##3##4##(1992-12#1)(2008-10#1)(2010-7#1)
and results are##7##3##(1991-3#1)(1992-12#1)(2008-10#2)(2008-12#1)(2010-7#1)(2011-2#1)
and results from##3##3##(1995-2#1)(2008-6#1)(2012-2#1)
and results in a##3##4##(1995-6#1)(2008-10#2)
and results in the##4##4##(1994-12#1)(1995-12#1)(2008-10#1)(2009-7#1)
and results in##15##3##(1993-2#1)(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#6)(2008-5#1)(2009-7#1)(2009-8#1)(2011-3#1)(2013-8#1)
and results obtained##2##3##(1992-9#1)(2008-10#1)
and results of the study##2##5##(2008-10#1)(2008-11#1)
and results of the##5##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
and results of##24##3##(1990-11#1)(1990-9#1)(1994-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-7#1)(2009-4#1)(2010-8#1)(2012-3#2)(2013-1#2)
and results presented##2##3##(2008-10#1)(2008-3#1)
and results were compared##2##4##(2008-10#2)
and results were##5##3##(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
and results##74##2##(1990-11#1)(1990-9#2)(1991-3#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and resveratrol##2##2##(2008-10#1)(2008-7#1)
and retail##3##2##(1993-3#1)(1994-3#1)(2008-10#1)
and retain a##2##3##(1994-3#1)(2008-11#1)
and retain##3##2##(1994-3#1)(1995-2#1)(2008-11#1)
and retained in the column##2##5##(2008-10#1)(2008-9#1)
and retained in the##3##4##(2008-10#1)(2008-9#2)
and retained##4##2##(2008-10#2)(2008-9#2)
and retaining##5##2##(1992-3#1)(1996-3#1)(2008-10#2)(2012-2#1)
and retentate##2##2##(2008-10#1)(2008-7#1)
and retention initiatives##2##3##(2008-11#2)
and retention of##10##3##(1991-2#1)(1994-3#2)(1996-12#1)(1996-3#2)(2008-12#1)(2008-9#1)(2009-5#1)(2012-2#1)
and retention##35##2##(1990-2#1)(1991-2#2)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#3)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#1)
and retinal##5##2##(2008-1#3)(2008-12#1)(2011-2#1)
and retinitis##2##2##(2008-9#1)(2011-2#1)
and retinol status in rats with##2##6##(2009-6#2)
and retinol##3##2##(1993-2#1)(2009-6#2)
and retinol-binding protein##2##3##(1990-12#1)(2009-6#1)
and retirement##2##2##(2008-10#1)(2008-9#1)
and retrieval of##3##3##(1994-12#1)(2008-11#1)(2008-8#1)
and retrieval##7##2##(1994-12#1)(2008-11#4)(2008-8#1)(2012-12#1)
and retrieving##4##2##(1994-3#2)(1997-2#1)(2009-12#1)
and retrograde##3##2##(1991-3#1)(2007-12#1)(2008-7#1)
and retrogradely transported to the neuronal##2##6##(1991-12#2)
and retrogradely##3##2##(1991-12#3)
and retroperitoneal##3##2##(2009-8#1)(2012-2#1)(2012-3#1)
and retrospective##4##2##(1994-6#1)(2008-11#1)(2008-7#1)(2012-3#1)
and retroviral##3##2##(2008-11#1)(2008-4#1)(2012-3#1)
and return to##4##3##(1991-3#1)(2009-3#1)(2009-6#1)(2012-3#1)
and return##5##2##(1991-3#1)(1993-1#1)(2009-3#1)(2009-6#1)(2012-3#1)
and returned to the control level after##2##7##(2008-6#2)
and returned to the##5##4##(1997-7#2)(2008-6#2)(2008-8#1)
and returned to##7##3##(1993-1#1)(1997-7#2)(2008-10#1)(2008-6#2)(2008-8#1)
and returned##10##2##(1993-1#1)(1997-7#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2013-1#1)
and returns##2##2##(2008-4#1)(2008-5#1)
and reusability##2##2##(2008-10#1)(2008-6#1)
and reuse oxalic acid in##2##5##(2013-1#2)
and reveal the##3##3##(2008-3#1)(2008-5#1)(2009-8#1)
and reveal##5##2##(1997-4#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
and revealed a##3##3##(2008-10#2)(2012-12#1)
and revealed that##2##3##(1990-12#1)(2011-2#1)
and revealed the##3##3##(1995-8#2)(2008-10#1)
and revealed##14##2##(1990-12#1)(1995-8#2)(1997-3#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
and reveals some##2##3##(2008-11#1)(2008-7#1)
and reveals##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
and reversal##3##2##(1996-2#1)(2008-10#1)(2013-8#1)
and reverse phase##2##3##(1995-3#1)(2008-10#1)
and reverse transcription##2##3##(1996-12#1)(2012-12#1)
and reverse transcription-polymerase chain reaction##2##5##(2008-10#2)
and reverse##14##2##(1990-11#2)(1992-6#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-9#1)(2010-10#1)(2012-12#1)
and reversed##4##2##(1990-11#1)(2008-10#3)
and reversed-phase HPLC##7##3##(1993-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
and reversed-phase##10##2##(1993-8#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#1)
and reversibility of##3##3##(2008-10#2)(2009-4#1)
and reversibility##4##2##(2008-10#3)(2009-4#1)
and reversible##11##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
and review of literature##11##4##(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
and review of the literature##24##5##(1992-12#2)(1994-8#1)(2008-1#1)(2008-10#3)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#3)
and review of the literature]##5##5##(1990-5#1)(1992-9#1)(1993-6#1)(2012-3#1)(2013-1#1)
and review of the##33##4##(1990-5#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-8#1)(2008-1#1)(2008-10#3)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)
and review of##46##3##(1990-5#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#8)
and review the literature##3##4##(2009-1#1)(2012-2#1)(2013-1#1)
and review the##4##3##(2008-11#1)(2009-1#1)(2012-2#1)(2013-1#1)
and review##67##2##(1990-5#1)(1991-12#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-8#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#6)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#12)
and reviewed the##2##3##(2010-12#1)(2010-8#1)
and reviewed##3##2##(2010-12#1)(2010-8#1)(2013-1#1)
and reviewing##2##2##(2008-11#1)(2010-1#1)
and reviews##8##2##(1991-2#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
and reward##4##2##(1991-12#1)(1994-2#1)(2008-11#2)
and rewarding##3##2##(1997-2#1)(2008-11#1)(2010-7#1)
and rewards##3##2##(2010-4#1)(2010-9#2)
and rheological##2##2##(2008-5#2)
and rhesus##2##2##(1991-9#1)(2008-9#1)
and rheumatoid arthritis##6##3##(1997-4#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-8#1)
and rhizosphere##3##2##(2008-10#3)
and rho##4##2##(1995-8#1)(2008-10#2)(2010-5#1)
and rhodamine B##2##3##(2008-10#2)
and rhodamine##3##2##(2008-10#3)
and rhodium##5##2##(2008-10#5)
and ribavirin in##2##3##(2011-2#1)(2013-1#1)
and ribavirin##7##2##(1994-8#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-7#1)
and ribosomal protein##2##3##(2008-10#2)
and ribosomal##3##2##(2008-10#3)
and rice flour##2##3##(2008-10#2)
and rice##9##2##(2008-10#6)(2008-11#1)(2008-12#1)(2009-10#1)
and rich in##2##3##(1997-8#1)(2010-4#1)
and rich##4##2##(1997-8#1)(2008-12#1)(2008-8#1)(2010-4#1)
and richness##2##2##(2008-11#1)(2008-8#1)
and ridge tillage systems##2##4##(2008-10#2)
and ridge tillage##4##3##(2008-10#4)
and rifampicin##2##2##(2008-10#1)(2011-2#1)
and right ventricular hypertrophy##2##4##(1996-11#1)(2012-12#1)
and right##24##2##(1991-2#1)(1992-12#1)(1996-11#1)(1996-9#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-11#3)(2010-12#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and rights##3##2##(1991-2#1)(1996-5#1)(2008-11#1)
and rigorous##2##2##(2008-10#1)(2008-2#1)
and ring##3##2##(1990-3#1)(2008-10#1)(2008-9#1)
and rinsing##2##2##(2008-10#1)(2008-3#1)
and ripening##2##2##(2008-10#1)(2012-2#1)
and risk assessment##5##3##(1995-9#1)(2008-10#3)(2008-9#1)
and risk behaviors##3##3##(1997-3#1)(2009-5#1)(2013-8#1)
and risk factor##3##3##(2010-9#1)(2011-2#2)
and risk factors for##6##4##(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
and risk factors in##4##4##(1996-6#1)(2008-10#1)(2012-12#1)(2013-8#1)
and risk factors of##5##4##(2008-11#1)(2008-7#1)(2010-7#1)(2010-8#1)(2012-12#1)
and risk factors were##3##4##(2010-7#2)(2012-2#1)
and risk factors##21##3##(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
and risk for##2##3##(2008-11#1)(2010-6#1)
and risk management##4##3##(1991-12#1)(1993-2#1)(1994-12#1)(2008-11#1)
and risk of breast##2##4##(1994-2#1)(2008-11#1)
and risk of cardiovascular##2##4##(1993-11#1)(2011-2#1)
and risk of coronary heart disease##2##6##(1991-8#1)(2008-12#1)
and risk of##16##3##(1991-8#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-9#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and risk reduction##2##3##(2011-2#1)(2013-8#1)
and risk##64##2##(1991-12#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-11#9)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
and risks of these##2##4##(2008-7#1)(2013-1#1)
and risks of##11##3##(1993-1#1)(1996-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
and risks##18##2##(1993-1#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-12#1)(2009-4#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#3)
and risky##2##2##(1996-2#1)(2013-8#1)
and rituximab##2##2##(2012-3#1)(2013-1#1)
and river water samples##6##4##(2008-10#6)
and river water##12##3##(2008-10#12)
and river waters##4##3##(2008-10#4)
and river##19##2##(2008-10#18)(2008-8#1)
and road##2##2##(2008-10#1)(2008-11#1)
and robust solid##2##3##(2008-10#2)
and robust time-based##2##3##(2008-10#2)
and robust##27##2##(1995-11#1)(2008-10#17)(2008-11#2)(2008-6#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
and robusta green coffee varieties##2##5##(2008-10#2)
and robusta##5##2##(2008-10#5)
and robustness of the##3##4##(1993-3#1)(2008-10#1)(2008-6#1)
and robustness of##4##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
and robustness##10##2##(1993-3#1)(2008-10#7)(2008-11#1)(2008-6#1)
and rock samples##3##3##(2008-10#3)
and roentgenographic##2##2##(1993-2#1)(2008-5#1)
and role in##2##3##(2012-2#1)(2013-1#1)
and role models##3##3##(1996-3#1)(2008-11#1)(2009-8#1)
and role of##4##3##(1993-1#1)(1993-6#1)(2011-2#1)(2012-2#1)
and role##13##2##(1990-12#1)(1993-1#1)(1993-6#1)(1996-3#1)(2008-11#2)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
and roles of##2##3##(1995-12#1)(2011-2#1)
and roller bottles##2##3##(2008-11#2)
and roller##3##2##(2008-11#3)
and room temperature fluorimetry##2##4##(2008-10#2)
and room temperature##3##3##(2008-10#3)
and root and##2##3##(2008-10#2)
and root dry##2##3##(2008-10#1)(2008-12#1)
and root growth##4##3##(2008-10#1)(2008-8#1)(2009-8#2)
and root mean##2##3##(2008-10#1)(2011-2#1)
and root rot of tomato##3##5##(2008-10#3)
and root rot of##8##4##(2008-10#8)
and root rot##17##3##(2008-10#17)
and root##55##2##(2008-1#1)(2008-10#39)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#7)(2010-11#2)(2011-2#1)(2012-8#1)(2013-8#1)
and roots of##6##3##(2008-10#5)(2008-12#1)
and roots were##4##3##(2008-10#4)
and roots##24##2##(2008-10#15)(2008-12#4)(2008-8#2)(2009-8#1)(2011-10#2)
and rose oil##4##3##(2008-10#4)
and rose to##2##3##(2008-9#1)(2009-6#1)
and rose##8##2##(2008-10#6)(2008-9#1)(2009-6#1)
and rosette##2##2##(2008-8#1)(2009-8#1)
and rotation in##2##3##(2008-6#1)(2008-9#1)
and rotation##3##2##(2008-11#1)(2008-6#1)(2008-9#1)
and rotational##2##2##(2008-10#1)(2008-2#1)
and rotenone##4##2##(1995-11#3)(2008-11#1)
and rough##2##2##(2008-10#1)(2008-7#1)
and round##2##2##(2008-9#1)(2012-2#1)
and route of##2##3##(1996-11#1)(2008-8#1)
and routine laboratory##2##3##(2011-2#1)(2012-3#1)
and routine##10##2##(1991-12#2)(1996-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and routinely##2##2##(2008-11#1)(2013-8#1)
and rsp3 genes##2##3##(2008-10#2)
and rubella##2##2##(1992-5#1)(1995-3#1)
and rubidium##2##2##(2008-10#2)
and rules##3##2##(1994-2#1)(2008-10#1)(2009-2#1)
and run##6##2##(1992-12#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)
and running##3##2##(1993-2#1)(2008-11#2)
and runs##2##2##(2008-10#1)(2008-7#1)
and rupture of##3##3##(2009-9#1)(2010-9#1)(2013-1#1)
and rupture##4##2##(1994-8#1)(2009-9#1)(2010-9#1)(2013-1#1)
and rural areas##6##3##(1991-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(2008-11#1)(2011-2#1)
and rural##19##2##(1991-3#1)(1992-12#3)(1992-2#1)(1993-12#1)(1994-1#2)(1994-2#1)(1994-3#1)(1996-3#2)(2008-10#3)(2008-11#1)(2011-2#2)(2012-3#1)
and rust##3##2##(2008-10#3)
and ruthenium in##2##3##(2008-10#2)
and ruthenium with##2##3##(2008-10#2)
and ruthenium##10##2##(2008-10#9)(2008-12#1)
and rutin were##2##3##(2008-10#2)
and rutin##4##2##(2008-10#3)(2008-9#1)
and s(r##2##2##(2008-10#2)
and sacral##3##2##(2010-6#1)(2013-8#2)
and safe alternative##2##3##(2008-10#1)(2011-2#1)
and safe in##4##3##(1995-5#1)(2008-1#1)(2010-12#1)(2012-3#1)
and safe technique##2##3##(1996-3#1)(2012-3#1)
and safe##25##2##(1993-1#1)(1994-3#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-7#2)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-3#2)(2013-1#1)
and safer##5##2##(1996-1#1)(1996-9#1)(2008-7#1)(2008-9#1)(2010-12#1)
and safety concerns##2##3##(2011-2#1)(2012-2#1)
and safety in##2##3##(2008-11#1)(2008-5#1)
and safety of a##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
and safety of this##4##4##(1992-2#1)(1997-3#2)(2008-11#1)
and safety of##37##3##(1990-9#1)(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1997-3#2)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#7)(2013-8#2)
and safety profile##2##3##(2008-10#1)(2008-6#1)
and safety recommendations##2##3##(2009-10#1)(2012-3#1)
and safety##84##2##(1990-9#2)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#2)(2008-10#5)(2008-11#7)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#12)(2013-8#2)
and salaries##3##2##(1992-1#1)(1994-1#1)(1995-1#1)
and salary##5##2##(1991-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(2012-12#1)
and sales##3##2##(2008-11#2)(2009-7#1)
and salicylic acid was##2##4##(2008-10#2)
and salicylic acid##7##3##(1993-11#1)(2008-10#3)(2008-5#2)(2009-8#1)
and salicylic##8##2##(1993-11#1)(2008-10#4)(2008-5#2)(2009-8#1)
and saline water##3##3##(2008-10#2)(2012-5#1)
and saline##6##2##(1994-2#1)(2008-10#4)(2012-5#1)
and saliva samples##3##3##(2008-10#2)(2013-1#1)
and saliva##14##2##(1990-5#1)(2008-10#8)(2008-12#1)(2009-6#1)(2010-11#1)(2013-1#1)(2013-8#1)
and salivary gland##2##3##(2008-10#2)
and salivary glands##7##3##(2008-10#7)
and salivary##9##2##(2008-10#9)
and salt##4##2##(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#1)
and sample acidity##2##3##(2008-10#2)
and sample consumption##2##3##(2008-10#2)
and sample flow rate##4##4##(2008-10#4)
and sample flow##5##3##(2008-10#5)
and sample pH##2##3##(2008-10#2)
and sample preparation##2##3##(2008-10#2)
and sample size##3##3##(1995-9#1)(2008-10#1)(2010-4#1)
and sample throughput of##4##4##(2008-10#4)
and sample throughput##8##3##(2008-10#8)
and sample volume##5##3##(2008-10#5)
and sample volumes##2##3##(2008-10#2)
and sample##60##2##(1994-9#1)(1995-9#1)(2008-10#53)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)
and sampled##2##2##(2008-10#1)(2008-7#1)
and samples of##4##3##(1993-12#1)(2008-10#3)
and samples##10##2##(1993-12#1)(2008-10#8)(2008-12#1)
and sampling frequencies##2##3##(2008-10#2)
and sampling frequency of##3##4##(2008-10#3)
and sampling frequency##4##3##(2008-10#4)
and sampling rate##2##3##(2008-10#2)
and sampling##19##2##(1993-9#1)(1994-9#1)(2008-10#14)(2008-11#2)(2012-3#1)
and sanitary##2##2##(2009-12#1)(2011-2#1)
and sanitation##2##2##(2008-10#1)(2008-7#1)
and saphenous vein##3##3##(1990-9#1)(2006-6#1)(2011-2#1)
and saphenous##4##2##(1990-9#1)(2006-6#1)(2011-2#2)
and saprophytic##2##2##(2008-10#2)
and satisfaction with care##2##4##(1995-2#1)(1997-3#1)
and satisfaction with the##2##4##(1995-2#1)(2008-9#1)
and satisfaction with##5##3##(1995-2#2)(1997-3#1)(2008-12#1)(2008-9#1)
and satisfaction within the disabled Medicare population##2##7##(1995-12#2)
and satisfaction##18##2##(1991-3#1)(1995-12#4)(1995-2#2)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
and satisfactory precision##2##3##(2008-10#2)
and satisfactory results##2##3##(1994-3#1)(2008-10#1)
and satisfactory##12##2##(1994-3#1)(1996-9#2)(2008-10#8)(2012-3#1)
and satisfying##2##2##(1993-12#1)(1994-2#1)
and saturable##5##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-6#1)(2007-12#1)
and saturated##3##2##(2008-10#2)(2008-3#1)
and save##2##2##(1996-3#1)(2008-9#1)
and scabies##4##2##(1991-2#1)(2008-12#3)
and scale##6##2##(1995-9#1)(1996-3#1)(2008-11#1)(2008-7#1)(2009-11#1)(2011-2#1)
and scale-up##4##2##(1992-12#1)(2008-11#2)(2008-7#1)
and scaleable##3##2##(2008-11#2)(2008-8#1)
and scan rate##5##3##(2008-10#5)
and scanning electron microscope##3##4##(2008-10#2)(2012-3#1)
and scanning electron microscopy of##2##5##(2008-10#1)(2010-4#1)
and scanning electron microscopy##14##4##(2007-12#1)(2008-10#9)(2008-7#1)(2009-10#1)(2010-4#1)(2013-1#1)
and scanning electron##20##3##(1995-8#1)(2007-12#1)(2008-10#13)(2008-7#1)(2009-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
and scanning tunneling##2##3##(1990-12#1)(2008-10#1)
and scanning##26##2##(1990-12#1)(1995-8#1)(2007-12#2)(2008-10#14)(2008-7#2)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
and scar management##3##3##(2012-3#3)
and scarce mitochondria##2##3##(2008-7#1)(2009-7#1)
and scattered electromagnetic fields##2##4##(2008-3#2)
and scattered##4##2##(2008-11#1)(2008-3#2)(2008-5#1)
and scattering##8##2##(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2009-12#1)
and scavenge##2##2##(1992-9#1)(2008-11#1)
and schizoaffective disorder##2##3##(2008-8#2)
and schizoaffective##3##2##(2008-8#3)
and schizophrenia##5##2##(1993-9#1)(2008-1#1)(2008-8#1)(2009-6#1)(2012-2#1)
and scholarly##2##2##(2010-2#1)(2010-4#1)
and school##5##2##(2008-11#1)(2009-7#2)(2010-1#1)(2012-12#1)
and science##4##2##(2008-11#2)(2008-12#1)(2013-8#1)
and scientific##17##2##(1992-1#1)(1992-2#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
and scientists##4##2##(1993-12#1)(2009-9#1)(2010-10#1)(2013-8#1)
and scintigraphy##2##2##(2010-6#1)(2013-1#1)
and scintillation##2##2##(2007-12#1)(2008-3#1)
and sclerotia##2##2##(2008-10#2)
and scope of##2##3##(1994-12#1)(2008-9#1)
and scope##3##2##(1994-12#1)(2008-9#1)(2010-8#1)
and scored##4##2##(1997-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
and scores##5##2##(1994-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
and scoring##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2010-11#1)
and screen##4##2##(2008-1#1)(2012-3#1)(2013-1#2)
and screen-printed electrodes##2##3##(2008-10#2)
and screened for the##2##4##(1996-12#1)(2008-10#1)
and screened for##4##3##(1994-12#1)(1996-12#1)(2008-10#2)
and screened##11##2##(1991-6#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-1#1)
and screening for##2##3##(2008-10#1)(2008-7#1)
and screening of##5##3##(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#1)
and screening##17##2##(1991-6#1)(1995-9#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and sea water samples##3##4##(2008-10#3)
and sea water##6##3##(2008-10#6)
and sea##10##2##(2008-10#9)(2008-2#1)
and sea-water##2##2##(2008-10#2)
and sealed##2##2##(2008-10#1)(2013-1#1)
and searched##3##2##(2008-10#2)(2013-8#1)
and searching##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
and seasonal changes##2##3##(1993-6#1)(2008-8#1)
and seasonal variation##2##3##(2008-10#1)(2008-5#1)
and seasonal##14##2##(1991-8#3)(1993-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
and seawater samples##3##3##(2008-10#3)
and seawater##15##2##(2008-10#11)(2008-2#3)(2012-5#1)
and second dissociation constants of##2##5##(2008-10#2)
and second dissociation constants##4##4##(2008-10#4)
and second dissociation##5##3##(2008-10#5)
and second order##2##3##(2008-10#1)(2010-5#1)
and second##41##2##(1990-3#1)(1990-8#1)(1993-1#1)(1993-3#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
and second-derivative##4##2##(2008-10#4)
and second-harmonic##2##2##(2008-3#2)
and second-order##5##2##(2007-11#1)(2008-10#2)(2008-5#2)
and secondary branching of##2##4##(2008-10#2)
and secondary spread##2##3##(2008-10#2)
and secondary##53##2##(1992-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#2)(1995-9#1)(1996-5#1)(1997-8#1)(2008-10#23)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#2)(2013-1#3)
and secondly to##4##3##(2008-10#3)(2010-8#1)
and secondly##6##2##(2008-10#3)(2008-11#1)(2010-8#1)(2013-1#1)
and secrete##10##2##(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2013-1#4)
and secreted by##4##3##(1993-3#1)(2008-5#1)(2008-6#1)(2010-6#1)
and secreted in##2##3##(1990-12#1)(2012-2#1)
and secreted##13##2##(1990-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-6#1)(2012-2#1)
and secretion of##8##3##(1991-5#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-11#2)(2008-5#1)(2008-8#1)
and secretion##15##2##(1990-2#1)(1991-5#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-11#4)(2008-5#1)(2008-8#2)(2011-2#1)
and secretions##2##2##(1994-12#1)(2008-12#1)
and secretory##2##2##(2006-6#1)(2010-11#1)
and sectioned##2##2##(1990-2#1)(2009-12#1)
and sectioning##2##2##(1997-8#1)(2008-4#1)
and sector##2##2##(2008-10#2)
and securing##3##2##(2008-11#2)(2009-10#1)
and security##6##2##(1991-3#2)(1992-2#1)(1996-12#2)(2008-10#1)
and sedation with intravenous##2##4##(1993-1#1)(1995-11#1)
and sedation##4##2##(1993-1#2)(1995-11#1)(2008-12#1)
and sedative##3##2##(1996-3#1)(2008-10#1)(2010-4#1)
and sedentary##2##2##(2008-11#1)(2008-7#1)
and sediment certified reference materials##2##5##(2008-10#2)
and sediment certified##3##3##(2008-10#3)
and sediment extracts##3##3##(2008-10#3)
and sediment samples##7##3##(2008-10#7)
and sediment##23##2##(2008-10#23)
and sedimentation##5##2##(1990-9#1)(2008-10#3)(2008-7#1)
and sediments are##2##3##(2008-10#2)
and sediments by##3##3##(2008-10#3)
and sediments##13##2##(2008-10#13)
and seed coat##4##3##(2008-10#3)(2013-8#1)
and seed production##2##3##(2008-10#1)(2008-8#1)
and seed were##2##3##(2008-10#2)
and seed##18##2##(2008-10#13)(2008-8#1)(2008-9#3)(2013-8#1)
and seedling growth of V##2##5##(2008-12#2)
and seedling growth of##4##4##(2008-12#4)
and seedling growth##5##3##(2008-12#5)
and seedling##13##2##(2008-10#5)(2008-12#7)(2008-7#1)
and seedlings##5##2##(2008-10#5)
and seeds of##2##3##(2008-10#1)(2013-8#1)
and seeds oil##2##3##(2008-10#2)
and seeds##12##2##(2008-10#7)(2008-8#1)(2008-9#2)(2009-8#1)(2013-8#1)
and seek##3##2##(1993-3#1)(2008-11#1)(2013-8#1)
and seeking##2##2##(2008-11#1)(2008-5#1)
and seem to##2##3##(1990-5#1)(2012-4#1)
and seem##3##2##(1990-5#1)(1992-3#1)(2012-4#1)
and seemed##2##2##(1990-9#1)(2008-10#1)
and segmental liver atrophy##2##4##(2012-2#2)
and segmental##7##2##(1993-12#1)(2011-2#2)(2012-2#4)
and segmentation##3##2##(1995-5#1)(2008-6#1)(2011-7#1)
and seizure##2##2##(1992-12#1)(2011-2#1)
and seizures##2##2##(2008-1#1)(2013-1#1)
and select the##3##3##(2011-3#1)(2013-1#2)
and selected by##2##3##(1993-12#1)(2008-10#1)
and selected for##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
and selected with##2##3##(2008-11#2)
and selected##24##2##(1991-1#1)(1991-10#1)(1993-12#1)(1993-8#1)(1993-9#1)(1996-2#1)(1997-8#1)(2006-5#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
and selecting##4##2##(2007-12#1)(2008-4#2)(2011-2#1)
and selection by##2##3##(2008-10#1)(2008-3#1)
and selection of patients##2##4##(2007-8#1)(2010-6#1)
and selection of##10##3##(1992-12#1)(1993-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
and selection on##2##3##(2008-8#1)(2008-9#1)
and selection##23##2##(1992-12#1)(1993-8#1)(1997-3#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#2)
and selective detection##2##3##(2008-10#2)
and selective determination of##6##4##(2008-10#6)
and selective determination##8##3##(2008-10#8)
and selective extraction##4##3##(2008-10#4)
and selective flow injection##4##4##(2008-10#4)
and selective flow-injection##2##3##(2008-10#2)
and selective for the##2##4##(2008-10#2)
and selective inhibitor of##2##4##(1990-8#1)(2008-5#1)
and selective method for the determination of##5##7##(2008-10#5)
and selective method for the##7##5##(2008-10#7)
and selective method for##9##4##(2008-10#9)
and selective method has been developed for##3##7##(2008-10#3)
and selective method has been##4##5##(2008-10#4)
and selective method is proposed for the##2##7##(2008-10#2)
and selective method is##8##4##(2008-10#8)
and selective method was developed for the##2##7##(2008-10#2)
and selective method##25##3##(2008-10#24)(2008-5#1)
and selective reagent##2##3##(1996-5#1)(2008-10#1)
and selective square-wave##2##3##(2008-10#2)
and selective##99##2##(1990-8#1)(1992-8#1)(1993-12#1)(1994-2#1)(1996-5#1)(2008-10#87)(2008-5#3)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and selectively##9##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
and selectivities##2##2##(2008-10#1)(2010-7#1)
and selectivity are discussed##2##4##(2008-10#2)
and selectivity are##3##3##(2008-10#3)
and selectivity for##5##3##(2008-10#5)
and selectivity of the sensor##2##5##(2008-10#2)
and selectivity of the##9##4##(2008-10#9)
and selectivity of##16##3##(2008-10#16)
and selectivity to##3##3##(2008-10#3)
and selectivity were##2##3##(2008-10#2)
and selectivity##64##2##(1993-11#1)(2008-10#59)(2008-3#1)(2008-9#1)(2010-10#1)(2012-2#1)
and selenate##2##2##(2008-10#2)
and selenium in##5##3##(2008-10#5)
and selenium were##3##3##(2008-10#3)
and selenium##25##2##(1993-12#1)(1997-8#1)(2008-10#22)(2009-5#1)
and selenocystine##2##2##(2008-10#1)(2010-11#1)
and selenomethionine##3##2##(2008-10#3)
and self##3##2##(1994-6#1)(2008-11#1)(2013-8#1)
and self-assembled##2##2##(2008-10#2)
and self-awareness##4##2##(2008-11#2)(2008-12#1)(2012-3#1)
and self-concept##3##2##(2009-7#3)
and self-directed##2##2##(1993-12#1)(2008-11#1)
and self-efficacy##4##2##(2008-4#1)(2010-9#1)(2013-1#2)
and self-esteem##6##2##(1990-2#1)(1994-12#1)(2008-12#1)(2011-2#1)(2012-2#2)
and self-help groups##2##3##(1994-12#1)(1995-1#1)
and self-help##4##2##(1994-12#1)(1995-1#1)(1995-3#1)(2010-10#1)
and self-perceived competency##2##3##(2008-8#2)
and self-regulation##3##2##(2008-12#2)(2012-3#1)
and self-reported##8##2##(1991-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)
and self-stretching##2##2##(2010-9#2)
and semantic##4##2##(1990-8#1)(1993-3#1)(2011-1#2)
and semi-quantitative##2##2##(2008-10#2)
and semi-structured interviews##2##3##(1991-6#1)(2012-3#1)
and semi-structured##3##2##(1991-6#1)(2008-1#1)(2012-3#1)
and semi-volatile halogenated compounds##2##4##(2009-8#2)
and semiconductor##2##2##(2008-10#2)
and seminal vesicles##3##3##(1997-8#1)(2012-12#2)
and send##2##2##(1995-1#1)(2011-2#1)
and senescence##9##2##(1995-2#1)(2008-10#1)(2008-7#1)(2013-1#6)
and senescent rats##3##3##(1991-2#2)(2013-7#1)
and senile##2##2##(2008-7#2)
and senior##3##2##(1993-12#1)(1994-2#1)(2009-4#1)
and sense of well-being##2##4##(2008-7#1)(2011-2#1)
and sense of##5##3##(1997-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
and sensing##4##2##(2008-10#3)(2008-7#1)
and sensitive and##4##3##(2008-10#4)
and sensitive assay##3##3##(2008-10#3)
and sensitive detection##2##3##(2008-10#2)
and sensitive determination of##8##4##(2008-10#8)
and sensitive flow cytometric##3##4##(1990-12#2)(2008-9#1)
and sensitive flow injection##5##4##(2008-10#5)
and sensitive flow##8##3##(1990-12#2)(2008-10#5)(2008-9#1)
and sensitive flow-injection##2##3##(2008-10#2)
and sensitive fluorometric##3##3##(2008-10#3)
and sensitive for##3##3##(1992-2#1)(2008-10#2)
and sensitive method for the determination of##9##7##(2008-10#9)
and sensitive method for the quantitative##2##6##(2008-10#1)(2010-1#1)
and sensitive method for the##19##5##(2008-10#16)(2008-5#1)(2010-1#1)(2010-4#1)
and sensitive method for##21##4##(2008-10#18)(2008-5#1)(2010-1#1)(2010-4#1)
and sensitive method has been developed for##2##7##(2008-10#2)
and sensitive method is described for the determination of##2##9##(2008-10#2)
and sensitive method is described for the##3##7##(2008-10#3)
and sensitive method is##4##4##(2008-10#4)
and sensitive method to determine##2##5##(2008-10#2)
and sensitive method was developed for##2##6##(2008-10#2)
and sensitive method was developed##3##5##(2008-10#2)(2011-1#1)
and sensitive method was##4##4##(2008-10#3)(2011-1#1)
and sensitive method##37##3##(1991-3#1)(2008-10#31)(2008-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)
and sensitive on-line##2##3##(2008-10#1)(2008-11#1)
and sensitive procedure for spectrophotometric determination of##2##7##(2008-10#2)
and sensitive procedure for##3##4##(2008-10#3)
and sensitive sequential injection spectrophotometric##2##5##(2008-10#2)
and sensitive spectrofluorimetric##2##3##(2008-10#2)
and sensitive spectrophotometric method##2##4##(2008-10#2)
and sensitive spectrophotometric methods are described##2##6##(2008-10#2)
and sensitive spectrophotometric methods for the determination of##2##8##(2008-10#2)
and sensitive spectrophotometric methods##4##4##(2008-10#4)
and sensitive spectrophotometric##7##3##(2008-10#7)
and sensitive square-wave voltammetric##2##4##(2008-10#2)
and sensitive technique for##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
and sensitive to##6##3##(2008-10#5)(2011-2#1)
and sensitive tool##2##3##(2008-10#1)(2008-9#1)
and sensitive##183##2##(1990-12#3)(1990-2#1)(1991-3#2)(1992-12#1)(1992-2#2)(1993-12#1)(1993-8#1)(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#149)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
and sensitively##7##2##(2008-10#4)(2008-7#1)(2008-9#1)(2010-3#1)
and sensitivity analysis##2##3##(1995-12#1)(2013-1#1)
and sensitivity and##2##3##(2008-10#1)(2012-12#1)
and sensitivity are##2##3##(2008-10#2)
and sensitivity for##4##3##(2008-10#4)
and sensitivity in##2##3##(1997-1#1)(2008-10#1)
and sensitivity of the##3##4##(2008-10#3)
and sensitivity of##11##3##(2008-10#9)(2008-11#1)(2008-3#1)
and sensitivity to##7##3##(1996-12#3)(2008-10#3)(2008-7#1)
and sensitivity were satisfactory##2##4##(2008-10#2)
and sensitivity were##4##3##(2008-10#4)
and sensitivity##65##2##(1991-7#1)(1992-3#1)(1995-12#1)(1995-6#1)(1996-12#3)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#45)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#1)
and sensor##2##2##(2008-10#1)(2008-3#1)
and sensorial##3##2##(2008-5#2)(2012-12#1)
and sensorineural deafness##2##3##(2008-9#1)(2011-1#1)
and sensors for##2##3##(1990-8#1)(2008-10#1)
and sensors##5##2##(1990-8#1)(2008-10#3)(2010-12#1)
and sensory properties##2##3##(2010-4#2)
and sensory##19##2##(1990-12#1)(1994-9#1)(1995-1#2)(1995-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#3)(2011-2#3)(2013-1#2)
and sent to##3##3##(1992-1#1)(2008-10#1)(2008-7#1)
and sentence##3##2##(2008-8#1)(2008-9#1)(2011-1#1)
and separate##6##2##(1994-3#1)(1997-7#1)(2008-10#3)(2011-2#1)
and separated by##2##3##(1990-5#1)(2008-10#1)
and separated from the##2##4##(2008-10#2)
and separated from##3##3##(2008-10#3)
and separated##13##2##(1990-5#1)(1991-9#1)(2008-10#11)
and separately##2##2##(2008-10#1)(2008-11#1)
and separating##3##2##(2008-10#2)(2008-9#1)
and separation conditions##2##3##(2008-10#2)
and separation factors##2##3##(2008-10#2)
and separation of a##2##4##(2008-10#2)
and separation of the##2##4##(1996-5#1)(2008-10#1)
and separation of total mercury##2##5##(2008-10#2)
and separation of trace##6##4##(2008-10#6)
and separation of##26##3##(1996-5#1)(2008-10#25)
and separation with##2##3##(2008-10#2)
and separation##49##2##(1995-3#2)(1996-5#1)(2008-10#45)(2008-11#1)
and sepsis##6##2##(1991-3#1)(1993-6#1)(2008-12#1)(2008-5#1)(2011-3#1)(2012-3#1)
and septal##2##2##(2012-2#1)(2013-1#1)
and septate junctions##2##3##(2008-7#2)
and septate##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
and septic arthritis##2##3##(1991-3#1)(2011-2#1)
and septic shock##5##3##(2008-5#1)(2011-2#4)
and septic##7##2##(1991-3#1)(2008-5#1)(2011-2#5)
and sequence analyses##3##3##(2008-10#2)(2008-11#1)
and sequence analysis of the##2##5##(2008-10#2)
and sequence analysis of##11##4##(1990-8#1)(1991-5#1)(1993-2#1)(1993-6#1)(1997-4#1)(2008-10#6)
and sequence analysis##13##3##(1990-8#1)(1991-5#1)(1993-2#1)(1993-6#1)(1997-4#1)(1997-9#1)(2008-10#7)
and sequence determination of the##2##5##(2008-10#1)(2010-6#1)
and sequence determination of##3##4##(2008-10#1)(2010-6#2)
and sequence determination##4##3##(2008-10#1)(2008-8#1)(2010-6#2)
and sequence of a##2##4##(1990-5#1)(1993-6#1)
and sequence of the human##2##5##(1994-11#1)(1996-8#1)
and sequence of the##5##4##(1994-11#1)(1996-8#1)(2008-10#2)(2008-11#1)
and sequence of##12##3##(1990-5#1)(1991-6#1)(1993-2#1)(1993-6#2)(1994-11#1)(1996-8#1)(2008-10#4)(2008-11#1)
and sequence similarity##3##3##(1991-6#1)(2009-10#2)
and sequence##49##2##(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#2)(1993-12#1)(1993-2#3)(1993-6#3)(1994-11#1)(1996-8#1)(1997-4#1)(1997-9#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2010-4#1)(2010-6#2)(2013-8#1)
and sequence-dependent##2##2##(2008-4#1)(2012-2#1)
and sequenced the##6##3##(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-7#1)(1997-8#1)
and sequenced##69##2##(1990-8#1)(1991-5#1)(1991-6#3)(1992-10#1)(1992-4#1)(1992-6#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-11#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#3)(1997-8#1)(2008-10#24)(2008-12#3)(2008-5#1)(2008-8#3)(2008-9#3)(2013-1#1)(2013-8#2)
and sequences of##2##3##(2008-10#1)(2008-8#1)
and sequences##3##2##(2008-10#1)(2008-8#1)(2010-9#1)
and sequencing of a##6##4##(1995-12#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-9#1)
and sequencing of an##2##4##(1991-6#1)(1997-2#1)
and sequencing of the genomic##2##5##(1996-12#1)(2008-8#1)
and sequencing of the##8##4##(1995-6#1)(1996-12#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-8#1)(2012-2#1)
and sequencing of##21##3##(1991-6#1)(1993-12#1)(1993-3#1)(1994-11#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-7#2)(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#2)
and sequencing the##2##3##(2008-10#1)(2011-2#1)
and sequencing##38##2##(1990-5#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-7#3)(1997-9#1)(2008-10#6)(2008-4#1)(2008-8#2)(2008-9#3)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
and sequential injection (SI)##2##4##(2008-10#2)
and sequential injection analysis##2##4##(2008-10#2)
and sequential injection##7##3##(2008-10#7)
and sequential##18##2##(1993-1#1)(2008-10#14)(2008-8#1)(2008-9#1)(2011-2#1)
and sera##3##2##(1993-1#1)(2008-10#1)(2008-11#1)
and serial##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
and serine hydroxymethyltransferase##2##3##(1997-1#2)
and serine##8##2##(1992-10#1)(1992-6#1)(1997-1#3)(2008-11#3)
and serious##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2013-8#1)
and serologic tests##2##3##(1991-12#1)(2012-3#1)
and serologic##7##2##(1990-3#1)(1991-12#1)(1995-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
and serological##7##2##(1990-3#1)(1995-2#1)(2007-8#1)(2008-10#4)
and serologically##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
and serology of##2##3##(2008-10#1)(2008-4#1)
and serology##4##2##(2008-10#1)(2008-4#2)(2008-5#1)
and serotonergic##3##2##(1991-7#1)(1993-1#1)(1996-12#1)
and serotonin release##2##3##(1990-8#1)(1992-12#1)
and serotonin##9##2##(1990-8#1)(1992-12#1)(1993-1#1)(1994-2#1)(1996-12#2)(2008-7#2)(2011-2#1)
and serotonin-dependent##2##2##(1992-12#2)
and serotype distribution##3##3##(2007-12#1)(2008-5#2)
and serotype##4##2##(2007-12#1)(2008-5#3)
and sertraline##2##2##(2012-2#1)(2012-3#1)
and serum biochemical##2##3##(2011-1#1)(2012-3#1)
and serum neopterin concentrations##3##4##(1990-2#3)
and serum samples##6##3##(2008-10#6)
and serum thiobarbituric acid reactive substances##2##6##(2008-10#2)
and serum thromboxane##2##3##(1990-12#2)
and serum was##2##3##(2008-10#2)
and serum##71##2##(1990-12#2)(1990-2#4)(1990-8#2)(1991-12#2)(1992-12#1)(1994-12#1)(1995-8#1)(2008-10#32)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
and serum-free##2##2##(2008-11#2)
and serve as a##2##4##(1995-1#1)(2009-11#1)
and serve as##5##3##(1995-1#1)(2008-9#1)(2009-10#1)(2009-11#1)(2013-8#1)
and serve##6##2##(1995-1#1)(2008-9#1)(2009-10#1)(2009-11#1)(2012-2#1)(2013-8#1)
and served as the control group##2##6##(1993-1#1)(1994-5#1)
and served as##4##3##(1993-1#1)(1994-5#1)(1996-12#1)(2010-11#1)
and serves##2##2##(1997-8#1)(2007-12#1)
and service delivery##6##3##(1993-1#1)(1993-3#1)(1995-12#1)(1995-3#1)(2008-11#1)(2010-10#1)
and service providers##2##3##(2008-11#2)
and service quality##2##3##(1994-12#1)(1995-2#1)
and service##22##2##(1993-1#1)(1993-3#2)(1994-1#2)(1994-12#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-11#3)(2009-3#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and services are discussed##2##4##(1991-2#2)
and services for##2##3##(1996-1#1)(1997-7#1)
and services in##2##3##(2012-12#1)(2012-2#1)
and services##16##2##(1991-2#2)(1991-3#1)(1992-2#1)(1993-1#2)(1994-1#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-7#1)(2008-11#1)(2010-8#1)(2012-12#2)(2012-2#1)
and serving##2##2##(1994-3#1)(1996-1#1)
and sesami##2##2##(2008-10#2)
and set##2##2##(2008-3#1)(2008-9#1)
and sets##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
and setting up a##2##4##(2008-10#2)
and setting##5##2##(2008-10#3)(2008-8#1)(2012-2#1)
and seven isolates##2##3##(2008-10#2)
and seven##24##2##(1993-12#1)(1995-9#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#3)(2012-3#2)(2013-8#1)
and seventh##3##2##(1995-8#1)(2007-12#1)(2008-10#1)
and seventy##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
and seventy-two##2##2##(1996-8#1)(2012-2#1)
and several of the##2##4##(1993-8#1)(2008-11#1)
and several organic##2##3##(2008-10#1)(2010-4#1)
and several other species##2##4##(1993-12#1)(2008-7#1)
and several other##6##3##(1993-12#1)(1994-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)
and several##67##2##(1991-2#1)(1993-1#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-1#1)(1995-12#3)(1996-2#2)(1996-5#1)(1997-5#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-10#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
and severe fibrosis##2##3##(2013-8#2)
and severe nausea##2##3##(1990-12#1)(2007-12#1)
and severe##45##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#2)(1991-1#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-8#4)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2012-8#1)(2013-8#4)
and severely##5##2##(1990-3#1)(1995-2#1)(1995-8#1)(2008-10#2)
and severity in##2##3##(2008-10#2)
and severity increased with increasing##2##5##(2008-10#2)
and severity increased with##3##4##(2008-10#3)
and severity increased##4##3##(2008-10#4)
and severity of abuse##2##4##(2012-12#2)
and severity of the##5##4##(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#1)
and severity of##35##3##(1991-12#1)(1993-12#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#14)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and severity##72##2##(1991-12#1)(1993-12#1)(1995-2#2)(1995-5#1)(1997-1#1)(1997-8#1)(2008-10#49)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and sewage##5##2##(1991-7#1)(2008-10#4)
and sex differences in##2##4##(2008-9#1)(2009-7#1)
and sex ratio##2##3##(2008-8#1)(2008-9#1)
and sex ratios##3##3##(2010-8#1)(2011-2#2)
and sex were##2##3##(2007-8#1)(2008-8#1)
and sex##35##2##(1990-2#1)(1991-11#1)(1991-8#2)(1993-1#1)(1993-3#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
and sexual abuse##3##3##(1995-5#2)(1996-1#1)
and sexual health##5##3##(1990-12#1)(2008-11#2)(2009-5#2)
and sexual identity##2##3##(2009-5#2)
and sexual reproduction##3##3##(2008-10#3)
and sexual risk behaviors##2##4##(2008-4#1)(2013-1#1)
and sexual risk##3##3##(2008-4#1)(2013-1#2)
and sexual selection##7##3##(2008-8#2)(2008-9#1)(2012-3#4)
and sexual##36##2##(1990-12#1)(1991-3#1)(1995-5#2)(1996-1#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#2)(2009-5#6)(2010-11#1)(2010-8#1)(2012-3#5)(2013-1#2)(2013-8#2)
and sexually transmitted##2##3##(2008-12#2)
and sexually##4##2##(2008-10#1)(2008-12#2)(2008-8#1)
and shading##3##2##(2008-10#1)(2008-9#2)
and shaking time##3##3##(2008-10#3)
and sham##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
and sham-irradiated##2##2##(2008-11#2)
and shape of the##3##4##(2008-5#1)(2008-7#1)(2013-8#1)
and shape of##6##3##(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#1)
and shape##18##2##(1995-5#1)(1997-6#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2010-9#1)(2013-8#1)
and share a##2##3##(2008-10#1)(2008-8#1)
and share##5##2##(1993-9#1)(1995-2#1)(2008-10#1)(2008-8#1)(2013-8#1)
and shared learning##2##3##(2008-11#2)
and shared##9##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#2)(2013-1#1)
and shares##2##2##(2008-10#1)(2008-12#1)
and sharing of##2##3##(2010-8#1)(2013-8#1)
and she died##2##3##(2009-3#1)(2011-2#1)
and she was##3##3##(2008-12#1)(2011-2#1)(2012-3#1)
and she##6##2##(2008-12#1)(2009-3#1)(2010-10#1)(2011-2#2)(2012-3#1)
and shear force##2##3##(2009-11#1)(2010-4#1)
and shear##6##2##(2008-11#2)(2008-5#1)(2009-11#1)(2010-4#1)(2012-2#1)
and sheep##10##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
and shellfish##2##2##(2008-10#1)(2008-11#1)
and shift##3##2##(1990-2#1)(2008-11#1)(2013-8#1)
and shifted##2##2##(1997-2#1)(1997-7#1)
and shifting the##2##3##(2008-2#1)(2008-3#1)
and shifting##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
and shifts##2##2##(1995-3#1)(2008-3#1)
and shock##2##2##(2008-8#1)(2010-5#1)
and shoot blight##7##3##(2008-10#7)
and shoot##15##2##(2008-10#13)(2008-9#1)(2013-1#1)
and shoots##5##2##(2008-10#2)(2008-12#3)
and short arm##2##3##(2008-9#2)
and short##16##2##(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-7#1)(2011-2#1)
and short-term##9##2##(1993-3#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-5#1)(2011-2#1)
and shortcomings##2##2##(1991-1#1)(2013-1#1)
and shortened##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
and shorter##3##2##(1993-2#1)(2008-7#1)(2011-1#1)
and shortness of breath##3##4##(2008-7#2)(2010-8#1)
and should allow##2##3##(1992-3#1)(2008-10#1)
and should be applicable to##2##5##(1991-5#1)(2010-12#1)
and should be carefully##2##4##(2008-1#1)(2011-1#1)
and should be confirmed by##2##5##(1996-2#1)(2008-10#1)
and should be considered a##2##5##(1993-1#1)(1997-3#1)
and should be considered as##2##5##(2008-3#1)(2011-2#1)
and should be considered in##4##5##(2008-11#1)(2008-6#1)(2009-8#1)(2012-3#1)
and should be considered when##2##5##(1993-6#1)(2008-8#1)
and should be considered##13##4##(1993-1#1)(1993-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
and should be evaluated##2##4##(1992-2#1)(2012-3#1)
and should be##44##3##(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
and should facilitate##2##3##(1995-6#1)(2008-10#1)
and should help to##2##4##(2008-10#1)(2013-8#1)
and should help##3##3##(1997-1#1)(2008-10#1)(2013-8#1)
and should not be confused with##2##6##(1997-3#1)(1997-8#1)
and should not be##4##4##(1997-3#1)(1997-8#1)(2008-10#1)(2011-2#1)
and should##77##2##(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-3#3)(2013-1#3)(2013-8#2)
and shoulder muscles##2##3##(2010-9#2)
and shoulder##4##2##(2008-11#1)(2010-9#3)
and show a##4##3##(1993-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
and show an##3##3##(1991-2#1)(1992-10#1)(1993-3#1)
and show excellent##2##3##(2008-5#1)(2008-7#1)
and show good agreement##2##4##(2008-10#1)(2008-2#1)
and show good##3##3##(2008-10#2)(2008-2#1)
and show how to##2##4##(1997-3#1)(2008-10#1)
and show how##5##3##(1997-2#1)(1997-3#1)(2008-10#1)(2008-9#1)(2013-8#1)
and show increased##2##3##(1997-7#1)(2011-10#1)
and show no##3##3##(1996-2#1)(2008-10#1)(2008-9#1)
and show that if##2##4##(2008-5#1)(2010-7#1)
and show that it##3##4##(1993-9#1)(1995-6#1)(2013-1#1)
and show that##17##3##(1993-9#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
and show the##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
and show##49##2##(1991-2#1)(1992-10#1)(1993-3#2)(1993-9#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#3)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-10#1)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
and showed a##9##3##(1991-12#1)(1993-9#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#1)(2013-8#1)
and showed an##2##3##(1990-6#1)(2008-2#1)
and showed excellent##2##3##(1993-1#1)(2011-3#1)
and showed good agreement##3##4##(2008-10#3)
and showed good##7##3##(2008-10#6)(2008-11#1)
and showed high##3##3##(1994-8#1)(2008-10#1)(2012-2#1)
and showed no##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
and showed only##2##3##(2008-10#2)
and showed significant##3##3##(2008-5#1)(2010-8#1)(2012-3#1)
and showed similar##2##3##(2008-5#1)(2011-2#1)
and showed that the##2##4##(2008-11#1)(2008-3#1)
and showed that##7##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
and showed the##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
and showed##71##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-6#2)(1993-9#1)(1994-8#1)(1997-1#1)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
and showing##2##2##(1995-2#1)(2011-2#1)
and shown to be a##2##5##(1997-2#1)(2008-10#1)
and shown to be##8##4##(1993-11#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2012-2#1)
and shown to contain##2##4##(1992-12#1)(2008-10#1)
and shown to##18##3##(1991-5#1)(1992-12#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)
and shows a##5##3##(1992-6#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
and shows how##2##3##(2008-10#1)(2008-11#1)
and shows no##2##3##(1990-2#1)(1991-2#1)
and shows that the##4##4##(1995-2#1)(2008-10#2)(2008-11#1)
and shows that##5##3##(1995-2#1)(2008-10#3)(2008-11#1)
and shows the##4##3##(1991-9#1)(1992-9#1)(2008-8#2)
and shows##31##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
and sialic acid##2##3##(2008-12#1)(2008-5#1)
and side chain##4##3##(2009-7#4)
and side effect profiles##2##4##(2011-10#2)
and side effects of##2##4##(1993-1#1)(2008-12#1)
and side effects##7##3##(1991-2#1)(1993-1#1)(1993-6#1)(1996-8#1)(2008-12#1)(2009-12#1)(2010-10#1)
and side##21##2##(1991-2#1)(1993-1#1)(1993-6#1)(1996-8#1)(1996-9#1)(2008-10#3)(2008-12#1)(2009-12#1)(2009-7#4)(2010-10#1)(2010-6#1)(2011-10#2)(2012-2#1)(2013-1#2)
and side-effects##2##2##(2008-5#1)(2008-7#1)
and sidechain##2##2##(2008-9#1)(2009-7#1)
and sigma##2##2##(1990-8#1)(1993-12#1)
and sigmoidoscopy##2##2##(1995-10#1)(2010-6#1)
and signal intensities##2##3##(2008-3#1)(2009-11#1)
and signal intensity##3##3##(2008-10#2)(2009-11#1)
and signal transduction in##2##4##(1996-2#1)(2010-5#1)
and signal transduction##7##3##(1993-8#1)(1996-2#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-5#2)
and signal##20##2##(1991-10#1)(1993-8#1)(1994-11#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#2)(2009-8#1)(2010-5#2)(2012-3#2)
and signal-to-noise ratio##3##3##(1997-8#1)(2008-3#1)(2010-9#1)
and signal-to-noise ratios##2##3##(2008-10#1)(2008-4#1)
and signal-to-noise##5##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-9#1)
and signaling of##2##3##(2008-10#1)(2010-5#1)
and signaling##10##2##(2008-10#2)(2008-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
and signalling##2##2##(1996-2#1)(2009-3#1)
and significance of##7##3##(1991-11#1)(1991-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2009-10#1)(2012-3#1)
and significant differences were found##3##5##(2008-10#2)(2013-1#1)
and significant differences##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
and significant increase##2##3##(2008-10#1)(2009-8#1)
and significant##29##2##(1991-6#1)(1996-3#1)(1997-1#1)(2008-10#12)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#3)(2011-2#1)(2013-1#1)(2013-8#3)
and significantly (P##2##3##(2008-10#2)
and significantly improved##2##3##(2008-10#2)
and significantly increased##3##3##(1991-5#1)(2008-10#1)(2010-10#1)
and significantly less##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
and significantly lower on the DOF On-Task score##2##8##(2010-8#2)
and significantly lower##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#2)
and significantly reduced the##2##4##(1991-12#1)(1993-8#1)
and significantly reduced##5##3##(1990-5#1)(1991-12#1)(1993-8#1)(1995-12#1)(2008-10#1)
and significantly with age##2##4##(2008-7#2)
and significantly with##3##3##(2008-10#1)(2008-7#2)
and significantly##36##2##(1990-5#2)(1991-12#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#1)(1997-2#1)(2008-10#14)(2008-11#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-2#1)(2013-8#1)
and signs of##7##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-12#1)
and signs##14##2##(1995-2#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#3)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)
and silica gel##2##3##(2008-10#2)
and silica##12##2##(1997-2#1)(2008-10#6)(2008-2#3)(2009-7#1)(2010-7#1)
and silicate##5##2##(2008-10#5)
and silicon were determined##2##4##(2008-10#2)
and silicon##5##2##(2008-10#5)
and silver staining##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
and silver##14##2##(2008-10#10)(2008-4#2)(2008-7#1)(2008-8#1)
and silver(I)##3##2##(2008-10#3)
and simian immunodeficiency##2##3##(1997-3#1)(1997-6#1)
and simian##3##2##(1997-3#1)(1997-6#1)(1997-8#1)
and similar levels of##2##4##(1995-8#1)(2008-10#1)
and similar results were obtained##2##5##(2008-10#2)
and similar results##3##3##(2008-10#3)
and similar to##3##3##(2008-10#1)(2008-11#1)(2012-6#1)
and similar##23##2##(1993-8#1)(1994-3#1)(1995-8#1)(1996-6#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-6#1)(2013-1#1)
and similarities##5##2##(2008-10#1)(2008-7#2)(2009-12#1)(2009-7#1)
and similarity of##2##3##(2008-12#1)(2012-3#1)
and similarity##3##2##(1996-6#1)(2008-12#1)(2012-3#1)
and similarly##2##2##(1994-2#1)(2008-3#1)
and simple analytical##2##3##(2008-10#2)
and simple and##2##3##(2008-10#2)
and simple determination of##2##4##(1992-3#1)(2008-10#1)
and simple means##2##3##(2006-6#1)(2008-10#1)
and simple method for the##2##5##(1995-3#1)(2008-10#1)
and simple method for##7##4##(1995-3#1)(2008-10#5)(2010-6#1)
and simple method has been developed for the##2##8##(2008-10#2)
and simple method to##3##4##(2008-10#2)(2008-12#1)
and simple method was##2##4##(2008-10#2)
and simple method##16##3##(1995-3#1)(2008-10#13)(2008-12#1)(2010-6#1)
and simple way to##2##4##(2008-10#1)(2008-5#1)
and simple way##3##3##(2008-10#2)(2008-5#1)
and simple##72##2##(1992-3#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-2#1)(2006-6#1)(2008-10#55)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)
and simpler##4##2##(2008-10#4)
and simplex##2##2##(2008-10#2)
and simplicity of the##2##4##(2008-10#2)
and simplicity of##4##3##(1997-7#1)(2008-10#2)(2009-9#1)
and simplicity##10##2##(1997-7#1)(2008-10#6)(2008-11#1)(2009-9#1)(2010-8#1)
and simplified##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
and simplify##3##2##(2008-11#2)(2011-2#1)
and simply##2##2##(2008-10#1)(2008-4#1)
and simulate##2##2##(2010-10#1)(2013-8#1)
and simulated data##2##3##(2008-11#1)(2008-3#1)
and simulated ischemia##3##3##(1994-2#3)
and simulated##11##2##(1994-1#1)(1994-2#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
and simulation of##2##3##(1994-8#1)(2008-3#1)
and simulation##4##2##(1994-8#1)(2008-3#1)(2009-3#1)(2013-1#1)
and simulations##2##2##(2008-11#1)(2008-8#1)
and simultaneous analysis of dichlorvos##2##5##(2008-10#2)
and simultaneous detection of##2##4##(2008-10#1)(2008-9#1)
and simultaneous determination of arsenic##2##5##(2008-10#2)
and simultaneous determination of##9##4##(2008-10#9)
and simultaneous surface or intracellular antigen expression##2##7##(2008-9#2)
and simultaneous visualization##2##3##(2009-11#1)(2011-2#1)
and simultaneous##32##2##(1995-5#1)(2008-10#23)(2008-5#1)(2008-9#3)(2009-11#1)(2011-2#2)(2013-1#1)
and simultaneously##14##2##(1990-5#1)(1994-12#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-6#1)(2010-7#1)(2011-2#2)
and sinapic acid##2##3##(2013-1#2)
and since##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
and single cells##2##3##(1992-12#1)(1993-3#1)
and single diffusion##2##3##(2012-2#2)
and single photon emission computed tomography##2##6##(1996-12#1)(2010-12#1)
and single photon emission##3##4##(1996-12#1)(2008-7#1)(2010-12#1)
and single port access##2##4##(2012-12#2)
and single positive##2##3##(1997-7#1)(2008-10#1)
and single##26##2##(1992-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-6#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#2)(2012-2#3)
and single-molecule fluorescence##2##3##(2007-12#1)(2008-10#1)
and single-molecule##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
and single-stranded##2##2##(1992-6#1)(1994-8#1)
and singly##2##2##(2008-3#1)(2011-3#1)
and sinking##2##2##(2008-10#1)(2008-8#1)
and sinks##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
and sinusoids##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
and site of##3##3##(1991-6#1)(1994-11#1)(2008-10#1)
and site##7##2##(1991-12#1)(1991-6#1)(1994-11#1)(2008-10#3)(2008-8#1)
and site-directed mutagenesis##3##3##(1994-8#1)(1995-8#1)(2008-10#1)
and site-directed mutants of##2##4##(1994-11#1)(1995-6#1)
and site-directed##5##2##(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#1)
and site-specific##2##2##(2008-10#1)(2008-11#1)
and sites##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
and sitting##2##2##(2008-11#1)(2011-2#1)
and situations##3##2##(1996-3#1)(2010-11#1)(2010-9#1)
and six isolates from##2##4##(2008-10#2)
and six months##3##3##(1993-3#1)(2008-11#1)(2011-2#1)
and six patients##2##3##(2008-1#1)(2011-2#1)
and six##36##2##(1990-3#2)(1991-9#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-5#3)(2010-1#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-7#1)
and sixth##4##2##(1996-1#1)(2008-3#1)(2010-1#1)(2013-7#1)
and sixty##2##2##(2011-1#1)(2012-12#1)
and size and##2##3##(2008-10#1)(2010-8#1)
and size distribution##2##3##(2008-10#1)(2011-2#1)
and size of the##10##4##(1993-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-5#1)(2010-8#1)(2010-9#1)
and size of##22##3##(1990-5#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#2)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2013-7#1)
and size##51##2##(1990-5#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-10#13)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#5)(2009-5#3)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#3)(2013-1#1)(2013-7#1)
and size-exclusion##2##2##(1991-9#1)(1993-8#1)
and sizes of##3##3##(2008-10#1)(2009-1#1)(2010-8#1)
and sizes##5##2##(2008-10#1)(2009-1#1)(2009-8#1)(2010-8#2)
and skeletal muscle##8##3##(1990-5#2)(1992-9#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)
and skeletal muscle-specific##2##3##(1995-2#1)(2008-8#1)
and skeletal##16##2##(1990-5#2)(1992-9#1)(1993-12#2)(1995-2#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-2#1)
and skill##4##2##(1996-12#1)(2008-11#2)(2011-2#1)
and skilled##4##2##(1995-3#2)(2008-11#1)(2008-9#1)
and skills needed##2##3##(1993-12#1)(2012-12#1)
and skills##12##2##(1991-1#1)(1993-12#1)(1996-3#1)(2008-11#4)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)
and skimmer##2##2##(2008-10#2)
and skin cancer##2##3##(2011-2#2)
and skin surface pH are##2##5##(2008-5#2)
and skin surface pH##3##4##(2008-5#3)
and skin surface##4##3##(2008-5#4)
and skin##44##2##(1991-6#1)(1992-3#1)(1993-6#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#19)(2008-7#1)(2008-8#1)(2008-9#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
and skull base##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
and skull##4##2##(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
and sky##2##2##(2008-2#1)(2008-3#1)
and slag##3##2##(2008-10#3)
and sleep problems##2##3##(1997-3#1)(2013-1#1)
and sleep##8##2##(1991-1#1)(1994-8#1)(1997-3#1)(2009-11#1)(2009-9#1)(2010-5#1)(2010-7#1)(2013-1#1)
and slightly less##2##3##(1995-2#1)(2008-9#1)
and slightly##7##2##(1995-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)
and slope##8##2##(2008-10#8)
and slopes##2##2##(2008-10#2)
and sloughing##4##2##(1991-8#4)
and slow the##2##3##(2008-10#1)(2012-2#1)
and slow##14##2##(1995-2#1)(1996-9#1)(2008-10#3)(2008-3#1)(2008-9#3)(2009-8#2)(2010-12#1)(2012-2#1)(2013-8#1)
and slower##2##2##(2008-10#1)(2008-7#1)
and slowly##3##2##(1993-12#1)(2008-7#1)(2012-3#1)
and sludge##2##2##(2008-10#1)(2010-12#1)
and slurry##6##2##(2008-10#6)
and small GTPases##2##3##(2011-2#1)(2012-2#1)
and small cell##3##3##(2008-1#1)(2011-2#1)(2012-3#1)
and small molecules##3##3##(2008-10#1)(2010-11#1)(2011-3#1)
and small sample sizes##2##4##(2008-10#2)
and small vessel vasculitis##3##4##(1997-8#2)(2008-10#1)
and small##54##2##(1990-6#1)(1991-12#2)(1993-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#2)(2008-1#3)(2008-10#16)(2008-11#3)(2008-12#2)(2008-3#2)(2008-8#3)(2010-11#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#2)
and small-scale##2##2##(2009-8#1)(2011-2#1)
and smaller##11##2##(1995-3#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2009-8#1)(2012-3#1)(2013-1#1)
and smoke##2##2##(1996-12#1)(2008-11#1)
and smoking##13##2##(1990-12#1)(1991-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)
and smooth muscle actin##2##4##(2008-11#1)(2013-8#1)
and smooth muscle cells##2##4##(1995-12#1)(1997-4#1)
and smooth muscle##8##3##(1992-6#2)(1993-8#1)(1994-6#1)(1995-12#1)(1997-4#1)(2008-11#1)(2013-8#1)
and smooth septate junctions##3##4##(2008-7#3)
and smooth##15##2##(1992-6#2)(1993-8#1)(1994-6#1)(1995-12#2)(1997-4#1)(2008-11#1)(2008-7#3)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
and so are##2##3##(1997-8#1)(2013-8#1)
and so forth##2##3##(1991-2#1)(2013-7#1)
and so is the##2##4##(2008-10#1)(2008-8#1)
and so is##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
and so it##3##3##(2007-12#1)(2010-6#1)(2013-1#1)
and so on to##2##4##(2008-10#1)(2012-3#1)
and so on##9##3##(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2011-3#1)(2011-4#1)(2012-3#1)
and so the##2##3##(2009-10#1)(2013-1#1)
and so to##2##3##(1990-12#1)(2008-10#1)
and so##43##2##(1990-12#1)(1991-2#1)(1992-6#2)(1993-1#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#11)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#2)(2011-3#1)(2011-4#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and social and academic##3##4##(2008-12#3)
and social and##5##3##(1996-12#1)(2008-11#1)(2008-12#3)
and social context##2##3##(2010-8#2)
and social costs##2##3##(1991-6#1)(2008-11#1)
and social factors##3##3##(1995-9#1)(2008-7#1)(2008-8#1)
and social features##2##3##(2008-6#1)(2011-2#1)
and social functioning##4##3##(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
and social impacts##2##3##(2008-1#1)(2008-10#1)
and social interaction##3##3##(1996-2#1)(2012-2#1)(2012-3#1)
and social learning##2##3##(2008-10#1)(2008-4#1)
and social life##2##3##(2010-11#1)(2011-2#1)
and social marketing##2##3##(1997-3#1)(2012-3#1)
and social phobia##3##3##(2008-4#2)(2012-2#1)
and social policies##2##3##(1992-1#1)(1994-5#1)
and social relationship)##2##3##(1994-12#2)
and social services##9##3##(1994-1#1)(1995-3#1)(1996-1#1)(1996-3#3)(2008-1#1)(2008-11#2)
and social skills##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
and social status##3##3##(1994-6#1)(2008-12#1)(2011-2#1)
and social support##10##3##(1992-3#1)(1996-2#3)(1996-3#2)(2009-5#1)(2009-7#1)(2010-11#1)(2013-1#1)
and social variables##2##3##(2008-7#1)(2012-2#1)
and social work##5##3##(2010-10#1)(2012-12#3)(2013-1#1)
and social##129##2##(1991-6#2)(1992-1#3)(1992-3#1)(1993-11#1)(1994-1#1)(1994-12#2)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#4)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#6)(1996-6#1)(1997-3#1)(1997-8#1)(2008-1#3)(2008-10#2)(2008-11#16)(2008-12#12)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#4)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-7#1)(2010-8#3)(2011-2#6)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#4)(2013-8#2)
and socially##3##2##(1995-5#1)(2008-11#2)
and societal##5##2##(2008-1#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-2#1)
and society##6##2##(1993-12#1)(1994-5#1)(1995-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
and socio-economic##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
and socioeconomic status##4##3##(2011-1#2)(2012-12#1)(2013-8#1)
and socioeconomic##8##2##(2008-11#1)(2009-12#1)(2010-1#1)(2011-1#2)(2012-12#1)(2013-8#2)
and sociological##2##2##(2008-10#1)(2008-11#1)
and sodium chloride concentration##2##4##(2008-10#1)(2011-2#1)
and sodium chloride##6##3##(2008-10#4)(2008-12#1)(2011-2#1)
and sodium citrate##2##3##(2008-10#1)(2011-2#1)
and sodium dodecyl sulfate (SDS)##3##5##(2008-10#2)(2008-4#1)
and sodium dodecyl sulfate##5##4##(2008-10#4)(2008-4#1)
and sodium dodecyl##9##3##(2008-10#8)(2008-4#1)
and sodium fluoride (NaF)##2##4##(2008-10#2)
and sodium iodide##2##3##(2008-10#2)
and sodium ions##3##3##(2008-10#3)
and sodium nitrate##2##3##(2008-10#2)
and sodium nitroprusside (SNP)##2##4##(2008-10#1)(2008-11#1)
and sodium nitroprusside in##2##4##(1995-8#1)(2008-10#1)
and sodium nitroprusside##6##3##(1995-8#3)(2008-10#2)(2008-11#1)
and sodium sulfite##3##3##(2008-10#3)
and sodium tetraphenylborate (NaTPB) as an##2##6##(2008-10#2)
and sodium tetraphenylborate (NaTPB) as##3##5##(2008-10#3)
and sodium tetraphenylborate##5##3##(2008-10#5)
and sodium##63##2##(1991-7#1)(1995-8#4)(2008-10#51)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2011-2#2)
and soft drinks##4##3##(2008-10#4)
and soft independent modelling of class analogy##2##7##(2008-10#2)
and soft independent##3##3##(2008-10#3)
and soft tissue##5##3##(1991-2#1)(2008-8#1)(2009-4#1)(2011-2#2)
and soft tissues##3##3##(2010-6#2)(2012-2#1)
and soft##23##2##(1991-2#2)(1993-11#1)(2008-10#12)(2008-8#1)(2009-4#1)(2010-5#1)(2010-6#2)(2011-2#2)(2012-2#1)
and soft-tissue##3##2##(1992-6#1)(2010-12#1)(2011-2#1)
and software tools for##2##4##(2010-11#1)(2011-3#1)
and software##12##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-3#1)(2012-2#1)
and soil microbial##2##3##(2008-10#2)
and soil moisture content##2##4##(2008-10#1)(2008-12#1)
and soil moisture##4##3##(1995-3#1)(2008-10#2)(2008-12#1)
and soil samples##8##3##(2008-10#8)
and soil treatments##3##3##(2008-10#3)
and soil type##2##3##(2012-9#2)
and soil##58##2##(1991-7#1)(1995-3#1)(2008-10#45)(2008-11#1)(2008-12#1)(2009-3#1)(2009-4#1)(2010-3#1)(2012-2#2)(2012-5#1)(2012-9#2)(2013-1#1)
and soils##4##2##(2008-10#4)
and solar radiation##2##3##(2008-10#2)
and solar##8##2##(2008-10#2)(2008-3#5)(2008-7#1)
and sole##2##2##(2009-10#1)(2011-2#1)
and soles##3##2##(1997-3#1)(2010-6#1)(2012-3#1)
and soleus##2##2##(1995-12#2)
and solid phase extraction##5##4##(2008-10#5)
and solid phase microextraction##2##4##(2008-10#2)
and solid phase##8##3##(2008-10#8)
and solid samples##2##3##(2008-10#2)
and solid##22##2##(2008-10#18)(2008-9#2)(2013-1#2)
and solid-phase extraction##3##3##(1992-11#1)(2008-10#2)
and solid-phase microextraction##2##3##(2008-10#2)
and solid-phase##6##2##(1992-11#1)(2008-10#5)
and solid-state##2##2##(2008-10#2)
and solidarity##2##2##(2008-12#1)(2011-2#1)
and solubility of##2##3##(2008-10#2)
and solubility##7##2##(2008-10#5)(2013-1#2)
and soluble##11##2##(1990-11#2)(1995-2#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)
and solution##11##2##(2008-10#6)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)
and solutions in##2##3##(1992-2#1)(2010-8#1)
and solutions##13##2##(1991-12#1)(1992-2#2)(1994-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-10#1)(2010-8#1)
and solvent extraction of##2##4##(2008-10#2)
and solvent extraction##6##3##(2008-10#6)
and solvent volume##2##3##(2008-10#2)
and solvent##26##2##(1991-9#1)(2008-10#21)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
and solvents##4##2##(2008-10#3)(2008-5#1)
and somatic complaints##2##3##(1996-2#1)(2008-10#1)
and somatic##7##2##(1995-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-9#2)
and somatosensory information##2##3##(1991-2#1)(2008-11#1)
and some applications##2##3##(1992-9#1)(2008-10#1)
and some are##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
and some aspects of authorship##2##5##(2008-10#2)
and some cancers##2##3##(2008-10#1)(2010-1#1)
and some genes##2##3##(2009-10#1)(2011-2#1)
and some have been##2##4##(2010-12#1)(2011-3#1)
and some have##4##3##(1991-9#1)(2010-12#1)(2011-3#2)
and some heavy##2##3##(2008-10#2)
and some isolates from##2##4##(2008-10#2)
and some of its##2##4##(2008-10#1)(2008-5#1)
and some of the##9##4##(1991-12#2)(1996-1#1)(2008-10#1)(2008-11#3)(2012-2#1)(2013-1#1)
and some of them##2##4##(1996-2#1)(2011-1#1)
and some of these##2##4##(2008-10#1)(2009-12#1)
and some of##17##3##(1991-12#2)(1996-1#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
and some organic##2##3##(2008-10#2)
and some others##2##3##(2008-10#1)(2011-2#1)
and some protonated##2##3##(2008-10#2)
and some related##2##3##(1993-6#1)(2010-7#1)
and some transition##2##3##(2008-10#2)
and some viruses##2##3##(2008-10#1)(2010-1#1)
and some##153##2##(1990-6#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-12#3)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#62)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)
and sometimes two##2##3##(1992-9#1)(2008-7#1)
and sometimes##25##2##(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#3)(2010-1#1)(2010-12#1)(2011-2#1)
and somewhat##5##2##(2008-10#2)(2008-3#1)(2008-9#1)(2012-3#1)
and song##3##2##(2008-9#2)(2011-1#1)
and sonicated##2##2##(1994-5#1)(2008-10#1)
and sonication##3##2##(2008-10#3)
and sophisticated##3##2##(1995-3#1)(2008-11#2)
and sorbed onto##2##3##(2008-10#2)
and sorbitol dehydrogenase##4##3##(1996-2#3)(2008-11#1)
and sorghum##2##2##(2008-10#1)(2009-10#1)
and sorption capacity##2##3##(2008-10#2)
and sorption on a C-18 bonded silica##2##7##(2008-10#2)
and sorption on##3##3##(2008-10#3)
and sorption##7##2##(2008-10#7)
and sorting of##3##3##(2008-9#2)(2013-8#1)
and sorting##5##2##(2008-4#1)(2008-9#3)(2013-8#1)
and sought##2##2##(2012-2#1)(2013-1#1)
and source of##3##3##(2008-4#1)(2011-2#2)
and source##4##2##(2008-11#1)(2008-4#1)(2011-2#2)
and sources of##5##3##(1993-2#1)(1997-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
and sources##6##2##(1993-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
and southeast##2##2##(2008-10#1)(2008-6#1)
and southern##12##2##(2008-10#9)(2008-9#1)(2011-2#2)
and soy##2##2##(2010-4#1)(2013-1#1)
and soya##2##2##(2008-10#1)(2008-5#1)
and soybean plants##2##3##(2008-10#2)
and soybean roots##2##3##(2008-10#2)
and soybean##16##2##(1995-11#1)(2008-10#12)(2008-11#2)(2010-10#1)
and space##8##2##(2008-10#4)(2008-11#1)(2009-8#1)(2010-11#1)(2013-1#1)
and space-time##2##2##(2007-12#1)(2008-3#1)
and spans a##2##3##(1993-3#1)(1997-8#1)
and sparing##3##2##(2008-10#1)(2012-2#2)
and spastic##2##2##(1996-2#1)(2009-11#1)
and spatial distribution of##2##4##(2008-10#1)(2008-8#1)
and spatial distribution##4##3##(2008-10#3)(2008-8#1)
and spatial dynamics##4##3##(2008-10#3)(2008-8#1)
and spatial information##2##3##(2008-3#1)(2008-9#1)
and spatial patterns##2##3##(2008-10#1)(2008-8#1)
and spatial scale##2##3##(2008-8#2)
and spatial spread of##3##4##(2008-10#3)
and spatial##49##2##(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#20)(2008-11#3)(2008-3#2)(2008-8#10)(2008-9#2)(2009-10#2)(2010-12#1)(2010-8#1)(2012-2#2)(2013-8#1)
and spatially##7##2##(1994-3#1)(2008-8#4)(2010-4#1)(2012-3#1)
and spatio-temporal##2##2##(2011-2#1)(2013-8#1)
and spatiotemporal variables##2##3##(2013-1#2)
and spatiotemporal##3##2##(2008-8#1)(2013-1#2)
and spawning##2##2##(2008-8#1)(2010-8#1)
and speakers who stammer##2##4##(2008-2#2)
and speakers##4##2##(2008-11#1)(2008-2#2)(2012-2#1)
and speaking##2##2##(2008-7#1)(2013-1#1)
and special##6##2##(1995-12#1)(1995-2#1)(2008-12#2)(2011-2#1)(2012-3#1)
and specialist##3##2##(2008-11#1)(2010-8#1)(2011-2#1)
and specialized##6##2##(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)
and specially##2##2##(2008-11#1)(2011-2#1)
and specialties##2##2##(1991-6#1)(1993-12#1)
and specialty##2##2##(1995-3#1)(2010-7#1)
and speciation analysis in##2##4##(2008-10#2)
and speciation analysis##3##3##(2008-10#3)
and speciation of arsenic by flow##2##6##(2008-10#2)
and speciation of arsenic by##3##5##(2008-10#3)
and speciation of arsenic in##2##5##(2008-10#2)
and speciation of arsenic##5##4##(2008-10#5)
and speciation of chromium in##3##5##(2008-10#3)
and speciation of chromium##5##4##(2008-10#5)
and speciation of inorganic arsenic##2##5##(2008-10#2)
and speciation of inorganic##4##4##(2008-10#4)
and speciation of##20##3##(2008-10#20)
and speciation##24##2##(2008-10#24)
and species abundance distributions##2##4##(2008-8#2)
and species composition##2##3##(2008-3#1)(2008-9#1)
and species of##2##3##(2008-10#1)(2011-2#1)
and species##29##2##(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#3)(2010-1#1)(2011-2#1)(2012-5#1)(2012-6#1)(2013-7#1)(2013-8#1)
and species'##2##2##(2008-8#2)
and species-specific##4##2##(2008-10#1)(2011-10#1)(2012-2#1)(2013-8#1)
and specific detection of##2##4##(2008-10#2)
and specific diagnostic##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
and specific flow##2##3##(2008-10#1)(2008-9#1)
and specific for##2##3##(2008-10#1)(2012-2#1)
and specific inhibitors of##2##4##(2008-5#1)(2008-9#1)
and specific leaf area##2##4##(2008-8#1)(2012-5#1)
and specific method for##5##4##(2008-10#4)(2011-3#1)
and specific productivity##2##3##(2008-11#2)
and specific##80##2##(1990-12#2)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-12#1)(1997-7#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#1)
and specifically##13##2##(1992-4#1)(1993-2#1)(1994-12#1)(1996-12#1)(2008-11#3)(2008-4#2)(2008-5#1)(2009-12#1)(2010-10#1)(2013-1#1)
and specificities##2##2##(1997-7#1)(2008-10#1)
and specificity 0##2##3##(2011-2#2)
and specificity of the##10##4##(1990-11#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#2)(2012-2#2)
and specificity of##23##3##(1990-11#1)(1990-9#1)(1991-2#1)(1993-6#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-2#2)
and specificity##50##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#1)(1993-3#1)(1993-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#12)(2012-12#2)(2012-2#5)(2012-3#1)
and spectral characteristics##2##3##(2008-12#1)(2013-8#1)
and spectral data##2##3##(2008-11#1)(2012-2#1)
and spectral properties of##3##4##(2008-10#1)(2008-3#2)
and spectral properties##4##3##(2008-10#1)(2008-3#2)(2009-8#1)
and spectral##22##2##(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-8#1)(2012-2#1)(2013-8#2)
and spectrofluorimetric determination of##4##4##(2008-10#4)
and spectrofluorimetric##6##2##(2008-10#6)
and spectrophotometric detection##11##3##(2008-10#11)
and spectrophotometric determination of EDTA##2##5##(2008-10#2)
and spectrophotometric determination of trace##2##5##(2008-10#2)
and spectrophotometric determination of##12##4##(2008-10#12)
and spectrophotometric determination##13##3##(2008-10#13)
and spectrophotometric measurements##2##3##(2008-10#2)
and spectrophotometric study##2##3##(2008-10#2)
and spectrophotometric##34##2##(1993-8#1)(2008-10#33)
and spectrophotometrically##2##2##(2008-10#2)
and spectrophotometry##5##2##(2008-10#5)
and spectroscopic study of##2##4##(2008-10#2)
and spectroscopic##9##2##(1994-11#1)(2008-10#7)(2008-4#1)
and spectroscopy##5##2##(1992-3#1)(2008-11#1)(2012-12#3)
and spectrum##2##2##(2008-10#1)(2013-8#1)
and speculate on##2##3##(2008-11#2)
and speculates on##2##3##(1993-3#1)(2008-9#1)
and speech##5##2##(2008-9#1)(2011-1#3)(2011-2#1)
and speed of##4##3##(2008-10#1)(2009-12#1)(2010-8#1)(2011-1#1)
and speed##10##2##(1994-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-12#1)(2010-8#1)(2011-1#1)
and spelling development##2##3##(2011-1#2)
and spelling##3##2##(2008-11#1)(2011-1#2)
and spent##5##2##(2008-10#2)(2010-4#2)(2010-8#1)
and sperm cells##2##3##(2007-12#1)(2008-12#1)
and sperm head##2##3##(2008-10#1)(2011-2#1)
and sperm##12##2##(1991-5#1)(1995-6#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)(2011-2#1)(2013-1#1)
and spermathecae##2##2##(2007-12#1)(2008-12#1)
and spermatogenesis##8##2##(2009-10#4)(2009-7#1)(2010-5#1)(2012-2#2)
and spermatozoa##2##2##(2008-7#1)(2012-2#1)
and spermine##5##2##(1990-7#2)(2008-10#3)
and spermiogenesis##3##2##(2007-12#1)(2008-9#1)(2012-2#1)
and spherical##2##2##(2008-7#1)(2011-2#1)
and spike timing##2##3##(2008-11#1)(2009-8#1)
and spike##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
and spiked samples##3##3##(2008-10#3)
and spiked water##2##3##(2008-10#2)
and spiked##15##2##(2008-10#15)
and spinal cord and##3##4##(1992-1#1)(1996-12#1)(1996-2#1)
and spinal cord of mice##2##5##(1997-2#2)
and spinal cord of##5##4##(1997-2#4)(1997-3#1)
and spinal cord##29##3##(1991-5#2)(1992-1#2)(1992-12#2)(1996-12#1)(1996-2#1)(1997-2#5)(1997-3#3)(1997-8#1)(2008-4#1)(2008-7#5)(2009-8#1)(2010-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
and spinal##33##2##(1990-9#1)(1991-5#2)(1992-1#2)(1992-12#2)(1996-12#1)(1996-2#1)(1997-2#5)(1997-3#3)(1997-8#1)(2008-4#1)(2008-7#7)(2008-8#1)(2009-8#1)(2010-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
and spindle##2##2##(2008-11#1)(2010-5#1)
and spine##2##2##(2008-11#1)(2010-12#1)
and spirit##2##2##(2008-12#1)(2012-2#1)
and spirits##2##2##(2008-10#1)(2009-7#1)
and spiritual##14##2##(1995-5#1)(2008-12#2)(2010-11#2)(2010-2#3)(2011-1#1)(2011-2#1)(2013-8#4)
and spirituality##2##2##(2010-10#1)(2013-8#1)
and spirometry##2##2##(2007-8#1)(2008-1#1)
and spleen were##3##3##(1993-3#1)(2008-5#1)(2010-7#1)
and spleen##18##2##(1990-12#1)(1991-6#2)(1993-3#1)(1994-11#1)(1995-12#2)(1996-12#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)
and spleens##2##2##(1995-2#1)(2008-10#1)
and splenic##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
and splenomegaly##2##2##(2008-5#1)(2011-2#1)
and split##2##2##(2008-8#1)(2012-2#1)
and splitting of##2##3##(2008-10#1)(2008-5#1)
and spontaneous##5##2##(1997-7#1)(2008-10#3)(2009-8#1)
and spontaneously##4##2##(1994-2#1)(2008-11#1)(2008-4#1)(2011-2#1)
and sporadic##2##2##(2010-12#1)(2011-2#1)
and sporangia##3##2##(2008-10#3)
and spore dispersal gradient on the spatio-temporal dynamics of plant disease epidemics##2##12##(2008-10#2)
and spore dispersal gradient on##3##5##(2008-10#3)
and spore germination in##2##4##(2008-10#2)
and spore germination##3##3##(2008-10#3)
and spore production##3##3##(2008-10#3)
and spore##12##2##(2008-10#11)(2012-2#1)
and spores##2##2##(2008-8#2)
and sport orientation##2##3##(2009-7#2)
and sports##4##2##(1996-6#1)(2010-1#1)(2010-7#1)(2013-1#1)
and sporulated##3##2##(2008-10#2)(2011-2#1)
and sporulation in##2##3##(2008-10#1)(2008-8#1)
and sporulation##14##2##(2008-10#13)(2008-8#1)
and spot##2##2##(2008-10#2)
and spray##3##2##(2008-10#3)
and spread of the pathogen##2##5##(2008-10#2)
and spread of##14##3##(1990-11#1)(1990-3#1)(2008-10#8)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
and spread through##2##3##(1992-5#1)(2013-8#1)
and spread##23##2##(1990-11#1)(1990-3#1)(1992-5#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
and spreading##6##2##(2008-10#3)(2008-9#2)(2009-3#1)
and spring barley##3##3##(2008-10#3)
and spring##13##2##(2008-10#9)(2008-11#2)(2008-12#1)(2012-3#1)
and squamometry##2##2##(2008-5#2)
and squamous cell carcinomas##3##4##(1991-11#1)(2012-3#2)
and squamous cell##5##3##(1991-11#1)(2012-3#4)
and square wave adsorptive stripping voltammetry##2##6##(2008-10#2)
and square wave voltammetric##4##4##(2008-10#4)
and square wave voltammetry (SWV)##3##5##(2008-10#3)
and square wave voltammetry using##3##5##(2008-10#3)
and square wave voltammetry were##2##5##(2008-10#2)
and square wave voltammetry##9##4##(2008-10#8)(2008-8#1)
and square wave##16##3##(2008-10#15)(2008-8#1)
and square-wave##4##2##(2008-10#4)
and squash##2##2##(2008-10#2)
and stability constant##2##3##(2008-10#2)
and stability constants of##2##4##(2008-10#2)
and stability constants##4##3##(2008-10#4)
and stability for the##2##4##(2008-10#2)
and stability for##3##3##(2008-10#3)
and stability in##2##3##(2008-10#1)(2008-8#1)
and stability indicating##2##3##(2008-10#2)
and stability of differentiated phenotype##3##5##(1995-11#3)
and stability of protein##2##4##(1991-6#1)(2008-11#1)
and stability of protonated spermidine and##2##6##(2008-10#2)
and stability of protonated##5##4##(2008-10#5)
and stability of the##10##4##(1994-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-3#1)
and stability of##32##3##(1991-6#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#3)(2007-12#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)
and stability to##2##3##(1994-11#1)(2008-5#1)
and stability was##2##3##(2008-10#1)(2008-5#1)
and stability##78##2##(1991-6#2)(1993-6#1)(1994-11#2)(1994-5#1)(1995-11#3)(1995-3#1)(2007-12#1)(2008-10#39)(2008-11#6)(2008-12#3)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
and stabilization of the##3##4##(1994-5#1)(2008-3#1)(2008-9#1)
and stabilization of##6##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)
and stabilization##8##2##(1994-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)
and stabilize##3##2##(1994-12#1)(2009-7#1)(2012-3#1)
and stabilized by the##2##4##(1997-4#1)(2008-4#1)
and stabilized##6##2##(1997-4#1)(2008-10#1)(2008-4#1)(2012-4#1)(2013-1#2)
and stabilizers for polyvinyl chloride (PVC) pipe##2##7##(2008-10#2)
and stabilizers##4##2##(2008-10#3)(2011-2#1)
and stabilizes##2##2##(2009-6#1)(2011-2#1)
and stabilizing##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2012-3#1)
and stable flow rate##2##4##(2008-10#2)
and stable##29##2##(1995-11#1)(1997-2#1)(1997-6#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#1)(2011-3#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#1)
and staff in##2##3##(1993-1#1)(2013-1#1)
and staff##18##2##(1992-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-3#2)(1997-5#1)(1997-8#1)(2008-11#3)(2008-12#2)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#2)
and staffing##3##2##(1996-2#1)(1996-3#2)
and stage##9##2##(1991-11#1)(1995-1#1)(1995-2#1)(2008-11#1)(2008-8#3)(2011-2#2)
and staged##2##2##(2008-7#1)(2012-2#1)
and stages of##2##3##(2012-2#1)(2012-3#1)
and staging of pancreatic##3##4##(2008-1#2)(2009-5#1)
and staging of##5##3##(2008-1#2)(2008-2#1)(2009-5#1)(2010-12#1)
and staging##6##2##(2008-1#2)(2008-2#1)(2009-5#1)(2010-12#2)
and stained with##2##3##(2008-7#1)(2011-2#1)
and stained##6##2##(1992-6#1)(2008-7#1)(2011-2#3)(2012-3#1)
and staining of##3##3##(2008-4#1)(2008-9#2)
and staining with##2##3##(2008-11#1)(2008-9#1)
and staining##8##2##(2008-11#1)(2008-4#2)(2008-9#5)
and stainless steel##8##3##(2008-10#5)(2008-7#1)(2013-8#2)
and stand##3##2##(2008-10#3)
and standard addition method##2##4##(2008-10#2)
and standard addition##5##3##(2008-10#5)
and standard deviation of##4##4##(2008-10#3)(2008-3#1)
and standard deviation##6##3##(2007-11#1)(2008-10#4)(2008-3#1)
and standard deviations were##4##4##(2008-10#2)(2011-2#2)
and standard deviations##5##3##(2008-10#3)(2011-2#2)
and standard reference materials##2##4##(2008-10#2)
and standard##40##2##(1992-4#1)(2007-11#1)(2008-10#26)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
and standardization of##2##3##(1993-3#1)(2008-10#1)
and standardize the##2##3##(1997-3#1)(2008-9#1)
and standardized##5##2##(1993-1#1)(1994-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
and standards for##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
and standards##8##2##(1991-3#2)(1992-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2010-5#1)
and starch##4##2##(2008-10#3)(2008-5#1)
and started##3##2##(2008-10#1)(2010-1#2)
and state health##2##3##(1996-1#1)(1997-2#1)
and state of aggregation of##2##5##(1994-5#2)
and state of##4##3##(1994-5#2)(2008-10#1)(2010-6#1)
and state##31##2##(1990-11#1)(1991-2#1)(1994-12#1)(1994-5#3)(1995-1#1)(1995-2#1)(1996-1#4)(1996-3#1)(1997-2#3)(1997-3#1)(2008-10#4)(2008-11#4)(2008-4#1)(2009-11#2)(2010-6#1)(2012-2#1)(2013-1#1)
and states##3##2##(1990-11#2)(2013-8#1)
and static headspace gas##2##4##(2008-10#2)
and static##9##2##(1992-3#1)(1992-6#2)(2008-10#4)(2012-2#2)
and stationary##3##2##(2008-10#2)(2008-11#1)
and statistical analysis of##2##4##(2008-10#2)
and statistical analysis##4##3##(2008-10#3)(2011-2#1)
and statistical parameters##2##3##(2008-10#1)(2008-12#1)
and statistical##15##2##(2008-10#9)(2008-12#2)(2008-7#1)(2008-9#2)(2011-2#1)
and statistically significant##5##3##(2008-10#1)(2008-12#1)(2008-9#2)(2009-3#1)
and statistically##12##2##(1991-2#1)(2008-10#2)(2008-12#1)(2008-9#2)(2009-1#1)(2009-3#1)(2012-3#1)(2013-1#3)
and statistics##2##2##(2008-3#1)(2008-7#1)
and status##2##2##(1992-12#1)(2010-10#1)
and staurosporine##3##2##(1990-8#1)(1993-3#1)(2008-10#1)
and steady##2##2##(1993-12#1)(2013-8#1)
and steady-state##4##2##(1995-2#1)(1997-1#1)(2008-10#1)(2012-3#1)
and stearic acid##3##3##(2008-10#3)
and stearic acids##2##3##(1994-8#1)(2008-10#1)
and stearic##5##2##(1994-8#1)(2008-10#4)
and steel##4##2##(2008-10#3)(2008-4#1)
and steels##2##2##(2008-10#2)
and stem cell##2##3##(2012-5#2)
and stem rot of##2##4##(2008-10#2)
and stem rot##6##3##(2008-10#6)
and stem##20##2##(1992-3#1)(2008-10#16)(2008-12#1)(2012-5#2)
and stems of##3##3##(2008-10#2)(2008-11#1)
and stems were##3##3##(2008-10#3)
and stems##13##2##(2008-10#11)(2008-11#2)
and stenosis##4##2##(1991-8#1)(1992-9#1)(2010-12#1)(2012-12#1)
and stent##3##2##(2008-11#2)(2011-2#1)
and stenting##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
and stepwise##3##2##(2008-10#3)
and steric##4##2##(1994-5#1)(2008-10#2)(2012-12#1)
and sterilization in##2##3##(2010-7#1)(2012-12#1)
and sterilization##4##2##(1992-12#1)(2010-7#1)(2012-12#1)(2013-8#1)
and steroid##3##2##(1994-6#1)(2010-10#1)(2012-2#1)
and steroids##4##2##(1997-1#2)(2008-10#1)(2010-2#1)
and stiffness##2##2##(2011-2#1)(2013-1#1)
and stilbene##2##2##(2008-10#2)
and still##10##2##(1993-3#1)(1994-6#1)(1996-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#2)(2013-1#1)
and stimulate##8##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
and stimulated##3##2##(1991-7#1)(1997-8#1)(2011-2#1)
and stimulates##5##2##(1995-11#1)(1995-12#1)(2007-11#2)(2008-11#1)
and stimulating##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
and stimulation of##5##3##(1992-6#1)(1993-3#1)(2008-8#1)(2008-9#1)(2013-7#1)
and stimulation##6##2##(1992-6#1)(1993-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-7#1)
and stirred##2##2##(2008-11#2)
and stirring time##3##3##(2008-10#3)
and stirring##6##2##(2008-10#5)(2008-11#1)
and stoichiometry##2##2##(2008-10#1)(2008-4#1)
and stomach cancer##2##3##(1990-12#1)(2012-3#1)
and stomach##12##2##(1990-12#1)(1995-11#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-1#1)(2011-2#1)(2012-3#2)
and stomatal##2##2##(2008-10#2)
and stone##2##2##(1996-3#1)(2008-10#1)
and stopped-flow##2##2##(2008-10#2)
and storage in##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
and storage of##3##3##(2008-9#3)
and storage stability were carried out##2##6##(2008-10#2)
and storage stability##9##3##(2008-10#9)
and storage##28##2##(2007-12#1)(2008-10#16)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#6)
and store##4##2##(1994-3#1)(2008-10#2)(2010-8#1)
and stored at##2##3##(2008-10#1)(2010-7#1)
and stored in the##2##4##(2008-10#1)(2013-1#1)
and stored in##4##3##(1997-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
and stored##11##2##(1997-1#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-7#1)(2010-8#1)(2013-1#1)
and straightforward##6##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-4#1)(2010-7#1)
and strain##9##2##(1993-9#1)(2007-12#2)(2008-10#2)(2009-7#1)(2013-1#3)
and strain-specific##2##2##(2008-12#1)(2011-2#1)
and strains##2##2##(2008-10#2)
and strategic planning##2##3##(1996-2#1)(2008-12#1)
and strategic##8##2##(1991-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2009-10#1)
and strategies for the##2##4##(2012-12#1)(2013-8#1)
and strategies for##8##3##(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-8#1)
and strategies of##2##3##(2010-4#1)(2013-1#1)
and strategies to##2##3##(2008-11#1)(2013-1#1)
and strategies##20##2##(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2012-12#2)(2013-1#3)(2013-8#1)
and strategy##3##2##(1991-3#1)(1995-3#1)(2008-1#1)
and stratified##6##2##(1994-9#1)(2007-12#2)(2008-3#1)(2009-5#1)(2011-2#1)
and stratify##2##2##(1995-12#1)(2008-11#1)
and strawberry##6##2##(2008-10#6)
and stray##2##2##(1996-12#2)
and stream##3##2##(2008-10#2)(2009-8#1)
and streamwater##2##2##(2008-10#2)
and strength of##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
and strength##7##2##(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-10#1)(2013-1#1)
and strengthen##2##2##(2008-11#1)(2008-3#1)
and strengthening##6##2##(1991-3#1)(2011-2#1)(2013-1#1)(2013-8#3)
and strengths##2##2##(2008-1#1)(2008-3#1)
and streptavidin##2##2##(1990-12#1)(2008-9#1)
and streptokinase##2##2##(1993-8#1)(1995-6#1)
and stress fractures##2##3##(1991-11#2)
and stress response##5##3##(2008-7#1)(2009-8#1)(2010-11#1)(2012-3#2)
and stress##21##2##(1991-11#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2009-10#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-2#1)(2012-3#2)
and stress-induced##2##2##(2008-11#2)
and stretched##2##2##(2008-9#1)(2012-2#1)
and striatum##4##2##(1994-2#1)(1995-11#1)(1996-2#1)(2008-7#1)
and strictly##2##2##(1996-3#1)(2008-10#1)
and stride##2##2##(2010-8#1)(2013-1#1)
and stripe rust severity##2##4##(2008-10#2)
and stripe rust##8##3##(2008-10#8)
and stripe##9##2##(2008-10#9)
and stripping##8##2##(2008-10#8)
and stroke is##2##3##(2008-9#2)
and stroke prevention##2##3##(1993-9#1)(2008-8#1)
and stroke##9##2##(1991-6#1)(1993-9#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2011-2#1)(2013-1#1)
and stromal cell##3##3##(2008-11#1)(2010-3#1)(2012-3#1)
and stromal cells##5##3##(2008-11#1)(2009-3#1)(2011-2#3)
and stromal##10##2##(2008-11#3)(2009-3#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#1)
and strong##20##2##(1990-12#1)(1990-8#1)(1991-7#1)(1992-12#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-9#1)(2012-6#1)
and strongly inhibited##2##3##(1991-5#1)(2011-2#1)
and strongly##16##2##(1991-5#1)(1995-2#1)(1996-2#1)(2008-10#7)(2008-11#2)(2008-8#1)(2011-2#2)(2012-2#1)
and strontium##2##2##(2008-10#2)
and structural and##2##3##(2008-8#1)(2010-11#1)
and structural characteristics of##2##4##(2008-10#1)(2008-11#1)
and structural characteristics##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
and structural characterization of the##2##5##(1993-8#1)(2008-10#1)
and structural characterization of##3##4##(1993-8#1)(2008-10#2)
and structural characterization##4##3##(1993-8#1)(2008-10#3)
and structural equation modeling##2##4##(2008-12#1)(2010-6#1)
and structural factors##2##3##(1990-9#1)(2009-3#1)
and structural integrity##2##3##(2008-4#1)(2008-9#1)
and structural properties##2##3##(1991-6#1)(2007-8#1)
and structural stability##2##3##(2008-10#2)
and structural##40##2##(1990-9#1)(1991-12#1)(1991-6#2)(1992-3#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-11#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#2)(2010-6#2)(2011-1#1)(2012-2#1)(2013-8#2)
and structurally##3##2##(1995-6#1)(2007-12#1)(2008-10#1)
and structure of a##2##4##(1992-2#1)(2010-5#1)
and structure of the##8##4##(1993-2#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-12#1)
and structure of##16##3##(1991-11#1)(1992-2#1)(1993-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-5#1)
and structure##25##2##(1991-11#1)(1992-2#1)(1993-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
and structure-activity relationships of##2##4##(1992-6#1)(2008-10#1)
and structure-activity##3##2##(1992-6#1)(1994-3#1)(2008-10#1)
and structures##6##2##(1991-2#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-8#1)
and student evaluation##2##3##(2008-11#2)
and student nurses##2##3##(2008-11#1)(2008-12#1)
and student support##2##3##(2008-11#2)
and student##8##2##(1996-1#1)(2008-11#5)(2008-12#2)
and students from##2##3##(2008-10#1)(2008-12#1)
and students in##2##3##(2008-11#2)
and students with##3##3##(2008-12#1)(2013-1#2)
and students##16##2##(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-12#4)(2010-10#1)(2011-2#2)(2013-1#2)
and students'##2##2##(2008-12#2)
and studied by##2##3##(2008-10#1)(2008-5#1)
and studied for##3##3##(2008-10#3)
and studied in##2##3##(2008-10#1)(2009-9#1)
and studied its##4##3##(2008-9#2)(2012-3#2)
and studied the##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
and studied##23##2##(1995-3#1)(2008-10#8)(2008-5#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-3#3)(2013-8#1)
and studies on##2##3##(2008-10#1)(2008-11#1)
and studies##4##2##(2008-10#1)(2008-11#1)(2010-12#1)(2013-8#1)
and study of##6##3##(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)
and study on its##3##4##(2008-8#3)
and study the##2##3##(2008-10#1)(2008-3#1)
and study##18##2##(1992-2#1)(1994-9#1)(1996-3#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#1)(2010-1#1)(2011-1#1)
and studying##2##2##(1997-8#1)(2008-11#1)
and stunting##2##2##(2008-10#2)
and styles of##2##3##(2008-10#2)
and stylet##2##2##(2007-12#2)
and styrene##3##2##(1996-5#1)(2008-12#1)(2008-3#1)
and subadult##2##2##(1997-9#1)(2010-4#1)
and subcellular distribution of##2##4##(1995-6#1)(2008-10#1)
and subcellular distribution##4##3##(1995-6#1)(2008-10#1)(2008-9#2)
and subcellular localization of##2##4##(1996-2#1)(2008-7#1)
and subcellular localization##4##3##(1996-2#1)(1996-6#1)(2008-7#1)(2008-9#1)
and subcellular##9##2##(1995-6#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-7#1)(2008-9#3)
and subclavian artery##2##3##(2008-7#2)
and subclavian##7##2##(2008-12#3)(2008-7#2)(2011-2#2)
and subcutaneous##6##2##(1992-9#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-1#1)(2013-8#1)
and subdivided##2##2##(2008-10#1)(2010-5#1)
and subgroup II##2##3##(2008-10#2)
and subgroup##5##2##(1995-12#1)(2008-10#4)
and subgroups##5##2##(1993-2#1)(1997-1#1)(1997-2#1)(2008-10#2)
and subject##2##2##(1996-2#1)(2008-11#1)
and subjected to a##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
and subjected to the##2##4##(1993-8#1)(2008-10#1)
and subjected to##15##3##(1993-8#1)(1995-12#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-9#2)(2012-9#1)(2013-1#2)
and subjective health##2##3##(2008-7#2)
and subjective##20##2##(1991-1#1)(1991-8#1)(1993-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-10#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
and sublethal##2##2##(2008-10#2)
and submitted to##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
and submitted##4##2##(1992-12#1)(2008-10#2)(2008-7#1)
and submucosal##2##2##(1993-8#1)(1997-4#1)
and subnormal##2##2##(1990-9#1)(2008-1#1)
and suboccipital##2##2##(2008-7#1)(2010-9#1)
and subsequent activation of the##2##5##(2009-8#1)(2012-2#1)
and subsequent amplification of##2##4##(1997-6#1)(2008-9#1)
and subsequent analysis##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
and subsequent determination by##2##4##(2008-10#2)
and subsequent determination##3##3##(2008-10#3)
and subsequent development of##3##4##(2008-10#3)
and subsequent development##4##3##(1994-11#1)(2008-10#3)
and subsequent elution of##2##4##(2008-10#2)
and subsequent evaluation##3##3##(2008-12#1)(2008-4#1)(2012-3#1)
and subsequent liver##2##3##(1994-6#1)(2009-7#1)
and subsequent measurement##2##3##(2008-10#2)
and subsequent signal##2##3##(2008-10#1)(2011-2#1)
and subsequent treatment##2##3##(2008-10#1)(2008-11#1)
and subsequent##143##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-6#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#59)(2008-11#7)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
and subsequently analysed by##2##4##(1993-9#1)(2008-11#1)
and subsequently determined##2##3##(2008-10#2)
and subsequently in##2##3##(2008-10#1)(2008-12#1)
and subsequently measured by##2##4##(2007-11#1)(2008-10#1)
and subsequently measured##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
and subsequently reduce##2##3##(2008-10#1)(2013-8#1)
and subsequently separated##2##3##(2008-10#2)
and subsequently the##2##3##(2008-8#1)(2010-6#1)
and subsequently to##3##3##(2008-9#1)(2009-12#1)(2010-10#1)
and subsequently treated by##2##4##(1993-8#1)(2008-10#1)
and subsequently treated##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
and subsequently##64##2##(1991-2#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-5#2)(1995-6#1)(1996-9#1)(2007-11#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#1)(2010-10#1)(2010-6#2)(2012-12#1)(2012-2#1)(2013-8#1)
and subsidies##2##2##(1992-12#1)(2008-1#1)
and substance abuse##6##3##(1996-1#1)(1996-12#1)(1997-2#1)(2009-9#1)(2011-2#1)(2012-2#1)
and substance use##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
and substance##11##2##(1996-1#1)(1996-12#1)(1997-2#1)(2008-11#2)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and substances##3##2##(2008-10#2)(2010-1#1)
and substantial##3##2##(1995-2#1)(2008-8#1)(2013-8#1)
and substantially##4##2##(2008-10#2)(2009-6#1)(2012-12#1)
and substantiated##2##2##(2008-10#1)(2008-5#1)
and substituted##3##2##(1990-5#1)(2008-10#1)(2011-2#1)
and substrate##14##2##(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(2008-10#2)(2008-5#2)(2008-7#4)(2011-1#1)(2011-2#1)
and subsurface drip##2##3##(2008-10#2)
and subsurface-drip irrigation##3##3##(2008-10#3)
and subsurface-drip##4##2##(2008-10#4)
and subtotal##3##2##(2010-12#1)(2011-2#2)
and success##2##2##(1992-2#1)(2008-9#1)
and successful thought suppression##2##4##(2012-3#2)
and successful treatment##2##3##(2008-7#1)(2013-7#1)
and successful##17##2##(1992-3#1)(1996-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
and successfully applied to the determination of##2##7##(2008-10#2)
and successfully applied to the##3##5##(2008-10#3)
and successfully applied to##4##4##(2008-10#4)
and successfully applied##5##3##(2008-10#5)
and successfully used##2##3##(2008-10#1)(2008-11#1)
and successfully##22##2##(1990-12#1)(1991-1#1)(1992-3#1)(1994-5#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2011-2#1)
and successive##2##2##(1991-3#1)(2010-6#1)
and succinic acids##2##3##(2008-10#2)
and succinic##3##2##(2008-10#3)
and such a##2##3##(1990-11#1)(1992-2#1)
and such association##2##3##(2008-10#1)(2008-9#1)
and such##10##2##(1990-11#1)(1992-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#3)
and sucrose synthase##2##3##(2011-2#2)
and sucrose##11##2##(1991-5#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#1)
and sudden cardiac death##2##4##(2008-12#1)(2009-10#1)
and sudden death##4##3##(2008-1#1)(2010-12#1)(2011-2#1)(2012-12#1)
and sudden##9##2##(2008-1#1)(2008-12#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
and suffering##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
and sufficient for##4##3##(1991-2#2)(2008-10#1)(2009-10#1)
and sufficient##14##2##(1991-2#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)
and sufficiently##2##2##(2008-10#1)(2010-4#1)
and sugar beet##5##3##(2008-10#5)
and sugar##8##2##(1997-8#1)(2008-10#6)(2013-1#1)
and sugars##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and suggest a role for##2##5##(1997-1#1)(2008-10#1)
and suggest a##7##3##(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-7#1)(2012-2#1)
and suggest how##2##3##(2008-12#1)(2008-8#1)
and suggest strategies##2##3##(1991-11#1)(2008-12#1)
and suggest that it##2##4##(2008-10#2)
and suggest that the##10##4##(1995-11#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2012-2#1)
and suggest that these##2##4##(1994-6#1)(1995-5#1)
and suggest that##50##3##(1990-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-5#1)(1995-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#2)(2010-10#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#3)
and suggest the##3##3##(1990-8#1)(1994-3#1)(2008-9#1)
and suggest##76##2##(1990-11#1)(1990-8#1)(1991-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#2)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#14)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
and suggested a##2##3##(2008-10#1)(2009-8#1)
and suggested that##4##3##(1997-8#1)(2008-11#1)(2008-8#1)(2011-1#1)
and suggested##14##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and suggestions are##2##3##(2008-12#2)
and suggestions for future research are##2##6##(2008-4#1)(2009-5#1)
and suggestions for future research##3##5##(2008-4#1)(2009-11#1)(2009-5#1)
and suggestions for##8##3##(1991-2#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-11#2)(2010-2#1)(2012-3#1)
and suggestions##14##2##(1991-2#1)(1994-3#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-8#1)(2012-3#1)
and suggestive##2##2##(2013-8#2)
and suggests a##3##3##(1993-8#1)(1996-1#1)(2010-7#1)
and suggests that the##3##4##(1991-7#1)(1994-2#1)(2008-11#1)
and suggests that they##2##4##(1997-2#1)(2008-7#1)
and suggests that##12##3##(1991-7#1)(1993-3#1)(1994-2#1)(1997-2#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)
and suggests the##2##3##(2008-10#2)
and suggests ways to##2##4##(1993-12#1)(2008-11#1)
and suggests##29##2##(1991-7#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
and suicidal##3##2##(2008-11#2)(2010-7#1)
and suicide##2##2##(1991-10#1)(2013-1#1)
and suitability of the habitat##2##5##(2008-10#2)
and suitability of the##3##4##(2008-10#2)(2009-8#1)
and suitable for##10##3##(1990-12#1)(1990-2#1)(1993-6#1)(2008-10#7)
and suitable##16##2##(1990-12#1)(1990-2#1)(1993-6#1)(2008-10#11)(2008-11#1)(2008-8#1)
and sulfate ions##2##3##(2008-10#2)
and sulfate##6##2##(1992-3#1)(2008-10#4)(2013-1#1)
and sulfate)##3##2##(2008-10#3)
and sulfhydryl##3##2##(1992-9#1)(2009-8#1)(2013-1#1)
and sulfide##4##2##(2008-10#4)
and sulfides##2##2##(2008-10#2)
and sulfite##2##2##(2008-10#2)
and sulfur dioxide##3##3##(2008-10#3)
and sulfur##5##2##(2008-10#3)(2010-11#2)
and sulphonic##3##2##(2008-10#3)
and sulphur##2##2##(2008-10#2)
and sulphuric acids##2##3##(2008-10#2)
and sulphuric##3##2##(2008-10#3)
and sum##2##2##(1994-9#1)(2008-10#1)
and summarizes the##2##3##(2008-6#1)(2013-1#1)
and summarizes##6##2##(1995-3#2)(2008-10#1)(2008-6#1)(2013-1#2)
and summary##5##2##(2008-11#3)(2008-7#1)(2008-9#1)
and sun##2##2##(1991-6#1)(2008-4#1)
and sunflower oil##2##3##(2013-1#2)
and sunflower##3##2##(2008-10#1)(2013-1#2)
and sunset##2##2##(2008-10#2)
and superficial##8##2##(1990-6#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
and superior##8##2##(1996-12#1)(1996-2#1)(2008-11#2)(2008-7#1)(2010-11#1)(2010-9#1)(2013-8#1)
and superoxide##2##2##(2008-10#2)
and supervised learning methods##2##4##(2008-10#2)
and supervised##3##2##(2008-10#3)
and supervision##2##2##(1991-2#2)
and supplemental##2##2##(2008-10#1)(2012-12#1)
and supplemented##5##2##(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
and supplies##2##2##(1997-6#1)(2011-2#1)
and supply##2##2##(1993-3#1)(2011-2#1)
and support for##5##3##(1994-3#1)(1996-3#1)(1997-3#1)(2008-11#1)(2013-8#1)
and support in##2##3##(2008-12#1)(2009-6#1)
and support staff##2##3##(1995-12#1)(1996-1#1)
and support the##5##3##(1993-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
and support to##2##3##(1997-7#1)(2009-5#1)
and support##40##2##(1991-1#2)(1992-2#1)(1992-3#1)(1993-8#1)(1994-3#2)(1994-8#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-12#5)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
and supported the##2##3##(2008-10#1)(2008-11#1)
and supported##10##2##(1993-2#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-8#1)
and supporting electrolyte##4##3##(2008-10#4)
and supporting##11##2##(1991-5#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-11#2)(2009-10#1)
and supportive##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
and supports the##6##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)
and supports##13##2##(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)
and suppressed by##2##3##(1993-3#1)(1993-6#1)
and suppressed the##5##3##(1994-8#1)(2008-11#2)(2011-2#2)
and suppressed##17##2##(1993-3#1)(1993-6#1)(1994-8#1)(2008-10#5)(2008-11#4)(2011-2#3)(2012-2#1)(2013-1#1)
and suppresses##2##2##(1995-2#1)(2009-10#1)
and suppressing##2##2##(2008-10#2)
and suppression of##4##3##(1990-5#1)(1997-2#1)(2008-10#1)(2008-9#1)
and suppression##7##2##(1990-5#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-9#1)(2012-3#2)
and supraoptic##3##2##(1996-12#2)(2008-8#1)
and surface EMG##2##3##(2011-2#1)(2012-2#1)
and surface area##3##3##(2008-10#2)(2008-5#1)
and surface charge##2##3##(2008-10#1)(2008-5#1)
and surface morphology##2##3##(2008-5#1)(2009-7#1)
and surface properties##2##3##(2008-10#1)(2008-3#1)
and surface water##2##3##(2008-10#2)
and surface##39##2##(1990-4#1)(1992-3#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#18)(2008-3#3)(2008-5#4)(2009-3#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
and surface-enhanced Raman scattering (SERS)##2##5##(2008-10#2)
and surfactant##6##2##(1994-3#1)(1996-5#1)(2008-10#3)(2010-5#1)
and surfactants##2##2##(2008-10#2)
and surgery are##2##3##(2011-2#1)(2013-1#1)
and surgery for##5##3##(1994-9#1)(1996-6#1)(1996-9#1)(2008-10#1)(2010-12#1)
and surgery was performed##2##4##(2008-10#1)(2011-2#1)
and surgery was##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
and surgery##13##2##(1994-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(2008-10#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
and surgical debridement##2##3##(2007-11#1)(2010-6#1)
and surgical management is##2##4##(2008-7#1)(2011-2#1)
and surgical management of##3##4##(2008-8#1)(2012-3#2)
and surgical management##5##3##(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#2)
and surgical outcomes##2##3##(1993-12#1)(2008-10#1)
and surgical therapy]##2##3##(1997-6#2)
and surgical treatment##9##3##(1990-9#1)(1993-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-3#1)
and surgical##55##2##(1990-3#1)(1990-9#2)(1993-12#3)(1993-3#1)(1993-6#2)(1996-9#1)(1997-5#1)(1997-6#2)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#6)(2012-3#5)(2013-1#1)
and surgically##2##2##(2009-10#1)(2013-1#1)
and surprisingly##2##2##(1997-9#1)(2008-11#1)
and surrogate##3##2##(2008-10#1)(2010-4#1)(2011-7#1)
and surrounded##2##2##(2007-12#1)(2011-2#1)
and surrounding solvent molecules)##2##4##(2008-10#2)
and surrounding##15##2##(1994-2#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-6#1)
and surveillance of##4##3##(1991-11#2)(2008-10#1)(2012-12#1)
and surveillance systems##2##3##(1997-3#2)
and surveillance##13##2##(1991-11#2)(1997-3#2)(2008-1#1)(2008-10#2)(2008-12#1)(2009-12#2)(2010-8#1)(2011-2#1)(2012-12#1)
and survey results##2##3##(2008-11#2)
and survey##3##2##(1995-2#1)(2008-11#2)
and surveys##2##2##(2009-5#1)(2013-1#1)
and survival in##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
and survival of neurons##2##4##(1993-3#1)(2013-8#1)
and survival of the##5##4##(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
and survival of##18##3##(1993-3#1)(1994-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and survival was##2##3##(1992-12#1)(2012-3#1)
and survival##50##2##(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#6)(2013-8#3)
and survive##2##2##(2008-10#2)
and survived##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
and survivin in superficial urothelial carcinoma##2##6##(2011-2#2)
and survivin in##3##3##(2011-2#3)
and survivin##9##2##(2011-2#9)
and survivorship of##2##3##(2013-1#2)
and survivorship##4##2##(2008-8#1)(2013-1#3)
and susceptibility to##9##3##(1992-2#1)(1992-6#1)(1995-6#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)
and susceptibility##12##2##(1992-2#1)(1992-6#1)(1995-6#1)(2008-10#5)(2008-8#1)(2011-2#2)(2012-3#1)
and susceptible cultivars##4##3##(2008-10#4)
and susceptible cv##2##3##(2008-10#2)
and susceptible inbred##2##3##(2008-10#2)
and susceptible to##4##3##(2008-10#3)(2008-11#1)
and susceptible##40##2##(1996-12#1)(2008-10#35)(2008-11#1)(2011-10#1)(2012-3#1)(2013-1#1)
and suspension##7##2##(2008-10#2)(2008-11#4)(2008-5#1)
and suspension)##2##2##(2008-10#2)
and sustainability##3##2##(2008-8#1)(2009-8#1)(2013-1#1)
and sustainable##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-7#1)
and sustained suppression##2##3##(2009-8#1)(2013-1#1)
and sustained##9##2##(1990-3#1)(1991-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#1)
and sustaining##4##2##(1992-3#1)(2008-1#1)(2008-11#1)(2013-1#1)
and sweat##2##2##(2008-5#2)
and sweet##4##2##(2008-10#4)
and swelling of##2##3##(2008-7#1)(2013-1#1)
and swelling##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
and swept##2##2##(2008-10#2)
and switch providers##2##3##(1993-12#2)
and swollen##2##2##(1997-5#1)(2008-10#1)
and sycamore##2##2##(2008-10#2)
and sylvestrene##2##2##(2008-11#2)
and symbiotic##2##2##(2008-10#1)(2008-8#1)
and symbolic##2##2##(2010-4#1)(2013-8#1)
and symmetric##2##2##(2008-10#1)(2009-7#1)
and sympatric##2##2##(2008-8#1)(2012-3#1)
and symptom development##4##3##(2008-10#3)(2008-9#1)
and symptom##8##2##(1996-1#1)(2008-10#5)(2008-9#1)(2009-1#1)
and symptomatic##7##2##(1994-12#1)(2008-10#3)(2009-7#1)(2011-2#2)
and symptomatology##4##2##(1990-9#1)(2008-10#3)
and symptomless##2##2##(2008-10#2)
and symptoms of##14##3##(1992-1#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2010-2#1)(2011-1#1)(2011-2#4)(2012-7#1)
and symptoms##39##2##(1991-8#1)(1992-1#1)(1992-5#1)(1997-2#1)(1997-8#3)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-3#2)(2012-7#1)(2013-1#3)
and synaptic##10##2##(1996-12#1)(1997-2#1)(1997-3#2)(2008-11#2)(2008-6#1)(2008-7#1)(2009-9#1)(2012-3#1)
and synchronization##2##2##(1996-2#1)(2008-11#1)
and synchronized##2##2##(2008-4#1)(2011-2#1)
and synchronous chemo-radiotherapy##2##3##(1990-6#2)
and synchronous##5##2##(1990-6#2)(1995-9#1)(2008-10#2)
and synchrony##2##2##(2009-8#1)(2013-8#1)
and syndesmotic##2##2##(2009-3#2)
and synergistic##3##2##(1995-5#1)(2008-10#1)(2009-3#1)
and synovial fluid##3##3##(1992-8#1)(1994-8#1)(2013-8#1)
and synovial##5##2##(1992-8#1)(1994-8#1)(2008-12#1)(2011-2#1)(2013-8#1)
and syntax##3##2##(2008-12#2)(2008-9#1)
and synthesis of##8##3##(1992-12#1)(1994-3#1)(1997-1#2)(2008-11#1)(2008-9#1)(2009-6#1)(2011-3#1)
and synthesis##13##2##(1991-5#1)(1992-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-1#3)(2008-11#1)(2008-9#2)(2009-6#1)(2011-3#1)
and synthesizing##3##2##(2008-4#2)(2008-9#1)
and synthetic mixtures of##2##4##(2008-10#2)
and synthetic mixtures##3##3##(2008-10#3)
and synthetic samples##3##3##(2008-10#3)
and synthetic##27##2##(1996-12#1)(2008-10#16)(2008-11#3)(2008-2#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and system##6##2##(1990-12#1)(1991-1#1)(1993-2#1)(1994-2#1)(2008-10#1)(2008-7#1)
and systematic errors in##2##4##(2007-12#1)(2008-6#1)
and systematic errors##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
and systematic##10##2##(2007-12#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-8#1)(2013-1#1)
and systemic effects##4##3##(1997-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
and systemic lupus erythematosus##2##4##(1990-9#1)(1997-8#1)
and systemic therapy##3##3##(1991-8#1)(1997-8#1)(2012-3#1)
and systemic##49##2##(1990-9#1)(1991-8#2)(1992-2#1)(1992-3#3)(1994-2#1)(1995-5#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-8#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#11)(2012-3#1)(2013-1#3)
and systemically in##2##3##(2008-10#1)(2008-8#1)
and systemically##7##2##(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#2)(2013-8#1)
and systems biological##2##3##(2008-10#1)(2012-2#1)
and systems for##2##3##(1994-1#1)(2010-7#1)
and systems of##3##3##(1992-4#2)(2008-11#1)
and systems##20##2##(1992-4#2)(1993-3#1)(1994-1#2)(1995-1#1)(1997-1#2)(2008-10#2)(2008-11#1)(2009-8#1)(2010-7#1)(2012-2#4)(2012-3#2)(2013-8#1)
and systems-driven##2##2##(2013-8#2)
and systolic blood pressure##3##4##(2008-10#1)(2011-1#1)(2012-3#1)
and systolic##5##2##(2008-10#1)(2008-12#2)(2011-1#1)(2012-3#1)
and t(0)##2##2##(2008-10#2)
and t(1/2) values &lt##2##4##(2008-10#2)
and t(1/2)##3##2##(2008-10#3)
and t-test##2##2##(1990-12#1)(2008-10#1)
and tRNA genes##2##3##(1996-6#1)(2012-3#1)
and tRNA##3##2##(1993-8#1)(1996-6#1)(2012-3#1)
and tables##2##2##(1994-6#1)(2008-11#1)
and tablets##3##2##(2008-10#3)
and tactics##3##2##(1993-12#1)(1994-12#1)(2013-1#1)
and tail##4##2##(1997-7#1)(2008-7#1)(2008-8#1)(2010-1#1)
and tailoring##3##2##(1994-3#1)(2008-6#1)(2010-12#1)
and take##4##2##(1995-6#1)(2008-11#1)(2008-8#1)(2013-1#1)
and taken##2##2##(2008-5#1)(2012-3#1)
and takes##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
and taking medication##2##3##(2008-7#2)
and taking##6##2##(1997-3#1)(2008-11#1)(2008-7#3)(2010-4#1)
and talking##2##2##(1992-3#1)(2011-2#1)
and tall fescue##3##3##(2008-10#3)
and tamoxifen##3##2##(1993-11#1)(2011-2#2)
and tan##2##2##(2008-10#2)
and tandem mass spectrometry##3##4##(2008-10#2)(2008-8#1)
and tandem##6##2##(2008-10#3)(2008-12#1)(2008-8#1)(2012-12#1)
and tangerine x grapefruit##2##4##(2008-10#2)
and tangible##3##2##(1991-3#1)(2013-1#2)
and tantalum##3##2##(2008-10#2)(2009-7#1)
and tap water and##3##4##(2008-10#3)
and tap water samples##10##4##(2008-10#10)
and tap water##17##3##(2008-10#17)
and tap##20##2##(2008-10#20)
and target organ##2##3##(2008-7#1)(2009-1#1)
and target##20##2##(1990-12#3)(1994-2#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)
and targeted##8##2##(1995-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)(2011-3#1)
and targeting##4##2##(2009-12#1)(2010-5#1)(2011-2#2)
and targets##4##2##(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
and tartaric acid##5##3##(2008-10#5)
and task##5##2##(1991-3#1)(2008-12#1)(2009-10#1)(2012-3#1)(2013-1#1)
and tasks##2##2##(1994-3#1)(1996-11#1)
and taste##2##2##(2008-10#1)(2009-10#1)
and tax##2##2##(1991-3#1)(1994-3#1)
and taxonomic##2##2##(2007-12#1)(2008-8#1)
and taxonomy##2##2##(2008-10#1)(2013-1#1)
and tea samples##4##3##(2008-10#4)
and tea##8##2##(2008-10#7)(2008-11#1)
and teacher##3##2##(2008-12#2)(2010-8#1)
and teachers##8##2##(2008-10#1)(2008-11#1)(2008-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
and teachers'##2##2##(2009-7#2)
and teachers)##2##2##(2009-7#1)(2010-1#1)
and teaching##8##2##(2008-11#4)(2008-12#2)(2010-1#1)(2010-10#1)
and team##3##2##(1992-5#1)(1994-1#1)(2010-10#1)
and tears##2##2##(1992-6#1)(2011-2#1)
and technical issues##2##3##(2010-4#1)(2011-2#1)
and technical##20##2##(1991-3#2)(1992-3#1)(1993-12#1)(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-2#1)(2013-1#2)
and technicians##2##2##(1994-12#1)(2012-2#1)
and technique##5##2##(1997-3#1)(2008-12#1)(2011-2#2)(2013-1#1)
and techniques in##4##3##(1993-2#1)(2007-12#1)(2008-12#1)(2009-3#1)
and techniques of##2##3##(2008-10#1)(2011-2#1)
and techniques that##2##3##(2011-2#2)
and techniques##17##2##(1992-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#3)
and technological##4##2##(2008-11#1)(2009-4#1)(2011-1#1)(2012-2#1)
and technologies##6##2##(2008-11#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-10#1)(2013-8#1)
and technologists##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
and technology in##2##3##(1994-12#1)(2010-11#1)
and technology##15##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1997-7#1)(2008-11#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-9#3)(2011-1#1)
and teflon##2##2##(2008-10#2)
and teicoplanin##4##2##(2008-10#4)
and telecare##2##2##(1996-2#1)(2013-8#1)
and telomerase##4##2##(2008-11#4)
and telomere length in##2##4##(2008-11#1)(2012-3#1)
and telomere length##3##3##(2008-11#1)(2012-3#2)
and telomere##4##2##(2008-11#2)(2012-3#2)
and temperate##2##2##(2008-10#1)(2012-2#1)
and temperature are##3##3##(2008-10#3)
and temperature can##2##3##(2008-10#1)(2008-11#1)
and temperature conditions##4##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
and temperature dependence##3##3##(1992-3#1)(2008-10#1)(2008-2#1)
and temperature dependent##2##3##(1994-8#1)(2008-11#1)
and temperature effects##2##3##(2008-10#1)(2008-11#1)
and temperature for##2##3##(2008-10#1)(2008-3#1)
and temperature measurements##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and temperature of##2##3##(2008-10#2)
and temperature on the##4##4##(1997-2#1)(2008-10#3)
and temperature on##13##3##(1997-2#1)(2008-10#8)(2008-11#1)(2009-7#1)(2009-8#1)(2010-4#1)
and temperature profiles##2##3##(1996-12#1)(2008-3#1)
and temperature was observed##2##4##(2008-10#2)
and temperature was##3##3##(2008-10#3)
and temperature were optimized##2##4##(2008-10#2)
and temperature were##6##3##(2008-10#6)
and temperature##94##2##(1990-5#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-2#2)(2007-12#4)(2008-10#49)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#7)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2012-6#1)
and temperature)##4##2##(2008-10#3)(2008-7#1)
and temperature-dependent##2##2##(1990-2#1)(2008-8#1)
and temperature-dispersion equations##2##3##(2008-3#2)
and temperatures##2##2##(2008-3#1)(2009-7#1)
and temporal analyses##2##3##(2008-10#2)
and temporal changes in##3##4##(2008-10#1)(2008-11#1)(2010-4#1)
and temporal characteristics##3##3##(2008-10#1)(2008-8#2)
and temporal distribution of##3##4##(2008-10#3)
and temporal dynamics of##2##4##(2008-10#1)(2009-8#1)
and temporal dynamics##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
and temporal patterns of##2##4##(2008-10#1)(2008-11#1)
and temporal patterns##3##3##(2008-10#2)(2008-11#1)
and temporal variability of##3##4##(1992-9#2)(2008-10#1)
and temporal variability##4##3##(1992-9#3)(2008-10#1)
and temporal variations##2##3##(2008-5#2)
and temporal##58##2##(1992-9#3)(1993-9#1)(1994-9#3)(1995-5#1)(1996-12#1)(1996-6#1)(1997-8#5)(2008-10#18)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
and temporally resolved##2##3##(2008-2#2)
and temporally varying##2##3##(2008-8#1)(2008-9#1)
and temporally##10##2##(1994-2#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#1)
and temporary##3##2##(1994-8#1)(1994-9#1)(2010-6#1)
and ten##8##2##(1994-12#1)(1997-8#1)(2008-12#3)(2008-7#1)(2012-12#1)(2013-1#1)
and tend to##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
and tended to##2##3##(2008-10#1)(2011-2#1)
and tendency##2##2##(1990-12#1)(2008-5#1)
and tender##2##2##(2008-10#1)(2010-11#1)
and tendon##3##2##(1997-3#1)(2008-12#1)(2009-7#1)
and tends to be##2##4##(2009-8#1)(2013-1#1)
and tends to##3##3##(2008-9#1)(2009-8#1)(2013-1#1)
and tens of##2##3##(1991-2#1)(2008-10#1)
and tensile##4##2##(2008-9#1)(2009-7#3)
and terminal##8##2##(1992-12#1)(1993-11#2)(1994-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-8#1)
and terminals##3##2##(1992-3#1)(1997-3#2)
and termination##2##2##(2008-11#1)(2008-4#1)
and terminology##3##2##(1992-3#1)(2011-2#1)(2012-2#1)
and ternary complexes of##2##4##(2008-10#2)
and ternary complexes##4##3##(2008-10#4)
and ternary mixtures##4##3##(2008-10#4)
and ternary##10##2##(2008-10#10)
and territory##2##2##(2008-8#2)
and terror##3##2##(1990-6#1)(2009-10#2)
and tert-butylhydroquinone##2##2##(2008-10#2)
and tertiary structural##2##3##(1994-5#2)
and tertiary structure##6##3##(2008-10#1)(2008-4#3)(2008-9#2)
and tertiary##13##2##(1990-6#1)(1993-2#1)(1994-5#2)(1995-1#1)(1995-12#1)(2008-10#2)(2008-4#3)(2008-9#2)
and test its predictions using data from##2##7##(2008-8#2)
and test solution pH##2##4##(2008-10#2)
and test##14##2##(1991-2#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#1)(2012-3#1)
and tested a##2##3##(2008-10#1)(2008-3#1)
and tested by##2##3##(2007-12#1)(2008-8#1)
and tested for the##3##4##(2008-10#3)
and tested for their##3##4##(1993-3#1)(2008-10#1)(2011-2#1)
and tested for##16##3##(1993-3#1)(2008-10#12)(2008-7#1)(2009-7#1)(2011-2#1)
and tested in a##2##4##(2008-10#1)(2008-5#1)
and tested in vitro##2##4##(2008-3#1)(2008-8#1)
and tested in##8##3##(1993-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)
and tested on##2##3##(2008-10#2)
and tested to##2##3##(1992-2#1)(2008-10#1)
and tested using##3##3##(2008-10#3)
and tested##70##2##(1992-2#1)(1993-2#1)(1993-3#3)(1996-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#34)(2008-11#2)(2008-2#2)(2008-3#9)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2011-2#4)(2012-2#1)(2012-3#1)
and testes##2##2##(1995-2#1)(2008-10#1)
and testicular self-exam##2##3##(2009-5#2)
and testicular##5##2##(1992-12#1)(1994-5#1)(2009-10#1)(2009-5#2)
and testified##2##2##(2008-10#1)(2008-8#1)
and testing a##2##3##(1997-3#1)(2008-10#1)
and testing for##3##3##(1993-6#1)(2008-11#1)(2013-1#1)
and testing of a##3##4##(1996-2#1)(2008-10#1)(2008-3#1)
and testing of the##2##4##(2008-10#1)(2010-10#1)
and testing of##11##3##(1995-6#1)(1996-2#2)(2008-10#2)(2008-3#1)(2008-4#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)
and testing the##2##3##(2010-8#2)
and testing##26##2##(1993-6#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-2#2)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2009-4#1)(2009-8#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
and testis##5##2##(1992-6#1)(1994-11#1)(1997-8#1)(2008-8#2)
and testosterone##3##2##(1990-11#1)(1994-2#1)(1994-3#1)
and tests for##3##3##(1996-2#1)(2008-7#1)(2012-3#1)
and tests##4##2##(1994-9#1)(1996-2#1)(2008-7#1)(2012-3#1)
and tetanus##3##2##(1995-3#1)(1995-5#1)(2011-2#1)
and tetrabromophthalic anhydride##2##3##(2008-10#2)
and tetrabutylammonium##2##2##(2008-10#1)(2009-5#1)
and tetracycline##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
and tetradecyldimethylbenzylammonium chloride##3##3##(2008-10#3)
and tetraiodofluorescein##2##2##(2008-10#2)
and tetramerization properties##2##3##(1993-8#2)
and tetraploid##2##2##(2008-10#1)(2008-11#1)
and text##2##2##(2008-10#1)(2008-11#1)
and textile##2##2##(2008-10#1)(2012-2#1)
and thalamus##2##2##(1996-12#1)(2008-7#1)
and thalassemia##2##2##(2008-10#1)(2013-1#1)
and thallium##11##2##(2008-10#11)
and thapsigargin##2##2##(1994-3#1)(1996-5#1)
and that &quot##2##3##(1991-3#1)(2008-9#1)
and that Cx43 transfection##2##4##(2008-11#2)
and that T##2##3##(2008-10#1)(2008-6#1)
and that a##13##3##(1990-2#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)
and that all three##2##4##(2008-10#1)(2008-8#1)
and that all##3##3##(2008-10#1)(2008-8#1)(2010-3#1)
and that an##3##3##(2008-10#1)(2008-9#1)(2010-4#1)
and that appear##2##3##(1993-3#1)(2009-10#1)
and that are##3##3##(2009-8#1)(2011-1#1)(2012-3#1)
and that both##3##3##(1991-10#1)(2008-10#2)
and that can##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
and that cell##2##3##(1992-6#1)(2008-11#1)
and that changes in##3##4##(1994-8#1)(2008-10#1)(2010-5#1)
and that difference was statistically significant##3##6##(2011-2#3)
and that differences##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
and that down-regulation of##2##4##(2008-11#1)(2011-2#1)
and that for the##2##4##(1996-12#1)(2008-10#1)
and that for##4##3##(1996-12#1)(2008-10#2)(2011-2#1)
and that in vitro##2##4##(2008-5#2)
and that in##4##3##(2008-10#1)(2008-12#1)(2008-5#2)
and that increased##2##3##(1995-6#1)(2008-11#1)
and that inhibition##2##3##(1994-8#1)(2008-11#1)
and that is##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
and that it has##2##4##(1990-12#1)(2008-7#1)
and that it is not##2##5##(2008-10#1)(2010-8#1)
and that it is##6##4##(1990-3#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-8#1)(2010-8#1)
and that it may be##2##5##(2008-10#1)(2008-11#1)
and that it may##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
and that it will be##2##5##(1996-8#1)(2008-8#1)
and that it##24##3##(1990-12#1)(1990-3#1)(1992-12#1)(1994-3#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)
and that its##5##3##(1995-11#1)(1995-2#1)(2008-12#1)(2011-1#1)(2012-3#1)
and that low doses actually reduce risk##2##7##(2008-7#2)
and that many of##2##4##(2008-7#1)(2009-8#1)
and that many##3##3##(1990-2#1)(2008-7#1)(2009-8#1)
and that most##2##3##(2008-10#1)(2008-11#1)
and that obtained##2##3##(2008-10#2)
and that of the##10##4##(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
and that of##33##3##(1991-12#1)(1991-5#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
and that our##2##3##(1991-12#1)(2008-5#1)
and that physicians rely primarily on direct experience for the information necessary to make a referral choice##2##17##(1994-1#2)
and that reduced##2##3##(1992-12#1)(2012-2#1)
and that requires##2##3##(1993-2#1)(2011-2#1)
and that sexual recombination##2##4##(2008-10#2)
and that sexual##3##3##(2008-10#2)(2012-3#1)
and that specific##3##3##(1992-3#1)(2008-10#1)(2012-12#1)
and that the best##2##4##(2008-10#1)(2011-2#1)
and that the male##2##4##(2008-8#1)(2010-5#1)
and that the mechanism of##2##5##(1990-2#1)(2013-8#1)
and that the new##2##4##(2008-11#1)(2009-6#1)
and that the three##2##4##(1995-6#1)(2008-10#1)
and that the two##3##4##(1990-5#1)(1996-2#1)(2008-10#1)
and that the use of##2##5##(2008-10#1)(2010-5#1)
and that the##132##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-2#3)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-11#1)(2008-10#31)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-5#2)(2010-7#2)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
and that their##3##3##(1997-2#1)(2008-10#1)(2008-6#1)
and that there is##2##4##(2008-11#1)(2012-2#1)
and that there##7##3##(1997-6#1)(2008-1#1)(2008-11#2)(2008-9#1)(2012-2#1)(2012-3#1)
and that these factors##2##4##(2008-10#1)(2012-3#1)
and that these##21##3##(1990-5#1)(1990-6#1)(1990-8#1)(1992-3#2)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
and that they could##2##4##(1996-9#1)(2008-9#1)
and that they may##2##4##(2008-5#1)(2010-5#1)
and that they were##3##4##(2008-11#2)(2008-9#1)
and that they##13##3##(1994-3#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#2)(2009-8#1)(2010-5#1)
and that this effect##3##4##(2008-7#1)(2009-4#1)(2011-2#1)
and that this increased##3##4##(1994-5#1)(2008-10#1)(2008-7#1)
and that this property##2##4##(2008-5#1)(2008-7#1)
and that this##26##3##(1994-12#2)(1994-2#1)(1994-5#1)(1995-12#2)(1995-6#1)(2006-6#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
and that treatment##2##3##(1992-9#1)(1995-2#1)
and that two of##2##4##(2008-10#1)(2012-3#1)
and that two##4##3##(1993-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
and that various##2##3##(2008-12#2)
and that we##2##3##(2008-8#1)(2010-11#1)
and that which is##2##4##(1993-8#1)(2008-11#1)
and that##612##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#6)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#8)(1995-3#1)(1995-5#1)(1995-6#8)(1995-8#3)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#7)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#3)(2008-10#127)(2008-11#54)(2008-12#13)(2008-2#1)(2008-3#12)(2008-4#4)(2008-5#20)(2008-6#3)(2008-7#21)(2008-8#37)(2008-9#22)(2009-10#6)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#11)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#6)(2010-8#1)(2011-1#7)(2011-10#1)(2011-2#22)(2011-3#1)(2012-12#1)(2012-2#13)(2012-3#19)(2013-1#8)(2013-8#4)
and thawing##10##2##(1994-11#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#2)
and the &quot##3##3##(2008-11#1)(2008-8#1)(2009-6#1)
and the 1##3##3##(2008-10#2)(2012-2#1)
and the 2##4##3##(1990-9#1)(2008-10#2)(2011-2#1)
and the 20##2##3##(2008-10#2)
and the 3' NCR##2##4##(2008-9#2)
and the 3' untranslated region##2##5##(1991-9#1)(2008-10#1)
and the 3'##8##3##(1991-9#1)(1996-6#1)(2008-10#4)(2008-9#2)
and the 30th##2##3##(1995-8#1)(2008-5#1)
and the 3sigma detection limit##2##5##(2008-10#2)
and the 4##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
and the 5##3##3##(2008-10#2)(2008-12#1)
and the 5'##5##3##(1996-8#1)(2008-10#1)(2008-8#3)
and the 5-year disease-free survival rate was##2##7##(1997-7#2)
and the A##2##3##(2008-9#1)(2010-7#1)
and the AD cases##2##4##(1991-1#2)
and the ANN##2##3##(2008-10#2)
and the ATPase##2##3##(1995-6#1)(2006-6#1)
and the Alb method##2##4##(2008-7#2)
and the American Association##2##4##(1991-1#1)(2008-1#1)
and the American##7##3##(1991-1#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-6#1)(2008-1#1)
and the Americas##3##3##(2008-10#3)
and the Ar##2##3##(2008-10#2)
and the Association##2##3##(2008-10#1)(2012-3#1)
and the C-terminal##6##3##(1993-2#1)(1993-8#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-9#1)
and the CH(3)##2##3##(2008-10#2)
and the CL##2##3##(2008-10#2)
and the CP##2##3##(2008-10#1)(2008-8#1)
and the California##2##3##(1995-12#1)(2008-11#1)
and the Caribbean Basin##3##4##(2008-10#3)
and the Caribbean##6##3##(1991-3#1)(2008-10#3)(2008-11#1)(2008-5#1)
and the Carolinas##2##3##(2008-8#2)
and the Caucasus##5##3##(2008-10#5)
and the Child##2##3##(1993-1#1)(2008-9#1)
and the Chinese##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
and the Czech Republic##2##4##(2008-11#1)(2008-5#1)
and the DNA##4##3##(1995-6#1)(2008-10#2)(2008-4#1)
and the Department of##2##4##(2007-8#1)(2008-11#1)
and the District of Columbia##2##5##(1997-1#1)(2010-5#1)
and the Dominican Republic##3##4##(2008-10#2)(2008-11#1)
and the Environmental##2##3##(1992-1#1)(2008-11#1)
and the European##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
and the F(1)##2##3##(2008-10#2)
and the FLACC##2##3##(2012-2#2)
and the Fano factor##2##4##(2010-10#2)
and the Food##2##3##(2010-9#1)(2012-2#1)
and the Fourier##2##3##(2008-3#2)
and the G1/G2##2##3##(2008-10#2)
and the GAB##2##3##(2008-10#2)
and the Global Assessment##2##4##(2008-11#1)(2011-1#1)
and the Global##5##3##(1991-2#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
and the Golgi##2##3##(2008-11#1)(2009-8#1)
and the Group Benefit Questionnaire##2##5##(2013-1#2)
and the HR##2##3##(2013-8#2)
and the Health##2##3##(1997-2#1)(2012-3#1)
and the IRMA##2##3##(1993-2#2)
and the Indian##2##3##(2009-11#1)(2010-12#1)
and the Institute of##2##4##(2010-10#1)(2012-2#1)
and the International##2##3##(2008-10#1)(2008-11#1)
and the Japanese##2##3##(2008-11#1)(2008-6#1)
and the LOD##2##3##(2008-10#2)
and the Medical##4##3##(1993-6#1)(1997-2#1)(1997-5#1)(2010-2#1)
and the Medicare##2##3##(1995-12#1)(1996-3#1)
and the Mediterranean##2##3##(2008-10#1)(2011-2#1)
and the Middle East##2##4##(1995-3#1)(2008-10#1)
and the Middle##3##3##(1995-3#1)(2008-10#2)
and the Ministry of Health##3##5##(1991-2#1)(2008-1#1)(2008-10#1)
and the N##2##3##(1994-5#1)(2008-5#1)
and the N-terminal##3##3##(1991-5#1)(1994-11#1)(1994-8#1)
and the National Institute of##2##5##(2008-9#1)(2011-2#1)
and the National Institute##3##4##(2008-9#1)(2010-5#1)(2011-2#1)
and the National##9##3##(1994-12#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
and the Netherlands##2##3##(2008-10#2)
and the Norwegian##2##3##(1992-5#1)(1994-9#1)
and the Nursing Interventions Classification were used to identify the appropriate nursing diagnosis##2##13##(2013-1#2)
and the R##9##3##(2008-10#9)
and the RSD of the method 0##2##7##(2008-10#2)
and the RSD of the##3##5##(2008-10#3)
and the RSD was##2##4##(2008-10#2)
and the RSD##6##3##(2008-10#6)
and the S182##2##3##(1995-8#2)
and the SE systems##2##4##(2008-10#2)
and the SMR of##2##4##(2008-10#1)(2009-7#1)
and the SPME##2##3##(2008-10#2)
and the Short##2##3##(2008-10#1)(2009-10#1)
and the Society for##2##4##(1996-8#1)(2013-8#1)
and the Society##4##3##(1994-12#1)(1996-8#1)(2013-1#1)(2013-8#1)
and the U##4##3##(1992-12#1)(1996-12#1)(2008-10#1)(2008-12#1)
and the US##2##3##(2008-5#1)(2010-8#1)
and the United Kingdom##6##4##(1992-1#1)(1995-1#2)(2008-10#2)(2013-8#1)
and the United States were##2##5##(2008-10#1)(2008-5#1)
and the United States##21##4##(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#3)(2008-10#12)(2008-11#1)(2008-5#1)(2009-7#1)
and the United##29##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-3#3)(1995-1#2)(2008-10#15)(2008-11#1)(2008-5#1)(2009-7#1)(2012-3#1)(2013-8#1)
and the University of##3##4##(1991-2#1)(1993-2#1)(2008-12#1)
and the World##2##3##(1993-11#1)(1996-2#1)
and the ability of cells to##2##6##(2008-10#1)(2008-11#1)
and the ability of##8##4##(1997-2#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)
and the ability to be##2##5##(2008-2#1)(2008-7#1)
and the ability to##19##4##(1990-5#1)(1992-8#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-5#1)
and the ability##27##3##(1990-5#1)(1992-8#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-5#1)
and the absence of##12##4##(1993-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
and the absolute##4##3##(1993-8#1)(1995-8#1)(2008-10#1)(2011-3#1)
and the absorbance is##2##4##(2008-10#2)
and the absorbance of the oxidized OPD##2##7##(2008-10#2)
and the absorbance of the##5##5##(2008-10#5)
and the absorbance##10##3##(2008-10#10)
and the absorption##2##3##(2008-10#1)(2008-3#1)
and the abundance of##2##4##(1994-2#1)(2008-11#1)
and the academic performance##2##4##(2013-8#2)
and the academic##3##3##(2008-12#1)(2013-8#2)
and the accumulation of##5##4##(1995-6#1)(1997-3#1)(2008-10#2)(2009-8#1)
and the accumulation time##2##4##(2008-10#2)
and the accumulation##8##3##(1995-6#1)(1997-3#1)(2008-10#4)(2008-11#1)(2009-8#1)
and the accuracy of##4##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
and the accuracy##8##3##(1991-8#1)(1992-3#1)(2008-10#4)(2008-11#1)(2008-6#1)
and the action##3##3##(1991-3#1)(2009-8#1)(2011-3#1)
and the actions of##2##4##(2008-7#1)(2008-9#1)
and the activation of##12##4##(1993-3#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#2)(2011-3#1)(2012-12#1)
and the activation##13##3##(1993-3#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)
and the active##6##3##(1996-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
and the activities of##5##4##(1991-12#1)(2008-11#2)(2008-7#1)(2008-9#1)
and the activity of the##2##5##(1994-6#1)(2013-1#1)
and the activity of##15##4##(1994-6#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-3#2)(2013-1#1)
and the activity##16##3##(1994-11#1)(1994-6#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-3#2)(2013-1#1)
and the actual##3##3##(1994-3#1)(2008-10#1)(2008-3#1)
and the acute phase response##2##5##(1992-9#1)(1993-12#1)
and the adaptive##2##3##(2008-10#1)(2008-7#1)
and the addition of##2##4##(2008-10#2)
and the adenosine receptor##2##4##(1995-8#2)
and the adhesion force##2##4##(2008-10#1)(2008-11#1)
and the adjacent##6##3##(1990-11#1)(1991-12#1)(2008-10#2)(2008-3#1)(2009-9#1)
and the advantage of##3##4##(2008-10#2)(2012-5#1)
and the advantage##4##3##(2008-10#2)(2012-3#1)(2012-5#1)
and the advantages of##3##4##(1997-1#1)(2008-11#1)(2008-4#1)
and the advantages##6##3##(1991-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)
and the agreement between observed and certified##2##7##(2008-10#2)
and the alternative##2##3##(2008-9#1)(2013-8#1)
and the amino acid composition of the##2##7##(1990-8#1)(2008-9#1)
and the amino acid sequence##2##5##(1991-9#1)(2013-8#1)
and the amino acid##6##4##(1990-8#1)(1991-9#1)(1995-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
and the amino##8##3##(1990-8#1)(1991-3#1)(1991-9#1)(1992-6#1)(1995-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
and the amount of the##2##5##(1992-6#1)(2008-8#1)
and the amount of##18##4##(1992-6#2)(1993-6#1)(1996-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)
and the amount##19##3##(1992-6#2)(1993-6#1)(1996-6#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)
and the amplified fragment length polymorphism marker##2##7##(2008-10#2)
and the amygdala##2##3##(1996-5#1)(2008-11#1)
and the analysis of the##3##5##(2008-10#2)(2008-11#1)
and the analysis of##6##4##(2008-10#3)(2008-11#2)(2008-3#1)
and the analysis##11##3##(2008-10#6)(2008-11#2)(2008-3#1)(2012-3#1)(2013-8#1)
and the analyte determined##2##4##(2008-10#2)
and the analyte##5##3##(2008-10#5)
and the analytes##5##3##(2008-10#5)
and the analytical characteristics##3##4##(2008-10#3)
and the analytical frequency was##2##5##(2008-10#2)
and the analytical performance##2##4##(2008-10#2)
and the analytical results were##3##5##(2008-10#3)
and the analytical##17##3##(2008-10#15)(2008-3#1)(2010-11#1)
and the annual##3##3##(1991-6#1)(1992-2#1)(2012-12#1)
and the antagonist##3##3##(1996-2#1)(2008-10#2)
and the anterior##6##3##(1991-6#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
and the antibodies were##2##4##(1993-8#1)(2008-9#1)
and the antibodies##3##3##(1993-8#1)(2008-8#1)(2008-9#1)
and the antibody was##2##4##(2008-10#2)
and the antibody##3##3##(2008-10#2)(2008-11#1)
and the anticancer##2##3##(2009-12#1)(2009-9#1)
and the antifungal##2##3##(2008-10#1)(2008-5#1)
and the antioxidant##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
and the apparent molar absorptivity##3##5##(2008-10#3)
and the apparent molar##4##4##(2008-10#4)
and the apparent##7##3##(1990-3#1)(1992-3#1)(2008-10#5)
and the appearance of##9##4##(1992-12#1)(1996-3#1)(2008-10#5)(2008-7#1)(2008-9#1)
and the appearance##10##3##(1992-12#1)(1995-6#1)(1996-3#1)(2008-10#5)(2008-7#1)(2008-9#1)
and the application of it to the determination of##2##9##(2008-10#2)
and the application of the internet of things in##2##9##(2012-3#2)
and the application of##14##4##(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#2)
and the application##17##3##(2008-10#6)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#2)
and the applied##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
and the approach##2##3##(1996-8#1)(2008-9#1)
and the appropriate##2##3##(2008-10#1)(2009-10#1)
and the aprX##2##3##(2008-10#2)
and the aqueous##3##3##(2008-10#3)
and the area of the##2##5##(1991-2#1)(2008-10#1)
and the area under the##2##5##(2008-10#1)(2008-11#1)
and the area##4##3##(1991-2#1)(2008-10#2)(2008-11#1)
and the assay of##2##4##(1991-11#1)(2008-11#1)
and the assay results were satisfactory##2##6##(2008-10#2)
and the assay##5##3##(1991-11#1)(2008-10#3)(2008-11#1)
and the assessment of##2##4##(2008-10#1)(2008-5#1)
and the associated##10##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
and the association with##2##4##(2008-10#2)
and the asymmetry##2##3##(2008-2#1)(2008-5#1)
and the atmosphere##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
and the atomic##3##3##(2008-10#2)(2008-3#1)
and the authors'##2##3##(2010-11#1)(2012-3#1)
and the availability of##6##4##(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)
and the availability##7##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)
and the available##4##3##(1991-6#1)(1994-5#1)(2008-8#1)(2010-11#1)
and the average duration of##2##5##(2011-2#2)
and the average flow##2##4##(2008-3#1)(2011-2#1)
and the average number and length of the introns per gene were##2##12##(1997-6#1)(1997-8#1)
and the average number##3##4##(1997-6#1)(1997-8#1)(2008-10#1)
and the average recovery##2##4##(2008-10#2)
and the average size of##2##5##(2008-5#1)(2011-1#1)
and the average##29##3##(1997-6#1)(1997-8#3)(2008-10#7)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
and the axillary##2##3##(2008-8#1)(2010-6#1)
and the bacterial##3##3##(1992-5#1)(2008-11#1)(2008-7#1)
and the bacterium##2##3##(2008-10#2)
and the band##2##3##(2008-10#1)(2008-9#1)
and the basal ES##2##4##(2012-2#2)
and the basal##3##3##(2008-7#1)(2012-2#2)
and the basic##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
and the basis for##2##4##(2008-10#1)(2008-11#1)
and the beginning of##4##4##(1996-5#1)(2008-10#1)(2012-2#1)(2013-1#1)
and the benefits of##4##4##(1995-9#1)(1997-6#1)(2008-11#2)
and the benefits##8##3##(1995-9#1)(1997-6#1)(1997-7#1)(2008-11#3)(2008-9#1)(2010-4#1)
and the best conditions##2##4##(2008-10#2)
and the best##10##3##(2008-10#4)(2008-9#1)(2009-1#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
and the beta##3##3##(1992-3#2)(1994-5#1)
and the beta-tubulin gene were##2##5##(2008-10#2)
and the better##2##3##(2008-11#2)
and the binding constant##2##4##(2008-10#2)
and the binding##6##3##(1995-6#1)(2008-10#4)(2009-10#1)
and the biological activity of##2##5##(2008-9#1)(2012-2#1)
and the biological##5##3##(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-2#1)
and the biosensor##2##3##(2008-10#2)
and the blood##3##3##(1994-5#1)(1997-1#1)(2008-1#1)
and the boric acid concentration##2##5##(2008-10#2)
and the brain##3##3##(1995-11#1)(2008-7#1)(2009-8#1)
and the broader##3##3##(2008-12#1)(2008-8#2)
and the buffer##3##3##(2008-10#2)(2008-4#1)
and the bulk##4##3##(2008-10#3)(2010-7#1)
and the calculated##5##3##(2008-10#4)(2009-7#1)
and the calibration curve is linear over##4##7##(2008-10#4)
and the calibration curve is linear##5##6##(2008-10#5)
and the calibration curve was linear##3##6##(2008-10#3)
and the calibration curve##8##4##(2008-10#8)
and the calibration curves##4##4##(2008-10#4)
and the calibration graph was linear##2##6##(2008-10#2)
and the calibration range##2##4##(2008-10#2)
and the calibration##17##3##(2008-10#17)
and the capillary##2##3##(2008-10#2)
and the capital##2##3##(1991-1#1)(1994-9#1)
and the cardiac##3##3##(1993-2#2)(1994-11#1)
and the cardiovascular system##2##4##(2009-6#1)(2010-12#1)
and the cardiovascular##3##3##(1991-1#1)(2009-6#1)(2010-12#1)
and the case##3##3##(1990-3#1)(1995-2#1)(2011-2#1)
and the catalytic##3##3##(1995-11#1)(1995-6#1)(2008-10#1)
and the caudal##2##3##(1990-3#1)(1997-3#1)
and the causal##2##3##(2008-10#2)
and the causes##2##3##(2008-10#1)(2008-12#1)
and the cell death##2##4##(1993-8#1)(2012-3#1)
and the cell##10##3##(1992-3#1)(1993-8#1)(1995-9#1)(2008-10#2)(2008-11#3)(2008-7#1)(2012-3#1)
and the cells##4##3##(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)
and the cellular##3##3##(1991-8#1)(2008-11#2)
and the central##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-5#1)
and the cerebral##2##3##(1994-2#1)(2008-7#1)
and the chain##2##3##(2008-12#2)
and the challenge of##2##4##(2010-1#1)(2012-3#1)
and the chance of##2##4##(1995-12#1)(2011-2#1)
and the change##2##3##(2008-7#1)(2009-12#1)
and the changed##2##3##(1997-4#1)(2010-6#1)
and the changes in##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
and the changes##6##3##(1993-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-8#1)
and the characteristic mass##3##4##(2008-10#3)
and the characteristic##5##3##(1992-6#1)(2008-10#3)(2008-11#1)
and the characteristics of##4##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
and the characterization of##2##4##(2008-10#1)(2012-3#1)
and the chemical variables##2##4##(2008-10#2)
and the chemical##8##3##(2008-10#8)
and the chest##3##3##(1991-12#1)(2012-2#1)(2013-1#1)
and the child##4##3##(1990-12#1)(2008-10#1)(2008-11#1)(2010-9#1)
and the child's##2##3##(1992-2#1)(2008-10#1)
and the choice of##3##4##(2008-10#2)(2008-9#1)
and the choice##4##3##(2008-10#2)(2008-9#1)(2009-8#1)
and the chromogenic##2##3##(1990-2#1)(2008-10#1)
and the chronic##2##3##(1991-3#1)(1993-2#1)
and the cladding modes increases##2##5##(2008-3#2)
and the clinical benefit of##2##5##(1997-7#2)
and the clinical evidence##2##4##(2011-2#2)
and the clinical response of##2##5##(1991-3#1)(2008-5#1)
and the clinical##19##3##(1991-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1997-7#2)(1997-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2010-6#1)(2011-2#3)(2013-1#1)(2013-7#1)
and the closely related##2##4##(1995-8#1)(2008-10#1)
and the coat protein (CP)##2##5##(2008-10#2)
and the coding##2##3##(1997-4#1)(2008-8#1)
and the coefficient of variation of##2##6##(2008-10#2)
and the coefficient of variation##5##5##(1992-3#1)(2008-10#4)
and the coefficient of##7##4##(1992-3#1)(2008-10#6)
and the coefficients of variation were##2##6##(2008-10#2)
and the collagen##2##3##(2008-8#1)(2013-1#1)
and the color##2##3##(2008-10#2)
and the colored##2##3##(2008-10#2)
and the column##2##3##(2008-10#2)
and the combination of the two##2##6##(2008-7#1)(2012-5#1)
and the combination of##3##4##(1993-3#1)(2008-7#1)(2012-5#1)
and the combination##4##3##(1993-3#1)(2008-10#1)(2008-7#1)(2012-5#1)
and the combined##2##3##(1994-12#1)(2008-10#1)
and the common##5##3##(1992-3#1)(2008-8#1)(2008-9#1)(2011-2#2)
and the communication##2##3##(2008-7#1)(2011-2#1)
and the community##2##3##(2008-11#1)(2013-1#1)
and the comparison of##2##4##(2008-10#2)
and the comparison##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
and the competition##2##3##(2008-10#1)(2008-7#1)
and the complementary##2##3##(1993-8#1)(2008-10#1)
and the complete##3##3##(2008-10#2)(2008-9#1)
and the complex##9##3##(1993-9#1)(1994-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-3#1)
and the complexes were##2##4##(2008-10#2)
and the complexity of##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
and the complexity##4##3##(2008-10#1)(2010-1#1)(2010-7#1)(2011-2#1)
and the compomer##2##3##(2008-5#1)(2011-2#1)
and the composition of the##2##5##(2008-10#2)
and the composition of##5##4##(2008-10#3)(2011-2#1)(2013-8#1)
and the composition##7##3##(2008-10#3)(2008-3#2)(2011-2#1)(2013-8#1)
and the compounds##2##3##(2008-10#2)
and the concentration of each ion in##2##7##(2008-10#2)
and the concentration of the##9##5##(1991-5#1)(1994-5#1)(2008-10#6)(2008-5#1)
and the concentration of##34##4##(1991-5#1)(1992-6#1)(1994-5#1)(2008-10#26)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
and the concentration##41##3##(1991-5#1)(1992-6#1)(1994-5#1)(2008-10#32)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
and the concentrations of##6##4##(2008-10#6)
and the concentrations##8##3##(2008-10#8)
and the concomitant##6##3##(1992-3#1)(1994-6#1)(1995-6#1)(1996-2#1)(2008-10#1)(2013-1#1)
and the conditions for##2##4##(2008-10#1)(2008-9#1)
and the conditions##5##3##(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)
and the connection##2##3##(2008-3#1)(2013-1#1)
and the consequences of their##2##5##(2008-11#1)(2010-1#1)
and the consequences of##5##4##(1996-5#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-4#1)
and the consequences##7##3##(1992-12#1)(1996-5#1)(2008-11#2)(2008-8#1)(2010-1#1)(2010-4#1)
and the consequent##2##3##(2008-10#1)(2008-9#1)
and the conserved##2##3##(2008-10#1)(2008-8#1)
and the constant##3##3##(2008-10#3)
and the consumer##2##3##(1992-1#1)(2008-8#1)
and the consumption of##4##4##(1994-2#1)(2008-10#1)(2010-8#1)(2011-2#1)
and the content of##4##4##(2008-10#3)(2013-7#1)
and the content##5##3##(2008-10#3)(2009-12#1)(2013-7#1)
and the contents of##2##4##(1995-5#1)(2008-10#1)
and the contents##3##3##(1995-5#1)(2008-10#1)(2008-12#1)
and the continuous##2##3##(1994-12#1)(2008-10#1)
and the control group##2##4##(2008-11#1)(2008-9#1)
and the control##7##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and the controversies##2##3##(2008-11#1)(2008-9#1)
and the conventional##3##3##(2008-10#2)(2010-6#1)
and the coordination##2##3##(2008-9#1)(2011-2#1)
and the correct##2##3##(1992-9#1)(2012-3#1)
and the correction##2##3##(2008-3#1)(2013-8#1)
and the correlation between##2##4##(2008-10#1)(2008-11#1)
and the correlation##5##3##(2008-10#3)(2008-11#1)(2012-2#1)
and the corresponding##21##3##(1990-11#1)(1993-3#1)(1995-6#1)(1997-4#1)(2008-10#8)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2013-1#1)
and the cost of##5##4##(1995-5#1)(2008-10#2)(2008-8#2)
and the cost##6##3##(1995-5#1)(2008-10#2)(2008-8#2)(2008-9#1)
and the costs associated with##2##5##(1994-2#1)(2008-11#1)
and the costs of##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
and the costs##6##3##(1994-2#1)(2008-10#2)(2008-11#2)(2008-9#1)
and the course of the##2##5##(2008-7#1)(2012-2#1)
and the course of##5##4##(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
and the course##6##3##(1994-12#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
and the creation of##2##4##(2008-10#1)(2012-2#1)
and the criteria##3##3##(1993-12#1)(1997-8#1)(2012-2#1)
and the critical##5##3##(1995-6#1)(2008-10#2)(2008-5#1)(2009-8#1)
and the crystal structure##3##4##(1991-3#1)(1992-12#1)(1996-5#1)
and the crystal##6##3##(1991-3#1)(1992-12#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-9#1)
and the cultural##2##3##(2008-1#1)(2008-11#1)
and the culture##3##3##(2008-11#2)(2009-3#1)
and the cumulative##2##3##(2008-7#1)(2013-1#1)
and the current##9##3##(1994-3#1)(1996-2#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-11#1)
and the cytogenetic##2##3##(2012-3#2)
and the cytotoxicity of the##2##5##(2008-5#1)(2008-8#1)
and the data compared with##2##5##(1997-8#1)(2008-10#1)
and the data obtained##3##4##(1993-8#1)(2008-10#2)
and the data of the FT-IR spectrum##2##7##(2008-10#2)
and the data were##2##4##(2008-10#2)
and the data##17##3##(1991-5#1)(1992-2#1)(1993-8#1)(1997-8#1)(2008-10#11)(2008-8#1)(2012-2#1)
and the date of##2##4##(1991-12#1)(2008-10#1)
and the date##4##3##(1991-11#1)(1991-12#1)(2008-10#1)(2008-7#1)
and the death and dying##2##5##(2011-2#2)
and the death##3##3##(1997-7#1)(2011-2#2)
and the decline of##2##4##(1995-3#1)(2012-7#1)
and the decrease in the##2##5##(2008-10#1)(2008-11#1)
and the decrease in##5##4##(1990-5#1)(2008-10#2)(2008-11#1)(2013-7#1)
and the decrease##6##3##(1990-5#1)(2008-10#3)(2008-11#1)(2013-7#1)
and the deduced##2##3##(1997-2#1)(2008-8#1)
and the definition of the##2##5##(1993-1#1)(2010-7#1)
and the definition of##4##4##(1993-1#1)(2008-10#1)(2008-8#1)(2010-7#1)
and the degradation##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
and the degree of the##3##5##(2008-11#1)(2008-9#1)(2013-8#1)
and the degree of##20##4##(1993-6#1)(1993-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2010-11#1)(2013-8#1)
and the degree##21##3##(1993-6#1)(1993-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2010-11#1)(2013-8#1)
and the delivery##2##3##(1993-3#1)(1996-2#1)
and the delta##2##3##(1993-8#1)(2008-10#1)
and the demonstration of##2##4##(2008-1#1)(2008-5#1)
and the density of##2##4##(1995-8#1)(2008-10#1)
and the dependence of the##3##5##(1995-11#1)(2008-10#1)(2008-3#1)
and the depolarizer concentration##3##4##(2008-10#3)
and the derived##2##3##(2008-10#1)(2008-3#1)
and the design of##2##4##(1995-5#1)(2008-10#1)
and the design##3##3##(1995-5#1)(2008-10#1)(2012-3#1)
and the detection and quantification limits##2##6##(2008-10#2)
and the detection limit (3sigma)##3##5##(2008-10#3)
and the detection limit for##3##5##(2008-10#3)
and the detection limit is 0##5##6##(2008-10#5)
and the detection limit is 1##3##6##(2008-10#3)
and the detection limit is##13##5##(2008-10#13)
and the detection limit of##3##5##(2008-10#3)
and the detection limit was 0##7##6##(2008-10#7)
and the detection limit was 1##3##6##(2008-10#3)
and the detection limit was 2##4##6##(2008-10#4)
and the detection limit was 4##2##6##(2008-10#2)
and the detection limit was down to 0##2##8##(2008-10#2)
and the detection limit was##31##5##(2008-10#31)
and the detection limit##59##4##(2008-10#59)
and the detection limits achieved##2##5##(2008-10#2)
and the detection limits for##3##5##(2008-10#3)
and the detection limits of##4##5##(2008-10#4)
and the detection limits##15##4##(2008-10#15)
and the detection of##3##4##(1991-12#1)(2008-10#1)(2013-1#1)
and the detection##82##3##(1991-12#1)(2008-10#80)(2013-1#1)
and the detector##2##3##(2008-10#1)(2008-3#1)
and the determination of the##5##5##(1996-11#1)(1997-1#1)(2008-10#2)(2009-7#1)
and the determination of##13##4##(1996-11#1)(1997-1#1)(1997-8#1)(2008-10#8)(2008-4#1)(2009-7#1)
and the determination##17##3##(1996-11#1)(1997-1#1)(1997-8#1)(2008-10#12)(2008-4#1)(2009-7#1)
and the determined values coincided with the certified values very well##2##11##(2008-10#2)
and the determined values obtained were in##2##7##(2008-10#2)
and the determined values##4##4##(2008-10#4)
and the developed##2##3##(2008-10#2)
and the developing##2##3##(2008-10#1)(2009-10#1)
and the development of a##2##5##(2008-10#1)(2008-11#1)
and the development of more##2##5##(1994-5#1)(2010-11#1)
and the development of new##4##5##(1991-12#1)(1997-8#1)(2008-10#1)(2011-2#1)
and the development of##35##4##(1991-12#1)(1993-3#1)(1994-5#1)(1996-2#1)(1997-1#1)(1997-8#2)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
and the developmental##3##3##(1997-1#1)(2008-11#1)(2009-12#1)
and the device is##2##4##(2007-12#1)(2008-1#1)
and the diagnosis is##2##4##(1991-2#1)(2013-1#1)
and the diagnosis was confirmed##2##5##(2008-7#1)(2010-12#1)
and the diagnosis was##3##4##(2008-7#1)(2009-4#1)(2010-12#1)
and the diagnosis##9##3##(1991-2#1)(1992-9#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-8#1)(2013-1#1)
and the diagnostic##2##3##(1991-8#1)(1996-12#1)
and the difference of##2##4##(2008-3#1)(2013-8#1)
and the difference##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
and the differences between##2##4##(1996-1#1)(2008-10#1)
and the differences##3##3##(1996-1#1)(2008-10#1)(2009-11#1)
and the different types of##2##5##(2008-10#1)(2013-1#1)
and the different##7##3##(2008-10#4)(2008-11#1)(2011-1#1)(2013-1#1)
and the differential diagnosis##3##4##(1990-12#1)(1993-8#1)(2008-11#1)
and the differential##4##3##(1990-12#1)(1993-8#1)(2008-10#1)(2008-11#1)
and the differentiation of##2##4##(1993-3#1)(2008-10#1)
and the differentiation##3##3##(1991-3#1)(1993-3#1)(2008-10#1)
and the difficulties encountered##2##4##(1997-3#1)(2008-7#1)
and the difficulties in##2##4##(2008-11#1)(2008-5#1)
and the difficulties##5##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
and the difficulty in##5##4##(2008-10#1)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
and the difficulty##6##3##(2008-10#2)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
and the diffusion##3##3##(1991-5#1)(2008-10#2)
and the digital darkroom##2##4##(2008-1#1)(2008-4#1)
and the direct##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
and the discovery of##2##4##(2009-5#1)(2011-3#1)
and the disease##11##3##(2008-10#6)(2008-8#1)(2009-12#1)(2011-2#3)
and the diseases##2##3##(2008-10#1)(2008-11#1)
and the disorganization of the##2##5##(2008-7#1)(2009-10#1)
and the dispersal of##2##4##(2008-10#1)(2010-3#1)
and the dissociation##2##3##(1995-11#1)(2008-10#1)
and the distance between the##3##5##(1993-12#1)(2008-10#1)(2008-3#1)
and the distance between##4##4##(1993-12#1)(1993-8#1)(2008-10#1)(2008-3#1)
and the distance##7##3##(1993-12#1)(1993-8#1)(2008-10#3)(2008-3#1)(2010-5#1)
and the distinctive##2##3##(1991-7#1)(1996-12#1)
and the distribution of persons is##2##6##(2012-2#2)
and the distribution of the##2##5##(2008-10#1)(2008-11#1)
and the distribution of values##3##5##(2008-7#1)(2013-1#2)
and the distribution of##10##4##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2011-7#1)(2012-2#2)(2013-1#2)
and the distribution##13##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2011-7#1)(2012-2#2)(2013-1#3)
and the diversity of##2##4##(1992-3#1)(2008-10#1)
and the dog##3##3##(1995-11#2)(2013-1#1)
and the donor##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
and the draining veins##2##4##(2008-7#1)(2012-3#1)
and the driving##2##3##(1991-12#1)(2008-11#1)
and the drug resistant##2##4##(2008-11#1)(2011-2#1)
and the drug##5##3##(1992-2#1)(1996-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
and the duration of the##5##5##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
and the duration of##7##4##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-1#2)
and the duration##10##3##(1996-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
and the dye##3##3##(1990-12#1)(2008-10#1)(2010-4#1)
and the dynamic range##2##4##(2008-10#2)
and the dynamic##5##3##(2008-10#3)(2010-8#1)(2013-1#1)
and the dynamics of##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
and the dynamics##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
and the early##4##3##(2008-10#1)(2008-11#2)(2010-8#1)
and the economic impact##2##4##(2008-10#2)
and the economic##3##3##(2008-10#2)(2008-11#1)
and the economy##2##3##(1997-6#1)(2013-8#1)
and the effect of foreign ions##2##6##(2008-10#2)
and the effect of pH##3##5##(2008-10#2)(2008-5#1)
and the effect of the##4##5##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
and the effect of##47##4##(1992-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-4#1)(2008-10#20)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2013-1#1)(2013-8#2)
and the effect on##2##4##(1994-2#1)(1996-12#1)
and the effect was##5##4##(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)
and the effect##55##3##(1992-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#2)
and the effective dose##2##4##(1995-12#1)(2008-12#1)
and the effective##8##3##(1992-2#1)(1995-12#1)(2008-10#4)(2008-12#1)(2012-2#1)
and the effectiveness of the##2##5##(1995-1#1)(1995-3#1)
and the effectiveness of##5##4##(1995-1#1)(1995-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
and the effects of the##3##5##(1994-6#1)(2008-11#1)(2008-3#1)
and the effects of these##2##5##(1993-3#1)(2008-7#1)
and the effects of##24##4##(1992-1#2)(1993-3#1)(1994-6#1)(1997-7#1)(2008-10#5)(2008-11#6)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
and the effects on the##3##5##(1992-6#1)(2011-3#2)
and the effects on##6##4##(1992-6#1)(2008-10#1)(2008-7#1)(2011-3#2)(2012-4#1)
and the effects##31##3##(1992-1#2)(1992-6#1)(1993-3#1)(1994-6#1)(1997-7#1)(2008-10#7)(2008-11#6)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)(2011-3#2)(2012-4#1)(2013-8#1)
and the efficacy of##2##4##(2008-5#2)
and the efficiency of##3##4##(1997-6#1)(2008-10#2)
and the efforts of##2##4##(1994-9#1)(2012-2#1)
and the efforts##3##3##(1994-9#1)(1997-7#1)(2012-2#1)
and the elderly##9##3##(1991-1#1)(1991-2#1)(1991-3#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-11#2)(2012-2#1)
and the electrode surface##2##4##(2008-10#2)
and the electrode##9##3##(2008-10#9)
and the electrodes##2##3##(2008-9#1)(2009-8#1)
and the electrophoretic##2##3##(1994-11#1)(2008-2#1)
and the electrostatic##2##3##(2008-10#2)
and the elements##2##3##(2008-10#1)(2008-9#1)
and the elimination of##2##4##(2008-10#2)
and the elution##2##3##(2008-10#2)
and the emergence of##3##4##(1994-12#1)(2009-3#1)(2010-1#1)
and the emerging##3##3##(1996-3#2)(1997-3#1)
and the emission##5##3##(1996-2#1)(2008-10#4)
and the emitted fluorescence##2##4##(2008-10#2)
and the end of##2##4##(2008-11#1)(2008-3#1)
and the end##4##3##(2008-11#1)(2008-3#1)(2009-3#1)(2010-1#1)
and the end-point volume of the titrant exists in the##3##10##(2008-10#3)
and the endogenous##2##3##(2008-11#1)(2013-7#1)
and the energetic##2##3##(2008-9#2)
and the energy##3##3##(2008-4#1)(2008-7#1)(2008-8#1)
and the enhanced##5##3##(2008-10#3)(2009-3#1)(2013-8#1)
and the enhancement of##3##4##(1996-2#1)(2008-10#1)(2011-2#1)
and the enhancement##4##3##(1996-2#1)(2008-10#2)(2011-2#1)
and the ensuing##4##3##(1996-2#1)(2010-11#1)(2010-12#1)(2012-3#1)
and the enthalpy##2##3##(1994-5#1)(2008-10#1)
and the entire##2##3##(1997-2#1)(2008-9#1)
and the entry##2##3##(2008-11#1)(2010-5#1)
and the environment##10##3##(1992-2#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-6#2)(2010-12#1)(2012-3#1)
and the environmental and##2##4##(2008-10#1)(2008-7#1)
and the environmental##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2009-3#1)
and the enzymatic activity##2##4##(1992-6#1)(2008-6#1)
and the enzymatic##5##3##(1990-12#1)(1992-6#1)(2008-10#2)(2008-6#1)
and the enzyme was##2##4##(1995-8#1)(1997-2#1)
and the enzyme##7##3##(1995-8#1)(1997-2#1)(2008-10#5)
and the enzymes##3##3##(1994-5#1)(2008-10#2)
and the equilibrium constant##2##4##(1995-6#1)(2008-10#1)
and the equilibrium constants##2##4##(2008-10#2)
and the equilibrium##8##3##(1995-6#1)(2008-10#5)(2008-8#1)(2008-9#1)
and the establishment of##4##4##(2008-10#3)(2008-11#1)
and the estimated##6##3##(2008-10#3)(2008-8#1)(2012-12#1)(2012-2#1)
and the etiology of##2##4##(2008-10#1)(2012-3#1)
and the etiology##3##3##(2008-10#2)(2012-3#1)
and the evaluation and##2##4##(2008-4#2)
and the evaluation of the##2##5##(1991-6#1)(2008-10#1)
and the evaluation of##4##4##(1991-6#1)(2008-10#2)(2008-11#1)
and the evaluation##6##3##(1991-6#1)(2008-10#2)(2008-11#1)(2008-4#2)
and the evidence##2##3##(2008-10#1)(2011-2#1)
and the evolution of its##2##5##(1992-1#1)(2008-10#1)
and the evolution of##16##4##(1992-1#1)(2008-10#2)(2008-8#7)(2008-9#2)(2009-6#2)(2011-2#1)(2012-3#1)
and the evolutionary##2##3##(2008-9#1)(2012-3#1)
and the exchange##2##3##(2008-11#1)(2008-7#1)
and the excitation##2##3##(1994-5#1)(2008-3#1)
and the existence of##5##4##(2008-10#3)(2008-7#1)(2008-8#1)
and the existence or not of##2##6##(1993-2#1)(2013-8#1)
and the existence##7##3##(1993-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2013-8#1)
and the existing##2##3##(2008-10#1)(2013-1#1)
and the expected##4##3##(2008-3#1)(2008-8#1)(2009-10#1)(2012-3#1)
and the experiment##2##3##(2008-3#1)(2008-7#1)
and the experimental conditions##2##4##(2008-10#2)
and the experimental##9##3##(1990-12#1)(2008-10#6)(2008-2#1)(2008-5#1)
and the expression level of##2##5##(2008-9#1)(2009-12#1)
and the expression of##13##4##(1994-3#1)(1996-12#2)(1997-8#1)(2008-11#3)(2008-8#3)(2008-9#1)(2010-10#1)(2011-2#1)
and the expression##17##3##(1994-3#1)(1996-12#2)(1997-8#2)(2008-11#3)(2008-8#3)(2008-9#2)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)
and the extent of##8##4##(1992-11#1)(1994-2#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
and the extent to which they##2##6##(2010-7#1)(2012-2#1)
and the extent to which##4##5##(2008-5#1)(2008-9#1)(2010-7#1)(2012-2#1)
and the extent##12##3##(1992-11#1)(1994-2#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-2#1)
and the extracellular##2##3##(1994-3#1)(2008-9#1)
and the extraction##6##3##(2008-10#6)
and the extracts##2##3##(2008-10#2)
and the extreme##2##3##(2008-10#1)(2008-7#1)
and the extremely##2##3##(2008-10#1)(2011-2#1)
and the fabrication##2##3##(2008-10#1)(2008-3#1)
and the facility with which it promotes the integration of research into EBP##2##13##(2013-1#2)
and the fact that the##3##5##(2008-10#1)(2008-11#1)(2013-1#1)
and the fact that##14##4##(1992-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the factors that##2##4##(2008-9#1)(2010-9#1)
and the factors which##3##4##(1992-1#1)(2008-7#1)(2010-9#1)
and the factors##6##3##(1992-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-9#2)
and the failure##2##3##(1997-3#1)(2008-11#1)
and the families##2##3##(1992-3#1)(2008-1#1)
and the family##2##3##(2009-9#1)(2010-9#1)
and the fast##3##3##(1995-3#1)(2007-12#1)(2013-8#1)
and the favorable##2##3##(1990-6#1)(2008-10#1)
and the feasibility##2##3##(2008-10#1)(2011-2#1)
and the female##2##3##(2008-10#1)(2013-8#1)
and the field##5##3##(2008-10#3)(2008-2#1)(2010-7#1)
and the fifth##5##3##(1992-5#1)(2008-10#1)(2008-7#1)(2011-2#2)
and the film##3##3##(2008-10#3)
and the final##13##3##(1992-4#1)(1995-6#1)(2008-10#7)(2008-11#2)(2008-7#1)(2010-5#1)
and the finding that the##2##5##(1995-11#1)(2008-10#1)
and the findings of##2##4##(1994-8#1)(2008-3#1)
and the findings##3##3##(1994-8#1)(2008-11#1)(2008-3#1)
and the first derivative##2##4##(2008-10#2)
and the first four##2##4##(1993-8#1)(1994-11#1)
and the first genome sequence of a member of the genus##2##11##(2011-2#2)
and the first##24##3##(1991-5#1)(1993-8#1)(1994-11#1)(1995-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-1#1)(2009-11#2)(2010-1#1)(2010-5#1)(2011-2#3)(2013-8#1)
and the flanking##2##3##(2008-10#1)(2008-8#1)
and the flow of##2##4##(1996-6#1)(2008-10#1)
and the flow rate##2##4##(2008-10#2)
and the flow##7##3##(1996-6#1)(2008-10#6)
and the flow-rate##2##3##(1997-2#1)(2008-10#1)
and the fluorescence intensity##2##4##(2008-10#2)
and the fluorescence##8##3##(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)
and the focal##3##3##(2008-2#2)(2013-1#1)
and the following##10##3##(1997-8#1)(2008-10#4)(2008-5#1)(2008-8#2)(2011-2#1)(2013-1#1)
and the formation constants##2##4##(2008-10#2)
and the formation of apoptotic bodies##3##6##(2008-11#1)(2008-7#1)(2012-3#1)
and the formation of the##2##5##(2008-10#2)
and the formation of##17##4##(1991-1#1)(1994-3#1)(1994-8#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#1)(2011-3#1)(2012-3#1)
and the formation##19##3##(1991-1#1)(1994-3#1)(1994-8#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#1)(2011-3#1)(2012-3#1)
and the four##2##3##(1993-3#1)(2013-8#1)
and the fourth##3##3##(1992-4#1)(1997-3#1)(2008-5#1)
and the fraction of##6##4##(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
and the fraction##7##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
and the fractional##2##3##(2008-3#1)(2008-7#1)
and the free##4##3##(1996-6#1)(2008-10#3)
and the frequency distribution of##2##5##(2008-10#1)(2008-7#1)
and the frequency of the##2##5##(2008-10#1)(2011-2#1)
and the frequency of##9##4##(1994-6#1)(1997-4#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#1)
and the frequency##13##3##(1994-6#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
and the frequent##2##3##(2008-5#1)(2013-8#1)
and the full range of##2##5##(2008-10#1)(2008-7#1)
and the full##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
and the function of##2##4##(2008-4#1)(2011-3#1)
and the functional##8##3##(1993-2#1)(1993-3#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#1)
and the functions of##3##4##(1994-2#1)(2008-10#1)(2008-11#1)
and the fungal pathogen##2##4##(2008-10#2)
and the fungal##3##3##(2008-10#3)
and the fungi##3##3##(2008-10#3)
and the fungus##3##3##(2008-10#2)(2008-9#1)
and the future of##3##4##(1991-1#1)(1996-1#1)(1997-1#1)
and the future##10##3##(1991-1#1)(1991-3#1)(1993-2#1)(1996-1#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#1)
and the gain##2##3##(2007-11#1)(2008-3#1)
and the gas##2##3##(2008-10#1)(2008-3#1)
and the gene##2##3##(1997-2#1)(2008-8#1)
and the general##7##3##(1990-3#2)(1993-2#1)(1993-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
and the generation of##5##4##(1992-12#1)(1994-11#1)(2008-1#1)(2008-5#1)(2008-9#1)
and the genetic diversity##2##4##(2008-10#1)(2008-6#1)
and the genetic##5##3##(2008-10#4)(2008-6#1)
and the genome##2##3##(2008-10#1)(2008-9#1)
and the geographic##2##3##(1991-3#1)(1994-1#1)
and the geometry of##3##4##(1991-9#1)(1993-5#1)(2008-10#1)
and the germination##2##3##(2008-10#1)(2011-2#1)
and the global##5##3##(1990-9#2)(2008-8#1)(2008-9#1)(2011-2#1)
and the good##3##3##(1990-2#1)(1992-5#1)(2008-10#1)
and the granule##2##3##(2008-6#1)(2013-8#1)
and the grating##2##3##(2007-12#1)(2008-3#1)
and the great##4##3##(1995-5#1)(2008-1#1)(2008-11#1)(2013-2#1)
and the greatest##7##3##(1996-5#1)(2008-10#6)
and the greenhouse effect##2##4##(1991-6#2)
and the greenhouse##3##3##(1991-6#2)(2008-10#1)
and the group##3##3##(1993-12#1)(2008-12#1)(2008-2#1)
and the growing##4##3##(1994-1#1)(2008-10#1)(2011-3#1)(2013-8#1)
and the growth of##4##4##(1997-1#1)(2008-10#2)(2013-8#1)
and the growth##12##3##(1993-9#1)(1997-1#1)(2008-10#2)(2008-11#5)(2008-8#1)(2009-6#1)(2013-8#1)
and the head##2##3##(2008-10#1)(2008-8#1)
and the healing##2##3##(2009-5#1)(2010-1#1)
and the health care provider##2##5##(2010-1#1)(2013-1#1)
and the health care system##3##5##(1992-12#1)(1993-12#1)(1997-6#1)
and the health care##8##4##(1991-3#1)(1992-12#2)(1993-12#1)(1997-3#1)(1997-6#1)(2010-1#1)(2013-1#1)
and the health##12##3##(1991-3#1)(1992-12#2)(1992-3#1)(1993-12#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-12#1)(2010-1#1)(2012-12#1)(2013-1#1)
and the heart rate from##2##5##(1991-6#2)
and the heart rate##3##4##(1990-5#1)(1991-6#2)
and the heart##5##3##(1990-5#1)(1991-6#2)(2008-9#1)(2010-12#1)
and the heat##2##3##(1992-2#1)(1993-8#1)
and the help##2##3##(1994-3#1)(1995-1#1)
and the heterologous##2##3##(2008-11#2)
and the high affinity##2##4##(1990-12#1)(2008-7#1)
and the high##12##3##(1990-12#1)(1997-7#1)(2008-10#3)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
and the higher##5##3##(2008-10#3)(2008-11#2)
and the highest level of##2##5##(2008-12#1)(2008-8#1)
and the highest##13##3##(1990-2#1)(2008-10#6)(2008-12#2)(2008-8#1)(2008-9#2)(2011-2#1)
and the highly##5##3##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
and the hippocampus##2##3##(2008-11#1)(2013-8#1)
and the histological diagnosis##2##4##(2008-10#1)(2011-1#1)
and the histological##4##3##(2008-10#1)(2009-8#1)(2010-12#1)(2011-1#1)
and the history of the##2##5##(2008-12#2)
and the history of##3##4##(2008-12#2)(2010-8#1)
and the hospital##5##3##(1990-9#1)(1991-12#1)(1994-3#1)(1996-3#1)(2013-1#1)
and the host##4##3##(2008-10#2)(2008-9#1)(2009-4#1)
and the human##5##3##(1995-6#3)(2008-5#1)(2010-8#1)
and the humidity##2##3##(2008-10#2)
and the hybrid##2##3##(2008-10#2)
and the hybridization##2##3##(2008-10#2)
and the hydrolysis##2##3##(2008-10#2)
and the hygromycin##2##3##(2008-10#1)(2008-11#1)
and the hyphal##2##3##(1996-6#1)(2008-7#1)
and the identification of##12##4##(1991-12#1)(1992-12#1)(1993-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#1)(2012-2#1)
and the identity of the##2##5##(2008-10#1)(2013-8#1)
and the idler##3##3##(2008-2#1)(2008-3#2)
and the image##3##3##(2007-12#2)(2008-12#1)
and the imaginary##3##3##(2008-3#3)
and the immediate##3##3##(2008-3#2)(2010-11#1)
and the immobilized##3##3##(2008-10#2)(2008-11#1)
and the immune system are##2##5##(2008-2#1)(2008-5#1)
and the immune system##5##4##(1997-9#1)(2008-10#1)(2008-2#2)(2008-5#1)
and the immune##6##3##(1997-9#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)
and the impact of the##2##5##(1992-9#1)(2008-3#1)
and the impact of##12##4##(1992-9#1)(1993-12#1)(2007-12#1)(2008-11#3)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
and the impact on##4##4##(1991-2#1)(1992-12#1)(2008-10#1)(2010-2#1)
and the impact that##2##4##(1992-1#1)(2010-7#1)
and the impact##21##3##(1991-2#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-4#1)(2012-2#1)(2012-3#2)
and the implantation of##2##4##(2011-2#2)
and the implementation of##3##4##(1992-1#1)(1997-3#1)(2012-3#1)
and the implications of this##2##5##(2008-10#1)(2008-12#1)
and the implications of##4##4##(1991-2#1)(2008-10#1)(2008-12#1)(2010-1#1)
and the implications##8##3##(1991-1#1)(1991-2#2)(1995-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-1#1)
and the importance of the##2##5##(2010-3#1)(2013-1#1)
and the importance of##14##4##(1990-9#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the importance##15##3##(1990-9#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the improved##2##3##(1997-3#1)(2008-10#1)
and the in vitro##2##4##(1993-1#1)(2008-8#1)
and the in##4##3##(1990-8#1)(1993-1#1)(2008-10#1)(2008-8#1)
and the inactive##2##3##(1992-6#1)(1995-12#1)
and the incidence of BYDV##2##5##(2008-10#2)
and the incidence of CSF leak was##2##7##(2012-3#2)
and the incidence of##22##4##(1991-3#1)(1991-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
and the incidence##25##3##(1991-3#1)(1991-8#1)(1996-3#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and the incidences of##2##4##(2008-9#1)(2011-2#1)
and the inclusion of##2##4##(2008-10#2)
and the increase in##5##4##(1991-3#1)(1992-3#1)(1995-6#1)(1997-2#1)(2008-8#1)
and the increase of##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
and the increase##9##3##(1991-3#1)(1992-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-5#1)
and the increased risk of##2##5##(2010-12#1)(2013-1#1)
and the increased##9##3##(1992-9#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
and the increasing##4##3##(1997-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
and the index of dispersion##2##5##(2008-10#2)
and the index of##3##4##(2008-10#2)(2008-5#1)
and the index##5##3##(1992-2#1)(2008-10#2)(2008-3#1)(2008-5#1)
and the indirect leucocyte migration inhibition factor (LMIF)##2##8##(1991-12#2)
and the indirect##4##3##(1991-12#2)(1994-2#1)(2008-10#1)
and the individual##8##3##(1992-3#1)(1994-8#1)(2008-10#3)(2008-8#2)(2011-3#1)
and the induction of##5##4##(1994-6#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
and the induction period##2##4##(2008-10#2)
and the induction##8##3##(1994-6#1)(2008-10#3)(2008-11#2)(2011-1#1)(2013-1#1)
and the inductively coupled##2##4##(2008-10#2)
and the inflammatory##3##3##(1997-8#1)(2008-5#1)(2013-1#1)
and the influence of the##4##5##(2008-10#2)(2008-11#1)(2009-11#1)
and the influence of##24##4##(1992-2#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-9#2)(2013-8#1)
and the influence on##2##4##(2008-11#1)(2011-2#1)
and the influence##28##3##(1992-2#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-7#1)(2008-9#2)(2009-11#1)(2010-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
and the information and##2##4##(1995-1#1)(1996-3#1)
and the information##6##3##(1993-6#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-9#1)(2010-10#1)
and the inherent##2##3##(2008-3#1)(2009-9#1)
and the inhibitory effect of##2##5##(2008-8#1)(2011-3#1)
and the inhibitory effect##3##4##(2008-8#1)(2008-9#1)(2011-3#1)
and the inhibitory effects##2##4##(1994-8#1)(1995-11#1)
and the inhibitory##6##3##(1992-7#1)(1994-8#1)(1995-11#1)(2008-8#1)(2008-9#1)(2011-3#1)
and the initial##5##3##(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#1)
and the initiation of##2##4##(2008-9#1)(2009-3#1)
and the injection##2##3##(1997-3#1)(2008-10#1)
and the integration##2##3##(1994-12#1)(2011-1#1)
and the intensity of stereotypy performance##2##6##(2008-11#2)
and the intensity of the##3##5##(1993-3#1)(2008-10#1)(2008-3#1)
and the intensity of##6##4##(1993-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
and the intensity##7##3##(1993-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)
and the interaction between##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
and the interaction##7##3##(1995-6#1)(2008-10#4)(2008-11#1)(2011-2#1)
and the interactions of##2##4##(2008-10#1)(2008-4#1)
and the interactions##5##3##(2008-10#3)(2008-4#1)(2008-8#1)
and the interference from##2##4##(2008-10#2)
and the interference of##3##4##(2008-10#2)(2008-5#1)
and the interference##8##3##(2008-10#5)(2008-5#1)(2013-8#2)
and the intergenic region##2##4##(2008-10#2)
and the intergenic##3##3##(2008-10#3)
and the intermediate##2##3##(2008-3#1)(2008-6#1)
and the internal transcribed spacer##2##5##(2008-10#2)
and the internal##5##3##(1991-2#1)(1991-3#1)(2008-10#3)
and the interpretation of the##2##5##(2008-10#1)(2008-4#1)
and the interval##2##3##(1991-2#1)(2008-10#1)
and the interventionist##2##3##(2008-12#1)(2011-2#1)
and the intestinal##2##3##(2008-11#1)(2008-9#1)
and the intracellular##6##3##(1990-12#1)(1994-11#1)(1996-6#1)(2008-10#1)(2008-11#2)
and the intrinsic##3##3##(2008-10#3)
and the introduction of##2##4##(1991-3#1)(2008-12#1)
and the invisible##2##3##(1993-12#1)(2011-2#1)
and the ion##3##3##(2008-10#3)
and the ion-pair##2##3##(2008-10#2)
and the ionic strength##3##4##(2008-10#3)
and the irradiation time##2##4##(2008-10#2)
and the isolate##3##3##(2008-10#3)
and the isolated##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2010-6#1)
and the issues##2##3##(1997-4#1)(2008-10#1)
and the journal##2##3##(1995-5#1)(2013-1#1)
and the judicial system##2##4##(1997-8#1)(2008-12#1)
and the key##4##3##(1997-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
and the kidneys##2##3##(2008-1#1)(2008-5#1)
and the kinetic##4##3##(1997-2#1)(2008-10#2)(2010-10#1)
and the kinetics of##4##4##(1993-3#1)(2008-10#2)(2011-2#1)
and the knee##2##3##(2013-1#2)
and the knowledge of##3##4##(2008-10#2)(2013-1#1)
and the knowledge##6##3##(1993-11#1)(2008-10#2)(2010-9#1)(2012-3#1)(2013-1#1)
and the known##3##3##(1992-6#1)(1996-5#1)(2008-7#1)
and the lack of##13##4##(1991-2#1)(1993-3#1)(1995-11#1)(1995-2#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)
and the large##5##3##(1991-3#1)(1995-8#1)(2008-10#1)(2012-3#2)
and the larger the##2##4##(2008-10#1)(2008-3#1)
and the larger##4##3##(1994-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
and the laser##2##3##(2008-3#2)
and the last##8##3##(1991-11#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-6#1)(2008-7#1)
and the late##2##3##(2008-10#1)(2008-11#1)
and the lateral##5##3##(1993-6#1)(1994-2#1)(2008-7#1)(2008-8#1)(2009-7#1)
and the latter was##2##4##(1994-11#1)(2008-10#1)
and the latter##11##3##(1990-8#1)(1991-8#1)(1993-6#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
and the law##2##3##(1993-2#1)(1996-2#1)
and the leaf##2##3##(2008-10#1)(2008-8#1)
and the learning##2##3##(2008-12#1)(2008-8#1)
and the least##2##3##(2008-12#1)(2008-7#1)
and the left ventricular##3##4##(1993-12#1)(2008-12#2)
and the left##8##3##(1990-6#1)(1991-3#1)(1993-12#1)(1996-6#1)(2008-12#2)(2008-7#1)(2012-3#1)
and the legal##2##3##(1997-5#1)(2010-7#1)
and the length of the##4##5##(2007-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
and the length of##7##4##(1995-3#1)(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
and the length##9##3##(1995-3#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-1#1)
and the lessons##4##3##(2010-12#1)(2012-2#1)(2013-1#2)
and the level of##14##4##(1991-2#1)(1992-1#1)(1993-11#1)(1995-1#1)(2008-10#2)(2008-11#4)(2008-8#2)(2008-9#1)(2010-10#1)
and the level##15##3##(1991-2#1)(1992-1#1)(1993-11#1)(1995-1#1)(2008-10#3)(2008-11#4)(2008-8#2)(2008-9#1)(2010-10#1)
and the levels of##3##4##(2008-10#1)(2008-5#2)
and the levels##4##3##(2008-10#1)(2008-12#1)(2008-5#2)
and the life span##2##4##(2008-10#2)
and the life##3##3##(2008-10#2)(2008-8#1)
and the lifetime of##2##4##(2008-10#1)(2008-9#1)
and the lifetime##3##3##(2008-10#2)(2008-9#1)
and the ligand##3##3##(1997-2#1)(2008-10#2)
and the ligation of##2##4##(2008-2#1)(2011-3#1)
and the likelihood of##3##4##(2008-8#1)(2010-10#1)(2012-3#1)
and the likelihood##5##3##(2008-4#2)(2008-8#1)(2010-10#1)(2012-3#1)
and the likely##2##3##(2008-8#1)(2012-2#1)
and the limit of detection is 0##3##7##(2008-10#3)
and the limit of detection is##5##6##(2008-10#4)(2013-1#1)
and the limit of detection was 0##2##7##(2008-10#2)
and the limit of detection was##5##6##(2008-10#5)
and the limit of detection##14##5##(2008-10#13)(2013-1#1)
and the limit of quantification (LOQ)##2##6##(2008-10#2)
and the limit of quantification##8##5##(2008-10#7)(2008-5#1)
and the limit of##24##4##(2008-10#22)(2008-5#1)(2013-1#1)
and the limitation of the##2##5##(1991-3#1)(2008-10#1)
and the limitation of##3##4##(1991-3#1)(2008-10#2)
and the limitations of##3##4##(2008-1#1)(2008-11#1)(2012-12#1)
and the limitations##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
and the limited##5##3##(1994-12#1)(2008-11#2)(2009-10#1)(2011-2#1)
and the limits of detection (LOD)##2##6##(2008-10#2)
and the limits of detection were c(L##2##7##(2008-10#2)
and the limits of detection were##3##6##(2008-10#3)
and the limits of detection##7##5##(2008-10#7)
and the limits##8##3##(2008-10#8)
and the line##2##3##(2008-10#1)(2008-3#1)
and the linear dynamic range##2##5##(2008-10#2)
and the linear dynamic##3##4##(2008-10#3)
and the linear range is##2##5##(2008-10#2)
and the linear range##10##4##(2008-10#10)
and the linear##18##3##(2008-10#16)(2008-7#2)
and the linearity is maintained in the concentration range 0##3##10##(2008-10#3)
and the linearity##5##3##(2008-10#5)
and the lipid##3##3##(2008-11#1)(2009-7#1)(2013-1#1)
and the liquid##4##3##(2008-10#4)
and the literature##4##3##(1997-8#1)(2008-7#1)(2010-12#1)(2013-1#1)
and the liver##5##3##(1990-11#1)(1993-3#1)(1995-12#1)(1995-2#1)(2010-12#1)
and the local##7##3##(1991-12#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)
and the localization of the##2##5##(2008-9#1)(2012-3#1)
and the locus##2##3##(1991-2#1)(2008-7#1)
and the logarithm of##3##4##(2008-10#3)
and the long-term##3##3##(1994-2#1)(2008-11#1)(2008-8#1)
and the loss of the##2##5##(2008-10#1)(2013-7#1)
and the loss of##6##4##(2008-10#2)(2009-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
and the low##4##3##(1996-3#1)(2008-10#3)
and the lower limit##2##4##(2008-10#2)
and the lower##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
and the lowest##10##3##(1990-12#1)(1993-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#1)
and the luminol solution were sequentially introduced into the flow cell based on an SIA programmed sequence##2##17##(2008-10#2)
and the lungs##2##3##(1996-12#1)(2008-10#1)
and the magneto-optic##2##3##(2008-3#2)
and the magnitude of the##6##5##(1994-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
and the magnitude of##8##4##(1994-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
and the main##9##3##(1991-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#2)
and the maintenance of##5##4##(1995-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
and the major##6##3##(1994-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)
and the majority of the##2##5##(2009-3#1)(2012-2#1)
and the majority of##8##4##(2008-1#1)(2008-10#3)(2009-3#1)(2009-6#1)(2012-2#2)
and the majority##10##3##(1992-5#1)(2008-1#1)(2008-10#4)(2009-3#1)(2009-6#1)(2012-2#2)
and the making of##2##4##(2008-7#1)(2009-11#1)
and the management of##8##4##(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)
and the management##10##3##(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
and the mandibular##2##3##(2013-1#2)
and the manner of##2##4##(1995-11#1)(2008-10#1)
and the mass##6##3##(1994-12#1)(1995-3#1)(2008-10#2)(2008-7#1)(2010-6#1)
and the mature##3##3##(1990-5#1)(1994-8#1)(1995-6#1)
and the maximal##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
and the maximum##13##3##(2007-12#1)(2008-10#9)(2008-11#1)(2008-6#1)(2010-1#1)
and the mean ages of##2##5##(1997-7#1)(2008-12#1)
and the mean insulin level during the last 20 min of the clamp##2##13##(1994-12#2)
and the mean time of##2##5##(2008-11#1)(2009-3#1)
and the mean time##3##4##(2008-11#1)(2008-9#1)(2009-3#1)
and the mean##29##3##(1990-11#2)(1992-11#1)(1993-1#1)(1994-12#2)(1994-3#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-1#1)
and the measured##2##3##(2008-3#2)
and the measurement##4##3##(2008-10#4)
and the measures##3##3##(1996-8#1)(2008-8#1)(2010-11#1)
and the mechanism of##2##4##(1995-8#1)(2008-10#1)
and the mechanism##6##3##(1992-9#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
and the mechanisms by which##3##5##(2008-11#1)(2011-3#1)(2012-2#1)
and the mechanisms##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2011-3#1)(2012-2#1)
and the media##3##3##(1991-5#1)(1996-2#1)(2008-3#1)
and the median##5##3##(1991-6#1)(1993-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
and the medical community's##2##4##(2011-2#1)(2013-8#1)
and the medical##5##3##(2008-7#2)(2010-6#1)(2011-2#1)(2013-8#1)
and the medium##4##3##(2008-11#2)(2008-3#1)(2013-1#1)
and the membrane can be used for more than 3 months without##2##12##(2008-10#2)
and the membrane##8##3##(1994-5#1)(1995-6#1)(2008-10#5)(2008-5#1)
and the mental##2##3##(2009-6#1)(2011-2#1)
and the metabolic syndrome##5##4##(2008-10#1)(2008-3#2)(2010-5#2)
and the metabolic##7##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-5#2)
and the metal ion##2##4##(2008-10#2)
and the metal was determined by##2##6##(2008-10#2)
and the metal##9##3##(2008-10#9)
and the method has been##2##5##(2008-10#2)
and the method is##3##4##(2008-10#3)
and the method of##3##4##(1993-3#1)(2008-10#1)(2013-8#1)
and the method##15##3##(1993-3#1)(2008-10#12)(2010-11#1)(2013-8#1)
and the methodology##2##3##(2009-9#1)(2011-2#1)
and the methods##3##3##(2008-10#1)(2008-11#1)(2009-10#1)
and the middle##2##3##(1995-6#1)(1996-2#1)
and the migration##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
and the mild##2##3##(2008-10#2)
and the minimization of##2##4##(2006-6#1)(2008-3#1)
and the minor##2##3##(2007-12#1)(2008-10#1)
and the mirror##2##3##(2008-2#2)
and the mitochondrial small subunit (mtSSU) ribosomal RNA##2##8##(2008-10#2)
and the mitochondrial small subunit (mtSSU)##3##6##(2008-10#3)
and the mitochondrial##4##3##(2008-10#3)(2010-4#1)
and the mixing##2##3##(2008-10#1)(2008-7#1)
and the mixture of##2##4##(2008-10#2)
and the mixture##4##3##(2008-10#4)
and the mixtures of crosses##2##5##(2008-10#2)
and the mode of action of the##2##7##(1997-1#1)(1997-7#1)
and the mode of##4##4##(1993-8#1)(1997-1#1)(1997-7#1)(2008-9#1)
and the mode##5##3##(1993-8#1)(1997-1#1)(1997-7#1)(2008-7#1)(2008-9#1)
and the model##10##3##(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#1)(2013-8#1)
and the models##3##3##(2008-11#1)(2008-8#1)(2010-2#1)
and the moderating##2##3##(1996-2#1)(2010-1#1)
and the modification##2##3##(2008-10#2)
and the modified##6##3##(2008-10#4)(2008-11#2)
and the modulation##3##3##(2008-3#2)(2008-5#1)
and the molar absorptivity##3##4##(2008-10#3)
and the molar ratio of##2##5##(2008-10#1)(2011-2#1)
and the molar##7##3##(2008-10#6)(2011-2#1)
and the mole fraction##2##4##(2008-10#2)
and the molecular weight##2##4##(1997-8#1)(2008-10#1)
and the molecular##6##3##(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-8#1)
and the moral##2##3##(2008-11#2)
and the more##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
and the morphological##2##3##(1993-9#1)(2007-12#1)
and the mortality rate##2##4##(1992-9#1)(2008-8#1)
and the mortality##3##3##(1992-9#1)(2008-8#1)(2013-8#1)
and the most appropriate##2##4##(2008-10#1)(2011-2#1)
and the most common##2##4##(2008-7#1)(2012-12#1)
and the most frequently##2##4##(2008-10#1)(2009-3#1)
and the most##19##3##(1990-5#1)(1996-11#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
and the mouth##2##3##(2008-11#1)(2008-5#1)
and the movement##2##3##(1997-3#1)(2008-10#1)
and the multiple##3##3##(2008-10#1)(2009-7#1)(2013-1#1)
and the mutant##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
and the mutation##3##3##(1994-11#1)(2008-12#2)
and the name##2##3##(2008-10#1)(2008-8#1)
and the native##3##3##(1997-8#1)(2008-10#2)
and the natural##4##3##(1997-8#1)(2008-12#1)(2008-5#1)(2009-6#1)
and the nature of the##7##5##(1992-6#1)(1994-8#1)(2008-10#3)(2009-11#1)(2012-2#1)
and the nature of##10##4##(1992-6#1)(1994-8#1)(2008-10#4)(2008-11#2)(2009-11#1)(2012-2#1)
and the necessity of##5##4##(1993-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(2008-11#1)
and the necessity##6##3##(1993-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(2008-11#1)(2009-8#1)
and the need for a##2##5##(1996-6#1)(2007-11#1)
and the need for immediate medical##2##6##(2010-10#2)
and the need for##15##4##(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
and the need to##6##4##(2008-10#2)(2008-11#1)(2009-8#1)(2010-1#1)(2010-12#1)
and the need##21##3##(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-7#1)(2011-2#1)(2012-3#1)
and the needle##2##3##(1992-12#1)(2008-10#1)
and the needs of##3##4##(1992-3#1)(2008-10#1)(2010-11#1)
and the negative##2##3##(2008-10#1)(2008-6#1)
and the nematode##2##3##(1995-6#1)(2008-10#1)
and the nervous system##4##4##(1996-11#1)(2008-5#3)
and the nervous##5##3##(1996-11#1)(2008-5#3)(2009-6#1)
and the neurological##3##3##(2008-7#1)(2011-2#2)
and the new European directive##2##5##(1996-8#2)
and the new##11##3##(1992-11#1)(1995-10#1)(1995-2#1)(1996-8#2)(2008-10#3)(2008-11#1)(2008-9#1)(2009-7#1)
and the next##3##3##(1994-8#1)(1997-4#1)(2013-8#1)
and the non-charged##2##3##(2008-10#2)
and the nonlinear##2##3##(2008-3#2)
and the normal##2##3##(1994-11#1)(1996-3#1)
and the normalized sporulation curve##2##5##(2008-10#2)
and the nucleotide sequence##2##4##(1993-9#1)(2008-10#1)
and the nucleotide##3##3##(1993-9#1)(1997-8#1)(2008-10#1)
and the nucleus##11##3##(1996-12#2)(1997-3#2)(2008-10#1)(2008-11#3)(2008-7#1)(2011-2#2)
and the number of cases##2##5##(1994-9#2)
and the number of conidia and appressoria were counted##2##9##(2008-10#2)
and the number of conidia##3##5##(2008-10#3)
and the number of embryos##2##5##(1992-3#1)(2008-12#1)
and the number of single cells##2##6##(2008-7#2)
and the number of##62##4##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-6#1)(1994-9#2)(1996-2#2)(2007-12#2)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2010-1#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
and the number##63##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-6#1)(1994-9#2)(1995-8#1)(1996-2#2)(2007-12#2)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2010-1#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
and the numbers of##2##4##(1997-5#1)(2008-11#1)
and the numerical##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
and the nursing##2##3##(2008-11#2)
and the objective##5##3##(1991-2#1)(2008-10#1)(2008-8#1)(2008-9#2)
and the observed##5##3##(1993-8#1)(2008-10#3)(2008-11#1)
and the obtained results were##2##5##(2008-10#2)
and the obtained results##6##4##(2008-10#6)
and the obtained##12##3##(2008-10#12)
and the occurrence of##3##4##(2008-7#1)(2009-3#1)(2011-2#1)
and the old##2##3##(2008-10#1)(2008-7#1)
and the older##3##3##(1996-12#1)(2008-10#2)
and the olfactory##2##3##(1994-2#1)(2008-7#1)
and the one##2##3##(1997-6#1)(2008-10#1)
and the ones##2##3##(1997-4#1)(2011-2#1)
and the ongoing##2##3##(1992-2#1)(1996-2#1)
and the only##7##3##(1997-4#1)(2007-8#1)(2008-10#3)(2011-2#1)(2012-2#1)
and the onset of##5##4##(1996-2#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
and the operating##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
and the opportunity to##2##4##(2008-9#1)(2013-8#1)
and the optical##4##3##(2008-10#2)(2008-3#2)
and the optimal##8##3##(1992-9#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)
and the optimization of##3##4##(2008-10#2)(2011-3#1)
and the optimized##4##3##(2008-10#4)
and the optimum conditions##2##4##(2008-10#2)
and the optimum##6##3##(2008-10#5)(2008-12#1)
and the organic solvent##2##4##(2008-10#2)
and the organic##3##3##(2008-10#3)
and the organism##2##3##(2008-10#1)(2008-8#1)
and the organization of the##2##5##(1992-3#1)(1995-5#1)
and the origin and##2##4##(2008-11#1)(2008-9#1)
and the origin##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
and the original##3##3##(2008-10#2)(2013-8#1)
and the osteotomy site##2##4##(2011-2#2)
and the osteotomy##3##3##(2009-10#1)(2011-2#2)
and the other 2##2##4##(1995-12#1)(2013-1#1)
and the other a##5##4##(1991-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
and the other as##2##4##(2008-10#2)
and the other consisting of##2##5##(2008-10#1)(2008-7#1)
and the other four##2##4##(1996-12#1)(2008-10#1)
and the other from##3##4##(2008-10#3)
and the other group##2##4##(1992-12#1)(2013-8#1)
and the other in a##2##5##(2008-10#1)(2012-12#1)
and the other in##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
and the other is a##2##5##(2008-3#2)
and the other is##3##4##(1992-9#1)(2008-3#2)
and the other six##2##4##(2008-10#1)(2008-5#1)
and the other two##3##4##(1995-3#1)(2008-10#2)
and the other was##3##4##(2008-10#1)(2013-1#2)
and the other which##2##4##(1990-5#1)(1990-8#1)
and the other with##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
and the other##111##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-9#1)(1993-1#1)(1993-11#2)(1994-11#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-12#2)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#37)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#5)(2013-8#2)
and the others##5##3##(1994-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
and the outcome##3##3##(1991-6#1)(1997-3#1)(2011-2#1)
and the outer##2##3##(2008-10#1)(2008-3#1)
and the output##9##3##(2008-10#2)(2008-3#2)(2008-7#1)(2010-8#4)
and the ovarian##2##3##(1990-11#1)(2008-12#1)
and the ovaries were exposed##2##5##(1992-3#2)
and the overall survival was##2##5##(2011-2#1)(2013-1#1)
and the overall survival##3##4##(2010-11#1)(2011-2#1)(2013-1#1)
and the overall##14##3##(1992-2#1)(1994-6#1)(2008-10#6)(2008-11#2)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
and the oxidation peak##2##4##(2008-10#2)
and the oxidation##3##3##(2008-10#3)
and the pH of the##5##5##(2008-10#4)(2008-5#1)
and the pH was adjusted to##2##6##(2008-10#2)
and the pH##10##3##(1994-5#1)(2008-10#8)(2008-5#1)
and the paired##2##3##(1990-12#1)(2011-2#1)
and the parameters##5##3##(1994-8#1)(2008-10#4)
and the parent drug##3##4##(2008-10#2)(2013-1#1)
and the parent##6##3##(1995-9#1)(2008-10#3)(2009-9#1)(2013-1#1)
and the parental##2##3##(2008-8#1)(2011-1#1)
and the partial sequence of##2##5##(1993-12#1)(2008-10#1)
and the partial##5##3##(1993-12#1)(2008-10#2)(2008-4#1)(2011-3#1)
and the participation##2##3##(2008-11#1)(2009-11#1)
and the pathogen##12##3##(2008-10#10)(2008-8#1)(2009-6#1)
and the pathogenesis of##2##4##(2013-1#2)
and the pathologic##2##3##(2008-9#1)(2010-6#1)
and the pathological##4##3##(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
and the patient died##2##4##(2009-8#1)(2011-2#1)
and the patient had an uneventful recovery##2##7##(2010-7#1)(2012-2#1)
and the patient had##4##4##(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
and the patient underwent##2##4##(2010-12#1)(2011-2#1)
and the patient was referred##2##5##(2008-8#1)(2011-1#1)
and the patient was treated##2##5##(2008-11#1)(2008-12#1)
and the patient was##10##4##(1993-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
and the patient##30##3##(1993-1#1)(1993-12#1)(1994-1#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and the patient's##2##3##(2011-2#1)(2012-2#1)
and the patients##6##3##(1990-9#1)(1991-1#1)(1996-2#1)(2010-11#1)(2010-12#1)(2013-8#1)
and the pattern of##4##4##(1994-5#1)(2008-10#3)
and the pattern##5##3##(1990-9#1)(1994-5#1)(2008-10#3)
and the paucity of##2##4##(1997-2#1)(1997-9#1)
and the peak current##2##4##(2008-10#2)
and the peak height##2##4##(1993-8#1)(2008-10#1)
and the peak##10##3##(1993-8#1)(1995-8#1)(2008-10#7)(2011-2#1)
and the perceived##6##3##(1992-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
and the percentage of##4##4##(1996-3#1)(1997-8#1)(2008-12#1)(2011-2#1)
and the percentage##5##3##(1996-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
and the percentages of##2##4##(1993-8#1)(2008-10#1)
and the performance of the##4##5##(2008-2#1)(2008-3#2)(2010-4#1)
and the performance of##7##4##(2008-10#3)(2008-2#1)(2008-3#2)(2010-4#1)
and the performance##9##3##(2008-10#5)(2008-2#1)(2008-3#2)(2010-4#1)
and the performances of the##2##5##(2008-10#2)
and the performances##3##3##(2008-10#3)
and the period of##3##4##(2008-8#1)(2011-2#1)(2012-4#1)
and the permeability of##2##4##(2008-10#1)(2008-7#1)
and the phase##2##3##(1991-9#1)(1995-2#1)
and the phenotypes##2##3##(1997-8#1)(2008-9#1)
and the phloem##2##3##(2008-10#1)(2008-11#1)
and the physical##7##3##(1991-1#1)(1994-3#1)(2008-10#1)(2008-2#2)(2008-9#1)(2013-1#1)
and the physician##2##3##(1990-9#1)(2007-12#1)
and the physiological##2##3##(2011-2#2)
and the physiopathological##2##3##(1992-5#1)(1993-6#1)
and the pineal hormone melatonin##2##5##(1991-6#1)(1992-12#1)
and the plants##3##3##(2008-10#2)(2008-9#1)
and the plasma##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
and the platinum group elements##2##5##(2008-10#2)
and the play##2##3##(1992-12#1)(2012-2#1)
and the point-measure##2##3##(2012-2#2)
and the polarization##3##3##(1991-5#1)(2007-12#1)(2008-3#1)
and the polycystic ovary syndrome##2##5##(2008-3#1)(2008-4#1)
and the polymerase chain reaction##2##5##(1991-9#1)(2008-10#1)
and the polyurethane foam##2##4##(2008-10#2)
and the population of##2##4##(1995-1#1)(1996-6#1)
and the population##9##3##(1994-2#1)(1995-1#1)(1996-6#1)(2008-10#4)(2008-8#1)(2011-2#1)
and the position of the##5##5##(2008-3#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
and the position of##7##4##(1990-5#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
and the positive##6##3##(1990-9#1)(1993-11#1)(1997-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
and the possibilities of##2##4##(2008-10#1)(2011-3#1)
and the possibilities##3##3##(2008-10#2)(2011-3#1)
and the possibility of##10##4##(1991-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
and the possibility##12##3##(1991-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
and the possible mechanism of catalytic reaction is proposed##2##9##(2008-10#2)
and the possible mechanism of catalytic reaction##3##7##(2008-10#3)
and the possible##20##3##(1991-5#1)(1992-12#1)(1996-2#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-6#1)(2010-12#2)(2012-2#1)(2012-4#1)
and the posterior##3##3##(1997-8#1)(2007-12#1)(2010-12#1)
and the postoperative##3##3##(1991-2#1)(2008-7#1)(2013-1#1)
and the potential for##8##4##(1991-6#1)(1996-12#1)(1997-1#1)(2008-10#2)(2011-2#3)
and the potential impact of##2##5##(2008-10#1)(2013-8#1)
and the potential of##8##4##(1994-1#1)(2008-10#5)(2009-10#1)(2012-2#1)
and the potential##34##3##(1991-6#1)(1994-1#1)(1994-11#1)(1996-12#1)(1997-1#1)(2008-10#11)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#2)
and the potentiation of##2##4##(1992-8#1)(2008-4#1)
and the potentiometric##2##3##(2008-10#2)
and the power of##2##4##(1996-3#1)(2009-6#1)
and the power##6##3##(1995-12#2)(1996-3#1)(2008-3#1)(2008-7#1)(2009-6#1)
and the practical##7##3##(1992-5#1)(1993-1#1)(1995-3#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-3#1)
and the practice##3##3##(1990-3#1)(2008-11#1)(2012-3#1)
and the practitioner##2##3##(1991-12#1)(1994-1#1)
and the precision and accuracy of the##2##7##(2008-10#2)
and the precision of the method##2##6##(2008-10#2)
and the precision of the##3##5##(2008-10#3)
and the precision was##2##4##(2008-10#2)
and the precision##15##3##(2008-10#15)
and the preconcentration##2##3##(2008-10#2)
and the predicted##2##3##(1995-2#1)(2008-10#1)
and the prediction##2##3##(2008-3#1)(2011-2#1)
and the preoperative##2##3##(2011-2#1)(2012-12#1)
and the presence of a##8##5##(1994-5#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
and the presence of abundant##2##5##(2008-7#1)(2009-10#1)
and the presence of an##3##5##(2008-10#1)(2008-11#1)(2013-1#1)
and the presence of calcium ions##2##6##(1995-8#1)(2008-10#1)
and the presence of congestive heart failure or weight loss##2##10##(2012-3#2)
and the presence of multiple##2##5##(1992-6#1)(2008-10#1)
and the presence of other##2##5##(2008-7#1)(2010-6#1)
and the presence of small##2##5##(2008-10#1)(2008-7#1)
and the presence of the##4##5##(1991-5#1)(1994-2#1)(2008-10#1)(2011-2#1)
and the presence of##66##4##(1991-5#2)(1992-6#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-8#2)(1996-3#1)(1997-3#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#2)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
and the presence or absence of##2##6##(1991-5#1)(2008-10#1)
and the presence##69##3##(1991-5#3)(1992-6#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-8#2)(1996-3#1)(1997-3#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#2)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
and the present##3##3##(1991-11#1)(1991-8#1)(2008-10#1)
and the prevalence of the##2##5##(2008-10#1)(2013-1#1)
and the prevalence of##7##4##(1994-2#1)(1997-5#1)(2008-10#2)(2009-12#1)(2009-8#1)(2013-1#1)
and the prevalence##9##3##(1994-2#1)(1997-5#1)(2008-10#3)(2008-7#1)(2009-12#1)(2009-8#1)(2013-1#1)
and the prevention of##4##4##(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
and the prevention##5##3##(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
and the primary##2##3##(2008-9#1)(2012-3#1)
and the principal##2##3##(1991-1#1)(2008-11#1)
and the principle of##2##4##(2008-10#2)
and the principles of##2##4##(2012-2#1)(2012-3#1)
and the probability of##10##4##(1992-2#1)(1995-12#1)(2008-10#3)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#1)
and the probability##11##3##(1992-2#1)(1995-12#1)(2008-10#3)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
and the probe##2##3##(2008-10#2)
and the problem##2##3##(2008-10#1)(2011-2#1)
and the problems##3##3##(1990-5#1)(1997-2#1)(1997-5#1)
and the procedure##4##3##(2008-10#3)(2008-7#1)
and the process of##3##4##(1991-2#1)(2008-11#1)(2008-12#1)
and the process##6##3##(1991-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-8#1)
and the produced##4##3##(1990-5#1)(2008-10#2)(2008-8#1)
and the product##4##3##(2008-10#2)(2011-2#2)
and the production of reactive oxygen species##2##7##(1994-5#1)(2008-10#1)
and the production of reactive oxygen##3##6##(1994-5#2)(2008-10#1)
and the production of##13##4##(1994-2#1)(1994-5#2)(2008-10#4)(2008-11#2)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
and the production##14##3##(1994-2#1)(1994-5#2)(2008-10#4)(2008-11#2)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
and the productivity of##2##4##(2008-10#1)(2008-11#1)
and the productivity##3##3##(2008-10#1)(2008-11#2)
and the products of##2##4##(1991-12#1)(2008-10#1)
and the products##3##3##(1991-12#1)(2008-10#2)
and the profile of##3##4##(1991-2#1)(2008-3#1)(2012-12#1)
and the progeny##2##3##(2008-10#2)
and the prognosis##3##3##(1991-8#1)(1996-9#1)(2007-8#1)
and the progress##2##3##(1991-12#1)(2008-7#1)
and the properties of the##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
and the properties of##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)
and the properties##7##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-2#1)
and the proportion of leaflets##2##5##(2008-10#2)
and the proportion of the##2##5##(2008-10#2)
and the proportion of##10##4##(1993-3#1)(1996-11#1)(2008-10#5)(2008-11#1)(2011-2#2)
and the proportion##11##3##(1993-3#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#2)
and the proportional##2##3##(1992-6#1)(2008-10#1)
and the proposed method##5##4##(2008-10#4)(2008-9#1)
and the proposed##9##3##(2008-10#7)(2008-6#1)(2008-9#1)
and the prospects##2##3##(2008-3#1)(2011-7#1)
and the protection##2##3##(2008-10#1)(2010-4#1)
and the protective effects##2##4##(2008-7#1)(2009-7#1)
and the protective##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)
and the protein##8##3##(1991-11#1)(1991-5#1)(1995-6#1)(1997-2#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)
and the proteins##2##3##(1995-2#1)(2008-4#1)
and the provision of##4##4##(1991-12#1)(1996-3#1)(2008-11#2)
and the proximal##2##3##(1996-8#1)(2008-7#1)
and the psychiatric##2##3##(1992-2#1)(1996-11#1)
and the public to##2##4##(1994-1#1)(2008-4#1)
and the public##11##3##(1992-1#1)(1994-1#1)(1996-11#1)(1996-2#2)(1996-6#1)(2008-12#2)(2008-4#1)(2009-12#2)
and the pulse##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
and the pump##2##3##(2008-2#1)(2008-3#1)
and the purification##2##3##(2008-1#1)(2008-10#1)
and the purity##2##3##(2008-10#1)(2008-7#1)
and the putative##2##3##(2008-10#1)(2012-3#1)
and the quality of life##2##5##(2008-7#1)(2012-3#1)
and the quality of the##2##5##(2008-3#1)(2008-8#1)
and the quality of##8##4##(1993-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
and the quality##9##3##(1993-1#1)(1993-3#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
and the quantification limit##3##4##(2008-10#3)
and the quantification##5##3##(2008-10#5)
and the quantitative determination of##2##5##(2008-10#2)
and the quantitative determination##3##4##(2008-10#3)
and the quantitative##4##3##(2008-10#4)
and the quantum##2##3##(2008-11#1)(2008-3#1)
and the quenching##3##3##(1995-8#1)(2008-10#2)
and the question of##2##4##(1991-12#1)(2008-12#1)
and the random##3##3##(2008-10#1)(2010-8#2)
and the range of##2##4##(2009-12#1)(2013-8#1)
and the range##3##3##(1996-2#1)(2009-12#1)(2013-8#1)
and the raphe##2##3##(1991-12#1)(1997-3#1)
and the rat##3##3##(1994-11#1)(1996-2#1)(2008-9#1)
and the rate constant##2##4##(2008-10#1)(2008-7#1)
and the rate of##11##4##(1994-3#1)(1994-8#1)(1996-2#1)(2008-10#4)(2008-11#2)(2011-1#1)(2012-3#1)
and the rate##17##3##(1990-6#1)(1994-3#1)(1994-8#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-7#2)(2011-1#1)(2012-3#2)
and the ratio of##6##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-3#1)
and the ratio##8##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-3#1)
and the reaction conditions##2##4##(2008-10#1)(2013-8#1)
and the reaction mechanisms presented##2##5##(2008-10#2)
and the reaction of##2##4##(2008-10#2)
and the reaction##14##3##(2008-10#12)(2008-8#1)(2013-8#1)
and the reactivity of##2##4##(2008-10#2)
and the reagent##6##3##(2008-10#5)(2008-5#1)
and the reagents##4##3##(2008-10#3)(2008-11#1)
and the received##2##3##(2008-3#2)
and the recent##2##3##(2009-9#1)(2010-5#1)
and the recently##2##3##(2008-10#1)(2010-12#1)
and the receptors##2##3##(1993-2#1)(2011-2#1)
and the recombinant##3##3##(2008-11#1)(2008-8#1)(2011-1#1)
and the reconstruction of##3##4##(1994-3#1)(1996-8#1)(2008-3#1)
and the reconstruction##4##3##(1994-3#1)(1996-8#1)(2008-11#1)(2008-3#1)
and the recoveries are in the range of##2##8##(2008-10#2)
and the recoveries are##3##4##(2008-10#3)
and the recoveries obtained##2##4##(2008-10#2)
and the recoveries of##2##4##(2008-10#2)
and the recoveries were in the range of##2##8##(2008-10#2)
and the recoveries##11##3##(2008-10#11)
and the recovery of##3##4##(2008-10#3)
and the recovery was##4##4##(2008-10#4)
and the recovery##16##3##(2008-10#16)
and the recycling of##2##4##(1994-8#1)(2008-9#1)
and the reduced##2##3##(2008-10#1)(2010-3#1)
and the reduction of##4##4##(2008-10#2)(2008-12#1)(2009-6#1)
and the reduction##6##3##(1991-1#1)(2008-10#3)(2008-12#1)(2009-6#1)
and the reference##10##3##(2008-10#7)(2008-3#3)
and the regional##4##3##(1994-3#1)(1997-2#1)(2008-10#2)
and the regioselectivity##2##3##(1996-5#1)(2008-8#1)
and the regression equation##2##4##(2008-10#2)
and the regression##3##3##(2008-10#3)
and the regulation of##6##4##(1994-12#1)(1996-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
and the regulation##7##3##(1994-12#1)(1996-2#1)(1997-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
and the regulatory gene##2##4##(2008-10#1)(2011-1#1)
and the regulatory##3##3##(1995-6#1)(2008-10#1)(2011-1#1)
and the related##5##3##(1991-1#1)(1995-2#1)(2008-10#2)(2011-3#1)
and the relation##2##3##(2008-8#1)(2013-1#1)
and the relationship between the two##2##6##(2008-11#1)(2009-8#1)
and the relationship between the##3##5##(2008-11#1)(2008-3#1)(2009-8#1)
and the relationship between##12##4##(1991-12#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-8#1)(2009-3#1)(2009-8#1)(2012-2#1)
and the relationship##14##3##(1991-12#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-8#1)(2009-3#1)(2009-8#1)(2012-2#1)
and the relationships##2##3##(2008-10#1)(2008-9#1)
and the relative standard deviation (R##12##6##(2008-10#12)
and the relative standard deviation (RSD)##2##6##(2008-10#2)
and the relative standard deviation for 0##3##7##(2008-10#3)
and the relative standard deviation for eight##2##7##(2008-10#2)
and the relative standard deviation for##7##6##(2008-10#7)
and the relative standard deviation is##5##6##(2008-10#5)
and the relative standard deviation of##2##6##(2008-10#2)
and the relative standard deviation was##5##6##(2008-10#5)
and the relative standard deviation##38##5##(2008-10#38)
and the relative standard deviations (R##3##6##(2008-10#3)
and the relative standard deviations were##3##6##(2008-10#3)
and the relative standard deviations##9##5##(2008-10#9)
and the relative standard##48##4##(2008-10#48)
and the relative##73##3##(1991-3#1)(1994-1#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#57)(2008-11#1)(2008-4#3)(2008-8#4)(2008-9#1)(2012-12#1)(2013-8#1)
and the release of##5##4##(1995-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
and the relevance##2##3##(2008-10#1)(2011-2#1)
and the relevant##7##3##(1990-8#1)(2008-10#5)(2010-1#1)
and the reliability of##2##4##(2009-1#1)(2010-8#1)
and the reliability##3##3##(2008-3#1)(2009-1#1)(2010-8#1)
and the remainder##3##3##(2008-10#1)(2008-9#1)(2010-12#1)
and the remaining isolates##2##4##(2008-10#2)
and the remaining##16##3##(1991-3#1)(1991-8#1)(1994-2#1)(1996-1#1)(1996-12#2)(1996-6#1)(2008-10#6)(2011-10#1)(2011-2#1)(2012-3#1)
and the removal of##3##4##(1995-6#1)(2008-10#1)(2011-2#1)
and the repeatability of##2##4##(2008-10#2)
and the repeatability##4##3##(2008-10#4)
and the representative##2##3##(2008-10#1)(2013-8#1)
and the reproducibility of the##4##5##(2008-10#2)(2008-9#1)(2010-7#1)
and the reproducibility of##5##4##(2008-10#2)(2008-9#1)(2010-5#1)(2010-7#1)
and the reproducibility was##2##4##(2008-10#2)
and the reproducibility##11##3##(2008-10#8)(2008-9#1)(2010-5#1)(2010-7#1)
and the reproductive##2##3##(2008-10#1)(2008-9#1)
and the required##3##3##(2008-10#2)(2008-3#1)
and the requirement for##3##4##(1996-1#1)(2010-7#1)(2013-8#1)
and the requirement##5##3##(1992-9#1)(1996-1#1)(2008-11#1)(2010-7#1)(2013-8#1)
and the requirements##2##3##(2012-3#2)
and the residual##4##3##(1991-1#1)(2008-10#2)(2009-10#1)
and the resin##2##3##(2008-10#2)
and the resin-phase (31)P##2##4##(2008-10#2)
and the resistance##2##3##(2008-10#1)(2011-3#1)
and the resistant##4##3##(2008-10#3)(2008-11#1)
and the resolution##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
and the resonance##2##3##(2008-3#2)
and the resource##2##3##(1992-2#1)(2008-10#1)
and the respective##2##3##(2008-10#2)
and the respiratory##3##3##(1994-11#1)(2008-5#1)(2012-3#1)
and the response of##5##4##(1991-3#1)(2008-10#1)(2008-8#2)(2013-8#1)
and the response surface##2##4##(2008-10#2)
and the response time##2##4##(2008-10#2)
and the response to##5##4##(1991-2#1)(1994-3#1)(2008-1#1)(2008-8#1)(2013-1#1)
and the response##16##3##(1991-2#1)(1991-3#1)(1991-6#1)(1994-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-8#3)(2013-1#1)(2013-8#1)
and the responses of##2##4##(2008-10#1)(2008-8#1)
and the rest##4##3##(1991-1#1)(2008-10#2)(2011-2#1)
and the restenosis rate##2##4##(2008-12#2)
and the result is##2##4##(1990-12#1)(2008-8#1)
and the result was satisfactory##2##5##(2008-10#2)
and the result##6##3##(1990-12#1)(2008-10#3)(2008-8#1)(2012-12#1)
and the resultant##6##3##(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
and the resulting solution is##3##5##(2008-10#3)
and the resulting solution##4##4##(2008-10#4)
and the resulting##32##3##(1991-2#2)(1993-8#1)(1996-1#1)(1997-8#1)(2008-10#17)(2008-3#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-10#1)(2010-5#1)(2012-2#2)
and the results agreed with the##2##6##(2008-10#2)
and the results agreed with##4##5##(2008-10#4)
and the results are compared with the##3##7##(2008-10#3)
and the results are compared with those##2##7##(2008-10#2)
and the results are compared with##6##6##(2008-10#5)(2008-3#1)
and the results are compared##8##5##(2008-10#7)(2008-3#1)
and the results are##11##4##(2008-10#8)(2008-3#1)(2010-12#1)(2012-2#1)
and the results compared with those obtained with##2##8##(2008-10#2)
and the results compared with those obtained##3##7##(2008-10#3)
and the results compared with those##4##6##(2008-10#4)
and the results demonstrated##2##4##(2008-10#2)
and the results for##3##4##(2008-10#2)(2008-9#1)
and the results from##2##4##(2008-10#1)(2008-9#1)
and the results indicated that the##2##6##(2008-8#1)(2011-3#1)
and the results indicated##3##4##(2008-10#1)(2008-8#1)(2011-3#1)
and the results obtained by##2##5##(2008-10#2)
and the results obtained were##2##5##(2008-10#2)
and the results obtained with the##2##6##(2008-10#2)
and the results obtained##12##4##(2008-10#11)(2011-2#1)
and the results of a##2##5##(1992-1#1)(2008-9#1)
and the results of our##2##5##(1990-9#1)(2008-8#1)
and the results of the first##2##6##(1990-2#1)(2008-5#1)
and the results of the##3##5##(1990-2#1)(2008-3#1)(2008-5#1)
and the results of##13##4##(1990-2#1)(1990-9#1)(1992-1#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
and the results show that##3##5##(2008-10#2)(2008-8#1)
and the results showed that the##2##6##(2008-10#2)
and the results showed that##4##5##(2008-10#4)
and the results showed##7##4##(2008-10#7)
and the results well agreed with the##2##7##(2008-10#2)
and the results were compared to##2##6##(2008-10#2)
and the results were compared with those obtained##2##8##(2008-10#2)
and the results were compared with those##3##7##(2008-10#3)
and the results were compared with##7##6##(1996-3#1)(2008-10#6)
and the results were compared##12##5##(1994-3#1)(1996-3#1)(2008-10#10)
and the results were consistent##2##5##(2008-10#1)(2013-1#1)
and the results were found to be##4##7##(1997-2#1)(2008-10#3)
and the results were in agreement with those obtained by##2##10##(2008-10#2)
and the results were in agreement with##3##7##(2008-10#3)
and the results were in good agreement with the##2##9##(2008-10#2)
and the results were in good agreement with those##2##9##(2008-10#2)
and the results were in good agreement with##4##8##(2008-10#4)
and the results were in##8##5##(2008-10#8)
and the results were satisfactory##2##5##(2008-10#2)
and the results were statistically compared##2##6##(2008-10#2)
and the results were##37##4##(1990-12#1)(1994-3#1)(1994-5#1)(1996-3#1)(1997-2#1)(2008-10#30)(2008-9#1)(2013-1#1)
and the results##118##3##(1990-12#2)(1990-2#1)(1990-9#1)(1992-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#83)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#3)(2008-9#4)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and the retention##2##3##(2008-10#1)(2011-2#1)
and the retrieved##2##3##(2008-3#2)
and the revised##2##3##(2008-9#1)(2010-11#1)
and the rhizosphere##2##3##(2008-10#2)
and the risk of cancer##2##5##(1990-8#1)(1994-2#1)
and the risk of##21##4##(1990-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(2008-11#3)(2008-12#3)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#2)
and the risk##23##3##(1990-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(2008-11#3)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#2)
and the risks##3##3##(1992-3#1)(1996-6#1)(2008-8#1)
and the rms##2##3##(1992-4#1)(2008-8#1)
and the role of the##8##5##(1992-2#1)(1993-12#1)(1995-2#1)(2008-11#2)(2008-6#1)(2009-7#1)(2012-3#1)
and the role of these##3##5##(1991-2#1)(2008-10#2)
and the role of##41##4##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(2006-6#1)(2008-10#4)(2008-11#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-2#1)(2013-8#1)
and the role##46##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2006-6#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-2#1)(2013-8#1)
and the roles of##2##4##(2008-10#1)(2011-2#1)
and the root##3##3##(2008-10#2)(2008-9#1)
and the safe##2##3##(1993-1#2)
and the safety of##2##4##(1992-5#1)(2008-10#1)
and the safety##3##3##(1992-5#1)(1994-6#1)(2008-10#1)
and the same##13##3##(1990-5#1)(1995-6#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)
and the sample size##2##4##(2008-10#2)
and the sample throughput was##2##5##(2008-10#2)
and the sample throughput##6##4##(2008-10#6)
and the sample##19##3##(2008-10#17)(2008-3#1)(2008-8#1)
and the samples were##2##4##(2008-10#1)(2011-3#1)
and the samples##3##3##(2008-10#2)(2011-3#1)
and the sampling frequency##2##4##(2008-10#2)
and the sampling rate was##2##5##(2008-10#2)
and the sampling##8##3##(2008-10#7)(2008-2#1)
and the scattering##2##3##(2008-3#2)
and the scientific##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
and the screening##2##3##(2010-10#1)(2012-12#1)
and the search for##2##4##(2008-4#1)(2012-2#1)
and the search##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
and the second is##3##4##(2008-3#2)(2008-8#1)
and the second most##2##4##(2008-5#1)(2010-10#1)
and the second one##2##4##(1994-11#1)(1995-6#1)
and the second was##2##4##(2008-10#1)(2009-8#1)
and the second##36##3##(1991-5#1)(1992-3#1)(1993-8#1)(1994-11#2)(1995-6#2)(1996-3#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-6#1)(2011-2#1)(2012-12#1)
and the secondary##4##3##(2007-12#1)(2008-10#2)(2008-9#1)
and the secretion of##3##4##(1993-3#1)(2008-11#2)
and the selective##2##3##(2008-10#1)(2009-7#1)
and the selectivity of##3##4##(2008-10#3)
and the selectivity##10##3##(2008-10#10)
and the sensing##2##3##(2008-10#2)
and the sensitivity and specificity of##2##6##(1990-9#1)(2012-2#1)
and the sensitivity of the method##2##6##(1990-12#1)(2008-10#1)
and the sensitivity of the##4##5##(1990-12#1)(2008-10#3)
and the sensitivity of##7##4##(1990-12#1)(2008-10#6)
and the sensitivity##12##3##(1990-12#1)(1990-9#1)(2008-10#9)(2012-2#1)
and the sensor##5##3##(2008-10#5)
and the sensors##2##3##(2008-10#2)
and the separation between the##2##5##(2008-10#1)(2009-2#1)
and the separation of##3##4##(2008-10#3)
and the separation##6##3##(2008-10#4)(2008-9#1)(2009-2#1)
and the septum##3##3##(1994-2#1)(1996-12#1)(2008-9#1)
and the sequence of##3##4##(1994-11#1)(1996-8#1)(2008-10#1)
and the sequence##5##3##(1992-8#1)(1994-11#1)(1996-8#1)(2008-10#1)(2008-8#1)
and the sequential##2##3##(2008-10#2)
and the service##2##3##(1991-1#1)(2008-12#1)
and the severity of the##2##5##(1990-9#1)(1997-6#1)
and the severity of##8##4##(1990-9#1)(1995-12#1)(1997-6#1)(2008-10#3)(2008-5#1)(2011-2#1)
and the sexual##2##3##(1996-11#1)(2008-10#1)
and the shaking time##2##4##(2008-10#2)
and the shape of the##2##5##(2008-3#2)
and the shape of##3##4##(2008-3#3)
and the shell##2##3##(2008-12#1)(2008-7#1)
and the short reaction time##2##5##(2008-10#1)(2008-9#1)
and the short##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
and the side##4##3##(1997-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
and the sigma##2##3##(1992-5#1)(2012-2#1)
and the signal##8##3##(2008-10#4)(2008-3#1)(2010-6#1)(2010-8#1)(2013-8#1)
and the signal-to-noise ratio of##2##5##(2008-10#1)(2008-3#1)
and the signal-to-noise ratio##3##4##(2008-10#1)(2008-3#2)
and the signaling pathways activated##2##5##(1997-7#1)(2008-4#1)
and the significance of the##2##5##(1991-9#1)(2009-8#1)
and the significance of##3##4##(1991-9#1)(1996-2#1)(2009-8#1)
and the simultaneous##2##3##(2008-10#1)(2013-1#1)
and the single##2##3##(1995-6#1)(2008-10#1)
and the sink##2##3##(2008-8#1)(2008-9#1)
and the site##2##3##(2008-10#1)(2012-3#1)
and the situation##2##3##(2008-10#1)(2009-5#1)
and the six##2##3##(2008-1#1)(2010-8#1)
and the size distribution of##2##5##(2008-10#1)(2009-5#1)
and the size of the calibration##2##6##(2008-10#2)
and the size of the##5##5##(1990-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
and the size of##7##4##(1990-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
and the size##11##3##(1990-5#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
and the skin##6##3##(2008-5#5)(2011-2#1)
and the slope of the##2##5##(2008-10#1)(2008-8#1)
and the slope was##2##4##(2008-10#2)
and the slope##7##3##(2008-10#5)(2008-2#1)(2008-8#1)
and the slow##3##3##(1991-12#1)(2008-5#1)(2010-12#1)
and the slowest##2##3##(2008-10#1)(2008-11#1)
and the small##2##3##(2008-11#1)(2008-8#1)
and the smaller##2##3##(2008-10#1)(2011-2#1)
and the smallest##2##3##(2008-10#1)(2011-2#1)
and the so-called##3##3##(1993-6#1)(1994-6#1)(2008-3#1)
and the social and##2##4##(1996-2#1)(2011-2#1)
and the social##3##3##(1996-2#1)(2008-12#1)(2011-2#1)
and the software##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
and the soil microbial community##2##5##(2008-10#2)
and the soil##5##3##(2008-10#2)(2008-11#1)(2008-9#1)(2010-10#1)
and the solid phase extraction (SPE)##2##6##(2008-10#2)
and the solution is##2##4##(2008-10#2)
and the solvent extraction##2##4##(1995-2#1)(2008-10#1)
and the spatial##3##3##(2008-10#1)(2008-8#2)
and the specific##10##3##(1990-12#1)(1995-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
and the specificity 84%##2##4##(1990-2#2)
and the specificity of the##3##5##(1996-12#1)(2008-10#1)(2009-12#1)
and the specificity of##4##4##(1996-12#1)(2008-10#1)(2009-12#1)(2010-6#1)
and the specificity was##2##4##(1996-12#2)
and the specificity##9##3##(1990-2#2)(1994-8#1)(1996-12#3)(2008-10#1)(2009-12#1)(2010-6#1)
and the spread of##3##4##(2008-10#1)(2008-9#1)(2010-1#1)
and the stability constant##2##4##(2008-10#2)
and the stability of the##3##5##(2008-10#2)(2008-5#1)
and the stability of##9##4##(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)
and the stability##14##3##(2008-10#9)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)
and the stable##3##3##(1997-1#1)(2008-8#1)(2011-2#1)
and the stage of##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
and the standard addition##2##4##(2008-10#2)
and the standard deviation of the##2##6##(2008-3#2)
and the standard deviation of##3##5##(2008-10#1)(2008-3#2)
and the standard deviation##4##4##(2008-10#2)(2008-3#2)
and the standard reference##2##4##(2008-1#1)(2008-10#1)
and the standard##15##3##(1991-12#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-5#1)(2010-6#1)
and the start of treatment##3##5##(2012-12#3)
and the start of##4##4##(1991-6#1)(2012-12#3)
and the state##2##3##(1996-3#1)(2010-6#1)
and the stationary##2##3##(2008-10#1)(2008-11#1)
and the statistical##2##3##(1993-11#1)(2010-8#1)
and the stimulation##2##3##(2008-9#2)
and the stimulatory##3##3##(1990-12#1)(2008-11#1)(2008-7#1)
and the strain##3##3##(2008-10#2)(2011-2#1)
and the stream##3##3##(2008-10#3)
and the strengths and##2##4##(2008-11#1)(2011-2#1)
and the structural##4##3##(2008-10#3)(2008-9#1)
and the structure of##5##4##(2008-10#3)(2008-8#1)(2013-8#1)
and the structure##6##3##(2008-10#3)(2008-8#2)(2013-8#1)
and the structures##2##3##(2008-12#1)(2011-2#1)
and the studies##2##3##(2008-8#1)(2010-2#1)
and the study of##2##4##(1993-1#1)(2012-2#1)
and the study##6##3##(1993-1#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
and the subsequent derivation##2##4##(2008-10#1)(2008-11#1)
and the subsequent##24##3##(1991-3#1)(1992-3#1)(1993-8#1)(1995-3#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#2)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)
and the substrate##3##3##(2008-10#2)(2008-7#1)
and the sum of all##2##5##(1991-12#1)(2008-10#1)
and the sum of the##2##5##(2008-10#2)
and the sum of##5##4##(1991-12#1)(2008-10#4)
and the supporting##2##3##(1996-1#1)(2007-8#1)
and the suppression of##2##4##(2008-10#1)(2008-11#1)
and the surface##4##3##(2008-10#1)(2008-3#1)(2008-5#2)
and the surgical##3##3##(1991-6#1)(1993-1#1)(2013-1#1)
and the surrounding##6##3##(1993-11#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-7#2)
and the survival##3##3##(1995-3#1)(1997-4#1)(2008-8#1)
and the susceptible cultivar##2##4##(2008-10#2)
and the susceptible##8##3##(2008-10#7)(2008-5#1)
and the swollen##2##3##(2008-5#1)(2011-2#1)
and the symptoms##3##3##(1991-6#1)(2008-7#1)(2010-8#1)
and the synthesis of##3##4##(1996-12#1)(2008-4#1)(2012-2#1)
and the synthesis##4##3##(1996-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
and the system has##2##4##(2008-10#1)(2010-8#1)
and the system##7##3##(1995-3#1)(1996-2#1)(2008-10#3)(2010-8#1)(2013-8#1)
and the systemic##2##3##(2008-7#1)(2012-3#1)
and the target##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
and the technical##4##3##(1995-5#1)(1997-2#1)(2008-11#1)(2012-2#1)
and the temperature were##2##4##(2008-10#1)(2008-2#1)
and the temperature##11##3##(1990-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)
and the template##2##3##(2008-10#2)
and the term##2##3##(2008-9#1)(2011-2#1)
and the terminal##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
and the test##3##3##(1995-9#1)(2012-3#1)(2013-1#1)
and the tetramethylarsonium cation##2##4##(2008-10#2)
and the therapeutic##2##3##(2012-12#1)(2013-1#1)
and the thermal##4##3##(2008-2#2)(2008-3#2)
and the thermodynamic parameters##2##4##(2008-10#2)
and the thermodynamic##6##3##(2008-10#4)(2008-5#1)(2008-8#1)
and the thickness of the##3##5##(1991-5#1)(2008-10#1)(2008-2#1)
and the thickness of##4##4##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
and the third##12##3##(1992-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#2)
and the three##7##3##(1991-6#1)(1991-8#1)(1993-6#1)(1995-3#1)(1997-9#1)(2008-3#1)(2013-8#1)
and the threshold for##2##4##(1994-2#1)(1995-11#1)
and the time of##4##4##(2008-10#2)(2008-7#1)(2008-8#1)
and the time to##2##4##(2008-10#1)(2013-1#1)
and the time##16##3##(1995-12#1)(1996-6#1)(2008-10#7)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and the timing of##5##4##(1995-5#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
and the timing##7##3##(1995-5#1)(2008-10#1)(2008-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
and the titer##2##3##(1992-12#1)(2013-8#1)
and the tools to##3##4##(1993-12#2)(2011-2#1)
and the total amount of##2##5##(1996-12#1)(2010-4#1)
and the total number of##3##5##(1994-2#1)(2008-10#1)(2010-1#1)
and the total##17##3##(1994-2#1)(1996-12#1)(2008-10#8)(2008-5#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)
and the traditional##2##3##(1996-2#1)(2008-10#1)
and the transcription##3##3##(1993-6#1)(2008-11#1)(2010-4#1)
and the transcriptional##2##3##(1996-12#1)(2010-1#1)
and the transient##2##3##(2008-3#1)(2012-2#1)
and the transition##2##3##(2009-6#1)(2011-2#1)
and the treatment of##3##4##(1995-9#1)(2008-10#1)(2008-4#1)
and the treatment##10##3##(1991-11#1)(1993-8#1)(1994-8#1)(1995-9#1)(1996-11#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-3#2)
and the treatments##2##3##(2008-10#1)(2008-12#1)
and the trends##2##3##(1991-3#1)(2008-5#1)
and the tumor##3##3##(1994-12#1)(2008-10#1)(2010-11#1)
and the tungsten##2##3##(2008-10#2)
and the two##22##3##(1991-12#1)(1993-1#1)(1993-6#1)(1994-5#1)(1996-5#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)
and the type of##8##4##(1991-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)
and the type##9##3##(1991-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)(2012-2#1)
and the types##2##3##(1991-3#1)(2011-2#1)
and the underlying##6##3##(1997-5#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-2#1)
and the unique##3##3##(1992-3#1)(2008-3#1)(2011-2#1)
and the unreacted##2##3##(2008-10#2)
and the upper limit##2##4##(2008-10#2)
and the upper##4##3##(2008-10#2)(2008-12#1)(2010-6#1)
and the uptake of##2##4##(1993-3#1)(2008-11#1)
and the uptake##4##3##(1990-2#1)(1993-3#1)(2008-10#1)(2008-11#1)
and the urinary##2##3##(1991-5#1)(2013-1#1)
and the use of an##2##5##(2008-10#1)(2013-1#1)
and the use of multiple##2##5##(2008-10#1)(2008-4#1)
and the use of oral contraceptives##2##6##(1991-8#1)(2008-11#1)
and the use of the##6##5##(2007-12#1)(2008-10#3)(2008-11#2)
and the use of unhealthy weight control methods##2##8##(2012-2#2)
and the use of##49##4##(1991-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
and the use##50##3##(1991-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
and the usual##3##3##(1991-3#1)(1996-2#1)(2009-12#1)
and the utilization of##2##4##(2008-10#1)(2008-8#1)
and the validity##3##3##(2008-10#2)(2012-2#1)
and the value of##7##4##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)
and the value##10##3##(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-9#1)
and the values for##2##4##(2010-12#1)(2013-1#1)
and the values obtained##2##4##(2008-10#2)
and the values of##2##4##(2008-10#2)
and the values##7##3##(2008-10#5)(2010-12#1)(2013-1#1)
and the vaporization behavior of##2##5##(2008-10#2)
and the variability##2##3##(2008-10#1)(2011-2#1)
and the variables##2##3##(2008-10#2)
and the variation in##2##4##(2008-10#1)(2008-7#1)
and the variation##6##3##(2008-10#4)(2008-7#1)(2008-9#1)
and the variations in the##2##5##(2008-10#2)
and the variations in##3##4##(1991-11#1)(2008-10#2)
and the various##5##3##(2008-10#2)(2009-9#1)(2010-11#1)(2013-8#1)
and the vastus lateralis##2##4##(2010-4#2)
and the ventral tegmental area (VTA)##2##6##(1996-12#1)(2008-7#1)
and the ventral tegmental area##4##5##(1996-12#2)(1997-3#1)(2008-7#1)
and the ventral##6##3##(1996-12#2)(1997-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
and the vertebral##2##3##(2008-7#1)(2011-2#1)
and the very low##2##4##(2008-10#2)
and the vessel##2##3##(2008-10#1)(2008-7#1)
and the virus##4##3##(2008-10#3)(2008-11#1)
and the volume of##3##4##(1990-12#1)(1995-3#1)(2008-10#1)
and the volume##5##3##(1990-12#1)(1995-3#1)(2008-10#2)(2008-11#1)
and the water##3##3##(2008-10#2)(2008-3#1)
and the way##3##3##(1997-7#1)(2008-12#1)(2009-10#1)
and the weak##2##3##(1992-6#1)(2008-10#1)
and the weight##2##3##(1991-2#1)(2008-12#1)
and the whole##4##3##(1991-8#1)(1993-12#1)(1994-3#1)(2012-9#1)
and the wider##6##3##(2008-11#1)(2010-10#1)(2010-12#3)(2011-1#1)
and the widespread##2##3##(1997-8#1)(2008-9#1)
and the width of the##2##5##(1993-12#1)(2008-10#1)
and the width of##3##4##(1993-12#1)(2008-10#2)
and the wild type was##2##5##(2008-10#2)
and the wild type##5##4##(2008-10#5)
and the working electrode##3##4##(2008-10#3)
and the working##7##3##(2008-10#6)(2008-4#1)
and the world##3##3##(1997-1#1)(2008-10#1)(2009-10#1)
and the yeast##2##3##(1997-6#1)(2008-5#1)
and the yield of##2##4##(2008-10#1)(2008-5#1)
and the##7876##2##(1990-11#16)(1990-12#25)(1990-2#15)(1990-3#8)(1990-5#21)(1990-6#7)(1990-8#17)(1990-9#17)(1991-1#34)(1991-10#1)(1991-11#9)(1991-12#37)(1991-2#42)(1991-3#39)(1991-5#21)(1991-6#24)(1991-7#2)(1991-8#16)(1991-9#11)(1992-1#19)(1992-10#2)(1992-11#4)(1992-12#34)(1992-2#27)(1992-3#32)(1992-4#4)(1992-5#15)(1992-6#18)(1992-7#1)(1992-8#5)(1992-9#17)(1993-1#21)(1993-11#14)(1993-12#40)(1993-2#27)(1993-3#37)(1993-5#3)(1993-6#30)(1993-8#34)(1993-9#4)(1994-1#17)(1994-11#26)(1994-12#27)(1994-2#34)(1994-3#31)(1994-5#29)(1994-6#18)(1994-8#29)(1994-9#9)(1995-1#14)(1995-10#1)(1995-11#18)(1995-12#31)(1995-2#34)(1995-3#35)(1995-5#14)(1995-6#48)(1995-8#29)(1995-9#7)(1996-1#13)(1996-11#10)(1996-12#40)(1996-2#52)(1996-3#29)(1996-5#16)(1996-6#19)(1996-8#13)(1996-9#5)(1997-1#17)(1997-2#28)(1997-3#41)(1997-4#16)(1997-5#12)(1997-6#12)(1997-7#26)(1997-8#43)(1997-9#4)(2006-6#6)(2007-11#10)(2007-12#49)(2007-8#5)(2008-1#38)(2008-10#2756)(2008-11#469)(2008-12#112)(2008-2#53)(2008-3#253)(2008-4#63)(2008-5#170)(2008-6#45)(2008-7#208)(2008-8#254)(2008-9#221)(2009-1#11)(2009-10#40)(2009-11#17)(2009-12#25)(2009-2#1)(2009-3#22)(2009-4#8)(2009-5#14)(2009-6#27)(2009-7#34)(2009-8#37)(2009-9#17)(2010-1#38)(2010-10#27)(2010-11#35)(2010-12#49)(2010-2#5)(2010-3#8)(2010-4#26)(2010-5#26)(2010-6#28)(2010-7#27)(2010-8#40)(2010-9#14)(2011-1#28)(2011-10#3)(2011-2#308)(2011-3#34)(2011-4#2)(2011-7#5)(2012-12#42)(2012-2#124)(2012-3#111)(2012-4#3)(2012-5#8)(2012-7#1)(2012-9#1)(2013-1#182)(2013-2#3)(2013-7#12)(2013-8#124)
and theca cells##2##3##(1990-8#1)(2008-9#1)
and theca##3##2##(1990-8#1)(2008-12#1)(2008-9#1)
and their 1-deoxy##2##3##(1992-12#2)
and their N-hydroxy metabolites##2##4##(1992-6#2)
and their Nernstian slopes were##2##5##(2008-10#2)
and their ability to##9##4##(1991-7#1)(1995-11#1)(1996-12#1)(2008-10#3)(2012-2#2)(2013-7#1)
and their acridine orange (AO) induced mutants##2##7##(2008-12#2)
and their activity##2##3##(2008-5#1)(2010-5#1)
and their aggregates with##2##4##(2008-1#1)(2008-10#1)
and their analogs##3##3##(2008-10#3)
and their analysis by##2##4##(2008-9#1)(2013-8#1)
and their analysis##3##3##(1992-12#1)(2008-9#1)(2013-8#1)
and their analytical##2##3##(2008-10#2)
and their application in##4##4##(2008-10#1)(2008-11#2)(2008-3#1)
and their application to the##4##5##(2008-10#3)(2009-12#1)
and their application to##10##4##(1995-3#2)(2008-10#5)(2008-9#1)(2009-12#1)(2011-2#1)
and their application##15##3##(1995-3#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)
and their applications in##3##4##(1997-2#1)(2008-12#2)
and their applications to##2##4##(2008-10#1)(2008-11#1)
and their applications##8##3##(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)
and their approach##2##3##(1993-1#1)(1996-8#1)
and their associated##7##3##(1991-3#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
and their association with##4##4##(1994-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
and their association##5##3##(1994-11#1)(2008-10#2)(2008-11#1)(2012-12#1)
and their biological##2##3##(2008-9#1)(2009-12#1)
and their biophysical##2##3##(1997-6#1)(2012-3#1)
and their caregivers##3##3##(1992-3#1)(1996-3#1)(2013-8#1)
and their carers##3##3##(2008-11#1)(2008-12#1)(2013-8#1)
and their causes##2##3##(2007-11#1)(2012-3#1)
and their changes##2##3##(2010-11#1)(2011-2#1)
and their characterization##3##3##(1995-3#1)(2008-10#2)
and their child##3##3##(1990-12#1)(2008-9#1)(2012-2#1)
and their children##4##3##(1991-11#1)(2008-12#1)(2008-6#1)(2012-2#1)
and their cognate##2##3##(2009-10#1)(2009-9#1)
and their combination##3##3##(2012-5#1)(2012-7#1)(2012-9#1)
and their combinations##3##3##(1996-12#1)(2008-10#1)(2012-3#1)
and their comparative##2##3##(2008-10#1)(2010-7#1)
and their comparison with##2##4##(2008-10#1)(2008-3#1)
and their comparison##4##3##(2008-10#3)(2008-3#1)
and their complexes##5##3##(2008-10#4)(2010-7#1)
and their components##3##3##(2008-10#3)
and their concentrations##2##3##(2008-10#1)(2008-11#1)
and their consequences##2##3##(2008-11#1)(2010-8#1)
and their contribution to##3##4##(2008-12#1)(2009-8#1)(2011-2#1)
and their correlation with##2##4##(2008-12#1)(2011-2#1)
and their correlation##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
and their corresponding##2##3##(1993-6#1)(2008-6#1)
and their current##3##3##(2008-10#1)(2008-12#1)(2009-9#1)
and their derivatives are##2##4##(2008-10#1)(2008-5#1)
and their derivatives##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
and their detection##4##3##(2007-12#1)(2008-10#3)
and their determination by##4##4##(2008-10#4)
and their determination##5##3##(2008-10#5)
and their determinations by##2##4##(2008-10#2)
and their development##2##3##(2007-12#1)(2010-9#1)
and their distribution in##2##4##(1996-12#1)(2009-7#1)
and their distribution##4##3##(1996-12#1)(2008-10#2)(2009-7#1)
and their diverse##2##3##(2008-10#1)(2013-8#1)
and their effect on the##2##5##(2008-10#1)(2008-11#1)
and their effect on##7##4##(1991-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-2#1)(2012-3#1)
and their effect##8##3##(1991-3#1)(1995-11#1)(2008-10#2)(2008-11#1)(2010-9#1)(2012-2#1)(2012-3#1)
and their effects on the##5##5##(1990-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
and their effects on##9##4##(1990-11#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)
and their effects##11##3##(1990-11#2)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
and their efficacy##2##3##(2008-2#1)(2008-5#1)
and their emerging##2##3##(2008-10#1)(2012-2#1)
and their evaluation##2##3##(2008-11#1)(2008-5#1)
and their existing##2##3##(2011-3#1)(2013-8#1)
and their expression is##2##4##(1994-11#1)(2011-1#1)
and their expression##6##3##(1990-12#1)(1993-8#1)(1994-11#1)(2008-11#1)(2009-10#1)(2011-1#1)
and their families##28##3##(1994-1#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-1#1)(1997-2#1)(1997-3#1)(2008-11#13)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
and their function##2##3##(1993-9#1)(2008-8#1)
and their gene transcripts were##2##5##(2008-5#2)
and their healthcare providers##2##4##(2011-1#1)(2013-1#1)
and their hosts##4##3##(1997-7#1)(2008-10#1)(2008-9#1)(2012-3#1)
and their hybrids##5##3##(2008-10#4)(2008-9#1)
and their hydroxy/N(4)-acetyl metabolites##2##4##(2008-10#2)
and their impact on the##3##5##(1994-5#1)(1996-12#1)(2008-7#1)
and their impact on##12##4##(1992-1#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-11#1)(2013-1#1)
and their impact##14##3##(1992-1#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#2)(2008-10#2)(2008-11#3)(2008-7#1)(2010-11#1)(2013-1#1)
and their implications for##4##4##(2008-10#1)(2008-9#2)(2009-4#1)
and their importance##3##3##(1993-3#1)(1995-1#1)(2008-10#1)
and their individual##2##3##(2008-10#2)
and their influence##3##3##(2008-10#2)(2008-9#1)
and their inhibitors##4##3##(2008-1#1)(2008-9#3)
and their interaction on##2##4##(2008-10#2)
and their interaction with##3##4##(1995-2#1)(2008-10#1)(2008-9#1)
and their interaction##6##3##(1995-2#1)(2008-10#4)(2008-9#1)
and their interactions on##2##4##(2008-10#2)
and their interactions with##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
and their interactions##10##3##(1994-9#1)(2008-10#7)(2008-4#1)(2008-9#1)
and their ligands##3##3##(2008-11#1)(2008-4#2)
and their limitations##3##3##(2008-11#1)(2008-9#1)(2009-12#1)
and their locations##2##3##(2010-10#1)(2013-1#1)
and their long-term##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
and their main##3##3##(2008-10#2)(2008-11#1)
and their management##5##3##(2008-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
and their mechanism of##2##4##(2008-4#1)(2012-2#1)
and their metabolites are##2##4##(2008-11#2)
and their metabolites in radish##2##5##(2008-10#2)
and their metabolites##8##3##(2008-10#4)(2008-11#4)
and their metal complexes##2##4##(2008-10#2)
and their metal##4##3##(2008-10#4)
and their mixture##2##3##(2008-10#2)
and their modes of action##2##5##(2008-11#2)
and their modulation by##2##4##(1993-2#1)(2008-5#1)
and their more##2##3##(2009-12#1)(2012-12#1)
and their morphology##2##3##(2008-11#1)(2013-1#1)
and their mothers##2##3##(2009-11#1)(2011-1#1)
and their neonates##4##3##(2011-1#4)
and their nucleotide sequences were determined according to##2##8##(1997-6#1)(1997-8#1)
and their nucleotide##3##3##(1997-6#1)(1997-8#1)(2013-8#1)
and their offspring##3##3##(2008-9#1)(2010-8#1)(2012-2#1)
and their optical##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
and their optimal values were##2##5##(2008-10#2)
and their optimal##3##3##(2008-10#3)
and their origin##2##3##(2008-5#1)(2008-8#1)
and their outer membrane components##2##5##(1995-12#2)
and their parasitic##2##3##(2008-8#1)(2013-1#1)
and their parents were##2##4##(1995-2#1)(2008-3#1)
and their parents##7##3##(1991-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
and their partial##2##3##(2008-10#1)(2008-8#1)
and their partners##4##3##(2008-12#1)(2008-6#1)(2008-7#2)
and their patients##4##3##(1990-6#1)(1995-2#1)(1995-3#2)
and their patterns of##2##4##(2010-10#1)(2012-2#1)
and their performance##2##3##(2008-10#1)(2008-11#1)
and their physicians##5##3##(1991-1#1)(2008-11#2)(2008-6#1)(2012-3#1)
and their possible##4##3##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
and their potential applications##2##4##(2009-4#1)(2013-1#1)
and their potential to##2##4##(2008-10#1)(2013-1#1)
and their potential##13##3##(1990-6#1)(1993-6#1)(2007-12#1)(2008-10#4)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#2)
and their prevalence##2##3##(1991-12#1)(2008-10#1)
and their quantification##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
and their receptors in##2##4##(1996-12#1)(2013-1#1)
and their receptors##3##3##(1996-12#1)(2011-2#1)(2013-1#1)
and their regulation##5##3##(1995-12#1)(2008-10#3)(2013-7#1)
and their related##2##3##(1995-11#1)(2009-10#1)
and their relation to##4##4##(1991-6#1)(1995-1#1)(1995-3#1)(2008-3#1)
and their relationship to breast##2##5##(1993-1#1)(2011-3#1)
and their relationship to the##3##5##(2008-11#1)(2008-3#1)(2013-8#1)
and their relationship to##9##4##(1990-9#1)(1993-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)(2013-8#1)
and their relationship with##3##4##(2008-10#2)(2012-9#1)
and their relationship##14##3##(1990-9#1)(1993-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#1)(2012-9#1)(2013-1#1)(2013-8#1)
and their relationships with##2##4##(1995-9#1)(2008-7#1)
and their relative##3##3##(1990-3#1)(2008-10#2)
and their relatives'##2##3##(2010-10#1)(2012-12#1)
and their respective control##2##4##(2009-6#1)(2011-2#1)
and their respective##8##3##(2008-10#4)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)
and their response to##2##4##(2008-10#1)(2013-8#1)
and their role in##4##4##(2008-11#1)(2010-2#2)(2012-2#1)
and their role##5##3##(2008-10#1)(2008-11#1)(2010-2#2)(2012-2#1)
and their significance for##2##4##(1990-9#1)(2008-12#1)
and their significance in##2##4##(1991-11#1)(1993-2#1)
and their significance##5##3##(1990-9#1)(1991-11#1)(1993-2#1)(2008-12#2)
and their simultaneous##2##3##(2008-10#2)
and their size##2##3##(2008-10#2)
and their social##2##3##(2008-1#1)(2009-7#1)
and their spatial pattern)##2##4##(2008-10#2)
and their spatial##3##3##(2008-10#2)(2013-8#1)
and their stability is a function of charges involved in the formation reaction##2##13##(2008-10#2)
and their stability##4##3##(2008-10#3)(2013-8#1)
and their staff##2##3##(1996-1#1)(2009-11#1)
and their standard##2##3##(2008-10#2)
and their statistical##2##3##(2008-10#1)(2009-4#1)
and their subsequent determination##2##4##(2008-10#2)
and their subsequent##11##3##(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#2)(2009-12#1)(2009-5#1)(2011-2#1)
and their susceptibility to##2##4##(2008-11#1)(2008-5#1)
and their susceptibility##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
and their target##2##3##(2009-8#1)(2011-2#1)
and their transcripts##2##3##(1993-2#1)(1994-2#1)
and their translation##2##3##(1997-2#1)(2008-9#1)
and their unique##3##3##(1993-3#1)(2010-6#1)(2010-7#1)
and their use in##5##4##(2008-10#2)(2008-11#1)(2008-4#1)(2013-1#1)
and their use##10##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2010-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
and their validity##5##3##(2008-10#1)(2013-1#4)
and their variation##2##3##(1994-12#1)(2008-5#1)
and their##883##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#3)(1991-6#3)(1991-7#1)(1992-1#4)(1992-12#4)(1992-2#5)(1992-3#3)(1992-5#2)(1992-6#5)(1993-1#2)(1993-12#2)(1993-2#5)(1993-3#3)(1993-6#4)(1993-8#4)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-11#4)(1995-12#6)(1995-2#6)(1995-3#13)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#6)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#4)(2007-11#2)(2007-12#10)(2008-1#3)(2008-10#237)(2008-11#84)(2008-12#23)(2008-2#2)(2008-3#9)(2008-4#14)(2008-5#24)(2008-6#8)(2008-7#12)(2008-8#17)(2008-9#33)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#7)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#5)(2010-10#5)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#10)(2011-1#14)(2011-2#38)(2011-3#6)(2012-12#5)(2012-2#19)(2012-3#11)(2012-4#1)(2012-5#1)(2012-7#1)(2012-9#2)(2013-1#26)(2013-7#2)(2013-8#20)
and thelytokous populations##2##3##(2008-10#2)
and thematic##2##2##(2008-12#1)(2010-9#1)
and themes##2##2##(2008-11#1)(2010-11#1)
and then a##4##3##(1992-1#1)(2008-10#1)(2008-11#1)(2010-12#1)
and then activated on the membranes##2##6##(1992-6#2)
and then adding##3##3##(2008-10#3)
and then after##2##3##(2008-10#1)(2013-1#1)
and then allow the##2##4##(2008-4#1)(2010-5#1)
and then an##3##3##(2008-10#3)
and then analyzed##2##3##(2008-10#1)(2008-4#1)
and then applied to the##4##5##(1996-3#1)(2008-10#3)
and then applied to##8##4##(1996-3#1)(2008-10#6)(2012-2#1)
and then back##2##3##(2007-12#1)(2008-10#1)
and then by##4##3##(1992-3#1)(2008-10#2)(2008-12#1)
and then declined to##2##4##(2008-10#2)
and then declined##9##3##(2008-10#9)
and then decreased significantly##2##4##(2008-10#1)(2008-12#1)
and then decreased##6##3##(1992-5#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)
and then decreases##2##3##(2008-10#1)(2008-9#1)
and then determined by##3##4##(2008-10#3)
and then determined##4##3##(2008-10#4)
and then directly##2##3##(2008-10#2)
and then exposed to##2##4##(1991-5#1)(2009-9#1)
and then extracted by##2##4##(2008-10#2)
and then extracted##4##3##(2008-10#2)(2008-11#1)(2008-6#1)
and then gradually##2##3##(2008-10#1)(2008-7#1)
and then had##2##3##(2007-8#1)(2008-11#1)
and then in the##2##4##(2008-10#2)
and then in##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
and then increased##6##3##(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#2)
and then incubated##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2010-3#1)
and then is##3##3##(2008-10#3)
and then measured##2##3##(1990-12#1)(2008-5#1)
and then mixed with##2##4##(2008-10#1)(2011-3#1)
and then progressively##2##3##(1993-8#1)(1995-8#1)
and then quantitatively##2##3##(2008-10#2)
and then rapidly##2##3##(2007-12#1)(2008-5#1)
and then reaches##2##3##(2008-10#2)
and then spread##2##3##(2008-10#2)
and then subjected to##3##4##(1991-5#1)(1995-6#2)
and then the ratio decreased with increase in the molar ratio of myristic acid to pyrene carboxylic acid##2##18##(2008-10#2)
and then the##21##3##(1993-2#1)(1995-2#1)(1997-1#1)(1997-6#1)(2008-10#10)(2008-12#1)(2008-8#2)(2011-3#1)(2012-3#2)(2013-1#1)
and then they##2##3##(2008-10#2)
and then to the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and then to##14##3##(1993-2#1)(1995-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)
and then transferred to##2##4##(2008-10#1)(2013-1#1)
and then transformed##2##3##(2008-10#1)(2008-4#1)
and then treated with##3##4##(2008-10#2)(2011-2#1)
and then used to##2##4##(2008-2#1)(2008-8#1)
and then used##4##3##(2008-12#1)(2008-2#1)(2008-8#1)(2010-8#1)
and then was##4##3##(1996-5#1)(2008-10#2)(2008-3#1)
and then were##5##3##(1993-11#1)(2008-10#2)(2008-9#2)
and then with##3##3##(2008-10#3)
and then##329##2##(1990-12#1)(1991-12#3)(1991-2#1)(1991-5#2)(1992-1#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#3)(1995-8#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#2)(2007-8#1)(2008-10#141)(2008-11#25)(2008-12#10)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#15)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#4)(2010-7#1)(2010-8#2)(2011-2#7)(2011-3#3)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#3)
and theophylline##4##2##(2008-10#3)(2010-11#1)
and theoretical considerations##2##3##(2008-10#1)(2010-10#1)
and theoretical foundations##2##3##(1995-2#1)(2008-12#1)
and theoretical investigations##2##3##(2008-11#1)(2008-2#1)
and theoretical predictions##2##3##(2008-3#1)(2013-1#1)
and theoretical##22##2##(1990-12#1)(1991-9#1)(1992-3#1)(1995-2#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-10#1)(2013-1#1)(2013-8#1)
and theoretically##7##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
and theories##6##2##(1995-1#1)(1997-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
and theory##6##2##(1993-2#1)(1996-2#1)(2008-11#3)(2008-8#1)
and therapeutic approaches##2##3##(2008-1#1)(2008-11#1)
and therapeutic aspects of the##2##5##(1990-9#1)(1993-6#1)
and therapeutic aspects of##5##4##(1990-9#1)(1992-5#1)(1993-6#1)(2007-8#1)(2012-3#1)
and therapeutic aspects##6##3##(1990-9#1)(1992-5#1)(1993-6#1)(2007-8#2)(2012-3#1)
and therapeutic effectiveness##2##3##(2009-3#1)(2013-8#1)
and therapeutic features##2##3##(1990-12#1)(2013-1#1)
and therapeutic implications##3##3##(1991-3#1)(2008-7#1)(2013-8#1)
and therapeutic modalities##2##3##(1993-1#1)(2008-11#1)
and therapeutic options##2##3##(1992-12#1)(2010-11#1)
and therapeutic potential##2##3##(2008-11#1)(2013-7#1)
and therapeutic strategies are##3##4##(1992-3#1)(2008-7#1)(2008-8#1)
and therapeutic strategies##7##3##(1992-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-8#1)
and therapeutic strategy##3##3##(2012-2#2)(2012-3#1)
and therapeutic##69##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-3#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-3#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#2)(2010-11#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#5)
and therapeutics to##2##3##(2008-11#2)
and therapeutics##7##2##(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2010-12#1)
and therapies##2##2##(2008-11#1)(2013-1#1)
and therapy are discussed##2##4##(1991-8#1)(1993-6#1)
and therapy in##2##3##(1996-11#1)(2011-2#1)
and therapy of##7##3##(1992-5#1)(1995-5#1)(1996-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
and therapy##34##2##(1990-9#1)(1991-12#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-3#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#3)(1997-7#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
and therapy]##3##2##(1990-3#1)(1993-3#1)(2008-1#1)
and there are many##2##4##(2008-10#1)(2013-1#1)
and there are no##2##4##(2011-2#1)(2012-3#1)
and there are##16##3##(1993-6#1)(1994-3#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#3)
and there has been no##2##5##(1994-12#1)(2008-10#1)
and there has been##3##4##(1994-12#1)(2008-10#1)(2009-10#1)
and there is a need for##2##6##(2011-1#1)(2013-1#1)
and there is a need##3##5##(2008-11#1)(2011-1#1)(2013-1#1)
and there is a##9##4##(2008-10#1)(2008-11#2)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
and there is also some##2##5##(1990-2#1)(1991-6#1)
and there is an##2##4##(1997-5#1)(2008-11#1)
and there is great##2##4##(2008-11#1)(2009-7#1)
and there is little##2##4##(1997-2#1)(2011-2#1)
and there is no clear evidence##2##6##(1996-3#1)(2013-1#1)
and there is no##8##4##(1996-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and there is##32##3##(1990-2#1)(1991-6#1)(1992-5#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#4)(2013-8#1)
and there may be##2##4##(2008-1#1)(2010-11#1)
and there was a##8##4##(1996-1#1)(2008-10#4)(2008-9#1)(2009-3#1)(2013-8#1)
and there was little##4##4##(2008-10#3)(2008-8#1)
and there was no evidence of##2##6##(2008-10#2)
and there was no significant difference between##2##7##(2008-8#1)(2008-9#1)
and there was no significant difference##3##6##(2008-8#1)(2008-9#1)(2013-1#1)
and there was no significant##4##5##(2006-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
and there was no##19##4##(1996-2#1)(1997-8#2)(2006-6#1)(2008-10#7)(2008-8#1)(2008-9#2)(2010-6#1)(2013-1#3)(2013-8#1)
and there was##41##3##(1990-12#1)(1993-12#1)(1996-1#1)(1996-2#1)(1997-8#2)(2006-6#1)(2008-10#16)(2008-11#1)(2008-8#3)(2008-9#3)(2009-3#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#4)(2013-8#3)
and there were 3##2##4##(1990-3#1)(2011-2#1)
and there were no significant differences in##3##7##(1991-2#1)(1993-1#1)(2008-10#1)
and there were no significant differences##4##6##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#1)
and there were no significant##5##5##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#1)(2008-7#1)
and there were no signs of##2##6##(1993-1#1)(1993-6#1)
and there were no##13##4##(1991-2#1)(1993-1#2)(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)
and there were##19##3##(1990-3#1)(1991-2#1)(1993-1#2)(1993-6#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#2)
and there##114##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-6#2)(1994-12#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#2)(2007-11#1)(2008-1#1)(2008-10#25)(2008-11#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#6)(2009-10#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#11)(2013-8#4)
and thereafter the##3##3##(1996-12#1)(2008-3#2)
and thereafter##12##2##(1991-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)
and thereby the##3##3##(2008-12#1)(2010-11#1)(2011-2#1)
and thereby##33##2##(1993-6#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-8#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#4)(2013-1#2)(2013-8#1)
and therefore a##3##3##(2008-10#2)(2011-2#1)
and therefore can be##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
and therefore can##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
and therefore could be##2##4##(1991-3#1)(2013-8#1)
and therefore could##3##3##(1991-3#1)(1995-12#1)(2013-8#1)
and therefore it is##2##4##(2008-7#1)(2012-7#1)
and therefore it##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-7#1)
and therefore its##3##3##(2009-8#2)(2012-6#1)
and therefore represent##2##3##(2008-10#2)
and therefore the##10##3##(1990-3#1)(1991-3#1)(1993-6#1)(1996-2#1)(2008-10#4)(2008-12#1)(2013-8#1)
and therefore they##2##3##(2011-2#2)
and therefore##105##2##(1990-3#1)(1991-12#1)(1991-3#2)(1991-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-2#2)(2007-8#2)(2008-10#24)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-6#1)(2011-2#8)(2011-3#1)(2012-2#4)(2012-3#2)(2012-6#1)(2012-7#2)(2013-1#3)(2013-8#4)
and thermal analysis of##2##4##(2008-10#2)
and thermal analysis##4##3##(2008-10#4)
and thermal data implied that##2##5##(2008-5#2)
and thermal desorption##4##3##(2008-10#4)
and thermal lensing of##2##4##(2008-3#2)
and thermal lensing##3##3##(2008-3#3)
and thermal stability of the##2##5##(2008-10#1)(2011-2#1)
and thermal stability of##5##4##(1995-8#1)(2008-10#3)(2011-2#1)
and thermal stability##8##3##(1995-8#2)(2008-10#4)(2008-9#1)(2011-2#1)
and thermal##41##2##(1991-2#1)(1993-8#1)(1995-8#2)(1996-3#1)(2008-10#18)(2008-2#1)(2008-3#9)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
and thermodynamic parameters for##2##4##(2008-10#2)
and thermodynamic parameters of##2##4##(1992-3#1)(2008-10#1)
and thermodynamic parameters##5##3##(1992-3#1)(2008-10#4)
and thermodynamic studies of the##2##5##(1990-9#1)(2008-10#1)
and thermodynamic##16##2##(1990-9#1)(1991-5#2)(1991-6#1)(1992-3#1)(1997-2#1)(2008-10#10)
and thermogenesis##2##2##(1995-8#1)(2012-3#1)
and these are##6##3##(1991-3#1)(1996-2#1)(2008-12#1)(2008-5#1)(2012-2#2)
and these changes##2##3##(1990-3#1)(2013-8#1)
and these compounds##2##3##(2008-10#2)
and these differences##3##3##(2010-8#1)(2013-8#2)
and these effects were##2##4##(2008-11#1)(2011-2#1)
and these effects##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
and these may##3##3##(2008-11#1)(2010-5#1)(2012-3#1)
and these values were##2##4##(1992-12#1)(1996-12#1)
and these values##3##3##(1992-12#1)(1996-12#1)(2008-4#1)
and these were compared##2##4##(2008-9#1)(2012-2#1)
and these were found to be##2##6##(1995-12#1)(2008-10#1)
and these were##8##3##(1995-12#1)(2008-10#4)(2008-9#1)(2009-12#1)(2012-2#1)
and these##78##2##(1990-3#1)(1991-3#1)(1992-12#1)(1992-9#2)(1993-12#2)(1994-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-7#1)(2008-10#23)(2008-11#9)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#3)
and theta##2##2##(1991-12#1)(2013-8#1)
and they also##3##3##(1996-8#1)(2008-12#1)(2008-5#1)
and they are most##2##4##(2008-8#1)(2009-8#1)
and they are##19##3##(1994-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-3#2)
and they can be##4##4##(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
and they can##6##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
and they did##2##3##(1993-6#1)(2008-11#1)
and they exhibit##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
and they had##2##3##(2008-11#1)(2011-2#1)
and they have a##2##4##(2008-2#1)(2013-1#1)
and they have been##2##4##(1997-2#1)(2012-2#1)
and they have##7##3##(1996-11#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)(2013-1#1)
and they may be##2##4##(2008-9#1)(2012-2#1)
and they may##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
and they suggest##2##3##(2008-4#1)(2011-2#1)
and they were also##2##4##(1995-6#1)(2008-10#1)
and they were##18##3##(1991-1#1)(1993-12#1)(1995-6#1)(2008-10#10)(2010-7#2)(2011-2#1)(2013-1#2)
and they##104##2##(1991-1#3)(1991-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#2)(2007-8#1)(2008-10#26)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
and thiabendazole##4##2##(2008-10#4)
and thiamine##2##2##(2008-10#1)(2008-7#1)
and thick##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
and thicker##2##2##(2011-2#2)
and thickness of##5##3##(2007-11#2)(2008-10#2)(2008-3#1)
and thickness##7##2##(2007-11#3)(2008-10#3)(2008-3#1)
and thimerosal##3##2##(1997-2#1)(2008-10#2)
and thin films##2##3##(2008-10#1)(2010-7#1)
and thin layer##2##3##(2008-11#1)(2013-1#1)
and thin##8##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2013-1#1)
and thinning of##2##3##(2012-2#1)(2013-1#1)
and thiocyanate have##2##3##(2008-10#2)
and thiocyanate ions##2##3##(2008-10#2)
and thiocyanate##5##2##(2008-10#5)
and thioglycolic acid##3##3##(2008-10#2)(2012-3#1)
and thiol groups##2##3##(2008-10#2)
and thiol##4##2##(2008-10#3)(2008-5#1)
and thiosulphate##2##2##(2008-10#2)
and thiourea##3##2##(2008-10#3)
and third line hormonotherapy in advanced post-menopausal breast cancer##2##9##(1993-1#2)
and third line##3##3##(1993-1#3)
and third##22##2##(1990-7#1)(1993-1#3)(1993-12#2)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#4)
and third-order##2##2##(2007-11#1)(2008-10#1)
and thirdly##2##2##(1995-5#1)(2008-11#1)
and thirteen##3##2##(2008-5#2)(2013-8#1)
and this article##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
and this can##2##3##(2008-3#1)(2010-10#1)
and this contributes to##2##4##(1994-11#1)(1996-2#1)
and this decline was##2##4##(2008-11#1)(2008-7#1)
and this decline##3##3##(1990-5#1)(2008-11#1)(2008-7#1)
and this directly##2##3##(2007-12#1)(2008-10#1)
and this effect was##5##4##(1990-5#1)(2008-10#2)(2008-11#1)(2008-9#1)
and this effect##12##3##(1990-5#1)(1991-12#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)(2010-5#1)
and this gene was designated as##2##6##(2008-8#2)
and this gene was##3##4##(2008-10#1)(2008-8#2)
and this has##2##3##(2008-6#1)(2011-2#1)
and this inhibition##2##3##(1991-5#1)(1993-8#1)
and this interaction##2##3##(1995-2#1)(2008-9#1)
and this is##14##3##(1991-7#1)(1993-12#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2009-3#1)(2010-10#1)(2011-3#1)
and this may be##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
and this may have##2##4##(1990-6#1)(1997-5#1)
and this may##6##3##(1990-6#1)(1993-8#1)(1997-5#1)(2008-10#2)(2008-5#1)
and this method##4##3##(1991-2#1)(2008-1#1)(2008-10#2)
and this paper##2##3##(1991-12#1)(2012-3#1)
and this resistance##2##3##(2008-10#2)
and this review will##3##4##(2008-10#2)(2013-8#1)
and this review##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
and this sequence##2##3##(1996-12#1)(2009-10#1)
and this system##2##3##(2008-10#2)
and this technique may##2##4##(2008-11#1)(2010-10#1)
and this type of##2##4##(2008-12#1)(2008-8#1)
and this unit##2##3##(1990-11#1)(2008-9#1)
and this was successfully##2##4##(2008-9#1)(2010-6#1)
and this was##14##3##(1990-5#1)(1993-1#1)(1993-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-9#1)(2010-6#1)(2011-2#1)
and this##173##2##(1990-11#3)(1990-12#3)(1990-5#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1992-12#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#1)(1995-12#2)(1995-2#4)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#40)(2008-11#10)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#9)(2009-10#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#4)(2011-1#2)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
and thoracic spine##3##3##(2008-12#3)
and thoracic##13##2##(1993-12#2)(1997-8#1)(2007-11#2)(2008-10#1)(2008-12#5)(2008-7#1)(2012-3#1)
and thorium##2##2##(2008-10#2)
and thorough##3##2##(1996-2#1)(1996-3#1)(2008-10#1)
and those for##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
and those from the##2##4##(1995-12#1)(2009-11#1)
and those from##9##3##(1995-12#1)(1995-5#1)(2008-10#4)(2009-11#1)(2011-2#1)(2012-12#1)
and those in##2##3##(1997-2#1)(2008-10#1)
and those not##2##3##(1992-12#1)(2009-12#1)
and those obtained by##2##4##(2008-10#2)
and those obtained using a##2##5##(2008-10#2)
and those obtained using##3##4##(2008-10#3)
and those obtained##9##3##(2008-10#7)(2008-5#1)(2011-2#1)
and those of the##4##4##(1994-3#1)(2008-10#3)
and those of##17##3##(1994-3#1)(1997-6#1)(2008-10#8)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
and those on##2##3##(1993-12#1)(2008-9#1)
and those reported##2##3##(1995-12#1)(2008-10#1)
and those that##7##3##(1991-5#1)(1994-2#1)(1997-2#1)(2008-12#1)(2008-9#1)(2009-3#1)(2012-2#1)
and those who are##2##4##(1991-2#1)(2010-10#1)
and those who were##2##4##(2008-1#1)(2008-6#1)
and those who##13##3##(1991-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
and those with a##2##4##(2008-9#1)(2013-1#1)
and those with##19##3##(1991-1#1)(1992-3#1)(1992-8#1)(1993-3#2)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
and those##132##2##(1990-5#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#2)(2008-12#4)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#4)(2012-9#1)(2013-1#7)(2013-8#2)
and thought##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
and three cases of##2##4##(2008-8#1)(2011-2#1)
and three different##5##3##(2008-10#1)(2008-5#2)(2008-8#1)(2013-1#1)
and three distinct##3##3##(2008-10#1)(2008-9#1)(2010-10#1)
and three in##2##3##(2008-10#2)
and three isolates##2##3##(2008-10#2)
and three months after##2##4##(1991-11#1)(1992-9#1)
and three months##3##3##(1991-11#2)(1992-9#1)
and three of the##2##4##(1997-9#1)(2008-10#1)
and three of##4##3##(1997-9#2)(2008-10#1)(2008-11#1)
and three on##2##3##(2011-2#2)
and three sets##2##3##(2008-10#2)
and three species of##2##4##(2008-10#1)(2010-8#1)
and three sub-subplots (deficit##2##4##(2008-10#2)
and three themes##2##3##(2010-11#1)(2012-3#1)
and three times higher##2##4##(1993-3#1)(1995-12#1)
and three were##4##3##(1997-8#1)(2008-10#2)(2008-5#1)
and three##133##2##(1990-3#1)(1991-11#2)(1991-5#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-8#2)(1996-9#1)(1997-7#1)(1997-8#1)(1997-9#2)(2007-12#1)(2008-10#52)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
and three-dimensional##6##2##(1992-11#1)(1995-2#1)(2008-11#1)(2008-5#1)(2009-11#1)(2013-1#1)
and three-way##2##2##(2008-10#2)
and threonine##4##2##(1996-2#1)(1997-8#1)(2008-4#1)(2008-5#1)
and threshold##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
and thresholds##3##2##(1993-12#1)(2008-10#1)(2008-9#1)
and thrive##3##2##(1994-12#1)(1997-1#1)(2012-2#1)
and throat##3##2##(1993-2#2)(2013-8#1)
and thrombectomy##3##2##(1996-6#1)(2011-2#2)
and thrombin##4##2##(1992-4#1)(1994-11#2)(2008-9#1)
and thrombosis##5##2##(1991-12#1)(2006-6#1)(2008-1#1)(2008-9#1)(2010-12#1)
and thromboxane##2##2##(2008-10#1)(2008-5#1)
and through artificial##2##3##(1994-3#1)(2008-10#1)
and through breast milk##2##4##(2011-1#1)(2013-1#1)
and through to##2##3##(1995-3#1)(2010-12#1)
and through##21##2##(1992-6#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
and throughout##4##2##(2008-11#1)(2010-7#1)(2011-2#1)(2012-12#1)
and thumb##4##2##(1996-2#1)(2008-12#1)(2008-9#2)
and thus a##4##3##(2008-10#3)(2010-8#1)
and thus also##2##3##(2008-3#1)(2008-8#1)
and thus be used##2##4##(2008-10#2)
and thus can be used##2##5##(2008-11#1)(2012-3#1)
and thus can be##3##4##(2008-11#1)(2008-5#1)(2012-3#1)
and thus can##4##3##(1993-2#1)(2008-11#1)(2008-5#1)(2012-3#1)
and thus constitutes##2##3##(2009-6#1)(2012-2#1)
and thus could be used##2##5##(2008-10#1)(2008-5#1)
and thus could be##4##4##(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
and thus could##5##3##(2008-10#1)(2008-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
and thus facilitate##2##3##(1996-6#1)(2009-4#1)
and thus have##2##3##(2007-9#1)(2008-8#1)
and thus improve##2##3##(1997-5#1)(2008-3#1)
and thus is##3##3##(1992-4#1)(1993-11#1)(2011-2#1)
and thus it##4##3##(1994-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
and thus its##2##3##(1997-7#1)(2008-10#1)
and thus may be##2##4##(2008-10#1)(2012-3#1)
and thus may##5##3##(1995-11#1)(1995-9#1)(1996-2#1)(2008-10#1)(2012-3#1)
and thus provides##2##3##(1995-6#1)(2012-2#1)
and thus the##11##3##(1991-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
and thus to##5##3##(1996-12#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-2#1)
and thus was##2##3##(1995-2#1)(2008-10#1)
and thus were not##2##4##(1992-2#1)(2008-10#1)
and thus were##4##3##(1992-2#1)(2008-10#1)(2010-7#1)(2011-2#1)
and thus##143##2##(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#3)(1993-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#5)(2008-8#7)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#4)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#2)
and thylakoid##3##2##(1994-11#1)(2008-10#1)(2009-10#1)
and thymine##2##2##(2008-10#1)(2008-11#1)
and thymus##4##2##(2008-10#2)(2008-5#2)
and thyroid function##2##3##(2008-7#2)
and thyroid hormone##2##3##(2008-7#2)
and thyroid##11##2##(1993-9#3)(2008-7#6)(2011-2#1)(2013-1#1)
and tibial##2##2##(2009-4#1)(2013-1#1)
and tibialis anterior muscles##2##4##(2012-3#1)(2013-8#1)
and tibialis##3##2##(1995-2#1)(2012-3#1)(2013-8#1)
and tick-borne##2##2##(2013-8#2)
and tickborne disease##2##3##(1997-7#2)
and tidal##2##2##(1991-12#1)(1996-5#1)
and tie##4##2##(2011-2#4)
and tightly##2##2##(2008-5#1)(2011-2#1)
and tilapia##2##2##(1994-11#2)
and tillage on##2##3##(2008-10#2)
and tillage##3##2##(2008-10#3)
and time and##3##3##(2008-10#2)(2008-5#1)
and time consuming##4##3##(1990-2#1)(1994-1#1)(2008-10#1)(2008-9#1)
and time course of##2##4##(2008-10#1)(2008-7#1)
and time course##3##3##(1991-5#1)(2008-10#1)(2008-7#1)
and time delay##2##3##(2008-11#1)(2010-10#1)
and time from##2##3##(1995-12#1)(2012-3#1)
and time of exposure to##2##5##(1996-12#1)(2008-10#1)
and time of exposure##3##4##(1996-12#1)(2008-10#1)(2012-4#1)
and time of##18##3##(1992-3#1)(1996-12#1)(2008-10#10)(2008-12#1)(2008-5#3)(2012-3#1)(2012-4#1)
and time series##2##3##(2008-10#1)(2008-7#1)
and time the##2##3##(2008-5#1)(2013-1#1)
and time to##5##3##(2008-10#2)(2010-4#1)(2012-3#1)(2013-8#1)
and time were##2##3##(2008-5#1)(2013-1#1)
and time##87##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(2008-10#33)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#6)(2013-8#1)
and time-consuming##8##2##(2008-10#4)(2008-11#1)(2008-9#1)(2010-6#1)(2010-8#1)
and time-dependent manner##5##3##(1996-2#1)(2008-10#1)(2008-11#2)(2011-2#1)
and time-dependent manners##2##3##(2008-9#1)(2011-2#1)
and time-dependent##14##2##(1992-9#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
and time-resolved fluorescence##2##3##(2008-10#1)(2008-8#1)
and time-resolved##5##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)
and time-saving##3##2##(1990-11#1)(1994-8#1)(2008-10#1)
and timely information##2##3##(1996-1#1)(2008-11#1)
and timely##12##2##(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
and times##2##2##(1993-2#1)(2008-3#1)
and timing noise added in##2##5##(2007-11#2)
and timing noise##3##3##(2007-11#3)
and timing of the##2##4##(1993-12#1)(2008-11#1)
and timing of##16##3##(1993-12#1)(1993-3#1)(1996-3#1)(2008-10#3)(2008-11#4)(2010-12#1)(2010-6#2)(2012-12#2)(2012-3#1)
and timing##23##2##(1993-12#1)(1993-3#1)(1996-3#1)(2007-11#4)(2008-10#4)(2008-11#4)(2010-12#1)(2010-6#2)(2012-12#2)(2012-2#2)(2012-3#1)
and tin in##2##3##(2008-10#2)
and tin is##2##3##(2008-10#2)
and tin##7##2##(2008-10#7)
and tinea##4##2##(2008-5#4)
and tinnitus##2##2##(2008-7#2)
and tiopronin##2##2##(1994-5#2)
and tissue architecture##2##3##(2008-5#1)(2010-9#1)
and tissue culture##5##3##(2008-11#2)(2008-9#1)(2011-3#1)(2012-3#1)
and tissue damage##4##3##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
and tissue engineering##3##3##(2008-11#2)(2009-12#1)
and tissue inhibitor of metalloproteinase-1##2##5##(2008-5#1)(2008-9#1)
and tissue inhibitor of##4##4##(2008-5#2)(2008-9#1)(2013-1#1)
and tissue repair##2##3##(2008-4#1)(2009-12#1)
and tissue selenium##2##3##(1993-12#2)
and tissue specificity##2##3##(2008-5#1)(2008-9#1)
and tissue##58##2##(1990-11#1)(1992-3#1)(1992-6#1)(1993-12#2)(1995-3#2)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-11#7)(2008-4#2)(2008-5#6)(2008-7#2)(2008-9#5)(2009-12#2)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
and tissue-specific##3##2##(1993-12#1)(2008-11#1)(2008-9#1)
and tissues by##2##3##(2008-10#2)
and tissues of the##2##4##(1996-2#1)(2008-12#1)
and tissues##28##2##(1993-12#1)(1995-12#1)(1996-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-12#1)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
and titanium trichloride##2##3##(2008-10#2)
and titanium##8##2##(2008-10#7)(2011-2#1)
and titanium(IV)##4##2##(2008-10#4)
and titrated##2##2##(2008-10#1)(2010-4#1)
and titrimetry##2##2##(2008-10#2)
and to a lesser degree##3##5##(1991-12#1)(2008-10#1)(2008-6#1)
and to a lesser extent in the##2##7##(1997-2#1)(1997-9#1)
and to a lesser extent on##2##6##(2008-10#2)
and to a lesser extent##20##5##(1992-6#1)(1993-12#1)(1994-8#1)(1997-2#1)(1997-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)
and to a lesser##23##4##(1991-12#1)(1992-6#1)(1993-12#1)(1994-8#1)(1997-2#1)(1997-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)
and to a##40##3##(1990-11#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-9#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)
and to achieve##2##3##(2011-2#1)(2013-1#1)
and to all##2##3##(1993-2#1)(1997-8#1)
and to allow##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
and to an##4##3##(1997-5#1)(2008-11#1)(2009-10#2)
and to analyse##2##3##(2011-2#1)(2012-5#1)
and to analyze##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
and to assess risk##2##4##(1996-12#1)(2008-12#1)
and to assess the##7##4##(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
and to assess whether##3##4##(2008-1#1)(2008-10#1)(2009-3#1)
and to assess##16##3##(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
and to avoid##2##3##(2011-2#1)(2012-2#1)
and to be##6##3##(1994-3#1)(1996-1#1)(2008-11#3)(2008-8#1)
and to better##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
and to calculate the##2##4##(2008-10#1)(2011-2#1)
and to carry out##3##4##(1992-3#1)(2008-10#2)
and to cause##2##3##(2008-10#1)(2008-3#1)
and to challenge##2##3##(2009-10#1)(2011-2#1)
and to changes in##2##4##(2009-7#1)(2013-1#1)
and to characterize##2##3##(1997-2#1)(2009-7#1)
and to clarify the##2##4##(1994-2#1)(2008-3#1)
and to clarify##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
and to compare the##3##4##(2008-10#2)(2013-1#1)
and to compare these results with##2##6##(2008-9#1)(2011-1#1)
and to compare these##3##4##(2008-3#1)(2008-9#1)(2011-1#1)
and to compare##11##3##(1994-2#1)(2008-10#4)(2008-3#1)(2008-9#1)(2010-10#1)(2011-1#1)(2013-1#2)
and to confirm##2##3##(2008-10#2)
and to consider##2##3##(1994-5#1)(2010-8#1)
and to control##2##3##(2008-5#2)
and to correlate##2##3##(1991-8#1)(2008-12#1)
and to decrease##2##3##(2008-11#1)(2008-4#1)
and to define its role in##2##6##(1994-3#1)(2008-10#1)
and to define##5##3##(1992-9#1)(1994-3#1)(1995-12#1)(2008-10#1)(2012-3#1)
and to demonstrate that##2##4##(1991-3#1)(2008-8#1)
and to demonstrate##3##3##(1991-3#1)(2008-3#1)(2008-8#1)
and to describe##5##3##(1992-1#1)(1994-1#1)(2008-11#1)(2010-11#1)(2012-2#1)
and to detect##7##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-12#1)
and to determine how##2##4##(2008-10#1)(2010-1#1)
and to determine if##3##4##(2008-10#3)
and to determine its##2##4##(1994-11#1)(2012-3#1)
and to determine the rate at which participating laboratories successfully completed tests initiated##2##13##(2008-10#2)
and to determine the##15##4##(1992-5#1)(2008-10#8)(2008-9#2)(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
and to determine their##5##4##(1995-10#1)(2008-11#2)(2012-2#2)
and to determine whether the##2##5##(2008-5#2)
and to determine whether##4##4##(1993-1#1)(2008-5#2)(2013-1#1)
and to determine##39##3##(1992-5#1)(1993-1#1)(1994-11#1)(1995-10#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#2)(2008-9#2)(2010-1#1)(2010-10#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
and to develop##4##3##(2008-10#2)(2008-9#1)(2011-3#1)
and to devise##2##3##(2008-10#1)(2013-1#1)
and to differentiate##3##3##(1995-2#1)(2008-2#1)(2010-10#1)
and to discuss the##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
and to discuss##7##3##(1991-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
and to document##2##3##(2008-10#1)(2010-6#1)
and to elucidate the##2##4##(1997-8#1)(2011-2#1)
and to elucidate##4##3##(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
and to encourage##3##3##(1995-11#1)(1997-6#1)(2008-9#1)
and to ensure the##2##4##(2008-7#1)(2012-2#1)
and to ensure##3##3##(2008-7#1)(2010-7#1)(2012-2#1)
and to establish a##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
and to establish the##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
and to establish##11##3##(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2010-3#1)(2012-12#1)
and to estimate the##3##4##(2008-10#1)(2010-8#2)
and to estimate##5##3##(2008-10#2)(2010-8#2)(2013-8#1)
and to evaluate the efficacy of##2##6##(1997-2#1)(2012-3#1)
and to evaluate the##8##4##(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-7#1)(2012-3#1)
and to evaluate##14##3##(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#6)(2008-11#2)(2011-7#1)(2012-3#1)
and to examine the##5##4##(2008-10#1)(2008-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
and to examine##9##3##(2008-10#2)(2008-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
and to explore the##2##4##(2008-9#1)(2012-3#1)
and to explore##4##3##(2008-9#1)(2012-3#1)(2013-1#2)
and to extend the##2##4##(2008-10#1)(2013-1#1)
and to facilitate##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
and to find##3##3##(2011-2#2)(2013-1#1)
and to focus##2##3##(1994-2#1)(2008-10#1)
and to follow##2##3##(1997-1#1)(2008-10#1)
and to further##2##3##(1995-2#1)(2008-9#1)
and to gain##2##3##(2008-10#1)(2008-9#1)
and to generate##3##3##(1993-8#1)(2008-11#1)(2009-6#1)
and to give##2##3##(2008-10#1)(2008-11#1)
and to guide##3##3##(1997-8#1)(2008-12#1)(2010-12#1)
and to have##10##3##(1990-3#1)(1991-3#1)(1991-8#1)(1993-1#1)(1996-2#1)(2008-11#2)(2008-3#1)(2009-9#1)(2013-1#1)
and to help prevent##2##4##(2008-12#1)(2010-12#1)
and to help##7##3##(1996-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-12#1)
and to identify novel##2##4##(2008-10#1)(2010-6#1)
and to identify the##6##4##(1995-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
and to identify##22##3##(1991-12#1)(1993-12#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and to illustrate the##2##4##(2008-10#1)(2012-2#1)
and to illustrate##4##3##(1994-3#1)(2008-10#1)(2010-1#1)(2012-2#1)
and to improve the quality of##3##6##(1993-3#1)(2008-12#1)(2010-4#1)
and to improve the##9##4##(1993-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)
and to improve##17##3##(1993-3#1)(1994-6#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2010-1#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
and to incorporate##2##3##(2008-10#2)
and to increase the##3##4##(2008-10#2)(2008-7#1)
and to increase##7##3##(2008-1#1)(2008-10#3)(2008-7#1)(2010-11#1)(2013-1#1)
and to induce##3##3##(2008-10#2)(2009-12#1)
and to influence the##2##4##(1997-3#1)(2008-10#1)
and to inform##3##3##(1994-1#1)(1996-6#1)(2012-2#1)
and to inhibit##3##3##(1993-8#1)(1995-2#1)(2008-1#1)
and to investigate the##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
and to investigate their##2##4##(2008-5#1)(2011-2#1)
and to investigate##8##3##(1995-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-2#1)
and to lay the foundation for##2##6##(2008-4#1)(2013-8#1)
and to maintain##3##3##(1994-8#1)(2008-10#1)(2010-12#1)
and to make##5##3##(1996-1#1)(1996-6#1)(2008-10#1)(2009-11#1)(2009-8#1)
and to map##2##3##(2008-10#2)
and to maximize##4##3##(1993-12#1)(1993-3#1)(2008-10#1)(2008-5#1)
and to meet##2##3##(1997-3#1)(2010-4#1)
and to model the##2##4##(1995-2#1)(2008-10#1)
and to monitor the##2##4##(2008-1#1)(2008-10#1)
and to monitor##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
and to obtain##3##3##(1996-1#1)(2008-10#1)(2010-7#1)
and to offer##2##3##(1991-3#1)(1995-12#1)
and to optimize the##2##4##(2008-3#1)(2011-2#1)
and to optimize##4##3##(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
and to outline the##2##4##(2008-10#1)(2008-11#1)
and to overcome the##2##4##(2008-10#2)
and to possess##2##3##(2008-10#1)(2013-1#1)
and to predict##2##3##(1993-2#1)(2010-8#1)
and to prepare##3##3##(1994-2#1)(1996-3#1)(2008-1#1)
and to present##3##3##(2008-11#1)(2012-12#2)
and to prevent##2##3##(1997-7#1)(2012-2#1)
and to promote the##3##4##(2008-9#1)(2012-12#1)(2013-1#1)
and to promote##4##3##(1991-12#1)(2008-9#1)(2012-12#1)(2013-1#1)
and to provide a##6##4##(2008-10#1)(2008-11#1)(2008-4#2)(2010-5#1)(2013-1#1)
and to provide information##2##4##(1992-2#1)(1996-6#1)
and to provide the##2##4##(1992-6#1)(2008-11#1)
and to provide##23##3##(1992-2#1)(1992-6#1)(1993-3#1)(1996-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
and to quantify the##2##4##(2008-2#1)(2008-6#1)
and to quantify##3##3##(2008-2#1)(2008-6#1)(2008-8#1)
and to rank##2##3##(2008-11#1)(2011-2#1)
and to real samples##2##4##(2008-10#2)
and to real##3##3##(2008-10#3)
and to recognize the##2##4##(2010-5#1)(2011-2#1)
and to reduce the##4##4##(2008-10#1)(2009-8#1)(2010-7#1)(2011-2#1)
and to reduce##8##3##(1994-6#1)(1997-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)
and to relate these##2##4##(2008-8#1)(2010-4#1)
and to relate##4##3##(2008-11#1)(2008-8#1)(2010-4#1)(2011-2#1)
and to remove##3##3##(2008-10#1)(2013-1#2)
and to review##2##3##(2008-3#1)(2008-8#1)
and to seek out##2##4##(1996-3#1)(2008-10#1)
and to show the##2##4##(1993-3#1)(1997-8#1)
and to show##4##3##(1993-3#1)(1997-8#1)(2008-11#1)(2012-2#1)
and to study the##3##4##(1994-5#1)(2008-10#1)(2012-3#1)
and to study##6##3##(1994-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-3#1)
and to suggest##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
and to support##4##3##(2010-11#1)(2012-3#2)(2013-1#1)
and to suppress##3##3##(1995-2#2)(2008-10#1)
and to test the##2##4##(2008-10#1)(2008-3#1)
and to test##5##3##(1996-6#1)(1997-1#1)(2008-10#1)(2008-3#1)(2010-8#1)
and to that##2##3##(2008-10#1)(2013-8#1)
and to the determination of##2##5##(2008-10#2)
and to the##40##3##(1990-3#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
and to their##4##3##(2008-10#3)(2010-10#1)
and to use##4##3##(1996-2#1)(2008-10#1)(2009-5#1)(2010-11#1)
and to validate##2##3##(2008-10#1)(2008-7#1)
and to verify the##2##4##(2008-7#1)(2011-2#1)
and to verify##4##3##(1990-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
and to##811##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#4)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#4)(1991-12#4)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#4)(1993-6#3)(1993-8#4)(1994-1#5)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#6)(1994-5#3)(1994-6#4)(1994-8#4)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#8)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#6)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#1)(1996-6#5)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#6)(1997-9#2)(2007-12#2)(2007-8#1)(2008-1#11)(2008-10#207)(2008-11#54)(2008-12#20)(2008-2#6)(2008-3#18)(2008-4#10)(2008-5#18)(2008-6#9)(2008-7#14)(2008-8#17)(2008-9#21)(2009-10#8)(2009-11#4)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#3)(2010-1#5)(2010-10#10)(2010-11#6)(2010-12#6)(2010-3#2)(2010-4#3)(2010-5#7)(2010-6#2)(2010-7#6)(2010-8#7)(2011-1#3)(2011-2#39)(2011-3#3)(2011-7#1)(2012-12#9)(2012-2#18)(2012-3#15)(2012-5#2)(2013-1#33)(2013-7#1)(2013-8#18)
and tobacco##17##2##(1993-11#1)(1994-12#1)(2008-1#3)(2008-10#12)
and tocopherols##3##2##(2008-10#3)
and toe##2##2##(2008-5#1)(2013-1#1)
and together##4##2##(2008-10#4)
and tolerability of##6##3##(1990-3#1)(1994-12#1)(1996-1#1)(2008-3#1)(2012-3#2)
and tolerability##9##2##(1990-3#1)(1994-12#1)(1996-1#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-3#2)(2013-1#1)
and tolerable##3##2##(1992-2#1)(2008-10#2)
and tolerance of##4##3##(2008-10#3)(2008-5#1)
and tolerance to##6##3##(2008-10#1)(2008-12#2)(2009-6#1)(2009-7#1)(2011-10#1)
and tolerance##17##2##(1991-11#1)(2008-10#7)(2008-12#2)(2008-5#1)(2009-6#1)(2009-7#1)(2011-10#4)
and tolerant##3##2##(2008-10#3)
and toluene##3##2##(2008-10#3)
and tomato in##2##3##(2008-10#2)
and tomato plants in##2##4##(2008-10#2)
and tomato plants##5##3##(2008-10#5)
and tomato were##2##3##(2008-10#2)
and tomato##38##2##(2008-10#38)
and tomorrow##2##2##(1996-12#1)(2011-3#1)
and tone##3##2##(1997-4#1)(2008-5#1)(2012-3#1)
and took##2##2##(2008-10#1)(2013-1#1)
and tools##8##2##(1993-12#1)(2008-11#2)(2008-8#1)(2009-3#1)(2010-11#1)(2010-8#1)(2013-1#1)
and top##2##2##(2008-10#1)(2009-11#1)
and topical antifungal##2##3##(2011-2#1)(2012-3#1)
and topical##4##2##(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and topographic##2##2##(2008-10#1)(2008-3#1)
and topographical##3##2##(1992-5#1)(1995-8#1)(2008-2#1)
and torsional##2##2##(1992-9#1)(2008-10#1)
and torso##2##2##(2008-7#1)(2013-1#1)
and tortuous##2##2##(1997-3#2)
and total arsenic in##3##4##(2008-10#3)
and total arsenic##4##3##(2008-10#4)
and total bilirubin##3##3##(2008-10#1)(2012-3#2)
and total cholesterol##3##3##(2008-10#1)(2009-7#1)(2013-8#1)
and total clutch mass in##2##5##(1991-5#2)
and total disease##2##3##(2008-10#2)
and total dissolved##3##3##(2008-10#3)
and total fresh weight of##2##5##(2008-12#2)
and total fresh weight##3##4##(2008-10#1)(2008-12#2)
and total hip##2##3##(1995-2#1)(2010-3#1)
and total inorganic##6##3##(2008-10#6)
and total ionic##2##3##(2008-10#2)
and total iron##5##3##(2008-10#5)
and total number of##2##4##(2008-4#1)(2009-5#1)
and total phenolic contents##2##4##(2013-8#2)
and total phosphates (inorganic phosphates plus purine nucleotides)##2##8##(2008-10#2)
and total phosphates##3##3##(2008-10#3)
and total phosphorus##2##3##(2008-10#2)
and total protein##4##3##(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
and total selenium##3##3##(2008-10#3)
and total soluble##2##3##(2008-10#2)
and total sulphur dioxide##4##4##(2008-10#4)
and total vanadium in##2##4##(2008-10#2)
and total vanadium##4##3##(2008-10#4)
and total##135##2##(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#1)(1993-1#2)(1993-12#4)(1993-2#1)(1993-6#2)(1993-9#1)(1994-3#1)(1995-2#2)(1997-1#1)(1997-5#1)(2008-10#73)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-3#3)(2013-1#3)(2013-8#6)
and toward##5##2##(1994-2#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-4#1)
and towards##2##2##(1991-12#1)(2008-10#1)
and toxic substances for the North American Great Lakes##3##9##(2008-11#3)
and toxic substances##4##3##(2008-11#3)(2010-7#1)
and toxic##10##2##(1991-9#1)(1996-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-7#1)(2011-2#1)
and toxicity of##3##3##(1991-8#1)(1994-8#1)(2012-2#1)
and toxicity##17##2##(1990-2#1)(1991-8#1)(1994-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#2)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
and toxicological##6##2##(1994-5#1)(2008-10#1)(2008-11#2)(2008-5#2)
and toxicology##2##2##(1995-11#1)(2010-7#1)
and toxin production##3##3##(1992-12#1)(2008-10#1)(2011-2#1)
and toxin##5##2##(1992-12#1)(1995-2#1)(2008-10#1)(2011-2#2)
and trace determination of##2##4##(2008-10#2)
and trace elements##4##3##(2008-10#4)
and trace metal##3##3##(2008-10#3)
and trace##15##2##(1993-6#1)(2008-10#13)(2008-8#1)
and traceability##2##2##(2008-10#2)
and tracking of##2##3##(2008-1#1)(2013-1#1)
and trade-offs##2##2##(2008-8#2)
and traditional Chinese medicine##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
and traditional Chinese##6##3##(2008-10#3)(2010-10#1)(2012-2#1)(2013-1#1)
and traditional##11##2##(2008-10#3)(2008-11#1)(2009-11#1)(2010-10#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
and traffic##2##2##(2008-10#1)(2008-5#1)
and train##3##2##(1993-1#1)(2008-10#1)(2008-9#1)
and trained##4##2##(2008-5#2)(2008-6#1)(2013-1#1)
and training are##2##3##(1993-1#1)(1996-6#1)
and training for##3##3##(1993-1#1)(2008-11#2)
and training in##4##3##(1997-7#1)(2008-1#1)(2008-11#1)(2008-12#1)
and training of##9##3##(1990-3#1)(1994-12#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2012-2#1)
and training programs##3##3##(1992-1#1)(1997-6#1)(2008-11#1)
and training to##2##3##(2010-10#1)(2012-12#1)
and training##51##2##(1990-3#1)(1991-1#1)(1992-1#2)(1993-1#3)(1993-3#1)(1994-1#1)(1994-12#3)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#2)(2008-1#2)(2008-10#3)(2008-11#11)(2008-12#5)(2008-6#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
and trait specific##2##3##(2012-3#2)
and trait##5##2##(2010-6#1)(2012-3#4)
and traits of##2##3##(2008-8#1)(2010-10#1)
and traits##4##2##(1994-9#1)(2008-8#1)(2010-10#1)(2010-5#1)
and trans##3##2##(1990-9#1)(1991-5#1)(1992-12#1)
and trans-editing##2##2##(2012-2#2)
and transactivate##2##2##(1995-8#2)
and transcript##2##2##(2008-11#1)(2011-2#1)
and transcription factors##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
and transcription of##2##3##(1995-11#1)(1996-6#1)
and transcription##14##2##(1994-11#1)(1994-12#1)(1995-11#2)(1996-6#1)(2008-10#3)(2008-11#2)(2008-8#2)(2009-10#1)(2013-1#1)
and transcriptional##8##2##(1995-11#1)(1995-6#1)(2008-9#3)(2012-12#1)(2012-2#2)
and transcriptionally##3##2##(1994-11#1)(2009-8#1)(2011-2#1)
and transcriptome##2##2##(2011-2#2)
and transcytosis##2##2##(1995-2#1)(2009-12#1)
and transepidermal water loss##2##4##(2008-5#2)
and transepidermal##3##2##(2008-5#3)
and transfected into##6##3##(1992-8#1)(1993-3#1)(1994-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
and transfected##8##2##(1992-8#1)(1993-3#2)(1994-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)
and transfection##3##2##(1995-8#1)(2008-9#1)(2011-2#1)
and transfer##7##2##(1990-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-5#1)
and transferred into##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
and transferred##8##2##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2009-1#1)(2012-2#1)
and transferrin##5##2##(1995-11#1)(2008-11#4)
and transferring##2##2##(1997-2#1)(2008-4#1)
and transform##3##2##(1996-1#1)(2008-12#1)(2008-4#1)
and transformation of##2##3##(2008-4#1)(2009-10#1)
and transformation##7##2##(1994-9#1)(1995-11#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#2)
and transformed cells##3##3##(1993-8#1)(1994-5#1)(2008-11#1)
and transformed##12##2##(1992-3#1)(1993-11#1)(1993-8#1)(1994-5#1)(1997-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#2)(2013-1#2)
and transforming growth factor##2##4##(2008-11#2)
and transforming growth factor-beta (TGF-beta)##2##5##(2008-11#2)
and transforming growth##4##3##(2008-11#4)
and transforming##5##2##(2008-11#4)(2008-8#1)
and transfusion##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
and transgender##2##2##(2008-12#2)
and transgenesis##2##2##(2008-11#1)(2008-4#1)
and transgenic mice##3##3##(1995-6#1)(2008-4#1)(2008-9#1)
and transgenic plants##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
and transgenic##10##2##(1992-8#1)(1995-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#2)(2013-8#1)
and transient increases##2##3##(1990-12#1)(2008-9#1)
and transient##19##2##(1990-12#1)(1991-12#1)(1992-6#2)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#4)(2011-10#1)(2011-2#1)(2013-1#1)
and transiently##3##2##(2008-10#2)(2008-11#1)
and transition metal ions##5##4##(2008-10#5)
and transition metals##3##3##(2008-10#3)
and transition##17##2##(1990-8#1)(1991-6#1)(2008-10#14)(2008-3#1)
and transitional##2##2##(1993-2#1)(2008-10#1)
and translated##2##2##(1995-6#1)(2009-10#1)
and translation of##2##3##(1995-6#1)(2008-11#1)
and translation##9##2##(1995-6#1)(1997-1#1)(2008-11#1)(2008-8#1)(2008-9#3)(2011-2#1)(2013-1#1)
and translational##5##2##(1993-2#1)(1993-8#1)(2008-11#1)(2010-5#1)(2013-1#1)
and translocations##2##2##(1997-7#1)(2009-10#1)
and translucens##2##2##(2008-10#2)
and transmembrane##4##2##(1993-1#1)(1993-8#1)(1997-1#1)(2013-1#1)
and transmission electron microscope##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
and transmission electron microscopy (TEM)##4##5##(2008-10#1)(2009-7#2)(2011-2#1)
and transmission electron microscopy at##2##5##(2008-10#1)(2008-7#1)
and transmission electron microscopy in order to##2##7##(2007-12#1)(2008-7#1)
and transmission electron microscopy to##2##5##(2008-10#2)
and transmission electron microscopy##22##4##(2007-12#5)(2008-10#7)(2008-11#1)(2008-7#5)(2008-8#1)(2009-7#2)(2011-2#1)
and transmission electron##26##3##(2007-12#6)(2008-10#8)(2008-11#1)(2008-7#6)(2008-8#2)(2009-7#2)(2011-2#1)
and transmission of##5##3##(2008-10#2)(2008-5#1)(2010-1#1)(2010-8#1)
and transmission rates##2##3##(2008-10#2)
and transmission##48##2##(1996-2#1)(2007-12#7)(2008-10#18)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#3)(2009-7#3)(2010-1#1)(2010-8#1)(2011-2#1)
and transmittable by##4##3##(2008-10#4)
and transmittance##2##2##(2008-10#1)(2008-3#1)
and transmitted by the##2##4##(2008-10#1)(2011-2#1)
and transmitted by##4##3##(2008-10#3)(2011-2#1)
and transmitted##5##2##(2008-10#4)(2011-2#1)
and transparency##4##2##(2008-11#1)(2013-7#1)(2013-8#2)
and transparent##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-11#1)
and transplantation##5##2##(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#1)
and transplanted##2##2##(2011-3#1)(2013-1#1)
and transport mechanism##2##3##(2008-10#2)
and transport of##4##3##(1996-9#1)(2008-10#2)(2013-8#1)
and transport properties of##2##4##(1992-8#1)(1997-1#1)
and transport##21##2##(1992-8#1)(1995-2#1)(1996-9#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-7#1)(2009-10#1)(2011-2#3)(2013-1#1)(2013-8#1)
and transportation##5##2##(2008-10#2)(2012-2#1)(2013-1#2)
and transported out of the system##2##6##(2008-10#2)
and transported to the##2##4##(1994-11#1)(1995-6#1)
and transported##7##2##(1994-11#1)(1995-6#1)(2008-10#5)
and transporting##3##2##(2008-9#1)(2013-1#2)
and transposon##4##2##(2008-9#1)(2009-10#2)(2010-5#1)
and transvaginal##3##2##(1995-3#1)(1996-1#2)
and transverse##4##2##(1991-6#1)(1992-2#1)(2008-7#1)(2012-3#1)
and trap##4##2##(2008-10#3)(2010-11#1)
and trapped in the flow cell equipped with the##2##9##(2008-10#2)
and trapped in##3##3##(2008-10#3)
and trapped##4##2##(2008-10#4)
and trapping of a##2##4##(2008-10#1)(2008-3#1)
and trapping##8##2##(1996-5#1)(2008-10#5)(2008-3#1)(2010-7#1)
and traps##2##2##(1995-12#1)(2008-10#1)
and trauma##4##2##(1990-11#1)(2008-11#2)(2008-6#1)
and traumatic##2##2##(2010-12#1)(2010-2#1)
and traumatology##3##2##(2007-8#2)(2013-1#1)
and travel##3##2##(1990-6#1)(1997-6#1)(2011-2#1)
and treat##11##2##(1995-11#1)(1995-5#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and treated by##2##3##(1990-6#1)(2008-10#1)
and treated for##2##3##(1996-3#1)(2008-7#1)
and treated in##2##3##(2010-10#1)(2011-2#1)
and treated with##10##3##(1993-3#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-11#1)(2012-4#1)(2013-1#1)
and treated##32##2##(1990-6#1)(1993-3#1)(1995-11#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-7#2)(2009-1#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
and treating##13##2##(1995-2#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
and treatment are discussed##3##4##(1994-9#1)(2008-11#1)(2013-1#1)
and treatment are##4##3##(1990-12#1)(1994-9#1)(2008-11#1)(2013-1#1)
and treatment efficacy##2##3##(1992-9#1)(1996-2#1)
and treatment for##6##3##(1990-12#1)(1993-1#1)(1993-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
and treatment in##8##3##(1990-3#1)(1997-8#1)(2008-12#2)(2009-12#1)(2010-5#1)(2012-12#2)
and treatment initiated##2##3##(2008-11#1)(2013-7#1)
and treatment is##5##3##(1992-2#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
and treatment issues##2##3##(1993-9#1)(1995-6#1)
and treatment modalities##2##3##(2010-8#1)(2011-2#1)
and treatment needs##2##3##(2008-1#1)(2008-7#1)
and treatment of LMM##2##4##(2011-2#2)
and treatment of a##2##4##(1996-6#1)(2010-12#1)
and treatment of bacterial##2##4##(2010-12#1)(2013-1#1)
and treatment of human##2##4##(1994-5#1)(2013-1#1)
and treatment of mood disorders##2##5##(2008-7#1)(2013-8#1)
and treatment of osteoporosis##2##4##(1990-11#1)(2008-7#1)
and treatment of patients with##2##5##(2010-10#1)(2011-7#1)
and treatment of prostate cancer##2##5##(2008-4#2)
and treatment of the##5##4##(1993-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
and treatment of this##6##4##(1992-5#1)(2010-12#1)(2011-2#1)(2011-7#1)(2013-1#2)
and treatment of various##2##4##(2013-7#1)(2013-8#1)
and treatment of##93##3##(1990-11#3)(1990-6#1)(1990-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-2#2)(1993-9#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-6#1)(1997-8#2)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#4)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#7)(2011-3#1)(2011-7#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
and treatment options##4##3##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
and treatment outcome##2##3##(2008-11#1)(2013-1#1)
and treatment planning##2##3##(1991-12#1)(1993-1#1)
and treatment procedures##2##3##(1992-1#1)(2008-10#1)
and treatment programs##2##3##(1995-6#1)(2010-9#1)
and treatment response##2##3##(1991-8#1)(2009-4#1)
and treatment results of##2##4##(1996-9#1)(2008-7#1)
and treatment with##13##3##(1995-12#1)(1996-11#1)(1997-2#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-2#2)
and treatment##243##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#1)(1993-1#3)(1993-2#3)(1993-9#2)(1994-1#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#5)(1997-7#1)(1997-8#3)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#14)(2008-12#8)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#14)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#22)(2011-3#2)(2011-7#3)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#21)(2013-7#2)(2013-8#6)
and treatment]##8##2##(1991-2#1)(1991-6#1)(1992-5#1)(1993-2#1)(1994-5#1)(1996-6#1)(1997-4#1)(2013-1#1)
and treatments##11##2##(1993-12#1)(2008-10#3)(2008-9#1)(2009-10#1)(2010-11#1)(2010-8#3)(2011-2#1)
and tree##3##2##(1990-8#1)(2008-5#1)(2013-1#1)
and trees##4##2##(2008-10#2)(2008-8#2)
and tremor in##2##3##(2008-7#1)(2012-3#1)
and tremor##3##2##(2008-7#2)(2012-3#1)
and trends in##2##3##(1991-3#1)(1996-3#1)
and trends##11##2##(1991-3#1)(1993-1#1)(1993-3#1)(1996-3#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#3)
and trial##3##2##(1993-3#1)(2008-11#1)(2010-5#1)
and trialkyl phosphine oxide##2##4##(2008-10#2)
and triamterene in##2##3##(2008-10#2)
and triamterene were##2##3##(2008-10#2)
and triamterene##5##2##(2008-10#5)
and trichloroethylene##3##2##(2008-10#2)(2008-7#1)
and trichrome##2##2##(2010-12#1)(2012-3#1)
and tricyclic antidepressants##4##3##(1991-8#1)(1997-8#3)
and tried for##2##3##(1995-12#1)(2008-10#1)
and triethylamine##3##2##(2008-10#2)(2008-7#1)
and trigger apoptosis##2##3##(2008-4#1)(2009-4#1)
and triggering of##2##3##(2008-10#1)(2009-8#1)
and triglyceride (p&lt##2##3##(2008-10#2)
and triglyceride levels##2##3##(2008-10#2)
and triglyceride##7##2##(2008-10#4)(2008-9#1)(2010-11#1)(2011-2#1)
and triglycerides##8##2##(1990-8#3)(1991-6#1)(1992-12#1)(1993-2#1)(2008-7#1)(2013-1#1)
and triglycerides)##2##2##(1992-12#1)(2013-1#1)
and triiodothyronine##2##2##(2008-11#1)(2008-7#1)
and trimethoprim-sulfamethoxazole##2##2##(1997-3#1)(2009-8#1)
and trimethylarsine oxide (TMAO)##2##4##(2008-10#2)
and trioctylphosphine oxide##2##3##(2008-10#2)
and triple##2##2##(1991-9#1)(1996-5#1)
and tris(2##3##2##(2008-10#3)
and triton-treated##3##2##(1994-11#3)
and trivalent cations indicate##2##4##(2008-10#2)
and trivalent cations##3##3##(2008-10#3)
and trivalent##5##2##(1993-6#1)(1995-5#1)(2008-10#3)
and trkC##2##2##(1996-12#2)
and trkC-like proteins##2##3##(1995-8#2)
and troglitazone##2##2##(2010-11#2)
and troponin I##3##3##(2008-10#2)(2011-2#1)
and troponin##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
and troubleshooting##2##2##(2008-4#1)(2008-9#1)
and true##2##2##(2008-10#1)(2011-2#1)
and truly##2##2##(1993-2#1)(1996-12#1)
and truncated##2##2##(1994-5#1)(1995-6#1)
and trunk##2##2##(2007-12#1)(2012-3#1)
and trust##2##2##(2008-12#1)(2013-1#1)
and trustworthy##2##2##(1992-3#1)(2008-10#1)
and trypsin##5##2##(1993-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
and trypsin)##2##2##(2008-10#2)
and tryptamine##2##2##(1993-6#1)(2008-10#1)
and tryptophan methyl##2##3##(2008-10#2)
and tryptophan##7##2##(2008-10#2)(2009-8#1)(2011-3#2)(2012-2#2)
and tubal##2##2##(1991-3#1)(2011-2#1)
and tube##2##2##(1994-6#1)(2010-6#1)
and tuber##3##2##(2008-10#3)
and tuberculosis##7##2##(2008-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
and tuberculosis]##2##2##(1996-11#1)(1996-3#1)
and tubular##4##2##(1993-12#2)(2011-2#1)(2013-8#1)
and tubule formation##2##3##(2008-11#1)(2012-4#1)
and tulipae##2##2##(2008-10#2)
and tumor cells##2##3##(2008-11#2)
and tumor necrosis factor##4##4##(1990-5#1)(1992-12#1)(1997-2#1)(2008-11#1)
and tumor necrosis factor-alpha (TNF-alpha)##2##5##(1995-12#1)(2008-7#1)
and tumor necrosis factor-alpha##4##4##(1992-8#1)(1995-12#1)(2008-10#1)(2008-7#1)
and tumor necrosis##9##3##(1990-5#1)(1992-12#1)(1992-8#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
and tumor size##2##3##(1990-12#1)(1990-8#1)
and tumor tissue##2##3##(1990-2#1)(2012-2#1)
and tumor##37##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
and tumorigenesis##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
and tumors##4##2##(2007-11#1)(2008-4#1)(2012-2#1)(2013-8#1)
and tumour necrosis factor##3##4##(1996-2#2)(2011-2#1)
and tumour##8##2##(1991-5#1)(1991-9#1)(1996-2#2)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
and tumours##2##2##(1993-8#1)(2012-12#1)
and tunable##3##2##(2008-12#2)(2008-2#1)
and tuned##2##2##(2008-3#2)
and tungsten##6##2##(2008-10#6)
and tunic##2##2##(2008-7#2)
and turbid##2##2##(1994-3#1)(2008-3#1)
and turbidity reduction assays##2##4##(2009-6#2)
and turbidity##7##2##(2008-10#5)(2009-6#2)
and turkey)##2##2##(2008-10#1)(2010-4#1)
and turned out to be##3##5##(1995-6#1)(1997-8#1)(2010-5#1)
and turnover of##2##3##(2007-12#1)(2008-1#1)
and turnover##4##2##(2007-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
and twelfth nerve##2##3##(2011-2#2)
and twelfth##3##2##(2008-10#1)(2011-2#2)
and twelve samples##2##3##(2008-10#2)
and twenty##2##2##(1990-3#1)(2008-5#1)
and twin##2##2##(2008-7#1)(2009-5#1)
and two cases##4##3##(2008-10#1)(2008-5#1)(2008-7#2)
and two different types of##2##5##(2008-10#1)(2008-7#1)
and two different##9##3##(2008-10#6)(2008-11#1)(2008-7#2)
and two forms of##3##4##(2008-10#1)(2010-5#2)
and two from##2##3##(1995-6#1)(2008-10#1)
and two groups##2##3##(1992-2#1)(1996-12#1)
and two in the##2##4##(2008-10#1)(2010-8#1)
and two in##4##3##(2008-10#3)(2010-8#1)
and two isolates of##3##4##(2008-10#3)
and two isolates##4##3##(2008-10#4)
and two minor##3##3##(1993-12#1)(1995-6#1)(1997-8#1)
and two new##4##3##(1996-12#1)(1997-8#1)(2008-10#2)
and two of##5##3##(1990-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
and two other##5##3##(1997-7#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)
and two patients##4##3##(1991-4#1)(1995-10#1)(2008-3#1)(2008-8#1)
and two sets of##2##4##(2008-10#2)
and two sets##3##3##(2008-10#3)
and two sites##2##3##(1994-5#1)(2008-10#1)
and two strains##2##3##(2008-10#1)(2011-2#1)
and two unknown##2##3##(2008-10#1)(2008-5#1)
and two weeks later##2##4##(1992-3#2)
and two were##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
and two##227##2##(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#2)(1995-6#2)(1995-9#1)(1996-12#4)(1996-3#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-12#1)(2008-10#101)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#10)(2008-9#9)(2009-5#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#2)
and two-component##2##2##(1995-5#1)(1997-7#1)
and two-dimensional##9##2##(1990-11#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)
and two-phase##2##2##(2008-10#1)(2010-11#1)
and two-photon absorption##2##3##(2010-7#2)
and two-photon microscopy##2##3##(2007-12#1)(2008-11#1)
and two-photon##6##2##(2007-12#1)(2008-11#1)(2008-3#2)(2010-7#2)
and two-stage##4##2##(2008-10#3)(2010-4#1)
and type 2 diabetes has risen substantially##2##7##(2008-3#2)
and type 2 diabetes##8##4##(2008-10#1)(2008-3#2)(2008-6#1)(2010-10#1)(2010-12#1)(2012-4#2)
and type 2##16##3##(1993-2#3)(1997-3#1)(2008-10#4)(2008-3#2)(2008-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-4#2)
and type I##2##3##(1995-12#1)(2008-2#1)
and type II##5##3##(1995-2#2)(2008-11#1)(2008-5#2)
and type X##2##3##(2008-11#2)
and type and##2##3##(2008-10#2)
and type of surgical##2##4##(2008-2#1)(2009-12#1)
and type of##19##3##(1992-1#1)(1993-12#1)(1994-3#1)(1994-9#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
and type##59##2##(1992-1#1)(1993-12#1)(1993-2#4)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-4#3)(2013-1#3)(2013-8#2)
and types of##5##3##(1992-1#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-2#1)
and types##6##2##(1992-1#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-2#1)(2013-1#1)
and typical##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
and typically##2##2##(1996-3#1)(2012-3#1)
and tyramine##2##2##(2008-7#2)
and tyrosinase##6##2##(1995-2#1)(2008-10#2)(2008-5#1)(2013-1#2)
and tyrosine hydroxylase (TH)##2##4##(2008-11#1)(2011-2#1)
and tyrosine kinase##3##3##(1990-12#1)(2011-3#1)(2013-1#1)
and tyrosine##13##2##(1990-12#1)(1994-11#1)(1994-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#2)
and ulcerative##4##2##(1991-3#1)(1993-2#1)(2010-12#1)(2013-1#1)
and ultimate##3##2##(1991-12#1)(2008-10#1)(2012-2#1)
and ultimately the##2##3##(2008-8#1)(2013-1#1)
and ultimately to##2##3##(2008-7#1)(2013-8#1)
and ultimately##19##2##(1992-12#1)(1993-1#1)(2007-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
and ultra high##2##3##(2008-10#1)(2009-3#1)
and ultra##5##2##(2008-10#3)(2008-7#1)(2009-3#1)
and ultra-pure##2##2##(2008-10#2)
and ultra-sensitive##2##2##(2008-10#1)(2009-12#1)
and ultrafiltration##3##2##(1993-8#1)(2008-10#2)
and ultrasonic method##2##3##(2008-10#1)(2008-5#1)
and ultrasonic##7##2##(1991-1#1)(2008-10#4)(2008-11#1)(2008-5#1)
and ultrasonographic##2##2##(1997-7#1)(2008-10#1)
and ultrasonography##4##2##(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
and ultrasound examination##2##3##(1990-9#1)(1996-11#1)
and ultrasound##12##2##(1990-11#1)(1990-9#1)(1991-3#1)(1996-11#1)(2008-10#3)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
and ultrastructural features of the##2##5##(1991-8#1)(2008-7#1)
and ultrastructural features##3##3##(1991-8#1)(1992-12#1)(2008-7#1)
and ultrastructural studies##5##3##(1992-2#1)(1993-11#1)(1994-8#1)(2007-12#1)(2008-5#1)
and ultrastructural study##4##3##(1993-11#1)(2008-5#1)(2008-7#1)(2009-7#1)
and ultrastructural##19##2##(1991-8#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-11#2)(1994-8#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-7#3)(2009-7#2)
and ultrastructurally##2##2##(1994-12#1)(2008-10#1)
and ultrastructure of##2##3##(2008-12#1)(2008-7#1)
and ultrastructure##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
and ultrathin##2##2##(1997-2#1)(2008-7#1)
and ultratrace##5##2##(2008-10#5)
and ultraviolet detection##6##3##(2008-10#6)
and ultraviolet##10##2##(1996-3#1)(1997-7#1)(2008-10#7)(2011-2#1)
and umbilical A/B ratio##2##4##(1994-3#2)
and umbilical##3##2##(1994-3#2)(2008-9#1)
and unacceptable##2##2##(1996-12#1)(2013-1#1)
and unaffected##2##2##(2012-5#1)(2013-1#1)
and unambiguous##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
and uncapped##3##2##(2008-10#3)
and uncertainty of single-shot##2##4##(2008-3#2)
and uncertainty of##5##3##(2008-10#1)(2008-3#2)(2012-12#2)
and uncertainty##13##2##(1993-3#1)(2008-10#6)(2008-11#1)(2008-3#2)(2010-10#1)(2012-12#2)
and unchanged##4##2##(2008-11#1)(2010-1#1)(2012-3#1)(2013-8#1)
and unclassified##2##2##(2008-1#1)(2008-10#1)
and uncommon##2##2##(1996-11#1)(2008-11#1)
and uncomplicated##2##2##(1992-12#1)(2011-2#1)
and under the##2##3##(2008-10#2)
and under##17##2##(1991-1#1)(1991-2#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-6#1)(2010-4#1)(2010-7#1)
and undergo##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
and undergoes##2##2##(1990-2#1)(2008-10#1)
and undergraduate##4##2##(1991-1#1)(2008-12#2)(2009-4#1)
and underlying mechanisms##2##3##(2008-12#1)(2013-1#1)
and underlying##6##2##(1996-2#1)(2008-12#1)(2008-9#1)(2009-9#1)(2013-1#1)(2013-8#1)
and underscore the importance of##2##5##(2011-2#1)(2013-8#1)
and underscore the##4##3##(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and understand the##5##3##(1995-3#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-4#1)
and understand##9##2##(1995-2#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-12#2)(2009-7#1)(2010-10#1)(2010-4#1)
and understanding of the##6##4##(1991-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-7#1)
and understanding of tumour hypoxia and##2##6##(2011-2#2)
and understanding of##17##3##(1991-12#1)(1991-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-8#1)(2009-4#2)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
and understanding the##3##3##(1991-2#1)(2012-3#1)(2012-5#1)
and understanding##30##2##(1991-12#1)(1991-2#1)(1991-6#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#4)(2008-8#2)(2009-12#1)(2009-4#3)(2009-7#1)(2011-2#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)
and understood##2##2##(2008-10#1)(2010-2#1)
and underwater##2##2##(2008-10#1)(2008-2#1)
and underwent a##2##3##(2007-8#1)(2012-2#1)
and underwent##11##2##(1990-6#1)(1993-1#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
and undiagnosed##2##2##(2008-5#1)(2009-6#1)
and uneven##2##2##(2008-10#1)(2011-2#1)
and unexpected##5##2##(1990-11#1)(1996-1#1)(2008-12#1)(2008-5#1)(2010-11#1)
and unfiltered##2##2##(2008-10#2)
and unfolding##2##2##(1991-6#1)(2009-7#1)
and unhealthy##2##2##(2011-2#1)(2012-2#1)
and uniform##5##2##(1994-2#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
and unilateral##4##2##(1996-2#1)(2009-7#1)(2012-2#1)(2013-1#1)
and unilaterally in##2##3##(1996-12#2)
and uninfected##4##2##(1994-9#1)(1997-3#1)(2008-10#2)
and uninformative variable elimination##2##4##(2008-10#2)
and uninoculated leaves##2##3##(2008-10#2)
and uninoculated##4##2##(2008-10#4)
and uninsured##3##2##(1997-3#2)(2011-2#1)
and unique features##2##3##(1997-2#1)(2008-10#1)
and unique##10##2##(1995-3#1)(1997-2#1)(2008-10#5)(2008-12#1)(2011-2#1)(2013-1#1)
and uniqueness##3##2##(2009-10#1)(2013-8#2)
and united##2##2##(1996-3#1)(2013-1#1)
and univariate calibration##2##3##(2008-10#2)
and universal##4##2##(1996-1#1)(2008-10#2)(2008-9#1)
and university##4##2##(1990-12#1)(1992-5#1)(2010-2#1)(2012-12#1)
and unknown##3##2##(1995-9#1)(2008-10#1)(2013-1#1)
and unnecessary##3##2##(1994-3#1)(2008-10#1)(2012-12#1)
and unpleasant##2##2##(1992-2#1)(2008-6#1)
and unpleasantness##4##2##(2008-10#4)
and unpredictable##2##2##(1996-6#1)(2008-11#1)
and unraveling##2##2##(1997-2#1)(2008-11#1)
and unrelated##2##2##(2008-10#1)(2012-12#1)
and unsaturated##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
and unstable##8##2##(1993-3#1)(2008-3#2)(2008-8#1)(2009-10#1)(2012-12#1)(2012-3#2)
and unstructured##2##2##(2009-12#1)(2010-8#1)
and unsymmetrical##3##2##(2008-10#3)
and until now##2##3##(1997-7#1)(2008-12#1)
and until##3##2##(1997-7#1)(2008-12#1)(2013-8#1)
and untreated control##2##3##(2008-10#1)(2008-12#1)
and untreated##10##2##(1990-2#2)(1991-6#1)(1995-12#1)(1995-6#1)(2008-10#4)(2008-12#1)
and unusual##7##2##(1993-9#1)(2008-12#1)(2008-7#1)(2010-10#1)(2012-2#2)(2013-1#1)
and unusually##2##2##(1991-2#1)(2008-8#1)
and up to 11##2##4##(2008-10#1)(2008-3#1)
and up to a##2##4##(1995-11#1)(2008-11#1)
and up to##11##3##(1990-8#1)(1995-11#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
and update##3##2##(2010-5#1)(2012-3#1)(2013-1#1)
and updated##6##2##(1994-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
and updating##4##2##(1994-2#2)(1995-9#2)
and upland##3##2##(2008-10#3)
and upper##12##2##(1997-8#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
and upregulation of##2##3##(2007-11#1)(2008-10#1)
and uptake of##2##3##(1994-5#1)(1996-2#1)
and uptake##5##2##(1994-5#1)(1996-2#1)(2009-9#2)(2013-1#1)
and uranium##3##2##(2008-10#3)
and uranium(VI)##4##2##(2008-10#4)
and urban##13##2##(1994-2#5)(1994-3#1)(1996-3#2)(2008-10#2)(2009-10#1)(2009-7#1)(2012-2#1)
and urea production##2##3##(2008-11#2)
and urea were##2##3##(1995-3#1)(2008-11#1)
and urea##15##2##(1995-3#4)(1995-6#1)(2008-10#5)(2008-11#4)(2011-2#1)
and urease##2##2##(1995-3#1)(2008-10#1)
and urethral##3##2##(2008-10#3)
and urgency of##3##3##(1996-1#1)(2008-9#1)(2010-7#1)
and urgency##4##2##(1990-3#1)(1996-1#1)(2008-9#1)(2010-7#1)
and urgent##2##2##(2008-11#1)(2010-10#1)
and uric acid were##2##4##(2008-10#1)(2013-1#1)
and uric acid##13##3##(2008-10#11)(2008-7#1)(2013-1#1)
and uric acid)##2##3##(2008-10#2)
and uric##16##2##(2008-10#14)(2008-7#1)(2013-1#1)
and urinary##12##2##(1990-12#1)(1991-12#1)(1992-5#1)(1996-1#1)(2008-10#3)(2008-7#2)(2011-2#2)(2013-1#1)
and urine by##2##3##(1992-11#1)(2013-1#1)
and urine is##2##3##(2008-10#2)
and urine media##2##3##(2008-10#2)
and urine sample##2##3##(2008-10#2)
and urine samples of##2##4##(2008-10#2)
and urine samples were##2##4##(1993-11#1)(2008-10#1)
and urine samples##14##3##(1993-11#1)(2008-10#13)
and urine using a##2##4##(1991-12#1)(2008-10#1)
and urine##54##2##(1990-2#1)(1991-12#2)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1997-2#1)(2007-12#1)(2008-10#40)(2008-11#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
and urine)##4##2##(2008-10#4)
and urodynamic##2##2##(2008-10#2)
and urokinase##2##2##(1992-6#1)(1995-6#1)
and usability##3##2##(2008-6#1)(2010-10#1)(2011-2#1)
and usage of##3##3##(1994-12#1)(2008-9#1)(2010-6#1)
and usage##5##2##(1991-12#1)(1994-12#1)(2008-11#1)(2008-9#1)(2010-6#1)
and use a##2##3##(1991-3#1)(2012-2#1)
and use for##4##3##(2008-10#3)(2008-11#1)
and use in##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
and use of a##5##4##(1993-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
and use of alcohol among##2##5##(1991-9#2)
and use of an##2##4##(1997-1#1)(2009-10#1)
and use of the##4##4##(1993-3#1)(2008-10#2)(2008-9#1)
and use of##67##3##(1990-11#1)(1991-12#1)(1991-9#3)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#14)(2008-11#6)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#1)
and use the##3##3##(2008-1#1)(2008-10#1)(2010-9#1)
and use them##2##3##(2008-1#1)(2010-1#1)
and use##100##2##(1990-11#1)(1990-6#1)(1991-12#3)(1991-3#1)(1991-9#3)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-12#1)(2008-1#3)(2008-10#20)(2008-11#11)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
and used a##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
and used as a##2##4##(2008-10#1)(2008-3#1)
and used as an##4##4##(1992-3#1)(2008-10#2)(2008-11#1)
and used as the##2##4##(2008-10#2)
and used as##18##3##(1990-5#1)(1992-3#1)(1992-9#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)
and used for determination of##2##5##(2008-10#2)
and used for determining##2##4##(2008-10#1)(2008-3#1)
and used for the determination of##2##6##(2008-10#1)(2008-7#1)
and used for the preconcentration##2##5##(2008-10#2)
and used for the##11##4##(2008-10#9)(2008-7#1)(2008-9#1)
and used for##34##3##(1995-12#1)(1995-8#1)(2008-10#22)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-6#1)
and used in the##2##4##(2008-10#2)
and used in##9##3##(1991-12#1)(1993-2#1)(1993-6#1)(2008-10#5)(2010-5#1)
and used the##3##3##(2008-11#2)(2011-2#1)
and used to amplify##2##4##(2008-10#2)
and used to calculate the##5##5##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)
and used to characterize the##2##5##(1994-5#1)(2008-10#1)
and used to design##2##4##(2008-10#1)(2008-11#1)
and used to determine##3##4##(2008-10#2)(2013-1#1)
and used to estimate##2##4##(2008-10#1)(2008-3#1)
and used to investigate##2##4##(1993-8#1)(2008-10#1)
and used to monitor##2##4##(2008-10#2)
and used to produce##2##4##(2008-10#2)
and used to study the##4##5##(1992-6#1)(2008-10#2)(2008-8#1)
and used to transform##2##4##(1990-5#1)(2008-8#1)
and used to##55##3##(1990-5#1)(1992-6#1)(1993-8#2)(1994-2#1)(1994-5#1)(1996-2#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#4)(2008-9#1)(2011-2#1)(2013-1#1)
and used with##2##3##(2008-10#1)(2012-3#1)
and used##140##2##(1990-5#2)(1991-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#75)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#9)(2008-9#4)(2009-7#1)(2010-5#1)(2010-6#2)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
and useful information##2##3##(2008-4#1)(2008-9#1)
and useful to##2##3##(1997-3#1)(2008-10#1)
and useful##16##2##(1993-2#1)(1994-6#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2013-1#1)
and usefulness of the##3##4##(1995-12#1)(2013-1#2)
and usefulness of##5##3##(1995-12#1)(2008-10#2)(2013-1#2)
and usefulness##7##2##(1995-12#1)(2008-10#3)(2008-12#1)(2013-1#2)
and user-friendly##2##2##(2008-10#2)
and users##4##2##(1991-3#2)(1993-3#1)(2008-11#1)
and uses a##2##3##(2008-11#1)(2008-4#1)
and uses of##3##3##(1993-2#1)(1993-3#1)(2009-5#1)
and uses the##3##3##(1997-3#1)(2008-7#1)(2009-6#1)
and uses##10##2##(1993-2#2)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)
and using a##6##3##(1990-12#1)(2008-10#3)(2009-8#1)(2012-2#1)
and using an##3##3##(2008-10#3)
and using different##2##3##(2008-10#1)(2008-11#1)
and using the##10##3##(1991-6#1)(2008-10#5)(2008-3#1)(2008-4#1)(2010-3#1)(2011-2#1)
and using##44##2##(1990-12#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-9#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
and usually are##2##3##(1992-9#1)(2008-10#1)
and usually benign##2##3##(2008-11#1)(2013-1#1)
and usually##18##2##(1992-3#1)(1992-9#1)(1993-3#1)(1996-12#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and uterine##5##2##(1990-6#2)(1994-3#1)(1995-1#1)(2013-1#1)
and utilisation##2##2##(2010-8#1)(2010-9#1)
and utilise##2##2##(2008-11#2)
and utilities##2##2##(2012-3#2)
and utility of##6##3##(1990-12#1)(1993-2#1)(1995-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
and utility##8##2##(1990-12#1)(1993-2#1)(1995-5#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and utilization of health care services##2##6##(1993-2#1)(1994-1#1)
and utilization of the Clearinghouse's services##2##6##(1994-1#2)
and utilization of the##3##4##(1994-1#3)
and utilization of##11##3##(1991-12#1)(1993-2#2)(1993-9#1)(1994-1#4)(1994-2#1)(1996-12#1)(2010-10#1)
and utilization on##2##3##(1992-12#1)(2008-10#1)
and utilization rates##2##3##(1993-1#2)
and utilization##29##2##(1991-12#1)(1992-12#1)(1993-1#3)(1993-2#2)(1993-9#1)(1994-1#6)(1994-12#2)(1994-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-11#1)(2011-1#1)
and utilize the##2##3##(2008-10#1)(2008-9#1)
and utilize##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
and utilized as##3##3##(1991-9#1)(2008-10#1)(2013-1#1)
and utilized in the##2##4##(2008-12#1)(2011-2#1)
and utilized in##3##3##(1996-3#1)(2008-12#1)(2011-2#1)
and utilized to##2##3##(2008-10#2)
and utilized##10##2##(1991-9#1)(1995-5#1)(1996-3#1)(2008-10#4)(2008-12#1)(2011-2#1)(2013-1#1)
and utilizes##2##2##(2008-10#1)(2012-3#1)
and utilizing##2##2##(1990-2#1)(2013-1#1)
and uveitis##2##2##(2010-12#1)(2012-3#1)
and vaccination##4##2##(1997-8#1)(2008-11#2)(2008-7#1)
and vaccine##4##2##(1996-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
and vaccines##6##2##(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
and vacuolar##4##2##(1995-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
and vacuolation of##2##3##(1995-11#1)(2008-10#1)
and vacuolation##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
and vacuum##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
and vagal##2##2##(2008-6#1)(2009-7#1)
and vaginal hysterectomy in##2##4##(1993-12#2)
and vaginal hysterectomy##3##3##(1993-12#3)
and vaginal##10##2##(1992-3#1)(1993-12#5)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
and valid##7##2##(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#1)
and validate a##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
and validate the##2##3##(2008-11#1)(2010-7#1)
and validate##10##2##(2008-10#4)(2008-11#2)(2008-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
and validated by##7##3##(2008-10#5)(2008-12#2)
and validated for##2##3##(2008-10#2)
and validated in the##2##4##(2008-10#2)
and validated in##3##3##(2008-10#3)
and validated using##3##3##(1990-12#1)(2008-10#2)
and validated with##2##3##(2008-10#2)
and validated##37##2##(1990-12#1)(1992-9#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
and validates the##2##3##(2008-10#2)
and validates##3##2##(2008-10#2)(2011-2#1)
and validating##2##2##(2008-10#1)(2013-1#1)
and validation are##2##3##(1997-7#1)(2008-10#1)
and validation of a##10##4##(1992-9#1)(2008-10#5)(2008-2#1)(2008-5#2)(2009-12#1)
and validation of an##4##4##(1990-2#1)(1996-12#1)(2008-10#1)(2009-12#1)
and validation of##24##3##(1990-2#1)(1992-9#1)(1996-12#1)(2008-10#12)(2008-2#1)(2008-5#3)(2008-7#1)(2009-12#2)(2010-3#1)(2011-2#1)
and validation sets##2##3##(2008-10#2)
and validation##41##2##(1990-2#1)(1992-9#1)(1996-12#1)(1997-7#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#2)(2009-12#2)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)
and validity in##2##3##(1993-12#1)(2008-11#1)
and validity of the##4##4##(1993-3#1)(2008-10#1)(2008-12#2)
and validity of##8##3##(1992-3#1)(1993-11#1)(1993-3#1)(2008-10#2)(2008-12#2)(2010-10#1)
and validity##12##2##(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#3)(2010-10#1)(2012-2#1)
and valine##2##2##(1996-2#1)(2008-10#1)
and valuable##6##2##(1990-3#1)(1993-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
and value of##4##3##(1992-6#1)(1993-3#1)(2008-9#1)(2011-2#1)
and value##11##2##(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-11#2)(2008-9#1)(2011-2#1)
and values##8##2##(1992-2#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
and van der Waals##2##4##(1993-8#1)(2010-4#1)
and vanadate##5##2##(1997-1#5)
and vanadium##8##2##(2008-10#8)
and vanadium(V)##4##2##(2008-10#4)
and vapor##5##2##(1992-3#1)(2008-3#4)
and vaporization##5##2##(1996-1#1)(2008-10#4)
and variability in##2##3##(1993-2#1)(2008-8#1)
and variability of##3##3##(1991-11#1)(2011-2#2)
and variability##6##2##(1991-11#1)(1993-2#1)(2008-8#1)(2011-2#3)
and variable##10##2##(1993-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2010-8#1)(2011-2#1)
and variably##2##2##(2008-11#1)(2012-3#1)
and variance of##2##3##(1992-9#1)(2008-10#1)
and variant scaffolds##2##3##(2012-2#2)
and variants##2##2##(1997-2#1)(2008-10#1)
and variation in##8##3##(1997-8#1)(2008-10#4)(2008-8#1)(2008-9#2)
and variation of##3##3##(2010-1#1)(2011-2#1)(2013-8#1)
and variation##15##2##(1997-8#1)(2008-10#7)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-2#1)(2013-8#1)
and variations in the##2##4##(1993-12#1)(2008-12#1)
and variations of##2##3##(2008-2#1)(2008-6#1)
and variations##4##2##(1993-12#1)(2008-12#1)(2008-2#1)(2008-6#1)
and varied from##2##3##(2008-10#1)(2012-2#1)
and varied in##2##3##(2008-10#1)(2008-11#1)
and varied##12##2##(1993-8#1)(2008-10#7)(2008-11#1)(2008-8#1)(2010-9#1)(2012-2#1)
and variety of##3##3##(1995-5#1)(1997-2#1)(2009-1#1)
and variety##4##2##(1995-5#1)(1997-2#1)(2008-10#1)(2009-1#1)
and various foreign##3##3##(2008-10#3)
and various forms of##2##4##(2008-10#1)(2011-3#1)
and various##48##2##(1992-3#1)(1992-9#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#19)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and varying##4##2##(1994-5#1)(2008-10#3)
and vascular endothelial##3##3##(1991-5#2)(1997-7#1)
and vascular plant##2##3##(2008-11#1)(2008-9#1)
and vascular plants##3##3##(2008-8#3)
and vascular reactivity##2##3##(2012-2#2)
and vascular smooth muscle##3##4##(1991-6#1)(2008-11#2)
and vascular##34##2##(1991-3#1)(1991-5#2)(1991-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1997-7#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#3)(2012-3#2)
and vasoactive intestinal polypeptide##2##4##(1995-11#1)(1997-1#1)
and vasopressin##2##2##(1997-4#2)
and vast##2##2##(1992-2#1)(2008-11#1)
and vector##6##2##(1995-2#1)(2008-10#3)(2011-2#2)
and vegetable protein##2##3##(2013-8#2)
and vegetable##10##2##(2008-10#5)(2009-5#2)(2013-1#1)(2013-8#2)
and vegetables and##2##3##(1994-2#1)(2008-10#1)
and vegetables##19##2##(1990-8#1)(1991-2#1)(1994-2#2)(1997-1#1)(2007-12#1)(2008-10#7)(2008-4#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
and vegetation##6##2##(2008-10#3)(2008-3#1)(2008-9#2)
and vegetative buds##2##3##(2008-10#2)
and vegetative compatibility groups (VCGs)##2##5##(2008-10#2)
and vegetative compatibility groups##3##4##(2008-10#3)
and vegetative compatibility##5##3##(2008-10#5)
and vegetative##9##2##(2008-10#9)
and velocity##5##2##(1996-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
and vendors##2##2##(1993-12#1)(2008-10#1)
and venlafaxine##3##2##(2008-11#1)(2012-2#2)
and venous##10##2##(1996-9#2)(1997-6#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-12#1)(2013-1#2)(2013-8#1)
and ventilation##2##2##(1994-6#1)(2010-7#1)
and ventilator##3##2##(2008-10#1)(2012-2#2)
and ventilatory##3##2##(1994-12#1)(1996-2#2)
and ventral PFC##2##3##(2008-11#2)
and ventral##9##2##(1993-6#1)(1996-12#2)(2007-12#1)(2008-11#3)(2008-6#1)(2011-2#1)
and ventricular fibrillation##2##3##(1996-3#2)
and ventricular function in##2##4##(2009-10#1)(2010-4#1)
and ventricular##8##2##(1996-3#3)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-6#1)
and ventrolateral flagella##2##3##(2007-12#2)
and ventrolateral##3##2##(2007-12#3)
and verbal##2##2##(2008-10#1)(2013-1#1)
and verbalized##2##2##(2010-6#1)(2011-2#1)
and verification of##2##3##(2008-11#1)(2008-9#1)
and verified by##4##3##(1993-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
and verified that##2##3##(2008-10#1)(2008-9#1)
and verified##9##2##(1993-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-2#1)(2013-1#1)
and verify##2##2##(2008-3#1)(2008-8#1)
and versatile##12##2##(2008-10#10)(2008-11#1)(2012-2#1)
and versatility of##2##3##(2008-10#2)
and vertebral##2##2##(2008-11#1)(2011-2#1)
and vertebrate##4##2##(1990-5#1)(2008-6#1)(2008-9#1)(2010-5#1)
and vertical components of##2##4##(1990-5#1)(2008-9#1)
and vertical##8##2##(1990-5#1)(1996-1#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-11#1)
and vertically##2##2##(2008-10#1)(2011-3#1)
and very expensive##2##3##(2008-10#1)(2008-11#1)
and very few##3##3##(1990-6#1)(2010-10#1)(2013-1#1)
and very good##3##3##(2008-10#2)(2013-1#1)
and very high##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
and very low##5##3##(1992-3#1)(1995-2#1)(2008-10#2)(2008-7#1)
and very sensitive method##2##4##(2008-10#2)
and very sensitive##5##3##(2008-10#4)(2012-12#1)
and very##43##2##(1990-6#2)(1991-3#1)(1992-1#1)(1992-3#1)(1995-2#1)(1996-8#1)(1997-4#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
and vesicle##2##2##(2008-11#1)(2011-2#1)
and vesicles of##2##3##(2007-12#1)(2009-10#1)
and vesicles##5##2##(1994-5#1)(2007-12#2)(2009-10#1)(2012-2#1)
and vesicular monoamine transporter##2##4##(1996-12#2)
and vesicular##5##2##(1996-12#3)(2008-7#1)(2013-1#1)
and vessel##2##2##(2008-10#1)(2010-12#1)
and vestibular##3##2##(1995-8#2)(2012-3#1)
and via##3##2##(2008-10#2)(2009-4#1)
and viability of the##4##4##(2008-11#1)(2008-5#1)(2011-2#2)
and viability of##5##3##(2008-11#2)(2008-5#1)(2011-2#2)
and viability##12##2##(1995-9#1)(2008-11#5)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
and viable cell density##2##4##(2008-11#2)
and viable cell##3##3##(2008-11#2)(2008-7#1)
and viable counts##3##3##(2008-10#3)
and viable##10##2##(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)(2010-12#1)(2012-3#1)
and vibrational Raman##2##3##(2008-3#2)
and vice versa##11##3##(1991-2#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-7#1)(2009-8#1)(2011-2#1)
and victimization##4##2##(2010-1#3)(2013-1#1)
and video##4##2##(2008-10#1)(2008-11#1)(2008-6#2)
and viewed as##2##3##(2008-10#1)(2008-12#1)
and viewed##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-7#1)
and vigorous##2##2##(2008-7#1)(2013-1#1)
and vinclozolin##6##2##(2008-10#6)
and vindesine##2##2##(1992-12#2)
and violence##6##2##(1990-2#1)(1994-9#1)(1996-1#1)(2008-11#1)(2008-12#1)(2010-8#1)
and viral RNA##2##3##(2008-10#1)(2008-8#1)
and viral genes##3##3##(1995-2#1)(2008-8#1)(2010-1#1)
and viral##23##2##(1991-2#1)(1995-2#2)(1995-5#1)(2008-10#4)(2008-11#7)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-3#1)
and virion##6##2##(1997-3#4)(2008-10#2)
and virtual##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
and virulence genes##2##3##(2008-10#1)(2012-3#1)
and virulence of the##2##4##(2008-10#1)(2008-7#1)
and virulence of##3##3##(2008-10#2)(2008-7#1)
and virulence phenotypes##2##3##(2008-10#2)
and virulence##21##2##(2008-10#15)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#2)
and virulent to##2##3##(2008-10#2)
and virulent##6##2##(2008-10#6)
and virus accumulation##2##3##(2008-10#2)
and virus replication##2##3##(1992-12#1)(2008-9#1)
and virus##17##2##(1992-12#1)(1997-3#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
and virus-induced vesicles##2##3##(2008-10#2)
and virus-infected##3##2##(2008-10#1)(2008-11#2)
and viruses##7##2##(1995-12#1)(1997-1#1)(2008-10#2)(2009-8#1)(2010-1#1)(2010-7#1)
and visceral leishmaniasis##2##3##(2008-12#1)(2013-1#1)
and visceral##9##2##(1992-6#1)(1995-1#1)(1997-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
and viscoelastic##2##2##(2008-5#1)(2012-2#1)
and viscosity of the##3##4##(2008-3#1)(2008-5#1)(2009-7#1)
and viscosity##5##2##(2008-3#1)(2008-5#3)(2009-7#1)
and visible light##2##3##(2008-10#1)(2008-11#1)
and visible##12##2##(1993-12#1)(1995-2#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)
and vision##3##2##(1994-1#1)(1996-11#1)(2013-1#1)
and visitors##2##2##(1992-2#1)(1996-12#1)
and visual field##3##3##(2011-2#3)
and visual##19##2##(1991-2#1)(1991-6#1)(1996-2#1)(1997-2#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-8#2)(2010-9#1)(2011-2#5)(2012-3#2)
and visualization of the##2##4##(2008-6#1)(2011-2#1)
and visualization of##5##3##(2008-4#1)(2008-6#2)(2011-2#2)
and visualization##12##2##(2008-10#2)(2008-4#4)(2008-6#3)(2011-2#2)(2011-7#1)
and visualize##2##2##(2008-10#1)(2008-4#1)
and visualized##2##2##(1995-6#1)(2008-10#1)
and visualizing##2##2##(2008-4#1)(2008-6#1)
and vitamin C##3##3##(1992-9#1)(1997-8#1)(2008-10#1)
and vitamin E##4##3##(1993-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
and vitamin##16##2##(1991-2#1)(1991-8#1)(1992-9#2)(1993-2#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-5#2)(2010-12#1)(2012-12#1)(2012-2#1)
and vitronectin##2##2##(2008-11#2)
and vocal##3##2##(2008-9#2)(2013-8#1)
and vocational##2##2##(1993-3#1)(2009-7#1)
and voice##2##2##(2009-10#1)(2011-1#1)
and volatile organic compounds##2##4##(2008-10#1)(2013-1#1)
and volatile##6##2##(1997-1#1)(2008-10#4)(2013-1#1)
and volatilization##2##2##(2008-10#2)
and voltage##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
and voltammetric determination of##3##4##(2008-10#3)
and voltammetric##7##2##(2008-10#7)
and voltammetry##3##2##(2008-10#3)
and volume measurements of##2##4##(2008-3#1)(2009-3#1)
and volume measurements##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
and volume of the##4##4##(1990-11#1)(2008-10#3)
and volume of##18##3##(1990-11#1)(1991-2#2)(1995-3#1)(2008-10#13)(2008-7#1)
and volume##42##2##(1990-11#3)(1990-8#2)(1991-2#3)(1992-12#2)(1995-3#1)(1996-1#1)(2008-10#17)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#4)(2013-1#1)
and volumes##5##2##(1995-12#1)(2008-10#2)(2008-12#1)(2008-6#1)
and volumetric##6##2##(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
and voluntary sector##2##3##(1994-12#1)(1996-3#1)
and voluntary##5##2##(1994-12#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)
and volunteer##2##2##(1992-3#1)(1993-12#1)
and volunteers##3##2##(1992-3#2)(1993-2#1)
and vomiting##15##2##(1990-12#1)(1990-6#1)(1991-6#1)(1997-8#1)(2008-10#3)(2008-7#3)(2010-12#3)(2010-7#1)(2011-2#1)
and vulnerability to##2##3##(2008-8#1)(2009-10#1)
and vulnerability##5##2##(2008-8#1)(2009-10#1)(2009-7#1)(2011-2#2)
and w/o##3##2##(2008-5#3)
and waist circumference##2##3##(2008-11#1)(2011-2#1)
and waist##3##2##(2008-11#1)(2011-2#2)
and walking##3##2##(2008-7#2)(2010-4#1)
and wall teichoic acid##2##4##(1995-6#2)
and warm##2##2##(1990-12#1)(2008-10#1)
and warrant further research##2##4##(2010-10#1)(2010-2#1)
and was 1##2##3##(1992-3#1)(2008-11#1)
and was a##2##3##(1992-3#1)(2008-11#1)
and was also##2##3##(1993-2#1)(2008-10#1)
and was applied for##2##4##(2008-10#2)
and was applied to a##2##5##(2008-10#2)
and was applied to the determination of##2##7##(2008-10#2)
and was applied to##4##4##(2008-10#4)
and was applied##8##3##(2008-10#8)
and was associated with the##2##5##(1993-3#1)(2010-12#1)
and was associated with##4##4##(1993-3#1)(2008-11#1)(2010-12#1)(2013-8#1)
and was at##2##3##(1990-12#1)(1994-8#1)
and was based on the##3##5##(2008-10#2)(2008-11#1)
and was based on##4##4##(2008-10#3)(2008-11#1)
and was below the##3##4##(1991-11#1)(2008-10#1)(2008-5#1)
and was characterized##2##3##(2008-10#1)(2012-2#1)
and was compared with##2##4##(1991-12#1)(2008-10#1)
and was confirmed##2##3##(2009-1#1)(2012-3#1)
and was consequently##2##3##(2008-10#1)(2008-8#1)
and was considerably##2##3##(2008-10#2)
and was consistent##2##3##(1997-3#1)(2008-8#1)
and was correlated with##2##4##(2008-10#2)
and was deemed##2##3##(2008-10#1)(2008-12#1)
and was described##2##3##(2008-10#2)
and was detected##2##3##(1997-8#1)(2008-7#1)
and was diagnosed as having##2##5##(1996-9#1)(2008-7#1)
and was diagnosed with##2##4##(2009-12#1)(2010-10#1)
and was diagnosed##5##3##(1996-9#1)(2008-7#1)(2009-12#1)(2010-10#2)
and was first##2##3##(2008-10#2)
and was found to be##7##5##(1993-9#1)(2008-10#6)
and was found to have##3##5##(2008-7#2)(2012-2#1)
and was found to##15##4##(1993-9#1)(2008-10#10)(2008-7#2)(2011-1#1)(2012-2#1)
and was found##17##3##(1993-9#1)(1995-11#1)(2008-10#10)(2008-7#2)(2008-9#1)(2011-1#1)(2012-2#1)
and was further##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
and was generally##2##3##(1991-2#1)(2012-2#1)
and was greater for##2##4##(2008-10#1)(2008-9#1)
and was greater##3##3##(2008-10#2)(2008-9#1)
and was greatest##2##3##(2008-10#2)
and was higher##2##3##(2008-9#1)(2011-2#1)
and was highly##4##3##(1991-7#1)(2008-10#3)
and was identified as##2##4##(2008-10#1)(2013-1#1)
and was identified in##2##4##(2008-10#2)
and was identified##4##3##(2008-10#3)(2013-1#1)
and was increased##2##3##(1994-11#1)(2008-10#1)
and was inhibited by##3##4##(1992-3#1)(2006-6#1)(2008-10#1)
and was injected##2##3##(2008-10#2)
and was lost##2##3##(1990-5#1)(2012-3#1)
and was maintained##2##3##(2008-11#1)(2008-4#1)
and was more##5##3##(1992-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
and was most##2##3##(2008-10#2)
and was much##2##3##(2008-10#1)(2009-2#1)
and was named##2##3##(2008-10#2)
and was negatively correlated##2##4##(2008-10#2)
and was negatively##3##3##(2008-10#2)(2013-8#1)
and was not affected by##2##5##(1990-2#1)(2008-10#1)
and was not detected##2##4##(1995-11#1)(2008-12#1)
and was not influenced by##3##5##(1990-12#1)(2008-10#1)(2008-11#1)
and was not##15##3##(1990-12#1)(1990-2#1)(1995-11#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2010-8#1)
and was only##2##3##(1992-3#1)(2011-2#1)
and was positioned##2##3##(2008-10#1)(2008-6#1)
and was proved to be##2##5##(1997-1#1)(2008-10#1)
and was purified by##2##4##(2008-10#1)(2008-11#1)
and was reduced##2##3##(1997-8#1)(2008-10#1)
and was restricted to the##2##5##(2008-10#2)
and was restricted to##3##4##(1997-1#1)(2008-10#2)
and was separated from the aqueous layer by adding sodium chloride##2##11##(2008-10#2)
and was shown to be a##2##6##(1993-12#1)(1994-11#1)
and was shown to be##4##5##(1993-12#1)(1994-11#1)(2008-10#2)
and was shown to##7##4##(1993-12#1)(1994-11#1)(1995-8#1)(2008-10#4)
and was significantly reduced##2##4##(2008-10#1)(2010-10#1)
and was significantly##7##3##(2008-10#6)(2010-10#1)
and was similar to##2##4##(2008-10#2)
and was slightly##2##3##(2008-10#1)(2010-10#1)
and was subsequently##2##3##(2008-10#1)(2010-7#1)
and was successfully applied to the##4##6##(2008-10#4)
and was successfully treated with##2##5##(2008-10#1)(2010-8#1)
and was successfully##7##3##(2008-10#6)(2010-8#1)
and was the##4##3##(1992-6#1)(2008-10#3)
and was then##5##3##(1990-8#1)(2008-10#2)(2008-11#1)(2012-12#1)
and was therefore##3##3##(1997-7#1)(2008-10#1)(2013-1#1)
and was thus##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
and was treated with##2##4##(2008-11#1)(2011-1#1)
and was treated##4##3##(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
and was used for##2##4##(2008-10#2)
and was used to##3##4##(2008-10#2)(2008-11#1)
and was used##7##3##(2008-10#6)(2008-11#1)
and was very##2##3##(2008-10#1)(2008-7#1)
and was well tolerated##2##4##(2008-3#1)(2011-2#1)
and was##339##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#4)(1992-6#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#5)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(1997-9#1)(2006-6#2)(2007-12#1)(2008-10#149)(2008-11#18)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#14)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#3)(2009-7#1)(2010-1#1)(2010-10#5)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#3)
and washed##2##2##(2008-10#1)(2011-1#1)
and washing##6##2##(2008-10#6)
and waste water samples##2##4##(2008-10#2)
and waste water##6##3##(2008-10#6)
and waste waters##5##3##(2008-10#5)
and waste##17##2##(1993-11#1)(2008-10#14)(2008-11#1)(2012-2#1)
and wastes##4##2##(1992-3#1)(2008-10#3)
and wastewater samples##6##3##(2008-10#6)
and wastewater##11##2##(2008-10#11)
and wastewaters##4##2##(2008-10#4)
and water by##2##3##(2008-10#2)
and water containing##2##3##(2008-10#2)
and water content##2##3##(2008-12#1)(2008-5#1)
and water deficit##2##3##(2009-8#1)(2012-5#1)
and water depth##3##3##(2008-10#1)(2009-11#2)
and water in##3##3##(2008-10#2)(2008-9#1)
and water potential##3##3##(2008-10#3)
and water samples with##2##4##(2008-10#2)
and water samples##14##3##(2008-10#14)
and water was##2##3##(1991-2#1)(2008-10#1)
and water##98##2##(1991-2#2)(1991-5#2)(1992-1#1)(1992-9#1)(1994-3#1)(1996-12#1)(2007-12#3)(2008-10#62)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#6)(2008-9#2)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
and water)##2##2##(1996-12#1)(2008-5#1)
and water-soluble##4##2##(1991-3#1)(1991-5#1)(2008-10#2)
and watermelon##6##2##(2008-10#6)
and waters by##2##3##(2008-10#2)
and waters##6##2##(2008-10#6)
and wave##2##2##(1992-11#1)(2010-7#1)
and waveguide##2##2##(2008-10#1)(2008-3#1)
and wavelength##6##2##(1996-2#1)(2007-12#1)(2008-10#3)(2008-9#1)
and wavelengths##2##2##(2008-10#1)(2008-3#1)
and wax##3##2##(2008-10#3)
and ways to##7##3##(1992-12#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)
and ways##9##2##(1991-3#1)(1992-12#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2013-8#1)
and we also##2##3##(2008-8#1)(2009-11#1)
and we can##2##3##(2011-2#1)(2012-3#1)
and we compare##2##3##(1996-3#1)(2008-8#1)
and we conclude that##2##4##(2008-8#1)(2013-1#1)
and we conclude##3##3##(2008-8#2)(2013-1#1)
and we demonstrate##3##3##(2008-2#1)(2008-6#1)(2013-1#1)
and we describe##2##3##(2008-9#1)(2010-7#1)
and we discuss##3##3##(2008-11#1)(2012-3#2)
and we examined##2##3##(2008-11#1)(2013-8#1)
and we found evidence that##2##5##(2009-10#1)(2011-2#1)
and we found##3##3##(2007-12#1)(2009-10#1)(2011-2#1)
and we got##2##3##(2008-10#1)(2010-7#1)
and we have##2##3##(1990-9#1)(1994-12#1)
and we now report##2##4##(1993-2#1)(2008-8#1)
and we propose##2##3##(2008-8#1)(2013-1#1)
and we review##2##3##(2008-10#1)(2011-2#1)
and we show that##2##4##(1995-11#1)(2012-2#1)
and we speculate that##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
and we speculate##4##3##(1996-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
and we suggest that##2##4##(2008-8#1)(2009-1#1)
and we suggest##3##3##(2008-8#1)(2009-1#1)(2010-3#1)
and we used##2##3##(2008-9#1)(2012-3#1)
and we##86##2##(1990-9#1)(1991-12#2)(1992-9#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#2)(1997-7#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#4)(2013-8#4)
and weak##9##2##(1996-12#1)(1997-1#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)
and weaker##6##2##(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
and weakly##8##2##(2008-10#5)(2008-11#3)
and weakness of##3##3##(1991-12#1)(2009-1#1)(2012-2#1)
and weakness##5##2##(1991-12#1)(1997-3#1)(2009-1#1)(2012-2#1)(2012-3#1)
and weaknesses##13##2##(1992-12#1)(1993-1#1)(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#1)
and wear##4##2##(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)
and weather conditions##2##3##(2008-10#2)
and weather variables##4##3##(2008-10#4)
and weather##8##2##(2008-10#7)(2008-9#1)
and weeds##3##2##(2008-10#2)(2008-12#1)
and weekly##2##2##(2008-10#1)(2008-11#1)
and weight and##3##3##(1997-8#1)(2007-8#1)(2008-10#1)
and weight loss##6##3##(2008-1#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and weight of the##2##4##(2008-11#1)(2008-12#1)
and weight of##4##3##(2008-11#1)(2008-12#2)(2008-9#1)
and weight reduction##3##3##(1996-11#1)(2008-3#2)
and weight##26##2##(1991-6#1)(1996-11#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
and weight-bearing##2##2##(2008-12#1)(2010-5#1)
and weights of##3##3##(1996-8#1)(2008-10#1)(2008-5#1)
and welfare##5##2##(1993-3#1)(1995-11#1)(1996-3#2)(1997-2#1)
and well tolerated in##3##4##(1996-1#1)(2008-11#2)
and well tolerated##7##3##(1990-12#1)(1991-11#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-8#1)
and well waters##2##3##(2008-10#2)
and well##23##2##(1990-12#1)(1991-11#1)(1994-12#1)(1996-1#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2013-8#1)
and well-being of##4##3##(2008-11#1)(2010-7#1)(2010-9#2)
and well-being##15##2##(1992-3#3)(1997-3#1)(2008-11#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
and well-defined##4##2##(2008-10#1)(2008-4#2)(2008-6#1)
and well-tolerated##3##2##(1994-8#1)(1995-5#1)(2008-11#1)
and wellbeing##3##2##(2010-10#2)(2011-2#1)
and wellness##3##2##(1994-12#1)(2010-7#1)(2013-1#1)
and went on to##2##4##(2008-10#2)
and were able to##8##4##(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-1#1)(2013-8#1)
and were all##3##3##(2008-10#2)(2010-11#1)
and were also##3##3##(1996-12#1)(2008-5#1)(2012-2#1)
and were asked to##3##4##(2008-11#3)
and were characterized by##4##4##(1992-3#1)(1992-6#1)(2008-10#1)(2013-1#1)
and were classified##2##3##(2008-5#1)(2011-2#1)
and were compared with those##2##5##(2008-10#2)
and were compared##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
and were considered##2##3##(2007-8#1)(2008-11#1)
and were cross-resistant to##2##4##(2008-5#2)
and were determined##2##3##(2008-10#2)
and were distinct from##2##4##(2008-10#2)
and were divided into five##2##5##(1995-12#1)(2008-10#1)
and were divided into##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
and were examined##2##3##(2008-12#1)(2008-7#1)
and were found in##2##4##(2008-10#2)
and were found to be##5##5##(1994-5#1)(1996-12#1)(2008-10#3)
and were found to##7##4##(1994-5#1)(1996-12#1)(2008-10#5)
and were found##10##3##(1994-5#1)(1996-12#1)(2008-10#8)
and were generally##2##3##(2008-9#1)(2013-8#1)
and were genetically##2##3##(2008-10#2)
and were given##2##3##(1991-2#1)(2012-3#1)
and were highly##2##3##(1995-11#1)(2008-10#1)
and were identified as##2##4##(2008-10#1)(2010-12#1)
and were identified##3##3##(2008-10#2)(2010-12#1)
and were in##4##3##(2008-10#4)
and were included in##2##4##(2009-7#1)(2013-1#1)
and were included##3##3##(1994-12#1)(2009-7#1)(2013-1#1)
and were increased##2##3##(1995-12#1)(2011-3#1)
and were incubated##2##3##(2008-12#1)(2008-5#1)
and were less than the##2##5##(1996-12#1)(2008-10#1)
and were less than##3##4##(1991-12#1)(1996-12#1)(2008-10#1)
and were less##5##3##(1991-12#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)
and were localized##2##3##(1997-3#1)(2008-10#1)
and were more effective##2##4##(2008-5#1)(2013-1#1)
and were more likely##2##4##(1995-12#1)(2012-3#1)
and were more##9##3##(1994-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-3#1)(2013-1#2)
and were no longer##2##4##(1993-1#1)(2010-8#1)
and were not pathogenic to##2##5##(2008-10#2)
and were not pathogenic##3##4##(2008-10#3)
and were not##11##3##(2008-10#8)(2008-12#1)(2010-8#1)(2012-12#1)
and were pathogenic on##3##4##(2008-10#3)
and were pathogenic##4##3##(2008-10#4)
and were present in##2##4##(1994-2#1)(2008-10#1)
and were readily##2##3##(2008-10#2)
and were relatively##2##3##(1993-12#1)(2008-5#1)
and were restricted to##2##4##(2008-10#2)
and were screened##2##3##(2008-10#1)(2011-2#1)
and were separated##3##3##(2008-10#3)
and were significantly##4##3##(2008-10#2)(2011-2#1)(2013-8#1)
and were studied##3##3##(1993-12#1)(2008-11#1)(2008-12#1)
and were subjected to##4##4##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)
and were subsequently##3##3##(2008-10#3)
and were the##3##3##(2008-10#2)(2011-2#1)
and were then##4##3##(1990-12#1)(2008-11#1)(2008-9#1)(2009-11#1)
and were treated##2##3##(2008-10#1)(2011-2#1)
and were unaffected by the presence##2##6##(2008-10#2)
and were used as##2##4##(2008-10#1)(2008-5#1)
and were used for##4##4##(1996-8#1)(2008-10#2)(2008-11#1)
and were used to##4##4##(2008-10#1)(2008-7#1)(2011-3#1)(2013-1#1)
and were used##11##3##(1996-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2011-3#1)(2013-1#1)
and were##286##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#1)(1995-11#1)(1995-12#5)(1995-6#1)(1996-12#5)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-8#1)(2008-10#130)(2008-11#16)(2008-12#8)(2008-3#1)(2008-4#2)(2008-5#13)(2008-7#4)(2008-8#2)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#10)(2013-8#4)
and west##3##2##(2008-10#3)
and western North America##3##4##(2008-10#2)(2008-8#1)
and western United States##2##4##(2008-10#2)
and western blot analysis##3##4##(2008-10#2)(2008-11#1)
and western blotting##3##3##(2008-10#1)(2008-11#2)
and western populations##4##3##(2008-10#3)(2008-12#1)
and western white pine##2##4##(2008-10#2)
and western##31##2##(2008-10#21)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#2)(2011-2#2)
and wet##6##2##(2008-10#4)(2008-3#1)(2010-8#1)
and wetness duration##5##3##(2008-10#5)
and wetness##8##2##(2008-10#8)
and what can##2##3##(2008-11#1)(2012-12#1)
and what do they##2##4##(1994-12#1)(1994-3#1)
and what is##4##3##(1991-12#1)(1996-3#1)(2008-9#1)(2010-5#1)
and what it means to##3##5##(1996-12#1)(2008-5#1)(2013-1#1)
and what it means##4##4##(1996-12#1)(2008-5#1)(2013-1#2)
and what it##5##3##(1996-12#1)(2008-11#1)(2008-5#1)(2013-1#2)
and what we##3##3##(2008-11#1)(2008-8#1)(2012-12#1)
and what##36##2##(1991-12#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-12#2)(2013-1#3)
and wheat flour##2##3##(2008-10#2)
and wheat germ##2##3##(1994-11#1)(2008-10#1)
and wheat##24##2##(1994-11#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-8#2)(2011-10#1)
and when the##7##3##(1994-3#1)(2008-10#4)(2008-11#1)(2009-8#1)
and when##30##2##(1990-6#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-3#2)(1994-5#1)(1995-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#7)(2008-11#6)(2008-6#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
and where the##3##3##(1990-12#1)(2008-10#1)(2010-7#1)
and where##19##2##(1990-12#1)(1990-6#1)(1993-12#1)(1994-12#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-7#1)(2013-1#1)
and whether a##3##3##(1993-2#1)(2010-7#1)(2013-1#1)
and whether it has##2##4##(2008-9#1)(2009-1#1)
and whether it is##2##4##(2008-10#1)(2011-2#1)
and whether it##5##3##(2008-10#1)(2008-3#1)(2008-9#1)(2009-1#1)(2011-2#1)
and whether the##11##3##(1993-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2013-8#1)
and whether there##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
and whether these##3##3##(2008-8#1)(2010-1#1)(2013-8#1)
and whether they##4##3##(1990-3#1)(1997-1#1)(2008-7#1)(2008-8#1)
and whether this##2##3##(1994-6#1)(2013-1#1)
and whether##48##2##(1990-3#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-6#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
and which are##6##3##(2008-10#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#1)
and which is##4##3##(1990-6#1)(1991-5#1)(2008-10#1)(2008-11#1)
and which were##2##3##(1994-8#1)(2008-9#1)
and which##33##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-9#1)(1994-2#2)(1994-8#1)(1995-12#1)(2006-6#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-10#1)(2011-2#4)(2011-8#1)
and while the##2##3##(1997-7#1)(2008-11#1)
and while##5##2##(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
and white pine blister rust##2##5##(2008-10#2)
and white##20##2##(1993-12#1)(1994-12#1)(1995-12#1)(2008-10#9)(2008-5#1)(2008-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
and who##15##2##(1991-12#1)(1992-3#1)(1993-3#1)(1996-6#2)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-3#3)(2013-1#2)
and whole blood by##2##4##(2008-10#2)
and whole blood##7##3##(2008-10#5)(2011-2#2)
and whole body##2##3##(2008-7#1)(2012-3#1)
and whole grains##2##3##(2010-1#1)(2012-2#1)
and whole##20##2##(1997-1#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
and whole-organism##2##2##(2008-10#1)(2010-5#1)
and whole-plant##2##2##(2008-10#1)(2009-8#1)
and whose##11##2##(1995-2#1)(1996-11#1)(1996-2#1)(2006-6#3)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-8#1)
and why it is##2##4##(1991-1#1)(2009-9#1)
and why the##3##3##(1994-12#1)(2008-11#1)(2009-5#1)
and why they##2##3##(2008-11#1)(2009-11#1)
and why##21##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-4#1)(2008-11#4)(2008-12#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2012-3#1)
and wide##7##2##(1992-9#1)(2008-12#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
and widely accepted##2##3##(2008-10#1)(2008-11#1)
and widely applicable##2##3##(2008-10#1)(2011-2#1)
and widely used##2##3##(2008-10#1)(2008-4#1)
and widely##9##2##(2008-10#3)(2008-11#2)(2008-4#1)(2010-11#1)(2011-2#2)
and widespread##8##2##(1992-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-4#1)(2010-1#1)
and width of##2##3##(2008-10#2)
and width##7##2##(1993-12#1)(2008-10#5)(2008-6#1)
and wild Solanum spp##2##4##(2008-10#2)
and wild Solanum##3##3##(2008-10#3)
and wild type##3##3##(1990-12#1)(2008-10#1)(2008-9#1)
and wild##17##2##(1990-12#1)(2008-10#10)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-8#1)
and wild-type strains##2##3##(2008-10#2)
and wild-type##10##2##(1994-5#1)(1995-2#1)(1995-8#1)(1997-8#1)(2008-10#4)(2008-7#1)(2013-8#1)
and wildlife##3##2##(2008-10#1)(2008-12#2)
and will aid in the development of##2##7##(2008-11#1)(2008-7#1)
and will also##2##3##(2008-4#1)(2008-8#1)
and will be##9##3##(1995-1#1)(1995-2#1)(2008-10#3)(2012-3#2)(2013-1#2)
and will continue to do so##2##6##(2008-11#1)(2012-6#1)
and will continue to##6##4##(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-6#1)
and will eventually become##2##4##(2008-10#2)
and will eventually##3##3##(1993-12#1)(2008-10#2)
and will have##2##3##(2008-10#1)(2009-5#1)
and will provide##3##3##(1996-2#1)(2008-10#1)(2010-1#1)
and will require##3##3##(1994-1#1)(2008-10#1)(2009-9#1)
and will##55##2##(1990-6#1)(1991-1#1)(1991-11#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#2)(1997-1#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#3)(2012-6#1)(2013-1#3)
and willing to##2##3##(1992-12#1)(2008-11#1)
and willingness to##3##3##(1994-1#1)(1994-12#1)(2011-1#1)
and wilt##3##2##(2008-10#3)
and wind speed##2##3##(2008-10#2)
and wind velocity##2##3##(2008-10#1)(2008-5#1)
and wind##5##2##(2008-10#4)(2008-5#1)
and wine##4##2##(1997-1#1)(2008-10#3)
and wines##3##2##(2008-10#3)
and winning##2##2##(2009-10#1)(2013-1#1)
and winter##10##2##(1994-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)
and wires##2##2##(1992-3#1)(2012-3#1)
and witches'-broom##2##2##(2008-10#2)
and with 0##2##3##(2008-10#1)(2011-2#1)
and with a history of##2##5##(1997-5#1)(2013-1#1)
and with a very##2##4##(1990-5#1)(2008-10#1)
and with a##19##3##(1990-11#1)(1990-5#2)(1991-6#1)(1993-12#1)(1997-5#1)(2008-10#7)(2008-3#1)(2009-9#1)(2011-2#2)(2013-1#2)
and with an##8##3##(1993-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
and with data##3##3##(1992-9#1)(2008-10#1)(2008-8#1)
and with different##4##3##(2008-10#2)(2008-5#1)(2009-11#1)
and with high##5##3##(2008-10#3)(2008-7#1)(2008-8#1)
and with it##2##3##(1995-2#1)(2008-10#1)
and with less##2##3##(1995-1#1)(1997-3#1)
and with minimal##3##3##(1994-3#1)(2013-1#2)
and with other##7##3##(1993-11#1)(1996-1#1)(2008-10#3)(2010-4#1)(2011-2#1)
and with reduced##2##3##(2008-10#1)(2008-11#1)
and with respect to##2##4##(1990-12#1)(1994-8#1)
and with the aid of##2##5##(2008-10#1)(2008-5#1)
and with the use of##2##5##(2008-10#1)(2010-6#1)
and with the##44##3##(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#4)(1992-12#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-2#2)(1996-8#1)(1997-2#1)(2008-10#14)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#2)
and with those obtained##2##4##(2008-10#2)
and with those of##3##4##(1993-6#1)(2008-10#1)(2010-8#1)
and with those##6##3##(1993-6#1)(2008-10#4)(2010-8#1)
and with##222##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#77)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#8)(2008-7#5)(2008-8#7)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#3)(2010-10#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-3#5)(2013-1#9)(2013-8#1)
and withdrawal##3##2##(1991-1#1)(1996-12#1)(2010-11#1)
and within a##2##3##(1995-3#1)(2008-9#1)
and within each##2##3##(2008-10#2)
and within populations##2##3##(2008-10#2)
and within the##5##3##(1990-9#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
and within##36##2##(1990-12#1)(1990-9#1)(1992-12#1)(1995-3#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-12#3)(2008-3#1)(2008-9#2)(2010-11#1)(2010-12#1)(2013-1#1)
and without a##5##3##(1991-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-9#1)
and without any##4##3##(1996-9#1)(2008-10#2)(2008-12#1)
and without modifier##3##3##(2008-10#3)
and without previous##2##3##(2008-10#1)(2011-2#1)
and without the need##3##4##(2008-10#2)(2008-11#1)
and without the##8##3##(1994-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)
and without##127##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#40)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#3)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#6)(2012-3#3)(2013-1#7)(2013-8#1)
and women are##3##3##(1995-12#1)(2012-12#1)(2012-2#1)
and women with##6##3##(1992-12#1)(1995-3#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-3#1)
and women##50##2##(1992-12#1)(1993-2#2)(1993-6#1)(1995-12#1)(1995-3#1)(1996-6#1)(1996-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
and women's##2##2##(1995-6#1)(2008-7#1)
and wood##6##2##(2008-10#5)(2008-9#1)
and word##3##2##(2008-11#1)(2008-12#2)
and work conditions##2##3##(1995-11#1)(2010-7#1)
and work##14##2##(1990-2#1)(1993-12#1)(1994-3#1)(1995-11#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-10#2)(2010-10#1)(2010-7#1)(2012-12#1)(2013-8#1)
and worked##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
and worker##3##2##(2008-8#2)(2010-11#1)
and workers##5##2##(2008-8#5)
and working conditions##2##3##(2008-10#1)(2010-10#1)
and working in##2##3##(2010-9#1)(2012-3#1)
and working##18##2##(1995-3#1)(2008-10#10)(2008-11#1)(2010-10#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
and workload##2##2##(2010-10#1)(2011-2#1)
and workplace##2##2##(1993-12#1)(2008-10#1)
and works of art##2##4##(2008-10#2)
and worldwide##5##2##(1996-1#1)(2008-10#1)(2008-11#1)(2013-1#2)
and worse##2##2##(2008-10#1)(2012-3#1)
and worsening##3##2##(2008-7#1)(2010-10#1)(2013-1#1)
and would be##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
and would##11##2##(1990-2#1)(1991-3#1)(1994-12#1)(1995-1#1)(1995-6#1)(1997-3#1)(2008-10#2)(2010-11#1)(2011-1#1)(2011-2#1)
and wound healing##2##3##(2007-8#1)(2012-12#1)
and wound##6##2##(1995-12#1)(2007-8#1)(2008-7#2)(2012-12#1)(2012-3#1)
and wounding##2##2##(2008-10#2)
and wrist##5##2##(2008-12#1)(2012-2#3)(2013-1#1)
and writing##3##2##(2008-11#1)(2008-12#2)
and written##3##2##(1991-2#1)(1993-12#1)(2008-4#1)
and x-ray##4##2##(1997-5#1)(2008-8#1)(2010-4#1)(2011-2#1)
and xanthine oxidase##2##3##(2008-10#1)(2008-11#1)
and xanthosine##2##2##(2009-12#2)
and xenografts##3##2##(2009-3#3)
and xylazine (0##2##3##(2012-3#2)
and xylazine##3##2##(2012-3#3)
and xylem##4##2##(2008-11#1)(2012-5#1)(2012-8#2)
and xylene##5##2##(2008-10#5)
and xylose##2##2##(2008-10#1)(2008-7#1)
and year of##2##3##(2008-7#1)(2013-1#1)
and year##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
and years of##2##3##(1996-1#1)(2008-10#1)
and years to##2##3##(1996-1#1)(1996-3#1)
and years##6##2##(1996-1#2)(1996-3#1)(2008-10#3)
and yeast cells##2##3##(2008-10#1)(2009-6#1)
and yeast extract##2##3##(2008-11#2)
and yeast##24##2##(1993-2#1)(1993-6#1)(1997-4#2)(2008-10#3)(2008-11#5)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-4#2)(2012-2#2)(2012-3#1)(2013-8#1)
and yeasts##3##2##(2008-5#1)(2013-1#2)
and yellow##10##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-9#2)(2010-8#1)(2011-1#1)
and yellowing apex and margin on the mature leaves##2##9##(2008-9#2)
and yellowing##4##2##(2008-10#2)(2008-9#2)
and yet##8##2##(1995-12#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2013-8#1)
and yield higher##2##3##(2008-5#1)(2008-7#1)
and yield in the field##2##5##(2008-10#2)
and yield in##3##3##(2008-10#2)(2008-9#1)
and yield loss##2##3##(2008-10#2)
and yield of##2##3##(2008-10#2)
and yield was##2##3##(2008-10#2)
and yield were##2##3##(2008-10#2)
and yield##28##2##(2008-10#17)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2013-1#2)
and yielded the##2##3##(2008-10#2)
and yielded##10##2##(1993-8#1)(1997-7#1)(2008-10#7)(2013-8#1)
and yields a##4##3##(2008-10#3)(2010-4#1)
and yields##8##2##(2008-10#5)(2008-3#1)(2010-4#1)(2010-7#1)
and yolk##2##2##(2008-10#1)(2008-12#1)
and you##2##2##(1993-12#1)(1995-2#1)
and young adults with##2##4##(2008-11#1)(2012-2#1)
and young adults##14##3##(2007-12#2)(2008-11#3)(2008-12#1)(2009-10#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and young children##5##3##(1996-2#1)(1997-1#2)(1997-8#1)(2008-11#1)
and young people##2##3##(1991-6#1)(2008-7#1)
and young##35##2##(1990-6#1)(1991-6#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-7#2)(2009-10#3)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
and younger##6##2##(2008-12#1)(2009-5#1)(2009-8#2)(2011-1#1)(2013-8#1)
and your hospital##2##3##(1994-12#1)(1994-2#1)
and your##7##2##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
and youth##5##2##(2008-11#3)(2009-7#1)(2010-1#1)
and yttrium##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
and zidovudine##2##2##(1992-6#1)(2011-3#1)
and zinc by##3##3##(2008-10#3)
and zinc determination##2##3##(2008-10#2)
and zinc from##2##3##(2008-10#2)
and zinc in##12##3##(2008-10#12)
and zinc ions##2##3##(2008-10#1)(2010-11#1)
and zinc on##3##3##(1994-6#1)(2008-10#1)(2013-8#1)
and zinc using##2##3##(2008-10#2)
and zinc were##5##3##(2008-10#4)(2011-2#1)
and zinc##64##2##(1992-3#1)(1994-6#1)(2008-10#52)(2008-11#1)(2008-12#1)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and zinc(II) by##2##3##(2008-10#2)
and zinc(II)##9##2##(1991-5#2)(2008-10#7)
and zinc)##2##2##(2008-10#1)(2008-11#1)
and zirconium##2##2##(1990-5#1)(2008-10#1)
and zirconium(IV)##2##2##(2008-10#2)
and zona incerta##2##3##(1996-12#2)
and zoospores##7##2##(2008-10#7)
and zucchini##2##2##(2008-10#2)
and ~1##2##2##(2008-3#2)
and α##2##2##(2010-11#1)(2011-2#1)
and α-zearalenol##2##2##(2013-1#2)
and β(3)-adrenoceptor agonists##2##3##(2010-12#2)
and β-cell##5##2##(2010-10#2)(2010-11#3)
and ≥3##2##2##(2013-1#2)
and##117356##1##(1990-10#16)(1990-11#292)(1990-12#340)(1990-2#286)(1990-3#198)(1990-4#10)(1990-5#358)(1990-6#220)(1990-7#25)(1990-8#249)(1990-9#197)(1991-1#258)(1991-10#43)(1991-11#159)(1991-12#520)(1991-2#462)(1991-3#421)(1991-4#8)(1991-5#309)(1991-6#374)(1991-7#52)(1991-8#197)(1991-9#165)(1992-1#202)(1992-10#63)(1992-11#78)(1992-12#485)(1992-2#347)(1992-3#486)(1992-4#72)(1992-5#112)(1992-6#293)(1992-7#19)(1992-8#92)(1992-9#256)(1993-1#349)(1993-11#180)(1993-12#649)(1993-2#429)(1993-3#512)(1993-5#20)(1993-6#352)(1993-8#476)(1993-9#137)(1994-1#270)(1994-11#384)(1994-12#550)(1994-2#448)(1994-3#501)(1994-5#431)(1994-6#230)(1994-8#499)(1994-9#145)(1995-1#201)(1995-10#26)(1995-11#401)(1995-12#648)(1995-2#658)(1995-3#338)(1995-5#263)(1995-6#506)(1995-8#366)(1995-9#118)(1996-1#321)(1996-10#3)(1996-11#162)(1996-12#759)(1996-2#705)(1996-3#464)(1996-5#260)(1996-6#257)(1996-8#112)(1996-9#118)(1997-1#495)(1997-2#681)(1997-3#656)(1997-4#182)(1997-5#117)(1997-6#190)(1997-7#364)(1997-8#618)(1997-9#57)(2006-5#11)(2006-6#132)(2007-11#158)(2007-12#533)(2007-7#3)(2007-8#116)(2007-9#12)(2008-1#550)(2008-10#38540)(2008-11#7335)(2008-12#2546)(2008-2#456)(2008-3#1873)(2008-4#1091)(2008-5#2370)(2008-6#588)(2008-7#2783)(2008-8#2991)(2008-9#3043)(2009-1#117)(2009-10#707)(2009-11#252)(2009-12#409)(2009-2#31)(2009-3#285)(2009-4#174)(2009-5#287)(2009-6#325)(2009-7#602)(2009-8#837)(2009-9#244)(2010-1#529)(2010-10#544)(2010-11#507)(2010-12#726)(2010-2#122)(2010-3#245)(2010-4#474)(2010-5#454)(2010-6#438)(2010-7#601)(2010-8#602)(2010-9#282)(2011-1#600)(2011-10#90)(2011-2#5175)(2011-3#470)(2011-4#7)(2011-5#2)(2011-7#76)(2011-8#9)(2011-9#19)(2012-12#868)(2012-2#2307)(2012-3#2224)(2012-4#59)(2012-5#108)(2012-6#43)(2012-7#35)(2012-8#19)(2012-9#25)(2013-1#3883)(2013-2#4)(2013-3#14)(2013-7#167)(2013-8#1955)
and/ or##2##2##(1997-3#1)(2008-10#1)
and/or CKD##2##2##(2012-3#2)
and/or DNA##2##2##(1993-8#1)(2013-1#1)
and/or IGF-I##2##2##(2008-11#1)(2013-1#1)
and/or M##2##2##(2008-10#1)(2008-6#1)
and/or a##5##2##(1996-2#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-10#1)
and/or an##3##2##(1990-2#1)(2009-3#1)(2010-5#1)
and/or are##2##2##(2008-10#1)(2008-4#1)
and/or basal##2##2##(2008-10#1)(2012-4#1)
and/or by##4##2##(1993-11#1)(2008-11#1)(2008-9#1)(2010-10#1)
and/or candidate genes##2##3##(2008-8#2)
and/or complete##2##2##(2012-2#1)(2013-8#1)
and/or hydrogen peroxide##2##3##(2008-10#2)
and/or increasing##2##2##(1996-3#1)(2012-2#1)
and/or its##5##2##(1995-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
and/or maintain##2##2##(2009-8#1)(2010-7#1)
and/or maintenance##2##2##(1993-6#1)(2008-11#1)
and/or mature##2##2##(2008-4#1)(2008-7#1)
and/or multiple##2##2##(2008-4#1)(2011-2#1)
and/or negatively##2##2##(2008-10#2)
and/or other##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
and/or oxidation##2##2##(2008-10#2)
and/or reactive##2##2##(1994-8#1)(2008-10#1)
and/or reduced##2##2##(1990-12#1)(2010-3#1)
and/or regional##2##2##(2008-10#1)(2012-3#1)
and/or renal##3##2##(1994-5#1)(1997-8#2)
and/or risk assessment##3##3##(2008-10#2)(2008-11#1)
and/or separation##2##2##(2008-10#2)
and/or soft tissue##2##3##(2013-1#2)
and/or surgical##2##2##(1996-3#1)(2011-2#1)
and/or the##13##2##(1990-6#1)(1992-6#1)(1994-11#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-3#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
and/or their##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)(2011-2#1)
and/or therapeutic##2##2##(1990-6#1)(2008-11#1)
and/or trans-acting##2##2##(1993-12#1)(1995-2#1)
and/or treatment##2##2##(2010-10#1)(2012-2#1)
and/or##532##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#4)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#6)(1991-2#5)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-5#2)(1992-6#5)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#3)(1995-6#3)(1995-8#4)(1996-12#4)(1996-2#3)(1996-3#5)(1996-6#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-6#2)(1997-7#2)(1997-8#7)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#110)(2008-11#31)(2008-12#10)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#12)(2008-6#2)(2008-7#18)(2008-8#14)(2008-9#20)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#9)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#7)(2010-8#1)(2011-1#4)(2011-2#38)(2011-3#2)(2012-12#5)(2012-2#24)(2012-3#16)(2012-4#1)(2012-5#1)(2012-9#2)(2013-1#22)(2013-8#7)
and15##2##1##(2008-11#2)
andExpansin genes##2##2##(2008-8#2)
andHind III##2##2##(2008-8#2)
andhemadsorption activities##2##2##(2008-11#2)
andin vitro##2##2##(2008-11#1)(2008-8#1)
andin##6##1##(2008-11#3)(2008-8#3)
andincreased##2##1##(2008-11#2)
andiyazi##3##1##(2008-10#3)
andoxygen##2##1##(2008-11#2)
andrhoV (alt)##5##2##(2008-9#5)
androgen ablation##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
androgen and glucocorticoid receptors##2##4##(1995-12#2)
androgen and glucocorticoid##3##3##(1995-12#3)
androgen binding component##3##3##(1990-11#3)
androgen binding##8##2##(1990-11#6)(2008-11#2)
androgen concentrations##3##2##(2008-4#1)(2010-11#1)(2013-8#1)
androgen excess##3##2##(2008-4#3)
androgen metabolism##2##2##(1990-11#1)(1995-8#1)
androgen production##2##2##(1993-9#1)(2012-3#1)
androgen receptor cDNA##2##3##(1991-5#1)(1995-12#1)
androgen receptor mRNA##2##3##(1991-5#2)
androgen receptor##18##2##(1990-11#5)(1991-5#6)(1995-12#1)(2008-4#3)(2008-9#1)(2010-1#1)(2012-2#1)
androgen receptor-mediated##2##2##(2010-1#1)(2011-2#1)
androgen##72##1##(1990-11#13)(1991-5#8)(1992-12#1)(1993-8#2)(1993-9#1)(1994-2#1)(1995-12#7)(1995-2#2)(1995-8#1)(2008-11#2)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#2)(2009-6#1)(2010-1#3)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
androgen-dependent##2##1##(1990-11#2)
androgen-regulated genes##2##2##(2008-6#1)(2010-1#1)
androgenic steroid##4##2##(1990-11#3)(1993-1#1)
androgenic##9##1##(1990-11#3)(1993-1#1)(1995-12#1)(2008-5#1)(2010-1#1)(2012-3#2)
androgens and glucocorticoids##2##3##(1995-12#1)(2008-7#1)
androgens and##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
androgens##19##1##(1990-11#4)(1994-2#1)(1994-8#1)(1995-12#4)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#2)
andrographolide were##2##2##(2008-10#2)
andrographolide##6##1##(2008-10#6)
android##3##1##(2008-11#3)
androids##4##1##(2008-11#4)
androstenedione reduction##2##2##(1994-6#2)
androstenedione##5##1##(1990-11#2)(1994-6#2)(1995-8#1)
anecdotal evidence##3##2##(2008-11#1)(2008-5#1)(2013-7#1)
anecdotal##7##1##(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
anecdotally##3##1##(2007-12#1)(2008-1#1)(2008-9#1)
anemia among##3##2##(2009-10#1)(2011-2#2)
anemia and##5##2##(1994-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
anemia associated with##3##3##(1995-1#1)(2008-7#1)(2012-3#1)
anemia by##2##2##(2008-4#1)(2012-3#1)
anemia in cancer patients##2##4##(2010-11#2)
anemia in##11##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-3#3)
anemia of##2##2##(1997-6#1)(2012-2#1)
anemia on##2##2##(2008-7#1)(2010-11#1)
anemia was##3##2##(1994-9#1)(2011-2#2)
anemia##72##1##(1991-2#1)(1991-6#2)(1992-6#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-6#4)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-8#1)(2010-11#4)(2010-12#1)(2010-6#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#6)(2012-9#1)(2013-1#1)
anemic##4##1##(2008-7#1)(2012-2#3)
anemone##3##1##(2008-10#3)
anergy##3##1##(2008-11#2)(2011-2#1)
anesthesia and##11##2##(1991-2#1)(1992-12#1)(1993-1#2)(2008-9#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-3#2)
anesthesia during##3##2##(2012-3#3)
anesthesia following##2##2##(1994-2#1)(2012-3#1)
anesthesia for cesarean section##2##4##(2012-12#1)(2012-3#1)
anesthesia for##7##2##(1993-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
anesthesia in the##4##3##(2010-8#2)(2011-3#1)(2013-8#1)
anesthesia in##10##2##(1993-1#1)(2010-8#2)(2011-3#1)(2012-3#5)(2013-8#1)
anesthesia is##2##2##(1992-12#1)(2011-2#1)
anesthesia on##2##2##(1993-1#1)(2013-8#1)
anesthesia practice##2##2##(2011-1#1)(2012-2#1)
anesthesia time##2##2##(1993-12#1)(1994-3#1)
anesthesia was##5##2##(1990-11#1)(1993-1#2)(2012-3#2)
anesthesia were##2##2##(1990-5#1)(2012-3#1)
anesthesia with##9##2##(2012-3#9)
anesthesia##105##1##(1990-11#3)(1990-5#2)(1991-2#1)(1992-12#7)(1993-1#18)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#6)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#37)(2013-1#3)(2013-8#2)
anesthesiologists##2##1##(1993-1#1)(2012-3#1)
anesthetic agent##4##2##(1993-1#1)(2009-8#1)(2011-1#1)(2012-3#1)
anesthetic agents##3##2##(2012-3#3)
anesthetic management##2##2##(2009-3#1)(2012-3#1)
anesthetic##40##1##(1990-5#3)(1991-1#1)(1991-6#1)(1993-1#13)(1994-2#1)(1995-3#1)(2008-10#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-1#2)(2010-5#1)(2010-8#3)(2011-1#1)(2012-3#7)(2013-1#1)
anesthetics##9##1##(1993-1#4)(1995-12#3)(2009-8#1)(2012-3#1)
anesthetized cats##2##2##(2008-8#1)(2012-3#1)
anesthetized dogs##3##2##(1992-3#1)(1994-8#1)(1997-1#1)
anesthetized rats and##2##3##(1992-3#1)(1997-2#1)
anesthetized rats##5##2##(1992-3#1)(1994-2#1)(1995-11#1)(1997-2#1)(2009-8#1)
anesthetized##23##1##(1990-9#1)(1991-3#1)(1992-3#4)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-1#2)(1997-2#2)(2008-10#1)(2008-8#1)(2009-8#2)(2011-2#3)(2012-3#2)
aneuploid tumor##2##2##(1994-12#2)
aneuploid##6##1##(1994-12#2)(2008-10#2)(2008-8#1)(2009-12#1)
aneuploidy in##2##2##(1991-6#1)(2009-7#1)
aneuploidy##12##1##(1990-3#1)(1991-6#1)(1994-12#1)(1995-9#1)(2008-4#1)(2009-12#1)(2009-7#1)(2012-3#3)(2013-1#2)
aneurysm and the##2##3##(2011-2#1)(2013-8#1)
aneurysm and##4##2##(1994-1#1)(2011-2#2)(2013-8#1)
aneurysm arising from fenestrated proximal anterior cerebral artery##2##8##(2013-8#2)
aneurysm arising from##3##3##(2010-7#1)(2013-8#2)
aneurysm by##2##2##(1997-6#2)
aneurysm causing##2##2##(2008-7#2)
aneurysm formation##2##2##(1997-8#1)(2009-10#1)
aneurysm in the##2##3##(1997-8#1)(2009-8#1)
aneurysm in##5##2##(1997-8#1)(2008-7#2)(2009-8#1)(2013-1#1)
aneurysm involving the##2##3##(2008-12#1)(2009-8#1)
aneurysm may##2##2##(2008-11#1)(2008-7#1)
aneurysm of the extracranial##2##4##(1992-5#1)(2008-7#1)
aneurysm of the middle cerebral artery##3##6##(2008-7#3)
aneurysm of the##9##3##(1991-6#1)(1992-5#1)(1997-8#1)(2008-7#5)(2011-2#1)
aneurysm of##15##2##(1991-6#1)(1992-5#2)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#7)(2011-2#1)(2013-1#1)
aneurysm repair##3##2##(2008-12#1)(2010-12#1)(2011-3#1)
aneurysm rupture##4##2##(2008-7#2)(2011-2#2)
aneurysm sac##2##2##(2011-3#2)
aneurysm should be##2##3##(1992-5#1)(2008-7#1)
aneurysm surgery and##3##3##(2012-3#3)
aneurysm surgery##4##2##(2008-7#1)(2012-3#3)
aneurysm was##4##2##(1997-6#1)(2008-7#2)(2013-1#1)
aneurysm which##2##2##(1991-6#1)(2013-8#1)
aneurysm with##4##2##(1991-8#1)(2008-11#1)(2011-2#2)
aneurysm##134##1##(1991-6#2)(1991-8#1)(1992-5#7)(1994-1#1)(1995-11#3)(1996-3#2)(1997-3#4)(1997-5#1)(1997-6#7)(1997-8#3)(2008-11#7)(2008-12#8)(2008-7#31)(2009-10#2)(2009-7#1)(2009-8#2)(2010-12#4)(2010-5#2)(2010-7#5)(2011-2#15)(2011-3#5)(2012-3#4)(2013-1#9)(2013-8#8)
aneurysmal SAH##2##2##(2012-3#2)
aneurysmal bone cyst##6##3##(2012-12#4)(2013-1#2)
aneurysmal bone##7##2##(2012-12#4)(2013-1#3)
aneurysmal dilatation of##2##3##(2011-3#1)(2012-2#1)
aneurysmal dilatation##3##2##(2008-7#1)(2011-3#1)(2012-2#1)
aneurysmal pattern##2##2##(2008-7#2)
aneurysmal protrusion at the##2##4##(2008-12#2)
aneurysmal rupture##3##2##(1997-8#3)
aneurysmal sac##3##2##(1997-3#2)(2011-3#1)
aneurysmal subarachnoid hemorrhage##2##3##(1995-11#1)(2012-3#1)
aneurysmal##31##1##(1995-11#1)(1997-3#5)(1997-6#1)(1997-8#3)(2008-12#3)(2008-7#3)(2009-7#1)(2010-7#1)(2011-3#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#3)
aneurysms and##6##2##(2008-7#3)(2009-9#1)(2012-2#1)(2013-1#1)
aneurysms are##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
aneurysms in##5##2##(1995-11#1)(1997-3#2)(2008-7#1)(2010-9#1)
aneurysms is##2##2##(1997-3#1)(2012-3#1)
aneurysms of the##3##3##(2008-7#2)(2010-7#1)
aneurysms of##4##2##(2008-7#2)(2009-8#1)(2010-7#1)
aneurysms that were##2##3##(1997-3#1)(2011-2#1)
aneurysms that##4##2##(1997-3#2)(2011-2#1)(2013-1#1)
aneurysms were located at the##2##5##(1997-3#1)(2008-7#1)
aneurysms were##7##2##(1992-5#1)(1995-11#1)(1997-3#1)(1997-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
aneurysms with##2##2##(2008-7#1)(2012-2#1)
aneurysms##72##1##(1992-5#1)(1995-11#4)(1997-3#8)(1997-6#1)(1997-8#2)(2008-11#2)(2008-7#15)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#9)(2012-2#2)(2012-3#6)(2013-1#4)(2013-8#9)
anew##3##1##(2008-10#1)(2008-11#1)(2009-10#1)
anger and##3##2##(2009-8#1)(2010-11#2)
anger expression##5##2##(2008-4#5)
anger intensity and the##3##4##(2010-11#3)
anger or##2##2##(1990-11#1)(2010-11#1)
anger##25##1##(1990-11#1)(1992-3#1)(1996-11#1)(2008-12#2)(2008-4#7)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#8)(2010-7#1)(2012-2#1)
angiitis is##2##2##(2008-7#1)(2010-6#1)
angiitis##5##1##(2008-7#3)(2010-6#1)(2012-3#1)
angina are##2##2##(2008-12#2)
angina pectoris##9##2##(1990-12#3)(2008-10#2)(2008-12#2)(2010-8#1)(2011-2#1)
angina##36##1##(1990-12#3)(1992-9#1)(1996-3#1)(1997-5#1)(2008-10#3)(2008-12#6)(2008-3#11)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
angina)##2##1##(1992-9#1)(2008-3#1)
angio-CT##2##1##(1995-11#2)
angioarchitectural##2##1##(1995-11#1)(1997-6#1)
angioarchitecture##4##1##(1995-11#1)(1996-9#1)(2011-2#2)
angiocentric lymphoma##2##2##(2009-1#2)
angiocentric##3##1##(2009-1#3)
angiodysplasia##2##1##(2010-6#1)(2012-2#1)
angioedema##4##1##(2008-8#1)(2013-1#3)
angiogenesis and##9##2##(2008-1#2)(2008-11#1)(2009-3#1)(2010-11#1)(2010-6#2)(2011-2#1)(2013-1#1)
angiogenesis at##2##2##(2011-2#2)
angiogenesis in##6##2##(1994-12#1)(1996-8#1)(2009-1#1)(2010-1#1)(2010-12#1)(2013-1#1)
angiogenesis inhibitors##3##2##(1994-12#1)(1997-1#2)
angiogenesis of##3##2##(2008-11#2)(2011-2#1)
angiogenesis through##2##2##(2013-1#2)
angiogenesis##48##1##(1994-12#3)(1996-10#1)(1996-8#1)(1997-1#2)(2008-1#3)(2008-11#6)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#4)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#7)(2013-1#7)(2013-8#3)
angiogenic factor##4##2##(1994-11#1)(1994-12#1)(2008-11#1)(2008-9#1)
angiogenic factors##4##2##(2008-1#2)(2009-8#1)(2012-3#1)
angiogenic inhibitors are##2##3##(2008-1#2)
angiogenic inhibitors in##2##3##(2008-1#2)
angiogenic inhibitors##8##2##(2008-1#8)
angiogenic##26##1##(1994-11#1)(1994-12#1)(2008-1#10)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
angiogram also##2##2##(2008-12#1)(2013-1#1)
angiogram##9##1##(1996-6#1)(2008-12#2)(2008-7#2)(2011-2#1)(2013-1#3)
angiograms##6##1##(1995-11#1)(1997-3#2)(2008-7#1)(2011-2#2)
angiographic cure was achieved in##2##5##(2008-7#2)
angiographic findings of##2##3##(1997-8#2)
angiographic findings##4##2##(1997-8#4)
angiographic restenosis##2##2##(2008-11#1)(2008-12#1)
angiographic vasospasm after AVM rupture##2##5##(2012-3#2)
angiographic vasospasm##3##2##(2012-3#3)
angiographic##27##1##(1991-2#1)(1992-3#1)(1992-9#1)(1994-9#1)(1996-6#1)(1996-9#2)(1997-3#3)(1997-8#7)(2008-11#2)(2008-12#1)(2008-7#3)(2012-3#4)
angiographically##4##1##(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)
angiography and angioplasty##3##3##(2011-2#3)
angiography and##15##2##(1992-9#1)(1993-6#1)(1997-6#1)(1997-8#1)(2008-12#1)(2009-10#1)(2011-2#8)(2012-3#1)
angiography before the second operation##2##5##(2008-7#2)
angiography confirmed##2##2##(1995-11#1)(2013-1#1)
angiography demonstrated##2##2##(2008-7#1)(2013-1#1)
angiography in patients##2##3##(1990-9#1)(2008-10#1)
angiography in##6##2##(1990-9#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
angiography is##3##2##(1996-9#1)(2008-11#1)(2008-7#1)
angiography may##3##2##(1996-9#1)(1997-8#1)(2008-11#1)
angiography of##2##2##(2008-12#1)(2011-2#1)
angiography or##3##2##(1993-6#1)(1997-3#1)(2011-2#1)
angiography proved to be##2##4##(2008-12#1)(2008-7#1)
angiography remains the##2##3##(1995-11#1)(2008-7#1)
angiography revealed##4##2##(2008-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
angiography showed a##2##3##(1996-3#1)(2010-10#1)
angiography showed##7##2##(1996-3#1)(1996-9#1)(2008-7#2)(2010-10#2)(2013-1#1)
angiography to##4##2##(1990-9#1)(2009-11#1)(2009-12#1)(2012-3#1)
angiography was##5##2##(1991-11#1)(1991-6#1)(1994-1#1)(2008-7#1)(2011-2#1)
angiography with 3D display##2##4##(1995-11#2)
angiography with##3##2##(1995-11#2)(1997-8#1)
angiography##120##1##(1990-9#3)(1991-11#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-6#2)(1993-8#2)(1994-1#3)(1995-11#5)(1996-3#1)(1996-9#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#5)(2008-10#1)(2008-11#7)(2008-12#9)(2008-3#1)(2008-7#19)(2009-10#3)(2009-11#1)(2009-12#1)(2009-8#2)(2010-10#3)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#23)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#1)
angioinvasive##2##1##(2008-5#1)(2013-1#1)
angioma##2##1##(1996-6#1)(2007-8#1)
angiomas##4##1##(1996-6#1)(2008-7#3)
angiomyolipoma##6##1##(1992-2#1)(2010-6#5)
angiopathy##3##1##(1996-11#1)(2012-2#1)(2013-1#1)
angioplasties##2##1##(2011-2#2)
angioplasty and stenting##2##3##(2008-12#1)(2012-3#1)
angioplasty and##6##2##(1997-8#2)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#1)
angioplasty by##2##2##(2008-11#2)
angioplasty for##2##2##(2008-11#1)(2008-7#1)
angioplasty in##2##2##(1997-8#1)(2008-3#1)
angioplasty of##3##2##(1991-3#1)(1997-8#1)(2013-1#1)
angioplasty with##3##2##(1991-5#1)(2008-11#1)(2011-2#1)
angioplasty##55##1##(1990-9#1)(1991-3#4)(1991-5#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-8#6)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#1)(2011-2#9)(2012-3#2)(2013-1#1)(2013-8#2)
angiosarcoma##2##1##(2013-7#2)
angiosperm trees##2##2##(2008-10#1)(2012-3#1)
angiosperm##7##1##(2008-10#4)(2009-8#1)(2010-5#1)(2012-3#1)
angiosperms##6##1##(2008-10#2)(2008-8#1)(2009-8#3)
angiotensin I##3##2##(1994-8#2)(2008-10#1)
angiotensin II (AII)##3##3##(1991-5#1)(1994-8#1)(1995-12#1)
angiotensin II in##2##3##(1994-8#1)(1996-2#1)
angiotensin II receptor antagonists##2##4##(1991-5#1)(2008-10#1)
angiotensin II receptor blockers##4##4##(1996-6#2)(2008-11#2)
angiotensin II receptor subtype##2##4##(1992-3#1)(1994-8#1)
angiotensin II receptor##13##3##(1991-5#4)(1992-3#2)(1994-8#1)(1995-11#1)(1996-6#2)(2008-10#1)(2008-11#2)
angiotensin II type##4##3##(1992-3#1)(1994-11#2)(2008-9#1)
angiotensin II##38##2##(1991-5#8)(1992-3#4)(1993-8#1)(1994-11#2)(1994-8#4)(1995-11#6)(1995-12#2)(1996-2#4)(1996-6#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)
angiotensin II-induced DNA synthesis##2##4##(1995-11#2)
angiotensin II-induced##4##2##(1994-2#1)(1995-11#3)
angiotensin III##2##2##(1994-2#2)
angiotensin converting enzyme (ACE)##2##4##(1993-12#1)(2008-1#1)
angiotensin converting enzyme##4##3##(1991-3#1)(1993-12#1)(1996-6#1)(2008-1#1)
angiotensin receptors##4##2##(1991-5#1)(1994-2#2)(1994-8#1)
angiotensin##69##1##(1991-3#1)(1991-5#11)(1992-3#4)(1993-12#1)(1993-8#2)(1994-11#2)(1994-2#5)(1994-3#3)(1994-8#7)(1995-11#10)(1995-12#2)(1996-2#4)(1996-6#3)(2008-1#2)(2008-10#2)(2008-11#5)(2008-5#1)(2008-9#1)(2009-1#1)(2013-1#2)
angiotensin-converting enzyme (ACE)##2##3##(2008-6#1)(2008-7#1)
angiotensin-converting enzyme and##2##3##(2008-11#1)(2008-6#1)
angiotensin-converting enzyme inhibitors##2##3##(2008-11#1)(2013-1#1)
angiotensin-converting enzyme##8##2##(1995-2#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#1)(2013-1#1)
angle X-ray diffraction##2##3##(2008-5#2)
angle X-ray##3##2##(2008-11#1)(2008-5#2)
angle and the##5##3##(2007-12#1)(2008-3#3)(2012-2#1)
angle and##16##2##(1992-9#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-3#4)(2009-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
angle closure glaucoma##2##3##(2011-2#2)
angle closure##6##2##(2011-2#4)(2013-1#2)
angle dependence##2##2##(2008-2#1)(2012-2#1)
angle for##3##2##(2008-3#3)
angle in the##3##3##(2008-3#3)
angle in##4##2##(2008-3#4)
angle is##2##2##(2008-3#2)
angle of incidence##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
angle of the##9##3##(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#1)(2012-2#1)
angle of##24##2##(1993-8#2)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#9)(2008-9#2)(2012-2#1)
angle on##2##2##(2008-3#1)(2012-3#1)
angle range##2##2##(2008-3#1)(2013-8#1)
angle shift##4##2##(2008-10#4)
angle to##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
angle was##3##2##(1992-4#1)(1994-5#1)(2008-10#1)
angle were##2##2##(2008-8#1)(2013-1#1)
angle with##2##2##(2008-2#1)(2012-2#1)
angle##150##1##(1991-9#1)(1992-4#2)(1992-9#2)(1993-8#3)(1994-5#4)(1994-9#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#28)(2008-11#2)(2008-2#5)(2008-3#44)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#4)(2009-8#1)(2011-2#20)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#3)
angles and residual strains in##3##5##(2008-9#3)
angles and residual strains##4##4##(2008-9#4)
angles and##7##2##(2008-2#1)(2008-9#4)(2011-2#1)(2013-1#1)
angles are##3##2##(1992-12#1)(2008-3#2)
angles in##2##2##(1992-12#1)(2008-3#1)
angles is##2##2##(2008-3#2)
angles of the##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
angles of##6##2##(1992-4#1)(1997-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
angles range from##2##3##(2007-12#1)(2008-3#1)
angles that##2##2##(2008-3#2)
angles were##2##2##(1992-4#1)(2011-2#1)
angles with##2##2##(2008-3#2)
angles##55##1##(1992-12#3)(1992-4#4)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#26)(2008-8#1)(2008-9#6)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
angry behaviors##2##2##(2010-11#2)
angry emotional expressions##2##3##(2008-11#2)
angry face##2##2##(1990-11#1)(2009-4#1)
angry faces##2##2##(2009-4#2)
angry facial expressions##2##3##(2008-11#1)(2009-4#1)
angry##14##1##(1990-11#1)(1991-3#1)(2008-11#4)(2009-4#4)(2010-10#1)(2010-11#3)
angstroms##2##1##(1990-11#1)(1992-9#1)
anguibactin##6##1##(2011-2#6)
angular and##2##2##(2008-3#1)(2013-1#1)
angular displacement##3##2##(2011-2#2)(2013-1#1)
angular displacements##2##2##(2013-1#2)
angular distribution of##5##3##(2008-10#2)(2008-2#2)(2008-3#1)
angular distribution##8##2##(2008-10#4)(2008-2#3)(2008-3#1)
angular gyrus##2##2##(2008-11#2)
angular leaf spot##10##3##(2008-10#10)
angular leaf##11##2##(2008-10#11)
angular measurement##2##2##(2012-2#1)(2013-1#1)
angular momentum##2##2##(2007-11#1)(2008-3#1)
angular optical scattering##2##3##(2008-3#2)
angular plate##2##2##(2013-1#2)
angular range##3##2##(2008-3#3)
angular speed##2##2##(2008-3#1)(2011-2#1)
angular velocity of the##2##4##(2011-2#2)
angular velocity##3##2##(2011-2#3)
angular##83##1##(1993-5#1)(1994-5#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#16)(2008-11#3)(2008-2#8)(2008-3#25)(2008-7#1)(2010-12#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#12)
angulated##2##1##(2008-9#1)(2012-2#1)
angulation##5##1##(2008-11#1)(2008-9#2)(2011-2#1)(2013-1#1)
angustifolia)##2##1##(2008-10#2)
anhedonia##3##1##(1993-9#1)(2008-7#2)
anhydride to give##2##3##(1996-5#1)(2008-11#1)
anhydride was##2##2##(1995-11#1)(2008-10#1)
anhydride##31##1##(1991-12#1)(1994-8#1)(1995-11#14)(1996-5#1)(2008-10#13)(2008-11#1)
anhydrides##5##1##(1994-3#1)(1995-11#4)
anhydrous methyl ethyl ketone##2##4##(2008-10#2)
anhydrous##12##1##(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
aniline from##2##2##(2008-10#2)
aniline in##3##2##(2008-10#3)
aniline was##3##2##(2008-10#3)
aniline with##2##2##(2008-10#2)
aniline##20##1##(2008-10#19)(2012-3#1)
anilines##2##1##(1994-5#1)(2008-10#1)
anilino-(1##3##1##(2008-10#3)
animal and food##2##3##(2008-10#1)(2013-8#1)
animal and human studies##2##4##(2008-2#1)(2009-7#1)
animal and human##7##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#3)
animal and plant cells##3##4##(2008-11#1)(2008-8#1)(2009-8#1)
animal and plant##5##3##(2008-11#1)(2008-8#2)(2009-8#1)(2011-2#1)
animal and##19##2##(1991-12#1)(1992-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#3)(2009-8#1)(2011-2#1)(2013-8#1)
animal as well as##2##4##(1996-2#1)(2008-11#1)
animal behavior##6##2##(2008-11#3)(2008-8#3)
animal care##2##2##(1997-7#1)(2008-9#1)
animal cell culture processes##2##4##(2008-11#2)
animal cell culture##17##3##(2008-11#15)(2008-7#2)
animal cell cultures##2##3##(2008-11#1)(2008-7#1)
animal cell##33##2##(2008-10#1)(2008-11#26)(2008-7#4)(2009-8#2)
animal cells and##2##3##(2008-11#1)(2008-4#1)
animal cells for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
animal cells in##3##3##(2008-11#2)(2013-1#1)
animal cells##27##2##(1993-2#2)(1994-11#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-11#14)(2008-4#2)(2008-8#3)(2008-9#1)(2013-1#1)
animal data##2##2##(2008-10#1)(2011-2#1)
animal diseases##2##2##(2010-7#1)(2011-2#1)
animal evolution##2##2##(2010-4#1)(2012-2#1)
animal experiments##8##2##(1991-12#2)(1991-2#1)(1996-8#1)(1997-7#1)(2008-7#1)(2010-1#1)(2012-3#1)
animal fats##2##2##(2009-3#1)(2011-2#1)
animal feed and##2##3##(2008-10#2)
animal feed##8##2##(2008-10#8)
animal feeds##8##2##(2008-10#6)(2011-2#2)
animal had##2##2##(2008-9#2)
animal health##5##2##(1997-7#2)(2008-10#1)(2008-4#1)(2013-1#1)
animal is misjudged as##2##4##(2013-1#2)
animal is##7##2##(1991-2#1)(2008-11#1)(2008-12#1)(2008-8#2)(2013-1#2)
animal lectins##2##2##(1990-5#2)
animal model and##2##3##(2008-10#1)(2008-9#1)
animal model for human##2##4##(2008-4#1)(2011-2#1)
animal model for##4##3##(1995-2#1)(2008-4#1)(2010-12#1)(2011-2#1)
animal model of##12##3##(1993-12#1)(1993-2#1)(1995-2#1)(1996-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-9#1)(2010-1#1)(2012-2#1)
animal model system##3##3##(2008-11#2)(2008-4#1)
animal model##45##2##(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-2#3)(1996-2#1)(1996-3#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2010-1#1)(2010-12#1)(2010-6#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)
animal models and##2##3##(1992-1#1)(2008-10#1)
animal models are used to##2##5##(2008-7#2)
animal models for##4##3##(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#1)
animal models have been##2##4##(2008-9#1)(2010-6#1)
animal models have##3##3##(2008-9#1)(2010-6#1)(2013-7#1)
animal models of human##2##4##(2008-12#1)(2009-8#1)
animal models of infection##3##4##(2008-7#3)
animal models of##22##3##(1992-6#1)(1992-9#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#3)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
animal models##69##2##(1992-1#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#2)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#5)(2008-5#4)(2008-7#5)(2008-9#7)(2009-10#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-5#1)(2010-6#5)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
animal or human##2##3##(2008-11#1)(2008-5#1)
animal origin##9##2##(1994-3#1)(2008-10#1)(2008-11#4)(2009-8#1)(2011-1#1)(2013-8#1)
animal pathogens##2##2##(2011-2#2)
animal populations##2##2##(2008-8#1)(2011-2#1)
animal protein##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
animal protein-free##2##2##(2011-2#2)
animal shelter##3##2##(1996-12#1)(2013-8#2)
animal species##7##2##(1992-6#2)(2008-12#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)
animal studies and##3##3##(1993-11#1)(2008-11#1)(2008-8#1)
animal studies have##3##3##(2008-10#2)(2009-10#1)
animal studies##16##2##(1991-12#1)(1992-6#2)(1993-11#1)(1995-9#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
animal study##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
animal testing##2##2##(2008-5#1)(2010-6#1)
animal that##2##2##(2008-9#2)
animal tissues##2##2##(2008-10#1)(2008-9#1)
animal tissues)##2##2##(2008-10#1)(2012-12#1)
animal to animal##2##3##(2008-10#2)
animal to##3##2##(1992-12#1)(2008-10#2)
animal was##2##2##(1992-8#1)(2012-2#1)
animal##467##1##(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-12#5)(1991-2#3)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#8)(1996-2#2)(1996-3#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#10)(1997-8#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#71)(2008-11#82)(2008-12#11)(2008-2#1)(2008-4#17)(2008-5#8)(2008-6#2)(2008-7#15)(2008-8#21)(2008-9#31)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#5)(2009-8#11)(2010-1#7)(2010-10#2)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#9)(2010-7#1)(2011-1#2)(2011-2#26)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#6)
animal's##5##1##(1993-12#1)(1996-12#1)(2008-11#2)(2008-4#1)
animal-derived##7##1##(2008-11#7)
animal-free medium##2##2##(2008-11#2)
animal-free##4##1##(2008-11#4)
animals aged##2##2##(1993-12#1)(1995-8#1)
animals and for##2##3##(2008-11#1)(2013-1#1)
animals and human##2##3##(1995-5#1)(2008-11#1)
animals and humans##8##3##(2008-10#2)(2008-11#1)(2008-12#3)(2011-2#1)(2012-2#1)
animals and in##2##3##(1991-2#1)(1996-5#1)
animals and##30##2##(1990-3#1)(1991-2#1)(1992-3#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-4#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
animals are not##2##3##(1994-6#1)(2011-2#1)
animals are##8##2##(1994-6#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)
animals as##6##2##(1997-2#1)(2008-10#1)(2008-12#1)(2010-4#1)(2011-2#2)
animals at##2##2##(1990-5#1)(2010-1#1)
animals but##2##2##(1995-2#1)(2008-7#1)
animals by##3##2##(1992-8#1)(2008-12#1)(2013-1#1)
animals can be##2##3##(1993-12#1)(1993-6#1)
animals can##5##2##(1993-12#1)(1993-6#1)(2008-8#2)(2009-8#1)
animals compared to##2##3##(1996-12#1)(2012-3#1)
animals compared##3##2##(1995-2#1)(1996-12#1)(2012-3#1)
animals developed##2##2##(1995-9#1)(2009-8#1)
animals did not##2##3##(1994-8#1)(2008-5#1)
animals died or were##2##4##(1996-6#1)(2008-9#1)
animals displayed a##2##3##(1992-8#1)(1993-3#1)
animals displayed##3##2##(1992-8#1)(1993-12#1)(1993-3#1)
animals failed to##2##3##(1994-3#2)
animals for##5##2##(1990-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
animals from##3##2##(1996-12#1)(2008-7#1)(2013-1#1)
animals had a##2##3##(2008-12#1)(2008-6#1)
animals had##5##2##(1990-11#1)(1990-5#1)(2008-12#2)(2008-6#1)
animals have been##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
animals have##6##2##(1990-8#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
animals in chemical##2##3##(2008-10#1)(2010-1#1)
animals in the##4##3##(1992-1#1)(2007-12#1)(2008-8#2)
animals in which##2##3##(1995-12#1)(2012-3#1)
animals in##18##2##(1990-3#2)(1992-1#2)(1992-12#1)(1993-6#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2010-1#2)(2012-3#3)
animals is##2##2##(1993-6#1)(2008-8#1)
animals of##2##2##(2010-1#1)(2013-1#1)
animals or##2##2##(2008-11#1)(2010-7#1)
animals over##2##2##(2011-2#1)(2012-2#1)
animals received##3##2##(1993-3#1)(1993-6#1)(1994-3#1)
animals show##2##2##(2008-11#1)(2009-8#1)
animals showed##9##2##(1991-2#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
animals studied##2##2##(1996-12#1)(2012-2#1)
animals than in controls##3##4##(2008-7#1)(2011-2#2)
animals than in##4##3##(1992-8#1)(2008-7#1)(2011-2#2)
animals that died##2##3##(2008-9#1)(2011-2#1)
animals that had been##2##4##(1993-6#1)(2008-11#1)
animals that##11##2##(1993-6#2)(2008-11#2)(2008-7#2)(2008-9#2)(2010-7#1)(2011-2#1)(2012-3#1)
animals the##3##2##(1991-5#1)(2008-7#1)(2008-8#1)
animals to##11##2##(1991-2#3)(1993-3#1)(1994-3#1)(2008-11#1)(2008-5#1)(2008-8#3)(2013-1#1)
animals was##7##2##(1991-2#1)(1993-12#1)(1994-3#1)(1996-12#1)(2008-11#1)(2009-6#1)(2011-2#1)
animals were also##2##3##(1993-3#1)(2008-9#1)
animals were housed##2##3##(1993-6#1)(2008-11#1)
animals were protected##4##3##(1995-5#3)(2008-9#1)
animals were randomly##2##3##(2009-3#1)(2013-1#1)
animals were sacrificed##2##3##(2008-7#1)(2013-1#1)
animals were tested for##3##4##(1993-6#1)(1994-2#1)(2011-2#1)
animals were treated with##2##4##(1996-12#1)(2013-7#1)
animals were treated##3##3##(1996-12#1)(2008-5#1)(2013-7#1)
animals were used##2##3##(2006-6#1)(2008-7#1)
animals were##48##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-3#2)(1993-6#3)(1994-2#2)(1994-3#1)(1994-8#1)(1995-5#3)(1996-12#2)(1997-1#1)(1997-9#1)(2006-6#1)(2008-11#1)(2008-12#3)(2008-5#4)(2008-7#5)(2008-9#2)(2009-3#3)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
animals when##2##2##(1996-2#1)(2008-7#1)
animals where##2##2##(2008-8#2)
animals which##5##2##(1995-9#1)(1996-12#1)(1996-3#1)(2008-5#1)(2013-7#1)
animals with##11##2##(1992-6#1)(1993-3#1)(1993-6#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)
animals##484##1##(1990-11#2)(1990-12#4)(1990-3#3)(1990-5#7)(1990-8#1)(1991-12#1)(1991-2#11)(1991-5#2)(1992-1#4)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#2)(1993-12#14)(1993-2#1)(1993-3#9)(1993-6#13)(1994-2#3)(1994-3#12)(1994-5#4)(1994-6#2)(1994-8#6)(1994-9#1)(1995-11#7)(1995-12#3)(1995-2#5)(1995-5#5)(1995-6#1)(1995-8#1)(1995-9#2)(1996-12#20)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-7#1)(1997-9#3)(2006-6#4)(2007-12#6)(2008-10#33)(2008-11#22)(2008-12#24)(2008-4#8)(2008-5#23)(2008-6#4)(2008-7#25)(2008-8#29)(2008-9#21)(2009-3#3)(2009-5#1)(2009-6#3)(2009-8#6)(2010-1#5)(2010-12#1)(2010-4#6)(2010-5#1)(2010-7#6)(2010-8#2)(2011-1#1)(2011-2#31)(2011-3#2)(2012-12#2)(2012-2#9)(2012-3#14)(2013-1#11)(2013-7#2)(2013-8#5)
animals)##2##1##(1996-12#1)(2008-7#1)
animate##4##1##(1997-6#1)(2008-11#2)(2008-12#1)
animated agents##2##2##(2008-11#2)
animated##5##1##(2008-11#3)(2009-10#1)(2011-2#1)
animation##3##1##(2008-6#2)(2010-8#1)
animations##4##1##(2008-6#1)(2010-8#1)(2010-9#2)
anion and cation exchange columns##2##5##(2008-10#2)
anion and cation##3##3##(2008-10#3)
anion and the##2##3##(1994-5#1)(2008-10#1)
anion and##14##2##(1994-5#1)(1994-8#1)(2008-10#10)(2008-11#1)(2009-8#1)
anion band##2##2##(2008-10#2)
anion binding##3##2##(1993-8#1)(1996-12#1)(2008-10#1)
anion carriers##2##2##(2008-10#2)
anion complex##2##2##(2008-10#2)
anion exchange and##3##3##(1991-5#1)(2008-10#2)
anion exchange chromatography##3##3##(1990-2#1)(1994-6#1)(2008-11#1)
anion exchange column##10##3##(1992-12#1)(2008-10#7)(2008-11#2)
anion exchange membranes##2##3##(2008-10#2)
anion exchange resin##5##3##(2008-10#5)
anion exchange##36##2##(1990-2#1)(1991-5#1)(1992-12#1)(1994-6#1)(1995-6#1)(2008-10#24)(2008-11#5)(2008-7#1)(2008-8#1)
anion exchanger##15##2##(2008-10#14)(2013-7#1)
anion excluder and##2##3##(2008-10#2)
anion excluder##5##2##(2008-10#5)
anion film modified carbon paste electrode##2##6##(2008-10#2)
anion formation##2##2##(1994-8#1)(2008-10#1)
anion in##3##2##(1992-11#1)(2008-10#2)
anion ionophores in##3##3##(2008-10#3)
anion of##3##2##(1996-5#1)(2008-10#2)
anion radicals##2##2##(2010-12#1)(2013-8#1)
anion to##2##2##(2008-10#2)
anion transport##3##2##(1994-6#1)(2011-2#2)
anion##179##1##(1990-2#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-12#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-5#2)(1994-6#2)(1994-8#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-8#1)(2008-10#130)(2008-11#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-7#1)(2013-7#1)(2013-8#1)
anion-exchange and##4##2##(2008-10#4)
anion-exchange chromatography##13##2##(1991-7#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-8#1)(2008-10#7)
anion-exchange column##7##2##(1991-7#1)(2008-10#6)
anion-exchange disks##2##2##(2008-10#2)
anion-exchange resin##10##2##(2008-10#10)
anion-exchange silica gels##2##3##(2008-10#2)
anion-exchange##50##1##(1991-7#3)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(2008-10#40)(2008-7#1)(2010-4#1)
anion-selective##3##1##(2008-10#3)
anionic additive on##2##3##(2008-10#2)
anionic additive##5##2##(2008-10#5)
anionic and cationic##3##3##(2008-10#2)(2008-5#1)
anionic and##8##2##(2008-10#7)(2008-5#1)
anionic arsenic##3##2##(2008-10#3)
anionic detergents##2##2##(1990-5#1)(2012-2#1)
anionic dye##2##2##(2008-10#2)
anionic polyelectrolytes##2##2##(2008-10#2)
anionic porphyrin##3##2##(2008-10#3)
anionic resin##3##2##(2008-10#3)
anionic response##2##2##(2008-10#2)
anionic site##3##2##(2008-10#3)
anionic slope of##2##3##(2008-10#2)
anionic species##8##2##(2008-10#8)
anionic surfactant##10##2##(2008-10#9)(2008-5#1)
anionic surfactants in##4##3##(2008-10#4)
anionic surfactants##16##2##(2008-10#11)(2008-5#5)
anionic##120##1##(1990-5#2)(1991-7#1)(1993-12#1)(1994-5#2)(1995-6#1)(1996-5#1)(2008-10#96)(2008-11#1)(2008-12#2)(2008-5#10)(2008-8#1)(2012-2#2)
anions (bromide##2##2##(2008-10#2)
anions and cations##8##3##(2008-10#8)
anions and complexing agents has been studied at 1##2##9##(2008-10#2)
anions and complexing agents##3##4##(2008-10#3)
anions and the##2##3##(2008-10#2)
anions and##29##2##(1993-12#2)(2008-10#25)(2010-7#1)(2013-1#1)
anions are##4##2##(2008-10#3)(2010-4#1)
anions at##3##2##(2008-10#3)
anions do not interfere##3##4##(2008-10#3)
anions found in##2##3##(2008-10#2)
anions in the##2##3##(2008-10#2)
anions in##13##2##(2008-10#13)
anions is##2##2##(2008-10#2)
anions of##2##2##(2008-10#2)
anions on the##4##3##(1994-5#1)(2008-10#3)
anions on##6##2##(1994-5#1)(2008-10#5)
anions present in##2##3##(2008-10#2)
anions present##3##2##(2008-10#3)
anions such as##3##3##(1994-5#1)(2008-10#2)
anions was##4##2##(2008-10#4)
anions were##8##2##(2008-10#7)(2012-7#1)
anions which##2##2##(2008-10#2)
anions with a##2##3##(2008-10#2)
anions with the##2##3##(2008-10#1)(2010-4#1)
anions with##7##2##(2008-10#5)(2010-4#2)
anions##180##1##(1993-12#2)(1994-5#3)(1997-8#1)(2008-10#161)(2008-11#2)(2010-4#7)(2010-7#1)(2012-7#1)(2013-1#2)
aniseed drinks by##2##3##(2008-10#2)
aniseed drinks##3##2##(2008-10#3)
anisette samples##4##2##(2008-10#4)
anisodamine##3##1##(2008-9#2)(2010-12#1)
anisometropic amblyopia##2##2##(2013-7#2)
anisometropic##4##1##(2013-7#4)
anisomycin##2##1##(1991-5#1)(1994-11#1)
anisopliae host infection process##2##4##(2010-10#2)
anisopliae##6##1##(2010-10#6)
anisotropic actuation##3##2##(2010-4#3)
anisotropic and##3##2##(2008-3#2)(2009-7#1)
anisotropic scattering planar media##2##4##(2008-3#2)
anisotropic scattering##6##2##(2008-10#1)(2008-3#5)
anisotropic semitransparent substrate##2##3##(2008-3#2)
anisotropic##29##1##(1995-3#1)(2008-10#2)(2008-3#17)(2008-6#2)(2008-8#1)(2009-3#1)(2009-7#2)(2010-4#3)
anisotropy can be##2##3##(2008-10#1)(2008-3#1)
anisotropy measurements##2##2##(2008-10#2)
anisotropy of the##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
anisotropy ratio##2##2##(2008-10#2)
anisotropy##32##1##(1991-3#1)(1991-5#1)(1991-9#1)(1995-3#1)(1997-6#1)(2008-10#19)(2008-3#8)
ankle and##6##2##(2009-11#1)(2011-2#3)(2012-12#1)(2012-3#1)
ankle arthrodesis was##2##3##(2008-12#1)(2009-7#1)
ankle arthrodesis with screws##4##4##(2011-2#4)
ankle arthrodesis##8##2##(2008-12#3)(2009-7#1)(2011-2#4)
ankle arthroscopy##6##2##(2009-1#4)(2010-7#2)
ankle arthrosis##5##2##(2008-12#2)(2011-2#3)
ankle fracture with##2##3##(2009-1#1)(2009-3#1)
ankle fracture##4##2##(2009-1#2)(2009-3#1)(2013-1#1)
ankle fractures##5##2##(2009-1#1)(2009-3#2)(2012-3#1)(2013-1#1)
ankle injuries##2##2##(2010-3#1)(2011-2#1)
ankle injury##2##2##(2012-3#2)
ankle instability##3##2##(2012-3#1)(2013-1#2)
ankle joint##11##2##(2009-7#3)(2010-5#2)(2011-2#2)(2012-2#3)(2012-3#1)
ankle pain##4##2##(2010-7#1)(2011-2#2)(2012-2#1)
ankle sprain##7##2##(2008-12#2)(2011-2#1)(2012-3#1)(2013-1#3)
ankle sprains##3##2##(2013-1#3)
ankle##110##1##(2008-12#11)(2009-1#10)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-7#8)(2010-3#3)(2010-5#6)(2010-7#5)(2011-2#25)(2012-12#1)(2012-2#13)(2012-3#10)(2013-1#12)
ankyloglossia##2##1##(1993-12#2)
ankylosing spondylitis (AS)##2##3##(2008-10#1)(2012-3#1)
ankylosing spondylitis##7##2##(2008-10#1)(2008-7#1)(2010-12#3)(2012-3#2)
ankylosing##11##1##(1991-8#1)(1993-11#2)(2008-10#2)(2008-7#1)(2010-12#3)(2012-3#2)
ankylosis##6##1##(2011-2#6)
ankyrin##2##1##(1991-7#1)(1996-12#1)
anlage and##2##2##(1995-8#1)(2011-2#1)
anlage##3##1##(1995-8#1)(1997-9#1)(2011-2#1)
annealed##3##1##(2008-2#1)(2013-8#2)
annealing of##2##2##(2009-5#2)
annealing temperature##2##2##(2008-10#2)
annealing##24##1##(1994-5#4)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#3)(2008-9#1)(2009-5#4)(2012-2#1)(2013-1#1)(2013-8#1)
annelids##2##1##(2009-8#2)
annetocin-IR cells##2##2##(2008-5#2)
annetocin-IR##3##1##(2008-5#3)
annetocin-secretory cells were##2##3##(2008-5#2)
annetocin-secretory cells##4##2##(2008-5#4)
annex##2##1##(2008-10#1)(2008-11#1)
annexin V to##2##3##(2008-11#2)
annexin V##11##2##(2006-6#3)(2008-10#1)(2008-11#7)
annexin V-FITC/PI staining##2##3##(2008-11#2)
annexin##15##1##(2006-6#3)(2008-10#1)(2008-11#10)(2010-12#1)
anniversary of##4##2##(1992-2#1)(1997-2#1)(2012-3#1)(2013-1#1)
anniversary##5##1##(1992-2#1)(1997-2#1)(2008-4#1)(2012-3#1)(2013-1#1)
annosum##6##1##(2008-10#4)(2010-10#2)
annotate##3##1##(2008-4#1)(2008-9#1)(2013-1#1)
annotated by##2##2##(2010-4#1)(2013-8#1)
annotated##8##1##(1992-1#1)(1996-12#1)(2007-12#1)(2008-4#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-8#1)
annotation of##4##2##(2008-9#2)(2010-11#1)(2011-2#1)
annotation transfer##2##2##(2012-2#2)
annotation##38##1##(2008-4#1)(2008-9#5)(2009-10#1)(2010-11#1)(2010-12#2)(2011-2#25)(2012-2#2)(2012-3#1)
annotations##3##1##(2008-4#1)(2012-2#2)
announce##3##1##(2010-11#1)(2011-2#1)(2013-1#1)
announced##9##1##(1995-12#3)(1996-1#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-9#1)(2013-1#1)
annual Norwegian##2##2##(1991-6#2)
annual and perennial##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
annual average costs of BYDV##2##5##(2008-10#2)
annual data for##2##3##(1991-12#1)(1997-2#1)
annual dose##3##2##(2008-7#1)(2009-11#2)
annual entomological inoculation rate##3##4##(2012-12#3)
annual incidence of##2##3##(1996-11#2)
annual incidence##6##2##(1996-11#4)(1996-8#1)(2008-1#1)
annual income##2##2##(2008-12#2)
annual meeting of the##2##4##(1997-7#1)(2008-8#1)
annual meeting of##3##3##(1997-7#1)(2008-8#1)(2009-4#1)
annual meeting##8##2##(1997-7#1)(2008-10#5)(2008-8#1)(2009-4#1)
annual mortality rate##3##3##(1995-3#3)
annual mortality##5##2##(1995-3#4)(2008-10#1)
annual per capita##2##3##(1994-2#1)(2012-3#1)
annual per##3##2##(1994-2#1)(1997-8#1)(2012-3#1)
annual plant Arabidopsis thaliana##2##4##(2008-9#2)
annual plant populations##2##3##(2008-8#2)
annual plant##8##2##(2008-8#5)(2008-9#3)
annual precipitation##2##2##(2008-10#2)
annual report of the american phytopathological society##4##7##(2008-10#4)
annual reports##3##2##(1990-3#1)(2012-12#1)(2012-3#1)
annual savings of##2##3##(1992-2#1)(2008-10#1)
annual scientific meeting##3##3##(2008-7#2)(2009-9#1)
annual screening##2##2##(2010-10#1)(2012-2#1)
annual variability in seed##2##4##(2008-9#2)
annual volume##2##2##(1992-2#1)(1995-2#1)
annual##155##1##(1990-3#1)(1991-12#4)(1991-2#2)(1991-6#2)(1992-1#1)(1992-12#2)(1992-2#4)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#4)(1996-1#2)(1996-11#4)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#19)(2008-9#9)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#9)(2012-12#6)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#1)
annually for##2##2##(1991-12#1)(2008-9#1)
annually worldwide##2##2##(2010-11#1)(2011-2#1)
annually##30##1##(1990-11#1)(1991-12#1)(1992-1#1)(1993-1#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
annualreviews##6##1##(2011-2#6)
annuals##2##1##(2008-9#2)
annular##12##1##(1995-5#2)(1996-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#2)
annulenes##3##1##(1996-5#3)
annuloplasty##6##1##(2008-10#5)(2010-9#1)
annulus fibrosus##2##2##(2009-3#1)(2012-2#1)
annulus or##2##2##(2008-10#1)(2008-9#1)
annulus##14##1##(1996-6#3)(2007-12#2)(2008-10#3)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)
annuum##11##1##(2008-10#11)
annuus L##3##2##(2008-10#3)
annuus##8##1##(2008-10#8)
ano-genital examination##3##2##(2009-9#1)(2010-4#2)
ano-genital##5##1##(2009-9#1)(2010-4#4)
anode##5##1##(1991-5#1)(2008-10#4)
anodic and cathodic##3##3##(2008-10#3)
anodic and##4##2##(2008-10#4)
anodic bonding of##2##3##(2008-10#2)
anodic current##2##2##(2008-10#1)(2008-12#1)
anodic electrodissolution##2##2##(2008-10#2)
anodic oxidation of hydrazine##2##4##(2008-10#2)
anodic oxidation of##4##3##(2008-10#4)
anodic oxidation##6##2##(2008-10#6)
anodic peak potential##4##3##(2008-10#4)
anodic peak was##3##3##(2008-10#3)
anodic peak##14##2##(2008-10#14)
anodic peaks of##2##3##(2008-10#2)
anodic peaks##6##2##(2008-10#6)
anodic potential##2##2##(2008-10#2)
anodic slime is determined##2##4##(2008-10#2)
anodic stripping differential pulse##3##4##(2008-10#3)
anodic stripping peak current##2##4##(2008-10#2)
anodic stripping peak##3##3##(2008-10#3)
anodic stripping voltammetric (ASV)##2##4##(2008-10#2)
anodic stripping voltammetric detection##2##4##(2008-10#2)
anodic stripping voltammetric determination of##2##5##(2008-10#2)
anodic stripping voltammetric method##2##4##(2008-10#2)
anodic stripping voltammetric##13##3##(2008-10#13)
anodic stripping voltammetry (ASV)##3##4##(2008-10#3)
anodic stripping voltammetry (SWASV)##3##4##(2008-10#3)
anodic stripping voltammetry and##3##4##(2008-10#3)
anodic stripping voltammetry at##2##4##(2008-10#2)
anodic stripping voltammetry using##3##4##(2008-10#3)
anodic stripping voltammetry with##4##4##(2008-10#4)
anodic stripping voltammetry##43##3##(2008-10#43)
anodic stripping##68##2##(2008-10#68)
anodic##122##1##(2008-10#120)(2008-12#1)(2013-1#1)
anodically##4##1##(2008-10#4)
anodisation##2##1##(2008-10#2)
anodised at##2##2##(2008-10#2)
anodized BDD electrodes##2##3##(2008-10#2)
anodized BDD##3##2##(2008-10#3)
anodized##7##1##(2008-10#5)(2009-7#2)
anogenital##4##1##(1994-1#1)(1996-1#3)
anomala ascospores##2##2##(2008-10#2)
anomala strain K##3##3##(2008-10#3)
anomala were##3##2##(2008-10#3)
anomala##18##1##(2008-10#18)
anomalies and##3##2##(1997-3#1)(2008-9#1)(2010-6#1)
anomalies are##2##2##(1997-3#1)(2008-10#1)
anomalies in##8##2##(1997-3#1)(2008-11#3)(2008-2#1)(2009-8#1)(2010-6#1)(2012-3#1)
anomalies of the##3##3##(1991-6#1)(1997-4#1)(2008-10#1)
anomalies of##5##2##(1991-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)
anomalies such as##2##3##(2008-10#1)(2012-12#1)
anomalies that##3##2##(1995-3#1)(1997-3#1)(2008-10#1)
anomalies were##4##2##(1993-12#2)(2008-11#2)
anomalies##67##1##(1991-6#2)(1993-12#3)(1995-3#1)(1997-3#14)(1997-4#2)(1997-5#1)(2008-1#1)(2008-10#7)(2008-11#15)(2008-2#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-6#3)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#5)(2013-1#1)(2013-8#1)
anomalous diffraction approximation##2##3##(2008-3#2)
anomalous diffraction##3##2##(2008-3#3)
anomalous muscles##2##2##(2008-9#1)(2012-2#1)
anomalous pulmonary venous connection to##3##5##(2008-11#3)
anomalous pulmonary venous connection##4##4##(2008-11#4)
anomalous##32##1##(1992-8#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-2#1)(2013-8#1)
anomalously##4##1##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
anomaly and##2##2##(2008-11#1)(2008-12#1)
anomaly in the##2##3##(1991-9#1)(2008-10#1)
anomaly in which##2##3##(1991-8#1)(1995-5#1)
anomaly in##5##2##(1991-8#1)(1991-9#1)(1995-5#1)(2008-10#2)
anomaly is##2##2##(1991-6#1)(2008-7#1)
anomaly of the##2##3##(2013-1#1)(2013-2#1)
anomaly of##4##2##(2010-11#2)(2013-1#1)(2013-2#1)
anomaly that##2##2##(2008-10#1)(2008-11#1)
anomaly##42##1##(1990-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1993-9#2)(1995-5#2)(1997-3#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#4)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-2#2)
anomer having##2##2##(1990-9#2)
anomerization##2##1##(1990-9#2)
anonymous questionnaire##3##2##(1991-9#1)(1997-4#1)(2008-12#1)
anonymous survey##2##2##(1993-11#1)(2008-10#1)
anonymous written##2##2##(1991-8#2)
anonymous##15##1##(1991-8#2)(1991-9#1)(1993-11#1)(1993-3#1)(1994-9#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2012-3#1)
anonymously##2##1##(1996-11#1)(2011-2#1)
anorectal motor function##3##3##(2011-2#3)
anorectal motor##4##2##(2011-2#4)
anorectal##9##1##(1992-3#1)(2011-2#7)(2012-2#1)
anorectic##2##1##(1997-5#1)(2012-3#1)
anorexia nervosa (AN)##2##3##(1991-11#1)(2013-1#1)
anorexia nervosa##9##2##(1991-1#1)(1991-11#2)(2012-3#3)(2013-1#3)
anorexia when administered##2##3##(1996-12#1)(1996-2#1)
anorexia##22##1##(1991-1#1)(1991-11#2)(1993-12#1)(1995-9#1)(1996-12#3)(1996-2#3)(1997-7#1)(2008-1#1)(2010-6#1)(2012-3#4)(2013-1#3)(2013-8#1)
another &quot##4##2##(1995-2#1)(1995-3#1)(2008-10#1)(2008-9#1)
another 6##2##2##(2008-1#1)(2010-3#1)
another and##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
another approach##3##2##(1994-3#1)(2008-11#1)(2011-2#1)
another as##2##2##(1992-9#1)(2008-10#1)
another by##4##2##(2008-10#2)(2008-9#2)
another factor##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
another for##3##2##(1994-8#1)(1997-7#1)(2008-11#1)
another general##2##2##(1995-6#1)(2008-11#1)
another group of##6##3##(1990-2#2)(1991-5#1)(1992-12#1)(1994-3#1)(2009-8#1)
another group##8##2##(1990-2#2)(1991-5#1)(1992-12#1)(1994-3#1)(2008-10#1)(2008-3#1)(2009-8#1)
another important##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
another in a##3##3##(1991-3#1)(1997-7#1)(2009-10#1)
another in##8##2##(1991-3#1)(1993-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2009-10#1)
another isolate of the##2##4##(2008-10#2)
another isolate##5##2##(2008-10#5)
another larger##2##2##(2008-10#1)(2008-5#1)
another mechanism##2##2##(1991-9#1)(2011-2#1)
another member of the##2##4##(2008-10#2)
another method##3##2##(2008-4#1)(2008-9#1)(2010-8#1)
another of##4##2##(1997-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
another one##9##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-12#1)(2011-2#1)
another person's##2##2##(2008-11#2)
another possible##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
another putative##2##2##(1996-3#1)(2008-10#1)
another recombinant##2##2##(2008-11#1)(2008-7#1)
another region##2##2##(1993-6#1)(2012-3#1)
another resin##2##2##(2008-10#2)
another simple##2##2##(2008-10#1)(2008-3#1)
another species##6##2##(1994-8#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#2)
another study##2##2##(2008-9#1)(2011-2#1)
another two##4##2##(1996-12#1)(1997-3#1)(2008-10#1)(2008-9#1)
another type of##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
another type##4##2##(1994-2#1)(2008-10#1)(2008-11#2)
another unit##2##2##(2008-10#1)(2008-9#1)
another using##2##2##(2008-10#2)
another way##2##2##(1991-6#1)(1994-2#1)
another wider##2##2##(1991-6#1)(2008-10#1)
another year##3##2##(1993-3#1)(2008-10#1)(2008-8#1)
another##358##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#3)(1991-9#1)(1992-12#2)(1992-4#1)(1992-9#2)(1993-12#5)(1993-2#4)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#5)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#3)(2007-11#1)(2007-12#1)(2008-1#5)(2008-10#99)(2008-11#29)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#17)(2009-10#1)(2009-12#1)(2009-3#3)(2009-6#3)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#15)(2012-12#1)(2012-2#6)(2012-3#8)(2013-1#5)(2013-8#2)
another's##6##1##(1996-1#1)(2008-11#4)(2013-8#1)
anovulatory infertility##2##2##(2010-11#1)(2013-8#1)
anovulatory##3##1##(2008-4#1)(2010-11#1)(2013-8#1)
anoxia or##2##2##(1991-2#2)
anoxic encephalopathy##2##2##(2012-3#2)
anoxic##5##1##(1992-9#1)(2008-11#2)(2012-3#2)
ans##4##1##(2013-1#4)
ansochromogenes differentiation##2##2##(2008-8#2)
ansochromogenes##9##1##(2008-8#7)(2008-9#2)
answer the question of how##2##5##(2008-9#1)(2009-8#1)
answer the question##3##3##(2008-9#1)(2009-8#1)(2011-2#1)
answer the##7##2##(1994-8#2)(1997-3#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
answer to the##2##3##(1995-8#1)(2011-2#1)
answer to##4##2##(1992-11#1)(1994-3#1)(1995-8#1)(2011-2#1)
answer##42##1##(1991-12#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-2#2)(2012-3#2)
answered by##4##2##(1990-2#1)(1993-6#1)(1995-1#1)(2012-2#1)
answered that they would##2##4##(1990-6#2)
answered the questionnaire##3##3##(1992-1#1)(2008-1#1)(2008-11#1)
answered the##4##2##(1992-1#1)(1993-2#1)(2008-1#1)(2008-11#1)
answered##19##1##(1990-2#1)(1990-6#2)(1991-3#1)(1992-1#1)(1993-2#2)(1993-6#1)(1994-3#1)(1995-1#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-6#1)(2009-6#1)(2012-2#1)
answering##5##1##(1994-12#1)(1994-3#1)(2010-1#1)(2010-12#2)
answers on##3##2##(2008-11#2)(2012-2#1)
answers that##2##2##(2012-3#1)(2013-1#1)
answers to the##2##3##(1991-1#1)(2011-2#1)
answers to##7##2##(1990-6#1)(1991-1#1)(1992-12#1)(1996-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
answers were##2##2##(2008-12#1)(2010-8#1)
answers##30##1##(1990-6#1)(1991-1#1)(1992-12#1)(1993-3#2)(1994-12#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
ant Pachycondyla obscuricornis##2##3##(2007-12#2)
ant and fungal##2##3##(2008-8#2)
ant species##2##2##(2008-8#1)(2012-3#1)
ant##24##1##(2007-12#4)(2008-10#2)(2008-5#1)(2008-8#10)(2012-2#4)(2012-3#2)(2013-1#1)
ant-cultivar conflict over##2##3##(2008-8#2)
ant-cultivar conflict##4##2##(2008-8#4)
antacids or H2 receptor antagonists and##2##6##(1995-10#2)
antagonism against postharvest wound pathogens##2##5##(2008-10#2)
antagonism against##3##2##(2008-10#3)
antagonism is##2##2##(2008-10#1)(2013-8#1)
antagonism of##5##2##(1992-8#1)(1996-2#1)(1997-2#1)(2008-10#2)
antagonism to##2##2##(1997-2#1)(2008-10#1)
antagonism was##2##2##(2008-10#2)
antagonism##27##1##(1992-8#2)(1996-2#1)(1997-2#3)(1997-7#1)(2008-10#16)(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
antagonist Ulocladium atrum##2##3##(2008-10#2)
antagonist and a##3##3##(2008-10#1)(2008-5#2)
antagonist and##9##2##(1995-8#1)(2008-10#5)(2008-5#2)(2012-12#1)
antagonist at##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
antagonist bicuculline##2##2##(1997-2#1)(2008-8#1)
antagonist decreased##2##2##(1993-8#1)(2008-10#1)
antagonist densities##3##2##(2008-10#3)
antagonist doses##2##2##(2008-10#2)
antagonist effects of naloxonazine##4##4##(1996-2#4)
antagonist for##2##2##(2008-8#1)(2010-8#1)
antagonist in the##2##3##(1996-2#1)(2008-10#1)
antagonist in##3##2##(1996-2#1)(2008-10#2)
antagonist is##3##2##(1992-6#1)(1995-12#1)(2008-10#1)
antagonist of the##8##3##(1994-8#1)(1996-2#1)(2008-11#1)(2008-7#2)(2008-8#2)(2012-3#1)
antagonist of##14##2##(1990-5#1)(1991-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2012-3#1)
antagonist tamoxifen##2##2##(2008-11#2)
antagonist that##2##2##(2008-11#1)(2009-10#1)
antagonist under development by##2##4##(2008-5#2)
antagonist under development##3##3##(1991-5#1)(2008-5#2)
antagonist with##2##2##(1996-2#1)(2008-8#1)
antagonist##191##1##(1990-12#2)(1990-5#3)(1991-1#1)(1991-5#3)(1991-6#2)(1992-3#1)(1992-4#2)(1992-6#3)(1992-8#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-2#8)(1994-3#2)(1994-5#2)(1994-8#4)(1995-11#6)(1995-12#2)(1995-2#3)(1995-8#1)(1996-12#2)(1996-2#18)(1997-2#7)(1997-4#6)(1997-7#1)(2006-6#3)(2008-10#55)(2008-11#7)(2008-4#1)(2008-5#8)(2008-7#5)(2008-8#13)(2008-9#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
antagonist)##3##1##(1995-12#1)(2008-10#1)(2008-5#1)
antagonist-pathogen##2##1##(2008-10#2)
antagonistic activities##2##2##(2008-10#2)
antagonistic activity against##2##3##(2008-10#2)
antagonistic activity of##4##3##(2008-10#2)(2008-12#2)
antagonistic activity##12##2##(2008-10#7)(2008-11#2)(2008-12#3)
antagonistic coevolution##2##2##(2008-8#1)(2008-9#1)
antagonistic effect on##3##3##(2008-7#1)(2008-8#1)(2009-8#1)
antagonistic effect##6##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)
antagonistic effects##4##2##(2008-10#3)(2008-12#1)
antagonistic fungus##2##2##(2008-10#2)
antagonistic interaction between##2##3##(2008-10#2)
antagonistic interactions##4##2##(2008-10#2)(2012-3#1)(2013-1#1)
antagonistic isolates##2##2##(2008-10#2)
antagonistic microorganisms in the field##2##5##(2008-10#2)
antagonistic microorganisms##3##2##(2008-10#3)
antagonistic or synergistic##2##3##(2008-10#2)
antagonistic or##3##2##(2008-10#2)(2008-7#1)
antagonistic pleiotropy##3##2##(2008-9#1)(2010-1#2)
antagonistic selection##2##2##(2008-8#2)
antagonistic species##2##2##(2008-8#2)
antagonistic yeast##2##2##(2008-10#2)
antagonistic##76##1##(1990-6#1)(1995-2#1)(2008-10#45)(2008-11#3)(2008-12#7)(2008-7#2)(2008-8#9)(2008-9#2)(2009-8#2)(2010-1#2)(2012-3#1)(2013-1#1)
antagonists and##3##2##(1995-10#2)(2008-10#1)
antagonists are##3##2##(2008-3#2)(2010-12#1)
antagonists for##2##2##(2008-10#1)(2008-8#1)
antagonists from##2##2##(1993-6#1)(2008-10#1)
antagonists in##7##2##(1990-5#1)(1990-6#1)(1992-11#1)(2008-1#1)(2008-10#2)(2008-8#1)
antagonists might##2##2##(2008-10#1)(2008-4#1)
antagonists of##8##2##(1992-11#1)(1993-1#1)(1995-6#1)(2006-6#1)(2008-10#3)(2008-8#1)
antagonists on##4##2##(1991-8#1)(1994-2#1)(2008-10#1)(2008-5#1)
antagonists or##2##2##(2008-10#2)
antagonists that##3##2##(1995-11#1)(2008-10#2)
antagonists to##3##2##(1994-11#1)(1995-8#1)(2008-10#1)
antagonists##102##1##(1990-5#1)(1990-6#1)(1991-5#2)(1991-8#2)(1992-11#2)(1993-1#1)(1993-6#1)(1994-11#6)(1994-2#2)(1994-5#1)(1994-8#1)(1995-10#2)(1995-11#7)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#2)(1997-2#1)(1997-4#3)(2006-6#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-12#2)(2009-7#2)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)
antagonists)##2##1##(2009-6#1)(2011-2#1)
antagonize the##4##2##(1992-6#1)(1994-11#1)(1994-12#1)(1997-2#1)
antagonize##10##1##(1992-6#1)(1994-11#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2010-10#1)(2013-1#1)(2013-7#1)
antagonized by##3##2##(1992-8#1)(1994-8#1)(1995-11#1)
antagonized the effects of##2##4##(1990-5#2)
antagonized the##4##2##(1990-5#2)(1993-8#1)(1996-2#1)
antagonized##8##1##(1990-5#2)(1992-8#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-2#2)
antagonizes the##2##2##(1994-3#1)(2008-11#1)
antagonizes##5##1##(1994-3#2)(1994-5#1)(2008-11#1)(2012-3#1)
antagonizing the##3##2##(1994-2#1)(1994-8#1)(2008-10#1)
antagonizing##4##1##(1994-2#1)(1994-8#1)(2008-10#1)(2008-11#1)
antazoline##4##1##(2008-10#4)
ante##3##1##(1992-1#1)(1996-3#1)(2008-7#1)
antebrachial fascia##2##2##(2008-9#1)(2009-1#1)
antebrachial##5##1##(2008-9#4)(2009-1#1)
antecedent##4##1##(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)
antecedents of parent's behavior##2##4##(1993-3#2)
antecedents of##3##2##(1993-3#3)
antecedents##7##1##(1993-3#3)(2008-11#2)(2009-12#1)(2011-2#1)
antefixes##2##1##(2008-10#2)
antegrade##2##1##(1991-3#1)(2008-11#1)
anteiso-branched fatty acids##2##3##(2011-1#2)
antemortem##2##1##(2008-12#1)(2008-7#1)
antenatal care and##2##3##(2008-1#1)(2008-11#1)
antenatal care##4##2##(2008-1#1)(2008-11#2)(2009-6#1)
antenatal clinics##2##2##(2013-1#2)
antenatal or neonatal seroprevalence data##2##5##(1994-9#2)
antenatal or neonatal##3##3##(1994-9#2)(2008-11#1)
antenatal screening##2##2##(2008-11#1)(2011-2#1)
antenatal##18##1##(1991-6#1)(1992-12#1)(1994-9#2)(1996-8#1)(2008-1#1)(2008-11#5)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#3)
antenatally##3##1##(1996-3#1)(2008-10#2)
antenna of##3##2##(2008-10#3)
antenna##12##1##(2008-10#6)(2008-3#4)(2008-5#1)(2008-9#1)
antennae in##2##2##(1996-2#1)(2008-7#1)
antennae##4##1##(1996-2#1)(2007-12#1)(2008-7#1)(2008-9#1)
antennal lobe##2##2##(2007-12#2)
antennal##10##1##(1994-8#1)(2007-12#6)(2008-10#1)(2008-7#1)(2008-9#1)
antennular flagella##2##2##(2007-12#2)
antennular neuropil##2##2##(2007-12#2)
antennular##6##1##(2007-12#6)
antennule##3##1##(2007-12#2)(2008-5#1)
antepartum##2##1##(1993-12#1)(1994-3#1)
anterior abdominal wall##4##3##(1991-1#2)(2008-11#1)(2012-12#1)
anterior and posterior intercondylar distances##2##5##(2013-1#2)
anterior and posterior surgery##2##4##(2008-8#2)
anterior and posterior##16##3##(1995-2#1)(1997-3#1)(2008-12#1)(2008-8#5)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#3)
anterior and##18##2##(1995-2#1)(1997-3#1)(2008-12#1)(2008-7#1)(2008-8#5)(2008-9#1)(2011-2#3)(2012-3#2)(2013-1#3)
anterior approach##2##2##(2008-7#1)(2008-8#1)
anterior cerebral artery##6##3##(1997-3#1)(2008-7#2)(2011-2#1)(2013-8#2)
anterior cervical discectomy and fusion (ACDF) in##2##7##(2012-12#2)
anterior cervical discectomy and fusion (ACDF)##4##6##(2012-12#4)
anterior cervical discectomy##7##3##(2008-7#1)(2012-12#4)(2012-3#2)
anterior cervical##9##2##(2008-7#3)(2012-12#4)(2012-3#2)
anterior cingulate and##3##3##(1994-3#1)(1996-2#1)(2008-11#1)
anterior cingulate cortex##4##3##(1994-3#1)(2008-11#3)
anterior cingulate##8##2##(1994-3#3)(1996-2#1)(2008-11#4)
anterior clinoidectomy via the##4##4##(2011-2#4)
anterior communicating artery aneurysm rupture##2##5##(2008-7#2)
anterior communicating artery aneurysm##4##4##(1996-3#2)(2008-7#2)
anterior communicating artery##8##3##(1996-3#2)(2008-7#6)
anterior compartment syndrome following ankle arthroscopy after Maisonneuve fracture##2##9##(2009-1#2)
anterior cranial vault pathology##2##4##(2011-2#2)
anterior cranial vault##3##3##(2011-2#3)
anterior cranial##5##2##(2011-2#5)
anterior cruciate ligament (ACL) reconstruction##2##5##(2013-1#2)
anterior cruciate ligament (ACL)##7##4##(1997-8#2)(2012-2#1)(2013-1#4)
anterior cruciate ligament reconstruction##7##4##(2008-11#3)(2013-1#4)
anterior cruciate ligament##18##3##(1990-6#1)(1997-8#2)(2008-11#3)(2009-1#1)(2012-2#1)(2013-1#10)
anterior fontanelle and##3##3##(2011-1#3)
anterior horn cells##3##3##(1991-7#1)(1995-12#1)(2008-7#1)
anterior horn##5##2##(1990-9#1)(1991-7#1)(1995-12#1)(2008-7#2)
anterior instrumentation##2##2##(2008-8#2)
anterior insula activity##2##3##(2008-11#2)
anterior insula##4##2##(2008-11#4)
anterior limb bud##2##3##(1993-12#2)
anterior limb##3##2##(1993-12#3)
anterior maxilla##2##2##(2013-1#2)
anterior muscles##3##2##(2010-9#1)(2012-3#1)(2013-8#1)
anterior pituitary cells##8##3##(1990-12#2)(1990-5#2)(1996-2#4)
anterior pituitary##12##2##(1990-12#2)(1990-5#4)(1992-10#1)(1996-2#4)(1997-2#1)
anterior posterior##2##2##(2010-12#1)(2012-2#1)
anterior region##6##2##(2007-12#2)(2008-7#1)(2009-1#2)(2013-1#1)
anterior resection##4##2##(1990-9#1)(1997-8#1)(2007-8#1)(2008-12#1)
anterior segment##6##2##(2010-1#1)(2010-9#1)(2011-7#4)
anterior skull base##3##3##(2011-2#3)
anterior spinal##2##2##(1997-6#1)(2008-8#1)
anterior tibial##2##2##(2008-12#2)
anterior to the##4##3##(2008-10#1)(2008-9#1)(2011-2#2)
anterior to##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)
anterior wall##4##2##(2011-2#1)(2011-7#1)(2012-12#2)
anterior##253##1##(1990-12#2)(1990-5#4)(1990-6#1)(1990-9#4)(1991-1#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-9#5)(1993-12#5)(1994-1#1)(1994-12#2)(1994-3#3)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-2#6)(1996-3#2)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#4)(2007-12#10)(2007-8#1)(2008-10#8)(2008-11#17)(2008-12#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#26)(2008-8#10)(2008-9#3)(2009-1#6)(2010-1#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#3)(2011-2#31)(2011-7#5)(2012-12#8)(2012-2#6)(2012-3#8)(2013-1#22)(2013-2#1)(2013-7#1)(2013-8#3)
anteriorly##5##1##(2007-12#1)(2008-12#1)(2008-7#1)(2009-1#1)(2013-1#1)
antero-lateral##2##1##(2008-12#1)(2008-5#1)
anterograde##7##1##(1990-11#1)(1995-2#3)(1997-3#1)(2008-7#2)
anterogradely labeled##2##2##(2008-11#1)(2008-7#1)
anterolateral approach for##2##3##(2011-2#2)
anterolateral approach##8##2##(2011-2#5)(2012-3#3)
anterolateral##15##1##(2008-11#1)(2010-5#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-3#4)
anteromedial and##2##2##(2010-7#1)(2013-1#1)
anteromedial##3##1##(2010-7#1)(2011-2#1)(2013-1#1)
anteroposterior diameter##3##2##(2013-1#3)
anteroposterior##6##1##(1995-5#1)(2008-10#1)(2010-9#1)(2013-1#3)
anthelmintic resistance##2##2##(1997-7#2)
anthelmintic##7##1##(1991-8#1)(1996-12#1)(1997-7#4)(2008-10#1)
anthelmintics in##2##2##(1991-8#1)(2008-10#1)
anthelmintics##3##1##(1991-8#1)(2008-10#2)
anther culture##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
anther was##2##2##(2008-8#2)
anther##13##1##(2008-10#3)(2008-8#9)(2008-9#1)
antheridia##2##1##(2008-10#1)(2010-3#1)
anthers##5##1##(1997-8#1)(2008-10#1)(2008-8#3)
anthesis in##4##2##(2008-10#4)
anthesis##34##1##(2008-10#30)(2008-11#2)(2008-8#1)(2008-9#1)
anthocyan##2##1##(2008-10#2)
anthocyanin##5##1##(2008-10#4)(2008-9#1)
anthocyanins##4##1##(2008-10#3)(2008-5#1)
anthracene and DTPP##2##3##(2008-10#2)
anthracene##13##1##(2008-10#13)
anthracis strains##3##2##(2012-2#3)
anthracis##12##1##(1992-12#1)(2008-10#2)(2010-1#2)(2011-2#3)(2012-2#4)
anthracnose (caused by Colletotrichum##2##4##(2008-10#2)
anthracnose and leaf blight##2##4##(2008-10#2)
anthracnose and##3##2##(2008-10#3)
anthracnose caused by Colletotrichum##2##4##(2008-10#2)
anthracnose caused by##3##3##(2008-10#3)
anthracnose fungus##2##2##(2008-10#2)
anthracnose in the##3##3##(2008-10#3)
anthracnose in##5##2##(2008-10#5)
anthracnose lesions##2##2##(2008-10#2)
anthracnose of##3##2##(2008-10#3)
anthracnose on##4##2##(2008-10#4)
anthracnose pathogen##4##2##(2008-10#4)
anthracnose resistance##5##2##(2008-10#5)
anthracnose severity##2##2##(2008-10#2)
anthracnose was##2##2##(2008-10#2)
anthracnose##57##1##(1997-4#1)(2008-10#56)
anthracycline##3##1##(1994-5#1)(1994-8#1)(2008-7#1)
anthracyclines##2##1##(1991-6#1)(2008-11#1)
anthramycin##2##1##(1991-3#2)
anthranilic acid##3##2##(2008-10#3)
anthraquinone##4##1##(2008-10#4)
anthraquinones##2##1##(2008-10#2)
anthrarufins##2##1##(2008-8#2)
anthrasteroids##2##1##(1990-11#2)
anthrax toxin##2##2##(2009-10#2)
anthrax##6##1##(1990-9#2)(1992-12#1)(2009-10#2)(2011-2#1)
anthropocentricisms##2##1##(2010-3#2)
anthropogenic and##2##2##(2008-10#1)(2008-11#1)
anthropogenic fulvic acids##2##3##(2008-10#2)
anthropogenic particle emissions##2##3##(2008-11#2)
anthropogenic platinum-group elements (PGE)##2##4##(2008-11#2)
anthropogenic sources##2##2##(2008-10#1)(2010-8#1)
anthropogenic##26##1##(2008-10#10)(2008-11#11)(2008-12#1)(2010-8#3)(2013-1#1)
anthropogenically##2##1##(2008-11#1)(2008-9#1)
anthropometric data##3##2##(1993-12#1)(2008-11#1)(2012-3#1)
anthropometric indicators##4##2##(2010-6#2)(2011-1#2)
anthropometric parameters##2##2##(2008-11#1)(2011-2#1)
anthropometric##13##1##(1993-12#1)(2008-11#2)(2008-7#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
anthropometry##4##1##(2008-10#1)(2008-7#1)(2010-6#1)(2013-1#1)
anthropomorphic phantom##2##2##(1993-9#1)(1997-8#1)
anthropomorphism##2##1##(2008-11#2)
anthryl##2##1##(2008-10#2)
anthurium blight##2##2##(2008-10#2)
anthurium##6##1##(2008-10#6)
anti S##2##2##(2008-10#1)(2009-9#1)
anti hypertensive##2##2##(2010-1#2)
anti##25##1##(1990-6#2)(1991-11#1)(1995-10#1)(1996-5#4)(1997-1#1)(2008-10#2)(2008-12#2)(2008-5#2)(2009-11#1)(2009-9#1)(2010-1#5)(2011-2#1)(2012-2#2)
anti-##2##1##(2008-10#1)(2010-10#1)
anti-B##2##1##(2008-10#1)(2008-9#1)
anti-CD3##3##1##(1995-12#2)(1995-2#1)
anti-CD8##2##1##(2008-5#1)(2013-1#1)
anti-CT##2##1##(2008-10#2)
anti-Candida##2##1##(2013-1#2)
anti-D##2##1##(2010-11#1)(2013-1#1)
anti-Fas antibody upon transduction##2##4##(2008-8#2)
anti-Fas antibody was##2##3##(2008-8#2)
anti-Fas antibody##6##2##(2008-8#6)
anti-Fas##8##1##(2008-8#8)
anti-HBV therapy##2##2##(2009-8#1)(2011-2#1)
anti-HBV##3##1##(2009-8#2)(2011-2#1)
anti-HBc##5##1##(1990-8#2)(1996-12#1)(1997-8#1)(2008-8#1)
anti-HCMV##2##1##(1996-12#2)
anti-HCV##6##1##(2008-1#1)(2013-1#1)(2013-8#4)
anti-HIV 5-phenyl-1-phenylamino-1H-imidazole##2##2##(2011-3#2)
anti-HIV activities##4##2##(2011-3#4)
anti-HIV activity of##2##3##(1990-10#1)(2011-2#1)
anti-HIV activity##5##2##(1990-10#1)(1990-8#1)(1996-5#1)(2009-8#1)(2011-2#1)
anti-HIV agent##3##2##(1990-10#1)(1991-3#2)
anti-HIV compounds##2##2##(2011-3#2)
anti-HIV drug##2##2##(1994-11#1)(2011-3#1)
anti-HIV##27##1##(1990-10#2)(1990-8#1)(1991-3#2)(1994-11#1)(1996-5#1)(2008-10#1)(2009-8#1)(2011-2#2)(2011-3#15)(2013-1#1)
anti-HIV-1 drug##2##2##(2011-3#2)
anti-HIV-1 drugs##7##2##(2011-2#3)(2011-3#4)
anti-HIV-1##14##1##(2011-2#5)(2011-3#9)
anti-HbPs antibodies##2##2##(1990-12#2)
anti-HbPs##3##1##(1990-12#3)
anti-Hofmeister##3##1##(2008-10#3)
anti-Hu##2##1##(1996-11#2)
anti-IL-6 mAb##2##2##(2008-10#2)
anti-IL-6##5##1##(2008-10#4)(2013-1#1)
anti-IgE antibody##2##2##(2008-11#2)
anti-IgE##3##1##(2008-11#2)(2012-12#1)
anti-IgG##3##1##(2008-10#3)
anti-Jk3 antibody##2##2##(1995-6#2)
anti-KLH IgM##2##2##(2008-9#2)
anti-LAS##3##1##(2008-10#3)
anti-OVA##2##1##(2008-11#2)
anti-PAP##2##1##(2008-10#2)
anti-PRP antibody##3##2##(1995-5#3)
anti-Phl p 1 IgG##2##4##(2012-2#2)
anti-Phl p##3##2##(2012-2#3)
anti-Ri##2##1##(1996-11#2)
anti-SecY##2##1##(1991-5#2)
anti-SsEno##2##1##(2009-6#2)
anti-Stokes##6##1##(2008-2#1)(2008-3#5)
anti-TB drugs##2##2##(2008-1#1)(2011-2#1)
anti-TB treatment##2##2##(1996-3#2)
anti-TB##4##1##(1996-3#2)(2008-1#1)(2011-2#1)
anti-TNF##7##1##(1990-5#1)(2008-8#1)(2010-12#1)(2011-2#3)(2013-1#1)
anti-TNF-alpha mAb treatment##2##3##(2008-10#2)
anti-TNF-alpha mAb##5##2##(1996-12#1)(2008-10#4)
anti-TNF-alpha##9##1##(1996-12#1)(2008-10#6)(2010-12#2)
anti-TNFs##2##1##(2010-12#2)
anti-TNP antibody was##3##3##(2008-10#3)
anti-TNP antibody##6##2##(2008-10#6)
anti-TNP##7##1##(2008-10#7)
anti-Vg monoclonal antibody##2##3##(2008-10#2)
anti-Vg##3##1##(2008-10#3)
anti-Yo##3##1##(1996-11#2)(1997-8#1)
anti-addictive##2##1##(1997-2#2)
anti-ageing##9##1##(2008-5#9)
anti-aging action##2##2##(1990-3#2)
anti-aging##12##1##(1990-3#2)(2008-5#7)(2008-7#1)(2011-2#1)(2013-7#1)
anti-androgen##2##1##(2010-1#1)(2011-2#1)
anti-angiogenic factors##2##2##(2013-1#2)
anti-angiogenic therapies##5##2##(1997-1#1)(2011-3#1)(2013-1#1)(2013-8#2)
anti-angiogenic##11##1##(1997-1#1)(2008-11#2)(2011-3#1)(2011-7#1)(2013-1#3)(2013-8#3)
anti-apoptotic gene##3##2##(2008-11#1)(2010-1#1)(2012-2#1)
anti-apoptotic proteins is##2##3##(2008-11#1)(2009-12#1)
anti-apoptotic proteins##4##2##(2008-11#1)(2009-12#3)
anti-apoptotic##20##1##(2008-11#5)(2009-12#4)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#4)(2012-2#3)(2013-1#1)
anti-asialo##2##1##(2008-10#2)
anti-atherogenic##2##1##(2008-10#1)(2013-8#1)
anti-cancer agent##2##2##(1993-2#1)(2008-11#1)
anti-cancer chemotherapy##2##2##(2008-11#1)(2013-1#1)
anti-cancer drug##2##2##(2008-11#1)(2009-9#1)
anti-cancer drugs##3##2##(2008-11#2)(2008-9#1)
anti-cancer therapy##6##2##(1994-12#1)(1997-1#1)(2008-9#1)(2011-2#1)(2013-1#2)
anti-cancer##21##1##(1993-2#1)(1994-12#1)(1997-1#1)(2008-11#6)(2008-9#2)(2009-9#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
anti-canine IgG##2##2##(2008-10#2)
anti-caspase-3##3##1##(2008-9#3)
anti-choice##3##1##(1995-6#3)
anti-chromatin##2##1##(2008-4#2)
anti-clotting##2##1##(2013-8#2)
anti-dandruff##4##1##(2008-5#4)
anti-depressant prescribing##2##2##(2008-11#2)
anti-depressant##5##1##(2008-11#4)(2009-12#1)
anti-diabetic##2##1##(2008-10#2)
anti-emetic drugs##2##2##(2008-10#2)
anti-estrogenic##3##1##(1991-3#1)(2010-5#2)
anti-forskolin##2##1##(2008-11#2)
anti-growth##2##1##(1990-12#1)(1996-2#1)
anti-human IgG##2##2##(1990-12#1)(2008-10#1)
anti-human##6##1##(1990-12#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-9#1)
anti-hypertensive treatment##2##2##(1990-11#1)(2008-7#1)
anti-hypertensive##4##1##(1990-11#1)(1993-11#1)(2008-10#1)(2008-7#1)
anti-id 2F10##2##2##(1995-2#2)
anti-idiotype##3##1##(1995-2#1)(2008-10#2)
anti-idiotypic##3##1##(2012-2#3)
anti-infective and symptomatic treatments##2##4##(2011-2#2)
anti-infective##4##1##(1997-3#1)(2011-2#3)
anti-inflammation and##2##2##(2008-5#1)(2011-3#1)
anti-inflammatories##2##1##(2008-10#2)
anti-inflammatory activity of##2##3##(2008-10#2)
anti-inflammatory activity##3##2##(2007-11#1)(2008-10#2)
anti-inflammatory agents##4##2##(1996-11#1)(1997-1#1)(2008-5#1)(2013-1#1)
anti-inflammatory cytokines##3##2##(2009-12#1)(2013-1#1)(2013-7#1)
anti-inflammatory drug##10##2##(1997-1#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-5#1)
anti-inflammatory drugs (NSAIDs)##4##3##(1993-2#1)(2008-12#1)(2010-1#1)(2012-2#1)
anti-inflammatory drugs and##3##3##(1990-3#1)(1997-6#1)(2008-11#1)
anti-inflammatory drugs##21##2##(1990-3#1)(1991-8#1)(1993-11#1)(1993-2#1)(1997-1#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
anti-inflammatory effect##3##2##(2008-10#2)(2008-3#1)
anti-inflammatory effects in##2##3##(2008-12#1)(2009-8#1)
anti-inflammatory effects of##3##3##(2008-12#1)(2009-1#1)(2013-1#1)
anti-inflammatory effects##7##2##(2008-12#2)(2009-1#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
anti-inflammatory properties##4##2##(2008-10#1)(2008-7#2)(2012-2#1)
anti-inflammatory##76##1##(1990-3#1)(1991-8#2)(1993-11#1)(1993-2#1)(1996-11#1)(1997-1#4)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#19)(2008-11#4)(2008-12#3)(2008-3#3)(2008-5#5)(2008-7#2)(2009-1#2)(2009-12#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#4)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
anti-invasive##3##1##(2008-11#3)
anti-kickback statute##2##2##(1993-1#1)(1995-12#1)
anti-malaria##2##1##(2010-1#2)
anti-metastatic activity##2##2##(2008-11#2)
anti-metastatic##4##1##(2008-11#3)(2013-1#1)
anti-metatype antibodies##5##2##(1992-6#5)
anti-metatype##7##1##(1992-6#7)
anti-microbial##3##1##(2008-10#1)(2010-7#1)(2013-1#1)
anti-mouse IgG##4##2##(1995-2#1)(2008-10#3)
anti-mouse##6##1##(1995-2#1)(2008-10#3)(2008-8#1)(2012-12#1)
anti-neoplastic##3##1##(2008-10#1)(2011-2#2)
anti-nociceptive effects##2##2##(2008-12#1)(2011-2#1)
anti-nociceptive##3##1##(2008-12#1)(2011-2#2)
anti-nuclear##4##1##(1993-3#1)(1995-2#1)(2008-10#2)
anti-oxidant##2##1##(2012-2#1)(2013-7#1)
anti-oxidants##7##1##(2008-11#1)(2008-5#3)(2010-1#1)(2012-2#2)
anti-oxidative##4##1##(2008-10#2)(2008-5#2)
anti-oxygen-quenching RTP##2##2##(2008-10#2)
anti-parallel##2##1##(1992-9#1)(2008-10#1)
anti-parkinsonian##2##1##(1992-3#1)(2008-7#1)
anti-peptide antisera##3##2##(1990-5#1)(2008-4#2)
anti-peptide##4##1##(1990-5#2)(2008-4#2)
anti-phospholipid##2##1##(2008-7#2)
anti-phosphopeptide antibodies##2##2##(2008-4#2)
anti-phosphotyrosine antibody##2##2##(1992-10#1)(1997-1#1)
anti-platelet##2##1##(2008-11#1)(2012-12#1)
anti-proliferative##4##1##(1996-2#1)(2009-9#1)(2013-1#2)
anti-pseudomonal##2##1##(2012-2#2)
anti-psychotic medication##2##2##(2010-1#1)(2013-8#1)
anti-psychotic##4##1##(2008-10#1)(2010-1#1)(2013-8#2)
anti-rabbit IgG antibody was##2##4##(2008-10#2)
anti-rabbit IgG##5##2##(2008-10#5)
anti-rabbit##6##1##(2008-10#6)
anti-reflux surgery##3##2##(2008-10#2)(2010-12#1)
anti-reflux##4##1##(2008-10#3)(2010-12#1)
anti-retroviral therapy##3##2##(2008-1#2)(2010-12#1)
anti-retroviral##7##1##(1992-12#1)(2008-1#3)(2010-12#2)(2013-1#1)
anti-sense##4##1##(2008-10#1)(2009-12#1)(2012-2#2)
anti-sheep red blood cell##2##4##(1993-12#1)(2008-10#1)
anti-thyroglobulin antibodies##2##2##(2008-7#1)(2013-1#1)
anti-thyroglobulin##3##1##(1991-8#1)(2008-7#1)(2013-1#1)
anti-trypanozoon antibodies##2##2##(2011-2#2)
anti-tuberculosis##3##1##(2008-10#1)(2009-6#1)(2013-1#1)
anti-tumor F(ab')2##2##2##(1997-2#2)
anti-tumor activity##3##2##(2008-11#2)(2010-11#1)
anti-tumor and##2##2##(2008-10#2)
anti-tumor necrosis factor (TNF) therapies##2##5##(2011-2#2)
anti-tumor necrosis factor##3##3##(2011-2#3)
anti-tumor reactions in##2##3##(2013-1#2)
anti-tumor##22##1##(1993-8#1)(1997-2#2)(2008-10#3)(2008-11#6)(2008-9#2)(2010-11#2)(2011-2#3)(2013-1#3)
anti-ulcer##2##1##(2008-10#1)(2011-3#1)
anti-viral drugs##2##2##(2012-2#1)(2013-8#1)
anti-viral##6##1##(1992-3#1)(1994-8#1)(2007-12#1)(2012-2#2)(2013-8#1)
antiadipogenic##3##1##(2008-5#3)
antiaggregating##3##1##(2008-7#3)
antiangiogenic##4##1##(1994-12#1)(2007-11#1)(2010-1#2)
antianxiety##2##1##(1994-2#2)
antiarrhythmic drug##2##2##(1993-6#1)(1994-8#1)
antiarrhythmic##7##1##(1992-3#2)(1993-6#1)(1994-8#1)(1996-3#1)(2008-7#1)(2013-1#1)
antiaxillary odour deodorant##2##3##(2008-5#2)
antibacterial activities against##2##3##(2008-12#2)
antibacterial activities##3##2##(2008-12#2)(2008-5#1)
antibacterial activity and##2##3##(2008-7#1)(2012-2#1)
antibacterial activity of##3##3##(2008-12#1)(2008-5#2)
antibacterial activity##6##2##(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)
antibacterial agent##3##2##(1990-6#1)(2008-10#1)(2008-5#1)
antibacterial agents##6##2##(1991-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
antibacterial and antifungal##4##3##(2008-10#3)(2012-2#1)
antibacterial efficacy##2##2##(2008-5#1)(2012-3#1)
antibacterial peptides##3##2##(1997-8#2)(2012-2#1)
antibacterial##45##1##(1990-6#1)(1991-3#1)(1992-5#1)(1997-3#1)(1997-5#1)(1997-8#3)(2008-10#7)(2008-11#2)(2008-12#3)(2008-5#13)(2008-7#2)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#1)
antibacterials##5##1##(1997-1#1)(2008-10#4)
antibiogram##5##1##(2012-3#1)(2013-1#4)
antibiosis by##2##2##(2008-10#2)
antibiosis##15##1##(2008-10#13)(2012-2#2)
antibiotic 2##7##2##(2008-10#7)
antibiotic activity##2##2##(2009-6#1)(2011-3#1)
antibiotic biosynthesis##2##2##(2008-10#2)
antibiotic drugs##2##2##(1996-11#1)(2008-10#1)
antibiotic in##3##2##(1990-3#2)(1991-3#1)
antibiotic mode of action##2##4##(2008-10#2)
antibiotic prescribing##2##2##(2010-4#1)(2013-1#1)
antibiotic production by##2##3##(2008-10#1)(2010-8#1)
antibiotic production##5##2##(2008-10#3)(2010-8#1)(2012-3#1)
antibiotic prophylaxis##5##2##(1990-11#1)(2008-10#2)(2012-12#1)(2012-2#1)
antibiotic regimen##2##2##(1994-3#1)(2008-11#1)
antibiotic regimens##2##2##(2010-5#1)(2010-6#1)
antibiotic resistance##6##2##(1991-3#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
antibiotic selection##2##2##(2010-1#1)(2010-6#1)
antibiotic susceptibility patterns##2##3##(2008-12#1)(2011-2#1)
antibiotic susceptibility##6##2##(2007-12#2)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
antibiotic therapy and##4##3##(1997-4#1)(2007-8#1)(2008-12#1)(2011-2#1)
antibiotic therapy in##3##3##(1993-11#1)(2010-12#1)(2010-6#1)
antibiotic therapy is##2##3##(1990-2#1)(2010-12#1)
antibiotic therapy##21##2##(1990-2#2)(1990-5#2)(1993-11#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-12#2)(2010-12#2)(2010-6#3)(2011-2#6)
antibiotic treatment of##2##3##(1993-8#1)(2011-2#1)
antibiotic treatment##14##2##(1990-2#2)(1991-6#1)(1993-8#1)(1995-9#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-6#2)(2011-2#1)
antibiotic use and##3##3##(2011-2#1)(2013-1#2)
antibiotic use##11##2##(1996-11#4)(2011-2#1)(2013-1#6)
antibiotic##166##1##(1990-11#1)(1990-2#5)(1990-3#2)(1990-5#2)(1991-1#1)(1991-3#4)(1991-6#1)(1992-12#2)(1993-11#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#3)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#6)(1996-6#4)(1997-2#2)(1997-4#2)(1997-7#1)(2007-12#2)(2007-8#2)(2008-10#36)(2008-11#5)(2008-12#4)(2008-5#2)(2008-7#2)(2008-9#4)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#8)(2010-8#1)(2011-1#2)(2011-2#13)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#1)
antibiotic-deficient##2##1##(2008-10#2)
antibiotic-injured##3##1##(2009-6#3)
antibiotics alone##4##2##(1991-1#1)(1994-12#1)(2010-5#1)(2013-8#1)
antibiotics already##2##2##(1997-4#1)(2012-2#1)
antibiotics and##11##2##(1990-5#1)(1996-11#2)(1996-3#1)(2008-10#3)(2008-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
antibiotics are##7##2##(1992-6#3)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
antibiotics as##2##2##(1997-4#1)(2008-10#1)
antibiotics can##2##2##(1994-8#1)(2011-2#1)
antibiotics could##2##2##(1991-3#1)(2008-10#1)
antibiotics for##2##2##(1996-11#1)(2008-9#1)
antibiotics from##2##2##(2008-10#1)(2008-8#1)
antibiotics have been##2##3##(1994-12#1)(2013-1#1)
antibiotics in pharmaceutical##2##3##(2008-10#2)
antibiotics in##16##2##(1994-12#1)(1994-3#1)(1996-3#1)(2007-11#1)(2008-10#8)(2008-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
antibiotics is##2##2##(1997-4#1)(2007-11#1)
antibiotics that are##2##3##(2008-10#1)(2009-8#1)
antibiotics that##4##2##(2008-10#2)(2009-8#1)(2011-2#1)
antibiotics was##4##2##(1994-8#1)(1996-11#1)(2008-10#1)(2008-11#1)
antibiotics were administered##3##3##(1994-12#1)(2011-2#1)(2013-8#1)
antibiotics were##10##2##(1991-1#2)(1994-12#1)(2008-10#1)(2009-1#1)(2009-6#1)(2010-6#1)(2011-2#2)(2013-8#1)
antibiotics with the##2##3##(2008-10#2)
antibiotics with##5##2##(1994-5#1)(2008-10#3)(2011-2#1)
antibiotics##162##1##(1990-5#2)(1991-1#4)(1991-3#2)(1991-4#2)(1992-3#1)(1992-6#3)(1993-8#1)(1994-12#6)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1996-11#6)(1996-3#2)(1996-6#1)(1997-4#7)(1997-7#1)(2006-5#2)(2007-11#2)(2008-10#42)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-6#3)(2009-8#3)(2010-12#2)(2010-5#1)(2010-6#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#15)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#3)
antiblastic drugs##2##2##(1991-8#1)(2013-1#1)
antiblastic##3##1##(1991-8#1)(2013-1#2)
antibodies (ADA)##2##2##(2008-10#2)
antibodies (ANA)##2##2##(1991-2#1)(1993-3#1)
antibodies (Abs)##2##2##(2008-11#1)(2011-2#1)
antibodies (scFvs)##3##2##(2008-10#2)(2008-4#1)
antibodies MAX##2##2##(1995-6#2)
antibodies against the##10##3##(1990-2#1)(1995-12#1)(1997-1#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)
antibodies against this##2##3##(1990-2#1)(2012-2#1)
antibodies against##54##2##(1990-2#2)(1990-5#1)(1991-5#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#7)(2008-11#9)(2008-4#3)(2008-8#5)(2008-9#3)(2009-8#1)(2011-2#5)(2012-2#1)(2012-3#2)
antibodies alone were present)##2##4##(1990-12#2)
antibodies and the##4##3##(1992-12#1)(1995-12#1)(2008-10#1)(2013-1#1)
antibodies and##30##2##(1992-12#1)(1992-6#2)(1993-8#1)(1995-12#1)(1995-2#2)(1996-6#1)(1996-9#1)(1997-8#1)(2006-6#1)(2008-10#10)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
antibodies are##15##2##(1991-2#1)(1995-12#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#1)(2010-4#1)(2013-8#2)
antibodies as##4##2##(1995-2#2)(1995-3#1)(2008-10#1)
antibodies by ELISA##2##3##(2010-3#1)(2011-2#1)
antibodies by##9##2##(1990-12#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)
antibodies can be##2##3##(1996-11#1)(2008-4#1)
antibodies can##3##2##(1996-11#1)(2008-4#2)
antibodies conjugated to##2##3##(2008-9#2)
antibodies could recognize##2##3##(2008-8#1)(2011-2#1)
antibodies could##3##2##(1996-12#1)(2008-8#1)(2011-2#1)
antibodies decreased##2##2##(1995-11#1)(1995-2#1)
antibodies developed##2##2##(2008-5#1)(2008-8#1)
antibodies did not##2##3##(1995-11#1)(2009-6#1)
antibodies directed against bovine##2##4##(1994-5#1)(1995-9#1)
antibodies directed against the##3##4##(1992-12#1)(1992-2#1)(1997-3#1)
antibodies directed against##7##3##(1990-12#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-9#1)(1997-3#1)(1997-5#1)
antibodies directed##8##2##(1990-12#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-9#1)(1997-3#1)(1997-5#1)(2008-9#1)
antibodies for apo(a)##2##3##(1993-2#2)
antibodies for routine##2##3##(2008-10#2)
antibodies for the##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
antibodies for##12##2##(1993-2#2)(1995-12#2)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
antibodies from##4##2##(2008-11#3)(2011-2#1)
antibodies generated against##2##3##(1990-5#1)(1995-6#1)
antibodies had##2##2##(1990-12#1)(1991-5#1)
antibodies has##2##2##(2008-11#1)(2008-9#1)
antibodies immunoreactive##2##2##(2008-9#2)
antibodies in human serum##2##4##(1991-5#1)(2008-10#1)
antibodies in plants##2##3##(2008-10#2)
antibodies in the##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
antibodies in##26##2##(1990-12#2)(1991-2#1)(1991-5#1)(1992-5#1)(1995-9#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#2)
antibodies indicated##2##2##(1997-9#1)(2008-12#1)
antibodies induced##2##2##(2008-10#1)(2008-8#1)
antibodies is##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
antibodies may##2##2##(1995-9#1)(1997-8#1)
antibodies obtained from##3##3##(1995-2#1)(1997-8#1)(2008-10#1)
antibodies obtained##4##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-4#1)
antibodies of##5##2##(1990-12#2)(2008-9#3)
antibodies on the##2##3##(2008-11#2)
antibodies on##7##2##(1996-5#1)(2008-10#3)(2008-11#3)
antibodies onto the##2##3##(2009-3#2)
antibodies or##6##2##(1991-2#1)(2008-11#1)(2008-4#3)(2008-9#1)
antibodies prepared##3##2##(1994-11#1)(2008-10#1)(2008-9#1)
antibodies raised against the##2##4##(1991-5#1)(1996-12#1)
antibodies raised against##9##3##(1990-8#1)(1991-5#2)(1992-8#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-6#1)
antibodies reactive##2##2##(1991-5#1)(1995-9#1)
antibodies recognizing##3##2##(2008-10#2)(2008-4#1)
antibodies revealed that##2##3##(1995-2#1)(2008-10#1)
antibodies revealed##3##2##(1995-2#1)(1995-6#1)(2008-10#1)
antibodies specific for##6##3##(1993-6#2)(1995-12#2)(2008-10#2)
antibodies specifically recognized##2##3##(1996-2#1)(2008-11#1)
antibodies that recognize##4##3##(1996-12#1)(2008-1#1)(2008-4#2)
antibodies that recognized##3##3##(1993-9#1)(2008-10#1)(2012-3#1)
antibodies that##17##2##(1993-9#1)(1994-11#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-4#2)(2008-9#1)(2012-3#1)
antibodies to be##2##3##(2008-10#2)
antibodies to the##5##3##(1990-12#1)(1992-6#2)(1994-11#1)(1995-12#1)
antibodies to##45##2##(1990-12#9)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#2)(1992-3#1)(1992-6#2)(1992-9#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
antibodies using##2##2##(2008-11#1)(2011-2#1)
antibodies was##7##2##(1990-12#1)(2007-12#1)(2008-10#4)(2012-2#1)
antibodies we##2##2##(1996-12#1)(2010-12#1)
antibodies were obtained##2##3##(2008-10#1)(2008-9#1)
antibodies were used to##3##4##(2008-10#2)(2008-9#1)
antibodies were used##5##3##(1995-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
antibodies were##22##2##(1990-12#2)(1991-5#1)(1993-8#1)(1995-12#1)(2006-6#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)
antibodies which##7##2##(1990-12#1)(1992-6#1)(1993-6#1)(1997-1#1)(1997-5#2)(2008-10#1)
antibodies with##9##2##(1995-3#1)(2008-10#4)(2008-11#2)(2008-9#1)(2013-8#1)
antibodies##612##1##(1990-12#30)(1990-2#2)(1990-5#6)(1990-6#2)(1990-8#2)(1991-12#2)(1991-2#7)(1991-3#2)(1991-5#8)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#13)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-2#3)(1993-3#4)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#5)(1994-12#5)(1994-5#4)(1995-11#4)(1995-12#20)(1995-2#14)(1995-3#2)(1995-5#1)(1995-6#12)(1995-8#1)(1995-9#6)(1996-11#4)(1996-12#13)(1996-2#5)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#5)(1997-8#4)(1997-9#4)(2006-6#4)(2007-12#4)(2008-1#4)(2008-10#128)(2008-11#58)(2008-12#4)(2008-4#34)(2008-5#12)(2008-6#2)(2008-7#9)(2008-8#18)(2008-9#38)(2009-11#1)(2009-12#2)(2009-3#5)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#2)(2011-2#24)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#9)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#6)
antibodies)##5##1##(1997-8#1)(2008-10#3)(2008-5#1)
antibody (AB)##2##2##(2008-10#2)
antibody (Ab)##4##2##(1993-12#1)(2008-10#1)(2008-11#2)
antibody (IgG##2##2##(1991-2#1)(2008-10#1)
antibody (SjAb)##2##2##(2008-10#2)
antibody 4-4-20##2##2##(1992-6#2)
antibody ELISA##2##2##(1991-12#1)(2008-10#1)
antibody Fab fragment##2##3##(2011-2#2)
antibody Fab##3##2##(2011-2#3)
antibody Fv fragment##3##3##(1993-8#3)
antibody activity in serum##2##4##(2008-10#2)
antibody activity in##3##3##(1995-5#1)(2008-10#2)
antibody activity##6##2##(1995-5#2)(1996-12#1)(2008-10#3)
antibody against IL-6##2##3##(1990-5#2)
antibody against a##3##3##(1995-6#1)(2008-11#1)(2010-6#1)
antibody against##23##2##(1990-5#2)(1992-11#1)(1992-3#1)(1993-8#2)(1993-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-1#2)(2008-10#2)(2008-11#6)(2010-12#1)(2010-6#1)(2012-2#1)
antibody aggregates##2##2##(2008-11#2)
antibody alpha##3##2##(1994-5#3)
antibody and##19##2##(1991-3#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-3#1)(2012-2#2)
antibody are##2##2##(2008-10#1)(2008-9#1)
antibody array##3##2##(2010-12#3)
antibody avidity##3##2##(1995-5#3)
antibody binding sites##2##3##(2008-8#1)(2008-9#1)
antibody binding##4##2##(1991-12#1)(2008-1#1)(2008-8#1)(2008-9#1)
antibody by##3##2##(2008-10#2)(2008-11#1)
antibody can be##2##3##(2008-4#1)(2008-9#1)
antibody can##4##2##(1991-5#1)(2008-11#1)(2008-4#1)(2008-9#1)
antibody characterization##2##2##(2008-10#1)(2008-5#1)
antibody concentration and##2##3##(2008-10#1)(2008-11#1)
antibody concentration##8##2##(2008-10#1)(2008-11#7)
antibody concentrations##3##2##(1995-5#2)(2011-2#1)
antibody conversion rate##2##3##(1995-12#2)
antibody could##2##2##(2008-9#1)(2013-1#1)
antibody detection##4##2##(1993-6#1)(1994-6#1)(2008-10#1)(2011-2#1)
antibody directed against##3##3##(2008-7#1)(2008-8#1)(2009-8#1)
antibody followed by##2##3##(2008-9#1)(2009-9#1)
antibody for a##2##3##(2008-10#1)(2008-11#1)
antibody for the##4##3##(1995-8#1)(2008-10#1)(2008-11#2)
antibody for##12##2##(1991-2#1)(1993-6#1)(1995-8#2)(2008-10#2)(2008-11#5)(2008-9#1)
antibody formation##2##2##(1995-11#1)(2008-7#1)
antibody fragment##2##2##(2008-8#1)(2011-1#1)
antibody fragments##3##2##(2008-10#2)(2013-8#1)
antibody from##2##2##(2008-10#2)
antibody gene##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
antibody in a##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
antibody in the##5##3##(1996-12#1)(2008-11#1)(2008-7#3)
antibody in##19##2##(1990-2#1)(1993-2#1)(1995-5#1)(1996-12#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-7#3)(2008-8#1)(2010-5#1)
antibody inhibition##2##2##(1994-8#1)(1995-11#1)
antibody is##5##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
antibody labeled with##2##3##(2008-10#2)
antibody labelled##3##2##(1992-6#2)(2008-10#1)
antibody levels should be##2##4##(1994-9#2)
antibody levels##7##2##(1990-12#1)(1991-11#1)(1994-9#2)(1996-12#1)(2008-10#1)(2013-1#1)
antibody library##3##2##(2008-10#3)
antibody of##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
antibody on the sensor chip##3##5##(2008-10#3)
antibody on the##5##3##(2008-10#5)
antibody on##8##2##(2008-10#5)(2008-11#3)
antibody or##3##2##(1993-8#1)(2008-10#1)(2008-7#1)
antibody phage display##2##3##(2008-4#1)(2008-8#1)
antibody produced from##2##3##(2008-11#2)
antibody produced##3##2##(1995-6#1)(2008-11#2)
antibody production against##2##3##(1990-12#1)(1995-12#1)
antibody production by in vitro immunized peripheral blood mononuclear cells##2##10##(2008-11#2)
antibody production by in vitro immunized##3##6##(2008-11#3)
antibody production by##8##3##(2008-11#7)(2008-4#1)
antibody production from##3##3##(2008-11#3)
antibody production in the##2##4##(2008-11#2)
antibody production in##10##3##(2008-11#8)(2008-4#1)(2008-8#1)
antibody production of##2##3##(2008-11#2)
antibody production rate##5##3##(2008-11#5)
antibody production was not##3##4##(2008-11#3)
antibody production was##4##3##(2008-11#4)
antibody production were##2##3##(2008-11#2)
antibody production##64##2##(1990-12#1)(1993-12#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-11#50)(2008-4#4)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
antibody productivity in##2##3##(2008-11#2)
antibody productivity of##2##3##(2008-11#2)
antibody productivity##10##2##(2008-11#10)
antibody products##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
antibody promiscuity##2##2##(2009-3#2)
antibody raised against the purified##2##5##(1993-12#1)(2007-12#1)
antibody raised against the##4##4##(1993-12#1)(1995-6#1)(2007-12#2)
antibody raised against##7##3##(1993-12#1)(1995-2#1)(1995-6#1)(2007-12#2)(2008-10#1)(2008-11#1)
antibody raised##9##2##(1991-5#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-6#1)(2007-12#2)(2008-10#1)(2008-11#1)
antibody reaction##2##2##(1991-12#1)(2008-10#1)
antibody response (TDAR)##4##3##(2008-10#4)
antibody response by##2##3##(1991-3#1)(2008-10#1)
antibody response to KLH##2##4##(2008-10#2)
antibody response to sheep red blood cells##2##7##(1993-12#1)(2008-10#1)
antibody response to sheep##3##4##(1993-12#1)(2008-10#2)
antibody response to##8##3##(1993-12#1)(1995-12#1)(1995-5#1)(2008-10#4)(2012-3#1)
antibody response##22##2##(1991-3#1)(1993-12#1)(1995-12#1)(1995-5#3)(2008-10#14)(2009-6#1)(2012-3#1)
antibody responses and##2##3##(1995-5#2)
antibody responses in##3##3##(1995-5#1)(2007-11#1)(2008-10#1)
antibody responses to##5##3##(1995-5#4)(2008-10#1)
antibody responses##17##2##(1995-5#8)(2007-11#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-6#1)
antibody revealed a##2##3##(2008-5#1)(2008-8#1)
antibody revealed##3##2##(1994-12#1)(2008-5#1)(2008-8#1)
antibody secretion##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
antibody showed##3##2##(1997-1#1)(2008-10#2)
antibody specific for the##4##4##(1990-12#1)(1994-11#1)(1995-2#2)
antibody specific for##7##3##(1990-12#2)(1994-11#1)(1995-2#2)(2008-10#1)(2008-11#1)
antibody specific##8##2##(1990-12#2)(1994-11#1)(1995-2#2)(2008-10#2)(2008-11#1)
antibody staining##2##2##(1991-5#1)(2008-7#1)
antibody support##2##2##(2008-10#2)
antibody synthesis##3##2##(1995-5#1)(2008-10#2)
antibody test##2##2##(1991-3#1)(2008-5#1)
antibody that##4##2##(1992-9#1)(1993-12#1)(2008-11#1)(2012-3#1)
antibody titer against##2##3##(2008-12#2)
antibody titer##7##2##(2008-11#3)(2008-12#3)(2008-4#1)
antibody titers##8##2##(1995-5#1)(2008-11#1)(2008-12#3)(2011-2#1)(2012-3#2)
antibody titre in the##2##4##(2008-11#1)(2012-2#1)
antibody titres##3##2##(1991-12#1)(1994-8#1)(2011-2#1)
antibody to a##2##3##(1997-1#1)(2008-7#1)
antibody to the enzyme##2##4##(2008-10#2)
antibody to the##12##3##(1991-3#2)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)
antibody to##30##2##(1991-12#1)(1991-3#2)(1992-6#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-8#1)
antibody using a##2##3##(2008-10#1)(2008-11#1)
antibody using##3##2##(2008-10#1)(2008-11#2)
antibody was also##2##3##(2007-12#1)(2008-10#1)
antibody was immobilized on the##2##5##(2008-10#2)
antibody was immobilized on##3##4##(2008-10#3)
antibody was immobilized##5##3##(2008-10#5)
antibody was produced against##3##4##(2008-10#3)
antibody was produced that##2##4##(1995-6#1)(2008-10#1)
antibody was produced##6##3##(1995-6#1)(1996-12#1)(2008-10#4)
antibody was purified##2##3##(1992-9#1)(2008-8#1)
antibody was used##2##3##(2008-10#1)(2008-8#1)
antibody was##45##2##(1990-12#1)(1990-5#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#2)(1995-6#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#20)(2008-11#6)(2008-5#1)(2008-8#4)(2012-2#1)(2012-3#1)
antibody were##10##2##(1992-3#1)(2008-10#5)(2008-11#1)(2008-8#2)(2011-2#1)
antibody which##2##2##(1995-12#1)(2008-10#1)
antibody with the magnetic beads after##2##6##(2008-10#2)
antibody with the##3##3##(2008-10#3)
antibody with##6##2##(2008-10#4)(2010-12#1)(2013-1#1)
antibody##751##1##(1990-11#2)(1990-12#10)(1990-2#2)(1990-5#4)(1990-8#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#6)(1991-5#6)(1991-9#2)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#2)(1992-6#9)(1992-9#2)(1993-1#1)(1993-12#8)(1993-2#3)(1993-3#1)(1993-6#4)(1993-8#17)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#11)(1995-2#11)(1995-3#2)(1995-5#29)(1995-6#7)(1995-8#3)(1996-12#9)(1996-2#1)(1997-1#8)(1997-2#4)(1997-3#1)(1997-7#1)(2006-6#4)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#176)(2008-11#175)(2008-12#8)(2008-4#17)(2008-5#13)(2008-7#17)(2008-8#37)(2008-9#20)(2009-12#1)(2009-3#3)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#20)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#8)(2013-8#6)
antibody)##5##1##(2008-10#5)
antibody-based##2##1##(2008-10#2)
antibody-binding##2##1##(2008-10#1)(2008-11#1)
antibody-coated##2##1##(1995-12#1)(2009-3#1)
antibody-dependent cellular cytotoxicity##2##3##(2008-1#1)(2008-11#1)
antibody-dependent##3##1##(2008-1#1)(2008-11#1)(2011-2#1)
antibody-forming cell response##2##3##(2008-10#2)
antibody-forming cell##7##2##(2008-10#7)
antibody-forming##8##1##(2008-10#8)
antibody-immobilized##4##1##(2008-10#3)(2008-11#1)
antibody-producing B cells##3##3##(2008-11#1)(2008-4#2)
antibody-producing##4##1##(2008-11#1)(2008-4#3)
anticancer PG##3##2##(2008-11#3)
anticancer activity of##2##3##(2009-4#1)(2013-1#1)
anticancer activity##6##2##(1993-1#1)(2009-12#1)(2009-4#1)(2011-2#1)(2013-1#2)
anticancer agent##3##2##(2010-11#1)(2011-2#1)(2012-3#1)
anticancer agents##9##2##(2008-11#2)(2008-5#4)(2009-9#1)(2010-7#1)(2011-2#1)
anticancer drug##12##2##(1992-2#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-7#1)(2012-2#1)
anticancer drugs##15##2##(1991-8#1)(2008-10#1)(2008-11#6)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2011-2#2)
anticancer treatments##2##2##(2010-11#1)(2011-2#1)
anticancer##64##1##(1991-8#1)(1992-2#1)(1992-9#1)(1993-1#1)(2008-10#2)(2008-11#17)(2008-5#6)(2008-7#4)(2008-8#1)(2009-12#7)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#3)(2010-11#3)(2010-7#2)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#2)
anticarcinogenic##3##1##(1993-11#1)(2008-10#1)(2009-8#1)
anticheater adaptations##3##2##(2008-8#3)
anticholinergic##3##1##(1990-3#1)(2008-11#1)(2008-5#1)
anticholinergics##4##1##(1997-1#1)(2011-1#1)(2011-2#2)
anticholinesterase##3##1##(1991-9#1)(2008-10#1)(2013-1#1)
anticipate and##2##2##(2008-11#1)(2008-9#1)
anticipate that##3##2##(2008-11#1)(2008-9#1)(2012-2#1)
anticipate##12##1##(1991-3#1)(1993-5#1)(2008-10#1)(2008-11#3)(2008-9#3)(2009-12#1)(2012-2#1)(2013-8#1)
anticipated changes in##2##3##(1992-2#1)(1996-12#1)
anticipated in##2##2##(1995-12#1)(2008-10#1)
anticipated to be##2##3##(2008-11#1)(2008-9#1)
anticipated to##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2011-7#1)
anticipated##48##1##(1990-12#2)(1991-2#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-12#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#3)(2009-10#1)(2010-3#2)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
anticipating the##2##2##(2008-11#1)(2010-10#1)
anticipating##5##1##(1995-1#2)(2008-11#1)(2010-10#1)(2010-7#1)
anticipation of##2##2##(2009-7#1)(2013-1#1)
anticipation##3##1##(2008-11#1)(2009-7#1)(2013-1#1)
anticipatory guidance##2##2##(2010-8#1)(2011-2#1)
anticipatory##9##1##(1992-1#1)(1997-8#1)(2008-11#2)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#2)
anticlastogenic effects##2##2##(2008-11#2)
anticoagulant drugs##2##2##(2013-1#2)
anticoagulant treatment##2##2##(2008-10#2)
anticoagulant##21##1##(1992-1#1)(1992-12#2)(1996-6#1)(1996-8#1)(1997-3#2)(2008-10#8)(2008-8#1)(2010-10#1)(2010-7#1)(2013-1#3)
anticoagulants for##2##2##(1996-6#1)(2012-12#1)
anticoagulants in##5##2##(1993-12#2)(2012-12#2)(2012-3#1)
anticoagulants were##2##2##(1994-3#2)
anticoagulants##16##1##(1993-12#2)(1994-3#2)(1996-6#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-7#1)(2012-12#5)(2012-3#1)
anticoagulated##4##1##(2008-10#2)(2011-2#2)
anticoagulation in primary##2##3##(1995-11#1)(1995-5#1)
anticoagulation in##3##2##(1992-1#1)(1995-11#1)(1995-5#1)
anticoagulation therapy##4##2##(2009-2#1)(2011-2#1)(2013-1#2)
anticoagulation##21##1##(1992-1#2)(1994-9#1)(1995-11#2)(1995-5#1)(1997-3#1)(1997-5#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
anticoagulation/antiaggregation##2##1##(2008-8#2)
anticonvulsant activity##2##2##(1992-3#1)(2008-5#1)
anticonvulsant drug##2##2##(1992-3#1)(1994-8#1)
anticonvulsant effect of##2##3##(1992-3#1)(2010-2#1)
anticonvulsant effects of NBQX##3##4##(1994-2#3)
anticonvulsant effects of##4##3##(1994-2#4)
anticonvulsant effects##6##2##(1990-5#2)(1994-2#4)
anticonvulsant efficacy of phenytoin##2##4##(1994-2#2)
anticonvulsant efficacy##3##2##(1992-3#1)(1994-2#2)
anticonvulsant##30##1##(1990-5#2)(1992-3#5)(1994-2#9)(1994-8#4)(1997-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#1)
anticonvulsants##2##1##(2008-10#1)(2010-7#1)
antidandruff efficacy and antimycotic activity##2##5##(2008-5#2)
antidandruff efficacy##5##2##(2008-5#5)
antidandruff shampoos##2##2##(2008-5#2)
antidandruff##9##1##(2008-10#1)(2008-5#8)
antidepressant drug##3##2##(2008-10#2)(2012-3#1)
antidepressant drugs##6##2##(1990-5#2)(2008-10#3)(2010-7#1)
antidepressant efficacy##3##2##(2008-6#1)(2008-7#1)(2012-3#1)
antidepressant fluoxetine##2##2##(2008-10#1)(2013-1#1)
antidepressant medication##2##2##(2008-6#1)(2009-8#1)
antidepressant treatment is##2##3##(2009-8#1)(2012-2#1)
antidepressant##28##1##(1990-5#2)(1996-12#1)(2008-10#7)(2008-4#1)(2008-6#4)(2008-7#2)(2009-8#2)(2010-1#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#3)(2013-1#2)
antidepressants has##2##2##(2008-9#1)(2012-2#1)
antidepressants in##3##2##(1991-11#1)(2008-11#1)(2012-3#1)
antidepressants was##2##2##(2008-10#1)(2012-3#1)
antidepressants##38##1##(1991-11#2)(1991-8#1)(1997-8#4)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#4)(2009-7#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#8)(2013-1#1)
antidepressive##2##1##(1991-11#1)(1994-6#1)
antidiabetic activity##3##2##(2011-3#2)(2013-1#1)
antidiabetic and##2##2##(2008-11#1)(2013-1#1)
antidiabetic##10##1##(1996-11#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-3#3)(2013-1#3)
antiemetic##6##1##(1990-12#1)(1990-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
antiemetics##2##1##(2008-7#1)(2012-3#1)
antiendometrial antibodies as an indicator for follow-up of##2##8##(1995-2#2)
antiendometrial antibodies##4##2##(1995-2#4)
antiepileptic drug##2##2##(1992-3#1)(2008-11#1)
antiepileptic drugs##3##2##(2008-7#1)(2008-8#2)
antiepileptic##8##1##(1992-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#3)
antiepileptics##3##1##(2008-10#1)(2008-11#1)(2011-1#1)
antiepileptogenic and anticonvulsant##2##3##(1994-2#2)
antiestrogen binding sites in##2##4##(2008-11#2)
antiestrogen binding sites##7##3##(2008-11#7)
antiestrogen##16##1##(1990-12#1)(1993-1#1)(2008-10#1)(2008-11#12)(2011-1#1)
antiestrogenic activity##3##2##(1991-3#1)(2008-11#2)
antiestrogenic##7##1##(1991-3#1)(2008-10#1)(2008-11#4)(2011-1#1)
antiestrogens##11##1##(2008-10#2)(2008-11#9)
antifeedant##2##1##(2008-11#1)(2013-8#1)
antifeeding and##2##2##(2013-8#2)
antifibrotic##2##1##(2008-5#1)(2013-8#1)
antiflogistics##2##1##(1996-6#1)(2008-10#1)
antifoam agents##3##2##(2008-7#3)
antifoam##7##1##(2008-10#1)(2008-7#6)
antifouling agent##5##2##(2008-10#5)
antifouling agents##2##2##(2008-10#2)
antifouling biocides##3##2##(2008-11#3)
antifouling##13##1##(2008-10#9)(2008-11#4)
antifreeze activity in##2##3##(2008-10#2)
antifreeze##4##1##(2008-10#4)
antifungal activities in##2##3##(2008-10#2)
antifungal activities of##2##3##(2008-10#1)(2008-11#1)
antifungal activities##5##2##(2008-10#4)(2008-11#1)
antifungal activity against##3##3##(2008-10#3)
antifungal activity in##3##3##(2008-10#2)(2008-11#1)
antifungal activity of##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
antifungal activity was##2##3##(2008-10#2)
antifungal activity##22##2##(2008-10#15)(2008-11#3)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
antifungal agent##2##2##(2008-10#1)(2008-11#1)
antifungal agents##6##2##(2007-8#1)(2008-5#2)(2011-2#2)(2013-8#1)
antifungal compounds and##2##3##(2008-10#2)
antifungal compounds in the filtrate##2##5##(2008-10#2)
antifungal compounds##8##2##(2008-10#8)
antifungal diene##5##2##(2008-10#5)
antifungal drug##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
antifungal drugs##4##2##(2008-5#3)(2011-2#1)
antifungal enzymes##2##2##(2008-10#2)
antifungal preparations##2##2##(2008-5#1)(2011-2#1)
antifungal protein##3##2##(1992-8#1)(2008-10#2)
antifungal susceptibility##4##2##(2008-5#3)(2011-2#1)
antifungal therapy##7##2##(2008-12#1)(2011-2#4)(2012-3#2)
antifungal##105##1##(1992-8#2)(1997-2#1)(2007-8#1)(2008-10#54)(2008-11#8)(2008-12#1)(2008-5#15)(2008-9#1)(2011-2#17)(2012-2#2)(2012-3#2)(2013-8#1)
antifungals tested##2##2##(2008-5#2)
antifungals##6##1##(1997-1#1)(2008-5#4)(2011-2#1)
antigay prejudice##2##2##(2008-12#2)
antigay##3##1##(2008-12#3)
antigen (Ag)##3##2##(1990-8#1)(1991-5#1)(2008-10#1)
antigen (PSA)##7##2##(1990-9#1)(1994-12#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)
antigen 125##2##2##(1997-8#1)(2011-2#1)
antigen and the##3##3##(1990-12#1)(1992-10#1)(2011-2#1)
antigen and##22##2##(1990-12#2)(1991-12#1)(1992-10#1)(1992-2#1)(1993-2#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
antigen are##3##2##(1995-2#1)(2008-10#1)(2009-12#1)
antigen as##2##2##(1991-12#1)(2008-10#1)
antigen binding##4##2##(1990-12#1)(1994-11#1)(1995-5#1)(2008-11#1)
antigen by##5##2##(1990-12#2)(1995-6#1)(2008-11#1)(2008-4#1)
antigen can##2##2##(1993-8#1)(1995-5#1)
antigen could be detected##2##4##(2008-5#1)(2008-9#1)
antigen dose##2##2##(2008-11#2)
antigen expression##8##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#5)
antigen for##4##2##(1996-12#2)(2008-11#2)
antigen from the##3##3##(1997-3#1)(2008-5#1)(2011-2#1)
antigen from##5##2##(1997-3#1)(2008-10#1)(2008-5#2)(2011-2#1)
antigen gene##2##2##(1990-5#1)(2008-9#1)
antigen immobilised membrane##2##3##(2008-10#2)
antigen immobilised##3##2##(2008-10#3)
antigen in the##3##3##(1997-8#1)(2008-10#2)
antigen in##13##2##(1993-2#1)(1995-5#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-5#1)(2011-3#1)
antigen is##5##2##(1990-12#1)(1994-11#1)(2008-8#2)(2011-2#1)
antigen of##11##2##(1996-12#3)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
antigen on##3##2##(1990-8#1)(2008-11#1)(2008-8#1)
antigen positive##2##2##(2008-8#1)(2010-11#1)
antigen presentation by##3##3##(1995-5#1)(2008-11#2)
antigen presentation##5##2##(1995-5#1)(1997-2#1)(2008-11#2)(2008-12#1)
antigen presenting cells##8##3##(1993-3#1)(1993-8#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2010-8#1)
antigen receptor##4##2##(1995-6#2)(1997-9#1)(2008-4#1)
antigen receptors##2##2##(1994-3#1)(1997-9#1)
antigen sampling##2##2##(2011-2#2)
antigen sensitization##2##2##(2008-11#2)
antigen specific human##2##3##(2008-11#2)
antigen specific##4##2##(2007-12#1)(2008-11#2)(2012-12#1)
antigen to##4##2##(1991-12#1)(1993-8#1)(2008-10#2)
antigen was detected##2##3##(2008-5#1)(2011-2#1)
antigen was expressed by##2##4##(1990-12#1)(2008-7#1)
antigen was##10##2##(1990-12#1)(1992-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
antigen were##2##2##(1995-2#1)(2008-4#1)
antigen when##2##2##(1993-8#1)(2008-11#1)
antigen with##2##2##(1990-5#1)(2010-6#1)
antigen##347##1##(1990-12#12)(1990-5#4)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-8#9)(1994-11#4)(1994-12#3)(1994-3#2)(1994-8#4)(1995-12#2)(1995-2#8)(1995-5#11)(1995-6#7)(1995-9#1)(1996-12#10)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#4)(1997-9#2)(2007-12#3)(2008-1#1)(2008-10#53)(2008-11#59)(2008-12#2)(2008-4#6)(2008-5#12)(2008-7#3)(2008-8#19)(2008-9#19)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-6#2)(2010-8#2)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
antigen)##5##1##(1990-12#2)(1990-8#1)(1992-5#1)(1992-6#1)
antigen-antibody complex##2##2##(2008-10#2)
antigen-antibody##6##1##(2008-10#6)
antigen-binding##2##1##(1997-2#1)(2008-10#1)
antigen-dose dependent changes in##2##4##(2008-11#2)
antigen-dose dependent##3##2##(2008-11#3)
antigen-induced##3##1##(1995-6#1)(2008-4#1)(2008-5#1)
antigen-mediated##2##1##(1995-6#1)(2008-10#1)
antigen-positive cells##2##2##(2008-5#1)(2008-7#1)
antigen-positive##3##1##(1997-7#1)(2008-5#1)(2008-7#1)
antigen-presenting activities##3##2##(1995-12#2)(2008-8#1)
antigen-presenting cells and##2##3##(1995-5#1)(2011-2#1)
antigen-presenting cells##6##2##(1995-5#3)(2011-2#1)(2012-3#2)
antigen-presenting##11##1##(1995-12#2)(1995-5#3)(2008-10#1)(2008-8#2)(2011-2#1)(2012-3#2)
antigen-pulsed macrophages##3##2##(2008-8#3)
antigen-specific B cells##2##3##(2008-11#2)
antigen-specific B##3##2##(2008-11#3)
antigen-specific IgE production##2##3##(2008-11#2)
antigen-specific T cells##9##3##(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#3)(2012-12#1)(2013-8#1)
antigen-specific T##10##2##(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#3)(2012-12#1)(2013-8#1)
antigen-specific human##3##2##(2008-11#3)
antigen-specific##29##1##(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#13)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#3)(2012-12#2)(2013-8#1)
antigen-stimulated##2##1##(2008-8#2)
antigenic and##3##2##(1995-12#1)(2012-2#1)(2013-8#1)
antigenic determinants##5##2##(2008-10#1)(2008-4#1)(2008-8#3)
antigenic differences##2##2##(2008-5#1)(2008-9#1)
antigenic diversity##2##2##(2008-10#1)(2008-5#1)
antigenic effect##2##2##(1995-2#1)(1996-3#1)
antigenic heterogeneity##2##2##(1996-12#1)(2008-10#1)
antigenic peptide##2##2##(2008-11#1)(2008-4#1)
antigenic properties##2##2##(1996-3#1)(2011-2#1)
antigenic residues can##2##3##(2012-2#2)
antigenic site residues##3##3##(2012-2#3)
antigenic site##5##2##(2012-2#4)(2013-8#1)
antigenic stimulation##3##2##(1997-1#1)(2008-11#1)(2008-4#1)
antigenic##56##1##(1991-11#1)(1993-1#1)(1993-12#1)(1995-12#1)(1995-2#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#2)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-4#4)(2008-5#11)(2008-8#4)(2008-9#1)(2011-2#2)(2012-2#7)(2013-8#2)
antigenically distinct##4##2##(2008-5#1)(2011-2#3)
antigenically known##2##2##(2008-10#2)
antigenically related##5##2##(1991-3#3)(2008-5#2)
antigenically##17##1##(1991-3#3)(1992-6#2)(1996-1#1)(2008-10#3)(2008-5#4)(2011-2#3)(2013-8#1)
antigenicity and immunogenicity##2##3##(1994-8#1)(1996-12#1)
antigenicity and##5##2##(1994-8#1)(1996-12#1)(2008-5#1)(2008-8#2)
antigenicity of##2##2##(2008-10#1)(2008-8#1)
antigenicity##15##1##(1994-8#1)(1996-1#1)(1996-12#3)(2008-10#2)(2008-5#3)(2008-8#3)(2013-8#2)
antigenotoxic##3##1##(2008-11#3)
antigens after##2##2##(2008-11#1)(2010-12#1)
antigens and the##3##3##(1997-1#1)(1997-7#1)(1997-8#1)
antigens and their##2##3##(1997-7#1)(2011-2#1)
antigens and##10##2##(1990-12#1)(1997-1#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
antigens as##2##2##(1994-5#1)(2008-5#1)
antigens by##3##2##(1997-8#1)(2008-5#1)(2012-2#1)
antigens for##2##2##(1997-7#1)(2008-8#1)
antigens from##8##2##(1995-5#1)(1996-12#1)(2008-10#5)(2008-4#1)
antigens have been##4##3##(1995-5#2)(2008-9#1)(2012-3#1)
antigens have##5##2##(1995-5#2)(2008-10#1)(2008-9#1)(2012-3#1)
antigens in the##3##3##(1992-9#1)(1993-11#1)(2008-10#1)
antigens in##16##2##(1991-12#1)(1991-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(2008-10#3)(2008-4#2)(2008-9#1)(2011-2#1)
antigens is##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
antigens may##2##2##(2008-5#1)(2012-3#1)
antigens of##8##2##(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-5#3)(2008-9#1)
antigens on##4##2##(1991-2#1)(1994-5#1)(2008-11#1)(2010-11#1)
antigens that are##4##3##(1995-6#1)(2008-4#2)(2011-2#1)
antigens that##5##2##(1994-11#1)(1995-6#1)(2008-4#2)(2011-2#1)
antigens to##5##2##(1990-5#1)(1995-12#1)(1995-5#1)(1997-8#1)(2008-9#1)
antigens was##3##2##(1990-12#1)(1995-5#1)(2008-11#1)
antigens were significantly lower##2##4##(2011-2#2)
antigens were##5##2##(1996-12#1)(2008-10#1)(2010-1#1)(2011-2#2)
antigens when##2##2##(1994-5#1)(2008-11#1)
antigens with##2##2##(1990-5#1)(1995-12#1)
antigens##185##1##(1990-12#13)(1990-5#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#2)(1994-2#1)(1994-5#3)(1994-8#2)(1995-11#1)(1995-12#6)(1995-2#1)(1995-5#16)(1995-6#3)(1996-1#1)(1996-12#5)(1997-1#2)(1997-3#1)(1997-7#3)(1997-8#3)(1997-9#1)(2006-6#2)(2007-11#2)(2007-12#1)(2008-10#22)(2008-11#12)(2008-4#19)(2008-5#12)(2008-8#4)(2008-9#12)(2009-3#1)(2010-1#1)(2010-11#2)(2010-12#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#2)
antigliadin antibodies##2##2##(1991-12#1)(2008-10#1)
antihistamine##2##1##(2008-10#1)(2013-1#1)
antihistamines##3##1##(2008-7#1)(2008-8#1)(2011-2#1)
antihuman##2##1##(1991-2#1)(2011-2#1)
antihyperglycemic##3##1##(1995-11#1)(2012-3#2)
antihyperlipidemic##2##1##(1990-2#1)(2013-1#1)
antihypertensive agent##3##2##(1991-5#1)(2008-8#1)(2010-7#1)
antihypertensive agents##3##2##(1995-2#1)(2009-1#1)(2010-4#1)
antihypertensive drug##3##2##(1997-8#1)(2008-10#2)
antihypertensive drugs##3##2##(1992-11#1)(1993-2#1)(1996-6#1)
antihypertensive effect##2##2##(1993-2#1)(2010-4#1)
antihypertensive medication in##2##3##(2008-1#1)(2008-11#1)
antihypertensive medications##2##2##(2008-11#1)(2008-8#1)
antihypertensive therapy##7##2##(1996-6#1)(1997-8#1)(2008-8#2)(2010-1#2)(2013-8#1)
antihypertensive treatment##9##2##(1993-2#2)(1997-5#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
antihypertensive##38##1##(1991-5#1)(1992-11#1)(1993-2#4)(1995-2#1)(1996-6#2)(1997-5#1)(1997-8#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-8#5)(2009-1#1)(2010-1#2)(2010-4#4)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
antihypertensives##3##1##(2008-10#1)(2008-11#2)
antiinflammatory activity##2##2##(2008-10#1)(2008-12#1)
antiinflammatory agents##2##2##(2008-7#2)
antiinflammatory drugs##5##2##(1990-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-12#1)
antiinflammatory properties##2##2##(1993-11#2)
antiinflammatory##14##1##(1990-9#1)(1993-11#2)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2009-12#1)(2011-2#1)(2013-8#1)
antimalarial control##2##2##(2010-1#2)
antimalarial drug##3##2##(1994-8#1)(2010-1#1)(2011-2#1)
antimalarial##12##1##(1991-8#1)(1994-8#1)(1997-5#1)(2008-10#1)(2010-1#5)(2011-2#1)(2012-12#1)(2012-3#1)
antimetastatic effects of##2##3##(1994-12#1)(1997-7#1)
antimetastatic##3##1##(1994-12#2)(1997-7#1)
antimicrobial activities##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
antimicrobial activity against##2##3##(1994-11#1)(2008-11#1)
antimicrobial activity of the##4##4##(2008-11#3)(2012-3#1)
antimicrobial activity of##8##3##(2008-11#3)(2008-5#1)(2012-3#1)(2013-1#3)
antimicrobial activity was##2##3##(2008-10#1)(2013-1#1)
antimicrobial activity##21##2##(1994-11#1)(1994-5#1)(2008-10#4)(2008-11#5)(2008-5#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#5)
antimicrobial agents against##2##3##(2008-7#1)(2011-2#1)
antimicrobial agents##20##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#9)(2008-9#1)(2011-2#3)(2013-1#3)
antimicrobial and##3##2##(1994-3#1)(2008-11#1)(2012-3#1)
antimicrobial clothes##3##2##(2012-3#3)
antimicrobial compounds##3##2##(2008-11#1)(2009-6#1)(2012-2#1)
antimicrobial drug##2##2##(1991-3#1)(2013-1#1)
antimicrobial peptide##5##2##(1994-5#2)(2011-2#3)
antimicrobial peptides##6##2##(1993-3#2)(1994-11#2)(2011-1#1)(2011-2#1)
antimicrobial properties of##2##3##(2010-4#1)(2013-1#1)
antimicrobial properties##3##2##(2010-4#1)(2013-1#2)
antimicrobial resistance and##2##3##(2011-2#1)(2013-1#1)
antimicrobial resistance patterns##2##3##(2012-2#1)(2013-8#1)
antimicrobial resistance##8##2##(1996-11#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
antimicrobial stewardship in##2##3##(2013-1#2)
antimicrobial stewardship programs##4##3##(2013-1#4)
antimicrobial stewardship##13##2##(2013-1#13)
antimicrobial substances##2##2##(2008-10#1)(2011-2#1)
antimicrobial susceptibility testing data##3##4##(2013-1#3)
antimicrobial susceptibility##5##2##(2011-2#1)(2013-1#4)
antimicrobial therapy in##3##3##(2010-6#1)(2011-2#2)
antimicrobial therapy is##2##3##(2008-10#1)(2011-2#1)
antimicrobial therapy##19##2##(1992-7#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-7#1)(2010-6#1)(2011-2#8)(2012-3#1)(2013-1#1)
antimicrobial treatment should be##2##4##(2008-10#2)
antimicrobial##158##1##(1991-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#2)(1994-11#3)(1994-3#1)(1994-5#3)(1996-11#1)(1996-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#17)(2008-11#10)(2008-12#1)(2008-5#7)(2008-7#11)(2008-9#1)(2009-6#2)(2010-4#5)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#23)(2012-12#1)(2012-2#5)(2012-3#12)(2013-1#36)(2013-8#4)
antimicrobial-based deodorant##2##2##(2008-5#2)
antimicrobial-resistant##2##1##(2011-2#1)(2013-1#1)
antimicrobials##9##1##(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
antimitotic##2##1##(1993-1#1)(2008-11#1)
antimony and##5##2##(2008-10#5)
antimony by##7##2##(2008-10#7)
antimony content##2##2##(2008-10#2)
antimony determination##3##2##(2008-10#3)
antimony in##19##2##(2008-10#19)
antimony##54##1##(2008-10#54)
antimony(III)##11##1##(2008-10#11)
antimony(III)-pyrogallol complex##2##2##(2008-10#2)
antimony(V)##4##1##(2008-10#4)
antimouse##2##1##(2008-10#1)(2008-11#1)
antimycin A##2##2##(1990-2#1)(1995-11#1)
antimycotic##5##1##(2008-5#3)(2011-2#2)
antimycotics##3##1##(2008-5#1)(2008-8#2)
antineoplastic agents##2##2##(1990-2#1)(2011-2#1)
antineoplastic##13##1##(1990-10#1)(1990-2#3)(1991-6#1)(2008-11#1)(2011-2#3)(2012-3#1)(2013-1#3)
antinociception and respiratory depression##2##4##(1996-2#2)
antinociception and##5##2##(1996-2#3)(1997-2#2)
antinociception##13##1##(1993-1#1)(1996-2#7)(1997-2#5)
antinociceptive action##2##2##(1992-3#1)(2011-2#1)
antinociceptive effect##5##2##(1996-2#3)(2008-11#2)
antinociceptive##11##1##(1992-3#2)(1996-2#5)(2008-11#3)(2011-2#1)
antinuclear antibodies##3##2##(1991-2#2)(2012-3#1)
antinuclear##4##1##(1991-2#2)(2012-2#1)(2012-3#1)
antiobesity effect of Safoof Mohazzil##2##5##(2013-1#2)
antioxidant abilities##2##2##(2009-8#2)
antioxidant activities##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
antioxidant activity in##5##3##(2008-10#2)(2008-11#1)(2013-1#2)
antioxidant activity of milk from##2##5##(2013-1#2)
antioxidant activity of pure compounds##2##5##(2008-10#2)
antioxidant activity of##11##3##(1992-9#1)(2008-10#8)(2013-1#2)
antioxidant activity than##3##3##(2013-8#3)
antioxidant activity were##2##3##(2008-10#1)(2009-3#1)
antioxidant activity##39##2##(1992-9#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#5)(2013-8#5)
antioxidant and free radical##2##4##(2008-10#1)(2008-12#1)
antioxidant and nutritional##2##3##(2011-2#2)
antioxidant and##11##2##(2008-10#1)(2008-12#2)(2008-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
antioxidant capacities##2##2##(2008-7#2)
antioxidant capacity determination##2##3##(2008-10#2)
antioxidant capacity in##3##3##(2008-10#2)(2008-7#1)
antioxidant capacity of##6##3##(2008-10#4)(2009-6#1)(2009-8#1)
antioxidant capacity##20##2##(2008-10#16)(2008-7#1)(2009-6#1)(2009-8#1)(2009-9#1)
antioxidant compounds##2##2##(2008-11#1)(2008-5#1)
antioxidant defence##2##2##(2009-6#1)(2012-6#1)
antioxidant enzyme##3##2##(2008-10#1)(2011-2#1)(2012-6#1)
antioxidant enzymes##4##2##(1990-3#1)(2008-7#1)(2010-5#1)(2013-1#1)
antioxidant functions##2##2##(1992-9#2)
antioxidant in##2##2##(2008-10#2)
antioxidant potential of##2##3##(2008-10#2)
antioxidant potential##5##2##(2008-10#5)
antioxidant properties of##8##3##(1994-8#1)(2008-10#5)(2008-5#1)(2013-1#1)
antioxidant properties##11##2##(1994-8#1)(2008-10#5)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
antioxidant status in hypercholesteremic##2##4##(2008-10#2)
antioxidant status##6##2##(1991-12#1)(2008-10#3)(2009-8#1)(2009-9#1)
antioxidant substances##2##2##(1992-9#1)(2008-10#1)
antioxidant supplementation##2##2##(2009-8#2)
antioxidant system in##2##3##(2008-7#1)(2010-5#1)
antioxidant system##6##2##(2008-7#2)(2010-5#1)(2012-6#1)(2013-1#2)
antioxidant values##2##2##(2008-11#2)
antioxidant vitamins##3##2##(1992-9#3)
antioxidant##186##1##(1990-3#1)(1991-12#1)(1992-9#8)(1993-12#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-8#1)(2008-10#79)(2008-11#13)(2008-12#4)(2008-5#7)(2008-7#10)(2009-3#3)(2009-6#3)(2009-8#9)(2009-9#2)(2010-4#2)(2010-5#3)(2010-7#2)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2012-6#3)(2013-1#14)(2013-8#7)
antioxidant/radical scavenger activity##2##3##(2008-5#2)
antioxidants 3-tert-butyl-4-hydroxyanisole##2##2##(2008-10#2)
antioxidants and##8##2##(1992-9#1)(1994-6#1)(2008-10#3)(2011-2#2)(2013-1#1)
antioxidants are##3##2##(2008-5#1)(2013-8#2)
antioxidants by##3##2##(2008-10#2)(2008-5#1)
antioxidants can##2##2##(2008-10#2)
antioxidants from##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
antioxidants in complex matrices##2##4##(2008-10#2)
antioxidants in##9##2##(2008-10#5)(2010-5#1)(2011-2#2)(2013-8#1)
antioxidants is##2##2##(1992-9#1)(2008-5#1)
antioxidants on##2##2##(1992-9#1)(2008-10#1)
antioxidants such as##5##3##(1993-2#1)(2008-11#1)(2008-5#2)(2013-1#1)
antioxidants that##3##2##(1992-9#1)(2009-8#1)(2011-2#1)
antioxidants was##2##2##(2008-10#1)(2009-3#1)
antioxidants##87##1##(1992-9#6)(1993-2#4)(1994-6#1)(1995-9#1)(2008-10#35)(2008-11#5)(2008-5#12)(2008-7#2)(2009-3#1)(2009-8#2)(2010-5#3)(2011-2#7)(2013-1#3)(2013-8#5)
antioxidative action##2##2##(2008-11#1)(2009-8#1)
antioxidative activity of##2##3##(2008-10#2)
antioxidative activity##3##2##(2008-10#2)(2013-7#1)
antioxidative defense##2##2##(2008-12#1)(2009-8#1)
antioxidative potential##2##2##(2008-11#2)
antioxidative property##3##2##(2008-11#3)
antioxidative##15##1##(2008-10#3)(2008-11#6)(2008-12#1)(2009-8#3)(2011-2#1)(2013-7#1)
antiparallel##4##1##(1992-4#1)(1993-8#1)(2008-9#1)(2011-2#1)
antiparasitic drugs##2##2##(1997-7#2)
antiparasitic##3##1##(1997-7#3)
antiparkinson##2##1##(2008-7#2)
antiparkinsonian##5##1##(1993-11#1)(1997-2#2)(2008-7#1)(2011-2#1)
antiperspirant (AP)##2##2##(2008-5#2)
antiperspirant salts##2##2##(2008-5#2)
antiperspirant##13##1##(2008-5#13)
antiperspirants##4##1##(2008-5#4)
antiphospholipid syndrome##4##2##(1997-8#1)(2008-8#1)(2012-3#2)
antiphospholipid##5##1##(1992-5#1)(1997-8#1)(2008-8#1)(2012-3#2)
antiplatelet agent##2##2##(2008-5#1)(2008-8#1)
antiplatelet agents##7##2##(1993-9#1)(2008-11#1)(2008-8#2)(2011-2#1)(2013-8#2)
antiplatelet therapy in infective##2##4##(2011-2#2)
antiplatelet therapy in##4##3##(2011-2#4)
antiplatelet therapy##5##2##(2008-11#1)(2011-2#4)
antiplatelet##22##1##(1990-11#1)(1991-11#1)(1993-9#1)(2008-11#3)(2008-5#1)(2008-8#4)(2011-2#9)(2013-8#2)
antiport##2##1##(1992-10#2)
antiporter##2##1##(1992-10#1)(2008-11#1)
antipredator##3##1##(2008-9#1)(2010-8#2)
antiproliferative action of##2##3##(1990-2#1)(1990-6#1)
antiproliferative activity in##2##3##(2008-4#1)(2010-11#1)
antiproliferative activity##6##2##(1990-12#1)(1997-1#2)(2008-4#1)(2008-8#1)(2010-11#1)
antiproliferative agent and##2##3##(1997-1#1)(2011-3#1)
antiproliferative and immunomodulating##2##3##(1995-12#1)(1997-5#1)
antiproliferative effects of LHRH##2##4##(2008-4#2)
antiproliferative effects##3##2##(1994-11#1)(2008-4#2)
antiproliferative##21##1##(1990-12#2)(1990-2#1)(1990-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-1#5)(1997-5#1)(2008-11#1)(2008-4#4)(2008-8#1)(2010-11#1)(2011-3#1)
antipsychotic agents##6##2##(1992-12#3)(2008-4#1)(2008-7#1)(2008-8#1)
antipsychotic drug##3##2##(1995-2#1)(2008-4#1)(2011-10#1)
antipsychotic drugs##5##2##(1992-6#1)(2008-11#1)(2008-7#2)(2011-2#1)
antipsychotic medication##2##2##(2009-7#1)(2013-8#1)
antipsychotic treatment##2##2##(2010-1#2)
antipsychotic##30##1##(1992-12#3)(1992-6#1)(1993-9#1)(1995-2#3)(2008-11#3)(2008-4#2)(2008-7#3)(2008-8#2)(2009-7#1)(2010-1#4)(2010-2#1)(2011-10#1)(2011-2#1)(2012-3#3)(2013-8#1)
antipsychotics##8##1##(2008-8#4)(2009-12#1)(2009-6#1)(2012-3#2)
antipyretic##2##1##(2008-10#2)
antipyretica##3##1##(2008-11#3)
antipyrine##2##1##(2008-10#2)
antiradical activity##2##2##(2008-11#2)
antiradical##3##1##(2008-11#3)
antireflection##2##1##(2008-2#1)(2008-3#1)
antireflection-coated##2##1##(2008-3#2)
antireflux procedure##2##2##(1992-9#2)
antireflux##4##1##(1992-9#2)(2008-10#1)(2013-1#1)
antirescue effect##3##2##(2008-8#3)
antiretroviral agents##2##2##(1990-8#1)(2011-3#1)
antiretroviral drug##5##2##(2008-11#5)
antiretroviral drugs##4##2##(2010-11#2)(2011-2#1)(2011-3#1)
antiretroviral therapy (ART)##2##3##(2011-2#2)
antiretroviral therapy in##2##3##(2009-7#1)(2010-11#1)
antiretroviral therapy##15##2##(2008-10#1)(2008-11#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#5)(2011-3#1)
antiretroviral##27##1##(1990-8#1)(2008-10#2)(2008-11#6)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#3)(2010-5#1)(2011-2#6)(2011-3#3)
antiretrovirals##2##1##(2011-2#1)(2013-8#1)
antirheumatic drugs##2##2##(1991-8#1)(2011-2#1)
antisense EDRF1##3##2##(2008-8#1)(2008-9#2)
antisense PDS##2##2##(1995-2#2)
antisense RNA was##2##3##(1992-12#1)(2008-10#1)
antisense RNA##12##2##(1992-12#2)(1994-11#2)(1995-2#1)(1997-6#1)(2008-10#1)(2008-8#4)(2011-1#1)
antisense RNAs##2##2##(2008-8#2)
antisense c-jun##2##2##(2008-11#2)
antisense expression plasmid##2##3##(2008-9#2)
antisense expression##4##2##(1994-11#1)(2008-8#1)(2008-9#2)
antisense oligodeoxynucleotide##3##2##(1995-12#1)(2008-11#1)(2011-2#1)
antisense oligodeoxynucleotides to##2##3##(1995-11#1)(2008-11#1)
antisense oligodeoxynucleotides##5##2##(1992-6#2)(1995-11#1)(2008-11#1)(2011-2#1)
antisense oligonucleotide##6##2##(1995-11#2)(2008-11#4)
antisense oligonucleotides##2##2##(2008-11#1)(2011-2#1)
antisense transcript##3##2##(1994-11#1)(1995-2#1)(2011-2#1)
antisense transgenic##2##2##(1996-12#2)
antisense##82##1##(1992-12#4)(1992-6#3)(1993-3#1)(1994-11#5)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-9#1)(1996-12#4)(1997-6#1)(1997-7#1)(2008-10#9)(2008-11#12)(2008-4#1)(2008-8#13)(2008-9#6)(2009-10#1)(2011-1#1)(2011-2#8)(2012-3#1)
antisense-TGFbeta##2##1##(2008-11#2)
antisense-TNFalpha##2##1##(2008-11#2)
antisenseabp transgenic tobacco protoplasts##2##4##(2008-8#2)
antisenseabp transgenic tobacco##3##3##(2008-8#3)
antiseptic##4##1##(2008-10#2)(2011-1#1)(2012-3#1)
antisera against the##2##3##(2008-10#2)
antisera against##4##2##(1996-12#1)(2008-10#3)
antisera in##4##2##(2008-10#4)
antisera recognized##2##2##(1990-5#1)(2008-10#1)
antisera to CIPs of##2##4##(2008-10#2)
antisera to##9##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-9#1)(2008-10#5)
antisera were##2##2##(2008-10#1)(2008-5#1)
antisera##41##1##(1990-5#3)(1991-1#1)(1991-12#1)(1992-9#1)(1993-9#1)(1995-6#1)(1995-8#1)(1996-12#2)(2008-10#24)(2008-4#2)(2008-5#3)(2010-6#1)
antiserum against##4##2##(1993-3#1)(1997-1#1)(2008-10#2)
antiserum and##2##2##(2008-10#2)
antiserum and/or##2##2##(2008-4#1)(2008-5#1)
antiserum raised against the##3##4##(1996-2#1)(2008-10#2)
antiserum raised against##7##3##(1993-9#1)(1995-12#1)(1996-2#1)(2008-10#4)
antiserum raised##8##2##(1993-9#1)(1995-12#1)(1996-2#1)(2008-10#5)
antiserum showed##3##2##(1992-9#1)(2008-10#2)
antiserum to a##2##3##(1991-9#1)(2008-10#1)
antiserum to##9##2##(1991-1#3)(1991-9#1)(1994-2#1)(2008-10#4)
antiserum were identified as##2##4##(2008-10#2)
antiserum were##3##2##(2008-10#2)(2008-5#1)
antiserum##57##1##(1990-11#1)(1990-5#1)(1991-1#3)(1991-9#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-12#2)(1996-2#2)(1997-1#1)(2008-10#30)(2008-11#3)(2008-4#2)(2008-5#4)(2008-8#1)(2012-3#1)
antisocial behavior##5##2##(2008-11#4)(2012-12#1)
antisocial behaviour##2##2##(2013-8#2)
antisocial##13##1##(1991-1#1)(2008-11#8)(2011-2#1)(2012-12#1)(2013-8#2)
antisperm monoclonal antibody 6B10##2##4##(2008-8#2)
antistaling##2##1##(2010-7#2)
antisymmetric stretching##2##2##(2008-10#2)
antisymmetric##5##1##(2008-10#3)(2008-2#1)(2008-3#1)
antitank mine##2##2##(2008-10#2)
antitheses in##2##2##(2009-10#1)(2012-2#1)
antithrombin III##4##2##(1992-10#1)(2008-7#3)
antithrombin##10##1##(1992-10#2)(2008-4#1)(2008-7#3)(2010-11#2)(2010-3#2)
antithrombotic activity##5##2##(2006-6#5)
antithrombotic drugs##2##2##(2008-5#1)(2011-2#1)
antithrombotic##14##1##(1992-9#1)(1997-2#1)(2006-6#6)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
antithyroid drugs##3##2##(2008-10#2)(2012-3#1)
antitopoisomerase##2##1##(2008-11#2)
antitoxin##4##1##(1996-11#1)(2008-10#3)
antitrust##8##1##(1991-9#1)(1993-1#3)(1994-1#1)(1996-12#2)(1997-2#1)
antitrypsin Pittsburgh##3##2##(1993-2#3)
antitrypsin##6##1##(1993-2#4)(1997-3#1)(2008-12#1)
antitubercular drugs in##2##3##(1997-8#1)(2008-10#1)
antitubercular drugs##3##2##(1997-8#1)(2008-10#2)
antitubercular##5##1##(1997-8#1)(2008-10#2)(2008-7#1)(2012-12#1)
antituberculous therapy##2##2##(1996-3#1)(2011-2#1)
antituberculous##6##1##(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
antitumor activity in##2##3##(1990-2#1)(2008-5#1)
antitumor activity##9##2##(1990-2#1)(1991-8#1)(1994-5#1)(2008-11#3)(2008-5#2)(2008-9#1)
antitumor agents##7##2##(1995-6#1)(2008-11#3)(2008-5#3)
antitumor and antimetastatic##2##3##(1994-12#2)
antitumor drug##3##2##(1991-6#1)(1993-8#1)(1995-6#1)
antitumor drugs##2##2##(1994-5#1)(2008-9#1)
antitumor effect on##2##3##(1997-7#2)
antitumor effect##5##2##(1994-5#1)(1997-7#2)(2008-8#2)
antitumor response##4##2##(1992-12#2)(1994-5#2)
antitumor##44##1##(1990-2#1)(1991-6#1)(1991-8#2)(1992-12#2)(1993-8#1)(1994-12#2)(1994-5#6)(1995-6#2)(1997-7#2)(2008-11#7)(2008-5#5)(2008-8#2)(2008-9#6)(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#2)
antitumoral##3##1##(1991-8#1)(2008-11#1)(2011-2#1)
antitumour##3##1##(1994-8#1)(1996-3#1)(2011-2#1)
antiulcer agent##3##2##(1993-3#2)(2008-11#1)
antiviral activities##3##2##(2008-11#1)(2011-2#1)(2011-3#1)
antiviral activity##3##2##(2008-11#1)(2008-8#1)(2011-3#1)
antiviral agents##3##2##(1995-9#1)(2008-10#1)(2013-1#1)
antiviral compounds##2##2##(2011-2#2)
antiviral drug##5##2##(1994-6#1)(1995-6#1)(2008-10#1)(2009-8#1)(2011-3#1)
antiviral drugs##2##2##(1995-2#1)(2011-2#1)
antiviral immunity##2##2##(2013-1#2)
antiviral signaling##2##2##(2013-1#2)
antiviral therapy in##2##3##(2013-1#2)
antiviral therapy##8##2##(1994-8#1)(2009-8#3)(2011-2#2)(2013-1#2)
antiviral treatment##4##2##(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
antiviral##48##1##(1990-10#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1997-5#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-8#1)(2009-7#1)(2009-8#5)(2011-2#7)(2011-3#5)(2013-1#12)
antivirals##2##1##(1997-1#1)(2009-8#1)
antiwrinkle activity##2##2##(2008-5#2)
antiwrinkle##3##1##(2008-5#3)
antral follicles##10##2##(1995-12#2)(2008-11#1)(2008-8#4)(2008-9#3)
antral##17##1##(1992-6#1)(1995-12#2)(1997-1#1)(2008-11#1)(2008-12#1)(2008-8#4)(2008-9#3)(2011-2#1)(2013-1#3)
antrum##2##1##(1994-11#1)(2011-2#1)
ants for##2##2##(2008-10#2)
ants was##2##2##(2008-10#2)
ants##25##1##(2007-12#2)(2008-10#10)(2008-5#1)(2008-8#9)(2012-2#3)
anuran##4##1##(1996-5#1)(2008-8#2)(2011-2#1)
anurans##6##1##(1996-5#1)(1997-3#2)(2008-7#1)(2008-8#2)
anuria##2##1##(1991-11#1)(2008-12#1)
anuric##6##1##(2011-2#6)
anus##5##1##(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#2)
anxieties and##2##2##(2008-11#1)(2009-10#1)
anxieties##10##1##(1991-3#1)(2008-11#1)(2009-10#2)(2011-2#6)
anxiety (negatively)##2##2##(2008-12#2)
anxiety among##2##2##(1995-1#1)(2010-2#1)
anxiety and anger##2##3##(2008-12#2)
anxiety and depression##5##3##(1992-3#1)(2008-11#2)(2008-12#1)(2012-12#1)
anxiety and muscle tension##2##4##(2010-12#2)
anxiety and##22##2##(1991-1#1)(1991-6#1)(1992-3#1)(1996-2#1)(2008-11#3)(2008-12#3)(2008-4#1)(2008-9#1)(2009-7#2)(2010-12#2)(2010-5#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
anxiety class (n =##2##4##(2009-7#2)
anxiety disorder and##2##3##(2013-8#2)
anxiety disorder##12##2##(2008-4#2)(2010-5#2)(2012-2#1)(2013-1#2)(2013-8#5)
anxiety disorders and##2##3##(2009-6#1)(2013-8#1)
anxiety disorders in##2##3##(1991-2#1)(2009-6#1)
anxiety disorders##18##2##(1991-2#3)(1993-2#1)(2008-4#1)(2009-11#1)(2009-6#4)(2010-2#1)(2012-2#3)(2013-8#4)
anxiety in##6##2##(1991-2#1)(1995-1#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
anxiety or##2##2##(1995-1#1)(2008-11#1)
anxiety symptoms in infants and toddlers with##2##7##(2012-2#2)
anxiety symptoms##6##2##(2012-2#5)(2013-1#1)
anxiety to##4##2##(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)
anxiety##151##1##(1990-6#1)(1991-1#2)(1991-2#5)(1991-6#1)(1992-3#1)(1993-2#1)(1993-3#3)(1995-1#7)(1995-2#1)(1996-2#3)(2008-10#1)(2008-11#15)(2008-12#11)(2008-4#8)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#4)(2009-7#10)(2010-1#1)(2010-12#6)(2010-2#3)(2010-5#4)(2010-6#3)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#16)(2012-3#1)(2013-1#9)(2013-8#15)
anxiolytic effects##4##2##(1993-3#2)(1994-2#1)(2012-2#1)
anxiolytic##12##1##(1990-11#1)(1993-3#3)(1994-2#2)(2008-10#2)(2008-11#2)(2008-9#1)(2012-2#1)
anxious and##2##2##(2008-4#1)(2013-8#1)
anxious coping##2##2##(2009-12#2)
anxious symptoms##2##2##(1992-2#2)
anxious##13##1##(1990-11#1)(1991-1#1)(1992-2#2)(2008-4#1)(2009-12#3)(2009-6#1)(2012-2#3)(2013-8#1)
any absorption##2##2##(1992-4#1)(2008-10#1)
any accidental##2##2##(2008-11#1)(2008-9#1)
any action##2##2##(1991-6#1)(2012-2#1)
any additional##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
any advantage over##2##3##(1994-3#1)(2009-1#1)
any adverse effect on the##2##5##(2008-11#1)(2008-3#1)
any adverse effect##4##3##(1991-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
any adverse##6##2##(1991-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-12#1)
any age##2##2##(1990-5#1)(1993-11#1)
any alteration##5##2##(1997-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
any analytical##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
any animal##2##2##(2008-11#1)(2009-1#1)
any anxiety disorder##2##3##(2013-8#2)
any apparent##5##2##(1995-2#1)(2008-10#2)(2008-11#1)(2013-1#1)
any appreciable##3##2##(2008-10#2)(2008-9#1)
any attempt##2##2##(1997-8#1)(2008-11#1)
any available##2##2##(2008-10#1)(2008-11#1)
any benefit##2##2##(1990-6#1)(1993-9#1)
any better##2##2##(1996-12#1)(2008-2#1)
any case##7##2##(1990-12#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
any cell type##2##3##(1995-2#1)(2008-9#1)
any cell##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
any change in the##2##4##(1992-1#1)(2011-2#1)
any change in##5##3##(1992-1#1)(1994-8#1)(1995-2#1)(2011-2#2)
any change##8##2##(1992-1#1)(1992-12#1)(1994-8#1)(1995-2#1)(2011-2#3)(2013-8#1)
any changes in##4##3##(2008-10#1)(2008-9#2)(2013-1#1)
any changes##6##2##(2008-10#2)(2008-7#1)(2008-9#2)(2013-1#1)
any chemical##3##2##(2008-10#3)
any clinical##4##2##(1995-2#1)(2009-8#1)(2013-1#1)(2013-7#1)
any combination of the##2##4##(2008-1#1)(2013-1#1)
any combination of##6##3##(1991-8#1)(1992-12#1)(1995-9#1)(2008-1#1)(2008-3#1)(2013-1#1)
any combination##10##2##(1991-8#1)(1992-12#1)(1995-11#1)(1995-9#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2013-1#1)
any complex##2##2##(1993-3#1)(2008-11#1)
any complications##4##2##(1991-12#1)(2008-7#1)(2010-7#1)(2012-3#1)
any compound that could##2##4##(2008-5#2)
any condition##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
any correlation between enzymatic activity and##2##6##(2010-12#2)
any correlation between##5##3##(2008-10#1)(2010-12#2)(2010-8#1)(2012-3#1)
any correlation##6##2##(2008-10#1)(2008-7#1)(2010-12#2)(2010-8#1)(2012-3#1)
any cross##2##2##(2008-10#1)(2008-3#1)
any cutaneous##2##2##(2008-10#1)(2012-3#1)
any data##2##2##(1991-12#1)(2013-8#1)
any decision##2##2##(2009-12#1)(2013-1#1)
any desired##5##2##(1993-8#1)(1994-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
any detectable##2##2##(1992-6#1)(1995-2#1)
any difference between##2##3##(1990-12#1)(2008-10#1)
any difference##4##2##(1990-12#1)(1995-11#1)(1995-5#1)(2008-10#1)
any differences resulting from##2##4##(1993-2#1)(2008-11#1)
any differences##4##2##(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)
any different##2##2##(1995-2#1)(2008-11#1)
any direct##4##2##(1995-2#1)(2008-10#2)(2008-7#1)
any divergence in##4##3##(2008-10#4)
any divergence##5##2##(2008-10#5)
any effect on the##9##4##(1991-11#1)(1991-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
any effect on##13##3##(1991-11#1)(1991-3#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
any effect##17##2##(1990-11#1)(1991-11#1)(1991-3#2)(1991-7#1)(1993-11#1)(1994-5#1)(1994-6#2)(1995-3#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
any effects##2##2##(2011-1#1)(2013-7#1)
any electron##2##2##(2008-10#2)
any evidence of##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
any external##2##2##(1996-6#1)(2008-3#1)
any fluorescence##2##2##(2008-10#1)(2008-9#1)
any further##10##2##(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
any future##2##2##(1992-2#1)(2008-5#1)
any gene##2##2##(1993-3#1)(2011-2#1)
any given##22##2##(1993-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#3)(2012-3#1)(2013-1#1)
any group of##2##3##(1993-1#1)(1995-2#1)
any group##3##2##(1993-1#1)(1995-2#1)(2011-2#1)
any growth##2##2##(2008-11#1)(2011-2#1)
any health care##2##3##(1991-12#1)(1994-1#1)
any increase in##3##3##(1997-7#1)(2008-11#1)(2008-6#1)
any individual##2##2##(2008-10#1)(2008-7#1)
any influence##2##2##(1993-8#1)(2008-10#1)
any information##2##2##(1993-12#1)(2013-1#1)
any instrument##3##2##(2008-9#1)(2013-1#2)
any interference##5##2##(2008-10#4)(2008-11#1)
any known##6##2##(1996-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)
any large-scale##2##2##(2008-4#2)
any level of##4##3##(2008-10#1)(2011-1#1)(2011-2#2)
any major##9##2##(1990-6#1)(1992-2#1)(2008-10#4)(2010-6#1)(2011-2#1)(2013-1#1)
any masking##2##2##(2008-10#2)
any model##2##2##(2008-10#1)(2008-8#1)
any need for##2##3##(2008-12#1)(2011-2#1)
any need##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
any new##2##2##(2011-2#1)(2011-3#1)
any of several##2##3##(1992-12#1)(2008-10#1)
any of the other##3##4##(2008-10#2)(2012-3#1)
any of the patients##2##4##(1991-3#1)(2008-1#1)
any of the seven##2##4##(2008-10#1)(2008-6#1)
any of the three##3##4##(2008-10#3)
any of the##58##3##(1990-6#1)(1991-3#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-11#1)(1994-8#1)(1995-6#1)(1997-8#2)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#3)(2008-7#2)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
any of these##10##3##(1994-2#1)(1995-6#1)(2008-10#2)(2008-7#2)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
any of##78##2##(1990-6#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-6#2)(1996-1#1)(1997-8#2)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)
any one##11##2##(1991-1#1)(1995-5#1)(2008-10#4)(2008-11#1)(2009-12#1)(2011-2#1)(2012-2#2)
any or all##2##3##(2008-10#1)(2008-3#1)
any organism##2##2##(2008-10#1)(2008-9#1)
any other form##2##3##(2008-10#1)(2010-6#1)
any other group##3##3##(1991-2#2)(2011-2#1)
any other known##2##3##(2008-10#1)(2008-6#1)
any other type of##2##4##(2008-10#1)(2013-1#1)
any other##60##2##(1990-8#1)(1991-2#2)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
any pair of##2##3##(2008-10#1)(2008-9#1)
any particular cell##2##3##(2008-11#1)(2008-4#1)
any particular##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
any positive##2##2##(2008-10#1)(2009-8#1)
any possible##4##2##(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
any postoperative##2##2##(2008-12#1)(2011-2#1)
any potyvirus##2##2##(2008-10#2)
any pre-treatment##5##2##(2008-10#5)
any preferential##2##2##(1993-3#1)(2008-7#1)
any preliminary##2##2##(2008-10#2)
any pretreatment of##2##3##(2008-10#1)(2008-11#1)
any pretreatment##8##2##(2008-10#6)(2008-11#1)(2008-9#1)
any previous##7##2##(2008-10#5)(2008-8#1)(2009-10#1)
any prior knowledge##2##3##(2008-10#1)(2008-9#1)
any prior##6##2##(2008-10#4)(2008-9#1)(2012-2#1)
any procedure##2##2##(1992-12#1)(2009-9#1)
any protection in vivo##2##4##(1995-11#2)
any protection##4##2##(1995-11#3)(2008-10#1)
any publication##2##2##(2008-11#1)(2008-9#1)
any reduction##3##2##(2008-10#3)
any region##2##2##(1995-6#1)(2008-10#1)
any relapse##2##2##(2009-11#1)(2010-12#1)
any relationship between##2##3##(1996-3#1)(2008-5#1)
any relationship##3##2##(1996-3#1)(2008-5#1)(2013-1#1)
any relief of##2##3##(1996-9#2)
any reported##5##2##(1993-12#1)(1993-6#1)(1995-8#2)(1996-2#1)
any sample##8##2##(2008-10#7)(2008-12#1)
any scientific##2##2##(2008-3#1)(2008-7#1)
any separation##6##2##(2008-10#6)
any serious interference##2##3##(2008-10#2)
any side effects##3##3##(1992-11#1)(1993-6#1)(2008-10#1)
any side-effects##2##2##(2008-5#1)(2008-7#1)
any significant change##3##3##(2008-10#2)(2011-2#1)
any significant changes in##2##4##(1995-6#1)(2011-2#1)
any significant difference in##2##4##(2007-8#1)(2008-10#1)
any significant difference##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
any significant differences##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2012-3#1)
any significant effect on the##4##5##(1993-11#1)(1995-3#1)(2008-10#1)(2013-1#1)
any significant effect on##5##4##(1993-11#1)(1995-3#1)(2008-10#1)(2011-3#1)(2013-1#1)
any significant effect##6##3##(1993-11#1)(1995-3#1)(2008-10#1)(2011-3#1)(2012-3#1)(2013-1#1)
any significant##37##2##(1990-11#1)(1991-2#1)(1992-9#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#2)(1997-8#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-3#4)(2013-1#3)(2013-8#1)
any signs of##2##3##(2008-10#1)(2008-11#1)
any signs##5##2##(1990-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
any single##7##2##(1994-9#1)(1995-12#2)(1995-2#1)(2008-11#1)(2010-11#1)(2012-3#1)
any site of##2##3##(2008-11#1)(2011-2#1)
any site##3##2##(1997-8#1)(2008-11#1)(2011-2#1)
any size##2##2##(1995-1#1)(2008-9#1)
any species and##2##3##(1995-6#1)(1995-8#1)
any species##5##2##(1995-6#1)(1995-8#1)(2008-10#2)(2008-8#1)
any specific##3##2##(1996-1#1)(2008-11#1)(2008-3#1)
any statistically significant##3##3##(2009-1#1)(2013-1#2)
any step of##2##3##(1995-8#1)(2008-11#1)
any such##4##2##(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)
any surgical##2##2##(2008-11#1)(2011-2#1)
any symptom##2##2##(1990-3#1)(1991-8#1)
any symptoms##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
any system##3##2##(2008-10#2)(2013-8#1)
any tested##2##2##(2008-10#2)
any therapeutic##3##2##(1990-12#1)(1990-2#1)(1996-11#1)
any toxic##2##2##(1992-6#1)(2008-10#1)
any treatment and##2##3##(1997-3#1)(2008-5#1)
any treatment##9##2##(1990-2#1)(1993-12#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
any two##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
any type of##3##3##(1994-3#1)(2008-10#2)
any unusual##2##2##(1992-5#1)(2008-12#1)
any visible##3##2##(2008-10#2)(2009-1#1)
any##1102##1##(1990-11#5)(1990-12#4)(1990-2#8)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#2)(1991-1#3)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#11)(1991-6#2)(1991-7#1)(1991-8#4)(1992-1#3)(1992-11#1)(1992-12#6)(1992-2#6)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#3)(1992-9#2)(1993-1#4)(1993-11#7)(1993-12#12)(1993-2#7)(1993-3#8)(1993-6#3)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#11)(1994-5#6)(1994-6#2)(1994-8#6)(1994-9#2)(1995-1#4)(1995-11#6)(1995-12#7)(1995-2#12)(1995-3#5)(1995-5#3)(1995-6#10)(1995-8#5)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#3)(1996-6#6)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#9)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#5)(2008-10#314)(2008-11#67)(2008-12#22)(2008-2#7)(2008-3#16)(2008-4#18)(2008-5#32)(2008-6#8)(2008-7#29)(2008-8#15)(2008-9#40)(2009-1#5)(2009-10#7)(2009-11#1)(2009-12#5)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#8)(2010-7#7)(2010-8#6)(2011-1#5)(2011-2#46)(2011-3#7)(2012-12#5)(2012-2#24)(2012-3#19)(2012-4#1)(2013-1#41)(2013-7#4)(2013-8#15)
anyone##7##1##(1992-1#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-6#1)(1997-3#1)(2012-3#1)
anything##5##1##(1992-5#1)(1993-12#1)(1994-2#1)(2008-11#1)(2008-6#1)
anyway##2##1##(1992-6#1)(1995-6#1)
anywhere in the##2##3##(2008-11#1)(2013-8#1)
anywhere##6##1##(1997-3#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-8#1)
aoronymphium##6##1##(2008-8#5)(2008-9#1)
aorta and##15##2##(1991-6#1)(1993-12#1)(1997-8#7)(2008-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-3#2)
aorta lesion##2##2##(1997-8#2)
aorta of##2##2##(2009-7#1)(2013-8#1)
aorta or##2##2##(1997-1#1)(2013-8#1)
aorta##73##1##(1990-2#1)(1991-6#1)(1993-12#2)(1993-3#1)(1994-11#2)(1996-11#1)(1997-1#1)(1997-5#4)(1997-8#19)(2008-10#4)(2008-11#3)(2008-12#2)(2008-6#1)(2009-7#3)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#4)(2012-2#4)(2012-3#3)(2013-1#1)(2013-3#5)(2013-8#3)
aorta) in##3##2##(1997-8#3)
aortic PWV##2##2##(2013-3#2)
aortic and pulmonary artery##2##4##(1993-12#1)(1995-2#1)
aortic aneurysm##18##2##(1991-8#1)(1992-5#4)(1994-1#1)(2008-11#1)(2008-12#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#2)(2011-2#1)(2011-3#1)
aortic aneurysms##2##2##(2010-12#1)(2012-2#1)
aortic arch and its##2##4##(1997-8#2)
aortic arch##7##2##(1997-8#3)(2008-12#1)(2010-7#2)(2011-2#1)
aortic bi-iliac##2##2##(2011-2#2)
aortic dissection in##2##3##(2013-1#2)
aortic dissection##5##2##(2008-11#1)(2009-6#1)(2013-1#3)
aortic endothelial cells##7##3##(1990-12#2)(1991-5#2)(1993-8#1)(2008-11#1)(2008-8#1)
aortic injury##4##2##(2008-12#3)(2010-12#1)
aortic regurgitation##9##2##(1997-5#1)(1997-8#5)(2008-11#2)(2009-10#1)
aortic replacement##2##2##(2012-2#2)
aortic rings##3##2##(1994-5#1)(2008-11#2)
aortic root##2##2##(2012-2#1)(2013-1#1)
aortic rupture##2##2##(2008-12#1)(2012-3#1)
aortic smooth muscle cells##4##4##(1991-5#1)(1992-8#1)(1993-3#1)(1995-11#1)
aortic stenosis and##2##3##(2012-2#2)
aortic stiffness##2##2##(2013-3#2)
aortic valve replacement##4##3##(1997-5#1)(2012-2#1)(2013-8#2)
aortic valve##20##2##(1997-5#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-8#3)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-8#2)
aortic wall##3##2##(1997-8#1)(2009-7#2)
aortic##131##1##(1990-12#2)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#2)(1992-5#5)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-5#4)(1997-8#12)(2008-10#3)(2008-11#10)(2008-12#10)(2008-8#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#5)(2009-8#1)(2010-12#8)(2010-7#4)(2010-9#1)(2011-2#7)(2011-3#1)(2012-2#12)(2012-3#1)(2013-1#5)(2013-3#7)(2013-8#3)
aortitis syndrome##2##2##(2008-7#2)
aortitis##6##1##(1997-5#4)(2008-7#2)
aorto-iliac##6##1##(1990-5#2)(1997-8#1)(2008-11#1)(2011-2#2)
aorto-ilio-femoral##2##1##(2011-3#2)
aortoarteritis##2##1##(1997-8#1)(2008-12#1)
aortomitral angle##3##2##(2008-10#3)
aortopulmonary artery##2##2##(2008-11#2)
apart and##3##2##(1994-11#1)(1995-3#1)(2012-3#1)
apart from the##2##3##(1991-8#1)(2008-10#1)
apart from##14##2##(1991-12#1)(1991-8#1)(1993-1#1)(1994-8#2)(2008-10#5)(2008-11#1)(2008-6#1)(2010-12#1)(2012-3#1)
apart##32##1##(1990-12#1)(1991-12#1)(1991-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-3#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-12#1)(2012-3#2)
apartment##3##1##(1996-5#2)(2011-2#1)
apatite##7##1##(2008-10#3)(2009-7#4)
ape chromosomes##3##2##(1997-6#3)
ape##5##1##(1997-6#5)
aperture dimension##2##2##(2008-3#2)
aperture field##3##2##(2011-2#3)
aperture imaging##2##2##(2008-3#1)(2009-12#1)
aperture is##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
aperture to##2##2##(2008-2#1)(2008-3#1)
aperture##50##1##(2007-12#2)(2008-10#7)(2008-2#9)(2008-3#24)(2008-6#1)(2009-12#1)(2009-8#1)(2011-2#4)(2013-8#1)
apertures##4##1##(2008-10#1)(2008-3#3)
apes##2##1##(1997-6#1)(2012-12#1)
apex and##5##2##(2008-9#2)(2009-2#1)(2010-5#1)(2011-2#1)
apex meningiomas##2##2##(2008-7#2)
apex point and##2##3##(2009-2#2)
apex point##3##2##(2009-2#3)
apex##41##1##(2007-12#1)(2007-8#2)(2008-10#5)(2008-7#4)(2008-9#2)(2009-2#8)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#9)(2012-2#2)(2013-1#4)(2013-7#1)
aphakic##2##1##(2011-2#2)
aphanidermatum in##3##2##(2008-10#3)
aphanidermatum##17##1##(2008-10#17)
aphasia##6##1##(1990-3#1)(1995-12#1)(1997-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
aphasic##2##1##(1997-3#1)(2008-10#1)
apheresis system##2##2##(2011-2#2)
apheresis##14##1##(1991-11#2)(2008-9#1)(2011-2#10)(2012-12#1)
aphid Schizaphis graminum##3##3##(1996-12#2)(2008-10#1)
aphid species##6##2##(2008-10#6)
aphid transmission##11##2##(2008-10#11)
aphid vector##4##2##(2008-10#4)
aphid vectors and##2##3##(2008-10#2)
aphid vectors##4##2##(2008-10#4)
aphid##62##1##(1996-12#6)(2007-12#2)(2008-10#46)(2008-9#3)(2009-8#3)(2012-2#2)
aphid-transmitted viruses in snap bean##2##5##(2008-10#2)
aphid-transmitted##5##1##(2008-10#5)
aphidicola##3##1##(1996-12#3)
aphids (Myzus persicae)##3##3##(2008-10#2)(2012-2#1)
aphids and##2##2##(2008-10#1)(2009-8#1)
aphids by##2##2##(2008-10#1)(2009-8#1)
aphids was##2##2##(2008-10#2)
aphids were##3##2##(2008-10#3)
aphids##26##1##(1996-12#1)(2007-12#2)(2008-10#15)(2009-8#4)(2012-2#4)
aphthosis##2##1##(2012-3#2)
apical and##4##2##(2008-9#1)(2011-2#1)(2012-2#2)
apical cells##2##2##(2008-7#2)
apical end##2##2##(2008-6#1)(2008-7#1)
apical infolding system##2##3##(2008-7#2)
apical leaves##2##2##(2008-10#2)
apical meristem explants##3##3##(2008-12#3)
apical meristem##10##2##(2008-10#1)(2008-12#4)(2009-8#5)
apical necrosis##3##2##(2008-10#3)
apical periodontitis##2##2##(2013-1#2)
apical plug was##2##3##(2013-1#2)
apical plug##3##2##(2013-1#3)
apical portion of##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
apical region##2##2##(2008-10#1)(2008-7#1)
apical seal##3##2##(1991-3#2)(2013-1#1)
apical third##2##2##(2013-1#2)
apical##94##1##(1991-3#2)(1995-8#1)(1997-1#1)(2007-12#7)(2008-10#11)(2008-11#4)(2008-12#4)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#3)(2009-10#2)(2009-6#1)(2009-8#7)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#19)(2013-1#16)
apices##3##1##(2008-10#1)(2008-8#1)(2013-1#1)
apicidin or HC-toxin##2##3##(2008-10#2)
apicidin##7##1##(2008-10#7)
apicoplast##2##1##(2012-2#2)
apigenin##4##1##(2008-10#1)(2008-11#3)
apiospermum external otitis##2##3##(2008-5#2)
aplasia of##2##2##(2011-1#1)(2013-1#1)
aplasia##7##1##(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
aplastic anaemia##3##2##(2012-2#3)
aplastic##6##1##(2011-1#1)(2012-2#3)(2012-3#2)
apnea##8##1##(1994-3#1)(1997-8#1)(2009-9#2)(2010-5#2)(2013-1#2)
apnoea##6##1##(1996-5#4)(1997-8#1)(2007-11#1)
apo B##7##2##(1994-11#4)(1995-8#1)(1997-8#2)
apo and##3##2##(1991-12#1)(2009-7#1)(2012-2#1)
apo##19##1##(1991-12#5)(1993-8#1)(1994-11#4)(1995-8#3)(1997-8#2)(2008-1#1)(2009-7#2)(2012-2#1)
apo(a)##7##1##(1993-2#5)(1995-8#1)(1996-8#1)
apo-E##6##1##(2008-10#6)
apoA-I##4##1##(2008-6#4)
apoB-100##2##1##(1995-2#1)(2008-6#1)
apoB100##2##1##(2008-6#2)
apoE##7##1##(1995-6#2)(1996-2#3)(2008-6#1)(2008-9#1)
apoE4##2##1##(2008-9#2)
apocrine carcinoma##3##2##(2008-10#3)
apocrine cysts##2##2##(1993-1#2)
apocrine secretion##2##2##(2008-5#2)
apocrine##15##1##(1993-1#4)(2008-10#4)(2008-12#1)(2008-5#6)
apocytochrome P450cam##2##2##(1993-8#2)
apocytochrome c##3##2##(2008-8#3)
apocytochrome##5##1##(1993-8#2)(2008-8#3)
apodization function##2##2##(2008-10#1)(2008-3#1)
apodization##3##1##(2008-10#1)(2008-3#2)
apoenzyme##4##1##(1993-6#3)(1994-5#1)
apolar##4##1##(2008-10#4)
apolipoprotein (apo) E##2##3##(1995-6#1)(2008-6#1)
apolipoprotein (apo)##5##2##(1993-2#1)(1995-6#1)(2008-6#3)
apolipoprotein A1##2##2##(1997-8#1)(2010-6#1)
apolipoprotein AI##3##2##(1991-12#1)(1993-12#2)
apolipoprotein B gene##3##3##(1995-2#2)(1997-8#1)
apolipoprotein B knockout##2##3##(1995-2#2)
apolipoprotein B##16##2##(1992-12#1)(1995-2#11)(1997-8#2)(2008-7#2)
apolipoprotein E##7##2##(1995-6#1)(1996-2#1)(2008-10#3)(2008-7#1)(2009-12#1)
apolipoprotein##41##1##(1991-12#1)(1992-12#1)(1993-12#2)(1993-2#1)(1994-11#2)(1995-2#11)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-8#3)(2008-10#3)(2008-6#4)(2008-7#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-6#1)(2013-8#1)
apolipoprotein(a)##2##1##(1996-8#1)(2008-6#1)
apolipoproteins##3##1##(1995-2#3)
apologies##2##1##(2008-10#1)(2012-3#1)
apomorphine-induced##2##1##(1992-12#1)(1996-2#1)
aponeuroses##2##1##(2013-1#2)
aponeurotic fibroma##2##2##(2012-3#2)
aponeurotic##3##1##(2009-9#1)(2012-3#2)
apoprotein B##3##2##(1991-2#1)(1991-5#2)
apoprotein##10##1##(1991-12#2)(1991-2#1)(1991-5#3)(1992-10#1)(1992-8#1)(1993-8#1)(1995-11#1)
apoptic##2##1##(2010-8#2)
apoptosis (programmed cell death)##2##4##(1993-2#1)(1995-8#1)
apoptosis after exposure##2##3##(2008-10#1)(2008-9#1)
apoptosis after##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
apoptosis and cell##2##3##(1994-9#1)(2011-2#1)
apoptosis and necrosis in##2##4##(2008-11#2)
apoptosis and necrosis of##2##4##(2008-9#1)(2013-1#1)
apoptosis and necrosis##4##3##(2008-11#2)(2008-9#1)(2013-1#1)
apoptosis and the##2##3##(2010-12#1)(2013-8#1)
apoptosis and##37##2##(1994-9#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-8#1)(2008-11#7)(2008-12#1)(2008-7#1)(2008-9#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#2)(2013-8#1)
apoptosis as##3##2##(1994-9#1)(2008-10#1)(2012-2#1)
apoptosis but##2##2##(1997-8#1)(2008-7#1)
apoptosis by##11##2##(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-3#1)
apoptosis can be##2##3##(2008-11#2)
apoptosis can##3##2##(2008-11#2)(2009-3#1)
apoptosis could not##2##3##(1994-11#1)(2008-7#1)
apoptosis could##3##2##(1994-11#1)(2008-11#1)(2008-7#1)
apoptosis detection##3##2##(2008-11#3)
apoptosis did not##2##3##(2008-10#2)
apoptosis followed##2##2##(2008-11#2)
apoptosis following##2##2##(2008-10#1)(2008-11#1)
apoptosis in HL-60 cells##2##4##(2008-8#1)(2011-2#1)
apoptosis in Parkinson's disease##3##4##(2008-7#3)
apoptosis in human##5##3##(1995-2#1)(2008-9#3)(2011-2#1)
apoptosis in inflammatory##2##3##(2010-12#1)(2013-1#1)
apoptosis in malignant cells##2##4##(2012-2#2)
apoptosis in response to##2##4##(2011-2#1)(2013-1#1)
apoptosis in the pancreas##2##4##(2008-7#2)
apoptosis in the##13##3##(1993-8#1)(1995-12#1)(1997-7#1)(2008-11#2)(2008-7#2)(2008-8#1)(2011-2#2)(2013-1#3)
apoptosis in vitro##2##3##(2008-10#2)
apoptosis in##64##2##(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1997-7#1)(2008-10#5)(2008-11#9)(2008-12#1)(2008-5#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#8)(2012-2#4)(2012-3#1)(2013-1#7)
apoptosis induced by##6##3##(1994-11#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)
apoptosis induced##7##2##(1994-11#1)(2008-11#2)(2008-8#1)(2011-2#2)(2013-1#1)
apoptosis induction by anti-Fas antibody##2##5##(2008-8#2)
apoptosis induction by##3##3##(2008-11#1)(2008-8#2)
apoptosis induction##11##2##(1995-2#2)(2008-11#1)(2008-12#2)(2008-8#4)(2008-9#1)(2009-3#1)
apoptosis inhibition##2##2##(2008-11#1)(2009-6#1)
apoptosis is##10##2##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#2)
apoptosis occurred in##3##3##(2008-10#1)(2008-8#2)
apoptosis occurs##3##2##(1994-11#1)(1995-6#1)(2008-4#1)
apoptosis of HMV-1 cells##2##4##(2008-11#2)
apoptosis of cancer##2##3##(2008-9#2)
apoptosis of the##6##3##(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)
apoptosis of tumor cells##2##4##(2008-9#1)(2009-3#1)
apoptosis of vascular endothelial cells##2##5##(1996-12#2)
apoptosis of##31##2##(1993-3#2)(1995-2#1)(1996-12#2)(1997-8#1)(2008-11#5)(2008-7#1)(2008-8#5)(2008-9#5)(2009-3#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
apoptosis regulators##2##2##(2008-11#1)(2009-12#1)
apoptosis to##2##2##(2009-9#1)(2011-2#1)
apoptosis triggered by##2##3##(2008-11#1)(2012-2#1)
apoptosis triggered##3##2##(1995-2#1)(2008-11#1)(2012-2#1)
apoptosis was observed##2##3##(2008-11#1)(2008-9#1)
apoptosis was##13##2##(1995-2#2)(2008-10#2)(2008-11#4)(2008-9#1)(2011-2#2)(2011-3#1)(2012-2#1)
apoptosis were##2##2##(2008-10#1)(2008-11#1)
apoptosis when##5##2##(1993-8#1)(1995-2#1)(2009-12#2)(2009-9#1)
apoptosis which is##2##3##(1993-3#1)(2008-11#1)
apoptosis within 24 h##2##4##(2008-7#1)(2008-9#1)
apoptosis##437##1##(1993-2#4)(1993-3#4)(1993-8#6)(1994-11#6)(1994-3#1)(1994-9#4)(1995-12#3)(1995-2#17)(1995-6#3)(1995-8#3)(1996-12#3)(1996-2#1)(1997-7#4)(1997-8#3)(2008-10#28)(2008-11#93)(2008-12#8)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#18)(2008-8#30)(2008-9#41)(2009-1#1)(2009-10#1)(2009-12#8)(2009-3#5)(2009-4#5)(2009-6#1)(2009-8#2)(2009-9#7)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#35)(2011-3#2)(2012-12#1)(2012-2#16)(2012-3#7)(2012-4#3)(2013-1#19)(2013-7#6)(2013-8#3)
apoptosis)##5##1##(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
apoptosis-inducing activity##3##2##(2008-11#2)(2008-9#1)
apoptosis-inducing gene##3##2##(2008-8#2)(2008-9#1)
apoptosis-inducing ligand (TRAIL)##3##3##(2009-3#2)(2012-2#1)
apoptosis-inducing ligand##4##2##(2009-3#2)(2012-2#2)
apoptosis-inducing##12##1##(2008-11#2)(2008-8#2)(2008-9#2)(2009-3#3)(2011-2#1)(2012-2#2)
apoptosis-related genes##2##2##(2008-9#1)(2010-11#1)
apoptosis-related##3##1##(2008-9#2)(2010-11#1)
apoptotic bodies##8##2##(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
apoptotic cell death in##4##4##(2008-11#2)(2008-7#1)(2011-2#1)
apoptotic cell death of##2##4##(1995-8#1)(2008-8#1)
apoptotic cell death##15##3##(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#3)(2012-2#2)
apoptotic cell##17##2##(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#3)(2012-2#2)
apoptotic cells by##2##3##(1995-2#1)(2008-12#1)
apoptotic cells##24##2##(1995-12#1)(1995-2#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-8#1)(2008-9#5)(2010-1#3)(2011-2#1)
apoptotic changes in##2##3##(2008-10#1)(2008-7#1)
apoptotic changes##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
apoptotic death##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
apoptotic effects of##3##3##(1995-2#1)(2008-11#1)(2011-2#1)
apoptotic nuclei##2##2##(2008-7#1)(2008-8#1)
apoptotic pathway##7##2##(2008-9#1)(2009-12#2)(2009-9#1)(2010-11#1)(2011-2#2)
apoptotic signal##2##2##(2008-11#1)(2008-9#1)
apoptotic signals##2##2##(2008-11#1)(2010-3#1)
apoptotic stimuli##2##2##(2008-11#1)(2008-9#1)
apoptotic suppressor gene##2##3##(1997-9#2)
apoptotic##103##1##(1995-12#2)(1995-2#6)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#1)(1997-9#3)(2008-10#5)(2008-11#15)(2008-12#4)(2008-5#1)(2008-7#9)(2008-8#4)(2008-9#14)(2009-12#3)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#9)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
aposklesis##3##1##(2008-7#3)
apothecia as##2##2##(2008-10#2)
apothecia developed##2##2##(2008-10#2)
apothecia from##2##2##(2008-10#2)
apothecia in##2##2##(2008-10#2)
apothecia of T##2##3##(2008-10#2)
apothecia of##4##2##(2008-10#4)
apothecia produced##2##2##(2008-10#2)
apothecia were##4##2##(2008-10#4)
apothecia##41##1##(2008-10#41)
apothecial emergence##2##2##(2008-10#2)
apothecial##5##1##(2008-10#5)
apotheosis##2##1##(2009-10#2)
appalling##3##1##(1995-6#1)(2009-10#2)
apparatus and##5##2##(1992-12#1)(1997-3#1)(2009-3#1)(2010-8#1)(2012-6#1)
apparatus as##3##2##(2008-10#2)(2008-11#1)
apparatus for##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
apparatus in##3##2##(2008-11#2)(2008-8#1)
apparatus is##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
apparatus of##2##2##(1990-5#1)(1997-3#1)
apparatus or##2##2##(1990-5#1)(1995-5#1)
apparatus to##2##2##(1990-2#1)(2008-7#1)
apparatus was##4##2##(1990-2#1)(2008-10#3)
apparatus were##2##2##(2008-10#2)
apparatus##99##1##(1990-12#1)(1990-2#3)(1990-5#3)(1991-5#1)(1992-1#1)(1992-12#1)(1993-2#1)(1995-12#2)(1995-5#1)(1996-2#1)(1997-3#2)(1997-6#1)(2007-12#3)(2008-10#32)(2008-11#10)(2008-12#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#5)(2011-2#3)(2012-2#4)(2012-6#1)
apparent K(m) for##4##3##(2008-7#4)
apparent K(m)##8##2##(1997-2#1)(2008-7#7)
apparent Km for##3##3##(1990-11#2)(1990-2#1)
apparent Km values##2##3##(1990-10#1)(1995-8#1)
apparent Km##6##2##(1990-10#1)(1990-11#2)(1990-2#1)(1995-8#1)(2008-11#1)
apparent activation energy##2##3##(1992-3#2)
apparent activation##3##2##(1990-12#1)(1992-3#2)
apparent affinity##2##2##(1993-6#2)
apparent after##2##2##(2008-5#1)(2010-5#1)
apparent association##2##2##(2008-10#1)(2008-8#1)
apparent binding constants##3##3##(2008-10#3)
apparent binding##5##2##(1991-5#1)(1997-2#1)(2008-10#3)
apparent change in the##2##4##(1994-8#1)(2013-8#1)
apparent change##3##2##(1994-8#1)(2008-11#1)(2013-8#1)
apparent changes in##3##3##(1996-12#1)(1997-2#1)(2008-11#1)
apparent changes##4##2##(1996-12#1)(1997-2#1)(2008-11#1)(2008-5#1)
apparent competition##6##2##(2008-8#1)(2008-9#5)
apparent complexation constants##2##3##(2008-10#2)
apparent coordination##2##2##(2008-10#1)(2008-9#1)
apparent diffusion coefficient##5##3##(2008-10#2)(2009-11#2)(2010-12#1)
apparent diffusion##6##2##(2008-10#3)(2009-11#2)(2010-12#1)
apparent discrepancies##2##2##(1990-6#1)(2013-8#1)
apparent dissociation constant of##2##4##(1996-3#1)(2008-9#1)
apparent dissociation constant##5##3##(1990-11#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-9#1)
apparent dissociation constants##2##3##(1991-5#1)(2008-10#1)
apparent dissociation##7##2##(1990-11#1)(1991-5#1)(1993-8#1)(1996-3#1)(2008-10#2)(2008-9#1)
apparent effect on##2##3##(1993-8#1)(1995-2#1)
apparent effect##3##2##(1993-8#1)(1995-2#1)(2008-9#1)
apparent effects##2##2##(2008-11#2)
apparent for##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
apparent from##2##2##(1996-2#1)(2008-10#1)
apparent heterogeneous electron transfer rate##2##5##(2008-10#2)
apparent heterogeneous##3##2##(2008-10#3)
apparent in the##5##3##(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
apparent in##10##2##(1991-6#1)(1993-8#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)
apparent increase in##5##3##(1991-12#1)(1991-9#1)(1995-5#1)(2008-10#2)
apparent molar absorption coefficient##2##4##(2008-10#2)
apparent molar absorptivity is 1##2##5##(2008-10#2)
apparent molar absorptivity is##6##4##(2008-10#6)
apparent molar absorptivity of##4##4##(2008-10#4)
apparent molar absorptivity##12##3##(2008-10#12)
apparent molar##17##2##(2008-10#17)
apparent molecular mass of##7##4##(1990-5#1)(1992-10#1)(1993-8#1)(1995-6#2)(1996-12#1)(1997-2#1)
apparent molecular mass##9##3##(1990-5#1)(1992-10#1)(1993-8#1)(1994-3#1)(1995-6#2)(1996-12#1)(1997-2#1)(2008-10#1)
apparent molecular masses of##2##4##(1990-5#1)(2008-10#1)
apparent molecular masses##3##3##(1990-5#1)(1997-2#1)(2008-10#1)
apparent molecular weight of##3##4##(1992-6#1)(1992-7#1)(1997-2#1)
apparent molecular weight##8##3##(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1994-8#1)(1997-2#1)(2008-11#2)
apparent molecular weights of##2##4##(1990-5#1)(1997-7#1)
apparent molecular##23##2##(1990-5#3)(1991-5#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-6#2)(1996-12#1)(1997-2#3)(1997-7#1)(2008-10#3)(2008-11#2)
apparent over the##2##3##(2008-10#1)(2012-3#1)
apparent paradox##3##2##(1994-11#1)(2008-5#1)(2008-9#1)
apparent recovery##2##2##(2008-10#2)
apparent relationship between##2##3##(2008-11#1)(2011-2#1)
apparent relationship##3##2##(2008-11#2)(2011-2#1)
apparent similarity##3##2##(1995-8#1)(1996-6#1)(2008-10#1)
apparent that the##4##3##(2006-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
apparent that##18##2##(1994-1#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2011-1#2)(2013-1#1)
apparent viscosity and##3##3##(2008-5#2)(2011-2#1)
apparent viscosity##5##2##(2008-5#4)(2011-2#1)
apparent##330##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#6)(1990-6#5)(1990-9#1)(1991-10#1)(1991-12#4)(1991-5#4)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#3)(1993-6#2)(1993-8#6)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#8)(1997-3#3)(1997-7#1)(1997-8#2)(2006-6#1)(2008-1#4)(2008-10#107)(2008-11#21)(2008-12#2)(2008-3#2)(2008-5#12)(2008-6#1)(2008-7#14)(2008-8#8)(2008-9#18)(2009-11#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#4)(2013-8#2)
apparently by##2##2##(1995-6#1)(2013-1#1)
apparently developed##2##2##(1997-8#1)(2008-10#1)
apparently does not##2##3##(1993-8#1)(1995-6#1)
apparently had##2##2##(1993-11#1)(1994-5#1)
apparently healthy adults##2##3##(2008-7#1)(2012-2#1)
apparently healthy##8##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-2#1)
apparently no##2##2##(1993-12#1)(2013-8#1)
apparently normal##2##2##(1993-12#2)
apparently not##4##2##(1991-10#1)(1991-12#1)(1991-8#1)(2008-10#1)
apparently paradoxical##2##2##(1997-1#1)(2013-1#1)
apparently unrelated##4##2##(1992-6#1)(2008-10#1)(2008-8#1)(2010-12#1)
apparently was not##2##3##(1992-3#1)(2008-10#1)
apparently was##3##2##(1992-3#1)(1997-3#1)(2008-10#1)
apparently without##3##2##(1995-6#1)(2008-5#1)(2010-4#1)
apparently##116##1##(1990-11#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-11#2)(1993-12#3)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#2)
appeal for##2##2##(2008-8#1)(2012-2#1)
appeal to the##3##3##(1991-2#1)(1996-5#1)(2012-2#1)
appeal to##5##2##(1991-2#1)(1996-5#1)(2012-2#2)(2013-1#1)
appeal##16##1##(1990-2#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-5#1)(1995-6#1)(1996-5#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#3)(2013-1#1)
appealing to##2##2##(2011-2#1)(2013-1#1)
appealing##10##1##(2008-10#2)(2008-11#2)(2008-8#2)(2010-4#1)(2011-2#1)(2013-1#2)
appeals court agreed##2##3##(1995-12#1)(1996-5#1)
appeals court##8##2##(1995-12#3)(1995-6#3)(1996-5#2)
appeals##11##1##(1995-12#3)(1995-6#4)(1996-5#2)(2010-12#1)(2010-8#1)
appear as##8##2##(1991-11#1)(1991-3#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
appear at##3##2##(2008-11#1)(2009-10#1)(2010-8#1)
appear clinically##2##2##(2008-11#1)(2010-6#1)
appear in the##7##3##(1993-2#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)
appear in##17##2##(1990-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#2)
appear more##3##2##(1993-12#2)(2010-12#1)
appear morphologically##3##2##(2008-10#1)(2011-2#2)
appear normal##2##2##(1991-7#1)(2008-10#1)
appear particularly##2##2##(2008-10#1)(2008-4#1)
appear promising##3##2##(1991-1#2)(2008-7#1)
appear related to##2##3##(2008-10#1)(2009-10#1)
appear similar to##2##3##(2008-10#1)(2008-4#1)
appear that##4##2##(1991-11#1)(1991-12#1)(1997-2#1)(2011-2#1)
appear to be a##3##4##(1995-1#1)(2008-10#1)(2008-8#1)
appear to be associated with##2##5##(1995-6#1)(2013-1#1)
appear to be derived from##2##5##(1994-3#1)(2008-10#1)
appear to be dominated by##2##5##(1992-9#1)(2011-2#1)
appear to be in##2##4##(1996-12#1)(2009-6#1)
appear to be involved in the##2##6##(2008-10#2)
appear to be involved in##3##5##(2008-10#3)
appear to be involved##5##4##(2008-10#4)(2010-5#1)
appear to be of##3##4##(2008-10#1)(2008-7#1)(2010-3#1)
appear to be required##2##4##(2008-10#1)(2010-5#1)
appear to be the##2##4##(2008-10#1)(2008-7#1)
appear to be##83##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#19)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#7)(2008-8#5)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
appear to change##2##3##(1991-12#1)(2008-5#1)
appear to disrupt##2##3##(1990-7#1)(1994-9#1)
appear to have a##3##4##(1991-11#1)(2008-12#1)(2008-8#1)
appear to have the##2##4##(2008-11#1)(2008-8#1)
appear to have##20##3##(1990-11#1)(1990-3#1)(1991-11#1)(1993-6#1)(1995-1#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
appear to improve##2##3##(2007-11#1)(2013-7#1)
appear to involve a##2##4##(1992-9#1)(1994-5#1)
appear to offer##2##3##(2008-10#1)(2008-11#1)
appear to represent a##3##4##(1991-2#1)(2008-7#1)(2011-2#1)
appear to result from##2##4##(2008-11#2)
appear to result##4##3##(1997-1#1)(2008-11#2)(2012-3#1)
appear to underlie##2##3##(1995-8#1)(2010-2#1)
appear to##180##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#29)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#10)(2008-8#9)(2008-9#6)(2009-10#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
appear##281##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-9#3)(1995-1#4)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#46)(2008-11#19)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#15)(2008-8#9)(2008-9#10)(2009-10#5)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#3)(2010-8#2)(2011-2#15)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#4)
appearance and behavior##2##3##(2008-11#2)
appearance and the##3##3##(1996-3#1)(1997-8#1)(2008-12#1)
appearance and##19##2##(1992-12#1)(1993-12#1)(1996-3#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
appearance for##3##2##(1996-11#1)(2008-11#1)(2012-3#1)
appearance in a##2##3##(2008-10#1)(2012-3#1)
appearance in the##2##3##(2008-12#1)(2008-7#1)
appearance in##7##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
appearance is##3##2##(1996-6#1)(2008-5#1)(2011-2#1)
appearance of a##11##3##(1992-10#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)(2012-3#1)
appearance of new##3##3##(2008-10#3)
appearance of the##24##3##(1991-6#1)(1992-6#1)(1993-12#1)(1994-11#2)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-6#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
appearance of these##3##3##(2008-11#2)(2012-2#1)
appearance of##108##2##(1990-10#1)(1990-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-6#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#5)(2013-1#3)
appearance on##3##2##(1991-11#1)(2008-10#1)(2010-6#1)
appearance self-concept##2##2##(2009-7#2)
appearance time of##2##3##(2008-10#2)
appearance was##3##2##(1993-6#1)(1997-8#1)(2010-6#1)
appearance with##4##2##(1990-8#1)(1990-9#1)(2010-6#1)(2013-1#1)
appearance##203##1##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-10#1)(1992-12#4)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-6#2)(1994-11#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#5)(2007-12#2)(2008-1#1)(2008-10#49)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#10)(2008-6#4)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#8)(2013-1#6)(2013-8#1)
appearance)##2##1##(2008-10#1)(2011-2#1)
appearances of the##4##3##(1997-8#2)(2012-2#2)
appearances of##9##2##(1991-8#1)(1997-8#2)(2008-1#1)(2008-7#1)(2012-2#3)(2013-8#1)
appearances##15##1##(1991-8#1)(1997-8#2)(2008-1#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#6)(2013-8#1)
appeared and##2##2##(2008-10#1)(2008-9#1)
appeared as a##4##3##(2008-10#2)(2008-5#1)(2012-3#1)
appeared as the##2##3##(2008-9#1)(2011-2#1)
appeared as##16##2##(1990-5#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
appeared at the##2##3##(2008-5#1)(2011-2#1)
appeared at##9##2##(1993-8#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2011-3#1)
appeared from##2##2##(1997-3#1)(2008-7#1)
appeared highly##3##2##(2008-10#2)(2008-9#1)
appeared in a##2##3##(1995-3#1)(2013-8#1)
appeared in the##6##3##(1990-3#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
appeared in##22##2##(1990-3#2)(1992-2#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
appeared more##3##2##(1995-8#1)(2008-10#1)(2012-12#1)
appeared necrotic##2##2##(2008-10#2)
appeared not to be##2##4##(1992-12#1)(2008-5#1)
appeared not##3##2##(1992-12#1)(1994-8#1)(2008-5#1)
appeared on the##3##3##(2008-10#3)
appeared on##5##2##(1993-12#1)(2008-10#3)(2008-5#1)
appeared only##2##2##(1994-6#1)(1996-2#1)
appeared similar to that##2##4##(2008-10#1)(2008-7#1)
appeared similar to##3##3##(1996-12#1)(2008-10#1)(2008-7#1)
appeared similar##4##2##(1996-12#1)(2008-10#2)(2008-7#1)
appeared suddenly##2##2##(2008-5#1)(2010-7#1)
appeared that the##8##3##(1993-8#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-3#1)
appeared that##9##2##(1993-8#1)(1995-9#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-3#1)
appeared to affect the##2##4##(1990-5#1)(2008-11#1)
appeared to arise##2##3##(1990-6#1)(2008-5#1)
appeared to be a sensitive##2##5##(1994-8#1)(2008-5#1)
appeared to be a useful##2##5##(1995-11#1)(2008-10#1)
appeared to be a##16##4##(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(2008-10#7)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)
appeared to be associated with##2##5##(2008-10#2)
appeared to be due##2##4##(2008-8#1)(2011-2#1)
appeared to be mainly##2##4##(2008-10#1)(2008-11#1)
appeared to be no##2##4##(1992-11#1)(2008-12#1)
appeared to be related to##3##5##(2008-10#2)(2008-8#1)
appeared to be stimulatory##2##4##(1993-12#2)
appeared to be the##2##4##(1994-3#1)(2008-10#1)
appeared to be##75##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-8#1)(1994-11#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1997-1#1)(1997-7#1)(2008-10#30)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
appeared to contain##3##3##(1993-6#1)(1997-3#1)(2008-10#1)
appeared to have a##2##4##(2009-3#1)(2012-2#1)
appeared to have had##2##4##(1995-8#1)(1996-1#1)
appeared to have##11##3##(1990-2#1)(1994-8#1)(1995-8#1)(1996-1#1)(2008-11#2)(2009-3#1)(2009-4#1)(2011-2#2)(2012-2#1)
appeared to induce##2##3##(1993-3#1)(2008-11#1)
appeared to label##2##3##(2007-12#2)
appeared to lose the ability to##2##6##(2008-10#2)
appeared to remain##2##3##(1996-6#1)(2008-10#1)
appeared to##145##2##(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#48)(2008-11#17)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-8#2)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
appeared when##3##2##(1992-3#1)(2008-12#1)(2008-5#1)
appeared with##2##2##(2008-11#2)
appeared##297##1##(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#3)(1990-8#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#5)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-12#2)(2008-10#102)(2008-11#26)(2008-12#3)(2008-4#1)(2008-5#17)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#2)(2013-8#5)
appearing as##2##2##(2007-12#1)(2009-6#1)
appearing at##2##2##(2008-10#1)(2008-9#1)
appearing in##7##2##(1995-3#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
appearing##29##1##(1992-2#1)(1995-3#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#3)(2011-7#1)(2013-1#1)
appears as a##5##3##(1991-12#1)(1995-12#1)(2008-10#3)
appears as##8##2##(1990-11#1)(1991-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)
appears at##2##2##(1993-8#1)(2008-10#1)
appears beneficial##2##2##(2008-10#1)(2011-2#1)
appears in##8##2##(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-9#2)(2010-5#1)
appears less##2##2##(1992-2#1)(1996-11#1)
appears more##3##2##(2006-6#1)(2011-2#1)(2012-2#1)
appears not to##2##3##(1995-11#1)(2009-8#1)
appears that the##16##3##(1991-6#1)(1992-6#2)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)(2013-1#1)
appears that this##2##3##(2008-6#1)(2012-2#1)
appears that##49##2##(1990-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-9#1)(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
appears to be a novel##2##5##(2008-10#1)(2011-2#1)
appears to be a##33##4##(1990-2#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1996-1#1)(1997-3#1)(2008-10#8)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
appears to be an important##3##5##(1990-12#1)(1993-2#1)(2008-9#1)
appears to be an##8##4##(1990-12#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
appears to be as##2##4##(1996-1#1)(2008-5#1)
appears to be associated with##2##5##(1993-8#1)(1994-12#1)
appears to be decreased##2##4##(2012-2#2)
appears to be feasible##2##4##(2008-11#1)(2008-3#1)
appears to be in##2##4##(1995-12#1)(2007-12#1)
appears to be inconsistent##2##4##(2008-10#1)(2008-12#1)
appears to be increasing##2##4##(2011-2#1)(2013-8#1)
appears to be involved in the##3##6##(1994-2#1)(2008-1#1)(2011-2#1)
appears to be involved in##5##5##(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
appears to be more##3##4##(1990-9#1)(2008-10#1)(2008-5#1)
appears to be no##2##4##(2008-7#1)(2013-1#1)
appears to be of##3##4##(1992-1#1)(2008-10#1)(2013-1#1)
appears to be regulated by##2##5##(1997-1#1)(2008-10#1)
appears to be related to##2##5##(1997-1#1)(2008-3#1)
appears to be similar##2##4##(1995-5#2)
appears to be the best##2##5##(1994-5#1)(2008-7#1)
appears to be the most##4##5##(1990-5#1)(2009-11#1)(2009-12#1)(2009-8#1)
appears to be the##13##4##(1990-5#2)(1991-3#1)(1994-5#1)(1995-2#1)(2008-10#4)(2008-7#1)(2009-11#1)(2009-12#1)(2009-8#1)
appears to be##153##3##(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-1#3)(1992-10#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#2)(1997-1#4)(1997-2#2)(1997-3#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#32)(2008-11#8)(2008-12#3)(2008-3#4)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
appears to correlate with##2##4##(2008-10#1)(2011-2#1)
appears to exhibit##2##3##(2008-12#1)(2009-12#1)
appears to function##2##3##(1993-12#1)(2008-10#1)
appears to have a##2##4##(1996-2#1)(2009-7#1)
appears to have been##3##4##(1990-3#1)(1994-12#1)(2008-9#1)
appears to have occurred##2##4##(1995-2#1)(2009-8#1)
appears to have##19##3##(1990-3#1)(1991-7#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-8#1)
appears to play a##5##4##(1990-5#1)(1992-10#1)(1994-2#1)(2008-10#1)(2012-2#1)
appears to play##6##3##(1990-5#1)(1992-10#1)(1992-8#1)(1994-2#1)(2008-10#1)(2012-2#1)
appears to represent a##2##4##(1991-12#1)(2008-10#1)
appears to require##2##3##(1995-6#1)(2008-7#1)
appears to##230##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#2)(1991-3#2)(1991-4#1)(1991-7#1)(1992-1#3)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-5#2)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#3)(1995-5#3)(1995-6#3)(1996-1#2)(1996-12#1)(1996-2#3)(1997-1#4)(1997-2#4)(1997-3#3)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#43)(2008-11#14)(2008-12#5)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#12)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-2#8)(2012-3#3)(2013-1#7)(2013-8#2)
appears##348##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#5)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#3)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#2)(1992-1#3)(1992-10#2)(1992-12#1)(1992-2#4)(1992-3#5)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#3)(1993-2#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-5#2)(1994-8#3)(1995-11#4)(1995-12#2)(1995-2#3)(1995-5#3)(1995-6#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#5)(1997-2#6)(1997-3#4)(1997-8#4)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#68)(2008-11#21)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#16)(2008-8#6)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#13)(2011-7#1)(2012-12#1)(2012-2#12)(2012-3#3)(2013-1#11)(2013-8#3)
appendage##6##1##(2007-12#1)(2008-11#2)(2008-7#1)(2010-12#1)(2011-2#1)
appendages in##2##2##(2007-12#1)(2011-2#1)
appendages##10##1##(2007-12#3)(2008-8#3)(2011-2#3)(2012-3#1)
appendectomies##2##1##(1992-2#2)
appendectomy##14##1##(1991-1#1)(1991-8#1)(1992-2#2)(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#4)(2011-2#2)(2012-12#1)
appendiceal neoplasm##2##2##(2011-2#2)
appendiceal##10##1##(1990-3#1)(2008-12#2)(2009-7#1)(2011-2#6)
appendicitis##8##1##(1992-2#1)(1993-6#2)(1997-8#3)(2008-12#1)(2011-2#1)
appendicular##6##1##(1991-11#1)(2007-12#3)(2011-2#2)
appendix and##2##2##(1997-8#2)
appendix presents##2##2##(1991-2#1)(2008-4#1)
appendix was##2##2##(1993-6#1)(2009-7#1)
appendix##32##1##(1991-2#1)(1992-2#1)(1993-6#1)(1997-8#4)(2008-10#2)(2008-12#6)(2008-4#3)(2008-9#4)(2009-7#5)(2011-2#4)(2012-3#1)
appetite and feeding problems in##2##5##(2011-1#2)
appetite and##4##2##(2011-1#2)(2011-2#1)(2013-8#1)
appetite regulation##3##2##(2009-8#3)
appetite##17##1##(1997-4#1)(1997-8#1)(2008-4#1)(2008-7#1)(2009-8#4)(2011-1#2)(2011-2#4)(2013-8#3)
appetitive##2##1##(2008-4#2)
apple (Malus domestica##2##3##(2008-9#2)
apple (Malus domestica)##2##3##(2008-10#1)(2009-8#1)
apple (Malus##4##2##(2008-10#1)(2008-9#2)(2009-8#1)
apple and pear##2##3##(2008-10#2)
apple and##6##2##(2008-10#6)
apple blossoms##6##2##(2008-10#6)
apple caused by the##2##4##(2008-10#2)
apple cultivars were##2##3##(2008-10#2)
apple cultivars##7##2##(2008-10#5)(2011-10#2)
apple cv##2##2##(2008-10#2)
apple domains##2##2##(2009-7#2)
apple flowers were##3##3##(2008-10#3)
apple flowers##4##2##(2008-10#4)
apple fruit against##2##3##(2008-10#2)
apple fruit##8##2##(2008-10#6)(2008-9#2)
apple fruits##5##2##(2008-10#4)(2008-9#1)
apple growth in##5##3##(2008-10#5)
apple in the##2##3##(2008-10#2)
apple in##7##2##(2008-10#7)
apple juice##5##2##(2008-10#5)
apple juices by##2##3##(2008-10#2)
apple leaves##7##2##(2008-10#7)
apple orchards##4##2##(2008-10#4)
apple pectin##5##2##(1990-9#2)(2008-10#3)
apple pomace##3##2##(1997-2#3)
apple proliferation phytoplasma##3##3##(2008-10#3)
apple proliferation##5##2##(2008-10#5)
apple replant disease##8##3##(2008-10#8)
apple root infection by##3##4##(2008-10#3)
apple roots##4##2##(2008-10#4)
apple samples##2##2##(2008-10#2)
apple scab##7##2##(2008-10#7)
apple seedling##2##2##(2008-10#2)
apple seedlings grown in##4##4##(2008-10#4)
apple seedlings##9##2##(2008-10#9)
apple sooty blotch##3##3##(2008-10#3)
apple stem##3##2##(2008-10#3)
apple tissue##5##2##(2008-10#5)
apple trees in the##2##4##(2008-10#2)
apple trees in##4##3##(2008-10#4)
apple trees infected with##2##4##(2008-10#2)
apple trees##17##2##(2008-10#17)
apple varieties##4##2##(2008-10#4)
apple was perceived as##2##4##(1996-2#2)
apple was##5##2##(1996-2#2)(2008-10#3)
apple wounds by##2##3##(2008-10#2)
apple wounds##5##2##(2008-10#5)
apple##229##1##(1990-9#2)(1996-2#2)(1997-2#3)(2008-10#207)(2008-11#2)(2008-8#1)(2008-9#5)(2009-7#2)(2009-8#1)(2011-10#4)
apple)##2##1##(2008-10#2)
apples and##2##2##(2008-10#1)(2008-8#1)
apples treated with##2##3##(2008-10#2)
apples were##2##2##(2008-10#2)
apples##28##1##(2008-10#26)(2008-12#1)(2008-8#1)
appliance##4##1##(2008-10#1)(2013-1#3)
appliances##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
applicability for##8##2##(1991-1#1)(1992-12#1)(2008-10#3)(2008-3#1)(2011-1#1)(2012-2#1)
applicability in the##2##3##(2008-10#1)(2012-3#1)
applicability in##9##2##(1991-12#1)(1995-2#1)(2007-11#1)(2008-10#4)(2010-12#1)(2012-3#1)
applicability of a##2##3##(2008-10#1)(2011-2#1)
applicability of the developed##3##4##(2008-10#3)
applicability of the method for##3##5##(2008-10#2)(2008-3#1)
applicability of the method was demonstrated by the##3##8##(2008-10#3)
applicability of the method was demonstrated by##4##7##(2008-10#4)
applicability of the method was##6##5##(2008-10#6)
applicability of the method##13##4##(2008-10#12)(2008-3#1)
applicability of the proposed method was##2##6##(2008-10#2)
applicability of the proposed method##4##5##(2008-10#4)
applicability of the proposed##7##4##(2008-10#7)
applicability of the##35##3##(2008-10#30)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#1)
applicability of these##3##3##(1993-12#1)(2010-11#1)(2013-8#1)
applicability of this method##3##4##(2008-10#3)
applicability of this##7##3##(1995-9#1)(2008-10#5)(2008-2#1)
applicability of##76##2##(1993-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-12#1)(2007-11#1)(2008-10#52)(2008-2#2)(2008-3#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#2)
applicability to real##2##3##(2008-10#2)
applicability to the##2##3##(2008-10#1)(2012-3#1)
applicability to##9##2##(2008-10#5)(2008-3#2)(2008-8#1)(2012-3#1)
applicability##114##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-11#2)(2008-10#69)(2008-2#3)(2008-3#7)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-6#2)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#2)
applicable across##2##2##(1991-2#1)(2008-10#1)
applicable also##2##2##(2008-7#1)(2009-5#1)
applicable concentration range##2##3##(2008-10#2)
applicable for routine##2##3##(2008-10#2)
applicable for the##7##3##(1993-9#1)(2008-10#5)(2008-4#1)
applicable for##27##2##(1993-9#1)(1995-3#1)(1996-3#1)(1996-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#2)(2011-2#1)(2012-2#2)
applicable in a##2##3##(2010-5#1)(2011-2#1)
applicable in the concentration range##2##5##(2008-10#2)
applicable in the##4##3##(1993-12#1)(2008-10#2)(2010-10#1)
applicable in##7##2##(1993-12#1)(2008-10#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
applicable target for##2##3##(2008-11#1)(2011-2#1)
applicable to a broad range of##2##6##(2008-11#1)(2008-8#1)
applicable to a##7##3##(2008-10#4)(2008-11#2)(2008-8#1)
applicable to automated##2##3##(2008-10#2)
applicable to in vitro##2##4##(2008-11#1)(2008-9#1)
applicable to many different##2##4##(2008-11#1)(2008-9#1)
applicable to many##4##3##(1994-3#1)(2008-11#1)(2008-8#1)(2008-9#1)
applicable to more##2##3##(2008-10#1)(2008-8#1)
applicable to other##7##3##(1993-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-2#1)
applicable to the analysis of##6##5##(2008-10#6)
applicable to the determination of##4##5##(2008-10#4)
applicable to the development of##2##5##(2008-1#1)(2011-1#1)
applicable to the study of##2##5##(1997-7#1)(2006-6#1)
applicable to the##26##3##(1991-12#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
applicable to##91##2##(1991-12#1)(1991-5#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-6#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#37)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#4)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)
applicable##161##1##(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#65)(2008-11#16)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#8)(2008-9#4)(2009-10#2)(2009-12#2)(2009-5#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#2)
applicant##6##1##(1991-11#1)(1991-12#1)(1993-1#3)(2010-12#1)
applicants for##2##2##(1991-11#1)(1994-9#1)
applicants to##2##2##(1992-3#1)(1993-2#1)
applicants##14##1##(1991-11#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-1#4)(1997-3#1)(2012-2#2)
application and##9##2##(1996-5#1)(2008-10#4)(2008-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
application are##4##2##(1997-7#1)(2008-10#1)(2010-9#1)(2013-1#1)
application as a##6##3##(2008-10#5)(2008-5#1)
application as##15##2##(1992-3#1)(1997-6#1)(2008-10#10)(2008-5#1)(2013-1#2)
application at##3##2##(1992-2#1)(2008-10#1)(2011-1#1)
application conditions##2##2##(2008-5#2)
application for determination of##3##4##(2008-10#3)
application for the determination of##3##5##(2008-10#3)
application for the##9##3##(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)
application for##34##2##(2008-10#20)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-3#1)(2013-1#2)
application has been##2##3##(2008-12#1)(2008-9#1)
application have##2##2##(1993-11#1)(2008-11#1)
application in a##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
application in the determination of##3##5##(2008-10#3)
application in the separation##2##4##(2008-10#2)
application in the##24##3##(1990-2#1)(1991-5#1)(1993-2#1)(1997-6#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-7#1)(2011-2#1)
application in##86##2##(1990-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-3#2)(1997-1#1)(1997-6#1)(2008-10#40)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-6#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
application is##9##2##(1992-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-10#1)
application of 1##2##3##(1997-3#1)(2008-12#1)
application of 12-O-tetradecanoylphorbol-13-acetate##2##3##(1992-8#2)
application of 2##3##3##(2008-12#2)(2011-2#1)
application of SA##2##3##(2008-10#2)
application of a problem-solving approach##2##5##(1993-2#2)
application of a##48##3##(1992-2#1)(1993-2#2)(1994-8#1)(1995-11#1)(1995-5#1)(1995-9#1)(2008-10#26)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#2)(2008-9#2)(2011-2#1)(2011-3#2)
application of ammonium molybdate##2##4##(2008-10#2)
application of an electric field##2##5##(2007-11#1)(2008-11#1)
application of an##15##3##(1993-3#1)(1997-1#1)(2007-11#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-10#1)
application of both##6##3##(1996-12#1)(2008-10#5)
application of broad-spectrum##2##3##(2008-10#1)(2008-7#1)
application of chemometrics##2##3##(2008-10#2)
application of data mining##2##4##(2008-9#2)
application of data##4##3##(1992-2#1)(2008-10#1)(2008-9#2)
application of different##4##3##(2008-10#3)(2010-3#1)
application of either##2##3##(2010-7#1)(2013-1#1)
application of evolved gas analysis-mass spectrometry (EGA-MS) with##2##8##(2008-10#2)
application of flow cytometry##2##4##(2008-9#2)
application of flow##3##3##(2008-10#1)(2008-9#2)
application of fungicide##2##3##(2008-10#2)
application of fungicides##2##3##(2008-10#2)
application of high-performance##2##3##(2008-10#2)
application of insecticides##2##3##(1997-7#1)(2008-11#1)
application of iprodione##3##3##(2008-10#3)
application of it##3##3##(1996-6#1)(2008-10#2)
application of neutral fluoride gel##2##5##(2013-1#2)
application of our##3##3##(1997-1#1)(2008-8#1)(2013-1#1)
application of pendimethalin at##2##4##(2011-1#2)
application of polymer##2##3##(2008-10#1)(2010-7#1)
application of putrescine##2##3##(2011-2#2)
application of small##3##3##(1990-5#1)(2008-10#1)(2010-3#1)
application of solid##2##3##(2008-10#2)
application of standard##2##3##(2008-11#1)(2008-4#1)
application of the analytical##2##4##(2008-10#1)(2008-3#1)
application of the method to the##2##6##(2008-10#2)
application of the method to##3##5##(2008-10#2)(2008-3#1)
application of the method##7##4##(2008-10#6)(2008-3#1)
application of the new##3##4##(1992-9#1)(2008-10#1)(2008-7#1)
application of the pathogen##2##4##(2008-10#2)
application of the proposed method to##2##6##(2008-10#2)
application of the proposed method##3##5##(2008-10#3)
application of the proposed##5##4##(2008-10#5)
application of the same##2##4##(2008-11#2)
application of the##103##3##(1990-12#1)(1990-9#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#50)(2008-11#8)(2008-12#1)(2008-3#9)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#4)
application of these methods to##2##5##(2008-10#1)(2008-8#1)
application of these methods##3##4##(2008-10#2)(2008-8#1)
application of these models##2##4##(2008-5#1)(2008-8#1)
application of these techniques to##4##5##(2008-3#2)(2008-8#1)(2010-9#1)
application of these##21##3##(1991-12#1)(1992-3#1)(1994-11#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#3)(2010-9#1)(2012-2#1)
application of this approach##2##4##(1994-5#1)(2010-11#1)
application of this methodology##3##4##(2008-10#2)(2009-8#1)
application of this technique in##2##5##(2008-5#1)(2013-1#1)
application of this technique##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
application of this##32##3##(1994-5#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#2)(2011-2#2)(2012-3#1)(2013-1#1)
application of treatments##2##3##(2008-10#2)
application of two##2##3##(2008-10#2)
application of ultrafiltration##2##3##(2008-10#2)
application of various##2##3##(2008-5#2)
application of##572##2##(1990-12#1)(1990-2#3)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#260)(2008-11#40)(2008-12#12)(2008-2#1)(2008-3#16)(2008-4#10)(2008-5#23)(2008-6#1)(2008-7#9)(2008-8#9)(2008-9#11)(2009-1#1)(2009-10#3)(2009-12#1)(2009-6#1)(2009-8#5)(2010-1#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#18)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#10)(2013-1#14)(2013-7#2)(2013-8#4)
application on the##2##3##(2008-10#1)(2008-5#1)
application on##8##2##(2008-10#3)(2008-12#3)(2008-5#2)
application process##2##2##(1996-3#1)(1997-1#1)
application range##4##2##(2008-10#2)(2008-3#2)
application rate##2##2##(2008-12#1)(2008-8#1)
application technique##2##2##(1994-9#1)(2008-5#1)
application that##2##2##(2008-12#1)(2008-9#1)
application thickness##2##2##(2008-5#2)
application times##4##2##(1992-12#1)(2008-5#1)(2012-3#2)
application to a##7##3##(1996-3#1)(2008-10#3)(2008-3#1)(2009-10#1)(2009-4#1)
application to amperometric detection of##2##5##(2008-10#2)
application to determination of##2##4##(2008-10#2)
application to environmental##2##3##(2008-10#1)(2011-2#1)
application to other##2##3##(2008-7#1)(2013-1#1)
application to spectrophotometric determination of##2##5##(2008-10#2)
application to the analysis of##3##5##(2008-10#3)
application to the determination of##9##5##(2008-10#9)
application to the direct##2##4##(2008-10#2)
application to the pulmonary##2##4##(1992-3#1)(2011-2#1)
application to the skin surface##2##5##(2008-5#2)
application to the study of##3##5##(2008-10#1)(2008-9#1)(2009-12#1)
application to the##36##3##(1990-2#1)(1992-3#1)(2008-10#23)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)
application to water samples##3##4##(2008-10#3)
application to##117##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-3#1)(1994-9#1)(1995-3#2)(1996-3#1)(2007-12#1)(2008-10#68)(2008-11#5)(2008-12#1)(2008-3#8)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#1)
application was 0##2##3##(2008-10#2)
application was##9##2##(2008-10#8)(2013-1#1)
application##1080##1##(1990-12#1)(1990-2#6)(1990-5#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1992-12#4)(1992-2#4)(1992-3#6)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#5)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#7)(1995-5#3)(1995-9#1)(1996-10#1)(1996-12#6)(1996-2#3)(1996-3#6)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#8)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#491)(2008-11#70)(2008-12#28)(2008-2#1)(2008-3#38)(2008-4#12)(2008-5#51)(2008-6#1)(2008-7#16)(2008-8#16)(2008-9#30)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#6)(2010-1#4)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#7)(2010-8#4)(2010-9#3)(2011-1#8)(2011-10#4)(2011-2#34)(2011-3#4)(2012-12#1)(2012-2#10)(2012-3#20)(2012-4#1)(2012-5#1)(2013-1#32)(2013-7#2)(2013-8#6)
application)##2##1##(2008-10#1)(2008-5#1)
applications and future##3##3##(2008-10#3)
applications and##19##2##(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-3#3)(2008-9#1)(2009-7#1)(2013-8#1)
applications are also##2##3##(2008-10#1)(2008-4#1)
applications are described##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
applications are##14##2##(1992-11#1)(1993-3#1)(1996-1#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
applications as a##2##3##(2008-10#1)(2012-2#1)
applications as##9##2##(2008-10#5)(2008-11#2)(2008-3#1)(2012-2#1)
applications based on##2##3##(2008-10#1)(2008-3#1)
applications discussed##2##2##(1997-6#1)(2008-10#1)
applications for the##4##3##(2008-10#2)(2008-9#1)(2012-2#1)
applications for##22##2##(1993-3#1)(1993-6#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-7#1)(2012-2#2)(2012-4#1)
applications has been##2##3##(1996-3#1)(1997-8#1)
applications has##3##2##(1996-3#1)(1997-8#1)(2013-1#1)
applications in a##2##3##(2008-10#1)(2008-2#1)
applications in both##2##3##(2008-5#1)(2011-7#1)
applications in cardiovascular##2##3##(2010-5#1)(2010-9#1)
applications in health##3##3##(1993-12#1)(1994-2#1)(1997-3#1)
applications in research##2##3##(2008-10#1)(2010-11#1)
applications in the##9##3##(1995-2#1)(2008-10#4)(2008-12#1)(2008-9#1)(2010-7#1)(2011-2#1)
applications in##73##2##(1992-12#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#2)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#1)
applications include##2##2##(2008-9#1)(2010-12#1)
applications including##2##2##(2008-10#1)(2010-4#1)
applications is##4##2##(2008-10#3)(2010-12#1)
applications of Pseudomonas putida 06909-rif/nal##6##5##(2008-10#6)
applications of Raman##2##3##(2008-10#1)(2009-12#1)
applications of a##4##3##(1991-2#1)(2008-10#3)
applications of electrogenerated chemiluminescence##2##4##(2008-10#2)
applications of molecular##2##3##(1997-7#1)(2010-9#1)
applications of protein##2##3##(1994-8#1)(2008-5#1)
applications of statistical##2##3##(1997-6#1)(2008-10#1)
applications of stripping##2##3##(2008-10#2)
applications of the fungicide metalaxyl and the nematicide phenamiphos##2##9##(2008-10#2)
applications of the##17##3##(1993-8#1)(1996-3#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-4#2)(2012-2#1)
applications of these##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
applications of this method##2##4##(1994-5#1)(2012-3#1)
applications of this##5##3##(1994-5#1)(2008-10#2)(2008-11#1)(2012-3#1)
applications of various##2##3##(2008-10#1)(2008-4#1)
applications of##132##2##(1990-7#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#62)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#4)(2009-12#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#3)(2012-2#4)(2012-3#3)(2013-1#6)
applications on##4##2##(1992-12#1)(2008-10#3)
applications only##2##2##(2008-10#1)(2008-3#1)
applications requiring##2##2##(2008-10#1)(2008-11#1)
applications such as##12##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-6#1)(2010-7#1)(2010-8#1)(2012-2#1)
applications that have##2##3##(2008-10#1)(2009-7#1)
applications that##7##2##(2008-10#3)(2009-12#1)(2009-7#1)(2012-2#1)(2013-1#1)
applications the##2##2##(2008-2#1)(2008-5#1)
applications to cancer##2##3##(2008-11#1)(2010-6#1)
applications to molecular##2##3##(2013-1#2)
applications to the analysis of##2##5##(2008-10#1)(2008-9#1)
applications to the##3##3##(2008-10#1)(2008-9#2)
applications to##23##2##(1992-12#1)(1994-9#2)(2007-11#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-6#1)(2012-2#1)(2013-1#3)
applications using##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
applications were##2##2##(1991-2#1)(2008-10#1)
applications when##2##2##(1991-2#1)(2008-10#1)
applications where the##2##3##(2008-10#1)(2010-4#1)
applications where##3##2##(2008-10#2)(2010-4#1)
applications which##2##2##(2008-10#1)(2011-2#1)
applications will##2##2##(2008-10#1)(2008-8#1)
applications with##2##2##(2008-10#2)
applications##618##1##(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#4)(1992-11#1)(1992-12#4)(1992-3#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#6)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#4)(1997-7#4)(1997-8#3)(2007-11#2)(2007-12#5)(2008-10#229)(2008-11#43)(2008-12#5)(2008-2#5)(2008-3#39)(2008-4#14)(2008-5#11)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#20)(2009-10#5)(2009-11#1)(2009-12#10)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#4)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#14)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#11)(2010-8#10)(2010-9#2)(2011-1#2)(2011-2#9)(2011-3#2)(2011-7#6)(2012-12#1)(2012-2#27)(2012-3#7)(2012-4#1)(2012-5#1)(2013-1#14)(2013-8#4)
applicator##6##1##(1992-1#2)(1996-3#1)(2009-11#1)(2011-2#1)(2013-1#1)
applicators##2##1##(2008-10#1)(2009-11#1)
applied 0##2##2##(2008-10#1)(2008-5#1)
applied a##5##2##(1993-2#1)(1996-3#1)(2008-10#2)(2010-6#1)
applied across a##2##3##(1990-8#1)(2008-10#1)
applied after##2##2##(2012-3#1)(2012-8#1)
applied alone##4##2##(2008-10#4)
applied also##3##2##(1990-9#1)(1995-5#1)(2008-10#1)
applied and found to##2##4##(2008-10#1)(2008-11#1)
applied and##12##2##(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2010-7#1)(2013-1#1)
applied as a spray##3##4##(2008-10#3)
applied as a##16##3##(2008-10#13)(2008-11#1)(2009-12#1)(2009-3#1)
applied as an analytical##2##4##(2008-10#2)
applied as an indicator electrode##3##5##(2008-10#3)
applied as an##7##3##(2008-10#5)(2008-11#1)(2008-6#1)
applied as the##2##3##(2008-10#2)
applied as##37##2##(2008-10#29)(2008-11#2)(2008-12#1)(2008-6#1)(2009-12#1)(2009-3#1)(2010-4#1)(2012-5#1)
applied at a rate of##2##5##(2008-10#2)
applied at a##4##3##(2008-10#3)(2008-12#1)
applied at different##4##3##(2008-10#2)(2012-8#1)(2013-1#1)
applied at the##6##3##(2008-10#5)(2008-8#1)
applied at##28##2##(2008-10#19)(2008-12#1)(2008-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-8#1)(2013-1#1)
applied before##5##2##(1992-2#1)(1997-4#1)(2008-10#3)
applied by##8##2##(2008-10#5)(2010-8#1)(2013-1#1)(2013-8#1)
applied current##10##2##(2008-10#8)(2009-10#1)(2009-12#1)
applied currents##2##2##(2008-10#1)(2009-12#1)
applied directly to##2##3##(2008-10#2)
applied directly##3##2##(2008-10#3)
applied during the##4##3##(2008-10#3)(2012-2#1)
applied during##7##2##(2008-10#3)(2008-11#1)(2008-4#2)(2012-2#1)
applied either##4##2##(2008-10#2)(2008-12#2)
applied electrical##2##2##(2009-5#1)(2010-1#1)
applied energy##3##2##(1993-1#3)
applied for a##3##3##(1990-2#1)(2008-10#2)
applied for analysis of##3##4##(2008-10#2)(2008-11#1)
applied for determination of##6##4##(2008-10#6)
applied for simultaneous determination of##3##5##(2008-10#3)
applied for simultaneous##4##3##(2008-10#3)(2008-2#1)
applied for studying##3##3##(2008-10#3)
applied for the analysis of##9##5##(2008-10#9)
applied for the determination of cobalt in synthetic mixtures##2##9##(2008-10#2)
applied for the determination of cobalt##3##6##(2008-10#3)
applied for the determination of nitrite##2##6##(2008-10#2)
applied for the determination of pyrimethamine##2##6##(2008-10#2)
applied for the determination of the##6##6##(1991-7#1)(2008-10#5)
applied for the determination of total##2##6##(2008-10#2)
applied for the determination of trace##3##6##(2008-10#3)
applied for the determination of##57##5##(1991-7#1)(2008-10#56)
applied for the direct determination of##2##6##(2008-10#2)
applied for the direct##3##4##(2008-10#3)
applied for the quantification of##2##5##(2008-10#1)(2009-8#1)
applied for the resolution of##2##5##(2008-10#2)
applied for the simultaneous determination of##4##6##(2008-10#4)
applied for the simultaneous spectrophotometric determination of##2##7##(2008-10#2)
applied for the simultaneous##6##4##(2008-10#6)
applied for the##113##3##(1991-7#1)(2008-10#109)(2008-11#1)(2009-6#1)(2009-8#1)
applied for##200##2##(1990-2#1)(1991-7#1)(1994-8#1)(1995-6#1)(2008-10#176)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#2)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
applied here##2##2##(2008-10#2)
applied in a##7##3##(2008-10#5)(2008-7#1)(2009-6#1)
applied in an##2##3##(2008-10#2)
applied in any##2##3##(2008-10#2)
applied in clinical##2##3##(2008-10#1)(2010-12#1)
applied in combination with##3##4##(2008-10#2)(2008-7#1)
applied in determination of##2##4##(2008-10#2)
applied in different##2##3##(2008-10#1)(2012-8#1)
applied in many##2##3##(2008-10#1)(2008-5#1)
applied in order to##5##4##(2008-10#3)(2008-5#1)(2012-2#1)
applied in pharmacokinetic study##2##4##(2011-3#2)
applied in pharmacokinetic##3##3##(2008-10#1)(2011-3#2)
applied in studies##3##3##(2008-10#3)
applied in the analysis of##2##5##(2008-10#2)
applied in the determination of##4##5##(2008-10#4)
applied in the##20##3##(1996-11#1)(1996-3#1)(2008-10#16)(2008-11#1)(2008-5#1)
applied in this##2##3##(2008-10#1)(2009-11#1)
applied in##96##2##(1994-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(2008-10#60)(2008-11#3)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-8#2)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#3)
applied method##2##2##(2008-10#1)(2008-11#1)
applied on the skin##2##4##(2008-5#1)(2011-3#1)
applied on the##12##3##(1996-1#1)(2008-10#4)(2008-5#4)(2010-8#1)(2011-3#1)(2013-1#1)
applied on##21##2##(1993-1#1)(1996-1#1)(1996-12#1)(2008-10#9)(2008-5#5)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
applied our##2##2##(2008-11#1)(2010-10#1)
applied over a##2##3##(1996-3#1)(2008-10#1)
applied over the range 0##2##5##(2008-10#2)
applied over the##4##3##(2008-10#2)(2008-9#1)(2009-1#1)
applied over##9##2##(1996-3#1)(2008-10#6)(2008-9#1)(2009-1#1)
applied potential and##2##3##(2008-10#2)
applied potential was##2##3##(2008-10#2)
applied potential##21##2##(2008-10#21)
applied public health##2##3##(1997-2#2)
applied quantity##2##2##(2008-5#2)
applied research##2##2##(2008-10#1)(2008-11#1)
applied satisfactorily to the determination of##8##6##(2008-10#8)
applied satisfactorily to the##10##4##(2008-10#10)
applied satisfactorily to##15##3##(2008-10#15)
applied satisfactorily##19##2##(2008-10#19)
applied simultaneously##2##2##(1991-3#1)(2008-10#1)
applied successfully for the determination of the##2##7##(2008-10#2)
applied successfully for the determination of##4##6##(2008-10#4)
applied successfully in##3##3##(2008-10#3)
applied successfully to determination of##2##5##(2008-10#2)
applied successfully to the analysis of##3##6##(2008-10#3)
applied successfully to the determination of trace##2##7##(2008-10#2)
applied successfully to the determination of##19##6##(2008-10#19)
applied successfully to the##24##4##(2008-10#24)
applied successfully to##30##3##(2008-10#29)(2008-11#1)
applied successfully##37##2##(2008-10#36)(2008-11#1)
applied tension##3##2##(2013-1#3)
applied the##12##2##(1992-2#1)(1992-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-12#1)
applied through##3##2##(2008-10#2)(2008-11#1)
applied to a system##2##4##(2008-10#2)
applied to a variety of##2##5##(2008-10#1)(2008-9#1)
applied to a##29##3##(1991-12#1)(1995-2#1)(2008-10#17)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-8#1)
applied to an##7##3##(1992-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2012-2#1)
applied to analyse##4##3##(2008-10#4)
applied to analysis of##6##4##(2008-10#5)(2012-12#1)
applied to analyze##5##3##(2008-10#5)
applied to assay the##2##4##(2008-10#2)
applied to assay##3##3##(2008-10#3)
applied to bacterial classification based on##2##6##(2008-10#2)
applied to blood##2##3##(2009-7#1)(2011-2#1)
applied to both##6##3##(1995-2#1)(2008-10#3)(2010-5#1)(2011-2#1)
applied to characterize##2##3##(2008-10#2)
applied to commercial##5##3##(2008-10#5)
applied to data##2##3##(1995-5#1)(2008-8#1)
applied to describe##2##3##(2008-10#1)(2008-3#1)
applied to detect the##2##4##(2008-10#2)
applied to detect##8##3##(2008-10#7)(2013-1#1)
applied to determination of##13##4##(2008-10#13)
applied to determine the##14##4##(2008-10#14)
applied to determine trace##3##4##(2008-10#3)
applied to determine##47##3##(2008-10#46)(2013-1#1)
applied to determining##2##3##(2008-10#2)
applied to develop##2##3##(2008-10#1)(2008-11#1)
applied to different##9##3##(2008-10#7)(2010-4#1)(2010-9#1)
applied to differential##2##3##(2008-10#2)
applied to direct glucose determination in##2##6##(2008-10#2)
applied to environmental##3##3##(2008-10#3)
applied to estimate the##2##4##(2008-10#2)
applied to estimate##5##3##(2008-10#4)(2012-2#1)
applied to evaluate##2##3##(2008-10#2)
applied to identify the##2##4##(2008-10#1)(2011-3#1)
applied to identify##3##3##(2008-10#1)(2010-12#1)(2011-3#1)
applied to investigate the##3##4##(2008-10#1)(2008-9#1)(2011-3#1)
applied to large-scale##2##3##(2008-4#1)(2008-9#1)
applied to many##3##3##(2008-10#2)(2008-11#1)
applied to measure the##2##4##(2011-2#1)(2012-2#1)
applied to measure##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
applied to measurements of##2##4##(2008-10#1)(2008-3#1)
applied to model##2##3##(2008-10#1)(2008-11#1)
applied to obtain##3##3##(2008-10#2)(2011-2#1)
applied to on-line##3##3##(2008-10#3)
applied to other##5##3##(2008-10#2)(2008-4#1)(2008-9#1)(2009-11#1)
applied to pharmaceutical formulations##3##4##(2008-10#3)
applied to real samples##2##4##(2008-10#2)
applied to real##6##3##(2008-10#4)(2012-3#1)(2013-8#1)
applied to river water##2##4##(2008-10#2)
applied to roots##2##3##(2008-10#2)
applied to sea water##2##4##(2008-10#2)
applied to several##6##3##(1990-5#1)(2008-10#5)
applied to soil##2##3##(2008-10#2)
applied to spiked##2##3##(2008-10#2)
applied to standard##2##3##(2008-10#1)(2008-7#1)
applied to studies of##2##4##(2008-10#1)(2008-5#1)
applied to study the##6##4##(2008-10#3)(2008-3#1)(2010-5#1)(2011-3#1)
applied to study##7##3##(2008-10#4)(2008-3#1)(2010-5#1)(2011-3#1)
applied to tap water and##2##5##(2008-10#2)
applied to tap water##4##4##(2008-10#4)
applied to the analyses of##4##5##(2008-10#4)
applied to the analysis of certified reference##2##7##(2008-10#2)
applied to the analysis of certified##3##6##(2008-10#3)
applied to the analysis of natural water samples##2##8##(2008-10#2)
applied to the analysis of natural##3##6##(2008-10#3)
applied to the analysis of real##3##6##(2008-10#3)
applied to the analysis of some##3##6##(2008-10#3)
applied to the analysis of the##3##6##(2008-10#3)
applied to the analysis of these##2##6##(2008-10#2)
applied to the analysis of##54##5##(2008-10#54)
applied to the assay of##2##5##(2008-10#2)
applied to the design##2##4##(2008-12#2)
applied to the detection of##3##5##(2008-10#3)
applied to the determination of As(III)##3##6##(2008-10#3)
applied to the determination of Captopril in##2##7##(2008-10#2)
applied to the determination of Ni##2##6##(2008-10#2)
applied to the determination of anionic##2##6##(2008-10#2)
applied to the determination of boron in##2##7##(2008-10#2)
applied to the determination of both##3##6##(2008-10#3)
applied to the determination of bromide in seawater##2##8##(2008-10#2)
applied to the determination of chloride in##2##7##(2008-10#2)
applied to the determination of chromium in##3##7##(2008-10#3)
applied to the determination of chromium(VI) in##2##7##(2008-10#2)
applied to the determination of chromium(VI)##3##6##(2008-10#3)
applied to the determination of cobalt in##2##7##(2008-10#2)
applied to the determination of cobalt##3##6##(2008-10#3)
applied to the determination of copper in river##2##8##(2008-10#2)
applied to the determination of copper in##5##7##(2008-10#5)
applied to the determination of fluoride in##2##7##(2008-10#2)
applied to the determination of free##2##6##(2008-10#2)
applied to the determination of hydrazine in water##3##8##(2008-10#3)
applied to the determination of iron in##2##7##(2008-10#2)
applied to the determination of iron##3##6##(2008-10#3)
applied to the determination of lead in##8##7##(2008-10#8)
applied to the determination of lead##10##6##(2008-10#10)
applied to the determination of nickel in##4##7##(2008-10#4)
applied to the determination of nickel##5##6##(2008-10#5)
applied to the determination of nitrite in##3##7##(2008-10#3)
applied to the determination of rhodium##2##6##(2008-10#2)
applied to the determination of silver in##3##7##(2008-10#3)
applied to the determination of sulfide in##2##7##(2008-10#2)
applied to the determination of the drug in##4##8##(2008-10#4)
applied to the determination of the drugs in##2##8##(2008-10#2)
applied to the determination of the##14##6##(2008-10#13)(2009-8#1)
applied to the determination of these compounds in##4##8##(2008-10#4)
applied to the determination of these metal ions in##2##9##(2008-10#2)
applied to the determination of these metals in##2##8##(2008-10#2)
applied to the determination of these##14##6##(2008-10#14)
applied to the determination of total##7##6##(2008-10#7)
applied to the determination of trace amounts of##5##8##(2008-10#5)
applied to the determination of trace levels of##2##8##(2008-10#2)
applied to the determination of trace##22##6##(2008-10#22)
applied to the determination of vanadium in##5##7##(2008-10#5)
applied to the determination of##270##5##(2008-10#269)(2009-8#1)
applied to the determination##276##4##(2008-10#275)(2009-8#1)
applied to the development of a capillary##2##7##(2008-10#2)
applied to the direct determination and potentiometric titration of##2##9##(2008-10#2)
applied to the direct determination of the##2##7##(2008-10#2)
applied to the direct determination of##8##6##(2008-10#8)
applied to the direct determination##10##5##(2008-10#10)
applied to the direct##11##4##(2008-10#11)
applied to the evaluation of##2##5##(1996-12#1)(2008-10#1)
applied to the extraction and determination of##5##7##(2008-10#5)
applied to the extraction of##2##5##(2008-10#2)
applied to the extraction##7##4##(2008-10#7)
applied to the measurement of##2##5##(2008-10#1)(2008-2#1)
applied to the monitoring of##3##5##(2008-10#3)
applied to the preconcentration of##3##5##(2008-10#3)
applied to the quantification of##3##5##(2008-10#3)
applied to the quantitation of##2##5##(2008-10#2)
applied to the recovery and determination of copper in##2##9##(2008-10#2)
applied to the recovery and determination of##3##7##(2008-10#3)
applied to the recovery##5##4##(2008-10#5)
applied to the results##2##4##(2008-10#2)
applied to the separation and##2##5##(2008-10#2)
applied to the simple##2##4##(2008-10#2)
applied to the simulated##2##4##(2008-10#2)
applied to the simultaneous determination of hydrazine and phenylhydrazine##2##9##(2008-10#2)
applied to the simultaneous determination of the##2##7##(2008-10#2)
applied to the simultaneous determination of three##2##7##(2008-10#2)
applied to the simultaneous determination of##19##6##(2008-10#19)
applied to the simultaneous##27##4##(2008-10#26)(2008-5#1)
applied to the speciation of antimony in##2##7##(2008-10#2)
applied to the speciation of chromium in##2##7##(2008-10#2)
applied to the speciation of##6##5##(2008-10#6)
applied to the speciation##8##4##(2008-10#8)
applied to the spectra##2##4##(2008-10#2)
applied to the spectrophotometric determination of chromium(VI)##2##7##(2008-10#2)
applied to the spectrophotometric determination of##3##6##(2008-10#3)
applied to the spectrophotometric##4##4##(2008-10#4)
applied to the##554##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-8#2)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-10#494)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#1)
applied to this##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
applied to three##3##3##(2008-10#2)(2012-2#1)
applied to tomato##2##3##(2008-10#2)
applied to treat##2##3##(2008-12#1)(2008-9#1)
applied to trees##2##3##(2008-10#1)(2010-4#1)
applied to two##8##3##(2008-10#6)(2008-3#1)(2008-7#1)
applied to various##2##3##(2008-10#2)
applied to water samples##2##4##(2008-10#2)
applied to##1045##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-8#2)(1992-12#1)(1992-3#3)(1993-12#2)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#4)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#4)(1997-8#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#833)(2008-11#22)(2008-12#4)(2008-2#4)(2008-3#26)(2008-4#6)(2008-5#12)(2008-7#8)(2008-8#7)(2008-9#9)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#5)(2010-7#4)(2010-9#1)(2011-1#1)(2011-2#14)(2011-3#3)(2012-12#2)(2012-2#10)(2012-3#1)(2012-5#1)(2013-1#8)(2013-8#6)
applied topically##2##2##(1993-1#1)(2008-5#1)
applied using a##3##3##(1994-2#1)(2008-11#1)(2013-1#1)
applied using##5##2##(1994-2#1)(2008-11#1)(2011-2#1)(2013-1#2)
applied very##2##2##(2008-10#1)(2010-8#1)
applied voltage and##2##3##(2008-10#2)
applied voltage##14##2##(2008-10#14)
applied water##2##2##(2008-10#2)
applied were##2##2##(2008-10#2)
applied with satisfactory results to##2##5##(2008-10#2)
applied with##9##2##(2008-10#6)(2008-12#1)(2008-3#1)(2008-9#1)
applied##1888##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-8#3)(1993-1#5)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#5)(1997-8#3)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1393)(2008-11#50)(2008-12#13)(2008-2#7)(2008-3#40)(2008-4#8)(2008-5#50)(2008-6#3)(2008-7#14)(2008-8#13)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#3)(2010-12#6)(2010-3#3)(2010-4#7)(2010-5#5)(2010-6#1)(2010-7#6)(2010-8#12)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#28)(2011-3#6)(2012-12#3)(2012-2#14)(2012-3#4)(2012-5#2)(2012-8#3)(2012-9#1)(2013-1#30)(2013-8#13)
applies the##4##2##(1997-6#1)(2008-10#1)(2008-4#2)
applies to##13##2##(1991-3#1)(1992-12#1)(1992-5#1)(1994-9#1)(1996-10#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-3#1)
applies##27##1##(1991-3#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-6#1)(1994-9#1)(1996-10#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-3#1)(2010-8#1)
apply a##11##2##(1991-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2010-2#1)
apply an##3##2##(1995-9#1)(2011-2#1)(2013-1#1)
apply for##6##2##(1991-3#1)(1994-12#1)(1994-3#1)(2012-2#1)(2013-1#2)
apply it##2##2##(1997-1#1)(2008-11#1)
apply the method to##2##4##(1995-12#1)(2008-8#1)
apply the model to##2##4##(2008-8#1)(2013-8#1)
apply the##22##2##(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
apply these##5##2##(1995-5#1)(1996-3#1)(2008-10#2)(2013-7#1)
apply this##10##2##(2008-10#4)(2008-11#3)(2008-4#1)(2008-8#1)(2013-1#1)
apply to other##2##3##(1995-2#1)(2010-8#1)
apply to the##4##3##(1995-2#2)(2008-4#2)
apply to##29##2##(1992-2#1)(1995-12#2)(1995-2#4)(1996-5#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
apply##132##1##(1991-1#2)(1991-3#1)(1992-2#1)(1992-3#1)(1994-12#3)(1994-3#1)(1995-12#3)(1995-2#4)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#32)(2008-11#14)(2008-12#2)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#2)(2008-8#6)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
applying a##22##2##(2008-10#15)(2008-11#3)(2008-3#1)(2008-5#3)
applying an external##2##3##(2008-10#1)(2008-3#1)
applying an##8##2##(2008-10#4)(2008-11#3)(2008-3#1)
applying different##2##2##(2008-10#1)(2008-11#1)
applying external##2##2##(2008-8#1)(2009-12#1)
applying for##2##2##(1991-12#1)(1996-8#1)
applying it to the##2##4##(2008-10#1)(2013-1#1)
applying it to##9##3##(2008-10#8)(2013-1#1)
applying multivariate##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
applying our##2##2##(2008-10#1)(2012-2#1)
applying spiritual care##3##3##(2010-11#3)
applying the method to##2##4##(2008-10#2)
applying the method##3##3##(2008-10#3)
applying the##32##2##(1993-12#1)(1994-8#1)(2008-10#20)(2008-3#3)(2008-4#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-8#2)
applying them to##3##3##(2008-6#1)(2013-1#2)
applying these##6##2##(1993-12#1)(1994-1#2)(2008-10#1)(2008-5#1)(2013-1#1)
applying this##4##2##(2008-11#2)(2009-3#1)(2011-2#1)
applying to##2##2##(1994-3#1)(2008-12#1)
applying##162##1##(1991-12#1)(1993-12#3)(1994-1#2)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-8#1)(2008-10#81)(2008-11#14)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#2)(2008-8#7)(2008-9#2)(2009-12#1)(2009-3#3)(2009-8#1)(2010-11#3)(2010-7#3)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
appointed##15##1##(1991-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-11#1)(2009-4#1)(2010-1#1)(2012-3#1)
appointment roles##2##2##(2008-11#1)(2008-12#1)
appointment##18##1##(1990-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-6#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#2)
appointments in##3##2##(1997-2#1)(2008-4#1)(2013-8#1)
appointments##13##1##(1990-9#1)(1991-2#2)(1992-3#1)(1993-9#1)(1996-1#2)(1996-3#1)(1997-2#1)(2008-11#1)(2008-4#1)(2013-8#2)
apportionment of##3##2##(2008-10#2)(2008-8#1)
apportionment##4##1##(2008-10#3)(2008-8#1)
apposition##5##1##(2008-10#4)(2012-3#1)
appositions##15##1##(2008-10#14)(2011-2#1)
appraisal and##2##2##(2008-5#1)(2012-3#1)
appraisal of the##4##3##(1991-1#1)(2008-1#1)(2008-11#1)(2013-8#1)
appraisal of##8##2##(1991-1#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2013-8#1)
appraisal process##2##2##(2008-11#2)
appraisal skills and##2##3##(2008-11#1)(2008-12#1)
appraisal skills##4##2##(2008-11#2)(2008-12#2)
appraisal##22##1##(1991-1#2)(1993-12#1)(2007-8#1)(2008-1#1)(2008-11#6)(2008-12#4)(2008-5#1)(2008-9#1)(2010-7#2)(2012-3#2)(2013-8#1)
appraisals of fit##2##3##(2009-10#2)
appraisals of##3##2##(2009-10#3)
appraisals##5##1##(2008-4#1)(2009-10#3)(2010-1#1)
appraise the##4##2##(1991-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
appraise##9##1##(1991-2#1)(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
appraised##9##1##(2008-1#1)(2008-10#5)(2008-11#2)(2011-2#1)
appraising##3##1##(2008-12#1)(2009-3#1)(2012-3#1)
appreciable effect on the##2##4##(1992-2#1)(2008-10#1)
appreciable effect##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
appreciable lag##2##2##(2008-5#2)
appreciable loss##2##2##(2008-11#1)(2012-2#1)
appreciable##26##1##(1991-5#1)(1991-6#1)(1992-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
appreciably##4##1##(1997-8#1)(2008-10#1)(2008-6#1)(2010-10#1)
appreciate the##8##2##(1991-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
appreciate##11##1##(1991-12#1)(1992-1#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
appreciated and##2##2##(1990-11#1)(2011-1#1)
appreciated by##2##2##(2008-8#1)(2010-10#1)
appreciated in##2##2##(1991-6#1)(2009-10#1)
appreciated that##2##2##(2008-8#1)(2009-5#1)
appreciated the##3##2##(1997-4#1)(2008-12#1)(2008-5#1)
appreciated##23##1##(1990-11#1)(1991-3#1)(1991-6#2)(1993-11#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
appreciation of the##9##3##(1991-12#1)(1996-3#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2013-1#1)(2013-8#2)
appreciation of##16##2##(1991-12#2)(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2013-1#2)(2013-8#2)
appreciation to##2##2##(1991-3#1)(2008-11#1)
appreciation##22##1##(1991-12#3)(1991-3#1)(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#2)(2013-1#2)(2013-8#2)
apprehension##5##1##(1995-1#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
apprenticeship##2##1##(1997-2#1)(2008-11#1)
appressed to the agar surface##2##5##(2008-10#2)
appressed##3##1##(2008-10#3)
appressoria and##3##2##(2008-10#3)
appressoria formed on##2##3##(2008-10#2)
appressoria formed##4##2##(2008-10#4)
appressoria of##4##2##(2008-10#4)
appressoria on##3##2##(2008-10#3)
appressoria was##4##2##(2008-10#4)
appressoria were##4##2##(2008-10#4)
appressoria with##2##2##(2008-10#2)
appressoria##47##1##(2008-10#47)
appressorial development##2##2##(2008-10#2)
appressorial formation##2##2##(2008-10#2)
appressorial##11##1##(2008-10#11)
appressorium formation in C##2##4##(2008-10#2)
appressorium formation in##3##3##(2008-10#3)
appressorium formation of##3##3##(2008-10#3)
appressorium formation##25##2##(2008-10#25)
appressorium##35##1##(2008-10#34)(2009-8#1)
appressorium-forming##2##1##(2008-10#2)
approach (TRA)##2##2##(2011-2#2)
approach a##2##2##(2008-3#1)(2010-10#1)
approach allowed the##2##3##(2008-10#2)
approach allowed##7##2##(2008-10#4)(2011-2#2)(2012-12#1)
approach allows a##2##3##(2008-10#1)(2009-10#1)
approach allows for##2##3##(2009-8#1)(2012-2#1)
approach allows rapid##2##3##(2008-9#2)
approach allows##13##2##(2008-10#5)(2008-3#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#2)(2012-2#1)
approach also##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
approach and a##2##3##(2008-10#1)(2008-12#1)
approach and review of the literature##2##6##(1992-12#1)(2008-10#1)
approach and the##7##3##(1991-3#1)(2008-10#3)(2008-8#1)(2010-1#1)(2013-8#1)
approach and##40##2##(1990-3#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-3#1)(1997-6#1)(2008-10#15)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
approach applied##2##2##(1997-8#1)(2009-11#1)
approach are outlined##2##3##(1994-3#1)(2008-10#1)
approach are##15##2##(1994-1#1)(1994-2#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
approach as##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
approach at##4##2##(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#1)
approach based on the##5##4##(2008-10#2)(2008-2#1)(2008-5#1)(2013-8#1)
approach based on##11##3##(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-6#1)(2013-8#1)
approach based##12##2##(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-6#1)(2013-8#1)
approach by##2##2##(1992-5#1)(2009-8#1)
approach can be successfully applied##2##5##(2008-10#2)
approach can be used to##2##5##(1996-12#1)(2008-10#1)
approach can be used##4##4##(1996-12#1)(2008-10#2)(2008-11#1)
approach can be##13##3##(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#2)
approach can improve the##2##4##(2008-10#1)(2008-6#1)
approach can provide##2##3##(1995-12#1)(2011-2#1)
approach can##26##2##(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#4)
approach combining##2##2##(2008-5#1)(2012-3#1)
approach consisting of##2##3##(1991-3#1)(2008-10#1)
approach could be##2##3##(2008-10#1)(2011-2#1)
approach could##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
approach developed##3##2##(1994-1#1)(2008-10#1)(2008-12#1)
approach does not##2##3##(2007-11#1)(2008-9#1)
approach enables##3##2##(1993-2#1)(2008-6#2)
approach for a##2##3##(2012-2#2)
approach for determination of##3##4##(2008-10#3)
approach for determination##4##3##(2008-10#3)(2010-8#1)
approach for evaluating##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
approach for monitoring access##2##4##(1997-2#2)
approach for predicting##2##3##(1992-9#1)(2008-10#1)
approach for resection of##2##4##(2011-2#2)
approach for screening##3##3##(2008-10#2)(2013-1#1)
approach for studying##2##3##(2008-10#1)(2008-8#1)
approach for the analysis of##2##5##(2008-10#2)
approach for the determination of##2##5##(1995-3#1)(2008-10#1)
approach for the development of##2##5##(2008-3#1)(2009-6#1)
approach for the treatment of##2##5##(1994-5#1)(2010-6#1)
approach for the##36##3##(1990-5#1)(1991-12#1)(1991-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#2)(2009-12#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
approach for this##2##3##(2008-5#1)(2012-3#1)
approach for##145##2##(1990-5#3)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#2)(2008-10#42)(2008-11#4)(2008-12#3)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#16)(2012-2#7)(2012-3#6)(2013-1#8)(2013-8#1)
approach gives##2##2##(2008-3#1)(2009-8#1)
approach had the##2##3##(2013-1#2)
approach had##3##2##(2013-1#3)
approach has been applied to##2##5##(2008-10#1)(2009-10#1)
approach has been applied##3##4##(2008-10#2)(2009-10#1)
approach has been developed##4##4##(2008-10#1)(2008-11#2)(2009-12#1)
approach has been used##4##4##(1995-12#1)(2008-10#2)(2011-2#1)
approach has been##22##3##(1994-5#1)(1995-12#1)(1995-3#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
approach has broad applications##2##4##(2008-4#1)(2010-11#1)
approach has the potential##2##4##(2008-11#1)(2012-2#1)
approach has the##3##3##(2008-11#1)(2012-2#2)
approach has##35##2##(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-7#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
approach identifies##2##2##(2008-11#1)(2008-7#1)
approach improved##2##2##(2008-10#2)
approach in a patient##2##4##(1996-3#1)(2008-11#1)
approach in a##4##3##(1996-3#1)(2008-11#1)(2011-2#1)(2012-3#1)
approach in the context of##2##5##(2008-10#1)(2008-5#1)
approach in the treatment of##2##5##(1990-9#1)(1993-6#1)
approach in the treatment##3##4##(1990-9#1)(1993-6#1)(2008-4#1)
approach in the##10##3##(1990-9#1)(1993-6#1)(1994-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-2#1)(2011-3#1)
approach in##40##2##(1990-6#2)(1990-9#1)(1992-1#2)(1993-2#2)(1993-6#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-3#2)(1997-8#1)(2008-10#6)(2008-11#7)(2008-4#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
approach including##2##2##(2008-10#1)(2011-2#1)
approach increases##2##2##(2009-8#1)(2013-8#1)
approach involves##2##2##(1994-5#1)(2008-10#1)
approach involving##4##2##(1993-8#1)(1994-6#1)(2008-10#2)
approach is a##2##3##(2008-10#1)(2008-3#1)
approach is based on a##2##5##(2008-10#1)(2008-3#1)
approach is based on##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
approach is capable of##2##4##(2008-10#1)(2013-1#1)
approach is difficult##2##3##(2008-10#1)(2008-9#1)
approach is illustrated##3##3##(1995-12#1)(2009-7#1)(2013-1#1)
approach is introduced in##2##4##(2008-10#2)
approach is introduced##3##3##(2008-10#2)(2008-7#1)
approach is more##3##3##(2008-10#2)(2008-8#1)
approach is necessary##2##3##(1995-5#1)(2008-12#1)
approach is needed##2##3##(1995-6#1)(2011-2#1)
approach is not##5##3##(2008-10#1)(2008-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
approach is presented##4##3##(1992-3#1)(2008-10#2)(2008-5#1)
approach is proposed##2##3##(2008-10#2)
approach is required##2##3##(2010-11#1)(2010-5#1)
approach is similar to that##2##5##(2008-7#1)(2008-9#1)
approach is that##4##3##(2008-10#1)(2008-8#1)(2009-8#1)(2010-7#1)
approach is the##2##3##(2008-10#1)(2008-11#1)
approach is to##6##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
approach is used in##2##4##(2008-3#1)(2008-9#1)
approach is used to##3##4##(2008-10#2)(2008-3#1)
approach is used##6##3##(1992-3#1)(2008-10#2)(2008-3#2)(2008-9#1)
approach is##103##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#26)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#5)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
approach makes##2##2##(2011-2#1)(2012-2#1)
approach may be##3##3##(1993-2#1)(2008-11#1)(2009-10#1)
approach may offer##2##3##(2008-11#1)(2011-2#1)
approach may##10##2##(1991-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-5#1)(2008-11#2)(2009-10#1)(2011-2#1)
approach of the##4##3##(1993-12#1)(2008-10#1)(2011-3#1)(2012-2#1)
approach of##24##2##(1991-2#1)(1993-12#1)(1995-12#1)(1995-2#1)(2008-10#7)(2008-11#5)(2008-4#1)(2009-3#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
approach offers##2##2##(2008-10#1)(2008-11#1)
approach on the##3##3##(2008-10#2)(2012-3#1)
approach on##7##2##(2008-10#3)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
approach over##2##2##(2011-2#2)
approach permits##2##2##(2008-10#1)(2011-2#1)
approach provides a##4##3##(2008-1#1)(2009-11#1)(2011-2#1)(2013-8#1)
approach provides##7##2##(2008-1#1)(2008-10#2)(2009-11#1)(2011-2#2)(2013-8#1)
approach reduces##2##2##(2008-10#1)(2010-11#1)
approach requires##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
approach should be##5##3##(2008-10#2)(2010-7#1)(2011-2#2)
approach should##6##2##(2008-10#3)(2010-7#1)(2011-2#2)
approach suggested##2##2##(2008-11#1)(2008-12#1)
approach taken in##2##3##(1995-11#1)(2008-11#1)
approach taken##5##2##(1991-12#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-12#1)
approach that included##2##3##(2008-12#2)
approach that is##3##3##(2008-6#1)(2011-2#1)(2013-8#1)
approach that##21##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
approach the##9##2##(1994-2#1)(1995-3#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-8#1)
approach their##2##2##(1997-7#1)(2008-8#1)
approach to a##8##3##(1992-3#1)(1993-3#1)(1993-6#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)
approach to address this##2##4##(2008-11#1)(2012-3#1)
approach to analysis of##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
approach to automated##2##3##(2008-9#2)
approach to construct a##2##4##(1995-3#1)(2008-10#1)
approach to construct##3##3##(1995-3#1)(2008-10#2)
approach to control##3##3##(2008-10#2)(2012-3#1)
approach to data analysis##2##4##(1996-6#1)(2008-12#1)
approach to data##6##3##(1996-6#1)(2008-10#1)(2008-11#3)(2008-12#1)
approach to determine the##2##4##(1995-12#1)(2008-10#1)
approach to determining the##2##4##(2008-8#1)(2010-11#1)
approach to education##2##3##(1995-2#1)(2008-12#1)
approach to estimate the##3##4##(2008-10#2)(2008-3#1)
approach to estimating##2##3##(1995-9#1)(2008-3#1)
approach to ethics##2##3##(2008-11#2)
approach to evaluate##2##3##(2008-10#1)(2011-2#1)
approach to financing##2##3##(1993-2#1)(2008-1#1)
approach to health##5##3##(1993-12#2)(1994-12#2)(2012-2#1)
approach to identify##3##3##(1993-8#1)(2008-11#1)(2012-2#1)
approach to identifying##2##3##(2008-11#1)(2010-7#1)
approach to improving##5##3##(1991-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)
approach to integrating##2##3##(1994-2#1)(2008-11#1)
approach to investigate the##4##4##(1993-12#1)(1997-1#1)(2008-10#2)
approach to investigation and##3##4##(2008-11#3)
approach to management of##2##4##(2008-7#1)(2010-12#1)
approach to management##4##3##(1992-12#1)(2008-7#1)(2010-12#1)(2011-2#1)
approach to measure##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
approach to medical##2##3##(1996-1#1)(2010-8#1)
approach to modeling##2##3##(2008-10#1)(2008-8#1)
approach to pest management##2##4##(2008-10#2)
approach to restructuring##2##3##(1994-3#1)(1995-2#1)
approach to selectively##2##3##(2008-10#1)(2009-8#1)
approach to separate##2##3##(2008-10#1)(2008-11#1)
approach to service##2##3##(1993-1#1)(1996-12#1)
approach to site identification using##2##5##(2008-11#2)
approach to strategic planning##4##4##(1994-2#2)(1994-3#1)(2012-3#1)
approach to study the##2##4##(2008-10#2)
approach to study##5##3##(2008-10#3)(2008-4#1)(2011-2#1)
approach to supporting##2##3##(1995-12#1)(2008-11#1)
approach to teaching##5##3##(2008-11#4)(2013-1#1)
approach to the analysis of##4##5##(1995-8#1)(2008-11#1)(2008-3#1)(2009-10#1)
approach to the craniocervical junction##2##5##(2011-2#2)
approach to the determination of##2##5##(2008-10#1)(2012-4#1)
approach to the development##2##4##(1997-1#1)(2008-11#1)
approach to the management of##4##5##(2008-10#2)(2008-11#1)(2008-7#1)
approach to the synthesis of##2##5##(2008-11#1)(2011-2#1)
approach to the treatment of early##2##6##(2008-7#2)
approach to the treatment of##6##5##(1991-11#1)(1992-2#1)(1996-3#2)(2008-7#2)
approach to the##60##3##(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-2#1)(1993-2#1)(1994-5#1)(1995-8#1)(1996-3#2)(1997-1#1)(1997-6#1)(2006-5#7)(2008-10#4)(2008-11#7)(2008-12#1)(2008-3#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2010-5#2)(2011-2#8)(2012-2#2)(2012-3#1)(2012-4#1)
approach to this##2##3##(1994-3#1)(2008-8#1)
approach to understanding##3##3##(1992-2#1)(2008-8#1)(2009-5#1)
approach to##371##2##(1990-12#2)(1990-3#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-9#2)(1993-1#2)(1993-12#5)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#8)(1996-6#1)(1997-1#7)(1997-2#1)(1997-3#2)(1997-6#2)(2006-5#7)(2008-1#3)(2008-10#60)(2008-11#46)(2008-12#6)(2008-3#11)(2008-4#6)(2008-5#1)(2008-6#5)(2008-7#8)(2008-8#10)(2008-9#8)(2009-10#4)(2009-11#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-3#1)(2010-5#6)(2010-7#1)(2010-8#3)(2011-2#25)(2011-3#1)(2012-12#1)(2012-2#12)(2012-3#12)(2012-4#1)(2013-1#4)(2013-8#7)
approach toward the##2##3##(2007-11#1)(2008-7#1)
approach toward##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
approach towards the##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
approach towards##7##2##(2008-10#2)(2008-11#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-1#1)
approach used for##2##3##(1990-5#1)(1997-2#1)
approach used to##2##3##(2008-10#1)(2011-2#1)
approach used##9##2##(1990-5#1)(1991-6#1)(1994-8#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-3#1)(2011-2#1)
approach uses##2##2##(2008-10#1)(2008-3#1)
approach using a##3##3##(1996-2#1)(2008-10#2)
approach using##13##2##(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2012-3#1)
approach utilizing##2##2##(2012-2#1)(2012-3#1)
approach was adopted for the##2##5##(2008-10#2)
approach was adopted##5##3##(2008-10#3)(2008-11#1)(2008-12#1)
approach was also##2##3##(1993-3#1)(2008-10#1)
approach was demonstrated##3##3##(2008-10#3)
approach was developed##4##3##(1994-3#1)(2008-10#3)
approach was evaluated by##2##4##(2008-10#2)
approach was not##2##3##(2008-10#1)(2008-11#1)
approach was performed##2##3##(2008-11#1)(2013-1#1)
approach was proposed to##2##4##(2008-10#1)(2011-2#1)
approach was proposed##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
approach was to##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
approach was used for the##2##5##(2008-11#1)(2008-7#1)
approach was used to##6##4##(2008-10#3)(2008-12#1)(2012-3#1)(2013-8#1)
approach was used##11##3##(2006-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
approach was##59##2##(1990-12#1)(1991-6#1)(1993-3#1)(1994-3#1)(2006-6#1)(2008-10#29)(2008-11#7)(2008-12#2)(2008-4#1)(2008-7#2)(2009-9#1)(2010-4#1)(2011-2#1)(2011-9#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
approach we have##2##3##(1995-2#1)(2008-5#1)
approach we##4##2##(1995-2#1)(2008-3#2)(2008-5#1)
approach were##4##2##(2008-10#3)(2012-12#1)
approach where##3##2##(1994-2#1)(2008-4#1)(2011-2#1)
approach which##3##2##(1995-9#1)(1997-7#1)(2010-7#1)
approach will##3##2##(2008-11#1)(2008-8#2)
approach with a##2##3##(2008-10#1)(2008-5#1)
approach with the##2##3##(2008-10#1)(2008-9#1)
approach with##26##2##(1990-12#1)(1996-11#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
approach yields an##2##3##(1996-3#2)
approach yields##5##2##(1996-3#2)(2008-3#1)(2008-9#1)(2012-2#1)
approach##1614##1##(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#6)(1990-6#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#10)(1991-3#6)(1991-5#1)(1991-6#6)(1992-1#8)(1992-12#6)(1992-2#5)(1992-3#6)(1992-5#1)(1992-9#6)(1993-1#4)(1993-11#1)(1993-12#10)(1993-2#10)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#7)(1994-11#1)(1994-12#6)(1994-2#12)(1994-3#7)(1994-5#6)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#11)(1995-2#11)(1995-3#8)(1995-5#5)(1995-6#5)(1995-8#3)(1995-9#2)(1996-1#11)(1996-11#2)(1996-12#5)(1996-2#9)(1996-3#19)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#8)(1997-2#7)(1997-3#5)(1997-5#1)(1997-6#7)(1997-7#4)(1997-8#5)(2006-5#7)(2006-6#1)(2007-11#2)(2008-1#6)(2008-10#369)(2008-11#129)(2008-12#40)(2008-2#7)(2008-3#51)(2008-4#25)(2008-5#22)(2008-6#21)(2008-7#39)(2008-8#50)(2008-9#41)(2009-1#2)(2009-10#18)(2009-11#4)(2009-12#7)(2009-3#5)(2009-5#5)(2009-6#3)(2009-7#9)(2009-8#13)(2009-9#4)(2010-1#4)(2010-10#10)(2010-11#11)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#13)(2010-6#2)(2010-7#9)(2010-8#13)(2010-9#1)(2011-1#5)(2011-2#147)(2011-3#7)(2011-7#1)(2011-9#1)(2012-12#14)(2012-2#49)(2012-3#45)(2012-4#1)(2013-1#57)(2013-7#2)(2013-8#26)
approach) versus##3##2##(2011-2#2)(2013-1#1)
approach)##9##1##(1995-11#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-3#1)(2013-1#3)
approach]##4##1##(1995-11#1)(1996-3#1)(2010-4#1)(2011-2#1)
approached 1##2##2##(2008-10#2)
approached by##3##2##(1992-9#1)(1995-11#1)(2008-11#1)
approached for##2##2##(2007-12#1)(2008-10#1)
approached in##2##2##(1991-2#1)(2008-10#1)
approached the##5##2##(1993-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-1#1)
approached to##2##2##(2008-10#1)(2008-8#1)
approached##32##1##(1991-12#1)(1991-2#2)(1992-9#1)(1993-1#1)(1995-11#1)(1997-6#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
approaches allow##2##2##(2008-9#1)(2009-5#1)
approaches and their##3##3##(1997-2#1)(2008-11#1)(2013-1#1)
approaches and##25##2##(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
approaches are discussed##2##3##(1994-8#1)(2013-1#1)
approaches are essential##2##3##(2008-10#1)(2008-11#1)
approaches are##25##2##(1994-3#1)(1994-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2011-3#2)(2012-3#2)(2013-1#3)
approaches as well as##3##4##(2008-9#2)(2012-3#1)
approaches as well##4##3##(2008-9#2)(2012-3#1)(2013-1#1)
approaches as##6##2##(2008-1#1)(2008-11#1)(2008-9#2)(2012-3#1)(2013-1#1)
approaches can be##2##3##(2008-8#1)(2009-12#1)
approaches can provide##2##3##(2009-12#1)(2012-3#1)
approaches can##5##2##(2008-11#1)(2008-8#1)(2009-12#2)(2012-3#1)
approaches described##3##2##(2008-4#1)(2008-9#1)(2011-1#1)
approaches discussed##2##2##(2008-10#1)(2008-11#1)
approaches for the##7##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-3#1)
approaches for##44##2##(1992-1#1)(1997-1#1)(1997-3#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#3)(2009-12#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
approaches have been described to##2##5##(2008-11#1)(2010-8#1)
approaches have been developed for##2##5##(2008-10#1)(2011-3#1)
approaches have been developed to##2##5##(2008-11#1)(2011-2#1)
approaches have been developed##5##4##(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2011-3#1)
approaches have been proposed for##2##5##(2010-12#1)(2012-3#1)
approaches have been proposed##3##4##(2008-10#1)(2010-12#1)(2012-3#1)
approaches have been##14##3##(1994-9#1)(2008-10#3)(2008-11#4)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
approaches have##20##2##(1994-9#1)(2008-10#4)(2008-11#4)(2009-7#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
approaches in the##2##3##(2008-10#1)(2012-2#1)
approaches in theoretical population##2##4##(2008-9#2)
approaches in##17##2##(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
approaches include##3##2##(2008-10#1)(2010-11#1)(2012-3#1)
approaches including##2##2##(1995-12#1)(2011-2#1)
approaches involving##2##2##(2007-11#2)
approaches is##6##2##(2008-10#2)(2008-9#2)(2010-12#1)(2013-1#1)
approaches may be used##2##4##(1991-6#1)(2008-11#1)
approaches may be##3##3##(1991-6#1)(2008-11#1)(2012-2#1)
approaches may##5##2##(1991-6#1)(2008-11#2)(2008-5#1)(2012-2#1)
approaches of##2##2##(2008-8#1)(2010-6#1)
approaches that can be##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
approaches that have been##2##4##(2008-3#1)(2010-7#1)
approaches that have##4##3##(1995-6#1)(2008-3#1)(2008-4#1)(2010-7#1)
approaches that may##3##3##(2008-11#1)(2010-12#1)(2010-8#1)
approaches that utilize##2##3##(2008-10#1)(2009-7#1)
approaches that##23##2##(1994-1#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)
approaches the##4##2##(2007-12#1)(2008-3#1)(2010-8#1)(2012-2#1)
approaches to a##2##3##(1995-5#1)(2013-1#1)
approaches to be##2##3##(2008-11#1)(2008-9#1)
approaches to couple therapy##4##4##(2012-2#4)
approaches to enhance##2##3##(2008-11#1)(2013-1#1)
approaches to improving##2##3##(2012-2#1)(2013-1#1)
approaches to learning##4##3##(2011-1#3)(2011-2#1)
approaches to management in##2##4##(2011-2#2)
approaches to management##3##3##(1992-2#1)(2011-2#2)
approaches to promote##2##3##(1996-2#1)(2013-1#1)
approaches to studying##2##3##(2012-2#1)(2013-8#1)
approaches to teaching##2##3##(2011-2#2)
approaches to the development of##2##5##(2008-11#1)(2009-6#1)
approaches to the##13##3##(1992-3#1)(1996-1#1)(1997-7#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-6#1)(2011-2#1)
approaches to this problem##2##4##(1994-9#1)(2010-11#1)
approaches to tobacco use##2##4##(1997-1#2)
approaches to treatment##4##3##(1997-3#1)(2007-11#1)(2008-9#1)(2013-1#1)
approaches to##133##2##(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#3)(1994-1#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#12)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2012-2#10)(2012-3#3)(2013-1#10)(2013-8#1)
approaches used to##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
approaches used##5##2##(1994-6#1)(2008-11#1)(2008-12#1)(2013-1#2)
approaches using##4##2##(2008-10#1)(2008-9#1)(2009-12#1)(2010-4#1)
approaches were##8##2##(2008-10#7)(2010-8#1)
approaches will##2##2##(1997-1#1)(2008-7#1)
approaches##516##1##(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-7#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#2)(1993-2#1)(1993-3#5)(1994-1#6)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#7)(1997-2#3)(1997-3#2)(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#3)(2008-10#89)(2008-11#48)(2008-12#15)(2008-2#2)(2008-3#10)(2008-4#15)(2008-5#8)(2008-6#5)(2008-7#11)(2008-8#12)(2008-9#22)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#5)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#2)(2010-10#3)(2010-11#8)(2010-12#10)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#8)(2011-1#7)(2011-2#37)(2011-3#4)(2012-2#22)(2012-3#18)(2012-5#1)(2013-1#34)(2013-8#6)
approaching cellular senescence##2##3##(2008-11#2)
approaching the##4##2##(2007-12#1)(2008-3#1)(2009-6#1)(2011-2#1)
approaching those##2##2##(2008-10#2)
approaching##23##1##(1993-12#1)(1994-6#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-7#3)(2008-9#2)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
appropriate (7-9)##2##2##(2010-12#2)
appropriate addition of##2##3##(2008-10#1)(2009-8#1)
appropriate administration##2##2##(1996-11#1)(2008-7#1)
appropriate administrative##3##2##(1991-12#1)(1994-3#1)(1997-3#1)
appropriate analysis of##2##3##(2008-10#1)(2009-8#1)
appropriate analytical##3##2##(2008-10#3)
appropriate and##10##2##(1993-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
appropriate antibiotic##2##2##(1994-12#1)(2011-2#1)
appropriate care for##2##3##(2008-11#1)(2012-12#1)
appropriate care to##2##3##(1991-3#1)(2013-8#1)
appropriate care##5##2##(1991-3#1)(2008-11#1)(2012-12#1)(2013-8#2)
appropriate cases##2##2##(2008-9#1)(2013-1#1)
appropriate cell lines##2##3##(2008-9#2)
appropriate choice of##2##3##(2008-10#1)(2008-3#1)
appropriate clinical management##2##3##(2012-2#1)(2013-1#1)
appropriate clinical##4##2##(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
appropriate combination of##2##3##(2008-10#1)(2008-11#1)
appropriate control strategy##2##3##(2008-10#1)(2008-8#1)
appropriate control##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
appropriate controls##2##2##(1995-6#1)(2008-9#1)
appropriate correction##2##2##(2008-10#2)
appropriate diagnostic##3##2##(1990-9#1)(2011-2#1)(2012-12#1)
appropriate experimental conditions##2##3##(2008-10#1)(2009-12#1)
appropriate experimental##3##2##(2008-10#1)(2009-12#1)(2012-3#1)
appropriate flow##2##2##(2008-10#1)(2008-7#1)
appropriate for a##2##3##(1990-2#1)(2008-4#1)
appropriate for the purpose##2##4##(2008-1#1)(2008-10#1)
appropriate for the##7##3##(1994-8#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)
appropriate for use##2##3##(1992-3#1)(2008-5#1)
appropriate for##46##2##(1990-2#1)(1991-1#1)(1992-3#1)(1994-8#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#6)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
appropriate form of##2##3##(1993-6#1)(2008-10#1)
appropriate genetic##2##2##(1997-3#1)(2008-8#1)
appropriate in order to##2##4##(2008-10#2)
appropriate in##7##2##(2008-10#3)(2010-12#3)(2010-6#1)
appropriate information##2##2##(1996-1#1)(2008-1#1)
appropriate level##2##2##(1991-3#1)(2013-1#1)
appropriate levels##2##2##(1997-1#1)(1997-7#1)
appropriate management##3##2##(2008-10#2)(2013-1#1)
appropriate manner##2##2##(2008-5#1)(2008-9#1)
appropriate measure##2##2##(2008-10#1)(2011-2#1)
appropriate measures##3##2##(1992-11#1)(1996-1#1)(2011-1#1)
appropriate medications##2##2##(2008-11#1)(2010-12#1)
appropriate methods for##3##3##(1990-5#1)(2008-11#1)(2008-9#1)
appropriate model##2##2##(2008-10#2)
appropriate molecular##2##2##(2008-10#1)(2008-4#1)
appropriate multidisciplinary##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
appropriate position##2##2##(1996-8#1)(1997-8#1)
appropriate practice##2##2##(2008-11#1)(2011-1#1)
appropriate regression##2##2##(2007-12#1)(2008-10#1)
appropriate sample##3##2##(2008-10#2)(2008-9#1)
appropriate scale##4##2##(2008-10#4)
appropriate screening##2##2##(2008-10#1)(2008-7#1)
appropriate selection of##2##3##(2008-10#2)
appropriate setting##2##2##(1994-12#2)
appropriate strategies##2##2##(2008-11#1)(2011-2#1)
appropriate surgical##4##2##(1992-5#1)(2008-7#2)(2012-3#1)
appropriate technique##2##2##(2008-10#2)
appropriate therapy##3##2##(2008-8#1)(2010-1#1)(2013-1#1)
appropriate timing of##2##3##(2010-10#1)(2013-8#1)
appropriate to study##2##3##(2008-10#1)(2008-9#1)
appropriate to the##3##3##(2007-12#1)(2008-10#2)
appropriate to##17##2##(1990-5#1)(1991-1#1)(1995-1#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
appropriate training and##2##3##(2008-11#1)(2008-6#1)
appropriate treatment##13##2##(1990-6#1)(1991-2#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
appropriate use of##3##3##(1993-3#1)(1996-2#1)(2011-1#1)
appropriate use##4##2##(1993-3#1)(1996-2#1)(2011-1#1)(2011-2#1)
appropriate utilization of##3##3##(1994-1#1)(1994-12#1)(1995-1#1)
appropriate volume##2##2##(1991-5#1)(2008-11#1)
appropriate##519##1##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#4)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#5)(1992-5#1)(1992-9#4)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#5)(1994-3#4)(1994-8#1)(1995-1#3)(1995-12#4)(1995-2#5)(1995-5#6)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#3)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#5)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#110)(2008-11#45)(2008-12#10)(2008-2#3)(2008-3#13)(2008-4#10)(2008-5#11)(2008-6#6)(2008-7#10)(2008-8#12)(2008-9#27)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#8)(2010-1#3)(2010-10#3)(2010-11#3)(2010-12#19)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#27)(2011-3#1)(2012-12#7)(2012-2#8)(2012-3#5)(2012-5#1)(2012-9#1)(2013-1#21)(2013-8#12)
appropriate?##2##1##(1992-9#1)(1995-3#1)
appropriated##3##1##(1997-1#1)(2008-5#1)(2010-1#1)
appropriately##38##1##(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1996-3#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#3)(2010-11#2)(2010-12#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
appropriateness criteria##2##2##(2010-12#2)
appropriateness for##2##2##(1993-1#1)(2010-4#1)
appropriateness of the##3##3##(1992-1#1)(1993-1#1)(1996-3#1)
appropriateness of##12##2##(1992-1#1)(1993-1#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)(2013-1#3)
appropriateness##20##1##(1992-1#1)(1993-1#2)(1995-5#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-4#2)(2013-1#5)
appropriation for##2##2##(1995-6#2)
appropriation##3##1##(1995-6#3)
approval and##3##2##(1991-3#1)(1995-5#1)(2008-10#1)
approval by the##2##3##(2008-9#1)(2012-3#1)
approval for##5##2##(1992-3#1)(1995-12#1)(2008-5#1)(2009-10#1)(2012-12#1)
approval in Japan##2##3##(2008-5#2)
approval in##3##2##(1996-5#1)(2008-5#2)
approval is##2##2##(1991-12#1)(2008-5#1)
approval of##11##2##(1991-12#1)(1992-8#1)(1993-12#1)(1993-9#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-12#1)
approval to##3##2##(1991-3#1)(1995-12#1)(2010-6#1)
approval##39##1##(1991-12#2)(1991-3#5)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-5#1)(1996-5#2)(2008-10#1)(2008-5#7)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-6#1)(2012-12#4)(2012-3#1)(2013-1#1)
approved a##5##2##(1991-1#1)(1996-5#2)(1997-2#1)(2013-1#1)
approved and##3##2##(2012-2#1)(2013-1#2)
approved as##2##2##(1990-2#1)(2011-3#1)
approved by FDA##2##3##(2011-2#1)(2011-3#1)
approved by the FDA##2##4##(2008-9#1)(2010-12#1)
approved by the US##2##4##(2008-9#1)(2011-2#1)
approved by the##7##3##(2008-6#1)(2008-9#2)(2010-12#1)(2011-2#2)(2012-3#1)
approved by##10##2##(2008-6#1)(2008-9#2)(2010-12#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)
approved for the##2##3##(2009-8#1)(2012-3#1)
approved for use##3##3##(2010-6#1)(2012-2#1)(2013-1#1)
approved for##10##2##(1995-6#1)(1997-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
approved in##2##2##(2008-5#1)(2011-1#1)
approved medications##3##2##(2009-7#1)(2010-12#2)
approved of##3##2##(2008-10#1)(2012-12#2)
approved standard##2##2##(2008-10#1)(2009-12#1)
approved the##2##2##(1990-6#1)(1996-5#1)
approved##70##1##(1990-2#1)(1990-6#1)(1991-1#1)(1992-3#1)(1993-3#1)(1995-2#1)(1995-6#2)(1996-5#4)(1996-9#1)(1997-2#2)(1997-8#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#4)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#5)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#5)
approves##4##1##(1992-8#1)(1994-2#1)(1995-6#2)
approving##3##1##(1995-12#1)(2008-11#1)(2010-6#1)
approx##24##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1993-12#3)(1993-2#2)(1993-6#1)(1994-8#3)(1996-12#1)(1997-1#1)(1997-7#2)(2008-10#1)(2008-11#3)(2008-5#1)(2011-2#1)
approximate methods##3##2##(1990-8#1)(2008-3#1)(2008-7#1)
approximate molecular weight of##3##4##(1990-12#1)(2008-10#1)(2008-8#1)
approximate molecular##4##2##(1990-12#2)(2008-10#1)(2008-8#1)
approximate##37##1##(1990-12#2)(1990-8#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-8#1)(1994-1#1)(1995-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
approximated by the##3##3##(1992-9#1)(2008-10#1)(2009-5#1)
approximated by##6##2##(1992-2#1)(1992-9#1)(2008-10#1)(2008-3#2)(2009-5#1)
approximated##12##1##(1992-2#1)(1992-9#1)(1997-2#1)(2008-10#4)(2008-3#3)(2009-5#1)(2013-8#1)
approximately -18##2##2##(1993-8#1)(2010-3#1)
approximately 0##36##2##(1991-11#3)(2008-10#19)(2008-11#4)(2008-2#2)(2008-3#5)(2010-1#1)(2010-4#1)(2012-3#1)
approximately 1 in##4##3##(1996-2#1)(2008-10#1)(2008-5#1)(2012-12#1)
approximately 1 m(2)##2##3##(2008-10#2)
approximately 1 microM##2##3##(1990-8#1)(1995-2#1)
approximately 1##58##2##(1990-8#1)(1991-11#1)(1992-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-10#34)(2008-11#3)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
approximately 1%##4##2##(2008-1#1)(2008-10#2)(2011-2#1)
approximately 10 to##2##3##(1991-8#1)(2008-10#1)
approximately 10##24##2##(1991-5#1)(1991-8#1)(1994-11#1)(1995-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-3#1)
approximately 10% of the##2##4##(1995-11#1)(2008-7#1)
approximately 10% of##5##3##(1991-2#1)(1995-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
approximately 10%##10##2##(1991-2#1)(1992-6#1)(1995-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
approximately 10(6)##2##2##(2008-10#2)
approximately 10-fold##5##2##(1995-6#1)(1995-8#1)(2008-10#3)
approximately 100 times##2##3##(2008-10#2)
approximately 100##14##2##(1993-9#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-12#1)
approximately 1000##3##2##(1991-10#1)(2008-3#1)(2008-5#1)
approximately 11 kb##3##3##(1996-3#1)(1996-8#1)(1997-7#1)
approximately 11##5##2##(1996-3#1)(1996-8#1)(1997-7#1)(2008-11#1)(2008-9#1)
approximately 12##9##2##(1993-11#1)(1993-8#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-1#1)
approximately 130##2##2##(1992-12#1)(1995-6#1)
approximately 140##2##2##(1995-12#1)(2012-12#1)
approximately 15 to 20% of##2##5##(2009-12#1)(2013-1#1)
approximately 15##10##2##(1993-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2009-12#1)(2013-1#1)
approximately 15%##4##2##(2008-10#3)(2010-4#1)
approximately 17##4##2##(1995-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
approximately 170##2##2##(1993-11#1)(2008-2#1)
approximately 18##5##2##(1997-7#1)(2008-10#3)(2008-9#1)
approximately 2 in##2##3##(1996-2#1)(2008-3#1)
approximately 2##24##2##(1994-11#1)(1995-2#3)(1996-2#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2012-2#1)
approximately 2%##3##2##(2008-10#3)
approximately 2%)##2##2##(2008-10#2)
approximately 2-fold##5##2##(1994-11#1)(1997-1#1)(1997-8#1)(2008-10#1)(2011-3#1)
approximately 20 kDa##2##3##(1995-12#1)(1997-7#1)
approximately 20 times##2##3##(2008-10#2)
approximately 20##16##2##(1990-5#1)(1992-6#1)(1995-12#1)(1995-8#1)(1995-9#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-9#1)
approximately 20%##6##2##(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-2#1)(2013-1#1)
approximately 200##10##2##(1990-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-5#2)
approximately 2000##2##2##(2008-11#1)(2008-9#1)
approximately 210##2##2##(1990-2#1)(1995-2#1)
approximately 23##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
approximately 24##2##2##(2008-10#1)(2008-2#1)
approximately 25##2##2##(1993-6#1)(1995-12#1)
approximately 25% of##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
approximately 25%##4##2##(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
approximately 27##2##2##(2008-10#2)
approximately 28##2##2##(2008-1#1)(2008-10#1)
approximately 3 days##3##3##(2008-10#1)(2008-7#2)
approximately 3 to##2##3##(2008-10#2)
approximately 3 x##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
approximately 3 years##2##3##(1997-5#1)(2010-1#1)
approximately 3##28##2##(1992-6#1)(1993-6#1)(1995-2#2)(1997-5#1)(2008-10#9)(2008-11#6)(2008-2#1)(2008-3#2)(2008-7#3)(2010-1#1)(2013-1#1)
approximately 3%##5##2##(1996-2#1)(2008-10#3)(2008-12#1)
approximately 30 mM##2##3##(1992-4#1)(2008-10#1)
approximately 30 to##2##3##(2008-10#1)(2012-2#1)
approximately 30##11##2##(1992-4#1)(2008-10#4)(2008-2#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
approximately 30% of the##2##4##(2008-5#1)(2008-8#1)
approximately 30% of##5##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
approximately 30%##9##2##(1991-11#1)(1992-12#1)(1993-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
approximately 300##4##2##(1991-3#1)(1992-1#1)(2008-10#1)(2009-12#1)
approximately 4 percent##2##3##(1994-1#1)(1996-3#1)
approximately 4##15##2##(1990-5#1)(1993-1#1)(1994-1#1)(1994-8#1)(1996-3#1)(2008-10#7)(2008-11#1)(2008-3#1)(2009-7#1)
approximately 4% of##3##3##(1993-9#1)(2008-4#1)(2009-9#1)
approximately 4%##4##2##(1993-9#1)(2008-3#1)(2008-4#1)(2009-9#1)
approximately 40 kDa##3##3##(1992-10#1)(1995-11#1)(2009-7#1)
approximately 40 mg##2##3##(2008-11#2)
approximately 40##12##2##(1992-10#1)(1994-2#1)(1995-11#1)(1995-2#1)(2008-11#4)(2008-3#1)(2008-8#1)(2009-7#1)(2010-9#1)
approximately 40%##3##2##(2008-3#1)(2008-4#1)(2008-7#1)
approximately 400##3##2##(1997-6#1)(2009-12#1)(2012-3#1)
approximately 45##2##2##(1995-6#1)(2008-9#1)
approximately 450##2##2##(1992-1#1)(1996-2#1)
approximately 46##2##2##(2008-10#2)
approximately 5 kb##2##3##(1993-3#1)(1994-11#1)
approximately 5 x##3##3##(2008-11#1)(2008-3#2)
approximately 5##21##2##(1992-2#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-3#3)(2013-8#1)
approximately 5% of##2##3##(2010-5#1)(2011-2#1)
approximately 5%##4##2##(2008-3#1)(2009-3#1)(2010-5#1)(2011-2#1)
approximately 50 mum##2##3##(2008-10#1)(2009-5#1)
approximately 50##11##2##(1992-6#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-12#1)(2013-1#1)
approximately 50% of the##2##4##(2008-10#1)(2009-10#1)
approximately 50% of##3##3##(2008-10#1)(2009-10#1)(2011-3#1)
approximately 50%##16##2##(1991-10#1)(1991-3#1)(1992-6#1)(1993-3#1)(1994-11#2)(1995-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-10#1)(2011-3#1)
approximately 500##4##2##(1990-12#1)(1993-8#1)(2008-10#1)(2009-12#1)
approximately 52##2##2##(2008-11#1)(2008-2#1)
approximately 56##2##2##(2008-6#1)(2009-10#1)
approximately 6##10##2##(1993-1#1)(1994-6#1)(2008-10#5)(2008-6#1)(2008-9#1)(2013-8#1)
approximately 60##12##2##(1991-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
approximately 60% of##3##3##(1994-11#1)(2008-10#1)(2012-12#1)
approximately 60%##6##2##(1993-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2012-12#1)
approximately 600 bp##2##3##(1993-6#2)
approximately 600##3##2##(1993-6#2)(2008-10#1)
approximately 65##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
approximately 650##2##2##(2008-10#1)(2008-11#1)
approximately 7##11##2##(1993-3#1)(1993-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#1)(2013-1#1)
approximately 7%##3##2##(2008-10#2)(2011-2#1)
approximately 70##4##2##(1990-11#1)(2008-10#3)
approximately 70% of##2##3##(1991-5#1)(2010-10#1)
approximately 70%##5##2##(1991-5#1)(1993-8#1)(1995-2#1)(2008-10#1)(2010-10#1)
approximately 70-fold##2##2##(1996-3#1)(2008-10#1)
approximately 75##3##2##(2008-11#1)(2008-9#2)
approximately 75%##4##2##(1994-2#1)(2008-10#1)(2008-11#2)
approximately 8 months##3##3##(1991-2#1)(2008-11#1)(2008-7#1)
approximately 8##8##2##(1991-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)
approximately 80 mug##2##3##(2008-10#1)(2008-11#1)
approximately 80##7##2##(1992-12#1)(1995-9#1)(1997-6#1)(2008-10#1)(2008-11#2)(2009-9#1)
approximately 80%##6##2##(1994-9#1)(1997-9#1)(2008-10#3)(2009-3#1)
approximately 85%##2##2##(2008-11#1)(2009-3#1)
approximately 850##2##2##(1995-6#1)(1997-6#1)
approximately 86##2##2##(2008-10#2)
approximately 9##5##2##(1991-12#1)(1992-3#1)(2008-10#2)(2008-11#1)
approximately 90##6##2##(1990-3#1)(2008-10#4)(2009-8#1)
approximately 90% of the##3##4##(1996-2#1)(2008-11#1)(2010-8#1)
approximately 90% of##4##3##(1996-2#1)(2008-11#2)(2010-8#1)
approximately 90%##8##2##(1996-2#1)(2008-10#1)(2008-11#3)(2009-10#1)(2010-8#1)(2012-3#1)
approximately 93##2##2##(2008-10#2)
approximately a##5##2##(1992-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
approximately an order of magnitude##2##5##(1991-5#1)(2008-2#1)
approximately constant##2##2##(1995-2#1)(2008-11#1)
approximately double##2##2##(1991-3#1)(2008-10#1)
approximately eight##2##2##(2008-11#2)
approximately equal to 0##2##4##(1991-5#1)(1994-5#1)
approximately equal to the sum of the genes in##2##9##(2008-10#2)
approximately equal to the##3##4##(2008-10#2)(2008-3#1)
approximately equal to##11##3##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#3)(1994-5#1)(2008-10#3)(2008-3#1)
approximately equal##17##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#3)(1994-11#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)
approximately every 2##2##3##(1994-9#1)(2008-10#1)
approximately five##3##2##(2008-10#3)
approximately from##3##2##(2008-10#1)(2010-3#2)
approximately half of##2##3##(1990-9#1)(2012-3#1)
approximately half##5##2##(1990-9#1)(1993-1#1)(2008-11#1)(2008-7#1)(2012-3#1)
approximately one third##2##3##(2008-2#1)(2009-1#1)
approximately one##7##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-1#1)(2011-2#1)(2012-12#1)
approximately one-third##2##2##(1994-12#1)(2008-10#1)
approximately proportional to the number of##2##6##(2008-10#2)
approximately proportional to the##3##4##(2008-10#2)(2008-3#1)
approximately six##2##2##(2008-10#1)(2008-8#1)
approximately the same##11##3##(1990-11#1)(1991-5#1)(1993-6#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-7#2)
approximately the##13##2##(1990-11#1)(1990-2#1)(1991-5#1)(1993-6#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-7#2)
approximately three times##2##3##(2008-11#1)(2008-2#1)
approximately three##4##2##(1995-5#1)(1996-3#1)(2008-11#1)(2008-2#1)
approximately twice as many##2##4##(1994-6#1)(2008-10#1)
approximately twice as##3##3##(1993-1#1)(1994-6#1)(2008-10#1)
approximately twice the##2##3##(2008-3#1)(2009-7#1)
approximately twice##5##2##(1993-1#1)(1994-6#1)(2008-10#1)(2008-3#1)(2009-7#1)
approximately two##3##2##(1991-6#1)(2008-5#1)(2013-1#1)
approximately two-fold##3##2##(1995-9#1)(1996-2#1)(2009-9#1)
approximately twofold##4##2##(1994-2#1)(2008-10#2)(2008-3#1)
approximately##874##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#3)(1990-8#1)(1990-9#5)(1991-1#1)(1991-10#3)(1991-11#6)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#7)(1991-6#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#8)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#5)(1993-8#8)(1993-9#2)(1994-1#1)(1994-11#10)(1994-12#2)(1994-2#6)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#4)(1995-11#2)(1995-12#5)(1995-2#16)(1995-3#1)(1995-5#1)(1995-6#12)(1995-8#4)(1995-9#3)(1996-12#2)(1996-2#7)(1996-3#4)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#5)(1997-9#2)(2006-6#1)(2007-12#5)(2008-1#4)(2008-10#339)(2008-11#72)(2008-12#3)(2008-2#22)(2008-3#52)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#17)(2008-8#11)(2008-9#19)(2009-1#1)(2009-10#6)(2009-12#4)(2009-3#4)(2009-5#6)(2009-7#3)(2009-8#2)(2009-9#5)(2010-1#3)(2010-10#1)(2010-12#2)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#9)(2011-3#2)(2012-12#7)(2012-2#4)(2012-3#7)(2013-1#10)(2013-8#6)
approximates the##2##2##(2008-3#1)(2008-8#1)
approximating the##2##2##(2011-2#1)(2013-1#1)
approximating##6##1##(1990-8#1)(2008-3#1)(2008-6#2)(2011-2#1)(2013-1#1)
approximation (such as##2##3##(2008-10#2)
approximation based on##2##3##(2008-3#2)
approximation for the##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
approximation for##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)
approximation is valid only for##2##5##(2008-3#2)
approximation is##4##2##(2008-3#4)
approximation of a##3##3##(2008-10#1)(2013-8#2)
approximation of the##5##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
approximation of##11##2##(1992-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2013-8#2)
approximation properties of##2##3##(2008-6#2)
approximation that##2##2##(1990-8#1)(2012-3#1)
approximation to the##2##3##(2008-3#2)
approximation to##7##2##(2008-3#7)
approximation##70##1##(1990-5#1)(1990-8#1)(1992-3#1)(1996-3#1)(2007-12#1)(2008-10#14)(2008-2#7)(2008-3#29)(2008-6#3)(2008-7#1)(2008-8#3)(2009-5#1)(2012-3#3)(2013-1#2)(2013-8#2)
approximations and##2##2##(2008-8#1)(2010-1#1)
approximations for##3##2##(2008-3#3)
approximations to##2##2##(1990-8#1)(2008-2#1)
approximations##14##1##(1990-8#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-8#1)(2009-10#1)(2010-1#1)
aprV5##2##1##(1993-12#2)
apricot and Japanese plum##2##4##(2008-10#2)
apricot and##3##2##(2008-10#3)
apricot pollen##3##2##(2008-10#3)
apricot##15##1##(2008-10#9)(2012-8#6)
aprotic solvents##2##2##(2008-10#2)
aprotic##5##1##(2008-10#5)
aprotinin##3##1##(1995-6#1)(2010-7#1)(2012-12#1)
après consentement##2##2##(2013-1#2)
après le##2##2##(2011-2#1)(2013-1#1)
après##7##1##(2011-2#1)(2013-1#6)
apt##2##1##(2009-3#1)(2012-3#1)
aptamer##4##1##(2009-12#1)(2010-12#1)(2010-7#1)(2013-1#1)
aptamers are##2##2##(2010-5#1)(2010-7#1)
aptamers as##2##2##(2010-11#1)(2010-7#1)
aptamers can be##3##3##(2009-12#1)(2010-5#1)(2010-7#1)
aptamers to##2##2##(2008-4#1)(2013-1#1)
aptamers##19##1##(2008-4#2)(2009-12#4)(2010-11#1)(2010-5#4)(2010-7#4)(2012-2#2)(2013-1#2)
aptera aptera##2##2##(2008-12#2)
aptera##4##1##(2008-12#4)
aptly##2##1##(2008-7#1)(2009-10#1)
aqua regia and##2##3##(2008-10#2)
aqua regia extraction##4##3##(2008-10#4)
aqua regia##15##2##(2008-10#15)
aqua-regia extractable content of the##2##5##(2008-10#2)
aquaculture##6##1##(2008-7#1)(2010-11#1)(2010-5#2)(2013-1#1)(2013-8#1)
aquaporin-2##2##1##(2013-8#2)
aquatic HS##4##2##(2008-10#4)
aquatic environments##9##2##(2008-10#6)(2008-9#2)(2009-4#1)
aquatic food webs##2##3##(2008-8#2)
aquatic food##3##2##(2008-8#3)
aquatic humic matter##2##3##(2008-10#2)
aquatic humic##8##2##(2008-10#8)
aquatic media##3##2##(2008-10#1)(2008-11#2)
aquatic plant Lemna minor##2##4##(2008-10#1)(2008-7#1)
aquatic plant##5##2##(2008-10#4)(2008-7#1)
aquatic plants##2##2##(2008-10#1)(2008-12#1)
aquatic realm##2##2##(2008-9#1)(2010-6#1)
aquatic##79##1##(1992-5#1)(1995-12#1)(2008-10#42)(2008-11#5)(2008-12#5)(2008-7#1)(2008-8#5)(2008-9#11)(2009-3#1)(2009-4#1)(2010-6#3)(2011-2#1)(2012-2#1)(2013-8#1)
aquaticus##5##1##(1997-8#1)(2008-10#1)(2008-12#3)
aqueduct##2##1##(2008-7#2)
aqueous acidic##2##2##(2008-10#2)
aqueous alkaline##2##2##(2008-10#2)
aqueous and micellar##2##3##(2008-10#2)
aqueous and organic phases##3##4##(2008-10#2)(2010-4#1)
aqueous and organic##5##3##(1990-5#1)(2008-10#2)(2010-4#2)
aqueous and##24##2##(1990-5#1)(1994-5#1)(2008-10#20)(2010-4#2)
aqueous and/or organic drops##2##4##(2008-10#2)
aqueous buffer##2##2##(2008-10#2)
aqueous dilution##2##2##(2008-10#2)
aqueous dilutions##2##2##(2008-10#1)(2010-7#1)
aqueous dispersions##2##2##(1994-5#1)(2008-5#1)
aqueous environment##5##2##(2008-10#3)(2013-1#2)
aqueous environmental##2##2##(2008-10#2)
aqueous exposure##3##2##(2008-5#3)
aqueous extract of Azadirachta indica##2##5##(2008-12#2)
aqueous extract of##6##3##(2008-10#1)(2008-11#1)(2008-12#2)(2012-2#2)
aqueous extract##10##2##(2008-10#3)(2008-11#2)(2008-12#3)(2012-2#2)
aqueous extracts of the##2##4##(2008-10#2)
aqueous extracts of##6##3##(2008-10#4)(2008-11#2)
aqueous extracts##8##2##(2008-10#5)(2008-11#2)(2012-2#1)
aqueous food simulants##2##3##(2008-10#2)
aqueous humor##6##2##(2008-12#5)(2011-3#1)
aqueous ion-pair formation (K(MLA)) of##2##5##(2008-10#2)
aqueous ion-pair formation (K(MLA))##3##4##(2008-10#3)
aqueous ionisation constant of##2##4##(2008-10#2)
aqueous matrix##3##2##(2008-10#3)
aqueous media was##2##3##(2008-10#2)
aqueous media##30##2##(1990-2#2)(2008-10#25)(2008-6#2)(2012-2#1)
aqueous medium at##2##3##(2008-10#2)
aqueous medium in##3##3##(1997-2#1)(2008-10#2)
aqueous medium using##3##3##(2008-10#3)
aqueous medium##29##2##(1997-2#2)(2008-10#27)
aqueous methanol##5##2##(2008-10#5)
aqueous micellar solutions of octyl-beta-D-thioglucoside##2##5##(2008-7#2)
aqueous micellar solutions of##3##4##(2008-10#1)(2008-7#2)
aqueous micellar solutions##4##3##(2008-10#2)(2008-7#2)
aqueous micellar##9##2##(2008-10#7)(2008-7#2)
aqueous mobile##2##2##(2008-10#2)
aqueous organic solvent##2##3##(2008-10#2)
aqueous ozone##3##2##(2008-10#3)
aqueous phase and##11##3##(2008-10#10)(2010-4#1)
aqueous phase as##3##3##(2008-10#2)(2008-7#1)
aqueous phase could be##2##4##(2008-10#2)
aqueous phase on##2##3##(2008-10#2)
aqueous phase to##2##3##(2008-10#2)
aqueous phase using##2##3##(2008-10#2)
aqueous phase was##3##3##(2008-10#2)(2008-5#1)
aqueous phase##57##2##(1990-5#1)(1991-5#1)(2008-10#47)(2008-5#4)(2008-7#3)(2010-4#1)
aqueous phases##3##2##(1991-5#1)(2008-10#2)
aqueous potassium##2##2##(2008-10#2)
aqueous sample extraction (RASE)##2##4##(2008-10#2)
aqueous sample extraction##4##3##(2008-10#4)
aqueous sample is##2##3##(2008-10#2)
aqueous sample solution##5##3##(2008-10#5)
aqueous sample##19##2##(2008-10#19)
aqueous samples and##2##3##(2008-10#2)
aqueous samples for##3##3##(2008-10#3)
aqueous samples is demonstrated##2##4##(2008-10#2)
aqueous samples is##4##3##(2008-10#4)
aqueous samples using##2##3##(2008-10#2)
aqueous samples was##2##3##(2008-10#2)
aqueous samples##33##2##(2008-10#33)
aqueous sodium##6##2##(2008-10#5)(2009-5#1)
aqueous solution and##14##3##(1990-5#1)(2008-10#12)(2008-5#1)
aqueous solution as##3##3##(2008-10#2)(2008-9#1)
aqueous solution at pH##4##4##(2008-10#4)
aqueous solution at##7##3##(2008-10#7)
aqueous solution by##4##3##(2008-10#4)
aqueous solution containing##7##3##(2008-10#4)(2008-8#1)(2008-9#1)(2011-2#1)
aqueous solution for##4##3##(2008-10#3)(2008-11#1)
aqueous solution in the presence of##2##6##(2008-10#2)
aqueous solution in##3##3##(2008-10#3)
aqueous solution of 0##2##4##(2008-10#2)
aqueous solution of the##2##4##(1997-2#1)(2008-10#1)
aqueous solution of##9##3##(1997-2#1)(2008-10#7)(2011-2#1)
aqueous solution to##3##3##(1990-5#1)(2008-10#2)
aqueous solution using##2##3##(2008-10#2)
aqueous solution was 0##2##4##(2008-10#2)
aqueous solution was##8##3##(2008-10#7)(2008-11#1)
aqueous solution were##6##3##(2008-10#4)(2008-5#1)(2008-8#1)
aqueous solution with##6##3##(1992-3#1)(2008-10#5)
aqueous solution##156##2##(1990-5#2)(1990-9#1)(1991-2#1)(1991-5#1)(1992-3#1)(1997-2#5)(2008-10#129)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2011-2#2)
aqueous solutions and##7##3##(2008-10#6)(2008-11#1)
aqueous solutions are##3##3##(2008-10#2)(2008-3#1)
aqueous solutions by##3##3##(2008-10#3)
aqueous solutions containing other##2##4##(2008-10#2)
aqueous solutions containing the##2##4##(2008-10#1)(2011-2#1)
aqueous solutions containing##12##3##(2008-10#10)(2008-5#1)(2011-2#1)
aqueous solutions in##2##3##(2008-10#2)
aqueous solutions into##3##3##(2008-10#3)
aqueous solutions of##11##3##(2008-10#11)
aqueous solutions was studied##3##4##(2008-10#3)
aqueous solutions was##6##3##(2008-10#6)
aqueous solutions were##4##3##(2008-10#4)
aqueous solutions##103##2##(2008-10#93)(2008-11#2)(2008-3#3)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#2)
aqueous solvent##3##2##(2008-10#3)
aqueous solvents##5##2##(2008-10#5)
aqueous standard solutions##3##3##(2008-10#3)
aqueous standard##5##2##(2008-10#5)
aqueous standards calibration##2##3##(2008-10#2)
aqueous standards for##2##3##(2008-10#2)
aqueous standards##20##2##(2008-10#20)
aqueous suspensions of##3##3##(2008-10#2)(2008-11#1)
aqueous to##3##2##(2008-10#3)
aqueous two-phase system of tetrabutylammonium bromide##2##6##(2008-10#2)
aqueous two-phase system of##4##4##(2008-10#4)
aqueous two-phase system##9##3##(2008-10#7)(2011-2#2)
aqueous two-phase systems##3##3##(2008-7#3)
aqueous two-phase##13##2##(2008-10#7)(2008-7#3)(2011-2#2)(2012-3#1)
aqueous##716##1##(1990-2#2)(1990-5#5)(1990-9#1)(1991-2#1)(1991-5#5)(1992-3#1)(1992-9#1)(1994-11#1)(1994-5#4)(1995-3#2)(1996-5#1)(1997-2#7)(2007-11#1)(2008-10#594)(2008-11#13)(2008-12#10)(2008-3#5)(2008-4#1)(2008-5#16)(2008-6#2)(2008-7#12)(2008-8#3)(2008-9#3)(2009-5#2)(2010-11#1)(2010-4#3)(2010-7#3)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#3)
aqueous-based##3##1##(1997-2#2)(2008-11#1)
aqueous/ethanolic solutions##2##2##(2008-10#2)
aquifer##2##1##(2008-10#2)
aquifers##2##1##(2008-10#2)
arNOX activity##2##2##(2009-9#2)
arab##2##1##(2008-1#1)(2008-10#1)
arabica and robusta##4##3##(2008-10#4)
arabica extracts##2##2##(2013-8#2)
arabica##8##1##(2008-10#4)(2013-8#4)
arabinose##2##1##(2008-10#1)(2011-1#1)
arachidic##2##1##(1995-11#1)(2008-10#1)
arachidonate release##5##2##(2008-11#5)
arachidonate##8##1##(1991-5#1)(1993-8#1)(2008-10#1)(2008-11#5)
arachidonic acid (AA)##3##3##(1992-12#1)(1993-8#1)(2008-11#1)
arachidonic acid and##4##3##(1990-12#1)(1993-8#1)(2008-7#1)(2013-1#1)
arachidonic acid liberation##5##3##(1994-3#2)(1995-11#3)
arachidonic acid metabolism##6##3##(1994-8#3)(2008-11#3)
arachidonic acid oxidation##2##3##(1994-5#1)(2009-8#1)
arachidonic acid release##3##3##(1997-1#1)(2008-11#1)(2011-2#1)
arachidonic acid##49##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-8#2)(1994-11#2)(1994-3#3)(1994-5#7)(1994-8#3)(1995-11#12)(1997-1#2)(2008-11#7)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
arachidonic##50##1##(1990-12#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-8#2)(1994-11#2)(1994-3#3)(1994-5#8)(1994-8#3)(1995-11#12)(1997-1#2)(2008-11#7)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
arachnoid cyst##5##2##(1991-11#3)(2008-7#1)(2009-9#1)
arachnoid##9##1##(1991-11#3)(2008-7#3)(2009-9#1)(2011-2#1)(2012-3#1)
aragonite crystal##2##2##(2008-7#2)
aragonite##14##1##(1990-11#1)(2008-10#7)(2008-7#6)
araneophagy##2##1##(2012-3#2)
arbitrarily primed polymerase chain reaction##2##5##(2008-10#1)(2008-11#1)
arbitrarily##13##1##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#1)
arbitrary and##2##2##(1996-6#1)(2008-6#1)
arbitrary illumination##2##2##(2008-3#2)
arbitrary orientation##4##2##(2008-2#1)(2008-3#3)
arbitrary primer##2##2##(2008-10#2)
arbitrary shape##2##2##(2007-11#1)(2008-3#1)
arbitrary time##2##2##(2008-10#1)(2008-5#1)
arbitrary##39##1##(1992-12#1)(1992-9#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#14)(2008-5#1)(2008-6#3)(2009-7#1)
arboreal##2##1##(1994-5#1)(2012-9#1)
arborescens##6##1##(2008-10#6)
arboreum##3##1##(2008-8#3)
arboricola pv##5##2##(2008-10#5)
arboricola##8##1##(2008-10#8)
arborization##2##1##(1997-1#1)(2012-2#1)
arbors##4##1##(1994-2#3)(1997-3#1)
arbuscular mycorrhizae##2##2##(2008-10#1)(2010-10#1)
arbuscular mycorrhizal fungi##3##3##(2008-11#1)(2008-8#1)(2013-8#1)
arbuscular mycorrhizal##7##2##(2008-10#3)(2008-11#2)(2008-8#1)(2013-8#1)
arbuscular##9##1##(2008-10#4)(2008-11#2)(2008-8#1)(2010-10#1)(2013-8#1)
arbutin##2##1##(2008-6#2)
arbutine##2##1##(2008-5#2)
arc furnace flue##2##3##(2008-10#2)
arc##14##1##(2008-10#5)(2008-11#2)(2008-3#5)(2008-5#1)(2008-9#1)
arced##2##1##(2008-10#1)(2008-7#1)
arch and##3##2##(1997-8#2)(2012-2#1)
arch is##2##2##(2010-7#1)(2011-2#1)
arch of##2##2##(2011-2#1)(2013-1#1)
arch##16##1##(1993-9#1)(1997-8#5)(2008-12#1)(2010-7#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
archaea##6##1##(2008-11#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)
archaeal##3##1##(1993-9#1)(2011-2#1)(2012-2#1)
archaebacteria##3##1##(1990-5#1)(2008-8#2)
archaeological ceramic##2##2##(2008-10#2)
archaeological glass##2##2##(2008-10#2)
archaeological samples##2##2##(2008-10#2)
archaeological##27##1##(1991-2#2)(2008-10#23)(2012-9#2)
archaeometric study##2##2##(2008-10#2)
archaeon##4##1##(1993-9#2)(2008-9#1)(2011-2#1)
archaic##2##1##(1994-3#1)(2008-10#1)
archeological##2##1##(2008-5#2)
arches##5##1##(1990-5#1)(2008-11#1)(2011-2#1)(2011-7#1)(2013-1#1)
archetypal##4##1##(1990-8#1)(1993-2#1)(2008-11#1)(2010-9#1)
archetype##2##1##(1996-2#1)(2008-10#1)
archipelago##2##1##(2008-8#1)(2010-4#1)
architects##5##1##(1994-3#1)(2012-3#4)
architectural distortion##2##2##(2009-12#2)
architectural terracotta##2##2##(2008-10#2)
architectural##15##1##(1991-11#1)(1991-12#1)(1995-8#3)(1997-3#1)(2008-10#6)(2008-9#1)(2009-12#2)
architecture and##5##2##(2008-10#1)(2008-9#1)(2011-2#3)
architecture as##2##2##(2010-3#1)(2011-2#1)
architecture is characteristic##2##3##(1991-2#1)(2008-11#1)
architecture is##7##2##(1991-2#1)(1997-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
architecture of a##2##3##(2008-10#1)(2008-11#1)
architecture of the##7##3##(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)
architecture of##14##2##(1990-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
architecture with##2##2##(2008-10#1)(2009-12#1)
architecture##65##1##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-2#1)(1995-8#2)(1997-6#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#4)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#4)(2010-9#1)(2011-2#10)(2011-7#1)(2012-12#1)(2012-3#1)
architectures and##2##2##(1997-6#1)(2008-3#1)
architectures are##3##2##(1990-11#2)(2008-3#1)
architectures##11##1##(1990-11#4)(1997-6#1)(2008-3#3)(2008-7#1)(2009-12#1)(2011-2#1)
archival##9##1##(1992-1#2)(1994-11#1)(1996-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
archive##3##1##(1990-3#1)(2008-10#1)(2012-2#1)
archived##5##1##(2008-10#3)(2008-9#1)(2011-2#1)
archives##4##1##(1992-1#2)(2008-10#1)(2009-12#1)
archiving##4##1##(1994-3#2)(2008-10#1)(2011-2#1)
archosaurs##3##1##(2008-8#3)
arcjet plume##2##2##(2008-2#1)(2008-3#1)
arcjet##8##1##(2008-2#6)(2008-3#2)
arcs##4##1##(2008-12#1)(2008-3#2)(2008-7#1)
arcsine##3##1##(1991-2#3)
arctic##4##1##(1991-5#1)(2008-10#1)(2008-9#1)(2012-3#1)
arcuate##5##1##(1994-2#1)(1996-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
arcus senilis##3##2##(2008-7#3)
arcus##4##1##(1997-8#1)(2008-7#3)
arduous##2##1##(1993-3#1)(2008-9#1)
are &quot##9##2##(1992-2#1)(1994-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
are (1) the##2##3##(2008-3#2)
are (1)##4##2##(2008-3#2)(2008-4#1)(2010-1#1)
are (i)##2##2##(2008-10#1)(2008-3#1)
are 0##46##2##(1993-8#1)(1994-12#1)(2008-10#40)(2008-11#1)(2008-3#2)(2008-9#1)
are 1##22##2##(2008-10#20)(2008-3#2)
are 100##2##2##(2008-10#1)(2008-11#1)
are 12##2##2##(2008-9#1)(2013-1#1)
are 13##2##2##(2008-9#2)
are 15##2##2##(2008-10#1)(2008-7#1)
are 18##2##2##(2008-10#2)
are 2##13##2##(1995-3#1)(2008-10#11)(2009-10#1)
are 3##9##2##(1994-2#1)(2008-10#6)(2008-11#1)(2008-3#1)
are 33##2##2##(2008-10#1)(2008-9#1)
are 4##9##2##(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#1)
are 40##2##2##(1994-11#1)(2008-10#1)
are 5##5##2##(1991-2#1)(2008-10#4)
are 6##7##2##(1992-6#1)(2008-10#5)(2008-11#1)
are 7##4##2##(1992-8#1)(1994-8#1)(2008-10#1)(2013-1#1)
are 76##2##2##(1994-1#1)(2008-3#1)
are 79##2##2##(1992-10#1)(1995-6#1)
are 9##2##2##(2008-10#2)
are HIV-positive##2##2##(1995-6#2)
are a class of##5##4##(2008-1#1)(2008-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
are a common feature of##2##5##(1995-6#1)(2008-8#1)
are a common##7##3##(1993-2#1)(1995-6#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
are a consequence of##3##4##(2008-10#3)
are a family of##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
are a few##3##3##(1993-12#1)(1997-2#1)(2010-10#1)
are a function of both##2##5##(2008-10#1)(2008-12#1)
are a group of##5##4##(1991-5#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)
are a heterogeneous group of##2##5##(2008-7#1)(2012-3#1)
are a heterogeneous group##3##4##(2008-7#1)(2010-3#1)(2012-3#1)
are a heterogeneous##4##3##(2008-10#1)(2008-7#1)(2010-3#1)(2012-3#1)
are a key##2##3##(2011-2#1)(2012-3#1)
are a large group of##2##5##(2008-10#1)(2008-12#1)
are a large##3##3##(2008-10#2)(2008-12#1)
are a major cause of##3##5##(2008-11#2)(2010-5#1)
are a major source of##2##5##(2008-11#1)(2013-1#1)
are a major##8##3##(1997-3#1)(2008-10#1)(2008-11#3)(2010-12#1)(2010-5#1)(2013-1#1)
are a new class of##2##5##(2008-9#1)(2011-3#1)
are a new##4##3##(1993-8#1)(2008-9#1)(2011-2#1)(2011-3#1)
are a novel class of##3##5##(2008-10#2)(2012-2#1)
are a number of possible##2##5##(1995-3#1)(2008-10#1)
are a number of##19##4##(1991-3#1)(1992-9#1)(1995-3#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
are a potential##3##3##(2008-10#2)(2011-2#1)
are a rare##6##3##(2008-10#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#1)
are a reality##2##3##(2008-10#1)(2008-11#1)
are a significant##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
are a source of##4##4##(1997-3#1)(2007-12#1)(2008-11#1)(2010-1#1)
are a type of##2##4##(1995-5#1)(1996-3#1)
are a useful##2##3##(2008-4#1)(2011-2#1)
are a valuable tool##2##4##(2008-1#1)(2008-5#1)
are a valuable##3##3##(2008-1#1)(2008-5#1)(2012-3#1)
are a##172##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(2007-12#1)(2008-1#3)(2008-10#26)(2008-11#16)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#11)(2011-3#2)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#5)(2013-8#1)
are able to cause##2##4##(2006-6#1)(2008-10#1)
are able to confer##3##4##(1992-7#1)(1993-8#2)
are able to detect##2##4##(2008-10#2)
are able to differentiate in##2##5##(2008-11#1)(2013-1#1)
are able to form##2##4##(1994-5#1)(2008-4#1)
are able to generate##2##4##(2008-3#1)(2010-7#1)
are able to induce##2##4##(2008-10#1)(2008-9#1)
are able to infect##2##4##(2008-10#2)
are able to obtain##3##4##(1995-5#1)(1997-2#1)(2008-7#1)
are able to provide##2##4##(2008-11#2)
are able to stimulate the##2##5##(1993-8#1)(2008-9#1)
are able to stimulate##4##4##(1993-8#2)(2008-9#1)(2012-2#1)
are able to##71##3##(1992-12#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-3#1)(1994-5#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#2)(2006-6#1)(2008-10#11)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
are able##72##2##(1992-12#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-3#1)(1994-5#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#2)(2006-6#1)(2008-10#11)(2008-11#11)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
are about to##2##3##(1991-2#1)(2008-5#1)
are about##12##2##(1991-2#1)(1994-5#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)
are absent##6##2##(1993-12#1)(1996-11#1)(2008-8#1)(2008-9#1)(2011-2#2)
are absorbed##2##2##(2008-3#1)(2012-2#1)
are abundant in the##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
are abundant in##6##3##(1990-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#1)
are abundant##9##2##(1990-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2013-1#1)
are acceptable##3##2##(1994-3#1)(2008-10#1)(2012-2#1)
are accepted##2##2##(2008-7#1)(2008-8#1)
are accessible to##2##3##(2008-10#1)(2008-11#1)
are accessible##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-7#1)
are accompanied by##7##3##(2008-10#1)(2008-4#1)(2008-9#3)(2010-12#1)(2013-8#1)
are accompanied##8##2##(2008-10#1)(2008-4#1)(2008-9#4)(2010-12#1)(2013-8#1)
are accomplished##2##2##(1991-2#1)(2008-10#1)
are accumulated in##2##3##(1994-3#1)(2008-7#1)
are accumulated##3##2##(1994-3#1)(2008-7#1)(2011-2#1)
are accumulating##2##2##(2008-7#1)(2011-2#1)
are accurately##2##2##(1997-8#1)(2008-3#1)
are achievable##2##2##(2008-12#1)(2010-6#1)
are achieved by##2##3##(2008-10#2)
are achieved##9##2##(2007-11#1)(2008-10#5)(2008-3#2)(2008-7#1)
are acquired in##2##3##(2008-10#1)(2008-11#1)
are acquired##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
are activated by##7##3##(1990-2#1)(1991-2#1)(1993-3#1)(1996-2#1)(2008-8#1)(2009-7#1)(2011-2#1)
are activated##15##2##(1990-2#1)(1991-2#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
are active at##2##3##(2008-11#1)(2011-2#1)
are active##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#2)
are actively involved##2##3##(1994-8#1)(2011-2#1)
are actively##5##2##(1990-2#1)(1992-6#1)(1994-8#1)(1997-7#1)(2011-2#1)
are actually based on##2##4##(2008-10#1)(2008-11#1)
are actually##5##2##(2008-10#2)(2008-11#2)(2009-4#1)
are adapted to##2##3##(1995-11#1)(2008-9#1)
are adapted##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
are adaptive##2##2##(2008-9#1)(2009-11#1)
are added to the mixture##2##5##(1995-8#1)(2008-10#1)
are added to the##3##4##(1995-8#1)(2008-10#2)
are added to##5##3##(1995-8#1)(2008-10#3)(2012-2#1)
are added##9##2##(1993-1#1)(1994-1#1)(1995-8#1)(2007-12#1)(2008-10#4)(2012-2#1)
are additional##6##2##(2006-6#1)(2008-10#1)(2008-12#1)(2008-9#2)(2010-5#1)
are addressed##11##2##(1992-1#1)(1996-12#1)(1996-3#2)(2008-10#2)(2009-12#1)(2009-5#1)(2010-11#1)(2010-8#1)(2013-1#1)
are adequate for##2##3##(2008-10#1)(2008-11#1)
are adequate##5##2##(1997-5#1)(2008-10#1)(2008-11#2)(2013-1#1)
are adjusted to##3##3##(1992-12#1)(2008-10#2)
are adjusted##4##2##(1992-12#1)(2008-10#2)(2009-12#1)
are administered##4##2##(1990-9#1)(1991-3#1)(1996-3#1)(2013-8#1)
are admitted to##3##3##(1994-2#1)(1997-5#1)(2008-3#1)
are adsorbed on##2##3##(2008-10#2)
are adsorbed##8##2##(2008-10#7)(2008-5#1)
are advised to##2##3##(1997-4#1)(2011-2#1)
are advised##3##2##(1997-4#1)(2011-2#2)
are advocated##2##2##(2008-7#1)(2012-2#1)
are affected by##8##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
are affected##15##2##(1991-9#1)(1993-3#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)
are alive##4##2##(1992-5#1)(2008-10#1)(2011-2#2)
are all important##3##3##(1996-3#1)(2010-11#1)(2012-2#1)
are all shown to##2##4##(1995-12#1)(2008-9#1)
are all##32##2##(1990-9#1)(1992-2#1)(1992-3#2)(1993-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(2007-11#1)(2008-10#6)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)
are allowed to##2##3##(1993-6#1)(2008-3#1)
are allowed##3##2##(1990-6#1)(1993-6#1)(2008-3#1)
are almost always##3##3##(1992-2#1)(2008-12#1)(2008-8#1)
are almost identical##2##3##(1997-8#1)(2010-7#1)
are almost##14##2##(1992-12#2)(1992-2#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2009-8#1)(2010-7#1)
are already##11##2##(1990-9#1)(1991-2#1)(2007-12#2)(2008-11#1)(2008-6#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-3#1)
are also a##2##3##(2008-10#1)(2011-4#1)
are also able to##2##4##(1995-8#1)(2008-5#1)
are also addressed##5##3##(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
are also among the##2##4##(2008-9#1)(2013-1#1)
are also associated with##5##4##(2008-12#1)(2008-5#1)(2010-3#1)(2010-4#1)(2012-3#1)
are also at##3##3##(2008-11#1)(2009-12#1)(2009-8#1)
are also available##2##3##(1996-2#1)(2008-7#1)
are also becoming##2##3##(2008-11#2)
are also being##2##3##(1996-3#1)(2008-10#1)
are also considered##4##3##(1995-12#1)(2008-10#2)(2008-9#1)
are also covered##2##3##(2011-2#1)(2012-2#1)
are also described##12##3##(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-9#1)(2009-9#1)(2012-3#2)
are also detailed##2##3##(2008-4#1)(2008-9#1)
are also developing##2##3##(1996-9#1)(2008-5#1)
are also discussed in the##2##5##(2008-10#1)(2008-6#1)
are also discussed in this##2##5##(2008-11#1)(2010-7#1)
are also discussed in##7##4##(2008-10#4)(2008-11#1)(2008-6#1)(2010-7#1)
are also discussed##43##3##(1991-12#1)(1995-2#1)(1995-3#2)(2007-12#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-12#1)(2010-12#1)(2010-7#2)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
are also effective##2##3##(1997-4#1)(2008-3#1)
are also estimated##2##3##(2008-3#1)(2008-8#1)
are also examined##2##3##(1991-3#1)(2008-11#1)
are also explored##3##3##(1992-1#1)(1992-12#1)(2010-9#1)
are also found in##2##4##(1997-7#1)(2009-8#1)
are also given for##2##4##(2008-4#2)
are also given##6##3##(2008-10#3)(2008-4#2)(2011-2#1)
are also in##2##3##(2008-3#1)(2010-5#1)
are also included##8##3##(1991-1#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#1)
are also investigated##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
are also involved in the##4##5##(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
are also involved in##6##4##(1996-2#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
are also involved##7##3##(1995-2#1)(1996-2#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
are also known to##2##4##(2008-11#1)(2012-2#1)
are also known##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
are also needed##3##3##(1992-12#1)(1997-7#1)(2012-2#1)
are also observed##2##3##(1994-5#1)(2009-7#1)
are also of interest##2##4##(2008-10#1)(2008-11#1)
are also present in##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
are also present##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
are also presented for##2##4##(1991-2#1)(1993-8#1)
are also presented##19##3##(1991-2#1)(1993-8#1)(2007-12#1)(2008-10#10)(2008-4#5)(2008-9#1)
are also proposed##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
are also provided for##4##4##(2007-9#1)(2008-4#2)(2010-10#1)
are also provided##8##3##(2007-9#1)(2008-12#1)(2008-4#4)(2010-10#1)(2012-2#1)
are also relevant##2##3##(2008-12#1)(2012-2#1)
are also reported##9##3##(1990-5#1)(2008-10#5)(2008-11#1)(2011-1#1)(2012-2#1)
are also reviewed##7##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)
are also seen##2##3##(1994-6#1)(2008-10#1)
are also shown##2##3##(2008-5#1)(2012-3#1)
are also some##2##3##(1995-3#1)(2008-12#1)
are also studied##2##3##(2008-10#2)
are also suggested##3##3##(2008-12#1)(2008-6#1)(2010-5#1)
are also summarized##4##3##(1991-12#1)(1996-1#1)(2008-11#2)
are also used to##3##4##(2008-3#2)(2008-7#1)
are also used##6##3##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-8#1)
are also useful in##2##4##(2008-3#1)(2008-4#1)
are also useful##3##3##(2008-3#1)(2008-4#1)(2012-3#1)
are also very##2##3##(1990-8#1)(2008-10#1)
are also well##2##3##(2009-12#2)
are also##307##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-5#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#65)(2008-11#30)(2008-12#7)(2008-2#2)(2008-3#12)(2008-4#25)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#10)(2009-12#5)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#3)(2011-4#1)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#10)(2013-1#8)(2013-7#1)(2013-8#4)
are altered during##2##3##(2008-3#1)(2013-1#1)
are altered in##2##3##(1993-3#1)(1996-12#1)
are altered##10##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2009-1#1)(2011-2#1)(2013-1#1)
are always##7##2##(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)
are amenable to##5##3##(2008-11#2)(2008-9#1)(2010-12#1)(2012-2#1)
are among the most common##2##5##(2008-12#1)(2010-8#1)
are among the most##8##4##(2008-10#3)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
are among the##18##3##(1992-11#1)(1992-3#1)(1994-12#1)(1997-9#1)(2008-10#3)(2008-12#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
are among##20##2##(1992-11#1)(1992-3#1)(1994-12#1)(1995-6#1)(1997-9#1)(2008-10#4)(2008-12#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
are an attractive alternative##2##4##(2008-10#2)
are an effective##2##3##(2011-3#1)(2013-1#1)
are an important part of##2##5##(2010-11#1)(2013-7#1)
are an important tool##2##4##(2008-10#1)(2008-9#1)
are an important##11##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#2)(2013-7#1)(2013-8#1)
are an integral component##2##4##(2008-10#1)(2008-5#1)
are an integral##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
are an unusual cause##2##4##(2009-8#1)(2013-8#1)
are an unusual##3##3##(2008-8#1)(2009-8#1)(2013-8#1)
are an##34##2##(1992-6#1)(1994-12#1)(1995-6#1)(1996-3#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
are analysed by##2##3##(2008-10#2)
are analysed in##4##3##(1990-3#1)(1991-6#1)(2008-10#2)
are analysed##12##2##(1990-3#2)(1991-6#1)(1996-2#1)(2008-10#7)(2010-11#1)
are analytically##2##2##(2008-10#1)(2013-8#1)
are analyzed and##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
are analyzed by a##2##4##(2008-2#1)(2008-3#1)
are analyzed by##7##3##(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-7#1)
are analyzed for##3##3##(1993-3#1)(1995-1#1)(2008-3#1)
are analyzed in##6##3##(1991-3#1)(1994-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
are analyzed to##3##3##(1997-1#1)(2008-2#1)(2013-1#1)
are analyzed using##3##3##(2008-10#3)
are analyzed with##3##3##(1991-3#1)(1997-2#1)(2013-1#1)
are analyzed##55##2##(1990-11#1)(1991-2#1)(1991-3#2)(1992-1#2)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-2#6)(2008-3#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2013-1#3)(2013-8#1)
are anchored##2##2##(1996-5#1)(2008-12#1)
are anomalous##2##2##(2008-6#1)(2008-9#1)
are antagonistic##2##2##(2008-10#1)(2008-11#1)
are antibiotics##2##2##(1997-4#2)
are anticipated##3##2##(1992-1#1)(2008-11#1)(2008-9#1)
are any##3##2##(1990-11#1)(2008-10#1)(2012-2#1)
are apparent##2##2##(2008-11#1)(2008-7#1)
are apparently##4##2##(1991-12#1)(2008-10#3)
are applicable to other##3##4##(1993-11#1)(2008-8#2)
are applicable to the##2##4##(2008-1#1)(2011-2#1)
are applicable to##13##3##(1993-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)
are applicable##15##2##(1993-11#1)(1993-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)
are applied as##2##3##(2008-10#1)(2010-4#1)
are applied for##2##3##(2008-10#1)(2008-3#1)
are applied in##4##3##(2008-10#2)(2008-5#1)(2009-6#1)
are applied to the##6##4##(1990-11#1)(1993-3#1)(2008-10#3)(2010-5#1)
are applied to##14##3##(1990-11#1)(1993-3#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2010-5#1)
are applied##27##2##(1990-11#1)(1991-8#1)(1993-3#1)(2008-10#13)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-4#1)(2010-5#1)
are appropriate for##5##3##(1991-1#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-2#1)
are appropriate##9##2##(1990-5#1)(1991-1#1)(1993-3#1)(1994-3#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-1#1)
are approved##2##2##(1997-8#1)(2011-1#1)
are approximately##5##2##(1995-2#1)(1996-12#1)(2007-12#1)(2008-7#1)(2009-12#1)
are arranged in a##3##4##(1991-6#1)(1996-2#1)(2007-12#1)
are arranged in##4##3##(1991-6#1)(1996-2#1)(2007-12#1)(2008-7#1)
are arranged##7##2##(1991-6#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)
are artificially##2##2##(1995-2#1)(2013-8#1)
are as follows##4##3##(2008-10#3)(2008-8#1)
are as low as##2##4##(1993-8#1)(2008-8#1)
are as##16##2##(1993-8#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-12#1)(2011-2#2)
are asked to##3##3##(1991-12#1)(1993-1#1)(2008-7#1)
are asked##4##2##(1991-12#1)(1993-1#1)(2008-7#1)(2012-2#1)
are aspirated##2##2##(2008-10#2)
are assembled into##2##3##(1993-8#1)(2011-2#1)
are assembled##3##2##(1991-2#1)(1993-8#1)(2011-2#1)
are assessed for##2##3##(2008-11#1)(2008-3#1)
are assessed##8##2##(1995-11#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-6#1)(2011-2#1)
are assigned to##2##3##(1992-3#1)(2008-12#1)
are assigned##4##2##(1992-3#1)(2008-12#1)(2008-4#1)(2012-2#1)
are associated with a low##2##5##(1993-6#1)(2008-4#1)
are associated with a poor##2##5##(2011-2#1)(2012-3#1)
are associated with a##11##4##(1993-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
are associated with an increased##2##5##(2008-7#1)(2009-10#1)
are associated with better##2##4##(2008-6#1)(2010-2#1)
are associated with certain##2##4##(1996-2#1)(2008-11#1)
are associated with considerable##2##4##(2010-10#1)(2012-3#1)
are associated with different##2##4##(2008-12#1)(2012-2#1)
are associated with elevated##2##4##(2008-7#2)
are associated with high##2##4##(1990-2#1)(2009-10#1)
are associated with higher##3##4##(2008-7#1)(2009-8#1)(2013-8#1)
are associated with improved##2##4##(2008-7#1)(2009-11#1)
are associated with increased##2##4##(2008-10#1)(2012-12#1)
are associated with poor##2##4##(1994-12#1)(2011-2#1)
are associated with the##18##4##(1992-5#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
are associated with various##2##4##(1995-2#1)(2013-8#1)
are associated with##118##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-3#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#16)(2008-11#7)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#3)
are associated##121##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-3#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#17)(2008-11#7)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#3)
are assumed to be##2##4##(1992-9#1)(2008-8#1)
are assumed to reflect##2##4##(1991-2#1)(2012-2#1)
are assumed to##8##3##(1991-2#1)(1992-9#1)(1996-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-2#1)
are asymptomatic##2##2##(1993-1#1)(1996-8#1)
are at a##4##3##(1991-5#1)(2007-12#1)(2008-4#1)(2010-11#1)
are at an increased risk##2##5##(2008-12#1)(2013-1#1)
are at an##6##3##(1997-7#1)(2008-1#1)(2008-12#1)(2012-3#1)(2013-1#2)
are at best only##2##4##(2009-8#1)(2011-3#1)
are at best##3##3##(2009-8#1)(2011-3#1)(2013-1#1)
are at high risk of##2##5##(1992-5#1)(2008-11#1)
are at higher risk##3##4##(1993-1#1)(2006-5#1)(2012-3#1)
are at increased risk for##4##5##(1994-12#1)(2008-10#1)(2008-11#2)
are at increased risk of developing##3##6##(2011-2#1)(2012-3#2)
are at increased risk of##7##5##(2006-5#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-3#2)
are at increased risk##11##4##(1994-12#1)(2006-5#1)(2008-10#1)(2008-11#3)(2010-12#1)(2011-2#2)(2012-3#2)
are at least two##3##4##(2008-8#1)(2012-2#2)
are at least##9##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
are at present##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
are at risk for developing##3##5##(2008-1#1)(2008-12#1)(2008-2#1)
are at risk for##9##4##(1991-12#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#1)(2011-2#1)
are at risk of##4##4##(2008-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
are at risk##16##3##(1990-9#1)(1991-12#1)(2008-1#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
are at the##4##3##(1990-11#1)(1994-1#1)(2008-7#1)(2010-4#1)
are at##76##2##(1990-11#1)(1990-9#1)(1991-12#2)(1991-5#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-5#2)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#8)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-4#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)
are attached to the##6##4##(1997-2#1)(2007-12#1)(2008-10#1)(2009-1#1)(2013-1#1)(2013-8#1)
are attached to##8##3##(1997-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2009-1#1)(2013-1#1)(2013-8#1)
are attached##10##2##(1997-2#1)(2007-12#1)(2008-10#4)(2008-12#1)(2009-1#1)(2013-1#1)(2013-8#1)
are attainable##2##2##(2008-10#1)(2008-3#1)
are attained##2##2##(2008-10#1)(2013-1#1)
are attempting to##2##3##(1991-3#1)(2008-11#1)
are attractive##4##2##(2008-7#1)(2010-7#1)(2011-2#2)
are attributable to##3##3##(1992-9#1)(1995-12#1)(2010-7#1)
are attributed to##4##3##(1992-6#1)(2007-12#1)(2012-2#1)(2013-8#1)
are attributes##2##2##(2008-12#1)(2010-8#1)
are automatically##4##2##(2008-10#3)(2008-11#1)
are autosomal##2##2##(2008-7#1)(2008-8#1)
are available and##3##3##(1997-5#1)(2009-7#1)(2013-1#1)
are available as##3##3##(1992-3#1)(2008-10#2)
are available for the##3##4##(1993-6#1)(1997-2#1)(2008-4#1)
are available for##17##3##(1991-9#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2012-2#1)(2012-3#1)
are available from##4##3##(1990-3#1)(1992-6#1)(2008-5#1)(2011-2#1)
are available in the##5##4##(2008-10#2)(2008-5#1)(2008-7#1)(2010-10#1)
are available in##9##3##(1993-1#1)(1997-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
are available on the##2##4##(2008-1#1)(2008-9#1)
are available on##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
are available to the##2##4##(2008-10#1)(2008-5#1)
are available to##10##3##(1993-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-10#1)
are available today##2##3##(1994-1#1)(2010-12#1)
are available##97##2##(1990-2#1)(1990-3#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1995-5#3)(1995-8#1)(1996-1#1)(1997-2#1)(1997-5#3)(1997-6#1)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
are avirulent to##2##3##(2008-10#2)
are awaiting##2##2##(1996-5#1)(1997-7#1)
are aware of##4##3##(2008-7#1)(2010-1#1)(2010-12#1)(2012-2#1)
are aware##6##2##(1995-8#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
are based on a##5##4##(1992-2#1)(1992-3#1)(1997-5#1)(2008-12#1)(2011-2#1)
are based on data##3##4##(1993-12#1)(2008-11#1)(2008-8#1)
are based on the formation##3##5##(2008-10#3)
are based on the hypothesis that##2##6##(2008-11#1)(2010-8#1)
are based on the oxidation of##4##6##(2008-10#4)
are based on the use of##3##6##(2008-10#2)(2012-3#1)
are based on the##38##4##(1990-5#2)(1992-2#1)(1996-3#1)(2008-10#16)(2008-11#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are based on##91##3##(1990-5#2)(1990-8#1)(1991-2#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#28)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
are based upon the##2##4##(2008-12#1)(2011-1#1)
are based upon##6##3##(1991-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)
are based##104##2##(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#4)(2008-3#4)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
are basic##5##2##(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#1)
are basically identical##2##3##(2008-9#1)(2011-2#1)
are basically##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
are becoming an##2##3##(2008-11#1)(2008-8#1)
are becoming increasingly##4##3##(1994-6#1)(1994-9#1)(2008-10#1)(2008-3#1)
are becoming##16##2##(1991-2#1)(1994-6#1)(1994-9#1)(1996-2#2)(1996-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)
are beginning to be##2##4##(2008-10#1)(2008-8#1)
are beginning to##4##3##(1992-1#1)(2008-10#1)(2008-8#2)
are beginning##5##2##(1992-1#1)(1996-2#1)(2008-10#1)(2008-8#2)
are being developed and##2##4##(2008-10#1)(2008-7#1)
are being developed##7##3##(1992-3#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)
are being discussed##2##3##(2008-12#1)(2013-1#1)
are being elucidated##2##3##(2010-11#1)(2012-2#1)
are being evaluated##2##3##(2008-5#1)(2010-10#1)
are being explored as##2##4##(2008-11#1)(2010-4#1)
are being explored##4##3##(2008-11#1)(2009-12#1)(2010-4#1)(2010-7#1)
are being identified##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
are being increasingly##2##3##(2008-4#1)(2010-2#1)
are being investigated##3##3##(1996-1#1)(2008-10#1)(2012-3#1)
are being made to##2##4##(1992-12#1)(2008-5#1)
are being performed##2##3##(2010-1#1)(2013-1#1)
are being planned##2##3##(2008-1#1)(2009-6#1)
are being tested##3##3##(2008-7#1)(2012-2#1)(2012-3#1)
are being undertaken##2##3##(1995-5#1)(2010-11#1)
are being used as##2##4##(1990-9#1)(2011-2#1)
are being used##6##3##(1990-9#1)(1996-2#1)(1997-6#1)(2011-2#1)(2012-2#2)
are being##82##2##(1990-12#1)(1990-9#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-5#1)(1996-1#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#8)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)
are believed to be##3##4##(1992-10#1)(2008-11#2)
are believed to##10##3##(1991-3#1)(1992-10#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#1)(2010-12#1)
are below##4##2##(1993-9#1)(2008-10#3)
are beneficial for##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
are beneficial to##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
are beneficial##9##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#3)
are benign##7##2##(1991-2#1)(2010-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are best explained##2##3##(2008-10#1)(2009-6#1)
are best suited for##2##4##(1990-11#1)(2008-9#1)
are best##12##2##(1990-11#1)(1991-2#1)(1993-12#1)(1994-6#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-2#1)
are better than##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
are better##8##2##(1991-12#1)(1993-12#1)(1995-11#1)(2008-10#3)(2008-11#1)(2009-3#1)
are between##6##2##(2008-10#6)
are biased##2##2##(2008-8#1)(2011-2#1)
are binding##2##2##(1993-3#1)(2008-10#1)
are biologically##3##2##(1992-12#1)(1994-6#1)(2011-2#1)
are blocked by##3##3##(1992-6#1)(1994-12#1)(1994-2#1)
are born##3##2##(1990-6#1)(1997-6#1)(2008-11#1)
are both located##2##3##(1992-8#1)(2008-10#1)
are both##32##2##(1991-1#1)(1991-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-11#2)(2010-6#1)(2011-2#3)(2013-1#2)
are bound to##2##3##(2008-10#1)(2008-9#1)
are bound##5##2##(1990-6#1)(2008-10#2)(2008-9#2)
are briefly described##4##3##(1991-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
are briefly discussed##5##3##(1990-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)
are briefly presented##2##3##(1996-3#1)(2008-3#1)
are briefly reviewed and##2##4##(2008-11#1)(2010-8#1)
are briefly reviewed##4##3##(1991-12#1)(1996-11#1)(2008-11#1)(2010-8#1)
are briefly summarized##3##3##(1995-12#1)(2008-10#1)(2009-6#1)
are briefly##20##2##(1990-9#1)(1991-1#1)(1991-12#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-8#1)
are broadened##2##2##(1994-5#1)(2008-10#1)
are broadly##2##2##(2008-12#1)(2010-12#1)
are brought in##2##3##(2008-10#1)(2008-11#1)
are brought into contact with##2##5##(2008-7#1)(2009-5#1)
are brought to##2##3##(1994-2#1)(2008-10#1)
are brought##8##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-2#1)
are built##5##2##(1993-12#1)(2007-8#1)(2008-10#2)(2009-5#1)
are but##2##2##(1995-2#1)(2013-1#1)
are ca##4##2##(2008-10#4)
are calculated for##6##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
are calculated from##2##3##(2008-5#2)
are calculated##18##2##(1994-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#2)(2008-8#1)
are candidates for##2##3##(2008-10#1)(2008-11#1)
are capable of causing##3##4##(1993-9#1)(2006-6#1)(2008-11#1)
are capable of differentiating into##2##5##(2008-9#2)
are capable of##32##3##(1990-11#1)(1990-2#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-12#1)(2006-6#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)
are capable##33##2##(1990-11#1)(1990-2#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-12#1)(2006-6#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)
are carcinogenic##2##2##(2008-10#1)(2008-12#1)
are carefully##6##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
are caring for##2##3##(2010-11#1)(2012-3#1)
are carried in##2##3##(2008-10#1)(2013-8#1)
are carried out in##4##4##(2008-10#3)(2009-12#1)
are carried out with##3##4##(2008-10#3)
are carried out##14##3##(1996-1#1)(2008-10#10)(2009-10#1)(2009-12#1)(2010-11#1)
are carried##18##2##(1995-6#1)(1996-1#1)(2008-10#12)(2009-10#1)(2009-12#1)(2010-11#1)(2013-8#1)
are categorized##2##2##(1991-11#1)(2008-10#1)
are caused by a##3##4##(1990-11#1)(1997-3#1)(2010-12#1)
are caused by##26##3##(1990-11#1)(1990-8#1)(1991-9#1)(1994-5#1)(1997-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
are caused##28##2##(1990-11#1)(1990-8#1)(1991-9#1)(1994-5#1)(1997-3#1)(2008-10#9)(2008-11#1)(2008-12#2)(2010-12#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
are central to the##2##4##(2008-10#1)(2008-11#1)
are central to##8##3##(1992-10#1)(1993-1#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
are central##11##2##(1992-10#1)(1993-1#1)(1993-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-12#1)
are certain##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
are challenged by##2##3##(1996-3#1)(2010-7#1)
are challenged to##3##3##(1990-6#1)(1995-12#1)(2008-12#1)
are challenged##6##2##(1990-6#1)(1995-12#1)(1996-3#1)(2008-12#1)(2010-7#1)(2013-8#1)
are challenging##2##2##(2009-8#1)(2012-3#1)
are changing##5##2##(1996-2#1)(1997-2#1)(2007-8#1)(2008-11#1)(2012-2#1)
are characterised by##6##3##(2008-1#1)(2008-10#3)(2009-8#1)(2012-2#1)
are characterised##7##2##(2008-1#1)(2008-10#4)(2009-8#1)(2012-2#1)
are characteristic of the##3##4##(1992-9#1)(1996-3#1)(2008-2#1)
are characteristic of##10##3##(1992-9#1)(1993-2#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
are characteristic##16##2##(1992-9#1)(1993-2#1)(1995-2#1)(1996-3#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
are characteristics of##2##3##(2008-10#1)(2008-11#1)
are characterized by a##4##4##(1993-9#1)(1997-1#1)(2008-8#1)(2009-3#1)
are characterized by high##2##4##(2008-3#1)(2010-5#1)
are characterized by the##2##4##(2007-12#1)(2013-1#1)
are characterized by##36##3##(1990-2#1)(1991-2#1)(1993-9#1)(1995-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-3#1)(2010-1#1)(2010-5#1)(2011-2#5)(2012-3#1)(2013-1#1)
are characterized in##2##3##(1996-2#1)(2008-9#1)
are characterized with##2##3##(2008-10#1)(2008-8#1)
are characterized##46##2##(1990-2#1)(1991-2#1)(1993-9#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
are checked##2##2##(2008-10#1)(2008-3#1)
are chemically similar##2##3##(2008-10#2)
are chemically##4##2##(2008-10#3)(2008-11#1)
are chlorinated to avoid excessive biofouling##2##6##(2008-10#2)
are chosen##3##2##(2008-10#2)(2008-3#1)
are chronically infected##2##3##(2009-5#1)(2009-7#1)
are classically##2##2##(2011-2#1)(2012-3#1)
are classified according to the##3##5##(2008-10#1)(2010-8#1)(2011-2#1)
are classified according to##4##4##(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
are classified as##5##3##(2008-10#2)(2010-11#1)(2010-6#1)(2011-2#1)
are classified into##3##3##(1997-6#1)(2008-6#1)(2011-2#1)
are classified##12##2##(1997-6#1)(2008-10#3)(2008-12#1)(2008-6#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#3)
are clear##2##2##(2013-8#2)
are clearly##14##2##(1991-8#1)(1992-11#1)(1993-12#1)(1993-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
are clinical##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#1)
are clinically and##2##3##(2011-1#1)(2011-2#1)
are clinically##7##2##(1997-1#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#1)
are clonal##2##2##(2008-10#2)
are close relatives##2##3##(2008-10#1)(2008-9#1)
are close to##2##3##(1996-12#1)(2008-10#1)
are close##6##2##(1994-5#1)(1996-12#1)(2008-10#2)(2008-9#1)(2012-2#1)
are closely associated with the##2##5##(2008-10#1)(2008-9#1)
are closely associated with##3##4##(2008-10#1)(2008-9#1)(2009-6#1)
are closely related to the##3##5##(1990-11#1)(2007-12#1)(2013-1#1)
are closely related to##6##4##(1990-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
are closely related##9##3##(1990-11#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
are closely##16##2##(1990-11#1)(1991-1#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
are clustered in the##2##4##(1997-6#1)(2008-10#1)
are clustered##6##2##(1994-11#1)(1997-6#1)(2008-10#2)(2008-9#1)(2012-2#1)
are collected and##2##3##(2008-10#2)
are collected by##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
are collected##13##2##(1996-3#1)(2008-1#1)(2008-10#6)(2008-8#2)(2008-9#2)(2011-2#1)
are combined in one##2##4##(1992-9#1)(2008-10#1)
are combined in##3##3##(1992-9#1)(2008-10#1)(2008-12#1)
are combined to##2##3##(2007-11#1)(2009-11#1)
are combined##7##2##(1991-6#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-11#2)
are comfortable##2##2##(1996-3#1)(1997-2#1)
are coming##2##2##(1992-2#1)(1994-3#1)
are commercially available##3##3##(1996-5#1)(2008-10#2)
are commercially##5##2##(1996-5#1)(2008-10#2)(2011-1#1)(2011-2#1)
are committed to##5##3##(1991-3#1)(1992-1#1)(1994-2#1)(2012-2#1)(2012-3#1)
are committed##6##2##(1991-3#1)(1992-1#1)(1994-2#1)(2008-4#1)(2012-2#1)(2012-3#1)
are common and##9##3##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-7#1)(2012-2#2)
are common in the##3##4##(2008-7#1)(2009-12#1)(2010-12#1)
are common in##17##3##(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-3#1)
are common to both##2##4##(1991-5#1)(2008-10#1)
are common to##5##3##(1991-5#1)(1997-3#1)(2008-10#2)(2008-4#1)
are common##55##2##(1991-2#1)(1991-5#1)(1992-9#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
are commonly encountered in##2##4##(2008-10#1)(2011-2#1)
are commonly found in##2##4##(2008-10#1)(2011-2#1)
are commonly used as##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
are commonly used for##2##4##(2008-10#1)(2010-1#1)
are commonly used in the analysis of##2##7##(2008-4#1)(2008-6#1)
are commonly used in the##4##5##(1997-8#1)(2008-10#1)(2008-4#1)(2008-6#1)
are commonly used in##6##4##(1995-12#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#1)
are commonly used to##4##4##(2008-10#2)(2008-8#1)(2012-5#1)
are commonly used##17##3##(1995-12#1)(1997-8#1)(2008-10#6)(2008-4#2)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)
are commonly##40##2##(1991-2#1)(1991-3#1)(1994-8#1)(1995-12#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#1)(2013-3#1)
are communicated##2##2##(1990-8#1)(2008-7#1)
are comparable to those obtained##2##5##(2008-10#2)
are comparable to those##5##4##(2008-10#5)
are comparable to##11##3##(2008-10#10)(2008-11#1)
are comparable with those##2##4##(1991-3#1)(2008-7#1)
are comparable with##3##3##(1991-3#1)(2008-10#1)(2008-7#1)
are comparable##19##2##(1991-3#1)(1993-11#1)(1997-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)
are compared and contrasted##2##4##(2008-10#2)
are compared for##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
are compared in a##2##4##(1995-9#1)(2008-5#1)
are compared in##5##3##(1991-2#1)(1995-9#1)(2008-3#2)(2008-5#1)
are compared over time##2##4##(1990-12#1)(1991-2#1)
are compared to the##4##4##(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)
are compared to those obtained with##2##6##(2008-10#2)
are compared to those##4##4##(1994-5#1)(2008-10#3)
are compared to##20##3##(1992-3#1)(1993-8#1)(1994-5#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)
are compared with experimental##2##4##(2008-2#1)(2008-3#1)
are compared with that##2##4##(2008-10#2)
are compared with the findings##2##5##(1991-2#1)(2008-11#1)
are compared with the results of##2##6##(2008-3#2)
are compared with the results##3##5##(2008-10#1)(2008-3#2)
are compared with the##18##4##(1991-2#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#8)
are compared with those determined##2##5##(2008-10#2)
are compared with those obtained by##2##6##(2008-10#1)(2008-3#1)
are compared with those obtained##6##5##(2008-10#4)(2008-3#2)
are compared with those of##5##5##(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
are compared with those##17##4##(2008-10#10)(2008-3#4)(2008-5#1)(2008-6#1)(2009-7#1)
are compared with##55##3##(1991-2#1)(1993-6#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-2#5)(2008-3#19)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)
are compared##111##2##(1990-12#1)(1991-2#3)(1992-3#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(2007-12#3)(2008-10#37)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#25)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
are compartmentalized##2##2##(2008-7#1)(2009-8#1)
are compatible with the##4##4##(1991-2#1)(2008-7#1)(2008-8#1)(2009-5#1)
are compatible with##9##3##(1990-12#1)(1991-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)
are compatible##11##2##(1990-12#1)(1991-2#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)
are compensated for by##2##4##(2008-3#1)(2013-1#1)
are compensated##4##2##(1995-1#1)(2008-3#1)(2008-7#1)(2013-1#1)
are competing##2##2##(1995-2#1)(2009-8#1)
are complementary and##2##3##(2008-8#1)(2012-3#1)
are complementary to the##2##4##(2008-10#1)(2008-9#1)
are complementary##6##2##(1995-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
are completed##2##2##(1995-12#1)(1997-6#1)
are completely##6##2##(1995-2#1)(1997-6#2)(2008-10#3)
are complex and##2##3##(1996-3#1)(2008-9#1)
are complex##10##2##(1995-5#1)(1996-3#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
are complexed with##4##3##(2008-10#4)
are complicated by the##2##4##(1997-3#1)(2008-8#1)
are complicated by##3##3##(1991-6#1)(1997-3#1)(2008-8#1)
are components of##2##3##(1991-1#1)(2011-2#1)
are composed of##7##3##(1993-8#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
are compressed##3##2##(1991-3#1)(1992-12#1)(2007-11#1)
are comprised of##2##3##(2008-9#1)(2012-2#1)
are comprised##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
are computed##3##2##(1990-11#1)(2008-6#1)(2009-3#1)
are conceived to##2##3##(2008-11#2)
are concentrated in##3##3##(1993-6#1)(2008-7#1)(2009-10#1)
are concentrated##7##2##(1993-6#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-12#1)
are concerned about##5##3##(1991-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1996-5#1)
are concerned with the##2##4##(1992-3#1)(1995-6#1)
are concerned with##3##3##(1992-3#1)(1995-6#1)(2008-11#1)
are concerned##12##2##(1991-2#1)(1992-3#2)(1993-11#1)(1993-3#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-1#1)(2013-1#1)
are concerns##4##2##(1997-1#1)(2008-11#1)(2009-3#1)(2012-3#1)
are conducive to##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
are conducted##6##2##(1992-12#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-7#1)(2013-8#1)
are confined to##2##3##(1992-3#1)(2008-7#1)
are confirmed in##2##3##(2008-10#1)(2012-3#1)
are confirmed##6##2##(1993-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
are confronted##3##2##(1996-2#1)(2007-11#1)(2008-11#1)
are connected by##3##3##(2008-7#1)(2010-10#1)(2013-1#1)
are connected to##3##3##(2008-9#2)(2012-5#1)
are connected with##2##3##(1991-9#1)(2009-8#1)
are connected##9##2##(1991-9#1)(1995-1#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-10#1)(2012-5#1)(2013-1#1)
are consecutively##2##2##(2008-10#1)(2010-12#1)
are conservative##2##2##(1992-2#1)(1993-12#1)
are conserved among the##2##4##(1996-8#1)(2008-5#1)
are conserved in##3##3##(1993-12#1)(1994-11#1)(2010-4#1)
are conserved##9##2##(1993-12#1)(1993-2#1)(1994-11#1)(1996-8#1)(1997-9#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)
are considerable##2##2##(1997-8#1)(2009-7#1)
are considerably less##2##3##(2008-10#1)(2011-2#1)
are considerably##5##2##(2008-10#4)(2011-2#1)
are considered a##2##3##(2008-12#1)(2009-4#1)
are considered as##5##3##(1991-6#1)(2008-10#3)(2008-5#1)
are considered in relation to##2##5##(2008-10#2)
are considered in the##2##4##(1993-3#1)(2012-2#1)
are considered in##6##3##(1993-3#1)(2008-10#3)(2011-2#1)(2012-2#1)
are considered the##3##3##(2008-10#2)(2010-1#1)
are considered to be##10##4##(1990-11#1)(1992-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
are considered to##12##3##(1990-11#1)(1991-3#1)(1992-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
are considered##80##2##(1990-11#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#24)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
are considering##2##2##(1993-2#1)(2008-11#1)
are consistent with a gene-for-gene##2##5##(2008-10#2)
are consistent with a role in##2##6##(2009-10#1)(2012-3#1)
are consistent with a role##3##5##(1990-3#1)(2009-10#1)(2012-3#1)
are consistent with a##16##4##(1990-3#1)(1991-5#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-10#7)(2009-10#1)(2009-12#1)(2012-3#1)
are consistent with current##2##4##(2008-3#1)(2008-4#1)
are consistent with other studies##2##5##(1997-9#1)(2008-12#1)
are consistent with other##3##4##(1996-12#1)(1997-9#1)(2008-12#1)
are consistent with previous reports##2##5##(2008-8#1)(2012-3#1)
are consistent with previous##4##4##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
are consistent with the hypothesis that the##5##7##(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#1)
are consistent with the hypothesis that##12##6##(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-12#1)
are consistent with the hypothesis##13##5##(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-12#1)(2013-8#1)
are consistent with the idea that##2##6##(1990-10#1)(2008-10#1)
are consistent with the idea##3##5##(1990-10#1)(2008-10#2)
are consistent with the involvement of##2##6##(1994-3#1)(1995-11#1)
are consistent with the notion that##2##6##(1990-8#1)(2011-2#1)
are consistent with the##40##4##(1990-10#1)(1990-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
are consistent with those obtained##2##5##(2008-10#2)
are consistent with those##3##4##(1993-3#1)(2008-10#2)
are consistent with##102##3##(1990-10#1)(1990-3#2)(1990-8#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-9#2)(2007-12#2)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#2)(2009-9#1)(2010-12#1)(2011-2#4)(2012-3#6)(2013-8#1)
are consistent##106##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-9#2)(2007-12#2)(2008-10#27)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#2)(2009-9#1)(2010-12#1)(2011-2#4)(2012-3#6)(2013-8#1)
are consistently##4##2##(2008-10#2)(2008-5#1)(2008-6#1)
are constantly##4##2##(1992-3#1)(1995-5#1)(2008-9#1)(2011-2#1)
are constrained by the##2##4##(2008-6#1)(2009-7#1)
are constrained by##4##3##(1996-3#1)(2008-6#1)(2008-8#1)(2009-7#1)
are constructed by##2##3##(2008-10#1)(2012-2#1)
are constructed##7##2##(1992-9#1)(2008-10#3)(2008-4#1)(2008-9#1)(2012-2#1)
are consumed##2##2##(2008-11#1)(2013-8#1)
are continuing##2##2##(1996-5#1)(2008-11#1)
are continuously##5##2##(1991-12#1)(2008-10#3)(2008-9#1)
are contraindicated##2##2##(2008-3#1)(2008-7#1)
are contrasted with##3##3##(2007-12#1)(2008-11#1)(2012-2#1)
are contrasted##4##2##(1992-1#1)(2007-12#1)(2008-11#1)(2012-2#1)
are contributing##3##2##(1994-11#1)(2008-5#1)(2011-2#1)
are controlled by##9##3##(1990-5#2)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#2)
are controlled##16##2##(1990-5#2)(1992-9#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2011-2#1)
are controversial##3##2##(2008-12#1)(2008-7#1)(2012-12#1)
are converted into##2##3##(1993-12#1)(2008-10#1)
are converted to##4##3##(2008-10#3)(2011-2#1)
are converted##6##2##(1993-12#1)(2008-10#4)(2011-2#1)
are coordinated##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
are corrected for##2##3##(1996-12#2)
are correlated to##2##3##(2008-11#1)(2010-8#1)
are correlated with##3##3##(2008-8#1)(2009-11#1)(2011-2#1)
are correlated##8##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
are corresponding##2##2##(2008-5#1)(2008-8#1)
are costly##3##2##(1994-2#1)(1995-5#1)(2008-10#1)
are coupled to##3##3##(2008-10#2)(2010-8#1)
are covalently attached to##2##4##(1991-3#1)(1995-3#1)
are covalently##4##2##(1991-3#1)(1995-3#1)(2008-10#1)(2008-8#1)
are covered by##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
are covered with##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
are covered##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
are created##5##2##(1996-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#1)
are critical components of##3##4##(1996-2#1)(2009-10#1)(2011-2#1)
are critical elements##2##3##(1993-12#1)(2008-11#1)
are critical for the##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
are critical for##12##3##(1993-8#1)(1994-1#1)(1994-5#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-9#1)(2009-10#1)(2013-1#1)
are critical to the##2##4##(2009-10#1)(2010-6#1)
are critical to##8##3##(1993-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2009-10#1)(2010-6#1)(2011-2#1)
are critical##37##2##(1993-1#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-5#1)(1995-8#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#6)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
are critically discussed##3##3##(2008-10#3)
are critically important##2##3##(2008-9#1)(2009-7#1)
are critically##11##2##(1997-7#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)
are criticized##2##2##(1996-2#1)(2009-6#1)
are cross-linked##2##2##(2008-2#1)(2013-8#1)
are crucial for##9##3##(1993-3#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-2#1)
are crucial to##2##3##(2008-8#1)(2012-2#1)
are crucial##15##2##(1993-3#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
are cultivated##2##2##(2008-10#2)
are cultured##4##2##(1991-2#1)(2008-11#2)(2013-1#1)
are currently available for the##2##5##(2008-5#1)(2009-1#1)
are currently available for##4##4##(2008-5#1)(2009-1#1)(2010-3#1)(2011-2#1)
are currently available##7##3##(2008-12#1)(2008-5#1)(2009-1#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
are currently being explored##2##4##(2008-7#1)(2013-8#1)
are currently being used##3##4##(1990-2#1)(2008-10#1)(2010-12#1)
are currently being##11##3##(1990-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2011-3#2)(2013-8#1)
are currently in##2##3##(2008-10#1)(2008-5#1)
are currently used as##2##4##(2008-5#1)(2012-2#1)
are currently used in##3##4##(2008-10#1)(2010-1#1)(2010-11#1)
are currently used##7##3##(2008-10#2)(2008-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-2#1)
are currently##54##2##(1990-2#1)(1991-12#1)(1992-1#1)(1992-2#2)(1996-1#1)(1997-2#2)(1997-5#1)(2006-6#1)(2007-12#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-5#3)(2008-7#1)(2009-1#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
are cut##3##2##(1995-12#1)(2008-3#1)(2011-2#1)
are data##2##2##(1991-2#1)(2008-11#1)
are deaf##3##2##(2008-9#1)(2011-2#2)
are dealing with##2##3##(1991-6#1)(1993-12#1)
are decreasing##2##2##(1997-8#1)(2011-2#1)
are deduced##2##2##(2008-10#1)(2009-8#1)
are deeply##2##2##(1991-5#1)(2008-10#1)
are deficient in##2##3##(1997-1#1)(1997-7#1)
are defined as##2##3##(1996-11#1)(2011-2#1)
are defined by##3##3##(2008-10#2)(2012-3#1)
are defined for##2##3##(2008-3#1)(2009-8#1)
are defined##14##2##(1991-2#1)(1992-9#1)(1995-9#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
are definitely##2##2##(1995-3#1)(2008-7#1)
are degraded in the endoplasmic reticulum##2##6##(1995-2#2)
are degraded##3##2##(1995-2#2)(2008-11#1)
are delayed##2##2##(1996-2#1)(2010-12#1)
are deleterious##2##2##(2008-8#2)
are delivered by##2##3##(2008-11#2)
are delivered##5##2##(2008-11#2)(2008-7#1)(2009-6#1)(2013-8#1)
are demonstrated by##2##3##(2008-10#1)(2008-3#1)
are demonstrated to##2##3##(2008-10#1)(2008-2#1)
are demonstrated with##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
are demonstrated##25##2##(1991-1#1)(1991-5#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#5)(2008-7#1)(2010-12#1)(2011-2#1)
are dependent on the nature of the##2##7##(1994-5#1)(2008-10#1)
are dependent on the nature of##3##6##(1993-3#1)(1994-5#1)(2008-10#1)
are dependent on the##8##4##(1993-3#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)
are dependent on##13##3##(1993-3#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-8#1)(2012-3#1)
are dependent##15##2##(1993-3#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
are depending on##2##3##(2008-5#1)(2009-1#1)
are depleted##2##2##(2008-9#1)(2012-3#1)
are deposited onto##2##3##(2008-10#1)(2008-7#1)
are deposited##4##2##(2008-10#3)(2008-7#1)
are derived and##2##3##(2008-2#1)(2008-3#1)
are derived for##4##3##(1994-9#1)(2008-3#1)(2008-9#1)(2013-8#1)
are derived from a##2##4##(1995-6#1)(2010-10#1)
are derived from the##3##4##(2008-10#2)(2008-8#1)
are derived from##18##3##(1990-5#1)(1993-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-6#1)(2008-8#1)(2010-10#2)
are derived that##2##3##(2007-12#1)(2008-8#1)
are derived##40##2##(1990-5#1)(1990-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-2#1)(1997-3#1)(2007-12#4)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#6)(2008-6#2)(2008-8#3)(2008-9#1)(2010-10#2)(2013-1#2)(2013-8#1)
are described along with##3##4##(2008-4#1)(2008-9#1)(2009-12#1)
are described and compared according to the##2##7##(2008-10#2)
are described and compared##3##4##(2008-10#2)(2008-2#1)
are described and discussed##3##4##(1990-9#1)(1995-11#1)(2008-11#1)
are described and illustrated##2##4##(2007-12#1)(2008-10#1)
are described and the##3##4##(1990-9#1)(1997-8#1)(2008-4#1)
are described and their##2##4##(2008-10#1)(2010-12#1)
are described and##18##3##(1990-12#1)(1990-9#2)(1991-3#1)(1995-11#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-6#1)
are described based on the##2##5##(2008-10#2)
are described by##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
are described elsewhere in the series##2##6##(2008-4#2)
are described elsewhere in the##3##5##(2008-4#3)
are described for the##7##4##(2008-10#5)(2008-4#1)(2008-9#1)
are described for##13##3##(2008-10#6)(2008-4#3)(2008-9#4)
are described here for the first time##2##7##(2008-10#2)
are described here##8##3##(2008-10#3)(2008-11#2)(2008-9#1)(2010-3#1)(2011-2#1)
are described in detail##3##4##(1997-6#1)(2008-10#1)(2008-4#1)
are described in the##2##4##(2008-11#1)(2011-3#1)
are described in this article##4##5##(1991-12#1)(1992-1#1)(1996-2#1)(2011-2#1)
are described in this paper##2##5##(2008-11#1)(2008-12#1)
are described in this unit##6##5##(2008-4#6)
are described in this##13##4##(1991-12#1)(1992-1#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-4#7)(2011-2#1)
are described in##22##3##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#8)(2011-2#1)(2011-3#1)
are described that##3##3##(2008-3#1)(2008-4#1)(2012-2#1)
are described with a##2##4##(1997-3#1)(2008-8#1)
are described with##3##3##(1997-3#1)(2008-8#1)(2013-1#1)
are described##203##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#3)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#73)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#26)(2008-5#4)(2008-8#1)(2008-9#8)(2009-10#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
are designated as##2##3##(1993-9#1)(2008-10#1)
are designated##4##2##(1993-9#1)(2008-10#3)
are designed to determine##2##4##(1994-9#1)(2008-8#1)
are designed to##13##3##(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)
are designed##18##2##(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-10#1)(2011-2#2)
are desired##4##2##(1995-3#1)(2008-5#1)(2008-8#2)
are detached##2##2##(2008-10#1)(2008-11#1)
are detailed##5##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
are detectable##4##2##(1990-12#1)(1996-5#1)(2008-11#1)(2013-1#1)
are detected at##3##3##(1992-10#1)(2008-10#1)(2008-3#1)
are detected by##5##3##(2008-10#3)(2008-3#1)(2008-9#1)
are detected early##2##3##(2008-10#1)(2008-4#1)
are detected even##2##3##(2008-10#2)
are detected in the##4##4##(1993-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
are detected in##9##3##(1993-12#1)(1993-3#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
are detected##30##2##(1992-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2011-2#1)
are determinants##2##2##(1997-4#1)(2009-8#1)
are determined as##2##3##(2008-12#1)(2008-5#1)
are determined by the##7##4##(1991-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)
are determined by##16##3##(1990-12#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-12#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)
are determined from##2##3##(2008-10#2)
are determined in##4##3##(2008-10#1)(2008-12#1)(2008-3#2)
are determined using##2##3##(2008-10#2)
are determined with##3##3##(2008-10#2)(2008-3#1)
are determined##48##2##(1990-12#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1997-7#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#3)(2008-9#1)(2009-8#1)
are developed and##2##3##(2008-10#1)(2013-1#1)
are developed for##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
are developed in##2##3##(1993-1#1)(2009-4#1)
are developed to##2##3##(2008-7#1)(2013-1#1)
are developed##27##2##(1992-11#1)(1993-1#2)(1993-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-4#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#2)
are developing##5##2##(1991-3#1)(1994-12#1)(1995-2#1)(2008-11#1)(2013-1#1)
are devoted to##3##3##(2008-10#2)(2008-9#1)
are diagnosed in##2##3##(2008-10#1)(2012-3#1)
are diagnosed##7##2##(1994-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-7#1)(2012-3#1)
are diagnostic##2##2##(2008-10#1)(2012-3#1)
are differences in the##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
are differences in##5##3##(1990-5#1)(1993-2#1)(2008-10#1)(2008-11#1)(2009-3#1)
are differences##6##2##(1990-5#1)(1993-2#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-7#1)
are different from other##2##4##(1993-12#1)(2008-11#1)
are different from those in##2##5##(1997-8#1)(2008-10#1)
are different from those##3##4##(1997-8#1)(2008-10#1)(2010-4#1)
are different from##8##3##(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#1)(2011-2#1)
are different in the##2##4##(2008-10#1)(2010-5#1)
are different in##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
are different##24##2##(1993-12#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)
are differentially expressed in the##2##5##(2008-11#1)(2008-5#1)
are differentially expressed in##4##4##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
are differentially expressed##6##3##(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
are differentially##11##2##(1992-6#1)(1996-12#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
are differentiated##4##2##(2008-10#3)(2010-12#1)
are differently##2##2##(2008-10#2)
are difficult because of the##2##5##(2008-10#1)(2009-7#1)
are difficult to detect##4##4##(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
are difficult to diagnose##2##4##(1997-4#1)(2011-2#1)
are difficult to interpret##6##4##(1991-11#1)(1993-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
are difficult to##25##3##(1991-11#1)(1993-2#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#2)(2013-1#2)
are difficult##29##2##(1991-11#1)(1993-2#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-2#2)(2013-1#3)
are digested##2##2##(2008-10#2)
are diluted##2##2##(1994-9#1)(2008-10#1)
are direct##2##2##(2008-10#1)(2008-9#1)
are directed to##3##3##(1990-5#1)(1990-8#1)(2008-11#1)
are directed##5##2##(1990-5#1)(1990-8#1)(2008-10#1)(2008-11#1)(2009-12#1)
are directly involved in##2##4##(1995-6#1)(1996-12#1)
are directly##16##2##(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-6#1)(2012-2#2)(2013-8#1)
are disappointing##4##2##(1994-2#1)(2008-11#1)(2009-4#1)(2011-3#1)
are discarded##3##2##(2008-10#3)
are discrete##2##2##(1996-12#1)(2008-12#1)
are discriminated##2##2##(1992-5#1)(2008-10#1)
are discussed and a##2##4##(1997-1#1)(2011-7#1)
are discussed and compared to other##2##6##(2007-12#1)(2010-3#1)
are discussed and compared with those of##3##7##(1993-11#1)(2008-10#1)(2008-3#1)
are discussed and compared with##4##5##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
are discussed and compared##6##4##(1993-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
are discussed and illustrated##2##4##(2008-10#1)(2012-2#1)
are discussed and the##3##4##(2008-10#3)
are discussed and##23##3##(1991-3#1)(1993-11#1)(1996-1#1)(1997-1#1)(2007-12#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
are discussed as well as the##2##6##(2008-10#2)
are discussed as well as##3##5##(1991-1#1)(2008-10#2)
are discussed as##9##3##(1991-1#1)(1991-2#1)(2008-10#3)(2008-11#1)(2009-3#1)(2011-1#1)(2013-8#1)
are discussed here##4##3##(1993-8#1)(1994-5#1)(2008-11#1)(2008-9#1)
are discussed herein##2##3##(1993-2#1)(2011-2#1)
are discussed in detail##11##4##(1990-2#1)(1994-2#1)(2008-10#6)(2008-3#1)(2008-4#1)(2011-2#1)
are discussed in light of the##2##6##(1997-8#1)(2010-7#1)
are discussed in light of##5##5##(1994-2#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-7#1)
are discussed in relation to the##8##6##(1992-12#1)(1994-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)
are discussed in relation to##16##5##(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2010-2#1)(2010-9#1)(2012-2#1)
are discussed in relation##17##4##(1990-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2010-2#1)(2010-9#1)(2012-2#1)
are discussed in terms of the##8##6##(1990-7#1)(1993-6#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-6#1)(2009-12#1)
are discussed in terms of their##2##6##(1991-2#1)(1997-2#1)
are discussed in terms of##18##5##(1990-7#1)(1991-2#1)(1991-3#1)(1993-6#2)(1995-11#1)(1995-2#1)(1997-2#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-12#1)
are discussed in the context of previous research##2##8##(2008-9#1)(2012-2#1)
are discussed in the context of##5##6##(1993-11#1)(1996-2#1)(2008-9#1)(2011-1#1)(2012-2#1)
are discussed in the##7##4##(1993-11#1)(1996-2#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
are discussed in this article##3##5##(1997-5#1)(2008-10#1)(2008-9#1)
are discussed in this paper##4##5##(1992-1#1)(2008-10#2)(2012-2#1)
are discussed in this review##2##5##(2009-10#1)(2010-7#1)
are discussed in this##12##4##(1992-1#1)(1997-5#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#1)
are discussed in##76##3##(1990-2#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-11#2)(1993-6#3)(1994-2#3)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2008-10#21)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
are discussed on the basis of the##2##7##(1994-6#1)(2009-6#1)
are discussed relative to the##2##5##(1996-3#1)(2008-10#1)
are discussed that##2##3##(1996-2#1)(2008-3#1)
are discussed to##2##3##(2009-12#1)(2013-1#1)
are discussed together with##2##4##(1990-12#1)(2009-12#1)
are discussed which##2##3##(2008-11#1)(2013-1#1)
are discussed with an##2##4##(1993-3#1)(2010-3#1)
are discussed with regard to##3##5##(1993-3#1)(2008-11#1)(2008-3#1)
are discussed with respect to their##2##6##(1994-8#1)(2008-7#1)
are discussed with respect to##3##5##(1993-8#1)(1994-8#1)(2008-7#1)
are discussed with##13##3##(1993-3#2)(1993-8#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)
are discussed##519##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#2)(1991-12#2)(1991-2#5)(1991-3#5)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#6)(1993-8#7)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-2#5)(1996-3#6)(1996-6#1)(1997-1#5)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2007-11#1)(2007-12#5)(2008-1#2)(2008-10#131)(2008-11#36)(2008-12#15)(2008-2#9)(2008-3#21)(2008-4#10)(2008-5#10)(2008-6#2)(2008-7#13)(2008-8#6)(2008-9#10)(2009-10#3)(2009-11#5)(2009-12#4)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#3)(2010-11#3)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#4)(2011-2#12)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#21)(2013-8#5)
are discussing the##2##3##(1990-9#1)(2011-2#1)
are disease free##2##3##(1990-6#1)(2008-10#1)
are dispersed by##2##3##(2008-8#1)(2013-1#1)
are dispersed##3##2##(1992-9#1)(2008-8#1)(2013-1#1)
are displayed##6##2##(2008-10#2)(2008-3#2)(2012-2#1)(2012-3#1)
are disproportionately represented##2##3##(2008-1#2)
are disproportionately##4##2##(2008-1#2)(2012-12#2)
are dissolved in##2##3##(2008-10#2)
are dissolved##3##2##(2008-10#3)
are distinct and##2##3##(2008-10#1)(2011-2#1)
are distinct from##6##3##(1991-12#1)(1997-5#1)(2008-10#3)(2008-11#1)
are distinct molecules##2##3##(1990-5#1)(1990-8#1)
are distinct##13##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1996-12#1)(1997-5#1)(2008-10#4)(2008-11#2)(2011-2#1)
are distinguished from##2##3##(1991-12#1)(2009-4#1)
are distinguished##6##2##(1991-12#1)(1993-12#1)(2008-10#2)(2009-4#1)(2010-5#1)
are distorted##2##2##(1993-8#1)(2011-2#1)
are distributed##5##2##(1992-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)
are diverse##2##2##(2008-10#1)(2008-9#1)
are diverted to##2##3##(1990-5#1)(2008-9#1)
are divided into two##3##4##(2008-11#2)(2008-6#1)
are divided into##8##3##(1995-5#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#2)(2013-8#1)
are divided##10##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#3)(2013-8#1)
are documented##3##2##(1997-8#1)(2007-12#1)(2008-11#1)
are doing##2##2##(1993-1#1)(1994-1#1)
are dominant##6##2##(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-3#1)
are dominated by##3##3##(1990-5#1)(1990-8#1)(2009-10#1)
are double##2##2##(2008-11#1)(2013-8#1)
are dramatically##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
are drawn from a##2##4##(2011-2#1)(2012-2#1)
are drawn from##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
are drawn##9##2##(1991-2#1)(1992-3#1)(1994-3#2)(2008-10#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
are drinking water##2##3##(2008-10#2)
are drinking##3##2##(2008-10#3)
are driving##2##2##(1993-12#1)(2008-11#1)
are due to a##2##4##(2008-4#1)(2012-2#1)
are due to the##9##4##(1990-2#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-3#1)
are due to##35##3##(1990-2#1)(1991-2#1)(1993-8#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
are due##36##2##(1990-12#1)(1990-2#1)(1991-2#1)(1993-8#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
are dying##2##2##(1993-12#1)(2011-2#1)
are dynamic and##3##3##(2009-7#1)(2010-11#1)(2013-8#1)
are dynamic##4##2##(1996-6#1)(2009-7#1)(2010-11#1)(2013-8#1)
are dynamically##3##2##(2008-6#1)(2008-9#1)(2012-3#1)
are each##2##2##(1995-2#1)(2009-10#1)
are easier to use than##2##5##(1992-3#1)(2012-2#1)
are easier to##3##3##(1992-3#1)(2008-10#1)(2012-2#1)
are easily performed##2##3##(2008-10#1)(2010-11#1)
are easily##16##2##(2007-11#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-11#1)(2012-2#1)
are easy to##4##3##(2008-10#2)(2008-7#1)(2010-11#1)
are easy##5##2##(2008-10#3)(2008-7#1)(2010-11#1)
are economically important##3##3##(2008-10#2)(2008-12#1)
are economically##6##2##(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)
are educated##2##2##(1994-3#1)(2008-11#1)
are effective and##2##3##(1990-8#1)(1996-6#1)
are effective for##2##3##(1993-2#1)(2012-12#1)
are effective in reducing##2##4##(2008-10#1)(2013-1#1)
are effective in##6##3##(2008-10#2)(2008-7#1)(2009-12#1)(2013-1#2)
are effective##27##2##(1990-8#1)(1991-6#1)(1993-2#1)(1995-11#1)(1995-2#1)(1996-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#3)
are efficient##3##2##(2008-11#1)(2008-12#1)(2009-10#1)
are efficiently##3##2##(2008-10#2)(2008-11#1)
are eight##2##2##(2008-1#1)(2012-2#1)
are either##9##2##(1992-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2012-3#1)
are elaborated upon##2##3##(2010-12#1)(2012-2#1)
are elaborated##4##2##(1990-2#1)(2010-12#1)(2010-8#1)(2012-2#1)
are elevated##5##2##(1993-9#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)
are eliminated##4##2##(2008-10#3)(2008-7#1)
are elucidated##2##2##(1995-1#1)(2008-10#1)
are eluted with##3##3##(2008-10#3)
are embedded in##2##3##(2008-11#2)
are embedded##7##2##(2008-10#1)(2008-11#3)(2010-8#1)(2013-8#2)
are emerging##3##2##(2008-11#2)(2012-3#1)
are emphasized##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
are employed as##2##3##(1995-1#1)(2008-10#1)
are employed in##3##3##(1997-2#1)(2008-7#1)(2010-12#1)
are employed##10##2##(1990-5#1)(1994-2#1)(1994-9#1)(1995-1#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-12#1)
are encoded by##4##3##(1992-6#1)(1993-2#1)(2008-4#1)(2009-10#1)
are encountered in the##2##4##(2008-4#1)(2009-8#1)
are encountered##4##2##(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
are encouraged to##4##3##(1991-3#1)(1993-3#1)(1994-2#1)(2008-11#1)
are encouraging##7##2##(1994-2#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
are endemic##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
are engaged in##3##3##(2011-2#1)(2012-2#2)
are engaged##6##2##(1995-2#1)(1996-2#1)(2008-7#1)(2011-2#1)(2012-2#2)
are enriched in##2##3##(2008-10#1)(2012-2#1)
are entirely##2##2##(2008-8#1)(2008-9#1)
are entropically stabilized##2##3##(2008-10#2)
are enumerated##2##2##(2008-10#1)(2008-11#1)
are equal to those##2##4##(1990-5#1)(1992-3#1)
are equal to##3##3##(1990-5#1)(1992-12#1)(1992-3#1)
are equal##4##2##(1990-5#1)(1992-12#1)(1992-3#1)(2008-10#1)
are equally effective##2##3##(2011-1#1)(2012-2#1)
are equally likely##2##3##(2008-9#2)
are equally##7##2##(2008-10#1)(2008-12#1)(2008-9#2)(2009-10#1)(2011-1#1)(2012-2#1)
are equipped to##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
are equivalent to##2##3##(2008-10#1)(2008-11#1)
are equivalent##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
are especially useful in##2##4##(2008-4#1)(2012-2#1)
are especially useful##3##3##(2008-4#1)(2010-7#1)(2012-2#1)
are especially##8##2##(1996-2#1)(1996-9#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-2#1)(2012-3#1)
are essential cofactors for##2##4##(1997-7#1)(2011-2#1)
are essential for its##2##4##(2009-7#1)(2011-3#1)
are essential for the##9##4##(1992-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#2)(2011-1#2)(2011-2#1)
are essential for##30##3##(1992-3#1)(1992-5#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-7#1)(2009-8#4)(2010-11#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
are essential in##3##3##(1992-3#1)(2008-10#1)(2013-7#1)
are essential to the##3##4##(1995-5#1)(1997-3#1)(2012-3#1)
are essential to##7##3##(1992-1#1)(1995-5#1)(1997-3#1)(2008-11#1)(2008-5#1)(2009-5#1)(2012-3#1)
are essential tools##2##3##(1996-1#1)(2008-12#1)
are essential##56##2##(1991-2#1)(1992-1#2)(1992-3#2)(1992-5#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
are essentially identical##2##3##(1992-8#1)(1997-8#1)
are essentially the same##2##4##(2008-10#1)(2008-12#1)
are essentially the##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
are essentially##10##2##(1992-8#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
are established by##2##3##(2008-10#2)
are established for##2##3##(2008-10#2)
are established##13##2##(1997-3#1)(2008-10#8)(2008-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
are estimated to##2##3##(1995-3#1)(1997-6#1)
are estimated##9##2##(1995-3#1)(1997-6#1)(2008-10#4)(2008-6#1)(2010-8#1)(2011-2#1)
are evaluated and##5##3##(2008-10#4)(2011-1#1)
are evaluated as##5##3##(1990-8#1)(1993-2#1)(2008-10#2)(2009-8#1)
are evaluated by comparing##2##4##(2008-10#1)(2008-11#1)
are evaluated by##5##3##(1997-2#1)(2008-10#3)(2008-11#1)
are evaluated for##2##3##(2007-12#1)(2008-12#1)
are evaluated in##3##3##(1992-2#1)(2008-10#1)(2012-2#1)
are evaluated with##3##3##(2008-10#2)(2008-3#1)
are evaluated##35##2##(1990-8#1)(1992-2#1)(1993-2#1)(1994-6#1)(1997-2#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
are evaluating##2##2##(2008-10#1)(2013-1#1)
are even##4##2##(2008-10#1)(2008-11#2)(2010-12#1)
are evident in##2##3##(1997-3#1)(2008-10#1)
are evident##3##2##(1993-12#1)(1997-3#1)(2008-10#1)
are evolutionarily##3##2##(1993-12#1)(2008-8#1)(2011-2#1)
are evolving##3##2##(1994-2#1)(1996-3#1)(2008-6#1)
are examined and the##2##4##(1991-3#1)(2008-10#1)
are examined and##3##3##(1991-3#1)(2008-10#1)(2009-6#1)
are examined by##2##3##(1997-8#1)(2008-2#1)
are examined for##3##3##(1991-1#1)(2008-10#1)(2010-2#1)
are examined in this article##2##5##(1991-3#1)(1995-12#1)
are examined in##9##3##(1990-3#1)(1991-3#1)(1992-5#1)(1995-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)
are examined to##2##3##(1993-3#1)(2013-1#1)
are examined using##3##3##(1997-2#1)(2008-10#2)
are examined##57##2##(1990-3#1)(1990-9#1)(1991-1#2)(1991-3#5)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
are examples of##4##3##(1993-2#1)(2008-11#1)(2011-2#2)
are excellent for##2##3##(1995-2#1)(2008-10#1)
are excellent##8##2##(1995-2#1)(2008-10#3)(2008-3#1)(2009-10#2)(2010-7#1)
are exceptional##2##2##(1995-2#1)(1997-3#1)
are exceptionally diverse##3##3##(2008-8#3)
are exceptionally##4##2##(2008-8#4)
are exclusively##2##2##(2008-11#1)(2012-3#1)
are expected to be##2##4##(1996-2#1)(2008-10#1)
are expected to form##2##4##(2008-3#1)(2008-6#1)
are expected to##21##3##(1991-3#1)(1993-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#5)(2008-6#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
are expected##25##2##(1991-3#1)(1993-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
are expensive##2##2##(2008-10#2)
are experienced by##2##3##(1993-3#1)(2009-8#1)
are experienced##3##2##(1993-3#1)(2008-11#1)(2009-8#1)
are experimentally##2##2##(2008-3#2)
are explained by##3##3##(1992-12#1)(2008-10#2)
are explained using##2##3##(2008-10#1)(2008-7#1)
are explained##10##2##(1992-12#1)(1994-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2011-1#1)
are exploited##2##2##(2008-10#1)(2008-11#1)
are explored and##2##3##(1992-2#1)(2008-10#1)
are explored in##2##3##(2008-12#1)(2010-6#1)
are explored##17##2##(1991-2#2)(1992-2#2)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#2)(2010-6#1)(2012-3#1)
are exposed to##13##3##(1991-5#1)(2008-10#3)(2009-12#2)(2009-7#1)(2010-11#1)(2011-2#2)(2013-1#2)(2013-8#1)
are exposed##14##2##(1991-5#1)(2008-10#3)(2009-12#2)(2009-7#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
are expressed as##4##3##(2008-10#1)(2008-9#1)(2010-11#1)(2010-7#1)
are expressed at##2##3##(2008-1#1)(2008-9#1)
are expressed by##2##3##(1993-12#1)(2008-1#1)
are expressed in a##3##4##(1994-5#1)(1996-2#1)(2010-7#1)
are expressed in the##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
are expressed in##20##3##(1990-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#3)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-10#1)(2010-7#1)(2011-2#3)(2013-1#1)
are expressed##40##2##(1990-5#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#3)(1996-2#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#4)(2008-7#2)(2008-9#2)(2009-10#3)(2010-11#1)(2010-7#3)(2011-2#4)(2012-3#1)(2013-1#1)
are extended##2##2##(1995-11#1)(2013-8#1)
are extensively##2##2##(1991-5#1)(2009-10#1)
are extracted and##2##3##(2008-10#1)(2008-6#1)
are extracted in##3##3##(2008-10#3)
are extracted into chloroform##2##4##(2008-10#2)
are extracted into the##2##4##(2008-10#2)
are extracted into##6##3##(2008-10#6)
are extracted##17##2##(2008-10#15)(2008-6#1)(2008-8#1)
are extreme##2##2##(1993-2#1)(2008-10#1)
are extremely rare and##2##4##(2008-7#1)(2013-7#1)
are extremely rare tumors##2##4##(1997-8#1)(2012-3#1)
are extremely rare##9##3##(1995-5#1)(1997-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#2)(2013-7#1)
are extremely sensitive##2##3##(1995-5#1)(2008-4#1)
are extremely uncommon##2##3##(2011-2#1)(2013-8#1)
are extremely well##2##3##(1990-11#1)(2008-8#1)
are extremely##22##2##(1990-11#1)(1995-5#2)(1997-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
are faced with the challenge of finding##2##7##(1996-1#1)(2008-12#1)
are faced with##5##3##(1990-11#1)(1993-3#1)(1996-1#1)(2008-11#1)(2008-12#1)
are faced##6##2##(1990-11#1)(1993-3#1)(1996-1#1)(2008-11#2)(2008-12#1)
are facing##6##2##(1991-3#1)(1991-9#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
are factors##3##2##(1993-6#1)(2010-10#1)(2011-1#1)
are fairly##5##2##(1990-2#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
are familiar with the##2##4##(1997-8#1)(2008-11#1)
are familiar##3##2##(1997-8#1)(2008-11#2)
are far better##2##3##(2008-10#2)
are far##6##2##(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)(2011-2#1)
are faring in##2##3##(2009-7#1)(2013-1#1)
are fast##4##2##(1994-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
are favored##3##2##(2008-10#1)(2008-8#2)
are favoured##2##2##(1997-7#1)(2010-12#1)
are feasible in the##2##4##(2008-11#1)(2008-9#1)
are feasible##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
are featured##2##2##(1995-3#1)(2010-7#1)
are fed##2##2##(2008-10#1)(2008-9#1)
are few data##3##3##(1992-3#1)(2010-12#1)(2012-3#1)
are few##19##2##(1992-3#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
are filiform##2##2##(2008-7#2)
are filled with##2##3##(2008-3#1)(2008-7#1)
are finding##2##2##(2008-11#1)(2010-7#1)
are first##6##2##(1990-12#1)(2008-10#3)(2008-4#1)(2013-1#1)
are first-order processes##2##3##(2008-10#1)(2008-5#1)
are fit for practice##2##4##(2008-11#2)
are fit to##2##3##(2008-10#1)(2008-3#1)
are fit##4##2##(2008-10#1)(2008-11#2)(2008-3#1)
are five##2##2##(2008-10#1)(2008-9#1)
are fixed##2##2##(1990-12#1)(2008-7#1)
are flawed##2##2##(1991-3#1)(1996-8#1)
are flexible enough##2##3##(2009-8#1)(2011-1#1)
are flexible##3##2##(2008-9#1)(2009-8#1)(2011-1#1)
are focused on##5##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
are followed by##3##3##(1991-3#1)(2008-10#1)(2008-4#1)
are followed##7##2##(1991-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)
are for the##4##3##(1992-12#1)(2008-10#2)(2008-4#1)
are for##9##2##(1992-1#1)(1992-12#1)(1996-1#1)(2008-10#3)(2008-4#1)(2011-3#1)(2012-2#1)
are forcing##2##2##(1992-1#1)(1997-8#1)
are formed and##2##3##(2008-10#2)
are formed as##2##3##(2008-10#1)(2011-2#1)
are formed at##3##3##(2008-10#2)(2010-11#1)
are formed by##3##3##(2007-12#1)(2008-10#2)
are formed in both##2##4##(2008-10#2)
are formed in##8##3##(1996-5#1)(2008-10#6)(2008-9#1)
are formed inside the##2##4##(2007-12#1)(2008-10#1)
are formed##35##2##(1991-6#1)(1992-4#1)(1996-5#3)(2007-12#3)(2008-10#23)(2008-12#1)(2008-9#1)(2010-11#1)(2011-2#1)
are formulated##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
are found for##2##3##(1994-5#1)(2008-10#1)
are found in a##2##4##(2008-10#1)(2008-9#1)
are found in the##10##4##(1990-12#1)(1991-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-12#1)(2012-2#1)
are found in##26##3##(1990-12#1)(1991-12#1)(1991-9#1)(1993-12#1)(1993-6#1)(1996-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#3)(2012-2#1)
are found not##2##3##(2008-10#1)(2008-8#1)
are found on##2##3##(2007-12#1)(2008-5#1)
are found to be extracted as##2##6##(2008-10#2)
are found to be more##2##5##(1993-12#1)(2008-3#1)
are found to be##23##4##(1993-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#2)(2009-10#1)(2009-5#1)(2012-2#1)
are found to have##2##4##(2008-9#1)(2011-3#1)
are found to##32##3##(1993-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2011-3#1)(2012-2#1)
are found##88##2##(1990-12#1)(1991-12#1)(1991-9#1)(1993-12#3)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-5#1)(1997-2#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#4)(2009-12#1)(2009-5#1)(2009-7#1)(2011-2#3)(2011-3#2)(2012-2#4)(2013-8#1)
are free of##2##3##(1993-9#1)(2008-11#1)
are freely##2##2##(2010-12#1)(2011-2#1)
are frequent##6##2##(1990-2#1)(2009-10#1)(2009-6#1)(2010-11#1)(2011-2#2)
are frequently associated with##2##4##(2011-1#1)(2013-1#1)
are frequently encountered in##2##4##(1997-8#1)(2011-2#1)
are frequently seen##2##3##(1996-6#1)(2011-2#1)
are frequently treated by##2##4##(1995-9#1)(2009-10#1)
are frequently treated##3##3##(1995-9#1)(2008-6#1)(2009-10#1)
are frequently used##2##3##(2008-12#1)(2010-5#1)
are frequently##30##2##(1992-3#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-6#2)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-6#1)(2009-10#2)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
are from the##2##3##(1994-1#1)(2013-1#1)
are from##10##2##(1994-1#1)(2008-10#5)(2010-12#1)(2013-1#2)(2013-8#1)
are fully##7##2##(2008-10#4)(2008-7#1)(2009-12#1)(2010-12#1)
are functional##4##2##(1993-2#1)(1994-2#1)(2008-11#1)(2012-3#1)
are functionally##4##2##(1995-2#1)(2008-10#1)(2010-4#1)(2013-1#1)
are functions of the##2##4##(2008-3#1)(2008-5#1)
are fundamental##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
are fundamentally different##3##3##(1990-5#1)(1995-1#1)(2008-11#1)
are fundamentally##4##2##(1990-5#1)(1995-1#1)(2008-10#1)(2008-11#1)
are further discussed in this addendum##2##6##(2009-8#2)
are further discussed##4##3##(2008-8#1)(2009-8#3)
are further##7##2##(2008-10#2)(2008-8#1)(2009-5#1)(2009-8#3)
are fused to##2##3##(2008-5#1)(2013-8#1)
are fused##4##2##(2008-5#1)(2008-7#2)(2013-8#1)
are gaining tremendous##2##3##(1991-3#1)(2008-10#1)
are gaining##7##2##(1991-3#1)(1993-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-2#1)
are general##3##2##(1994-3#1)(1995-3#1)(2008-11#1)
are generalized##2##2##(2008-10#1)(2008-3#1)
are generally applicable to##2##4##(1997-7#1)(2008-10#1)
are generally associated with##2##4##(2010-1#1)(2010-12#1)
are generally associated##3##3##(1997-1#1)(2010-1#1)(2010-12#1)
are generally considered##2##3##(1996-2#1)(2008-10#1)
are generally less##2##3##(2008-3#1)(2008-8#1)
are generally not##6##3##(1992-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
are generally##52##2##(1992-1#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#4)(1996-5#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
are generated by##3##3##(1993-8#1)(2008-10#1)(2009-10#1)
are generated from the##2##4##(2008-10#1)(2008-6#1)
are generated from##5##3##(2007-11#1)(2008-10#2)(2008-6#1)(2009-10#1)
are generated with##2##3##(1996-12#1)(2008-2#1)
are generated##15##2##(1993-8#1)(1996-12#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#2)(2010-12#1)
are genes##4##2##(1994-9#1)(2008-9#3)
are genetically distinct from##3##4##(2008-10#3)
are genetically distinct##5##3##(2008-10#5)
are genetically##14##2##(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
are geographically##2##2##(1997-3#1)(2011-2#1)
are given and##2##3##(2008-10#2)
are given as##2##3##(2008-10#1)(2008-8#1)
are given for both##2##4##(2008-9#2)
are given for##16##3##(1990-5#1)(2007-11#1)(2008-10#7)(2008-3#2)(2008-4#2)(2008-9#3)
are given in the##3##4##(2008-10#3)
are given in this paper##2##5##(2008-10#2)
are given in this##3##4##(2008-10#2)(2008-9#1)
are given in##7##3##(1992-9#1)(2008-10#5)(2008-9#1)
are given of##3##3##(1992-1#1)(2008-11#1)(2008-4#1)
are given to demonstrate the##2##5##(1995-5#1)(2008-10#1)
are given to##4##3##(1995-5#1)(2008-10#1)(2008-4#1)(2009-12#1)
are given##70##2##(1990-2#1)(1990-5#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#25)(2008-11#2)(2008-3#7)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
are giving##2##2##(1992-1#1)(1996-9#1)
are going to be available##4##5##(2008-12#3)(2011-3#1)
are going to be##6##4##(1991-12#1)(1996-3#1)(2008-12#3)(2011-3#1)
are going to##8##3##(1991-12#1)(1996-3#1)(2008-12#3)(2011-3#1)(2013-1#2)
are going##10##2##(1991-12#1)(1996-3#1)(2008-12#3)(2009-5#1)(2011-3#1)(2013-1#3)
are good candidates to##2##4##(2010-11#1)(2012-3#1)
are good candidates##3##3##(2010-11#1)(2012-3#1)(2013-8#1)
are good##11##2##(1992-3#1)(1993-1#1)(1997-8#1)(2008-10#5)(2010-11#1)(2012-3#1)(2013-8#1)
are governed by##3##3##(2008-10#2)(2012-3#1)
are greater than##2##3##(2008-10#1)(2008-8#1)
are greater##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
are greatest##2##2##(1992-4#1)(2013-1#1)
are greatly improved##2##3##(2008-10#1)(2009-9#1)
are greatly influenced by##2##4##(2009-5#1)(2011-3#1)
are greatly##8##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-3#1)
are grouped under the##2##4##(2009-10#1)(2011-2#1)
are grouped##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
are growing##7##2##(1992-12#1)(1994-3#3)(1996-3#1)(2012-3#1)(2013-1#1)
are grown in##2##3##(2008-10#1)(2008-4#1)
are grown##11##2##(2008-10#8)(2008-4#1)(2008-7#1)(2009-11#1)
are handled##2##2##(1990-2#1)(2008-10#1)
are hard to##3##3##(1990-3#1)(2008-11#1)(2008-12#1)
are having##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
are health##2##2##(1996-1#1)(1996-2#1)
are heavily##2##2##(2008-10#1)(2013-7#1)
are helpful##3##2##(1991-3#1)(1997-8#1)(2008-12#1)
are here##6##2##(2008-10#4)(2008-11#1)(2013-8#1)
are heterogeneous##2##2##(2010-1#1)(2011-2#1)
are heterogeneously##2##2##(1997-2#1)(2008-11#1)
are heterozygous for##2##3##(2008-10#1)(2008-7#1)
are high##15##2##(1994-5#1)(1996-9#1)(2008-10#4)(2008-3#1)(2008-8#4)(2009-10#1)(2009-8#1)(2010-4#1)(2013-8#1)
are higher for##3##3##(1992-12#1)(1996-12#2)
are higher in##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
are higher than the##3##4##(2008-10#1)(2008-6#1)(2012-2#1)
are higher than those##2##4##(2008-10#2)
are higher than##8##3##(2008-10#5)(2008-6#1)(2008-8#1)(2012-2#1)
are higher##25##2##(1991-2#1)(1992-12#1)(1996-12#2)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-8#5)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
are highlighted##20##2##(1992-1#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
are highly conserved##5##3##(1991-6#1)(1993-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
are highly correlated##2##3##(1990-5#1)(2008-9#1)
are highly desirable##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
are highly expressed in##4##4##(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)
are highly homologous to##2##4##(1993-9#1)(2008-8#1)
are highly resistant to##3##4##(2009-10#1)(2011-2#2)
are highly resistant##4##3##(2009-10#1)(2011-2#3)
are highly selective for##2##4##(1990-8#1)(1994-12#1)
are highly selective##3##3##(1990-8#1)(1994-12#1)(2008-10#1)
are highly sensitive to##5##4##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)
are highly specific##2##3##(2008-10#1)(2013-8#1)
are highly susceptible to##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
are highly##78##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#2)(1992-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-2#2)(2007-12#1)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-8#1)(2011-2#6)(2011-9#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
are homologous to##4##3##(1996-6#2)(2008-10#2)
are homologous##8##2##(1993-3#1)(1996-6#2)(2008-10#2)(2008-7#1)(2012-12#1)(2013-8#1)
are homozygous for the##2##4##(1995-2#1)(2008-10#1)
are homozygous for##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
are human##2##2##(2007-12#1)(2010-12#1)
are hydrochloric acid##2##3##(2008-10#2)
are hypothesized##2##2##(2008-10#1)(2008-8#1)
are ideal##2##2##(2008-5#1)(2009-5#1)
are ideally suited##2##3##(2009-10#1)(2012-3#1)
are ideally##3##2##(2009-10#1)(2010-5#1)(2012-3#1)
are identical or##2##3##(1996-6#1)(2008-10#1)
are identical to the##2##4##(1993-12#1)(2008-10#1)
are identical to those in##2##5##(1992-11#1)(2008-9#1)
are identical to those of##2##5##(2008-10#1)(2008-7#1)
are identical to those##5##4##(1992-11#1)(2008-10#2)(2008-7#1)(2008-9#1)
are identical to##8##3##(1992-11#1)(1993-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-6#1)
are identical with##2##3##(1992-6#1)(1997-7#1)
are identical##19##2##(1992-11#1)(1992-6#1)(1993-12#2)(1994-12#1)(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#6)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)
are identified and##4##3##(1992-2#1)(2008-2#1)(2010-11#1)(2013-1#1)
are identified as##5##3##(1993-12#1)(2008-10#2)(2008-3#2)
are identified by##3##3##(1996-2#1)(2008-3#1)(2008-9#1)
are identified in##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
are identified through##3##3##(1992-1#1)(1996-3#1)(2013-1#1)
are identified with##2##3##(1997-2#1)(2008-3#1)
are identified##37##2##(1992-1#2)(1992-2#1)(1993-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-9#4)(2009-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#2)
are ill##2##2##(1994-9#1)(1995-12#1)
are illustrated by##2##3##(1996-6#1)(2008-10#1)
are illustrated through##2##3##(1997-4#1)(2013-8#1)
are illustrated with##2##3##(2008-11#1)(2009-10#1)
are illustrated##13##2##(1993-6#1)(1995-1#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
are immobilized on the##2##4##(2008-10#1)(2008-4#1)
are immobilized on##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
are immobilized##6##2##(2008-10#4)(2008-11#1)(2008-4#1)
are impacted by##2##3##(2009-7#1)(2009-9#1)
are impaired##5##2##(1993-3#1)(1997-1#1)(2008-11#1)(2008-7#1)(2013-7#1)
are implemented##6##2##(1991-12#1)(1994-1#1)(1994-6#1)(2008-11#2)(2008-4#1)
are implementing##3##2##(1994-1#1)(2012-2#1)(2013-1#1)
are implicated in##3##3##(2008-10#2)(2008-11#1)
are implicated##4##2##(1990-3#1)(2008-10#2)(2008-11#1)
are important and##2##3##(2009-7#1)(2013-1#1)
are important factors to##3##4##(2008-11#1)(2009-12#1)(2013-1#1)
are important factors##5##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)
are important for the##11##4##(1995-6#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#2)
are important for understanding##2##4##(2008-10#1)(2009-7#1)
are important for##27##3##(1993-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#2)(2010-11#1)(2011-2#4)(2012-2#1)(2013-1#2)
are important in the##3##4##(1995-5#1)(2010-9#1)(2011-2#1)
are important in##15##3##(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
are important to the##2##4##(2008-11#1)(2011-3#1)
are important to##10##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-3#1)(2012-2#1)
are important tools for##2##4##(2010-8#1)(2013-1#1)
are important##102##2##(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-5#3)(1995-6#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#3)(2009-8#2)(2010-11#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#5)(2012-5#1)(2013-1#7)(2013-8#1)
are imposed##2##2##(2008-3#2)
are impractical##2##2##(2008-10#1)(2008-3#1)
are improved##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
are in a better position to##2##6##(2008-11#1)(2008-3#1)
are in a range##2##4##(1993-9#1)(2008-3#1)
are in a unique position to##2##6##(1996-1#1)(2008-11#1)
are in a##13##3##(1993-9#1)(1994-1#1)(1996-1#1)(1997-6#2)(2008-10#1)(2008-11#4)(2008-3#2)(2008-7#1)
are in accord with##2##4##(1991-9#1)(1992-6#1)
are in accordance with the##2##5##(1994-8#1)(1995-11#1)
are in accordance with##3##4##(1994-8#1)(1995-11#1)(2008-10#1)
are in agreement at a 95% confidence level##2##8##(2008-10#2)
are in agreement at the 95% confidence level and within an acceptable range of error##2##15##(2008-10#2)
are in agreement at the 95% confidence level##3##8##(2008-10#3)
are in agreement at##5##4##(2008-10#5)
are in agreement with previous##5##5##(1994-5#1)(2008-10#3)(2008-7#1)
are in agreement with the##6##5##(2008-10#4)(2008-3#1)(2013-1#1)
are in agreement with##15##4##(1994-5#1)(2006-6#1)(2008-10#10)(2008-3#1)(2008-7#1)(2013-1#1)
are in agreement##21##3##(1994-5#1)(2006-6#1)(2008-10#16)(2008-3#1)(2008-7#1)(2013-1#1)
are in close##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
are in contact with##2##4##(1995-2#1)(2008-10#1)
are in excellent agreement with the##2##6##(1990-8#1)(2008-10#1)
are in excellent agreement with##6##5##(1990-8#1)(2007-11#1)(2008-10#3)(2008-3#1)
are in excellent agreement##8##4##(1990-8#1)(2007-11#1)(2008-10#3)(2008-3#3)
are in excellent##9##3##(1990-8#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-3#3)
are in fact##2##3##(2008-10#1)(2012-2#1)
are in good agreement with the##7##6##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-7#1)
are in good agreement with those obtained by the##2##9##(2008-10#2)
are in good agreement with those obtained by##5##8##(2008-10#5)
are in good agreement with those obtained##6##7##(2008-10#5)(2008-3#1)
are in good agreement with those##7##6##(2008-10#6)(2008-3#1)
are in good agreement with##19##5##(2007-11#1)(2008-10#11)(2008-2#2)(2008-3#4)(2010-7#1)
are in good agreement##27##4##(1994-5#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#5)(2010-7#1)
are in good##29##3##(1994-5#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#5)(2010-7#1)(2013-8#1)
are in line with the##2##5##(1990-12#1)(2009-11#1)
are in need of##3##4##(1994-3#2)(2013-1#1)
are in place##3##3##(1996-2#1)(2010-9#1)(2012-12#1)
are in progress##5##3##(1993-11#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
are in the early stages of##3##6##(1996-3#1)(2008-10#1)(2011-2#1)
are in the process of##2##5##(2008-10#1)(2008-11#1)
are in the range of 0##3##6##(2008-10#3)
are in the range of 1##2##6##(2008-10#2)
are in the range of##11##5##(2008-10#10)(2010-10#1)
are in the range##17##4##(2008-10#16)(2010-10#1)
are in the##37##3##(1993-2#1)(1994-2#1)(1994-3#2)(1996-11#1)(1996-3#1)(1997-1#1)(2008-10#22)(2008-11#2)(2008-7#2)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)
are in turn##2##3##(2010-12#1)(2013-7#1)
are in##169##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-6#4)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#71)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#12)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
are inappropriate##2##2##(1992-2#1)(2008-1#1)
are incapable of##2##3##(1997-6#1)(2008-10#1)
are included for##4##3##(1997-2#1)(2008-4#3)
are included in the##6##4##(1992-3#1)(1995-5#1)(2008-10#3)(2008-3#1)
are included in##11##3##(1992-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-10#3)(2008-3#1)(2009-4#1)(2010-8#1)
are included that describe##2##4##(2008-9#2)
are included##35##2##(1991-3#1)(1992-3#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#7)(2008-8#1)(2008-9#4)(2009-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
are incomplete##2##2##(1995-1#1)(2008-10#1)
are inconclusive##2##2##(1994-9#1)(2012-12#1)
are inconsistent with the##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
are inconsistent with##4##3##(2008-10#2)(2012-12#1)(2012-3#1)
are incorporated into the##2##4##(2008-3#2)
are incorporated into##5##3##(2008-10#2)(2008-12#1)(2008-3#2)
are incorporating##2##2##(2008-11#1)(2008-12#1)
are increased in##4##3##(1992-1#1)(1994-11#1)(1995-12#1)(2011-1#1)
are increased##10##2##(1992-1#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
are increasing##10##2##(1991-2#2)(1993-1#1)(1994-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2010-9#1)(2011-2#1)
are increasingly being##3##3##(1990-11#1)(1995-2#1)(2012-2#1)
are increasingly##15##2##(1990-11#1)(1993-2#2)(1994-2#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
are indeed##4##2##(2008-10#1)(2008-11#1)(2009-5#1)(2010-2#1)
are independent and##2##3##(2008-7#1)(2013-1#1)
are independent of the##2##4##(1990-5#1)(2008-7#1)
are independent of##5##3##(1990-5#1)(1995-3#1)(2008-4#1)(2008-7#2)
are independent##13##2##(1990-2#1)(1990-5#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#5)(2011-3#1)(2013-1#1)
are independently##3##2##(1991-3#1)(1992-9#1)(2008-7#1)
are indicated for##2##3##(2008-3#1)(2010-11#1)
are indicated to##2##3##(2008-10#1)(2013-1#1)
are indicated##11##2##(1992-2#1)(1994-3#1)(1996-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
are indications that##2##3##(2006-6#1)(2008-10#1)
are indications##3##2##(2006-6#1)(2008-10#1)(2008-8#1)
are indicative of##6##3##(1991-12#1)(1993-8#1)(2008-10#2)(2008-11#1)(2009-4#1)
are indispensable##3##2##(1994-2#1)(2010-11#1)(2012-2#1)
are indispensible##2##2##(2008-2#1)(2013-3#1)
are indistinguishable from##2##3##(2008-10#2)
are indistinguishable##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
are individually##2##2##(1994-2#1)(2010-1#1)
are induced by##4##3##(1991-2#1)(1992-12#1)(1997-8#1)(2008-10#1)
are induced in##2##3##(1994-8#1)(1995-12#1)
are induced to##2##3##(1995-6#1)(2011-2#1)
are induced##10##2##(1991-2#1)(1992-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2009-8#1)(2011-2#1)
are infected##3##2##(1993-3#1)(1997-6#1)(2008-11#1)
are inflammatory##2##2##(2009-8#1)(2011-2#1)
are influenced by the##2##4##(1996-12#1)(2008-10#1)
are influenced by various factors##2##5##(2008-11#1)(2008-2#1)
are influenced by##16##3##(1990-2#1)(1991-3#1)(1992-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
are informative##2##2##(2008-7#1)(2008-8#1)
are infrequent##3##2##(1990-2#1)(2008-1#1)(2012-3#1)
are inhibited##2##2##(1990-11#1)(1995-8#1)
are inhibitors of##2##3##(2009-8#1)(2011-2#1)
are initialized as##2##3##(2008-10#2)
are initially##7##2##(1996-2#1)(1996-9#1)(2008-3#1)(2008-8#2)(2009-8#1)(2011-2#1)
are initiated by##2##3##(2008-8#1)(2012-2#1)
are initiated##5##2##(1993-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
are injected into a##3##4##(2008-10#3)
are injected into##4##3##(2008-10#4)
are injected##5##2##(2008-10#5)
are innervated by##2##3##(1994-9#1)(1997-3#1)
are inoculated##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
are insensitive to the##2##4##(2008-3#2)
are insensitive to##7##3##(1994-5#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-12#1)
are insignificant##2##2##(2008-2#1)(2008-3#1)
are insufficient to##2##3##(2008-11#1)(2011-2#1)
are insufficient##6##2##(1997-6#1)(2008-1#1)(2008-11#2)(2010-5#1)(2011-2#1)
are integral to##2##3##(1992-12#1)(2008-11#1)
are integral##4##2##(1992-12#1)(2008-11#2)(2011-2#1)
are integrated in##3##3##(2008-5#1)(2009-11#1)(2012-2#1)
are integrated with##2##3##(2008-11#1)(2008-12#1)
are integrated##7##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2012-2#1)
are interesting##2##2##(2012-2#1)(2013-8#1)
are intermediate##3##2##(2008-11#1)(2013-8#2)
are internalized##2##2##(1991-12#1)(1995-8#1)
are interpreted as##3##3##(1991-5#1)(2007-12#1)(2011-2#1)
are interpreted in##2##3##(1997-3#1)(2008-3#1)
are interpreted##9##2##(1991-5#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#1)(2011-2#2)
are interrelated##2##2##(2010-8#1)(2013-1#1)
are intimately linked##2##3##(2008-11#1)(2008-2#1)
are intrinsic##2##2##(1996-12#1)(1996-2#1)
are intrinsically##3##2##(1993-12#1)(2008-9#1)(2010-8#1)
are introduced and compared##2##4##(2008-11#1)(2011-7#1)
are introduced and##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-9#1)(2011-7#1)
are introduced for##3##3##(1990-5#1)(1995-5#1)(2008-3#1)
are introduced into the##2##4##(2008-7#1)(2008-9#1)
are introduced into##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
are introduced to##4##3##(1990-11#1)(1991-3#1)(2008-10#1)(2009-4#1)
are introduced##26##2##(1990-11#1)(1990-5#1)(1991-3#1)(1995-5#1)(1996-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-9#1)(2011-7#1)(2013-1#1)(2013-7#1)
are intronless##2##2##(1992-6#1)(2009-10#1)
are inversely##3##2##(2008-10#2)(2008-9#1)
are investigated and the##2##4##(2008-10#1)(2008-3#1)
are investigated and##6##3##(2008-10#4)(2008-2#1)(2008-3#1)
are investigated as##2##3##(2008-10#2)
are investigated by a##2##4##(1992-9#1)(2010-11#1)
are investigated by##4##3##(1992-9#1)(1996-11#1)(2008-10#1)(2010-11#1)
are investigated for the##2##4##(2008-10#2)
are investigated in terms of##2##5##(2008-3#1)(2010-6#1)
are investigated in##6##3##(1993-3#1)(1993-8#1)(2008-10#1)(2008-3#1)(2010-6#1)(2010-7#1)
are investigated with##2##3##(2008-10#2)
are investigated##39##2##(1990-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-11#1)(2008-10#16)(2008-11#1)(2008-2#6)(2008-3#4)(2008-8#2)(2010-11#1)(2010-6#1)(2010-7#2)
are involved in a##2##4##(2008-9#1)(2011-2#1)
are involved in the biosynthesis of##2##6##(1996-12#1)(2008-10#1)
are involved in the development of##3##6##(1997-8#1)(2008-10#1)(2010-5#1)
are involved in the etiology of##2##6##(2008-10#1)(2008-7#1)
are involved in the induction of##2##6##(2008-10#2)
are involved in the induction##3##5##(2008-10#3)
are involved in the maintenance of##2##6##(2008-5#1)(2008-9#1)
are involved in the pathogenesis of##2##6##(1993-12#1)(2008-10#1)
are involved in the regulation of##4##6##(1993-12#1)(1995-2#1)(2006-6#1)(2010-12#1)
are involved in the##39##4##(1991-12#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#12)(2008-5#1)(2008-7#2)(2008-9#4)(2009-12#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
are involved in this##2##4##(2008-10#1)(2008-11#1)
are involved in##94##3##(1991-12#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#3)(1997-3#1)(1997-8#2)(2006-6#4)(2007-12#3)(2008-10#24)(2008-11#5)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#7)(2009-10#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
are involved##108##2##(1991-12#1)(1992-7#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#3)(1997-3#1)(1997-8#2)(2006-6#5)(2007-12#3)(2008-1#1)(2008-10#28)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#3)(2013-8#1)
are isolated from##3##3##(2008-10#1)(2008-5#2)
are isolated##7##2##(1990-2#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-1#1)
are issues##2##2##(2009-5#1)(2011-2#1)
are its##4##2##(2008-10#2)(2008-11#1)(2009-10#1)
are jointly##2##2##(1992-1#1)(2008-3#1)
are just##4##2##(1991-12#1)(1994-2#1)(2008-7#1)(2009-8#1)
are kept##4##2##(1997-6#1)(2008-12#1)(2008-9#1)(2009-8#1)
are key components of the##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
are key components##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
are key enzymes##2##3##(2011-2#1)(2012-5#1)
are key to success##2##4##(1996-12#1)(2011-2#1)
are key to##5##3##(1996-12#1)(2010-10#1)(2011-2#2)(2011-3#1)
are key##26##2##(1992-3#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)
are killed##3##2##(1990-12#1)(2008-8#1)(2012-3#1)
are known and##3##3##(1995-9#1)(2008-10#1)(2011-3#1)
are known as##7##3##(1997-5#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-9#1)(2012-2#2)
are known for##2##3##(2008-10#1)(2012-5#1)
are known to be a##2##5##(2008-11#1)(2012-2#1)
are known to be involved in##2##6##(1993-12#1)(2008-11#1)
are known to be relatively##2##5##(2008-1#1)(2008-7#1)
are known to be##21##4##(1990-9#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#2)
are known to cause##2##4##(1991-12#1)(2008-11#1)
are known to contain##3##4##(1997-3#1)(2008-10#1)(2008-11#1)
are known to form##2##4##(2008-10#1)(2008-8#1)
are known to have##3##4##(1990-2#1)(2012-2#1)(2013-1#1)
are known to induce##2##4##(1995-9#1)(2008-7#1)
are known to mediate##2##4##(2009-8#1)(2010-7#1)
are known to occur##2##4##(1990-11#1)(2011-2#1)
are known to produce##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
are known to regulate##2##4##(1995-2#1)(2012-2#1)
are known to##61##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#2)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#2)(1997-3#1)(2008-1#1)(2008-10#10)(2008-11#10)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#2)
are known##86##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#3)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#3)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#14)(2008-11#11)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#7)(2012-5#1)(2013-1#2)
are lacking##13##2##(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
are large##8##2##(1996-9#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
are largely due to##2##4##(2008-8#1)(2012-2#1)
are largely explained by##2##4##(1996-3#1)(2008-8#1)
are largely resistant to##2##4##(1995-2#1)(2011-3#1)
are largely responsible for##2##4##(1997-7#1)(2008-10#1)
are largely unknown##5##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-4#1)
are largely##23##2##(1992-4#1)(1995-2#2)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)
are larger than##2##3##(1995-6#1)(2008-10#1)
are larger##4##2##(1995-6#1)(2008-10#2)(2008-8#1)
are leading to##2##3##(1996-1#1)(2012-5#1)
are left##2##2##(2008-11#1)(2008-6#1)
are less confusion and more clarity##2##6##(2013-1#2)
are less effective##2##3##(2012-2#1)(2012-3#1)
are less likely to##3##4##(1991-11#1)(1992-2#1)(2008-12#1)
are less pronounced##2##3##(2008-10#1)(2008-7#1)
are less severe##3##3##(2008-10#2)(2008-8#1)
are less than##10##3##(1990-5#1)(1992-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#2)
are less well##2##3##(2008-1#1)(2008-8#1)
are less##43##2##(1990-5#1)(1991-11#1)(1992-2#3)(1994-12#1)(1994-8#1)(1995-2#1)(1996-2#2)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
are liberated##2##2##(1994-9#1)(2008-10#1)
are likely the##2##3##(1995-12#1)(2008-10#1)
are likely to act as##2##5##(1995-8#1)(2013-8#1)
are likely to be related to##2##6##(2008-10#1)(2011-2#1)
are likely to be##22##4##(1992-6#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-8#4)(2011-2#1)(2012-2#2)
are likely to influence##2##4##(1997-1#1)(2010-5#1)
are likely to play a role in##2##7##(1992-12#1)(1992-6#1)
are likely to play a##3##5##(1992-12#1)(1992-6#1)(2008-10#1)
are likely to provide##2##4##(2009-7#1)(2010-11#1)
are likely to##57##3##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#3)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-1#3)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are likely##71##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#4)(1993-12#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#3)(1997-2#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-5#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
are limited and##3##3##(2008-11#1)(2009-10#1)(2010-10#1)
are limited by the##5##4##(1994-6#1)(2008-10#2)(2008-9#1)(2011-2#1)
are limited by##9##3##(1994-6#1)(2008-10#3)(2008-3#1)(2008-9#3)(2011-2#1)
are limited for##2##3##(2008-10#1)(2009-7#1)
are limited in##3##3##(2008-1#1)(2008-9#1)(2013-8#1)
are limited to##4##3##(2008-10#1)(2008-9#1)(2009-10#1)(2012-12#1)
are limited##30##2##(1994-6#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#5)(2009-10#2)(2009-7#1)(2010-10#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
are linear in the range##2##5##(2008-10#2)
are linear in the##4##4##(2008-10#3)(2008-2#1)
are linear up to 50##2##5##(2008-10#2)
are linear up to##3##4##(2008-10#3)
are linear##15##2##(2008-10#11)(2008-2#1)(2008-4#1)(2010-1#1)(2012-3#1)
are linearly##4##2##(2008-10#4)
are linked to the##5##4##(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)
are linked to##15##3##(1991-6#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#3)(2010-10#1)(2013-8#1)
are linked##17##2##(1991-6#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#3)(2010-10#1)(2013-8#1)
are listed in##3##3##(1991-3#1)(1996-1#1)(2010-3#1)
are listed##9##2##(1991-3#1)(1993-8#1)(1995-6#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-3#1)
are living##2##2##(1997-6#1)(2008-11#1)
are localized in##4##3##(1997-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
are localized##6##2##(1996-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2013-1#1)
are locally##3##2##(2007-12#1)(2008-7#1)(2008-9#1)
are located at##4##3##(1993-2#1)(1993-6#1)(1995-8#1)(1997-8#1)
are located in the cytoplasmic##2##5##(1993-3#1)(2011-2#1)
are located in the##8##4##(1992-3#1)(1993-3#1)(1993-8#1)(1996-9#1)(1997-9#1)(2008-10#2)(2011-2#1)
are located in##13##3##(1992-3#1)(1993-3#1)(1993-8#1)(1996-9#1)(1997-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
are located on the##2##4##(2008-5#1)(2009-9#1)
are located on##5##3##(1993-6#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-9#1)
are located within##2##3##(1994-12#1)(1996-8#1)
are located##37##2##(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#1)(1997-9#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-3#1)
are long##2##2##(2008-5#1)(2013-1#1)
are lost to the##3##4##(1991-2#1)(1993-12#1)(1996-1#1)
are lost##8##2##(1991-2#1)(1993-12#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-6#1)(2010-4#1)
are low##8##2##(1994-1#1)(2007-11#1)(2008-11#2)(2008-8#4)
are lower for##4##3##(1995-2#1)(2008-10#3)
are lower in##2##3##(1993-8#1)(1996-5#1)
are lower than the##2##4##(2008-10#1)(2011-2#1)
are lower than those in the##2##6##(2010-8#1)(2011-2#1)
are lower than those in##3##5##(2008-10#1)(2010-8#1)(2011-2#1)
are lower than those##4##4##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
are lower than##8##3##(2008-10#3)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#2)
are lower##15##2##(1993-8#1)(1995-2#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#2)(2012-3#1)
are made for future research##2##5##(1992-3#1)(2008-12#1)
are made for future##3##4##(1992-3#1)(2008-11#1)(2008-12#1)
are made for##8##3##(1991-1#1)(1992-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)
are made of##2##3##(1995-3#1)(2008-7#1)
are made on##3##3##(1991-3#1)(1991-6#1)(2011-3#1)
are made to the##2##4##(1991-12#1)(2008-2#1)
are made to##4##3##(1991-12#1)(1992-12#1)(1995-9#1)(2008-2#1)
are made##43##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#3)(1992-3#1)(1992-9#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-8#1)
are mainly localized##2##3##(1994-11#1)(1997-7#1)
are mainly##15##2##(1991-5#2)(1994-11#1)(1994-2#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
are maintained in##3##3##(1994-3#1)(2008-11#2)
are maintained##13##2##(1994-3#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-8#2)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)
are major sources of##2##4##(2010-5#1)(2011-2#1)
are major targets##2##3##(2008-10#1)(2012-2#1)
are major##17##2##(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
are malignant##2##2##(2008-2#1)(2010-12#1)
are mandated##2##2##(1997-3#1)(2013-1#1)
are mandatory to##2##3##(2010-12#1)(2011-2#1)
are mandatory##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
are many reports of##2##4##(1991-5#1)(2008-10#1)
are many##32##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#2)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#2)(2008-8#1)(2009-1#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
are marked by a##2##4##(1996-12#1)(2008-8#1)
are markedly##5##2##(1992-3#1)(1995-11#1)(2008-10#2)(2012-12#1)
are measurable##2##2##(1994-1#1)(2008-3#1)
are measured as a function of##2##6##(2008-3#2)
are measured at##3##3##(2008-10#3)
are measured by##2##3##(2008-2#1)(2008-3#1)
are measured in##3##3##(2008-3#2)(2010-11#1)
are measured to##2##3##(2008-11#1)(2009-7#1)
are measured##27##2##(1991-6#1)(1993-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-11#1)
are mediated by the##2##4##(1991-2#1)(1996-3#1)
are mediated by##10##3##(1991-2#1)(1991-5#1)(1993-6#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
are mediated##15##2##(1990-11#1)(1991-2#1)(1991-5#1)(1993-6#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#3)(2013-8#1)
are medically##3##2##(1993-11#1)(1997-1#2)
are members of a##3##4##(1995-8#1)(1996-12#1)(2012-2#1)
are members of the##7##4##(1991-5#1)(1996-2#1)(2008-10#4)(2008-9#1)
are members of##13##3##(1991-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-9#2)(2012-2#3)
are mentioned##5##2##(1997-7#1)(2008-1#1)(2008-7#1)(2009-12#1)(2011-1#1)
are met##4##2##(1992-1#1)(1996-3#1)(1997-1#1)(2013-1#1)
are methods for##3##3##(2008-4#1)(2008-9#1)(2010-7#1)
are methods##5##2##(2008-10#1)(2008-4#1)(2008-9#2)(2010-7#1)
are mild##3##2##(2013-1#3)
are minimal##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
are minimized##2##2##(2008-10#2)
are missing##2##2##(1995-12#1)(2009-10#1)
are mixed##5##2##(2008-10#1)(2008-4#1)(2008-8#2)(2010-10#1)
are modeled##2##2##(2007-12#1)(2008-11#1)
are moderately##2##2##(1995-2#1)(2008-10#1)
are modified by##3##3##(1990-5#1)(2008-5#1)(2008-7#1)
are modified##5##2##(1990-5#1)(2008-5#1)(2008-7#2)(2011-1#1)
are modulated by##2##3##(1994-5#1)(2013-8#1)
are modulated##3##2##(1994-5#1)(2008-5#1)(2013-8#1)
are monitored##3##2##(1997-6#1)(2008-10#1)(2008-4#1)
are more and more##2##4##(1991-6#1)(2009-7#1)
are more closely related to each other##2##7##(2008-8#1)(2011-2#1)
are more closely related to##4##5##(2008-10#1)(2008-8#1)(2011-2#2)
are more closely##5##3##(1995-12#1)(2008-10#1)(2008-8#1)(2011-2#2)
are more common in males##2##5##(1997-3#1)(2008-10#1)
are more common##9##3##(1993-11#1)(1997-3#1)(2008-10#3)(2011-2#2)(2012-2#1)(2012-3#1)
are more difficult to##2##4##(2008-10#1)(2008-11#1)
are more effective than##3##4##(1993-2#1)(1996-5#1)(2013-1#1)
are more effective##6##3##(1991-2#1)(1991-3#1)(1993-2#1)(1996-5#1)(1997-1#1)(2013-1#1)
are more efficient##2##3##(2008-10#1)(2008-8#1)
are more frequent than##2##4##(2008-7#1)(2012-2#1)
are more frequent##4##3##(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
are more frequently##2##3##(2008-5#1)(2013-1#1)
are more important than the##2##5##(1995-1#1)(2008-11#1)
are more important than##4##4##(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
are more likely to experience##2##5##(2008-10#1)(2008-9#1)
are more likely to##24##4##(1991-12#1)(1993-11#1)(1993-12#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#3)(2009-6#1)(2009-7#2)(2010-10#2)(2010-12#1)(2011-2#3)(2012-2#1)
are more likely##25##3##(1991-12#1)(1993-11#1)(1993-12#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#3)(2009-6#1)(2009-7#2)(2010-10#2)(2010-12#1)(2011-2#3)(2012-2#1)
are more often##4##3##(1992-3#1)(1994-12#1)(2008-4#1)(2008-5#1)
are more potent##2##3##(2008-12#1)(2009-9#1)
are more prevalent in##2##4##(2008-11#1)(2009-5#1)
are more prevalent##3##3##(2008-1#1)(2008-11#1)(2009-5#1)
are more related to the##2##5##(1991-5#1)(2008-8#1)
are more resistant than##2##4##(2008-10#1)(2013-1#1)
are more resistant to##3##4##(1993-12#1)(2008-11#1)(2009-8#1)
are more resistant##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
are more responsive to##2##4##(1993-12#1)(2012-2#1)
are more selective##2##3##(1995-11#1)(2008-11#1)
are more sensitive##2##3##(1991-10#1)(2008-10#1)
are more similar to each other##2##6##(1993-6#1)(2008-10#1)
are more stable##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
are more suitable for##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
are more susceptible##2##3##(2012-2#1)(2013-1#1)
are more than##2##3##(1992-12#1)(2011-2#1)
are more##152##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-6#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#24)(2008-11#11)(2008-12#1)(2008-4#7)(2008-5#7)(2008-7#2)(2008-8#10)(2008-9#6)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#3)(2010-5#1)(2010-7#4)(2011-2#11)(2012-2#6)(2012-3#2)(2013-1#5)
are morphologically similar to##2##4##(2008-10#1)(2010-3#1)
are morphologically similar##3##3##(2007-12#1)(2008-10#1)(2010-3#1)
are morphologically##9##2##(1995-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2010-4#1)(2012-3#1)
are most abundant##2##3##(2008-5#1)(2008-8#1)
are most appropriate##2##3##(2008-2#1)(2008-3#1)
are most commonly##2##3##(2009-8#1)(2012-3#1)
are most frequently##5##3##(1991-12#1)(2007-12#1)(2008-10#2)(2012-3#1)
are most likely to##3##4##(2008-5#1)(2008-8#1)(2012-2#1)
are most likely##8##3##(1993-6#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#2)
are most often##4##3##(1994-2#1)(2010-11#1)(2010-12#1)(2012-12#1)
are most suitable for##2##4##(2008-10#2)
are most##47##2##(1991-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#4)(2009-8#3)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
are mostly##8##2##(1997-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-12#1)(2013-1#1)
are motile##2##2##(2008-5#1)(2011-2#1)
are moving##3##2##(2008-10#1)(2009-7#1)(2010-9#1)
are much less sensitive to##2##5##(2008-5#1)(2009-9#1)
are much less##6##3##(1994-2#1)(1996-1#1)(2008-5#1)(2009-1#1)(2009-9#1)(2010-4#1)
are much lower##2##3##(2008-10#1)(2010-6#1)
are much more##8##3##(1990-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)
are much smaller than##2##4##(2008-10#1)(2008-3#1)
are much##22##2##(1990-11#1)(1994-2#1)(1996-1#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-7#1)
are multiple and##2##3##(2008-5#1)(2011-2#1)
are multiple##9##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-2#3)
are mutagenic##2##2##(1991-12#1)(2008-10#1)
are mutually exclusive##2##3##(1995-9#1)(2011-2#1)
are mutually##3##2##(1995-9#1)(2008-9#1)(2011-2#1)
are narrow##2##2##(2007-12#1)(2013-1#1)
are native##2##2##(2008-10#1)(2008-8#1)
are natural##7##2##(1991-3#1)(1992-3#1)(1997-2#1)(2008-6#1)(2008-7#1)(2011-2#2)
are naturally##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
are near##2##2##(1997-8#1)(2008-10#1)
are nearly##5##2##(1992-3#1)(1994-5#1)(2008-10#2)(2008-2#1)
are necessary for efficient##2##4##(2008-11#1)(2008-2#1)
are necessary for the##6##4##(1990-9#1)(1991-7#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-5#1)
are necessary for##22##3##(1990-9#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-9#1)(1995-2#1)(1995-5#1)(2006-6#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-2#1)
are necessary to further##2##4##(2008-10#1)(2011-2#1)
are necessary to support##3##4##(2008-10#1)(2012-2#2)
are necessary to##14##3##(1996-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
are necessary##45##2##(1990-9#1)(1991-12#1)(1991-7#1)(1992-3#2)(1993-9#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(2006-6#1)(2008-10#7)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
are needed and##2##3##(2008-10#1)(2008-5#1)
are needed for the##2##4##(2008-10#2)
are needed for##13##3##(1993-12#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#1)
are needed in order to##3##5##(2008-10#2)(2013-1#1)
are needed in the##3##4##(1991-3#1)(1992-3#1)(2011-2#1)
are needed in##8##3##(1991-3#1)(1992-3#1)(2008-10#3)(2011-2#2)(2013-1#1)
are needed to address##2##4##(2010-9#1)(2012-12#1)
are needed to better##2##4##(2011-2#1)(2013-1#1)
are needed to confirm the##3##5##(1991-12#1)(2010-12#1)(2011-2#1)
are needed to confirm##5##4##(1991-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
are needed to determine the##2##5##(2013-1#1)(2013-8#1)
are needed to determine##4##4##(1997-3#1)(2008-12#1)(2013-1#1)(2013-8#1)
are needed to elucidate the##3##5##(1995-6#1)(2009-8#1)(2012-12#1)
are needed to fully##2##4##(2008-10#1)(2012-12#1)
are needed to identify##3##4##(2009-12#1)(2010-11#1)(2013-8#1)
are needed to##42##3##(1991-12#1)(1991-3#1)(1993-3#1)(1995-6#1)(1997-3#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
are needed##101##2##(1991-12#2)(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#2)(1997-1#1)(1997-3#3)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#19)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#2)
are needs##2##2##(1996-3#1)(2008-10#1)
are negative##4##2##(1997-2#1)(2008-5#1)(2008-9#1)(2012-3#1)
are negatively##3##2##(1992-2#1)(2008-10#1)(2012-2#1)
are neither##2##2##(2008-10#1)(2008-9#1)
are neurons##2##2##(2007-12#2)
are new##10##2##(1990-9#1)(1996-3#1)(2008-10#1)(2008-11#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
are no clear##2##3##(2008-10#1)(2008-8#1)
are no longer##3##3##(2008-10#1)(2008-12#1)(2009-8#1)
are no more##2##3##(1994-2#1)(1997-6#1)
are no reports##2##3##(2011-1#1)(2013-1#1)
are no significant differences between the##2##6##(1993-8#1)(2008-10#1)
are no significant differences between##3##5##(1993-8#1)(2008-10#2)
are no significant##4##3##(1993-8#1)(2008-10#2)(2008-11#1)
are no##46##2##(1990-11#1)(1990-2#1)(1990-9#1)(1992-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
are non-toxic##2##2##(2008-10#1)(2008-5#1)
are nonspecific##2##2##(2010-1#1)(2011-2#1)
are normal##5##2##(1991-2#1)(1993-12#1)(1997-7#1)(2008-11#1)(2008-9#1)
are normally##6##2##(1992-9#1)(1994-9#1)(1995-2#1)(2008-3#1)(2009-12#1)(2012-3#1)
are not a##8##3##(1993-2#1)(1994-8#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2013-1#1)
are not able to##4##4##(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
are not adequately##2##3##(1990-11#1)(2012-3#1)
are not affected##3##3##(1990-2#1)(1992-3#1)(1995-11#1)
are not always adequate##2##4##(1997-8#1)(2011-2#1)
are not always##8##3##(1993-1#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2011-3#1)
are not associated with##3##4##(2008-10#1)(2009-12#1)(2009-8#1)
are not available##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
are not based##2##3##(1994-3#1)(2008-7#1)
are not capable of##2##4##(1992-6#1)(2009-5#1)
are not clearly##3##3##(1997-4#1)(2008-11#1)(2011-2#1)
are not commonly##3##3##(1993-12#2)(2008-8#1)
are not completely##4##3##(2008-10#2)(2008-5#1)(2013-7#1)
are not conclusive##2##3##(1997-4#1)(2012-2#1)
are not considered##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
are not consistent with##2##4##(2008-10#2)
are not defined##3##3##(1995-12#1)(1997-4#1)(2008-7#1)
are not designed to##2##4##(1994-3#1)(2008-9#1)
are not detected##2##3##(2008-10#1)(2008-4#1)
are not directly##4##3##(1994-9#1)(2008-11#1)(2008-2#1)(2013-8#1)
are not easy##2##3##(1993-11#1)(2013-1#1)
are not effective##3##3##(1997-1#1)(2008-10#2)
are not essential for##2##4##(1993-2#1)(1993-9#1)
are not familiar with##2##4##(2010-8#1)(2013-8#1)
are not far##2##3##(1997-7#1)(2008-7#1)
are not feasible##2##3##(2008-10#2)
are not found in##2##4##(2008-5#1)(2012-3#1)
are not found##3##3##(2007-12#1)(2008-5#1)(2012-3#1)
are not free##2##3##(2013-1#1)(2013-8#1)
are not fully known##2##4##(2008-10#1)(2012-2#1)
are not fully understood##3##4##(2010-5#1)(2011-2#1)(2013-1#1)
are not fully##8##3##(1991-6#1)(2008-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
are not identified##2##3##(1994-9#1)(2008-10#1)
are not in##2##3##(2007-12#1)(2008-7#1)
are not involved##2##3##(1995-12#1)(2008-4#1)
are not known##6##3##(1995-11#1)(1995-12#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-3#1)
are not likely to be##3##5##(1995-9#1)(2008-11#1)(2009-6#1)
are not likely to##4##4##(1995-9#1)(2008-11#2)(2009-6#1)
are not linear##2##3##(2008-10#2)
are not major##2##3##(2008-10#1)(2009-6#1)
are not met##2##3##(2010-3#1)(2013-8#1)
are not mutually exclusive##2##4##(2008-9#1)(2010-10#1)
are not necessarily##9##3##(1992-3#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2013-8#1)
are not necessary##5##3##(2008-10#3)(2010-7#1)(2011-2#1)
are not new##2##3##(1994-12#1)(2008-12#1)
are not observed##3##3##(1992-6#1)(1997-2#1)(2013-8#1)
are not only##6##3##(1997-7#1)(2008-11#1)(2009-12#1)(2012-2#1)(2013-1#2)
are not possible##3##3##(1993-3#1)(1996-3#1)(1997-3#1)
are not present in##2##4##(2008-7#1)(2009-8#1)
are not present##6##3##(1991-5#1)(2008-10#3)(2008-7#1)(2009-8#1)
are not readily##5##3##(1991-5#1)(1993-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
are not related to##3##4##(1995-2#1)(1996-8#1)(2008-7#1)
are not restricted to##2##4##(2008-10#1)(2008-6#1)
are not sensitive##2##3##(2008-10#2)
are not significant##3##3##(2008-10#2)(2013-8#1)
are not significantly different from##2##5##(1990-12#1)(2008-10#1)
are not significantly different##3##4##(1990-12#1)(2008-10#2)
are not so##2##3##(2008-4#1)(2013-8#1)
are not specific##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
are not standardized##2##3##(1992-3#1)(1993-12#1)
are not statistically significant##2##4##(2008-10#1)(2012-12#1)
are not sufficient to##4##4##(1991-3#1)(2008-11#1)(2008-5#1)(2009-8#1)
are not suitable for##2##4##(2008-10#1)(2008-11#1)
are not suitable##3##3##(2008-10#1)(2008-11#2)
are not the cause of##2##5##(1992-12#1)(1995-5#1)
are not the##9##3##(1990-12#1)(1991-12#1)(1992-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
are not to be##2##4##(1991-3#1)(1994-9#1)
are not totally##2##3##(1991-12#1)(1996-11#1)
are not uncommon##3##3##(2008-9#1)(2012-12#1)(2012-2#1)
are not universally##2##3##(2008-10#1)(2008-12#1)
are not very##2##3##(2008-10#1)(2010-9#1)
are not visible##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
are not well understood##9##4##(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2010-1#1)(2011-1#1)(2011-2#1)
are not well##14##3##(1990-2#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)
are not yet available##2##4##(2008-10#1)(2011-2#1)
are not yet##9##3##(1991-12#1)(2008-10#2)(2008-6#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#1)
are not##404##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#5)(1991-3#3)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#2)(2008-1#2)(2008-10#80)(2008-11#26)(2008-12#8)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#10)(2008-6#4)(2008-7#14)(2008-8#9)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#17)(2011-3#2)(2011-7#1)(2012-12#3)(2012-2#11)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#10)
are notable for##2##3##(1997-2#1)(2013-1#1)
are notable##3##2##(1997-2#1)(2011-2#1)(2013-1#1)
are noted in##2##3##(2009-9#1)(2010-12#1)
are noted##9##2##(1991-2#1)(1992-1#1)(1992-3#1)(1992-9#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2012-12#1)
are novel##2##2##(1990-5#1)(2008-9#1)
are now available##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
are now becoming##2##3##(1997-2#1)(2008-6#1)
are now beginning to##3##4##(1991-3#1)(2011-2#2)
are now being used##2##4##(2008-11#1)(2011-2#1)
are now being##9##3##(1991-12#1)(1994-9#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
are now emerging##2##3##(2008-11#1)(2010-10#1)
are now in operation##2##4##(1997-5#1)(2008-10#1)
are now in##4##3##(1997-2#1)(1997-5#1)(2008-10#1)(2011-2#1)
are now more##2##3##(2008-11#1)(2008-7#1)
are now part of##2##4##(1996-3#1)(2011-2#1)
are now possible##2##3##(2008-10#1)(2008-7#1)
are now reported##2##3##(1994-8#1)(2011-2#1)
are now required##2##3##(1996-12#1)(2008-11#1)
are now widely used##2##4##(1990-2#1)(1993-2#1)
are now widely##4##3##(1990-2#1)(1993-12#1)(1993-2#1)(2009-3#1)
are now##72##2##(1990-2#1)(1991-12#1)(1991-3#2)(1992-2#1)(1993-12#3)(1993-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#7)(2011-3#2)(2011-7#1)(2012-3#1)(2013-1#3)(2013-8#1)
are nowadays##2##2##(2008-10#1)(2010-6#1)
are numerous and##2##3##(1993-12#1)(1995-1#1)
are numerous##9##2##(1993-12#1)(1995-1#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
are obese##3##2##(2008-1#1)(2008-3#1)(2009-9#1)
are obligate intracellular pathogens that cause a##2##7##(2009-8#1)(2012-3#1)
are obligate intracellular##3##3##(2008-9#1)(2009-8#1)(2012-3#1)
are obligate##4##2##(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
are observed at##3##3##(2008-10#2)(2008-7#1)
are observed between##3##3##(1992-4#1)(1993-3#1)(2008-10#1)
are observed for##3##3##(1994-5#1)(2008-10#1)(2011-2#1)
are observed in the##5##4##(1990-5#1)(1995-11#1)(2008-10#1)(2010-12#1)(2012-12#1)
are observed in various##2##4##(1997-8#1)(2008-10#1)
are observed in##14##3##(1990-5#1)(1995-11#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-7#2)(2009-8#3)(2010-12#1)(2012-12#1)(2012-3#1)
are observed##47##2##(1990-5#1)(1991-11#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-5#2)(1995-11#1)(1997-8#1)(2007-12#2)(2008-10#12)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
are obtained at##3##3##(2008-10#2)(2008-2#1)
are obtained by##6##3##(2008-10#3)(2008-3#2)(2009-11#1)
are obtained for each##2##4##(2008-10#1)(2010-8#1)
are obtained for##8##3##(2008-10#4)(2008-3#2)(2008-4#1)(2010-8#1)
are obtained from the##2##4##(2008-3#1)(2008-6#1)
are obtained from##7##3##(2008-10#4)(2008-3#1)(2008-6#1)(2012-2#1)
are obtained in the##2##4##(2008-10#1)(2008-3#1)
are obtained in##5##3##(1990-12#1)(2008-10#3)(2008-3#1)
are obtained using##2##3##(1994-11#1)(2008-10#1)
are obtained when##2##3##(2007-12#1)(2013-8#1)
are obtained with##5##3##(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
are obtained##67##2##(1990-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-10#33)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-2#2)(2013-8#1)
are obvious##2##2##(2008-8#1)(2010-6#1)
are occurring in##3##3##(1995-1#1)(1996-2#1)(2008-10#1)
are of a##5##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
are of concern##2##3##(2008-10#2)
are of doubtful##2##3##(2008-1#1)(2008-10#1)
are of fundamental##2##3##(2008-10#1)(2008-8#1)
are of great importance##3##4##(1991-2#1)(2008-9#1)(2013-1#1)
are of great##7##3##(1991-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
are of importance in the##2##5##(1992-9#1)(2010-12#1)
are of importance##3##3##(1992-9#1)(2008-10#1)(2010-12#1)
are of interest for##2##4##(2008-3#1)(2013-8#1)
are of interest to##3##4##(2008-10#1)(2010-5#1)(2011-2#1)
are of interest##5##3##(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
are of limited##2##3##(1997-2#1)(2008-5#1)
are of major importance##3##4##(1991-2#1)(2008-5#1)(2010-8#1)
are of particular importance##2##4##(1993-3#1)(2011-2#1)
are of particular interest##2##4##(1995-3#1)(2008-9#1)
are of particular##6##3##(1993-3#1)(1994-8#1)(1995-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
are of special interest for their ability to degrade##2##9##(2011-2#2)
are of special interest##3##4##(1990-9#1)(2011-2#2)
are of the##10##3##(1991-2#1)(1991-3#1)(1994-5#2)(1995-8#1)(2008-11#1)(2008-6#1)(2009-10#2)(2012-2#1)
are of##82##2##(1990-9#1)(1991-2#4)(1991-3#1)(1992-9#3)(1993-3#1)(1994-1#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#2)(2009-8#4)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
are off##2##2##(2008-4#1)(2012-2#1)
are offered for##2##3##(1992-12#1)(2008-10#1)
are offered which##2##3##(2008-11#1)(2008-12#1)
are offered##14##2##(1991-2#1)(1992-12#1)(1993-12#1)(1996-1#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-8#1)
are often a##2##3##(2008-10#1)(2010-4#1)
are often at##2##3##(1990-11#1)(2011-2#1)
are often called##2##3##(2008-1#1)(2011-7#1)
are often found in##2##4##(2008-10#1)(2008-5#1)
are often limited by##2##4##(2008-10#1)(2011-2#1)
are often limited##5##3##(1994-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-7#1)
are often made##2##3##(1997-2#1)(2010-3#1)
are often not##5##3##(1991-1#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#1)
are often overlooked##2##3##(2010-4#1)(2012-5#1)
are often present in##2##4##(2007-12#1)(2008-10#1)
are often present##4##3##(2007-12#1)(2008-10#3)
are often required to##2##4##(2008-11#1)(2013-1#1)
are often seen in##2##4##(1997-8#1)(2008-7#1)
are often seen on##2##4##(2008-1#1)(2009-9#1)
are often seen##5##3##(1996-11#1)(1997-8#1)(2008-1#1)(2008-7#1)(2009-9#1)
are often the##3##3##(2008-10#1)(2012-2#1)(2012-5#1)
are often used as##2##4##(1992-3#1)(2008-10#1)
are often used to##3##4##(1997-6#1)(2009-2#1)(2011-2#1)
are often used##7##3##(1992-3#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#1)
are often##125##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-1#1)(1992-12#2)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-5#2)(1995-9#1)(1996-11#2)(1996-2#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#2)(2007-12#3)(2008-1#3)(2008-10#17)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#6)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-7#3)(2012-2#5)(2012-3#1)(2012-5#2)(2013-1#5)(2013-8#1)
are on a##3##3##(2008-11#2)(2012-2#1)
are on the rise##2##4##(1993-5#1)(2008-11#1)
are on the##5##3##(1991-11#1)(1992-3#1)(1993-5#1)(2008-11#1)(2011-2#1)
are on##10##2##(1991-11#1)(1992-3#1)(1992-6#1)(1993-5#1)(2008-10#1)(2008-11#3)(2011-2#1)(2012-2#1)
are one of the most common##2##6##(2007-8#1)(2011-2#1)
are one of the most##6##5##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#3)
are one of the##9##4##(2007-8#1)(2008-10#1)(2008-11#3)(2011-2#4)
are one##11##2##(1994-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2011-2#5)
are ongoing##2##2##(2007-9#1)(2008-11#1)
are only moderately##2##3##(2008-11#1)(2010-4#1)
are only some of the##2##5##(1997-2#1)(2008-11#1)
are only##31##2##(1993-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
are open##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
are operated##2##2##(2008-11#1)(2008-3#1)
are optimal##2##2##(1997-4#1)(2011-2#1)
are optimised by##2##3##(2008-10#2)
are optimised##5##2##(2008-10#5)
are optimized by##2##3##(2008-10#2)
are optimized to##2##3##(2008-10#2)
are optimized##13##2##(2008-10#11)(2008-7#1)(2013-1#1)
are organized as##3##3##(1993-12#1)(1994-5#1)(2008-9#1)
are organized in##2##3##(1993-2#1)(2008-8#1)
are organized into##2##3##(1992-9#1)(2008-6#1)
are organized##10##2##(1992-9#1)(1993-12#2)(1993-2#1)(1994-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
are oriented in##2##3##(2008-10#1)(2008-11#1)
are other##5##2##(1994-1#1)(1996-11#1)(1996-3#1)(2012-2#1)(2012-3#1)
are otherwise##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-8#1)
are outlined and##2##3##(2008-10#1)(2008-11#1)
are outlined in##3##3##(2008-4#1)(2009-4#1)(2012-2#1)
are outlined##24##2##(1991-12#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
are over-represented in##2##3##(2008-12#1)(2010-6#1)
are paid by##2##3##(1992-12#1)(1994-2#1)
are paid##6##2##(1992-12#1)(1993-1#1)(1993-3#1)(1994-2#1)(2008-11#1)(2009-11#1)
are paired##2##2##(2007-12#2)
are parasites of##2##3##(2011-2#1)(2012-2#1)
are part of a##4##4##(1993-6#1)(2008-11#2)(2012-3#1)
are part of the##6##4##(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
are part of##13##3##(1993-2#1)(1993-6#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#2)
are partially##7##2##(1993-2#1)(2008-10#4)(2009-10#1)(2013-8#1)
are particularly important during##2##4##(2008-11#1)(2013-1#1)
are particularly important##4##3##(1992-4#1)(2008-11#1)(2012-2#1)(2013-1#1)
are particularly suited for##2##4##(2008-10#1)(2008-3#1)
are particularly useful for##4##4##(1996-12#1)(2008-4#1)(2008-9#1)(2009-7#1)
are particularly useful##6##3##(1993-12#1)(1996-12#1)(1997-1#1)(2008-4#1)(2008-9#1)(2009-7#1)
are particularly##28##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-4#1)(1993-12#2)(1995-12#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
are partly##2##2##(2008-7#1)(2010-12#1)
are parts of##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
are passed##2##2##(2008-10#2)
are pathogenic to##2##3##(2008-10#2)
are pathogenic##3##2##(2008-10#3)
are pathogens of##3##3##(2008-10#3)
are pathogens##4##2##(2008-10#4)
are patients##2##2##(2011-2#2)
are perceived##2##2##(2008-11#1)(2013-1#1)
are perfectly##3##2##(2008-10#2)(2008-4#1)
are performed by##2##3##(1993-2#1)(2008-10#1)
are performed in##5##3##(2008-10#2)(2008-2#1)(2010-11#1)(2011-3#1)
are performed to##3##3##(1995-3#1)(2008-3#2)
are performed##24##2##(1993-2#2)(1995-3#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#2)(2011-3#2)(2012-2#1)
are perhaps##2##2##(2010-7#1)(2012-2#1)
are persistent##2##2##(2007-12#1)(2008-10#1)
are perspective##2##2##(2008-10#1)(2009-9#1)
are perturbed##2##2##(2008-5#1)(2013-8#1)
are phosphorylated##4##2##(1994-11#2)(1995-6#1)(2011-2#1)
are phylogenetically##4##2##(1995-6#1)(2008-10#1)(2008-6#1)(2012-2#1)
are physically active##2##3##(1994-3#1)(2013-1#1)
are physically##5##2##(1994-3#1)(1997-4#1)(2010-9#1)(2013-1#1)(2013-8#1)
are physiologically##4##2##(2008-11#1)(2008-8#1)(2010-10#1)(2012-2#1)
are pivotal##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
are placed in##2##3##(1991-3#1)(2008-8#1)
are placed##3##2##(1991-3#1)(2008-8#1)(2008-9#1)
are placing##2##2##(1992-3#1)(1996-3#1)
are planned to##2##3##(2008-11#1)(2008-5#1)
are planned##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
are planning##3##2##(1992-8#1)(1995-1#1)(2008-9#1)
are playing a role in##2##5##(2008-7#1)(2009-1#1)
are playing##3##2##(2008-7#1)(2009-1#1)(2010-12#1)
are pluripotent##2##2##(2008-10#1)(2008-9#1)
are pointed out##4##3##(2008-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
are polymorphic##2##2##(1996-8#1)(2008-9#1)
are poor and##2##3##(1994-1#1)(2008-10#1)
are poor##5##2##(1994-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
are poorly understood and##2##4##(2008-10#1)(2008-5#1)
are poorly understood##8##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-10#1)(2012-2#1)(2013-8#1)
are poorly##13##2##(1993-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
are positioned##4##2##(1993-8#2)(1995-8#1)(2008-10#1)
are positively related##3##3##(1992-2#1)(2008-8#1)(2010-12#1)
are positively##4##2##(1992-2#1)(2008-8#1)(2008-9#1)(2010-12#1)
are possible in##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
are possible##23##2##(1991-2#1)(1994-5#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
are possibly##2##2##(2008-10#1)(2008-11#1)
are postsynaptic targets of##2##4##(1992-3#2)
are potent inhibitors of##4##4##(1990-8#1)(1994-11#1)(1995-11#2)
are potent##6##2##(1990-8#1)(1994-11#1)(1994-6#1)(1995-11#2)(2008-5#1)
are potential##8##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
are potentially at risk##2##4##(1991-12#1)(2013-1#1)
are potentially useful for##3##4##(1993-9#1)(2008-10#1)(2008-2#1)
are potentially useful##4##3##(1993-9#1)(2008-10#1)(2008-2#1)(2009-7#1)
are potentially##12##2##(1991-12#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
are potentiated##2##2##(1995-11#1)(2008-11#1)
are powerful##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
are practically##2##2##(2008-10#1)(2012-2#1)
are preceded by##2##3##(1997-1#1)(2008-4#1)
are precise##4##2##(2008-10#4)
are preconcentrated##3##2##(2008-10#3)
are predictable##2##2##(2008-10#1)(2008-9#1)
are predicted by##5##3##(1991-1#1)(1993-3#1)(2008-8#1)(2011-2#2)
are predicted for##2##3##(2008-9#1)(2012-5#1)
are predicted to be##2##4##(1990-11#1)(1995-8#1)
are predicted to##7##3##(1990-11#1)(1994-5#1)(1994-9#1)(1995-8#1)(2008-9#1)(2011-2#2)
are predicted##17##2##(1990-11#1)(1990-5#1)(1991-1#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#4)(2012-2#1)(2012-5#1)
are predisposed to##2##3##(2008-6#1)(2010-6#1)
are predominantly##3##2##(1995-5#1)(2008-5#1)(2009-10#1)
are preferable##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
are preferentially##2##2##(1990-5#1)(2013-8#1)
are preferred##3##2##(1996-3#1)(2008-1#1)(2009-8#1)
are prepared as##2##3##(2008-10#1)(2008-4#1)
are prepared by##5##3##(2008-10#5)
are prepared for the##2##4##(1997-1#1)(2008-11#1)
are prepared for##3##3##(1992-2#1)(1997-1#1)(2008-11#1)
are prepared to##2##3##(2008-11#2)
are prepared##17##2##(1990-12#1)(1992-11#1)(1992-2#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-4#1)
are preparing##2##2##(1993-12#1)(2008-12#1)
are prerequisites for##2##3##(1995-5#1)(2008-11#1)
are prescribed##4##2##(2008-5#1)(2012-12#1)(2013-1#2)
are present and##2##3##(1991-7#1)(2008-10#1)
are present at##4##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
are present during##2##3##(2008-11#1)(2010-3#1)
are present in a##2##4##(1994-2#1)(1996-12#1)
are present in all##5##4##(1992-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
are present in each##2##4##(1990-2#1)(2012-3#1)
are present in the##29##4##(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-11#1)(1995-12#1)(1996-12#1)(1997-1#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
are present in##61##3##(1990-2#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-8#1)(1994-11#2)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-1#2)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-4#1)(2008-7#3)(2008-8#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
are present on##3##3##(1997-8#1)(2007-12#1)(2008-10#1)
are present which##2##3##(1996-3#1)(2008-10#1)
are present##91##2##(1990-2#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-8#1)(1994-11#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#28)(2008-11#10)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#4)(2010-3#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
are presented and discussed##9##4##(1996-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)
are presented and the##2##4##(2008-10#1)(2009-9#1)
are presented and##18##3##(1995-12#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2009-9#1)
are presented as##9##3##(1991-12#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-9#1)(2013-8#1)
are presented for the determination of##2##6##(2008-10#2)
are presented for the##9##4##(1991-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)
are presented for##25##3##(1991-3#1)(1992-12#1)(1993-1#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)
are presented from##2##3##(1993-6#1)(2008-12#1)
are presented here for##2##4##(1990-8#1)(1992-2#1)
are presented here##4##3##(1990-8#1)(1992-2#1)(2008-11#1)(2010-7#1)
are presented in the##7##4##(1990-3#1)(2008-10#3)(2010-10#1)(2010-9#1)(2012-3#1)
are presented in this article##5##5##(1991-2#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-11#1)
are presented in this paper##2##5##(2008-10#2)
are presented in this##9##4##(1991-2#1)(1992-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-5#1)
are presented in##22##3##(1990-3#1)(1991-2#1)(1992-2#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-8#1)(2010-9#1)(2012-3#1)
are presented on health##2##4##(1993-2#2)
are presented on##3##3##(1991-3#1)(1993-2#2)
are presented that illustrate the##2##5##(2008-11#1)(2012-2#1)
are presented that##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
are presented to illustrate the##2##5##(1996-12#1)(1996-9#1)
are presented to illustrate##3##4##(1996-12#1)(1996-9#1)(1997-2#1)
are presented to##13##3##(1990-9#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-11#1)(2010-12#1)
are presented together with##3##4##(1990-2#1)(2008-10#1)(2011-2#1)
are presented which##3##3##(1993-1#1)(1997-6#1)(2008-10#1)
are presented##260##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#7)(1992-3#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1994-1#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#60)(2008-11#13)(2008-12#6)(2008-2#10)(2008-3#37)(2008-4#7)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#8)(2009-3#1)(2009-5#3)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2010-9#5)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
are presenting a case##2##4##(2011-2#1)(2012-3#1)
are presenting a##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
are presenting##7##2##(2008-10#2)(2008-5#1)(2010-7#1)(2011-2#2)(2012-3#1)
are presently being##2##3##(1993-2#1)(1997-1#1)
are presently##6##2##(1993-2#1)(1997-1#1)(2008-10#2)(2013-1#1)(2013-8#1)
are prevalent in##3##3##(2008-11#1)(2008-8#1)(2012-3#1)
are prevalent##5##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#2)
are primarily##9##2##(1997-7#1)(2008-10#2)(2008-8#2)(2008-9#2)(2009-7#1)(2011-1#1)
are primary##3##2##(2008-12#1)(2009-6#1)(2012-2#1)
are prime##2##2##(2008-11#1)(2011-2#1)
are printed##2##2##(2008-10#1)(2008-3#1)
are private##2##2##(1997-8#1)(2011-2#1)
are probably involved in##2##4##(2008-8#1)(2009-8#1)
are probably involved##3##3##(2008-5#1)(2008-8#1)(2009-8#1)
are probably related to##2##4##(2008-9#1)(2009-8#1)
are probably the##2##3##(1994-6#1)(2008-9#1)
are probably##20##2##(1990-12#1)(1992-9#1)(1994-6#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#2)(2012-3#1)
are processed by##2##3##(1996-2#1)(2008-10#1)
are processed##7##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-7#1)
are produced by##10##3##(1990-11#1)(1995-11#1)(2008-10#4)(2008-8#2)(2010-11#1)(2010-7#1)
are produced in##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
are produced##21##2##(1990-11#2)(1995-11#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-7#1)(2012-2#2)(2013-1#1)
are products of##3##3##(1995-2#1)(2008-7#1)(2009-12#1)
are progressing##2##2##(1991-1#1)(2009-12#1)
are progressively##2##2##(2008-10#1)(2010-12#1)
are projected to##3##3##(1995-12#1)(1996-2#1)(1997-2#1)
are projected##4##2##(1995-12#2)(1996-2#1)(1997-2#1)
are promising and##2##3##(2008-9#1)(2012-2#1)
are promising for##3##3##(1995-2#1)(2008-3#1)(2009-7#1)
are promising##9##2##(1995-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-8#1)
are prone to##8##3##(1995-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
are pronounced##3##2##(1992-9#1)(2008-11#1)(2008-5#1)
are properly assessed##2##3##(2008-3#1)(2008-5#1)
are properly##5##2##(1995-12#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
are proportional to the##2##4##(2008-10#2)
are proportional to##3##3##(2008-10#3)
are proposed and##5##3##(2008-10#3)(2008-3#1)(2010-11#1)
are proposed for the##2##4##(2008-10#1)(2010-5#1)
are proposed for##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)
are proposed in##2##3##(2008-10#1)(2008-3#1)
are proposed to##6##3##(1991-12#1)(1992-5#1)(1997-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
are proposed##43##2##(1991-10#1)(1991-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1995-9#1)(1997-7#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#5)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#2)(2013-8#2)
are protected from##3##3##(1996-2#1)(2008-6#1)(2013-1#1)
are protected##5##2##(1996-2#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
are protocols for##2##3##(2008-9#2)
are proved##2##2##(2008-3#1)(2011-2#1)
are proven for the##2##4##(1996-5#1)(2013-8#1)
are provided by the##2##4##(2008-10#1)(2013-7#1)
are provided by##8##3##(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#4)(2013-7#1)
are provided for the##2##4##(2008-4#2)
are provided for##16##3##(1995-3#1)(2007-9#1)(2008-10#1)(2008-4#6)(2008-9#6)(2009-5#1)
are provided in##2##3##(2008-4#1)(2008-9#1)
are provided to##7##3##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-4#1)(2012-2#1)
are provided with##6##3##(1994-6#1)(1995-12#1)(2008-12#1)(2008-2#1)(2009-11#1)(2009-2#1)
are provided##76##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#15)(2008-5#1)(2008-7#1)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-11#2)(2010-8#4)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
are providing##3##2##(2009-12#1)(2010-8#1)(2011-1#1)
are proving##2##2##(1994-12#1)(2008-10#1)
are published##3##2##(1993-12#1)(2008-11#1)(2012-12#1)
are pursuing##2##2##(2008-10#1)(2008-11#1)
are putative##2##2##(1993-12#1)(1995-9#1)
are quantified##2##2##(2008-11#1)(2008-3#1)
are quantitative##3##2##(2008-10#3)
are quantitatively extracted##2##3##(2008-10#2)
are quantitatively##7##2##(1995-2#1)(1995-5#1)(2008-10#5)
are questionable##2##2##(2008-10#1)(2013-1#1)
are questions about##2##3##(2008-11#2)
are quite different##5##3##(1993-12#1)(1993-8#1)(1994-1#1)(2008-7#1)(2008-8#1)
are quite stable##2##3##(2008-10#2)
are quite##17##2##(1991-2#1)(1993-12#1)(1993-8#1)(1994-1#1)(2008-10#8)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)
are randomly##2##2##(2008-11#1)(2013-8#1)
are rapid##5##2##(2008-10#3)(2008-5#1)(2008-9#1)
are rapidly changing##2##3##(1993-2#1)(1996-3#1)
are rapidly induced##2##3##(1991-5#1)(1991-7#1)
are rapidly##13##2##(1991-5#1)(1991-7#1)(1993-2#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)
are rare and##5##3##(1990-9#1)(1992-12#1)(2008-10#1)(2011-2#1)(2011-3#1)
are rare benign##2##3##(2012-12#1)(2013-8#1)
are rare in##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
are rare tumours##3##3##(2008-7#1)(2012-2#2)
are rare##49##2##(1990-8#1)(1990-9#1)(1991-6#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#3)
are rarely##5##2##(1996-11#1)(1996-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
are rather resistant to##2##4##(1996-2#1)(2009-9#1)
are rather##6##2##(1996-2#1)(2008-10#2)(2008-9#1)(2009-9#1)(2012-2#1)
are reaching##2##2##(2008-10#1)(2012-2#1)
are readily available##2##3##(2008-11#1)(2008-8#1)
are readily##11##2##(1992-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)
are realistic##2##2##(1993-2#1)(1995-1#1)
are rearranged##2##2##(1996-6#1)(2008-2#1)
are reasonable##2##2##(2008-10#2)
are reasonably##4##2##(1990-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
are receiving##3##2##(1993-2#1)(2010-12#1)(2013-1#1)
are recent##2##2##(2008-10#1)(2008-7#1)
are recognised##2##2##(1992-6#1)(2008-11#1)
are recognized as##4##3##(2008-10#1)(2010-7#1)(2012-12#1)(2013-8#1)
are recognized by##2##3##(1993-8#1)(2008-10#1)
are recognized##14##2##(1993-11#1)(1993-8#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2010-6#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
are recommendations##2##2##(2008-12#1)(2008-4#1)
are recommended for patients with##2##5##(2012-12#1)(2012-3#1)
are recommended for##4##3##(2011-2#1)(2012-12#1)(2012-3#2)
are recommended##13##2##(1991-2#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
are recorded by##2##3##(2008-10#1)(2012-2#1)
are recorded##9##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#2)(2013-8#1)
are recovered from##2##3##(2008-10#2)
are recovered quantitatively##3##3##(2008-10#3)
are recovered##6##2##(1995-8#1)(2008-10#5)
are reduced in##4##3##(1993-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
are reduced##15##2##(1990-11#1)(1991-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#2)(2012-2#2)(2012-7#1)
are referred for##2##3##(2011-2#2)
are referred to as &quot##2##5##(1997-6#1)(2009-12#1)
are referred to as##7##4##(1997-6#1)(2008-10#3)(2008-9#1)(2009-12#1)(2012-2#1)
are referred to##9##3##(1997-6#1)(2008-10#4)(2008-4#1)(2008-9#1)(2009-12#1)(2012-2#1)
are referred##12##2##(1995-2#1)(1997-6#1)(2008-10#4)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-2#1)
are reflected by##2##3##(1994-6#1)(2008-10#1)
are reflected in the##2##4##(1992-3#2)
are reflected in##3##3##(1992-3#2)(2010-10#1)
are reflected##7##2##(1992-3#2)(1993-2#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-10#1)
are reflective##2##2##(2008-12#1)(2010-11#1)
are refractory to##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
are regarded as a##2##4##(2010-5#1)(2012-2#1)
are regarded as##6##3##(1993-2#1)(2008-11#1)(2009-6#1)(2010-5#1)(2012-2#2)
are regarded##7##2##(1991-3#1)(1993-2#1)(2008-11#1)(2009-6#1)(2010-5#1)(2012-2#2)
are regularly##3##2##(1992-3#1)(2008-11#2)
are regulated by a##2##4##(1994-12#1)(2009-9#1)
are regulated by##8##3##(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(2008-11#1)(2009-8#1)(2009-9#1)(2011-1#1)
are regulated in##4##3##(1996-2#2)(1997-2#1)(2011-2#1)
are regulated##19##2##(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#2)(1997-2#1)(2008-11#2)(2008-5#2)(2008-9#3)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
are rejected##2##2##(2008-10#1)(2008-8#1)
are related to the##17##4##(1990-8#1)(1991-12#1)(1991-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-9#1)(2009-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
are related to##35##3##(1990-8#1)(1991-12#1)(1991-3#3)(1992-3#1)(1993-12#1)(1994-6#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#1)
are related##46##2##(1990-8#1)(1991-12#2)(1991-3#3)(1992-3#1)(1993-12#1)(1994-6#1)(1997-2#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
are relatively easy to##3##4##(1996-12#1)(2008-10#1)(2011-2#1)
are relatively few##2##3##(1996-2#1)(2008-7#1)
are relatively rare##2##3##(2008-10#1)(2010-11#1)
are relatively uncommon##2##3##(2009-1#1)(2013-1#1)
are relatively##21##2##(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#7)(2008-7#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
are released during##2##3##(1992-12#1)(1993-2#1)
are released from the##2##4##(2008-5#1)(2011-2#1)
are released from##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
are released##7##2##(1992-12#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
are relevant for##4##3##(1997-7#1)(2008-3#1)(2009-10#1)(2013-1#1)
are relevant to##6##3##(2008-10#1)(2008-11#1)(2009-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
are relevant##11##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-3#1)(2010-12#1)(2012-3#2)(2013-1#2)
are reliable##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
are reluctant to##2##3##(1991-2#1)(2010-8#1)
are remarkably similar to those##2##5##(1993-3#1)(2008-9#1)
are remarkably similar##3##3##(1993-3#1)(1995-11#1)(2008-9#1)
are remarkably##4##2##(1993-3#1)(1995-11#1)(2008-8#1)(2008-9#1)
are removed##3##2##(2008-11#2)(2008-4#1)
are remunerated##2##2##(1994-12#2)
are repeated##2##2##(1992-3#1)(2008-11#1)
are replaced by##2##3##(2008-11#1)(2008-3#1)
are replaced##3##2##(1997-7#1)(2008-11#1)(2008-3#1)
are reported and##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
are reported as##3##3##(2008-10#2)(2008-3#1)
are reported for the##4##4##(2008-10#1)(2008-11#1)(2008-3#2)
are reported for##11##3##(1990-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2013-1#1)
are reported here##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
are reported in##4##3##(2007-8#1)(2008-10#2)(2012-3#1)
are reported to be##4##4##(2008-10#2)(2008-9#1)(2011-2#1)
are reported to have##2##4##(2013-8#2)
are reported to##12##3##(2008-10#5)(2008-9#1)(2010-1#1)(2011-2#1)(2013-8#4)
are reported with##3##3##(1996-11#1)(2007-12#1)(2008-10#1)
are reported##126##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#3)(1993-2#1)(1994-6#1)(1996-11#2)(1996-5#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#56)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#5)
are reporting##11##2##(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2013-8#1)
are reports of##4##3##(1991-2#1)(2008-10#1)(2009-11#1)(2013-1#1)
are represented by the##2##4##(2008-3#1)(2009-1#1)
are represented by##6##3##(2008-11#1)(2008-3#2)(2008-4#2)(2009-1#1)
are represented in##3##3##(1997-3#1)(2008-11#1)(2013-1#1)
are represented##11##2##(1995-12#1)(1997-3#1)(2008-11#2)(2008-3#2)(2008-4#3)(2009-1#1)(2013-1#1)
are reproducible within##3##3##(2008-10#3)
are reproducible##6##2##(2008-10#6)
are requested##2##2##(1991-11#1)(2008-10#1)
are required due to the##2##5##(2008-10#1)(2012-3#1)
are required for both##2##4##(1994-9#2)
are required for the##6##4##(1993-12#1)(1994-5#1)(1995-2#1)(2008-4#1)(2009-10#1)(2012-3#1)
are required for##29##3##(1991-5#1)(1993-12#1)(1994-11#2)(1994-5#1)(1994-9#2)(1995-2#1)(1995-6#2)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-1#1)(2011-2#1)(2012-3#2)
are required in the##2##4##(2010-12#1)(2012-12#1)
are required in##6##3##(2008-10#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
are required to be##2##4##(1992-2#1)(2008-6#1)
are required to confirm the##2##5##(2008-10#1)(2008-11#1)
are required to establish##2##4##(2008-12#1)(2012-3#1)
are required to##25##3##(1990-6#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
are required with##2##3##(1997-1#1)(2010-11#1)
are required##92##2##(1990-6#1)(1990-9#1)(1991-5#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-9#2)(1995-2#2)(1995-6#2)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#15)(2008-11#9)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#8)(2012-4#1)(2013-1#3)(2013-8#2)
are resistant to##13##3##(1994-11#1)(1995-12#1)(2008-10#6)(2008-11#2)(2009-9#1)(2011-2#1)(2013-8#1)
are resistant##15##2##(1994-11#1)(1995-12#2)(2008-10#7)(2008-11#2)(2009-9#1)(2011-2#1)(2013-8#1)
are respiratory##2##2##(2013-1#1)(2013-8#1)
are responding##4##2##(2008-10#1)(2008-6#1)(2012-2#2)
are responsible for a##4##4##(1997-3#1)(2011-2#3)
are responsible for the##14##4##(1991-2#1)(1997-9#1)(2008-10#4)(2008-5#2)(2009-8#1)(2010-11#1)(2011-2#3)(2013-1#1)
are responsible for these##3##4##(1993-3#1)(1995-12#1)(2008-11#1)
are responsible for##41##3##(1991-1#1)(1991-2#1)(1992-10#2)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#3)(2009-8#3)(2010-11#1)(2011-2#7)(2013-1#1)
are responsible##44##2##(1991-1#1)(1991-2#1)(1992-10#2)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-9#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#3)(2009-8#3)(2010-11#1)(2011-2#7)(2013-1#1)
are responsive to##4##3##(1995-8#1)(1996-2#1)(2008-11#1)(2008-7#1)
are restricted to a##3##4##(2008-11#1)(2008-8#1)(2013-1#1)
are restricted to the##2##4##(1995-2#1)(2008-10#1)
are restricted to##7##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#1)
are retained in the##2##4##(2008-10#1)(2012-12#1)
are retained on a##2##4##(2008-10#2)
are retained on##3##3##(2008-10#3)
are retained##7##2##(1995-2#1)(2008-10#4)(2008-9#1)(2012-12#1)
are retrieved##2##2##(2008-10#1)(2008-3#1)
are revealed by##3##3##(1994-5#1)(1995-6#1)(1996-11#1)
are revealed##5##2##(1994-5#1)(1995-6#1)(1996-11#1)(1996-9#1)(2009-10#1)
are revealing the##2##3##(1997-8#1)(2013-8#1)
are reviewed and##5##3##(1991-3#1)(1992-2#1)(1996-12#1)(1997-7#1)(2008-7#1)
are reviewed as##2##3##(2008-8#1)(2010-9#1)
are reviewed here##4##3##(2008-10#1)(2008-4#2)(2011-2#1)
are reviewed in this article##3##5##(2008-11#1)(2009-12#1)(2012-2#1)
are reviewed in##7##3##(1991-2#1)(1997-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-2#1)
are reviewed##86##2##(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1993-12#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#6)(2008-8#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-6#1)(2010-9#4)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are rich in##2##3##(2012-12#1)(2013-8#1)
are risk factors for##2##4##(2011-2#1)(2011-3#1)
are risk##3##2##(2011-2#2)(2011-3#1)
are routinely##3##2##(2008-10#2)(2009-12#1)
are safe and##2##3##(2008-11#1)(2008-2#1)
are said to##2##3##(1996-2#1)(2013-8#1)
are satisfactory for##2##3##(1992-3#1)(2008-10#1)
are satisfactory##6##2##(1992-3#1)(2008-10#5)
are satisfied##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
are scanned##2##2##(2008-10#1)(2008-3#1)
are scarce##4##2##(2008-12#1)(2008-9#2)(2012-3#1)
are scenarios##2##2##(2008-10#1)(2008-11#1)
are scheduled for##2##3##(1996-2#1)(2008-5#1)
are scheduled##3##2##(1993-3#1)(1996-2#1)(2008-5#1)
are scoring##2##2##(2008-9#2)
are screened for##2##3##(2008-10#1)(2011-1#1)
are screened##3##2##(1991-6#1)(2008-10#1)(2011-1#1)
are sedentary##2##2##(2008-10#1)(2013-1#1)
are seeking##2##2##(1994-2#1)(2008-9#1)
are seen as##2##3##(1992-3#1)(2008-11#1)
are seen to##2##3##(1992-1#1)(2008-11#1)
are seen##6##2##(1992-1#1)(1992-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
are selected and##2##3##(2008-10#1)(2008-11#1)
are selected by##3##3##(1994-12#1)(2012-12#2)
are selected for##2##3##(2008-10#1)(2011-2#1)
are selected to##2##3##(1991-12#1)(2008-8#1)
are selected##12##2##(1991-12#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#2)
are selective for specific##2##4##(1997-2#1)(2008-11#1)
are selective for##3##3##(1997-2#1)(2008-11#1)(2008-5#1)
are selectively##3##2##(2008-10#2)(2008-11#1)
are sensitive to the##2##4##(1994-6#1)(2013-1#1)
are sensitive to##15##3##(1994-6#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
are sensitive##16##2##(1994-6#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
are separate##4##2##(1990-8#1)(2008-10#2)(2008-11#1)
are separated by##9##3##(1995-6#1)(1995-8#1)(1996-3#1)(2008-10#4)(2008-8#1)(2013-8#1)
are separated from the##2##4##(2008-10#2)
are separated from##5##3##(1992-11#1)(1992-6#1)(2008-10#2)(2008-9#1)
are separated on a##4##4##(2008-10#3)(2008-4#1)
are separated on##5##3##(2008-10#3)(2008-4#2)
are separated##23##2##(1992-11#1)(1992-6#1)(1995-6#1)(1995-8#1)(1996-3#1)(2008-10#12)(2008-4#3)(2008-8#1)(2008-9#1)(2013-8#1)
are sequentially##2##2##(2008-10#1)(2008-9#1)
are serious##3##2##(2008-10#2)(2009-3#1)
are seven##3##2##(1996-1#1)(2011-2#1)(2012-2#1)
are several##25##2##(1993-3#1)(1996-2#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
are severe and##2##3##(2012-3#1)(2013-1#1)
are severe##4##2##(2012-3#1)(2013-1#3)
are severely##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
are shaped by##2##3##(2008-11#1)(2011-2#1)
are shaped##4##2##(2008-11#1)(2009-5#1)(2011-2#2)
are shared##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
are shed##3##2##(2008-11#1)(2009-9#2)
are shorter than##2##3##(1993-2#1)(2008-10#1)
are shorter##4##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
are showed##2##2##(2008-10#1)(2008-5#1)
are shown for##3##3##(1996-3#1)(2008-10#2)
are shown to agree well with##2##6##(2008-3#2)
are shown to be##11##4##(1991-12#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2010-3#1)(2010-7#1)(2012-3#1)
are shown to##22##3##(1991-1#1)(1991-12#1)(1992-4#1)(1994-5#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-6#1)(2008-8#3)(2010-3#1)(2010-7#1)(2012-3#2)
are shown##37##2##(1991-1#1)(1991-12#1)(1991-6#1)(1992-4#1)(1994-5#1)(1995-6#1)(1996-3#2)(1997-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#5)(2008-5#1)(2008-6#2)(2008-8#3)(2010-11#1)(2010-3#1)(2010-7#1)(2012-3#3)(2013-8#1)
are sick##2##2##(1994-6#1)(2012-3#1)
are significant challenges##2##3##(1995-12#1)(2008-12#1)
are significant differences between##2##4##(1992-2#1)(2008-4#1)
are significant differences##3##3##(1992-2#1)(2008-4#1)(2010-12#1)
are significant factors##2##3##(2008-10#2)
are significant##20##2##(1992-2#1)(1994-8#1)(1995-12#1)(1996-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
are significantly better##2##3##(2008-10#2)
are significantly different##3##3##(1995-3#1)(2008-10#1)(2012-3#1)
are significantly less##2##3##(1995-12#1)(2008-10#1)
are significantly lower##3##3##(2008-11#1)(2010-7#1)(2013-8#1)
are significantly more##5##3##(2008-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-2#1)
are significantly reduced##3##3##(1990-6#1)(2008-10#1)(2008-3#1)
are significantly related to##2##4##(1996-1#1)(2008-11#1)
are significantly##30##2##(1990-6#1)(1992-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-8#3)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#2)
are silenced##2##2##(2011-2#1)(2013-8#1)
are similar in the##2##4##(1991-11#1)(2010-12#1)
are similar in##8##3##(1991-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2010-12#2)(2011-2#1)
are similar to other##2##4##(1994-9#1)(2010-8#1)
are similar to that##3##4##(1991-3#1)(2008-10#1)(2008-8#1)
are similar to the##4##4##(1993-12#1)(1995-2#1)(2008-7#1)(2013-1#1)
are similar to those observed##2##5##(1992-12#1)(2008-5#1)
are similar to those of##7##5##(1992-2#1)(1993-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-8#1)
are similar to those##13##4##(1991-6#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-2#1)(2007-11#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-8#1)
are similar to##34##3##(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-9#1)(1995-2#2)(2007-11#1)(2008-10#6)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-6#1)(2009-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
are similar##46##2##(1991-11#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-6#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
are simple and##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
are simple##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
are simpler##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
are simply##2##2##(1995-1#1)(2011-2#1)
are simulated##5##2##(1991-12#1)(2008-10#2)(2008-3#2)
are simultaneously present in##2##4##(1994-5#1)(2008-10#1)
are simultaneously##9##2##(1994-5#1)(1997-3#1)(2008-10#5)(2008-3#1)(2010-12#1)
are single-stranded##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
are situated##2##2##(1996-8#1)(1997-9#1)
are six##3##2##(1994-2#1)(1995-12#1)(2010-1#1)
are slight##2##2##(2008-10#2)
are slightly##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
are small##13##2##(1992-9#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
are smaller than the##2##4##(2008-10#1)(2013-8#1)
are smaller than##3##3##(2008-10#1)(2011-3#1)(2013-8#1)
are smaller##5##2##(2008-10#1)(2010-6#1)(2011-3#1)(2012-2#1)(2013-8#1)
are so different##2##3##(1996-1#2)
are so##10##2##(1993-12#1)(1996-1#2)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
are solely##2##2##(2009-8#1)(2010-8#1)
are solid##2##2##(2007-11#1)(2010-4#1)
are solved##2##2##(2008-5#1)(2010-10#1)
are some of the most##3##5##(2008-10#2)(2009-12#1)
are some of the##4##4##(2008-10#2)(2008-11#1)(2009-12#1)
are some of##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)
are some##21##2##(1992-3#1)(1995-3#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are sometimes difficult to##2##4##(2010-10#1)(2012-2#1)
are sometimes difficult##3##3##(2008-7#1)(2010-10#1)(2012-2#1)
are sometimes##6##2##(1996-2#1)(1997-2#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
are somewhat##4##2##(2008-10#1)(2008-12#1)(2012-5#1)(2013-1#1)
are spared##2##2##(1994-8#1)(2009-10#1)
are sparse##2##2##(2008-11#1)(2013-1#1)
are specialized##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
are specific for the##2##4##(2008-10#1)(2013-8#1)
are specific for##9##3##(2008-10#3)(2008-4#1)(2008-7#1)(2013-8#4)
are specific to the##4##4##(1992-6#1)(1995-12#1)(2008-12#1)(2009-8#1)
are specific to##7##3##(1992-6#1)(1995-12#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-8#1)(2012-3#1)
are specific##19##2##(1992-6#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#3)(2009-11#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-8#4)
are specifically expressed##2##3##(1991-5#1)(2010-7#1)
are specifically##4##2##(1991-5#1)(2008-4#1)(2008-7#1)(2010-7#1)
are spent##3##2##(1990-2#1)(1996-2#1)(2011-2#1)
are spiked##2##2##(2008-10#2)
are split##2##2##(2008-3#1)(2008-7#1)
are sporadic and##2##3##(2009-12#1)(2013-1#1)
are stabilized by##2##3##(1991-9#1)(2011-2#1)
are stabilized##3##2##(1991-9#1)(2008-2#1)(2011-2#1)
are stable for##3##3##(2008-10#2)(2008-5#1)
are stable in##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
are stable##16##2##(1995-2#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2012-3#1)
are stained##2##2##(2008-10#1)(2008-5#1)
are standardized##2##2##(2010-8#1)(2011-2#1)
are statistically significant##2##3##(2008-10#2)
are statistically##3##2##(2008-10#3)
are still alive##7##3##(1990-6#1)(1990-9#1)(1992-9#1)(1995-2#1)(1997-5#1)(2011-2#1)(2013-8#1)
are still being##2##3##(1997-5#1)(2010-1#1)
are still insufficient##2##3##(2009-7#1)(2012-2#1)
are still largely##4##3##(1990-6#1)(2008-9#1)(2010-12#1)(2010-6#1)
are still not##7##3##(1996-5#1)(2008-10#2)(2009-3#1)(2010-12#1)(2011-2#2)
are still relatively##2##3##(2008-4#1)(2008-9#1)
are still some##2##3##(2008-10#1)(2011-3#1)
are still unclear##4##3##(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
are still##71##2##(1990-11#1)(1990-6#2)(1990-9#1)(1991-3#1)(1992-6#2)(1992-9#2)(1993-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-5#2)(1997-7#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-6#1)(2011-2#4)(2011-3#2)(2012-2#2)(2013-1#5)(2013-8#2)
are stimulated by##2##3##(1995-5#1)(2010-10#1)
are stimulated##5##2##(1990-12#1)(1991-5#1)(1995-5#1)(2008-4#1)(2010-10#1)
are stirred##2##2##(2008-10#1)(2008-11#1)
are stored##3##2##(1992-12#1)(2007-12#1)(2008-3#1)
are strong##2##2##(2008-7#2)
are strongly affected by##2##4##(2008-11#1)(2008-3#1)
are strongly associated with##3##4##(1995-2#1)(2008-1#1)(2008-11#1)
are strongly correlated##2##3##(2008-10#1)(2009-3#1)
are strongly influenced by##3##4##(2008-10#2)(2008-8#1)
are strongly needed##2##3##(2010-11#1)(2011-2#1)
are strongly##24##2##(1991-12#1)(1992-4#1)(1995-2#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-8#2)(2008-9#1)(2009-3#2)(2010-11#1)(2011-2#1)(2012-3#1)
are structurally and##2##3##(1996-2#1)(2010-10#1)
are structurally related##2##3##(1993-12#1)(1997-8#1)
are structurally similar to##2##4##(1993-8#1)(2011-1#1)
are structurally##8##2##(1993-12#1)(1993-8#1)(1996-2#2)(1997-8#1)(2008-10#1)(2010-10#1)(2011-1#1)
are structures##2##2##(2008-11#1)(2011-2#1)
are studied by##5##3##(2008-10#3)(2008-4#1)(2008-9#1)
are studied in detail##2##4##(2008-10#2)
are studied in##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
are studied to##2##3##(2008-10#2)
are studied with##2##3##(1995-2#1)(2008-10#1)
are studied##32##2##(1992-3#2)(1995-2#1)(2008-10#18)(2008-11#2)(2008-3#4)(2008-4#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)
are subject to##6##3##(2008-10#1)(2008-11#2)(2008-8#1)(2009-12#1)(2010-1#1)
are subjected to electrical##2##4##(1991-5#1)(1994-8#1)
are subjected to##10##3##(1991-5#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#2)
are subsequently##5##2##(1994-2#1)(2008-10#1)(2008-11#2)(2008-5#1)
are substantial##2##2##(2008-8#1)(2009-10#1)
are substantially##7##2##(1992-12#1)(1993-12#1)(1995-3#1)(2008-10#2)(2008-8#2)
are successful in##2##3##(2008-10#1)(2012-2#1)
are successful##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
are successfully##6##2##(1990-9#1)(1993-3#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-8#1)
are such##4##2##(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
are suffering from##2##3##(1994-6#1)(2008-10#1)
are sufficient for##4##3##(1993-8#1)(1995-11#1)(2008-10#1)(2008-3#1)
are sufficient to##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
are sufficient##9##2##(1993-12#1)(1993-8#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)
are sufficiently##8##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2010-7#1)
are suggested for##2##3##(2008-11#1)(2008-3#1)
are suggested to be##2##4##(2011-2#2)
are suggested to##5##3##(1993-3#1)(1996-2#1)(2011-2#3)
are suggested##20##2##(1990-3#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-2#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#3)(2011-7#1)(2013-1#1)
are suggestive##2##2##(2008-10#1)(2008-9#1)
are suitable for a##2##4##(2008-10#1)(2008-4#1)
are suitable for influenza virus cultivation##2##6##(2008-11#2)
are suitable for the##3##4##(2008-10#3)
are suitable for##22##3##(1997-2#1)(2008-10#11)(2008-11#5)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
are suitable##28##2##(1997-2#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-3#1)(2008-4#2)(2008-6#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
are summarised##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
are summarized in##2##3##(2008-10#2)
are summarized##14##2##(1991-12#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
are superimposed on the##2##4##(2008-2#1)(2008-3#1)
are superimposed on##3##3##(2008-2#1)(2008-3#1)(2009-12#1)
are superior to the##2##4##(1995-5#1)(2008-5#1)
are superior to##6##3##(1994-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)
are supplied for##2##3##(2008-9#2)
are supplied##5##2##(2008-9#3)(2011-1#1)(2011-2#1)
are supported by##3##3##(2008-11#1)(2008-5#1)(2012-3#1)
are supported##6##2##(1997-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)
are supposed to##4##3##(1990-12#1)(2008-5#1)(2012-12#1)(2013-1#1)
are suppressed##2##2##(2012-3#1)(2013-8#1)
are surrounded by an##2##4##(2008-10#1)(2011-2#1)
are surrounded by##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
are surveyed##2##2##(1997-4#1)(1997-6#1)
are susceptible to fungal##2##4##(2008-10#1)(2011-10#1)
are susceptible to infection##2##4##(2008-10#2)
are susceptible to##11##3##(1991-3#1)(2008-10#8)(2011-10#1)(2012-2#1)
are suspected to##2##3##(2006-6#1)(2008-7#1)
are suspected##7##2##(1991-12#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
are suspended##2##2##(2007-12#1)(2008-10#1)
are synchronously##2##2##(2008-10#1)(2010-5#1)
are synthesized by##2##3##(2008-4#1)(2013-1#1)
are synthesized from##2##3##(1997-8#1)(2008-4#1)
are synthesized##6##2##(1997-8#1)(2008-10#1)(2008-4#2)(2011-1#1)(2013-1#1)
are systematically##3##2##(2008-10#2)(2008-11#1)
are tabulated##2##2##(2008-10#1)(2008-8#1)
are taken as##2##3##(2008-10#1)(2008-11#1)
are taken into account##5##4##(1993-12#1)(2008-11#1)(2008-3#2)(2011-3#1)
are taken to##2##3##(1994-8#1)(1997-6#1)
are taken up by##2##4##(1995-6#1)(2008-11#1)
are taken up##3##3##(1995-6#1)(2008-11#1)(2008-9#1)
are taken##15##2##(1993-12#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-9#1)(2010-10#1)(2011-3#1)(2012-12#1)
are taking place##2##3##(2008-10#1)(2008-2#1)
are taking##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
are targeted##4##2##(1992-12#1)(1994-2#1)(2009-8#1)(2011-1#1)
are taught##5##2##(1991-12#1)(1994-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
are termed##2##2##(1995-2#1)(2013-8#1)
are tested for##3##3##(2008-10#1)(2008-4#2)
are tested to##2##3##(2008-10#2)
are tested##16##2##(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#2)(2009-11#2)(2011-2#1)(2013-1#1)
are that it##2##3##(2008-10#1)(2008-11#1)
are that the##2##3##(1993-8#1)(2008-9#1)
are that there is##2##4##(2008-8#1)(2008-9#1)
are that##10##2##(1993-8#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)
are the basis for##2##4##(1997-1#1)(1997-5#1)
are the basis of##2##4##(2009-8#1)(2010-6#1)
are the basis##4##3##(1997-1#1)(1997-5#1)(2009-8#1)(2010-6#1)
are the building blocks of##2##5##(1992-11#1)(2008-11#1)
are the central##2##3##(2011-2#1)(2013-1#1)
are the dominant##2##3##(2008-10#1)(2008-11#1)
are the first##9##3##(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-8#1)
are the following##5##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)
are the key to##2##4##(1991-1#1)(2008-7#1)
are the key##9##3##(1991-1#1)(1994-3#1)(1995-11#1)(1997-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-7#1)
are the largest##3##3##(2008-11#1)(2010-11#1)(2010-7#1)
are the loss of##2##4##(2008-10#1)(2012-3#1)
are the lowest##2##3##(2008-10#2)
are the main advantages##2##4##(2008-10#2)
are the main components of##2##5##(1997-2#1)(2008-10#1)
are the main##20##3##(1990-3#1)(1994-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#11)(2009-10#1)(2011-2#2)(2012-3#1)
are the mainstay of##3##4##(2008-11#1)(2010-12#2)
are the mainstays##2##3##(1993-9#1)(2008-9#1)
are the major cause of##2##5##(2008-10#1)(2008-4#1)
are the major source##2##4##(2008-3#1)(2012-2#1)
are the major##17##3##(1991-3#1)(1995-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
are the majors)##2##3##(2008-11#2)
are the most abundant##3##4##(1992-9#1)(1996-8#1)(1997-2#1)
are the most common form of##2##6##(2008-11#1)(2013-1#1)
are the most common type of##2##6##(2008-9#1)(2013-1#1)
are the most common##20##4##(1991-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#4)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#3)
are the most effective##3##4##(1997-1#2)(2008-7#1)
are the most important factors in##3##6##(1994-1#2)(2008-7#1)
are the most important factors##4##5##(1994-1#2)(2008-7#1)(2013-8#1)
are the most important##13##4##(1991-3#1)(1994-1#2)(1995-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-7#1)(2013-1#1)(2013-8#1)
are the most likely##2##4##(1990-2#1)(2008-7#1)
are the most potent##2##4##(1991-3#1)(2011-2#1)
are the most promising##2##4##(2008-10#1)(2008-5#1)
are the most widely used##2##5##(2008-11#1)(2008-6#1)
are the most##68##3##(1990-2#1)(1991-3#2)(1991-6#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#1)(1994-1#2)(1995-1#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2010-12#1)(2011-2#4)(2011-7#1)(2012-3#2)(2013-1#4)(2013-8#1)
are the ones##2##3##(1992-3#1)(1997-6#1)
are the only##6##3##(1990-11#1)(1991-11#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)
are the other##2##3##(2008-10#1)(2008-5#1)
are the preferred##2##3##(2008-10#1)(2008-9#1)
are the primary driving force##2##5##(1994-5#1)(1995-3#1)
are the primary##10##3##(1994-5#1)(1995-3#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-10#1)
are the principal##2##3##(1997-3#1)(2008-10#1)
are the principle##2##3##(2008-5#1)(2008-9#1)
are the result of##9##4##(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2010-5#1)(2013-8#1)
are the results##3##3##(1990-12#1)(1991-2#1)(2008-7#1)
are the rule##3##3##(1997-3#1)(2008-10#1)(2010-7#1)
are the same as##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
are the same##12##3##(1996-2#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-12#1)
are the second##2##3##(1996-11#1)(2011-3#1)
are the two most##2##4##(1991-2#1)(2008-10#1)
are the two##7##3##(1991-2#1)(2008-10#3)(2012-12#2)(2012-2#1)
are the use of##3##4##(1995-2#1)(1995-5#1)(2007-12#1)
are the##374##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#5)(1991-5#1)(1991-6#4)(1992-11#3)(1992-3#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#4)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#4)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#7)(1996-3#3)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#72)(2008-11#30)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#10)(2008-8#11)(2008-9#18)(2009-10#3)(2009-4#2)(2009-6#1)(2009-8#5)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#3)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#1)(2011-2#18)(2011-3#2)(2011-7#1)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#5)
are their##3##2##(1994-12#1)(1995-1#1)(2008-10#1)
are themselves##3##2##(1994-12#1)(2008-9#2)
are then used##2##3##(2008-10#1)(2008-3#1)
are then##31##2##(1990-12#1)(1993-12#2)(1994-12#1)(1994-2#1)(1995-2#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#2)(2009-12#1)(2013-1#1)
are there##5##2##(1994-3#1)(1996-1#1)(2010-11#1)(2010-12#1)(2012-12#1)
are therefore likely to##3##4##(1991-6#1)(2008-9#1)(2011-2#1)
are therefore##15##2##(1991-6#1)(1992-12#1)(1993-3#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
are thermally desorbed##2##3##(2008-10#2)
are they##9##2##(1990-2#1)(1992-12#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#1)(2010-10#1)
are they?##2##2##(2008-4#1)(2009-3#1)
are thoroughly##2##2##(2008-10#1)(2008-8#1)
are those between##2##3##(2009-10#2)
are those of##2##3##(1995-9#1)(2009-10#1)
are those that##2##3##(2008-11#1)(2008-3#1)
are those who##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
are those##14##2##(1991-9#1)(1995-2#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#4)(2010-2#1)(2012-3#1)
are thought of##2##3##(2008-10#1)(2009-10#1)
are thought to be important##2##5##(1990-11#1)(2008-8#1)
are thought to be##9##4##(1990-11#1)(1994-2#1)(1994-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
are thought to play important##2##5##(2011-2#1)(2013-1#1)
are thought to play##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
are thought to result from##2##5##(1995-6#1)(2011-2#1)
are thought to result##3##4##(1995-6#1)(1997-8#1)(2011-2#1)
are thought to##29##3##(1990-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#1)
are thought##31##2##(1990-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-9#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#1)
are three##10##2##(1992-9#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)
are thus likely##2##3##(1995-5#1)(2011-2#1)
are thus more##2##3##(1992-3#1)(2008-8#1)
are thus##11##2##(1992-1#1)(1992-3#1)(1995-5#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2011-2#1)
are tightly controlled by##2##4##(2012-2#2)
are tightly packed and##3##4##(1994-5#1)(2008-9#2)
are tightly##8##2##(1994-12#1)(1994-5#1)(1995-6#1)(2008-9#2)(2012-2#2)(2013-7#1)
are titrated##2##2##(2008-10#2)
are to be obtained##2##4##(2008-4#2)
are to be##22##3##(1990-12#1)(1991-11#1)(1992-11#1)(1992-3#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#2)(2009-11#1)(2011-2#1)(2011-3#1)(2012-2#1)
are to describe##2##3##(2008-12#1)(2013-1#1)
are to develop##2##3##(1992-9#1)(2008-8#1)
are to establish##2##3##(2008-3#1)(2009-8#1)
are to provide##3##3##(1990-11#1)(2010-8#1)(2012-2#1)
are to##57##2##(1990-11#1)(1990-12#2)(1991-11#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-2#3)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#2)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#1)
are tolerated##3##2##(2008-10#3)
are too costly to be##2##5##(2008-10#1)(2008-9#1)
are too large to##2##4##(2008-6#1)(2008-9#1)
are too small##2##3##(1991-3#1)(2008-9#1)
are too##15##2##(1991-3#1)(1992-12#1)(1994-3#1)(1996-2#1)(2008-10#2)(2008-6#1)(2008-8#2)(2008-9#3)(2013-1#3)
are toxic##3##2##(2008-10#3)
are traditionally##3##2##(1994-9#1)(2008-10#1)(2008-3#1)
are trained##3##2##(1992-3#1)(2008-11#1)(2013-1#1)
are transcribed##6##2##(1996-6#1)(1997-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
are transferred to##2##3##(2008-11#1)(2008-4#1)
are transferred##5##2##(2008-10#2)(2008-11#2)(2008-4#1)
are transformed##4##2##(2008-5#1)(2008-7#2)(2010-10#1)
are transforming##2##2##(1991-3#1)(2013-8#1)
are transiently##2##2##(1994-11#1)(2013-1#1)
are translated into##2##3##(2010-4#1)(2012-2#1)
are transmitted by##3##3##(2008-10#3)
are transmitted##7##2##(1992-3#1)(2007-12#1)(2008-10#3)(2008-3#2)
are transported by a##2##4##(1994-8#1)(2010-4#1)
are transported from the##2##4##(2008-10#1)(2008-5#1)
are transported from##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
are transported##7##2##(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
are trapped##2##2##(2008-10#1)(2012-2#1)
are treated by##2##3##(2008-7#1)(2013-1#1)
are treated with##6##3##(1990-11#1)(1996-6#1)(2008-10#2)(2008-7#1)(2008-8#1)
are treated##13##2##(1990-11#1)(1993-8#1)(1996-6#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#1)
are triggered by##2##3##(2007-12#1)(2009-8#1)
are triggered##3##2##(2007-12#1)(2008-10#1)(2009-8#1)
are true##3##2##(2008-8#1)(2009-3#1)(2011-2#1)
are trying to##4##3##(1995-6#1)(1997-4#1)(1997-6#1)(2008-11#1)
are tumors##2##2##(2008-10#1)(2011-2#1)
are tuned##2##2##(2008-4#1)(2009-10#1)
are two different##3##3##(2008-10#2)(2008-9#1)
are two important##3##3##(2009-8#1)(2011-1#1)(2013-1#1)
are two kinds of##2##4##(1993-3#1)(2011-3#1)
are two main##2##3##(2008-4#1)(2008-8#1)
are two major##5##3##(2008-10#3)(2008-8#1)(2012-2#1)
are two reasons##2##3##(1994-6#1)(2008-3#1)
are two types of##7##4##(1991-2#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2012-2#1)
are two types##8##3##(1991-2#1)(1993-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2012-2#1)
are two##59##2##(1990-5#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-5#2)(1994-6#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-6#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#2)
are type##2##2##(2008-10#1)(2008-7#1)
are typical of##6##3##(1990-12#1)(1993-2#1)(2008-12#1)(2008-3#2)(2008-7#1)
are typical##9##2##(1990-12#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#2)
are typically used in##2##4##(2008-9#1)(2010-12#1)
are typically##17##2##(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
are ubiquitous in the##2##4##(2010-6#1)(2011-2#1)
are ubiquitous in##4##3##(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
are ubiquitous##9##2##(2008-10#2)(2008-11#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-7#1)(2013-8#1)
are unable to##12##3##(1991-11#1)(1994-3#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#3)(2013-1#1)
are unaffected by##2##3##(1991-12#1)(1996-8#1)
are unavailable##2##2##(2008-10#1)(2011-2#1)
are uncertain##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
are unclear##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-2#1)
are uncommon##6##2##(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
are under development##3##3##(2008-3#1)(2008-8#1)(2010-10#1)
are under investigation##2##3##(2008-10#1)(2013-7#1)
are under the control of the##2##6##(2008-11#1)(2008-5#1)
are under the##4##3##(1991-11#1)(2008-11#1)(2008-5#1)(2012-3#1)
are under##21##2##(1991-11#1)(1994-3#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-7#1)
are undergoing##4##2##(2008-5#2)(2012-2#1)(2013-1#1)
are underlined##3##2##(1990-9#1)(1992-9#1)(2008-10#1)
are understood##2##2##(2008-4#1)(2009-10#1)
are undertaken##3##2##(1994-12#1)(2011-2#1)(2012-3#1)
are underway to##2##3##(2009-1#1)(2012-2#1)
are underway##6##2##(1997-3#1)(2008-11#1)(2008-5#2)(2009-1#1)(2012-2#1)
are undoubtedly##2##2##(1991-8#1)(2009-10#1)
are unique in##3##3##(1996-12#1)(2007-12#1)(2013-8#1)
are unique##12##2##(1991-12#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-10#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
are uniquely##4##2##(1992-1#1)(1994-9#1)(2007-12#1)(2013-8#1)
are universally present in##2##4##(2008-10#1)(2009-4#1)
are unknown##17##2##(1993-2#1)(1995-2#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2012-3#2)(2013-1#1)(2013-8#1)
are unlikely to##12##3##(1996-12#2)(1997-7#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2013-1#1)
are unrelated##2##2##(1990-8#1)(2008-11#1)
are unresponsive to##2##3##(1997-1#1)(2008-7#1)
are unusual##4##2##(1990-5#1)(1995-3#1)(2008-7#2)
are up to##4##3##(2008-10#1)(2008-11#2)(2013-8#1)
are urged to##3##3##(1995-2#1)(1996-2#1)(2008-11#1)
are urgently required##2##3##(1995-5#1)(2010-6#1)
are urgently##3##2##(1995-5#1)(2010-6#1)(2011-2#1)
are used and##2##3##(1990-2#1)(2008-10#1)
are used as a model##2##5##(1997-2#1)(2008-10#1)
are used as a##5##4##(1991-6#1)(1997-2#1)(2008-10#2)(2010-8#1)
are used as polarization##2##4##(2008-3#2)
are used as##31##3##(1991-6#1)(1992-9#1)(1993-2#1)(1994-11#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-7#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
are used by##4##3##(1990-12#1)(1995-2#1)(2008-11#1)(2013-8#1)
are used for the##3##4##(2008-10#1)(2010-12#1)(2010-8#1)
are used for##32##3##(1990-3#1)(1991-12#1)(1993-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-9#1)(2009-8#2)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
are used frequently##2##3##(2008-12#1)(2013-1#1)
are used in a##4##4##(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
are used in the##6##4##(2008-11#1)(2008-3#3)(2008-4#1)(2009-8#1)
are used in##26##3##(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
are used primarily to##2##4##(1991-6#1)(2008-10#1)
are used therapeutically##2##3##(1995-2#1)(2008-1#1)
are used to control the##2##5##(2008-10#1)(2008-5#1)
are used to describe##2##4##(1997-2#1)(2008-11#1)
are used to determine##2##4##(2008-10#1)(2008-3#1)
are used to establish##2##4##(2008-10#1)(2008-3#1)
are used to estimate the##3##5##(1991-3#1)(1994-3#1)(2008-11#1)
are used to examine the##3##5##(2009-12#1)(2010-3#1)(2010-6#1)
are used to guide##2##4##(2013-1#2)
are used to identify##2##4##(2008-9#1)(2011-3#1)
are used to illustrate the##4##5##(1995-11#1)(1995-12#1)(2008-10#1)(2008-4#1)
are used to illustrate##6##4##(1995-11#1)(1995-12#1)(2008-10#2)(2008-4#2)
are used to investigate##2##4##(2008-7#1)(2009-8#1)
are used to measure the##2##5##(2008-10#1)(2008-9#1)
are used to measure##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
are used to quantify the##2##5##(2008-2#1)(2008-7#1)
are used to treat##3##4##(2008-10#1)(2010-8#1)(2011-2#1)
are used to verify##2##4##(2008-9#1)(2010-5#1)
are used to##72##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#11)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
are used##209##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-9#1)(1996-6#1)(1997-2#3)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#47)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#30)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#5)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
are useful as##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
are useful for studying the##2##5##(2008-10#1)(2008-8#1)
are useful for studying##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
are useful for##15##3##(1993-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)(2011-2#2)(2013-8#1)
are useful in##10##3##(1993-2#1)(1994-12#1)(1994-6#1)(1995-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)
are useful markers##2##3##(2008-11#1)(2009-8#1)
are useful to##7##3##(1996-6#1)(1997-1#1)(2008-10#4)(2012-3#1)
are useful tools##2##3##(1995-12#1)(2010-11#1)
are useful##53##2##(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-9#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-5#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-8#2)
are using##4##2##(1997-1#1)(2009-10#1)(2010-11#1)(2010-7#1)
are usually characterised##2##3##(2008-10#1)(2010-11#1)
are usually detected##2##3##(2008-10#1)(2012-2#1)
are usually more##2##3##(1995-5#1)(2008-10#1)
are usually not##2##3##(1993-6#1)(2009-6#1)
are usually performed on##2##4##(1993-6#1)(2008-10#1)
are usually performed##4##3##(1993-6#1)(1997-8#1)(2008-10#1)(2011-2#1)
are usually transferred from##2##4##(1994-6#1)(2008-10#1)
are usually##56##2##(1990-11#1)(1991-1#1)(1992-12#1)(1992-9#1)(1993-6#2)(1994-6#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
are utilized to##4##3##(1994-1#1)(2008-10#2)(2013-1#1)
are utilized##7##2##(1994-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2013-1#1)
are valid##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
are validated##2##2##(2008-10#2)
are valuable for##4##3##(2008-12#1)(2010-3#1)(2012-2#1)(2012-5#1)
are valuable in the##2##4##(2008-10#1)(2008-11#1)
are valuable in##6##3##(1992-2#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-8#1)
are valuable tools for##2##4##(2008-7#1)(2012-3#1)
are valuable tools##4##3##(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
are valuable##18##2##(1992-2#1)(1993-2#1)(1995-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2012-2#2)(2012-3#1)(2012-5#1)
are variables##2##2##(1993-1#1)(2012-2#1)
are varied##3##2##(1996-2#1)(1996-3#1)(2008-10#1)
are various##2##2##(2008-10#1)(2008-2#1)
are verified##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
are versatile##2##2##(1996-5#1)(2008-10#1)
are very closely related##3##4##(2008-10#3)
are very common##2##3##(2009-8#1)(2012-2#1)
are very different##4##3##(1990-5#1)(1991-3#1)(1997-8#1)(2008-10#1)
are very high##2##3##(2008-10#2)
are very important in##2##4##(1990-9#1)(1994-5#1)
are very important##6##3##(1990-9#1)(1994-5#1)(2008-10#1)(2010-5#1)(2010-7#1)(2012-3#1)
are very limited##2##3##(2008-7#1)(2012-7#1)
are very promising##2##3##(2008-10#1)(2008-7#1)
are very rare##7##3##(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
are very sensitive to##3##4##(2008-10#1)(2008-4#2)
are very similar to##3##4##(2008-10#2)(2008-7#1)
are very similar##10##3##(1997-7#1)(1997-8#1)(2008-10#5)(2008-7#2)(2008-8#1)
are very small##2##3##(2008-10#2)
are very stable and##2##4##(2008-10#1)(2008-11#1)
are very stable##4##3##(2008-10#3)(2008-11#1)
are very useful in##4##4##(2008-10#1)(2008-11#1)(2008-9#2)
are very useful##6##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#2)
are very##87##2##(1990-5#1)(1990-9#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-8#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-10#35)(2008-11#6)(2008-12#3)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-8#1)
are viable##3##2##(1993-12#1)(2008-10#2)
are video films that continuously and dynamically display anatomic structures in 3D space at different velocities##2##16##(2012-3#2)
are viewed as##2##3##(1996-5#1)(2009-7#1)
are viewed##3##2##(1996-5#1)(2008-7#1)(2009-7#1)
are virulent##2##2##(2008-10#2)
are visible at##2##3##(2008-3#1)(2008-7#1)
are visible##5##2##(2008-3#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
are vital##3##2##(1996-2#1)(2008-10#1)(2012-2#1)
are warning##2##2##(1992-8#1)(2008-12#1)
are warranted to##6##3##(1992-12#1)(2008-5#1)(2008-7#3)(2011-2#1)
are warranted##9##2##(1992-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
are we and where are we##2##6##(1990-6#1)(2013-1#1)
are we to##2##3##(1990-9#1)(2008-10#1)
are we##17##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-3#1)(1992-2#2)(1996-12#1)(1996-3#1)(1996-8#1)(2008-10#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
are weighted##2##2##(2008-10#1)(2008-7#1)
are well conserved##2##3##(1990-5#1)(2008-6#1)
are well correlated##2##3##(2008-10#2)
are well defined##2##3##(2008-7#1)(2011-1#1)
are well documented##5##3##(1990-6#1)(1993-11#1)(2008-6#1)(2012-2#1)(2013-8#1)
are well known to be##2##5##(1994-11#1)(2008-11#1)
are well known to##5##4##(1994-11#1)(1997-1#1)(2008-11#1)(2008-7#1)(2013-1#1)
are well known##12##3##(1990-2#1)(1994-11#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-1#1)(2013-8#1)
are well separated##2##3##(2008-10#2)
are well suited for##4##4##(2008-10#1)(2008-4#2)(2010-8#1)
are well suited to##2##4##(1993-2#1)(2008-11#1)
are well suited##6##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-8#1)
are well tolerated##2##3##(2008-5#1)(2013-1#1)
are well##51##2##(1990-2#2)(1990-5#1)(1990-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2009-12#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
are well-documented##2##2##(2008-11#1)(2013-1#1)
are well-known##2##2##(1996-6#1)(2008-5#1)
are widely distributed in##2##4##(2008-10#1)(2009-12#1)
are widely distributed##4##3##(2008-10#1)(2008-12#1)(2009-12#1)(2010-5#1)
are widely used for##2##4##(2008-11#1)(2008-9#1)
are widely used in##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)
are widely used##9##3##(1994-8#1)(2008-10#1)(2008-11#2)(2008-9#2)(2010-1#1)(2010-11#1)(2010-5#1)
are widely##24##2##(1994-8#1)(1997-5#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-9#4)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#2)(2011-2#1)(2012-3#1)
are widespread##5##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-12#1)
are willing to##2##3##(1994-1#1)(2012-2#1)
are within 3##2##3##(2008-10#2)
are within the##4##3##(1993-6#1)(2008-10#2)(2013-1#1)
are within##9##2##(1993-6#1)(2008-10#4)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
are working##5##2##(1993-2#1)(1995-6#1)(2008-10#1)(2008-7#2)
are worth##2##2##(1991-3#1)(2008-8#1)
are yet to be##2##4##(2008-1#1)(2008-11#1)
are yet##5##2##(2008-1#1)(2008-11#2)(2008-8#1)(2009-3#1)
are you##2##2##(2008-12#1)(2009-12#1)
are##14273##1##(1990-10#1)(1990-11#41)(1990-12#38)(1990-2#41)(1990-3#19)(1990-4#1)(1990-5#39)(1990-6#21)(1990-7#1)(1990-8#29)(1990-9#36)(1991-1#29)(1991-10#4)(1991-11#19)(1991-12#84)(1991-2#74)(1991-3#87)(1991-5#30)(1991-6#42)(1991-7#4)(1991-8#13)(1991-9#14)(1992-1#35)(1992-10#7)(1992-11#16)(1992-12#71)(1992-2#49)(1992-3#86)(1992-4#13)(1992-5#11)(1992-6#33)(1992-7#3)(1992-8#8)(1992-9#48)(1993-1#31)(1993-11#23)(1993-12#101)(1993-2#68)(1993-3#82)(1993-5#3)(1993-6#42)(1993-8#56)(1993-9#24)(1994-1#36)(1994-11#32)(1994-12#57)(1994-2#66)(1994-3#57)(1994-5#63)(1994-6#27)(1994-8#33)(1994-9#34)(1995-1#31)(1995-10#2)(1995-11#34)(1995-12#83)(1995-2#121)(1995-3#36)(1995-5#57)(1995-6#63)(1995-8#32)(1995-9#25)(1996-1#51)(1996-11#25)(1996-12#69)(1996-2#111)(1996-3#76)(1996-5#29)(1996-6#27)(1996-8#15)(1996-9#16)(1997-1#72)(1997-2#78)(1997-3#67)(1997-4#27)(1997-5#24)(1997-6#51)(1997-7#52)(1997-8#90)(1997-9#7)(2006-5#4)(2006-6#15)(2007-11#36)(2007-12#145)(2007-8#8)(2007-9#3)(2008-1#96)(2008-10#3282)(2008-11#968)(2008-12#256)(2008-2#135)(2008-3#512)(2008-4#303)(2008-5#299)(2008-6#95)(2008-7#388)(2008-8#433)(2008-9#464)(2009-1#13)(2009-10#126)(2009-11#36)(2009-12#88)(2009-2#3)(2009-3#34)(2009-4#30)(2009-5#42)(2009-6#43)(2009-7#78)(2009-8#162)(2009-9#47)(2010-1#40)(2010-10#84)(2010-11#97)(2010-12#119)(2010-2#22)(2010-3#26)(2010-4#41)(2010-5#57)(2010-6#49)(2010-7#88)(2010-8#79)(2010-9#31)(2011-1#68)(2011-10#6)(2011-2#618)(2011-3#64)(2011-4#1)(2011-7#12)(2011-9#1)(2012-12#90)(2012-2#361)(2012-3#276)(2012-4#2)(2012-5#12)(2012-7#4)(2013-1#385)(2013-3#2)(2013-7#20)(2013-8#221)
area (mm(2))##2##2##(2011-2#1)(2012-3#1)
area 37##2##2##(1996-2#2)
area along##2##2##(2008-10#2)
area and the##4##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
area and##50##2##(1990-5#1)(1990-8#1)(1994-6#1)(1994-8#1)(1995-1#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#6)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-5#1)
area are##5##2##(1991-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
area around the##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
area around##4##2##(1992-1#1)(2008-10#2)(2008-5#1)
area as compared to##2##4##(2007-12#1)(2011-2#1)
area as compared##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
area as##5##2##(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
area at a##2##3##(2013-1#1)(2013-8#1)
area at##5##2##(2008-10#3)(2013-1#1)(2013-8#1)
area because##2##2##(2008-10#2)
area between##3##2##(1995-3#1)(1997-8#1)(2010-9#1)
area by##7##2##(2008-10#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
area can be##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
area can##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
area compared with##2##3##(2008-10#2)
area contains##2##2##(2010-6#1)(2013-8#1)
area counts for most##2##4##(2008-10#2)
area covered##3##2##(2008-10#2)(2008-11#1)
area during##2##2##(1991-12#1)(2010-11#1)
area easily##2##2##(2008-5#1)(2011-2#1)
area effects##3##2##(2008-8#1)(2008-9#2)
area for##16##2##(1994-3#1)(1996-11#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-5#2)(2009-4#1)(2011-2#1)(2012-2#2)(2013-3#1)
area from##5##2##(2008-10#2)(2008-11#1)(2010-9#1)(2011-2#1)
area had##3##2##(1993-6#1)(1995-12#1)(2008-10#1)
area has been##2##3##(2008-10#2)
area has##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
area have##3##2##(1993-1#1)(2008-10#1)(2008-2#1)
area health boards##2##3##(1992-1#2)
area in the##15##3##(1994-8#1)(1995-2#1)(1996-11#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)
area in which##4##3##(1997-1#1)(2008-10#3)
area in##35##2##(1993-8#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
area increased##2##2##(2008-12#1)(2012-5#1)
area into##2##2##(2008-10#2)
area involved in##2##3##(2008-7#1)(2008-9#1)
area is the##2##3##(2008-10#1)(2011-2#1)
area is##21##2##(1991-12#2)(1994-1#1)(1994-3#1)(1996-11#2)(1996-3#1)(2008-10#7)(2008-11#2)(2008-2#1)(2011-2#2)(2012-12#1)(2012-9#1)
area it is##2##3##(1993-8#1)(2008-2#1)
area may have##2##3##(1995-12#1)(2007-12#1)
area may##3##2##(1995-12#1)(2007-12#1)(2008-10#1)
area measurements##5##2##(2008-10#5)
area near##2##2##(1990-11#1)(2008-3#1)
area occupied by##2##3##(1994-12#1)(2008-4#1)
area of 0##2##3##(2008-10#1)(2008-11#1)
area of 2##2##3##(2008-10#2)
area of Argentina##2##3##(2008-10#2)
area of Health##2##3##(2012-2#1)(2012-3#1)
area of Southern##2##3##(2008-7#1)(2013-8#1)
area of a##4##3##(2008-10#2)(2013-1#2)
area of clinical##2##3##(2008-11#1)(2010-11#1)
area of each##2##3##(2008-10#2)
area of health##2##3##(1991-2#1)(1991-6#1)
area of influence##4##3##(2008-10#4)
area of intensive##2##3##(2008-10#1)(2013-8#1)
area of interest##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
area of research##8##3##(1997-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)
area of significant##2##3##(2008-9#1)(2010-6#1)
area of source##2##3##(2008-10#2)
area of study##2##3##(2008-9#1)(2012-2#1)
area of the brain##2##4##(2008-11#1)(2008-5#1)
area of the rat##2##4##(1992-3#1)(1994-8#1)
area of the##52##3##(1990-9#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#15)(2008-11#3)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#6)(2012-3#1)(2013-1#3)(2013-8#2)
area of##206##2##(1990-2#1)(1990-9#1)(1991-11#3)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-10#61)(2008-11#23)(2008-12#9)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#3)(2009-3#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-2#9)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#9)(2013-8#5)
area on the##3##3##(1991-2#1)(2008-10#2)
area on##6##2##(1990-8#1)(1991-2#1)(2008-10#4)
area or##2##2##(2008-10#1)(2010-6#1)
area ratio##2##2##(2008-10#1)(2008-7#1)
area ratios##4##2##(2008-10#4)
area showed##2##2##(2008-5#1)(2011-2#1)
area than##2##2##(1991-3#1)(2008-11#1)
area that has##3##3##(1995-1#1)(2008-11#2)
area that is##2##3##(1990-8#1)(2008-9#1)
area that##11##2##(1990-8#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2013-8#1)
area the##3##2##(1995-2#1)(2008-10#2)
area there##2##2##(1991-6#1)(1994-12#1)
area to the##4##3##(2008-10#3)(2013-8#1)
area to##15##2##(1992-3#1)(1994-3#1)(1995-3#1)(2008-10#5)(2008-11#3)(2011-2#1)(2013-1#2)(2013-8#1)
area under the curve (AUC)##3##5##(1994-12#1)(2008-11#1)(2012-3#1)
area under the curve of##2##5##(2008-10#1)(2012-3#1)
area under the curve##10##4##(1992-9#1)(1994-12#2)(2008-10#3)(2008-11#1)(2010-8#1)(2012-3#2)
area under the disease progress curve (AUDPC)##8##7##(2008-10#8)
area under the disease progress curve and##2##7##(2008-10#2)
area under the disease progress curve##16##6##(2008-10#16)
area under the disease progress##17##5##(2008-10#17)
area under the##39##3##(1992-9#1)(1994-12#2)(1994-9#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#1)(2012-3#2)
area under##46##2##(1992-9#1)(1994-12#2)(1994-9#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-8#1)(2012-3#2)
area ventralis telencephali##2##3##(2008-6#2)
area was##19##2##(1993-6#1)(2008-10#12)(2008-5#2)(2009-11#1)(2009-3#1)(2010-7#1)(2013-1#1)
area were compared##2##3##(1997-1#1)(2009-3#1)
area were##12##2##(1996-1#1)(1997-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-8#1)
area where##5##2##(1995-1#1)(2008-1#1)(2008-10#3)
area with##5##2##(1994-8#1)(2008-10#2)(2008-5#1)(2013-1#1)
area within##2##2##(1994-9#1)(2008-10#1)
area##958##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#5)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#4)(1991-6#4)(1991-8#2)(1992-1#8)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#2)(1994-12#5)(1994-2#3)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#7)(1994-9#2)(1995-1#4)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#1)(1995-8#3)(1996-1#7)(1996-11#6)(1996-12#5)(1996-2#10)(1996-3#5)(1996-5#1)(1997-1#4)(1997-2#6)(1997-3#14)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#304)(2008-11#76)(2008-12#25)(2008-2#9)(2008-3#9)(2008-4#3)(2008-5#27)(2008-6#4)(2008-7#27)(2008-8#34)(2008-9#29)(2009-10#4)(2009-11#3)(2009-12#3)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#7)(2010-11#6)(2010-12#2)(2010-4#3)(2010-5#2)(2010-6#12)(2010-7#12)(2010-8#10)(2010-9#5)(2011-2#44)(2011-9#1)(2012-12#6)(2012-2#14)(2012-3#16)(2012-5#2)(2012-9#3)(2013-1#31)(2013-3#1)(2013-7#2)(2013-8#20)
area) was##2##2##(2008-10#1)(2011-2#1)
area)##12##1##(1995-8#1)(2008-10#7)(2008-11#2)(2008-9#1)(2011-2#1)
area-restricted##2##1##(2008-9#2)
area]##4##1##(1993-5#1)(1994-6#1)(1997-3#1)(2009-5#1)
areal##2##1##(1994-3#1)(2008-7#1)
areas 17 and 18 of the##2##6##(2008-8#2)
areas 17 and 18 of##3##5##(2008-8#3)
areas activated by##2##3##(2008-5#1)(2008-9#1)
areas affected by##2##3##(2008-10#1)(2012-3#1)
areas and are##2##3##(1997-3#1)(2010-9#1)
areas and is##2##3##(1992-2#1)(2008-10#1)
areas and was##2##3##(1993-12#1)(2008-10#1)
areas and with##2##3##(2008-7#1)(2013-1#1)
areas and##27##2##(1990-2#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#1)
areas are##9##2##(1993-12#1)(1994-1#1)(1994-2#1)(1996-11#1)(1997-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
areas as well as##2##4##(2008-11#2)
areas as##6##2##(1991-12#1)(1994-1#1)(2008-11#2)(2009-10#1)(2010-7#1)
areas associated with##2##3##(2008-10#2)
areas at##2##2##(1994-3#1)(2008-10#1)
areas burn after##2##3##(1990-8#2)
areas by##5##2##(1990-8#1)(1992-12#1)(2008-10#2)(2008-9#1)
areas can##3##2##(1992-12#1)(1996-3#1)(2010-10#1)
areas could be##2##3##(1994-8#1)(1996-12#1)
areas could##3##2##(1994-8#1)(1996-12#1)(2008-10#1)
areas examined##2##2##(1997-2#2)
areas for future research##2##4##(2008-11#1)(2012-2#1)
areas for future##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
areas for improvement##2##3##(1996-2#1)(2008-11#1)
areas for##11##2##(1992-2#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#6)(2012-2#1)
areas from##3##2##(1992-2#1)(2008-3#1)(2013-1#1)
areas had##2##2##(2008-10#1)(2008-8#1)
areas in the dorsal##2##4##(1997-3#1)(2007-12#1)
areas in the##15##3##(1990-8#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
areas in which##4##3##(1996-3#1)(2008-8#1)(2010-12#1)(2011-2#1)
areas in##45##2##(1990-8#1)(1991-6#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-11#3)(1996-2#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#2)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#2)
areas including##2##2##(1996-1#1)(2008-1#1)
areas involves##2##2##(1994-3#1)(2010-10#1)
areas is##7##2##(1992-12#1)(1993-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(2010-12#1)(2010-7#1)
areas it##2##2##(1996-3#1)(2013-8#1)
areas of Italy##2##3##(1993-2#1)(2008-10#1)
areas of Spain##2##3##(2008-10#2)
areas of acute##3##3##(2008-11#1)(2011-2#2)
areas of biological##2##3##(2008-10#1)(2008-9#1)
areas of interest##2##3##(2008-11#1)(2013-1#1)
areas of low##4##3##(2008-8#1)(2008-9#2)(2012-12#1)
areas of nursing##2##3##(2008-11#1)(2008-12#1)
areas of potential##2##3##(1991-1#1)(2012-2#1)
areas of research that##5##4##(2008-10#1)(2008-11#1)(2009-10#1)(2011-3#1)(2013-1#1)
areas of research##7##3##(2008-10#1)(2008-11#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-3#1)(2013-1#1)
areas of skin##2##3##(1996-12#1)(2008-5#1)
areas of the United States##2##5##(2011-2#2)
areas of the brain##2##4##(1995-2#1)(2008-7#1)
areas of the country##2##4##(1994-6#1)(1996-1#1)
areas of the dorsal horn##2##5##(1997-3#2)
areas of the face##2##4##(2008-5#1)(2010-6#1)
areas of the world##7##4##(2008-10#6)(2013-1#1)
areas of the##45##3##(1991-10#1)(1992-12#1)(1994-6#1)(1995-2#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2010-11#1)(2010-6#1)(2011-2#4)(2013-1#2)
areas of##199##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#5)(2007-12#2)(2008-1#1)(2008-10#49)(2008-11#18)(2008-12#8)(2008-3#3)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#8)(2009-10#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#6)(2011-2#14)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#4)
areas on the##3##3##(2008-10#3)
areas on##6##2##(1997-8#1)(2008-10#4)(2008-7#1)
areas or##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
areas presents##2##2##(1991-2#1)(2008-12#1)
areas previously##2##2##(1995-2#1)(2008-10#1)
areas relating to##2##3##(2010-11#1)(2013-1#1)
areas should be##2##3##(2008-10#1)(2012-5#1)
areas should##3##2##(1994-3#1)(2008-10#1)(2012-5#1)
areas such as##8##3##(1994-3#1)(1995-11#1)(1997-2#1)(2008-12#2)(2008-5#1)(2010-12#1)(2012-2#1)
areas than in##2##3##(2008-10#2)
areas than##4##2##(1994-3#1)(2008-10#2)(2009-4#1)
areas that were##2##3##(2008-10#2)
areas that##12##2##(1990-9#1)(1994-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2012-2#1)
areas to control##2##3##(2008-10#2)
areas to##7##2##(1994-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
areas was##5##2##(2008-10#4)(2008-11#1)
areas were more##2##3##(1996-3#1)(2010-4#1)
areas were##19##2##(1990-8#1)(1992-12#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#6)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#3)
areas where##14##2##(1991-6#1)(1993-12#1)(1993-2#1)(1996-5#1)(1997-8#1)(2008-10#5)(2009-10#1)(2009-12#1)(2009-7#1)(2012-3#1)
areas which##3##2##(1994-3#1)(1996-2#1)(2011-2#1)
areas with a##2##3##(2008-10#2)
areas with different##3##3##(2008-10#2)(2008-3#1)
areas with##19##2##(1990-11#1)(2008-10#11)(2008-3#1)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
areas within##2##2##(1994-2#1)(2008-10#1)
areas##756##1##(1990-11#1)(1990-2#2)(1990-6#4)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#4)(1991-6#2)(1992-1#1)(1992-12#11)(1992-2#3)(1992-3#2)(1992-9#2)(1993-1#3)(1993-12#10)(1993-2#3)(1993-3#6)(1993-6#1)(1993-8#1)(1994-1#6)(1994-11#1)(1994-12#1)(1994-2#8)(1994-3#14)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#1)(1995-8#3)(1996-1#6)(1996-11#6)(1996-12#9)(1996-2#9)(1996-3#20)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#14)(1997-3#10)(1997-7#2)(1997-8#4)(2007-12#4)(2008-1#3)(2008-10#193)(2008-11#57)(2008-12#20)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#18)(2008-6#2)(2008-7#18)(2008-8#12)(2008-9#14)(2009-10#9)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#6)(2010-11#4)(2010-12#7)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#8)(2010-7#4)(2010-8#4)(2010-9#7)(2011-1#1)(2011-2#33)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#11)(2012-3#8)(2012-5#3)(2013-1#35)(2013-8#16)
areas'##2##1##(1997-3#1)(2011-2#1)
areas) was##2##2##(2008-10#1)(2011-2#1)
areas)##4##1##(1996-2#1)(2008-10#2)(2011-2#1)
areflexia##2##1##(2012-3#2)
aren't##5##1##(1992-8#1)(1994-2#1)(1997-3#1)(2010-12#1)(2011-2#1)
arena for##2##2##(1997-1#1)(2011-2#1)
arena of##3##2##(1994-2#1)(2009-3#1)(2012-3#1)
arena##12##1##(1994-2#1)(1995-2#1)(1997-1#1)(2008-11#4)(2009-3#1)(2010-6#1)(2011-2#2)(2012-3#1)
arenaria##6##1##(2008-10#6)
arenas in which##2##3##(1991-2#1)(2008-1#1)
arenas in##3##2##(1991-2#1)(2008-1#2)
arenas##4##1##(1991-2#1)(2008-1#2)(2008-12#1)
areola##2##1##(2011-2#2)
areolar##4##1##(1993-11#1)(2011-2#3)
aresult of##2##2##(2008-10#1)(2008-11#1)
argan oil samples##2##3##(2011-2#2)
argan oil##4##2##(2011-2#4)
argan##5##1##(2011-2#5)
arginase activity in##2##3##(1992-5#2)
arginase##7##1##(1992-5#3)(2013-8#4)
arginine and calcium carbonate##2##4##(2011-2#2)
arginine and##6##2##(1995-3#1)(1996-2#1)(2011-2#3)(2013-7#1)
arginine at##2##2##(1995-2#1)(2008-9#1)
arginine in##2##2##(1991-6#1)(2008-10#1)
arginine##43##1##(1991-6#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-3#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#4)(2010-1#1)(2010-6#1)(2011-2#8)(2012-3#1)(2013-7#3)(2013-8#1)
arginine-glycine-aspartic acid##3##2##(2008-11#1)(2010-12#2)
arginyl##2##1##(1990-2#1)(2006-6#1)
arginyl-##2##1##(1994-8#2)
argon and##5##2##(1993-3#2)(2008-10#3)
argon beam coagulator (ABC)##2##4##(1993-12#1)(1994-3#1)
argon beam coagulator##4##3##(1993-12#2)(1994-3#2)
argon flow delivers the##2##4##(2008-10#2)
argon flow##5##2##(2008-10#5)
argon gas##3##2##(2008-10#2)(2013-1#1)
argon laser##6##2##(1990-11#1)(1993-1#2)(2008-3#2)(2008-9#1)
argon plasma coagulation##2##3##(2010-12#1)(2013-1#1)
argon plasma##5##2##(2008-10#3)(2010-12#1)(2013-1#1)
argon##41##1##(1990-11#1)(1993-1#2)(1993-12#2)(1993-3#2)(1994-3#2)(2008-10#22)(2008-2#2)(2008-3#4)(2008-9#1)(2010-12#1)(2013-1#2)
argon-ion laser##2##2##(2008-10#1)(2008-9#1)
arguably the most##2##3##(2008-10#1)(2010-5#1)
arguably the##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
arguably##4##1##(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#1)
argue against the##2##3##(2008-8#1)(2008-9#1)
argue against##3##2##(1991-7#1)(2008-8#1)(2008-9#1)
argue for the##4##3##(1993-6#1)(1997-1#1)(2007-12#1)(2010-3#1)
argue for##5##2##(1993-6#1)(1993-8#1)(1997-1#1)(2007-12#1)(2010-3#1)
argue that a##5##3##(2008-11#3)(2008-12#1)(2008-8#1)
argue that current##2##3##(2008-8#1)(2010-9#1)
argue that the##10##3##(1991-2#1)(1992-2#1)(1997-1#1)(2008-11#3)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
argue that these##2##3##(1997-2#1)(2011-2#1)
argue that this##3##3##(1997-3#1)(2008-11#1)(2010-7#1)
argue that##52##2##(1991-2#1)(1992-2#1)(1993-2#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#10)(2008-12#2)(2008-6#1)(2008-8#6)(2008-9#6)(2010-3#2)(2010-4#2)(2010-7#2)(2010-9#2)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
argue##66##1##(1991-2#1)(1991-7#1)(1992-2#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-12#1)(2008-11#10)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#7)(2010-3#3)(2010-4#2)(2010-7#2)(2010-9#2)(2011-2#1)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#2)
argued in##3##2##(1995-2#1)(2008-7#1)(2009-10#1)
argued that the##8##3##(1995-6#1)(1996-5#1)(2008-10#1)(2008-9#2)(2010-3#1)(2013-1#2)
argued that this##2##3##(1991-3#1)(1995-5#1)
argued that##30##2##(1991-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#2)(1996-5#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-3#1)(2013-1#4)
argued to##2##2##(2008-11#1)(2008-8#1)
argued##38##1##(1991-3#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-5#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-9#1)(2010-3#1)(2013-1#4)
argues against an##2##3##(1990-5#1)(1995-6#1)
argues against the##2##3##(2008-7#1)(2008-8#1)
argues against##6##2##(1990-5#1)(1995-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
argues for##3##2##(1996-3#1)(2008-12#1)(2008-7#1)
argues that the##3##3##(1992-3#1)(2008-12#1)(2010-1#1)
argues that there##2##3##(1991-2#1)(2008-6#1)
argues that##24##2##(1991-12#1)(1991-2#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-6#1)(2009-12#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-8#2)
argues##34##1##(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#2)(2011-2#2)(2013-1#1)(2013-8#2)
arguing that##3##2##(1995-6#1)(2010-9#1)(2012-2#1)
arguing##5##1##(1995-6#1)(2008-10#1)(2010-9#1)(2012-12#1)(2012-2#1)
argument for##5##2##(1991-6#1)(1994-11#1)(1995-11#1)(1996-1#2)
argument that##5##2##(1995-12#1)(1995-6#1)(2008-11#1)(2008-8#2)
argument##17##1##(1991-2#1)(1991-6#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#2)(2008-11#1)(2008-8#4)
arguments for##8##2##(1994-1#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
arguments of##3##2##(1994-1#1)(2008-9#1)(2009-10#1)
arguments##26##1##(1991-6#1)(1994-1#3)(1996-2#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#2)
argyrophilia##2##1##(1997-3#2)
argyrophilic##2##1##(2007-12#1)(2013-1#1)
arid##6##1##(2008-10#2)(2008-8#2)(2012-7#1)(2012-9#1)
arise as a result of##2##5##(1997-2#1)(2008-11#1)
arise as a##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
arise as##6##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-3#1)
arise at##2##2##(2008-10#1)(2012-2#1)
arise by##2##2##(1994-12#1)(2011-2#1)
arise due to##3##3##(2010-1#1)(2011-1#1)(2012-3#1)
arise during##3##2##(1992-10#1)(2008-10#1)(2012-3#1)
arise from the##10##3##(1991-8#1)(2008-11#1)(2008-5#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
arise from##27##2##(1991-8#1)(1992-9#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
arise in##12##2##(1990-6#1)(1994-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
arise when the##2##3##(2008-11#1)(2008-8#1)
arise when##8##2##(1991-12#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2013-8#1)
arise##87##1##(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#2)
arisen in the##2##3##(2008-6#1)(2008-8#1)
arisen in##3##2##(2008-6#1)(2008-8#2)
arisen independently##5##2##(1997-7#1)(2008-10#3)(2009-6#1)
arisen##19##1##(1994-11#1)(1995-3#1)(1997-7#1)(2008-10#9)(2008-6#1)(2008-8#3)(2009-6#1)(2010-11#1)(2010-3#1)
arises as a##2##3##(1997-7#1)(2008-11#1)
arises as##3##2##(1997-7#1)(2008-11#1)(2011-2#1)
arises from a##2##3##(1995-6#1)(2011-2#1)
arises from the##6##3##(1995-8#1)(2008-10#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
arises from##15##2##(1991-3#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-2#1)
arises in##3##2##(2010-10#1)(2010-3#1)(2013-1#1)
arises when##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
arises##38##1##(1991-3#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#4)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)
arising at the##2##3##(1996-9#1)(2008-9#1)
arising at##3##2##(1994-9#1)(1996-9#1)(2008-9#1)
arising from a##5##3##(2008-10#2)(2010-7#1)(2012-3#2)
arising from the complex##2##4##(2008-11#1)(2008-3#1)
arising from the inferior vena cava##4##6##(2008-11#3)(2013-1#1)
arising from the##34##3##(1990-5#1)(1992-12#1)(1993-3#1)(1993-8#1)(1996-9#1)(1997-6#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
arising from two##2##3##(1993-2#1)(2012-2#1)
arising from##80##2##(1990-5#1)(1991-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#21)(2008-11#7)(2008-12#2)(2008-3#3)(2008-7#2)(2008-8#3)(2008-9#2)(2010-10#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#3)
arising in a##2##3##(2008-10#1)(2008-5#1)
arising in the##7##3##(1990-2#1)(1991-6#1)(2009-1#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
arising in##16##2##(1990-2#1)(1991-6#1)(1994-12#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-1#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
arising out of##2##3##(1995-2#1)(2008-10#1)
arising##115##1##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-9#2)(1997-6#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#8)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-1#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-5#3)(2010-6#1)(2010-7#2)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#5)(2013-8#6)
arithmetic average and##2##3##(2008-10#2)
arithmetic average##4##2##(2008-10#4)
arithmetic mean##2##2##(2008-10#2)
arithmetic means##2##2##(2008-10#1)(2008-8#1)
arithmetic##15##1##(2008-10#10)(2008-11#1)(2008-8#1)(2009-12#1)(2012-3#2)
arm (p &lt##2##3##(1993-11#2)
arm and##3##2##(2008-12#1)(2010-9#2)
arm as##2##2##(2009-10#1)(2011-2#1)
arm circumference (inverse)##2##3##(2008-7#2)
arm movements in##2##3##(1990-11#1)(2008-7#1)
arm movements##4##2##(1990-11#1)(2008-7#3)
arm number##2##2##(2008-12#2)
arm of Saccharomyces cerevisiae chromosome VII##2##6##(1995-9#1)(1996-3#1)
arm of Saccharomyces cerevisiae chromosome##3##5##(1995-9#1)(1996-3#2)
arm of barley chromosome 3H##2##5##(2008-10#2)
arm of barley chromosome##3##4##(2008-10#3)
arm of chromosome 1##2##4##(2008-10#1)(2012-3#1)
arm of chromosome IV##2##4##(1996-3#1)(1996-6#1)
arm of chromosome VII##3##4##(1995-9#1)(1996-3#1)(1996-6#1)
arm of chromosome XI##3##4##(1993-9#1)(1996-6#2)
arm of chromosome##31##3##(1993-9#1)(1995-9#4)(1996-3#3)(1996-6#5)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#10)(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#2)
arm of human chromosome##2##4##(1996-2#1)(1997-8#1)
arm of the##7##3##(1996-6#1)(1997-3#1)(2008-10#3)(2009-10#1)(2013-1#1)
arm of wheat chromosome##3##4##(2008-10#3)
arm of wheat##4##3##(2008-10#4)
arm of##60##2##(1993-12#1)(1993-2#1)(1993-9#1)(1995-9#5)(1996-2#1)(1996-3#6)(1996-6#7)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2008-10#23)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
arm was##2##2##(1993-6#1)(2013-8#1)
arm##141##1##(1990-11#1)(1991-3#1)(1992-12#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-9#5)(1996-2#1)(1996-3#6)(1996-5#1)(1996-6#8)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-12#7)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#9)(2009-1#1)(2009-10#2)(2010-12#1)(2010-7#1)(2010-9#2)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#4)
armadillo##4##1##(2008-5#3)(2008-9#1)
armadillos##3##1##(2008-5#1)(2008-9#2)
armamentarium for##2##2##(2008-9#1)(2012-3#1)
armamentarium##7##1##(1996-1#1)(1996-12#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#2)
armed crown##2##2##(2008-10#2)
armed##5##1##(2008-10#4)(2008-12#1)
armeniacae and E##3##3##(2008-10#3)
armeniacae##6##1##(2008-10#6)
armeniacum##5##1##(2008-10#5)
armeniacum-derived genes##2##2##(2008-10#2)
armigera and##2##2##(2008-8#2)
armigera##8##1##(2008-11#1)(2008-12#2)(2008-8#5)
armor##3##1##(2008-10#1)(2012-2#2)
armoraciae##5##1##(2008-10#5)
arms and##2##2##(2008-1#1)(2008-7#1)
arms of##6##2##(1997-6#1)(1997-8#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-8#1)
arms were##2##2##(1994-8#1)(2008-10#1)
arms##28##1##(1991-3#1)(1992-12#1)(1993-6#1)(1994-8#3)(1996-3#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#2)(2009-10#1)(2010-6#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
army recruits##2##2##(2008-12#2)
army##6##1##(1991-3#1)(2008-12#3)(2013-1#2)
armyworm##2##1##(1992-6#1)(2008-10#1)
aroma compound##2##2##(2008-10#2)
aroma compounds in##3##3##(2008-10#3)
aroma compounds##9##2##(2008-10#9)
aroma of##2##2##(2008-10#2)
aroma profile of cooked beef##2##5##(2008-10#2)
aroma release##3##2##(2008-10#3)
aroma##27##1##(2008-10#22)(2008-5#1)(2010-7#1)(2011-2#3)
aromas##4##1##(2008-10#2)(2010-4#1)(2011-2#1)
aromatase activity##4##2##(1993-8#2)(1994-2#2)
aromatase cytochrome P-450##2##3##(1994-2#1)(1995-8#1)
aromatase inhibitors##5##2##(1990-11#1)(1991-5#1)(1995-8#1)(1996-11#1)(2013-8#1)
aromatase mRNA##5##2##(1993-8#5)
aromatase##24##1##(1990-11#1)(1991-5#3)(1993-8#9)(1994-2#5)(1995-8#3)(1996-11#1)(2012-2#1)(2013-8#1)
aromatherapy massage in##2##3##(2008-10#2)
aromatherapy massage##8##2##(2008-10#8)
aromatherapy##10##1##(2008-10#10)
aromatic acids##2##2##(2008-10#2)
aromatic aldehydes##7##2##(1996-5#2)(2008-10#2)(2010-4#1)(2011-3#1)(2012-3#1)
aromatic amines##6##2##(1992-6#2)(1997-2#1)(2008-10#3)
aromatic amino acids##8##3##(2008-10#7)(2008-11#1)
aromatic and##2##2##(1992-6#1)(1996-5#1)
aromatic carboxylic acids##5##3##(2008-10#5)
aromatic cations##3##2##(2008-10#3)
aromatic compounds on##2##3##(2008-10#2)
aromatic compounds were##2##3##(2008-10#1)(2011-10#1)
aromatic compounds##20##2##(2008-10#16)(2008-11#1)(2008-3#1)(2011-1#1)(2011-10#1)
aromatic fraction##3##2##(2008-10#3)
aromatic hydrocarbon##7##2##(2008-10#5)(2011-1#2)
aromatic hydrocarbons (PAH) and##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
aromatic hydrocarbons (PAH) in the##2##5##(2008-10#2)
aromatic hydrocarbons (PAH) in##3##4##(2008-10#3)
aromatic hydrocarbons (PAH)##6##3##(1995-11#1)(2008-10#4)(2008-11#1)
aromatic hydrocarbons (PAHs) and##2##4##(2008-10#2)
aromatic hydrocarbons (PAHs) by##2##4##(2008-10#2)
aromatic hydrocarbons (PAHs) in##10##4##(2008-10#10)
aromatic hydrocarbons (PAHs)##27##3##(1994-3#1)(2008-10#25)(2010-5#1)
aromatic hydrocarbons and##7##3##(1995-11#1)(2008-10#4)(2008-11#1)(2010-7#1)
aromatic hydrocarbons in water samples##6##5##(2008-10#6)
aromatic hydrocarbons in water##7##4##(2008-10#7)
aromatic hydrocarbons in##14##3##(2008-10#14)
aromatic hydrocarbons##79##2##(1994-3#1)(1995-11#2)(2008-10#70)(2008-11#3)(2010-5#1)(2010-7#1)(2011-1#1)
aromatic index##2##2##(2008-10#2)
aromatic or aliphatic##2##3##(2008-4#1)(2012-3#1)
aromatic or##3##2##(2008-4#1)(2010-7#1)(2012-3#1)
aromatic residues##3##2##(1994-8#1)(2008-11#2)
aromatic ring system and##2##4##(1993-12#2)
aromatic ring system##3##3##(1993-12#3)
aromatic ring##6##2##(1993-12#3)(2008-10#1)(2010-4#1)(2013-1#1)
aromatic rings##2##2##(1993-3#1)(2008-10#1)
aromatic solvent-aqueous solution##2##3##(2008-10#2)
aromatic structures##2##2##(2008-10#2)
aromatic##195##1##(1990-11#1)(1990-12#1)(1992-6#3)(1993-12#3)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-8#2)(1996-5#5)(1997-2#2)(1997-3#1)(2008-10#140)(2008-11#9)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#4)(2011-10#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
aromatica##3##1##(2011-1#3)
aromaticity##4##1##(1996-5#1)(2008-10#3)
aromatics##3##1##(2008-10#2)(2008-11#1)
aromatisation##2##1##(2008-10#2)
aromatization##2##1##(1994-2#1)(1996-5#1)
arose as a##4##3##(1994-1#2)(1996-6#1)(2008-10#1)
arose as##6##2##(1994-1#2)(1994-2#1)(1996-6#1)(2008-10#1)(2011-1#1)
arose by single mutations within##2##5##(2008-10#2)
arose by##3##2##(1990-7#1)(2008-10#2)
arose from a##2##3##(2011-2#2)
arose from the##6##3##(1995-2#1)(2008-10#1)(2008-12#1)(2013-1#2)(2013-2#1)
arose from##13##2##(1995-2#1)(1997-3#1)(2008-10#2)(2008-12#2)(2008-7#2)(2011-2#2)(2013-1#2)(2013-2#1)
arose in the##2##3##(1997-1#1)(1997-2#1)
arose in##3##2##(1997-1#1)(1997-2#1)(2010-1#1)
arose on the##2##3##(2008-11#2)
arose through the##2##3##(2008-10#1)(2012-3#1)
arose through##4##2##(2008-10#2)(2010-8#1)(2012-3#1)
arose##35##1##(1990-7#1)(1994-1#2)(1994-2#1)(1994-5#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-7#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-2#1)
around +/-2%##3##2##(2008-10#3)
around -0##7##2##(2008-10#5)(2008-9#2)
around 0##9##2##(2008-10#7)(2008-11#1)(2012-2#1)
around 1##8##2##(2008-10#4)(2008-11#1)(2008-5#1)(2009-11#1)(2012-12#1)
around 10##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
around 10%##2##2##(2008-10#1)(2008-12#1)
around 100##2##2##(1996-11#1)(2008-10#1)
around 20##5##2##(1992-6#1)(2008-10#4)
around 200##3##2##(1995-2#1)(2008-10#2)
around 2000##2##2##(1990-3#1)(2010-1#1)
around 3%##3##2##(2008-10#3)
around 30%##2##2##(2008-6#1)(2013-8#1)
around 600##2##2##(1997-2#1)(2012-3#1)
around a##18##2##(1992-1#1)(1996-3#1)(1996-9#1)(2008-10#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)(2012-3#1)
around an##6##2##(2008-10#3)(2008-6#1)(2011-2#1)(2013-8#1)
around health##2##2##(2009-8#1)(2010-2#1)
around in##2##2##(2008-5#1)(2008-8#1)
around infection##2##2##(2008-10#2)
around pH##6##2##(2008-10#6)
around the cell periphery##2##4##(2012-2#2)
around the clock##2##3##(1991-12#1)(2008-9#1)
around the equilibrium##2##3##(2009-5#2)
around the foot and ankle##2##5##(2010-3#1)(2012-2#1)
around the globe##3##3##(1990-11#1)(2008-10#1)(2013-1#1)
around the infection##3##3##(2008-10#3)
around the lesion##2##3##(1996-9#1)(2008-10#1)
around the mouth##2##3##(2008-5#1)(2011-2#1)
around the periphery of the##2##5##(2008-10#1)(2008-9#1)
around the polypropylene and human hair##2##6##(2012-3#2)
around the solute##2##3##(2008-10#2)
around the time of##3##4##(1992-3#1)(1994-11#1)(2008-11#1)
around the world to##2##4##(1997-2#1)(2008-10#1)
around the world##17##3##(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
around the world)##2##3##(2011-3#2)
around the##136##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#3)(1995-2#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-7#2)(2007-12#1)(2007-9#1)(2008-10#34)(2008-11#11)(2008-12#2)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#8)(2011-3#2)(2012-2#6)(2012-3#3)(2013-1#9)(2013-8#2)
around their##2##2##(2008-11#1)(2008-7#1)
around these##2##2##(1994-11#1)(2008-10#1)
around this##2##2##(2010-12#1)(2012-12#1)
around three##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
around##369##1##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-5#3)(1994-8#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#2)(2007-12#4)(2007-9#1)(2008-10#130)(2008-11#26)(2008-12#12)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#8)(2008-8#9)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-9#1)(2011-2#11)(2011-3#2)(2012-12#2)(2012-2#11)(2012-3#9)(2013-1#14)(2013-8#9)
around-the-clock##3##1##(2008-11#2)(2013-1#1)
arousal and PLM indexes##2##4##(2012-3#2)
arousal phase##2##2##(2008-8#2)
arousal##9##1##(2008-11#4)(2008-7#1)(2008-8#2)(2012-3#2)
aroused##2##1##(2009-10#1)(2013-7#1)
arrange##3##1##(1990-12#1)(1992-6#1)(1996-11#1)
arranged around an##2##3##(2008-6#1)(2011-2#1)
arranged around##3##2##(2008-6#1)(2010-6#1)(2011-2#1)
arranged in a split-split-plot design##2##5##(2008-10#2)
arranged in a##13##3##(1991-6#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
arranged in parallel##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
arranged in##25##2##(1991-6#1)(1992-12#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
arranged to##2##2##(1997-2#1)(2008-10#1)
arranged##51##1##(1991-6#1)(1992-12#1)(1992-4#1)(1993-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-12#2)(2008-10#13)(2008-11#3)(2008-12#3)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#3)(2009-1#1)(2009-9#1)(2010-12#1)(2010-6#2)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
arrangement and the##2##3##(1996-3#1)(2009-7#1)
arrangement and##3##2##(1992-2#1)(1996-3#1)(2009-7#1)
arrangement between the##2##3##(1993-12#1)(2008-11#1)
arrangement in the##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
arrangement in##6##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
arrangement is##4##2##(1992-1#1)(2008-10#2)(2008-7#1)
arrangement of collagen fibrils##2##4##(2008-7#2)
arrangement of molecules##2##3##(1996-5#1)(2008-7#1)
arrangement of the##3##3##(1992-4#1)(2008-10#1)(2008-7#1)
arrangement of##26##2##(1990-4#1)(1990-5#2)(1990-8#1)(1992-4#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-8#1)
arrangement with a hospital##2##4##(1996-3#2)
arrangement with a##3##3##(1996-3#2)(2009-8#1)
arrangement with##7##2##(1996-3#2)(1996-8#1)(2008-10#2)(2008-3#1)(2009-8#1)
arrangement##70##1##(1990-4#1)(1990-5#2)(1990-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-7#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#8)(2009-7#1)(2009-8#2)(2013-1#1)
arrangements for##2##2##(2008-11#1)(2011-2#1)
arrangements of##5##2##(1990-11#1)(1991-10#1)(2008-4#1)(2009-6#1)(2011-2#1)
arrangements##30##1##(1990-11#1)(1991-10#2)(1991-12#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#2)
array (IDA)##2##2##(2008-10#2)
array (PDA) and##2##3##(2008-10#2)
array CGH##2##2##(2008-9#1)(2012-3#1)
array analysis##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
array and a##4##3##(2007-11#2)(2008-10#1)(2008-3#1)
array and##12##2##(2007-11#2)(2008-10#7)(2008-3#2)(2012-3#1)
array based##2##2##(2008-10#2)
array biosensor##2##2##(2008-10#2)
array comprising##2##2##(2008-10#1)(2010-10#1)
array design (OAD)##2##3##(2008-10#2)
array design##5##2##(2008-10#4)(2012-3#1)
array detection##15##2##(1997-2#1)(2008-10#14)
array detector (DAD)##4##3##(2008-10#4)
array detector##19##2##(2008-10#18)(2008-3#1)
array for the##2##3##(2008-10#1)(2008-9#1)
array for##6##2##(2008-10#2)(2008-9#2)(2009-9#1)(2011-2#1)
array has been##2##3##(2008-10#1)(2008-3#1)
array illuminator##4##2##(2008-3#4)
array is##2##2##(2008-10#1)(2008-3#1)
array of factors##2##3##(2008-4#1)(2012-2#1)
array of six##2##3##(2008-10#2)
array of##52##2##(1991-3#1)(1992-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(2008-10#18)(2008-11#3)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-9#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
array spectrophotometer##5##2##(2008-10#5)
array technologies##2##2##(2008-4#2)
array technology##3##2##(2008-10#1)(2008-4#1)(2010-10#1)
array to##4##2##(2008-10#1)(2012-2#1)(2012-3#2)
array was##7##2##(2008-10#3)(2008-9#3)(2011-2#1)
array with##4##2##(2008-10#2)(2008-2#1)(2012-3#1)
array##236##1##(1991-2#2)(1991-3#1)(1992-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-6#1)(2007-11#3)(2008-10#117)(2008-11#3)(2008-2#9)(2008-3#23)(2008-4#9)(2008-7#4)(2008-8#1)(2008-9#15)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-8#3)(2011-2#5)(2011-9#1)(2012-2#4)(2012-3#7)(2013-1#3)(2013-7#2)(2013-8#3)
array-based##4##1##(2008-10#2)(2008-11#1)(2008-3#1)
arrayed in##2##2##(2008-3#1)(2008-8#1)
arrayed on##2##2##(2008-9#2)
arrayed##8##1##(1993-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-12#1)
arrays and##2##2##(2008-7#1)(2011-2#1)
arrays are##2##2##(2008-10#1)(2008-3#1)
arrays containing##4##2##(2008-10#2)(2008-4#2)
arrays in the##2##3##(2008-11#1)(2012-3#1)
arrays in##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-3#1)
arrays of electrodes##2##3##(2008-10#2)
arrays of##12##2##(1992-9#1)(2008-10#7)(2008-2#1)(2008-9#1)(2010-5#1)(2011-2#1)
arrays to##2##2##(2011-2#1)(2012-2#1)
arrays were##2##2##(2008-10#2)
arrays with polymer-network liquid crystals##2##5##(2008-3#2)
arrays with##4##2##(2008-10#1)(2008-3#3)
arrays##77##1##(1992-9#1)(2007-12#1)(2008-10#27)(2008-11#3)(2008-2#1)(2008-3#9)(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#8)(2009-10#2)(2009-12#3)(2009-7#2)(2010-5#1)(2010-8#2)(2011-2#7)(2012-2#1)(2012-3#1)
arrest and apoptosis##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
arrest and##9##2##(1990-12#1)(1991-5#1)(1992-12#1)(1997-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
arrest at##5##2##(1990-9#1)(1997-7#3)(2008-11#1)
arrest before##2##2##(1997-1#1)(2008-10#1)
arrest cell growth##2##3##(1997-3#2)
arrest in##9##2##(1990-11#1)(1990-9#1)(1993-3#1)(1993-8#1)(1997-3#2)(1997-7#1)(2008-11#1)(2012-3#1)
arrest induced by##2##3##(2008-11#1)(2008-9#1)
arrest of##9##2##(1992-6#1)(1994-11#2)(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#2)
arrest or##4##2##(2006-6#1)(2008-7#1)(2011-2#2)
arrest phenotype##2##2##(1997-3#2)
arrest rates##2##2##(2010-7#1)(2013-8#1)
arrest the cell##2##3##(2008-9#2)
arrest the##4##2##(1996-12#1)(2008-11#1)(2008-9#2)
arrest were##2##2##(1997-7#1)(2008-7#1)
arrest##100##1##(1990-11#1)(1990-12#3)(1990-9#2)(1991-3#2)(1991-5#1)(1992-12#3)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-6#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#7)(1997-7#7)(2006-6#1)(2008-10#3)(2008-11#14)(2008-7#4)(2008-8#1)(2008-9#6)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#3)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
arrested and##2##2##(1995-12#1)(2011-2#1)
arrested at##2##2##(1993-3#1)(2008-10#1)
arrested in the##4##3##(1993-3#1)(2008-10#1)(2008-11#2)
arrested in##5##2##(1993-3#1)(2008-10#1)(2008-11#2)(2008-8#1)
arrested with##2##2##(1995-2#1)(2008-11#1)
arrested##20##1##(1990-12#1)(1991-2#1)(1992-3#1)(1993-3#2)(1993-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#1)(2011-2#2)
arresting##2##1##(1991-3#1)(2010-6#1)
arrests##3##1##(2008-10#1)(2008-5#1)(2009-7#1)
arrhenomanes and P##2##3##(2008-10#2)
arrhenomanes##7##1##(2008-10#7)
arrhenotokous##3##1##(2008-10#3)
arrhizus lipase##2##2##(2008-7#2)
arrhizus##3##1##(2008-7#3)
arrhythmia and##2##2##(2007-8#1)(2012-3#1)
arrhythmia##15##1##(1990-9#2)(1991-6#1)(1996-8#1)(2007-8#1)(2008-7#2)(2010-12#1)(2010-8#2)(2011-2#3)(2012-3#1)(2013-1#1)
arrhythmias and##2##2##(2008-12#1)(2013-1#1)
arrhythmias in##4##2##(1992-3#2)(1992-6#1)(2013-8#1)
arrhythmias##26##1##(1990-6#1)(1990-9#5)(1991-11#1)(1992-3#2)(1992-6#1)(1996-3#1)(2008-12#1)(2009-10#3)(2010-12#1)(2010-6#2)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
arrhythmogenic right ventricular dysplasia##6##4##(1996-3#3)(2008-12#1)(2012-2#1)(2012-3#1)
arrhythmogenic##8##1##(1996-3#3)(2008-12#2)(2012-2#2)(2012-3#1)
arrival at the##2##3##(2009-4#1)(2011-1#1)
arrival at##3##2##(2009-4#1)(2009-8#1)(2011-1#1)
arrival in the##2##3##(2010-7#1)(2012-2#1)
arrival in##3##2##(2008-5#1)(2010-7#1)(2012-2#1)
arrival##13##1##(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
arrivals##4##1##(2010-8#4)
arrive at##7##2##(1995-1#1)(1995-3#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
arrive##9##1##(1995-1#1)(1995-3#1)(1997-7#1)(2008-12#1)(2008-8#2)(2010-12#1)(2011-2#1)(2013-1#1)
arrived at by##2##3##(1992-2#1)(2008-11#1)
arrived at##8##2##(1990-3#1)(1991-3#1)(1992-2#1)(1993-8#1)(2008-10#3)(2008-11#1)
arrived##12##1##(1990-3#1)(1991-3#1)(1992-2#1)(1993-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-1#2)
arriving##2##1##(2008-11#1)(2009-8#1)
arrow##2##1##(1996-1#1)(2008-6#1)
arrows in line drawings##2##4##(2008-6#2)
arsenal of##3##2##(2008-10#2)(2008-11#1)
arsenal##4##1##(2008-10#3)(2008-11#1)
arsenate (As(V))##3##2##(2008-10#3)
arsenate [As(V)]##2##2##(2008-10#2)
arsenate and##4##2##(2008-10#3)(2008-11#1)
arsenate determination##2##2##(2008-10#2)
arsenate is##3##2##(2008-10#3)
arsenate##32##1##(2008-10#30)(2008-11#1)(2008-3#1)
arsenazo III##3##2##(2008-10#3)
arsenazo##4##1##(2008-10#4)
arsenazo(III)##3##1##(2008-10#3)
arsenazo-DBC-Al(3+) in the##2##3##(2008-10#2)
arsenazo-DBC-Al(3+)##3##1##(2008-10#3)
arsenic (As)##5##2##(2008-10#4)(2013-1#1)
arsenic (the##2##2##(2008-10#2)
arsenic acid##5##2##(2008-10#5)
arsenic and antimony in##3##4##(2008-10#3)
arsenic and antimony##4##3##(2008-10#4)
arsenic and selenium species##4##4##(2008-10#4)
arsenic and selenium##11##3##(2008-10#11)
arsenic and##23##2##(1995-11#1)(2008-10#21)(2010-11#1)
arsenic as##2##2##(1995-11#1)(2008-10#1)
arsenic at##4##2##(2008-10#4)
arsenic based on##2##3##(2008-10#2)
arsenic by##7##2##(2008-10#7)
arsenic compound##2##2##(2008-10#2)
arsenic compounds in##6##3##(2008-10#6)
arsenic compounds present in##2##4##(2008-10#2)
arsenic compounds##21##2##(2008-10#19)(2008-11#2)
arsenic concentration##3##2##(2008-10#3)
arsenic concentrations in the##2##4##(2008-10#1)(2009-7#1)
arsenic concentrations##4##2##(2008-10#3)(2009-7#1)
arsenic contaminated##2##2##(2008-10#2)
arsenic content in##2##3##(2008-10#2)
arsenic content##6##2##(2008-10#6)
arsenic determination in##4##3##(2008-10#4)
arsenic determination##11##2##(2008-10#11)
arsenic in ambient##2##3##(2008-10#2)
arsenic in groundwater##3##3##(2008-10#3)
arsenic in samples of##2##4##(2008-10#2)
arsenic in the##3##3##(1995-11#1)(2008-10#2)
arsenic in these##2##3##(2008-10#2)
arsenic in water samples##2##4##(2008-10#2)
arsenic in water##5##3##(2008-10#5)
arsenic in##54##2##(1995-11#2)(2008-10#52)
arsenic is determined##2##3##(2008-10#2)
arsenic is##6##2##(2008-10#6)
arsenic metabolites by C57 BL/6J mice##2##6##(1995-11#2)
arsenic metabolites in the##2##4##(2008-10#2)
arsenic metabolites##8##2##(1995-11#6)(2008-10#2)
arsenic solution##2##2##(2008-10#2)
arsenic speciation in fish##2##4##(2008-10#2)
arsenic speciation in##9##3##(2008-10#9)
arsenic speciation pattern##3##3##(2008-10#3)
arsenic speciation##16##2##(2008-10#16)
arsenic species from##2##3##(2008-10#2)
arsenic species in the extracts##2##5##(2008-10#2)
arsenic species in the##3##4##(2008-10#3)
arsenic species in##17##3##(2008-10#17)
arsenic species present##2##3##(2008-10#2)
arsenic species using##3##3##(2008-10#3)
arsenic species was##4##3##(2008-10#4)
arsenic species##56##2##(2008-10#56)
arsenic trioxide##3##2##(2008-10#1)(2008-8#2)
arsenic using##5##2##(2008-10#5)
arsenic via##2##2##(2008-10#2)
arsenic was determined##2##3##(2008-10#2)
arsenic was##7##2##(2008-10#7)
arsenic were##4##2##(1995-11#1)(2008-10#3)
arsenic##356##1##(1995-11#15)(2008-10#329)(2008-11#3)(2008-8#2)(2009-7#1)(2010-1#2)(2010-11#1)(2013-1#3)
arsenic(III##3##1##(2008-10#3)
arsenic(III) and##5##2##(2008-10#5)
arsenic(V) in##4##2##(2008-10#4)
arsenic(V)##9##1##(2008-10#9)
arsenic)##5##1##(2008-10#5)
arsenic-contaminated##2##1##(2008-10#2)
arsenical in##2##2##(2008-10#2)
arsenical##3##1##(2008-10#3)
arsenicals in##2##2##(2008-10#2)
arsenicals##3##1##(2008-10#3)
arsenics##3##1##(2008-10#3)
arsenite (As(III))##3##2##(2008-10#3)
arsenite [As(III)]##2##2##(2008-10#2)
arsenite and##3##2##(2008-10#3)
arsenite oxidation##2##2##(2008-10#2)
arsenite##27##1##(1994-11#4)(1995-11#1)(2008-10#21)(2008-11#1)
arsenite-exposed##2##1##(1994-11#2)
arsenobetaine (AB)##2##2##(2008-10#2)
arsenobetaine (AsB) and arsenocholine (AsC)##2##5##(2008-10#2)
arsenobetaine (AsB)##7##2##(2008-10#7)
arsenobetaine was##2##2##(2008-10#2)
arsenobetaine##16##1##(2008-10#16)
arsenocholine (AsC)##3##2##(2008-10#3)
arsenocholine##5##1##(2008-10#5)
arsenosugars##6##1##(2008-10#6)
arsenous acid##2##2##(2008-10#2)
arsine generation##2##2##(2008-10#2)
arsine##9##1##(1995-11#1)(2008-10#8)
arsines##4##1##(2008-10#4)
art and##7##2##(1993-2#2)(1993-3#1)(2008-11#3)(2010-11#1)
art are##2##2##(2010-7#1)(2011-2#1)
art for##2##2##(1995-2#1)(2008-12#1)
art of medicine##2##3##(1993-11#1)(2012-12#1)
art of##10##2##(1993-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
art therapy##2##2##(1993-2#1)(1995-2#1)
art##62##1##(1990-11#1)(1993-11#1)(1993-2#3)(1993-3#3)(1994-8#1)(1995-2#2)(1997-1#1)(2008-10#18)(2008-11#7)(2008-12#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
artefacts##2##1##(2008-10#2)
artemether##4##1##(1994-8#4)
arteria lusoria##4##2##(2008-11#4)
arteria##6##1##(2008-11#4)(2008-3#1)(2011-3#1)
arterial administration of##2##3##(1997-8#1)(2013-1#1)
arterial adventitia##2##2##(1997-8#1)(2008-11#1)
arterial and portal venous embolization##2##5##(1997-8#2)
arterial and venous##6##3##(1997-6#1)(2008-12#1)(2009-7#1)(2010-12#1)(2013-1#2)
arterial and##12##2##(1990-11#1)(1994-3#1)(1997-6#1)(1997-8#3)(2008-12#1)(2009-7#1)(2010-12#1)(2013-1#3)
arterial autograft model##2##3##(2006-6#2)
arterial autograft##3##2##(2006-6#3)
arterial autografts and##2##3##(2006-6#2)
arterial blood pressure##14##3##(1991-6#1)(1993-1#1)(1997-8#1)(2007-8#2)(2008-5#1)(2009-5#1)(2011-2#2)(2012-3#3)(2013-8#2)
arterial blood##18##2##(1991-6#1)(1993-1#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-8#2)
arterial disease##7##2##(1992-11#1)(1995-2#1)(1996-8#1)(2008-8#2)(2012-2#2)
arterial duct##2##2##(2012-12#2)
arterial elasticity##5##2##(2013-8#5)
arterial hyper-enhancement##2##2##(2010-12#2)
arterial hypertension (PAH)##6##3##(2009-10#1)(2010-10#5)
arterial hypertension and##3##3##(1991-8#1)(2008-10#1)(2011-2#1)
arterial hypertension in##4##3##(2010-10#2)(2011-2#2)
arterial hypertension is##2##3##(2008-11#1)(2010-10#1)
arterial hypertension or##2##3##(2008-3#1)(2010-10#1)
arterial hypertension##33##2##(1991-8#1)(1993-9#1)(1996-3#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#2)(2009-10#1)(2010-10#12)(2011-2#6)(2011-3#2)(2012-3#1)
arterial hypertension]##4##2##(1992-6#1)(1993-11#1)(1993-2#1)(1997-4#1)
arterial inflow##2##2##(2008-9#2)
arterial lesion##2##2##(1997-8#1)(2006-6#1)
arterial line##2##2##(1990-11#2)
arterial lines were##2##3##(1990-11#2)
arterial lines##3##2##(1990-11#3)
arterial occlusion (n =##2##4##(1997-8#2)
arterial occlusion##7##2##(1997-8#4)(2011-2#1)(2013-8#2)
arterial or venous##2##3##(1997-6#1)(2008-7#1)
arterial oxygen tension (PaO2)##2##4##(1997-3#1)(2011-2#1)
arterial oxygen##4##2##(1993-1#1)(1996-3#1)(1997-3#1)(2011-2#1)
arterial perfusion##2##2##(1997-1#1)(2012-2#1)
arterial pressure (MAP)##2##3##(2009-8#1)(2011-2#1)
arterial pressure##10##2##(1991-11#1)(1991-6#1)(1994-3#1)(1996-3#1)(2008-11#1)(2009-1#2)(2009-8#1)(2011-2#2)
arterial smooth muscle##3##3##(1994-11#1)(1995-8#1)(1997-4#1)
arterial smooth##4##2##(1994-11#1)(1995-8#1)(1997-4#2)
arterial stiffness##7##2##(2009-7#1)(2010-7#1)(2013-7#4)(2013-8#1)
arterial system##6##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2013-2#1)
arterial thrombosis##4##2##(1990-9#1)(2006-6#1)(2011-2#2)
arterial vessels##2##2##(2008-8#1)(2011-2#1)
arterial wall##10##2##(2006-6#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-1#1)(2009-7#1)(2011-2#2)(2013-1#1)
arterial##214##1##(1990-11#6)(1990-5#3)(1990-9#1)(1991-11#2)(1991-3#1)(1991-6#3)(1991-8#1)(1992-11#1)(1992-6#1)(1993-1#3)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-2#2)(1995-8#4)(1996-3#6)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-6#3)(1997-8#14)(2006-6#9)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#6)(2009-1#3)(2009-10#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-10#12)(2010-12#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#25)(2011-3#4)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#11)(2013-2#1)(2013-7#4)(2013-8#12)
arteries and the##3##3##(2008-7#2)(2013-7#1)
arteries and veins##2##3##(1996-8#1)(2010-4#1)
arteries and##18##2##(1991-6#1)(1994-11#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-7#4)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
arteries from cyclosporine-treated rats##2##4##(1992-3#2)
arteries from##5##2##(1992-3#3)(1993-8#1)(2009-1#1)
arteries in the##4##3##(2008-11#1)(2011-3#1)(2012-3#2)
arteries in##8##2##(1993-8#1)(1994-5#1)(2008-11#1)(2011-3#1)(2012-3#4)
arteries is##2##2##(1997-8#1)(2011-2#1)
arteries of the lower##2##4##(1997-8#1)(2012-2#1)
arteries of the##3##3##(1997-8#1)(2008-7#1)(2012-2#1)
arteries of##4##2##(1992-3#1)(1997-8#1)(2008-7#1)(2012-2#1)
arteries to##2##2##(1991-12#1)(1997-4#1)
arteries was##2##2##(1997-8#1)(2011-2#1)
arteries were##11##2##(1993-8#1)(1994-11#1)(1996-6#2)(1996-9#1)(1997-8#1)(2008-7#1)(2011-2#2)(2012-3#2)
arteries with##3##2##(1994-11#2)(2009-10#1)
arteries##114##1##(1990-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#4)(1992-6#1)(1992-9#2)(1993-8#3)(1994-11#4)(1994-5#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-8#9)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#7)(2008-7#13)(2009-1#1)(2009-10#1)(2009-8#5)(2010-10#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#12)(2011-3#1)(2012-2#3)(2012-3#9)(2013-1#1)(2013-7#1)(2013-8#1)
arteriography##4##1##(1990-3#1)(1996-6#1)(2007-9#1)(2012-2#1)
arterioles##5##1##(1997-1#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
arteriosclerosis##2##1##(1997-8#1)(2008-5#1)
arteriosclerotic##8##1##(1991-3#1)(1993-11#1)(1994-11#5)(1997-3#1)
arteriovenous fistula in##2##3##(1993-6#1)(2008-11#1)
arteriovenous fistula##10##2##(1991-6#1)(1993-6#1)(1996-9#3)(2008-1#2)(2008-11#1)(2008-7#2)
arteriovenous fistulae (AVF)##3##3##(1996-9#2)(2008-7#1)
arteriovenous fistulae##12##2##(1991-6#1)(1996-9#7)(2008-11#1)(2008-7#3)
arteriovenous fistulas##6##2##(1996-3#2)(2008-7#4)
arteriovenous malformation (AVM)##6##3##(2008-7#5)(2013-1#1)
arteriovenous malformation in##2##3##(2008-7#1)(2010-10#1)
arteriovenous malformation##23##2##(2008-7#20)(2010-10#1)(2013-1#2)
arteriovenous malformations (AVM)##2##3##(1996-6#1)(2008-7#1)
arteriovenous malformations (AVMs) were evaluated##2##5##(2008-7#2)
arteriovenous malformations (AVMs) were##4##4##(2008-7#4)
arteriovenous malformations (AVMs)##13##3##(1997-3#1)(2008-7#11)(2012-3#1)
arteriovenous malformations in the##2##4##(2008-7#2)
arteriovenous malformations of the##4##4##(2008-7#4)
arteriovenous malformations with##3##3##(2008-7#3)
arteriovenous malformations##38##2##(1991-2#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-6#2)(2008-7#29)(2012-3#1)
arteriovenous shunt##2##2##(1996-9#2)
arteriovenous shunts##7##2##(1995-11#1)(1996-3#1)(1996-9#4)(2008-7#1)
arteriovenous##107##1##(1991-11#1)(1991-2#2)(1991-6#2)(1993-6#1)(1995-11#2)(1996-3#5)(1996-6#2)(1996-9#16)(1997-3#3)(1997-6#3)(2008-1#2)(2008-11#3)(2008-7#59)(2010-10#1)(2011-3#1)(2012-3#2)(2013-1#2)
arteritis and##6##2##(1997-8#6)
arteritis in Mexico##2##3##(1997-8#2)
arteritis in##12##2##(1997-8#12)
arteritis is##4##2##(1994-9#1)(1997-8#3)
arteritis##68##1##(1994-9#4)(1997-8#64)
artery Doppler velocimetry##2##3##(1994-3#2)
artery after##2##2##(2010-7#1)(2012-12#1)
artery and the##4##3##(2008-8#1)(2011-2#2)(2013-2#1)
artery and##14##2##(1996-9#1)(1997-6#2)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-2#4)(2013-2#1)(2013-8#1)
artery aneurysm##15##2##(1991-6#1)(1992-5#1)(1996-3#2)(1997-6#1)(2008-7#3)(2010-5#2)(2011-2#4)(2013-1#1)
artery aneurysms##7##2##(2008-11#1)(2010-5#1)(2011-2#4)(2013-8#1)
artery are##2##2##(1991-6#1)(2008-7#1)
artery arises##2##2##(2008-11#1)(2011-2#1)
artery associated with##2##3##(1991-6#1)(2008-7#1)
artery at the##2##3##(1996-9#1)(1997-6#1)
artery by a##2##3##(2008-3#1)(2008-7#1)
artery by##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
artery bypass graft surgery##4##4##(1995-2#1)(2008-11#1)(2012-12#1)(2013-8#1)
artery bypass graft##8##3##(1992-11#1)(1994-12#1)(1995-2#1)(2008-11#2)(2008-12#1)(2012-12#1)(2013-8#1)
artery bypass surgery##7##3##(1990-2#1)(1990-6#1)(2006-6#1)(2008-11#3)(2012-12#1)
artery bypass##28##2##(1990-2#2)(1990-6#1)(1992-11#1)(1993-12#1)(1994-12#1)(1995-2#1)(2006-6#1)(2008-11#6)(2008-12#2)(2011-2#4)(2012-12#2)(2012-3#4)(2013-1#1)(2013-8#1)
artery disease and##2##3##(1990-3#1)(2008-7#1)
artery disease at##2##3##(2008-7#1)(2011-2#1)
artery disease was##2##3##(1990-3#1)(1996-6#1)
artery disease##44##2##(1990-3#2)(1992-9#1)(1993-2#1)(1995-3#1)(1996-6#1)(1997-8#2)(2008-10#1)(2008-11#10)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#2)(2009-12#1)(2010-2#4)(2010-9#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
artery dissection is a##2##4##(2008-7#1)(2010-10#1)
artery dissection is##4##3##(1991-8#1)(2008-7#1)(2010-10#1)(2011-2#1)
artery dissection##15##2##(1991-8#2)(2008-7#5)(2010-10#3)(2011-2#3)(2013-1#2)
artery distal to the occlusion##2##5##(1993-3#1)(1997-6#1)
artery elasticity##3##2##(2008-10#1)(2013-8#2)
artery embolization##2##2##(2012-3#2)
artery following##2##2##(2008-12#1)(2008-7#1)
artery from the##3##3##(2008-12#1)(2011-2#1)(2013-8#1)
artery from##4##2##(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
artery function##2##2##(2009-1#1)(2009-5#1)
artery in a##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
artery in##8##2##(2008-11#1)(2008-7#3)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
artery involvement##2##2##(1997-8#2)
artery is a##2##3##(2011-2#1)(2013-1#1)
artery is##10##2##(1991-3#1)(1993-3#2)(1997-8#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
artery lesion##3##2##(1997-8#3)
artery lesions##2##2##(1997-8#1)(2008-11#1)
artery ligation##3##2##(1994-1#3)
artery obstruction##2##2##(2008-7#1)(2011-2#1)
artery occlusion and##5##3##(1992-6#1)(2011-2#3)(2013-1#1)
artery occlusion##13##2##(1992-6#1)(1996-12#1)(1997-2#1)(1997-8#2)(2008-7#1)(2011-2#5)(2013-1#1)(2013-7#1)
artery of##2##2##(1996-6#1)(2008-3#1)
artery or##3##2##(1997-1#1)(2008-11#1)(2011-3#1)
artery pseudoaneurysm##5##2##(2008-12#1)(2008-7#1)(2012-2#3)
artery reconstruction with a##2##4##(2008-7#2)
artery reconstruction##3##2##(2008-7#3)
artery smooth muscle cells##3##4##(1990-8#1)(1995-2#1)(2011-3#1)
artery smooth muscle##4##3##(1990-8#1)(1995-2#1)(2010-12#1)(2011-3#1)
artery spasm and##3##3##(2008-7#2)(2011-2#1)
artery spasm##10##2##(2008-7#4)(2011-2#6)
artery stenosis in##2##3##(2008-11#1)(2009-10#1)
artery stenosis##24##2##(1997-8#3)(2008-11#2)(2008-12#6)(2008-7#2)(2009-10#1)(2011-2#4)(2012-3#3)(2013-1#3)
artery stenting##6##2##(2008-11#2)(2009-10#1)(2010-12#1)(2013-1#2)
artery testing##2##2##(2008-12#2)
artery to##3##2##(2008-7#1)(2009-1#1)(2011-2#1)
artery using##2##2##(2008-7#1)(2012-12#1)
artery was##10##2##(1996-3#1)(1997-1#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
artery were##4##2##(1995-11#1)(2008-7#2)(2012-3#1)
artery with##4##2##(1997-6#1)(2008-7#2)(2008-9#1)
artery##508##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-3#5)(1991-5#1)(1991-6#6)(1991-8#3)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#7)(1993-6#2)(1993-8#2)(1994-1#4)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#3)(1995-11#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#6)(1996-6#3)(1996-9#6)(1997-1#3)(1997-2#1)(1997-3#6)(1997-5#2)(1997-6#10)(1997-8#21)(2006-6#3)(2008-1#1)(2008-10#3)(2008-11#49)(2008-12#34)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#69)(2008-8#4)(2008-9#9)(2009-1#3)(2009-10#4)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#9)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#6)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#72)(2011-3#3)(2012-12#6)(2012-2#12)(2012-3#22)(2013-1#28)(2013-2#4)(2013-7#2)(2013-8#23)
artery)##2##1##(2011-2#2)
artery]##4##1##(1991-3#1)(1991-6#1)(1991-8#1)(2013-8#1)
arthritic##4##1##(2008-11#2)(2010-5#1)(2013-1#1)
arthritis (RA)##9##2##(2007-8#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
arthritis a##3##2##(1993-11#1)(2013-1#2)
arthritis and degenerative##3##3##(2011-2#1)(2013-1#2)
arthritis and osteomyelitis##2##3##(2013-8#2)
arthritis and##15##2##(1990-3#1)(1992-5#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
arthritis are##2##2##(2008-5#1)(2008-7#1)
arthritis in a##2##3##(2011-2#1)(2012-3#1)
arthritis is##2##2##(2007-11#1)(2012-3#1)
arthritis patients##4##2##(2008-5#1)(2008-8#1)(2013-8#2)
arthritis should be##2##3##(2008-8#1)(2013-8#1)
arthritis##117##1##(1990-2#1)(1990-3#1)(1991-11#1)(1991-3#1)(1991-8#3)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#6)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#9)(2008-7#1)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-7#1)(2010-1#2)(2010-11#3)(2010-12#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#14)(2013-1#10)(2013-8#12)
arthrodesis from the##2##3##(2008-8#1)(2012-3#1)
arthrodesis from##3##2##(2008-8#2)(2012-3#1)
arthrodesis of the##3##3##(2008-8#1)(2010-5#1)(2012-3#1)
arthrodesis was##3##2##(2008-12#1)(2009-7#1)(2013-8#1)
arthrodesis with##6##2##(2011-2#4)(2012-3#1)(2013-1#1)
arthrodesis##32##1##(2008-12#5)(2008-8#7)(2009-7#1)(2010-5#4)(2011-2#5)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#1)
arthrogryposis multiplex congenita]##2##3##(2008-10#1)(2009-5#1)
arthrogryposis##4##1##(2008-10#3)(2009-5#1)
arthroplasties##2##1##(1996-9#1)(2008-11#1)
arthroplasty for##2##2##(2008-9#1)(2010-11#1)
arthroplasty in##3##2##(2012-2#2)(2013-1#1)
arthroplasty of the##2##3##(2008-9#1)(2013-1#1)
arthroplasty of##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
arthroplasty with##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
arthroplasty##66##1##(1994-3#3)(1997-6#1)(2008-8#5)(2008-9#8)(2009-3#7)(2009-4#1)(2010-11#4)(2010-5#1)(2011-2#5)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#14)
arthropod gap and##2##3##(2008-7#2)
arthropod pests##2##2##(2008-10#1)(2010-10#1)
arthropod##12##1##(2007-12#4)(2008-10#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
arthropod-dominated##2##1##(2008-8#2)
arthropods##8##1##(1997-7#1)(2007-12#4)(2008-7#1)(2008-9#2)
arthroscopic ankle##2##2##(2008-12#1)(2009-1#1)
arthroscopic reconstruction of the##2##4##(2013-1#2)
arthroscopic reconstruction of##3##3##(2013-1#3)
arthroscopic##13##1##(2008-12#1)(2008-8#2)(2008-9#1)(2009-1#1)(2011-2#2)(2013-1#6)
arthroscopical##2##1##(1993-11#1)(2013-1#1)
arthroscopically##2##1##(2008-11#1)(2008-9#1)
arthroscopy##17##1##(2008-9#5)(2009-1#4)(2010-7#2)(2011-2#1)(2012-3#2)(2013-1#3)
arthrosis##10##1##(1991-3#1)(1996-6#1)(1997-6#2)(2008-12#2)(2008-7#1)(2011-2#3)
arthrosporioides##3##1##(2008-10#3)
artichoke isolates##2##2##(2008-10#2)
artichoke##11##1##(2008-10#11)
article (Capps##2##2##(2008-12#2)
article about##2##2##(2010-9#1)(2012-3#1)
article addresses the##3##3##(1994-3#1)(2008-11#1)(2008-9#1)
article addresses##7##2##(1991-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-11#2)(2008-9#1)
article also##9##2##(1991-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)(2013-8#1)
article are##6##2##(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)(2010-11#1)(2013-1#1)
article concludes with##6##3##(1996-6#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-4#1)
article concludes##11##2##(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)
article considers the##4##3##(1991-6#1)(2008-10#1)(2013-1#2)
article considers##9##2##(1991-6#1)(1995-1#1)(2008-10#1)(2008-11#2)(2010-12#1)(2013-1#3)
article contains a##2##3##(1993-6#1)(2008-10#1)
article contains##6##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-6#1)(1997-3#1)(2008-10#1)
article deals with##2##3##(2008-8#1)(2009-7#1)
article describes a##11##3##(1991-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1997-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
article describes an innovative##2##4##(2008-11#1)(2008-12#1)
article describes an##7##3##(1990-11#1)(1992-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
article describes our##2##3##(1990-11#1)(2008-10#1)
article describes the recent##2##4##(2008-11#2)
article describes the use of##2##5##(1997-2#1)(2008-5#1)
article describes the##46##3##(1990-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
article describes##96##2##(1990-11#3)(1991-1#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-11#1)(1993-3#3)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-11#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#6)(2008-10#12)(2008-11#10)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
article discusses the##28##3##(1990-11#1)(1991-12#3)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#3)(1994-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-1#4)
article discusses various##2##3##(1994-6#1)(2011-2#1)
article discusses##51##2##(1990-11#1)(1991-1#1)(1991-12#3)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#4)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
article employs##2##2##(1996-3#1)(2008-10#1)
article evaluates##3##2##(1996-2#1)(2007-12#1)(2012-2#1)
article examines a##2##3##(1992-2#1)(2012-2#1)
article examines the##19##3##(1991-1#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#3)(2008-10#1)(2008-11#3)(2011-2#3)(2013-1#1)
article examines##42##2##(1991-1#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#3)(1996-1#1)(1996-2#2)(1996-3#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#1)(2011-2#4)(2012-2#1)(2013-1#2)
article explains##6##2##(1991-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(2008-10#1)(2008-2#1)
article explores the##9##3##(1993-3#1)(1996-12#1)(1997-1#1)(2008-11#2)(2011-1#1)(2011-2#2)(2012-2#1)
article explores##20##2##(1993-3#1)(1995-1#1)(1995-12#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#3)(2008-11#2)(2008-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
article focuses on the##12##4##(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-12#1)(2010-7#1)
article focuses on##18##3##(1991-1#1)(1991-2#2)(1991-6#1)(1992-12#2)(1992-2#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)
article focuses##19##2##(1991-1#1)(1991-2#2)(1991-6#1)(1992-12#2)(1992-2#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
article for the##2##3##(2009-4#1)(2010-7#1)
article has##19##2##(1994-2#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#10)(2012-3#1)
article highlights the##4##3##(1992-12#1)(2008-11#2)(2013-1#1)
article highlights##9##2##(1992-12#1)(2008-10#1)(2008-11#3)(2010-4#1)(2012-3#1)(2013-1#2)
article in##2##2##(2010-7#1)(2012-2#1)
article includes a##2##3##(1991-11#1)(2008-12#1)
article includes an##2##3##(1991-6#1)(1994-1#1)
article includes##7##2##(1991-1#1)(1991-11#1)(1991-6#1)(1992-12#1)(1994-1#1)(2008-12#2)
article introduces the##2##3##(1991-2#1)(2012-3#1)
article introduces##4##2##(1991-2#1)(2009-5#1)(2012-3#1)(2013-1#1)
article is a##6##3##(1992-2#1)(1993-12#1)(2007-9#1)(2010-9#1)(2012-2#2)
article is an overview of##2##5##(1992-1#1)(1997-3#1)
article is an##10##3##(1992-1#1)(1997-3#1)(2008-11#5)(2012-2#2)(2012-3#1)
article is intended as##2##4##(1991-2#1)(1994-6#1)
article is intended##3##3##(1991-2#1)(1994-6#1)(2008-11#1)
article is the##2##3##(1993-12#1)(2008-11#1)
article is to provide a##5##5##(1997-3#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
article is to provide the##2##5##(2009-5#1)(2010-9#1)
article is to provide##9##4##(1997-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
article is to##43##3##(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#2)
article is##73##2##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#3)(1994-1#2)(1994-3#1)(1994-6#1)(1995-12#1)(1996-2#3)(1997-3#2)(1997-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#9)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#9)(2012-3#3)(2013-1#5)(2013-8#2)
article lays##2##2##(1995-12#1)(1997-3#1)
article on the##2##3##(1994-1#1)(2008-9#1)
article on##17##2##(1990-12#1)(1991-1#1)(1994-1#1)(2008-11#3)(2008-7#5)(2008-9#1)(2009-5#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
article outlines##11##2##(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-2#2)(2008-11#2)
article presents a brief##2##4##(1990-12#1)(1991-9#1)
article presents a##24##3##(1990-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-1#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-7#1)(2012-2#1)(2013-1#5)
article presents an overview of##3##5##(2008-5#2)(2013-8#1)
article presents an##5##3##(1993-6#1)(2008-5#2)(2008-9#1)(2013-8#1)
article presents the##8##3##(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#2)(2013-8#1)
article presents##55##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#2)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#4)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-7#1)(2012-2#1)(2013-1#5)(2013-8#2)
article proposes##3##2##(1997-2#1)(2008-11#1)(2012-3#1)
article provides a brief overview of the##2##7##(2010-12#1)(2010-7#1)
article provides a brief##3##4##(2009-5#1)(2010-12#1)(2010-7#1)
article provides a##13##3##(1994-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-5#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
article provides information##2##3##(1991-6#1)(2010-7#1)
article provides##38##2##(1991-12#1)(1991-6#1)(1993-3#3)(1994-1#2)(1994-12#2)(1994-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
article reports on a##2##4##(1993-3#1)(2008-7#1)
article reports on##8##3##(1993-3#1)(1994-2#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-7#1)
article reports the results of a study##2##7##(1992-1#1)(1996-1#1)
article reports the results of a##4##6##(1992-1#1)(1992-3#1)(1996-1#1)(1996-12#1)
article reports the##5##3##(1992-1#1)(1992-3#1)(1995-1#1)(1996-1#1)(1996-12#1)
article reports##19##2##(1992-1#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2011-2#1)
article reviews existing literature and##2##5##(1996-2#1)(2008-11#1)
article reviews research on##2##4##(1995-2#1)(2012-3#1)
article reviews some of the##3##5##(2008-10#1)(2008-7#1)(2008-9#1)
article reviews the current##5##4##(1997-4#1)(2008-11#1)(2010-11#1)(2010-12#1)(2011-7#1)
article reviews the factors##2##4##(2008-1#1)(2008-4#1)
article reviews the##48##3##(1992-2#1)(1993-12#1)(1994-2#2)(1996-2#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-12#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#4)(2011-7#1)(2012-2#2)(2013-1#5)(2013-8#3)
article reviews##77##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-12#3)(1994-2#3)(1994-9#1)(1995-2#1)(1996-2#3)(1996-3#1)(1997-2#2)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#10)(2008-12#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#4)(2011-7#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#5)
article selection##2##2##(1991-12#1)(2010-2#1)
article sets out##3##3##(2010-11#1)(2012-12#1)(2013-8#1)
article shows##2##2##(1994-1#1)(2013-8#1)
article stresses##2##2##(1995-12#1)(2011-2#1)
article suggests##2##2##(1996-2#1)(2013-1#1)
article summarizes##12##2##(1990-11#1)(1992-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-3#1)(1997-1#2)(2008-10#1)(2008-6#1)(2009-5#1)(2012-2#1)
article takes a##3##3##(1991-1#1)(2008-8#1)(2013-8#1)
article takes##6##2##(1991-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2013-8#1)
article that##8##2##(2008-11#7)(2012-3#1)
article there##2##2##(2012-3#1)(2013-1#1)
article was to##4##3##(2010-11#1)(2011-7#1)(2012-2#1)(2013-1#1)
article was##12##2##(1991-2#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
article we##18##2##(1990-9#1)(1992-12#2)(1994-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
article were##2##2##(2010-9#1)(2013-1#1)
article will focus on the##2##5##(1995-12#1)(1997-8#1)
article will provide##2##3##(2010-4#1)(2011-2#1)
article will review##5##3##(1994-3#1)(1995-2#1)(1996-1#1)(1997-1#1)(2008-7#1)
article will##25##2##(1991-12#1)(1993-1#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
article##1108##1##(1990-11#7)(1990-12#2)(1990-3#1)(1990-9#1)(1991-1#17)(1991-11#1)(1991-12#17)(1991-2#23)(1991-3#7)(1991-6#6)(1991-9#1)(1992-1#10)(1992-12#17)(1992-2#13)(1992-3#7)(1993-1#10)(1993-11#2)(1993-12#15)(1993-2#8)(1993-3#19)(1993-6#4)(1994-1#23)(1994-12#15)(1994-2#21)(1994-3#17)(1994-6#2)(1994-9#3)(1995-1#10)(1995-11#1)(1995-12#17)(1995-2#11)(1995-3#16)(1996-1#16)(1996-11#2)(1996-12#7)(1996-2#26)(1996-3#18)(1996-6#3)(1997-1#12)(1997-2#22)(1997-3#19)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2007-12#3)(2007-9#1)(2008-1#7)(2008-10#60)(2008-11#123)(2008-12#26)(2008-2#3)(2008-3#1)(2008-4#14)(2008-5#8)(2008-6#7)(2008-7#25)(2008-8#23)(2008-9#25)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#3)(2009-5#11)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#7)(2010-1#8)(2010-10#2)(2010-11#9)(2010-12#12)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#6)(2010-7#15)(2010-8#2)(2010-9#13)(2011-1#5)(2011-2#44)(2011-3#3)(2011-7#4)(2012-12#5)(2012-2#43)(2012-3#29)(2013-1#45)(2013-7#3)(2013-8#25)
articles and##4##2##(1992-1#1)(2010-12#1)(2013-1#1)(2013-8#1)
articles dealing with##2##3##(1996-3#1)(2008-11#1)
articles for##3##2##(1994-3#1)(2010-5#1)(2013-8#1)
articles have##2##2##(1991-2#1)(2012-2#1)
articles in the literature##2##4##(1993-2#1)(2012-2#1)
articles in this##2##3##(1993-1#1)(1997-1#1)
articles in##9##2##(1993-1#1)(1993-2#1)(1994-12#1)(1997-1#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
articles on##10##2##(1991-11#1)(1993-12#2)(1997-2#1)(2008-10#2)(2008-7#1)(2011-7#1)(2012-12#1)(2012-3#1)
articles published between##2##3##(2012-12#1)(2012-3#1)
articles published in this issue of the##4##7##(1994-12#1)(1997-2#1)(1997-3#2)
articles published##12##2##(1994-12#1)(1994-3#1)(1997-2#1)(1997-3#2)(2012-12#4)(2012-3#1)(2013-1#2)
articles reporting##2##2##(2011-2#1)(2012-3#1)
articles that included##2##3##(2011-2#1)(2013-1#1)
articles that##6##2##(2008-10#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
articles was##2##2##(2012-12#1)(2012-2#1)
articles were analyzed##2##3##(2012-3#2)
articles were identified##2##3##(2012-12#1)(2013-1#1)
articles were included##2##3##(2011-2#2)
articles were##14##2##(2008-12#1)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#2)
articles##118##1##(1991-11#2)(1991-2#1)(1992-1#1)(1993-1#1)(1993-12#3)(1993-2#1)(1994-12#4)(1994-3#5)(1995-1#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#3)(1997-3#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#12)(2011-7#1)(2012-12#18)(2012-2#6)(2012-3#7)(2013-1#14)(2013-8#2)
articular cartilage##8##2##(1993-12#1)(1997-6#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
articular chondrocalcinosis##3##2##(1991-11#2)(1993-2#1)
articular membranes##3##2##(2008-7#3)
articular reduction##2##2##(2008-8#2)
articular surfaces##3##2##(2012-3#1)(2013-1#2)
articular##28##1##(1991-11#2)(1993-12#1)(1993-2#1)(1997-6#1)(2008-11#1)(2008-7#3)(2008-8#2)(2009-9#1)(2010-10#1)(2011-2#4)(2012-2#1)(2012-3#7)(2013-1#3)
articulate the##6##2##(1992-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-9#1)(2012-2#1)
articulate##13##1##(1992-3#1)(1994-12#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
articulated##7##1##(2007-12#2)(2008-11#2)(2008-12#3)
articulates##3##1##(1996-2#1)(2008-11#2)
articulating##5##1##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
articulation of##2##2##(2008-12#2)
articulation##9##1##(2008-12#3)(2008-9#2)(2013-1#2)(2013-8#2)
artiellia isolates than##2##3##(2008-10#2)
artiellia##11##1##(2008-10#11)
artifact in##2##2##(1994-12#1)(2008-3#1)
artifact##11##1##(1994-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2009-7#2)(2009-8#2)
artifacts and##2##2##(2008-10#1)(2010-8#1)
artifacts that##2##2##(1990-3#1)(2008-4#1)
artifacts##24##1##(1990-3#1)(1994-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#3)
artificial and##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
artificial cerebrospinal fluid##2##3##(1994-8#1)(2008-10#1)
artificial chromosome (YAC)##3##3##(1996-12#1)(1997-8#1)(2008-4#1)
artificial chromosome##17##2##(1996-12#1)(1996-8#1)(1997-8#5)(2008-10#1)(2008-4#1)(2008-8#5)(2009-10#1)(2010-10#1)(2011-2#1)
artificial chromosomes##4##2##(1995-6#1)(1997-2#1)(2008-4#2)
artificial disc replacement (C-ADR)##5##4##(2012-12#5)
artificial disc replacement##11##3##(2012-12#11)
artificial electron##2##2##(2008-11#2)
artificial evolution##3##2##(2008-8#3)
artificial feeding##2##2##(1997-7#1)(2008-10#1)
artificial grammar##2##2##(2008-5#2)
artificial inoculation of##2##3##(2008-10#2)
artificial inoculation##9##2##(2008-10#9)
artificial intelligence##4##2##(2007-8#1)(2008-10#1)(2010-8#2)
artificial intervention##2##2##(2008-10#2)
artificial liver support##2##3##(2008-11#1)(2010-12#1)
artificial liver##7##2##(2008-11#5)(2010-12#2)
artificial medium##4##2##(1992-12#4)
artificial mouth system and##2##4##(2008-10#2)
artificial mouth system##3##3##(2008-10#3)
artificial mouth##6##2##(2008-10#6)
artificial nests##3##2##(2008-8#1)(2008-9#2)
artificial neural network (ANN) model##4##5##(2008-10#4)
artificial neural network (ANN)##14##4##(2008-10#13)(2013-1#1)
artificial neural network for the##2##5##(2008-10#1)(2008-11#1)
artificial neural network for##3##4##(2008-10#2)(2008-11#1)
artificial neural network is##3##4##(2008-10#1)(2010-8#2)
artificial neural network##37##3##(2008-10#28)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#4)(2013-1#2)
artificial neural networks (ANN)##5##4##(2008-10#4)(2010-8#1)
artificial neural networks (ANNs)##6##4##(2008-10#6)
artificial neural networks and##2##4##(2008-10#2)
artificial neural networks for##2##4##(2008-10#2)
artificial neural networks in##2##4##(2008-10#2)
artificial neural networks##39##3##(1995-5#2)(1996-2#1)(2008-10#35)(2010-8#1)
artificial neural##77##2##(1995-5#2)(1996-2#1)(2008-10#64)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#5)(2013-1#2)
artificial nutrition and hydration##2##4##(1990-11#2)
artificial salivas##2##2##(2008-10#2)
artificial samples##3##2##(2008-10#2)(2008-5#1)
artificial sea water and##2##4##(2008-10#2)
artificial seawater##4##2##(2008-10#4)
artificial selection on##3##3##(2008-8#1)(2008-9#2)
artificial selection##7##2##(2008-8#4)(2008-9#2)(2010-4#1)
artificial surfaces##6##2##(1990-2#1)(2008-10#2)(2013-1#3)
artificial sweeteners##2##2##(2008-10#2)
artificial textures##2##2##(2008-5#2)
artificial turf##3##2##(2013-1#3)
artificial urinary sphincter##3##3##(2008-10#3)
artificial water##2##2##(2008-10#1)(2012-7#1)
artificial##285##1##(1990-11#3)(1990-2#1)(1991-3#1)(1991-9#1)(1992-12#4)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#2)(1997-7#1)(1997-8#5)(2007-12#1)(2007-8#2)(2008-10#128)(2008-11#14)(2008-3#3)(2008-4#3)(2008-5#10)(2008-8#17)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#10)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#12)(2012-2#1)(2012-3#1)(2012-7#2)(2013-1#13)
artificially coloured hair##2##3##(2008-5#2)
artificially infected##5##2##(2008-10#5)
artificially infested soil##2##3##(2008-10#2)
artificially infested with##2##3##(2008-10#2)
artificially infested##4##2##(2008-10#4)
artificially inoculated chickpea##2##3##(2008-10#2)
artificially inoculated with##5##3##(2008-10#5)
artificially inoculated##15##2##(2008-10#14)(2010-4#1)
artificially##46##1##(1990-9#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-3#1)(2008-10#30)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
artisanal##2##1##(2011-2#2)
artist##5##1##(2008-10#5)
artistic##3##1##(2008-10#1)(2008-12#1)(2008-3#1)
arts##7##1##(1994-12#1)(2008-12#1)(2010-11#1)(2011-2#3)(2012-3#1)
artwork##3##1##(1997-3#1)(2008-10#1)(2008-7#1)
artworks##2##1##(2008-10#2)
artérielle##2##1##(2011-2#2)
arundinis##2##1##(2008-10#2)
arvalis)##2##1##(2012-3#2)
arvense##3##1##(2008-10#2)(2008-11#1)
arvensis##4##1##(2008-10#2)(2013-1#2)
arvicoline rodents##2##2##(2008-9#2)
aryl chloride##2##2##(2010-5#1)(2010-8#1)
aryl hydrocarbon (Ah) receptor##2##4##(1993-12#1)(1995-11#1)
aryl hydrocarbon receptor##3##3##(2008-10#2)(2013-1#1)
aryl hydrocarbon##5##2##(1993-12#1)(1995-11#1)(2008-10#2)(2013-1#1)
aryl##21##1##(1990-11#3)(1993-12#3)(1995-11#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-5#1)(2010-8#3)(2013-1#1)
arylacetamide deacetylase##2##2##(1991-5#2)
arylalkylamine N-acetyltransferase##3##2##(1994-2#1)(1995-11#1)(2008-5#1)
arylamine##3##1##(1991-5#1)(1992-6#1)(1993-3#1)
arylamines##2##1##(2008-10#2)
arylating quinones##3##2##(2009-9#3)
arylating##4##1##(2009-9#4)
arylhydrocarbon##3##1##(2008-11#3)
arylsulfatase##3##1##(1990-2#1)(1997-3#2)
as &quot##48##2##(1991-3#2)(1992-1#1)(1992-9#1)(1993-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
as 'active oxygen'##2##3##(2008-10#2)
as (1)##2##2##(2008-11#1)(2012-2#1)
as 0##51##2##(1993-1#2)(1994-8#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#2)(2010-4#1)(2012-2#2)
as 1##33##2##(1997-3#1)(1997-6#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
as 10##12##2##(1991-8#1)(1994-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2013-1#1)
as 10% of##3##3##(1995-2#1)(2007-12#1)(2010-11#1)
as 10%##4##2##(1995-2#1)(2007-12#1)(2008-10#1)(2010-11#1)
as 10(-5) M##2##3##(2008-10#2)
as 100##8##2##(2007-11#1)(2008-10#4)(2008-9#1)(2010-7#1)(2013-8#1)
as 12##4##2##(1993-8#1)(2008-10#3)
as 13##2##2##(2007-12#1)(2010-8#1)
as 15##3##2##(2008-10#3)
as 16##2##2##(2008-3#1)(2012-2#1)
as 19##2##2##(2008-3#1)(2011-1#1)
as 1x10(-8)M##2##2##(2008-10#2)
as 2##15##2##(1992-3#1)(1997-3#1)(2008-10#11)(2008-3#1)(2012-2#1)
as 20 days after##2##4##(2008-10#1)(2012-3#1)
as 20##6##2##(2008-10#2)(2008-11#2)(2008-3#1)(2012-3#1)
as 24##2##2##(2008-10#1)(2008-5#1)
as 25##4##2##(2008-10#4)
as 3##9##2##(1992-12#1)(1993-8#1)(1995-8#1)(2008-10#4)(2011-1#1)(2011-2#1)
as 30##3##2##(1992-3#1)(2008-7#1)(2012-3#1)
as 300##3##2##(1991-3#1)(2008-10#1)(2008-11#1)
as 32##2##2##(1994-8#1)(2008-2#1)
as 4 h after##2##4##(2008-10#2)
as 4##7##2##(1992-12#1)(1995-8#1)(2008-10#4)(2009-5#1)
as 5##13##2##(1992-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
as 5-Br-PADAP chelates##2##3##(2008-10#2)
as 50##4##2##(2008-10#3)(2008-3#1)
as 50%##2##2##(1992-5#1)(2008-10#1)
as 500##2##2##(2008-11#1)(2012-12#1)
as 6 x##2##3##(2008-3#2)
as 6##6##2##(1990-3#1)(1995-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
as 60##3##2##(1995-5#1)(2008-3#2)
as 600##2##2##(1994-2#1)(2008-10#1)
as 7##3##2##(1993-8#1)(2008-10#1)(2008-3#1)
as 70##2##2##(1994-9#1)(2008-8#1)
as 8##2##2##(2008-10#2)
as 80%##2##2##(2008-10#1)(2012-12#1)
as 90##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
as A##4##2##(2008-10#1)(2008-12#1)(2009-2#1)(2013-8#1)
as AAF##2##2##(1991-5#2)
as African American men##2##4##(2009-5#2)
as AgL and##2##3##(2008-10#2)
as BNP-45##2##2##(1991-5#2)
as BSA##2##2##(2008-10#2)
as Bacillus anthracis##2##3##(2011-2#2)
as Bacillus##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
as Bloch##2##2##(2009-10#2)
as C##15##2##(2008-10#12)(2008-5#1)(2010-3#2)
as CD4##2##2##(1995-2#1)(2010-12#1)
as CHO##2##2##(1994-3#1)(2008-11#1)
as CL##2##2##(2008-10#2)
as Colletotrichum acutatum##2##3##(2008-10#2)
as DNA##6##2##(2008-10#2)(2008-9#2)(2009-5#1)(2010-8#1)
as E##2##2##(2008-10#2)
as European wheat mosaic virus##2##5##(2008-8#2)
as F##6##2##(2008-10#6)
as Fourier##2##2##(2008-10#2)
as G##2##2##(2008-10#1)(2008-12#1)
as HPLC##3##2##(2008-10#3)
as Japanese##2##2##(2012-12#1)(2013-1#1)
as L##2##2##(2008-10#2)
as LOP for##2##3##(2008-8#2)
as MX(3)##2##2##(2008-10#2)
as Markers of##2##3##(1994-12#1)(2012-3#1)
as Markers##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
as Medicare##2##2##(1992-12#1)(1994-12#1)
as Mg2+##3##2##(1995-2#1)(1995-6#1)(2008-6#1)
as Munchausen's syndrome##2##3##(2010-12#2)
as NA##2##2##(2008-10#2)
as Na(+) and##2##3##(2008-10#2)
as Na(+)##3##2##(2008-10#3)
as P##11##2##(2008-10#10)(2008-4#1)
as PDL increased##2##3##(2008-11#2)
as Potential Inhibitors of HIV##2##5##(1996-5#2)
as Potential Inhibitors of##3##4##(1996-5#3)
as Potential##4##2##(1996-5#3)(2012-2#1)
as Predictors of##2##3##(2012-3#1)(2013-1#1)
as Pseudomonas spp##2##3##(2008-10#2)
as Pseudomonas##4##2##(2008-10#3)(2012-2#1)
as R##7##2##(1995-12#1)(2008-10#5)(2012-2#1)
as RNA##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
as RSD##3##2##(2008-10#3)
as Revealed by##2##3##(2008-10#1)(2012-3#1)
as S##4##2##(2008-10#2)(2008-2#1)(2012-3#1)
as Se##2##2##(2008-10#2)
as Serratia##2##2##(2008-10#2)
as T##6##2##(1996-12#1)(2008-10#3)(2010-3#2)
as TNF##2##2##(1990-5#1)(1997-2#1)
as Th(PBI)(4)##2##2##(2008-10#2)
as Trolox##2##2##(2008-10#1)(2008-11#1)
as X##6##2##(2008-10#6)
as Xanthomonas##2##2##(2008-10#2)
as [Formula##2##2##(2008-10#1)(2012-2#1)
as a &quot##9##3##(1990-3#1)(1992-12#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#1)
as a 'dual action'##2##4##(2012-2#2)
as a 1##2##3##(1993-2#1)(2008-10#1)
as a 20%##2##3##(1994-5#1)(2008-7#1)
as a DNA##3##3##(1990-5#1)(1991-5#1)(2011-2#1)
as a Maisonneuve fracture##2##4##(2009-1#2)
as a Majocchi granuloma##2##4##(2012-3#2)
as a backbone for##2##4##(2008-10#1)(2008-8#1)
as a barrier to##2##4##(2008-10#1)(2008-11#1)
as a base catalyst in the##2##6##(1993-8#2)
as a base##3##3##(1993-8#2)(2008-5#1)
as a basis for the##2##5##(2008-10#1)(2008-11#1)
as a basis for##12##4##(1991-6#1)(1993-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2012-3#1)(2013-1#2)
as a basis##16##3##(1991-6#1)(1993-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#2)
as a binder##2##3##(2008-10#2)
as a binding##2##3##(1992-6#1)(2008-10#1)
as a biocontrol agent of##2##5##(2008-10#2)
as a biocontrol agent##3##4##(2008-10#2)(2008-12#1)
as a biological control agent##3##5##(2008-10#3)
as a biological##9##3##(1997-4#1)(2008-10#6)(2008-9#1)(2011-2#1)
as a biomarker for##3##4##(2008-10#1)(2010-5#1)(2013-8#1)
as a biomarker of##5##4##(2008-10#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-8#1)
as a biomarker##11##3##(2008-10#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-5#1)(2012-2#2)(2013-8#3)
as a biosensor##3##3##(2008-10#3)
as a blocking##2##3##(2008-10#1)(2008-8#1)
as a bridge between##2##4##(2008-10#1)(2012-3#1)
as a bridge therapy##2##4##(2008-10#2)
as a bridge##7##3##(2008-10#4)(2008-11#1)(2011-2#1)(2012-3#1)
as a broad##2##3##(1993-8#1)(2008-11#1)
as a by-product of##3##4##(1994-3#2)(2008-9#1)
as a cancer##2##3##(2008-11#1)(2011-2#1)
as a candidate for a##2##5##(2008-11#1)(2008-12#1)
as a candidate##10##3##(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2010-1#1)(2012-3#2)
as a carbon source##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
as a carrier and##2##4##(2008-10#2)
as a carrier solution##2##4##(2008-10#2)
as a carrier##14##3##(1993-11#1)(1996-12#1)(2008-10#8)(2008-5#1)(2008-8#1)(2011-2#2)
as a case example##2##4##(1997-2#1)(2008-11#1)
as a case of##2##4##(2008-11#1)(2008-12#1)
as a case study##6##4##(1993-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
as a case##11##3##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
as a catalyst for the##2##5##(2008-10#2)
as a catalyst##7##3##(2008-10#7)
as a causative##2##3##(2008-8#1)(2013-1#1)
as a cause of##15##4##(1991-12#1)(1992-12#1)(1994-2#1)(2008-7#2)(2010-10#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)
as a cause##16##3##(1991-12#1)(1992-12#1)(1994-2#1)(2008-7#3)(2010-10#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)
as a cell##2##3##(2008-10#1)(2008-5#1)
as a cellular##3##3##(1995-2#1)(2008-11#1)(2012-12#1)
as a central##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
as a characteristic of##2##4##(1990-11#1)(2008-12#1)
as a cheap##2##3##(2008-10#1)(2008-11#1)
as a chelating agent##4##4##(2008-10#4)
as a chelating##7##3##(2008-10#7)
as a chemical modifier##4##4##(2008-10#4)
as a chemical##7##3##(2008-10#6)(2008-11#1)
as a chiral selector##3##4##(2008-10#3)
as a chiral##8##3##(2008-10#8)
as a chromogenic reagent for the##2##6##(2008-10#2)
as a chromogenic reagent for##3##5##(2008-10#3)
as a chromogenic reagent##4##4##(2008-10#4)
as a clinical entity##2##4##(1996-11#1)(2008-12#1)
as a clinical##6##3##(1993-3#1)(1994-12#1)(1995-2#1)(1996-11#1)(2008-12#1)(2009-9#1)
as a color##3##3##(2008-10#3)
as a colored reagent##2##4##(2008-10#2)
as a combination of##3##4##(2008-3#2)(2009-10#1)
as a combination##4##3##(1990-8#1)(2008-3#2)(2009-10#1)
as a common##5##3##(2008-10#3)(2008-5#1)(2008-7#1)
as a communication##2##3##(1990-12#1)(2008-11#1)
as a community##2##3##(2010-9#1)(2012-2#1)
as a comparison##3##3##(2008-10#3)
as a competitor##2##3##(1995-2#1)(2008-10#1)
as a complement to##3##4##(1996-3#1)(2007-12#1)(2011-2#1)
as a complementary##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
as a complex##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
as a complexing##3##3##(2008-10#3)
as a complication of##3##4##(2008-7#1)(2008-9#1)(2012-3#1)
as a complication##4##3##(2008-7#2)(2008-9#1)(2012-3#1)
as a component of the##4##5##(1991-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
as a component of##8##4##(1991-9#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as a component##9##3##(1990-12#1)(1991-9#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as a composite##2##3##(2008-12#1)(2008-8#1)
as a compromise between##2##4##(2008-10#2)
as a condition##2##3##(1994-12#1)(1995-12#1)
as a consequence of the##5##5##(1990-2#1)(1994-3#1)(2008-10#1)(2008-8#1)(2009-10#1)
as a consequence of##21##4##(1990-2#1)(1991-1#1)(1992-6#1)(1993-8#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)(2013-1#4)
as a consequence##29##3##(1990-2#1)(1991-1#1)(1992-6#1)(1993-8#1)(1994-3#1)(1995-8#1)(2008-10#9)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#4)
as a constant ionic medium##2##5##(2008-10#2)
as a constant##3##3##(2008-10#2)(2008-8#1)
as a constraint##2##3##(2008-2#1)(2009-8#1)
as a content##2##3##(2008-11#1)(2008-12#1)
as a control##18##3##(1993-8#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-11#3)(2008-5#3)(2008-9#1)(2009-3#1)(2009-8#1)(2012-2#1)(2012-3#2)
as a covariate##2##3##(2009-12#1)(2013-8#1)
as a critical##4##3##(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
as a cross-linking agent##2##4##(2008-10#2)
as a crucial##2##3##(2008-11#1)(2008-7#1)
as a culture substratum##2##4##(2008-11#2)
as a decision support##2##4##(2008-10#1)(2008-11#1)
as a defense##2##3##(2008-10#1)(2008-8#1)
as a delay CS##2##4##(2008-5#2)
as a detector for##4##4##(2008-10#4)
as a detector##9##3##(2008-10#9)
as a diagnostic tool in##2##5##(1991-12#1)(2008-9#1)
as a diagnostic tool##5##4##(1991-12#1)(2008-9#3)(2009-12#1)
as a diagnostic##7##3##(1991-12#1)(2008-3#1)(2008-9#3)(2009-12#1)(2010-8#1)
as a diffusive##2##3##(2008-10#2)
as a direct##9##3##(1990-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)
as a disease##3##3##(2008-10#3)
as a distinct##7##3##(1991-1#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)
as a dominant##3##3##(2008-3#2)(2008-8#1)
as a downstream effector of##2##5##(1997-2#1)(2008-11#1)
as a downstream##3##3##(1997-2#1)(2008-11#1)(2011-2#1)
as a drug##3##3##(1990-2#1)(2010-2#1)(2012-2#1)
as a dual##2##3##(2008-10#1)(2010-11#1)
as a dynamic##3##3##(2008-8#1)(2009-7#1)(2010-10#1)
as a facilitator##2##3##(1991-2#1)(2008-7#1)
as a factor##4##3##(2007-8#1)(2008-11#1)(2008-2#1)(2013-8#1)
as a family##2##3##(1992-3#1)(2008-9#1)
as a fast##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
as a field##3##3##(2008-10#2)(2010-5#1)
as a fingerprint##2##3##(1993-8#1)(2008-10#1)
as a first step##4##4##(1991-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
as a first##11##3##(1991-2#1)(1994-1#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-1#1)(2011-2#2)
as a first-line treatment##2##4##(2008-10#1)(2011-2#1)
as a first-line##5##3##(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
as a fluorescent##5##3##(1990-2#1)(2008-10#3)(2008-11#1)
as a fluorimetric##2##3##(2008-10#2)
as a foliar##2##3##(2008-10#2)
as a food##3##3##(1993-11#1)(2008-11#1)(2012-2#1)
as a foundation for##5##4##(1996-1#1)(2008-10#2)(2008-11#1)(2010-10#1)
as a framework for##6##4##(1992-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-11#1)(2011-1#1)
as a framework##7##3##(1992-2#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-11#1)(2011-1#1)
as a full agonist##2##4##(1995-11#1)(2009-8#1)
as a full##3##3##(1995-11#1)(2008-10#1)(2009-8#1)
as a function of a##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
as a function of age##2##5##(1995-8#2)
as a function of both temperature and##2##7##(1994-5#1)(2008-10#1)
as a function of both the##2##6##(2008-10#1)(2008-7#1)
as a function of both##6##5##(1994-5#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-8#1)
as a function of concentration##3##5##(2008-10#3)
as a function of inhalation flow rate##2##7##(1994-2#1)(1997-2#1)
as a function of its##2##5##(1994-5#1)(2008-3#1)
as a function of pH and##3##6##(1996-12#1)(2008-10#2)
as a function of pH have been##3##7##(2008-10#3)
as a function of pH in##2##6##(2008-10#2)
as a function of pH##13##5##(1990-5#1)(1996-12#1)(2008-10#11)
as a function of parameters##2##5##(2008-3#1)(2009-8#1)
as a function of particle size##3##6##(2008-10#3)
as a function of temperature and##2##6##(2008-10#2)
as a function of temperature##10##5##(2008-10#8)(2008-11#1)(2008-9#1)
as a function of the cylinder rotation angle##2##8##(2008-3#2)
as a function of the number of extinction trials##2##9##(2008-5#2)
as a function of the number of##3##7##(2008-5#3)
as a function of the time##2##6##(2008-10#2)
as a function of the##42##5##(1990-12#1)(1991-11#1)(1991-2#1)(1992-3#1)(1994-5#1)(1995-9#1)(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#13)(2008-3#9)(2008-5#6)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)
as a function of their##2##5##(2008-10#2)
as a function of time##15##5##(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2010-4#1)(2010-7#1)
as a function of wavelength##2##5##(2008-3#2)
as a function of##193##4##(1990-10#1)(1990-12#1)(1990-5#2)(1991-1#2)(1991-11#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-5#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-7#1)(2007-12#2)(2008-10#80)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#23)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#2)
as a function##196##3##(1990-10#1)(1990-12#1)(1990-5#2)(1991-1#2)(1991-11#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-5#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-7#1)(2007-12#2)(2008-10#82)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#23)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#2)
as a functional##7##3##(1992-9#1)(1994-2#1)(2008-10#2)(2010-4#1)(2010-6#1)(2013-1#1)
as a fungal##2##3##(2008-10#2)
as a further step##2##4##(1995-2#1)(2008-10#1)
as a further##3##3##(1995-2#1)(2008-10#1)(2009-12#1)
as a fusion protein##2##4##(1990-11#1)(2009-9#1)
as a gas##2##3##(2008-3#1)(2010-12#1)
as a gene carrier##2##4##(2008-10#2)
as a gene transfer vector##2##5##(1997-3#2)
as a gene##5##3##(1997-3#2)(2008-10#2)(2008-8#1)
as a general prophylactic##2##4##(2008-10#2)
as a general##10##3##(1996-5#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-6#1)(2012-2#1)
as a good##3##3##(2008-11#2)(2008-7#1)
as a group have##2##4##(1991-12#1)(1995-12#1)
as a group##5##3##(1991-12#1)(1995-12#1)(2007-8#1)(2008-10#1)(2009-8#1)
as a guide for##3##4##(1991-12#1)(1996-2#1)(2012-2#1)
as a guide of##2##4##(1996-3#1)(2008-10#1)
as a guide to##3##4##(1990-8#1)(2009-10#1)(2011-2#1)
as a guide##11##3##(1990-8#1)(1991-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2008-10#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
as a heterogeneous##3##3##(2008-10#2)(2012-3#1)
as a high##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)
as a highly selective and sensitive fluorescence probe for##2##9##(2008-12#2)
as a highly##5##3##(1997-2#1)(1997-4#1)(2008-10#1)(2008-12#2)
as a host##5##3##(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#1)
as a human##2##3##(2007-12#1)(2010-10#1)
as a hybridization##2##3##(1992-10#1)(2008-10#1)
as a hydrophilic-interaction chromatographic##2##4##(2008-10#2)
as a key##8##3##(1992-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2012-2#1)(2013-8#1)
as a labor admission test##2##5##(1994-3#2)
as a leading cause of##2##5##(2010-3#1)(2012-3#1)
as a learning strategy##2##4##(2008-11#1)(2008-12#1)
as a learning##8##3##(1997-6#1)(2008-11#6)(2008-12#1)
as a lesion##2##3##(1990-5#1)(1996-3#1)
as a less##3##3##(1992-6#1)(2008-10#1)(2013-8#1)
as a ligand##6##3##(1995-2#1)(2008-10#4)(2008-11#1)
as a light detector##2##4##(2008-10#2)
as a light source##4##4##(2007-12#1)(2008-10#2)(2012-3#1)
as a light##6##3##(2007-12#1)(2008-10#4)(2012-3#1)
as a linear##2##3##(2008-10#1)(2008-7#1)
as a local probe##2##4##(2007-12#1)(2008-3#1)
as a local##4##3##(1993-1#1)(2007-12#1)(2008-3#1)(2009-6#1)
as a long-term##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
as a low##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
as a main##4##3##(2008-10#2)(2008-5#1)(2010-4#1)
as a major cause of##2##5##(1991-6#1)(1997-1#1)
as a major##19##3##(1991-2#1)(1991-6#1)(1993-3#1)(1997-1#1)(1997-8#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#2)(2013-1#1)
as a management##2##3##(1992-12#1)(2008-10#1)
as a marker for##7##4##(1994-2#1)(1995-1#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
as a marker of the##2##5##(1992-6#1)(2009-12#1)
as a marker of##9##4##(1992-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#2)(2012-3#1)(2012-9#1)
as a marker##19##3##(1992-6#1)(1994-2#1)(1995-1#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#3)(2012-3#1)(2012-9#1)
as a masking agent for the determination of##2##8##(2008-10#2)
as a masking agent for##3##5##(2008-10#3)
as a masking agent##6##4##(2008-10#6)
as a mass##2##3##(2008-10#1)(2010-11#1)
as a matrix for the##2##5##(2008-10#1)(2008-11#1)
as a matrix modifier##2##4##(2008-10#2)
as a matrix##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
as a matter of##3##4##(1997-5#1)(2008-7#2)
as a means of improving the##2##6##(2008-11#1)(2008-7#1)
as a means of improving##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
as a means of##27##4##(1992-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1996-1#1)(2008-10#6)(2008-11#7)(2008-3#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
as a means to##11##4##(1995-1#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-7#1)(2012-2#1)
as a means##38##3##(1992-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-10#9)(2008-11#9)(2008-3#1)(2008-7#1)(2008-8#3)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
as a measure of N nutrition##2##6##(2012-8#1)(2012-9#1)
as a measure of distress tolerance##2##6##(2013-8#2)
as a measure of the##5##5##(2006-6#1)(2008-10#2)(2008-4#1)(2009-12#1)
as a measure of##23##4##(1990-2#1)(1991-3#2)(1994-11#1)(1994-12#1)(1996-1#1)(2006-6#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-7#1)(2009-12#2)(2012-2#1)(2012-8#1)(2012-9#1)(2013-8#2)
as a measure to##2##4##(2008-10#1)(2008-6#1)
as a measure##25##3##(1990-2#1)(1991-3#2)(1994-11#1)(1994-12#1)(1996-1#1)(2006-6#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#2)(2012-2#1)(2012-8#1)(2012-9#1)(2013-8#2)
as a measurement##2##3##(2008-10#1)(2008-11#1)
as a mechanism for##2##4##(1996-3#1)(2008-11#1)
as a mechanism of##2##4##(2008-10#1)(2008-8#1)
as a mechanism##5##3##(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
as a mediating##2##3##(1992-3#1)(2008-10#1)
as a mediator for the##2##5##(2008-10#2)
as a mediator for##3##4##(2008-10#3)
as a mediator of##3##4##(1995-2#1)(2008-11#1)(2010-1#1)
as a mediator##12##3##(1995-2#1)(2008-10#7)(2008-11#1)(2009-10#1)(2010-1#1)(2011-2#1)
as a medium##2##3##(2008-10#2)
as a member of a##2##5##(1993-3#1)(2008-12#1)
as a member of##4##4##(1993-3#1)(1995-2#1)(2008-12#1)(2011-1#1)
as a membrane##3##3##(1990-5#1)(2008-10#2)
as a method for the##3##5##(1997-2#1)(2008-10#1)(2008-5#1)
as a method for##11##4##(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2009-3#1)(2012-3#1)
as a method of##8##4##(2008-10#2)(2008-11#2)(2008-12#1)(2009-10#1)(2011-2#1)(2012-12#1)
as a method to##4##4##(1995-5#1)(2008-11#1)(2008-4#1)(2013-8#1)
as a method##26##3##(1995-5#1)(1997-2#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-4#4)(2008-5#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
as a microtubule protein##2##4##(1993-6#2)
as a minor##3##3##(2008-10#3)
as a mirror of##2##4##(2013-8#2)
as a mixture of##4##4##(2008-10#3)(2012-12#1)
as a mobile phase##7##4##(2008-10#6)(2008-11#1)
as a mobile##8##3##(2008-10#7)(2008-11#1)
as a model compound##2##4##(1993-8#1)(1995-12#1)
as a model for##14##4##(1991-9#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#1)(2012-3#1)
as a model of##5##4##(1991-5#1)(2008-10#1)(2008-11#1)(2010-1#1)(2013-1#1)
as a model sample##2##4##(2008-10#2)
as a model system for##3##5##(2008-10#2)(2011-1#1)
as a model system##12##4##(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
as a model to study##2##5##(1994-5#1)(2008-10#1)
as a model to##3##4##(1994-5#1)(2008-10#2)
as a model##59##3##(1991-5#1)(1991-9#1)(1993-8#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#20)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
as a moderator##3##3##(2009-11#1)(2010-1#2)
as a modifier##5##3##(2008-10#5)
as a molecular marker##2##4##(2008-10#2)
as a molecular##5##3##(2008-10#2)(2008-11#1)(2009-6#1)(2009-8#1)
as a monolayer##2##3##(2008-11#1)(2008-4#1)
as a monomer##2##3##(1993-8#1)(1994-11#1)
as a more##6##3##(1995-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
as a multidimensional##2##3##(2008-10#1)(2012-2#1)
as a multivariate##2##3##(2008-10#1)(2010-11#1)
as a mycoherbicide##2##3##(2008-10#2)
as a national##2##3##(2009-5#1)(2013-1#1)
as a natural##4##3##(1990-5#1)(2008-10#1)(2012-12#1)(2013-1#1)
as a necessary##3##3##(1992-1#1)(1993-8#1)(2009-8#1)
as a necrotrophic##2##3##(2008-10#2)
as a negative regulator of##2##5##(2009-10#1)(2013-1#1)
as a negative##5##3##(1994-8#1)(2008-10#1)(2009-10#1)(2009-8#1)(2013-1#1)
as a neoplastic##2##3##(1992-3#1)(2008-4#1)
as a neutral carrier##4##4##(2008-10#4)
as a new anticoagulant##2##4##(2008-10#2)
as a new biosorbent for the##2##6##(2008-10#2)
as a new biosorbent##3##4##(2008-10#3)
as a new host for##2##5##(2012-2#2)
as a new source of##2##5##(2008-10#1)(2012-2#1)
as a new source##3##4##(2008-10#2)(2012-2#1)
as a new strategy of##2##5##(2008-10#1)(2008-8#1)
as a new##57##3##(1991-8#1)(1996-5#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#6)(2013-1#3)(2013-8#1)
as a noninvasive##2##3##(2009-10#1)(2013-1#1)
as a nonlinear##3##3##(2007-11#1)(2008-3#2)
as a novel approach##2##4##(2008-10#1)(2013-1#1)
as a novel carrier##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
as a novel ionophore for potentiometric##2##6##(2008-10#2)
as a novel ionophore for##4##5##(2008-10#4)
as a novel ionophore##6##4##(2008-10#6)
as a novel##32##3##(2008-10#18)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
as a number of##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
as a pH-sensitive##2##3##(2008-10#2)
as a paradigm##3##3##(2008-11#1)(2009-8#1)(2013-1#1)
as a parameter for##2##4##(2008-5#1)(2008-7#1)
as a part of hormone##2##5##(2008-11#1)(2012-3#1)
as a part of the##4##5##(1990-12#1)(1992-1#1)(2008-10#1)(2008-11#1)
as a part of##16##4##(1990-12#1)(1991-12#1)(1992-1#1)(1995-12#1)(1997-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
as a partner##2##3##(1991-12#1)(1992-3#1)
as a passive##3##3##(2008-10#2)(2008-2#1)
as a patient education tool among##2##6##(2009-5#2)
as a percent##2##3##(2008-10#1)(2008-11#1)
as a percentage of the##4##5##(1996-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
as a percentage of##8##4##(1996-2#1)(2008-10#3)(2008-11#2)(2010-8#2)
as a permanent chemical modifier##3##5##(2008-10#3)
as a permanent modifier##2##4##(2008-10#2)
as a permanent##5##3##(2008-10#5)
as a personal##2##3##(2008-12#2)
as a phase##3##3##(2007-12#1)(2008-3#2)
as a pilot##2##3##(2008-10#1)(2011-9#1)
as a plasticizer##2##3##(2008-10#2)
as a platform for the competitive immuno-reaction of HRP-SjAb and SjAb with SjAg##2##13##(2008-10#2)
as a platform for##6##4##(2008-10#2)(2010-12#3)(2010-5#1)
as a platform##7##3##(2008-10#2)(2010-12#3)(2010-5#1)(2012-2#1)
as a player in the##2##5##(2008-11#1)(2013-8#1)
as a point in##2##4##(1997-6#1)(2008-9#1)
as a point##3##3##(1997-6#1)(2008-11#1)(2008-9#1)
as a polarizing beam splitter##2##5##(2008-3#2)
as a population of spatially referenced##2##6##(2008-10#2)
as a positive control##3##4##(1992-12#1)(2008-10#1)(2008-5#1)
as a positive##6##3##(1992-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
as a possible cause of##4##5##(1995-2#1)(2008-12#1)(2011-2#1)(2012-12#1)
as a possible cause##6##4##(1992-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
as a possible##20##3##(1991-11#1)(1992-11#1)(1992-2#1)(1995-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-8#1)
as a potent##6##3##(1990-2#1)(1994-11#1)(1995-5#1)(1996-2#1)(2008-5#1)(2013-1#1)
as a potential model for##2##5##(2008-11#1)(2008-6#1)
as a potential protective##2##4##(1990-12#1)(2009-11#1)
as a potential target for##2##5##(1995-9#1)(2012-2#1)
as a potential therapeutic##2##4##(2011-2#1)(2012-2#1)
as a potential tool for##2##5##(2008-10#2)
as a potential treatment for##5##5##(2008-5#4)(2012-2#1)
as a potential treatment##6##4##(2008-5#5)(2012-2#1)
as a potential##35##3##(1990-12#1)(1992-12#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-5#7)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#3)(2012-2#4)(2013-8#1)
as a potentially##2##3##(2008-10#1)(2010-5#1)
as a potentiometric sensor##3##4##(2008-10#3)
as a potentiometric##5##3##(2008-10#5)
as a power##2##3##(2007-12#1)(2008-8#1)
as a powerful##8##3##(2008-10#4)(2008-11#1)(2008-4#2)(2011-2#1)
as a practicable##2##3##(1990-5#1)(2008-3#1)
as a practical##5##3##(1990-5#1)(2008-11#2)(2008-12#2)
as a pre-column chelating##2##4##(2008-10#2)
as a pre-column derivatizing reagent##2##5##(2008-10#2)
as a pre-column##5##3##(2008-10#5)
as a pre-plant##2##3##(2008-10#2)
as a precolumn derivatizing reagent##2##5##(2008-10#2)
as a preconcentration##2##3##(2008-10#2)
as a precursor of##3##4##(1994-5#1)(1997-2#1)(2008-11#1)
as a precursor##5##3##(1990-8#1)(1993-12#1)(1994-5#1)(1997-2#1)(2008-11#1)
as a predictive##3##3##(1996-12#1)(2008-5#1)(2010-12#1)
as a predictor of##7##4##(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
as a predictor##8##3##(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#3)
as a preliminary##2##3##(2008-10#1)(2008-8#1)
as a preoperative##2##3##(1990-11#1)(1993-1#1)
as a presentation of##2##4##(1996-3#1)(2011-2#1)
as a presenting##3##3##(2008-9#2)(2011-2#1)
as a preservation agent##2##4##(2008-10#2)
as a preservative##2##3##(2008-5#1)(2011-2#1)
as a previously##2##3##(2008-10#2)
as a primary cause for##2##5##(2008-1#1)(2011-1#1)
as a primary##12##3##(1990-6#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2011-1#1)(2012-12#1)
as a prior step to its determination by flame atomic spectroscopy##2##11##(2008-10#2)
as a priority##3##3##(1993-3#1)(2013-1#2)
as a probe to##3##4##(1993-2#1)(1996-6#1)(1997-1#1)
as a probe##22##3##(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-11#1)(1995-12#1)(1995-6#1)(1996-6#3)(1997-1#1)(2008-10#4)(2008-8#4)
as a profession##2##3##(2008-5#1)(2012-2#1)
as a prognostic factor##2##4##(2007-8#1)(2011-2#1)
as a prognostic indicator##2##4##(1994-12#1)(2008-7#1)
as a prognostic##4##3##(1994-12#1)(2007-8#1)(2008-7#1)(2011-2#1)
as a promising candidate for##2##5##(2008-9#1)(2011-2#1)
as a promising##6##3##(2008-11#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)
as a promoter##4##3##(1991-6#1)(1997-8#1)(2008-8#1)(2008-9#1)
as a prophylactic##2##3##(2008-5#1)(2011-2#1)
as a proportion##2##3##(2007-12#1)(2008-10#1)
as a protective factor against##2##5##(1995-12#1)(2009-11#1)
as a protective factor for##2##5##(2009-12#1)(2013-8#1)
as a protective factor##4##4##(1995-12#1)(2009-11#1)(2009-12#1)(2013-8#1)
as a protective##6##3##(1995-12#1)(2008-10#1)(2009-11#1)(2009-12#1)(2013-1#1)(2013-8#1)
as a prototype of a##3##5##(2008-10#2)(2011-2#1)
as a prototype##5##3##(1992-3#1)(2008-10#2)(2008-12#1)(2011-2#1)
as a proxy for##3##4##(2008-10#1)(2010-8#1)(2011-2#1)
as a pseudostationary##2##3##(2008-10#2)
as a public health problem##2##5##(2009-5#1)(2010-9#1)
as a public##4##3##(1996-2#1)(2008-12#1)(2009-5#1)(2010-9#1)
as a putative##2##3##(1993-12#1)(2012-2#1)
as a quality##3##3##(1993-12#1)(1997-1#1)(2008-10#1)
as a quantitative##2##3##(1996-6#1)(2008-9#1)
as a radioactive##2##3##(1995-2#1)(2008-10#1)
as a radiosensitizer##2##3##(1990-6#1)(1991-2#1)
as a rapid and simple##2##5##(2008-10#2)
as a rapid and##4##4##(2008-10#4)
as a rapid##11##3##(2008-10#10)(2008-11#1)
as a rare cause of##3##5##(2008-12#1)(2009-4#1)(2011-2#1)
as a rare complication of##2##5##(2012-12#1)(2012-3#1)
as a rare##7##3##(1996-8#1)(2008-12#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
as a reagent##3##3##(2008-10#2)(2008-9#1)
as a receptor for##2##4##(1995-2#1)(1995-6#1)
as a redox##3##3##(2008-10#2)(2008-11#1)
as a reducing agent##2##4##(2008-10#2)
as a reduction in##2##4##(2008-10#1)(2008-9#1)
as a reference electrode##2##4##(2008-10#2)
as a reference method##2##4##(2008-10#2)
as a reference##14##3##(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)
as a regulator of##2##4##(1995-12#1)(2009-8#1)
as a regulatory##2##3##(2008-10#2)
as a reliable##5##3##(1991-12#1)(2008-10#3)(2010-12#1)
as a replacement for the##2##5##(1992-3#1)(2008-10#1)
as a replacement for##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
as a replacement##6##3##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
as a reporter for the##2##5##(1997-8#1)(2008-4#1)
as a reporter gene##2##4##(1991-5#1)(2008-11#1)
as a reporter molecule##2##4##(2008-7#1)(2008-9#1)
as a reporter##15##3##(1991-5#1)(1992-6#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)
as a representative##7##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)
as a reservoir for##2##4##(1997-5#1)(2008-10#1)
as a reservoir##3##3##(1995-2#1)(1997-5#1)(2008-10#1)
as a response to##4##4##(1990-2#1)(2008-10#2)(2012-7#1)
as a response##5##3##(1990-2#1)(2008-10#2)(2009-8#1)(2012-7#1)
as a result of a##14##5##(1991-11#1)(1994-1#2)(1995-6#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)
as a result of an##4##5##(1994-2#1)(1996-6#1)(2008-5#1)(2013-1#1)
as a result of both##2##5##(2008-11#1)(2011-2#1)
as a result of enzymatic##2##5##(2008-10#2)
as a result of higher##2##5##(2008-8#1)(2012-5#1)
as a result of insufficient##2##5##(2010-5#1)(2011-2#1)
as a result of its##2##5##(2008-10#2)
as a result of the continuous##2##6##(2008-10#1)(2008-11#1)
as a result of the##31##5##(1991-12#1)(1994-11#1)(1994-9#1)(1996-9#1)(1997-2#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#2)(2010-11#1)(2011-1#1)(2011-2#3)(2013-1#2)
as a result of their##5##5##(1995-1#1)(1995-3#1)(2008-11#1)(2009-12#1)(2013-1#1)
as a result of##147##4##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#3)(1992-6#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#3)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#32)(2008-11#15)(2008-12#2)(2008-3#4)(2008-5#5)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#3)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#4)
as a result##158##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#3)(1992-6#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#3)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#37)(2008-11#15)(2008-12#2)(2008-3#4)(2008-5#5)(2008-7#5)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#3)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#6)
as a review of the literature##2##6##(2009-3#1)(2011-2#1)
as a ribosomal protein##2##4##(1996-6#1)(2013-8#1)
as a right to##2##4##(1995-12#2)
as a right##4##3##(1995-12#2)(2008-7#1)(2013-8#1)
as a risk factor for##5##5##(1990-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
as a risk factor##6##4##(1990-8#1)(2008-4#1)(2011-2#2)(2012-3#1)(2013-8#1)
as a risk##8##3##(1990-8#1)(2008-4#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
as a route to##2##4##(2008-11#1)(2008-8#1)
as a routine##7##3##(1991-6#2)(1994-9#1)(1996-11#1)(2008-10#2)(2011-1#1)
as a rule##4##3##(1991-6#1)(1995-5#1)(1996-1#1)(2008-7#1)
as a safe##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
as a sample introduction##2##4##(2008-10#2)
as a sample##7##3##(2008-10#7)
as a scientific##3##3##(1992-12#1)(2008-10#1)(2008-11#1)
as a screening tool for##3##5##(1993-12#1)(2008-10#1)(2013-1#1)
as a screening##8##3##(1993-12#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
as a second line therapy##2##5##(1990-2#1)(2008-5#1)
as a second##6##3##(1990-2#1)(1995-11#1)(1997-7#1)(2008-11#1)(2008-5#1)(2010-8#1)
as a second-line##2##3##(1992-12#2)
as a seed treatment##2##4##(2008-10#2)
as a seed##3##3##(1994-11#1)(2008-10#2)
as a selectable marker##2##4##(1997-8#1)(2008-10#1)
as a selection##2##3##(2008-11#1)(2008-4#1)
as a selective fluorescence quenching##2##5##(2008-10#2)
as a selective##11##3##(1990-2#1)(1995-11#1)(2008-10#8)(2008-7#1)
as a sensing##2##3##(2008-10#1)(2008-3#1)
as a sensitive and##2##4##(1997-7#1)(2008-10#1)
as a sensitive##4##3##(1997-7#1)(2008-10#3)
as a sensor element##2##4##(2008-10#1)(2011-2#1)
as a sensor for the##2##5##(2008-10#2)
as a sensor for##3##4##(2008-10#3)
as a sensor##10##3##(2008-10#7)(2008-9#1)(2011-2#1)(2013-1#1)
as a separate##2##3##(1994-12#1)(2008-10#1)
as a series of##3##4##(2008-4#1)(2009-4#1)(2012-2#1)
as a serious complication of##2##5##(2010-5#2)
as a serious##4##3##(2008-10#1)(2010-5#2)(2012-3#1)
as a serum##2##3##(2008-11#1)(2012-3#1)
as a set of##3##4##(2008-10#2)(2008-12#1)
as a short##2##3##(2008-10#1)(2010-6#1)
as a signal##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)
as a signaling##2##3##(2009-6#1)(2012-2#1)
as a significant risk factor for##2##6##(2008-2#1)(2012-3#1)
as a significant##8##3##(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-1#1)(2011-10#1)(2011-2#1)(2012-3#1)
as a simple and##4##4##(2008-10#3)(2008-11#1)
as a simple model##2##4##(2008-10#2)
as a simple##15##3##(1991-12#1)(1997-7#1)(2008-10#8)(2008-11#4)(2013-1#1)
as a single agent in##3##5##(1991-6#2)(1994-8#1)
as a single agent##5##4##(1991-6#2)(1994-8#2)(2009-12#1)
as a single band##2##4##(1992-12#1)(1992-8#1)
as a single copy in the##2##6##(1992-3#1)(1997-4#1)
as a single copy##6##4##(1992-3#1)(1993-2#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-8#1)
as a single dose##2##4##(1992-12#2)
as a single##37##3##(1990-2#1)(1991-11#1)(1991-6#2)(1992-12#3)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-6#2)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-5#1)(2010-6#1)(2012-3#1)(2013-8#1)
as a single-copy##2##3##(1993-9#1)(1995-6#1)
as a social##3##3##(1992-2#1)(2008-11#1)(2009-10#1)
as a sole carbon source##6##5##(2008-10#3)(2008-11#1)(2012-2#1)(2012-3#1)
as a sole##10##3##(1991-12#1)(1992-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
as a solid catalyst for the determination of##2##8##(2008-10#2)
as a solid catalyst##3##4##(2008-10#3)
as a solid phase reagent for##2##6##(2008-10#2)
as a solid phase##6##4##(2008-10#6)
as a solid support##4##4##(2008-10#4)
as a solid##16##3##(2008-10#15)(2013-1#1)
as a solid-state##2##3##(2008-10#2)
as a solvent##2##3##(2008-10#1)(2008-5#1)
as a sorbent##2##3##(2008-10#2)
as a source of resistance to##3##6##(2008-10#3)
as a source of##20##4##(1991-2#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#8)(2008-9#1)(2009-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
as a source##21##3##(1991-2#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#8)(2008-9#1)(2009-9#1)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)
as a special##2##3##(1995-2#2)
as a species##2##3##(2010-10#1)(2011-2#1)
as a specific##8##3##(1993-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-11#2)(2008-8#1)(2010-6#1)
as a spectrophotometric##3##3##(2008-10#3)
as a spray##4##3##(1992-2#1)(2008-10#3)
as a stability indicating##3##4##(2008-10#3)
as a stable##3##3##(1994-5#1)(2008-11#1)(2008-4#1)
as a standard for##2##4##(2010-8#2)
as a standard##8##3##(1992-9#1)(1995-9#1)(2008-10#3)(2010-8#2)(2013-1#1)
as a starting point for##2##5##(2008-10#1)(2010-11#1)
as a starting point##4##4##(1996-5#1)(2008-10#2)(2010-11#1)
as a starting##5##3##(1993-8#1)(1996-5#1)(2008-10#2)(2010-11#1)
as a stationary phase and the##2##6##(2008-10#2)
as a stationary phase##4##4##(2008-10#4)
as a strategic##2##3##(1996-2#1)(1996-3#1)
as a strategy to##6##4##(1996-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
as a strategy##9##3##(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#1)(2011-3#1)(2012-2#1)(2013-8#1)
as a strong##3##3##(2008-11#1)(2012-3#1)(2013-7#1)
as a structural##3##3##(1995-8#1)(1997-1#1)(2008-10#1)
as a subset##2##3##(2008-10#1)(2010-7#1)
as a substitute for##3##4##(1995-3#1)(2008-3#1)(2013-1#1)
as a substitute##4##3##(1995-3#1)(2008-1#1)(2008-3#1)(2013-1#1)
as a substrate for the##2##5##(2008-10#2)
as a substrate for##7##4##(1993-8#1)(1994-5#1)(1994-8#1)(2008-10#3)(2009-9#1)
as a substrate in##2##4##(1997-8#1)(2011-2#1)
as a substrate##20##3##(1990-9#2)(1993-3#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-10#7)(2008-11#2)(2009-9#1)(2011-2#1)
as a suitable model##2##4##(2008-10#1)(2008-11#1)
as a suitable##8##3##(2008-10#5)(2008-11#1)(2008-5#2)
as a sunscreen##2##3##(2008-10#1)(2008-5#1)
as a superposition of##2##4##(1997-6#1)(2008-10#1)
as a supplement to##2##4##(1990-9#1)(1991-6#1)
as a supplement##3##3##(1990-9#1)(1991-6#1)(2008-11#1)
as a support##4##3##(2008-10#3)(2008-11#1)
as a surfactant##3##3##(2008-5#1)(2009-10#1)(2013-1#1)
as a surgical##2##3##(2008-4#1)(2008-7#1)
as a surrogate for##3##4##(2010-11#1)(2011-2#1)(2013-8#1)
as a surrogate##7##3##(2008-10#1)(2008-6#1)(2009-11#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
as a target for cancer##2##5##(2011-2#2)
as a target for the##2##5##(1995-5#1)(2013-1#1)
as a target for##8##4##(1995-5#1)(1996-1#1)(1997-7#1)(2008-8#1)(2010-11#1)(2011-2#2)(2013-1#1)
as a target of##3##4##(1993-8#1)(2008-12#1)(2011-2#1)
as a target##13##3##(1993-8#1)(1995-5#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-11#1)(2011-2#3)(2013-1#1)
as a tau##2##3##(1993-6#2)
as a teaching and learning strategy##3##6##(2008-11#3)
as a teaching and##4##4##(2008-11#3)(2008-12#1)
as a teaching method##4##4##(2008-11#3)(2008-12#1)
as a teaching strategy##2##4##(2008-11#1)(2008-12#1)
as a teaching##11##3##(1995-12#1)(2008-11#7)(2008-12#3)
as a team##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
as a technique for the##3##5##(2008-10#1)(2008-2#1)(2008-7#1)
as a technique for##5##4##(2008-10#3)(2008-2#1)(2008-7#1)
as a technique##6##3##(2008-10#3)(2008-2#1)(2008-7#1)(2011-3#1)
as a template for##2##4##(2008-10#1)(2008-11#1)
as a template##4##3##(1992-6#1)(1993-12#1)(2008-10#1)(2008-11#1)
as a temporary##3##3##(2009-7#1)(2010-2#1)(2013-1#1)
as a test analyte##2##4##(2008-10#2)
as a test case##2##4##(2008-11#1)(2008-3#1)
as a test of##2##4##(2008-10#1)(2008-8#1)
as a test sample##2##4##(2007-12#1)(2008-10#1)
as a test##9##3##(1992-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
as a theoretical##3##3##(1995-1#1)(2008-10#1)(2008-12#1)
as a therapeutic agent in##2##5##(2007-11#1)(2008-6#1)
as a therapeutic target for##2##5##(2008-1#1)(2010-11#1)
as a therapeutic target##3##4##(2008-1#1)(2008-11#1)(2010-11#1)
as a therapeutic##9##3##(1991-12#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#2)(2010-11#1)(2012-3#1)
as a therapy##2##3##(2010-7#1)(2012-2#1)
as a thin layer##2##4##(2008-10#2)
as a thin##3##3##(2008-10#2)(2008-3#1)
as a threat to##2##4##(2008-10#1)(2008-11#1)
as a threshold value for##2##5##(2008-10#2)
as a threshold##4##3##(2008-10#4)
as a titrant##4##3##(2008-10#4)
as a tool for the##3##5##(2008-10#2)(2010-11#1)
as a tool for##15##4##(1997-6#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#2)(2011-1#1)
as a tool in##2##4##(2008-8#2)
as a tool to study##3##5##(1996-6#1)(2010-6#1)(2010-8#1)
as a tool to##14##4##(1990-7#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2010-6#2)(2010-8#1)(2013-1#1)
as a tool##33##3##(1990-7#1)(1994-12#1)(1996-6#1)(1997-6#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2009-10#1)(2010-11#2)(2010-6#2)(2010-8#1)(2011-1#1)(2013-1#1)
as a trace CS##2##4##(2008-5#2)
as a trace##3##3##(2008-5#3)
as a tracer for##2##4##(1997-7#1)(2008-11#1)
as a tracer in##2##4##(1990-5#1)(2008-10#1)
as a tracer##5##3##(1990-5#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
as a transcription factor##3##4##(1993-12#1)(2010-5#1)(2011-2#1)
as a transducer##2##3##(1995-2#1)(2008-10#1)
as a transient intermediate which undergoes a subsequent Diels-Alder cycloaddition with##2##11##(1996-5#2)
as a transition##2##3##(1991-1#1)(1991-5#1)
as a transmitter##2##3##(1992-6#1)(2008-3#1)
as a treatment for the##2##5##(2008-11#1)(2008-3#1)
as a treatment for##7##4##(2008-11#2)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
as a treatment option for##2##5##(2008-4#1)(2008-7#1)
as a treatment##10##3##(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#2)
as a trigger for##2##4##(2008-11#2)
as a tumor marker##2##4##(1993-1#2)
as a tumor suppressor##4##4##(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
as a tumor##8##3##(1993-1#2)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
as a type of##3##4##(2008-4#2)(2012-12#1)
as a typical##6##3##(2008-10#3)(2011-2#1)(2012-2#1)(2013-8#1)
as a unique##7##3##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)
as a universal##4##3##(2008-10#2)(2008-11#1)(2009-6#1)
as a useful and##2##4##(1993-12#1)(2013-1#1)
as a useful biomarker##2##4##(2009-11#1)(2010-1#1)
as a useful vascular access site for##2##7##(2011-2#2)
as a useful##14##3##(1991-3#1)(1993-12#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-1#1)(2011-2#3)(2013-1#1)
as a usual##2##3##(1995-12#1)(2008-6#1)
as a vaccine##5##3##(1995-5#2)(2009-6#1)(2011-2#2)
as a valuable tool##2##4##(1991-6#1)(2008-10#1)
as a valuable##5##3##(1991-6#1)(2008-10#2)(2008-12#1)(2009-1#1)
as a vector for##2##4##(2008-10#1)(2011-2#1)
as a vector##4##3##(2008-10#3)(2011-2#1)
as a very##4##3##(1992-9#1)(2008-3#1)(2008-9#1)(2009-7#1)
as a viable##4##3##(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)
as a virus##2##3##(2008-10#2)
as a visual cue##2##4##(2008-8#2)
as a visual##3##3##(2008-11#1)(2008-8#2)
as a vital##3##3##(1996-6#1)(1997-3#1)(2008-11#1)
as a water##2##3##(2008-10#2)
as a wavelength##2##3##(2008-10#1)(2008-3#1)
as a way of##2##4##(2008-12#1)(2008-8#1)
as a way to##2##4##(2008-10#1)(2008-11#1)
as a way##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
as a weak initiator##2##4##(1991-8#1)(1995-9#1)
as a weak##4##3##(1991-8#1)(1994-3#2)(1995-9#1)
as a whole and##4##4##(1995-5#1)(1997-7#1)(2008-10#1)(2008-11#1)
as a whole##31##3##(1992-3#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
as a working electrode##6##4##(2008-10#6)
as a working##8##3##(2008-10#6)(2008-12#2)
as a##3150##2##(1990-10#1)(1990-11#6)(1990-12#9)(1990-2#11)(1990-3#2)(1990-5#14)(1990-6#2)(1990-7#2)(1990-8#7)(1990-9#6)(1991-1#7)(1991-10#3)(1991-11#6)(1991-12#19)(1991-2#8)(1991-3#10)(1991-5#7)(1991-6#13)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#19)(1992-2#5)(1992-3#17)(1992-4#2)(1992-6#13)(1992-8#4)(1992-9#6)(1993-1#8)(1993-11#4)(1993-12#17)(1993-2#5)(1993-3#9)(1993-6#9)(1993-8#24)(1993-9#2)(1994-1#6)(1994-11#9)(1994-12#15)(1994-2#7)(1994-3#11)(1994-5#9)(1994-6#2)(1994-8#8)(1994-9#4)(1995-1#6)(1995-11#12)(1995-12#18)(1995-2#30)(1995-3#7)(1995-5#13)(1995-6#16)(1995-8#10)(1995-9#5)(1996-1#10)(1996-11#4)(1996-12#11)(1996-2#11)(1996-3#15)(1996-5#8)(1996-6#14)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#19)(1997-3#9)(1997-4#9)(1997-5#4)(1997-6#5)(1997-7#10)(1997-8#10)(1997-9#1)(2006-6#1)(2007-11#4)(2007-12#26)(2007-8#6)(2008-1#10)(2008-10#984)(2008-11#244)(2008-12#65)(2008-2#11)(2008-3#87)(2008-4#31)(2008-5#89)(2008-6#19)(2008-7#73)(2008-8#86)(2008-9#71)(2009-1#4)(2009-10#21)(2009-11#11)(2009-12#18)(2009-3#9)(2009-4#5)(2009-5#6)(2009-6#18)(2009-7#12)(2009-8#23)(2009-9#8)(2010-1#15)(2010-10#14)(2010-11#15)(2010-12#15)(2010-2#3)(2010-3#5)(2010-4#8)(2010-5#17)(2010-6#11)(2010-7#13)(2010-8#24)(2010-9#4)(2011-1#14)(2011-10#1)(2011-2#114)(2011-3#6)(2011-7#3)(2011-9#1)(2012-12#21)(2012-2#68)(2012-3#57)(2012-4#2)(2012-5#2)(2012-7#1)(2012-8#1)(2012-9#2)(2013-1#91)(2013-7#5)(2013-8#47)
as abnormal##2##2##(2008-10#1)(2012-3#1)
as about##2##2##(2008-1#1)(2008-10#1)
as above##5##2##(1997-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
as acceptable##3##2##(2008-10#2)(2008-11#1)
as acceptor##3##2##(2008-10#3)
as acceptors##2##2##(1992-12#1)(2008-10#1)
as access##2##2##(1997-2#1)(2008-12#1)
as accuracy##4##2##(2008-10#2)(2012-2#1)(2013-1#1)
as accurate as##2##3##(2008-10#1)(2012-2#1)
as actin##4##2##(1993-3#2)(2008-9#1)(2012-2#1)
as active##9##2##(1993-6#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#1)
as acute##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
as additional##5##2##(2007-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
as additive##5##2##(1990-3#1)(2008-10#4)
as adjunctive therapy in##2##4##(1994-12#1)(2011-2#1)
as adjunctive therapy##4##3##(1994-12#1)(2011-10#1)(2011-2#2)
as adjunctive treatment of##2##4##(2011-1#1)(2011-2#1)
as adjunctive treatment##3##3##(2011-1#1)(2011-2#1)(2013-8#1)
as adjunctive##7##2##(1994-12#1)(2011-1#1)(2011-10#1)(2011-2#3)(2013-8#1)
as adjuvant##2##2##(2008-10#1)(2008-11#1)
as administrators##2##2##(1992-2#1)(1993-12#1)
as adsorbent##3##2##(2008-10#2)(2013-1#1)
as adult##4##2##(1994-3#2)(2008-10#1)(2013-1#1)
as adults##5##2##(1996-11#1)(2008-10#2)(2008-11#1)(2013-1#1)
as advanced##3##2##(1992-5#1)(1994-3#1)(2013-8#1)
as affected by##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
as against##2##2##(1991-6#1)(2008-5#1)
as age and##4##3##(1994-3#1)(2009-8#1)(2012-12#1)(2013-8#1)
as age##10##2##(1990-8#1)(1994-3#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
as alanine##2##2##(2008-12#1)(2008-7#1)
as alcohol##3##2##(2008-11#1)(2010-5#1)(2013-8#1)
as alkaline phosphatase##2##3##(2008-10#1)(2008-11#1)
as all##4##2##(2008-10#2)(2008-7#1)(2008-9#1)
as alpha##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
as alpha- and##2##3##(1995-3#1)(2008-12#1)
as also their##2##3##(1993-11#1)(2008-11#1)
as also##10##2##(1991-5#1)(1992-11#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)
as alternative##8##2##(1997-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2011-2#1)
as alternatives to##6##3##(2008-10#4)(2008-11#1)(2010-7#1)
as amperometric detector##2##3##(2008-10#2)
as amperometric##3##2##(2008-10#3)
as amplitude##2##2##(2008-3#2)
as an &quot##3##3##(1992-2#1)(2008-8#1)(2013-8#1)
as an AC suspension##2##4##(2008-10#2)
as an Entry##2##3##(1996-5#1)(2010-10#1)
as an ability to##2##4##(2008-9#1)(2012-3#1)
as an absorbing solution##2##4##(2008-10#2)
as an acceptor##2##3##(1996-5#1)(2008-11#1)
as an activator of##2##4##(2008-5#1)(2011-2#1)
as an activator##9##3##(2008-10#7)(2008-5#1)(2011-2#1)
as an active##5##3##(1992-3#1)(1995-6#1)(2008-10#2)(2008-11#1)
as an additional##12##3##(1991-3#1)(1995-11#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#5)(2011-2#1)
as an additive in##2##4##(2008-10#1)(2011-2#1)
as an additive##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
as an address##2##3##(2008-11#1)(2009-11#1)
as an adjunct therapy##2##4##(2008-7#2)
as an adjunct to##3##4##(2007-7#1)(2012-2#1)(2013-1#1)
as an adjunct##6##3##(2007-7#1)(2008-11#1)(2008-7#2)(2012-2#1)(2013-1#1)
as an adjuvant to##2##4##(1990-2#1)(2010-7#1)
as an adjuvant##4##3##(1990-2#2)(2010-7#1)(2011-2#1)
as an adult##2##3##(2008-10#1)(2010-4#1)
as an adverse##2##3##(2008-10#1)(2009-4#1)
as an agent##2##3##(2008-10#1)(2011-2#1)
as an aid in the##2##5##(1994-6#1)(2008-4#1)
as an aid in##5##4##(1991-11#1)(1991-12#1)(1994-6#1)(1997-8#1)(2008-4#1)
as an aid to##3##4##(1996-12#1)(2008-12#1)(2010-4#1)
as an aid##9##3##(1991-11#1)(1991-12#1)(1994-6#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-4#1)
as an alternative and##2##4##(2008-10#2)
as an alternative biocatalyst##2##4##(2008-10#2)
as an alternative for##2##4##(1991-1#1)(2008-10#1)
as an alternative method to##3##5##(2008-10#2)(2008-5#1)
as an alternative method##4##4##(2008-10#3)(2008-5#1)
as an alternative natural reagent for##2##6##(2008-10#2)
as an alternative technique##2##4##(1991-12#1)(2008-10#1)
as an alternative to conventional##3##5##(2008-10#2)(2009-4#1)
as an alternative to more##2##5##(1996-2#1)(2012-3#1)
as an alternative to the##7##5##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
as an alternative to traditional##2##5##(1992-1#1)(2012-12#1)
as an alternative to##36##4##(1990-9#1)(1991-3#1)(1992-1#1)(1994-2#2)(1994-9#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#2)
as an alternative##65##3##(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1994-2#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#28)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
as an amendment##2##3##(2008-10#2)
as an amperometric detector for flow injection analysis##2##8##(2008-10#2)
as an amperometric detector for the##2##6##(2008-10#2)
as an amperometric detector for##6##5##(2008-10#6)
as an amperometric sensor for##3##5##(2008-10#3)
as an amperometric##9##3##(2008-10#9)
as an analytical reagent##2##4##(2008-10#1)(2008-9#1)
as an analytical##9##3##(2008-10#7)(2008-9#1)(2009-12#1)
as an animal model of##3##5##(1996-8#1)(2008-4#1)(2008-6#1)
as an animal model##4##4##(1996-2#1)(1996-8#1)(2008-4#1)(2008-6#1)
as an antigen##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)
as an antioxidant##2##3##(2008-10#1)(2008-11#1)
as an antiulcer agent##2##4##(1993-3#2)
as an application of##2##4##(2008-10#1)(2011-2#1)
as an assessment strategy##2##4##(2008-11#2)
as an assessment##4##3##(2008-11#4)
as an association##2##3##(1996-11#1)(2008-10#1)
as an attractive##2##3##(2008-11#1)(2009-7#1)
as an average##2##3##(2008-11#1)(2013-1#1)
as an early##4##3##(2008-4#1)(2009-12#1)(2009-8#1)(2013-8#1)
as an effective research tool for estimation of##2##8##(2008-11#2)
as an effective treatment##2##4##(1997-6#1)(2008-7#1)
as an effective##13##3##(1993-3#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
as an efficient##5##3##(2008-10#3)(2008-11#1)(2011-3#1)
as an electroactive material##3##4##(2008-10#3)
as an electroactive##4##3##(2008-10#4)
as an electrochemical##5##3##(2008-10#5)
as an electron##2##3##(1991-5#1)(1996-3#1)
as an element of##2##4##(1991-3#1)(1992-12#1)
as an emerging##3##3##(2009-5#1)(2010-10#1)(2010-11#1)
as an emission##2##3##(2008-10#2)
as an endogenous##2##3##(1996-12#1)(2008-11#1)
as an enhancer of##2##4##(2008-10#2)
as an enzymatic##2##3##(2008-10#1)(2012-2#1)
as an enzyme##3##3##(2008-10#2)(2008-5#1)
as an epidemic##4##3##(1992-2#2)(2008-10#1)(2010-12#1)
as an essential##9##3##(1992-6#1)(1993-6#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
as an estimate##2##3##(1990-5#1)(2009-12#1)
as an example for##2##4##(2013-8#2)
as an example of the##4##5##(2008-10#2)(2009-8#1)(2010-12#1)
as an example of##9##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#2)
as an example to show##2##5##(2008-11#1)(2008-8#1)
as an example to##3##4##(2008-11#1)(2008-8#1)(2012-3#1)
as an example with##2##4##(1997-8#1)(2008-10#1)
as an example##33##3##(1992-11#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-8#2)
as an excellent##5##3##(1991-2#1)(2008-10#4)
as an excisional##2##3##(1991-1#1)(1994-12#1)
as an excitation source##2##4##(2008-10#2)
as an exemplar##2##3##(2008-10#1)(2008-11#1)
as an exogenous##2##3##(2008-11#1)(2008-5#1)
as an experimental model##2##4##(1996-12#1)(2008-10#1)
as an experimental##5##3##(1994-2#1)(1996-12#1)(2008-10#3)
as an expert##3##3##(1994-12#1)(2010-10#1)(2012-2#1)
as an explanation for##3##4##(2008-8#2)(2008-9#1)
as an exploratory##2##3##(2008-10#1)(2012-3#1)
as an expression##2##3##(2008-10#1)(2008-8#1)
as an extension of the##2##5##(1992-3#1)(2008-3#1)
as an extension of##4##4##(1991-12#1)(1992-3#1)(2008-3#1)(2010-7#1)
as an external##2##3##(1992-1#1)(2008-10#1)
as an extracellular##2##3##(2008-5#1)(2008-9#1)
as an extractant for##2##4##(2008-10#2)
as an extractant in##2##4##(2008-10#2)
as an extractant##10##3##(2008-10#10)
as an extraction##3##3##(2008-10#3)
as an illustrative example##2##4##(2008-10#1)(2011-2#1)
as an immobilized##2##3##(2008-10#2)
as an immunogen##2##3##(1991-9#1)(2008-11#1)
as an important aspect of##2##5##(1997-4#1)(2008-8#1)
as an important component##2##4##(2008-11#1)(2008-5#1)
as an important factor in##2##5##(1997-8#1)(2008-5#1)
as an important factor##3##4##(1997-8#1)(2008-4#1)(2008-5#1)
as an important method##2##4##(2008-11#1)(2013-3#1)
as an important part of##2##5##(1993-12#1)(2008-11#1)
as an important##29##3##(1992-2#1)(1993-12#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-3#1)
as an improved##2##3##(2008-10#2)
as an improvement in##2##4##(1995-11#1)(2011-2#1)
as an in vitro##2##4##(2008-11#2)
as an in##4##3##(2008-11#2)(2008-3#1)(2008-5#1)
as an increase in the##2##5##(2008-10#1)(2008-11#1)
as an increase in##8##4##(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#1)
as an increased##2##3##(2008-9#1)(2011-2#1)
as an independent risk factor for##2##6##(2008-6#1)(2008-9#1)
as an independent##8##3##(1993-3#1)(1994-12#3)(1996-8#1)(2008-6#1)(2008-9#1)(2013-1#1)
as an index for##4##4##(1990-2#1)(1993-12#1)(2008-11#2)
as an index of##7##4##(1992-6#1)(1993-6#1)(2008-11#2)(2008-5#1)(2010-11#1)(2012-3#1)
as an index##12##3##(1990-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#4)(2008-5#1)(2010-11#1)(2012-3#1)
as an indication of the##2##5##(1990-5#1)(2008-4#1)
as an indication of##3##4##(1990-5#1)(2008-10#1)(2008-4#1)
as an indication##4##3##(1990-2#1)(1990-5#1)(2008-10#1)(2008-4#1)
as an indicator electrode for##2##5##(2008-10#2)
as an indicator electrode in potentiometric titration of##9##8##(2008-10#9)
as an indicator electrode in potentiometric##10##6##(2008-10#10)
as an indicator electrode in the potentiometric titration of##4##9##(2008-10#4)
as an indicator electrode in the potentiometric##5##7##(2008-10#5)
as an indicator electrode in##15##5##(2008-10#15)
as an indicator electrode##20##4##(2008-10#20)
as an indicator for##5##4##(1995-2#2)(2008-11#1)(2008-12#1)(2008-7#1)
as an indicator of the##3##5##(2008-10#3)
as an indicator of##11##4##(1994-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
as an indicator##41##3##(1994-2#1)(1995-2#2)(1997-8#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)
as an indirect##4##3##(1997-1#1)(2008-11#1)(2008-8#1)(2011-2#1)
as an infection##2##3##(1992-9#1)(2011-2#1)
as an inhibitor of##4##4##(1995-6#1)(2008-11#3)
as an inhibitor##5##3##(1991-5#1)(1995-6#1)(2008-11#3)
as an inhibitory neurotransmitter of##2##5##(1991-5#2)
as an initial screening##2##4##(2008-10#2)
as an initial##5##3##(2008-10#4)(2008-11#1)
as an initiator##3##3##(1995-9#1)(2008-12#1)(2009-8#1)
as an integral part of##3##5##(2008-3#1)(2010-11#1)(2012-2#1)
as an integral part##4##4##(1995-5#1)(2008-3#1)(2010-11#1)(2012-2#1)
as an integral##5##3##(1995-5#1)(2008-3#1)(2010-11#1)(2012-2#2)
as an integrator##2##3##(2009-8#1)(2011-2#1)
as an interesting##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
as an internal control##2##4##(2008-10#2)
as an internal standard (IS)##2##5##(2008-10#2)
as an internal standard##15##4##(1993-3#1)(1995-12#1)(2008-10#12)(2008-11#1)
as an internal##18##3##(1993-3#1)(1995-12#1)(2008-10#14)(2008-11#1)(2008-9#1)
as an intervention##2##3##(1994-3#1)(2008-6#1)
as an intracavity##2##3##(2008-3#2)
as an intracellular##3##3##(2008-10#2)(2013-1#1)
as an intrinsic##4##3##(1994-3#1)(2008-11#1)(2010-11#1)(2011-2#1)
as an ion carrier##2##4##(2008-10#2)
as an ion discriminator##2##4##(2008-10#2)
as an ion pair##2##4##(2008-10#2)
as an ion##9##3##(2008-10#8)(2008-11#1)
as an ion-pair##2##3##(2008-10#2)
as an ionic##2##3##(2008-10#2)
as an ionization##2##3##(2008-10#2)
as an ionophore for##3##4##(2008-10#3)
as an ionophore in##2##4##(2008-10#2)
as an ionophore was prepared##2##5##(2008-10#2)
as an ionophore was##3##4##(2008-10#3)
as an ionophore##11##3##(2008-10#11)
as an isolated##6##3##(2008-10#1)(2008-7#2)(2013-1#3)
as an object of##2##4##(2012-3#1)(2013-1#1)
as an objective##2##3##(2008-10#1)(2008-3#1)
as an occupational##2##3##(2008-11#1)(2013-8#1)
as an open##2##3##(2009-12#1)(2011-2#1)
as an opportunity to##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
as an optical##2##3##(1996-5#1)(2007-12#1)
as an optimal##2##3##(1992-9#1)(2008-10#1)
as an oral##2##3##(2008-5#2)
as an organic modifier##4##4##(2008-10#4)
as an organic##6##3##(1995-12#1)(2008-10#5)
as an output coupler##2##4##(2008-2#2)
as an oxidant##3##3##(2008-10#3)
as an##795##2##(1990-11#2)(1990-2#6)(1990-5#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#4)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#2)(1992-6#3)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#6)(1993-6#4)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#4)(1994-6#1)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#4)(1997-8#5)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#298)(2008-11#80)(2008-12#10)(2008-2#8)(2008-3#11)(2008-4#8)(2008-5#21)(2008-6#5)(2008-7#16)(2008-8#15)(2008-9#15)(2009-10#5)(2009-11#2)(2009-12#5)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#7)(2010-12#3)(2010-4#3)(2010-6#4)(2010-7#5)(2010-8#3)(2011-2#30)(2011-3#2)(2011-7#1)(2012-12#3)(2012-2#22)(2012-3#12)(2012-5#1)(2013-1#18)(2013-3#1)(2013-7#2)(2013-8#10)
as analysis of##2##3##(2008-10#1)(2013-8#1)
as analyte##2##2##(2008-10#2)
as analytes##4##2##(2008-10#3)(2008-4#1)
as analytical method for##2##4##(2008-10#1)(2008-5#1)
as analytical method##3##3##(2008-10#2)(2008-5#1)
as analytical signal##5##3##(2008-10#5)
as analytical tools##2##3##(2008-10#2)
as analytical##15##2##(2008-10#14)(2008-5#1)
as anchor##2##2##(2008-10#2)
as androgen##2##2##(2009-5#1)(2011-2#1)
as animal##3##2##(1992-9#1)(1997-7#1)(2008-12#1)
as anion##4##2##(2008-10#4)
as anionic##3##2##(2008-10#3)
as another possible##2##3##(2008-10#1)(2008-7#1)
as another##7##2##(1994-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#1)
as antagonists##2##2##(1990-5#1)(2011-2#1)
as antibiotics##4##2##(1992-3#1)(2008-11#1)(2009-8#1)(2011-1#1)
as antibodies##4##2##(1990-2#1)(1992-6#1)(2008-11#1)(2008-4#1)
as antigen##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
as antigens##3##2##(1990-5#1)(1995-11#1)(1995-12#1)
as antioxidant##2##2##(2008-11#1)(2013-1#1)
as antioxidants##2##2##(1992-9#2)
as antitumor##2##2##(2008-11#1)(2011-3#1)
as any##3##2##(2008-12#1)(2008-4#1)(2009-4#1)
as apoptosis##5##2##(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
as apparent##2##2##(2008-10#1)(2011-3#1)
as applied to##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
as applied##6##2##(2008-10#3)(2008-3#1)(2008-4#1)(2013-1#1)
as appropriate##3##2##(1997-1#1)(1997-2#1)(2011-2#1)
as approximately##2##2##(2008-10#1)(2008-3#1)
as aptamers##2##2##(2009-12#1)(2010-11#1)
as aqueous##2##2##(2008-10#2)
as are the##5##3##(1991-2#1)(1992-3#1)(1994-5#1)(1997-3#1)(2008-7#1)
as are##14##2##(1991-2#1)(1992-3#1)(1994-5#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
as arterial##2##2##(1997-6#1)(2008-11#1)
as artificial##2##2##(2008-10#1)(2009-5#1)
as ascospores##3##2##(2008-10#3)
as assayed by##2##3##(2008-10#2)
as assayed##3##2##(1993-12#1)(2008-10#2)
as assessed by the##3##4##(1992-3#1)(2008-11#1)(2010-1#1)
as assessed by##20##3##(1991-5#1)(1992-3#1)(1995-11#1)(1995-12#1)(2008-10#5)(2008-11#5)(2009-11#1)(2009-12#1)(2010-1#1)(2013-8#3)
as assessed in##2##3##(1994-6#1)(2012-3#1)
as assessed on##3##3##(2008-7#2)(2008-9#1)
as assessed##27##2##(1991-5#1)(1992-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(2008-10#5)(2008-11#5)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#1)(2012-2#1)(2012-3#2)(2013-8#3)
as associated with##3##3##(1993-12#1)(2008-9#1)(2011-2#1)
as asthma##3##2##(1994-11#1)(2010-12#1)(2011-2#1)
as asthmatics##2##2##(1994-3#1)(1997-4#1)
as asymptomatic##3##2##(1990-8#1)(2010-6#1)(2011-3#1)
as at least##2##3##(1997-1#1)(2013-1#1)
as at##12##2##(1995-11#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2009-3#1)(2012-2#1)(2013-1#1)
as atmospheric##2##2##(2008-11#1)(2012-2#1)
as atrial##2##2##(2012-12#1)(2013-1#1)
as auxiliary##2##2##(2008-10#2)
as available##2##2##(2008-11#1)(2012-12#1)
as awareness of##2##3##(1994-1#1)(1996-9#1)
as background##2##2##(2008-10#1)(2008-3#1)
as basal##2##2##(1997-1#2)
as based on##2##3##(2011-2#1)(2013-1#1)
as basic##2##2##(1997-6#1)(1997-8#1)
as being a##4##3##(1991-8#1)(2008-11#2)(2008-5#1)
as being in the##2##4##(1992-3#1)(2013-1#1)
as being the##2##3##(2008-3#1)(2013-1#1)
as being##40##2##(1991-8#1)(1992-3#1)(1993-6#1)(1996-11#1)(1997-2#1)(2008-10#7)(2008-11#7)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
as belonging to##4##3##(2008-10#4)
as benign##4##2##(2011-1#2)(2011-2#1)(2012-3#1)
as berries aged##2##3##(2008-10#2)
as berries##4##2##(2008-10#3)(2012-12#1)
as best##3##2##(1991-6#1)(2008-11#1)(2012-2#1)
as better##2##2##(2008-10#1)(2010-10#1)
as between##3##2##(1992-12#1)(1994-8#1)(2008-1#1)
as binder##2##2##(2008-10#2)
as biocontrol agents against##2##4##(2008-10#2)
as biocontrol agents of##2##4##(2008-10#2)
as biocontrol agents##4##3##(2008-10#4)
as biological control agents##2##4##(2008-10#2)
as biological##10##2##(2008-10#6)(2008-11#2)(2008-5#1)(2011-3#1)
as biomarkers for##3##3##(2008-10#1)(2010-5#1)(2012-2#1)
as biomarkers of##3##3##(2008-10#1)(2010-5#2)
as biomarkers##7##2##(2008-10#2)(2008-6#1)(2010-5#3)(2012-2#1)
as biomass##2##2##(2008-10#1)(2008-9#1)
as biosensors##2##2##(2007-12#1)(2008-10#1)
as blood##6##2##(2008-10#3)(2010-11#1)(2010-4#1)(2012-2#1)
as body mass index##3##4##(2008-7#3)
as body##5##2##(2008-7#3)(2009-4#1)(2010-5#1)
as bone##3##2##(1991-11#1)(2008-9#1)(2011-7#1)
as both a##8##3##(1995-2#1)(1995-8#1)(2008-10#3)(2009-8#1)(2012-5#1)(2013-1#1)
as both##30##2##(1990-12#1)(1990-8#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(2008-10#14)(2009-10#1)(2009-8#1)(2012-2#1)(2012-5#1)(2013-1#2)
as bovine serum albumin##2##4##(2008-10#2)
as bovine##3##2##(2008-10#2)(2008-11#1)
as breast##4##2##(1997-3#1)(1997-8#1)(2010-6#1)(2012-2#1)
as bridge##2##2##(2008-10#1)(2010-6#1)
as buffer##2##2##(2008-10#2)
as business##2##2##(1991-12#1)(2012-3#1)
as by increasing##2##3##(2008-10#1)(2008-6#1)
as by##26##2##(1990-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as c-Myc##2##2##(2008-11#1)(2011-2#1)
as calcite##2##2##(2008-10#2)
as calculated##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
as calibration##3##2##(2008-10#2)(2008-3#1)
as calmagite##2##2##(2008-10#2)
as can##2##2##(2008-12#1)(2011-2#1)
as cancer##5##2##(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
as candidate genes##2##3##(1997-2#1)(2008-10#1)
as candidate##3##2##(1997-2#1)(2008-10#1)(2008-9#1)
as capturing##2##2##(1993-2#1)(2009-10#1)
as carbohydrate##2##2##(1990-11#1)(2010-7#1)
as carbon##2##2##(2008-10#1)(2012-12#1)
as carrier for##2##3##(2008-10#2)
as carrier##15##2##(1994-3#1)(2008-10#13)(2008-7#1)
as carriers in##2##3##(2008-10#2)
as carriers##8##2##(1995-9#1)(2008-10#6)(2008-7#1)
as cartilage replacement materials##2##4##(2009-9#2)
as case##2##2##(1992-1#1)(1995-1#1)
as catalyst##10##2##(1996-5#1)(2008-10#8)(2011-2#1)
as catalysts##3##2##(1994-12#1)(2008-12#1)(2009-9#1)
as cathode##2##2##(2008-10#2)
as cationic##2##2##(2008-10#2)
as cause##2##2##(2009-4#1)(2013-1#1)
as caused by rotational Raman scattering##2##6##(2008-3#2)
as caused by##4##3##(1996-3#1)(2008-10#1)(2008-3#2)
as causes of##2##3##(1997-4#1)(2013-1#1)
as cell surface##2##3##(2009-9#1)(2011-2#1)
as cell##11##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#4)(2012-5#1)
as cells##5##2##(1993-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
as cellular##4##2##(1994-6#1)(2009-8#1)(2012-12#1)(2013-1#1)
as cerebral##2##2##(2008-8#1)(2010-12#1)
as certain##4##2##(1995-5#1)(2008-10#1)(2008-8#1)(2009-10#1)
as changes in##4##3##(1990-5#1)(1995-2#1)(2008-11#1)(2012-3#1)
as changes##6##2##(1990-5#1)(1995-2#1)(2008-11#2)(2010-4#1)(2012-3#1)
as chemical descriptors##6##3##(2008-10#6)
as chemical detectors##2##3##(2008-10#2)
as chemical modifier##13##3##(2008-10#13)
as chemical modifiers##4##3##(2008-10#4)
as chemical##32##2##(1994-5#1)(1995-11#1)(2008-10#29)(2008-11#1)
as chemiluminescent##2##2##(2008-10#2)
as chemopreventive##2##2##(2008-10#1)(2009-12#1)
as children##3##2##(1990-5#1)(1994-6#1)(1996-11#1)
as chimeric##2##2##(1992-6#1)(2008-8#1)
as chiral selector##3##3##(2008-10#3)
as chiral selectors##2##3##(2008-10#2)
as chiral stationary phase##2##4##(2008-10#2)
as chiral##11##2##(2008-10#9)(2011-1#1)(2011-2#1)
as chloride##3##2##(1994-5#2)(2008-10#1)
as chromogenic reagent for##2##4##(2008-10#2)
as chromogenic reagent##6##3##(2008-10#6)
as chromogenic##7##2##(2008-10#7)
as chronic##3##2##(1991-12#1)(2010-10#1)(2013-1#1)
as classical##2##2##(2008-10#1)(2010-7#1)
as clinical##9##2##(1991-3#1)(1994-12#3)(1995-12#1)(2008-10#1)(2008-11#2)(2011-1#1)
as clinicians##3##2##(1997-1#1)(2013-1#2)
as cloning##2##2##(2008-9#2)
as close as possible to the##4##6##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
as close as possible to##5##5##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
as close as##6##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
as close to##2##3##(2008-9#1)(2012-2#1)
as close##8##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
as closed##2##2##(2008-10#1)(2012-3#1)
as coenzyme##2##2##(2013-8#2)
as cognitive##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
as collagen##3##2##(1992-6#1)(2008-5#1)(2012-2#1)
as commercial##3##2##(2008-10#2)(2012-2#1)
as common as##4##3##(1992-11#1)(2008-7#1)(2008-8#1)(2010-6#1)
as common##7##2##(1992-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2011-4#1)
as compared to 0##2##4##(2008-10#1)(2008-8#1)
as compared to control##2##4##(2008-12#1)(2012-2#1)
as compared to other##3##4##(2008-10#2)(2008-12#1)
as compared to patients##2##4##(2010-2#1)(2013-1#1)
as compared to rabeprazole and lansoprazole##2##6##(2012-2#2)
as compared to sham##2##4##(1993-6#1)(1996-12#1)
as compared to standard##2##4##(1990-8#1)(2013-1#1)
as compared to that of##5##5##(1993-8#1)(1997-4#1)(2008-10#2)(2011-2#1)
as compared to the control##2##5##(1994-8#1)(2008-11#1)
as compared to the controls##2##5##(1992-12#1)(1994-5#1)
as compared to the other yeast strains##3##7##(2008-10#3)
as compared to the##32##4##(1992-12#1)(1992-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2011-2#3)
as compared to their##2##4##(1994-2#1)(2012-2#1)
as compared to those of##2##5##(1990-5#1)(2012-3#1)
as compared to those##7##4##(1990-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
as compared to##128##3##(1990-5#3)(1990-8#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-12#3)(1996-3#1)(1997-2#3)(1997-4#1)(1997-8#3)(2007-12#1)(2008-10#33)(2008-11#12)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#3)(2011-2#6)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
as compared with a##2##4##(2008-3#1)(2008-7#1)
as compared with control##3##4##(1993-12#1)(2008-10#1)(2008-7#1)
as compared with intravenous##2##4##(1993-11#1)(1997-7#1)
as compared with normal##2##4##(1993-6#1)(2012-2#1)
as compared with other##3##4##(2008-10#2)(2011-2#1)
as compared with patients##2##4##(1996-3#2)
as compared with that##4##4##(1992-6#1)(2008-10#1)(2008-5#1)(2012-12#1)
as compared with the control##3##5##(1993-1#1)(2008-10#1)(2008-9#1)
as compared with the##23##4##(1993-1#1)(1993-12#1)(1995-2#1)(1997-2#1)(2008-10#15)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)
as compared with those in##2##5##(1996-3#1)(2008-11#1)
as compared with those of##2##5##(2008-10#1)(2008-9#1)
as compared with those##5##4##(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
as compared with untreated##2##4##(1993-8#1)(2010-11#1)
as compared with##75##3##(1990-9#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#3)(1997-2#2)(1997-7#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
as compared##203##2##(1990-5#3)(1990-8#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#2)(1994-1#2)(1994-11#1)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1996-12#3)(1996-2#1)(1996-3#4)(1997-2#5)(1997-4#1)(1997-7#1)(1997-8#3)(2007-12#1)(2008-10#62)(2008-11#13)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#3)(2010-9#1)(2011-2#9)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
as complementary##4##2##(1992-3#1)(2008-11#1)(2008-9#1)(2012-2#1)
as complete##2##2##(2008-10#2)
as complex as##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
as complex##7##2##(1991-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-1#1)
as complexes with##2##3##(2008-10#1)(2008-5#1)
as complexing agent##5##3##(2008-10#5)
as complexing##8##2##(2008-10#8)
as components of##4##3##(2008-11#1)(2008-5#1)(2010-1#1)(2010-6#1)
as components##5##2##(2008-11#2)(2008-5#1)(2010-1#1)(2010-6#1)
as comprehensive##3##2##(1994-3#1)(1994-8#1)(2011-2#1)
as concentration of##3##3##(2008-10#2)(2008-11#1)
as concentration##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
as confidence##2##2##(2008-10#1)(2009-10#1)
as confirmed by##5##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
as confirmed##6##2##(1990-8#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
as consumption##2##2##(2008-11#1)(2013-1#1)
as contaminant in##3##3##(2008-10#3)
as contaminants in##2##3##(2008-10#2)
as contaminants##3##2##(2008-10#2)(2008-5#1)
as contributing factors##2##3##(2011-2#1)(2012-2#1)
as contributing to##2##3##(2008-7#2)
as contributing##6##2##(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)
as control##12##2##(1996-12#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#3)(2008-9#1)(2011-2#2)(2012-3#2)
as controls for##2##3##(1997-9#1)(2008-10#1)
as controls##18##2##(1990-12#1)(1990-5#1)(1991-8#1)(1992-3#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-9#1)(2008-10#3)(2008-5#1)(2008-7#4)(2013-1#1)
as conventional##8##2##(1991-3#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-7#1)
as copper(II)##3##2##(2008-10#3)
as core##2##2##(1996-1#1)(2008-8#1)
as counter##2##2##(2008-10#2)
as criteria##4##2##(2008-10#3)(2008-12#1)
as critical##9##2##(1995-2#1)(1995-5#1)(1996-5#1)(2008-5#1)(2009-10#1)(2009-3#1)(2011-2#1)(2011-7#1)(2012-2#1)
as crucial##3##2##(2008-5#1)(2009-3#1)(2013-1#1)
as culture##2##2##(1995-2#1)(1996-12#1)
as cultures aged##2##3##(2008-10#2)
as cultures##3##2##(2008-10#2)(2008-7#1)
as cumulative##3##2##(2008-11#2)(2008-5#1)
as current##2##2##(1994-6#1)(2008-11#1)
as customers##2##2##(1992-3#1)(1994-1#1)
as data of##2##3##(2008-2#1)(2012-3#1)
as data##7##2##(1991-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-3#1)
as day##2##2##(1991-5#1)(2008-11#1)
as decreasing##3##2##(2008-9#1)(2012-2#1)(2012-3#1)
as deduced from##2##3##(1993-12#1)(1993-6#1)
as deep##3##2##(1994-3#1)(1996-2#1)(2012-3#1)
as defense##2##2##(2009-10#1)(2011-2#1)
as defined by the##2##4##(1994-11#1)(2007-12#1)
as defined by##9##3##(1994-11#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
as defined##12##2##(1994-11#1)(1994-9#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)
as degradation##2##2##(2008-10#2)
as delivery##2##2##(1995-5#1)(2010-8#1)
as demonstrated by the##2##4##(2008-10#1)(2013-1#1)
as demonstrated by##13##3##(1995-11#1)(1995-12#1)(1997-1#1)(2008-10#6)(2008-5#1)(2011-2#2)(2013-1#1)
as demonstrated##16##2##(1992-6#1)(1993-2#1)(1995-11#1)(1995-12#1)(1997-1#1)(2008-10#6)(2008-5#2)(2011-2#2)(2013-1#1)
as dependent variables##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
as depressed##2##2##(1995-12#1)(2008-12#1)
as depression##4##2##(1992-8#1)(2008-11#1)(2010-12#1)(2012-2#1)
as derived from##2##3##(2008-12#1)(2010-8#1)
as dermal##2##2##(2008-10#1)(2012-3#1)
as described above##3##3##(1995-12#1)(1996-2#1)(2011-2#1)
as described by##7##3##(1990-3#1)(1993-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#1)
as described for##3##3##(1995-6#1)(2008-5#1)(2011-10#1)
as described here##2##3##(2008-4#2)
as described in alternate protocols##2##5##(2008-4#2)
as described in the##4##4##(1997-3#1)(2008-4#1)(2008-7#1)(2011-7#1)
as described in this unit##2##5##(2008-4#2)
as described in this##3##4##(1997-1#1)(2008-4#2)
as described in##10##3##(1997-1#1)(1997-3#1)(2008-10#1)(2008-4#5)(2008-7#1)(2011-7#1)
as described##35##2##(1990-3#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#11)(2008-5#2)(2008-7#1)(2010-10#2)(2011-10#1)(2011-2#1)(2011-7#1)
as desired##2##2##(2008-10#1)(2008-5#1)
as detected by##8##3##(1997-3#1)(1997-9#1)(2008-10#3)(2008-9#2)(2012-3#1)
as detecting##2##2##(2008-10#1)(2010-7#1)
as detection system##2##3##(2008-10#2)
as detection##7##2##(2008-10#7)
as detector##9##2##(2008-10#8)(2011-3#1)
as detectors##6##2##(2008-10#6)
as determinants of##3##3##(1996-3#1)(2011-2#1)(2011-3#1)
as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##3##8##(2008-10#3)
as determined by the number of##2##6##(1993-12#1)(1997-3#1)
as determined by the##10##4##(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-8#1)(1997-3#1)(2008-10#2)(2010-5#1)(2011-2#1)
as determined by##59##3##(1990-5#2)(1990-6#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-3#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
as determined from the##2##4##(1990-11#1)(2008-10#1)
as determined from##3##3##(1990-11#1)(2008-10#1)(2008-9#1)
as determined using##2##3##(1993-8#1)(2013-1#1)
as determined##68##2##(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#3)(1993-8#3)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-3#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
as developed##3##2##(1997-7#1)(2008-10#2)
as diagnostic tool##3##3##(2008-10#3)
as diagnostic##10##2##(2008-10#6)(2010-12#1)(2010-5#1)(2013-7#1)(2013-8#1)
as did antigens from##2##4##(2008-10#2)
as did the##4##3##(1990-5#1)(1992-4#1)(1997-3#1)(2008-10#1)
as did##19##2##(1990-5#2)(1992-4#1)(1993-8#1)(1997-3#1)(2006-6#1)(2008-10#10)(2008-6#1)(2008-7#1)(2009-4#1)
as differences in the##2##4##(2008-10#1)(2009-10#1)
as differences in##4##3##(1992-2#1)(1997-3#1)(2008-10#1)(2009-10#1)
as differences##5##2##(1992-2#1)(1997-3#1)(2008-10#1)(2009-10#1)(2010-1#1)
as different##6##2##(1997-2#1)(1997-6#1)(2008-10#2)(2008-5#1)(2009-6#1)
as differentiating##2##2##(2012-3#2)
as differentiation##2##2##(2008-12#1)(2008-8#1)
as difficult##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
as diffusion##2##2##(1993-12#1)(2010-12#1)
as dimethyl##2##2##(2008-10#1)(2008-11#1)
as direct##5##2##(1997-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-8#1)
as discrete##2##2##(2012-3#1)(2013-1#1)
as discriminant##2##2##(2008-10#2)
as discussed##2##2##(1990-11#1)(2008-8#1)
as disease incidence increased##2##4##(2008-10#2)
as disease incidence##3##3##(2008-10#3)
as disease##12##2##(1995-12#1)(1997-3#1)(2008-10#7)(2008-7#1)(2009-7#1)(2011-2#1)
as disposable##3##2##(2008-10#3)
as distinct##3##2##(2008-10#1)(2008-6#1)(2010-10#1)
as diverse as##3##3##(2010-4#1)(2012-2#2)
as do##4##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
as docking##2##2##(1995-2#1)(1995-6#1)
as does its##2##3##(1995-11#1)(1997-7#1)
as does the##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
as does##5##2##(1995-11#1)(1997-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
as done##2##2##(2009-11#1)(2012-2#1)
as donor##4##2##(1996-5#1)(2008-10#1)(2008-9#2)
as drug or##2##3##(2008-11#1)(2011-2#1)
as drug##9##2##(1992-3#1)(2008-11#2)(2008-12#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
as dual##3##2##(2008-1#1)(2013-8#2)
as duration of##4##3##(1991-12#1)(2008-10#2)(2013-1#1)
as each##2##2##(1994-1#1)(2008-9#1)
as early as 1##2##4##(1997-3#1)(2008-10#1)
as early as 2##2##4##(1997-3#1)(2008-10#1)
as early as the##2##4##(2009-7#1)(2013-1#1)
as early as##26##3##(1990-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-12#1)(1997-3#2)(2008-10#8)(2008-12#2)(2008-7#3)(2009-7#1)(2010-4#1)(2012-3#1)(2013-1#2)
as early##32##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#1)(1997-3#2)(2008-10#9)(2008-12#3)(2008-7#3)(2008-8#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#2)
as education and##2##3##(2008-12#1)(2011-1#1)
as effective and##3##3##(1991-8#1)(1994-3#1)(1997-7#1)
as effective as possible##2##4##(2008-10#2)
as effective as the##3##4##(1992-12#1)(2008-10#1)(2013-1#1)
as effective as their##2##4##(2008-5#2)
as effective as##15##3##(1991-3#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-9#1)(1996-1#1)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#1)
as effective in##2##3##(2008-10#1)(2013-1#1)
as effective##33##2##(1991-3#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-3#2)(1995-2#1)(1995-9#1)(1996-1#1)(1997-7#2)(2007-11#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
as effectively as the##3##4##(2008-10#2)(2013-1#1)
as effectively as##8##3##(1990-5#1)(1991-12#1)(1994-8#1)(2008-10#4)(2013-1#1)
as efficient as##2##3##(2008-10#2)
as efficient##4##2##(2008-10#3)(2008-8#1)
as either##15##2##(2008-10#7)(2008-8#2)(2008-9#2)(2009-12#1)(2011-2#1)(2013-1#2)
as electroactive##4##2##(2008-10#4)
as electrocatalysts for the##2##4##(2008-10#2)
as electrode##2##2##(2008-10#1)(2013-1#1)
as electrolyte##2##2##(2008-10#2)
as electron exchanger##2##3##(2008-10#2)
as electron##5##2##(2008-10#5)
as elemental##2##2##(2008-10#1)(2010-11#1)
as elements##2##2##(1994-12#1)(2011-2#1)
as elevated##3##2##(2008-7#1)(2010-4#1)(2011-2#1)
as eluent and##3##3##(2008-10#3)
as eluent##13##2##(2008-10#13)
as embryonic##2##2##(2008-5#1)(2008-7#1)
as emulsifying##2##2##(2008-10#1)(2008-5#1)
as encoding a##2##3##(1991-6#1)(1991-9#1)
as encoding##3##2##(1991-6#1)(1991-9#1)(2008-10#1)
as endothelial##2##2##(2009-10#1)(2011-2#1)
as endpoints##2##2##(1992-9#1)(1994-2#1)
as energy##5##2##(2008-10#1)(2008-7#1)(2008-8#2)(2013-8#1)
as enhanced##4##2##(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#1)
as enriched##2##2##(2008-7#1)(2008-9#1)
as environmental##3##2##(2008-10#2)(2012-3#1)
as environmentally##2##2##(2008-10#2)
as enzymatic##2##2##(2008-10#2)
as enzyme immobilization##2##3##(2008-10#2)
as enzyme##6##2##(2008-10#5)(2011-2#1)
as essential##5##2##(1995-1#1)(1996-11#1)(2008-10#1)(2008-12#1)(2009-6#1)
as estimated by the##2##4##(1997-2#1)(2008-10#1)
as estimated##5##2##(1991-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
as estimation of##2##3##(2008-10#1)(2012-2#1)
as ethanol##2##2##(2008-10#2)
as eukaryotic##2##2##(2008-9#1)(2011-2#1)
as evaluated from##2##3##(1992-12#1)(2008-10#1)
as evaluated##4##2##(1992-12#1)(1993-12#1)(2008-10#1)(2008-11#1)
as even##2##2##(2008-5#1)(2010-6#1)
as evidence for##3##3##(1994-5#1)(1996-2#1)(2010-11#1)
as evidence of##2##3##(2008-10#1)(2008-8#1)
as evidence that the##2##4##(1991-5#1)(2007-12#1)
as evidence that##4##3##(1991-5#1)(1993-9#1)(2007-12#1)(2008-11#1)
as evidence##10##2##(1991-5#1)(1993-9#1)(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)
as evidenced by a##3##4##(1993-3#1)(1997-3#1)(2008-10#1)
as evidenced by increased##2##4##(1997-3#1)(2011-2#1)
as evidenced by the fact that##2##6##(2008-10#1)(2008-11#1)
as evidenced by the##6##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
as evidenced by##19##3##(1993-12#1)(1993-3#1)(1994-5#1)(1995-2#1)(1997-3#2)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#1)
as evidenced##20##2##(1993-12#1)(1993-3#1)(1994-5#1)(1995-2#1)(1997-3#2)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
as evident##2##2##(1994-11#1)(2008-10#1)
as excitation and emission##2##4##(2008-10#2)
as excitation and##3##3##(2008-10#3)
as excitation source is##2##4##(2008-10#2)
as excitation source##4##3##(2008-10#4)
as excitation##7##2##(2008-10#7)
as exemplified by the formation of##2##6##(2008-10#2)
as exemplified by the##3##4##(2008-10#2)(2008-5#1)
as exemplified by##4##3##(1997-1#1)(2008-10#2)(2008-5#1)
as expected for##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
as expected from##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
as expected##25##2##(1992-12#1)(1993-2#1)(1994-5#2)(1995-8#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
as experimental##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2012-3#1)
as exposure to##2##3##(2008-11#1)(2012-3#1)
as exposure##3##2##(1993-8#1)(2008-11#1)(2012-3#1)
as expressed by##3##3##(1990-2#1)(2008-10#2)
as expressed in##3##3##(2008-10#3)
as expressed##6##2##(1990-2#1)(2008-10#5)
as expression##3##2##(1996-11#1)(2008-10#1)(2012-3#1)
as external##6##2##(2008-10#4)(2008-12#1)(2008-7#1)
as extracellular##5##2##(1990-5#1)(1995-6#1)(2007-12#1)(2008-5#1)(2009-12#1)
as extractant##8##2##(2008-10#8)
as extractants##4##2##(2008-10#4)
as extraction solvent##2##3##(2008-10#2)
as extraction solvent)##2##3##(2008-10#2)
as extraction##6##2##(2008-10#6)
as factors in the optimization##4##5##(2008-10#4)
as factors in the##5##4##(2008-10#5)
as factors in##6##3##(2008-10#5)(2010-8#1)
as factors that##2##3##(1996-2#1)(2008-8#1)
as factors##12##2##(1996-2#1)(2008-10#7)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
as family##3##2##(1992-1#1)(2008-11#1)(2012-2#1)
as far as possible##3##4##(1997-7#1)(2008-11#1)(2011-2#1)
as far as the##5##4##(1997-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
as far as##15##3##(1991-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
as far##17##2##(1991-2#1)(1991-6#1)(1993-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
as fast##3##2##(2008-10#2)(2008-3#1)
as fatigue##2##2##(2008-10#1)(2009-1#1)
as feeding##2##2##(2008-10#1)(2008-9#1)
as females##2##2##(1995-2#1)(2012-3#1)
as fever##2##2##(2008-1#1)(2011-2#1)
as few as 100##2##4##(2008-9#1)(2013-8#1)
as few as##5##3##(2008-10#2)(2008-9#1)(2012-12#1)(2013-8#1)
as few##6##2##(1991-12#1)(2008-10#2)(2008-9#1)(2012-12#1)(2013-8#1)
as filter##2##2##(2008-10#1)(2013-1#1)
as final product##2##3##(2008-10#2)
as first##4##2##(1991-6#1)(1997-8#1)(2008-3#1)(2011-2#1)
as first-line therapy##2##3##(1994-12#1)(2013-8#1)
as first-line##3##2##(1994-12#1)(2008-9#1)(2013-8#1)
as fixed anionic##2##3##(2008-10#2)
as fixed##3##2##(2008-10#2)(2008-8#1)
as flow rate##2##3##(2008-10#2)
as flow##10##2##(2008-10#7)(2008-9#2)(2010-7#1)
as fluorescein##2##2##(2008-4#1)(2008-9#1)
as fluorescence##5##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-7#1)
as fluorescent##6##2##(2008-10#4)(2008-8#1)(2008-9#1)
as fluorophore##2##2##(2008-10#2)
as foliar##2##2##(2008-10#2)
as follows (in ng##2##4##(2008-10#2)
as follows##56##2##(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1993-12#3)(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#14)(2008-11#3)(2008-5#3)(2008-7#2)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#3)
as food additives##2##3##(1994-3#1)(2011-2#1)
as food##4##2##(1994-3#1)(2008-8#1)(2010-7#1)(2011-2#1)
as for other##3##3##(1997-8#1)(2008-10#1)(2010-12#1)
as for the##17##3##(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#2)
as for##58##2##(1990-11#1)(1993-2#1)(1993-3#2)(1994-12#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#19)(2008-11#5)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
as forms of##2##3##(1997-3#1)(2012-3#1)
as found by##2##3##(1993-9#1)(2008-10#1)
as found##4##2##(1992-9#1)(1993-9#1)(1997-6#1)(2008-10#1)
as four##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)
as free radical scavenger##2##4##(1995-11#1)(2008-5#1)
as free##5##2##(1994-8#1)(1995-11#1)(2008-10#2)(2008-5#1)
as freezing##2##2##(2008-11#1)(2008-7#1)
as frequent as##2##3##(1990-12#1)(1997-3#1)
as frequent##4##2##(1990-12#1)(1997-3#1)(2011-2#1)(2011-3#1)
as frequently##2##2##(2008-10#1)(2008-11#1)
as full term infants##2##4##(1990-11#2)
as full##4##2##(1990-11#2)(2008-11#1)(2008-7#1)
as fully##2##2##(1993-6#1)(2008-10#1)
as function of##3##3##(2008-10#3)
as functional##4##2##(1995-3#1)(2009-5#1)(2010-10#1)(2013-1#1)
as functions of the##7##4##(2008-2#1)(2008-3#4)(2008-8#1)(2011-2#1)
as functions of##11##3##(1990-8#1)(1991-12#1)(2008-2#2)(2008-3#4)(2008-8#2)(2011-2#1)
as fundamental##2##2##(2008-10#1)(2012-2#1)
as fusion proteins##2##3##(1995-11#1)(2008-10#1)
as future##2##2##(1994-12#1)(2012-3#1)
as gas##2##2##(2008-10#1)(2008-11#1)
as gene expression##4##3##(1996-6#1)(2008-11#1)(2010-11#1)(2011-3#1)
as gene##10##2##(1994-11#1)(1996-6#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-8#1)
as general##4##2##(1993-1#1)(2008-4#1)(2008-7#1)(2010-6#1)
as generalized##2##2##(2008-10#2)
as generally##2##2##(2008-5#1)(2010-7#1)
as genes##2##2##(2008-5#1)(2010-11#1)
as genetic##7##2##(1995-1#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)
as genetically##3##2##(2008-10#2)(2008-11#1)
as glucose##4##2##(1992-12#1)(2008-10#1)(2008-12#1)(2011-1#1)
as glutathione##4##2##(1992-9#1)(2008-5#2)(2010-5#1)
as good as or better than##2##6##(1996-3#1)(2008-9#1)
as good as the##2##4##(1997-8#1)(2009-11#1)
as good as those##2##4##(2009-6#1)(2011-2#1)
as good as##9##3##(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#1)
as good##18##2##(1994-8#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-2#1)(2013-1#3)
as great as##5##3##(2008-10#1)(2008-3#3)(2012-2#1)
as great##8##2##(1992-12#1)(2008-10#1)(2008-3#3)(2008-4#1)(2012-2#1)(2013-8#1)
as green##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
as group##2##2##(2006-6#1)(2008-4#1)
as growth in##2##3##(1993-1#1)(1994-1#1)
as growth##5##2##(1992-12#1)(1993-1#1)(1994-1#1)(2008-7#1)(2010-5#1)
as has been##3##3##(1991-2#1)(1994-2#1)(2008-10#1)
as has the role of training to implement pain assessment##2##10##(2013-1#2)
as has the##3##3##(2008-10#1)(2013-1#2)
as has##10##2##(1991-2#1)(1994-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#2)
as having a significant##2##4##(2008-5#1)(2011-2#1)
as having a##10##3##(1992-7#1)(1994-2#1)(1996-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)
as having the##2##3##(1991-11#1)(2008-11#1)
as having##36##2##(1991-11#2)(1991-4#1)(1992-7#1)(1993-1#1)(1993-3#1)(1994-2#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-3#1)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#2)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
as he was##2##3##(2008-10#1)(2010-7#1)
as he##3##2##(1991-8#1)(2008-10#1)(2010-7#1)
as health advocates##2##3##(1992-2#1)(2008-11#1)
as health care##2##3##(1993-12#1)(2008-11#1)
as health##9##2##(1992-2#1)(1993-12#1)(1993-3#2)(2008-11#2)(2010-12#1)(2010-9#1)(2011-1#1)
as healthy leaf area duration##2##5##(2008-10#2)
as healthy##6##2##(1991-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
as heat##3##2##(1996-2#1)(2012-2#1)(2013-8#1)
as heavy##2##2##(2008-10#1)(2008-12#1)
as helper##2##2##(2008-10#1)(2008-8#1)
as her##2##2##(2008-11#1)(2008-8#1)
as heterologous probes##2##3##(2008-10#2)
as heterologous##3##2##(2008-10#2)(2008-11#1)
as high as 0##2##4##(2008-10#1)(2008-9#1)
as high as 1##2##4##(2008-10#1)(2008-3#1)
as high as 100##2##4##(2008-10#1)(2010-7#1)
as high as 3##2##4##(1993-8#1)(1995-8#1)
as high as 90##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
as high as 90%##2##4##(2008-3#1)(2012-12#1)
as high as in the##3##5##(2008-11#2)(2008-8#1)
as high as##56##3##(1990-11#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#16)(2008-11#9)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
as high##80##2##(1990-11#2)(1991-6#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#22)(2008-11#12)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-7#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
as higher##2##2##(2008-10#1)(2008-8#1)
as highly concentrated##2##3##(2008-10#1)(2011-2#1)
as highly##4##2##(2008-10#3)(2011-2#1)
as homogeneous as possible##2##4##(1995-12#1)(2008-10#1)
as hospital##3##2##(1993-2#1)(2010-12#1)(2012-12#1)
as hospitals##3##2##(1991-2#1)(2007-12#1)(2012-12#1)
as host differentials##2##3##(2008-10#2)
as host##5##2##(1997-7#1)(2008-10#3)(2008-11#1)
as hosts for##2##3##(2008-11#1)(2012-2#1)
as hot##2##2##(1991-6#1)(2009-10#1)
as how##4##2##(2008-12#1)(2008-6#1)(2009-5#1)(2010-11#1)
as human##13##2##(1992-10#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)
as hybridization probes##3##3##(2008-10#3)
as hybridization##4##2##(2008-10#4)
as hydrogen sulfide##2##3##(2008-10#2)
as hydrogen##6##2##(2008-10#4)(2010-5#1)(2010-7#1)
as hydrophobic##3##2##(2008-10#3)
as hydroxides##2##2##(2008-10#2)
as hypertension##7##2##(1996-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2009-1#1)(2012-2#1)
as ideal##2##2##(2008-10#1)(2009-8#1)
as identified by##3##3##(1991-8#1)(2008-10#1)(2009-5#1)
as identified##5##2##(1991-8#1)(2008-10#2)(2009-5#1)(2010-10#1)
as idiopathic##2##2##(2010-10#1)(2013-8#1)
as if it##2##3##(1992-9#1)(1995-12#1)
as if they were##3##4##(1995-12#1)(2009-1#1)(2011-2#1)
as if they##4##3##(1995-12#1)(2009-1#1)(2011-2#2)
as if##7##2##(1992-9#1)(1993-12#1)(1995-12#2)(2009-1#1)(2011-2#2)
as illustrated by a##3##4##(1991-6#1)(2008-10#1)(2010-8#1)
as illustrated by##5##3##(1991-6#1)(2008-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
as illustrated##6##2##(1991-6#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
as illustrations##2##2##(2008-10#1)(2008-11#1)
as imaging##2##2##(2010-6#1)(2012-2#1)
as immunogens##3##2##(2008-10#2)(2008-5#1)
as implemented##2##2##(1994-2#1)(2009-12#1)
as important as the##2##4##(2008-11#2)
as important as##4##3##(2008-10#1)(2008-11#3)
as important in##4##3##(1991-6#1)(1996-3#1)(2008-11#1)(2012-3#1)
as important##19##2##(1991-6#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-6#1)(2009-3#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
as improved##5##2##(1992-12#1)(1997-2#1)(2008-10#1)(2010-12#1)(2013-1#1)
as in a##5##3##(1994-3#1)(2008-10#1)(2008-6#1)(2009-11#1)(2012-12#1)
as in all##2##3##(1996-11#1)(1997-1#1)
as in an##2##3##(1994-3#1)(2008-10#1)
as in human##2##3##(2008-11#1)(2008-6#1)
as in intact plants##2##4##(2008-10#1)(2008-11#1)
as in mammals##2##3##(1997-7#2)
as in other##3##3##(1993-6#1)(2008-11#1)(2012-2#1)
as in pharmaceutical##2##3##(2008-10#1)(2008-5#1)
as in the case of the##3##6##(1991-5#1)(2008-10#2)
as in the case of##9##5##(1991-5#1)(1995-12#1)(2008-10#6)(2008-11#1)
as in the other##2##4##(1993-12#1)(2008-10#1)
as in the##67##3##(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-12#2)(1992-9#1)(1993-12#2)(1995-12#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-7#1)(2008-10#22)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-10#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
as in vitro##4##3##(1993-8#1)(1995-3#1)(1997-7#1)(2008-10#1)
as in vivo##2##3##(2008-5#1)(2009-5#1)
as in##194##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-12#2)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#5)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#55)(2008-11#17)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#8)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
as incidence of##2##3##(2008-10#1)(2012-12#1)
as incidence##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
as increased##8##2##(1992-8#1)(1996-2#1)(2008-1#1)(2008-6#1)(2008-8#1)(2010-1#1)(2012-12#1)(2012-3#1)
as increases##2##2##(1992-6#1)(2008-4#1)
as independent factors##2##3##(2011-2#1)(2013-8#1)
as independent of##2##3##(2008-10#1)(2012-12#1)
as independent variables##2##3##(2008-10#2)
as independent##13##2##(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
as indicated by a##3##4##(1995-8#1)(2008-8#1)(2012-7#1)
as indicated by low##2##4##(2008-10#2)
as indicated by the##7##4##(1991-2#1)(2008-10#5)(2013-1#1)
as indicated by##29##3##(1990-5#1)(1991-2#1)(1993-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(2008-10#14)(2008-11#3)(2008-8#2)(2012-2#1)(2012-7#1)(2012-9#1)(2013-1#1)
as indicated##31##2##(1990-5#1)(1991-2#1)(1993-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(2008-10#15)(2008-11#4)(2008-8#2)(2012-2#1)(2012-7#1)(2012-9#1)(2013-1#1)
as indicator electrode##2##3##(2008-10#2)
as indicator##5##2##(2008-10#4)(2009-12#1)
as indicators of##3##3##(1997-7#1)(2008-10#1)(2010-11#1)
as indices of##3##3##(1992-3#1)(1996-12#1)(2008-7#1)
as indices##4##2##(1992-3#1)(1996-12#1)(2008-10#1)(2008-7#1)
as individual##8##2##(1992-6#1)(1993-6#1)(2008-10#2)(2008-8#1)(2009-12#1)(2009-7#1)(2011-2#1)
as individuals##2##2##(2008-11#1)(2011-1#1)
as infection##3##2##(2008-10#2)(2012-12#1)
as infectious mononucleosis##2##3##(1992-2#1)(2008-9#1)
as infectious##5##2##(1990-8#1)(1992-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
as inferred from##2##3##(1996-5#1)(2010-3#1)
as information##2##2##(2008-11#1)(2011-2#1)
as inhibitors of##2##3##(1996-2#1)(2008-11#1)
as inhibitors##5##2##(1990-11#2)(1996-2#1)(2008-11#1)(2012-3#1)
as inhibitory##3##2##(1997-2#1)(2008-11#1)(2008-7#1)
as initial##4##2##(1991-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
as inoculum sources for##2##4##(2008-10#2)
as inoculum##6##2##(2008-10#6)
as input variables##4##3##(2008-10#3)(2013-8#1)
as input##8##2##(2008-10#5)(2008-3#1)(2012-12#1)(2013-8#1)
as inputs for the##2##4##(2008-10#2)
as inputs for##3##3##(2008-10#3)
as inputs##4##2##(2008-10#4)
as insensitivity to##2##3##(2008-10#1)(2009-8#1)
as insulin##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
as insurance##2##2##(1991-3#1)(1995-12#1)
as intense##2##2##(1995-3#1)(2008-5#1)
as interference##2##2##(2008-10#2)
as intermediaries##2##2##(1996-12#1)(1997-8#1)
as intermediate hosts##2##3##(2011-2#1)(2013-8#1)
as intermediate##3##2##(2011-2#2)(2013-8#1)
as internal reference##2##3##(2008-10#2)
as internal standard (IS)##2##4##(2008-10#2)
as internal standard for##2##4##(2008-10#2)
as internal standard to compensate##2##5##(2008-10#2)
as internal standard to##3##4##(2008-10#3)
as internal standard##20##3##(2008-10#17)(2008-12#1)(2009-8#1)(2011-3#1)
as internal##30##2##(1994-12#1)(2008-10#24)(2008-12#2)(2009-8#1)(2011-2#1)(2011-3#1)
as intracellular##2##2##(1995-8#1)(2010-7#1)
as intravenous##3##2##(1993-1#2)(2010-7#1)
as introducing##3##2##(2008-9#1)(2010-10#1)(2012-2#1)
as intron##2##2##(1993-2#2)
as ion associates##2##3##(2008-10#2)
as ion##7##2##(2008-10#7)
as ionic strength##2##3##(2008-10#2)
as ionophore with##2##3##(2008-10#2)
as ionophore##10##2##(2008-10#10)
as ionophores##5##2##(2008-10#5)
as iron##3##2##(2008-10#2)(2008-11#1)
as is often##2##3##(2008-11#1)(2011-2#1)
as is the case for##2##5##(1991-6#1)(1994-5#1)
as is the case in##3##5##(2008-8#1)(2009-10#1)(2011-2#1)
as is the case##8##4##(1991-6#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-7#1)
as is the##13##3##(1990-10#1)(1991-6#1)(1992-1#1)(1994-5#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-7#1)
as is##31##2##(1990-10#1)(1990-9#1)(1991-6#1)(1992-1#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-7#1)
as isolated##5##2##(1993-8#1)(1997-3#1)(2008-11#1)(2008-12#1)(2013-1#1)
as isolates##2##2##(2008-10#2)
as isotope##2##2##(2008-10#2)
as it accumulates##2##3##(1994-9#1)(2013-8#1)
as it can be##2##4##(2008-11#2)
as it can##3##3##(2008-11#2)(2008-12#1)
as it determines##2##3##(2008-10#1)(2013-1#1)
as it evolves##2##3##(1997-3#1)(2008-6#1)
as it has##2##3##(2008-10#1)(2011-2#1)
as it is in the##3##5##(1990-5#1)(1995-11#1)(2008-7#1)
as it is in##4##4##(1990-5#1)(1995-11#1)(2007-12#1)(2008-7#1)
as it is the case##2##5##(2008-10#1)(2008-5#1)
as it is##19##3##(1990-5#1)(1991-1#1)(1991-6#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
as it normally##2##3##(1992-3#1)(2008-5#1)
as it provides##2##3##(2008-10#1)(2010-6#1)
as it related to##4##4##(2008-11#1)(2008-12#3)
as it relates to##10##4##(1994-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
as it requires##2##3##(2008-9#1)(2009-8#1)
as it was##7##3##(1997-1#1)(2008-10#4)(2008-12#1)(2010-12#1)
as it##94##2##(1990-5#1)(1991-1#1)(1991-6#1)(1992-3#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-2#2)(1997-1#1)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#22)(2008-11#6)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
as it's##2##2##(2008-10#1)(2008-9#1)
as its 1##2##3##(2008-10#2)
as its##50##2##(1990-10#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2011-2#4)(2012-3#2)(2013-1#1)
as judged by the##3##4##(1993-8#1)(2008-11#1)(2013-1#1)
as judged by##10##3##(1990-10#1)(1990-5#1)(1991-12#1)(1993-8#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2013-1#1)
as judged##11##2##(1990-10#1)(1990-5#1)(1991-12#1)(1993-3#1)(1993-8#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2013-1#1)
as key##8##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
as laboratory##2##2##(2008-11#1)(2008-8#1)
as lactate dehydrogenase##2##3##(2008-7#1)(2010-12#1)
as lactate##3##2##(1994-8#1)(2008-7#1)(2010-12#1)
as lamellae##2##2##(1994-5#1)(2008-7#1)
as large as##5##3##(1992-3#1)(1993-1#1)(2008-2#1)(2008-3#1)(2009-11#1)
as large##8##2##(1992-3#1)(1993-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)
as larger##2##2##(1995-6#1)(2008-10#1)
as late as##2##3##(1992-12#1)(2008-7#1)
as latent##2##2##(2008-10#1)(2008-5#1)
as leaves##2##2##(2008-10#1)(2009-8#1)
as lecturers##2##2##(2008-11#2)
as less##6##2##(1996-6#1)(2008-10#1)(2009-10#1)(2009-11#1)(2010-8#1)(2013-1#1)
as ligand##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
as light source and##2##4##(2008-10#2)
as light##7##2##(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-2#1)
as likely as##2##3##(2008-11#2)
as likely coding sequences##2##4##(1995-12#2)
as likely to have##3##4##(1994-12#1)(1995-2#1)(2011-2#1)
as likely to##6##3##(1994-12#1)(1995-2#2)(2010-10#1)(2011-2#1)(2013-1#1)
as likely##11##2##(1994-12#1)(1995-12#3)(1995-2#2)(2008-11#2)(2010-10#1)(2011-2#1)(2013-1#1)
as limit of detection##3##4##(2008-10#3)
as limiting##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
as linear##3##2##(2008-10#2)(2013-8#1)
as linearity##3##2##(2008-10#2)(2009-8#1)
as lipophilic additive##2##3##(2008-10#2)
as lipophilic##3##2##(2008-10#3)
as liquid##2##2##(2008-10#2)
as little as 0##6##4##(2008-10#4)(2008-6#1)(2010-4#1)
as little as 1##2##4##(2008-11#1)(2008-4#1)
as little as one##2##4##(2008-10#1)(2008-11#1)
as little as##25##3##(1992-12#1)(1993-9#1)(1994-2#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
as local##5##2##(1990-11#1)(2008-10#2)(2008-7#1)(2013-1#1)
as logbeta##2##2##(2008-10#2)
as long as possible##2##4##(1991-8#1)(2010-7#1)
as long as the##9##4##(1993-12#1)(1994-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
as long as there is##2##5##(1997-1#1)(2008-8#1)
as long as there##3##4##(1997-1#1)(2008-10#1)(2008-8#1)
as long as##24##3##(1991-8#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-8#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)
as long##30##2##(1991-8#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-8#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)(2012-3#1)
as low as 0##20##4##(1994-8#1)(2008-10#16)(2008-11#2)(2012-2#1)
as low as 1##8##4##(2008-10#7)(2008-2#1)
as low as 10(-8) M##2##5##(2008-10#2)
as low as 100##2##4##(2008-10#2)
as low as 2##3##4##(1992-3#1)(2008-10#2)
as low as 4##2##4##(2008-10#1)(2009-5#1)
as low as 5##2##4##(2008-10#1)(2008-3#1)
as low as a single##2##5##(1993-12#1)(2008-9#1)
as low as those##2##4##(1993-8#1)(2008-10#1)
as low as##68##3##(1992-3#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-12#1)(2008-10#51)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-3#1)(2012-2#2)
as low##73##2##(1992-3#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-12#1)(2008-1#1)(2008-10#54)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-3#1)(2012-2#2)(2013-8#1)
as lower##4##2##(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
as mRNA##2##2##(1995-11#1)(2011-2#1)
as main##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
as maintaining##2##2##(2008-5#1)(2008-7#1)
as major##6##2##(2008-10#3)(2008-11#2)(2009-7#1)
as male parents##2##3##(2008-8#2)
as male##4##2##(2008-8#2)(2009-6#1)(2009-8#1)
as malignant##2##2##(2011-2#1)(2012-2#1)
as manganese##2##2##(2008-10#2)
as many as##9##3##(1997-6#1)(2008-10#6)(2008-12#1)(2012-12#1)
as many##30##2##(1991-2#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#10)(2008-12#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#1)(2012-12#1)(2012-2#2)
as markers for##2##3##(2008-10#1)(2008-9#1)
as markers##7##2##(2008-10#5)(2008-9#1)(2009-8#1)
as masking agents##3##3##(2008-10#3)
as masking##5##2##(2008-10#5)
as mass##3##2##(2008-10#1)(2011-2#2)
as massive##3##2##(2008-12#2)(2012-12#1)
as maternal##4##2##(1992-12#1)(2008-9#2)(2010-6#1)
as mating##2##2##(2008-10#1)(2008-11#1)
as mean relative##2##3##(2008-10#2)
as mean##6##2##(1991-12#1)(2008-10#3)(2011-2#1)(2012-3#1)
as means of##2##3##(2008-10#2)
as measured by ELISA##2##4##(1997-2#1)(2008-8#1)
as measured by an##2##4##(1994-11#1)(2008-10#1)
as measured by bacterial populations in##2##6##(2008-10#2)
as measured by in##2##4##(1995-12#1)(1997-2#1)
as measured by the##7##4##(1993-6#1)(1994-3#1)(2008-10#2)(2010-9#2)(2012-12#1)
as measured by##51##3##(1990-11#2)(1990-5#1)(1992-6#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#2)(2006-6#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-12#2)(2010-9#2)(2012-12#1)(2013-1#2)
as measured in##3##3##(1997-8#1)(2008-10#2)
as measured with a##3##4##(2008-10#1)(2008-12#2)
as measured with##4##3##(2008-10#1)(2008-12#3)
as measured##63##2##(1990-11#2)(1990-5#1)(1992-6#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#2)(1997-8#1)(2006-6#1)(2008-10#15)(2008-11#7)(2008-12#4)(2008-3#1)(2008-8#1)(2010-1#1)(2010-12#3)(2010-9#2)(2012-12#1)(2013-1#2)(2013-8#1)
as measures of##2##3##(1993-12#1)(2011-2#1)
as measures##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
as mechanically##2##2##(2008-3#1)(2009-8#1)
as mechanisms##2##2##(1996-3#1)(2013-1#1)
as mediated by##2##3##(2008-9#1)(2010-2#1)
as mediator of##2##3##(2008-10#1)(2008-4#1)
as mediator##4##2##(2008-10#3)(2008-4#1)
as medical##4##2##(1994-12#1)(2008-11#1)(2011-3#1)(2013-1#1)
as medicine##2##2##(2010-1#1)(2011-1#1)
as medium##4##2##(2008-10#3)(2008-11#1)
as members of the##6##4##(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)
as members of##8##3##(1993-11#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)
as membrane carrier was prepared##2##5##(2008-10#2)
as membrane carrier##3##3##(2008-10#3)
as membrane##7##2##(2008-10#7)
as metabolic##5##2##(1992-10#1)(2008-10#1)(2010-1#1)(2011-2#2)
as metabolites##2##2##(1994-8#1)(2008-10#1)
as metal extractant##2##3##(2008-10#2)
as metal##6##2##(2008-10#6)
as methanol##4##2##(2008-10#4)
as methods for##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
as methods##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2010-10#1)
as methyl##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
as microwave##2##2##(2008-10#2)
as minor##5##2##(1994-5#1)(2008-10#3)(2008-11#1)
as mixed##3##2##(1994-12#1)(2008-10#2)
as mobile carrier##2##3##(2008-10#2)
as mobile phase and##5##4##(2008-10#4)(2011-1#1)
as mobile phase in##3##4##(2008-10#3)
as mobile phase##24##3##(2008-10#21)(2009-8#1)(2011-1#1)(2012-2#1)
as mobile phases##2##3##(2008-10#2)
as mobile##28##2##(2008-10#25)(2009-8#1)(2011-1#1)(2012-2#1)
as model analytes##2##3##(2008-10#2)
as model compounds##3##3##(2008-10#3)
as model##18##2##(1997-6#1)(2008-10#15)(2008-9#1)(2011-1#1)
as models for##2##3##(1995-12#1)(1995-2#1)
as models##4##2##(1991-5#1)(1995-12#1)(1995-2#1)(2008-9#1)
as modern##2##2##(2008-10#1)(2008-9#1)
as modifier##6##2##(2008-10#6)
as modulator of##2##3##(1992-6#1)(2011-2#1)
as molecular markers##2##3##(1997-8#1)(2012-5#1)
as molecular sensors##2##3##(2008-10#2)
as molecular##11##2##(1997-8#1)(2008-10#5)(2008-3#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-5#1)
as molybdoarsenate##2##2##(2008-10#2)
as monitored##2##2##(1992-1#1)(2008-10#1)
as monotherapy##3##2##(1992-3#1)(2011-10#2)
as more or less##2##4##(2008-11#1)(2013-1#1)
as more supportive##2##3##(2009-7#1)(2010-1#1)
as more##17##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2009-7#2)(2010-1#1)(2010-12#2)(2011-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
as most##9##2##(1991-2#1)(1992-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
as much as 10##2##4##(2007-12#1)(2008-3#1)
as much as 10% of the##2##6##(1995-2#1)(2007-12#1)
as much as 4##2##4##(1992-12#1)(1995-8#1)
as much as possible##3##4##(1994-3#1)(2008-4#1)(2009-7#1)
as much as the##2##4##(1997-8#1)(2012-2#1)
as much as##53##3##(1990-10#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(1997-1#1)(1997-8#1)(2007-11#3)(2007-12#4)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#11)(2008-4#1)(2008-9#1)(2009-7#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#1)
as much##65##2##(1990-10#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-8#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#1)
as multiple erythematous macules and patches##2##6##(2010-6#2)
as multiple##14##2##(1990-2#1)(1997-1#1)(2008-10#3)(2010-12#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
as multiples of##2##3##(1993-2#1)(2008-9#1)
as myocardial##3##2##(1997-5#1)(2008-10#1)(2013-8#1)
as n =##2##3##(2008-10#2)
as native human endonexin II##2##5##(1994-11#2)
as natural##10##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)
as necessary for##2##3##(2008-11#1)(2009-8#1)
as necessary##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
as needed##4##2##(2008-10#3)(2013-1#1)
as negative controls##2##3##(1993-3#1)(2012-3#1)
as negative regulators##2##3##(2009-8#2)
as negative##7##2##(1993-3#1)(2008-11#1)(2008-12#1)(2009-8#2)(2010-7#1)(2012-3#1)
as neurons##4##2##(1992-12#1)(2008-11#2)(2008-7#1)
as neutral carrier##5##3##(2008-10#5)
as neutral carriers for##2##4##(2008-10#2)
as neutral carriers##7##3##(2008-10#7)
as neutral ionophores##4##3##(2008-10#4)
as neutral##21##2##(2008-10#21)
as never before##2##3##(1991-2#1)(2008-11#1)
as new markers of##2##4##(1994-12#1)(1996-12#1)
as new members of the##2##5##(2008-10#1)(2013-8#1)
as new##18##2##(1991-2#1)(1991-6#1)(1993-12#1)(1994-12#1)(1996-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
as next-generation##3##2##(2011-3#3)
as nitrate##3##2##(2008-10#3)
as nitrite##4##2##(2008-10#4)
as no significant##2##3##(2008-10#1)(2011-2#1)
as no##5##2##(2008-10#2)(2010-6#1)(2011-2#1)(2013-1#1)
as nonlinear##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
as normal##7##2##(1991-6#1)(1993-11#1)(1995-2#1)(1997-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
as normalization of##2##3##(2008-10#1)(2008-7#1)
as not##5##2##(1992-6#1)(2008-10#2)(2008-12#1)(2009-3#1)
as novel##6##2##(2008-10#4)(2010-6#1)(2013-1#1)
as nuclear##2##2##(1995-2#1)(2008-9#1)
as number of##5##3##(1991-3#1)(2008-10#2)(2008-9#1)(2012-9#1)
as numbers of##2##3##(1995-12#1)(2008-10#1)
as numerous##7##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-9#1)(2010-6#1)
as observed in many##2##4##(2008-8#2)
as observed in##7##3##(1994-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)
as observed##11##2##(1992-6#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-11#1)(2010-1#1)
as occupational##2##2##(1990-3#1)(2008-10#1)
as occurs in##2##3##(1990-2#1)(1995-2#1)
as occurs##3##2##(1990-2#1)(1995-2#2)
as of November##2##3##(1991-3#1)(2013-1#1)
as of the end of##2##5##(1992-9#1)(2011-1#1)
as of the##5##3##(1992-9#1)(2008-10#2)(2008-11#1)(2011-1#1)
as of##22##2##(1991-3#1)(1991-8#1)(1992-9#2)(1994-5#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
as often##4##2##(1994-3#1)(2007-12#1)(2008-5#1)(2008-7#1)
as on the##12##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#2)
as on their##2##3##(2008-10#2)
as on##29##2##(1990-5#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-8#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#1)
as on-line##2##2##(2008-10#2)
as oncogenes##2##2##(2011-2#2)
as one of the main##2##5##(2008-10#1)(2012-2#1)
as one of the major##3##5##(1994-12#1)(2008-10#2)
as one of the many##2##5##(2008-12#2)
as one of the most important##2##6##(2008-10#1)(2009-8#1)
as one of the most##7##5##(1994-1#1)(1997-3#1)(2007-11#1)(2008-10#3)(2009-8#1)
as one of the##29##4##(1994-1#1)(1994-12#1)(1997-3#1)(2007-11#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
as one of##32##3##(1994-1#1)(1994-12#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
as one##46##2##(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#15)(2008-11#7)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
as only a##2##3##(2008-10#1)(2008-11#1)
as only##5##2##(2007-11#1)(2008-10#2)(2008-11#1)(2013-1#1)
as open-chain analogues of neplanocin A##2##6##(2008-11#2)
as operational##2##2##(2008-10#2)
as opposed to a##3##4##(1997-3#1)(2008-7#1)(2010-11#1)
as opposed to the##6##4##(1990-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)
as opposed to##24##3##(1990-3#1)(1991-5#1)(1992-3#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#2)(2013-8#1)
as optical##3##2##(2008-10#1)(2008-3#2)
as optimal##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
as or##3##2##(1996-3#1)(2008-9#1)(2009-1#1)
as organic modifier##2##3##(2008-10#2)
as organic solvent##4##3##(2008-10#3)(2008-7#1)
as organic##9##2##(2008-10#7)(2008-11#1)(2008-7#1)
as orientation##2##2##(2008-10#1)(2008-11#1)
as original##2##2##(2008-10#2)
as other##28##2##(1991-11#1)(1991-12#1)(1991-3#2)(1992-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-2#2)(2013-1#1)
as our##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
as out-patients##2##2##(1990-6#1)(1991-6#1)
as outpatients##2##2##(1994-2#1)(2011-1#1)
as over##2##2##(2008-2#1)(2012-2#1)
as overweight##3##2##(2008-10#2)(2012-2#1)
as oxidant##7##2##(2008-10#6)(2013-1#1)
as oxidants##2##2##(1990-5#1)(2008-10#1)
as oxidative stress##2##3##(2008-7#1)(2012-2#1)
as oxidizing agent##2##3##(2008-10#2)
as oxidizing reagent##2##3##(2008-10#2)
as oxidizing##4##2##(2008-10#4)
as oxygen##4##2##(2008-10#1)(2008-11#1)(2010-4#1)(2013-8#1)
as p53##2##2##(2008-7#1)(2012-2#1)
as pH##29##2##(2008-10#28)(2011-1#1)
as palpable##3##2##(1997-4#1)(2008-7#1)(2013-1#1)
as pancreas##2##2##(1995-2#2)
as parameters##2##2##(2008-11#1)(2011-2#1)
as paraneoplastic syndromes##2##3##(1994-9#1)(2012-3#1)
as parasites##2##2##(2008-10#1)(2008-9#1)
as parents##2##2##(2010-5#1)(2011-1#1)
as part of a strategy##2##5##(2008-1#1)(2008-7#1)
as part of a study##2##5##(2008-11#1)(2009-4#1)
as part of a##29##4##(1991-6#1)(1991-9#1)(1992-3#1)(1994-1#1)(1995-3#1)(1995-6#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-7#1)(2009-4#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
as part of an integrated##3##5##(2008-10#2)(2008-11#1)
as part of an##9##4##(1990-10#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#2)
as part of the routine##2##5##(1994-6#1)(2008-9#1)
as part of the##32##4##(1991-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-9#2)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-8#1)
as part of their##8##4##(1992-10#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
as part of##96##3##(1990-10#1)(1991-3#1)(1991-6#3)(1991-9#1)(1992-10#1)(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(2008-1#1)(2008-10#9)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-12#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
as partial##5##2##(1992-1#1)(2008-10#2)(2008-8#1)(2011-2#1)
as partially##2##2##(1995-2#1)(2008-10#1)
as participant##2##2##(1996-2#1)(2013-1#1)
as participants in##2##3##(2008-12#2)
as particulate##3##2##(2008-10#2)(2008-5#1)
as partners##2##2##(1992-1#1)(2013-1#1)
as parts of##2##3##(2006-6#1)(2008-11#1)
as passive##5##2##(2008-12#1)(2008-8#2)(2009-1#1)(2012-2#1)
as pathogens##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
as pathovars##3##2##(2008-10#3)
as patient##3##2##(2009-3#1)(2010-8#1)(2012-3#1)
as patients##4##2##(1992-3#1)(1993-11#1)(2008-11#1)(2011-2#1)
as peak height##3##3##(2008-10#3)
as peak##4##2##(2008-10#4)
as people age##2##3##(2008-7#1)(2009-12#1)
as people##3##2##(2008-7#1)(2008-9#1)(2009-12#1)
as per the##2##3##(2008-10#1)(2013-1#1)
as per##4##2##(1993-2#1)(2008-10#2)(2013-1#1)
as perceived by the clinical nurses and chief nurses##2##9##(2013-1#2)
as perceived by the##4##4##(2008-3#1)(2009-6#1)(2013-1#2)
as perceived by##9##3##(1993-2#1)(1994-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-9#1)(2013-1#2)
as percent##2##2##(2008-10#2)
as percentage of##4##3##(1996-12#1)(2008-10#3)
as percentage##7##2##(1996-12#1)(2008-10#6)
as performed##2##2##(2008-11#1)(2008-7#1)
as permanent##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2011-3#1)
as pesticides##2##2##(2008-10#1)(2010-7#1)
as pharmaceutical##2##2##(2008-10#1)(2010-7#1)
as phenol##2##2##(2008-10#2)
as phenotypic##2##2##(2008-10#1)(2008-4#1)
as physical##7##2##(1991-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-7#1)
as pigmented##2##2##(2008-11#1)(2010-6#1)
as plant##5##2##(2008-10#3)(2008-12#1)(2008-8#1)
as plasticizer##7##2##(2008-10#7)
as plasticizers##2##2##(2008-10#2)
as plasticizing solvent mediators were prepared and investigated as##2##9##(2008-10#2)
as plasticizing solvent mediators were prepared and##3##7##(2008-10#3)
as plasticizing solvent##5##3##(2008-10#5)
as points##2##2##(2008-6#1)(2011-2#1)
as polymerase chain reaction##2##4##(2008-10#2)
as polymorphic##2##2##(2008-10#1)(2008-5#1)
as poor##3##2##(2008-11#1)(2009-3#1)(2012-3#1)
as pore##2##2##(2008-10#1)(2010-10#1)
as positive and negative##2##4##(1997-7#1)(2008-11#1)
as positive control##2##3##(2008-5#1)(2010-7#1)
as positive controls##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
as positive##11##2##(1990-6#1)(1993-3#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2013-1#1)
as possibilities for##2##3##(2008-11#2)
as possible and##5##3##(2008-10#2)(2010-10#1)(2010-7#1)(2011-2#1)
as possible in##2##3##(1991-6#1)(1995-12#1)
as possible regulators of##2##4##(1995-12#1)(1995-8#1)
as possible to the##5##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
as possible to##7##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)
as possible##59##2##(1990-11#1)(1990-9#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-8#1)(1996-1#1)(1997-3#2)(1997-7#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
as post##3##2##(1996-8#1)(2010-12#1)(2012-3#1)
as potassium##5##2##(2008-10#5)
as potent##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
as potential atypical antipsychotic agents##2##5##(1992-12#2)
as potential sources of##2##4##(2008-10#1)(2008-11#1)
as potential##37##2##(1991-3#1)(1992-12#2)(1993-2#1)(1996-5#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#3)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
as potentially##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
as potentiometric##3##2##(2008-10#3)
as powerful##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2009-7#1)
as practical##4##2##(1994-12#1)(2008-10#3)
as precipitant##5##2##(2008-10#3)(2008-8#2)
as preconcentration##3##2##(2008-10#3)
as precursor##2##2##(1995-6#1)(2008-9#1)
as precursors for##2##3##(1995-3#1)(2013-1#1)
as precursors##4##2##(1992-6#1)(1995-3#1)(2010-4#1)(2013-1#1)
as predicted by the##4##4##(2008-10#1)(2008-8#2)(2009-8#1)
as predicted##9##2##(2008-10#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-6#1)
as prediction##2##2##(1997-8#1)(2008-11#1)
as predictive##2##2##(2008-10#1)(2012-3#1)
as predictors of mortality in##3##5##(2011-2#3)
as predictors of##9##3##(2008-11#1)(2008-7#2)(2010-1#1)(2011-2#4)(2012-12#1)
as predictors##11##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-1#1)(2011-2#4)(2012-12#1)
as premature##2##2##(2008-10#1)(2008-11#1)
as preparation##2##2##(1995-1#1)(2012-3#1)
as presence of##3##3##(2009-12#1)(2011-2#2)
as prevention of##3##3##(2013-7#2)(2013-8#1)
as preventive##2##2##(1997-5#1)(2008-10#1)
as previous##4##2##(1994-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
as previously described##2##3##(1992-8#1)(1994-2#1)
as previously reported##2##3##(2008-10#2)
as previously##7##2##(1990-11#1)(1992-8#1)(1994-2#1)(2008-10#2)(2008-7#1)(2013-1#1)
as primary therapy for##2##4##(2011-2#2)
as primary therapy##3##3##(1990-11#1)(2011-2#2)
as primary##21##2##(1990-11#1)(1992-12#1)(1993-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-8#2)
as primer##2##2##(2008-8#1)(2008-9#1)
as primers##3##2##(1991-5#1)(1995-6#1)(1997-7#1)
as probable##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
as probe##9##2##(1991-5#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-8#2)(2008-9#2)
as probes for##4##3##(2008-10#3)(2008-9#1)
as probes to##2##3##(1994-11#1)(2008-10#1)
as probes##16##2##(1993-2#1)(1994-11#1)(2008-10#7)(2008-8#4)(2008-9#2)(2009-6#1)
as probiotics##4##2##(2011-2#2)(2012-2#1)(2013-7#1)
as procalpain I##2##3##(1992-6#2)
as product of##2##3##(2008-10#2)
as product##3##2##(2008-10#3)
as production##3##2##(2011-2#1)(2013-8#2)
as prognostic indicators##2##3##(2008-11#1)(2012-2#1)
as prognostic##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
as promising##10##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-6#1)(2009-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
as promoting##2##2##(2008-6#1)(2010-10#1)
as prophylactic##2##2##(2011-2#1)(2013-8#1)
as prophylaxis against##3##3##(2008-7#2)(2009-8#1)
as protective##2##2##(1994-11#1)(2013-8#1)
as protein kinase##2##3##(1992-9#1)(2010-4#1)
as protein##10##2##(1992-9#1)(1994-11#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-2#1)
as proteins or##2##3##(2008-12#1)(2008-5#1)
as proteins##7##2##(2008-10#3)(2008-12#1)(2008-5#2)(2009-8#1)
as prototype##2##2##(2008-10#1)(2013-1#1)
as proven##2##2##(2008-11#1)(2011-2#1)
as providers of##2##3##(1996-3#1)(1997-2#1)
as providing##9##2##(1990-6#1)(1991-2#1)(1996-1#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-12#1)(2012-3#1)
as public##4##2##(1991-12#1)(1996-1#1)(1996-3#1)(2013-1#1)
as pulmonary##2##2##(2011-2#1)(2012-3#1)
as pure stands##2##3##(2008-10#2)
as pure##3##2##(2008-10#2)(2008-5#1)
as putative##2##2##(2008-10#2)
as quality##3##2##(1995-2#1)(2010-12#1)(2013-1#1)
as quantitative##2##2##(2008-10#1)(2013-1#1)
as quickly as possible##3##4##(1990-9#1)(2008-11#1)(2013-8#1)
as quickly as##4##3##(1990-9#1)(2008-11#1)(2008-9#1)(2013-8#1)
as race 1##3##3##(2008-10#3)
as race 2##6##3##(2008-10#6)
as race##11##2##(2008-10#11)
as radiation source##2##3##(2008-10#2)
as random##3##2##(2008-10#2)(2010-5#1)
as rapidly as##3##3##(2008-10#2)(2008-11#1)
as rapidly##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
as rate of##2##3##(2008-10#1)(2008-9#1)
as rate##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
as rats##3##2##(1994-2#1)(2009-10#2)
as raw material and##2##4##(2008-10#2)
as raw material##5##3##(2008-10#4)(2008-5#1)
as read-out for##2##3##(2013-8#2)
as readily as##3##3##(2008-10#2)(2008-11#1)
as reagent##6##2##(2008-10#6)
as real##3##2##(2008-10#2)(2008-3#1)
as reasons for##2##3##(2008-11#1)(2008-7#1)
as recent experiences##2##3##(2007-12#1)(2009-10#1)
as recently##3##2##(1991-5#1)(2008-10#1)(2013-8#1)
as receptor##2##2##(2009-9#1)(2011-3#1)
as recipient##2##2##(2008-8#1)(2008-9#1)
as recognition##2##2##(2008-10#2)
as recorded in##2##3##(2008-11#1)(2013-8#1)
as recurrent##2##2##(2008-10#1)(2011-3#1)
as red##3##2##(2008-7#2)(2012-12#1)
as redox##3##2##(2008-10#2)(2008-11#1)
as reduced##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
as reducing##3##2##(2008-10#2)(2012-12#1)
as reductant##4##2##(2008-10#3)(2008-8#1)
as reduction##2##2##(2008-11#2)
as reductions##2##2##(2008-10#1)(2011-2#1)
as reference method##5##3##(2008-10#5)
as reference value pH standard##2##5##(2008-10#2)
as reference##25##2##(1995-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2010-10#1)(2012-3#1)(2013-1#1)
as reflected by##3##3##(1992-12#1)(2008-11#1)(2008-7#1)
as reflected##4##2##(1991-12#1)(1992-12#1)(2008-11#1)(2008-7#1)
as regards the##3##3##(1995-5#1)(2008-10#1)(2011-2#1)
as regards##13##2##(1990-6#1)(1991-6#2)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-5#1)(2008-10#2)(2009-11#1)(2011-2#1)
as registered nurses##2##3##(1994-3#1)(2008-11#1)
as registered##4##2##(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)
as related to##4##3##(2008-10#2)(2008-9#1)(2011-1#1)
as related##6##2##(1996-5#1)(1997-7#1)(2008-10#2)(2008-9#1)(2011-1#1)
as relative standard deviation (R##8##5##(2008-10#8)
as relative standard deviation (RSD)##3##5##(2008-10#2)(2009-8#1)
as relative standard deviation##27##4##(2008-10#26)(2009-8#1)
as relative standard##29##3##(2008-10#28)(2009-8#1)
as relative##32##2##(2008-10#30)(2008-11#1)(2009-8#1)
as reported from##2##3##(2008-10#1)(2011-3#1)
as reported in the literature##2##5##(2008-10#1)(2009-7#1)
as reported in the##3##4##(1992-9#1)(2008-10#1)(2009-7#1)
as reported in##5##3##(1992-9#1)(2008-10#1)(2008-11#1)(2009-7#1)(2013-1#1)
as reported previously##4##3##(1995-12#1)(2008-10#2)(2008-11#1)
as reported##13##2##(1992-9#1)(1993-8#1)(1995-12#1)(2008-10#5)(2008-11#2)(2009-7#1)(2011-3#1)(2013-1#1)
as reporter gene##2##3##(2008-8#1)(2011-3#1)
as reporter##3##2##(1990-5#1)(2008-8#1)(2011-3#1)
as reporters of##2##3##(2007-12#1)(2012-2#1)
as representative of the##2##4##(2008-10#1)(2009-7#1)
as reproductive##2##2##(2008-1#1)(2008-8#1)
as required for##2##3##(2007-11#1)(2008-9#1)
as required##8##2##(1996-1#1)(2007-11#1)(2008-10#3)(2008-4#2)(2008-9#1)
as researchers##6##2##(1995-1#3)(1996-3#1)(2008-12#2)
as reservoirs##2##2##(2008-10#2)
as resistance##2##2##(2008-9#1)(2011-2#1)
as resistant##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
as resources##2##2##(1997-2#1)(2011-1#1)
as response##2##2##(2008-10#2)
as responses##2##2##(2008-5#1)(2008-8#1)
as restriction##2##2##(2008-10#2)
as result of##2##3##(2008-7#1)(2011-2#1)
as results of##2##3##(1991-2#1)(2008-10#1)
as results##4##2##(1991-2#1)(2008-10#1)(2011-1#1)(2011-3#1)
as revealed by in##2##4##(1995-6#1)(2008-11#1)
as revealed by##16##3##(1990-5#1)(1991-10#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
as revealed##17##2##(1990-5#1)(1991-10#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
as reversible##2##2##(2008-10#2)
as risk factors##2##3##(1996-6#1)(2011-2#1)
as risk##5##2##(1995-5#1)(1996-6#1)(1996-8#1)(2008-11#1)(2011-2#1)
as running buffer##2##3##(2008-10#2)
as safe##4##2##(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
as safety##2##2##(1997-5#1)(2009-10#1)
as salicylate##2##2##(2008-10#2)
as salicylic acid##2##3##(2008-10#1)(2008-5#1)
as salient##2##2##(1997-3#1)(2008-1#1)
as salvage##3##2##(1991-6#1)(2011-2#1)(2012-12#1)
as sample matrix##2##3##(2008-10#2)
as sample volume##3##3##(2008-10#3)
as sample##12##2##(2008-10#12)
as samples##4##2##(2008-10#3)(2008-9#1)
as satisfactory##2##2##(2008-10#2)
as scan rate##2##3##(2008-10#2)
as scanning##4##2##(2008-10#3)(2009-7#1)
as screening method##2##3##(2008-10#2)
as screening##7##2##(1993-2#1)(2008-10#5)(2011-3#1)
as second line##2##3##(1994-2#1)(1997-7#1)
as second##5##2##(1993-6#1)(1994-11#1)(1994-2#1)(1997-7#1)(2008-12#1)
as secondary##6##2##(2008-10#4)(2008-5#1)(2010-1#1)
as seed treatments##2##3##(2008-10#2)
as seed##4##2##(2008-10#3)(2008-9#1)
as seeking##2##2##(2008-9#1)(2010-2#1)
as seen by the##2##4##(1994-6#1)(2009-7#1)
as seen in##7##3##(1991-12#1)(1995-11#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-7#1)
as seen on##2##3##(2008-9#1)(2012-2#1)
as seen##13##2##(1990-9#1)(1991-12#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
as selection of##2##3##(2008-10#2)
as selection##3##2##(1992-12#1)(2008-10#2)
as selective##12##2##(1990-3#1)(2008-10#9)(2008-12#1)(2012-2#1)
as sensing material##3##3##(2008-10#3)
as sensing materials##2##3##(2008-10#2)
as sensing##6##2##(2008-10#6)
as sensitive probes##2##3##(1991-3#1)(2008-10#1)
as sensitive to##2##3##(2008-10#1)(2011-2#1)
as sensitive##9##2##(1991-3#2)(1992-3#1)(2008-10#5)(2011-2#1)
as sensitivity to##2##3##(2008-5#1)(2013-1#1)
as sensitivity##5##2##(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
as sensitizing##2##2##(2008-10#2)
as sensor##2##2##(2008-10#2)
as sensors in##2##3##(2008-10#2)
as sensors##4##2##(2008-10#3)(2010-7#1)
as separate##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
as separation##2##2##(2008-10#2)
as serious##2##2##(2008-10#1)(2013-1#1)
as serum##3##2##(2008-10#1)(2008-11#2)
as service##2##2##(1993-1#1)(2008-12#1)
as several##5##2##(2008-10#4)(2010-10#1)
as severe as##2##3##(2008-10#2)
as severe##7##2##(2007-12#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#1)
as sexual##2##2##(1996-11#1)(2009-12#1)
as she##2##2##(1995-11#1)(2008-4#1)
as short as##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
as short##5##2##(1993-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
as show##3##2##(2008-10#3)
as showing##3##2##(1991-2#1)(2008-9#2)
as shown by the presence##2##5##(1995-12#1)(2011-2#1)
as shown by the##10##4##(1990-12#1)(1990-2#1)(1990-9#1)(1991-6#1)(1995-12#1)(2008-10#2)(2010-12#1)(2011-2#2)
as shown by##27##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)
as shown in##4##3##(1990-5#1)(1995-3#1)(2008-10#1)(2008-11#1)
as shown##34##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-9#1)(1991-5#1)(1991-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)
as sick##3##2##(1991-9#2)(1996-1#1)
as signal##4##2##(2008-7#3)(2010-9#1)
as signaling##2##2##(2008-10#1)(2008-9#1)
as signalling molecules##2##3##(2012-6#2)
as signalling##3##2##(2008-11#1)(2012-6#2)
as signals##2##2##(1996-11#1)(2008-9#1)
as significant##5##2##(2008-10#2)(2008-7#1)(2010-6#1)(2010-7#1)
as significantly##2##2##(1992-2#1)(2011-2#1)
as similar##2##2##(1995-2#1)(2008-10#1)
as simple##5##2##(2008-10#3)(2008-8#1)(2012-3#1)
as simultaneous##2##2##(2008-7#1)(2008-9#1)
as single##9##2##(1994-8#1)(2008-5#2)(2008-8#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as single-chain##2##2##(1993-8#1)(1995-3#1)
as single-photon##2##2##(2008-3#1)(2012-2#1)
as size##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
as small as##7##3##(2008-10#3)(2008-2#1)(2008-3#2)(2009-12#1)
as small##15##2##(1994-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2009-12#1)(2010-6#1)(2011-10#1)
as smooth as##2##3##(1996-1#1)(2008-10#1)
as smooth##3##2##(1996-1#1)(2008-10#1)(2008-6#1)
as sodium##11##2##(1995-11#1)(2008-10#5)(2008-11#2)(2010-4#1)(2010-7#1)(2012-2#1)
as soft##3##2##(2008-10#2)(2008-12#1)
as soil##6##2##(2008-10#5)(2008-11#1)
as sole carbon source##2##4##(2008-10#1)(2008-9#1)
as sole##5##2##(1995-5#1)(1997-5#1)(2008-10#2)(2008-9#1)
as solid phase extractant##2##4##(2008-10#2)
as solid phase##10##3##(1992-9#1)(2008-10#9)
as solid support##2##3##(2008-10#2)
as solid##20##2##(1992-9#1)(2008-10#18)(2010-4#1)
as solid-state##2##2##(2008-10#2)
as solution##4##2##(2008-10#4)
as solvent mediator and##3##4##(2008-10#3)
as solvent##11##2##(2008-10#8)(2008-11#1)(2012-2#2)
as some##16##2##(1993-12#1)(1994-11#1)(1996-2#1)(1997-1#1)(2006-6#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-10#1)
as sometimes##2##2##(2008-10#2)
as soon as possible and##3##5##(2008-10#1)(2010-10#1)(2011-2#1)
as soon as possible##9##4##(1990-9#1)(1991-6#1)(1994-3#1)(1996-1#1)(2008-10#2)(2010-10#1)(2010-6#1)(2011-2#1)
as soon as the##2##4##(1990-9#1)(2009-8#1)
as soon as##22##3##(1990-9#2)(1991-12#1)(1991-6#1)(1994-3#1)(1996-1#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#2)(2013-1#2)
as sorbent material##2##3##(2008-10#2)
as sorbent##6##2##(2008-10#6)
as sorbents for##2##3##(2008-10#2)
as source of##2##3##(1990-5#1)(2010-3#1)
as source##4##2##(1990-5#1)(2008-11#1)(2008-8#1)(2010-3#1)
as sources of##4##3##(2008-10#1)(2008-8#1)(2010-2#1)(2012-2#1)
as specific##10##2##(1991-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-6#1)(2013-1#2)
as spectrophotometric##3##2##(2008-10#3)
as speed##2##2##(1994-8#1)(2008-10#1)
as spontaneous##2##2##(2008-11#1)(2012-12#1)
as stabiliser##2##2##(2008-10#2)
as stabilizer##2##2##(1994-8#1)(2008-10#1)
as standard##6##2##(1992-11#1)(2008-10#4)(2013-1#1)
as starting##5##2##(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)
as stated##3##2##(1991-6#1)(2008-10#2)
as stationary phase##2##3##(2008-10#2)
as stationary phases##2##3##(2008-10#2)
as stationary##4##2##(2008-10#4)
as steady state##2##3##(1996-3#1)(2008-10#1)
as stimulation of##2##3##(1995-11#1)(2008-5#1)
as storage##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
as strain##2##2##(2008-10#1)(2013-1#1)
as strains##2##2##(2008-10#1)(2008-11#1)
as stroke##2##2##(1996-2#1)(2008-7#1)
as strong##4##2##(1993-8#1)(1996-8#1)(2008-10#1)(2008-6#1)
as students##2##2##(1991-3#1)(2008-12#1)
as studied by##2##3##(2008-10#2)
as studies##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
as study##2##2##(2010-5#1)(2011-3#1)
as subcutaneous##2##2##(1997-8#1)(2013-1#1)
as subgroup##2##2##(2008-10#2)
as subjects##3##2##(1993-2#1)(2007-12#1)(2008-5#1)
as substitutes for##2##3##(2008-11#1)(2008-8#1)
as substrate##19##2##(1990-5#2)(1994-11#1)(1994-8#1)(1995-2#1)(1997-2#2)(2008-10#7)(2008-11#1)(2008-4#1)(2010-10#1)(2012-2#2)
as substrates for the##2##4##(1994-5#1)(2010-1#1)
as substrates for##6##3##(1994-5#1)(1994-8#2)(2009-6#1)(2010-1#1)(2010-7#1)
as substrates##14##2##(1993-8#1)(1994-5#4)(1994-8#3)(2008-10#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-7#1)
as successful condom users##2##4##(2008-11#2)
as successful##3##2##(2008-11#3)
as such by##2##3##(1995-12#1)(2009-6#1)
as such##25##2##(1990-5#1)(1991-11#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2012-2#1)
as sucrose##2##2##(2008-5#2)
as sudden infant death syndrome##2##5##(1991-11#1)(1991-9#1)
as sudden##3##2##(1991-11#1)(1991-9#1)(2008-10#1)
as suffering from##2##3##(1995-2#1)(2008-10#1)
as suggested by the##2##4##(1992-12#1)(2008-10#1)
as suggested by##5##3##(1992-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2012-4#1)
as suggested##6##2##(1992-12#1)(2008-10#2)(2008-2#1)(2009-10#1)(2012-4#1)
as suitable##6##2##(1991-5#1)(2008-10#4)(2008-11#1)
as sulphate ion##2##3##(2008-10#2)
as sulphate##3##2##(2008-10#3)
as superoxide dismutase##3##3##(1992-9#1)(2008-10#2)
as superoxide##4##2##(1992-12#1)(1992-9#1)(2008-10#2)
as support to##2##3##(2008-11#1)(2008-7#1)
as support##4##2##(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
as supported by the##2##4##(2008-10#1)(2009-10#1)
as supporting electrolyte and##2##4##(2008-10#2)
as supporting electrolyte##7##3##(2008-10#7)
as supporting electrolytes##2##3##(2008-10#2)
as supporting##10##2##(2008-10#9)(2013-8#1)
as supportive##2##2##(1990-2#1)(2009-7#1)
as surface##2##2##(1995-3#1)(2010-4#1)
as surfactant##4##2##(2008-10#4)
as surrogate biomarkers##2##3##(2008-12#1)(2010-1#1)
as surrogate markers for##2##4##(2009-6#1)(2013-1#1)
as surrogate##6##2##(1993-2#1)(1994-9#1)(2008-12#1)(2009-6#1)(2010-1#1)(2013-1#1)
as susceptible##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
as symptoms##2##2##(2011-2#1)(2013-1#1)
as systemic##4##2##(1997-5#1)(2008-12#1)(2010-1#1)(2013-1#1)
as taking##3##2##(2010-10#1)(2011-2#2)
as target cell##2##3##(2008-12#1)(2008-9#1)
as target cells##2##3##(1993-3#1)(2008-8#1)
as target##7##2##(1993-3#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-8#1)
as targets for##3##3##(1997-7#1)(2011-2#1)(2012-2#1)
as targets##4##2##(1997-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
as taxonomic##2##2##(2008-10#1)(2008-12#1)
as technical##2##2##(2008-10#1)(2008-12#1)
as temperature##9##2##(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2013-8#1)
as temperatures increased##2##3##(2008-10#2)
as template##10##2##(1997-7#2)(2008-10#4)(2008-8#3)(2008-9#1)
as templates for##4##3##(1996-8#1)(2008-10#1)(2008-7#1)(2010-11#1)
as templates##6##2##(1995-6#2)(1996-8#1)(2008-10#1)(2008-7#1)(2010-11#1)
as temporary##2##2##(2008-9#1)(2009-12#1)
as ten##2##2##(1993-12#1)(2008-10#1)
as terminal##2##2##(2009-8#1)(2009-9#1)
as ternary complexes##2##3##(2008-10#2)
as test##7##2##(1992-8#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
as testing##2##2##(2008-10#1)(2010-7#1)
as testosterone##2##2##(2008-8#1)(2013-8#1)
as that in##3##3##(1991-10#1)(2008-8#1)(2008-9#1)
as that observed in the##2##5##(1991-2#1)(2008-10#1)
as that observed##4##3##(1991-2#1)(2008-10#2)(2012-2#1)
as that of the##10##4##(1993-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)
as that of##27##3##(1990-5#1)(1993-11#1)(1993-9#1)(1995-6#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#1)(2011-2#1)
as that##48##2##(1990-5#1)(1991-10#1)(1991-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
as the &quot##11##3##(1991-2#1)(1996-1#1)(1996-12#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-3#1)
as the BGE##2##3##(2008-10#2)
as the NaCl rate increased##2##5##(2008-10#2)
as the ability of##2##4##(2007-9#1)(2008-8#1)
as the absorbent##2##3##(2008-10#2)
as the active ingredient##2##4##(2008-10#1)(2008-5#1)
as the active part##3##4##(2008-10#3)
as the active##11##3##(1993-6#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-5#1)
as the analytical signal##2##4##(2008-10#2)
as the analytical##6##3##(2008-10#6)
as the anionic additive##2##4##(2008-10#2)
as the authors##3##3##(1991-1#1)(2008-12#1)(2011-2#1)
as the average##2##3##(2008-10#2)
as the base##3##3##(2008-10#2)(2011-2#1)
as the basic##2##3##(2008-10#1)(2008-7#1)
as the basis for a##2##5##(2008-10#2)
as the basis for the##2##5##(2008-10#1)(2008-11#1)
as the basis for##11##4##(1993-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2010-3#1)(2010-7#1)
as the basis of the##2##5##(1991-3#1)(2013-1#1)
as the basis of##5##4##(1991-3#1)(1994-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
as the basis##16##3##(1991-3#1)(1993-12#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#1)
as the benchmark##2##3##(2008-5#1)(2013-1#1)
as the best for##2##4##(2008-10#2)
as the best##10##3##(1991-12#2)(1993-3#1)(2008-10#5)(2009-8#1)(2011-3#1)
as the binding##2##3##(2008-10#1)(2010-4#1)
as the buffer##3##3##(2008-10#3)
as the carbon source##2##4##(2008-10#2)
as the carrier gas##2##4##(2008-10#2)
as the carrier##6##3##(1997-2#1)(2008-10#5)
as the catalyst and##2##4##(2008-10#1)(2008-12#1)
as the catalyst##6##3##(1995-2#1)(2008-10#3)(2008-12#1)(2008-5#1)
as the causal agent of##2##5##(2008-10#2)
as the cause of##4##4##(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
as the cause##8##3##(2008-1#1)(2008-11#1)(2010-1#2)(2010-10#1)(2011-2#2)(2012-2#1)
as the cell##4##3##(2008-11#2)(2013-1#2)
as the cells##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
as the cellular##2##3##(1992-8#1)(2008-10#1)
as the center##2##3##(1996-3#1)(2008-2#1)
as the central##2##3##(2008-10#1)(2012-2#1)
as the change##3##3##(2008-10#2)(2008-11#1)
as the chemical##8##3##(1991-5#1)(2008-10#5)(2008-5#1)(2008-8#1)
as the choice##2##3##(1995-12#1)(1995-5#1)
as the chromogenic reagent##2##4##(2008-10#2)
as the clinical##2##3##(2008-11#1)(2008-5#1)
as the common##2##3##(2008-11#1)(2009-12#1)
as the complexing##2##3##(2008-10#2)
as the complexities##2##3##(1994-1#1)(2008-10#1)
as the components##2##3##(1996-12#1)(2008-11#1)
as the concentration of the##2##5##(2008-10#1)(2008-12#1)
as the concentration of##6##4##(1994-8#1)(2008-10#3)(2008-11#1)(2008-12#1)
as the concentration##11##3##(1994-8#1)(2008-10#8)(2008-11#1)(2008-12#1)
as the control##4##3##(1991-8#1)(1993-1#1)(1994-5#1)(2008-5#1)
as the conventional##3##3##(1997-8#1)(2008-10#2)
as the core of##2##4##(2008-10#1)(2012-3#1)
as the core##3##3##(2008-10#1)(2012-3#2)
as the critical##3##3##(1992-3#1)(2008-11#1)(2008-3#1)
as the degree##2##3##(1993-3#1)(2008-6#1)
as the detection of##3##4##(1994-3#1)(1997-6#1)(2008-10#1)
as the detection system##2##4##(2008-10#2)
as the detection##6##3##(1994-3#1)(1997-6#1)(2008-10#4)
as the detector of##2##4##(2008-10#2)
as the detector##6##3##(2008-10#6)
as the development of##4##4##(1994-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
as the difference between##6##4##(1991-11#1)(2008-10#4)(2009-11#1)
as the difference in disease##2##5##(2008-10#2)
as the difference in##5##4##(1992-12#1)(2008-10#3)(2009-8#1)
as the difference##11##3##(1991-11#1)(1992-12#1)(2008-10#7)(2009-11#1)(2009-8#1)
as the disease##2##3##(1997-5#1)(2008-2#1)
as the distance##2##3##(2008-10#2)
as the dominant##2##3##(1995-3#1)(2011-3#1)
as the effect of##7##4##(2008-10#7)
as the eluent##3##3##(2008-10#3)
as the enzyme##2##3##(1995-12#1)(1997-1#1)
as the error##2##3##(2008-10#2)
as the etiological##2##3##(2008-9#1)(2011-2#1)
as the excitation source##2##4##(2008-10#1)(2008-7#1)
as the excitation##3##3##(2008-10#2)(2008-7#1)
as the existence of##2##4##(2008-10#1)(2008-7#1)
as the experimental##2##3##(2008-10#1)(2008-7#1)
as the extent of##5##4##(1997-8#1)(2008-10#1)(2010-4#1)(2010-5#1)(2011-2#1)
as the extractants##3##3##(2008-10#3)
as the extracting##2##3##(2008-10#2)
as the extraction##4##3##(2008-10#4)
as the features of##2##4##(1991-8#1)(2012-2#1)
as the fifth##2##3##(1991-9#1)(1992-12#1)
as the first choice##2##4##(1992-9#1)(2013-1#1)
as the first step##4##4##(1995-2#1)(2008-10#2)(2012-2#1)
as the first##23##3##(1990-12#1)(1991-5#1)(1992-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-8#1)(2008-10#5)(2008-8#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
as the first-line##2##3##(2010-12#1)(2012-3#1)
as the formation of##3##4##(1992-12#1)(2008-4#1)(2012-2#1)
as the function of##2##4##(2008-10#1)(2008-7#1)
as the functional##6##3##(1997-4#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-10#1)
as the fungus##2##3##(2008-10#2)
as the generator##2##3##(2007-12#1)(2008-10#1)
as the glucose##2##3##(2008-10#2)
as the gold standard##3##4##(2009-3#1)(2012-12#2)
as the health##2##3##(1996-1#1)(2010-4#1)
as the host##3##3##(2008-10#2)(2008-5#1)
as the human##2##3##(1993-6#1)(2010-5#1)
as the importance of##2##4##(2008-10#1)(2012-2#1)
as the incident##2##3##(2008-2#1)(2008-3#1)
as the independent variable##2##4##(2008-10#2)
as the indicator electrode##3##4##(2008-10#3)
as the indicator##6##3##(2008-10#6)
as the initial##3##3##(1993-2#1)(1997-8#1)(2011-2#1)
as the input##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
as the intensity of##2##4##(1993-3#1)(1995-8#1)
as the interference##2##3##(2008-10#2)
as the internal standard##7##4##(2008-10#7)
as the internal##8##3##(2008-10#8)
as the intracellular##2##3##(1995-11#1)(2011-2#1)
as the intrinsic##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
as the ion##2##3##(2008-10#2)
as the ionic strength was increased##2##6##(1997-2#2)
as the ionic##3##3##(1990-2#1)(1997-2#2)
as the key##7##3##(1991-12#1)(1992-11#1)(1992-3#1)(1994-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
as the leading##3##3##(1997-1#1)(2008-1#1)(2008-10#1)
as the length of##2##4##(2008-10#1)(2011-3#1)
as the level of##2##4##(1997-1#1)(2010-4#1)
as the ligand##3##3##(1990-11#1)(2008-10#1)(2010-12#1)
as the light source and the other##2##7##(2008-10#2)
as the light source and the##3##6##(2008-10#3)
as the light source##5##4##(2008-10#5)
as the main##16##3##(1990-5#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2009-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
as the major##15##3##(1994-1#1)(1994-11#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-1#1)
as the measure##2##3##(2007-8#1)(2008-10#1)
as the mechanism##2##3##(2008-11#1)(2008-8#1)
as the method is##2##4##(2008-10#1)(2008-11#1)
as the method of choice for##2##6##(2008-9#1)(2010-12#1)
as the method of##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
as the method##6##3##(2008-10#2)(2008-11#2)(2008-9#1)(2010-12#1)
as the minimum##2##3##(1996-12#1)(2008-10#1)
as the mobile phase##6##4##(1991-7#1)(1993-11#1)(2008-10#4)
as the mobile##7##3##(1991-7#1)(1993-11#1)(2008-10#5)
as the model##7##3##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)
as the molecular##2##3##(2008-10#1)(2008-5#1)
as the molecule##2##3##(2008-10#1)(2010-5#1)
as the more##3##3##(1992-12#1)(2008-10#1)(2012-3#1)
as the most appropriate##3##4##(2008-10#2)(2011-2#1)
as the most common##3##4##(2008-12#1)(2011-2#1)(2013-8#1)
as the most critical##2##4##(2012-3#1)(2013-8#1)
as the most effective##2##4##(2008-10#1)(2008-11#1)
as the most important##4##4##(1995-1#1)(2008-11#1)(2010-3#1)(2013-8#1)
as the most suitable##2##4##(2008-10#2)
as the most##36##3##(1991-6#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-1#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
as the name##2##3##(2008-10#1)(2010-5#1)
as the natural##2##3##(1995-12#1)(2011-3#1)
as the need for##2##4##(2008-10#1)(2011-1#1)
as the need##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
as the new##2##3##(2008-3#1)(2010-6#1)
as the number of##12##4##(1993-12#1)(1995-12#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)
as the number##13##3##(1993-12#1)(1995-12#1)(1997-6#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)
as the older##2##3##(1994-5#1)(2008-10#1)
as the only active##2##4##(2008-10#2)
as the only means of##2##5##(1991-2#1)(2008-11#1)
as the only##7##3##(1991-2#1)(1991-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
as the optimal##4##3##(2008-10#1)(2008-6#1)(2009-7#1)(2012-3#1)
as the optimum##4##3##(2008-10#4)
as the organic##3##3##(2008-10#3)
as the original##2##3##(2008-10#1)(2008-9#1)
as the outcome of##2##4##(2008-12#1)(2012-2#1)
as the outcome##3##3##(1993-1#1)(2008-12#1)(2012-2#1)
as the oxidant##2##3##(2008-10#1)(2008-5#1)
as the pH##7##3##(1990-5#1)(2008-10#6)
as the percentage of##5##4##(2006-6#1)(2008-10#3)(2011-2#1)
as the percentage##6##3##(2006-6#1)(2008-10#3)(2008-9#1)(2011-2#1)
as the physiological##2##3##(1994-5#1)(2008-1#1)
as the plant##2##3##(2008-10#2)
as the potential##4##3##(1991-12#1)(1997-2#1)(2008-10#1)(2009-12#1)
as the precursor##2##3##(2008-10#1)(2008-2#1)
as the predominant##5##3##(1990-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
as the presence of the##2##5##(1996-3#1)(2008-12#1)
as the presence of##6##4##(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#1)
as the presenting##3##3##(1990-3#1)(2010-10#1)(2010-6#1)
as the primary##13##3##(1990-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
as the prime##2##3##(1995-3#1)(1996-1#1)
as the principal##2##3##(2008-10#1)(2008-11#1)
as the probe##5##3##(2008-10#2)(2008-2#1)(2008-8#2)
as the product of##2##4##(2008-10#2)
as the professional##2##3##(1991-1#1)(2012-3#1)
as the propellant##2##3##(1996-1#1)(1996-2#1)
as the proportion of##3##4##(2008-10#2)(2008-3#1)
as the proposed##2##3##(2008-11#1)(2011-1#1)
as the protection##2##3##(2013-1#2)
as the pulse duration##2##4##(1991-2#2)
as the pulse##4##3##(1991-2#2)(2007-12#2)
as the pump##2##3##(2008-2#1)(2008-3#1)
as the quality of##3##4##(1996-2#1)(1997-4#1)(2008-8#1)
as the range of##3##4##(2008-12#1)(2008-8#1)(2013-1#1)
as the range##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
as the ratio between the##2##5##(2008-10#1)(2008-6#1)
as the ratio of##6##4##(1991-6#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)
as the ratio##8##3##(1991-6#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)
as the reagent##2##3##(2008-10#2)
as the recognition##2##3##(1992-10#1)(2008-10#1)
as the recording##3##3##(2008-3#3)
as the reference##5##3##(1991-5#1)(2008-10#3)(2008-11#1)
as the regulation##2##3##(2008-9#2)
as the relative standard deviation##3##5##(2008-10#3)
as the relative standard##5##4##(2008-10#5)
as the relative##8##3##(1996-5#1)(2008-10#5)(2008-8#1)(2010-11#1)
as the response##3##3##(2008-10#3)
as the result of##4##4##(1994-3#1)(2008-10#2)(2008-11#1)
as the result##5##3##(1994-3#1)(2008-10#3)(2008-11#1)
as the results##3##3##(2008-10#2)(2008-5#1)
as the role of##5##4##(2008-10#1)(2008-4#1)(2010-11#1)(2010-12#1)(2013-8#1)
as the same##2##3##(2008-11#1)(2008-9#1)
as the sample##2##3##(2008-10#2)
as the samples##3##3##(2008-10#2)(2012-2#1)
as the scale##2##3##(2008-11#2)
as the scan##2##3##(2008-10#2)
as the scientific community##3##4##(2008-12#1)(2012-2#2)
as the selection##4##3##(1997-6#1)(2008-10#1)(2008-8#1)(2009-8#1)
as the sensing material##2##4##(2008-10#2)
as the sensing##3##3##(2008-10#3)
as the signal##2##3##(1993-12#1)(2008-12#1)
as the simultaneous##2##3##(2008-10#1)(2009-8#1)
as the site##2##3##(2012-12#2)
as the size parameter##2##4##(2008-3#2)
as the size##3##3##(2008-3#2)(2008-5#1)
as the smallest units of##2##5##(2008-10#2)
as the sole carbon source##2##5##(2008-10#1)(2011-1#1)
as the sole source of##2##5##(2008-10#1)(2008-7#1)
as the sole##12##3##(1991-9#1)(1996-5#1)(1997-7#1)(2008-10#5)(2008-7#2)(2010-5#1)(2011-1#1)
as the solid##4##3##(1990-6#1)(2008-10#3)
as the solution##2##3##(1995-1#1)(2008-10#1)
as the solvent##7##3##(2008-10#5)(2008-11#1)(2012-2#1)
as the source of##5##4##(2008-10#3)(2008-11#1)(2008-4#1)
as the source##6##3##(2008-10#4)(2008-11#1)(2008-4#1)
as the specific##3##3##(2008-10#2)(2008-11#1)
as the standard##6##3##(2008-10#3)(2010-12#1)(2010-3#1)(2012-2#1)
as the stationary phase##4##4##(2008-10#4)
as the stimulus intensity is increased##2##6##(2008-7#2)
as the stimulus##3##3##(2008-7#2)(2008-8#1)
as the study##2##3##(1991-12#1)(2008-11#1)
as the substrate##4##3##(2008-10#3)(2008-5#1)
as the substrates##2##3##(1993-6#1)(2008-10#1)
as the supporting electrolyte##2##4##(2008-10#2)
as the supporting##3##3##(2008-10#3)
as the symptoms##2##3##(2010-8#1)(2013-1#1)
as the target##4##3##(2008-10#3)(2012-2#1)
as the template##3##3##(2008-10#3)
as the test##5##3##(2008-10#4)(2008-3#1)
as the testing##2##3##(2008-10#1)(2009-11#1)
as the therapeutic##2##3##(2008-11#1)(2008-6#1)
as the thickness of the##2##5##(2008-3#1)(2008-7#1)
as the thickness of##4##4##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
as the third##2##3##(2008-10#2)
as the three##2##3##(1997-8#1)(2008-10#1)
as the time of##2##4##(2008-10#2)
as the time##3##3##(2008-10#3)
as the titrant##3##3##(2008-10#3)
as the total concentration of##2##5##(2008-10#2)
as the total##3##3##(2008-10#3)
as the tumor##3##3##(1990-6#1)(2011-2#1)(2013-1#1)
as the two##2##3##(2008-10#2)
as the type species##2##4##(2011-2#2)
as the type##3##3##(1996-12#1)(2011-2#2)
as the underlying##3##3##(1991-9#1)(2008-1#1)(2011-3#1)
as the university considers that there are grounds for such action##2##11##(2008-10#2)
as the use of##7##4##(2008-10#5)(2008-11#1)(2009-10#1)
as the water##2##3##(2008-10#1)(2008-7#1)
as the wild type##5##4##(1993-3#1)(2008-10#3)(2008-9#1)
as the wild-type##2##3##(1992-6#1)(2008-10#1)
as the women##2##3##(1996-1#1)(2009-4#1)
as the working electrode##5##4##(2008-10#5)
as the working##6##3##(2008-10#6)
as the##1601##2##(1990-11#5)(1990-12#6)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-11#4)(1991-12#12)(1991-2#7)(1991-3#5)(1991-5#6)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#8)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#5)(1993-1#6)(1993-11#1)(1993-12#12)(1993-2#4)(1993-3#7)(1993-6#7)(1993-8#3)(1994-1#5)(1994-11#11)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#6)(1994-8#7)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#11)(1995-2#9)(1995-3#4)(1995-5#6)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#12)(1996-12#8)(1996-2#7)(1996-3#7)(1996-5#6)(1996-9#1)(1997-1#7)(1997-2#13)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#7)(2006-6#1)(2007-12#9)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#611)(2008-11#97)(2008-12#26)(2008-2#13)(2008-3#44)(2008-4#9)(2008-5#37)(2008-6#14)(2008-7#34)(2008-8#35)(2008-9#38)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#7)(2009-7#7)(2009-8#14)(2010-1#8)(2010-10#5)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#6)(2010-4#5)(2010-5#11)(2010-6#4)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#57)(2011-3#13)(2011-4#2)(2011-7#2)(2012-12#10)(2012-2#31)(2012-3#20)(2012-6#1)(2012-9#2)(2013-1#34)(2013-8#19)
as their own##3##3##(1995-1#1)(1995-2#1)(2012-3#1)
as their##65##2##(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-8#4)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#3)(2013-1#2)
as therapeutic agents##2##3##(1990-9#1)(2008-5#1)
as therapeutic##7##2##(1990-9#2)(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
as therapeutics##4##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
as there are##2##3##(1992-2#1)(2008-11#1)
as there is no##2##4##(2008-3#1)(2013-1#1)
as there is##4##3##(1997-1#1)(2008-3#1)(2008-8#1)(2013-1#1)
as there was##2##3##(1990-5#1)(2008-10#1)
as there##9##2##(1990-5#1)(1992-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
as these are##3##3##(2008-10#2)(2010-11#1)
as these cells##2##3##(2009-3#1)(2013-1#1)
as these##18##2##(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
as they age##3##3##(2008-10#1)(2008-12#1)(2010-1#1)
as they allow##2##3##(2008-5#1)(2009-4#1)
as they apply to##5##4##(1992-2#1)(2008-10#1)(2008-11#1)(2010-6#1)(2010-7#1)
as they are quite##2##4##(2008-10#1)(2010-12#1)
as they are##15##3##(1995-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-11#1)(2010-12#3)(2011-2#1)(2011-7#1)(2013-1#3)(2013-8#1)
as they could##2##3##(2008-10#1)(2011-2#1)
as they do not##2##4##(2008-10#1)(2011-1#1)
as they increase##2##3##(1990-12#1)(2007-12#1)
as they may##2##3##(2008-11#1)(2009-5#1)
as they provide##2##3##(2008-9#1)(2010-9#1)
as they relate to the##4##5##(1991-2#1)(1997-2#1)(2008-5#1)(2008-9#1)
as they relate to##5##4##(1991-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
as they were##5##3##(2008-5#2)(2008-7#2)(2013-1#1)
as they##83##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#4)(2008-3#2)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
as thiocyanate complexes##2##3##(2008-10#2)
as thiocyanate##3##2##(2008-10#3)
as this is##2##3##(1991-12#1)(2012-2#1)
as this population##2##3##(2011-2#2)
as this##27##2##(1991-12#1)(1995-12#1)(1995-2#1)(1997-1#2)(1997-2#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#2)(2010-5#2)(2011-2#3)(2012-2#2)(2013-1#2)
as those in the##3##4##(1991-12#1)(2008-4#1)(2010-1#1)
as those in##5##3##(1991-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2010-1#1)
as those normally##2##3##(1994-9#1)(2010-1#1)
as those of the##2##4##(1994-11#1)(1997-8#1)
as those of##13##3##(1993-8#1)(1994-11#2)(1994-12#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#2)(2009-6#1)(2013-1#1)
as those that are##2##4##(1997-3#1)(2011-2#1)
as those that##3##3##(1997-3#1)(2009-10#1)(2011-2#1)
as those with##6##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#1)
as those##58##2##(1991-12#1)(1992-10#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-12#2)(1997-3#2)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
as though##2##2##(1993-12#1)(1995-3#1)
as three times the standard deviation of the##4##8##(2008-10#4)
as three times the standard deviation of##6##7##(2008-10#6)
as three times##7##3##(2008-10#6)(2010-8#1)
as three##9##2##(2008-10#8)(2010-8#1)
as thumb##2##2##(1995-12#1)(2008-9#1)
as tillage##2##2##(2008-10#2)
as time##7##2##(2008-10#1)(2008-11#3)(2008-9#1)(2010-9#1)(2011-2#1)
as tissue##4##2##(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#1)
as titrant##2##2##(2008-10#2)
as to a##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
as to assess##2##3##(1993-3#1)(2012-2#1)
as to develop##3##3##(2012-12#1)(2012-2#1)(2013-8#1)
as to establish##2##3##(2008-10#1)(2013-1#1)
as to how the##2##4##(2008-10#1)(2008-8#1)
as to how they##2##4##(2010-9#2)
as to how##9##3##(1994-2#1)(1994-3#1)(2008-10#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-9#2)
as to its##2##3##(2008-10#1)(2008-11#1)
as to perform##2##3##(2008-10#1)(2010-8#1)
as to the##27##3##(1992-1#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-3#1)(1996-5#1)(1996-9#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
as to their##4##3##(1994-11#1)(1995-12#1)(1995-2#1)(2010-10#1)
as to what##5##3##(1993-1#1)(1993-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
as to whether##7##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
as to##138##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-6#2)(2007-12#1)(2008-1#2)(2008-10#30)(2008-11#9)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#7)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#6)(2010-8#2)(2010-9#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
as too##2##2##(1995-6#1)(2010-8#1)
as tools for monitoring##2##4##(2008-11#2)
as tools for##3##3##(2008-11#3)
as tools to##2##3##(1991-2#1)(2008-9#1)
as tools##6##2##(1991-2#1)(2008-11#3)(2008-7#1)(2008-9#1)
as topical##2##2##(1993-1#1)(2008-8#1)
as total##2##2##(2008-6#1)(2013-1#1)
as toxic##2##2##(2008-10#2)
as training##2##2##(2008-10#1)(2012-3#1)
as transcription##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)
as treatment of##5##3##(1994-12#1)(2009-7#1)(2010-12#1)(2011-2#2)
as treatment##10##2##(1994-12#1)(1994-3#1)(1996-8#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
as treatments for spatial##2##4##(1993-3#2)
as true##4##2##(1993-2#1)(2008-10#2)(2013-7#1)
as tumor##2##2##(2008-11#1)(2011-2#1)
as two##15##2##(1995-11#1)(1997-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
as two-dimensional##2##2##(1996-2#1)(2008-3#1)
as type##2##2##(2008-10#1)(2009-3#1)
as types of##5##3##(1994-12#2)(2008-10#3)
as typical##3##2##(2007-12#1)(2008-8#1)(2009-7#1)
as under##2##2##(2008-5#1)(2012-2#1)
as undifferentiated##2##2##(2008-11#1)(2011-2#1)
as undiluted##2##2##(2008-10#2)
as unique reagents in##2##4##(2008-10#1)(2010-7#1)
as unique##3##2##(2008-10#1)(2010-7#2)
as universal##3##2##(2008-10#3)
as useful##4##2##(2008-10#1)(2008-11#2)(2009-6#1)
as usual##3##2##(2008-10#2)(2010-10#1)
as usually##2##2##(2008-10#1)(2012-2#1)
as various##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)
as varying##2##2##(1997-2#1)(2008-10#1)
as vascular##3##2##(2008-1#1)(2008-9#1)(2010-7#1)
as vectors for##2##3##(2008-11#1)(2011-3#1)
as vectors##7##2##(1994-11#1)(2008-10#2)(2008-11#1)(2009-5#1)(2011-3#1)(2012-2#1)
as vehicles for##2##3##(1995-5#1)(2008-10#1)
as vehicles##3##2##(1995-5#1)(2008-10#1)(2012-2#1)
as very##4##2##(1991-3#1)(2008-10#2)(2013-1#1)
as viable##2##2##(2008-10#1)(2008-11#1)
as viral##3##2##(1996-2#1)(2008-10#2)
as virulent##2##2##(2008-10#2)
as virus##3##2##(2008-10#2)(2013-8#1)
as visual##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
as visualized##2##2##(1996-12#1)(2008-12#1)
as vitamin##2##2##(1992-9#1)(2011-2#1)
as volatile##2##2##(1994-3#1)(2008-10#1)
as volunteer##2##2##(1996-3#2)
as volunteers and##2##3##(1994-3#1)(1995-12#1)
as volunteers##8##2##(1991-12#2)(1994-3#1)(1995-12#1)(1996-3#2)(2008-12#1)(2012-3#1)
as was seen in##2##4##(1994-8#1)(2008-8#1)
as was seen##3##3##(1993-6#1)(1994-8#1)(2008-8#1)
as was the case for##2##5##(1991-7#1)(2013-1#1)
as was the case in the##2##6##(1995-6#1)(2008-10#1)
as was the case##4##4##(1991-7#1)(1995-6#1)(2008-10#1)(2013-1#1)
as was the##10##3##(1990-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
as was##27##2##(1990-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#2)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#2)
as waste##2##2##(2008-10#1)(2008-9#1)
as water##7##2##(2008-10#5)(2008-3#1)(2008-5#1)
as ways##2##2##(1991-2#1)(2008-11#1)
as we know##3##3##(2008-10#2)(2008-2#1)
as we##10##2##(1995-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)
as well as 11##2##4##(2008-10#2)
as well as CHA's accentuation of ethanol's motor impairment##2##9##(1997-2#2)
as well as P##3##4##(2008-10#2)(2008-4#1)
as well as a large##2##5##(2008-10#1)(2012-12#1)
as well as a number of##2##6##(2008-10#1)(2008-11#1)
as well as a##55##4##(1990-7#1)(1990-8#1)(1991-1#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-6#1)(1996-12#1)(1996-3#2)(2007-12#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
as well as abiotic##2##4##(2009-10#1)(2011-2#1)
as well as additional##2##4##(2007-12#1)(2008-10#1)
as well as all##2##4##(2008-10#1)(2008-9#1)
as well as all-cause mortality##2##5##(1993-12#2)
as well as alpha##2##4##(2008-10#1)(2008-7#1)
as well as alterations in##3##5##(2008-10#1)(2008-12#1)(2010-6#1)
as well as alternative##3##4##(1997-7#1)(2008-4#1)(2008-6#1)
as well as an important##2##5##(2008-10#1)(2008-7#1)
as well as an increase in##5##6##(2008-10#1)(2008-11#1)(2009-11#1)(2012-2#1)(2013-1#1)
as well as an##18##4##(1995-2#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2009-11#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
as well as apoptosis##2##4##(2008-5#1)(2011-2#1)
as well as at the##4##5##(1995-11#1)(2008-10#1)(2008-12#1)(2012-2#1)
as well as at##7##4##(1995-11#1)(1995-2#1)(2008-10#2)(2008-12#1)(2009-3#1)(2012-2#1)
as well as because##2##4##(2009-12#1)(2012-3#1)
as well as being a##3##5##(2008-11#2)(2008-5#1)
as well as being##5##4##(2008-11#2)(2008-5#1)(2009-10#1)(2009-6#1)
as well as between##2##4##(1994-8#1)(2008-1#1)
as well as binding##2##4##(1993-12#1)(2009-7#1)
as well as body##2##4##(2008-7#1)(2009-4#1)
as well as by the##2##5##(2008-9#1)(2009-8#1)
as well as by their##2##5##(1995-12#1)(2010-2#1)
as well as by##24##4##(1990-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as well as cases of##2##5##(1991-9#1)(2007-12#1)
as well as certain##2##4##(2008-10#1)(2009-10#1)
as well as changes in##3##5##(1990-5#1)(2008-11#1)(2012-3#1)
as well as changes##5##4##(1990-5#1)(2008-11#2)(2010-4#1)(2012-3#1)
as well as clinical##3##4##(1995-12#1)(2008-10#1)(2011-1#1)
as well as common##2##4##(2011-2#1)(2011-4#1)
as well as conditions##2##4##(2008-10#1)(2012-2#1)
as well as controls##2##4##(1995-3#1)(2008-7#1)
as well as data##4##4##(1991-12#1)(1997-3#1)(2008-10#1)(2012-3#1)
as well as decreased##2##4##(2011-2#1)(2013-1#1)
as well as decreasing##2##4##(2012-2#1)(2012-3#1)
as well as different##3##4##(1997-6#1)(2008-10#1)(2008-5#1)
as well as directly##2##4##(2009-8#1)(2011-1#1)
as well as enzymes##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
as well as external##3##4##(2008-10#2)(2008-12#1)
as well as factors##2##4##(1996-2#1)(2013-1#1)
as well as fine##2##4##(1997-2#1)(2008-10#1)
as well as fluorescent##2##4##(2008-8#1)(2008-9#1)
as well as for the key role of Mg(2+) in the reaction##2##12##(2013-1#2)
as well as for the##12##5##(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#2)
as well as for##39##4##(1993-3#1)(1994-12#2)(1997-7#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
as well as four##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
as well as from other##2##5##(1992-2#1)(2008-7#1)
as well as from the##3##5##(1994-12#1)(2012-2#2)
as well as from##13##4##(1992-2#1)(1992-6#1)(1993-1#1)(1994-12#1)(1995-11#1)(1995-6#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-2#2)
as well as gene expression##2##5##(1996-6#1)(2008-11#1)
as well as high##5##4##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-1#1)
as well as human##3##4##(1997-6#1)(2008-6#1)(2012-2#1)
as well as in a##3##5##(1994-3#1)(2008-10#1)(2012-12#1)
as well as in other##2##5##(2008-11#1)(2012-2#1)
as well as in patients with##3##6##(2008-10#1)(2011-2#1)(2013-1#1)
as well as in the total##2##6##(2009-6#1)(2009-8#1)
as well as in the##34##5##(1991-3#1)(1992-12#2)(1993-12#1)(1996-1#1)(1997-7#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-7#2)
as well as in their##2##5##(2008-10#1)(2010-8#1)
as well as in##112##4##(1990-12#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-12#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#32)(2008-11#11)(2008-12#4)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)
as well as increased##3##4##(1992-8#1)(2008-1#1)(2008-6#1)
as well as infectious##2##4##(2008-9#1)(2012-2#1)
as well as introducing##2##4##(2008-9#1)(2012-2#1)
as well as its##25##4##(1993-3#1)(1993-6#2)(1994-11#1)(1995-11#1)(1996-2#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#2)(2012-3#2)
as well as less##2##4##(2009-11#1)(2013-1#1)
as well as limiting##2##4##(2008-10#1)(2008-11#1)
as well as many##5##4##(1992-12#1)(1995-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
as well as maternal##2##4##(1992-12#1)(2008-9#1)
as well as measures##2##4##(1993-12#1)(2008-11#1)
as well as metabolic##2##4##(2008-10#1)(2011-2#1)
as well as methods for##2##5##(2008-2#1)(2008-9#1)
as well as more##3##4##(2009-7#1)(2010-12#2)
as well as morphological##2##4##(2008-12#1)(2009-8#1)
as well as natural##2##4##(2008-10#2)
as well as new##2##4##(2008-4#1)(2011-2#1)
as well as numerous##4##4##(1991-2#1)(2008-11#1)(2009-12#1)(2010-6#1)
as well as of the##3##5##(2008-10#2)(2008-11#1)
as well as of##14##4##(1991-8#1)(1994-5#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#2)(2013-8#1)
as well as on how##2##5##(2008-12#1)(2012-2#1)
as well as on the##11##5##(1990-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)
as well as on##24##4##(1990-5#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-8#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#1)
as well as one##3##4##(1997-7#1)(2008-10#1)(2008-9#1)
as well as optimization##2##4##(2008-3#1)(2012-2#1)
as well as other##23##4##(1991-3#2)(1992-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-2#2)(2013-1#1)
as well as others##2##4##(2008-4#1)(2010-10#1)
as well as patients##2##4##(1992-3#1)(1993-11#1)
as well as physical##2##4##(2009-12#1)(2009-7#1)
as well as plant##2##4##(2008-10#2)
as well as possible##4##4##(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
as well as potential##6##4##(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
as well as previous##2##4##(2008-11#1)(2011-2#1)
as well as protein##3##4##(2009-8#1)(2010-4#1)(2012-2#1)
as well as protocols for##2##5##(2008-9#2)
as well as recently##2##4##(1991-5#1)(2013-8#1)
as well as recommendations for long-term##2##6##(2008-9#2)
as well as reduced##2##4##(2008-10#1)(2011-2#1)
as well as related##2##4##(1996-5#1)(1997-7#1)
as well as samples##2##4##(2008-10#1)(2008-9#1)
as well as serum##2##4##(2008-10#1)(2008-11#1)
as well as several##2##4##(2008-10#2)
as well as show##2##4##(2008-10#2)
as well as simple##2##4##(2008-10#1)(2008-8#1)
as well as small##2##4##(2008-11#1)(2008-3#1)
as well as some of the##5##6##(1997-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)
as well as some of##6##5##(1997-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)
as well as some##13##4##(1993-12#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-9#1)(2009-10#1)
as well as sound##2##4##(2008-12#1)(2012-2#1)
as well as specific##2##4##(2013-1#2)
as well as storage##3##4##(2008-10#2)(2008-9#1)
as well as studies##2##4##(2008-10#1)(2008-11#1)
as well as support##3##4##(2008-11#1)(2008-9#1)(2012-2#1)
as well as synthetic##2##4##(1992-11#1)(2008-11#1)
as well as taking##2##4##(2011-2#2)
as well as technological##2##4##(1991-3#1)(1994-12#1)
as well as that of the##2##6##(2008-10#1)(2011-2#1)
as well as that of##5##5##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
as well as the characteristics of##2##6##(2008-11#1)(2008-7#1)
as well as the chemical##3##5##(1991-5#1)(2008-10#1)(2008-5#1)
as well as the conditions for##2##6##(2008-10#1)(2008-9#1)
as well as the conditions##3##5##(2008-10#2)(2008-9#1)
as well as the determination of##2##6##(1990-12#1)(2008-10#1)
as well as the development of##3##6##(1994-8#1)(2008-11#1)(2011-2#1)
as well as the effect of##2##6##(2008-10#2)
as well as the effects of##2##6##(2008-10#1)(2008-5#1)
as well as the extent of##2##6##(2008-10#1)(2011-2#1)
as well as the factors that##2##6##(1991-11#1)(2008-12#1)
as well as the functional##3##5##(1997-4#1)(2008-6#1)(2008-7#1)
as well as the fundamentals of##2##6##(1994-12#2)
as well as the identification of##2##6##(1995-9#1)(2008-10#1)
as well as the influence of##2##6##(2008-10#1)(2008-11#1)
as well as the intrinsic##2##5##(2008-10#1)(2008-3#1)
as well as the location##2##5##(2008-10#1)(2008-8#1)
as well as the number of##2##6##(2008-10#2)
as well as the other##2##5##(2008-7#1)(2008-8#1)
as well as the possibility##2##5##(2008-10#1)(2008-3#1)
as well as the possible##4##5##(2008-10#4)
as well as the presence of##2##6##(2008-10#1)(2008-12#1)
as well as the principles of##2##6##(2008-10#1)(2010-7#1)
as well as the quality of##2##6##(1996-2#1)(1997-4#1)
as well as the reduction##2##5##(2008-11#1)(2008-7#1)
as well as the relative##3##5##(1996-5#1)(2008-8#1)(2010-11#1)
as well as the repeatability##2##5##(2008-10#2)
as well as the results of a##2##7##(2008-10#1)(2008-5#1)
as well as the role of##4##6##(2008-10#1)(2010-11#1)(2010-12#1)(2013-8#1)
as well as the specific##2##5##(2008-10#1)(2008-11#1)
as well as the thickness of##2##6##(2008-10#1)(2008-3#1)
as well as the tissue##3##5##(1992-6#1)(2008-11#1)(2012-3#1)
as well as the use of##3##6##(2008-10#1)(2008-11#1)(2009-10#1)
as well as the##300##4##(1990-12#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#1)(1992-1#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#3)(1995-11#3)(1995-12#1)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#3)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#90)(2008-11#23)(2008-12#4)(2008-3#9)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#8)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#4)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#7)(2013-8#5)
as well as their implications##2##5##(2008-5#1)(2009-8#1)
as well as their possible##2##5##(2008-10#1)(2009-8#1)
as well as their##33##4##(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-3#1)(1997-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2009-7#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#1)
as well as those of##2##5##(1994-11#1)(2008-10#1)
as well as those##8##4##(1994-11#1)(2008-10#4)(2008-12#1)(2009-8#1)(2011-2#1)
as well as through##2##4##(2010-1#1)(2012-3#1)
as well as tissue##3##4##(2008-10#1)(2008-6#1)(2011-2#1)
as well as to a##2##5##(2012-12#1)(2013-1#1)
as well as to develop##2##5##(2012-12#1)(2013-8#1)
as well as to identify##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
as well as to the##7##5##(1996-5#1)(1996-9#1)(2008-10#4)(2008-3#1)
as well as to##39##4##(1992-1#1)(1994-11#1)(1994-2#2)(1995-2#1)(1996-5#1)(1996-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-9#3)(2010-10#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
as well as treatment##3##4##(2010-12#1)(2011-2#1)(2013-1#1)
as well as two##3##4##(1997-9#1)(2008-11#1)(2008-9#1)
as well as use of##2##5##(1991-2#1)(2008-10#1)
as well as various##4##4##(1994-5#1)(2008-10#1)(2008-11#1)(2010-5#1)
as well as visual##2##4##(2008-11#1)(2013-1#1)
as well as with the##5##5##(1990-2#1)(1993-8#1)(2008-10#2)(2012-2#1)
as well as with two other##2##6##(2010-4#1)(2012-2#1)
as well as with##20##4##(1990-2#1)(1992-3#1)(1993-8#1)(1994-8#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#2)
as well as within the##2##5##(1991-12#1)(2008-8#1)
as well as within##5##4##(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#2)
as well as yeast##2##4##(1993-8#1)(1997-8#1)
as well as##1605##3##(1990-12#6)(1990-2#1)(1990-5#5)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#5)(1991-11#3)(1991-12#6)(1991-2#5)(1991-3#7)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#9)(1993-1#2)(1993-11#2)(1993-12#10)(1993-2#2)(1993-3#4)(1993-6#7)(1993-8#7)(1994-1#5)(1994-11#6)(1994-12#13)(1994-2#4)(1994-3#6)(1994-5#3)(1994-8#10)(1995-11#10)(1995-12#8)(1995-2#14)(1995-3#3)(1995-5#8)(1995-6#11)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#11)(1996-3#6)(1996-5#5)(1996-6#2)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#2)(1997-4#4)(1997-6#6)(1997-7#10)(1997-8#7)(1997-9#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#9)(2007-8#2)(2008-1#9)(2008-10#405)(2008-11#129)(2008-12#34)(2008-2#7)(2008-3#36)(2008-4#23)(2008-5#36)(2008-6#14)(2008-7#32)(2008-8#38)(2008-9#57)(2009-10#15)(2009-11#4)(2009-12#8)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#11)(2009-7#11)(2009-8#18)(2009-9#1)(2010-1#8)(2010-10#13)(2010-11#10)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#9)(2010-5#8)(2010-6#12)(2010-7#8)(2010-8#8)(2010-9#2)(2011-1#10)(2011-2#80)(2011-3#4)(2011-4#1)(2011-7#2)(2011-8#1)(2012-12#11)(2012-2#60)(2012-3#30)(2013-1#54)(2013-7#3)(2013-8#24)
as well asforpolicy makers##2##4##(2013-8#2)
as well the##2##3##(2008-11#1)(2011-4#1)
as well to##2##3##(2008-10#1)(2013-3#1)
as were isolates##2##3##(2008-10#2)
as were##6##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-9#1)
as whole##3##2##(1995-12#1)(2008-4#1)(2010-1#1)
as wild-type##2##2##(1995-2#1)(2008-10#1)
as with any##2##3##(2008-10#1)(2012-2#1)
as with the##7##3##(1990-2#1)(1991-5#1)(1993-8#1)(2008-10#3)(2012-2#1)
as with##29##2##(1990-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#3)(2013-1#1)
as withdrawal symptoms##2##3##(2009-7#1)(2011-1#1)
as within##6##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#2)
as working electrode##5##3##(2008-10#5)
as working##9##2##(1991-12#1)(2008-10#8)
as would be##2##3##(2008-10#1)(2013-1#1)
as would##4##2##(1991-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
as yet no##2##3##(2010-12#1)(2012-12#1)
as yet unknown##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
as yet##22##2##(1991-9#1)(1992-3#1)(1993-2#1)(1993-9#1)(1996-11#2)(1997-3#2)(2008-10#4)(2008-11#4)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#2)(2012-12#1)
as zinc##3##2##(2008-10#2)(2013-7#1)
as##17232##1##(1990-10#7)(1990-11#42)(1990-12#31)(1990-2#39)(1990-3#17)(1990-4#1)(1990-5#73)(1990-6#14)(1990-7#4)(1990-8#35)(1990-9#31)(1991-1#26)(1991-10#8)(1991-11#25)(1991-12#76)(1991-2#59)(1991-3#58)(1991-4#1)(1991-5#56)(1991-6#60)(1991-7#8)(1991-8#23)(1991-9#24)(1992-1#23)(1992-10#8)(1992-11#14)(1992-12#76)(1992-2#32)(1992-3#64)(1992-4#5)(1992-5#5)(1992-6#51)(1992-7#3)(1992-8#18)(1992-9#66)(1993-1#46)(1993-11#26)(1993-12#93)(1993-2#46)(1993-3#58)(1993-6#53)(1993-8#79)(1993-9#13)(1994-1#34)(1994-11#66)(1994-12#81)(1994-2#44)(1994-3#70)(1994-5#60)(1994-6#16)(1994-8#71)(1994-9#22)(1995-1#24)(1995-10#1)(1995-11#71)(1995-12#91)(1995-2#126)(1995-3#34)(1995-5#59)(1995-6#69)(1995-8#44)(1995-9#16)(1996-1#51)(1996-11#30)(1996-12#73)(1996-2#72)(1996-3#64)(1996-5#45)(1996-6#29)(1996-8#12)(1996-9#14)(1997-1#63)(1997-2#101)(1997-3#74)(1997-4#29)(1997-5#13)(1997-6#40)(1997-7#61)(1997-8#68)(1997-9#5)(2006-5#2)(2006-6#12)(2007-11#24)(2007-12#96)(2007-7#1)(2007-8#14)(2007-9#1)(2008-1#73)(2008-10#5715)(2008-11#1228)(2008-12#364)(2008-2#87)(2008-3#345)(2008-4#169)(2008-5#440)(2008-6#114)(2008-7#362)(2008-8#401)(2008-9#461)(2009-1#14)(2009-10#105)(2009-11#36)(2009-12#74)(2009-2#1)(2009-3#45)(2009-4#29)(2009-5#40)(2009-6#74)(2009-7#84)(2009-8#147)(2009-9#29)(2010-1#75)(2010-10#90)(2010-11#77)(2010-12#103)(2010-2#16)(2010-3#32)(2010-4#66)(2010-5#77)(2010-6#84)(2010-7#101)(2010-8#82)(2010-9#29)(2011-1#87)(2011-10#6)(2011-2#682)(2011-3#63)(2011-4#6)(2011-7#16)(2011-8#2)(2011-9#1)(2012-12#124)(2012-2#422)(2012-3#290)(2012-4#5)(2012-5#8)(2012-6#4)(2012-7#4)(2012-8#1)(2012-9#6)(2013-1#479)(2013-3#2)(2013-7#30)(2013-8#235)
as-deposited BDD and glassy carbon electrodes##2##6##(2008-10#2)
as-deposited BDD and##3##3##(2008-10#3)
as-synthesized##2##1##(2008-10#1)(2008-7#1)
asFP595 and##3##2##(2009-9#3)
asFP595##4##1##(2009-9#4)
asbestiform##2##1##(1991-12#1)(1991-3#1)
asbestos abatement##4##2##(1991-12#4)
asbestos exposure in##2##3##(1991-12#2)
asbestos exposure##12##2##(1991-12#9)(2008-12#1)(2010-12#1)(2010-5#1)
asbestos fibers from##2##3##(1991-12#2)
asbestos fibers in##2##3##(1991-12#2)
asbestos fibers##10##2##(1991-12#9)(1991-3#1)
asbestos in place##3##3##(1991-12#3)
asbestos in##8##2##(1991-12#7)(1997-5#1)
asbestos is##3##2##(1991-12#2)(1995-2#1)
asbestos was##2##2##(1991-12#2)
asbestos##65##1##(1991-12#57)(1991-3#1)(1992-1#1)(1995-2#2)(1997-5#1)(2008-12#1)(2010-12#1)(2010-5#1)
asbestos-containing building materials##2##3##(1991-12#2)
asbestos-containing materials in##2##3##(1991-12#2)
asbestos-containing materials##4##2##(1991-12#4)
asbestos-containing##6##1##(1991-12#6)
asbestos-induced pleural fibrosis##3##3##(1991-12#3)
asbestos-induced pleural##4##2##(1991-12#4)
asbestos-induced##7##1##(1991-12#7)
asbestos-related disease##3##2##(1991-12#3)
asbestos-related diseases in the##2##4##(1995-2#1)(2013-8#1)
asbestos-related##11##1##(1991-12#9)(1995-2#1)(2013-8#1)
asbestosis##10##1##(1991-12#10)
ascending and##2##2##(1991-6#1)(2013-1#1)
ascending aorta##10##2##(1997-5#4)(1997-8#2)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
ascending colon##3##2##(1991-6#1)(2008-11#1)(2008-12#1)
ascending##21##1##(1991-6#2)(1996-9#1)(1997-5#4)(1997-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-3#2)
ascent for##2##2##(2013-1#2)
ascertain the##13##2##(1996-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
ascertain whether##3##2##(1993-3#1)(2006-6#1)(2008-11#1)
ascertain##29##1##(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-7#1)(2006-6#2)(2008-10#7)(2008-11#4)(2008-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
ascertained by##6##2##(2008-10#5)(2008-12#1)
ascertained in##2##2##(1990-5#1)(2013-1#1)
ascertained##17##1##(1990-5#1)(1991-2#1)(1995-12#1)(1997-3#1)(2008-10#6)(2008-12#2)(2008-7#1)(2010-6#1)(2013-1#2)(2013-8#1)
ascertaining that##2##2##(2008-9#1)(2012-12#1)
ascertaining the##3##2##(1994-1#1)(2008-10#1)(2008-9#1)
ascertaining##6##1##(1994-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2012-12#1)
ascertainment bias##2##2##(2012-3#2)
ascertainment##3##1##(1994-12#1)(2012-3#2)
asci##8##1##(2008-10#8)
ascidian Styela canopus##2##3##(2008-7#2)
ascidian##3##1##(2008-6#1)(2008-7#2)
ascites and##3##2##(2008-10#2)(2012-3#1)
ascites hepatoma cell line of AH109A##3##6##(2008-11#3)
ascites hepatoma cell line##4##4##(2008-11#4)
ascites hepatoma##10##2##(1993-8#3)(2008-11#7)
ascites tumour##4##2##(1990-5#2)(1990-6#2)
ascites##34##1##(1990-5#2)(1990-6#2)(1991-11#1)(1991-12#3)(1993-8#4)(2008-10#3)(2008-11#10)(2010-10#1)(2011-2#6)(2012-3#2)
ascitic fluid##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-12#1)
ascitic fluids##2##2##(1990-2#2)
ascitic##14##1##(1990-2#2)(1994-3#2)(1995-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#3)(2009-8#1)(2010-12#1)
ascitis##2##1##(1993-6#2)
ascocarps as a percentage of M##2##6##(2008-10#2)
ascocarps on##3##2##(2008-10#3)
ascocarps##9##1##(2008-10#9)
ascomycete fungi##2##2##(2008-10#2)
ascomycete##13##1##(1995-6#1)(2008-10#9)(2010-3#2)(2012-3#1)
ascomycetes##3##1##(2008-10#2)(2010-7#1)
ascorbate and##5##2##(1990-2#1)(1993-2#1)(2008-10#3)
ascorbate in##2##2##(2008-10#1)(2008-5#1)
ascorbate is##2##2##(2012-2#2)
ascorbate oxidase##4##2##(2008-10#4)
ascorbate peroxidase##2##2##(2008-10#2)
ascorbate to##3##2##(1990-9#1)(2008-11#1)(2008-5#1)
ascorbate using##2##2##(2008-10#1)(2009-9#1)
ascorbate##53##1##(1990-2#1)(1990-9#8)(1992-12#2)(1992-3#2)(1993-2#1)(1993-8#1)(2008-10#20)(2008-11#3)(2008-5#2)(2009-9#5)(2012-2#7)(2013-8#1)
ascorbic Acid on##2##3##(2008-11#1)(2008-5#1)
ascorbic acid (AA) and uric acid (UA)##2##7##(2008-10#2)
ascorbic acid (AA) and##5##4##(1993-3#1)(2008-10#4)
ascorbic acid (AA) in##3##4##(2008-10#3)
ascorbic acid (AA) is##2##4##(2008-10#1)(2008-5#1)
ascorbic acid (AA)##15##3##(1992-12#1)(1993-3#1)(2008-10#12)(2008-5#1)
ascorbic acid (Vitamin C)##2##4##(2008-10#2)
ascorbic acid (vitamin C)##2##4##(1992-9#1)(2008-10#1)
ascorbic acid (vitamin##3##3##(1992-9#1)(2008-10#2)
ascorbic acid and copper##2##4##(2008-10#2)
ascorbic acid and sorbic acid in fruit juices##2##8##(2008-10#2)
ascorbic acid and sorbic acid##3##5##(2008-10#3)
ascorbic acid and uric acid##5##5##(2008-10#5)
ascorbic acid and##27##3##(1993-2#1)(1993-3#1)(2008-10#24)(2008-5#1)
ascorbic acid as##2##3##(2008-10#1)(2008-5#1)
ascorbic acid at##3##3##(2008-10#3)
ascorbic acid based on##3##4##(2008-10#3)
ascorbic acid concentration##2##3##(2008-10#2)
ascorbic acid in pharmaceuticals##2##4##(2008-10#2)
ascorbic acid in the##2##4##(2008-10#2)
ascorbic acid in##22##3##(1992-12#1)(2008-10#21)
ascorbic acid is##2##3##(2008-10#1)(2008-5#1)
ascorbic acid or##2##3##(2008-10#1)(2008-5#1)
ascorbic acid pretreatment##3##3##(1993-12#3)
ascorbic acid provided##2##3##(2008-11#2)
ascorbic acid to##2##3##(2008-10#2)
ascorbic acid was linear##2##4##(2008-10#2)
ascorbic acid was##13##3##(2008-10#12)(2008-5#1)
ascorbic acid##203##2##(1990-5#2)(1990-9#1)(1992-12#2)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#2)(2008-10#170)(2008-11#3)(2008-12#1)(2008-5#12)(2010-7#1)(2011-2#2)
ascorbic acid&gt##2##2##(2008-10#2)
ascorbic##213##1##(1990-5#2)(1990-9#1)(1992-12#2)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#2)(2008-10#178)(2008-11#4)(2008-12#1)(2008-5#13)(2010-7#1)(2011-2#2)
ascorbyl palmitate and##2##3##(2008-5#2)
ascorbyl##4##1##(2008-5#4)
ascospore discharge##5##2##(2008-10#5)
ascospore dispersal##2##2##(2008-10#2)
ascospore germination in##2##3##(2008-10#2)
ascospore germination##6##2##(2008-10#6)
ascospore infection##3##2##(2008-10#3)
ascospore production and##2##3##(2008-10#2)
ascospore production were greatest##2##4##(2008-10#2)
ascospore production were##3##3##(2008-10#3)
ascospore production##9##2##(2008-10#9)
ascospore progeny##4##2##(2008-10#4)
ascospore release##20##2##(2008-10#20)
ascospore showers##5##2##(2008-10#5)
ascospore##65##1##(2008-10#65)
ascospores also##2##2##(2008-10#2)
ascospores and conidia##3##3##(2008-10#3)
ascospores and##7##2##(2008-10#7)
ascospores are##2##2##(2008-10#2)
ascospores at##3##2##(2008-10#3)
ascospores collected##2##2##(2008-10#2)
ascospores discharged from##2##3##(2008-10#2)
ascospores discharged##3##2##(2008-10#3)
ascospores in##8##2##(2008-10#8)
ascospores may be##2##3##(2008-10#2)
ascospores of##7##2##(2008-10#7)
ascospores per##3##2##(2008-10#3)
ascospores was studied##2##3##(2008-10#2)
ascospores was##3##2##(2008-10#3)
ascospores were captured##2##3##(2008-10#2)
ascospores were detectable##2##3##(2008-10#2)
ascospores were detected##2##3##(2008-10#2)
ascospores were released##2##3##(2008-10#2)
ascospores were##11##2##(2008-10#11)
ascospores##91##1##(2008-10#90)(2010-3#1)
ascosporic##4##1##(2008-10#4)
ascribable##3##1##(1992-9#1)(2008-10#1)(2008-5#1)
ascribed to a##3##3##(1994-5#1)(1996-11#1)(2008-10#1)
ascribed to the##10##3##(1993-8#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-9#1)(2011-2#2)
ascribed to##23##2##(1993-8#1)(1994-5#1)(1996-11#1)(1997-2#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-8#2)(2009-9#1)(2011-1#1)(2011-2#2)
ascribed##27##1##(1991-12#1)(1993-8#1)(1994-5#1)(1996-11#1)(1997-2#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-8#2)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#2)
asd gene##2##2##(2008-9#2)
aseptic loosening##3##2##(2009-4#1)(2013-1#2)
aseptic##8##1##(1992-9#1)(2008-11#1)(2009-4#2)(2011-2#1)(2012-3#1)(2013-1#2)
aseptically##3##1##(2008-11#1)(2008-12#1)(2011-2#1)
asexual development##2##2##(2008-10#2)
asexual endophytes##2##2##(2008-8#2)
asexual form##2##2##(2008-10#2)
asexual genetic exchange##2##3##(2008-10#2)
asexual propagules##2##2##(2008-10#2)
asexual reproduction in##2##3##(2008-10#1)(2009-5#1)
asexual reproduction of##2##3##(2008-10#2)
asexual reproduction##13##2##(2008-10#11)(2009-5#1)(2012-3#1)
asexual reproductive##2##2##(2009-5#1)(2013-8#1)
asexual##46##1##(2008-10#39)(2008-8#2)(2009-5#2)(2010-3#1)(2012-3#1)(2013-8#1)
asexually##2##1##(2008-10#1)(2008-8#1)
ash and##7##2##(2008-10#7)
ash content of##3##3##(2008-10#2)(2010-4#1)
ash content##4##2##(2008-10#3)(2010-4#1)
ash deriving from a solid waste incinerator and##2##8##(2008-10#2)
ash samples##6##2##(2008-10#6)
ash##43##1##(1991-2#1)(2008-10#39)(2010-11#1)(2010-4#2)
ashed at 550 degrees C##2##5##(2008-10#2)
ashed##3##1##(2008-10#3)
ashes were##3##2##(2008-10#3)
ashes##10##1##(2008-10#9)(2008-11#1)
ashing method##3##2##(2008-10#3)
ashing procedure##4##2##(2008-10#4)
ashing##26##1##(2008-10#26)
asialo-orosomucoid##5##1##(1995-6#5)
asialofetuin##3##1##(2008-9#3)
asian##6##1##(2008-10#2)(2009-12#1)(2012-2#1)(2013-1#2)
asiatica were##2##2##(2008-10#2)
asiatica##10##1##(2008-10#8)(2008-5#1)(2009-8#1)
aside##4##1##(1994-1#1)(1995-6#1)(2008-10#1)(2008-12#1)
asignificant##2##1##(2008-11#2)
ask how##2##2##(2009-12#1)(2011-2#1)
ask whether##2##2##(2008-12#1)(2008-7#1)
ask##10##1##(1993-5#1)(1994-1#1)(1994-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)
asked about the##2##3##(2012-12#2)
asked about##4##2##(2008-10#1)(2008-9#1)(2012-12#2)
asked by##2##2##(1995-2#1)(2008-11#1)
asked for##8##2##(1990-2#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)
asked the##3##2##(1995-6#1)(1996-5#1)(2008-12#1)
asked to be##3##3##(1991-12#1)(2010-11#2)
asked to complete the##2##4##(2008-11#2)
asked to complete##6##3##(1993-1#1)(2008-10#1)(2008-11#3)(2008-7#1)
asked to give##3##3##(1990-11#1)(2008-11#1)(2009-11#1)
asked to identify the##2##4##(2008-11#2)
asked to rate the##2##4##(1995-3#1)(2008-10#1)
asked to rate##4##3##(1991-6#1)(1995-3#1)(2008-10#1)(2008-12#1)
asked to view the##2##4##(1993-1#1)(2008-5#1)
asked to##46##2##(1990-11#2)(1991-12#1)(1991-6#1)(1993-1#2)(1995-3#1)(1996-2#2)(2008-10#5)(2008-11#13)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-8#1)(2013-1#2)(2013-8#1)
asked which of##2##3##(1994-3#1)(2008-8#1)
asked##89##1##(1990-11#3)(1990-2#1)(1991-12#1)(1991-6#1)(1992-1#1)(1993-1#2)(1993-12#2)(1994-12#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-2#3)(1996-5#1)(1997-4#1)(2008-10#7)(2008-11#19)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#1)
asking##5##1##(1992-12#1)(1995-2#1)(2008-8#1)(2011-2#1)(2013-8#1)
asks##8##1##(1994-12#1)(1996-12#1)(2008-11#3)(2008-8#1)(2010-7#1)(2012-3#1)
asp##3##1##(1997-3#2)(2010-8#1)
asparagi##5##1##(2008-10#5)
asparagine 43##2##2##(1994-11#2)
asparagine and glutamine##3##3##(2008-11#3)
asparagine and##4##2##(1992-6#1)(2008-11#3)
asparagine##18##1##(1992-6#2)(1994-11#2)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#5)(2008-7#4)
asparagine-linked glycosylation sites##3##3##(1993-6#1)(2008-11#1)(2008-8#1)
asparagine-linked glycosylation##4##2##(1993-6#1)(2008-11#1)(2008-8#2)
asparagine-linked##7##1##(1992-10#3)(1993-6#1)(2008-11#1)(2008-8#2)
asparagus##11##1##(2008-10#11)
aspartame##3##1##(2008-4#2)(2010-9#1)
aspartase##3##1##(1991-5#2)(1992-11#1)
aspartate aminotransferase (AST)##4##3##(1994-5#1)(1997-3#1)(2008-10#1)(2009-8#1)
aspartate aminotransferase##10##2##(1993-2#2)(1994-5#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-12#2)(2009-8#1)(2013-8#1)
aspartate and##5##2##(1995-6#4)(2011-2#1)
aspartate complex##5##2##(1991-12#3)(1995-6#2)
aspartate efflux##2##2##(1991-3#2)
aspartate formation in##2##3##(1991-3#2)
aspartate formation##4##2##(1991-3#4)
aspartate production##2##2##(1991-3#2)
aspartate receptor##3##2##(1991-12#2)(1992-9#1)
aspartate##46##1##(1991-12#5)(1991-3#8)(1992-9#1)(1993-2#2)(1994-5#1)(1995-6#16)(1995-8#1)(1997-3#1)(1997-5#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
aspartic acid at position##2##4##(1994-3#1)(1997-3#1)
aspartic acid at##3##3##(1993-8#1)(1994-3#1)(1997-3#1)
aspartic acid##13##2##(1990-10#1)(1990-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
aspartic peptidases##2##2##(2008-4#2)
aspartic##22##1##(1990-10#1)(1990-12#2)(1991-9#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-6#2)(1997-3#1)(1997-8#1)(2008-10#3)(2008-4#4)(2008-5#2)(2008-7#1)(2011-2#1)
aspartyl protease is##2##3##(1994-5#1)(1995-8#1)
aspartyl protease##6##2##(1994-5#2)(1995-8#4)
aspartyl residues##2##2##(1991-9#2)
aspartyl##11##1##(1991-9#3)(1994-5#2)(1995-6#1)(1995-8#4)(2006-6#1)
aspartylglucosaminuria##2##1##(1991-7#2)
aspect of a##2##3##(1992-2#1)(2013-1#1)
aspect of the##20##3##(1991-1#1)(1991-3#1)(1993-8#1)(1994-1#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
aspect of this##3##3##(1991-6#1)(2008-4#1)(2008-5#1)
aspect of##57##2##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-3#3)(1995-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-9#1)(2010-10#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
aspect ratio##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
aspect ratios##4##2##(1991-12#2)(2008-3#2)
aspect was##2##2##(1991-8#1)(2008-10#1)
aspect were##2##2##(1993-2#1)(2008-10#1)
aspect##86##1##(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#3)(1995-5#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
aspects and##12##2##(1990-9#1)(1991-2#1)(1991-3#1)(1993-3#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2012-12#1)(2012-3#1)(2013-8#1)
aspects are discussed##2##3##(1997-5#1)(2008-11#1)
aspects are##6##2##(1990-11#1)(1991-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
aspects as##3##2##(1996-1#1)(2011-2#1)(2013-1#1)
aspects beyond##2##2##(2008-11#1)(2012-2#1)
aspects concerning the##2##3##(1997-4#1)(2008-11#1)
aspects for which##2##3##(2008-10#2)
aspects for##3##2##(2008-10#3)
aspects in the##6##3##(1995-8#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)
aspects in##10##2##(1995-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#4)(2012-12#1)
aspects include##2##2##(2008-11#1)(2008-6#1)
aspects is presented##2##3##(2008-10#1)(2008-11#1)
aspects is##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
aspects of Patient Focused care team##2##6##(1994-2#2)
aspects of Patient Focused##3##4##(1993-12#1)(1994-2#2)
aspects of QoL##2##3##(2008-10#1)(2013-1#1)
aspects of a##3##3##(1994-2#1)(1996-6#1)(2009-8#1)
aspects of an##2##3##(1995-3#1)(2008-8#1)
aspects of care##4##3##(1991-3#1)(1992-3#1)(1993-2#1)(2008-11#1)
aspects of chronic##2##3##(2008-11#1)(2008-4#1)
aspects of data##2##3##(2008-4#1)(2010-1#1)
aspects of disease##4##3##(2008-10#2)(2010-3#1)(2011-2#1)
aspects of gestational diabetes##2##4##(1996-11#2)
aspects of health care##2##4##(1993-3#1)(2010-11#1)
aspects of lung##2##3##(2010-7#1)(2012-3#1)
aspects of pathogenesis##2##3##(2008-5#1)(2010-5#1)
aspects of phage therapy##2##4##(2012-2#2)
aspects of road traffic##2##4##(2010-11#2)
aspects of routine##2##3##(1994-6#1)(2008-10#1)
aspects of systemic##2##3##(1992-9#1)(2013-1#1)
aspects of the ICU##2##4##(1992-2#2)
aspects of the disease##2##4##(1993-6#1)(2010-12#1)
aspects of the management of##2##5##(2008-11#1)(2013-1#1)
aspects of the molecular##2##4##(1994-11#1)(2010-1#1)
aspects of the organization of##2##5##(1995-11#1)(1995-5#1)
aspects of the present##2##4##(2008-10#1)(2008-11#1)
aspects of the use of##2##5##(2008-10#1)(2011-2#1)
aspects of the vaccine##2##4##(2008-11#2)
aspects of the##88##3##(1990-12#1)(1990-9#4)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#4)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-1#3)(1995-11#1)(1995-5#2)(1996-1#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#18)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
aspects of their##6##3##(1993-2#1)(1994-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
aspects of these##5##3##(1991-12#1)(1992-5#1)(2008-11#1)(2008-9#1)(2009-11#1)
aspects of this condition##2##4##(2008-4#1)(2012-2#1)
aspects of this##11##3##(1994-3#1)(1994-6#1)(2008-12#1)(2008-4#2)(2008-7#1)(2010-4#1)(2010-5#1)(2011-7#1)(2012-2#1)(2013-1#1)
aspects of treatment##2##3##(1996-11#1)(2010-12#1)
aspects of tumour hypoxia##2##4##(2009-4#2)
aspects of##333##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#6)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1992-12#1)(1992-2#6)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#3)(1994-6#2)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#4)(1996-11#4)(1996-12#1)(1996-2#2)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#49)(2008-11#27)(2008-12#8)(2008-2#1)(2008-4#11)(2008-5#9)(2008-7#8)(2008-8#7)(2008-9#12)(2009-10#4)(2009-11#3)(2009-12#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#3)(2011-2#17)(2011-7#1)(2012-12#1)(2012-2#11)(2012-3#12)(2013-1#11)(2013-8#2)
aspects on##2##2##(2008-10#1)(2008-7#1)
aspects related to##5##3##(2008-11#1)(2008-9#1)(2012-12#2)(2013-8#1)
aspects that##4##2##(1994-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
aspects to##2##2##(1992-12#1)(2008-11#1)
aspects were##2##2##(1991-8#1)(2008-10#1)
aspects##476##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#8)(1991-12#2)(1991-2#2)(1991-3#6)(1991-6#2)(1991-8#1)(1992-12#2)(1992-2#6)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#3)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-8#1)(1996-1#5)(1996-11#5)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2007-12#5)(2007-8#2)(2008-1#2)(2008-10#70)(2008-11#51)(2008-12#10)(2008-2#1)(2008-4#11)(2008-5#15)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#15)(2009-10#5)(2009-11#3)(2009-12#3)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#3)(2011-2#25)(2011-7#1)(2012-12#7)(2012-2#12)(2012-3#16)(2012-5#2)(2013-1#19)(2013-8#7)
aspects]##9##1##(1990-5#1)(1990-9#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-11#1)
asper##8##1##(2008-10#5)(2010-8#3)
aspera and S##2##3##(2008-10#2)
aspera and##3##2##(2008-10#3)
aspera##5##1##(2008-10#4)(2012-2#1)
asperata##3##1##(2008-10#3)
aspergillosis in##3##2##(2007-8#1)(2008-5#1)(2013-8#1)
aspergillosis is a##2##3##(2011-2#2)
aspergillosis with##3##2##(2013-1#1)(2013-8#2)
aspergillosis##20##1##(1994-3#1)(1995-9#1)(2007-8#2)(2008-10#3)(2008-5#5)(2011-2#4)(2013-1#1)(2013-8#3)
aspergillus##2##1##(2007-8#1)(2013-8#1)
aspheric##2##1##(2008-3#2)
aspherical lens##3##2##(2008-2#3)
aspherical##4##1##(2008-2#3)(2008-3#1)
asphyxia at birth##2##3##(1994-3#2)
asphyxia##4##1##(1991-6#1)(1994-3#2)(1995-11#1)
aspirate revealed##2##2##(2008-12#1)(2009-6#1)
aspirate##8##1##(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-6#1)
aspirated and##2##2##(2008-10#2)
aspirated in##2##2##(2008-10#2)
aspirated into a##2##3##(2008-10#2)
aspirated into the holding coil##2##5##(2008-10#2)
aspirated into##5##2##(2008-10#5)
aspirated sample##2##2##(2008-10#2)
aspirated to##2##2##(2008-10#2)
aspirated##18##1##(2008-10#17)(2010-12#1)
aspirates with##3##2##(2008-11#2)(2012-2#1)
aspirates##9##1##(1992-5#1)(1996-12#1)(2008-11#4)(2008-9#1)(2011-2#1)(2012-2#1)
aspiration and##4##2##(2008-11#1)(2008-8#1)(2010-7#1)(2012-12#1)
aspiration biopsy (FNAB)##4##3##(1997-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
aspiration biopsy in##2##3##(2011-1#1)(2012-3#1)
aspiration biopsy##8##2##(1990-2#1)(1991-6#1)(1997-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
aspiration cytology##8##2##(1990-6#2)(2008-10#1)(2008-7#1)(2010-11#2)(2010-8#1)(2012-2#1)
aspiration lesions##2##2##(1993-3#1)(1997-3#1)
aspiration of the##5##3##(2008-10#3)(2008-2#1)(2012-2#1)
aspiration of##11##2##(1997-8#1)(2008-10#5)(2008-2#1)(2010-7#1)(2012-2#3)
aspiration or##2##2##(1994-9#1)(2010-7#1)
aspiration##55##1##(1990-2#1)(1990-6#2)(1991-3#1)(1991-6#2)(1992-2#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-7#3)(2008-8#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)
aspirations##3##1##(1990-9#1)(2008-11#1)(2009-6#1)
aspirin and heat stress##2##4##(1991-12#2)
aspirin and##7##2##(1991-12#3)(1997-6#1)(2008-11#1)(2008-12#1)(2011-2#1)
aspirin in##3##2##(2008-10#1)(2008-11#2)
aspirin is##2##2##(2008-3#1)(2011-2#1)
aspirin or##3##2##(1992-6#1)(1996-11#1)(2008-11#1)
aspirin was##2##2##(1997-6#1)(2008-11#1)
aspirin##46##1##(1990-5#1)(1991-12#3)(1992-2#1)(1992-5#1)(1992-6#2)(1993-2#1)(1993-3#4)(1996-11#1)(1997-6#3)(2006-6#2)(2008-10#3)(2008-11#11)(2008-12#2)(2008-3#2)(2008-5#2)(2008-8#3)(2011-2#2)(2013-8#2)
aspiring##3##1##(2008-11#1)(2011-2#1)(2013-8#1)
aspx for revised estimates##6##4##(2011-2#6)
assailant##2##1##(2008-10#1)(2008-12#1)
assault on##2##2##(1991-9#1)(1994-2#1)
assault##15##1##(1991-9#1)(1994-2#1)(1996-5#2)(2008-10#1)(2008-12#2)(2008-9#1)(2009-5#2)(2010-7#1)(2012-3#4)
assay (0##2##2##(2008-10#2)
assay (ELISA) and the##2##4##(2008-10#2)
assay (ELISA) and##5##3##(2008-1#1)(2008-10#4)
assay (ELISA) for##8##3##(1990-2#1)(1994-3#1)(2008-10#4)(2008-11#1)(2011-2#1)
assay (ELISA) using##2##3##(2008-10#2)
assay (ELISA)##37##2##(1990-2#1)(1994-3#2)(1995-11#2)(1996-9#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-4#2)(2011-2#1)(2011-3#1)
assay also##4##2##(1992-3#1)(2008-10#3)
assay and ELISA##2##3##(2008-10#2)
assay and by a##2##4##(2008-10#1)(2008-5#1)
assay and real-time##2##3##(2010-11#1)(2012-2#1)
assay and the##4##3##(1994-8#2)(2008-10#1)(2013-8#1)
assay and western##2##3##(2008-10#2)
assay and##45##2##(1990-2#1)(1991-11#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-8#2)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
assay as well as##2##4##(2010-4#1)(2013-1#1)
assay as##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
assay at##3##2##(2008-10#2)(2011-1#1)
assay based on##6##3##(2008-10#4)(2011-2#1)(2013-1#1)
assay based##7##2##(1990-6#1)(2008-10#4)(2011-2#1)(2013-1#1)
assay by##10##2##(1990-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)
assay can be##6##3##(2008-10#4)(2008-11#1)(2008-4#1)
assay can##8##2##(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)
assay conditions##5##2##(1990-2#1)(1993-8#1)(2008-4#1)(2008-9#1)(2012-2#1)
assay confirmed##2##2##(1991-12#1)(2008-8#1)
assay described##3##2##(2008-10#1)(2008-4#1)(2010-4#1)
assay detected##6##2##(2008-10#4)(2008-12#1)(2012-2#1)
assay developed##2##2##(1990-12#1)(2008-10#1)
assay development and##3##3##(2008-10#2)(2010-11#1)
assay enables##4##2##(1996-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
assay for detecting##4##3##(2008-10#3)(2008-4#1)
assay for human##2##3##(1995-11#1)(2008-1#1)
assay for protein##2##3##(2008-10#2)
assay for rapid##2##3##(2008-10#1)(2010-4#1)
assay for simultaneous##2##3##(2008-4#1)(2013-8#1)
assay for the detection of##4##5##(1996-12#1)(2008-10#2)(2008-11#1)
assay for the determination of##3##5##(1990-12#2)(2008-10#1)
assay for the determination##4##4##(1990-12#2)(2008-10#2)
assay for the measurement of apoptosis##2##6##(2008-11#2)
assay for the quantification of##2##5##(2008-12#1)(2010-1#1)
assay for the##21##3##(1990-12#2)(1991-12#1)(1995-6#1)(1996-12#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-4#1)(2009-12#1)(2010-1#1)(2012-2#1)
assay for##89##2##(1990-12#2)(1990-2#4)(1991-12#2)(1991-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-8#1)(2008-1#2)(2008-10#33)(2008-11#6)(2008-12#2)(2008-4#9)(2008-7#1)(2008-9#3)(2009-12#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#2)
assay format##2##2##(2008-10#2)
assay formats##2##2##(2008-10#2)
assay had a##2##3##(2008-10#2)
assay had##3##2##(2008-10#2)(2011-2#1)
assay has a linearity interval between 0##2##7##(2008-10#2)
assay has a##5##3##(1991-2#1)(1992-12#1)(2008-10#3)
assay has been developed to##2##5##(1991-9#1)(2008-10#1)
assay has been developed##4##4##(1991-9#1)(2008-10#3)
assay has been##7##3##(1990-2#1)(1991-9#1)(2008-10#4)(2011-3#1)
assay has##13##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-12#1)(1995-8#1)(2008-10#7)(2011-3#1)
assay in a##4##3##(1990-11#1)(1991-3#1)(2008-10#1)(2010-8#1)
assay in pharmaceutical preparations##2##4##(2008-10#2)
assay in pharmaceutical##3##3##(2008-10#3)
assay in which##2##3##(1990-12#1)(2008-10#1)
assay in##28##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-3#1)(1995-6#1)(1995-8#1)(2008-10#12)(2008-11#2)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
assay incorporating##2##2##(2008-10#1)(2009-6#1)
assay indicated that the##2##4##(1993-12#1)(2013-1#1)
assay indicated that##4##3##(1993-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
assay is a##4##3##(2008-11#1)(2010-5#1)(2011-2#1)(2013-8#1)
assay is based on the##4##5##(1990-12#1)(2008-10#3)
assay is based on##5##4##(1990-12#1)(2008-10#4)
assay is designed##2##3##(2008-9#2)
assay is performed##3##3##(2008-10#2)(2008-9#1)
assay is proposed for##2##4##(2008-10#2)
assay is sensitive##3##3##(1990-12#1)(1996-12#1)(2011-3#1)
assay is simple##3##3##(1990-12#2)(2008-4#1)
assay is useful for##2##4##(2008-11#1)(2008-4#1)
assay is##49##2##(1990-12#4)(1991-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#21)(2008-11#7)(2008-4#3)(2008-8#1)(2008-9#4)(2010-5#1)(2011-2#2)(2011-3#1)(2013-8#1)
assay kit##2##2##(2008-10#2)
assay may be##4##3##(1990-12#1)(2008-10#3)
assay medium##2##2##(2008-10#2)
assay method##3##2##(2008-10#1)(2008-5#2)
assay of AZT##2##3##(2008-10#2)
assay of S-perindopril##3##3##(2008-10#3)
assay of ascorbic acid##2##4##(2008-10#2)
assay of bromazepam##2##3##(2008-10#2)
assay of fleroxacin in##2##4##(2008-10#2)
assay of glucose##2##3##(2008-10#2)
assay of l-lactate and pyruvate in##2##6##(2008-10#2)
assay of lead in##2##4##(2008-10#2)
assay of perphenazine##5##3##(2008-10#5)
assay of promethazine hydrochloride##2##4##(2008-10#2)
assay of proteins in##2##4##(2008-10#2)
assay of proteins##5##3##(2008-10#5)
assay of the##5##3##(1995-12#1)(2008-10#2)(2008-4#1)(2010-5#1)
assay of these##2##3##(1992-3#1)(2008-8#1)
assay of various##2##3##(2008-10#2)
assay of##126##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#2)(1992-3#1)(1995-12#1)(1996-12#1)(2008-10#101)(2008-11#2)(2008-12#1)(2008-4#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)
assay on a##3##3##(2008-10#2)(2008-4#1)
assay on##8##2##(2008-10#4)(2008-11#2)(2008-4#1)(2013-8#1)
assay or##4##2##(1997-8#1)(2008-10#3)
assay procedure##2##2##(2008-10#1)(2008-11#1)
assay procedures##2##2##(1990-2#1)(2008-10#1)
assay produced##2##2##(1997-2#1)(2008-10#1)
assay proved to be##2##4##(2008-10#1)(2008-11#1)
assay provides a##2##3##(1990-12#1)(2008-10#1)
assay provides##4##2##(1990-12#1)(2008-10#2)(2013-8#1)
assay results##5##2##(2008-10#4)(2008-6#1)
assay revealed that##3##3##(1994-3#1)(2008-11#2)
assay revealed##6##2##(1994-3#1)(1995-12#1)(2008-11#3)(2013-8#1)
assay showed that laminin 332##2##5##(2013-8#2)
assay showed that the##3##4##(1994-8#1)(2008-8#1)(2008-9#1)
assay showed that##10##3##(1994-8#1)(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#3)(2011-2#1)(2013-8#2)
assay showed the##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
assay showed##18##2##(1994-8#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#3)(2011-2#1)(2013-8#6)
assay suggested that##2##3##(2008-9#1)(2011-3#1)
assay system##11##2##(1990-10#1)(1990-11#1)(1990-12#1)(1995-11#1)(2008-10#4)(2008-11#3)
assay systems##7##2##(1990-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-9#1)
assay techniques##2##2##(2008-10#2)
assay technology##2##2##(2013-1#2)
assay that##8##2##(2008-10#3)(2008-11#3)(2008-12#1)(2013-1#1)
assay the##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
assay time##3##2##(2008-10#3)
assay to detect##5##3##(1991-5#1)(1992-12#1)(2008-10#2)(2011-2#1)
assay to determine##2##3##(1997-7#1)(2008-11#1)
assay to quantify##3##3##(1996-12#1)(2008-10#2)
assay to study##2##3##(1995-2#1)(2008-7#1)
assay to##17##2##(1991-5#1)(1992-12#1)(1995-2#1)(1996-12#1)(1997-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
assay used in this##2##4##(2010-4#2)
assay used in##3##3##(2008-4#1)(2010-4#2)
assay used##7##2##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#2)
assay using a##3##3##(2008-10#3)
assay using the##6##3##(1994-5#1)(2008-10#3)(2008-11#1)(2009-10#1)
assay using##29##2##(1990-12#1)(1990-2#2)(1994-5#1)(1995-8#1)(1997-7#1)(2008-10#13)(2008-11#2)(2008-12#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
assay utilizing##2##2##(1990-12#1)(2008-10#1)
assay was 1##2##3##(2008-10#2)
assay was a##2##3##(2008-10#2)
assay was able to detect##2##5##(2012-2#1)(2013-1#1)
assay was able to##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
assay was also used to##2##5##(2008-10#1)(2008-5#1)
assay was also used##3##4##(2008-10#2)(2008-5#1)
assay was applied to##2##4##(1991-12#1)(2008-10#1)
assay was developed for the##2##5##(1990-12#1)(2008-10#1)
assay was developed to simultaneously##2##5##(2008-10#1)(2013-8#1)
assay was developed to##5##4##(2008-10#4)(2013-8#1)
assay was developed using##2##4##(2008-10#1)(2008-11#1)
assay was developed##12##3##(1990-12#1)(2008-10#8)(2008-11#2)(2013-8#1)
assay was found to##2##4##(2008-10#2)
assay was performed##2##3##(2008-10#1)(2008-5#1)
assay was used to determine##2##5##(1993-8#1)(2008-10#1)
assay was used to measure##2##5##(1990-2#1)(1992-3#1)
assay was used to##8##4##(1990-2#1)(1992-3#1)(1993-8#1)(2008-10#3)(2013-1#1)(2013-8#1)
assay was used##9##3##(1990-2#1)(1992-3#1)(1993-8#1)(2008-10#3)(2009-9#1)(2013-1#1)(2013-8#1)
assay was##58##2##(1990-12#3)(1990-2#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-11#1)(2008-10#33)(2008-11#4)(2008-12#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#3)
assay we##2##2##(2008-10#1)(2008-5#1)
assay were compared##2##3##(2008-10#1)(2008-5#1)
assay were determined##2##3##(1990-9#1)(2008-10#1)
assay were evaluated##2##3##(2008-10#1)(2013-8#1)
assay were##11##2##(1990-9#1)(2008-10#7)(2008-5#1)(2008-9#1)(2013-8#1)
assay which can##2##3##(1997-6#1)(2008-11#1)
assay which##3##2##(1993-2#1)(1997-6#1)(2008-11#1)
assay will be##2##3##(2008-10#1)(2008-11#1)
assay will##3##2##(2008-10#2)(2008-11#1)
assay with a##6##3##(1992-11#1)(1995-11#1)(2008-10#3)(2008-7#1)
assay with##14##2##(1992-11#1)(1995-11#1)(2008-10#9)(2008-11#1)(2008-7#1)(2013-1#1)
assay yielded##2##2##(1995-2#1)(1996-2#1)
assay##1095##1##(1990-10#1)(1990-11#3)(1990-12#26)(1990-2#16)(1990-5#4)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#11)(1991-2#2)(1991-3#3)(1991-5#8)(1991-9#4)(1992-11#4)(1992-12#5)(1992-3#5)(1992-6#5)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#6)(1993-3#1)(1993-6#3)(1993-8#7)(1993-9#1)(1994-11#7)(1994-12#2)(1994-3#3)(1994-5#2)(1994-8#4)(1995-11#7)(1995-12#4)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#8)(1995-9#2)(1996-12#9)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#2)(2008-1#4)(2008-10#526)(2008-11#90)(2008-12#14)(2008-3#1)(2008-4#43)(2008-5#20)(2008-6#4)(2008-7#7)(2008-8#11)(2008-9#35)(2009-10#2)(2009-12#1)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#9)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#26)(2011-3#10)(2012-12#1)(2012-2#14)(2012-3#6)(2013-1#18)(2013-8#25)
assay)##13##1##(1993-2#1)(1994-5#1)(2008-10#5)(2008-11#2)(2008-8#1)(2009-8#1)(2011-2#2)
assayed by ELISA##3##3##(1992-11#1)(1992-6#1)(2008-5#1)
assayed by PCR##2##3##(2008-10#1)(2008-5#1)
assayed by##12##2##(1992-11#1)(1992-6#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-5#2)
assayed for##20##2##(1990-12#1)(1990-5#2)(1992-6#1)(1993-2#1)(1994-5#1)(1995-6#1)(2008-10#11)(2008-4#1)(2008-8#1)
assayed in the##2##3##(1990-10#1)(2008-10#1)
assayed in vitro##2##3##(1991-10#1)(1995-11#1)
assayed in##10##2##(1990-10#1)(1991-10#1)(1993-12#1)(1995-11#1)(1995-2#2)(2006-6#1)(2008-10#2)(2008-7#1)
assayed on##3##2##(2008-10#2)(2008-7#1)
assayed the##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
assayed using##4##2##(1995-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
assayed with##4##2##(2008-10#3)(2008-11#1)
assayed##90##1##(1990-10#1)(1990-12#1)(1990-5#3)(1991-10#1)(1992-11#1)(1992-6#3)(1993-12#1)(1993-2#1)(1993-3#2)(1994-5#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#2)(1997-7#1)(2006-6#1)(2008-10#48)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2011-2#1)
assaying antibody##2##2##(2008-4#2)
assaying##10##1##(1992-2#1)(2008-10#4)(2008-4#5)
assays aiming##2##2##(2008-5#1)(2010-11#1)
assays also##2##2##(2008-10#2)
assays and##24##2##(1991-12#1)(1992-12#1)(2008-10#13)(2008-11#4)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
assays are not##3##3##(2008-10#2)(2008-4#1)
assays are##21##2##(2008-10#10)(2008-11#1)(2008-12#2)(2008-4#5)(2008-5#1)(2008-9#2)
assays as well as##2##4##(2008-10#1)(2008-8#1)
assays as##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
assays based on the##2##4##(2008-10#1)(2012-2#1)
assays based on##4##3##(2008-10#2)(2008-4#1)(2012-2#1)
assays based##5##2##(2008-10#2)(2008-4#1)(2011-1#1)(2012-2#1)
assays but##2##2##(2008-10#1)(2009-6#1)
assays can be performed##2##4##(2008-10#2)
assays can be##4##3##(1992-3#1)(2008-1#1)(2008-10#2)
assays can##5##2##(1992-3#1)(1994-12#1)(2008-1#1)(2008-10#2)
assays could##2##2##(2008-10#2)
assays demonstrate that the##2##4##(1995-2#1)(2008-9#1)
assays demonstrated##3##2##(2008-11#1)(2010-4#1)(2011-2#1)
assays developed##2##2##(2008-10#2)
assays failed to##2##3##(1997-3#1)(2008-10#1)
assays for monitoring##2##3##(2008-10#1)(2010-7#1)
assays for rapid detection of##2##5##(2008-10#1)(2012-2#1)
assays for rapid##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
assays for the detection of##2##5##(2008-10#2)
assays for the##6##3##(1990-2#1)(2008-10#4)(2011-2#1)
assays for##32##2##(1990-2#1)(1995-11#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-4#3)(2008-9#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
assays from##2##2##(2008-10#1)(2011-2#1)
assays had##2##2##(2008-10#2)
assays have been developed##2##4##(2008-10#2)
assays have been##3##3##(2008-10#2)(2008-4#1)
assays have##10##2##(1993-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-7#1)
assays in the##3##3##(1990-8#1)(1997-2#1)(2008-10#1)
assays in which##2##3##(2008-10#1)(2008-4#1)
assays in##16##2##(1990-8#1)(1991-5#1)(1993-8#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-4#1)(2008-9#2)(2009-10#1)(2012-3#1)
assays indicated##3##2##(2008-10#2)(2010-4#1)
assays is##4##2##(2008-10#1)(2008-4#1)(2008-9#2)
assays it##2##2##(1992-9#1)(2008-6#1)
assays may##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
assays measure##2##2##(2008-10#1)(2008-4#1)
assays of##27##2##(1992-4#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-6#1)(2008-10#10)(2008-4#2)(2008-9#5)(2009-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
assays on##8##2##(1992-6#1)(2008-10#5)(2008-11#1)(2008-8#1)
assays or##4##2##(2008-10#3)(2012-2#1)
assays performed##2##2##(1995-6#1)(2008-10#1)
assays provide##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
assays revealed the##2##3##(2008-10#2)
assays revealed##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
assays showed that##2##3##(1995-8#1)(1996-12#1)
assays showed##7##2##(1994-8#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-8#1)(2013-1#1)
assays since they##2##3##(2008-10#1)(2008-4#1)
assays such as##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
assays than##2##2##(2008-10#1)(2008-8#1)
assays that measure##2##3##(2008-4#1)(2008-9#1)
assays that##12##2##(1993-8#1)(1995-8#1)(2008-10#5)(2008-4#4)(2008-9#1)
assays to detect##3##3##(2008-10#2)(2008-4#1)
assays to##13##2##(2008-10#8)(2008-11#2)(2008-4#2)(2013-1#1)
assays used for##2##3##(2008-10#1)(2013-1#1)
assays used##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
assays using##10##2##(1995-6#2)(1997-2#1)(2008-10#3)(2008-8#1)(2010-11#2)(2011-1#1)
assays was evaluated##2##3##(2008-10#2)
assays was##6##2##(1994-11#1)(2008-10#3)(2011-2#1)(2012-2#1)
assays we##3##2##(1995-2#1)(2008-12#1)(2012-3#1)
assays were also##3##3##(2008-10#3)
assays were conducted##2##3##(2008-10#2)
assays were developed to##2##4##(2008-10#2)
assays were developed##5##3##(2008-10#5)
assays were performed##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
assays were used to investigate the##2##6##(2008-10#1)(2011-2#1)
assays were used to##5##4##(2008-10#4)(2011-2#1)
assays were##30##2##(1995-2#1)(1997-7#1)(2008-10#22)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#2)
assays which##3##2##(2008-10#1)(2008-4#1)(2009-12#1)
assays with the##2##3##(1993-6#1)(2008-10#1)
assays with##14##2##(1992-8#1)(1993-6#1)(2008-10#8)(2008-11#1)(2008-8#1)(2009-12#1)(2012-3#1)
assays##562##1##(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#4)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#3)(1993-8#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#7)(1995-5#3)(1995-6#7)(1995-8#3)(1995-9#3)(1996-12#3)(1996-2#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#3)(2007-12#1)(2008-1#1)(2008-10#270)(2008-11#22)(2008-12#5)(2008-4#34)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#36)(2009-10#2)(2009-12#5)(2009-6#5)(2010-10#1)(2010-11#5)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#4)(2011-1#6)(2011-2#14)(2012-12#5)(2012-2#18)(2012-3#3)(2012-4#1)(2013-1#9)(2013-8#2)
assemblage of##5##2##(1990-8#1)(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
assemblage##12##1##(1990-8#1)(2007-12#1)(2008-8#2)(2008-9#4)(2010-8#3)(2011-2#1)
assemblages in the##2##3##(1990-8#1)(2007-12#1)
assemblages of##4##2##(1990-8#1)(2007-12#1)(2008-3#1)(2008-6#1)
assemblages##9##1##(1990-8#2)(2007-12#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-8#1)
assemble a laboratory population##2##4##(2008-10#2)
assemble a##4##2##(1993-8#1)(2008-10#2)(2012-3#1)
assemble into##4##2##(1994-3#1)(2008-8#2)(2013-8#1)
assemble their##2##2##(2008-7#1)(2009-7#1)
assemble##17##1##(1993-8#1)(1994-3#2)(1995-2#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#3)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
assembled in a##2##3##(2008-10#1)(2008-3#1)
assembled in vitro##3##3##(1993-8#1)(2008-2#1)(2008-8#1)
assembled in##8##2##(1993-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)
assembled into##6##2##(1993-8#1)(1996-12#1)(2008-8#2)(2009-12#1)(2011-2#1)
assembled on the##2##3##(2008-10#2)
assembled on##4##2##(2008-10#4)
assembled onto##2##2##(1995-2#1)(2008-10#1)
assembled sequences##2##2##(2008-4#1)(2010-4#1)
assembled to##6##2##(1996-2#1)(2008-10#3)(2010-12#1)(2012-2#1)
assembled with##6##2##(1991-2#1)(1997-4#1)(1997-9#2)(2008-10#2)
assembled##69##1##(1990-2#1)(1991-2#1)(1993-6#1)(1993-8#4)(1994-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#3)(1997-4#1)(1997-9#2)(2008-10#26)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#4)(2010-5#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#1)
assemblies of##3##2##(1990-2#1)(2008-11#1)(2009-11#1)
assemblies were##2##2##(2008-10#2)
assemblies##22##1##(1990-2#1)(1992-9#1)(1996-2#2)(1997-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
assembling and##2##2##(2008-10#1)(2008-9#1)
assembling the##2##2##(2008-9#1)(2010-8#1)
assembling##14##1##(1993-12#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#2)(2010-8#1)
assembly and##14##2##(1990-5#1)(1993-8#1)(1994-12#1)(1995-8#2)(2008-10#1)(2008-11#1)(2008-4#2)(2009-7#1)(2010-5#1)(2011-3#1)(2012-3#2)
assembly by##2##2##(1996-5#1)(2008-10#1)
assembly composed##2##2##(2011-2#2)
assembly errors##2##2##(2011-2#2)
assembly for##2##2##(2008-10#1)(2008-7#1)
assembly from##2##2##(2008-3#1)(2011-2#1)
assembly in##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
assembly is##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
assembly of nucleosomes##2##3##(2008-8#2)
assembly of the##10##3##(1991-10#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-8#2)(2008-9#2)(2012-2#1)(2013-1#1)
assembly of##35##2##(1990-2#1)(1991-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-6#2)(1995-8#2)(1997-7#1)(2008-10#3)(2008-11#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-7#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
assembly on the##2##3##(2008-10#2)
assembly on##4##2##(2008-10#2)(2008-4#2)
assembly or function##2##3##(1994-11#1)(1997-3#1)
assembly that##2##2##(2008-10#1)(2011-2#1)
assembly with the##2##3##(1995-12#1)(2008-10#1)
assembly##144##1##(1990-2#1)(1990-5#1)(1991-10#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#4)(1995-8#5)(1995-9#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#41)(2008-11#6)(2008-3#2)(2008-4#6)(2008-7#12)(2008-8#10)(2008-9#4)(2009-11#1)(2009-7#2)(2010-12#1)(2010-5#1)(2011-2#12)(2011-3#3)(2012-2#5)(2012-3#5)(2013-1#3)(2013-8#1)
assert##2##1##(1997-5#1)(2008-11#1)
assertion that##3##2##(1994-6#1)(1995-12#1)(2007-12#1)
assertion##9##1##(1994-6#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-9#1)(2009-10#1)(2011-2#1)
assertions##4##1##(2008-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
assertive##4##1##(2008-11#3)(2008-12#1)
assertiveness##3##1##(2008-11#3)
asserts##2##1##(1992-3#1)(2008-11#1)
assess and##3##2##(1996-2#1)(2008-5#1)(2013-1#1)
assess genetic##3##2##(2008-10#3)
assess how##3##2##(2010-6#1)(2010-8#1)(2011-2#1)
assess its##8##2##(1991-2#1)(1992-12#1)(2008-10#2)(2008-11#2)(2009-4#1)(2013-1#1)
assess learning##2##2##(2008-11#1)(2008-12#1)
assess risks##2##2##(2008-11#2)
assess soils and##2##3##(2008-10#2)
assess the ability##5##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-9#1)
assess the accuracy of the##2##5##(1992-2#1)(2008-10#1)
assess the accuracy of##3##4##(1992-2#1)(1994-3#1)(2008-10#1)
assess the advantages and##2##4##(2008-10#1)(2008-3#1)
assess the effect of##10##4##(1996-6#1)(1997-1#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
assess the effects##7##3##(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
assess the efficacy of a##2##5##(2009-2#1)(2012-3#1)
assess the efficacy of##3##4##(1992-9#1)(2009-2#1)(2012-3#1)
assess the efficacy##6##3##(1992-9#1)(2008-5#2)(2008-8#1)(2009-2#1)(2012-3#1)
assess the functional##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
assess the genetic diversity##3##4##(2008-10#2)(2008-7#1)
assess the genetic##4##3##(2008-10#3)(2008-7#1)
assess the health##2##3##(1994-9#1)(2013-8#1)
assess the impact of a##2##5##(1992-1#1)(2008-8#1)
assess the impact of##12##4##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
assess the impact##14##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
assess the level of##2##4##(2008-10#1)(2012-3#1)
assess the mechanisms##2##3##(2008-9#1)(2009-8#1)
assess the potential##5##3##(2008-10#3)(2008-5#1)(2012-3#1)
assess the prevalence##5##3##(2008-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
assess the prognostic value##2##4##(2008-11#1)(2012-12#1)
assess the quality of##4##4##(1991-3#1)(2008-10#2)(2008-3#1)
assess the relative##9##3##(1995-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-4#1)(2012-3#1)
assess the reliability of##2##4##(1992-12#1)(2008-10#1)
assess the role of##2##4##(1995-11#1)(2011-1#1)
assess the safety##2##3##(2008-10#1)(2009-12#1)
assess the severity##3##3##(1995-11#1)(2011-2#1)(2013-1#1)
assess the technical##3##3##(1996-1#1)(2013-8#2)
assess the usefulness of##2##4##(1990-5#1)(1991-3#1)
assess the usefulness##3##3##(1990-5#1)(1991-3#1)(2011-2#1)
assess the##250##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-9#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#2)(1996-2#1)(1996-6#2)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#3)(2008-10#64)(2008-11#14)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#18)(2008-7#7)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#6)(2012-2#6)(2012-3#15)(2012-8#1)(2013-1#13)(2013-8#7)
assess their##11##2##(1993-12#2)(1993-9#1)(1996-12#1)(1997-3#1)(2008-4#1)(2008-9#2)(2011-2#2)(2013-1#1)
assess these##2##2##(1995-9#1)(1996-3#1)
assess this##3##2##(2008-11#2)(2008-8#1)
assess various##2##2##(2008-10#1)(2008-12#1)
assess whether the##4##3##(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
assess whether##19##2##(1994-11#1)(1994-3#1)(1995-11#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
assess##498##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#4)(1992-3#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#3)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#4)(1996-3#3)(1996-6#4)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#1)(2007-12#1)(2007-9#1)(2008-1#4)(2008-10#117)(2008-11#38)(2008-12#12)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#27)(2008-6#1)(2008-7#15)(2008-8#11)(2008-9#17)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#27)(2011-3#1)(2011-8#1)(2012-12#11)(2012-2#13)(2012-3#18)(2012-8#1)(2013-1#30)(2013-8#10)
assessable##2##1##(1991-7#1)(2010-11#1)
assessed after##2##2##(2008-10#1)(2008-5#1)
assessed and##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
assessed as##5##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#2)
assessed at##11##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#2)
assessed before##2##2##(2008-10#1)(2010-12#1)
assessed both##2##2##(1996-12#1)(1996-6#1)
assessed by a##2##3##(2008-10#1)(2013-1#1)
assessed by analyzing##2##3##(1992-2#1)(1997-2#1)
assessed by comparing##3##3##(1997-3#1)(2008-10#2)
assessed by evaluating##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
assessed by fluorescent##2##3##(2008-10#2)
assessed by means of the##2##5##(1990-11#1)(2008-7#1)
assessed by means of##4##4##(1990-11#1)(2008-7#1)(2009-1#1)(2010-6#1)
assessed by measuring the##3##4##(1990-5#1)(1995-3#1)(2009-12#1)
assessed by the##17##3##(1992-3#1)(1993-3#1)(1993-6#1)(1994-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-1#1)(2013-1#2)
assessed by use of##4##4##(1995-11#1)(2008-11#1)(2008-3#1)(2013-1#1)
assessed by##124##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#2)(1994-3#1)(1994-5#2)(1995-11#2)(1995-12#1)(1995-3#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-3#3)(1997-8#1)(2008-10#40)(2008-11#15)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-8#2)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-4#1)(2013-1#5)(2013-8#6)
assessed during##4##2##(1994-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
assessed for a##2##3##(1993-12#1)(2008-3#1)
assessed for the presence##2##4##(2008-10#1)(2012-3#1)
assessed for the##4##3##(2008-10#3)(2012-3#1)
assessed for their ability to act##2##6##(1990-11#1)(2008-10#1)
assessed for their ability to##3##5##(1990-11#1)(1995-11#1)(2008-10#1)
assessed for their##6##3##(1990-11#1)(1995-11#1)(2008-10#4)
assessed for##38##2##(1990-11#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(2008-10#20)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-7#1)(2012-3#2)
assessed from the##2##3##(2008-10#1)(2010-7#1)
assessed from##5##2##(2008-10#3)(2010-3#1)(2010-7#1)
assessed immune function in##3##4##(2008-10#2)(2008-8#1)
assessed in a##7##3##(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2013-1#1)
assessed in an##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
assessed in relation to the##2##5##(1995-11#1)(2012-12#1)
assessed in terms of the##2##5##(1994-2#1)(2008-11#1)
assessed in terms of##5##4##(1994-2#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
assessed in the##7##3##(1990-8#1)(2008-10#3)(2008-5#1)(2012-5#1)(2013-1#1)
assessed in two##2##3##(1993-11#1)(2008-10#1)
assessed in##55##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1993-11#1)(1994-2#3)(1994-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#2)
assessed on a##3##3##(2008-2#1)(2008-7#1)(2013-8#1)
assessed on the##3##3##(2008-11#1)(2008-9#1)(2010-12#1)
assessed on##12##2##(1990-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#2)(2010-12#1)(2012-2#1)(2013-8#1)
assessed over an##2##3##(2008-9#1)(2011-2#1)
assessed over##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
assessed prior to##2##3##(2008-11#1)(2013-8#1)
assessed separately##2##2##(2008-5#2)
assessed the effect of##2##4##(2008-10#1)(2010-8#1)
assessed the effects of the##2##5##(1992-2#1)(1996-2#1)
assessed the effects of##7##4##(1992-2#1)(1993-3#1)(1996-2#1)(2009-10#1)(2010-9#1)(2012-3#2)
assessed the efficacy of##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
assessed the relationships between##2##4##(2008-10#1)(2013-1#1)
assessed the##45##2##(1991-3#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
assessed through##8##2##(2008-10#5)(2008-3#1)(2012-3#1)(2013-1#1)
assessed to be##2##3##(2008-11#1)(2012-2#1)
assessed to##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
assessed under##2##2##(2008-6#1)(2008-8#1)
assessed using a##6##3##(1994-12#1)(2008-10#2)(2009-3#2)(2013-1#1)
assessed using the##11##3##(2008-7#2)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#1)
assessed using##36##2##(1994-12#2)(1994-5#1)(1997-3#1)(2006-6#1)(2008-10#9)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2009-7#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#4)(2013-8#3)
assessed when##2##2##(2008-10#1)(2013-1#1)
assessed whether##2##2##(2008-12#1)(2010-11#1)
assessed with a##5##3##(1993-12#1)(2008-10#1)(2008-5#2)(2010-7#1)
assessed with the##8##3##(2008-10#4)(2008-7#1)(2012-2#2)(2013-8#1)
assessed with##23##2##(1993-12#1)(2008-10#9)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-7#1)(2012-2#3)(2013-1#3)(2013-8#1)
assessed##550##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#4)(1996-2#4)(1996-3#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#7)(1997-6#1)(1997-7#1)(1997-8#4)(2006-6#2)(2007-11#1)(2008-10#169)(2008-11#29)(2008-12#12)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#22)(2008-6#3)(2008-7#13)(2008-8#7)(2008-9#18)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#19)(2012-12#4)(2012-2#13)(2012-3#18)(2012-4#2)(2012-5#3)(2012-6#1)(2013-1#31)(2013-8#20)
assesses how##2##2##(1997-3#1)(2008-11#1)
assesses the effect of##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
assesses the extent to which##2##5##(1997-2#1)(2012-2#1)
assesses the##14##2##(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#2)
assesses##22##1##(1997-2#3)(1997-3#2)(1997-8#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
assessing and treating##2##3##(2008-8#1)(2013-1#1)
assessing and##4##2##(1997-2#1)(2008-8#1)(2009-10#1)(2013-1#1)
assessing aortic valvular insufficiency##2##4##(1994-3#2)
assessing balance##3##2##(2010-12#3)
assessing cardiovascular##2##2##(2010-12#1)(2013-8#1)
assessing changes in##2##3##(2008-11#1)(2012-2#1)
assessing learning and##2##3##(2008-10#1)(2008-11#1)
assessing patients with##2##3##(2008-1#1)(2008-11#1)
assessing patients##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
assessing the effects of##6##4##(1994-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)
assessing the impact of periodontal diseases on##2##7##(2013-1#2)
assessing the percentage of##2##4##(2008-10#1)(2008-4#1)
assessing the practice of##2##4##(2008-11#2)
assessing the risk of##3##4##(2007-11#1)(2008-10#2)
assessing the state of##2##4##(2010-9#1)(2013-1#1)
assessing the##54##2##(1991-1#1)(1993-12#1)(1994-1#1)(1995-11#1)(1996-9#1)(1997-2#2)(1997-7#1)(2007-11#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2013-1#5)(2013-8#1)
assessing these##2##2##(1995-11#1)(2008-11#1)
assessing this##2##2##(2008-11#1)(2009-5#1)
assessing##159##1##(1990-8#1)(1991-1#2)(1991-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-3#3)(1995-11#2)(1995-3#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#26)(2008-11#22)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#6)(2008-7#4)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#3)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-2#6)(2011-7#1)(2011-8#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#2)
assessment -##2##2##(2008-11#2)
assessment activities##3##2##(1996-1#1)(1997-3#2)
assessment and advice##2##3##(2011-2#2)
assessment and care##2##3##(2008-11#1)(2009-11#1)
assessment and improvement##5##3##(1993-3#1)(1996-1#1)(1997-1#2)(1997-2#1)
assessment and intervention##2##3##(2008-7#1)(2010-7#1)
assessment and management of##4##4##(2010-1#1)(2010-10#2)(2010-12#1)
assessment and management##7##3##(2008-10#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-7#1)(2012-2#1)
assessment and prevention of##2##4##(1996-8#1)(2009-4#1)
assessment and the##4##3##(1992-12#1)(1993-3#1)(2008-7#1)(2012-2#1)
assessment and treatment of##3##4##(2008-10#1)(2010-9#2)
assessment and treatment##9##3##(1991-12#1)(1992-1#1)(1997-8#1)(2008-10#1)(2008-11#2)(2010-9#2)(2011-3#1)
assessment and##79##2##(1991-12#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-11#1)(2009-4#2)(2009-5#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-7#2)(2010-9#4)(2011-2#6)(2011-3#3)(2012-2#3)(2013-1#1)(2013-8#2)
assessment approach##2##2##(2008-11#2)
assessment are outlined##2##3##(2008-10#1)(2008-11#1)
assessment are##6##2##(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)
assessment as##4##2##(1996-12#1)(2008-12#1)(2009-12#1)(2013-1#1)
assessment at##2##2##(2008-10#1)(2013-1#1)
assessment based on##2##3##(2008-12#1)(2008-5#1)
assessment by##4##2##(1997-8#1)(2008-10#1)(2010-10#1)(2011-2#1)
assessment can be##2##3##(1992-3#1)(2008-5#1)
assessment can##3##2##(1992-12#1)(1992-3#1)(2008-5#1)
assessment data##5##2##(1995-2#1)(1996-2#1)(1997-1#1)(2007-9#1)(2008-10#1)
assessment for a##2##3##(1992-9#1)(2013-1#1)
assessment for the##5##3##(1997-3#1)(1997-6#1)(2008-10#2)(2010-9#1)
assessment for##21##2##(1992-9#2)(1994-2#1)(1995-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
assessment from##2##2##(1994-2#1)(2008-7#1)
assessment in a##2##3##(1992-12#1)(1996-1#1)
assessment in the##6##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
assessment in##22##2##(1990-2#1)(1992-12#1)(1994-1#1)(1994-2#1)(1996-1#2)(2008-10#5)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#3)(2010-7#1)(2011-2#2)
assessment information##2##2##(1994-12#1)(2009-11#1)
assessment instruments##4##2##(2010-9#2)(2011-2#1)(2012-2#1)
assessment is a##2##3##(1990-2#1)(1994-2#1)
assessment is##11##2##(1990-2#1)(1992-5#1)(1994-2#1)(1997-8#1)(2008-11#3)(2008-12#1)(2008-5#1)(2010-7#1)(2012-2#1)
assessment may##2##2##(1992-12#1)(1996-8#1)
assessment method##3##2##(2008-12#1)(2008-9#2)
assessment methods##4##2##(2008-10#2)(2008-11#1)(2010-11#1)
assessment model##3##2##(2008-10#3)
assessment models##4##2##(2008-10#3)(2008-12#1)
assessment of CAN##2##3##(2012-2#2)
assessment of a##6##3##(2008-10#1)(2008-11#2)(2011-2#1)(2012-3#1)(2013-8#1)
assessment of airway##2##3##(2008-10#1)(2010-5#1)
assessment of all##2##3##(2008-11#1)(2011-2#1)
assessment of atherosclerotic plaque##2##4##(2010-9#2)
assessment of biological activity of##2##5##(2008-12#2)
assessment of biological##4##3##(2008-10#1)(2008-12#2)(2010-11#1)
assessment of bone##2##3##(2008-7#1)(2009-7#1)
assessment of both##2##3##(2008-10#1)(2008-9#1)
assessment of chronic##2##3##(2008-4#1)(2012-3#1)
assessment of citrus tristeza virus incidence##2##6##(2008-10#2)
assessment of clinical##3##3##(1993-9#1)(1995-2#1)(2008-11#1)
assessment of competence##2##3##(2008-11#1)(2008-8#1)
assessment of disease##3##3##(1992-9#1)(2008-10#2)
assessment of estrogenicity##2##3##(2008-10#2)
assessment of feeding##2##3##(2008-11#2)
assessment of immunogenicity##2##3##(1995-5#1)(2008-10#1)
assessment of new cosmetic ingredients##2##5##(2008-5#2)
assessment of new##4##3##(2008-11#1)(2008-5#2)(2008-9#1)
assessment of pain##2##3##(1997-8#1)(2010-6#1)
assessment of potential##2##3##(2008-10#1)(2010-12#1)
assessment of practical##2##3##(2008-11#2)
assessment of respiratory exposure to outdoor air pollutants##2##8##(1996-3#2)
assessment of risk##2##3##(2008-5#1)(2011-2#1)
assessment of skin##4##3##(2008-5#4)
assessment of the effects of##2##5##(2008-10#2)
assessment of the efficacy##2##4##(2008-5#2)
assessment of the method##2##4##(2008-10#2)
assessment of the performance of##2##5##(2008-5#1)(2009-8#1)
assessment of the true##2##4##(1992-3#1)(2013-1#1)
assessment of the viability##2##4##(1992-2#1)(2008-5#1)
assessment of the##66##3##(1990-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#12)(2008-11#7)(2008-4#1)(2008-5#7)(2008-9#1)(2009-10#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#5)(2011-8#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
assessment of their##2##3##(2008-10#1)(2008-9#1)
assessment of thyroid function in psychiatric patients##2##7##(2008-4#2)
assessment of thyroid function##4##4##(2008-4#2)(2008-6#1)(2013-1#1)
assessment of tissue##2##3##(2009-3#1)(2012-2#1)
assessment of total##2##3##(2008-10#2)
assessment of unwanted immunogenicity##3##4##(2008-10#3)
assessment of##350##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#2)(1991-1#4)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#4)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#5)(2007-11#1)(2008-10#75)(2008-11#37)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#23)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#11)(2009-1#5)(2009-10#7)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#5)(2010-12#5)(2010-3#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-9#3)(2011-1#2)(2011-2#17)(2011-8#1)(2012-12#2)(2012-2#10)(2012-3#7)(2012-5#1)(2013-1#12)(2013-8#10)
assessment performed##2##2##(2012-3#1)(2013-1#1)
assessment practices##11##2##(1991-12#1)(2008-10#1)(2008-12#3)(2010-11#6)
assessment procedures##2##2##(2009-11#1)(2010-5#1)
assessment process for##3##3##(2008-10#1)(2008-11#2)
assessment process is##2##3##(1996-1#1)(2008-5#1)
assessment process##8##2##(1996-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2013-8#1)
assessment processes used##2##3##(2008-11#2)
assessment revealed##2##2##(1991-2#1)(1994-2#1)
assessment should be##3##3##(2008-11#1)(2013-1#2)
assessment should##5##2##(2008-11#1)(2012-2#1)(2013-1#3)
assessment situation##2##2##(2008-11#2)
assessment strategies in##2##3##(2008-11#2)
assessment strategies##3##2##(2008-11#3)
assessment strategy##9##2##(2008-11#8)(2009-11#1)
assessment techniques##2##2##(1992-3#1)(2010-7#1)
assessment tests##2##2##(2008-12#1)(2013-1#1)
assessment that##4##2##(1991-3#1)(2008-2#1)(2008-6#1)(2013-8#1)
assessment time##2##2##(2008-10#2)
assessment to##3##2##(2008-10#1)(2008-9#1)(2009-3#1)
assessment tool##6##2##(2008-11#5)(2011-2#1)
assessment tools can##2##3##(2008-10#1)(2008-12#1)
assessment tools that are##2##4##(1994-12#1)(2010-11#1)
assessment tools##11##2##(1991-3#1)(1994-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-11#2)(2010-7#1)(2011-2#1)
assessment using##4##2##(2008-5#2)(2008-7#1)(2012-2#1)
assessment was performed##2##3##(1992-12#1)(2013-1#1)
assessment was##4##2##(1992-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
assessment were##3##2##(1996-12#1)(2008-11#1)(2011-2#1)
assessment will##2##2##(1996-1#1)(2008-10#1)
assessment with##4##2##(2008-12#1)(2008-9#1)(2010-8#1)(2010-9#1)
assessment##849##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-6#2)(1991-1#4)(1991-12#5)(1991-2#4)(1991-3#6)(1991-5#1)(1991-6#3)(1992-1#1)(1992-12#13)(1992-2#3)(1992-3#4)(1992-5#3)(1992-6#1)(1992-9#4)(1993-1#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#4)(1994-12#3)(1994-2#12)(1994-3#4)(1994-5#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#5)(1995-5#4)(1995-9#1)(1996-1#9)(1996-12#8)(1996-2#7)(1996-3#4)(1996-6#1)(1996-8#3)(1997-1#7)(1997-2#5)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#10)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#141)(2008-11#118)(2008-12#27)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#44)(2008-6#6)(2008-7#21)(2008-8#4)(2008-9#25)(2009-1#6)(2009-10#8)(2009-11#9)(2009-12#4)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#3)(2010-11#18)(2010-12#11)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#9)(2010-8#1)(2010-9#13)(2011-1#5)(2011-2#45)(2011-3#4)(2011-8#1)(2012-12#4)(2012-2#27)(2012-3#9)(2012-5#2)(2013-1#36)(2013-8#20)
assessments and##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2010-11#1)(2010-4#1)(2013-1#1)
assessments are##5##2##(1997-8#2)(2008-10#1)(2008-11#1)(2012-3#1)
assessments at##3##2##(2008-10#1)(2008-4#1)(2009-12#1)
assessments in##2##2##(2008-10#1)(2008-5#1)
assessments of the##3##3##(2008-10#2)(2008-11#1)
assessments of##26##2##(1991-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-6#2)(2011-2#1)(2012-3#1)
assessments were##7##2##(1996-1#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#2)
assessments##95##1##(1991-3#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1997-8#2)(2008-10#21)(2008-11#10)(2008-12#6)(2008-4#2)(2008-5#8)(2008-7#1)(2008-9#4)(2009-10#4)(2009-12#2)(2009-3#1)(2009-5#1)(2009-9#2)(2010-11#2)(2010-4#1)(2010-6#2)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
assessor##2##1##(2008-11#1)(2008-5#1)
assessors was##2##2##(2008-10#1)(2008-5#1)
assessors##7##1##(2008-10#3)(2008-11#1)(2008-5#2)(2013-1#1)
asset to##3##2##(1992-1#1)(2008-11#2)
asset##11##1##(1992-1#1)(1994-2#2)(1994-3#3)(1995-5#1)(2008-10#1)(2008-11#2)(2010-8#1)
assets to##2##2##(1994-2#1)(2008-11#1)
assets##8##1##(1992-2#2)(1994-1#1)(1994-2#2)(2008-11#1)(2008-12#1)(2012-2#1)
assign##12##1##(1994-9#1)(1996-2#1)(1996-5#1)(1997-6#1)(2008-10#3)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
assignation##2##1##(2008-10#1)(2010-9#1)
assigned a##4##2##(1993-6#1)(1996-6#1)(2010-2#1)(2012-2#1)
assigned by##5##2##(1995-2#1)(2008-10#2)(2011-2#1)(2012-2#1)
assigned for##3##2##(1993-8#1)(2008-11#1)(2008-4#1)
assigned higher ratings with the##2##5##(2008-9#2)
assigned into##5##2##(2008-11#1)(2009-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
assigned on the genome##4##4##(1996-6#1)(1996-8#2)(1997-6#1)
assigned on the##5##3##(1995-6#1)(1996-6#1)(1996-8#2)(1997-6#1)
assigned on##6##2##(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-6#1)
assigned the##3##2##(1997-8#1)(2008-10#2)
assigned to a##9##3##(1994-2#1)(2008-10#1)(2008-12#2)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
assigned to chromosomes##2##3##(1993-12#1)(1996-12#1)
assigned to either a##3##4##(1991-12#1)(2008-12#1)(2008-4#1)
assigned to either##5##3##(1991-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)
assigned to four##2##3##(2008-12#1)(2010-8#1)
assigned to one##5##3##(2008-4#1)(2010-10#1)(2010-4#1)(2011-2#2)
assigned to receive##5##3##(1993-1#1)(1994-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
assigned to six##3##3##(2008-10#3)
assigned to the##15##3##(1991-12#2)(1992-3#1)(1994-11#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
assigned to two##2##3##(1993-1#1)(2008-10#1)
assigned to##85##2##(1991-12#3)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#8)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
assigned##159##1##(1991-1#1)(1991-12#3)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-6#4)(1996-1#1)(1996-12#2)(1996-6#4)(1996-8#3)(1997-2#1)(1997-6#4)(1997-8#3)(2007-12#1)(2008-10#33)(2008-11#6)(2008-12#9)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-11#2)(2009-3#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#6)(2012-3#4)(2013-1#7)(2013-8#3)
assigning a##3##2##(1992-2#1)(2008-7#1)(2013-8#1)
assigning the##3##2##(1995-6#1)(2008-12#1)(2010-11#1)
assigning##11##1##(1992-2#2)(1994-12#1)(1995-6#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
assignment and##3##2##(2008-10#1)(2008-11#2)
assignment are##2##2##(2008-12#2)
assignment in##2##2##(2008-12#1)(2008-9#1)
assignment of Rv1567c##2##3##(2009-7#2)
assignment of a##3##3##(2008-10#1)(2009-7#1)(2012-2#1)
assignment of the N-terminal##4##4##(2009-7#4)
assignment of the##18##3##(1991-2#1)(1993-2#1)(1995-9#1)(2008-10#1)(2009-7#13)(2013-1#1)
assignment of##48##2##(1991-2#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-6#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#25)(2009-8#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
assignment test##3##2##(2013-1#3)
assignment to##3##2##(1990-8#1)(2008-11#2)
assignment##83##1##(1990-8#1)(1991-2#1)(1992-2#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-6#2)(1997-6#1)(2008-10#8)(2008-11#7)(2008-12#7)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#28)(2009-8#2)(2010-10#1)(2010-11#1)(2012-2#3)(2013-1#8)
assignments and##2##2##(1993-8#1)(2008-10#1)
assignments for the##8##3##(1990-5#1)(1994-5#1)(2009-7#6)
assignments for##10##2##(1990-5#1)(1993-8#1)(1994-5#1)(2008-12#1)(2009-7#6)
assignments of a##2##3##(2009-7#2)
assignments of an engineered intein based on Mycobacterium tuberculosis RecA##2##10##(2009-7#2)
assignments of the 34 kDa ketopantoate reductase##2##7##(2009-7#2)
assignments of the 34 kDa##4##5##(2009-7#4)
assignments of the##16##3##(1990-9#1)(2008-9#1)(2009-7#14)
assignments of##29##2##(1990-9#1)(1991-5#1)(2008-8#1)(2008-9#2)(2009-7#24)
assignments to##2##2##(2008-10#1)(2008-12#1)
assignments were determined##2##3##(2009-7#2)
assignments##56##1##(1990-5#1)(1990-9#1)(1991-5#1)(1993-8#2)(1994-5#1)(1995-2#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-8#2)(2008-9#2)(2009-7#33)(2012-12#1)
assigns##2##1##(1997-1#1)(2010-10#1)
assimilate the##2##2##(2008-11#1)(2013-8#1)
assimilate##5##1##(2008-10#1)(2008-11#2)(2008-12#1)(2013-8#1)
assimilated##4##1##(2008-9#1)(2010-4#2)(2011-1#1)
assimilation in##3##2##(1991-9#1)(1997-1#1)(2011-2#1)
assimilation is##2##2##(1992-10#1)(1997-1#1)
assimilation of##4##2##(1991-9#1)(1992-10#1)(2008-10#1)(2009-8#1)
assimilation rate##3##2##(2008-8#1)(2008-9#1)(2012-5#1)
assimilation theory##3##2##(2009-7#1)(2011-2#2)
assimilation##27##1##(1991-9#2)(1992-10#2)(1993-12#2)(1997-1#4)(2008-10#4)(2008-8#1)(2008-9#3)(2009-7#2)(2009-8#2)(2011-2#4)(2012-5#1)
assimilative##3##1##(2008-10#2)(2012-2#1)
assimilis##5##1##(2008-9#5)
assist clinical##2##2##(2008-11#1)(2010-11#1)
assist devices##7##2##(2008-8#1)(2010-6#5)(2011-2#1)
assist efforts##2##2##(1997-7#1)(2008-10#1)
assist in the diagnosis of##2##5##(1991-12#1)(2010-3#1)
assist in the diagnosis##3##4##(1991-12#1)(2010-3#1)(2011-2#1)
assist in the##12##3##(1991-12#1)(1995-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)
assist in##39##2##(1991-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(1996-2#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#2)(2010-10#1)(2010-3#1)(2011-2#5)(2012-12#2)(2012-2#3)
assist individuals##2##2##(2010-10#1)(2013-8#1)
assist physicians in##2##3##(2008-10#1)(2010-6#1)
assist radiologists##2##2##(1993-1#1)(1993-3#1)
assist the development of##4##4##(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#1)
assist the pediatric nurse practitioner in##2##6##(2009-9#1)(2010-10#1)
assist the##17##2##(1993-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-7#1)
assist them##2##2##(1992-1#1)(1995-1#1)
assist with##3##2##(2008-11#1)(2009-6#1)(2013-8#1)
assist##113##1##(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-1#3)(2008-10#21)(2008-11#10)(2008-12#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#6)(2010-7#2)(2010-9#1)(2011-2#7)(2011-7#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
assistance from##2##2##(1991-12#1)(2010-12#1)
assistance in##4##2##(1991-12#1)(2008-10#1)(2008-11#2)
assistance of##5##2##(1993-1#1)(1993-8#1)(1995-12#1)(2008-12#1)(2011-1#1)
assistance to##3##2##(1991-6#1)(1993-3#1)(1995-2#1)
assistance with##2##2##(1996-3#1)(2008-9#1)
assistance##39##1##(1990-12#1)(1991-1#2)(1991-12#2)(1991-6#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#3)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#6)(2013-1#2)
assistant medical##2##2##(2009-11#2)
assistant##12##1##(1992-1#3)(1996-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#2)(2010-11#1)(2012-2#1)(2012-3#1)
assistant's##3##1##(1992-1#1)(2009-4#2)
assistants##11##1##(1992-1#1)(1995-2#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-4#2)(2010-11#2)(2010-5#1)
assisted acid##2##2##(2008-10#1)(2011-2#1)
assisted by a##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
assisted by##13##2##(1994-2#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-2#1)(2012-2#1)(2013-8#1)
assisted conception##3##2##(1990-6#1)(1994-9#1)(1996-9#1)
assisted digestion procedure##2##3##(2008-10#2)
assisted digestion##4##2##(2008-10#4)
assisted extraction##3##2##(2008-10#3)
assisted in##3##2##(1993-9#1)(2009-1#1)(2011-3#1)
assisted living##13##2##(2008-12#10)(2010-8#2)(2013-8#1)
assisted pseudo-digestion of##2##3##(2008-10#2)
assisted pseudo-digestion##4##2##(2008-10#4)
assisted reproductive techniques##2##3##(1996-9#1)(2012-3#1)
assisted reproductive technologies##2##3##(1992-2#1)(2008-11#1)
assisted reproductive##5##2##(1992-2#1)(1996-9#1)(2008-11#1)(2012-3#2)
assisted suicide##8##2##(1991-8#8)
assisted vaginal hysterectomies##3##3##(1993-12#1)(1995-1#2)
assisted vaginal hysterectomy (LAVH)##2##4##(1994-2#1)(1995-3#1)
assisted vaginal hysterectomy##11##3##(1993-12#6)(1994-2#3)(1995-3#2)
assisted vaginal##16##2##(1993-12#7)(1994-2#5)(1995-1#2)(1995-3#2)
assisted with##3##2##(2008-10#1)(2012-2#2)
assisted##113##1##(1990-6#1)(1991-8#8)(1992-2#1)(1992-3#1)(1993-12#7)(1993-9#1)(1994-2#6)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1996-9#4)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#37)(2008-11#5)(2008-12#11)(2008-2#1)(2009-1#1)(2010-11#1)(2010-7#1)(2010-8#3)(2011-2#3)(2011-3#1)(2012-2#5)(2012-3#2)(2013-8#3)
assisted-acid##2##1##(2008-10#2)
assisting in##2##2##(2008-10#2)
assisting##15##1##(1991-12#1)(1992-8#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-10#1)(2010-9#2)(2012-2#1)(2012-3#1)(2013-8#1)
assistive device##3##2##(2008-12#1)(2012-2#2)
assistive devices##2##2##(1992-3#1)(2012-2#1)
assistive##6##1##(1991-12#1)(1992-3#1)(2008-12#1)(2012-2#3)
assists the##2##2##(2008-10#1)(2008-9#1)
assists##7##1##(1997-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-7#1)(2013-1#1)
associate formation##3##2##(2008-10#3)
associate formed##3##2##(2008-10#3)
associate of##3##2##(2008-10#3)
associate with the##4##3##(1993-8#1)(1995-6#2)(2008-10#1)
associate with##13##2##(1993-8#1)(1994-11#1)(1995-6#3)(2008-10#3)(2008-11#1)(2008-12#2)(2009-8#1)(2010-12#1)
associate##49##1##(1990-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#4)(1997-3#1)(1997-6#1)(2008-10#23)(2008-11#1)(2008-12#2)(2008-6#1)(2009-7#1)(2009-8#4)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
associated (r(2) = 0##2##4##(2008-10#2)
associated and##2##2##(2008-11#2)
associated as##2##2##(1995-12#1)(1995-5#1)
associated benefits##2##2##(1994-2#1)(1997-3#1)
associated cardiac##2##2##(2008-10#1)(2008-7#1)
associated exonuclease activity##2##3##(1995-2#2)
associated factors among##3##3##(1996-2#1)(2008-10#2)
associated factors in##3##3##(2009-10#1)(2013-1#1)(2013-8#1)
associated factors##13##2##(1996-2#1)(2008-10#4)(2009-10#1)(2012-12#1)(2013-1#4)(2013-8#2)
associated genes##2##2##(2010-11#1)(2011-2#1)
associated in##6##2##(1993-12#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
associated intensity modulation##2##3##(2008-3#2)
associated lymphoid##2##2##(1997-1#1)(2011-2#1)
associated malformations##3##2##(1995-11#1)(2012-3#2)
associated medical##2##2##(1997-8#1)(2008-11#1)
associated metal ions##3##3##(2008-10#3)
associated minimum tillage##2##3##(2008-10#2)
associated myositis##2##2##(2013-1#2)
associated only##2##2##(2008-10#1)(2011-2#1)
associated problems##2##2##(2008-11#1)(2008-7#1)
associated production##7##2##(2008-11#7)
associated protein##3##2##(1992-10#1)(2008-11#2)
associated proteins##5##2##(1991-1#1)(1996-12#1)(2008-9#1)(2009-8#2)
associated risk##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
associated side effects##3##3##(2009-7#2)(2013-8#1)
associated significantly with##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
associated to a##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
associated to flow injection (FI) was studied##2##7##(2008-10#2)
associated to the##11##3##(1990-3#1)(2008-10#7)(2008-5#1)(2009-10#1)(2009-6#1)
associated to##49##2##(1990-2#1)(1990-3#1)(1991-6#2)(1994-12#1)(1994-5#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-5#1)(2009-6#1)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
associated tuberculosis##2##2##(1995-10#2)
associated with &quot##2##3##(2008-5#1)(2011-2#1)
associated with AD##2##3##(1996-2#1)(2008-5#1)
associated with D##2##3##(2008-10#2)
associated with GLS##3##3##(2008-10#3)
associated with HCC##2##3##(1993-2#1)(2013-8#1)
associated with HIV##2##3##(1991-1#1)(2011-2#1)
associated with HIV-1##2##3##(1997-3#1)(2008-2#1)
associated with MMD##2##3##(2008-10#2)
associated with Rsp2##2##3##(2008-10#2)
associated with a better outcome##2##5##(2008-11#1)(2008-7#1)
associated with a better##3##4##(2008-11#1)(2008-7#1)(2009-12#1)
associated with a decrease in the##2##6##(2008-7#1)(2012-2#1)
associated with a decrease in##6##5##(1990-12#1)(1996-2#1)(2008-7#2)(2009-9#1)(2012-2#1)
associated with a decrease##7##4##(1990-12#1)(1996-2#1)(1996-6#1)(2008-7#2)(2009-9#1)(2012-2#1)
associated with a decreased likelihood of##2##6##(2010-11#1)(2013-1#1)
associated with a decreased##4##4##(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
associated with a defective##2##4##(1995-2#1)(2008-9#1)
associated with a greater##4##4##(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
associated with a high##9##4##(1993-11#1)(1995-6#1)(1996-9#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-8#1)
associated with a higher risk of##2##6##(2013-1#1)(2013-8#1)
associated with a higher risk##3##5##(2008-8#1)(2013-1#1)(2013-8#1)
associated with a higher##6##4##(1996-2#1)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#1)
associated with a history of##2##5##(1996-8#1)(2013-8#1)
associated with a history##3##4##(1996-8#1)(2013-8#2)
associated with a loss of##2##5##(1992-3#1)(2011-2#1)
associated with a low##4##4##(1993-6#1)(2008-4#1)(2011-2#1)(2013-8#1)
associated with a more##2##4##(1990-8#1)(2008-8#1)
associated with a number of##3##5##(1997-4#1)(2008-6#1)(2009-5#1)
associated with a poor outcome##3##5##(2008-8#1)(2011-2#1)(2012-3#1)
associated with a poor prognosis##5##5##(1994-12#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
associated with a poor##8##4##(1994-12#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
associated with a range of##3##5##(2008-10#1)(2013-1#2)
associated with a rapid##2##4##(2010-12#1)(2013-1#1)
associated with a reduction in##5##5##(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
associated with a reduction##6##4##(2008-10#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
associated with a rise in##2##5##(2008-10#2)
associated with a significant##4##4##(1990-9#1)(2008-10#1)(2010-6#1)(2012-2#1)
associated with a substantial##2##4##(1991-8#1)(1997-3#1)
associated with a variety of##5##5##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#2)
associated with a very##2##4##(2008-10#1)(2009-12#1)
associated with a##158##3##(1990-12#1)(1990-3#1)(1990-8#3)(1990-9#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#2)(1995-2#1)(1995-6#1)(1996-2#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#3)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#14)(2013-8#10)
associated with abnormal##4##3##(1990-8#1)(2008-7#1)(2008-9#1)(2012-12#1)
associated with abnormalities in##2##4##(1995-12#1)(2011-2#1)
associated with activation##2##3##(1995-8#1)(2010-12#1)
associated with active##2##3##(2008-1#1)(2013-1#1)
associated with acute renal##2##4##(2011-2#1)(2012-3#1)
associated with acute##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
associated with adherence##2##3##(1996-3#1)(2010-11#1)
associated with adverse##4##3##(2008-7#2)(2013-1#1)(2013-8#1)
associated with aerosols##2##3##(2008-10#1)(2008-3#1)
associated with aflatoxin##2##3##(2008-10#2)
associated with age##4##3##(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
associated with aging##2##3##(2008-7#1)(2013-7#1)
associated with alendronate##2##3##(2008-11#2)
associated with all##3##3##(1997-2#1)(2008-7#1)(2010-6#1)
associated with altered##2##3##(1995-11#1)(2008-10#1)
associated with an abnormal##2##4##(1993-11#1)(1997-3#1)
associated with an effect on##2##5##(1994-8#2)
associated with an important##2##4##(1993-8#1)(2008-5#1)
associated with an increase in##4##5##(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
associated with an increase##5##4##(1990-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
associated with an increased likelihood of##3##6##(2010-11#1)(2013-1#2)
associated with an increased prevalence of##2##6##(2008-7#1)(2012-5#1)
associated with an increased risk for##4##6##(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
associated with an increased risk of##6##6##(1992-8#1)(1993-11#1)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
associated with an increased risk##10##5##(1992-8#1)(1993-11#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
associated with an increased##24##4##(1990-12#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)
associated with an isolated hydronephrosis##2##5##(2008-10#2)
associated with an##60##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#1)
associated with anemia##3##3##(1992-6#1)(2011-2#2)
associated with angiocentric##2##3##(2009-1#2)
associated with any of the##2##5##(2008-10#1)(2012-3#1)
associated with any##5##3##(2008-10#3)(2008-12#1)(2012-3#1)
associated with apoptosis##2##3##(2008-10#1)(2008-9#1)
associated with automation##2##3##(2008-10#2)
associated with avian##2##3##(2008-5#2)
associated with better##7##3##(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-2#1)(2012-2#1)
associated with bilateral##2##3##(2010-11#1)(2012-2#1)
associated with biological control##2##4##(2008-10#2)
associated with biological##4##3##(1997-6#1)(2008-10#3)
associated with both##10##3##(1990-8#1)(1991-10#1)(1991-5#1)(2008-10#3)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
associated with cancer##6##3##(1997-7#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-8#1)
associated with cardiac##2##3##(2008-10#1)(2012-12#1)
associated with cardiovascular##3##3##(2008-7#1)(2010-4#1)(2011-1#1)
associated with cell wall##2##4##(2008-10#2)
associated with cell##7##3##(1992-10#1)(1996-2#1)(2008-10#3)(2008-11#1)(2009-3#1)
associated with central##2##3##(2010-11#1)(2011-1#1)
associated with cerebral##3##3##(2010-1#1)(2011-2#1)(2013-1#1)
associated with certain##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
associated with chronic##5##3##(1997-1#1)(2008-12#1)(2008-9#1)(2010-1#2)
associated with citrus##2##3##(2008-10#2)
associated with clavulanic acid##2##4##(1990-3#2)
associated with cleft##2##3##(2010-11#1)(2012-12#1)
associated with clinical symptoms##2##4##(2008-12#1)(2013-1#1)
associated with clinical##5##3##(2008-12#2)(2008-5#1)(2011-2#1)(2013-1#1)
associated with colonic polyposis -##2##5##(2009-12#2)
associated with common##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
associated with complications such as##2##5##(2007-12#1)(2012-12#1)
associated with complications##3##3##(2007-12#1)(2010-12#1)(2012-12#1)
associated with conditions##2##3##(2011-2#1)(2013-1#1)
associated with current##4##3##(2008-10#3)(2013-1#1)
associated with death pathways##2##4##(2008-11#2)
associated with decreased##11##3##(1997-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-10#1)(2011-2#2)(2013-8#1)
associated with degenerative##2##3##(2013-1#1)(2013-8#1)
associated with delivering##2##3##(2008-12#2)
associated with differences in##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
associated with different##4##3##(2008-10#2)(2008-12#1)(2012-2#1)
associated with disease progression##2##4##(2010-4#1)(2013-1#1)
associated with disease##5##3##(1995-3#1)(2008-10#1)(2009-6#1)(2010-4#1)(2013-1#1)
associated with diseased##3##3##(2008-10#3)
associated with dynamic##2##3##(2010-10#1)(2012-2#1)
associated with each##4##3##(1996-1#1)(2007-12#1)(2008-10#1)(2008-8#1)
associated with early sexual activity##2##5##(2013-8#2)
associated with early sexual##3##4##(2013-8#3)
associated with either##3##3##(1990-11#1)(2009-10#1)(2010-1#1)
associated with elevated plasma##2##4##(2008-11#1)(2008-7#1)
associated with elevated serum##2##4##(1991-8#1)(2012-5#1)
associated with elevated##11##3##(1991-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-7#1)(2012-5#1)(2013-1#1)
associated with enhanced##4##3##(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#1)
associated with epileptic##2##3##(2008-7#1)(2010-4#1)
associated with fewer##3##3##(2011-2#1)(2012-2#2)
associated with four##3##3##(2008-10#2)(2013-8#1)
associated with gastric##2##3##(2008-12#1)(2011-2#1)
associated with gene##2##3##(2008-8#1)(2012-3#1)
associated with good response in##2##5##(2011-2#2)
associated with greater##12##3##(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
associated with growth##2##3##(1992-12#1)(1994-5#1)
associated with health##3##3##(1993-2#1)(1997-2#1)(2010-5#1)
associated with heavy##3##3##(1991-12#1)(1995-3#1)(2013-1#1)
associated with hepatitis C##3##4##(2010-4#1)(2013-1#2)
associated with high disease severity##2##5##(2008-10#2)
associated with high mortality##2##4##(2011-2#1)(2012-3#1)
associated with high##14##3##(1990-2#1)(1994-8#1)(2008-10#3)(2008-9#1)(2009-10#2)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
associated with high-risk sexual behavior##2##5##(2013-1#2)
associated with higher rates of##3##5##(2008-11#1)(2009-8#1)(2013-1#1)
associated with higher##14##3##(1993-6#1)(1994-12#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
associated with human##3##3##(1997-8#1)(2008-2#1)(2010-1#1)
associated with hypospadias##2##3##(2008-10#2)
associated with immunity##2##3##(2008-8#1)(2012-3#1)
associated with impairment of##2##4##(1994-12#1)(2008-7#1)
associated with implementing##2##3##(1991-1#1)(1993-12#1)
associated with improved treatment response and##2##6##(2009-11#2)
associated with improved##8##3##(1997-1#1)(2008-12#1)(2008-7#2)(2009-11#2)(2010-4#1)(2012-2#1)
associated with increased cardiovascular risk##2##5##(2008-6#1)(2012-3#1)
associated with increased mortality##2##4##(2011-2#2)
associated with increased risk for##4##5##(1993-12#2)(1993-3#1)(2010-10#1)
associated with increased risk of##5##5##(2006-5#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
associated with increased risk##9##4##(1993-12#2)(1993-3#1)(2006-5#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
associated with increased##40##3##(1991-12#1)(1991-3#1)(1992-8#1)(1993-12#2)(1993-3#1)(1995-12#1)(1996-12#1)(1997-1#1)(2006-5#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
associated with increases in the##2##5##(1991-5#1)(2008-10#1)
associated with individual change in##2##5##(2008-12#2)
associated with individual##3##3##(2008-12#2)(2013-1#1)
associated with indoor##2##3##(1991-3#2)
associated with infection by##2##4##(2008-10#2)
associated with infection##3##3##(2008-10#3)
associated with inflammation##2##3##(2012-12#1)(2013-1#1)
associated with inflammatory bowel##2##4##(2011-2#2)
associated with injection##2##3##(2013-1#1)(2013-8#1)
associated with intensive##2##3##(2008-10#2)
associated with internal##2##3##(1990-5#1)(2008-10#1)
associated with intracranial##2##3##(2008-7#1)(2012-12#1)
associated with its##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
associated with lack of##2##4##(2009-10#1)(2013-1#1)
associated with late##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
associated with left##2##3##(1991-8#1)(2008-12#1)
associated with less##8##3##(2008-10#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-9#1)(2013-1#2)
associated with limb##2##3##(1991-8#1)(2012-2#1)
associated with long##2##3##(2008-10#1)(2012-2#1)
associated with loss of##5##4##(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#2)
associated with loss##6##3##(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)
associated with low##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
associated with lower levels of##2##5##(1995-3#1)(2012-2#1)
associated with lower##9##3##(1995-3#1)(2008-7#2)(2009-7#1)(2010-7#2)(2012-2#1)(2013-1#2)
associated with major gene controlling litter size in commercial pig breeds##2##11##(2008-8#2)
associated with major##4##3##(2008-8#2)(2011-2#2)
associated with marked##2##3##(1996-2#1)(2008-10#1)
associated with massive##2##3##(2008-10#1)(2008-7#1)
associated with maternal##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
associated with medical##2##3##(1990-11#1)(2009-9#1)
associated with metabolic##2##3##(2011-1#1)(2011-2#1)
associated with microvascular decompression for trigeminal neuralgia##2##7##(2011-2#2)
associated with minimally invasive##2##4##(2011-2#2)
associated with mitochondrial##2##3##(1994-11#1)(2009-9#1)
associated with moral##2##3##(2008-11#1)(2013-8#1)
associated with more negative##2##4##(2008-12#1)(2010-1#1)
associated with more##15##3##(1995-3#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2013-1#1)
associated with multiple##4##3##(2010-7#1)(2011-2#2)(2011-7#1)
associated with neoplastic##2##3##(1992-3#1)(2012-2#1)
associated with nitrogen fixation##2##4##(2009-7#2)
associated with normal##4##3##(1996-2#1)(2008-10#2)(2011-1#1)
associated with obesity##3##3##(2010-5#1)(2011-1#1)(2013-1#1)
associated with one##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
associated with oral##2##3##(2013-1#2)
associated with other##7##3##(1993-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
associated with outcomes##2##3##(2008-12#2)
associated with pain##4##3##(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)
associated with partial resistance to##3##5##(2008-10#3)
associated with partial resistance##6##4##(2008-10#6)
associated with pathogenicity##2##3##(2008-10#1)(2008-5#1)
associated with physical##2##3##(2008-11#1)(2009-5#1)
associated with physician##2##3##(1993-1#1)(2013-1#1)
associated with plant##2##3##(2007-12#1)(2008-10#1)
associated with plants##3##3##(2008-10#3)
associated with plasma##2##3##(1997-8#1)(2008-7#1)
associated with poor outcome##4##4##(1994-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
associated with poor prognosis##2##4##(2011-2#1)(2011-3#1)
associated with poor survival##2##4##(1991-2#1)(2008-7#1)
associated with poor##14##3##(1991-2#1)(1994-12#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-5#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-8#1)
associated with poorer##5##3##(2008-1#1)(2008-9#1)(2009-9#1)(2011-2#2)
associated with positive discography in patients with lumbar discogenic pain are caused by##2##13##(2012-12#2)
associated with positive##4##3##(1992-12#1)(2011-2#1)(2012-12#2)
associated with previous##2##3##(2008-1#1)(2012-3#1)
associated with proliferation##2##3##(2008-10#1)(2011-2#1)
associated with protein##2##3##(1994-5#1)(2008-11#1)
associated with pulmonary hypertension##2##4##(2010-12#1)(2012-3#1)
associated with pulmonary##3##3##(2008-7#1)(2010-12#1)(2012-3#1)
associated with putting##2##3##(2010-12#1)(2013-1#1)
associated with rapid##2##3##(1997-3#1)(2010-6#1)
associated with reduced##9##3##(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-1#2)(2011-2#1)
associated with reduction of##2##4##(2008-10#1)(2013-1#1)
associated with reductions in##4##4##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
associated with relatively##2##3##(2008-10#2)
associated with repeat prescriptions##3##4##(2008-11#3)
associated with repeat##4##3##(2008-11#4)
associated with repetitive##2##3##(1991-5#1)(2012-3#1)
associated with resistance to##9##4##(2008-10#9)
associated with resistance were##2##4##(2008-10#2)
associated with resistance##16##3##(2008-10#15)(2008-9#1)
associated with risk of##3##4##(2008-11#1)(2008-6#1)(2010-4#1)
associated with risk##5##3##(2008-11#2)(2008-6#1)(2010-4#1)(2010-7#1)
associated with rupture##2##3##(1990-11#1)(2010-7#1)
associated with sCysC in SLE##2##5##(2013-1#2)
associated with serious##2##3##(2013-1#2)
associated with several other##2##4##(2011-1#1)(2012-2#1)
associated with several##6##3##(1994-11#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
associated with severe enterorrhagia##2##4##(1990-9#2)
associated with severe periodontitis in rural##2##6##(2008-10#2)
associated with severe periodontitis in##3##5##(2008-10#3)
associated with severe periodontitis##4##4##(2008-10#4)
associated with severe##11##3##(1990-9#2)(2008-10#4)(2008-7#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
associated with sexual##4##3##(1995-12#1)(2009-5#2)(2010-4#1)
associated with significant morbidity##2##4##(2008-7#1)(2011-2#1)
associated with significant reductions in##3##5##(1995-1#1)(2008-10#2)
associated with significant##13##3##(1995-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
associated with significantly##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
associated with six##2##3##(1993-1#1)(2008-10#1)
associated with smoking##6##3##(1990-9#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#2)
associated with some##4##3##(1994-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
associated with specific##7##3##(1990-6#1)(2008-10#2)(2010-12#1)(2011-2#2)(2012-3#1)
associated with successful##2##3##(1994-3#1)(2008-10#1)
associated with such##2##3##(1994-2#1)(2008-2#1)
associated with susceptibility to##2##4##(1995-5#1)(2008-10#1)
associated with susceptibility##3##3##(1995-5#1)(2008-10#1)(2011-2#1)
associated with tall##2##3##(2008-10#2)
associated with the activation of##2##5##(2009-12#1)(2012-2#1)
associated with the appearance of##2##5##(1995-8#1)(2011-2#1)
associated with the best##2##4##(1995-5#1)(2011-2#1)
associated with the contribution from the downward path##2##8##(2008-3#2)
associated with the course##2##4##(2008-10#1)(2008-11#1)
associated with the degree of##2##5##(2008-8#2)
associated with the development of##6##5##(1995-2#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
associated with the development##7##4##(1995-2#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
associated with the disease##5##4##(2008-10#2)(2013-1#2)(2013-8#1)
associated with the host##2##4##(2008-10#1)(2008-5#1)
associated with the identification of##2##5##(2008-10#1)(2009-8#1)
associated with the implementation of##2##5##(2008-10#1)(2008-11#1)
associated with the importance##2##4##(1995-1#1)(2009-8#1)
associated with the induction of##4##5##(1991-3#1)(1995-8#1)(2008-10#1)(2008-11#1)
associated with the injection of##2##5##(2011-2#2)
associated with the introduction of##2##5##(1993-1#1)(2008-11#1)
associated with the loss of##2##5##(2008-11#1)(2011-3#1)
associated with the metabolic syndrome##4##5##(2008-1#1)(2010-4#2)(2011-2#1)
associated with the nucleus##2##4##(1993-8#1)(1997-1#1)
associated with the observed##3##4##(1993-3#1)(2008-12#1)(2011-2#1)
associated with the occurrence of##2##5##(1995-2#1)(2013-1#1)
associated with the presence of##8##5##(1991-8#1)(1992-3#1)(1992-5#1)(1996-12#1)(2008-10#2)(2011-2#1)(2013-1#1)
associated with the prevalence of##2##5##(1993-5#1)(2008-3#1)
associated with the production of##2##5##(2006-6#1)(2008-8#1)
associated with the rare##2##4##(2008-10#1)(2012-3#1)
associated with the risk of RA##2##6##(2010-12#2)
associated with the risk of##3##5##(2008-11#1)(2010-12#2)
associated with the surgical##2##4##(1996-9#1)(2011-2#1)
associated with the use of##6##5##(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2013-1#1)
associated with the##270##3##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#3)(1994-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-12#1)(1996-3#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-7#2)(1997-8#2)(2006-6#3)(2007-12#2)(2008-1#2)(2008-10#69)(2008-11#18)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#5)(2009-9#2)(2010-10#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#14)(2013-8#6)
associated with their use##5##4##(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
associated with their##11##3##(1995-3#1)(1995-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2011-3#2)(2013-1#1)
associated with them##3##3##(2008-10#2)(2008-11#1)
associated with these disorders##2##4##(1997-3#1)(2012-3#1)
associated with these##17##3##(1990-11#1)(1993-2#1)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-9#1)(2012-3#1)
associated with this disease##2##4##(2008-10#1)(2010-5#1)
associated with this##17##3##(1991-3#1)(1994-2#1)(2008-1#1)(2008-10#6)(2008-4#1)(2009-1#1)(2009-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
associated with three##3##3##(2008-10#2)(2010-12#1)
associated with tolerance##3##3##(2008-10#2)(2011-10#1)
associated with traumatic##2##3##(2008-7#2)
associated with treatment##4##3##(2008-11#2)(2010-6#1)(2013-8#1)
associated with tremolite##2##3##(1991-12#2)
associated with tumor##3##3##(1991-8#1)(2008-9#1)(2013-1#1)
associated with two##2##3##(2008-10#2)
associated with typical##2##3##(1997-2#1)(2013-1#1)
associated with urinary flow impairment##2##5##(2008-10#2)
associated with use of##2##4##(2008-11#1)(2013-8#1)
associated with using the traditional##2##5##(2008-10#1)(2008-11#1)
associated with using##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
associated with various##5##3##(1995-2#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-8#1)
associated with vascular##2##3##(2010-10#1)(2013-8#1)
associated with very##2##3##(1993-3#1)(2010-1#1)
associated with victimization##3##3##(2009-5#3)
associated with viral contaminations in##2##5##(2008-11#2)
associated with viral##4##3##(2008-11#2)(2008-8#1)(2013-1#1)
associated with vitamin##2##3##(2007-9#1)(2012-2#1)
associated with yellow##2##3##(2008-10#2)
associated with##1952##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#6)(1990-5#9)(1990-6#3)(1990-7#1)(1990-8#9)(1990-9#9)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#9)(1991-2#2)(1991-3#11)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#8)(1992-5#2)(1992-6#5)(1992-8#2)(1992-9#4)(1993-1#6)(1993-11#8)(1993-12#12)(1993-2#6)(1993-3#7)(1993-5#1)(1993-6#10)(1993-8#9)(1993-9#1)(1994-1#4)(1994-11#3)(1994-12#11)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#3)(1994-8#3)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#13)(1995-2#12)(1995-3#8)(1995-5#6)(1995-6#9)(1995-8#9)(1995-9#3)(1996-1#4)(1996-11#1)(1996-12#8)(1996-2#10)(1996-3#3)(1996-6#6)(1996-8#1)(1996-9#4)(1997-1#10)(1997-2#7)(1997-3#13)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#10)(2006-5#1)(2006-6#3)(2007-11#2)(2007-12#14)(2007-9#3)(2008-1#13)(2008-10#400)(2008-11#100)(2008-12#44)(2008-2#7)(2008-3#18)(2008-4#15)(2008-5#33)(2008-6#8)(2008-7#93)(2008-8#36)(2008-9#53)(2009-1#7)(2009-10#9)(2009-11#11)(2009-12#15)(2009-3#4)(2009-5#19)(2009-6#3)(2009-7#12)(2009-8#15)(2009-9#10)(2010-1#14)(2010-10#16)(2010-11#14)(2010-12#27)(2010-2#3)(2010-3#2)(2010-4#15)(2010-5#7)(2010-6#13)(2010-7#13)(2010-8#2)(2010-9#6)(2011-1#14)(2011-10#1)(2011-2#125)(2011-3#5)(2011-7#2)(2012-12#31)(2012-2#55)(2012-3#53)(2012-5#4)(2012-6#1)(2013-1#132)(2013-7#3)(2013-8#62)
associated##2296##1##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#3)(1990-3#7)(1990-5#9)(1990-6#3)(1990-7#1)(1990-8#9)(1990-9#9)(1991-1#5)(1991-10#3)(1991-11#2)(1991-12#10)(1991-2#3)(1991-3#12)(1991-4#1)(1991-5#5)(1991-6#4)(1991-7#2)(1991-8#8)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#10)(1992-5#2)(1992-6#5)(1992-8#2)(1992-9#6)(1993-1#7)(1993-11#8)(1993-12#13)(1993-2#6)(1993-3#7)(1993-5#1)(1993-6#10)(1993-8#13)(1993-9#2)(1994-1#4)(1994-11#3)(1994-12#13)(1994-2#7)(1994-3#8)(1994-5#5)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#6)(1995-10#3)(1995-11#3)(1995-12#17)(1995-2#15)(1995-3#8)(1995-5#7)(1995-6#10)(1995-8#9)(1995-9#3)(1996-1#4)(1996-11#1)(1996-12#9)(1996-2#11)(1996-3#4)(1996-6#6)(1996-8#1)(1996-9#4)(1997-1#15)(1997-2#7)(1997-3#15)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#12)(2006-5#1)(2006-6#3)(2007-11#2)(2007-12#15)(2007-8#3)(2007-9#3)(2008-1#16)(2008-10#485)(2008-11#128)(2008-12#47)(2008-2#8)(2008-3#22)(2008-4#18)(2008-5#42)(2008-6#10)(2008-7#108)(2008-8#41)(2008-9#62)(2009-1#8)(2009-10#13)(2009-11#11)(2009-12#16)(2009-3#6)(2009-5#22)(2009-6#4)(2009-7#15)(2009-8#19)(2009-9#10)(2010-1#15)(2010-10#18)(2010-11#16)(2010-12#30)(2010-2#3)(2010-3#2)(2010-4#15)(2010-5#9)(2010-6#14)(2010-7#14)(2010-8#3)(2010-9#7)(2011-1#14)(2011-10#2)(2011-2#146)(2011-3#5)(2011-7#2)(2012-12#34)(2012-2#63)(2012-3#64)(2012-5#4)(2012-6#1)(2013-1#154)(2013-7#3)(2013-8#72)
associates and##3##2##(2008-10#1)(2008-7#2)
associates of##6##2##(2008-10#5)(2008-7#1)
associates with the##4##3##(1994-12#1)(1995-2#1)(1997-1#1)(2008-10#1)
associates with##13##2##(1990-5#1)(1993-9#1)(1994-11#2)(1994-12#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-8#1)(2009-6#1)(2012-2#1)
associates##35##1##(1990-2#1)(1990-5#1)(1991-1#1)(1993-9#1)(1994-11#2)(1994-12#2)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#15)(2008-7#3)(2008-8#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
associating##6##1##(1991-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
association (GWA)##2##2##(2011-2#1)(2012-3#1)
association among##3##2##(2008-10#2)(2011-2#1)
association analysis of##2##3##(2012-3#2)
association analysis##3##2##(2011-2#1)(2012-3#2)
association and dissociation##3##3##(1991-5#1)(1993-1#1)(2008-10#1)
association and##9##2##(1991-5#1)(1993-1#1)(1996-2#1)(2008-10#4)(2008-8#1)(2009-10#1)
association areas##3##2##(1997-2#2)(2011-2#1)
association as a##2##3##(2008-10#2)
association as##3##2##(2008-10#3)
association between IBS and##2##4##(2013-1#2)
association between age##2##3##(2008-8#1)(2011-2#1)
association between different types of exercise training##2##7##(2013-1#2)
association between different##3##3##(1993-8#1)(2013-1#2)
association between family##2##3##(2011-2#1)(2013-8#1)
association between interparental conflict and##3##5##(2010-1#3)
association between maternal##2##3##(2009-7#1)(2011-2#1)
association between migraine##3##3##(2008-9#3)
association between perceived##2##3##(2011-2#1)(2012-2#1)
association between prenatal care and birth##2##6##(1992-2#1)(1995-2#1)
association between religion and under-five mortality##2##6##(2009-6#2)
association between the frequency of family dinners and positive and negative dimensions of##2##13##(2013-1#2)
association between the##20##3##(1990-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#4)
association between these##2##3##(2008-10#1)(2012-3#1)
association between this##2##3##(2008-6#1)(2012-12#1)
association between##139##2##(1990-12#1)(1990-8#3)(1991-12#2)(1991-3#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#1)(2010-1#6)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#19)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#19)(2013-8#6)
association complex of##2##3##(2008-10#2)
association complex##9##2##(2008-10#9)
association complexes##2##2##(2008-10#2)
association constant for##3##3##(2008-10#3)
association constant of the##2##4##(2008-10#2)
association constant of##4##3##(2008-10#4)
association constant##11##2##(1996-5#1)(2008-10#10)
association constants of##3##3##(2008-10#3)
association constants vary##2##3##(2008-10#2)
association constants were##3##3##(2008-10#3)
association constants##21##2##(2008-10#20)(2008-8#1)
association cortex##3##2##(1997-2#3)
association for##2##2##(1994-2#1)(2008-10#1)
association from##2##2##(2008-10#1)(2008-8#1)
association has been##2##3##(1996-1#1)(2010-6#1)
association has##5##2##(1993-8#1)(1996-1#1)(2008-10#2)(2010-6#1)
association in##6##2##(1997-8#1)(2008-10#4)(2012-5#1)
association is##11##2##(1990-2#1)(1997-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
association of Borrelia burgdorferi##2##4##(2011-2#2)
association of a##2##3##(2008-10#1)(2009-7#1)
association of the##9##3##(1990-2#1)(1995-6#1)(1997-3#1)(2008-10#4)(2008-5#1)(2010-12#1)
association of these##4##3##(1991-3#1)(2008-10#3)
association of this##5##3##(1995-6#1)(2008-10#2)(2009-8#1)(2012-12#1)
association of two##3##3##(2008-10#2)(2008-2#1)
association of##109##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-8#1)(1991-3#1)(1993-8#1)(1995-2#2)(1995-6#2)(1995-9#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#40)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#7)(2012-12#3)(2012-2#8)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
association particles##2##2##(2008-10#2)
association process##2##2##(2008-10#2)
association rate constant##3##3##(1993-3#1)(2008-10#2)
association rate##7##2##(1993-1#1)(1993-3#1)(1993-8#2)(2008-10#3)
association structures##2##2##(2008-5#2)
association studies (GWAS)##2##3##(2010-12#1)(2011-2#1)
association studies##10##2##(1994-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-3#3)
association study##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
association to##2##2##(1990-8#1)(2009-1#1)
association was found between the##3##5##(1990-8#1)(1995-12#1)(2008-10#1)
association was found between##4##4##(1990-8#1)(1995-12#1)(2008-10#1)(2011-2#1)
association was observed##2##3##(1991-6#1)(2013-1#1)
association was##17##2##(1990-8#1)(1991-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
association with a##5##3##(1993-1#1)(1993-6#1)(2008-10#2)(2010-5#1)
association with an##2##3##(2011-2#1)(2012-2#1)
association with each other##3##4##(2007-12#1)(2008-10#1)(2010-5#1)
association with increased##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
association with malignant##2##3##(2011-2#2)
association with other##4##3##(1997-1#1)(2008-10#2)(2013-1#1)
association with risk factors##2##4##(2011-2#1)(2012-12#1)
association with the##22##3##(1992-3#1)(1994-12#4)(1994-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-12#1)
association with##143##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-3#2)(1994-6#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#3)(2007-11#1)(2007-12#3)(2008-10#25)(2008-11#7)(2008-12#5)(2008-7#8)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#11)(2012-12#5)(2012-2#9)(2012-3#2)(2013-1#7)
association##621##1##(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#1)(1990-8#7)(1990-9#1)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-1#8)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#3)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#8)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#7)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#179)(2008-11#18)(2008-12#11)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#19)(2008-8#9)(2008-9#13)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#7)(2009-8#6)(2009-9#1)(2010-1#9)(2010-10#1)(2010-11#3)(2010-12#6)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#52)(2012-12#15)(2012-2#23)(2012-3#18)(2012-5#2)(2013-1#36)(2013-8#7)
association&quot##2##1##(2008-11#2)
association)##2##1##(1990-2#1)(2008-10#1)
associations among##2##2##(2008-10#1)(2008-8#1)
associations and that##2##3##(1993-6#1)(2009-7#1)
associations and##7##2##(1993-3#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2009-7#1)(2011-2#1)
associations are##2##2##(2008-8#1)(2013-8#1)
associations between the##5##3##(1994-12#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
associations between these##2##3##(2008-7#1)(2013-8#1)
associations between##36##2##(1994-12#1)(1994-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
associations can##2##2##(1992-2#1)(1996-12#1)
associations for##2##2##(2008-10#1)(2010-1#1)
associations in##2##2##(2009-7#1)(2009-8#1)
associations of Mhc##2##3##(2008-8#2)
associations of the##2##3##(1997-8#1)(2012-2#1)
associations of##15##2##(1997-8#2)(2008-10#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2012-2#1)(2013-8#1)
associations or##2##2##(2009-10#1)(2012-3#1)
associations to##4##2##(2008-10#3)(2010-12#1)
associations were found with##2##4##(2008-7#1)(2009-5#1)
associations were found##5##3##(1997-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-5#1)
associations were##12##2##(1997-4#1)(2008-10#2)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-1#2)(2013-8#1)
associations with##13##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
associations##150##1##(1990-8#1)(1991-12#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#3)(2008-10#38)(2008-11#4)(2008-12#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#5)(2009-10#2)(2009-5#4)(2009-7#5)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#9)(2011-4#1)(2012-12#3)(2012-2#3)(2012-3#6)(2012-5#1)(2013-1#12)(2013-8#6)
associative learning##5##2##(2008-8#1)(2009-8#2)(2012-2#2)
associative##12##1##(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#2)(2012-2#2)(2013-1#4)
associé à##2##2##(2013-1#2)
associée à##2##2##(2013-1#2)
assortative mating##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
assorted psychiatric and pain##2##4##(1993-1#2)
assorted psychiatric and##3##3##(1993-1#3)
assorted##5##1##(1993-1#3)(1994-3#1)(2008-9#1)
assortment (required for the evolution of##2##6##(2008-8#2)
assortment##6##1##(2008-8#6)
assulta##5##1##(2008-8#5)
assume a##8##2##(1992-1#1)(1992-2#1)(1992-4#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)
assume that the##5##3##(1991-6#1)(1995-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
assume that##24##2##(1991-12#1)(1991-6#2)(1992-12#1)(1995-2#1)(1996-2#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#2)(2011-2#1)(2011-3#1)(2012-3#1)
assume the##3##2##(1992-3#1)(1994-12#1)(2008-7#1)
assume##45##1##(1991-12#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#4)(2011-2#1)(2011-3#1)(2012-3#2)
assumed a##2##2##(1994-9#1)(2008-8#1)
assumed by##4##2##(1992-3#1)(1995-12#1)(1997-8#1)(2008-9#1)
assumed for the##2##3##(2008-10#1)(2008-3#1)
assumed for##3##2##(2008-10#1)(2008-3#2)
assumed from##3##2##(2008-10#2)(2013-8#1)
assumed proportional to the##2##4##(2008-10#1)(2008-5#1)
assumed that the##9##3##(1993-11#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-8#1)
assumed that this##2##3##(1994-11#1)(2009-1#1)
assumed that##27##2##(1991-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
assumed to be the result of##2##6##(2007-12#1)(2008-9#1)
assumed to be the same##2##5##(2008-10#1)(2010-11#1)
assumed to be the##4##4##(2007-12#1)(2008-10#1)(2008-9#1)(2010-11#1)
assumed to be##16##3##(1991-12#1)(1992-9#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-3#1)
assumed to consist of##2##4##(2008-10#1)(2008-3#1)
assumed to have##4##3##(2010-10#1)(2012-12#1)(2013-1#2)
assumed to reflect##4##3##(1991-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
assumed to##35##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-10#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
assumed##110##1##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#33)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#5)(2009-1#1)(2009-11#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
assumes a##2##2##(1992-12#1)(2007-11#1)
assumes that the##5##3##(1992-2#1)(2008-10#1)(2008-3#2)(2008-5#1)
assumes that##19##2##(1992-2#1)(1994-1#1)(1994-5#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-6#1)
assumes the##2##2##(2008-3#1)(2013-1#1)
assumes##26##1##(1992-12#1)(1992-2#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-12#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2010-6#1)(2013-1#2)
assuming a##7##2##(1991-3#1)(1995-9#1)(1996-12#1)(2008-10#4)
assuming that a##3##3##(1996-6#1)(2008-4#1)(2008-9#1)
assuming that the##8##3##(1995-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
assuming that##16##2##(1995-9#1)(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
assuming the formation of the##2##5##(2008-10#2)
assuming the##6##2##(2008-10#4)(2009-11#1)(2013-1#1)
assuming##41##1##(1991-3#2)(1993-2#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-6#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#3)
assumption is##2##2##(2008-11#1)(2011-2#1)
assumption may be##2##3##(2008-3#1)(2012-3#1)
assumption of a##4##3##(2008-7#3)(2011-2#1)
assumption of an##2##3##(1997-6#1)(2008-3#1)
assumption of the##2##3##(1995-12#1)(2012-3#1)
assumption of##22##2##(1995-12#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
assumption that the##6##3##(1995-3#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
assumption that##24##2##(1992-12#1)(1995-3#1)(1995-9#1)(1996-3#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#3)(2008-9#2)(2009-7#1)(2013-1#1)
assumption##64##1##(1992-12#1)(1992-9#2)(1993-3#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#2)(1997-6#1)(2007-11#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#12)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-7#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
assumptions about the##5##3##(2008-10#2)(2008-9#2)(2010-10#1)
assumptions about##10##2##(2008-10#3)(2008-11#1)(2008-9#3)(2009-12#1)(2010-10#1)(2010-8#1)
assumptions and##7##2##(1992-2#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
assumptions are violated##2##3##(2008-10#1)(2012-2#1)
assumptions are##6##2##(1995-9#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
assumptions for##2##2##(1995-12#1)(2008-8#1)
assumptions in##2##2##(2008-10#1)(2010-1#1)
assumptions made in##2##3##(1991-2#1)(1995-12#1)
assumptions made##4##2##(1991-2#1)(1995-12#1)(2008-8#1)(2008-9#1)
assumptions of normality##2##3##(1996-3#1)(2008-10#1)
assumptions of the##5##3##(1995-8#1)(2008-10#2)(2008-9#1)(2010-3#1)
assumptions of##16##2##(1995-8#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#2)(2010-3#1)(2012-2#1)
assumptions that##2##2##(1994-9#1)(2008-8#1)
assumptions underlying the##2##3##(2008-9#2)
assumptions underlying##3##2##(2008-12#1)(2008-9#2)
assumptions used##2##2##(2008-3#1)(2010-10#1)
assumptions##85##1##(1991-2#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-9#2)(1995-12#3)(1995-8#1)(1995-9#3)(1996-3#3)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#8)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#11)(2009-10#1)(2009-12#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-3#1)(2010-8#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
assurance (QA)##5##2##(1994-2#2)(1995-3#3)
assurance and quality control##3##4##(2008-10#2)(2008-4#1)
assurance and##10##2##(1994-1#1)(1994-6#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-4#1)(2012-2#1)
assurance as##2##2##(1996-1#1)(2008-9#1)
assurance for##2##2##(1991-12#1)(1994-2#1)
assurance in##7##2##(1990-6#1)(1990-9#1)(1992-1#1)(1996-3#1)(1997-4#1)(2010-12#1)(2012-2#1)
assurance of##3##2##(1997-8#1)(2008-10#1)(2008-5#1)
assurance that##2##2##(2008-4#1)(2013-1#1)
assurance to##2##2##(1994-2#1)(2008-9#1)
assurance##84##1##(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#1)(1992-1#1)(1992-5#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-2#6)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#5)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-4#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#7)(2008-9#3)(2010-12#2)(2012-12#3)(2012-2#5)(2013-1#1)
assurances##2##1##(1993-12#1)(2011-2#1)
assure a##3##2##(1992-11#1)(2010-11#1)(2010-9#1)
assure the##6##2##(2008-4#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
assure##23##1##(1991-2#1)(1992-11#1)(1994-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)
assured##2##1##(2008-11#1)(2012-2#1)
assures##2##1##(1991-12#1)(2011-1#1)
assuring that##4##2##(1994-2#1)(1996-2#1)(1997-1#1)(2008-11#1)
assuring the##4##2##(1995-3#1)(2008-10#2)(2012-2#1)
assuring##14##1##(1990-3#1)(1993-1#1)(1994-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-2#1)
astaxanthin from##3##2##(2008-10#3)
astaxanthin##13##1##(2008-10#4)(2008-12#2)(2010-10#3)(2013-8#4)
astaxanthin-overproduction mutant##2##2##(2010-10#2)
aster yellows (AY)##2##3##(2008-10#2)
aster yellows phytoplasma##2##3##(2008-10#2)
aster yellows subgroups##2##3##(2008-10#2)
aster yellows##12##2##(2008-10#12)
aster##18##1##(2008-10#18)
asthenia##3##1##(2008-7#1)(2012-3#2)
asthma and AR##2##3##(2012-12#2)
asthma and atopy in children##2##5##(2008-10#2)
asthma and atopy##5##3##(2008-10#5)
asthma and chronic obstructive pulmonary disease (COPD)##2##7##(1992-3#1)(1996-1#1)
asthma and to##2##3##(1997-1#1)(2008-11#1)
asthma and##21##2##(1992-3#1)(1994-6#1)(1996-1#1)(1997-1#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#5)(2013-1#1)
asthma are##4##2##(2011-1#1)(2011-2#1)(2012-12#2)
asthma care##3##2##(2010-9#2)(2011-1#1)
asthma control##4##2##(2009-9#1)(2010-9#1)(2012-12#2)
asthma education##5##2##(1997-1#2)(2008-10#1)(2010-9#1)(2013-1#1)
asthma exacerbations in##2##3##(2010-8#2)
asthma exacerbations##4##2##(2008-11#2)(2010-8#2)
asthma in the##2##3##(2008-10#1)(2008-11#1)
asthma in##9##2##(1996-6#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-6#1)(2012-12#1)
asthma is##3##2##(1990-3#1)(2008-10#1)(2013-1#1)
asthma management##5##2##(1994-1#1)(1997-1#1)(2010-9#1)(2013-1#2)
asthma or chronic obstructive pulmonary disease##2##6##(2010-12#1)(2010-2#1)
asthma or##4##2##(2007-11#1)(2008-11#1)(2010-12#1)(2010-2#1)
asthma patients##5##2##(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)
asthma symptoms##2##2##(1997-1#1)(2012-12#1)
asthma treatment##2##2##(2008-8#1)(2010-5#1)
asthma with##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
asthma##188##1##(1990-3#3)(1990-9#1)(1991-2#3)(1992-3#5)(1993-1#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#6)(1996-2#4)(1996-6#1)(1997-1#11)(1997-5#1)(2007-11#1)(2008-1#4)(2008-10#19)(2008-11#21)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#6)(2009-1#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-5#5)(2010-6#5)(2010-8#3)(2010-9#13)(2011-1#3)(2011-2#4)(2012-12#24)(2012-2#2)(2012-3#2)(2013-1#12)
asthma-related outcomes##2##2##(2008-11#1)(2012-12#1)
asthma?##3##1##(2008-10#1)(2010-5#1)(2012-3#1)
asthma]##2##1##(1993-9#1)(2011-2#1)
asthmatic children##2##2##(2008-1#1)(2008-11#1)
asthmatic individuals##4##2##(1992-3#2)(2010-1#2)
asthmatic patients##4##2##(1997-1#1)(2008-10#2)(2012-12#1)
asthmatic response##2##2##(2008-10#2)
asthmatic##16##1##(1992-3#3)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2010-1#3)(2012-12#1)
asthmatics##6##1##(1994-3#1)(1996-1#1)(1997-1#1)(1997-4#2)(2009-1#1)
astonishing##4##1##(1991-3#1)(1992-1#1)(2009-4#1)(2009-6#1)
astonishingly##2##1##(2010-3#1)(2011-2#1)
astragaloi##2##1##(2008-10#2)
astrocyte cell lines and##4##4##(2008-11#4)
astrocyte cell lines##6##3##(2008-11#6)
astrocyte cultures##4##2##(2008-11#4)
astrocyte processes##2##2##(1992-12#1)(2008-7#1)
astrocyte response to##2##3##(1990-7#2)
astrocyte##23##1##(1990-7#5)(1992-12#1)(1992-6#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-11#11)(2008-7#2)
astrocytes and C6##2##3##(1992-6#2)
astrocytes and##7##2##(1992-6#2)(1994-2#1)(2008-7#2)(2013-7#2)
astrocytes in denervated neuropil regions in##2##6##(1997-3#2)
astrocytes in##5##2##(1997-3#3)(2009-6#1)(2013-1#1)
astrocytes number in##3##3##(2008-12#3)
astrocytes produce erythropoietin (Epo) and neurons express its receptor##2##9##(2008-11#2)
astrocytes##60##1##(1992-6#4)(1994-2#3)(1995-12#1)(1995-2#2)(1996-12#5)(1997-1#2)(1997-3#3)(2008-11#14)(2008-12#4)(2008-7#15)(2009-6#1)(2013-1#2)(2013-7#4)
astrocytic##6##1##(1994-11#2)(2008-11#1)(2008-7#1)(2009-8#2)
astrocytoma cells##3##2##(1993-8#1)(1995-12#1)(1997-7#1)
astrocytoma##8##1##(1993-8#1)(1995-12#2)(1997-7#1)(2013-1#4)
astrocytomas in adults##2##3##(2008-7#2)
astrocytomas##8##1##(1994-8#1)(2008-7#7)
astroglial##2##1##(1990-7#1)(2008-7#1)
astrogliosis and##2##2##(2009-8#2)
astrogliosis##8##1##(2009-8#8)
astrology and##2##2##(2008-11#2)
astronomy##2##1##(1995-6#1)(2008-3#1)
asy##2##1##(2008-8#1)(2008-9#1)
asymmetric and##2##2##(2008-2#1)(2008-8#1)
asymmetric dispersal rates##3##3##(2008-8#3)
asymmetric distribution##3##2##(1994-2#2)(2012-2#1)
asymmetric divisions##2##2##(2007-12#1)(2009-8#1)
asymmetric expansion##2##2##(1995-2#1)(2008-11#1)
asymmetric flow field-flow fractionation##2##4##(2011-2#2)
asymmetric fusion##6##2##(2008-8#6)
asymmetric stretching##3##2##(2008-10#3)
asymmetric synapses##2##2##(1995-12#1)(2008-7#1)
asymmetric synthesis of##3##3##(1996-5#1)(2008-11#2)
asymmetric unit and##2##3##(1992-4#1)(1992-9#1)
asymmetric unit are##2##3##(1992-4#1)(2008-9#1)
asymmetric unit in##2##3##(2008-8#2)
asymmetric unit##16##2##(1992-4#4)(1992-9#2)(1993-8#1)(2008-8#4)(2008-9#5)
asymmetric##88##1##(1992-11#1)(1992-3#2)(1992-4#4)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#5)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#2)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#10)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#22)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#2)(2010-6#2)(2010-7#1)(2011-2#4)(2012-2#4)
asymmetrical##8##1##(1991-2#1)(1993-3#1)(1994-5#1)(1997-2#1)(2008-8#2)(2012-3#1)(2013-1#1)
asymmetries in##3##2##(1990-12#1)(2008-8#2)
asymmetries##6##1##(1990-12#1)(1993-12#2)(2008-8#2)(2010-4#1)
asymmetry and##4##2##(2008-8#1)(2008-9#2)(2009-8#1)
asymmetry as a##2##3##(2008-8#2)
asymmetry in the##3##3##(1992-3#1)(1993-12#1)(2008-2#1)
asymmetry in##9##2##(1992-3#1)(1993-12#1)(2008-2#1)(2008-8#3)(2010-4#2)(2013-1#1)
asymmetry is##3##2##(2008-2#1)(2008-5#1)(2008-8#1)
asymmetry of interactions##2##3##(2008-8#2)
asymmetry of##8##2##(2008-3#1)(2008-8#7)
asymmetry on##2##2##(1994-8#2)
asymmetry parameter##4##2##(2008-2#3)(2008-3#1)
asymmetry was##7##2##(2008-10#4)(2008-5#1)(2008-6#1)(2010-4#1)
asymmetry##54##1##(1992-3#1)(1992-9#1)(1993-12#1)(1994-8#2)(1995-2#1)(2008-10#5)(2008-2#5)(2008-3#3)(2008-5#5)(2008-6#1)(2008-8#20)(2008-9#3)(2009-8#1)(2010-4#4)(2013-1#1)
asymptomatic Japanese##2##2##(2012-12#1)(2012-3#1)
asymptomatic after##2##2##(2008-10#2)
asymptomatic and##7##2##(1993-11#1)(2007-8#1)(2008-10#1)(2011-2#2)(2011-3#1)(2013-1#1)
asymptomatic at##3##2##(1990-8#1)(2012-2#1)(2013-1#1)
asymptomatic bacteriuria##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
asymptomatic but##2##2##(1991-4#1)(1996-3#1)
asymptomatic essential hypertension##2##3##(2012-2#2)
asymptomatic leaves##3##2##(2008-10#3)
asymptomatic mutant##2##2##(2008-10#2)
asymptomatic or##4##2##(1990-8#1)(2008-10#1)(2011-2#1)(2012-12#1)
asymptomatic patients with##3##3##(1991-12#1)(2009-5#1)(2011-2#1)
asymptomatic patients##6##2##(1990-9#1)(1991-12#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
asymptomatic plants##6##2##(2008-10#6)
asymptomatic subjects##6##2##(2008-12#4)(2009-8#1)(2013-1#1)
asymptomatic with##2##2##(2008-12#1)(2013-8#1)
asymptomatic##129##1##(1990-3#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-3#4)(1996-8#1)(1996-9#2)(1997-3#3)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#8)(2008-5#1)(2008-7#7)(2008-8#3)(2009-4#1)(2009-5#2)(2009-8#4)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#12)(2011-3#2)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#13)(2013-8#1)
asymptote##4##1##(2008-10#3)(2013-7#1)
asymptotic absorption##3##2##(2008-3#3)
asymptotic at##2##2##(2008-10#2)
asymptotic distribution##2##2##(1994-9#1)(2010-1#1)
asymptotic properties##2##2##(2009-10#1)(2010-11#1)
asymptotic##28##1##(1994-9#1)(1996-3#2)(2008-10#5)(2008-2#1)(2008-3#5)(2008-8#2)(2008-9#5)(2009-10#3)(2010-1#1)(2010-11#1)(2010-7#1)(2013-8#1)
asymptotically##3##1##(1996-3#1)(2013-8#2)
asynchronous##11##1##(1995-9#1)(1996-2#2)(1996-8#2)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-12#1)
asynchrony of left ventricular contraction##2##5##(2008-10#2)
asynchrony of##3##2##(2008-10#3)
asynchrony##11##1##(1996-2#1)(2008-10#10)
at &gt##10##2##(1995-8#1)(1997-2#1)(2008-10#8)
at &lt##8##2##(1995-8#2)(2008-10#6)
at &quot##2##2##(1994-6#1)(2008-10#1)
at +0##14##2##(2008-10#14)
at +5##2##2##(2008-9#2)
at -0##39##2##(1990-5#1)(2008-10#37)(2008-8#1)
at -1##19##2##(2008-10#18)(2011-2#1)
at -1010mV##3##2##(2008-10#3)
at -150mV##2##2##(2008-10#2)
at -20 degrees C##4##4##(2008-10#3)(2008-11#1)
at -200##2##2##(2008-10#2)
at -3##3##2##(2008-10#2)(2009-5#1)
at -40##2##2##(1992-8#1)(2008-10#1)
at -5 degrees C##3##4##(2008-10#3)
at -5##4##2##(2008-10#4)
at -50##2##2##(2008-10#2)
at -7##2##2##(1992-9#1)(2008-10#1)
at -78 degrees C##5##4##(1996-5#5)
at -80##2##2##(2008-10#1)(2008-8#1)
at 0 degrees C##5##4##(2008-10#4)(2008-7#1)
at 0 h and##2##4##(1995-12#2)
at 0 to 25 degrees C##2##6##(2008-10#2)
at 0 to##4##3##(2008-10#3)(2008-7#1)
at 0##102##2##(1990-3#2)(1991-11#3)(1992-12#2)(1992-6#3)(1992-7#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#3)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#59)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-11#1)(2012-2#1)(2013-8#3)
at 0800 h##3##3##(2008-10#3)
at 1 and 2##2##4##(2007-8#1)(2008-10#1)
at 1 and 3 months##3##5##(1993-12#1)(2011-2#1)(2013-1#1)
at 1 and##7##3##(1993-12#1)(1994-8#1)(2007-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
at 1 day in vitro##2##5##(1996-12#2)
at 1 day##3##3##(1996-12#2)(2008-11#1)
at 1 degrees C followed by##2##6##(2008-10#2)
at 1 degrees C##6##4##(2008-10#6)
at 1 g liter(-1) for##2##5##(2008-10#2)
at 1 h##3##3##(1993-1#1)(1994-5#1)(1995-8#1)
at 1 mM##2##3##(2008-10#1)(2011-2#1)
at 1 microg##2##3##(2008-10#2)
at 1 month##2##3##(1995-2#1)(2008-12#1)
at 1 week##2##3##(2008-10#1)(2013-1#1)
at 1 year##4##3##(1991-2#1)(2010-5#1)(2012-12#1)(2012-3#1)
at 1##118##2##(1991-11#2)(1991-2#1)(1991-3#1)(1992-3#1)(1992-4#2)(1993-1#1)(1993-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#2)(1997-2#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-10#34)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#16)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#2)(2011-2#9)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#5)
at 1-h Post##2##3##(2013-1#2)
at 10 and 30##2##4##(2008-11#1)(2012-3#1)
at 10 and##8##3##(1997-9#1)(2008-10#3)(2008-11#1)(2012-3#2)(2013-1#1)
at 10 days##4##3##(1997-3#1)(2008-10#2)(2013-1#1)
at 10 degrees C##3##4##(2008-10#2)(2010-4#1)
at 10 mM##4##3##(1992-7#2)(1995-8#1)(2008-6#1)
at 10 min##2##3##(1993-1#1)(2013-1#1)
at 10 mug##2##3##(2008-10#2)
at 10 mug/ml##2##3##(2008-10#2)
at 10##57##2##(1990-2#1)(1990-5#1)(1992-12#1)(1992-7#2)(1993-1#2)(1995-8#1)(1997-2#1)(1997-3#1)(1997-9#1)(2007-12#2)(2008-10#23)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#4)
at 10(-7) mol##2##3##(2008-10#2)
at 10(-7)##3##2##(1990-11#1)(2008-10#2)
at 100 degrees C##4##4##(1997-8#1)(2008-10#3)
at 100 mug/ml##2##3##(2008-10#2)
at 100 nM##2##3##(1994-11#1)(1994-8#1)
at 100##24##2##(1992-7#1)(1994-11#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#11)(2008-12#1)(2008-3#1)(2009-7#1)(2010-12#1)(2010-3#2)(2011-1#1)
at 100% RH but##2##4##(2008-10#2)
at 100% RH##3##3##(1996-12#1)(2008-10#2)
at 100% relative humidity##2##4##(2008-10#2)
at 100%##6##2##(1996-12#1)(2008-10#5)
at 1000##2##2##(1990-3#1)(2008-11#1)
at 105##5##2##(1990-11#1)(1995-12#1)(2008-10#2)(2011-3#1)
at 1064 nm##3##3##(2008-10#2)(2008-2#1)
at 1064##4##2##(2008-10#2)(2008-2#2)
at 10°C##5##2##(2011-2#5)
at 11##6##2##(1995-8#1)(2008-11#2)(2008-12#2)(2008-3#1)
at 110##2##2##(1995-12#1)(2008-10#1)
at 1100 degrees C##3##4##(2008-10#1)(2010-4#2)
at 115##2##2##(2008-10#1)(2009-4#1)
at 12 degrees C##3##4##(2008-10#3)
at 12 months##10##3##(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#1)
at 12 to##4##3##(2008-10#3)(2008-11#1)
at 12 weeks##2##3##(1992-12#1)(2008-10#1)
at 12##30##2##(1992-12#1)(1992-5#1)(1993-3#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-9#1)(2010-3#2)(2011-2#1)(2012-2#4)(2012-3#4)(2013-1#1)
at 120##2##2##(2008-10#1)(2013-1#1)
at 12°C##2##2##(2011-1#2)
at 13 degrees C##2##4##(2008-10#2)
at 13##6##2##(1990-6#1)(2008-10#3)(2008-12#1)(2012-3#1)
at 135 degrees C##2##4##(2008-10#2)
at 136##2##2##(2008-1#1)(2008-10#1)
at 14 and##2##3##(2008-10#2)
at 14 days##2##3##(1996-2#1)(2008-10#1)
at 14 dpi and##2##4##(2008-10#2)
at 14 dpi##5##3##(2008-10#5)
at 14##15##2##(1994-12#2)(1996-2#1)(2008-10#9)(2008-12#2)(2008-7#1)
at 140 mm Hg##3##4##(2008-11#3)
at 14MPa and 45 degrees C for 40min##2##8##(2010-4#2)
at 15 degrees C##9##4##(2008-10#9)
at 15 degrees##10##3##(2008-10#9)(2009-3#1)
at 15 months of age##2##5##(2010-6#2)
at 15 months##5##3##(2010-6#5)
at 15 to##3##3##(2008-10#3)
at 15##33##2##(2006-6#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#3)(2009-3#1)(2010-6#5)(2010-7#1)(2012-3#1)
at 150 degrees C##2##4##(2008-10#2)
at 150 mOsm kg(-1)##2##4##(2008-11#2)
at 150##8##2##(1993-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-12#1)
at 150W of microwave##2##4##(2008-10#2)
at 1525cm(-1)##2##2##(2008-10#2)
at 1540 nm##2##3##(2008-2#1)(2008-3#1)
at 155##2##2##(2008-10#2)
at 16##6##2##(2008-10#5)(2008-8#1)
at 17##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
at 170 degrees C for##2##5##(2008-10#2)
at 18 degrees C in##2##5##(2008-10#2)
at 18 degrees C##5##4##(2008-10#5)
at 18 hours##2##3##(1991-12#1)(2008-12#1)
at 18 months##4##3##(2008-4#1)(2011-2#1)(2013-1#2)
at 18##18##2##(1991-12#1)(1995-11#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
at 180 mg/liter##3##3##(2008-10#3)
at 180##4##2##(2008-10#3)(2009-11#1)
at 193 nm##3##3##(2008-3#3)
at 195 mm Hg##2##4##(2008-11#2)
at 1mM##2##2##(2008-10#1)(2012-2#1)
at 2 and 24##2##4##(1992-9#1)(1994-8#1)
at 2 and##4##3##(1992-9#1)(1994-12#1)(1994-8#1)(2008-10#1)
at 2 h##2##3##(2008-7#1)(2010-8#1)
at 2 months##7##3##(2008-10#1)(2012-2#4)(2012-3#1)(2013-1#1)
at 2 to 4##2##4##(2008-10#2)
at 2 x 10(6)##4##4##(2008-10#3)(2008-7#1)
at 2 x##6##3##(2008-10#5)(2008-7#1)
at 2 years##5##3##(1991-11#1)(1997-2#1)(1997-4#1)(2008-7#2)
at 2##69##2##(1991-11#1)(1991-12#1)(1991-6#1)(1992-4#2)(1992-9#1)(1993-8#4)(1994-12#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#28)(2008-11#4)(2008-7#4)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
at 2-4 days##2##3##(1997-3#2)
at 2-4##3##2##(1995-11#1)(1997-3#2)
at 2-week intervals##2##3##(1995-12#1)(2008-10#1)
at 20 and##3##3##(2008-10#3)
at 20 days##2##3##(1997-9#1)(2013-8#1)
at 20 degrees C and##2##5##(2008-12#1)(2010-4#1)
at 20 degrees C##22##4##(1991-5#1)(1995-8#1)(2008-10#16)(2008-12#2)(2008-3#1)(2010-4#1)
at 20 degrees##23##3##(1991-5#1)(1995-8#1)(2008-10#17)(2008-12#2)(2008-3#1)(2010-4#1)
at 20 mg/kg##2##3##(1993-3#1)(2008-10#1)
at 20 or##3##3##(2008-10#3)
at 20 to 25 degrees C##3##6##(2008-10#3)
at 20 to##4##3##(2008-10#4)
at 20##48##2##(1991-5#1)(1993-3#1)(1995-8#1)(1997-1#2)(1997-9#1)(2008-10#30)(2008-11#2)(2008-12#3)(2008-3#2)(2008-7#1)(2009-1#1)(2010-4#1)(2011-2#1)(2013-8#1)
at 20%##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
at 20+/-1 degrees C##2##4##(2008-10#2)
at 200 and##2##3##(2008-10#1)(2012-3#1)
at 200 degrees C##3##4##(2008-10#3)
at 200 mg/kg##2##3##(1991-12#2)
at 200 nm##3##3##(2008-10#3)
at 200##12##2##(1991-12#2)(2008-10#9)(2012-3#1)
at 205 nm##3##3##(2008-10#3)
at 21 degrees C##2##4##(2008-10#2)
at 21 h##2##3##(1995-12#2)
at 21##9##2##(1995-12#2)(2008-10#3)(2008-5#1)(2013-1#1)(2013-8#2)
at 215 nm##3##3##(2008-10#3)
at 215nm##2##2##(2008-10#2)
at 22 degrees C##6##4##(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)
at 22 degrees##8##3##(1994-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-9#1)
at 22 weeks##2##3##(2013-1#2)
at 22##12##2##(1993-12#1)(1994-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-9#1)(2013-1#2)
at 220 nm##2##3##(2008-10#2)
at 220##4##2##(2008-10#3)(2008-3#1)
at 225##3##2##(2008-10#3)
at 226 nm##2##3##(2008-10#2)
at 226##3##2##(2008-10#2)(2008-3#1)
at 226nm##2##2##(2008-10#2)
at 23 degrees C##4##4##(1993-9#2)(2008-10#2)
at 23##7##2##(1990-8#1)(1993-9#2)(2008-10#3)(2008-7#1)
at 230 and 294 K##2##5##(2008-3#2)
at 230 nm##3##3##(2008-10#3)
at 230##6##2##(2008-10#4)(2008-3#2)
at 24 degrees C##11##4##(1997-1#1)(2008-10#10)
at 24 h after##2##4##(2008-10#2)
at 24 h##4##3##(1994-5#1)(2008-10#3)
at 24 months##2##3##(1993-11#1)(2011-2#1)
at 24 weeks##3##3##(2010-4#1)(2011-2#1)(2012-3#1)
at 24##24##2##(1990-8#1)(1993-11#1)(1994-5#1)(1997-1#1)(2008-10#13)(2008-12#1)(2010-4#1)(2011-2#3)(2012-3#1)(2012-6#1)
at 24-h##2##2##(1995-11#1)(2008-10#1)
at 240##3##2##(2008-7#1)(2011-2#2)
at 2400 ppm##2##3##(1990-5#2)
at 25 degrees C and constant ionic strength##2##8##(2008-10#2)
at 25 degrees C and continuous wetness##2##7##(2008-10#2)
at 25 degrees C and in##4##6##(2008-10#4)
at 25 degrees C and##16##5##(2008-10#16)
at 25 degrees C are##2##5##(2008-10#2)
at 25 degrees C by##3##5##(2008-10#3)
at 25 degrees C in the##2##6##(1995-11#1)(2008-10#1)
at 25 degrees C in##4##5##(1995-11#1)(2008-10#3)
at 25 degrees C were##4##5##(1993-8#1)(2008-10#2)(2008-11#1)
at 25 degrees C with##2##5##(2008-10#2)
at 25 degrees C##97##4##(1990-10#1)(1991-3#1)(1991-5#1)(1993-8#1)(1995-11#1)(2008-10#81)(2008-11#2)(2008-5#3)(2008-8#4)(2009-7#1)(2010-4#1)
at 25 degrees##101##3##(1990-10#1)(1990-9#2)(1991-3#1)(1991-5#1)(1993-8#1)(1995-11#1)(2008-10#82)(2008-11#3)(2008-5#3)(2008-8#4)(2009-7#1)(2010-4#1)
at 25 kGy##2##3##(2008-10#2)
at 25##112##2##(1990-10#1)(1990-9#2)(1991-3#1)(1991-5#1)(1993-8#1)(1995-11#1)(1997-3#1)(2008-10#90)(2008-11#3)(2008-5#4)(2008-8#4)(2009-7#1)(2010-4#1)(2012-3#1)
at 250##6##2##(2008-10#4)(2008-11#1)(2011-2#1)
at 254 nm##4##3##(2008-10#3)(2009-8#1)
at 254##5##2##(2008-10#4)(2009-8#1)
at 254nm##3##2##(2008-10#2)(2011-2#1)
at 26 weeks and in all##2##6##(2008-9#2)
at 26 weeks##6##3##(2008-9#6)
at 26##10##2##(2008-10#3)(2008-9#7)
at 263##2##2##(2008-10#2)
at 265##2##2##(1993-3#1)(2008-3#1)
at 27 degrees C##2##4##(2008-10#1)(2008-12#1)
at 27 weeks##6##3##(2008-9#6)
at 27##8##2##(2008-10#1)(2008-12#1)(2008-9#6)
at 28 degrees C and##2##5##(2008-10#1)(2008-5#1)
at 28 degrees C##4##4##(2008-10#3)(2008-5#1)
at 28 dpi##2##3##(2008-10#2)
at 28 to##2##3##(2008-10#2)
at 28##10##2##(2008-10#8)(2008-5#1)(2013-1#1)
at 280 and##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
at 280 nm##5##3##(2008-10#5)
at 280##10##2##(1994-5#1)(2008-10#8)(2008-8#1)
at 282 nm##2##3##(2008-10#2)
at 285 nm##3##3##(2008-10#3)
at 285##4##2##(2008-10#4)
at 287 nm##2##3##(2008-10#2)
at 290##2##2##(1994-5#1)(2008-10#1)
at 295K##2##2##(2008-10#2)
at 298 K and##2##4##(2008-10#2)
at 298 K##5##3##(2008-10#5)
at 298##10##2##(2008-10#10)
at 2min##2##2##(2008-10#2)
at 3 X 10(-7) M##2##5##(1990-5#2)
at 3 X##3##3##(1990-5#3)
at 3 and 12 months##2##5##(1991-2#1)(2013-1#1)
at 3 and 6 months##3##5##(2008-10#1)(2009-11#1)(2013-1#1)
at 3 and##7##3##(1991-2#1)(2008-10#1)(2008-3#1)(2009-11#2)(2013-1#2)
at 3 days##2##3##(2008-10#1)(2008-5#1)
at 3 h##2##3##(1994-5#1)(2008-10#1)
at 3 months and##2##4##(1997-3#1)(2012-12#1)
at 3 months of age##2##5##(1995-8#2)
at 3 months##10##3##(1991-3#1)(1994-1#1)(1995-8#2)(1997-3#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
at 3 years of##2##4##(1994-1#1)(2012-2#1)
at 3 years##4##3##(1994-1#2)(2008-7#1)(2012-2#1)
at 3##56##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-3#1)(1994-1#3)(1994-5#1)(1995-8#2)(1997-3#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#3)(2009-11#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)
at 3-month##3##2##(2008-10#2)(2009-11#1)
at 30 and 70% bloom##2##5##(2008-10#2)
at 30 and##3##3##(2008-10#2)(2008-7#1)
at 30 days and##2##4##(2008-11#2)
at 30 days##7##3##(2008-10#2)(2008-11#2)(2009-11#1)(2013-8#2)
at 30 degrees C##20##4##(1997-2#1)(1997-8#2)(2008-10#13)(2008-12#2)(2008-7#1)(2008-9#1)
at 30 degrees##21##3##(1997-2#1)(1997-8#2)(2008-10#13)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)
at 30 microM##2##3##(1993-6#1)(1995-8#1)
at 30 min incubation with dexamethasone##2##6##(1994-3#2)
at 30 min was##2##4##(1994-3#1)(2008-7#1)
at 30 min##9##3##(1990-8#1)(1994-3#3)(1995-2#1)(1996-12#1)(2008-7#2)(2013-8#1)
at 30 min)##2##3##(2009-9#1)(2012-3#1)
at 30##47##2##(1990-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-3#3)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#2)(2008-10#18)(2008-11#2)(2008-12#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2012-3#1)(2013-8#3)
at 300 degrees C##3##4##(2008-10#2)(2010-4#1)
at 300 mOsm kg(-1)##2##4##(2008-11#2)
at 300##14##2##(1997-1#1)(2008-10#7)(2008-11#3)(2008-3#2)(2010-4#1)
at 303 K##2##3##(2008-10#2)
at 306 nm##2##3##(2008-10#2)
at 309##2##2##(2008-10#2)
at 30°C##3##2##(2011-2#3)
at 31 degrees C##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
at 31##6##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)
at 310 nm##3##3##(2008-10#2)(2008-5#1)
at 315##2##2##(1992-9#1)(2008-10#1)
at 32 degrees C and##2##5##(2008-10#1)(2008-11#1)
at 32 degrees C##9##4##(1991-2#2)(2008-10#5)(2008-11#1)(2008-5#1)
at 32 degrees C)##2##4##(2008-11#2)
at 32 degrees##11##3##(1991-2#2)(2008-10#5)(2008-11#3)(2008-5#1)
at 32##12##2##(1991-2#2)(2008-10#5)(2008-11#3)(2008-5#1)(2013-1#1)
at 320 nm##2##3##(2008-10#1)(2012-2#1)
at 320##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
at 33 degrees C##2##4##(2008-11#2)
at 33##7##2##(2008-10#4)(2008-11#2)(2013-1#1)
at 330 nm##2##3##(2008-10#2)
at 333nm##2##2##(2008-10#2)
at 34##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
at 340 nm##2##3##(1993-3#1)(2008-10#1)
at 346 nm##2##3##(2008-10#2)
at 348##2##2##(2008-10#1)(2008-3#1)
at 35 degrees C and##2##5##(2008-10#2)
at 35 degrees C##11##4##(2008-10#11)
at 35##16##2##(2008-10#15)(2008-11#1)
at 35-69##3##2##(1992-6#3)
at 350nm##2##2##(2008-10#2)
at 352 and 500 nm##2##5##(2008-10#2)
at 355 nm##4##3##(2008-10#3)(2008-3#1)
at 355##6##2##(2008-10#3)(2008-3#3)
at 36 degrees C##5##4##(2008-10#5)
at 36##8##2##(2008-10#7)(2013-1#1)
at 360 nm##3##3##(1993-2#1)(2008-10#2)
at 360##4##2##(1993-2#1)(2008-10#3)
at 360nm##2##2##(2008-10#2)
at 361nm##2##2##(2008-10#2)
at 365 nm##3##3##(1993-8#2)(2008-10#1)
at 37 degrees C and##5##5##(1990-12#1)(2008-11#1)(2008-5#2)(2010-1#1)
at 37 degrees C but##2##5##(1991-2#2)
at 37 degrees C for##4##5##(1992-6#1)(1993-8#1)(1994-8#1)(1995-2#1)
at 37 degrees C in##2##5##(1995-6#1)(2008-10#1)
at 37 degrees C under a 5% CO(2) atmosphere##2##9##(2008-11#2)
at 37 degrees C under##3##5##(1994-8#1)(2008-11#2)
at 37 degrees C##42##4##(1990-12#1)(1991-12#1)(1991-2#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-2#2)(1995-6#2)(1997-1#1)(2008-10#4)(2008-11#7)(2008-5#7)(2008-7#1)(2010-1#1)
at 37 degrees C) and##2##5##(1990-12#1)(1992-3#1)
at 37 degrees##45##3##(1990-12#2)(1991-12#1)(1991-2#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#4)(1995-12#1)(1995-2#2)(1995-6#2)(1997-1#1)(2008-10#4)(2008-11#7)(2008-5#7)(2008-7#1)(2010-1#1)
at 37##48##2##(1990-12#2)(1991-12#1)(1991-2#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#4)(1995-12#1)(1995-2#2)(1995-6#2)(1997-1#1)(2008-10#5)(2008-11#7)(2008-5#8)(2008-7#1)(2010-1#2)
at 370##2##2##(2008-10#1)(2008-11#1)
at 375 nm##3##3##(2008-10#3)
at 377 nm##2##3##(2008-10#2)
at 37°C##3##2##(2013-1#3)
at 38##2##2##(2008-10#1)(2008-12#1)
at 380##2##2##(2008-2#1)(2008-8#1)
at 39 weeks##6##3##(2008-9#6)
at 39##7##2##(2008-9#7)
at 395 nm##2##3##(2008-10#2)
at 4 and##2##3##(2008-10#2)
at 4 degrees C and##2##5##(2008-10#1)(2008-11#1)
at 4 degrees C for##5##5##(1990-12#1)(1991-11#1)(2008-11#2)(2008-9#1)
at 4 degrees C in the##2##6##(2008-10#2)
at 4 degrees C or##2##5##(2008-10#1)(2008-8#1)
at 4 degrees C was##2##5##(2008-10#2)
at 4 degrees C##37##4##(1990-11#3)(1990-12#1)(1991-11#1)(1993-8#1)(1995-2#1)(1995-6#1)(2008-10#20)(2008-11#4)(2008-5#1)(2008-8#3)(2008-9#1)
at 4 h##2##3##(1995-11#1)(2008-10#1)
at 4 months##2##3##(2010-3#1)(2013-1#1)
at 4 to 5 years##2##5##(2012-12#2)
at 4 weeks and##2##4##(2011-2#2)
at 4 weeks##4##3##(2008-12#1)(2011-2#3)
at 4##62##2##(1990-11#3)(1990-12#1)(1990-2#1)(1991-11#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-4#1)(2013-1#1)
at 4-amino-2##2##2##(1994-5#2)
at 40 degrees C##12##4##(2008-10#9)(2008-5#3)
at 40 weeks##3##3##(1995-8#1)(2012-12#2)
at 40##18##2##(1995-8#1)(2008-10#12)(2008-5#3)(2012-12#2)
at 40%##3##2##(1995-12#1)(2008-12#1)(2013-1#1)
at 400 nm##3##3##(2008-10#1)(2008-2#1)(2010-1#1)
at 400##9##2##(2008-10#6)(2008-2#1)(2010-1#2)
at 400nm##2##2##(2008-10#2)
at 41##4##2##(1993-8#1)(2008-9#1)(2011-2#2)
at 410##3##2##(2008-10#2)(2008-11#1)
at 415 nm##2##3##(2008-10#2)
at 415##3##2##(2008-10#3)
at 42##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
at 420 nm##4##3##(2008-10#4)
at 420##5##2##(2008-10#4)(2008-2#1)
at 420nm##3##2##(2008-10#3)
at 425 nm##2##3##(2008-10#2)
at 43 weeks##8##3##(2008-9#8)
at 43##10##2##(2008-12#1)(2008-9#9)
at 430##2##2##(2008-10#2)
at 430nm##2##2##(2008-10#2)
at 435 nm##3##3##(2008-10#3)
at 440 nm##3##3##(2008-10#3)
at 440##6##2##(2008-10#5)(2008-11#1)
at 45 days##2##3##(2008-10#1)(2008-7#1)
at 45 degrees C and##2##5##(1997-2#1)(2008-10#1)
at 45 degrees C for##5##5##(1994-8#2)(2008-10#1)(2008-5#2)
at 45 degrees C##11##4##(1994-8#2)(1997-2#1)(2008-10#6)(2008-5#2)
at 45 degrees##14##3##(1994-8#2)(1997-2#1)(2008-10#6)(2008-2#1)(2008-5#2)(2011-2#2)
at 45##18##2##(1993-11#1)(1994-8#2)(1997-2#1)(2008-10#7)(2008-2#1)(2008-5#2)(2008-7#1)(2010-11#1)(2011-2#2)
at 45%##2##2##(2011-2#1)(2013-8#1)
at 450##2##2##(1993-8#1)(2008-10#1)
at 450nm##3##2##(2008-10#3)
at 455nm##2##2##(2008-10#2)
at 460 nm##2##3##(2008-10#2)
at 465 nm##2##3##(1994-3#1)(2008-10#1)
at 47##4##2##(1992-5#1)(1996-5#1)(2008-10#2)
at 470 nm##7##3##(2008-10#5)(2008-11#2)
at 470##10##2##(2008-10#6)(2008-11#3)(2008-3#1)
at 470nm##4##2##(2008-10#4)
at 475 nm##2##3##(2008-10#2)
at 479 nm##2##3##(2008-10#2)
at 48 h after##2##4##(1996-12#1)(2008-10#1)
at 48 h##4##3##(1996-12#1)(2008-10#2)(2009-9#1)
at 48##6##2##(1996-12#1)(2008-10#4)(2009-9#1)
at 480##2##2##(2008-10#1)(2008-3#1)
at 480nm##2##2##(2008-10#2)
at 488 nm##2##3##(2008-3#1)(2008-9#1)
at 490 nm##4##3##(2008-10#4)
at 490##5##2##(2008-10#4)(2008-11#1)
at 4 h post exercise##2##4##(2013-1#2)
at 5 and 25 cm##2##5##(2008-10#2)
at 5 and##5##3##(2008-10#3)(2011-2#1)(2013-1#1)
at 5 degrees C and##3##5##(2008-10#2)(2010-4#1)
at 5 degrees C##7##4##(1993-2#1)(1995-6#1)(2008-10#4)(2010-4#1)
at 5 g##2##3##(2008-11#2)
at 5 years##7##3##(1991-2#1)(1991-8#2)(1994-12#1)(1994-6#1)(2008-11#1)(2008-7#1)
at 5##43##2##(1990-2#1)(1991-12#1)(1991-2#2)(1991-8#2)(1992-2#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#1)(1995-8#2)(1997-1#1)(2008-10#16)(2008-11#3)(2008-3#3)(2008-7#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#1)
at 5% significance##2##3##(2008-8#1)(2013-1#1)
at 5%##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
at 50 and 200##2##4##(1991-12#1)(2008-10#1)
at 50 degrees C and##2##5##(2008-10#2)
at 50 degrees C for##2##5##(2008-5#1)(2008-6#1)
at 50 degrees C##8##4##(1994-5#1)(2008-10#5)(2008-5#1)(2008-6#1)
at 50##25##2##(1991-12#3)(1994-5#1)(1995-8#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
at 50%##5##2##(2008-1#1)(2008-10#2)(2008-2#1)(2011-3#1)
at 500 nm##3##3##(2008-10#3)
at 500 rpm##2##3##(2008-11#2)
at 500##9##2##(2008-10#4)(2008-11#3)(2008-3#1)(2009-1#1)
at 500nm##2##2##(2008-10#2)
at 505 nm##4##3##(2008-10#4)
at 50°C##2##2##(2013-1#2)
at 510 nm##4##3##(2008-10#3)(2008-11#1)
at 514 nm##2##3##(2008-10#1)(2008-11#1)
at 515 nm##2##3##(2008-10#2)
at 52##2##2##(2008-10#2)
at 520 nm##5##3##(2008-10#5)
at 525 nm##5##3##(2008-10#5)
at 530 nm##3##3##(2008-10#2)(2008-3#1)
at 530##4##2##(2008-10#3)(2008-3#1)
at 532 nm##3##3##(2008-2#1)(2008-3#2)
at 540 nm##5##3##(2008-10#5)
at 546 nm##2##3##(2008-10#2)
at 55 degrees C and##2##5##(2008-12#1)(2008-6#1)
at 55 degrees C##3##4##(2008-10#1)(2008-12#1)(2008-6#1)
at 55 degrees##4##3##(1990-9#1)(2008-10#1)(2008-12#1)(2008-6#1)
at 55##5##2##(1990-9#1)(2008-10#2)(2008-12#1)(2008-6#1)
at 550##4##2##(2008-10#4)
at 550nm##2##2##(2008-10#2)
at 551 nm##2##3##(2008-10#2)
at 555 nm##3##3##(2008-10#3)
at 555##4##2##(2008-10#4)
at 56##5##2##(2008-10#4)(2008-7#1)
at 560 nm##5##3##(2008-10#5)
at 560##6##2##(2008-10#6)
at 562 nm##3##3##(2008-10#3)
at 562##4##2##(2008-10#3)(2011-2#1)
at 570nm##3##2##(2008-10#3)
at 58##2##2##(1993-12#1)(2008-10#1)
at 580 nm##5##3##(2008-10#4)(2008-8#1)
at 580##6##2##(2008-10#5)(2008-8#1)
at 580nm##2##2##(2008-10#2)
at 585##2##2##(2008-10#2)
at 590##2##2##(2008-10#2)
at 595 nm##4##3##(2008-10#4)
at 5mugl(-1)##2##2##(2008-10#2)
at 6 and 12 months##3##5##(2008-7#1)(2011-2#1)(2013-1#1)
at 6 and##5##3##(1995-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
at 6 degrees C##4##4##(2008-10#3)(2008-2#1)
at 6 h##4##3##(1995-11#2)(1995-8#1)(2008-10#1)
at 6 months compared with##3##5##(2008-7#1)(2013-1#2)
at 6 months##10##3##(1991-2#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-1#3)
at 6 weeks##2##3##(1991-2#1)(1995-3#1)
at 6##47##2##(1991-2#2)(1993-12#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#5)
at 6-month follow-up##2##3##(2008-8#1)(2010-10#1)
at 60 degrees C and##2##5##(2008-10#1)(2008-6#1)
at 60 degrees C for##2##5##(2008-10#2)
at 60 degrees C##6##4##(2008-10#5)(2008-6#1)
at 60 degrees##8##3##(2008-10#6)(2008-6#1)(2013-1#1)
at 60 min##2##3##(1997-1#1)(2011-2#1)
at 60 months##2##3##(1991-8#1)(2012-12#1)
at 60##19##2##(1990-8#1)(1991-8#1)(1992-1#1)(1994-11#1)(1995-11#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
at 600 nm##2##3##(2008-10#2)
at 600##5##2##(2008-10#3)(2008-12#1)(2008-9#1)
at 605 nm##2##3##(2008-10#2)
at 610 nm##3##3##(1990-2#1)(2008-10#2)
at 612##3##2##(2008-10#3)
at 616 nm##2##3##(2008-10#2)
at 620 nm##2##3##(2008-10#1)(2008-8#1)
at 620##3##2##(2008-10#2)(2008-8#1)
at 635 nm##2##3##(2008-10#2)
at 640 nm##2##3##(2008-10#1)(2008-3#1)
at 640##3##2##(2008-10#2)(2008-3#1)
at 65 degrees C##2##4##(2008-10#2)
at 65 degrees##3##3##(1992-6#1)(2008-10#2)
at 65##5##2##(1992-6#1)(2008-10#4)
at 665 nm##2##3##(2008-10#2)
at 672##2##2##(2008-3#1)(2008-7#1)
at 7 days after##2##4##(1994-5#1)(2008-10#1)
at 7 days##5##3##(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)
at 7 months##3##3##(1995-8#2)(1997-3#1)
at 7##21##2##(1991-8#1)(1994-5#1)(1995-8#2)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#2)(2012-2#1)(2013-1#1)
at 7- to 10-day intervals##2##5##(2008-10#2)
at 70 degrees C##2##4##(2008-10#1)(2008-11#1)
at 70##6##2##(1995-6#1)(2008-10#3)(2008-11#2)
at 700 ppm##2##3##(2008-10#2)
at 700##6##2##(1991-2#1)(2008-10#5)
at 700nm##2##2##(2008-10#2)
at 713 cm(-1)##3##3##(2008-10#3)
at 72##2##2##(1992-5#1)(2008-10#1)
at 75##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
at 765 and 865 nm##3##5##(2008-2#2)(2008-3#1)
at 77 K##3##3##(2008-10#1)(2009-11#2)
at 77##5##2##(2008-10#3)(2009-11#2)
at 770 nm##2##3##(2008-2#2)
at 8 months##2##3##(2008-4#1)(2010-3#1)
at 8 weeks (P&lt##3##4##(2009-3#3)
at 8 weeks##6##3##(2008-10#2)(2009-3#3)(2011-2#1)
at 8##19##2##(1991-6#2)(1992-12#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2009-3#3)(2010-10#1)(2010-3#1)(2011-2#1)
at 8%##2##2##(2009-7#1)(2013-1#1)
at 80 degrees C##10##4##(2007-12#1)(2008-10#8)(2008-7#1)
at 80 mumol/kg##2##3##(1993-12#2)
at 80##17##2##(1993-12#3)(2007-12#1)(2008-10#9)(2008-7#3)(2013-8#1)
at 800 degrees C##2##4##(2008-10#2)
at 800##4##2##(2008-10#2)(2010-1#1)(2010-4#1)
at 814 nm##2##3##(2008-10#2)
at 84##2##2##(2008-10#2)
at 85 degrees C##3##4##(2008-2#2)(2008-7#1)
at 85##4##2##(2008-2#2)(2008-7#1)(2013-8#1)
at 850 degrees C##2##4##(2013-8#2)
at 850##3##2##(2008-2#1)(2013-8#2)
at 88##2##2##(1992-8#1)(2013-1#1)
at 890 mmol * kg(-1)##2##5##(2008-8#2)
at 9##9##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)
at 90 days##2##3##(2008-8#1)(2009-11#1)
at 90 degrees##2##3##(2008-10#1)(2013-1#1)
at 90##6##2##(2008-10#2)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#1)
at 90%##4##2##(2008-10#3)(2008-11#1)
at 90°C##2##2##(2011-1#2)
at 946 nm##3##3##(2008-2#1)(2008-3#2)
at 95##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
at 95% confidence level##16##4##(2008-10#16)
at 95% confidence##17##3##(2008-10#17)
at 95%##18##2##(2008-10#18)
at 96 h after##3##4##(2008-10#3)
at 96 h##4##3##(2008-10#4)
at 96##7##2##(2008-10#5)(2008-8#1)(2011-2#1)
at 985 nm##2##3##(2007-12#2)
at AD and PD affects the##2##6##(2011-2#2)
at AD and PD##4##4##(2011-2#4)
at AD##6##2##(2008-12#2)(2011-2#4)
at AR##4##2##(2013-8#4)
at Ac##3##2##(1991-3#3)
at Alliant##2##2##(1994-2#2)
at Army##2##2##(2012-2#2)
at Bodie##2##2##(2008-8#2)
at Brigham and Women's Hospital##3##5##(1994-3#1)(2010-5#2)
at C##2##2##(1990-5#2)
at C-2##6##2##(1996-5#5)(2008-5#1)
at C-3 of##2##3##(1996-5#1)(2008-11#1)
at C-4 and##2##3##(1996-5#2)
at C-4 of##3##3##(1993-8#2)(1996-5#1)
at C-4##6##2##(1993-8#3)(1996-5#3)
at CE##2##2##(2008-12#2)
at CNTs##2##2##(2008-10#2)
at CT##2##2##(2012-12#1)(2012-2#1)
at Cinzana##2##2##(2008-10#2)
at City University##2##3##(2008-11#2)
at Córdoba##2##2##(2008-10#2)
at DNA level##2##3##(2008-8#2)
at Dunedin Hospital##2##3##(2008-7#2)
at E(cell)=1##2##2##(2008-10#2)
at ED 15##2##3##(1993-3#2)
at ED##3##2##(1993-3#3)
at East Chapman##2##3##(2008-10#2)
at East##3##2##(1997-3#1)(2008-10#2)
at Fiji##2##2##(2008-1#2)
at HIV##2##2##(2008-1#1)(2009-5#1)
at HMDE##2##2##(2008-10#2)
at Harvard##3##2##(1990-11#1)(1992-3#1)(2010-5#1)
at High##2##2##(1995-6#1)(2008-10#1)
at I=0##2##2##(2008-10#2)
at Janelia is##2##3##(2008-9#2)
at Janelia##6##2##(2008-9#6)
at Johns Hopkins##2##3##(1994-12#1)(2011-2#1)
at KE##2##2##(2008-12#2)
at Kaiser Permanente##2##3##(1995-2#1)(2010-8#1)
at L2-3 and L3-4##2##4##(2013-1#2)
at L2-3##4##2##(2012-3#1)(2013-1#3)
at L5-S1##2##2##(2009-3#1)(2012-2#1)
at Lariboisiere Hospital##2##3##(2011-2#2)
at Loma Linda##3##3##(1993-2#3)
at Loop7##2##2##(2008-9#2)
at Mount Barker and##2##4##(2008-10#2)
at Mount##3##2##(2008-10#2)(2008-9#1)
at NB##2##2##(2013-8#2)
at National Public Health Laboratory##2##5##(2012-3#2)
at National##3##2##(2008-10#1)(2012-3#2)
at North##2##2##(1997-6#1)(2010-5#1)
at Northumbria##2##2##(2008-11#2)
at P &lt##3##3##(2008-10#2)(2010-1#1)
at P&lt##3##2##(2008-12#2)(2008-7#1)
at PMI##2##2##(2009-10#2)
at Palmyra Atoll##2##3##(2010-8#2)
at Palmyra##3##2##(2010-8#3)
at R stage##2##3##(1990-5#2)
at R##3##2##(1990-5#2)(2008-10#1)
at RH &gt##2##3##(2008-10#2)
at RH##3##2##(2008-10#3)
at Recovery 1 and 2##2##5##(1994-2#2)
at Resolute Bay##2##3##(2008-3#2)
at SS##2##2##(2008-12#2)
at Samanko##2##2##(2008-10#2)
at Serine 133##2##3##(2008-11#2)
at Shifa##2##2##(2013-7#2)
at Sri Venkateswara University##4##4##(2008-10#4)
at St##4##2##(1993-2#1)(1995-12#1)(1995-6#1)(2008-7#1)
at T##2##2##(1991-3#1)(2008-3#1)
at T1 and T2##2##4##(2009-10#2)
at T1##5##2##(2009-10#3)(2009-7#1)(2013-1#1)
at T2##3##2##(2009-10#1)(2009-7#1)(2013-1#1)
at T4 middle promoters##2##4##(1995-2#2)
at The##7##2##(1992-1#1)(1992-2#1)(1993-1#1)(1993-3#1)(2008-11#1)(2008-12#1)(2012-2#1)
at Thr160##3##2##(1997-1#3)
at Time 1##2##3##(2008-12#1)(2010-4#1)
at Time 2##2##3##(2010-4#2)
at Time##5##2##(2008-12#1)(2010-10#1)(2010-4#3)
at Urbana##2##2##(2008-10#2)
at Wave 1 were##3##4##(2013-8#3)
at West##2##2##(1993-12#1)(2009-10#1)
at Xq28##3##2##(2008-12#2)(2012-3#1)
at Yale University##3##3##(1996-1#1)(1996-9#1)(2008-11#1)
at Yale##4##2##(1996-1#1)(1996-9#2)(2008-11#1)
at a 1##3##3##(2008-3#3)
at a 95% confidence level##6##5##(2008-10#6)
at a 95%##7##3##(2008-10#7)
at a boron-doped diamond##2##4##(2008-10#2)
at a carbon fiber microdisk electrode##2##6##(2008-10#2)
at a carbon paste electrode modified##2##6##(2008-10#2)
at a carbon paste electrode##4##5##(2008-10#4)
at a carbon##8##3##(2008-10#8)
at a certain##2##3##(2008-3#1)(2008-9#1)
at a community level on a statewide basis##2##8##(1996-3#2)
at a community##3##3##(1996-3#2)(2008-1#1)
at a comparatively##2##3##(1993-3#1)(2008-10#1)
at a concentration as low as##2##6##(2008-10#2)
at a concentration level of##3##5##(2008-10#3)
at a concentration level##4##4##(2008-10#4)
at a concentration of 0##2##5##(2008-10#1)(2008-11#1)
at a concentration of 1##7##5##(1995-11#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-5#1)
at a concentration of 10(-9) mol/l and##2##7##(2011-2#2)
at a concentration of 100 µg/mL##2##6##(2011-1#2)
at a concentration of 100##4##5##(1997-4#1)(2008-10#1)(2011-1#2)
at a concentration of 20##2##5##(2008-10#1)(2008-11#1)
at a concentration of 3##2##5##(1990-5#1)(2008-10#1)
at a concentration of approximately##3##5##(2008-11#2)(2008-8#1)
at a concentration of##34##4##(1990-5#1)(1993-3#1)(1993-8#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#8)(2008-11#8)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#3)(2012-3#1)
at a concentration##43##3##(1990-5#1)(1991-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#14)(2008-11#9)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#3)(2012-3#1)
at a constant flow rate##2##5##(2008-10#2)
at a constant rate##2##4##(2008-10#1)(2008-11#1)
at a constant temperature##2##4##(2008-10#2)
at a constant##16##3##(1994-8#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-3#1)(2011-2#1)
at a controlled rate##2##4##(2008-10#1)(2008-7#1)
at a cost of##2##4##(1994-9#1)(2008-10#1)
at a cost##5##3##(1994-3#1)(1994-9#1)(2008-10#1)(2008-11#2)
at a crime scene##2##4##(2008-10#1)(2008-12#1)
at a defined##2##3##(2008-10#1)(2008-11#1)
at a density##2##3##(1997-3#1)(2008-10#1)
at a depth of##2##4##(1990-11#1)(1996-2#1)
at a different##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
at a dilution rate of##2##5##(2008-7#2)
at a distance of##10##4##(1992-1#1)(2008-10#7)(2008-3#1)(2008-8#1)
at a distance##15##3##(1992-1#1)(1997-3#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-8#2)
at a distinct##2##3##(2008-11#1)(2012-3#1)
at a dosage of##2##4##(1994-2#1)(2008-9#1)
at a dose of 0##2##5##(2008-12#1)(2013-1#1)
at a dose of 10##2##5##(1994-8#1)(2008-6#1)
at a dose of 2##2##5##(2008-11#1)(2008-12#1)
at a dose of 40##2##5##(1991-2#1)(2008-8#1)
at a dose of##19##4##(1991-2#1)(1991-6#1)(1994-3#2)(1994-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
at a dose##23##3##(1990-6#1)(1991-2#1)(1991-6#1)(1994-3#2)(1994-8#3)(1995-12#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
at a faster rate##2##4##(1991-3#1)(2008-10#1)
at a fixed##10##3##(1991-1#1)(1996-3#1)(2008-10#5)(2008-3#1)(2008-7#1)(2012-3#1)
at a flow rate of 0##4##6##(2008-10#4)
at a flow rate of 1##7##6##(2008-10#7)
at a flow rate of 2##4##6##(2008-10#4)
at a flow rate of##24##5##(2008-10#24)
at a flow rate##25##4##(2008-10#25)
at a flow-rate of 1##2##5##(2008-10#2)
at a flow-rate of##3##4##(2008-10#3)
at a frequency of 0##2##5##(2008-10#1)(2011-2#1)
at a frequency of##6##4##(1995-3#1)(2008-10#4)(2011-2#1)
at a frequency##7##3##(1993-12#1)(1995-3#1)(2008-10#4)(2011-2#1)
at a given time##2##4##(1995-3#1)(2008-9#1)
at a given##7##3##(1995-3#1)(2008-10#5)(2008-9#1)
at a glassy carbon electrode##7##5##(2008-10#7)
at a glassy carbon##9##4##(2008-10#9)
at a gold electrode modified with##2##6##(2008-10#2)
at a gold##4##3##(1991-7#1)(2008-10#3)
at a hanging mercury drop electrode (HMDE)##2##7##(2008-10#2)
at a hanging mercury drop electrode##6##6##(2008-10#6)
at a health center]##4##4##(1991-11#1)(1993-3#1)(1995-11#1)(1997-4#1)
at a health##5##3##(1991-11#1)(1993-3#1)(1995-11#1)(1996-3#1)(1997-4#1)
at a high density##2##4##(2008-10#1)(2008-11#1)
at a high level##3##4##(1993-6#1)(2008-11#1)(2013-1#1)
at a high##13##3##(1990-12#1)(1990-6#1)(1993-6#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2013-1#1)
at a higher rate than##4##5##(1990-8#1)(1995-5#1)(2008-11#2)
at a higher rate##6##4##(1990-8#1)(1995-5#1)(2008-10#2)(2008-11#2)
at a higher risk##3##4##(2008-4#1)(2010-12#1)(2011-2#1)
at a higher##17##3##(1990-8#1)(1994-11#1)(1995-5#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#1)(2010-12#1)(2010-6#1)(2011-2#2)
at a highly boron-doped diamond electrode##2##6##(2008-10#2)
at a large##4##3##(1991-3#1)(2009-9#1)(2012-2#2)
at a larger size##2##4##(2008-8#1)(2009-10#1)
at a later date##2##4##(1995-6#1)(2008-10#1)
at a later stage of##2##5##(2008-11#1)(2010-1#1)
at a later stage##5##4##(2008-11#3)(2010-1#2)
at a later time##2##4##(1991-12#1)(1993-11#1)
at a later##10##3##(1991-12#1)(1993-11#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-11#3)(2010-1#2)
at a level of##6##4##(1990-8#1)(2008-10#3)(2008-11#1)(2008-3#1)
at a level that would##2##5##(2008-10#1)(2009-3#1)
at a level that##3##4##(2008-10#1)(2008-12#1)(2009-3#1)
at a level##15##3##(1990-8#1)(1991-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2012-3#1)
at a local##3##3##(1993-6#2)(2008-8#1)
at a low level##5##4##(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)
at a low temperature##3##4##(2008-10#2)(2008-11#1)
at a low##14##3##(1992-3#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-12#1)
at a lower extent##2##4##(1990-12#2)
at a lower##8##3##(1990-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)
at a maximum##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)
at a mean age of##3##5##(1997-3#3)
at a mean temperature of##2##5##(2008-10#2)
at a mean##6##3##(1994-2#1)(1997-3#3)(2008-10#2)
at a median##5##3##(1990-12#1)(1992-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
at a mercury electrode##5##4##(2008-10#5)
at a mercury##6##3##(2008-10#6)
at a minimum##3##3##(1997-2#1)(2008-7#1)(2008-8#1)
at a more##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
at a much higher##2##4##(1994-6#1)(2008-10#1)
at a much lower##2##4##(2008-10#2)
at a much##5##3##(1992-12#1)(1994-6#1)(2008-10#3)
at a nafion-loaded carbon paste electrode##2##6##(2008-10#2)
at a net flux of##2##5##(2008-7#2)
at a nominal resolution of##2##5##(2008-10#2)
at a nominal##3##3##(2008-10#3)
at a nuclear##2##3##(1994-6#1)(2008-8#1)
at a number of##3##4##(1991-2#1)(2008-11#1)(2008-5#1)
at a pH of##3##4##(2008-10#3)
at a pH range of##2##5##(2008-10#1)(2008-7#1)
at a pH range##4##4##(2008-10#3)(2008-7#1)
at a pH value##2##4##(2008-10#2)
at a pH##13##3##(2008-10#11)(2008-7#2)
at a pH&gt##2##3##(2008-10#1)(2009-11#1)
at a paediatric##2##3##(2008-11#1)(2011-2#1)
at a particular##2##3##(1993-9#1)(2008-11#1)
at a peak potential of##2##5##(2008-10#2)
at a peak##3##3##(2008-10#2)(2008-11#1)
at a perfusion rate of##2##5##(2008-10#2)
at a platinum electrode in##2##5##(2008-10#2)
at a poly(3-methylthiophene)##2##3##(2008-10#2)
at a polypyrrole electrode modified##2##5##(2008-10#2)
at a position##5##3##(1990-5#1)(1993-6#1)(2008-10#2)(2008-3#1)
at a potential of -0##4##5##(2008-10#4)
at a potential of##5##4##(2008-10#4)(2012-2#1)
at a potential##6##3##(2008-10#5)(2012-2#1)
at a preconcentration time of##2##5##(2008-10#2)
at a private psychiatric hospital##2##5##(1991-2#1)(1992-3#1)
at a range of##3##4##(1996-2#1)(2008-10#1)(2008-12#1)
at a rate of 0##3##5##(1992-12#1)(2008-10#2)
at a rate of 1##2##5##(1990-9#1)(2008-10#1)
at a rate of 2% (vol/vol)##2##6##(2008-10#2)
at a rate of##17##4##(1990-9#1)(1992-12#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-7#1)
at a rate similar to that##2##6##(1993-8#1)(1995-2#1)
at a rate##23##3##(1990-9#1)(1991-9#1)(1992-12#1)(1993-8#2)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-7#1)(2009-11#1)
at a ratio of 1##3##5##(1995-2#1)(2008-10#1)(2013-1#1)
at a ratio of##4##4##(1995-2#1)(1996-2#1)(2008-10#1)(2013-1#1)
at a reasonable cost##2##4##(1992-1#1)(2008-10#1)
at a relatively high frequency##2##5##(2008-10#1)(2008-11#1)
at a relatively high##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
at a relatively low##4##4##(2008-10#3)(2008-11#1)
at a relatively##8##3##(1993-12#1)(2008-10#4)(2008-11#2)(2008-8#1)
at a repetition rate of##2##5##(2008-3#2)
at a resolution of##2##4##(2008-10#2)
at a retention##2##3##(2008-10#2)
at a sample flow rate of##2##6##(2008-10#2)
at a sampling frequency of##3##5##(2008-10#2)(2013-1#1)
at a sampling rate of 30 h(-1)##2##7##(2008-10#2)
at a sampling rate of 60##2##6##(2008-10#2)
at a sampling rate of 90 h(-1)##2##7##(2008-10#2)
at a sampling rate of 90##3##6##(2008-10#3)
at a sampling rate of##10##5##(2008-10#10)
at a sampling##14##3##(2008-10#13)(2013-1#1)
at a scale##2##3##(2008-10#2)
at a separation voltage of##5##5##(2008-10#5)
at a signal-to-noise ratio of 3##2##6##(2008-10#2)
at a signal-to-noise ratio of##3##5##(2008-10#3)
at a signal-to-noise ratio##4##4##(2008-10#4)
at a silver electrode##2##4##(2008-10#2)
at a similar##5##3##(1990-9#1)(1994-3#1)(2008-10#1)(2008-12#1)(2009-10#1)
at a single locus##3##4##(2008-10#2)(2008-8#1)
at a single site##3##4##(1996-6#1)(2008-10#1)(2008-11#1)
at a single time point##2##5##(1995-12#1)(2011-2#1)
at a single##17##3##(1995-12#1)(1995-3#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#3)
at a site##3##3##(1994-8#1)(2008-9#1)(2009-8#1)
at a slightly##3##3##(2008-10#2)(2008-8#1)
at a small##2##3##(2008-9#1)(2012-3#1)
at a specific site##2##4##(1991-9#1)(2013-8#1)
at a specific##10##3##(1991-9#1)(1993-2#1)(1995-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2013-8#1)
at a static mercury drop electrode##2##6##(2008-10#2)
at a steady##2##3##(2008-11#1)(2010-11#1)
at a strongly##2##3##(2008-3#1)(2008-9#1)
at a temperature around##2##4##(2008-7#2)
at a temperature of 25 degrees C##2##7##(2008-11#1)(2008-12#1)
at a temperature of##9##4##(2008-10#6)(2008-11#1)(2008-12#1)(2009-7#1)
at a temperature##14##3##(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#2)(2009-7#1)
at a tertiary care##2##4##(2013-8#2)
at a tertiary##3##3##(2013-1#1)(2013-8#2)
at a time for##2##4##(1994-3#1)(2008-10#1)
at a time of##2##4##(2010-12#1)(2013-1#1)
at a time when##4##4##(2008-10#4)
at a time##16##3##(1994-3#1)(1996-12#1)(2008-10#8)(2008-7#1)(2010-12#1)(2013-1#3)(2013-8#1)
at a total of##2##4##(1991-11#1)(2008-10#1)
at a total##5##3##(1991-11#1)(1992-3#1)(2008-10#3)
at a university##2##3##(2008-11#1)(2012-3#1)
at a very##2##3##(2008-10#2)
at a wavelength of 1##4##5##(2008-2#2)(2008-3#2)
at a wavelength of##9##4##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#4)
at a wavelength##12##3##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#6)
at a young age##2##4##(1994-9#1)(2011-2#1)
at a younger age##3##4##(2008-7#1)(2010-1#1)(2011-2#1)
at a younger##4##3##(1994-8#1)(2008-7#1)(2010-1#1)(2011-2#1)
at a##816##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#6)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#5)(1993-6#5)(1993-8#3)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#5)(1994-6#4)(1994-8#7)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#7)(1997-4#3)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#4)(2008-1#3)(2008-10#376)(2008-11#61)(2008-12#17)(2008-2#6)(2008-3#30)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#19)(2008-8#18)(2008-9#10)(2009-10#2)(2009-11#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#4)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#20)(2012-12#4)(2012-2#8)(2012-3#9)(2012-5#2)(2013-1#16)(2013-7#1)(2013-8#6)
at abdominal hysterectomy##2##3##(1991-12#2)
at about -1##2##3##(2008-10#2)
at about 0##5##3##(2008-10#5)
at about##21##2##(1991-11#1)(1991-6#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-5#1)(2009-9#1)(2011-1#1)
at acidic pH##3##3##(1991-5#1)(1994-5#1)(2008-10#1)
at acidic##5##2##(1991-5#1)(1994-5#1)(2008-10#2)(2008-11#1)
at acupoints##2##2##(2010-7#1)(2013-1#1)
at admission and at discharge##2##5##(1991-2#1)(2011-2#1)
at admission and##3##3##(1991-2#1)(2011-2#2)
at admission were##2##3##(1994-12#1)(2012-3#1)
at admission##6##2##(1991-2#1)(1994-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
at adolescence##2##2##(1990-12#1)(2008-4#1)
at age 4##3##3##(2008-9#1)(2011-1#1)(2013-1#1)
at age fourteen years##2##4##(2012-3#2)
at age##18##2##(1990-6#1)(1995-8#2)(1997-3#3)(2008-9#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-3#5)(2013-1#1)
at age-2##2##2##(2011-2#2)
at ages##2##2##(1995-11#1)(2008-10#1)
at air-water interface##2##3##(2008-10#2)
at alkaline pH##2##3##(2008-11#1)(2008-9#1)
at alkaline##3##2##(2008-11#1)(2008-9#1)(2009-7#1)
at all ages##3##3##(1991-3#1)(1996-12#1)(2008-9#1)
at all concentration##2##3##(2008-10#2)
at all concentrations##3##3##(2008-10#2)(2008-11#1)
at all developmental##2##3##(1995-12#1)(2011-2#1)
at all doses##4##3##(1993-6#1)(2008-11#1)(2008-12#2)
at all for##2##3##(1996-1#1)(2008-10#1)
at all four##2##3##(1991-2#1)(2008-4#1)
at all growth stages##2##4##(2008-10#2)
at all in##4##3##(1995-11#1)(1997-8#1)(2008-10#1)(2008-3#1)
at all levels of the##4##5##(1992-12#1)(1993-12#1)(1997-3#1)(2008-12#1)
at all levels of##6##4##(1992-12#1)(1993-12#1)(1995-12#1)(1997-3#1)(2008-12#1)(2008-8#1)
at all levels##13##3##(1992-12#1)(1993-12#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-1#1)
at all loci##2##3##(2008-10#1)(2008-11#1)
at all sites##2##3##(2008-10#2)
at all stages##3##3##(2008-10#2)(2008-9#1)
at all temperatures and##2##4##(2008-10#2)
at all temperatures##10##3##(1990-9#1)(2008-10#8)(2011-2#1)
at all tested##2##3##(2008-12#1)(2013-1#1)
at all the##2##3##(2008-10#1)(2008-9#1)
at all three##3##3##(1991-2#1)(2008-10#1)(2008-3#1)
at all times##2##3##(1990-12#1)(2010-10#1)
at all treatment##2##3##(2008-10#1)(2013-1#1)
at all##135##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-3#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#3)(2008-10#43)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#10)
at alpha##6##2##(1995-11#6)
at altitudes##2##2##(1991-5#1)(2008-2#1)
at ambient pressure in##2##4##(2008-10#1)(2008-3#1)
at ambient pressure##5##3##(1996-5#1)(2008-10#3)(2008-3#1)
at ambient temperature##11##3##(2008-10#6)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)
at ambient##17##2##(1996-5#1)(2008-10#10)(2008-3#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)
at amino acid##3##3##(1993-8#1)(1994-11#1)(1997-3#1)
at an MOI of 0##2##5##(2008-11#1)(2008-9#1)
at an N concentration of##2##5##(2008-10#2)
at an RPE that corresponded to##2##6##(2013-8#2)
at an academic##2##3##(1991-1#1)(2012-3#1)
at an accelerated##2##3##(2008-12#1)(2013-8#1)
at an acceptable level##2##4##(1991-2#1)(2009-8#1)
at an analytical##3##3##(2008-10#3)
at an angle##5##3##(1992-9#1)(2008-10#1)(2008-3#2)(2013-1#1)
at an applied potential of 0##2##6##(2008-10#2)
at an applied potential of##3##5##(2008-10#3)
at an applied##4##3##(2008-10#4)
at an average follow-up of##2##5##(2008-8#1)(2011-2#1)
at an average of##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
at an average##9##3##(1993-1#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
at an earlier stage##2##4##(1992-3#1)(1997-7#1)
at an earlier##3##3##(1992-3#1)(1997-7#1)(2010-12#1)
at an early age##3##4##(2008-10#1)(2008-9#1)(2012-12#1)
at an early stage of development##2##6##(2008-10#1)(2010-3#1)
at an early stage of##5##5##(2008-10#3)(2008-5#1)(2010-3#1)
at an early stage##15##4##(1994-3#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-3#1)(2012-3#1)(2013-1#2)
at an early##20##3##(1993-3#1)(1994-3#1)(1997-8#1)(2008-10#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
at an electrochemically##2##3##(2008-10#2)
at an elevated level in##2##5##(1991-7#1)(1996-12#1)
at an elevated##3##3##(1991-7#1)(1996-12#1)(2013-1#1)
at an emission wavelength of##2##5##(2008-10#2)
at an emission wavelength##3##4##(2008-10#3)
at an excitation wavelength of##2##5##(2008-10#2)
at an increased##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
at an intensity of##2##4##(2008-9#1)(2013-8#1)
at an interim analysis##2##4##(2012-2#2)
at an intermediate##3##3##(2008-3#1)(2008-8#2)
at an operating##2##3##(2008-10#2)
at an optimum##2##3##(2008-10#2)
at an##135##2##(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-7#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-3#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#37)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#5)
at and##6##2##(1990-8#1)(1993-6#1)(1996-8#1)(2008-10#2)(2008-11#1)
at annual##2##2##(1991-12#1)(1991-2#1)
at another##4##2##(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)
at antagonist densities of##2##4##(2008-10#2)
at antagonist##3##2##(2008-10#3)
at anthesis##5##2##(2008-10#5)
at any given temperature##2##4##(2008-10#2)
at any given##6##3##(2008-10#3)(2010-8#2)(2013-1#1)
at any level of##2##4##(2011-1#1)(2011-2#1)
at any of the##3##4##(2008-10#1)(2008-6#1)(2010-1#1)
at any point in##2##4##(2008-10#1)(2008-12#1)
at any point##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
at any single##2##3##(1994-9#1)(1995-12#1)
at any stage of the disease##2##6##(1993-2#1)(2012-2#1)
at any stage of the##3##5##(1993-2#2)(2012-2#1)
at any stage of##5##4##(1993-2#2)(2008-10#1)(2012-2#1)(2013-1#1)
at any stage##6##3##(1993-2#2)(2008-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
at any temperature##2##3##(1993-9#1)(2008-10#1)
at any time##8##3##(1991-3#1)(1994-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)
at any##49##2##(1991-3#2)(1993-2#2)(1993-9#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
at appropriate##5##2##(1990-10#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
at approximately the same rate##2##5##(1993-6#1)(1995-8#1)
at approximately the same##3##4##(1991-5#1)(1993-6#1)(1995-8#1)
at approximately the##4##3##(1991-5#1)(1993-6#1)(1995-8#1)(2008-10#1)
at approximately##25##2##(1991-5#1)(1992-6#1)(1993-6#1)(1993-8#2)(1995-8#2)(1996-2#2)(2008-1#1)(2008-10#9)(2008-3#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-3#1)
at around pH 5-6##2##4##(2008-10#2)
at around pH##4##3##(2008-10#4)
at around##9##2##(1993-3#1)(1997-1#1)(2008-10#6)(2008-5#1)
at as##2##2##(1991-3#1)(2008-10#1)
at atmospheric pressure##2##3##(2008-10#1)(2008-3#1)
at autopsy##6##2##(1995-11#2)(1996-11#1)(2008-7#1)(2008-9#2)
at b =##3##3##(2009-11#3)
at b##4##2##(2008-10#1)(2009-11#3)
at bare##2##2##(2008-10#2)
at bars##2##2##(2008-12#2)
at base##2##2##(1991-11#1)(1995-2#1)
at baseline and after##2##4##(2012-3#1)(2013-8#1)
at baseline and at the##2##5##(2008-10#1)(2008-3#1)
at baseline and at##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
at baseline and##9##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
at baseline##35##2##(1992-9#1)(1994-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#3)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#5)(2013-1#8)(2013-8#3)
at basic pH##4##3##(2008-10#4)
at being##3##2##(2009-10#1)(2010-1#1)(2012-3#1)
at best##16##2##(1991-3#1)(1994-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#2)(2009-8#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
at between##2##2##(2008-10#1)(2008-11#1)
at bilateral##3##2##(2010-7#1)(2012-2#2)
at birth##19##2##(1991-6#1)(1994-1#1)(1994-3#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)
at bismuth film electrodes##2##4##(2008-10#2)
at bismuth film screen-printed##2##4##(2008-10#2)
at bismuth film##5##3##(2008-10#5)
at bloom and fruit developmental stages##2##6##(2008-10#2)
at bloom stage##2##3##(2008-10#2)
at bloom##6##2##(2008-10#6)
at booting and panicle exsertion stages##3##6##(2008-10#3)
at both doses##2##3##(1991-3#1)(1994-12#1)
at both ends of##2##4##(2008-1#1)(2008-8#1)
at both ends##4##3##(1995-6#1)(2008-1#1)(2008-4#1)(2008-8#1)
at both sites##5##3##(1996-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
at both the transcriptional and##2##5##(1991-6#1)(1993-8#1)
at both the##19##3##(1991-6#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-9#1)(2009-8#2)(2010-5#1)(2012-2#1)
at both time points##2##4##(2009-10#1)(2011-2#1)
at both##69##2##(1990-5#1)(1991-3#1)(1991-6#2)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#30)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-8#2)(2010-1#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
at budbreak##2##2##(2008-10#2)
at ca##3##2##(2008-10#2)(2008-11#1)
at carbon nanotube##2##3##(2008-10#2)
at carbon paste electrode##3##4##(2008-10#3)
at carbon paste##4##3##(2008-10#4)
at carbon##10##2##(2008-10#9)(2010-6#1)
at cell densities of 5##2##5##(2008-10#1)(2008-7#1)
at cell-cell##2##2##(2009-8#2)
at cellular and##2##3##(2008-5#1)(2008-9#1)
at certain##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
at chain##2##2##(1997-6#1)(2008-10#1)
at chance##2##2##(1993-3#1)(1996-2#1)
at chromosomal##2##2##(2008-11#1)(2011-2#1)
at chromosome##3##2##(1995-6#1)(1996-12#2)
at clinical follow-up##2##3##(2011-1#2)
at clinical level##2##3##(2008-11#2)
at clinical##7##2##(2008-11#2)(2008-12#1)(2008-7#1)(2011-1#2)(2013-1#1)
at close##2##2##(2008-10#1)(2008-9#1)
at codon##2##2##(1992-8#1)(1993-11#1)
at collapsed replication forks##2##4##(2012-3#2)
at comparable levels of##2##4##(1993-11#1)(2009-4#1)
at comparable##4##2##(1993-11#1)(1995-8#1)(2009-4#1)(2011-7#1)
at concentration levels between##3##4##(2008-10#3)
at concentration levels from##2##4##(2008-10#2)
at concentration levels##9##3##(2008-10#9)
at concentration of##4##3##(2008-10#2)(2008-12#1)(2012-2#1)
at concentration##18##2##(1995-8#1)(2008-10#15)(2008-12#1)(2012-2#1)
at concentrations &gt##2##3##(1994-8#1)(2008-10#1)
at concentrations above 1##2##4##(2008-10#1)(2008-9#1)
at concentrations above##4##3##(1994-6#1)(2008-10#2)(2008-9#1)
at concentrations as high as 200##2##6##(2008-10#1)(2012-2#1)
at concentrations as high as##5##5##(2008-10#1)(2008-11#3)(2012-2#1)
at concentrations as low as 0##3##6##(2008-10#1)(2008-11#2)
at concentrations as low as##6##5##(2008-10#4)(2008-11#2)
at concentrations as##11##3##(2008-10#5)(2008-11#5)(2012-2#1)
at concentrations below##3##3##(2008-10#2)(2012-12#1)
at concentrations between 0##2##4##(2008-10#2)
at concentrations between##4##3##(2008-10#4)
at concentrations from 0##2##4##(1993-6#2)
at concentrations greater than##2##4##(2008-10#1)(2008-5#1)
at concentrations higher than##2##4##(1991-5#1)(2008-11#1)
at concentrations in the##2##4##(2008-11#1)(2008-5#1)
at concentrations lower##2##3##(2008-10#2)
at concentrations of 0##2##4##(2008-10#1)(2008-9#1)
at concentrations of##13##3##(1990-2#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-9#1)
at concentrations ranging from##2##4##(2008-10#1)(2008-11#1)
at concentrations that##6##3##(1995-2#1)(2008-10#3)(2011-1#1)(2011-3#1)
at concentrations up to##3##4##(2008-10#3)
at concentrations##69##2##(1990-2#1)(1991-2#1)(1991-5#2)(1993-6#3)(1994-6#1)(1994-8#1)(1995-2#1)(2008-10#40)(2008-11#9)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
at conception##2##2##(2008-10#1)(2010-12#1)
at conducting and electrogenerated polymer modified electrodes##2##7##(2008-10#2)
at conducting##3##2##(2008-10#3)
at conserved##3##2##(1993-12#1)(1995-8#1)(2010-5#1)
at considerably##2##2##(2008-10#1)(2009-10#1)
at constant pH##2##3##(2008-10#1)(2008-11#1)
at constant temperatures##2##3##(2008-10#2)
at constant total volume##2##4##(2008-10#2)
at constant##14##2##(2008-10#12)(2008-11#1)(2011-2#1)
at contributing to##2##3##(2009-12#1)(2011-2#1)
at controlling##4##2##(1993-3#1)(2008-10#1)(2009-12#1)(2010-11#1)
at cool temperatures##2##3##(2008-10#1)(2008-8#1)
at critical##2##2##(1994-12#1)(2008-4#1)
at crop anthesis##2##3##(2008-10#2)
at day 1##3##3##(2010-6#2)(2013-1#1)
at day##10##2##(1993-8#2)(2008-10#2)(2008-11#1)(2010-6#2)(2011-1#1)(2013-1#2)
at days 14 and 21 p##5##6##(2008-5#5)
at days##8##2##(2008-5#5)(2008-7#1)(2010-6#2)
at defined time points##2##4##(2012-2#1)(2012-3#1)
at densities##2##2##(2008-10#2)
at depths of 0 to##2##5##(2008-10#2)
at depths of##5##3##(2008-10#4)(2013-8#1)
at depths##7##2##(2008-10#5)(2013-8#2)
at developing##4##2##(1996-3#1)(2008-10#2)(2008-12#1)
at diagnosis and##2##3##(1990-12#1)(1992-12#1)
at diagnosis was##3##3##(1990-12#1)(2008-7#1)(2011-2#1)
at diagnosis##18##2##(1990-12#5)(1990-8#1)(1991-6#2)(1992-12#1)(1993-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
at different ages##8##3##(1990-5#1)(1993-12#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-7#2)(2008-9#1)
at different concentrations to##2##4##(2008-10#2)
at different concentrations##6##3##(2008-10#4)(2008-11#2)
at different developmental stages##4##4##(1993-3#1)(2007-12#1)(2008-11#1)(2011-2#1)
at different doses##2##3##(2008-10#1)(2008-9#1)
at different electrodes##2##3##(2008-10#2)
at different experimental conditions##2##4##(2008-10#2)
at different growth stages##2##4##(2008-10#2)
at different incubation##2##3##(2008-10#1)(2011-2#1)
at different ionic strengths in##2##5##(2008-10#2)
at different ionic strengths##5##4##(1994-5#1)(2008-10#4)
at different levels of##4##4##(2008-10#2)(2008-11#2)
at different levels##9##3##(2008-10#3)(2008-11#2)(2008-8#1)(2009-10#1)(2009-7#1)(2013-1#1)
at different locations in##3##4##(2008-10#2)(2008-5#1)
at different locations##5##3##(1997-3#1)(2008-10#3)(2008-5#1)
at different pH values##7##4##(1994-11#2)(2008-10#4)(2008-5#1)
at different pH##13##3##(1994-11#2)(2008-10#9)(2008-5#2)
at different phases of the cell cycle##2##7##(2008-11#2)
at different rates##2##3##(1996-2#1)(2008-10#1)
at different scales##3##3##(2008-8#2)(2010-7#1)
at different spatial scales##2##4##(2008-8#2)
at different stages of the##4##5##(1993-9#1)(2008-10#1)(2008-8#1)(2009-10#1)
at different stages of their development##2##6##(2009-10#1)(2009-8#1)
at different stages of##11##4##(1990-5#1)(1993-9#1)(1995-12#1)(2008-10#2)(2008-8#2)(2009-10#2)(2009-6#1)(2009-8#1)
at different stages##17##3##(1990-5#1)(1993-9#1)(1995-12#1)(2008-10#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-5#1)
at different temperature and##2##4##(2008-10#2)
at different temperature##3##3##(2008-10#3)
at different temperatures and##6##4##(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
at different temperatures##16##3##(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
at different time intervals##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
at different time##7##3##(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
at different times after##2##4##(1994-5#1)(2008-10#1)
at different times during##2##4##(2008-10#1)(2008-8#1)
at different times##12##3##(1994-5#1)(1994-8#1)(1997-3#1)(2008-10#5)(2008-8#2)(2008-9#1)(2011-2#1)
at different wavelengths##3##3##(1990-8#1)(2008-10#1)(2008-4#1)
at different##194##2##(1990-5#3)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#2)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#85)(2008-11#10)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#13)(2008-9#6)(2009-10#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#7)(2011-3#2)(2012-2#3)(2012-3#3)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#3)
at dilution rates##2##3##(2008-11#1)(2008-7#1)
at discharge##8##2##(1990-2#1)(1991-2#2)(2009-3#1)(2011-2#4)
at discrete##2##2##(2008-10#1)(2008-8#1)
at disease onset##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
at disease##5##2##(2008-10#2)(2012-12#1)(2012-3#1)(2013-8#1)
at disproportionately higher concentrations in humans than in##2##8##(2010-11#2)
at distances of##3##3##(1995-2#1)(2008-10#2)
at dose levels of##2##4##(1994-5#1)(2010-1#1)
at dose##3##2##(1994-5#1)(2009-2#1)(2010-1#1)
at doses of 0##2##4##(1995-11#2)
at doses of up to 10##2##6##(1992-11#1)(2008-5#1)
at doses of##9##3##(1992-11#1)(1992-6#2)(1995-11#2)(1995-2#1)(2008-5#2)(2012-2#1)
at doses that did not##2##5##(1996-2#1)(2008-5#1)
at doses that##3##3##(1996-12#1)(1996-2#1)(2008-5#1)
at doses##19##2##(1990-5#1)(1992-11#1)(1992-6#2)(1994-8#1)(1995-11#2)(1995-2#2)(1996-12#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2012-2#1)
at each level##2##3##(1996-3#1)(2008-8#1)
at each location##2##3##(2008-10#2)
at each of the three##2##5##(2008-11#1)(2013-8#1)
at each of the##5##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
at each of three##2##4##(2008-10#2)
at each of##9##3##(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
at each position##2##3##(2008-10#1)(2008-9#1)
at each stage of##3##4##(2008-12#1)(2008-4#1)(2013-8#1)
at each stage##4##3##(2008-12#2)(2008-4#1)(2013-8#1)
at each step##3##3##(1994-1#1)(2008-10#1)(2008-11#1)
at each time point##3##4##(2011-10#1)(2011-2#1)(2012-2#1)
at each##51##2##(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-10#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#3)
at earlier time points##3##4##(1997-2#1)(2008-10#1)(2012-4#1)
at earlier##6##2##(1993-6#2)(1997-2#1)(2008-10#1)(2011-2#1)(2012-4#1)
at early and late##4##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
at early stages of##3##4##(2007-8#1)(2008-10#2)
at early##13##2##(1997-3#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2012-4#1)
at eight##2##2##(2008-10#1)(2008-8#1)
at either end of the##2##5##(2008-3#1)(2008-8#1)
at either end##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
at either the##2##3##(1990-5#1)(2008-4#1)
at either##17##2##(1990-5#1)(1995-11#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2013-8#1)
at ejaculation/orgasm##2##2##(2010-11#2)
at elevated iron##2##3##(2008-10#2)
at elevated levels in##2##4##(1991-9#1)(2008-10#1)
at elevated temperatures##7##3##(1990-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
at elevated##15##2##(1990-5#1)(1991-9#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#2)
at encouraging##2##2##(1997-3#1)(2010-10#1)
at end of##2##3##(2009-11#1)(2011-2#1)
at end##3##2##(1996-2#1)(2009-11#1)(2011-2#1)
at entry##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
at equal##3##2##(2008-10#2)(2008-8#1)
at equilibrium##9##2##(1990-8#1)(2008-10#2)(2008-12#2)(2008-8#3)(2008-9#1)
at equivalent levels##3##3##(1995-11#1)(2008-11#1)(2013-1#1)
at equivalent##5##2##(1995-11#1)(1996-1#1)(2008-11#1)(2008-8#1)(2013-1#1)
at establishing##2##2##(2008-10#1)(2010-12#1)
at estimating##2##2##(2008-7#1)(2013-8#1)
at evaluating the##4##3##(2008-10#1)(2008-5#2)(2012-4#1)
at evaluating##5##2##(2008-10#1)(2008-5#2)(2011-2#1)(2012-4#1)
at every##5##2##(1993-12#1)(1997-2#1)(2008-10#2)(2012-2#1)
at expression rates##2##3##(2008-11#2)
at expression##3##2##(2008-11#3)
at extremely low##2##3##(2008-10#1)(2008-11#1)
at extremely##3##2##(2008-10#2)(2008-11#1)
at fast##2##2##(1992-2#1)(2008-9#1)
at femtogram levels##2##3##(2008-10#2)
at femtomolar concentrations##2##3##(2008-10#1)(2010-1#1)
at fertilization##4##2##(1994-5#1)(2008-6#1)(2009-12#1)(2013-1#1)
at finding##3##2##(1994-6#1)(2008-6#1)(2013-8#1)
at first attempt in all the patients within##2##8##(2010-7#2)
at first birth##3##3##(2009-5#3)
at first glance##2##3##(1995-12#1)(2013-8#1)
at first intercourse was significantly associated with##2##7##(1990-9#2)
at first intercourse was##3##4##(1990-9#3)
at first intercourse##6##3##(1990-9#6)
at first##30##2##(1990-6#1)(1990-9#6)(1991-6#1)(1992-1#1)(1992-5#1)(1995-12#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#5)(2008-7#1)(2008-8#1)(2009-5#3)(2010-7#3)(2011-2#1)(2013-8#1)
at five Canadian pediatric##2##4##(1993-6#1)(2010-7#1)
at five different##2##3##(2008-12#1)(2012-5#1)
at five years##2##3##(1996-11#1)(2012-3#1)
at five##14##2##(1993-6#1)(1996-11#1)(2008-10#3)(2008-12#2)(2008-6#1)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
at fixed##4##2##(1995-3#1)(2008-10#3)
at flow rate of##2##4##(2008-10#2)
at flow rate##3##3##(2008-10#3)
at flow rates##2##3##(1996-2#1)(2008-10#1)
at flow##6##2##(1996-2#1)(2008-10#5)
at flow-rate of##2##3##(2008-10#2)
at flowering##5##2##(2008-10#3)(2012-3#1)(2013-8#1)
at follow up##2##3##(1997-6#1)(2011-2#1)
at follow-up for##2##3##(1990-6#1)(1993-11#1)
at follow-up##14##2##(1990-11#1)(1990-6#1)(1993-11#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-11#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-5#2)(2013-8#1)
at follow-ups of 4 to##2##5##(2012-12#2)
at four and five weeks)##2##5##(2012-2#2)
at four concentration levels##2##4##(2008-10#1)(2008-5#1)
at four different##5##3##(2008-10#4)(2013-1#1)
at four locations##2##3##(2008-10#2)
at four points in time##2##5##(2008-12#1)(2010-5#1)
at four sites##2##3##(1992-3#1)(2008-11#1)
at four##32##2##(1992-3#1)(1994-3#1)(1996-3#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-2#3)(2013-1#1)(2013-3#1)
at fragile sites##3##3##(2011-2#3)
at frequencies##2##2##(2008-10#2)
at frequent time##2##3##(2008-10#1)(2011-2#1)
at full bloom##2##3##(2008-10#2)
at full##6##2##(1996-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-6#1)
at gathering##2##2##(1995-12#1)(2011-2#1)
at gene##2##2##(1995-9#1)(2008-11#1)
at genetic##2##2##(1996-6#1)(2012-3#1)
at gestational##2##2##(1995-11#1)(1996-11#1)
at glassy carbon##2##3##(2008-10#2)
at gold electrode##2##3##(2008-10#2)
at gold##6##2##(2008-10#6)
at great##2##2##(2008-12#1)(2010-11#1)
at greater risk for##2##4##(2008-11#2)
at greater risk##6##3##(1996-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)
at greater than##4##3##(1992-3#1)(2008-10#1)(2008-5#1)(2010-11#1)
at greater##11##2##(1992-3#1)(1993-1#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)
at greatest risk##2##3##(2008-7#1)(2013-8#1)
at habitat##2##2##(2008-8#1)(2013-1#1)
at half the##2##3##(2008-10#1)(2008-3#1)
at hand##6##2##(1997-1#1)(1997-3#1)(2008-11#2)(2008-4#1)(2010-3#1)
at harvest and after##2##4##(2008-10#2)
at harvest##11##2##(2008-10#10)(2008-7#1)
at healthcare##2##2##(1993-2#1)(1995-1#1)
at high RH (96%)##2##4##(2008-10#2)
at high RH##3##3##(2008-10#3)
at high cell densities of##2##5##(2008-11#1)(2008-7#1)
at high concentration##3##3##(1996-2#1)(2008-11#1)(2008-9#1)
at high concentrations##11##3##(1992-12#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
at high doses of##2##4##(2008-11#1)(2008-7#1)
at high doses##5##3##(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#1)
at high field##2##3##(1996-2#1)(1997-6#1)
at high frequencies##2##3##(2008-10#2)
at high frequency##5##3##(2008-8#2)(2008-9#2)(2010-1#1)
at high level##2##3##(2008-10#1)(2008-11#1)
at high levels in##6##4##(1992-10#1)(1994-11#1)(1995-2#2)(1996-2#1)(2008-1#1)
at high levels##10##3##(1992-10#1)(1993-9#1)(1994-11#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#1)
at high pH##5##3##(1991-9#1)(1992-9#1)(1995-6#1)(2008-10#2)
at high pressure and##2##4##(1995-6#2)
at high pressure##3##3##(1995-6#2)(1996-2#1)
at high risk for##6##4##(1992-9#1)(1995-1#1)(2008-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
at high risk of acute##2##5##(2009-12#1)(2013-1#1)
at high risk of##9##4##(1990-2#1)(1992-5#1)(1993-1#1)(2008-11#1)(2008-7#1)(2009-12#2)(2011-2#1)(2013-1#1)
at high risk##18##3##(1990-2#1)(1992-5#2)(1992-9#1)(1993-1#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-10#2)(2011-2#2)(2013-1#2)
at high salt concentrations##3##4##(1990-5#1)(2008-10#1)(2011-2#1)
at high salt##4##3##(1990-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
at high social##2##3##(1993-3#2)
at high speed##2##3##(2008-3#1)(2008-7#1)
at high temperature with hydrochloric acid##2##6##(2008-10#2)
at high temperature##4##3##(2008-10#4)
at high temperatures (25##2##4##(2008-10#2)
at high temperatures##6##3##(1995-3#1)(2008-10#4)(2008-8#1)
at high##129##2##(1990-2#1)(1990-5#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-9#2)(1994-11#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#3)(1996-12#2)(1996-2#4)(1997-2#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#38)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#10)(2008-8#5)(2008-9#4)(2009-12#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-7#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)
at higher concentrations##7##3##(1993-3#1)(2008-10#4)(2008-11#1)(2008-8#1)
at higher dose##2##3##(1994-5#1)(2011-1#1)
at higher doses##3##3##(1993-1#1)(1997-2#1)(2011-1#1)
at higher flow rates##2##4##(2008-10#1)(2008-7#1)
at higher frequencies##2##3##(1993-8#1)(2008-10#1)
at higher levels##4##3##(1994-1#1)(1996-12#1)(2008-10#1)(2008-12#1)
at higher pH##2##3##(2008-10#2)
at higher risk for##3##4##(1992-2#1)(1993-1#1)(2007-11#1)
at higher risk of##2##4##(2009-5#1)(2012-3#1)
at higher risk##7##3##(1992-2#2)(1993-1#1)(2006-5#1)(2007-11#1)(2009-5#1)(2012-3#1)
at higher temperatures##9##3##(2008-10#8)(2008-6#1)
at higher values##3##3##(2008-10#3)
at higher##77##2##(1991-2#1)(1992-2#2)(1993-1#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-5#1)(1996-12#1)(1997-2#2)(2006-5#1)(2007-11#1)(2008-10#30)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-5#3)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#2)
at highest risk of##2##4##(1996-5#1)(2011-2#1)
at highest risk##4##3##(1996-5#1)(2009-5#1)(2010-9#1)(2011-2#1)
at his hospital##3##3##(1991-1#1)(1993-12#1)(1994-2#1)
at his##6##2##(1991-1#2)(1993-12#1)(1994-2#1)(2008-12#1)(2010-8#1)
at home and##3##3##(1991-8#1)(1996-11#1)(2011-2#1)
at home with##2##3##(1992-3#1)(2010-5#1)
at home##33##2##(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#3)(1994-6#1)(1995-2#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#3)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-2#1)
at hospitals##6##2##(1990-3#1)(1994-3#1)(1995-2#2)(2008-11#1)(2011-2#1)
at hours##2##2##(1994-3#1)(2013-8#1)
at http##7##2##(1997-6#1)(1997-8#1)(2008-1#1)(2008-3#1)(2009-2#1)(2009-3#1)(2011-2#1)
at identical##2##2##(1993-6#1)(2008-5#1)
at identifying##5##2##(2008-10#1)(2008-5#1)(2009-1#1)(2010-10#1)(2013-8#1)
at impact##4##2##(2011-2#4)
at improving##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
at in situ##2##3##(2008-10#2)
at in##4##2##(1997-8#1)(2008-10#2)(2009-7#1)
at increased risk for##9##4##(1994-12#1)(2008-10#1)(2008-11#5)(2008-8#1)(2011-2#1)
at increased risk##16##3##(1994-12#1)(2006-5#1)(2008-10#1)(2008-11#6)(2008-8#1)(2010-12#1)(2011-2#3)(2012-3#2)
at increased##19##2##(1992-1#1)(1992-9#1)(1994-12#1)(2006-5#1)(2008-10#1)(2008-11#7)(2008-8#1)(2010-12#1)(2011-2#3)(2012-3#2)
at increasing doses##2##3##(1991-6#1)(2011-2#1)
at increasing##6##2##(1991-6#1)(1994-8#1)(1997-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
at individual boutons##2##3##(1997-7#2)
at individual##5##2##(1997-7#2)(1997-9#1)(2008-10#1)(2010-10#1)
at inducing##2##2##(2008-10#1)(2013-8#1)
at industrial##2##2##(2008-11#1)(2011-2#1)
at infection##2##2##(2008-10#1)(2008-11#1)
at infinite##2##2##(1993-8#1)(2008-10#1)
at inhibiting the growth##2##4##(2008-10#1)(2008-11#1)
at inhibiting##6##2##(1992-3#1)(1992-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
at initial##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
at inoculation##11##2##(2008-10#10)(2008-5#1)
at intake##3##2##(2009-11#1)(2013-8#2)
at intermediate levels of##2##4##(2008-8#2)
at intermediate##9##2##(1993-8#1)(2008-10#1)(2008-8#3)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
at interphase##2##2##(1990-3#2)
at intervals of##8##3##(1994-2#1)(1997-2#1)(2008-10#5)(2011-1#1)
at intervals##13##2##(1991-2#1)(1994-2#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
at ionic strength##2##3##(1995-2#1)(2008-10#1)
at its C-terminus##3##3##(1996-6#1)(2008-11#1)(2011-2#1)
at its second##2##3##(2007-12#1)(2008-8#1)
at its##34##2##(1991-12#1)(1993-2#1)(1994-5#2)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#4)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-8#1)
at known##2##2##(1995-8#1)(2008-10#1)
at lambda##4##2##(1994-5#2)(2008-10#1)(2008-3#1)
at lambda(max)##6##2##(2008-10#4)(2008-5#1)(2008-9#1)
at laparoscopy##2##2##(2008-10#2)
at large##14##2##(1992-12#1)(1992-2#2)(1993-12#1)(1994-2#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-2#1)
at larger distances##2##3##(2008-3#2)
at larger##3##2##(2008-3#2)(2010-8#1)
at last##5##2##(1992-12#1)(1996-3#1)(2008-10#2)(2011-2#1)
at late##6##2##(1990-6#1)(2008-10#3)(2009-8#1)(2010-4#1)
at later time points##2##4##(1993-11#1)(2008-8#1)
at later##5##2##(1993-11#1)(2008-10#2)(2008-8#1)(2010-8#1)
at least 1 month##2##4##(2008-10#2)
at least 1##10##3##(1990-6#1)(1994-12#1)(2008-10#6)(2008-8#1)(2013-1#1)
at least 1% of##2##4##(1993-12#1)(2008-11#1)
at least 10 times##2##4##(2008-10#1)(2008-7#1)
at least 10##6##3##(2008-10#3)(2008-7#2)(2010-12#1)
at least 100##5##3##(2008-10#4)(2008-7#1)
at least 12##2##3##(2008-10#2)
at least 15##3##3##(1990-12#1)(1994-3#1)(2008-11#1)
at least 150##2##3##(2010-8#1)(2011-2#1)
at least 18##3##3##(2008-10#2)(2012-2#1)
at least 2##12##3##(1996-12#1)(2008-10#9)(2008-11#1)(2011-2#1)
at least 20##5##3##(1991-12#1)(1995-12#1)(2008-10#2)(2008-6#1)
at least 20%##2##3##(1996-3#1)(2008-11#1)
at least 24##4##3##(1992-6#1)(1993-3#1)(1995-12#1)(2008-10#1)
at least 3 months##13##4##(2008-10#12)(2008-8#1)
at least 3 of##2##4##(2012-12#1)(2013-1#1)
at least 3##21##3##(2008-10#12)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
at least 30 days##2##4##(1995-2#1)(2011-2#1)
at least 30##4##3##(1991-6#1)(1995-2#1)(2008-2#1)(2011-2#1)
at least 35%##2##3##(2008-10#2)
at least 4##7##3##(1990-12#1)(1994-3#1)(1997-3#1)(2008-10#2)(2012-12#1)(2013-1#1)
at least 40 days##2##4##(2008-10#2)
at least 40##4##3##(1994-11#1)(2008-10#2)(2008-7#1)
at least 5 days##2##4##(2008-10#1)(2008-5#1)
at least 5##9##3##(1990-5#1)(1994-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
at least 50##3##3##(2008-10#2)(2008-11#1)
at least 50%##2##3##(2008-10#1)(2011-2#1)
at least 6 months and##2##5##(1990-12#1)(2008-10#1)
at least 6 months##8##4##(1990-12#1)(1991-8#1)(1995-2#1)(1996-1#1)(2008-10#3)(2008-8#1)
at least 6##12##3##(1990-12#1)(1990-9#1)(1991-8#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-8#1)
at least 60##2##3##(2008-10#1)(2011-2#1)
at least 90##4##3##(1996-12#1)(2008-10#3)
at least a##7##3##(1991-3#1)(1993-8#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
at least an order of magnitude##2##6##(2008-10#1)(2008-3#1)
at least an##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2010-11#1)
at least as good as##4##5##(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
at least as good##5##4##(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
at least as##9##3##(1993-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
at least at##3##3##(1991-3#1)(2008-11#1)(2013-8#1)
at least eight##2##3##(2008-10#1)(2008-8#1)
at least five##7##3##(1993-6#1)(2008-10#3)(2010-8#1)(2011-1#1)(2012-12#1)
at least for 3 months##2##5##(2008-10#2)
at least for##13##3##(1996-3#1)(2008-10#5)(2008-3#1)(2009-10#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
at least four##8##3##(1993-9#1)(1995-6#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)
at least in part##30##4##(1990-8#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-8#3)(2011-2#3)(2012-2#1)
at least in the context of##2##6##(2008-10#1)(2012-2#1)
at least in the##6##4##(2008-10#2)(2008-11#1)(2010-4#1)(2012-2#2)
at least in those##2##4##(2008-10#1)(2011-2#1)
at least in##44##3##(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-5#2)(2008-8#3)(2010-4#1)(2011-2#4)(2012-2#4)
at least nine##7##3##(1993-8#1)(1995-2#1)(2008-10#4)(2011-1#1)
at least once a week##3##5##(2009-3#1)(2010-11#1)(2011-2#1)
at least once a##4##4##(1991-9#1)(2009-3#1)(2010-11#1)(2011-2#1)
at least once##7##3##(1991-9#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#1)
at least one 24-hour quit attempt##2##6##(2013-1#2)
at least one criterion##2##4##(1993-8#2)
at least one month##2##4##(1996-3#1)(1997-8#1)
at least one of the##6##5##(1993-2#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
at least one of##7##4##(1993-2#1)(2008-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
at least one other##3##4##(1990-11#1)(1994-6#1)(2013-8#1)
at least one year##4##4##(2008-11#2)(2010-2#1)(2011-1#1)
at least one##79##3##(1990-11#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-6#2)(1995-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2008-10#16)(2008-11#8)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#1)
at least part of the##3##5##(1994-6#1)(2008-10#2)
at least part of##4##4##(1991-5#1)(1994-6#1)(2008-10#2)
at least partially##7##3##(1993-1#1)(1993-12#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-7#1)
at least partly##8##3##(1994-8#2)(1997-7#1)(2008-10#3)(2009-10#1)(2012-2#1)
at least seven##2##3##(2008-10#1)(2008-12#1)
at least several##2##3##(2008-10#2)
at least similar##2##3##(2008-11#1)(2012-12#1)
at least six##4##3##(2008-10#2)(2008-7#1)(2013-8#1)
at least some of the##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
at least some of these##2##5##(2008-10#1)(2008-11#1)
at least some of##6##4##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)
at least some specific##2##4##(1990-6#1)(1995-9#1)
at least some##19##3##(1990-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
at least the##7##3##(1990-11#1)(1994-12#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-8#1)
at least three different##4##4##(1995-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
at least three distinct##3##4##(1994-5#1)(2008-10#1)(2008-5#1)
at least three major##2##4##(2011-2#2)
at least three times##8##4##(1991-2#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)
at least three##29##3##(1991-2#2)(1993-6#1)(1994-5#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-3#1)
at least twice as##2##4##(2008-11#1)(2008-5#1)
at least twice##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
at least two different##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
at least two distinct##2##4##(1990-8#1)(2010-10#1)
at least two genes##3##4##(2008-10#2)(2009-10#1)
at least two groups##2##4##(2008-10#2)
at least two months##3##4##(2008-10#2)(2008-6#1)
at least two of these##2##5##(1997-8#1)(2008-7#1)
at least two of##3##4##(1997-8#1)(2008-7#1)(2012-3#1)
at least two orders of magnitude##2##6##(2008-10#2)
at least two##51##3##(1990-12#1)(1990-5#1)(1990-8#1)(1992-10#2)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#15)(2008-11#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#2)(2011-2#2)(2012-2#3)(2012-3#2)
at least when##2##3##(1992-3#1)(2008-10#1)
at least within the##2##4##(2008-11#1)(2010-8#1)
at least within##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
at least##559##2##(1990-11#2)(1990-12#4)(1990-5#4)(1990-6#3)(1990-8#4)(1990-9#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#2)(1992-10#2)(1992-2#1)(1992-3#3)(1992-6#2)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#5)(1993-8#8)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#6)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#3)(1997-1#3)(1997-2#3)(1997-3#5)(1997-6#3)(1997-7#3)(1997-8#5)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#172)(2008-11#41)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#13)(2008-6#6)(2008-7#18)(2008-8#15)(2008-9#9)(2009-10#4)(2009-3#2)(2009-6#3)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#5)(2011-2#26)(2012-12#9)(2012-2#12)(2012-3#9)(2012-4#1)(2012-5#1)(2013-1#18)(2013-8#5)
at less than##4##3##(2008-10#3)(2008-11#1)
at less##6##2##(2008-10#5)(2008-11#1)
at level##3##2##(2008-10#2)(2008-11#1)
at levels above##3##3##(1996-1#1)(2008-10#2)
at levels as low as##2##5##(2008-10#2)
at levels greater than##2##4##(2008-10#1)(2008-11#1)
at levels near the detection limits up to at least##4##10##(2008-10#4)
at levels near the detection limits##5##6##(2008-10#5)
at levels observed in##2##4##(2008-10#2)
at levels of 0##4##4##(2008-10#3)(2012-2#1)
at levels of##10##3##(2008-10#7)(2008-11#1)(2012-2#2)
at levels up to##2##4##(2008-10#1)(2011-2#1)
at levels which could be##2##5##(1993-9#1)(2008-10#1)
at levels##38##2##(1991-5#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-1#1)(2008-10#25)(2008-11#3)(2011-2#1)(2012-2#2)
at light##2##2##(2008-10#2)
at limiting##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
at local and regional scales##3##5##(2008-8#3)
at local##7##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#3)(2012-12#1)
at locations in##2##3##(2008-10#2)
at locations##3##2##(2008-10#3)
at long##2##2##(1997-2#1)(2008-10#1)
at longer##2##2##(1995-11#1)(2008-12#1)
at low CBS concentrations##3##4##(1993-8#3)
at low and high##5##4##(1991-9#1)(1992-3#1)(1995-12#1)(2008-10#1)(2008-11#1)
at low concentration levels##2##4##(2008-10#2)
at low concentration of##2##4##(1996-2#1)(2008-10#1)
at low concentration##11##3##(1996-2#1)(2008-10#6)(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
at low concentrations (0##2##4##(2006-6#1)(2008-10#1)
at low concentrations by##2##4##(2008-10#2)
at low concentrations in##2##4##(2008-10#1)(2008-12#1)
at low concentrations##20##3##(1992-7#1)(1994-8#1)(1997-1#1)(2006-6#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-7#1)
at low cost##2##3##(2008-3#1)(2008-8#1)
at low dose##2##3##(2008-7#1)(2012-2#1)
at low doses of##4##4##(2008-7#4)
at low doses##5##3##(1994-8#1)(2008-7#4)
at low dye##2##3##(2008-3#1)(2010-4#1)
at low enzyme##2##3##(2011-2#2)
at low frequencies##4##3##(2008-10#3)(2008-9#1)
at low level during##2##4##(1993-9#1)(2008-8#1)
at low levels in a##2##5##(2008-10#1)(2008-6#1)
at low levels in##5##4##(1993-2#1)(2008-10#3)(2008-6#1)
at low levels##10##3##(1993-2#1)(1993-6#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-6#1)(2008-7#1)
at low or high##2##4##(2008-11#1)(2008-9#1)
at low or##3##3##(2008-11#1)(2008-9#1)(2010-12#1)
at low pH (D)##2##4##(1991-9#2)
at low pH##13##3##(1990-5#1)(1990-8#2)(1991-9#2)(1993-8#2)(1994-8#1)(2008-10#4)(2010-4#1)
at low population##2##3##(2008-10#1)(2008-8#1)
at low potentials##2##3##(2008-10#2)
at low risk of##2##4##(2008-10#1)(2010-7#1)
at low risk##3##3##(2008-10#2)(2010-7#1)
at low room##2##3##(1996-1#1)(2008-5#1)
at low temperature##8##3##(1993-6#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)
at low temperatures##7##3##(1993-8#2)(2008-10#3)(2008-3#1)(2008-8#1)
at low##148##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-9#3)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-8#11)(1993-9#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#50)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#3)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-7#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
at lower and higher temperatures##2##5##(2008-10#2)
at lower concentrations##6##3##(1997-2#1)(2008-10#4)(2008-8#1)
at lower doses##4##3##(1990-11#1)(1991-10#1)(1997-2#1)(2008-7#1)
at lower levels##3##3##(1992-10#1)(2008-10#1)(2012-2#1)
at lower rates##2##3##(2008-10#1)(2008-6#1)
at lower temperatures##3##3##(2008-10#1)(2008-9#2)
at lower##41##2##(1990-11#1)(1991-10#1)(1992-10#1)(1994-12#1)(1997-2#2)(2008-10#22)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-4#2)(2012-2#1)
at m/z##4##2##(2008-10#3)(2008-11#1)
at mRNA level##2##3##(1993-8#2)
at mRNA##3##2##(1993-8#2)(2013-8#1)
at major##2##2##(1993-3#1)(2010-5#1)
at maturity and##6##3##(2008-8#2)(2008-9#4)
at maturity##11##2##(2008-10#2)(2008-8#3)(2008-9#6)
at maximum##7##2##(2008-10#6)(2010-10#1)
at medical##2##2##(1994-2#1)(2009-5#1)
at membrane##3##2##(1991-5#1)(1994-11#1)(2008-10#1)
at mercury##4##2##(2008-10#4)
at microdisk gold##2##3##(2008-10#2)
at micromolar##2##2##(2008-10#1)(2008-11#1)
at mild##2##2##(2008-9#2)
at minimal##2##2##(2008-11#2)
at mitochondria and##2##3##(2008-9#1)(2011-2#1)
at mitochondria##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
at moderate##4##2##(1994-9#1)(2008-10#2)(2008-5#1)
at monitoring sites##2##3##(2008-10#2)
at monitoring##3##2##(2008-10#2)(2008-11#1)
at more negative potentials##2##4##(2008-10#2)
at more##7##2##(1990-5#1)(1995-12#1)(2008-10#3)(2008-11#1)(2011-1#1)
at most 2##2##3##(2008-10#1)(2008-11#1)
at most##7##2##(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#1)
at much lower levels##2##4##(1995-2#1)(2008-11#1)
at much lower##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
at much slower rates##2##4##(1992-2#1)(2008-6#1)
at much##6##2##(1992-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
at mug l(-1)##2##3##(2008-10#2)
at multiple APs##2##3##(2008-10#2)
at multiple sites##5##3##(2008-10#5)
at multiple##19##2##(1992-12#1)(1993-9#1)(2008-10#11)(2008-2#1)(2008-9#1)(2009-12#1)(2010-4#2)(2010-7#1)
at nanogram levels by##2##4##(2008-10#2)
at nanogram per milliliter##2##4##(2008-10#2)
at nanogram##5##2##(2008-10#5)
at nanomolar##2##2##(2008-10#1)(2012-2#1)
at national##2##2##(2008-10#1)(2008-11#1)
at near##4##2##(1995-6#1)(2008-10#1)(2008-3#1)(2010-1#1)
at near-neutral pH##2##3##(2010-4#2)
at nearly##2##2##(1993-9#1)(2008-10#1)
at neutral pH and##2##4##(1994-5#1)(2008-10#1)
at neutral pH##11##3##(1993-8#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-10#1)
at neutral##14##2##(1993-8#1)(1994-5#1)(2008-10#8)(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#1)
at ng##2##2##(2008-10#2)
at ng/g levels##2##3##(1997-2#2)
at night##12##2##(1990-5#1)(1992-5#1)(1997-4#2)(1997-6#1)(2008-10#2)(2008-12#2)(2008-5#2)(2009-3#1)
at nine different##3##3##(2008-10#2)(2008-3#1)
at nine##5##2##(2008-10#4)(2008-3#1)
at normal##6##2##(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(2008-10#1)(2010-4#1)
at novel##2##2##(1993-2#1)(1995-6#1)
at nuclear##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
at nucleotide position##6##3##(1993-3#1)(1994-11#2)(2008-10#1)(2008-11#2)
at nucleotide##12##2##(1990-7#1)(1993-3#1)(1994-11#4)(1997-3#1)(2008-10#2)(2008-11#2)(2012-3#1)
at nucleotides##2##2##(2008-10#2)
at nutrition risk##2##3##(1992-12#2)
at oblique##2##2##(1990-11#1)(2008-3#1)
at obtaining##2##2##(2008-7#1)(2009-10#1)
at older ages##2##3##(1992-6#2)
at older##3##2##(1992-6#2)(1993-12#1)
at once##7##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)
at one and##2##3##(1997-8#1)(2010-10#1)
at one end to##2##4##(2008-10#1)(2008-7#1)
at one end##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
at one location##2##3##(2008-10#2)
at one of five##2##4##(2008-10#1)(2008-4#1)
at one of the##2##4##(1996-2#1)(2008-10#1)
at one of##4##3##(1996-2#1)(2008-10#2)(2008-4#1)
at one site##2##3##(1990-11#1)(2008-10#1)
at one time##2##3##(2008-10#1)(2008-8#1)
at one year##5##3##(1991-6#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
at one##42##2##(1990-11#1)(1991-6#1)(1993-3#1)(1995-5#1)(1996-2#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#2)(2012-12#1)(2012-3#2)(2013-1#3)
at only two##2##3##(2008-10#1)(2008-3#1)
at onset of##2##3##(2008-9#1)(2011-2#1)
at onset##4##2##(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
at open circuit##5##3##(2008-10#5)
at operation##3##2##(1991-6#1)(2008-10#2)
at optimal##6##2##(1994-8#1)(1995-8#1)(2008-10#3)(2008-3#1)
at optimum conditions##2##3##(2008-10#2)
at optimum##4##2##(2008-10#3)(2012-2#1)
at or above##3##3##(2008-10#2)(2008-7#1)
at or below##2##3##(2008-10#2)
at or near the##5##4##(1993-3#1)(1994-11#1)(1996-8#1)(2008-10#2)
at or near##7##3##(1993-3#1)(1994-11#2)(1996-8#1)(2008-10#2)(2008-8#1)
at or##15##2##(1993-3#1)(1994-11#2)(1996-8#1)(1997-1#1)(2008-10#6)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
at oral hyperkeratosis and##2##4##(2012-3#2)
at other locations##2##3##(2008-10#1)(2010-8#1)
at other times##3##3##(1993-3#1)(2008-10#1)(2009-8#1)
at other##15##2##(1993-3#1)(1994-3#1)(1996-1#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-8#1)(2009-8#2)(2010-11#1)(2010-8#1)
at our hospital##3##3##(1990-6#1)(1993-11#1)(1995-1#1)
at our institute##2##3##(2008-11#2)
at our institution from##2##4##(1994-1#1)(2012-3#1)
at our institution##5##3##(1994-1#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
at our##17##2##(1990-6#1)(1990-9#1)(1993-11#1)(1994-1#1)(1995-1#1)(1995-10#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
at over##2##2##(1992-9#1)(2008-3#1)
at pH 1##12##3##(1990-5#1)(1992-12#1)(2008-10#10)
at pH 10##10##3##(2008-10#7)(2008-5#2)(2013-1#1)
at pH 12##9##3##(2008-10#8)(2008-8#1)
at pH 2##16##3##(2008-10#16)
at pH 3##29##3##(1992-12#2)(2008-10#26)(2008-5#1)
at pH 4##35##3##(1994-5#1)(2008-10#28)(2008-12#1)(2008-7#2)(2009-7#1)(2013-1#2)
at pH 5##65##3##(1991-12#1)(1992-4#1)(1993-8#1)(1994-5#1)(2006-6#1)(2008-10#52)(2008-11#5)(2008-6#1)(2009-10#1)(2011-2#1)
at pH 6 in##2##4##(1990-8#1)(2011-2#1)
at pH 6##37##3##(1990-5#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-8#1)(1996-2#1)(2008-10#23)(2008-11#1)(2008-5#2)(2011-2#2)(2011-3#1)
at pH 6-8##2##3##(1994-8#1)(2008-10#1)
at pH 7 and##3##4##(1992-4#1)(2008-10#1)(2013-1#1)
at pH 7##66##3##(1990-5#2)(1990-8#1)(1992-3#2)(1992-4#1)(1993-8#6)(1994-8#1)(2008-10#43)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
at pH 8##22##3##(1993-8#1)(2008-10#19)(2008-11#2)
at pH 9 and##3##4##(1990-8#1)(2008-10#2)
at pH 9##17##3##(1990-8#1)(2008-10#13)(2008-9#1)(2009-3#2)
at pH =##2##3##(2008-5#1)(2009-11#1)
at pH approximately 0##2##4##(2008-10#2)
at pH approximately##3##3##(2008-10#3)
at pH close to##2##4##(2008-10#1)(2008-5#1)
at pH higher than##3##4##(2008-10#3)
at pH of##4##3##(2008-10#4)
at pH range##2##3##(2008-10#2)
at pH values of##2##4##(2008-10#2)
at pH values ranging from##3##5##(2008-10#2)(2010-4#1)
at pH values##6##3##(1994-11#1)(2008-10#4)(2010-4#1)
at pH##358##2##(1990-5#5)(1990-8#4)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#5)(1992-3#2)(1992-4#2)(1993-8#9)(1994-11#1)(1994-5#2)(1994-8#2)(1996-2#1)(2006-6#1)(2008-10#276)(2008-11#10)(2008-12#2)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-4#2)(2011-2#4)(2011-3#2)(2013-1#4)
at pH&gt##3##2##(2008-10#3)
at pH&lt##2##2##(2008-10#2)
at pHs below##2##3##(2008-10#2)
at pHs##3##2##(2008-10#3)
at particular risk##2##3##(2008-10#1)(2011-2#1)
at particular##4##2##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
at passage 10##2##3##(2011-3#2)
at passage##5##2##(2008-11#1)(2011-3#4)
at pathogen##2##2##(2008-10#1)(2009-8#1)
at peak##5##2##(2008-10#1)(2009-8#1)(2010-3#3)
at percentages##2##2##(2008-10#2)
at phase##2##2##(2008-3#2)
at physiological ionic strength##2##4##(1994-5#2)
at physiological ionic##3##3##(1994-5#3)
at physiological levels##3##3##(2008-10#2)(2013-1#1)
at physiological pH##3##3##(2008-10#3)
at physiological temperature##3##3##(2008-10#1)(2013-8#2)
at physiological##16##2##(1993-2#1)(1993-8#1)(1994-5#3)(2008-10#6)(2008-12#1)(2013-1#1)(2013-8#3)
at pilot scale##3##3##(2008-11#2)(2010-4#1)
at pilot##4##2##(1995-3#1)(2008-11#2)(2010-4#1)
at pit hardening stage##2##4##(2008-10#2)
at platinum electrode##2##3##(2008-10#2)
at play##2##2##(1997-3#1)(2008-10#1)
at population##3##2##(2008-10#2)(2008-9#1)
at position 143##2##3##(2008-10#2)
at position 6##3##3##(1994-3#2)(1994-8#1)
at position 68*##2##3##(2011-2#2)
at position##38##2##(1992-10#1)(1993-8#1)(1994-11#1)(1994-3#4)(1994-8#1)(1995-2#1)(1996-5#1)(1997-3#2)(1997-7#1)(1997-8#3)(2006-6#2)(2008-10#10)(2008-12#5)(2008-8#1)(2011-2#3)(2012-2#1)
at positions of codons 153 and 191##2##7##(1997-8#2)
at positions##12##2##(1991-12#1)(1993-6#1)(1994-3#1)(1994-5#4)(1995-2#1)(1997-8#2)(2008-10#2)
at post-test##2##2##(2013-1#2)
at potential of##3##3##(2008-10#2)(2013-1#1)
at potential penetration sites##2##4##(2008-10#2)
at potential##6##2##(2008-10#5)(2013-1#1)
at potentials##5##2##(1997-2#2)(2008-10#3)
at ppb level##3##3##(2008-10#3)
at ppb levels##3##3##(2008-10#3)
at ppb##7##2##(2008-10#7)
at present##18##2##(1990-11#1)(1990-3#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#1)
at presentation##5##2##(2008-10#1)(2008-2#1)(2010-5#1)(2013-1#2)
at preserving##2##2##(1994-3#1)(2011-2#1)
at pressures of##2##3##(1996-5#1)(2008-2#1)
at pressures##4##2##(1996-5#1)(2008-2#1)(2008-3#2)
at preventing##5##2##(1996-1#1)(2008-10#2)(2012-2#1)(2013-1#1)
at primary##2##2##(1994-2#1)(1994-6#1)
at producing##2##2##(1990-5#1)(2013-1#1)
at promoting##2##2##(1993-11#1)(2008-11#1)
at providing##3##2##(2008-4#2)(2012-12#1)
at random##11##2##(1991-8#2)(1995-12#1)(2008-10#5)(2010-8#1)(2012-3#1)(2013-1#1)
at rates as##2##3##(2008-10#1)(2008-8#1)
at rates##7##2##(1995-8#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#1)
at reasonable cost##2##3##(1991-1#1)(2008-10#1)
at reasonable##3##2##(1991-1#1)(2008-10#2)
at reduced##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
at reducing##7##2##(1995-1#1)(2008-10#2)(2008-2#1)(2008-8#2)(2011-2#1)
at regular intervals##6##3##(1992-2#1)(2008-10#2)(2008-11#2)(2008-4#1)
at regular time intervals##2##4##(2008-10#2)
at regular##8##2##(1992-2#1)(2008-10#4)(2008-11#2)(2008-4#1)
at relative humidities##4##3##(2008-10#4)
at relatively low concentrations##2##4##(2008-10#2)
at relatively low##5##3##(1996-2#1)(2008-10#4)
at relatively##8##2##(1992-3#1)(1996-2#1)(2008-10#4)(2008-3#1)(2013-1#1)
at removing##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
at residue##3##2##(1995-2#1)(1995-8#1)(2008-9#1)
at residues##2##2##(1993-8#1)(2008-11#1)
at rest and##4##3##(1996-8#1)(2008-7#1)(2013-1#1)(2013-8#1)
at rest##15##2##(1996-8#1)(1997-4#1)(2008-7#3)(2009-3#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#3)(2013-8#3)
at risk and##3##3##(1996-2#1)(2008-10#1)(2012-12#1)
at risk due to##2##4##(2008-12#1)(2011-2#1)
at risk for HIV##2##4##(1996-5#1)(2009-12#1)
at risk for developing##4##4##(2008-1#1)(2008-12#2)(2008-2#1)
at risk for##33##3##(1991-1#1)(1991-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1996-12#3)(1996-5#1)(2008-1#2)(2008-11#3)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
at risk from##2##3##(2012-12#1)(2013-1#1)
at risk of developing##5##4##(1992-12#1)(2008-6#1)(2010-10#1)(2012-3#2)
at risk of infection##2##4##(1990-3#1)(2009-12#1)
at risk of##26##3##(1990-3#2)(1991-1#1)(1991-12#1)(1992-12#1)(1993-2#1)(1993-9#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
at risk##87##2##(1990-3#2)(1990-9#2)(1991-1#2)(1991-12#4)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#7)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-5#1)(2010-9#1)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#1)
at risk?##5##2##(1992-2#1)(1994-12#1)(1997-1#1)(2008-11#1)(2009-12#1)
at room temperature and at##2##5##(2008-10#1)(2008-5#1)
at room temperature and##12##4##(1997-2#1)(2008-10#6)(2008-3#1)(2008-5#2)(2009-11#1)(2012-2#1)
at room temperature for 5min##2##5##(2008-10#2)
at room temperature for##4##4##(2008-10#3)(2008-5#1)
at room temperature in##4##4##(1996-5#1)(2008-10#2)(2008-3#1)
at room temperature is##2##4##(2007-11#1)(2008-10#1)
at room temperature or at 45 degrees C for##2##9##(2008-5#2)
at room temperature to##2##4##(2008-10#1)(2008-12#1)
at room temperature were##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
at room temperature##78##3##(1993-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#41)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#5)(2008-8#3)(2009-11#1)(2010-3#1)(2010-4#2)(2010-9#1)(2012-2#3)(2013-1#1)(2013-8#2)
at room##80##2##(1993-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#43)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#5)(2008-8#3)(2009-11#1)(2010-3#1)(2010-4#2)(2010-9#1)(2012-2#3)(2013-1#1)(2013-8#2)
at room-temperature##2##2##(2012-2#2)
at satellite##2##2##(2008-2#1)(2008-3#1)
at saturation by S1##3##4##(1992-3#3)
at saturation##5##2##(1991-5#1)(1992-3#3)(1994-5#1)
at school##14##2##(1994-6#1)(1996-11#1)(1996-9#1)(2008-11#2)(2008-12#5)(2012-12#1)(2012-2#1)(2013-1#2)
at scientific##2##2##(1992-12#1)(2010-4#1)
at second##2##2##(2008-12#1)(2012-2#1)
at selected##2##2##(2008-9#1)(2009-11#1)
at serine residues 434 and 463##2##6##(2011-2#2)
at seven##5##2##(2008-10#4)(2010-2#1)
at several levels##2##3##(2008-10#1)(2012-12#1)
at several stages##2##3##(1992-12#1)(1996-2#1)
at several time##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
at several wavelengths##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
at several##29##2##(1992-12#1)(1992-6#1)(1995-12#1)(1996-2#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2010-5#2)(2012-12#1)
at short##5##2##(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
at significant##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
at significantly##3##2##(2008-11#1)(2011-2#2)
at similar##7##2##(1991-6#1)(1992-10#1)(1993-6#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-12#1)
at single##4##2##(2008-10#2)(2008-4#1)(2011-2#1)
at site##2##2##(1991-5#1)(2008-10#1)
at sites containing##2##3##(1995-8#1)(2008-10#1)
at sites of potential antagonist##2##5##(2008-10#2)
at sites of potential##4##4##(2008-10#4)
at sites of##8##3##(1997-3#1)(2008-10#6)(2011-2#1)
at sites that##2##3##(1993-8#1)(2008-10#1)
at sites##18##2##(1993-8#1)(1995-8#2)(1997-3#1)(2008-10#11)(2008-9#2)(2011-2#1)
at six different temperatures (ranging from 30 to 55 degrees C at intervals of 5 degrees C)##2##17##(2008-10#2)
at six different##3##3##(2008-10#2)(2008-5#1)
at six months##3##3##(1991-11#1)(2008-11#2)
at six##11##2##(1991-11#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2013-8#1)
at some point in their##2##5##(2008-9#1)(2009-5#1)
at some point in##3##4##(2008-9#1)(2009-5#1)(2013-1#1)
at some point##5##3##(2008-9#1)(2009-5#2)(2013-1#2)
at some##15##2##(1991-1#1)(1993-6#1)(1994-2#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-1#3)
at specific##14##2##(1991-2#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-1#2)(2012-2#1)(2012-3#1)
at stage VIII of the epithelial cycle##2##7##(2009-10#1)(2012-2#1)
at stage##7##2##(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2012-2#2)
at stages##7##2##(2008-10#3)(2008-6#2)(2009-10#1)(2012-2#1)
at standard##2##2##(2007-12#1)(2008-11#1)
at steady state##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
at sub-micromolar##2##2##(2008-10#2)
at sub-mug l(-1)##2##3##(2008-10#2)
at sub-nanogram levels##2##3##(2008-10#2)
at sub-nanogram##3##2##(2008-10#3)
at sub-picomolar level##2##3##(2008-10#2)
at submicromolar levels##2##3##(2008-10#2)
at subzero temperatures##2##3##(2008-10#2)
at such a low level##2##5##(2008-10#2)
at such a##3##3##(2008-10#2)(2008-3#1)
at sufficient##2##2##(1997-7#1)(2010-10#1)
at surgery was##4##3##(2009-3#2)(2012-3#1)(2013-1#1)
at surgery##8##2##(2008-12#1)(2008-9#2)(2009-3#2)(2010-3#1)(2012-3#1)(2013-1#1)
at synapses##3##2##(1997-2#1)(2008-7#1)(2009-9#1)
at t=25 degrees C##2##4##(2008-10#2)
at temperature of##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
at temperature##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
at temperatures above##2##3##(2008-10#2)
at temperatures as high as##2##5##(1994-9#1)(2008-10#1)
at temperatures between##2##3##(2008-11#1)(2013-8#1)
at temperatures from 20 to##2##5##(2008-10#2)
at temperatures from 6 to##2##5##(2008-10#2)
at temperatures from##8##3##(2008-10#8)
at temperatures of##5##3##(2008-10#3)(2008-11#1)(2009-8#1)
at temperatures ranging from##4##4##(2008-10#4)
at temperatures up to##3##4##(2008-10#2)(2009-7#1)
at temperatures##36##2##(1994-9#1)(1996-5#1)(1997-2#1)(2008-10#25)(2008-11#2)(2008-3#2)(2008-9#1)(2009-7#1)(2009-8#1)(2013-8#1)
at term and##2##3##(1994-3#2)
at term##13##2##(1990-11#2)(1993-3#1)(1994-3#5)(1996-11#1)(1997-4#1)(2012-12#1)(2013-1#2)
at that location##2##3##(2008-10#1)(2008-11#1)
at that moment##3##3##(2010-8#3)
at that time##4##3##(2008-10#2)(2009-1#1)(2013-8#1)
at that##15##2##(1991-6#1)(1992-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#1)(2009-1#1)(2010-8#3)(2013-8#1)
at the &quot##3##3##(2008-11#1)(2008-8#1)(2010-7#1)
at the 0##13##3##(2008-10#13)
at the 1##4##3##(2008-10#4)
at the 1-year##2##3##(2008-10#1)(2011-2#1)
at the 10##4##3##(2008-10#4)
at the 15th##2##3##(1995-8#1)(2008-7#1)
at the 1989##2##3##(1992-1#1)(1993-3#1)
at the 1998##2##3##(2008-10#1)(2008-11#1)
at the 1999##6##3##(2008-11#6)
at the 2##6##3##(1996-5#1)(2008-10#4)(2008-3#1)
at the 20 mug##2##4##(2008-10#2)
at the 2000 APS Annual Meeting##2##6##(2008-11#2)
at the 2000##8##3##(2008-11#8)
at the 2001 APS/MSA/SON Joint Meeting##4##6##(2008-11#4)
at the 2001##8##3##(2008-11#8)
at the 2002 APS Annual Meeting##2##6##(2008-11#2)
at the 2002##8##3##(2008-10#2)(2008-11#6)
at the 2003 APS Annual Meeting##2##6##(2008-11#2)
at the 2003##9##3##(2008-11#8)(2008-6#1)
at the 2004 APS Annual Meeting##2##6##(2008-11#2)
at the 2004##7##3##(2008-11#7)
at the 2005 APS Annual Meeting##2##6##(2008-11#2)
at the 2005##8##3##(2008-11#8)
at the 2006 APS Annual Meeting##2##6##(2008-11#2)
at the 2006##9##3##(2008-10#1)(2008-11#8)
at the 2007 APS Annual Meeting##2##6##(2008-11#2)
at the 2007##4##3##(2008-11#4)
at the 25##2##3##(2008-10#2)
at the 3' end of the##3##6##(1992-8#1)(2008-10#2)
at the 3' end of##4##5##(1992-8#1)(2008-10#3)
at the 3' end##5##4##(1992-8#1)(2008-10#3)(2013-8#1)
at the 3'##6##3##(1992-8#1)(1994-8#1)(2008-10#3)(2013-8#1)
at the 3'-end of##3##4##(1993-9#1)(2013-1#2)
at the 4-cell stage##2##4##(1993-3#2)
at the 5 microg##2##4##(2008-10#2)
at the 5##8##3##(2008-10#6)(2008-12#1)(2008-4#1)
at the 5' and 3'##3##5##(2008-10#3)
at the 5'##6##3##(1995-6#1)(2008-10#3)(2008-8#1)(2013-8#1)
at the 8th##2##3##(1992-3#1)(2011-4#1)
at the 95% confidence level##19##5##(2008-10#19)
at the 95%##22##3##(2008-10#22)
at the AM1##2##3##(1996-5#1)(2008-10#1)
at the BTB during the##2##5##(2009-10#1)(2012-2#1)
at the BTB##7##3##(2009-10#3)(2012-2#4)
at the C terminus of the##2##6##(1991-6#1)(1995-6#1)
at the C terminus##3##4##(1991-6#1)(1995-2#1)(1995-6#1)
at the C##4##3##(1991-6#1)(1993-9#1)(1995-2#1)(1995-6#1)
at the C-terminal##3##3##(1994-12#1)(1996-12#1)(2012-2#1)
at the C-terminus of the##2##5##(1994-12#1)(2008-10#1)
at the C-terminus##6##3##(1994-11#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
at the Center for Diabetes Research##2##6##(1990-11#2)
at the Center for##4##4##(1990-11#2)(2008-11#1)(2010-5#1)
at the Center##5##3##(1990-11#2)(2008-10#1)(2008-11#1)(2010-5#1)
at the Clinical Hospital##2##4##(2011-2#1)(2013-1#1)
at the DNA##3##3##(1991-6#1)(2008-4#2)
at the Department of##11##4##(1990-9#1)(1991-9#1)(1992-2#1)(1997-4#1)(2010-6#1)(2011-2#4)(2013-1#2)
at the Department##12##3##(1990-9#1)(1991-9#1)(1992-2#1)(1997-4#1)(2008-10#1)(2010-6#1)(2011-2#4)(2013-1#2)
at the ED(50)##2##3##(2008-11#2)
at the G(2)/M##2##3##(2008-11#2)
at the Hg electrode##2##4##(2008-10#2)
at the ICPD##2##3##(1994-9#2)
at the Institut Pasteur##2##4##(2010-1#2)
at the Institute##2##3##(1997-8#1)(2011-2#1)
at the Istituto Nazionale Tumori##2##5##(1990-12#1)(1991-6#1)
at the Istituto##3##3##(1990-12#1)(1991-6#1)(2008-10#1)
at the L4-L5##3##3##(1996-6#3)
at the L5-S1##3##3##(1996-6#2)(2012-2#1)
at the LSPV-LA-J##2##3##(2011-2#2)
at the MCA bifurcation##2##4##(2008-12#2)
at the MER##2##3##(2008-10#2)
at the Mexican Institute of Social Security##2##7##(2011-2#2)
at the Mount Sinai##2##4##(1995-8#1)(1996-3#1)
at the N-terminal end##3##4##(1993-8#1)(1995-11#1)(1995-8#1)
at the N-terminal##4##3##(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#1)
at the N-terminus of the##2##5##(1992-6#1)(1997-3#1)
at the N-terminus##5##3##(1990-5#1)(1992-6#1)(1995-8#1)(1997-3#1)(2008-9#1)
at the NEE##2##3##(2008-10#2)
at the NH2 terminus##3##4##(1992-9#1)(1993-3#1)(1995-6#1)
at the National Cancer Institute##2##5##(2008-10#1)(2008-11#1)
at the National Cancer##3##4##(2008-10#1)(2008-11#2)
at the National Institute of Standards and Technology##2##8##(2008-3#2)
at the National##9##3##(1994-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2011-2#1)(2012-12#1)
at the Nordic School of Public Health##2##7##(1991-2#2)
at the Norwegian Institute of##2##5##(1996-6#1)(2010-6#1)
at the Norwegian##3##3##(1991-2#1)(1996-6#1)(2010-6#1)
at the Pi-ta##2##3##(2008-10#2)
at the S phase##2##4##(1993-8#2)
at the SLCO1B1##2##3##(2011-2#2)
at the Sertoli##2##3##(2012-2#2)
at the Surgical Department of##2##5##(1993-3#1)(2008-10#1)
at the Surgical##3##3##(1993-3#1)(1997-8#1)(2008-10#1)
at the TG##2##3##(2012-2#2)
at the Translocator Protein (TSPO) (18##2##6##(2012-2#2)
at the University of Dundee##2##5##(2008-11#2)
at the University of Michigan##2##5##(1991-3#1)(2008-11#1)
at the University of New##2##5##(1993-1#1)(1996-1#1)
at the University of##27##4##(1990-11#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-6#1)(1993-8#1)(1995-2#1)(1996-1#2)(1996-3#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-2#2)(2013-8#2)
at the University##28##3##(1990-11#1)(1991-11#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-6#1)(1993-8#1)(1995-2#1)(1996-1#2)(1996-3#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-2#2)(2013-8#2)
at the active site of##3##5##(1990-9#1)(1991-5#1)(1994-5#1)
at the active site##5##4##(1990-5#1)(1990-9#1)(1991-5#1)(1994-5#1)(1995-8#1)
at the active##7##3##(1990-5#1)(1990-9#1)(1991-5#1)(1994-5#1)(1994-8#1)(1995-8#1)(2008-5#1)
at the adult plant stage in##2##6##(2008-10#2)
at the adult plant stage##4##5##(2008-10#4)
at the adult##5##3##(2008-10#5)
at the age of 40##2##5##(2008-5#1)(2012-3#1)
at the age of##14##4##(1991-11#1)(1991-6#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-5#3)(2008-7#3)(2010-10#1)(2012-3#1)(2013-1#1)
at the air-liquid interface##6##4##(2008-10#2)(2008-5#4)
at the airway##3##3##(1992-2#2)(1996-12#1)
at the alpha##2##3##(1996-12#1)(1996-5#1)
at the amino acid position##2##5##(1991-11#1)(2013-8#1)
at the amino acid##4##4##(1991-11#1)(1993-6#1)(2008-8#1)(2013-8#1)
at the amino terminus##4##4##(1996-12#2)(1997-8#1)(2008-10#1)
at the amino##8##3##(1991-11#1)(1993-6#1)(1996-12#2)(1997-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
at the ankle and##2##4##(2009-11#1)(2011-2#1)
at the annual##3##3##(1993-12#1)(2008-5#1)(2011-2#1)
at the anterior pole##2##4##(1994-12#1)(2007-12#1)
at the anterior##7##3##(1994-12#2)(2007-12#3)(2008-7#1)(2011-2#1)
at the apical ES##4##4##(2012-2#4)
at the apical##9##3##(1995-8#1)(2008-7#1)(2012-2#6)(2013-1#1)
at the area##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
at the back##2##3##(2008-12#1)(2008-5#1)
at the basal ES##3##4##(2012-2#3)
at the basal##6##3##(1997-1#1)(2008-7#1)(2012-2#3)(2012-3#1)
at the base of the##4##5##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
at the base of##6##4##(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
at the base recognition and catalytic sites##2##7##(1992-4#2)
at the base##8##3##(1992-4#2)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
at the baseline##2##3##(2012-4#1)(2013-1#1)
at the basic##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
at the bedside##2##3##(1993-3#1)(1996-2#1)
at the beginning and##2##4##(2008-11#1)(2011-2#1)
at the beginning of an##2##5##(1990-2#1)(2008-7#1)
at the beginning of each##4##5##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
at the beginning of the##15##5##(1990-12#1)(1992-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)
at the beginning of##30##4##(1990-12#1)(1990-2#1)(1992-2#1)(1993-12#1)(1994-3#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)
at the beginning##36##3##(1990-12#1)(1990-2#1)(1992-2#1)(1993-12#1)(1994-3#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-1#2)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#1)(2012-7#1)
at the blood-testis barrier##2##4##(2009-10#1)(2012-2#1)
at the bottom of the##2##5##(2008-11#1)(2008-3#1)
at the bottom of##3##4##(1992-4#1)(2008-11#1)(2008-3#1)
at the carbon paste electrode##3##5##(2008-10#3)
at the carbon##4##3##(2008-10#3)(2008-11#1)
at the carboxyl terminus##3##4##(1992-8#1)(1992-9#2)
at the carboxyl##4##3##(1992-8#1)(1992-9#2)(2008-10#1)
at the cell periphery##2##4##(2007-12#1)(2009-8#1)
at the cell surface##6##4##(1993-8#1)(1994-3#1)(2008-10#1)(2008-4#2)(2009-9#1)
at the cell##10##3##(1993-8#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-8#1)(2009-9#1)
at the cellular and##2##4##(2008-7#1)(2013-1#1)
at the cellular level##8##4##(1993-11#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
at the cellular##11##3##(1993-11#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
at the center of origin##2##5##(2008-10#2)
at the center of the##5##5##(1993-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2011-2#1)
at the center of##8##4##(1993-8#1)(2008-10#3)(2008-3#1)(2009-7#1)(2011-2#1)(2012-12#1)
at the center##9##3##(1991-8#1)(1993-8#1)(2008-10#3)(2008-3#1)(2009-7#1)(2011-2#1)(2012-12#1)
at the central##3##3##(1990-11#1)(2008-9#2)
at the centre of##2##4##(1997-4#1)(2012-7#1)
at the cervical##3##3##(1993-12#1)(2008-12#1)(2008-7#1)
at the community level##7##4##(1994-8#1)(1996-12#1)(2008-8#1)(2008-9#1)(2013-1#3)
at the completion of the##2##5##(2008-10#1)(2011-2#1)
at the concentration level##2##4##(2008-10#2)
at the concentration levels##2##4##(2008-10#2)
at the concentration of 1##2##5##(2008-11#1)(2008-5#1)
at the concentration of##6##4##(2008-10#2)(2008-11#2)(2008-5#1)(2012-3#1)
at the concentration range of 0##2##6##(2008-10#2)
at the concentration range of##3##5##(2008-10#3)
at the concentration range##4##4##(2008-10#4)
at the concentration##14##3##(2008-10#10)(2008-11#2)(2008-5#1)(2012-3#1)
at the concentrations##2##3##(2008-10#2)
at the conclusion of the##2##5##(2008-11#2)
at the conclusion of##3##4##(1994-1#1)(2008-11#2)
at the core of the##3##5##(2008-10#2)(2011-2#1)
at the core of##6##4##(1991-2#1)(1993-3#1)(2008-10#2)(2008-12#1)(2011-2#1)
at the core##9##3##(1991-2#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
at the correct##5##3##(1992-5#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#1)
at the cost of##4##4##(1993-2#1)(2008-11#1)(2008-8#1)(2009-9#1)
at the critical##2##3##(1990-5#1)(1997-2#1)
at the detection##5##3##(2008-10#5)
at the detector##2##3##(2008-10#1)(2008-3#1)
at the determination of##2##4##(2008-10#2)
at the different##7##3##(1995-9#1)(1996-12#1)(2008-10#3)(2008-11#1)(2011-2#1)
at the distal end of the##2##6##(2008-10#1)(2008-9#1)
at the distal end of##3##5##(1992-12#1)(2008-10#1)(2008-9#1)
at the distal##6##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)
at the dorsal##2##3##(2007-12#1)(2011-2#1)
at the dosage of##2##4##(1991-2#1)(2007-8#1)
at the dose of 30##2##5##(1996-2#1)(2011-2#1)
at the dose of##5##4##(1990-9#2)(1996-2#1)(2008-9#1)(2011-2#1)
at the doses##3##3##(1994-11#1)(1995-12#1)(2013-1#1)
at the dough stage##3##4##(2008-10#3)
at the dough##4##3##(2008-10#4)
at the dropping mercury electrode##2##5##(2008-10#2)
at the duodeno-jejunal flexure##2##4##(2008-12#2)
at the dura##2##3##(1996-9#1)(2008-7#1)
at the earliest##2##3##(1990-2#1)(2008-10#1)
at the early control##2##4##(2013-1#2)
at the early stage of##3##5##(2008-10#2)(2013-1#1)
at the early stages of##2##5##(2008-11#1)(2008-6#1)
at the early##9##3##(2008-10#2)(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#3)
at the edge of the##2##5##(2008-10#2)
at the edge of##3##4##(2008-10#3)
at the edge##4##3##(2008-10#3)(2008-3#1)
at the elbow##4##3##(2008-12#1)(2008-9#2)(2013-1#1)
at the electrode surface##11##4##(2008-10#10)(2009-12#1)
at the electrode##16##3##(2008-10#15)(2009-12#1)
at the electron microscope level##3##5##(2008-10#3)
at the electron##4##3##(1995-3#1)(2008-10#3)
at the emergency department##3##4##(2008-10#2)(2011-1#1)
at the emergency##4##3##(1993-12#1)(2008-10#2)(2011-1#1)
at the end of a capillary tip##4##7##(2008-10#4)
at the end of a##7##5##(2008-10#6)(2008-8#1)
at the end of each##4##5##(1994-3#1)(2008-10#1)(2008-6#1)(2011-1#1)
at the end of the Early Bronze Age##3##8##(2008-10#3)
at the end of the course##2##6##(2008-11#1)(2013-8#1)
at the end of the first year##2##7##(1996-12#1)(2011-1#1)
at the end of the first##3##6##(1996-12#1)(2008-10#1)(2011-1#1)
at the end of the growth phase##2##7##(2008-11#2)
at the end of the second##3##6##(1996-12#1)(2008-8#1)(2013-1#1)
at the end of the stress##2##6##(1994-2#1)(2008-11#1)
at the end of the therapy##2##6##(1992-12#1)(2013-7#1)
at the end of the treatment##4##6##(1990-9#1)(1991-8#1)(1997-3#1)(2013-1#1)
at the end of the##56##5##(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#2)(1994-2#2)(1994-9#1)(1996-12#3)(1997-3#1)(2008-10#14)(2008-11#6)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
at the end of their##3##5##(2008-11#1)(2008-5#1)(2012-12#1)
at the end of therapy##2##5##(2008-9#1)(2013-1#1)
at the end of##91##4##(1990-2#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-8#1)(1996-12#4)(1997-2#2)(1997-3#1)(1997-6#1)(2008-10#26)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-12#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
at the end##92##3##(1990-2#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-8#1)(1996-12#4)(1997-2#2)(1997-3#1)(1997-6#1)(2008-10#26)(2008-11#8)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-12#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
at the end-point were##2##4##(2008-10#2)
at the ends of##2##4##(2008-11#1)(2008-9#1)
at the ends##3##3##(2008-11#1)(2008-9#1)(2009-9#1)
at the entrance##2##3##(2008-10#1)(2011-2#1)
at the equivalence point##2##4##(2008-10#2)
at the estrogen##2##3##(1992-6#1)(2008-11#1)
at the exit site##2##4##(2011-2#2)
at the exit##4##3##(2008-2#1)(2008-3#1)(2011-2#2)
at the expected##2##3##(1995-2#1)(2008-11#1)
at the expense of the##2##5##(1990-9#1)(2012-3#1)
at the expense of##10##4##(1990-9#1)(1995-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-1#1)(2012-3#1)(2012-9#1)
at the experimental##2##3##(2008-10#2)
at the exponential##2##3##(2008-11#2)
at the farm##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
at the fastest##2##3##(1994-3#1)(2008-10#1)
at the fiber input##2##4##(2007-12#2)
at the field scale##3##4##(2008-10#3)
at the field##5##3##(2008-10#5)
at the final harvest##2##4##(2008-10#2)
at the final##4##3##(2008-10#2)(2011-2#1)(2012-2#1)
at the first##9##3##(1990-6#1)(1997-6#1)(2007-9#1)(2008-10#2)(2009-12#1)(2010-8#1)(2011-2#2)
at the flow rate of##3##5##(2008-10#3)
at the flow rate##4##4##(2008-10#4)
at the follow-up##2##3##(1997-3#1)(2008-12#1)
at the following##3##3##(1995-8#1)(2008-10#2)
at the four##2##3##(2008-10#1)(2013-3#1)
at the four-leaf stage##2##4##(2008-10#2)
at the front##2##3##(2008-10#2)
at the fundamental##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
at the gene level##2##4##(2008-10#1)(2008-11#1)
at the gene##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
at the genetic##2##3##(2011-10#1)(2012-3#1)
at the genome##2##3##(1995-5#1)(2009-6#1)
at the genomic level##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
at the genomic##4##3##(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
at the glassy carbon electrode##2##5##(2008-10#2)
at the glucose-6-phosphate isomerase and peptidase loci##2##7##(2008-10#2)
at the gold electrode##2##4##(2008-10#2)
at the gonads##3##3##(2009-11#3)
at the greatest risk##2##4##(2008-7#1)(2013-8#1)
at the hanging mercury drop electrode (HMDE)##4##7##(2008-10#4)
at the hanging mercury drop electrode was##2##7##(2008-10#2)
at the hanging mercury drop electrode##7##6##(2008-10#7)
at the hanging##8##3##(2008-10#8)
at the head-neck junction##2##4##(2013-1#2)
at the heart of##5##4##(2008-11#2)(2008-5#1)(2008-9#1)(2010-11#1)
at the heart##6##3##(2008-11#2)(2008-5#1)(2008-9#1)(2010-11#1)(2012-2#1)
at the hexane-water interface##3##4##(2008-10#3)
at the high dose##2##4##(1995-11#1)(2008-10#1)
at the high##4##3##(1995-11#1)(2008-10#2)(2008-3#1)
at the higher##6##3##(2008-10#5)(2008-11#1)
at the highest concentration##2##4##(2008-10#1)(2008-9#1)
at the highest dose##3##4##(1993-6#1)(2008-10#1)(2008-5#1)
at the highest level##3##4##(1993-3#1)(2008-10#2)
at the highest##17##3##(1993-3#1)(1993-6#1)(1996-6#1)(2006-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)
at the hip##2##3##(2010-10#1)(2011-2#1)
at the histological level##2##4##(2008-10#2)
at the horizontal##2##3##(2008-3#1)(2008-9#1)
at the hospital##9##3##(1991-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2009-4#1)(2010-7#2)(2012-2#1)
at the implant##2##3##(2012-3#1)(2013-1#1)
at the implanted##2##3##(2008-9#1)(2009-3#1)
at the individual##4##3##(2008-11#1)(2008-8#3)
at the initial##6##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)
at the initiation of##5##4##(2008-11#1)(2011-2#4)
at the injection site##4##4##(1990-6#1)(1994-5#1)(2011-2#2)
at the injection##5##3##(1990-6#1)(1993-1#1)(1994-5#1)(2011-2#2)
at the input and the##2##5##(2008-3#2)
at the input##3##3##(2008-3#3)
at the interface between the##2##5##(2008-10#1)(2008-9#1)
at the interface between##8##4##(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
at the interface of the##4##5##(1991-12#1)(2008-10#3)
at the interface of##8##4##(1991-12#1)(2008-10#5)(2008-3#1)(2009-12#1)
at the interface##21##3##(1991-12#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2013-8#1)
at the internal##2##3##(1995-5#1)(1997-3#1)
at the isosbestic point with##2##5##(2008-10#2)
at the junction between the##2##5##(2007-12#1)(2012-3#1)
at the junction of##3##4##(1990-5#1)(2007-12#2)
at the junction##6##3##(1990-5#1)(1996-12#1)(2007-12#3)(2012-3#1)
at the larval stage##2##4##(2008-8#2)
at the last##2##3##(1991-2#1)(1993-1#1)
at the late stage of##2##5##(2008-11#1)(2008-9#1)
at the late##7##3##(1993-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
at the latest##2##3##(1993-6#1)(2013-7#1)
at the leaf##2##3##(2008-10#2)
at the leaflet and leaf levels##2##6##(2008-10#2)
at the leaflet and leaf##3##5##(2008-10#3)
at the leaflet##5##3##(2008-10#5)
at the left##2##3##(1991-3#1)(2013-1#1)
at the level of 0##2##5##(2008-10#1)(2008-12#1)
at the level of both##2##5##(2008-11#1)(2008-8#1)
at the level of individual##3##5##(1997-7#1)(2010-10#1)(2011-2#1)
at the level of single##2##5##(2008-8#1)(2012-3#1)
at the level of the knee##2##6##(2012-2#2)
at the level of the##14##5##(1990-3#1)(1991-6#1)(1994-2#1)(1997-5#1)(2008-10#3)(2008-5#1)(2008-7#2)(2010-7#1)(2012-2#2)(2013-1#1)
at the level of transcription##5##5##(1993-6#1)(1993-9#2)(1994-2#1)(2008-11#1)
at the level of##52##4##(1990-3#1)(1991-6#1)(1992-10#1)(1993-6#1)(1993-9#2)(1994-2#2)(1995-8#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
at the levels of##4##4##(2008-10#1)(2008-11#1)(2011-2#2)
at the local level##4##4##(1992-2#1)(1994-2#1)(1996-1#1)(2008-10#1)
at the local##7##3##(1992-2#1)(1994-2#1)(1996-1#1)(1997-3#2)(2008-10#2)
at the low mug l(-1)##2##5##(2008-10#2)
at the low mug##3##4##(2008-10#3)
at the low nanomolar level##2##5##(2008-10#2)
at the low##7##3##(2008-10#7)
at the lower end of the##2##6##(2008-10#1)(2011-2#1)
at the lower temperature##2##4##(2008-10#1)(2008-11#1)
at the lower##8##3##(2008-10#4)(2008-11#2)(2011-2#2)
at the lowest##2##3##(1994-11#1)(2008-10#1)
at the lumbar spine##2##4##(2010-3#2)
at the m-RNA level of cyclooxygenase-2##2##6##(1997-1#2)
at the mRNA level##2##4##(1996-12#1)(1997-7#1)
at the mRNA##3##3##(1994-8#1)(1996-12#1)(1997-7#1)
at the manufacturer's##2##3##(2008-3#2)
at the margin of##2##4##(2008-10#2)
at the margins##2##3##(1997-7#1)(2008-10#1)
at the maximum absorption wavelength of##2##6##(2008-10#2)
at the maximum absorption wavelength##3##5##(2008-10#3)
at the medial##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
at the medium##2##3##(2008-10#2)
at the meeting##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
at the membrane level##2##4##(1990-2#1)(1997-2#1)
at the membrane##5##3##(1990-2#1)(1992-12#2)(1997-2#1)(2012-2#1)
at the membrane/solution interface##2##4##(2008-10#2)
at the mercury electrode and##4##5##(2008-10#4)
at the mercury electrode surface##3##5##(2008-10#3)
at the mercury electrode##7##4##(2008-10#7)
at the mercury##8##3##(2008-10#8)
at the microbiological laboratory##2##4##(2010-6#2)
at the minimum##2##3##(2008-11#1)(2008-8#1)
at the modified electrode are##2##5##(2008-10#2)
at the modified electrode##3##4##(2008-10#3)
at the molecular level##14##4##(1992-6#1)(1997-8#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2011-2#1)(2012-2#1)
at the molecular##17##3##(1992-6#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
at the moment of##3##4##(1990-3#1)(1990-9#1)(2013-1#1)
at the moment##7##3##(1990-3#1)(1990-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
at the monolayer/water interface##2##4##(1991-3#2)
at the more##2##3##(1990-5#1)(2008-12#1)
at the most##3##3##(1995-12#1)(2008-10#1)(2008-8#1)
at the mu##2##3##(1992-3#1)(2008-11#1)
at the mug##3##3##(2008-10#3)
at the muscular portion##2##4##(2008-9#2)
at the nanogram level is##2##5##(2008-10#2)
at the nanogram level##3##4##(2008-10#3)
at the nanometer##2##3##(2008-7#1)(2009-12#1)
at the national##2##3##(1994-12#1)(2008-11#1)
at the needle##2##3##(1991-12#1)(2008-10#1)
at the nest##2##3##(2008-8#2)
at the new##2##3##(2008-11#1)(2008-8#1)
at the nonreducing terminal were used as substrates##2##8##(1994-5#2)
at the nonreducing##3##3##(1994-5#2)(2008-7#1)
at the nuclear pore##2##4##(1995-2#1)(2011-2#1)
at the nuclear##4##3##(1995-2#1)(2009-8#1)(2011-2#2)
at the nucleotide and amino acid levels##2##7##(1995-8#1)(2008-10#1)
at the nucleotide##3##3##(1993-6#1)(1995-8#1)(2008-10#1)
at the ocean##2##3##(1990-8#1)(2008-8#1)
at the oil-water##2##3##(2008-10#1)(2008-5#1)
at the onset of the##2##5##(2008-10#1)(2008-7#1)
at the onset of##11##4##(1994-11#1)(1997-2#2)(1997-3#1)(2008-10#2)(2008-7#2)(2010-10#1)(2010-12#1)(2012-3#1)
at the optimal##2##3##(1991-5#1)(2008-7#1)
at the optimum##4##3##(2008-10#3)(2008-3#1)
at the origin##2##3##(2010-8#1)(2013-8#1)
at the other##5##3##(2008-10#3)(2008-12#1)(2009-6#1)
at the outer##3##3##(1992-3#1)(1997-7#1)(2013-8#1)
at the outlet of the##2##5##(2008-10#2)
at the output of##2##4##(2008-3#2)
at the output##6##3##(2008-10#2)(2008-3#4)
at the outset##2##3##(1995-1#1)(2008-12#1)
at the pH##2##3##(1993-3#1)(2008-10#1)
at the parts-per-trillion level##2##4##(2008-10#2)
at the peak##3##3##(2008-10#2)(2008-7#1)
at the periphery of the##3##5##(1991-2#1)(2008-10#1)(2009-2#1)
at the periphery of##4##4##(1991-2#1)(2008-10#1)(2008-8#1)(2009-2#1)
at the periphery##6##3##(1991-2#1)(1994-2#1)(1996-5#1)(2008-10#1)(2008-8#1)(2009-2#1)
at the phase##2##3##(2008-10#1)(2008-3#1)
at the plasma membrane##2##4##(1994-8#1)(2009-9#1)
at the platinum##2##3##(2008-10#2)
at the point of##4##4##(1997-3#1)(2008-10#1)(2008-11#2)
at the point where##2##4##(2008-5#1)(2008-8#1)
at the point##6##3##(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)
at the population level##6##4##(2008-10#3)(2008-11#1)(2008-8#2)
at the population##8##3##(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#2)(2011-2#1)
at the position of##2##4##(1997-7#1)(2008-8#1)
at the post-translational level##2##4##(2008-8#1)(2013-1#1)
at the posterior##4##3##(1993-12#1)(2007-12#3)
at the posttranscriptional level##2##4##(1994-11#1)(2008-8#1)
at the potential of##4##4##(2008-10#4)
at the potential##5##3##(1992-12#1)(2008-10#4)
at the preclinical##2##3##(2008-10#1)(2010-10#1)
at the present time##5##4##(1992-3#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-4#1)
at the primary##9##3##(1993-2#1)(1993-9#1)(1994-5#1)(1995-3#1)(2008-10#1)(2011-2#2)(2012-2#2)
at the promoter##3##3##(2008-11#1)(2011-2#2)
at the protein level##3##4##(1994-11#1)(2011-10#1)(2013-1#1)
at the protein##4##3##(1994-11#1)(2011-10#1)(2011-2#1)(2013-1#1)
at the putative##2##3##(1990-10#1)(1991-9#1)
at the radial##2##3##(2008-10#1)(2009-6#1)
at the range of##3##4##(2008-10#3)
at the rate of##5##4##(2008-10#2)(2008-12#1)(2011-1#1)(2012-2#1)
at the reducing##2##3##(1992-10#1)(1994-5#1)
at the regional and##2##4##(1992-5#1)(2008-4#1)
at the regional scale##2##4##(2008-10#2)
at the regional##6##3##(1990-11#1)(1992-5#1)(2008-10#2)(2008-4#2)
at the remote site##3##4##(1990-5#1)(1997-4#2)
at the replication fork##2##4##(1991-12#2)
at the replication##3##3##(1991-12#2)(2012-3#1)
at the request of the##5##5##(1990-11#1)(1997-4#1)(2008-10#3)
at the research station##2##4##(2008-10#1)(2008-11#1)
at the retention time##2##4##(2008-10#1)(2008-11#1)
at the right middle cerebral artery##2##6##(2008-12#1)(2013-8#1)
at the right middle##3##4##(2008-12#1)(2013-1#1)(2013-8#1)
at the right time##2##4##(1993-12#1)(2008-11#1)
at the right##10##3##(1990-11#1)(1993-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)(2010-9#1)(2013-1#1)(2013-8#1)
at the root of##2##4##(1990-11#1)(2009-6#1)
at the root##4##3##(1990-11#1)(2008-10#2)(2009-6#1)
at the same age##2##4##(1990-11#1)(1991-11#1)
at the same concentration##2##4##(2008-10#1)(2008-11#1)
at the same concentrations##4##4##(1994-8#1)(2008-10#2)(2008-11#1)
at the same dose##2##4##(1992-6#1)(2008-6#1)
at the same frequency##3##4##(1995-12#1)(2008-10#1)(2008-3#1)
at the same institution##2##4##(1990-6#1)(2011-2#1)
at the same level as##2##5##(2008-10#1)(2008-9#1)
at the same level in the##2##6##(2008-6#1)(2008-7#1)
at the same level##6##4##(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)
at the same location##2##4##(2008-3#2)
at the same locus##2##4##(2008-10#2)
at the same point##2##4##(1992-2#1)(1993-12#1)
at the same position##2##4##(1993-2#1)(2008-8#1)
at the same rate##3##4##(1991-2#1)(2008-10#1)(2008-11#1)
at the same site as rotenone##2##6##(1990-5#2)
at the same site as##3##5##(1990-5#3)
at the same site##7##4##(1990-5#3)(2008-10#2)(2008-12#1)(2011-2#1)
at the same temperature##2##4##(2008-8#1)(2012-2#1)
at the same time as##3##5##(2008-10#1)(2008-5#1)(2010-8#1)
at the same time to##3##5##(2008-10#2)(2013-1#1)
at the same time##42##4##(1990-11#1)(1990-5#1)(1991-12#1)(1991-6#2)(1992-12#1)(1993-11#1)(1993-8#1)(1994-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#2)(2009-8#1)(2010-12#1)(2010-7#3)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
at the same wavelength##2##4##(2008-10#1)(2008-3#1)
at the same##101##3##(1990-11#2)(1990-2#1)(1990-5#4)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#26)(2008-11#6)(2008-12#2)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-7#3)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)
at the sampling unit scale##2##5##(2008-10#2)
at the sampling##4##3##(2008-10#4)
at the sampling-unit##2##3##(2008-10#2)
at the scale of##4##4##(2008-10#2)(2008-9#1)(2012-2#1)
at the second base##2##4##(1992-8#1)(1994-11#1)
at the second##4##3##(1992-8#1)(1994-11#1)(2008-10#1)(2012-3#1)
at the seedling stage and##2##5##(2008-10#2)
at the seedling stage##7##4##(2008-10#7)
at the seedling##9##3##(2008-10#9)
at the selected##2##3##(2008-10#1)(2008-8#1)
at the self-assembled electrode##2##4##(2008-10#2)
at the sensor surface##2##4##(2008-10#2)
at the separation##3##3##(2008-10#2)(2008-3#1)
at the seventh##2##3##(1993-8#1)(1994-11#1)
at the shortest##2##3##(1991-2#1)(2013-8#1)
at the single cell level##2##5##(2007-12#1)(2011-2#1)
at the single##5##3##(2007-12#1)(2008-10#1)(2008-6#1)(2011-2#2)
at the site most distant from commercial potato production##2##9##(2008-10#2)
at the site of application in##4##6##(2008-9#4)
at the site of infection##5##5##(1996-8#1)(2008-10#1)(2009-8#1)(2010-6#1)(2011-1#1)
at the site of the##2##5##(1991-3#1)(2006-6#1)
at the site of##21##4##(1991-3#1)(1992-12#1)(1992-6#1)(1996-5#1)(1996-8#1)(2006-6#1)(2008-10#3)(2008-8#1)(2008-9#4)(2009-8#1)(2010-6#3)(2011-1#1)(2012-2#1)(2012-9#1)
at the site##27##3##(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1996-5#1)(1996-8#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#4)(2009-8#1)(2010-6#3)(2011-1#1)(2012-2#2)(2012-9#1)
at the sites of##3##4##(1990-5#1)(1994-5#1)(2013-7#1)
at the sites##6##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-7#1)
at the skin##2##3##(2008-5#1)(2012-2#1)
at the skull base##2##4##(2011-2#2)
at the source##2##3##(2008-10#1)(2008-8#1)
at the species level##5##4##(2008-5#1)(2010-4#1)(2011-2#2)(2012-6#1)
at the species##6##3##(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#2)(2012-6#1)
at the stage of##5##4##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
at the start of a##2##5##(2008-11#1)(2009-12#1)
at the start of the##4##5##(1991-5#1)(2008-12#1)(2008-5#1)(2013-1#1)
at the start of##9##4##(1990-9#1)(1991-5#1)(1992-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2013-1#1)
at the state and local level##2##6##(1997-2#1)(2011-9#1)
at the state and##4##4##(1997-1#1)(1997-2#1)(2010-9#1)(2011-9#1)
at the static mercury drop electrode##2##6##(2008-10#2)
at the study site##2##4##(2008-10#2)
at the study##3##3##(1994-11#1)(2008-10#2)
at the surface of the##5##5##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
at the surface of##12##4##(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
at the surface##20##3##(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-7#1)
at the surgical##2##3##(2010-3#1)(2010-6#1)
at the tail##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
at the target##4##3##(1995-1#1)(1997-2#1)(2008-11#1)(2010-10#1)
at the terminal##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
at the thalami##2##3##(2012-3#2)
at the three##5##3##(1991-2#1)(2008-10#2)(2010-7#1)(2010-8#1)
at the time of admission##2##5##(1991-8#1)(1992-3#1)
at the time of colposcopy##2##5##(1992-3#2)
at the time of diagnosis##4##5##(1993-1#1)(1994-12#1)(2008-7#1)(2010-12#1)
at the time of examination##2##5##(1991-12#1)(1997-8#1)
at the time of implantation##2##5##(2008-9#1)(2010-6#1)
at the time of initial##2##5##(1992-2#1)(2012-3#1)
at the time of inoculation##2##5##(2008-10#2)
at the time of presentation##4##5##(1995-10#1)(1997-8#1)(2010-12#1)(2012-3#1)
at the time of sampling##2##5##(1992-12#1)(2008-5#1)
at the time of surgery##3##5##(1991-3#1)(1993-11#1)(2008-7#1)
at the time of the survey##3##6##(1991-2#1)(2013-1#2)
at the time of the##9##5##(1990-3#1)(1990-6#1)(1991-2#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-1#1)(2013-1#2)
at the time of their##3##5##(1996-12#1)(2010-1#1)(2012-3#1)
at the time of##67##4##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-11#2)(1994-12#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-8#2)(2008-10#13)(2008-11#2)(2008-5#1)(2008-7#3)(2008-9#4)(2009-1#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#5)(2013-1#5)
at the time the##2##4##(1996-5#1)(2013-8#1)
at the time when##2##4##(2008-9#1)(2011-2#1)
at the time##75##3##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-11#2)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-5#1)(1997-8#2)(2008-10#14)(2008-11#2)(2008-5#1)(2008-7#3)(2008-9#5)(2009-1#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#6)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#1)
at the tip of the##6##5##(1994-12#1)(2007-12#1)(2008-10#3)(2010-12#1)
at the tip of##7##4##(1994-12#1)(2007-12#1)(2008-10#4)(2010-12#1)
at the tip##8##3##(1994-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-12#1)
at the tips of##3##4##(2008-10#1)(2008-7#1)(2010-3#1)
at the tips##4##3##(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)
at the tissue##2##3##(1992-1#1)(1992-12#1)
at the titration end-point##2##4##(2008-10#2)
at the top of##2##4##(1995-6#1)(2007-11#1)
at the top##5##3##(1995-6#1)(2007-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
at the transcriptional level by##2##5##(2008-10#1)(2013-1#1)
at the transcriptional level##7##4##(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2013-1#1)
at the transition##2##3##(2008-7#1)(2009-7#1)
at the triangle##2##3##(2008-6#2)
at the turn of the##2##5##(2010-1#1)(2011-2#1)
at the two CO(2) concentrations in##2##6##(2008-10#2)
at the two##5##3##(2008-10#2)(2008-2#2)(2008-8#1)
at the ultrastructural level##2##4##(2008-10#1)(2008-7#1)
at the university of##2##4##(2008-11#2)
at the upper##5##3##(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#1)
at the upstream##4##3##(1995-2#1)(1996-3#1)(2008-1#1)(2008-9#1)
at the ventral##2##3##(2007-12#1)(2008-5#1)
at the very##3##3##(1994-2#1)(2008-7#1)(2008-9#1)
at the vinylic positions##2##4##(2009-6#2)
at the waveguide surface##2##4##(2008-10#2)
at the wavelength of##4##4##(2008-10#3)(2008-11#1)
at the whole##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
at the work place##2##4##(1995-2#1)(2009-12#1)
at the working##2##3##(2008-10#1)(2008-11#1)
at the workshop##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
at the wound site##2##4##(2008-10#2)
at the##2461##2##(1990-10#1)(1990-11#10)(1990-12#4)(1990-2#9)(1990-3#6)(1990-5#15)(1990-6#6)(1990-8#2)(1990-9#9)(1991-10#1)(1991-11#8)(1991-12#13)(1991-2#15)(1991-3#17)(1991-5#8)(1991-6#15)(1991-8#3)(1991-9#5)(1992-1#5)(1992-10#2)(1992-11#1)(1992-12#14)(1992-2#8)(1992-3#16)(1992-4#4)(1992-5#3)(1992-6#5)(1992-8#5)(1992-9#4)(1993-1#8)(1993-11#4)(1993-12#16)(1993-2#5)(1993-3#15)(1993-5#1)(1993-6#8)(1993-8#13)(1993-9#5)(1994-1#4)(1994-11#11)(1994-12#12)(1994-2#10)(1994-3#4)(1994-5#14)(1994-8#7)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#10)(1995-12#13)(1995-2#12)(1995-3#6)(1995-5#3)(1995-6#12)(1995-8#12)(1995-9#2)(1996-1#6)(1996-11#1)(1996-12#18)(1996-2#9)(1996-3#7)(1996-5#14)(1996-6#8)(1996-8#1)(1996-9#9)(1997-1#7)(1997-2#11)(1997-3#22)(1997-4#11)(1997-5#2)(1997-6#9)(1997-7#7)(1997-8#12)(2006-6#3)(2007-11#2)(2007-12#26)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#734)(2008-11#204)(2008-12#49)(2008-2#12)(2008-3#55)(2008-4#17)(2008-5#54)(2008-6#11)(2008-7#63)(2008-8#68)(2008-9#57)(2009-1#1)(2009-10#11)(2009-11#7)(2009-12#10)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#13)(2009-7#8)(2009-8#17)(2009-9#6)(2010-1#16)(2010-10#9)(2010-11#3)(2010-12#11)(2010-2#1)(2010-3#6)(2010-4#5)(2010-5#3)(2010-6#13)(2010-7#11)(2010-8#11)(2010-9#5)(2011-1#12)(2011-10#2)(2011-2#119)(2011-3#1)(2011-4#2)(2011-9#1)(2012-12#7)(2012-2#57)(2012-3#33)(2012-4#1)(2012-6#1)(2012-7#2)(2012-9#2)(2013-1#64)(2013-3#1)(2013-7#4)(2013-8#29)
at their disposal##2##3##(1994-3#1)(2012-12#1)
at their first##3##3##(1990-6#1)(1994-2#1)(2010-1#1)
at their##31##2##(1990-6#1)(1991-10#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#5)(1994-2#1)(1994-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
at thermal##2##2##(1993-8#1)(2008-11#1)
at these concentrations##2##3##(2008-11#2)
at these loci##2##3##(1993-6#1)(2008-10#1)
at these sites##2##3##(2008-10#2)
at these##25##2##(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1997-3#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2011-3#3)(2012-3#1)
at this concentration##2##3##(1992-12#1)(2008-10#1)
at this dose##3##3##(1990-6#1)(1992-12#1)(2013-1#1)
at this electrode##2##3##(2008-10#2)
at this hospital##3##3##(1990-11#1)(1990-3#1)(2011-2#1)
at this level##2##3##(2008-10#1)(2008-5#1)
at this locus##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
at this meeting##2##3##(2008-5#1)(2011-2#1)
at this modified electrode##3##4##(2008-10#3)
at this pH##2##3##(2008-10#1)(2008-11#1)
at this point##2##3##(2008-10#1)(2008-6#1)
at this position##4##3##(1994-5#1)(1995-2#1)(2008-12#1)(2009-8#1)
at this site##4##3##(1993-3#1)(2008-12#2)(2012-2#1)
at this stage##3##3##(2008-11#2)(2008-8#1)
at this time##9##3##(1991-1#1)(1996-2#1)(1996-3#2)(2008-10#1)(2008-11#1)(2009-1#1)(2009-8#1)(2013-1#1)
at this##71##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#2)(1991-3#1)(1992-12#2)(1993-3#2)(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(2008-10#19)(2008-11#6)(2008-12#4)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2009-1#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#3)
at those##2##2##(1995-1#1)(2008-3#1)
at three concentration levels##2##4##(2008-10#2)
at three different concentration levels##2##5##(2008-10#2)
at three different sites in##2##5##(2008-10#1)(2008-8#1)
at three different##11##3##(2008-10#8)(2008-11#2)(2008-8#1)
at three levels##2##3##(1997-7#1)(2008-11#1)
at three##46##2##(1993-2#1)(1993-6#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-7#1)(2008-10#20)(2008-11#6)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
at time 3##2##3##(2008-11#2)
at time of##7##3##(1992-5#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-11#1)
at time##11##2##(1992-5#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#4)(2008-7#1)(2010-11#1)
at times##10##2##(1991-12#1)(1995-3#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)
at trace concentration levels##3##4##(2008-10#3)
at trace level##4##3##(2008-10#4)
at trace levels by##2##4##(2008-10#2)
at trace levels in##5##4##(2008-10#5)
at trace levels##20##3##(2008-10#20)
at trace##29##2##(2008-10#29)
at translational level##3##3##(2008-8#3)
at treatment##2##2##(1996-11#1)(2013-1#1)
at twice the##2##3##(1994-8#1)(2007-11#1)
at twice##3##2##(1994-8#1)(2007-11#1)(2008-10#1)
at two concentrations##2##3##(2008-10#2)
at two different concentrations##2##4##(2008-10#2)
at two different levels##2##4##(1991-6#1)(2008-7#1)
at two different##8##3##(1991-6#1)(2008-10#5)(2008-4#1)(2008-7#1)
at two distinct##3##3##(1990-5#1)(1994-12#1)(2008-3#1)
at two field locations##2##4##(2008-10#1)(2008-11#1)
at two field##3##3##(2008-10#2)(2008-11#1)
at two levels##5##3##(1994-12#1)(1996-12#1)(2008-10#2)(2009-8#1)
at two locations in eastern##2##5##(2008-10#2)
at two locations in##3##4##(2008-10#3)
at two locations##6##3##(2008-10#6)
at two sampling times##2##4##(2008-10#2)
at two sites##2##3##(2008-10#2)
at two time points##2##4##(2010-1#2)
at two wavelengths##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
at two##70##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#28)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-5#1)(2010-7#1)
at typical##2##2##(2008-10#2)
at tyrosine residues##2##3##(1994-11#1)(2011-2#1)
at ultratrace##2##2##(2008-10#2)
at variable##2##2##(1992-2#1)(2008-10#1)
at various concentrations of##3##4##(1995-8#1)(1997-8#1)(2008-10#1)
at various concentrations##7##3##(1993-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-10#3)
at various distances##2##3##(1997-2#1)(2008-10#1)
at various levels##2##3##(2009-4#1)(2011-2#1)
at various pH##2##3##(2008-10#2)
at various phi values##2##4##(1996-12#2)
at various stages of##5##4##(1997-2#1)(1997-4#1)(2008-10#2)(2008-9#1)
at various stages##7##3##(1994-11#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-9#1)(2011-2#1)
at various temperatures##4##3##(1990-9#1)(2008-10#3)
at various time intervals after##2##5##(2008-10#1)(2008-5#1)
at various time intervals over##2##5##(2008-11#1)(2008-5#1)
at various time intervals##4##4##(2008-10#1)(2008-11#1)(2008-5#2)
at various time points##2##4##(2008-1#1)(2013-7#1)
at various time##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-7#1)
at various times throughout the##2##5##(1992-1#1)(2008-5#1)
at various times##8##3##(1992-1#1)(2008-10#5)(2008-5#1)(2010-8#1)
at various wavelengths##2##3##(2008-10#1)(2008-3#1)
at various##79##2##(1990-3#1)(1990-9#1)(1991-3#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-2#2)(1997-4#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#35)(2008-11#4)(2008-2#1)(2008-3#6)(2008-5#5)(2008-6#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#2)(2013-7#1)
at varying##6##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
at vegetative##2##2##(2012-2#1)(2013-8#1)
at very high levels##2##4##(2008-10#2)
at very high##7##3##(1994-9#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
at very low concentrations##6##4##(1990-12#1)(1991-5#1)(2008-10#3)(2008-5#1)
at very low levels of##2##5##(1993-8#1)(2008-11#1)
at very low levels##7##4##(1993-8#1)(2008-10#3)(2008-11#2)(2008-9#1)
at very low##18##3##(1990-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-9#1)(2009-7#1)
at very##28##2##(1990-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-9#1)(1996-1#1)(2008-10#11)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-3#1)
at wavelength##2##2##(1997-2#1)(2008-10#1)
at wavelengths of##2##3##(2008-3#2)
at wavelengths##5##2##(1991-5#1)(2008-3#4)
at week##3##2##(2008-5#1)(2013-1#2)
at weekly intervals##3##3##(2008-10#2)(2008-6#1)
at weeks##2##2##(2008-11#1)(2011-2#1)
at what##7##2##(1993-11#1)(1994-12#2)(2006-6#1)(2008-10#1)(2008-11#1)(2009-7#1)
at whatever##2##2##(1992-3#1)(1996-12#1)
at which a##2##3##(2008-10#1)(2008-3#1)
at which the##23##3##(1991-2#1)(1993-3#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-8#1)
at which they##4##3##(1991-8#1)(1994-3#1)(2008-10#1)(2008-8#1)
at which this##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
at which##81##2##(1990-2#1)(1991-2#1)(1991-8#2)(1992-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#24)(2008-11#5)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#5)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
at will##2##2##(1995-12#1)(2008-10#1)
at women##2##2##(2008-1#1)(2008-4#1)
at work in##3##3##(1993-3#1)(2008-7#1)(2008-9#1)
at work##14##2##(1993-3#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
at your##2##2##(1993-3#1)(1994-3#1)
at zero##3##2##(2008-10#1)(2008-8#1)(2010-1#1)
at zero-crossing##2##2##(2008-10#2)
at##11610##1##(1990-10#3)(1990-11#35)(1990-12#25)(1990-2#23)(1990-3#21)(1990-5#58)(1990-6#21)(1990-7#2)(1990-8#28)(1990-9#35)(1991-1#14)(1991-10#3)(1991-11#26)(1991-12#45)(1991-2#56)(1991-3#46)(1991-5#32)(1991-6#42)(1991-7#3)(1991-8#14)(1991-9#20)(1992-1#16)(1992-10#13)(1992-11#3)(1992-12#51)(1992-2#25)(1992-3#58)(1992-4#13)(1992-5#14)(1992-6#23)(1992-7#5)(1992-8#13)(1992-9#23)(1993-1#23)(1993-11#19)(1993-12#52)(1993-2#32)(1993-3#69)(1993-5#3)(1993-6#46)(1993-8#87)(1993-9#22)(1994-1#14)(1994-11#46)(1994-12#39)(1994-2#38)(1994-3#45)(1994-5#54)(1994-6#20)(1994-8#47)(1994-9#18)(1995-1#11)(1995-10#2)(1995-11#48)(1995-12#58)(1995-2#61)(1995-3#24)(1995-5#13)(1995-6#56)(1995-8#52)(1995-9#4)(1996-1#27)(1996-11#16)(1996-12#65)(1996-2#53)(1996-3#31)(1996-5#45)(1996-6#17)(1996-8#6)(1996-9#17)(1997-1#32)(1997-2#63)(1997-3#74)(1997-4#25)(1997-5#8)(1997-6#22)(1997-7#30)(1997-8#52)(1997-9#3)(2006-5#2)(2006-6#15)(2007-11#14)(2007-12#59)(2007-8#6)(2007-9#1)(2008-1#41)(2008-10#4496)(2008-11#719)(2008-12#214)(2008-2#84)(2008-3#312)(2008-4#57)(2008-5#223)(2008-6#66)(2008-7#267)(2008-8#287)(2008-9#250)(2009-1#9)(2009-10#46)(2009-11#33)(2009-12#28)(2009-2#5)(2009-3#22)(2009-4#11)(2009-5#18)(2009-6#26)(2009-7#40)(2009-8#50)(2009-9#21)(2010-1#50)(2010-10#40)(2010-11#27)(2010-12#32)(2010-2#9)(2010-3#21)(2010-4#46)(2010-5#31)(2010-6#30)(2010-7#38)(2010-8#51)(2010-9#11)(2011-1#52)(2011-10#3)(2011-2#393)(2011-3#24)(2011-4#2)(2011-7#2)(2011-9#1)(2012-12#64)(2012-2#201)(2012-3#162)(2012-4#6)(2012-5#8)(2012-6#2)(2012-7#4)(2012-8#1)(2012-9#2)(2013-1#314)(2013-3#2)(2013-7#9)(2013-8#152)
at-line##2##1##(2008-10#1)(2008-11#1)
at-risk populations##2##2##(2008-8#1)(2009-9#1)
at-risk##10##1##(1997-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
ataxia and##3##2##(2008-9#1)(2012-12#1)(2012-3#1)
ataxia telangiectasia##4##2##(2008-7#4)
ataxia##21##1##(1991-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-8#2)(2008-7#8)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
ataxias##7##1##(2008-7#5)(2012-3#2)
ataxic##2##1##(2008-7#1)(2012-2#1)
atc6-1##2##1##(2009-10#2)
atelectasis##3##1##(1991-3#2)(1997-3#1)
atherogenesis##9##1##(1991-12#1)(1992-5#1)(1995-2#1)(1995-8#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-5#1)
atherogenic dyslipidemia##2##2##(2008-3#2)
atherogenic index##2##2##(2008-12#2)
atherogenic##9##1##(1992-3#1)(2008-1#1)(2008-12#2)(2008-3#2)(2008-9#2)(2009-10#1)
atheromatous##2##1##(1997-8#1)(2012-3#1)
atherosclerosis (P less than 0##2##5##(1991-9#2)
atherosclerosis and cardiovascular disease##3##4##(2008-6#3)
atherosclerosis and cardiovascular##4##3##(2008-10#1)(2008-6#3)
atherosclerosis and##17##2##(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-6#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
atherosclerosis by##2##2##(1996-2#1)(2008-7#1)
atherosclerosis in the##2##3##(2008-1#1)(2013-1#1)
atherosclerosis in##4##2##(2008-1#2)(2008-11#1)(2013-1#1)
atherosclerosis is##2##2##(1997-8#1)(2010-12#1)
atherosclerosis plaque##2##2##(2012-3#2)
atherosclerosis plaques##5##2##(2012-3#5)
atherosclerosis##99##1##(1991-12#1)(1991-9#3)(1993-2#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-8#10)(2008-1#7)(2008-10#5)(2008-11#9)(2008-3#1)(2008-6#12)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#4)(2011-2#3)(2012-12#1)(2012-2#7)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#2)
atherosclerotic arteries##3##2##(2008-4#3)
atherosclerotic disease##5##2##(1995-2#1)(2006-6#1)(2008-8#1)(2012-12#1)(2012-2#1)
atherosclerotic lesions##5##2##(1992-5#1)(1997-8#1)(2008-6#1)(2010-9#2)
atherosclerotic patients##3##2##(1991-9#1)(2008-7#2)
atherosclerotic plaque##9##2##(2008-10#1)(2008-6#1)(2008-8#1)(2010-9#4)(2011-2#2)
atherosclerotic plaques and##2##3##(1991-9#1)(2008-7#1)
atherosclerotic plaques##6##2##(1991-9#1)(1997-8#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-8#1)
atherosclerotic process##3##2##(2008-6#1)(2008-7#1)(2011-2#1)
atherosclerotic##43##1##(1991-9#2)(1992-5#1)(1993-3#1)(1995-2#1)(1997-8#2)(2006-6#1)(2008-10#1)(2008-12#2)(2008-4#3)(2008-6#4)(2008-7#5)(2008-8#2)(2010-9#7)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
atherothrombosis##2##1##(2011-2#2)
athlete identity##2##2##(2010-7#2)
athlete is##2##2##(2010-1#1)(2012-3#1)
athlete triad##3##2##(2010-1#3)
athlete##15##1##(2009-1#1)(2010-1#4)(2010-7#2)(2011-2#6)(2012-3#2)
athletes aged##2##2##(2010-1#1)(2013-1#1)
athletes and asthmatic individuals with EIB##2##6##(2010-1#2)
athletes and##4##2##(2010-1#2)(2010-7#1)(2013-1#1)
athletes from##2##2##(2009-11#1)(2012-2#1)
athletes may##2##2##(2010-1#1)(2013-1#1)
athletes with##2##2##(1996-6#1)(2010-1#1)
athletes##45##1##(1990-6#1)(1993-3#1)(1995-1#1)(1996-6#3)(2009-11#1)(2009-7#2)(2009-9#1)(2010-1#12)(2010-7#2)(2012-2#1)(2012-3#5)(2013-1#14)(2013-8#1)
athletic##6##1##(2009-1#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#2)
athleticism##3##1##(2009-7#3)
athymic##3##1##(1993-1#1)(1997-7#1)(2008-10#1)
atlantica##3##1##(2008-10#3)
atlanto-occipital dissociation##2##2##(2012-12#2)
atlantoaxial fusion##3##2##(2012-12#3)
atlantoaxial##6##1##(2008-12#2)(2012-12#3)(2012-3#1)
atlas##7##1##(1997-4#2)(2008-8#2)(2012-3#1)(2013-1#2)
atm##6##1##(2008-10#1)(2008-3#5)
atm)##2##1##(1996-12#1)(2008-10#1)
atmosphere and to##2##3##(2008-10#1)(2008-3#1)
atmosphere and##5##2##(1997-1#1)(2008-10#2)(2008-3#2)
atmosphere at##2##2##(1991-5#1)(2008-10#1)
atmosphere by honeycomb##2##3##(2008-10#2)
atmosphere by##3##2##(2008-10#3)
atmosphere from##2##2##(2008-11#1)(2008-3#1)
atmosphere is##3##2##(2008-10#1)(2008-3#2)
atmosphere of##8##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#3)(2013-1#1)
atmosphere that##2##2##(1991-12#1)(2008-3#1)
atmosphere with##3##2##(2008-10#1)(2008-3#2)
atmosphere##91##1##(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1995-3#3)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#26)(2008-11#15)(2008-12#1)(2008-2#2)(2008-3#30)(2008-5#3)(2010-4#1)(2011-2#2)(2013-1#1)
atmospheres in##2##2##(2008-10#2)
atmospheres##11##1##(2008-10#5)(2008-11#2)(2008-3#1)(2009-7#1)(2010-4#1)(2011-2#1)
atmospheric CO(2)##5##2##(2008-10#3)(2008-3#1)(2009-8#1)
atmospheric CO2##2##2##(2013-8#2)
atmospheric absorption##2##2##(2008-3#2)
atmospheric aerosol##10##2##(2008-10#6)(2008-2#1)(2008-3#3)
atmospheric aerosols covered by molecules##2##5##(2008-3#2)
atmospheric aerosols##8##2##(2008-10#1)(2008-2#3)(2008-3#4)
atmospheric and##2##2##(2008-10#1)(2008-3#1)
atmospheric chemistry and##2##3##(2008-11#2)
atmospheric chemistry##3##2##(1996-1#1)(2008-11#2)
atmospheric constituents##3##2##(2008-11#1)(2008-3#2)
atmospheric correction algorithm##2##3##(2008-3#2)
atmospheric correction##5##2##(2008-2#2)(2008-3#3)
atmospheric events##2##2##(2008-10#2)
atmospheric model##2##2##(2008-3#2)
atmospheric nitrogen##2##2##(2008-10#1)(2011-2#1)
atmospheric optical phenomena##2##3##(2008-3#2)
atmospheric optics##2##2##(2008-3#2)
atmospheric oxygen##2##2##(2008-10#2)
atmospheric parameters##3##2##(2008-2#1)(2008-3#2)
atmospheric particulate matter##3##3##(2008-10#3)
atmospheric particulate##4##2##(2008-10#4)
atmospheric path##2##2##(2008-3#2)
atmospheric pollutants##2##2##(2008-11#1)(2008-3#1)
atmospheric pollution##4##2##(1991-3#1)(2008-2#1)(2011-2#2)
atmospheric populations of G##2##4##(2008-10#2)
atmospheric populations##3##2##(2008-10#3)
atmospheric pressure##12##2##(1996-1#1)(2008-10#6)(2008-3#5)
atmospheric products##3##2##(2008-3#3)
atmospheric species##2##2##(2008-3#2)
atmospheric trace gases##2##3##(2008-10#2)
atmospheric trace##3##2##(2008-10#2)(2008-3#1)
atmospheric transmittance##2##2##(2008-3#2)
atmospheric turbulence##3##2##(1992-11#1)(2008-3#2)
atmospheric water##2##2##(2008-10#1)(2008-3#1)
atmospheric##173##1##(1991-3#1)(1991-6#1)(1992-11#1)(1995-3#1)(1996-1#3)(2008-10#43)(2008-11#10)(2008-2#15)(2008-3#89)(2009-8#1)(2011-2#3)(2012-2#1)(2013-8#4)
atmospheric-dust##2##1##(2008-3#2)
atom at the##2##3##(1991-3#1)(2008-5#1)
atom in the##2##3##(1991-3#1)(1995-11#1)
atom in##3##2##(1991-3#1)(1995-11#1)(2008-5#1)
atom of the##2##3##(1991-3#1)(1994-5#1)
atom of##10##2##(1991-3#1)(1991-9#1)(1993-8#1)(1994-5#1)(1996-5#2)(2008-8#4)
atom ratio and##2##3##(2008-10#2)
atom transfer radical polymerization (ATRP)##2##5##(2008-10#2)
atom transfer radical polymerization##3##4##(2008-10#2)(2008-12#1)
atom trapping##2##2##(2008-10#2)
atom##50##1##(1991-3#5)(1991-9#1)(1992-12#1)(1992-4#3)(1993-8#1)(1994-5#2)(1995-11#1)(1995-3#1)(1996-5#2)(2008-10#18)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#4)(2010-2#1)
atomic absorption analysis of##2##4##(2008-10#2)
atomic absorption and emission##3##4##(2008-10#3)
atomic absorption and##4##3##(2008-10#4)
atomic absorption detection##3##3##(2008-10#3)
atomic absorption determination of##4##4##(2008-10#4)
atomic absorption determination##5##3##(2008-10#5)
atomic absorption is##2##3##(2008-10#2)
atomic absorption method is described for the determination of##2##9##(2008-10#2)
atomic absorption method##6##3##(2008-10#6)
atomic absorption spectrometer##20##3##(2008-10#20)
atomic absorption spectrometric determination of cadmium and lead##3##8##(2008-10#3)
atomic absorption spectrometric determination of##18##5##(2008-10#18)
atomic absorption spectrometric determination##20##4##(2008-10#20)
atomic absorption spectrometric determinations##4##4##(2008-10#4)
atomic absorption spectrometric method##4##4##(2008-10#4)
atomic absorption spectrometric procedure##2##4##(2008-10#2)
atomic absorption spectrometric##43##3##(2008-10#43)
atomic absorption spectrometry (AAS) determination was investigated##2##7##(2008-10#2)
atomic absorption spectrometry (AAS)##13##4##(2008-10#13)
atomic absorption spectrometry (CVAAS) was##2##5##(2008-10#2)
atomic absorption spectrometry (CVAAS)##7##4##(2008-10#7)
atomic absorption spectrometry (ETAAS) is##4##5##(2008-10#4)
atomic absorption spectrometry (ETAAS) method##2##5##(2008-10#2)
atomic absorption spectrometry (ETAAS) was##3##5##(2008-10#3)
atomic absorption spectrometry (ETAAS)##32##4##(2008-10#32)
atomic absorption spectrometry (GFAAS)##24##4##(2008-10#24)
atomic absorption spectrometry (TCAAS) was##2##5##(2008-10#2)
atomic absorption spectrometry after##11##4##(2008-10#11)
atomic absorption spectrometry and##5##4##(2008-10#5)
atomic absorption spectrometry as an##2##5##(2008-10#2)
atomic absorption spectrometry as##3##4##(2008-10#3)
atomic absorption spectrometry at##2##4##(2008-10#2)
atomic absorption spectrometry by##2##4##(2008-10#2)
atomic absorption spectrometry detection##2##4##(2008-10#2)
atomic absorption spectrometry determination of##2##5##(2008-10#2)
atomic absorption spectrometry determination##3##4##(2008-10#3)
atomic absorption spectrometry for##5##4##(2008-10#5)
atomic absorption spectrometry has been described##2##6##(2008-10#2)
atomic absorption spectrometry has been developed##2##6##(2008-10#2)
atomic absorption spectrometry has been##5##5##(2008-10#5)
atomic absorption spectrometry in##7##4##(2008-10#7)
atomic absorption spectrometry is described##3##5##(2008-10#3)
atomic absorption spectrometry is proposed##2##5##(2008-10#2)
atomic absorption spectrometry is##8##4##(2008-10#8)
atomic absorption spectrometry method for determination of##2##7##(2008-10#2)
atomic absorption spectrometry using a##2##5##(2008-10#2)
atomic absorption spectrometry using##12##4##(2008-10#12)
atomic absorption spectrometry utilizing##2##4##(2008-10#2)
atomic absorption spectrometry was used for the determination of##2##9##(2008-10#2)
atomic absorption spectrometry was used for##3##6##(2008-10#3)
atomic absorption spectrometry was used##4##5##(2008-10#4)
atomic absorption spectrometry was##6##4##(2008-10#6)
atomic absorption spectrometry with##12##4##(2008-10#12)
atomic absorption spectrometry##392##3##(1991-12#1)(2008-10#389)(2008-5#1)(2011-2#1)
atomic absorption spectrometry)##2##3##(2008-10#2)
atomic absorption spectrophotometer##4##3##(2008-10#4)
atomic absorption spectrophotometric method##4##4##(1991-2#1)(2008-10#3)
atomic absorption spectrophotometric##5##3##(1991-2#1)(2008-10#4)
atomic absorption spectrophotometry (FAAS)##5##4##(2008-10#5)
atomic absorption spectrophotometry##21##3##(2008-10#21)
atomic absorption spectroscopy (AAS)##4##4##(1996-3#1)(2008-10#3)
atomic absorption spectroscopy##15##3##(1994-11#1)(1996-3#1)(2008-10#13)
atomic absorption##539##2##(1991-12#1)(1991-2#1)(1992-3#2)(1994-11#1)(1996-3#1)(2008-10#531)(2008-5#1)(2011-2#1)
atomic and background signals##2##4##(2008-10#2)
atomic and##4##2##(2008-10#3)(2010-7#1)
atomic beams##2##2##(2008-3#2)
atomic bomb survivor cancer mortality data##2##6##(2013-1#2)
atomic bomb survivor data##2##4##(2013-1#2)
atomic bomb survivor##4##3##(2013-1#4)
atomic bomb##5##2##(2013-1#5)
atomic cloud##2##2##(2008-2#2)
atomic emission detection##2##3##(2008-10#2)
atomic emission spectrometry using##2##4##(2008-10#2)
atomic emission spectrometry with##3##4##(2008-10#3)
atomic emission spectrometry##63##3##(1992-3#1)(2008-10#62)
atomic emission spectroscopy##5##3##(2008-10#5)
atomic emission##85##2##(1992-3#1)(2008-10#83)(2008-11#1)
atomic fluorescence spectrometer##2##3##(2008-10#2)
atomic fluorescence spectrometric detection##2##4##(2008-10#2)
atomic fluorescence spectrometric##4##3##(2008-10#4)
atomic fluorescence spectrometry (AFS) detection##2##5##(2008-10#2)
atomic fluorescence spectrometry (AFS)##4##4##(2008-10#4)
atomic fluorescence spectrometry (HGAFS)##2##4##(2008-10#2)
atomic fluorescence spectrometry after##2##4##(2008-10#2)
atomic fluorescence spectrometry was##2##4##(2008-10#2)
atomic fluorescence spectrometry with##2##4##(2008-10#2)
atomic fluorescence spectrometry##29##3##(2008-10#29)
atomic fluorescence##42##2##(2008-10#42)
atomic force microscope (AFM)##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
atomic force microscope##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
atomic force microscopy (AFM) and##2##5##(2008-10#2)
atomic force microscopy (AFM)##11##4##(2008-10#8)(2008-11#1)(2008-4#1)(2009-7#1)
atomic force microscopy and##2##4##(2008-10#2)
atomic force microscopy##20##3##(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
atomic force##26##2##(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
atomic number density##2##3##(2008-3#2)
atomic number##6##2##(2008-10#4)(2008-3#2)
atomic spectrometric techniques##2##3##(2008-10#2)
atomic spectrometric##3##2##(2008-10#3)
atomic spectrometry methods##2##3##(2008-10#2)
atomic spectrometry techniques##2##3##(2008-10#2)
atomic spectrometry##10##2##(2008-10#10)
atomic spectroscopy##5##2##(2008-10#5)
atomic##761##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#3)(1992-4#1)(1994-11#1)(1994-5#1)(1996-3#1)(2008-10#701)(2008-11#3)(2008-12#2)(2008-2#10)(2008-3#10)(2008-4#2)(2008-5#4)(2008-7#2)(2009-7#1)(2010-7#4)(2011-2#3)(2012-2#1)(2013-1#6)(2013-8#1)
atomic-scale##2##1##(2008-8#1)(2010-7#1)
atomisation temperatures##3##2##(2008-10#3)
atomisation##9##1##(2008-10#9)
atomiser##4##1##(2008-10#4)
atomization and background absorption profiles##2##5##(2008-10#2)
atomization and##4##2##(2008-10#4)
atomization atomic absorption spectrometry (ETAAS)##2##5##(2008-10#2)
atomization atomic absorption spectrometry##3##4##(2008-10#3)
atomization temperature##2##2##(2008-10#2)
atomization##47##1##(2008-10#46)(2011-2#1)
atomized mist##2##2##(2011-2#2)
atomized##4##1##(2008-10#2)(2011-2#2)
atomizer and##4##2##(1996-2#1)(2008-10#3)
atomizer was##2##2##(2008-10#2)
atomizer##37##1##(1996-2#2)(2008-10#35)
atoms and 0##2##3##(1994-5#2)
atoms and##6##2##(1994-5#3)(2008-10#1)(2008-2#1)(2008-5#1)
atoms are##2##2##(2008-10#1)(2012-2#1)
atoms from##2##2##(1991-9#1)(2011-2#1)
atoms in the structure##3##4##(1996-12#2)(2008-10#1)
atoms in the##6##3##(1990-12#1)(1996-12#2)(1996-5#1)(1997-2#1)(2008-10#1)
atoms in##14##2##(1990-12#1)(1991-5#1)(1992-4#1)(1996-12#2)(1996-5#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-3#1)
atoms was identified##2##3##(2008-10#1)(2013-8#1)
atoms was##4##2##(2008-10#3)(2013-8#1)
atoms##54##1##(1990-12#1)(1990-9#1)(1991-5#2)(1991-9#1)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-5#6)(1996-12#2)(1996-5#1)(1997-2#1)(2008-10#17)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
atopic asthma##2##2##(2008-11#1)(2010-5#1)
atopic dermatitis in##2##3##(2013-1#2)
atopic dermatitis##10##2##(1991-2#4)(2008-5#1)(2011-2#1)(2013-1#4)
atopic diseases##2##2##(1991-2#1)(2008-10#1)
atopic##24##1##(1990-3#1)(1991-2#7)(1994-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#4)
atopy at 15 months##2##4##(2010-6#2)
atopy##15##1##(1991-2#1)(2008-1#1)(2008-10#7)(2009-10#1)(2010-6#4)(2012-3#1)
atorvastatin##2##1##(2010-10#1)(2013-8#1)
atracurium##4##1##(2010-7#4)
atranorin##4##1##(2008-5#4)
atrazine and simazine##5##3##(2008-10#5)
atrazine and##10##2##(2008-10#10)
atrazine in water##2##3##(2008-10#2)
atrazine in##7##2##(2008-10#7)
atrazine were##3##2##(2008-10#3)
atrazine##53##1##(2008-10#53)
atresia is##3##2##(2008-7#2)(2012-3#1)
atresia was##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
atresia##25##1##(1994-6#3)(1997-3#3)(2008-7#7)(2008-8#8)(2010-3#1)(2012-3#3)
atretic follicles##4##2##(2008-11#2)(2008-8#2)
atretic##5##1##(2008-11#3)(2008-8#2)
atria and##3##2##(1995-11#1)(2013-1#2)
atria##7##1##(1992-6#1)(1995-11#1)(2009-5#1)(2013-1#4)
atrial arrhythmias##2##2##(2012-12#2)
atrial cells##2##2##(1996-2#2)
atrial fibrillation (AF)##2##3##(2012-12#1)(2012-3#1)
atrial fibrillation and##3##3##(2007-7#1)(2008-12#1)(2010-6#1)
atrial fibrillation##25##2##(1994-8#1)(1996-3#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-7#2)(2009-12#2)(2010-12#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
atrial fibrillation]##2##2##(2008-10#1)(2012-3#1)
atrial fibrosis##3##2##(2012-12#2)(2013-8#1)
atrial myxoma##4##2##(2008-11#1)(2009-6#1)(2012-12#2)
atrial myxomas##4##2##(2012-12#4)
atrial natriuretic factor (ANF)##2##4##(1990-9#1)(1994-8#1)
atrial natriuretic##3##2##(1990-9#1)(1994-8#1)(2011-2#1)
atrial septal defect and##2##4##(2008-11#2)
atrial septal defect##11##3##(2008-11#11)
atrial septal defects##6##3##(1997-8#2)(2008-11#2)(2009-10#1)(2012-3#1)
atrial septal##18##2##(1997-8#2)(2008-11#13)(2009-10#2)(2012-3#1)
atrial tachyarrhythmias##2##2##(2010-4#2)
atrial##95##1##(1990-9#3)(1994-11#1)(1994-8#2)(1996-11#2)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2007-7#1)(2008-10#2)(2008-11#18)(2008-12#3)(2008-3#3)(2008-7#2)(2009-10#2)(2009-12#2)(2009-6#1)(2010-11#2)(2010-12#2)(2010-4#7)(2010-6#2)(2011-2#1)(2012-12#12)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#2)
atrio-ventricular##2##1##(2008-10#1)(2008-7#1)
atrioventricular block##3##2##(2008-11#1)(2009-12#1)(2013-8#1)
atrioventricular conduction##2##2##(1992-6#1)(2008-10#1)
atrioventricular re-entry tachycardia using##2##4##(2008-11#2)
atrioventricular##9##1##(1992-6#2)(2008-10#1)(2008-11#4)(2009-12#1)(2013-8#1)
atrium##12##1##(1991-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#4)(2013-2#2)
atrogin-1##3##1##(2013-1#3)
atrophic##15##1##(1991-11#1)(1995-3#1)(1997-1#2)(2008-5#1)(2008-7#1)(2010-5#2)(2010-6#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
atrophied##4##1##(2011-7#1)(2012-12#1)(2012-2#2)
atrophy after##2##2##(2008-10#1)(2011-2#1)
atrophy and##14##2##(1992-12#1)(1993-8#1)(1996-3#1)(1997-1#2)(2008-10#2)(2010-12#1)(2011-2#2)(2012-2#3)(2013-8#1)
atrophy as##2##2##(2008-10#1)(2010-12#1)
atrophy caused by##2##3##(2008-10#1)(2011-2#1)
atrophy in##3##2##(1993-3#1)(2012-2#1)(2013-1#1)
atrophy of the##5##3##(1997-3#1)(1997-7#1)(2008-7#1)(2010-12#1)(2011-2#1)
atrophy of##6##2##(1997-3#1)(1997-7#1)(2008-7#1)(2010-12#1)(2011-2#2)
atrophy on##2##2##(2008-7#1)(2012-12#1)
atrophy##72##1##(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#3)(1997-3#1)(1997-7#1)(2008-10#9)(2008-2#1)(2008-5#3)(2008-7#9)(2009-11#1)(2009-9#1)(2010-12#7)(2010-6#1)(2011-1#2)(2011-2#13)(2011-7#1)(2012-12#1)(2012-2#7)(2013-1#3)(2013-8#1)
atropine and pethidine##3##3##(2008-10#3)
atropine and##5##2##(1994-8#1)(2008-10#3)(2008-12#1)
atropine##20##1##(1990-5#1)(1990-9#1)(1994-8#1)(1994-9#1)(1996-12#2)(1996-2#1)(1997-4#2)(2008-10#5)(2008-12#1)(2008-8#1)(2010-4#2)(2011-2#1)(2013-1#1)
atropine-resistant##3##1##(1990-5#1)(1993-6#1)(1997-4#1)
atropine-sensitive and##2##2##(1993-6#1)(1997-4#1)
atropine-sensitive##3##1##(1993-6#1)(1997-4#2)
atroseptica##2##1##(2008-10#2)
atroviride##5##1##(2008-10#5)
atrum (1 x 10(6) conidia per ml)##2##7##(2008-10#2)
atrum 385##6##2##(2008-10#6)
atrum conidia on##2##3##(2008-10#2)
atrum in##2##2##(2008-10#2)
atrum strains##4##2##(2008-10#4)
atrum##38##1##(2008-10#38)
attach to the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
attach to##6##2##(2008-10#1)(2008-11#3)(2011-1#1)(2011-2#1)
attach##12##1##(1996-12#1)(2008-10#2)(2008-11#5)(2008-9#2)(2011-1#1)(2011-2#1)
attached at one port of##2##5##(2008-10#2)
attached at one##3##3##(2008-10#2)(2008-7#1)
attached at##4##2##(1994-5#1)(2008-10#2)(2008-7#1)
attached to a##8##3##(1991-2#1)(2008-10#6)(2010-8#1)
attached to each##2##3##(1997-2#1)(2008-12#1)
attached to the back##2##4##(2013-1#2)
attached to the bottom##2##4##(2008-11#1)(2008-4#1)
attached to the enzyme##2##4##(2008-10#2)
attached to the fiber##2##4##(2008-11#1)(2008-3#1)
attached to the flow cells##2##5##(2008-10#2)
attached to the##37##3##(1993-8#1)(1997-2#1)(2007-12#1)(2008-10#16)(2008-11#8)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
attached to yeast##3##3##(2008-10#3)
attached to##81##2##(1990-12#1)(1990-5#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-8#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-2#2)(2007-12#1)(2008-10#32)(2008-11#12)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-1#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
attached##113##1##(1990-12#1)(1990-5#3)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#2)(1992-6#1)(1993-8#2)(1994-5#2)(1994-8#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(2007-12#1)(2008-10#45)(2008-11#18)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#4)(2008-9#2)(2009-1#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
attaching and effacing##2##3##(2008-9#1)(2011-1#1)
attaching to##2##2##(2008-11#2)
attaching##9##1##(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#2)(2011-1#1)
attachment and##10##2##(1991-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2012-5#1)
attachment method##2##2##(2008-10#1)(2012-5#1)
attachment of the##5##3##(1994-12#1)(2008-10#2)(2009-4#1)(2013-1#1)
attachment of##32##2##(1990-8#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
attachment on##3##2##(1995-6#1)(2010-3#1)(2012-2#1)
attachment protein##3##2##(2009-7#1)(2009-8#1)(2012-5#1)
attachment proteins##4##2##(2008-10#3)(2012-5#1)
attachment rate##5##2##(2008-10#2)(2008-11#3)
attachment site##6##2##(1995-6#2)(1996-12#1)(2008-10#1)(2008-8#1)(2009-7#1)
attachment sites##3##2##(1992-10#1)(1995-6#2)
attachment styles##2##2##(2008-12#2)
attachment through##2##2##(2008-10#2)
attachment to the##2##3##(2008-11#1)(2013-8#1)
attachment to##19##2##(1992-12#1)(1992-9#1)(1993-6#1)(1995-2#1)(2008-10#5)(2008-11#4)(2008-5#1)(2011-2#1)(2012-4#1)(2012-5#1)(2013-8#2)
attachment was##2##2##(2008-10#1)(2008-8#1)
attachment##150##1##(1990-8#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-9#1)(1993-6#2)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#8)(1996-12#1)(1996-3#2)(2007-12#3)(2008-10#44)(2008-11#20)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#5)(2009-10#1)(2009-12#3)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#3)(2012-2#9)(2012-4#1)(2012-5#7)(2013-1#4)(2013-8#2)
attachments##4##1##(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)
attack and##6##2##(1991-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
attack at##2##2##(1994-5#1)(2008-9#1)
attack by##4##2##(2008-10#3)(2013-8#1)
attack from##2##2##(2008-8#1)(2010-1#1)
attack in##2##2##(1990-9#1)(2008-10#1)
attack of the##2##3##(1996-5#1)(2011-10#1)
attack of##4##2##(1993-6#1)(1996-5#1)(2011-10#1)(2011-2#1)
attack on##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
attack or##2##2##(2007-12#1)(2008-8#1)
attack rate is##2##3##(2008-8#2)
attack rate##3##2##(2008-8#2)(2009-8#1)
attack when##2##2##(2008-10#1)(2008-9#1)
attack##85##1##(1990-9#2)(1991-3#4)(1993-6#1)(1994-5#2)(1995-2#1)(1996-5#2)(2007-12#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-8#6)(2008-9#5)(2009-10#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-7#2)(2010-9#1)(2011-10#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
attacked by##4##2##(2008-10#3)(2008-8#1)
attacked##7##1##(2008-10#4)(2008-8#1)(2010-3#1)(2012-3#1)
attacking##8##1##(2008-10#4)(2008-8#1)(2008-9#2)(2013-8#1)
attacks and##3##2##(1991-3#1)(2008-4#1)(2011-1#1)
attacks of abdominal pain##2##4##(1997-5#1)(2009-7#1)
attacks of##11##2##(1990-11#2)(1995-5#1)(1997-5#1)(2008-10#1)(2008-8#3)(2009-7#2)(2011-2#1)
attacks or##2##2##(2008-9#1)(2012-3#1)
attacks##38##1##(1990-11#2)(1991-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#2)(2009-7#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
attain a##5##2##(1992-12#1)(1993-3#1)(1995-6#1)(1997-8#1)(2008-8#1)
attain##18##1##(1992-12#1)(1993-3#1)(1995-6#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-4#1)
attainable in##2##2##(2008-10#1)(2008-7#1)
attainable##10##1##(2008-10#7)(2008-3#1)(2008-7#1)(2012-12#1)
attained a##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
attained by the##2##3##(1991-6#1)(2008-7#1)
attained by##9##2##(1991-6#1)(1992-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
attained for##2##2##(2008-10#1)(2012-2#1)
attained in the bioreactor##2##4##(2008-11#2)
attained in the##5##3##(1993-6#1)(2008-10#1)(2008-11#3)
attained in##9##2##(1990-5#1)(1992-12#1)(1993-6#1)(2008-10#3)(2008-11#3)
attained its maximum value##2##4##(2008-10#2)
attained the relatively##2##3##(2008-9#2)
attained the##5##2##(2008-10#2)(2008-11#1)(2008-9#2)
attained through the##2##3##(2008-10#1)(2010-8#1)
attained through##3##2##(1994-2#1)(2008-10#1)(2010-8#1)
attained using##5##2##(2008-10#4)(2008-11#1)
attained were##2##2##(1992-2#1)(2008-10#1)
attained when##2##2##(2008-10#1)(2008-6#1)
attained with##3##2##(1994-11#1)(2008-11#1)(2009-3#1)
attained within##4##2##(2008-10#3)(2011-1#1)
attained##86##1##(1990-2#1)(1990-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-2#1)(2008-10#41)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
attaining##6##1##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
attainment of AUC/MIC##4##3##(2011-2#4)
attainment of##10##2##(1992-3#1)(2009-11#1)(2011-2#4)(2012-5#2)(2013-8#2)
attainment##19##1##(1992-3#1)(1994-3#1)(2008-11#3)(2009-10#1)(2009-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#5)(2012-5#2)(2013-8#2)
attains##3##1##(1994-5#1)(1997-3#1)(2008-8#1)
attempt and##2##2##(1992-1#1)(2008-7#1)
attempt at an##2##3##(1996-2#1)(2008-12#1)
attempt at##7##2##(1995-5#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2013-8#1)
attempt has been made to##4##5##(2008-10#2)(2013-1#2)
attempt in##5##2##(1996-5#1)(2010-2#1)(2010-7#2)(2013-1#1)
attempt is made to##2##4##(2008-10#1)(2013-1#1)
attempt is##3##2##(2008-10#1)(2010-6#1)(2013-1#1)
attempt of insertion##2##3##(2010-7#2)
attempt of##3##2##(2008-7#1)(2010-7#2)
attempt to answer##2##3##(1992-2#1)(1997-3#1)
attempt to apply##2##3##(2008-10#1)(2008-11#1)
attempt to clarify##2##3##(2008-12#1)(2008-9#1)
attempt to determine##2##3##(1993-1#1)(2012-2#1)
attempt to enhance##2##3##(2008-10#2)
attempt to highlight##2##3##(2012-2#1)(2013-1#1)
attempt to make a##3##4##(1997-8#1)(2008-11#1)(2011-2#1)
attempt to reproduce the##2##4##(2008-10#2)
attempt to##83##2##(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2008-10#19)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
attempt was made to find##2##5##(2008-5#1)(2012-2#1)
attempt was made to##6##4##(1990-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
attempt was##9##2##(1990-6#1)(1993-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
attempt##130##1##(1990-6#1)(1991-2#1)(1991-5#1)(1992-1#3)(1992-2#1)(1992-3#3)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#3)(2008-10#29)(2008-11#8)(2008-12#4)(2008-3#3)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#6)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#4)
attempted by##3##2##(2008-10#2)(2008-7#1)
attempted here##2##2##(1994-11#1)(1997-3#1)
attempted in##3##2##(1991-8#1)(2008-11#1)(2008-7#1)
attempted suicide##2##2##(1992-1#1)(2008-11#1)
attempted to characterize the##2##4##(1990-5#1)(2008-10#1)
attempted to clarify the##2##4##(2008-11#1)(2013-8#1)
attempted to develop a##2##4##(2008-10#1)(2010-1#1)
attempted to develop##3##3##(2008-10#1)(2010-1#1)(2010-8#1)
attempted to identify the##2##4##(2008-11#1)(2010-8#1)
attempted to identify##5##3##(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)(2012-3#1)
attempted to obtain##2##3##(2008-11#1)(2008-6#1)
attempted to##44##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(2008-10#5)(2008-11#8)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-6#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#1)
attempted##79##1##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#15)(2008-11#13)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#8)(2009-6#1)(2010-1#1)(2010-11#1)(2010-7#2)(2010-8#2)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#2)(2013-8#1)
attempting to develop##2##3##(2008-12#1)(2011-2#1)
attempting to provide##2##3##(1991-3#1)(2010-10#1)
attempting to##17##2##(1991-3#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#3)(2008-7#2)(2009-1#1)(2010-10#1)(2011-2#1)(2012-3#1)
attempting##19##1##(1991-3#1)(1995-3#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#3)(2008-7#2)(2009-1#1)(2010-10#1)(2011-2#2)(2012-3#1)
attempts and##5##2##(1992-12#1)(2010-6#1)(2013-1#3)
attempts are##2##2##(1992-12#1)(2008-10#1)
attempts at##6##2##(1991-3#1)(1993-3#1)(1995-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
attempts by the##2##3##(1991-1#1)(2013-8#1)
attempts for##2##2##(2008-8#1)(2010-6#1)
attempts have been made to##2##5##(1997-2#1)(2013-1#1)
attempts have been##4##3##(1997-2#1)(2008-11#1)(2010-12#1)(2013-1#1)
attempts have##5##2##(1991-1#1)(1997-2#1)(2008-11#1)(2010-12#1)(2013-1#1)
attempts that##2##2##(2008-11#1)(2013-1#1)
attempts to develop##2##3##(2009-8#1)(2012-2#1)
attempts to engage##2##3##(1997-3#1)(2008-12#1)
attempts to establish##2##3##(1992-1#1)(1992-3#1)
attempts to incorporate##3##3##(1992-1#1)(2011-1#2)
attempts to induce##2##3##(2008-10#2)
attempts to integrate##2##3##(2008-12#2)
attempts to isolate##2##3##(2008-10#1)(2008-5#1)
attempts to provide a##2##4##(1994-9#1)(2010-10#1)
attempts to provide##4##3##(1994-9#1)(2008-11#2)(2010-10#1)
attempts to synthesize##2##3##(2008-9#1)(2012-3#1)
attempts to use##2##3##(2008-10#1)(2008-9#1)
attempts to##66##2##(1990-3#1)(1991-1#1)(1991-11#1)(1992-1#2)(1992-3#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
attempts were##5##2##(2008-10#2)(2013-1#3)
attempts##115##1##(1990-3#1)(1991-1#3)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#3)(1992-12#2)(1992-3#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#16)(2008-11#11)(2008-12#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-1#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#4)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#14)(2013-8#2)
attend to##4##2##(1997-8#1)(2008-11#1)(2009-8#1)(2012-2#1)
attend##19##1##(1990-6#1)(1992-2#1)(1992-5#1)(1993-3#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2012-12#3)(2012-2#2)(2012-3#1)
attendance and##2##2##(2008-5#1)(2008-7#1)
attendance at##3##2##(1991-12#1)(2010-2#1)(2012-12#1)
attendance rate was##2##3##(1991-6#1)(1992-2#1)
attendance was##2##2##(1991-6#1)(2008-12#1)
attendance##26##1##(1991-12#2)(1991-6#4)(1992-2#2)(1994-3#1)(1994-6#3)(1997-2#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
attendant##7##1##(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#2)
attendants##2##1##(2010-5#1)(2013-1#1)
attended a##3##2##(1995-1#1)(1997-4#1)(2010-10#1)
attended an##3##2##(1993-1#1)(2008-9#1)(2013-1#1)
attended by##6##2##(1995-12#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-5#1)
attended the##2##2##(1992-12#1)(1995-1#1)
attended this##2##2##(2008-5#1)(2009-5#1)
attended to##5##2##(1991-6#1)(1994-3#1)(2008-11#2)(2013-1#1)
attended##31##1##(1991-6#3)(1992-12#1)(1993-1#1)(1994-3#1)(1995-1#2)(1995-12#1)(1997-4#1)(2008-11#6)(2008-5#3)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#3)
attendees were##2##2##(1995-12#1)(2008-5#1)
attendees##8##1##(1991-12#2)(1991-3#1)(1995-12#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-5#1)
attenders##3##1##(1991-6#2)(1992-2#1)
attending a##11##2##(1991-8#2)(1993-2#1)(1993-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2013-1#1)
attending an##2##2##(2008-11#1)(2008-5#1)
attending physicians##3##2##(1992-12#1)(2008-3#1)(2010-8#1)
attending school in Cartagena##2##4##(2011-2#2)
attending school##3##2##(2011-2#2)(2012-12#1)
attending the University##2##3##(2008-11#1)(2011-2#1)
attending the##10##2##(1993-2#1)(1995-6#1)(2008-11#1)(2008-7#1)(2011-2#4)(2013-1#1)(2013-8#1)
attending to##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
attending##51##1##(1990-2#1)(1991-8#2)(1992-12#2)(1992-3#1)(1993-12#2)(1993-2#2)(1993-6#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#8)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
attention and##10##2##(1992-1#1)(1992-3#1)(1994-2#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)
attention as a##4##3##(1996-6#1)(2008-8#1)(2010-1#1)(2012-2#1)
attention as##8##2##(1996-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-1#1)(2010-7#1)(2012-2#1)
attention because of##4##3##(1992-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
attention because##5##2##(1992-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)
attention biases##2##2##(2008-11#2)
attention by##2##2##(2008-11#1)(2009-8#1)
attention deficit hyperactivity disorder##7##4##(2008-11#2)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)
attention deficit hyperactivity##8##3##(2008-11#3)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)
attention deficit##12##2##(1995-1#1)(1996-6#1)(2008-11#3)(2008-9#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2012-2#1)
attention deficit/hyperactivity disorder##5##3##(1997-8#4)(2011-2#1)
attention due to its##3##4##(2008-10#1)(2008-11#2)
attention due to##5##3##(2008-10#3)(2008-11#2)
attention from##2##2##(2008-11#1)(2013-8#1)
attention has been devoted to##2##5##(2008-11#2)
attention has been focussed on##2##5##(2010-9#1)(2013-8#1)
attention has been given to##4##5##(1992-1#1)(2008-11#1)(2009-3#1)(2010-8#1)
attention has been paid to the role of##2##8##(2009-4#1)(2011-1#1)
attention has been paid to the##8##6##(1991-3#1)(2008-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)
attention has been paid to##11##5##(1991-3#2)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)
attention has been paid##12##4##(1991-3#2)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-2#1)
attention has been##22##3##(1991-3#2)(1992-1#1)(2008-10#2)(2008-11#4)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-2#1)(2013-8#1)
attention has focused##2##3##(1991-12#1)(2012-2#1)
attention has turned to##2##4##(2008-11#1)(2009-12#1)
attention has##28##2##(1991-12#1)(1991-3#2)(1992-1#1)(1997-6#1)(2008-10#2)(2008-11#6)(2008-5#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-2#1)(2013-8#1)
attention in recent years##2##4##(2010-9#1)(2013-1#1)
attention in the##9##3##(1992-12#1)(1996-6#1)(2008-11#1)(2008-3#1)(2008-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
attention in##23##2##(1991-6#1)(1992-12#1)(1995-12#1)(1996-11#1)(1996-6#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-9#1)(2012-2#2)(2013-1#3)(2013-8#1)
attention is directed##3##3##(2008-11#1)(2008-6#1)(2011-2#1)
attention is given to the##3##5##(1992-3#1)(2008-10#1)(2008-9#1)
attention is given to##6##4##(1992-3#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
attention is paid to the##4##5##(1990-6#1)(1992-3#1)(2008-10#1)(2008-9#1)
attention is paid to##8##4##(1990-6#1)(1992-3#1)(1995-5#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-3#1)
attention is##24##2##(1990-6#1)(1992-3#2)(1992-5#1)(1995-5#2)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#3)(2010-9#1)(2011-2#1)(2011-3#1)
attention must be paid to##5##5##(1995-5#1)(2008-7#2)(2010-11#1)(2013-1#1)
attention must be##6##3##(1995-5#1)(1997-1#1)(2008-7#2)(2010-11#1)(2013-1#1)
attention of an##2##3##(2008-6#1)(2008-9#1)
attention of the##4##3##(1991-3#1)(1991-6#1)(2008-10#2)
attention of##9##2##(1991-3#1)(1991-6#1)(1994-2#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-8#1)(2013-1#1)
attention on the##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
attention on##8##2##(1992-12#1)(1992-2#1)(1993-6#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)
attention only##2##2##(2008-10#1)(2009-7#1)
attention should be paid to##3##5##(1995-3#1)(2008-11#1)(2011-2#1)
attention to a##2##3##(2008-11#1)(2012-3#1)
attention to an##2##3##(2008-8#1)(2011-2#1)
attention to both##2##3##(1993-1#1)(1996-8#1)
attention to male##2##3##(2008-9#1)(2012-3#1)
attention to physical##2##3##(2010-12#1)(2011-2#1)
attention to the##19##3##(1990-9#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-6#1)(2009-8#1)(2010-5#1)
attention to##76##2##(1990-9#2)(1991-1#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#4)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-8#1)(2010-1#4)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#2)
attention towards##2##2##(2008-11#1)(2012-2#1)
attention was paid to the##4##5##(1994-3#2)(2008-10#1)(2008-12#1)
attention was paid to##6##4##(1994-3#2)(2008-10#2)(2008-12#1)(2008-7#1)
attention was##8##2##(1994-3#2)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)
attention##343##1##(1990-6#2)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#3)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#6)(1994-3#3)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-6#4)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#7)(2007-11#1)(2008-1#1)(2008-10#33)(2008-11#53)(2008-12#9)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#8)(2008-8#12)(2008-9#18)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#9)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#6)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#14)(2011-3#4)(2012-12#5)(2012-2#9)(2012-3#4)(2013-1#14)(2013-2#1)(2013-8#7)
attention-deficit##2##1##(2008-11#1)(2008-8#1)
attention-deficit/hyperactivity disorder##3##2##(2008-2#1)(2011-2#2)
attentional load##2##2##(2013-8#2)
attentional processes##2##2##(1996-2#1)(2008-4#1)
attentional style##2##2##(2008-4#2)
attentional##18##1##(1996-2#1)(2008-11#6)(2008-4#4)(2009-4#4)(2013-8#3)
attentive##2##1##(2010-7#1)(2012-2#1)
attenuata##3##1##(1993-12#2)(2010-3#1)
attenuate the##11##2##(1990-2#1)(1992-8#1)(1993-8#1)(1995-1#1)(2008-10#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
attenuate##18##1##(1990-2#1)(1990-5#1)(1992-8#1)(1993-8#1)(1995-1#1)(1997-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
attenuated by##11##2##(1994-2#2)(1994-5#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-5#1)(2012-12#1)(2012-2#1)
attenuated following the addition of HGF##2##6##(2008-11#2)
attenuated in the presence of a##2##6##(1996-5#2)
attenuated in the presence of##3##5##(1996-5#2)(2008-11#1)
attenuated in##6##2##(1991-8#1)(1994-11#1)(1996-2#1)(1996-5#2)(2008-11#1)
attenuated poliovirus##2##2##(1995-5#2)
attenuated the##6##2##(1994-11#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
attenuated total reflectance Fourier transform infrared##3##6##(2008-10#3)
attenuated total reflectance infrared##2##4##(2008-10#2)
attenuated total reflectance##7##3##(2008-10#7)
attenuated total reflectance-Fourier transform infrared spectroscopy##2##6##(2008-10#2)
attenuated total reflection (ATR)##2##4##(2008-10#2)
attenuated total reflection spectroscopy##2##4##(2008-10#2)
attenuated total reflection##7##3##(2008-10#7)
attenuated total##19##2##(2008-10#18)(2008-5#1)
attenuated virus##2##2##(1995-5#1)(2011-2#1)
attenuated with##3##2##(1994-11#1)(2008-11#1)(2010-12#1)
attenuated##87##1##(1991-2#1)(1991-8#1)(1993-6#1)(1994-11#3)(1994-2#2)(1994-5#1)(1995-12#1)(1995-5#6)(1995-8#1)(1996-2#2)(1996-5#2)(1997-1#1)(2008-10#22)(2008-11#9)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
attenuates the##3##2##(1995-12#1)(2008-10#1)(2012-2#1)
attenuates##15##1##(1991-1#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-7#1)(2010-10#3)(2010-5#1)(2011-3#1)(2012-2#1)(2013-8#3)
attenuating##4##1##(1994-5#1)(1994-6#1)(2011-2#1)(2012-3#1)
attenuation at##4##2##(2008-3#2)(2011-2#1)(2012-3#1)
attenuation by##4##2##(2008-11#1)(2008-7#3)
attenuation correction##2##2##(2012-12#2)
attenuation of the##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
attenuation of##10##2##(1992-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-8#1)(2011-2#1)
attenuation spectrum##4##2##(2008-3#4)
attenuation##45##1##(1991-9#1)(1992-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#15)(2008-7#4)(2008-9#4)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
attenuator##2##1##(1993-9#1)(2008-3#1)
attest to##2##2##(2008-11#1)(2008-8#1)
attests to##2##2##(2008-12#1)(2008-9#1)
attine##4##1##(2008-8#4)
attitude and general##2##3##(1990-2#1)(2008-10#1)
attitude and practice of##2##4##(2013-1#2)
attitude and practice##5##3##(2008-1#1)(2013-1#4)
attitude and##8##2##(1990-2#1)(2008-1#1)(2008-10#1)(2010-10#1)(2013-1#4)
attitude in##2##2##(1991-11#1)(2010-12#1)
attitude of a##2##3##(2009-10#1)(2011-3#1)
attitude of the##3##3##(1992-12#1)(2008-1#1)(2009-10#1)
attitude of##9##2##(1990-2#2)(1990-6#1)(1992-12#1)(2008-1#1)(2009-10#2)(2011-3#1)(2012-3#1)
attitude toward##4##2##(1996-11#1)(2009-5#1)(2010-12#1)(2011-2#1)
attitude towards the##5##3##(1994-6#1)(1996-9#1)(1997-3#1)(2008-5#1)(2013-1#1)
attitude towards##9##2##(1992-2#2)(1994-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2008-5#1)(2013-1#2)
attitude##52##1##(1990-11#1)(1990-2#5)(1990-6#2)(1991-11#1)(1991-12#2)(1992-12#1)(1992-2#2)(1993-11#1)(1993-3#1)(1994-6#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#1)
attitudes about obesity##2##3##(2010-10#2)
attitudes about##4##2##(1993-3#1)(2008-11#1)(2010-10#2)
attitudes and behavior##2##3##(2009-7#1)(2013-1#1)
attitudes and behaviors##2##3##(2009-4#1)(2011-1#1)
attitudes and beliefs##2##3##(1994-12#1)(2013-8#1)
attitudes and practices##4##3##(1990-8#1)(1995-1#1)(2008-11#2)
attitudes and##22##2##(1990-11#1)(1990-8#1)(1992-3#1)(1993-6#1)(1994-12#2)(1995-1#1)(2008-10#2)(2008-11#5)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
attitudes are##2##2##(1992-2#1)(2009-9#1)
attitudes did##2##2##(2009-9#2)
attitudes for##2##2##(2010-3#1)(2012-3#1)
attitudes in##3##2##(2008-11#1)(2008-12#1)(2009-10#1)
attitudes of the##2##3##(1994-1#1)(1996-6#1)
attitudes of##20##2##(1991-2#2)(1993-2#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-3#1)(1996-6#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-3#1)
attitudes to##5##2##(2008-11#2)(2008-12#1)(2008-9#1)(2013-1#1)
attitudes toward life and death##3##5##(1992-1#3)
attitudes toward the##2##3##(2008-11#1)(2011-2#1)
attitudes toward their##2##3##(1994-3#1)(1996-2#1)
attitudes toward##24##2##(1992-1#3)(1994-3#2)(1995-1#1)(1996-1#1)(1996-2#1)(1996-8#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#2)(2013-1#1)
attitudes towards Internet use##2##4##(2013-1#2)
attitudes towards cochlear implants##2##4##(2008-9#2)
attitudes towards##12##2##(1990-6#1)(1996-6#1)(2008-11#1)(2008-9#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#3)
attitudes were##3##2##(1991-2#2)(2008-7#1)
attitudes##143##1##(1990-11#2)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#5)(1992-1#4)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#4)(1995-1#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#3)(1996-8#1)(2008-1#1)(2008-10#3)(2008-11#19)(2008-12#4)(2008-7#4)(2008-9#4)(2009-10#3)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#7)(2010-10#9)(2010-11#1)(2010-12#5)(2010-3#5)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#10)(2013-8#1)
attitudinal##3##1##(1994-12#1)(1996-2#1)(2010-11#1)
attorney##6##1##(1992-1#1)(1994-1#1)(1995-12#1)(1996-5#3)
attorneys##4##1##(1991-2#1)(1995-12#1)(2008-11#2)
attract the##4##2##(1994-1#2)(2008-4#1)(2013-1#1)
attract##17##1##(1990-2#1)(1993-1#1)(1994-1#2)(1995-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#1)(2010-9#1)(2013-1#3)
attracted a##3##2##(2008-11#1)(2008-4#1)(2010-9#1)
attracted to##3##2##(2008-8#2)(2009-8#1)
attracted##15##1##(1991-2#1)(1994-9#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
attracting the##3##2##(1990-11#1)(2009-8#1)(2010-9#1)
attracting##10##1##(1990-11#1)(1992-3#1)(1996-8#1)(2008-10#2)(2008-11#1)(2009-8#2)(2010-7#1)(2010-9#1)
attraction and repulsion##2##3##(2008-9#1)(2012-2#1)
attraction and##4##2##(1992-12#1)(2008-9#2)(2012-2#1)
attraction between##2##2##(2008-10#2)
attraction of##2##2##(2008-12#1)(2009-8#1)
attraction##15##1##(1992-12#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#2)(2012-2#1)(2013-8#2)
attractive alternative for##2##3##(2008-11#1)(2008-8#1)
attractive alternative##10##2##(1997-8#1)(2008-10#5)(2008-11#2)(2008-8#1)(2012-2#1)
attractive as##5##2##(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#2)
attractive concept##2##2##(1992-12#1)(2010-10#1)
attractive drug##2##2##(2008-7#1)(2012-2#1)
attractive for use##2##3##(2008-10#1)(2008-7#1)
attractive for##8##2##(2008-10#5)(2008-7#1)(2008-8#1)(2010-7#1)
attractive in##2##2##(2008-1#1)(2009-7#1)
attractive male characters##2##3##(2008-8#2)
attractive male traits##2##3##(2008-8#2)
attractive male##6##2##(2008-8#6)
attractive properties##3##2##(2008-10#2)(2008-6#1)
attractive prospect##2##2##(1994-12#1)(2013-8#1)
attractive sink##3##2##(2008-8#3)
attractive than the buffer##3##4##(2008-10#3)
attractive than the##4##3##(2008-10#3)(2008-5#1)
attractive than##6##2##(2008-10#5)(2008-5#1)
attractive to the##2##3##(1990-8#1)(2013-8#1)
attractive to##10##2##(1990-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
attractive traits##5##2##(2008-8#5)
attractive##115##1##(1990-8#2)(1992-12#1)(1992-3#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#35)(2008-11#11)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#18)(2008-9#1)(2009-4#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-2#8)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#3)
attractiveness of##5##2##(2008-10#3)(2008-5#1)(2009-8#1)
attractiveness##16##1##(1994-3#1)(2008-10#7)(2008-5#4)(2008-9#2)(2009-8#1)(2013-8#1)
attractors##2##1##(2008-11#1)(2008-8#1)
attributable to differences in##2##4##(1995-12#1)(2008-10#1)
attributable to differences##4##3##(1995-12#1)(2008-10#3)
attributable to individual##2##3##(2008-4#1)(2008-7#1)
attributable to the##14##3##(1992-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-7#1)
attributable to##48##2##(1991-12#2)(1992-12#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
attributable##52##1##(1990-9#1)(1991-12#2)(1992-12#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-7#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
attribute the##3##2##(1990-8#1)(2008-9#1)(2010-2#1)
attribute this to the##2##4##(2008-11#1)(2009-12#1)
attribute##11##1##(1990-8#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-12#1)(2010-2#1)(2012-5#1)
attributed the##2##2##(2008-10#1)(2008-8#1)
attributed to Hashimoto's##2##3##(2011-2#2)
attributed to a number of##2##5##(2008-7#2)
attributed to a##11##3##(1990-5#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-1#1)
attributed to an##3##3##(1994-5#1)(2008-10#2)
attributed to differences in##3##4##(2008-10#3)
attributed to differences##4##3##(2008-10#4)
attributed to direct##2##3##(1994-8#1)(2011-2#1)
attributed to high##2##3##(2008-10#1)(2008-4#1)
attributed to increased##2##3##(1991-2#1)(1996-8#1)
attributed to the higher##2##4##(2008-10#1)(2008-8#1)
attributed to the increase in##2##5##(2008-10#1)(2008-11#1)
attributed to the use of##2##5##(1994-12#1)(2012-2#1)
attributed to the##58##3##(1990-12#1)(1990-5#2)(1991-12#2)(1992-10#1)(1992-3#1)(1994-12#1)(1994-3#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#29)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#1)(2011-2#1)(2012-2#3)
attributed to their##5##3##(1994-5#1)(2008-10#2)(2008-11#1)(2009-3#1)
attributed to two##2##3##(2008-10#2)
attributed to##161##2##(1990-12#1)(1990-5#3)(1991-12#2)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-12#1)(2008-10#60)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#8)(2008-9#8)(2009-10#1)(2009-11#2)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#1)
attributed##171##1##(1990-12#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-12#1)(2008-10#63)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#8)(2008-8#9)(2008-9#8)(2009-10#1)(2009-11#2)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-4#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#1)
attributes associated with##2##3##(2008-10#1)(2008-9#1)
attributes for##3##2##(1995-9#1)(2008-5#1)(2012-2#1)
attributes in##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
attributes of the##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
attributes of##9##2##(1993-1#1)(1995-2#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#2)
attributes that##2##2##(1995-12#1)(2013-1#1)
attributes were##2##2##(2008-5#1)(2010-4#1)
attributes which##2##2##(1993-2#1)(2008-12#1)
attributes##55##1##(1991-5#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-5#8)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#3)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#2)
attributing to##3##2##(1990-3#1)(2008-10#1)(2008-9#1)
attribution of##2##2##(1991-12#1)(2008-10#1)
attribution##4##1##(1991-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
attrition and##2##2##(2008-8#1)(2013-8#1)
attrition##11##1##(1994-3#6)(1997-2#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-8#1)
atypia##3##1##(2009-12#1)(2011-2#1)(2012-3#1)
atypical antipsychotic agents##4##3##(1992-12#2)(2008-4#1)(2008-8#1)
atypical antipsychotic##6##2##(1992-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)
atypical antipsychotics##5##2##(2008-8#3)(2009-12#1)(2012-3#1)
atypical cells##2##2##(2008-11#2)
atypical clinical symptoms##2##3##(2008-7#1)(2010-12#1)
atypical clinical##3##2##(1990-5#1)(2008-7#1)(2010-12#1)
atypical forms##2##2##(2008-11#1)(2008-5#1)
atypical melanocytes##2##2##(2010-6#2)
atypical patterns of##2##3##(2012-2#2)
atypical presentation and##2##3##(2008-12#1)(2010-10#1)
atypical presentation##4##2##(2008-12#1)(2009-8#1)(2010-10#1)(2012-12#1)
atypical protein kinase C by##2##5##(2008-3#2)
atypical protein kinase C##4##4##(2008-3#4)
atypical symptoms##2##2##(2008-10#2)
atypical teratoid/rhabdoid tumor of the##2##5##(2011-2#2)
atypical thymic carcinoid##2##3##(2011-2#2)
atypical##94##1##(1990-3#1)(1990-5#1)(1990-6#1)(1992-12#3)(1992-9#1)(1993-2#1)(1994-12#1)(1996-11#2)(1996-3#1)(2008-1#2)(2008-10#11)(2008-11#8)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#7)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)
au cours de la grossesse##3##5##(2011-2#1)(2013-1#2)
au service d'hématologie et d'oncologie pédiatrique à l'hôpital 20 Août du CHU IBN ROCHD de Casablanca##2##16##(2013-1#2)
au traitement##2##2##(2011-2#2)
au##18##1##(2008-11#2)(2011-2#5)(2012-3#1)(2013-1#10)
audible pop##2##2##(2008-12#2)
audible##5##1##(2008-12#5)
audience##14##1##(1991-3#1)(1993-1#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#3)(2010-10#1)(2010-11#1)(2013-1#2)
audiences##2##1##(1992-12#1)(2013-1#1)
audio computer-assisted self-interview##2##3##(2013-1#2)
audio##5##1##(1994-3#1)(2008-11#1)(2008-12#1)(2013-1#2)
audio-video##2##1##(1993-2#1)(2011-2#1)
audio-visual information##2##2##(2011-1#2)
audio-visual##5##1##(2007-9#1)(2011-1#4)
audiological##4##1##(1990-12#3)(2008-9#1)
audiologists##2##1##(2008-9#2)
audiometry##2##1##(2008-9#2)
audiotaped##2##1##(2008-11#1)(2008-12#1)
audiovisual##2##1##(2008-10#1)(2013-8#1)
audit and##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
audit of##5##2##(1993-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
audit tool##4##2##(2008-11#3)(2010-12#1)
audit was used to##2##4##(1994-3#1)(2012-12#1)
audit##38##1##(1991-8#2)(1991-9#1)(1992-2#1)(1993-1#6)(1994-12#2)(1994-3#1)(1996-2#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-11#6)(2008-7#1)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
audited##3##1##(1996-9#1)(2008-8#1)(2013-1#1)
auditing##5##1##(1991-3#1)(1994-2#1)(1996-1#1)(2010-5#1)(2011-2#1)
audition##2##1##(2008-9#2)
auditive##3##1##(1991-6#1)(2011-2#2)
auditor##4##1##(1993-1#3)(1995-6#1)
auditory attention##5##2##(2008-9#3)(2010-5#2)
auditory brainstem response##3##3##(2008-9#3)
auditory canal##2##2##(2008-7#1)(2013-7#1)
auditory cortex and##2##3##(2013-8#2)
auditory cortex of##2##3##(1996-2#1)(2010-7#1)
auditory cortex##15##2##(1996-2#3)(2008-11#4)(2010-12#1)(2010-7#4)(2013-8#3)
auditory nerve potential##2##3##(2008-8#2)
auditory nerve##7##2##(2008-8#5)(2008-9#2)
auditory neuropathy##2##2##(2008-9#2)
auditory sensory memory##2##3##(1995-12#1)(2008-9#1)
auditory system##4##2##(1995-12#1)(1996-6#1)(2008-9#1)(2013-8#1)
auditory##78##1##(1991-1#1)(1991-12#3)(1994-2#1)(1995-12#2)(1996-2#5)(1996-6#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#5)(2008-9#25)(2010-12#1)(2010-5#5)(2010-7#4)(2010-9#1)(2011-1#2)(2013-1#2)(2013-7#1)(2013-8#8)
audits##14##1##(1994-12#2)(1994-3#1)(1995-12#1)(2007-12#1)(2008-11#3)(2012-2#2)(2012-3#3)(2013-1#1)
augite##3##1##(2008-10#3)
augment the effectiveness of##2##4##(2008-11#1)(2008-6#1)
augment the##9##2##(1994-8#1)(2008-11#4)(2008-6#1)(2008-8#3)
augment##18##1##(1990-11#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#3)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
augmentation of the##3##3##(1990-6#1)(1992-8#1)(2008-11#1)
augmentation of##15##2##(1990-6#1)(1992-3#1)(1992-8#1)(2008-10#2)(2008-11#7)(2010-6#1)(2011-2#1)(2013-8#1)
augmentation was##3##2##(2008-11#2)(2012-3#1)
augmentation##29##1##(1990-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(2008-10#4)(2008-11#11)(2008-12#1)(2008-6#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-3#2)(2013-8#1)
augmented by##5##2##(1993-3#2)(1997-1#1)(1997-8#1)(2008-6#1)
augmented the##4##2##(1995-6#1)(1996-12#1)(2008-11#1)(2013-1#1)
augmented with##5##2##(1993-1#1)(2008-3#1)(2012-3#3)
augmented##38##1##(1991-7#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#6)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
augmenting the##3##2##(1996-12#1)(2008-10#1)(2010-11#1)
augmenting##8##1##(1996-12#1)(2008-10#1)(2008-11#2)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
augments the##2##2##(1995-6#1)(2013-1#1)
augments##7##1##(1993-9#1)(1995-6#1)(1995-8#1)(2008-11#1)(2010-7#1)(2013-1#2)
aura and ischemic stroke##2##4##(2008-9#2)
aura and##3##2##(2008-9#3)
aura##9##1##(2008-9#8)(2011-2#1)
aurantiacus##2##1##(1996-2#2)
auratus##8##1##(1994-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2010-8#2)
aureofaciens NRRL##2##2##(2008-10#2)
aureofaciens##5##1##(2008-10#5)
aureus and##11##2##(1996-12#1)(1997-8#1)(2008-11#2)(2009-6#2)(2010-6#1)(2011-2#1)(2012-2#3)
aureus cells##3##2##(2009-6#1)(2012-2#2)
aureus in a##2##3##(2008-10#1)(2010-8#1)
aureus in##6##2##(2008-10#1)(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#1)
aureus infection##2##2##(2011-2#2)
aureus is##4##2##(2006-6#1)(2008-10#1)(2008-11#1)(2010-6#1)
aureus were##2##2##(2011-2#2)
aureus##90##1##(1990-12#1)(1990-5#3)(1991-3#1)(1992-6#4)(1994-3#2)(1995-5#1)(1996-12#7)(1996-6#1)(1996-8#2)(1997-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#7)(2008-12#8)(2008-9#4)(2009-6#4)(2010-12#1)(2010-2#1)(2010-6#5)(2010-8#1)(2011-2#9)(2012-2#9)(2013-1#3)(2013-8#4)
auricles##2##1##(2008-5#1)(2012-3#1)
auricular acupuncture##6##2##(2008-11#2)(2010-6#4)
auricular##8##1##(2008-10#1)(2008-11#2)(2008-7#1)(2010-6#4)
australia##2##1##(2008-10#1)(2012-2#1)
authentic##18##1##(1990-8#1)(1991-5#1)(1994-11#1)(1995-12#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-6#1)(2011-2#2)
authentication and##3##2##(2008-11#2)(2011-2#1)
authentication##8##1##(2008-10#4)(2008-11#3)(2011-2#1)
authenticity of tea##2##3##(2008-10#2)
authenticity of the##2##3##(1991-5#1)(1996-6#1)
authenticity of##8##2##(1991-5#1)(1996-6#1)(2008-10#4)(2008-11#1)(2010-11#1)
authenticity##10##1##(1991-5#1)(1996-6#1)(2008-10#6)(2008-11#1)(2010-11#1)
author addresses##3##2##(1992-3#1)(1994-3#1)(1996-12#1)
author analyzes##2##2##(1991-3#1)(1995-5#1)
author and##4##2##(1991-11#1)(1992-3#1)(1996-12#1)(2008-12#1)
author argues that##3##3##(1991-2#1)(1994-1#1)(2008-11#1)
author argues##4##2##(1991-2#1)(1994-1#1)(2008-11#1)(2011-2#1)
author believes##3##2##(1992-2#1)(1996-1#1)(2008-9#1)
author concludes that##2##3##(1993-12#1)(1997-2#1)
author concludes##4##2##(1993-12#1)(1997-2#1)(2010-11#1)(2011-2#1)
author describes how##2##3##(1991-12#1)(1992-2#1)
author describes the##4##3##(1996-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
author describes##14##2##(1991-1#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1996-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#2)
author discusses the##12##3##(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1997-4#1)(2008-6#1)
author discusses##23##2##(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#2)(1993-12#3)(1993-2#3)(1994-12#1)(1994-2#1)(1994-6#1)(1996-12#1)(1997-4#2)(2008-6#1)(2008-9#1)
author examines##4##2##(1992-1#1)(1993-1#1)(1994-1#1)(1995-2#1)
author explores##2##2##(1996-2#1)(2009-6#1)
author has##3##2##(1992-1#1)(2009-9#1)(2011-3#1)
author of##5##2##(1991-1#1)(1992-3#1)(1993-3#1)(2008-12#1)(2010-10#1)
author offers##6##2##(1991-12#1)(1992-12#3)(1993-1#1)(2010-10#1)
author presents a##5##3##(1991-3#1)(1992-12#1)(1995-2#1)(1995-5#1)(2008-9#1)
author presents##9##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1995-2#1)(1995-5#1)(2008-12#2)(2008-9#1)
author provides a##2##3##(1993-12#1)(2008-9#1)
author relates how the##2##4##(1992-2#1)(1994-2#1)
author respectfully##2##2##(2009-9#2)
author suggests that the##2##4##(1996-12#1)(1997-3#1)
author suggests that##4##3##(1991-11#1)(1993-2#1)(1996-12#1)(1997-3#1)
author summarizes##3##2##(1991-2#1)(1993-6#1)(2009-12#1)
author##172##1##(1990-9#2)(1991-1#8)(1991-11#4)(1991-12#3)(1991-2#5)(1991-3#9)(1991-6#2)(1991-8#1)(1992-1#5)(1992-12#7)(1992-2#8)(1992-3#6)(1993-1#2)(1993-12#7)(1993-2#8)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-5#3)(1996-1#2)(1996-12#7)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2007-8#1)(2008-11#8)(2008-12#8)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#6)(2009-12#2)(2009-6#1)(2009-9#5)(2010-10#2)(2010-11#1)(2011-2#10)(2011-3#3)(2012-2#1)(2012-3#1)(2013-1#2)
author's##20##1##(1991-1#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
authoritative##3##1##(1993-12#1)(1996-1#1)(2008-12#1)
authorities and the##2##3##(1993-11#1)(1994-3#1)
authorities and##5##2##(1993-11#1)(1994-3#1)(2008-11#2)(2008-5#1)
authorities have##4##2##(1992-1#1)(1997-3#1)(2008-10#2)
authorities in the##3##3##(1997-2#1)(2008-10#2)
authorities in##4##2##(1997-2#1)(2008-10#2)(2008-6#1)
authorities of the##3##3##(1990-6#1)(2008-10#1)(2012-12#1)
authorities or##2##2##(1997-3#2)
authorities to##3##2##(1990-3#1)(1991-6#1)(2011-2#1)
authorities##38##1##(1990-3#2)(1990-6#1)(1991-6#2)(1992-1#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-6#2)(1996-11#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(2008-10#5)(2008-11#6)(2008-5#2)(2008-6#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
authority and resources##2##3##(1995-12#1)(2012-3#1)
authority and##4##2##(1995-12#1)(1995-2#1)(2009-6#1)(2012-3#1)
authority to##5##2##(1991-1#1)(1991-12#1)(1994-12#2)(2010-9#1)
authority##25##1##(1991-1#1)(1991-12#2)(1992-1#1)(1993-1#1)(1994-12#3)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(2008-11#3)(2008-12#4)(2009-6#1)(2010-9#1)(2012-3#1)
authorization bill##4##2##(1995-6#3)(1996-5#1)
authorization of##2##2##(1997-6#1)(2012-2#1)
authorization##9##1##(1992-3#1)(1995-6#3)(1996-5#2)(1997-6#1)(2008-5#1)(2012-2#1)
authorized##16##1##(1992-3#1)(1994-3#1)(1995-2#2)(2010-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
authors analyze the##2##3##(1995-12#1)(1996-3#1)
authors analyze##4##2##(1991-6#1)(1995-12#1)(1995-5#1)(1996-3#1)
authors analyzed##2##2##(2010-5#1)(2012-3#1)
authors and readers##3##3##(2010-12#3)
authors and##5##2##(2008-10#1)(2010-12#3)(2013-8#1)
authors are##4##2##(2008-7#1)(2010-1#1)(2011-2#2)
authors argue that##4##3##(1993-3#1)(2008-11#2)(2008-12#1)
authors as##2##2##(2008-7#1)(2010-7#1)
authors believe that the##2##4##(2008-7#1)(2008-9#1)
authors believe that##5##3##(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
authors believe##7##2##(1994-6#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
authors conclude that there##2##4##(1994-2#1)(2008-10#1)
authors conclude that##8##3##(1991-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(2008-10#2)(2008-11#1)
authors conclude##9##2##(1991-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(2008-10#2)(2008-11#1)(2013-8#1)
authors considered##2##2##(1991-2#1)(2008-10#1)
authors deal with the##2##4##(1993-2#1)(2008-10#1)
authors demonstrate that##2##3##(2010-10#2)
authors describe a##11##3##(1991-6#1)(1993-12#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-9#1)(2011-7#1)
authors describe the##11##3##(1992-12#1)(1993-2#1)(1993-6#1)(1994-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-9#1)(2010-1#1)(2012-12#1)(2013-1#1)
authors describe##31##2##(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#2)(2009-4#2)(2009-9#1)(2010-1#1)(2010-9#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#1)
authors discuss the##10##3##(1991-12#1)(1993-1#1)(1993-2#1)(1993-6#1)(1996-6#1)(2007-12#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-3#1)
authors discuss##19##2##(1991-11#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-6#1)(2007-12#1)(2008-9#3)(2011-2#1)(2011-7#1)(2012-3#1)
authors estimated the##2##3##(2010-10#1)(2013-1#1)
authors examined##2##2##(2009-5#1)(2012-3#1)
authors explore##4##2##(1991-12#1)(1994-12#1)(1994-3#1)(2010-10#1)
authors find that##2##3##(1993-12#1)(1994-3#1)
authors found##4##2##(1992-5#1)(1994-12#1)(2011-2#1)(2013-8#1)
authors have argued##2##3##(1995-2#1)(1995-5#1)
authors have developed a##2##4##(1993-2#1)(2008-9#1)
authors have developed##3##3##(1993-2#1)(2008-9#1)(2011-2#1)
authors have suggested##2##3##(1991-12#1)(2013-1#1)
authors have##22##2##(1990-5#1)(1991-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
authors hypothesize that##2##3##(2008-11#1)(2010-1#1)
authors identified##2##2##(1995-12#1)(2010-10#1)
authors of##8##2##(1993-3#1)(1994-3#1)(1996-12#1)(1997-4#1)(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#1)
authors performed##3##2##(1993-3#1)(2011-2#1)(2012-2#1)
authors present a##8##3##(1991-6#1)(2008-11#1)(2008-12#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)
authors present the##6##3##(1993-2#1)(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
authors present their##2##3##(1990-5#1)(1995-5#1)
authors present##21##2##(1990-5#1)(1991-6#1)(1992-12#1)(1993-2#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#4)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-3#2)
authors propose a##3##3##(2010-6#1)(2013-1#2)
authors propose##6##2##(1995-11#1)(2008-7#1)(2010-1#1)(2010-6#1)(2013-1#2)
authors provide##3##2##(2008-11#1)(2008-9#2)
authors recommend##4##2##(2008-9#2)(2011-2#1)(2012-3#1)
authors report on##6##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1996-2#1)(1996-3#1)
authors report the results of##2##5##(1990-9#1)(1993-12#1)
authors report the##10##3##(1990-9#1)(1991-11#2)(1993-12#1)(1994-2#1)(1996-3#1)(2008-7#2)(2010-12#1)(2011-2#1)
authors report##45##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#5)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#4)(1993-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-3#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#5)(2009-10#1)(2010-12#2)(2011-2#3)(2012-3#1)(2013-8#3)
authors reviewed##2##2##(2011-2#1)(2013-1#1)
authors suggest a##2##3##(1990-9#1)(2013-1#1)
authors suggest that the##2##4##(1996-1#1)(2011-2#1)
authors suggest that##9##3##(1996-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#3)
authors suggest##13##2##(1990-9#1)(1991-3#1)(1993-12#1)(1996-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#3)(2013-1#1)
authors to##8##2##(1991-2#1)(1994-2#1)(2008-5#1)(2009-4#1)(2009-5#1)(2013-1#3)
authors use##3##2##(2008-11#1)(2009-11#1)(2010-10#1)
authors using##2##2##(2008-10#1)(2009-9#1)
authors##413##1##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#6)(1991-1#1)(1991-11#8)(1991-12#6)(1991-2#3)(1991-3#5)(1991-6#7)(1991-8#2)(1992-1#1)(1992-12#6)(1992-2#5)(1992-3#1)(1992-5#10)(1993-1#3)(1993-11#3)(1993-12#7)(1993-2#10)(1993-3#7)(1993-6#8)(1994-1#1)(1994-12#5)(1994-2#4)(1994-3#5)(1994-6#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#1)(1995-5#4)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#8)(1996-6#4)(1997-2#2)(1997-4#1)(2007-12#1)(2008-1#4)(2008-10#20)(2008-11#27)(2008-12#7)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#16)(2008-8#4)(2008-9#22)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#2)(2009-9#2)(2010-1#4)(2010-10#13)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#29)(2011-3#2)(2011-7#4)(2012-12#4)(2012-2#3)(2012-3#12)(2013-1#14)(2013-8#8)
authors' own##3##2##(1992-3#2)(2011-3#1)
authors'##28##1##(1990-11#1)(1990-9#1)(1992-1#1)(1992-3#2)(1993-3#2)(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-3#2)(2012-3#2)
autism are##2##2##(2008-11#1)(2012-3#1)
autism is##3##2##(1997-8#1)(2008-11#1)(2012-3#1)
autism spectrum disorders##2##3##(2008-11#1)(2012-2#1)
autism spectrum##4##2##(2008-11#1)(2010-7#1)(2012-12#1)(2012-2#1)
autism##31##1##(1991-2#3)(1995-1#1)(1997-8#3)(2008-11#9)(2010-7#3)(2012-12#1)(2012-2#1)(2012-3#9)(2013-8#1)
autistic symptoms##2##2##(2008-11#2)
autistic##12##1##(1997-8#2)(2008-11#8)(2010-4#1)(2012-2#1)
auto- and##2##2##(1992-6#1)(2008-9#1)
auto-##3##1##(1992-6#1)(2008-10#1)(2008-9#1)
autoactivation##2##1##(1991-9#1)(1994-5#1)
autoantibodies against##2##2##(1996-11#1)(2010-4#1)
autoantibodies and##3##2##(2008-10#3)
autoantibodies in##3##2##(1995-3#1)(2011-2#1)(2013-1#1)
autoantibodies to##4##2##(2008-4#1)(2010-4#1)(2012-3#1)(2013-7#1)
autoantibodies##33##1##(1994-12#2)(1995-2#1)(1995-3#1)(1996-11#5)(2008-10#3)(2008-4#1)(2008-7#1)(2009-8#1)(2010-4#2)(2011-2#4)(2012-3#6)(2013-1#1)(2013-7#5)
autoantibody and##2##2##(2013-1#1)(2013-7#1)
autoantibody##5##1##(2008-10#1)(2008-4#2)(2013-1#1)(2013-7#1)
autoantigen##3##1##(1995-12#1)(1995-2#2)
autoantigens##2##1##(1995-2#1)(1997-8#1)
autoassociative neural networks##2##3##(2008-10#2)
autoassociative##3##1##(2008-10#2)(2008-11#1)
autocatalytic##8##1##(1992-6#2)(1995-6#1)(2008-10#5)
autochthonous sources##2##2##(2008-9#1)(2013-1#1)
autochthonous##7##1##(2008-10#2)(2008-4#1)(2008-9#2)(2010-4#1)(2013-1#1)
autoclaved or##3##2##(2008-10#2)(2008-11#1)
autoclaved pistachio shoots##2##3##(2008-10#2)
autoclaved rockwool##3##2##(2008-10#3)
autoclaved soil##2##2##(2008-10#1)(2008-12#1)
autoclaved##18##1##(2008-10#15)(2008-11#1)(2008-12#1)(2013-1#1)
autocorrelation analysis##4##2##(2008-10#4)
autocorrelation function##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
autocorrelation functions##3##2##(1992-9#1)(2008-11#1)(2008-8#1)
autocorrelation in##3##2##(2008-10#1)(2008-8#2)
autocorrelation of##4##2##(2007-12#2)(2008-8#2)
autocorrelation##35##1##(1992-9#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#8)(2013-1#2)
autocrine and paracrine##3##3##(1995-8#1)(2013-1#1)(2013-7#1)
autocrine growth of##2##3##(2008-11#2)
autocrine growth##3##2##(2008-11#3)
autocrine loop##2##2##(1990-5#1)(2008-11#1)
autocrine##24##1##(1990-2#1)(1990-5#2)(1993-3#3)(1995-12#1)(1995-8#1)(2008-11#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-8#1)(2013-1#2)(2013-7#1)
autoepitopes##4##1##(1995-2#4)
autofluorescence##7##1##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#2)(2011-7#1)
autogenic##2##1##(1991-2#1)(2012-3#1)
autogenous bone##2##2##(2010-3#1)(2010-5#1)
autogenous##9##1##(1996-2#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-5#1)(2011-3#2)(2012-3#2)
autograft and##3##2##(2009-3#2)(2012-3#1)
autograft for##2##2##(2008-7#1)(2013-8#1)
autograft of##2##2##(2006-6#1)(2008-11#1)
autograft was##2##2##(2010-3#2)
autograft##24##1##(2006-6#3)(2008-11#1)(2008-7#4)(2009-3#5)(2010-3#2)(2011-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
autograft)##2##1##(2010-5#1)(2013-1#1)
autografts##8##1##(2006-6#4)(2009-3#3)(2010-3#1)
autoimmune MRL-lpr mice##3##3##(1993-3#3)
autoimmune and##2##2##(1991-2#1)(2012-3#1)
autoimmune demyelinating##2##2##(2011-2#1)(2012-3#1)
autoimmune diabetes##4##2##(2008-10#3)(2009-5#1)
autoimmune disease and##5##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
autoimmune disease in##4##3##(1993-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
autoimmune disease##27##2##(1993-3#1)(1995-12#1)(1995-2#2)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
autoimmune diseases and##2##3##(2008-10#1)(2013-8#1)
autoimmune diseases##21##2##(1992-5#1)(1997-5#1)(2008-10#6)(2008-4#1)(2011-2#4)(2012-3#4)(2013-1#2)(2013-8#2)
autoimmune disorder##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
autoimmune disorders such as##2##4##(2011-2#1)(2013-1#1)
autoimmune disorders##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
autoimmune encephalomyelitis (EAE)##3##3##(1995-12#1)(2010-12#1)(2012-2#1)
autoimmune encephalomyelitis##7##2##(1995-12#2)(2010-12#2)(2012-2#2)(2013-7#1)
autoimmune etiology##3##2##(2008-4#1)(2012-3#1)(2013-1#1)
autoimmune hepatitis##5##2##(1996-11#4)(2008-10#1)
autoimmune liver disease##2##3##(1992-12#2)
autoimmune liver##3##2##(1992-12#2)(1997-8#1)
autoimmune mechanisms##2##2##(1997-8#1)(2012-3#1)
autoimmune neurologic diseases##2##3##(2012-3#2)
autoimmune phenomena##2##2##(2007-11#1)(2009-8#1)
autoimmune polyglandular disease type I (APECED)##2##6##(1997-2#2)
autoimmune polyglandular##3##2##(1997-2#2)(2012-3#1)
autoimmune reactions towards endocrine pancreas and##2##6##(1994-12#2)
autoimmune reactions##3##2##(1994-12#2)(2008-10#1)
autoimmune response##2##2##(1995-12#1)(2011-2#1)
autoimmune thyroiditis##2##2##(1991-8#2)
autoimmune##134##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-8#2)(1992-12#2)(1992-5#1)(1993-3#4)(1993-5#1)(1994-12#2)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1996-11#6)(1996-2#1)(1997-2#2)(1997-5#1)(1997-8#5)(2007-11#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-4#7)(2008-5#4)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#11)(2012-2#6)(2012-3#16)(2013-1#7)(2013-7#3)(2013-8#3)
autoimmune-prone MRL(+/+)##2##2##(2008-10#2)
autoimmune-prone##4##1##(2008-10#4)
autoimmunity and##3##2##(2008-10#1)(2008-7#2)
autoimmunity in##6##2##(2008-10#3)(2008-7#2)(2008-9#1)
autoimmunity was##3##2##(2008-10#3)
autoimmunity##38##1##(1993-3#2)(1995-5#1)(1997-8#1)(2008-10#17)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-5#3)(2011-2#3)(2012-3#1)(2013-1#2)
autoinducer##2##1##(1995-2#1)(2009-6#1)
autologous CTL##2##2##(2008-11#2)
autologous and allograft limbal##3##4##(2010-10#3)
autologous blood donation##5##3##(1996-9#4)(2009-3#1)
autologous blood##9##2##(1990-2#1)(1992-9#1)(1996-9#6)(2009-3#1)
autologous bone marrow transplantation##2##4##(1994-5#2)
autologous bone marrow##4##3##(1994-5#2)(1995-1#1)(2008-11#1)
autologous bone##6##2##(1994-5#2)(1995-1#1)(2008-11#1)(2008-7#1)(2011-7#1)
autologous cultured osteoblasts mixed with fibrin##2##6##(2008-11#2)
autologous cultured##3##2##(2008-11#3)
autologous reconstruction##2##2##(2013-1#2)
autologous stem cell transplantation##2##4##(2012-12#2)
autologous stem cell##3##3##(2012-12#2)(2012-4#1)
autologous transplantation##2##2##(2012-10#1)(2012-12#1)
autologous tumor##2##2##(1994-5#1)(1996-10#1)
autologous##53##1##(1990-12#1)(1990-2#1)(1992-9#1)(1994-5#5)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-9#9)(2008-11#10)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#3)(2011-2#1)(2011-7#1)(2012-10#1)(2012-12#3)(2012-2#1)(2012-3#4)(2012-4#1)(2013-1#4)
automasking algorithm##3##2##(2012-2#3)
automate the##2##2##(2008-10#2)
automate##5##1##(2008-10#4)(2010-10#1)
automated DNA##3##2##(1994-3#1)(2008-4#1)(2008-9#1)
automated and##9##2##(1990-12#1)(1991-2#1)(1993-9#1)(1997-2#1)(2008-10#4)(2008-11#1)
automated assay##2##2##(2008-10#2)
automated batch##2##2##(2008-10#2)
automated by##2##2##(2008-10#1)(2010-8#1)
automated cell culture platform##2##4##(2008-11#2)
automated cell##4##2##(2008-11#4)
automated coagulation analysers##3##3##(2008-10#3)
automated continuous flow##2##3##(2008-10#2)
automated continuous##3##2##(2008-10#3)
automated device##3##2##(2010-7#3)
automated differential static##2##3##(2008-10#2)
automated discectomy##3##2##(1996-3#3)
automated equipment##2##2##(1990-2#1)(2008-10#1)
automated flow cytometry##2##3##(2008-11#2)
automated flow injection system for##2##5##(2008-10#2)
automated flow injection system##4##4##(2008-10#4)
automated flow injection##6##3##(2008-10#6)
automated flow##9##2##(2008-10#7)(2008-11#2)
automated high-throughput##2##2##(2008-11#1)(2009-7#1)
automated in-situ monitoring of total dissolved iron and total dissolved manganese in underground water##2##14##(2008-10#2)
automated liquid handling system##2##4##(2008-10#2)
automated method##6##2##(2008-10#6)
automated methodology##2##2##(2008-10#2)
automated on-line##2##2##(2008-10#2)
automated operation##2##2##(2008-10#2)
automated procedures##2##2##(2008-10#2)
automated process##3##2##(2008-10#2)(2010-1#1)
automated sample handling in##2##4##(2008-10#1)(2008-9#1)
automated sample handling##3##3##(1997-6#1)(2008-10#1)(2008-9#1)
automated sample##7##2##(1997-6#1)(2008-10#5)(2008-9#1)
automated sampling##2##2##(2008-10#1)(2011-2#1)
automated screening##2##2##(2008-10#2)
automated sequential injection##2##3##(2008-10#2)
automated solid-phase##3##2##(1992-6#1)(2008-10#1)(2012-2#1)
automated system for liquid-liquid extraction##2##5##(2008-10#2)
automated system for the##3##4##(2008-10#3)
automated system for##5##3##(2008-10#5)
automated system##13##2##(1991-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2010-12#1)
automated systems##2##2##(2008-10#2)
automated test methods##3##3##(2008-10#3)
automated test##6##2##(2008-10#6)
automated using##2##2##(2008-10#2)
automated##219##1##(1990-12#2)(1990-2#3)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#4)(1997-2#5)(1997-6#4)(1997-7#1)(2008-10#144)(2008-11#15)(2008-3#3)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-7#3)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#1)
automatic analyser##2##2##(2008-10#2)
automatic and##7##2##(2008-10#7)
automatic determination of##4##3##(2008-10#3)(2008-3#1)
automatic determination##5##2##(2008-10#4)(2008-3#1)
automatic filtration##2##2##(2008-10#2)
automatic flow##3##2##(2008-10#3)
automatic membrane inlet mass spectrometric##2##5##(2008-10#2)
automatic method for the determination of##3##6##(2008-10#3)
automatic method for the##4##4##(2008-10#4)
automatic method##5##2##(2008-10#5)
automatic methods##3##2##(2008-10#3)
automatic monitoring##2##2##(2008-10#1)(2008-11#1)
automatic potentiometric##2##2##(2008-10#2)
automatic system based on##2##4##(2008-10#2)
automatic system##3##2##(2008-10#2)(2011-2#1)
automatic##91##1##(1990-12#1)(1991-12#1)(1997-2#1)(2008-10#65)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2010-12#1)(2010-7#2)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
automatically analyzed by##2##3##(1994-6#1)(2008-10#1)
automatically##37##1##(1993-12#1)(1994-6#2)(1995-12#2)(2008-10#18)(2008-11#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-3#1)(2012-2#1)
automating the##3##2##(2008-10#3)
automating##4##1##(2008-10#3)(2008-9#1)
automation and##3##2##(2008-10#3)
automation as one##2##3##(2008-10#2)
automation development of pharmaceutical##2##4##(2008-10#2)
automation development##3##2##(2008-10#3)
automation of the##6##3##(2008-10#6)
automation of##14##2##(2008-10#13)(2011-2#1)
automation support must##2##3##(2008-10#2)
automation##56##1##(1992-11#1)(2008-10#53)(2011-2#1)(2013-1#1)
automobile catalysts##2##2##(2008-10#1)(2008-11#1)
automobile emission##2##2##(2008-11#2)
automobile##10##1##(2008-10#4)(2008-11#6)
automotive catalysts are##2##3##(2008-11#2)
automotive catalysts##3##2##(2008-11#3)
automotive##9##1##(2008-10#6)(2008-11#3)
autonomic dysfunction##7##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#1)
autonomic nerve differentiation##3##3##(2009-7#3)
autonomic nervous system##10##3##(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-8#1)(2012-2#3)(2013-1#1)(2013-8#1)
autonomic nervous##13##2##(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-8#2)(2010-11#1)(2010-5#1)(2012-2#3)(2013-1#1)(2013-8#1)
autonomic neuropathy##4##2##(2009-12#1)(2011-2#1)(2012-2#2)
autonomic system (AS)##2##3##(2008-12#2)
autonomic system##4##2##(2008-12#4)
autonomic##45##1##(1991-1#1)(1994-3#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-12#7)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#4)
autonomous operation##3##2##(2008-10#2)(2010-7#1)
autonomous##15##1##(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
autonomously replicating##2##2##(1997-8#1)(2008-8#1)
autonomously##6##1##(1990-6#1)(1997-8#1)(2008-10#2)(2008-8#2)
autonomy and belongingness##2##3##(2009-7#2)
autonomy and##8##2##(1990-6#1)(1992-1#1)(1997-8#1)(2008-11#1)(2009-7#2)(2010-11#1)(2013-8#1)
autonomy may##2##2##(1991-2#1)(2008-12#1)
autonomy##31##1##(1990-6#1)(1990-8#1)(1991-2#3)(1992-1#1)(1993-9#1)(1994-1#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-8#2)(2008-11#2)(2008-12#3)(2008-6#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-8#1)(2013-8#1)
autophagic process##2##2##(2011-2#1)(2013-1#1)
autophagic vacuoles##2##2##(2008-11#2)
autophagic##8##1##(2008-11#2)(2008-7#1)(2011-2#2)(2013-1#3)
autophagy and##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
autophagy in##3##2##(2008-11#2)(2008-7#1)
autophagy is##2##2##(2008-7#1)(2012-3#1)
autophagy##23##1##(2008-11#4)(2008-7#7)(2012-2#1)(2012-3#3)(2013-1#8)
autophagy-dedicated##2##1##(2013-1#2)
autophosphorylated EGF-R##2##2##(1995-6#2)
autophosphorylated##5##1##(1992-9#1)(1995-6#2)(1995-8#2)
autophosphorylation and##2##2##(1995-2#1)(1995-8#1)
autophosphorylation in##2##2##(1993-8#1)(1994-11#1)
autophosphorylation of the##2##3##(1993-8#1)(1995-6#1)
autophosphorylation sites##2##2##(1995-6#1)(1996-2#1)
autophosphorylation##18##1##(1990-12#1)(1992-10#1)(1993-6#2)(1993-8#4)(1994-11#1)(1995-2#2)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)
autopsies performed##2##2##(2008-11#1)(2010-6#1)
autopsies##5##1##(1993-2#1)(2008-11#1)(2008-5#1)(2010-6#1)(2012-2#1)
autopsy case##2##2##(1995-11#1)(2011-2#1)
autopsy findings##2##2##(1995-11#1)(1996-11#1)
autopsy in##2##2##(2008-5#1)(2008-9#1)
autopsy was performed##2##3##(1997-8#1)(2013-1#1)
autopsy##30##1##(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-2#1)(1995-11#5)(1995-12#1)(1995-3#1)(1996-11#5)(1997-8#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-8#1)(2011-2#1)(2013-1#2)
autoradiographic##5##1##(1991-10#1)(1994-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
autoradiography##12##1##(1991-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#1)
autoreactivity to##2##2##(1995-12#2)
autoreactivity##3##1##(1995-12#3)
autoreceptors##2##1##(2008-7#1)(2008-8#1)
autoregression##2##1##(2008-10#1)(2008-8#1)
autoregressive##8##1##(2008-12#1)(2008-3#1)(2008-8#2)(2009-4#1)(2009-7#1)(2009-8#1)(2013-1#1)
autoregulation is##3##2##(1996-6#1)(2009-1#2)
autoregulation of##2##2##(1993-9#1)(1994-12#1)
autoregulation##7##1##(1993-9#1)(1994-12#1)(1996-6#2)(2009-1#3)
autoregulatory##5##1##(1997-7#1)(2008-6#1)(2008-7#2)(2009-1#1)
autosampler cup##4##2##(2008-10#4)
autosampler cups##3##2##(2008-10#3)
autosampler##17##1##(2008-10#16)(2013-1#1)
autosomal dominant DI##2##3##(1997-8#2)
autosomal dominant and##2##3##(2008-11#1)(2008-7#1)
autosomal dominant disease with##2##4##(2008-12#1)(2013-1#1)
autosomal dominant neurohypophyseal##2##3##(1997-8#2)
autosomal dominant##32##2##(1993-12#1)(1996-2#1)(1997-1#2)(1997-3#4)(1997-6#1)(1997-8#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#1)(2010-12#1)(2010-6#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
autosomal recessive disease##3##3##(1995-6#1)(1997-1#1)(2011-1#1)
autosomal recessive disorder characterized by##2##5##(2011-1#2)
autosomal recessive disorder##4##3##(2008-7#1)(2011-1#2)(2012-12#1)
autosomal recessive##20##2##(1990-8#1)(1990-9#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2010-2#1)(2011-1#3)(2011-3#1)(2012-12#1)(2012-3#1)
autosomal##65##1##(1990-8#1)(1990-9#1)(1993-12#1)(1995-6#1)(1996-2#2)(1996-8#1)(1997-1#3)(1997-3#4)(1997-6#1)(1997-8#5)(2008-11#2)(2008-12#7)(2008-4#4)(2008-6#1)(2008-7#8)(2008-8#2)(2010-12#1)(2010-2#1)(2010-6#2)(2010-9#1)(2011-1#4)(2011-3#1)(2012-12#2)(2012-3#5)(2013-1#3)(2013-8#1)
autosomes##6##1##(1993-12#2)(2008-12#2)(2008-7#1)(2010-5#1)
autotetraploid species##2##2##(1993-3#2)
autotransplantation of##2##2##(1997-8#1)(2013-1#1)
autotransplantation##3##1##(1997-8#1)(2013-1#2)
autotrasplantation##2##1##(2013-1#2)
autoxidation##2##1##(2008-10#1)(2008-5#1)
autumn and winter##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
autumn and##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
autumn of##2##2##(2010-8#1)(2013-1#1)
autumn temperatures##2##2##(2012-7#2)
autumn was##2##2##(2008-10#1)(2010-8#1)
autumn##27##1##(1994-12#1)(1996-12#2)(2008-10#11)(2008-11#1)(2008-5#2)(2010-8#6)(2011-9#1)(2012-7#2)(2013-1#1)
autumn)##2##1##(2008-10#1)(2008-8#1)
autumnal##5##1##(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#1)
autumnata##2##1##(2008-11#2)
aux##8##1##(2008-11#3)(2009-10#1)(2013-1#4)
auxiliary cells##2##2##(2008-7#2)
auxiliary electrode and##2##3##(2008-10#2)
auxiliary electrode##4##2##(2008-10#4)
auxiliary personnel##2##2##(1997-8#1)(2008-10#1)
auxiliary telescope##3##2##(2008-3#3)
auxiliary value##2##2##(1991-8#2)
auxiliary##23##1##(1991-2#1)(1991-5#1)(1991-8#2)(1993-6#1)(1997-8#1)(2007-8#1)(2008-10#10)(2008-3#4)(2008-7#2)
auxin and cytokinin##6##3##(2008-12#1)(2008-7#2)(2009-8#3)
auxin in the##2##3##(2008-8#1)(2009-8#1)
auxin responsive##2##2##(2008-9#1)(2009-8#1)
auxin signaling##2##2##(2009-8#2)
auxin transport is##2##3##(2009-8#2)
auxin transport##3##2##(2009-8#3)
auxin##39##1##(2008-10#5)(2008-12#2)(2008-7#4)(2008-8#6)(2008-9#4)(2009-6#3)(2009-8#15)
auxins combinations##2##2##(2008-12#2)
auxins##8##1##(2008-10#2)(2008-12#2)(2009-8#4)
auxological##2##1##(2011-1#1)(2013-1#1)
auxotroph##6##1##(2008-10#3)(2008-11#2)(2008-8#1)
auxotrophic##2##1##(2008-10#1)(2008-8#1)
availability and the##3##3##(2008-10#3)
availability and use of##2##4##(1991-12#1)(1994-12#1)
availability and use##3##3##(1991-12#2)(1994-12#1)
availability and##16##2##(1991-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-1#3)(2009-8#1)(2011-10#1)(2011-2#1)
availability in the##2##3##(2008-10#1)(2013-8#1)
availability in##8##2##(2008-10#3)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#2)
availability is##2##2##(2008-10#1)(2008-8#1)
availability of complete genome##2##4##(2008-4#1)(2008-9#1)
availability of complete##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
availability of free##3##3##(2008-10#2)(2008-5#1)
availability of information##2##3##(2008-10#1)(2012-2#1)
availability of inoculum##2##3##(2008-10#2)
availability of local##2##3##(2012-12#1)(2013-1#1)
availability of material##2##3##(2010-11#2)
availability of metals##2##3##(2008-10#2)
availability of more##2##3##(1992-2#1)(2010-8#1)
availability of new##2##3##(2008-3#2)
availability of nursing home substitutes##2##5##(2008-11#2)
availability of the##8##3##(1994-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
availability of these##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
availability of##120##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#2)(1992-10#2)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-10#28)(2008-11#7)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#7)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#3)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#5)(2013-1#5)(2013-8#2)
availability on the##2##3##(1992-3#1)(2008-10#1)
availability to##2##2##(2008-10#2)
availability##207##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#2)(1991-3#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-1#3)(2008-10#53)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#17)(2008-9#12)(2009-1#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#3)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#9)(2012-3#4)(2012-5#1)(2012-8#1)(2013-1#6)(2013-8#5)
available about the##2##3##(1995-5#1)(2008-10#1)
available about##3##2##(1995-5#1)(2008-10#1)(2009-3#1)
available alternatives##2##2##(1991-2#1)(2008-10#1)
available and provide##2##3##(2008-11#1)(2013-8#1)
available and the##3##3##(2007-11#1)(2008-9#1)(2012-2#1)
available and##21##2##(1994-9#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
available are##2##2##(2009-10#1)(2011-3#1)
available as a##2##3##(2008-11#1)(2008-9#1)
available as##11##2##(1992-3#1)(2008-10#5)(2008-11#2)(2008-9#1)(2009-6#1)(2013-1#1)
available at the time##2##4##(1995-12#1)(2013-8#1)
available at the##6##3##(1992-9#1)(1995-12#1)(2008-11#1)(2009-2#1)(2013-1#1)(2013-8#1)
available at##11##2##(1992-9#1)(1994-3#1)(1995-12#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-2#1)(2012-5#1)(2013-1#1)(2013-8#2)
available binding##2##2##(2008-11#1)(2010-11#1)
available biological##2##2##(2008-10#1)(2011-2#1)
available but##2##2##(1996-2#1)(2008-12#1)
available chlorine##4##2##(1991-5#1)(2008-10#3)
available clinical##4##2##(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
available concerning##5##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
available data are##3##3##(1991-12#1)(2008-11#1)(2008-8#1)
available data for##2##3##(2008-3#1)(2008-8#1)
available data from##2##3##(2008-10#1)(2011-2#1)
available data on the##3##4##(1993-2#1)(2010-8#1)(2013-7#1)
available data on##7##3##(1990-8#1)(1993-2#1)(1994-3#1)(2009-4#1)(2010-8#1)(2012-12#1)(2013-7#1)
available data regarding the##3##4##(2009-10#1)(2013-1#2)
available data to##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
available data##31##2##(1990-8#1)(1991-12#3)(1993-2#1)(1994-3#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-4#1)(2010-11#1)(2010-8#2)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
available databases##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
available evidence in##2##3##(2008-11#1)(2008-12#1)
available evidence##12##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#2)(2010-12#1)(2012-3#1)
available expertise and##2##3##(2009-8#2)
available expertise##3##2##(2009-8#2)(2010-11#1)
available for a##2##3##(1995-11#1)(2008-7#1)
available for analysis##4##3##(2008-10#2)(2009-12#1)(2012-3#1)
available for assessing##2##3##(1994-12#1)(2013-1#1)
available for clinical use##2##4##(1991-9#1)(2011-2#1)
available for clinical##3##3##(1991-9#1)(1995-5#1)(2011-2#1)
available for further##3##3##(1995-8#1)(2008-9#1)(2010-1#1)
available for its##2##3##(2010-7#1)(2011-2#1)
available for over##2##3##(1994-2#1)(2012-3#1)
available for the first dose##2##5##(2012-12#2)
available for the treatment of##2##5##(1993-6#1)(2009-1#1)
available for the##22##3##(1993-6#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2011-2#1)(2012-12#2)
available for these##2##3##(2008-2#1)(2008-3#1)
available for this##3##3##(2008-5#1)(2008-7#1)(2010-3#1)
available for##97##2##(1991-1#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#3)(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-10#15)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#6)(2009-1#2)(2009-12#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#1)
available from experimental##2##3##(2008-10#1)(2012-12#1)
available from the literature##2##4##(1993-8#1)(2008-11#1)
available from the##18##3##(1992-2#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-8#10)
available from##29##2##(1990-3#1)(1992-2#1)(1992-6#1)(1993-8#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#10)
available herbal##2##2##(2008-5#2)
available in a##5##3##(1991-1#1)(1993-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
available in all##2##3##(1990-6#1)(1997-5#1)
available in most##2##3##(2008-11#1)(2008-9#1)
available in the literature##3##4##(2008-7#1)(2010-10#1)(2012-12#1)
available in the##20##3##(1990-11#1)(1991-3#1)(2008-10#3)(2008-12#3)(2008-5#2)(2008-7#2)(2009-11#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#3)
available in##55##2##(1990-11#1)(1990-6#2)(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1996-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-10#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
available information on the##3##4##(1993-1#1)(2008-10#1)(2011-2#1)
available information on##5##3##(1993-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
available information##12##2##(1992-9#1)(1993-1#1)(2008-10#2)(2008-11#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
available instruments##5##2##(1992-3#1)(2008-4#1)(2008-9#1)(2013-1#2)
available is##5##2##(1992-12#1)(1993-11#1)(1994-9#1)(2008-10#1)(2012-2#1)
available literature on the##3##4##(2008-11#2)(2008-4#1)
available literature on##4##3##(2008-11#3)(2008-4#1)
available literature##13##2##(1996-12#1)(2008-11#4)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#1)(2012-2#1)(2012-3#1)
available materials##2##2##(2008-10#2)
available methods for##2##3##(2008-10#1)(2009-1#1)
available methods##3##2##(2008-10#1)(2009-1#1)(2011-3#1)
available on the market##2##4##(2008-10#1)(2008-6#1)
available on the##17##3##(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2012-3#1)
available on this##2##3##(2008-11#1)(2008-5#1)
available on##28##2##(1991-6#1)(1993-1#1)(1994-12#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#1)
available online (www##2##3##(2010-12#2)
available online##3##2##(2009-2#1)(2010-12#2)
available only##4##2##(1991-12#1)(1992-12#1)(2008-3#1)(2011-2#1)
available or##2##2##(1993-1#1)(2008-8#1)
available over the##2##3##(2008-8#1)(2009-5#1)
available reagents##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
available regarding the##2##3##(2008-11#1)(2013-1#1)
available resources##5##2##(1993-1#1)(1994-3#1)(2008-11#2)(2008-5#1)
available since##2##2##(1991-12#1)(2009-8#1)
available software##2##2##(1992-9#1)(2009-11#1)
available standards##2##2##(2008-10#1)(2013-1#1)
available systems##2##2##(1990-5#1)(1996-2#1)
available technology##3##2##(1997-2#1)(2008-11#1)(2012-12#1)
available through##3##2##(1992-3#1)(1997-6#1)(1997-8#1)
available to all##2##3##(2008-11#2)
available to allow##2##3##(1993-2#1)(2008-10#1)
available to determine the##2##4##(2008-10#1)(2008-5#1)
available to quantify##2##3##(2008-10#1)(2013-1#1)
available to the##11##3##(1992-5#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)
available to those##2##3##(1995-12#1)(2008-7#1)
available to treat##2##3##(2008-8#1)(2011-2#1)
available to##74##2##(1991-1#1)(1991-3#2)(1992-5#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-11#10)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#3)
available today##4##2##(1994-1#1)(2008-11#1)(2008-5#1)(2010-12#1)
available treatments and the##2##4##(2008-7#1)(2012-3#1)
available treatments##5##2##(2008-11#2)(2008-7#1)(2011-2#1)(2012-3#1)
available under##2##2##(2008-10#1)(2011-10#1)
available were##2##2##(1994-1#1)(1997-3#1)
available when##2##2##(1992-3#1)(2008-7#1)
available with the##2##3##(2008-10#1)(2008-6#1)
available with##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
available within##2##2##(2008-9#2)
available##917##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-12#11)(1991-2#3)(1991-3#8)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#4)(1992-12#3)(1992-2#5)(1992-3#9)(1992-5#2)(1992-6#2)(1992-9#5)(1993-1#6)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#3)(1993-6#1)(1993-8#2)(1994-1#3)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#3)(1995-5#6)(1995-8#1)(1996-1#8)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#3)(1996-5#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#7)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#205)(2008-11#73)(2008-12#20)(2008-2#7)(2008-3#17)(2008-4#21)(2008-5#31)(2008-6#7)(2008-7#23)(2008-8#18)(2008-9#32)(2009-1#4)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#5)(2010-10#6)(2010-11#11)(2010-12#9)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#4)(2011-10#4)(2011-2#44)(2011-3#8)(2012-12#18)(2012-2#23)(2012-3#16)(2012-5#1)(2012-9#1)(2013-1#34)(2013-7#1)(2013-8#18)
available)##2##1##(2008-7#1)(2010-7#1)
avaiting##2##1##(1994-9#1)(2011-3#1)
avalanche photodiodes##6##2##(2007-12#2)(2008-3#4)
avalanche##8##1##(2007-12#2)(2008-3#5)(2011-2#1)
avascular##6##1##(2008-10#1)(2008-12#1)(2011-2#3)(2013-1#1)
avec##9##1##(2013-1#9)
avellanae and##2##2##(2008-10#2)
avenaceum##5##1##(2008-10#5)
avenae and M##2##3##(2008-10#2)
avenae and U##2##3##(2008-10#2)
avenae and##7##2##(2008-10#7)
avenae females##2##2##(2008-10#2)
avenae subsp##17##2##(2008-10#17)
avenae##39##1##(2008-10#39)
avenue for##4##2##(1992-3#1)(1995-12#1)(2008-10#1)(2008-4#1)
avenue##7##1##(1991-1#1)(1992-3#1)(1995-12#1)(2008-10#2)(2008-4#1)(2011-2#1)
avenues for drug discovery##2##4##(2010-11#2)
avenues for##9##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#2)
avenues in##2##2##(1992-1#1)(1996-12#1)
avenues##17##1##(1992-1#1)(1994-12#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-11#2)(2012-2#2)
average 0##4##2##(1993-11#1)(2008-10#1)(2008-7#1)(2012-2#1)
average 14##2##2##(1991-2#1)(2013-1#1)
average Medicare##2##2##(1992-12#1)(1994-1#1)
average accuracy of##2##3##(2008-3#1)(2010-8#1)
average adjusted##2##2##(1993-3#1)(1996-3#1)
average age for##2##3##(1997-3#1)(2013-1#1)
average age of##9##3##(1990-12#1)(1994-12#1)(2008-9#3)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
average age was##5##3##(2008-12#1)(2011-2#2)(2011-7#1)(2013-1#1)
average age##26##2##(1990-12#1)(1991-12#1)(1991-8#2)(1994-12#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-9#3)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2011-7#1)(2013-1#4)
average and the##2##3##(2008-10#1)(2008-12#1)
average and##9##2##(1990-9#1)(1996-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2012-12#1)
average annual rate of##4##4##(1993-1#1)(1993-3#2)(1996-1#1)
average annual##12##2##(1993-1#1)(1993-3#2)(1996-1#1)(1996-8#1)(2008-10#2)(2010-12#1)(2011-2#3)(2013-1#1)
average arterial##2##2##(1997-8#1)(2008-3#1)
average between##2##2##(2008-10#2)
average biofilm density and##2##4##(2008-7#2)
average cell##7##2##(1995-9#1)(2008-10#1)(2008-11#3)(2008-9#1)(2012-2#1)
average clutch size##2##3##(1991-5#1)(2008-9#1)
average coefficient of variation##2##4##(2008-10#1)(2012-2#1)
average concentrations##3##2##(2008-10#3)
average cost##6##2##(1992-12#2)(1993-1#1)(1995-1#1)(1995-12#1)(2012-12#1)
average costs of##3##3##(1997-1#1)(2008-10#2)
average costs##7##2##(1991-12#1)(1992-12#1)(1993-12#1)(1996-3#1)(1997-1#1)(2008-10#2)
average daily doses##6##3##(2008-9#6)
average daily##8##2##(1992-12#1)(2008-9#7)
average daytime##2##2##(2008-10#2)
average degree##4##2##(1990-5#1)(2008-10#1)(2011-2#2)
average density of##4##3##(1994-9#1)(1997-6#1)(1997-8#1)(2013-8#1)
average density##5##2##(1994-9#1)(1997-6#1)(1997-8#1)(2010-7#1)(2013-8#1)
average detection probability##2##3##(2008-10#2)
average detection##4##2##(2008-10#4)
average diameter##5##2##(2008-10#1)(2008-11#2)(2010-6#1)(2011-2#1)
average dose of##2##3##(1990-12#1)(1997-8#1)
average duration of symptoms##2##4##(2008-1#1)(2013-1#1)
average duration of the##2##4##(2011-2#1)(2013-8#1)
average duration of##5##3##(2008-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
average duration##6##2##(2008-1#1)(2008-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
average error##2##2##(2008-10#2)
average flow velocity of##3##4##(2011-2#3)
average flow velocity##4##3##(2011-2#4)
average flow##5##2##(2008-3#1)(2011-2#4)
average follow-up of##5##3##(1992-3#1)(2008-8#1)(2009-3#1)(2011-2#2)
average follow-up was##3##3##(2008-9#1)(2009-3#2)
average follow-up##9##2##(1992-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#3)(2011-2#2)
average for##3##2##(2010-6#1)(2011-2#1)(2012-12#1)
average fracture gap was##2##4##(2009-3#2)
average genetic distance of##2##4##(2008-10#1)(2011-2#1)
average genetic distance##3##3##(2008-10#2)(2011-2#1)
average genetic similarity##2##3##(2008-10#2)
average genetic##8##2##(2008-10#6)(2008-9#1)(2011-2#1)
average growth##2##2##(1991-12#1)(2008-7#1)
average improvement in##3##3##(2008-9#3)
average in##3##2##(1996-11#1)(1996-2#1)(2008-10#1)
average insert##4##2##(1997-2#2)(1997-6#1)(2008-8#1)
average length of stay##4##4##(1992-1#1)(1992-12#1)(1992-2#1)(2008-11#1)
average length of##7##3##(1992-1#1)(1992-12#1)(1992-2#2)(2008-10#1)(2008-11#1)(2009-10#1)
average length##9##2##(1992-1#1)(1992-12#1)(1992-2#2)(1993-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-1#1)
average levels of##4##3##(1993-1#1)(2008-10#1)(2008-12#1)(2009-7#1)
average life expectancy##2##3##(1991-6#1)(1993-9#1)
average life##4##2##(1991-6#1)(1993-9#1)(1995-6#1)(2008-10#1)
average molecular mass##3##3##(1990-5#1)(2008-5#2)
average molecular weight of##3##4##(2008-10#2)(2008-5#1)
average molecular##6##2##(1990-5#1)(2008-10#2)(2008-5#3)
average mortality##4##2##(1995-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
average number of##16##3##(1990-9#1)(1991-7#1)(1992-2#1)(1994-6#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
average number##19##2##(1990-9#1)(1991-7#1)(1992-2#1)(1994-6#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
average of 1##3##3##(1991-5#1)(2011-1#1)(2012-2#1)
average of 4##4##3##(2008-10#1)(2008-9#1)(2012-12#1)(2013-7#1)
average of 59##2##3##(1996-12#1)(2008-9#1)
average of 9##2##3##(2008-9#1)(2009-3#1)
average of the##2##3##(2008-11#1)(2012-2#1)
average of##71##2##(1990-12#2)(1990-2#1)(1991-3#1)(1991-5#2)(1992-4#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-12#4)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#4)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#3)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)
average on##3##2##(2008-10#2)(2012-12#1)
average outcome##2##2##(1996-6#1)(2008-10#1)
average output power of##4##4##(2008-2#2)(2008-3#2)
average output power##7##3##(2007-11#1)(2008-2#2)(2008-3#4)
average particle size##2##3##(2008-5#1)(2009-11#1)
average particle##3##2##(2008-5#1)(2008-7#1)(2009-11#1)
average patient##3##2##(2007-12#1)(2009-3#2)
average per capita##5##3##(1991-3#1)(1993-3#3)(1996-3#1)
average per diem##2##3##(1991-12#1)(1994-2#1)
average per##7##2##(1991-12#1)(1991-3#1)(1993-3#3)(1994-2#1)(1996-3#1)
average pore##2##2##(2008-10#1)(2012-2#1)
average power##7##2##(1992-12#1)(2007-11#2)(2007-12#1)(2008-3#2)(2012-2#1)
average prediction error##2##3##(2008-10#1)(2008-11#1)
average prediction##3##2##(2008-10#2)(2008-11#1)
average probability of##2##3##(2008-12#1)(2011-3#1)
average pump power of##2##4##(2008-2#1)(2008-3#1)
average pump power##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
average rate of##3##3##(2008-11#2)(2010-8#1)
average rates##2##2##(1992-12#1)(2010-12#1)
average recoveries from##2##3##(2008-10#2)
average recoveries of OFL##2##4##(2008-10#2)
average recoveries of##6##3##(2008-10#5)(2008-5#1)
average recoveries##13##2##(2008-10#12)(2008-5#1)
average recovery for these samples was##3##6##(2008-10#3)
average recovery for##5##3##(2008-10#4)(2008-5#1)
average recovery of 100##2##4##(2008-10#2)
average recovery of##12##3##(2008-10#12)
average recovery##24##2##(2008-10#22)(2008-5#1)(2011-2#1)
average relative standard deviation of##2##5##(2008-10#2)
average relative standard deviation##5##4##(2008-10#5)
average relative standard##6##3##(2008-10#6)
average relative##10##2##(2008-10#10)
average score was##2##3##(1990-2#2)
average signal##2##2##(2008-10#1)(2010-8#1)
average similarity##4##2##(2008-10#4)
average size of the##2##4##(1996-1#1)(1996-2#1)
average size of##6##3##(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-5#1)(2011-1#1)
average size##7##2##(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#2)(2008-5#1)(2011-1#1)
average specific growth rate##3##4##(2008-11#3)
average specific hMab productivity##2##4##(2008-11#2)
average specific##5##2##(2008-11#5)
average surface roughness##2##3##(2012-2#2)
average survival##3##2##(1994-6#2)(1997-4#1)
average temperature during##2##3##(2008-10#2)
average temperature##7##2##(2008-10#3)(2008-8#2)(2008-9#2)
average time##9##2##(1996-9#1)(2008-3#2)(2008-8#2)(2010-6#3)(2012-12#1)
average torque##3##2##(2008-12#3)
average value of##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
average value##7##2##(1990-8#1)(1993-3#1)(2008-10#4)(2011-2#1)
average values##5##2##(2008-1#1)(2008-10#3)(2008-7#1)
average was##2##2##(2008-10#1)(2008-5#1)
average weight##3##2##(1991-12#1)(1995-12#1)(2008-11#1)
average with##3##2##(1995-5#1)(2008-8#1)(2011-2#1)
average##744##1##(1990-12#4)(1990-2#4)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#3)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1992-1#4)(1992-12#14)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#2)(1993-1#4)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#10)(1993-9#1)(1994-1#6)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#9)(1996-2#5)(1996-3#11)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#2)(1997-8#6)(2007-11#3)(2007-12#4)(2008-1#6)(2008-10#195)(2008-11#37)(2008-12#11)(2008-2#7)(2008-3#25)(2008-5#9)(2008-6#3)(2008-7#23)(2008-8#28)(2008-9#40)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#10)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#7)(2010-7#1)(2010-8#6)(2011-1#3)(2011-2#47)(2011-3#3)(2011-7#1)(2012-12#7)(2012-2#18)(2012-3#6)(2013-1#18)(2013-3#1)(2013-7#1)(2013-8#12)
average) and##2##2##(1997-2#1)(2008-10#1)
average)##8##1##(1995-11#1)(1997-2#3)(1997-8#1)(2008-10#1)(2011-2#2)
averaged 1##4##2##(1994-2#1)(2008-10#2)(2008-5#1)
averaged 3##2##2##(2008-5#1)(2008-6#1)
averaged 5##2##2##(2008-10#2)
averaged##47##1##(1991-12#2)(1991-2#1)(1993-1#3)(1993-3#1)(1994-2#2)(1995-1#1)(1995-3#2)(1997-1#1)(1997-4#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2010-8#1)(2012-2#2)
averages of##4##2##(2008-10#1)(2008-3#1)(2012-12#1)(2013-8#1)
averages##13##1##(1995-2#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2012-12#1)(2013-8#1)
averaging of the##2##3##(2008-9#2)
averaging of##3##2##(2008-3#1)(2008-9#2)
averaging the##3##2##(1992-1#1)(2008-10#2)
averaging##26##1##(1992-1#1)(1992-4#1)(1993-2#1)(1994-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
aversion to##2##2##(1991-1#1)(2008-5#1)
aversion##13##1##(1991-1#1)(1994-5#1)(1994-8#2)(2008-5#9)
aversive event##3##2##(2008-11#3)
aversive##12##1##(1993-6#2)(1996-2#1)(2008-11#4)(2008-4#1)(2008-6#1)(2010-10#1)(2010-8#1)(2012-2#1)
avert##2##1##(2008-11#1)(2011-2#1)
averted##4##1##(1997-6#1)(2008-11#2)(2009-8#1)
avian chlamydial MOMP gene recombinant adenovirus##3##6##(2011-2#3)
avian influenza virus##2##3##(2011-3#2)
avian influenza viruses##2##3##(2013-8#2)
avian influenza##7##2##(2008-9#1)(2011-3#2)(2013-8#4)
avian species##4##2##(2008-5#2)(2008-8#1)(2008-9#1)
avian##42##1##(1990-11#1)(1990-5#1)(1993-6#2)(1995-12#1)(1995-2#2)(1997-1#1)(2008-10#3)(2008-5#10)(2008-8#6)(2008-9#3)(2010-6#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-8#5)
avian-like H1N1##2##2##(2011-2#2)
avian-like##3##1##(2011-2#3)
aviation jet fuel##2##3##(2008-10#2)
aviation##10##1##(2008-10#2)(2008-11#1)(2009-10#4)(2012-3#3)
avid##2##1##(2008-4#1)(2012-12#1)
avidin and##3##2##(2008-10#2)(2008-12#1)
avidin layer##2##2##(2008-10#2)
avidin to##2##2##(1993-6#1)(2008-10#1)
avidin##19##1##(1992-6#1)(1993-6#5)(2008-10#7)(2008-12#5)(2011-2#1)
avidin- and##2##2##(1993-6#1)(2008-10#1)
avidin-biotin binding##2##2##(2008-10#2)
avidity##6##1##(1995-5#3)(2008-10#1)(2008-2#1)(2008-4#1)
avidly##2##1##(1995-8#1)(2008-5#1)
avifauna##2##1##(2008-8#1)(2008-9#1)
avirulence (Avr) genes##2##3##(2008-10#2)
avirulence and##2##2##(2008-10#2)
avirulence gene in##3##3##(2008-10#3)
avirulence gene of##2##3##(2008-10#2)
avirulence gene##15##2##(2008-10#15)
avirulence genes in##4##3##(2008-10#4)
avirulence genes##13##2##(2008-10#13)
avirulence genotype##3##2##(2008-10#3)
avirulence in##3##2##(2008-10#3)
avirulence locus##3##2##(2008-10#3)
avirulence on##3##2##(2008-10#3)
avirulence##57##1##(2008-10#57)
avirulent and virulent cultures segregated in a##2##7##(2008-10#2)
avirulent and virulent##3##3##(2008-10#3)
avirulent isolates of P##2##4##(2008-10#2)
avirulent isolates of##3##3##(2008-10#3)
avirulent isolates##4##2##(2008-10#4)
avirulent on##6##2##(2008-10#6)
avirulent strains##3##2##(2008-10#3)
avirulent to Xa21##2##3##(2008-10#2)
avirulent to##11##2##(2008-10#11)
avirulent##41##1##(1995-2#1)(1995-5#1)(2008-10#39)
avium complex##2##2##(2008-11#2)
avium##4##1##(2007-12#1)(2008-11#2)(2008-5#1)
avocado (Persea americana) crude extract##2##5##(2008-10#2)
avocado fruit##6##2##(2008-10#6)
avocado fruits##2##2##(2008-10#2)
avocado tissue (Persea americana)##2##4##(2008-10#2)
avocado##17##1##(2008-10#17)
avoid an##2##2##(2008-12#1)(2010-12#1)
avoid high##2##2##(2008-1#1)(2009-8#1)
avoid it##2##2##(1996-12#1)(2012-12#1)
avoid or##4##2##(1991-12#1)(1991-6#1)(2008-10#1)(2012-3#1)
avoid possible interferences##2##3##(2008-10#2)
avoid possible##4##2##(1991-12#1)(2008-10#3)
avoid the potential##2##3##(1993-3#1)(2009-12#1)
avoid the side##2##3##(1993-1#1)(2008-10#1)
avoid the use of##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
avoid the##31##2##(1992-5#1)(1993-1#1)(1993-3#1)(1993-8#1)(1995-2#1)(1996-11#1)(1996-3#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#2)
avoid unnecessary surgery##2##3##(2012-12#1)(2012-2#1)
avoid unnecessary##4##2##(1992-9#1)(2009-6#1)(2012-12#1)(2012-2#1)
avoid##170##1##(1990-11#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#3)(1997-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#44)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#7)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#5)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#16)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#4)
avoidable##3##1##(2008-11#3)
avoidance and##3##2##(1997-2#1)(2008-9#1)(2009-8#1)
avoidance behavior##2##2##(1992-6#1)(2008-6#1)
avoidance of##15##2##(1992-9#1)(1993-3#1)(1996-9#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
avoidance responding##2##2##(1992-12#1)(2008-6#1)
avoidance task##3##2##(1991-2#2)(2008-6#1)
avoidance training##3##2##(1997-2#2)(2008-6#1)
avoidance##49##1##(1991-2#3)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1996-9#1)(1997-2#3)(1997-6#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-6#10)(2008-8#1)(2008-9#9)(2009-8#2)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
avoidance)##2##1##(2008-8#1)(2008-9#1)
avoidant beliefs##2##2##(2008-12#2)
avoidant coping##2##2##(2009-5#1)(2009-7#1)
avoidant personality disorder##2##3##(2010-2#2)
avoidant##8##1##(2008-11#1)(2008-12#2)(2009-5#1)(2009-7#2)(2010-2#2)
avoided by##9##2##(1996-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2011-2#1)(2012-12#1)
avoided##57##1##(1990-11#1)(1990-5#1)(1992-3#2)(1993-11#1)(1993-2#1)(1994-3#2)(1995-2#1)(1996-11#1)(2007-12#1)(2008-10#17)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-12#4)(2013-1#2)(2013-8#1)
avoiding a##3##2##(2008-10#2)(2011-2#1)
avoiding or reducing##2##3##(1992-3#1)(1996-9#1)
avoiding the##7##2##(2008-10#2)(2008-11#2)(2008-3#1)(2010-8#1)(2011-2#1)
avoiding##51##1##(1991-1#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-5#1)(1995-12#1)(1996-9#2)(2008-10#13)(2008-11#5)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-8#3)
avoids some##2##2##(1995-2#1)(1997-7#1)
avoids the use of##2##4##(2008-10#2)
avoids the##14##2##(1990-3#2)(1991-3#1)(2008-10#6)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-3#1)
avoids time-consuming##2##2##(2008-10#1)(2008-9#1)
avoids##30##1##(1990-3#2)(1991-3#1)(1993-3#1)(1995-2#1)(1997-7#1)(2008-10#13)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#3)(2010-12#1)(2012-3#1)(2013-1#1)
avons##2##1##(2013-1#2)
avr1 and Avr1 basidiospores##2##4##(2008-10#2)
avr1##3##1##(2008-10#3)
avrBs1##4##1##(2008-10#4)
avrBs2 gene##2##2##(2008-10#2)
avrBs2##3##1##(2008-10#3)
avrI-2##3##1##(2008-10#3)
avulsion##2##1##(1991-8#1)(2008-9#1)
await##6##1##(1993-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
awaited##2##1##(1994-12#1)(2008-11#1)
awaiting approval##2##2##(1996-5#1)(2008-5#1)
awaiting##3##1##(1996-5#1)(1997-7#1)(2008-5#1)
awaits##4##1##(1993-1#1)(2008-10#2)(2008-11#1)
awake##5##1##(1994-2#1)(1997-2#1)(2007-12#1)(2010-12#1)(2013-8#1)
awaken##2##1##(1997-6#1)(2008-11#1)
awakening##5##1##(1997-2#1)(2008-11#1)(2009-12#1)(2012-3#1)(2013-1#1)
award##12##1##(1992-3#1)(1993-1#1)(1995-12#2)(1995-6#3)(1996-2#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
awarded the##2##2##(1996-3#1)(2010-7#1)
awarded##9##1##(1991-3#1)(1995-12#2)(1996-3#1)(2008-10#2)(2009-4#1)(2010-7#1)(2013-1#1)
awards##2##1##(1994-9#1)(2008-12#1)
aware of its##2##3##(2008-10#1)(2010-1#1)
aware of the adverse##2##4##(2008-8#1)(2012-12#1)
aware of the potential for##2##5##(1996-12#1)(2008-7#1)
aware of the potential##3##4##(1996-12#1)(2008-7#1)(2008-9#1)
aware of the##24##3##(1990-6#2)(1991-2#1)(1992-3#1)(1994-3#1)(1996-12#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
aware of their##2##3##(2010-6#1)(2013-1#1)
aware of these##3##3##(1991-12#1)(2010-1#1)(2012-2#1)
aware of this##5##3##(1997-4#1)(2008-12#2)(2008-5#1)(2012-3#1)
aware of##56##2##(1990-6#3)(1991-12#1)(1991-2#2)(1992-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-12#1)(2010-6#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
aware that the##2##3##(2008-7#1)(2013-8#1)
aware that there##2##3##(2012-12#1)(2012-2#1)
aware that##7##2##(1995-6#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-8#1)
aware##71##1##(1990-6#3)(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-2#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#2)
awareness about##2##2##(2009-10#1)(2013-1#1)
awareness among health professionals##2##4##(2008-11#1)(2012-3#1)
awareness among##8##2##(2008-11#1)(2008-12#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
awareness and concern##2##3##(1992-1#1)(2008-11#1)
awareness and##20##2##(1992-1#1)(1992-12#1)(1994-1#1)(1994-3#1)(1997-6#1)(2008-11#1)(2008-12#5)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#2)(2013-1#3)
awareness in the##2##3##(2009-9#1)(2012-3#1)
awareness in##5##2##(1997-6#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-3#1)
awareness intervention followed by semantic##2##5##(2011-1#2)
awareness intervention##3##2##(2011-1#3)
awareness of TC##2##3##(2009-5#2)
awareness of and confidence in adopting##2##6##(2010-8#2)
awareness of and##4##3##(2009-8#1)(2010-8#2)(2013-1#1)
awareness of the need to##2##5##(1995-1#1)(2011-2#1)
awareness of the potential##2##4##(1995-9#1)(2012-3#1)
awareness of the##18##3##(1992-12#1)(1992-3#1)(1995-1#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
awareness of##53##2##(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1994-1#2)(1995-1#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#3)(2009-11#1)(2009-5#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#3)(2013-7#1)
awareness on##3##2##(1995-9#1)(2008-12#2)
awareness##147##1##(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-1#6)(1994-3#1)(1995-1#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#2)(2008-1#1)(2008-10#6)(2008-11#15)(2008-12#15)(2008-5#1)(2008-7#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#2)(2010-6#1)(2010-8#4)(2011-1#14)(2011-2#9)(2012-2#4)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#2)
away from hospital##2##3##(1991-3#1)(1993-12#1)
away from the inoculation##2##4##(2008-10#2)
away from the##24##3##(1993-3#2)(1993-6#1)(1994-8#1)(1995-10#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
away from##56##2##(1991-3#3)(1993-12#1)(1993-3#2)(1993-6#1)(1994-8#1)(1995-10#1)(1995-5#1)(1997-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-3#3)(2013-8#5)
away##80##1##(1991-3#3)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-4#2)(2010-6#1)(2010-7#2)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#6)
awn##3##1##(2008-10#3)
awns emerging##2##2##(2008-10#2)
awns##3##1##(2008-10#3)
axei##2##1##(1996-12#2)
axenic##5##1##(2008-10#5)
axes are##2##2##(2008-10#1)(2008-3#1)
axes of##3##2##(2008-3#1)(2013-8#2)
axes##16##1##(1993-8#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-6#1)(2009-8#1)(2010-6#1)(2013-8#2)
axes)##2##1##(1995-11#1)(2008-8#1)
axial and##4##2##(1996-9#1)(2008-2#1)(2008-3#1)(2013-1#1)
axial eye growth##3##3##(2010-1#3)
axial flow pump##2##3##(2008-8#2)
axial images##2##2##(2010-12#1)(2012-2#1)
axial position##2##2##(1995-11#1)(2008-3#1)
axial skeleton##3##2##(1991-11#1)(2011-2#2)
axial structures##2##2##(1993-12#1)(2008-6#1)
axial##55##1##(1991-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#7)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#2)(2010-1#3)(2010-11#1)(2010-12#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
axially##2##1##(2008-10#1)(2008-3#1)
axilla secretions##4##2##(2008-5#4)
axilla##26##1##(1992-12#1)(1994-12#1)(2008-5#20)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#1)
axillary aerobic coryneform isolates##2##4##(2008-5#2)
axillary bacterial##2##2##(2008-5#2)
axillary buds##3##2##(2008-8#2)(2013-1#1)
axillary dissection##3##2##(1994-12#2)(2013-1#1)
axillary lymph nodes##4##3##(1993-2#1)(1994-12#1)(2008-10#1)(2010-6#1)
axillary lymph##5##2##(1993-2#1)(1994-12#1)(2008-10#1)(2010-6#2)
axillary malodor##2##2##(2008-5#2)
axillary malodour##2##2##(2008-5#2)
axillary microflora##5##2##(2008-5#5)
axillary nerve##5##2##(2008-8#1)(2008-9#2)(2013-1#2)
axillary odour##2##2##(2008-5#2)
axillary shoots and##2##3##(2009-8#2)
axillary skin##12##2##(2008-5#12)
axillary stratum corneum##3##3##(2008-5#3)
axillary##65##1##(1990-8#1)(1991-8#1)(1993-2#1)(1994-12#3)(1997-7#2)(2008-1#1)(2008-10#1)(2008-5#38)(2008-8#3)(2008-9#2)(2009-8#3)(2010-6#3)(2012-3#1)(2013-1#5)
axillo-axillary bypass##2##2##(1993-3#2)
axis and##9##2##(1992-4#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
axis can be##2##3##(1994-5#1)(2008-3#1)
axis formation##3##2##(2008-6#3)
axis in the##6##3##(1991-12#2)(1995-12#1)(2007-11#1)(2008-3#1)(2010-4#1)
axis in##8##2##(1991-12#2)(1995-12#2)(2007-11#1)(2008-3#1)(2010-4#1)(2010-5#1)
axis is##2##2##(2008-5#1)(2013-1#1)
axis of each##2##3##(2009-5#1)(2012-2#1)
axis of symmetry##3##3##(1996-5#1)(2008-3#1)(2008-6#1)
axis of the##8##3##(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
axis of##21##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
axis view) (p &lt##3##4##(2008-10#3)
axis view) (p##4##3##(2008-10#4)
axis was##4##2##(1991-3#1)(1993-6#1)(1994-2#1)(2008-10#1)
axis were investigated##2##3##(1996-12#1)(2008-10#1)
axis were##4##2##(1996-12#1)(2008-10#1)(2013-1#2)
axis with##2##2##(2008-3#1)(2013-8#1)
axis##125##1##(1991-12#2)(1991-3#1)(1992-4#1)(1993-6#1)(1994-2#4)(1994-5#2)(1994-9#1)(1995-12#3)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#19)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#6)
axis)##2##1##(1995-12#1)(2012-2#1)
axisymmetric##4##1##(2008-3#4)
axoaxonic synapses##3##2##(1997-3#3)
axolotl##5##1##(1994-11#1)(1997-9#4)
axolotls##4##1##(1997-9#4)
axon collaterals##2##2##(1997-3#2)
axon terminals in the##2##4##(1995-6#1)(2008-5#1)
axon terminals in##3##3##(1995-6#1)(1996-12#1)(2008-5#1)
axon terminals##7##2##(1995-12#2)(1995-6#1)(1996-12#1)(2008-5#1)(2008-7#2)
axon##18##1##(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#2)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#4)(2012-2#3)
axonal injury##2##2##(1990-5#1)(2008-7#1)
axonal integrity##2##2##(1996-5#1)(2009-6#1)
axonal processes##2##2##(2007-12#1)(2008-11#1)
axonal regeneration##3##2##(1996-12#1)(2011-2#1)(2012-2#1)
axonal transport##5##2##(1995-2#1)(1996-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
axonal##44##1##(1990-5#1)(1995-12#2)(1995-2#3)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-11#4)(2008-5#1)(2008-7#11)(2009-6#1)(2010-12#1)(2011-2#1)(2011-7#2)(2012-2#4)(2012-3#4)(2013-1#2)
axoneme##4##1##(2008-7#4)
axonopodis pv##44##2##(2008-10#44)
axonopodis##48##1##(2008-10#48)
axons and##5##2##(1995-2#1)(1997-3#2)(2008-7#2)
axons can##2##2##(2008-7#1)(2011-2#1)
axons exhibited##2##2##(1997-3#1)(2008-11#1)
axons form synapses with neurons##2##5##(2011-2#2)
axons form##4##2##(2008-5#2)(2011-2#2)
axons in##2##2##(1995-12#1)(2008-11#1)
axons of##5##2##(1990-5#1)(1995-12#1)(2008-7#1)(2012-2#2)
axons that##2##2##(1997-3#1)(2008-5#1)
axons to##2##2##(1995-2#1)(2007-12#1)
axons##46##1##(1990-5#1)(1992-12#2)(1993-12#1)(1994-8#1)(1995-12#2)(1995-2#2)(1997-3#8)(2007-12#2)(2008-11#5)(2008-5#5)(2008-7#7)(2009-6#1)(2011-2#7)(2012-2#2)
axotomized##3##1##(1996-12#2)(1997-3#1)
axotomy##3##1##(1990-5#2)(1997-3#1)
ayahuasca##7##1##(2013-8#7)
azacrown##3##1##(2008-10#3)
azacrown-1 and##2##2##(2008-10#2)
azadiene 27##2##2##(1996-5#2)
azadirachtin##2##1##(2008-8#2)
azafenidin##2##1##(2008-10#2)
azathioprine##12##1##(1991-8#1)(1992-5#1)(2008-10#4)(2009-5#1)(2010-12#2)(2012-3#3)
azathioprine/6-mercaptopurine and##2##2##(2010-12#2)
azathioprine/6-mercaptopurine##5##1##(2010-12#5)
azide##14##1##(1993-8#1)(1994-5#3)(1995-8#1)(1996-5#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-5#2)
azimuth##2##1##(2008-3#2)
azimuthal modes in distorted spheres##2##5##(2008-2#2)
azimuthal modes in##3##3##(2008-2#3)
azimuthal modes##4##2##(2008-2#4)
aziridine##3##1##(1991-5#2)(1997-2#1)
azithromycin##4##1##(2008-10#3)(2010-12#1)
azo compounds as##2##3##(2008-10#2)
azo compounds##3##2##(2008-10#3)
azo dye##7##2##(2008-10#4)(2008-2#1)(2011-1#2)
azo dyes##8##2##(2008-10#7)(2011-1#1)
azo spacer##2##2##(2008-10#2)
azo##30##1##(1990-6#1)(2008-10#25)(2008-2#1)(2011-1#3)
azo-compound##3##1##(2008-10#3)
azo-dye##2##1##(2008-10#1)(2008-3#1)
azo-histidine##2##1##(2008-10#2)
azobenzene arsonic acid compound##3##4##(2008-10#3)
azobenzene moieties##2##2##(1995-6#1)(2008-10#1)
azobenzene##12##1##(1995-6#3)(2008-10#9)
azodyes and their complexes with##2##5##(2008-10#2)
azodyes##4##1##(2008-10#4)
azole##4##1##(2008-10#1)(2008-5#3)
azole-resistant##2##1##(2008-10#1)(2008-5#1)
azoles##4##1##(2008-5#4)
azomethine-H##3##1##(2008-10#3)
azoospermia factor##2##2##(1993-12#2)
azoospermia##6##1##(1993-12#2)(1993-9#1)(1997-8#2)(2008-10#1)
azoospermic##2##1##(1997-8#1)(2008-12#1)
azoxystrobin and##3##2##(2008-10#3)
azoxystrobin##6##1##(2008-10#6)
azure-dye##2##1##(2008-10#2)
azurol S (CAS)##2##3##(2008-10#2)
azurol S##3##2##(2008-10#3)
azygos vein##6##2##(2008-11#2)(2011-2#4)
azygos##7##1##(1996-3#1)(2008-11#2)(2011-2#4)
b = 0##4##3##(1997-1#2)(2009-11#2)
b =##12##2##(1992-11#1)(1992-12#1)(1992-9#1)(1996-5#1)(1997-1#5)(2009-11#3)
b and##8##2##(1994-5#3)(1995-5#1)(2008-11#1)(2008-12#2)(2008-6#1)
b conjugate##4##2##(1995-5#2)(2007-11#1)(2008-10#1)
b in##2##2##(1996-5#1)(2008-10#1)
b locus##2##2##(2008-10#2)
b mating##2##2##(2008-10#2)
b types##3##2##(2008-10#3)
b##95##1##(1990-12#3)(1991-3#2)(1992-11#1)(1992-12#2)(1992-9#1)(1993-12#6)(1993-8#1)(1994-5#6)(1995-2#1)(1995-3#1)(1995-5#8)(1996-5#3)(1997-1#8)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#2)(2008-12#2)(2008-6#2)(2009-11#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-4#1)(2010-5#2)(2011-2#3)(2012-3#1)
b( *)##3##2##(2010-4#3)
b(5)##6##1##(2008-7#6)
b(7)##3##1##(2008-10#3)
b(b)##4##1##(2008-3#4)
b) is##2##2##(2008-10#2)
b) the##4##2##(1991-6#1)(1993-1#1)(2008-7#1)(2012-2#1)
b)##20##1##(1990-6#1)(1991-3#1)(1991-6#2)(1993-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2010-1#2)(2012-2#2)
b-wave##2##1##(2009-12#2)
b5 genes##2##2##(1992-6#2)
b5##9##1##(1992-6#9)
bFGF + FeSO(4)##2##3##(2008-11#2)
bFGF and its receptor##3##4##(1995-12#3)
bFGF and its##4##3##(1994-11#1)(1995-12#3)
bFGF and##8##2##(1994-11#2)(1995-12#3)(2008-11#3)
bFGF gene expression##2##3##(1992-3#1)(1995-12#1)
bFGF in##6##2##(1992-3#1)(1995-12#3)(2010-8#1)(2013-8#1)
bFGF mRNA##7##2##(1992-3#3)(1994-11#1)(1995-12#3)
bFGF was##2##2##(1992-3#1)(1995-12#1)
bFGF##49##1##(1991-12#2)(1992-3#7)(1994-11#5)(1995-12#19)(2008-11#14)(2010-8#1)(2013-8#1)
bHLH transcription factor##2##3##(2008-9#1)(2010-11#1)
bHLH##3##1##(2008-9#1)(2009-8#1)(2010-11#1)
bZIP genes##2##2##(2008-10#1)(2013-8#1)
bZIP protein##2##2##(2008-9#2)
bZIP transcription##2##2##(2008-10#1)(2008-9#1)
bZIP##9##1##(2008-10#4)(2008-9#3)(2013-8#2)
babies (&lt##2##2##(1994-3#1)(2009-9#1)
babies and young children##2##4##(1996-2#1)(1997-8#1)
babies and##4##2##(1995-12#1)(1996-2#1)(1997-8#1)(2008-11#1)
babies born with##2##3##(1997-1#1)(2008-11#1)
babies born##3##2##(1997-1#1)(2008-11#1)(2012-12#1)
babies were##2##2##(2009-11#2)
babies who##2##2##(1994-6#1)(2012-3#1)
babies with##5##2##(1994-6#2)(1996-6#1)(1997-1#1)(2008-11#1)
babies##32##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-5#1)(1994-1#1)(1994-3#3)(1994-6#3)(1995-12#2)(1996-2#1)(1996-6#1)(1997-1#2)(1997-5#1)(1997-8#1)(2008-11#4)(2009-11#2)(2009-9#1)(2010-6#1)(2012-12#2)(2012-3#1)
baboon and human##3##3##(1993-6#3)
baboon and##5##2##(1993-6#3)(2008-9#2)
baboon##11##1##(1993-6#5)(1996-12#1)(2008-9#5)
baboons##2##1##(1996-12#1)(2008-4#1)
baby at##2##2##(2008-11#1)(2011-2#1)
baby hamster kidney##3##3##(1995-12#1)(2008-5#1)(2011-3#1)
baby who##2##2##(1997-3#1)(2008-11#1)
baby with##4##2##(1996-2#1)(2008-11#2)(2009-12#1)
baby##33##1##(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-2#2)(1997-3#1)(2008-1#1)(2008-11#7)(2008-5#2)(2009-12#1)(2009-5#1)(2009-9#1)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#1)(2013-8#1)
baccalaureate health administration##2##3##(1991-1#1)(1996-2#1)
baccalaureate nursing program##2##3##(2008-11#2)
baccalaureate nursing students##4##3##(2008-11#3)(2008-12#1)
baccalaureate nursing##8##2##(2008-11#6)(2008-12#2)
baccalaureate students##2##2##(1996-2#1)(2008-12#1)
baccalaureate##18##1##(1991-1#3)(1994-12#1)(1996-2#2)(2008-11#8)(2008-12#4)
baccatum##2##1##(2008-10#2)
bacilli and##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
bacilli in##3##2##(1995-2#1)(1996-8#1)(2008-1#1)
bacilli##15##1##(1995-2#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-2#5)(2012-2#3)
bacilliform##2##1##(2008-10#2)
bacillus##7##1##(2008-1#1)(2008-10#2)(2008-9#1)(2013-1#3)
bacitracin##2##1##(1994-6#1)(2013-1#1)
back and leg pain##4##4##(2012-3#3)(2013-1#1)
back and##14##2##(1997-3#1)(2008-11#1)(2008-12#5)(2008-5#1)(2011-2#1)(2012-3#4)(2013-1#1)
back extraction of zinc##2##4##(2008-10#2)
back extraction of##4##3##(2008-10#4)
back extraction##5##2##(2008-10#5)
back from a##2##3##(2008-3#1)(2013-8#1)
back in##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
back injuries##2##2##(1996-1#1)(1997-7#1)
back into the##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)
back into##11##2##(1991-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2009-7#1)(2010-10#1)
back of the##3##3##(1991-6#1)(2008-9#1)(2011-2#1)
back of##7##2##(1991-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)
back over##2##2##(2008-10#2)
back pain and##6##3##(2008-12#3)(2010-1#1)(2011-2#1)(2012-2#1)
back pain associated with##3##4##(1991-8#1)(2010-12#2)
back pain is##2##3##(1993-6#1)(2008-12#1)
back pain syndrome##3##3##(2007-11#2)(2008-4#1)
back pain with##2##3##(1992-12#1)(2013-1#1)
back pain##63##2##(1991-8#1)(1992-12#2)(1993-6#4)(1995-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-11#4)(2008-12#14)(2008-4#1)(2009-1#2)(2009-4#4)(2009-7#2)(2009-9#1)(2010-1#5)(2010-12#2)(2010-9#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)
back pain]##2##2##(1996-6#1)(1997-3#1)
back propagation of##3##3##(1997-7#1)(2008-10#1)(2009-8#1)
back propagation##6##2##(1997-7#1)(2008-10#2)(2009-8#1)(2010-8#2)
back the##3##2##(1996-5#1)(2008-11#1)(2008-7#1)
back to a##2##3##(1994-9#1)(2008-5#1)
back to the##16##3##(1994-12#2)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-6#1)(2012-3#1)
back to##43##2##(1991-1#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-3#2)
back##221##1##(1991-1#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-12#2)(1993-1#1)(1993-2#2)(1993-6#5)(1994-12#2)(1994-9#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#4)(1997-7#5)(1997-8#1)(2007-11#4)(2007-12#1)(2008-10#34)(2008-11#12)(2008-12#27)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-1#2)(2009-10#2)(2009-4#4)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#6)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#3)(2010-8#3)(2010-9#4)(2011-2#11)(2012-12#3)(2012-2#3)(2012-3#8)(2013-1#11)(2013-8#2)
back-extracted##2##1##(2008-10#2)
back-extraction##3##1##(2008-10#3)
back-flushed##2##1##(2008-10#2)
back-illuminated##2##1##(2008-10#1)(2008-3#1)
back-pressure##2##1##(2008-10#2)
back-projection##3##1##(1994-9#2)(2011-2#1)
back-propagation learning algorithm was##2##4##(2008-10#2)
back-propagation learning##5##2##(2008-10#5)
back-propagation##10##1##(2008-10#10)
back-scattered##2##1##(2008-10#2)
back-titration##3##1##(2008-10#3)
back-up##5##1##(2008-11#2)(2008-9#2)(2011-2#1)
backbone and side chain##3##4##(2009-7#3)
backbone and side-chain##2##3##(2009-7#2)
backbone and##7##2##(1991-5#1)(2008-9#1)(2009-7#5)
backbone assignment of##2##3##(2009-7#2)
backbone atoms##3##2##(1994-5#2)(2008-8#1)
backbone of##5##2##(1993-12#1)(1995-8#1)(2008-9#2)(2013-1#1)
backbone resonance assignments of the 34 kDa##2##7##(2009-7#2)
backbone resonance assignments##3##3##(2009-7#3)
backbone resonance##4##2##(2009-7#4)
backbone##44##1##(1990-8#1)(1991-5#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-5#4)(1995-8#1)(2008-10#8)(2008-4#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-7#12)(2012-2#2)(2013-1#1)
backbones##3##1##(1995-3#1)(2008-10#2)
backcalculation##2##1##(1992-9#2)
backcross populations##2##2##(2008-10#1)(2008-9#1)
backcross##21##1##(1995-2#1)(1996-12#2)(2008-10#14)(2008-8#2)(2008-9#1)(2013-8#1)
backcrossed##2##1##(2008-10#1)(2008-9#1)
backcrosses to the susceptible##2##4##(2008-10#2)
backcrosses to the##3##3##(2008-10#3)
backcrosses##7##1##(2008-10#6)(2008-8#1)
backcrossing##4##1##(1991-12#2)(2008-10#2)
backflush mode##2##2##(2008-10#1)(2008-11#1)
background absorbance##3##2##(2008-10#3)
background absorption##6##2##(2008-10#6)
background and##10##2##(1993-3#1)(1993-6#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
background correction and##3##3##(2008-10#3)
background correction##13##2##(2008-10#13)
background corrector##3##2##(2008-10#3)
background current##5##2##(2008-10#5)
background electrolyte at##2##3##(2008-10#2)
background electrolyte##8##2##(2008-10#8)
background electrolytes (BGE)##2##3##(2008-10#2)
background environmental##2##2##(2008-10#1)(2008-9#1)
background fluorescence##3##2##(2008-10#1)(2008-9#1)(2010-3#1)
background for the##4##3##(2008-9#2)(2011-2#1)(2012-12#1)
background for##7##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)(2012-12#1)
background in##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
background incidence of##2##3##(1991-12#1)(1994-12#1)
background information on##4##3##(1991-12#1)(1994-2#1)(1996-12#1)(2008-9#1)
background information##6##2##(1991-12#1)(1994-2#1)(1996-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
background is##3##2##(2008-10#2)(2008-3#1)
background level of##3##3##(1991-12#1)(2008-10#2)
background levels of##2##3##(2008-10#2)
background levels##5##2##(1990-12#1)(1995-12#1)(2008-10#3)
background noise##6##2##(2008-10#5)(2009-12#1)
background of the##6##3##(1995-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2012-3#1)
background of##26##2##(1990-12#1)(1994-3#1)(1995-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-8#1)
background salt##2##2##(2008-10#2)
background signal##5##2##(2008-10#4)(2008-3#1)
background signals are##2##3##(2008-3#2)
background signals caused by##2##4##(2008-10#2)
background signals from a##3##4##(2008-3#3)
background signals from##5##3##(2008-10#1)(2008-3#4)
background signals in##2##3##(2008-3#2)
background signals##24##2##(2008-10#7)(2008-3#16)(2010-7#1)
background variables##2##2##(2010-2#1)(2011-2#1)
background##260##1##(1990-12#3)(1990-2#1)(1991-12#4)(1991-2#2)(1991-6#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-6#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#119)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#23)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#2)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#3)
backgrounds and##5##2##(2008-10#1)(2008-11#3)(2008-12#1)
backgrounds in##4##2##(2008-10#3)(2008-11#1)
backgrounds of##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
backgrounds##31##1##(1993-1#2)(1994-12#1)(1994-2#1)(1996-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#4)(2008-9#3)(2009-5#1)(2011-2#1)(2012-3#2)
backing substrate##2##2##(2008-10#1)(2009-5#1)
backing##6##1##(2008-10#1)(2008-3#2)(2009-5#2)(2009-7#1)
backpressure##2##1##(2008-10#2)
backpropagation and##2##2##(2008-10#1)(2008-3#1)
backpropagation models##2##2##(2008-10#2)
backpropagation##7##1##(2008-10#5)(2008-3#1)(2010-8#1)
backs##3##1##(1993-12#1)(2010-8#2)
backscatter and##2##2##(2008-3#2)
backscatter data##3##2##(2008-3#3)
backscatter from##4##2##(2008-2#1)(2008-3#3)
backscatter lidar##4##2##(2008-2#1)(2008-3#3)
backscatter ratio##2##2##(2008-3#2)
backscatter##38##1##(2008-2#9)(2008-3#29)
backscattered light##3##2##(2008-2#3)
backscattered##8##1##(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)
backscattering and##2##2##(2008-3#2)
backscattering by##2##2##(2008-3#2)
backscattering coefficients##2##2##(2008-2#1)(2008-3#1)
backscattering from##2##2##(2008-3#2)
backscattering of##2##2##(2008-2#1)(2008-3#1)
backscattering##30##1##(2008-2#3)(2008-3#27)
backside wear##3##2##(2008-8#3)
backup##4##1##(1994-2#1)(1997-2#1)(2008-10#1)(2008-9#1)
backward anisotropic scattering##3##3##(2008-3#3)
backward light scattering (BLS) signals##2##5##(2008-10#2)
backward light scattering##3##3##(2008-10#3)
backward##21##1##(1991-3#1)(1994-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#7)(2009-3#1)(2010-10#1)(2011-2#2)(2012-2#1)
backwards##3##1##(2008-9#1)(2010-6#1)(2011-1#1)
baclofen enantiomers##2##2##(2008-10#2)
baclofen in##2##2##(2008-10#1)(2011-2#1)
baclofen##14##1##(1990-5#4)(1995-2#1)(2008-10#3)(2011-2#6)
bacoside A##3##2##(2012-2#3)
bacoside##4##1##(2012-2#4)
bacteraemia##3##1##(2008-5#1)(2013-8#2)
bacteremia##8##1##(1990-2#1)(1990-3#1)(1991-3#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
bacteria and EPS I were##2##5##(2008-10#2)
bacteria and fungi##4##3##(2006-6#1)(2008-11#1)(2008-5#2)
bacteria and its##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
bacteria and other##2##3##(2008-10#2)
bacteria and protozoa##2##3##(2008-9#2)
bacteria and the##2##3##(2008-10#2)
bacteria and yeast##4##3##(2008-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
bacteria and##42##2##(1991-3#1)(1992-12#1)(1993-12#1)(1995-6#1)(2006-6#2)(2008-10#13)(2008-11#5)(2008-5#4)(2008-7#1)(2008-9#3)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
bacteria are##8##2##(1990-8#1)(1991-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
bacteria as well as##2##4##(1994-5#1)(2008-10#1)
bacteria as well##3##3##(1994-5#1)(2008-10#2)
bacteria as##5##2##(1994-5#1)(2008-10#2)(2010-8#2)
bacteria associated with##3##3##(2008-10#3)
bacteria at the##2##3##(2009-8#1)(2011-2#1)
bacteria at##5##2##(2008-10#2)(2009-8#1)(2011-2#1)(2012-2#1)
bacteria but##2##2##(2008-10#1)(2008-11#1)
bacteria by##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
bacteria can##3##2##(2008-10#1)(2009-3#1)(2011-2#1)
bacteria could be##2##3##(2008-10#2)
bacteria could##3##2##(2008-10#3)
bacteria during##4##2##(2008-10#3)(2013-1#1)
bacteria for##3##2##(2008-10#2)(2012-2#1)
bacteria from##7##2##(2008-10#1)(2008-5#2)(2011-2#1)(2012-2#2)(2013-8#1)
bacteria has##2##2##(2011-1#1)(2011-2#1)
bacteria have##2##2##(2008-10#1)(2008-5#1)
bacteria in the##11##3##(1996-3#1)(1996-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
bacteria in their##2##3##(1996-12#1)(2008-10#1)
bacteria in##29##2##(1996-12#1)(1996-3#1)(1996-9#1)(2006-6#1)(2008-10#14)(2008-4#1)(2008-5#2)(2008-9#3)(2011-1#1)(2011-2#3)(2012-2#1)
bacteria increased##2##2##(2008-8#1)(2011-2#1)
bacteria into##2##2##(2008-10#2)
bacteria is##6##2##(1991-2#1)(1993-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
bacteria isolated from##6##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#2)
bacteria isolated##8##2##(1991-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#2)
bacteria may##2##2##(2008-10#1)(2008-4#1)
bacteria of##5##2##(2008-8#1)(2009-8#2)(2011-2#1)(2012-3#1)
bacteria on pear##2##3##(2008-10#2)
bacteria on the##2##3##(2008-10#1)(2008-8#1)
bacteria on##10##2##(2008-10#7)(2008-8#1)(2009-6#1)(2013-1#1)
bacteria or##5##2##(2006-6#1)(2008-10#3)(2010-11#1)
bacteria play an##2##3##(2008-9#1)(2011-2#1)
bacteria that are##2##3##(2008-10#1)(2011-1#1)
bacteria that##11##2##(2006-5#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2011-1#2)(2011-2#1)
bacteria through##2##2##(2008-10#2)
bacteria to##10##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#2)
bacteria was##8##2##(1996-12#1)(2008-10#4)(2008-5#2)(2008-7#1)
bacteria were applied##3##3##(2008-10#3)
bacteria were found##2##3##(2008-10#1)(2008-5#1)
bacteria were isolated from##4##4##(2008-10#2)(2012-2#2)
bacteria were not##4##3##(2008-10#3)(2008-11#1)
bacteria were##24##2##(1996-12#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#2)
bacteria when##2##2##(2008-12#1)(2011-1#1)
bacteria which##2##2##(2007-12#1)(2008-10#1)
bacteria with##5##2##(1995-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
bacteria within the##3##3##(1996-6#1)(2012-2#1)(2013-8#1)
bacteria##469##1##(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#4)(1991-8#1)(1992-11#1)(1992-12#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-11#4)(1994-5#2)(1994-9#3)(1995-2#1)(1995-6#1)(1996-12#10)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-8#3)(2006-5#1)(2006-6#7)(2007-12#6)(2008-10#171)(2008-11#25)(2008-12#8)(2008-3#1)(2008-4#4)(2008-5#25)(2008-7#9)(2008-8#9)(2008-9#17)(2009-3#1)(2009-6#6)(2009-8#6)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#17)(2011-2#34)(2012-12#1)(2012-2#24)(2012-3#5)(2012-8#1)(2013-1#14)(2013-7#1)(2013-8#11)
bacteria's##2##1##(1995-2#1)(2008-10#1)
bacteria)##4##1##(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
bacterial 16S rRNA##2##3##(2010-6#1)(2012-2#1)
bacterial DNA sequences##2##3##(2010-7#2)
bacterial DNA##5##2##(1995-6#1)(2008-10#1)(2009-6#1)(2010-7#2)
bacterial adherence to leaves##2##4##(2008-10#2)
bacterial adherence##3##2##(2008-10#2)(2013-8#1)
bacterial and fungal infections##2##4##(2007-8#1)(2013-1#1)
bacterial and fungal##4##3##(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
bacterial and viral pathogens##2##4##(2008-10#1)(2010-12#1)
bacterial and viral##4##3##(1991-2#1)(2008-10#1)(2008-5#1)(2010-12#1)
bacterial and##13##2##(1991-2#1)(1991-3#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
bacterial antagonists##3##2##(2008-10#3)
bacterial artificial chromosome (BAC) library##4##5##(2008-10#1)(2008-8#2)(2010-10#1)
bacterial artificial chromosome (BAC)##7##4##(1997-8#1)(2008-10#1)(2008-8#3)(2009-10#1)(2010-10#1)
bacterial artificial chromosome##8##3##(1997-8#1)(2008-10#1)(2008-8#4)(2009-10#1)(2010-10#1)
bacterial artificial chromosomes (BACs)##2##4##(2008-4#2)
bacterial artificial##11##2##(1997-8#1)(2008-10#2)(2008-4#2)(2008-8#4)(2009-10#1)(2010-10#1)
bacterial bioreporters##3##2##(2011-2#3)
bacterial blight and blast##2##4##(2009-10#2)
bacterial blight caused##2##3##(2008-10#2)
bacterial blight disease##2##3##(2008-10#1)(2008-8#1)
bacterial blight of anthurium##2##4##(2008-10#2)
bacterial blight of##6##3##(2008-10#6)
bacterial blight pathogen##2##3##(2008-10#2)
bacterial blight resistance##6##3##(2008-10#4)(2008-8#2)
bacterial blight##30##2##(2008-10#24)(2008-8#3)(2008-9#1)(2009-10#2)
bacterial bodies##2##2##(2009-6#2)
bacterial burden##2##2##(2012-12#1)(2012-2#1)
bacterial canker development in##2##4##(2008-10#2)
bacterial canker is##2##3##(2008-10#2)
bacterial canker##14##2##(2008-10#14)
bacterial cell##5##2##(1991-9#1)(2008-10#4)
bacterial cells and##3##3##(1994-11#1)(2008-10#1)(2008-3#1)
bacterial cells by##2##3##(2008-10#2)
bacterial cells to positively charged##2##5##(2008-10#2)
bacterial cells to##5##3##(2008-10#5)
bacterial cells##23##2##(1993-8#1)(1994-11#1)(2007-12#1)(2008-10#15)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
bacterial colonization##7##2##(1991-3#2)(1996-2#1)(2008-10#4)
bacterial communities##3##2##(2008-10#2)(2009-6#1)
bacterial community composition##2##3##(2010-6#2)
bacterial community##6##2##(2008-10#3)(2010-6#3)
bacterial components##3##2##(1996-12#2)(2011-2#1)
bacterial contamination##8##2##(1991-12#2)(1991-3#1)(2008-10#2)(2009-6#2)(2013-8#1)
bacterial conversion of daidzein##2##4##(2010-1#2)
bacterial counts##3##2##(2008-10#2)(2012-2#1)
bacterial culture##4##2##(1992-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
bacterial cultures##4##2##(1992-8#1)(2008-10#2)(2008-9#1)
bacterial disease of##2##3##(2008-10#2)
bacterial disease##4##2##(2008-10#3)(2013-8#1)
bacterial endotoxin##2##2##(1996-12#1)(2008-4#1)
bacterial expression vector##2##3##(2008-10#2)
bacterial expression##5##2##(1995-5#1)(2008-10#2)(2008-4#1)(2011-2#1)
bacterial fruit blotch##2##3##(2008-10#2)
bacterial gene expression##3##3##(2008-10#2)(2008-7#1)
bacterial growth by##2##3##(2008-5#2)
bacterial growth in##3##3##(2008-5#2)(2008-8#1)
bacterial growth inhibition##3##3##(2008-5#2)(2011-2#1)
bacterial growth##22##2##(1997-8#1)(2008-10#4)(2008-4#1)(2008-5#9)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
bacterial infection in##4##3##(2008-10#2)(2010-12#1)(2012-3#1)
bacterial infection##12##2##(1990-12#2)(2006-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#2)
bacterial infections in##5##3##(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#1)
bacterial infections##12##2##(1990-9#1)(1992-5#1)(1994-9#1)(1996-12#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
bacterial isolates##4##2##(1991-3#1)(2008-10#3)
bacterial kidney disease in salmonids##2##5##(2009-6#2)
bacterial leaf spot of radish caused by Xanthomonas campestris pv##2##10##(2008-10#2)
bacterial leaf spot of radish##3##5##(2008-10#3)
bacterial leaf spot##4##3##(2008-10#4)
bacterial leaf##6##2##(2008-10#6)
bacterial life##4##2##(2008-8#4)
bacterial load##2##2##(2008-12#1)(2009-8#1)
bacterial luciferase##3##2##(2008-10#1)(2008-11#2)
bacterial meningitis##7##2##(1996-3#1)(2008-11#2)(2010-12#2)(2011-2#2)
bacterial movement to##2##3##(2008-10#1)(2013-8#1)
bacterial movement##4##2##(2008-10#2)(2013-8#2)
bacterial multiplication in##2##3##(2008-10#2)
bacterial multiplication##5##2##(2008-10#5)
bacterial numbers##3##2##(1996-12#1)(2008-5#2)
bacterial pathogen##3##2##(2008-10#3)
bacterial pathogens##12##2##(2008-10#6)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#2)
bacterial peritonitis and##3##3##(2009-8#1)(2011-2#2)
bacterial peritonitis##7##2##(2009-8#4)(2011-2#2)(2012-3#1)
bacterial population size##2##3##(2008-10#2)
bacterial population##8##2##(2008-10#8)
bacterial populations in the##3##4##(2008-10#3)
bacterial populations in##5##3##(2008-10#5)
bacterial populations on##3##3##(2008-10#3)
bacterial populations##18##2##(2008-10#18)
bacterial prostatitis and##2##3##(2008-10#2)
bacterial prostatitis##6##2##(2008-10#6)
bacterial proteins##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
bacterial resistance##5##2##(1991-3#1)(2008-10#2)(2013-1#2)
bacterial sensor performance##2##3##(2011-1#2)
bacterial sensor##5##2##(2008-10#2)(2009-8#1)(2011-1#2)
bacterial sensors##2##2##(2011-1#2)
bacterial signal##2##2##(1990-11#1)(1997-7#1)
bacterial species on##2##3##(2008-10#2)
bacterial species##12##2##(1995-2#2)(2008-10#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
bacterial speck disease##2##3##(2008-10#2)
bacterial speck on plants##2##4##(2008-10#2)
bacterial speck##9##2##(2008-10#9)
bacterial spot of tomato##3##4##(2008-10#3)
bacterial spot of##4##3##(2008-10#4)
bacterial spot##14##2##(2008-10#14)
bacterial spread##2##2##(2008-10#2)
bacterial strain##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
bacterial strains isolated from##2##4##(2008-10#2)
bacterial strains isolated##3##3##(1990-2#1)(2008-10#2)
bacterial strains tested##2##3##(2008-10#1)(2011-2#1)
bacterial strains to##2##3##(2008-10#2)
bacterial strains were##2##3##(2008-10#2)
bacterial strains##18##2##(1990-2#1)(2006-6#1)(2008-10#10)(2008-12#1)(2011-1#1)(2011-2#2)(2013-8#2)
bacterial systems##2##2##(2008-10#1)(2008-11#1)
bacterial taxa##2##2##(2008-10#1)(2011-2#1)
bacterial therapy##2##2##(1991-3#2)
bacterial toxins##3##2##(2008-7#1)(2011-2#2)
bacterial traits##2##2##(2008-10#2)
bacterial two-hybrid system##2##3##(2008-9#2)
bacterial type##2##2##(1997-8#1)(2011-2#1)
bacterial vaginosis##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#2)
bacterial virulence factors##2##3##(1996-12#2)
bacterial virulence##6##2##(1996-12#2)(2009-8#1)(2011-2#1)(2013-1#2)
bacterial volatiles##3##2##(2009-8#3)
bacterial wilt##5##2##(2008-10#5)
bacterial##584##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#10)(1991-9#1)(1992-2#4)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#5)(1993-9#2)(1994-11#1)(1994-12#2)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#9)(1996-2#1)(1996-3#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#4)(2006-5#1)(2006-6#1)(2007-12#4)(2007-8#1)(2008-10#265)(2008-11#12)(2008-12#6)(2008-3#1)(2008-4#7)(2008-5#23)(2008-7#12)(2008-8#17)(2008-9#16)(2009-10#3)(2009-6#10)(2009-8#15)(2010-1#3)(2010-10#2)(2010-12#6)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#1)(2011-1#10)(2011-2#33)(2012-12#3)(2012-2#15)(2012-3#8)(2013-1#10)(2013-8#14)
bacterially expressed##4##2##(1994-11#2)(1994-5#1)(2008-10#1)
bacterially produced salicylic##2##3##(2008-10#2)
bacterially produced##3##2##(2008-10#2)(2008-4#1)
bacterially##7##1##(1994-11#2)(1994-5#1)(2008-10#3)(2008-4#1)
bactericidal activity##4##2##(1991-2#1)(1995-5#1)(2008-12#1)(2013-8#1)
bactericidal effect##2##2##(2008-5#1)(2012-2#1)
bactericidal##12##1##(1991-2#1)(1992-8#1)(1995-5#1)(2008-12#1)(2008-5#3)(2012-2#3)(2013-1#1)(2013-8#1)
bactericide##2##1##(2008-10#2)
bactericides##6##1##(2008-10#5)(2008-5#1)
bacteriocin##2##1##(2008-10#2)
bacteriologic response##2##2##(1996-3#1)(2011-2#1)
bacteriologic##3##1##(1996-3#1)(2008-5#1)(2011-2#1)
bacteriological investigation##2##2##(2011-2#1)(2012-3#1)
bacteriological methods##3##2##(2008-12#2)(2008-9#1)
bacteriological##13##1##(1990-9#1)(1995-9#1)(2008-11#1)(2008-12#3)(2008-9#1)(2010-6#2)(2011-2#2)(2012-3#2)
bacteriophage 434 repressor##2##3##(2008-8#2)
bacteriophage DNAs##2##2##(1994-8#2)
bacteriophage MS2##2##2##(2008-11#1)(2008-2#1)
bacteriophage T3##2##2##(1996-2#2)
bacteriophage T4 late##2##3##(1995-6#2)
bacteriophage T4##6##2##(1990-5#1)(1995-2#1)(1995-6#2)(1997-7#2)
bacteriophage lambda##3##2##(1993-9#1)(1995-2#2)
bacteriophage##37##1##(1990-11#1)(1990-5#1)(1991-5#3)(1993-9#2)(1994-8#2)(1995-2#3)(1995-6#2)(1996-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#8)(2008-9#1)(2009-6#1)(2012-2#2)
bacteriophages##5##1##(1990-11#1)(1993-9#1)(2008-4#1)(2008-8#1)(2012-2#1)
bacteriopheophytin##3##1##(2008-8#1)(2008-9#2)
bacteriopheophytins in the reaction centers##2##5##(2008-9#2)
bacteriorhodopsin##4##1##(1990-5#2)(1994-5#1)(1997-6#1)
bacteriostatic##2##1##(2010-7#1)(2012-2#1)
bacterium Cellulomonas fimi##2##3##(1992-11#2)
bacterium Pseudomonas##4##2##(2008-10#3)(2008-8#1)
bacterium Ralstonia solanacearum##2##3##(2008-10#2)
bacterium Serratia marcescens##2##3##(2008-10#1)(2009-6#1)
bacterium Serratia##3##2##(2008-10#2)(2009-6#1)
bacterium Xylella fastidiosa##2##3##(2008-10#2)
bacterium and##4##2##(1997-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
bacterium has##2##2##(2008-10#1)(2008-8#1)
bacterium is##2##2##(1996-11#1)(2013-1#1)
bacterium that has##2##3##(2008-10#1)(2011-2#1)
bacterium that##5##2##(2008-10#3)(2011-2#2)
bacterium was##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
bacterium with##2##2##(2008-10#1)(2009-8#1)
bacterium##96##1##(1990-12#1)(1991-12#1)(1992-11#2)(1993-8#3)(1996-11#1)(1996-12#2)(1996-2#2)(1997-1#1)(2008-10#45)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#8)(2008-9#3)(2009-6#2)(2009-8#2)(2011-1#3)(2011-2#11)(2012-2#2)(2013-1#2)
bacterium-like organisms##2##2##(2008-10#2)
bacteriurea##2##1##(2012-3#2)
bacterized##2##1##(2008-10#2)
baculovirus expressing##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
baculovirus expression system##5##3##(1992-10#1)(1993-6#2)(1995-6#1)(2008-11#1)
baculovirus expression vector system##3##4##(2008-11#2)(2008-7#1)
baculovirus expression vector##4##3##(1993-6#1)(2008-11#2)(2008-7#1)
baculovirus expression##10##2##(1992-10#1)(1993-6#3)(1995-6#1)(2008-11#4)(2008-7#1)
baculovirus infected##2##2##(1993-8#1)(2008-11#1)
baculovirus surface-display##2##2##(2013-8#2)
baculovirus system##3##2##(1992-10#1)(1992-3#1)(2008-11#1)
baculovirus##43##1##(1992-10#2)(1992-3#2)(1993-6#4)(1993-8#2)(1995-6#1)(1997-3#3)(2008-10#2)(2008-11#17)(2008-7#7)(2013-8#3)
baculovirus-infected insect cells##2##3##(1993-6#1)(2008-11#1)
baculovirus-insect cell system##4##3##(1992-3#1)(2008-11#2)(2008-7#1)
baculoviruses##5##1##(1993-6#1)(1993-8#1)(1997-8#2)(2008-7#1)
bad breath##2##2##(1997-4#2)
bad care##3##2##(2010-10#3)
bad for##2##2##(2010-9#2)
bad##30##1##(1993-11#1)(1993-12#2)(1994-2#1)(1994-6#1)(1995-8#1)(1997-3#2)(1997-4#2)(2008-10#3)(2008-11#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#3)(2010-11#1)(2010-5#1)(2010-9#2)(2011-3#1)(2012-3#1)(2013-8#2)
badge of##2##2##(2008-8#2)
badge##4##1##(2008-10#1)(2008-8#3)
badly##2##1##(1997-3#1)(2008-10#1)
badnavirus##3##1##(2008-10#3)
baetica##3##1##(2008-10#3)
baffle##5##1##(1995-3#4)(2010-6#1)
baffle)##2##1##(1995-3#2)
bag##9##1##(1991-12#1)(1996-6#1)(2008-10#6)(2008-11#1)
bag-1##8##1##(2008-11#8)
bags##12##1##(1993-3#1)(1995-5#1)(2008-10#8)(2012-2#2)
baicalein##3##1##(2008-10#2)(2008-11#1)
baicalin and quercetin in Scutellariae Radix and its##2##8##(2008-10#2)
bait region##4##2##(2008-11#4)
bait##11##1##(1993-2#1)(1997-7#1)(2008-11#5)(2008-8#1)(2008-9#2)(2011-2#1)
bait-lamina test##3##2##(2008-11#3)
baited##3##1##(1994-8#1)(2008-10#1)(2012-2#1)
baiting##3##1##(2008-10#3)
baits##2##1##(1992-5#1)(2008-10#1)
baker's yeast strains##3##3##(2010-7#3)
baker's yeast##11##2##(1995-3#1)(2008-10#2)(2010-7#6)(2011-1#2)
baker's##12##1##(1990-3#1)(1995-3#1)(2008-10#2)(2010-7#6)(2011-1#2)
bakery applications##2##2##(2010-7#2)
bakery waste##2##2##(2008-10#2)
bakery##7##1##(1990-3#2)(2008-10#2)(2010-7#2)(2011-2#1)
baking##9##1##(1990-3#2)(2008-10#5)(2010-7#2)
balance and##11##2##(1991-11#1)(1991-6#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-12#1)(2008-4#2)(2010-11#1)(2010-7#1)(2013-1#1)
balance between cell proliferation and##2##5##(2008-11#2)
balance between cell##3##3##(2008-11#2)(2008-9#1)
balance between the##3##3##(1993-12#1)(2008-9#1)(2010-4#1)
balance between##32##2##(1991-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-8#1)(2008-9#5)(2009-12#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-8#2)
balance during##4##2##(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#1)
balance has##2##2##(2008-11#2)
balance in computer posturography##2##4##(2010-12#2)
balance in the##4##3##(1991-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
balance in##12##2##(1991-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#2)
balance is maintained##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
balance is##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-7#1)
balance model of in vivo neutrophil formation following bone marrow rescue therapy##2##12##(2008-11#2)
balance of the##5##3##(1994-8#1)(2008-5#1)(2008-9#1)(2012-3#2)
balance of##20##2##(1994-11#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
balance the##6##2##(1995-6#1)(1996-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
balance to##2##2##(2008-11#1)(2013-1#1)
balance was##2##2##(2008-12#1)(2012-2#1)
balance##158##1##(1991-11#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#20)(2008-12#7)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#2)(2010-7#7)(2010-9#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#5)(2012-6#1)(2012-7#1)(2013-1#9)(2013-8#8)
balanced against the##3##3##(1997-3#1)(1997-8#1)(2008-3#1)
balanced against##4##2##(1997-3#1)(1997-8#1)(2008-3#1)(2008-7#1)
balanced by##5##2##(1990-5#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
balanced perspective##2##2##(1993-12#1)(2008-8#1)
balanced scorecard##3##2##(1995-12#2)(2008-11#1)
balanced scorecards##3##2##(2008-11#3)
balanced supplementation##2##2##(2008-11#2)
balanced translocations##2##2##(2010-1#1)(2013-8#1)
balanced##51##1##(1990-5#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-1#1)(1995-12#3)(1995-9#2)(1996-9#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#11)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
balances the##2##2##(2008-8#1)(2010-11#1)
balances##16##1##(1991-3#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)
balancing the##4##2##(2008-8#1)(2009-12#1)(2009-5#1)(2013-1#1)
balancing##17##1##(1992-2#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#4)
ball after##2##2##(2008-6#2)
ball and##2##2##(2008-6#1)(2011-2#1)
ball##30##1##(1996-1#1)(1997-7#4)(2008-10#1)(2008-11#3)(2008-6#11)(2008-9#1)(2010-4#1)(2011-2#7)(2013-1#1)
ballistic movements##2##2##(2008-7#2)
balloon angioplasty and##2##3##(2008-11#1)(2012-3#1)
balloon angioplasty##5##2##(1991-3#1)(1997-8#1)(2008-11#1)(2012-3#2)
balloon catheter##7##2##(1995-10#1)(1996-6#1)(1997-3#3)(1997-6#2)
balloon dilatation##7##2##(1991-3#1)(2008-10#1)(2010-12#1)(2013-1#4)
balloon dilation##5##2##(2010-12#5)
balloon flights##2##2##(2008-11#1)(2008-3#1)
balloon in##3##2##(1997-3#1)(2013-1#2)
balloon occlusion##2##2##(2008-11#1)(2008-7#1)
balloon##61##1##(1991-3#2)(1992-3#1)(1995-10#1)(1996-6#1)(1996-9#1)(1997-3#5)(1997-6#6)(1997-8#2)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#7)(2010-12#7)(2011-2#3)(2012-3#2)(2013-1#8)
ballooning##6##1##(2008-10#1)(2008-11#3)(2009-6#1)(2010-5#1)
balls were##2##2##(2011-2#2)
balls##4##1##(2008-2#2)(2011-2#2)
bamboo##4##1##(2008-10#3)(2008-8#1)
ban in##2##2##(1996-1#2)
ban on abortions##2##3##(1995-6#1)(1996-5#1)
ban on the##2##3##(1995-6#1)(1996-5#1)
ban on##8##2##(1992-3#1)(1995-6#2)(1996-1#1)(1996-5#3)(2011-3#1)
ban the##2##2##(1991-5#1)(2010-9#1)
ban##18##1##(1991-5#1)(1992-3#2)(1995-6#6)(1996-1#3)(1996-5#3)(2009-7#1)(2010-9#1)(2011-3#1)
banana is##2##2##(2008-10#2)
banana roots##2##2##(2008-10#2)
banana##24##1##(2008-10#24)
banana-growing regions##2##2##(2008-10#2)
bananas and##2##2##(2008-10#2)
bananas##3##1##(2008-10#3)
band (MW##2##2##(1992-12#1)(2008-11#1)
band 11q23##2##2##(1995-6#1)(2011-3#1)
band 3##3##2##(2008-3#1)(2013-7#2)
band 7##2##2##(2008-2#1)(2008-7#1)
band and the##2##3##(1993-8#1)(2008-3#1)
band and##4##2##(1993-8#1)(2007-12#1)(2008-11#1)(2008-3#1)
band at##7##2##(1995-11#1)(2008-10#5)(2008-3#1)
band detection limits##2##3##(2008-3#2)
band gap##3##2##(1990-11#1)(2008-10#1)(2012-2#1)
band in rat##2##3##(1992-6#1)(2008-9#1)
band in the##3##3##(2008-10#2)(2008-8#1)
band in##11##2##(1992-6#1)(1993-2#1)(1997-3#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
band intensity and band area measurements##3##6##(2008-10#3)
band intensity##4##2##(2008-10#4)
band is##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
band ligation##9##2##(2013-1#9)
band of about##2##3##(2008-10#1)(2008-8#1)
band of approximately##2##3##(1991-12#1)(2008-10#1)
band of the##2##3##(1992-3#1)(2008-10#1)
band of##31##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1997-3#1)(2007-12#1)(2008-10#11)(2008-3#3)(2008-4#1)(2008-8#3)(2008-9#1)(2010-12#1)(2013-1#1)
band patterns was##2##3##(2008-12#2)
band patterns##6##2##(2008-12#5)(2008-5#1)
band shifts##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
band showed##2##2##(2008-10#2)
band signature##2##2##(2008-3#2)
band was not detected##2##4##(2008-10#1)(2008-5#1)
band was observed in##2##4##(1995-11#1)(2008-10#1)
band was##10##2##(1991-12#1)(1995-11#2)(1995-6#1)(2008-10#4)(2008-5#1)(2011-3#1)
band with an##2##3##(1992-8#1)(2009-9#1)
band with##6##2##(1992-8#1)(1996-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-3#1)
band##207##1##(1990-11#1)(1990-8#4)(1991-12#2)(1991-5#2)(1991-9#2)(1992-1#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#3)(1994-5#2)(1995-11#4)(1995-2#1)(1995-6#3)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2007-12#2)(2008-10#68)(2008-11#5)(2008-12#6)(2008-2#5)(2008-3#23)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#4)(2009-9#1)(2010-12#1)(2010-3#2)(2011-3#2)(2012-12#2)(2012-2#2)(2013-1#11)(2013-7#2)(2013-8#3)
band)##2##1##(2008-3#1)(2008-5#1)
bandage##4##1##(1991-2#2)(2010-3#1)(2011-2#1)
bandages##2##1##(1991-2#1)(1992-2#1)
bandgap##5##1##(2007-12#2)(2008-3#1)(2008-7#1)(2012-3#1)
banding and##2##2##(1997-3#1)(2008-11#1)
banding in##2##2##(2008-10#1)(2012-12#1)
banding pattern##7##2##(2008-10#6)(2008-12#1)
banding patterns resulting from##2##4##(2008-10#2)
banding patterns##13##2##(2008-10#13)
banding##38##1##(1991-2#1)(1992-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(2008-10#23)(2008-11#1)(2008-12#2)(2008-2#1)(2012-12#4)(2012-3#1)
bandpass filters##2##2##(2007-11#1)(2008-10#1)
bandpass of##2##2##(2008-10#1)(2008-3#1)
bandpass##6##1##(2007-11#2)(2008-10#2)(2008-3#2)
bands and##2##2##(2008-10#1)(2008-8#1)
bands are##4##2##(2008-10#2)(2008-12#1)(2010-11#1)
bands assigned to the transition moments Q(X)##2##7##(2008-9#2)
bands at the##2##3##(1995-12#1)(2008-12#1)
bands at##8##2##(1995-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)
bands between##3##2##(2008-11#1)(2008-8#2)
bands corresponding to##4##3##(2008-10#3)(2010-12#1)
bands for##2##2##(2008-10#2)
bands from##3##2##(2008-10#2)(2008-9#1)
bands in the##7##3##(1996-5#1)(2008-10#6)
bands in##12##2##(1996-5#1)(2008-10#8)(2008-11#1)(2008-9#2)
bands is##2##2##(2008-10#2)
bands obtained##2##2##(2008-10#1)(2008-9#1)
bands of the##6##3##(1995-12#1)(2008-10#3)(2008-3#2)
bands of these##2##3##(2008-10#2)
bands of##26##2##(1993-3#1)(1994-11#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#3)(2010-10#1)(2011-2#1)
bands or spots##2##3##(2010-11#2)
bands revealed##2##2##(2008-10#1)(2008-7#1)
bands that were##4##3##(1991-12#1)(2008-10#3)
bands that##9##2##(1991-12#1)(1995-11#1)(2008-10#5)(2008-3#2)
bands was##2##2##(2008-10#1)(2008-9#1)
bands were detected in##2##4##(2008-10#1)(2008-8#1)
bands were present in##2##4##(2008-10#2)
bands were##10##2##(1993-1#1)(2008-10#7)(2008-12#1)(2008-8#1)
bands with##2##2##(1990-5#1)(2008-10#1)
bands##153##1##(1990-5#1)(1991-12#2)(1991-5#1)(1992-4#1)(1993-1#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#4)(1996-12#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#79)(2008-11#5)(2008-12#5)(2008-3#11)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#11)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2013-8#1)
bandwidth and##2##2##(2008-3#1)(2010-4#1)
bandwidth of &lt##2##3##(2008-3#2)
bandwidth of the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
bandwidth of##9##2##(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#4)(2009-5#2)
bandwidth##36##1##(1994-8#2)(1997-8#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#20)(2008-7#1)(2009-10#1)(2009-5#2)(2010-4#1)
bandwidth) and##2##2##(2008-3#2)
bandwidth)##3##1##(2008-3#3)
bandwidths are##2##2##(2007-12#1)(2008-3#1)
bandwidths of##2##2##(1991-2#1)(2008-3#1)
bandwidths##8##1##(1991-2#2)(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#1)
bank in##2##2##(1990-11#1)(2008-8#1)
bank of##3##2##(1996-12#1)(2008-12#1)(2011-1#1)
bank voles##2##2##(2012-3#2)
bank was##2##2##(1990-11#1)(2011-2#1)
bank##24##1##(1990-11#2)(1993-12#1)(1995-11#2)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#4)(2010-10#1)(2011-1#1)(2011-2#4)(2012-3#3)
banking##3##1##(1995-6#1)(2011-2#1)(2012-2#1)
bankruptcy filings##4##2##(2008-11#4)
bankruptcy##8##1##(2008-11#8)
banks and##2##2##(2011-2#2)
banks##18##1##(1991-9#1)(1995-2#1)(1995-6#3)(1995-9#1)(1996-3#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2011-2#3)(2012-3#1)
banksiana##2##1##(2008-10#2)
banned the use of##2##4##(1991-12#1)(1994-6#1)
banned##3##1##(1991-12#1)(1991-6#1)(1994-6#1)
bans##2##1##(1993-5#1)(1995-6#1)
bar and##2##2##(2008-10#1)(2008-8#1)
bar##26##1##(1990-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-8#2)(2009-1#1)(2009-7#2)(2010-8#3)(2012-12#1)(2012-3#1)(2013-1#1)
bar)##2##1##(2008-10#2)
barbadense##2##1##(2008-10#2)
barbed##2##1##(2008-12#1)(2012-2#1)
barber-surgeons##2##1##(1996-3#2)
barbituric acid##5##2##(2008-10#4)(2008-11#1)
barbituric##6##1##(2008-10#5)(2008-11#1)
bare GC electrode##2##3##(2008-10#2)
bare GCE##2##2##(2008-10#2)
bare SOWG and##2##3##(2008-10#2)
bare SOWG##3##2##(2008-10#3)
bare glassy carbon electrode##2##4##(2008-10#2)
bare metal stents was##2##4##(2008-11#1)(2008-12#1)
bare metal stents##5##3##(2008-11#3)(2008-12#2)
bare silica##2##2##(2008-10#2)
bare soil##4##2##(2008-10#4)
bare##45##1##(1997-2#2)(1997-7#1)(2008-10#29)(2008-11#4)(2008-12#2)(2008-3#4)(2008-7#1)(2008-8#1)(2012-2#1)
barely detectable##5##2##(1992-3#1)(1993-12#1)(2008-10#2)(2008-9#1)
barely visible##2##2##(1991-12#1)(2008-10#1)
barely##15##1##(1991-12#1)(1992-3#3)(1993-12#1)(1994-12#1)(1997-7#1)(2008-10#5)(2008-9#2)(2013-7#1)
bariatric surgery##7##2##(1993-3#3)(2010-8#2)(2012-12#1)(2013-8#1)
bariatric##8##1##(1993-3#4)(2010-8#2)(2012-12#1)(2013-8#1)
barium and potassium in a mixture##2##6##(2008-10#2)
barium and potassium##4##3##(2008-10#4)
barium and##5##2##(2008-10#5)
barium enema##3##2##(1997-5#1)(1997-8#1)(2011-2#1)
barium hydroxide##3##2##(2008-10#3)
barium ions##2##2##(2008-10#2)
barium##28##1##(1994-12#1)(1997-5#1)(1997-8#1)(2008-10#19)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#2)
bark beetle##6##2##(2008-10#6)
bark beetles##5##2##(2008-10#4)(2008-8#1)
bark canker##2##2##(2008-10#2)
bark of##7##2##(2008-10#3)(2008-11#1)(2008-12#2)(2012-2#1)
bark or##2##2##(2008-10#1)(2008-11#1)
bark samples##4##2##(2008-10#4)
bark tissues##2##2##(2008-10#2)
bark##43##1##(2008-10#36)(2008-11#2)(2008-12#2)(2008-8#1)(2010-3#1)(2012-2#1)
barley (Hordeum vulgare L##4##4##(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
barley (Hordeum##6##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-9#1)
barley aleurone##3##2##(2008-8#3)
barley alpha-amylase andA##2##3##(2008-8#2)
barley alpha-amylase##3##2##(2008-8#3)
barley and##11##2##(1991-12#1)(2008-10#8)(2008-12#1)(2008-9#1)
barley breeding##2##2##(2008-10#2)
barley chromosome##5##2##(2008-10#5)
barley chromosomes##2##2##(2008-10#2)
barley cultivar##3##2##(2008-10#3)
barley cultivars and##2##3##(2008-10#2)
barley cultivars with different##2##4##(2008-10#2)
barley cultivars with##3##3##(2008-10#3)
barley cultivars##11##2##(2008-10#10)(2008-9#1)
barley cv##5##2##(2008-10#5)
barley fields located##2##3##(2008-10#2)
barley fields##3##2##(2008-10#3)
barley genotype##2##2##(2008-10#2)
barley genotypes##5##2##(2008-10#5)
barley germ plasm##2##3##(2008-10#2)
barley germplasm##2##2##(2008-10#2)
barley in the##5##3##(2008-10#5)
barley in##10##2##(2008-10#10)
barley is##5##2##(2008-10#3)(2008-9#1)(2009-10#1)
barley leaf##2##2##(2008-10#2)
barley leaves##4##2##(2008-10#4)
barley or##2##2##(2008-10#2)
barley powdery mildew##2##3##(2008-10#2)
barley scald##2##2##(2008-10#2)
barley seed##2##2##(1995-6#2)
barley seedlings##2##2##(2008-10#2)
barley stripe rust##2##3##(2008-10#2)
barley stripe##3##2##(1997-3#1)(2008-10#2)
barley was##3##2##(2008-10#2)(2008-12#1)
barley yellow dwarf virus (BYDV)##2##5##(2008-10#1)(2008-8#1)
barley yellow dwarf virus##3##4##(2008-10#2)(2008-8#1)
barley yellow dwarf##7##3##(2008-10#6)(2008-8#1)
barley##188##1##(1991-12#2)(1991-5#1)(1992-9#1)(1995-6#5)(1997-3#1)(2008-10#152)(2008-11#2)(2008-12#8)(2008-8#7)(2008-9#6)(2009-10#3)
barn##4##1##(1990-5#2)(2008-9#2)
barnacle Megabalanus rosa##5##3##(1990-5#4)(1993-6#1)
barnacle##6##1##(1990-5#4)(1993-6#2)
barnase was##2##2##(2008-8#2)
barnase##4##1##(1991-6#1)(2008-8#3)
baroreceptor inhibition of neurosecretory##2##4##(1990-5#2)
baroreceptor inhibition of##3##3##(1990-5#3)
baroreceptor##6##1##(1990-5#5)(2010-6#1)
barrel##3##1##(1991-3#1)(1997-3#2)
barrier against##2##2##(2008-10#2)
barrier and##6##2##(1997-2#1)(2008-10#2)(2010-12#1)(2012-2#2)
barrier cells in##2##3##(1991-5#1)(2008-7#1)
barrier cells##5##2##(1991-5#1)(2008-7#4)
barrier for##2##2##(2008-10#1)(2013-1#1)
barrier function in##5##3##(2008-5#4)(2008-7#1)
barrier function of the##3##4##(2008-5#2)(2009-10#1)
barrier function of##4##3##(2008-5#3)(2009-10#1)
barrier function##28##2##(2008-5#23)(2008-7#2)(2009-10#1)(2010-10#1)(2011-2#1)
barrier in the##2##3##(1994-5#1)(2008-7#1)
barrier in##7##2##(1990-5#1)(1994-5#1)(2008-10#4)(2008-7#1)
barrier integrity##2##2##(2008-5#1)(2012-2#1)
barrier into##3##2##(2009-8#2)(2012-2#1)
barrier of##3##2##(1992-3#1)(1994-11#1)(1994-5#1)
barrier properties##5##2##(2008-5#3)(2010-7#1)(2011-2#1)
barrier structure##2##2##(2008-5#2)
barrier that##2##2##(1997-1#1)(2011-2#1)
barrier to gene flow##2##4##(2008-10#2)
barrier to the development of##2##5##(1994-1#1)(2011-3#1)
barrier to the##8##3##(1994-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-3#1)
barrier to##24##2##(1994-1#1)(1994-3#1)(1996-3#1)(1997-1#2)(1997-2#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)(2011-3#1)(2013-1#1)
barrier was##2##2##(2008-10#1)(2010-11#1)
barrier zone##2##2##(2008-10#2)
barrier##164##1##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#4)(1991-5#1)(1992-1#1)(1992-3#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#3)(1995-2#2)(1996-3#1)(1997-1#6)(1997-2#3)(2008-10#29)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#49)(2008-7#8)(2008-8#2)(2009-10#6)(2009-4#1)(2009-8#7)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-2#9)(2013-1#3)
barrier&quot##2##1##(2011-2#2)
barriers and##11##2##(1990-2#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
barriers are##2##2##(1996-3#1)(2012-3#1)
barriers at sites of##2##4##(2008-10#2)
barriers between##4##2##(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#1)
barriers have##2##2##(1995-12#1)(2010-11#1)
barriers in the##2##3##(2009-11#1)(2010-1#1)
barriers in##7##2##(2008-7#1)(2009-11#1)(2009-12#1)(2010-1#1)(2012-2#1)(2012-3#2)
barriers of##5##2##(2007-12#1)(2008-11#3)(2013-8#1)
barriers perceived##2##2##(1994-1#1)(2013-1#1)
barriers that can##2##3##(2008-11#1)(2010-11#1)
barriers that##7##2##(2008-10#2)(2008-11#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-2#1)
barriers they encountered##2##3##(2010-4#1)(2011-1#1)
barriers to care##2##3##(1995-12#2)
barriers to health care##3##4##(1997-2#3)
barriers to implementation of##2##4##(1996-2#1)(2013-1#1)
barriers to implementation##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
barriers to pain management##2##4##(2009-12#1)(2010-11#1)
barriers to the##4##3##(1994-1#1)(1996-3#1)(1996-5#1)(2008-11#1)
barriers to training##2##3##(1996-3#1)(2011-2#1)
barriers to##50##2##(1993-12#2)(1994-1#1)(1994-12#1)(1995-12#4)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#2)(2010-7#1)(2011-2#6)(2011-9#1)(2012-12#1)(2013-1#5)
barriers were identified in##2##4##(2008-10#2)
barriers were##4##2##(2008-1#1)(2008-10#2)(2012-3#1)
barriers##143##1##(1990-2#1)(1992-8#1)(1993-12#2)(1994-1#5)(1994-12#1)(1995-12#6)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(2007-12#2)(2008-1#2)(2008-10#16)(2008-11#16)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#2)(2009-12#3)(2009-5#2)(2010-1#1)(2010-11#12)(2010-4#1)(2010-7#3)(2011-1#4)(2011-2#9)(2011-3#1)(2011-9#1)(2012-12#2)(2012-2#3)(2012-3#8)(2013-1#10)(2013-7#1)(2013-8#2)
bars and##2##2##(2008-12#1)(2011-2#1)
bars##14##1##(1992-1#1)(1992-2#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-6#1)(2008-8#2)(2010-8#1)(2011-2#1)
basal ACTH##2##2##(1995-12#2)
basal Ca2+ concentration##2##3##(1996-2#2)
basal ES at the##3##4##(2012-2#3)
basal ES##9##2##(2009-10#2)(2012-2#7)
basal NF-κB activity##2##3##(2012-3#2)
basal acid secretion##2##3##(1997-1#2)
basal acid##3##2##(1997-1#3)
basal activity of##2##3##(1994-11#1)(1995-6#1)
basal activity##3##2##(1992-7#1)(1994-11#1)(1995-6#1)
basal and##15##2##(1990-8#1)(1992-12#1)(1992-7#1)(1992-8#1)(1996-2#3)(1997-1#1)(2008-1#1)(2008-11#1)(2009-10#1)(2011-2#3)(2012-3#1)
basal body##3##2##(2008-7#3)
basal cell carcinoma (BCC)##2##4##(1997-3#2)
basal cell carcinoma syndrome##4##4##(1997-3#4)
basal cell carcinoma##8##3##(1997-3#6)(2012-3#1)(2013-8#1)
basal cell carcinomas##2##3##(1997-3#1)(2012-3#1)
basal cell##11##2##(1997-3#7)(2012-3#3)(2013-8#1)
basal cerebral##2##2##(1996-3#2)
basal conditions##4##2##(1991-3#1)(1997-2#2)(2008-11#1)
basal diet##2##2##(2008-10#1)(2013-1#1)
basal distance##2##2##(2010-4#2)
basal ectoplasmic specialization (basal ES)##2##5##(2009-10#1)(2012-2#1)
basal expression##3##2##(1993-12#1)(1993-6#1)(2008-6#1)
basal forebrain##5##2##(1991-12#2)(1997-3#1)(2008-7#2)
basal fourth and fifth metatarsal arthritis##2##6##(2010-11#2)
basal function##2##2##(2012-3#2)
basal ganglia hematoma##2##3##(2013-1#2)
basal ganglia to##2##3##(1996-12#2)
basal ganglia##24##2##(1992-6#1)(1996-12#3)(1997-3#2)(2008-6#1)(2008-7#7)(2009-10#1)(2009-11#2)(2012-2#1)(2013-1#4)(2013-8#2)
basal ganglial##2##2##(2008-11#2)
basal insulin##2##2##(2008-1#1)(2012-4#1)
basal keratinocyte##2##2##(1991-12#1)(2008-5#1)
basal keratinocytes##2##2##(2008-12#1)(2013-1#1)
basal lamina##9##2##(2007-12#2)(2008-10#2)(2008-12#3)(2008-5#1)(2009-10#1)
basal layer of##3##3##(1996-2#1)(2010-6#1)(2013-1#1)
basal layer##5##2##(1996-2#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
basal leaves##2##2##(2008-10#2)
basal level of##3##3##(1994-11#1)(1997-1#1)(2008-11#1)
basal level##5##2##(1994-11#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-6#1)
basal levels by##2##3##(1995-2#1)(1996-12#1)
basal levels of##3##3##(1994-3#1)(2012-3#1)(2013-8#1)
basal levels##7##2##(1994-3#1)(1995-2#1)(1996-12#1)(2008-10#2)(2012-3#1)(2013-8#1)
basal media with##2##3##(2008-11#1)(2008-12#1)
basal media##7##2##(2008-11#5)(2008-12#1)(2013-1#1)
basal medium was##3##3##(2008-11#3)
basal medium##11##2##(1994-3#2)(2008-10#3)(2008-11#6)
basal metabolic rate (BMR)##2##4##(2008-8#1)(2008-9#1)
basal region of##2##3##(1995-12#1)(2008-7#1)
basal region##3##2##(1995-12#1)(2008-7#2)
basal secretion##4##2##(1995-11#1)(1997-1#2)(2008-7#1)
basal set of##2##3##(2008-7#2)
basal species##2##2##(2008-9#2)
basal to##3##2##(2008-8#2)(2009-10#1)
basal tone or##2##3##(1997-4#2)
basal transcription##5##2##(1993-6#1)(1993-9#1)(1995-2#1)(1995-6#2)
basal values##2##2##(1991-6#1)(1993-6#1)
basal##265##1##(1990-8#3)(1991-10#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-9#2)(1992-12#1)(1992-6#1)(1992-7#3)(1992-8#2)(1993-12#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#4)(1995-11#3)(1995-12#4)(1995-2#4)(1995-6#4)(1995-8#2)(1996-12#6)(1996-2#6)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#9)(1997-2#2)(1997-3#10)(1997-4#2)(1997-7#1)(2007-12#2)(2008-1#3)(2008-10#20)(2008-11#23)(2008-12#6)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#22)(2008-8#7)(2008-9#5)(2009-10#9)(2009-11#2)(2009-6#1)(2010-11#3)(2010-4#2)(2010-6#1)(2011-2#9)(2012-2#11)(2012-3#13)(2012-4#1)(2013-1#10)(2013-8#5)
basal-to-apical direction##3##2##(2008-9#2)(2011-2#1)
basalis##10##1##(1990-5#3)(1991-12#1)(1991-9#2)(1993-3#2)(2008-8#1)(2008-9#1)
basally##2##1##(1996-12#1)(2008-7#1)
base + moisturizer##2##3##(2008-5#2)
base alterations##2##2##(1996-6#2)
base and##13##2##(1997-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2011-2#3)(2013-1#1)
base are##3##2##(2008-7#1)(2009-5#1)(2011-2#1)
base at##2##2##(2008-8#1)(2008-9#1)
base calling##2##2##(1995-8#1)(2008-4#1)
base changes##2##2##(1991-7#1)(2008-12#1)
base composition##3##2##(1993-2#1)(1994-9#1)(2008-5#1)
base electrode##2##2##(2008-10#2)
base extension##2##2##(2008-12#1)(2011-2#1)
base for##7##2##(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
base in##10##2##(1992-8#1)(1994-5#1)(2008-1#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#2)
base is##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
base ligand##2##2##(2008-10#2)
base ligands##2##2##(2008-10#2)
base line##4##2##(2008-10#3)(2008-5#1)
base model##4##2##(1995-2#1)(2011-2#3)
base of the Andes mountains in Venezuela##2##7##(2008-5#2)
base of the##14##3##(1991-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#3)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
base of##35##2##(1991-2#1)(1992-9#1)(1994-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#2)(2012-3#1)(2013-1#8)
base pair (bp)##2##3##(1993-3#1)(1995-6#1)
base pair sequence corresponding to the##2##6##(1996-12#2)
base pair sequence##3##3##(1996-12#2)(1996-6#1)
base pair##19##2##(1991-11#1)(1992-3#3)(1993-3#1)(1994-8#1)(1995-12#1)(1995-6#3)(1996-12#2)(1996-6#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-7#1)
base pairing##7##2##(1991-5#3)(1997-6#1)(2008-4#1)(2011-2#2)
base pairs (bp)##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
base pairs and##3##3##(1993-11#1)(2008-10#1)(2008-9#1)
base pairs in length##2##4##(1991-5#1)(1997-9#1)
base pairs in##4##3##(1991-5#1)(1995-12#1)(1997-9#1)(2010-7#1)
base pairs with a##2##4##(1991-9#1)(1997-9#1)
base pairs##31##2##(1991-5#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-9#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#3)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#1)
base pairs)##3##2##(1992-3#1)(2008-10#1)(2008-6#1)
base sequence of the##2##4##(1992-3#2)
base solution##2##2##(2008-10#2)
base stacking##4##2##(1991-5#4)
base substitution in the##2##4##(1993-3#1)(2008-10#1)
base substitution##3##2##(1993-3#1)(2008-10#2)
base substitutions##2##2##(1990-8#1)(1995-6#1)
base their##2##2##(1993-6#1)(2008-12#1)
base to##5##2##(1992-9#1)(2008-10#2)(2008-5#1)(2011-10#1)
base was##4##2##(1991-2#1)(2011-2#3)
base which is##2##3##(1996-2#1)(2008-10#1)
base which##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
base with##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
base##350##1##(1990-8#1)(1991-11#1)(1991-2#3)(1991-5#8)(1991-6#1)(1991-7#2)(1991-9#2)(1992-2#1)(1992-3#9)(1992-4#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#5)(1994-5#5)(1994-8#1)(1994-9#2)(1995-12#4)(1995-2#2)(1995-6#8)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#5)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#3)(1997-9#2)(2006-6#1)(2007-12#1)(2008-1#4)(2008-10#98)(2008-11#10)(2008-12#8)(2008-2#1)(2008-4#8)(2008-5#14)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#5)(2009-1#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#2)(2011-10#1)(2011-2#45)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#15)(2013-7#1)
base) as##2##2##(2008-10#2)
base)##5##1##(2008-10#5)
base-catalyzed##3##1##(1993-8#1)(1996-5#1)(2008-10#1)
base-line##2##1##(2008-10#2)
base-pair##5##1##(1992-3#1)(1993-9#1)(1994-11#1)(2008-10#1)(2009-10#1)
base-triple##2##1##(1993-1#2)
based SPR##2##2##(2008-10#2)
based and##2##2##(1993-1#1)(1993-12#1)
based approach for##2##3##(1994-11#1)(2013-8#1)
based assays##2##2##(2008-5#1)(2008-9#1)
based biosensor for##3##3##(2008-10#3)
based biosensor##5##2##(2008-10#5)
based biosensors##2##2##(2008-10#2)
based both on electrostatic##2##4##(2008-10#2)
based cancer##2##2##(2010-11#1)(2011-3#1)
based clinical##2##2##(2008-12#2)
based detection of##2##3##(2008-10#1)(2009-5#1)
based detection##4##2##(2008-10#3)(2009-5#1)
based either on##2##3##(2008-10#1)(2008-9#1)
based electrode##2##2##(2008-10#2)
based electrodes##5##2##(2008-10#5)
based enzyme##2##2##(2008-10#2)
based in the##8##3##(2008-10#5)(2009-7#2)(2009-8#1)
based in##22##2##(1996-1#1)(1996-5#2)(1996-6#1)(2008-10#6)(2008-12#2)(2008-5#2)(2008-8#1)(2009-5#1)(2009-7#3)(2009-8#1)(2013-8#2)
based inner contacts##2##3##(2008-10#2)
based instruments##2##2##(2008-10#1)(2008-9#1)
based ion-selective electrodes##3##3##(2008-10#3)
based is##2##2##(1997-3#1)(2008-11#1)
based largely on##2##3##(1993-2#1)(2008-7#1)
based learning##12##2##(2008-11#9)(2008-12#3)
based mainly on##5##3##(1991-9#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
based membrane##3##2##(2008-10#3)
based membranes of##4##3##(2008-10#4)
based membranes##5##2##(2008-10#5)
based mental disorders##2##3##(2010-4#2)
based method##6##2##(1996-3#1)(2008-10#2)(2008-3#1)(2010-7#2)
based methods are##2##3##(1996-3#1)(2008-9#1)
based methods##5##2##(1994-12#1)(1996-3#1)(2008-9#1)(2012-12#2)
based minerals##2##2##(2008-10#2)
based modeling of##2##3##(1997-6#1)(2013-8#1)
based on 1##6##3##(2007-12#1)(2008-10#4)(2008-11#1)
based on 16S##3##3##(2008-10#2)(2011-1#1)
based on 2##3##3##(2008-10#3)
based on 3##3##3##(1995-12#1)(2008-10#2)
based on 5##3##3##(2008-10#3)
based on AFLP data and##2##5##(2008-10#2)
based on AFLP##3##3##(2008-10#3)
based on AFLP-finger##2##3##(2008-2#2)
based on COM##2##3##(2012-3#2)
based on DNA fingerprinting with##2##5##(2008-10#2)
based on DNA##3##3##(2008-10#2)(2010-5#1)
based on ITS##2##3##(2008-10#2)
based on N##6##3##(2008-10#6)
based on N-methylformamide##2##3##(2008-10#2)
based on RAPD analysis##2##4##(2008-10#2)
based on RAPD##4##3##(2008-10#4)
based on RNA##2##3##(2008-9#1)(2013-1#1)
based on ZnO/chitosan composite##2##4##(2008-10#2)
based on [2##2##3##(2008-10#2)
based on a combination of##8##5##(2008-10#3)(2008-7#1)(2009-11#1)(2011-2#2)(2013-1#1)
based on a continuum##2##4##(1992-1#1)(2008-4#1)
based on a large##2##4##(2008-10#1)(2009-10#1)
based on a likelihood ratio##2##5##(2008-10#1)(2008-12#1)
based on a molecular##2##4##(2008-10#2)
based on a new##3##4##(1991-3#1)(2008-6#1)(2010-8#1)
based on a novel##3##4##(2008-10#3)
based on a photochemical reaction##2##5##(2008-10#2)
based on a piezoelectric##2##4##(2008-10#2)
based on a recently synthesized##3##5##(2008-10#3)
based on a sample of##3##5##(1994-6#1)(2010-11#1)(2010-5#1)
based on a sandwich##2##4##(2008-10#2)
based on a set of##2##5##(2008-10#2)
based on a signal-to-noise ratio of##2##6##(2008-10#2)
based on a signal-to-noise ratio##3##5##(2008-10#3)
based on a simple classification##2##5##(2008-7#2)
based on a simple##6##4##(2007-11#1)(2008-3#2)(2008-7#2)(2008-9#1)
based on a single##5##4##(1994-9#1)(2008-10#2)(2008-8#1)(2009-12#1)
based on a special##2##4##(2008-10#1)(2008-3#1)
based on a specific##2##4##(2007-12#1)(2008-10#1)
based on a visual substitution process##2##6##(1991-2#2)
based on a##230##3##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-9#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-9#2)(1997-2#2)(1997-5#1)(2007-11#2)(2007-12#2)(2008-10#112)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#26)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#9)(2012-2#3)(2013-1#3)(2013-8#3)
based on absorption##3##3##(2008-10#3)
based on active##2##3##(2008-3#1)(2008-8#1)
based on actual##3##3##(2008-11#1)(2008-3#2)
based on adsorptive accumulation of##2##5##(2008-10#2)
based on adsorptive stripping technique##2##5##(2008-10#2)
based on adsorptive stripping##3##4##(2008-10#3)
based on adsorptive##5##3##(2008-10#5)
based on all##2##3##(2008-10#1)(2011-2#1)
based on amplified fragment length polymorphism##2##6##(2008-10#2)
based on an analysis of##2##5##(1993-12#1)(2008-10#1)
based on an array of##5##5##(2008-10#4)(2008-3#1)
based on an indirect##2##4##(2008-10#2)
based on an iterative##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
based on an optical reflective device##2##6##(2008-10#2)
based on an##51##3##(1992-2#1)(1993-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-6#1)(2008-10#24)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#2)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#1)
based on analyses of##2##4##(2008-10#2)
based on analysis of spiked samples and solutions including matrix components##2##11##(2008-10#2)
based on analysis of##5##4##(2008-10#5)
based on analyzing##2##3##(2008-8#1)(2011-2#1)
based on arrays of##2##4##(2008-10#2)
based on arrays##3##3##(2008-10#2)(2008-3#1)
based on available##4##3##(2008-11#1)(2009-8#1)(2011-2#1)(2011-3#1)
based on average##3##3##(2008-10#2)(2013-8#1)
based on bis(acetylacetone)propylenediimine##2##3##(2008-10#2)
based on both##5##3##(2008-11#2)(2008-9#1)(2011-3#1)(2013-1#1)
based on capillary electrophoresis with##2##5##(2008-10#2)
based on capillary##5##3##(2008-10#4)(2008-5#1)
based on carbon##5##3##(2008-10#4)(2008-7#1)
based on careful##2##3##(1994-12#1)(2012-3#1)
based on changes##2##3##(1997-6#1)(2008-10#1)
based on chemical##4##3##(1994-5#1)(2008-10#3)
based on chemically modified ring-disc electrode and its application for simultaneous measurements of nitric oxide##2##15##(2008-10#2)
based on chemically modified##5##4##(2008-10#5)
based on chi(2)##2##3##(2008-10#2)
based on clinical##9##3##(1992-12#1)(1993-3#1)(1996-1#1)(2008-1#1)(2008-5#1)(2008-8#2)(2012-3#2)
based on colorimetric detection##2##4##(2008-10#2)
based on complexation##2##3##(2008-10#2)
based on computed tomography (CT)##2##5##(2009-3#1)(2012-2#1)
based on conditional##2##3##(2008-5#1)(2012-2#1)
based on continuous##7##3##(2008-10#7)
based on controlled adsorptive##2##4##(2008-10#2)
based on coupling##2##3##(2008-10#2)
based on current##3##3##(2009-8#1)(2010-12#1)(2010-3#1)
based on data collected from##2##5##(2008-10#1)(2013-1#1)
based on data collected##3##4##(1994-6#1)(2008-10#1)(2013-1#1)
based on data from##7##4##(1996-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
based on data##16##3##(1991-12#1)(1993-12#1)(1993-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
based on detection of##2##4##(2008-10#1)(2010-7#1)
based on difference##2##3##(2008-10#1)(2009-8#1)
based on differences##2##3##(2008-10#1)(2008-3#1)
based on different##3##3##(2008-10#3)
based on direct determination of##2##5##(2008-10#2)
based on direct##4##3##(2008-10#3)(2008-8#1)
based on disease##3##3##(2008-10#3)
based on either a##2##4##(2008-10#1)(2012-3#1)
based on electrochemical reduction##2##4##(2008-10#2)
based on electrochemical##3##3##(2008-10#3)
based on electrodeposition of nanometer-sized##2##5##(2008-10#2)
based on electropolymerized##4##3##(2008-10#4)
based on electrostatic interaction of natural polymers##2##7##(2008-10#2)
based on empirical##2##3##(2010-9#1)(2013-1#1)
based on enzyme inhibition analysis##2##5##(2008-10#2)
based on enzyme##3##3##(2008-10#3)
based on evaluation of##2##4##(2008-10#1)(2013-8#1)
based on evidence from the published literature and panelists' own##2##10##(2010-12#2)
based on evidence##4##3##(2008-11#1)(2010-12#2)(2010-5#1)
based on experience##3##3##(2008-10#1)(2011-3#2)
based on experiences##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
based on experimental##2##3##(1994-12#1)(2008-7#1)
based on expert##2##3##(2010-6#1)(2011-10#1)
based on extensive##3##3##(1991-9#1)(2008-10#1)(2013-1#1)
based on external##3##3##(2007-12#1)(2008-10#2)
based on extraction##2##3##(2008-10#2)
based on fatty acid##2##4##(2008-10#2)
based on five##2##3##(1997-1#1)(2008-10#1)
based on fixed##2##3##(2008-11#1)(2013-8#1)
based on flow##2##3##(2008-10#2)
based on fluorescence quenching of##2##5##(2008-10#2)
based on fluorescence quenching##3##4##(2008-10#3)
based on fluorescence##7##3##(2008-10#7)
based on four-wave mixing in microstructure fiber##2##7##(2007-11#2)
based on gel##2##3##(1993-8#1)(2008-8#1)
based on genetic analysis of##2##5##(2008-10#2)
based on genetic evidence##2##4##(1997-6#1)(2011-2#1)
based on genetic##8##3##(1997-6#1)(2008-10#4)(2008-9#1)(2011-2#1)(2012-3#1)
based on glyoxal bis(2-hydroxyanil)##2##4##(2008-10#2)
based on gold##2##3##(2008-10#2)
based on graphite paste (graphite powder and paraffin oil) has been constructed##2##12##(2008-10#2)
based on high##2##3##(2008-10#2)
based on high-resolution##2##3##(2008-3#1)(2012-2#1)
based on higher##2##3##(1992-2#1)(2013-8#1)
based on highly##2##3##(2008-10#1)(2008-3#1)
based on his##2##3##(1995-6#1)(2008-11#1)
based on histological##3##3##(2007-12#1)(2011-2#1)(2011-3#1)
based on history and##2##4##(2008-12#1)(2013-1#1)
based on host##3##3##(2008-10#3)
based on hyphal##2##3##(2008-10#2)
based on immobilised##2##3##(2008-10#2)
based on immobilization of##2##4##(2008-10#2)
based on immobilized##5##3##(2008-10#5)
based on in situ##2##4##(2008-10#1)(2008-9#1)
based on in##4##3##(2008-10#3)(2008-9#1)
based on incidence##3##3##(2008-10#3)
based on inclusion##2##3##(2008-10#1)(2012-12#1)
based on independent component analysis##2##5##(2008-10#1)(2009-11#1)
based on indirect##2##3##(2008-10#1)(2008-9#1)
based on information##3##3##(1995-12#1)(1996-3#1)(2008-12#1)
based on integrated absorbance##2##4##(2008-10#2)
based on international##2##3##(2011-2#1)(2013-8#1)
based on ion##3##3##(2008-10#3)
based on its catalysis##2##4##(2008-10#2)
based on its catalytic effect on the oxidation of carminic acid by hydrogen peroxide##2##14##(2008-10#2)
based on its catalytic effect on the oxidation of carminic acid by##3##12##(2008-10#3)
based on its catalytic effect on the oxidation of##6##9##(2008-10#6)
based on its catalytic effect on the oxidation##7##8##(2008-10#7)
based on its catalytic effect on the##9##7##(2008-10#9)
based on its catalytic effect on##10##6##(2008-10#10)
based on its catalytic##12##4##(2008-10#12)
based on its enhancing effect on the oxidation of Mn(II)##2##10##(2008-10#2)
based on its enhancing effect on the##3##7##(2008-10#3)
based on its inhibitory effect on the##2##7##(2008-10#2)
based on its inhibitory effect on##3##6##(2008-10#3)
based on its interaction with##3##5##(2008-10#3)
based on its reaction with##4##5##(2008-10#4)
based on its##46##3##(2008-10#42)(2008-9#1)(2009-10#1)(2010-11#1)(2011-3#1)
based on knowledge##2##3##(1990-6#1)(2008-11#1)
based on laser##3##3##(2008-10#2)(2009-5#1)
based on lesion##2##3##(2008-10#2)
based on light##2##3##(2008-10#2)
based on line##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
based on linear##3##3##(2008-10#3)
based on linkage##2##3##(1994-2#1)(2008-10#1)
based on liquid##3##3##(2008-10#2)(2009-8#1)
based on local##2##3##(1994-6#1)(2008-8#1)
based on low##2##3##(2008-10#1)(2008-12#1)
based on macrocyclic##3##3##(2008-10#3)
based on magnetic resonance imaging##2##5##(2012-3#1)(2013-1#1)
based on manganese##2##3##(2008-10#2)
based on mass##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
based on maximum likelihood##3##4##(2008-10#2)(2008-12#1)
based on measurement of##2##4##(1991-12#1)(2010-5#1)
based on measurement##3##3##(1991-12#1)(2008-10#1)(2010-5#1)
based on measuring the##2##4##(2008-10#1)(2011-3#1)
based on measuring##3##3##(2008-10#1)(2011-3#1)(2012-3#1)
based on medical##3##3##(1991-2#1)(1993-2#1)(1997-3#1)
based on microwave digestion##2##4##(2008-10#2)
based on microwave##3##3##(2008-10#3)
based on miniaturized solid-state##2##4##(2008-10#2)
based on mitochondrial##4##3##(2008-10#2)(2013-8#2)
based on mixed##2##3##(2008-10#2)
based on molecular##3##3##(1997-3#1)(2008-10#1)(2008-8#1)
based on morphology##3##3##(1996-6#1)(2008-10#1)(2012-3#1)
based on multicommutation##6##3##(2008-10#6)
based on multiple##2##3##(1996-3#1)(2012-3#1)
based on new##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
based on nickel##2##3##(2008-10#2)
based on nitrogen balance studies##2##5##(2013-8#2)
based on novel##2##3##(2008-10#1)(2010-11#1)
based on nuclear##2##3##(2008-10#1)(2008-9#1)
based on nucleic acid hybridization##2##5##(2008-10#2)
based on observed##2##3##(2008-10#2)
based on only one##2##4##(2008-10#1)(2011-1#1)
based on optical##3##3##(2008-11#1)(2008-3#1)(2009-7#1)
based on our##6##3##(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2013-8#1)
based on paraffin/graphite modified with sweet potato##2##7##(2008-10#2)
based on partial##2##3##(2008-10#2)
based on peak##2##3##(2008-10#2)
based on periodically poled lithium niobate##3##6##(2007-12#1)(2008-3#2)
based on pi-coordinating##2##3##(2008-10#2)
based on plant##2##3##(2008-10#2)
based on polyaniline##2##3##(2008-10#2)
based on porous##2##3##(2008-10#2)
based on previous##2##3##(2008-7#1)(2011-2#1)
based on previously##2##3##(2008-10#1)(2008-3#1)
based on published data##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
based on published##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
based on quantitative##2##3##(2008-10#1)(2011-3#1)
based on radiological##2##3##(2010-11#1)(2011-2#1)
based on random##2##3##(2008-10#2)
based on recent##5##3##(1996-1#1)(2008-11#1)(2008-7#1)(2008-9#2)
based on recovery studies##2##4##(2008-10#2)
based on redox reaction##2##4##(2008-10#2)
based on redox##3##3##(2008-10#3)
based on reflectance##2##3##(2008-10#2)
based on replicate analysis##2##4##(2008-10#2)
based on results of##4##4##(2008-10#1)(2010-10#1)(2012-2#2)
based on results##7##3##(2008-10#3)(2010-10#2)(2012-2#2)
based on salicylate hydroxylase##2##4##(2008-10#2)
based on selective##4##3##(2008-10#4)
based on self-assembled monolayer##3##4##(2008-10#3)
based on self-assembled##4##3##(2008-10#4)
based on separation of the##2##5##(2008-10#2)
based on separation of##3##4##(2008-10#3)
based on separation##4##3##(2008-10#4)
based on sequence analyses##2##4##(2008-10#2)
based on sequence##8##3##(1997-8#1)(2008-10#6)(2011-2#1)
based on sequences of the internal transcribed spacer##2##8##(2008-10#2)
based on sequences of the##4##5##(2008-10#3)(2011-2#1)
based on sequential injection analysis##2##5##(2008-10#2)
based on sequential##3##3##(2008-10#3)
based on serum##2##3##(2008-6#1)(2009-9#1)
based on several##3##3##(1996-3#1)(2008-5#1)(2011-2#1)
based on severity##4##3##(2008-10#2)(2011-3#1)(2013-1#1)
based on sex##2##3##(1991-12#1)(2008-8#1)
based on signal##2##3##(2008-10#2)
based on simple aqueous standards##2##5##(2008-10#2)
based on simple##3##3##(2008-10#2)(2010-10#1)
based on simultaneous resolution of the overlapping bands in the whole set of absorption##2##14##(2008-10#2)
based on single##2##3##(2008-10#1)(2008-11#1)
based on singular value decomposition##3##5##(2008-10#3)
based on small numbers##2##4##(1993-12#1)(1994-6#1)
based on small##4##3##(1993-12#1)(1994-6#1)(2008-10#1)(2008-11#1)
based on soft##2##3##(2008-10#2)
based on soil##2##3##(2008-10#2)
based on solid phase extraction##3##5##(2008-10#3)
based on solid phase##4##4##(2008-10#4)
based on solid##5##3##(1997-2#1)(2008-10#4)
based on solid-phase extraction##3##4##(2008-10#3)
based on solid-phase##6##3##(2008-10#6)
based on some##3##3##(2008-10#3)
based on sound##2##3##(2008-12#1)(2010-12#1)
based on spectral##2##3##(2008-5#1)(2013-8#1)
based on spectrophotometric detection##2##4##(2008-10#2)
based on spectrophotometric measurement##2##4##(2008-10#2)
based on spectrophotometric##4##3##(2008-10#4)
based on standard##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2011-1#1)
based on statistical##4##3##(2008-10#3)(2008-11#1)
based on stomach##2##3##(1996-12#2)
based on stopped-flow##2##3##(2008-10#2)
based on studies##3##3##(2008-10#2)(2008-7#1)
based on studying the##2##4##(2008-10#1)(2011-2#1)
based on supercritical##2##3##(2008-10#1)(2010-10#1)
based on surface##4##3##(2008-10#4)
based on symptoms##2##3##(2008-10#2)
based on systematic##3##3##(2010-10#1)(2011-2#1)(2012-3#1)
based on temperature##3##3##(2008-10#3)
based on tetrathia-12-crown-4##2##3##(2008-10#2)
based on that##3##3##(2008-10#2)(2011-2#1)
based on the &quot##2##4##(1995-6#1)(2008-10#1)
based on the CL##5##4##(2008-10#5)
based on the DNA##2##4##(2008-10#1)(2008-12#1)
based on the N-terminal amino acid##2##6##(1993-9#1)(2008-6#1)
based on the ability of a##2##6##(1995-2#1)(1995-5#1)
based on the ability of##6##5##(1995-2#1)(1995-5#1)(2008-11#1)(2008-4#3)
based on the ability##7##4##(1995-2#1)(1995-5#1)(2008-11#1)(2008-4#3)(2008-6#1)
based on the adsorption of##4##5##(2008-10#4)
based on the adsorption##6##4##(2008-10#6)
based on the analysis of##3##5##(2008-10#2)(2010-10#1)
based on the analytic hierarchy process##2##6##(2008-10#1)(2011-2#1)
based on the application of##5##5##(1993-11#1)(2008-10#2)(2008-11#1)(2013-1#1)
based on the assumption of##2##5##(2008-10#2)
based on the assumption that##5##5##(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)
based on the assumption##7##4##(2008-10#4)(2008-11#1)(2008-3#1)(2009-7#1)
based on the available##2##4##(2008-11#1)(2012-2#1)
based on the best##2##4##(1996-2#1)(2008-9#1)
based on the bioluminescence inhibition of Vibrio fischeri##2##8##(2008-10#2)
based on the calculation of##2##5##(2008-10#2)
based on the calculation##3##4##(2008-10#3)
based on the catalytic effect of##16##6##(2008-10#16)
based on the catalytic##17##4##(2008-10#17)
based on the cathodic adsorptive stripping of##2##7##(2008-10#2)
based on the change in##2##5##(2008-10#1)(2008-3#1)
based on the changes in##3##5##(2008-10#2)(2008-6#1)
based on the chemical##4##4##(2008-10#4)
based on the chemiluminescence reaction of##3##6##(2008-10#3)
based on the chemiluminescence##7##4##(2008-10#7)
based on the chromogenic reaction##2##5##(2008-10#2)
based on the color##3##4##(2008-10#3)
based on the combination of##3##5##(2008-10#3)
based on the combined##3##4##(2008-10#3)
based on the comparison##2##4##(1996-3#1)(2008-10#1)
based on the competitive##4##4##(2008-10#4)
based on the complex formation##2##5##(2008-10#2)
based on the complex##4##4##(2008-10#3)(2008-3#1)
based on the complexation##5##4##(2008-10#5)
based on the concept of##4##5##(2008-10#2)(2008-3#1)(2013-1#1)
based on the concept##5##4##(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)
based on the coupling of a##2##6##(2008-10#2)
based on the coupling of##5##5##(2008-10#5)
based on the coupling##6##4##(2008-10#6)
based on the current##2##4##(2008-10#1)(2010-12#1)
based on the derivatization##3##4##(2008-10#3)
based on the detection of##6##5##(2008-10#6)
based on the determination of##2##5##(2008-10#2)
based on the development of##4##5##(2008-10#3)(2008-5#1)
based on the different##2##4##(2008-10#1)(2008-5#1)
based on the differential##3##4##(2008-10#1)(2008-9#1)(2010-7#1)
based on the direct##5##4##(2008-10#5)
based on the effective##2##4##(2008-10#2)
based on the employment of a##2##6##(2008-10#2)
based on the employment of##3##5##(2008-10#3)
based on the enhancement of##4##5##(2008-10#4)
based on the enzymatic##2##4##(2008-10#2)
based on the evaluation of##3##5##(2008-10#3)
based on the evolution of CS(2)##2##6##(2008-10#2)
based on the experimental##2##4##(2008-10#2)
based on the fact that the##3##6##(2008-10#3)
based on the fact that##7##5##(1993-9#1)(2008-10#6)
based on the factors##2##4##(1992-2#1)(2013-1#1)
based on the fast##2##4##(2008-10#2)
based on the finding that the##2##6##(1995-6#1)(2008-10#1)
based on the finding that##3##5##(1995-6#1)(2008-10#1)(2009-10#1)
based on the finding##4##4##(1995-6#1)(1996-11#1)(2008-10#1)(2009-10#1)
based on the findings##2##4##(1996-3#1)(2008-12#1)
based on the fluorescence enhancement of##2##6##(2008-10#2)
based on the fluorescence quenching of a##2##7##(2008-10#2)
based on the fluorescence quenching of##5##6##(2008-10#5)
based on the fluorescence##13##4##(2008-10#12)(2008-9#1)
based on the following##3##4##(2008-10#3)
based on the formation of a 1##2##7##(2008-10#2)
based on the formation of a##11##6##(2008-10#11)
based on the formation of an##2##6##(2008-10#2)
based on the formation of the##3##6##(2008-10#3)
based on the formation of##28##5##(2008-10#28)
based on the formation##29##4##(2008-10#29)
based on the genetic##2##4##(2008-10#1)(2012-3#1)
based on the glucose##2##4##(2008-10#1)(2012-12#1)
based on the hypothesis that##3##5##(2008-11#1)(2009-8#1)(2010-8#1)
based on the immobilization##2##4##(2008-10#2)
based on the inhibition##4##4##(2008-10#4)
based on the inhibitory effect of##2##6##(2008-10#2)
based on the integration of##3##5##(2008-10#3)
based on the interaction of##5##5##(2008-10#5)
based on the interaction##7##4##(2008-1#1)(2008-10#6)
based on the ion-pair complex##2##5##(2008-10#2)
based on the ion-pair##3##4##(2008-10#3)
based on the knowledge of the##2##6##(2008-10#1)(2008-5#1)
based on the lack of##2##5##(1993-12#1)(2009-8#1)
based on the level of##2##5##(2008-10#2)
based on the linear-no-threshold##2##4##(2008-12#1)(2012-2#1)
based on the maximum##2##4##(2008-6#1)(2012-3#1)
based on the mean##2##4##(2008-10#2)
based on the measurement of the##5##6##(2008-10#5)
based on the measurement of##11##5##(2008-10#8)(2008-3#1)(2008-9#2)
based on the model of##2##5##(2008-10#1)(2008-7#1)
based on the model##3##4##(1996-12#1)(2008-10#1)(2008-7#1)
based on the modification of##2##5##(2008-10#2)
based on the observed##2##4##(1994-5#1)(1995-12#1)
based on the oxidation of the##2##6##(2008-10#2)
based on the oxidation of##15##5##(2008-10#15)
based on the oxidation##18##4##(2008-10#18)
based on the polymerase chain reaction (PCR)##2##7##(2008-10#2)
based on the premise that##3##5##(2008-11#1)(2008-9#1)(2013-1#1)
based on the presence of##7##5##(1990-8#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
based on the presence or absence of an##2##8##(2008-10#1)(2008-12#1)
based on the presence or absence of##5##7##(2008-10#3)(2008-12#1)(2010-7#1)
based on the presence##13##4##(1990-5#1)(1990-8#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2010-7#1)
based on the principle of##2##5##(2008-10#1)(2008-11#1)
based on the principle##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
based on the proportion of##2##5##(2008-10#2)
based on the quantitative##3##4##(2008-10#1)(2009-12#1)(2012-2#1)
based on the rapid reaction of##2##6##(2008-10#2)
based on the rapid##4##4##(2008-10#4)
based on the reaction among##2##5##(2008-10#2)
based on the reaction between##13##5##(2008-10#13)
based on the reaction of these##3##6##(2008-10#3)
based on the reaction of##22##5##(2008-10#22)
based on the reaction with##2##5##(2008-10#2)
based on the reaction##39##4##(2008-10#39)
based on the recently##2##4##(2009-10#1)(2013-8#1)
based on the reduction of the##3##6##(2008-10#3)
based on the reduction of##7##5##(2008-10#7)
based on the results obtained##2##5##(2008-10#2)
based on the results of this investigation##2##7##(2008-10#2)
based on the results of this##3##6##(2008-10#2)(2011-2#1)
based on the results of##7##5##(1995-1#1)(2008-10#3)(2009-10#1)(2011-2#1)(2012-2#1)
based on the results##9##4##(1995-1#1)(2008-10#5)(2009-10#1)(2011-2#1)(2012-2#1)
based on the reversible##2##4##(2008-10#2)
based on the same##9##4##(2008-10#8)(2011-2#1)
based on the sensitizing effect of##2##6##(2008-10#2)
based on the separation of##2##5##(2008-10#2)
based on the separation##4##4##(2008-10#4)
based on the sequence data of the##2##7##(2008-10#2)
based on the sequence of the##2##6##(2008-10#1)(2008-4#1)
based on the sequence of##4##5##(2008-10#2)(2008-4#1)(2010-4#1)
based on the sequence##7##4##(2008-10#5)(2008-4#1)(2010-4#1)
based on the sequential injection##2##5##(2008-10#2)
based on the sequential##4##4##(2008-10#3)(2008-12#1)
based on the signal-to-noise ratio of 3##2##7##(2008-10#2)
based on the simultaneous##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
based on the study of##3##5##(2008-10#2)(2010-8#1)
based on the surface##2##4##(1995-12#1)(2008-10#1)
based on the theory of##2##5##(2008-10#1)(2013-8#1)
based on the treatment of##2##5##(1992-6#1)(2008-10#1)
based on the type of##2##5##(2008-4#1)(2008-7#1)
based on the typical##2##4##(2008-6#1)(2012-3#1)
based on the use of a##3##6##(2008-10#2)(2008-11#1)
based on the use of the peroxyoxalate##2##7##(2008-10#2)
based on the use of the##6##6##(2008-10#6)
based on the use of##39##5##(1990-12#2)(1995-5#1)(2008-10#28)(2008-11#3)(2008-3#3)(2012-3#1)(2013-1#1)
based on the view##2##4##(2008-11#2)
based on the##902##3##(1990-12#6)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-2#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#2)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#3)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#613)(2008-11#27)(2008-12#9)(2008-2#8)(2008-3#22)(2008-4#9)(2008-5#9)(2008-6#9)(2008-7#9)(2008-8#9)(2008-9#11)(2009-10#8)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#5)(2011-1#2)(2011-2#11)(2011-3#2)(2012-12#3)(2012-2#9)(2012-3#6)(2013-1#13)(2013-8#7)
based on their Zn##2##4##(2008-10#2)
based on their condensation reactions with##2##6##(2008-10#2)
based on their different##2##4##(2008-10#1)(2009-5#1)
based on their reaction with##2##5##(2008-10#2)
based on their##41##3##(2007-12#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
based on these##10##3##(1992-9#1)(1993-3#1)(1994-12#1)(2008-10#3)(2008-3#1)(2010-10#1)(2010-8#1)(2011-2#1)
based on this##10##3##(1991-7#1)(1994-3#1)(2008-10#6)(2008-3#1)(2008-7#1)
based on three##6##3##(1996-11#1)(2008-10#4)(2008-11#1)
based on traditional##2##3##(2008-10#2)
based on two##11##3##(1991-6#1)(1995-12#1)(1996-9#1)(2008-10#6)(2008-3#1)(2009-5#1)
based on two-photon##2##3##(1992-8#1)(2007-12#1)
based on tyrosinase-modified##2##3##(2008-10#2)
based on urease##2##3##(2008-10#2)
based on various##3##3##(1997-2#1)(2008-10#1)(2008-6#1)
based on visual assessment of##2##5##(2008-10#1)(2008-11#1)
based on visual##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
based on wheat##2##3##(2008-10#2)
based on which the##2##4##(2008-10#2)
based on which##3##3##(2008-10#2)(2013-8#1)
based on##2739##2##(1990-12#9)(1990-2#1)(1990-5#3)(1990-6#6)(1990-8#4)(1990-9#5)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#6)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#10)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#9)(1993-2#5)(1993-3#8)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#12)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#8)(1995-1#2)(1995-12#8)(1995-2#9)(1995-3#3)(1995-5#6)(1995-6#4)(1995-8#1)(1995-9#6)(1996-1#3)(1996-11#3)(1996-12#13)(1996-2#6)(1996-3#7)(1996-5#1)(1996-6#5)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#3)(2007-11#7)(2007-12#11)(2007-8#2)(2008-1#8)(2008-10#1607)(2008-11#84)(2008-12#27)(2008-2#22)(2008-3#92)(2008-4#22)(2008-5#37)(2008-6#17)(2008-7#38)(2008-8#43)(2008-9#43)(2009-10#12)(2009-11#3)(2009-12#5)(2009-3#5)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#8)(2009-8#16)(2009-9#4)(2010-1#6)(2010-10#19)(2010-11#10)(2010-12#8)(2010-3#3)(2010-4#5)(2010-5#8)(2010-6#7)(2010-7#10)(2010-8#12)(2010-9#1)(2011-1#9)(2011-10#1)(2011-2#66)(2011-3#16)(2011-9#1)(2012-12#12)(2012-2#27)(2012-3#33)(2012-5#1)(2013-1#58)(2013-8#42)
based only on the##2##4##(1991-3#1)(2008-10#1)
based only on##7##3##(1991-3#2)(2008-10#3)(2008-8#1)(2012-3#1)
based practice##9##2##(2008-11#7)(2008-12#1)(2010-7#1)
based primarily on##5##3##(1991-3#1)(1992-4#1)(1993-12#1)(1995-12#1)(2008-8#1)
based sensor##5##2##(2008-10#4)(2008-7#1)
based sensors##2##2##(2008-10#2)
based service##3##2##(1990-3#1)(1993-12#2)
based solely on##7##3##(1994-12#1)(1994-3#1)(1995-6#1)(1997-3#1)(1997-7#1)(2008-11#1)(2010-9#1)
based specifically on##2##3##(1993-3#1)(2008-6#1)
based studies##2##2##(2008-10#1)(2013-1#1)
based study was##3##3##(2012-3#1)(2013-1#2)
based study##4##2##(2012-3#2)(2013-1#2)
based system##3##2##(2008-10#2)(2010-12#1)
based tools##2##2##(2008-12#1)(2008-5#1)
based upon its enhancing effect on the CL reaction of luminol with hydrogen peroxide##2##14##(2008-10#2)
based upon its##3##3##(1992-6#1)(2008-10#2)
based upon the##26##3##(1990-12#1)(1994-1#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
based upon their##3##3##(1991-7#1)(2008-4#1)(2010-5#1)
based upon##71##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#24)(2008-11#3)(2008-12#3)(2008-4#2)(2008-7#2)(2008-9#3)(2009-12#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#2)
based##3146##1##(1990-11#1)(1990-12#10)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#8)(1990-8#5)(1990-9#5)(1991-1#3)(1991-11#3)(1991-12#3)(1991-2#9)(1991-3#10)(1991-4#1)(1991-5#3)(1991-6#6)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#11)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#17)(1993-2#6)(1993-3#9)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#15)(1994-2#5)(1994-3#3)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#8)(1995-1#2)(1995-11#1)(1995-12#9)(1995-2#9)(1995-3#3)(1995-5#7)(1995-6#5)(1995-8#1)(1995-9#6)(1996-1#4)(1996-11#3)(1996-12#13)(1996-2#7)(1996-3#12)(1996-5#4)(1996-6#6)(1996-9#2)(1997-1#5)(1997-2#8)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#7)(1997-7#2)(1997-8#5)(2007-11#7)(2007-12#11)(2007-8#2)(2008-1#10)(2008-10#1739)(2008-11#126)(2008-12#51)(2008-2#22)(2008-3#96)(2008-4#25)(2008-5#42)(2008-6#20)(2008-7#46)(2008-8#53)(2008-9#57)(2009-1#1)(2009-10#12)(2009-11#3)(2009-12#6)(2009-3#5)(2009-4#1)(2009-5#10)(2009-6#2)(2009-7#11)(2009-8#18)(2009-9#5)(2010-1#7)(2010-10#21)(2010-11#15)(2010-12#11)(2010-3#3)(2010-4#7)(2010-5#9)(2010-6#7)(2010-7#14)(2010-8#15)(2010-9#2)(2011-1#12)(2011-10#1)(2011-2#79)(2011-3#18)(2011-9#1)(2012-12#16)(2012-2#33)(2012-3#43)(2012-5#1)(2013-1#68)(2013-7#1)(2013-8#51)
baseline aerobic fitness level##2##4##(2013-8#2)
baseline and after##4##3##(2012-3#2)(2012-4#1)(2013-8#1)
baseline and##19##2##(1991-1#1)(1992-9#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#2)
baseline at##3##2##(1990-7#1)(2011-2#1)(2013-1#1)
baseline by##2##2##(2011-2#2)
baseline correction##2##2##(2008-10#2)
baseline data##7##2##(1991-12#1)(1993-1#1)(2008-1#1)(2008-10#2)(2010-9#1)(2011-2#1)
baseline differences##2##2##(2008-11#1)(2008-12#1)
baseline disability##2##2##(2012-12#2)
baseline drift##7##2##(2008-10#7)
baseline established between##5##3##(2008-10#5)
baseline for##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
baseline from##2##2##(2008-10#2)
baseline hemoglobin A1c##2##3##(2012-5#2)
baseline in all##2##3##(2010-7#1)(2011-2#1)
baseline in##6##2##(2008-10#1)(2010-7#1)(2011-2#3)(2013-1#1)
baseline information##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
baseline levels##3##2##(1990-10#1)(2012-2#1)(2013-1#1)
baseline microflora##2##2##(2008-5#2)
baseline of##5##2##(1992-2#1)(2008-1#1)(2008-7#2)(2013-1#1)
baseline performance##2##2##(1993-3#1)(2012-3#1)
baseline resolution of##2##3##(2008-10#2)
baseline resolution##5##2##(2008-10#5)
baseline risk of##2##3##(2008-11#2)
baseline risk##3##2##(2008-11#3)
baseline score##2##2##(2008-6#1)(2008-7#1)
baseline separation of a##2##4##(2008-10#2)
baseline separation of##5##3##(2008-10#5)
baseline separation with##3##3##(2008-10#3)
baseline separation##10##2##(2008-10#10)
baseline service use##2##3##(2012-3#2)
baseline startle##3##2##(2008-11#3)
baseline testing##2##2##(2008-12#1)(2008-8#1)
baseline than##3##2##(2013-1#1)(2013-8#2)
baseline values##4##2##(1996-3#1)(2013-1#2)(2013-8#1)
baseline was significantly##2##3##(2011-2#1)(2013-1#1)
baseline was##5##2##(2008-10#1)(2011-2#2)(2013-1#2)
baseline weight##2##2##(2008-3#1)(2009-12#1)
baseline##244##1##(1990-10#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#2)(1992-2#2)(1992-9#3)(1993-1#3)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#5)(2008-10#73)(2008-11#12)(2008-12#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#14)(2012-12#3)(2012-2#7)(2012-3#11)(2012-4#1)(2012-5#2)(2013-1#31)(2013-8#14)
baseline) in the##2##3##(2008-10#1)(2013-1#1)
baseline) in##3##2##(1993-1#1)(2008-10#1)(2013-1#1)
baseline)##6##1##(1993-1#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
baselines##2##1##(1992-1#1)(2013-8#1)
basement membrane and##2##3##(1992-12#1)(2009-10#1)
basement membrane is##2##3##(2008-11#1)(2009-10#1)
basement membrane##27##2##(1992-12#3)(1992-3#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-6#1)(2008-11#7)(2008-7#1)(2009-10#5)(2011-2#1)(2012-2#2)(2013-8#1)
basement membranes##2##2##(2008-11#1)(2012-3#1)
basement##29##1##(1992-12#3)(1992-3#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-6#1)(2008-11#8)(2008-7#1)(2009-10#5)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
bases and of##3##3##(1996-2#2)(2008-10#1)
bases and the##2##3##(1991-9#1)(2008-10#1)
bases and##12##2##(1991-9#1)(1996-12#1)(1996-2#2)(2008-10#7)(2010-4#1)
bases for the##2##3##(2008-4#1)(2008-7#1)
bases for##6##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
bases from the##2##3##(1997-2#2)
bases from##4##2##(1994-2#1)(1997-2#2)(2008-10#1)
bases in the##2##3##(1994-5#1)(2012-2#1)
bases in##9##2##(1990-5#2)(1992-3#1)(1994-5#1)(1995-12#1)(1996-6#1)(2008-4#1)(2009-12#1)(2012-2#1)
bases of the##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)
bases of##17##2##(1991-5#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-8#1)(2008-9#2)(2010-4#1)
bases on the##2##3##(2008-10#1)(2008-5#1)
bases on##4##2##(2008-10#2)(2008-5#1)(2010-8#1)
bases that##2##2##(2008-10#2)
bases upstream from##2##3##(1992-10#1)(1995-6#1)
bases were used##2##3##(1993-3#1)(2008-10#1)
bases were##6##2##(1993-3#1)(1996-2#1)(2008-10#2)(2008-9#1)(2011-3#1)
bases with the##3##3##(1996-2#2)(2008-11#1)
bases with##5##2##(1991-9#1)(1995-2#1)(1996-2#2)(2008-11#1)
bases##113##1##(1990-5#3)(1991-5#1)(1991-9#3)(1992-10#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-6#3)(1996-12#1)(1996-2#5)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#41)(2008-11#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#7)(2009-12#2)(2010-4#4)(2010-5#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
bases)##4##1##(1992-10#1)(1996-12#1)(1997-6#1)(2008-9#1)
basic age##2##2##(2011-2#1)(2013-8#1)
basic amino acid residues##2##4##(1995-6#1)(1995-8#1)
basic and clinical##7##3##(1994-12#1)(1997-8#1)(2008-5#1)(2008-9#3)(2013-8#1)
basic and##13##2##(1994-12#2)(1994-6#1)(1996-5#1)(1997-8#1)(2008-11#2)(2008-5#1)(2008-9#4)(2013-8#1)
basic anion##2##2##(2008-10#2)
basic beta-crystallins##2##2##(1991-6#2)
basic biological##2##2##(2008-10#2)
basic change##2##2##(1993-2#1)(1994-2#1)
basic characteristics##2##2##(1991-1#1)(2008-11#1)
basic component##2##2##(2008-10#1)(2011-2#1)
basic components of##2##3##(1996-12#1)(2013-1#1)
basic components##3##2##(1996-12#1)(2009-12#1)(2013-1#1)
basic compounds##3##2##(2008-10#3)
basic concepts and##2##3##(1993-12#1)(2008-11#1)
basic concepts of##4##3##(1993-3#1)(1994-3#1)(2008-12#1)(2011-2#1)
basic concepts##8##2##(1993-12#1)(1993-3#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
basic conditions and##2##3##(1990-5#1)(2008-10#1)
basic conditions##3##2##(1990-5#1)(2008-10#2)
basic data##2##2##(2008-7#2)
basic descriptive##2##2##(1991-12#1)(2010-9#1)
basic fetoprotein##2##2##(1991-8#2)
basic fibroblast growth factor (bFGF) and##2##6##(1995-12#1)(2008-11#1)
basic fibroblast growth factor (bFGF)##4##5##(1992-3#1)(1995-12#2)(2008-11#1)
basic fibroblast growth factor##13##4##(1992-3#2)(1995-11#2)(1995-12#4)(2008-11#5)
basic health##2##2##(1997-5#1)(2011-2#1)
basic idea##3##2##(1997-2#1)(2008-10#1)(2012-3#1)
basic information about##3##3##(1990-3#1)(1997-7#1)(2010-5#1)
basic information##7##2##(1990-12#1)(1990-3#1)(1997-7#1)(2008-10#2)(2008-4#1)(2010-5#1)
basic knowledge of##2##3##(2008-10#1)(2010-7#1)
basic knowledge##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
basic life support##2##3##(2008-11#2)
basic life##3##2##(2008-11#2)(2008-8#1)
basic mechanisms of##3##3##(2008-4#1)(2009-5#1)(2010-9#1)
basic mechanisms##5##2##(2008-4#1)(2009-5#1)(2010-10#1)(2010-9#1)(2013-1#1)
basic media##4##2##(2008-10#4)
basic medium##7##2##(2008-10#7)
basic metabolism##2##2##(2008-7#1)(2010-10#1)
basic molecular##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
basic nursing##2##2##(2012-3#1)(2013-8#1)
basic pH and##2##3##(2008-10#2)
basic pH##6##2##(2008-10#6)
basic phospholipase A2 from##2##4##(2008-8#2)
basic principle in##2##3##(1992-1#1)(1997-6#1)
basic principle##3##2##(1992-1#1)(1997-6#1)(2008-12#1)
basic principles of the##3##4##(1994-5#1)(2008-9#1)(2011-7#1)
basic principles of##9##3##(1992-2#1)(1994-5#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-7#1)(2011-7#1)
basic principles##11##2##(1992-2#1)(1994-5#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2010-7#1)(2011-7#1)
basic problems##2##2##(2010-1#1)(2012-3#1)
basic procedures##3##2##(2008-4#2)(2008-7#1)
basic properties##2##2##(2008-10#1)(2010-9#1)
basic protein##8##2##(1990-10#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-8#1)
basic proteins##3##2##(2008-10#2)(2008-9#1)
basic protocol describes##3##3##(2008-4#2)(2008-9#1)
basic protocol is##2##3##(2008-4#2)
basic protocol##12##2##(2008-2#1)(2008-4#9)(2008-9#2)
basic protocols for##4##3##(2008-4#2)(2008-9#2)
basic protocols##8##2##(2008-4#5)(2008-9#3)
basic region##5##2##(1993-2#1)(1995-8#2)(2008-10#1)(2009-8#1)
basic reproductive number##8##3##(2008-10#6)(2008-8#1)(2013-8#1)
basic research on biological agents##2##5##(1992-12#2)
basic research on##4##3##(1992-12#2)(1997-8#1)(2008-10#1)
basic research##13##2##(1991-12#1)(1992-12#2)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2009-12#1)(2012-2#1)
basic residue##2##2##(1995-6#1)(2009-8#1)
basic residues in the##2##4##(1995-6#2)
basic residues##4##2##(1995-6#3)(2008-7#1)
basic science##2##2##(2009-3#1)(2012-3#1)
basic scientific##2##2##(2011-2#1)(2011-7#1)
basic scientists##2##2##(1992-1#1)(2008-9#1)
basic solution##3##2##(2008-10#3)
basic solutions##3##2##(2008-10#3)
basic treatment##2##2##(1993-2#1)(2007-8#1)
basic##404##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-5#2)(1991-1#1)(1991-12#6)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#2)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#5)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1995-1#1)(1995-11#4)(1995-12#6)(1995-3#1)(1995-5#1)(1995-6#7)(1995-8#4)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-12#2)(2007-8#1)(2008-10#84)(2008-11#26)(2008-12#10)(2008-2#2)(2008-3#7)(2008-4#29)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#26)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#13)(2011-7#2)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#10)(2013-8#4)
basically in##2##2##(2008-10#2)
basically##16##1##(1991-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
basicity and##2##2##(2008-10#2)
basicity of##2##2##(2008-10#2)
basicity##7##1##(2008-10#7)
basicola alone##2##2##(2008-10#2)
basicola to##2##2##(2008-10#2)
basicola utilized##2##2##(2008-10#2)
basicola##24##1##(2008-10#24)
basiconica##6##1##(2007-12#6)
basics##5##1##(2008-4#3)(2009-12#1)(2013-1#1)
basidiocarps##2##1##(2008-10#1)(2008-11#1)
basidiomycete fungus##2##2##(1993-12#1)(2010-7#1)
basidiomycete##6##1##(1993-12#1)(2008-10#2)(2010-7#1)(2013-1#2)
basidiomycetes##7##1##(2008-10#3)(2011-1#1)(2013-1#3)
basidiospore##5##1##(2008-10#5)
basidiospores were observed to cause infection on##2##7##(2008-10#2)
basidiospores##9##1##(2008-10#9)
basil and##2##2##(2008-10#2)
basil##6##1##(2008-10#6)
basilar artery##11##2##(1996-6#1)(1997-6#3)(2008-7#1)(2011-2#3)(2012-3#1)(2013-8#2)
basilar skull fracture##2##3##(2008-11#1)(2008-12#1)
basilar tip aneurysm##5##3##(1997-6#3)(2008-7#2)
basilar tip##6##2##(1997-6#3)(2008-7#3)
basilar trunk aneurysms##2##3##(2008-7#2)
basilar##23##1##(1996-6#1)(1997-3#1)(1997-6#6)(2008-11#1)(2008-12#1)(2008-7#7)(2011-2#3)(2012-3#1)(2013-8#2)
basilensis HMF14##5##2##(2011-1#5)
basilici##4##1##(2008-10#4)
basin and its##2##3##(2008-11#1)(2008-12#1)
basin and##4##2##(2008-11#1)(2008-12#1)(2009-12#1)(2010-8#1)
basin of##6##2##(1990-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)
basin##21##1##(1990-8#2)(2008-10#7)(2008-11#5)(2008-12#3)(2009-12#1)(2009-5#1)(2010-8#2)
basing on##2##2##(2008-12#1)(2009-10#1)
basing##3##1##(2008-10#1)(2008-12#1)(2009-10#1)
basins##2##1##(2008-10#1)(2008-6#1)
basis a##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
basis and##8##2##(1993-6#1)(1994-2#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
basis for a##7##3##(1991-6#1)(2008-10#4)(2008-7#1)(2008-9#1)
basis for developing##2##3##(2008-10#1)(2008-7#1)
basis for discussion##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
basis for one##2##3##(1992-3#1)(2008-12#1)
basis for our##2##3##(2008-3#1)(2013-1#1)
basis for such##2##3##(2008-10#1)(2008-5#1)
basis for the##30##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-10#2)(1995-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
basis for their##3##3##(1991-2#1)(2008-10#1)(2008-12#1)
basis for this##11##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2012-3#2)(2013-1#1)
basis for understanding the##2##4##(2008-8#1)(2010-12#1)
basis for understanding##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
basis for##130##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#3)(2007-12#1)(2008-10#20)(2008-11#12)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#5)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#7)(2013-1#6)(2013-8#4)
basis function##7##2##(2008-10#6)(2010-1#1)
basis in the##4##3##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
basis in##10##2##(1992-1#1)(1993-8#1)(1995-3#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)
basis of a##26##3##(1990-2#1)(1990-9#1)(1991-3#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2013-1#2)
basis of differences##3##3##(2008-10#2)(2010-1#1)
basis of the##81##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-2#2)(1997-6#1)(2008-10#31)(2008-11#5)(2008-3#3)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-5#1)(2011-3#1)(2012-3#2)(2013-1#4)
basis of these differences##2##4##(1993-12#1)(2008-10#1)
basis of these##21##3##(1991-3#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-6#1)(2009-11#1)(2013-1#1)
basis of this##14##3##(1991-2#1)(1993-12#1)(1995-8#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
basis of##372##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#3)(1990-8#1)(1990-9#5)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#7)(1991-6#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#103)(2008-11#22)(2008-12#2)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#18)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#4)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#3)(2012-12#1)(2012-2#5)(2012-3#9)(2013-1#13)(2013-8#2)
basis to##7##2##(1991-12#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-6#1)(2008-9#1)
basis underlying##3##2##(2008-11#1)(2009-12#1)(2012-3#1)
basis with a##2##3##(2008-10#1)(2013-1#1)
basis##631##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#6)(1990-5#4)(1990-8#1)(1990-9#6)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#7)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-12#9)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#6)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#10)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#10)(1996-3#5)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#5)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#3)(1997-9#2)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#147)(2008-11#46)(2008-12#7)(2008-2#1)(2008-3#11)(2008-4#8)(2008-5#10)(2008-6#5)(2008-7#17)(2008-8#26)(2008-9#20)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#5)(2010-11#3)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#4)(2011-1#3)(2011-2#19)(2011-3#4)(2011-9#1)(2012-12#1)(2012-2#8)(2012-3#20)(2013-1#23)(2013-8#7)
basis)##4##1##(2008-10#3)(2008-4#1)
basitarsi of##2##2##(2007-12#2)
basitarsus##6##1##(2007-12#6)
basket##7##1##(1992-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
basolateral amygdala##6##2##(1990-5#1)(1993-6#4)(1997-7#1)
basolateral membrane##4##2##(1993-3#1)(1994-3#1)(2008-11#2)
basolateral membranes from dog kidney##2##5##(1993-3#2)
basolateral membranes with##2##3##(1993-3#2)
basolateral membranes##8##2##(1990-5#1)(1993-3#6)(2012-2#1)
basolateral##25##1##(1990-5#3)(1993-3#7)(1993-6#4)(1994-3#1)(1997-7#1)(2008-11#7)(2008-7#1)(2012-2#1)
basonuclin gene##4##2##(2008-9#4)
basonuclin##9##1##(2008-9#9)
basophil activation test##2##3##(2012-3#2)
basophilic and eosinophilic differentiation in##2##5##(2008-11#2)
basophilic cells##5##2##(2008-11#1)(2008-7#4)
basophilic##11##1##(1990-5#2)(2008-11#4)(2008-7#5)
basophils##6##1##(2008-11#5)(2008-6#1)
basses##2##1##(2008-10#1)(2009-10#1)
basteri##4##1##(2007-12#4)
bat immunology##2##2##(2013-1#2)
bat##8##1##(2008-12#1)(2009-8#2)(2011-2#2)(2013-1#3)
batangensis##2##1##(2008-10#2)
batch and column techniques##3##4##(2008-10#3)
batch and column##5##3##(2008-10#5)
batch and fed-batch culture##2##4##(2008-11#2)
batch and fed-batch cultures##4##4##(2008-11#4)
batch and fed-batch hydrolysis##2##4##(2011-2#2)
batch and fed-batch##13##3##(2008-11#8)(2008-7#2)(2011-2#3)
batch and flow injection##2##4##(2008-10#2)
batch and flow##3##3##(2008-10#3)
batch and perfusion cultures##2##4##(2008-11#2)
batch and##32##2##(2008-10#13)(2008-11#11)(2008-12#1)(2008-6#1)(2008-7#3)(2011-2#3)
batch components##3##2##(2011-2#3)
batch cultivation of##2##3##(2008-7#2)
batch cultivation##5##2##(2008-11#2)(2008-7#3)
batch culture and##4##3##(2008-11#3)(2012-2#1)
batch culture of infected##2##4##(2008-11#2)
batch culture of##5##3##(1994-8#1)(2008-11#2)(2008-7#2)
batch culture to##2##3##(2008-11#2)
batch culture##39##2##(1994-8#3)(2008-11#31)(2008-7#4)(2012-2#1)
batch cultures##22##2##(1995-9#1)(2008-11#18)(2008-7#1)(2008-8#1)(2012-3#1)
batch equilibrium##6##2##(1997-2#3)(2008-10#3)
batch experiments##4##2##(2008-10#3)(2013-1#1)
batch fecundity and##2##3##(2010-8#2)
batch fecundity estimates##2##3##(2010-8#2)
batch fecundity##6##2##(2010-8#6)
batch fermentation##4##2##(2008-11#1)(2008-7#3)
batch fermentations##5##2##(2008-11#1)(2008-7#3)(2012-3#1)
batch injection analysis (BIA)##3##4##(2008-10#3)
batch injection analysis##7##3##(2008-10#7)
batch method and##3##3##(2008-10#3)
batch method##7##2##(2008-10#7)
batch mode of##2##3##(2008-10#2)
batch mode##10##2##(2008-10#7)(2008-11#1)(2008-7#2)
batch of##6##2##(2008-10#3)(2013-8#3)
batch operating mode##3##3##(2008-11#3)
batch or##6##2##(2008-10#1)(2008-11#5)
batch phase/medium composition##2##3##(2008-11#2)
batch procedure##4##2##(2008-10#4)
batch process##3##2##(2008-11#1)(2008-7#2)
batch studies##3##2##(2008-10#3)
batch suspension##2##2##(2008-11#2)
batch system##4##2##(2008-10#4)
batch##234##1##(1994-8#3)(1995-9#1)(1997-2#3)(2008-10#79)(2008-11#86)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#31)(2008-8#1)(2009-6#1)(2010-8#7)(2011-1#1)(2011-2#10)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
batch-spawning##2##1##(2010-8#2)
batch-type##2##1##(2008-10#1)(2008-11#1)
batchculture##4##1##(2008-11#4)
batches (B1##2##2##(2008-11#2)
batches of an##2##3##(2008-11#1)(2011-2#1)
batches of the##3##3##(2010-2#2)(2011-2#1)
batches of##13##2##(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2010-2#3)(2011-2#2)
batches with a##2##3##(2008-11#1)(2008-7#1)
batches##32##1##(2008-10#9)(2008-11#9)(2008-5#3)(2008-7#1)(2008-9#1)(2010-2#3)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
batchwise##9##1##(2008-10#9)
bath and##4##2##(2008-10#4)
bath##36##1##(1993-8#1)(1994-5#3)(1995-2#1)(1997-4#1)(2008-10#24)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
bathed##3##1##(2008-7#1)(2009-8#1)(2013-1#1)
bathing in polluted water##2##4##(2008-10#2)
bathing in##3##2##(2008-10#3)
bathing solution##2##2##(1994-12#1)(2008-10#1)
bathing##7##1##(1994-12#1)(2008-10#5)(2011-2#1)
bathochromic shifts##2##2##(1996-5#1)(2008-10#1)
bathochromic##4##1##(1996-5#1)(2008-10#3)
bathocuproine##2##1##(2008-10#2)
bathophenanthroline-ferrous as##2##2##(2008-10#2)
baths##5##1##(2008-10#4)(2010-8#1)
bathymetric##3##1##(2008-3#2)(2010-8#1)
bats are##2##2##(2009-8#1)(2013-1#1)
bats have##2##2##(2013-1#2)
bats##17##1##(2008-12#1)(2009-8#6)(2013-1#10)
battered children##2##2##(1995-5#2)
battered women##2##2##(2009-5#2)
battered##11##1##(1993-2#1)(1995-5#8)(2009-5#2)
batterers in##2##2##(2009-5#2)
batterers##5##1##(2009-5#5)
batterie##2##1##(2008-10#2)
batteries##5##1##(2008-10#3)(2010-9#1)(2012-3#1)
battering##4##1##(1995-5#1)(2009-5#3)
battery electrolyte##2##2##(2008-10#2)
battery of tests##2##3##(2008-9#2)
battery of##6##2##(2008-11#1)(2008-9#2)(2009-10#2)(2012-2#1)
battery##20##1##(1992-3#1)(1995-12#1)(1996-5#3)(2008-10#5)(2008-11#2)(2008-5#1)(2008-9#4)(2009-10#2)(2012-2#1)
battle to##2##2##(1995-2#1)(1996-5#1)
battle##6##1##(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#1)(2012-2#1)
battles##2##1##(1993-5#1)(1996-2#1)
bay laurel green leaf litter##2##5##(2008-10#2)
bay laurel##6##2##(2008-10#6)
bay##9##1##(2008-10#8)(2008-6#1)
bayanus##5##1##(1996-6#5)
bayesian##2##1##(2008-10#1)(2011-2#1)
bc-1(2)##8##1##(2008-10#8)
bcNOS##2##1##(2010-12#2)
bcd##3##1##(1994-12#3)
bcl-2 alpha and bcl-2 beta mRNA##2##6##(1993-3#2)
bcl-2 alpha##3##2##(1993-3#3)
bcl-2 and bag-1##7##3##(2008-11#7)
bcl-2 and##9##2##(2008-10#1)(2008-11#7)(2008-7#1)
bcl-2 beta mRNA##3##3##(1993-3#3)
bcl-2 expression##4##2##(2008-11#2)(2008-7#2)
bcl-2 gene##3##2##(1993-3#2)(1994-3#1)
bcl-2 had a significantly##2##4##(2008-10#2)
bcl-2 in##3##2##(2008-11#3)
bcl-2 mRNAs##2##2##(1993-3#2)
bcl-2 transfected cells grown in##2##5##(2008-11#2)
bcl-2 transfected cells##5##3##(2008-11#5)
bcl-2 transfected##7##2##(2008-11#7)
bcl-2##57##1##(1993-3#10)(1994-3#3)(2008-10#6)(2008-11#33)(2008-7#5)
bcl-2/scid mice##2##2##(1994-3#2)
be &quot##3##2##(1995-3#1)(2008-11#1)(2013-1#1)
be (0##2##2##(2008-10#1)(2008-11#1)
be 1##32##2##(1995-11#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
be 100%##5##2##(1994-12#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-9#1)
be 2##32##2##(1992-3#2)(1996-5#1)(2008-10#28)(2011-1#1)
be 7##6##2##(1991-5#1)(1994-9#1)(2008-10#4)
be a basic##2##3##(1994-11#1)(2008-11#1)
be a better##3##3##(1996-1#1)(2008-10#2)
be a biomarker##2##3##(2010-1#1)(2010-12#1)
be a by-product##2##3##(2008-10#1)(2009-8#1)
be a candidate##3##3##(2008-8#1)(2008-9#1)(2009-9#1)
be a cause of##2##4##(2008-11#1)(2008-5#1)
be a cell##2##3##(1993-8#1)(2008-10#1)
be a central##6##3##(1994-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-2#1)(2013-1#1)
be a challenge to##2##4##(1992-1#1)(2008-10#1)
be a challenge##3##3##(1992-1#1)(2008-10#1)(2012-3#1)
be a challenging task##2##4##(2008-10#2)
be a challenging##3##3##(2008-10#3)
be a common cause of##2##5##(1997-3#1)(2010-1#1)
be a common##8##3##(1990-5#1)(1991-10#1)(1994-11#1)(1997-3#1)(2008-10#1)(2009-8#1)(2010-1#1)(2011-1#1)
be a consequence of##4##4##(1992-6#1)(1994-5#1)(2008-11#1)(2008-8#1)
be a correlation between##2##4##(2008-9#1)(2009-9#1)
be a critical parameter##2##4##(1991-2#1)(2010-7#1)
be a critical##3##3##(1991-2#1)(1995-8#1)(2010-7#1)
be a crucial##3##3##(1991-12#1)(2008-5#1)(2010-12#1)
be a direct##3##3##(1993-9#1)(1995-2#1)(2008-11#1)
be a distinct##2##3##(2008-10#1)(2013-8#1)
be a fast##4##3##(2008-10#2)(2008-11#1)(2009-12#1)
be a form of##3##4##(2008-8#1)(2012-12#1)(2012-3#1)
be a general##5##3##(2008-10#2)(2008-7#1)(2008-8#2)
be a good candidate##2##4##(2008-10#1)(2008-11#1)
be a good##15##3##(1993-12#1)(1994-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#2)
be a greater##2##3##(2008-10#1)(2012-3#1)
be a helpful##2##3##(2008-11#1)(2012-3#1)
be a high##4##3##(1994-5#1)(2008-11#2)(2008-8#1)
be a highly##3##3##(2008-10#2)(2008-3#1)
be a key##6##3##(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2013-8#1)
be a large##2##3##(1997-6#1)(2008-9#1)
be a lengthy##2##3##(1992-12#1)(1992-2#1)
be a major component of##2##5##(1997-8#1)(2008-5#1)
be a major##13##3##(1990-8#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-11#1)(1994-11#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-5#1)(2010-10#1)(2012-3#1)
be a marker of##2##4##(2011-2#1)(2012-3#1)
be a marker##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
be a mechanism for##2##4##(2008-10#1)(2008-11#1)
be a mechanism##3##3##(2008-10#1)(2008-11#1)(2010-1#1)
be a model##2##3##(2008-11#2)
be a more specific##2##4##(2008-10#2)
be a more##12##3##(1993-12#1)(1994-11#1)(1994-5#1)(2008-10#7)(2008-5#1)(2011-2#1)
be a new##2##3##(2008-10#1)(2008-8#1)
be a novel##6##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
be a part of the##3##5##(1997-8#1)(2008-10#1)(2008-3#1)
be a part of##4##4##(1997-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
be a possible##4##3##(1993-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
be a potent##6##3##(1991-5#1)(1992-3#1)(1993-12#1)(1995-12#1)(2008-11#2)
be a potential##2##3##(2008-10#2)
be a powerful tool for##2##5##(2008-10#1)(2008-11#1)
be a powerful tool in##3##5##(2008-11#1)(2010-8#1)(2013-8#1)
be a powerful tool##7##4##(1993-2#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-8#1)(2013-8#1)
be a powerful##13##3##(1993-2#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#5)(2008-3#1)(2010-10#1)(2010-8#1)(2013-8#1)
be a prerequisite for##2##4##(1997-1#1)(2008-9#1)
be a primary##3##3##(1995-1#1)(2008-10#1)(2013-1#1)
be a problem##2##3##(2008-10#1)(2008-3#1)
be a promising##9##3##(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-7#1)
be a rapid and##2##4##(2008-10#1)(2010-4#1)
be a rapid##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
be a reasonable##2##3##(1993-1#1)(2008-10#1)
be a recombinant##2##3##(2008-10#2)
be a result of##2##4##(2008-10#1)(2008-11#1)
be a revolutionary##2##3##(2009-6#1)(2010-7#1)
be a risk factor##2##4##(1992-3#1)(1997-1#1)
be a sensitive##6##3##(1994-11#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
be a sign##2##3##(2008-10#1)(2010-6#1)
be a significant##10##3##(1991-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
be a simple##5##3##(1991-3#1)(1996-12#1)(2008-10#2)(2008-7#1)
be a source of##5##4##(2008-10#2)(2008-11#1)(2010-6#1)(2013-1#1)
be a suitable##8##3##(1996-1#1)(2008-10#5)(2008-11#1)(2008-5#1)
be a target for##3##4##(1992-6#1)(2011-2#1)(2013-1#1)
be a target##4##3##(1992-6#1)(2009-6#1)(2011-2#1)(2013-1#1)
be a tool##2##3##(1995-12#1)(2008-10#1)
be a unique##2##3##(1993-2#1)(1997-6#1)
be a useful tool for the##2##6##(1990-2#1)(1992-12#1)
be a useful tool for##5##5##(1990-2#1)(1992-12#1)(1995-11#1)(2008-10#1)(2008-11#1)
be a useful tool in the##4##6##(1996-9#1)(2008-10#2)(2010-4#1)
be a useful tool in##7##5##(1991-11#1)(1996-9#1)(2008-10#3)(2010-4#1)(2010-7#1)
be a useful tool##14##4##(1990-2#1)(1991-11#1)(1992-12#1)(1995-11#1)(1996-9#1)(2008-10#5)(2008-11#1)(2010-4#1)(2010-7#1)(2011-2#1)
be a useful##34##3##(1990-2#1)(1991-11#1)(1991-3#1)(1992-12#2)(1993-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-9#1)(2008-10#13)(2008-11#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#2)
be a valid##2##3##(1995-3#1)(2008-10#1)
be a valuable tool##3##4##(1993-2#1)(1997-2#1)(2008-11#1)
be a valuable##8##3##(1992-1#1)(1993-2#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#2)(2010-7#1)
be a very##10##3##(1990-11#1)(1990-9#1)(1994-12#1)(2008-10#3)(2008-11#1)(2010-7#1)(2012-2#2)
be a viable##8##3##(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
be a vital##2##3##(1993-2#1)(2008-9#1)
be a##553##2##(1990-11#4)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#3)(1991-5#2)(1992-1#3)(1992-12#7)(1992-2#3)(1992-3#4)(1992-6#5)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#6)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#3)(1994-11#7)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#5)(2007-12#1)(2008-1#2)(2008-10#128)(2008-11#47)(2008-12#5)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#15)(2008-8#21)(2008-9#21)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#6)(2009-7#2)(2009-8#7)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#1)(2010-12#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#7)(2010-7#7)(2010-8#1)(2011-1#1)(2011-2#22)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#14)(2012-3#12)(2013-1#19)(2013-7#2)(2013-8#9)
be able to recognize the##2##5##(2011-3#1)(2012-3#1)
be able to recognize##3##4##(2011-2#1)(2011-3#1)(2012-3#1)
be able to stimulate##2##4##(2008-5#1)(2013-1#1)
be able to##62##3##(1990-2#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#2)(1996-1#1)(1996-2#1)(1996-3#3)(2007-12#1)(2008-10#10)(2008-11#6)(2008-12#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#5)
be able##64##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#2)(1996-1#1)(1996-2#1)(1996-3#3)(2007-12#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#5)
be abnormal in##3##3##(1991-12#1)(2008-12#1)(2009-11#1)
be abolished by##2##3##(1994-3#1)(2008-8#1)
be abolished##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
be above##2##2##(1996-3#1)(2008-10#1)
be absent##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
be absorbed in the##2##4##(2008-10#2)
be absorbed##4##2##(1992-12#1)(2008-10#2)(2008-8#1)
be accelerated##2##2##(1994-3#1)(2008-11#1)
be acceptable for##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
be acceptable##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)
be accepted or##2##3##(1991-12#1)(2008-11#1)
be accepted##5##2##(1991-12#1)(1992-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
be accessed from##2##3##(1991-12#1)(2008-10#1)
be accessed##5##2##(1991-12#1)(1994-3#1)(2008-10#1)(2009-2#1)(2010-12#1)
be accessible##4##2##(1994-2#1)(1995-2#1)(2008-11#1)(2012-3#1)
be accommodated##3##2##(1997-3#1)(2008-11#1)(2008-8#1)
be accompanied by a##2##4##(1992-8#1)(2008-12#1)
be accompanied by##5##3##(1992-8#1)(1993-2#1)(1994-9#1)(2008-12#1)(2008-8#1)
be accomplished by##9##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#1)
be accomplished using##2##3##(2008-10#1)(2008-11#1)
be accomplished##20##2##(1993-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#2)
be accounted for by##5##4##(1990-10#1)(1995-6#1)(2008-10#1)(2009-5#1)(2011-2#1)
be accounted for in##2##4##(2008-5#1)(2009-5#1)
be accounted for##8##3##(1990-10#1)(1990-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2009-5#2)(2011-2#1)
be accumulated##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
be accurate##9##2##(1993-3#1)(1995-11#1)(2007-12#1)(2008-10#4)(2010-11#1)(2012-2#1)
be accurately##10##2##(1990-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-1#1)
be achieved at##2##3##(2008-10#1)(2008-11#1)
be achieved by the##2##4##(2008-10#1)(2008-5#1)
be achieved by##23##3##(1990-2#1)(1990-9#1)(1993-9#1)(1995-11#1)(1996-2#1)(1997-7#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-8#1)
be achieved for##2##3##(2008-10#2)
be achieved in the##3##4##(1992-9#1)(1997-6#1)(2008-10#1)
be achieved in##8##3##(1992-9#1)(1993-1#1)(1997-6#1)(2008-10#2)(2010-12#1)(2013-1#1)(2013-7#1)
be achieved through##7##3##(1994-12#1)(1994-3#1)(1995-2#1)(2008-11#2)(2011-2#1)(2012-7#1)
be achieved using a variety of##2##6##(1992-9#1)(2008-12#1)
be achieved using the##2##4##(2008-11#1)(2009-12#1)
be achieved using##7##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)
be achieved with differential##2##4##(2008-3#1)(2008-7#1)
be achieved with the##4##4##(1995-3#1)(2008-10#2)(2008-3#1)
be achieved with##10##3##(1995-3#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#1)
be achieved without##3##3##(1995-12#1)(1997-8#1)(2008-5#1)
be achieved##99##2##(1990-2#1)(1990-9#2)(1991-3#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-6#1)(1997-7#3)(1997-8#1)(2008-10#32)(2008-11#9)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#2)
be acknowledged and##2##3##(1994-12#1)(2012-2#1)
be acquired by##2##3##(2008-10#2)
be acquired##10##2##(2007-12#1)(2008-10#7)(2011-7#1)(2012-3#1)
be acting##4##2##(1990-11#1)(1993-6#1)(2012-2#2)
be activated by the##3##4##(1995-12#1)(1995-6#1)(2008-11#1)
be activated by##10##3##(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#2)(1996-12#1)(2008-11#1)(2008-9#1)(2013-8#1)
be activated##14##2##(1993-8#2)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#2)(1996-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-7#1)(2013-8#1)
be active##6##2##(1992-10#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
be adapted for the##2##4##(1990-12#1)(2008-4#1)
be adapted for##5##3##(1990-12#1)(1994-3#1)(2008-10#1)(2008-4#2)
be adapted to the##2##4##(2008-10#1)(2008-3#1)
be adapted to##13##3##(1990-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-8#1)
be adapted##20##2##(1990-12#1)(1990-5#1)(1993-12#1)(1994-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-8#1)
be added and##2##3##(2008-10#1)(2008-9#1)
be added in##2##3##(1995-2#1)(2012-12#1)
be added to the list of##2##6##(2008-11#1)(2009-1#1)
be added to the##6##4##(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-1#1)(2011-2#1)
be added to##8##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2011-2#1)
be added##12##2##(1995-2#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-12#1)
be addressed in##7##3##(1992-9#1)(1994-1#1)(1994-12#1)(1997-2#1)(2009-12#1)(2011-1#1)(2011-2#1)
be addressed to##5##3##(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
be addressed when##2##3##(2008-9#1)(2012-2#1)
be addressed##31##2##(1992-12#1)(1992-9#1)(1993-12#1)(1994-1#3)(1994-12#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-12#2)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)
be adequate for##4##3##(1991-12#1)(2008-10#3)
be adequate##5##2##(1991-12#1)(2008-10#4)
be adequately##7##2##(1996-11#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
be adjusted##10##2##(1995-2#1)(1997-4#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-5#1)(2012-12#1)
be administered safely##2##3##(1992-3#1)(2010-12#1)
be administered to##5##3##(1994-2#1)(1994-9#1)(2008-3#1)(2010-12#1)(2013-8#1)
be administered##14##2##(1990-11#1)(1990-6#1)(1992-3#1)(1994-2#1)(1994-9#1)(1996-3#1)(1997-5#1)(2008-3#2)(2010-12#2)(2011-2#1)(2013-8#2)
be admitted for##2##3##(1992-6#1)(2006-5#1)
be admitted##4##2##(1992-6#1)(1995-5#1)(1996-3#1)(2006-5#1)
be adopted by##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
be adopted in##2##3##(2008-10#1)(2008-12#1)
be adopted to##2##3##(2008-10#1)(2008-6#1)
be adopted##14##2##(1990-2#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2013-8#1)
be advanced##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
be advantageous in##3##3##(1997-7#1)(2008-8#1)(2013-1#1)
be advantageous##9##2##(1997-7#1)(2008-10#2)(2008-3#2)(2008-8#2)(2008-9#1)(2013-1#1)
be advised to##3##3##(1996-11#1)(2009-5#1)(2012-2#1)
be advised##4##2##(1994-3#1)(1996-11#1)(2009-5#1)(2012-2#1)
be advocated##3##2##(1992-3#1)(1997-5#1)(2008-4#1)
be affected by a##3##4##(1994-11#1)(1997-8#1)(2013-1#1)
be affected by the##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
be affected by##19##3##(1993-6#1)(1994-11#1)(1994-3#2)(1997-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#2)(2010-10#1)(2013-1#1)(2013-8#1)
be affected in##3##3##(1992-3#1)(1997-1#1)(2008-12#1)
be affected##27##2##(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#2)(1996-3#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-8#2)(2010-10#1)(2013-1#1)(2013-8#1)
be aggravated by##2##3##(2008-7#1)(2011-2#1)
be aggressive##2##2##(1996-3#1)(2007-8#1)
be aided by##2##3##(1992-9#1)(2008-7#1)
be aimed at##3##3##(1996-3#1)(2008-2#1)(2011-2#1)
be aimed##4##2##(1991-2#1)(1996-3#1)(2008-2#1)(2011-2#1)
be alert##2##2##(2008-12#1)(2010-12#1)
be allocated to##2##3##(2008-8#1)(2009-5#1)
be allowed##2##2##(2008-12#1)(2012-2#1)
be almost##2##2##(2008-11#1)(2011-2#1)
be already##2##2##(2008-1#1)(2008-10#1)
be also used##3##3##(2008-10#2)(2010-8#1)
be also##17##2##(1990-3#1)(1991-3#1)(2008-10#7)(2008-11#3)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
be altered by##4##3##(1990-2#1)(1993-12#1)(2008-11#1)(2008-6#1)
be altered##12##2##(1990-2#1)(1990-6#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-11#1)(2012-2#1)
be ameliorated by##2##3##(2008-1#1)(2011-1#1)
be ameliorated##3##2##(1993-11#1)(2008-1#1)(2011-1#1)
be amenable to##3##3##(1997-7#1)(2008-10#1)(2008-6#1)
be among the##5##3##(1994-9#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
be an absolute##2##3##(1992-1#1)(1994-8#1)
be an active##2##3##(1992-2#1)(2008-9#1)
be an additional##6##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
be an alternative##6##3##(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
be an appropriate##4##3##(2008-10#1)(2008-11#1)(2013-1#2)
be an attractive##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
be an early##3##3##(1991-1#1)(2011-2#1)(2012-12#1)
be an effective and##2##4##(2008-10#2)
be an effective approach to##2##5##(2008-10#1)(2010-12#1)
be an effective intervention for##2##5##(2008-10#1)(2008-12#1)
be an effective means of##3##5##(1993-11#1)(2008-5#1)(2012-2#1)
be an effective means##4##4##(1993-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
be an effective method for##2##5##(1991-2#1)(2011-2#1)
be an effective method##4##4##(1991-2#1)(1991-7#1)(2008-10#1)(2011-2#1)
be an effective treatment for##2##5##(2012-3#2)
be an effective treatment##3##4##(2011-2#1)(2012-3#2)
be an effective##35##3##(1991-2#1)(1991-4#1)(1991-7#1)(1993-11#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)
be an efficient##7##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-2#1)
be an essential##5##3##(1991-6#1)(1992-1#1)(1996-1#1)(1996-2#1)(2013-8#1)
be an important determinant of##3##5##(1990-12#1)(1994-5#1)(2008-10#1)
be an important factor in##2##5##(1996-12#1)(2010-6#1)
be an important factor##5##4##(1996-12#1)(2009-11#1)(2009-8#1)(2010-6#1)(2013-7#1)
be an important mechanism of##3##5##(2008-10#2)(2011-2#1)
be an important mechanism##7##4##(1993-2#1)(2008-10#4)(2008-8#1)(2011-2#1)
be an important part of##3##5##(1993-3#1)(2013-1#2)
be an important target for##2##5##(1995-2#1)(2013-8#1)
be an important##39##3##(1990-12#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-12#2)(2008-10#11)(2008-11#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
be an increase in##2##4##(1992-2#1)(2011-2#1)
be an index of##2##4##(1993-11#1)(2008-11#1)
be an indicator##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
be an interesting##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
be an invaluable tool##3##4##(1996-1#1)(2008-10#1)(2008-9#1)
be an##197##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#4)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-11#3)(1993-2#2)(1993-3#2)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#46)(2008-11#12)(2008-12#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#8)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#16)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#4)
be analysed##10##2##(1991-8#2)(2008-10#5)(2008-11#1)(2008-5#1)(2010-8#1)
be analyzed by##6##3##(1993-12#1)(1996-1#1)(2008-10#2)(2008-4#2)
be analyzed in the##3##4##(2008-10#2)(2008-4#1)
be analyzed in##8##3##(1991-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
be analyzed with##3##3##(2008-10#2)(2008-9#1)
be analyzed##34##2##(1991-5#1)(1993-12#2)(1996-1#1)(2008-10#18)(2008-11#1)(2008-4#5)(2008-9#3)(2011-1#1)(2011-2#1)(2013-8#1)
be another##4##2##(1991-2#1)(2008-11#1)(2009-3#2)
be answered by##2##3##(1995-1#1)(2012-2#1)
be answered##6##2##(1994-3#1)(1995-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#1)
be anticipated##6##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
be applicable for##8##3##(1996-8#1)(2008-10#3)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
be applicable in the##2##4##(2008-10#1)(2010-10#1)
be applicable in##3##3##(2008-10#1)(2010-10#1)(2011-2#1)
be applicable to a##4##4##(2008-10#4)
be applicable to other##2##4##(2008-10#1)(2010-2#1)
be applicable to the determination of##2##6##(2008-10#2)
be applicable to the##6##4##(2006-6#1)(2008-10#4)(2008-5#1)
be applicable to##19##3##(1991-5#1)(2006-6#1)(2008-10#11)(2008-11#3)(2008-5#1)(2010-12#1)(2010-2#1)
be applicable##32##2##(1991-5#1)(1994-3#1)(1996-8#1)(2006-6#1)(2008-10#15)(2008-11#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)
be applied as a##2##4##(2008-10#1)(2009-3#1)
be applied as an##2##4##(2008-10#1)(2008-6#1)
be applied as##4##3##(2008-10#2)(2008-6#1)(2009-3#1)
be applied by##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
be applied for the##2##4##(2008-10#2)
be applied for##10##3##(1994-8#1)(1995-6#1)(2008-10#6)(2008-11#1)(2013-1#1)
be applied in order to##2##5##(2008-5#1)(2012-2#1)
be applied in other##2##4##(2011-2#1)(2013-8#1)
be applied in the##3##4##(1996-11#1)(2008-10#2)
be applied in##21##3##(1996-11#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
be applied satisfactorily for##3##4##(2008-10#3)
be applied successfully to##5##4##(2008-10#4)(2008-11#1)
be applied to a##3##4##(2008-11#1)(2008-3#1)(2008-9#1)
be applied to determine##3##4##(2008-10#3)
be applied to other##4##4##(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)
be applied to public health##2##5##(2008-7#1)(2012-2#1)
be applied to the determination of##6##6##(2008-10#6)
be applied to the determination##8##5##(2008-10#8)
be applied to the##20##4##(1996-12#1)(1997-8#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)
be applied to##63##3##(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1995-2#1)(1996-12#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
be applied with##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
be applied##148##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#64)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-11#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#7)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
be appreciated##4##2##(1993-11#1)(2008-8#1)(2009-10#1)(2013-1#1)
be approached##3##2##(1991-12#1)(1991-2#1)(2008-10#1)
be appropriate for##6##3##(2008-10#2)(2008-8#1)(2010-12#2)(2013-1#1)
be appropriate##11##2##(1991-12#1)(1994-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-12#3)(2013-1#1)
be approved##2##2##(1992-3#1)(2008-5#1)
be approximate##2##2##(1992-6#1)(2008-9#1)
be approximated by##2##3##(2008-10#1)(2008-3#1)
be approximated##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
be approximately##15##2##(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
be argued that##2##3##(2008-11#1)(2009-10#1)
be argued##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
be as effective as##5##4##(1991-3#1)(1992-12#1)(1996-1#1)(2008-10#1)(2008-5#1)
be as high as##4##4##(2008-10#1)(2008-9#1)(2012-12#1)(2013-8#1)
be as important as##3##4##(2008-10#1)(2008-11#2)
be as important##4##3##(1995-6#1)(2008-10#1)(2008-11#2)
be as##32##2##(1991-3#1)(1992-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
be ascertained##4##2##(1991-2#1)(1995-12#1)(2013-1#1)(2013-8#1)
be ascribed to the##6##4##(2008-10#3)(2008-3#1)(2008-8#1)(2009-9#1)
be ascribed to##11##3##(1994-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#2)(2009-9#1)
be ascribed##13##2##(1994-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#2)(2009-6#1)(2009-9#1)
be asked##5##2##(2008-11#2)(2008-4#1)(2010-10#1)(2011-2#1)
be assembled##4##2##(1990-2#1)(1995-2#1)(2008-8#1)(2010-12#1)
be assessed by##5##3##(2008-10#1)(2008-11#3)(2008-5#1)
be assessed for##2##3##(1993-1#1)(2008-10#1)
be assessed##21##2##(1990-12#1)(1991-11#1)(1993-1#1)(1994-2#1)(1995-11#1)(1997-1#1)(2008-10#4)(2008-11#5)(2008-5#2)(2010-12#1)(2010-3#1)(2011-2#2)
be assigned to a##2##4##(1994-2#1)(2008-10#1)
be assigned to##5##3##(1994-2#1)(1995-12#1)(2008-10#3)
be assigned##7##2##(1994-2#1)(1995-12#1)(2008-10#5)
be assisted##2##2##(1993-9#1)(1994-2#1)
be associated to a##2##4##(2008-11#1)(2011-2#1)
be associated to##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
be associated with a variety of##3##6##(2008-11#1)(2011-2#1)(2012-3#1)
be associated with a##12##4##(1992-3#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
be associated with the##11##4##(1992-12#1)(1994-5#1)(1995-6#1)(1996-3#1)(2006-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)(2013-1#1)
be associated with##77##3##(1990-5#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#7)(2012-2#1)(2012-3#4)(2013-1#8)(2013-8#3)
be associated##82##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#8)(2012-2#1)(2012-3#4)(2013-1#8)(2013-8#3)
be assumed by##2##3##(1995-12#1)(1997-8#1)
be assumed that##3##3##(1991-1#1)(2008-7#1)(2009-1#1)
be assumed to be##2##4##(2007-12#1)(2010-3#1)
be assumed to##5##3##(2007-12#1)(2008-10#2)(2010-10#1)(2010-3#1)
be assumed##12##2##(1991-1#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-10#1)(2010-3#1)
be asymptomatic##4##2##(1991-4#1)(2008-1#1)(2008-12#1)(2013-1#1)
be at a##2##3##(2008-8#1)(2011-2#1)
be at greater##2##3##(1993-1#1)(1996-11#1)
be at least partly##2##4##(1997-7#1)(2008-10#1)
be at least##5##3##(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#1)
be at risk for##2##4##(1996-12#1)(2009-2#1)
be at risk##3##3##(1996-12#1)(1997-1#1)(2009-2#1)
be at the##4##3##(1991-5#1)(2008-10#1)(2008-5#1)(2013-8#1)
be at##28##2##(1991-5#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#2)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2011-2#3)(2013-8#1)
be attained using##4##3##(2008-10#4)
be attained##12##2##(1990-5#1)(1992-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-3#1)
be attempted##3##2##(2008-7#1)(2010-11#1)(2011-2#1)
be attractive##4##2##(2008-10#2)(2009-7#1)(2013-1#1)
be attributable to##6##3##(1991-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(2008-11#1)(2010-11#1)
be attributable##7##2##(1991-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(2008-11#1)(2010-11#1)
be attributed to its##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
be attributed to the##19##4##(1990-12#1)(1992-10#1)(1996-3#1)(2008-10#9)(2008-11#2)(2008-8#1)(2008-9#2)(2009-11#1)(2012-2#1)
be attributed to##45##3##(1990-12#1)(1992-10#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-9#1)
be attributed##47##2##(1990-12#1)(1990-8#1)(1992-10#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-9#1)
be augmented##3##2##(1994-5#1)(1997-1#1)(2008-11#1)
be automated##4##2##(2008-10#3)(2008-11#1)
be automatically##3##2##(2008-10#2)(2008-8#1)
be available for##2##3##(2008-10#1)(2009-1#1)
be available in the##4##4##(1990-11#1)(2008-12#3)
be available to##2##3##(2008-10#1)(2012-3#1)
be available##21##2##(1990-11#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-12#4)(2008-8#1)(2009-1#1)(2011-1#1)(2011-3#1)(2012-3#1)
be avoided by##3##3##(1996-11#1)(2008-7#2)
be avoided if##2##3##(1995-2#1)(2009-11#1)
be avoided in##3##3##(1994-3#2)(2008-10#1)
be avoided##32##2##(1990-5#1)(1992-3#2)(1993-11#1)(1993-2#1)(1994-3#2)(1995-2#1)(1996-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-1#1)(2009-11#1)(2009-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
be aware of the potential##2##5##(1996-12#1)(2008-9#1)
be aware of the##9##4##(1994-3#1)(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
be aware of this possible##2##5##(2008-12#1)(2012-3#1)
be aware of this##4##4##(1997-4#1)(2008-12#2)(2012-3#1)
be aware of##23##3##(1991-2#1)(1994-3#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
be aware that##3##3##(2010-9#1)(2012-2#2)
be aware##28##2##(1991-2#1)(1992-2#1)(1994-3#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
be based on a##7##4##(1991-2#2)(1992-1#1)(1995-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
be based on an##2##4##(1992-2#1)(2008-7#1)
be based on the##9##4##(1991-5#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-12#1)
be based on##31##3##(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1994-12#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
be because##4##2##(1990-11#1)(2006-6#1)(2008-11#1)(2011-2#1)
be beneficial for the##2##4##(2008-10#1)(2012-12#1)
be beneficial for##8##3##(1995-12#1)(2008-10#3)(2011-2#1)(2012-12#2)(2013-1#1)
be beneficial in the treatment of##2##6##(1990-10#1)(2011-2#1)
be beneficial in##8##3##(1990-10#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)
be beneficial to##4##3##(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
be beneficial##30##2##(1990-10#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#2)
be best achieved##2##3##(2008-10#1)(2009-5#1)
be best##7##2##(1994-2#1)(1995-1#1)(2008-10#2)(2009-5#1)(2012-2#2)
be better able to##3##4##(1993-11#1)(2008-11#2)
be better suited for##2##4##(2008-10#1)(2011-2#1)
be better suited##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
be better than##7##3##(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
be better understood##5##3##(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
be better##32##2##(1993-11#1)(1994-3#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#3)
be between##10##2##(1991-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#1)
be biased##4##2##(1996-3#1)(2008-10#1)(2008-8#1)(2010-3#1)
be blocked by##2##3##(1997-7#1)(2008-12#1)
be borne in mind##3##4##(1994-6#1)(2008-1#1)(2008-12#1)
be borne##4##2##(1994-6#1)(1994-9#1)(2008-1#1)(2008-12#1)
be both##8##2##(1990-2#1)(1991-11#1)(2008-10#4)(2009-5#1)(2011-2#1)
be bound to##3##3##(2008-10#2)(2012-3#1)
be bound##4##2##(2008-10#2)(2010-11#1)(2012-3#1)
be broadly applicable##2##3##(2008-9#1)(2009-10#1)
be broadly##4##2##(2008-4#1)(2008-9#1)(2009-10#1)(2013-1#1)
be broken into##2##3##(2008-10#1)(2008-9#1)
be broken##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
be brought together##2##3##(1996-1#1)(2008-11#1)
be brought##6##2##(1994-6#1)(1996-1#1)(2008-10#2)(2008-11#1)(2013-7#1)
be built##2##2##(2008-11#1)(2008-7#1)
be calculated by##3##3##(2008-10#2)(2008-2#1)
be calculated from the##2##4##(2008-5#1)(2008-8#1)
be calculated from##4##3##(2008-10#2)(2008-5#1)(2008-8#1)
be calculated##13##2##(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-12#1)
be candidates for##2##3##(1990-4#1)(2008-10#1)
be capable of##15##3##(1994-2#1)(1995-5#1)(2008-10#5)(2008-11#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#2)
be careful##3##2##(1992-3#1)(1995-2#1)(2008-5#1)
be carefully considered##3##3##(1995-11#1)(1995-12#1)(2008-7#1)
be carefully evaluated with##2##4##(2011-2#1)(2013-1#1)
be carefully evaluated##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
be carefully monitored##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
be carefully##20##2##(1991-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#4)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
be carried out by the##2##5##(2008-10#2)
be carried out by##4##4##(2008-10#4)
be carried out in order to##2##6##(1994-6#1)(2008-10#1)
be carried out in the##2##5##(1996-5#1)(2008-10#1)
be carried out in##8##4##(1994-2#1)(1994-6#1)(1996-5#2)(2008-10#3)(2008-2#1)
be carried out on a##2##5##(1992-5#1)(2009-12#1)
be carried out on##4##4##(1992-5#1)(1993-12#1)(2008-10#1)(2009-12#1)
be carried out with##2##4##(2008-10#1)(2011-1#1)
be carried out##27##3##(1992-5#1)(1993-12#1)(1994-2#1)(1994-6#1)(1996-5#2)(2008-10#14)(2008-2#1)(2008-4#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#1)
be carried##29##2##(1992-5#1)(1993-12#1)(1994-2#1)(1994-6#1)(1996-5#2)(2008-10#15)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#1)
be casual##2##2##(2011-2#1)(2012-3#1)
be catalyzed by##2##3##(1993-12#1)(1994-5#1)
be catalyzed##3##2##(1993-12#1)(1994-5#1)(2008-10#1)
be categorized##3##2##(2010-5#1)(2012-2#1)(2013-1#1)
be caused by a##8##4##(1992-1#1)(1994-11#1)(1994-12#2)(2008-10#2)(2008-11#1)(2009-6#1)
be caused by changes##2##4##(2008-11#1)(2008-9#1)
be caused by the##3##4##(2008-10#2)(2010-3#1)
be caused by##31##3##(1990-11#1)(1991-5#1)(1992-1#1)(1994-11#1)(1994-12#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)
be caused##32##2##(1990-11#1)(1991-5#1)(1992-1#1)(1994-11#1)(1994-12#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)
be central##2##2##(1990-5#1)(1997-1#1)
be challenging##6##2##(1995-3#1)(2008-10#1)(2009-12#1)(2010-10#1)(2010-6#1)(2012-2#1)
be changed to##2##3##(1991-12#1)(1991-6#1)
be changed##6##2##(1991-12#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)
be characterized as##9##3##(1996-11#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#2)(2013-8#1)
be characterized by a##4##4##(1990-4#1)(1996-3#1)(2008-11#1)(2012-2#1)
be characterized by##14##3##(1990-4#1)(1991-3#1)(1992-12#2)(1996-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2012-2#1)(2013-8#2)
be characterized##28##2##(1990-4#1)(1991-3#1)(1992-12#2)(1996-11#1)(1996-3#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-8#5)
be checked##2##2##(1990-8#1)(2008-10#1)
be chemically##3##2##(1994-5#1)(2008-10#1)(2008-12#1)
be chosen##4##2##(1990-11#1)(1992-3#1)(1995-5#1)(2013-8#1)
be clarified##3##2##(2008-11#1)(2009-6#1)(2011-2#1)
be classified as##8##3##(1990-11#1)(1993-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)
be classified in##2##3##(2008-4#1)(2011-10#1)
be classified into##10##3##(1992-7#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-3#1)(2013-1#1)
be classified##27##2##(1990-11#1)(1992-7#1)(1993-1#1)(1996-6#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-10#1)(2011-2#1)(2011-3#1)(2013-1#1)
be cleaned##2##2##(2008-10#1)(2008-11#1)
be clearly##7##2##(1991-2#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-2#1)
be cleaved by##2##3##(1991-3#1)(2008-5#1)
be cleaved##4##2##(1991-3#1)(1993-12#1)(2008-5#1)(2009-6#1)
be clinical##2##2##(1994-12#1)(2010-9#1)
be clinically##5##2##(1992-3#1)(1995-5#1)(2009-11#1)(2010-10#1)(2010-12#1)
be cloned##4##2##(1997-2#1)(2008-4#3)
be close to##7##3##(1990-11#1)(1995-11#1)(1995-3#1)(2008-10#2)(2009-5#1)(2010-6#1)
be closely linked##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
be closely related##2##3##(2008-10#1)(2012-3#1)
be closely##8##2##(1995-6#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-3#1)
be coated with##2##3##(1997-2#1)(2008-10#1)
be collected and##4##3##(2008-10#2)(2008-9#1)(2010-8#1)
be collected##7##2##(2008-10#2)(2008-12#2)(2008-9#1)(2010-8#1)(2011-2#1)
be combined in##2##3##(2008-3#1)(2009-3#1)
be combined with a##2##4##(1995-12#1)(2011-2#1)
be combined with other##2##4##(2008-10#1)(2008-11#1)
be combined with##11##3##(1995-12#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2011-2#2)(2013-1#2)
be combined##17##2##(1995-12#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-1#2)
be common to##2##3##(1991-7#1)(2008-1#1)
be common##4##2##(1991-7#1)(2008-1#1)(2008-10#1)(2008-12#1)
be compared to##3##3##(1995-2#1)(2008-7#1)(2010-6#1)
be compared with the##2##4##(1992-2#1)(2008-10#1)
be compared with##6##3##(1992-2#1)(1993-8#1)(1994-3#1)(2008-10#3)
be compared##17##2##(1991-6#1)(1992-2#1)(1993-8#1)(1994-3#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)(2013-1#1)
be compatible##4##2##(2008-10#3)(2008-7#1)
be compensated by##5##3##(1995-5#1)(1995-6#1)(2008-10#2)(2013-8#1)
be compensated##8##2##(1991-2#1)(1995-5#1)(1995-6#1)(2008-10#4)(2013-8#1)
be competent##3##2##(2008-12#1)(2008-5#1)(2010-11#1)
be competitive##2##2##(1993-2#1)(2008-10#1)
be complemented by##2##3##(2011-2#1)(2012-12#1)
be complete or partial##2##4##(1991-6#1)(2010-5#1)
be complete##4##2##(1991-6#1)(2008-11#1)(2010-5#1)(2010-8#1)
be completed in only##2##4##(2008-10#1)(2008-3#1)
be completed in##9##3##(1995-11#1)(2008-10#7)(2008-3#1)
be completed within##3##3##(2008-10#2)(2008-5#1)
be completed##17##2##(1994-3#1)(1995-11#1)(1997-1#1)(2008-10#11)(2008-3#1)(2008-5#1)(2013-8#1)
be completely blocked by##2##4##(2008-8#2)
be completely separated##2##3##(2008-10#2)
be completely##12##2##(1994-12#1)(1995-8#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)
be complex and##2##3##(2012-2#1)(2012-3#1)
be complex##3##2##(1990-11#1)(2012-2#1)(2012-3#1)
be complicated by##4##3##(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)
be complicated##5##2##(1992-11#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)
be composed of##2##3##(1995-11#1)(2008-10#1)
be compromised##3##2##(2008-10#1)(2010-11#1)(2012-2#1)
be concentrated in the##2##4##(1991-12#1)(2008-10#1)
be concentrated##7##2##(1991-12#1)(2008-10#4)(2008-12#1)(2009-8#1)
be concerned##2##2##(1992-1#1)(1992-3#1)
be concluded that the##5##4##(2008-10#4)(2008-5#1)
be concluded that##22##3##(1994-8#1)(1996-11#1)(1996-6#1)(1997-6#2)(2008-10#8)(2008-12#1)(2008-5#1)(2009-8#1)(2011-3#1)(2012-2#4)(2012-9#1)
be concluded##24##2##(1994-12#1)(1994-8#1)(1996-11#1)(1996-6#1)(1997-6#2)(2008-10#8)(2008-12#1)(2008-5#1)(2009-8#1)(2011-3#1)(2012-2#4)(2012-9#1)(2013-1#1)
be conditioned by##3##3##(2008-10#3)
be conducted in##4##3##(1991-9#1)(1993-3#1)(1997-6#1)(2008-12#1)
be conducted to##3##3##(2009-12#1)(2010-11#1)(2010-8#1)
be conducted using##4##3##(1992-3#1)(2008-10#2)(2008-5#1)
be conducted##15##2##(1991-9#1)(1992-3#1)(1993-3#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#1)
be confirmed by##7##3##(1996-2#1)(2008-10#2)(2008-12#2)(2009-12#1)(2012-12#1)
be confirmed##15##2##(1991-3#1)(1993-12#1)(1996-2#1)(2008-10#3)(2008-12#3)(2008-7#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
be confounded by##2##3##(1994-9#1)(2008-10#1)
be confused with##5##3##(1997-3#1)(1997-4#1)(1997-8#1)(2008-9#1)(2011-2#1)
be connected to##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
be connected with##2##3##(2008-10#1)(2008-11#1)
be connected##9##2##(1995-3#1)(2008-10#5)(2008-11#2)(2012-2#1)
be conservative##2##2##(2008-8#1)(2010-12#1)
be considerable##3##2##(2008-8#1)(2010-5#1)(2013-1#1)
be considerably##3##2##(1996-12#1)(1997-4#1)(2008-7#1)
be considered a new##2##4##(1995-12#1)(2008-10#1)
be considered a risk factor for##2##6##(1997-3#1)(2008-11#1)
be considered a valid##2##4##(1991-6#1)(2010-12#1)
be considered a##25##3##(1991-6#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#2)(1997-3#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
be considered an adequate##2##4##(1990-6#1)(1991-12#1)
be considered an##12##3##(1990-6#1)(1991-12#1)(1993-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
be considered as a possible cause##2##6##(2008-10#1)(2008-12#1)
be considered as a possible##3##5##(2008-10#1)(2008-12#1)(2012-12#1)
be considered as a##20##4##(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)
be considered as an##7##4##(1994-3#1)(2008-10#2)(2008-4#1)(2011-2#2)(2013-1#1)
be considered as the##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
be considered as useful##2##4##(2008-10#1)(2008-11#1)
be considered as##51##3##(1990-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(2007-12#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
be considered at##4##3##(2008-11#1)(2009-7#1)(2009-8#1)(2012-6#1)
be considered by##3##3##(1993-11#1)(1994-1#1)(2011-2#1)
be considered for##10##3##(1993-11#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#3)(2013-8#1)
be considered if the##2##4##(1996-6#1)(2011-2#1)
be considered if##3##3##(1996-6#1)(2009-12#1)(2011-2#1)
be considered in a##2##4##(2008-11#1)(2012-3#1)
be considered in any##4##4##(1993-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
be considered in clinical##2##4##(2008-6#1)(2012-3#1)
be considered in the differential diagnosis of##8##7##(1996-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#2)
be considered in the differential diagnosis##11##6##(1996-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-8#1)
be considered in the##15##4##(1996-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#3)(2013-8#2)
be considered in##46##3##(1990-3#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-9#1)(1996-11#1)(1997-2#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#8)(2012-3#6)(2013-1#1)(2013-8#2)
be considered to be a##3##5##(2008-5#1)(2008-8#1)(2012-3#1)
be considered to be##5##4##(1992-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-3#1)
be considered to##10##3##(1992-11#1)(1994-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-3#1)
be considered when determining##2##4##(1993-2#1)(2008-11#1)
be considered when developing##2##4##(2008-10#1)(2008-11#1)
be considered when##22##3##(1993-2#2)(1993-6#1)(1994-5#1)(1995-1#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
be considered within##2##3##(1990-6#1)(2008-12#1)
be considered##255##2##(1990-3#1)(1990-6#3)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-1#2)(1995-12#3)(1995-5#1)(1996-11#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-8#3)(2007-12#3)(2008-1#1)(2008-10#50)(2008-11#19)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#34)(2011-3#1)(2012-12#6)(2012-2#1)(2012-3#9)(2012-6#1)(2013-1#5)(2013-8#5)
be consistent with the##2##4##(2008-11#1)(2008-3#1)
be consistent with##7##3##(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)
be consistent##9##2##(1995-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2009-12#1)
be consistently##3##2##(2008-10#2)(2012-3#1)
be constant##2##2##(1991-5#1)(2008-10#1)
be constructed##8##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)
be contaminated##4##2##(1994-3#1)(2008-10#1)(2008-11#2)
be continued for##3##3##(1990-9#1)(1992-11#1)(1994-9#1)
be continued##6##2##(1990-11#1)(1990-9#1)(1992-11#1)(1994-9#1)(2008-8#1)(2010-1#1)
be continuously used##2##3##(2008-10#2)
be continuously##5##2##(1991-11#1)(2008-10#3)(2008-4#1)
be controlled by##13##3##(1993-6#1)(1994-3#1)(1995-12#1)(2008-10#6)(2008-5#1)(2009-7#1)(2011-2#2)
be controlled or##2##3##(1992-3#1)(1993-3#1)
be controlled with##4##3##(1997-1#1)(2008-11#1)(2008-7#1)(2009-8#1)
be controlled##34##2##(1992-3#1)(1993-3#2)(1993-6#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#4)
be convenient##2##2##(2008-11#1)(2008-4#1)
be converted to##3##3##(2008-10#3)
be converted##6##2##(1996-5#1)(2008-10#4)(2011-3#1)
be correct##3##2##(2008-6#1)(2008-7#2)
be corrected for##2##3##(1996-12#1)(2008-10#1)
be corrected##5##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2009-7#1)
be correlated to the##2##4##(2008-10#1)(2008-11#1)
be correlated to##4##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
be correlated with a##2##4##(1991-6#1)(1996-12#1)
be correlated with the##7##4##(1991-12#1)(1991-6#1)(1992-6#1)(1995-11#1)(2007-12#1)(2008-10#2)
be correlated with their##2##4##(2008-10#1)(2008-9#1)
be correlated with##12##3##(1991-12#1)(1991-6#2)(1992-6#1)(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-9#1)
be correlated##17##2##(1991-12#1)(1991-6#2)(1992-6#1)(1993-3#1)(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)
be cost-effective##2##2##(1997-7#1)(2012-12#1)
be covalently bound##3##3##(1990-2#1)(1993-6#1)(2008-10#1)
be covalently##4##2##(1990-2#1)(1993-6#1)(2008-10#1)(2008-5#1)
be covered##5##2##(1991-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
be created by##2##3##(2008-4#1)(2011-2#1)
be created##5##2##(2008-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
be critical for##6##3##(1995-5#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-7#1)
be critical to the##2##4##(2008-10#1)(2013-8#1)
be critical##10##2##(1995-5#1)(1995-6#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-7#1)(2013-8#1)
be critically##4##2##(1994-6#1)(2008-1#1)(2008-10#2)
be crucial for##2##3##(2009-6#2)
be crucial to##2##3##(2008-10#1)(2008-12#1)
be crucial##8##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#2)(2011-2#1)(2012-5#1)
be cultured in##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
be cultured##6##2##(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
be curative##3##2##(1997-2#1)(2010-10#1)(2012-12#1)
be cured by##2##3##(1995-6#1)(1996-11#1)
be cured##6##2##(1991-9#1)(1995-6#1)(1996-11#1)(1996-6#1)(2010-4#1)(2010-8#1)
be dangerous to life##2##4##(2011-2#2)
be dealt with##2##3##(1991-3#1)(1996-2#1)
be debated##3##2##(1995-5#1)(2008-11#1)(2008-8#1)
be decreased by##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
be decreased##11##2##(1993-3#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-10#1)(2012-2#2)(2012-3#1)
be deduced that the##2##4##(2008-10#2)
be deduced##5##2##(2007-12#1)(2008-10#3)(2008-2#1)
be deficient##3##2##(2008-10#1)(2008-11#1)(2009-4#1)
be defined and##3##3##(1991-12#1)(2012-2#1)(2013-1#1)
be defined as the##2##4##(2008-1#1)(2008-8#1)
be defined as##6##3##(1993-6#1)(2008-1#1)(2008-4#1)(2008-8#2)(2012-12#1)
be defined by##2##3##(2008-8#1)(2010-6#1)
be defined for##2##3##(1995-12#1)(2008-10#1)
be defined##21##2##(1991-12#1)(1993-12#1)(1993-6#1)(1995-12#2)(1996-6#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#3)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
be degraded##5##2##(2008-10#2)(2008-5#2)(2011-2#1)
be deleterious##2##2##(2008-10#1)(2011-2#1)
be delineated##2##2##(1996-2#1)(2013-8#1)
be delivered to##4##3##(1993-9#1)(2008-3#1)(2008-5#1)(2010-7#1)
be delivered##11##2##(1993-9#1)(1995-5#1)(1997-1#2)(2008-11#3)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)
be demonstrated to##3##3##(1992-12#1)(1995-2#1)(2012-2#1)
be demonstrated using##2##3##(2008-10#1)(2008-5#1)
be demonstrated##20##2##(1990-11#1)(1990-3#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-11#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#2)
be dependent on the##9##4##(1991-3#1)(1991-5#1)(1995-1#1)(1995-6#1)(2008-10#2)(2008-11#2)(2011-2#1)
be dependent on##17##3##(1991-3#1)(1991-5#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(2008-10#4)(2008-11#3)(2011-2#2)
be dependent upon##5##3##(1997-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
be dependent##23##2##(1991-3#1)(1991-5#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#4)(2011-2#3)
be depleted##3##2##(1991-3#1)(2008-5#1)(2008-7#1)
be deposited##4##2##(1996-9#2)(2008-10#1)(2008-11#1)
be depressed##2##2##(2007-11#1)(2008-10#1)
be derived for##3##3##(2008-10#3)
be derived from a##4##4##(1996-2#1)(1997-6#1)(2008-11#1)(2009-6#1)
be derived from the##3##4##(1991-12#1)(2008-11#1)(2008-7#1)
be derived from##21##3##(1991-12#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#1)(2009-6#4)(2012-2#1)(2012-3#1)
be derived##32##2##(1990-11#1)(1991-12#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-6#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#4)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
be described as a##4##4##(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)
be described by a##6##4##(2008-10#4)(2008-7#2)
be described by the##3##4##(1991-5#1)(2008-10#1)(2013-1#1)
be described by##9##3##(1991-5#1)(2008-10#5)(2008-7#2)(2013-1#1)
be described##24##2##(1991-5#1)(1995-3#2)(1997-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-4#1)(2011-3#1)(2013-1#1)
be designated##5##2##(2008-10#5)
be designed to##3##3##(1996-2#1)(2008-11#1)(2008-4#1)
be designed##10##2##(1996-1#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2012-2#1)
be desirable to##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
be desirable##4##2##(1993-1#1)(2008-11#1)(2008-4#1)(2013-1#1)
be desorbed with##4##3##(2008-10#4)
be desorbed##5##2##(2008-10#4)(2008-7#1)
be detected after##2##3##(1995-11#1)(2008-10#1)
be detected among##2##3##(2008-10#2)
be detected and##9##3##(2008-10#7)(2008-11#1)(2008-9#1)
be detected as##4##3##(1993-8#1)(1995-12#1)(2008-10#2)
be detected at##5##3##(1996-2#1)(2008-10#3)(2008-6#1)
be detected by UV##2##4##(2008-10#2)
be detected by##20##3##(1990-9#1)(1991-3#1)(1994-9#1)(1996-12#2)(1997-2#1)(2008-10#5)(2008-4#4)(2008-9#2)(2009-6#1)(2010-12#1)(2013-1#1)
be detected directly##2##3##(1993-9#1)(2008-12#1)
be detected for##2##3##(1995-2#1)(2008-10#1)
be detected in the##14##4##(1990-5#1)(1993-6#1)(1994-12#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#3)
be detected in##43##3##(1990-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-6#2)(1997-5#1)(2007-11#1)(2008-10#16)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#6)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
be detected on##2##3##(1994-6#1)(2008-7#1)
be detected using##2##3##(2007-12#1)(2009-7#1)
be detected with the##2##4##(1991-3#1)(2008-10#1)
be detected with##7##3##(1991-3#1)(2008-10#4)(2008-8#1)(2010-1#1)
be detected##141##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#4)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#3)(1996-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#54)(2008-11#4)(2008-12#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#5)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
be determined accurately##2##3##(2008-10#1)(2008-5#1)
be determined by the##5##4##(2008-10#4)(2008-3#1)
be determined by this##2##4##(2008-10#2)
be determined by##25##3##(1990-8#1)(1996-3#1)(2008-10#17)(2008-11#1)(2008-3#3)(2009-11#1)(2012-12#1)
be determined directly##4##3##(2008-10#3)(2008-11#1)
be determined during##2##3##(1995-6#1)(2008-10#1)
be determined from the##2##4##(2008-10#1)(2011-2#1)
be determined from##4##3##(2008-10#3)(2011-2#1)
be determined in an##2##4##(2008-10#1)(2010-3#1)
be determined in the concentration##2##5##(2008-10#2)
be determined in the presence of##4##6##(2008-10#4)
be determined in the##17##4##(2008-10#17)
be determined in##36##3##(1992-5#1)(2008-10#32)(2008-11#1)(2010-3#1)(2012-2#1)
be determined indirectly##3##3##(2008-10#3)
be determined over##3##3##(2008-10#2)(2008-7#1)
be determined simultaneously with the concentration ratios of##3##8##(2008-10#3)
be determined simultaneously with##4##4##(2008-10#4)
be determined simultaneously##9##3##(2008-10#9)
be determined using##4##3##(2008-10#4)
be determined with a##4##4##(2008-10#4)
be determined with##10##3##(2008-10#10)
be determined without##2##3##(2008-10#2)
be determined##161##2##(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#110)(2008-11#6)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
be detrimental to##4##3##(1992-2#1)(2008-11#1)(2008-12#1)(2008-8#1)
be detrimental##6##2##(1992-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
be devastating##2##2##(2011-2#1)(2012-3#1)
be developed and##2##3##(2008-10#1)(2008-11#1)
be developed as a##2##4##(2008-8#1)(2011-3#1)
be developed as##3##3##(2008-8#1)(2011-2#1)(2011-3#1)
be developed for##3##3##(2008-10#3)
be developed in order to##2##5##(1993-11#1)(2008-11#1)
be developed in##3##3##(1993-11#1)(2008-11#1)(2008-5#1)
be developed to##6##3##(1992-12#1)(2008-11#2)(2008-3#1)(2011-1#1)(2013-1#1)
be developed##45##2##(1992-12#2)(1993-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-4#1)(1997-5#1)(2008-10#9)(2008-11#8)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-8#1)(2010-11#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
be diagnosed in##2##3##(1990-3#1)(1991-3#1)
be diagnosed##9##2##(1990-3#1)(1990-9#1)(1991-3#1)(1996-11#1)(1997-8#1)(2009-1#1)(2010-6#1)(2010-9#1)(2013-8#1)
be differences in##2##3##(2008-8#1)(2012-12#1)
be different for different##2##4##(2008-10#1)(2012-2#1)
be different from##7##3##(1996-2#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-10#1)(2010-4#1)
be different than##2##3##(1996-12#1)(2008-10#1)
be different##17##2##(1993-12#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-4#1)(2012-2#1)
be differentially##5##2##(1995-2#2)(2008-10#2)(2009-9#1)
be differentiated by##3##3##(2008-10#2)(2012-3#1)
be differentiated from other##2##4##(2008-12#1)(2010-6#1)
be differentiated from##3##3##(2008-12#1)(2010-6#1)(2011-1#1)
be differentiated into##2##3##(2008-11#1)(2008-9#1)
be differentiated##14##2##(1991-2#1)(1996-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-3#1)
be difficult and##2##3##(2008-12#1)(2010-11#1)
be difficult or##2##3##(1997-3#1)(1997-8#1)
be difficult to achieve##2##4##(1992-3#1)(2013-1#1)
be difficult to obtain##2##4##(1991-2#1)(2008-10#1)
be difficult to##10##3##(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#2)
be difficult##30##2##(1990-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
be diluted##2##2##(2008-10#2)
be directed at##2##3##(1997-8#1)(2013-8#1)
be directed toward##2##3##(1993-2#1)(1996-1#1)
be directed##8##2##(1993-2#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-8#1)
be directly involved in the##2##5##(1993-8#1)(1995-12#1)
be directly##19##2##(1992-3#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(2008-1#1)(2008-10#8)(2008-7#1)(2010-1#1)(2010-8#1)(2012-3#1)
be discerned##2##2##(2008-10#1)(2011-2#1)
be disclosed##4##2##(1991-3#1)(2008-10#1)(2009-4#2)
be discounted##4##2##(1990-6#1)(2008-8#1)(2013-1#2)
be discovered and##2##3##(2008-10#1)(2011-2#1)
be discovered##7##2##(1995-12#1)(1996-11#1)(2008-10#2)(2009-8#1)(2011-2#2)
be discriminated##4##2##(2008-10#4)
be discussed with##2##3##(1997-5#1)(2009-3#1)
be discussed##36##2##(1995-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
be disregarded##2##2##(2008-10#1)(2012-3#1)
be disrupted##3##2##(1994-11#1)(2008-10#1)(2009-10#1)
be disseminated by##2##3##(2008-10#1)(2013-8#1)
be disseminated##3##2##(1993-12#1)(2008-10#1)(2013-8#1)
be dissociated from##3##3##(1993-8#1)(1995-6#1)(2013-8#1)
be dissociated##6##2##(1993-6#1)(1993-8#1)(1995-6#1)(2008-8#2)(2013-8#1)
be dissolved##3##2##(2008-10#3)
be distinct##4##2##(2006-6#1)(2008-10#2)(2009-10#1)
be distinguished by##6##3##(1993-8#1)(1993-9#1)(2008-10#1)(2008-11#1)(2011-2#2)
be distinguished from each other##3##5##(2008-10#1)(2008-4#1)(2009-5#1)
be distinguished from##11##3##(1992-2#1)(1994-9#1)(2008-10#4)(2008-4#1)(2009-3#1)(2009-5#1)(2012-2#1)(2013-1#1)
be distinguished on the##2##4##(1993-8#1)(2008-10#1)
be distinguished##37##2##(1992-2#1)(1993-8#2)(1993-9#1)(1994-9#1)(1996-9#1)(1997-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
be distributed##3##2##(1990-5#1)(1993-11#1)(2008-10#1)
be divided in##2##3##(1996-12#1)(2012-9#1)
be divided into at least##2##5##(1995-11#1)(2008-10#1)
be divided into four##3##4##(1997-8#1)(2008-10#1)(2009-8#1)
be divided into two##10##4##(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
be divided into##27##3##(1990-5#1)(1995-11#1)(1995-12#1)(1997-8#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
be divided##30##2##(1990-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-8#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2011-2#1)(2012-9#1)(2013-1#1)
be documented##2##2##(1991-3#1)(1996-11#1)
be dominated by##3##3##(1992-9#1)(2008-9#1)(2011-2#1)
be done at##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2010-7#1)
be done in##6##3##(1994-8#1)(1997-1#1)(1997-2#1)(2008-10#2)(2009-7#1)
be done through the##2##4##(2008-10#1)(2012-12#1)
be done to ensure##2##4##(1991-1#1)(1992-11#1)
be done to##9##3##(1991-1#1)(1992-11#1)(1996-8#1)(2008-10#2)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)
be dose##3##2##(1992-5#1)(2008-5#1)(2013-1#1)
be downloaded and run##2##4##(2008-4#1)(2008-9#1)
be downloaded##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
be drawn from##9##3##(1991-12#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-12#1)(2013-8#1)
be drawn##17##2##(1991-12#1)(1992-3#1)(1993-12#1)(1995-5#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2010-12#1)(2013-8#1)
be driven by the##2##4##(1993-9#1)(2010-1#1)
be driven by##4##3##(1993-9#1)(2008-8#1)(2008-9#1)(2010-1#1)
be due in##2##3##(1993-11#1)(1995-9#1)
be due to a##7##4##(1993-1#1)(1993-8#1)(1994-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
be due to an##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
be due to inadequate##3##4##(1993-9#1)(2008-10#1)(2012-3#1)
be due to its##2##4##(1993-3#1)(2012-2#1)
be due to the fact that##2##6##(2008-11#1)(2008-9#1)
be due to the##21##4##(1991-2#1)(1992-9#1)(1993-2#1)(1996-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-3#1)(2013-1#1)
be due to their##2##4##(2011-2#1)(2012-2#1)
be due to##84##3##(1990-2#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-3#2)(2008-10#23)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#2)
be due##93##2##(1990-2#2)(1991-12#1)(1991-2#3)(1991-3#1)(1992-12#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-3#3)(1997-7#1)(2008-10#23)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#2)
be durable##3##2##(2008-10#2)(2012-12#1)
be early##2##2##(2008-11#1)(2010-6#1)
be easily achieved##5##3##(2008-10#4)(2008-9#1)
be easily and##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
be easily detected##3##3##(2006-6#1)(2008-10#1)(2008-3#1)
be easily distinguished from##2##4##(2008-10#2)
be easily obtained##2##3##(2009-3#1)(2011-2#1)
be easily performed##2##3##(2008-10#1)(2011-2#1)
be easily regenerated and##2##4##(2008-10#2)
be easily regenerated##3##3##(2008-10#3)
be easily separated##3##3##(2008-10#3)
be easily##70##2##(1990-12#1)(1994-11#2)(1994-3#2)(1995-8#1)(1996-9#1)(2006-6#1)(2007-12#1)(2008-10#38)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
be ecologically##2##2##(2008-11#1)(2008-8#1)
be effective for the##2##4##(1997-6#1)(2008-11#1)
be effective for##7##3##(1997-6#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-1#1)
be effective in obtaining##2##4##(1992-9#1)(2006-6#1)
be effective in preventing##3##4##(1992-3#1)(1995-3#1)(2010-7#1)
be effective in##22##3##(1992-12#2)(1992-3#1)(1992-9#1)(1995-3#1)(1997-1#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#3)(2013-1#3)
be effective to##2##3##(2008-11#1)(2012-2#1)
be effective##54##2##(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-6#1)(2008-10#7)(2008-11#8)(2008-12#2)(2008-6#1)(2008-7#3)(2009-10#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#4)(2013-8#1)
be effectively##13##2##(1992-9#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-8#1)
be efficient##10##2##(1995-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
be efficiently##11##2##(2008-10#3)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#2)
be either##11##2##(1995-11#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
be elaborated##2##2##(2008-10#2)
be elevated##2##2##(2010-9#1)(2013-8#1)
be elicited by##4##3##(1992-8#1)(2008-11#2)(2013-8#1)
be eliminated by addition of##2##5##(2008-10#1)(2008-8#1)
be eliminated by using##2##4##(2008-10#2)
be eliminated by##12##3##(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)
be eliminated##26##2##(1992-1#1)(1994-2#1)(1994-3#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2013-8#1)
be elucidated##13##2##(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-4#1)(2008-9#1)(2009-7#2)(2009-8#1)(2011-2#1)(2013-1#2)
be eluted by##2##3##(2008-10#2)
be eluted from##2##3##(2008-10#2)
be eluted##8##2##(2008-10#8)
be emphasized##4##2##(1993-12#1)(1996-3#1)(2008-4#1)(2011-3#1)
be employed as a##3##4##(2008-10#3)
be employed as##4##3##(2008-1#1)(2008-10#3)
be employed for the##3##4##(2008-10#2)(2009-7#1)
be employed for##8##3##(1992-5#1)(2008-10#4)(2008-12#1)(2009-7#1)(2012-3#1)
be employed in the##2##4##(1990-12#1)(2008-12#1)
be employed in##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-2#1)
be employed to##8##3##(2008-10#1)(2008-11#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-7#1)(2013-1#1)
be employed##39##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-6#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#2)
be emulated##2##2##(2008-6#1)(2013-8#1)
be encoded by##2##3##(2013-8#2)
be encountered by##2##3##(2008-11#1)(2012-2#1)
be encountered##7##2##(1996-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#3)
be encouraged by##2##3##(1991-8#1)(2008-10#1)
be encouraged to##4##3##(1993-2#1)(2008-11#1)(2010-11#1)(2012-3#1)
be encouraged##10##2##(1991-8#1)(1993-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2010-11#2)(2011-2#1)(2012-3#1)
be engaged in##2##3##(1995-12#1)(2008-12#1)
be engaged##3##2##(1995-12#1)(2008-12#2)
be engineered to##3##3##(2010-7#1)(2011-2#1)(2012-3#1)
be engineered##4##2##(2008-11#1)(2010-7#1)(2011-2#1)(2012-3#1)
be enhanced by the addition of##3##6##(2007-11#1)(2008-10#2)
be enhanced by the##4##4##(2007-11#1)(2008-10#3)
be enhanced by##14##3##(1993-2#1)(1994-6#1)(1996-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)
be enhanced##21##2##(1993-2#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-9#1)(2009-7#1)(2012-3#1)
be enrolled##3##2##(1994-2#1)(2008-11#1)(2008-5#1)
be entirely##3##2##(2008-10#3)
be entitled to##2##3##(1993-12#1)(1994-3#1)
be equal to the##2##4##(2008-10#1)(2009-12#1)
be equal to##6##3##(1991-5#1)(2008-10#3)(2009-12#1)(2010-12#1)
be equally important##2##3##(1993-11#1)(1993-2#1)
be equally##7##2##(1993-11#1)(1993-2#1)(1993-6#1)(1996-2#1)(2008-11#1)(2010-7#1)(2011-2#1)
be equivalent to a##2##4##(2008-10#1)(2012-3#1)
be equivalent to##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
be equivalent##6##2##(1996-2#1)(2008-10#3)(2008-11#1)(2012-3#1)
be eradicated##2##2##(1994-9#1)(2008-11#1)
be especially useful##2##3##(2007-11#1)(2008-10#1)
be especially##9##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-7#1)
be essential for the##3##4##(1990-5#1)(1993-12#1)(2008-5#1)
be essential for##23##3##(1990-5#1)(1992-12#1)(1993-12#2)(1995-11#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#5)(2012-2#2)
be essential to##2##3##(2008-10#1)(2008-8#1)
be essential##28##2##(1990-5#1)(1992-12#1)(1993-12#2)(1995-11#2)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#3)
be established between the##2##4##(2008-10#2)
be established between##4##3##(2008-10#3)(2008-9#1)
be established if##2##3##(1994-12#1)(2008-7#1)
be established in##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
be established##36##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
be estimated as##2##3##(2008-10#1)(2008-11#1)
be estimated by##3##3##(2008-10#2)(2008-7#1)
be estimated from the##2##4##(1996-3#1)(2008-8#1)
be estimated from##4##3##(1996-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
be estimated with##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
be estimated##18##2##(1992-2#1)(1992-6#1)(1992-9#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#1)(2011-2#1)
be evaluated and##2##3##(2008-10#2)
be evaluated before##2##3##(2008-10#1)(2008-8#1)
be evaluated by##4##3##(1997-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
be evaluated carefully##3##3##(2006-5#1)(2009-2#1)(2012-3#1)
be evaluated for##2##3##(2011-2#1)(2012-12#1)
be evaluated in##5##3##(1991-8#1)(1992-2#1)(2008-10#2)(2010-11#1)
be evaluated to##4##3##(2008-10#1)(2008-9#2)(2013-7#1)
be evaluated##45##2##(1990-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-6#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-5#2)(2007-11#1)(2008-1#1)(2008-10#13)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
be evidence##2##2##(1997-1#1)(1997-8#1)
be evidenced##2##2##(2008-10#1)(2012-3#1)
be evolutionarily stable##3##3##(2008-8#2)(2008-9#1)
be evolutionarily##4##2##(2008-8#2)(2008-9#1)(2012-3#1)
be examined in##3##3##(1990-12#1)(2008-11#1)(2013-1#1)
be examined##12##2##(1990-12#2)(1993-11#1)(1994-8#1)(1995-11#1)(1996-1#1)(2008-1#1)(2008-11#2)(2008-9#1)(2013-1#2)
be exceeded##2##2##(2008-10#2)
be excluded##14##2##(1990-9#1)(1991-11#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-8#1)
be exercised##2##2##(1993-6#1)(2008-11#1)
be expanded to##3##3##(1991-9#1)(2008-10#1)(2013-1#1)
be expanded##8##2##(1991-9#1)(1993-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
be expected for##2##3##(1997-6#1)(2011-2#1)
be expected in the##2##4##(1996-2#1)(2007-12#1)
be expected in##6##3##(1996-2#1)(2007-12#1)(2008-10#3)(2013-8#1)
be expected only if##2##4##(2008-2#1)(2008-3#1)
be expected to increase##2##4##(1996-11#1)(2008-11#1)
be expected to##15##3##(1992-12#1)(1993-1#1)(1994-5#1)(1995-1#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-1#1)
be expected when##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2012-7#1)
be expected##46##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#1)
be expensive##3##2##(1990-3#1)(1994-1#1)(2008-11#1)
be explained adequately by##2##4##(1994-8#1)(2008-9#1)
be explained by a##7##4##(1990-11#1)(1993-1#1)(1993-8#1)(2008-1#1)(2008-10#3)
be explained by an##3##4##(1994-5#1)(2008-5#1)(2008-9#1)
be explained by differences##2##4##(2008-8#1)(2009-7#1)
be explained by its##2##4##(1995-11#1)(2008-10#1)
be explained by the##13##4##(1990-5#1)(1992-12#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-1#1)(2010-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
be explained by##47##3##(1990-11#1)(1990-5#1)(1992-12#2)(1993-1#2)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
be explained in terms of##5##5##(1990-8#1)(1991-3#1)(1993-8#1)(1997-2#1)(2008-10#1)
be explained in##6##3##(1990-8#2)(1991-3#1)(1993-8#1)(1997-2#1)(2008-10#1)
be explained on##2##3##(1990-5#1)(1996-2#1)
be explained with##2##3##(1996-3#1)(2008-10#1)
be explained##76##2##(1990-11#1)(1990-5#2)(1990-8#2)(1991-3#1)(1992-12#2)(1992-2#1)(1993-1#2)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#19)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
be exploited as##2##3##(2008-10#1)(2013-1#1)
be exploited for##2##3##(2008-10#1)(2012-2#1)
be exploited to##8##3##(2008-10#3)(2008-3#1)(2008-6#1)(2009-6#1)(2011-2#1)(2013-7#1)
be exploited##17##2##(1993-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
be explored##11##2##(1991-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
be exposed##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
be expressed as##6##3##(2008-10#3)(2008-11#2)(2008-7#1)
be expressed by a##2##4##(1992-11#1)(2008-10#1)
be expressed by##4##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
be expressed in the##3##4##(2008-11#1)(2008-8#1)(2010-5#1)
be expressed in##10##3##(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-5#2)(2011-1#2)
be expressed##34##2##(1991-6#1)(1992-10#1)(1992-11#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-10#8)(2008-11#7)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2010-5#2)(2011-1#2)(2012-12#1)
be extended from##2##3##(2008-10#2)
be extended to the##2##4##(2008-10#2)
be extended to##9##3##(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-7#1)(2012-3#1)
be extended##19##2##(1990-8#1)(1994-6#1)(1996-3#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-7#1)(2010-8#1)(2012-3#1)
be extensive##2##2##(2008-10#2)
be extensively##3##2##(2008-10#1)(2008-8#1)(2009-11#1)
be extracted by##2##3##(2008-10#2)
be extracted from the##3##4##(1997-6#1)(2008-10#1)(2008-11#1)
be extracted from##5##3##(1997-6#1)(2008-10#2)(2008-11#1)(2010-11#1)
be extracted into##2##3##(2008-10#2)
be extracted##15##2##(1997-6#1)(2008-10#12)(2008-11#1)(2010-11#1)
be extremely difficult##3##3##(1995-6#1)(1996-1#1)(2008-10#1)
be extremely sensitive to##2##4##(1996-2#1)(1997-6#1)
be extremely sensitive##3##3##(1996-2#1)(1997-6#1)(2008-10#1)
be extremely useful##2##3##(2008-12#1)(2008-2#1)
be extremely##12##2##(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
be fabricated##2##2##(2008-10#1)(2010-4#1)
be faced##3##2##(1991-2#1)(1997-2#1)(2012-2#1)
be facilitated by##5##3##(1992-12#1)(1995-1#1)(1995-12#1)(2008-5#1)(2008-8#1)
be facilitated through##2##3##(2008-10#1)(2008-11#1)
be facilitated##13##2##(1992-12#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)
be familiar with the##2##4##(2008-2#1)(2012-2#1)
be familiar with##4##3##(1994-5#1)(2008-11#1)(2008-2#1)(2012-2#1)
be familiar##5##2##(1994-5#1)(2008-11#1)(2008-2#1)(2012-12#1)(2012-2#1)
be far more##2##3##(2008-8#1)(2012-2#1)
be far##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2012-2#1)
be favorable##2##2##(1997-8#1)(2008-10#1)
be favored by##2##3##(2008-8#1)(2008-9#1)
be favored##4##2##(2008-8#1)(2008-9#3)
be feasible##7##2##(1992-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-7#1)
be feasibly##2##2##(2011-2#1)(2013-1#1)
be filled with##3##3##(1993-1#1)(2008-10#1)(2008-9#1)
be filtered##2##2##(2008-10#2)
be fitted to##2##3##(2008-3#1)(2012-3#1)
be fitted##4##2##(1997-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
be fixed##2##2##(2008-8#1)(2013-1#1)
be focused on##4##3##(1992-12#1)(1996-3#1)(1997-1#1)(2008-10#1)
be folded##2##2##(2008-10#1)(2008-4#1)
be followed by a##2##4##(1994-2#1)(2008-10#1)
be followed by##6##3##(1994-2#1)(2008-10#3)(2008-11#1)(2008-9#1)
be followed up##5##3##(1997-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
be followed##19##2##(1994-2#1)(1995-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
be for##2##2##(2008-10#1)(2013-1#1)
be forced to##4##3##(1994-2#1)(1996-5#3)
be forced##5##2##(1994-2#1)(1996-5#3)(2012-3#1)
be formed in##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
be formed with##2##3##(1994-5#1)(2008-7#1)
be formed##14##2##(1994-5#1)(1995-3#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)
be found at##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
be found by##3##3##(1997-8#1)(2008-10#2)
be found during##2##3##(1990-5#1)(1996-1#1)
be found in medium containing##2##5##(2008-8#2)
be found in the##6##4##(2008-10#3)(2008-11#1)(2008-9#1)(2009-11#1)
be found in##24##3##(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#3)
be found##54##2##(1990-5#1)(1990-6#1)(1991-11#1)(1992-12#1)(1993-12#1)(1993-6#1)(1995-11#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2013-7#1)
be free from##3##3##(2008-10#2)(2010-11#1)
be free of##2##3##(1993-12#1)(2012-2#1)
be free##7##2##(1993-12#2)(1993-8#1)(2008-10#2)(2010-11#1)(2012-2#1)
be fully established##2##3##(2008-11#1)(2008-12#1)
be fully explained by##2##4##(1997-3#1)(2010-8#1)
be fully explained##3##3##(1997-3#1)(2008-11#1)(2010-8#1)
be fully##15##2##(1991-12#1)(1993-3#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-12#2)(2009-10#1)(2010-8#1)(2011-2#2)
be functionally important##2##3##(2008-10#1)(2010-1#1)
be functionally related to##2##4##(2008-10#1)(2008-8#1)
be functionally##9##2##(1995-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-1#1)(2010-10#1)
be further improved by##2##4##(2008-10#1)(2008-11#1)
be further investigated##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
be further##25##2##(1990-8#1)(1994-3#1)(1995-12#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
be gained by##3##3##(2009-10#1)(2009-12#1)(2012-3#1)
be gained##8##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2011-10#1)(2012-3#1)
be generalized to##2##3##(2008-10#1)(2008-11#1)
be generalized##3##2##(2008-10#2)(2008-11#1)
be generated by##2##3##(1995-2#1)(2008-8#1)
be generated in the##2##4##(2008-10#1)(2008-7#1)
be generated in##4##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
be generated to##2##3##(1996-2#1)(2010-5#1)
be generated##15##2##(1991-5#2)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)
be genetically##7##2##(1991-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-9#1)
be given a##4##3##(1994-9#1)(1996-11#1)(1997-3#1)(1997-8#1)
be given in##2##3##(2007-11#1)(2012-2#1)
be given the##3##3##(2008-11#1)(2013-1#2)
be given to the##2##4##(1990-11#1)(2011-1#1)
be given to##9##3##(1990-11#1)(1991-2#1)(1994-9#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#2)
be given##36##2##(1990-11#1)(1991-2#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-9#3)(1995-5#1)(1996-11#3)(1997-2#1)(1997-3#1)(1997-8#3)(2007-11#1)(2008-11#5)(2008-5#1)(2008-9#3)(2009-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
be good##11##2##(1990-6#1)(1992-12#1)(1994-1#1)(1997-8#1)(2008-10#5)(2008-7#1)(2008-9#1)
be granted##2##2##(1996-8#1)(2012-3#1)
be greater in##2##3##(1996-12#1)(2013-1#1)
be greater##11##2##(1990-12#1)(1992-2#1)(1993-6#1)(1994-3#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-2#1)(2013-1#1)
be greatest##2##2##(1996-5#1)(2008-9#1)
be greatly enhanced by##9##4##(2008-10#7)(2008-9#1)(2013-1#1)
be greatly enhanced##11##3##(2008-10#9)(2008-9#1)(2013-1#1)
be greatly##16##2##(2008-10#10)(2008-12#1)(2008-4#1)(2008-9#1)(2009-11#1)(2010-4#1)(2013-1#1)
be grouped##8##2##(1991-2#1)(2008-10#6)(2012-2#1)
be grown in##2##3##(2008-10#2)
be guided by##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
be guided##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
be hampered by##2##3##(1995-2#1)(2008-10#1)
be harmful##2##2##(1997-5#1)(2012-3#1)
be harvested##2##2##(2008-8#1)(2012-2#1)
be hazardous to##2##3##(1992-5#1)(2008-11#1)
be held in##2##3##(1994-6#1)(2011-4#1)
be held##5##2##(1994-6#1)(1995-12#1)(1996-1#1)(2011-4#1)(2012-3#1)
be helpful for##7##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
be helpful in the##4##4##(1992-12#1)(1997-2#1)(1997-8#1)(2011-2#1)
be helpful in##10##3##(1992-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#2)
be helpful to##9##3##(1996-6#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#1)(2010-8#1)
be helpful##31##2##(1992-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
be high##4##2##(1990-3#1)(1990-6#1)(2008-10#1)(2008-8#1)
be higher in##4##3##(1992-9#1)(2008-11#1)(2008-12#1)(2012-12#1)
be higher than##7##3##(1994-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#1)(2013-1#1)
be higher##14##2##(1992-9#1)(1994-11#1)(1996-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
be highlighted##6##2##(1997-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
be highly dependent##2##3##(2008-10#2)
be highly expressed##2##3##(2008-8#1)(2011-2#1)
be highly useful##2##3##(2008-10#1)(2011-1#1)
be highly##35##2##(1990-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-2#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#4)(2009-7#1)(2011-1#1)(2011-2#3)(2012-3#1)
be homogeneous##2##2##(1990-5#1)(1994-5#1)
be homologous to##3##3##(1995-2#1)(2008-8#1)(2009-6#1)
be homologous##5##2##(1991-12#1)(1995-2#1)(1996-12#1)(2008-8#1)(2009-6#1)
be host specific##2##3##(2008-10#2)
be host##3##2##(2008-10#3)
be ideally##2##2##(2008-10#1)(2008-11#1)
be identical to the##3##4##(1993-6#1)(1994-11#1)(1995-6#1)
be identical to##7##3##(1993-6#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#2)
be identical##10##2##(1990-8#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
be identified and##4##3##(1992-2#1)(1994-6#1)(2008-4#1)(2011-1#1)
be identified as##7##3##(1993-3#1)(1997-2#1)(2008-10#3)(2010-4#1)(2012-2#1)
be identified by##5##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#2)
be identified in a##2##4##(2008-10#2)
be identified in##6##3##(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-8#1)
be identified using##5##3##(1995-2#1)(2008-10#2)(2008-9#2)
be identified with##3##3##(1991-11#1)(1997-6#1)(2009-8#1)
be identified##63##2##(1991-11#1)(1991-6#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#3)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#6)(2008-9#2)(2009-12#1)(2009-8#2)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)
be ignored##9##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-5#1)(2013-8#1)
be immobilized##2##2##(2008-10#1)(2008-11#1)
be impaired##5##2##(1990-11#1)(2008-10#1)(2008-7#2)(2010-11#1)
be implanted##2##2##(2008-11#1)(2008-8#1)
be implemented in a##2##4##(1996-1#1)(2007-11#1)
be implemented in##7##3##(1991-2#1)(1996-1#1)(2007-11#1)(2008-11#1)(2011-2#1)(2013-1#2)
be implemented on##3##3##(1993-9#1)(2008-10#1)(2012-12#1)
be implemented to##2##3##(2008-10#1)(2013-1#1)
be implemented##32##2##(1991-2#2)(1992-1#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-3#2)(2010-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
be implicated in the##3##4##(2008-8#1)(2008-9#1)(2009-8#1)
be implicated in##4##3##(1991-3#1)(2008-8#1)(2008-9#1)(2009-8#1)
be implicated##5##2##(1991-3#1)(1992-12#1)(2008-8#1)(2008-9#1)(2009-8#1)
be important factors##3##3##(2008-10#1)(2008-11#2)
be important for the##7##4##(1994-8#1)(1995-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-6#1)
be important for##17##3##(1992-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-10#1)(2011-2#1)
be important in the##9##4##(1990-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
be important in##28##3##(1990-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-8#2)(2010-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
be important to##5##3##(1997-7#1)(2008-10#2)(2009-6#1)(2010-6#1)
be important##70##2##(1990-11#1)(1990-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
be imposed##2##2##(1991-2#1)(2008-10#1)
be impossible##2##2##(1990-12#1)(2008-11#1)
be imprinted##2##2##(2008-11#1)(2011-2#1)
be improved and##2##3##(2008-10#1)(2008-11#1)
be improved by increasing##2##4##(1996-3#1)(2008-10#1)
be improved by using##2##4##(2008-10#1)(2010-7#1)
be improved by##18##3##(1992-2#1)(1993-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
be improved if the##2##4##(2007-12#1)(2013-8#1)
be improved in the##2##4##(2009-3#1)(2013-1#1)
be improved upon##3##3##(1990-5#1)(2008-10#1)(2010-12#1)
be improved with##2##3##(2008-10#1)(2008-7#1)
be improved##47##2##(1990-5#1)(1990-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#3)(2010-12#1)(2010-7#1)(2010-8#3)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
be in a##8##3##(1994-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#3)(2009-3#1)
be in place to##2##4##(2008-11#1)(2008-12#1)
be in place##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
be in the##17##3##(1990-12#1)(1991-2#1)(1994-5#1)(1996-2#1)(1997-4#1)(2008-10#11)(2013-1#1)
be in this##2##3##(2008-10#1)(2008-9#1)
be in##57##2##(1990-12#1)(1991-2#2)(1992-6#1)(1994-5#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#26)(2008-11#5)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
be inactive##4##2##(1996-5#3)(2011-3#1)
be inadequate##6##2##(1993-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#2)
be included as##2##3##(2008-10#1)(2010-11#1)
be included in the differential diagnosis of##3##7##(1997-7#1)(2013-1#1)(2013-8#1)
be included in the differential diagnosis##4##6##(1997-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
be included in the##12##4##(1996-6#1)(1997-7#1)(2008-10#4)(2008-9#1)(2010-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
be included in##17##3##(1996-6#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-9#1)(2010-11#3)(2012-12#1)(2013-1#1)(2013-8#1)
be included##28##2##(1995-5#1)(1996-6#1)(1997-7#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-4#3)(2008-5#1)(2008-9#1)(2010-11#4)(2012-12#1)(2013-1#1)(2013-8#1)
be inconclusive##2##2##(2008-5#1)(2008-7#1)
be incorporated in##4##3##(1996-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
be incorporated into the optical system##2##6##(2008-3#2)
be incorporated into the##9##4##(1992-12#1)(1993-1#1)(1994-3#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-9#1)
be incorporated into##21##3##(1992-12#1)(1993-1#1)(1994-3#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
be incorporated##29##2##(1991-12#1)(1992-12#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2012-12#2)(2012-3#1)(2013-8#1)
be incorrectly##2##2##(2008-10#1)(2009-1#1)
be increased by##6##3##(1991-9#1)(2008-10#3)(2008-11#1)(2008-3#1)
be increased in##7##3##(1990-2#1)(1993-3#1)(1994-8#1)(2008-10#3)(2013-8#1)
be increased to##4##3##(1993-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
be increased##31##2##(1990-2#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
be independent of##9##3##(1991-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-5#1)(2012-2#1)
be independent##10##2##(1990-12#1)(1991-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-5#1)(2012-2#1)
be independently##4##2##(1992-9#1)(2007-12#1)(2012-3#2)
be indicated in the##2##4##(2010-12#1)(2013-1#1)
be indicated##6##2##(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#2)
be indicative of the##2##4##(1991-2#1)(2008-8#1)
be indicative of##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
be indicative##4##2##(1991-2#1)(2008-10#1)(2008-8#1)(2010-7#1)
be indirect##2##2##(2008-10#1)(2008-8#1)
be individualized##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
be individually tailored and##2##4##(2008-10#1)(2011-2#1)
be individually##3##2##(2008-10#2)(2011-2#1)
be induced by a##5##4##(1993-3#1)(1994-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
be induced by##14##3##(1993-3#1)(1994-12#1)(1994-8#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#1)(2009-8#1)(2011-10#1)
be induced in the##2##4##(2008-4#1)(2009-8#1)
be induced in##5##3##(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
be induced##37##2##(1990-7#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#2)(2011-10#1)(2012-2#1)
be infected by##3##3##(2008-10#3)
be infected with##2##3##(1996-9#1)(2008-10#1)
be infected##9##2##(1996-9#1)(2008-10#6)(2008-9#1)(2011-2#1)
be inferred from##4##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
be inferred##10##2##(2008-11#3)(2008-3#2)(2008-5#2)(2008-8#2)(2010-6#1)
be influenced by the##9##4##(1994-5#1)(1996-12#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
be influenced by##28##3##(1990-6#1)(1992-6#1)(1993-6#1)(1994-5#1)(1996-12#2)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
be influenced##31##2##(1990-3#1)(1990-6#1)(1992-6#1)(1993-6#1)(1994-5#1)(1996-12#2)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-8#2)(2008-9#2)(2010-2#1)(2011-2#1)(2013-1#1)
be informative##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-12#1)
be informed by##2##3##(2008-11#1)(2008-6#1)
be informed of the##2##4##(1996-1#1)(2008-8#1)
be informed##5##2##(1992-2#1)(1996-1#1)(2008-11#1)(2008-6#1)(2008-8#1)
be inhibited by a##2##4##(1995-2#1)(1996-2#1)
be inhibited by##10##3##(1993-8#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-11#1)(2008-8#1)(2010-3#1)(2013-8#1)
be inhibited##15##2##(1991-5#1)(1993-8#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#2)(2010-3#1)(2013-8#1)
be inhibitory##3##2##(2008-11#3)
be initiated by##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2012-3#1)
be initiated in##2##3##(1994-2#1)(2011-2#1)
be initiated to##3##3##(2009-9#1)(2011-2#1)(2012-2#1)
be initiated##15##2##(1992-9#1)(1994-2#1)(1994-9#1)(2008-10#3)(2008-11#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
be injected into##2##3##(2008-4#1)(2012-2#1)
be injected##5##2##(2008-10#2)(2008-4#1)(2010-11#1)(2012-2#1)
be inserted into the##2##4##(1994-8#1)(2013-1#1)
be inserted##4##2##(1994-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
be instilled via##2##3##(2008-10#2)
be instrumental in##4##3##(1996-3#1)(2008-10#1)(2008-11#2)
be instrumental##6##2##(1993-11#1)(1996-3#1)(2008-10#1)(2008-11#2)(2012-2#1)
be insufficient##3##2##(2008-8#1)(2008-9#1)(2010-6#1)
be integral##3##2##(1995-8#1)(2010-8#1)(2012-3#1)
be integrated in##2##3##(2008-12#1)(2008-6#1)
be integrated into##3##3##(1993-6#1)(1994-12#1)(1995-2#1)
be integrated to##2##3##(1995-12#1)(2009-12#1)
be integrated with##4##3##(1994-1#1)(2008-10#2)(2008-6#1)
be integrated##12##2##(1993-6#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-6#2)(2009-12#1)(2011-1#1)
be interested in##2##3##(2008-11#1)(2010-10#1)
be interpreted according to##2##4##(2008-5#2)
be interpreted as##6##3##(1991-2#1)(1993-8#1)(1995-3#1)(2008-10#2)(2010-3#1)
be interpreted in terms of##3##5##(1994-5#1)(2008-10#2)
be interpreted in##5##3##(1991-6#1)(1994-5#1)(2008-10#2)(2008-8#1)
be interpreted with##4##3##(1994-12#1)(1997-1#1)(2008-5#1)(2011-1#1)
be interpreted##24##2##(1991-2#1)(1991-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#4)(2008-8#2)(2010-3#1)(2011-1#1)
be introduced into the##2##4##(1996-1#1)(2008-10#1)
be introduced##11##2##(1990-3#1)(1992-1#1)(1996-1#1)(2008-10#3)(2008-3#1)(2008-7#2)(2010-11#1)(2011-3#1)
be invalid##3##2##(1995-2#1)(2013-1#2)
be investigated by##2##3##(1992-5#1)(2008-10#1)
be investigated further##2##3##(2009-12#1)(2010-12#1)
be investigated in##2##3##(2008-10#1)(2008-11#1)
be involved in both##2##4##(1994-2#1)(2008-10#1)
be involved in determining the##3##5##(1990-8#1)(1997-7#1)(2008-10#1)
be involved in its##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
be involved in the expression of##2##6##(2008-5#1)(2013-8#1)
be involved in the induction of##2##6##(2008-10#1)(2008-7#1)
be involved in the pathogenesis of##5##6##(1994-11#1)(1995-5#1)(2008-1#1)(2010-10#1)(2013-8#1)
be involved in the process of##2##6##(1996-12#1)(2008-10#1)
be involved in the regulation of##3##6##(2008-8#1)(2009-8#1)(2010-12#1)
be involved in the##54##4##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-8#2)(2010-10#3)(2010-12#2)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#2)
be involved in##115##3##(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#23)(2008-11#10)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#4)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#3)
be involved with##5##3##(1996-9#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-7#1)
be involved##138##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-12#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#11)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#11)(2008-9#4)(2009-10#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
be irreversible##3##2##(1990-2#1)(1992-9#1)(1995-9#1)
be isolated from##6##3##(1990-8#1)(1996-6#1)(2008-6#1)(2008-9#3)
be isolated##14##2##(1990-8#1)(1996-6#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#3)(2011-2#1)(2012-2#1)
be joined##3##2##(2008-4#3)
be judged##2##2##(2008-9#1)(2012-2#1)
be just##2##2##(1992-11#1)(2008-11#1)
be justified##2##2##(1997-4#1)(2011-1#1)
be kept in mind##8##4##(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
be kept##15##2##(1996-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
be key##2##2##(1992-8#1)(1996-2#1)
be known##2##2##(1997-8#1)(2008-10#1)
be labeled##3##2##(1991-3#1)(2008-9#1)(2011-2#1)
be large##2##2##(2008-3#1)(2008-8#1)
be larger than##4##3##(1997-1#1)(2008-11#1)(2008-3#1)(2010-11#1)
be larger##6##2##(1997-1#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-11#1)
be launched in##3##3##(2008-3#1)(2008-5#2)
be launched##4##2##(2008-3#2)(2008-5#2)
be leading##2##2##(2008-11#1)(2008-12#1)
be learned by##3##3##(1993-12#1)(2008-12#2)
be learned##7##2##(1991-11#1)(1992-2#1)(1993-12#1)(2008-10#1)(2008-12#2)(2008-8#1)
be led by##2##3##(1996-1#1)(2008-10#1)
be left##2##2##(2008-9#1)(2011-2#1)
be less important##3##3##(1990-5#1)(2008-10#1)(2008-7#1)
be less likely to##3##4##(1993-1#1)(2008-9#2)
be less than one##2##4##(1992-9#1)(2008-10#1)
be less than##14##3##(1992-9#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-9#1)(2012-3#1)
be less##39##2##(1990-12#1)(1990-5#1)(1992-12#1)(1992-9#1)(1993-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#5)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
be limited and##2##3##(1995-12#1)(2008-11#1)
be limited to##7##3##(1991-6#1)(1991-9#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-11#1)
be limited##11##2##(1991-6#1)(1991-9#1)(1995-11#1)(1995-12#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)
be linked to the##3##4##(1995-12#1)(2008-7#1)(2012-2#1)
be linked to##15##3##(1991-6#1)(1992-8#1)(1993-1#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
be little##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
be localized to the##2##4##(1995-2#1)(1997-1#1)
be localized##6##2##(1995-2#1)(1995-6#1)(1997-1#1)(2008-5#2)(2009-10#1)
be located at##2##3##(2008-11#1)(2008-6#1)
be located in the##3##4##(1990-2#1)(2008-8#1)(2010-8#1)
be located in##4##3##(1990-2#1)(2008-8#1)(2010-8#1)(2011-2#1)
be located on the##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
be located##15##2##(1990-2#1)(1990-9#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
be longer##2##2##(2010-12#1)(2013-8#1)
be lost in the##2##4##(2008-10#1)(2008-11#1)
be lost##5##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
be low##5##2##(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2011-2#1)
be lower than##2##3##(2008-10#1)(2008-6#1)
be lower##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
be lowered##4##2##(1991-12#1)(1993-12#1)(2008-10#2)
be made and##2##3##(1992-9#1)(2012-2#1)
be made at the##2##4##(2008-10#1)(2008-3#1)
be made available##3##3##(2008-7#1)(2013-1#2)
be made between##3##3##(2008-7#1)(2008-9#1)(2011-1#1)
be made by##4##3##(1992-5#1)(2008-11#1)(2008-12#1)(2008-5#1)
be made in##8##3##(1992-3#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)
be made more##2##3##(1994-9#1)(2012-2#1)
be made on##4##3##(1993-11#1)(2008-8#1)(2008-9#1)(2009-10#1)
be made to##6##3##(1994-5#1)(1996-3#1)(2008-9#2)(2009-5#1)(2013-1#1)
be made when##2##3##(1992-9#1)(2008-4#1)
be made with##4##3##(2008-1#1)(2008-10#2)(2009-8#1)
be made##72##2##(1990-2#1)(1991-1#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-11#1)(1994-1#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-3#2)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#7)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#5)
be mainly related to the##3##5##(2008-11#2)(2008-5#1)
be mainly##8##2##(2008-10#1)(2008-11#2)(2008-5#3)(2012-2#2)
be maintained as##3##3##(2008-4#2)(2008-6#1)
be maintained by##2##3##(2008-10#1)(2008-7#1)
be maintained for##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
be maintained in the##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
be maintained in##7##3##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2013-8#1)
be maintained without##2##3##(2008-9#1)(2009-10#1)
be maintained##28##2##(1993-9#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-10#1)(2013-1#1)(2013-8#1)
be managed##10##2##(1992-2#1)(1992-3#1)(1994-2#2)(2008-10#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
be manipulated by##2##3##(2008-10#2)
be manipulated to##2##3##(2008-10#1)(2009-12#1)
be manipulated##7##2##(1994-3#1)(2008-10#4)(2008-11#1)(2009-12#1)
be many##2##2##(2008-8#1)(2012-3#1)
be mapped##3##2##(1990-5#1)(1996-8#1)(2008-10#1)
be marked##3##2##(1994-5#1)(2008-11#2)
be markedly##2##2##(1993-12#1)(1995-12#1)
be marketed##2##2##(1995-12#1)(1996-9#1)
be masked by##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
be matched##3##2##(2008-10#1)(2008-3#1)(2009-10#1)
be measured and##2##3##(2008-10#1)(2008-11#1)
be measured at##2##3##(2008-10#1)(2008-7#1)
be measured by##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
be measured in a##2##4##(2008-10#1)(2008-9#1)
be measured in the##2##4##(2008-10#2)
be measured in##6##3##(2008-10#5)(2008-9#1)
be measured with an##2##4##(2008-3#1)(2008-4#1)
be measured with##7##3##(2008-10#3)(2008-3#3)(2008-4#1)
be measured##42##2##(1990-12#1)(1992-12#1)(1994-9#1)(2008-10#22)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-7#1)(2012-2#1)(2012-3#1)
be mediated by a##3##4##(1992-8#1)(2008-11#1)(2009-1#1)
be mediated by the##5##4##(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)
be mediated by##24##3##(1990-12#1)(1990-5#1)(1992-8#1)(1994-3#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
be mediated through##5##3##(1991-1#1)(1994-11#1)(1994-3#1)(1995-12#1)(2009-8#1)
be mediated via##2##3##(1990-5#1)(1995-8#1)
be mediated##31##2##(1990-12#1)(1990-5#2)(1991-1#1)(1992-8#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
be met by##3##3##(2008-11#2)(2008-5#1)
be met##14##2##(1991-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-11#5)(2008-5#1)(2012-3#1)(2013-8#1)
be metabolized##2##2##(1992-10#1)(2008-6#1)
be mindful of the##2##4##(2008-11#1)(2011-2#1)
be mindful of##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
be minimized by##5##3##(2008-10#3)(2008-3#1)(2011-2#1)
be minimized in##2##3##(1993-12#1)(2011-2#1)
be minimized##14##2##(1993-12#1)(1995-5#1)(1995-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2011-2#2)(2012-2#2)
be misleading##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2012-2#1)
be missed##3##2##(2008-5#1)(2010-8#1)(2012-2#1)
be modeled##3##2##(2008-10#3)
be modified by##7##3##(1993-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
be modified in##2##3##(1991-2#1)(2008-5#1)
be modified to##2##3##(1994-3#1)(2008-10#1)
be modified##19##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-3#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
be modulated by##4##3##(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
be modulated##8##2##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
be monitored and##2##3##(2013-1#2)
be monitored by##6##3##(1994-5#1)(2008-10#5)
be monitored in##5##3##(1997-1#1)(2008-10#2)(2008-8#1)(2013-8#1)
be monitored with##3##3##(1997-6#1)(2008-10#1)(2012-2#1)
be monitored##28##2##(1994-5#1)(1997-1#1)(1997-6#1)(2008-10#16)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#2)(2013-1#2)(2013-8#1)
be more abundant##2##3##(2008-10#1)(2010-5#1)
be more accurate##2##3##(2008-10#1)(2008-11#1)
be more aggressive##2##3##(1990-2#1)(2008-10#1)
be more appropriate##3##3##(2008-12#1)(2010-2#1)(2011-2#1)
be more clearly##2##3##(2008-11#1)(2008-5#1)
be more complex##2##3##(2008-10#1)(2008-9#1)
be more effective than##2##4##(2008-7#1)(2010-1#1)
be more effective##13##3##(1992-5#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-1#1)(2010-4#2)(2012-2#2)
be more efficient than##2##4##(2008-11#1)(2008-3#1)
be more efficient##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
be more important in##2##4##(2008-8#1)(2013-1#1)
be more important than##2##4##(2009-3#1)(2013-8#1)
be more important##5##3##(2008-8#1)(2009-3#1)(2010-1#1)(2013-1#1)(2013-8#1)
be more likely##2##3##(1993-12#1)(1995-1#1)
be more reliable##2##3##(1996-3#1)(2011-2#1)
be more sensitive##5##3##(1990-12#1)(2008-10#3)(2008-11#1)
be more stable##3##3##(2008-8#1)(2009-10#1)(2009-8#1)
be more suitable for##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
be more suitable##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)
be more susceptible to##2##4##(1992-3#1)(2008-8#1)
be more than##5##3##(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
be more useful##3##3##(1994-8#1)(1997-3#1)(2008-10#1)
be more widespread than##3##4##(1996-3#1)(2008-10#1)(2008-8#1)
be more##140##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-3#3)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#26)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#5)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#7)(2012-7#1)(2013-1#6)(2013-8#2)
be most##13##2##(1993-12#1)(1994-3#1)(1995-1#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
be much more##3##3##(1991-11#1)(1993-2#1)(2008-11#1)
be much##12##2##(1991-11#1)(1993-2#1)(1993-3#1)(2008-10#5)(2008-11#2)(2009-7#1)(2011-2#1)
be multifactorial##2##2##(2007-11#1)(2011-2#1)
be named##4##2##(1995-6#2)(2008-10#2)
be nearly##3##2##(1996-8#1)(2008-10#1)(2008-11#1)
be necessary for##12##3##(1992-3#1)(1993-8#1)(1993-9#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-8#1)
be necessary to##16##3##(1990-3#1)(1991-12#1)(1994-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-7#1)(2012-2#2)
be necessary##37##2##(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-8#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
be needed in##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
be needed to##10##3##(1991-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)
be needed##23##2##(1990-11#1)(1990-6#1)(1991-12#1)(1996-2#1)(1997-5#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2013-1#1)
be neglected##4##2##(2008-11#1)(2008-3#2)(2012-3#1)
be negligible##5##2##(1993-2#1)(1997-7#1)(2008-10#3)
be new##5##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-3#2)
be no##14##2##(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-7#1)(2013-1#1)
be normal##4##2##(1992-9#1)(1996-11#1)(2008-10#1)(2008-11#1)
be not##2##2##(2008-11#1)(2008-7#1)
be notably##2##2##(1992-3#1)(2008-10#1)
be noted##7##2##(1997-5#1)(2008-10#3)(2008-11#1)(2010-6#1)(2011-2#1)
be nurtured##2##2##(1994-12#1)(2008-12#1)
be observed as##2##3##(2008-10#2)
be observed between the##2##4##(1993-1#1)(2007-12#1)
be observed by##2##3##(2008-10#1)(2008-11#1)
be observed from##3##3##(2008-10#3)
be observed in the##3##4##(1996-12#1)(2008-10#1)(2013-7#1)
be observed in##12##3##(1993-2#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-11#1)(2009-12#1)(2013-7#1)
be observed##56##2##(1990-5#2)(1993-1#1)(1993-2#2)(1994-11#1)(1996-12#2)(1996-9#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#15)(2008-11#5)(2008-2#1)(2008-5#4)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
be obtained about the##2##4##(1992-5#1)(1994-5#1)
be obtained after##2##3##(2008-5#1)(2008-8#1)
be obtained by the##3##4##(1991-12#1)(2008-10#2)
be obtained by##21##3##(1991-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)
be obtained directly##2##3##(2008-10#1)(2008-8#1)
be obtained for##2##3##(2008-10#1)(2008-3#1)
be obtained from the##4##4##(2008-10#2)(2008-3#1)(2012-2#1)
be obtained from##9##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
be obtained in##10##3##(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)
be obtained on##2##3##(2008-10#1)(2008-4#1)
be obtained over a##2##4##(2008-3#1)(2008-4#1)
be obtained through a##3##4##(1994-12#1)(2008-12#1)(2008-9#1)
be obtained through##5##3##(1994-12#1)(2008-12#1)(2008-9#2)(2011-2#1)
be obtained using a##2##4##(2008-10#1)(2008-5#1)
be obtained using##5##3##(1992-3#1)(2008-10#2)(2008-2#1)(2008-5#1)
be obtained when the##2##4##(2008-10#2)
be obtained when##3##3##(2008-10#2)(2008-12#1)
be obtained with##7##3##(2008-10#1)(2008-11#3)(2008-2#1)(2009-5#1)(2013-8#1)
be obtained within##2##3##(2008-10#1)(2008-4#1)
be obtained##119##2##(1991-12#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-12#3)(1994-5#1)(1995-2#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#49)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#7)(2009-11#1)(2009-5#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#4)
be of a##2##3##(1993-6#1)(2008-10#1)
be of fundamental##2##3##(1990-2#1)(2011-2#1)
be of great help to##2##5##(2010-7#2)
be of great help##3##4##(1997-2#1)(2010-7#2)
be of great interest##2##4##(2008-10#1)(2008-9#1)
be of great value in##2##5##(1991-6#1)(2009-8#1)
be of great##12##3##(1991-6#1)(1997-2#1)(2008-10#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2010-7#2)(2011-1#1)
be of importance for##2##4##(1991-9#1)(2008-5#1)
be of importance in##4##4##(1990-11#1)(1995-8#1)(2008-3#1)(2011-2#1)
be of importance##9##3##(1990-11#1)(1991-9#1)(1995-8#1)(2006-6#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#2)
be of interest to##2##4##(2008-11#1)(2008-4#1)
be of interest##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
be of little##2##3##(1991-2#1)(2008-10#1)
be of particular##5##3##(1993-12#2)(2008-9#1)(2012-3#1)(2013-8#1)
be of significant##2##3##(2008-10#2)
be of therapeutic##2##3##(1993-2#1)(2008-10#1)
be of use in##2##4##(2008-11#1)(2008-3#1)
be of use##3##3##(2008-11#2)(2008-3#1)
be of value in##4##4##(1992-1#1)(2008-11#1)(2008-9#2)
be of value to##2##4##(2008-11#1)(2010-8#1)
be of value##9##3##(1992-1#1)(1993-2#1)(2008-11#3)(2008-5#1)(2008-9#2)(2010-8#1)
be of##91##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-12#3)(1993-2#2)(1993-6#1)(1994-8#2)(1995-11#2)(1995-8#2)(1997-2#1)(1997-5#1)(1997-6#1)(2006-6#1)(2008-10#14)(2008-11#7)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#7)(2009-6#1)(2009-8#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
be offered by##2##3##(1994-2#1)(2013-1#1)
be offered##8##2##(1990-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(2011-2#2)(2013-1#2)
be offset by##2##3##(2008-8#1)(2013-1#1)
be offset##3##2##(1994-9#1)(2008-8#1)(2013-1#1)
be omitted##4##2##(1990-8#1)(1991-3#1)(2008-10#1)(2008-11#1)
be on the##4##3##(1991-12#1)(1992-2#1)(1996-5#1)(2011-2#1)
be on##9##2##(1991-12#1)(1992-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
be one mechanism##2##3##(1993-6#1)(2008-10#1)
be one of the factors responsible for##3##7##(1995-12#1)(2008-12#1)(2013-8#1)
be one of the factors##7##5##(1995-12#1)(1997-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
be one of the most important##3##6##(1990-12#1)(2008-11#1)(2008-7#1)
be one of the most##5##5##(1990-12#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
be one of the reasons for##2##6##(2008-10#1)(2008-8#1)
be one of the##22##4##(1990-12#1)(1994-2#1)(1995-12#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
be one of##26##3##(1990-12#1)(1994-2#1)(1995-12#2)(1996-1#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
be one reason##2##3##(2008-11#1)(2008-9#1)
be one##34##2##(1990-12#1)(1993-6#1)(1994-2#1)(1995-12#2)(1996-1#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
be ongoing##2##2##(1992-3#1)(2008-3#1)
be only##11##2##(1990-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(2008-10#4)(2008-8#1)(2012-12#1)(2012-2#1)
be operated##6##2##(1996-11#1)(2008-10#3)(2008-12#1)(2008-3#1)
be operative##2##2##(2008-10#1)(2012-3#1)
be optimistic##2##2##(1992-12#1)(1996-3#1)
be optimized##8##2##(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)
be or not to be##2##5##(2012-3#1)(2013-1#1)
be or##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
be organized##4##2##(1991-2#1)(1995-3#1)(2008-11#2)
be otherwise##2##2##(2008-11#1)(2008-4#1)
be outlined##5##2##(1997-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2012-2#1)
be over##3##2##(2008-10#2)(2008-5#1)
be overcome by##6##3##(1990-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
be overcome##16##2##(1990-6#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
be overestimated##2##2##(2008-11#1)(2008-8#1)
be overlooked in##2##3##(2011-2#1)(2013-8#1)
be overlooked##4##2##(2008-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
be owing to##2##3##(2008-5#1)(2011-2#1)
be paid to##11##3##(1992-12#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#1)
be paid##13##2##(1992-12#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#1)
be part of a##4##4##(1992-3#1)(1994-8#1)(2008-11#2)
be part of an##4##4##(1992-2#1)(1992-4#1)(2008-10#1)(2008-11#1)
be part of the##5##4##(1996-2#1)(1997-3#1)(2008-7#1)(2008-9#1)(2010-11#1)
be part of##18##3##(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-8#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2012-2#1)
be partially##12##2##(1992-12#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-6#1)
be particularly useful for##3##4##(2008-10#2)(2008-8#1)
be particularly useful to##3##4##(1993-3#1)(2008-2#1)(2011-2#1)
be particularly useful##8##3##(1993-3#1)(2008-10#3)(2008-2#1)(2008-8#1)(2011-2#2)
be particularly##24##2##(1991-1#1)(1991-3#1)(1993-3#1)(1995-12#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
be partly##6##2##(1991-11#1)(2008-10#3)(2008-11#1)(2009-12#1)
be passed##2##2##(1993-8#1)(2008-8#1)
be perceived##3##2##(2009-12#1)(2009-8#1)(2012-3#1)
be performed after##2##3##(2008-10#2)
be performed at##3##3##(1993-11#1)(2008-7#1)(2010-5#1)
be performed by the##3##4##(1993-12#1)(2008-10#1)(2008-5#1)
be performed by##5##3##(1993-12#1)(2008-10#1)(2008-5#2)(2010-7#1)
be performed for##4##3##(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)
be performed in a##2##4##(2008-11#1)(2008-7#1)
be performed in order to##3##5##(1990-2#1)(2013-1#2)
be performed in the##4##4##(1990-12#1)(2008-10#3)
be performed in##24##3##(1990-12#1)(1990-2#1)(1991-3#1)(1992-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#2)(2013-1#2)
be performed on the##3##4##(1991-3#1)(2008-11#1)(2011-2#1)
be performed on##7##3##(1991-3#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
be performed only##4##3##(1991-6#1)(1994-3#1)(2008-7#1)(2012-2#1)
be performed to##6##3##(2008-11#2)(2008-12#1)(2008-3#1)(2009-8#1)(2012-12#1)
be performed using a##2##4##(2008-4#1)(2009-10#1)
be performed using##5##3##(2008-10#3)(2008-4#1)(2009-10#1)
be performed with the##3##4##(1990-12#1)(2008-10#2)
be performed with##8##3##(1990-12#1)(1990-2#1)(1992-3#1)(1995-1#1)(2008-10#2)(2008-3#1)(2008-7#1)
be performed##96##2##(1990-12#2)(1990-2#2)(1991-3#5)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-1#2)(1996-1#1)(1996-11#2)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)
be phased out##2##3##(1996-2#1)(2008-10#1)
be phased##3##2##(1992-1#1)(1996-2#1)(2008-10#1)
be phosphorylated##3##2##(1995-6#1)(1997-2#1)(2011-2#1)
be placed in an##2##4##(2008-11#2)
be placed in##5##3##(1996-1#1)(2008-10#2)(2008-11#2)
be placed on the##4##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
be placed on##7##3##(1995-9#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-9#1)
be placed##16##2##(1994-1#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#1)
be plastic##2##2##(2008-10#1)(2008-8#1)
be played##2##2##(1993-12#1)(1993-2#1)
be positioned in##2##3##(2011-2#2)
be positive##4##2##(1995-12#1)(2009-7#1)(2012-12#1)(2013-8#1)
be positively correlated with##2##4##(1991-12#1)(2008-8#1)
be positively related to##2##4##(2008-9#1)(2009-7#1)
be positively##7##2##(1991-12#1)(1995-11#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)
be possible by##6##3##(1996-12#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-7#1)(2013-8#1)
be possible in##2##3##(1994-6#1)(2012-12#1)
be possible to##22##3##(1993-12#1)(1995-5#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2011-3#1)(2012-2#1)
be possible##38##2##(1991-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#4)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
be potent##5##2##(1991-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
be potential##3##2##(1992-1#1)(2008-10#1)(2011-2#1)
be potentially useful for##2##4##(1995-11#1)(2009-7#1)
be potentially##8##2##(1994-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-7#1)(2010-1#1)(2013-8#1)
be preceded by##2##3##(1992-4#1)(2008-11#1)
be precisely##2##2##(1997-8#1)(2008-10#1)
be predicted by##4##3##(1997-6#1)(2008-10#2)(2008-7#1)
be predicted from##6##3##(1993-6#1)(1997-2#1)(2008-10#3)(2008-3#1)
be predicted using##2##3##(2008-10#2)
be predicted##22##2##(1990-12#1)(1993-6#1)(1997-2#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
be preferable to##3##3##(1993-3#1)(2008-10#1)(2011-2#1)
be preferable##9##2##(1993-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
be preferentially##2##2##(2008-4#1)(2009-8#1)
be preferred##4##2##(1993-11#1)(2008-3#1)(2010-12#1)(2012-12#1)
be prepared by##2##3##(1997-1#1)(2008-10#1)
be prepared for##2##3##(2008-11#1)(2008-9#1)
be prepared in##5##3##(2008-10#2)(2008-11#2)(2008-4#1)
be prepared to##3##3##(1991-1#1)(2008-10#1)(2010-12#1)
be prepared with##2##3##(2008-10#1)(2013-8#1)
be prepared##21##2##(1991-1#1)(1991-3#1)(1997-1#1)(2008-10#8)(2008-11#5)(2008-4#1)(2008-9#2)(2010-12#1)(2013-8#1)
be prescribed##5##2##(1993-6#1)(2008-11#1)(2008-7#1)(2008-8#2)
be present at##3##3##(1996-8#1)(2008-7#1)(2011-2#1)
be present in a##3##4##(1991-6#1)(2008-10#2)
be present in other##2##4##(2008-9#1)(2010-5#1)
be present in the##5##4##(1994-12#1)(2008-10#2)(2008-7#1)(2010-11#1)
be present in##30##3##(1991-6#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-10#12)(2008-12#3)(2008-7#4)(2008-8#1)(2008-9#3)(2010-11#1)(2010-12#1)(2010-5#1)
be present on##3##3##(1995-2#1)(1997-2#1)(2008-4#1)
be present##54##2##(1991-12#1)(1991-5#2)(1991-6#1)(1994-12#1)(1995-2#2)(1996-8#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)
be presented##13##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
be preserved##3##2##(2008-10#2)(2012-3#1)
be prevented by a##2##4##(1991-3#1)(2007-8#1)
be prevented by##13##3##(1991-3#1)(1992-5#1)(1993-12#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
be prevented or##2##3##(2008-12#1)(2008-5#1)
be prevented##23##2##(1991-3#1)(1992-5#1)(1993-12#1)(1995-12#1)(1996-6#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
be primary##3##2##(2008-10#2)(2008-5#1)
be prioritized##2##2##(2009-8#1)(2010-7#1)
be processed with##2##3##(2008-10#2)
be processed##8##2##(1990-5#1)(1995-2#1)(2008-10#4)(2008-3#1)(2012-2#1)
be produced at##2##3##(2008-10#1)(2008-11#1)
be produced by the##2##4##(1994-9#1)(1995-11#1)
be produced by##10##3##(1994-9#1)(1995-11#1)(1995-6#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)
be produced from##2##3##(1994-3#1)(2008-11#1)
be produced in##2##3##(1990-11#1)(2008-11#1)
be produced##18##2##(1990-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)
be promising##4##2##(2008-10#1)(2008-11#2)(2012-2#1)
be promoted by##2##3##(1993-12#1)(2008-8#1)
be promoted##7##2##(1993-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
be promptly##3##2##(1993-12#1)(2008-11#1)(2012-12#1)
be properly controlled##2##3##(2008-10#2)
be properly evaluated##2##3##(2008-10#1)(2012-12#1)
be properly##9##2##(1993-8#1)(2008-10#5)(2008-12#1)(2012-12#1)(2013-1#1)
be proportional to##3##3##(1990-3#1)(2008-10#1)(2008-7#1)
be proposed##6##2##(1990-9#1)(1994-2#1)(1997-1#1)(2008-11#1)(2008-4#1)(2009-7#1)
be protected by##3##3##(1995-5#1)(2008-10#1)(2010-1#1)
be protected from##2##3##(1993-6#1)(2008-11#1)
be protected##8##2##(1993-6#1)(1995-5#2)(1997-5#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-1#1)
be protective for##2##3##(2008-12#1)(2013-1#1)
be protective##4##2##(2008-12#1)(2008-8#1)(2009-7#1)(2013-1#1)
be provided by##4##3##(1997-9#1)(2008-11#1)(2008-8#1)(2008-9#1)
be provided with##2##3##(1992-3#1)(2008-10#1)
be provided##17##2##(1992-3#1)(1994-12#1)(1995-2#1)(1995-9#1)(1997-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
be published in##5##3##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-5#1)
be published##10##2##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-5#1)(2010-12#3)(2011-2#2)
be purchased##3##2##(1994-2#1)(2008-11#1)(2010-3#1)
be purified##3##2##(1994-5#1)(1996-12#1)(2013-8#1)
be put##3##2##(1991-3#1)(2010-8#1)(2012-12#1)
be qualitatively##2##2##(2008-10#1)(2013-1#1)
be quantified in##2##3##(2008-10#1)(2010-8#1)
be quantified with##5##3##(2008-10#4)(2008-5#1)
be quantified##21##2##(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
be quantitative##3##2##(2008-10#3)
be quantitatively adsorbed on##5##4##(2008-10#5)
be quantitatively adsorbed##6##3##(2008-10#6)
be quantitatively##15##2##(2008-10#15)
be quite different##2##3##(2010-10#1)(2010-11#1)
be quite##14##2##(1991-6#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-10#1)(2010-11#1)
be raised##4##2##(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
be rapidly##5##2##(2008-10#2)(2008-4#1)(2012-2#1)(2013-8#1)
be rather high##2##3##(2008-10#1)(2008-3#1)
be rather##3##2##(2008-10#2)(2008-3#1)
be rationally##2##2##(1995-2#1)(2008-5#1)
be reached by##2##3##(2008-3#1)(2013-8#1)
be reached##11##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
be readily achieved##2##3##(2008-10#1)(2008-3#1)
be readily detected##2##3##(2008-10#2)
be readily implemented##2##3##(2008-10#1)(2008-11#1)
be readily##30##2##(1990-8#1)(1991-10#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)
be realized##8##2##(1993-1#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-4#1)(2012-2#1)
be recalled##2##2##(1993-12#2)
be receiving##2##2##(1991-12#1)(1996-12#1)
be recognised by##2##3##(2007-12#1)(2009-7#1)
be recognised##3##2##(2007-12#1)(2008-11#1)(2009-7#1)
be recognized##7##2##(1995-11#1)(1995-6#1)(2008-9#1)(2009-8#1)(2011-2#3)
be recommended as##2##3##(1991-3#1)(2011-2#1)
be recommended for patients##2##4##(2011-2#1)(2013-1#1)
be recommended for routine use##2##5##(1991-6#1)(2008-10#1)
be recommended for routine##3##4##(1991-6#1)(2008-10#2)
be recommended for the##2##4##(1990-8#1)(2008-11#1)
be recommended for##11##3##(1990-8#1)(1991-6#1)(1993-2#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
be recommended##19##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-11#1)(1993-2#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#4)(2013-1#2)
be reconciled##2##2##(2008-11#1)(2008-9#1)
be recorded in##2##3##(2008-4#1)(2010-7#1)
be recorded reliably##2##3##(1996-6#2)
be recorded when##2##3##(2008-11#1)(2008-3#1)
be recorded##11##2##(1996-6#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2013-1#1)
be recovered from the##2##4##(2008-10#2)
be recovered from##5##3##(2008-10#4)(2008-6#1)
be recovered##9##2##(2008-10#6)(2008-3#1)(2008-6#1)(2012-12#1)
be recruited to##3##3##(1995-2#1)(1996-2#1)(2012-2#1)
be recruited##6##2##(1995-2#1)(1996-2#1)(2008-11#1)(2008-5#1)(2010-11#1)(2012-2#1)
be reduced and##2##3##(2008-11#1)(2008-3#1)
be reduced by the##2##4##(1992-2#1)(2011-2#1)
be reduced by##17##3##(1992-2#1)(1993-8#1)(1996-11#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
be reduced in##5##3##(1990-11#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
be reduced significantly##4##3##(1997-2#1)(2008-10#2)(2008-3#1)
be reduced to about##2##4##(1996-6#1)(2010-8#1)
be reduced to##5##3##(1996-6#1)(2008-10#2)(2008-2#1)(2010-8#1)
be reduced##53##2##(1990-11#1)(1992-2#1)(1993-12#1)(1993-8#2)(1996-1#1)(1996-11#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#14)(2008-11#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-7#2)(2009-12#1)(2010-5#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
be reduced?##2##2##(1995-9#1)(1997-8#1)
be referred to as##3##4##(2008-10#2)(2008-7#1)
be referred to##6##3##(1990-6#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-2#1)
be referred##7##2##(1990-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)
be refined##2##2##(2008-6#1)(2008-9#1)
be reflected in##3##3##(1993-6#1)(2008-11#1)(2008-7#1)
be reflected##5##2##(1993-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-3#1)
be regarded as a##5##4##(1991-3#1)(1994-2#1)(2008-10#3)
be regarded as an##2##4##(1995-11#1)(1997-4#1)
be regarded as random##2##4##(2008-10#2)
be regarded as##16##3##(1991-3#1)(1992-2#1)(1994-2#1)(1995-11#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#8)(2011-2#1)
be regarded##18##2##(1990-2#1)(1991-3#1)(1992-2#1)(1994-2#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#8)(2011-2#1)
be regenerated by##10##3##(2008-10#10)
be regenerated##14##2##(1992-9#1)(2008-10#13)
be registered##3##2##(1991-11#1)(2008-11#2)
be regulated by##17##3##(1993-12#1)(1993-8#1)(1995-11#2)(1995-8#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2009-8#2)(2010-3#1)(2011-10#1)
be regulated in##2##3##(2008-10#1)(2011-2#1)
be regulated##24##2##(1991-12#1)(1993-12#1)(1993-8#1)(1995-11#2)(1995-8#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-3#2)(2011-10#1)(2011-2#1)
be reinforced##2##2##(1994-8#1)(2009-7#1)
be related in##2##3##(1990-8#1)(2008-10#1)
be related to a##4##4##(1990-5#1)(1992-6#1)(1994-8#1)(2008-11#1)
be related to differences in##3##5##(2008-10#1)(2008-5#1)(2009-7#1)
be related to fundamental differences##2##5##(2008-5#1)(2008-9#1)
be related to its##3##4##(1995-8#1)(1997-1#1)(2008-7#1)
be related to the clinical##2##5##(1990-5#1)(1991-6#1)
be related to the##32##4##(1990-3#1)(1990-5#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-7#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-8#1)
be related to their##3##4##(1995-3#1)(2008-10#2)
be related to these##2##4##(2008-9#1)(2011-2#1)
be related to##85##3##(1990-3#1)(1990-5#2)(1990-8#1)(1991-6#2)(1992-6#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-8#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#7)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
be related with##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
be related##95##2##(1990-3#1)(1990-5#2)(1990-8#2)(1991-6#2)(1992-6#2)(1993-11#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-5#2)(1994-8#3)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#7)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
be relatively##16##2##(1994-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
be released##7##2##(1991-2#1)(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#3)
be relevant for##2##3##(2008-7#1)(2012-2#1)
be relevant in##2##3##(1994-8#1)(2008-10#1)
be relevant to##5##3##(2008-11#1)(2008-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
be relevant##15##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#2)
be reliably employed##2##3##(2008-10#1)(2008-11#1)
be reliably##8##2##(1992-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2012-2#1)
be remembered##2##2##(1994-9#1)(2010-1#1)
be removed by##11##3##(1993-12#1)(1993-6#1)(1993-8#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#2)
be removed from the##3##4##(2008-10#2)(2008-5#1)
be removed from##6##3##(2008-10#3)(2008-5#2)(2009-9#1)
be removed##28##2##(1990-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-5#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2011-2#6)
be rendered##2##2##(1997-4#1)(2008-6#1)
be repeated##2##2##(2008-11#2)
be repeatedly##3##2##(2008-10#2)(2008-9#1)
be replaced by a##2##4##(2008-11#2)
be replaced by##6##3##(1996-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)
be replaced with a##2##4##(1991-3#1)(2009-5#1)
be replaced with##5##3##(1991-3#1)(1993-2#1)(1994-12#1)(2009-5#1)(2010-7#1)
be replaced##14##2##(1991-3#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-5#1)(2010-7#1)(2011-2#1)
be replicated##2##2##(1995-6#1)(1997-3#1)
be reported and##2##3##(1993-3#1)(1994-9#1)
be reported in##5##3##(1992-6#1)(2008-10#2)(2008-12#1)(2013-1#1)
be reported to##2##3##(1997-8#1)(2008-11#1)
be reported##15##2##(1990-5#1)(1992-6#1)(1993-3#1)(1994-9#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2010-6#1)(2013-1#1)
be representative of the##2##4##(1994-6#1)(2008-10#1)
be representative of##4##3##(1994-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
be represented by a##2##4##(2008-11#1)(2008-2#1)
be represented by##6##3##(1990-8#2)(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
be represented##9##2##(1990-8#2)(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-5#1)(2010-1#1)
be reproduced in##4##3##(1997-7#1)(2008-11#1)(2008-5#1)(2011-2#1)
be reproduced with##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
be reproduced##8##2##(1992-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#1)
be reproducible##2##2##(2008-10#1)(2008-5#1)
be required for##14##3##(1991-7#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-8#1)(2008-10#5)(2008-3#1)(2008-9#1)(2010-3#1)(2013-1#1)
be required to##13##3##(1992-2#1)(1993-12#1)(1993-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
be required##40##2##(1990-6#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
be rescued by##2##3##(2008-7#1)(2011-2#1)
be rescued##4##2##(1990-2#1)(1994-3#1)(2008-7#1)(2011-2#1)
be reserved for##4##3##(1992-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
be reserved##5##2##(1992-9#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
be resistant to##4##3##(2008-10#3)(2009-9#1)
be resistant##6##2##(2008-10#5)(2009-9#1)
be resolved by##6##3##(2008-10#3)(2008-6#1)(2008-9#1)(2011-1#1)
be resolved with##2##3##(2008-10#1)(2011-2#1)
be resolved##19##2##(1991-2#1)(1991-3#1)(1993-9#1)(1995-3#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)
be responsible for the##22##4##(1990-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-1#1)(2012-3#1)
be responsible for##47##3##(1990-2#1)(1990-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)
be responsible##49##2##(1990-2#1)(1990-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#13)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)
be restored in##2##3##(1997-7#1)(2009-8#1)
be restored with##2##3##(2011-2#1)(2013-1#1)
be restored##12##2##(1990-5#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)
be restricted to##3##3##(1995-2#1)(2008-7#2)
be restricted##7##2##(1995-2#1)(2008-7#2)(2010-11#1)(2012-12#1)(2013-1#2)
be retained as##2##3##(2008-10#2)
be retained in##2##3##(2008-10#1)(2011-2#1)
be retained on##2##3##(2008-10#2)
be retained##8##2##(1992-2#1)(1997-2#1)(2008-10#5)(2011-2#1)
be retrieved##4##2##(2008-3#3)(2011-3#1)
be reused for##2##3##(2008-10#2)
be reused##6##2##(2008-10#6)
be revealed##2##2##(2007-12#1)(2008-4#1)
be reversed by##3##3##(1994-8#1)(2013-7#1)(2013-8#1)
be reversed##7##2##(1990-6#1)(1993-8#1)(1994-8#1)(2013-7#2)(2013-8#2)
be reviewed##11##2##(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2009-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
be revised to##2##3##(1996-5#1)(2008-1#1)
be revised##4##2##(1994-2#1)(1996-3#1)(1996-5#1)(2008-1#1)
be right##2##2##(1993-1#1)(2008-11#1)
be robust##2##2##(2008-10#1)(2008-11#1)
be roughly##2##2##(2008-10#1)(2008-11#1)
be routinely##6##2##(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
be ruled out in##2##4##(2007-11#1)(2011-2#1)
be ruled out##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#1)
be run##2##2##(2008-10#2)
be safe and##3##3##(1995-5#1)(1996-12#1)(2008-11#1)
be safe##7##2##(1995-5#1)(1996-12#1)(1996-2#1)(2008-11#1)(2009-1#1)(2010-7#1)(2013-1#1)
be safely used##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
be safely##9##2##(1993-12#1)(1995-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#2)
be said##5##2##(1990-2#1)(1992-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
be sampled##5##2##(2008-10#4)(2011-2#1)
be satisfactory for##2##3##(2008-10#2)
be satisfactory##4##2##(2008-10#4)
be saved##2##2##(2008-6#1)(2008-7#1)
be screened regularly##2##3##(1990-12#1)(2011-2#1)
be screened##4##2##(1990-12#1)(2008-11#2)(2011-2#1)
be secreted##3##2##(2008-11#2)(2009-3#1)
be seen as a##2##4##(2008-11#1)(2011-2#1)
be seen as##6##3##(1997-7#1)(2008-11#2)(2008-12#2)(2011-2#1)
be seen in the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
be seen in##9##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
be seen that##3##3##(2008-12#1)(2008-3#1)(2008-8#1)
be seen##30##2##(1991-6#1)(1994-9#1)(1996-9#1)(1997-7#1)(2008-10#5)(2008-11#5)(2008-12#5)(2008-3#1)(2008-7#1)(2008-8#4)(2011-2#3)(2012-2#1)(2013-1#1)
be selected for##4##3##(1995-5#1)(1996-3#1)(2008-10#2)
be selected to##3##3##(2008-10#1)(2008-8#1)(2012-9#1)
be selected##14##2##(1995-5#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#2)(2010-12#1)(2012-12#1)(2012-9#1)
be selectively##6##2##(1990-9#1)(2008-10#3)(2008-7#1)(2011-2#1)
be sensitive to##6##3##(1994-2#1)(1997-2#1)(2008-3#2)(2009-10#1)(2012-2#1)
be sensitive##8##2##(1994-2#1)(1997-2#1)(2008-10#2)(2008-3#2)(2009-10#1)(2012-2#1)
be sent to##3##3##(1997-2#1)(2009-12#1)(2011-3#1)
be separated by##5##3##(1996-2#1)(2008-10#3)(2008-11#1)
be separated from the##3##4##(1995-5#1)(2008-10#1)(2010-8#1)
be separated from##11##3##(1995-5#1)(2008-10#9)(2010-8#1)
be separated into two##3##4##(2008-10#3)
be separated into##6##3##(1992-11#1)(2008-10#5)
be separated using##2##3##(2008-10#2)
be separated##43##2##(1991-12#1)(1991-3#1)(1992-11#1)(1995-5#1)(1996-2#1)(2008-10#33)(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)(2013-8#1)
be sequenced##4##2##(1995-6#1)(2008-10#2)(2011-2#1)
be serious##3##2##(2008-12#1)(2010-1#1)(2012-12#1)
be seriously considered##4##3##(1991-2#1)(1994-6#1)(2008-11#1)(2010-1#1)
be seriously##6##2##(1991-2#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2010-1#1)
be served##3##2##(1991-11#1)(1997-2#1)(2008-10#1)
be set up##2##3##(2008-3#1)(2009-10#1)
be set##4##2##(1996-2#1)(2008-3#1)(2009-10#1)(2013-8#1)
be several##3##2##(1990-5#1)(1994-2#1)(1997-1#1)
be shared by##2##3##(2008-8#1)(2011-2#1)
be shared##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
be shifted##3##2##(1991-3#1)(2008-3#2)
be shortened##3##2##(2008-10#2)(2010-8#1)
be shown that the##2##4##(1997-1#1)(2013-8#1)
be shown that##3##3##(1997-1#1)(2008-10#1)(2013-8#1)
be shown to be##2##4##(1991-5#1)(2008-10#1)
be shown to##3##3##(1991-5#1)(1995-12#1)(2008-10#1)
be shown##15##2##(1991-5#1)(1991-7#1)(1993-2#1)(1995-12#1)(1997-1#2)(2008-10#6)(2008-11#1)(2009-12#1)(2013-8#1)
be significant##11##2##(1993-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#2)
be significantly (P&lt##2##3##(2008-10#1)(2008-12#1)
be significantly increased##3##3##(1997-3#1)(2008-11#1)(2013-1#1)
be significantly influenced by the##2##5##(2011-2#2)
be significantly influenced by##3##4##(2011-2#2)(2012-2#1)
be significantly##34##2##(1992-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1996-1#2)(1997-3#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)
be similar in##4##3##(1991-5#1)(1995-5#1)(2008-10#1)(2011-2#1)
be similar to that##3##4##(1990-2#1)(2009-11#1)(2011-10#1)
be similar to##8##3##(1990-2#1)(2008-10#2)(2008-9#1)(2009-11#1)(2011-10#1)(2011-2#1)(2012-2#1)
be similar##17##2##(1990-2#1)(1991-5#1)(1995-5#2)(2008-10#6)(2008-3#1)(2008-9#1)(2009-11#1)(2011-10#1)(2011-2#2)(2012-2#1)
be similarly##4##2##(1990-11#1)(1991-3#1)(2007-12#1)(2012-3#1)
be simultaneously##7##2##(1994-5#1)(2008-10#5)(2009-10#1)
be slowly##2##2##(1997-8#1)(2008-5#1)
be small##2##2##(2008-3#1)(2013-1#1)
be so##2##2##(1997-5#1)(2008-8#1)
be soluble##2##2##(2008-10#1)(2008-4#1)
be solved##11##2##(1990-2#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-12#1)(2010-1#1)
be speciated##2##2##(2008-10#2)
be specific to##2##3##(1993-6#1)(2009-10#1)
be specific##6##2##(1993-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-6#1)
be specifically##8##2##(1992-8#1)(1993-2#1)(1993-9#1)(1996-12#1)(1996-6#1)(2008-11#2)(2011-2#1)
be specified##2##2##(2008-7#1)(2011-2#1)
be stable in##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
be stable##11##2##(1990-5#1)(1992-6#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)
be started within 24##2##4##(2011-2#2)
be started##5##2##(2008-10#1)(2011-2#3)(2013-1#1)
be statistically##10##2##(1990-2#2)(2008-10#3)(2008-5#2)(2010-7#1)(2010-8#1)(2011-2#1)
be still##2##2##(2008-8#1)(2011-3#1)
be stimulated by##5##3##(1990-5#2)(1993-12#1)(1995-6#1)(2009-3#1)
be stimulated##6##2##(1990-5#2)(1991-6#1)(1993-12#1)(1995-6#1)(2009-3#1)
be stopped##4##2##(1996-6#1)(2008-8#1)(2009-5#1)(2013-1#1)
be stored at 4 degrees C for##2##7##(1990-12#1)(1991-11#1)
be stored at##3##3##(1990-12#1)(1991-11#1)(2008-10#1)
be stored in##4##3##(1997-6#1)(2008-10#1)(2008-3#1)(2012-3#1)
be stored##9##2##(1990-12#2)(1991-11#1)(1997-6#1)(2008-10#3)(2008-3#1)(2012-3#1)
be straightforward##2##2##(2008-10#1)(2008-9#1)
be stressed##2##2##(2008-10#1)(2008-11#1)
be strictly##2##2##(1997-2#1)(2008-5#1)
be strong##2##2##(1992-2#1)(2012-2#1)
be stronger##2##2##(1997-8#1)(2008-9#1)
be strongly affected by##2##4##(2008-10#2)
be strongly##13##2##(1991-12#1)(1996-2#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)
be structurally distinct from##2##4##(1990-8#1)(1995-2#1)
be structurally##3##2##(1990-8#1)(1994-5#1)(1995-2#1)
be structured to##4##3##(1994-3#2)(2008-11#1)(2008-8#1)
be structured##5##2##(1994-3#2)(2008-11#1)(2008-8#2)
be studied and##2##3##(2008-10#2)
be studied as##2##3##(2010-4#1)(2013-1#1)
be studied by##2##3##(1993-8#1)(2008-10#1)
be studied in the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
be studied in##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
be studied##20##2##(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-1#1)
be subdivided##2##2##(2008-10#1)(2008-12#1)
be subject to##5##3##(1997-3#1)(2008-10#3)(2012-3#1)
be subjected to a##2##4##(1995-5#1)(2008-10#1)
be subjected to##5##3##(1992-1#1)(1995-5#1)(1996-5#1)(2008-10#2)
be subjected##6##2##(1992-1#1)(1993-3#1)(1995-5#1)(1996-5#1)(2008-10#2)
be submitted to##2##3##(1992-6#1)(2010-12#1)
be subsequently##2##2##(2008-10#1)(2012-2#1)
be substantial##2##2##(1992-2#1)(2008-10#1)
be substantially##4##2##(1992-3#1)(1994-3#1)(2008-10#2)
be substituted for##3##3##(1990-12#1)(2011-2#2)
be successful in##7##3##(1991-2#1)(1994-9#1)(1997-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)
be successful##22##2##(1991-2#1)(1992-12#1)(1993-3#2)(1994-1#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-5#1)
be successfully applied to the##4##5##(2008-10#4)
be successfully applied to##5##4##(2008-10#4)(2008-3#1)
be successfully applied##8##3##(2008-10#7)(2008-3#1)
be successfully performed##2##3##(2008-10#1)(2008-12#1)
be successfully treated##2##3##(1997-8#1)(2008-11#1)
be successfully used to determine##2##5##(2008-10#1)(2012-2#1)
be successfully used to##3##4##(2008-10#1)(2010-4#1)(2012-2#1)
be successfully used##7##3##(2008-10#3)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
be successfully##26##2##(1997-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-4#1)(2011-2#3)(2012-2#1)
be such##3##2##(1996-2#2)(2008-12#1)
be sufficient for##7##3##(1993-11#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-3#1)(2009-12#1)(2012-2#1)
be sufficient to##5##3##(1994-5#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
be sufficient##14##2##(1991-2#1)(1993-11#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
be sufficiently##2##2##(2009-7#1)(2012-2#1)
be suitable for the##12##4##(1990-12#1)(2008-10#6)(2008-11#3)(2008-8#1)(2009-7#1)
be suitable for##15##3##(1990-12#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-8#1)(2009-7#1)
be suitable##20##2##(1990-12#1)(1991-9#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-8#1)(2009-7#1)
be summarized##6##2##(1993-2#1)(1995-9#2)(1997-1#1)(2008-7#1)(2013-7#1)
be superimposed by##2##3##(1993-12#1)(2013-1#1)
be superimposed##3##2##(1993-12#1)(2008-11#1)(2013-1#1)
be supplemented with##2##3##(1995-5#1)(2008-10#1)
be supplied##2##2##(1990-11#1)(2008-11#1)
be supported by##4##3##(1991-11#1)(1993-12#1)(2008-11#1)(2008-12#1)
be supported##6##2##(1991-11#1)(1993-12#1)(2008-11#3)(2008-12#1)
be supportive##2##2##(1994-2#1)(2010-6#1)
be suppressed by a##2##4##(1993-8#1)(1995-11#1)
be suppressed by the##2##4##(2008-10#1)(2008-11#1)
be suppressed by##6##3##(1993-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
be suppressed##7##2##(1993-12#1)(1993-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
be sure##4##2##(1993-1#1)(2008-11#1)(2010-5#1)(2011-2#1)
be susceptible to##4##3##(1993-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
be susceptible##5##2##(1993-2#1)(2008-10#2)(2011-1#1)(2011-2#1)
be suspected in##2##3##(1990-2#1)(2010-10#1)
be suspected##7##2##(1990-2#1)(1990-3#1)(1997-4#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
be sustained##3##2##(2008-10#1)(2013-1#2)
be synthesized in##3##3##(1991-6#1)(1993-3#1)(1994-11#1)
be synthesized##8##2##(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1997-1#1)(2008-10#1)(2008-4#1)
be tailored to##2##3##(2008-10#1)(2009-7#1)
be tailored##4##2##(2007-11#1)(2008-10#1)(2009-7#1)(2013-8#1)
be taken as##2##3##(2008-10#1)(2008-11#1)
be taken for##2##3##(1994-12#1)(2011-2#1)
be taken in##2##3##(1997-3#1)(2008-7#1)
be taken into account in the##4##6##(1994-12#1)(1995-3#1)(2008-10#2)
be taken into account in##9##5##(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#4)(2008-5#1)(2013-1#1)
be taken into account when##2##5##(2008-10#1)(2013-8#1)
be taken into account##23##4##(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
be taken into consideration in##2##5##(1991-11#1)(2013-8#1)
be taken into consideration##6##4##(1991-11#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
be taken into##32##3##(1991-11#1)(1991-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#2)
be taken to be##2##4##(1997-2#1)(2010-4#1)
be taken to ensure##2##4##(1994-3#1)(2008-4#1)
be taken to prevent##2##4##(2008-10#2)
be taken to##13##3##(1990-12#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-2#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-4#1)
be taken when##2##3##(2008-9#1)(2013-8#1)
be taken##77##2##(1990-12#1)(1991-11#1)(1991-12#1)(1993-12#1)(1994-12#2)(1994-3#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
be targeted by##4##3##(2008-10#1)(2009-4#1)(2009-8#1)(2011-2#1)
be targeted##8##2##(1997-7#1)(2008-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
be taught##2##2##(1994-12#1)(2011-2#1)
be tempted to##2##3##(1994-2#1)(1995-3#1)
be terminated##2##2##(1996-1#1)(2008-8#1)
be tested by##2##3##(2008-9#1)(2010-12#1)
be tested in the field##2##5##(1996-12#1)(2008-10#1)
be tested in##6##3##(1990-3#1)(1995-5#1)(1996-12#1)(1997-4#1)(2008-10#1)(2013-8#1)
be tested##23##2##(1990-3#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2013-8#2)
be that the##2##3##(2008-10#1)(2013-8#1)
be that##7##2##(1994-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
be the &quot##2##3##(2009-7#1)(2012-2#1)
be the basis of##4##4##(1996-12#1)(2008-10#2)(2008-8#1)
be the basis##5##3##(1996-12#1)(2008-10#2)(2008-8#1)(2012-3#1)
be the best##20##3##(1990-3#1)(1990-9#1)(1994-5#1)(1994-6#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
be the case in##2##4##(2008-9#1)(2011-2#1)
be the case##5##3##(1990-6#1)(1992-3#1)(2008-9#2)(2011-2#1)
be the cause of##6##4##(1990-11#1)(1991-6#1)(1992-9#1)(1994-3#1)(2008-4#1)(2011-2#1)
be the cause##8##3##(1990-11#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-4#1)(2011-2#1)
be the consequence of##2##4##(2008-5#1)(2008-8#1)
be the consequence##3##3##(2008-5#1)(2008-8#1)(2010-10#1)
be the controlling##2##3##(2008-10#1)(2009-5#1)
be the first case##2##4##(2008-12#1)(2013-1#1)
be the first imaging##2##4##(1993-6#1)(2010-6#1)
be the first step##2##4##(1994-8#1)(2010-11#1)
be the first##18##3##(1990-2#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-8#2)(1996-11#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
be the focus of##2##4##(2008-10#1)(2008-11#1)
be the important##2##3##(2008-9#1)(2011-3#1)
be the key to the##2##5##(1997-1#1)(2011-9#1)
be the key to##3##4##(1994-3#1)(1997-1#1)(2011-9#1)
be the key##6##3##(1994-3#1)(1997-1#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-9#1)
be the main cause of##2##5##(2008-11#1)(2008-8#1)
be the main cause##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
be the main##14##3##(1991-6#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-8#2)(2009-11#1)
be the major##11##3##(1994-1#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-8#1)
be the mechanism##3##3##(1993-2#1)(2012-2#1)(2013-8#1)
be the most important##4##4##(1991-3#1)(1994-12#1)(1994-6#1)(2008-8#1)
be the most promising##2##4##(2008-10#2)
be the most##33##3##(1990-5#1)(1991-3#1)(1992-1#1)(1994-12#1)(1994-6#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-8#1)
be the only##8##3##(1992-3#1)(1994-9#1)(1996-11#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#1)
be the optimal##2##3##(1995-2#1)(2012-3#1)
be the optimum##2##3##(2008-10#1)(2008-8#1)
be the primary##4##3##(1996-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
be the reason for##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
be the result of a##4##5##(2008-10#1)(2008-7#1)(2008-9#2)
be the result of the##2##5##(1991-12#1)(2008-10#1)
be the result of##18##4##(1991-12#1)(1992-12#1)(1993-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-7#2)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)
be the result##19##3##(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-7#2)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)
be the same##6##3##(1994-1#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)
be the source of##3##4##(1992-12#1)(2008-12#1)(2008-9#1)
be the treatment##2##3##(2008-12#1)(2010-10#1)
be the underlying##2##3##(1994-3#1)(2008-7#1)
be the##277##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#3)(1991-3#3)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-9#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-2#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#3)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#62)(2008-11#12)(2008-12#8)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#13)(2008-8#17)(2008-9#15)(2009-11#2)(2009-12#2)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#4)(2010-10#4)(2010-11#2)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-2#7)(2011-3#1)(2011-9#1)(2012-2#9)(2012-3#4)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#3)
be their##2##2##(1991-2#1)(1991-3#1)
be then##2##2##(2008-10#1)(2010-11#1)
be they##2##2##(2008-10#2)
be those##2##2##(1993-12#1)(2008-10#1)
be tightly##2##2##(1997-3#1)(2009-8#1)
be time##2##2##(2008-10#1)(2010-10#1)
be titrated##2##2##(2008-10#2)
be to prevent##2##3##(2008-10#1)(2011-2#1)
be to see##2##3##(1994-9#1)(1995-1#1)
be to##26##2##(1990-11#1)(1990-5#1)(1992-5#1)(1992-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1997-7#3)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
be tolerated at##2##3##(1990-11#1)(2008-10#1)
be tolerated##12##2##(1990-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
be too##3##2##(1990-2#1)(2008-7#1)(2010-11#1)
be totally##2##2##(2008-7#1)(2009-7#1)
be toxic to##2##3##(1992-12#1)(2008-11#1)
be toxic##4##2##(1992-12#1)(2008-10#2)(2008-11#1)
be traced back to##3##4##(2008-10#3)
be traced to##3##3##(1994-12#1)(2008-10#2)
be traced##9##2##(1993-8#1)(1994-12#1)(2008-10#6)(2009-6#1)
be tracked##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
be trained in##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
be trained to##2##3##(1992-3#1)(2011-2#1)
be trained##7##2##(1992-3#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
be transcribed##4##2##(2008-11#2)(2008-8#1)(2008-9#1)
be transferred into##2##3##(2008-8#2)
be transferred to the##2##4##(2008-10#1)(2008-11#1)
be transferred to##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
be transferred##10##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-8#3)(2010-6#1)(2013-1#1)(2013-8#1)
be transformed##4##2##(1994-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
be transmitted by##2##3##(2008-10#1)(2011-2#1)
be transmitted from##3##3##(1990-9#1)(2008-10#2)
be transmitted through##3##3##(1996-5#2)(2008-10#1)
be transmitted##13##2##(1990-9#1)(1995-9#1)(1996-5#2)(2008-10#6)(2008-7#1)(2008-9#1)(2011-2#1)
be transported over long distances in##2##6##(2008-10#1)(2008-11#1)
be transported to##2##3##(2008-10#2)
be transported##9##2##(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#1)
be trapped##2##2##(2008-10#1)(2009-12#1)
be treated as##4##3##(1990-9#2)(2008-10#1)(2008-3#1)
be treated by##3##3##(1997-4#1)(1997-8#1)(2008-7#1)
be treated simultaneously##2##3##(2008-10#2)
be treated successfully##2##3##(1995-2#1)(2008-9#1)
be treated surgically##3##3##(1990-12#2)(2012-3#1)
be treated using##2##3##(1996-3#1)(2008-10#1)
be treated with a##2##4##(1991-3#1)(2009-4#1)
be treated with##20##3##(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-5#1)(1996-11#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#3)(2009-4#1)(2011-2#2)(2013-1#2)
be treated##50##2##(1990-12#2)(1990-2#1)(1990-9#4)(1991-3#2)(1991-6#1)(1991-9#2)(1992-5#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-11#3)(1996-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#8)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#2)
be triggered by##5##3##(1996-12#1)(1997-6#1)(2008-11#1)(2009-4#1)(2012-3#1)
be triggered##6##2##(1996-12#1)(1997-6#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-3#1)
be true##5##2##(1993-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
be tuned##5##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
be turned##2##2##(1992-12#1)(2008-8#1)
be unable to##6##3##(1992-2#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-8#1)
be unacceptable##2##2##(1996-8#1)(2008-7#1)
be unambiguously##2##2##(2008-10#1)(2010-10#1)
be under the##2##3##(1992-10#1)(2010-6#1)
be under##5##2##(1992-10#1)(2008-10#2)(2008-8#1)(2010-6#1)
be understood and##2##3##(2008-1#1)(2013-8#1)
be understood##13##2##(1990-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
be undertaken at##3##3##(1993-12#1)(1996-6#1)(2008-5#1)
be undertaken##8##2##(1992-3#1)(1992-9#1)(1993-12#1)(1995-12#1)(1996-6#2)(2008-5#1)(2012-3#1)
be unique##7##2##(1992-12#1)(1992-5#1)(2008-10#2)(2008-4#1)(2012-2#1)(2013-8#1)
be uniquely##4##2##(1991-12#1)(2008-9#1)(2009-8#1)(2010-6#1)
be universal##2##2##(1990-12#1)(2008-11#1)
be unstable##2##2##(2008-8#1)(2013-1#1)
be unsuccessful##2##2##(1997-1#1)(2008-12#1)
be unsuitable for##2##3##(1996-5#1)(2008-10#1)
be unusually##2##2##(1991-7#1)(2008-8#1)
be updated##2##2##(1991-9#1)(2012-3#1)
be used and##2##3##(2008-11#1)(2008-3#1)
be used as a new##7##5##(2008-10#3)(2008-5#3)(2008-9#1)
be used as a prognostic##2##5##(2008-7#1)(2011-2#1)
be used as a rapid and##2##6##(2008-10#2)
be used as a surrogate##2##5##(2008-6#1)(2009-3#1)
be used as a tool##3##5##(2008-8#1)(2010-6#2)
be used as a##69##4##(1993-11#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#3)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
be used as an alternative##4##5##(2008-10#4)
be used as an effective##2##5##(2008-10#1)(2008-11#1)
be used as an indicator##2##5##(2008-10#1)(2008-3#1)
be used as an##21##4##(1990-5#1)(1991-11#1)(1993-9#1)(2008-10#9)(2008-11#3)(2008-3#3)(2008-5#2)(2011-2#1)
be used as reference##2##4##(2008-10#1)(2008-11#1)
be used as the##8##4##(1994-3#1)(2008-10#5)(2008-11#1)(2013-8#1)
be used as##148##3##(1990-11#1)(1990-5#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#51)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#2)(2010-6#4)(2011-2#4)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#4)
be used by##10##3##(1991-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-3#1)(2009-6#1)(2009-8#1)(2013-1#1)
be used directly##4##3##(1995-6#1)(2008-10#2)(2011-1#1)
be used for a##3##4##(2008-10#2)(2012-2#1)
be used for at least 3 months without any divergence in##2##11##(2008-10#2)
be used for at least 3 months without any##6##9##(2008-10#6)
be used for at least##14##5##(2008-10#14)
be used for detection##2##4##(2008-10#2)
be used for determination of##3##5##(2008-10#3)
be used for evaluation##2##4##(2008-10#1)(2011-2#1)
be used for measuring##2##4##(1992-1#1)(2008-10#1)
be used for more than##9##5##(2008-10#9)
be used for prediction##2##4##(2008-10#1)(2012-2#1)
be used for quantitative##3##4##(2008-10#3)
be used for studying##2##4##(2008-10#2)
be used for the design of##2##6##(2009-3#1)(2011-2#1)
be used for the determination of trace##2##7##(2008-10#2)
be used for the determination of##11##6##(2008-10#11)
be used for the evaluation of##2##6##(1990-11#1)(2008-10#1)
be used for the production of##2##6##(2008-11#1)(2008-8#1)
be used for the##46##4##(1990-11#1)(1990-2#1)(1991-3#1)(1993-1#1)(2008-10#32)(2008-11#4)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)
be used for##172##3##(1990-11#1)(1990-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-6#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#97)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-3#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
be used if##3##3##(2011-2#1)(2012-2#2)
be used in a##14##4##(2008-10#11)(2008-3#1)(2008-4#1)(2011-2#1)
be used in an##2##4##(2008-10#2)
be used in conjunction with##3##5##(2008-10#1)(2008-4#1)(2008-6#1)
be used in future##2##4##(2008-10#1)(2012-2#1)
be used in order to##3##5##(1991-6#1)(2008-10#2)
be used in pH range of##2##6##(2008-10#2)
be used in the pH range from##4##7##(2008-10#4)
be used in the pH range##6##6##(2008-10#6)
be used in the##27##4##(1990-11#1)(1990-2#1)(1992-6#1)(2008-10#13)(2008-11#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#3)(2013-1#4)
be used in##100##3##(1990-11#2)(1990-2#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-6#1)(2008-10#43)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#6)
be used or##2##3##(2008-10#1)(2010-5#1)
be used to achieve##2##4##(2008-10#1)(2008-11#1)
be used to assess##4##4##(2008-11#1)(2009-11#1)(2009-8#1)(2013-1#1)
be used to calculate the##3##5##(2008-10#2)(2008-3#1)
be used to compare the##2##5##(1993-12#1)(2008-10#1)
be used to compare##3##4##(1993-12#1)(2008-10#1)(2008-9#1)
be used to confirm##2##4##(2008-5#1)(2012-2#1)
be used to describe##4##4##(1991-2#1)(2008-3#1)(2008-9#1)(2010-12#1)
be used to detect and##2##5##(2008-10#2)
be used to detect##16##4##(2008-10#10)(2008-4#5)(2010-6#1)
be used to determine the concentration of##2##7##(2008-10#1)(2008-9#1)
be used to determine the##13##5##(1990-12#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
be used to determine##27##4##(1990-12#1)(1993-12#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
be used to develop##3##4##(2008-11#1)(2010-7#1)(2012-2#1)
be used to distinguish among##2##5##(1993-6#1)(2008-8#1)
be used to distinguish##4##4##(1993-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
be used to enhance the##2##5##(2008-3#1)(2012-2#1)
be used to enhance##4##4##(2008-11#2)(2008-3#1)(2012-2#1)
be used to establish##3##4##(2008-10#1)(2008-11#2)
be used to evaluate the##4##5##(1991-1#1)(1997-8#1)(2008-10#1)(2008-9#1)
be used to evaluate##6##4##(1991-1#1)(1997-8#1)(2008-10#2)(2008-9#1)(2012-2#1)
be used to generate##4##4##(2008-1#1)(2008-4#1)(2011-3#1)(2012-2#1)
be used to identify specific##2##5##(2008-4#1)(2010-11#1)
be used to identify##11##4##(1993-3#1)(1995-2#1)(2008-10#5)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#1)
be used to improve##3##4##(1994-3#1)(2009-10#1)(2009-6#1)
be used to measure##3##4##(1997-1#1)(2008-3#1)(2013-1#1)
be used to model##2##4##(2008-10#1)(2011-2#1)
be used to monitor the hydrolysis##2##6##(2008-10#2)
be used to monitor the##3##5##(2008-10#2)(2008-4#1)
be used to monitor##5##4##(2008-10#3)(2008-11#1)(2008-4#1)
be used to obtain##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
be used to optimize##2##4##(2008-3#1)(2008-5#1)
be used to predict the##4##5##(1997-9#1)(2008-10#1)(2008-7#1)(2013-8#1)
be used to predict##8##4##(1997-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
be used to prevent##2##4##(2008-11#1)(2009-8#1)
be used to produce##7##4##(1997-7#1)(2008-11#1)(2008-2#2)(2009-12#1)(2009-5#1)(2010-3#1)
be used to provide##2##4##(2008-10#1)(2008-4#1)
be used to quantify##3##4##(2008-10#2)(2008-4#1)
be used to quantitate##3##4##(1990-12#1)(2008-4#2)
be used to reduce##2##4##(1991-12#1)(2008-11#1)
be used to remove##2##4##(2008-10#1)(2008-6#1)
be used to search##2##4##(1993-8#1)(2013-1#1)
be used to study the##3##5##(2008-10#1)(2008-4#1)(2013-8#1)
be used to study##7##4##(1993-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-9#1)(2013-8#1)
be used to support##2##4##(1994-6#1)(2008-10#1)
be used to tailor##2##4##(2009-12#1)(2013-1#1)
be used to target##2##4##(2011-2#1)(2012-3#1)
be used to test##5##4##(1995-6#1)(2008-1#1)(2008-10#1)(2010-8#1)(2012-3#1)
be used to treat##3##4##(1992-1#1)(1997-6#1)(2008-11#1)
be used to##294##3##(1990-12#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#2)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2008-1#4)(2008-10#92)(2008-11#25)(2008-12#6)(2008-2#5)(2008-3#12)(2008-4#17)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#12)(2009-10#1)(2009-11#2)(2009-12#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#10)(2012-3#4)(2013-1#7)(2013-8#8)
be used when##4##3##(2008-10#3)(2008-12#1)
be used with##15##3##(1991-3#1)(1992-3#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#2)(2013-1#3)
be used##846##2##(1990-11#4)(1990-12#3)(1990-2#2)(1990-5#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#2)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#6)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#3)(1997-1#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#3)(1997-9#1)(2007-11#1)(2007-12#2)(2008-1#5)(2008-10#326)(2008-11#58)(2008-12#15)(2008-2#9)(2008-3#25)(2008-4#37)(2008-5#16)(2008-6#4)(2008-7#15)(2008-8#12)(2008-9#27)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#5)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#8)(2010-7#6)(2010-8#6)(2010-9#1)(2011-1#5)(2011-2#27)(2011-3#3)(2012-12#4)(2012-2#21)(2012-3#9)(2013-1#28)(2013-8#18)
be useful and##2##3##(1997-5#1)(2010-8#1)
be useful as a##9##4##(1993-1#1)(1996-2#1)(2008-10#5)(2008-11#2)
be useful as##13##3##(1993-1#1)(1996-2#1)(2008-10#8)(2008-11#2)(2011-2#1)
be useful for characterizing the##2##5##(1992-1#1)(2008-11#1)
be useful for in##2##4##(1996-12#1)(2008-4#1)
be useful for screening##2##4##(2008-10#2)
be useful for studying the##2##5##(1995-2#1)(2008-11#1)
be useful for studying##3##4##(1995-2#2)(2008-11#1)
be useful for the##12##4##(2008-10#6)(2008-12#1)(2008-5#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
be useful for##70##3##(1990-8#2)(1992-1#1)(1994-6#1)(1995-2#3)(1996-12#1)(2008-10#32)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
be useful in determining##2##4##(2008-10#1)(2010-4#1)
be useful in developing##6##4##(1994-11#1)(2008-10#3)(2011-3#1)(2013-8#1)
be useful in further##2##4##(1993-8#1)(2012-3#1)
be useful in predicting##3##4##(1992-3#1)(1996-6#1)(2013-1#1)
be useful in screening for##2##5##(1996-3#1)(2008-10#1)
be useful in screening##3##4##(1996-3#1)(2008-10#1)(2012-3#1)
be useful in studying the##2##5##(1993-6#1)(2008-4#1)
be useful in the diagnosis##2##5##(1996-11#1)(2011-2#1)
be useful in the management of##2##6##(1997-8#1)(2009-11#1)
be useful in the##14##4##(1991-5#1)(1993-12#1)(1996-11#1)(1997-8#1)(2008-10#4)(2009-10#1)(2009-11#1)(2010-4#1)(2011-2#2)(2012-2#1)
be useful in understanding##2##4##(1996-12#1)(2008-10#1)
be useful in##72##3##(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-8#3)(2008-10#22)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
be useful to identify##3##4##(2008-11#1)(2008-4#2)
be useful to##27##3##(1992-2#2)(1997-3#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-4#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-8#1)
be useful##203##2##(1990-8#3)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#3)(2008-10#71)(2008-11#16)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#6)
be usefully employed##2##3##(1990-2#1)(1990-8#1)
be utilised as##2##3##(2007-8#1)(2008-11#1)
be utilized as a##2##4##(2008-10#1)(2008-4#1)
be utilized as##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
be utilized for the##3##4##(2008-10#3)
be utilized for##8##3##(1990-12#1)(1994-11#1)(2008-10#4)(2008-3#1)(2009-10#1)
be utilized in##3##3##(2008-10#2)(2013-8#1)
be utilized to##6##3##(1992-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2013-1#1)
be utilized##25##2##(1990-12#1)(1992-2#1)(1994-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-10#3)(2009-12#1)(2013-1#1)(2013-8#2)
be vaccinated##3##2##(1990-11#1)(1996-11#1)(2009-5#1)
be valid##2##2##(2008-10#1)(2008-3#1)
be validated##2##2##(2008-11#1)(2011-7#1)
be valuable for##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
be valuable in the##2##4##(1997-8#1)(2011-7#1)
be valuable in##3##3##(1990-11#1)(1997-8#1)(2011-7#1)
be valuable to##2##3##(2008-9#1)(2013-1#1)
be valuable tools##2##3##(1991-2#1)(2008-8#1)
be valuable##11##2##(1990-11#1)(1991-2#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-7#1)(2012-3#1)(2013-1#1)
be varied##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
be vectored##2##2##(2008-10#2)
be very effective##5##3##(2008-10#2)(2011-2#1)(2013-1#2)
be very helpful in##3##4##(2008-12#1)(2009-5#1)(2010-9#1)
be very high##2##3##(2008-11#1)(2012-3#1)
be very important for##3##4##(1990-12#1)(2008-10#1)(2010-7#1)
be very important##5##3##(1990-12#1)(2008-10#2)(2008-7#1)(2010-7#1)
be very similar##2##3##(1993-9#1)(2008-10#1)
be very useful for##6##4##(1997-2#1)(1997-8#1)(2008-10#3)(2010-1#1)
be very useful in##3##4##(1997-8#1)(2008-11#1)(2009-2#1)
be very useful##11##3##(1994-2#1)(1997-2#1)(1997-8#2)(2008-10#3)(2008-11#1)(2009-2#1)(2010-1#1)(2013-1#1)
be very##59##2##(1990-12#1)(1992-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-8#4)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
be via##2##2##(2008-10#1)(2008-11#1)
be viable##4##2##(1992-1#1)(1994-1#1)(1996-8#1)(1997-1#1)
be viewed as a##2##4##(1994-12#1)(2008-4#1)
be viewed as##9##3##(1991-3#2)(1992-12#1)(1993-12#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
be viewed in##2##3##(1996-1#1)(1997-8#1)
be viewed##13##2##(1991-3#2)(1992-12#1)(1993-12#1)(1994-12#1)(1996-1#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2011-7#1)(2013-1#1)
be violated##2##2##(2012-3#1)(2013-1#1)
be visualized by##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
be visualized##8##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)
be warranted##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
be weighed against##4##3##(1994-6#1)(2008-11#1)(2010-12#1)(2013-1#1)
be weighed##6##2##(1994-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
be welfare-improving##2##2##(2010-5#2)
be well informed about the##2##5##(2008-9#1)(2009-9#1)
be well predicted using a linear combination of the##2##9##(2008-10#2)
be well separated within##4##4##(2008-10#4)
be well separated##5##3##(2008-10#5)
be well##22##2##(1993-1#1)(1994-1#1)(1996-2#2)(1997-8#1)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#1)
be widely##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
be wider##2##2##(1994-9#1)(2008-8#1)
be willing to##4##3##(1991-2#1)(1994-2#1)(1997-1#1)(2008-8#1)
be withdrawn##3##2##(1992-5#1)(1993-3#1)(2008-4#1)
be within##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
be worth##2##2##(1991-6#1)(1997-1#1)
be worthwhile##2##2##(1996-8#1)(2008-12#1)
be written##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2009-4#1)(2010-8#1)(2013-1#1)
be##12545##1##(1990-10#2)(1990-11#42)(1990-12#42)(1990-2#46)(1990-3#17)(1990-4#4)(1990-5#42)(1990-6#23)(1990-7#1)(1990-8#28)(1990-9#20)(1991-1#19)(1991-10#2)(1991-11#22)(1991-12#63)(1991-2#61)(1991-3#64)(1991-4#4)(1991-5#31)(1991-6#37)(1991-7#10)(1991-8#13)(1991-9#19)(1992-1#28)(1992-10#7)(1992-11#15)(1992-12#69)(1992-2#53)(1992-3#76)(1992-4#4)(1992-5#16)(1992-6#32)(1992-7#1)(1992-8#8)(1992-9#32)(1993-1#37)(1993-11#32)(1993-12#91)(1993-2#49)(1993-3#53)(1993-6#44)(1993-8#53)(1993-9#20)(1994-1#22)(1994-11#41)(1994-12#66)(1994-2#57)(1994-3#75)(1994-5#49)(1994-6#30)(1994-8#49)(1994-9#39)(1995-1#23)(1995-11#45)(1995-12#78)(1995-2#89)(1995-3#33)(1995-5#42)(1995-6#50)(1995-8#23)(1995-9#14)(1996-1#51)(1996-11#44)(1996-12#67)(1996-2#56)(1996-3#76)(1996-5#25)(1996-6#31)(1996-8#20)(1996-9#17)(1997-1#72)(1997-2#65)(1997-3#53)(1997-4#24)(1997-5#28)(1997-6#35)(1997-7#52)(1997-8#95)(1997-9#4)(2006-5#3)(2006-6#9)(2007-11#26)(2007-12#56)(2007-8#7)(2007-9#2)(2008-1#61)(2008-10#3511)(2008-11#940)(2008-12#242)(2008-2#59)(2008-3#263)(2008-4#194)(2008-5#263)(2008-6#70)(2008-7#343)(2008-8#401)(2008-9#361)(2009-1#16)(2009-10#57)(2009-11#38)(2009-12#59)(2009-2#6)(2009-3#29)(2009-4#23)(2009-5#37)(2009-6#37)(2009-7#48)(2009-8#97)(2009-9#26)(2010-1#40)(2010-10#67)(2010-11#74)(2010-12#89)(2010-2#6)(2010-3#27)(2010-4#39)(2010-5#35)(2010-6#46)(2010-7#58)(2010-8#68)(2010-9#9)(2011-1#70)(2011-10#7)(2011-2#519)(2011-3#39)(2011-4#2)(2011-7#9)(2011-8#1)(2011-9#1)(2012-12#83)(2012-2#258)(2012-3#185)(2012-4#2)(2012-5#2)(2012-6#2)(2012-7#4)(2012-9#5)(2013-1#323)(2013-7#23)(2013-8#196)
be?##5##1##(1994-3#1)(1997-4#1)(2008-6#1)(2008-7#1)(2012-3#1)
beachieved##2##1##(2008-11#2)
beacon##10##1##(2008-10#4)(2008-3#6)
beacons for##2##2##(2008-10#1)(2008-3#1)
beacons##12##1##(2008-10#8)(2008-3#2)(2008-9#2)
bead and##2##2##(2008-10#1)(2008-11#1)
bead in##2##2##(2008-10#2)
bead injection (BI)##2##3##(2008-10#2)
bead injection##14##2##(2008-10#14)
bead##54##1##(1990-12#1)(2008-10#32)(2008-11#3)(2008-4#3)(2008-6#7)(2008-7#1)(2008-9#3)(2010-12#1)(2012-2#3)
bead-based##2##1##(2008-1#1)(2008-9#1)
beads after##3##2##(2008-10#2)(2008-7#1)
beads and##8##2##(1995-6#1)(2008-10#2)(2008-11#2)(2009-5#1)(2011-2#1)(2013-1#1)
beads are automatically discarded from the flow cell##2##8##(2008-10#2)
beads are##7##2##(1990-12#1)(2008-10#6)
beads as##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
beads by##5##2##(2008-10#2)(2008-11#1)(2008-6#2)
beads can be##2##3##(2008-10#2)
beads for##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
beads in a##4##3##(2008-10#3)(2008-11#1)
beads in the##4##3##(2008-10#3)(2008-11#1)
beads in##9##2##(2008-10#7)(2008-11#2)
beads is##2##2##(2008-4#2)
beads of##2##2##(2008-10#1)(2012-2#1)
beads on##2##2##(1997-2#1)(2008-10#1)
beads that##3##2##(2008-10#2)(2013-1#1)
beads to a##2##3##(2008-9#2)
beads to##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#3)
beads under the##2##3##(2008-10#1)(2008-11#1)
beads was##2##2##(2008-10#1)(2008-7#1)
beads were prepared##2##3##(2008-10#1)(2008-11#1)
beads were##11##2##(2008-10#9)(2008-11#2)
beads with##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
beads##157##1##(1990-12#2)(1995-6#4)(1995-8#2)(1996-12#1)(1997-2#3)(2006-6#1)(2008-10#88)(2008-11#24)(2008-4#6)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#5)(2009-5#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#2)
beads) to##2##2##(1994-3#1)(2008-10#1)
beads)##5##1##(1994-3#2)(2008-10#3)
beagle dogs##2##2##(2011-2#1)(2012-3#1)
beak and feather disease##3##4##(1992-2#1)(2008-5#2)
beaker##2##1##(2008-10#2)
beaks##3##1##(2009-7#1)(2011-2#2)
beam (from##2##2##(2008-3#2)
beam and the##2##3##(1997-2#1)(2008-3#1)
beam and##7##2##(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#4)
beam at##3##2##(1997-8#1)(2008-3#2)
beam attenuation spectrum and##2##4##(2008-3#2)
beam by##3##2##(2008-2#1)(2008-3#2)
beam deflection##6##2##(2008-2#2)(2008-3#4)
beam delivery##4##2##(2008-3#4)
beam divergence and##2##3##(2008-3#2)
beam divergence##9##2##(1995-2#1)(2008-2#1)(2008-3#7)
beam ellipticity##2##2##(2008-3#2)
beam energy##2##2##(2008-10#1)(2008-2#1)
beam fanning##4##2##(2008-3#4)
beam from##2##2##(2008-10#1)(2012-2#1)
beam has##2##2##(2008-2#1)(2008-3#1)
beam in a##2##3##(2008-2#1)(2009-11#1)
beam in##5##2##(2008-2#1)(2008-3#3)(2009-11#1)
beam intensities##2##2##(2008-3#2)
beam intensity ratio of 1##2##5##(2008-3#2)
beam intensity##4##2##(2008-3#4)
beam interference##2##2##(2008-2#2)
beam into##2##2##(2007-11#1)(2008-3#1)
beam irradiation##7##2##(1991-6#1)(1992-12#1)(1994-11#2)(2008-11#1)(2009-2#1)(2009-7#1)
beam is##9##2##(2008-2#1)(2008-3#8)
beam model##5##2##(2009-11#5)
beam of M(2) approximately##2##4##(2008-3#2)
beam of light##2##3##(2008-3#2)
beam of##9##2##(1992-8#1)(2008-10#2)(2008-2#1)(2008-3#4)(2009-11#1)
beam on the##2##3##(2008-10#1)(2008-3#1)
beam profile##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
beam quality of the##3##4##(2007-12#1)(2008-3#2)
beam quality of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
beam quality##12##2##(2007-12#1)(2008-2#3)(2008-3#8)
beam shaping##3##2##(2008-2#2)(2008-3#1)
beam splitter##12##2##(2007-12#3)(2008-10#1)(2008-3#8)
beam splitting and beam combining##2##5##(2008-3#2)
beam that is circulating in##2##5##(2008-3#2)
beam that##4##2##(2008-2#1)(2008-3#3)
beam to##2##2##(2008-3#2)
beam was##9##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#5)
beam with##5##2##(2008-2#3)(2008-3#1)(2009-5#1)
beam##293##1##(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#2)(1994-3#2)(1995-2#1)(1995-3#1)(1997-2#2)(1997-8#2)(2007-11#4)(2007-12#10)(2008-10#24)(2008-11#2)(2008-2#44)(2008-3#157)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#12)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#6)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
beam's##3##1##(1993-9#1)(2008-3#2)
beam)##3##1##(2008-3#3)
beam-propagation method##3##2##(2008-3#3)
beam-propagation model##2##2##(2008-2#1)(2008-3#1)
beam-propagation##6##1##(2008-2#2)(2008-3#4)
beam-quality degradation##2##2##(2008-3#2)
beam-quality##4##1##(2008-3#4)
beam-shaping##2##1##(2008-2#1)(2008-3#1)
beam-splitter##2##1##(2008-3#2)
beam/hollow cathode-optical emission spectroscopy##2##4##(2010-11#2)
beams and##3##2##(2008-2#1)(2008-3#2)
beams are##3##2##(2008-3#3)
beams in the##2##3##(2008-3#2)
beams in##8##2##(2007-12#2)(2008-3#6)
beams is##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
beams##46##1##(1993-9#2)(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#7)(2008-3#24)(2009-11#3)(2009-7#1)(2012-2#1)
bean (Phaseolus vulgaris)##14##3##(2008-10#14)
bean (Phaseolus##17##2##(2008-10#15)(2008-12#2)
bean and alfalfa##2##3##(2008-10#2)
bean and pea##2##3##(2008-10#2)
bean and soybean##2##3##(2008-10#2)
bean and the##2##3##(2008-10#1)(2008-8#1)
bean and##12##2##(2008-10#10)(2008-8#1)(2013-8#1)
bean anthracnose##3##2##(2008-10#3)
bean breeding line##2##3##(2008-10#2)
bean cultivars##3##2##(2008-10#3)
bean fields in##2##3##(2008-10#2)
bean gene pools##2##3##(2008-10#2)
bean gene##3##2##(2008-10#3)
bean genotypes##3##2##(2008-10#2)(2013-8#1)
bean isolate##2##2##(2008-10#2)
bean leaf##3##2##(2008-10#3)
bean plants and##2##3##(2008-10#2)
bean plants##11##2##(2008-10#11)
bean population##4##2##(2008-8#4)
bean production##2##2##(2008-10#2)
bean samples##8##2##(2008-10#8)
bean seedlings##4##2##(2008-10#2)(2008-9#2)
bean seeds inoculated with##2##4##(2008-10#2)
bean yellow mosaic##2##3##(2008-10#2)
bean##184##1##(1990-3#2)(1994-11#1)(1995-12#2)(2008-10#150)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#10)(2008-9#3)(2009-8#3)(2010-11#3)(2011-10#1)(2013-8#5)
bean)##2##1##(1995-2#1)(2008-10#1)
bean-growing##2##1##(2008-10#2)
beans (Phaseolus##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
beans and##3##2##(2008-10#3)
beans from##3##2##(2008-10#3)
beans in the artificial mouth##2##5##(2008-10#2)
beans in the##3##3##(2008-10#3)
beans in##5##2##(2008-10#5)
beans##43##1##(2008-10#34)(2008-3#5)(2008-7#1)(2013-8#3)
bear a##4##2##(1993-8#1)(2008-3#1)(2008-5#1)(2008-8#1)
bear on##4##2##(1994-2#1)(1994-3#1)(2010-1#1)(2010-9#1)
bear the##4##2##(1996-5#1)(2008-11#1)(2008-2#1)(2011-2#1)
bear##25##1##(1991-12#1)(1993-8#1)(1994-2#2)(1994-3#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#1)
bearing a single##2##3##(2009-12#1)(2011-2#1)
bearing a##6##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
bearing an##2##2##(2008-9#1)(2010-8#1)
bearing either##2##2##(1990-8#1)(1993-8#1)
bearing in##3##2##(2010-11#1)(2012-12#2)
bearing on##3##2##(1996-3#1)(2008-8#1)(2012-2#1)
bearing the##6##2##(1991-9#1)(1997-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
bearing##67##1##(1990-2#1)(1990-8#1)(1991-9#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-8#2)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)
bears an##3##2##(2008-11#1)(2009-10#1)(2013-1#1)
bears some##2##2##(2008-8#1)(2008-9#1)
bears##12##1##(1994-6#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2013-1#1)
beast##3##1##(2009-10#3)
beat frequencies##2##2##(2007-11#1)(2008-3#1)
beat##13##1##(1991-5#1)(1994-11#1)(1996-6#1)(2007-11#4)(2008-12#1)(2008-3#3)(2009-10#1)(2012-3#1)
beating cardiac##2##2##(1994-11#1)(1996-2#1)
beating heart##2##2##(2009-12#1)(2012-3#1)
beating of##2##2##(2008-2#2)
beating##16##1##(1994-11#2)(1996-2#1)(2008-11#3)(2008-2#4)(2008-3#1)(2008-7#2)(2009-12#1)(2012-3#2)
beats##4##1##(1991-6#1)(1996-3#1)(1996-6#2)
beats/min##6##1##(1991-6#1)(2007-12#1)(2008-7#2)(2009-8#1)(2013-1#1)
beauty and##2##2##(2008-10#1)(2008-5#1)
beauty##4##1##(2008-10#1)(2008-11#1)(2008-5#2)
became a major##2##3##(2008-10#1)(2010-11#1)
became a##10##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-8#1)(2010-11#1)(2012-2#1)(2012-3#1)
became adapted to##2##3##(2008-11#1)(2008-8#1)
became an important##2##3##(2008-8#1)(2010-11#1)
became an##3##2##(2006-6#1)(2008-8#1)(2010-11#1)
became apparent that##2##3##(1994-2#1)(2008-11#1)
became apparent##4##2##(1993-1#1)(1994-2#1)(2008-11#2)
became asymptotic##2##2##(2008-10#2)
became available##3##2##(1992-9#1)(2008-11#1)(2011-2#1)
became aware of##2##3##(1997-3#1)(2008-12#1)
became clear##5##2##(1991-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
became diseased##3##2##(2008-10#3)
became dominant in##2##3##(2008-10#2)
became evident after##2##3##(1991-6#1)(1995-2#1)
became evident that##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
became evident##8##2##(1991-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#1)
became infected during##3##3##(2008-10#2)(2008-5#1)
became infected in the##2##4##(1996-5#1)(2008-10#1)
became infected with##4##3##(2008-10#4)
became infected##15##2##(1996-5#1)(2008-10#13)(2008-5#1)
became involved##2##2##(1991-8#1)(2008-4#1)
became less##3##2##(2008-10#3)
became manifest##2##2##(1993-2#1)(1997-4#1)
became more complex##2##3##(1994-2#1)(2008-10#1)
became more similar##2##3##(2011-2#2)
became more##13##2##(1990-5#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
became much##2##2##(2008-8#1)(2011-3#1)
became necrotic and##2##3##(2008-10#2)
became necrotic##3##2##(2008-10#3)
became obvious that##2##3##(2008-5#2)
became obvious##3##2##(2008-11#1)(2008-5#2)
became of##2##2##(2008-10#2)
became pregnant##3##2##(1990-2#1)(1996-8#1)(2011-1#1)
became progressively##2##2##(2008-6#1)(2009-8#1)
became resistant to##2##3##(1993-8#1)(2008-8#1)
became sensitive to amiloride##2##4##(1991-5#2)
became stronger##2##2##(2008-10#1)(2008-3#1)
became susceptible##2##2##(2008-10#2)
became the dominant##2##3##(1996-3#1)(2013-8#1)
became the##9##2##(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
became##215##1##(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#4)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-8#2)(1993-9#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#66)(2008-11#15)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#4)(2009-7#2)(2009-8#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
because a##9##2##(1991-12#1)(1992-12#1)(2008-10#5)(2008-8#1)(2009-6#1)
because all##7##2##(1997-7#1)(2008-10#4)(2008-11#1)(2008-8#1)
because at##3##2##(1992-3#1)(1996-2#1)(2008-7#1)
because both##5##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)
because changes in##2##3##(1993-1#1)(2008-8#1)
because data##2##2##(2008-10#2)
because diagnosis is##2##3##(1990-3#1)(2008-5#1)
because different##2##2##(2008-4#1)(2008-9#1)
because each##2##2##(2008-10#1)(2008-9#1)
because early##2##2##(2008-11#1)(2011-2#1)
because environmental##2##2##(2008-11#1)(2008-9#1)
because he was##2##3##(1995-6#2)
because he##5##2##(1995-12#1)(1995-6#2)(1996-5#1)(2013-1#1)
because in##4##2##(2008-10#3)(2008-9#1)
because infection##3##2##(2008-10#3)
because it allows##5##3##(1997-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
because it also##2##3##(1997-1#1)(2006-6#1)
because it can##7##3##(1991-9#1)(1996-6#1)(1997-5#1)(2008-10#2)(2009-1#1)(2013-8#1)
because it does not##4##4##(2008-10#3)(2008-4#1)
because it has been##4##4##(1990-8#1)(1997-2#1)(2011-2#1)(2012-2#1)
because it has##8##3##(1990-8#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
because it is a##2##4##(1992-6#1)(2008-10#1)
because it is important to##2##5##(2008-4#1)(2013-1#1)
because it is##21##3##(1991-3#1)(1992-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
because it may##4##3##(1993-11#1)(2008-11#2)(2008-7#1)
because it prevents##2##3##(2008-10#1)(2008-7#1)
because it provides a##2##4##(2008-10#1)(2009-3#1)
because it provides##3##3##(2008-10#2)(2009-3#1)
because it was##10##3##(1995-6#1)(1997-6#2)(2008-10#6)(2008-7#1)
because it##95##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-11#2)(1993-3#1)(1994-8#1)(1995-6#2)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2008-10#32)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#6)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
because its##7##2##(1995-2#1)(1995-8#1)(2008-10#4)(2009-12#1)
because many##3##2##(2008-11#2)(2008-12#1)
because more##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
because most##5##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
because much##2##2##(1995-5#1)(2008-10#1)
because neither##2##2##(2007-11#1)(2013-8#1)
because no##10##2##(2008-10#7)(2011-3#1)(2012-3#1)(2013-8#1)
because of a lack of##2##5##(2008-11#1)(2009-6#1)
because of a##19##3##(1993-12#1)(1993-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#3)(2013-8#1)
because of an##7##3##(1997-4#1)(2008-1#1)(2011-1#2)(2012-3#1)(2013-1#2)
because of differences in##3##4##(1991-11#1)(2008-1#1)(2008-7#1)
because of difficulty in##2##4##(2008-3#1)(2011-7#1)
because of difficulty##3##3##(1992-3#1)(2008-3#1)(2011-7#1)
because of his##2##3##(1995-12#1)(2008-11#1)
because of its high##6##4##(1992-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
because of its higher##2##4##(2008-10#1)(2008-5#1)
because of its##44##3##(1990-5#1)(1992-6#1)(1992-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#1)
because of lack of##2##4##(1995-11#1)(2009-12#1)
because of limited##2##3##(1990-2#1)(2011-2#1)
because of low##3##3##(1996-1#1)(1997-1#1)(2008-10#1)
because of poor##2##3##(2008-10#1)(2008-12#1)
because of precipitation##2##3##(2008-10#2)
because of previous##2##3##(1990-12#1)(2011-2#1)
because of serious side effects##2##5##(2008-10#1)(2011-2#1)
because of severe##4##3##(1990-12#1)(1994-6#1)(2008-12#1)(2011-2#1)
because of side effects##2##4##(1991-6#1)(2011-2#1)
because of slow##3##3##(1991-3#1)(1997-3#1)(2012-2#1)
because of the ability of the##2##6##(2008-3#1)(2008-5#1)
because of the ability##3##4##(1994-9#1)(2008-3#1)(2008-5#1)
because of the complex##2##4##(2009-10#1)(2011-2#1)
because of the complexity of the##3##6##(1995-5#1)(2008-10#1)(2010-12#1)
because of the difficulty##2##4##(2008-11#2)
because of the extremely##2##4##(2008-10#1)(2011-2#1)
because of the genetic##2##4##(2008-10#1)(2010-7#1)
because of the high##5##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
because of the higher##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
because of the importance##2##4##(2008-11#1)(2011-2#1)
because of the increasing##2##4##(2008-8#1)(2012-3#1)
because of the lack of a##2##6##(1997-6#1)(2008-10#1)
because of the lack of##5##5##(1997-6#1)(1997-7#1)(2008-10#1)(2013-1#1)(2013-8#1)
because of the low##4##4##(1996-9#1)(2008-7#1)(2011-1#1)(2012-3#1)
because of the presence of##3##5##(1991-11#1)(1992-2#1)(2008-10#1)
because of the reduced##2##4##(2008-10#1)(2011-2#1)
because of the risk of##2##5##(2008-8#1)(2013-1#1)
because of the risk##3##4##(1992-3#1)(2008-8#1)(2013-1#1)
because of the small##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
because of the use of##2##5##(2008-10#1)(2008-11#1)
because of the##137##3##(1990-11#1)(1990-12#1)(1991-11#1)(1992-2#3)(1992-3#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#25)(2008-11#13)(2008-12#4)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#9)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#2)
because of their high##5##4##(1995-6#1)(2008-11#2)(2008-7#1)(2008-9#1)
because of their##29##3##(1992-12#2)(1992-5#1)(1995-6#1)(1997-1#1)(2006-5#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#4)(2013-7#2)(2013-8#1)
because of this##2##3##(1993-1#1)(2008-11#1)
because of##414##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#4)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-9#2)(1994-11#1)(1994-2#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#4)(2006-5#2)(2007-12#1)(2008-1#2)(2008-10#62)(2008-11#30)(2008-12#9)(2008-2#2)(2008-3#18)(2008-5#16)(2008-6#1)(2008-7#17)(2008-8#12)(2008-9#11)(2009-1#3)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#4)(2011-1#5)(2011-2#42)(2011-7#2)(2012-12#5)(2012-2#7)(2012-3#11)(2013-1#18)(2013-7#2)(2013-8#6)
because only##2##2##(2008-11#1)(2011-2#1)
because preoperative##2##2##(1996-9#1)(2013-1#1)
because responding##2##2##(2008-5#2)
because similar##2##2##(1997-1#1)(2008-10#1)
because some##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
because such##4##2##(2008-11#1)(2008-2#1)(2011-1#1)(2012-2#1)
because the data##2##3##(2008-10#1)(2008-11#1)
because the first##2##3##(1990-3#1)(2008-10#1)
because the liver##2##3##(2008-1#1)(2010-7#1)
because the patient##2##3##(1993-12#1)(2013-1#1)
because the prevention of##2##4##(2008-10#1)(2010-12#1)
because the spatial pattern of CTV incidence at the within-group scale##2##11##(2008-10#2)
because the##109##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-9#3)(1994-1#1)(1994-3#1)(1995-11#2)(1995-12#1)(1996-3#1)(1996-5#5)(1996-6#1)(1997-3#3)(1997-6#2)(2008-1#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#2)(2010-7#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
because their##7##2##(1993-9#1)(2008-10#3)(2008-11#1)(2010-8#1)(2013-8#1)
because there are only##2##4##(2007-12#1)(2011-2#1)
because there are##4##3##(1992-3#1)(2007-12#1)(2008-8#1)(2011-2#1)
because there is a##3##4##(2008-10#1)(2011-2#2)
because there is no known##2##5##(1995-6#1)(2013-1#1)
because there is no##6##4##(1995-2#1)(1995-6#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
because there is##9##3##(1995-2#1)(1995-6#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)
because there##15##2##(1992-3#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#3)(2013-1#1)
because these##5##2##(1990-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
because they are##7##3##(2008-10#2)(2008-4#1)(2008-9#1)(2009-4#1)(2012-2#2)
because they can##3##3##(1997-3#1)(2008-10#1)(2012-3#1)
because they do not##3##4##(1996-6#1)(2008-10#1)(2008-8#1)
because they have##2##3##(2008-10#1)(2008-11#1)
because they may##2##3##(2008-7#1)(2008-9#1)
because they provide##2##3##(2008-9#1)(2011-2#1)
because they were##4##3##(1996-12#1)(2008-10#1)(2010-9#1)(2013-1#1)
because they##50##2##(1991-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)
because this##8##2##(1992-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
because we##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-7#1)(2012-2#1)
because working wavelength determination was more precise and spectral overlap was less##2##12##(2008-10#2)
because##1000##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-9#3)(1992-11#2)(1992-12#5)(1992-2#6)(1992-3#8)(1992-5#2)(1992-6#2)(1992-9#4)(1993-1#5)(1993-11#6)(1993-12#5)(1993-2#2)(1993-3#6)(1993-6#2)(1993-9#6)(1994-1#2)(1994-11#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#9)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#11)(1995-8#2)(1996-1#4)(1996-11#4)(1996-12#6)(1996-2#3)(1996-3#2)(1996-5#9)(1996-6#6)(1996-9#3)(1997-1#8)(1997-2#4)(1997-3#10)(1997-4#4)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#6)(2006-5#2)(2006-6#2)(2007-11#1)(2007-12#3)(2008-1#4)(2008-10#229)(2008-11#65)(2008-12#16)(2008-2#6)(2008-3#29)(2008-4#11)(2008-5#26)(2008-6#3)(2008-7#31)(2008-8#50)(2008-9#38)(2009-1#5)(2009-10#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#4)(2010-10#3)(2010-11#4)(2010-12#8)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#12)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#69)(2011-3#1)(2011-7#2)(2012-12#8)(2012-2#20)(2012-3#24)(2013-1#37)(2013-7#3)(2013-8#12)
beclomethasone dipropionate##2##2##(1996-1#1)(2008-10#1)
beclomethasone##3##1##(1996-1#1)(1997-2#1)(2008-10#1)
become &quot##3##2##(1996-1#1)(2008-11#2)
become a major##5##3##(2008-10#1)(2008-11#1)(2009-11#1)(2010-7#1)(2011-2#1)
become a part of##2##4##(1995-12#1)(2008-10#1)
become a powerful tool for##2##5##(2008-10#1)(2008-8#1)
become a powerful tool##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
become a powerful##7##3##(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
become a priority##2##3##(2008-9#1)(2013-1#1)
become a serious##2##3##(1991-6#1)(1996-3#1)
become a##58##2##(1990-9#1)(1991-6#1)(1992-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#10)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-9#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
become active##3##2##(2008-4#1)(2013-1#2)
become an accepted##2##3##(1997-4#1)(2010-11#1)
become an essential##2##3##(1992-1#1)(2008-10#1)
become an important##6##3##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2011-3#1)(2011-7#1)
become an##23##2##(1992-1#1)(1994-2#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#2)(2011-3#2)(2011-7#1)(2012-2#1)(2012-3#1)
become apparent that##5##3##(1997-1#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
become apparent##7##2##(1997-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
become available in##2##3##(2011-2#1)(2013-1#1)
become available##13##2##(1992-1#1)(1992-3#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
become capable##2##2##(2008-11#1)(2008-12#1)
become clinical##2##2##(1997-1#1)(2008-12#1)
become confluent##2##2##(1991-5#1)(1992-3#1)
become established##3##2##(2008-10#3)
become familiar##2##2##(2008-11#1)(2011-2#1)
become feasible with##2##3##(2008-10#1)(2008-11#1)
become feasible##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
become fragmented in the micropylar end##2##6##(2008-11#1)(2008-9#1)
become important##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2012-5#1)
become increasingly important##6##3##(1995-1#2)(2008-10#2)(2008-11#1)(2010-12#1)
become increasingly##18##2##(1995-1#2)(1995-2#1)(1995-3#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-9#2)(2009-6#1)(2010-12#1)(2012-2#1)(2012-3#1)
become infected##4##2##(2008-10#3)(2013-1#1)
become institutionalised##2##2##(2011-2#2)
become involved in##2##3##(1996-3#1)(2008-11#1)
become involved##3##2##(1994-1#1)(1996-3#1)(2008-11#1)
become known##2##2##(1992-12#1)(2009-5#1)
become less##3##2##(1990-11#1)(2008-1#1)(2008-10#1)
become linked##2##2##(2008-11#1)(2008-7#1)
become locally##2##2##(2008-6#1)(2008-9#1)
become manifest##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
become members of##2##3##(1997-5#1)(2008-11#1)
become more aware of##3##4##(2008-10#1)(2010-6#1)(2010-9#1)
become more of##2##3##(2008-11#1)(2008-9#1)
become more prevalent##2##3##(2008-10#1)(2012-12#1)
become more##31##2##(1991-12#1)(1992-3#1)(1993-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
become one of the##4##4##(1991-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
become one##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
become organized into##2##3##(2008-11#1)(2008-9#1)
become part of##6##3##(1992-1#1)(2006-6#1)(2008-10#1)(2008-12#1)(2009-11#1)(2010-9#1)
become particularly##2##2##(2008-7#1)(2012-2#1)
become popular##2##2##(1993-1#1)(2012-2#1)
become possible##2##2##(2008-5#1)(2010-12#1)
become prevalent in##2##3##(1991-2#1)(2008-10#1)
become resistant to tamoxifen##2##4##(1993-1#2)
become resistant to##5##3##(1993-1#2)(2008-10#3)
become resistant##6##2##(1993-1#2)(2008-10#4)
become routine in##2##3##(2008-9#1)(2010-5#1)
become significant##3##2##(2007-11#1)(2008-10#1)(2011-3#1)
become standard##2##2##(2010-12#1)(2012-12#1)
become symptomatic##3##2##(2008-10#2)(2010-12#1)
become the most##5##3##(1994-9#1)(2008-10#3)(2008-12#1)
become the predominant##2##3##(1995-6#1)(2008-1#1)
become the standard##4##3##(1994-12#1)(2008-11#1)(2011-2#2)
become the##36##2##(1991-9#1)(1994-12#3)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#1)(2011-2#4)(2012-2#2)(2013-1#1)
become very##3##2##(2008-10#2)(2010-1#1)
become widely used##3##3##(1996-1#1)(2008-11#1)(2013-1#1)
become widely##5##2##(1996-1#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
become##408##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#4)(1993-1#4)(1993-11#1)(1993-12#4)(1994-1#2)(1994-12#6)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#3)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#7)(1996-5#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#5)(2008-1#5)(2008-10#77)(2008-11#46)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#18)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#3)(2011-2#26)(2011-3#6)(2011-7#1)(2012-12#5)(2012-2#14)(2012-3#5)(2012-5#1)(2013-1#13)(2013-8#7)
becomes a more##2##3##(1994-12#1)(2008-11#1)
becomes a##14##2##(1991-11#1)(1991-2#1)(1993-12#1)(1994-12#2)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)(2012-2#1)(2013-7#1)
becomes active##2##2##(2008-10#2)
becomes an##2##2##(1995-2#1)(2008-10#1)
becomes available##3##2##(1991-3#1)(1993-12#1)(2008-7#1)
becomes evident##2##2##(2008-10#1)(2011-2#1)
becomes increasingly##4##2##(1995-2#1)(2008-11#1)(2008-9#1)(2009-9#1)
becomes large##2##2##(2008-2#1)(2008-3#1)
becomes more and more##2##4##(2008-10#1)(2008-9#1)
becomes more##12##2##(1991-7#1)(1992-3#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)
becomes possible##2##2##(2008-10#1)(2008-5#1)
becomes progressively##3##2##(2008-10#1)(2008-12#1)(2010-7#1)
becomes the##6##2##(1993-12#1)(1994-12#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-8#1)
becomes##125##1##(1990-12#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#3)(1993-8#2)(1994-12#5)(1994-3#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#26)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#7)(2008-7#5)(2008-8#4)(2008-9#6)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
becoming a smoker (AOR = 1##2##6##(2013-1#2)
becoming a##14##2##(1994-3#1)(1996-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#3)
becoming an important##6##3##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)
becoming an increasingly##5##3##(2006-6#1)(2008-8#1)(2010-10#1)(2013-1#2)
becoming an##13##2##(2006-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#2)
becoming available##3##2##(2008-10#2)(2008-6#1)
becoming aware of the##2##4##(1991-2#1)(2008-6#1)
becoming increasingly important##2##3##(2008-11#1)(2011-2#1)
becoming increasingly popular##2##3##(1994-9#1)(2011-2#1)
becoming increasingly##9##2##(1994-6#1)(1994-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2011-2#2)
becoming infected with##2##3##(1995-6#1)(2008-9#1)
becoming infected##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
becoming more##9##2##(1991-3#1)(1992-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2010-7#1)(2011-2#1)
becoming the##6##2##(1990-2#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
becoming##103##1##(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#4)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#15)(2008-11#14)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
bed bioreactor using##2##3##(2008-11#2)
bed bioreactor##8##2##(2008-11#8)
bed boost##2##2##(2011-2#2)
bed by##2##2##(2008-10#1)(2008-11#1)
bed for##3##2##(2008-10#2)(2008-11#1)
bed of##5##2##(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)
bed reactor##3##2##(2008-11#1)(2008-7#2)
bed size##2##2##(1993-12#1)(1996-1#1)
bed was##3##2##(2008-10#2)(2008-11#1)
bed##77##1##(1990-12#1)(1991-2#4)(1993-12#1)(1994-2#1)(1995-11#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#16)(2008-11#28)(2008-12#1)(2008-7#9)(2008-9#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-3#1)(2013-1#2)
bed)##2##1##(2008-11#1)(2010-12#1)
bedding##3##1##(1991-11#2)(2008-10#1)
bedrest##2##1##(1993-6#2)
beds and##4##2##(1997-6#1)(2013-8#3)
beds are##3##2##(1991-1#1)(1997-6#1)(2011-2#1)
beds in##2##2##(1996-3#1)(2008-11#1)
beds is##2##2##(1997-5#1)(2010-9#1)
beds where stem gall had##2##5##(2008-10#2)
beds##52##1##(1990-9#1)(1991-1#3)(1991-3#1)(1991-6#4)(1991-8#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-3#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2008-10#5)(2008-11#3)(2008-12#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-9#3)(2011-2#3)(2013-8#7)
bedside##12##1##(1993-3#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-11#2)(2009-6#3)(2010-5#1)
bee products##3##2##(2008-10#3)
bee venom##2##2##(2008-10#2)
bee##18##1##(2007-12#1)(2008-10#7)(2008-6#3)(2008-7#3)(2008-8#1)(2013-1#3)
beef and##2##2##(2008-10#1)(2013-1#1)
beef cattle##4##2##(1991-3#2)(2012-3#2)
beef herds##2##2##(2012-3#2)
beef patties##9##2##(2010-4#9)
beef##48##1##(1990-5#2)(1991-3#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(2008-10#16)(2008-11#1)(2010-4#14)(2012-3#5)(2013-1#3)
beef-in-sauce products##3##2##(2011-2#3)
beehives were##2##2##(2008-10#2)
beekeepers##4##1##(2008-10#4)
been a concern##2##3##(2008-12#1)(2011-1#1)
been a major##4##3##(1990-6#1)(2008-10#2)(2008-5#1)
been a problem##2##3##(1995-9#1)(2008-9#1)
been a source of##2##4##(2008-10#1)(2008-12#1)
been a well known##2##4##(1994-5#1)(1997-5#1)
been a##87##2##(1990-11#1)(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-9#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-5#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-3#2)(1997-1#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-10#13)(2008-11#12)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-4#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
been able to##15##3##(1992-9#1)(1994-9#1)(1996-11#1)(1996-8#1)(1997-7#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-8#2)(2012-2#1)
been absorbed##2##2##(2008-10#1)(2008-6#1)
been accompanied by an##2##4##(2008-10#1)(2008-11#1)
been accompanied by##5##3##(1996-2#1)(2008-10#2)(2008-11#2)
been accomplished##11##2##(1991-6#1)(1992-2#1)(1997-6#1)(2008-10#7)(2012-3#1)
been achieved at##2##3##(1995-12#1)(2010-4#1)
been achieved by##5##3##(1992-9#1)(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
been achieved for##2##3##(2007-12#1)(2008-10#1)
been achieved in the##4##4##(1997-7#1)(2008-12#1)(2008-7#1)(2011-2#1)
been achieved in##8##3##(1996-3#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
been achieved using##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
been achieved with##2##3##(2008-10#2)
been achieved##54##2##(1991-2#1)(1992-9#1)(1993-1#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#23)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#3)(2010-12#1)(2010-4#2)(2011-2#3)(2011-4#1)(2012-12#2)(2012-3#1)
been acknowledged##3##2##(2008-11#2)(2011-2#1)
been acquired in##2##3##(2008-10#1)(2008-3#1)
been acquired##8##2##(1997-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)
been adapted in##2##3##(1995-12#1)(2008-10#1)
been adapted to##3##3##(2008-11#1)(2008-12#1)(2010-7#1)
been adapted##5##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)
been added as##2##3##(1994-12#1)(2008-11#1)
been added to the##2##4##(2008-10#1)(2008-3#1)
been added to##6##3##(2008-10#4)(2008-3#1)(2013-7#1)
been added##9##2##(1994-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2013-7#1)
been addressed by##3##3##(2008-9#1)(2012-2#2)
been addressed in##2##3##(2008-11#1)(2008-9#1)
been addressed##8##2##(2008-10#2)(2008-11#1)(2008-9#2)(2010-1#1)(2012-2#2)
been adequately##3##2##(1997-8#1)(2008-11#1)(2010-5#1)
been administered to##2##3##(1995-5#1)(2010-8#1)
been administered##6##2##(1990-9#1)(1995-5#1)(2008-12#1)(2010-8#2)(2011-3#1)
been admitted##2##2##(1990-12#1)(2012-3#1)
been adopted##3##2##(1994-9#1)(2010-8#1)(2011-3#1)
been advised##3##2##(1991-6#1)(2008-10#1)(2010-11#1)
been advocated to##2##3##(1991-3#1)(1991-6#1)
been advocated##8##2##(1991-3#1)(1991-6#1)(1996-3#2)(2008-11#2)(2010-2#1)(2013-1#1)
been also##15##2##(2008-10#13)(2008-8#1)(2010-7#1)
been always a##2##3##(2008-10#1)(2008-11#1)
been always##3##2##(1990-9#1)(2008-10#1)(2008-11#1)
been an emerging##2##3##(2012-3#1)(2013-8#1)
been an important##3##3##(2008-8#1)(2008-9#1)(2010-7#1)
been an##29##2##(1990-3#1)(1992-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
been analysed in##2##3##(1991-5#1)(2008-10#1)
been analysed using the##2##4##(2008-10#2)
been analysed##12##2##(1991-5#1)(2008-10#10)(2008-3#1)
been analyzed by##6##3##(1992-2#1)(1992-9#1)(1995-6#1)(2008-10#2)(2008-8#1)
been analyzed in##3##3##(1991-5#1)(1994-3#1)(2008-10#1)
been analyzed##18##2##(1991-5#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2012-3#1)
been applied for the determination of##4##6##(2008-10#4)
been applied for the##7##4##(2008-10#7)
been applied for##15##3##(2008-10#14)(2012-3#1)
been applied in the##4##4##(2008-10#4)
been applied in##15##3##(2008-10#12)(2008-11#1)(2008-8#1)(2010-12#1)
been applied to determine##8##4##(2008-10#8)
been applied to different##2##4##(2008-10#1)(2010-9#1)
been applied to the analysis of##9##6##(2008-10#9)
been applied to the determination of trace##10##7##(2008-10#10)
been applied to the determination of##51##6##(2008-10#51)
been applied to the direct determination of##3##7##(2008-10#3)
been applied to the##83##4##(1991-2#1)(1992-3#1)(2008-10#79)(2008-8#1)(2010-7#1)
been applied to##131##3##(1990-5#1)(1991-2#1)(1992-3#2)(1996-1#1)(2008-10#117)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)
been applied##193##2##(1990-5#1)(1990-9#1)(1991-2#1)(1992-3#2)(1996-1#1)(1996-3#1)(2008-10#168)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-3#1)
been appreciated##4##2##(2008-8#2)(2008-9#1)(2012-3#1)
been approached##3##2##(1992-9#1)(2008-10#1)(2012-12#1)
been approved##9##2##(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
been assessed by##3##3##(1994-3#1)(2008-11#1)(2013-1#1)
been assessed in##3##3##(2008-10#2)(2008-5#1)
been assessed with##3##3##(2008-10#3)
been assessed##15##2##(1994-3#1)(1995-3#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
been assigned for##2##3##(1993-8#1)(2008-11#1)
been assigned to the##4##4##(1996-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
been assigned to##7##3##(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
been assigned##13##2##(1993-8#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)
been associated to##2##3##(2009-6#1)(2013-1#1)
been associated with a##5##4##(2008-10#2)(2008-6#1)(2011-2#1)(2013-8#1)
been associated with the##5##4##(1997-1#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-8#1)
been associated with##37##3##(1992-3#1)(1993-3#1)(1993-6#1)(1994-5#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-5#3)(2008-6#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#5)
been associated##41##2##(1992-3#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#5)
been assumed to##2##3##(2008-10#1)(2013-1#1)
been assumed##6##2##(2008-10#3)(2008-11#1)(2008-2#1)(2013-1#1)
been at##2##2##(2008-11#1)(2012-7#1)
been attained##3##2##(1996-2#1)(2008-11#1)(2008-3#1)
been attempted##5##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
been attributed to a##2##4##(2008-10#1)(2008-7#1)
been attributed to the##4##4##(2008-10#3)(2008-8#1)
been attributed to their##2##4##(1994-5#1)(2009-3#1)
been attributed to##17##3##(1991-2#1)(1991-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-1#1)(2012-2#1)
been attributed##18##2##(1991-2#1)(1991-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-1#1)(2012-2#1)
been available for##5##3##(1994-2#1)(1995-11#1)(2008-5#1)(2008-6#1)(2008-9#1)
been available in##2##3##(1996-3#1)(2012-3#1)
been available##12##2##(1991-12#1)(1994-2#1)(1995-11#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-3#1)
been based on##2##3##(1997-6#1)(2008-8#1)
been briefly##3##2##(2008-10#3)
been built##5##2##(2008-11#1)(2008-3#3)(2008-8#1)
been calculated and##3##3##(2008-10#2)(2008-3#1)
been calculated##16##2##(1992-9#1)(1993-2#1)(1994-5#1)(1997-4#1)(2008-10#10)(2008-3#2)
been called##5##2##(1990-5#1)(1994-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
been carried out at the##2##5##(1997-6#1)(2008-10#1)
been carried out at##3##4##(1997-6#1)(2008-10#2)
been carried out by##13##4##(1990-3#1)(2008-10#11)(2012-3#1)
been carried out for the##2##5##(2008-10#1)(2010-12#1)
been carried out for##4##4##(2008-10#2)(2008-3#1)(2010-12#1)
been carried out in order to##2##6##(1994-5#1)(2008-10#1)
been carried out in the##3##5##(2008-10#2)(2011-2#1)
been carried out in##12##4##(1994-5#1)(2008-10#7)(2008-11#2)(2008-5#1)(2011-2#1)
been carried out on the##2##5##(2008-10#1)(2008-3#1)
been carried out on##5##4##(2008-10#4)(2008-3#1)
been carried out to##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
been carried out using a##2##5##(2008-10#2)
been carried out using##6##4##(2008-10#4)(2009-3#1)(2010-7#1)
been carried out within the##2##5##(1990-3#1)(2008-3#1)
been carried out within##3##4##(1990-3#1)(2008-3#1)(2010-7#1)
been carried out##68##3##(1990-3#2)(1990-9#2)(1994-5#1)(1997-6#1)(2008-10#42)(2008-11#3)(2008-3#3)(2008-5#4)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-3#3)
been carried##70##2##(1990-3#2)(1990-9#2)(1994-5#1)(1997-6#1)(2008-10#42)(2008-11#3)(2008-3#3)(2008-5#4)(2008-7#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-3#3)
been categorized as##2##3##(2008-5#1)(2013-1#1)
been categorized##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
been certified##3##2##(1991-6#1)(2008-10#1)(2013-1#1)
been challenged##2##2##(2008-1#1)(2008-10#1)
been characterised by##2##3##(2008-10#2)
been characterised##5##2##(1996-2#1)(2008-10#3)(2012-5#1)
been characterized by##10##3##(1993-1#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
been characterized in##7##3##(1990-11#2)(1991-7#1)(1993-2#1)(2008-10#1)(2009-8#1)(2012-2#1)
been characterized using##2##3##(2008-10#2)
been characterized##39##2##(1990-11#2)(1991-7#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-6#2)(2008-10#14)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
been chemically##2##2##(1995-5#1)(2008-10#1)
been chosen as##3##3##(1991-5#1)(2008-10#2)
been chosen##4##2##(1991-5#1)(2008-10#3)
been cited as##2##3##(2008-7#1)(2008-8#1)
been cited##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
been clarified##2##2##(1993-3#1)(2012-2#1)
been classified as##3##3##(2008-7#1)(2010-6#1)(2012-3#1)
been classified into##2##3##(2008-6#1)(2012-3#1)
been classified##6##2##(1996-12#1)(2008-6#1)(2008-7#1)(2010-6#1)(2012-3#2)
been clearly established##2##3##(2008-10#1)(2011-2#1)
been clearly##11##2##(1990-11#1)(1990-8#1)(2008-10#4)(2008-11#1)(2011-2#3)(2012-2#1)
been clinically##3##2##(2009-8#1)(2011-2#1)(2011-3#1)
been cloned and sequenced##6##4##(1993-12#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
been cloned and##11##3##(1990-5#1)(1992-10#1)(1993-12#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)
been cloned from a##3##4##(1993-12#1)(1994-11#1)(1996-2#1)
been cloned from##5##3##(1993-12#1)(1994-11#1)(1996-2#1)(2008-8#1)(2008-9#1)
been cloned##31##2##(1990-5#1)(1992-10#1)(1993-12#3)(1994-11#1)(1995-12#1)(1995-6#2)(1996-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#4)(2010-12#1)(2011-1#1)
been collected##12##2##(1994-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
been combined with##3##3##(2008-10#2)(2008-8#1)
been combined##4##2##(2008-10#3)(2008-8#1)
been commercialized##2##2##(1992-11#1)(2012-3#1)
been compared to##6##3##(1993-9#1)(2008-10#2)(2008-11#3)
been compared with that of##5##5##(1996-2#1)(2008-10#4)
been compared with the##2##4##(1990-9#1)(2008-10#1)
been compared with those##2##4##(2008-10#2)
been compared with##14##3##(1990-9#1)(1996-2#1)(2008-10#11)(2008-3#1)
been compared##33##2##(1990-9#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-10#21)(2008-11#4)(2008-3#3)
been compiled##3##2##(2008-10#2)(2008-11#1)
been completed##10##2##(1991-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)
been completely sequenced##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
been completely##5##2##(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#1)
been conclusively##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
been conducted on##5##3##(2008-10#2)(2011-2#2)(2012-2#1)
been conducted to##5##3##(2008-11#2)(2008-12#1)(2008-6#1)(2010-12#1)
been conducted##25##2##(1996-2#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#2)(2011-2#3)(2012-2#1)(2013-1#3)
been confirmed by##5##3##(1990-9#1)(2008-10#2)(2008-8#1)(2009-12#1)
been confirmed in##5##3##(1997-9#1)(2008-10#2)(2008-12#1)(2008-9#1)
been confirmed to##2##3##(2008-10#1)(2013-1#1)
been confirmed##20##2##(1990-9#1)(1995-8#1)(1997-9#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-7#1)(2013-1#2)
been conjugated##2##2##(2008-7#1)(2008-9#1)
been conserved##3##2##(1997-9#1)(2009-6#1)(2012-2#1)
been considered a##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
been considered as a##2##4##(2008-12#1)(2012-3#1)
been considered as an##2##4##(1997-6#1)(2010-6#1)
been considered as##7##3##(1997-6#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-5#1)(2010-6#1)(2012-3#1)
been considered in##2##3##(2008-10#1)(2013-1#1)
been considered to be##2##4##(2008-11#1)(2011-2#1)
been considered##25##2##(1995-2#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#2)
been consistent##2##2##(1994-12#1)(2008-11#1)
been constructed and##2##3##(2008-9#2)
been constructed for##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
been constructed##20##2##(1991-6#1)(1993-12#1)(1996-3#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2011-2#2)
been controlled by operating##2##4##(2008-7#2)
been controlled by##4##3##(2008-10#2)(2008-7#2)
been controlled##6##2##(2008-10#3)(2008-7#2)(2013-1#1)
been controversial##3##2##(1990-5#1)(2008-7#1)(2010-6#1)
been correlated with the##2##4##(1997-6#1)(2008-10#1)
been correlated with##6##3##(1991-6#1)(1997-6#1)(2008-10#2)(2008-9#1)(2012-3#1)
been correlated##7##2##(1991-6#1)(1997-6#1)(2008-10#3)(2008-9#1)(2012-3#1)
been coupled##4##2##(1992-9#1)(2008-10#2)(2010-7#1)
been created##4##2##(1991-6#1)(2008-11#1)(2010-6#2)
been critically##4##2##(2008-10#3)(2011-3#1)
been criticized for##2##3##(1994-12#1)(1996-2#1)
been criticized##6##2##(1991-1#1)(1994-12#1)(1996-1#1)(1996-2#1)(2008-10#1)(2013-1#1)
been crucial##2##2##(2008-11#2)
been cultured##2##2##(2008-11#2)
been debated##3##2##(1991-9#1)(1996-3#1)(2008-8#1)
been decided##2##2##(1996-12#1)(2011-3#1)
been decreasing##3##2##(1990-3#1)(1991-3#1)(1992-2#1)
been deduced##5##2##(1992-10#1)(1995-8#1)(2008-10#3)
been defined as a##2##4##(1995-12#1)(2008-10#1)
been defined as##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
been defined by##4##3##(1996-2#1)(2008-5#1)(2010-8#2)
been defined in##3##3##(2009-12#1)(2012-2#1)(2012-3#1)
been defined##19##2##(1991-11#1)(1992-12#1)(1995-12#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2009-12#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)
been delivered##3##2##(1991-1#1)(2008-11#1)(2011-2#1)
been demonstrated by##7##3##(1993-6#1)(1994-5#1)(2008-10#3)(2008-3#1)(2008-8#1)
been demonstrated in##17##3##(1990-8#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
been demonstrated to be a##4##5##(2008-10#2)(2008-11#1)(2011-2#1)
been demonstrated to be##10##4##(1991-6#1)(1995-6#1)(2008-10#4)(2008-11#1)(2010-12#1)(2010-5#1)(2011-2#1)
been demonstrated to have##2##4##(2009-3#1)(2013-7#1)
been demonstrated to##15##3##(1991-6#1)(1992-5#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
been demonstrated##100##2##(1990-2#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-2#2)(2007-11#1)(2008-10#27)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
been deployed##2##2##(1997-2#1)(2008-11#1)
been deposited##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
been derived from##7##3##(1992-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2010-8#1)(2012-4#1)
been derived##11##2##(1992-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-4#1)
been described and##6##3##(2008-10#3)(2009-7#1)(2010-12#1)(2011-2#1)
been described as a##2##4##(2008-10#1)(2012-12#1)
been described as##10##3##(1990-11#1)(1990-5#1)(1992-6#1)(1994-2#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-2#1)(2012-12#1)
been described by##3##3##(1996-1#1)(2008-10#1)(2010-12#1)
been described earlier##2##3##(2008-11#1)(2008-7#1)
been described for the##12##4##(1994-9#1)(2008-10#11)
been described for##23##3##(1994-9#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2013-1#3)
been described in other##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
been described in the literature##4##5##(2008-10#1)(2012-12#1)(2012-2#2)
been described in##24##3##(1990-5#1)(1992-12#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
been described on##2##3##(1992-10#1)(1995-8#1)
been described so far##3##4##(1991-6#1)(2008-5#1)(2013-1#1)
been described that##4##3##(1994-5#1)(2008-12#1)(2010-6#1)(2013-1#1)
been described to be##2##4##(1993-6#1)(2010-5#1)
been described to##4##3##(1993-6#1)(2008-11#1)(2010-5#1)(2010-8#1)
been described with##2##3##(1997-3#1)(2011-2#1)
been described##132##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#44)(2008-11#10)(2008-12#4)(2008-3#2)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#1)
been designed and synthesized##2##4##(2008-10#2)
been designed and##5##3##(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
been designed so##2##3##(2008-5#1)(2010-8#1)
been designed to##5##3##(1993-3#1)(2008-10#1)(2008-3#1)(2010-1#1)(2012-2#1)
been designed##20##2##(1993-3#1)(1995-3#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2010-1#1)(2010-8#1)(2012-2#1)
been detected in many##2##4##(2008-10#2)
been detected in the##3##4##(1995-8#1)(2010-12#1)(2011-2#1)
been detected in##16##3##(1990-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
been detected with##2##3##(1997-7#1)(2008-3#1)
been detected##32##2##(1990-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-7#1)(1997-8#2)(2008-10#13)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
been determined and##4##3##(1993-3#1)(1996-3#1)(2008-10#2)
been determined at##11##3##(1993-8#1)(1994-12#1)(2008-10#8)(2008-3#1)
been determined by means of##3##5##(2008-10#2)(2008-3#1)
been determined by the##2##4##(2008-10#1)(2008-5#1)
been determined by##23##3##(1990-8#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-5#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
been determined for##3##3##(1993-3#1)(1994-5#1)(2008-10#1)
been determined in##10##3##(1992-12#1)(1992-6#1)(2008-10#8)
been determined simultaneously with##2##4##(2008-10#2)
been determined simultaneously##3##3##(2008-10#3)
been determined using##6##3##(1992-7#1)(1994-5#2)(2008-10#3)
been determined##107##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#4)(1996-2#1)(1996-3#2)(1996-8#1)(1997-2#1)(2008-10#62)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#1)
been developed and applied##3##4##(2008-10#3)
been developed and used##3##4##(2008-10#2)(2008-11#1)
been developed and validated##2##4##(2008-10#1)(2008-5#1)
been developed and##28##3##(1991-2#1)(1992-1#1)(1993-11#1)(1996-1#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#2)(2013-1#1)
been developed as##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)
been developed based##7##3##(1992-3#1)(2008-10#5)(2008-4#1)
been developed by##12##3##(2008-10#11)(2013-1#1)
been developed for a##3##4##(1996-5#1)(2008-3#1)(2008-9#1)
been developed for analysis of##2##5##(2008-10#1)(2012-12#1)
been developed for determination of##6##5##(2008-10#6)
been developed for measuring##2##4##(2008-10#1)(2008-5#1)
been developed for the detection of##2##6##(2008-10#2)
been developed for the detection##3##5##(2008-10#3)
been developed for the determination of##37##6##(2008-10#36)(2008-3#1)
been developed for the determination##38##5##(2008-10#37)(2008-3#1)
been developed for the extraction of##2##6##(2008-10#2)
been developed for the simultaneous determination of##8##7##(2008-10#8)
been developed for the simultaneous##10##5##(2008-10#9)(2008-5#1)
been developed for the##102##4##(1994-2#1)(1996-12#1)(2008-10#90)(2008-11#4)(2008-3#3)(2008-5#1)(2009-12#1)(2010-6#1)
been developed for##160##3##(1990-6#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-10#131)(2008-11#4)(2008-3#7)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#2)(2010-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-3#1)(2012-12#1)
been developed in##13##3##(2008-10#10)(2008-11#1)(2010-7#1)(2011-2#1)
been developed that##6##3##(1994-12#1)(1997-1#1)(2008-2#1)(2008-3#1)(2012-2#2)
been developed to allow##3##4##(1992-3#1)(2008-1#1)(2008-10#1)
been developed to assess##2##4##(2008-10#2)
been developed to be##2##4##(2008-11#1)(2008-12#1)
been developed to detect##2##4##(2008-10#1)(2008-11#1)
been developed to predict the##2##5##(1991-12#1)(2008-10#1)
been developed to provide a##2##5##(1996-2#1)(2008-10#1)
been developed to tackle##2##4##(2011-2#1)(2013-1#1)
been developed to##53##3##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-12#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
been developed using##10##3##(2008-10#10)
been developed which##6##3##(1993-3#1)(2008-10#3)(2009-10#1)(2009-12#1)
been developed with a##3##4##(2008-10#1)(2008-11#1)(2009-7#1)
been developed with##7##3##(1990-2#1)(1994-5#1)(2008-10#3)(2008-11#1)(2009-7#1)
been developed##488##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1993-11#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#344)(2008-11#17)(2008-12#3)(2008-2#2)(2008-3#15)(2008-4#4)(2008-5#7)(2008-7#4)(2008-9#6)(2009-10#1)(2009-12#4)(2009-7#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#4)(2010-4#1)(2010-6#1)(2010-7#6)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
been devised##4##2##(1992-11#1)(2008-10#1)(2008-11#1)(2010-3#1)
been diagnosed as##2##3##(1991-9#1)(1996-11#1)
been diagnosed with##4##3##(2008-7#1)(2010-10#1)(2013-1#2)
been diagnosed##9##2##(1991-9#1)(1994-12#1)(1996-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#2)
been difficult to##8##3##(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2013-8#1)
been difficult##12##2##(1993-12#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2011-7#1)(2013-8#1)
been directed at##2##3##(2008-5#1)(2009-12#1)
been directed##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#2)
been disappointing##2##2##(2010-7#1)(2010-8#1)
been discovered in the##2##4##(1991-7#1)(2008-7#1)
been discovered in##7##3##(1990-11#2)(1991-7#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-7#1)
been discovered to##2##3##(2008-5#1)(2013-7#1)
been discovered##14##2##(1990-11#2)(1991-7#1)(1994-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2013-7#1)
been discussed in terms of the##2##6##(2008-10#1)(2008-11#1)
been discussed in the literature##2##5##(2008-7#1)(2011-2#1)
been discussed in the##5##4##(2008-10#2)(2008-7#1)(2011-2#1)(2011-3#1)
been discussed in##10##3##(2008-10#5)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2011-3#1)
been discussed##27##2##(2008-10#19)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
been disseminated##2##2##(2008-10#2)
been distributed##3##2##(1990-2#2)(1997-3#1)
been divided into##2##3##(2008-10#1)(2011-2#1)
been documented in##4##3##(1997-1#1)(2007-12#1)(2008-12#1)(2012-2#1)
been documented##16##2##(1994-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
been done in##6##3##(1991-3#1)(1997-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
been done with##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
been done##18##2##(1990-12#1)(1991-3#2)(1994-3#1)(1996-1#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
been elaborated##4##2##(1992-11#1)(2008-10#3)
been eliminated##3##2##(2008-10#3)
been elucidated##8##2##(1991-6#1)(1993-1#1)(1995-12#1)(1995-9#1)(1996-5#1)(2008-10#2)(2012-2#1)
been employed for##8##3##(1990-12#1)(1992-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-2#1)
been employed in the##2##4##(1991-12#1)(2013-1#1)
been employed in##4##3##(1991-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
been employed to##8##3##(1993-8#1)(2008-10#5)(2008-9#1)(2012-3#1)
been employed##29##2##(1990-12#1)(1991-12#1)(1992-12#1)(1993-8#1)(1996-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#2)(2012-3#1)(2013-1#1)
been endorsed by##2##3##(2008-1#1)(2013-1#1)
been endorsed##4##2##(1997-7#1)(2008-1#1)(2013-1#1)(2013-8#1)
been engineered##2##2##(1997-3#1)(2013-8#1)
been enhanced##2##2##(2008-10#1)(2010-7#1)
been enough##2##2##(1997-1#1)(2008-10#1)
been established and the##2##4##(2011-3#1)(2012-2#1)
been established and##8##3##(2008-10#2)(2010-12#3)(2010-6#1)(2011-3#1)(2012-2#1)
been established as##3##3##(1994-8#1)(2007-11#1)(2010-12#1)
been established by##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
been established for##4##3##(1990-11#1)(2008-10#2)(2011-3#1)
been established in##5##3##(2008-1#1)(2008-10#1)(2008-9#1)(2010-1#1)(2012-3#1)
been established to##2##3##(2008-11#1)(2008-5#1)
been established##65##2##(1990-11#1)(1990-8#1)(1991-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-1#3)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-6#1)(2011-2#4)(2011-3#3)(2012-2#2)(2012-3#5)(2013-1#1)
been estimated##14##2##(1991-2#1)(1992-2#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2010-11#1)(2011-2#2)
been evaluated by##7##3##(1994-3#1)(2008-10#5)(2009-7#1)
been evaluated for##13##3##(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#1)
been evaluated in terms of##2##5##(2008-10#2)
been evaluated in##11##3##(1993-2#1)(1994-8#1)(2008-10#3)(2008-11#2)(2009-1#1)(2009-7#1)(2010-1#1)(2013-1#1)
been evaluated on##2##3##(2008-10#1)(2009-7#1)
been evaluated using##5##3##(1990-11#1)(1990-12#1)(2008-10#2)(2008-9#1)
been evaluated##73##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#1)(1992-2#1)(1993-2#2)(1994-3#1)(1994-8#1)(1995-3#1)(2008-10#42)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-7#3)(2010-1#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
been evidenced in the##2##4##(1996-1#1)(2012-5#1)
been evidenced in##3##3##(1996-1#1)(2012-3#1)(2012-5#1)
been evidenced##4##2##(1996-1#1)(2008-7#1)(2012-3#1)(2012-5#1)
been examined and##3##3##(2008-10#3)
been examined as##3##3##(2008-10#3)
been examined for##3##3##(1997-7#1)(2008-3#1)(2008-5#1)
been examined in the##2##4##(1995-5#1)(2008-10#1)
been examined in##7##3##(1993-2#1)(1993-3#1)(1995-5#2)(2008-10#2)(2010-1#1)
been examined with##2##3##(2008-10#1)(2009-8#1)
been examined##44##2##(1991-2#1)(1991-3#1)(1991-9#1)(1993-2#2)(1993-3#1)(1995-11#1)(1995-5#2)(1997-2#1)(1997-7#1)(2008-10#21)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)
been explained##5##2##(2008-10#2)(2008-11#1)(2008-2#2)
been exploited for##5##3##(1995-5#1)(2008-10#2)(2009-12#1)(2009-3#1)
been exploited to##2##3##(2008-10#1)(2008-4#1)
been exploited##10##2##(1990-8#1)(1995-5#1)(1996-11#1)(2008-10#4)(2008-4#1)(2009-12#1)(2009-3#1)
been explored for##4##3##(2008-10#3)(2009-12#1)
been explored##12##2##(1990-8#1)(1992-9#1)(2008-10#5)(2008-11#2)(2008-9#1)(2009-12#1)(2013-1#1)
been exposed to##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
been exposed##9##2##(1990-9#1)(1991-12#2)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
been expressed in Escherichia coli##3##5##(1991-3#1)(1995-2#1)(1995-6#1)
been expressed in##4##3##(1991-3#1)(1995-2#1)(1995-6#1)(2008-8#1)
been expressed##6##2##(1991-3#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-8#1)(2012-2#1)
been extended for##2##3##(2008-10#1)(2008-3#1)
been extended to##4##3##(1995-5#1)(2008-10#2)(2008-7#1)
been extended##8##2##(1995-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)
been extensive##2##2##(1994-1#1)(2008-10#1)
been extensively explored##2##3##(2008-10#1)(2012-2#1)
been extensively investigated##3##3##(2009-11#2)(2013-8#1)
been extensively studied##6##3##(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-2#1)
been extensively##18##2##(1994-2#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2011-2#1)(2012-2#2)(2013-8#1)
been extracted##3##2##(2008-10#3)
been fabricated by##2##3##(2008-10#1)(2008-3#1)
been fabricated##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
been fed##3##2##(1990-11#1)(1997-5#1)(2011-2#1)
been firmly established##2##3##(1995-8#1)(2008-11#1)
been focused on##5##3##(1996-1#1)(2008-10#3)(2013-8#1)
been focused##9##2##(1996-1#1)(2008-10#4)(2008-11#1)(2009-8#1)(2011-2#1)(2013-8#1)
been followed up##2##3##(1997-8#1)(2008-10#1)
been followed##3##2##(1996-3#1)(1997-8#1)(2008-10#1)
been formed##3##2##(1996-1#1)(2008-10#2)
been found by##3##3##(2008-10#2)(2008-3#1)
been found in association with##2##5##(2008-7#1)(2013-1#1)
been found in some##2##4##(1997-7#1)(2007-12#1)
been found in the##6##4##(1993-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
been found in##31##3##(1990-5#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2012-2#2)(2013-1#1)(2013-7#1)
been found previously##2##3##(1994-8#1)(2008-10#1)
been found that the##6##4##(2008-10#5)(2008-5#1)
been found that##14##3##(2008-10#9)(2008-5#2)(2008-9#1)(2009-11#1)(2010-4#1)
been found to be in the##2##6##(2008-10#2)
been found to be##28##4##(1992-5#1)(1997-2#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#1)(2009-1#1)(2010-11#1)(2010-7#1)(2011-2#3)(2013-8#1)
been found to cause##2##4##(2009-12#1)(2012-3#1)
been found to##51##3##(1990-12#1)(1990-5#1)(1991-12#1)(1992-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-8#1)
been found##132##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-5#1)(1992-5#2)(1993-6#1)(1994-8#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#48)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
been fully elucidated##4##3##(1990-2#1)(2007-11#1)(2008-6#1)(2012-2#1)
been fully##19##2##(1990-2#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
been further##6##2##(1990-3#1)(1994-11#1)(1994-3#1)(2008-10#1)(2011-1#2)
been gained##3##2##(2008-10#2)(2013-1#1)
been gaining##2##2##(2008-10#1)(2012-2#1)
been generated by the##2##4##(1993-6#1)(2009-10#1)
been generated by##6##3##(1993-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
been generated##14##2##(1992-9#1)(1993-6#1)(1995-9#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-10#1)(2010-10#1)(2012-2#1)
been genetically modified to##2##4##(2007-12#1)(2008-10#1)
been genetically##7##2##(1992-3#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)
been given to##7##3##(1992-1#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-8#1)
been given##15##2##(1992-1#2)(1993-6#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-8#1)(2012-3#1)
been good##2##2##(1992-11#1)(2008-11#1)
been greatly##3##2##(1997-6#1)(2008-9#1)(2013-1#1)
been hampered by##4##3##(2008-10#1)(2008-11#2)(2008-4#1)
been hampered##5##2##(2008-10#2)(2008-11#2)(2008-4#1)
been hard to##2##3##(1995-5#1)(1997-4#1)
been held responsible##2##3##(1995-6#1)(2008-7#1)
been helpful in##2##3##(1995-6#1)(2008-11#1)
been higher##2##2##(1990-11#1)(2010-4#1)
been highly conserved in##2##4##(1995-2#1)(1997-9#1)
been highly conserved##4##3##(1992-12#1)(1993-6#1)(1995-2#1)(1997-9#1)
been hindered by the##3##4##(1997-7#1)(2008-11#1)(2010-5#1)
been hindered by##4##3##(1996-9#1)(1997-7#1)(2008-11#1)(2010-5#1)
been hindered##6##2##(1996-3#1)(1996-9#1)(1997-7#1)(2008-11#2)(2010-5#1)
been identified among##2##3##(2008-10#1)(2012-2#1)
been identified and characterized##3##4##(1995-12#1)(1996-12#1)(2008-7#1)
been identified and##9##3##(1993-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-11#1)
been identified as a key##2##5##(1994-12#1)(2009-11#1)
been identified as a##16##4##(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2013-8#1)
been identified as key##2##4##(2008-10#1)(2008-11#1)
been identified as the##2##4##(1996-2#1)(2011-2#1)
been identified as##36##3##(1991-3#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
been identified at##2##3##(2008-7#1)(2008-9#1)
been identified by the##3##4##(1996-2#1)(1996-9#1)(1997-8#1)
been identified by##10##3##(1993-2#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-8#1)(2008-10#3)(2008-11#1)(2012-5#1)
been identified for##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
been identified from##3##3##(2008-10#2)(2010-7#1)
been identified in a##6##4##(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
been identified in the##4##4##(2008-10#2)(2008-11#1)(2010-5#1)
been identified in##19##3##(1993-8#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-9#1)(2010-5#2)(2012-3#2)(2013-7#1)
been identified to##5##3##(1991-12#1)(2008-10#1)(2008-12#2)(2008-9#1)
been identified using##2##3##(1993-12#1)(2008-10#1)
been identified with##2##3##(1992-3#1)(2008-7#1)
been identified##145##2##(1990-12#1)(1990-8#1)(1991-12#3)(1991-3#3)(1991-5#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2006-5#1)(2007-12#1)(2008-10#36)(2008-11#12)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#2)(2012-5#1)(2013-7#1)(2013-8#1)
been ignored##2##2##(2010-7#1)(2012-2#1)
been imaged##2##2##(2008-5#1)(2010-1#1)
been immobilized##4##2##(2008-10#4)
been implanted##3##2##(2008-7#1)(2008-9#1)(2012-12#1)
been implemented in the##3##4##(1994-1#1)(2008-2#1)(2010-5#1)
been implemented in##4##3##(1994-1#1)(2008-2#1)(2010-5#1)(2012-3#1)
been implemented##13##2##(1994-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
been implicated as a cause of##2##6##(2011-2#2)
been implicated as a##5##4##(2008-8#1)(2009-8#1)(2011-2#3)
been implicated as##8##3##(1995-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#3)(2013-1#1)
been implicated in a##4##4##(1992-11#1)(1996-12#1)(2008-4#1)(2009-6#1)
been implicated in growth of##2##5##(2011-2#2)
been implicated in several##3##4##(2009-12#1)(2012-2#2)
been implicated in the pathogenesis of##4##6##(1996-12#1)(2008-1#1)(2008-7#1)(2013-8#1)
been implicated in the regulation of##3##6##(1992-9#1)(2008-9#1)(2012-2#1)
been implicated in the##21##4##(1992-10#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
been implicated in various##3##4##(2008-4#1)(2012-2#1)(2013-7#1)
been implicated in##50##3##(1992-10#3)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-5#2)(1995-2#2)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#5)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#2)
been implicated##61##2##(1992-10#3)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-5#2)(1995-2#3)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#8)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#2)
been imposed##2##2##(2008-10#1)(2008-3#1)
been improved##9##2##(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)
been in the##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
been in##14##2##(1991-2#1)(1993-3#1)(1996-11#1)(1996-5#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-3#1)(2012-3#1)
been included in the##4##4##(1995-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
been included in##6##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
been included##10##2##(1993-11#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)
been inconclusive##2##2##(2006-5#1)(2011-1#1)
been inconsistent##3##2##(2008-10#1)(2010-1#1)(2013-8#1)
been incorporated into##4##3##(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
been incorporated##5##2##(1996-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
been increased##4##2##(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
been increasingly used##2##3##(2012-2#1)(2012-3#1)
been increasingly##5##2##(1992-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
been incriminated in the##2##4##(2011-2#1)(2012-2#1)
been incriminated in##4##3##(2007-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
been induced by##2##3##(1994-8#1)(2008-11#1)
been induced##5##2##(1994-8#1)(1995-12#1)(2008-11#2)(2008-8#1)
been infected with HIV##2##4##(1996-11#1)(1997-6#1)
been infected##4##2##(1995-12#1)(1995-9#1)(1996-11#1)(1997-6#1)
been initiated##6##2##(1997-6#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-2#1)
been instituted##2##2##(1991-12#1)(1996-5#1)
been integrated in##2##3##(2008-11#1)(2013-1#1)
been integrated##7##2##(1994-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2012-3#1)(2013-1#1)
been intensively##3##2##(2008-9#1)(2009-8#1)(2011-2#1)
been interpreted##3##2##(2008-10#2)(2009-6#1)
been introduced as##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
been introduced for##2##3##(2008-10#2)
been introduced in##2##3##(1997-8#1)(2008-11#1)
been introduced to##6##3##(1997-8#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-2#2)
been introduced##25##2##(1990-12#1)(1992-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2008-10#7)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
been invented##2##2##(2008-10#1)(2008-6#1)
been investigated and found##2##4##(2008-10#2)
been investigated and the##2##4##(2008-10#2)
been investigated and##13##3##(1995-11#1)(2008-10#8)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
been investigated as a##2##4##(2008-10#1)(2010-1#1)
been investigated as##10##3##(2008-10#4)(2008-11#2)(2008-12#1)(2009-9#1)(2010-1#1)(2012-2#1)
been investigated at##3##3##(2008-10#3)
been investigated by means of##4##5##(2008-10#3)(2011-2#1)
been investigated by measuring the##2##5##(2008-10#2)
been investigated by using##3##4##(1991-9#1)(2008-10#2)
been investigated by##24##3##(1991-9#1)(1993-8#1)(1994-3#2)(1994-5#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#1)
been investigated for the##2##4##(2008-10#2)
been investigated for##8##3##(1997-7#1)(2008-10#5)(2010-12#1)(2011-1#1)
been investigated in detail##8##4##(1994-5#1)(2008-10#7)
been investigated in the present work##2##6##(2008-11#1)(2009-10#1)
been investigated in the##6##4##(1991-6#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)
been investigated in this##2##4##(2008-12#1)(2011-2#1)
been investigated in##26##3##(1991-6#1)(1994-5#1)(1994-8#1)(1997-4#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-4#1)
been investigated over the##2##4##(2008-10#2)
been investigated previously##2##3##(2008-10#2)
been investigated through##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
been investigated using##6##3##(1993-6#1)(2008-10#4)(2009-8#1)
been investigated with the##2##4##(1996-5#1)(2008-10#1)
been investigated with##4##3##(1996-5#1)(2007-12#1)(2008-10#2)
been investigated##189##2##(1990-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#3)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#117)(2008-11#10)(2008-12#2)(2008-3#8)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#3)(2013-8#1)
been involved in the##5##4##(1990-5#1)(1996-6#1)(2008-10#1)(2012-2#2)
been isolated and characterized##3##4##(1991-5#1)(1995-6#1)(2008-11#1)
been isolated and sequenced##2##4##(1991-6#1)(1992-4#1)
been isolated and##7##3##(1991-5#1)(1991-6#1)(1992-4#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)
been isolated from a##3##4##(1992-10#1)(1993-2#1)(1995-3#1)
been isolated from the##5##4##(1990-8#1)(1991-9#1)(1992-6#1)(2008-11#2)
been isolated from##25##3##(1990-2#1)(1990-8#2)(1991-9#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-6#2)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#3)
been isolated##40##2##(1990-2#1)(1990-8#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#3)(1997-1#1)(1997-3#1)(1997-7#2)(2008-10#3)(2008-11#5)(2008-2#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
been issued##2##2##(2008-9#1)(2010-7#1)
been kept##2##2##(1996-12#1)(2008-10#1)
been known for##6##3##(2008-2#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#2)
been known to##10##3##(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#1)(2010-7#1)(2011-2#1)
been known##22##2##(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#1)
been largely##10##2##(1992-11#1)(1997-8#1)(2008-10#3)(2008-7#1)(2008-8#3)(2010-10#1)
been learned##6##2##(1993-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-1#1)(2011-3#1)
been limited by its##2##4##(2011-2#1)(2012-3#1)
been limited by##7##3##(2008-12#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
been limited to##7##3##(1994-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-7#1)(2013-1#1)
been limited##25##2##(1992-2#1)(1994-6#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
been linked to##11##3##(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
been linked with##7##3##(2007-12#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
been linked##19##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
been little##5##2##(1996-1#1)(1997-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
been localized to the##2##4##(1995-11#1)(1995-2#1)
been localized##3##2##(1990-8#1)(1995-11#1)(1995-2#1)
been located on##2##3##(2008-10#1)(2008-7#1)
been located##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
been lost##4##2##(1996-3#1)(2008-10#1)(2008-7#2)
been lower##2##2##(2008-2#1)(2010-12#1)
been made and##2##3##(2008-10#2)
been made by##5##3##(2008-10#4)(2010-8#1)
been made for##3##3##(1996-3#1)(2008-10#2)
been made in identifying the##2##5##(2008-11#2)
been made in the##9##4##(1990-9#1)(1995-3#1)(2008-11#3)(2009-12#1)(2010-10#1)(2010-7#1)(2011-2#1)
been made in this##2##4##(2008-11#1)(2011-2#1)
been made in understanding the##2##5##(2008-11#1)(2011-1#1)
been made in understanding##3##4##(2008-11#1)(2011-1#1)(2011-2#1)
been made in##26##3##(1990-9#1)(1992-2#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#10)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#1)
been made on the basis of the##2##7##(1992-12#1)(2008-10#1)
been made on##4##3##(1992-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
been made to develop##2##4##(2008-10#1)(2008-11#1)
been made to##18##3##(1991-1#1)(1991-2#1)(1995-2#2)(1997-2#1)(2008-10#5)(2008-11#3)(2009-8#1)(2012-3#1)(2013-1#3)
been made##82##2##(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#23)(2008-11#14)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#2)(2009-8#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
been mainly##2##2##(2008-10#2)
been maintained##7##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-3#1)(2013-1#1)
been managed##4##2##(1996-3#1)(1997-2#1)(2008-11#1)(2008-9#1)
been mapped to##2##3##(1994-12#1)(2012-3#1)
been mapped##8##2##(1990-7#1)(1993-9#1)(1994-12#1)(1996-8#1)(2008-10#2)(2008-8#1)(2012-3#1)
been mathematically##2##2##(2008-11#1)(2008-3#1)
been measured at##2##3##(2008-10#1)(2008-11#1)
been measured by##2##3##(1996-2#1)(2008-10#1)
been measured in the range##2##5##(2008-10#2)
been measured in the##4##4##(2008-10#2)(2008-3#1)(2010-11#1)
been measured in##12##3##(1994-2#1)(2008-10#4)(2008-3#2)(2008-8#1)(2010-11#2)(2010-4#1)(2013-1#1)
been measured##26##2##(1994-2#1)(1996-2#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-3#4)(2008-8#1)(2009-3#1)(2010-11#2)(2010-4#1)(2011-2#1)(2013-1#1)
been mixed##2##2##(1991-12#1)(2008-10#1)
been models##2##2##(2008-9#1)(2013-1#1)
been modified##11##2##(1995-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2010-8#1)(2011-3#1)
been more than##2##3##(1994-12#1)(2010-10#1)
been more##8##2##(1990-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
been most##2##2##(2008-10#2)
been moved to##2##3##(2008-10#1)(2009-4#1)
been mutated##2##2##(2008-11#1)(2009-12#1)
been named##5##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-8#1)(2011-1#1)
been neglected##3##2##(2008-12#1)(2008-8#2)
been no##22##2##(1990-6#1)(1994-12#1)(1994-2#1)(1997-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#3)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
been noted in##6##3##(1991-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)
been noted##11##2##(1991-2#2)(1996-12#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-10#1)(2010-11#1)
been notified##2##2##(1996-5#1)(2008-11#1)
been observed and##3##3##(1991-5#1)(1993-2#1)(2008-5#1)
been observed by##3##3##(1995-6#1)(2008-4#1)(2009-1#1)
been observed for##4##3##(2008-10#3)(2008-5#1)
been observed in the##4##4##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
been observed in##22##3##(1991-3#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#2)(2012-2#1)
been observed that##9##3##(1991-2#1)(2008-10#5)(2008-11#1)(2010-1#1)(2012-3#1)
been observed to be##3##4##(1993-12#1)(2008-3#1)(2012-12#1)
been observed to##7##3##(1993-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2012-12#1)
been observed##85##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#26)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
been obtained and##2##3##(2008-10#2)
been obtained at##3##3##(1991-5#1)(1997-7#1)(2008-2#1)
been obtained by##6##3##(1995-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)
been obtained for the##2##4##(2008-10#2)
been obtained for##5##3##(2008-10#4)(2008-3#1)
been obtained from a##2##4##(1994-11#1)(2008-1#1)
been obtained from##7##3##(1991-5#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#1)
been obtained##54##2##(1990-5#2)(1991-5#2)(1994-11#1)(1995-11#1)(1997-5#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#1)(2009-3#1)(2010-4#2)(2010-8#1)(2011-3#1)(2013-1#1)
been of##3##2##(1994-6#1)(1997-8#1)(2011-2#1)
been offered##4##2##(1994-9#1)(2008-10#2)(2008-11#1)
been on the##5##3##(1997-1#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
been on##11##2##(1993-2#1)(1996-2#2)(1996-6#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
been only##9##2##(1991-3#1)(1992-2#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-6#1)(2013-7#1)(2013-8#1)
been operated##2##2##(1990-3#1)(2012-12#1)
been optimised for##2##3##(2008-10#2)
been optimised to##2##3##(2008-10#2)
been optimised##10##2##(2008-10#10)
been optimized and the##4##4##(2008-10#4)
been optimized and##5##3##(2008-10#4)(2009-8#1)
been optimized on##2##3##(2008-10#2)
been optimized##24##2##(1991-5#1)(2008-10#21)(2008-4#1)(2009-8#1)
been or are##2##3##(1991-12#1)(2008-11#1)
been organized in##2##3##(2008-10#1)(2008-11#1)
been outlined##2##2##(2008-10#1)(2010-1#1)
been overcome##3##2##(2008-10#2)(2008-4#1)
been overlooked##5##2##(1991-6#1)(2008-12#1)(2008-7#2)(2009-6#1)
been paid to##12##3##(1991-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)
been paid##14##2##(1990-9#1)(1991-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-2#1)
been partially##3##2##(1991-11#1)(2008-10#1)(2009-9#1)
been particularly##4##2##(1990-3#1)(1995-2#1)(1995-9#1)(2008-10#1)
been performed by##10##3##(2008-10#9)(2008-9#1)
been performed for##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
been performed in##13##3##(1990-12#1)(1990-9#1)(1993-6#1)(1994-2#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#1)(2012-3#1)
been performed with##2##3##(2008-10#1)(2008-9#1)
been performed##63##2##(1990-12#1)(1990-9#1)(1992-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-5#2)(2007-12#1)(2008-10#26)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-9#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
been placed on the##3##4##(1993-2#1)(1996-3#1)(2008-12#1)
been placed on##4##3##(1993-2#1)(1996-3#1)(2008-12#1)(2013-8#1)
been placed##8##2##(1993-2#1)(1996-3#1)(2008-10#3)(2008-12#1)(2010-12#1)(2013-8#1)
been possible to##6##3##(1993-8#1)(1996-8#1)(2008-10#3)(2008-3#1)
been possible##9##2##(1993-8#1)(1996-8#1)(2008-10#4)(2008-3#1)(2009-12#1)(2010-6#1)
been postulated to be##2##4##(2008-7#1)(2012-2#1)
been postulated to##3##3##(1995-2#1)(2008-7#1)(2012-2#1)
been postulated##12##2##(1990-3#1)(1990-5#1)(1991-2#1)(1995-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
been prepared and##13##3##(1992-3#1)(2008-10#11)(2008-4#1)
been prepared by##5##3##(2008-10#5)
been prepared for##2##3##(1992-2#1)(2008-1#1)
been prepared in##2##3##(1992-2#1)(1992-3#1)
been prepared using##2##3##(2008-10#2)
been prepared##32##2##(1992-2#2)(1992-3#2)(2008-1#1)(2008-10#23)(2008-4#2)(2008-5#1)(2012-3#1)
been present for##2##3##(1990-3#1)(2008-11#1)
been present##4##2##(1990-3#1)(1991-12#1)(2008-11#1)(2008-9#1)
been presented for##3##3##(1993-3#1)(2008-12#1)(2009-11#1)
been presented##17##2##(1991-12#1)(1991-3#2)(1993-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)
been prevented##2##2##(2008-11#1)(2008-5#1)
been previously described##6##3##(2008-10#2)(2008-7#2)(2008-8#1)(2010-1#1)
been previously implicated in##2##4##(2009-8#1)(2010-12#1)
been previously reported for##2##4##(1996-12#1)(2008-10#1)
been previously reported in the literature##2##6##(2009-7#1)(2011-2#1)
been previously reported in the##3##5##(2009-7#1)(2010-6#1)(2011-2#1)
been previously reported in##4##4##(2009-1#1)(2009-7#1)(2010-6#1)(2011-2#1)
been previously reported##15##3##(1994-2#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-3#2)
been previously shown##3##3##(2008-10#1)(2008-12#1)(2009-7#1)
been previously##46##2##(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-6#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
been primarily##2##2##(1996-3#1)(2010-8#1)
been problematic##3##2##(2008-10#1)(2009-3#1)(2010-10#1)
been processed by##3##3##(2008-10#2)(2010-8#1)
been processed##5##2##(1997-5#1)(2008-10#3)(2010-8#1)
been produced in##2##3##(1995-12#1)(2008-11#1)
been produced##11##2##(1995-12#1)(1995-5#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2011-3#1)
been proposed and developed##2##4##(2009-4#1)(2012-3#1)
been proposed and##6##3##(1996-5#1)(2008-10#2)(2009-4#1)(2010-6#1)(2012-3#1)
been proposed as a##9##4##(1990-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-7#1)(2013-1#1)
been proposed as an##4##4##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
been proposed as##18##3##(1990-5#1)(1995-5#1)(1996-8#1)(1997-2#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-7#1)(2012-2#2)(2013-1#2)
been proposed based on the##3##5##(2008-10#2)(2013-1#1)
been proposed based on##4##4##(1990-8#1)(2008-10#2)(2013-1#1)
been proposed by##2##3##(1991-12#1)(2008-10#1)
been proposed for the##4##4##(1990-5#1)(2008-10#3)
been proposed for##16##3##(1990-5#1)(1993-1#1)(1997-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
been proposed in##6##3##(1994-6#1)(1997-8#1)(2008-7#2)(2008-9#1)(2011-1#1)
been proposed to be##3##4##(1992-3#1)(2008-9#1)(2010-3#1)
been proposed to explain the##3##5##(2008-7#1)(2009-12#1)(2012-3#1)
been proposed to explain this##2##5##(2008-10#1)(2008-9#1)
been proposed to explain##5##4##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-3#1)
been proposed to##23##3##(1990-11#1)(1992-3#1)(1993-6#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-8#1)
been proposed##126##2##(1990-11#1)(1990-5#3)(1990-8#1)(1991-12#3)(1991-5#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-10#35)(2008-11#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#7)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-7#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#3)
been proved to be##6##4##(2008-10#4)(2008-8#1)(2013-1#1)
been proved to##8##3##(1994-6#1)(2008-10#4)(2008-12#1)(2008-8#1)(2013-1#1)
been proved##18##2##(1992-5#1)(1994-6#1)(1996-3#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
been proven to be##3##4##(2008-10#1)(2008-11#1)(2009-3#1)
been proven to##4##3##(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
been proven##10##2##(1993-2#1)(1993-3#1)(1996-11#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-3#1)(2013-1#1)
been provided##5##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)
been published for##2##3##(2008-11#1)(2013-1#1)
been published in##10##3##(1997-8#2)(2008-11#6)(2013-1#2)
been published on##4##3##(1991-2#1)(2008-10#1)(2008-11#1)(2010-12#1)
been published##34##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-6#1)(1994-8#1)(1997-6#1)(1997-8#2)(2008-10#6)(2008-11#8)(2008-2#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#4)
been purified from##4##3##(1992-8#1)(1994-5#1)(1995-2#1)(2008-8#1)
been purified to homogeneity##5##4##(1990-11#2)(1991-12#1)(1993-12#1)(2008-8#1)
been purified to##6##3##(1990-11#2)(1991-12#1)(1993-12#1)(1994-8#1)(2008-8#1)
been purified##12##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-8#2)
been quantified##4##2##(2008-10#3)(2011-2#1)
been quantitatively##2##2##(2008-10#1)(2008-4#1)
been questioned because of the##2##5##(1994-9#1)(2008-10#1)
been questioned because##3##3##(1994-9#1)(2008-10#2)
been questioned due to the##2##5##(1992-6#1)(2010-12#1)
been questioned##8##2##(1992-12#1)(1992-6#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)
been rarely described##2##3##(2008-7#2)
been rarely##4##2##(2007-12#1)(2008-7#2)(2010-8#1)
been reached as to##2##4##(1995-2#1)(2013-8#1)
been reached##8##2##(1990-6#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
been realized##3##2##(1997-6#1)(2008-10#1)(2008-4#1)
been receiving increasing attention##2##4##(2013-8#2)
been receiving##3##2##(2008-10#1)(2013-8#2)
been recently developed##4##3##(2008-11#1)(2008-5#1)(2010-11#1)(2011-3#1)
been recently##27##2##(1990-5#1)(1991-6#1)(1994-5#1)(1994-8#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
been recognised##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
been recognized as a##4##4##(1997-1#1)(2009-8#1)(2012-2#1)(2013-1#1)
been recognized as##10##3##(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
been recognized that the##2##4##(2008-5#1)(2008-7#1)
been recognized that##4##3##(2008-5#1)(2008-7#2)(2010-1#1)
been recognized##22##2##(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#1)
been recommended as##2##3##(1991-6#1)(2008-9#1)
been recommended by##2##3##(2008-1#1)(2008-8#1)
been recommended##10##2##(1991-6#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
been recorded##10##2##(2007-11#1)(2008-10#2)(2008-3#2)(2009-10#1)(2010-8#2)(2011-2#1)(2013-8#1)
been recovered from##3##3##(1996-8#1)(2008-10#1)(2008-8#1)
been recovered##5##2##(1996-8#1)(2008-10#2)(2008-5#1)(2008-8#1)
been regarded as a##2##4##(1995-2#1)(2010-11#1)
been regarded as an##2##4##(1996-2#1)(2008-11#1)
been regarded as##7##3##(1993-3#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-5#1)
been registered##4##2##(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)
been related to the##2##4##(1993-9#1)(2008-9#1)
been related to##5##3##(1993-9#1)(1994-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
been relatively little##2##3##(2008-5#1)(2008-8#1)
been relatively##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
been remarkably##2##2##(2010-6#1)(2011-2#1)
been removed##3##2##(1992-9#1)(1997-3#1)(2008-11#1)
been repeatedly##5##2##(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
been replaced##3##2##(1996-11#1)(2010-5#1)(2013-8#1)
been reported as a##2##4##(2008-7#1)(2013-1#1)
been reported as##7##3##(1996-11#3)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
been reported before in the literature##2##6##(1997-8#1)(2011-2#1)
been reported before in the##3##5##(1997-8#1)(2008-11#1)(2011-2#1)
been reported during##2##3##(2008-7#1)(2009-12#1)
been reported for the##3##4##(2008-10#1)(2008-9#1)(2009-11#1)
been reported for##9##3##(1993-8#1)(1995-6#1)(2008-10#4)(2008-9#1)(2009-11#1)(2012-2#1)
been reported from birds##2##4##(2008-5#2)
been reported from##3##3##(2008-10#1)(2008-5#2)
been reported in Korea##2##4##(2010-6#2)
been reported in a##3##4##(2009-8#1)(2012-2#1)(2012-3#1)
been reported in other##2##4##(1997-7#1)(1997-9#1)
been reported in patients with##2##5##(1994-12#1)(2010-1#1)
been reported in the literature##7##5##(1990-12#1)(1996-11#1)(2008-7#1)(2008-8#1)(2013-1#3)
been reported in the medical literature##4##6##(1990-8#1)(2010-6#2)(2013-1#1)
been reported in the##21##4##(1990-12#1)(1990-8#1)(1991-12#1)(1994-3#1)(1996-11#1)(1997-2#1)(1997-8#1)(2008-7#1)(2008-8#1)(2010-6#5)(2010-7#1)(2012-2#1)(2013-1#4)(2013-8#1)
been reported in##56##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#3)(1992-6#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-7#1)(1997-8#3)(1997-9#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#7)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#2)
been reported previously in##2##4##(2008-10#1)(2011-1#1)
been reported previously##10##3##(1993-8#1)(1995-6#1)(1997-3#1)(2008-10#4)(2009-11#1)(2011-1#1)(2013-8#1)
been reported recently##2##3##(2008-11#1)(2013-1#1)
been reported so far##4##4##(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
been reported to be##12##4##(1992-8#1)(1994-12#2)(1994-5#1)(1995-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#2)
been reported to cause##3##4##(2008-10#3)
been reported to date##3##4##(2008-7#1)(2012-3#1)(2013-1#1)
been reported to exhibit##3##4##(1995-2#1)(2008-11#1)(2008-5#1)
been reported to have a##2##5##(2012-3#1)(2013-8#1)
been reported to have##3##4##(1994-12#1)(2012-3#1)(2013-8#1)
been reported to increase##3##4##(2008-10#2)(2011-2#1)
been reported to occur in the##2##6##(1995-10#1)(2013-1#1)
been reported to occur in##4##5##(1995-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
been reported to occur##5##4##(1995-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
been reported to play a##2##5##(1992-6#1)(2013-8#1)
been reported to##53##3##(1991-11#1)(1991-3#1)(1992-6#1)(1992-8#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
been reported with##6##3##(2008-10#3)(2011-2#1)(2012-3#1)(2013-8#1)
been reported worldwide##2##3##(1995-3#1)(2013-1#1)
been reported##257##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-8#3)(1992-6#3)(1992-8#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-12#4)(1994-3#2)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#4)(1996-12#4)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#5)(1997-9#1)(2007-12#1)(2008-10#58)(2008-11#8)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#9)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#11)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#22)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#20)(2013-8#10)
been researched##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
been resolved##4##2##(2008-10#3)(2008-3#1)
been restricted to##2##3##(2008-7#1)(2011-2#1)
been restricted##5##2##(2008-11#2)(2008-7#2)(2011-2#1)
been restructured##2##2##(1994-12#1)(1995-12#1)
been revealed##5##2##(1991-9#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-11#1)
been routinely##2##2##(2008-10#1)(2008-9#1)
been run##2##2##(1990-3#1)(2008-3#1)
been satisfactorily##16##2##(2008-10#15)(2008-7#1)
been scaled up##2##3##(2008-11#1)(2008-7#1)
been scaled##3##2##(2008-11#2)(2008-7#1)
been seen in##3##3##(1994-2#1)(2012-3#1)(2013-1#1)
been seen##7##2##(1994-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#2)
been selected for the##3##4##(2008-10#3)
been selected for##7##3##(1992-12#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-8#1)
been selected##11##2##(1992-12#1)(1996-9#1)(1997-7#1)(2008-10#6)(2008-7#1)(2008-8#1)
been separated into##2##3##(1994-12#1)(2008-10#1)
been separated##12##2##(1994-12#1)(2008-10#7)(2008-11#2)(2008-7#1)(2008-8#1)
been sequenced##3##2##(1996-6#1)(2008-10#2)
been shown that a##2##4##(1995-9#1)(2008-7#1)
been shown that in##2##4##(1994-8#1)(2008-10#1)
been shown that the##8##4##(1990-11#1)(1997-7#1)(2008-10#4)(2008-3#1)(2013-8#1)
been shown that##27##3##(1990-11#1)(1994-2#1)(1994-8#2)(1995-9#1)(1997-2#1)(1997-7#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
been shown to alter the natural##2##6##(2008-7#1)(2010-12#1)
been shown to alter##3##4##(2008-4#1)(2008-7#1)(2010-12#1)
been shown to be a##11##5##(1990-11#1)(1990-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#2)
been shown to be capable of##4##6##(2008-10#2)(2008-11#1)(2011-2#1)
been shown to be effective##4##5##(2008-11#3)(2009-10#1)
been shown to be involved in the##2##7##(2008-10#1)(2010-10#1)
been shown to be involved in##3##6##(1994-5#1)(2008-10#1)(2010-10#1)
been shown to be more##3##5##(2008-2#1)(2009-8#1)(2012-2#1)
been shown to be present##2##5##(1991-5#1)(1995-2#1)
been shown to be regulated##2##5##(2010-3#1)(2011-2#1)
been shown to be##77##4##(1990-11#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#14)(2008-11#5)(2008-2#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
been shown to belong to##2##5##(2008-10#1)(2008-5#1)
been shown to bind##3##4##(1994-5#1)(1995-6#1)(2008-5#1)
been shown to cause##6##4##(1993-12#1)(2008-10#3)(2008-9#1)(2011-2#1)
been shown to contribute to##3##5##(2008-9#1)(2009-12#1)(2012-12#1)
been shown to correlate with##3##5##(1996-12#1)(2009-11#1)(2009-12#1)
been shown to decrease##2##4##(2009-7#1)(2010-11#1)
been shown to enhance##2##4##(2008-11#1)(2012-12#1)
been shown to exist in##3##5##(1993-8#1)(1995-11#1)(2008-9#1)
been shown to function as a##2##6##(2008-10#1)(2010-10#1)
been shown to have##9##4##(1993-12#1)(1993-3#1)(1993-8#1)(1997-1#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-7#1)
been shown to improve the##4##5##(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)
been shown to improve##7##4##(2007-8#1)(2008-11#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
been shown to induce##5##4##(1993-12#1)(1995-5#1)(1997-3#1)(2008-11#1)(2013-1#1)
been shown to influence the##2##5##(2008-7#1)(2009-10#1)
been shown to influence##4##4##(1991-6#1)(1997-1#1)(2008-7#1)(2009-10#1)
been shown to inhibit pepsinogen secretion##2##6##(1995-8#2)
been shown to inhibit##3##4##(1995-8#2)(2010-11#1)
been shown to interact with##3##5##(1993-8#1)(1994-5#1)(1995-2#1)
been shown to interact##4##4##(1993-8#1)(1994-5#1)(1995-2#1)(2008-4#1)
been shown to markedly##2##4##(2008-12#1)(2013-8#1)
been shown to modulate the##2##5##(2008-10#1)(2008-11#1)
been shown to modulate##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
been shown to occur in##2##5##(2008-11#1)(2008-7#1)
been shown to play an important role in##2##8##(2008-7#1)(2008-9#1)
been shown to play##5##4##(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)
been shown to promote##4##4##(1995-6#1)(1995-8#1)(2008-10#1)(2013-1#1)
been shown to provide##7##4##(1994-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-10#2)(2010-12#1)
been shown to reduce##4##4##(1993-3#1)(1994-6#1)(1995-6#1)(1996-6#1)
been shown to suppress##2##4##(2008-10#1)(2010-7#1)
been shown to##228##3##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#5)(1995-8#3)(1996-12#4)(1996-2#4)(1996-3#1)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#20)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#5)(2009-3#2)(2009-7#2)(2009-8#5)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#4)
been shown##270##2##(1990-11#3)(1990-12#3)(1990-2#2)(1990-5#2)(1990-8#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#5)(1995-8#3)(1995-9#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-6#1)(1997-1#6)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#44)(2008-11#23)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#5)(2009-3#2)(2009-7#2)(2009-8#5)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#3)(2010-3#1)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#11)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#6)
been significantly reduced##2##3##(2008-10#1)(2012-2#1)
been significantly##6##2##(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
been simultaneously##3##2##(2008-10#3)
been slower##2##2##(1990-11#1)(1995-2#1)
been so##4##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
been solved##3##2##(1991-6#1)(1992-4#1)(1995-2#1)
been spatially##2##2##(2008-5#1)(2013-1#1)
been specifically designed to##2##4##(1996-1#1)(2008-4#1)
been specifically designed##3##3##(1996-1#1)(2008-4#2)
been specifically##4##2##(1996-1#1)(2008-3#1)(2008-4#2)
been speculated that##4##3##(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)
been speculated to be the##2##5##(2008-5#1)(2012-2#1)
been speculated##6##2##(2008-10#1)(2008-5#2)(2009-6#1)(2011-2#1)(2012-2#1)
been stabilized##2##2##(2008-11#1)(2008-4#1)
been stable##2##2##(1997-6#1)(2009-3#1)
been statistically##2##2##(2008-10#1)(2010-8#1)
been studied and##11##3##(1990-11#1)(2008-10#9)(2008-3#1)
been studied as a function of pH##2##7##(1990-5#1)(2008-10#1)
been studied as a function of##3##6##(1990-5#1)(2008-10#2)
been studied as a##5##4##(1990-5#1)(2008-10#3)(2008-4#1)
been studied by spectrophotometry##2##4##(2008-10#2)
been studied by using##2##4##(2008-10#1)(2008-8#1)
been studied by##31##3##(1990-5#1)(1990-8#1)(1990-9#1)(1992-4#1)(1992-9#1)(1993-8#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2012-3#1)
been studied experimentally##2##3##(2008-3#1)(2008-9#1)
been studied extensively##9##3##(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-2#2)
been studied for decades##3##4##(2008-10#3)
been studied for the##2##4##(2008-10#2)
been studied for##10##3##(2008-10#9)(2008-8#1)
been studied in detail to optimize the conditions for determination in##2##11##(2008-10#2)
been studied in detail to optimize the conditions for determination##3##10##(2008-10#3)
been studied in detail to optimize the conditions for##5##9##(2008-10#5)
been studied in detail##10##4##(2008-10#9)(2008-5#1)
been studied in the##4##4##(1992-12#1)(1997-3#1)(2008-10#2)
been studied in##28##3##(1990-5#1)(1992-12#1)(1993-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(1997-3#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-5#1)
been studied spectrophotometrically##2##3##(2008-10#2)
been studied to##4##3##(2008-10#3)(2010-7#1)
been studied using##13##3##(1994-11#1)(1994-5#1)(2008-10#8)(2008-8#1)(2009-5#1)(2009-7#1)
been studied with the##2##4##(2008-3#1)(2011-2#1)
been studied with##8##3##(1993-6#1)(1997-4#1)(2008-10#2)(2008-3#2)(2011-2#1)(2013-1#1)
been studied##228##2##(1990-11#1)(1990-5#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-5#3)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#137)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#6)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#6)(2012-5#1)(2013-1#1)
been subjected to a##2##4##(2008-11#1)(2010-7#1)
been subjected to##9##3##(2008-10#1)(2008-11#4)(2009-7#1)(2010-7#1)(2012-3#2)
been submitted to##3##3##(1997-2#1)(2011-2#1)(2013-1#1)
been submitted##5##2##(1997-2#1)(2008-5#1)(2011-2#1)(2013-1#2)
been successful in##7##3##(1992-2#1)(1994-12#1)(1996-3#1)(1997-2#1)(2008-11#1)(2010-10#1)(2013-1#1)
been successful##9##2##(1992-2#1)(1994-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2010-10#2)(2013-1#1)
been successfully applied for##15##4##(2008-10#14)(2009-6#1)
been successfully applied to analyze the##2##6##(2008-10#2)
been successfully applied to the determination of trace##3##8##(2008-10#3)
been successfully applied to the determination of##23##7##(2008-10#23)
been successfully applied to the##29##5##(2008-10#29)
been successfully applied to##47##4##(2008-10#46)(2012-12#1)
been successfully applied##64##3##(2008-10#61)(2009-6#1)(2011-2#1)(2012-12#1)
been successfully expressed in##2##4##(2008-11#1)(2008-7#1)
been successfully incorporated into##2##4##(1996-1#1)(2012-2#1)
been successfully performed##2##3##(2008-7#1)(2009-4#1)
been successfully tested for##2##4##(2008-10#2)
been successfully tested##4##3##(2008-10#3)(2011-2#1)
been successfully used to##6##4##(2008-10#3)(2008-11#2)(2012-2#1)
been successfully used##13##3##(2008-10#9)(2008-11#2)(2008-3#1)(2012-2#1)
been successfully utilized##3##3##(1997-8#1)(2008-10#2)
been successfully##107##2##(1993-2#1)(1996-1#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#84)(2008-11#4)(2008-3#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
been suffering##3##2##(2008-11#1)(2010-6#1)(2013-8#1)
been suggested as a##3##4##(2008-11#1)(2008-9#1)(2012-2#1)
been suggested as##9##3##(1990-11#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
been suggested by##2##3##(2008-8#1)(2013-1#1)
been suggested for##4##3##(1993-6#1)(1997-8#1)(2008-10#1)(2008-8#1)
been suggested in##3##3##(1991-11#1)(2008-12#1)(2012-2#1)
been suggested that##29##3##(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2011-2#1)(2013-1#3)(2013-7#1)
been suggested to be involved in##2##6##(1995-6#1)(2009-9#1)
been suggested to be##8##4##(1991-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(2008-12#1)(2009-11#1)(2009-7#1)(2009-9#1)
been suggested to play##2##4##(1993-12#1)(2009-8#1)
been suggested to##19##3##(1991-2#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
been suggested##77##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#2)(1992-12#1)(1993-12#1)(1993-6#2)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#7)(2013-7#1)
been superseded by##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
been supported##2##2##(1994-3#1)(2008-9#1)
been synthesised for the##2##4##(2008-10#2)
been synthesized and characterized##3##4##(2008-10#3)
been synthesized and##7##3##(1995-3#1)(2008-10#6)
been synthesized in##6##3##(1990-8#1)(1995-6#1)(2008-10#2)(2012-2#1)(2012-3#1)
been synthesized##31##2##(1990-8#1)(1991-5#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#3)(2008-10#18)(2012-2#1)(2012-3#1)
been systematically investigated##3##3##(2008-10#2)(2010-11#1)
been systematically##6##2##(1991-2#1)(2008-10#3)(2010-11#1)(2012-12#1)
been taken into account##3##4##(2008-10#1)(2008-3#2)
been taken to##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
been taken##13##2##(1990-8#2)(1992-6#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2010-8#1)(2012-3#1)
been termed##5##2##(1993-8#1)(2008-10#2)(2008-11#1)(2010-6#1)
been tested as##3##3##(2007-11#1)(2008-10#2)
been tested for the##3##4##(2008-10#2)(2008-12#1)
been tested for##12##3##(1996-2#1)(1996-3#1)(2008-10#7)(2008-12#1)(2008-3#1)(2013-1#1)
been tested in##3##3##(1997-1#1)(2008-10#2)
been tested on##6##3##(2007-12#1)(2008-10#4)(2010-8#1)
been tested##43##2##(1990-6#1)(1991-3#1)(1992-9#1)(1993-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#27)(2008-12#1)(2008-3#1)(2008-8#2)(2010-8#1)(2013-1#1)(2013-8#1)
been that##3##2##(1997-1#1)(2008-8#2)
been the subject of##5##4##(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)
been the##43##2##(1991-3#1)(1992-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1996-2#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
been thoroughly##5##2##(2008-10#2)(2009-7#1)(2012-2#1)(2013-8#1)
been thought to be##4##4##(1996-12#1)(2008-6#1)(2010-12#1)(2012-2#1)
been thought to##5##3##(1996-12#2)(2008-6#1)(2010-12#1)(2012-2#1)
been thought##6##2##(1994-8#1)(1996-12#2)(2008-6#1)(2010-12#1)(2012-2#1)
been through##2##2##(1996-11#1)(2011-2#1)
been to##10##2##(1991-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#1)
been traditionally##2##2##(2007-12#1)(2008-8#1)
been trained##5##2##(1990-11#1)(1996-5#1)(2008-10#3)
been transferred to##2##3##(1995-6#1)(2008-9#1)
been transferred##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
been transformed##2##2##(1996-5#1)(1997-1#1)
been transmitted##2##2##(1990-3#1)(1995-9#1)
been treated by##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
been treated with##13##3##(1991-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-5#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
been treated##27##2##(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
been tried to##2##3##(2010-7#1)(2010-8#1)
been tried##4##2##(2008-10#2)(2010-7#1)(2010-8#1)
been unable to##2##3##(1995-3#1)(2010-12#1)
been unclear##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
been under##4##2##(2008-10#1)(2010-10#1)(2012-2#1)(2013-1#1)
been undertaken to##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
been undertaken##8##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
been uniformly##2##2##(2008-10#1)(2008-7#1)
been unsuccessful##2##2##(1992-9#1)(2008-10#1)
been updated##2##2##(1993-3#1)(2008-10#1)
been used as an##7##4##(2008-10#5)(2008-7#1)(2010-4#1)
been used as the##3##4##(2008-10#2)(2008-11#1)
been used as##32##3##(1996-12#1)(1997-6#1)(2008-10#23)(2008-11#3)(2008-7#1)(2008-9#1)(2010-4#2)
been used by##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
been used effectively in##2##4##(2009-10#1)(2011-2#1)
been used extensively in##2##4##(1995-12#1)(2008-10#1)
been used extensively##4##3##(1995-12#1)(2008-10#2)(2008-7#1)
been used for the determination of the##2##7##(2008-10#2)
been used for the determination of##10##6##(2008-10#10)
been used for the##23##4##(2008-10#21)(2008-4#1)(2010-12#1)
been used for this##3##4##(1995-5#1)(2008-10#2)
been used for##61##3##(1992-3#1)(1995-5#1)(1996-9#1)(2007-8#1)(2008-10#41)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-1#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
been used in combination with##2##5##(2008-10#1)(2013-1#1)
been used in the##11##4##(1994-5#1)(1995-11#1)(1996-3#1)(2008-10#3)(2008-9#1)(2010-8#2)(2012-12#1)(2012-2#1)
been used in##28##3##(1991-1#1)(1991-11#1)(1992-5#1)(1994-5#1)(1995-11#1)(1996-3#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-9#1)(2010-12#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
been used successfully in##3##4##(2008-10#1)(2009-10#1)(2010-11#1)
been used successfully##7##3##(1997-2#1)(2008-10#4)(2009-10#1)(2010-11#1)
been used to control##2##4##(2008-10#2)
been used to detect##5##4##(2008-10#3)(2008-9#2)
been used to determine the##6##5##(1990-9#1)(1991-2#1)(1994-5#1)(2008-10#2)(2008-7#1)
been used to determine##12##4##(1990-9#1)(1991-2#1)(1994-5#1)(2008-10#8)(2008-7#1)
been used to evaluate the##2##5##(2008-10#2)
been used to identify##3##4##(2008-10#2)(2012-3#1)
been used to investigate the##5##5##(1994-5#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
been used to monitor the##3##5##(1994-5#1)(2008-10#1)(2008-11#1)
been used to monitor##4##4##(1994-5#1)(2008-10#2)(2008-11#1)
been used to obtain##2##4##(2008-3#1)(2009-11#1)
been used to optimize the##2##5##(2008-10#2)
been used to probe the##3##5##(1995-6#1)(2008-10#2)
been used to study the##9##5##(1994-5#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-9#2)
been used to study##15##4##(1991-12#1)(1994-5#1)(1994-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-9#2)(2013-1#1)
been used to treat##3##4##(1993-11#1)(1993-2#1)(2008-8#1)
been used to##115##3##(1990-11#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#6)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-5#1)(2008-1#1)(2008-10#52)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
been used widely##2##3##(2008-10#1)(2010-10#1)
been used##292##2##(1990-11#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-3#3)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#7)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#146)(2008-11#15)(2008-12#3)(2008-3#8)(2008-4#7)(2008-5#6)(2008-7#6)(2008-8#4)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#5)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
been useful##2##2##(1991-3#1)(2008-10#1)
been using##2##2##(1993-3#1)(1994-1#1)
been utilized as##6##3##(1996-5#1)(2008-10#3)(2008-11#1)(2008-9#1)
been utilized for##4##3##(1990-12#1)(2008-10#2)(2009-10#1)
been utilized in##2##3##(2008-10#1)(2008-12#1)
been utilized to##6##3##(1990-5#1)(1995-3#1)(1997-1#1)(2008-10#2)(2012-12#1)
been utilized##19##2##(1990-12#2)(1990-5#1)(1995-3#1)(1996-5#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2012-12#1)
been vaccinated##4##2##(1990-11#1)(1995-9#1)(2009-5#2)
been validated by##6##3##(2008-10#6)
been validated in##2##3##(2008-5#1)(2008-7#1)
been validated##19##2##(1990-2#1)(2008-10#9)(2008-5#1)(2008-7#2)(2010-9#1)(2011-2#2)(2013-1#3)
been verified experimentally##2##3##(1997-1#1)(1997-6#1)
been verified##11##2##(1994-2#1)(1997-1#1)(1997-6#1)(2008-10#7)(2008-3#1)
been very limited##2##3##(2008-10#1)(2012-2#1)
been very##8##2##(1990-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
been visualized by##3##3##(1995-12#1)(2008-11#1)(2008-9#1)
been visualized##4##2##(1995-12#1)(1996-2#1)(2008-11#1)(2008-9#1)
been well defined##2##3##(2008-10#1)(2011-1#1)
been well described##2##3##(2008-11#1)(2011-2#1)
been well documented##7##3##(1994-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
been well established##5##3##(2008-10#2)(2009-10#1)(2009-4#1)(2011-2#1)
been well studied##3##3##(1991-12#1)(2008-1#2)
been well##28##2##(1991-12#2)(1994-12#2)(1996-11#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
been widely accepted##2##3##(1991-6#1)(2013-1#1)
been widely applied##2##3##(2010-12#1)(2013-8#1)
been widely discussed##3##3##(1994-2#1)(2008-11#1)(2009-6#1)
been widely recognized##2##3##(2009-8#1)(2010-12#1)
been widely used as##3##4##(2008-10#2)(2008-5#1)
been widely used for the##4##5##(1997-8#1)(2008-10#2)(2008-11#1)
been widely used for##7##4##(1997-8#1)(2008-10#3)(2008-11#2)(2008-3#1)
been widely used in##7##4##(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)
been widely used##19##3##(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2010-6#1)(2012-3#2)(2013-1#2)
been widely##41##2##(1991-6#1)(1994-2#1)(1995-6#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
been withdrawn##10##2##(2008-10#1)(2008-11#8)(2012-3#1)
been without##2##2##(1990-8#1)(2008-1#1)
been written##11##2##(1992-1#1)(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2010-10#1)(2012-2#2)
been##6821##1##(1990-11#34)(1990-12#16)(1990-2#11)(1990-3#16)(1990-5#33)(1990-6#17)(1990-7#2)(1990-8#21)(1990-9#17)(1991-1#4)(1991-10#3)(1991-11#9)(1991-12#38)(1991-2#28)(1991-3#32)(1991-5#16)(1991-6#24)(1991-7#3)(1991-8#3)(1991-9#11)(1992-1#15)(1992-10#8)(1992-11#9)(1992-12#19)(1992-2#18)(1992-3#15)(1992-4#5)(1992-5#6)(1992-6#13)(1992-7#1)(1992-8#2)(1992-9#22)(1993-1#8)(1993-11#13)(1993-12#24)(1993-2#24)(1993-3#26)(1993-6#22)(1993-8#20)(1993-9#11)(1994-1#9)(1994-11#10)(1994-12#30)(1994-2#24)(1994-3#22)(1994-5#38)(1994-6#15)(1994-8#27)(1994-9#20)(1995-1#4)(1995-10#1)(1995-11#17)(1995-12#34)(1995-2#37)(1995-3#14)(1995-5#17)(1995-6#39)(1995-8#18)(1995-9#8)(1996-1#21)(1996-11#19)(1996-12#27)(1996-2#36)(1996-3#39)(1996-5#20)(1996-6#10)(1996-8#7)(1996-9#7)(1997-1#35)(1997-2#30)(1997-3#21)(1997-4#11)(1997-5#14)(1997-6#24)(1997-7#26)(1997-8#40)(1997-9#4)(2006-5#3)(2006-6#1)(2007-11#11)(2007-12#25)(2007-8#5)(2007-9#1)(2008-1#41)(2008-10#2513)(2008-11#468)(2008-12#88)(2008-2#31)(2008-3#153)(2008-4#59)(2008-5#148)(2008-6#27)(2008-7#180)(2008-8#127)(2008-9#163)(2009-1#8)(2009-10#29)(2009-11#16)(2009-12#31)(2009-3#19)(2009-4#13)(2009-5#13)(2009-6#22)(2009-7#24)(2009-8#46)(2009-9#9)(2010-1#36)(2010-10#35)(2010-11#30)(2010-12#55)(2010-2#2)(2010-3#9)(2010-4#19)(2010-5#22)(2010-6#35)(2010-7#42)(2010-8#37)(2010-9#7)(2011-1#30)(2011-10#1)(2011-2#220)(2011-3#30)(2011-4#2)(2011-7#5)(2012-12#30)(2012-2#126)(2012-3#119)(2012-4#3)(2012-5#5)(2012-6#1)(2012-7#3)(2013-1#168)(2013-2#1)(2013-7#9)(2013-8#71)
beer and wine##2##3##(1997-1#1)(2008-10#1)
beer and##3##2##(1997-1#1)(2008-10#2)
beer aroma##2##2##(2008-10#2)
beer fermentation##5##2##(2008-10#3)(2008-7#2)
beer samples##6##2##(2008-10#6)
beer were##2##2##(2008-10#2)
beer##41##1##(1991-5#1)(1997-1#1)(2008-10#31)(2008-7#2)(2009-7#1)(2011-1#1)(2012-2#4)
beers by##3##2##(2008-10#3)
beers##13##1##(2008-10#13)
bees were##2##2##(2008-10#2)
bees##11##1##(2007-12#2)(2008-10#3)(2008-6#1)(2008-7#2)(2008-9#1)(2013-1#2)
beet cyst nematode##5##3##(2008-10#2)(2008-12#3)
beet cyst##6##2##(2008-10#2)(2008-12#4)
beet seedlings##4##2##(2008-10#4)
beet yellow stunt virus##2##4##(2008-10#2)
beet##61##1##(2008-10#44)(2008-12#15)(2012-3#2)
beetle##24##1##(2008-10#13)(2008-12#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)
beetles at##2##2##(2008-10#1)(2008-9#1)
beetles infested with P##3##4##(2008-10#3)
beetles may##2##2##(2008-10#1)(2008-12#1)
beetles were##2##2##(2008-10#2)
beetles##27##1##(2008-10#18)(2008-12#1)(2008-8#4)(2008-9#3)(2009-10#1)
beets and##3##2##(2008-10#3)
beets##12##1##(2008-10#12)
before 1960##2##2##(2008-10#1)(2010-1#1)
before a##9##2##(1994-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-12#1)(2013-1#1)
before age##3##2##(1993-1#1)(1997-4#1)(2012-12#1)
before an##3##2##(1994-2#1)(2008-10#1)(2013-1#1)
before analysis##6##2##(1990-12#1)(2008-10#5)
before and 2##2##3##(2008-10#2)
before and after a##4##4##(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
before and after an##2##4##(2008-10#1)(2008-9#1)
before and after each##2##4##(1996-12#1)(2013-8#1)
before and after exposure##2##4##(2008-10#1)(2013-1#1)
before and after one##2##4##(1991-11#1)(2011-1#1)
before and after the addition of##2##6##(2008-10#2)
before and after the intervention##2##5##(2008-12#2)
before and after the treatment##2##5##(2010-12#1)(2013-1#1)
before and after the##24##4##(1991-5#1)(1991-6#1)(1992-2#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-12#4)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-2#2)(2012-5#1)(2013-1#3)
before and after treatment##2##4##(2011-1#1)(2013-1#1)
before and after##91##3##(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-6#2)(1994-1#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(2006-6#1)(2007-12#2)(2008-10#13)(2008-11#2)(2008-12#6)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#5)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#2)
before and at the end of##2##6##(2008-10#1)(2008-7#1)
before and during the##2##4##(1992-12#1)(2008-10#1)
before and during##7##3##(1990-5#1)(1992-12#1)(1993-1#1)(1994-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
before and##109##2##(1990-5#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-6#2)(1994-1#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-10#19)(2008-11#2)(2008-12#6)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#6)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#10)(2013-8#2)
before any##5##2##(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
before aspiration into the##2##4##(2008-10#2)
before attempting##2##2##(1997-6#1)(2008-10#1)
before becoming##2##2##(1991-11#1)(2008-9#1)
before beginning##3##2##(1994-1#1)(1996-3#1)(2013-1#1)
before being##6##2##(1990-12#1)(1991-12#1)(1996-12#1)(2007-12#1)(2008-10#2)
before canopy development##2##3##(2008-10#2)
before canopy##3##2##(2008-10#3)
before committing##2##2##(1991-3#1)(2008-7#1)
before conception##2##2##(1990-9#1)(1994-3#1)
before conducting##2##2##(1996-5#1)(2013-1#1)
before current##2##2##(1995-5#1)(2012-3#1)
before death##4##2##(1990-9#1)(1995-11#1)(1996-11#1)(2009-6#1)
before decomposition##2##2##(2008-10#2)
before determining##2##2##(2008-5#1)(2008-7#1)
before discharge##2##2##(2008-11#1)(2010-7#1)
before each##2##2##(1993-6#1)(2008-8#1)
before entering##2##2##(2008-10#2)
before examination##2##2##(1993-1#1)(1997-1#1)
before exposure##2##2##(1990-11#1)(2011-2#1)
before fertilization##2##2##(2008-11#1)(2009-12#1)
before final##2##2##(2008-10#1)(2008-11#1)
before for##2##2##(2008-1#1)(2008-10#1)
before freezing##2##2##(2008-10#2)
before further##2##2##(2008-10#1)(2008-3#1)
before giving##2##2##(2010-1#1)(2012-2#1)
before harvest##3##2##(2008-10#3)
before hatching##2##2##(2008-11#1)(2008-8#1)
before he##2##2##(1994-12#1)(1996-5#1)
before induction##3##2##(1995-12#1)(2010-7#2)
before infection##2##2##(2008-10#2)
before initiating##2##2##(2010-12#1)(2011-2#1)
before initiation of##2##3##(2008-10#1)(2013-1#1)
before injection##2##2##(2011-3#1)(2012-3#1)
before inoculation reduced##2##3##(2008-10#2)
before inoculation with##7##3##(2008-10#7)
before inoculation##12##2##(2008-10#12)
before irradiation##3##2##(2008-10#1)(2008-9#2)
before it is##2##3##(2008-11#1)(2008-2#1)
before it##6##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
before its##2##2##(2008-10#2)
before mating##2##2##(2008-8#1)(2008-9#1)
before measurement##2##2##(2008-10#1)(2008-5#1)
before onset of the##2##4##(1991-12#1)(1996-11#1)
before or after##8##3##(1992-5#1)(1994-8#1)(2008-10#3)(2008-9#1)(2012-12#1)(2013-1#1)
before or##14##2##(1990-6#1)(1990-9#1)(1992-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(2008-10#3)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
before organ transplantation##2##3##(1997-5#2)
before pregnancy##2##2##(1997-8#1)(2009-1#1)
before public##2##2##(1994-2#1)(1996-2#1)
before reaching the##2##3##(2008-4#1)(2008-7#1)
before reaching##4##2##(1993-6#1)(2008-10#1)(2008-4#1)(2008-7#1)
before registration##2##2##(2008-11#2)
before spawning##2##2##(2010-8#2)
before start##2##2##(1994-12#1)(2008-8#1)
before such##2##2##(2008-10#1)(2010-10#1)
before surgery and##4##3##(1995-2#1)(2009-5#1)(2010-11#1)(2010-8#1)
before surgery##15##2##(1992-5#1)(1993-6#1)(1995-2#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
before testing##2##2##(2008-11#1)(2010-8#1)
before the advent of##2##4##(1996-11#1)(2009-10#1)
before the age of##9##4##(1990-12#1)(1992-1#1)(1996-11#1)(1997-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
before the appearance of##2##4##(1992-5#1)(2008-1#1)
before the completion of##2##4##(2012-2#2)
before the disease##2##3##(2008-10#2)
before the interview##2##3##(1990-12#2)
before the onset of##12##4##(1990-12#1)(1990-3#1)(1990-8#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-7#2)(2011-2#1)(2013-7#1)
before the operation##3##3##(1990-3#1)(1994-3#1)(2008-10#1)
before the past 12 months##2##5##(2009-5#2)
before the patient##2##3##(1994-9#1)(2008-7#1)
before the second operation##3##4##(2008-7#3)
before the start of the##2##5##(2008-8#1)(2012-2#1)
before the start of##5##4##(1991-6#1)(1996-6#1)(2008-8#1)(2010-12#1)(2012-2#1)
before the study##4##3##(1997-5#1)(2008-1#1)(2008-12#1)(2008-7#1)
before the##136##2##(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#2)(1993-3#2)(1994-2#1)(1994-3#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#21)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#10)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-7#2)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
before their##7##2##(2008-10#3)(2008-11#2)(2008-8#1)(2011-2#1)
before these##2##2##(1992-3#1)(2008-5#1)
before they are##3##3##(1992-12#1)(1994-3#1)(1995-5#1)
before they##9##2##(1992-12#1)(1993-2#1)(1994-3#1)(1995-5#1)(2008-10#4)(2008-11#1)
before this##5##2##(1990-6#1)(1995-12#1)(2008-10#2)(2010-10#1)
before to##2##2##(2008-11#1)(2013-8#1)
before transplantation##4##2##(1997-5#1)(2011-2#1)(2011-3#1)(2012-2#1)
before treatment and##2##3##(1991-9#1)(2008-10#1)
before treatment##6##2##(1991-9#1)(1994-6#1)(2008-1#1)(2008-10#2)(2012-3#1)
before using##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
before visible##3##2##(2008-10#2)(2008-11#1)
before widespread##2##2##(1993-3#1)(2011-2#1)
before you##2##2##(1994-2#1)(1994-3#1)
before##767##1##(1990-11#1)(1990-12#11)(1990-2#1)(1990-3#4)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#3)(1991-11#4)(1991-12#5)(1991-2#7)(1991-3#7)(1991-5#3)(1991-6#6)(1991-7#3)(1991-9#2)(1992-1#1)(1992-12#7)(1992-2#5)(1992-3#1)(1992-5#5)(1992-6#3)(1992-8#1)(1993-1#4)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#7)(1993-6#6)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#7)(1994-3#10)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#4)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#4)(1995-8#1)(1996-1#3)(1996-11#5)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#5)(1996-6#4)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#6)(1997-5#5)(1997-6#1)(1997-8#4)(2006-6#2)(2007-12#5)(2007-8#1)(2008-1#8)(2008-10#180)(2008-11#36)(2008-12#16)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#26)(2008-8#17)(2008-9#18)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#10)(2010-2#1)(2010-4#3)(2010-6#3)(2010-7#8)(2010-8#9)(2011-1#2)(2011-2#40)(2011-3#6)(2012-12#9)(2012-2#20)(2012-3#17)(2012-5#1)(2013-1#33)(2013-7#2)(2013-8#8)
before-after study##2##2##(2008-12#2)
beforehand##2##1##(2008-10#1)(2008-7#1)
began and##2##2##(1990-10#1)(1992-2#1)
began at##3##2##(1991-11#1)(2008-10#1)(2010-8#1)
began in the early##2##4##(2008-3#1)(2009-7#1)
began in the##3##3##(2008-3#1)(2009-7#1)(2013-1#1)
began in##10##2##(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
began to appear##2##3##(2008-2#1)(2011-2#1)
began to be##2##3##(1992-6#1)(2008-5#1)
began to form##2##3##(2008-10#1)(2008-11#1)
began to take##2##3##(2011-2#1)(2013-8#1)
began to##23##2##(1992-6#1)(1993-12#1)(1995-6#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
began with a##2##3##(2010-8#1)(2011-2#1)
began with the##4##3##(1997-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
began with##7##2##(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
began##68##1##(1990-10#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-8#2)(2011-2#6)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
begin a##2##2##(2008-3#1)(2008-7#1)
begin by##2##2##(2008-11#1)(2008-6#1)
begin in##2##2##(2008-5#1)(2008-7#1)
begin to explore##2##3##(1994-6#1)(1997-1#1)
begin to##19##2##(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-1#1)(1997-7#1)(2008-1#3)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
begin with##5##2##(2008-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
begin##50##1##(1990-3#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#2)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-5#2)(1997-1#1)(1997-7#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
beginner##2##1##(2008-11#1)(2012-3#1)
beginning a##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
beginning and##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
beginning at##6##2##(1992-3#1)(1995-8#1)(2008-10#3)(2009-9#1)
beginning before the##2##3##(1992-2#1)(2008-7#1)
beginning in##4##2##(1992-2#1)(1996-3#1)(2008-10#1)(2009-10#1)
beginning nursing##2##2##(2008-11#1)(2008-12#1)
beginning of the##30##3##(1990-12#1)(1990-2#1)(1991-8#1)(1992-2#1)(1994-5#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2012-2#1)
beginning of##64##2##(1990-12#1)(1990-2#2)(1991-12#2)(1991-8#1)(1992-2#1)(1993-12#2)(1994-3#1)(1994-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#19)(2008-11#6)(2008-12#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#2)(2013-1#3)
beginning on day##2##3##(1994-8#2)
beginning to be##4##3##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
beginning to emerge##3##3##(1995-9#1)(2011-2#2)
beginning to##23##2##(1991-3#1)(1992-1#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-2#4)
beginning with the development of a concept and needs assessment and ending with the influence a women's health center has on health care for others##2##25##(1994-3#2)
beginning with the##5##3##(1994-3#2)(2008-10#1)(2013-1#1)(2013-8#1)
beginning with##9##2##(1992-1#1)(1994-3#2)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
beginning##147##1##(1990-12#1)(1990-2#2)(1991-12#4)(1991-3#1)(1991-8#1)(1992-1#2)(1992-2#3)(1992-3#1)(1993-12#2)(1994-1#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#33)(2008-11#15)(2008-12#5)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#6)(2013-8#1)
beginnings##4##1##(1996-3#1)(2008-10#2)(2008-9#1)
begins at##5##2##(1996-11#1)(2008-10#2)(2008-12#1)(2008-6#1)
begins by identifying##2##3##(2008-11#2)
begins by##5##2##(1994-3#1)(2008-11#3)(2008-12#1)
begins to##7##2##(1993-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2013-1#1)
begins with a##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)
begins with##10##2##(1992-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)
begins##41##1##(1992-3#1)(1993-5#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-1#2)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
begomovirus species##9##2##(2008-10#9)
begomovirus##21##1##(2008-10#21)
begomoviruses and##2##2##(2008-10#2)
begomoviruses from##3##2##(2008-10#3)
begomoviruses in##3##2##(2008-10#3)
begomoviruses may##2##2##(2008-10#2)
begomoviruses with##2##2##(2008-10#2)
begomoviruses##31##1##(2008-10#31)
begun to develop##2##3##(1994-1#1)(2006-6#1)
begun to provide##2##3##(2008-10#1)(2011-2#1)
begun to##19##2##(1993-3#1)(1994-1#1)(1994-2#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-9#1)(2012-12#1)(2012-2#1)
begun##27##1##(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-9#1)(2006-6#1)(2008-10#3)(2008-11#5)(2008-5#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
behalf of##10##2##(1991-2#1)(1992-1#1)(1992-2#1)(1994-1#1)(1995-6#3)(2010-10#1)(2013-7#1)(2013-8#1)
behalf##15##1##(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-1#1)(1995-12#1)(1995-6#3)(2009-5#2)(2010-10#1)(2010-7#1)(2013-7#1)(2013-8#1)
behave as##4##2##(1993-8#1)(2008-11#1)(2008-3#1)(2008-9#1)
behave in##2##2##(2008-10#1)(2008-11#1)
behave like the##2##3##(1994-6#1)(2008-10#1)
behave like##4##2##(1992-12#1)(1994-6#1)(2008-10#2)
behave##13##1##(1992-12#1)(1993-8#1)(1994-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#2)
behaved in a similar##3##4##(1990-12#1)(2008-11#1)(2008-9#1)
behaved in a##4##3##(1990-12#1)(2008-11#2)(2008-9#1)
behaved in##5##2##(1990-12#1)(1995-2#1)(2008-11#2)(2008-9#1)
behaved like##2##2##(2008-10#1)(2008-8#1)
behaved similarly##2##2##(1990-11#1)(2008-10#1)
behaved##14##1##(1990-11#1)(1990-12#1)(1991-12#1)(1993-8#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)
behaves as a reversed-phase packing##2##5##(2008-10#2)
behaves as a##7##3##(2008-10#5)(2010-8#1)(2012-2#1)
behaves as##8##2##(1991-9#1)(2008-10#5)(2010-8#1)(2012-2#1)
behaves like a##3##3##(1991-11#1)(2008-10#1)(2008-3#1)
behaves like##4##2##(1991-11#1)(1991-7#1)(2008-10#1)(2008-3#1)
behaves##17##1##(1991-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
behaving animals##2##2##(1991-2#1)(2008-4#1)
behaving##5##1##(1991-2#2)(1993-6#1)(2008-11#1)(2008-4#1)
behavior affects##2##2##(2008-3#1)(2008-8#1)
behavior after##2##2##(1997-8#1)(2008-9#1)
behavior among##4##2##(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)
behavior and children's early emotion regulation skills##2##7##(2011-2#2)
behavior and determination of##3##4##(2008-10#3)
behavior and of##2##3##(2011-2#1)(2013-8#1)
behavior and the##10##3##(1991-2#1)(1992-2#1)(1993-3#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
behavior and were##2##3##(2008-4#1)(2012-2#1)
behavior and##66##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#16)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#5)(2008-9#1)(2009-8#2)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#3)
behavior are##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
behavior as a##3##3##(1993-8#1)(2008-6#1)(2013-8#1)
behavior at all##2##3##(1991-2#1)(2008-10#1)
behavior at##12##2##(1991-2#1)(1993-8#2)(1995-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-3#1)(2013-1#1)
behavior between the##2##3##(2008-10#1)(2010-10#1)
behavior between##6##2##(2008-10#2)(2008-4#1)(2008-9#2)(2010-10#1)
behavior by##2##2##(2008-9#1)(2009-10#1)
behavior can be##2##3##(1995-3#1)(2008-10#1)
behavior can##3##2##(1995-3#1)(2008-10#1)(2008-8#1)
behavior change##7##2##(1993-12#2)(1997-6#1)(2008-4#2)(2008-6#1)(2013-1#1)
behavior disorders##3##2##(2008-11#1)(2013-8#2)
behavior does not##2##3##(1991-6#1)(2009-10#1)
behavior during the##2##3##(1991-2#1)(1995-2#1)
behavior during##3##2##(1991-2#1)(1995-2#1)(1995-3#1)
behavior following##2##2##(1991-2#1)(2008-11#1)
behavior for##8##2##(1992-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-7#2)(2010-2#1)
behavior genetics##2##2##(2008-8#2)
behavior has been##2##3##(2009-8#1)(2013-8#1)
behavior in Drosophila##2##3##(2008-8#1)(2008-9#1)
behavior in a##6##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-7#1)(2013-1#1)
behavior in both situation##2##4##(1990-12#2)
behavior in continuous##3##3##(2008-11#1)(2008-7#2)
behavior in response to##2##4##(2008-11#1)(2013-8#1)
behavior in the presence of##2##5##(2008-5#1)(2008-8#1)
behavior in the##14##3##(1990-6#1)(1991-12#1)(1993-2#1)(1994-2#1)(1995-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)
behavior in##62##2##(1990-12#2)(1990-6#1)(1991-12#1)(1992-6#2)(1993-2#1)(1993-6#1)(1994-2#2)(1995-8#1)(1997-3#1)(2008-10#6)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#6)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
behavior is associated with##3##4##(1990-12#1)(2009-5#1)(2013-1#1)
behavior is influenced by##2##4##(2008-10#1)(2008-8#1)
behavior is more##2##3##(2008-10#1)(2008-9#1)
behavior is not##2##3##(2009-7#1)(2011-2#1)
behavior is the##2##3##(1990-12#1)(2009-8#1)
behavior is##31##2##(1990-12#2)(1992-12#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#6)(2008-9#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#2)
behavior may##2##2##(2008-11#1)(2009-9#1)
behavior observed##5##2##(2008-10#3)(2008-7#1)(2009-11#1)
behavior of a tunnel diode##2##5##(2008-3#2)
behavior of a##12##3##(2008-10#3)(2008-11#2)(2008-3#4)(2008-8#1)(2008-9#1)(2011-2#1)
behavior of adult##2##3##(1994-8#1)(2012-12#1)
behavior of an##2##3##(2008-10#1)(2008-8#1)
behavior of divalent first row transition##2##6##(2008-10#2)
behavior of divalent##3##3##(2008-10#3)
behavior of epinephrine at##2##4##(2008-10#2)
behavior of hemin##2##3##(2008-10#2)
behavior of individual##2##3##(1994-9#1)(2008-9#1)
behavior of some##7##3##(2008-10#6)(2012-3#1)
behavior of the chemically modified electrode##2##6##(2008-10#2)
behavior of the complex##2##4##(2008-10#1)(2008-8#1)
behavior of the modified electrode##2##5##(2008-10#2)
behavior of the networks##2##4##(2008-11#2)
behavior of the##57##3##(1990-11#1)(1990-8#2)(1991-2#1)(1991-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#29)(2008-11#2)(2008-3#5)(2008-8#3)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
behavior of these##5##3##(1996-5#1)(2008-10#1)(2010-10#1)(2011-2#2)
behavior of uranium##2##3##(2008-10#2)
behavior of##241##2##(1990-11#2)(1990-6#2)(1990-8#2)(1991-2#2)(1991-9#1)(1992-10#1)(1993-8#3)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-2#2)(1996-5#3)(1997-8#2)(2008-1#1)(2008-10#125)(2008-11#9)(2008-12#2)(2008-3#13)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#17)(2008-9#6)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#3)(2010-10#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
behavior on the##2##3##(2010-10#1)(2011-2#1)
behavior on##7##2##(2008-10#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#2)
behavior or##2##2##(2008-9#1)(2013-1#1)
behavior problems##8##2##(1995-2#1)(2008-12#1)(2009-11#1)(2009-9#1)(2010-11#4)
behavior revealed##2##2##(2008-10#1)(2008-8#1)
behavior score was##2##3##(1990-12#2)
behavior such as##2##3##(2008-1#1)(2012-2#1)
behavior than##3##2##(1990-2#1)(2008-12#1)(2010-7#1)
behavior that is##2##3##(2007-11#1)(2008-11#1)
behavior that##5##2##(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
behavior therapy##6##2##(2012-2#2)(2013-1#4)
behavior to##5##2##(1992-2#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
behavior using##4##2##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
behavior was also##2##3##(2008-10#1)(2008-3#1)
behavior was found##2##3##(2008-8#1)(2010-4#1)
behavior was used to##2##4##(2008-10#1)(2012-3#1)
behavior was##18##2##(1991-2#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#2)(2012-3#1)(2013-1#1)
behavior were studied##2##3##(1990-2#1)(2008-10#1)
behavior were##4##2##(1990-2#1)(2008-10#2)(2010-10#1)
behavior which##2##2##(1991-8#1)(2008-11#1)
behavior with the##2##3##(2007-11#1)(2008-10#1)
behavior with##11##2##(2007-11#1)(2008-10#5)(2008-11#1)(2008-8#2)(2009-7#1)(2013-8#1)
behavior would##2##2##(2008-11#1)(2008-9#1)
behavior##829##1##(1990-11#3)(1990-12#6)(1990-2#3)(1990-6#3)(1990-8#4)(1991-12#1)(1991-2#10)(1991-3#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-6#2)(1992-9#2)(1993-12#8)(1993-2#1)(1993-3#7)(1993-6#4)(1993-8#8)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#5)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#7)(1995-3#2)(1995-6#1)(1995-8#3)(1996-2#5)(1996-3#1)(1996-5#3)(1997-1#3)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#203)(2008-11#75)(2008-12#28)(2008-2#2)(2008-3#23)(2008-4#9)(2008-5#6)(2008-6#6)(2008-7#15)(2008-8#70)(2008-9#31)(2009-10#3)(2009-11#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#16)(2009-8#11)(2009-9#7)(2010-10#8)(2010-11#6)(2010-2#2)(2010-3#1)(2010-4#6)(2010-6#3)(2010-7#5)(2010-8#3)(2010-9#1)(2011-2#25)(2011-3#1)(2012-12#6)(2012-2#12)(2012-3#13)(2012-5#2)(2013-1#50)(2013-8#17)
behavior?##2##1##(1995-3#1)(2008-6#1)
behavioral activation therapy##2##3##(2009-11#2)
behavioral activation##4##2##(1996-12#1)(2009-11#3)
behavioral and morphological##2##3##(2008-8#2)
behavioral and neurochemical##3##3##(1997-2#1)(2008-4#1)(2011-2#1)
behavioral and physiological responses##2##4##(2008-9#2)
behavioral and physiological##3##3##(2008-10#1)(2008-9#2)
behavioral and##21##2##(1991-1#1)(1993-6#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
behavioral assumptions##2##2##(2008-8#2)
behavioral avoidance##2##2##(2012-2#2)
behavioral change##6##2##(1991-3#2)(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)
behavioral changes##4##2##(1996-2#3)(2010-9#1)
behavioral conditions##2##2##(1994-2#1)(2008-5#1)
behavioral control##2##2##(2008-5#1)(2013-1#1)
behavioral decision##2##2##(2008-9#2)
behavioral deficits##3##2##(1991-2#2)(1997-2#1)
behavioral disturbances##4##2##(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
behavioral ecologists##2##2##(2008-8#2)
behavioral ecology##3##2##(2008-8#2)(2008-9#1)
behavioral effects of##2##3##(1991-1#1)(1991-2#1)
behavioral effects##5##2##(1991-1#1)(1991-2#2)(1993-3#1)(2012-3#1)
behavioral emergencies##2##2##(2010-9#2)
behavioral enrichment##3##2##(2009-8#3)
behavioral genetic##2##2##(2008-8#1)(2012-3#1)
behavioral health##5##2##(1991-3#1)(1995-1#1)(1996-2#1)(2008-6#1)(2010-9#1)
behavioral improvement##3##2##(1996-2#1)(2013-8#2)
behavioral interventions##3##2##(2008-2#1)(2013-1#2)
behavioral isolation##4##2##(2008-9#4)
behavioral momentum theory##2##3##(2010-10#2)
behavioral momentum##4##2##(2010-10#4)
behavioral or physiological##2##3##(2008-8#2)
behavioral outcomes##2##2##(2009-8#1)(2013-8#1)
behavioral paradigms##3##2##(1992-12#1)(1993-3#1)(2008-4#1)
behavioral patterns##3##2##(2008-4#1)(2008-8#1)(2013-1#1)
behavioral problems##3##2##(1991-2#1)(1996-1#1)(2008-8#1)
behavioral responses##5##2##(1995-8#1)(2008-8#2)(2010-1#2)
behavioral state##4##2##(2009-8#4)
behavioral studies##2##2##(2008-11#1)(2008-7#1)
behavioral support##2##2##(2008-9#1)(2013-1#1)
behavioral tasks on the##2##4##(1997-2#2)
behavioral tasks##5##2##(1997-2#4)(2008-5#1)
behavioral tests##4##2##(1996-2#2)(2008-10#1)(2009-8#1)
behavioral trait##3##2##(2008-8#1)(2008-9#2)
behavioral traits##2##2##(2008-9#2)
behavioral variables##2##2##(2008-7#1)(2009-8#1)
behavioral##221##1##(1991-1#3)(1991-2#8)(1991-3#3)(1992-12#3)(1992-6#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#1)(1997-2#9)(1997-8#1)(2007-12#2)(2008-10#5)(2008-11#15)(2008-12#1)(2008-2#1)(2008-4#10)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#29)(2008-9#15)(2009-11#5)(2009-8#14)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#1)(2010-5#1)(2010-7#2)(2010-9#4)(2011-1#1)(2011-10#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#11)(2013-8#13)
behaviorally##4##1##(1993-1#1)(2009-8#2)(2013-8#1)
behaviors (e##2##2##(2010-9#1)(2013-1#1)
behaviors across all##2##3##(2010-7#1)(2013-1#1)
behaviors among adolescents##3##3##(1996-1#1)(2008-11#1)(2013-1#1)
behaviors among##7##2##(1996-1#1)(2008-11#1)(2008-12#1)(2009-7#1)(2013-1#2)(2013-8#1)
behaviors and social##2##3##(1995-3#1)(2008-11#1)
behaviors and##22##2##(1991-1#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2009-5#2)(2009-7#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
behaviors are##3##2##(2007-11#1)(2008-10#1)(2009-8#1)
behaviors associated with the##2##4##(2009-7#1)(2011-2#1)
behaviors associated with##4##3##(1991-1#1)(1993-6#1)(2009-7#1)(2011-2#1)
behaviors at##2##2##(2008-12#1)(2011-2#1)
behaviors by##2##2##(2008-9#1)(2009-12#1)
behaviors during the##2##3##(2008-11#2)
behaviors for the##2##3##(1991-12#1)(2009-11#1)
behaviors for##6##2##(1991-12#1)(1992-1#1)(2008-11#1)(2009-11#2)(2013-1#1)
behaviors in the use of hospital care##2##7##(1994-2#2)
behaviors in the##5##3##(1994-2#2)(2009-7#1)(2011-2#1)(2013-1#1)
behaviors in their##2##3##(2009-11#1)(2010-8#1)
behaviors in##29##2##(1990-12#1)(1993-6#1)(1994-2#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-7#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#5)(2013-8#1)
behaviors is##2##2##(2009-5#1)(2011-2#1)
behaviors observed for##2##3##(2008-10#1)(2009-12#1)
behaviors of adolescents##2##3##(1996-1#1)(2010-9#1)
behaviors of these##4##3##(2008-10#3)(2008-11#1)
behaviors of##27##2##(1995-8#1)(1996-1#2)(2008-10#10)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#2)
behaviors regarding##2##2##(2009-4#1)(2012-12#1)
behaviors such as##3##3##(1996-1#2)(2008-8#1)
behaviors that##7##2##(2008-11#1)(2008-4#1)(2010-11#2)(2010-2#2)(2011-2#1)
behaviors under##2##2##(2008-10#1)(2008-11#1)
behaviors were examined##2##3##(2008-9#1)(2009-10#1)
behaviors were##9##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-10#1)
behaviors##257##1##(1990-12#1)(1991-1#3)(1991-12#3)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#3)(1993-6#4)(1994-2#7)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#5)(1996-9#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#29)(2008-11#25)(2008-12#7)(2008-3#1)(2008-4#9)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#7)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#3)(2010-11#4)(2010-2#4)(2010-5#8)(2010-7#5)(2010-8#6)(2010-9#5)(2011-1#2)(2011-10#1)(2011-2#8)(2012-12#3)(2012-2#10)(2012-3#1)(2013-1#28)(2013-8#12)
behaviour amongst##2##2##(2008-10#2)
behaviour and the##2##3##(2008-10#1)(2009-7#1)
behaviour and##19##2##(1991-2#2)(1993-2#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
behaviour by##6##2##(1993-6#3)(2008-11#2)(2009-6#1)
behaviour for##4##2##(1997-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
behaviour has been##2##3##(2008-5#1)(2012-2#1)
behaviour in the##2##3##(1992-3#1)(2008-5#1)
behaviour in##16##2##(1992-3#1)(1993-3#1)(1996-2#3)(1996-3#1)(2008-10#3)(2008-11#3)(2008-5#1)(2009-8#1)(2010-1#1)(2013-1#1)
behaviour is##6##2##(1993-9#1)(2008-10#3)(2012-3#1)(2013-1#1)
behaviour of 3##2##3##(2008-10#2)
behaviour of both##2##3##(2008-10#1)(2008-11#1)
behaviour of copper(II) and silver(I) with##2##6##(2008-10#2)
behaviour of gold##2##3##(2008-10#2)
behaviour of human##2##3##(1992-2#1)(2008-5#1)
behaviour of maleic hydrazide##2##4##(2008-10#2)
behaviour of some##4##3##(2008-10#4)
behaviour of the herbicide##2##4##(2008-10#2)
behaviour of the markers##2##4##(2008-10#2)
behaviour of the##26##3##(1990-11#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-5#3)(2008-7#1)(2009-7#2)(2013-1#1)(2013-8#1)
behaviour of these##4##3##(1993-6#1)(2008-10#2)(2009-7#1)
behaviour of##114##2##(1990-11#1)(1990-9#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-8#1)(1996-11#1)(1996-12#1)(2007-12#1)(2008-1#2)(2008-10#68)(2008-11#8)(2008-12#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-7#7)(2010-8#2)(2011-1#1)(2011-2#4)(2012-7#1)(2013-1#2)(2013-8#1)
behaviour on##2##2##(2008-11#1)(2010-8#1)
behaviour or##2##2##(1990-2#1)(2008-12#1)
behaviour problems##2##2##(2008-9#1)(2013-1#1)
behaviour that##3##2##(1996-12#1)(2008-10#1)(2009-10#1)
behaviour was##8##2##(1990-11#1)(1996-2#1)(2008-10#3)(2008-5#1)(2010-8#1)(2011-1#1)
behaviour with##2##2##(2008-11#1)(2008-5#1)
behaviour##287##1##(1990-11#2)(1990-2#1)(1990-5#2)(1990-9#2)(1991-2#4)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#6)(1993-9#2)(1994-12#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#4)(1997-5#1)(2007-12#1)(2008-1#3)(2008-10#105)(2008-11#30)(2008-12#5)(2008-5#14)(2008-7#9)(2008-9#6)(2009-10#3)(2009-6#2)(2009-7#13)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-6#1)(2010-8#8)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#3)
behavioural and neural responses to gaze shifts were modulated by the social context##2##13##(2008-11#2)
behavioural and##8##2##(1993-6#1)(2008-11#5)(2008-12#1)(2010-8#1)
behavioural changes##4##2##(1990-3#2)(1991-2#2)
behavioural control##2##2##(1996-5#1)(2008-11#1)
behavioural deficits in##2##3##(1994-8#1)(1997-2#1)
behavioural deficits##5##2##(1991-2#1)(1994-8#3)(1997-2#1)
behavioural problems##2##2##(1992-2#1)(2008-11#1)
behavioural responses##2##2##(1996-2#2)
behavioural risk##2##2##(2010-6#1)(2013-8#1)
behavioural sciences##2##2##(2008-11#1)(2012-2#1)
behavioural##71##1##(1990-3#2)(1991-2#5)(1991-6#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-3#3)(1994-8#5)(1995-3#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#11)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#9)(2010-10#1)(2010-6#6)(2010-8#2)(2011-2#1)(2012-2#4)(2013-8#2)
behaviourally##2##1##(2008-1#1)(2012-2#1)
behaviours among##2##2##(2010-6#1)(2013-8#1)
behaviours and attitudes##3##3##(2008-11#2)(2010-3#1)
behaviours and##5##2##(1992-1#1)(2008-11#2)(2010-3#1)(2011-2#1)
behaviours in##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
behaviours of##4##2##(2008-1#1)(2008-10#2)(2008-7#1)
behaviours that##2##2##(2008-5#1)(2012-2#1)
behaviours were##2##2##(2008-10#1)(2008-9#1)
behaviours##31##1##(1992-1#1)(1993-2#1)(1995-1#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#2)(2010-10#2)(2010-3#1)(2010-6#3)(2011-2#4)(2012-2#1)(2013-8#1)
behind a##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
behind in##2##2##(1995-5#1)(2008-11#1)
behind such##2##2##(2008-10#1)(2008-9#1)
behind the development of##2##4##(2008-10#1)(2010-1#1)
behind the##23##2##(1991-1#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
behind their##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
behind these##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
behind this##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
behind##79##1##(1991-1#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-3#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-6#2)(1997-7#1)(2007-12#2)(2008-10#12)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
being &quot##5##2##(2008-12#5)
being 0##4##2##(2008-10#4)
being 1##4##2##(1996-2#1)(2008-10#1)(2008-7#2)
being 20##2##2##(1990-2#1)(2008-11#1)
being 4##2##2##(2008-10#2)
being a successful designer##2##4##(2012-3#2)
being a successful##3##3##(2012-3#3)
being a useful tool##2##4##(2008-10#1)(2008-5#1)
being a##40##2##(1991-7#1)(1991-8#1)(1993-8#1)(1996-2#1)(1996-3#2)(1997-7#2)(2008-10#6)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#4)
being able to##7##3##(1991-3#1)(2008-11#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
being about##2##2##(1991-5#1)(2008-10#1)
being accumulated##2##2##(2008-10#1)(2008-9#1)
being added##2##2##(2008-10#2)
being addressed##3##2##(1997-3#1)(2008-8#1)(2008-9#1)
being administered##2##2##(1991-8#1)(2010-11#1)
being admitted to an##2##4##(2012-12#2)
being also##2##2##(1995-12#1)(2008-10#1)
being an##11##2##(1991-11#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#3)
being analyzed##5##2##(2008-10#2)(2008-11#2)(2010-10#1)
being applied to##3##3##(2008-10#1)(2010-4#1)(2010-5#1)
being as##2##2##(2008-1#1)(2012-2#1)
being assessed##2##2##(2008-11#2)
being associated with the##2##4##(1995-8#1)(2013-8#1)
being associated with##6##3##(1995-8#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
being based on##2##3##(1995-5#1)(2008-10#1)
being between##2##2##(2008-10#2)
being cared for in##2##4##(2008-11#1)(2011-2#1)
being carried##2##2##(2008-10#1)(2011-2#1)
being close to##3##3##(2008-10#3)
being collected##2##2##(1994-2#1)(2008-10#1)
being compared##4##2##(1992-2#1)(1996-2#1)(2008-10#2)
being conducted by##2##3##(1994-12#1)(1995-6#1)
being conducted##5##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2009-7#1)
being confronted with##2##3##(1990-11#1)(2010-7#1)
being considered as a##2##4##(2011-2#1)(2013-1#1)
being considered as##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
being considered for##2##3##(1995-2#1)(2008-1#1)
being considered##9##2##(1990-9#1)(1995-2#1)(2008-1#1)(2008-10#3)(2011-2#1)(2013-1#1)(2013-7#1)
being controlled##2##2##(1990-12#1)(2010-1#1)
being dependent on##2##3##(2008-10#1)(2010-10#1)
being depressed and##2##3##(1996-6#1)(2010-2#1)
being derived from##2##3##(1993-1#1)(2008-10#1)
being detected##4##2##(1991-6#1)(1992-2#1)(2008-10#1)(2011-2#1)
being developed and##3##3##(1997-5#1)(2008-10#1)(2008-7#1)
being developed for##2##3##(2008-10#1)(2008-6#1)
being developed##16##2##(1992-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-1#1)(1997-5#2)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#1)
being diagnosed with##2##3##(1995-2#1)(2008-12#1)
being directly##2##2##(1995-8#1)(2008-10#1)
being discharged##3##2##(1995-3#1)(2008-11#1)(2009-3#1)
being discovered##2##2##(2008-12#1)(2008-4#1)
being discussed##3##2##(1997-1#1)(2008-12#1)(2013-1#1)
being done to##2##3##(1992-8#1)(2008-11#1)
being done##4##2##(1992-8#1)(1997-3#1)(2008-10#1)(2008-11#1)
being due to##2##3##(2008-8#1)(2013-1#1)
being elicited##2##2##(2008-10#1)(2013-8#1)
being eliminated##2##2##(1991-6#1)(2013-1#1)
being employed in##2##3##(1997-6#1)(2008-10#1)
being employed##4##2##(1997-6#1)(2008-10#2)(2008-4#1)
being equal##2##2##(2008-10#2)
being essential##2##2##(1991-9#1)(2011-2#1)
being evaluated for##2##3##(1997-1#1)(2013-8#1)
being evaluated##5##2##(1997-1#1)(2008-5#1)(2008-9#1)(2010-10#1)(2013-8#1)
being examined##3##2##(2007-8#1)(2008-11#1)(2011-2#1)
being explored for##2##3##(2008-7#1)(2009-12#1)
being explored##8##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-7#1)(2013-8#1)
being exposed to##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
being followed##3##2##(1991-3#1)(2012-2#1)(2013-1#1)
being followed-up##2##2##(2008-1#1)(2013-1#1)
being formed##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
being found with the##2##4##(1990-9#1)(2008-10#1)
being found##7##2##(1990-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
being given by##2##3##(1991-3#1)(1993-12#1)
being given to##2##3##(1992-3#1)(1993-11#1)
being given##5##2##(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(2012-3#1)
being greater than##2##3##(1994-3#1)(2008-10#1)
being higher##3##2##(1995-1#1)(2008-10#2)
being highest in##2##3##(2008-10#1)(2008-9#1)
being highly##7##2##(1990-6#1)(1994-2#1)(2008-10#3)(2008-4#1)(2008-7#1)
being identified##6##2##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
being implemented##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
being in a##3##3##(1995-12#1)(2008-10#1)(2010-11#1)
being in delirium##2##3##(2010-10#2)
being in the##8##3##(1992-3#1)(1993-8#2)(1994-2#1)(1996-6#1)(2008-10#1)(2010-10#1)(2013-1#1)
being in##19##2##(1991-8#1)(1992-3#1)(1993-8#2)(1994-2#1)(1995-12#2)(1996-6#1)(2008-10#3)(2008-11#2)(2010-10#3)(2010-11#1)(2013-1#2)
being increasingly adopted##2##3##(2010-2#1)(2011-2#1)
being increasingly##8##2##(1993-11#1)(2008-4#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#2)
being induced##2##2##(2008-10#1)(2008-8#1)
being infected##2##2##(2008-8#1)(2008-9#1)
being injected##2##2##(2008-7#1)(2011-2#1)
being installed##2##2##(2008-3#1)(2013-1#1)
being introduced##2##2##(1992-3#1)(2008-11#1)
being investigated as##2##3##(2008-10#2)
being investigated##8##2##(1996-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-3#1)
being involved in##3##3##(1995-6#1)(2008-11#1)(2008-9#1)
being involved##4##2##(1995-6#1)(2008-11#1)(2008-7#1)(2008-9#1)
being largely##2##2##(2008-1#1)(2008-10#1)
being less than##3##3##(1997-7#1)(2010-11#1)(2012-2#1)
being less##6##2##(1997-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
being made to##3##3##(1992-12#1)(2008-11#1)(2008-5#1)
being made##7##2##(1992-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-12#1)
being male##3##2##(2008-1#1)(2011-2#1)(2012-3#1)
being managed##2##2##(1995-2#1)(2010-1#1)
being measured##3##2##(1993-1#1)(2008-7#1)(2008-9#1)
being mediated##2##2##(1994-11#1)(2008-7#1)
being met in##2##3##(2008-8#1)(2010-10#1)
being met##6##2##(1992-8#1)(1995-12#1)(1996-1#1)(2008-8#1)(2010-10#1)(2013-1#1)
being monitored##2##2##(2008-10#1)(2008-7#1)
being more##13##2##(1992-8#1)(1994-11#1)(1997-1#1)(2008-10#5)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)
being normal##2##2##(1995-11#1)(2010-11#1)
being not##2##2##(2008-5#1)(2008-7#1)
being observed##2##2##(2008-7#2)
being obtained##2##2##(2008-10#1)(2008-5#1)
being of##3##2##(1991-6#1)(1996-1#1)(2008-11#1)
being often##2##2##(2010-10#1)(2013-1#1)
being on the##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
being on##5##2##(2008-10#1)(2008-11#2)(2008-9#1)(2013-1#1)
being one of the##3##4##(2008-10#1)(2008-12#1)(2012-12#1)
being one of##4##3##(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)
being only##2##2##(2008-10#1)(2008-11#1)
being oxidized##3##2##(2008-10#3)
being performed##5##2##(1991-1#1)(1997-2#1)(2008-9#1)(2010-1#1)(2013-1#1)
being placed##2##2##(2007-12#1)(2008-11#1)
being planned##4##2##(2008-1#1)(2008-12#1)(2009-6#1)(2010-7#1)
being possible##2##2##(2008-10#2)
being prescribed##3##2##(2008-11#2)(2010-4#1)
being presented##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
being realized##2##2##(1992-1#1)(1993-2#1)
being recorded##2##2##(2008-5#1)(2010-8#1)
being rejected##2##2##(2008-10#1)(2013-1#1)
being related to##2##3##(2010-4#1)(2011-2#1)
being relatively##3##2##(1993-3#1)(2007-12#1)(2008-10#1)
being released##2##2##(2007-12#1)(2010-3#1)
being reported##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
being restricted to the##2##4##(2008-2#1)(2012-2#1)
being run##2##2##(2008-11#1)(2012-12#1)
being separated##2##2##(1991-12#1)(2008-10#1)
being served##2##2##(1992-2#1)(1997-2#1)
being sexually##2##2##(1997-6#1)(2009-5#1)
being shown##2##2##(2008-10#1)(2008-7#1)
being significantly##2##2##(1994-3#1)(2008-10#1)
being slightly##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
being sought##2##2##(1994-6#1)(2013-1#1)
being spent on##2##3##(1992-2#1)(2008-11#1)
being studied##3##2##(1994-2#1)(2008-7#1)(2011-3#1)
being susceptible##2##2##(2008-10#1)(2008-11#1)
being taken##3##2##(1990-9#1)(2010-8#1)(2011-2#1)
being tested for##2##3##(2008-5#1)(2012-2#1)
being tested in##2##3##(1996-5#1)(2008-5#1)
being tested##7##2##(1996-5#1)(1997-6#1)(2008-5#2)(2008-7#1)(2012-2#1)(2012-3#1)
being that the##2##3##(2010-6#1)(2013-8#1)
being the case##2##3##(1995-1#1)(2008-10#1)
being the least##2##3##(1993-2#1)(2011-1#1)
being the most common##3##4##(2008-10#1)(2011-2#2)
being the most effective##2##4##(2013-1#2)
being the most##14##3##(1991-3#1)(1995-11#1)(2008-10#5)(2010-12#1)(2010-6#1)(2011-2#3)(2013-1#2)
being the subject of##2##4##(2008-10#1)(2012-3#1)
being the##57##2##(1991-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-6#2)(1995-1#1)(1995-11#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#5)
being through##2##2##(2008-9#1)(2010-8#1)
being to##5##2##(1990-5#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
being too##2##2##(2011-2#1)(2012-3#1)
being treated with a##2##4##(1993-2#1)(2013-1#1)
being treated with##8##3##(1991-11#1)(1993-2#2)(1997-1#1)(2008-11#1)(2010-10#1)(2011-1#1)(2013-1#1)
being treated##9##2##(1991-11#1)(1993-2#2)(1996-6#1)(1997-1#1)(2008-11#1)(2010-10#1)(2011-1#1)(2013-1#1)
being undertaken##5##2##(1993-2#1)(1994-12#1)(1995-5#1)(2008-11#1)(2010-11#1)
being used as an##2##4##(1997-1#1)(2008-11#1)
being used as##7##3##(1990-9#1)(1997-1#1)(2008-11#3)(2010-6#1)(2011-2#1)
being used for##5##3##(2008-10#4)(2011-2#1)
being used in the##4##4##(1990-12#1)(2008-11#2)(2011-2#1)
being used in##10##3##(1990-12#1)(2008-10#1)(2008-11#4)(2010-12#1)(2011-2#1)(2012-2#2)
being used to study##2##4##(2008-11#1)(2008-7#1)
being used to##13##3##(1990-11#1)(1994-5#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)
being used##48##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1994-2#1)(1994-5#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#11)(2008-11#10)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#8)(2012-2#2)(2013-1#1)
being useful in##2##3##(1993-1#1)(2008-10#1)
being utilized##2##2##(2008-9#1)(2012-2#1)
being very##3##2##(1992-2#1)(2008-12#1)(2011-2#1)
being well##2##2##(2008-8#1)(2013-8#1)
being within##3##2##(2008-10#3)
being##1000##1##(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#5)(1992-3#4)(1992-8#4)(1992-9#3)(1993-1#4)(1993-11#2)(1993-12#1)(1993-2#7)(1993-3#1)(1993-6#2)(1993-8#6)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#6)(1995-11#3)(1995-12#11)(1995-2#7)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#4)(1996-1#4)(1996-11#1)(1996-12#6)(1996-2#8)(1996-3#4)(1996-5#2)(1996-6#3)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#7)(1997-4#2)(1997-5#7)(1997-6#4)(1997-7#5)(1997-8#4)(2007-12#8)(2007-8#1)(2008-1#11)(2008-10#229)(2008-11#91)(2008-12#27)(2008-2#1)(2008-3#8)(2008-4#9)(2008-5#16)(2008-6#3)(2008-7#33)(2008-8#20)(2008-9#30)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#10)(2010-10#18)(2010-11#12)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#4)(2010-6#5)(2010-7#9)(2010-8#8)(2010-9#1)(2011-1#7)(2011-2#57)(2011-3#4)(2012-12#12)(2012-2#26)(2012-3#17)(2013-1#41)(2013-7#1)(2013-8#13)
being)##2##1##(1996-3#1)(2009-8#1)
belief in the 10##2##4##(2008-12#2)
belief in the##3##3##(1990-12#1)(2008-12#2)
belief in##4##2##(1990-12#1)(2008-12#2)(2010-2#1)
belief that the##2##3##(1994-2#1)(2008-12#1)
belief that##17##2##(1990-12#1)(1990-5#1)(1991-6#2)(1992-2#1)(1994-2#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
belief##29##1##(1990-12#2)(1990-5#1)(1991-6#2)(1992-2#1)(1993-1#1)(1994-2#1)(1994-8#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#2)(2011-2#2)(2013-1#1)
beliefs about the##4##3##(2009-10#2)(2013-8#2)
beliefs about##10##2##(2008-11#1)(2008-12#2)(2009-10#2)(2010-4#2)(2012-3#1)(2013-8#2)
beliefs among##2##2##(2010-5#1)(2013-1#1)
beliefs and the##2##3##(2010-1#1)(2011-2#1)
beliefs and values##2##3##(2008-11#1)(2008-12#1)
beliefs and##13##2##(2008-11#1)(2008-12#1)(2008-9#2)(2010-1#3)(2010-5#1)(2011-1#2)(2011-2#3)
beliefs may##2##2##(2008-12#1)(2009-10#1)
beliefs were##2##2##(2008-12#1)(2010-5#1)
beliefs##54##1##(1994-12#2)(1994-2#1)(1995-1#1)(2008-11#4)(2008-12#10)(2008-9#3)(2009-10#5)(2009-4#1)(2009-6#1)(2010-1#4)(2010-10#1)(2010-4#3)(2010-5#6)(2011-1#4)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
believe in##3##2##(1996-1#1)(2008-7#1)(2013-1#1)
believe is##3##2##(1995-1#1)(2008-3#1)(2008-9#1)
believe it is##3##3##(1993-12#1)(1997-2#1)(2008-7#1)
believe it##5##2##(1993-12#1)(1994-2#1)(1997-2#1)(2008-7#1)(2009-6#1)
believe that it is##2##4##(1991-12#1)(2012-3#1)
believe that the##17##3##(1992-2#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2012-3#1)(2013-1#1)
believe that they##3##3##(2008-1#1)(2008-7#1)(2008-9#1)
believe that this is a##2##5##(2009-1#1)(2011-2#1)
believe that this is##3##4##(2009-1#1)(2010-3#1)(2011-2#1)
believe that this##5##3##(1992-2#1)(2009-1#1)(2010-3#1)(2011-2#2)
believe that##59##2##(1990-3#2)(1991-1#1)(1991-12#1)(1992-2#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#7)(2008-8#2)(2008-9#6)(2009-1#2)(2009-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
believe the use of##2##4##(2008-3#1)(2008-6#1)
believe the##7##2##(1990-2#2)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
believe this##4##2##(1994-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
believe##101##1##(1990-2#2)(1990-3#2)(1991-1#1)(1991-12#3)(1992-2#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#3)(1997-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#4)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#9)(2009-1#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#1)
believed that i##2##3##(2008-1#2)
believed that the##3##3##(1994-8#1)(1996-2#1)(2012-12#1)
believed that##26##2##(1990-12#1)(1991-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-6#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#2)(2009-5#1)(2010-7#1)(2010-9#1)(2011-10#1)(2011-2#1)(2012-12#2)(2013-1#2)
believed to affect##2##3##(2008-8#1)(2010-12#1)
believed to be involved in the##4##6##(2008-11#1)(2010-3#1)(2013-8#2)
believed to be new##2##4##(2008-3#2)
believed to be the##3##4##(1992-9#1)(1997-2#1)(2008-3#1)
believed to be##27##3##(1992-10#1)(1992-9#1)(1993-1#1)(1994-11#2)(1994-5#1)(1997-2#1)(1997-8#1)(1997-9#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#2)
believed to cause##2##3##(2008-10#1)(2008-4#1)
believed to contain##2##3##(1991-6#1)(1996-12#1)
believed to play##5##3##(1995-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
believed to##59##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-1#1)(1994-11#2)(1994-5#1)(1995-11#2)(1995-12#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(1997-9#1)(2008-10#8)(2008-11#7)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#4)(2013-1#1)(2013-8#2)
believed##88##1##(1990-12#1)(1991-3#2)(1991-6#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-1#3)(2008-10#11)(2008-11#8)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-3#1)(2010-7#2)(2010-9#1)(2011-10#1)(2011-2#5)(2012-12#2)(2013-1#4)(2013-8#2)
believer##2##1##(1996-12#1)(2011-2#1)
believes that the##2##3##(1993-12#1)(2012-3#1)
believes that##6##2##(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(2008-4#1)(2012-3#1)
believes##14##1##(1990-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
believing##3##1##(1991-2#1)(1995-12#1)(2008-11#1)
bell pepper##9##2##(2008-10#9)
bell##10##1##(2008-10#10)
bell-shaped dose-response curve##2##3##(2008-11#2)
bell-shaped##3##1##(2008-11#3)
bellicosus##2##1##(2008-9#2)
belly##4##1##(1996-12#2)(2009-10#2)
belong to a new##2##4##(1993-2#1)(1997-2#1)
belong to a single##2##4##(2008-10#2)
belong to a##11##3##(1993-2#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-8#3)(2011-2#1)(2012-2#1)
belong to four##2##3##(2008-10#1)(2008-5#1)
belong to the class of##2##5##(1995-12#1)(2008-11#1)
belong to the same##4##4##(1991-5#2)(2008-10#1)(2008-8#1)
belong to the##34##3##(1991-11#1)(1991-5#2)(1992-12#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-1#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
belong to two##3##3##(2008-10#2)(2008-11#1)
belong to##77##2##(1990-9#1)(1991-11#1)(1991-5#2)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#9)(2008-9#1)(2009-1#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
belong##82##1##(1990-9#1)(1991-11#1)(1991-5#2)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#28)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#9)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)
belonged to a single##3##4##(2008-10#3)
belonged to a##6##3##(2008-10#5)(2011-2#1)
belonged to different##2##3##(2008-10#1)(2011-2#1)
belonged to either##2##3##(2008-10#1)(2008-12#1)
belonged to genotype##2##3##(2008-10#1)(2013-8#1)
belonged to subgenogroup B5##2##4##(2008-12#2)
belonged to the same cluster as##2##6##(2008-10#1)(2008-12#1)
belonged to the same##4##4##(2008-10#3)(2008-12#1)
belonged to the##17##3##(1996-11#1)(2008-10#10)(2008-12#2)(2008-5#2)(2010-11#1)(2013-8#1)
belonged to##57##2##(1996-11#1)(2008-10#35)(2008-12#6)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#4)
belonged##60##1##(1996-11#1)(2007-8#1)(2008-10#36)(2008-12#6)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#4)
belonging to a##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
belonging to family##3##3##(2008-10#2)(2010-10#1)
belonging to subgroup##2##3##(2008-10#2)
belonging to the Bacillus##2##4##(2011-2#2)
belonging to the CSF-1 transduction pathway##2##6##(1997-7#2)
belonging to the S##2##4##(2008-10#2)
belonging to the family##5##4##(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-2#1)
belonging to the genera##2##4##(2008-10#1)(2013-8#1)
belonging to the genus##2##4##(2008-10#2)
belonging to the same##3##4##(1997-6#1)(2008-1#1)(2008-3#1)
belonging to the three##2##4##(2008-10#1)(2010-8#1)
belonging to the##51##3##(1990-5#1)(1991-12#2)(1993-3#1)(1995-2#1)(1995-6#2)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#3)
belonging to three##2##3##(2008-10#2)
belonging to two##5##3##(1997-9#1)(2008-10#3)(2008-12#1)
belonging to##105##2##(1990-5#1)(1991-12#2)(1991-9#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#2)(1996-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#2)(2008-1#1)(2008-10#53)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#2)(2008-9#4)(2009-12#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#3)
belonging##108##1##(1990-5#1)(1991-12#2)(1991-9#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#2)(1996-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#2)(2008-1#1)(2008-10#53)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#2)(2008-9#4)(2009-12#2)(2009-7#4)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#3)
belongingness (i##2##2##(2009-7#2)
belongingness##6##1##(2009-7#6)
belongs to a##6##3##(1993-6#1)(1995-6#1)(1996-2#1)(2010-11#1)(2010-8#1)(2011-2#1)
belongs to family##3##3##(2008-12#1)(2008-8#1)(2013-8#1)
belongs to the family of##2##5##(1993-6#1)(2009-7#1)
belongs to the family##3##4##(1993-6#1)(2009-7#1)(2011-2#1)
belongs to the order##2##4##(2008-9#1)(2011-2#1)
belongs to the##26##3##(1993-6#1)(1994-11#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-8#1)
belongs to##44##2##(1993-6#2)(1994-1#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#10)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-8#3)
belongs##47##1##(1993-6#2)(1994-1#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#11)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-8#3)
below 0##10##2##(2008-10#9)(2009-7#1)
below 1##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
below 10##7##2##(1991-11#1)(2008-10#4)(2008-12#1)(2011-3#1)
below 10%##4##2##(2008-10#3)(2008-11#1)
below 1000 m##3##3##(1996-12#3)
below 15##2##2##(1995-11#2)
below 15%##2##2##(2008-10#2)
below 2##5##2##(2008-10#3)(2008-11#1)(2012-12#1)
below 2% for##2##3##(2008-10#2)
below 2%##5##2##(2008-10#5)
below 3##2##2##(2008-10#2)
below 30##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
below 300##2##2##(1990-9#1)(2008-10#1)
below 37 degrees##2##3##(2008-10#1)(2008-11#1)
below 4##7##2##(1993-12#1)(2008-10#5)(2011-1#1)
below 5##5##2##(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#2)
below 6 degrees C##2##4##(2008-10#2)
below 6##3##2##(1996-3#1)(2008-10#2)
below 8##2##2##(2008-10#2)
below 8%##2##2##(2008-10#2)
below a critical##2##3##(2008-8#2)
below a##5##2##(1995-8#1)(2007-12#1)(2008-12#1)(2008-8#2)
below age##2##2##(1990-6#1)(1994-6#1)
below and above the isoelectric points##2##6##(2008-10#2)
below and above the##5##4##(1994-2#1)(1995-3#1)(2008-10#2)(2008-7#1)
below and##6##2##(1994-2#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-7#1)
below its##2##2##(2009-5#1)(2010-4#1)
below or##3##2##(1991-2#1)(2008-10#2)
below that of the##2##4##(1994-12#1)(2008-10#1)
below that##6##2##(1993-6#1)(1993-9#1)(1994-12#1)(2008-10#2)(2010-11#1)
below the &quot##3##3##(1991-11#3)
below the aircraft##2##3##(2008-3#2)
below the average##2##3##(1995-12#1)(1996-2#1)
below the concentrations##2##3##(2008-10#2)
below the critical depth of 2##2##6##(2008-10#2)
below the critical##4##3##(2007-12#1)(2008-10#3)
below the detection limit##3##4##(2008-10#3)
below the level of detection##2##5##(2008-10#2)
below the level of##3##4##(2008-10#2)(2008-5#1)
below the level##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
below the limit of detection##2##5##(2012-2#1)(2012-8#1)
below the lower##2##3##(1993-8#1)(2008-10#1)
below the threshold for##2##4##(2008-10#2)
below the threshold##6##3##(2008-10#6)
below the##90##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#3)(1991-5#1)(1992-6#1)(1993-8#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-8#2)(2007-12#3)(2008-10#36)(2008-11#5)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#3)(2012-8#1)(2013-1#2)
below their##2##2##(2008-8#1)(2008-9#1)
below this threshold##2##3##(2008-10#2)
below this##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
below those of##2##3##(1993-9#1)(2008-10#1)
below those##3##2##(1993-9#1)(1994-6#1)(2008-10#1)
below threshold##3##2##(2008-3#1)(2008-8#1)(2009-11#1)
below values##2##2##(1991-3#1)(2012-3#1)
below which##7##2##(1992-9#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-12#1)
below##273##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-6#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#2)(2007-12#5)(2008-1#1)(2008-10#127)(2008-11#8)(2008-12#4)(2008-3#10)(2008-5#4)(2008-7#3)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#6)(2012-2#5)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#1)
belt was##3##2##(2013-1#3)
belt##5##1##(1993-3#1)(2009-9#1)(2013-1#3)
belts##2##1##(1993-3#1)(2010-1#1)
bench##7##1##(1996-2#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-1#1)(2010-6#1)
bench-scale##2##1##(2008-11#1)(2011-2#1)
bench-top##2##1##(2008-10#1)(2008-9#1)
benchmark for##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
benchmark of US$50##2##3##(2009-8#2)
benchmark products##2##2##(2008-5#2)
benchmark##17##1##(1991-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2009-8#2)(2012-2#1)(2013-1#2)
benchmarking and##3##2##(1994-12#1)(1994-3#1)(1996-12#1)
benchmarking project##3##2##(2008-11#3)
benchmarking##11##1##(1994-1#1)(1994-12#4)(1994-3#1)(1996-1#1)(1996-12#1)(2008-11#3)
benchmarks for##3##2##(1993-3#1)(2012-2#2)
benchmarks##8##1##(1993-3#1)(1994-1#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#2)
bend occurs##2##2##(1993-8#2)
bend sites##3##2##(1996-2#3)
bend##15##1##(1993-12#1)(1993-8#3)(1995-8#2)(1996-2#4)(2008-3#3)(2011-2#1)(2012-2#1)
bending and##5##2##(2008-5#3)(2010-4#1)(2012-2#1)
bending in##4##2##(1992-6#1)(1993-8#1)(2010-4#1)(2013-1#1)
bending of the##3##3##(1991-7#1)(1992-6#1)(2008-9#1)
bending of##4##2##(1991-7#1)(1992-6#1)(2007-12#1)(2008-9#1)
bending##42##1##(1991-7#1)(1992-6#4)(1993-8#3)(1995-8#1)(1997-6#7)(2007-12#1)(2008-12#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#3)(2010-4#4)(2012-12#1)(2012-2#2)(2013-1#4)
bends##3##1##(1992-2#1)(1992-6#1)(1993-8#1)
beneath a##2##2##(2008-10#2)
beneath the##12##2##(1991-12#1)(1994-12#1)(1995-6#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
beneath##21##1##(1991-12#1)(1994-12#1)(1995-6#3)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
beneficence##3##1##(1991-2#1)(1995-9#1)(2010-11#1)
beneficial and##6##2##(1997-1#1)(2008-10#1)(2008-7#1)(2010-1#1)(2011-1#1)(2013-8#1)
beneficial bacteria in the##2##4##(1996-9#1)(2012-2#1)
beneficial bacteria##3##2##(1996-9#1)(2012-2#2)
beneficial changes in##3##3##(1991-2#1)(2013-1#2)
beneficial effect is##2##3##(1995-2#1)(1995-3#1)
beneficial effect of the##2##4##(1996-1#1)(2013-1#1)
beneficial effect of##10##3##(1992-12#1)(1996-1#1)(1997-3#1)(1997-5#1)(2008-10#3)(2013-1#2)(2013-7#1)
beneficial effect on##7##3##(1991-11#1)(2008-11#1)(2009-3#1)(2009-7#1)(2011-2#2)(2012-3#1)
beneficial effect##22##2##(1990-2#1)(1991-11#1)(1992-12#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-11#1)(2009-3#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
beneficial effects in##4##3##(1997-6#1)(2008-10#1)(2009-10#1)(2009-6#1)
beneficial effects of##12##3##(1996-2#2)(2008-10#4)(2008-5#1)(2008-7#2)(2009-11#1)(2012-12#1)(2012-2#1)
beneficial effects on##3##3##(2008-10#1)(2009-3#1)(2010-3#1)
beneficial effects##28##2##(1993-1#1)(1996-2#2)(1997-6#1)(2008-10#8)(2008-5#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
beneficial for improving##2##3##(2008-10#1)(2013-1#1)
beneficial for patients##2##3##(1995-12#1)(2011-2#1)
beneficial for the##6##3##(1993-3#1)(2008-10#1)(2009-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
beneficial for##20##2##(1991-3#1)(1993-3#1)(1995-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-1#1)(2009-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
beneficial in many##2##3##(2008-10#1)(2008-3#1)
beneficial in the##4##3##(1990-10#1)(2008-9#1)(2010-10#1)(2011-2#1)
beneficial in##17##2##(1990-10#1)(1990-2#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#2)(2011-2#3)(2011-3#1)(2012-2#1)
beneficial influence##2##2##(1991-6#1)(2008-5#1)
beneficial or##2##2##(2008-10#1)(2012-2#1)
beneficial properties##2##2##(2008-10#2)
beneficial role##4##2##(2008-1#1)(2010-1#1)(2011-2#1)(2012-2#1)
beneficial to health##2##3##(2008-11#1)(2008-7#1)
beneficial to human health##2##4##(2008-7#1)(2010-1#1)
beneficial to patients with##2##4##(2008-9#1)(2011-2#1)
beneficial to the##3##3##(1996-6#1)(2011-2#1)(2013-1#1)
beneficial to##18##2##(1996-6#1)(2008-11#4)(2008-12#1)(2008-7#3)(2008-9#2)(2009-6#1)(2010-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
beneficial##180##1##(1990-10#1)(1990-2#2)(1991-11#1)(1991-2#3)(1991-3#2)(1991-6#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#3)(1996-2#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#33)(2008-11#9)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#13)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#3)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#5)(2010-10#4)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#7)
beneficiaries admitted##2##2##(1994-12#1)(1995-12#1)
beneficiaries and##2##2##(1994-2#1)(1997-3#1)
beneficiaries are##5##2##(1991-3#1)(1995-12#3)(1996-2#1)
beneficiaries during##2##2##(1991-2#1)(1992-12#1)
beneficiaries for##3##2##(1992-12#1)(1994-3#1)(1995-12#1)
beneficiaries have higher##2##3##(1992-2#1)(1995-2#1)
beneficiaries have##5##2##(1991-2#1)(1992-2#1)(1995-2#1)(1996-3#2)
beneficiaries in##5##2##(1991-3#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-3#1)
beneficiaries of##2##2##(1995-1#1)(2008-8#1)
beneficiaries to##3##2##(1995-2#1)(1996-3#1)(1997-2#1)
beneficiaries under##2##2##(1991-3#1)(1995-12#1)
beneficiaries with information##2##3##(1997-3#2)
beneficiaries with##3##2##(1997-2#1)(1997-3#2)
beneficiaries##97##1##(1991-1#1)(1991-2#5)(1991-3#6)(1992-1#1)(1992-12#5)(1992-2#3)(1993-1#3)(1993-12#4)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#4)(1994-3#3)(1995-1#1)(1995-12#12)(1995-2#7)(1995-3#1)(1996-1#1)(1996-2#6)(1996-3#8)(1997-2#5)(1997-3#11)(1997-6#1)(2008-8#1)(2009-12#1)
beneficiaries'##3##1##(1994-1#1)(1994-12#1)(1997-2#1)
beneficiary population##2##2##(1991-1#1)(1991-3#1)
beneficiary##10##1##(1991-1#1)(1991-2#1)(1991-3#3)(1992-2#1)(1993-12#1)(1993-3#1)(1997-3#2)
benefit and##11##2##(1994-2#1)(1994-6#1)(1995-3#2)(2008-4#1)(2008-8#2)(2010-8#1)(2011-2#2)(2013-1#1)
benefit as##2##2##(2008-3#1)(2011-10#1)
benefit both##2##2##(2010-10#1)(2013-8#1)
benefit by##4##2##(2008-8#2)(2012-2#2)
benefit for##6##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-12#1)(2013-1#1)
benefit from a##6##3##(1991-2#1)(1992-3#1)(1993-2#1)(1997-3#1)(2008-11#1)(2012-7#1)
benefit from adjuvant##2##3##(1993-1#1)(2011-2#1)
benefit from more##2##3##(2010-11#1)(2012-2#1)
benefit from such##4##3##(1990-6#1)(1996-6#1)(1997-6#1)(2013-8#1)
benefit from the experiences of##2##5##(1990-6#1)(1991-2#1)
benefit from the use of##2##5##(1992-2#1)(2011-2#1)
benefit from the##12##3##(1990-6#1)(1991-12#1)(1991-2#1)(1992-2#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-3#1)
benefit from this approach##2##4##(2008-10#1)(2013-8#1)
benefit from this technique##2##4##(2008-12#1)(2010-7#1)
benefit from this##6##3##(1992-12#1)(2008-10#1)(2008-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
benefit from treatment with##2##4##(2009-4#1)(2010-5#1)
benefit from##73##2##(1990-6#2)(1991-12#2)(1991-2#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#2)(1994-6#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-8#2)(2008-9#4)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-7#2)(2013-1#1)(2013-8#3)
benefit has##2##2##(1994-12#1)(2008-9#1)
benefit in a##3##3##(2010-10#1)(2010-12#1)(2013-1#1)
benefit in##11##2##(1992-1#1)(1994-2#1)(2008-10#2)(2010-10#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)
benefit is##3##2##(1994-3#1)(1996-1#1)(2008-7#1)
benefit may##2##2##(1991-3#1)(1994-2#1)
benefit more from##2##3##(2008-12#1)(2012-12#1)
benefit mosquitoes##2##2##(2008-12#2)
benefit of a##3##3##(2008-12#1)(2013-1#2)
benefit of early##2##3##(1996-11#1)(2008-9#1)
benefit of the##10##3##(1992-2#1)(1995-11#1)(1996-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-11#2)(2013-1#2)
benefit of this##2##3##(2010-5#1)(2011-1#1)
benefit of##55##2##(1992-2#1)(1994-2#2)(1995-11#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-7#2)(1997-8#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#7)(2008-9#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#5)
benefit on the##2##3##(2011-2#1)(2013-1#1)
benefit only##2##2##(2008-6#1)(2008-8#1)
benefit package##3##2##(1992-1#1)(1992-3#1)(1995-12#1)
benefit patients with##2##3##(2008-12#1)(2013-8#1)
benefit patients##3##2##(1994-12#1)(2008-12#1)(2013-8#1)
benefit plans##2##2##(1991-1#1)(1992-3#1)
benefit that##2##2##(2008-10#1)(2008-11#1)
benefit the##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
benefit to##10##2##(1993-12#1)(1994-6#1)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-8#1)
benefit was##2##2##(1995-1#1)(2013-1#1)
benefit will##2##2##(1993-1#1)(2012-3#1)
benefit##284##1##(1990-6#3)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#4)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#10)(1994-3#1)(1994-6#3)(1995-1#5)(1995-11#2)(1995-12#3)(1995-3#3)(1995-5#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#18)(2008-12#6)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#22)(2008-9#12)(2009-10#1)(2009-4#3)(2009-5#1)(2009-8#2)(2010-10#4)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#19)(2011-3#2)(2012-12#3)(2012-2#7)(2012-3#8)(2012-7#2)(2013-1#15)(2013-7#1)(2013-8#6)
benefited from##10##2##(1991-6#1)(1997-3#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
benefited##16##1##(1991-6#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-12#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
benefiting from##2##2##(1996-1#1)(2008-9#1)
benefiting##3##1##(1996-1#1)(2008-9#1)(2012-2#1)
benefits and barriers##2##3##(1997-3#1)(2008-11#1)
benefits and costs##7##3##(1993-1#1)(1995-3#1)(2008-8#4)(2009-4#1)
benefits and risks of##7##4##(1993-1#1)(2008-10#1)(2009-12#1)(2010-4#1)(2012-2#1)(2013-1#2)
benefits and risks##8##3##(1993-1#1)(2008-10#1)(2009-12#1)(2010-4#2)(2012-2#1)(2013-1#2)
benefits and##37##2##(1990-2#1)(1991-3#1)(1992-3#1)(1993-1#3)(1993-12#1)(1995-1#1)(1995-2#1)(1995-3#2)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#5)(2009-12#2)(2009-4#2)(2010-1#1)(2010-4#2)(2010-8#1)(2012-2#1)(2013-1#4)
benefits are similar##2##3##(1994-12#1)(2009-6#1)
benefits are##7##2##(1994-12#1)(1995-12#1)(2008-10#2)(2008-5#1)(2009-1#1)(2009-6#1)
benefits associated with##3##3##(1994-1#2)(2008-8#1)
benefits because of##2##3##(1994-6#1)(2008-10#1)
benefits can be##2##3##(1997-7#1)(2011-2#1)
benefits can##3##2##(1991-3#1)(1997-7#1)(2011-2#1)
benefits experienced##2##2##(1995-1#2)
benefits for both##3##3##(2008-11#1)(2009-10#1)(2013-1#1)
benefits for the##2##3##(2008-11#1)(2008-12#1)
benefits for##19##2##(1992-12#1)(1992-2#2)(1993-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-6#1)(2011-1#1)(2013-1#1)
benefits from a##2##3##(1997-2#1)(2010-8#1)
benefits from both##2##3##(2008-10#1)(2008-9#1)
benefits from its##2##3##(1991-3#1)(1997-7#1)
benefits from##10##2##(1991-3#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#1)
benefits have##2##2##(2010-12#1)(2012-2#1)
benefits in terms of##3##4##(2008-10#1)(2008-5#1)(2010-12#1)
benefits in the##2##3##(1996-2#1)(2008-6#1)
benefits in##14##2##(1995-1#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-2#1)
benefits of a##4##3##(1991-2#1)(1994-2#1)(1996-3#1)(2008-12#1)
benefits of health care##2##4##(1995-12#1)(2008-4#1)
benefits of probiotics##2##3##(2008-10#1)(2013-7#1)
benefits of the##12##3##(1992-2#2)(1996-3#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
benefits of these##2##3##(1996-3#1)(2008-10#1)
benefits of this##7##3##(2008-12#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
benefits of using##5##3##(1995-1#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
benefits of##104##2##(1990-11#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-2#3)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#3)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#12)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
benefits or##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
benefits package##2##2##(1994-12#1)(1994-8#1)
benefits provided by##2##3##(2008-10#1)(2008-8#1)
benefits than##2##2##(2008-9#1)(2009-8#1)
benefits that##5##2##(2008-11#2)(2008-8#1)(2009-3#1)(2013-1#1)
benefits the##3##2##(2008-11#2)(2008-8#1)
benefits to the##3##3##(2008-12#1)(2008-9#1)(2011-1#1)
benefits to##16##2##(1992-2#1)(1994-2#1)(1994-6#1)(1995-1#2)(1996-5#1)(2008-10#1)(2008-12#1)(2008-9#2)(2010-12#3)(2010-7#1)(2011-1#1)(2012-3#1)
benefits##330##1##(1990-11#1)(1990-2#2)(1991-12#1)(1991-2#4)(1991-3#6)(1991-6#1)(1992-12#1)(1992-2#6)(1992-3#2)(1993-1#5)(1993-12#3)(1993-2#1)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#5)(1994-3#1)(1994-6#3)(1994-8#1)(1995-1#8)(1995-12#6)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#5)(1996-3#3)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#29)(2008-11#30)(2008-12#10)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#22)(2008-9#16)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#6)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#4)(2009-8#2)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#10)(2010-2#1)(2010-4#2)(2010-6#3)(2010-7#2)(2010-8#5)(2011-1#3)(2011-2#7)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#1)
benefitted##2##1##(1995-1#1)(2009-9#1)
benign and malignant conditions of##2##5##(1991-3#1)(1993-11#1)
benign and malignant##14##3##(1990-11#1)(1990-12#1)(1991-3#1)(1993-11#2)(1995-3#2)(2008-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
benign and##19##2##(1990-11#1)(1990-12#1)(1991-3#1)(1992-9#1)(1993-11#2)(1995-3#2)(2008-11#1)(2008-12#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
benign breast##3##2##(1993-1#2)(2008-12#1)
benign cervical tumors##3##3##(1991-2#3)
benign condition##3##2##(2012-3#1)(2013-1#1)(2013-8#1)
benign conditions##3##2##(2008-11#1)(2010-11#1)(2012-2#1)
benign disease##3##2##(1992-2#1)(1993-12#1)(2010-5#1)
benign diseases##2##2##(1990-5#1)(1990-6#1)
benign esophageal diseases##3##3##(2013-1#3)
benign esophageal##5##2##(2013-1#5)
benign gastric ulcer##2##3##(1990-3#2)
benign gastric##4##2##(1990-3#3)(1992-9#1)
benign group##2##2##(2011-2#2)
benign in##3##2##(1992-5#1)(2008-11#1)(2011-1#1)
benign intraductal papilloma##2##3##(1991-2#2)
benign lesion##4##2##(1990-12#1)(2008-10#1)(2009-5#1)(2012-3#1)
benign lesions##5##2##(1990-12#1)(1994-12#1)(1997-7#1)(2010-12#1)(2011-2#1)
benign liver##2##2##(2008-1#1)(2013-1#1)
benign melanocytic nevi##2##3##(2011-2#2)
benign melanocytic##3##2##(2008-7#1)(2011-2#2)
benign metastatic##2##2##(2012-3#2)
benign nature##2##2##(2009-8#1)(2010-12#1)
benign neoplasms##2##2##(1991-2#1)(2012-2#1)
benign or malignant##2##3##(1993-6#1)(2009-12#1)
benign or##3##2##(1993-6#1)(2009-12#1)(2011-2#1)
benign pain##3##2##(2008-4#3)
benign pilomatrixoma##2##2##(1994-8#2)
benign prostatic hyperplasia and##2##4##(2008-11#1)(2008-5#1)
benign prostatic hyperplasia##6##3##(1990-9#2)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
benign prostatic##7##2##(1990-11#1)(1990-9#2)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
benign renal##2##2##(1992-2#1)(2013-8#1)
benign soft tissue##2##3##(2010-6#1)(2012-2#1)
benign thyroid##3##2##(1990-6#1)(2008-12#2)
benign tumor with a##2##4##(2008-10#1)(2010-3#1)
benign tumor##8##2##(1994-12#1)(2008-10#2)(2008-12#3)(2009-5#1)(2010-3#1)
benign tumors of the##3##4##(1995-11#1)(2010-3#1)(2013-8#1)
benign tumors##4##2##(1995-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
benign tumour of the##2##4##(2008-10#1)(2008-7#1)
benign tumour##3##2##(1993-3#1)(2008-10#1)(2008-7#1)
benign uterine leiomyoma##2##3##(2012-3#2)
benign##194##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#5)(1990-8#1)(1990-9#4)(1991-11#2)(1991-2#6)(1991-3#1)(1991-4#1)(1991-8#2)(1992-2#3)(1992-5#2)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-5#1)(1994-8#2)(1995-11#2)(1995-3#4)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#10)(2008-4#4)(2008-5#1)(2008-7#4)(2008-9#1)(2009-1#2)(2009-12#3)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-5#1)(2010-6#3)(2011-1#3)(2011-2#12)(2011-3#1)(2012-12#5)(2012-2#11)(2012-3#14)(2013-1#17)(2013-8#7)
benign&quot##2##1##(1993-6#1)(1997-2#1)
benignity of##2##2##(1991-6#1)(1992-5#1)
benomyl##10##1##(2008-10#10)
benomyl-resistant##4##1##(2008-10#4)
benorilate##3##1##(2008-10#3)
benserazide##6##1##(1990-8#2)(2008-10#4)
bensulfuron-methyl##2##1##(2008-10#2)
bent DNA##3##2##(1996-3#1)(1997-6#1)(2008-8#1)
bent step-index##2##2##(2008-3#2)
bent##14##1##(1992-9#1)(1993-8#1)(1995-8#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-3#4)(2008-8#1)(2008-9#1)(2011-2#1)
bentazon##3##1##(2008-10#3)
bentgrass##11##1##(2008-10#11)
benthamiana and N##2##3##(2008-10#2)
benthamiana and##4##2##(2008-10#4)
benthamiana leaves##2##2##(2008-10#2)
benthamiana##31##1##(1995-2#2)(2008-10#28)(2011-2#1)
benthic##3##1##(2008-9#2)(2013-1#1)
bentonite##5##1##(2008-10#5)
bentonites##2##1##(2008-10#2)
benz[a]anthracene##2##1##(1995-11#1)(2008-10#1)
benzaldehyde##5##1##(2008-10#4)(2008-5#1)
benzalkonium chloride##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
benzamide##2##1##(2008-10#2)
benzamides##7##1##(1990-5#2)(2008-10#3)(2008-7#2)
benzathine##4##1##(1997-5#2)(2008-10#2)
benzene and##11##2##(2008-10#10)(2008-3#1)
benzene concentration##3##2##(2008-3#3)
benzene derivatives##2##2##(2008-10#2)
benzene in##4##2##(2008-10#4)
benzene sulfonate##4##2##(2008-10#4)
benzene sulfonic acid##3##3##(2008-10#3)
benzene vapours##2##2##(2008-10#2)
benzene was##3##2##(2008-10#3)
benzene##78##1##(1994-3#1)(2008-10#68)(2008-11#4)(2008-3#4)(2010-6#1)
benzeneethanol##2##1##(2008-10#2)
benzenes##3##1##(2008-10#3)
benzenesulfinate##2##1##(1996-5#2)
benzilate is negative##2##3##(1995-11#2)
benzilate##3##1##(1995-11#3)
benzimidazole anthelmintics##2##2##(2008-10#2)
benzimidazole##7##1##(1996-12#1)(2008-10#5)(2008-11#1)
benzimidazole-resistant##2##1##(1991-8#2)
benzimidazole-susceptible##2##1##(1991-8#2)
benzimidazolylazo group##2##2##(2008-10#2)
benzindenoazepine##2##1##(2008-11#2)
benzo (a) anthracene##2##3##(2008-10#2)
benzo 15 crown 5##2##4##(2008-10#2)
benzo##5##1##(2008-10#5)
benzo(a)pyrene in##2##2##(2008-10#2)
benzo(a)pyrene##13##1##(1993-8#2)(2008-10#9)(2008-11#1)(2010-1#1)
benzo(b##2##1##(2008-10#2)
benzo(g##2##1##(2008-10#2)
benzo(k)fluoranthene##2##1##(2008-10#2)
benzo-15-crown-5##2##1##(2008-10#2)
benzo-18-crown-6##5##1##(2008-10#5)
benzoN(4) nickel(II) macrocyclic complexes##2##4##(2008-10#2)
benzo[1##2##1##(1996-5#1)(2008-10#1)
benzo[12]crown-4##3##1##(2008-10#3)
benzo[15]crown-5##3##1##(2008-10#3)
benzo[3n]crown-n##2##1##(2008-10#2)
benzo[a]pyrene (BaP)##2##2##(2008-10#1)(2011-1#1)
benzo[a]pyrene in##4##2##(2008-10#4)
benzo[a]pyrene##16##1##(1994-5#1)(2008-10#13)(2011-1#2)
benzo[g##2##1##(2008-10#2)
benzoate and##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
benzoate##9##1##(2008-10#3)(2008-6#1)(2010-2#1)(2010-4#2)(2012-2#2)
benzodiazepine binding sites##2##3##(1995-11#1)(1995-12#1)
benzodiazepine binding##4##2##(1995-11#3)(1995-12#1)
benzodiazepine pharmacology##2##2##(1995-11#2)
benzodiazepine receptor radioligand binding by##2##5##(1995-11#1)(1995-12#1)
benzodiazepine receptor##10##2##(1994-2#2)(1995-11#4)(1995-12#1)(1996-2#1)(2012-2#2)
benzodiazepine site ligands##2##3##(1995-11#2)
benzodiazepine site##3##2##(1995-11#3)
benzodiazepine##30##1##(1994-2#3)(1995-11#16)(1995-12#2)(1996-12#1)(1996-2#5)(2008-10#1)(2012-2#2)
benzodiazepines in##2##2##(2008-10#1)(2012-2#1)
benzodiazepines##9##1##(1991-3#1)(1994-2#1)(1995-12#1)(2008-10#3)(2010-1#1)(2011-10#1)(2012-2#1)
benzoic acid was##2##3##(2008-10#2)
benzoic acid##12##2##(2008-10#12)
benzoic##14##1##(2008-10#14)
benzophenone phenylhydrazone##2##2##(2008-10#2)
benzophenone##10##1##(2008-10#9)(2008-5#1)
benzophenone-3##3##1##(2008-5#3)
benzoquinone##3##1##(2008-10#3)
benzothiadiazole (BTH)##2##2##(2008-10#2)
benzothiadiazole##3##1##(2008-10#3)
benzothiaxolyldiazoaminoazobenzene##2##1##(2008-10#2)
benzothiazole##6##1##(2008-10#2)(2010-2#3)(2010-7#1)
benzoyl carbonyl##2##2##(1991-3#2)
benzoyl groups##2##2##(1990-9#1)(1996-5#1)
benzoyl peroxide##6##2##(2008-10#6)
benzoyl##13##1##(1990-9#1)(1991-3#2)(1996-5#1)(2008-10#9)
benzoylurea (BU) insecticides##2##3##(2008-10#2)
benzoylurea##4##1##(2008-10#4)
benzyl alcohol and##2##3##(2008-10#2)
benzyl alcohol##5##2##(2008-10#5)
benzyl##11##1##(2008-10#9)(2010-2#1)(2013-1#1)
benzyl3##3##1##(1994-8#3)
benzylisoquinoline##2##1##(2008-10#2)
benzyloxyresorufin##4##1##(1994-8#4)
benzylpenicillin##4##1##(1992-12#2)(2011-1#2)
berbamine##6##1##(1995-11#6)
berberine##6##1##(2008-10#3)(2012-3#3)
bereaved##6##1##(1991-2#1)(2008-11#4)(2008-12#1)
bereavement##7##1##(1991-11#1)(1991-2#1)(2008-12#4)(2012-3#1)
berghei##4##1##(1992-6#2)(1993-8#1)(1995-5#1)
bermudagrass genotypes##4##2##(2008-10#4)
bermudagrass##5##1##(2008-10#5)
berries aged##3##2##(2008-10#3)
berries of##5##2##(2008-10#5)
berries was##2##2##(2008-10#2)
berries were##4##2##(2008-10#4)
berries##50##1##(2008-10#49)(2012-12#1)
berry and rachis susceptibility##2##4##(2008-10#2)
berry development##2##2##(2008-10#2)
berry##22##1##(2008-10#22)
beryllium and##2##2##(1990-5#1)(2008-10#1)
beryllium concentrations##2##2##(2008-10#2)
beryllium oxide##2##2##(2008-10#2)
beryllium##36##1##(1990-5#3)(2008-10#33)
beside the##2##2##(1994-11#1)(2011-3#1)
beside##4##1##(1994-11#1)(1995-11#1)(2008-10#1)(2011-3#1)
besides the##11##2##(1991-5#1)(2008-10#4)(2008-8#1)(2009-8#2)(2010-7#1)(2011-2#1)(2012-3#1)
besides##33##1##(1990-6#1)(1991-5#1)(1991-6#1)(1995-12#1)(1997-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-7#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#1)
best accuracy##3##2##(2008-10#2)(2011-2#1)
best achieved by##2##3##(2008-10#1)(2010-7#1)
best achieved##3##2##(2008-10#1)(2009-5#1)(2010-7#1)
best after##2##2##(2008-11#1)(2012-2#1)
best agreement##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
best aided##2##2##(2012-2#2)
best analytical conditions##2##3##(2008-10#2)
best analytical##7##2##(2008-10#7)
best and##2##2##(2008-3#1)(2008-4#1)
best approach##4##2##(1991-12#1)(1996-1#1)(2008-10#1)(2009-12#1)
best arterial and##2##3##(2013-1#2)
best at##2##2##(1992-8#1)(2008-7#1)
best basis wavelet functions##2##4##(2010-8#2)
best basis##3##2##(2008-10#1)(2010-8#2)
best be##2##2##(2008-6#1)(2008-9#1)
best candidate for##2##3##(1993-9#1)(2006-6#1)
best candidate##3##2##(1993-9#1)(2006-6#1)(2008-10#1)
best clinical##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
best conditions for##8##3##(1996-12#1)(2008-10#6)(2011-2#1)
best conditions##13##2##(1996-12#1)(2008-10#9)(2008-11#1)(2011-2#1)(2013-1#1)
best corrected visual acuity (BCVA)##2##5##(2011-2#2)
best corrected visual acuity##3##4##(2010-10#1)(2011-2#2)
best correlation##2##2##(1993-2#1)(2012-2#1)
best described as a##2##4##(1991-5#1)(2008-10#1)
best described by##4##3##(1996-2#1)(2008-10#2)(2008-9#1)
best described the##4##3##(2008-10#4)
best described##11##2##(1991-5#1)(1996-2#1)(2008-10#7)(2008-9#1)(2011-2#1)
best detection limit##2##3##(2008-10#2)
best detection##3##2##(2008-10#3)
best diagnostic##4##2##(1990-9#1)(1991-2#1)(1992-12#1)(2013-8#1)
best estimate##2##2##(2008-2#1)(2013-1#1)
best explained##3##2##(1993-8#1)(2008-10#1)(2009-6#1)
best extraction##3##2##(2008-10#3)
best fit into##2##3##(1994-12#1)(2008-10#1)
best fit of##2##3##(2008-10#2)
best fit##11##2##(1994-12#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-3#1)(2012-2#1)
best for the##2##3##(2008-10#2)
best for##9##2##(1994-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
best in##3##2##(1994-6#1)(2008-10#1)(2008-8#1)
best interests##7##2##(1990-6#2)(1991-2#1)(1995-2#1)(1997-8#1)(2010-9#2)
best known as##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
best known##11##2##(1995-5#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-8#1)(2013-1#1)
best life histories##2##3##(2008-8#2)
best management of##2##3##(2012-3#1)(2013-1#1)
best management##4##2##(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
best medium for##2##3##(2008-10#2)
best method of##3##3##(1996-8#1)(2008-3#1)(2013-1#1)
best method##5##2##(1990-12#1)(1994-5#1)(1996-8#1)(2008-3#1)(2013-1#1)
best model##5##2##(1996-12#1)(2008-10#3)(2011-2#1)
best models##3##2##(2008-10#3)
best of a bad##2##4##(2008-8#1)(2008-9#1)
best of both##2##3##(1993-2#1)(2012-2#1)
best of times##2##3##(1991-6#1)(2008-11#1)
best of##24##2##(1991-6#1)(1993-2#1)(1994-1#1)(1994-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
best option##3##2##(1996-3#1)(2008-11#1)(2008-9#1)
best overall##3##2##(2008-10#2)(2010-4#1)
best performance was exhibited by the membrane having##2##8##(2008-10#2)
best performance was obtained##2##4##(2008-10#2)
best performance was##8##3##(2008-10#7)(2008-12#1)
best performance##15##2##(1995-3#1)(2008-10#12)(2008-11#1)(2008-12#1)
best practice##8##2##(2008-11#1)(2008-8#1)(2010-10#5)(2010-4#1)
best practices for##2##3##(2008-11#1)(2012-2#1)
best practices##6##2##(1994-12#1)(2008-11#1)(2012-2#3)(2013-1#1)
best predictors##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
best response characteristics##2##3##(2008-10#2)
best response##3##2##(1991-8#1)(2008-10#2)
best result for##2##3##(2008-10#2)
best result##7##2##(2008-10#7)
best results are obtained##2##4##(2008-10#2)
best results in##2##3##(2011-2#1)(2012-3#1)
best results were obtained using##5##5##(2008-10#2)(2008-5#1)(2008-7#2)
best results were obtained##13##4##(2008-10#8)(2008-5#3)(2008-7#2)
best results were##14##3##(2008-10#8)(2008-5#3)(2008-7#2)(2010-4#1)
best results##32##2##(1990-11#1)(2008-10#20)(2008-11#1)(2008-5#3)(2008-7#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
best retention##2##2##(2008-10#1)(2008-11#1)
best scientific##2##2##(2008-12#1)(2008-4#1)
best sensitivity##2##2##(2008-10#2)
best separation##4##2##(2008-10#4)
best strategy##3##2##(2008-8#1)(2011-2#1)(2011-3#1)
best studied##2##2##(2008-12#1)(2011-2#1)
best suited for##4##3##(1990-11#1)(2008-10#2)(2008-9#1)
best suited to##2##3##(1993-12#1)(2008-10#1)
best suited##6##2##(1990-11#1)(1993-12#1)(2008-10#3)(2008-9#1)
best surgical##2##2##(2008-11#1)(2008-12#1)
best system##4##2##(1991-2#1)(1996-2#1)(2008-10#1)(2012-2#1)
best to##7##2##(2008-10#3)(2008-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
best treatment##6##2##(1991-9#1)(1997-8#1)(2008-6#1)(2008-7#2)(2012-3#1)
best understood##3##2##(2007-12#1)(2008-4#1)(2012-2#1)
best##596##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-12#4)(1991-2#4)(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#5)(1993-2#3)(1993-3#2)(1993-8#2)(1993-9#1)(1994-1#3)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1996-1#3)(1996-12#3)(1996-2#3)(1996-3#3)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-8#3)(2006-6#3)(2007-12#2)(2008-1#1)(2008-10#225)(2008-11#30)(2008-12#19)(2008-2#1)(2008-3#14)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#16)(2008-8#13)(2008-9#17)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-10#7)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#23)(2011-3#2)(2012-12#2)(2012-2#17)(2012-3#11)(2013-1#26)(2013-7#1)(2013-8#7)
best&quot##2##1##(1992-12#1)(2008-8#1)
best-performing##2##1##(2008-12#1)(2011-1#1)
bestatin and##2##2##(1994-8#1)(1997-4#1)
bestatin##7##1##(1994-2#2)(1994-8#1)(1995-6#1)(1996-2#2)(1997-4#1)
besylate##7##1##(2008-10#6)(2013-8#1)
beta (IL-1 beta)##2##3##(1995-12#1)(1996-12#1)
beta -galactosidase or phytase##2##4##(2008-11#2)
beta 1 and##3##3##(1993-8#1)(1994-8#1)(1995-2#1)
beta 1 chain##2##3##(1992-2#2)
beta 1##33##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-10#6)(1992-2#4)(1992-3#1)(1992-8#2)(1993-8#12)(1994-8#1)(1995-2#2)(1995-6#2)
beta 1- and beta 2-subunit mRNAs##2##6##(1996-12#2)
beta 1-3##2##2##(1996-12#2)
beta 1-9##2##2##(1995-12#2)
beta 1-receptor##2##2##(1992-3#2)
beta 1g##2##2##(1993-8#2)
beta 2 and##4##3##(1995-11#3)(2010-8#1)
beta 2 gamma##5##3##(1995-11#5)
beta 2 integrin##2##3##(2008-11#2)
beta 2##30##2##(1990-12#1)(1990-8#1)(1992-9#1)(1993-6#1)(1993-8#2)(1995-11#15)(2008-11#6)(2010-6#2)(2010-8#1)
beta 2-agonists are##2##3##(1997-1#2)
beta 2-agonists##3##2##(1994-6#1)(1997-1#2)
beta 2-microglobulin and##2##3##(1991-2#1)(1995-2#1)
beta 2-microglobulin##7##2##(1991-2#1)(1995-12#4)(1995-2#1)(1997-3#1)
beta 3##9##2##(1990-8#1)(1995-11#7)(1995-6#1)
beta 3-adrenoceptor##8##2##(1995-11#8)
beta 4##10##2##(1990-8#1)(1991-10#2)(1992-4#2)(1995-11#4)(2010-8#1)
beta 40##3##2##(1995-12#3)
beta 42##3##2##(1995-12#3)
beta =##4##2##(1992-11#1)(1992-9#1)(1996-5#1)(2008-8#1)
beta A##2##2##(1991-5#2)
beta A2 and beta A4##2##5##(1991-6#2)
beta A2##3##2##(1991-6#3)
beta A4##4##2##(1991-6#4)
beta AP plaques##2##3##(1991-10#2)
beta AP##3##2##(1991-10#3)
beta APP expression##2##3##(1991-10#2)
beta APP##7##2##(1991-10#7)
beta Gal##3##2##(1990-5#1)(1993-9#2)
beta H globin gene##2##4##(1991-5#2)
beta S##3##2##(1992-8#1)(1993-8#1)(1995-11#1)
beta Tub##6##2##(1993-6#6)
beta actin cDNA##2##3##(2010-5#2)
beta actin gene##2##3##(2010-5#2)
beta actin##5##2##(2010-5#5)
beta and epsilon and beta and delta##2##7##(2008-8#2)
beta and gamma##6##3##(1991-5#1)(1992-6#1)(1993-6#1)(1995-11#1)(2008-11#1)(2008-8#1)
beta and##20##2##(1991-5#1)(1992-4#1)(1992-6#1)(1993-6#2)(1994-11#1)(1995-11#1)(1995-12#2)(1996-2#2)(2008-10#3)(2008-11#1)(2008-8#5)
beta at##2##2##(1994-11#1)(1995-2#1)
beta blockers##5##2##(2008-11#2)(2008-7#1)(2009-6#2)
beta cell##6##2##(1990-11#1)(1994-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-7#1)
beta cells in##2##3##(2008-10#1)(2008-11#1)
beta cells##7##2##(1991-7#1)(1993-8#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2009-8#1)
beta chain##2##2##(1993-8#1)(2008-4#1)
beta from##3##2##(1994-11#1)(1995-2#1)(2008-11#1)
beta function for##2##3##(2008-10#2)
beta function##4##2##(2008-10#4)
beta gamma subunits of##2##4##(1992-9#1)(1995-8#1)
beta gamma##6##2##(1992-9#1)(1993-6#1)(1993-9#2)(1995-8#2)
beta gene##3##2##(1993-8#2)(1995-8#1)
beta interferon##4##2##(1991-6#3)(2010-12#1)
beta is##2##2##(1995-2#1)(2013-8#1)
beta mRNA levels##2##3##(1993-3#1)(1996-12#1)
beta mRNA##6##2##(1993-3#3)(1996-12#3)
beta mutant##3##2##(1993-8#2)(1995-2#1)
beta or##2##2##(1990-5#1)(2008-3#1)
beta polypeptide##3##2##(1994-5#3)
beta polypeptides##3##2##(1993-6#1)(1994-5#2)
beta protein##4##2##(1994-11#1)(1995-12#3)
beta receptor##5##2##(1994-6#2)(1995-12#1)(1995-2#1)(1997-7#1)
beta receptors##2##2##(1995-12#1)(1995-5#1)
beta subunit gene##2##3##(1995-6#1)(1996-2#1)
beta subunit of##4##3##(1993-12#1)(1994-11#1)(1995-2#2)
beta subunit##26##2##(1992-3#1)(1992-6#1)(1992-9#4)(1993-12#1)(1993-8#2)(1994-11#3)(1994-12#1)(1995-2#4)(1995-6#4)(1995-8#3)(1996-2#1)(2008-8#1)
beta subunits##13##2##(1990-8#1)(1991-10#2)(1991-7#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-12#1)(1995-11#2)(1995-8#1)
beta system##4##2##(1996-12#4)
beta values##3##2##(2008-10#3)
beta was##3##2##(1990-10#1)(1994-3#1)(1995-12#1)
beta were##3##2##(1994-11#2)(1994-3#1)
beta with##2##2##(1995-2#1)(1995-6#1)
beta##517##1##(1990-10#4)(1990-11#8)(1990-12#3)(1990-5#4)(1990-8#8)(1991-10#16)(1991-12#1)(1991-2#1)(1991-5#9)(1991-6#14)(1991-7#2)(1992-10#6)(1992-11#1)(1992-2#4)(1992-3#6)(1992-4#5)(1992-6#3)(1992-8#5)(1992-9#9)(1993-12#4)(1993-2#2)(1993-3#5)(1993-6#15)(1993-8#33)(1993-9#5)(1994-11#33)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#9)(1994-6#4)(1994-8#1)(1995-11#39)(1995-12#31)(1995-2#25)(1995-5#1)(1995-6#20)(1995-8#15)(1996-11#1)(1996-12#25)(1996-2#13)(1996-5#6)(1997-1#4)(1997-3#3)(1997-7#1)(2008-1#1)(2008-10#28)(2008-11#21)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#11)(2008-9#2)(2009-6#2)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#5)(2010-6#2)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#6)
beta(1##2##1##(1990-5#1)(2008-10#1)
beta(1)##4##1##(2008-10#3)(2008-11#1)
beta(1)gamma(2) subunits##2##2##(2008-9#2)
beta(155)-PCB chromophores##2##2##(2008-8#2)
beta(2##2##1##(2008-3#2)
beta(2)##4##1##(2008-10#2)(2008-11#1)(2009-10#1)
beta(2)-tomatine and tomatidine##2##3##(2008-10#2)
beta(9##2##1##(2008-3#2)
beta(I)##2##1##(2008-10#2)
beta(lambda) was##2##2##(2008-3#2)
beta(nuc) for##2##2##(2009-8#2)
beta(nuc)##3##1##(2009-8#3)
beta) and##3##2##(1990-5#1)(1995-12#2)
beta)##19##1##(1990-5#9)(1994-5#1)(1995-12#3)(1995-6#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-9#1)
beta- and##8##2##(1993-8#1)(1995-6#1)(2008-10#6)
beta-##21##1##(1990-11#1)(1990-12#1)(1992-3#6)(1993-8#1)(1994-5#1)(1995-6#1)(2008-10#10)
beta-1##60##1##(1991-5#3)(1992-11#2)(1992-7#4)(2008-10#47)(2008-9#3)(2009-8#1)
beta-1b##2##1##(1996-8#2)
beta-2 microglobulin##2##2##(1995-1#1)(2008-7#1)
beta-2##3##1##(1995-1#1)(2008-7#1)(2011-2#1)
beta-2-microglobulin##2##1##(1994-8#1)(1997-8#1)
beta-AP(1-40)##5##1##(2008-8#5)
beta-APP release##2##2##(1993-8#2)
beta-APP##5##1##(1993-8#5)
beta-BaB(2)O(4)##2##1##(2008-2#1)(2008-3#1)
beta-CCE##4##1##(1995-11#1)(1996-2#3)
beta-CD and##5##2##(2008-10#3)(2008-11#2)
beta-CD as##2##2##(2008-10#2)
beta-CD at##2##2##(2008-10#2)
beta-CD concentration##2##2##(2008-10#2)
beta-CD was##3##2##(2008-10#2)(2008-11#1)
beta-CD with##2##2##(2008-10#1)(2008-11#1)
beta-CD##41##1##(2008-10#35)(2008-11#6)
beta-CDP##2##1##(2008-10#2)
beta-CGRP gene##4##2##(1992-6#4)
beta-CGRP##14##1##(1992-6#14)
beta-Carotene##3##1##(2009-6#1)(2009-8#2)
beta-Correction##2##1##(2008-10#2)
beta-Cyclodextrin##2##1##(2008-10#2)
beta-D-GalpA-(1--&gt##3##1##(1992-12#3)
beta-D-galactopyranosyl##2##1##(2009-8#2)
beta-D-glucuronidase (GUS) activity##2##3##(2008-10#2)
beta-Galactosidase##2##1##(2008-11#1)(2009-8#1)
beta-Man##2##1##(1990-5#1)(1994-5#1)
beta-Mono-##2##1##(1996-5#2)
beta-MyHC gene##3##2##(1995-2#3)
beta-PDH##2##1##(1994-11#2)
beta-actin mRNA##3##2##(1996-12#1)(1996-2#1)(2008-8#1)
beta-actin promoter##4##2##(1993-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
beta-actin were##2##2##(1996-12#1)(1996-2#1)
beta-actin##14##1##(1993-12#1)(1995-2#1)(1996-12#2)(1996-2#3)(2008-11#3)(2008-8#2)(2008-9#2)
beta-adducin##3##1##(1994-11#3)
beta-adrenergic##5##1##(1994-2#1)(1995-2#1)(2010-4#2)(2010-7#1)
beta-adrenoceptor##2##1##(1995-11#1)(1997-2#1)
beta-amino##3##1##(2008-10#1)(2008-5#1)(2011-3#1)
beta-amylase in##2##2##(2008-9#2)
beta-amylase is##2##2##(2008-9#2)
beta-amylase##7##1##(2008-9#7)
beta-amyloid is##2##2##(1992-12#2)
beta-amyloid peptide##2##2##(1991-10#1)(1996-2#1)
beta-amyloid precursor protein##6##3##(1991-10#2)(1992-12#1)(1992-6#1)(1993-8#2)
beta-amyloid##16##1##(1991-10#3)(1992-12#5)(1992-6#3)(1993-8#2)(1996-2#1)(2008-8#2)
beta-barium borate nonlinear##2##3##(2008-2#2)
beta-binomial distribution##17##2##(2008-10#17)
beta-binomial##27##1##(2008-10#27)
beta-blockade##2##1##(1995-2#1)(2010-4#1)
beta-blocker with##2##2##(1995-2#1)(2008-10#1)
beta-blocker##6##1##(1995-2#1)(1997-8#2)(2008-10#3)
beta-blockers##17##1##(1991-11#1)(1993-2#2)(1994-12#1)(1995-2#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2010-4#2)(2011-2#2)
beta-blocking##3##1##(1992-3#1)(2008-7#2)
beta-carboline##3##1##(2008-10#3)
beta-carotene 15##2##2##(2009-6#2)
beta-carotene and##3##2##(1992-9#2)(2009-8#1)
beta-carotene##15##1##(1992-9#4)(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#5)(2009-8#1)(2013-8#2)
beta-caryophyllene##3##1##(2009-8#3)
beta-casein##4##1##(1996-2#1)(2008-10#1)(2008-8#1)(2010-5#1)
beta-catenin##8##1##(1994-11#2)(2008-11#1)(2009-8#5)
beta-cell function and insulin sensitivity##4##5##(1994-12#4)
beta-cell function and##6##3##(1994-12#4)(2008-4#1)(2009-8#1)
beta-cell function##8##2##(1991-7#1)(1994-12#5)(2008-4#1)(2009-8#1)
beta-cell secretory##3##2##(1991-7#1)(1992-6#1)(1994-12#1)
beta-cell##16##1##(1991-7#3)(1992-6#1)(1994-12#7)(1995-8#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-11#1)
beta-cells##15##1##(1994-11#3)(1996-2#4)(2008-10#1)(2008-11#2)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#2)
beta-chain##8##1##(1993-3#1)(1993-8#1)(1994-11#2)(1995-3#2)(1995-6#2)
beta-correction spectrophotometry using##2##3##(2008-10#2)
beta-correction spectrophotometry##7##2##(2008-10#7)
beta-correction##9##1##(2008-10#9)
beta-crystallin##3##1##(1991-6#3)
beta-crystallins##3##1##(1991-6#3)
beta-cyclodextrin (CD)##2##2##(2008-10#2)
beta-cyclodextrin (beta-CD) and##4##3##(2008-10#4)
beta-cyclodextrin (beta-CD) has been##3##4##(2008-10#3)
beta-cyclodextrin (beta-CD)##14##2##(2008-10#14)
beta-cyclodextrin and##4##2##(2008-10#3)(2008-11#1)
beta-cyclodextrin as a chiral##2##4##(2008-10#2)
beta-cyclodextrin as##3##2##(2008-10#3)
beta-cyclodextrin bonded##2##2##(2008-10#2)
beta-cyclodextrin concentration##2##2##(2008-10#2)
beta-cyclodextrin were##2##2##(2008-10#2)
beta-cyclodextrin##43##1##(2008-10#42)(2008-11#1)
beta-cyclodextrins##3##1##(2008-10#3)
beta-diketonates##5##1##(2008-10#5)
beta-diol##3##1##(1990-11#3)
beta-elimination##3##1##(1996-5#1)(2009-8#2)
beta-endorphin release##3##2##(1990-12#3)
beta-endorphin##20##1##(1990-12#7)(1991-6#2)(1992-3#5)(1995-12#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-7#1)
beta-erythrofuranose##2##1##(1990-9#2)
beta-estradiol##11##1##(1990-11#1)(1990-2#1)(1995-11#4)(1995-12#2)(1995-6#1)(2008-11#2)
beta-gal expression levels##2##3##(2008-7#2)
beta-gal expression##3##2##(2008-7#3)
beta-gal##5##1##(1997-8#1)(2008-7#4)
beta-galactosidase (beta Gal)##2##3##(1990-5#1)(1993-9#1)
beta-galactosidase activities##2##2##(1994-11#1)(2008-8#1)
beta-galactosidase activity##7##2##(1994-11#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#1)(2011-2#2)
beta-galactosidase and carboxypeptidase##4##3##(1993-8#4)
beta-galactosidase and##5##2##(1993-8#5)
beta-galactosidase gene##6##2##(1994-5#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
beta-galactosidase in##2##2##(1993-12#1)(1997-8#1)
beta-galactosidase production##2##2##(2008-11#2)
beta-galactosidase yield##3##2##(2008-11#3)
beta-galactosidase##54##1##(1990-5#1)(1993-12#2)(1993-8#5)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#1)(1995-12#2)(1996-3#1)(1997-3#1)(1997-7#2)(1997-8#7)(2008-10#4)(2008-11#11)(2008-7#3)(2008-8#4)(2009-8#2)(2010-8#1)(2011-2#2)
beta-galactosidase-catalyzed cleavage of 4-nitrophenyl-2-deoxy-beta-D-galactopyranoside##2##4##(2009-8#2)
beta-globin gene (IVS-2-654 C--&gt##2##4##(2008-8#2)
beta-globin gene##5##2##(1996-2#1)(2008-11#1)(2008-8#3)
beta-globin mRNA##3##2##(2008-11#1)(2008-8#2)
beta-globin##12##1##(1993-6#1)(1996-2#2)(2008-11#4)(2008-8#5)
beta-glucan##3##1##(1991-5#1)(1994-6#2)
beta-glucosidase activity##2##2##(2008-10#2)
beta-glucosidase##9##1##(1995-6#4)(2008-10#3)(2008-11#1)(2008-8#1)
beta-glucuronidase (GUS) reporter gene and##2##5##(2008-10#2)
beta-glucuronidase (GUS)##4##2##(2008-10#4)
beta-glucuronidase activity##3##2##(2008-10#3)
beta-glucuronidase##14##1##(1990-6#1)(1991-12#1)(1993-8#1)(2008-10#8)(2008-11#1)(2008-8#1)(2008-9#1)
beta-glycan##2##1##(1995-12#2)
beta-hydroxylase##5##1##(1991-5#2)(1995-12#2)(1997-3#1)
beta-hydroxysteroid dehydrogenase##3##2##(1990-11#2)(1995-11#1)
beta-hydroxysteroid##4##1##(1990-11#2)(1994-6#1)(1995-11#1)
beta-keratins##3##1##(2011-2#3)
beta-ketoacyl-ACP synthases I and II##2##5##(1995-6#2)
beta-ketoacyl-ACP synthases##3##2##(1995-6#3)
beta-lactam antibiotic##3##2##(1994-8#1)(2008-10#2)
beta-lactam antibiotics##5##2##(1994-8#3)(2010-6#1)(2011-2#1)
beta-lactam##12##1##(1992-12#1)(1993-8#1)(1994-8#4)(2008-10#2)(2008-7#1)(2010-6#2)(2011-2#1)
beta-lactamase##2##1##(2008-11#1)(2010-6#1)
beta-lactams##5##1##(1993-8#3)(2008-7#1)(2010-6#1)
beta-lactoglobulin as##2##2##(1997-2#1)(2008-11#1)
beta-lactoglobulin##9##1##(1997-2#3)(2008-10#2)(2008-11#2)(2008-7#2)
beta-mercaptoethanol and##2##2##(2008-10#1)(2008-8#1)
beta-mercaptoethanol##5##1##(2008-10#3)(2008-11#1)(2008-8#1)
beta-methyl##5##1##(1992-3#4)(2008-5#1)
beta-methylene##2##1##(1990-5#1)(1996-5#1)
beta-methylene-ATP = UTP##2##3##(1995-8#2)
beta-methylene-ATP##3##1##(1995-8#3)
beta-migrating##2##1##(1995-2#1)(1995-6#1)
beta-myosin heavy chain##2##3##(1995-2#2)
beta-myrcene##2##1##(2008-10#2)
beta-nicotinamide adenine dinucleotide##2##3##(2008-10#2)
beta-oxidation##3##1##(1990-5#2)(1996-12#1)
beta-peptide##4##1##(1996-2#1)(2008-5#3)
beta-pinene##4##1##(2008-10#2)(2008-11#1)(2008-12#1)
beta-pleated sheet##3##2##(1997-9#2)(2008-10#1)
beta-pleated##4##1##(1997-9#3)(2008-10#1)
beta-protein precursor##3##2##(1991-6#1)(1992-12#2)
beta-protein##4##1##(1991-6#1)(1992-12#3)
beta-secretase##4##1##(2008-11#4)
beta-sheet and##2##2##(1996-2#1)(2008-8#1)
beta-sheet structure##2##2##(2008-10#1)(2008-5#1)
beta-sheet##11##1##(1991-6#1)(1992-4#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)
beta-sitosterol##3##1##(2008-10#1)(2008-12#2)
beta-strands##2##1##(1993-8#1)(2008-10#1)
beta-subunit gene##2##2##(1995-2#2)
beta-subunit of##4##2##(1990-2#1)(1993-8#1)(1996-12#2)
beta-subunit##9##1##(1990-2#1)(1993-8#1)(1995-2#2)(1996-12#2)(1996-2#3)
beta-subunits of##3##2##(1990-2#1)(1991-3#1)(2008-8#1)
beta-subunits##8##1##(1990-2#1)(1990-4#2)(1991-3#2)(1995-6#1)(2008-8#1)(2009-7#1)
beta-thalassaemia##2##1##(1995-5#1)(2008-8#1)
beta-threo-2-pentulofuranose (0##2##2##(1990-9#2)
beta-threofuranose##2##1##(1990-9#2)
beta-tubulin and##2##2##(2008-10#1)(2010-3#1)
beta-tubulin gene##8##2##(2008-10#6)(2008-9#2)
beta-tubulin genes##2##2##(2008-10#2)
beta-tubulin##18##1##(2008-10#14)(2008-9#3)(2010-3#1)
beta-turn##6##1##(1991-10#2)(1991-5#1)(1991-6#2)(2008-9#1)
beta-type complex##3##2##(2008-10#3)
beta-type##7##1##(1994-8#3)(2008-10#4)
beta-unsaturated ketones 3a-3j in good to excellent isolated yields with complete E-stereoselectivity##2##12##(2010-7#2)
beta-unsaturated##4##1##(2008-10#1)(2010-7#3)
beta1 and##2##2##(2008-11#2)
beta1##6##1##(2008-10#2)(2008-11#3)(2008-8#1)
beta1-42##2##1##(2008-5#2)
beta2##2##1##(2008-11#1)(2011-2#1)
beta2-microglobulin (beta2m)##2##2##(1997-9#1)(2008-4#1)
beta2-microglobulin##4##1##(1997-9#2)(2008-4#1)(2011-2#1)
beta2m##13##1##(1997-9#12)(2008-4#1)
beta2m)##4##1##(1997-9#4)
beta3 integrin##5##2##(2006-6#1)(2009-9#4)
beta3 subunit##2##2##(2006-6#2)
beta3##11##1##(2006-6#4)(2008-10#1)(2008-11#2)(2009-9#4)
beta=-0##2##1##(2008-10#2)
betaAR##2##1##(2010-4#2)
betaGal activities##2##2##(1997-7#2)
betaTC3 cells##3##2##(1997-1#2)(2008-11#1)
betablockers##3##1##(2008-10#3)
betaine and##2##2##(1991-12#1)(2008-8#1)
betaine samples##2##2##(2008-10#2)
betaine##16##1##(1991-12#6)(2008-10#6)(2008-5#3)(2008-8#1)
betamethasone##2##1##(1991-1#1)(2008-10#1)
bethylid##3##1##(2008-9#3)
better HEI score##2##3##(2011-2#2)
better able to##5##3##(1992-2#1)(1993-11#1)(1996-3#1)(2008-11#2)
better acceptance##2##2##(1993-11#1)(1997-8#1)
better access to##2##3##(1995-12#1)(2010-1#1)
better accuracy##4##2##(2008-10#3)(2008-3#1)
better adapted to##2##3##(2010-1#1)(2012-6#1)
better adherence to##2##3##(1995-2#1)(2008-11#1)
better adherence##3##2##(1995-2#1)(2008-11#1)(2010-9#1)
better and##7##2##(1992-9#1)(1995-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
better approach##3##2##(1991-2#1)(1995-2#1)(1996-1#1)
better at the##2##3##(2008-4#1)(2013-7#1)
better at##5##2##(2008-10#3)(2008-4#1)(2013-7#1)
better care##3##2##(1995-8#1)(2008-5#1)(2010-8#1)
better characterized##2##2##(2008-10#1)(2008-6#1)
better clinical##5##2##(1990-2#1)(2008-11#2)(2008-7#1)(2013-1#1)
better compared##2##2##(1990-9#1)(2008-10#1)
better compliance##2##2##(1990-2#1)(2008-1#1)
better comprehension of##2##3##(2007-8#1)(2013-1#1)
better control of the##2##4##(2008-11#1)(2008-9#1)
better control of##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
better control##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
better define##7##2##(1990-6#1)(2008-10#3)(2011-2#1)(2013-1#2)
better detection limits##2##3##(2008-10#2)
better detection##4##2##(2008-10#3)(2010-12#1)
better determine##2##2##(2008-4#1)(2012-3#1)
better during##2##2##(1991-8#1)(2008-11#1)
better efficiency##3##2##(1996-9#1)(2008-10#1)(2008-3#1)
better equipped##2##2##(1993-2#1)(2009-3#1)
better explained by##3##3##(2013-1#3)
better fit##4##2##(1995-12#1)(2008-10#2)(2013-1#1)
better for the##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
better for##10##2##(1992-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
better guidelines##2##2##(1993-2#1)(2009-8#1)
better habitats##3##2##(2008-8#3)
better health and##2##3##(1997-2#1)(2008-7#1)
better health##10##2##(1994-1#1)(1994-3#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#3)
better identification##2##2##(2008-9#1)(2010-10#1)
better in this##2##3##(1991-2#1)(2008-11#1)
better in those who##2##4##(2013-1#2)
better in##9##2##(1991-2#1)(1993-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#3)
better information##3##2##(1996-1#1)(2008-10#1)(2011-1#1)
better knowledge of the##3##4##(1990-12#1)(1992-12#1)(2008-10#1)
better knowledge of##5##3##(1990-12#1)(1992-12#1)(1996-6#1)(2008-10#2)
better known as##2##3##(2010-1#1)(2012-2#1)
better known##3##2##(2010-1#1)(2012-2#1)(2012-3#1)
better linearity##2##2##(2008-10#2)
better long-term results##2##3##(1993-11#1)(2011-2#1)
better long-term##4##2##(1993-11#1)(2008-10#1)(2011-2#2)
better management of##2##3##(2008-10#1)(2009-11#1)
better management##3##2##(1992-1#1)(2008-10#1)(2009-11#1)
better on##2##2##(2008-2#1)(2010-7#1)
better outcome in##2##3##(1995-11#1)(2008-11#1)
better outcome##7##2##(1992-9#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-11#1)
better outcomes##5##2##(1995-2#1)(2008-11#1)(2011-2#3)
better overall physical##2##3##(2009-11#1)(2013-1#1)
better overall##4##2##(2008-10#1)(2009-11#1)(2012-2#1)(2013-1#1)
better patient##2##2##(2010-8#1)(2011-2#1)
better performance in##2##3##(2008-10#1)(2008-11#1)
better performance of##2##3##(2008-10#1)(2008-11#1)
better performance than the##2##4##(2008-10#1)(2008-3#1)
better performance than##6##3##(2008-10#5)(2008-3#1)
better performance##16##2##(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
better planning##2##2##(2008-11#1)(2013-1#1)
better precision##3##2##(2008-10#3)
better prediction ability##2##3##(2008-10#2)
better prediction##3##2##(2008-10#3)
better prognosis with##2##3##(2013-1#1)(2013-8#1)
better prognosis##9##2##(1991-2#1)(1992-9#1)(1993-1#1)(1994-6#1)(2008-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
better protect##2##2##(2008-10#1)(2009-4#1)
better quality of##3##3##(1990-6#1)(1991-2#1)(2011-2#1)
better quality##7##2##(1990-6#1)(1991-2#1)(2008-10#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-2#1)
better reflect##2##2##(2008-10#2)
better resolution and##3##3##(2008-10#3)
better response##4##2##(1990-9#1)(1991-2#1)(2008-10#1)(2009-8#1)
better results than regimen A in##2##6##(1997-7#2)
better results than regimen A##3##5##(1997-7#3)
better results than##7##3##(1991-6#1)(1997-7#3)(2008-7#1)(2009-3#1)(2012-2#1)
better results##16##2##(1991-6#1)(1992-9#1)(1994-3#1)(1997-7#3)(2008-10#3)(2008-11#2)(2008-7#1)(2009-3#2)(2012-2#1)(2013-8#1)
better screening##2##2##(2009-1#1)(2012-12#1)
better selectivity##4##2##(2008-10#4)
better sensitivity##3##2##(2008-10#3)
better separation##2##2##(2008-10#2)
better short-term##2##2##(2008-6#1)(2013-8#1)
better stability##2##2##(2008-5#2)
better suited to##3##3##(1991-12#1)(2008-10#1)(2008-7#1)
better suited##5##2##(1991-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
better survival##2##2##(2008-11#1)(2010-7#1)
better than 0##13##3##(1991-2#1)(2008-10#10)(2008-3#2)
better than 1##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
better than 1%##4##3##(2008-10#3)(2008-3#1)
better than 2##2##3##(1992-11#1)(2008-10#1)
better than 2%##2##3##(2008-10#2)
better than 3%##3##3##(2008-10#3)
better than 4%##2##3##(2008-10#2)
better than 5%##2##3##(2008-3#2)
better than 7%##2##3##(2008-10#2)
better than a##2##3##(2008-10#1)(2009-7#1)
better than chance##3##3##(1993-3#1)(2008-10#1)(2008-5#1)
better than other##2##3##(2008-10#1)(2013-8#1)
better than that obtained##2##4##(2008-10#2)
better than that of##4##4##(2008-1#1)(2008-10#2)(2008-3#1)
better than that##7##3##(2008-1#1)(2008-10#5)(2008-3#1)
better than the figure-of-8##2##4##(2009-3#2)
better than the results obtained##2##5##(2007-12#1)(2008-10#1)
better than the##19##3##(1997-7#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
better than those obtained by##3##5##(2008-10#2)(2008-11#1)
better than those obtained##5##4##(2008-10#4)(2008-11#1)
better than those of##2##4##(2008-10#1)(2010-4#1)
better than those##12##3##(1997-3#1)(1997-4#1)(2008-10#8)(2008-11#1)(2010-4#1)
better than##130##2##(1990-8#1)(1991-2#1)(1991-3#2)(1992-11#1)(1993-1#1)(1993-3#3)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#4)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#62)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#12)(2008-5#3)(2008-9#3)(2009-10#1)(2009-3#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
better the##2##2##(2008-10#1)(2008-5#1)
better tool##2##2##(2008-1#1)(2008-10#1)
better understand how##3##3##(2008-11#1)(2010-9#1)(2013-1#1)
better understand the biological##2##4##(1993-8#1)(2010-12#1)
better understand the development and perpetuation of most spinal pain and related disorders##2##13##(2008-12#2)
better understand the role of##2##5##(2008-11#2)
better understand the##32##3##(1990-8#1)(1992-6#1)(1993-8#1)(1997-9#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2009-1#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#1)
better understand this##3##3##(2008-10#1)(2008-7#1)(2009-10#1)
better understand##46##2##(1990-8#1)(1992-6#1)(1993-8#1)(1997-9#1)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#4)(2012-3#4)(2013-1#3)
better understanding and##2##3##(1997-8#1)(2008-4#1)
better understanding of how##2##4##(2008-11#1)(2010-9#1)
better understanding of its##2##4##(2008-10#1)(2013-1#1)
better understanding of the role of##3##6##(1995-12#1)(2009-12#1)(2012-3#1)
better understanding of the##32##4##(1990-11#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
better understanding of##49##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-10#14)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
better understanding##53##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#14)(2008-11#5)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
better use##2##2##(2007-11#1)(2013-8#1)
better ways of##2##3##(1991-1#1)(1994-3#1)
better ways##3##2##(1991-1#1)(1994-3#1)(1996-1#1)
better when##2##2##(2008-10#1)(2012-4#1)
better with the##2##3##(2009-8#1)(2011-2#1)
better with##6##2##(2008-10#2)(2008-2#1)(2009-8#1)(2011-2#1)(2012-3#1)
better##774##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-12#2)(1991-2#11)(1991-3#4)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#4)(1993-1#2)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#4)(1993-8#2)(1994-1#5)(1994-12#4)(1994-2#2)(1994-3#4)(1994-6#2)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#5)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-7#5)(1997-8#5)(1997-9#1)(2007-11#1)(2007-12#7)(2007-8#2)(2008-1#6)(2008-10#222)(2008-11#53)(2008-12#6)(2008-2#7)(2008-3#23)(2008-4#6)(2008-5#15)(2008-6#9)(2008-7#11)(2008-8#13)(2008-9#20)(2009-1#2)(2009-10#3)(2009-11#4)(2009-12#3)(2009-3#6)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#7)(2010-10#7)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#7)(2010-8#7)(2010-9#5)(2011-1#4)(2011-2#46)(2011-3#3)(2011-7#1)(2012-12#5)(2012-2#20)(2012-3#22)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#35)(2013-7#4)(2013-8#19)
better&quot##4##1##(2008-12#4)
better?##5##1##(1992-12#1)(1992-2#1)(1994-3#2)(2009-5#1)
between &quot##6##2##(1993-12#2)(1995-3#1)(2008-11#1)(2008-8#1)(2010-6#1)
between (i)##2##2##(2008-10#1)(2008-3#1)
between -0##3##2##(2008-10#3)
between 0 and 5##2##4##(2008-10#2)
between 0 and##12##3##(1996-1#1)(2008-10#9)(2008-7#1)(2013-1#1)
between 0##122##2##(1990-2#1)(1990-5#1)(1992-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-10#99)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#3)
between 1 and 1##2##4##(1992-9#1)(2009-10#1)
between 1 and 4##2##4##(1993-6#1)(2008-10#1)
between 1 and 5##2##4##(1990-9#1)(2008-10#1)
between 1 and##23##3##(1990-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(2008-10#16)(2008-11#1)(2009-10#1)(2012-2#1)
between 1##58##2##(1990-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-8#2)(1996-12#1)(1997-8#1)(2008-10#41)(2008-11#2)(2009-10#1)(2010-4#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
between 1-[G'(1)]-1-[G'(4)]##2##2##(1996-5#2)
between 10 and 40##2##4##(2008-10#2)
between 10 and##15##3##(1992-12#1)(2008-10#11)(2008-11#1)(2010-3#1)(2012-12#1)
between 10##21##2##(1992-12#1)(2008-10#16)(2008-11#1)(2010-3#1)(2012-12#2)
between 10% and##2##3##(2008-7#1)(2011-2#1)
between 10(-6) and##2##3##(2008-10#2)
between 10(-9) and##2##3##(2008-10#2)
between 100 °C and 140 °C##2##6##(2011-2#2)
between 100##5##2##(1994-8#1)(2008-10#2)(2011-2#2)
between 1000 and##2##3##(2008-10#2)
between 12 and##5##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
between 12 to##2##3##(2008-10#2)
between 12##8##2##(1997-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
between 13##2##2##(2008-5#1)(2013-1#1)
between 14##2##2##(2008-10#2)
between 15 and##8##3##(2008-10#7)(2008-11#1)
between 15##10##2##(1995-12#1)(1995-3#1)(2008-10#7)(2008-11#1)
between 16 and##3##3##(2008-10#2)(2009-10#1)
between 16##5##2##(2008-1#1)(2008-10#3)(2009-10#1)
between 18 and##2##3##(2008-10#2)
between 18##4##2##(2008-10#2)(2012-12#2)
between 1850 and##2##3##(2009-10#1)(2011-2#1)
between 19 and##2##3##(2008-10#1)(2011-2#1)
between 19##3##2##(2008-10#2)(2011-2#1)
between 1950 and 1985##2##4##(1990-8#2)
between 1978 and##2##3##(1990-3#1)(1992-2#1)
between 1980 and##6##3##(1993-2#1)(1995-3#1)(1997-5#1)(2008-8#1)(2010-7#1)(2012-2#1)
between 1981 and##4##3##(1991-2#1)(1992-12#1)(2008-10#1)(2012-3#1)
between 1981/1982 and 1991/1992##2##4##(2009-10#2)
between 1982 and##2##3##(1997-6#1)(2008-11#1)
between 1984 and##4##3##(1992-12#2)(1995-12#1)(1996-3#1)
between 1985 and##3##3##(1991-8#1)(1997-7#1)(2008-9#1)
between 1986 and 1988##2##4##(1992-2#1)(1993-1#1)
between 1986 and##3##3##(1992-2#1)(1993-1#1)(1994-6#1)
between 1987 and##2##3##(1992-2#1)(2008-10#1)
between 1988 and 2000##2##4##(1991-1#2)
between 1988 and##5##3##(1991-1#2)(2008-5#1)(2008-9#1)(2012-3#1)
between 1990 and##4##3##(1996-11#1)(2008-10#1)(2013-1#2)
between 1991 and##4##3##(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)
between 1992 and##3##3##(1995-12#1)(2012-3#1)(2013-1#1)
between 1993 and##2##3##(1997-3#1)(2008-10#1)
between 1994 and##2##3##(2008-10#1)(2012-3#1)
between 1995 and##4##3##(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
between 1996 and##2##3##(2008-10#1)(2011-2#1)
between 1998 and 2002##2##4##(2008-10#2)
between 1998 and##4##3##(2008-10#3)(2012-12#1)
between 1999 and##2##3##(2008-10#1)(2008-5#1)
between 1x10(-6) and##2##3##(2008-10#2)
between 2 and 10##2##4##(2008-10#2)
between 2 and 6##2##4##(1997-3#1)(2013-1#1)
between 2 and##12##3##(1997-3#1)(2008-10#8)(2009-4#1)(2011-10#1)(2013-1#1)
between 2##30##2##(1991-5#1)(1994-11#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#20)(2008-11#1)(2009-4#1)(2010-1#1)(2011-10#1)(2013-1#1)
between 20 and 30##2##4##(1994-3#1)(2011-2#1)
between 20 and##6##3##(1994-3#2)(2008-10#3)(2011-2#1)
between 20##7##2##(1994-3#2)(2008-10#3)(2010-7#1)(2011-2#1)
between 200 and##2##3##(2008-10#2)
between 200##3##2##(2008-10#2)(2012-2#1)
between 2000 and 2004##2##4##(2008-11#1)(2009-10#1)
between 2000 and##10##3##(2008-10#2)(2008-11#3)(2009-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
between 2001 and 2003##2##4##(2008-12#1)(2010-3#1)
between 2001 and##3##3##(2008-12#1)(2008-9#1)(2010-3#1)
between 2002 and 2005##2##4##(2008-10#1)(2010-3#1)
between 2002 and 2008##2##4##(2009-6#1)(2012-3#1)
between 2002 and##5##3##(2008-10#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-3#1)
between 2004 and 2008##2##4##(2012-3#1)(2013-8#1)
between 2004 and##4##3##(2008-12#1)(2012-3#2)(2013-8#1)
between 2005 and 2008##2##4##(2010-11#1)(2011-3#1)
between 2005 and##3##3##(2010-11#1)(2011-3#1)(2012-3#1)
between 2006 and 2010##4##4##(2012-12#2)(2013-1#2)
between 2006 and##6##3##(2010-4#1)(2010-7#1)(2012-12#2)(2013-1#2)
between 21##3##2##(2012-12#2)(2012-3#1)
between 22 and##2##3##(1993-3#1)(2008-10#1)
between 22##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
between 25 and 50%##3##4##(2008-7#3)
between 25 and##8##3##(2008-10#3)(2008-5#1)(2008-7#3)(2012-3#1)
between 25##11##2##(2008-10#4)(2008-5#1)(2008-7#3)(2012-3#1)(2013-1#2)
between 26 and##2##3##(1996-11#1)(2010-3#1)
between 27 and##2##3##(2010-3#1)(2011-2#1)
between 28 and##2##3##(2008-12#1)(2008-7#1)
between 2x10(-6) and##2##3##(2008-10#2)
between 3 and 6##2##4##(2008-11#1)(2008-7#1)
between 3 and 7##2##4##(2008-5#1)(2008-7#1)
between 3 and##8##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
between 3##18##2##(1997-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)
between 30 and 40##2##4##(2008-10#1)(2008-5#1)
between 30 and 70%##2##4##(2008-10#1)(2008-5#1)
between 30 and##10##3##(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-2#1)
between 30##12##2##(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2011-2#1)
between 300 and##2##3##(2008-10#2)
between 300##3##2##(2008-10#2)(2008-11#1)
between 32 and##3##3##(1996-11#1)(2008-10#1)(2009-5#1)
between 35 and##2##3##(2008-10#1)(2013-1#1)
between 38 and##2##3##(2008-10#2)
between 4 and 10##2##4##(2008-10#1)(2008-9#1)
between 4 and 20##2##4##(2008-10#2)
between 4 and 8##2##4##(1996-12#1)(2008-10#1)
between 4 and##14##3##(1996-12#1)(2008-10#11)(2008-9#1)(2013-1#1)
between 4##21##2##(1996-12#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-3#2)(2013-1#2)
between 40 and##3##3##(1990-5#1)(2008-10#2)
between 4000 and##2##3##(2008-10#1)(2008-11#1)
between 41 and##2##3##(2008-11#1)(2010-8#1)
between 42##2##2##(1991-5#2)
between 45 and##2##3##(1990-5#1)(1991-3#1)
between 45##3##2##(1990-5#1)(1991-3#1)(2008-10#1)
between 5 and 10##2##4##(2008-10#1)(2008-11#1)
between 5 and 100 mg l(-1)##2##6##(2008-10#2)
between 5 and 20##3##4##(1995-3#1)(2008-10#1)(2011-2#1)
between 5 and##14##3##(1995-3#1)(2008-10#9)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
between 5##24##2##(1990-12#1)(1995-3#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
between 50 and##8##3##(1993-2#1)(2008-10#5)(2010-3#1)(2012-12#1)
between 50##9##2##(1993-2#1)(2008-10#5)(2010-3#1)(2012-12#1)(2013-1#1)
between 50% and##2##3##(1990-8#1)(2013-1#1)
between 6 and 8##2##4##(1997-3#1)(2008-10#1)
between 6 and##4##3##(1997-3#1)(2008-10#3)
between 6##7##2##(1997-3#1)(2008-10#4)(2008-5#1)(2011-1#1)
between 60 and##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
between 60##4##2##(1996-6#1)(2008-10#1)(2011-2#2)
between 65 and##2##3##(2008-3#1)(2011-2#1)
between 7##8##2##(1992-3#1)(1993-8#1)(2008-10#4)(2008-11#1)(2012-12#1)
between 70 and##3##3##(2008-10#3)
between 70##4##2##(2008-10#3)(2009-3#1)
between 79 and##2##3##(2008-10#2)
between 79##3##2##(2008-10#3)
between 8 and 12 years of age##2##7##(1991-2#1)(2009-10#1)
between 8 and 12##3##4##(1991-2#1)(2008-10#1)(2009-10#1)
between 8 and##6##3##(1991-2#1)(1991-5#1)(1995-8#1)(2008-10#2)(2009-10#1)
between 8##10##2##(1991-2#1)(1991-5#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-10#1)
between 80 and##6##3##(1991-6#1)(1992-11#1)(2008-10#4)
between 82 and##2##3##(2008-10#1)(2008-2#1)
between 85##2##2##(2008-10#2)
between 86##4##2##(2008-10#4)
between 9##4##2##(2008-10#3)(2008-3#1)
between 90 and##2##3##(2008-10#1)(2008-7#1)
between 90##3##2##(2008-10#2)(2008-7#1)
between 91 and##2##3##(2008-10#2)
between 91##3##2##(2008-10#3)
between 92 and##5##3##(2008-10#5)
between 92##8##2##(2008-10#8)
between 93 and##2##3##(2008-10#2)
between 93##3##2##(2008-10#3)
between 94 and##2##3##(2008-10#2)
between 94##3##2##(2008-10#3)
between 95 and 100%##2##4##(2008-10#1)(2012-12#1)
between 95 and##5##3##(2008-10#4)(2012-12#1)
between 95##10##2##(2008-10#9)(2012-12#1)
between 96 and##4##3##(2008-10#4)
between 96##7##2##(2008-10#7)
between 97 and##4##3##(2008-10#4)
between 97##10##2##(2008-10#10)
between 98##6##2##(2008-10#6)
between 99##2##2##(2008-10#2)
between A and##2##3##(2008-10#1)(2008-6#1)
between A##3##2##(2008-10#2)(2008-6#1)
between A59 and RI##2##4##(1997-3#2)
between ARMD and##2##3##(2011-2#2)
between ASY and##2##3##(2008-9#2)
between Acridine Orange and Safranine T##3##6##(2008-10#3)
between Afro-Andean and Andean isolates from Africa##2##7##(2008-10#2)
between Afro-Andean##3##2##(2008-10#3)
between April##3##2##(2008-11#1)(2010-10#1)(2012-3#1)
between August##2##2##(1992-1#1)(2008-10#1)
between B##4##2##(1990-12#1)(2008-10#2)(2008-9#1)
between BALB/c and##2##3##(1996-12#1)(2008-12#1)
between BALB/cJ (mean##3##3##(2008-5#3)
between BMI and##2##3##(2009-7#1)(2011-2#1)
between C##5##2##(1993-9#1)(2008-10#3)(2008-8#1)
between CA[n]##2##2##(2008-10#2)
between CEVd and##2##3##(2008-10#2)
between Canadian##2##2##(2008-10#1)(2008-11#1)
between Caucasians and##2##3##(2008-1#2)
between D##2##2##(2008-10#2)
between DNA and##2##3##(2008-10#1)(2008-8#1)
between DNA##6##2##(1994-12#1)(2008-10#3)(2008-8#1)(2008-9#1)
between December##4##2##(2008-11#1)(2011-1#1)(2013-1#2)
between E##4##2##(1995-6#1)(1996-12#1)(2008-9#2)
between EAS and ENA and between EAS and WNA##2##9##(2008-8#2)
between EAS and ENA##4##4##(2008-8#4)
between EAS and WNA##3##4##(2008-8#3)
between EAS and##7##3##(2008-8#7)
between EAS##8##2##(2008-8#8)
between EH and##2##3##(2008-9#2)
between ENA and WNA##2##4##(2008-8#2)
between EV71##3##2##(2013-8#3)
between Eastern##2##2##(2008-8#1)(2009-10#1)
between F##4##2##(2008-10#4)
between Fe(II) and##2##3##(2008-10#2)
between GT##2##2##(2008-5#1)(2009-10#1)
between Group##2##2##(1993-2#2)
between Groups##2##2##(2010-12#1)(2010-7#1)
between H##4##2##(2008-10#1)(2013-1#3)
between HIV##4##2##(1993-11#1)(2008-4#1)(2008-6#1)(2013-8#1)
between HMG proteins and the##2##5##(2008-8#2)
between HMO##3##2##(1991-3#1)(1997-2#1)(2008-11#1)
between HPLC##2##2##(2008-10#1)(2013-8#1)
between I##4##2##(2008-10#1)(2008-11#1)(2012-3#2)
between ICP-MS and##2##3##(2008-10#2)
between IP3- and Ca(2+)-sensitive##2##4##(1996-5#2)
between January 1##2##3##(2009-6#1)(2011-2#1)
between January 1993 and##2##4##(1996-2#1)(2008-9#1)
between January 2002 and December##2##5##(2010-11#1)(2013-1#1)
between January 2002 and##3##4##(2008-10#1)(2010-11#1)(2013-1#1)
between January and##2##3##(2008-11#1)(2011-2#1)
between January##15##2##(1991-2#1)(1994-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
between Japanese Black and##2##4##(2013-1#2)
between Japanese##3##2##(2008-12#1)(2013-1#2)
between July##2##2##(1991-1#1)(2008-5#1)
between June and##2##3##(1994-9#1)(2008-10#1)
between June##4##2##(1994-9#1)(1995-12#1)(2008-10#1)(2008-7#1)
between L##3##2##(2008-10#3)
between Lysholm##2##2##(2013-1#2)
between May##3##2##(1996-11#1)(1996-5#1)(2008-10#1)
between N##2##2##(2008-10#2)
between November##3##2##(2011-2#2)(2012-3#1)
between ON and OFF states##2##5##(2008-7#2)
between P##8##2##(2008-10#8)
between PM10 and##2##3##(2011-2#2)
between PM10##3##2##(2011-2#3)
between Pb##2##2##(2008-10#2)
between Pipizini and##2##3##(2008-8#2)
between R##2##2##(2008-10#2)
between RFLP##2##2##(2008-10#1)(2008-9#1)
between Rpc1 and the##2##4##(2008-10#2)
between S##2##2##(2008-10#1)(2008-11#1)
between SNPs##2##2##(2008-10#1)(2010-12#1)
between SPL and##2##3##(2011-1#2)
between Savannah and Genghis##2##4##(2008-10#2)
between September##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
between T##4##2##(1991-8#1)(2007-12#1)(2008-10#2)
between T2 and T3##2##4##(1990-6#1)(1991-8#1)
between TB##2##2##(2008-10#1)(2010-5#1)
between TJ and anchoring junction##2##5##(2009-10#2)
between TNT and##2##3##(2008-10#2)
between TPA and CA15##2##4##(1990-8#2)
between TPA and##3##3##(1990-8#3)
between Trichoderma spp##2##3##(2008-10#2)
between US-1 and##3##3##(2008-10#3)
between V##3##2##(2008-10#3)
between Verticillium##2##2##(2008-10#2)
between a Triticum isolate##2##4##(2008-10#2)
between a disposable electrochemical DNA biosensor and a Vibrio fischeri-based luminescent sensor for the detection of toxicants in water samples##2##20##(2008-10#2)
between a high##2##3##(1990-8#1)(1990-9#1)
between a single##2##3##(2008-10#1)(2008-11#1)
between a wide range of##2##5##(2008-10#2)
between a##65##2##(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-10#25)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-8#2)(2010-5#1)(2011-2#2)(2012-3#2)(2013-8#2)
between absorbance and analyte concentration##2##5##(2008-10#2)
between absorbance##4##2##(2008-10#4)
between abundance##2##2##(2008-8#1)(2012-6#1)
between academic##4##2##(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)
between academics and##2##3##(1993-12#1)(1995-12#1)
between active and inactive##2##4##(1994-12#1)(2008-10#1)
between active##3##2##(1994-12#1)(2008-10#2)
between adjacent images##2##3##(2008-3#2)
between adjacent laminar flows in##2##5##(2008-10#2)
between adjacent laminar flows##3##4##(2008-10#3)
between adjacent##15##2##(1992-4#1)(1994-5#1)(2007-12#1)(2008-10#6)(2008-3#2)(2009-8#2)(2012-2#1)(2013-1#1)
between age and##2##3##(2008-7#1)(2011-2#1)
between age##6##2##(2008-7#2)(2008-8#2)(2011-2#1)(2012-3#1)
between albuminuria##2##2##(1992-9#2)
between all##11##2##(1997-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
between alleles##2##2##(2008-10#1)(2008-8#1)
between alpha-cyclodextrin##2##2##(2008-10#2)
between ambient##2##2##(2008-11#2)
between an aqueous##3##3##(2008-10#3)
between an##17##2##(1990-8#1)(1993-1#1)(2007-12#1)(2008-10#7)(2008-9#1)(2010-8#1)(2011-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
between analyses##2##2##(2008-10#2)
between analytical##3##2##(2008-10#3)
between and among##2##3##(1997-1#1)(2009-11#1)
between and within##3##3##(2008-10#2)(2008-9#1)
between and##7##2##(1997-1#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-11#1)(2010-11#1)
between anger intensity and the##2##5##(2010-11#2)
between anger##3##2##(2010-11#3)
between antibody##2##2##(2008-1#1)(2008-11#1)
between antigenically##3##2##(2008-10#1)(2011-2#2)
between anxiety##3##2##(2009-6#1)(2009-7#1)(2013-8#1)
between any two isolates##2##4##(2008-10#1)(2008-5#1)
between any two##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
between any##5##2##(1996-2#1)(2008-10#1)(2008-5#2)(2011-3#1)
between appearance##2##2##(2008-10#1)(2008-11#1)
between aqueous and##4##3##(1990-5#1)(2008-10#3)
between aqueous##5##2##(1990-5#1)(2008-10#4)
between avidin and##2##3##(2008-10#1)(2008-12#1)
between bacteria and##2##3##(1991-3#1)(2006-6#1)
between bacterial##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
between baseline##2##2##(1995-2#1)(2008-3#1)
between basic and clinical##2##4##(1994-12#1)(2008-5#1)
between basic##4##2##(1992-12#1)(1994-12#1)(2008-5#1)(2008-9#1)
between batches##2##2##(2008-11#1)(2008-5#1)
between behavioral##2##2##(2008-8#2)
between being##2##2##(2009-7#1)(2011-2#1)
between benign and malignant endometrial##2##5##(1995-3#2)
between benign and##3##3##(1995-3#2)(2013-8#1)
between benzene and water##2##4##(2008-10#2)
between biliverdin and bovine serum albumin##2##6##(2008-10#2)
between biological##2##2##(2008-10#1)(2008-7#1)
between biology and##2##3##(2008-10#1)(2013-1#1)
between biotin and##2##3##(2008-10#1)(2008-9#1)
between blood##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
between body mass index##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
between body##11##2##(1992-3#1)(1997-8#1)(2008-10#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)
between bone##3##2##(2009-7#1)(2010-8#1)(2013-1#1)
between both methods were##2##4##(2008-10#2)
between both methods##3##3##(2008-10#3)
between both occasions##2##3##(2008-10#2)
between both##28##2##(1990-5#1)(1991-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(2008-10#13)(2008-11#2)(2008-5#1)(2009-8#2)(2010-10#1)(2010-2#1)(2011-2#2)(2013-1#1)
between boys##2##2##(2009-5#1)(2013-8#1)
between brain##4##2##(1995-5#1)(2008-7#1)(2012-2#2)
between breast cancer and##2##4##(2008-5#1)(2013-1#1)
between breastfeeding duration##2##3##(2008-10#1)(2010-6#1)
between breastfeeding##5##2##(2008-10#2)(2010-6#3)
between breeds##3##2##(1995-2#2)(1996-12#1)
between cancer##3##2##(1991-3#1)(2008-11#1)(2013-8#1)
between cankers on small branches##2##5##(2008-10#2)
between caregivers##3##2##(2008-7#1)(2010-2#1)(2013-1#1)
between cases##2##2##(1990-8#1)(2012-2#1)
between cell##10##2##(1993-3#1)(2008-11#6)(2008-7#1)(2008-9#2)
between cells##3##2##(2008-11#1)(2009-8#1)(2013-1#1)
between cerebral##3##2##(1995-11#1)(2008-7#2)
between certain##2##2##(1993-2#1)(2008-9#1)
between chains decreased##2##3##(2008-8#1)(2008-9#1)
between changes in##4##3##(2008-7#1)(2013-8#3)
between chemical and##2##3##(2008-10#2)
between chemical##4##2##(1995-11#1)(2008-10#3)
between child##3##2##(1995-2#1)(2008-12#1)(2009-5#1)
between children##2##2##(2010-12#1)(2011-1#1)
between children's##3##2##(1995-2#1)(2008-12#1)(2012-2#1)
between chronic##7##2##(1993-11#1)(1996-6#1)(2009-8#2)(2010-12#1)(2011-2#1)(2013-8#1)
between citrus viroids##2##3##(2008-10#2)
between clinical and##4##3##(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
between clinical##12##2##(1991-6#1)(1993-3#2)(1997-7#1)(2008-12#1)(2008-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-8#1)
between clinicians##2##2##(2008-11#1)(2009-9#1)
between closely similar DNA sequences##3##5##(2008-4#1)(2008-9#2)
between closely##5##2##(2008-4#2)(2008-9#2)(2012-3#1)
between coding##2##2##(2008-11#1)(2010-7#1)
between common##2##2##(2008-8#1)(2010-12#1)
between competition and dispersal##2##4##(2008-8#2)
between competition and##3##3##(2008-8#2)(2009-1#1)
between competitive##4##2##(2008-8#3)(2009-7#1)
between concurrent##2##2##(2011-2#2)
between conditions##4##2##(1991-5#1)(1994-9#1)(2009-11#1)(2013-8#1)
between consumer##2##2##(2008-11#1)(2008-8#1)
between contaminated##2##2##(2007-12#1)(2008-10#1)
between continents##3##2##(2008-10#3)
between control and##7##3##(1991-5#1)(1994-5#1)(1995-11#1)(2008-10#2)(2008-12#1)(2008-7#1)
between control##9##2##(1991-5#1)(1994-5#1)(1995-11#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
between conventional##2##2##(2007-12#1)(2008-10#1)
between copper(II) and##2##3##(2008-10#2)
between corresponding##2##2##(1992-4#1)(2008-10#1)
between cost and##2##3##(1992-12#1)(1995-2#1)
between cost##3##2##(1992-12#1)(1995-2#1)(2008-10#1)
between countries##4##2##(1991-11#1)(1994-2#1)(2008-10#1)(2008-2#1)
between crown##2##2##(2008-10#2)
between crystal##2##2##(2008-10#1)(2011-2#1)
between cultivars##2##2##(2008-10#1)(2011-10#1)
between current##3##2##(2008-10#1)(2009-5#1)(2010-8#1)
between cytochrome##3##2##(1994-5#1)(2008-10#1)(2008-7#1)
between cytoplasmic##2##2##(2006-6#1)(2008-9#1)
between data##2##2##(2007-11#1)(2010-10#1)
between days reliability##3##3##(2010-12#3)
between days##9##2##(2008-10#5)(2008-5#1)(2010-12#3)
between degree of##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
between delta##2##2##(2008-8#1)(2011-1#1)
between depression and##2##3##(2008-11#1)(2010-2#1)
between determined and##2##3##(2008-10#2)
between diabetic and control##2##4##(1994-11#1)(2008-10#1)
between diabetic and##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
between diagnostic groups##2##3##(2010-5#2)
between diagnostic##3##2##(1990-12#1)(2010-5#2)
between dietary##2##2##(1994-2#2)
between different hospitals and different counties##2##6##(1991-11#2)
between different treatment##2##3##(1995-5#1)(2009-8#1)
between different types of##3##4##(1993-8#1)(2013-1#2)
between different##44##2##(1990-5#1)(1991-11#2)(1992-3#1)(1993-8#2)(1994-8#1)(1995-11#1)(1995-5#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
between direct and indirect##2##4##(2008-10#1)(2012-2#1)
between disease severity and##5##4##(2008-10#5)
between disease##13##2##(1995-9#1)(2008-10#12)
between distinct##2##2##(2008-11#2)
between domestic##2##2##(1996-12#1)(2011-2#1)
between dopamine-##2##2##(1995-11#2)
between dose and##2##3##(2008-11#1)(2008-7#1)
between double##2##2##(2008-10#2)
between drinkers and non-drinkers##2##4##(2008-1#1)(2008-10#1)
between drug##9##2##(1990-2#1)(1992-2#1)(2008-10#4)(2008-11#2)(2008-8#1)
between dural arteries and##2##4##(2008-7#2)
between each of##2##3##(2008-11#1)(2008-9#1)
between each##9##2##(1991-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2013-8#1)
between ear##2##2##(2008-10#2)
between early and late##3##4##(2008-10#2)(2008-11#1)
between early##9##2##(1990-3#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-8#1)(2013-8#1)
between eastern and western populations##3##5##(2008-10#3)
between eastern and western##4##4##(2008-10#3)(2009-10#1)
between eastern and##5##3##(2008-10#4)(2009-10#1)
between education and##2##3##(2008-11#2)
between efficiency##2##2##(1995-12#1)(2012-3#1)
between egg size and##2##4##(1991-5#1)(2010-8#1)
between either##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
between electrical and mechanical asynchrony##3##5##(2008-10#3)
between electrodes##3##2##(1992-12#2)(2008-10#1)
between elevated##2##2##(1997-7#1)(2011-2#1)
between environmental##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
between estimated and actual severity##3##5##(2008-10#3)
between ethnic groups on the##2##5##(2008-1#2)
between evidence and##3##3##(1993-12#2)(2008-3#1)
between executive function and##5##4##(2009-10#5)
between expected##2##2##(1994-12#1)(2008-10#1)
between experimental and##2##3##(2008-10#2)
between experimental##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
between experiments##5##2##(1997-3#1)(2008-3#1)(2009-12#1)(2009-8#2)
between experts##2##2##(1993-12#1)(2010-5#1)
between exposure to##2##3##(2008-12#1)(2012-2#1)
between exposure##3##2##(2008-12#1)(2008-7#1)(2012-2#1)
between expression levels and telomere length##2##6##(2012-3#2)
between expression of##4##3##(1993-1#1)(2008-11#2)(2009-10#1)
between expression##7##2##(1993-1#1)(2008-11#3)(2009-10#1)(2012-3#2)
between extracurricular activities##3##3##(2009-7#3)
between family##10##2##(1996-9#1)(1997-2#1)(2008-11#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#3)(2013-8#1)
between fibronectin##2##2##(2008-7#2)
between field##2##2##(2008-10#2)
between fields##3##2##(2008-10#3)
between first##3##2##(1991-8#1)(1992-9#1)(2009-4#1)
between fish##2##2##(1995-11#1)(2008-10#1)
between five##3##2##(2008-10#1)(2009-6#1)(2011-2#1)
between fluorescence##2##2##(2008-10#1)(2008-3#1)
between food##3##2##(2008-1#1)(2008-5#1)(2009-8#1)
between formats##2##2##(2010-10#2)
between fortuitous and biologically##2##4##(1996-3#2)
between four##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
between free##2##2##(1991-12#1)(2008-10#1)
between functional##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
between fungal##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
between fungicide##2##2##(2008-10#2)
between gallbladder##2##2##(2010-12#1)(2013-8#1)
between gene##2##2##(1991-9#1)(2008-10#1)
between general##2##2##(1997-4#1)(2012-3#1)
between genes##4##2##(2011-3#1)(2012-3#2)(2013-7#1)
between genetic and geographic distance##3##5##(2008-10#3)
between genetic and##5##3##(2008-10#4)(2010-12#1)
between genetic##9##2##(2008-10#8)(2010-12#1)
between genetically##3##2##(1995-12#1)(1995-2#1)(2008-8#1)
between genetics and##2##3##(2008-7#1)(2011-2#1)
between genomic##2##2##(1993-8#1)(2008-11#1)
between genotype and phenotype##2##4##(2008-10#1)(2008-8#1)
between genotype and##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
between genotype##4##2##(1996-12#1)(2008-10#2)(2008-8#1)
between genotypes##4##2##(2008-10#4)
between germination##2##2##(2008-10#1)(2011-2#1)
between global##2##2##(2008-10#1)(2008-9#1)
between green and##2##3##(2008-10#1)(2008-3#1)
between group members##2##3##(2008-9#2)
between group size and##4##4##(1994-3#2)(2008-8#2)
between group##9##2##(1994-3#2)(2008-10#1)(2008-8#2)(2008-9#2)(2010-1#1)(2012-2#1)
between groups (p##2##3##(2011-2#1)(2013-1#1)
between groups and##2##3##(2009-7#1)(2011-2#1)
between groups in##5##3##(1996-1#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
between groups of##2##3##(1994-9#1)(1997-9#1)
between groups were##3##3##(1994-3#1)(2011-2#1)(2013-1#1)
between groups##28##2##(1994-3#1)(1994-9#1)(1996-1#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-12#3)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-3#1)(2013-1#8)
between growing##2##2##(1996-8#1)(2008-10#1)
between growth and##2##3##(2008-8#1)(2010-7#1)
between growth of##2##3##(2008-10#2)
between growth##9##2##(2008-10#4)(2008-12#1)(2008-8#2)(2010-7#1)(2012-6#1)
between hIL-6 and hIL-6R##2##4##(2008-8#2)
between hIL-6 and##3##3##(2008-8#3)
between hIL-6##4##2##(2008-8#4)
between health care##2##3##(1993-1#1)(1994-1#1)
between health professionals and##2##4##(2008-11#1)(2012-3#1)
between health professionals##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
between health##11##2##(1993-1#1)(1994-1#1)(1996-11#1)(2008-1#2)(2008-11#3)(2008-12#1)(2012-3#1)(2013-1#1)
between healthy and##4##3##(1997-2#1)(2008-10#2)(2009-8#1)
between healthy##8##2##(1992-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2009-8#1)
between heavy##2##2##(2008-10#2)
between helices##3##2##(1993-8#1)(1995-2#2)
between heparinized##2##2##(2011-2#2)
between heterozygosity and##2##3##(2008-8#2)
between high##7##2##(1992-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-6#1)(2012-2#1)
between higher education##3##3##(2008-11#2)(2008-12#1)
between higher##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
between home and##2##3##(1997-5#1)(2009-10#1)
between home##8##2##(1991-3#1)(1992-2#1)(1997-5#1)(2008-8#3)(2009-10#1)(2010-7#1)
between hospital##5##2##(1995-12#1)(1996-3#2)(2008-11#1)(2013-1#1)
between hospitals and##2##3##(1991-1#1)(1994-1#1)
between hospitals##3##2##(1991-1#1)(1992-2#1)(1994-1#1)
between host and parasite##4##4##(2008-8#2)(2010-8#1)(2012-3#1)
between host and##6##3##(2008-10#1)(2008-12#1)(2008-8#2)(2010-8#1)(2012-3#1)
between host species##2##3##(2008-10#1)(2012-3#1)
between host##14##2##(2008-10#7)(2008-12#1)(2008-8#3)(2010-8#1)(2012-3#2)
between hosts##3##2##(2008-10#3)
between human and##4##3##(1996-12#1)(2008-11#1)(2008-4#1)(2012-3#1)
between human##8##2##(1992-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
between humans and##3##3##(2008-11#1)(2011-2#2)
between hydrogen peroxide and##3##4##(2008-10#2)(2009-4#1)
between hydrogen peroxide##4##3##(2008-10#3)(2009-4#1)
between hydrogenotrophic sulphate-reducers##2##3##(2008-7#2)
between illness##2##2##(1994-6#1)(2008-11#1)
between implants and##2##3##(2012-2#2)
between implants##3##2##(2012-2#3)
between in vitro and in vivo##3##6##(1991-2#1)(1992-6#1)(2008-5#1)
between in vitro##4##3##(1991-2#1)(1992-6#1)(2008-10#1)(2008-5#1)
between in##6##2##(1990-5#1)(1991-2#1)(1992-6#1)(2008-10#1)(2008-12#1)(2008-5#1)
between in-phase and opposed-phase##2##4##(1997-8#2)
between inbred##2##2##(1994-5#1)(2009-10#1)
between incidence and severity##2##4##(2008-10#2)
between incidence of##2##3##(2008-10#2)
between incidence##6##2##(2008-10#6)
between income##2##2##(1993-3#1)(2010-7#1)
between increased##4##2##(2008-8#1)(2011-2#1)(2013-8#2)
between increasing##3##2##(2008-10#1)(2010-1#1)(2012-3#1)
between individual##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
between individuals and groups##2##4##(1993-12#1)(2009-12#1)
between individuals and##3##3##(1993-12#1)(2008-8#1)(2009-12#1)
between individuals##11##2##(1993-12#1)(2007-11#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2012-3#1)(2013-1#1)
between infected##2##2##(2012-2#1)(2013-8#1)
between initial##2##2##(1991-2#1)(2008-6#1)
between injection##2##2##(1997-4#1)(2008-10#1)
between inoculation##2##2##(2008-10#2)
between inorganic##2##2##(2008-10#2)
between inpatients and outpatients##2##4##(2011-2#2)
between intensity##2##2##(2008-10#1)(2008-7#1)
between ion##2##2##(2008-10#1)(2009-8#1)
between iron(III) and##2##3##(2008-10#2)
between iron(III)##3##2##(2008-10#3)
between isolates from the##2##4##(2008-10#2)
between isolates of P##2##4##(2008-10#2)
between isolates of##8##3##(2008-10#8)
between isolates within##2##3##(2008-10#2)
between isolates##19##2##(2008-10#19)
between it and the##2##4##(2008-3#1)(2013-8#1)
between its##4##2##(1990-7#1)(2008-11#1)(2010-8#1)(2012-3#1)
between knowledge##2##2##(1997-6#1)(2013-1#1)
between known concentrations and concentrations derived from##2##7##(2008-10#2)
between known##3##2##(2008-10#2)(2008-9#1)
between laboratories##2##2##(1990-12#1)(2008-10#1)
between laboratory##3##2##(1992-3#1)(2006-6#1)(2008-10#1)
between lactic acid##2##3##(2008-10#1)(2013-1#1)
between lambda(1)##2##2##(2008-10#2)
between leaf##3##2##(2008-10#2)(2008-9#1)
between learning##2##2##(2008-11#2)
between left##2##2##(2008-11#1)(2012-2#1)
between lemma and palea##2##4##(2008-10#2)
between lemma##3##2##(2008-10#3)
between levels of##4##3##(1994-3#1)(1996-12#1)(2008-8#1)(2012-2#1)
between levels##7##2##(1994-3#1)(1995-8#1)(1996-12#1)(2008-11#2)(2008-8#1)(2012-2#1)
between lines##2##2##(2008-8#1)(2012-3#1)
between lipid##3##2##(1994-5#1)(1996-2#1)(2008-10#1)
between local and##2##3##(2008-8#2)
between local##8##2##(1994-2#1)(1996-10#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-12#1)
between log S##2##3##(2008-8#2)
between log##3##2##(2008-10#1)(2008-8#2)
between long##3##2##(2008-10#2)(2008-8#1)
between maize and##2##3##(1990-8#1)(2012-3#1)
between maize##3##2##(1990-8#1)(2008-10#1)(2012-3#1)
between male and female components of the mate recognition system##2##10##(2008-9#2)
between male and female##6##4##(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
between males and females##6##4##(1990-3#1)(1991-2#1)(1994-6#1)(2008-8#1)(2012-3#2)
between males##7##2##(1990-3#1)(1991-2#1)(1994-6#1)(2008-8#2)(2012-3#2)
between malignancy and##2##3##(1991-3#1)(1993-8#1)
between mammography##2##2##(2011-2#1)(2013-1#1)
between managers and employees##2##4##(1994-12#2)
between markers##2##2##(2008-12#1)(2013-1#1)
between maternal acculturation and##2##4##(2009-7#2)
between maternal##6##2##(2009-11#1)(2009-12#1)(2009-7#2)(2011-2#1)(2012-2#1)
between maximum##2##2##(2008-8#1)(2010-8#1)
between mean##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
between measured and calculated##3##4##(2008-2#1)(2008-3#2)
between measured and##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
between measured##6##2##(2008-10#1)(2008-2#1)(2008-3#4)
between measurements##4##2##(1996-3#1)(2008-10#1)(2008-3#2)
between mechanical##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
between medical care##3##3##(1995-12#1)(2008-11#2)
between medical##5##2##(1995-1#1)(1995-12#1)(1996-6#1)(2008-11#2)
between medicine and##2##3##(2010-10#1)(2013-8#1)
between melody recognition##2##3##(2008-9#2)
between men and women##5##4##(1993-2#2)(1996-8#1)(2008-10#1)(2009-10#1)
between men and##6##3##(1993-2#2)(1996-8#1)(2008-10#1)(2009-10#1)(2013-8#1)
between mental##4##2##(1993-3#1)(2008-12#1)(2010-12#1)(2010-7#1)
between mercury##2##2##(1995-2#1)(2008-10#1)
between methods##3##2##(2008-10#3)
between migraine with aura and##2##5##(2008-9#2)
between migraine with##3##3##(2008-9#3)
between migraine##5##2##(2008-9#5)
between mitochondria and ATPases##4##4##(2008-7#4)
between mitochondrial##2##2##(1994-11#1)(2013-1#1)
between mixed##2##2##(2008-10#2)
between model and##2##3##(2008-11#1)(2008-7#1)
between model##4##2##(2008-11#3)(2008-7#1)
between models##2##2##(2008-10#2)
between molecular markers and##2##4##(2008-10#2)
between molecular##7##2##(2008-10#5)(2008-3#1)(2008-5#1)
between molecules##2##2##(1992-9#1)(2010-7#1)
between morphological##2##2##(2008-11#1)(2008-8#1)
between mouse and##2##3##(1995-2#1)(1997-8#1)
between mutant and##2##3##(1995-2#1)(2008-10#1)
between native and##2##3##(1995-3#1)(2008-6#1)
between naturally occurring##2##3##(2008-4#1)(2008-9#1)
between negative##2##2##(2008-9#1)(2010-10#1)
between neighboring##6##2##(1996-12#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-5#1)
between neural networks##2##3##(2008-11#2)
between neural##3##2##(2008-11#3)
between neurons and##2##3##(2008-5#1)(2009-8#1)
between neurotransmitter##2##2##(1995-11#1)(1996-12#1)
between new##2##2##(1991-11#1)(2012-2#1)
between nine##2##2##(2008-10#1)(2013-1#1)
between nitrogen and##2##3##(2008-10#2)
between normal and##3##3##(1990-12#1)(1990-9#1)(2013-1#1)
between normal##10##2##(1990-12#1)(1990-9#1)(1993-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#2)(2012-3#1)(2013-1#1)
between nucleoporins and##2##3##(2011-2#2)
between nucleotides##2##2##(1993-2#1)(2012-2#1)
between number of##2##3##(2008-10#1)(2013-1#1)
between number##3##2##(1990-12#1)(2008-10#1)(2013-1#1)
between nurses and##2##3##(1993-2#1)(2013-8#1)
between nurses##3##2##(1993-2#1)(2008-11#1)(2013-8#1)
between nutritional##2##2##(2008-11#1)(2013-1#1)
between obese and##2##3##(1996-12#1)(2011-2#1)
between obesity##2##2##(2008-1#1)(2009-7#1)
between observed and##5##3##(2008-10#5)
between observed##7##2##(2008-10#5)(2008-3#1)(2012-4#1)
between odour##2##2##(2008-10#1)(2008-5#1)
between old and young##2##4##(2009-10#1)(2009-8#1)
between one##6##2##(1994-5#2)(2008-10#4)
between oocytes##2##2##(1990-7#1)(1995-11#1)
between oral##4##2##(1990-6#1)(2008-11#1)(2012-3#1)(2013-8#1)
between organelles##2##2##(2009-5#1)(2011-2#1)
between organic##2##2##(2008-10#2)
between organisms##2##2##(2008-7#1)(2008-9#1)
between our##2##2##(2010-6#1)(2012-3#1)
between oxalate##2##2##(2008-10#1)(2012-2#1)
between p53 and##3##3##(2010-10#2)(2011-2#1)
between p53##5##2##(1997-7#1)(2008-5#1)(2010-10#2)(2011-2#1)
between pH 2##3##3##(2008-10#3)
between pH 6##2##3##(2008-10#2)
between pH 7##2##3##(1994-5#1)(2008-6#1)
between pH##12##2##(1994-11#1)(1994-5#1)(2008-10#9)(2008-6#1)
between pK(a)##3##2##(2008-10#3)
between pairs of##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2013-1#1)
between parasite##2##2##(2008-10#1)(2008-8#1)
between parent##2##2##(1990-12#1)(1994-3#1)
between parents and##6##3##(1990-12#2)(1995-1#1)(1997-7#1)(2008-11#1)(2013-1#1)
between partially##2##2##(1995-2#1)(2008-10#1)
between parts of##2##3##(1996-1#1)(2010-3#1)
between pathogen##3##2##(2008-10#3)
between pathotypes##2##2##(2008-10#2)
between patient##2##2##(2008-1#1)(2008-11#1)
between patients and##6##3##(1995-5#1)(2008-4#1)(2008-7#1)(2013-1#3)
between patients in different##2##4##(2011-2#2)
between patients treated##2##3##(1990-6#1)(1990-8#1)
between patients who##2##3##(2011-1#1)(2013-1#1)
between patients with##5##3##(1997-5#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
between patients##21##2##(1990-6#1)(1990-8#1)(1994-12#1)(1995-5#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#6)
between peak height and the concentration of##3##7##(2008-10#3)
between peak height and##6##4##(2008-10#6)
between peak height##7##3##(2008-10#7)
between peak##11##2##(2008-10#11)
between people's##2##2##(2010-2#2)
between perceived##4##2##(1993-12#1)(2009-7#1)(2011-2#1)(2012-2#1)
between perceptions of family connectedness and body satisfaction##2##8##(2010-10#2)
between peri-implantitis and##2##3##(2013-1#2)
between peripheral##2##2##(1991-3#1)(1996-1#1)
between persons##2##2##(1994-12#1)(2008-10#1)
between phases of the micellar system##2##6##(1990-5#2)
between phospholipase activity and##2##4##(2008-5#2)
between physical##6##2##(2008-10#1)(2008-9#1)(2010-2#2)(2012-2#1)(2013-1#1)
between physician and patient##3##4##(1993-11#2)(1995-2#1)
between physicians and##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
between physicians##6##2##(1991-6#1)(1995-12#1)(2008-11#1)(2009-2#1)(2011-2#1)(2013-8#1)
between plant##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
between plants and herbivores##2##4##(2008-8#2)
between plants and##6##3##(2008-10#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-10#1)
between plants##8##2##(2008-10#2)(2008-8#2)(2008-9#2)(2009-8#1)(2011-10#1)
between plasma and##3##3##(1992-12#1)(1994-8#2)
between plasma##10##2##(1992-12#1)(1992-9#2)(1994-8#2)(2008-5#1)(2008-7#2)(2010-3#1)(2013-1#1)
between platelet##3##2##(1991-12#1)(1992-12#1)(2008-7#1)
between polar growth and cell cycle##2##6##(2009-8#2)
between population##2##2##(2008-10#2)
between populations in##2##3##(2008-10#1)(2008-9#1)
between populations of the##3##4##(2008-10#3)
between populations of##4##3##(2008-10#3)(2010-2#1)
between populations was##2##3##(2008-10#1)(2012-3#1)
between populations##18##2##(2008-10#11)(2008-8#2)(2008-9#2)(2010-2#1)(2012-3#2)
between positions##3##2##(1995-6#1)(1997-9#2)
between positive and negative##2##4##(2008-10#1)(2009-8#1)
between positive##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
between potential##2##2##(2008-8#1)(2013-8#1)
between practice and##2##3##(1993-2#1)(2010-10#1)
between pre-eclampsia##3##2##(2011-2#3)
between precipitation and##2##3##(2008-10#1)(2008-8#1)
between predicted and experimental##2##4##(2008-10#2)
between predicted and##3##3##(2008-10#3)
between predicted##5##2##(1991-12#1)(2008-10#4)
between prenatal care and birth outcome##2##6##(1995-2#2)
between prenatal care and birth##3##5##(1992-2#1)(1995-2#2)
between prenatal##5##2##(1992-2#1)(1995-2#2)(2008-11#1)(2013-1#1)
between primary and secondary##2##4##(1995-2#1)(2008-10#1)
between primary care##2##3##(1993-9#1)(2011-1#1)
between primary##7##2##(1990-2#1)(1993-9#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2011-1#1)
between professional##3##2##(1990-2#1)(1996-3#1)(2008-9#1)
between protein kinase C##2##4##(2008-11#2)
between protein##7##2##(1990-12#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
between proteins##5##2##(2008-10#1)(2008-4#2)(2008-9#1)(2011-2#1)
between proximal##2##2##(1990-9#1)(2008-11#1)
between psychological##2##2##(2010-4#1)(2012-2#1)
between public##4##2##(1993-2#1)(1995-12#1)(1996-2#1)(1996-3#1)
between purchasers and providers##3##4##(1994-1#2)(1997-1#1)
between queens and##2##3##(2008-5#1)(2008-8#1)
between queens##3##2##(2008-5#1)(2008-8#2)
between race##2##2##(2008-10#1)(2008-11#1)
between rat and human##2##4##(2012-2#2)
between reaction##2##2##(2008-10#1)(2010-10#1)
between reactive oxygen metabolites and##2##5##(2012-12#1)(2012-3#1)
between reactive oxygen##3##3##(2008-7#1)(2012-12#1)(2012-3#1)
between redox##2##2##(2008-10#2)
between regions##7##2##(1990-8#1)(2008-10#4)(2008-6#1)(2013-8#1)
between related##2##2##(2008-10#2)
between relative##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
between relatives##8##2##(1997-7#1)(2008-9#2)(2009-10#3)(2012-3#2)
between religion and##6##3##(2009-11#4)(2009-6#2)
between reproductive##2##2##(2008-8#1)(2008-9#1)
between research and practice##7##4##(2010-10#5)(2013-1#2)
between research and##9##3##(1992-12#1)(2010-10#5)(2010-4#1)(2013-1#2)
between research##10##2##(1992-12#1)(2008-8#1)(2010-10#5)(2010-4#1)(2013-1#2)
between researchers and##3##3##(1997-3#1)(2010-10#1)(2010-4#1)
between researchers##4##2##(1997-3#1)(2010-10#2)(2010-4#1)
between resident##2##2##(2008-10#1)(2008-8#1)
between residues##3##2##(1992-4#2)(2008-11#1)
between resistance to##3##3##(2008-10#2)(2008-8#1)
between resistant and susceptible##4##4##(2008-10#4)
between resistant##6##2##(2008-10#6)
between response##2##2##(2008-10#1)(2010-1#1)
between results obtained by the proposed method and##2##8##(2008-10#2)
between results obtained by the##4##5##(2008-10#4)
between results obtained by##5##4##(2008-10#5)
between results obtained##7##3##(2008-10#6)(2008-5#1)
between results of##2##3##(2008-10#2)
between results##12##2##(2008-10#11)(2008-5#1)
between rice and Arabidopsis##2##4##(2009-10#2)
between rice and##3##3##(2008-8#1)(2009-10#2)
between salicylic acid##2##3##(2008-10#1)(2009-8#1)
between samples##5##2##(2008-10#5)
between sampling##3##2##(2008-10#3)
between satellites and floaters##2##4##(2008-8#2)
between science and##2##3##(2008-11#1)(2013-1#1)
between screen-based sedentary behavior and##2##5##(2013-1#2)
between screen-based##3##2##(2013-1#3)
between seasons##2##2##(2008-10#2)
between secondary##2##2##(2008-4#1)(2008-8#1)
between segments##2##2##(2008-12#1)(2012-3#1)
between sensitive##3##2##(2008-10#3)
between sensitivity and##2##3##(2008-10#1)(2011-2#1)
between sequence##2##2##(2008-9#1)(2011-2#1)
between sequences##3##2##(1996-6#1)(2008-6#2)
between serotonergic##2##2##(2008-5#1)(2008-7#1)
between serum 25-hydroxyvitamin D##2##4##(2011-2#2)
between serum##6##2##(1991-12#1)(2006-6#1)(2011-1#1)(2011-2#3)
between service##2##2##(1996-12#1)(2008-12#1)
between several##7##2##(1990-5#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-4#1)
between sex##2##2##(1991-6#1)(2008-10#1)
between sexes##4##2##(2008-12#1)(2008-8#2)(2010-5#1)
between sexting##4##2##(2013-1#4)
between sexual##5##2##(2008-9#1)(2009-10#1)(2009-5#2)(2012-3#1)
between shyness and social phobia##2##5##(2008-4#2)
between siblings##3##2##(1997-7#1)(2008-8#1)(2008-9#1)
between sides##2##2##(2010-9#1)(2013-1#1)
between signal##2##2##(2008-8#1)(2009-8#1)
between signals##2##2##(2008-8#2)
between simple##2##2##(1994-9#1)(2010-1#1)
between single##3##2##(2008-10#2)(2008-4#1)
between sites##5##2##(2008-10#3)(2008-8#2)
between size at maturity and asymptotic size##4##7##(2008-9#4)
between size##6##2##(1994-11#1)(2008-3#1)(2008-9#4)
between skin and the nervous system##3##6##(2008-5#3)
between skin and##4##3##(2008-5#4)
between small##2##2##(1994-5#1)(2010-8#1)
between smoking##3##2##(1996-3#1)(2013-1#2)
between social support and##3##4##(1992-3#1)(2009-7#1)(2013-8#1)
between social##7##2##(1992-12#1)(1992-3#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-8#2)
between socioeconomic##2##2##(2008-12#1)(2011-1#1)
between soil and##2##3##(2008-10#2)
between soil##4##2##(2008-10#4)
between solute and##2##3##(2008-10#2)
between some of the##2##4##(1990-5#1)(2008-10#1)
between some##4##2##(1990-5#1)(2008-10#2)(2011-2#1)
between southern and northern##2##4##(2008-8#2)
between spatially##4##2##(1992-4#1)(1996-2#1)(2008-9#1)(2010-3#1)
between species and##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)
between species is##2##3##(2008-8#1)(2009-6#1)
between species or##2##3##(2008-8#2)
between species richness##2##3##(2008-8#2)
between species##30##2##(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#10)(2008-9#1)(2009-6#1)(2011-2#3)(2011-3#1)(2012-3#5)(2012-5#1)
between specific##2##2##(2009-6#1)(2011-2#1)
between sperm##2##2##(2008-8#2)
between spontaneous##3##2##(2008-11#1)(2013-8#2)
between spores##2##2##(2008-10#1)(2011-2#1)
between states##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
between sterile and fertile##2##4##(2008-8#2)
between strains from##2##3##(2008-10#2)
between strains of different##2##4##(2008-10#2)
between strains of##4##3##(2008-10#4)
between strains##8##2##(2008-10#7)(2008-5#1)
between stress and##3##3##(2008-7#1)(2009-7#1)(2009-8#1)
between stress##5##2##(1992-3#1)(2008-7#2)(2009-7#1)(2009-8#1)
between structural##2##2##(1992-4#1)(2008-11#1)
between structure and##5##3##(1992-6#1)(2008-10#1)(2009-5#2)(2012-2#1)
between structure##6##2##(1992-6#1)(2008-10#2)(2009-5#2)(2012-2#1)
between students'##2##2##(2008-12#1)(2009-7#1)
between subjects with##2##3##(1995-8#1)(2008-7#1)
between subpopulations##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2013-1#1)
between substrate##2##2##(1993-8#1)(1994-5#1)
between support##2##2##(1992-3#1)(2008-12#1)
between surface##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
between survival and##2##3##(2008-10#1)(2008-8#1)
between survival of##2##3##(2008-10#1)(2012-3#1)
between survival##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
between surviving and##2##3##(1994-12#1)(2009-6#1)
between susceptible and resistant cultivars##2##5##(2008-10#2)
between susceptible and resistant##3##4##(2008-10#3)
between susceptible##4##2##(2008-10#4)
between symptoms##2##2##(2008-7#1)(2010-2#1)
between technical##3##2##(1992-1#1)(1993-1#1)(2010-10#1)
between temperate##2##2##(2008-10#1)(2012-3#1)
between the 1##2##3##(2008-10#1)(2008-3#1)
between the 2 groups##4##4##(1991-11#2)(2012-3#1)(2013-1#1)
between the 2##6##3##(1991-11#2)(2008-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
between the 5S and 18S genes##2##6##(2008-10#2)
between the A and##2##4##(1997-7#1)(2008-10#1)
between the Ab production efficiency and the##2##7##(2008-11#2)
between the CA##2##3##(1995-11#1)(1995-3#1)
between the CER3 and PA-d(31)##3##5##(2008-10#3)
between the IVB and the IVB/IVT groups (p = 0##2##10##(2011-2#2)
between the Indiana##2##3##(2008-10#2)
between the LV and RV##2##5##(2008-10#2)
between the MPUT and parameters of grip force control##2##9##(2013-1#2)
between the N-terminal##2##3##(1994-5#1)(2008-10#1)
between the PFC##3##3##(2013-8#3)
between the Rsa I genotype and the##2##7##(2008-8#2)
between the T##2##3##(2008-10#2)
between the TSK mutation and##2##5##(1997-8#2)
between the US-1 and US-8##2##5##(2008-10#2)
between the X##2##3##(2008-10#1)(2008-8#1)
between the ability of##2##4##(1996-3#1)(2008-10#1)
between the ability##3##3##(1996-3#1)(2008-10#1)(2011-2#1)
between the absorbance##3##3##(2008-10#3)
between the age of##2##4##(1991-11#1)(1991-3#1)
between the age##5##3##(1991-11#1)(1991-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
between the ages of##4##4##(1990-2#1)(1995-12#1)(2008-9#1)(2012-2#1)
between the alpha- and beta-conformations of fac-Re(CO)(3)(dpknph)Cl##3##7##(2008-10#3)
between the alpha- and##4##4##(1995-3#1)(2008-10#3)
between the amount of##4##4##(1994-3#1)(2008-10#3)
between the analyte and the##2##5##(2008-10#1)(2010-7#1)
between the analyte and##4##4##(2008-10#3)(2010-7#1)
between the analyte##6##3##(2008-10#5)(2010-7#1)
between the antagonist and##2##4##(2008-10#2)
between the average##2##3##(2008-10#2)
between the binding##2##3##(1996-2#1)(1996-5#1)
between the biological##2##3##(1995-2#1)(2008-9#1)
between the bone##2##3##(1991-11#1)(2011-2#1)
between the cells and##2##4##(2008-11#1)(2008-7#1)
between the cells of the##2##5##(2008-10#1)(2008-11#1)
between the cells##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
between the certified##3##3##(2008-10#3)
between the change in##2##4##(1995-8#1)(2008-10#1)
between the characteristic##2##3##(2010-10#1)(2013-8#1)
between the child's##3##3##(1993-2#2)(2008-12#1)
between the circadian clock and##2##5##(2009-8#2)
between the clinical##4##3##(1994-6#1)(1995-5#1)(2008-1#1)(2012-12#1)
between the clusters##2##3##(2008-10#1)(2008-6#1)
between the concentration of##7##4##(2008-10#6)(2008-8#1)
between the concentrations##2##3##(1992-11#1)(2008-10#1)
between the control and##2##4##(2008-2#1)(2011-3#1)
between the core##2##3##(2008-11#1)(2008-3#1)
between the cytoplasm and the nucleus##2##6##(2011-2#2)
between the daily##2##3##(2008-11#1)(2012-2#1)
between the data##2##3##(2008-10#1)(2008-6#1)
between the degree of##9##4##(1990-2#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
between the development of##2##4##(2010-1#1)(2013-1#1)
between the diagnosis##2##3##(2011-2#1)(2012-12#1)
between the different##10##3##(1990-9#1)(1992-9#1)(1994-12#1)(1994-2#1)(2008-10#3)(2008-11#1)(2009-5#1)(2012-3#1)
between the distribution of##3##4##(1992-2#1)(2008-10#2)
between the drug and##2##4##(1994-5#1)(2008-10#1)
between the drug##4##3##(1994-5#1)(2008-10#3)
between the duct##2##3##(2007-12#2)
between the dysthymic group and major depression group##2##8##(2011-2#2)
between the education##2##3##(2008-11#2)
between the effect of##2##4##(2008-10#1)(2010-11#1)
between the effects of##4##4##(1993-6#1)(1995-5#1)(2008-11#1)(2012-3#1)
between the electrode and##2##4##(2008-10#1)(2008-12#1)
between the electrode##3##3##(2008-10#2)(2008-12#1)
between the estimation and production trials##2##6##(2013-8#2)
between the estimation and production##3##5##(2013-8#3)
between the expected##2##3##(2008-10#2)
between the expression of##3##4##(1990-12#1)(2011-3#2)
between the extracellular##2##3##(1993-2#1)(2008-10#1)
between the films##2##3##(2008-10#2)
between the first and second##4##5##(1995-5#1)(1995-8#1)(2008-10#1)(2011-2#1)
between the first##5##3##(1995-5#1)(1995-8#1)(2008-10#2)(2011-2#1)
between the fluorescence intensity and##2##5##(2008-10#2)
between the fluorescence##4##3##(2008-10#4)
between the four##2##3##(2008-10#1)(2008-7#1)
between the fraction of##2##4##(2008-10#2)
between the frequency of social support##2##6##(2009-7#2)
between the frequency of##4##4##(2009-7#2)(2013-1#2)
between the frequency##6##3##(2007-12#1)(2008-10#1)(2009-7#2)(2013-1#2)
between the functional##2##3##(1993-12#1)(2008-10#1)
between the fungal##2##3##(2008-10#1)(2011-10#1)
between the genetic variation and##2##5##(2010-1#1)(2013-8#1)
between the genetic##4##3##(2008-10#1)(2010-1#1)(2011-2#1)(2013-8#1)
between the group of patients##2##5##(1992-12#1)(2011-2#1)
between the group of##3##4##(1992-12#1)(2010-6#1)(2011-2#1)
between the groups##14##3##(1991-2#1)(1995-1#1)(1997-7#2)(2008-3#1)(2008-7#2)(2009-12#1)(2010-7#1)(2011-2#4)(2012-3#1)
between the health service##2##4##(1997-8#1)(2008-12#1)
between the health##4##3##(1992-2#1)(1997-8#1)(2008-1#1)(2008-12#1)
between the home##2##3##(1992-2#1)(1995-3#1)
between the hospitals##2##3##(1991-2#1)(1991-9#1)
between the host##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
between the immobilized##2##3##(2008-10#2)
between the in vitro and in vivo##2##7##(2008-5#1)(2009-12#1)
between the in vitro and in##3##6##(2008-5#1)(2009-12#2)
between the in vitro##4##4##(2008-5#2)(2009-12#2)
between the incidence##2##3##(2008-10#2)
between the increase in##3##4##(1994-5#1)(1996-12#1)(2008-10#1)
between the index##4##3##(1992-2#1)(1996-2#1)(2008-11#1)(2008-3#1)
between the intensity##3##3##(2008-10#2)(2008-3#1)
between the intracellular##2##3##(1996-5#1)(2008-11#1)
between the iol and hut operons##2##6##(1995-12#2)
between the latter##2##3##(2008-9#1)(2009-7#1)
between the left##4##3##(2010-3#2)(2011-2#2)
between the level of##6##4##(1992-2#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-1#1)(2013-8#1)
between the levels of##2##4##(1994-12#1)(2008-10#1)
between the logarithm of##2##4##(2008-10#2)
between the major##2##3##(2008-10#2)
between the male and female##3##5##(2008-11#1)(2008-12#1)(2008-8#1)
between the markers##4##3##(1995-6#1)(2008-11#1)(2009-2#2)
between the masticatory##2##3##(2010-9#1)(2012-12#1)
between the mean##3##3##(2008-10#1)(2008-3#2)
between the measured##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
between the measures##2##3##(2008-10#1)(2012-3#1)
between the medical##2##3##(1995-12#1)(2008-12#1)
between the metabolic##2##3##(2008-1#1)(2008-10#1)
between the metabolome and##2##4##(2009-8#1)(2012-5#1)
between the metal##3##3##(2008-10#3)
between the methods##4##3##(1992-5#1)(2008-10#3)
between the model and##2##4##(2008-7#1)(2011-2#1)
between the model##8##3##(1990-12#2)(1994-5#1)(2008-7#3)(2010-10#1)(2011-2#1)
between the muscle##2##3##(1995-12#1)(2010-12#1)
between the natural##2##3##(2008-10#1)(2008-11#1)
between the normal and the##2##5##(1995-12#1)(2009-8#1)
between the normal and##3##4##(1995-12#1)(2008-5#1)(2009-8#1)
between the normal##4##3##(1995-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
between the number of pops and##2##6##(2008-12#2)
between the number of##10##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#1)(2011-2#1)(2013-8#1)
between the nursing##2##3##(2008-11#2)
between the observed and##2##4##(2008-10#1)(2008-8#1)
between the observed##3##3##(2008-10#2)(2008-8#1)
between the obtained results and##2##5##(2008-10#2)
between the olfactory bulb and the piriform cortex##2##8##(2013-1#2)
between the onset of symptoms and diagnosis##2##7##(2012-12#2)
between the onset of symptoms and##4##6##(2012-12#4)
between the onset of##5##4##(2008-7#1)(2012-12#4)
between the organic##2##3##(2008-10#1)(2010-4#1)
between the original##2##3##(2008-10#1)(2013-8#1)
between the parents##2##3##(1990-12#1)(2008-10#1)
between the peak area of##2##5##(2008-10#2)
between the peak area##3##4##(2008-10#3)
between the peak##7##3##(2008-10#7)
between the performance of##2##4##(2008-10#1)(2008-9#1)
between the phylogenetic##2##3##(2011-2#1)(2012-3#1)
between the plasma##3##3##(1992-11#1)(2008-9#1)(2009-9#1)
between the populations##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
between the potential change (peak height) and the##2##8##(2008-10#2)
between the potential##3##3##(2008-10#3)
between the predicted and##2##4##(2008-10#2)
between the predicted##4##3##(1991-5#1)(2008-10#3)
between the presence of##2##4##(2008-10#1)(2011-2#1)
between the probe and##2##4##(2008-10#1)(2008-3#1)
between the proportion of##2##4##(2008-11#1)(2009-5#1)
between the proposed method and the##2##6##(2008-10#2)
between the proposed method and##3##5##(2008-10#3)
between the proposed##8##3##(2008-10#8)
between the protein and the##2##5##(1994-3#1)(1997-2#1)
between the rate of##3##4##(2008-7#1)(2008-8#1)(2010-4#1)
between the ratio of##3##4##(2008-10#3)
between the receptor##2##3##(2008-7#2)
between the redox##2##3##(2008-10#1)(2008-9#1)
between the relative##5##3##(1994-8#1)(2008-10#3)(2008-11#1)
between the resistance and##2##4##(2008-10#2)
between the resistance##3##3##(2008-10#3)
between the resistant##7##3##(2008-10#7)
between the responses##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
between the results obtained by the proposed method and##2##9##(2008-10#2)
between the results obtained by the proposed##3##7##(2008-10#3)
between the results obtained by the##5##6##(2008-10#5)
between the results obtained by##6##5##(2008-10#6)
between the results obtained in##2##5##(2008-10#2)
between the results obtained##9##4##(2008-10#9)
between the results of##3##4##(1995-5#1)(2008-10#1)(2013-1#1)
between the results##15##3##(1995-5#1)(2008-10#13)(2013-1#1)
between the risk##3##3##(1991-6#1)(2009-7#1)(2013-8#1)
between the sample##2##3##(2008-10#1)(2008-3#1)
between the second##2##3##(1997-3#1)(2009-7#1)
between the sensor##2##3##(2008-10#2)
between the separation##3##3##(2008-10#3)
between the services##2##3##(2012-3#2)
between the severity of##3##4##(1993-8#1)(2008-11#1)(2011-2#1)
between the sexes##5##3##(2008-7#1)(2008-8#2)(2012-3#1)(2013-8#1)
between the shape of##2##4##(1991-2#1)(2008-8#1)
between the signal and the##2##5##(2008-10#1)(2008-2#1)
between the signal sequence and##2##5##(1991-6#1)(2008-11#1)
between the signal##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-2#1)
between the site of##2##4##(1991-6#2)
between the sixth and seventh##2##5##(1995-8#1)(2007-12#1)
between the spatial##3##3##(2008-10#2)(2013-8#1)
between the species##6##3##(2008-10#2)(2008-8#3)(2012-3#1)
between the spectral##2##3##(2008-10#1)(2008-3#1)
between the strains##2##3##(2008-10#2)
between the structural##2##3##(1997-6#1)(2008-10#1)
between the structure of the##3##5##(1993-8#1)(2008-10#2)
between the structure of##4##4##(1993-8#1)(2008-10#2)(2008-4#1)
between the structure##5##3##(1993-8#1)(2008-10#2)(2008-4#1)(2008-8#1)
between the three groups##2##4##(1997-3#1)(2008-5#1)
between the three syndromic groups##2##5##(2009-10#2)
between the three##10##3##(1992-4#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#2)(2011-2#1)(2013-8#1)
between the time##3##3##(1991-12#1)(1993-3#1)(2008-11#1)
between the total##2##3##(1991-5#1)(2008-10#1)
between the transmitted##2##3##(2008-3#2)
between the treatments##2##3##(2008-10#1)(2008-8#1)
between the two cell lines##3##5##(2008-11#1)(2008-9#2)
between the two cell##4##4##(1993-3#1)(2008-11#1)(2008-9#2)
between the two cyanine subunits##2##5##(2008-10#2)
between the two extremes##2##4##(2008-10#1)(2008-9#1)
between the two fungi likely##2##5##(2008-10#2)
between the two groups at##2##5##(2011-2#1)(2013-1#1)
between the two groups of##4##5##(2008-10#3)(2008-7#1)
between the two groups##29##4##(1990-2#1)(1991-11#1)(1992-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#4)
between the two host-adapted populations##2##5##(2008-10#2)
between the two major##3##4##(1995-8#1)(2008-10#1)(2009-6#1)
between the two methods of analysis##2##6##(2008-10#2)
between the two methods were##2##5##(2008-10#2)
between the two methods##11##4##(1992-12#1)(2008-10#10)
between the two populations##2##4##(2008-10#2)
between the two proteins##6##4##(1991-9#2)(1993-8#1)(2008-2#1)(2009-10#1)(2012-2#1)
between the two receptor##2##4##(1993-6#1)(2008-11#1)
between the two samples##2##4##(2008-10#1)(2010-1#1)
between the two species in##3##5##(1991-6#1)(2008-8#2)
between the two species##9##4##(1991-6#2)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#2)
between the two strains##2##4##(2008-10#2)
between the two subunits##2##4##(1992-6#1)(2010-5#1)
between the two techniques##2##4##(1995-5#1)(2008-8#1)
between the two treatment##2##4##(1992-9#1)(1997-7#1)
between the two types of##3##5##(1993-1#1)(1993-8#1)(2013-8#1)
between the two##188##3##(1990-2#1)(1990-6#1)(1991-11#1)(1991-3#2)(1991-6#4)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#3)(1993-12#2)(1993-3#2)(1993-6#3)(1993-8#4)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#62)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#2)(2010-8#4)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#3)
between the upper and lower##2##5##(2008-10#1)(2012-12#1)
between the upper and##3##4##(2008-10#2)(2012-12#1)
between the use of##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
between the variables##3##3##(2008-10#3)
between the various##6##3##(2008-10#2)(2008-3#1)(2009-1#1)(2010-6#1)(2013-1#1)
between the years##3##3##(1997-2#1)(2008-11#1)(2013-1#1)
between the##1446##2##(1990-11#3)(1990-12#4)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#4)(1990-9#3)(1991-11#7)(1991-12#2)(1991-2#9)(1991-3#4)(1991-5#7)(1991-6#12)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#8)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#3)(1992-9#5)(1993-1#5)(1993-12#11)(1993-2#7)(1993-3#7)(1993-6#7)(1993-8#9)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#12)(1994-6#4)(1994-8#6)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#8)(1995-2#4)(1995-3#5)(1995-5#7)(1995-6#3)(1995-8#9)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#7)(1996-2#6)(1996-3#2)(1996-5#3)(1996-6#4)(1997-1#2)(1997-2#6)(1997-3#8)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#9)(1997-9#2)(2007-11#1)(2007-12#11)(2007-8#1)(2008-1#5)(2008-10#506)(2008-11#73)(2008-12#23)(2008-2#10)(2008-3#48)(2008-4#6)(2008-5#29)(2008-6#18)(2008-7#37)(2008-8#49)(2008-9#40)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#5)(2009-2#2)(2009-3#3)(2009-5#6)(2009-6#2)(2009-7#11)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#6)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#8)(2010-5#4)(2010-6#4)(2010-7#6)(2010-8#10)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#56)(2011-3#4)(2011-4#1)(2012-12#17)(2012-2#15)(2012-3#27)(2012-5#2)(2012-9#1)(2013-1#31)(2013-7#1)(2013-8#32)
between their##13##2##(1993-1#1)(1993-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#1)(2009-7#1)(2013-1#1)(2013-8#1)
between them and##2##3##(1991-12#1)(2008-12#1)
between them was##2##3##(1994-11#1)(2008-8#1)
between them##25##2##(1991-12#1)(1991-3#1)(1993-2#1)(1994-11#1)(1994-8#1)(1996-5#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#5)(2009-11#1)(2009-8#1)(2012-3#1)
between theory and experiment##2##4##(2007-11#1)(2008-5#1)
between theory and practice##2##4##(1997-3#1)(2008-11#1)
between theory and##4##3##(1997-3#1)(2007-11#1)(2008-11#1)(2008-5#1)
between theory##5##2##(1997-3#1)(2007-11#1)(2008-11#2)(2008-5#1)
between these factors##3##3##(1991-11#1)(2008-7#1)(2013-8#1)
between these fungi##2##3##(2008-10#2)
between these groups##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
between these parameters##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
between these possibilities##2##3##(1994-5#1)(2009-8#1)
between these species##2##3##(2008-10#2)
between these two groups##3##4##(1990-2#1)(2008-1#1)(2008-8#1)
between these two methods##3##4##(2008-10#3)
between these two##33##3##(1990-2#1)(1996-5#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
between these variables##2##3##(2008-10#1)(2009-8#1)
between these##90##2##(1990-2#1)(1991-11#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#3)(1995-5#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#27)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#4)(2010-10#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#3)
between this polymorphism and##2##4##(2008-12#1)(2008-6#1)
between this##15##2##(1991-2#1)(1993-6#1)(1995-1#1)(1995-3#1)(2008-10#6)(2008-12#1)(2008-6#1)(2012-12#1)(2013-1#2)
between those of##2##3##(1994-5#1)(2008-5#1)
between those##13##2##(1991-6#1)(1994-2#1)(1994-5#1)(1996-2#1)(2008-10#4)(2008-5#2)(2008-9#1)(2012-12#1)(2013-1#1)
between three##3##2##(2008-10#2)(2012-3#1)
between tight##2##2##(2009-10#2)
between today's##2##2##(1993-3#2)
between total##4##2##(1992-12#1)(2008-10#3)
between training and##2##3##(1993-2#1)(2009-3#1)
between training##3##2##(1993-2#1)(1996-3#1)(2009-3#1)
between traits##4##2##(2008-8#1)(2012-3#3)
between transdermal and oral granisetron##3##5##(2010-12#3)
between transgenic and##2##3##(2008-10#1)(2008-12#1)
between transgenic##3##2##(2008-10#2)(2008-12#1)
between treated and##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
between treatment and##2##3##(1993-9#1)(2012-3#1)
between treatment groups##5##3##(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)
between treatment##9##2##(1993-9#1)(2008-11#1)(2010-4#1)(2012-12#2)(2012-2#2)(2012-3#2)
between treatments##7##2##(1993-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-9#1)(2012-12#1)
between trials##4##2##(2008-10#1)(2010-11#2)(2013-8#1)
between true and##2##3##(2008-10#2)
between true##3##2##(2008-10#2)(2008-11#1)
between tumor##2##2##(2011-2#1)(2013-8#1)
between twins##2##2##(1997-7#1)(2008-12#1)
between two Drosophila species##2##4##(2008-9#2)
between two adjacent##2##3##(1994-5#1)(2008-10#1)
between two and##2##3##(1992-9#1)(2008-2#1)
between two consecutive##2##3##(2008-10#1)(2008-7#1)
between two groups##2##3##(2011-2#1)(2012-3#1)
between two sibling##2##3##(1996-6#1)(2008-9#1)
between two##80##2##(1990-11#1)(1991-12#2)(1991-5#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#3)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#22)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#5)(2009-8#1)(2009-9#2)(2010-12#1)(2011-2#2)(2012-3#4)(2013-8#2)
between types of##3##3##(1992-12#1)(1992-3#1)(1995-2#1)
between types##4##2##(1992-12#1)(1992-3#1)(1994-12#1)(1995-2#1)
between unrelated individuals##2##3##(2008-8#1)(2012-3#1)
between up and down##2##4##(2008-11#2)
between urea##2##2##(1995-3#1)(2009-8#1)
between using 1##2##3##(1993-3#2)
between using##5##2##(1993-3#2)(2008-9#1)(2009-8#1)(2011-2#1)
between values##2##2##(2008-10#1)(2008-8#1)
between variables##2##2##(2008-10#2)
between various##8##2##(1990-6#1)(1996-2#1)(2008-10#2)(2008-3#1)(2010-10#1)(2010-8#1)(2011-2#1)
between vascular##2##2##(2006-6#1)(2008-12#1)
between viable##2##2##(2008-10#1)(2008-9#1)
between villous height and the##2##5##(2013-1#2)
between viral and##2##3##(2008-10#1)(2011-3#1)
between viral##3##2##(1997-1#1)(2008-10#1)(2011-3#1)
between virulence and##2##3##(2008-10#2)
between virulence##3##2##(2008-10#3)
between viruses##2##2##(2008-10#2)
between visual##4##2##(1996-2#1)(2008-5#2)(2008-8#1)
between water##2##2##(2008-10#2)
between weather##2##2##(2008-10#2)
between weight-related beliefs and consumption of##2##6##(2011-2#2)
between what##4##2##(1991-1#1)(1991-3#1)(1996-3#1)(2010-10#1)
between wheat##4##2##(1993-11#1)(2008-10#1)(2008-9#1)(2009-12#1)
between whole##2##2##(2008-10#1)(2010-1#1)
between wild##2##2##(2008-10#1)(2008-12#1)
between working conditions and##2##4##(1992-5#2)
between years##12##2##(2008-10#11)(2012-3#1)
between young##3##2##(2008-10#1)(2008-7#2)
between younger and older##2##4##(2008-5#1)(2013-8#1)
between yttrium and##3##3##(2008-10#3)
between##6280##1##(1990-11#7)(1990-12#21)(1990-2#14)(1990-3#7)(1990-4#3)(1990-5#21)(1990-6#11)(1990-7#2)(1990-8#23)(1990-9#8)(1991-1#8)(1991-11#17)(1991-12#23)(1991-2#26)(1991-3#23)(1991-5#22)(1991-6#21)(1991-8#8)(1991-9#7)(1992-1#8)(1992-10#1)(1992-11#5)(1992-12#27)(1992-2#20)(1992-3#17)(1992-4#11)(1992-5#4)(1992-6#8)(1992-7#1)(1992-8#2)(1992-9#22)(1993-1#19)(1993-11#10)(1993-12#27)(1993-2#30)(1993-3#23)(1993-5#1)(1993-6#17)(1993-8#31)(1993-9#7)(1994-1#11)(1994-11#16)(1994-12#22)(1994-2#20)(1994-3#19)(1994-5#39)(1994-6#16)(1994-8#19)(1994-9#11)(1995-1#8)(1995-10#1)(1995-11#17)(1995-12#32)(1995-2#33)(1995-3#20)(1995-5#19)(1995-6#13)(1995-8#24)(1995-9#7)(1996-1#12)(1996-10#1)(1996-11#11)(1996-12#36)(1996-2#31)(1996-3#24)(1996-5#12)(1996-6#13)(1996-8#3)(1996-9#4)(1997-1#16)(1997-2#21)(1997-3#27)(1997-4#8)(1997-5#6)(1997-6#8)(1997-7#18)(1997-8#21)(1997-9#6)(2006-6#8)(2007-11#6)(2007-12#22)(2007-8#4)(2008-1#27)(2008-10#2139)(2008-11#313)(2008-12#115)(2008-2#26)(2008-3#108)(2008-4#34)(2008-5#124)(2008-6#38)(2008-7#150)(2008-8#287)(2008-9#216)(2009-1#6)(2009-10#58)(2009-11#16)(2009-12#18)(2009-2#4)(2009-3#16)(2009-4#9)(2009-5#19)(2009-6#21)(2009-7#45)(2009-8#57)(2009-9#10)(2010-1#31)(2010-10#46)(2010-11#19)(2010-12#35)(2010-2#12)(2010-3#14)(2010-4#18)(2010-5#14)(2010-6#15)(2010-7#23)(2010-8#33)(2010-9#10)(2011-1#23)(2011-10#7)(2011-2#248)(2011-3#13)(2011-4#1)(2012-12#57)(2012-2#96)(2012-3#133)(2012-4#5)(2012-5#8)(2012-6#2)(2012-8#1)(2012-9#4)(2013-1#200)(2013-7#6)(2013-8#122)
between-day##7##1##(1991-2#1)(1992-11#1)(2008-10#5)
between-group difference in##2##3##(2008-12#1)(2011-2#1)
between-group##4##1##(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)
between-study##3##1##(2008-10#2)(2013-1#1)
bevacizumab injection##2##2##(2011-2#2)
bevacizumab##9##1##(2010-10#1)(2011-2#4)(2011-3#1)(2013-1#2)(2013-8#1)
beverage samples##2##2##(2008-10#2)
beverage##14##1##(1995-2#1)(2008-1#1)(2008-10#7)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)
beverages (SSB)##2##2##(2011-2#1)(2012-2#1)
beverages and##4##2##(1997-1#1)(2008-10#2)(2011-2#1)
beverages by##4##2##(2008-10#4)
beverages such as##3##3##(2008-10#2)(2012-12#1)
beverages using##3##2##(2008-10#3)
beverages were##2##2##(2008-10#1)(2010-9#1)
beverages with##3##2##(2008-10#2)(2012-2#1)
beverages##51##1##(1991-9#1)(1997-1#3)(2008-10#30)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#4)(2013-1#1)
beyond 2##2##2##(2008-11#1)(2008-8#1)
beyond 5##2##2##(1991-11#1)(2012-12#1)
beyond a##2##2##(1997-1#1)(2008-10#1)
beyond any reported##2##3##(1993-12#1)(1993-6#1)
beyond the scope of##3##4##(1996-12#1)(1997-3#1)(2008-9#1)
beyond the site of##3##4##(1992-3#3)
beyond the year 2000##2##4##(1997-3#2)
beyond the##51##2##(1991-6#1)(1992-12#1)(1992-3#3)(1993-12#3)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#3)(1997-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
beyond this##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
beyond those##3##2##(1994-5#1)(2008-9#2)
beyond what is##2##3##(1994-1#1)(2008-11#1)
beyond##128##1##(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#5)(1993-12#4)(1993-2#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-2#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-6#1)(2008-1#1)(2008-10#12)(2008-11#12)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#2)(2009-5#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#4)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
bezafibrate##2##1##(1991-2#2)
bg/bg-nu/+ mice##3##2##(2008-5#3)
bg/bg-nu/nu mice##3##2##(2008-5#3)
bg/bg-nu/nu##4##1##(2008-5#4)
bgq60 structural gene##2##3##(1995-6#2)
bi- and triantennary complex-type##2##4##(1994-5#2)
bi- and triantennary##3##3##(1994-5#2)(2008-8#1)
bi- and##6##2##(1994-5#2)(2008-10#3)(2008-8#1)
bi- or##2##2##(2008-10#1)(2013-1#1)
bi-##8##1##(1994-5#2)(2008-10#4)(2008-8#1)(2013-1#1)
bi-directional sex-changing##2##2##(2010-8#2)
bi-directional##7##1##(1993-8#1)(2008-10#1)(2009-3#2)(2010-8#2)(2011-2#1)
bi-enzymatic##2##1##(2008-10#2)
bi-phasic##3##1##(1994-8#1)(2008-11#1)(2013-8#1)
biamperometric end-point detection##2##3##(2008-10#2)
biamperometric##5##1##(2008-10#5)
bias across##2##2##(2008-11#1)(2009-5#1)
bias and the##2##3##(1995-12#1)(2008-3#1)
bias and##14##2##(1992-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#3)
bias can##2##2##(1995-12#1)(2013-1#1)
bias caused by environmental covariances##2##5##(2008-8#2)
bias caused by##3##3##(2008-10#1)(2008-8#2)
bias current##2##2##(2008-3#2)
bias during##2##2##(1993-3#1)(2008-10#1)
bias error##4##2##(2008-10#4)
bias for##2##2##(1995-5#1)(2008-11#1)
bias in phenotypic estimates of selection##2##6##(2008-8#2)
bias in phenotypic estimates of##3##5##(2008-8#3)
bias in the##11##3##(1992-2#1)(1995-8#1)(1996-3#1)(2008-10#5)(2008-12#1)(2013-1#2)
bias in##25##2##(1992-2#2)(1995-2#1)(1995-8#1)(1996-3#2)(2008-10#5)(2008-12#1)(2008-8#5)(2010-7#2)(2010-9#1)(2012-3#1)(2013-1#2)(2013-8#2)
bias is##5##2##(1995-12#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
bias than##2##2##(1993-12#1)(2008-11#1)
bias that##3##2##(1995-5#1)(2008-9#1)(2013-1#1)
bias to##2##2##(1996-2#1)(2012-3#1)
bias was##4##2##(1996-2#1)(2008-10#1)(2008-12#1)(2009-1#1)
bias were##2##2##(2008-10#1)(2010-7#1)
bias##142##1##(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#1)(1992-2#3)(1992-9#2)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-12#4)(1995-2#2)(1995-5#4)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#4)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#32)(2008-11#11)(2008-12#4)(2008-3#4)(2008-7#2)(2008-8#18)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-7#5)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#5)(2013-8#5)
biased about their health)##2##4##(2008-4#2)
biased and##2##2##(1993-12#1)(1995-12#1)
biased by##2##2##(2008-8#1)(2010-3#1)
biased in favour of##2##4##(1991-2#1)(2010-3#1)
biased random walk##2##3##(2008-9#1)(2013-8#1)
biased to##2##2##(1992-3#1)(2008-10#1)
biased##32##1##(1991-2#1)(1992-3#1)(1993-12#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#4)(2008-9#1)(2009-10#3)(2010-3#3)(2010-8#1)(2011-2#1)(2013-8#1)
biases and##4##2##(1994-2#1)(2008-10#1)(2008-12#1)(2008-3#1)
biases in##4##2##(1997-3#1)(2008-11#1)(2010-8#1)(2011-2#1)
biases##25##1##(1991-2#1)(1994-2#1)(1994-8#1)(1997-3#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#4)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
biasing##2##1##(2008-8#2)
bibliographic database##2##2##(1991-12#1)(1992-12#1)
bibliographic##11##1##(1991-12#1)(1992-1#1)(1992-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-2#1)(2012-3#4)
bibliography##6##1##(1992-1#1)(2008-10#2)(2009-6#1)(2011-2#1)(2013-1#1)
bibliometric##2##1##(1996-11#1)(2010-12#1)
bicarbonate and##3##2##(2008-10#3)
bicarbonate buffer##4##2##(2008-10#1)(2008-11#3)
bicarbonate##14##1##(1991-1#1)(1994-3#1)(2008-10#4)(2008-11#5)(2011-1#2)(2013-8#1)
bicellular##2##1##(2007-12#1)(2008-10#1)
biceps brachii##2##2##(2008-12#1)(2009-1#1)
biceps##5##1##(1990-8#1)(2008-10#1)(2008-12#1)(2009-1#1)(2010-8#1)
bichromatic##2##1##(2007-12#2)
bicine ligands##2##2##(2008-10#2)
bicistronic expression vectors##2##3##(2008-11#2)
bicistronic expression##3##2##(2008-11#3)
bicistronic##4##1##(2008-11#4)
bicoid##2##1##(1994-12#2)
bicolor##11##1##(1993-3#1)(1994-5#1)(2008-10#4)(2009-10#1)(2011-1#4)
bicornuate uterus##3##2##(2013-1#3)
bicuculline (0##2##2##(1992-3#1)(1997-2#1)
bicuculline but not##2##3##(2008-8#2)
bicuculline##11##1##(1992-3#1)(1993-3#1)(1997-2#3)(2008-7#2)(2008-8#3)(2008-9#1)
bicycle##4##1##(1996-1#1)(2009-3#1)(2010-12#1)(2011-2#1)
bicyclic##2##1##(1996-5#1)(2010-7#1)
bicyclo[3##3##1##(1996-5#3)
bidding##3##1##(1992-11#1)(2008-10#1)(2008-9#1)
bidentate##3##1##(2008-10#2)(2012-2#1)
bidirectional reflectance distribution function (BRDF)##2##5##(2008-3#2)
bidirectional reflectance distribution function##3##4##(2008-3#3)
bidirectional##18##1##(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#3)(2012-3#1)
biennial breast cancer screening##2##4##(2012-12#2)
biennial##5##1##(2008-10#1)(2008-5#1)(2012-12#3)
bienzyme biosensor##2##2##(2008-10#2)
bienzyme electrode##2##2##(2008-10#2)
bienzyme##5##1##(2008-10#5)
bienzymic##2##1##(2008-10#2)
biexponential##3##1##(1991-5#1)(1996-2#1)(2008-5#1)
bifid##5##1##(1997-3#2)(2008-10#2)(2012-3#1)
bifida##5##1##(1990-9#1)(1997-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
bifidobacteria##4##1##(2008-12#3)(2011-2#1)
biflavonoids##5##1##(2008-11#5)
biflexa##5##1##(2008-9#5)
bifunctional chelators have been##2##4##(2012-3#2)
bifunctional chelators##3##2##(2012-3#3)
bifunctional##17##1##(1990-8#2)(1994-11#1)(1994-8#1)(1997-2#3)(2008-10#4)(2008-4#1)(2011-1#1)(2012-3#4)
bifurcated fiber optic sensor and##2##5##(2008-10#2)
bifurcated optical fiber##3##3##(2008-10#2)(2008-7#1)
bifurcated##8##1##(2008-10#5)(2008-7#1)(2010-8#1)(2011-2#1)
bifurcation lesions##2##2##(2008-11#2)
bifurcation of##2##2##(1994-5#1)(2008-3#1)
bifurcation##23##1##(1990-8#1)(1994-2#1)(1994-5#1)(1995-3#1)(2008-11#2)(2008-12#4)(2008-3#1)(2008-8#3)(2008-9#1)(2009-8#3)(2010-10#1)(2013-1#1)(2013-8#3)
bifurcations##5##1##(1993-5#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#1)
big EDN3##2##2##(1994-12#2)
big PTTH##2##2##(1995-11#2)
big##33##1##(1991-2#1)(1992-8#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1997-2#1)(1997-8#2)(2008-10#3)(2008-11#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
big-vein disease##2##2##(2008-10#2)
big-vein symptoms##2##2##(2008-10#2)
big-vein##6##1##(2008-10#6)
bigger than##2##2##(2008-10#2)
bigger##15##1##(1991-12#1)(1994-3#2)(1995-12#1)(1997-5#1)(2008-10#5)(2008-7#1)(2009-10#2)(2010-10#1)(2011-2#1)
biggest##13##1##(1991-2#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
bilateral THA##2##2##(2009-3#2)
bilateral TKA##3##2##(2009-3#3)
bilateral adrenal masses##2##3##(2013-1#2)
bilateral adrenal##3##2##(2013-1#3)
bilateral and##2##2##(1992-5#2)
bilateral anterior##3##2##(2008-11#2)(2011-2#1)
bilateral basal ganglia##4##3##(2009-11#2)(2013-1#2)
bilateral breast##5##2##(1992-2#1)(1994-12#2)(2008-10#2)
bilateral cleft lip and palate##3##5##(2013-1#3)
bilateral cochlear implant recipients##2##4##(2008-9#1)(2012-2#1)
bilateral cochlear implant##3##3##(2008-9#2)(2012-2#1)
bilateral cochlear implantation##3##3##(2008-9#2)(2012-2#1)
bilateral cochlear implants##3##3##(2012-2#3)
bilateral cochlear##9##2##(2008-9#4)(2012-2#5)
bilateral destruction of##3##3##(1990-5#2)(1993-3#1)
bilateral diffuse##2##2##(2013-1#2)
bilateral disease##4##2##(1993-1#1)(2010-3#1)(2012-2#2)
bilateral ibotenic acid##2##3##(1990-5#1)(1994-3#1)
bilateral implantation##3##2##(2012-2#3)
bilateral increase in##2##3##(1990-9#2)
bilateral increase##3##2##(1990-9#2)(1994-8#1)
bilateral increases in##2##3##(2012-2#1)(2013-8#1)
bilateral increases##3##2##(1996-12#1)(2012-2#1)(2013-8#1)
bilateral lesions of the##4##4##(1990-5#1)(1993-3#1)(1993-6#1)(1994-3#1)
bilateral lesions of##6##3##(1990-5#1)(1993-3#1)(1993-6#1)(1994-3#1)(2008-7#2)
bilateral loculated pyopneumothorax##2##3##(2010-5#2)
bilateral oophorectomy##2##2##(2013-1#2)
bilateral or##2##2##(1991-11#1)(2008-12#1)
bilateral prolonged##2##2##(2012-3#2)
bilateral pulmonary##2##2##(2008-10#1)(2010-11#1)
bilateral renal##3##2##(2008-1#1)(2008-10#2)
bilateral shoulder pain##2##3##(2008-12#1)(2009-3#1)
bilateral swelling of##2##3##(2008-5#1)(2011-2#1)
bilateral symmetry##2##2##(2010-4#1)(2010-6#1)
bilateral testicular masses##2##3##(2008-10#2)
bilateral total##3##2##(2009-3#3)
bilateral visual cortex##2##3##(2008-7#1)(2013-8#1)
bilateral##218##1##(1990-3#1)(1990-5#6)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#4)(1992-9#1)(1993-1#2)(1993-3#3)(1993-6#2)(1994-12#5)(1994-3#5)(1994-8#2)(1995-2#1)(1996-12#1)(1996-2#4)(1996-6#1)(1997-3#1)(1997-6#3)(1997-8#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#4)(2008-5#6)(2008-7#13)(2008-8#3)(2008-9#7)(2009-11#2)(2009-3#10)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-2#9)(2011-3#2)(2012-12#3)(2012-2#20)(2012-3#7)(2013-1#28)(2013-8#10)
bilaterally in the##2##3##(1996-12#1)(2012-2#1)
bilaterally in##6##2##(1990-6#1)(1994-8#1)(1996-12#2)(2008-10#1)(2012-2#1)
bilaterally lesioned animals##2##3##(1990-5#1)(2008-7#1)
bilaterally were##2##2##(1996-2#1)(2012-12#1)
bilaterally##30##1##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-2#1)(1994-2#1)(1994-3#1)(1994-8#2)(1996-12#2)(1996-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
bilaterian##4##1##(2010-4#2)(2011-2#1)(2012-2#1)
bilaterians##2##1##(2009-6#1)(2010-4#1)
bilayer membrane##2##2##(2008-8#1)(2009-5#1)
bilayer modified gold##2##3##(2008-10#2)
bilayer structure##2##2##(1991-5#1)(2008-8#1)
bilayer##35##1##(1991-5#2)(1992-9#4)(1993-8#4)(1994-5#2)(2008-10#11)(2008-11#2)(2008-8#3)(2008-9#2)(2009-11#2)(2009-5#1)(2009-8#1)(2009-9#1)
bilayers could accommodate##2##3##(1993-8#2)
bilayers of##2##2##(2008-5#1)(2008-9#1)
bilayers##31##1##(1990-5#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-5#2)(2008-10#19)(2008-11#2)(2008-5#2)(2008-9#1)
bile acid transport##2##3##(1991-9#2)
bile acid##11##2##(1991-9#3)(1992-3#2)(2008-10#5)(2013-1#1)
bile acids in serum##3##4##(1993-2#3)
bile acids in##4##3##(1993-2#3)(1995-9#1)
bile acids were##4##3##(1993-2#4)
bile acids##15##2##(1992-3#3)(1993-2#7)(1995-9#1)(2008-11#1)(2013-1#3)
bile and##3##2##(2008-10#2)(2013-1#1)
bile canalicular contractions##2##3##(1993-3#2)
bile canalicular##4##2##(1993-3#2)(2008-11#2)
bile duct stones can be##2##5##(1991-3#1)(1997-8#1)
bile duct stones##5##3##(1991-3#2)(1997-8#2)(2010-12#1)
bile duct##26##2##(1990-5#2)(1990-9#4)(1991-3#4)(1991-8#1)(1992-3#1)(1993-12#1)(1995-11#1)(1996-11#1)(1997-8#2)(2008-2#1)(2009-9#2)(2010-12#4)(2013-1#2)
bile ducts##5##2##(2008-11#1)(2008-2#1)(2012-2#1)(2013-1#2)
bile flow in##2##3##(1993-3#1)(2012-2#1)
bile flow##7##2##(1993-3#3)(2008-11#1)(2012-2#3)
bile in##2##2##(1990-8#1)(2012-2#1)
bile##99##1##(1990-5#3)(1990-8#1)(1990-9#4)(1991-3#7)(1991-8#1)(1991-9#3)(1992-3#6)(1993-12#1)(1993-2#10)(1993-3#8)(1995-11#2)(1995-9#1)(1996-11#1)(1997-8#2)(2008-10#7)(2008-11#12)(2008-2#2)(2009-8#1)(2009-9#2)(2010-12#4)(2011-2#1)(2012-2#9)(2013-1#11)
bile-pancreatic juice diversion were##2##4##(2008-7#2)
bile-pancreatic juice diversion##3##3##(2008-7#3)
biliary anatomical variants##2##3##(2012-2#2)
biliary atresia##3##2##(1994-6#3)
biliary cases##3##2##(2011-2#3)
biliary diseases##3##2##(1991-3#1)(2010-12#2)
biliary drainage##2##2##(1990-2#1)(1992-3#1)
biliary flow##2##2##(1991-3#1)(2012-2#1)
biliary lithiasis##3##2##(1990-3#3)
biliary obstruction##5##2##(2012-2#2)(2013-1#3)
biliary pancreatitis##3##2##(2007-8#2)(2012-12#1)
biliary stenting##2##2##(2008-12#1)(2013-1#1)
biliary strictures##2##2##(2013-1#2)
biliary tract##11##2##(1990-5#1)(1990-8#1)(1992-3#1)(1992-9#6)(2009-8#1)(2013-1#1)
biliary##82##1##(1990-2#1)(1990-3#3)(1990-5#2)(1990-8#2)(1990-9#1)(1991-3#7)(1991-6#2)(1991-8#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#9)(1994-6#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2009-8#2)(2009-9#1)(2010-12#9)(2011-2#5)(2012-12#2)(2012-2#7)(2013-1#11)
biligonigerus##3##1##(2008-7#3)
bilinear##4##1##(2008-10#2)(2008-2#1)(2012-2#1)
bilingual##8##1##(2008-11#2)(2008-12#2)(2010-8#1)(2011-2#3)
bilingualism##4##1##(2008-11#4)
bilirubin and##2##2##(2008-10#2)
bilirubin measurement##2##2##(2008-11#1)(2011-2#1)
bilirubin were##2##2##(2008-10#1)(2013-1#1)
bilirubin##30##1##(1993-1#1)(2007-12#1)(2008-10#14)(2008-11#2)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#6)
bilirubinometry##2##1##(2008-11#1)(2011-2#1)
bilirubins##5##1##(1990-8#1)(2008-10#4)
biliteracies##2##1##(2008-11#2)
biliverdin IX alpha##2##3##(1990-8#1)(1994-5#1)
biliverdin and##3##2##(2008-10#3)
biliverdin##10##1##(1990-8#3)(1994-5#1)(2008-10#6)
biliverdins##6##1##(1990-8#6)
bill files##2##2##(1991-1#1)(1993-3#1)
bill that##4##2##(1995-6#1)(1996-5#3)
bill to##4##2##(1994-3#1)(1995-6#2)(2008-8#1)
bill##36##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-3#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#12)(1996-5#9)(1997-2#2)(1997-5#1)(2008-11#1)(2008-8#1)(2012-3#1)
billboards##2##1##(1997-6#2)
billing records##2##2##(2011-2#2)
billing##10##1##(1991-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-6#1)(2011-2#2)(2012-3#1)
billion in##10##2##(1991-1#1)(1992-12#1)(1992-3#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#1)(2008-2#2)(2013-8#1)
billion people##4##2##(1995-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
billion to##4##2##(1992-2#1)(2008-10#1)(2008-3#1)(2012-12#1)
billion##51##1##(1990-2#1)(1991-1#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1994-1#2)(1994-2#2)(1994-9#3)(1995-5#1)(1995-6#3)(1996-3#1)(1996-5#4)(1997-3#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#3)(2009-4#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
billion)##3##1##(1992-6#1)(1996-1#2)
billions of##2##2##(2008-7#1)(2013-8#1)
billions##4##1##(1994-5#1)(2008-7#1)(2010-3#1)(2013-8#1)
bills were##2##2##(2008-11#2)
bills##9##1##(1994-2#1)(1994-8#2)(1997-3#1)(2008-11#3)(2013-1#2)
bimaculatus##8##1##(2008-5#4)(2008-6#2)(2008-7#2)
bimodal distribution of##2##3##(2008-10#1)(2009-7#1)
bimodal distribution##9##2##(2008-10#3)(2008-3#2)(2009-7#4)
bimodal##19##1##(1991-2#1)(1992-10#1)(1993-6#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2009-7#5)
bimodality##2##1##(2008-10#1)(2008-9#1)
bimolecular##4##1##(1992-8#1)(1993-3#1)(1995-6#1)(2008-8#1)
bin##2##1##(2008-5#1)(2012-3#1)
binary and ternary complexes##3##4##(2008-10#3)
binary and ternary mixtures##2##4##(2008-10#2)
binary and ternary##7##3##(2008-10#7)
binary and##9##2##(1995-12#1)(2008-10#8)
binary complex##3##2##(1994-5#1)(2008-10#2)
binary complexes##3##2##(2008-10#3)
binary data##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
binary diffraction gratings##2##3##(2008-3#2)
binary epidemic##2##2##(2008-10#2)
binary epidemics##3##2##(2008-10#3)
binary extraction system##2##3##(2008-10#2)
binary form of Taylor's power law##4##6##(2008-10#4)
binary form of##6##3##(2008-10#6)
binary logistic regression model##3##4##(2011-2#3)
binary logistic regression##4##3##(2011-2#3)(2013-1#1)
binary mixture of##3##3##(2008-10#3)
binary mixture##5##2##(2008-10#5)
binary mixtures can##2##3##(2008-10#1)(2008-2#1)
binary mixtures containing##2##3##(2008-10#2)
binary mixtures of these compounds##2##5##(2008-10#2)
binary mixtures of##11##3##(2008-10#9)(2008-7#2)
binary mixtures using##2##3##(2008-10#2)
binary mixtures with##3##3##(2008-10#2)(2008-3#1)
binary mixtures##32##2##(2008-10#27)(2008-2#1)(2008-3#1)(2008-7#3)
binary mobile phase##2##3##(2008-10#2)
binary power law analysis##2##4##(2008-10#2)
binary power law##7##3##(2008-10#7)
binary power##8##2##(2008-10#8)
binary system##2##2##(1992-1#1)(2008-10#1)
binary vector##2##2##(2008-10#1)(2011-1#1)
binary vectors##2##2##(2008-10#2)
binary zone##2##2##(2008-3#2)
binary##125##1##(1992-1#1)(1992-9#1)(1994-5#1)(1995-12#2)(2008-10#91)(2008-11#2)(2008-2#1)(2008-3#12)(2008-5#1)(2008-7#3)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
bind actin##2##2##(1990-5#1)(2011-2#1)
bind and##2##2##(1991-5#1)(2011-2#1)
bind as##2##2##(1995-8#1)(1996-2#1)
bind at##2##2##(1990-9#1)(2012-3#1)
bind both##2##2##(1990-5#1)(1995-2#1)
bind efficiently##2##2##(1995-8#1)(2008-4#1)
bind metal ions##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
bind metal##4##2##(2008-10#2)(2010-11#1)(2011-2#1)
bind selectively##2##2##(2008-4#1)(2009-12#1)
bind specifically to##4##3##(1991-12#1)(1992-6#1)(2008-10#1)(2008-9#1)
bind the sequence##2##3##(1993-6#2)
bind the##10##2##(1993-6#3)(1995-2#2)(2008-10#3)(2010-12#1)(2011-2#1)
bind to CCAAT##2##3##(1995-2#1)(2008-9#1)
bind to a protein##2##4##(2008-1#1)(2008-10#1)
bind to a##5##3##(1994-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-7#1)
bind to and##3##3##(1991-9#1)(1994-5#1)(1995-8#1)
bind to specific##2##3##(1997-7#1)(2008-4#1)
bind to the HIV-1##2##4##(2008-4#1)(2013-1#1)
bind to the enzyme##2##4##(1994-5#1)(1995-6#1)
bind to the same##3##4##(1993-8#2)(2008-8#1)
bind to the##21##3##(1992-6#1)(1993-8#4)(1994-5#2)(1995-6#2)(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#1)(2013-1#1)
bind to##70##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-6#1)(1993-8#5)(1994-11#1)(1994-12#1)(1994-5#4)(1995-12#1)(1995-2#2)(1995-6#4)(1995-8#1)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#7)(2009-7#1)(2013-1#1)(2013-7#1)
bind with high affinity##2##4##(1996-12#1)(2006-6#1)
bind with##6##2##(1996-12#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-8#1)
bind##144##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#3)(1990-8#1)(1990-9#2)(1991-12#1)(1991-5#3)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#2)(1993-6#4)(1993-8#5)(1994-11#3)(1994-12#2)(1994-5#5)(1995-12#1)(1995-2#6)(1995-6#5)(1995-8#7)(1996-12#1)(1996-2#1)(1997-6#2)(1997-7#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#13)(2008-9#9)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
binder of##2##2##(2008-10#2)
binder viscosity##2##2##(2008-10#2)
binder##13##1##(1993-8#1)(2008-10#12)
binders##8##1##(2008-10#2)(2008-4#1)(2012-12#4)(2013-1#1)
binding (IC50##2##2##(1994-8#1)(1995-2#1)
binding (i##2##2##(1997-2#2)
binding ability of##3##3##(2008-10#3)
binding ability##6##2##(1990-6#1)(2008-10#5)
binding activities##2##2##(1993-8#1)(2008-9#1)
binding activity and##2##3##(1995-8#1)(1997-7#1)
binding activity is##2##3##(1995-6#1)(2011-1#1)
binding activity##13##2##(1990-12#1)(1991-12#1)(1993-3#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-7#2)(2008-8#3)(2008-9#1)(2011-1#1)
binding affinities of##4##3##(1990-11#1)(1993-6#1)(2008-11#1)(2009-12#1)
binding affinities##7##2##(1990-11#1)(1993-6#1)(1994-5#1)(1995-11#1)(2008-11#1)(2008-8#1)(2009-12#1)
binding affinity between##3##3##(2008-10#1)(2009-3#1)(2012-2#1)
binding affinity for##4##3##(1993-6#1)(1995-6#1)(2008-10#2)
binding affinity in##2##3##(1995-8#1)(2008-10#1)
binding affinity of##3##3##(1991-5#1)(1995-11#1)(2008-8#1)
binding affinity to##2##3##(1997-3#1)(2008-10#1)
binding affinity##30##2##(1991-12#1)(1991-5#1)(1993-1#1)(1993-6#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#6)(2008-4#1)(2008-8#4)(2009-3#1)(2010-1#1)(2010-6#1)(2012-2#1)
binding and dissociation##2##3##(2008-5#1)(2008-7#1)
binding and release##3##3##(2008-7#2)(2011-2#1)
binding and state##2##3##(1994-5#2)
binding and the##5##3##(1996-2#1)(2008-10#3)(2008-7#1)
binding and##51##2##(1990-12#1)(1991-3#1)(1991-9#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1997-1#2)(1997-8#1)(2008-10#10)(2008-5#1)(2008-7#4)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
binding approximately##2##2##(1997-1#2)
binding aptamers##2##2##(2009-12#2)
binding are##2##2##(1993-2#1)(1993-8#1)
binding assay and##3##3##(1992-3#1)(1995-8#1)(2008-9#1)
binding assay demonstrated that##2##4##(2008-9#1)(2010-6#1)
binding assay##16##2##(1990-11#1)(1990-12#2)(1992-3#1)(1992-6#2)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-9#3)(2010-6#1)
binding assays showed##2##3##(1996-12#1)(1997-6#1)
binding assays with##2##3##(2008-10#1)(2008-11#1)
binding assays##18##2##(1992-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-5#1)
binding at the same##2##4##(1990-5#1)(1994-8#1)
binding at##5##2##(1990-5#1)(1993-8#1)(1994-8#1)(1995-6#1)(2010-11#1)
binding between##5##2##(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#1)
binding but##2##2##(1993-8#1)(1995-2#1)
binding by##12##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-9#1)(2009-7#1)(2011-2#1)
binding can be##3##3##(1993-8#1)(1996-12#1)(2008-10#1)
binding capacities##2##2##(2008-10#1)(2008-9#1)
binding capacity of##7##3##(1990-12#1)(1991-5#1)(1993-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
binding capacity##14##2##(1990-12#1)(1990-5#1)(1991-5#2)(1993-3#1)(1993-6#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#2)(2012-2#1)
binding cavity##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
binding characteristics of##8##3##(1991-9#1)(1993-1#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)
binding characteristics##13##2##(1990-11#1)(1991-5#2)(1991-9#1)(1993-1#1)(1993-8#1)(1994-5#1)(1995-11#2)(1995-12#1)(1996-2#1)(2008-10#2)
binding constant (K)##2##3##(2008-10#2)
binding constant for the##2##4##(2008-10#2)
binding constant of the##4##4##(1993-8#1)(2008-10#3)
binding constant of##6##3##(1993-8#2)(2008-10#4)
binding constant##18##2##(1993-8#2)(1994-5#1)(1997-2#1)(2008-10#14)
binding constants for##2##3##(2008-10#1)(2008-5#1)
binding constants of##4##3##(1992-10#1)(1992-4#1)(1993-1#1)(2008-10#1)
binding constants##11##2##(1992-10#1)(1992-4#1)(1993-1#1)(1994-5#1)(2008-10#6)(2008-5#1)
binding curves##3##2##(1993-8#1)(1997-2#1)(2008-10#1)
binding data##2##2##(1993-1#1)(2008-11#1)
binding decreased##2##2##(1993-8#1)(1996-2#1)
binding domain between##2##3##(2008-8#2)
binding domain of##4##3##(1991-12#1)(1995-6#1)(2006-6#1)(2008-9#1)
binding domain##17##2##(1991-12#2)(1992-1#1)(1995-6#4)(2006-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-6#1)(2011-2#1)
binding domains on the##2##4##(1993-3#2)
binding domains##5##2##(1993-3#2)(1996-2#1)(2008-11#1)(2008-8#1)
binding energies##4##2##(2008-9#1)(2010-7#3)
binding energy##3##2##(1993-8#1)(2008-10#1)(2013-8#1)
binding enthalpy##2##2##(1992-10#2)
binding experiments##2##2##(2008-8#1)(2008-9#1)
binding factor##3##2##(1995-2#1)(2008-11#2)
binding factors##4##2##(1991-5#1)(1993-8#2)(2008-9#1)
binding fold##2##2##(2008-11#2)
binding for##3##2##(1993-6#1)(1994-8#1)(2008-10#1)
binding force##2##2##(1990-2#1)(2008-5#1)
binding free energy##2##3##(1995-2#1)(2008-4#1)
binding in a##4##3##(1994-11#1)(1994-3#1)(1995-11#1)(2008-4#1)
binding in rat brain##2##4##(1995-11#1)(1996-2#1)
binding in rat##4##3##(1991-5#1)(1995-11#1)(1996-2#1)(1997-1#1)
binding in the##4##3##(1990-2#1)(1994-2#1)(2010-11#1)(2013-8#1)
binding in vitro##2##3##(1995-6#1)(2009-4#1)
binding in##28##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-1#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-11#1)(2012-2#1)(2013-8#1)
binding inhibiting##2##2##(1995-12#2)
binding interaction##3##2##(1990-5#1)(2008-10#1)(2008-12#1)
binding interactions##4##2##(2008-10#1)(2008-9#3)
binding is##13##2##(1990-11#1)(1990-6#1)(1990-8#2)(1993-6#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)
binding kinetics##3##2##(2006-6#1)(2008-10#1)(2009-10#1)
binding mechanism##2##2##(2008-10#2)
binding media##9##2##(2008-10#9)
binding mode##3##2##(1994-5#1)(2009-7#1)(2013-1#1)
binding model for##2##3##(1994-5#1)(2008-10#1)
binding model##5##2##(1994-5#4)(2008-10#1)
binding modes##3##2##(1994-5#1)(2008-4#1)(2008-9#1)
binding motif##4##2##(1991-12#1)(2008-10#1)(2009-12#1)(2013-1#1)
binding number and##2##3##(2008-10#2)
binding number##5##2##(2008-10#5)
binding occurs at##2##3##(1993-8#1)(1994-5#1)
binding occurs##3##2##(1993-8#1)(1994-5#1)(2008-10#1)
binding of 125I-EGF##2##3##(1993-3#2)
binding of CaM kinase II##2##5##(1993-6#2)
binding of E##2##3##(2008-10#2)
binding of ESA to the cell surface##2##7##(2008-11#2)
binding of NBMPR##2##3##(1994-8#2)
binding of a##7##3##(1994-11#1)(1995-2#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
binding of agonists to the A1 adenosine receptor##2##8##(1993-3#1)(1994-5#1)
binding of agonists to the##3##5##(1993-3#1)(1994-5#2)
binding of alpha-actinin to actin is##2##6##(1993-8#2)
binding of an##2##3##(1991-3#1)(2008-11#1)
binding of both##2##3##(1990-12#1)(2008-7#1)
binding of charged ligands to##2##5##(1997-2#2)
binding of coumestrol##2##3##(1995-11#2)
binding of d- and##2##4##(2008-10#2)
binding of fibrinogen to##3##4##(1995-2#2)(2006-6#1)
binding of human##2##3##(1995-6#1)(1996-12#1)
binding of metal##2##3##(1994-11#1)(2008-10#1)
binding of the##23##3##(1990-11#1)(1990-12#1)(1992-4#1)(1993-1#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#4)(1994-6#1)(1996-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
binding of##206##2##(1990-11#4)(1990-12#4)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#5)(1993-3#6)(1993-6#6)(1993-8#7)(1993-9#2)(1994-11#7)(1994-3#1)(1994-5#14)(1994-6#1)(1994-8#5)(1995-11#11)(1995-12#2)(1995-2#10)(1995-6#5)(1996-12#5)(1996-2#4)(1996-8#1)(1997-2#6)(1997-4#1)(1997-9#1)(2006-6#2)(2007-11#1)(2008-10#29)(2008-11#9)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-7#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#2)
binding on the##2##3##(1994-5#1)(2008-10#1)
binding on##6##2##(1994-5#1)(2008-10#4)(2008-8#1)
binding parameters of##3##3##(1994-2#1)(1995-2#1)(2008-10#1)
binding parameters##7##2##(1994-2#1)(1995-2#1)(2008-10#5)
binding partners to##2##3##(2008-9#1)(2013-1#1)
binding partners##5##2##(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
binding phase##3##2##(2008-10#2)(2009-7#1)
binding pocket##4##2##(1992-4#1)(1994-5#2)(2012-2#1)
binding process##7##2##(1991-12#1)(1997-2#2)(1997-6#1)(2008-10#3)
binding properties and##3##3##(1993-8#1)(1995-8#1)(2008-10#1)
binding properties in##2##3##(1995-11#1)(2009-10#1)
binding properties of the##3##4##(1991-3#1)(1992-3#1)(2008-9#1)
binding properties of##6##3##(1991-3#2)(1992-3#1)(1996-3#1)(2008-10#1)(2008-9#1)
binding properties##15##2##(1990-8#1)(1991-3#2)(1992-3#1)(1993-8#1)(1995-11#1)(1995-8#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-10#1)(2010-7#1)
binding protein and##3##3##(1990-6#1)(1992-6#1)(1997-4#1)
binding protein gene##2##3##(2008-8#2)
binding protein##47##2##(1990-5#1)(1990-6#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-11#3)(1994-2#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#2)(1997-3#2)(1997-4#1)(1997-7#2)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-4#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-1#1)
binding proteins and##3##3##(1993-9#1)(2011-2#1)(2012-2#1)
binding proteins in##6##3##(1993-6#1)(2008-8#5)
binding proteins##28##2##(1992-4#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1996-12#1)(1997-2#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#6)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
binding ratio##2##2##(2008-10#2)
binding region as##2##3##(2008-10#1)(2008-6#1)
binding region of GIP##3##4##(1997-4#3)
binding region of the##2##4##(1991-12#1)(2008-8#1)
binding region of##5##3##(1991-12#1)(1997-4#3)(2008-8#1)
binding region##7##2##(1991-12#1)(1997-4#3)(2008-10#1)(2008-6#1)(2008-8#1)
binding requires##2##2##(2008-10#1)(2008-4#1)
binding sequences##3##2##(1995-6#2)(2008-8#1)
binding site and the##2##4##(1994-5#1)(2008-9#1)
binding site and##6##3##(1990-5#1)(1994-5#2)(1997-5#1)(2008-9#1)(2012-3#1)
binding site by DHEA##3##4##(2008-10#3)
binding site for the##5##4##(1990-5#2)(1993-12#1)(1993-3#1)(2009-8#1)
binding site for##14##3##(1990-5#2)(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-8#1)(2012-2#1)
binding site in the##4##4##(1990-5#1)(1992-3#1)(1996-2#1)(2008-10#1)
binding site in##7##3##(1990-5#1)(1990-8#1)(1992-3#1)(1996-12#1)(1996-2#1)(2008-10#2)
binding site is located##2##4##(1991-12#1)(1995-2#1)
binding site is##4##3##(1991-12#1)(1995-2#2)(1995-6#1)
binding site of the##2##4##(1995-11#1)(2008-10#1)
binding site of##8##3##(1992-9#1)(1993-2#1)(1995-11#1)(1995-8#1)(2008-10#2)(2008-8#1)(2011-2#1)
binding site on the##2##4##(1990-7#1)(2009-8#1)
binding site on##6##3##(1990-7#1)(1992-3#1)(1993-8#1)(1995-2#1)(2008-8#1)(2009-8#1)
binding site was##2##3##(1991-7#1)(2008-9#1)
binding site which##2##3##(1991-5#1)(1994-3#1)
binding site##84##2##(1990-10#1)(1990-5#5)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-3#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-3#2)(1994-5#6)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#2)
binding site(s)##4##2##(1993-6#1)(2006-6#1)(2008-1#1)(2012-2#1)
binding sites and##5##3##(1990-12#3)(2008-11#1)(2013-1#1)
binding sites are##4##3##(1991-5#1)(1993-8#1)(1995-8#1)(2008-11#1)
binding sites for IgE##2##4##(2008-10#2)
binding sites for [3H]-staurosporine##3##4##(1990-8#3)
binding sites for several##2##4##(1994-11#1)(2008-11#1)
binding sites for##19##3##(1990-8#3)(1991-5#2)(1991-6#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
binding sites in the##14##4##(1990-2#2)(1992-6#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-3#2)
binding sites in##23##3##(1990-2#2)(1990-5#2)(1991-5#2)(1992-6#1)(1994-3#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-9#1)(2009-8#1)(2011-3#2)(2012-2#1)(2012-3#1)
binding sites is##3##3##(1993-8#1)(1995-8#1)(2012-3#1)
binding sites of##5##3##(1995-12#1)(2008-10#4)
binding sites on##2##3##(2008-9#1)(2010-5#1)
binding sites per##2##3##(1993-6#1)(2008-11#1)
binding sites that##2##3##(2008-11#1)(2008-8#1)
binding sites to##2##3##(1995-2#1)(2008-10#1)
binding sites was##2##3##(1995-12#1)(1995-8#1)
binding sites were##4##3##(1994-2#2)(1994-5#1)(2008-7#1)
binding sites with a Kd of##2##6##(1993-8#1)(1995-8#1)
binding sites with a##3##4##(1990-8#1)(1993-8#1)(1995-8#1)
binding sites with##6##3##(1990-8#1)(1993-1#1)(1993-8#1)(1995-8#2)(2012-2#1)
binding sites within##4##3##(2008-11#2)(2012-3#1)(2013-1#1)
binding sites##129##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#2)(1990-8#4)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#5)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#2)(1995-11#3)(1995-12#4)(1995-2#1)(1995-6#3)(1995-8#6)(1996-2#3)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#18)(2008-11#14)(2008-7#5)(2008-8#3)(2008-9#2)(2009-8#2)(2010-5#1)(2011-2#1)(2011-3#2)(2012-2#4)(2012-3#3)(2013-1#3)
binding species##2##2##(1992-4#1)(2008-10#1)
binding specificity##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
binding studies with##4##3##(1991-7#1)(1993-3#1)(1995-11#1)(2008-10#1)
binding studies##9##2##(1991-7#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-11#1)
binding study##2##2##(1991-6#1)(2008-10#1)
binding that##2##2##(1995-2#1)(1996-12#1)
binding the##3##2##(1993-8#1)(2008-10#1)(2009-8#1)
binding to DNA##5##3##(1992-7#1)(1995-8#1)(1996-2#1)(2008-8#1)(2008-9#1)
binding to a##5##3##(1993-6#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-2#1)
binding to both##2##3##(1995-2#1)(2008-9#1)
binding to bovine##2##3##(1990-8#1)(2008-3#1)
binding to class II MHC##3##5##(1993-3#3)
binding to human serum albumin##2##5##(2008-10#2)
binding to human##4##3##(1992-10#1)(2006-6#1)(2008-10#2)
binding to immobilized Interleukin-1alpha##2##4##(2008-10#2)
binding to immobilized##3##3##(2008-10#3)
binding to its receptor##2##4##(1995-2#1)(1995-6#1)
binding to its##3##3##(1995-2#1)(1995-6#1)(2009-8#1)
binding to specific##3##3##(1993-8#1)(2008-4#1)(2008-8#1)
binding to the ER##2##4##(2008-11#2)
binding to the alpha 1 beta 1 dimer##2##8##(1993-8#2)
binding to the receptor##2##4##(1995-2#1)(1995-6#1)
binding to the##45##3##(1990-11#1)(1990-12#3)(1990-5#1)(1990-8#2)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-8#3)(1994-5#2)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-8#1)
binding to these##2##3##(1990-12#1)(1993-8#1)
binding to vascular muscle##2##4##(1991-6#2)
binding to##150##2##(1990-11#3)(1990-12#4)(1990-4#1)(1990-5#2)(1990-8#4)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#2)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-3#5)(1993-6#4)(1993-8#9)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#7)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#9)(1995-5#2)(1995-6#7)(1995-8#3)(1996-12#1)(1996-2#5)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-10#16)(2008-11#8)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#6)(2009-7#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
binding using##5##2##(1990-11#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-4#1)
binding was observed##2##3##(2008-10#2)
binding was##29##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-4#1)(1992-8#1)(1993-6#3)(1993-8#2)(1994-2#1)(1994-3#1)(1996-12#2)(1996-2#6)(2008-10#4)(2008-11#1)(2010-5#1)
binding were##9##2##(1990-5#1)(1993-8#1)(1995-11#3)(2008-10#2)(2008-11#1)(2008-8#1)
binding with a##4##3##(1993-6#1)(1994-8#1)(2008-10#2)
binding with the##4##3##(1993-6#1)(1997-8#1)(2008-10#1)(2012-2#1)
binding with##17##2##(1990-6#1)(1993-6#2)(1994-8#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#6)(2010-11#2)(2012-2#1)
binding##1427##1##(1990-10#3)(1990-11#22)(1990-12#19)(1990-2#7)(1990-4#2)(1990-5#21)(1990-6#6)(1990-7#2)(1990-8#16)(1991-1#1)(1991-10#3)(1991-12#11)(1991-3#9)(1991-5#21)(1991-6#8)(1991-7#3)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#7)(1992-12#6)(1992-3#10)(1992-4#6)(1992-6#10)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#16)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#20)(1993-6#33)(1993-8#53)(1993-9#4)(1994-11#24)(1994-2#14)(1994-3#7)(1994-5#59)(1994-6#2)(1994-8#19)(1995-11#41)(1995-12#23)(1995-2#41)(1995-5#3)(1995-6#41)(1995-8#26)(1996-12#27)(1996-2#36)(1996-3#3)(1996-5#2)(1996-8#2)(1997-1#8)(1997-2#21)(1997-3#7)(1997-4#7)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#7)(1997-9#2)(2006-6#7)(2007-11#2)(2008-1#1)(2008-10#247)(2008-11#65)(2008-12#5)(2008-3#3)(2008-4#15)(2008-5#10)(2008-6#2)(2008-7#22)(2008-8#53)(2008-9#59)(2009-10#4)(2009-12#6)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#9)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#10)(2010-12#2)(2010-4#2)(2010-5#5)(2010-6#4)(2010-7#6)(2011-1#4)(2011-2#22)(2011-3#2)(2012-12#1)(2012-2#29)(2012-3#7)(2013-1#19)(2013-8#5)
binding)##2##1##(1994-2#1)(1996-3#1)
binding-sites##3##1##(1994-11#2)(2010-5#1)
bindings##3##1##(1992-3#2)(2008-10#1)
binds and internalizes##2##3##(1994-5#1)(1995-6#1)
binds and##6##2##(1992-10#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-6#1)
binds at##2##2##(1990-5#1)(2012-2#1)
binds directly to##3##3##(1995-6#1)(2011-2#1)(2012-2#1)
binds multiple##2##2##(1996-12#1)(2011-2#1)
binds not only##2##3##(1995-11#1)(2008-5#1)
binds specifically to the##2##4##(1995-2#1)(2008-9#1)
binds the##5##2##(1993-8#1)(1995-11#1)(1995-6#1)(1996-8#1)(2009-7#1)
binds to a specific##3##4##(1990-5#1)(1997-7#1)(2008-2#1)
binds to a##6##3##(1990-5#1)(1992-8#1)(1996-12#1)(1997-7#2)(2008-2#1)
binds to an##3##3##(1994-8#1)(1995-6#1)(1996-12#1)
binds to and activates##2##4##(2007-11#1)(2011-2#1)
binds to and##3##3##(1994-5#1)(2007-11#1)(2011-2#1)
binds to both##3##3##(1992-6#1)(1993-3#1)(1995-2#1)
binds to the##7##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-5#1)(1995-11#1)(2008-6#1)(2009-8#1)
binds to their##2##3##(1994-3#1)(2009-8#1)
binds to two##2##3##(1994-11#1)(2008-9#1)
binds to##55##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#2)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#3)(1993-8#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#3)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#2)(2010-5#1)(2011-2#2)(2012-2#2)
binds very##2##2##(1990-8#1)(1994-11#1)
binds with##3##2##(1994-5#1)(2008-10#2)
binds##118##1##(1990-12#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#2)(1992-10#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#3)(1993-6#2)(1993-8#3)(1994-11#5)(1994-3#1)(1994-5#6)(1994-8#2)(1995-11#3)(1995-2#6)(1995-6#6)(1995-8#4)(1996-12#5)(1996-2#1)(1996-3#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(2006-6#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-7#2)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#7)(2012-2#4)
binge drinking##4##2##(2008-10#1)(2009-5#3)
binge##6##1##(2008-10#2)(2009-5#3)(2011-2#1)
binocular fusion##3##2##(2008-9#3)
binocular##7##1##(1990-8#1)(2008-7#1)(2008-9#3)(2011-2#1)(2013-8#1)
binomial distribution for##2##3##(2008-10#2)
binomial distribution##14##2##(2008-10#12)(2008-3#1)(2010-5#1)
binomial function##2##2##(2008-10#2)
binomial index of dispersion (D) and##2##6##(2008-10#2)
binomial##26##1##(1994-9#1)(2008-10#22)(2008-11#1)(2008-3#1)(2010-5#1)
bins##3##1##(2008-10#1)(2008-5#2)
binuclear##6##1##(1995-2#1)(1997-7#2)(2008-10#3)
binucleate Rhizoctonia (BNR)##2##3##(2008-10#2)
binucleate Rhizoctonia spp##5##3##(2008-10#5)
binucleate Rhizoctonia##9##2##(2008-10#9)
binucleate##12##1##(2007-12#1)(2008-10#11)
bio-analytical##2##1##(2008-10#2)
bio-control##6##1##(2008-10#6)
bio-economic##2##1##(2008-10#2)
bio-imaging and##2##2##(2008-10#2)
bio-machined##2##1##(2008-8#2)
bio-medical##2##1##(2008-1#1)(2011-2#1)
bio-mimetic##2##1##(2008-10#2)
bio-molecules##3##1##(2008-10#2)(2011-2#1)
bioabsorbable##4##1##(2009-5#1)(2011-2#3)
bioaccumulation of##4##2##(2008-10#1)(2008-12#3)
bioaccumulation potential##2##2##(2008-11#2)
bioaccumulation##12##1##(1991-12#1)(2008-10#3)(2008-11#3)(2008-12#4)(2012-12#1)
bioaccumulative##4##1##(2008-11#4)
bioactive amines in##3##3##(2008-10#3)
bioactive component##2##2##(2008-10#1)(2011-1#1)
bioactive compounds##7##2##(2008-10#4)(2008-11#1)(2011-1#1)(2011-2#1)
bioactive glass##4##2##(2009-7#4)
bioactive molecules##2##2##(2008-10#1)(2013-1#1)
bioactive peptides##4##2##(1991-5#1)(1994-8#1)(1995-3#1)(2011-2#1)
bioactive##46##1##(1991-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-7#7)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
bioactives##2##1##(2008-5#2)
bioactivities of##3##2##(2008-10#1)(2011-3#1)(2013-1#1)
bioactivities##4##1##(2008-10#2)(2011-3#1)(2013-1#1)
bioactivity against##2##2##(2008-11#1)(2009-2#1)
bioactivity and##2##2##(2008-11#1)(2009-2#1)
bioactivity data##2##2##(2013-1#2)
bioactivity of the##2##3##(2008-10#2)
bioactivity of##6##2##(2008-10#3)(2009-7#1)(2011-3#1)(2012-2#1)
bioactivity##22##1##(1993-8#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-8#2)(2009-2#2)(2009-7#2)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#2)
bioadhesion##2##1##(2008-5#2)
bioanalysis##8##1##(2008-10#5)(2010-11#3)
bioanalytical applications##3##2##(2008-10#2)(2010-11#1)
bioanalytical assays##4##2##(2008-10#3)(2010-11#1)
bioanalytical columns prepared with##2##4##(2008-10#2)
bioanalytical method##3##2##(2010-11#3)
bioanalytical methods in##2##3##(2010-11#2)
bioanalytical methods##6##2##(2008-10#2)(2010-11#4)
bioanalytical##28##1##(2008-10#14)(2010-11#12)(2010-7#1)(2011-2#1)
bioartificial islet##2##2##(2010-10#2)
bioartificial liver support systems##2##4##(2008-11#2)
bioartificial liver support##3##3##(2008-11#2)(2010-12#1)
bioartificial liver##7##2##(2008-11#3)(2010-12#1)(2011-2#1)(2012-2#2)
bioartificial##10##1##(2008-11#4)(2010-10#2)(2010-12#1)(2011-2#1)(2012-2#2)
bioassay and##7##2##(1993-12#1)(2008-10#5)(2009-12#1)
bioassay for screening##2##3##(2008-10#2)
bioassay for the##2##3##(2008-10#2)
bioassay for##8##2##(1990-12#1)(2008-10#6)(2008-6#1)
bioassay is##2##2##(2008-10#1)(2008-4#1)
bioassay method##3##2##(2008-10#1)(2008-4#1)(2011-3#1)
bioassay of##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
bioassay on##2##2##(2008-10#1)(2008-8#1)
bioassay to measure##2##3##(2008-10#2)
bioassay was##3##2##(2008-10#1)(2008-12#2)
bioassay##68##1##(1990-12#1)(1991-12#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-2#1)(2008-10#42)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-6#2)(2011-3#2)(2013-1#1)(2013-8#1)
bioassays and##2##2##(2008-10#1)(2013-8#1)
bioassays are##2##2##(2008-10#2)
bioassays for##2##2##(1990-12#1)(2008-10#1)
bioassays in##2##2##(1993-12#1)(2008-10#1)
bioassays were##2##2##(2008-11#1)(2008-12#1)
bioassays with##2##2##(2008-10#1)(2008-9#1)
bioassays##34##1##(1990-12#1)(1993-12#2)(1994-11#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
bioavailability and##5##2##(2008-10#1)(2008-11#2)(2008-5#2)
bioavailability in humans##2##3##(1992-9#1)(2011-2#1)
bioavailability in##3##2##(1992-9#1)(2010-12#1)(2011-2#1)
bioavailability is##2##2##(2008-10#1)(2012-2#1)
bioavailability of##14##2##(2008-10#5)(2008-11#2)(2009-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
bioavailability that##2##2##(2008-10#1)(2012-2#1)
bioavailability was##3##2##(1991-2#1)(2008-10#1)(2011-3#1)
bioavailability##51##1##(1991-2#1)(1992-9#3)(1997-1#1)(2008-10#12)(2008-11#5)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#4)(2011-3#4)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#1)
biocatalysis in##2##2##(2008-7#1)(2011-1#1)
biocatalysis##8##1##(1997-7#1)(2008-7#1)(2011-1#4)(2012-2#2)
biocatalyst for##2##2##(2011-1#2)
biocatalyst recycling##2##2##(2011-1#2)
biocatalyst##13##1##(1997-7#1)(2008-10#2)(2008-7#2)(2011-1#6)(2011-2#2)
biocatalysts##7##1##(1995-3#2)(2008-10#1)(2011-1#4)
biocatalytic##5##1##(2008-10#4)(2011-2#1)
biochanin A##3##2##(2010-3#3)
biochemical activity##2##2##(1991-9#1)(1997-7#1)
biochemical analysis##9##2##(1992-6#1)(2008-10#3)(2009-6#1)(2012-2#1)(2013-8#3)
biochemical and histological##2##3##(2009-8#1)(2012-3#1)
biochemical and##22##2##(1990-9#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
biochemical assays##3##2##(2008-10#2)(2012-2#1)
biochemical basis for##2##3##(1992-10#1)(2009-8#1)
biochemical basis of##3##3##(1990-8#1)(1996-2#1)(2008-10#1)
biochemical basis##5##2##(1990-8#1)(1992-10#1)(1996-2#1)(2008-10#1)(2009-8#1)
biochemical changes##4##2##(1991-2#1)(1997-2#1)(2008-12#1)(2012-2#1)
biochemical characteristics##2##2##(1990-10#1)(2013-8#1)
biochemical characterization of the##2##4##(1991-2#1)(1995-6#1)
biochemical characterization of##5##3##(1991-2#1)(1991-9#1)(1993-8#1)(1995-5#1)(1995-6#1)
biochemical characterization##6##2##(1991-2#1)(1991-9#1)(1993-8#1)(1995-5#1)(1995-6#1)(2008-10#1)
biochemical data##5##2##(2008-10#2)(2011-2#2)(2013-8#1)
biochemical differences##2##2##(1994-2#1)(2008-10#1)
biochemical effects of the##2##4##(1992-3#1)(1993-8#1)
biochemical effects of##4##3##(1992-3#1)(1993-8#1)(2010-1#2)
biochemical effects##5##2##(1992-3#1)(1993-8#1)(2008-7#1)(2010-1#2)
biochemical evidence##3##2##(1990-12#1)(1993-3#1)(1994-11#1)
biochemical function##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
biochemical investigations##2##2##(2008-9#1)(2013-1#1)
biochemical marker for##5##3##(1990-8#2)(2007-12#1)(2008-10#2)
biochemical markers of##4##3##(1990-2#1)(1993-8#1)(1994-2#1)(2008-11#1)
biochemical markers##6##2##(1990-2#1)(1993-8#1)(1994-2#1)(2008-11#1)(2011-1#1)(2013-1#1)
biochemical measurements of##2##3##(2008-7#1)(2008-8#1)
biochemical measurements##4##2##(2008-11#1)(2008-7#2)(2008-8#1)
biochemical mechanism##4##2##(1991-5#1)(2008-10#1)(2010-7#2)
biochemical mechanisms##4##2##(1990-8#1)(1997-2#1)(2008-5#1)(2011-2#1)
biochemical nature of##2##3##(2008-11#1)(2008-6#1)
biochemical networks##6##2##(2008-11#1)(2008-7#2)(2010-10#3)
biochemical oxygen demand##3##3##(2008-10#3)
biochemical parameters in##2##3##(2008-12#1)(2012-2#1)
biochemical parameters including##2##3##(1994-5#1)(2012-2#1)
biochemical parameters##12##2##(1994-5#1)(1997-4#1)(2008-11#1)(2008-12#1)(2011-10#2)(2012-2#3)(2012-3#3)
biochemical pathways##3##2##(2008-11#1)(2011-1#2)
biochemical processes##8##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#3)(2012-5#1)(2013-8#1)
biochemical properties as##2##3##(1995-11#1)(2008-10#1)
biochemical properties##6##2##(1995-11#1)(1995-6#1)(1997-7#1)(2008-10#1)(2009-3#1)(2012-2#1)
biochemical reactions##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
biochemical research##2##2##(2011-3#1)(2012-3#1)
biochemical responses##5##2##(1994-6#1)(2011-10#1)(2012-5#1)(2012-6#2)
biochemical results##2##2##(1997-8#1)(2011-2#1)
biochemical studies have##2##3##(1996-12#1)(2008-5#1)
biochemical studies##6##2##(1995-2#1)(1996-12#1)(1997-7#1)(2008-5#1)(2008-7#1)(2009-6#1)
biochemical study##2##2##(2008-10#1)(2010-3#1)
biochemical systems##2##2##(2008-10#1)(2008-7#1)
biochemical tests of liver function##2##5##(1992-12#2)
biochemical tests##7##2##(1992-12#2)(1992-5#1)(2008-10#3)(2010-6#1)
biochemical##248##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#5)(1990-9#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#5)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#49)(2008-11#17)(2008-12#4)(2008-2#1)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#5)(2010-1#2)(2010-10#3)(2010-11#2)(2010-3#2)(2010-6#1)(2010-7#4)(2011-1#4)(2011-10#5)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#9)(2012-5#2)(2012-6#3)(2013-1#10)(2013-8#7)
biochemically and serologically##2##3##(1996-12#1)(2008-5#1)
biochemically and##5##2##(1996-12#1)(1997-6#1)(2008-5#2)(2012-2#1)
biochemically##14##1##(1992-12#1)(1993-3#1)(1995-2#1)(1996-12#2)(1997-6#1)(2008-10#1)(2008-12#1)(2008-5#3)(2011-1#1)(2012-2#1)(2012-3#1)
biochemicals##2##1##(2009-9#1)(2013-8#1)
biochemist##2##1##(1994-12#1)(1997-6#1)
biochemistry and##6##2##(1991-5#1)(1992-11#1)(1995-5#1)(1997-1#1)(2008-11#1)(2011-2#1)
biochemistry has##2##2##(1994-12#1)(2011-2#1)
biochemistry in##3##2##(1994-12#3)
biochemistry of##2##2##(2008-11#1)(2008-5#1)
biochemistry tests##2##2##(1997-8#1)(2013-8#1)
biochemistry training##2##2##(1994-12#2)
biochemistry values##2##2##(1991-11#1)(2008-5#1)
biochemistry##51##1##(1991-11#1)(1991-5#1)(1992-11#1)(1994-12#27)(1995-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#3)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
biochemists##9##1##(1994-12#8)(2008-10#1)
biochip##2##1##(2009-12#2)
biochips##2##1##(2008-7#1)(2010-11#1)
biocidal agents##2##2##(2008-9#1)(2010-7#1)
biocidal##4##1##(2008-10#2)(2008-9#1)(2010-7#1)
biocide##6##1##(2007-12#1)(2008-10#2)(2008-7#3)
biocides and##2##2##(2008-10#2)
biocides##5##1##(2008-10#2)(2008-11#3)
biocompatibility and##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
biocompatibility##16##1##(1990-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#2)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
biocompatible and##2##2##(2008-10#1)(2008-5#1)
biocompatible dialysis##2##2##(2008-10#1)(2011-2#1)
biocompatible polymers##3##2##(2008-10#3)
biocompatible##12##1##(2008-10#5)(2008-11#1)(2008-5#2)(2011-2#3)(2013-1#1)
biocomposites##2##1##(2008-10#2)
biocontrol activity against##4##3##(2008-10#4)
biocontrol activity of##6##3##(2008-10#6)
biocontrol activity##18##2##(2008-10#18)
biocontrol agent Trichoderma##3##3##(2008-10#3)
biocontrol agent of##7##3##(2008-10#7)
biocontrol agent that##2##3##(2008-10#2)
biocontrol agent was##3##3##(2008-10#3)
biocontrol agent##27##2##(2008-10#26)(2008-12#1)
biocontrol agents against##4##3##(2008-10#4)
biocontrol agents of soilborne pathogens##2##5##(2008-10#2)
biocontrol agents of##4##3##(2008-10#4)
biocontrol agents were##3##3##(2008-10#3)
biocontrol agents##31##2##(2008-10#31)
biocontrol capacities##2##2##(2008-10#2)
biocontrol characteristics##2##2##(2008-10#2)
biocontrol efficacy of##2##3##(2008-10#2)
biocontrol efficacy was##2##3##(2008-10#2)
biocontrol efficacy##10##2##(2008-10#10)
biocontrol fungus##5##2##(2008-10#5)
biocontrol isolates##7##2##(2008-10#7)
biocontrol mechanisms##3##2##(2008-10#3)
biocontrol of##9##2##(2008-10#6)(2008-5#1)(2012-2#2)
biocontrol potential##4##2##(2008-10#4)
biocontrol pseudomonads##3##2##(2008-10#3)
biocontrol strains of##2##3##(2008-10#1)(2008-5#1)
biocontrol strains##6##2##(2008-10#5)(2008-5#1)
biocontrol strategies##2##2##(2008-10#2)
biocontrol treatments##3##2##(2008-10#3)
biocontrol yeasts##5##2##(2008-10#5)
biocontrol##164##1##(2008-10#158)(2008-12#1)(2008-5#2)(2012-2#2)(2013-8#1)
bioconversion of##3##2##(1997-2#1)(2008-12#1)(2012-2#1)
bioconversion##9##1##(1997-2#1)(2008-10#1)(2008-12#2)(2008-6#2)(2008-7#1)(2012-2#2)
biocorrosion behaviors of##2##3##(2012-2#2)
biocorrosion behaviors##3##2##(2012-2#3)
biocorrosion##5##1##(2012-12#1)(2012-2#4)
biodegradable##9##1##(1993-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-4#1)(2010-6#1)(2013-1#1)
biodegradation by bacteria##2##3##(2011-1#2)
biodegradation of##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#2)(2011-1#1)
biodegradation##20##1##(2008-10#4)(2008-11#2)(2008-7#1)(2009-3#4)(2009-9#2)(2010-7#1)(2011-1#6)
biodiesel blends (0-100%##2##3##(2008-10#2)
biodiesel blends##4##2##(2008-10#4)
biodiesel production##5##2##(2009-3#5)
biodiesel##15##1##(2008-10#4)(2009-3#11)
biodiversity of these##2##3##(2008-10#1)(2008-8#1)
biodiversity of##5##2##(2008-10#1)(2008-8#1)(2011-2#3)
biodiversity##12##1##(2008-10#2)(2008-8#2)(2011-2#4)(2012-2#3)(2012-3#1)
bioelectrode was tested##2##3##(2008-10#2)
bioelectrode##4##1##(2008-10#4)
bioengineering##7##1##(2008-11#3)(2008-3#1)(2008-9#1)(2009-12#2)
bioequivalence##3##1##(1992-9#1)(1996-2#1)(2008-10#1)
bioethical##8##1##(1994-12#4)(1995-3#1)(2008-7#2)(2013-8#1)
bioethics##5##1##(1991-2#1)(1996-2#1)(1997-3#1)(2010-8#1)(2013-8#1)
biofeedback##4##1##(2008-10#1)(2013-1#3)
biofilm community##2##2##(2009-4#2)
biofilm decay in##3##3##(2009-6#3)
biofilm density and substrate consumption rates##2##6##(2008-7#2)
biofilm density and##3##3##(2008-7#3)
biofilm density##4##2##(2008-7#4)
biofilm development##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
biofilm formation was##2##3##(2008-10#1)(2008-7#1)
biofilm formation##13##2##(2007-12#1)(2008-10#1)(2008-7#5)(2009-6#2)(2013-1#1)(2013-8#3)
biofilm on the##2##3##(2008-10#1)(2008-7#1)
biofilm to##3##2##(2008-7#2)(2009-6#1)
biofilm viability##3##2##(2013-1#3)
biofilm was##3##2##(2008-7#3)
biofilm##55##1##(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#24)(2008-9#2)(2009-4#2)(2009-6#7)(2012-2#1)(2013-1#7)(2013-8#5)
biofilm-forming##2##1##(2013-1#1)(2013-8#1)
biofilms and##2##2##(2008-7#1)(2009-4#1)
biofilms in the##3##3##(2008-5#1)(2008-9#1)(2011-2#1)
biofilms in##6##2##(2008-5#1)(2008-9#2)(2009-4#1)(2011-2#2)
biofilms##21##1##(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#5)(2009-4#3)(2011-2#3)(2012-2#2)(2013-1#3)
biofilter##3##1##(2008-7#3)
biofluids##4##1##(2008-10#2)(2009-11#1)(2010-11#1)
biofortification##5##1##(2011-2#1)(2013-8#4)
biofouling##4##1##(2008-10#3)(2010-8#1)
biofuel##2##1##(2009-8#1)(2011-2#1)
biofuels##2##1##(2009-6#1)(2013-1#1)
biogenesis and##4##2##(2011-2#1)(2012-3#2)(2013-1#1)
biogenesis is##2##2##(2011-2#1)(2012-2#1)
biogenesis##23##1##(1994-12#1)(2008-1#2)(2008-11#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
biogenic amine receptors##2##3##(2008-7#2)
biogenic amine##4##2##(1997-1#1)(2008-10#1)(2008-7#2)
biogenic amines##11##2##(2008-10#8)(2008-7#3)
biogenic detritus##2##2##(2008-11#2)
biogenic##22##1##(1997-1#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-7#5)
biogeochemical cycles##2##2##(2008-10#1)(2011-2#1)
biogeochemical cycling##2##2##(2008-10#2)
biogeochemical##6##1##(2008-10#4)(2011-2#1)(2013-8#1)
biogeographical##2##1##(2008-9#2)
biogeography of the##2##3##(2008-6#1)(2012-2#1)
biogeography of##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
biogeography##8##1##(2008-6#1)(2008-8#3)(2008-9#2)(2012-2#2)
biographies##2##1##(2008-11#2)
bioimaging##3##1##(2010-11#1)(2010-4#2)
bioinformatic##3##1##(2008-10#1)(2008-9#1)(2013-8#1)
bioinformatics approach##2##2##(2008-6#1)(2011-3#1)
bioinformatics software##2##2##(2008-4#1)(2013-8#1)
bioinformatics to##2##2##(2008-11#1)(2009-4#1)
bioinformatics##12##1##(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#3)(2011-3#1)(2013-8#1)
bioinorganic chemistry##2##2##(2010-11#2)
bioisosteres##2##1##(1992-10#1)(2008-10#1)
biolistic##5##1##(2008-10#5)
bioload##3##1##(2012-2#3)
biologic activity of##3##3##(1991-3#1)(1995-3#1)(1995-5#1)
biologic activity##6##2##(1991-3#2)(1995-3#1)(1995-5#1)(2010-12#1)(2013-1#1)
biologic aggressiveness of the##2##4##(1991-2#1)(1994-6#1)
biologic basis##2##2##(1993-12#1)(2013-1#1)
biologic behavior##4##2##(1990-2#1)(1991-6#1)(1992-10#1)(2008-11#1)
biologic functions of##2##3##(2013-1#1)(2013-7#1)
biologic functions##3##2##(2013-1#2)(2013-7#1)
biologic properties##3##2##(1997-3#1)(2013-1#2)
biologic therapies##2##2##(2008-6#2)
biologic##41##1##(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#4)(1991-6#1)(1992-10#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-9#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#8)(2013-7#1)
biological actions##3##2##(1993-2#1)(2008-7#1)(2009-3#1)
biological activities and##3##3##(2008-8#1)(2011-1#1)(2011-3#1)
biological activities of##5##3##(2008-5#1)(2010-5#1)(2011-2#1)(2013-8#2)
biological activities were evaluated##2##4##(2008-5#1)(2013-1#1)
biological activities were##3##3##(2008-5#1)(2008-9#1)(2013-1#1)
biological activities##18##2##(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#2)(2013-1#1)(2013-8#2)
biological activity and##3##3##(1995-2#1)(2008-5#1)(2011-2#1)
biological activity in##3##3##(1992-5#1)(1993-8#2)
biological activity of the##5##4##(1990-8#1)(1997-7#1)(2008-8#1)(2009-3#1)(2009-6#1)
biological activity of this##2##4##(1992-6#1)(2011-3#1)
biological activity of##24##3##(1990-2#1)(1990-8#1)(1992-6#2)(1994-11#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-6#1)(2011-3#1)(2012-2#1)
biological activity was##2##3##(1990-12#1)(1995-12#1)
biological activity##63##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-5#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-8#5)(1994-11#1)(1995-11#1)(1995-12#2)(1995-2#1)(1997-7#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-5#4)(2008-7#2)(2008-8#8)(2008-9#3)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-6#1)(2010-9#2)(2011-2#2)(2011-3#1)(2012-2#1)
biological agents for##2##3##(1992-12#1)(2010-10#1)
biological agents##8##2##(1992-12#3)(2008-5#2)(2008-9#1)(2010-10#1)(2012-3#1)
biological and biochemical##2##3##(2008-10#2)
biological and chemical monitoring##2##4##(2008-10#2)
biological and chemical##4##3##(2008-10#4)
biological and clinical##3##3##(2008-11#1)(2010-11#1)(2012-2#1)
biological and environmental samples##5##4##(2008-10#5)
biological and environmental##7##3##(2008-10#7)
biological and genetic markers##2##4##(2013-1#1)(2013-8#1)
biological and genetic##4##3##(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
biological and medical##2##3##(1991-6#1)(2008-12#1)
biological and molecular characteristics##2##4##(2008-10#2)
biological and molecular##5##3##(2008-10#5)
biological and pharmacological activities##2##4##(2008-10#1)(2011-1#1)
biological and psychosocial##2##3##(2008-1#1)(2008-4#1)
biological and soil samples##2##4##(2008-10#2)
biological and##54##2##(1991-6#1)(1994-5#1)(1995-8#1)(1997-1#1)(1997-5#1)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
biological applications##3##2##(2008-11#2)(2012-12#1)
biological approaches##2##2##(2009-6#1)(2010-7#1)
biological aspects of##2##3##(2008-5#1)(2012-12#1)
biological aspects##4##2##(2008-5#1)(2012-12#2)(2012-3#1)
biological assay (MTT-assay)##2##3##(2008-11#2)
biological assay##6##2##(1990-12#2)(1994-5#1)(2008-10#1)(2008-11#2)
biological assays##3##2##(2008-10#3)
biological attack##2##2##(2010-7#2)
biological basis of##3##3##(1993-9#1)(2008-10#1)(2013-1#1)
biological behavior of##4##3##(1990-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
biological behavior##6##2##(1990-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
biological behaviour of##3##3##(1993-6#1)(2008-7#2)
biological cells##2##2##(2008-10#1)(2009-9#1)
biological certified reference materials##3##4##(2008-10#3)
biological characteristics and##2##3##(2008-8#1)(2013-8#1)
biological characteristics of##3##3##(2008-4#2)(2012-2#1)
biological characteristics##10##2##(1990-9#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-4#2)(2008-8#1)(2012-2#1)(2013-8#1)
biological components##2##2##(2008-10#1)(2009-7#1)
biological conditions##2##2##(2008-10#1)(2008-7#1)
biological control activity##3##3##(2008-10#3)
biological control agent##11##3##(2008-10#9)(2008-5#1)(2010-10#1)
biological control agents (BCAs)##2##4##(2008-10#2)
biological control agents##12##3##(2008-10#11)(2008-8#1)
biological control and##2##3##(2008-10#2)
biological control by##4##3##(2008-10#4)
biological control in##4##3##(1991-2#1)(2008-10#3)
biological control is##2##3##(2008-10#1)(2008-8#1)
biological control of Fusarium wilt of tomato##2##7##(2008-10#2)
biological control of fire blight##3##5##(2008-10#3)
biological control of leaf spot##2##5##(2008-10#2)
biological control of plant pathogens##2##5##(2008-10#2)
biological control of plant##3##4##(2008-10#3)
biological control of postharvest diseases##4##5##(2008-10#4)
biological control of soilborne##2##4##(2008-10#2)
biological control of the##2##4##(2008-10#2)
biological control of##37##3##(2008-10#36)(2008-8#1)
biological control or##2##3##(2008-10#2)
biological control##109##2##(1991-2#1)(1997-7#1)(2008-10#100)(2008-11#1)(2008-5#1)(2008-8#4)(2010-10#1)
biological criteria##3##2##(2011-2#2)(2012-2#1)
biological data##6##2##(1992-6#1)(1994-5#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
biological defense research##4##3##(1992-12#4)
biological differences##3##2##(2008-10#2)(2010-11#1)
biological dosimetry##3##2##(2008-10#1)(2008-7#2)
biological effect##5##2##(1991-12#1)(1996-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
biological effects and##2##3##(1995-2#1)(2008-11#1)
biological effects of##8##3##(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#1)
biological effects##18##2##(1993-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
biological efficacy##2##2##(1992-9#2)
biological events##4##2##(1991-12#1)(1992-6#1)(2008-10#1)(2008-5#1)
biological evidence to##2##3##(2011-2#1)(2013-1#1)
biological evidence##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
biological evolution##3##2##(2010-3#3)
biological experiments##2##2##(1995-12#1)(2010-10#1)
biological factors##3##2##(1992-11#1)(2008-8#1)(2010-11#1)
biological fluid##7##2##(2008-10#5)(2008-12#1)(2008-4#1)
biological fluids and##2##3##(2008-10#2)
biological fluids were##2##3##(1995-11#1)(2008-10#1)
biological fluids##39##2##(1992-1#1)(1992-12#1)(1995-11#1)(1997-7#1)(2008-10#32)(2008-11#1)(2008-4#1)(2013-8#1)
biological function of##4##3##(1991-2#1)(2008-11#2)(2011-1#1)
biological function##11##2##(1991-2#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-9#1)(2011-1#1)(2012-2#3)
biological functions of##4##3##(1991-5#1)(1995-6#1)(2008-9#1)(2011-2#1)
biological functions##8##2##(1991-5#1)(1993-9#1)(1995-6#1)(2008-11#1)(2008-9#2)(2011-1#1)(2011-2#1)
biological hazards##2##2##(1992-12#1)(2012-3#1)
biological importance##5##2##(1991-5#1)(2008-10#3)(2012-3#1)
biological information##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)
biological insight##2##2##(2008-10#1)(2008-11#1)
biological macromolecules##5##2##(1997-6#3)(2008-10#1)(2008-11#1)
biological markers in##2##3##(1991-11#2)
biological markers##8##2##(1991-11#3)(1993-2#1)(2008-10#1)(2008-7#1)(2011-2#2)
biological mashed tomato##2##3##(2008-10#2)
biological material in##2##3##(2008-10#1)(2009-12#1)
biological material##7##2##(1994-6#1)(2008-10#3)(2008-11#1)(2009-12#1)(2012-3#1)
biological materials and##4##3##(2008-10#4)
biological materials by##6##3##(1991-7#1)(2008-10#5)
biological materials in##2##3##(2008-10#1)(2009-12#1)
biological materials##25##2##(1991-7#1)(2008-10#18)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-2#1)
biological matrices by##3##3##(2008-10#3)
biological matrices##11##2##(2008-10#8)(2010-11#1)(2012-12#2)
biological mechanism for triggering of ABA accumulation under water stress##2##10##(2008-8#2)
biological mechanisms##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2013-1#1)
biological membranes##7##2##(1992-9#1)(1994-5#2)(1997-2#1)(2008-10#2)(2008-11#1)
biological molecules##7##2##(2008-10#5)(2008-4#1)(2009-5#1)
biological monitoring of##2##3##(2008-10#2)
biological monitoring##3##2##(2008-10#3)
biological motion##4##2##(2008-11#4)
biological network##2##2##(2010-10#1)(2010-12#1)
biological networks and##2##3##(2008-11#1)(2010-12#1)
biological networks##3##2##(2008-11#1)(2010-10#1)(2010-12#1)
biological neural##3##2##(2008-11#3)
biological or##3##2##(1992-12#1)(1993-3#1)(2008-11#1)
biological organisms##2##2##(2008-8#1)(2010-11#1)
biological oxidation##2##2##(2008-10#1)(2008-5#1)
biological oxygen demand##2##3##(2008-10#2)
biological parameters##5##2##(1993-6#1)(1996-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
biological parts##2##2##(2008-11#1)(2012-2#1)
biological pathways##4##2##(2008-11#1)(2008-4#1)(2009-12#1)(2010-10#1)
biological phenomena##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
biological phenomenon##2##2##(2008-9#1)(2011-3#1)
biological problems##3##2##(1994-9#1)(2008-11#1)(2011-2#1)
biological process of##2##3##(2009-10#1)(2011-2#1)
biological process##3##2##(2009-10#1)(2011-2#1)(2013-8#1)
biological processes and##3##3##(2011-2#2)(2012-2#1)
biological processes that##2##3##(2008-10#1)(2010-10#1)
biological processes##24##2##(1996-6#1)(1997-7#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)
biological products##3##2##(2008-10#1)(2008-11#2)
biological profiles##4##2##(2011-3#4)
biological properties of##5##3##(2008-11#1)(2008-5#2)(2009-7#2)
biological properties##15##2##(1993-8#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-5#3)(2008-9#1)(2009-7#2)(2012-3#1)
biological rationale and##2##3##(1990-11#1)(2008-10#1)
biological rationale##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
biological reference material##2##3##(2008-10#2)
biological reference materials##4##3##(2008-10#4)
biological reference##6##2##(2008-10#6)
biological relevance of these##2##4##(1995-2#1)(1997-1#1)
biological relevance of##4##3##(1995-2#1)(1997-1#2)(2009-8#1)
biological relevance##6##2##(1990-5#1)(1995-2#1)(1997-1#2)(2008-4#1)(2009-8#1)
biological research##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
biological response##3##2##(1997-4#1)(2008-5#2)
biological responses##4##2##(1996-2#2)(2008-10#1)(2008-5#1)
biological role of##3##3##(1991-2#1)(2008-5#1)(2013-7#1)
biological role##5##2##(1991-2#1)(1995-2#1)(2008-11#1)(2008-5#1)(2013-7#1)
biological roles##2##2##(2008-11#1)(2012-2#1)
biological sample is##2##3##(2008-10#1)(2009-12#1)
biological sample##7##2##(1993-12#1)(2008-10#5)(2009-12#1)
biological samples (human blood and urine)##2##6##(2008-10#2)
biological samples and##3##3##(2008-10#3)
biological samples by##8##3##(2008-10#8)
biological samples is##3##3##(2008-10#3)
biological samples to##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
biological samples using##3##3##(2008-10#2)(2009-12#1)
biological samples was##2##3##(2008-10#2)
biological samples with satisfactory results##2##5##(2008-10#2)
biological samples with##5##3##(2008-10#4)(2008-4#1)
biological samples##94##2##(1993-2#1)(1994-8#1)(2008-10#80)(2008-11#1)(2008-4#4)(2009-12#4)(2010-11#1)(2010-6#1)(2011-2#1)
biological signals##2##2##(2008-11#2)
biological significance##9##2##(1990-9#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2012-2#1)
biological species##6##2##(2008-10#2)(2008-6#1)(2008-8#1)(2010-10#2)
biological specimens##3##2##(1994-8#1)(2008-9#2)
biological studies##2##2##(1991-11#1)(1995-3#1)
biological substrate##3##2##(1992-1#1)(2008-10#1)(2008-4#1)
biological suppression##2##2##(2008-10#2)
biological system##2##2##(1995-5#1)(2008-10#1)
biological systems and##2##3##(2008-10#1)(2008-4#1)
biological systems are##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
biological systems in##2##3##(2010-7#1)(2013-8#1)
biological systems##31##2##(1990-3#1)(1991-5#1)(1992-3#2)(1994-9#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2010-11#2)(2010-7#1)(2013-1#2)(2013-8#1)
biological tests##2##2##(2008-10#1)(2013-1#1)
biological therapies##4##2##(2009-12#2)(2010-12#1)(2013-1#1)
biological time##2##2##(2010-11#1)(2010-7#1)
biological tissue##5##2##(2007-12#3)(2009-10#1)(2009-8#1)
biological tissues##9##2##(2008-10#5)(2009-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
biological treatments##2##2##(2010-7#1)(2012-3#1)
biological variability##2##2##(2008-10#1)(2010-7#1)
biological variation is##2##3##(2008-6#1)(2008-7#1)
biological warfare##4##2##(1992-12#3)(2008-11#1)
biological weapons##5##2##(1992-12#4)(2010-7#1)
biological##1035##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#3)(1991-11#4)(1991-12#2)(1991-2#3)(1991-5#4)(1991-6#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#22)(1992-3#2)(1992-5#2)(1992-6#5)(1992-9#8)(1993-1#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#7)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#3)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#420)(2008-11#67)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#21)(2008-5#32)(2008-6#3)(2008-7#20)(2008-8#43)(2008-9#28)(2009-10#4)(2009-11#1)(2009-12#15)(2009-3#4)(2009-5#5)(2009-6#3)(2009-7#10)(2009-8#6)(2009-9#1)(2010-10#11)(2010-11#11)(2010-12#10)(2010-3#4)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#12)(2010-8#1)(2010-9#4)(2011-1#8)(2011-2#28)(2011-3#12)(2012-12#6)(2012-2#24)(2012-3#13)(2013-1#14)(2013-7#2)(2013-8#14)
biologically active in##2##3##(1992-12#1)(2008-10#1)
biologically active peptides##2##3##(1995-3#1)(2008-5#1)
biologically active protein##2##3##(1993-6#1)(2008-8#1)
biologically active##27##2##(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#5)(1994-5#2)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#2)
biologically and clinically##2##3##(1996-3#1)(2011-2#1)
biologically and##6##2##(1996-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
biologically derived##3##2##(2008-10#3)
biologically important##8##2##(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)
biologically inactive##4##2##(1993-8#1)(1995-2#1)(2008-12#1)(2010-6#1)
biologically meaningful##3##2##(2008-10#2)(2008-8#1)
biologically or clinically##2##3##(2011-2#2)
biologically plausible##2##2##(2008-10#1)(2008-9#1)
biologically relevant##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
biologically##90##1##(1990-3#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#5)(1993-8#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-4#1)(2008-10#26)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#3)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#7)(2012-2#1)(2013-8#1)
biologicals##4##1##(2008-11#3)(2012-3#1)
biologics##5##1##(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)
biologist controversies##2##2##(2013-8#2)
biologist##6##1##(2008-10#1)(2008-4#2)(2008-9#1)(2013-8#2)
biologists and##2##2##(2008-10#1)(2008-9#1)
biologists to##4##2##(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)
biologists##24##1##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#4)(2008-9#5)(2009-6#2)(2009-8#2)(2010-11#1)(2010-5#1)(2012-12#2)(2013-8#1)
biology and clinical importance##2##4##(2008-6#2)
biology and clinical##3##3##(2008-10#1)(2008-6#2)
biology and the##7##3##(1993-1#1)(1997-7#3)(2008-11#1)(2008-12#1)(2008-5#1)
biology and##38##2##(1993-1#1)(1993-11#1)(1997-6#1)(1997-7#3)(2008-10#5)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
biology for##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
biology has been##2##3##(2008-9#1)(2012-3#1)
biology has##5##2##(2008-12#1)(2008-9#1)(2009-5#1)(2012-3#2)
biology have been##2##3##(1994-5#1)(2008-8#1)
biology have##5##2##(1994-5#1)(2008-8#1)(2009-1#1)(2010-5#1)(2012-3#1)
biology in##9##2##(1997-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#2)
biology is##2##2##(2008-11#1)(2009-12#1)
biology of the##10##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2012-5#1)(2013-8#1)
biology of this##2##3##(1997-1#1)(2008-10#1)
biology of##37##2##(1995-5#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#1)(2008-8#4)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#3)(2012-5#1)(2013-1#1)(2013-8#1)
biology rather than##2##3##(1990-11#1)(2008-8#1)
biology to##6##2##(1995-9#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)
biology##226##1##(1990-11#1)(1991-2#1)(1991-5#2)(1992-2#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-5#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-6#3)(1997-7#9)(2007-12#2)(2008-10#23)(2008-11#20)(2008-12#7)(2008-4#10)(2008-5#10)(2008-6#2)(2008-8#15)(2008-9#18)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-4#2)(2010-5#4)(2010-7#4)(2010-8#2)(2011-1#1)(2011-2#13)(2012-12#2)(2012-2#6)(2012-3#18)(2012-5#1)(2013-1#4)(2013-8#10)
bioluminescence inhibition of##4##3##(2008-10#4)
bioluminescence inhibition tests##2##3##(2008-10#2)
bioluminescence inhibition##7##2##(2008-10#7)
bioluminescence##19##1##(1995-2#1)(2007-12#1)(2008-10#12)(2008-5#2)(2011-1#1)(2011-3#1)(2012-2#1)
bioluminescent bacterial sensor##2##3##(2008-10#1)(2011-1#1)
bioluminescent##7##1##(2007-12#1)(2008-10#3)(2011-1#1)(2012-2#1)(2013-1#1)
biomachining processes##2##2##(2008-8#2)
biomachining##5##1##(2008-8#5)
biomarker and##2##2##(2008-10#1)(2010-1#1)
biomarker compounds##2##2##(2008-11#2)
biomarker discovery##7##2##(2008-4#1)(2010-5#2)(2010-7#3)(2013-8#1)
biomarker for assessing the##2##4##(2010-5#2)
biomarker for##8##2##(2008-10#3)(2010-1#1)(2010-5#2)(2012-2#1)(2013-8#1)
biomarker in##5##2##(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
biomarker of##8##2##(2008-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
biomarker studies##7##2##(1991-12#1)(2010-5#4)(2012-2#2)
biomarker to##2##2##(2009-6#1)(2010-1#1)
biomarker##65##1##(1991-12#1)(2008-10#7)(2008-11#3)(2008-4#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#2)(2010-1#3)(2010-10#2)(2010-12#2)(2010-5#17)(2010-7#3)(2010-9#2)(2011-2#3)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#4)
biomarker-discovery platforms##2##2##(2010-7#2)
biomarkers and##3##2##(2010-5#2)(2011-2#1)
biomarkers are##4##2##(2008-10#1)(2010-5#2)(2011-3#1)
biomarkers can##2##2##(2008-10#1)(2010-5#1)
biomarkers for the##2##3##(2008-10#1)(2010-7#1)
biomarkers for##12##2##(2008-10#1)(2008-12#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#2)
biomarkers have##2##2##(2008-10#1)(2012-2#1)
biomarkers in the##2##3##(2010-5#1)(2011-2#1)
biomarkers in##9##2##(2008-6#1)(2010-12#2)(2010-5#2)(2011-2#3)(2012-2#1)
biomarkers is a##2##3##(2010-5#1)(2010-9#1)
biomarkers of exposure##2##3##(2008-10#1)(2010-5#1)
biomarkers of##7##2##(2008-10#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-5#2)
biomarkers##68##1##(2008-10#11)(2008-12#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-12#8)(2010-5#15)(2010-7#2)(2010-9#3)(2011-2#11)(2011-3#1)(2012-2#8)(2013-1#3)(2013-8#1)
biomass accumulation in##2##3##(2008-10#1)(2012-8#1)
biomass accumulation##3##2##(2008-10#2)(2012-8#1)
biomass allocation##2##2##(2008-8#2)
biomass and chlorophyll##2##3##(2008-12#2)
biomass and##10##2##(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#2)(2008-9#1)
biomass carbon and nitrogen##2##4##(2008-10#2)
biomass concentration reached##2##3##(2008-5#1)(2008-7#1)
biomass concentration##5##2##(2008-5#2)(2008-7#3)
biomass dynamics##2##2##(2008-7#2)
biomass in##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
biomass is##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
biomass of a##2##3##(2008-10#2)
biomass of##7##2##(2008-10#6)(2008-8#1)
biomass partitioning##2##2##(2008-8#2)
biomass production and##2##3##(2008-10#2)
biomass production##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
biomass was##6##2##(2008-10#3)(2008-12#1)(2008-7#1)(2013-1#1)
biomass were##3##2##(2008-10#3)
biomass##134##1##(2008-10#55)(2008-11#11)(2008-12#6)(2008-5#4)(2008-7#22)(2008-8#15)(2008-9#7)(2009-8#2)(2010-4#1)(2010-7#1)(2011-2#4)(2012-3#2)(2012-8#1)(2013-1#3)
biomaterial##4##1##(2008-10#1)(2009-12#1)(2009-7#2)
biomaterials have been investigated##2##4##(2011-3#1)(2012-2#1)
biomaterials have been##3##3##(2009-12#1)(2011-3#1)(2012-2#1)
biomaterials have##4##2##(2008-10#1)(2009-12#1)(2011-3#1)(2012-2#1)
biomaterials##19##1##(1991-3#1)(2008-10#5)(2008-11#5)(2008-12#1)(2009-12#2)(2009-7#2)(2011-3#1)(2012-2#1)(2012-5#1)
biomechanical effects of zoledronic##2##4##(2013-1#2)
biomechanical model##2##2##(2008-12#1)(2009-3#1)
biomechanical principles##2##2##(2008-8#2)
biomechanical properties##4##2##(2008-5#1)(2009-3#1)(2009-8#1)(2010-9#1)
biomechanical study##2##2##(2009-3#1)(2013-1#1)
biomechanical##31##1##(1993-9#1)(1994-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#3)(2009-4#1)(2009-7#4)(2009-8#1)(2010-9#2)(2011-2#1)(2011-7#1)(2012-12#2)(2013-1#5)
biomechanically##2##1##(2012-3#1)(2013-1#1)
biomechanics of##4##2##(2008-12#1)(2013-1#3)
biomechanics##10##1##(2008-12#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#5)
biomedical and##3##2##(2009-12#1)(2010-4#1)(2013-1#1)
biomedical applications##5##2##(1994-11#1)(1994-3#1)(2008-11#1)(2009-12#1)(2009-7#1)
biomedical research##6##2##(1993-3#1)(2008-11#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
biomedical##39##1##(1993-3#1)(1994-11#1)(1994-3#2)(1994-9#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2009-11#1)(2009-12#3)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
biomedically##2##1##(2008-11#2)
biometrological##3##1##(2008-5#3)
biomicroscopy##2##1##(2009-5#1)(2010-9#1)
biomimetic##8##1##(1995-3#1)(2008-10#3)(2008-5#1)(2009-7#2)(2010-5#1)
biomolecular interactions##2##2##(2008-10#1)(2008-4#1)
biomolecular##8##1##(1997-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#1)
biomolecule##3##1##(2008-10#2)(2010-7#1)
biomolecules and bioparticles##2##3##(2010-7#2)
biomolecules and##6##2##(1997-6#1)(2008-5#1)(2010-7#3)(2011-1#1)
biomolecules in##2##2##(1997-6#1)(2008-10#1)
biomolecules inside##2##2##(2008-10#1)(2008-9#1)
biomolecules##26##1##(1997-6#4)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#3)(2010-12#1)(2010-7#4)(2011-1#1)(2011-2#2)(2013-1#2)
biomonitoring of lead (Pb)##2##4##(2008-10#2)
biomonitoring of##4##2##(2008-10#3)(2008-12#1)
biomonitoring##7##1##(2008-10#4)(2008-11#1)(2008-12#2)
bioparticle##3##1##(2008-7#3)
bioparticles##3##1##(2010-7#3)
biopeptide##4##1##(2008-5#4)
biopharmaceutical process##3##2##(2008-11#2)(2010-11#1)
biopharmaceutical product##3##2##(2008-11#1)(2012-2#2)
biopharmaceutical##11##1##(2008-11#7)(2010-11#1)(2012-2#2)(2012-3#1)
biopharmaceuticals and##2##2##(2008-10#1)(2011-2#1)
biopharmaceuticals are##2##2##(2008-11#2)
biopharmaceuticals##12##1##(2008-10#3)(2008-11#6)(2011-2#3)
biophysical and biochemical##2##3##(2012-2#2)
biophysical and##3##2##(2012-2#3)
biophysical characteristics##2##2##(2008-10#1)(2010-7#1)
biophysical parameters##2##2##(2008-5#1)(2012-3#1)
biophysical properties of##2##3##(1997-1#1)(2008-9#1)
biophysical properties##6##2##(1997-1#1)(2008-11#1)(2008-9#2)(2009-12#1)(2013-1#1)
biophysical##31##1##(1996-12#2)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#5)(2008-8#2)(2008-9#3)(2009-12#2)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
biophysics##2##1##(2008-5#1)(2012-3#1)
biopolymer##9##1##(2008-10#7)(2008-11#1)(2008-5#1)
biopolymers##7##1##(1995-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)
biopreparation treatments##3##2##(2008-10#3)
biopreparation##4##1##(2008-10#4)
biopreparation-treated##2##1##(2008-10#2)
biopreparations##3##1##(2008-10#3)
biopriming##4##1##(2008-10#4)
bioprocess QbD framework##2##3##(2012-2#2)
bioprocess QbD##3##2##(2012-2#3)
bioprocess environment##2##2##(2008-11#2)
bioprocess##16##1##(1997-7#1)(2008-10#1)(2008-11#5)(2012-2#5)(2013-1#4)
bioprocesses##4##1##(2008-10#1)(2008-11#1)(2013-1#2)
bioprocessing##6##1##(1997-2#3)(2008-11#2)(2012-3#1)
biopsied##6##1##(1994-12#1)(2008-10#3)(2010-6#1)(2012-3#1)
biopsies and##4##2##(1990-11#1)(1991-11#1)(2008-5#2)
biopsies from the##2##3##(1993-1#1)(1996-8#1)
biopsies from##4##2##(1993-1#1)(1996-8#1)(2008-9#1)(2012-12#1)
biopsies of##3##2##(1991-3#1)(2008-5#1)(2011-2#1)
biopsies revealing##2##2##(1992-3#1)(2010-12#1)
biopsies showing##2##2##(1993-2#1)(2008-7#1)
biopsies were taken##2##3##(2008-10#1)(2010-12#1)
biopsies were##8##2##(1991-11#1)(1994-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#2)
biopsies##64##1##(1990-11#3)(1990-12#1)(1990-2#1)(1991-11#5)(1991-3#1)(1992-12#2)(1992-3#3)(1993-1#1)(1993-2#4)(1994-1#2)(1994-12#2)(1994-3#1)(1996-11#1)(1996-8#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#5)(2008-7#2)(2008-9#2)(2009-8#3)(2010-11#1)(2010-12#5)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
biopsy (16##2##2##(1991-11#1)(2013-1#1)
biopsy Gleason score##2##3##(2010-11#1)(2011-2#1)
biopsy and##9##2##(1990-2#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)(2011-2#2)(2012-3#1)
biopsy can be##2##3##(2008-2#1)(2008-9#1)
biopsy can##4##2##(2008-1#1)(2008-2#1)(2008-9#1)(2012-3#1)
biopsy confirmed##2##2##(2012-2#1)(2013-1#1)
biopsy could##2##2##(1991-8#1)(2008-12#1)
biopsy demonstrated a##2##3##(1990-2#2)
biopsy demonstrated##3##2##(1990-2#2)(2008-5#1)
biopsy for breast##2##3##(1997-8#1)(2012-2#1)
biopsy for##8##2##(1997-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-8#1)
biopsy from the##2##3##(1991-6#1)(1997-3#1)
biopsy from##3##2##(1991-6#1)(1997-3#1)(1997-8#1)
biopsy in the diagnosis##2##4##(2008-11#1)(2011-1#1)
biopsy in the##5##3##(1994-2#1)(2008-1#1)(2008-11#1)(2011-1#1)(2011-2#1)
biopsy in##13##2##(1990-11#1)(1994-2#1)(1996-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
biopsy is##5##2##(2008-11#1)(2011-2#1)(2012-2#3)
biopsy may##2##2##(2012-3#2)
biopsy of the##10##3##(1990-11#1)(1990-3#1)(1991-11#1)(1994-9#1)(2010-11#2)(2011-2#2)(2012-3#2)
biopsy of##16##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1994-9#1)(1996-11#1)(2010-11#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
biopsy or##3##2##(1991-3#1)(2011-2#2)
biopsy revealed##4##2##(1991-3#1)(2008-10#1)(2010-11#1)(2013-1#1)
biopsy samples##2##2##(1996-6#1)(2010-12#1)
biopsy showed a##3##3##(2013-8#3)
biopsy showed##6##2##(1997-3#1)(2009-1#1)(2011-2#1)(2013-8#3)
biopsy specimen##5##2##(2007-9#1)(2009-3#1)(2010-11#2)(2010-6#1)
biopsy specimens revealed##2##3##(2010-10#1)(2011-2#1)
biopsy specimens##13##2##(1992-12#1)(1994-1#1)(1996-8#1)(1997-8#1)(2008-12#4)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#2)
biopsy to confirm##2##3##(2008-1#1)(2013-8#1)
biopsy was performed in##2##4##(2011-2#2)
biopsy was performed##4##3##(2009-8#1)(2011-2#3)
biopsy was taken##2##3##(2011-2#1)(2012-2#1)
biopsy was##10##2##(2009-1#1)(2009-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-8#1)
biopsy##200##1##(1990-11#2)(1990-2#4)(1990-3#2)(1990-6#1)(1991-11#2)(1991-2#1)(1991-3#4)(1991-6#4)(1991-8#2)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-5#1)(1996-11#5)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#6)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#7)(2008-11#4)(2008-12#8)(2008-2#1)(2008-5#4)(2008-7#5)(2008-9#2)(2009-1#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#9)(2010-12#7)(2010-6#3)(2010-7#1)(2011-1#3)(2011-2#32)(2011-7#1)(2012-12#1)(2012-2#16)(2012-3#15)(2013-1#10)(2013-8#8)
biopsy]##2##1##(1991-6#1)(1997-2#1)
biopsychosocial model##3##2##(2008-10#1)(2008-4#1)(2009-9#1)
biopsychosocial##8##1##(1995-11#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-9#1)(2011-2#1)
bioreactor by##2##2##(2008-11#2)
bioreactor configuration and##2##3##(2008-11#1)(2008-7#1)
bioreactor cultivation##2##2##(2008-11#1)(2011-2#1)
bioreactor culture##3##2##(2008-11#2)(2008-7#1)
bioreactor cultures##2##2##(2008-11#2)
bioreactor for continuous ultra-slow uniaxial distraction of a##2##8##(2011-2#2)
bioreactor for##6##2##(2008-11#3)(2008-7#1)(2011-2#2)
bioreactor scale##3##2##(2008-11#2)(2008-7#1)
bioreactor system for##2##3##(1995-3#1)(2008-11#1)
bioreactor system##6##2##(1995-3#1)(2008-11#5)
bioreactor systems##2##2##(2008-11#2)
bioreactor to##3##2##(2008-11#3)
bioreactor under##3##2##(2008-11#2)(2011-2#1)
bioreactor using magnetic resonance##2##4##(2008-11#1)(2008-7#1)
bioreactor using##3##2##(2008-11#2)(2008-7#1)
bioreactor was compared##2##3##(2008-11#1)(2008-7#1)
bioreactor was##5##2##(2008-11#4)(2008-7#1)
bioreactor were##2##2##(2008-11#2)
bioreactor with a##3##3##(2008-11#3)
bioreactor with##9##2##(2008-11#9)
bioreactor##131##1##(1995-3#1)(2008-10#4)(2008-11#104)(2008-7#13)(2010-5#1)(2011-2#6)(2012-2#2)
bioreactors and##2##2##(2008-10#1)(2008-11#1)
bioreactors in##2##2##(2008-11#2)
bioreactors##30##1##(2008-10#2)(2008-11#24)(2008-7#2)(2011-2#2)
biorecognition elements##2##2##(2008-10#1)(2010-11#1)
biorecognition groups to solids##2##4##(2008-10#2)
biorecognition##6##1##(2008-10#5)(2010-11#1)
bioremediation of##3##2##(2008-7#1)(2012-2#2)
bioremediation##9##1##(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#2)
bioreporter##3##1##(2008-10#1)(2011-2#2)
bioreporters##6##1##(2011-1#1)(2011-2#5)
biorheological##3##1##(2008-9#3)
biosafety##3##1##(2008-11#1)(2008-8#1)(2008-9#1)
biosensing devices##2##2##(2008-10#1)(2009-12#1)
biosensing system##2##2##(2008-10#2)
biosensing##14##1##(2008-10#10)(2008-3#1)(2009-12#1)(2010-7#1)(2013-1#1)
biosensor and##9##2##(2008-10#7)(2008-9#2)
biosensor applications##2##2##(2008-10#2)
biosensor are##3##2##(2008-10#3)
biosensor array##2##2##(2008-10#1)(2008-9#1)
biosensor based on a ruthenium complex mediator of low redox potential##2##11##(2008-10#2)
biosensor based on the##4##4##(2008-10#4)
biosensor based on urate oxidase-peroxidase coupled enzyme system for##2##9##(2008-10#2)
biosensor based on##36##3##(2008-10#36)
biosensor can be used##2##4##(2008-10#2)
biosensor can##4##2##(2008-10#4)
biosensor could##3##2##(2008-10#3)
biosensor design##2##2##(2008-10#2)
biosensor device is##2##3##(2008-10#2)
biosensor devices##2##2##(2008-10#2)
biosensor displayed##2##2##(2008-10#2)
biosensor exhibited##3##2##(2008-10#3)
biosensor for detecting##2##3##(2008-10#2)
biosensor for detection of##3##4##(2008-10#3)
biosensor for detection##4##3##(2008-10#4)
biosensor for determination of##4##4##(2008-10#4)
biosensor for isocitrate##2##3##(2008-10#2)
biosensor for phenol##2##3##(2008-10#2)
biosensor for phenols##2##3##(2008-10#2)
biosensor for the detection of DNA strand cleaving agents##2##9##(2008-10#2)
biosensor for the detection of##8##5##(2008-10#8)
biosensor for the detection##9##4##(2008-10#9)
biosensor for the determination of##3##5##(2008-10#3)
biosensor for the##22##3##(1995-3#1)(2008-10#21)
biosensor for##63##2##(1995-3#1)(2008-10#61)(2008-11#1)
biosensor has been##6##3##(2008-10#6)
biosensor has##8##2##(2008-10#8)
biosensor in##4##2##(2008-10#4)
biosensor is a##2##3##(2008-10#2)
biosensor is based on an##2##5##(2008-10#2)
biosensor is based on##3##4##(2008-10#3)
biosensor is described##2##3##(2008-10#2)
biosensor is##19##2##(2008-10#19)
biosensor method##4##2##(1995-12#1)(2008-10#3)
biosensor on a##2##3##(2008-10#2)
biosensor performance##3##2##(1994-8#1)(2008-10#2)
biosensor prepared by##2##3##(2008-10#2)
biosensor responded##2##2##(2008-10#2)
biosensor response for##2##3##(2008-10#2)
biosensor response##7##2##(2008-10#7)
biosensor showed a##3##3##(2008-10#3)
biosensor showed##5##2##(2008-10#5)
biosensor shows a##2##3##(2008-10#2)
biosensor technology##3##2##(1995-12#1)(2008-10#1)(2009-3#1)
biosensor to##4##2##(2008-10#3)(2013-8#1)
biosensor using an##2##3##(2008-10#2)
biosensor using##3##2##(2008-10#3)
biosensor was applied##2##3##(2008-10#2)
biosensor was constructed##2##3##(2008-10#2)
biosensor was developed for the##2##5##(2008-10#2)
biosensor was developed for##3##4##(2008-10#3)
biosensor was developed##5##3##(1995-3#1)(2008-10#4)
biosensor was fabricated by##2##4##(2008-10#2)
biosensor was investigated##2##3##(2008-10#2)
biosensor was used##3##3##(2008-10#3)
biosensor was##31##2##(1995-3#1)(2008-10#30)
biosensor with##3##2##(2008-10#3)
biosensor##351##1##(1994-8#1)(1995-12#3)(1995-3#2)(2008-10#333)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-3#3)(2013-8#1)
biosensors and##2##2##(2008-10#2)
biosensors are##3##2##(2008-10#2)(2009-3#1)
biosensors based on the##5##4##(2008-10#5)
biosensors based on##16##3##(2008-10#16)
biosensors by##2##2##(2008-10#1)(2008-9#1)
biosensors for the##2##3##(2008-10#2)
biosensors for##4##2##(2008-10#4)
biosensors in a##2##3##(2008-10#1)(2008-9#1)
biosensors in##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
biosensors is##5##2##(2008-10#4)(2009-3#1)
biosensors obtained##2##2##(2008-10#2)
biosensors to monitor##2##3##(2008-10#1)(2008-11#1)
biosensors to##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
biosensors were proposed##2##3##(2008-10#2)
biosensors were##12##2##(2008-10#12)
biosensors##116##1##(1995-3#2)(2007-12#1)(2008-10#102)(2008-11#1)(2008-3#1)(2008-9#2)(2009-3#2)(2010-7#3)(2013-8#2)
biosolid extract##4##2##(2011-2#4)
biosorbent##5##1##(2008-10#3)(2008-12#2)
biosorption of##3##2##(2008-10#2)(2008-12#1)
biosorption##8##1##(2008-10#5)(2008-12#1)(2011-2#2)
biostatistical recommendations##2##2##(2008-12#2)
biostatistical##4##1##(2008-12#4)
biosurveillance##4##1##(2010-8#3)(2011-9#1)
biosynthesis and##8##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)
biosynthesis by##2##2##(1995-6#1)(2008-10#1)
biosynthesis gene##2##2##(2008-10#1)(2008-9#1)
biosynthesis genes##4##2##(2008-10#4)
biosynthesis in##10##2##(1990-4#1)(1991-5#1)(1995-6#1)(1997-2#2)(2008-11#3)(2009-8#1)(2011-10#1)
biosynthesis inhibitor##2##2##(2008-10#2)
biosynthesis is##4##2##(1993-9#1)(2008-10#1)(2008-9#1)(2012-2#1)
biosynthesis of a##2##3##(1990-5#1)(1993-11#1)
biosynthesis of the##8##3##(1993-2#1)(1993-8#1)(2008-10#4)(2008-7#1)(2011-2#1)
biosynthesis of##34##2##(1990-5#1)(1991-5#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-5#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-6#3)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
biosynthesis was##3##2##(1990-11#1)(1994-11#1)(2010-10#1)
biosynthesis##135##1##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-5#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-7#1)(2008-10#30)(2008-11#6)(2008-12#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#13)(2009-10#2)(2009-6#5)(2009-7#1)(2009-8#3)(2010-10#1)(2010-2#1)(2011-1#5)(2011-10#1)(2011-2#5)(2012-2#11)(2012-3#2)(2013-8#1)
biosynthetic enzymes##2##2##(1992-4#1)(2013-1#1)
biosynthetic genes##6##2##(1992-4#2)(1993-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
biosynthetic pathway##7##2##(1994-8#1)(1995-2#3)(2008-10#1)(2008-11#1)(2012-2#1)
biosynthetic pathways##3##2##(2008-10#2)(2008-11#1)
biosynthetic precursors##2##2##(1994-11#1)(2008-11#1)
biosynthetic##31##1##(1990-12#1)(1992-4#3)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#3)(2008-10#4)(2008-11#3)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#5)(2012-3#1)(2013-1#1)
biota##3##1##(2008-10#3)
biotech##5##1##(2008-11#3)(2010-5#1)(2011-2#1)
biotechnological applications##6##2##(2008-10#1)(2008-11#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
biotechnological approaches##2##2##(2008-11#1)(2011-1#1)
biotechnological##13##1##(2008-10#1)(2008-11#6)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#2)(2011-2#1)
biotechnology are##2##2##(1997-6#1)(2008-11#1)
biotechnology in##2##2##(2008-11#2)
biotechnology##33##1##(1994-12#1)(1994-3#1)(1995-1#1)(1997-6#5)(2008-10#5)(2008-11#14)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-7#1)
biotests##2##1##(2008-11#2)
biotherapeutic##5##1##(2008-10#3)(2008-11#1)(2008-5#1)
biotherapeutics##6##1##(2008-10#5)(2011-2#1)
biotic and abiotic stresses##3##4##(2008-8#1)(2010-10#2)
biotic and abiotic##5##3##(2008-10#2)(2008-8#1)(2010-10#2)
biotic and##6##2##(2008-10#3)(2008-8#1)(2010-10#2)
biotic or abiotic##2##3##(2008-10#1)(2008-8#1)
biotic##24##1##(2008-10#10)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#2)(2011-2#1)
biotin and##5##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#2)
biotin is##2##2##(2008-10#2)
biotin was##2##2##(2008-10#1)(2008-12#1)
biotin##31##1##(1990-12#1)(1992-6#1)(1993-6#1)(1995-2#6)(2008-10#15)(2008-12#2)(2008-4#1)(2008-9#3)(2011-2#1)
biotin-avidin##2##1##(2008-10#2)
biotinylated BSM-BSA##2##2##(2008-10#2)
biotinylated DNA##3##2##(1995-8#1)(2008-10#2)
biotinylated derivative##2##2##(1992-6#1)(1995-6#1)
biotinylated protein##4##2##(1990-12#2)(1992-6#1)(2008-11#1)
biotinylated##45##1##(1990-12#2)(1992-6#2)(1993-6#4)(1994-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(1997-2#3)(1997-3#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)(2012-3#1)
biotinylation and##2##2##(1993-6#1)(1997-2#1)
biotinylation##9##1##(1993-6#1)(1997-2#5)(2006-6#1)(2008-4#2)
biotissues##2##1##(1994-3#2)
biotopes##2##1##(2011-2#2)
biotransformation of##11##2##(1990-6#2)(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-3#1)
biotransformation reactions##2##2##(2009-12#1)(2011-2#1)
biotransformation##25##1##(1990-6#2)(1994-6#2)(1995-6#1)(2008-10#5)(2008-11#3)(2008-5#3)(2008-6#2)(2008-7#3)(2009-12#1)(2011-1#1)(2011-2#1)(2011-3#1)
biotransformed##2##1##(1993-8#1)(2008-5#1)
biotreatment##2##1##(2008-6#2)
biotrophic fungi##2##2##(2008-10#1)(2010-3#1)
biotrophic##14##1##(2008-10#10)(2010-3#3)(2012-2#1)
biotype B)##2##2##(2008-10#2)
biotype##11##1##(1992-5#1)(2008-10#10)
biotypes maintained##2##2##(2008-10#2)
biotypes of##3##2##(2008-10#3)
biotypes##13##1##(2008-10#13)
biovar 1##2##2##(2008-10#2)
biovar N2 strains from Japan##2##5##(2008-10#2)
biovar N2 strains##3##3##(2008-10#3)
biovar##10##1##(2008-10#9)(2011-2#1)
biovolume##5##1##(2008-11#5)
bipartite closterovirus##3##2##(2008-10#3)
bipartite##19##1##(1993-2#1)(2008-10#16)(2009-8#1)(2013-1#1)
biphasic dose-response relationships##3##3##(2008-7#3)
biphasic dose-response##4##2##(2008-7#4)
biphasic increase##2##2##(1990-2#1)(1996-12#1)
biphasic##30##1##(1990-2#3)(1990-5#1)(1991-10#2)(1991-5#2)(1991-9#1)(1992-7#1)(1993-11#1)(1994-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-2#2)(2008-1#1)(2008-5#1)(2008-7#5)(2010-5#1)(2010-8#1)(2011-2#1)(2012-4#1)(2013-8#1)
biphenyl##4##1##(2008-10#3)(2011-2#1)
biphenyls and##2##2##(1993-12#1)(2008-11#1)
biphenyls in##4##2##(1993-12#1)(2008-10#3)
biphenyls##22##1##(1993-12#4)(1994-3#1)(2008-10#14)(2008-11#3)
bipolar coagulation##3##2##(1995-3#3)
bipolar disorder in children and adolescents##2##6##(2008-8#2)
bipolar disorder in##3##3##(2008-8#2)(2012-3#1)
bipolar disorder##22##2##(2008-4#2)(2008-8#5)(2009-11#4)(2009-6#1)(2010-6#1)(2010-7#4)(2012-2#2)(2012-3#3)
bipolar electrosurgical##2##2##(1992-12#2)
bipolar sensory##2##2##(2007-12#2)
bipolar##47##1##(1991-2#1)(1992-12#4)(1993-1#1)(1994-2#1)(1995-1#1)(1995-3#3)(2007-12#2)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2009-10#1)(2009-11#4)(2009-6#1)(2010-6#2)(2010-7#4)(2010-8#1)(2012-2#3)(2012-3#5)(2013-1#1)
bipolarity##4##1##(2009-10#4)
bipy can be##2##3##(2008-10#2)
bipy##4##1##(2008-10#4)
bipy)##2##1##(2008-10#2)
bipyridilium herbicides##2##2##(2008-10#2)
bipyridyl groups##2##2##(2008-10#2)
bipyridyl##5##1##(2008-10#5)
biracial/ethnic youth and young adults##2##5##(2013-8#2)
biracial/ethnic##4##1##(2013-8#4)
biradical##2##1##(1993-6#1)(1996-5#1)
biradicals##2##1##(1996-5#2)
birch (Betula##2##2##(2008-11#1)(2012-5#1)
birch bark##3##2##(2008-10#3)
birch leaf##2##2##(2008-11#2)
birch##12##1##(2008-10#3)(2008-11#4)(2012-12#1)(2012-3#1)(2012-5#3)
bird species##2##2##(2008-9#1)(2012-3#1)
bird##18##1##(1995-10#1)(1996-8#2)(2008-10#2)(2008-8#7)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
birds and mammals##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
birds and the##2##3##(2008-5#1)(2008-8#1)
birds and##11##2##(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#2)
birds are##2##2##(2008-11#1)(2008-8#1)
birds because##2##2##(1995-3#1)(2008-8#1)
birds in the Central##2##4##(2011-2#2)
birds in##6##2##(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#3)
birds of##3##2##(1992-2#1)(2008-8#1)(2011-2#1)
birds that##2##2##(2008-5#1)(2008-8#1)
birds with##3##2##(2008-8#2)(2011-2#1)
birds##90##1##(1991-11#2)(1992-2#2)(1994-11#2)(1995-3#2)(1995-9#1)(1996-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#15)(2008-7#1)(2008-8#28)(2008-9#18)(2009-8#1)(2010-5#1)(2011-2#9)(2012-3#3)
birefringence and##5##2##(2008-3#3)(2010-4#2)
birefringence compensation##2##2##(2008-3#2)
birefringence of##2##2##(2008-2#1)(2008-3#1)
birefringence##21##1##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#12)(2009-10#1)(2010-4#2)
birefringent filter##2##2##(2007-12#1)(2008-3#1)
birefringent materials##2##2##(2008-3#2)
birefringent##9##1##(2007-12#2)(2008-2#2)(2008-3#5)
birth and##6##2##(2009-5#1)(2011-2#2)(2012-3#2)(2013-1#1)
birth certificates##2##2##(2012-12#2)
birth cohort##6##2##(1990-6#1)(2008-10#1)(2009-7#1)(2010-6#1)(2012-12#1)(2013-8#1)
birth cohorts (65##2##3##(2008-7#2)
birth cohorts##3##2##(2008-7#3)
birth control pill##2##3##(1997-6#2)
birth control##4##2##(1994-9#1)(1997-6#2)(1997-8#1)
birth defects and##3##3##(2008-7#1)(2010-1#2)
birth defects identified##2##3##(2012-12#2)
birth defects surveillance##3##3##(2012-12#3)
birth defects##16##2##(2008-11#2)(2008-7#2)(2008-8#1)(2010-1#2)(2012-12#8)(2012-3#1)
birth during##3##2##(2010-11#1)(2011-1#2)
birth in the##2##3##(2009-10#1)(2012-3#1)
birth in##5##2##(1995-8#1)(2008-12#1)(2009-10#1)(2012-3#1)(2013-8#1)
birth incidence##3##2##(2008-11#3)
birth of the##2##3##(1996-9#1)(2012-12#1)
birth of##6##2##(1991-6#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-12#1)(2012-12#1)
birth rate##4##2##(1996-11#1)(1997-8#1)(2008-11#1)(2008-9#1)
birth rates##2##2##(2008-8#1)(2012-3#1)
birth to##5##2##(1990-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
birth weight and##3##3##(1995-12#1)(2007-12#1)(2013-8#1)
birth weight in##3##3##(1991-12#1)(2008-11#2)
birth weight of##3##3##(2012-12#1)(2012-3#2)
birth weight was##2##3##(1992-2#1)(2007-12#1)
birth weight##38##2##(1991-12#6)(1991-6#1)(1992-2#2)(1993-12#1)(1993-3#2)(1994-3#1)(1995-12#2)(1995-8#2)(1996-11#1)(1996-6#1)(2007-12#2)(2008-10#1)(2008-11#6)(2011-1#2)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#1)
birth weights##5##2##(1991-12#1)(1994-6#2)(2008-11#2)
birth were##2##2##(1991-6#1)(2009-11#1)
birth##207##1##(1990-5#1)(1990-6#5)(1990-9#1)(1991-11#1)(1991-12#8)(1991-2#1)(1991-6#4)(1992-2#2)(1993-12#2)(1993-3#3)(1994-1#1)(1994-3#5)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#4)(1995-5#1)(1995-8#3)(1996-11#4)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#3)(2008-10#8)(2008-11#19)(2008-12#4)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#6)(2009-5#4)(2009-7#1)(2010-1#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-6#3)(2011-1#4)(2011-2#10)(2012-12#16)(2012-2#7)(2012-3#15)(2013-1#10)(2013-8#4)
birth)##4##1##(1994-8#1)(1995-12#2)(2007-11#1)
birth?##2##1##(2008-7#1)(2013-1#1)
birthday##3##1##(1995-3#1)(1997-6#2)
birthing##3##1##(1994-1#1)(1996-12#1)(2009-6#1)
births and deaths##2##3##(2008-11#1)(2008-9#1)
births has##2##2##(1990-6#1)(1991-3#1)
births in##2##2##(1995-2#1)(2012-12#1)
births##30##1##(1990-12#1)(1990-6#4)(1990-9#1)(1991-11#2)(1991-3#3)(1995-12#2)(1995-2#1)(2008-10#1)(2008-11#3)(2008-9#1)(2011-2#4)(2012-12#2)(2013-1#5)
bis(2##7##1##(2008-10#7)
bis(2-ethylhexyl)sebacate (DOS) as##2##3##(2008-10#2)
bis(2-ethylhexyl)sebacate (DOS)##3##2##(2008-10#3)
bis(2-nitrophenyl)disulfide##2##1##(2008-10#2)
bis(heptamethine cyanine)##2##2##(2008-10#2)
bis(trimethylsilyl)trifluoroacetamide##2##1##(2008-10#2)
bis- and trisphosphates##2##3##(1997-1#2)
bis- and##3##2##(1997-1#2)(2008-10#1)
bis-cyanines##2##1##(2008-10#2)
bis[4-(1##2##1##(2008-10#2)
bis[4-N-(1-aza-4##2##1##(2008-10#2)
biscuit##2##1##(2008-1#1)(2008-10#1)
bisection##4##1##(2009-10#4)
bisexual##14##1##(2008-12#12)(2009-5#2)
bismuth and selenium in##2##4##(2008-10#2)
bismuth and selenium##3##3##(2008-10#3)
bismuth and##4##2##(2008-10#4)
bismuth by##2##2##(2008-10#2)
bismuth cysteine##2##2##(2010-11#2)
bismuth determination in##2##3##(2008-10#2)
bismuth determination##3##2##(2008-10#3)
bismuth film electrode (BiFE)##2##4##(2008-10#2)
bismuth film electrode##5##3##(2008-10#5)
bismuth film electrodes##3##3##(2008-10#3)
bismuth film##12##2##(2008-10#12)
bismuth glutathione##2##2##(2010-11#2)
bismuth subcitrate##3##2##(2008-10#1)(2010-11#2)
bismuth was##3##2##(2008-10#3)
bismuth were##4##2##(2008-10#4)
bismuth##79##1##(2008-10#66)(2008-2#1)(2010-11#9)(2013-1#3)
bismuth(III) was##2##2##(2008-10#2)
bismuth(III)##15##1##(2008-10#15)
bismuth-film electrode##3##2##(2008-10#3)
bismuth-film##4##1##(2008-10#4)
bismuthine##2##1##(2008-10#2)
bisoprolol##2##1##(2008-10#2)
bisoxabenzonorbornadienes##2##1##(2008-8#2)
bisphenol A (BPA)##3##3##(2008-10#2)(2009-8#1)
bisphenol A and malachite green##2##5##(2010-5#2)
bisphenol A and##3##3##(2008-10#1)(2010-5#2)
bisphenol A##13##2##(2008-10#6)(2009-8#2)(2010-5#3)(2012-2#1)(2013-1#1)
bisphenol##16##1##(2008-10#9)(2009-8#2)(2010-5#3)(2012-2#1)(2013-1#1)
bisphosphate##2##1##(1993-8#1)(2009-10#1)
bisphosphonate therapy##4##2##(2008-11#2)(2012-12#1)(2012-3#1)
bisphosphonate##10##1##(2008-11#5)(2010-3#2)(2012-12#1)(2012-3#1)(2013-1#1)
bisphosphonate-related osteonecrosis of the##2##4##(2012-12#2)
bisphosphonates##9##1##(1996-11#1)(2008-11#3)(2009-12#1)(2010-1#1)(2010-3#1)(2012-12#1)(2013-1#1)
bisporus##7##1##(1997-1#2)(2008-10#4)(2011-1#1)
bisquinolines##7##1##(1992-6#7)
bistable##2##1##(2008-3#1)(2008-7#1)
bistatic##3##1##(2008-3#3)
bisulphate was##2##2##(2008-10#2)
bisulphate##5##1##(2008-10#5)
bit##10##1##(1996-5#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-3#3)(2013-8#1)
bite of##3##2##(1991-2#1)(2010-1#2)
bite##18##1##(1991-2#1)(1996-11#4)(1996-5#1)(2008-12#3)(2008-4#1)(2010-1#3)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
bites occurred##2##2##(1996-11#2)
bites##16##1##(1996-11#3)(1996-3#1)(2006-5#1)(2008-1#1)(2008-4#3)(2011-2#1)(2013-8#6)
bithorax complex##2##2##(2012-3#2)
biting preferences##2##2##(2010-1#2)
biting##8##1##(1996-5#3)(2010-1#3)(2012-12#2)
bits##6##1##(2007-11#1)(2008-3#3)(2008-4#1)(2008-7#1)
bitten##2##1##(1996-11#1)(2010-1#1)
bitter rot##5##2##(2008-10#5)
bitter##13##1##(2008-10#8)(2008-5#1)(2010-5#1)(2013-8#3)
bitterling##7##1##(2008-5#2)(2010-8#5)
bitterness##2##1##(2011-2#2)
bitumen-in-water emulsion##2##2##(2008-10#2)
biuret assay##2##2##(2008-10#2)
biuret##7##1##(2008-10#6)(2009-8#1)
bivalent metal ions##2##3##(2008-10#2)
bivalent##8##1##(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-9#1)
bivalirudin##2##1##(2008-3#1)(2011-2#1)
bivalve##4##1##(2008-10#2)(2010-11#1)(2010-8#1)
bivalves##4##1##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
bivalvia##2##1##(2008-12#2)
bivariate analysis##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
bivariate correlation##2##2##(2008-10#2)
bivariate##15##1##(1994-2#1)(1995-1#1)(1995-9#1)(2008-10#5)(2008-3#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
biventricular##2##1##(2008-10#1)(2008-12#1)
biweekly##2##1##(2008-10#2)
bizarre##7##1##(1992-3#1)(1995-12#1)(1997-5#1)(2008-1#1)(2009-10#1)(2010-3#1)(2011-2#1)
bjoerkna##2##1##(2012-2#2)
black African##2##2##(1991-11#1)(2008-1#1)
black Americans##2##2##(1996-12#1)(2011-2#1)
black T##2##2##(2008-10#2)
black and Hispanic##3##3##(1994-9#1)(2011-2#2)
black and pu-erh teas##2##4##(2008-10#2)
black and red stripes##2##4##(2011-2#2)
black and red##3##3##(2011-2#3)
black and white##3##3##(1995-12#1)(2011-2#2)
black and##13##2##(1994-9#1)(1995-12#1)(2008-10#2)(2011-2#9)
black bean aphid##2##3##(2009-8#2)
black beneficiaries were##2##3##(1995-2#2)
black beneficiaries##3##2##(1995-2#3)
black box##3##2##(2008-11#1)(2009-10#2)
black carbon##4##2##(2008-3#4)
black coated microdisk electrodes##2##4##(2008-10#2)
black leading edges stimulated an ETR##2##6##(2011-2#2)
black macule##3##2##(2010-6#3)
black on pink##2##3##(2008-10#2)
black patients with##2##3##(1995-12#2)
black patients##4##2##(1993-9#1)(1995-12#3)
black root##2##2##(2008-10#2)
black rot in##2##3##(2008-10#2)
black rot is##2##3##(2008-10#2)
black rot of##2##3##(2008-10#2)
black rot symptoms##2##3##(2008-10#2)
black rot##19##2##(2008-10#19)
black sand##3##2##(2008-3#3)
black seed##4##2##(2008-12#4)
black shale samples##2##3##(2008-10#2)
black shank##2##2##(2008-10#2)
black spot##3##2##(2008-10#3)
black spruce##2##2##(2008-10#2)
black tea on the##2##4##(2009-8#2)
black tea##12##2##(2008-10#2)(2008-11#3)(2009-8#7)
black tooth stains##4##3##(2013-1#4)
black women##6##2##(2013-1#6)
black##157##1##(1991-1#2)(1991-11#2)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#5)(1995-2#3)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#65)(2008-11#6)(2008-12#4)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#9)(2010-10#2)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#1)(2011-2#16)(2012-2#2)(2013-1#12)
black-box##3##1##(2008-11#3)
black-rotted fruit##2##2##(2008-10#2)
black-spot development and fruit softening##2##5##(2008-10#2)
black-spot symptoms##2##2##(2008-10#2)
black-spot##4##1##(2008-10#4)
blackcurrant##4##1##(2012-4#4)
blackish##2##1##(2008-1#1)(2008-5#1)
blackleg disease##3##2##(2008-10#2)(2011-10#1)
blackleg##5##1##(2008-10#4)(2011-10#1)
blacklight##2##1##(2008-10#2)
blacks##4##1##(1995-12#1)(2011-2#3)
bladder and kidney##2##3##(1991-8#2)
bladder and##12##2##(1991-8#3)(2008-10#4)(2009-4#1)(2011-2#4)
bladder augmentation##2##2##(2008-10#2)
bladder cancer cells##2##3##(2013-8#2)
bladder cancer patients##2##3##(2013-8#2)
bladder cancer##22##2##(1991-8#1)(1993-11#1)(1993-2#1)(2008-10#1)(2008-11#2)(2009-4#3)(2011-2#3)(2013-8#10)
bladder cases##3##2##(2008-10#3)
bladder contractions##5##2##(1992-3#3)(2008-7#2)
bladder drainage##2##2##(1995-2#1)(2011-2#1)
bladder duplication with exstrophy of one moiety##3##7##(2008-10#3)
bladder dysfunction##2##2##(2008-10#1)(2008-12#1)
bladder endometriosis##2##2##(2010-12#2)
bladder exstrophy##10##2##(2008-10#10)
bladder function##2##2##(1992-12#1)(1992-3#1)
bladder in a##2##3##(2008-10#1)(2010-11#1)
bladder in children##2##3##(2008-10#2)
bladder in##5##2##(2008-10#3)(2010-11#1)(2011-1#1)
bladder injury##2##2##(1995-1#1)(1996-2#1)
bladder necrosis##2##2##(2008-10#1)(2011-2#1)
bladder of##3##2##(1992-12#1)(2008-10#1)(2012-2#1)
bladder outflow obstruction##3##3##(2008-10#3)
bladder outlet obstruction##3##3##(2008-10#2)(2011-2#1)
bladder outlet##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
bladder smooth muscle##5##3##(1994-8#4)(2008-10#1)
bladder sonography##3##2##(2012-12#3)
bladder stones##2##2##(1994-5#1)(2008-10#1)
bladder tumour##3##2##(2008-10#1)(2012-12#2)
bladder tumours can be##2##4##(1991-9#2)
bladder tumours##12##2##(1991-6#8)(1991-9#2)(2011-2#1)(2012-12#1)
bladder was##4##2##(1992-3#1)(1993-2#1)(2008-10#1)(2012-12#1)
bladder without cutaneous hemangiomatosis##2##4##(2008-10#2)
bladder##218##1##(1990-5#2)(1990-6#1)(1990-8#2)(1991-6#9)(1991-8#4)(1991-9#3)(1992-1#1)(1992-12#10)(1992-3#7)(1992-6#1)(1993-11#2)(1993-2#6)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#5)(1995-1#1)(1995-2#1)(1996-2#2)(1996-3#1)(2008-10#79)(2008-11#3)(2008-12#6)(2008-7#3)(2008-8#1)(2009-11#3)(2009-4#4)(2010-11#3)(2010-12#4)(2011-1#1)(2011-2#17)(2012-12#10)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#10)
blade##4##1##(2008-10#3)(2013-1#1)
blades##6##1##(1992-1#3)(2008-10#3)
blame##3##1##(1994-1#1)(1994-12#1)(1997-8#1)
blamed##4##1##(1990-3#1)(1991-6#1)(1996-5#1)(2008-10#1)
blaming##2##1##(1993-3#1)(2008-9#1)
blank and##3##2##(2008-10#2)(2012-3#1)
blank determination##2##2##(2008-10#1)(2008-5#1)
blank levels##3##2##(2008-10#3)
blank measurements##3##2##(2008-10#3)
blank of the##2##3##(2008-10#2)
blank of##4##2##(2008-10#4)
blank samples##2##2##(2008-10#2)
blank signal##6##2##(2008-10#6)
blank solution##3##2##(2008-10#3)
blank values##4##2##(2008-10#4)
blank was##4##2##(2008-10#4)
blank##70##1##(1990-5#1)(2008-10#65)(2008-12#1)(2008-5#1)(2012-12#1)(2012-3#1)
blank)##8##1##(2008-10#8)
blanket##2##1##(1992-3#2)
blanks are##2##2##(2008-10#2)
blanks of##3##2##(2008-10#3)
blanks##12##1##(1995-6#1)(2008-10#11)
blast and##3##2##(2008-10#3)
blast caused by Magnaporthe grisea##2##5##(2008-10#1)(2009-10#1)
blast caused by Magnaporthe##3##4##(2008-10#1)(2009-10#1)(2012-2#1)
blast caused by##4##3##(2008-10#2)(2009-10#1)(2012-2#1)
blast cells##2##2##(1995-12#1)(2008-12#1)
blast control##2##2##(2008-10#2)
blast epidemic##2##2##(2008-10#2)
blast formation of##2##3##(1995-12#2)
blast in##4##2##(2008-10#3)(2012-2#1)
blast infection##2##2##(2008-10#2)
blast on##2##2##(2008-10#2)
blast pathogen##3##2##(2008-10#3)
blast proliferation##3##2##(2006-6#3)
blast resistance genes##3##3##(2008-10#3)
blast resistance##10##2##(2008-10#9)(2009-10#1)
blast severity was##2##3##(2008-10#2)
blast severity##4##2##(2008-10#4)
blast than##2##2##(2008-10#2)
blast##92##1##(1995-12#3)(1997-4#1)(2006-6#6)(2008-10#71)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#3)(2011-2#1)(2012-2#3)(2013-8#1)
blastocyst biopsy##2##2##(2012-3#2)
blastocyst development##3##2##(2008-9#3)
blastocyst stage in##2##3##(2008-11#1)(2008-5#1)
blastocyst stage##4##2##(2008-11#1)(2008-5#1)(2008-9#2)
blastocyst##24##1##(1992-2#1)(2008-10#1)(2008-11#2)(2008-5#5)(2008-9#11)(2012-3#4)
blastocysts derived in the serum-supplemented medium##2##6##(2008-11#2)
blastocysts derived in##3##3##(2008-11#3)
blastocysts in##2##2##(1996-8#1)(2013-8#1)
blastocysts##24##1##(1996-8#5)(1997-8#1)(2008-11#9)(2008-5#1)(2008-9#5)(2012-3#1)(2013-1#1)(2013-8#1)
blastoderm##2##1##(1993-9#1)(2007-12#1)
blastomeres##2##1##(1993-6#1)(2008-6#1)
blastospores were##3##2##(2008-10#3)
blastospores##4##1##(2008-10#4)
blasts were##3##2##(2006-6#2)(2009-12#1)
blasts##13##1##(1991-2#1)(1995-2#2)(2006-6#5)(2008-10#3)(2009-12#1)(2011-2#1)
blastula##2##1##(1997-7#1)(2008-8#1)
blazed gratings##2##2##(2008-3#2)
blazed##4##1##(2008-3#4)
bleach##4##1##(2008-10#4)
bleached##2##1##(2008-10#1)(2008-3#1)
bleaching event##2##2##(2008-9#1)(2012-2#1)
bleaching events##3##2##(2008-9#3)
bleaching has been##2##3##(2008-3#1)(2008-5#1)
bleaching of##4##2##(2008-10#3)(2008-5#1)
bleaching##27##1##(2008-10#6)(2008-3#2)(2008-5#4)(2008-6#5)(2008-9#6)(2012-2#4)
blebbing and##2##2##(2008-10#1)(2008-11#1)
blebbing##5##1##(2008-10#1)(2008-11#1)(2009-12#1)(2010-2#1)(2012-3#1)
bled##2##1##(1997-6#1)(2008-7#1)
bleed##7##1##(1995-11#1)(1996-6#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-2#1)(2013-7#1)
bleeding after##2##2##(2013-1#2)
bleeding and##5##2##(1990-9#2)(2008-10#1)(2011-2#1)(2013-1#1)
bleeding as##2##2##(2012-2#1)(2013-1#1)
bleeding complications##5##2##(2008-7#1)(2008-8#1)(2011-2#3)
bleeding disorders##2##2##(2008-11#1)(2011-2#1)
bleeding esophageal varices##3##3##(2013-1#3)
bleeding esophageal##4##2##(2013-1#4)
bleeding from the##2##3##(2008-7#2)
bleeding from##5##2##(1991-6#1)(2008-7#2)(2013-1#2)
bleeding in patients##2##3##(2008-7#1)(2012-3#1)
bleeding in the##3##3##(1996-11#1)(2008-7#1)(2012-3#1)
bleeding in##13##2##(1995-11#1)(1996-11#2)(2008-7#2)(2010-2#1)(2011-2#4)(2012-3#2)(2013-8#1)
bleeding is##2##2##(2011-2#2)
bleeding made##2##2##(1992-12#1)(1996-11#1)
bleeding need##2##2##(1995-11#1)(2009-8#1)
bleeding of##3##2##(1997-8#1)(2008-4#1)(2011-2#1)
bleeding or##3##2##(2008-7#1)(2009-12#1)(2009-8#1)
bleeding patterns in##2##3##(2011-2#2)
bleeding prevention##2##2##(2011-2#2)
bleeding profile##2##2##(2009-3#2)
bleeding rate##2##2##(2008-7#1)(2012-3#1)
bleeding requiring##2##2##(1991-1#1)(1995-12#1)
bleeding risk##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
bleeding were##2##2##(1990-11#1)(1995-3#1)
bleeding who##3##2##(2009-6#1)(2011-2#1)(2013-1#1)
bleeding##146##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-12#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#4)(1997-3#1)(1997-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#13)(2008-8#4)(2009-12#1)(2009-3#4)(2009-6#1)(2009-8#5)(2010-12#2)(2010-2#1)(2010-6#2)(2010-7#1)(2011-2#36)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#19)(2013-8#2)
bleedings##4##1##(1995-11#1)(2008-10#1)(2011-2#2)
bleeds##6##1##(1995-11#1)(1996-6#2)(2009-3#3)
blend of##5##2##(1993-1#1)(1993-12#1)(2008-10#1)(2009-8#2)
blend##15##1##(1993-1#1)(1993-12#1)(1997-3#1)(2008-10#5)(2009-7#2)(2009-8#4)(2013-8#1)
blended with##3##2##(2008-12#1)(2008-5#1)(2009-7#1)
blended##10##1##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2009-7#1)(2012-3#1)(2013-1#1)
blending in##2##2##(2008-10#2)
blending the reagent##2##3##(2008-10#2)
blending the##3##2##(2008-10#2)(2008-5#1)
blending##11##1##(2008-10#6)(2008-5#2)(2008-6#1)(2009-7#2)
blends by##2##2##(2008-10#1)(2008-2#1)
blends of##2##2##(2008-2#1)(2008-9#1)
blends##17##1##(2008-10#9)(2008-2#2)(2008-9#1)(2009-7#4)(2010-4#1)
bleomycin##2##1##(1990-12#1)(1995-10#1)
blessings##3##1##(2008-12#3)
blight (caused by##4##3##(2008-10#4)
blight and##15##2##(1992-8#1)(2008-10#11)(2008-9#1)(2009-10#2)
blight are##2##2##(2008-10#2)
blight caused by Xanthomonas##2##4##(2008-10#1)(2009-10#1)
blight caused by##5##3##(2008-10#3)(2009-10#1)(2009-6#1)
blight caused##6##2##(2008-10#4)(2009-10#1)(2009-6#1)
blight developed##3##2##(2008-10#3)
blight development##4##2##(2008-10#4)
blight disease of##2##3##(2008-10#2)
blight disease##8##2##(2008-10#7)(2008-8#1)
blight diseases##2##2##(2008-10#2)
blight epidemics##8##2##(2008-10#8)
blight forecasters##2##2##(2008-10#2)
blight fungus##4##2##(2008-10#3)(2008-9#1)
blight has##2##2##(2008-10#2)
blight in##19##2##(2008-10#19)
blight infection##3##2##(2008-10#3)
blight is##4##2##(2008-10#4)
blight management##2##2##(2008-10#2)
blight of barley##2##3##(2008-10#2)
blight of cassava##2##3##(2008-10#2)
blight of onion##4##3##(2008-10#4)
blight of pistachio##5##3##(2008-10#5)
blight of##34##2##(2008-10#34)
blight on##4##2##(2008-10#4)
blight pathogen##10##2##(2008-10#9)(2008-8#1)
blight pathogens##2##2##(2008-10#2)
blight resistance gene##2##3##(2008-10#1)(2008-8#1)
blight resistance in##4##3##(2008-10#4)
blight resistance##12##2##(2008-10#9)(2008-8#3)
blight severity##7##2##(2008-10#7)
blight symptoms##3##2##(2008-10#3)
blight than##3##2##(2008-10#3)
blight was##9##2##(2008-10#9)
blight were##4##2##(2008-10#4)
blight would##2##2##(2008-10#2)
blight##296##1##(1992-8#1)(2008-10#281)(2008-8#6)(2008-9#3)(2009-10#3)(2009-6#1)(2011-10#1)
blight)##2##1##(2008-10#2)
blight-infected plants##2##2##(2008-10#2)
blighted blossoms##2##2##(2008-10#2)
blighted##7##1##(2008-10#7)
blind and##2##2##(2011-2#1)(2012-3#1)
blind assessment##2##2##(1991-1#1)(2009-11#1)
blind elderly##3##2##(2008-7#3)
blind randomized##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
blind study##2##2##(1997-2#1)(2010-7#1)
blind trial and##2##3##(1995-11#1)(1997-1#1)
blind trial##5##2##(1995-11#1)(1997-1#1)(2008-10#2)(2008-5#1)
blind##34##1##(1990-5#2)(1991-1#1)(1993-1#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#3)
blind&quot##2##1##(2008-10#1)(2008-11#1)
blinded to##3##2##(2008-12#1)(2008-8#1)(2010-7#1)
blinded##10##1##(1997-8#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#2)
blinding diseases##2##2##(2008-7#1)(2011-7#1)
blinding##8##1##(1995-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-10#2)(2011-2#1)(2011-7#1)
blindness in##3##2##(2008-5#1)(2010-10#1)(2011-2#1)
blindness##16##1##(1991-8#3)(1997-3#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2011-9#1)(2012-12#1)
blister rust epidemic##2##3##(2008-10#2)
blister rust fungus##2##3##(2008-10#2)
blister rust##23##2##(2008-10#23)
blister##27##1##(1990-2#1)(2008-10#25)(2008-11#1)
blistering##2##1##(1991-12#1)(2012-3#1)
blisters##2##1##(1991-11#1)(1997-5#1)
bloc mastoidectomy##2##2##(2008-7#2)
bloc##7##1##(1996-3#1)(2008-10#1)(2008-4#1)(2008-7#3)(2011-2#1)
block and##7##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
block are sampled##2##3##(2008-10#2)
block are##3##2##(1992-5#1)(2008-10#2)
block design with##2##3##(2008-10#2)
block design##7##2##(2008-10#6)(2010-8#1)
block developed in 1##2##4##(2012-3#2)
block for##2##2##(2008-11#1)(2010-7#1)
block grants##2##2##(1991-1#1)(1997-2#1)
block in the##2##3##(1993-9#1)(1995-6#1)
block in##6##2##(1993-9#1)(1995-6#1)(2008-10#2)(2010-2#1)(2010-6#1)
block of the##2##3##(1990-3#1)(2008-10#1)
block of##8##2##(1990-3#1)(1992-6#1)(2008-10#3)(2008-8#1)(2009-8#1)(2010-7#1)
block phase measures##2##3##(2011-2#2)
block phase##3##2##(1994-2#1)(2011-2#2)
block proliferation##2##2##(2011-1#1)(2012-3#1)
block radiography##4##2##(1997-8#4)
block the expression of##2##4##(1997-6#1)(2008-8#1)
block the##22##2##(1990-5#1)(1991-1#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-3#2)(2012-3#1)
block using##2##2##(2008-10#1)(2008-11#1)
block was##4##2##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
block##156##1##(1990-3#1)(1990-5#1)(1991-1#2)(1991-2#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#7)(1996-2#3)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#4)(2008-10#32)(2008-11#9)(2008-12#5)(2008-3#1)(2008-7#2)(2008-8#8)(2008-9#4)(2009-12#2)(2009-7#2)(2009-8#4)(2009-9#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#5)(2010-8#3)(2011-1#1)(2011-2#9)(2011-3#2)(2012-2#4)(2012-3#9)(2013-1#2)(2013-8#1)
block)##3##1##(1997-1#1)(2008-10#2)
blockade by##2##2##(1991-2#1)(1994-11#1)
blockade of the##2##3##(1996-2#1)(2006-6#1)
blockade of##14##2##(1990-5#2)(1993-6#1)(1995-2#2)(1996-2#1)(1996-5#1)(2006-6#1)(2008-11#3)(2008-5#1)(2008-8#1)(2011-2#1)
blockade with##2##2##(1993-1#1)(1993-6#1)
blockade##44##1##(1990-5#2)(1991-2#1)(1991-7#1)(1993-1#3)(1993-6#3)(1994-11#2)(1995-2#3)(1996-12#1)(1996-2#1)(1996-5#1)(2006-6#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-4#2)(2010-5#3)(2010-7#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
blockage of##3##2##(1990-12#1)(2011-2#1)(2011-3#1)
blocked by a##2##3##(1995-2#1)(2008-7#1)
blocked by pretreatment with##2##4##(1993-6#1)(2012-2#1)
blocked by pretreatment##3##3##(1993-6#1)(1995-2#1)(2012-2#1)
blocked by strychnine##2##3##(1995-2#2)
blocked by the known##2##4##(2008-11#2)
blocked by the protein##2##4##(1995-6#1)(2010-7#1)
blocked by the##11##3##(1990-5#1)(1995-6#1)(1996-2#2)(2008-10#1)(2008-11#3)(2008-8#1)(2010-7#1)(2013-1#1)
blocked by##53##2##(1990-5#2)(1991-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#4)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#5)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#4)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#2)(2008-8#5)(2008-9#1)(2010-4#2)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
blocked in##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
blocked phenolic OH groups##2##4##(2008-10#2)
blocked the effect of##2##4##(1991-1#1)(1997-1#1)
blocked the increase in##3##4##(1990-7#1)(1992-12#1)(1994-8#1)
blocked the##16##2##(1990-12#1)(1990-7#1)(1991-1#1)(1992-12#1)(1994-2#3)(1994-8#1)(1996-12#1)(1997-1#1)(1997-2#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
blocked##118##1##(1990-11#2)(1990-12#2)(1990-5#3)(1990-7#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#5)(1994-11#3)(1994-12#1)(1994-2#8)(1994-3#1)(1994-5#2)(1994-8#3)(1995-11#1)(1995-2#6)(1995-6#4)(1995-8#2)(1996-12#7)(1996-2#4)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#3)(2008-10#7)(2008-11#11)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-12#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#1)
blocker##20##1##(1990-5#1)(1991-8#1)(1994-2#4)(1995-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)
blocker)##2##1##(2008-10#1)(2008-11#1)
blockers and##7##2##(1995-11#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)
blockers are##2##2##(1996-6#1)(2008-7#1)
blockers for##2##2##(1990-2#1)(1996-2#1)
blockers in##2##2##(2008-11#1)(2008-7#1)
blockers of##2##2##(1992-3#1)(2008-8#1)
blockers such as##2##3##(1994-8#2)
blockers##46##1##(1990-2#1)(1990-6#1)(1990-8#1)(1992-3#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-2#1)(1996-2#3)(1996-3#1)(1996-6#5)(2008-10#4)(2008-11#9)(2008-3#1)(2008-7#5)(2008-8#1)(2009-6#4)(2011-2#2)(2012-12#1)
blocking agent##2##2##(2008-9#1)(2011-1#1)
blocking agents##3##2##(1993-1#2)(2008-10#1)
blocking in##2##2##(2008-8#1)(2012-3#1)
blocking of##5##2##(1990-12#1)(1992-5#1)(2008-10#1)(2008-12#1)(2010-12#1)
blocking reagents##2##2##(1990-12#1)(2008-10#1)
blocking the##9##2##(1993-6#1)(1995-2#2)(1997-5#1)(2008-10#1)(2008-11#1)(2008-8#2)(2013-1#1)
blocking##55##1##(1990-12#4)(1990-2#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#3)(1996-2#1)(1997-5#1)(1997-7#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-8#3)(2008-9#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
blocks and##5##2##(1991-9#1)(1996-3#1)(2008-10#1)(2008-4#2)
blocks are##2##2##(1995-6#1)(2008-4#1)
blocks for##8##2##(1996-3#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
blocks from##2##2##(1997-8#1)(2008-5#1)
blocks in##5##2##(2008-10#2)(2008-8#2)(2012-3#1)
blocks of heterochromatin##2##3##(2008-12#2)
blocks of##9##2##(1992-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2009-8#1)
blocks or##2##2##(2008-12#1)(2010-7#1)
blocks the##8##2##(1990-12#2)(1990-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-7#1)(2008-8#1)
blocks were##2##2##(2007-8#1)(2013-1#1)
blocks with##2##2##(2008-10#1)(2008-9#1)
blocks##85##1##(1990-12#3)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-2#1)(1995-2#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-3#6)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#6)(2008-12#5)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#1)(2009-8#2)(2010-1#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
blood LPA##2##2##(2011-2#2)
blood after##4##2##(1993-8#1)(2008-10#2)(2008-7#1)
blood and body##2##3##(1991-1#2)
blood and lymphatic##2##3##(2008-9#1)(2010-7#1)
blood and plasma##2##3##(1996-5#1)(2008-10#1)
blood and saliva##2##3##(2008-10#1)(2013-1#1)
blood and tissue##3##3##(1992-3#1)(2008-5#1)(2012-3#1)
blood and urine##4##3##(1997-2#1)(2008-10#2)(2012-3#1)
blood and##53##2##(1991-1#2)(1991-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#2)(1995-2#1)(1996-5#1)(1997-2#1)(2006-6#2)(2008-10#21)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
blood anticoagulated with##2##3##(2008-10#2)
blood antioxidant system##2##3##(2013-1#2)
blood are##2##2##(2008-11#1)(2013-1#1)
blood as well as##2##4##(2008-7#1)(2008-9#1)
blood at##2##2##(2008-10#1)(2008-11#1)
blood banking##2##2##(1995-6#1)(2011-2#1)
blood banks##4##2##(1995-6#3)(2011-2#1)
blood by the##2##3##(1995-2#1)(2008-11#1)
blood by##11##2##(1995-2#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)
blood cardioplegia##3##2##(1991-3#3)
blood cell##20##2##(1990-8#1)(1993-12#1)(1995-8#1)(1997-6#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#4)
blood cells and##2##3##(2008-9#1)(2012-12#1)
blood cells as well as##2##5##(1990-12#1)(1994-8#1)
blood cells in##4##3##(1996-9#1)(2008-10#1)(2008-9#2)
blood cells was##2##3##(1990-2#1)(2008-11#1)
blood cells with##2##3##(1990-12#1)(2008-11#1)
blood cells##59##2##(1990-12#2)(1990-2#1)(1990-8#2)(1992-11#2)(1993-12#2)(1994-11#2)(1994-8#2)(1995-2#1)(1996-9#1)(1997-6#1)(2008-10#15)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#5)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
blood chemistry parameters##2##3##(2013-1#2)
blood chemistry##3##2##(2008-5#1)(2013-1#2)
blood circulation##4##2##(2008-10#1)(2010-3#1)(2013-8#2)
blood clots##2##2##(2008-10#1)(2013-1#1)
blood clotting##2##2##(2008-8#1)(2011-2#1)
blood coagulation factor##2##3##(1992-12#1)(2008-8#1)
blood coagulation##11##2##(1990-11#1)(1991-3#1)(1991-9#1)(1992-12#2)(1995-2#1)(2006-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
blood collection##2##2##(2010-6#2)
blood component##3##2##(1990-11#1)(1995-2#1)(2008-12#1)
blood components##6##2##(1991-3#2)(2008-9#1)(2010-7#1)(2011-3#1)(2013-8#1)
blood concentration##3##2##(1991-3#1)(2011-2#2)
blood conservation##2##2##(1990-2#1)(2010-7#1)
blood cortisol##2##2##(2011-2#1)(2012-3#1)
blood could be##2##3##(2011-2#2)
blood count##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
blood culture##5##2##(2008-5#1)(2010-6#2)(2011-2#2)
blood culture-positive##3##2##(2010-6#3)
blood cultures and##2##3##(2011-2#1)(2012-3#1)
blood cultures were##2##3##(2007-12#1)(2008-7#1)
blood cultures##11##2##(2007-12#2)(2008-7#1)(2010-6#5)(2011-2#2)(2012-3#1)
blood derived##2##2##(1997-8#1)(2008-5#1)
blood donation##6##2##(1992-2#1)(1996-9#4)(2009-3#1)
blood donors were##2##3##(2008-11#1)(2011-2#1)
blood donors##14##2##(1990-6#3)(1993-2#1)(1996-11#2)(2008-10#1)(2008-11#1)(2011-2#4)(2013-1#2)
blood draws##2##2##(2012-2#2)
blood drives##2##2##(2008-10#2)
blood ethanol concentrations##2##3##(2008-11#2)
blood ethanol levels##2##3##(2008-11#2)
blood ethanol##4##2##(2008-11#4)
blood flow (CBF)##7##3##(2008-12#1)(2008-7#6)
blood flow and##6##3##(1994-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
blood flow by##2##3##(2008-7#1)(2013-8#1)
blood flow changes##2##3##(1995-2#1)(1996-6#1)
blood flow conditions##3##3##(1997-1#1)(2006-6#2)
blood flow for##2##3##(2008-7#1)(2013-1#1)
blood flow from the##2##4##(1996-9#1)(2010-12#1)
blood flow in the##3##4##(1992-1#1)(1996-12#1)(2012-3#1)
blood flow in##8##3##(1992-1#1)(1992-6#1)(1995-5#3)(1996-12#1)(1996-6#1)(2012-3#1)
blood flow of##5##3##(2008-10#5)
blood flow through the reproductive organs##2##6##(2008-12#2)
blood flow through the##5##4##(1997-1#1)(2008-12#4)
blood flow to##2##3##(2008-10#1)(2008-12#1)
blood flow velocity of the##2##5##(1996-3#1)(2008-3#1)
blood flow velocity were##2##4##(2013-1#2)
blood flow velocity##9##3##(1996-2#1)(1996-3#2)(2007-11#3)(2008-3#1)(2013-1#2)
blood flow was##3##3##(1995-5#1)(1996-2#1)(2008-5#1)
blood flow were measured##2##4##(2008-12#1)(2013-3#1)
blood flow##98##2##(1991-2#1)(1992-1#1)(1992-3#1)(1992-6#4)(1994-2#2)(1995-11#1)(1995-2#2)(1995-5#7)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-6#4)(1996-9#1)(1997-1#5)(1997-4#1)(2006-6#2)(2007-11#3)(2008-10#9)(2008-12#7)(2008-3#1)(2008-5#4)(2008-7#9)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2012-3#2)(2013-1#9)(2013-3#1)(2013-8#4)
blood for##3##2##(1993-3#1)(2008-11#1)(2008-9#1)
blood from##4##2##(2008-10#4)
blood gas analysis##2##3##(2010-10#1)(2011-2#1)
blood gas##5##2##(1997-3#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-12#1)
blood gases##3##2##(1993-2#1)(2009-1#1)(2012-3#1)
blood glucose concentrations##3##3##(1990-5#1)(1993-1#1)(2013-8#1)
blood glucose level##7##3##(2008-1#1)(2008-10#3)(2011-3#1)(2012-2#2)
blood glucose levels and##3##4##(2010-11#1)(2010-2#1)(2012-3#1)
blood glucose levels##11##3##(1994-12#1)(1997-2#1)(2008-10#2)(2010-11#4)(2010-2#1)(2012-3#1)(2012-5#1)
blood glucose of##2##3##(2010-2#1)(2012-2#1)
blood glucose##45##2##(1990-5#2)(1991-12#1)(1993-1#3)(1993-11#1)(1993-2#1)(1994-12#2)(1997-2#1)(2008-1#2)(2008-10#6)(2008-7#2)(2009-11#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#6)(2010-4#1)(2011-1#1)(2011-3#2)(2012-2#3)(2012-3#1)(2012-5#2)(2013-8#1)
blood group and##3##3##(1990-6#1)(1995-6#1)(2013-1#1)
blood group antigens##4##3##(1990-12#1)(1994-8#2)(1995-6#1)
blood group system##4##3##(2012-2#2)(2013-1#2)
blood group##19##2##(1990-12#1)(1990-6#1)(1993-1#2)(1994-8#2)(1995-2#1)(1995-6#3)(2008-10#1)(2012-2#4)(2012-3#1)(2013-1#3)
blood in the##6##3##(1990-2#1)(1993-3#1)(1996-5#1)(2009-1#1)(2010-11#1)(2013-8#1)
blood in##18##2##(1990-2#1)(1991-3#1)(1992-3#2)(1993-3#1)(1993-6#1)(1995-6#1)(1996-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-11#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
blood is a##2##3##(2008-10#1)(2008-9#1)
blood is##12##2##(1991-11#1)(1992-5#1)(1996-9#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-9#2)
blood lactate concentration##2##3##(2013-8#2)
blood lactate##5##2##(2008-10#1)(2009-1#1)(2013-1#1)(2013-8#2)
blood leukocytes##4##2##(1992-6#1)(2008-10#1)(2009-6#1)(2013-1#1)
blood levels of##6##3##(1993-1#1)(1993-3#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
blood levels##10##2##(1990-5#1)(1991-1#1)(1992-9#1)(1993-1#1)(1993-3#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-1#1)
blood lipid##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
blood lipids##5##2##(1997-5#1)(2011-2#3)(2013-8#1)
blood loss during##2##3##(1993-1#1)(2011-2#1)
blood loss using##2##3##(1994-3#1)(2012-3#1)
blood loss was##2##3##(1992-2#1)(2008-10#1)
blood loss##30##2##(1991-6#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#5)(1995-1#1)(1996-1#1)(1996-9#1)(1997-8#1)(2008-10#2)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#3)
blood lymphocyte##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
blood lymphocytes (PBL) from##2##4##(2008-9#1)(2013-1#1)
blood lymphocytes (PBL)##4##3##(1995-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
blood lymphocytes##28##2##(1990-5#2)(1991-12#2)(1991-2#1)(1993-8#2)(1994-3#1)(1994-6#1)(1995-12#3)(1997-3#1)(2008-11#8)(2008-4#1)(2008-9#5)(2013-1#1)
blood monocytes##2##2##(2008-9#2)
blood mononuclear cells##18##3##(1990-2#1)(1992-6#2)(2008-10#2)(2008-11#6)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#2)(2011-3#1)
blood mononuclear##19##2##(1990-2#1)(1992-6#2)(2008-10#2)(2008-11#6)(2008-4#1)(2008-7#3)(2008-9#1)(2011-2#2)(2011-3#1)
blood of##11##2##(1990-12#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
blood or blood products##2##4##(2011-3#1)(2013-1#1)
blood or urine##3##3##(1990-2#1)(1993-12#2)
blood or##11##2##(1990-2#2)(1993-12#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-3#1)(2013-1#1)
blood oxygenation##2##2##(2008-11#2)
blood pH##2##2##(2011-2#2)
blood perfusion##2##2##(2012-12#1)(2013-8#1)
blood plasma and erythrocyte##2##4##(2008-10#2)
blood plasma and##4##3##(2008-10#3)(2008-9#1)
blood plasma samples##4##3##(2008-10#4)
blood plasma##24##2##(1992-5#1)(1995-12#1)(2008-10#19)(2008-9#1)(2011-2#1)(2013-1#1)
blood platelets##3##2##(1992-12#1)(2006-6#1)(2008-1#1)
blood pressure (BP) and##3##4##(2008-11#2)(2013-8#1)
blood pressure (BP) levels##2##4##(2010-4#2)
blood pressure (BP)##9##3##(2008-1#1)(2008-11#2)(2008-8#1)(2010-4#3)(2010-7#1)(2013-8#1)
blood pressure among##2##3##(2008-1#1)(2013-8#1)
blood pressure and the##3##4##(1990-5#1)(1997-8#1)(2012-3#1)
blood pressure and##13##3##(1990-5#1)(1991-6#1)(1994-6#1)(1996-6#1)(1997-8#2)(2008-5#1)(2008-7#2)(2009-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
blood pressure at##2##3##(2008-7#1)(2012-3#1)
blood pressure control##8##3##(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-1#1)(2013-1#1)(2013-8#1)
blood pressure decreased from##2##4##(1990-11#1)(1991-6#1)
blood pressure during##2##3##(1994-3#1)(2008-10#1)
blood pressure for##2##3##(1997-2#1)(2008-5#1)
blood pressure in##12##3##(1991-6#1)(1994-3#1)(1997-5#3)(1997-8#2)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
blood pressure index##4##3##(1993-12#4)
blood pressure is##6##3##(1993-11#1)(1993-2#1)(1997-2#1)(1997-5#1)(2008-5#2)
blood pressure measurement in##2##4##(1994-3#1)(2008-10#1)
blood pressure measurement##4##3##(1994-3#1)(2008-10#1)(2008-12#1)(2010-8#1)
blood pressure monitoring in##4##4##(1994-9#1)(2008-1#1)(2010-1#2)
blood pressure monitoring##11##3##(1990-11#2)(1994-9#1)(1997-8#1)(2008-1#3)(2010-1#3)(2012-3#1)
blood pressure or##2##3##(1993-1#1)(2008-3#1)
blood pressure readings##3##3##(2008-5#3)
blood pressure should be##3##4##(1993-2#1)(1996-6#2)
blood pressure stability##2##3##(2011-2#2)
blood pressure values##2##3##(2008-5#1)(2008-7#1)
blood pressure was##5##3##(1990-5#1)(1997-8#1)(2008-1#1)(2008-5#1)(2012-3#1)
blood pressure were##2##3##(2012-3#1)(2013-8#1)
blood pressure with##2##3##(1994-3#1)(2008-7#1)
blood pressure##206##2##(1990-11#6)(1990-5#2)(1991-6#7)(1992-12#3)(1992-2#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#6)(1994-11#1)(1994-12#1)(1994-3#6)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#3)(1997-2#4)(1997-5#6)(1997-8#7)(2007-8#2)(2008-1#14)(2008-10#10)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#19)(2008-8#5)(2009-1#2)(2009-11#2)(2009-5#2)(2009-7#2)(2010-1#4)(2010-4#5)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#14)(2013-1#2)(2013-8#11)
blood pressure-related##2##2##(2010-4#1)(2012-12#1)
blood pressures##2##2##(1997-8#1)(2008-10#1)
blood products##9##2##(1996-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-3#2)(2013-1#1)
blood sample##7##2##(1991-6#1)(1994-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)
blood samples by##4##3##(1992-3#1)(2008-10#2)(2008-5#1)
blood samples collected from##2##4##(2009-12#1)(2012-3#1)
blood samples from##6##3##(1996-12#1)(2008-10#2)(2010-1#1)(2011-2#2)
blood samples of##2##3##(2013-1#2)
blood samples taken from##2##4##(1990-8#1)(2008-10#1)
blood samples were collected from the##2##6##(2008-12#1)(2008-9#1)
blood samples were collected##7##4##(1990-12#1)(1991-6#1)(1997-2#1)(2008-12#1)(2008-9#1)(2010-8#1)(2013-1#1)
blood samples were drawn from the##2##6##(2008-1#1)(2008-10#1)
blood samples were drawn##4##4##(1991-6#1)(2008-1#1)(2008-10#1)(2012-3#1)
blood samples were extracted##2##4##(2008-10#1)(2011-2#1)
blood samples were taken before##2##5##(2013-1#1)(2013-8#1)
blood samples were taken##4##4##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
blood samples were##19##3##(1990-12#1)(1991-6#2)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
blood samples##57##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#2)(1992-3#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-9#3)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-1#5)(2013-8#1)
blood sampling##8##2##(1990-9#1)(1996-3#3)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
blood serum and whole blood##3##5##(2008-10#3)
blood serum samples##6##3##(2008-10#6)
blood serum using##2##3##(2008-10#2)
blood serum##25##2##(1995-11#1)(2008-10#20)(2013-1#4)
blood spatters##2##2##(1995-11#2)
blood specimen##3##2##(2008-11#1)(2010-6#2)
blood specimens from##3##3##(1996-12#2)(1997-3#1)
blood stasis##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
blood stem##4##2##(2008-11#2)(2010-6#1)(2011-2#1)
blood stimulation##2##2##(2008-4#2)
blood sugar levels##2##3##(1993-11#1)(2008-1#1)
blood sugar##8##2##(1993-11#1)(1994-12#1)(1994-8#1)(1996-11#1)(2008-1#1)(2008-12#2)(2010-10#1)
blood supply by##2##3##(1995-6#1)(2008-7#1)
blood supply to the##3##4##(1997-8#1)(2011-2#2)
blood supply to##4##3##(1997-8#1)(2011-2#2)(2012-12#1)
blood supply##15##2##(1995-12#1)(1995-6#2)(1996-9#3)(1997-8#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)
blood tests in##2##3##(1993-3#1)(2008-10#1)
blood to##4##2##(1993-3#1)(1996-9#1)(2008-10#1)(2011-2#1)
blood transfusion and##2##3##(2008-10#1)(2011-2#1)
blood transfusion in##3##3##(1995-12#1)(2013-1#2)
blood transfusion##16##2##(1991-8#1)(1995-12#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#3)(2013-1#3)
blood transfusions and##2##3##(1990-5#1)(2008-1#1)
blood transfusions or pregnancy##2##4##(1991-3#2)
blood transfusions##10##2##(1990-5#1)(1991-3#2)(1995-12#1)(1995-6#1)(1996-3#1)(2008-1#2)(2010-11#1)(2013-1#1)
blood units##4##2##(1991-8#2)(2010-11#2)
blood urea nitrogen (BUN)##2##4##(1994-5#2)
blood urea nitrogen##3##3##(1994-5#2)(2011-2#1)
blood using##6##2##(2008-10#4)(2008-11#2)
blood velocity##2##2##(1996-6#1)(2013-8#1)
blood vessel endothelium##2##3##(2009-10#1)(2010-11#1)
blood vessel##9##2##(1991-12#1)(1996-3#1)(2008-3#1)(2009-10#1)(2010-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
blood vessels and##6##3##(1994-9#1)(1996-3#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-3#1)
blood vessels of##4##3##(2008-11#3)(2013-1#1)
blood vessels were##2##3##(2011-2#2)
blood vessels##33##2##(1994-9#3)(1995-12#1)(1996-3#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-2#6)(2012-3#2)(2013-1#1)(2013-8#2)
blood volume and##3##3##(2008-5#1)(2008-7#1)(2010-7#1)
blood volume##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)
blood was##14##2##(1990-2#1)(1991-12#1)(1991-2#1)(1995-6#1)(1996-3#2)(2008-10#2)(2008-5#1)(2011-2#3)(2013-1#2)
blood were##7##2##(1993-8#1)(1997-5#1)(2008-10#4)(2011-2#1)
blood which##2##2##(1990-12#1)(1993-3#1)
blood with##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
blood withdrawn##2##2##(1996-9#2)
blood##1377##1##(1990-11#9)(1990-12#8)(1990-2#14)(1990-3#2)(1990-5#9)(1990-6#4)(1990-8#5)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#9)(1991-2#8)(1991-3#13)(1991-6#11)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#7)(1992-2#4)(1992-3#7)(1992-5#3)(1992-6#8)(1992-9#5)(1993-1#9)(1993-11#6)(1993-12#12)(1993-2#15)(1993-3#10)(1993-6#3)(1993-8#5)(1994-1#1)(1994-11#5)(1994-12#8)(1994-2#4)(1994-3#15)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#4)(1995-1#2)(1995-11#8)(1995-12#10)(1995-2#13)(1995-5#7)(1995-6#14)(1995-8#2)(1996-1#2)(1996-11#4)(1996-12#8)(1996-2#6)(1996-3#14)(1996-5#3)(1996-6#9)(1996-9#20)(1997-1#9)(1997-2#7)(1997-3#4)(1997-4#1)(1997-5#10)(1997-6#4)(1997-8#11)(2006-6#11)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#22)(2008-10#237)(2008-11#76)(2008-12#26)(2008-3#5)(2008-4#16)(2008-5#34)(2008-6#5)(2008-7#48)(2008-8#18)(2008-9#57)(2009-1#6)(2009-10#2)(2009-11#4)(2009-12#3)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#7)(2010-10#4)(2010-11#15)(2010-12#5)(2010-2#6)(2010-3#1)(2010-4#9)(2010-6#19)(2010-7#13)(2010-8#9)(2011-1#5)(2011-2#86)(2011-3#9)(2012-12#11)(2012-2#16)(2012-3#39)(2012-5#2)(2013-1#74)(2013-3#1)(2013-7#1)(2013-8#34)
blood)##3##1##(2008-10#2)(2013-8#1)
blood-##2##1##(1993-2#1)(2009-8#1)
blood-borne##3##1##(1990-7#1)(1992-12#1)(2008-10#1)
blood-brain barrier##13##2##(1990-5#2)(1990-7#1)(1992-3#2)(1994-5#1)(1995-2#2)(1997-2#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
blood-brain##15##1##(1990-5#2)(1990-7#1)(1992-3#2)(1994-5#1)(1995-2#2)(1997-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
blood-cerebrospinal fluid##2##2##(2008-7#1)(2013-7#1)
blood-clotting products##3##2##(1996-5#3)
blood-injection-injury##2##1##(2012-2#2)
blood-pressure##2##1##(1990-9#1)(1994-3#1)
blood-testis barrier (BTB)##3##3##(2009-10#1)(2012-2#2)
blood-testis barrier##5##2##(2009-10#2)(2012-2#3)
blood]##3##1##(1996-11#1)(2010-12#1)(2013-8#1)
bloodless##2##1##(1992-3#1)(2012-3#1)
bloodstream infection##2##2##(2008-10#1)(2010-12#1)
bloodstream##6##1##(2008-10#1)(2008-7#1)(2010-12#2)(2010-6#1)(2012-2#1)
bloody##5##1##(1990-11#2)(1992-6#1)(2008-12#1)(2011-2#1)
bloom and fruit developmental stages##3##5##(2008-10#3)
bloom and fruit##5##3##(2008-10#5)
bloom and##9##2##(2008-10#8)(2008-8#1)
bloom developed##2##2##(2008-10#2)
bloom in##2##2##(2008-10#2)
bloom of##2##2##(1993-11#1)(2008-10#1)
bloom stage##3##2##(2008-10#3)
bloom stages##6##2##(2008-10#6)
bloom to suppress##2##3##(2008-10#2)
bloom to##3##2##(2008-10#3)
bloom##54##1##(1993-11#1)(2008-10#48)(2008-8#4)(2009-8#1)
blooming effect##2##2##(2008-2#2)
blooming##4##1##(1997-4#1)(2008-2#3)
blooms##7##1##(2008-3#1)(2008-8#4)(2009-8#1)(2010-5#1)
blossom blight of prunes##2##4##(2008-10#2)
blossom blight##8##2##(2008-10#8)
blossom protection##2##2##(2008-10#2)
blossom were##2##2##(2008-10#2)
blossom##19##1##(2008-10#19)
blossoms and##3##2##(2008-10#3)
blossoms from##2##2##(2008-10#2)
blossoms in the orchard##2##4##(2008-10#2)
blossoms in the##3##3##(2008-10#3)
blossoms in##5##2##(2008-10#5)
blossoms inoculated with##2##3##(2008-10#2)
blossoms of##3##2##(2008-10#3)
blossoms prior to##2##3##(2008-10#2)
blossoms sampled##2##2##(2008-10#2)
blossoms were inoculated with##2##4##(2008-10#2)
blossoms were##4##2##(2008-10#4)
blossoms##51##1##(2008-10#51)
blot analyses indicated that##4##4##(1992-3#1)(1993-12#2)(1997-8#1)
blot analyses of##3##3##(1993-3#1)(2008-10#2)
blot analyses revealed that##2##4##(2008-10#2)
blot analyses##16##2##(1991-10#1)(1992-3#1)(1993-12#3)(1993-3#1)(1994-11#1)(1996-12#1)(1997-8#1)(2008-10#7)
blot analysis and in##2##4##(2008-11#1)(2008-6#1)
blot analysis and the##2##4##(2008-8#1)(2010-12#1)
blot analysis and##6##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)
blot analysis confirmed##3##3##(1997-7#1)(2008-10#2)
blot analysis demonstrated##4##3##(2008-10#1)(2008-5#1)(2008-8#2)
blot analysis of##12##3##(1993-9#1)(1994-11#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#4)(2011-2#1)
blot analysis revealed that the##4##5##(1995-6#1)(1997-7#1)(2008-10#1)(2008-6#1)
blot analysis revealed that##11##4##(1992-4#1)(1993-3#1)(1995-6#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)
blot analysis revealed##15##3##(1992-4#1)(1993-3#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#2)(2009-3#1)
blot analysis reveals##2##3##(1990-8#1)(2008-11#1)
blot analysis showed that the##5##5##(1990-5#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-8#1)
blot analysis showed that##10##4##(1990-5#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-8#1)
blot analysis showed##16##3##(1990-5#1)(1994-11#2)(1995-6#2)(1996-12#2)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-8#1)(2011-2#1)
blot analysis using##4##3##(1994-11#1)(1995-11#1)(2008-10#1)(2008-9#1)
blot analysis was##2##3##(1996-12#1)(1997-8#1)
blot analysis with##3##3##(1995-6#1)(1996-6#1)(2008-11#1)
blot analysis##101##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-4#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#5)(1995-11#1)(1995-2#2)(1995-6#6)(1996-12#7)(1996-2#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#4)(1997-8#8)(2008-10#17)(2008-11#10)(2008-5#2)(2008-6#2)(2008-8#8)(2008-9#2)(2009-3#1)(2010-12#2)(2011-2#3)
blot and immunoprecipitation##2##3##(1993-3#1)(2008-11#1)
blot and##14##2##(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-5#1)(2013-8#1)
blot assay##4##2##(1995-2#1)(2008-9#3)
blot assays##2##2##(2008-10#2)
blot hybridization analysis of##2##4##(2008-10#2)
blot hybridization analysis##6##3##(1996-6#1)(2008-10#5)
blot hybridization with##3##3##(2008-10#3)
blot hybridization##20##2##(1992-3#1)(1994-1#2)(1996-6#1)(2008-10#14)(2008-4#1)(2008-9#1)
blot hybridizations showed that##2##4##(2008-10#2)
blot hybridizations to detect##2##4##(2008-10#2)
blot hybridizations##5##2##(2008-10#5)
blot immunoassays##2##2##(2008-10#2)
blot with##2##2##(1995-6#1)(1997-1#1)
blot##223##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-3#3)(1992-4#1)(1993-12#8)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#6)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#9)(1996-12#11)(1996-2#1)(1996-6#3)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#5)(1997-8#9)(1997-9#1)(2008-10#55)(2008-11#13)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#19)(2008-9#16)(2009-3#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
blotch (STB)##2##2##(2008-10#2)
blotch and##2##2##(2008-10#2)
blotch disease##5##2##(2008-10#5)
blotch in##4##2##(2008-10#4)
blotch of##5##2##(2008-10#5)
blotch on##2##2##(2008-10#2)
blotch pathogen##4##2##(2008-10#4)
blotch resistance in##2##3##(2008-10#2)
blotch resistance##6##2##(2008-10#6)
blotch##53##1##(2008-10#53)
blots can be##2##3##(2008-4#2)
blots using##2##2##(1993-12#1)(2009-9#1)
blots with the##2##3##(1993-12#1)(1995-12#1)
blots with##3##2##(1993-12#1)(1995-12#1)(2008-10#1)
blots##28##1##(1991-12#2)(1993-12#2)(1993-2#1)(1994-11#1)(1995-12#3)(1995-6#1)(1996-12#1)(2008-10#10)(2008-4#4)(2008-5#1)(2008-9#1)(2009-9#1)
blotted##2##1##(2008-10#2)
blotting analysis##7##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)
blotting and hybridization##2##3##(2008-4#2)
blotting and##6##2##(1992-10#1)(1995-12#1)(2008-4#2)(2008-6#1)(2012-12#1)
blotting demonstrated that##2##3##(1995-8#1)(2008-9#1)
blotting indicated that the##2##4##(2008-10#1)(2008-8#1)
blotting of##5##2##(1994-11#2)(2008-10#1)(2008-11#1)(2008-9#1)
blotting revealed##2##2##(1993-8#1)(1994-12#1)
blotting using##3##2##(1996-12#1)(1997-1#1)(2008-11#1)
blotting was employed##2##3##(1990-12#1)(2008-11#1)
blotting with##4##2##(1997-1#1)(2008-8#2)(2010-12#1)
blotting##74##1##(1990-12#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#13)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#8)(2008-9#9)(2010-12#3)(2011-3#3)(2012-12#1)(2012-3#2)
blow##4##1##(1991-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
blowfly##2##1##(1997-7#1)(2008-11#1)
blubber of ringed seal##2##4##(2008-10#2)
blubber of ringed##3##3##(2008-10#3)
blubber of##4##2##(2008-10#4)
blubber##6##1##(2008-10#6)
blue (MB) and##2##3##(2008-10#2)
blue (MB)##13##2##(2008-10#13)
blue (MTB) as##2##3##(2008-10#2)
blue (VB)##2##2##(2008-10#2)
blue LED##3##2##(2008-10#3)
blue and gray##2##3##(2008-10#2)
blue and the##2##3##(2008-10#1)(2008-7#1)
blue and##16##2##(1992-12#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)
blue color##4##2##(2008-10#4)
blue complex is monitored##2##4##(2008-10#2)
blue complex is##3##3##(2008-10#3)
blue complex##15##2##(2008-10#15)
blue derivative##2##2##(2008-10#2)
blue dye exclusion##3##3##(2008-11#3)
blue dye##7##2##(1990-2#1)(1994-12#1)(2008-10#2)(2008-11#3)
blue form of##2##3##(1994-5#1)(2008-10#1)
blue from##2##2##(2008-10#2)
blue in the presence of##2##5##(2008-10#2)
blue in the##4##3##(2008-10#3)(2008-7#1)
blue in##6##2##(2008-10#5)(2008-7#1)
blue into##2##2##(2008-10#2)
blue is##4##2##(2008-10#4)
blue light##4##2##(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
blue method##7##2##(2008-10#7)
blue mold on##2##3##(2008-10#2)
blue mold##13##2##(2008-10#13)
blue reaction##2##2##(2008-10#2)
blue sensitized##2##2##(2008-10#2)
blue shift of the##2##4##(2008-10#1)(2008-8#1)
blue staining##2##2##(2008-11#1)(2008-4#1)
blue tits##2##2##(2008-8#2)
blue was##2##2##(2008-10#2)
blue were##2##2##(2008-10#2)
blue with##2##2##(2008-10#2)
blue##246##1##(1990-12#2)(1990-2#2)(1990-9#1)(1991-1#1)(1991-11#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#2)(1995-8#1)(2007-11#1)(2008-10#175)(2008-11#16)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#3)(2013-1#1)
blue)##5##1##(1997-2#1)(2006-6#1)(2008-10#3)
blue-coloured##2##1##(1990-12#1)(2008-10#1)
blue-green alga Spirulina platensis##2##4##(2008-10#1)(2008-8#1)
blue-green##6##1##(2008-10#3)(2008-8#2)(2013-1#1)
blue-stain fungi##2##2##(2008-10#2)
blue-stained##2##1##(1993-9#1)(2008-10#1)
blueberries##2##1##(2008-10#2)
blueberry##8##1##(2008-10#8)
bluegill Lepomis macrochirus larvae##2##4##(2010-8#2)
bluegills##3##1##(2008-6#3)
blueprint for public##2##3##(1995-12#1)(1997-3#1)
blueprint for##7##2##(1994-12#2)(1995-1#1)(1995-12#2)(1997-3#2)
blueprint##9##1##(1993-2#1)(1994-12#2)(1995-1#1)(1995-12#2)(1997-3#3)
bluish##3##1##(1991-6#1)(2008-10#1)(2008-5#1)
blunt abdominal trauma##4##3##(1990-2#2)(2008-10#1)(2010-1#1)
blunt abdominal##6##2##(1990-2#4)(2008-10#1)(2010-1#1)
blunt head injury##2##3##(2008-7#2)
blunt head##5##2##(2008-7#2)(2011-2#3)
blunt thoracic trauma are##2##4##(2012-2#2)
blunt trauma##5##2##(1990-9#1)(2008-12#1)(2009-2#1)(2009-6#1)(2011-2#1)
blunt##30##1##(1990-2#4)(1990-9#4)(1991-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-6#1)(2010-1#1)(2011-2#4)(2012-2#5)
blunt-ended nuclei##2##2##(1994-6#1)(2010-6#1)
blunted##2##1##(1995-8#1)(2008-4#1)
blur##7##1##(2008-3#7)
blurred vision##4##2##(2008-7#2)(2013-1#1)(2013-8#1)
blurred##6##1##(1996-3#1)(2008-11#1)(2008-7#2)(2013-1#1)(2013-8#1)
blurring the##2##2##(1991-3#1)(2008-3#1)
blurring##4##1##(1991-3#1)(1994-12#1)(2008-3#1)(2011-2#1)
boar spermatozoa##2##2##(2013-1#2)
boar##4##1##(2010-4#1)(2013-1#3)
board and senior##2##3##(1993-12#1)(1994-2#1)
board and##3##2##(1993-12#1)(1994-2#1)(2010-5#1)
board in##2##2##(1995-12#1)(2010-4#1)
board members##4##2##(2008-11#1)(2010-12#3)
board of directors##2##3##(1995-6#1)(1996-3#1)
board of##5##2##(1995-6#1)(1996-3#1)(2008-8#1)(2012-3#1)(2013-1#1)
board##54##1##(1991-1#4)(1991-12#3)(1992-2#1)(1992-3#6)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#4)(1995-12#5)(1995-3#2)(1995-6#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
boards and management##2##3##(1994-12#1)(2008-11#1)
boards and##5##2##(1994-12#1)(1994-2#1)(1995-3#1)(2008-11#1)(2012-2#1)
boards are##2##2##(1991-1#1)(1994-12#1)
boards of directors##2##3##(1994-12#1)(1996-1#1)
boards should##2##2##(1991-12#1)(2008-11#1)
boards##40##1##(1991-1#5)(1991-12#3)(1992-1#3)(1992-3#3)(1994-12#6)(1994-2#2)(1995-1#1)(1995-3#3)(1996-1#2)(2008-10#1)(2008-11#3)(2008-4#3)(2012-2#5)
boat##3##1##(1994-9#1)(2008-10#1)(2009-7#1)
bodes well for##2##3##(1995-9#1)(2011-2#1)
bodies and##17##2##(1996-12#1)(2007-12#1)(2008-10#4)(2008-7#9)(2009-10#1)(2009-5#1)
bodies are##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
bodies can##2##2##(2008-11#1)(2009-6#1)
bodies from##4##2##(1995-11#1)(2008-10#2)(2009-8#1)
bodies in the oleosin knockdown##2##5##(2009-10#2)
bodies in the##10##3##(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-9#1)(2009-10#2)(2011-2#1)
bodies in##18##2##(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2011-2#2)
bodies of the##2##3##(2009-10#1)(2011-2#1)
bodies of##8##2##(1990-5#1)(1996-12#1)(1997-3#1)(2008-10#2)(2009-10#1)(2011-2#1)(2013-8#1)
bodies to##2##2##(2013-1#1)(2013-8#1)
bodies was##2##2##(1995-8#1)(2008-11#1)
bodies were present##2##3##(2008-6#1)(2008-7#1)
bodies were##9##2##(1991-10#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-3#1)(2012-3#1)
bodies with##2##2##(2008-7#1)(2009-10#1)
bodies##159##1##(1990-3#1)(1990-5#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-3#1)(1991-8#1)(1993-3#1)(1993-9#1)(1995-11#3)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#3)(1996-5#2)(1997-2#1)(1997-3#7)(2007-12#6)(2008-10#28)(2008-11#11)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#22)(2008-8#2)(2008-9#3)(2009-10#11)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#5)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#8)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#6)
bodies)##2##1##(2008-7#1)(2008-8#1)
bodily##2##1##(2009-10#1)(2009-11#1)
body COM acceleration##2##3##(2013-1#2)
body and the##2##3##(2008-10#1)(2008-5#1)
body and##24##2##(1992-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
body are##5##2##(1995-1#1)(2008-10#3)(2009-7#1)
body area##2##2##(2008-9#1)(2010-8#1)
body balance##6##2##(2008-12#5)(2010-9#1)
body burden##3##2##(2008-10#2)(2009-12#1)
body cavity##4##2##(1993-3#1)(1996-12#1)(1997-3#1)(2008-9#1)
body composition and inflammation in##2##5##(2011-2#2)
body composition and##3##3##(2011-2#2)(2012-2#1)
body composition##12##2##(1993-12#1)(1996-11#1)(2008-11#2)(2008-4#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#1)
body condition##3##2##(1996-8#2)(2008-9#1)
body core temperature##3##3##(2008-5#3)
body details##2##2##(2008-7#2)
body dose##3##2##(1997-1#1)(2008-7#2)
body extracts##2##2##(2008-10#2)
body fat and muscle##2##4##(2008-7#2)
body fat and##4##3##(2008-11#1)(2008-4#1)(2008-7#2)
body fat distribution and##2##4##(2010-6#2)
body fat distribution##4##3##(2010-6#4)
body fat##16##2##(2008-11#2)(2008-4#2)(2008-7#3)(2009-7#1)(2010-6#4)(2012-2#3)(2013-8#1)
body fatness##2##2##(2008-10#1)(2012-2#1)
body fluid##2##2##(2011-2#1)(2012-2#1)
body fluids and##2##3##(2008-10#2)
body fluids##12##2##(1991-1#1)(1994-12#1)(1994-8#1)(1996-5#1)(2008-10#7)(2008-9#1)
body formation##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
body fracture##3##2##(2010-5#3)
body granuloma##2##2##(2012-12#2)
body homeostasis##2##2##(2012-2#2)
body image and sexual health among adolescent boys##2##8##(2009-5#2)
body image dissatisfaction##2##3##(2012-2#2)
body image##7##2##(2009-5#3)(2010-11#2)(2012-2#2)
body in##4##2##(2008-12#2)(2009-11#1)(2010-6#1)
body into the##3##3##(2009-8#2)(2011-2#1)
body is##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
body kinematics of##2##3##(2011-2#2)
body language##2##2##(2011-2#2)
body length of##3##3##(2008-6#1)(2013-1#2)
body length##6##2##(2008-6#2)(2008-8#1)(2013-1#3)
body lotion##3##2##(2008-10#3)
body mass index (BMI) were##2##5##(2008-7#1)(2010-1#1)
body mass index (BMI)##14##4##(1991-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
body mass index and serum cholesterol##2##6##(2008-7#2)
body mass index and##7##4##(2008-10#1)(2008-11#1)(2008-7#4)(2011-2#1)
body mass index is##2##4##(2011-1#1)(2011-2#1)
body mass index##64##3##(1991-11#2)(1993-12#1)(1994-12#4)(2008-10#5)(2008-11#6)(2008-12#2)(2008-7#9)(2008-8#1)(2010-1#1)(2010-4#3)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
body mass indices##2##3##(2009-3#1)(2012-2#1)
body mass##79##2##(1991-11#2)(1993-12#1)(1994-12#4)(2007-12#2)(2008-10#6)(2008-11#6)(2008-12#2)(2008-7#9)(2008-8#4)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#3)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#10)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#3)
body mass)##2##2##(2010-8#1)(2012-2#1)
body measurements##2##2##(1996-8#2)
body occlusion in##2##3##(2008-7#2)
body of data##4##3##(1993-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
body of evidence indicates##2##4##(1990-9#1)(2009-3#1)
body of evidence##11##3##(1990-9#1)(1992-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-6#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
body of knowledge##3##3##(1995-12#1)(2008-12#1)(2011-1#1)
body of literature on##2##4##(2008-8#1)(2012-3#1)
body of literature##7##3##(2007-12#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#1)(2012-3#1)
body of research##6##3##(2008-12#1)(2008-6#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-8#1)
body of the##7##3##(1992-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-6#1)
body of##52##2##(1990-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-10#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
body on##3##2##(1996-12#1)(2007-8#1)(2013-1#1)
body or##3##2##(1996-2#1)(2007-11#1)(2011-2#1)
body organs##5##2##(1994-5#1)(2008-12#2)(2008-7#1)(2011-2#1)
body parts##3##2##(1992-3#1)(2008-9#1)(2010-4#1)
body plans##2##2##(2009-6#1)(2010-4#1)
body posture##3##2##(2009-8#3)
body righting##2##2##(1992-12#2)
body satisfaction may co-occur among##2##5##(2012-2#2)
body satisfaction were##2##3##(2009-5#1)(2010-10#1)
body satisfaction##8##2##(2009-5#1)(2010-10#5)(2012-2#2)
body signals##4##2##(2008-11#4)
body site##4##2##(2008-5#2)(2009-4#2)
body sites##2##2##(2008-5#2)
body size and##7##3##(2007-12#1)(2008-8#3)(2008-9#1)(2010-8#2)
body size in##2##3##(1995-2#1)(2008-8#1)
body size of##2##3##(2008-8#1)(2008-9#1)
body size##31##2##(1991-12#1)(1995-2#2)(2007-12#3)(2008-5#1)(2008-8#9)(2008-9#8)(2009-8#1)(2010-8#3)(2012-3#3)
body stalk##2##2##(1997-3#2)
body strength##2##2##(2010-1#2)
body surface area##4##3##(2008-8#2)(2010-5#1)(2011-2#1)
body surface##7##2##(2008-10#1)(2008-5#1)(2008-8#2)(2010-5#1)(2011-2#1)(2011-3#1)
body temperature and##2##3##(1992-2#1)(2013-1#1)
body temperature##9##2##(1992-2#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2013-1#1)
body temperatures##2##2##(1992-3#1)(2008-8#1)
body tissues##3##2##(1996-3#2)(2011-2#1)
body to##2##2##(2008-5#1)(2008-7#1)
body wall##2##2##(1997-3#1)(1997-7#1)
body was##4##2##(2008-10#1)(2009-3#1)(2013-1#2)
body weight and##7##3##(2008-10#1)(2008-11#2)(2008-7#1)(2011-3#1)(2012-2#2)
body weight changes##2##3##(2011-2#1)(2013-8#1)
body weight for##2##3##(2008-12#1)(2008-9#1)
body weight gain##3##3##(2008-12#1)(2008-5#2)
body weight gains##4##3##(2008-5#3)(2011-2#1)
body weight in##3##3##(1993-8#1)(2008-9#2)
body weight of##5##3##(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
body weight or##3##3##(1994-12#1)(2008-1#1)(2012-2#1)
body weight to##2##3##(2008-9#1)(2010-4#1)
body weight##70##2##(1990-9#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-12#2)(1994-8#1)(1996-12#2)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#5)(2009-7#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#5)(2011-3#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#4)
body weight) was##2##3##(2008-10#1)(2012-2#1)
body weight)##4##2##(2008-10#1)(2008-11#1)(2012-2#2)
body weights of##12##3##(2008-5#1)(2008-9#11)
body weights were similar to those of vehicle controls##2##9##(2008-9#2)
body weights##17##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#13)
body were##3##2##(1992-3#1)(2008-5#1)(2008-7#1)
body with##3##2##(1996-1#1)(2009-3#1)(2010-8#1)
body wt##4##2##(1993-11#1)(2012-3#1)(2013-1#2)
body##705##1##(1990-3#3)(1990-5#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-12#3)(1992-2#5)(1992-3#8)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#8)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#6)(1997-1#3)(1997-3#4)(1997-7#2)(1997-8#3)(2007-11#4)(2007-12#13)(2007-8#10)(2008-1#4)(2008-10#68)(2008-11#33)(2008-12#25)(2008-3#1)(2008-4#4)(2008-5#31)(2008-6#7)(2008-7#45)(2008-8#29)(2008-9#39)(2009-1#2)(2009-10#6)(2009-11#2)(2009-12#4)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#7)(2010-1#6)(2010-10#9)(2010-11#3)(2010-12#3)(2010-4#8)(2010-5#8)(2010-6#12)(2010-7#2)(2010-8#9)(2010-9#2)(2011-1#6)(2011-2#41)(2011-3#5)(2012-12#6)(2012-2#36)(2012-3#19)(2013-1#47)(2013-7#3)(2013-8#24)
bog water)##2##2##(2008-10#2)
bog##3##1##(2008-10#2)(2008-8#1)
bogs##2##1##(2008-8#2)
bohemine##6##1##(2008-11#6)
boiled##4##1##(2008-10#4)
boiling point##3##2##(2008-10#3)
boiling points##3##2##(2008-10#3)
boiling##17##1##(1996-12#1)(2008-10#15)(2011-2#1)
boldness##2##1##(2008-8#2)
bole##3##1##(2008-10#3)
boll##2##1##(2008-10#2)
bolls##5##1##(2008-10#5)
bolus dispersion##6##2##(1997-2#6)
bolus dose##3##2##(1993-1#1)(2008-11#1)(2011-2#1)
bolus insulin##2##2##(2008-1#2)
bolus is injected##2##3##(1997-1#1)(2008-10#1)
bolus of##3##2##(1996-11#1)(2008-10#1)(2008-7#1)
bolus##26##1##(1992-2#1)(1993-1#1)(1995-12#1)(1996-11#1)(1997-1#2)(1997-2#6)(2007-12#2)(2008-1#4)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#2)
bomb and##4##2##(1995-12#1)(2008-10#3)
bomb##12##1##(1991-5#1)(1995-12#1)(2008-10#5)(2013-1#5)
bombacina##2##1##(2008-10#2)
bombarded##2##1##(2008-10#1)(2008-7#1)
bombardment of##2##2##(2008-10#1)(2008-5#1)
bombardment##17##1##(1995-3#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-9#2)
bombesin##6##1##(1992-8#1)(1994-3#4)(2010-6#1)
bombolitin III##4##2##(1994-5#4)
bombs and##2##2##(2008-10#2)
bombs##6##1##(2008-10#4)(2008-12#1)(2013-1#1)
bombyxin genes have##2##3##(2008-6#2)
bombyxin genes##3##2##(2008-6#3)
bombyxin##6##1##(2008-6#6)
bona fide##2##2##(1995-2#1)(2008-4#1)
bond and##4##2##(1995-11#1)(2008-10#3)
bond angle##2##2##(1992-9#1)(2008-8#1)
bond angles##4##2##(1992-4#1)(2008-8#1)(2008-9#2)
bond assignments##2##2##(1993-8#2)
bond at##3##2##(1992-12#1)(1995-6#1)(2008-9#1)
bond between the##3##3##(1992-3#1)(1993-1#1)(1994-5#1)
bond between##5##2##(1992-3#1)(1993-1#2)(1994-5#1)(2008-10#1)
bond cleavage##3##2##(1990-2#1)(1996-5#2)
bond distances##2##2##(1993-8#1)(2008-10#1)
bond formation##4##2##(1990-8#1)(1993-9#1)(1994-11#1)(2009-8#1)
bond forming##3##2##(2008-10#2)(2010-7#1)
bond in the##3##3##(1992-12#1)(1992-3#1)(1993-6#1)
bond in##7##2##(1992-12#1)(1992-3#1)(1993-6#1)(1994-5#2)(1996-5#1)(2008-10#1)
bond induced by##2##3##(1996-5#1)(2008-10#1)
bond length and##2##3##(2008-8#1)(2008-9#1)
bond length of##2##3##(2008-9#1)(2011-2#1)
bond length##4##2##(2008-8#1)(2008-9#2)(2011-2#1)
bond lengths and##4##3##(1992-4#2)(2008-8#1)(2008-9#1)
bond of##4##2##(1990-5#1)(2008-10#2)(2012-12#1)
bond strength and##2##3##(2013-1#2)
bond strength of##8##3##(2010-12#1)(2013-1#7)
bond strength when##2##3##(2013-1#2)
bond strength##16##2##(2010-12#1)(2013-1#15)
bond strengths##2##2##(2013-1#2)
bond was##2##2##(2008-10#1)(2008-8#1)
bond with the##2##3##(1995-8#1)(1996-5#1)
bond with##4##2##(1991-5#1)(1995-8#1)(1996-5#1)(2008-12#1)
bond##131##1##(1990-2#1)(1990-5#1)(1990-8#2)(1991-5#4)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#2)(1992-4#6)(1992-6#1)(1992-9#1)(1993-1#2)(1993-6#1)(1993-8#6)(1993-9#2)(1994-11#2)(1994-5#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-5#7)(1997-7#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#11)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#7)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#18)
bonded diethylenetriamine##2##2##(2008-10#2)
bonded glucose##3##2##(2008-10#3)
bonded phase##4##2##(1992-6#1)(2008-10#3)
bonded silica gel##2##3##(2008-10#2)
bonded silica stationary phase##3##4##(2008-10#3)
bonded silica stationary phases##2##4##(2008-10#2)
bonded silica stationary##5##3##(2008-10#5)
bonded silica##11##2##(2008-10#11)
bonded to a##2##3##(2008-10#1)(2013-1#1)
bonded to the##2##3##(1994-5#1)(2008-10#1)
bonded to##5##2##(1994-5#1)(2008-10#3)(2013-1#1)
bonded with##3##2##(2008-10#2)(2013-1#1)
bonded##40##1##(1991-3#1)(1992-6#1)(1994-5#1)(1995-3#1)(1997-2#1)(2008-10#30)(2008-2#1)(2008-5#1)(2009-8#1)(2013-1#2)
bonding and##2##2##(1993-2#1)(1994-3#1)
bonding between##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
bonding of##3##2##(2008-10#3)
bonding through an##2##3##(2008-10#2)
bonding to##2##2##(1990-8#1)(2009-9#1)
bonding##39##1##(1990-8#1)(1991-5#1)(1993-2#1)(1993-8#1)(1994-3#1)(2008-10#23)(2008-3#1)(2008-5#2)(2009-11#1)(2009-9#1)(2010-7#1)(2013-1#5)
bonds and##5##2##(1990-5#2)(1991-3#1)(1992-10#1)(1996-5#1)
bonds are##6##2##(1990-5#1)(1992-12#1)(1993-9#1)(1994-11#1)(2008-7#1)(2010-7#1)
bonds between##2##2##(2008-8#1)(2013-1#1)
bonds can##2##2##(2008-10#1)(2008-11#1)
bonds in##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
bonds of the##2##3##(1991-5#1)(1992-10#1)
bonds of##3##2##(1991-5#1)(1992-10#1)(1996-5#1)
bonds on the carboxyl side of##2##6##(1994-5#2)
bonds on##3##2##(1994-5#2)(2008-10#1)
bonds to##2##2##(1990-5#1)(1994-5#1)
bonds were##4##2##(1990-5#2)(2008-10#1)(2009-7#1)
bonds with##2##2##(2008-10#1)(2008-7#1)
bonds##75##1##(1990-5#7)(1991-3#1)(1991-5#2)(1991-9#1)(1992-10#2)(1992-12#2)(1992-8#3)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-5#6)(1995-3#2)(1996-5#2)(2008-1#3)(2008-10#20)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#3)(2009-9#1)(2010-7#1)(2011-1#1)(2013-1#1)
bone GLA-protein##4##2##(1990-2#4)
bone allografts##2##2##(1996-3#2)
bone and cartilage##2##3##(1990-11#2)
bone and soft tissue tumors##2##5##(2011-2#2)
bone and soft tissue##4##4##(2008-8#1)(2009-4#1)(2011-2#2)
bone and soft##5##3##(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#2)
bone and##19##2##(1990-11#2)(1994-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-6#2)(2011-2#4)(2013-1#1)(2013-8#1)
bone architecture and bone mineral properties##2##6##(2011-2#2)
bone architecture##3##2##(2011-2#3)
bone are##2##2##(2009-7#1)(2011-2#1)
bone atrophy##2##2##(2011-7#1)(2013-1#1)
bone biopsies##2##2##(1991-11#2)
bone biopsy##2##2##(1991-11#2)
bone by##2##2##(1997-1#1)(2013-1#1)
bone cells##7##2##(1994-11#1)(1997-1#1)(2007-11#1)(2008-11#3)(2011-1#1)
bone changes and##2##3##(2008-9#1)(2011-2#1)
bone changes##4##2##(2008-10#1)(2008-9#2)(2011-2#1)
bone cholesteatoma##5##2##(2011-2#5)
bone cyst##7##2##(2012-12#5)(2013-1#2)
bone cysts##2##2##(2012-12#1)(2013-1#1)
bone defect##3##2##(2008-11#1)(2008-7#2)
bone defects was##2##3##(2008-11#2)
bone defects##4##2##(2008-11#2)(2008-7#1)(2010-6#1)
bone densitometry##2##2##(2008-8#1)(2011-2#1)
bone density and##2##3##(1991-11#1)(2007-8#1)
bone density##12##2##(1991-11#3)(1994-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#1)
bone destruction and##3##3##(2010-6#2)(2012-3#1)
bone destruction##6##2##(2007-11#1)(2008-12#1)(2010-6#2)(2012-3#2)
bone development##2##2##(1991-5#2)
bone disease##5##2##(2008-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
bone erosion##3##2##(2011-2#3)
bone flap##2##2##(2008-7#2)
bone for##2##2##(2010-3#1)(2011-2#1)
bone formation in##4##3##(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
bone formation##14##2##(1990-11#1)(1991-5#1)(2008-10#1)(2008-11#2)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
bone fracture##4##2##(1991-2#1)(2007-8#1)(2008-8#1)(2009-7#1)
bone fractures##4##2##(2008-7#1)(2009-3#2)(2013-1#1)
bone fragments##4##2##(2013-1#4)
bone graft##16##2##(1995-12#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-5#2)(2010-6#2)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
bone grafting##8##2##(1996-3#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#1)
bone grafts##3##2##(1992-4#1)(2010-6#2)
bone growth##2##2##(1996-11#1)(2013-1#1)
bone height##2##2##(2012-12#1)(2013-1#1)
bone in the##4##3##(1990-11#1)(2007-8#1)(2008-7#1)(2009-7#1)
bone in##12##2##(1990-11#1)(1994-12#1)(1996-3#1)(2007-8#1)(2008-1#2)(2008-7#1)(2009-7#2)(2010-6#1)(2011-2#1)(2013-1#1)
bone involvement##3##2##(1991-11#1)(1997-8#1)(2010-6#1)
bone is presented##2##3##(2008-9#1)(2009-7#1)
bone is##8##2##(1996-3#2)(2008-7#1)(2008-9#1)(2009-7#3)(2011-2#1)
bone lesions##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
bone level##3##2##(2008-11#1)(2013-1#2)
bone loss##15##2##(1991-11#1)(1996-3#1)(2008-11#2)(2008-12#1)(2008-7#2)(2010-5#3)(2010-6#1)(2011-2#1)(2013-1#3)
bone marrow (BM)##3##3##(2008-11#1)(2008-9#1)(2010-8#1)
bone marrow and spleen##2##4##(1991-6#1)(2010-8#1)
bone marrow and##6##3##(1991-6#1)(1992-2#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-3#1)
bone marrow aspirate##4##3##(2008-11#3)(2008-12#1)
bone marrow biopsy showed##2##4##(2009-1#1)(2013-8#1)
bone marrow biopsy##3##3##(1991-6#1)(2009-1#1)(2013-8#1)
bone marrow cells in##2##4##(2008-11#1)(2010-11#1)
bone marrow cells of##3##4##(1997-8#1)(2010-1#2)
bone marrow cells was##2##4##(1990-6#1)(2008-7#1)
bone marrow cells##20##3##(1990-3#2)(1990-6#1)(1992-8#1)(1994-5#1)(1997-8#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-1#2)(2010-11#3)(2010-6#1)(2010-8#1)
bone marrow derived##4##3##(1994-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
bone marrow mesenchymal stem cells##5##5##(2008-11#4)(2010-12#1)
bone marrow microenvironment##2##3##(2010-8#1)(2011-2#1)
bone marrow mononuclear cells##5##4##(2008-10#1)(2010-6#4)
bone marrow mononuclear##6##3##(2008-10#1)(2010-6#5)
bone marrow necrosis##2##3##(2008-12#2)
bone marrow oedema##2##3##(2011-2#2)
bone marrow or stem cell##2##5##(2011-2#2)
bone marrow or##4##3##(2008-11#1)(2009-10#1)(2011-2#2)
bone marrow stromal cell line##4##5##(2008-10#1)(2008-11#3)
bone marrow stromal##5##3##(2008-10#1)(2008-11#4)
bone marrow suppression##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
bone marrow toxicity##2##3##(2008-11#1)(2008-5#1)
bone marrow transplant##3##3##(1995-1#1)(2008-11#1)(2013-8#1)
bone marrow transplantation or##2##4##(1993-2#1)(2008-11#1)
bone marrow transplantation##11##3##(1993-2#1)(1994-5#2)(1997-5#1)(1997-7#1)(2008-11#3)(2010-6#1)(2013-7#1)(2013-8#1)
bone marrow##147##2##(1990-3#2)(1990-6#2)(1991-2#1)(1991-6#4)(1992-2#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-8#4)(1994-5#4)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2008-10#8)(2008-11#35)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#10)(2009-1#1)(2009-10#1)(2009-8#1)(2010-1#5)(2010-11#4)(2010-12#1)(2010-6#11)(2010-8#10)(2011-2#10)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
bone marrow-derived stromal##2##3##(2008-11#1)(2008-8#1)
bone marrow-derived##6##2##(1992-10#1)(1997-8#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-6#1)
bone mass and##2##3##(2010-10#1)(2010-3#1)
bone mass in##2##3##(1991-11#1)(2010-3#1)
bone mass##8##2##(1991-11#3)(2008-12#1)(2010-10#2)(2010-3#2)
bone matrix##5##2##(1991-11#1)(1991-5#2)(1997-1#1)(2008-11#1)
bone may##2##2##(2008-12#1)(2011-2#1)
bone metabolism##8##2##(1991-11#1)(1992-6#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
bone metastases##21##2##(1990-2#1)(1991-8#3)(1993-11#1)(2008-1#2)(2008-10#5)(2008-7#3)(2011-2#6)
bone metastasis and##3##3##(1994-12#2)(2010-3#1)
bone metastasis##11##2##(1990-2#1)(1994-12#6)(1997-3#1)(1997-7#1)(2010-3#1)(2011-2#1)
bone mineral density (BMD) and##2##5##(2010-1#1)(2011-2#1)
bone mineral density (BMD) in##2##5##(2011-2#2)
bone mineral density (BMD)##7##4##(1991-11#1)(2008-8#1)(2010-1#1)(2010-3#1)(2011-2#3)
bone mineral density in Vietnamese women##2##6##(2010-3#2)
bone mineral density in##3##4##(2010-3#2)(2011-2#1)
bone mineral density##18##3##(1991-11#2)(1996-8#2)(2008-11#1)(2008-8#1)(2010-1#2)(2010-10#1)(2010-3#3)(2011-2#5)(2012-3#1)
bone mineral##24##2##(1991-11#3)(1994-9#1)(1996-8#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-1#2)(2010-10#1)(2010-3#3)(2011-2#7)(2012-3#1)
bone morphogenetic protein-2##2##3##(2011-2#2)
bone morphogenetic##6##2##(1991-5#1)(1996-11#1)(2011-2#4)
bone of##5##2##(1991-11#1)(1995-9#1)(2008-7#1)(2011-2#2)
bone or##2##2##(2013-1#2)
bone osteomyelitis##3##2##(2010-6#3)
bone pain##3##2##(1991-11#1)(1997-7#1)(2008-10#1)
bone quality##5##2##(1991-11#1)(1995-9#1)(2010-10#1)(2011-2#1)(2011-7#1)
bone regeneration##2##2##(2010-6#1)(2012-12#1)
bone resection for##2##3##(1996-3#1)(2011-2#1)
bone resection##4##2##(1996-3#1)(2011-2#3)
bone resorption by##2##3##(2008-11#2)
bone resorption in##2##3##(1993-6#2)
bone resorption induced by##2##4##(1993-6#2)
bone resorption##24##2##(1991-11#1)(1993-6#9)(2008-10#1)(2008-11#6)(2008-12#1)(2011-2#1)(2011-7#1)(2013-1#4)
bone resorptive##2##2##(2011-2#2)
bone samples##2##2##(2008-10#1)(2011-2#1)
bone scan##4##2##(1991-11#1)(2009-6#1)(2010-6#1)(2011-2#1)
bone scintigraphic##3##2##(2011-2#3)
bone scintigraphy in##2##3##(2007-11#2)
bone scintigraphy##5##2##(2007-11#2)(2009-3#1)(2009-4#1)(2011-2#1)
bone sclerosis##3##2##(1991-11#1)(2011-2#2)
bone substitutes##2##2##(2009-7#2)
bone tissue engineering##6##3##(2009-7#6)
bone tissue in rheumatoid arthritis##2##5##(2007-11#2)
bone tissue in##3##3##(2007-11#2)(2010-6#1)
bone tissue##14##2##(1996-3#1)(2007-11#2)(2007-8#2)(2008-12#1)(2009-7#7)(2010-6#1)
bone tumor##2##2##(2008-5#1)(2011-2#1)
bone tumors of adulthood##2##4##(2008-2#2)
bone tumors##7##2##(2008-2#4)(2011-2#3)
bone tumours##2##2##(2008-1#1)(2012-12#1)
bone tunnel##5##2##(2013-1#5)
bone turnover markers##2##3##(2010-10#1)(2011-2#1)
bone turnover##6##2##(1990-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)
bone union##7##2##(2007-8#5)(2008-11#1)(2010-12#1)
bone volume##2##2##(2011-2#1)(2012-12#1)
bone was##3##2##(1995-9#1)(2011-2#1)(2012-2#1)
bone were##2##2##(2009-7#2)
bone width##2##2##(2012-12#1)(2013-1#1)
bone with##4##2##(2008-7#1)(2011-2#1)(2013-1#2)
bone##740##1##(1990-11#4)(1990-2#7)(1990-3#2)(1990-6#2)(1990-9#1)(1991-11#35)(1991-2#2)(1991-5#8)(1991-6#4)(1991-8#4)(1992-10#1)(1992-2#3)(1992-4#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-2#1)(1993-6#9)(1993-8#4)(1994-11#1)(1994-12#10)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-9#3)(1996-11#3)(1996-3#18)(1996-8#2)(1997-1#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#5)(2007-11#8)(2007-8#14)(2008-1#5)(2008-10#30)(2008-11#69)(2008-12#14)(2008-2#4)(2008-4#1)(2008-5#5)(2008-7#30)(2008-8#7)(2008-9#20)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#6)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#44)(2009-8#1)(2010-1#7)(2010-10#5)(2010-11#8)(2010-12#3)(2010-3#9)(2010-5#7)(2010-6#34)(2010-8#10)(2011-1#1)(2011-2#117)(2011-7#4)(2012-12#20)(2012-2#5)(2012-3#16)(2013-1#56)(2013-7#1)(2013-8#9)
bone-marrow-derived##4##1##(1994-6#1)(2010-6#3)
bone-resorbing activity##5##2##(2008-11#5)
bone-resorbing osteoclasts##2##2##(2008-11#2)
bone-resorbing##8##1##(2008-11#8)
bones and##4##2##(2009-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
bones are##2##2##(1991-11#1)(2008-10#1)
bones buried##2##2##(2008-10#2)
bones of the##3##3##(1995-9#1)(1997-3#1)(2010-6#1)
bones of##6##2##(1995-9#1)(1997-3#1)(2008-10#3)(2010-6#1)
bones were##2##2##(2008-12#1)(2008-9#1)
bones##40##1##(1990-9#1)(1991-11#1)(1993-6#1)(1995-9#1)(1997-3#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-12#5)(2008-7#1)(2008-9#2)(2009-1#2)(2009-9#1)(2010-1#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-3#1)
bont tick##2##2##(1996-12#1)(2010-1#1)
bony and##2##2##(2008-8#1)(2012-3#1)
bony fusion##2##2##(2012-3#2)
bony groove##2##2##(2008-7#2)
bony structures##2##2##(2009-7#1)(2011-2#1)
bony##25##1##(2008-7#2)(2008-8#1)(2009-11#2)(2009-3#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
book##18##1##(1993-12#1)(1993-3#1)(1994-3#2)(1997-7#1)(2008-10#5)(2008-11#2)(2008-8#3)(2009-10#1)(2011-2#1)(2013-1#1)
booklet##2##1##(1996-8#1)(2009-12#1)
booklets##2##1##(1990-6#1)(1996-2#1)
books##12##1##(1994-2#1)(1994-3#2)(1995-1#1)(1995-6#1)(2008-10#4)(2010-5#1)(2010-8#1)(2013-8#1)
boom and##2##2##(2008-10#1)(2008-11#1)
boom##5##1##(2008-10#1)(2008-11#3)(2009-5#1)
boost##7##1##(1994-3#2)(1994-5#1)(2008-5#1)(2011-2#2)(2012-3#1)
boosted by##2##2##(2007-12#1)(2011-2#1)
boosted##4##1##(1994-12#1)(2007-12#1)(2008-11#1)(2011-2#1)
booster sessions##2##2##(2013-1#2)
booster##4##1##(1990-8#1)(2013-1#3)
boosting##4##1##(2008-11#2)(2010-7#1)(2013-1#1)
boot##3##1##(2008-10#3)
bootstrap analysis of##2##3##(2008-10#2)
bootstrap analysis##5##2##(2008-10#4)(2010-1#1)
bootstrap procedure##2##2##(2008-10#2)
bootstrap support for##2##3##(2008-10#2)
bootstrap support##4##2##(2008-10#4)
bootstrap values##4##2##(2008-10#2)(2008-6#1)(2008-9#1)
bootstrap##26##1##(1992-9#1)(2008-10#20)(2008-6#2)(2008-9#1)(2010-1#1)(2010-4#1)
bootstrapping##3##1##(2008-10#1)(2008-4#1)(2010-8#1)
borate and##3##2##(1990-3#1)(2008-10#2)
borate buffer (pH 8##2##4##(2008-10#2)
borate buffer (pH 9##5##4##(2008-10#5)
borate buffer (pH##8##3##(2008-10#8)
borate buffer with the##2##4##(2008-10#2)
borate buffer##15##2##(2008-10#15)
borate complex##2##2##(2008-10#2)
borate##51##1##(1990-3#3)(2008-10#42)(2008-2#4)(2008-3#1)(2010-11#1)
borax##3##1##(2008-10#3)
border cell production##2##3##(2008-10#2)
border cell##5##2##(2008-10#5)
border cells with##2##3##(2008-10#2)
border cells##12##2##(2008-10#12)
border crossing for##3##3##(1994-3#1)(1995-12#1)(1997-3#1)
border crossing##5##2##(1994-3#3)(1995-12#1)(1997-3#1)
border membrane##3##2##(1991-9#2)(2008-9#1)
border of the##6##3##(1990-12#1)(1994-3#1)(2007-12#2)(2008-10#1)(2008-9#1)
border of##11##2##(1990-12#1)(1994-3#1)(2007-12#2)(2008-10#2)(2008-9#2)(2010-3#1)(2012-2#1)(2013-1#1)
border to##2##2##(2008-7#2)
border##49##1##(1990-12#1)(1991-9#2)(1992-12#1)(1992-2#1)(1994-3#4)(1995-12#1)(1997-3#3)(2007-12#4)(2008-10#22)(2008-7#3)(2008-9#3)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
border-crossing##3##1##(1995-12#2)(1997-3#1)
bordering the##5##2##(1990-8#1)(2007-12#1)(2008-10#2)(2011-2#1)
bordering##6##1##(1990-8#1)(2007-12#1)(2008-10#3)(2011-2#1)
borderline and##2##2##(1990-2#2)
borderline personality disorder has##2##4##(2009-10#2)
borderline personality disorder##6##3##(2008-11#1)(2009-10#3)(2009-9#1)(2013-1#1)
borderline personality##9##2##(1992-1#1)(2008-11#1)(2009-10#4)(2009-9#2)(2013-1#1)
borderline##33##1##(1990-2#6)(1990-9#1)(1992-1#3)(1997-3#1)(1997-8#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#4)(2009-8#1)(2009-9#2)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
borders##9##1##(1990-12#1)(1990-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
bore no##3##2##(2008-10#1)(2011-2#2)
bore##11##1##(1997-3#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#2)
boreal##3##1##(2008-8#1)(2008-9#2)
borer##11##1##(1995-6#2)(2007-12#2)(2008-10#5)(2008-7#2)
borers##2##1##(2008-10#2)
boric acid as a modifier##2##5##(2008-10#2)
boric acid as a##3##4##(2008-10#3)
boric acid concentration##3##3##(2008-10#3)
boric acid##15##2##(2008-10#15)
boric##17##1##(2008-10#17)
born at the##3##3##(1991-11#1)(1992-2#1)(1995-2#1)
born at##7##2##(1991-11#1)(1991-12#1)(1992-2#1)(1995-2#1)(2008-11#3)
born during##2##2##(1991-11#1)(2011-2#1)
born from##3##2##(1994-11#1)(2012-3#2)
born in the##6##3##(1992-2#1)(1996-11#1)(2008-11#1)(2008-12#1)(2011-2#2)
born in##15##2##(1990-12#1)(1990-3#1)(1992-2#1)(1993-12#1)(1996-11#1)(1997-5#1)(1997-6#1)(2008-11#1)(2008-12#2)(2010-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
born into a##3##3##(1994-8#2)(2008-8#1)
born into##4##2##(1994-8#2)(2008-11#1)(2008-8#1)
born prematurely##3##2##(1994-1#1)(1994-3#1)(1996-11#1)
born to##2##2##(1994-9#1)(2012-12#1)
born with##6##2##(1990-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-7#1)
born##62##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-6#1)(1992-2#2)(1993-12#3)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#3)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
borne by##2##2##(1994-9#1)(1996-3#1)
borne out##2##2##(2008-8#2)
borne##10##1##(1994-6#1)(1994-9#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-8#2)(2010-10#1)(2011-2#2)
borohydride and##2##2##(2008-10#2)
borohydride reduction of##2##3##(2008-10#1)(2010-6#1)
borohydride reduction##4##2##(2008-10#3)(2010-6#1)
borohydride##16##1##(2008-10#15)(2010-6#1)
boron at##2##2##(2008-10#2)
boron complex##2##2##(2008-10#2)
boron concentration##2##2##(1990-3#2)
boron doped diamond##4##3##(2008-10#4)
boron in##14##2##(2008-10#14)
boron##51##1##(1990-3#10)(2008-10#41)
boron(III)##2##1##(2008-10#2)
boron-doped diamond (BDD)##2##3##(2008-10#2)
boron-doped diamond electrode##4##3##(2008-10#4)
boron-doped diamond microelectrode##2##3##(2008-10#2)
boron-doped diamond thin film electrode##5##5##(2008-10#5)
boron-doped diamond thin film##7##4##(2008-10#7)
boron-doped diamond##17##2##(2008-10#17)
borreliacidal antibodies##3##2##(2008-9#3)
borrowed from##2##2##(1993-3#1)(1996-2#1)
borrowed##3##1##(1993-3#1)(1996-2#1)(2008-12#1)
bortezomib may##2##2##(2011-2#2)
bortezomib##5##1##(2011-2#5)
bosentan##7##1##(2009-10#3)(2010-10#4)
boson peak##2##2##(1995-3#2)
bosutinib##3##1##(2010-11#3)
botanical cannabis##2##2##(2013-8#2)
botanical origin of##3##3##(2008-10#3)
botanical origin##6##2##(2008-10#6)
botanical origins##3##2##(2008-10#3)
botanical##21##1##(1993-11#1)(2008-10#13)(2008-12#1)(2008-5#1)(2013-8#5)
botanists##2##1##(2008-10#2)
both 1##3##2##(2008-10#2)(2008-12#1)
both As(III) and As(V)##2##4##(2008-10#2)
both B##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
both CO concentrations##3##3##(1990-5#3)
both Cr(VI)##2##2##(2008-10#2)
both CymMV and ORSV in##2##5##(2008-10#2)
both D##2##2##(2008-10#2)
both DNA and##2##3##(2008-12#1)(2009-10#1)
both DNA##3##2##(2008-12#1)(2009-10#1)(2012-2#1)
both DNA-A and DNA-B##2##4##(2008-10#2)
both Fe(II) and Fe(III)##2##4##(2008-10#1)(2010-4#1)
both HA##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
both HGF and EGF##2##4##(1991-12#2)
both HIV-1##2##2##(2011-2#1)(2011-3#1)
both IORT and WBI##2##4##(2011-2#2)
both LTA and WTA##2##4##(1995-6#2)
both MAT##2##2##(1992-6#1)(2008-10#1)
both N- and##2##3##(2008-1#1)(2011-2#1)
both Na and##2##3##(2008-5#1)(2008-9#1)
both P##6##2##(1994-2#2)(2008-10#4)
both PLS-1 and##2##3##(2008-10#2)
both PS1 and PS2 bind##2##5##(1995-8#2)
both PS1 and PS2##3##4##(1995-8#3)
both Phytophthora spp##2##3##(2008-10#2)
both RNA##2##2##(1992-3#1)(2013-8#1)
both S##4##2##(2008-10#3)(2012-3#1)
both SDS and##2##3##(2008-10#1)(2008-5#1)
both STATs 1 and 3##2##5##(2012-3#2)
both States##3##2##(1991-1#2)(1994-3#1)
both TIEG2 and MAO B##2##5##(2009-12#2)
both UV and##2##3##(2008-10#2)
both UV##3##2##(2008-10#3)
both V##3##2##(1991-9#1)(2008-10#2)
both a good##2##3##(2008-10#1)(2013-1#1)
both a##45##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#1)(1993-1#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-5#1)(2013-1#1)(2013-8#1)
both accuracy and precision##2##4##(2008-10#1)(2008-3#1)
both accurate and##2##3##(2008-10#1)(2009-1#1)
both acid and alkaline##2##4##(2008-10#1)(2008-11#1)
both acidic and##2##3##(2008-10#1)(2012-6#1)
both acidic##3##2##(2008-10#2)(2012-6#1)
both acquisition and retention##2##4##(2012-2#2)
both activated##2##2##(1993-8#1)(1995-2#1)
both active and##2##3##(1996-6#1)(2008-10#1)
both active##5##2##(1993-1#1)(1996-6#1)(2008-10#3)
both activities##4##2##(1991-9#1)(1995-2#2)(2008-5#1)
both acute and chronic##4##4##(2008-11#1)(2010-6#1)(2012-12#1)(2013-1#1)
both acute and##7##3##(1991-1#1)(2008-11#1)(2010-6#1)(2012-12#1)(2012-3#2)(2013-1#1)
both adhesion formation and##2##4##(1992-1#1)(1992-3#1)
both affected by##2##3##(2008-10#1)(2010-10#1)
both age##2##2##(2008-10#1)(2008-7#1)
both agents##2##2##(1991-2#1)(2008-10#1)
both alpha- and##2##3##(1992-3#1)(1992-6#1)
both alternatives##2##2##(1991-1#1)(1991-12#1)
both ammonium##2##2##(2008-10#2)
both among##2##2##(1996-1#1)(2010-10#1)
both an##9##2##(1991-5#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-11#1)(2013-8#1)
both analytes are##2##3##(2008-10#2)
both analytes was##2##3##(2008-10#2)
both analytes##22##2##(2008-10#22)
both analytical##2##2##(2008-10#2)
both anatomical##2##2##(1991-6#1)(2012-12#1)
both anchorage-dependent and anchorage-independent##3##4##(1994-3#1)(1997-1#2)
both angiogenesis and##2##3##(2008-1#1)(2010-11#1)
both animal and human##2##4##(2008-7#1)(2009-7#1)
both animal and##3##3##(1991-12#1)(2008-7#1)(2009-7#1)
both animal##7##2##(1991-12#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)
both anions##4##2##(2008-10#3)(2012-7#1)
both antibodies##4##2##(1991-2#1)(1995-6#2)(2008-8#1)
both antigens##3##2##(1990-12#2)(2008-10#1)
both antioxidants and##2##3##(2008-10#1)(2013-1#1)
both antioxidants##4##2##(2008-10#3)(2013-1#1)
both antisera##2##2##(1990-5#1)(2008-5#1)
both approaches##7##2##(1995-5#1)(2008-10#4)(2008-11#1)(2011-2#1)
both appropriate##2##2##(2008-11#1)(2008-6#1)
both approximately##2##2##(1993-6#1)(2008-10#1)
both are##9##2##(1992-9#1)(1993-12#1)(1997-8#2)(2008-10#2)(2008-7#1)(2008-9#1)(2010-10#1)
both areas##3##2##(1992-3#1)(1997-2#2)
both arrest##2##2##(1997-3#1)(2010-7#1)
both as a bulk drug and in formulations was developed and validated##2##12##(2008-10#2)
both as a##5##3##(1991-6#1)(1992-12#1)(2008-10#3)
both as##14##2##(1991-6#1)(1992-12#1)(1993-6#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)
both asexual and sexual reproduction##2##5##(2008-10#2)
both assays##3##2##(1991-12#1)(2008-10#1)(2012-2#1)
both at the light and electron##2##6##(2008-7#2)
both at the##12##3##(1994-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-1#1)(2011-2#1)(2013-8#1)
both at##23##2##(1991-2#1)(1994-12#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
both axial##2##2##(2008-2#1)(2011-7#1)
both bare##2##2##(2008-10#2)
both batch and column##3##4##(2008-10#3)
both batch and##6##3##(2008-10#4)(2008-11#1)(2008-7#1)
both be##3##2##(2008-11#2)(2008-5#1)
both before and after##4##4##(1994-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
both being##3##2##(1990-6#1)(1994-2#1)(2013-1#1)
both beneficial and##3##3##(2008-10#1)(2010-1#1)(2013-8#1)
both benign and##2##3##(1991-3#1)(2012-2#1)
both biochemical and##5##3##(1994-9#1)(2008-10#1)(2008-6#1)(2011-10#1)(2011-2#1)
both biochemical##6##2##(1994-9#1)(2008-10#2)(2008-6#1)(2011-10#1)(2011-2#1)
both biocontrol agents##3##3##(2008-10#3)
both biocontrol##4##2##(2008-10#4)
both body size and##2##4##(2007-12#1)(2008-8#1)
both body##3##2##(2007-12#1)(2008-8#1)(2010-10#1)
both boys and girls##3##4##(2010-1#1)(2011-1#1)(2012-2#1)
both brain##2##2##(1994-2#1)(2008-7#1)
both bulk##2##2##(2008-3#1)(2012-2#1)
both by the##4##3##(2008-10#2)(2008-5#1)(2012-12#1)
both by##16##2##(1990-12#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2012-12#1)
both cDNAs##2##2##(1991-5#1)(1993-12#1)
both cancer##2##2##(2009-12#1)(2009-9#1)
both carbonate/hydrogencarbonate and hydroxide selective##2##5##(2008-10#2)
both cardiac and##2##3##(1995-2#1)(2008-11#1)
both cases##42##2##(1990-5#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(2006-6#1)(2008-10#18)(2008-11#1)(2008-3#3)(2008-7#4)(2009-1#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
both cell growth##2##3##(2008-11#1)(2008-7#1)
both cell lines##9##3##(1994-11#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-11#2)(2010-1#1)(2011-2#1)(2012-12#1)
both cell types##5##3##(1990-2#1)(1995-8#1)(2008-11#2)(2008-5#1)
both cell##21##2##(1990-2#1)(1991-5#1)(1991-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-7#1)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)
both cells##7##2##(1993-8#2)(1994-12#1)(1997-8#1)(2008-11#1)(2008-9#1)(2011-2#1)
both cellular##2##2##(1994-8#1)(2008-11#1)
both cerebral hemispheres##4##3##(1996-2#1)(2008-7#1)(2011-2#2)
both cerebral##5##2##(1990-12#1)(1996-2#1)(2008-7#1)(2011-2#2)
both changes in##2##3##(1994-9#1)(2008-11#1)
both changes##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
both children and adults##5##4##(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)
both classes of##6##3##(1993-9#1)(2008-11#2)(2008-7#3)
both clinical and##4##3##(1992-1#1)(1993-12#1)(2008-11#1)(2009-10#1)
both clinical##7##2##(1992-1#1)(1993-12#1)(1995-5#1)(1997-1#1)(2008-11#2)(2009-10#1)
both clinically and##3##3##(2008-11#1)(2009-10#1)(2010-12#1)
both clones##2##2##(1990-8#1)(2008-11#1)
both coding and non-coding##2##4##(2007-12#1)(2011-2#1)
both cognitive and##2##3##(2009-8#1)(2012-12#1)
both collagen##2##2##(2008-11#1)(2008-5#1)
both common and##2##3##(2012-2#1)(2012-5#1)
both common##3##2##(2010-12#1)(2012-2#1)(2012-5#1)
both community and##2##3##(1995-2#1)(2012-2#1)
both community##3##2##(1995-2#1)(2008-11#1)(2012-2#1)
both components##3##2##(2008-10#1)(2008-11#2)
both compounds in##2##3##(2008-10#2)
both compounds##10##2##(1994-5#1)(2008-10#9)
both conditions##7##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-11#2)
both conducting and##2##3##(2008-10#1)(2008-7#1)
both conducting##3##2##(2008-10#1)(2008-7#2)
both constitutive and##2##3##(2008-11#1)(2008-8#1)
both constructs##2##2##(1994-11#1)(2008-12#1)
both containing##2##2##(2008-10#1)(2008-7#1)
both contributed to##2##3##(1996-1#1)(2008-11#1)
both control and##4##3##(2008-11#4)
both conventional and##2##3##(2008-10#1)(2011-2#1)
both conventional##6##2##(1992-12#1)(2008-10#2)(2008-9#2)(2011-2#1)
both cost##2##2##(1994-12#1)(2008-10#1)
both countries##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
both crops##7##2##(2008-10#5)(2008-12#2)
both cultivars were##2##3##(2008-10#2)
both cultivars##14##2##(2008-10#14)
both current and future##2##4##(1994-2#1)(2013-1#1)
both current##4##2##(1994-2#1)(1997-1#1)(2009-4#1)(2013-1#1)
both cyclic voltammetry##2##3##(2008-10#2)
both cytoplasmic and##2##3##(1992-10#1)(2008-9#1)
both devices##4##2##(1996-2#1)(2008-11#1)(2008-5#1)(2010-7#1)
both diagnostic##3##2##(1993-1#1)(2008-9#2)
both direct and indirect##7##4##(1991-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)
both direct##8##2##(1991-12#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)
both directly##2##2##(2008-12#1)(2012-3#1)
both disciplines##2##2##(1993-3#1)(2012-2#1)
both disease##2##2##(1994-9#1)(2008-7#1)
both diseases##5##2##(2008-10#4)(2011-2#1)
both doctors and patients##2##4##(2008-8#1)(2013-1#1)
both domestic and##2##3##(2009-8#1)(2010-8#1)
both domestic##3##2##(1996-12#1)(2009-8#1)(2010-8#1)
both dose##2##2##(1996-12#1)(2010-5#1)
both doses##3##2##(1991-3#1)(1994-12#1)(1994-2#1)
both drugs##12##2##(1990-9#2)(2008-10#6)(2008-5#2)(2011-10#1)(2013-1#1)
both during##6##2##(1993-12#1)(1995-12#1)(1995-3#1)(2008-1#1)(2009-8#1)(2013-1#1)
both ear##2##2##(2008-10#2)
both early##2##2##(2008-5#2)
both ecological and##2##3##(2008-8#2)
both efficacy and##2##3##(2008-10#1)(2012-3#1)
both egg##3##2##(2008-8#1)(2010-8#2)
both electrodes##2##2##(2008-10#2)
both elements##3##2##(1990-5#1)(2008-10#2)
both enantiomers of##2##3##(1992-11#1)(2011-1#1)
both enantiomers##5##2##(1992-11#1)(1994-8#1)(2008-10#2)(2011-1#1)
both ends##6##2##(1993-3#1)(1995-6#1)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)
both enhanced##2##2##(1990-5#1)(2008-6#1)
both entities are##2##3##(1991-8#1)(2008-7#1)
both entities##3##2##(1991-8#1)(2008-5#1)(2008-7#1)
both environmental and##3##3##(2008-10#2)(2011-2#1)
both environmental##5##2##(2008-10#2)(2008-8#2)(2011-2#1)
both environments##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
both enzyme##4##2##(1997-6#1)(2008-10#1)(2008-7#2)
both enzymes were##2##3##(2008-11#1)(2008-7#1)
both enzymes##7##2##(1993-9#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
both eukaryotic##2##2##(1997-4#1)(2009-7#1)
both experimental##4##2##(1995-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
both experiments##8##2##(1993-3#1)(2008-10#7)
both external and##2##3##(1996-2#1)(2008-4#1)
both external##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
both extraction##3##2##(2008-10#3)
both eyes##9##2##(1995-9#1)(2008-5#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
both factors##6##2##(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)
both fast##3##2##(2008-10#2)(2008-6#1)
both fatigue protocols##2##3##(2013-8#2)
both female and male##4##4##(1990-3#1)(1992-8#1)(1994-2#1)(2010-8#1)
both field and greenhouse##2##4##(2008-10#2)
both field and##3##3##(2008-10#3)
both field locations##2##3##(2008-10#2)
both field##7##2##(2007-12#1)(2008-10#6)
both for the##10##3##(1991-1#1)(1994-12#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-7#1)
both for##28##2##(1991-1#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-12#2)(1995-3#1)(1996-12#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-6#2)(2010-7#1)(2012-3#1)
both forms of##5##3##(1991-5#1)(1993-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
both formulations##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
both fractions##4##2##(1990-5#1)(1996-2#1)(2008-10#2)
both from the##10##3##(1994-12#1)(1995-2#1)(1996-2#1)(2008-10#5)(2008-12#1)(2011-2#1)
both from##15##2##(1994-12#1)(1995-2#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-12#2)(2011-2#1)
both fungi were##2##3##(2008-10#2)
both fungi##10##2##(2008-10#9)(2008-5#1)
both fungicides##6##2##(2008-10#6)
both genders and##2##3##(2006-6#1)(2011-2#1)
both genders##4##2##(1994-2#1)(2006-6#1)(2011-1#1)(2011-2#1)
both gene##4##2##(2008-10#3)(2010-10#1)
both general and##2##3##(1991-2#1)(2008-11#1)
both general##4##2##(1991-2#1)(1991-3#1)(2008-11#1)(2012-2#1)
both generations##2##2##(2008-10#1)(2009-12#1)
both genes and##2##3##(2008-10#2)
both genes##8##2##(1991-5#1)(1991-6#1)(1993-2#1)(2008-10#5)
both genetic and environmental factors##2##5##(2011-2#1)(2012-2#1)
both genetic and environmental##4##4##(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
both genetic and##6##3##(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
both genetic##8##2##(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#2)(2011-2#1)(2012-2#1)
both genetically##2##2##(2008-7#1)(2012-3#1)
both genomic##2##2##(2008-10#2)
both genotypes##5##2##(2008-10#3)(2010-4#1)(2013-1#1)
both glucose and##2##3##(1994-12#1)(2013-1#1)
both government and##2##3##(2008-11#2)
both groups combined##2##3##(1994-2#1)(2008-12#1)
both groups of##9##3##(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2009-11#1)(2009-9#1)(2011-2#1)(2012-2#1)
both groups were##4##3##(2008-11#1)(2008-5#1)(2012-3#2)
both groups##66##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#2)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1996-1#2)(1997-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#5)(2009-11#2)(2009-12#1)(2009-3#4)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#8)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
both growth##2##2##(2008-10#2)
both have##7##2##(1992-3#1)(1996-2#1)(1997-8#1)(2008-11#2)(2008-3#1)(2010-7#1)
both health##2##2##(1992-12#1)(2010-12#1)
both healthy##2##2##(2008-10#1)(2008-11#1)
both heat-treated##2##2##(2008-10#2)
both heterodimers##2##2##(1996-2#2)
both high##7##2##(2008-10#3)(2008-3#2)(2010-2#1)(2011-2#1)
both host and##2##3##(1995-5#1)(2008-8#1)
both host species##2##3##(2008-10#2)
both host##7##2##(1995-5#1)(2008-10#3)(2008-8#3)
both hosts##5##2##(2008-10#5)
both human and mouse##2##4##(2008-4#1)(2008-9#1)
both human and rat##2##4##(1992-10#1)(1994-3#1)
both human and##7##3##(1992-10#1)(1994-3#1)(1997-8#1)(2008-4#1)(2008-9#2)(2012-12#1)
both human##11##2##(1990-2#1)(1992-10#1)(1994-3#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-9#2)(2011-2#1)(2012-12#1)
both humoral and##2##3##(1995-5#1)(2008-11#1)
both humoral##3##2##(1995-12#1)(1995-5#1)(2008-11#1)
both hydrophilic and hydrophobic##3##4##(2009-9#1)(2010-10#2)
both hypotheses##2##2##(2008-11#1)(2008-8#1)
both immobilized##4##2##(1997-2#1)(2008-10#2)(2008-11#1)
both implants at##2##3##(2012-2#2)
both implants##5##2##(2012-2#5)
both in children and##2##4##(2008-7#1)(2011-2#1)
both in normal and##2##4##(1995-12#1)(2008-9#1)
both in normal##3##3##(1993-3#1)(1995-12#1)(2008-9#1)
both in terms of their##2##5##(2008-10#1)(2008-11#1)
both in terms of##8##4##(1993-12#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-4#1)
both in the laboratory and in##2##6##(2008-10#1)(2008-5#1)
both in the laboratory and##3##5##(2008-10#2)(2008-5#1)
both in the presence and##2##5##(2008-10#1)(2008-11#1)
both in the presence of##3##5##(1992-12#1)(2008-10#1)(2008-11#1)
both in the presence##5##4##(1992-12#1)(2008-10#2)(2008-11#2)
both in the##33##3##(1990-2#1)(1992-12#2)(1992-2#1)(1994-2#1)(1996-12#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
both in their##2##3##(1991-3#1)(2008-1#1)
both in vitro and in vivo##11##6##(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)
both in vitro and in##13##5##(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#3)(2008-8#2)(2011-1#1)(2011-2#1)
both in vitro##16##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#4)(2008-8#2)(2011-1#1)(2011-2#2)
both in vivo and in vitro##8##6##(1990-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-11#2)(2008-4#1)(2009-6#1)
both in##134##2##(1990-2#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1996-1#1)(1996-12#4)(1996-2#1)(1997-3#1)(2008-1#2)(2008-10#37)(2008-11#20)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-6#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
both increase##2##2##(1994-5#1)(2008-10#1)
both increases##2##2##(2008-9#1)(2012-3#1)
both individual##2##2##(1991-1#1)(2013-1#1)
both indoors and outdoors##3##4##(2008-10#1)(2012-12#2)
both induced##3##2##(1991-3#1)(2008-10#1)(2008-9#1)
both inhibited##3##2##(1990-2#1)(1994-8#1)(1996-2#1)
both inoculated and uninoculated##2##4##(2008-10#2)
both inoculum##2##2##(2008-10#2)
both inorganic##2##2##(2008-10#2)
both inpatient and outpatient##3##4##(1995-2#1)(1996-3#1)(2013-1#1)
both inpatient and##4##3##(1995-2#1)(1996-3#1)(1997-1#1)(2013-1#1)
both inside and outside the##2##5##(2008-2#1)(2011-2#1)
both instant and lasting relief of##2##6##(2011-2#2)
both insulin and##3##3##(1994-11#1)(2008-7#1)(2010-6#1)
both insulin##4##2##(1994-11#1)(2008-7#1)(2010-11#1)(2010-6#1)
both intact##2##2##(1994-11#2)
both internal and external##3##4##(1992-12#1)(2008-11#1)(2008-3#1)
both internal##6##2##(1992-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
both internalizing and externalizing##2##4##(1995-2#1)(2008-12#1)
both interventions##3##2##(2008-12#1)(2009-8#1)(2011-1#1)
both intra- and##2##3##(2008-7#1)(2009-6#1)
both intrinsic and extrinsic##3##4##(2008-7#1)(2010-1#1)(2013-1#1)
both intrinsic##4##2##(2008-7#1)(2009-10#1)(2010-1#1)(2013-1#1)
both ionic##2##2##(2008-10#2)
both ions##2##2##(2008-10#2)
both isolates##4##2##(2008-10#3)(2008-5#1)
both its##5##2##(1994-5#2)(1996-6#1)(2008-4#1)(2009-8#1)
both laser##2##2##(2008-10#1)(2008-3#1)
both leaf and##2##3##(2008-10#2)
both leaf##3##2##(2008-10#3)
both light and##2##3##(2008-10#2)
both light##4##2##(1993-9#1)(2008-10#3)
both linear##2##2##(2008-10#1)(2008-11#1)
both liver and##2##3##(1990-5#1)(2012-2#1)
both liver##3##2##(1990-5#2)(2012-2#1)
both loading##3##2##(2008-10#1)(2009-3#2)
both lobes##4##2##(2009-8#1)(2010-11#1)(2011-1#1)(2013-1#1)
both local and systemic##3##4##(2008-10#2)(2011-2#1)
both local and##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-2#1)
both local##11##2##(1994-2#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2010-9#1)(2011-2#1)(2013-1#1)
both located on##2##3##(1993-12#1)(2008-10#1)
both located##4##2##(1992-8#1)(1993-12#1)(2008-10#2)
both locations##3##2##(2008-10#3)
both low and high##2##4##(2008-10#1)(2009-8#1)
both low##3##2##(2008-10#1)(2008-3#1)(2009-8#1)
both lower##3##2##(1993-8#1)(1996-2#1)(2012-12#1)
both lungs##4##2##(2008-11#1)(2010-12#1)(2010-2#1)(2011-2#1)
both male and female##5##4##(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)
both males and females##2##4##(2012-2#1)(2013-1#1)
both mass##2##2##(1997-2#1)(2008-10#1)
both materials##3##2##(2008-10#1)(2008-5#2)
both mating types in##2##4##(2008-10#2)
both mating types were##2##4##(2008-10#2)
both mating types##6##3##(2008-10#6)
both may##3##2##(1997-9#1)(2008-10#1)(2009-1#1)
both measurements##2##2##(2008-10#1)(2008-3#1)
both mechanical and##2##3##(2009-8#1)(2011-2#1)
both mechanical##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
both media##3##2##(2008-10#1)(2008-11#1)(2012-4#1)
both medical and##4##3##(1994-12#2)(1996-6#1)(2013-1#1)
both members of the##2##4##(1993-12#1)(2008-10#1)
both membrane##2##2##(1991-5#1)(2008-10#1)
both men and women##7##4##(2008-10#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-10#1)(2013-1#2)
both men and##8##3##(1990-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-10#1)(2013-1#2)
both metal ions##2##3##(2008-10#2)
both metals in##5##3##(2008-10#5)
both metals##13##2##(2008-10#13)
both methodologies##3##2##(2008-10#3)
both methods are in good agreement##2##6##(2008-10#2)
both methods are##5##3##(2008-10#5)
both methods of##2##3##(2008-11#1)(2012-3#1)
both methods to##3##3##(2008-10#3)
both methods were compared##2##4##(2008-10#1)(2012-3#1)
both methods were##5##3##(2008-10#4)(2012-3#1)
both methods##44##2##(1990-12#1)(1992-3#1)(1997-8#1)(2007-12#1)(2008-10#34)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#2)
both mitogenic##2##2##(1991-3#1)(1995-2#1)
both models##8##2##(2008-10#6)(2008-7#1)(2012-12#1)
both modes##7##2##(1994-8#1)(2007-12#1)(2008-10#4)(2012-3#1)
both monovalent##2##2##(1993-6#1)(2011-2#1)
both more##3##2##(2008-10#1)(2010-11#1)(2013-8#1)
both mother and##2##3##(1995-1#1)(2008-1#1)
both mouse and##2##3##(1991-5#1)(2008-4#1)
both mouse##5##2##(1991-5#1)(1993-6#1)(2008-4#1)(2008-5#1)(2012-2#1)
both murine and human##3##4##(1995-11#1)(2008-4#2)
both native and##2##3##(2008-10#1)(2008-8#1)
both native##3##2##(2008-10#2)(2008-8#1)
both natural and synthetic##2##4##(2008-11#1)(2012-2#1)
both natural and##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
both natural##6##2##(1996-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-2#1)
both necessary and sufficient##4##4##(1991-2#2)(1995-2#1)(2009-10#1)
both negatively##2##2##(2008-9#1)(2011-2#1)
both nitric and hydrochloric acid##2##5##(2008-10#2)
both no##2##2##(2008-11#2)
both normal and##8##3##(1990-12#1)(1992-3#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
both normal##11##2##(1990-12#1)(1992-3#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-1#1)(2009-8#1)(2010-4#1)(2011-2#1)
both objective and##2##3##(2008-7#1)(2011-2#1)
both of the parametric and nonparametric component##2##7##(2009-10#2)
both of the##11##3##(1993-6#1)(1994-12#3)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#2)
both of them##3##3##(2008-10#2)(2008-9#1)
both of these##17##3##(1991-3#1)(1992-2#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)
both of which are##5##4##(1993-1#1)(1993-8#1)(2008-10#1)(2008-8#1)(2010-12#1)
both of which have a##2##5##(1992-6#1)(2008-10#1)
both of which have##3##4##(1992-6#1)(1996-6#1)(2008-10#1)
both of which were##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
both of which##18##3##(1991-11#1)(1992-6#1)(1993-1#1)(1993-8#2)(1995-8#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#2)
both of##65##2##(1991-11#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#3)(1994-12#3)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(2008-10#15)(2008-11#8)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#3)(2010-11#1)(2010-12#1)(2010-5#1)(2012-2#2)(2013-1#2)(2013-8#1)
both oils##4##2##(2008-10#2)(2008-11#1)(2009-3#1)
both on the##4##3##(1995-2#1)(2008-10#3)
both on##14##2##(1992-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(2008-10#7)(2008-11#1)(2010-12#1)(2012-3#1)
both operational and##2##3##(1994-12#1)(2008-10#1)
both organic and inorganic##3##4##(2008-10#3)
both organic and##4##3##(2008-10#4)
both organisms##4##2##(2008-10#1)(2008-7#1)(2010-10#1)(2012-2#1)
both p &lt##4##3##(2008-9#4)
both pH##3##2##(1991-5#1)(1994-8#1)(2008-10#1)
both parameters##4##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
both parent##2##2##(2008-11#1)(2010-5#1)
both parental##4##2##(2008-10#1)(2008-11#1)(2008-8#2)
both parenting and##3##3##(2010-1#3)
both parents and##4##3##(1995-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
both parents##8##2##(1995-1#1)(2008-10#1)(2008-12#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
both particle##2##2##(2008-10#2)
both parties##2##2##(1992-2#1)(2008-7#1)
both pathogen##3##2##(2008-10#3)
both pathogens##15##2##(2008-10#15)
both pathotypes##2##2##(2008-10#2)
both patient and##2##3##(2008-10#1)(2008-5#1)
both patient##5##2##(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
both patients and nurses##2##4##(2009-12#1)(2010-3#1)
both patients and##3##3##(2009-12#1)(2010-3#1)(2013-8#1)
both patients##10##2##(1991-3#2)(2008-7#5)(2009-12#1)(2010-3#1)(2013-8#1)
both people and##2##3##(2008-10#1)(2008-11#1)
both peptides##4##2##(1990-5#2)(1992-6#1)(1994-5#1)
both pharmacological and non-pharmacological##2##4##(1993-2#1)(2009-7#1)
both pharmacological and##4##3##(1993-2#1)(2008-11#1)(2009-7#1)(2010-12#1)
both physical and mental##2##4##(2010-6#1)(2012-3#1)
both physical and##4##3##(2008-10#1)(2008-7#1)(2010-6#1)(2012-3#1)
both plant AChEs##2##3##(2009-8#2)
both plant##4##2##(2008-10#2)(2009-8#2)
both plants##3##2##(2008-10#3)
both plasmids##2##2##(1993-8#1)(1994-11#1)
both players' previous##2##3##(2008-8#2)
both point mutations##2##3##(1991-7#1)(2008-7#1)
both polarization and anisotropy##2##4##(2008-10#2)
both polarization states##3##3##(2007-11#1)(2008-3#2)
both polarization##7##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)
both polyclonal antibodies##2##3##(1992-6#1)(1995-12#1)
both polymers##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
both populations is##2##3##(1991-2#1)(2008-9#1)
both populations of##2##3##(1993-3#1)(2013-8#1)
both populations##13##2##(1990-8#4)(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2013-8#2)
both positive and negative##6##4##(1993-1#1)(1993-12#1)(1995-3#1)(1995-8#1)(2008-3#1)(2009-5#1)
both positive and##7##3##(1993-1#1)(1993-12#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-3#1)(2009-5#1)
both positive##11##2##(1992-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
both posterior##2##2##(1994-9#1)(1997-6#1)
both potato and tomato##4##4##(2008-10#4)
both potato and##5##3##(2008-10#5)
both pp 44 and pp 42##2##6##(1993-8#2)
both practical and##3##3##(1992-3#1)(2008-11#1)(2008-3#1)
both practice and##2##3##(1991-1#1)(2008-11#1)
both pre- and##3##3##(1990-12#1)(1992-3#1)(2008-12#1)
both preparations##2##2##(2008-1#1)(2008-10#1)
both primary##2##2##(2008-10#1)(2010-5#1)
both procedures##7##2##(2008-10#5)(2008-4#1)(2008-9#1)
both processes##8##2##(1993-3#1)(1993-8#1)(1996-2#1)(2008-10#3)(2009-7#1)(2009-8#1)
both produced##2##2##(1993-11#1)(2008-6#1)
both products##3##2##(1991-3#1)(1993-12#1)(2008-5#1)
both promoter activation and gene amplification##2##6##(2008-11#2)
both promoters were##2##3##(1992-6#2)
both proposed##2##2##(1994-5#1)(2008-10#1)
both protein and mRNA##2##4##(1993-3#1)(2013-1#1)
both protein and##5##3##(1993-12#1)(1993-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
both protein kinase C##2##4##(1993-3#1)(1994-11#1)
both protein##10##2##(1991-5#1)(1993-12#1)(1993-3#2)(1994-11#1)(1995-6#1)(2008-4#2)(2012-2#1)(2013-1#1)
both proteins were##2##3##(2009-10#1)(2009-3#1)
both proteins##10##2##(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#1)(2009-10#1)(2009-3#1)(2011-2#1)
both provinces##4##2##(1994-2#1)(2008-10#3)
both qualitative and quantitative##5##4##(2008-10#3)(2010-10#2)
both quality and##2##3##(1994-1#1)(2008-11#1)
both quantitative and qualitative##6##4##(1993-1#1)(2008-10#3)(2008-11#1)(2008-12#1)
both races##4##2##(2008-10#4)
both rat##2##2##(1990-5#1)(1997-1#1)
both rats and##3##3##(2008-10#2)(2008-9#1)
both rats##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
both recent and##2##3##(2008-10#1)(2010-4#1)
both receptors##2##2##(2008-11#1)(2011-2#1)
both reduced##4##2##(1992-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
both reducing##2##2##(2008-5#1)(2012-2#1)
both reference materials##2##3##(2008-10#2)
both reference##3##2##(2008-10#3)
both regions##2##2##(1996-12#1)(1996-2#1)
both renal##2##2##(1994-5#1)(1994-8#1)
both reported##2##2##(1997-2#1)(2012-12#1)
both research and clinical##2##4##(2008-10#1)(2011-7#1)
both research and##3##3##(2008-10#1)(2008-11#1)(2011-7#1)
both resistance##2##2##(2008-10#2)
both resistant and susceptible##2##4##(2008-10#1)(2011-10#1)
both respiratory##2##2##(2008-10#1)(2010-7#1)
both responses##2##2##(1993-6#1)(1997-2#1)
both root##2##2##(2008-10#2)
both roots and##2##3##(2008-10#2)
both routes##2##2##(1996-12#1)(2008-9#1)
both rural and urban##3##4##(1996-3#1)(2009-7#1)(2012-2#1)
both safe and##3##3##(1994-2#1)(2011-2#1)(2012-3#1)
both sample introduction##2##3##(2008-10#2)
both sample##5##2##(2008-10#5)
both samples and##2##3##(2008-10#2)
both samples##6##2##(2008-10#4)(2009-11#1)(2010-1#1)
both sampling periods##2##3##(2008-10#2)
both sampling##4##2##(2008-10#4)
both scientific and##2##3##(1996-6#1)(2008-10#1)
both scientific##4##2##(1996-6#1)(2008-10#1)(2012-2#1)(2013-1#1)
both seedling and##2##3##(2008-10#2)
both selectively##2##2##(1994-8#1)(2011-2#1)
both sensitive##2##2##(1990-2#1)(2008-10#1)
both sensors##3##2##(2008-10#3)
both serum##2##2##(1990-3#1)(1995-2#1)
both sets##2##2##(1992-12#1)(2008-10#1)
both sexes and##2##3##(1991-6#1)(2012-3#1)
both sexes in##4##3##(1991-6#1)(1997-4#1)(2008-10#1)(2012-3#1)
both sexes of##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
both sexes##42##2##(1990-11#2)(1990-2#1)(1990-3#1)(1991-6#4)(1992-12#1)(1993-8#2)(1994-2#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-5#2)(2008-7#6)(2008-8#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
both sexual and asexual reproduction##4##5##(2008-10#4)
both sexual and##5##3##(2008-10#4)(2008-9#1)
both sexual##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2009-5#1)
both short-term and long-term##4##4##(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
both short-term##5##2##(2008-8#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
both sides of the root##2##5##(2008-10#2)
both sides of the##7##4##(1990-2#1)(2008-10#4)(2008-7#1)(2011-2#1)
both sides##16##2##(1990-2#1)(1993-3#1)(2008-10#7)(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
both significant and insignificant##2##4##(2008-10#2)
both simulated and real##2##4##(2008-10#2)
both simulated and##3##3##(2008-10#2)(2008-3#1)
both sites and##2##3##(2008-10#2)
both sites##7##2##(1991-3#1)(1996-2#1)(2008-10#3)(2012-2#1)(2013-8#1)
both size and##3##3##(1993-9#1)(2008-10#1)(2008-4#1)
both size##4##2##(1993-9#1)(1995-11#1)(2008-10#1)(2008-4#1)
both small and##3##3##(1996-2#1)(2008-11#1)(2010-11#1)
both small##4##2##(1996-2#1)(2008-11#2)(2010-11#1)
both soapnut and jatropha##2##4##(2009-3#2)
both soil##2##2##(2008-10#1)(2012-6#1)
both soils##2##2##(2008-10#2)
both soluble and##2##3##(1995-2#1)(2008-4#1)
both soluble##3##2##(1995-2#1)(2006-6#1)(2008-4#1)
both sources##4##2##(1994-5#2)(2008-10#1)(2009-7#1)
both spatial and##2##3##(2008-2#1)(2008-3#1)
both species to##2##3##(1990-2#1)(2008-10#1)
both species were##5##3##(1991-8#1)(1993-8#1)(2008-10#2)(2010-8#1)
both species##45##2##(1990-2#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-8#1)(1994-11#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#1)(2010-8#3)(2012-8#1)
both spectral##2##2##(2008-3#2)
both spontaneous and##2##3##(2006-6#1)(2008-7#1)
both spontaneous##3##2##(2006-6#1)(2008-7#1)(2008-8#1)
both spore##3##2##(2008-10#3)
both spring and##2##3##(2008-10#2)
both stages##2##2##(2008-11#1)(2012-2#1)
both static and dynamic##6##4##(2008-10#6)
both stimuli##2##2##(1993-3#1)(2008-10#1)
both strains grew##2##3##(2008-10#2)
both strains##18##2##(1993-12#2)(1994-5#1)(1996-12#1)(2008-10#11)(2008-11#2)(2011-2#1)
both strands##2##2##(1992-3#1)(1996-6#1)
both students and##3##3##(1996-1#1)(2008-11#1)(2008-12#1)
both studied##4##2##(2008-10#2)(2008-12#1)(2010-1#1)
both studies##24##2##(2008-10#2)(2008-9#20)(2010-1#2)
both subjects##2##2##(1994-2#1)(1996-1#1)
both substances##4##2##(2008-10#3)(2009-7#1)
both substrates##9##2##(1990-11#1)(1991-9#1)(1994-5#1)(1994-6#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
both susceptible and resistant##2##4##(2008-10#2)
both susceptible and##4##3##(2008-10#4)
both suspension and##4##3##(2008-11#4)
both symmetric##2##2##(1993-8#1)(2008-8#1)
both synthetic and##3##3##(2008-10#2)(2008-11#1)
both synthetic##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
both systems##13##2##(1993-2#1)(1994-8#1)(2008-10#8)(2008-11#3)
both techniques##15##2##(1991-12#1)(1992-11#1)(1996-1#1)(1997-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2010-7#1)(2012-2#1)
both technologies##2##2##(2010-8#2)
both temperature and##4##3##(1994-5#1)(2007-12#1)(2008-10#2)
both test##2##2##(1997-2#1)(2008-11#1)
both tested##6##2##(1995-5#1)(2008-10#3)(2008-12#1)(2008-5#1)
both tests##3##2##(1994-8#1)(2008-10#2)
both the 5' and##2##4##(2008-10#2)
both the SNC and##2##4##(1996-12#2)
both the ability to##2##4##(2008-11#1)(2008-8#1)
both the absence##3##3##(1991-5#1)(2008-10#2)
both the amino##2##3##(2008-10#2)
both the amount of##3##4##(2008-10#2)(2009-8#1)
both the batch and##2##4##(2008-10#1)(2008-7#1)
both the benefits##2##3##(1995-1#1)(2008-8#1)
both the cases##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
both the cell##2##3##(1995-9#1)(2009-3#1)
both the cellular##2##3##(1993-8#1)(2010-1#1)
both the cytoplasmic and##2##4##(1992-10#1)(2008-9#1)
both the developed##2##3##(1997-7#1)(2008-10#1)
both the epidermis and##2##4##(1996-12#1)(2008-5#1)
both the expression##2##3##(1995-12#1)(2008-8#1)
both the extraction##2##3##(2008-10#2)
both the formation of##2##4##(1995-6#1)(1997-8#1)
both the formation##3##3##(1995-6#1)(1997-8#1)(2008-10#1)
both the frequency##2##3##(1995-3#1)(2008-7#1)
both the fundamental##2##3##(2008-3#1)(2008-7#1)
both the global##2##3##(2008-10#2)
both the groups##2##3##(2011-2#1)(2012-2#1)
both the high##2##3##(2008-10#1)(2010-1#1)
both the host##2##3##(2008-8#1)(2011-2#1)
both the human and##2##4##(2011-2#1)(2012-3#1)
both the initial##2##3##(1993-11#1)(2008-8#1)
both the inner and outer##2##5##(1991-10#1)(2013-8#1)
both the intensity##2##3##(2007-12#1)(2008-10#1)
both the level of##2##4##(2008-10#1)(2009-8#1)
both the level##3##3##(1996-2#1)(2008-10#1)(2009-8#1)
both the male##2##3##(1990-5#1)(2013-1#1)
both the mean##2##3##(2008-3#1)(2010-10#1)
both the model##2##3##(1994-2#1)(2008-7#1)
both the nature of##2##4##(2012-12#1)(2012-2#1)
both the nature##3##3##(2010-4#1)(2012-12#1)(2012-2#1)
both the number of##6##4##(1997-7#1)(2008-10#3)(2009-8#1)(2011-1#1)
both the number##7##3##(1990-5#1)(1997-7#1)(2008-10#3)(2009-8#1)(2011-1#1)
both the ophthalmologist and the##2##5##(2013-1#1)(2013-7#1)
both the patient and the##3##5##(1991-12#1)(2009-9#1)(2012-12#1)
both the patients##2##3##(1990-9#1)(2008-11#1)
both the plasma membrane and the##2##6##(2008-11#1)(2009-8#1)
both the plasma##3##3##(1992-6#1)(2008-11#1)(2009-8#1)
both the positive##2##3##(2008-11#1)(2010-5#1)
both the rate of##2##4##(2008-10#1)(2008-8#1)
both the reduction and oxidation##2##5##(2008-10#2)
both the reduction##3##3##(2008-10#2)(2009-8#1)
both the relative and absolute##2##5##(2008-8#2)
both the relative##3##3##(1995-5#1)(2008-8#2)
both the right and##2##4##(2008-10#1)(2008-7#1)
both the same##2##3##(1995-12#1)(2008-10#1)
both the sensitivity and##2##4##(2008-10#2)
both the separation##2##3##(2008-10#2)
both the size##2##3##(2008-10#1)(2011-2#1)
both the species##2##3##(2008-10#1)(2010-7#1)
both the time##3##3##(2008-10#3)
both the use of##3##4##(2008-10#1)(2009-10#1)(2009-12#1)
both the wild-type##2##3##(2008-10#2)
both the##492##2##(1990-11#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-5#2)(1991-6#3)(1992-1#1)(1992-10#1)(1992-12#4)(1992-3#5)(1992-6#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#4)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#6)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#3)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#4)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#143)(2008-11#32)(2008-12#6)(2008-2#1)(2008-3#15)(2008-4#7)(2008-5#9)(2008-6#4)(2008-7#14)(2008-8#21)(2008-9#15)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#4)(2009-8#8)(2009-9#1)(2010-1#3)(2010-10#2)(2010-4#6)(2010-5#7)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#22)(2012-12#4)(2012-2#10)(2012-3#10)(2012-6#1)(2013-1#12)(2013-7#2)(2013-8#5)
both their##9##2##(1991-3#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2013-1#1)
both theoretical##2##2##(1994-12#1)(1996-3#1)
both theory and##2##3##(2008-12#1)(2010-11#1)
both these##7##2##(1991-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
both through##3##2##(1997-1#1)(2008-11#1)(2008-9#1)
both thyrocytes and C cells##2##5##(2012-3#2)
both thyroid##2##2##(1990-3#1)(2008-4#1)
both time and##2##3##(2012-2#1)(2013-8#1)
both time points##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
both time##5##2##(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
both tissues##3##2##(1996-12#1)(1996-2#1)(2008-6#1)
both to the##5##3##(1990-2#1)(2008-10#1)(2009-10#1)(2012-12#1)(2013-1#1)
both to##13##2##(1990-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
both tomato and potato##2##4##(2008-10#2)
both tomato and##3##3##(2008-10#3)
both total##2##2##(1993-12#1)(2008-10#1)
both traditional##3##2##(1992-1#1)(1994-6#1)(1996-2#1)
both transcription##2##2##(2008-11#2)
both transcriptional and posttranscriptional##2##4##(2008-11#1)(2012-12#1)
both transcriptional and##3##3##(1995-6#1)(2008-11#1)(2012-12#1)
both treatment##2##2##(2010-12#1)(2012-2#1)
both treatments and##2##3##(2009-5#1)(2010-1#1)
both treatments##8##2##(1991-3#1)(2008-10#2)(2008-9#3)(2009-5#1)(2010-1#1)
both tributaries##2##2##(2010-8#2)
both tumor##3##2##(2011-2#3)
both two-photon##2##2##(2008-8#2)
both type##2##2##(2008-10#2)
both types of##26##3##(1993-8#2)(1994-8#1)(1997-1#1)(2006-6#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#2)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
both types##27##2##(1993-8#2)(1994-8#1)(1997-1#1)(2006-6#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
both tyrosine phosphorylation and respiratory-burst activity##2##6##(1994-6#2)
both tyrosine##3##2##(1994-6#2)(1996-2#1)
both tyrosine-kinase-dependent and -independent pathways##2##5##(1994-6#2)
both undergraduate and##2##3##(2008-11#1)(2008-12#1)
both univariate and##2##3##(2008-10#1)(2013-8#1)
both urban and##2##3##(1993-12#1)(2008-11#1)
both urban##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
both vaccines##2##2##(1995-5#2)
both viral##2##2##(2008-11#1)(2008-9#1)
both virulence and##3##3##(2008-10#2)(2013-1#1)
both virulence##5##2##(2008-10#4)(2013-1#1)
both viruses was##2##3##(2008-10#1)(2008-9#1)
both viruses were##2##3##(2008-10#2)
both viruses##17##2##(1995-12#3)(2008-10#13)(2008-9#1)
both visual##2##2##(2008-5#1)(2013-1#1)
both was##2##2##(2008-10#1)(2008-9#1)
both water and##3##3##(1992-9#1)(2008-3#1)(2012-12#1)
both were##8##2##(1992-6#1)(1995-8#1)(2008-10#4)(2008-12#1)(2012-3#1)
both when##4##2##(2008-10#3)(2008-11#1)
both with and without##4##4##(1995-2#1)(2008-10#1)(2008-9#1)(2009-3#1)
both with native##2##3##(1995-11#1)(2008-10#1)
both with the##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
both with##18##2##(1992-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-5#1)(2013-1#1)
both within and among##2##4##(2008-8#1)(2008-9#1)
both within and between patches##2##5##(2008-8#2)
both within and between##7##4##(1990-12#1)(1993-1#1)(2008-8#2)(2009-10#1)(2010-7#1)(2012-3#1)
both within and outside##2##4##(2008-10#1)(2013-1#1)
both within and##13##3##(1990-12#1)(1993-1#1)(2008-10#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-7#1)(2012-3#2)(2013-1#1)
both within the##2##3##(2008-10#1)(2008-7#1)
both within##17##2##(1990-12#1)(1990-8#1)(1993-1#1)(2008-10#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-7#1)(2012-3#2)(2013-1#1)
both women and##2##3##(1991-6#1)(1991-8#1)
both years##27##2##(1996-12#1)(2008-10#21)(2008-11#4)(2011-2#1)
both young and old rats##2##5##(1994-8#1)(2008-7#1)
both##4455##1##(1990-11#6)(1990-12#18)(1990-2#14)(1990-3#7)(1990-5#22)(1990-6#3)(1990-8#16)(1990-9#5)(1991-1#11)(1991-10#2)(1991-11#3)(1991-12#16)(1991-2#13)(1991-3#21)(1991-5#17)(1991-6#16)(1991-7#1)(1991-8#5)(1991-9#7)(1992-1#8)(1992-10#4)(1992-11#4)(1992-12#21)(1992-2#10)(1992-3#26)(1992-4#3)(1992-6#18)(1992-8#6)(1992-9#10)(1993-1#10)(1993-11#6)(1993-12#33)(1993-2#7)(1993-3#21)(1993-6#22)(1993-8#38)(1993-9#6)(1994-1#5)(1994-11#15)(1994-12#29)(1994-2#31)(1994-3#14)(1994-5#24)(1994-6#10)(1994-8#30)(1994-9#10)(1995-1#7)(1995-11#29)(1995-12#26)(1995-2#34)(1995-3#9)(1995-5#15)(1995-6#31)(1995-8#21)(1995-9#6)(1996-1#20)(1996-11#3)(1996-12#37)(1996-2#37)(1996-3#14)(1996-5#9)(1996-6#12)(1996-8#5)(1996-9#3)(1997-1#23)(1997-2#30)(1997-3#12)(1997-4#9)(1997-6#9)(1997-7#14)(1997-8#15)(1997-9#4)(2006-6#9)(2007-11#5)(2007-12#23)(2007-8#1)(2007-9#1)(2008-1#15)(2008-10#1443)(2008-11#292)(2008-12#80)(2008-2#19)(2008-3#77)(2008-4#34)(2008-5#104)(2008-6#21)(2008-7#120)(2008-8#120)(2008-9#141)(2009-1#7)(2009-10#28)(2009-11#8)(2009-12#16)(2009-2#2)(2009-3#15)(2009-4#3)(2009-5#6)(2009-6#11)(2009-7#23)(2009-8#32)(2009-9#7)(2010-1#34)(2010-10#27)(2010-11#13)(2010-12#16)(2010-2#5)(2010-3#3)(2010-4#21)(2010-5#21)(2010-6#16)(2010-7#17)(2010-8#20)(2010-9#3)(2011-1#17)(2011-10#5)(2011-2#150)(2011-3#5)(2011-7#3)(2012-12#28)(2012-2#85)(2012-3#67)(2012-4#3)(2012-5#2)(2012-6#3)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#105)(2013-7#5)(2013-8#56)
both)##8##1##(1990-12#1)(1991-7#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
bothin vitro andin vivo##2##4##(2008-8#2)
bothin##3##1##(2008-8#3)
botrocetin##4##1##(1993-3#3)(1994-11#1)
bottle gourd##2##2##(2013-8#2)
bottle##8##1##(1991-5#1)(2008-10#1)(2008-11#3)(2008-7#1)(2013-8#2)
bottled##5##1##(2008-10#5)
bottleneck of##3##2##(2008-3#1)(2008-7#1)(2010-7#1)
bottleneck##15##1##(2008-10#6)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#2)(2010-7#1)(2011-2#1)
bottlenecks in##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
bottlenecks##7##1##(1991-5#1)(2007-8#1)(2008-11#2)(2010-8#1)(2012-3#1)(2013-1#1)
bottles were##2##2##(2008-10#2)
bottles##14##1##(2008-10#5)(2008-11#7)(2008-5#1)(2008-7#1)
bottom line##7##2##(1994-1#2)(1997-6#1)(2008-9#3)(2011-2#1)
bottom phase##3##2##(2008-10#3)
bottom##43##1##(1990-8#1)(1992-4#1)(1994-1#2)(1995-8#2)(1997-6#1)(2008-10#9)(2008-11#3)(2008-2#6)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#6)(2009-11#2)(2011-2#2)(2012-4#1)(2013-1#3)(2013-8#1)
bottom-up##5##1##(2008-11#2)(2010-3#1)(2011-2#1)(2012-2#1)
botulinum and non-proteolytic C##2##4##(2011-2#2)
botulinum during##2##2##(2011-2#2)
botulinum neurotoxin##5##2##(1994-11#3)(2011-2#2)
botulinum toxin type A injection into the detrusor##2##8##(2008-10#2)
botulinum toxin type A##4##4##(2008-10#3)(2008-8#1)
botulinum toxin##11##2##(2008-10#3)(2008-8#3)(2009-4#2)(2011-2#1)(2012-3#2)
botulinum type##5##2##(1992-3#2)(1993-2#1)(2007-12#2)
botulinum##38##1##(1992-3#5)(1993-2#1)(1994-11#3)(2007-12#3)(2008-10#3)(2008-7#1)(2008-8#3)(2009-4#2)(2011-2#15)(2012-3#2)
botulism in Ontario##3##3##(2007-12#3)
botulism in##5##2##(1991-3#1)(2007-12#4)
botulism##7##1##(1991-3#1)(2007-12#4)(2011-2#2)
bought##2##1##(1993-3#1)(2008-1#1)
bound antigen##2##2##(1990-12#2)
bound at the##2##3##(2008-10#2)
bound at##7##2##(1990-8#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-7#1)
bound by##6##2##(1991-5#1)(1992-10#1)(1992-6#1)(1995-2#1)(2008-9#1)(2010-11#1)
bound in##5##2##(1993-8#1)(1995-8#1)(2008-10#2)(2009-8#1)
bound is##2##2##(1990-6#1)(2008-10#1)
bound labelled##2##2##(1995-11#1)(2008-10#1)
bound ligand##3##2##(1992-6#1)(1994-8#1)(2008-10#1)
bound mainly to##2##3##(2008-10#1)(2008-8#1)
bound metal##2##2##(2008-10#2)
bound on##2##2##(2008-2#1)(2008-6#1)
bound onto##2##2##(2008-10#2)
bound proteins##2##2##(1990-5#2)
bound residues##2##2##(2008-11#2)
bound sialic acid##2##3##(1990-5#1)(1994-11#1)
bound specifically##2##2##(2008-11#1)(2008-9#1)
bound than dimers in which the hydrogen bond##2##8##(2010-7#2)
bound to DNA##3##3##(1990-5#1)(1996-2#1)(2008-10#1)
bound to MTSC4##2##3##(2008-8#2)
bound to a component in##2##5##(1993-3#2)
bound to a##9##3##(1993-3#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)
bound to actin##3##3##(1991-5#1)(1994-5#2)
bound to aminopropyl-glass bead##2##4##(2008-10#2)
bound to one##2##3##(1993-1#1)(2008-10#1)
bound to organic matter##3##4##(2008-10#3)
bound to proteins##3##3##(2008-10#3)
bound to silica##2##3##(2008-10#2)
bound to the RRE##2##4##(1993-8#2)
bound to the negative##2##4##(2008-11#2)
bound to the same##2##4##(1994-5#1)(1995-2#1)
bound to the surface of##2##5##(1995-2#1)(2008-10#1)
bound to the surface##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
bound to the##36##3##(1990-12#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-5#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-5#2)(1995-2#2)(1997-6#1)(2008-10#8)(2008-11#6)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2012-2#1)
bound to transferrin##2##3##(2008-10#2)
bound to##118##2##(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1991-10#1)(1991-3#1)(1991-5#5)(1992-10#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#4)(1993-6#5)(1993-8#2)(1994-5#6)(1994-8#1)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#39)(2008-11#11)(2008-4#4)(2008-5#3)(2008-8#5)(2008-9#1)(2010-1#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
bound via##2##2##(2008-10#1)(2008-7#1)
bound water##2##2##(1991-11#1)(2008-10#1)
bound with##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
bound zinc##2##2##(1994-5#2)
bound##262##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#1)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-5#9)(1991-8#1)(1992-10#2)(1992-3#1)(1992-6#3)(1993-1#1)(1993-3#4)(1993-6#6)(1993-8#5)(1994-11#3)(1994-3#1)(1994-5#14)(1994-6#1)(1994-8#4)(1995-11#3)(1995-2#5)(1995-5#1)(1995-6#6)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#3)(1997-2#1)(1997-6#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#77)(2008-11#19)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#6)(2009-3#1)(2009-5#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
boundaries and##9##2##(1993-12#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2012-3#2)
boundaries between##2##2##(2008-11#1)(2009-10#1)
boundaries of the##3##3##(1993-12#1)(1997-1#1)(1997-3#1)
boundaries##43##1##(1991-12#1)(1992-1#1)(1993-12#2)(1995-8#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#3)(2013-1#1)
boundary and##2##2##(2008-11#1)(2008-8#1)
boundary between##5##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
boundary condition and##2##3##(2008-3#2)
boundary condition##8##2##(2008-2#1)(2008-3#7)
boundary conditions##4##2##(2008-3#2)(2013-8#2)
boundary in##3##2##(1991-9#1)(2008-8#2)
boundary integral##2##2##(2009-10#2)
boundary is##2##2##(2008-2#1)(2008-4#1)
boundary issues##2##2##(1997-2#1)(2008-12#1)
boundary layer##10##2##(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#1)
boundary layers##2##2##(2008-3#2)
boundary##80##1##(1990-5#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-6#4)(1996-12#1)(1997-1#2)(1997-2#1)(1997-6#1)(2008-10#5)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#18)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#5)(2009-10#2)(2009-8#1)(2010-10#3)(2013-1#2)(2013-8#3)
boundary-layer##2##1##(2008-2#2)
bounded by##4##2##(2008-6#1)(2008-8#1)(2011-2#2)
bounds for##2##2##(1995-9#1)(2008-7#1)
bounds##9##1##(1992-9#1)(1995-9#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2012-3#1)
bout of##4##2##(2008-5#2)(2013-1#1)(2013-8#1)
bout##12##1##(2008-10#2)(2008-5#3)(2008-8#3)(2013-1#1)(2013-8#3)
bouton##2##1##(1997-3#2)
boutons at##2##2##(1997-3#1)(1997-7#1)
boutons immunoreactive for##2##3##(1997-2#2)
boutons were##3##2##(1997-2#1)(1997-3#1)(2008-7#1)
boutons##17##1##(1997-2#8)(1997-3#4)(1997-7#4)(2008-7#1)
bouts of##2##2##(1997-7#1)(2007-12#1)
bouts##7##1##(1997-7#1)(2007-12#1)(2008-5#1)(2008-8#3)(2010-1#1)
bovine EFIA#1##3##2##(1993-2#3)
bovine TIMP##2##2##(1990-8#2)
bovine adrenal chromaffin cells##4##4##(1992-6#1)(1994-5#2)(1995-11#1)
bovine adrenal medullary cells##2##4##(1994-8#2)
bovine adrenal medullary##3##3##(1994-8#3)
bovine adrenal##8##2##(1992-6#1)(1994-5#2)(1994-8#3)(1995-11#1)(2009-9#1)
bovine albumin serum##2##3##(2008-10#2)
bovine albumin##3##2##(2008-10#2)(2008-11#1)
bovine and##3##2##(1992-10#1)(1992-6#1)(2008-7#1)
bovine aortic endothelial cells##6##4##(1990-12#2)(1991-5#2)(1993-8#1)(2008-11#1)
bovine aortic##7##2##(1990-12#2)(1991-5#2)(1993-8#1)(1994-11#1)(2008-11#1)
bovine beta-crystallin##2##2##(1991-6#2)
bovine blastocysts##3##2##(2008-11#3)
bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme##2##9##(1997-2#2)
bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase##4##8##(1997-2#4)
bovine brain lipid extract##2##4##(1991-5#2)
bovine brain##18##2##(1990-8#3)(1991-5#3)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-2#5)(2013-7#1)
bovine chromaffin cells##2##3##(1995-11#2)
bovine corneal endothelial##2##3##(2008-11#2)
bovine erythrocytes##2##2##(1994-8#1)(2008-10#1)
bovine hemoglobin##5##2##(1995-3#4)(2008-10#1)
bovine hepatocytes##2##2##(2008-11#2)
bovine lactoferrin##7##2##(1996-12#7)
bovine leukemia virus-transformed##2##3##(1995-8#1)(2008-11#1)
bovine liver and kidney tissues##2##5##(2008-10#2)
bovine liver and##4##3##(1992-10#1)(2008-10#3)
bovine liver##8##2##(1992-10#1)(1992-12#1)(2008-10#6)
bovine milk##4##2##(2008-10#2)(2012-2#2)
bovine psi EFIA#1 gene##2##4##(1993-2#2)
bovine psi EFIA#1##3##3##(1993-2#3)
bovine pulmonary endothelial##2##3##(1994-5#2)
bovine retinal on-bipolar cell##2##4##(1993-8#2)
bovine retinal##4##2##(1993-3#1)(1993-8#2)(1997-1#1)
bovine seminal RNase##3##3##(1990-5#3)
bovine seminal plasma##3##3##(1990-5#1)(1994-3#2)
bovine seminal##6##2##(1990-5#4)(1994-3#2)
bovine serum (FBS)##7##3##(1995-3#1)(2008-11#6)
bovine serum albumin (BSA) and##4##5##(2008-10#3)(2008-7#1)
bovine serum albumin (BSA) in an antigen conjugate##2##8##(2008-11#2)
bovine serum albumin (BSA) in##3##5##(2008-10#1)(2008-11#2)
bovine serum albumin (BSA) was##4##5##(1995-12#1)(2008-10#3)
bovine serum albumin (BSA)##28##4##(1995-12#1)(2008-10#22)(2008-11#3)(2008-3#1)(2008-7#1)
bovine serum albumin and##7##4##(2008-10#5)(2008-11#1)(2008-7#1)
bovine serum albumin by##2##4##(2008-10#1)(2008-5#1)
bovine serum albumin##50##3##(1993-8#2)(1995-12#1)(1997-1#1)(2008-10#33)(2008-11#6)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)
bovine serum albumin)##2##3##(2008-10#2)
bovine serum samples##2##3##(2008-10#2)
bovine serum##70##2##(1990-6#1)(1993-8#2)(1995-12#2)(1995-3#1)(1997-1#1)(2008-10#40)(2008-11#16)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)
bovine spongiform encephalopathy##4##3##(1997-8#1)(2008-11#1)(2011-2#2)
bovine trypsin##3##2##(1990-12#3)
bovine urine##2##2##(2008-10#2)
bovine viral diarrhoea virus##2##4##(1997-5#2)
bovine viral##3##2##(1997-5#2)(2008-11#1)
bovine##274##1##(1990-12#6)(1990-5#4)(1990-6#1)(1990-8#8)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#4)(1991-9#3)(1992-10#6)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#10)(1993-3#2)(1993-6#3)(1993-8#10)(1994-11#3)(1994-3#2)(1994-5#7)(1994-6#1)(1994-8#9)(1995-11#5)(1995-12#7)(1995-3#5)(1995-5#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#11)(1996-3#1)(1996-6#1)(1997-1#4)(1997-2#5)(1997-5#2)(1997-8#1)(2008-10#57)(2008-11#39)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#5)(2009-9#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
bovis BCG in##2##3##(2013-1#2)
bovis BCG##3##2##(1996-11#1)(2013-1#2)
bovis##10##1##(1996-11#2)(1996-12#1)(2011-2#4)(2013-1#2)(2013-8#1)
bowel and##4##2##(1990-2#1)(1991-12#1)(1996-3#1)(1996-6#1)
bowel cancer##4##2##(1991-6#3)(2012-3#1)
bowel disease (IBD)##4##3##(2008-11#1)(2009-12#1)(2010-12#1)(2011-2#1)
bowel disease##24##2##(1992-6#2)(1994-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#2)(2009-8#1)(2010-12#8)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
bowel obstruction##12##2##(1997-8#1)(2008-12#2)(2009-8#5)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
bowel preparation and##2##3##(2008-1#2)
bowel preparation##3##2##(2008-1#2)(2013-1#1)
bowel syndrome##9##2##(1991-12#3)(1994-3#1)(1995-10#1)(2010-12#1)(2013-1#3)
bowel##115##1##(1990-11#2)(1990-2#1)(1990-8#1)(1991-12#5)(1991-3#1)(1991-6#4)(1992-12#1)(1992-6#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#3)(1995-12#2)(1996-3#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#4)(2008-4#1)(2009-1#1)(2009-12#4)(2009-8#6)(2010-12#24)(2011-2#7)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#13)(2013-7#1)
bowels##4##1##(1996-6#3)(2012-3#1)
box and##4##2##(1993-12#1)(1993-8#1)(2010-11#1)(2010-5#1)
box binding##3##2##(1993-8#2)(2012-3#1)
box##54##1##(1991-6#1)(1992-3#1)(1993-12#3)(1993-6#5)(1993-8#5)(1993-9#2)(1994-11#1)(1994-3#1)(1995-6#1)(1997-8#4)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#8)(2008-9#5)(2009-10#2)(2009-8#1)(2010-11#2)(2010-5#3)(2011-2#1)(2012-3#1)(2013-1#1)
box&quot##3##1##(1991-1#1)(1993-9#1)(1995-2#1)
box-containing##2##1##(1993-8#1)(2011-2#1)
boxer##2##1##(1995-2#2)
boxers##4##1##(2010-1#4)
boxes and##4##2##(1993-12#1)(1993-6#2)(1994-11#1)
boxes##15##1##(1991-6#2)(1993-12#1)(1993-6#2)(1993-8#3)(1994-11#2)(1994-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
boxing##5##1##(1992-2#1)(2010-1#4)
boy and##3##2##(1996-5#1)(2010-5#1)(2012-2#1)
boy presented with haematuria and##2##5##(2008-10#2)
boy presented with##6##3##(2008-10#4)(2008-11#1)(2010-9#1)
boy presented##7##2##(2008-10#4)(2008-11#1)(2010-9#1)(2012-12#1)
boy presenting##2##2##(2008-11#1)(2009-9#1)
boy who had##2##3##(2007-8#1)(2008-10#1)
boy who presented with##5##4##(1996-6#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
boy who##12##2##(1996-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
boy with a##2##3##(2008-10#1)(2010-8#1)
boy with the##3##3##(1994-3#1)(2008-10#1)(2012-3#1)
boy with##20##2##(1991-11#1)(1991-8#1)(1994-3#2)(1997-3#2)(1997-7#1)(2008-10#5)(2008-11#2)(2008-7#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)
boy##70##1##(1990-6#1)(1991-11#2)(1991-8#1)(1994-3#2)(1995-5#3)(1996-11#1)(1996-5#4)(1996-6#2)(1996-9#1)(1997-3#3)(1997-7#1)(2007-8#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-7#2)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)
boyhood##2##1##(2012-2#2)
boys and girls##10##3##(1990-2#1)(1991-9#1)(1996-6#1)(2008-10#1)(2008-11#1)(2009-7#2)(2010-1#1)(2011-1#1)(2012-2#1)
boys and men##3##3##(2009-10#1)(2013-8#2)
boys and##34##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-6#1)(1991-9#4)(1995-5#1)(1996-6#2)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-10#1)(2009-7#2)(2010-1#1)(2011-1#6)(2011-2#1)(2012-2#2)(2013-8#2)
boys recovered##2##2##(2013-8#2)
boys were##2##2##(2008-12#1)(2013-8#1)
boys who were satisfied with their bodies##2##7##(2009-5#2)
boys who were##3##3##(2009-5#3)
boys with##5##2##(2008-10#2)(2009-5#1)(2011-1#2)
boys##91##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-6#1)(1990-9#2)(1991-6#1)(1991-9#4)(1993-3#1)(1994-12#2)(1995-5#1)(1996-11#2)(1996-6#4)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#5)(2008-4#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#8)(2009-7#4)(2010-1#2)(2010-10#3)(2011-1#10)(2011-2#3)(2012-2#4)(2013-1#6)(2013-8#9)
boys) with a median age of##2##6##(2011-1#2)
boys) with a##3##3##(2008-1#1)(2011-1#2)
boys)##11##1##(2008-1#1)(2008-11#1)(2009-7#2)(2009-9#1)(2010-1#2)(2011-1#3)(2013-1#1)
bp (X##4##2##(2008-10#4)
bp 5'-untranslated region##2##3##(1991-7#1)(2010-5#1)
bp DNA##2##2##(2008-12#1)(2008-8#1)
bp and##10##2##(1993-6#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#4)
bp as##2##2##(1993-6#1)(1997-7#1)
bp cDNA##2##2##(2008-8#2)
bp downstream##4##2##(1993-12#2)(1995-2#1)(1996-6#1)
bp encoding##2##2##(2011-2#2)
bp for D##3##3##(2008-10#3)
bp for X##4##3##(2008-10#4)
bp for##9##2##(1994-11#1)(2008-10#8)
bp fragment from##2##3##(1995-9#1)(1996-3#1)
bp fragment##4##2##(1995-9#1)(1996-3#1)(2008-5#1)(2008-8#1)
bp from##2##2##(1996-3#1)(1996-6#1)
bp genome with its 3##2##5##(2011-2#2)
bp genome with its##3##4##(2011-2#3)
bp genome##4##2##(2011-2#4)
bp in length and contains an##2##6##(1993-2#1)(2008-8#1)
bp in length##7##3##(1993-2#1)(1997-8#1)(2008-10#1)(2008-8#4)
bp in size##2##3##(2008-10#1)(2010-5#1)
bp in##13##2##(1993-2#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-8#5)(2010-5#2)
bp is##4##2##(1990-11#1)(1996-6#1)(2008-10#1)(2008-9#1)
bp long and##3##3##(1993-2#1)(1997-7#1)(2008-10#1)
bp long clone##2##3##(1997-7#2)
bp long genome with its 1##4##6##(2011-2#4)
bp long genome with its 2##5##6##(2011-2#5)
bp long genome with its 3##5##6##(2011-2#5)
bp long genome with its 4##2##6##(2011-2#2)
bp long genome with its##19##5##(2011-2#19)
bp long genome##21##3##(2011-2#21)
bp long single replicon genome with its##4##7##(2011-2#4)
bp long##33##2##(1993-2#1)(1995-12#1)(1997-7#4)(2008-10#1)(2008-9#1)(2011-2#25)
bp of 5'##2##3##(1995-2#1)(2008-9#1)
bp of the##4##3##(1993-12#1)(1993-2#1)(1997-8#1)(2008-6#1)
bp of##12##2##(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#2)(1995-2#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
bp on average)##2##3##(1997-2#2)
bp on##3##2##(1996-2#1)(1997-2#2)
bp sequence##2##2##(1991-5#1)(2008-9#1)
bp target##2##2##(2008-10#1)(2012-3#1)
bp to##2##2##(2008-10#1)(2008-8#1)
bp upstream from the##2##4##(1991-6#1)(1993-12#1)
bp upstream of##2##3##(1997-7#1)(2008-8#1)
bp upstream##6##2##(1991-6#1)(1993-12#2)(1997-7#2)(2008-8#1)
bp##218##1##(1990-11#3)(1990-12#1)(1990-8#2)(1991-5#3)(1991-6#2)(1991-7#1)(1992-3#2)(1993-12#5)(1993-2#5)(1993-6#4)(1993-8#1)(1994-11#3)(1994-2#2)(1995-12#3)(1995-2#3)(1995-8#3)(1995-9#3)(1996-12#1)(1996-2#3)(1996-3#4)(1996-6#8)(1997-2#3)(1997-6#4)(1997-7#9)(1997-8#8)(2008-10#39)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#23)(2008-9#14)(2010-5#4)(2011-2#43)(2012-3#3)
bp) and##4##2##(1997-6#1)(2008-10#2)(2009-6#1)
bp) containing##2##2##(1991-5#1)(1995-12#1)
bp) contains##2##2##(1995-12#1)(2008-5#1)
bp) in the##2##3##(1997-6#1)(2008-8#1)
bp) of##2##2##(1995-8#1)(2009-6#1)
bp)##25##1##(1991-5#2)(1993-8#3)(1994-11#1)(1995-12#2)(1995-8#1)(1997-6#2)(2008-10#8)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#2)(2012-3#1)
bpV(pic) and vanadate##4##3##(1997-1#4)
bpV(pic)##7##1##(1997-1#7)
bqsS##2##1##(2009-6#2)
br /&gt##12##2##(2007-11#12)
brace##2##1##(2011-2#2)
braces##3##1##(2007-8#3)
brachial artery flow-mediated vasodilatation##5##4##(2008-11#5)
brachial plexus injuries##3##3##(2008-8#2)(2008-9#1)
brachial plexus palsy##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2010-9#1)
brachial plexus##13##2##(2008-11#1)(2008-8#3)(2008-9#3)(2010-9#1)(2012-2#2)(2013-1#3)
brachial##22##1##(1991-11#1)(2008-11#6)(2008-8#3)(2008-9#3)(2009-1#3)(2010-9#1)(2012-2#2)(2013-1#3)
brachii##4##1##(2008-12#1)(2009-1#1)(2012-3#2)
brachiocephalic##2##1##(1997-8#1)(2008-1#1)
brachydactyly##3##1##(1997-3#1)(2010-6#1)(2011-1#1)
brachytherapy for##2##2##(1991-8#1)(1994-2#1)
brachytherapy in the##2##3##(1993-9#1)(1994-8#1)
brachytherapy in##4##2##(1993-9#1)(1994-8#1)(1995-12#1)(2008-10#1)
brachytherapy##12##1##(1991-8#2)(1993-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#2)(2009-11#2)(2009-2#1)
brachyuran##2##1##(2007-12#2)
brackets##6##1##(1996-5#1)(2008-10#2)(2013-1#3)
bracovirus##3##1##(2010-4#3)
bracts##2##1##(2008-10#1)(2009-8#1)
bradycardia##14##1##(1990-5#1)(1990-9#1)(2008-12#1)(2008-7#6)(2010-4#1)(2011-2#4)
bradycardic##3##1##(1997-2#3)
bradykinesia##3##1##(2008-7#2)(2012-12#1)
bradykinin##5##1##(1991-5#1)(1992-6#1)(1997-1#2)(2008-5#1)
bradykinin- and ATP-induced increases in [Ca2+]i##2##6##(1995-11#2)
bradykinin- and ATP-induced##3##3##(1995-11#3)
bragg##3##1##(2008-3#3)
brain AVMs##2##2##(1997-3#2)
brain CSF##3##2##(1993-1#3)
brain PI with##2##3##(1996-2#2)
brain PI##3##2##(1996-2#3)
brain RNA##2##2##(1990-7#2)
brain acetylcholine levels##2##3##(1992-8#2)
brain activation during##2##3##(1994-3#1)(1996-2#1)
brain activity##7##2##(2008-11#2)(2008-6#1)(2009-8#1)(2013-8#3)
brain after##2##2##(1996-2#1)(2008-10#1)
brain and body##2##3##(1995-1#1)(2008-9#1)
brain and gut tissue of##2##5##(1994-11#2)
brain and heart##3##3##(2008-10#2)(2010-8#1)
brain and spinal cord##7##4##(1996-12#1)(1997-3#1)(2008-7#2)(2010-12#2)(2013-1#1)
brain and##50##2##(1990-11#1)(1991-2#1)(1991-5#2)(1991-7#1)(1993-12#1)(1994-11#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
brain are##10##2##(1994-2#1)(1995-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-12#1)(2010-9#1)(2013-1#1)
brain area##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
brain areas##13##2##(1994-2#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-9#1)(2013-8#1)
brain as revealed by##2##4##(1990-5#1)(1995-6#1)
brain as##6##2##(1990-5#1)(1994-5#1)(1995-6#1)(1996-12#1)(2009-12#1)(2009-6#1)
brain ascorbate##2##2##(1990-9#2)
brain but##2##2##(1992-6#1)(1995-2#1)
brain by in situ hybridization histochemistry##2##6##(1996-12#2)
brain by in situ hybridization##3##5##(1992-12#1)(1996-12#2)
brain by in##4##3##(1992-12#1)(1996-12#2)(1997-1#1)
brain by##10##2##(1992-12#1)(1995-2#1)(1996-12#3)(1997-1#2)(2008-10#2)(2008-4#1)
brain cAMP##2##2##(2008-8#2)
brain cDNA library was screened##2##5##(1992-6#1)(2008-9#1)
brain cDNA library##7##3##(1992-6#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-8#1)(2008-9#1)
brain cDNA##10##2##(1992-6#1)(1993-8#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-8#1)(2008-9#1)
brain cannabinoid##2##2##(1991-4#2)
brain cells##6##2##(1994-2#2)(2008-11#1)(2008-8#3)
brain changes##3##2##(2008-11#1)(2008-6#1)(2009-7#1)
brain circuitry##2##2##(2013-8#2)
brain connectivity##2##2##(1995-5#2)
brain damage and##3##3##(1996-12#1)(1996-2#1)(1996-3#1)
brain damage in##2##3##(1990-12#1)(2011-2#1)
brain damage##16##2##(1990-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
brain development and##5##3##(2008-11#1)(2012-12#1)(2012-2#3)
brain development##13##2##(1995-2#1)(1996-2#1)(2008-1#1)(2008-11#2)(2011-2#2)(2012-12#1)(2012-2#5)
brain disease##2##2##(1990-8#1)(1995-3#1)
brain disorders##4##2##(1997-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
brain during the##2##3##(1995-2#1)(1997-2#1)
brain dysfunction##2##2##(1995-8#1)(2008-4#1)
brain endothelial cells##2##3##(2008-5#1)(2013-1#1)
brain expansion##2##2##(2012-3#2)
brain extracts##2##2##(1990-8#1)(1996-12#1)
brain finger protein gene (ZNF179)##2##5##(1997-3#2)
brain following##2##2##(1995-12#1)(1996-12#1)
brain free magnesium concentration##3##4##(2008-7#3)
brain free magnesium##5##3##(2008-7#5)
brain function##11##2##(1991-1#1)(1992-12#1)(1995-5#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#1)(2009-7#1)(2013-8#2)
brain functioning##2##2##(2009-7#1)(2013-1#1)
brain functions##2##2##(1992-12#1)(2013-8#1)
brain has been##6##3##(1992-6#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
brain has##9##2##(1992-6#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-4#1)
brain have been##2##3##(2008-7#1)(2011-2#1)
brain heart infusion agar##2##4##(2008-10#1)(2008-12#1)
brain heart infusion##3##3##(1993-12#1)(2008-10#1)(2008-12#1)
brain hexokinase##3##2##(1991-5#3)
brain homogenate##3##2##(1991-1#1)(1996-2#1)(2013-7#1)
brain homogenates##2##2##(1994-11#1)(1996-2#1)
brain imaging techniques##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
brain imaging##10##2##(1995-2#1)(2008-11#2)(2008-8#1)(2009-5#3)(2009-9#1)(2011-2#1)(2013-8#1)
brain in##10##2##(1990-11#1)(1993-3#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
brain infarct##2##2##(2011-2#2)
brain information processing##2##3##(2008-11#2)
brain injured individual##2##3##(1994-12#2)
brain injuries##3##2##(1994-12#1)(2012-2#1)(2013-1#1)
brain injury##44##2##(1990-12#3)(1991-11#2)(1991-12#4)(1992-3#1)(1993-6#1)(1994-12#2)(1997-2#3)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#8)(2009-10#2)(2009-11#1)(2010-1#2)(2010-5#2)(2010-9#2)(2011-2#1)(2011-7#2)(2012-2#1)(2013-1#2)(2013-8#2)
brain is##15##2##(1993-8#3)(1994-5#2)(1995-12#1)(2008-10#2)(2008-11#4)(2008-8#1)(2009-5#1)(2009-8#1)
brain lead##3##2##(1992-12#3)
brain lesions##4##2##(1991-2#2)(1994-3#1)(2008-5#1)
brain lipid##3##2##(1991-5#2)(1996-2#1)
brain magnetic resonance imaging (MRI)##2##5##(2011-2#1)(2012-2#1)
brain magnetic resonance imaging##3##4##(2011-2#2)(2012-2#1)
brain maturation and##2##3##(1992-12#1)(2008-11#1)
brain maturation##3##2##(1992-12#1)(1993-3#1)(2008-11#1)
brain may##2##2##(1997-8#1)(2009-7#1)
brain mechanisms##2##2##(2009-5#1)(2013-8#1)
brain membranes##6##2##(1990-8#2)(1993-6#4)
brain metabolic##2##2##(1994-2#2)
brain metabolism in##2##3##(1991-10#1)(1994-2#1)
brain metabolism##3##2##(1991-10#1)(1994-2#2)
brain metastases##3##2##(1991-2#1)(1992-12#1)(2010-9#1)
brain metastasis##3##2##(1990-12#1)(1991-2#1)(2011-3#1)
brain model##2##2##(2009-5#1)(2010-11#1)
brain must##3##2##(1990-5#1)(2009-8#2)
brain natriuretic peptide##3##3##(1991-5#1)(1994-8#1)(2011-2#1)
brain networks##7##2##(2008-11#1)(2008-8#1)(2009-8#4)(2013-8#1)
brain neurosecretory cells##2##3##(1995-11#2)
brain nuclei##2##2##(1994-2#2)
brain of rats##2##3##(1990-5#1)(1993-3#1)
brain of the##10##3##(1994-2#1)(1996-12#2)(1997-3#1)(2007-12#4)(2008-6#2)
brain of##21##2##(1990-5#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-8#1)(1996-12#3)(1996-5#1)(1997-3#1)(2007-12#4)(2008-6#3)(2008-7#2)(2013-8#1)
brain on##2##2##(1993-12#1)(1996-12#1)
brain or##2##2##(1997-3#1)(2010-6#1)
brain parenchyma##6##2##(1992-12#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
brain perfusion##2##2##(2008-9#1)(2012-3#1)
brain plasticity##2##2##(2008-7#1)(2011-2#1)
brain postsynaptic##2##2##(1996-12#2)
brain potentials##2##2##(1991-1#1)(2008-11#1)
brain region##5##2##(1996-12#2)(2008-7#2)(2012-2#1)
brain regions and spinal cord of##3##6##(1997-2#3)
brain regions and spinal cord##4##5##(1997-2#4)
brain regions and##5##3##(1997-2#4)(2008-12#1)
brain regions are##3##3##(2008-11#1)(2010-5#1)(2010-6#1)
brain regions but##2##3##(1993-8#1)(1995-2#1)
brain regions of the##2##4##(1993-8#1)(1994-2#1)
brain regions of##9##3##(1991-10#1)(1992-1#2)(1993-8#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-2#1)
brain regions were##2##3##(1990-5#1)(1995-2#1)
brain regions##45##2##(1990-5#1)(1991-10#1)(1991-2#1)(1992-1#2)(1993-8#2)(1994-2#3)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#7)(1996-2#1)(1997-2#5)(2008-11#7)(2008-12#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-5#2)(2010-6#1)(2013-8#1)
brain samples by##2##3##(2008-10#2)
brain samples##4##2##(2008-10#3)(2010-11#1)
brain sections##3##2##(1996-2#2)(2008-7#1)
brain size##8##2##(2012-3#8)
brain slice##2##2##(1996-2#1)(2008-4#1)
brain slices##4##2##(1993-6#1)(2008-4#2)(2008-5#1)
brain specific##3##2##(1993-8#2)(1996-12#1)
brain stem catecholaminergic##2##3##(1994-2#2)
brain stem##14##2##(1990-5#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-2#2)(1996-2#1)(2008-7#5)(2012-3#1)
brain stimulation reward##2##3##(1992-12#1)(1993-6#1)
brain stimulation##10##2##(1992-12#1)(1993-6#1)(1994-2#1)(2008-11#1)(2010-12#2)(2010-7#2)(2012-2#1)(2012-3#1)
brain structure and function##3##4##(2009-7#2)(2012-2#1)
brain structure and##5##3##(1993-9#1)(2009-7#3)(2012-2#1)
brain structure##6##2##(1993-9#1)(2007-12#1)(2009-7#3)(2012-2#1)
brain structures##4##2##(1996-12#2)(2008-6#2)
brain syndrome##2##2##(2008-7#2)
brain systems##3##2##(1995-5#1)(2008-2#1)(2013-8#1)
brain temperature##2##2##(1991-9#2)
brain that##4##2##(1996-12#1)(1996-2#1)(2008-4#1)(2009-5#1)
brain tissue in##2##3##(1995-12#1)(2008-6#1)
brain tissue was diagnosed at 12 wks##2##7##(2012-3#2)
brain tissue was##3##3##(2008-7#1)(2012-3#2)
brain tissue##21##2##(1990-10#1)(1990-2#1)(1990-5#1)(1993-9#1)(1994-11#3)(1995-12#1)(1996-12#2)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#3)(2010-11#1)(2011-2#1)(2012-3#2)
brain tissues##8##2##(1990-5#1)(1994-11#1)(1995-6#1)(1997-2#3)(2008-7#1)(2011-2#1)
brain to##4##2##(1991-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
brain tumor cells##2##3##(1990-6#1)(2013-1#1)
brain tumor##8##2##(1990-6#1)(1995-12#1)(1995-2#1)(2008-11#1)(2009-11#2)(2013-1#1)(2013-8#1)
brain tumors in##2##3##(1995-2#1)(2013-8#1)
brain tumors##13##2##(1995-2#2)(2008-11#1)(2008-12#3)(2011-2#5)(2013-8#2)
brain tumour##4##2##(1990-6#2)(1991-6#1)(2008-7#1)
brain tumours##4##2##(2008-7#2)(2011-3#1)(2012-2#1)
brain using##4##2##(1993-8#1)(2008-7#1)(2012-2#1)(2012-3#1)
brain ventricles##2##2##(2008-5#1)(2010-7#1)
brain was##3##2##(1992-10#1)(2010-1#1)(2012-3#1)
brain were##5##2##(1994-5#1)(1995-11#1)(1996-2#2)(2008-10#1)
brain##987##1##(1990-10#1)(1990-11#2)(1990-12#8)(1990-2#1)(1990-3#5)(1990-5#12)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#2)(1991-1#6)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#7)(1991-4#2)(1991-5#12)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-12#16)(1992-3#4)(1992-6#9)(1992-8#3)(1993-1#5)(1993-12#4)(1993-2#1)(1993-3#9)(1993-6#11)(1993-8#14)(1993-9#5)(1994-11#11)(1994-12#5)(1994-2#25)(1994-3#6)(1994-5#9)(1994-6#1)(1994-8#12)(1994-9#1)(1995-1#1)(1995-11#9)(1995-12#14)(1995-2#14)(1995-3#1)(1995-5#7)(1995-6#6)(1995-8#4)(1996-11#2)(1996-12#51)(1996-2#31)(1996-3#5)(1996-5#1)(1996-6#3)(1996-8#2)(1997-1#5)(1997-2#26)(1997-3#9)(1997-4#1)(1997-6#1)(1997-8#5)(1997-9#1)(2007-12#12)(2008-1#3)(2008-10#36)(2008-11#73)(2008-12#10)(2008-2#3)(2008-4#17)(2008-5#14)(2008-6#14)(2008-7#79)(2008-8#19)(2008-9#8)(2009-10#5)(2009-11#3)(2009-12#5)(2009-5#16)(2009-6#3)(2009-7#11)(2009-8#23)(2009-9#8)(2010-1#10)(2010-11#3)(2010-12#8)(2010-5#7)(2010-6#3)(2010-7#5)(2010-8#1)(2010-9#8)(2011-1#1)(2011-2#26)(2011-3#3)(2011-7#2)(2012-12#3)(2012-2#25)(2012-3#24)(2013-1#20)(2013-7#4)(2013-8#31)
brain)##2##1##(2010-11#1)(2013-7#1)
brain-damaged##2##1##(1991-2#1)(1993-3#1)
brain-derived neurotrophic factor (BDNF) was##2##5##(1996-12#1)(1997-2#1)
brain-derived neurotrophic factor (BDNF)##6##4##(1996-12#1)(1997-2#2)(2008-7#2)(2012-2#1)
brain-derived neurotrophic factor##9##3##(1996-12#1)(1997-2#4)(2008-7#2)(2011-2#1)(2012-2#1)
brain-derived##11##1##(1990-7#1)(1996-12#1)(1997-2#5)(2008-7#2)(2011-2#1)(2012-2#1)
brain-injured##3##1##(1995-3#1)(2009-8#2)
brain-specific##3##1##(1993-12#1)(1995-6#2)
brains are##2##2##(2008-4#1)(2010-11#1)
brains of##10##2##(1992-12#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-11#2)(2008-5#1)(2011-2#1)
brains with##2##2##(1994-11#1)(1996-12#1)
brains##42##1##(1990-5#2)(1991-7#2)(1992-12#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-12#4)(1996-2#2)(1997-2#2)(1997-3#1)(2007-12#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2009-10#1)(2010-11#1)(2011-2#1)(2012-3#2)
brainstem response##5##2##(2008-9#4)(2013-1#1)
brainstem##17##1##(1990-9#1)(1991-10#1)(1992-3#1)(1994-2#2)(1996-12#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#4)(2012-3#2)(2013-1#1)
bramble finch##2##2##(2008-8#2)
bran and##3##2##(1993-11#1)(1997-2#1)(2008-10#1)
bran##10##1##(1993-11#3)(1997-2#1)(2008-10#5)(2013-8#1)
branch of the ulnar nerve##2##5##(2008-9#2)
branch of the##8##3##(1995-8#1)(1997-1#1)(2008-9#3)(2011-1#1)(2012-3#2)
branch of##12##2##(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
branch point is##2##3##(2007-12#2)
branch point##3##2##(2007-12#2)(2008-4#1)
branch retinal##2##2##(2010-3#1)(2013-1#1)
branch surfaces##2##2##(2008-10#2)
branch##54##1##(1992-2#1)(1994-1#1)(1995-8#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-10#12)(2008-11#5)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#7)(2009-9#2)(2010-10#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
branched distal##2##2##(2007-12#2)
branched phosphatidylcholines##2##2##(1997-2#2)
branched##23##1##(1990-8#1)(1991-12#1)(1993-12#2)(1996-5#1)(1997-2#3)(2007-12#4)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)
branched-chain amino acid##2##3##(1994-5#2)
branched-chain amino##4##2##(1993-12#1)(1994-5#3)
branched-chain##5##1##(1990-12#1)(1993-12#1)(1994-5#3)
branches and##6##2##(1993-3#1)(1997-8#2)(2008-10#2)(2008-8#1)
branches in##2##2##(1997-3#1)(2009-10#1)
branches of the##8##3##(1990-12#1)(1994-9#1)(1997-3#3)(2008-11#1)(2012-3#2)
branches of##17##2##(1990-12#1)(1992-6#1)(1994-12#1)(1994-9#1)(1997-3#4)(2007-12#1)(2008-10#2)(2008-11#3)(2011-2#1)(2012-3#2)
branches that##2##2##(2008-10#2)
branches##61##1##(1990-12#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-2#1)(1996-9#1)(1997-3#5)(1997-8#9)(2007-12#1)(2008-10#14)(2008-11#4)(2008-12#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
branchial HSP70##2##2##(2010-5#2)
branchial##11##1##(2008-11#1)(2008-7#6)(2010-5#4)
branching at##2##2##(1997-1#1)(2008-10#1)
branching hierarchy##2##2##(1990-8#1)(2008-10#1)
branching of germ tubes##2##4##(2008-10#2)
branching of##6##2##(2007-12#1)(2008-10#3)(2008-7#1)(2012-2#1)
branching pattern of##2##3##(1997-3#1)(2013-1#1)
branching patterns##3##2##(1997-3#1)(2011-2#2)
branching points##3##2##(1997-3#1)(2008-10#2)
branching##28##1##(1990-8#1)(1997-1#1)(1997-3#3)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-8#2)(2011-2#2)(2012-2#2)(2013-1#2)
brand##11##1##(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#4)(2012-2#1)(2013-1#2)
brandies and##2##2##(2008-10#2)
brandies##7##1##(2008-10#7)
brands of beer##2##3##(2008-10#2)
brands of##10##2##(1992-2#1)(2008-10#6)(2008-5#2)(2013-1#1)
brands were##2##2##(2008-10#1)(2013-1#1)
brands##14##1##(1992-2#1)(2008-10#8)(2008-5#2)(2013-1#3)
brasiliensis##6##1##(2008-4#2)(2008-5#3)(2013-8#1)
brass samples and##2##3##(2008-10#2)
brass##8##1##(2008-10#8)
brassicae in##2##2##(2008-10#2)
brassicae##18##1##(2008-10#18)
brassicas and##2##2##(2008-10#2)
brassinosteroid (BR)##2##2##(2008-9#1)(2009-8#1)
brassinosteroid##4##1##(2008-9#2)(2009-8#2)
brazzein##4##1##(2008-9#4)
breach##4##1##(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
breached##4##1##(1995-2#1)(1995-6#1)(1997-5#1)(2010-1#1)
breaches may##2##2##(2012-12#2)
breaches##4##1##(2007-12#2)(2012-12#2)
bread and##2##2##(1990-8#1)(2010-1#1)
bread wheat##9##2##(1991-12#1)(2008-10#8)
bread##16##1##(1990-8#1)(1991-12#1)(1991-6#2)(2008-10#10)(2010-1#1)(2011-2#1)
breadth of species##2##3##(2008-8#1)(2012-3#1)
breadth of##8##2##(1993-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-3#1)
breadth##17##1##(1993-12#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#4)(2012-3#2)
break and##3##2##(2008-10#3)
break down##2##2##(1990-11#1)(2008-10#1)
break of##2##2##(2008-8#1)(2012-2#1)
break repair##4##2##(1996-2#1)(1997-7#1)(2008-7#1)(2012-3#1)
break the##5##2##(1991-3#1)(1992-12#1)(2008-10#3)
break through volume##2##3##(2008-10#2)
break##40##1##(1990-11#1)(1990-3#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-12#1)(1996-2#2)(1997-7#1)(2008-10#15)(2008-11#2)(2008-7#2)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-4#4)(2012-8#1)(2013-1#2)(2013-7#1)
break-up##2##1##(1997-6#1)(2009-8#1)
breakage in##4##2##(1992-1#1)(1997-3#1)(2008-10#1)(2012-3#1)
breakage is##3##2##(2008-5#1)(2012-3#2)
breakage##24##1##(1992-1#1)(1995-6#2)(1997-3#1)(2008-10#3)(2008-5#5)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-3#7)
breakdown and its role in the acrosome reaction##2##8##(2008-8#2)
breakdown and##5##2##(2008-10#2)(2008-8#3)
breakdown in##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
breakdown is##2##2##(2008-2#1)(2008-8#1)
breakdown models##2##2##(2008-3#2)
breakdown of the##2##3##(1995-3#1)(2009-8#1)
breakdown of##19##2##(1993-6#2)(1993-8#1)(1995-3#1)(2008-10#7)(2008-12#1)(2008-7#2)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#1)
breakdown products of##4##3##(1994-8#1)(2008-11#2)(2010-5#1)
breakdown products##11##2##(1994-8#1)(2008-10#4)(2008-11#5)(2010-5#1)
breakdown pulses##4##2##(1991-5#4)
breakdown region##2##2##(2008-3#2)
breakdown spectrometry (LIBS)##2##3##(2008-10#2)
breakdown spectrometry##4##2##(2008-10#4)
breakdown threshold of##2##3##(2008-3#2)
breakdown##82##1##(1991-5#7)(1992-8#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-8#1)(1995-3#1)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#11)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-3#1)
breakfast##5##1##(1991-6#1)(2010-8#1)(2013-1#2)(2013-8#1)
breaking##14##1##(1990-8#1)(1994-5#1)(1997-6#1)(2008-10#8)(2008-12#1)(2011-2#1)(2011-3#1)
breakpoint##7##1##(1996-12#3)(2008-4#1)(2008-8#1)(2008-9#1)(2011-3#1)
breakpoints##4##1##(1994-11#1)(1997-3#1)(2008-5#1)(2011-2#1)
breaks and##4##2##(1994-8#1)(2008-5#1)(2008-9#1)(2011-2#1)
breaks can##2##2##(2008-7#1)(2008-9#1)
breaks down##7##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
breaks in##3##2##(1993-9#1)(1997-7#1)(2008-4#1)
breaks with##2##2##(2008-10#1)(2008-9#1)
breaks##51##1##(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#4)(1995-8#1)(1997-7#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#12)(2009-10#1)(2009-8#1)(2011-2#5)(2012-12#1)(2012-3#1)(2012-4#2)(2013-1#3)(2013-8#1)
breakthrough capacities##2##2##(2008-10#2)
breakthrough in##4##2##(1997-6#1)(2008-11#1)(2013-1#2)
breakthrough volume and##3##3##(2008-10#3)
breakthrough volume##6##2##(2008-10#6)
breakthrough##22##1##(1997-6#1)(2008-10#13)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
breakthroughs in the##2##3##(2010-12#1)(2013-8#1)
breakthroughs in##4##2##(1993-12#1)(2008-10#1)(2010-12#1)(2013-8#1)
breakthroughs##7##1##(1993-12#1)(1994-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2010-12#1)(2013-8#1)
breakup##3##1##(2007-11#1)(2008-7#1)(2009-8#1)
bream##5##1##(2008-10#1)(2010-5#4)
breast MRI##2##2##(2009-11#2)
breast and MXT##2##3##(1993-1#2)
breast and cervical cancer screening##3##5##(1990-8#1)(1997-1#1)(1997-2#1)
breast and cervical cancer##4##4##(1990-8#2)(1997-1#1)(1997-2#1)
breast and endometrial cancer cells##3##5##(2011-2#3)
breast and endometrial cancer##5##4##(2008-10#2)(2011-2#3)
breast and ovarian cancer xenografts##2##5##(1997-7#2)
breast and ovarian cancer##4##4##(1997-7#4)
breast and prostate cancer##3##4##(2008-7#1)(2011-2#2)
breast and prostate##4##3##(2008-11#1)(2008-7#1)(2011-2#2)
breast and uterine cervix cancer in##2##6##(1990-6#2)
breast and##32##2##(1990-12#1)(1990-6#2)(1990-8#2)(1993-1#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1997-1#1)(1997-2#2)(1997-7#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#1)
breast are##3##2##(1991-8#1)(1994-6#1)(2008-7#1)
breast cancer (n =##3##4##(1993-1#3)
breast cancer and primary biliary##3##5##(1992-12#3)
breast cancer and to##2##4##(1990-11#1)(2012-3#1)
breast cancer and##27##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-6#1)(1991-8#1)(1992-12#3)(1993-1#3)(1993-11#2)(1994-12#1)(1994-3#1)(1996-3#1)(1997-7#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
breast cancer are##4##3##(1992-2#1)(1996-11#2)(2012-3#1)
breast cancer but##2##3##(1994-9#1)(2008-10#1)
breast cancer cases##3##3##(1997-3#1)(2008-5#1)(2012-3#1)
breast cancer cell line##4##4##(1990-11#1)(2008-11#2)(2011-1#1)
breast cancer cell lines##9##4##(1992-4#1)(1993-1#1)(1997-7#1)(2008-11#3)(2011-1#1)(2011-2#1)(2013-1#1)
breast cancer cell##17##3##(1990-11#1)(1992-4#1)(1993-1#1)(1993-11#1)(1997-7#1)(2008-11#7)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
breast cancer cells in vitro##2##5##(1994-8#1)(1997-7#1)
breast cancer cells in##7##4##(1994-12#2)(1994-8#1)(1997-7#1)(2008-11#1)(2012-2#2)
breast cancer cells##33##3##(1990-12#1)(1990-5#2)(1992-4#1)(1993-1#1)(1994-12#2)(1994-8#1)(1995-10#1)(1997-7#1)(2008-11#6)(2010-6#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
breast cancer families##3##3##(1994-9#1)(1997-7#1)(2008-10#1)
breast cancer has##5##3##(1990-12#1)(1997-7#2)(2010-8#1)(2011-2#1)
breast cancer have##2##3##(1996-11#1)(2008-4#1)
breast cancer in a##2##4##(1992-12#1)(2008-10#1)
breast cancer in males##2##4##(1997-7#2)
breast cancer in post-menopausal##2##4##(2008-10#1)(2013-8#1)
breast cancer in women##2##4##(1993-1#1)(2010-1#1)
breast cancer in##20##3##(1990-8#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-11#1)(1994-12#1)(1994-6#1)(1997-7#3)(2008-10#2)(2010-1#1)(2010-8#4)(2012-3#1)(2013-8#1)
breast cancer is##3##3##(1990-6#1)(1994-12#1)(2012-3#1)
breast cancer mortality##3##3##(1997-1#1)(1997-7#1)(2012-12#1)
breast cancer patient##2##3##(1993-11#1)(2008-9#1)
breast cancer patients after surgery##3##5##(1994-12#3)
breast cancer patients and their families##2##6##(1994-3#1)(1995-2#1)
breast cancer patients and##3##4##(1992-2#1)(1994-3#1)(1995-2#1)
breast cancer patients in##2##4##(1993-1#1)(2008-10#1)
breast cancer patients who##2##4##(1993-1#1)(2012-3#1)
breast cancer patients with##3##4##(1992-12#1)(1993-11#1)(2011-2#1)
breast cancer patients##30##3##(1990-12#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-1#4)(1993-11#4)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
breast cancer progression##2##3##(2011-2#1)(2012-2#1)
breast cancer risk##5##3##(1990-6#2)(1995-9#2)(2012-3#1)
breast cancer screening clinic for underserved women##2##7##(2011-2#2)
breast cancer screening##15##3##(1992-2#1)(1994-3#1)(1995-12#1)(1996-2#2)(1997-1#3)(2010-8#1)(2011-2#2)(2012-12#4)
breast cancer susceptibility gene##2##4##(1994-9#1)(1995-12#1)
breast cancer susceptibility##4##3##(1994-9#2)(1995-12#1)(1997-7#1)
breast cancer treated by##2##4##(1991-8#1)(2011-2#1)
breast cancer treated##4##3##(1991-8#2)(2011-2#2)
breast cancer treatment##4##3##(2010-8#1)(2011-2#2)(2013-1#1)
breast cancer tumor##2##3##(2013-1#2)
breast cancer was studied##2##4##(1990-12#1)(1993-1#1)
breast cancer was##5##3##(1990-12#1)(1991-2#1)(1992-12#1)(1993-1#1)(2012-3#1)
breast cancer were treated with##2##5##(1991-6#1)(1997-7#1)
breast cancer were##7##3##(1990-12#1)(1990-8#1)(1991-6#1)(1994-12#1)(1997-7#2)(2012-12#1)
breast cancer which##4##3##(1990-11#1)(1991-8#1)(2012-3#1)(2013-7#1)
breast cancer who##5##3##(1997-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
breast cancer with an##3##4##(1990-6#1)(1991-8#2)
breast cancer with##5##3##(1990-6#1)(1991-8#2)(1993-1#1)(1997-3#1)
breast cancer without##2##3##(1993-11#1)(1994-12#1)
breast cancer xenografts##3##3##(2012-2#1)(2013-1#1)(2013-8#1)
breast cancer##422##2##(1990-11#4)(1990-12#14)(1990-2#4)(1990-5#2)(1990-6#7)(1990-8#8)(1991-2#3)(1991-3#1)(1991-6#6)(1991-8#9)(1992-12#7)(1992-2#12)(1992-4#2)(1992-7#1)(1993-1#27)(1993-11#34)(1993-2#2)(1993-9#1)(1994-12#17)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#7)(1994-9#5)(1995-10#1)(1995-12#6)(1995-2#1)(1995-8#3)(1995-9#6)(1996-10#1)(1996-11#4)(1996-2#2)(1996-3#3)(1997-1#7)(1997-3#3)(1997-7#20)(1997-8#5)(2008-10#12)(2008-11#14)(2008-12#4)(2008-4#6)(2008-5#4)(2008-7#7)(2008-9#1)(2009-1#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-6#6)(2010-7#4)(2010-8#10)(2011-1#6)(2011-2#28)(2012-12#7)(2012-2#11)(2012-3#20)(2013-1#23)(2013-7#3)(2013-8#8)
breast cancer]##4##2##(1993-2#1)(2011-3#2)(2013-8#1)
breast cancers##24##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1993-1#2)(1993-11#5)(1994-12#2)(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
breast carcinogenesis##3##2##(1990-6#2)(1993-11#1)
breast carcinoma##19##2##(1990-12#1)(1991-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#7)(1994-2#1)(1994-3#1)(1997-8#2)(2011-2#1)(2012-3#1)
breast carcinomas in##2##3##(1994-12#1)(1996-10#1)
breast carcinomas##3##2##(1994-12#1)(1996-10#1)(2008-11#1)
breast conservation##2##2##(1994-12#1)(2010-7#1)
breast conserving surgery##2##3##(1997-7#1)(2011-2#1)
breast conserving therapy##2##3##(2011-2#2)
breast conserving##5##2##(1994-12#1)(1997-7#1)(2011-2#3)
breast cyst fluids##2##3##(1993-1#2)
breast cyst##6##2##(1993-1#2)(2008-12#4)
breast cysts##2##2##(2008-12#2)
breast disease##2##2##(1993-1#1)(2008-12#1)
breast diseases##3##2##(1993-1#1)(2008-12#1)(2012-2#1)
breast epithelial and stromal cells from Li-Fraumeni syndrome##2##8##(2011-2#2)
breast epithelial and stromal cells##3##5##(2011-2#3)
breast epithelial##8##2##(1990-12#1)(1993-1#4)(2011-2#3)
breast feeding##2##2##(1991-6#1)(2008-1#1)
breast imaging##2##2##(1990-8#1)(2008-3#1)
breast implants is##2##3##(2012-2#2)
breast implants##3##2##(2012-2#3)
breast in##4##2##(1990-11#1)(1991-2#1)(1992-2#1)(1994-12#1)
breast involvement##2##2##(1992-2#2)
breast irradiation##3##2##(1994-12#1)(2009-2#1)(2011-2#1)
breast is##2##2##(1992-2#1)(2012-3#1)
breast lesion##2##2##(1993-1#1)(2012-2#1)
breast lesions##4##2##(1990-2#1)(2012-2#3)
breast microcysts##3##2##(1990-11#3)
breast milk and##2##3##(2008-10#2)
breast milk##15##2##(1991-6#1)(2008-10#5)(2010-6#1)(2011-1#1)(2012-2#5)(2013-1#2)
breast mound##2##2##(2013-1#2)
breast or##3##2##(2008-7#2)(2009-4#1)
breast radiotherapy##2##2##(2009-2#2)
breast reconstruction##13##2##(1990-9#3)(1992-5#2)(1993-11#1)(1994-12#1)(2013-1#6)
breast screening##3##2##(1993-2#1)(2012-12#2)
breast stromal fibroblasts and##2##4##(2013-1#2)
breast stromal fibroblasts##3##3##(2013-1#3)
breast surgery##2##2##(1992-9#2)
breast tissue##6##2##(1990-12#1)(1990-2#1)(1993-1#1)(1993-11#1)(2008-11#1)(2009-11#1)
breast tissues##2##2##(1990-12#1)(2011-2#1)
breast tumor cell line##2##4##(1995-10#1)(1995-6#1)
breast tumor cell##3##3##(1995-10#1)(1995-6#2)
breast tumor##5##2##(1993-11#1)(1995-10#1)(1995-6#2)(2008-10#1)
breast tumors##3##2##(1992-9#1)(1997-7#1)(2008-10#1)
breast tumour##2##2##(2011-3#2)
breast was##2##2##(1991-2#1)(2008-10#1)
breast##729##1##(1990-11#11)(1990-12#21)(1990-2#7)(1990-5#2)(1990-6#12)(1990-8#17)(1990-9#4)(1991-12#1)(1991-2#11)(1991-3#1)(1991-6#8)(1991-8#10)(1992-12#7)(1992-2#20)(1992-3#1)(1992-4#2)(1992-5#5)(1992-7#2)(1992-9#5)(1993-1#43)(1993-11#50)(1993-2#7)(1993-6#2)(1993-9#2)(1994-12#38)(1994-2#6)(1994-3#5)(1994-6#6)(1994-8#7)(1994-9#5)(1995-10#2)(1995-12#9)(1995-2#1)(1995-6#3)(1995-8#3)(1995-9#6)(1996-1#1)(1996-10#2)(1996-11#4)(1996-2#3)(1996-3#3)(1997-1#8)(1997-2#3)(1997-3#3)(1997-7#28)(1997-8#11)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#18)(2008-12#14)(2008-3#2)(2008-4#8)(2008-5#6)(2008-7#14)(2008-9#2)(2009-1#3)(2009-11#3)(2009-12#2)(2009-2#4)(2009-4#3)(2009-5#1)(2010-1#1)(2010-12#1)(2010-6#9)(2010-7#6)(2010-8#12)(2011-1#8)(2011-2#48)(2011-3#4)(2012-12#12)(2012-2#27)(2012-3#27)(2013-1#42)(2013-7#3)(2013-8#11)
breast-cancer##2##1##(2008-10#1)(2013-1#1)
breast-conserving surgery##3##2##(1991-2#1)(1996-11#1)(2011-2#1)
breast-conserving##6##1##(1991-2#1)(1994-12#1)(1994-8#1)(1996-11#1)(2011-2#2)
breast-fed their##2##2##(1991-11#2)
breast-fed##5##1##(1991-11#4)(2011-2#1)
breast-feeding##5##1##(1991-11#2)(2010-11#1)(2011-2#1)(2012-2#1)
breast-specific##2##1##(1990-8#1)(2013-1#1)
breastfed children##2##2##(1991-8#1)(2010-6#1)
breastfed##5##1##(1991-8#3)(2010-6#2)
breastfeeding duration and##2##3##(2008-10#1)(2010-6#1)
breastfeeding duration##3##2##(2008-10#2)(2010-6#1)
breastfeeding to##3##2##(1991-8#2)(2013-1#1)
breastfeeding##32##1##(1991-8#4)(2008-10#6)(2008-11#2)(2010-12#3)(2010-6#7)(2011-1#1)(2012-2#8)(2013-1#1)
breasts##3##1##(1992-9#1)(1994-12#1)(2008-10#1)
breath holding##6##2##(2013-8#6)
breath holds##2##2##(1996-2#2)
breath hydrogen excretion##4##3##(1996-6#4)
breath hydrogen##5##2##(1996-6#4)(2011-2#1)
breath##39##1##(1990-2#1)(1996-2#3)(1996-6#4)(1997-4#3)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-6#1)(2010-10#3)(2010-11#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#7)
breath-hold##7##1##(1997-8#2)(2009-11#4)(2013-8#1)
breath-holding##5##1##(2008-10#4)(2009-11#1)
breathe##4##1##(1993-3#1)(2009-6#2)(2011-2#1)
breathed##3##1##(1991-12#1)(1993-1#1)(1995-12#1)
breathing and##2##2##(1995-3#1)(2012-2#1)
breathing is##2##2##(2008-10#1)(2012-2#1)
breathing pattern and##2##3##(1992-3#2)
breathing pattern of##2##3##(1996-2#2)
breathing pattern##8##2##(1992-3#3)(1994-12#1)(1996-2#2)(1996-3#1)(2008-10#1)
breathing patterns##2##2##(1991-12#1)(1994-12#1)
breathing##42##1##(1991-12#2)(1991-6#1)(1992-3#3)(1994-12#4)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-3#3)(2008-1#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-11#1)(2010-5#1)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#9)(2012-3#2)
breathlessness##2##1##(2010-10#1)(2010-5#1)
breaths##3##1##(1996-2#1)(2011-2#1)(2012-2#1)
bred##7##1##(2008-10#2)(2008-8#3)(2008-9#1)(2012-3#1)
breed assignment test##2##3##(2013-1#2)
breed##17##1##(1994-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-8#1)(2010-4#1)(2013-1#4)(2013-8#1)
breed-related##2##1##(1996-12#2)
breed-specific legislation##2##2##(2013-8#2)
breeder##7##1##(1995-9#2)(2008-5#2)(2008-8#1)(2008-9#2)
breeders for##2##2##(2008-10#2)
breeders##10##1##(2008-10#4)(2008-5#1)(2008-8#3)(2008-9#2)
breeding and##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
breeding are##2##2##(2008-10#1)(2013-8#1)
breeding colony##2##2##(1995-6#2)
breeding experience on female##2##4##(2008-8#2)
breeding for FHB resistance##2##4##(2008-10#2)
breeding for SSLB resistance##2##4##(2008-10#2)
breeding for resistance to##3##4##(2008-10#3)
breeding for resistance##5##3##(2008-10#5)
breeding for##13##2##(2008-10#13)
breeding habitat##2##2##(2008-8#1)(2008-9#1)
breeding in##5##2##(2008-8#3)(2008-9#1)(2010-10#1)
breeding is##2##2##(2008-8#2)
breeding line##7##2##(2008-10#7)
breeding lines##7##2##(2008-10#7)
breeding of##4##2##(1995-2#1)(2008-10#1)(2008-8#1)(2009-10#1)
breeding population##2##2##(2008-9#2)
breeding programs in##3##3##(2008-10#3)
breeding programs##18##2##(2008-10#16)(2009-8#1)(2012-3#1)
breeding schemes##3##2##(2008-10#3)
breeding season in##2##3##(2008-8#1)(2008-9#1)
breeding season reproductive##2##3##(2010-8#2)
breeding season##13##2##(2008-8#8)(2008-9#2)(2010-8#3)
breeding strategies##3##2##(2008-10#2)(2012-4#1)
breeding strategy##2##2##(2008-10#1)(2008-9#1)
breeding system##2##2##(2008-9#2)
breeding to##3##2##(2008-10#1)(2008-8#2)
breeding values##2##2##(2008-8#2)
breeding##161##1##(1995-2#1)(1995-6#3)(1996-6#1)(2007-8#1)(2008-10#70)(2008-5#1)(2008-7#1)(2008-8#48)(2008-9#18)(2009-10#1)(2009-8#1)(2010-10#4)(2010-8#3)(2011-2#2)(2012-3#2)(2012-4#2)(2013-8#2)
breeds and##2##2##(2008-5#1)(2013-1#1)
breeds of livestock##2##3##(1997-7#1)(2011-2#1)
breeds of##3##2##(1996-12#1)(1997-7#1)(2011-2#1)
breeds the##2##2##(1995-2#2)
breeds##18##1##(1995-2#3)(1996-11#1)(1996-12#5)(1997-7#1)(2008-5#1)(2008-8#3)(2011-2#2)(2013-1#2)
breve UCC2003##7##2##(2011-1#3)(2011-2#4)
breve##8##1##(2008-11#1)(2011-1#3)(2011-2#4)
brevifolium##2##1##(2008-10#2)
brevipes##2##1##(2008-10#2)
brevirostris##3##1##(2010-8#3)
brevis##6##1##(2008-11#1)(2008-12#1)(2010-5#2)(2011-2#1)(2012-2#1)
brewer's yeast##3##2##(2011-2#3)
brewing##4##1##(1991-5#1)(2008-10#3)
brick##2##1##(2008-10#2)
bricks and##2##2##(2008-10#1)(2013-8#1)
bricks##3##1##(2008-10#2)(2013-8#1)
bridge MTs##2##2##(2009-10#2)
bridge between the two##2##4##(1994-12#1)(2012-3#1)
bridge between the##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
bridge between##6##2##(1994-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2012-3#1)
bridge in##2##2##(1990-8#1)(2008-10#1)
bridge of##2##2##(1992-6#1)(2013-1#1)
bridge the##9##2##(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)
bridge to liver transplantation##2##4##(2008-11#1)(2013-1#1)
bridge to##5##2##(2008-11#1)(2010-6#2)(2013-1#2)
bridge##55##1##(1990-8#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-5#2)(1997-3#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#4)(2009-8#1)(2010-4#1)(2010-6#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)
bridged##2##1##(1997-3#1)(2008-10#1)
bridges##8##1##(1990-5#1)(1992-12#1)(1996-3#1)(1996-5#1)(2008-7#2)(2009-9#1)(2011-2#1)
bridging between##3##2##(2008-11#1)(2010-11#1)(2011-2#1)
bridging the gap between##2##4##(1996-3#1)(2008-3#1)
bridging the gap##3##3##(1993-3#1)(1996-3#1)(2008-3#1)
bridging the##8##2##(1993-3#1)(1993-8#1)(1995-12#1)(1996-3#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-4#1)
bridging##20##1##(1993-3#1)(1993-8#1)(1995-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#3)
brief and##2##2##(1995-12#1)(2008-11#1)
brief description of the##6##4##(1991-11#1)(1992-2#1)(2008-11#3)(2010-5#1)
brief description of##9##3##(1991-11#1)(1992-2#1)(1996-2#1)(1997-3#1)(2008-11#3)(2008-8#1)(2010-5#1)
brief discussion of the##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
brief discussion of##6##3##(1990-5#1)(2008-10#1)(2008-11#1)(2009-9#1)(2012-12#1)(2013-1#1)
brief history of##3##3##(1991-9#1)(2008-11#1)(2008-5#1)
brief history##5##2##(1991-9#1)(1995-5#1)(1996-12#1)(2008-11#1)(2008-5#1)
brief in##2##2##(1991-12#1)(1996-12#1)
brief interventions##6##2##(2008-11#6)
brief introduction##5##2##(2008-10#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-2#1)
brief motivational##2##2##(2008-11#1)(2008-8#1)
brief overview of the##10##4##(1992-12#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#1)
brief overview of##17##3##(1992-12#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
brief overview##22##2##(1992-1#1)(1992-12#1)(1994-12#1)(1995-2#1)(1995-9#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
brief period##2##2##(1996-3#1)(2008-10#1)
brief pulse ECT##2##3##(2012-12#2)
brief pulse##3##2##(2012-12#3)
brief review of the literature##4##5##(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
brief review of the##8##4##(1990-12#1)(1993-6#1)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
brief review of##11##3##(1990-12#1)(1993-6#1)(2008-11#1)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#2)(2012-12#1)(2012-3#1)(2013-1#1)
brief review##15##2##(1990-12#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#2)(2012-12#1)(2012-3#1)(2013-1#1)
brief##156##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#4)(1997-8#1)(2006-6#1)(2008-10#13)(2008-11#28)(2008-4#8)(2008-5#8)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#1)(2011-2#2)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#8)(2013-8#1)
briefing##2##1##(1995-6#1)(2008-11#1)
briefly considered##2##2##(2008-10#2)
briefly describe the##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
briefly described##8##2##(1991-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-12#1)(2011-1#1)
briefly discuss##5##2##(2008-11#2)(2008-8#1)(2010-5#1)(2012-2#1)
briefly discussed##7##2##(1990-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)
briefly review##2##2##(2008-7#1)(2013-2#1)
briefly reviewed##5##2##(1991-12#1)(1996-11#1)(1997-8#1)(2008-11#1)(2010-8#1)
briefly reviews the##2##3##(1997-2#1)(2008-9#1)
briefly summarize##2##2##(2008-11#1)(2012-2#1)
briefly the##3##2##(1997-1#1)(2008-10#1)(2012-2#1)
briefly##79##1##(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-11#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#14)(2008-11#10)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-3#1)(2012-2#4)(2013-1#1)(2013-2#1)
bright and dark##2##3##(1991-5#2)
bright and##3##2##(1991-5#3)
bright field##2##2##(2008-3#2)
bright future##3##2##(1992-11#1)(2008-12#1)(2011-7#1)
bright light##4##2##(2008-3#1)(2013-1#3)
bright red##2##2##(2008-11#1)(2013-1#1)
bright signal##2##2##(1997-8#2)
bright spot##2##2##(2008-3#2)
bright##30##1##(1990-2#1)(1991-5#4)(1992-11#1)(1994-12#1)(1995-2#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#6)(2008-8#1)(2008-9#1)(2010-1#1)(2011-7#1)(2013-1#5)
bright-field##2##1##(2008-9#1)(2011-2#1)
brightest##2##1##(2008-10#1)(2008-4#1)
brightfield##3##1##(2008-4#2)(2008-9#1)
brightness##8##1##(1995-6#1)(2008-10#2)(2008-2#1)(2013-8#4)
brilliant##7##1##(1995-3#1)(2008-10#4)(2008-4#1)(2010-8#1)
brine shrimp##4##2##(2007-12#2)(2008-9#2)
brine##6##1##(2007-12#2)(2008-10#2)(2008-9#2)
bring a##3##2##(1992-1#1)(1996-3#1)(2008-10#1)
bring about##13##2##(1990-11#1)(1994-8#1)(1997-3#1)(2008-10#2)(2008-11#3)(2010-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
bring specificity##2##2##(2008-11#1)(2011-2#1)
bring the##7##2##(1992-1#1)(1994-6#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
bring to##3##2##(1995-3#1)(2008-12#2)
bring together##6##2##(1993-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
bring##57##1##(1990-11#1)(1990-8#1)(1992-1#2)(1992-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#9)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
bringing together##3##2##(1995-5#1)(2008-4#1)(2010-7#1)
bringing##14##1##(1991-3#1)(1993-1#1)(1995-5#1)(1997-2#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
brings about a##3##3##(1990-5#2)(2008-10#1)
brings out##2##2##(2008-11#1)(2008-3#1)
brings the##2##2##(2008-10#2)
brings to##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
brings together the##2##3##(2008-9#1)(2012-3#1)
brings together##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
brings##23##1##(1990-5#2)(1993-12#1)(1994-1#1)(1995-2#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-9#2)(2010-1#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
brisk##3##1##(1991-12#1)(2010-12#1)(2013-8#1)
british columbia##3##2##(2009-3#2)(2013-1#1)
brittle stars##2##2##(2013-8#2)
brittle##8##1##(1991-12#2)(2009-7#2)(2010-10#1)(2013-8#3)
brix##2##1##(2008-10#2)
broad VMT##2##2##(2013-1#2)
broad acceptance##2##2##(1994-3#1)(2009-5#1)
broad and tunable control over##2##5##(2008-12#2)
broad and##3##2##(2008-10#1)(2008-12#2)
broad applications##4##2##(2008-11#1)(2008-4#1)(2010-11#1)(2012-2#1)
broad bean plants##4##3##(2008-10#4)
broad bean stain##2##3##(1995-12#2)
broad bean##10##2##(1995-12#2)(2008-10#7)(2008-8#1)
broad groups of##2##3##(2011-2#1)(2012-12#1)
broad host range##5##3##(2008-10#3)(2008-11#1)(2012-2#1)
broad host##6##2##(2008-10#3)(2008-11#1)(2012-2#2)
broad neck##2##2##(1997-6#2)
broad range of##44##3##(1995-2#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#17)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
broad range##48##2##(1995-2#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#20)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
broad resistance##2##2##(2008-10#2)
broad signal##2##2##(1995-12#2)
broad spectrum and##2##3##(1991-8#1)(2008-10#1)
broad spectrum of activity##5##4##(2008-10#3)(2008-5#1)(2011-2#1)
broad spectrum of##23##3##(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#3)(2008-8#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
broad spectrum##26##2##(1991-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
broad subject##2##2##(1991-12#1)(2008-11#1)
broad substrate##2##2##(1997-7#1)(2011-1#1)
broad view of##2##3##(1992-3#1)(2008-12#1)
broad##205##1##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#5)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#63)(2008-11#18)(2008-12#9)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#2)
broad-area semiconductor##2##2##(2008-3#2)
broad-area##5##1##(2008-3#5)
broad-based##2##1##(1994-1#1)(2012-3#1)
broad-range##3##1##(1996-8#1)(2008-7#1)(2011-2#1)
broad-scale##2##1##(2008-10#1)(2008-9#1)
broad-sense##2##1##(2008-10#2)
broad-spectrum and##2##2##(2009-10#1)(2011-2#1)
broad-spectrum antibiotic##3##2##(2008-12#1)(2010-5#1)(2010-6#1)
broad-spectrum resistance##3##2##(2008-10#3)
broad-spectrum##18##1##(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-5#1)(2010-6#1)(2011-2#1)
broadband##12##1##(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#6)(2008-7#1)
broadcast##2##1##(1996-5#1)(2008-8#1)
broaden the##4##2##(2007-12#1)(2008-10#2)(2010-12#1)
broaden##7##1##(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-12#1)
broadened by##3##2##(1994-5#1)(2008-2#1)(2008-3#1)
broadened##6##1##(1994-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
broadening caused by##2##3##(1990-12#1)(2007-12#1)
broadening in##2##2##(2008-10#1)(2008-2#1)
broadening##19##1##(1990-12#1)(1992-8#1)(1994-5#3)(1995-1#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)
broader community##2##2##(1997-2#1)(2013-1#1)
broader context of##2##3##(2008-10#1)(2009-8#1)
broader context##6##2##(1993-2#1)(2008-10#1)(2009-8#1)(2010-1#1)(2010-3#2)
broader perspective##2##2##(1997-3#1)(2009-6#1)
broader spectrum of##4##3##(2008-10#1)(2008-11#2)(2010-7#1)
broader tuning##2##2##(2008-3#2)
broader##54##1##(1992-10#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#2)(2008-3#4)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#5)
broadest##4##1##(2008-10#3)(2008-8#1)
broadly applicable##4##2##(2008-11#1)(2008-9#1)(2009-10#1)(2009-12#1)
broadly defined##2##2##(2008-10#1)(2008-12#1)
broadly##25##1##(1993-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-9#1)(2013-1#2)
broccoli head##3##2##(2008-10#3)
broccoli or grass##2##3##(2008-10#2)
broccoli residue##5##2##(2008-10#5)
broccoli residues##2##2##(2008-10#2)
broccoli roots##2##2##(2008-10#2)
broccoli treatments##2##2##(2008-10#2)
broccoli##29##1##(2008-10#28)(2008-12#1)
broiler chickens##2##2##(2008-10#1)(2008-5#1)
broiler chicks##3##2##(2008-12#3)
broiler##7##1##(1995-9#1)(2008-10#1)(2008-12#3)(2008-5#2)
broilers##4##1##(1991-11#1)(1995-9#1)(2008-5#2)
broke down##4##2##(2008-10#2)(2008-5#1)(2009-5#1)
broke##7##1##(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-5#1)(2009-5#1)
broken down##2##2##(1997-3#1)(2011-2#1)
broken up##2##2##(2008-4#1)(2010-5#1)
broken##20##1##(1990-9#1)(1996-11#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#2)(2010-5#1)(2011-2#1)(2013-8#1)
bromate and##7##2##(2008-10#6)(2008-9#1)
bromate as##3##2##(2008-10#2)(2008-9#1)
bromate by##2##2##(2008-10#1)(2008-9#1)
bromate concentrations##2##2##(2008-10#2)
bromate in##8##2##(2008-10#4)(2008-9#4)
bromate is##2##2##(2008-10#1)(2008-9#1)
bromate was##2##2##(2008-10#1)(2008-9#1)
bromate##52##1##(2008-10#34)(2008-9#18)
bromate)##2##1##(2008-10#2)
bromazepam##5##1##(1990-8#2)(2008-10#3)
bromelain##2##1##(1990-5#2)
bromhexine##4##1##(2008-10#3)(2009-7#1)
bromi populations##4##2##(2008-10#4)
bromi##12##1##(2008-10#12)
bromide (CPB)##4##2##(2008-10#4)
bromide (CTAB)##13##2##(2008-10#11)(2008-11#2)
bromide (CTMAB)##3##2##(2008-10#3)
bromide (EB) and##2##3##(2008-10#2)
bromide (TBAB) and##2##3##(2008-10#2)
bromide (TTAB)##2##2##(1997-2#1)(2008-10#1)
bromide adsorbent##2##2##(2008-10#2)
bromide and##11##2##(1994-5#1)(2008-10#8)(2008-11#1)(2008-9#1)
bromide as##3##2##(2008-10#3)
bromide by##3##2##(2008-10#3)
bromide in the##2##3##(1995-3#1)(2008-10#1)
bromide in##10##2##(1995-3#1)(2008-10#8)(2008-9#1)
bromide intercalation##2##2##(1994-5#2)
bromide ion in a developer was##2##6##(2008-10#2)
bromide ion in a developer##6##5##(2008-10#6)
bromide ion in##8##3##(2008-10#8)
bromide ion##11##2##(2008-10#11)
bromide ion-selective electrode detector##2##4##(2008-10#2)
bromide ion-selective##3##2##(2008-10#3)
bromide ions##5##2##(2008-10#5)
bromide is##2##2##(2008-10#2)
bromide on the##4##3##(1990-2#1)(2008-10#2)(2008-11#1)
bromide or##2##2##(2008-10#2)
bromide selective##2##2##(2008-10#2)
bromide solution##2##2##(2008-10#2)
bromide was##4##2##(2008-10#4)
bromide##181##1##(1990-2#2)(1990-5#2)(1990-8#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-5#6)(1995-3#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#145)(2008-11#8)(2008-9#5)(2010-7#1)(2012-3#1)
bromide)##2##1##(2008-10#1)(2008-11#1)
bromides##3##1##(2008-10#3)
brominated##3##1##(2008-10#2)(2008-9#1)
bromination##5##1##(2008-10#5)
bromine treatment gives##2##3##(2008-10#2)
bromine##17##1##(1991-12#1)(1991-3#1)(1996-5#3)(2008-10#12)
bromo##2##1##(2008-10#1)(2012-2#1)
bromoalcohols##3##1##(2008-10#3)
bromoalkanes##2##1##(2008-10#2)
bromocresol green##8##2##(2008-10#8)
bromocresol orange##2##2##(2008-10#2)
bromocresol##10##1##(2008-10#10)
bromocriptine##3##1##(1991-1#2)(2008-7#1)
bromodeoxyuridine##5##1##(1995-11#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-6#1)
bromoethane##2##1##(2008-10#2)
bromoform##2##1##(2008-10#2)
bromophenols in fish##3##3##(2008-10#3)
bromophenols in##4##2##(2008-10#4)
bromophenols##7##1##(2008-10#7)
bromopropylate##3##1##(2008-10#3)
bromopyrogallol red##2##2##(2008-10#2)
bromouridine##2##1##(2008-9#2)
bromovirus##2##1##(2008-10#2)
bronchial artery##2##2##(1997-1#1)(2012-3#1)
bronchial asthma##7##2##(1991-2#2)(1992-3#1)(2008-12#1)(2010-2#2)(2010-6#1)
bronchial circulation##3##2##(1992-3#1)(1997-1#2)
bronchial epithelium and##2##3##(2011-2#2)
bronchial obstruction episodes##2##3##(2008-1#2)
bronchial tree##5##2##(1994-9#1)(1995-12#2)(1996-1#1)(1997-1#1)
bronchial vasculature##5##2##(1997-1#5)
bronchial##52##1##(1991-12#1)(1991-2#2)(1991-8#1)(1992-3#2)(1992-5#2)(1992-9#3)(1994-12#2)(1994-9#1)(1995-12#4)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#11)(2008-1#2)(2008-12#1)(2008-5#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#2)(2012-3#2)
bronchiectasis##7##1##(1994-12#1)(1997-3#1)(2007-8#3)(2008-1#1)(2011-3#1)
bronchiolar##4##1##(1995-12#1)(2013-1#3)
bronchiolitis obliterans syndrome (BOS)##2##4##(2011-3#1)(2012-2#1)
bronchiolitis obliterans syndrome##4##3##(2011-3#3)(2012-2#1)
bronchiolitis##8##1##(1994-6#2)(2010-12#1)(2011-3#4)(2012-2#1)
bronchiseptica##2##1##(2013-8#2)
bronchitis and##3##2##(2007-12#1)(2008-7#2)
bronchitis virus##11##2##(1996-11#1)(2008-5#10)
bronchitis##32##1##(1991-11#3)(1991-9#1)(1992-5#1)(1993-6#1)(1994-3#1)(1996-1#2)(1996-11#2)(1997-1#2)(1997-4#1)(2007-12#1)(2008-5#12)(2008-7#3)(2013-8#2)
bronchoalveolar lavage (BAL)##2##3##(2008-12#1)(2011-2#1)
bronchoalveolar lavage##10##2##(1990-2#1)(1991-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-12#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
bronchoalveolar##12##1##(1990-2#1)(1991-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
bronchoconstriction##5##1##(1996-3#2)(2010-1#3)
bronchodilation##2##1##(1992-2#1)(2011-3#1)
bronchodilator##5##1##(1992-2#1)(1992-3#1)(1997-1#1)(2008-10#1)(2010-1#1)
bronchodilators##4##1##(1996-11#1)(1997-1#2)(2011-2#1)
bronchoesophageal fistula##2##2##(2012-3#2)
bronchoesophageal##3##1##(1997-1#1)(2012-3#2)
bronchogenic##2##1##(2010-5#1)(2011-3#1)
bronchopneumonia##2##1##(2008-5#1)(2011-2#1)
bronchopulmonary dysplasia##4##2##(1990-11#1)(2010-5#2)(2012-3#1)
bronchopulmonary##8##1##(1990-11#1)(1990-9#1)(1994-3#1)(2008-11#1)(2010-5#2)(2012-3#1)(2013-1#1)
bronchoscopic##3##1##(1992-5#1)(2010-2#1)(2013-1#1)
bronchoscopy##8##1##(1994-12#1)(1994-2#2)(2010-10#2)(2010-2#1)(2011-2#1)(2012-3#1)
bronchospasm##3##1##(2008-7#1)(2009-5#1)(2010-7#1)
bronchus##5##1##(1990-12#1)(1997-1#1)(2010-2#1)(2013-1#2)
brood adoption##2##2##(2008-9#2)
brood amalgamation##3##2##(2008-9#3)
brood desertion and##2##3##(2008-9#2)
brood desertion##3##2##(2008-9#3)
brood food proteins##3##3##(2008-6#3)
brood food##4##2##(2008-6#4)
brood parasitic##2##2##(2010-8#2)
brood parasitism##8##2##(2008-8#4)(2008-9#2)(2010-8#2)
brood##34##1##(2008-6#5)(2008-8#9)(2008-9#15)(2010-8#5)
broods##8##1##(2008-9#8)
broom device##2##2##(2009-6#2)
broom##6##1##(2008-10#4)(2009-6#2)
brooms at##2##2##(2008-10#2)
brooms##7##1##(2008-10#7)
broth and##2##2##(2008-9#1)(2012-2#1)
broth containing##2##2##(2008-10#2)
broth microdilution##3##2##(2008-12#2)(2008-5#1)
broth of##3##2##(2008-11#2)(2009-6#1)
broth plus 1% casamino acids##2##5##(2008-10#2)
broth##29##1##(2008-10#15)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2012-2#2)
brother was##2##2##(1994-11#1)(2008-10#1)
brother##8##1##(1990-9#1)(1994-11#1)(1996-6#1)(2008-10#2)(2008-7#1)(2011-2#2)
brothers##10##1##(2008-10#1)(2009-5#2)(2010-1#1)(2011-2#2)(2012-12#3)(2012-3#1)
brought about by##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
brought about the##2##3##(2008-10#1)(2008-9#1)
brought about##10##2##(1994-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
brought by##3##2##(2008-10#2)(2008-4#1)
brought down##2##2##(1994-6#1)(2008-9#1)
brought in##3##2##(2008-10#2)(2008-11#1)
brought into contact with##3##4##(2008-7#1)(2009-5#2)
brought into##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#2)
brought out in##2##3##(2008-10#2)
brought the##2##2##(1990-12#1)(2011-2#1)
brought to light##3##3##(1994-6#1)(2008-10#1)(2008-8#1)
brought to the##4##3##(1991-11#1)(1991-3#1)(2008-10#1)(2010-12#1)
brought to##12##2##(1991-11#1)(1991-3#2)(1994-2#1)(1994-6#1)(2008-10#4)(2008-8#1)(2010-12#1)(2010-7#1)
brought together##7##2##(1996-1#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-9#1)
brought up to##2##3##(2011-2#1)(2013-7#1)
brought up##3##2##(2011-2#2)(2013-7#1)
brought##64##1##(1990-12#1)(1991-11#1)(1991-3#2)(1993-1#1)(1994-1#1)(1994-2#1)(1994-6#2)(1995-1#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-12#1)(2010-7#1)(2011-2#5)(2011-9#1)(2012-2#2)(2012-3#1)(2013-7#1)
brown adipose tissue##4##3##(2011-2#2)(2013-1#2)
brown alga##6##2##(2008-10#2)(2008-11#2)(2008-12#2)
brown algae##2##2##(2008-11#1)(2012-2#1)
brown algal##2##2##(2009-8#2)
brown hare##3##2##(2013-1#3)
brown necrotic##2##2##(2008-10#2)
brown pigment production##2##3##(2008-10#2)
brown plant-hoppers##2##2##(2008-10#2)
brown rice##2##2##(2013-1#2)
brown rot in##4##3##(2008-10#4)
brown rot incidence##3##3##(2008-10#3)
brown rot infections in##2##4##(2008-10#2)
brown rot infections##3##3##(2008-10#3)
brown rot of##4##3##(2008-10#4)
brown rot##30##2##(2008-10#30)
brown spot lesions##4##3##(2008-10#4)
brown spot of##3##3##(2008-10#3)
brown spot##13##2##(2008-10#13)
brown stem rot##13##3##(2008-10#13)
brown stem##15##2##(2008-10#15)
brown to##4##2##(2008-10#4)
brown##114##1##(1990-11#1)(2008-10#88)(2008-11#4)(2008-12#3)(2009-5#1)(2009-8#3)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#8)
brown-pigmented##2##1##(2008-10#1)(2011-2#1)
brownish##3##1##(2008-5#1)(2010-6#1)(2011-2#1)
brucei##8##1##(1993-9#2)(2009-7#4)(2011-2#2)
brucellar##2##1##(2012-3#2)
brucellosis##3##1##(1991-3#1)(2011-2#2)
bruises##4##1##(2008-11#1)(2008-7#1)(2010-7#2)
bruising##3##1##(2008-11#2)(2010-7#1)
brush border##5##2##(1990-12#1)(1991-9#2)(2008-7#2)
brush layer##2##2##(2009-5#2)
brush phase##3##2##(2008-10#3)
brush##21##1##(1990-12#1)(1991-9#2)(1994-12#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-7#2)(2009-5#6)(2009-6#2)
brush-border membrane##2##2##(1994-8#1)(1995-11#1)
brush-border##4##1##(1991-5#1)(1994-8#1)(1995-11#1)(2013-1#1)
brush-modified##3##1##(2010-7#3)
brushes##4##1##(2009-5#1)(2010-7#3)
brushing with##3##2##(2013-1#3)
brushing##12##1##(1997-2#1)(2008-5#2)(2011-2#1)(2012-2#3)(2013-1#5)
brut&quot##2##1##(2008-10#2)
bruxism##2##1##(2010-6#2)
bryoniae and##3##2##(2008-10#3)
bryoniae##6##1##(2008-10#6)
bryozoan##3##1##(2011-2#3)
bryozoans##4##1##(2008-9#2)(2011-2#2)
bubble##9##1##(1993-5#1)(1995-2#2)(2008-10#2)(2008-11#3)(2010-3#1)
bubbles##9##1##(2008-10#4)(2008-11#2)(2008-3#1)(2012-2#2)
bubbling##2##1##(2008-10#2)
buccal cells##3##2##(2008-12#1)(2008-5#2)
buccal mucosa##3##2##(1991-2#1)(1992-9#1)(2008-10#1)
buccal##10##1##(1991-2#1)(1992-9#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
buckling##2##1##(1992-8#1)(2008-9#1)
bucks##3##1##(1991-2#1)(1995-3#1)(1995-9#1)
bud and##4##2##(1995-8#1)(2008-10#2)(2011-2#1)
bud at##2##2##(1990-5#1)(2008-10#1)
bud break##8##2##(2008-10#3)(2012-4#4)(2012-8#1)
bud burst##2##2##(2009-8#1)(2012-4#1)
bud development and##2##3##(2011-2#1)(2012-4#1)
bud development##5##2##(2008-8#1)(2009-8#2)(2011-2#1)(2012-4#1)
bud necrosis virus##3##3##(2008-10#3)
bud size##2##2##(2009-8#2)
bud##48##1##(1990-5#1)(1993-12#4)(1995-8#3)(1997-3#1)(2008-10#21)(2008-8#1)(2009-8#6)(2011-2#2)(2012-4#6)(2012-8#2)(2013-1#1)
budbreak##6##1##(2008-10#5)(2012-8#1)
budded virus##4##2##(1997-3#2)(2008-11#2)
budded##6##1##(1996-3#2)(1997-3#2)(2008-11#2)
budding and fission##2##3##(1995-6#1)(2009-8#1)
budding and##4##2##(1995-6#1)(1996-6#1)(2008-10#1)(2009-8#1)
budding of##2##2##(2008-10#1)(2011-2#1)
budding yeast Saccharomyces cerevisiae##6##4##(1993-8#2)(1995-12#1)(1996-3#1)(1997-7#1)(2012-3#1)
budding yeast and##2##3##(1993-8#1)(1995-6#1)
budding yeast##19##2##(1993-8#3)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#2)(1996-6#3)(1997-7#1)(2008-11#1)(2008-9#3)(2012-3#2)
budding##42##1##(1993-8#3)(1995-12#1)(1995-2#2)(1995-6#2)(1996-3#2)(1996-6#5)(1997-1#4)(1997-3#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-9#3)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#2)
buddy##3##1##(2008-12#3)
budesonide##6##1##(1997-2#1)(2007-11#3)(2010-12#2)
budget for##4##2##(1996-5#2)(2008-10#1)(2008-11#1)
budget of the peatland##2##4##(2008-8#2)
budget of##8##2##(1991-1#1)(1997-1#1)(2008-11#3)(2008-8#2)(2008-9#1)
budget strategies on the needs of the frail elderly##2##9##(1993-1#2)
budget##43##1##(1991-1#1)(1991-12#2)(1991-3#1)(1992-12#1)(1993-1#3)(1993-2#1)(1993-3#2)(1993-5#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-1#1)(2013-8#2)
budgeted##2##1##(1995-12#1)(1997-2#1)
budgeting##13##1##(1991-12#1)(1992-12#1)(1993-1#3)(1993-2#2)(1994-1#2)(1994-2#1)(1996-2#1)(2008-11#1)(2008-9#1)
budgets of##2##2##(1990-2#1)(2008-11#1)
budgets##19##1##(1990-2#1)(1991-12#2)(1991-2#1)(1991-3#1)(1994-1#2)(1994-12#1)(1996-12#1)(1997-2#1)(2008-11#6)(2008-3#1)(2008-8#1)(2013-8#1)
buds of##3##2##(2008-10#2)(2013-1#1)
buds##27##1##(1993-12#1)(2008-10#14)(2008-8#3)(2009-8#2)(2010-2#1)(2011-2#1)(2012-8#1)(2013-1#4)
buffalo meat is more suitable for processing in##2##8##(2010-4#2)
buffalo meat##7##2##(2010-4#7)
buffalo##9##1##(1990-3#1)(2010-4#7)(2011-2#1)
buffaloes##2##1##(1991-8#1)(2010-4#1)
buffer (0##9##2##(1992-10#2)(2008-10#6)(2008-7#1)
buffer (1##2##2##(2008-10#2)
buffer (5##2##2##(2008-10#2)
buffer (50mM##2##2##(2008-10#2)
buffer (pH 1##2##3##(2008-10#2)
buffer (pH 10##2##3##(2008-10#2)
buffer (pH 2##5##3##(2008-10#5)
buffer (pH 3##3##3##(2008-10#3)
buffer (pH 4##6##3##(2008-10#6)
buffer (pH 6##6##3##(2008-10#6)
buffer (pH 7##16##3##(2008-10#16)
buffer (pH 8##7##3##(2008-10#7)
buffer (pH##64##2##(2008-10#64)
buffer against##2##2##(2008-8#1)(2013-1#1)
buffer and 0##3##3##(1992-10#1)(2008-10#2)
buffer and the##3##3##(2008-10#3)
buffer and##22##2##(1992-10#1)(1997-2#1)(2008-10#18)(2008-11#1)(2008-9#1)
buffer as a##4##3##(2008-10#4)
buffer as##7##2##(2008-10#7)
buffer at pH 5##2##4##(2008-10#2)
buffer at pH 6##5##4##(2008-10#4)(2008-5#1)
buffer at pH 7##5##4##(2008-10#5)
buffer at pH 8##5##4##(2008-10#5)
buffer at pH##27##3##(2008-10#26)(2008-5#1)
buffer at##31##2##(2008-10#30)(2008-5#1)
buffer capacity##5##2##(2008-10#5)
buffer concentration##10##2##(2008-10#10)
buffer concentrations and##2##3##(2008-10#2)
buffer containing 0##4##3##(1990-12#1)(2008-10#3)
buffer containing##9##2##(1990-12#1)(1997-1#1)(2008-10#6)(2009-3#1)
buffer for##2##2##(1993-8#1)(2008-10#1)
buffer in the##4##3##(2008-10#3)(2008-11#1)
buffer in##7##2##(2008-10#4)(2008-11#1)(2008-4#1)(2009-10#1)
buffer layer##2##2##(2008-3#2)
buffer media##6##2##(2008-10#6)
buffer medium (pH##2##3##(2008-10#2)
buffer medium##5##2##(2008-10#5)
buffer of pH 5##2##4##(2008-10#2)
buffer of pH 7##2##4##(2008-10#2)
buffer of pH##5##3##(2008-10#5)
buffer of##6##2##(2008-10#6)
buffer pH 4##3##3##(2008-10#3)
buffer pH 5##3##3##(2008-10#3)
buffer pH 9##3##3##(2008-10#3)
buffer pH##18##2##(2008-10#16)(2011-2#2)
buffer salt##2##2##(1997-2#1)(2008-10#1)
buffer solution (pH 4##4##4##(2008-10#4)
buffer solution (pH 6##4##4##(2008-10#4)
buffer solution (pH##13##3##(2008-10#13)
buffer solution after##2##3##(2008-10#1)(2009-7#1)
buffer solution and##4##3##(2008-10#4)
buffer solution at pH##5##4##(2008-10#5)
buffer solution at##7##3##(1994-3#1)(2008-10#6)
buffer solution by##2##3##(2008-10#2)
buffer solution containing##6##3##(2008-10#6)
buffer solution of pH##2##4##(2008-10#2)
buffer solution of##3##3##(2008-10#3)
buffer solution used##3##3##(2008-10#3)
buffer solution was##4##3##(2008-10#4)
buffer solution##90##2##(1990-5#2)(1993-8#1)(1994-3#1)(2008-10#81)(2008-4#1)(2008-8#1)(2009-7#1)(2010-10#1)(2013-1#1)
buffer solution)##3##2##(2008-10#3)
buffer solutions (pH##2##3##(2008-10#2)
buffer solutions and in##2##4##(2008-10#1)(2008-8#1)
buffer solutions containing##2##3##(2008-10#1)(2008-8#1)
buffer solutions##18##2##(2008-10#12)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#2)
buffer system##4##2##(2008-10#4)
buffer to adjust##2##3##(2008-10#2)
buffer to the##2##3##(1992-10#1)(2008-10#1)
buffer to##5##2##(1992-10#1)(1994-3#1)(2008-10#3)
buffer used##2##2##(2008-10#2)
buffer was 6##2##3##(1997-2#1)(2008-10#1)
buffer was investigated##3##3##(2008-10#3)
buffer was used and the##2##5##(2008-10#2)
buffer was used and##3##4##(2008-10#2)(2008-11#1)
buffer was used##4##3##(2008-10#3)(2008-11#1)
buffer was##12##2##(1990-5#1)(1997-2#1)(2008-10#9)(2008-11#1)
buffer were studied##2##3##(2008-10#2)
buffer while##2##2##(1991-5#1)(2008-10#1)
buffer with##5##2##(2008-10#5)
buffer##537##1##(1990-12#4)(1990-5#4)(1991-5#2)(1992-10#4)(1992-11#1)(1992-3#1)(1993-8#2)(1994-3#3)(1995-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(2008-10#459)(2008-11#8)(2008-12#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#4)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#3)
buffer)##5##1##(1990-12#1)(1992-12#1)(2008-10#3)
buffered at pH 4##2##4##(2008-10#2)
buffered at pH 5##2##4##(2008-10#2)
buffered at pH##6##3##(1996-2#1)(2008-10#5)
buffered at##7##2##(1996-2#1)(2008-10#6)
buffered medium at pH##2##4##(2008-10#2)
buffered medium##3##2##(2008-10#3)
buffered mobile##2##2##(2008-10#1)(2008-5#1)
buffered saline##7##2##(1994-11#2)(2008-10#5)
buffered solution##5##2##(1991-5#1)(2008-10#4)
buffered solutions##3##2##(1991-5#1)(2008-10#1)(2009-12#1)
buffered##42##1##(1991-5#2)(1994-11#2)(1996-2#2)(2008-10#28)(2008-11#2)(2008-5#2)(2009-12#1)(2010-1#1)(2010-7#1)(2013-8#1)
buffering capacity of##2##3##(2008-10#1)(2011-2#1)
buffering capacity##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
buffering of acidified samples##2##4##(2008-10#2)
buffering##13##1##(1992-3#1)(1995-2#1)(2008-10#9)(2011-2#1)(2013-7#1)
buffers and the##2##3##(2008-10#1)(2008-9#1)
buffers and##4##2##(2008-10#3)(2008-9#1)
buffers at##2##2##(2008-10#2)
buffers of##3##2##(1993-3#1)(2008-10#2)
buffers##34##1##(1993-3#1)(1993-6#2)(2008-10#25)(2008-8#1)(2008-9#1)(2011-2#3)(2013-8#1)
bug##3##1##(2007-12#1)(2008-10#1)(2013-8#1)
bugs in##2##2##(2009-1#1)(2013-8#1)
bugs##8##1##(2008-7#2)(2009-1#1)(2013-8#5)
build a##16##2##(1993-12#1)(1994-2#2)(1995-12#1)(1996-3#2)(1997-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
build and##3##2##(2008-4#1)(2010-10#1)(2011-7#1)
build on the##2##3##(1996-3#1)(2008-12#1)
build on##6##2##(1996-3#1)(1997-2#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-4#1)
build up##3##2##(2008-10#2)(2010-7#1)
build##46##1##(1992-9#1)(1993-12#1)(1994-2#2)(1995-12#1)(1996-3#3)(1997-1#3)(1997-2#2)(2008-10#9)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2013-1#2)
build-up of carbonaceous residues##2##4##(2008-10#2)
build-up##5##1##(2008-10#3)(2008-5#1)(2010-12#1)
building a##7##2##(1992-3#1)(1994-3#1)(2008-10#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)
building and##5##2##(1991-2#1)(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#1)
building block of##3##3##(1992-6#1)(2009-8#1)(2010-7#1)
building block##4##2##(1992-6#1)(2008-10#1)(2009-8#1)(2010-7#1)
building blocks for the##2##4##(2008-11#2)
building blocks for##6##3##(1996-3#1)(2008-11#2)(2008-7#1)(2011-1#1)(2012-2#1)
building blocks##14##2##(1992-11#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-11#3)(2008-4#2)(2008-7#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
building in##2##2##(1991-2#1)(1996-1#1)
building maintenance workers##3##3##(1991-12#3)
building materials##4##2##(1991-12#2)(2008-10#2)
building of##2##2##(2009-7#1)(2013-1#1)
building on##3##2##(1993-3#1)(1997-2#1)(2010-10#1)
building relationships with##2##3##(1995-12#1)(2010-7#1)
building the##7##2##(1997-3#2)(2008-10#2)(2008-3#1)(2009-3#1)(2010-5#1)
building##100##1##(1991-12#10)(1991-2#3)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-12#1)(1995-5#1)(1996-1#2)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-6#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
building-related##3##1##(1994-9#2)(2008-10#1)
buildings and##2##2##(1992-2#1)(2008-7#1)
buildings with asbestos-containing materials##2##4##(1991-12#2)
buildings##13##1##(1991-12#7)(1992-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
builds a##2##2##(1993-5#1)(2008-5#1)
builds on##2##2##(1997-3#1)(2012-2#1)
builds##7##1##(1993-5#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
buildup##3##1##(1996-12#1)(2008-3#1)(2008-8#1)
built a##2##2##(2008-3#2)
built by##4##2##(1997-3#1)(2008-10#2)(2008-3#1)
built for the##2##3##(2008-11#1)(2008-5#1)
built for##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
built in##2##2##(1992-2#1)(2012-3#1)
built on##3##2##(1993-12#1)(2008-11#1)(2013-1#1)
built up##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
built with the##2##3##(2008-10#2)
built with##7##2##(2008-10#6)(2009-5#1)
built##56##1##(1990-11#1)(1990-3#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-3#2)(2007-8#1)(2008-10#20)(2008-11#5)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#1)
built-in##3##1##(2008-10#1)(2010-4#1)(2010-8#1)
built-up##3##1##(2008-10#2)(2008-9#1)
bulb##31##1##(1993-3#1)(1996-12#1)(1996-9#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#5)(2009-12#7)(2012-2#2)(2013-1#5)
bulbar##4##1##(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
bulbil production##2##2##(2009-5#2)
bulbil##3##1##(2009-5#3)
bulbocastanum and S##2##3##(2008-10#2)
bulbocastanum##3##1##(2008-10#3)
bulbs##4##1##(1993-3#1)(1994-2#1)(2008-10#1)(2008-7#1)
bulgaricus OLL1073R-1##2##2##(2008-11#2)
bulging##2##1##(2008-7#1)(2009-10#1)
bulk acoustic wave (BAW) sensor##2##5##(2008-10#2)
bulk acoustic wave (BAW)##5##4##(2008-10#5)
bulk acoustic wave impedance biosensor##2##5##(2008-10#2)
bulk acoustic wave##13##3##(2008-10#13)
bulk acoustic##14##2##(2008-10#14)
bulk analysis##2##2##(1991-12#1)(2009-12#1)
bulk and##8##2##(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)
bulk culture##2##2##(2008-11#2)
bulk drug and in##3##4##(2008-10#3)
bulk drug and its##3##4##(2008-10#3)
bulk drug and##6##3##(2008-10#6)
bulk drug##7##2##(2008-10#7)
bulk form##3##2##(2008-10#3)
bulk insulating materials##2##3##(2013-8#2)
bulk liquid membrane##5##3##(2008-10#5)
bulk liquid##8##2##(2008-10#6)(2008-11#2)
bulk liquids##5##2##(2008-11#5)
bulk material##3##2##(2008-11#1)(2010-4#1)(2012-2#1)
bulk materials and##2##3##(2007-12#1)(2010-5#1)
bulk mating##3##2##(2008-10#3)
bulk media##2##2##(2007-12#2)
bulk milk somatic cell##2##4##(1996-3#1)(1996-8#1)
bulk modified##2##2##(2008-10#2)
bulk of the##7##3##(2008-10#4)(2008-3#1)(2008-8#1)(2012-2#1)
bulk of##15##2##(2008-10#6)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-10#1)(2012-2#1)
bulk optode for the##2##4##(2008-10#2)
bulk optode##4##2##(2008-10#4)
bulk phase##3##2##(2008-10#2)(2008-7#1)
bulk segregant analysis##2##3##(2008-10#2)
bulk soil##2##2##(2008-10#1)(2008-11#1)
bulk solution##6##2##(1997-2#1)(2008-10#5)
bulk water##3##2##(2008-5#3)
bulk##170##1##(1990-8#1)(1991-12#1)(1992-11#2)(1993-8#1)(1994-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#94)(2008-11#14)(2008-12#4)(2008-2#2)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#3)
bulk-modified##2##1##(2008-10#2)
bulk-optic##2##1##(2008-3#2)
bulked plant samples##3##3##(2008-10#3)
bulked segregant analysis##7##3##(1995-6#1)(2008-10#5)(2008-9#1)
bulked segregant##8##2##(1995-6#2)(2008-10#5)(2008-9#1)
bulked##13##1##(1995-6#2)(2008-10#10)(2008-9#1)
bulkiness of the##2##3##(2008-10#2)
bulkiness##3##1##(2008-10#3)
bulking agents##4##2##(2008-12#4)
bulking##5##1##(2008-12#4)(2013-1#1)
bulks##7##1##(2008-10#6)(2008-8#1)
bulky##9##1##(1991-5#2)(1992-12#1)(1994-5#1)(2008-10#3)(2008-6#1)(2012-3#1)
bull##2##1##(1997-6#1)(2008-10#1)
bullata##3##1##(2008-10#3)
bulldog##2##1##(1997-5#1)(2009-8#1)
bullfrog##8##1##(1990-5#2)(1996-2#1)(1997-7#5)
bullied##5##1##(2008-11#1)(2008-12#2)(2009-7#2)
bullosa##14##1##(1991-11#2)(1991-12#2)(1992-3#2)(1997-5#1)(2012-12#1)(2012-3#6)
bully##2##1##(2008-11#1)(2010-1#1)
bully-victims and non-involved adolescents##2##4##(2009-7#2)
bully-victims##3##1##(2009-7#3)
bullying and victimization##2##3##(2010-1#2)
bullying and##3##2##(2009-7#1)(2010-1#2)
bullying behavior##2##2##(2009-7#2)
bullying##24##1##(2008-11#7)(2008-12#4)(2009-7#10)(2010-1#3)
bumetanide##4##1##(1990-5#1)(1992-3#2)(1994-3#1)
bumps##3##1##(2008-10#2)(2009-8#1)
bundle and##2##2##(1996-2#1)(2008-7#1)
bundle branch block and##2##4##(2008-12#1)(2010-8#1)
bundle branch block##6##3##(1994-1#1)(2008-10#1)(2008-12#2)(2010-8#2)
bundle of##2##2##(1991-2#1)(1995-12#1)
bundle with##2##2##(1991-12#1)(2008-7#1)
bundle##32##1##(1991-12#1)(1991-2#3)(1992-12#1)(1993-3#2)(1994-1#1)(1995-12#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-9#1)(2010-8#2)(2013-1#3)
bundled##5##1##(2008-10#1)(2008-3#1)(2009-7#1)(2009-9#1)(2011-2#1)
bundles and##4##2##(2008-10#3)(2012-2#1)
bundles in##3##2##(2008-10#3)
bundles of##4##2##(1997-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
bundles##32##1##(1993-3#1)(1993-8#2)(1994-6#1)(1997-3#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#5)(2013-1#2)
bundling and##2##2##(2009-11#1)(2012-2#1)
bundling##6##1##(2009-11#1)(2009-9#1)(2011-2#2)(2012-2#2)
bunion surgery##2##2##(2010-9#2)
bunion##3##1##(2010-9#3)
bunt fungus##2##2##(2008-10#2)
bunt of wheat##3##3##(2008-10#3)
bunt##10##1##(2008-10#10)
buoyancy##10##1##(1996-12#1)(2008-10#1)(2008-12#8)
buoyant density of##2##3##(1990-5#1)(2008-10#1)
buoyant density##4##2##(1990-5#1)(1993-8#1)(2008-10#2)
buoyant smoke##4##2##(1996-12#4)
buoyant##9##1##(1990-5#1)(1993-8#1)(1996-12#4)(2008-10#2)(2008-7#1)
bupivacaine and##2##2##(2011-2#2)
bupivacaine plus##3##2##(1993-1#1)(2011-2#2)
bupivacaine with##3##2##(1993-1#2)(2011-2#1)
bupivacaine##20##1##(1993-1#4)(1995-3#1)(2007-8#1)(2008-10#2)(2008-7#4)(2011-2#7)(2012-12#1)
buprenorphine##19##1##(1991-1#4)(2008-11#8)(2008-6#7)
bupropion and##2##2##(1991-1#1)(2013-8#1)
bupropion##7##1##(1991-1#1)(2010-11#2)(2012-3#1)(2013-8#3)
bur##2##1##(2008-9#1)(2013-8#1)
burden among##2##2##(2008-1#1)(2013-8#1)
burden and##5##2##(2008-1#1)(2008-10#1)(2010-10#1)(2011-3#1)(2013-8#1)
burden in the##4##3##(1996-1#1)(1996-12#1)(2008-10#1)(2013-1#1)
burden in##6##2##(1992-1#1)(1996-1#1)(1996-12#1)(2008-10#1)(2010-3#1)(2013-1#1)
burden is##3##2##(1991-12#1)(2010-4#1)(2012-2#1)
burden of hypertension##3##3##(2008-11#1)(2010-4#2)
burden of illness##2##3##(1994-9#1)(2012-12#1)
burden of pneumococcal##2##3##(2007-12#1)(2008-10#1)
burden of stroke##3##3##(2008-8#2)(2009-7#1)
burden of##40##2##(1991-12#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-3#1)(2007-12#2)(2008-10#2)(2008-11#4)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#2)
burden on##2##2##(1997-7#1)(2007-11#1)
burden to##3##2##(1995-11#1)(2008-11#1)(2009-8#1)
burden##84##1##(1990-12#1)(1991-12#2)(1992-1#1)(1992-2#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#5)(2008-11#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#3)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#7)
burden-of-illness score##3##2##(1994-9#3)
burden-of-illness##4##1##(1994-9#4)
burdens of##2##2##(1996-12#1)(2008-7#1)
burdens the##2##2##(1996-12#1)(2008-7#1)
burdens##19##1##(1991-12#1)(1991-3#2)(1995-1#1)(1995-12#1)(1996-12#6)(1997-3#1)(2008-10#1)(2008-6#1)(2008-7#3)(2009-9#1)(2011-2#1)
burdensome for##2##2##(2008-12#1)(2010-10#1)
burdensome##3##1##(1995-2#1)(2008-12#1)(2010-10#1)
bureaucracy##7##1##(1993-1#1)(1994-2#2)(1994-5#1)(1995-3#1)(1997-5#1)(2008-1#1)
bureaucratic##6##1##(1991-3#1)(1996-1#1)(2008-1#2)(2008-11#1)(2008-6#1)
burgdorferi##20##1##(1990-2#3)(1992-3#3)(1995-5#1)(2008-9#7)(2011-2#6)
burgeoning##4##1##(1994-1#1)(2008-11#1)(2008-5#2)
burial##6##1##(2008-10#6)
burials##3##1##(2008-10#3)
buried at##3##2##(1992-4#1)(2008-10#2)
buried in soil and##2##4##(2008-10#2)
buried in the##2##3##(1994-5#1)(2008-10#1)
buried in##5##2##(1994-5#1)(2008-10#4)
buried penis##2##2##(1991-8#1)(2008-10#1)
buried residues##4##2##(2008-10#4)
buried##32##1##(1991-8#1)(1992-4#1)(1994-5#1)(1995-12#1)(2007-12#1)(2008-10#24)(2008-9#1)(2011-1#1)(2012-2#1)
burn injury is##2##3##(2008-8#2)
burn injury##8##2##(1996-3#1)(2008-8#6)(2012-3#1)
burn patients##2##2##(1990-2#1)(2009-6#1)
burn##22##1##(1990-2#1)(1990-8#2)(1996-3#1)(2008-8#6)(2009-1#1)(2009-6#1)(2010-10#3)(2010-7#2)(2012-3#4)(2013-7#1)
burned out again##2##3##(2013-1#2)
burned out##3##2##(2008-11#1)(2013-1#2)
burned##8##1##(1991-3#1)(2008-10#4)(2008-11#1)(2013-1#2)
burner head##2##2##(2008-10#2)
burner##11##1##(2008-10#2)(2008-2#2)(2008-3#7)
burnetii##8##1##(1991-8#1)(1992-5#1)(1995-12#6)
burning##16##1##(1991-6#1)(1992-6#1)(2008-10#1)(2008-11#4)(2008-3#4)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#1)
burnout and vital exhaustion##2##4##(2008-11#2)
burnout and##8##2##(1994-3#1)(1996-2#1)(1997-1#1)(2008-11#4)(2010-2#1)
burnout in##2##2##(1991-3#1)(2008-10#1)
burnout phase##4##2##(1996-2#1)(1997-1#3)
burnout##50##1##(1991-3#1)(1992-1#6)(1994-3#1)(1995-1#2)(1996-2#9)(1997-1#5)(2008-10#7)(2008-11#9)(2010-2#6)(2010-7#2)(2013-1#2)
burns and shocks##2##3##(2011-2#2)
burns##15##1##(1991-6#1)(1992-12#1)(1992-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)
burnt##2##1##(2008-10#2)
burr hole##3##2##(1997-6#1)(2008-7#2)
burr##4##1##(1997-6#1)(2008-7#3)
burrows##3##1##(2008-5#1)(2011-2#1)(2012-3#1)
bursa and liver##2##3##(2008-5#2)
bursa and##3##2##(2008-5#3)
bursa of Fabricius and##2##4##(2008-5#1)(2008-9#1)
bursa##8##1##(2008-5#7)(2008-9#1)
bursae##2##1##(2008-5#1)(2010-3#1)
burst firing was##2##3##(1996-2#2)
burst firing##4##2##(1996-2#4)
burst in##5##2##(1995-6#1)(2008-10#4)
burst of##5##2##(1994-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
burst stimulation in##2##3##(1992-6#1)(2010-7#1)
burst swimming##2##2##(2010-8#2)
burst##49##1##(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-6#2)(1994-6#4)(1994-8#1)(1995-6#7)(1996-2#5)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#1)(2012-4#1)(2013-8#1)
burst)##2##1##(2008-10#1)(2008-9#1)
bursting##3##1##(1991-5#1)(2008-11#2)
bursts of##2##2##(1994-3#1)(2013-8#1)
bursts##8##1##(1990-9#1)(1994-3#1)(1994-8#2)(1997-2#1)(2008-3#1)(2013-8#2)
burying##5##1##(1993-3#4)(1994-2#1)
bus##5##1##(1995-12#1)(1997-6#1)(2008-3#2)(2012-12#1)
buses##3##1##(1997-6#1)(2008-11#1)(2008-3#1)
bush##5##1##(1995-10#1)(2008-10#3)(2010-1#1)
bushen##3##1##(2013-8#3)
business and##6##2##(1991-12#1)(1991-2#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)
business network##2##2##(1993-3#2)
business plan##2##2##(1993-2#1)(2010-7#1)
business planning and##2##3##(2008-11#2)
business process##3##2##(1993-12#2)(1993-3#1)
business skills##2##2##(1996-3#1)(1997-2#1)
business##82##1##(1990-2#1)(1991-12#7)(1991-2#3)(1991-3#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1993-1#3)(1993-12#2)(1993-2#2)(1993-3#5)(1994-1#4)(1994-12#2)(1994-2#2)(1994-3#2)(1995-2#3)(1995-6#1)(1996-1#2)(1996-2#2)(1996-3#6)(1996-5#1)(1997-1#4)(1997-2#2)(1997-3#1)(2008-10#1)(2008-11#10)(2008-12#1)(2008-5#1)(2010-7#2)(2012-3#3)(2013-8#1)
businesses have##2##2##(1993-1#1)(1994-2#1)
businesses##9##1##(1991-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-5#1)(2008-11#2)
businessperson##2##1##(2012-3#2)
busy##4##1##(1996-2#1)(2008-12#1)(2010-3#1)(2012-2#1)
but 1##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
but 10##2##2##(2008-10#1)(2008-7#1)
but 7##2##2##(1991-6#1)(1995-8#1)
but L##2##2##(2008-11#1)(2010-8#1)
but Not##2##2##(2008-10#1)(2012-3#1)
but a comprehensive##2##3##(1992-12#1)(1997-8#1)
but a few##4##3##(1992-6#1)(2008-10#1)(2011-2#1)(2012-12#1)
but a recent study##2##4##(2008-1#1)(2008-11#1)
but a significant##2##3##(2009-3#1)(2011-2#1)
but a similar##3##3##(2006-6#1)(2008-4#1)(2011-1#1)
but a##58##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-3#1)(2010-11#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-12#2)(2013-8#1)
but about##2##2##(2007-12#1)(2008-10#1)
but above##2##2##(2008-10#1)(2008-8#1)
but absent##2##2##(1995-6#1)(2008-10#1)
but accuracy did not##2##4##(2013-1#2)
but accurate##2##2##(2008-10#1)(2008-3#1)
but actually##2##2##(1990-12#1)(1994-2#1)
but affects##2##2##(2008-8#1)(2009-12#1)
but after##7##2##(1990-12#1)(1990-5#1)(1992-12#1)(2008-10#2)(2008-8#1)(2010-12#1)
but aggressive##3##2##(1992-12#1)(1993-3#1)(2008-12#1)
but all##6##2##(1990-3#1)(1994-12#1)(1997-3#1)(2008-10#3)
but allow##2##2##(1995-6#1)(2008-10#1)
but allows##4##2##(1992-6#1)(1993-3#1)(2008-8#1)(2010-8#1)
but almost##2##2##(2010-11#1)(2012-3#1)
but also a new##2##4##(2008-2#1)(2008-9#1)
but also a##4##3##(2008-10#1)(2008-2#1)(2008-9#2)
but also as a##2##4##(2008-10#1)(2008-9#1)
but also as##5##3##(2008-10#4)(2008-9#1)
but also at##3##3##(2007-12#1)(2009-1#1)(2012-3#1)
but also by the##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
but also by##8##3##(1994-3#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2011-2#1)
but also during##2##3##(2008-7#1)(2011-2#1)
but also effectively##2##3##(1994-1#1)(2008-10#1)
but also facilitate the##2##4##(2008-9#1)(2010-10#1)
but also for a##2##4##(1991-6#1)(2013-8#1)
but also for##18##3##(1991-2#1)(1991-6#1)(1993-3#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
but also from##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
but also have##2##3##(2011-2#1)(2013-1#1)
but also improves the##2##4##(2008-10#1)(2008-12#1)
but also in other##2##4##(1997-6#1)(2008-11#1)
but also in terms of##2##5##(1997-1#1)(2008-10#1)
but also in the##8##4##(1992-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
but also in##27##3##(1990-5#1)(1992-6#1)(1993-6#1)(1995-6#1)(1997-1#2)(1997-6#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-3#2)(2011-2#2)
but also increased the##2##4##(2008-10#1)(2008-8#1)
but also into##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
but also may##2##3##(2008-11#1)(2013-1#1)
but also more##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
but also of the##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)
but also of##6##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)
but also on its##3##4##(1991-2#2)(2008-5#1)
but also on the##2##4##(2008-10#1)(2010-12#1)
but also on##11##3##(1991-2#2)(1997-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
but also other##2##3##(2010-8#1)(2013-1#1)
but also present##2##3##(1997-2#1)(2008-10#1)
but also provide##2##3##(1993-3#1)(2011-2#1)
but also reduced the##2##4##(2008-10#1)(2011-1#1)
but also reveals##2##3##(2009-12#1)(2012-3#1)
but also the##22##3##(1991-6#1)(1992-3#1)(1994-3#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
but also their##2##3##(1995-12#1)(2012-2#1)
but also to the##4##4##(2008-10#1)(2008-8#1)(2009-3#1)(2013-1#1)
but also to##25##3##(1990-5#2)(1994-1#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#2)
but also will##2##3##(1997-1#1)(2008-11#1)
but also with##5##3##(1997-3#1)(2008-6#1)(2008-8#2)(2012-12#1)
but also##322##2##(1990-12#2)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#5)(1991-6#3)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#4)(2008-10#61)(2008-11#41)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#15)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#3)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#22)(2012-12#2)(2012-2#9)(2012-3#8)(2013-1#11)(2013-8#5)
but an##12##2##(1991-11#2)(1997-3#1)(2008-10#1)(2008-5#3)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)
but another##2##2##(1997-3#1)(2008-10#1)
but apparently##3##2##(2008-5#1)(2009-8#1)(2013-8#1)
but are also##3##3##(1997-7#1)(2009-12#1)(2009-8#1)
but are limited##2##3##(2008-3#1)(2013-1#1)
but are not limited to##2##5##(2009-11#2)
but are not##8##3##(1991-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-12#1)(2009-11#2)(2009-6#1)
but are##38##2##(1991-3#2)(1992-9#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#2)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
but as a##3##3##(2008-7#1)(2011-3#1)(2013-1#1)
but as an##2##3##(1991-12#1)(2008-8#1)
but as##11##2##(1991-12#1)(1992-12#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
but at a lower##2##4##(1990-12#1)(2008-10#1)
but at a##8##3##(1990-12#1)(2008-10#3)(2008-6#1)(2009-10#1)(2012-2#1)(2012-3#1)
but at least some##2##4##(2013-1#2)
but at low##2##3##(2008-10#2)
but at##26##2##(1990-12#1)(1990-5#1)(1994-12#1)(1995-8#1)(2008-10#10)(2008-6#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#3)
but barely##2##2##(1994-12#1)(2008-10#1)
but became##2##2##(1992-3#1)(2008-5#1)
but because of the##2##4##(1997-8#1)(2008-12#1)
but because of##3##3##(1997-8#1)(2008-12#1)(2008-8#1)
but because##5##2##(1997-8#1)(2008-12#1)(2008-8#2)(2008-9#1)
but below the##2##3##(2008-10#2)
but blocked##3##2##(1990-12#1)(1994-2#1)(1996-5#1)
but both##6##2##(1994-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)
but by a##2##3##(1991-12#1)(2012-2#1)
but by different##2##3##(1991-5#1)(2012-3#1)
but by##13##2##(1990-3#1)(1991-12#1)(1991-5#1)(1995-11#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-2#2)(2012-3#1)
but can also##3##3##(2008-10#1)(2008-5#1)(2010-10#1)
but can be##8##3##(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)
but can##18##2##(1992-3#1)(1992-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
but cannot be##2##3##(1991-12#1)(2011-2#1)
but cannot##4##2##(1991-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
but carotenoids content##2##3##(2008-12#2)
but carries##2##2##(1995-11#1)(2008-12#1)
but caused##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
but clearly##2##2##(2008-11#1)(2008-6#1)
but cleavage##2##2##(2007-12#1)(2009-8#1)
but clinical##2##2##(2008-10#1)(2011-2#1)
but common##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
but compatible with##2##3##(2008-10#1)(2008-9#1)
but completely##2##2##(1993-6#1)(1996-2#1)
but concomitantly##2##2##(1994-8#1)(1997-4#1)
but consistent##2##2##(2009-11#1)(2013-8#1)
but contain##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
but continued##3##2##(2007-12#1)(2008-10#2)
but could be##3##3##(2008-10#1)(2008-11#2)
but could##10##2##(1993-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2010-3#1)(2012-2#2)
but daily##2##2##(2008-9#2)
but decreased in##2##3##(1997-2#1)(2008-11#1)
but decreased to##2##3##(2008-10#1)(2008-6#1)
but decreased with##2##3##(2008-10#2)
but decreased##11##2##(1990-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2010-5#1)(2011-2#1)
but decreases with##2##3##(2008-8#1)(2009-7#1)
but decreases##4##2##(1992-6#1)(1993-6#1)(2008-8#1)(2009-7#1)
but decreasing##2##2##(2008-10#1)(2008-8#1)
but despite##2##2##(2008-11#2)
but determined##2##2##(2008-10#1)(2010-6#1)
but did affect the##2##4##(2008-10#1)(2008-11#1)
but did enhance##2##3##(1995-11#1)(1997-1#1)
but did inhibit##2##3##(2006-6#1)(2008-10#1)
but did not act on##2##5##(2008-8#2)
but did not affect the##4##5##(1993-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
but did not affect##7##4##(1993-8#1)(1995-11#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
but did not amplify##2##4##(2008-10#1)(2008-11#1)
but did not change##2##4##(1990-3#1)(1994-6#1)
but did not decrease##2##4##(2008-5#1)(2008-8#1)
but did not differ##2##4##(2009-9#1)(2010-1#1)
but did not for##2##4##(1993-8#1)(2008-10#1)
but did not increase##2##4##(1993-8#1)(2008-8#1)
but did not influence##2##4##(1993-8#1)(2013-1#1)
but did not predict##2##4##(2008-7#1)(2013-1#1)
but did not react with##2##5##(2008-10#1)(2008-11#1)
but did not##60##3##(1990-3#1)(1990-5#2)(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#4)(1994-5#1)(1994-6#1)(1995-11#1)(1996-1#1)(2008-10#20)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
but did react with##2##4##(2008-10#1)(2008-5#1)
but did reduce##2##3##(2008-10#2)
but did show##2##3##(1990-8#1)(2008-10#1)
but did##83##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-2#1)(1996-1#1)(1997-1#1)(2006-6#1)(2008-10#31)(2008-11#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
but died##2##2##(1995-11#1)(2010-10#1)
but differ in##2##3##(1995-8#1)(2007-12#1)
but differed in##2##3##(2008-10#1)(2008-5#1)
but differences in##2##3##(2008-10#2)
but differences##4##2##(2008-10#4)
but different between##2##3##(2008-10#2)
but different##15##2##(1993-6#1)(1994-3#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-10#1)(2012-3#1)(2012-6#1)
but differs##2##2##(1994-5#1)(2008-9#1)
but disease##3##2##(2008-10#3)
but displayed##3##2##(1994-6#1)(2012-12#1)(2013-1#1)
but distinct from that##2##4##(2008-11#1)(2009-10#1)
but distinct from##3##3##(1995-2#1)(2008-11#1)(2009-10#1)
but distinct##6##2##(1991-3#1)(1995-2#1)(2008-10#2)(2008-11#1)(2009-10#1)
but do not##11##3##(1993-6#1)(1994-3#1)(1995-2#1)(1996-12#2)(2008-10#3)(2008-4#1)(2008-9#1)(2011-2#1)
but do##14##2##(1993-6#1)(1994-3#1)(1995-2#1)(1996-12#2)(2008-10#3)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
but does not cause##2##4##(1991-5#1)(1994-5#1)
but does not##12##3##(1991-5#1)(1992-6#1)(1994-5#1)(1996-2#2)(1997-3#1)(2008-10#4)(2008-8#2)
but does##16##2##(1991-5#1)(1992-6#1)(1994-5#2)(1996-2#2)(1997-1#1)(1997-3#1)(2008-10#4)(2008-8#2)(2008-9#1)(2012-2#1)
but due to##2##3##(2008-10#2)
but during##2##2##(1992-3#1)(2008-12#1)
but each##4##2##(2008-10#2)(2008-7#1)(2010-4#1)
but early##2##2##(1997-3#1)(2008-9#1)
but either##2##2##(1995-2#1)(2010-4#1)
but enhanced##2##2##(1995-2#1)(2008-9#1)
but enhances##2##2##(2008-10#1)(2008-6#1)
but especially##5##2##(1997-5#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
but even##3##2##(1994-3#1)(2008-8#2)
but evidence##2##2##(2008-10#1)(2010-9#1)
but experimental##2##2##(2008-8#1)(2012-2#1)
but expressed##3##2##(1993-3#1)(1994-3#1)(2008-11#1)
but failed to##6##3##(1992-8#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#2)
but failed##7##2##(1992-8#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#3)
but fails to##2##3##(1995-6#1)(2008-8#1)
but few have##2##3##(2008-12#1)(2008-9#1)
but few studies have##2##4##(2008-4#1)(2010-1#1)
but few studies##3##3##(2008-4#1)(2008-8#1)(2010-1#1)
but few##11##2##(1991-2#1)(1991-5#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
but fewer##2##2##(2010-1#1)(2011-1#1)
but final##2##2##(2008-5#1)(2010-11#1)
but fluorescence##2##2##(1990-12#1)(2008-10#1)
but for the##2##3##(2008-10#1)(2008-11#1)
but for##15##2##(1994-5#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)
but formed a##2##3##(2008-10#1)(2008-12#1)
but found to##2##3##(2008-10#1)(2008-7#1)
but four##4##2##(1991-9#1)(1992-3#1)(1994-6#1)(2011-2#1)
but frequently##2##2##(2008-10#1)(2011-2#1)
but from##2##2##(1997-8#1)(2008-11#1)
but further##6##2##(1994-8#1)(1997-3#1)(2008-10#2)(2008-4#1)(2011-2#1)
but generally##7##2##(1990-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
but genetic##2##2##(2008-7#1)(2011-2#1)
but good##2##2##(1994-9#1)(2008-10#1)
but group##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
but growth##3##2##(2008-1#1)(2008-11#1)(2011-1#1)
but had a##5##3##(1993-6#1)(2008-10#2)(2008-9#1)(2013-1#1)
but had no effect on##4##5##(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)
but had no effect##5##4##(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2012-3#1)
but had no##10##3##(1991-9#1)(1992-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-12#1)(2008-4#1)(2012-12#1)(2012-3#1)
but had##24##2##(1991-11#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
but has a##2##3##(2008-10#1)(2013-1#1)
but has been##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
but has no effect on##2##5##(1995-3#1)(2013-8#1)
but has no##3##3##(1995-3#1)(2008-10#1)(2013-8#1)
but has not been##2##4##(1995-6#1)(2008-7#1)
but has not##3##3##(1995-6#1)(2008-7#1)(2009-5#1)
but has##26##2##(1990-5#1)(1991-2#2)(1991-6#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
but have also been##2##4##(2008-9#1)(2013-1#1)
but have different##2##3##(1993-12#1)(2011-2#1)
but have not##2##3##(2008-10#1)(2008-9#1)
but have##15##2##(1993-1#1)(1993-12#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-6#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
but health care##2##3##(1997-1#1)(2008-11#1)
but high##2##2##(2008-5#1)(2012-12#1)
but higher##8##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)
but highly##5##2##(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
but his##2##2##(1990-11#1)(1991-11#1)
but if##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
but in a##3##3##(1991-7#1)(2008-10#1)(2011-2#1)
but in addition##3##3##(2008-10#2)(2009-7#1)
but in all##2##3##(1993-2#1)(2008-5#1)
but in fact##2##3##(1997-3#1)(2013-1#1)
but in general##2##3##(1996-9#1)(2008-9#1)
but in only##2##3##(2008-7#1)(2008-8#1)
but in the absence of##2##5##(2008-4#1)(2008-8#1)
but in the case of##4##5##(1993-6#1)(2008-10#3)
but in the conventional tillage treatment##2##6##(2008-10#2)
but in the present##2##4##(1990-5#1)(2008-11#1)
but in the##24##3##(1990-5#1)(1991-2#1)(1993-6#1)(1995-6#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
but in##71##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-3#1)(2008-10#19)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
but increased during##2##3##(2008-7#1)(2008-8#1)
but increased in##2##3##(2008-11#1)(2012-8#1)
but increased##14##2##(1992-6#1)(1994-6#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2012-4#1)(2012-8#1)(2013-1#1)
but increases##5##2##(1995-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
but independent##4##2##(1994-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
but induces##2##2##(1997-6#1)(2008-7#1)
but inhibited by##2##3##(1993-6#1)(1997-1#1)
but inhibited##6##2##(1991-5#1)(1993-12#1)(1993-6#1)(1997-1#1)(2008-10#1)(2009-3#1)
but inhibits##2##2##(1993-8#1)(1994-11#1)
but instead##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
but is a##3##3##(1993-12#1)(2008-10#1)(2009-7#1)
but is absent##2##3##(2008-10#1)(2013-8#1)
but is also##5##3##(1994-9#1)(1996-12#1)(1997-2#1)(2012-3#2)
but is expected to##2##4##(1997-6#1)(2011-2#1)
but is not always##2##4##(2008-11#2)
but is not the##2##4##(2008-10#2)
but is not##13##3##(1992-6#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)
but is##68##2##(1990-9#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-9#3)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-6#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
but it also##5##3##(1990-11#1)(1993-2#1)(2008-10#1)(2008-9#1)(2009-10#1)
but it can also##3##4##(2008-12#1)(2008-9#1)(2013-1#1)
but it can##6##3##(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#3)
but it did not##3##4##(2008-10#2)(2008-11#1)
but it did##4##3##(2008-10#2)(2008-11#2)
but it does not##2##4##(2008-10#1)(2008-5#1)
but it does##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
but it has no##2##4##(1997-7#1)(2008-10#1)
but it has##5##3##(1997-7#1)(2008-10#2)(2008-5#1)(2012-2#1)
but it is also##2##4##(2008-4#1)(2009-8#1)
but it is necessary##2##4##(2008-10#1)(2010-7#1)
but it is still##2##4##(2008-7#1)(2008-8#1)
but it is unclear##2##4##(2013-1#1)(2013-8#1)
but it is##25##3##(1992-12#1)(1994-12#2)(1996-5#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#3)(2013-8#1)
but it may also be##2##5##(2008-10#1)(2008-8#1)
but it may##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
but it remains##2##3##(2008-8#2)
but it should be##3##4##(2008-10#1)(2010-5#1)(2011-1#1)
but it was not##5##4##(1991-3#1)(2008-10#2)(2008-11#2)
but it was##13##3##(1991-3#1)(1994-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-9#1)(2010-11#1)(2012-2#1)
but it##94##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-12#3)(1994-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-7#2)(2008-10#20)(2008-11#11)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#6)(2008-9#5)(2009-10#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#1)
but its concentration##2##3##(1991-5#1)(2008-11#1)
but its expression is##2##4##(2007-12#1)(2008-11#1)
but its expression##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
but its function##2##3##(1993-3#1)(2012-2#1)
but its role in the##3##5##(1995-2#1)(2012-2#1)(2013-1#1)
but its role in##4##4##(1994-11#1)(1995-2#1)(2012-2#1)(2013-1#1)
but its role##6##3##(1994-11#1)(1995-2#1)(1997-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
but its##35##2##(1990-2#1)(1991-5#1)(1993-3#1)(1994-1#1)(1994-11#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#3)
but lack##5##2##(1993-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)
but lacked##2##2##(1990-7#1)(2008-10#1)
but lacking a##2##3##(1997-1#1)(2010-8#1)
but lacking##4##2##(1997-1#1)(2008-12#2)(2010-8#1)
but lacks the##3##3##(1996-6#1)(2009-9#1)(2010-5#1)
but large##2##2##(2008-10#1)(2008-11#1)
but largely##2##2##(1992-1#1)(2010-6#1)
but later##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
but less than##2##3##(1990-12#1)(2008-10#1)
but less##17##2##(1990-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2013-1#1)
but levels##2##2##(1995-12#1)(2010-8#1)
but limited##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
but limits##2##2##(2008-10#1)(2008-12#1)
but little is known about the##3##6##(2012-2#1)(2012-3#1)(2013-1#1)
but little is known about##6##5##(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
but little or no##4##4##(2008-10#4)
but little##13##2##(1991-8#1)(1996-3#1)(2008-10#4)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
but low##6##2##(1990-8#1)(1992-3#1)(2008-10#2)(2008-7#1)(2008-9#1)
but lower##3##2##(1995-1#1)(2008-9#1)(2013-1#1)
but maintained##2##2##(1993-8#1)(2008-11#1)
but many##4##2##(2008-10#1)(2008-7#2)(2010-10#1)
but marked##2##2##(1991-6#1)(2008-9#1)
but markedly##3##2##(1994-3#1)(2008-10#1)(2013-8#1)
but may also be##2##4##(2012-2#1)(2012-3#1)
but may also##4##3##(1990-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
but may be an##2##4##(2011-2#1)(2013-1#1)
but may be##10##3##(1992-3#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
but may instead reflect##2##4##(1996-2#1)(2008-11#1)
but may##31##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
but might##2##2##(1996-2#1)(2008-11#1)
but moderate##2##2##(2008-10#2)
but more##21##2##(1990-11#1)(1994-5#1)(1996-5#1)(1996-6#1)(1997-5#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#2)(2010-2#1)(2013-8#1)
but morphologically##2##2##(2011-2#1)(2012-3#1)
but most of the##2##4##(1992-2#1)(1995-9#1)
but most of them##2##4##(2008-10#1)(2012-4#1)
but most of##4##3##(1992-2#1)(1995-9#1)(2008-10#1)(2012-4#1)
but most##12##2##(1992-2#1)(1992-3#1)(1995-9#1)(1997-1#1)(1997-9#1)(2008-10#3)(2008-12#1)(2008-9#2)(2012-4#1)
but mostly##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
but much##3##2##(1995-5#1)(2009-7#1)(2011-2#1)
but must be##2##3##(2008-10#1)(2013-1#1)
but nearly##2##2##(1995-8#1)(2010-4#1)
but necessary##3##2##(1991-12#1)(1994-2#1)(2011-2#1)
but negative for##2##3##(1991-6#1)(2008-11#1)
but negative##4##2##(1991-6#1)(1997-2#1)(2008-11#1)(2009-9#1)
but neither##7##2##(2008-10#4)(2008-5#1)(2009-1#1)(2011-2#1)
but never in##2##3##(2008-10#2)
but never##5##2##(1994-2#1)(1994-5#1)(2008-10#3)
but nevertheless##2##2##(1995-12#1)(2009-8#1)
but new##3##2##(1997-5#1)(2008-10#1)(2012-3#1)
but no apothecia of##2##4##(2008-10#2)
but no detectable##2##3##(2008-8#1)(2009-6#1)
but no difference##2##3##(2008-7#1)(2008-9#1)
but no differences##2##3##(1990-8#1)(2008-11#1)
but no evidence of##4##4##(1991-1#1)(1996-12#1)(2009-1#1)(2010-4#1)
but no evidence##6##3##(1991-1#1)(1996-12#1)(2008-10#1)(2009-1#1)(2010-4#1)(2011-2#1)
but no general##2##3##(1991-12#1)(2008-9#1)
but no greater##2##3##(1995-2#1)(1995-3#1)
but no increase in##2##4##(2008-10#2)
but no obvious difference##2##4##(1995-3#1)(2008-11#1)
but no significant changes were##2##5##(2008-10#1)(2012-3#1)
but no significant difference##2##4##(1993-6#1)(2008-7#1)
but no significant differences were found##2##6##(1993-2#1)(2011-3#1)
but no significant differences were##3##5##(1993-2#1)(2008-10#1)(2011-3#1)
but no significant##13##3##(1993-2#2)(1993-6#1)(2008-10#4)(2008-7#1)(2008-8#1)(2011-3#1)(2012-3#1)(2013-8#2)
but no such##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
but no##91##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-2#2)(1993-6#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-8#1)(2008-10#28)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2011-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
but none of the analytes##2##5##(2008-10#2)
but none of the##4##4##(2008-10#2)(2012-2#1)(2013-8#1)
but none of##5##3##(1995-12#1)(2008-10#2)(2012-2#1)(2013-8#1)
but none was##2##3##(1990-5#1)(2011-1#1)
but none##16##2##(1990-5#1)(1994-2#1)(1995-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
but not B##2##3##(1991-1#1)(2008-10#1)
but not DMNQ##2##3##(2009-9#2)
but not N##2##3##(2008-10#2)
but not a##4##3##(1995-6#1)(2008-10#2)(2008-11#1)
but not accounted for##2##4##(2008-12#2)
but not after##2##3##(1993-12#1)(2008-5#1)
but not all##17##3##(1991-10#1)(1992-6#1)(1993-3#1)(1995-1#1)(1997-9#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#3)
but not always##2##3##(2008-10#1)(2008-11#1)
but not among##2##3##(2008-11#1)(2012-2#1)
but not any##2##3##(2008-10#1)(2008-11#1)
but not as a##3##4##(2008-12#1)(2008-5#2)
but not at 50 mg/kg##2##5##(1991-12#2)
but not at##18##3##(1991-11#1)(1991-12#2)(1991-2#1)(1993-3#1)(1994-5#1)(1995-8#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-8#1)
but not between plasma##2##4##(1994-8#1)(2008-7#1)
but not between##4##3##(1994-8#1)(2008-7#1)(2008-8#1)(2010-9#1)
but not by a##2##4##(1994-2#2)
but not by phorbol##2##4##(1994-11#1)(1996-2#1)
but not by the##2##4##(1996-2#1)(2008-10#1)
but not by##45##3##(1992-12#1)(1992-3#2)(1992-8#2)(1993-3#2)(1993-8#2)(1994-11#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#3)(1997-7#1)(2008-10#10)(2008-11#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-9#1)(2010-5#1)
but not completely##3##3##(2008-11#1)(2010-8#1)(2013-8#1)
but not enough to##3##4##(1994-1#1)(2008-10#1)(2008-11#1)
but not exclusively##2##3##(1990-5#1)(2008-4#1)
but not for the##2##4##(1996-2#1)(2008-10#1)
but not for those##2##4##(1993-11#1)(2009-7#1)
but not for##25##3##(1990-12#1)(1990-5#1)(1992-6#1)(1993-11#1)(1993-8#1)(1996-2#2)(1997-3#1)(2008-10#8)(2008-8#1)(2008-9#2)(2009-7#2)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
but not from the##2##4##(1990-5#1)(1996-12#1)
but not from##9##3##(1990-5#1)(1994-12#1)(1996-12#1)(2008-10#4)(2008-7#1)(2009-9#1)
but not healthy##2##3##(2008-10#2)
but not hematopoietic##2##3##(2010-8#2)
but not in a##2##4##(1994-11#1)(2008-10#1)
but not in cerebellum##2##4##(1997-2#2)
but not in females##2##4##(1994-6#1)(2013-8#1)
but not in human##2##4##(1997-1#1)(2008-10#1)
but not in liver##2##4##(1996-12#1)(2008-8#1)
but not in maize leaves showing##2##6##(2008-10#2)
but not in normal##2##4##(2008-8#1)(2011-2#1)
but not in old ones##2##5##(2008-7#2)
but not in the hippocampus##2##5##(2008-11#2)
but not in the other##2##5##(2008-5#1)(2013-8#1)
but not in the##39##4##(1990-5#1)(1991-1#1)(1991-2#1)(1992-1#1)(1993-8#1)(1994-8#1)(1995-6#1)(1995-8#2)(1997-7#1)(2008-10#10)(2008-11#4)(2008-5#4)(2008-7#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
but not in their##2##4##(1995-2#1)(2008-8#1)
but not in##136##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-7#2)(2008-10#41)(2008-11#9)(2008-12#1)(2008-5#5)(2008-7#6)(2008-8#6)(2008-9#4)(2009-1#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-10#1)(2011-2#5)(2013-1#2)(2013-7#1)(2013-8#3)
but not least##2##3##(1991-3#1)(2008-11#1)
but not mRNA##2##3##(1994-2#2)
but not more##2##3##(2008-8#1)(2008-9#1)
but not normal##2##3##(1992-3#1)(2011-2#1)
but not nuclear##2##3##(1990-8#1)(1994-6#1)
but not of##10##3##(1990-5#2)(1993-3#1)(1995-8#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2010-11#1)
but not on the##3##4##(1992-6#1)(1993-1#1)(2008-10#1)
but not on##17##3##(1991-2#1)(1991-5#1)(1992-6#1)(1993-1#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-10#7)(2008-5#1)(2008-8#1)(2013-8#1)
but not other##2##3##(1994-8#2)
but not overall##2##3##(2008-8#1)(2011-2#1)
but not significantly##4##3##(1993-3#1)(1997-7#2)(2008-3#1)
but not that of the##2##5##(1991-7#1)(2008-10#1)
but not that of##5##4##(1991-7#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-11#1)
but not that##8##3##(1991-7#1)(1992-10#1)(1993-9#1)(1994-11#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-11#1)
but not the mutant##2##4##(1990-5#1)(1995-6#1)
but not the other##2##4##(1990-5#1)(2008-9#1)
but not the##43##3##(1990-5#3)(1991-8#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#1)
but not through##2##3##(2008-8#1)(2010-8#1)
but not to other##2##4##(1997-3#1)(2012-12#1)
but not to##22##3##(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-8#1)
but not vice versa##2##4##(2009-7#1)(2012-2#1)
but not when##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
but not with HbA1c level##2##5##(2012-5#2)
but not with a##3##4##(2008-10#1)(2008-5#2)
but not with either##2##4##(1997-4#1)(2008-10#1)
but not with the##3##4##(1997-7#1)(2008-10#1)(2013-8#1)
but not with##25##3##(1990-5#2)(1993-12#1)(1993-6#2)(1994-2#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-8#1)(2010-1#1)(2012-4#1)(2012-5#2)(2013-8#1)
but not within##3##3##(1997-9#1)(2008-10#2)
but not yet##3##3##(1994-9#1)(2008-10#1)(2008-7#1)
but not##645##2##(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#13)(1990-8#5)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-3#3)(1992-6#5)(1992-8#3)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#5)(1993-3#11)(1993-6#6)(1993-8#6)(1993-9#2)(1994-1#1)(1994-11#6)(1994-12#2)(1994-2#9)(1994-3#3)(1994-5#6)(1994-6#7)(1994-8#8)(1994-9#2)(1995-1#1)(1995-11#8)(1995-12#2)(1995-2#11)(1995-3#1)(1995-6#6)(1995-8#9)(1996-12#12)(1996-2#13)(1996-3#2)(1996-5#2)(1996-6#2)(1997-1#3)(1997-2#8)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#9)(1997-8#1)(1997-9#3)(2006-6#1)(2007-12#1)(2008-10#158)(2008-11#46)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#16)(2008-8#26)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#5)(2009-7#6)(2009-8#5)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#4)(2010-3#1)(2010-5#3)(2010-8#8)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#4)(2012-4#1)(2012-5#2)(2013-1#5)(2013-7#1)(2013-8#11)
but now##2##2##(1997-7#1)(2012-2#1)
but of##3##2##(1991-12#1)(2008-4#1)(2011-7#1)
but often##7##2##(1991-11#1)(1991-3#1)(1997-4#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
but on the##2##3##(2009-12#1)(2011-2#1)
but on##3##2##(2009-12#1)(2011-2#1)(2012-3#1)
but one of the nonpathogenic isolates##2##6##(2008-10#2)
but one of the##10##4##(1992-3#1)(2007-12#1)(2008-10#6)(2008-9#1)(2009-11#1)
but one patient##2##3##(2008-11#1)(2011-2#1)
but one##29##2##(1990-12#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-2#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-2#2)(2013-1#1)
but only 2##2##3##(2008-10#1)(2008-9#1)
but only 3##2##3##(1997-7#1)(2008-10#1)
but only a few##3##4##(2008-10#1)(2008-8#1)(2012-2#1)
but only a##5##3##(2008-10#2)(2008-8#2)(2012-2#1)
but only at##2##3##(1990-2#1)(2008-3#1)
but only by##2##3##(1990-3#1)(2008-10#1)
but only for##2##3##(1997-4#1)(2008-10#1)
but only if##2##3##(1991-1#1)(2008-11#1)
but only in the##4##4##(1991-5#1)(2008-10#3)
but only in##9##3##(1990-2#1)(1991-5#1)(1994-8#1)(1996-12#1)(2008-10#3)(2008-11#1)(2012-4#1)
but only on##2##3##(2008-10#1)(2008-8#1)
but only one##3##3##(1992-3#1)(1992-5#1)(2008-5#1)
but only rarely##2##3##(2008-10#2)
but only the##2##3##(1995-8#1)(2008-10#1)
but only three##2##3##(2008-10#1)(2008-9#1)
but only two of them##2##5##(2008-10#1)(2008-5#1)
but only two##3##3##(1991-6#1)(2008-10#1)(2008-5#1)
but only when##3##3##(2008-10#2)(2013-1#1)
but only##91##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#33)(2008-11#5)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)
but other##10##2##(1990-11#1)(1990-5#1)(1992-9#1)(1997-5#1)(2008-10#2)(2008-8#1)(2010-1#1)(2012-2#1)(2013-1#1)
but others##2##2##(1997-6#1)(2008-5#1)
but otherwise##5##2##(2008-10#1)(2008-7#2)(2013-1#2)
but over##2##2##(1996-3#1)(2008-9#1)
but oxendolone##2##2##(1990-11#2)
but partial##2##2##(1992-7#1)(2008-10#1)
but particularly in##2##3##(1995-2#1)(2008-7#1)
but patients treated with##2##4##(1997-3#1)(2012-12#1)
but patients##3##2##(1990-8#1)(1997-3#1)(2012-12#1)
but perceived##2##2##(2008-9#1)(2013-8#1)
but persistent##3##2##(1992-6#1)(1994-6#1)(1997-3#1)
but poorly##2##2##(1992-6#1)(2011-2#1)
but population##2##2##(2008-10#2)
but possessed##2##2##(1991-5#1)(2008-10#1)
but potentially serious##2##3##(2011-2#1)(2012-3#1)
but potentially##6##2##(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
but presented##2##2##(2008-10#1)(2013-1#1)
but prior to##2##3##(1994-11#1)(1994-12#1)
but probably##4##2##(1991-11#1)(1993-11#1)(2008-10#2)
but production was##2##3##(2008-10#2)
but production##3##2##(2008-10#3)
but progressive##2##2##(1991-2#1)(2012-3#1)
but ranged from##2##3##(2008-10#2)
but rare##2##2##(2008-5#1)(2008-7#1)
but rarely##8##2##(1993-12#1)(1996-11#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
but rather a##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
but rather are##2##3##(2008-10#1)(2012-3#1)
but rather by##2##3##(1993-8#1)(2008-11#1)
but rather due to##2##4##(1990-5#1)(2008-9#1)
but rather to provide##2##4##(2008-10#1)(2011-2#1)
but rather to the##2##4##(2008-10#1)(2009-10#1)
but rather to##9##3##(1992-12#1)(2008-10#3)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#2)
but rather##41##2##(1990-11#1)(1990-5#2)(1991-5#1)(1992-12#1)(1993-8#1)(1994-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
but reacted##2##2##(2008-10#2)
but recent##6##2##(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
but recovered##2##2##(2008-10#2)
but reduced the##2##3##(1990-3#1)(2011-2#1)
but reduced##6##2##(1990-3#1)(1994-3#1)(1994-6#1)(1997-3#1)(2008-10#1)(2011-2#1)
but reductions##2##2##(1995-12#1)(2008-11#1)
but related##3##2##(1994-11#1)(2008-11#1)(2008-8#1)
but relatively##5##2##(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)
but remain##3##2##(2008-10#3)
but remained##3##2##(1994-5#1)(2008-10#1)(2013-1#1)
but remains##3##2##(1993-6#1)(1996-2#1)(2008-10#1)
but reproducible##3##2##(2008-10#3)
but require##3##2##(1995-5#1)(2008-10#1)(2009-12#1)
but required##2##2##(2012-2#1)(2013-1#1)
but requires##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
but resistance##2##2##(2008-10#1)(2008-11#1)
but resistant to##4##3##(2008-10#4)
but resulted in##2##3##(2008-10#1)(2009-6#1)
but results in##2##3##(1994-11#1)(2010-7#1)
but results##3##2##(1994-11#1)(2009-10#1)(2010-7#1)
but retained##3##2##(2008-10#1)(2008-5#1)(2010-11#1)
but retaining##2##2##(1993-8#1)(1995-2#1)
but rhizosphere##2##2##(2008-10#1)(2013-8#1)
but scientific##3##2##(2008-10#2)(2013-1#1)
but seldom##2##2##(1995-12#1)(2010-11#1)
but sensitive to##2##3##(2008-10#2)
but serious##2##2##(2008-11#1)(2013-1#1)
but serum##3##2##(2008-5#1)(2008-6#1)(2012-3#1)
but several##3##2##(1991-5#1)(1994-3#1)(2008-10#1)
but should be carried out over time##2##7##(2011-1#1)(2011-2#1)
but should##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
but show##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
but showed a##3##3##(2008-10#3)
but showed no##2##3##(1994-11#1)(2008-9#1)
but showed##9##2##(1990-11#1)(1994-11#1)(1994-8#1)(2008-10#5)(2008-9#1)
but shows##3##2##(1996-12#1)(2011-2#1)(2012-3#1)
but significant decrease##2##3##(2008-10#1)(2008-11#1)
but significant increases in##3##4##(1990-3#1)(1995-11#1)(2008-10#1)
but significant increases##4##3##(1990-3#1)(1995-11#1)(2008-10#1)(2013-8#1)
but significant##21##2##(1990-11#1)(1990-3#1)(1991-5#1)(1991-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
but significantly enhanced##2##3##(1997-4#1)(2008-10#1)
but significantly greater##4##3##(2008-10#3)(2009-7#1)
but significantly higher##2##3##(2008-10#1)(2013-8#1)
but significantly increased##2##3##(1995-12#1)(2008-7#1)
but significantly reduced##2##3##(1994-3#1)(2008-10#1)
but significantly##20##2##(1990-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-4#1)(2008-10#8)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
but similar##3##2##(1996-6#1)(1997-3#1)(2008-5#1)
but slowed##2##2##(1996-3#1)(2008-7#1)
but so##2##2##(1994-3#1)(2008-3#1)
but some##13##2##(1990-2#1)(1991-12#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
but sometimes##3##2##(2008-10#2)(2008-5#1)
but statistically significant##8##3##(1992-2#1)(1996-8#2)(2008-10#3)(2009-3#1)(2011-2#1)
but steadily##2##2##(1993-6#1)(2008-10#1)
but still##20##2##(1990-10#1)(1993-3#1)(1996-11#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
but stronger##2##2##(1995-1#1)(2008-10#1)
but strongly##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
but studies of##2##3##(1990-12#1)(2008-9#1)
but subsequently##2##2##(1994-8#1)(2010-7#1)
but such a##2##3##(1992-9#1)(2009-6#1)
but such##6##2##(1992-12#1)(1992-9#1)(2008-10#2)(2008-5#1)(2009-6#1)
but suffer from##2##3##(1990-11#1)(2012-2#1)
but suggest that##2##3##(1991-12#1)(1997-2#1)
but suggests that##2##3##(2008-10#1)(2008-11#1)
but susceptible to##2##3##(2008-10#2)
but susceptible##3##2##(2008-10#3)
but tended to##2##3##(1993-8#1)(2008-10#1)
but that at##2##3##(2008-10#1)(2008-7#1)
but that important##2##3##(1994-11#1)(2008-11#1)
but that it is##4##4##(1992-6#1)(1993-9#1)(2008-3#1)(2010-5#1)
but that it##8##3##(1992-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-3#1)(2010-5#1)
but that of##9##3##(1990-3#1)(2008-10#2)(2008-11#1)(2008-8#3)(2010-6#1)(2012-2#1)
but that the##3##3##(1994-2#1)(2008-5#1)(2012-2#1)
but that there is a##2##5##(1992-12#1)(2011-2#1)
but that this##2##3##(2008-10#1)(2008-7#1)
but that##64##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#6)(2008-9#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#4)(2013-8#2)
but the ability##2##3##(1992-6#1)(2008-7#1)
but the amounts were##2##4##(2008-10#2)
but the appearance of##2##4##(1992-2#1)(1994-5#1)
but the binding was##2##4##(1993-6#1)(2010-5#1)
but the calculation##2##3##(2008-10#1)(2013-1#1)
but the causal##2##3##(2008-10#2)
but the concentration##2##3##(2008-10#2)
but the data##2##3##(1994-9#1)(2013-1#1)
but the degree of##2##4##(1995-11#1)(2008-10#1)
but the detection limits##2##4##(2008-10#2)
but the detection##3##3##(2008-10#2)(2010-12#1)
but the differences were not statistically significant##2##7##(2008-1#1)(2008-10#1)
but the differences were not##3##5##(1992-2#1)(2008-1#1)(2008-10#1)
but the differences##4##3##(1992-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
but the distribution##2##3##(2008-10#2)
but the effect is##2##4##(2008-5#1)(2011-2#1)
but the effect of##5##4##(1996-2#1)(2008-10#3)(2011-2#1)
but the effect##9##3##(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
but the effects of##3##4##(1997-4#1)(2008-10#1)(2009-9#1)
but the effects##4##3##(1997-4#1)(2008-10#2)(2009-9#1)
but the enzyme##2##3##(1991-9#1)(1992-3#1)
but the expression of##3##4##(1995-12#1)(2011-2#1)(2011-3#1)
but the expression##4##3##(1995-12#1)(2008-8#1)(2011-2#1)(2011-3#1)
but the extent##2##3##(2008-10#2)
but the first##2##3##(1997-3#1)(2008-11#1)
but the formation of##2##4##(1993-3#1)(2007-12#1)
but the former##3##3##(1992-6#1)(2011-2#1)(2012-3#1)
but the function of these##2##5##(2008-9#1)(2013-1#1)
but the function of##4##4##(2008-9#3)(2013-1#1)
but the genetic##2##3##(1996-12#1)(2012-3#1)
but the highest##2##3##(2008-10#1)(2008-11#1)
but the isolates##2##3##(2008-10#2)
but the latter##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
but the levels##5##3##(1992-2#1)(2008-10#3)(2011-2#1)
but the mechanism by which these##2##6##(1994-11#1)(2008-11#1)
but the mechanism of##4##4##(1993-9#1)(1995-6#1)(2008-5#1)(2009-12#1)
but the mechanism##6##3##(1993-9#1)(1994-11#1)(1995-6#1)(2008-11#1)(2008-5#1)(2009-12#1)
but the mechanisms##5##3##(1996-11#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)
but the molecular##2##3##(2008-11#1)(2013-1#1)
but the most##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
but the nature of##2##4##(2008-5#1)(2011-2#1)
but the number of##2##4##(2008-8#1)(2013-1#1)
but the opposite##2##3##(2008-10#1)(2008-7#1)
but the other##3##3##(2008-10#2)(2011-2#1)
but the patient##3##3##(1997-4#1)(2011-3#1)(2013-8#1)
but the peak##2##3##(1992-9#1)(2008-10#1)
but the presence of##3##4##(2008-11#1)(2008-7#1)(2010-4#1)
but the principles##3##3##(2008-4#1)(2010-12#1)(2011-2#1)
but the procedure is##2##4##(2008-9#1)(2011-2#1)
but the process of##2##4##(1993-6#1)(2011-2#1)
but the process##4##3##(1992-3#1)(1993-6#1)(2008-10#1)(2011-2#1)
but the rate at which##2##5##(2010-12#1)(2013-8#1)
but the rate##4##3##(1990-9#1)(2008-10#1)(2010-12#1)(2013-8#1)
but the reduction##2##3##(2008-10#1)(2008-7#1)
but the relative##2##3##(2008-10#1)(2012-3#1)
but the remaining##2##3##(2008-10#1)(2013-8#1)
but the response##2##3##(1995-8#1)(2008-7#1)
but the results##4##3##(1994-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
but the same##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
but the sequences##2##3##(1992-3#1)(2008-9#1)
but the specific##2##3##(2008-11#1)(2010-2#1)
but the two##4##3##(1995-11#1)(2008-10#1)(2010-4#1)(2012-2#1)
but the underlying##2##3##(1993-1#1)(2012-2#1)
but the use of##6##4##(2008-10#3)(2012-12#1)(2013-1#2)
but the##377##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#5)(1992-3#3)(1992-4#1)(1992-6#3)(1992-9#3)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#112)(2008-11#27)(2008-12#5)(2008-3#5)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#13)(2008-8#9)(2008-9#18)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#22)(2011-3#3)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#12)(2013-8#7)
but their effect on##2##4##(2008-7#1)(2013-1#1)
but their##30##2##(1991-8#1)(1993-9#1)(1994-6#1)(1995-12#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
but then##3##2##(2008-10#1)(2009-8#1)(2010-5#1)
but there are few##2##4##(1993-2#1)(1994-6#1)
but there are several##2##4##(1993-3#1)(2010-6#1)
but there are##7##3##(1993-2#1)(1993-3#1)(1994-6#1)(2008-9#1)(2010-6#2)(2013-8#1)
but there has been no##4##5##(1990-6#1)(2008-11#1)(2008-7#1)(2008-9#1)
but there has been##6##4##(1990-6#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
but there have been few##2##5##(2008-9#1)(2012-3#1)
but there have been##4##4##(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)
but there is a##5##4##(1994-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)
but there is evidence##2##4##(1992-7#1)(2012-2#1)
but there is no significant##2##5##(2008-9#1)(2009-5#1)
but there is no##6##4##(2008-11#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
but there is still a need for##2##7##(2008-5#1)(2013-1#1)
but there is still##6##4##(1990-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
but there is##25##3##(1990-9#1)(1992-7#1)(1994-6#1)(1994-8#1)(1996-8#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
but there was a##5##4##(1990-5#1)(1995-8#1)(2007-12#1)(2010-1#1)(2010-6#1)
but there was no correlation##2##5##(2011-2#2)
but there was no evidence of##2##6##(1991-1#1)(1991-6#1)
but there was no significant##3##5##(2008-10#1)(2008-11#1)(2013-1#1)
but there was no##11##4##(1991-1#1)(1991-3#1)(1991-6#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
but there was##23##3##(1990-5#1)(1991-1#1)(1991-3#1)(1991-6#1)(1994-3#1)(1995-2#1)(1995-8#2)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2009-4#1)(2010-1#1)(2010-6#1)(2011-2#3)(2013-1#1)
but there were no##2##4##(2008-10#1)(2008-12#1)
but there were significant##2##4##(2008-10#1)(2008-12#1)
but there were##8##3##(1990-9#1)(2008-10#4)(2008-12#2)(2008-9#1)
but there##76##2##(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-3#1)(1991-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-8#2)(1996-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#7)(2008-12#5)(2008-5#2)(2008-7#3)(2008-9#6)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-6#3)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
but these were not##3##4##(2008-10#3)
but these were##5##3##(1990-12#1)(2008-10#4)
but these##22##2##(1990-12#1)(1991-1#1)(1991-6#1)(1992-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
but they also##3##3##(1995-12#1)(2008-7#1)(2010-2#1)
but they are also##2##4##(2008-11#1)(2013-1#1)
but they are##10##3##(1994-3#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-12#1)(2010-5#1)(2013-1#1)
but they can be##2##4##(2008-10#1)(2008-4#1)
but they could##2##3##(1996-6#1)(2009-7#1)
but they do not##3##4##(2008-10#1)(2008-11#1)(2009-11#1)
but they have##4##3##(1993-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
but they may##3##3##(1994-8#1)(2008-5#1)(2013-1#1)
but they were not##3##4##(2008-10#2)(2013-1#1)
but they were##12##3##(1995-12#1)(1997-3#1)(2008-10#6)(2008-12#1)(2008-7#1)(2013-1#2)
but they##53##2##(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-6#1)(1997-3#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#5)
but this did not##2##4##(2008-7#1)(2008-9#1)
but this effect was##5##4##(1997-1#1)(2008-10#3)(2008-12#1)
but this effect##6##3##(1997-1#1)(2008-10#3)(2008-12#1)(2008-8#1)
but this is##6##3##(1993-9#1)(2008-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
but this may be##3##4##(1993-1#1)(2006-6#1)(2008-7#1)
but this may##4##3##(1993-1#1)(2006-6#1)(2008-11#1)(2008-7#1)
but this was not##3##4##(1997-1#1)(2008-12#1)(2013-1#1)
but this was##4##3##(1997-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
but this##51##2##(1990-6#1)(1990-8#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-8#1)(1993-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1997-1#2)(2006-6#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-7#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
but those of##2##3##(2008-10#1)(2008-6#1)
but those##6##2##(1992-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-6#1)
but time##2##2##(2008-11#1)(2013-8#1)
but to a lesser degree##2##5##(1994-8#1)(2008-3#1)
but to a lesser extent than##2##6##(1995-8#1)(2012-2#1)
but to a lesser extent##3##5##(1995-6#1)(1995-8#1)(2012-2#1)
but to a lesser##5##4##(1994-8#1)(1995-6#1)(1995-8#1)(2008-3#1)(2012-2#1)
but to a##11##3##(1990-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2012-2#1)
but to date##2##3##(2008-7#1)(2008-8#1)
but to the##3##3##(1996-1#1)(2008-11#1)(2008-8#1)
but to##28##2##(1990-11#1)(1990-3#1)(1994-1#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2010-10#1)(2012-2#3)(2013-7#1)(2013-8#1)
but took##2##2##(1991-3#1)(2008-10#1)
but transient##3##2##(1996-12#2)(1997-1#1)
but treatment with##2##3##(2008-12#1)(2011-2#1)
but two patients##2##3##(1993-2#1)(2008-9#1)
but two##10##2##(1993-2#2)(2007-12#1)(2008-10#4)(2008-9#1)(2011-2#1)(2012-3#1)
but ultimately##2##2##(2008-11#1)(2009-6#1)
but unknown##2##2##(2008-10#2)
but until recently##2##3##(2011-7#1)(2012-3#1)
but unwanted##2##2##(1992-2#1)(2009-12#1)
but up to##2##3##(2008-5#1)(2008-9#1)
but up##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
but use##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
but useful##3##2##(2008-7#1)(2011-10#1)(2013-8#1)
but using##2##2##(2008-10#2)
but usually##2##2##(2007-12#1)(2008-7#1)
but values##2##2##(2010-8#1)(2012-2#1)
but variable##2##2##(1996-2#1)(2008-10#1)
but very low##2##3##(2008-10#2)
but very##9##2##(1993-8#1)(1994-2#1)(2007-11#1)(2008-10#4)(2008-5#1)(2012-2#1)
but was absent from##2##4##(1994-11#1)(2008-10#1)
but was found##2##3##(1992-12#1)(2013-1#1)
but was ineffective##2##3##(2008-10#2)
but was lower##2##3##(1990-5#1)(1992-3#1)
but was not as effective as##2##6##(2008-10#1)(2013-1#1)
but was not##16##3##(1991-12#1)(1997-3#2)(2008-10#7)(2008-12#1)(2008-9#2)(2011-2#1)(2013-1#2)
but was reduced by##3##4##(1993-6#1)(1996-2#1)(2008-10#1)
but was significantly lower##2##4##(2008-10#1)(2011-2#1)
but was unchanged##2##3##(1990-5#1)(1994-2#1)
but was weakly related to##2##5##(2008-10#2)
but was##77##2##(1990-5#2)(1991-12#1)(1991-5#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#2)(1997-3#3)(2007-12#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
but we##7##2##(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-6#1)
but weak##3##2##(1996-12#1)(1997-3#1)(2011-2#1)
but weakly##3##2##(1992-10#1)(2008-8#1)(2008-9#1)
but well##4##2##(1992-3#1)(2008-10#1)(2008-7#1)(2010-10#1)
but were ineffective against##2##4##(1994-6#1)(2008-10#1)
but were less##2##3##(2008-10#1)(2008-8#1)
but were more##3##3##(1994-11#1)(2008-10#1)(2008-12#1)
but were not detected##2##4##(1994-8#1)(2008-10#1)
but were not##7##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)
but were significantly##3##3##(2008-10#2)(2012-5#1)
but were##49##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#3)(2012-5#1)(2013-1#1)(2013-8#1)
but when the##3##3##(2008-5#1)(2009-5#1)(2010-1#1)
but when##18##2##(1993-6#1)(1996-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-7#1)(2010-9#1)
but where hybrids are##2##4##(2013-1#2)
but where##4##2##(1991-9#1)(2008-5#1)(2013-1#2)
but whether##3##2##(1997-1#1)(1997-7#1)(2013-7#1)
but which##8##2##(1991-5#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
but who##2##2##(2012-2#1)(2013-1#1)
but will not##2##3##(2008-10#1)(2008-11#1)
but will##7##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-2#1)
but with a##8##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
but with different##5##3##(2008-10#4)(2008-5#1)
but with higher##2##3##(2008-10#1)(2008-11#1)
but with the##7##3##(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-8#1)
but with##46##2##(1990-11#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-8#1)(1997-2#1)(2006-6#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#2)
but without the##4##3##(2008-10#2)(2011-2#1)(2012-2#1)
but without##14##2##(1991-12#1)(1996-11#1)(1997-7#1)(2008-10#4)(2009-8#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
but##4439##1##(1990-10#2)(1990-11#21)(1990-12#25)(1990-2#11)(1990-3#14)(1990-4#1)(1990-5#37)(1990-6#5)(1990-7#1)(1990-8#12)(1990-9#6)(1991-1#9)(1991-10#2)(1991-11#8)(1991-12#24)(1991-2#20)(1991-3#17)(1991-4#1)(1991-5#23)(1991-6#23)(1991-7#5)(1991-8#8)(1991-9#10)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#17)(1992-2#9)(1992-3#25)(1992-4#2)(1992-5#5)(1992-6#26)(1992-7#2)(1992-8#4)(1992-9#10)(1993-1#11)(1993-11#7)(1993-12#20)(1993-2#13)(1993-3#27)(1993-5#1)(1993-6#30)(1993-8#24)(1993-9#11)(1994-1#8)(1994-11#21)(1994-12#19)(1994-2#34)(1994-3#23)(1994-5#30)(1994-6#21)(1994-8#28)(1994-9#13)(1995-1#8)(1995-10#1)(1995-11#29)(1995-12#24)(1995-2#45)(1995-3#8)(1995-5#11)(1995-6#26)(1995-8#31)(1995-9#3)(1996-1#7)(1996-11#7)(1996-12#34)(1996-2#41)(1996-3#17)(1996-5#12)(1996-6#9)(1996-8#4)(1996-9#5)(1997-1#27)(1997-2#26)(1997-3#37)(1997-4#10)(1997-5#6)(1997-6#12)(1997-7#25)(1997-8#19)(1997-9#4)(2006-6#7)(2007-11#1)(2007-12#21)(2008-1#6)(2008-10#1101)(2008-11#286)(2008-12#85)(2008-2#4)(2008-3#42)(2008-4#25)(2008-5#106)(2008-6#25)(2008-7#147)(2008-8#160)(2008-9#153)(2009-1#6)(2009-10#31)(2009-11#13)(2009-12#20)(2009-3#11)(2009-4#5)(2009-5#8)(2009-6#17)(2009-7#24)(2009-8#37)(2009-9#17)(2010-1#18)(2010-10#21)(2010-11#16)(2010-12#27)(2010-2#3)(2010-3#12)(2010-4#11)(2010-5#21)(2010-6#18)(2010-7#19)(2010-8#25)(2010-9#7)(2011-1#20)(2011-10#5)(2011-2#194)(2011-3#11)(2011-4#1)(2011-7#2)(2012-12#27)(2012-2#97)(2012-3#79)(2012-4#4)(2012-5#3)(2012-6#3)(2012-7#1)(2012-8#2)(2013-1#131)(2013-7#6)(2013-8#71)
butane gas abuse##2##3##(2011-2#2)
butane gas##3##2##(2011-2#3)
butane##7##1##(2008-10#2)(2008-11#1)(2011-2#4)
butanol##8##1##(2008-10#3)(2013-1#5)
butch##3##1##(2008-12#3)
butorphanol##4##1##(1991-1#1)(2010-7#2)(2012-3#1)
butter##2##1##(1990-8#1)(2008-10#1)
butterflies##5##1##(2008-8#1)(2008-9#2)(2013-1#2)
butterfly rash##2##2##(2013-1#2)
butterfly##14##1##(1997-8#2)(2008-8#8)(2008-9#1)(2012-3#1)(2013-1#2)
buttock##4##1##(2012-12#3)(2013-8#1)
button of columnar epithelium##2##4##(1991-2#2)
button##9##1##(1991-2#4)(2008-10#1)(2010-10#1)(2011-2#1)(2013-8#2)
buttressing bone formation##2##3##(2013-1#2)
buttressing bone##3##2##(2013-1#3)
butyl methoxy dibenzoyl methane##2##4##(2008-5#2)
butyl phosphonate (DBBP)##2##3##(2008-10#2)
butyl rhodamine B##4##3##(2008-10#4)
butyl##13##1##(1990-5#1)(2008-10#10)(2008-5#2)
butyl(3-hydroxybutyl)tin dilaurate##2##2##(1993-12#2)
butylated hydroxytoluene (BHT)##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
butylated hydroxytoluene##6##2##(1994-5#2)(2008-10#1)(2008-11#1)(2008-5#2)
butylated##8##1##(1994-5#2)(2008-10#3)(2008-11#1)(2008-5#2)
butyltin##5##1##(2008-10#3)(2008-11#2)
butyltins##3##1##(2008-10#3)
butyrate and##3##2##(1990-3#1)(1997-1#1)(2008-11#1)
butyrate in##2##2##(1990-3#1)(1990-6#1)
butyrate treatment##3##2##(1993-6#1)(2008-11#2)
butyrate##33##1##(1990-3#3)(1990-6#4)(1993-6#3)(1994-11#1)(1997-1#1)(2008-11#21)
butyrate)##2##1##(2008-11#2)
butyric acid##7##2##(1990-6#1)(1994-8#1)(2008-10#1)(2008-11#4)
butyric##8##1##(1990-6#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#4)
butyrylcholinesterase (BuChE)##2##2##(2008-10#1)(2008-7#1)
butyrylcholinesterase##9##1##(1992-8#2)(2008-10#4)(2008-7#2)(2009-8#1)
buy##7##1##(1991-9#1)(1992-8#1)(1993-5#1)(1994-6#1)(1995-2#2)(1995-9#1)
buy-in##3##1##(2013-1#3)
buyang huanwu decoction##2##3##(2013-8#2)
buying##3##1##(1991-1#1)(1994-3#1)(1997-3#1)
bv##9##1##(2008-10#2)(2008-6#2)(2008-8#1)(2011-2#4)
by &gt##9##2##(1995-2#2)(2008-10#6)(2010-8#1)
by &quot##9##2##(1993-12#1)(1993-2#4)(1993-3#1)(1995-3#1)(2008-10#1)(2009-10#1)
by (1)##2##2##(2008-10#1)(2008-5#1)
by (1)H NMR##3##3##(2008-10#3)
by (1)H##4##2##(1996-5#1)(2008-10#3)
by (13)C NMR spectrometry##2##4##(2008-10#2)
by (13)C NMR##3##3##(2008-10#2)(2013-1#1)
by (i)##4##2##(2008-10#3)(2008-12#1)
by 0##14##2##(1993-1#3)(1994-2#2)(1995-12#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-9#1)(2013-1#1)
by 1 week##2##3##(2008-10#1)(2013-8#1)
by 1##36##2##(1990-11#2)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-9#1)(2010-10#1)(2011-2#2)(2013-8#2)
by 1%##2##2##(2008-10#1)(2008-8#1)
by 10##6##2##(1996-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#1)
by 10%##8##2##(1991-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(2008-10#2)(2008-2#1)(2011-2#1)
by 10-fold##2##2##(1992-1#1)(2008-7#1)
by 100##3##2##(1990-8#1)(1996-12#1)(2008-10#1)
by 11##4##2##(1996-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
by 12##7##2##(1991-1#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
by 12%##3##2##(2010-6#1)(2011-2#1)(2011-3#1)
by 120 days##2##3##(2013-1#2)
by 120##3##2##(2008-10#1)(2013-1#2)
by 13##5##2##(1990-6#1)(1995-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
by 13%##2##2##(2008-10#1)(2011-2#1)
by 13C-NMR##2##2##(1997-1#2)
by 13C-n##2##2##(1990-9#2)
by 14##2##2##(2007-8#1)(2013-1#1)
by 14%##2##2##(2008-10#1)(2010-6#1)
by 15##8##2##(1991-3#1)(1992-3#1)(2008-10#4)(2008-8#2)
by 15%##2##2##(2008-2#1)(2008-8#1)
by 16 percent##2##3##(1991-1#1)(2008-11#1)
by 16##8##2##(1990-6#1)(1991-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
by 16S rRNA##2##3##(1997-2#1)(2012-2#1)
by 17##7##2##(1995-6#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
by 17%##2##2##(1993-3#1)(2010-11#1)
by 18 h##2##3##(1995-11#1)(2008-10#1)
by 18##5##2##(1990-6#1)(1995-11#1)(1996-12#1)(2008-10#1)(2012-2#1)
by 180##2##2##(1996-12#1)(2008-3#1)
by 19##3##2##(1993-3#1)(2008-10#1)(2008-8#1)
by 1H NMR##3##3##(1993-3#1)(1994-5#1)(2011-3#1)
by 1H##4##2##(1991-5#1)(1993-3#1)(1994-5#1)(2011-3#1)
by 1H-NMR##2##2##(1993-2#1)(1994-5#1)
by 2 days##4##3##(1997-3#1)(2008-10#2)(2008-11#1)
by 2##30##2##(1990-10#1)(1990-11#1)(1991-6#1)(1993-3#1)(1993-6#2)(1994-5#1)(1994-8#1)(1997-3#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2009-9#1)(2010-9#1)(2011-3#1)(2013-8#3)
by 2-3##2##2##(1993-2#1)(2008-10#1)
by 2-fold##2##2##(1992-1#1)(1993-8#1)
by 20 microM##2##3##(1993-3#2)
by 20##6##2##(1993-3#2)(2007-12#1)(2008-10#2)(2008-5#1)
by 20%##6##2##(1990-8#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)
by 2005##3##2##(1995-12#1)(1996-2#1)(2008-1#1)
by 2010##2##2##(2008-11#1)(2010-3#1)
by 2015##2##2##(2008-11#1)(2008-12#1)
by 21##3##2##(2008-10#2)(2008-5#1)
by 22%##2##2##(2008-10#2)
by 23%##2##2##(1993-12#1)(2008-10#1)
by 24 hours##2##3##(1997-3#1)(2008-7#1)
by 24##5##2##(1997-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
by 25 and##2##3##(1994-8#2)
by 25##6##2##(1994-8#2)(1995-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
by 25% in##2##3##(2008-10#1)(2013-1#1)
by 25%##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
by 26##2##2##(2008-10#1)(2008-9#1)
by 27%##2##2##(2008-10#1)(2013-1#1)
by 28##2##2##(1996-12#1)(2008-7#1)
by 3 days##4##3##(2008-10#2)(2008-11#2)
by 3##17##2##(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#7)(2008-11#2)(2008-3#1)(2011-2#1)(2013-1#1)
by 3'##2##2##(1997-3#1)(2008-8#1)
by 3-methylcholanthrene##3##2##(1992-8#1)(2008-11#2)
by 30##7##2##(1991-1#1)(1991-12#1)(1994-11#1)(1997-8#1)(2008-10#2)(2012-12#1)
by 30% in##2##3##(1994-8#1)(1997-9#1)
by 30%##6##2##(1990-8#1)(1994-8#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-8#1)
by 30-40%##2##2##(2011-2#1)(2013-8#1)
by 31 +/-##2##3##(1996-2#1)(1997-1#1)
by 31##4##2##(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#1)
by 32##2##2##(1992-2#1)(2008-10#1)
by 33##2##2##(1990-6#1)(2008-10#1)
by 34##3##2##(1991-8#1)(2008-10#1)(2008-9#1)
by 35%##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
by 4 weeks##3##3##(1996-12#1)(2008-10#2)
by 4##14##2##(1990-11#1)(1990-2#1)(1992-3#1)(1994-12#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
by 40% and##2##3##(2008-11#1)(2008-5#1)
by 40%##11##2##(1990-11#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)
by 41%##2##2##(1996-2#1)(2008-10#1)
by 42##2##2##(2008-10#2)
by 42%##2##2##(1997-1#1)(2011-2#1)
by 43##2##2##(1997-4#1)(2008-10#1)
by 43%##2##2##(1995-12#1)(2008-10#1)
by 44%##2##2##(1997-1#1)(2008-10#1)
by 48 h##2##3##(1996-12#1)(2008-7#1)
by 48##3##2##(1990-2#1)(1996-12#1)(2008-7#1)
by 49##2##2##(2008-10#1)(2008-9#1)
by 5##12##2##(1995-2#1)(1997-1#1)(1997-8#2)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)
by 5'##2##2##(2008-9#1)(2010-5#1)
by 50##3##2##(2008-10#2)(2008-5#1)
by 50% at a##2##4##(1997-1#1)(2008-10#1)
by 50% of##2##3##(1992-6#1)(2009-10#1)
by 50%##16##2##(1991-5#1)(1992-6#1)(1995-8#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#2)(2009-10#1)(2010-8#1)
by 500##2##2##(2008-10#1)(2008-3#1)
by 52##2##2##(1995-12#1)(2008-10#1)
by 54%##2##2##(1991-3#1)(1996-2#1)
by 55##2##2##(1991-5#1)(2008-10#1)
by 55%##2##2##(1997-2#1)(2008-11#1)
by 6 months##3##3##(2008-9#2)(2013-1#1)
by 6 weeks##2##3##(1996-5#1)(2013-1#1)
by 6##10##2##(1992-12#1)(1993-1#1)(1996-5#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-1#3)
by 60%##3##2##(2008-11#2)(2008-8#1)
by 65%##2##2##(2008-10#1)(2008-11#1)
by 67##2##2##(1994-8#1)(1995-12#1)
by 68%##2##2##(2008-11#2)
by 7 days##2##3##(2008-10#2)
by 7##10##2##(1991-8#1)(1994-5#1)(1994-8#1)(1996-1#1)(2008-10#5)(2009-4#1)
by 70##3##2##(1992-2#1)(2008-10#1)(2008-9#1)
by 71##2##2##(1994-8#1)(2008-4#1)
by 72##2##2##(1994-8#1)(2008-10#1)
by 73%##2##2##(1996-11#1)(2008-10#1)
by 75##2##2##(2008-10#2)
by 75% and##2##3##(1997-3#1)(2008-10#1)
by 8##2##2##(2008-10#2)
by 80 to 90%##2##4##(1997-8#1)(2008-10#1)
by 84##2##2##(2008-10#2)
by 85%##3##2##(1991-1#1)(2008-10#1)(2008-5#1)
by 9##7##2##(1990-12#1)(1990-3#2)(1995-3#1)(1995-6#1)(2008-10#1)(2012-2#1)
by 95% at##2##3##(1997-1#1)(2008-10#1)
by 95%##6##2##(1997-1#1)(2008-10#3)(2008-2#1)(2008-8#1)
by 96##2##2##(2008-10#2)
by A##23##2##(1991-3#1)(1991-9#1)(1993-11#1)(1994-11#1)(2008-10#15)(2009-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
by AAS and##2##3##(2008-10#2)
by AAS##8##2##(2008-10#8)
by ADR##3##2##(1990-2#1)(2011-3#2)
by AFLP analysis##2##3##(2008-10#2)
by AFLP##7##2##(2008-10#7)
by AFM##2##2##(2008-10#1)(2008-7#1)
by AFS##3##2##(1996-12#1)(2008-10#2)
by AG490##2##2##(2011-2#2)
by AIDS##2##2##(1990-12#1)(1997-6#1)
by ANOVA##2##2##(2008-10#1)(2013-1#1)
by ASM##2##2##(2008-10#2)
by ATP##3##2##(1992-12#1)(1993-6#1)(1993-8#1)
by Acidovorax avenae subsp##3##4##(2008-10#3)
by Adult##2##2##(2008-10#2)
by African##3##2##(2009-5#1)(2011-2#1)(2012-2#1)
by Agrobacterium tumefaciens##3##3##(2008-10#1)(2011-2#2)
by Agrobacterium##5##2##(2008-10#1)(2008-8#2)(2011-2#2)
by Alternaria##4##2##(2008-10#4)
by American##2##2##(2012-3#1)(2013-8#1)
by Aphanomyces euteiches##2##3##(2008-10#2)
by Aphis gossypii##2##3##(2008-10#2)
by Application of##2##3##(2008-10#2)
by Armillaria ostoyae##2##3##(2008-10#2)
by Armillaria spp##2##3##(2008-10#2)
by Armillaria##5##2##(2008-10#5)
by Aspergillus flavus and A##2##5##(2008-10#2)
by Aspergillus flavus##8##3##(2008-10#8)
by Aspergillus##11##2##(1993-2#1)(2008-10#8)(2008-7#1)(2013-1#1)
by Aulacorthum solani##2##3##(2008-10#2)
by B cells##2##3##(1995-5#1)(2008-4#1)
by B##14##2##(1995-5#1)(2008-10#9)(2008-12#1)(2008-4#1)(2010-1#1)(2013-8#1)
by B-mode##2##2##(2010-12#1)(2013-8#1)
by BABA##2##2##(2008-10#1)(2009-6#1)
by BBM vesicles##2##3##(1991-9#2)
by BBR treatment##3##3##(2012-3#3)
by BMI (beta = 0##2##5##(2010-4#2)
by BNR##2##2##(2008-10#2)
by BQ##2##2##(2009-9#2)
by Bacillus spp##6##3##(2008-10#6)
by Bacillus##10##2##(1992-3#1)(2008-10#7)(2010-1#1)(2011-2#1)
by Barley yellow dwarf virus##2##5##(2008-10#2)
by Bcl-2##2##2##(2008-11#1)(2008-8#1)
by Bemisia tabaci##2##3##(2008-10#2)
by BisEMA##2##2##(2013-1#2)
by Blocking##2##2##(2011-2#1)(2013-1#1)
by BmNPV##2##2##(2008-11#2)
by Botrytis cinerea and##3##4##(2008-10#3)
by Botrytis cinerea was##3##4##(2008-10#3)
by Botrytis cinerea##9##3##(2008-10#9)
by C##21##2##(1991-9#1)(1996-12#1)(2007-12#1)(2008-10#15)(2008-5#1)(2010-4#1)(2011-2#1)
by C-banding##2##2##(2008-12#2)
by C3##2##2##(2008-10#2)
by C9-1S##2##2##(2008-10#2)
by CCD##2##2##(2008-10#1)(2008-9#1)
by CCK##2##2##(1993-6#1)(1994-2#1)
by CCK-8S##2##2##(1996-2#2)
by CD##3##2##(1990-5#1)(1991-1#1)(2008-4#1)
by CE##2##2##(2008-10#2)
by CHA0##2##2##(2008-10#2)
by CHO cells##7##3##(1992-10#1)(2008-11#6)
by CMV##2##2##(2008-10#2)
by CO 2 laser##2##4##(1991-2#1)(1993-1#1)
by CO##3##2##(1991-2#1)(1991-5#1)(1993-1#1)
by CO(2)##4##2##(1991-5#1)(2008-10#3)
by CS##2##2##(2011-1#1)(2012-3#1)
by CT##6##2##(1992-9#1)(1993-1#1)(1996-6#1)(2008-7#1)(2009-1#1)(2011-2#1)
by CTAB##2##2##(2008-11#2)
by CVAAS##2##2##(2008-10#2)
by CYSDV##3##2##(2008-10#3)
by CZE##2##2##(2008-10#2)
by Ca(2+)##3##2##(2008-11#1)(2008-8#2)
by Ca2+ and Mg2+##2##4##(1990-5#1)(1995-11#1)
by Ca2+ channel blockers##2##4##(1995-11#2)
by Ca2+##8##2##(1990-5#2)(1994-3#1)(1995-11#3)(1995-6#2)
by CaM-kinase II##2##3##(1995-2#2)
by Canadian##3##2##(1991-12#1)(1993-3#1)(2008-11#1)
by Candida##2##2##(2008-10#1)(2008-5#1)
by Cb##2##2##(1995-12#2)
by Cd##3##2##(2008-10#3)
by Cell##2##2##(2008-10#1)(2010-5#1)
by Cephalosporium gramineum##2##3##(2008-10#2)
by Cercospora arachidicola##3##3##(2008-10#3)
by Cercospora##5##2##(2008-10#5)
by Cercosporidium personatum##2##3##(2008-10#2)
by Cladosporium tenuissimum##2##3##(2008-10#2)
by Cladosporium##4##2##(2008-10#3)(2012-2#1)
by Clostridium botulinum##2##3##(1993-2#1)(2007-12#1)
by Clostridium##4##2##(1993-2#1)(2007-12#1)(2008-6#1)(2013-1#1)
by Co(II)##2##2##(2008-10#2)
by Cochliobolus heterostrophus##3##3##(2008-10#3)
by Cochliobolus##6##2##(2008-10#6)
by Colletotrichum acutatum##3##3##(2008-10#3)
by Colletotrichum coccodes##2##3##(2008-10#2)
by Colletotrichum graminicola##3##3##(2008-10#3)
by Colletotrichum##17##2##(2008-10#16)(2008-11#1)
by Congress##2##2##(1991-1#1)(1992-1#1)
by Conidia##2##2##(2008-10#2)
by Cu(2+)##3##2##(2008-10#2)(2009-8#1)
by Cu(II)##3##2##(2008-10#3)
by Cucumber mosaic virus (CMV)##2##5##(2008-10#2)
by Cx43 transfection##2##3##(2008-11#2)
by Cylindrocarpon destructans##2##3##(2008-10#2)
by D##5##2##(2008-10#4)(2008-11#1)
by DGT##2##2##(2008-10#2)
by DNA damage##5##3##(2008-11#3)(2010-3#1)(2013-1#1)
by DNA fingerprinting##3##3##(2008-10#3)
by DNA fragmentation##2##3##(1995-2#1)(2008-11#1)
by DNA##21##2##(1990-5#1)(1995-2#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
by Different##2##2##(2008-10#1)(2008-11#1)
by DnaC##2##2##(1991-12#2)
by Dr##11##2##(1993-9#1)(1995-6#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-8#4)(2008-5#1)
by Dutch##2##2##(1996-11#1)(1996-8#1)
by E##10##2##(1990-12#1)(1991-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2009-12#1)(2010-6#1)
by EA##2##2##(1995-2#1)(1996-12#1)
by EDTA##6##2##(1994-5#1)(2008-10#5)
by EFS##2##2##(1997-4#2)
by EGTA##2##2##(2008-10#1)(2008-8#1)
by ELISA and##6##3##(1992-6#1)(2008-10#3)(2008-11#1)(2008-8#1)
by ELISA at##2##3##(2008-10#2)
by ELISA in##3##3##(1995-12#1)(2008-9#1)(2010-3#1)
by ELISA is##2##3##(2008-10#1)(2008-11#1)
by ELISA with##2##3##(1992-11#1)(1995-12#1)
by ELISA##29##2##(1990-12#1)(1991-2#1)(1992-11#2)(1992-6#1)(1993-11#1)(1995-12#3)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-3#2)(2011-2#1)
by EMF##2##2##(2008-10#1)(2011-2#1)
by EMSA##2##2##(1995-8#1)(2008-11#1)
by EPR spectroscopy##2##3##(2008-10#2)
by EPR##4##2##(1993-8#1)(2008-10#2)(2008-5#1)
by ERW##2##2##(2008-11#2)
by ESA##2##2##(2008-11#2)
by ET AAS##4##3##(2008-10#4)
by ET##5##2##(2008-10#4)(2012-3#1)
by ETAAS using##2##3##(2008-10#2)
by ETAAS##12##2##(2008-10#12)
by ETV-ICP-MS##3##2##(2008-10#3)
by Erwinia amylovora##4##3##(2008-10#4)
by Escherichia coli##8##3##(1992-6#1)(1993-6#1)(1993-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2010-6#2)
by European##3##2##(2008-10#2)(2008-12#1)
by Exserohilum##2##2##(2008-10#2)
by F##13##2##(2008-10#13)
by FA##2##2##(1993-6#2)
by FAAS after##2##3##(2008-10#2)
by FAAS and##2##3##(2008-10#2)
by FAAS##20##2##(2008-10#20)
by FACS##4##2##(2008-11#3)(2012-3#1)
by FCM##2##2##(2009-6#2)
by FI-CV-AAS after##2##3##(2008-10#2)
by FI-CV-AAS##3##2##(2008-10#3)
by FI-HGAAS##4##2##(2008-10#4)
by FIA##2##2##(2008-10#2)
by FISH analysis##4##3##(1996-6#1)(1996-8#1)(2008-11#1)(2009-8#1)
by FISH##7##2##(1996-6#1)(1996-8#1)(1997-2#1)(2008-11#2)(2008-9#1)(2009-8#1)
by FPGA##2##2##(2012-3#2)
by FPLC##3##2##(1990-5#1)(1993-8#1)(2008-9#1)
by FT-IR spectroscopy##4##3##(2008-10#4)
by FT-IR##8##2##(2008-10#8)
by FT-Raman##2##2##(2008-10#2)
by FTIR spectroscopy applying the constant ratio method##2##8##(2008-10#2)
by FTIR spectroscopy##4##3##(2008-10#4)
by FTIR##8##2##(2008-10#8)
by Fe##3##2##(2008-10#2)(2010-6#1)
by FeCl(3)##2##2##(2008-10#1)(2013-1#1)
by Ficoll-Paque##3##2##(2008-11#2)(2008-9#1)
by Flame##2##2##(2008-10#2)
by Flesia and Korb##2##4##(2008-3#2)
by Fluorescent##2##2##(2008-10#2)
by Fourier Transform##2##3##(2008-10#2)
by Fourier transform infrared (FTIR) spectroscopy##2##6##(2008-10#1)(2008-8#1)
by Fourier transform infrared spectroscopy##3##5##(2008-10#3)
by Fourier transform infrared##7##4##(2008-10#6)(2008-8#1)
by Fourier transform##8##3##(2008-10#7)(2008-8#1)
by Fourier##11##2##(2008-10#9)(2008-11#1)(2008-8#1)
by French##2##2##(2010-1#1)(2011-2#1)
by Fusarium graminearum##5##3##(2008-10#4)(2011-10#1)
by Fusarium moniliforme##2##3##(2008-10#2)
by Fusarium oxysporum f##12##4##(2008-10#12)
by Fusarium spp##3##3##(2008-10#3)
by Fusarium verticillioides##2##3##(2008-10#2)
by Fusarium##28##2##(2008-10#27)(2011-10#1)
by G##3##2##(2008-10#3)
by GABA##4##2##(2008-8#1)(2008-9#2)(2010-12#1)
by GC and GC/MS##3##4##(2008-11#1)(2008-12#2)
by GC and##4##3##(2008-11#1)(2008-12#2)(2012-2#1)
by GC##6##2##(2008-11#1)(2008-12#2)(2009-8#1)(2012-2#1)(2013-8#1)
by GC-FID##3##2##(2008-10#3)
by GC-MS##15##2##(1991-5#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-11#1)(2011-3#1)
by GC-MS]##2##2##(2012-3#1)(2013-8#1)
by GC/FID##2##2##(2008-10#2)
by GC/MS and##2##3##(2008-10#1)(2008-12#1)
by GC/MS##10##2##(1995-2#1)(2008-10#6)(2008-11#2)(2008-12#1)
by GDP##2##2##(1991-5#1)(1993-8#1)
by GF-AAS##3##2##(2008-10#3)
by GFAAS##9##2##(2008-10#9)
by GRP##2##2##(1992-6#2)
by GSTT (100 and 30 mg x L(-1))##2##8##(2011-3#2)
by GTP-binding##2##2##(1992-8#1)(1993-3#1)
by Gaeumannomyces graminis var##3##4##(2008-10#3)
by GeneMark as##2##3##(1995-12#2)
by GeneMark##3##2##(1995-12#3)
by Genome##2##2##(2008-10#1)(2010-5#1)
by Glucose##2##2##(2011-2#1)(2012-2#1)
by H##8##2##(1995-12#1)(1995-2#1)(1997-1#2)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
by H(2)O(2)##4##2##(2008-10#4)
by H-point standard addition method (HPSAM)##2##6##(2008-10#2)
by H-point standard addition method##5##5##(2008-10#5)
by H2O2##4##2##(1995-8#1)(1997-8#3)
by HB##2##2##(2008-8#2)
by HIV-1##3##2##(2008-11#2)(2011-3#1)
by HMOs##2##2##(1993-3#1)(1996-3#1)
by HMW-BCGF##2##2##(1991-3#2)
by HPLC and##5##3##(2008-10#4)(2009-8#1)
by HPLC using a##2##4##(1993-11#1)(2008-10#1)
by HPLC using##6##3##(1993-11#1)(2008-10#5)
by HPLC with UV detection##2##5##(2008-10#2)
by HPLC with##6##3##(2008-10#6)
by HPLC##52##2##(1993-11#1)(1994-8#1)(2008-10#39)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#3)(2010-2#1)(2012-2#1)
by HPLC-ICP-MS##5##2##(2008-10#5)
by HPLC-ICPMS##2##2##(2008-10#1)(2010-11#1)
by HPLC-UV##3##2##(2008-10#3)
by HPLC/UV##2##2##(2008-5#2)
by HPLC]##2##2##(2013-8#2)
by HRV analysis##2##3##(2009-11#2)
by HRV##3##2##(2009-11#2)(2013-8#1)
by HS-SPME##2##2##(2008-10#2)
by HSF##2##2##(2008-5#2)
by HSP70##2##2##(1993-8#1)(2008-9#1)
by HeLa##2##2##(1993-8#1)(1995-6#1)
by Helicobacter pylori##2##3##(1990-11#1)(2011-2#1)
by Hg(2+) and##2##3##(2008-10#2)
by Hg(2+)##3##2##(2008-10#3)
by Howard##2##2##(1996-5#1)(2013-1#1)
by ICI D1694##2##3##(1994-8#2)
by ICP##5##2##(2008-10#5)
by ICP-AES after##3##3##(2008-10#3)
by ICP-AES analysis##2##3##(2008-10#2)
by ICP-AES using##2##3##(2008-10#2)
by ICP-AES##19##2##(2008-10#19)
by ICP-MS and##3##3##(2008-10#3)
by ICP-MS##18##2##(2008-10#18)
by ICP-OES##5##2##(2008-10#5)
by ICPMS##2##2##(2008-10#2)
by IFN-gamma##5##2##(2008-11#4)(2013-8#1)
by IL-1 and IL-6##2##4##(1994-6#2)
by IL-1 and##3##3##(1994-6#2)(2008-8#1)
by IL-1##5##2##(1990-12#1)(1994-6#2)(1995-6#1)(2008-8#1)
by IL-17##2##2##(2007-11#1)(2009-12#1)
by IL-2##3##2##(2008-8#3)
by IPTG##4##2##(1993-8#1)(1993-9#1)(1994-8#1)(2013-1#1)
by IR##7##2##(2008-10#6)(2008-11#1)
by IVC##3##2##(1990-2#3)
by J##5##2##(1990-11#1)(2008-10#3)(2008-3#1)
by J774##2##2##(1994-11#1)(1994-8#1)
by JHBP##2##2##(2012-2#2)
by Japanese##2##2##(2008-10#1)(2011-2#1)
by Jones##2##2##(2012-12#1)(2013-1#1)
by July##2##2##(1995-6#1)(2010-3#1)
by K##2##2##(2011-2#1)(2012-2#1)
by KCl##2##2##(2008-12#1)(2008-6#1)
by KMnO(4)##2##2##(2008-10#2)
by Karl Fischer titration##2##4##(2008-10#2)
by Kjeldahl##2##2##(2008-10#2)
by Kohonen artificial neural networks##2##5##(2008-10#2)
by L##6##2##(1996-12#3)(2008-10#2)(2011-2#1)
by L-Glu##2##2##(1997-2#2)
by LA-ICP-MS##5##2##(2008-10#5)
by LC##5##2##(2008-10#5)
by LC-ESI-MS##2##2##(2008-10#2)
by LC-ICP-MS##2##2##(2008-10#2)
by LC-MS##3##2##(2008-10#2)(2011-2#1)
by LIF##2##2##(2008-3#1)(2008-4#1)
by LPS##5##2##(1995-12#1)(1997-1#1)(2008-8#3)
by La(3+)##3##2##(2008-10#2)(2008-11#1)
by La3+##2##2##(1997-2#2)
by Laccase of##2##3##(2008-10#2)
by Latreille in##2##3##(2010-1#2)
by Li##2##2##(2008-10#1)(2008-5#1)
by M##14##2##(1990-12#1)(2008-10#10)(2010-10#1)(2010-7#1)(2012-3#1)
by M-CSF##2##2##(1991-5#2)
by MDR cells##3##3##(1990-2#3)
by MHC class##2##3##(1995-5#1)(2012-12#1)
by MHT and HT##2##4##(2011-2#2)
by MHT##4##2##(2011-2#4)
by MLR##2##2##(2008-10#2)
by MPTP##2##2##(1990-7#2)
by MRI##7##2##(1995-11#1)(1996-6#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-9#1)(2013-1#1)
by MS##2##2##(2010-12#1)(2012-2#1)
by MTT##4##2##(2008-9#1)(2009-9#1)(2011-3#2)
by Magnaporthe grisea##4##3##(2008-10#3)(2009-10#1)
by Magnaporthe##5##2##(2008-10#3)(2009-10#1)(2012-2#1)
by Malassezia furfur##2##3##(2008-5#2)
by Malassezia##3##2##(2008-5#3)
by Medicaid##5##2##(1992-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)
by Medicare and##3##3##(1993-3#1)(1996-3#1)(1997-3#1)
by Medicare beneficiaries##3##3##(1993-12#1)(1994-1#1)(1995-3#1)
by Medicare##14##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#2)(1994-1#1)(1995-12#2)(1995-3#1)(1996-3#2)(1997-3#1)
by Mg2+##3##2##(1990-5#2)(1995-6#1)
by Microsphaeropsis sp##2##3##(2008-10#2)
by Miller##2##2##(2008-1#1)(2008-10#1)
by Monilinia fructicola##5##3##(2008-10#5)
by Monilinia vaccinii-corymbosi##3##3##(2008-10#3)
by Monilinia##10##2##(2008-10#10)
by Mycosphaerella fragariae##2##3##(2008-10#2)
by Mycosphaerella graminicola on##2##4##(2008-10#2)
by Mycosphaerella##8##2##(2008-10#8)
by Myzus persicae##2##3##(2008-10#2)
by N-bromosuccinimide##2##2##(1992-6#1)(2008-10#1)
by N-ethylmaleimide##2##2##(1995-8#2)
by N-terminal sequencing##3##3##(1993-12#1)(1997-8#1)(2008-10#1)
by N-terminal##4##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-8#1)
by NAC##4##2##(2008-11#1)(2009-9#2)(2011-2#1)
by NAGO##2##2##(1995-5#2)
by NAT##2##2##(2011-2#2)
by NGF##5##2##(1991-12#1)(1997-2#1)(2008-11#3)
by NIR spectroscopy##3##3##(2008-10#3)
by NK cells##2##3##(2008-4#1)(2008-8#1)
by NMDA##4##2##(2008-8#4)
by NMR##8##2##(1992-3#1)(1992-4#1)(1993-1#1)(1994-5#1)(1997-1#1)(2008-11#1)(2009-7#1)(2012-2#1)
by NO##2##2##(1995-11#1)(2008-7#1)
by NaCl##2##2##(1997-8#1)(2009-8#1)
by National##2##2##(2008-10#2)
by Native##3##2##(2008-10#2)(2012-2#1)
by Nonpathogenic Fusarium oxysporum##2##4##(2008-10#2)
by Nonpathogenic Fusarium##4##3##(2008-10#4)
by Nonpathogenic##5##2##(2008-10#5)
by Northern analysis##3##3##(1995-11#1)(1996-2#1)(2008-9#1)
by Northern blot analysis##7##4##(1993-2#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-5#1)
by Northern blot and##2##4##(1993-3#1)(2010-5#1)
by Northern blot##11##3##(1992-3#1)(1993-2#1)(1993-3#2)(1993-9#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-5#1)(2008-9#1)(2010-5#1)
by Northern blotting##5##3##(1991-5#1)(1994-11#1)(1996-6#2)(2008-6#1)
by Northern##21##2##(1991-5#1)(1992-3#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1995-11#2)(1995-6#1)(1996-2#1)(1996-6#2)(1997-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-5#1)
by Nuclear##2##2##(2008-10#2)
by O(2)##2##2##(2008-10#2)
by OA##2##2##(1994-11#2)
by P##38##2##(1991-3#1)(2008-10#34)(2008-11#1)(2011-10#1)(2012-12#1)
by P2 Tin protein##2##4##(1997-3#2)
by PACAP##2##2##(1995-11#2)
by PAP##2##2##(2008-10#2)
by PCA##2##2##(2008-10#2)
by PCR amplification##2##3##(1993-9#1)(2008-8#1)
by PCR and used for##2##5##(1995-8#1)(2008-8#1)
by PCR and##14##3##(1994-8#1)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-5#2)(2008-8#3)(2008-9#1)
by PCR from##2##3##(1995-8#1)(2011-2#1)
by PCR in##5##3##(2008-10#4)(2008-12#1)
by PCR or##3##3##(1997-3#1)(2008-10#1)(2008-2#1)
by PCR with##2##3##(1996-6#1)(2008-10#1)
by PCR##55##2##(1993-3#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-8#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#17)(2008-12#3)(2008-2#1)(2008-5#3)(2008-8#9)(2008-9#3)(2009-8#2)(2010-1#1)(2010-5#1)(2011-2#1)
by PEG method##2##3##(2008-8#1)(2008-9#1)
by PET##2##2##(1995-2#1)(1996-2#1)
by PEUs##3##2##(2008-11#3)
by PFGE##2##2##(1992-6#1)(2008-10#1)
by PI##3##2##(1994-11#1)(2008-9#2)
by PKC##2##2##(1993-3#1)(2008-11#1)
by PLS##2##2##(2008-10#2)
by PMA##9##2##(1993-6#1)(1994-6#3)(1994-8#1)(1995-2#1)(1995-6#1)(2006-6#1)(2008-11#1)
by PPAR gamma 2##2##4##(1994-12#2)
by PQ##3##2##(1995-8#3)
by Pantoea agglomerans##2##3##(2008-10#2)
by Parkinson's disease##2##3##(2008-7#1)(2009-10#1)
by Partial Least##2##3##(2008-10#2)
by Pb2+##3##2##(1995-11#3)
by Penicillium expansum##6##3##(2008-10#6)
by Penicillium##9##2##(2008-10#8)(2011-2#1)
by Peronospora##2##2##(2008-10#2)
by Peyer's##3##2##(1997-1#1)(2008-11#2)
by Phomopsis cucurbitae##2##3##(2008-10#2)
by Phomopsis obscurans##2##3##(2008-10#2)
by Phomopsis##5##2##(2008-10#5)
by Phytophthora and Pythium##2##4##(2008-10#2)
by Phytophthora infestans##4##3##(2008-10#3)(2009-6#1)
by Phytophthora lateralis##2##3##(2008-10#2)
by Phytophthora nicotianae and P##2##5##(2008-10#2)
by Phytophthora parasitica##2##3##(2008-10#2)
by Phytophthora##18##2##(2008-10#17)(2009-6#1)
by Pipes##2##2##(1996-2#2)
by Plasmopara viticola##4##3##(2008-10#4)
by Pleurotus ostreatus##3##3##(2008-5#2)(2011-1#1)
by Pneumocystis##2##2##(1992-2#1)(2010-12#1)
by Polymerase Chain Reaction##2##4##(2008-10#1)(2008-12#1)
by President##2##2##(1991-12#1)(1995-12#1)
by Pseudomonas fluorescens##6##3##(2008-10#6)
by Pseudomonas putida##2##3##(2008-7#1)(2011-2#1)
by Pseudomonas spp##3##3##(2008-10#3)
by Pseudomonas syringae pv##8##4##(2008-10#8)
by Pseudomonas syringae##12##3##(2008-10#11)(2009-8#1)
by Pseudomonas##24##2##(1995-2#1)(2008-10#20)(2008-7#1)(2009-8#1)(2011-2#1)
by Puccinia striiformis##6##3##(2008-10#6)
by Puccinia##15##2##(2008-10#15)
by Pythium aphanidermatum##5##3##(2008-10#5)
by Pythium group F##2##4##(2008-10#2)
by Pythium spp##3##3##(2008-10#3)
by Pythium ultimum##8##3##(2008-10#8)
by Pythium##19##2##(2008-10#19)
by QCM##2##2##(2008-10#2)
by QTL##2##2##(2008-10#1)(2008-12#1)
by R##15##2##(2008-10#14)(2008-7#1)
by RA##5##2##(1994-11#1)(2008-11#3)(2008-8#1)
by RAPD##3##2##(2008-10#3)
by RFLP analysis##3##3##(2008-10#3)
by RFLP##5##2##(2008-10#4)(2008-8#1)
by RIA##3##2##(1991-6#1)(2008-7#1)(2008-9#1)
by RNA gel blot##2##4##(2012-3#2)
by RNA polymerase containing sigma##2##5##(1990-12#1)(1993-12#1)
by RNA polymerase containing##3##4##(1990-12#1)(1993-12#1)(1995-6#1)
by RNA polymerase##5##3##(1990-12#1)(1993-12#1)(1995-6#2)(1997-7#1)
by RNA##12##2##(1990-12#1)(1993-12#2)(1995-6#2)(1997-7#1)(2008-10#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#2)
by RNAi##3##2##(2010-1#1)(2011-1#1)(2012-2#1)
by RNase##2##2##(1995-2#1)(1995-6#1)
by RP-HPLC##5##2##(2008-10#3)(2012-2#2)
by RT-PCR analysis##2##3##(1994-11#1)(2008-9#1)
by RT-PCR and##4##3##(2008-11#1)(2008-9#1)(2011-3#1)(2013-8#1)
by RT-PCR in##2##3##(2008-10#1)(2008-12#1)
by RT-PCR technique##2##3##(2008-8#1)(2008-9#1)
by RT-PCR with##3##3##(2008-11#1)(2008-9#2)
by RT-PCR##23##2##(1994-11#1)(1997-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#5)(2008-9#7)(2011-3#1)(2013-8#3)
by Ralstonia solanacearum##7##3##(2008-10#7)
by Raman spectroscopy##4##3##(1991-5#2)(2008-10#1)(2008-2#1)
by Rayleigh light scattering##2##4##(2008-10#2)
by Rayleigh##3##2##(2008-10#2)(2008-3#1)
by Real-Time Polymerase Chain Reaction##3##5##(2008-10#3)
by Real-Time##4##2##(2008-10#3)(2008-12#1)
by Repetitive##2##2##(2008-10#1)(2008-5#1)
by Restriction##2##2##(2008-10#2)
by Rhizoctonia solani##6##3##(2008-10#6)
by Rhizoctonia##7##2##(2008-10#7)
by Rhizopus oryzae##2##3##(2008-10#2)
by Rhodotorula##3##2##(2009-11#3)
by Rhynchosporium secalis##2##3##(2008-10#2)
by Rives' technique##2##3##(1992-5#2)
by Robert##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
by Roche##2##2##(2008-5#2)
by Rp-cAMPS##2##2##(1993-6#2)
by Russian##2##2##(2012-3#1)(2013-8#1)
by S##13##2##(1991-3#2)(2008-10#10)(2010-12#1)
by S-1(A2)##2##2##(1992-4#2)
by S1 nuclease protection analysis##2##5##(1992-3#1)(1993-3#1)
by S1 nuclease##3##3##(1992-3#1)(1993-3#1)(1994-11#1)
by S1##6##2##(1992-3#4)(1993-3#1)(1994-11#1)
by SDS-PAGE and##6##3##(1990-12#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
by SDS-PAGE electrophoresis##2##3##(1990-11#2)
by SDS-PAGE in the##2##4##(1995-11#2)
by SDS-PAGE##17##2##(1990-11#2)(1990-12#1)(1993-8#1)(1994-8#1)(1995-11#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#1)(2012-3#1)(2013-1#1)
by SEM##5##2##(2008-10#1)(2008-5#2)(2009-7#1)(2013-1#1)
by SMVEA##2##2##(2008-10#2)
by SPE##4##2##(1997-2#1)(2008-10#3)
by SPE(60)##2##2##(2008-10#2)
by SWAdSV##2##2##(2008-10#2)
by Scanning##2##2##(1990-11#1)(2008-5#1)
by Scatchard plot##2##3##(2008-10#2)
by Sclerotinia sclerotiorum##4##3##(2008-10#4)
by Sclerotinia##6##2##(2008-10#6)
by Sclerotium rolfsii##2##3##(2008-10#2)
by Se deficiency##2##3##(2012-2#2)
by Sephadex column##2##3##(2008-10#2)
by Sephadex##3##2##(2008-10#2)(2008-11#1)
by Sertoli cells##2##3##(2009-10#1)(2012-2#1)
by Southern blot analysis##5##4##(1996-6#1)(1997-8#2)(2008-10#1)(2008-11#1)
by Southern blot hybridization##4##4##(2008-10#4)
by Southern blot##10##3##(1996-6#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-9#1)
by Southern hybridization and##2##4##(2008-10#1)(2008-8#1)
by Southern hybridization with##2##4##(2008-10#1)(2008-8#1)
by Southern hybridization##7##3##(1993-3#1)(2008-10#3)(2008-8#2)(2008-9#1)
by Southern##19##2##(1993-3#1)(1996-6#1)(1997-8#2)(2008-10#10)(2008-11#1)(2008-8#2)(2008-9#2)
by Soxhlet##3##2##(2008-10#3)
by Stagonospora nodorum##3##3##(2008-10#3)
by Staphylococcus aureus##3##3##(1994-3#1)(2008-12#1)(2008-9#1)
by Staphylococcus##4##2##(1994-3#1)(2008-12#1)(2008-9#1)(2013-8#1)
by State##2##2##(1997-2#1)(1997-3#1)
by Stemphylium vesicarium##2##3##(2008-10#2)
by Stenotrophomonas maltophilia Strain C3##2##5##(2008-10#2)
by Stenotrophomonas maltophilia##3##3##(2008-10#3)
by Stoppa's technique##2##3##(1992-5#2)
by Streptomyces hygroscopicus##2##3##(2010-8#2)
by Streptomyces##7##2##(2008-10#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-2#2)
by Swiss 3T3 cells##2##4##(1994-3#2)
by Swiss##3##2##(1994-3#2)(2011-2#1)
by T##15##2##(1992-8#1)(1996-2#1)(2007-11#1)(2008-10#8)(2008-5#2)(2010-11#1)(2013-8#1)
by T-tube extraction##2##3##(1991-3#2)
by T3##2##2##(1994-11#1)(2008-10#1)
by TBTO##2##2##(2008-10#2)
by TCA and##3##3##(1997-1#1)(2008-10#2)
by TCAAS##2##2##(2008-10#2)
by TCDD##4##2##(1992-12#1)(1995-11#1)(2008-10#2)
by TCE##2##2##(2008-10#2)
by TDM##2##2##(1991-11#2)
by TEA+##2##2##(1993-3#1)(1994-11#1)
by TG-FTIR##2##2##(2008-10#2)
by TLC and##2##3##(1990-2#1)(2008-11#1)
by TLC on##2##3##(2008-5#2)
by TLC##7##2##(1990-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#1)
by TNF##2##2##(1992-7#1)(2008-9#1)
by TNF-alpha##3##2##(1993-6#2)(2008-9#1)
by TP53##2##2##(2011-2#1)(2013-1#1)
by TPA##5##2##(1990-12#1)(1996-12#1)(1997-1#2)(2008-9#1)
by TPKI and TPKII##2##4##(1995-12#2)
by TPKI##3##2##(1995-12#3)
by TRH (500 nM)##2##4##(1992-8#2)
by TRUS##3##2##(1997-8#1)(2011-2#2)
by TSWV##3##2##(2008-10#3)
by TYLCV-Is##3##2##(2008-10#3)
by Talaromyces flavus##2##3##(2008-10#2)
by Taphrina deformans##2##3##(2008-10#2)
by Tax protein##2##3##(2008-8#2)
by Thielaviopsis basicola##2##3##(2008-10#2)
by Treatment##2##2##(2008-10#1)(2010-4#1)
by Trichoderma spp##3##3##(2008-10#3)
by Trichoderma##8##2##(2008-10#8)
by Trichophyton tonsurans##3##3##(2008-5#3)
by Trichophyton##4##2##(2008-5#4)
by Triton X-100##2##3##(1997-8#1)(2008-10#1)
by Two##2##2##(2008-10#2)
by U##9##2##(1995-3#2)(2008-10#6)(2011-3#1)
by US##2##2##(2008-10#1)(2008-9#1)
by UV absorption##2##3##(2008-10#1)(2008-4#1)
by UV light##2##3##(2008-10#2)
by UV radiation##3##3##(2008-10#2)(2011-2#1)
by UV spectrophotometry##2##3##(2008-10#2)
by UV##17##2##(1995-6#1)(2008-10#14)(2008-4#1)(2011-2#1)
by UV-Vis spectroscopy##3##3##(2008-10#3)
by UV-Vis##4##2##(2008-10#4)
by UV-vis spectroscopy##2##3##(2008-10#2)
by UV-vis##6##2##(2008-10#6)
by UV-visible spectrophotometry##2##3##(2008-10#2)
by UV-visible##3##2##(2008-10#3)
by UVB##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
by UVC irradiation##2##3##(2008-11#2)
by Use of a##2##4##(2008-3#2)
by Use of##4##3##(2008-3#4)
by Using##3##2##(2008-10#2)(2008-12#1)
by V##8##2##(2008-10#7)(2009-8#1)
by V108LRUH1##2##2##(2008-10#2)
by Venturia nashicola##2##3##(2008-10#2)
by ViraPap##2##2##(1994-1#2)
by ViraType##2##2##(1994-1#2)
by W##3##2##(1993-12#1)(2008-5#1)(2010-7#1)
by WT##2##2##(1995-5#1)(2011-1#1)
by Western blot analysis##4##4##(1993-6#1)(2008-8#1)(2010-12#1)(2011-2#1)
by Western blot using##2##4##(2008-5#1)(2008-8#1)
by Western blot##15##3##(1991-10#1)(1993-6#1)(1994-5#1)(1996-12#1)(2008-5#2)(2008-8#3)(2008-9#2)(2010-12#1)(2011-2#2)(2012-2#1)
by Western blotting of##2##4##(1994-11#1)(2008-11#1)
by Western blotting##10##3##(1994-11#1)(1995-6#1)(1997-1#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-3#1)(2012-3#1)
by Western##26##2##(1991-10#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-1#2)(2008-11#1)(2008-5#3)(2008-8#4)(2008-9#3)(2010-12#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
by X-ray absorption##2##3##(2010-11#1)(2011-2#1)
by X-ray analysis##2##3##(1996-5#2)
by X-ray diffraction (XRD)##3##4##(2008-10#3)
by X-ray diffraction##9##3##(1994-5#1)(1996-5#1)(2008-10#6)(2013-8#1)
by X-ray fluorescence (XRF)##2##4##(2008-10#1)(2008-5#1)
by X-ray fluorescence spectrometry##3##4##(2008-10#3)
by X-ray fluorescence##7##3##(2008-10#5)(2008-5#1)(2013-8#1)
by X-ray photoelectron##3##3##(2008-10#3)
by X-ray powder##2##3##(2011-3#1)(2013-8#1)
by X-ray##33##2##(1991-8#1)(1992-4#1)(1994-5#1)(1996-5#4)(2008-1#1)(2008-10#17)(2008-5#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-8#4)
by XRD##2##2##(2008-10#1)(2013-8#1)
by XRF##4##2##(2008-10#3)(2008-5#1)
by Xanthomonas axonopodis pv##2##4##(2008-10#2)
by Xanthomonas oryzae pv##3##4##(2008-10#2)(2009-10#1)
by Xanthomonas##13##2##(2008-10#12)(2009-10#1)
by ZETAAS##2##2##(2008-10#2)
by Zeeman ETAAS using##2##4##(2008-10#2)
by Zeeman-corrected electrothermal##2##3##(2008-10#2)
by a &quot##4##3##(1990-8#1)(1992-12#1)(2008-10#1)(2008-11#1)
by a 1##2##3##(2008-10#1)(2010-3#1)
by a 3##2##3##(2008-10#1)(2009-5#1)
by a C##3##3##(2008-10#3)
by a CCK type##2##4##(1994-2#2)
by a DNA##3##3##(1997-3#1)(2008-11#1)(2008-4#1)
by a HPLC##2##3##(2008-10#2)
by a back##2##3##(1995-2#1)(1997-7#1)
by a batch##3##3##(2008-10#3)
by a broad band##2##4##(2008-10#2)
by a carbon##2##3##(2008-10#2)
by a central##2##3##(1995-8#1)(1996-12#1)
by a change in##2##4##(1995-6#1)(2008-9#1)
by a chemical reaction##2##4##(2008-10#1)(2008-7#1)
by a chemical##4##3##(2008-10#3)(2008-7#1)
by a child##2##3##(2008-9#1)(2013-1#1)
by a classical##3##3##(2008-10#2)(2009-11#1)
by a clinical exam##2##4##(2008-7#1)(2010-12#1)
by a clinical pharmacist##2##4##(2008-11#2)
by a clinical##6##3##(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
by a colorimetric assay##2##4##(2008-10#1)(2008-11#1)
by a colorimetric method##2##4##(2008-10#2)
by a colorimetric##4##3##(2008-10#3)(2008-11#1)
by a combination of both##2##5##(2008-10#1)(2008-7#1)
by a combination of##23##4##(1990-11#1)(1990-12#1)(1993-12#1)(1996-12#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-11#1)(2011-3#1)(2013-1#1)
by a combination##24##3##(1990-11#1)(1990-12#1)(1993-12#1)(1996-12#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-11#1)(2011-3#1)(2013-1#1)
by a commercial##4##3##(2007-12#1)(2008-10#3)
by a common##4##3##(1990-2#1)(1994-8#1)(1995-8#1)(2009-10#1)
by a complex network##2##4##(2009-8#1)(2010-8#1)
by a complex##9##3##(1994-12#1)(2008-10#1)(2008-4#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-2#1)
by a computer program##3##4##(1994-6#1)(1997-2#1)(2008-10#1)
by a computer##5##3##(1994-6#1)(1997-2#1)(2008-1#1)(2008-10#2)
by a considerable##2##3##(1995-1#1)(2008-10#1)
by a constant##2##3##(2008-10#2)
by a continuous##3##3##(2008-10#2)(2008-11#1)
by a conventional##5##3##(1993-2#1)(2008-10#4)
by a cross##3##3##(2008-11#1)(2008-5#1)(2010-2#1)
by a decline##4##3##(1990-3#1)(1990-7#1)(1991-2#1)(1992-12#1)
by a decrease in the##5##5##(1991-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
by a decrease in##10##4##(1991-5#1)(1992-8#1)(1994-3#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)
by a decrease##13##3##(1991-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-5#1)
by a decreased##2##3##(2008-11#1)(2011-2#1)
by a deficiency##3##3##(1996-8#1)(2008-5#1)(2011-2#1)
by a dense##2##3##(1997-3#1)(2008-5#1)
by a detailed analysis of##2##5##(2008-3#1)(2010-1#1)
by a difference##2##3##(1997-2#1)(2011-2#1)
by a different##4##3##(1990-5#1)(2008-12#1)(2008-9#1)(2011-2#1)
by a diffuse##3##3##(1990-6#1)(1995-12#1)(1997-1#1)
by a diode array##2##4##(2008-10#1)(2008-2#1)
by a diode##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
by a direct##6##3##(1990-5#1)(1991-6#1)(1992-9#1)(1993-3#1)(1995-8#1)(1996-8#1)
by a discussion##8##3##(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)
by a diverse##2##3##(2008-10#1)(2011-2#1)
by a dramatic decrease in##2##5##(1990-3#1)(1992-1#1)
by a dramatic##3##3##(1990-3#1)(1992-1#1)(2013-1#1)
by a dual##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
by a factor of 1##2##5##(1995-11#1)(2008-10#1)
by a factor of 10##2##5##(1992-3#1)(2008-10#1)
by a factor of 2##5##5##(1992-12#1)(2008-10#3)(2008-3#1)
by a factor of 3##4##5##(2008-10#3)(2009-5#1)
by a factor of 6##3##5##(2008-10#3)
by a factor of up to##2##6##(2008-10#1)(2011-2#1)
by a factor of##34##4##(1992-12#1)(1992-3#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(2007-12#1)(2008-10#21)(2008-3#1)(2009-5#1)(2011-2#1)
by a factor ranging from##2##5##(1992-12#1)(2008-10#1)
by a factor##40##3##(1990-8#3)(1992-12#2)(1992-3#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(2007-12#1)(2008-10#23)(2008-3#1)(2009-5#1)(2011-2#1)
by a family of##2##4##(1996-2#1)(2008-5#1)
by a fast##3##3##(2008-10#2)(2008-7#1)
by a few##6##3##(1991-3#1)(1992-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-9#1)
by a fiber##3##3##(2007-12#2)(2008-2#1)
by a flame##3##3##(2008-10#3)
by a flow injection##3##4##(2008-10#3)
by a flow of##2##4##(2008-10#2)
by a flow##7##3##(2008-10#6)(2008-9#1)
by a fluorescence##2##3##(2008-10#2)
by a focused##2##3##(2008-10#1)(2008-2#1)
by a functional##2##3##(1997-8#1)(2009-1#1)
by a gene##5##3##(1990-5#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-8#1)
by a general##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
by a giant##2##3##(1991-11#1)(2009-10#1)
by a given##2##3##(1992-3#1)(2008-11#1)
by a good##2##3##(2011-2#2)
by a group of##4##4##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
by a group##5##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
by a high##7##3##(1994-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#2)
by a higher##2##3##(2008-11#1)(2009-7#1)
by a highly##5##3##(1992-9#1)(1995-3#1)(2008-10#2)(2008-3#1)
by a home-made##2##3##(2008-10#2)
by a hospital##2##3##(1991-1#1)(2008-10#1)
by a host##2##3##(2008-10#1)(2008-8#1)
by a jet nebulizer##2##4##(1994-12#1)(1996-3#1)
by a labeling##2##3##(1996-5#1)(2008-10#1)
by a lack of##6##4##(2008-10#1)(2008-12#2)(2009-7#1)(2010-10#1)(2013-1#1)
by a large##2##3##(2009-12#1)(2013-1#1)
by a layer of##2##4##(2008-10#2)
by a light##2##3##(1991-2#1)(2008-10#1)
by a linear regression##2##4##(2008-10#1)(2013-8#1)
by a linear##4##3##(2008-10#3)(2013-8#1)
by a local##3##3##(1994-8#1)(1997-2#1)(2013-8#1)
by a long##2##3##(2008-7#1)(2013-1#1)
by a loss##2##3##(1996-12#1)(2008-11#1)
by a low##3##3##(1993-12#1)(1997-1#1)(2009-7#1)
by a lower##3##3##(1993-8#1)(2007-12#1)(2013-8#1)
by a luciferase##2##3##(2008-11#1)(2011-2#1)
by a mass##2##3##(1992-6#1)(2008-10#1)
by a maximum of##2##4##(1990-5#2)
by a maximum##5##3##(1990-5#2)(1993-3#1)(2008-10#1)(2009-5#1)
by a mean##2##3##(2008-11#1)(2008-7#1)
by a mechanism##4##3##(1991-12#1)(1995-12#1)(1995-8#1)(2008-10#1)
by a membrane##2##3##(1991-8#1)(2008-10#1)
by a meta-analysis of##2##4##(2008-10#1)(2008-11#1)
by a method##3##3##(1993-2#1)(2008-10#1)(2008-11#1)
by a microcomputer##3##3##(2008-10#3)
by a mild##2##3##(2008-11#1)(2008-5#1)
by a mixture of##5##4##(2007-8#1)(2008-10#3)(2008-9#1)
by a model##3##3##(1990-11#1)(1994-9#1)(2011-2#1)
by a modification##3##3##(2008-10#2)(2008-11#1)
by a modified##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
by a more reduced##2##4##(2008-1#2)
by a more##4##3##(1996-3#1)(2008-1#2)(2008-10#1)
by a moving##2##3##(2008-7#1)(2010-9#1)
by a multidisciplinary team##2##4##(1990-6#1)(2013-1#1)
by a multidisciplinary##4##3##(1990-6#1)(1996-1#1)(2010-12#1)(2013-1#1)
by a mutation in the##3##5##(1995-2#1)(2008-12#1)(2012-3#1)
by a mutation##4##3##(1995-2#1)(2008-12#1)(2012-3#2)
by a natural##2##3##(2008-9#1)(2012-2#1)
by a nested##2##3##(2008-10#2)
by a new technique##2##4##(1991-2#1)(2008-4#1)
by a new##15##3##(1991-2#1)(1995-12#1)(1996-3#1)(1996-5#1)(2008-10#8)(2008-4#1)(2011-1#1)(2012-3#1)
by a newly##2##3##(1991-2#1)(2008-10#1)
by a non-linear method##2##4##(2008-10#2)
by a non-linear##3##3##(2008-10#2)(2009-8#1)
by a nonlinear##2##3##(2008-10#2)
by a novel##7##3##(1994-8#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-8#1)
by a nuclear gene##2##4##(1995-6#1)(2008-10#1)
by a number of##16##4##(1990-8#1)(1990-9#1)(1995-2#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-1#1)
by a pair of##2##4##(1990-11#1)(2008-3#1)
by a parameter##2##3##(2008-10#1)(2008-3#1)
by a particular##5##3##(1990-4#1)(1992-3#1)(2008-10#3)
by a passive sampler##2##4##(2008-10#2)
by a passive##4##3##(2007-11#1)(2008-10#3)
by a pathway##2##3##(1994-11#1)(1995-8#1)
by a patient with##2##4##(1996-2#1)(1997-4#1)
by a pedometer)##2##3##(2013-1#2)
by a period of##2##4##(1990-5#1)(2008-10#1)
by a photocatalytic oxidation method using##2##6##(2008-10#2)
by a physician##6##3##(1991-1#1)(1993-3#1)(1997-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
by a plant##2##3##(2008-9#1)(2009-8#1)
by a plethora of##2##4##(2008-10#1)(2009-9#1)
by a porous##3##3##(2008-10#2)(2008-7#1)
by a post-receptor defect##2##4##(1994-12#2)
by a powerful##2##3##(2008-9#1)(2012-2#1)
by a primary##2##3##(2007-8#1)(2011-2#1)
by a prior##4##3##(2008-10#2)(2008-4#1)(2010-5#1)
by a process of##2##4##(2008-8#1)(2011-2#1)
by a process##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
by a proper##2##3##(2008-10#1)(2008-2#1)
by a proportional##2##3##(2008-10#1)(2008-8#1)
by a protein##2##3##(1995-6#1)(1997-1#1)
by a pulsed##5##3##(1992-1#1)(2008-10#1)(2008-3#3)
by a pure##2##3##(2008-5#1)(2008-8#1)
by a rapid decline in##2##5##(2008-8#1)(2010-1#1)
by a rapid##4##3##(2008-8#1)(2010-1#1)(2011-2#2)
by a recent##4##3##(1992-6#1)(1995-12#1)(2008-11#1)(2008-9#1)
by a recently##5##3##(2008-10#5)
by a recombinant##2##3##(2008-11#1)(2008-8#1)
by a recovery##3##3##(2008-10#2)(2013-8#1)
by a reduced##2##3##(2008-7#2)
by a reduction in##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
by a reduction##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
by a reference##4##3##(2008-10#4)
by a relative##2##3##(2008-10#1)(2013-8#1)
by a resonance##2##3##(2008-10#2)
by a reversed-phase##3##3##(2008-10#3)
by a review of##2##4##(1991-6#1)(2010-6#1)
by a second##6##3##(1990-11#1)(1990-5#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-6#1)
by a segmental##2##3##(2007-12#1)(2009-10#1)
by a sensitive##3##3##(1990-6#1)(2008-10#2)
by a sequence of##2##4##(2009-6#1)(2013-8#1)
by a sequential##2##3##(2008-10#2)
by a series of##8##4##(1990-2#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)
by a set of##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
by a short##2##3##(1993-3#1)(2008-10#1)
by a shortage of##2##4##(1993-2#1)(2008-12#1)
by a signal##2##3##(1993-12#1)(1994-11#1)
by a significant increase in##3##5##(1994-3#1)(2007-11#1)(2009-8#1)
by a significant increase##4##4##(1994-3#1)(2007-11#1)(2008-11#1)(2009-8#1)
by a significant##10##3##(1994-3#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2009-8#1)(2010-11#1)
by a similar##4##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
by a simple and##3##4##(2008-10#3)
by a simple##16##3##(1991-3#1)(1996-12#1)(1996-5#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
by a single dominant gene##7##5##(2008-10#7)
by a single dominant##11##4##(2008-10#11)
by a single dose##2##4##(1995-11#1)(2008-12#1)
by a single gene##7##4##(1995-6#1)(2008-10#6)
by a single step##2##4##(1993-6#1)(1995-11#1)
by a single##50##3##(1990-8#1)(1992-12#1)(1993-12#1)(1993-6#1)(1995-11#2)(1995-6#1)(2008-10#33)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#2)(2013-1#1)
by a slight##2##3##(2008-10#1)(2008-7#1)
by a slow##3##3##(1991-8#1)(1994-6#1)(1997-1#1)
by a small##7##3##(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)
by a smaller##2##3##(2009-8#1)(2010-8#1)
by a sol-gel##2##3##(2008-10#2)
by a solution##2##3##(2008-10#2)
by a special##3##3##(2008-11#1)(2008-8#1)(2013-8#1)
by a specific##2##3##(1992-3#1)(1995-2#1)
by a spectrophotometric method##5##4##(2008-10#5)
by a spectrophotometric##6##3##(2008-10#6)
by a square-wave voltammetric scan##2##5##(2008-10#2)
by a standard##5##3##(2008-10#3)(2008-5#1)(2012-2#1)
by a standardized##2##3##(1996-11#1)(2008-10#1)
by a strain of##2##4##(2008-10#1)(2008-6#1)
by a stream of##2##4##(2008-10#2)
by a strong##4##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-9#1)
by a study##2##3##(2008-10#1)(2008-5#1)
by a substantial##2##3##(2008-10#1)(2013-1#1)
by a suitable##2##3##(2008-10#1)(2008-5#1)
by a supported##2##3##(2008-10#2)
by a surface plasmon resonance##2##5##(2008-10#1)(2008-11#1)
by a surface##4##3##(2008-10#3)(2008-11#1)
by a sustained##3##3##(1992-6#1)(2007-11#1)(2008-11#1)
by a synthetic##2##3##(1995-2#1)(2007-11#1)
by a syringe##2##3##(2008-10#2)
by a thin film of chlorogenic acid##2##7##(2008-10#2)
by a thin##5##3##(2008-10#2)(2008-2#1)(2009-11#2)
by a third independent##2##4##(1994-3#1)(2013-1#1)
by a third##4##3##(1994-3#1)(2008-12#2)(2013-1#1)
by a transient##3##3##(1993-1#1)(1994-2#1)(2008-11#1)
by a tumor promoting phorbol ester##2##6##(1994-11#2)
by a type##2##3##(1994-2#2)
by a typical##2##3##(2008-10#1)(2012-2#1)
by a unilateral##2##3##(1995-2#1)(1996-2#1)
by a unique##4##3##(1993-8#1)(1997-9#1)(2008-3#1)(2008-4#1)
by a user##2##3##(2008-10#1)(2011-1#1)
by a variety of agents##2##5##(1995-6#1)(2008-8#1)
by a variety of##16##4##(1994-12#1)(1995-6#1)(1996-2#2)(1997-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
by a vector##2##3##(2008-10#2)
by a weak##2##3##(1990-11#1)(1995-3#1)
by a wide range of##2##5##(2008-11#1)(2008-3#1)
by a wide##4##3##(1996-2#1)(2008-11#1)(2008-3#1)(2010-6#1)
by a wild-type strain of##2##5##(2008-10#2)
by a##1490##2##(1990-10#1)(1990-11#6)(1990-12#7)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#11)(1990-6#4)(1990-7#1)(1990-8#9)(1990-9#5)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#13)(1991-3#3)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#5)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#10)(1992-2#1)(1992-3#7)(1992-5#2)(1992-6#4)(1992-8#4)(1992-9#5)(1993-1#4)(1993-11#1)(1993-12#10)(1993-2#6)(1993-3#7)(1993-6#4)(1993-8#5)(1993-9#5)(1994-11#10)(1994-12#14)(1994-2#6)(1994-3#6)(1994-5#4)(1994-6#4)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#8)(1995-12#10)(1995-2#18)(1995-3#3)(1995-5#2)(1995-6#12)(1995-8#13)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#7)(1996-2#9)(1996-3#8)(1996-5#4)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#7)(1997-4#4)(1997-6#3)(1997-7#2)(1997-8#3)(1997-9#1)(2006-6#2)(2007-11#6)(2007-12#20)(2007-8#4)(2008-1#7)(2008-10#516)(2008-11#87)(2008-12#23)(2008-2#20)(2008-3#73)(2008-4#11)(2008-5#32)(2008-6#5)(2008-7#39)(2008-8#34)(2008-9#27)(2009-1#2)(2009-10#9)(2009-11#5)(2009-12#4)(2009-3#2)(2009-5#3)(2009-6#3)(2009-7#11)(2009-8#13)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#3)(2011-1#7)(2011-2#35)(2011-3#3)(2012-12#7)(2012-2#14)(2012-3#15)(2012-5#1)(2012-7#1)(2013-1#35)(2013-8#13)
by abdominal pain##2##3##(1997-8#1)(2013-1#1)
by abdominal##4##2##(1997-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
by aberrant expression of##2##4##(2008-9#1)(2013-1#1)
by aberrant##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
by abiotic##3##2##(2008-10#2)(2008-9#1)
by about 30%##2##3##(1993-2#1)(2008-6#1)
by about 50%##4##3##(1990-11#1)(1993-3#1)(2008-10#1)(2013-8#1)
by about##29##2##(1990-11#1)(1991-5#1)(1993-2#1)(1993-3#1)(1995-8#1)(1996-2#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#3)
by absence of##2##3##(2008-10#2)
by absorbance##3##2##(1993-3#1)(2008-10#2)
by absorption##3##2##(1992-12#1)(2008-10#2)
by academic##2##2##(2008-12#1)(2010-1#1)
by accelerated solvent extraction##2##4##(2008-10#2)
by accelerated solvent##3##3##(2008-10#3)
by accelerated##4##2##(2008-10#3)(2008-5#1)
by accident##2##2##(1990-5#1)(2011-2#1)
by accumulation of##5##3##(2008-10#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-3#1)
by acetonitrile##2##2##(2008-10#2)
by acetylation rate##2##3##(2008-10#2)
by acetylation##3##2##(2008-10#3)
by acetylcholine##3##2##(1990-5#1)(1996-5#1)(1997-3#1)
by acetylcholinesterase##2##2##(2008-10#2)
by acid digestion##3##3##(2008-10#3)
by acid hydrolysis##2##3##(2008-10#1)(2008-5#1)
by acid treatment##2##3##(2008-10#2)
by acid##12##2##(1993-8#1)(2008-10#10)(2008-5#1)
by acid-base titration##2##3##(2008-10#2)
by acidic##2##2##(1996-5#1)(2008-10#1)
by acidification##2##2##(2008-10#1)(2008-9#1)
by acquiring a##2##3##(2008-3#1)(2008-9#1)
by acquisition of##2##3##(2008-10#1)(2011-2#1)
by acting as a##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
by acting##6##2##(1992-3#1)(1994-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)
by activated##8##2##(1991-9#1)(1992-3#1)(1994-5#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)
by activating the##4##3##(1994-8#1)(2008-10#1)(2008-6#1)(2011-1#1)
by activating##12##2##(1993-8#1)(1994-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-6#1)(2011-1#1)(2013-1#1)
by activation of the##3##4##(1993-9#1)(1997-7#1)(2009-8#1)
by activation of##8##3##(1992-12#1)(1993-9#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-2#1)
by activation##9##2##(1992-12#1)(1993-9#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-2#1)
by active##2##2##(2008-8#1)(2011-2#1)
by activin A##2##3##(1995-8#2)
by activities##2##2##(1992-12#1)(1995-2#1)
by activity##2##2##(1993-12#1)(2008-10#1)
by actual##4##2##(1990-8#1)(1993-2#1)(2008-11#2)
by acute##4##2##(1991-9#1)(1994-2#1)(2008-11#1)(2008-4#1)
by adapting the##2##3##(2008-11#1)(2008-3#1)
by adapting##4##2##(2008-10#1)(2008-11#2)(2008-3#1)
by adding 0##4##3##(2008-10#2)(2008-11#2)
by adding a##6##3##(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
by adding an##2##3##(2008-10#1)(2010-7#1)
by adding copper##2##3##(1997-8#1)(2008-11#1)
by adding sodium##3##3##(2008-10#3)
by adding the##4##3##(2008-10#4)
by adding unlabeled##2##3##(1992-3#1)(1993-6#1)
by adding##63##2##(1990-11#1)(1992-3#1)(1992-9#1)(1993-6#1)(1997-1#1)(1997-8#1)(2008-10#38)(2008-11#7)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-7#2)(2011-2#3)(2013-1#1)
by addition of a##3##4##(1996-5#1)(2008-10#1)(2008-2#1)
by addition of ferrous##2##4##(1992-8#1)(2008-10#1)
by addition of recombinant##2##4##(1990-5#1)(1997-7#1)
by addition of##35##3##(1990-5#1)(1991-5#1)(1992-8#1)(1996-5#2)(1997-7#1)(2008-10#19)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-11#1)(2011-3#1)
by addition##36##2##(1990-5#1)(1991-5#1)(1992-8#1)(1996-5#2)(1997-7#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-11#1)(2011-3#1)
by additional##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
by addressing##2##2##(1993-9#1)(2009-10#1)
by adenosine diphosphate##2##3##(1997-6#1)(2006-6#1)
by adenosine##6##2##(1993-6#1)(1994-11#1)(1995-8#1)(1997-6#1)(2006-6#1)(2008-5#1)
by adhesion##3##2##(1990-8#1)(2008-5#1)(2009-5#1)
by adjacent##2##2##(1995-8#1)(2008-10#1)
by adjusting the##5##3##(1990-2#1)(1995-5#1)(2008-10#2)(2008-12#1)
by adjusting##9##2##(1990-2#1)(1995-5#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-12#1)
by adjustment of##2##3##(2008-10#1)(2008-3#1)
by administering##3##2##(2009-8#1)(2012-2#2)
by administration of##7##3##(1991-5#1)(1992-12#1)(2008-10#2)(2009-8#1)(2012-2#1)(2013-7#1)
by adolescents##3##2##(2008-11#1)(2009-7#1)(2010-9#1)
by adopting a##2##3##(1994-1#1)(2008-4#1)
by adopting##3##2##(1994-1#1)(2008-4#1)(2008-8#1)
by adoption and##2##3##(2009-11#2)
by adoption##5##2##(2008-10#1)(2009-11#4)
by adsorbing##3##2##(2008-10#2)(2008-9#1)
by adsorption cathodic##2##3##(2008-10#2)
by adsorption chronopotentiometry##2##3##(2008-10#2)
by adsorption of##4##3##(2008-10#4)
by adsorption##15##2##(2008-10#15)
by adsorptive cathodic stripping voltammetry##4##5##(2008-10#4)
by adsorptive square-wave anodic stripping voltammetry on##2##7##(2008-10#2)
by adsorptive square-wave##3##3##(2008-10#3)
by adsorptive stripping voltammetry##8##4##(2008-10#8)
by adsorptive voltammetry##2##3##(2008-10#2)
by adsorptive##20##2##(2008-10#20)
by adult cochlear implant##2##4##(2008-9#2)
by adult##9##2##(1991-1#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-9#4)(2010-12#1)
by adults##4##2##(2008-10#2)(2008-9#1)(2009-10#1)
by aerosol##4##2##(1992-3#2)(1994-12#1)(1997-2#1)
by affecting the##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
by affecting##7##2##(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-5#1)(2013-1#1)
by affinity chromatography and##2##4##(1991-9#1)(2008-8#1)
by affinity chromatography on##2##4##(1993-8#1)(1997-2#1)
by affinity chromatography using##2##4##(1991-5#1)(2008-9#1)
by affinity chromatography##12##3##(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1995-6#1)(1997-2#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)
by agar dilution##2##3##(2008-5#1)(2012-3#1)
by agarose gel electrophoresis##2##4##(1993-8#1)(1995-8#1)
by agarose gel##3##3##(1992-3#1)(1993-8#1)(1995-8#1)
by age and##2##3##(1991-6#1)(2008-12#1)
by age##18##2##(1990-6#1)(1991-6#1)(1992-2#1)(1994-9#1)(1995-2#1)(1997-2#2)(1997-3#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-3#1)(2013-8#1)
by aged##2##2##(1991-3#1)(1996-2#1)
by agenesis of the##2##4##(2008-10#1)(2011-2#1)
by agents that##2##3##(1996-2#1)(2008-4#1)
by agents##3##2##(1996-2#1)(2008-4#1)(2008-7#1)
by aggressive##3##2##(2008-1#1)(2008-7#1)(2012-3#1)
by aging##2##2##(1994-2#1)(2008-10#1)
by air bags##2##3##(1993-3#1)(1995-5#1)
by air##8##2##(1993-3#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-2#1)
by airborne##3##2##(2008-10#2)(2008-3#1)
by airway epithelial and vascular endothelial cells##2##7##(1991-5#2)
by airway##3##2##(1991-5#2)(2011-2#1)
by alanine##4##2##(2008-10#3)(2010-5#1)
by alcohol##5##2##(1990-9#1)(1992-12#1)(2008-10#1)(2009-7#1)(2012-12#1)
by alkali##3##2##(2008-10#3)
by alkaline extraction##2##3##(1991-9#1)(2008-6#1)
by alkaline phosphatase##2##3##(1993-8#1)(2008-11#1)
by alkaline##8##2##(1991-10#1)(1991-9#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-9#1)
by all of##2##3##(1997-3#1)(2010-7#1)
by all patients##3##3##(2007-8#1)(2008-7#2)
by all the three##2##4##(2008-10#1)(2008-11#1)
by all the##7##3##(1993-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#1)
by all three##6##3##(1996-12#2)(2008-10#3)(2008-11#1)
by all##44##2##(1993-11#2)(1993-12#3)(1993-3#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-9#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-7#3)(2008-9#1)(2010-7#1)(2010-8#2)(2012-12#1)(2013-8#1)
by alliances##3##2##(2013-1#3)
by allowing for##2##3##(2008-10#1)(2008-3#1)
by allowing the##2##3##(2008-11#1)(2008-7#1)
by allowing##12##2##(1990-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#2)(2013-1#1)
by almost##3##2##(1992-3#1)(1994-8#1)(2008-11#1)
by alteration of##3##3##(1995-6#1)(2011-2#1)(2012-3#1)
by alterations in##3##3##(1991-5#1)(1994-5#1)(2012-2#1)
by altered##2##2##(2008-10#2)
by altering the##6##3##(1992-4#1)(2007-12#1)(2008-8#1)(2011-2#2)(2012-2#1)
by altering##10##2##(1990-12#1)(1992-4#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)(2012-2#1)
by alternating current##3##3##(2008-10#3)
by alternative splicing##2##3##(1993-8#1)(1995-12#1)
by alternative##3##2##(1993-8#1)(1995-12#1)(2008-11#1)
by amine##2##2##(2008-10#2)
by amino acid analysis and##2##5##(1995-3#1)(1995-6#1)
by amino acid analysis##5##4##(1991-12#1)(1992-6#1)(1995-3#1)(1995-6#1)(2008-4#1)
by amino acid##9##3##(1991-12#1)(1992-6#1)(1993-12#1)(1995-3#1)(1995-6#2)(1997-7#1)(2008-10#1)(2008-4#1)
by ammonium sulfate precipitation and##3##5##(2008-10#2)(2008-4#1)
by ammonium sulfate precipitation##4##4##(2008-10#3)(2008-4#1)
by ammonium sulfate##5##3##(1991-12#1)(2008-10#3)(2008-4#1)
by ammonium##7##2##(1990-5#1)(1991-12#1)(2008-10#4)(2008-4#1)
by amperometry##2##2##(2008-10#2)
by amplification of##3##3##(2008-10#2)(2013-8#1)
by amplification##5##2##(2008-10#2)(2008-11#1)(2013-8#2)
by amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
by amplified fragment length polymorphism##4##5##(2008-10#4)
by amplified fragment length polymorphisms##2##5##(2008-10#2)
by amplified fragment length##6##4##(2008-10#6)
by amplifying##3##2##(1994-11#1)(1997-4#1)(2011-2#1)
by amygdala lesions##2##3##(1993-6#2)
by an &quot##2##3##(1990-3#1)(2008-8#1)
by an HPLC method##2##4##(2008-10#2)
by an HPLC##3##3##(2008-10#3)
by an aberrant##2##3##(2011-2#1)(2012-3#1)
by an abnormal##3##3##(2008-11#2)(2013-8#1)
by an absence of##2##4##(1991-2#1)(1994-12#1)
by an accumulation of##2##4##(1997-7#1)(2011-2#1)
by an accumulation##4##3##(1997-7#1)(2008-10#2)(2011-2#1)
by an acute##4##3##(1990-8#1)(1990-9#1)(2011-2#1)(2012-3#1)
by an alternative technique##2##4##(2008-10#2)
by an alternative##4##3##(2008-10#3)(2008-9#1)
by an amorphous##2##3##(2008-10#2)
by an analysis of##2##4##(2008-10#2)
by an annular##2##3##(1995-5#1)(2008-10#1)
by an antibody##3##3##(1990-5#1)(1993-12#1)(2008-7#1)
by an atomic absorption##2##4##(2008-10#2)
by an atomic##3##3##(2008-10#3)
by an audit##2##3##(1993-1#2)
by an automated##4##3##(1991-2#1)(2008-10#3)
by an average of##6##4##(1991-5#1)(1997-4#1)(2008-10#2)(2008-8#1)(2013-1#1)
by an average##7##3##(1990-6#1)(1991-5#1)(1997-4#1)(2008-10#2)(2008-8#1)(2013-1#1)
by an early##2##3##(2008-10#1)(2011-3#1)
by an electrical##2##3##(2008-10#2)
by an electrochemical##2##3##(2008-10#2)
by an electronic##2##3##(2008-10#1)(2010-8#1)
by an endoscopic transsphenoidal approach##3##5##(2011-2#3)
by an enhanced##2##3##(2008-10#1)(2008-11#1)
by an environmental##2##3##(1991-12#1)(2013-8#1)
by an equation##2##3##(2008-10#1)(2013-8#1)
by an experienced##2##3##(1991-12#1)(1991-3#1)
by an expert##3##3##(2010-8#2)(2012-2#1)
by an extensive##2##3##(2008-10#1)(2009-8#1)
by an extinguished##2##3##(2008-5#2)
by an increase in the##9##5##(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
by an increase in##23##4##(1992-6#1)(1993-3#1)(1995-11#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-8#3)
by an increase of##2##4##(2008-5#2)
by an increase##28##3##(1992-6#1)(1993-3#1)(1994-11#1)(1995-11#1)(1996-11#1)(1996-2#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-8#3)
by an increased##6##3##(1990-6#1)(1993-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
by an increasing##2##3##(2008-10#1)(2008-5#1)
by an independent##3##3##(1997-3#1)(2008-10#2)
by an indirect mechanism##2##4##(1992-12#1)(2008-10#1)
by an indirect##4##3##(1992-12#1)(2008-10#2)(2008-5#1)
by an individual surface protrusion##2##5##(2008-3#2)
by an individual##3##3##(1996-12#1)(2008-3#2)
by an infinite##2##3##(2008-2#2)
by an inhibition of##2##4##(1992-3#1)(2008-10#1)
by an intense##2##3##(1992-8#1)(2008-2#1)
by an intracellular##2##3##(2008-10#1)(2009-8#1)
by an isocratic##3##3##(2008-10#3)
by an isoleucine to serine mutation##2##6##(2008-10#2)
by an isoleucine to##4##4##(2008-10#4)
by an on-line continuous precipitation-dissolution flow system##2##7##(2008-10#2)
by an on-line##4##3##(1992-11#1)(2008-10#3)
by an open##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
by an optical##2##3##(1995-5#1)(2008-10#1)
by an order of magnitude##5##5##(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
by an unknown##2##3##(2010-10#1)(2012-2#1)
by an##338##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#112)(2008-11#27)(2008-12#5)(2008-2#5)(2008-3#11)(2008-5#8)(2008-7#11)(2008-8#9)(2008-9#3)(2009-1#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#3)(2010-1#3)(2010-10#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#13)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#4)(2012-9#1)(2013-1#8)(2013-8#10)
by analogy to##2##3##(1996-2#1)(2008-8#1)
by analogy##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
by analyses of several##2##4##(2008-10#2)
by analyses of##3##3##(2008-10#3)
by analyses##4##2##(2008-10#4)
by analysing a##4##3##(1992-12#1)(2008-10#3)
by analysing certified reference##2##4##(2008-10#2)
by analysing several certified reference materials##2##6##(2008-10#2)
by analysing several##3##3##(2008-10#3)
by analysing spiked##2##3##(2008-10#2)
by analysing the##2##3##(2008-5#1)(2013-1#1)
by analysing two##3##3##(2008-10#3)
by analysing##27##2##(1992-12#1)(2008-10#22)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
by analysis of certified reference materials and##2##7##(2008-10#2)
by analysis of certified reference materials##3##6##(2008-10#3)
by analysis of certified reference##4##5##(2008-10#4)
by analysis of the##5##4##(2008-10#4)(2008-2#1)
by analysis of variance##2##4##(2008-10#1)(2009-2#1)
by analysis of##33##3##(1991-6#1)(1995-8#1)(1996-2#3)(1996-6#1)(1997-8#1)(2008-10#20)(2008-12#1)(2008-2#1)(2008-9#2)(2009-2#1)(2013-1#1)
by analysis##36##2##(1991-6#1)(1994-5#1)(1995-8#1)(1996-2#3)(1996-6#1)(1997-8#1)(2008-10#22)(2008-12#1)(2008-2#1)(2008-9#2)(2009-2#1)(2013-1#1)
by analytical##2##2##(1994-5#1)(2008-11#1)
by analyzing a certified reference material##3##6##(2008-10#3)
by analyzing a series of seven replicates##2##7##(2008-10#2)
by analyzing a##11##3##(2008-10#11)
by analyzing samples##2##3##(2008-10#1)(2008-5#1)
by analyzing the##9##3##(1992-9#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)
by analyzing two##2##3##(2008-10#2)
by analyzing##57##2##(1992-2#1)(1992-9#1)(1997-2#2)(1997-3#1)(2008-10#38)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
by anchoring##2##2##(2008-10#1)(2013-8#1)
by and large##2##3##(1991-12#1)(2012-2#1)
by and##7##2##(1991-12#1)(1992-3#1)(2008-10#2)(2008-11#1)(2010-10#1)(2012-2#1)
by androgen##3##2##(1991-5#1)(1993-8#1)(2013-1#1)
by angiotensin II##2##3##(1995-12#2)
by anion exchange##2##3##(1995-6#1)(2008-10#1)
by anion-exchange chromatography##3##3##(1992-6#1)(1993-6#1)(2008-10#1)
by anion-exchange##6##2##(1992-6#1)(1993-6#1)(2008-10#4)
by ankle##2##2##(2009-1#1)(2011-2#1)
by annexin V##2##3##(2008-10#1)(2008-11#1)
by annexin##3##2##(2008-10#1)(2008-11#2)
by anodic adsorptive stripping voltammetry##2##5##(2008-10#2)
by anodic stripping differential pulse##2##5##(2008-10#2)
by anodic stripping voltammetry with##2##5##(2008-10#2)
by anodic stripping voltammetry##6##4##(2008-10#6)
by anodic stripping##9##3##(2008-10#9)
by anodic##14##2##(2008-10#14)
by another##13##2##(1992-4#1)(1996-5#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
by anti-Fas antibody##3##3##(2008-8#3)
by antibiotic##2##2##(1990-5#1)(2010-1#1)
by antibodies##5##2##(1994-11#1)(1996-12#1)(1997-5#1)(2008-9#1)(2011-2#1)
by antioxidants##3##2##(1992-9#1)(2008-7#1)(2011-2#1)
by antisense##5##2##(1995-11#1)(2008-8#2)(2008-9#2)
by ants##4##2##(2008-10#3)(2008-8#1)
by any of the##2##4##(2008-11#1)(2008-6#1)
by any other##2##3##(2008-10#1)(2008-8#1)
by any##20##2##(1993-1#1)(1995-2#1)(2008-10#12)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-8#1)
by apolipoprotein E##2##3##(1995-6#1)(1996-2#1)
by apoptosis##11##2##(1993-3#1)(1994-11#2)(1994-3#1)(1995-6#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-2#1)(2013-1#1)
by application of a##2##4##(2008-10#1)(2008-3#1)
by application of the##3##4##(2008-10#2)(2009-8#1)
by application of##15##3##(1994-3#1)(1996-2#1)(2008-10#10)(2008-3#1)(2008-7#1)(2009-8#1)
by application to##3##3##(2008-10#2)(2008-3#1)
by application##20##2##(1994-3#1)(1996-2#1)(2008-10#14)(2008-3#2)(2008-7#1)(2009-8#1)
by applying a##16##3##(2008-10#12)(2008-11#3)(2008-5#1)
by applying an##5##3##(2008-10#3)(2008-11#2)
by applying artificial neural networks##2##5##(2008-10#2)
by applying it to a##2##5##(2008-10#2)
by applying it to##6##4##(2008-10#6)
by applying the method##2##4##(2008-10#2)
by applying the non-linear##2##4##(2010-8#2)
by applying the##8##3##(2008-10#5)(2009-8#1)(2010-8#2)
by applying these##2##3##(2008-10#1)(2008-5#1)
by applying##69##2##(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(2008-10#43)(2008-11#9)(2008-5#4)(2008-6#1)(2008-8#1)(2009-3#2)(2009-8#1)(2010-7#1)(2010-8#2)(2011-2#1)
by appropriate##6##2##(1992-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
by appropriately##2##2##(2008-10#2)
by approximately 1000##2##3##(1991-10#1)(2008-5#1)
by approximately 2##2##3##(2008-10#1)(2008-11#1)
by approximately a##2##3##(1992-6#1)(2008-5#1)
by approximately##27##2##(1991-10#1)(1992-2#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1996-2#1)(1997-2#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-7#1)(2010-4#1)
by aqua regia##2##3##(2008-10#2)
by aquatic HS##2##3##(2008-10#2)
by aqueous##5##2##(2008-10#2)(2008-5#1)(2010-7#1)(2012-3#1)
by arachidonic acid##5##3##(1990-12#1)(1994-11#1)(1995-11#3)
by aromatase##2##2##(1994-2#1)(2012-2#1)
by aromatic##2##2##(2008-10#2)
by around##2##2##(1996-11#1)(2011-2#1)
by artificial inoculation##3##3##(2008-10#3)
by artificial neural networks##3##4##(2008-10#3)
by artificial##8##2##(1997-7#1)(2008-10#6)(2013-1#1)
by as much as 1##2##5##(2008-10#1)(2008-3#1)
by as much as a##3##5##(1995-5#1)(2008-2#1)(2008-3#1)
by as much as##14##4##(1990-10#1)(1995-11#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-9#1)(2012-2#1)(2013-8#1)
by ascorbate##3##2##(2008-10#1)(2009-9#2)
by ascorbic acid##4##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-5#1)
by ascorbic and uric##2##4##(2008-10#2)
by ascorbic##6##2##(1990-5#1)(1993-12#1)(2008-10#3)(2008-5#1)
by ascospores at##2##3##(2008-10#2)
by ascospores##7##2##(2008-10#7)
by ashing the##2##3##(2008-10#2)
by asking##3##2##(1992-12#1)(1995-2#1)(2013-8#1)
by assaying##4##2##(1992-2#1)(2008-10#2)(2008-4#1)
by assessing the##3##3##(2008-10#1)(2009-10#1)(2013-1#1)
by assessing##4##2##(2008-10#1)(2009-10#1)(2009-7#1)(2013-1#1)
by association of##2##3##(1990-2#1)(2012-2#1)
by association##3##2##(1990-2#1)(2008-11#1)(2012-2#1)
by assuming that the##3##4##(1995-9#1)(2008-11#1)(2008-3#1)
by assuming that##5##3##(1995-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
by assuming##10##2##(1995-9#2)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
by astrocyte##3##2##(2008-11#2)(2008-7#1)
by asymmetric##2##2##(2008-8#1)(2011-2#1)
by at least two##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
by at least##15##3##(1993-8#1)(1994-5#1)(1995-5#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
by atmospheric aerosols##3##3##(2008-2#1)(2008-3#2)
by atmospheric##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
by atomic absorption spectrometry (AAS)##3##5##(2008-10#3)
by atomic absorption spectrometry has been##3##6##(2008-10#3)
by atomic absorption spectrometry##24##4##(2008-10#24)
by atomic absorption spectrophotometry with flame##2##6##(2008-10#2)
by atomic absorption spectrophotometry with##3##5##(2008-10#3)
by atomic absorption spectrophotometry##5##4##(2008-10#5)
by atomic absorption spectroscopy (AAS)##2##5##(1996-3#1)(2008-10#1)
by atomic absorption spectroscopy##5##4##(1994-11#1)(1996-3#1)(2008-10#3)
by atomic absorption##37##3##(1994-11#1)(1996-3#1)(2008-10#35)
by atomic fluorescence spectrometry##2##4##(2008-10#2)
by atomic fluorescence##4##3##(2008-10#4)
by atomic force microscopy (AFM)##2##5##(2008-10#2)
by atomic force microscopy in the imaging##2##7##(2008-5#2)
by atomic force microscopy##5##4##(2008-10#3)(2008-5#2)
by atomic force##6##3##(2008-10#3)(2008-5#2)(2008-7#1)
by atomic spectrometry##3##3##(2008-10#3)
by atomic##51##2##(1994-11#1)(1996-3#1)(2008-10#46)(2008-5#2)(2008-7#1)
by attaching##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
by attachment of##2##3##(2008-10#2)
by attenuated total reflectance##3##4##(2008-10#3)
by attenuated total reflection##3##4##(2008-10#3)
by attenuated total##7##3##(2008-10#7)
by atypical##2##2##(1990-6#1)(2008-8#1)
by autoclaving##2##2##(2008-11#2)
by automated##6##2##(1992-6#1)(1994-11#1)(2008-10#4)
by automatic##2##2##(2008-10#1)(2012-3#1)
by automobile##2##2##(2008-11#2)
by autopsy##2##2##(1991-12#1)(2008-5#1)
by autoradiography##2##2##(1991-12#1)(1995-2#1)
by available##2##2##(1991-12#1)(2008-11#1)
by averaging the##2##3##(1992-1#1)(2008-10#1)
by averaging##3##2##(1992-1#1)(2008-10#2)
by avoiding##6##2##(2008-10#2)(2008-6#2)(2008-8#1)(2011-2#1)
by back##2##2##(2008-10#1)(2009-1#1)
by backcrossing to##2##3##(1991-12#1)(2008-10#1)
by backcrossing##3##2##(1991-12#2)(2008-10#1)
by baclofen##2##2##(1990-5#1)(1995-2#1)
by bacteria or##2##3##(2008-10#1)(2010-11#1)
by bacteria##12##2##(2008-10#6)(2008-12#1)(2010-11#1)(2011-1#2)(2011-2#2)
by bacterial##6##2##(2008-10#3)(2009-8#1)(2010-12#1)(2012-2#1)
by base##2##2##(1993-12#1)(1997-6#1)
by basic##3##2##(1995-12#1)(1995-6#1)(2009-8#1)
by batch##8##2##(2008-10#5)(2008-4#1)(2008-7#2)
by behavioral##3##2##(2010-10#1)(2010-5#1)(2013-8#1)
by being##6##2##(1991-12#1)(1995-2#1)(1997-7#2)(2008-9#1)(2010-8#1)
by beneficiaries##2##2##(1991-2#1)(1997-3#1)
by benzoic acid##2##3##(2008-10#2)
by beryllium##2##2##(1990-5#1)(2008-10#1)
by beta-correction spectrophotometry and##2##4##(2008-10#2)
by beta-correction spectrophotometry##3##3##(2008-10#3)
by betaine##2##2##(1991-12#2)
by between##5##2##(2008-10#5)
by bicuculline##3##2##(1992-3#1)(2008-8#1)(2008-9#1)
by bilateral##5##2##(1990-5#1)(1993-3#1)(2009-3#1)(2010-9#1)(2013-1#1)
by binary##2##2##(2008-10#1)(2013-1#1)
by binding of##5##3##(1992-4#1)(1993-8#2)(1994-5#1)(1995-2#1)
by binding to the estrogen receptor##2##6##(2008-11#2)
by binding to the##4##4##(2008-10#1)(2008-11#3)
by binding to##7##3##(1993-9#1)(2008-10#1)(2008-11#3)(2009-8#1)(2010-5#1)
by binding##18##2##(1992-4#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-11#3)(2009-12#1)(2009-8#1)(2010-5#1)
by bioassay##2##2##(1992-6#1)(2008-10#1)
by biochemical##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
by bioelectrical impedance analysis##2##4##(2011-2#1)(2012-3#1)
by biogenic##4##2##(2008-10#4)
by biological and##2##3##(1994-5#1)(2008-10#1)
by biological##5##2##(1992-5#1)(1994-5#1)(2008-10#3)
by biologically##3##2##(2008-10#3)
by biotechnology##2##2##(1994-3#1)(2008-11#1)
by biotinylated##2##2##(1993-6#1)(1997-2#1)
by birth##4##2##(2009-11#4)
by bisphenol A##2##3##(2010-5#2)
by blending##2##2##(2008-5#1)(2009-7#1)
by blinded##3##2##(1997-8#1)(2008-8#1)(2013-1#1)
by blocking the##3##3##(1995-2#1)(2008-8#1)(2013-1#1)
by blocking##11##2##(1990-7#1)(1995-2#2)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
by blood##3##2##(1995-6#1)(2009-7#2)
by body##2##2##(2008-11#1)(2011-2#1)
by bone marrow##2##3##(1997-8#1)(2008-11#1)
by bone##3##2##(1997-8#1)(2008-11#1)(2011-2#1)
by bootstrap##2##2##(2008-10#1)(2010-4#1)
by both batch and column techniques##2##6##(2008-10#2)
by both batch and##3##4##(2008-10#3)
by both cell types##2##4##(1990-2#1)(2008-5#1)
by both direct##2##3##(1991-12#1)(1994-8#1)
by both methods are##2##4##(2008-10#2)
by both methods at##2##4##(2008-10#2)
by both methods##6##3##(2008-10#6)
by both procedures##2##3##(2008-10#2)
by both techniques##3##3##(1992-11#1)(1996-1#1)(2008-10#1)
by both the##16##3##(1992-12#2)(1993-11#1)(2008-10#8)(2008-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
by both transabdominal and transvaginal##2##5##(1996-1#2)
by both##131##2##(1990-2#2)(1990-5#1)(1991-12#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-1#3)(1996-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#62)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
by bovine##6##2##(1994-8#1)(1995-11#1)(1996-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
by brain##3##2##(2008-12#2)(2011-2#1)
by breath##2##2##(2011-2#1)(2013-8#1)
by breeding programs##2##3##(2008-10#1)(2009-8#1)
by bringing##2##2##(1997-2#1)(2008-5#1)
by bromate##4##2##(2008-10#4)
by bromide ions##2##3##(2008-10#2)
by budding##3##2##(2008-10#3)
by building##2##2##(2008-3#1)(2010-10#1)
by bulk##2##2##(2008-10#2)
by bulked segregant analysis##2##4##(2008-10#2)
by bumetanide and##2##3##(1990-5#1)(1992-3#1)
by bushen##2##2##(2013-8#2)
by butyrate##5##2##(1990-3#1)(2008-11#4)
by c-myc##2##2##(1992-6#1)(2008-11#1)
by cAMP in##2##3##(1994-11#2)
by cAMP##5##2##(1994-11#2)(1995-6#1)(2008-11#2)
by cDNA array##3##3##(2008-9#3)
by cDNA##5##2##(1990-5#1)(1997-9#1)(2008-9#3)
by ca##3##2##(2008-10#3)
by cadmium##2##2##(1993-12#2)
by calcium##4##2##(1994-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
by calculating the average##2##4##(1993-3#1)(1996-8#1)
by calculating the distances##2##4##(2010-7#2)
by calculating the##12##3##(1993-3#1)(1996-12#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2010-4#1)(2010-7#2)
by calculating##17##2##(1993-3#1)(1996-12#1)(1996-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2010-4#1)(2010-7#2)(2010-8#1)(2012-2#1)
by calculation##2##2##(2008-11#1)(2008-3#1)
by calibration##4##2##(2008-10#3)(2008-9#1)
by cancer cells##2##3##(2008-11#1)(2009-4#1)
by cancer##8##2##(1990-3#1)(1990-9#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-4#1)(2013-1#1)
by capillary electrophoresis (CE) with##3##5##(2008-10#3)
by capillary electrophoresis (CE)##6##4##(2008-10#6)
by capillary electrophoresis in##2##4##(2008-10#1)(2008-12#1)
by capillary electrophoresis with electrochemical detection##3##6##(2008-10#3)
by capillary electrophoresis with laser-induced fluorescence##2##6##(2008-10#2)
by capillary electrophoresis with##9##4##(2008-10#9)
by capillary electrophoresis##48##3##(1997-2#1)(2008-10#46)(2008-12#1)
by capillary gas chromatography##2##4##(2008-10#2)
by capillary isotachophoresis##3##3##(2008-10#3)
by capillary zone electrophoresis (CZE)##3##5##(2008-10#3)
by capillary zone electrophoresis using##2##5##(2008-10#2)
by capillary zone electrophoresis with##6##5##(2008-10#6)
by capillary zone electrophoresis##29##4##(1992-12#2)(2008-10#27)
by capillary##89##2##(1991-2#1)(1992-12#2)(1997-2#3)(2008-10#82)(2008-12#1)
by capsaicin##3##2##(2008-11#3)
by carbachol was##2##3##(1994-11#1)(1996-12#1)
by carbamylcholine chloride##2##3##(1995-8#2)
by carbon paste electrode##2##4##(2008-10#2)
by carbon##7##2##(1991-9#2)(1993-6#1)(2008-10#3)(2008-11#1)
by cardiac##3##2##(1993-3#1)(1993-6#1)(1994-5#1)
by cardiovascular##2##2##(1996-11#1)(2009-10#1)
by carefully##2##2##(2008-5#1)(2008-7#1)
by caregivers##2##2##(1992-3#1)(2010-10#1)
by carrying out the##3##4##(2008-10#2)(2011-2#1)
by carrying out##7##3##(1990-11#1)(2008-10#5)(2011-2#1)
by case##3##2##(1996-3#1)(2008-8#1)(2013-1#1)
by casein kinase II##2##4##(1993-8#2)
by casein kinase##3##3##(1993-8#3)
by casting##3##2##(2008-10#3)
by catalase##2##2##(1993-6#1)(2008-10#1)
by catalysis of the##2##4##(2008-10#2)
by catalytic adsorptive##3##3##(2008-10#3)
by catalytic##4##2##(2008-10#4)
by cathepsin D##2##3##(1994-5#1)(1995-8#1)
by cathodic stripping voltammetry at##2##5##(2008-10#2)
by cathodic stripping voltammetry##5##4##(2008-10#5)
by cathodic stripping##9##3##(2008-10#9)
by cathodic##10##2##(2008-10#10)
by cationic##3##2##(2008-10#1)(2008-8#2)
by causing a##2##3##(2008-10#1)(2008-7#1)
by causing##7##2##(1997-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
by cell culture##2##3##(2008-11#1)(2008-5#1)
by cell fusion##2##3##(1993-3#1)(2008-11#1)
by cell##23##2##(1991-5#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-8#1)
by cells##12##2##(1994-11#1)(1994-8#2)(2008-11#5)(2008-8#1)(2010-8#1)(2011-2#2)
by cellular##6##2##(1994-3#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
by cellulase##3##2##(2008-10#3)
by central##6##2##(1992-6#1)(1996-2#1)(2008-10#3)(2010-12#1)
by centrifugation and##4##3##(1992-12#1)(1994-6#1)(2008-10#1)(2008-5#1)
by centrifugation##9##2##(1992-12#1)(1994-6#1)(2008-10#4)(2008-11#1)(2008-5#2)
by cerebral##2##2##(1992-6#1)(2008-7#1)
by certain##6##2##(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)
by cesium chloride##2##3##(2008-10#1)(2008-9#1)
by challenging##2##2##(2008-10#1)(2008-9#1)
by chance##4##2##(1993-3#1)(1994-2#1)(2008-10#1)(2011-2#1)
by changes in the time##2##5##(2011-2#2)
by changes in the##8##4##(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(2009-12#1)(2011-2#2)(2013-7#1)
by changes in##22##3##(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-8#1)(2008-9#3)(2009-12#1)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
by changes##24##2##(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
by changing the##23##3##(1990-5#1)(1990-6#1)(1992-6#1)(1997-1#1)(2008-10#13)(2008-2#1)(2008-3#2)(2008-9#2)(2011-2#1)
by changing##30##2##(1990-5#1)(1990-6#1)(1992-6#1)(1995-6#2)(1997-1#2)(1997-8#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)
by characterization of##2##3##(2008-10#2)
by characterizing##2##2##(2008-10#2)
by chelation##2##2##(1996-5#1)(2008-10#1)
by chemical reduction method##2##4##(2012-2#2)
by chemical reduction##3##3##(2008-10#1)(2012-2#2)
by chemical##22##2##(1990-5#1)(1992-3#1)(1993-3#1)(1993-8#2)(1994-9#1)(1995-2#1)(1995-9#1)(2008-10#8)(2008-5#1)(2010-4#1)(2010-6#1)(2012-2#3)
by chemicals##2##2##(2008-11#1)(2008-5#1)
by chemiluminescence##5##2##(2008-10#5)
by chemometric##4##2##(2008-10#4)
by chemotherapy##8##2##(1990-8#1)(2007-8#2)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
by chicken##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
by children and##3##3##(1995-5#1)(2008-11#2)
by children##5##2##(1995-5#1)(2008-11#2)(2010-12#1)(2012-2#1)
by chitin##2##2##(2008-10#2)
by chlorine##2##2##(1991-6#1)(2008-10#1)
by chloroperoxidase##2##2##(1994-5#2)
by chloroquine and##2##3##(1993-8#1)(1995-8#1)
by cholesterol##2##2##(1991-9#1)(2008-4#1)
by chondrocytes##3##2##(1993-12#2)(2011-2#1)
by choosing##3##2##(2008-12#2)(2008-9#1)
by chromatin##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
by chromatographic and##2##3##(1997-1#1)(2008-11#1)
by chromatographic techniques##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
by chromatographic##6##2##(1997-1#1)(2008-10#2)(2008-11#2)(2010-4#1)
by chromatography on##2##3##(1995-11#1)(1996-6#1)
by chromatography##4##2##(1995-11#1)(1996-6#1)(2008-10#2)
by chromium(VI) in##2##3##(2008-10#2)
by chromosome##2##2##(2008-11#1)(2008-9#1)
by chronic EtOH treatment##2##4##(2008-10#2)
by chronic EtOH##3##3##(2008-10#3)
by chronic granulomatous##2##3##(1990-3#1)(2008-5#1)
by chronic pain patients##2##4##(1991-1#1)(2010-9#1)
by chronic pain##3##3##(1991-1#1)(1997-8#1)(2010-9#1)
by chronic##18##2##(1990-3#1)(1991-1#1)(1991-11#1)(1991-4#2)(1991-5#1)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#3)(2008-5#3)(2008-7#1)(2010-9#1)
by chronically mentally ill Medicaid##2##5##(1994-2#2)
by cigarette##2##2##(1991-12#1)(1993-8#1)
by circular dichroism##2##3##(1990-5#1)(2008-4#1)
by circular##3##2##(1990-5#1)(2008-11#1)(2008-4#1)
by circulating##2##2##(1990-6#1)(2008-7#1)
by citrus##2##2##(2008-10#1)(2013-8#1)
by clarifying the##2##3##(2008-11#1)(2013-1#1)
by class##4##2##(2007-12#1)(2009-7#1)(2013-1#2)
by classical methods##2##3##(2008-10#2)
by classical##10##2##(2007-12#1)(2008-10#5)(2008-12#2)(2008-5#1)(2010-5#1)
by clear##2##2##(1991-8#1)(2008-7#1)
by cleavage with cyanogen bromide##2##5##(1990-5#2)
by cleavage##3##2##(1990-5#2)(2008-10#1)
by cleaving##2##2##(1992-4#1)(2011-1#1)
by clients##2##2##(1996-2#1)(2008-9#1)
by climate##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
by clinical and##2##3##(2008-11#1)(2009-1#1)
by clinical##7##2##(1991-8#1)(1992-5#1)(2008-10#1)(2008-11#2)(2009-1#1)(2013-1#1)
by clinicians and##2##3##(2008-11#1)(2008-12#1)
by clinicians##5##2##(1991-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2013-1#1)
by clofibrate##2##2##(1990-12#1)(1990-2#1)
by clonal##2##2##(2008-10#1)(2013-1#1)
by cloning and sequencing##2##4##(1995-6#1)(2008-10#1)
by cloning and##4##3##(1991-5#1)(1995-6#1)(2008-10#1)(2008-8#1)
by cloning##7##2##(1991-5#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
by closed##2##2##(1990-5#1)(2013-8#1)
by closely##2##2##(2008-10#1)(2008-2#1)
by closing##2##2##(2008-10#2)
by cloud-point extraction##2##3##(2008-10#2)
by co-culturing the##2##3##(2008-11#2)
by co-injecting##2##2##(2008-10#1)(2013-1#1)
by co-injection of##2##3##(1991-12#1)(1993-12#1)
by coating##4##2##(2008-10#4)
by cochlear implant##2##3##(2008-9#2)
by cochlear##3##2##(2008-9#3)
by coculturing##2##2##(2008-11#2)
by coexisting##3##2##(2008-10#2)(2012-2#1)
by coexpression of##2##3##(1993-6#1)(1995-11#1)
by colchicine##2##2##(1993-6#1)(2008-11#1)
by cold vapor atomic absorption spectrometry##4##6##(2008-10#4)
by cold vapour atomic absorption spectrometry (CVAAS)##2##7##(2008-10#2)
by cold vapour atomic absorption spectrometry##4##6##(2008-10#4)
by cold vapour atomic absorption##5##5##(2008-10#5)
by cold##12##2##(1995-11#1)(2008-10#10)(2009-8#1)
by collecting data##2##3##(2008-11#1)(2008-5#1)
by collecting##9##2##(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-2#1)
by column chromatography##4##3##(2008-10#1)(2008-9#1)(2009-6#1)(2012-2#1)
by column method##3##3##(2008-10#3)
by column##13##2##(1990-11#1)(2008-10#8)(2008-4#1)(2008-9#1)(2009-6#1)(2012-2#1)
by combination of flow injection##2##5##(2008-10#2)
by combination of##8##3##(2008-10#6)(2008-7#1)(2011-2#1)
by combinatorial##2##2##(2008-4#1)(2011-2#1)
by combined##8##2##(1990-3#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)
by combining liquid chromatography and##2##5##(2008-10#2)
by combining the##6##3##(2008-10#3)(2008-11#1)(2012-2#2)
by combining##34##2##(1990-5#1)(1993-2#1)(1995-5#1)(1996-1#1)(1997-6#2)(2008-10#12)(2008-11#3)(2008-2#1)(2008-6#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-2#4)(2013-1#1)
by combustion##2##2##(2008-10#2)
by commercial##7##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)
by commercially##2##2##(2008-10#1)(2009-11#1)
by committees##2##2##(1994-12#1)(1996-1#1)
by common solvent##2##3##(2012-2#2)
by common##7##2##(1993-6#1)(1996-12#1)(2008-10#1)(2011-2#1)(2012-2#3)
by community pharmacists##2##3##(2008-11#1)(2011-1#1)
by community##5##2##(1997-2#1)(2008-11#1)(2010-10#1)(2011-1#1)(2013-1#1)
by comparative##8##2##(1996-2#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#2)
by comparing results##2##3##(2008-10#2)
by comparing the concentrations##2##4##(2008-10#2)
by comparing the results obtained##2##5##(2008-10#2)
by comparing the results with##3##5##(2008-10#3)
by comparing the results##5##4##(2008-10#5)
by comparing the##29##3##(1992-9#1)(1994-5#1)(1997-2#1)(1997-6#1)(2008-10#19)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)(2010-6#1)
by comparing their##2##3##(2008-10#1)(2013-1#1)
by comparing them with##2##4##(2008-10#1)(2011-3#1)
by comparing with##3##3##(2008-10#2)(2008-5#1)
by comparing##60##2##(1991-3#1)(1992-9#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#34)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#3)(2012-12#1)(2013-1#1)
by comparison of the results##2##5##(2008-10#2)
by comparison of the##6##4##(1991-5#1)(2007-11#1)(2008-10#3)(2010-12#1)
by comparison of##10##3##(1991-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#2)(2010-12#1)
by comparison to##2##3##(1997-2#1)(2008-10#1)
by comparison with a##4##4##(2008-10#3)(2008-3#1)
by comparison with the##5##4##(1997-8#1)(2008-10#3)(2008-8#1)
by comparison with##19##3##(1992-6#1)(1994-5#1)(1997-8#1)(2008-10#13)(2008-3#2)(2008-8#1)
by comparison##34##2##(1991-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#19)(2008-12#1)(2008-3#4)(2008-8#1)(2010-12#1)
by comparisons##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
by competing##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
by competition##8##2##(1995-2#2)(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)
by competitive polymerase chain reaction##2##5##(1995-12#1)(2008-10#1)
by competitive##5##2##(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
by complementary##2##2##(2008-10#1)(2008-8#1)
by complementation##6##2##(1993-9#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-9#1)
by complete##2##2##(2008-11#1)(2012-3#1)
by complex##10##2##(1991-3#1)(1992-9#1)(1997-7#1)(1997-8#1)(2010-11#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
by complexation with##4##3##(2008-10#4)
by complexation##5##2##(2008-10#5)
by complexing with##2##3##(2008-10#2)
by complexing##3##2##(2008-10#3)
by components of the##3##4##(2008-7#1)(2009-8#1)(2010-2#1)
by compounds##2##2##(1991-5#1)(2008-10#1)
by computational##3##2##(2008-11#2)(2008-7#1)
by computed tomography##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
by computed##5##2##(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
by computer##5##2##(1991-2#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
by computerised##2##2##(2010-5#1)(2011-2#1)
by computing the mean##2##4##(1992-9#1)(2008-10#1)
by computing the##3##3##(1992-9#1)(2008-10#1)(2009-7#1)
by computing##5##2##(1992-9#1)(1997-3#1)(2008-10#2)(2009-7#1)
by concentrated##3##2##(2008-10#3)
by concentrating##2##2##(1993-12#1)(2008-10#1)
by concentration##2##2##(2008-10#1)(2008-2#1)
by concerns##2##2##(1992-1#1)(1992-2#1)
by concurrent##2##2##(1990-5#1)(2008-10#1)
by conditioned##5##2##(1993-6#2)(1996-5#1)(2008-11#1)(2012-4#1)
by conducting a##2##3##(2008-10#1)(2008-8#1)
by conducting##7##2##(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)
by conductivity##2##2##(2008-10#2)
by confocal laser scanning microscopy##2##5##(2008-11#2)
by confocal laser##3##3##(2007-12#1)(2008-11#2)
by confocal microscopy##3##3##(2008-10#2)(2008-11#1)
by confocal##7##2##(2007-12#1)(2008-10#2)(2008-11#3)(2013-1#1)
by conidia##5##2##(2008-10#5)
by conjugation##2##2##(2008-10#2)
by consecutive##2##2##(2008-10#2)
by consensus##7##2##(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#3)
by conserving##2##2##(2008-11#1)(2012-2#1)
by considering the##6##3##(2008-10#4)(2008-11#1)(2008-3#1)
by considering##14##2##(1997-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-8#1)
by constant##2##2##(1995-11#1)(2008-10#1)
by constant-wavelength synchronous spectrofluorimetry in##2##5##(2008-10#2)
by constructing nuclear and mitochondrial gene genealogies##2##7##(2008-10#2)
by constructing##5##2##(2008-10#3)(2008-8#1)(2010-7#1)
by consumers in##2##3##(2007-12#1)(2008-5#1)
by consumers##3##2##(2007-12#1)(2008-5#2)
by consumption of##2##3##(2011-2#1)(2012-2#1)
by contact sensitizers##2##3##(2008-10#2)
by contact with the##2##4##(1995-2#1)(2008-10#1)
by contact with##5##3##(1995-2#1)(1995-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
by contact##9##2##(1995-2#2)(1995-9#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-8#1)
by contamination##2##2##(2008-11#1)(2008-5#1)
by continuous exposure to##2##4##(2008-11#1)(2008-12#1)
by continuous flow##2##3##(2008-10#2)
by continuous hydride generation##2##4##(2008-10#2)
by continuous##16##2##(1995-2#1)(1996-2#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#1)
by contrast##9##2##(1991-3#1)(1992-3#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#3)
by control##3##2##(1995-2#1)(2008-9#2)
by controlled proteolysis##2##3##(1995-6#1)(2008-7#1)
by controlled##6##2##(1991-7#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-7#1)(2009-7#1)
by controlling the levels of##2##5##(1992-12#2)
by controlling the##6##3##(1992-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)
by controlling##10##2##(1992-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-9#1)(2012-2#1)
by convenience##2##2##(2013-1#2)
by conventional electron microscopy##2##4##(2008-5#1)(2008-8#1)
by conventional methods##3##3##(1994-8#1)(2008-11#1)(2012-12#1)
by conventional nebulisation##2##3##(2008-10#2)
by conventional##34##2##(1990-11#1)(1991-7#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(2008-10#15)(2008-11#3)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#2)(2010-12#1)(2012-12#1)(2013-1#1)
by conversion of the##2##4##(1996-12#1)(2007-12#1)
by conversion of##6##3##(1990-11#1)(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#2)
by conversion##8##2##(1990-11#1)(1995-9#1)(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#3)
by coordinating##2##2##(1996-3#1)(2008-10#1)
by copolymerization of styrene and poly(ethylene oxide) macromonomer##2##8##(2008-10#2)
by copolymerization of##3##3##(2007-12#1)(2008-10#2)
by copper##4##2##(2008-10#4)
by copper(II)##2##2##(2008-10#2)
by coprecipitation with##2##3##(2008-10#2)
by coprecipitation##4##2##(2008-10#4)
by coronary angiography##2##3##(2008-10#1)(2011-2#1)
by coronary##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
by correlating the##2##3##(2008-10#2)
by correlating##3##2##(1997-6#1)(2008-10#2)
by correlation##2##2##(2008-1#1)(2008-10#1)
by cortical##3##2##(1995-12#1)(2008-7#2)
by cosinor##2##2##(2008-11#2)
by counting##7##2##(1993-8#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-8#1)
by country##2##2##(2009-7#1)(2012-3#1)
by coupling CHA with##2##4##(2008-10#2)
by coupling a##3##3##(2008-10#3)
by coupling it through##2##4##(2008-10#2)
by coupling it##3##3##(2008-10#3)
by coupling of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
by coupling the##4##3##(2008-10#3)(2008-4#1)
by coupling with##4##3##(2008-10#4)
by coupling##25##2##(2008-10#22)(2008-3#1)(2008-4#1)(2012-2#1)
by covalent approach##2##3##(2008-10#2)
by covalent attachment##2##3##(1995-6#1)(2008-10#1)
by covalent##8##2##(1995-6#1)(2008-10#7)
by creating a##6##3##(1993-12#1)(1995-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)
by creating##9##2##(1993-12#1)(1995-12#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)
by crop rotation and##2##4##(2008-12#2)
by crop rotation##4##3##(2008-10#2)(2008-12#2)
by cross pathogenicity##2##3##(2008-10#2)
by cross##3##2##(2008-10#3)
by cross-linking with glutaraldehyde##4##4##(2008-10#4)
by cross-linking##6##2##(2008-10#4)(2008-5#1)(2009-10#1)
by cross-validation##2##2##(2008-10#2)
by crossing resistant##2##3##(2008-10#2)
by crossing##7##2##(1994-3#1)(2008-10#6)
by crosslinking##3##2##(1993-8#1)(1995-2#1)(2008-10#1)
by crowded glands with##2##4##(2011-2#2)
by crude##2##2##(2008-12#1)(2010-12#1)
by cultivar##2##2##(2008-10#2)
by cultural##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
by culture isolation##2##3##(2008-5#2)
by culture on##2##3##(2008-11#1)(2009-11#1)
by culture##11##2##(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#4)(2009-11#1)(2009-7#1)(2011-2#1)
by culturing a##2##3##(2008-11#2)
by culturing##6##2##(2008-11#5)(2008-9#1)
by curcumin##3##2##(2008-10#1)(2011-2#2)
by current##4##2##(1990-2#1)(1997-3#1)(2008-8#1)(2013-8#1)
by cyanide##2##2##(1992-12#2)
by cyclic and##4##3##(2008-10#4)
by cyclic voltammetry (CV) and##2##5##(2008-10#2)
by cyclic voltammetry (CV)##8##4##(2008-10#8)
by cyclic voltammetry and##6##4##(2008-10#5)(2013-1#1)
by cyclic voltammetry##30##3##(2008-10#29)(2013-1#1)
by cyclic##39##2##(1994-11#1)(2008-10#36)(2008-4#1)(2013-1#1)
by cyclization##2##2##(2008-10#1)(2008-8#1)
by cycloheximide##2##2##(1995-6#1)(2008-11#1)
by cyclosporine A##2##3##(1992-12#1)(1994-8#1)
by cysteine##2##2##(2008-10#2)
by cystic##2##2##(1992-12#1)(1992-9#1)
by cytochemical##3##2##(1993-11#1)(2008-10#2)
by cytokines##4##2##(1994-3#1)(1997-1#1)(2008-5#1)(2012-2#1)
by cytometry##2##2##(2008-11#1)(2008-9#1)
by cytoplasmic##4##2##(1990-8#1)(2008-7#1)(2008-8#1)(2013-1#1)
by daily##3##2##(2008-10#2)(2013-8#1)
by data from##2##3##(1996-11#1)(2008-11#1)
by data##4##2##(1996-11#1)(2008-10#2)(2008-11#1)
by day##6##2##(1990-12#1)(1993-12#1)(2006-6#1)(2008-11#2)(2011-9#1)
by decomposition##2##2##(2008-10#2)
by decrease in##2##3##(2008-10#1)(2013-7#1)
by decreased##2##2##(1993-2#1)(1995-2#1)
by decreases in##2##3##(1991-3#1)(1997-1#1)
by decreasing its##2##3##(1990-5#1)(2008-10#1)
by decreasing the##4##3##(1990-5#1)(2008-11#1)(2008-7#1)(2012-2#1)
by decreasing##11##2##(1990-5#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)
by defining a##2##3##(1993-12#1)(2008-10#1)
by defining the##3##3##(1991-12#1)(2010-10#1)(2012-2#1)
by defining##6##2##(1991-12#1)(1993-12#1)(1994-1#1)(2008-10#1)(2010-10#1)(2012-2#1)
by degenerative disc disease##2##4##(2011-2#1)(2012-12#1)
by delayed##4##2##(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
by delaying the##2##3##(2008-10#1)(2010-12#1)
by delaying##4##2##(2008-10#2)(2008-7#1)(2010-12#1)
by deletion##3##2##(1995-6#2)(2008-9#1)
by delivering##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
by dementia##2##2##(2008-5#1)(2008-7#1)
by demonstrating that##3##3##(2009-12#1)(2009-4#1)(2013-8#1)
by demonstrating##6##2##(1991-11#1)(1993-12#1)(1996-2#1)(2009-12#1)(2009-4#1)(2013-8#1)
by denaturing gradient gel electrophoresis (DGGE)##2##6##(2008-10#1)(2010-6#1)
by denaturing gradient gel electrophoresis##3##5##(2008-10#2)(2010-6#1)
by denaturing##4##2##(2008-10#3)(2010-6#1)
by densitometry##3##2##(1990-6#1)(2008-4#2)
by density gradient centrifugation##3##4##(1994-8#1)(2008-9#1)(2011-2#1)
by dental##4##2##(2008-4#2)(2011-2#1)(2012-3#1)
by deposition##3##2##(2008-10#3)
by derivative spectrophotometric##3##3##(2008-10#3)
by derivative spectrophotometry##4##3##(2008-10#4)
by derivative##10##2##(2008-10#10)
by derivatization with##2##3##(2008-11#2)
by dermal application for 26##2##5##(2008-9#2)
by describing##3##2##(1992-2#1)(2008-6#1)(2008-8#1)
by detailed##2##2##(2009-3#1)(2011-2#1)
by detecting the##2##3##(2008-3#1)(2009-12#1)
by detecting##9##2##(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-12#1)(2009-6#1)(2010-8#1)
by detection of##5##3##(2008-10#3)(2008-3#1)(2008-9#1)
by determination of the##3##4##(1994-11#1)(2008-10#2)
by determination of##5##3##(1994-11#1)(2008-10#4)
by determination##6##2##(1994-11#1)(2008-10#5)
by determining the total##2##4##(2008-10#2)
by determining the##19##3##(1992-4#1)(1994-3#1)(2008-10#12)(2008-11#2)(2008-5#2)(2011-2#1)
by determining##33##2##(1992-4#1)(1994-3#1)(1996-12#1)(2008-10#22)(2008-11#3)(2008-5#2)(2008-8#2)(2011-2#1)
by developing a##3##3##(2008-10#2)(2008-11#1)
by developing##6##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)
by development of a##2##4##(2010-1#1)(2013-1#1)
by development of##3##3##(1992-12#1)(2010-1#1)(2013-1#1)
by dew##3##2##(2008-10#3)
by dexamethasone##5##2##(1993-3#1)(1995-8#1)(1997-1#2)(2008-11#1)
by diabetes##3##2##(2008-4#1)(2011-3#1)(2013-1#1)
by diagnosis-related##2##2##(1991-3#1)(1992-2#1)
by diagnostic##2##2##(2008-10#2)
by dialysis##2##2##(1994-11#1)(2008-4#1)
by dichloromethane##2##2##(2008-10#2)
by dielectric##2##2##(2008-3#2)
by diene##2##2##(1991-5#1)(1994-5#1)
by diepoxybutane##2##2##(1997-3#1)(2008-4#1)
by diet##2##2##(1991-2#2)
by dietary##6##2##(1993-12#1)(1995-9#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-3#1)
by difference##9##2##(1991-3#1)(2008-10#7)(2008-2#1)
by difference-frequency##2##2##(2008-2#1)(2008-3#1)
by differences in##9##3##(2008-10#3)(2008-8#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
by differences##11##2##(2008-10#4)(2008-8#3)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
by different authors##3##3##(1994-3#1)(2008-10#1)(2013-1#1)
by different degrees of##2##4##(1991-7#1)(1994-11#1)
by different effectors##2##3##(1990-3#2)
by different kinds of##2##4##(2008-3#1)(2008-4#1)
by different levels of##2##4##(2008-10#1)(2012-3#1)
by different mechanisms##5##3##(1991-1#1)(1991-5#1)(1997-8#1)(2012-3#2)
by different pathways##2##3##(1995-6#1)(2008-10#1)
by different strains##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
by different##73##2##(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-3#2)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#22)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
by differential absorption##2##3##(2008-2#1)(2008-3#1)
by differential centrifugation##2##3##(1993-8#1)(2008-10#1)
by differential pulse adsorptive stripping voltammetry##3##6##(2008-10#3)
by differential pulse anodic stripping voltammetry (DPASV)##3##7##(2008-10#3)
by differential pulse anodic stripping voltammetry##11##6##(2008-10#11)
by differential pulse cathodic stripping##2##5##(2008-10#2)
by differential pulse polarography (DPP)##4##5##(2008-10#4)
by differential pulse polarography##10##4##(2008-10#10)
by differential pulse stripping##2##4##(2008-10#2)
by differential pulse voltammetry##5##4##(2008-10#5)
by differential pulse##36##3##(2008-10#36)
by differential scanning calorimetry (DSC)##3##5##(1993-8#1)(2008-10#1)(2008-11#1)
by differential scanning calorimetry##6##4##(1993-8#3)(2008-10#1)(2008-11#1)(2011-2#1)
by differential##55##2##(1990-11#1)(1992-9#1)(1993-8#4)(2007-12#1)(2008-10#41)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#1)
by differentiation##2##2##(2008-11#2)
by diffuse reflectance##5##3##(2008-10#5)
by diffusion##5##2##(1990-12#1)(1991-5#1)(2008-10#3)
by digestion of the##4##4##(2008-10#3)(2008-2#1)
by digestion of##6##3##(1992-6#1)(1996-12#1)(2008-10#3)(2008-2#1)
by digestion with##5##3##(1990-2#1)(1990-5#1)(1992-6#1)(2008-1#2)
by digestion##11##2##(1990-2#1)(1990-5#1)(1992-6#2)(1996-12#1)(2008-1#2)(2008-10#3)(2008-2#1)
by digital##4##2##(1991-7#1)(2008-10#2)(2008-11#1)
by dilute##2##2##(2008-10#2)
by dimethyl sulfoxide##3##3##(1993-3#2)(2008-10#1)
by diode laser##2##3##(2008-10#1)(2008-3#1)
by diode##3##2##(2008-10#2)(2008-3#1)
by dipping##2##2##(2008-10#1)(2010-1#1)
by direct and derivative##2##4##(2008-10#2)
by direct and##4##3##(2008-10#3)(2008-11#1)
by direct chemiluminescence##2##3##(2008-10#2)
by direct contact##2##3##(1995-11#1)(2008-10#1)
by direct interaction##2##3##(1993-8#2)
by direct protein##2##3##(1991-6#1)(2008-9#1)
by direct##60##2##(1990-5#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-8#1)(2008-10#28)(2008-11#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-4#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
by directed##2##2##(2008-8#1)(2008-9#1)
by directly measuring the##2##4##(1991-3#1)(2008-10#1)
by directly##4##2##(1991-3#1)(1995-3#1)(2008-10#1)(2008-9#1)
by discussing the##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
by discussing##8##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
by disease##2##2##(2008-10#1)(2008-5#1)
by dispersal##2##2##(2008-8#1)(2008-9#1)
by dispersion##3##2##(2008-10#2)(2008-3#1)
by disrupting the##2##3##(2008-10#1)(2008-7#1)
by disrupting##4##2##(1995-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
by dissolved oxygen##2##3##(2008-10#2)
by dissolved##3##2##(2008-10#3)
by dissolving##7##2##(2008-10#4)(2008-5#1)(2010-4#1)(2012-2#1)
by distal##2##2##(2008-12#1)(2011-2#1)
by distance##12##2##(2008-10#6)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#2)
by distillation in the presence of##2##6##(2008-10#2)
by distillation##4##2##(2008-10#4)
by distinct##7##2##(1990-5#1)(1995-2#1)(2008-10#3)(2011-2#1)(2012-2#1)
by diverse##3##2##(1996-6#1)(2008-10#2)
by dividing##3##2##(1993-6#1)(2008-8#1)(2008-9#1)
by docking##2##2##(1991-6#1)(2013-8#1)
by doctors##6##2##(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)
by dog##2##2##(2008-10#1)(2013-1#1)
by dopamine##2##2##(2008-10#1)(2008-7#1)
by dopaminergic##2##2##(1995-11#1)(1996-2#1)
by doping##2##2##(2008-10#2)
by dose##3##2##(2008-10#3)
by double photon absorptiometry##2##4##(1991-11#2)
by double##4##2##(1991-11#2)(2008-10#2)
by double-antibody##2##2##(2008-10#2)
by down-regulating##2##2##(2008-11#1)(2012-3#1)
by downregulating the expression of##2##5##(2009-8#1)(2012-12#1)
by downregulating##4##2##(2009-8#1)(2012-12#2)(2013-1#1)
by doxorubicin treatment##2##3##(2011-2#2)
by doxorubicin##4##2##(1991-6#1)(2011-2#3)
by doxycycline]##2##2##(1997-5#1)(2009-5#1)
by dramatic##2##2##(1991-3#1)(2008-8#1)
by drawing and discharging##2##4##(2008-10#2)
by drawing##3##2##(1995-8#1)(2008-10#2)
by drinking water##2##3##(2008-9#2)
by drought##2##2##(2008-8#1)(2012-6#1)
by drug##5##2##(1990-9#1)(1993-12#1)(1995-1#1)(2008-10#1)(2013-8#1)
by drugs##4##2##(1990-11#1)(1990-9#1)(2008-7#1)(2009-4#1)
by dry ashing##2##3##(2008-10#2)
by dry periods##2##3##(2008-10#2)
by dry##4##2##(2008-10#4)
by drying##2##2##(2008-10#1)(2012-2#1)
by dual photon absorptiometry##2##4##(1991-11#2)
by dual##3##2##(1991-11#2)(2008-10#1)
by dual-energy##2##2##(2008-8#1)(2011-2#1)
by each sample##2##3##(2008-10#1)(2008-4#1)
by each sponsor sector##2##4##(1991-12#1)(1994-1#1)
by each##20##2##(1991-12#1)(1992-2#1)(1994-1#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-3#1)(2013-1#1)
by earlier##2##2##(1992-3#1)(2008-7#1)
by early diagnosis##2##3##(1992-9#1)(2013-1#1)
by early##6##2##(1990-9#1)(1992-1#1)(1992-9#2)(2008-11#1)(2013-1#1)
by echocardiography and the##2##4##(2008-11#2)
by echocardiography##8##2##(1997-8#2)(2008-10#1)(2008-11#4)(2011-2#1)
by ecological and##2##3##(2008-8#1)(2008-9#1)
by ecological##5##2##(2008-8#2)(2008-9#1)(2010-10#1)(2012-3#1)
by economic##2##2##(2008-10#1)(2008-11#1)
by education##2##2##(1995-12#1)(2009-10#1)
by either C##2##3##(2008-10#2)
by either a##6##3##(1992-1#1)(1994-5#1)(2008-10#3)(2013-8#1)
by either direct##2##3##(2008-5#1)(2009-9#1)
by either of the##2##4##(1993-11#1)(2008-10#1)
by either##51##2##(1991-5#1)(1992-1#1)(1992-11#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-2#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#5)(2009-9#1)(2011-10#1)(2012-12#1)(2013-8#2)
by electric##3##2##(1997-6#2)(2008-10#1)
by electrical stimulation of the##3##5##(1996-2#1)(2010-7#2)
by electrical stimulation of##4##4##(1996-2#2)(2010-7#2)
by electrical stimulation##7##3##(1996-2#2)(2008-9#1)(2009-8#1)(2010-7#2)(2011-2#1)
by electrical##13##2##(1991-5#1)(1996-2#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#2)(2011-2#3)
by electro-optic##2##2##(2008-2#1)(2013-8#1)
by electroacupuncture##4##2##(1995-12#1)(1996-12#2)(2010-7#1)
by electroantennography##2##2##(2008-10#2)
by electrochemical and##2##3##(2008-10#2)
by electrochemical deposition##3##3##(2008-10#3)
by electrochemical impedance##2##3##(2008-10#2)
by electrochemical method##2##3##(2008-10#2)
by electrochemical##11##2##(2008-10#11)
by electrochemically##2##2##(2008-10#2)
by electrodeposition of##4##3##(2008-10#3)(2010-4#1)
by electrodeposition##5##2##(2008-10#4)(2010-4#1)
by electrolysis##2##2##(2008-10#1)(2008-11#1)
by electron and##2##3##(2008-10#1)(2010-7#1)
by electron beam evaporation##3##4##(2008-10#3)
by electron beam irradiation##5##4##(1991-6#1)(1994-11#2)(2008-11#1)(2009-7#1)
by electron beam##8##3##(1991-6#1)(1994-11#2)(2008-10#3)(2008-11#1)(2009-7#1)
by electron microscopy and X-ray##2##5##(2008-10#1)(2008-5#1)
by electron microscopy and##3##4##(1994-11#1)(2008-10#1)(2008-5#1)
by electron microscopy##13##3##(1990-2#1)(1994-11#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#2)
by electron##28##2##(1990-2#1)(1990-5#1)(1991-6#1)(1994-11#3)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-7#1)(2010-7#1)
by electronic##3##2##(2008-10#1)(2008-7#1)(2009-1#1)
by electrophoresis and##3##3##(2008-10#2)(2013-8#1)
by electrophoresis##9##2##(1995-2#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
by electrophoretic mobility shift##3##4##(2008-11#2)(2008-9#1)
by electrophoretic mobility##4##3##(1995-11#1)(2008-11#2)(2008-9#1)
by electrophoretic##5##2##(1995-11#1)(2008-11#3)(2008-9#1)
by electropolymerization of##5##3##(2008-10#5)
by electropolymerization##6##2##(2008-10#6)
by electroporation of##2##3##(2008-10#1)(2008-9#1)
by electroporation##5##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
by electrospray ionization##2##3##(1990-12#1)(2010-11#1)
by electrospray ionization-ion##2##3##(2008-10#2)
by electrospray mass spectrometry##2##4##(2008-10#2)
by electrospray##6##2##(1990-12#1)(2008-10#4)(2010-11#1)
by electrostatic##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
by electrothermal atomic absorption spectrometry (ETAAS) was##2##7##(2008-10#2)
by electrothermal atomic absorption spectrometry (ETAAS)##14##6##(2008-10#14)
by electrothermal atomic absorption spectrometry after complexation and sorption on##2##10##(2008-10#2)
by electrothermal atomic absorption spectrometry after##5##6##(2008-10#5)
by electrothermal atomic absorption spectrometry in##2##6##(2008-10#2)
by electrothermal atomic absorption spectrometry using permanent modifiers##2##8##(2008-10#2)
by electrothermal atomic absorption spectrometry using##7##6##(2008-10#7)
by electrothermal atomic absorption spectrometry with##2##6##(2008-10#2)
by electrothermal atomic absorption spectrometry##52##5##(2008-10#52)
by electrothermal atomic absorption spectroscopy##3##5##(2008-10#3)
by electrothermal atomic absorption##57##4##(2008-10#57)
by electrothermal atomization absorption spectrometry##2##5##(2008-10#2)
by electrothermal atomization##3##3##(2008-10#3)
by electrothermal vaporization inductively coupled plasma mass spectrometry##3##8##(2008-10#3)
by electrothermal vaporization##6##3##(2008-10#6)
by electrothermal##67##2##(2008-10#67)
by elemental analysis##7##3##(2008-10#7)
by elemental##8##2##(2008-10#8)
by elevated plasma##2##3##(1994-5#1)(1994-8#1)
by elevated##5##2##(1994-5#1)(1994-8#1)(1996-12#1)(2011-2#1)(2013-8#1)
by elevating the##2##3##(1996-2#1)(2008-10#1)
by eliminating the##3##3##(1996-2#1)(2008-3#1)(2011-2#1)
by eliminating##5##2##(1996-1#1)(1996-12#1)(1996-2#1)(2008-3#1)(2011-2#1)
by ellipsometry##2##2##(2008-10#2)
by eluting the##2##3##(2008-10#2)
by eluting##4##2##(2008-10#4)
by elution with##6##3##(2008-10#6)
by elution##9##2##(2008-10#9)
by embolization##2##2##(2008-7#2)
by emerging##2##2##(2008-8#1)(2012-2#1)
by emotional##2##2##(1990-11#1)(2008-11#1)
by employing a##6##3##(1990-5#1)(2008-10#5)
by employing an##2##3##(1995-8#1)(2008-10#1)
by employing the##4##3##(2008-10#2)(2008-8#1)(2009-10#1)
by employing##29##2##(1990-5#1)(1992-12#1)(1995-5#1)(1995-8#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
by encoding##2##2##(1997-3#1)(1997-5#1)
by endogenous##8##2##(1994-3#1)(2008-1#1)(2008-11#3)(2008-7#1)(2008-8#2)
by endoscopic##6##2##(1992-7#1)(1996-3#1)(1997-8#1)(2008-12#2)(2013-1#1)
by endothelial cells##3##3##(1992-10#1)(1994-6#1)(2008-11#1)
by energy dispersive X-ray fluorescence spectrometry##2##6##(2008-10#2)
by energy dispersive X-ray fluorescence##4##5##(2008-10#4)
by energy##6##2##(1992-4#1)(2008-10#5)
by enhanced##5##2##(2008-10#2)(2010-6#1)(2011-1#2)
by enhancing##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
by ensuring the##2##3##(2010-6#1)(2010-8#1)
by ensuring##4##2##(1996-2#1)(2010-6#1)(2010-8#1)(2012-12#1)
by entrapment##2##2##(2008-10#2)
by environmental changes##2##3##(2009-8#1)(2011-2#1)
by environmental covariances##3##3##(2008-8#3)
by environmental factors##4##3##(2008-10#2)(2009-8#1)(2013-1#1)
by environmental##18##2##(1995-11#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-8#3)(2009-4#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
by enzymatic digestion##2##3##(1990-5#2)
by enzymatic##9##2##(1990-5#2)(1993-8#1)(2008-10#4)(2008-4#1)(2008-7#1)
by enzyme##7##2##(1995-11#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-7#1)
by enzyme-linked immunosorbent assay using##2##5##(2008-10#1)(2010-4#1)
by enzyme-linked immunosorbent assay##11##4##(1990-5#1)(2008-10#7)(2010-4#1)(2011-2#1)(2012-3#1)
by enzyme-linked##12##2##(1990-5#1)(2008-10#7)(2010-4#1)(2011-2#2)(2012-3#1)
by enzymes##2##2##(1990-8#1)(2008-10#1)
by eosin Y##2##3##(2008-10#2)
by epifluorescence microscopy##2##3##(2008-10#2)
by epigenetic##2##2##(2009-4#1)(2012-12#1)
by episodes of##2##3##(1997-8#1)(2012-3#1)
by establishing a##2##3##(2008-10#2)
by establishing##5##2##(1994-12#1)(2008-10#3)(2008-11#1)
by estimating the##2##3##(1991-2#1)(1995-12#1)
by estimating##3##2##(1991-2#1)(1995-12#1)(2008-10#1)
by estradiol##3##2##(1990-5#1)(1992-4#1)(1994-3#1)
by estrogen##10##2##(1992-9#1)(1995-11#1)(2008-11#7)(2008-6#1)
by estrogens in##2##3##(1990-5#2)
by ethanol##4##2##(2008-11#1)(2008-7#1)(2009-12#1)(2012-3#1)
by ethyl##2##2##(1996-2#1)(2008-10#1)
by ethylene##2##2##(2008-10#1)(2009-8#1)
by evaluating disease suppression##2##4##(2008-10#2)
by evaluating disease##3##3##(2008-10#3)
by evaluating several parameters##2##4##(2008-5#1)(2013-1#1)
by evaluating the##5##3##(1993-6#1)(2008-10#3)(2008-11#1)
by evaluating##13##2##(1990-12#1)(1993-6#1)(2008-10#6)(2008-11#2)(2008-5#1)(2012-3#1)(2013-1#1)
by evaluation of the##2##4##(2008-10#1)(2008-3#1)
by evaporation##2##2##(1995-3#1)(2008-10#1)
by every 0##4##3##(2013-1#4)
by every##5##2##(2008-11#1)(2013-1#4)
by evolutionary##2##2##(2008-10#1)(2008-8#1)
by evolving factor analysis (EFA)##2##5##(2008-10#2)
by evolving##3##2##(2008-10#2)(2012-2#1)
by examination of##2##3##(2008-7#1)(2008-8#1)
by examining the##3##3##(1997-9#1)(2008-10#1)(2008-11#1)
by examining whether##2##3##(1993-3#1)(1995-12#1)
by examining##20##2##(1990-11#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2009-7#1)(2013-1#1)
by example##2##2##(1996-3#1)(2012-2#1)
by excessive##2##2##(2008-4#1)(2011-1#1)
by exchanging##2##2##(2008-10#2)
by exclusion##2##2##(2009-8#1)(2011-2#1)
by exercise##5##2##(1990-3#1)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
by exogenous##7##2##(1993-3#1)(1995-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-7#1)
by exon##2##2##(1993-6#1)(1997-9#1)
by expansion of the##2##4##(1993-1#1)(2010-8#1)
by experienced##3##2##(2008-8#2)(2013-8#1)
by experiment##2##2##(2008-10#1)(2008-3#1)
by experimental and##2##3##(2008-10#1)(2012-5#1)
by experimental design##2##3##(2008-10#2)
by experimental##11##2##(1993-6#1)(1993-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2012-5#1)
by experiments##4##2##(2008-10#1)(2008-11#2)(2008-3#1)
by expert##2##2##(1993-12#1)(1994-3#1)
by experts##6##2##(1991-3#1)(2008-10#2)(2009-8#1)(2011-2#2)
by explicitly##2##2##(1995-6#1)(2008-3#1)
by exploiting the##2##3##(2008-10#1)(2008-11#1)
by exploiting##4##2##(2008-10#3)(2008-11#1)
by exploring the##3##3##(2008-10#1)(2008-8#1)(2010-3#1)
by exploring##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
by exposing plants to##2##4##(2008-10#1)(2011-10#1)
by exposing the##2##3##(2008-11#1)(2013-1#1)
by exposing##5##2##(2008-10#1)(2008-11#1)(2011-10#1)(2012-2#1)(2013-1#1)
by exposure to low temperature##2##5##(2008-11#2)
by exposure to##8##3##(1995-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)
by exposure##10##2##(1990-5#1)(1995-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
by expressing##5##2##(1993-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
by expression of##2##3##(1994-11#1)(2008-8#1)
by expression##3##2##(1994-11#1)(2008-11#1)(2008-8#1)
by extended##3##2##(2008-1#1)(2012-2#2)
by extending##2##2##(1997-7#1)(2008-11#1)
by extension of the##2##4##(2008-3#1)(2008-5#1)
by extension##4##2##(1995-9#1)(2008-1#1)(2008-3#1)(2008-5#1)
by extensive##6##2##(1997-2#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-6#1)
by external calibration##2##3##(2008-10#2)
by external##15##2##(1990-2#1)(1990-6#1)(1990-9#1)(1992-9#1)(1993-11#1)(1996-1#1)(2008-10#6)(2008-11#2)(2013-8#1)
by externally##2##2##(2008-8#1)(2011-2#1)
by extinction##2##2##(1992-12#1)(1993-6#1)
by extracellular matrix##2##3##(2008-11#1)(2012-3#1)
by extracellular##11##2##(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
by extracting##5##2##(1996-12#1)(2008-10#3)(2008-9#1)
by extraction and##2##3##(2008-10#2)
by extraction chromatography##2##3##(2008-10#2)
by extraction into##3##3##(2008-10#3)
by extraction of the##2##4##(1992-3#1)(2008-10#1)
by extraction of##3##3##(1992-3#1)(1996-12#1)(2008-10#1)
by extraction using##2##3##(2008-10#2)
by extraction with##3##3##(2008-10#3)
by extraction##21##2##(1992-3#1)(1996-12#1)(2008-10#17)(2009-8#1)(2013-1#1)
by extractive##3##2##(2008-10#2)(2011-2#1)
by extrapolation##3##2##(1992-6#1)(2008-10#2)
by extrinsic##2##2##(1994-3#1)(2011-2#1)
by extrusion##2##2##(1996-5#1)(2012-3#1)
by fMLP##3##2##(1994-11#1)(1995-6#1)(1996-2#1)
by face-to-face##2##2##(1996-5#1)(2007-9#1)
by facilitating the##3##3##(1992-10#1)(1993-8#1)(2008-11#1)
by facilitating##5##2##(1992-10#1)(1993-8#1)(2008-11#3)
by factor analysis##2##3##(2008-10#2)
by factor##5##2##(1991-3#1)(1991-9#1)(1997-7#1)(2008-10#2)
by factorial design##3##3##(2008-10#3)
by factorial##4##2##(2008-10#4)
by factors such as##3##4##(1995-3#1)(2008-11#1)(2012-12#1)
by factors##6##2##(1992-3#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
by familial##2##2##(1991-1#1)(2011-2#1)
by family physicians##2##3##(2008-10#1)(2008-11#1)
by family##10##2##(1991-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2009-9#1)(2010-7#1)(2011-2#1)
by far the most##2##4##(1994-11#1)(2010-12#1)
by far the##4##3##(1993-1#1)(1994-11#1)(2008-5#1)(2010-12#1)
by far##10##2##(1990-6#1)(1993-1#1)(1994-11#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#1)
by fast##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
by fatty acids##5##3##(1992-8#1)(1993-9#2)(1996-3#1)(2008-10#1)
by fatty##6##2##(1992-8#1)(1993-9#2)(1996-3#1)(2008-10#2)
by federal##2##2##(1996-12#1)(1996-2#1)
by feedback-based flow ratiometry##2##4##(2008-10#2)
by feeding##4##2##(1990-5#1)(1993-12#1)(1997-1#1)(2008-10#1)
by female##2##2##(1995-12#1)(2008-8#1)
by females##5##2##(2007-12#1)(2008-9#3)(2012-3#1)
by fetal blood sampling##2##4##(1990-9#1)(1996-3#1)
by fetal##5##2##(1990-9#2)(1994-3#1)(1996-3#1)(2012-3#1)
by fever##3##2##(1994-9#1)(2009-11#1)(2013-8#1)
by feverfew extracts##2##3##(2008-10#2)
by feverfew##3##2##(2008-10#3)
by fibroblasts##2##2##(1994-11#1)(1995-12#1)
by fibrous##2##2##(1997-5#1)(2010-12#1)
by field##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
by filamentous fungi##2##3##(1997-7#1)(2008-5#1)
by filling the##2##3##(2008-10#1)(2008-2#1)
by filling##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
by filter##2##2##(1993-8#1)(2010-10#1)
by filtering##2##2##(2008-10#2)
by filtration##3##2##(1992-11#1)(2008-10#1)(2012-2#1)
by finding the##2##3##(1992-12#1)(2008-11#1)
by finding##6##2##(1992-12#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-11#1)
by fine needle aspiration cytology##2##5##(1990-6#1)(2010-8#1)
by fine needle aspiration##4##4##(1990-6#1)(1991-6#2)(2010-8#1)
by fine##5##2##(1990-6#1)(1991-6#2)(2008-3#1)(2010-8#1)
by first##10##2##(2008-10#7)(2008-11#1)(2008-6#1)(2012-2#1)
by first-derivative##2##2##(2008-10#2)
by fitting the data##3##4##(1990-8#1)(2008-10#1)(2010-4#1)
by fitting the##9##3##(1990-8#1)(2008-10#5)(2008-8#1)(2009-8#1)(2010-4#1)
by fitting##14##2##(1990-8#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-4#1)(2013-8#1)
by five replicate##2##3##(2008-10#2)
by five##11##2##(1992-6#1)(1997-2#1)(2008-10#7)(2008-5#1)(2008-8#1)
by fixing##2##2##(1991-11#1)(2008-10#1)
by flame AAS##8##3##(2008-10#8)
by flame atomic absorption spectrometry (FAAS) and##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) in##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) is##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) was##2##7##(2008-10#2)
by flame atomic absorption spectrometry (FAAS)##31##6##(2008-10#31)
by flame atomic absorption spectrometry##66##5##(2008-10#66)
by flame atomic absorption spectrophotometry (FAAS)##2##6##(2008-10#2)
by flame atomic absorption spectrophotometry after preconcentration##2##7##(2008-10#2)
by flame atomic absorption spectrophotometry##6##5##(2008-10#6)
by flame atomic absorption##74##4##(2008-10#74)
by flame atomic##77##3##(2008-10#77)
by flame##89##2##(2008-10#89)
by flavonoids##4##2##(2008-10#1)(2008-11#2)(2008-9#1)
by flotation##3##2##(2008-10#2)(2008-4#1)
by flow cytometric analysis##2##4##(1993-2#1)(2008-9#1)
by flow cytometry and##2##4##(2008-11#2)
by flow cytometry for##2##4##(2008-7#1)(2008-9#1)
by flow cytometry has##2##4##(2008-9#2)
by flow cytometry in##3##4##(2008-11#1)(2008-9#2)
by flow cytometry##44##3##(1993-11#1)(1993-2#1)(1995-8#1)(1996-6#1)(1997-7#2)(2006-6#1)(2008-11#8)(2008-4#1)(2008-7#3)(2008-9#23)(2012-4#1)(2013-1#1)
by flow injection (FI)##2##4##(2008-10#2)
by flow injection analysis (FIA)##3##5##(2008-10#3)
by flow injection analysis in##2##5##(2008-10#2)
by flow injection analysis with on-line##2##6##(2008-10#2)
by flow injection analysis with##5##5##(2008-10#5)
by flow injection analysis##17##4##(2008-10#17)
by flow injection flame atomic absorption spectrometry##2##7##(2008-10#2)
by flow injection hydride generation atomic##2##6##(2008-10#2)
by flow injection hydride generation##4##5##(2008-10#4)
by flow injection method##2##4##(2008-10#2)
by flow injection with amperometric detection##2##6##(2008-10#2)
by flow injection##39##3##(2008-10#39)
by flow injection-hydride generation-atomic##2##4##(2008-10#2)
by flow injection-inductively coupled plasma optical emission spectrometry##2##8##(2008-10#2)
by flow reversal##2##3##(2008-10#2)
by flow##99##2##(1993-11#1)(1993-2#2)(1994-5#1)(1995-8#1)(1996-6#1)(1997-7#2)(2006-6#1)(2008-10#49)(2008-11#9)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#25)(2012-4#1)(2013-1#1)
by flow-injection analysis##6##3##(2008-10#6)
by flow-injection##13##2##(2008-10#13)
by flowing nitrogen##2##3##(2008-10#2)
by flowing##4##2##(2008-10#4)
by fluorescein##2##2##(1996-12#1)(2008-10#1)
by fluorescence detection##2##3##(2008-10#2)
by fluorescence in situ hybridization (FISH)##2##6##(1997-2#1)(2008-9#1)
by fluorescence in situ hybridization##4##5##(1997-2#1)(1997-8#1)(2008-9#1)(2011-2#1)
by fluorescence microscopy##3##3##(1996-6#1)(2008-10#2)
by fluorescence quenching of##2##4##(2008-10#2)
by fluorescence quenching##4##3##(1993-8#1)(2008-10#3)
by fluorescence spectroscopy##2##3##(2008-10#2)
by fluorescence##30##2##(1992-10#1)(1993-2#1)(1993-8#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#18)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)
by fluorescent microscopy##2##3##(1990-5#1)(1997-2#1)
by fluorescent##8##2##(1990-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)
by fluorescing hyphae of##2##4##(2008-10#2)
by fluorimetry##2##2##(1994-3#1)(2008-10#1)
by focusing on the##2##4##(1992-2#1)(2008-8#1)
by focusing on##3##3##(1992-2#1)(2008-11#1)(2008-8#1)
by focusing##5##2##(1992-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
by focussed sonication##2##3##(2008-10#2)
by focussed##3##2##(2008-10#3)
by following the##4##3##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
by following##5##2##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
by food##3##2##(1995-10#1)(2008-11#1)(2011-2#1)
by forced##2##2##(1997-3#1)(2008-10#1)
by formaldehyde##2##2##(2008-10#1)(2008-12#1)
by formation of##6##3##(1990-11#1)(1995-6#1)(2008-10#2)(2008-3#1)(2009-8#1)
by forming a##5##3##(1992-6#1)(1995-8#1)(2008-10#3)
by forming##12##2##(1991-7#1)(1991-9#1)(1992-6#1)(1995-8#1)(2008-10#5)(2008-11#1)(2009-8#1)(2011-2#1)
by forskolin##2##2##(1994-11#1)(1997-1#1)
by four##10##2##(1990-5#1)(1990-8#1)(1996-5#1)(2008-10#4)(2008-11#1)(2009-3#1)(2013-8#1)
by fragments##2##2##(2008-8#1)(2012-12#1)
by free radicals##2##3##(1992-9#1)(1993-2#1)
by free##5##2##(1992-9#1)(1993-2#1)(1996-2#1)(1997-8#1)(2008-10#1)
by free-radical##2##2##(1992-9#1)(2008-3#1)
by freezing##2##2##(1992-9#1)(1994-11#1)
by frequency##5##2##(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#2)
by fructose##2##2##(2008-9#2)
by fruit##3##2##(2008-10#2)(2013-8#1)
by full-length##2##2##(2008-8#1)(2011-2#1)
by fully##2##2##(2008-8#1)(2009-12#1)
by fumigation##2##2##(2008-10#1)(2008-11#1)
by fumonisin##2##2##(2008-10#2)
by functional##5##2##(1995-12#1)(2008-11#3)(2009-8#1)
by fungal cell##2##3##(2008-10#2)
by fungal##6##2##(2008-10#4)(2008-5#1)(2013-8#1)
by further improving##2##3##(1992-3#1)(1997-3#1)
by further##9##2##(1992-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#2)(2010-12#1)
by fusicoccin##2##2##(1995-2#2)
by fusing##5##2##(2008-11#4)(2008-4#1)
by fusion of##2##3##(2009-12#1)(2011-2#1)
by fusion##5##2##(2008-10#3)(2009-12#1)(2011-2#1)
by future##2##2##(1995-1#1)(1996-2#1)
by gamma##2##2##(1996-5#1)(1997-1#1)
by gas chromatography (GC) with flame##2##6##(2008-10#2)
by gas chromatography (GC)##8##4##(2008-10#8)
by gas chromatography and##3##4##(2008-10#3)
by gas chromatography coupled with mass##2##6##(2008-10#2)
by gas chromatography coupled##3##4##(2008-10#3)
by gas chromatography in##3##4##(1994-5#1)(2008-10#1)(2012-2#1)
by gas chromatography using##6##4##(2008-10#5)(2009-8#1)
by gas chromatography with electron impact mass spectrometric detection in the selected ion monitoring mode (GC-MS-SIM)##2##16##(2008-10#2)
by gas chromatography with electron##3##5##(2008-10#3)
by gas chromatography with mass spectrometric detection##4##7##(2008-10#4)
by gas chromatography with##9##4##(2008-10#9)
by gas chromatography##49##3##(1991-12#1)(1994-5#1)(2008-10#42)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
by gas chromatography-mass spectrometry (GC-MS)##5##5##(1990-5#1)(2008-10#3)(2008-5#1)
by gas chromatography-mass spectrometry##15##4##(1990-5#1)(1992-3#1)(2008-10#10)(2008-11#1)(2008-5#1)(2013-8#1)
by gas chromatography-mass##17##3##(1990-5#1)(1992-3#1)(2008-10#12)(2008-11#1)(2008-5#1)(2013-8#1)
by gas chromatography/mass spectrometry (GC/MS)##2##5##(1995-11#1)(2008-10#1)
by gas chromatography/mass spectrometry##3##4##(1995-11#1)(2008-10#2)
by gas##77##2##(1990-5#1)(1991-12#1)(1992-3#1)(1994-5#1)(1995-11#1)(2008-10#64)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
by gastrin##5##2##(1994-8#4)(1997-1#1)
by gavage##3##2##(1992-12#1)(2008-10#1)(2010-1#1)
by gel electrophoresis##4##3##(1995-6#1)(2008-11#1)(2008-4#1)(2013-1#1)
by gel filtration and##2##4##(1992-12#1)(2008-10#1)
by gel filtration chromatography and##2##5##(2008-10#2)
by gel filtration chromatography##4##4##(1991-9#1)(2008-10#3)
by gel filtration to##2##4##(1994-8#1)(2008-10#1)
by gel filtration##11##3##(1991-9#1)(1992-12#1)(1993-6#1)(1994-8#2)(1995-11#1)(2008-10#5)
by gel##18##2##(1991-9#1)(1992-12#1)(1993-6#1)(1994-8#2)(1995-11#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
by gender and##3##3##(2011-2#2)(2012-3#1)
by gender##9##2##(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
by gene targeting##2##3##(2008-11#1)(2008-2#1)
by gene##8##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
by general practitioners and##2##4##(1997-4#1)(2011-2#1)
by general practitioners in##2##4##(1991-9#1)(2013-1#1)
by general practitioners##7##3##(1991-9#1)(1997-4#2)(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
by general##11##2##(1991-9#1)(1997-4#2)(1997-8#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
by generating##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
by genes##2##2##(2008-8#1)(2010-3#1)
by genetic engineering##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
by genetic##11##2##(1995-2#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-8#3)(2008-9#1)(2013-8#1)
by genome##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
by genomic##2##2##(2008-10#1)(2008-8#1)
by gentle##3##2##(2008-10#2)(2008-8#1)
by geographical information systems##2##4##(2008-10#2)
by geographical##5##2##(1993-11#1)(1994-12#1)(2008-10#2)(2012-3#1)
by geometrical##2##2##(2008-10#1)(2008-3#1)
by germ tubes##2##3##(2008-10#2)
by germ##3##2##(2008-10#2)(2009-10#1)
by giving##4##2##(1990-2#1)(1994-9#1)(2008-10#2)
by glass electrode##2##3##(2008-10#2)
by glass##3##2##(2008-10#3)
by glibenclamide##2##2##(1992-3#2)
by global##2##2##(1993-12#1)(2008-10#1)
by glow discharge quadrupole mass spectrometry##2##6##(2008-10#2)
by glucocorticoids##2##2##(1995-12#1)(2008-11#1)
by glucose in##2##3##(1994-8#2)
by glucose starvation##2##3##(2008-11#1)(2008-7#1)
by glucose##7##2##(1993-12#1)(1994-8#2)(2008-11#3)(2008-7#1)
by glutamate##3##2##(2008-11#1)(2008-7#2)
by glutaraldehyde with##2##3##(2008-10#2)
by glutaraldehyde##5##2##(2008-10#5)
by glutathione##2##2##(1995-6#1)(2008-10#1)
by glycerol##2##2##(2008-10#1)(2008-11#1)
by glycine##4##2##(1992-9#1)(1995-2#1)(1997-8#1)(2008-10#1)
by glycinebetaine##2##2##(1997-4#2)
by glycosidase digestions##2##3##(2008-8#2)
by gold##3##2##(2008-10#2)(2008-9#1)
by governments##2##2##(2008-10#1)(2008-11#1)
by gradient##2##2##(1997-3#1)(2008-10#1)
by gradual##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
by grafting##7##2##(2008-10#7)
by graphite furnace atomic absorption spectrometry (GFAAS) using##2##8##(2008-10#2)
by graphite furnace atomic absorption spectrometry (GFAAS)##16##7##(2008-10#16)
by graphite furnace atomic absorption spectrometry after##6##7##(2008-10#6)
by graphite furnace atomic absorption spectrometry##39##6##(1991-12#1)(2008-10#38)
by graphite furnace atomic absorption##40##5##(1991-12#1)(2008-10#39)
by graphite furnace atomic##41##4##(1991-12#1)(2008-10#40)
by graphite furnace##42##3##(1991-12#1)(2008-10#41)
by graphite##43##2##(1991-12#1)(2008-10#42)
by greater##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
by group##5##2##(1995-5#1)(2008-12#1)(2009-7#1)(2010-1#1)(2010-4#1)
by growing##2##2##(2008-10#1)(2008-11#1)
by growth factors##2##3##(1996-2#1)(2010-10#1)
by growth##4##2##(1991-9#1)(1996-2#1)(2010-10#1)(2011-2#1)
by gut##2##2##(2008-12#1)(2011-2#1)
by half##3##2##(1995-5#2)(2008-11#1)
by hampering the##2##3##(2008-4#1)(2008-7#1)
by hand and##3##3##(2008-6#1)(2010-5#2)
by hand##5##2##(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#2)
by having a##2##3##(2008-3#1)(2012-3#1)
by having##5##2##(1994-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-3#1)
by head##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
by headspace SPME##2##3##(2008-10#1)(2012-12#1)
by headspace##3##2##(2008-10#2)(2012-12#1)
by health care##8##3##(1991-1#1)(1992-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(2008-11#1)(2010-10#1)(2010-9#1)
by health challenges##2##3##(2008-1#2)
by health professionals##2##3##(2008-11#1)(2008-12#1)
by health##22##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
by healthy##4##2##(1996-6#1)(2008-10#1)(2009-8#1)(2011-2#1)
by heart##2##2##(2008-12#1)(2008-5#1)
by heat shock##3##3##(1993-8#1)(1997-7#2)
by heat##10##2##(1991-5#1)(1991-9#1)(1993-8#1)(1997-7#2)(2007-12#1)(2008-10#3)(2011-2#1)
by heating##9##2##(1990-5#1)(2008-10#7)(2008-9#1)
by heavy##4##2##(1993-12#1)(2008-10#2)(2008-8#1)
by heme##2##2##(2008-8#1)(2011-1#1)
by heparin##4##2##(1990-12#1)(1992-10#1)(1993-8#1)(1994-3#1)
by hepatocytes##3##2##(1990-5#1)(1994-8#2)
by high inoculum##2##3##(2008-10#2)
by high levels of##2##4##(2008-8#1)(2009-8#1)
by high performance capillary electrophoresis##2##5##(2008-10#2)
by high performance liquid chromatography (HPLC) and##2##7##(2008-10#2)
by high performance liquid chromatography (HPLC) using##2##7##(2008-10#2)
by high performance liquid chromatography (HPLC) with##2##7##(2008-10#2)
by high performance liquid chromatography (HPLC)##11##6##(2008-10#10)(2008-5#1)
by high performance liquid chromatography and##2##6##(2008-10#2)
by high performance liquid chromatography with fluorescence detection##3##8##(2008-10#3)
by high performance liquid chromatography with##6##6##(2008-10#6)
by high performance liquid chromatography##26##5##(1990-8#1)(1993-6#1)(2008-10#23)(2008-5#1)
by high performance liquid chromatography-electrospray ionization-quadrupole ion trap mass spectrometry##2##10##(2008-8#2)
by high performance liquid chromatography-electrospray##3##5##(2008-10#1)(2008-8#2)
by high performance liquid chromatography/electrospray/mass spectrometry##2##6##(2008-10#2)
by high performance liquid##34##4##(1990-8#1)(1993-6#1)(2008-10#29)(2008-5#1)(2008-8#2)
by high performance##36##3##(1990-8#1)(1993-6#1)(2008-10#31)(2008-5#1)(2008-8#2)
by high pressure liquid chromatography (HPLC)##2##6##(2008-10#1)(2011-1#1)
by high resolution##2##3##(1994-6#1)(1995-8#1)
by high temperature##3##3##(1997-2#1)(2013-8#2)
by high##70##2##(1990-2#1)(1990-8#2)(1991-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-8#1)(1997-2#1)(2008-10#40)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
by high-contrast##2##2##(2008-9#2)
by high-performance anion-exchange chromatography with##2##5##(1991-7#1)(2008-10#1)
by high-performance capillary##2##3##(1997-2#1)(2008-10#1)
by high-performance liquid chromatography (HPLC) and##2##6##(2008-10#1)(2009-8#1)
by high-performance liquid chromatography (HPLC) with##4##6##(2008-10#4)
by high-performance liquid chromatography (HPLC)##12##5##(2008-10#11)(2009-8#1)
by high-performance liquid chromatography and##3##5##(1992-11#1)(2008-10#2)
by high-performance liquid chromatography with##6##5##(1992-1#1)(2008-10#4)(2008-5#1)
by high-performance liquid chromatography##32##4##(1992-1#1)(1992-11#1)(1997-2#2)(2008-10#25)(2008-5#1)(2009-8#2)
by high-performance liquid chromatography-inductively coupled plasma mass spectrometry##2##8##(2008-10#2)
by high-performance liquid##35##3##(1992-1#1)(1992-11#1)(1997-2#2)(2008-10#28)(2008-5#1)(2009-8#2)
by high-performance##41##2##(1991-7#1)(1992-1#1)(1992-11#1)(1997-2#3)(2008-10#30)(2008-4#1)(2008-5#1)(2009-8#2)(2012-2#1)
by high-resolution##3##2##(1994-5#1)(2008-10#1)(2009-3#1)
by higher##11##2##(1990-2#1)(1990-9#1)(1991-12#1)(1995-3#1)(2008-10#3)(2008-8#2)(2011-2#1)(2013-1#1)
by highly selective##2##3##(2008-10#1)(2008-7#1)
by highly##11##2##(1990-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
by his own##2##3##(1995-5#1)(2011-2#1)
by his##6##2##(1992-2#1)(1995-5#1)(2008-2#1)(2009-1#1)(2010-1#1)(2011-2#1)
by histamine in##2##3##(1994-6#1)(1996-2#1)
by histochemical staining##3##3##(1992-1#1)(1993-12#1)(1997-3#1)
by histochemical##4##2##(1992-1#1)(1993-12#1)(1997-3#1)(2008-10#1)
by histological and##2##3##(1997-5#1)(2011-2#1)
by histological##5##2##(1996-6#1)(1997-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
by histology##2##2##(2011-2#1)(2013-1#1)
by histopathology##2##2##(1997-8#1)(2008-5#1)
by homogeneous##4##2##(2008-10#4)
by homologous recombination in##4##4##(1995-2#1)(2008-4#2)(2010-1#1)
by homologous recombination of##2##4##(2008-9#2)
by homologous recombination##11##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#2)(2010-1#1)
by homologous##12##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#2)(2010-1#1)
by homology##3##2##(1994-5#1)(1994-8#1)(2008-9#1)
by hormones and##2##3##(1993-12#1)(1996-2#1)
by horseradish peroxidase##3##3##(2008-10#3)
by hospital administrators##2##3##(1991-1#1)(1993-1#1)
by hospital##8##2##(1990-12#1)(1991-1#1)(1993-1#1)(1993-3#1)(1994-1#2)(2008-11#2)
by hospitals and##3##3##(1992-1#1)(2008-11#2)
by hospitals##7##2##(1991-3#1)(1992-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-11#2)
by host##6##2##(2008-10#4)(2008-8#2)
by hot##3##2##(1992-3#2)(1993-8#1)
by human intestinal bacteria##2##4##(2008-11#2)
by human leukocytes and rat##2##5##(1991-5#2)
by human monocytes##2##3##(1994-11#1)(1995-8#1)
by human skin fibroblasts##2##4##(2008-5#2)
by human##30##2##(1990-3#1)(1991-3#1)(1991-5#2)(1992-6#2)(1993-6#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(2006-6#1)(2008-11#6)(2008-5#2)(2008-8#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-3#1)(2012-5#1)
by humans##8##2##(1993-11#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
by hybrid##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
by hybridization analysis with##2##4##(1997-2#1)(2008-4#1)
by hybridization analysis##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
by hybridization to##3##3##(1993-12#1)(2008-11#2)
by hybridization with##4##3##(1995-6#1)(1996-6#1)(1996-8#1)(2008-10#1)
by hybridization##11##2##(1993-12#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2012-2#1)
by hybridizing##3##2##(2008-10#2)(2008-4#1)
by hybridoma technique##2##3##(2008-8#1)(2008-9#1)
by hybridoma##5##2##(2008-11#3)(2008-8#1)(2008-9#1)
by hybrids##2##2##(2008-8#1)(2008-9#1)
by hydrazine##2##2##(1991-3#1)(2008-10#1)
by hydride generation atomic absorption spectrometry (HGAAS)##2##7##(2008-10#2)
by hydride generation atomic absorption spectrometry##5##6##(2008-10#5)
by hydride generation atomic fluorescence spectrometry (HG-AFS)##2##7##(2008-10#2)
by hydride generation atomic fluorescence spectrometry##4##6##(2008-10#4)
by hydride generation atomic##9##4##(2008-10#9)
by hydride generation gas phase molecular absorption spectrometry##3##8##(2008-10#3)
by hydride generation##18##3##(2008-10#18)
by hydride generation-atomic fluorescence spectrometry##3##5##(2008-10#3)
by hydride generation-atomic##4##3##(2008-10#4)
by hydride generation-gas phase molecular absorption spectrometry##2##7##(2008-10#2)
by hydride##29##2##(2008-10#29)
by hydrochloric acid##2##3##(2008-10#2)
by hydrodynamic amperometry##2##3##(2008-10#2)
by hydrodynamic voltammetry##2##3##(2008-10#2)
by hydrodynamic##5##2##(1990-8#1)(2008-10#4)
by hydrogen peroxide and##3##4##(2008-10#3)
by hydrogen peroxide in##2##4##(2008-10#2)
by hydrogen peroxide##13##3##(1992-12#1)(1994-5#1)(2008-10#11)
by hydrogen##15##2##(1992-12#1)(1994-5#1)(1995-3#1)(2008-10#11)(2008-3#1)
by hydrolysis of##3##3##(1996-2#1)(1996-5#1)(2008-10#1)
by hydrophobic##6##2##(1990-2#1)(1990-5#1)(1992-6#1)(1997-7#1)(2008-10#2)
by hydroxide##2##2##(2008-10#2)
by hydroxy##2##2##(2008-10#2)
by hydroxyurea##2##2##(1993-9#1)(2012-3#1)
by hypertension##3##2##(2009-7#1)(2011-2#1)(2013-1#1)
by hyphenated##2##2##(2008-10#1)(2010-11#1)
by hypochlorite##4##2##(2008-10#4)
by hypoxia and##2##3##(1994-2#1)(2010-8#1)
by hypoxia in##2##3##(1996-12#1)(2010-11#1)
by hypoxia##7##2##(1994-2#1)(1996-12#1)(1997-1#1)(2010-11#3)(2010-8#1)
by i##6##2##(1993-8#1)(1997-4#2)(2008-11#1)(2008-12#1)(2008-9#1)
by identification of the##2##4##(1995-6#1)(2012-3#1)
by identification of##3##3##(1995-6#1)(2009-12#1)(2012-3#1)
by identifying the##2##3##(2008-11#1)(2010-8#1)
by identifying##13##2##(1992-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
by image analysis##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
by image##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
by imaging##2##2##(2008-3#1)(2013-1#1)
by immature##2##2##(1995-12#1)(2013-1#1)
by immersing the##3##3##(2008-10#3)
by immersing##4##2##(2008-10#3)(2009-7#1)
by immobilising##2##2##(2008-10#2)
by immobilization##2##2##(2008-10#1)(2008-7#1)
by immobilized##4##2##(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
by immobilizing glucose oxidase##2##4##(2008-10#2)
by immobilizing polyphenol oxidase##2##4##(2008-10#2)
by immobilizing##16##2##(2008-10#15)(2008-11#1)
by immune cells##2##3##(1994-11#1)(2013-1#1)
by immune##3##2##(1994-11#1)(2008-10#1)(2013-1#1)
by immunization of rabbits with a conjugate of##2##8##(2008-10#2)
by immunization of rabbits with##3##5##(1996-2#1)(2008-10#2)
by immunization of rabbits##4##4##(1996-2#1)(2008-10#3)
by immunization of##5##3##(1995-5#1)(1996-2#1)(2008-10#3)
by immunization with##5##3##(2008-4#3)(2008-9#1)(2011-2#1)
by immunization##10##2##(1995-5#1)(1996-2#1)(2008-10#3)(2008-4#3)(2008-9#1)(2011-2#1)
by immunizing##2##2##(1991-5#1)(2008-8#1)
by immuno-PCR##2##2##(2008-8#2)
by immunoaffinity chromatography on##2##4##(1990-11#1)(1993-9#1)
by immunoaffinity chromatography##5##3##(1990-11#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-11#1)
by immunoaffinity##6##2##(1990-11#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-11#1)
by immunoassay##3##2##(1995-2#1)(1995-8#1)(2011-2#1)
by immunoblot analysis##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
by immunoblot##4##2##(1993-8#1)(1995-8#1)(2008-10#1)(2008-11#1)
by immunoblotting and##2##3##(1995-11#1)(2008-11#1)
by immunoblotting to##2##3##(1991-5#1)(2007-12#1)
by immunoblotting##11##2##(1991-12#1)(1991-5#1)(1992-6#1)(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)
by immunochemical##3##2##(1994-8#1)(1996-2#1)(1997-2#1)
by immunocytochemical##3##2##(1993-3#1)(2008-11#1)(2008-7#1)
by immunocytochemistry##5##2##(1992-6#1)(1994-2#2)(2008-10#1)(2008-9#1)
by immunodetection of##2##3##(2008-10#1)(2008-12#1)
by immunoelectron microscopy##4##3##(1995-6#2)(1996-3#1)(2011-1#1)
by immunofluorescence##5##2##(1995-12#1)(2008-10#1)(2008-5#2)(2012-2#1)
by immunohistochemical##6##2##(1991-5#1)(1997-3#1)(2010-7#1)(2011-2#2)(2013-1#1)
by immunohistochemistry and##3##3##(1997-2#1)(2011-2#1)(2013-8#1)
by immunohistochemistry##5##2##(1991-10#1)(1997-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
by immunological##2##2##(2008-10#2)
by immunostaining for##2##3##(1997-3#1)(2008-9#1)
by immunostaining##4##2##(1997-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
by impaired##2##2##(1994-11#1)(2008-11#1)
by imperfect##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
by implanting##2##2##(2008-12#1)(2012-3#1)
by implementing the##2##3##(1994-12#1)(2012-12#1)
by implementing##3##2##(1994-12#1)(2008-10#1)(2012-12#1)
by impregnation##2##2##(2008-10#2)
by improved##2##2##(1997-2#1)(2009-11#1)
by improvements in##2##3##(2008-8#1)(2012-3#1)
by improving the##3##3##(2008-10#2)(2009-11#1)
by improving##8##2##(1991-7#1)(2008-10#3)(2009-11#1)(2011-2#2)(2012-2#1)
by in situ hybridization and##2##5##(1996-12#1)(2008-11#1)
by in situ hybridization histochemistry##3##5##(1996-12#2)(1996-2#1)
by in situ hybridization##16##4##(1992-12#1)(1995-6#2)(1996-12#7)(1996-2#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
by in situ##20##3##(1992-12#1)(1995-12#1)(1995-6#2)(1996-12#7)(1996-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
by in vitro and in vivo##2##6##(2008-10#1)(2011-2#1)
by in vitro immunization##6##4##(2008-11#6)
by in vitro site-specific recombination##2##5##(2008-4#1)(2012-2#1)
by in vitro site-specific##3##4##(2008-4#2)(2012-2#1)
by in vitro##25##3##(1990-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#9)(2008-4#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
by in vivo##7##3##(1994-2#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-8#1)
by in##52##2##(1990-5#1)(1992-12#1)(1994-2#1)(1995-12#2)(1995-2#2)(1995-6#3)(1996-12#7)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#12)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
by inactivation of##2##3##(1994-12#1)(2008-11#1)
by including the##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
by including##15##2##(1991-1#1)(1993-8#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-7#1)
by inclusion of##5##3##(1991-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
by incomplete##3##2##(1992-9#1)(1997-3#1)(2008-7#1)
by incorporating a##2##3##(2008-10#1)(2012-3#1)
by incorporating the##4##3##(1993-12#1)(2008-10#3)
by incorporating three##2##3##(2008-10#2)
by incorporating##15##2##(1993-12#1)(1996-9#1)(2008-10#11)(2008-7#1)(2012-3#1)
by incorporation of##2##3##(1994-5#1)(2008-10#1)
by incorporation##3##2##(1994-5#1)(2008-10#1)(2008-4#1)
by increased##28##2##(1990-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-3#2)(1994-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
by increases in##4##3##(1995-12#1)(2010-4#2)(2012-12#1)
by increasing local##2##3##(2008-10#2)
by increasing the concentration of##3##5##(1997-2#1)(2008-10#1)(2008-7#1)
by increasing the number of##2##5##(2008-10#1)(2012-12#1)
by increasing the##22##3##(1993-11#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2012-12#1)
by increasing their##5##3##(1991-5#1)(1992-1#1)(2008-4#1)(2012-3#1)(2013-1#1)
by increasing##57##2##(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-12#2)(1996-3#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#1)
by incubating##5##2##(1990-11#1)(1997-2#1)(2008-10#2)(2008-11#1)
by incubation with##8##3##(1990-12#1)(1991-5#1)(1992-12#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-1#1)
by incubation##9##2##(1990-12#1)(1991-1#1)(1991-5#1)(1992-12#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-1#1)
by independent##4##2##(1995-5#1)(1996-5#1)(2008-10#2)
by indigenous##3##2##(2008-10#3)
by indirect immunofluorescence##2##3##(2008-10#2)
by indirect##7##2##(1992-12#1)(1994-3#1)(2008-10#4)(2008-8#1)
by individual##9##2##(2008-10#1)(2008-11#1)(2008-9#3)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
by individuals##4##2##(1994-12#1)(2008-12#2)(2009-6#1)
by inducible nitric oxide synthase (iNOS)##2##6##(2008-5#1)(2011-1#1)
by inducing a##3##3##(1995-8#1)(2008-9#1)(2013-1#1)
by inducing the##2##3##(1996-2#1)(2010-8#1)
by inducing##15##2##(1990-8#1)(1994-8#1)(1995-8#1)(1996-2#2)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
by induction of apoptosis##2##4##(2008-9#1)(2011-2#1)
by induction of##7##3##(1991-5#1)(1992-12#1)(1997-7#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
by induction##9##2##(1991-5#1)(1992-12#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
by inductively coupled plasma atomic emission spectrometry (ICP-AES)##4##8##(2008-10#4)
by inductively coupled plasma atomic emission spectrometry after##2##8##(2008-10#2)
by inductively coupled plasma atomic emission spectrometry##21##7##(1992-3#1)(2008-10#20)
by inductively coupled plasma atomic emission spectroscopy##2##7##(2008-10#2)
by inductively coupled plasma atomic emission##24##6##(1992-3#1)(2008-10#23)
by inductively coupled plasma mass spectrometry (ICP-MS)##7##7##(2008-10#7)
by inductively coupled plasma mass spectrometry##19##6##(2008-10#19)
by inductively coupled plasma optical emission spectrometry (ICP-OES)##4##8##(2008-10#4)
by inductively coupled plasma optical emission spectrometry##8##7##(2008-10#8)
by inductively coupled plasma##55##4##(1992-3#2)(2008-10#53)
by inductively coupled plasma-atomic emission spectrometry (ICP-AES)##5##7##(2008-10#5)
by inductively coupled plasma-atomic emission spectrometry##13##6##(2008-10#13)
by inductively coupled plasma-atomic emission spectroscopy (ICP-AES)##2##7##(2008-10#2)
by inductively coupled plasma-atomic emission##16##5##(2008-10#16)
by inductively coupled plasma-mass spectrometry##3##5##(2008-10#3)
by inductively coupled plasma-optical emission##3##5##(2008-10#3)
by inductively coupled##80##3##(1992-3#2)(2008-10#78)
by inductively##81##2##(1992-3#2)(2008-10#79)
by infected##5##2##(1997-1#1)(2008-10#2)(2011-2#1)(2012-3#1)
by infection of##4##3##(1996-6#1)(2008-2#1)(2008-9#1)(2013-8#1)
by infection with##6##3##(1996-11#1)(2008-10#2)(2008-7#1)(2011-2#2)
by infection##15##2##(1990-12#1)(1996-11#1)(1996-6#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#2)(2013-8#1)
by inference##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
by inflammation##2##2##(2009-1#1)(2012-12#1)
by inflammatory##4##2##(2008-4#1)(2009-8#1)(2010-12#1)(2012-3#1)
by influencing the##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
by influencing##5##2##(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
by infrared##6##2##(1993-1#1)(2008-10#3)(2008-3#1)(2008-5#1)
by infusion of##2##3##(1993-3#2)
by ingestion##2##2##(2008-10#1)(2009-6#1)
by inhalation##4##2##(1992-3#1)(1996-2#1)(1997-1#2)
by inhibiting the##5##3##(1997-2#1)(2008-10#2)(2008-11#1)(2011-3#1)
by inhibiting##14##2##(1990-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
by inhibition of the##2##4##(1992-3#2)
by inhibition of##7##3##(1992-3#2)(1994-2#1)(2008-10#2)(2008-11#1)(2009-9#1)
by inhibition##8##2##(1992-3#2)(1994-2#1)(2008-10#3)(2008-11#1)(2009-9#1)
by inhibitors of##2##3##(1994-3#1)(2009-9#1)
by inhibitory##3##2##(1993-3#1)(1997-2#1)(2008-10#1)
by initial conditions##4##3##(2008-10#3)(2008-8#1)
by initial##8##2##(1990-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)
by injecting a##4##3##(1994-8#1)(2008-10#3)
by injecting the##2##3##(1993-6#1)(2008-11#1)
by injecting##21##2##(1993-6#1)(1994-8#2)(2008-10#12)(2008-11#2)(2008-9#2)(2011-2#2)
by injection into##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
by injection of##10##3##(1990-5#1)(1991-1#1)(1991-12#1)(1993-8#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
by injection##14##2##(1990-5#1)(1991-1#1)(1991-12#2)(1993-8#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)
by injections of##2##3##(1994-8#1)(1996-2#1)
by inoculating plants##2##3##(2008-10#2)
by inoculating##8##2##(2008-10#7)(2008-8#1)
by inoculation of##4##3##(2008-10#4)
by inoculation with the##2##4##(2008-10#2)
by inoculation with##8##3##(2008-10#8)
by inoculation##13##2##(2008-10#13)
by inoculum##2##2##(2008-10#2)
by inorganic##2##2##(1991-5#1)(2008-10#1)
by inositol##2##2##(1993-6#1)(2008-11#1)
by insects##6##2##(2008-10#2)(2008-8#2)(2009-8#1)(2010-1#1)
by insertion of a##2##4##(1993-2#1)(1997-3#1)
by insertion of##3##3##(1993-2#1)(1997-3#1)(2008-8#1)
by insertion##4##2##(1991-6#1)(1993-2#1)(1997-3#1)(2008-8#1)
by inspection of##2##3##(1992-9#1)(2008-6#1)
by instillation##2##2##(2010-10#1)(2012-3#1)
by insulin and##2##3##(1994-11#1)(2008-3#1)
by insulin but##2##3##(1994-11#1)(1996-2#1)
by insulin resistance##2##3##(1994-12#1)(2010-11#1)
by insulin##10##2##(1993-8#1)(1994-11#2)(1994-12#1)(1996-11#1)(1996-2#3)(2008-3#1)(2010-11#1)
by insurance##3##2##(1994-1#1)(1996-2#1)(1997-1#1)
by intact##2##2##(1994-8#1)(2009-8#1)
by integrated##2##2##(2008-10#2)
by integrating##5##2##(2008-10#2)(2008-3#1)(2009-7#1)(2009-8#1)
by integration of##2##3##(2008-11#1)(2008-3#1)
by integration##4##2##(2008-11#2)(2008-3#1)(2010-11#1)
by integrative##2##2##(2009-12#1)(2013-8#1)
by intense##4##2##(2008-5#2)(2009-6#1)(2010-6#1)
by intensive##2##2##(1996-11#2)
by interacting with##6##3##(1994-11#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
by interaction with##5##3##(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-9#1)
by interaction##9##2##(1990-12#1)(1990-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-9#3)
by interactions##2##2##(2008-8#1)(2009-12#1)
by intercellular##2##2##(1995-2#1)(2008-5#1)
by interference##2##2##(1992-11#1)(1995-2#1)
by interfering with the##2##4##(2010-7#1)(2011-2#1)
by interfering with##3##3##(2008-11#1)(2010-7#1)(2011-2#1)
by interfering##4##2##(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
by interferons##3##2##(1997-1#3)
by interleukin-1##3##2##(1993-8#1)(1994-6#2)
by interleukin-1beta was##2##3##(1997-1#2)
by interleukin-1beta##5##2##(1997-1#5)
by interleukin-4##3##2##(1997-1#3)
by internal##10##2##(1990-3#1)(1991-3#1)(1991-7#1)(2008-10#3)(2008-12#2)(2009-8#1)(2011-2#1)
by international##2##2##(2008-10#2)
by internucleosomal DNA##2##3##(1993-3#1)(1995-8#1)
by interpolating##2##2##(2008-11#1)(2008-8#1)
by interval##2##2##(2008-10#1)(2008-12#1)
by intestinal##3##2##(1997-1#1)(2010-11#1)(2011-2#1)
by intimate##2##2##(2008-10#1)(2012-12#1)
by intra- and##2##3##(1992-12#1)(2008-10#1)
by intra-accumbens##2##2##(1993-6#2)
by intracellular##8##2##(1991-2#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-7#1)(2013-1#2)
by intracerebral##2##2##(1994-8#1)(2008-8#1)
by intracytoplasmic##3##2##(1991-8#1)(2007-12#1)(2008-9#1)
by intraluminal##2##2##(1992-6#1)(1996-6#1)
by intramolecular##2##2##(1993-8#1)(2008-4#1)
by intramuscular injection of##3##4##(1997-8#3)
by intramuscular injection##4##3##(1991-3#1)(1997-8#3)
by intranasal##4##2##(2008-10#2)(2012-12#2)
by intraperitoneal##4##2##(1991-6#1)(1996-2#1)(2008-9#1)(2011-3#1)
by intravascular##2##2##(1994-5#1)(2008-6#1)
by intravenous##6##2##(1990-3#1)(1993-6#1)(2008-9#1)(2009-5#1)(2010-6#1)(2013-1#1)
by introducing a##6##3##(1992-6#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
by introducing human##2##3##(2008-11#2)
by introducing##20##2##(1992-6#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
by introduction##2##2##(2008-10#1)(2008-11#1)
by introns and##2##3##(1993-8#1)(1994-11#1)
by inverse##2##2##(1997-2#1)(2008-10#1)
by inversion##2##2##(1994-8#1)(2008-11#1)
by investigating the effect of##2##5##(2008-10#2)
by investigating the##6##3##(2008-10#4)(2008-11#1)(2009-12#1)
by investigating##11##2##(2008-10#5)(2008-11#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-3#1)
by iodide##2##2##(2008-10#2)
by ion chromatography (IC) with##3##5##(2008-10#3)
by ion chromatography (IC)##4##4##(2008-10#4)
by ion chromatography##11##3##(2008-10#11)
by ion exchange and##5##4##(1993-9#1)(2008-10#4)
by ion exchange chromatography##3##4##(1994-8#1)(2008-10#1)(2009-9#1)
by ion exchange##9##3##(1993-9#1)(1994-8#1)(2008-10#6)(2009-9#1)
by ion mobility increment##2##4##(2008-10#2)
by ion mobility##3##3##(2008-10#3)
by ion##26##2##(1993-9#1)(1994-8#1)(2008-10#23)(2009-9#1)
by ion-chromatography##2##2##(2008-10#2)
by ion-exchange chromatography and##2##4##(1993-8#1)(1997-1#1)
by ion-exchange chromatography##3##3##(1993-8#1)(1997-1#1)(2008-10#1)
by ion-exchange##7##2##(1993-8#2)(1997-1#1)(2008-10#3)(2008-7#1)
by ion-pair reversed-phase high-performance liquid chromatography with spectrophotometric detection##2##9##(2008-10#2)
by ion-pair reversed-phase##3##3##(2008-10#3)
by ion-pair##7##2##(2008-10#7)
by ion-pairing##2##2##(2008-11#1)(2010-11#1)
by ionic##2##2##(1992-12#1)(2008-10#1)
by ionizing radiation##2##3##(2008-9#1)(2012-2#1)
by ionomycin##2##2##(1994-3#1)(1995-11#1)
by iridium##2##2##(1991-8#1)(2008-10#1)
by iron and##2##3##(2008-10#2)
by iron in##2##3##(1993-2#1)(2008-10#1)
by iron limitation##2##3##(1996-12#1)(2012-2#1)
by iron##9##2##(1993-2#1)(1996-12#1)(2008-10#4)(2012-2#2)(2013-8#1)
by irradiation of##2##3##(1990-5#1)(2008-10#1)
by irradiation was##3##3##(1994-11#1)(1995-6#2)
by irradiation##10##2##(1990-5#1)(1994-11#1)(1995-6#5)(2008-10#1)(2010-10#1)(2011-2#1)
by irrigation##2##2##(2008-10#1)(2013-8#1)
by isoelectric focusing##3##3##(2008-10#1)(2008-4#2)
by isolated##4##2##(1990-2#1)(1991-3#1)(2008-12#1)(2008-5#1)
by isolates from##2##3##(2008-10#2)
by isolates of##2##3##(2008-10#2)
by isolates##5##2##(2008-10#5)
by isolating##3##2##(2008-10#2)(2011-2#1)
by isolation##2##2##(2008-10#2)
by isotope dilution inductively coupled##2##5##(2008-10#2)
by isotope dilution##6##3##(2008-10#6)
by isotope##9##2##(1991-9#1)(1993-8#1)(2008-10#7)
by isotopic##2##2##(1994-5#1)(2008-10#1)
by it##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
by iterative##2##2##(2008-11#2)
by its ability to##6##4##(1993-8#2)(1995-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
by its catalytic##2##3##(2008-10#2)
by its enhancement effect on the##2##6##(2008-10#2)
by its inhibition##2##3##(2008-10#2)
by its interaction with##2##4##(1994-11#1)(2008-10#1)
by its lack of##2##4##(1992-5#1)(2013-1#1)
by its native##2##3##(2008-10#1)(2008-7#1)
by its overall##2##3##(2008-10#1)(2008-4#1)
by its reaction with##2##4##(2008-10#2)
by its very##2##3##(2009-10#1)(2010-12#1)
by its##74##2##(1990-5#1)(1990-8#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-10#28)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#3)
by itself had no##2##4##(1996-2#2)
by itself##11##2##(1990-11#1)(1994-2#2)(1995-5#1)(1995-8#1)(1996-2#2)(2008-10#2)(2008-11#1)(2012-12#1)
by jet nebulizers##4##3##(1992-3#1)(1994-12#1)(1995-3#2)
by jet##5##2##(1991-1#1)(1992-3#1)(1994-12#1)(1995-3#2)
by keeping the##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
by keeping##4##2##(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
by key##2##2##(1994-12#1)(2010-2#1)
by kinetic##5##2##(1996-12#1)(2008-10#3)(2008-11#1)
by kriging data from##2##4##(2008-10#2)
by kriging##3##2##(2008-10#3)
by l-ascorbic acid##2##3##(2008-10#2)
by labeling##2##2##(1995-12#1)(1995-6#1)
by laboratory##2##2##(1990-3#1)(2008-11#1)
by lactofen##2##2##(2008-10#2)
by laparoscopy and##2##3##(1992-3#1)(1995-1#1)
by laparoscopy##5##2##(1991-2#1)(1991-3#1)(1992-3#1)(1995-1#1)(1996-1#1)
by laparotomy and##2##3##(1994-3#1)(1996-1#1)
by laparotomy##4##2##(1991-2#1)(1991-3#1)(1994-3#1)(1996-1#1)
by large amounts of##2##4##(2008-10#2)
by large##7##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)
by larvae##2##2##(2008-10#1)(2008-8#1)
by larval##3##2##(2008-9#3)
by laser ablation##4##3##(1991-2#1)(2008-10#2)(2010-11#1)
by laser scanning confocal microscopy##2##5##(2008-11#1)(2008-7#1)
by laser scanning##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
by laser##18##2##(1990-12#1)(1990-5#1)(1991-2#2)(1994-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-11#1)(2011-7#1)
by laser-induced fluorescence##2##3##(2008-3#2)
by laser-induced incandescence##2##3##(2008-3#2)
by laser-induced##5##2##(2008-10#1)(2008-3#4)
by lateral##3##2##(2007-12#1)(2008-12#1)(2008-6#1)
by law##3##2##(1997-3#1)(1997-8#1)(2009-10#1)
by layer-by-layer deposition##2##3##(2008-10#2)
by layer-by-layer##3##2##(2008-10#3)
by leakage##2##2##(1995-11#1)(2008-10#1)
by leaving##2##2##(2008-11#1)(2011-2#1)
by leptin##4##2##(2012-3#4)
by lesion##3##2##(2008-10#2)(2008-11#1)
by lesioning##2##2##(1994-8#1)(2008-7#1)
by lesions of the##2##4##(1994-2#1)(1996-5#1)
by lesions of##3##3##(1994-2#1)(1996-5#1)(1997-1#1)
by less than 5%##2##4##(2008-10#1)(2011-2#1)
by less than##3##3##(2008-10#2)(2011-2#1)
by less##5##2##(2008-10#4)(2011-2#1)
by leukocytes##2##2##(1995-12#1)(2008-5#1)
by levels of##2##3##(1993-8#1)(2009-8#1)
by lidoflazine and##2##3##(1994-8#2)
by ligand binding##3##3##(1993-8#1)(1994-5#1)(1995-2#1)
by ligands##2##2##(2008-10#2)
by light and##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
by light microscopy##6##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
by light scattering technique##3##4##(2008-10#3)
by light was##2##3##(2008-10#1)(2011-1#1)
by light##20##2##(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-7#2)(2008-9#3)(2009-8#1)(2010-6#1)(2011-1#1)
by light-scattering##2##2##(2008-10#2)
by limitations in the##2##4##(2008-2#1)(2008-3#1)
by limited##4##2##(1992-4#1)(1993-8#1)(2008-10#1)(2008-9#1)
by limiting the##2##3##(2008-8#1)(2008-9#1)
by limiting##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2013-8#1)
by linear regression##3##3##(2008-10#3)
by linear sweep voltammetry##6##4##(2008-10#6)
by linear sweep##8##3##(2008-10#8)
by linear##20##2##(2008-10#16)(2008-2#2)(2008-3#1)(2013-8#1)
by lines##2##2##(2008-11#1)(2008-8#1)
by liquid chromatographic##3##3##(2008-10#3)
by liquid chromatography (LC)##4##4##(2008-10#4)
by liquid chromatography and##2##4##(2008-10#2)
by liquid chromatography coupled with##3##5##(2008-10#3)
by liquid chromatography with##2##4##(2008-10#2)
by liquid chromatography##20##3##(2008-10#19)(2008-5#1)
by liquid chromatography-electrospray##2##3##(2008-10#2)
by liquid chromatography-electrospray-mass spectrometry##2##4##(2008-10#2)
by liquid chromatography-hydride##2##3##(2008-10#2)
by liquid chromatography-mass spectrometry##3##4##(2008-10#3)
by liquid chromatography-tandem mass spectrometry##2##5##(2008-10#2)
by liquid##44##2##(1995-11#1)(2008-10#41)(2008-11#1)(2008-5#1)
by liquid-liquid extraction using##2##4##(2008-10#2)
by liquid-liquid extraction##5##3##(2008-10#5)
by liquid-phase microextraction##2##3##(2008-10#2)
by little##2##2##(2011-2#1)(2012-2#1)
by live##2##2##(1997-8#1)(2009-10#1)
by liver and##2##3##(1993-12#1)(1994-11#1)
by liver biopsy##2##3##(2011-1#1)(2013-1#1)
by liver##7##2##(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-6#1)(2011-1#1)(2013-1#1)
by loading##2##2##(2008-10#1)(2008-5#1)
by local administration of##2##4##(1996-11#1)(2011-2#1)
by local biotypes##2##3##(2008-10#2)
by local councils##2##3##(1997-8#2)
by local environmental constraints##2##4##(2010-6#2)
by local environmental##3##3##(2008-10#1)(2010-6#2)
by local##20##2##(1995-12#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-6#2)(2011-2#2)(2011-9#1)
by locally##2##2##(1994-3#1)(2008-10#1)
by long##3##2##(1992-8#1)(2008-10#1)(2008-8#1)
by long-term##6##2##(1992-2#1)(1993-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
by longicomin##2##2##(2008-8#2)
by looking##2##2##(2008-8#1)(2012-2#1)
by loss of##6##3##(1996-3#1)(1996-5#1)(1997-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
by loss##7##2##(1996-3#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
by low concentrations of##4##4##(1991-5#1)(1992-6#1)(1992-8#1)(1994-8#1)
by low concentrations##5##3##(1990-7#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-8#1)
by low temperature##2##3##(2008-11#1)(2008-7#1)
by low temperatures##2##3##(2008-10#2)
by low##28##2##(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(2008-10#12)(2008-11#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-7#1)(2013-1#1)
by low-level##2##2##(1993-8#2)
by lower##9##2##(1990-9#1)(1992-12#2)(2008-10#3)(2008-8#1)(2013-1#1)(2013-8#1)
by lowering the##4##3##(2008-10#3)(2008-11#1)
by lowering##5##2##(2008-10#3)(2008-11#1)(2010-5#1)
by lubricin addition##2##3##(2010-10#2)
by luminescence##2##2##(2008-10#2)
by lung##2##2##(1990-6#1)(2012-2#1)
by lysosomal##2##2##(2010-8#2)
by m-Nis##2##2##(2011-3#2)
by mAb##2##2##(1990-5#1)(1996-12#1)
by mRNA##2##2##(1994-8#1)(2008-9#1)
by macrophages in##2##3##(1990-12#1)(2008-10#1)
by macrophages##10##2##(1990-12#1)(1991-5#4)(1995-5#1)(2008-10#2)(2008-11#1)(2013-7#1)
by macroscopic##2##2##(1991-12#1)(2012-2#1)
by magnesium##2##2##(1991-1#1)(2008-7#1)
by magnetic resonance imaging (MRI)##3##5##(2008-9#1)(2010-9#2)
by magnetic resonance imaging##8##4##(1997-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#2)(2011-2#1)(2012-12#1)
by magnetic##9##2##(1992-3#1)(1997-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#2)(2011-2#1)(2012-12#1)
by maintaining the##2##3##(2008-10#1)(2013-8#1)
by maintaining##7##2##(2008-10#2)(2008-7#2)(2008-8#1)(2012-2#1)(2013-8#1)
by major##3##2##(1990-11#1)(1997-8#1)(2008-10#1)
by making their##2##3##(1995-12#1)(1996-2#1)
by making use of a##2##5##(2008-10#1)(2008-9#1)
by making use of the##2##5##(2008-10#2)
by making use of##4##4##(2008-10#3)(2008-9#1)
by making##17##2##(1994-9#1)(1995-12#1)(1996-2#1)(2008-10#9)(2008-11#2)(2008-9#2)(2012-12#1)
by malaria##4##2##(2012-12#4)
by male##3##2##(1991-1#1)(2008-8#1)(2009-5#1)
by males and##2##3##(2008-9#1)(2012-3#1)
by males##5##2##(2008-8#1)(2008-9#1)(2010-8#2)(2012-3#1)
by mammalian##2##2##(1991-3#1)(1997-7#1)
by management##3##2##(1993-12#1)(2008-10#1)(2013-8#1)
by manganese##3##2##(2008-10#1)(2008-7#2)
by manipulating the##2##3##(1997-2#1)(2013-1#1)
by manipulating##10##2##(1994-3#1)(1997-2#1)(2008-11#3)(2008-8#1)(2009-12#2)(2013-1#2)
by manipulation of##2##3##(1996-12#1)(1996-5#1)
by manual and##3##3##(2008-10#2)(2013-1#1)
by manual##7##2##(2008-10#5)(2010-9#1)(2013-1#1)
by manufacturers##4##2##(1993-11#1)(2008-10#1)(2010-6#1)(2012-2#1)
by many factors##2##3##(2008-5#1)(2011-1#1)
by many##22##2##(1993-1#1)(1994-12#1)(1995-3#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
by mapping##2##2##(1995-3#1)(2008-10#1)
by marine##3##2##(2008-12#2)(2013-1#1)
by mass spectrometric##2##3##(1993-8#1)(2013-1#1)
by mass spectrometry and##2##4##(2008-2#1)(2008-5#1)
by mass spectrometry##9##3##(1993-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
by mass##17##2##(1993-8#3)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
by maternal##5##2##(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)
by mating with##3##3##(2008-8#3)
by mating##8##2##(1991-5#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-8#3)
by matrix effects##2##3##(1997-2#1)(2008-10#1)
by matrix##8##2##(1993-3#1)(1997-2#1)(2008-10#5)(2008-2#1)
by matrix-assisted laser desorption/ionization time-of-flight##2##5##(2008-10#1)(2008-11#1)
by matrix-assisted laser desorption/ionization##5##4##(2008-10#1)(2008-11#4)
by matrix-assisted##6##2##(2008-10#1)(2008-11#5)
by maximal##3##2##(1994-11#1)(2009-1#1)(2013-1#1)
by maximum likelihood##2##3##(1994-9#1)(2012-3#1)
by mean##4##2##(1990-12#1)(2008-10#2)(2008-7#1)
by means of EDTA exchange##2##5##(2008-10#2)
by means of a laser##2##5##(1993-2#1)(2008-3#1)
by means of a new##3##5##(2008-10#2)(2008-11#1)
by means of a portable##2##5##(1997-4#1)(2008-10#1)
by means of a quantitative##2##5##(2008-10#1)(2011-2#1)
by means of a questionnaire##2##5##(1994-6#1)(2008-9#1)
by means of a##64##4##(1990-2#1)(1990-8#1)(1991-12#2)(1991-3#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-10#36)(2008-11#3)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2011-2#1)(2013-7#1)
by means of air##2##4##(2008-10#1)(2008-11#1)
by means of an intracavity##2##5##(2008-3#2)
by means of an##13##4##(1990-6#1)(1991-8#1)(1992-12#1)(2007-12#1)(2008-10#3)(2008-3#3)(2009-10#1)(2010-6#1)(2012-12#1)
by means of aqueous standards##2##5##(2008-10#2)
by means of artificial neural networks##3##6##(2008-10#3)
by means of automated##2##4##(2008-10#1)(2013-1#1)
by means of chemical##2##4##(2008-10#1)(2012-2#1)
by means of different##2##4##(2008-10#2)
by means of electrochemical##2##4##(2008-10#2)
by means of electron microscopy##2##5##(2008-10#1)(2008-9#1)
by means of fluorescence##4##4##(1994-5#1)(2008-10#3)
by means of high##2##4##(2008-10#1)(2008-11#1)
by means of high-performance##2##4##(2008-10#1)(2010-12#1)
by means of its##2##4##(1993-6#1)(2008-3#1)
by means of linear##2##4##(2008-10#2)
by means of positive displacement with air through a time-based injector##2##11##(2008-10#2)
by means of questionnaires to##2##5##(1992-5#1)(1997-4#1)
by means of scanning##2##4##(2008-3#1)(2008-6#1)
by means of the Langmuir##2##5##(1994-5#1)(2008-10#1)
by means of the standard additions method##2##7##(2008-10#2)
by means of the##46##4##(1990-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-6#1)(1994-5#1)(1997-6#1)(1997-8#1)(2008-10#23)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#1)
by means of this##3##4##(1993-3#1)(2008-3#1)(2008-8#1)
by means of two##2##4##(2008-10#1)(2008-11#1)
by means of##310##3##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#3)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-5#4)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#155)(2008-11#17)(2008-12#3)(2008-2#4)(2008-3#18)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#1)
by means##313##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#3)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-5#4)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#155)(2008-11#19)(2008-12#3)(2008-2#4)(2008-3#18)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#1)
by measurement of the##6##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
by measurement of##12##3##(1991-8#1)(1994-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
by measurement##13##2##(1991-8#1)(1994-2#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
by measurements of##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
by measuring the absorbance##2##4##(2008-10#2)
by measuring the amount of##2##5##(2008-10#1)(2008-5#1)
by measuring the change in absorbance##2##6##(2008-10#2)
by measuring the change##3##4##(2008-10#3)
by measuring the decrease in the absorbance of##3##8##(2008-10#3)
by measuring the decrease in##7##5##(2008-10#7)
by measuring the decrease of fluorescence##2##6##(2008-10#2)
by measuring the decrease##9##4##(2008-10#9)
by measuring the intensity of##2##5##(2008-10#2)
by measuring the peak current##2##5##(2008-10#2)
by measuring the ratio##2##4##(2008-10#1)(2008-3#1)
by measuring the release of##3##5##(1990-5#1)(1993-6#1)(2008-11#1)
by measuring the##70##3##(1990-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-8#1)(2008-10#46)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2011-2#1)(2013-1#1)
by measuring##107##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-8#1)(2008-10#62)(2008-11#6)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-2#3)(2013-1#1)
by mechanical inoculation of##3##4##(2008-10#3)
by mechanical inoculation##5##3##(2008-10#5)
by mechanical strain##2##3##(1995-2#2)
by mechanical##12##2##(1995-2#2)(2008-10#7)(2008-11#2)(2009-7#1)
by mediating##2##2##(2008-10#1)(2008-11#1)
by medical librarians##2##3##(1991-2#2)
by medical practitioners##2##3##(2008-10#2)
by medical students##4##3##(2008-11#1)(2008-3#1)(2009-6#2)
by medical##16##2##(1991-2#2)(1994-12#2)(1994-3#1)(1995-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2009-10#1)(2009-6#2)(2011-2#1)
by medium##4##2##(2008-10#1)(2008-11#3)
by melatonin##4##2##(1990-5#1)(1993-6#1)(2008-10#1)(2011-2#1)
by members of the##6##4##(1994-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
by members of##7##3##(1994-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2009-8#1)(2013-8#1)
by membrane##4##2##(2008-10#3)(2008-8#1)
by membrane-associated##2##2##(1990-8#1)(1995-6#1)
by men##2##2##(1993-9#1)(2008-11#1)
by mental health professionals##2##4##(1994-1#1)(2008-11#1)
by mental health##3##3##(1994-1#1)(1995-1#1)(2008-11#1)
by mental##4##2##(1994-1#1)(1995-1#1)(2008-11#1)(2008-5#1)
by merging##3##2##(2008-10#2)(2008-9#1)
by mesulergine##2##2##(1994-2#2)
by metered-dose inhaler##2##3##(2008-8#2)
by metformin##2##2##(1994-8#2)
by methods##2##2##(1994-11#1)(2008-11#1)
by methyl viologen##2##3##(1991-5#1)(2008-10#1)
by methyl##5##2##(1991-5#1)(1994-5#1)(2008-10#3)
by methylation##3##2##(1994-8#2)(2008-9#1)
by miRNAs##2##2##(2008-10#1)(2008-11#1)
by micellar electrokinetic capillary chromatography##4##5##(2008-10#4)
by micellar electrokinetic chromatography (MEKC)##3##5##(2008-10#3)
by micellar electrokinetic chromatography##4##4##(2008-10#4)
by micellar electrokinetic##8##3##(2008-10#8)
by micellar##9##2##(2008-10#9)
by microarray analysis##3##3##(2008-10#2)(2010-3#1)
by microarray##4##2##(2008-10#2)(2010-3#1)(2013-8#1)
by microbes##2##2##(2008-11#1)(2010-3#1)
by microbial##4##2##(1990-6#1)(2008-10#2)(2008-11#1)
by microdialysis##3##2##(1994-8#1)(1997-2#1)(2008-10#1)
by microinjection##5##2##(1997-7#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)
by microprojectile bombardment##2##3##(2008-9#2)
by microsatellite##2##2##(2008-10#1)(2008-9#1)
by microscopic examination##2##3##(2008-10#1)(2012-12#1)
by microscopic##4##2##(2008-10#2)(2009-8#1)(2012-12#1)
by microscopy and##2##3##(2008-5#1)(2008-7#1)
by microscopy##5##2##(1991-11#1)(2008-11#2)(2008-5#1)(2008-7#1)
by microsomal##2##2##(1993-11#1)(1994-8#1)
by microsurgery##2##2##(1992-3#2)
by microsurgical##2##2##(1996-9#1)(2008-7#1)
by microwave induced plasma atomic emission spectrometry##2##7##(2008-10#2)
by microwave irradiation##2##3##(2008-10#2)
by microwave plasma torch atomic emission spectrometry##2##7##(2008-10#2)
by microwave plasma##3##3##(2008-10#3)
by microwave##10##2##(2008-10#9)(2008-5#1)
by microwave-assisted digestion##2##3##(2008-10#2)
by microwave-assisted##3##2##(2008-10#3)
by microwaves##3##2##(2008-10#1)(2011-2#2)
by mild##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
by mimicking##2##2##(1993-8#1)(2008-10#1)
by minocycline##2##2##(2008-7#2)
by minor##2##2##(2008-10#1)(2010-10#1)
by mitochondria##4##2##(1994-5#2)(2009-8#1)(2011-2#1)
by mitogen-activated protein kinases##2##4##(1996-2#2)
by mixed##3##2##(2008-10#1)(2008-7#2)
by mixing the##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
by mixing##13##2##(1993-8#1)(2008-10#11)(2008-3#1)
by model##3##2##(2008-10#3)
by modern##3##2##(2008-7#2)(2010-5#1)
by modification of the##2##4##(2008-10#2)
by modification of##4##3##(1994-5#1)(2008-10#3)
by modified##5##2##(1993-8#1)(2008-10#4)
by modifying the##5##3##(1995-12#1)(2008-10#3)(2008-3#1)
by modifying##9##2##(1995-12#1)(1997-2#1)(2008-10#5)(2008-3#1)(2011-2#1)
by modulating the expression of##3##5##(2008-11#1)(2008-9#1)(2009-10#1)
by modulating the##8##3##(1990-12#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-10#1)(2012-2#1)
by modulating##13##2##(1990-12#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
by modulation of##2##3##(1994-3#1)(2008-2#1)
by modulation##3##2##(1994-3#1)(2008-10#1)(2008-2#1)
by molecular beam epitaxy##4##4##(1995-3#1)(2007-12#1)(2009-11#2)
by molecular cloning##2##3##(1993-2#1)(1995-11#1)
by molecular dynamics##3##3##(1994-8#1)(2008-10#1)(2008-4#1)
by molecular markers##2##3##(2008-10#1)(2008-8#1)
by molecular modeling##2##3##(2008-10#1)(2008-4#1)
by molecular replacement using the##2##5##(1992-4#1)(1993-8#1)
by molecular replacement##7##3##(1992-4#1)(1993-8#2)(2008-8#3)(2008-9#1)
by molecular##32##2##(1992-4#1)(1993-2#1)(1993-8#2)(1994-1#1)(1994-8#1)(1995-11#2)(1995-3#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#2)(2009-11#2)(2009-3#1)(2012-2#1)
by monitoring the change in##2##5##(1995-6#1)(2008-11#1)
by monitoring the##13##3##(1992-12#1)(1994-9#1)(1995-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2009-5#1)
by monitoring##18##2##(1992-12#1)(1994-9#1)(1995-6#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2009-5#1)
by monoclonal antibodies##4##3##(1990-12#1)(1996-12#1)(2008-10#1)(2008-5#1)
by monoclonal antibody##4##3##(1995-2#1)(2006-6#1)(2008-10#1)(2008-8#1)
by monoclonal##10##2##(1990-12#1)(1995-2#1)(1996-12#1)(2006-6#2)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
by more than 25%##2##4##(2008-10#1)(2011-1#1)
by more than 50%##3##4##(1993-11#1)(2008-7#1)(2010-3#1)
by more than one##2##4##(2008-10#2)
by more than##18##3##(1993-11#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
by more##24##2##(1993-11#1)(1993-2#1)(1994-3#1)(1996-2#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
by morphine##3##2##(1991-1#1)(1994-2#1)(1995-11#1)
by morphological##4##2##(2008-10#2)(2008-9#2)
by morphology##3##2##(2008-10#2)(2011-2#1)
by most isolates##2##3##(2008-10#2)
by most of the##2##4##(1993-8#1)(2013-1#1)
by most##14##2##(1990-9#1)(1992-12#1)(1993-8#1)(1995-6#1)(1996-2#1)(1997-9#1)(2008-10#5)(2008-5#1)(2012-2#1)(2013-1#1)
by mothers##3##2##(1995-1#1)(2009-8#2)
by motor##2##2##(1996-5#1)(2010-7#1)
by mounting##2##2##(2011-2#1)(2012-2#1)
by mouse##2##2##(1995-2#1)(2008-8#1)
by mouth##3##2##(1991-4#1)(1997-1#1)(2012-2#1)
by movement##3##2##(1993-6#1)(2008-10#1)(2013-8#1)
by moving##3##2##(1991-1#1)(2008-10#2)
by mu##4##2##(2008-10#4)
by mucosal routes##2##3##(1997-3#2)
by multiple genes##2##3##(2008-6#1)(2012-3#1)
by multiple linear regression##3##4##(2008-10#1)(2009-7#1)(2013-1#1)
by multiple regression##2##3##(1994-12#1)(2013-8#1)
by multiple##35##2##(1992-6#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1996-2#1)(2008-10#10)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
by multiplex PCR##2##3##(2008-12#1)(2011-2#1)
by multiplex RT-PCR##2##3##(2008-10#1)(2013-8#1)
by multiplex##6##2##(2008-10#3)(2008-12#1)(2011-2#1)(2013-8#1)
by multiplying##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
by multivariate calibration##2##3##(2008-10#2)
by multivariate spectrophotometric calibration##2##4##(2008-10#2)
by multivariate##8##2##(1991-8#1)(2008-10#7)
by murine##2##2##(1994-5#1)(2008-9#1)
by mutation##4##2##(2008-10#2)(2010-5#1)(2011-1#1)
by mutations in##11##3##(1990-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
by mutations##14##2##(1990-5#1)(1994-11#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
by mycelial##2##2##(2008-10#2)
by myocardial infarction##2##3##(1993-1#1)(2011-2#1)
by myocardial##3##2##(1993-1#1)(2011-2#1)(2013-8#1)
by myristic acid co-chemisorption##2##4##(2008-10#2)
by naloxone##3##2##(1992-3#1)(1995-12#1)(1996-2#1)
by nanoindentation##2##2##(2009-7#1)(2010-4#1)
by native##4##2##(1997-3#1)(2008-10#1)(2008-11#2)
by natural selection##3##3##(2008-9#1)(2012-3#2)
by natural##10##2##(1991-5#1)(1997-3#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-3#3)(2013-1#1)
by naturally occurring##4##3##(1994-11#1)(1995-9#2)(2008-10#1)
by near infrared##2##3##(2008-10#2)
by near##4##2##(1995-12#1)(2008-10#2)(2011-1#1)
by near-infrared spectroscopy##2##3##(2008-10#2)
by near-infrared##5##2##(2008-10#4)(2008-5#1)
by nearly##3##2##(1995-2#1)(2008-5#1)(2008-7#1)
by nebulization##2##2##(1995-3#2)
by neck##2##2##(1997-3#1)(2008-12#1)
by necrotizing##2##2##(2008-1#1)(2008-10#1)
by needle##2##2##(2008-10#1)(2008-7#1)
by negative##2##2##(2008-10#1)(2008-11#1)
by nematode##2##2##(2008-10#2)
by neonatal##2##2##(1993-3#1)(2008-11#1)
by nerve##3##2##(1996-12#1)(2008-11#1)(2008-5#1)
by nested##3##2##(2008-10#2)(2008-12#1)
by networks of##2##3##(1990-5#1)(2010-1#1)
by neuronal##3##2##(1994-8#1)(2008-5#1)(2008-7#1)
by neutral##4##2##(1992-6#1)(1995-6#1)(2008-6#1)(2008-8#1)
by neutrophil##2##2##(1991-5#1)(1997-1#1)
by new##3##2##(1995-2#1)(2008-11#1)(2008-3#1)
by nickel##2##2##(2008-10#1)(2010-2#1)
by nicotine##2##2##(1996-2#1)(2009-7#1)
by nine##5##2##(1990-12#1)(1995-2#1)(2008-10#2)(2008-11#1)
by nitrate##3##2##(2008-10#2)(2011-2#1)
by nitric acid##2##3##(2008-10#2)
by nitric oxide##3##3##(1992-3#1)(2008-12#1)(2009-10#1)
by nitric##5##2##(1992-3#1)(2008-10#2)(2008-12#1)(2009-10#1)
by nitrite##2##2##(2008-10#2)
by no means##4##3##(1995-1#1)(2008-11#1)(2008-9#1)(2009-3#1)
by no##6##2##(1995-1#1)(2008-11#2)(2008-9#1)(2009-12#1)(2009-3#1)
by noise##2##2##(2008-10#1)(2008-9#1)
by non##2##2##(2008-10#2)
by non-Medicare payers##2##3##(1994-12#2)
by non-Medicare##3##2##(1993-3#1)(1994-12#2)
by non-invasive methods##2##3##(1990-9#1)(1993-12#1)
by non-invasive##3##2##(1990-9#1)(1993-12#1)(2008-5#1)
by non-linear regression##5##3##(2008-10#5)
by non-linear##7##2##(2008-10#7)
by non-suppressed##2##2##(2008-10#2)
by nonlinear regression analysis##3##4##(1993-3#1)(2008-10#2)
by nonlinear##5##2##(1993-3#1)(2007-12#1)(2008-10#2)(2008-7#1)
by nonprofit##2##2##(1992-3#2)
by nonspherical particles with##2##4##(2008-3#2)
by noradrenaline##3##2##(1997-4#3)
by normal human fibroblasts##3##4##(2008-5#3)
by normal##10##2##(1992-9#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-5#3)(2009-12#1)(2012-7#1)
by normal-phase##2##2##(2008-10#2)
by northern blot##3##3##(2008-10#2)(2008-4#1)
by not##2##2##(1995-8#1)(2012-2#1)
by novel##3##2##(1990-5#1)(2008-10#1)(2012-2#1)
by nuclear magnetic resonance spectroscopy##2##5##(1994-5#1)(2008-10#1)
by nuclear magnetic resonance##5##4##(1991-6#1)(1994-5#1)(2008-10#3)
by nuclear transfer##2##3##(2008-11#1)(2008-9#1)
by nuclear##11##2##(1991-6#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2010-3#1)
by nuclease protection##2##3##(1995-2#1)(2008-4#1)
by nuclease##3##2##(1990-7#1)(1995-2#1)(2008-4#1)
by nucleotide sequence analysis of##2##5##(2008-10#2)
by nucleotide##3##2##(1994-12#1)(2008-10#2)
by numerical##6##2##(1991-5#1)(2008-3#3)(2008-5#1)(2013-8#1)
by numerous##4##2##(1990-11#1)(1993-12#1)(2008-10#1)(2011-2#1)
by nurse##5##2##(1990-12#1)(2008-11#3)(2008-12#1)
by nurses##10##2##(1996-2#1)(2008-11#3)(2008-12#1)(2012-2#1)(2013-1#4)
by nursing students##4##3##(2008-11#4)
by nursing##9##2##(1991-2#2)(2008-11#4)(2010-10#1)(2013-1#2)
by nutrient##3##2##(2008-5#1)(2008-7#2)
by observation##3##2##(1990-12#1)(2008-11#1)(2008-2#1)
by observing##5##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
by obtaining##2##2##(2008-10#2)
by occlusion##2##2##(2008-5#1)(2008-7#1)
by okadaic acid##3##3##(1994-11#1)(1995-11#1)(1995-8#1)
by older##2##2##(2012-12#1)(2012-2#1)
by oleic acid##3##3##(1990-5#1)(1993-9#2)
by on-line column##2##3##(2008-10#2)
by on-line elution##3##3##(2008-10#3)
by on-line reaction with##2##4##(2008-10#2)
by on-line##24##2##(2008-10#24)
by once##2##2##(2007-11#1)(2008-8#1)
by oncogene transfection##2##3##(2008-11#2)
by oncogene##4##2##(1994-9#1)(2008-11#3)
by oncogenes##2##2##(2008-11#2)
by one (5%)##2##3##(1996-9#2)
by one of the##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
by one of two##3##4##(1994-11#1)(2008-10#1)(2008-5#1)
by one of##10##3##(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)
by one or##3##3##(2008-10#1)(2008-9#2)
by one position downstream##2##4##(1997-7#2)
by one species##2##3##(2008-8#2)
by one surgeon##2##3##(2008-7#1)(2008-9#1)
by one##41##2##(1990-11#1)(1993-3#1)(1994-11#1)(1996-9#2)(1997-7#2)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#6)(2009-5#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)
by one- or two-dimensional##2##4##(1993-8#1)(2008-10#1)
by one-step##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
by ongoing##2##2##(2008-6#1)(2009-8#1)
by only a single##2##4##(1991-9#1)(2008-8#1)
by only a##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
by only##16##2##(1991-9#1)(1993-8#1)(1993-9#1)(1995-12#1)(2008-10#7)(2008-3#1)(2008-8#1)(2009-5#1)(2010-8#1)(2013-7#1)
by open##7##2##(1997-8#1)(2008-10#3)(2008-12#1)(2009-4#1)(2012-3#1)
by operating##4##2##(2008-7#3)(2011-2#1)
by optical emission##2##3##(2008-10#2)
by optical microscopy##2##3##(2008-10#2)
by optical##13##2##(1994-11#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#1)
by optimization of##2##3##(2008-10#2)
by optimizing the##2##3##(2007-12#1)(2008-10#1)
by optimizing##4##2##(2007-12#1)(2008-10#2)(2013-8#1)
by oral gavage##2##3##(2008-10#2)
by oral##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#1)(2012-2#1)
by ordering##2##2##(1996-12#2)
by ordinary##3##2##(2008-10#2)(2008-3#1)
by organic##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
by orthogonal##2##2##(2008-10#2)
by other authors##3##3##(2008-10#2)(2008-5#1)
by other factors##3##3##(1990-3#1)(1995-12#1)(2008-11#1)
by other investigators##2##3##(1994-2#1)(2008-8#1)
by other methods##8##3##(1991-2#1)(2008-10#3)(2008-2#1)(2008-4#2)(2013-8#1)
by other##56##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
by others as##2##3##(2008-10#1)(2008-5#1)
by others##13##2##(1993-12#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
by ouabain##2##2##(1992-3#1)(1994-3#1)
by our group##4##3##(2008-10#3)(2010-12#1)
by our##22##2##(1992-6#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-3#2)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-1#2)
by outlining##2##2##(1994-3#1)(2008-11#1)
by over##4##2##(1992-3#1)(1997-1#1)(2009-10#1)(2010-5#1)
by overexpression of##5##3##(1993-11#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-7#1)
by overgrowth##2##2##(2008-11#2)
by overlapping##3##2##(1991-2#1)(1993-9#1)(2010-10#1)
by oxidation of##6##3##(2008-10#6)
by oxidation with##4##3##(2008-10#4)
by oxidation##12##2##(1991-7#1)(2008-10#10)(2013-7#1)
by oxidative##2##2##(2008-10#1)(2011-2#1)
by p53##2##2##(1994-9#1)(2008-5#1)
by pH titration##2##3##(2008-10#2)
by pH##7##2##(2008-10#6)(2008-5#1)
by packing##3##2##(2008-10#3)
by pain##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
by pairing##2##2##(2008-10#1)(2010-11#1)
by parallel##4##2##(2008-10#4)
by parameter##2##2##(2008-10#2)
by parental##2##2##(1993-1#1)(2008-9#1)
by parents of children##2##4##(1992-2#1)(2008-11#1)
by parents##11##2##(1992-2#2)(1993-3#1)(1995-12#1)(2008-11#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#2)
by partial least squares (PLS)##2##5##(2008-10#2)
by partial least squares regression##2##5##(2008-10#2)
by partial least squares##7##4##(2008-10#7)
by partial least-squares##3##3##(2008-10#3)
by partial##17##2##(1991-8#1)(2008-10#12)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
by partially##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
by participant##2##2##(2009-11#1)(2012-2#1)
by participants for impact##2##4##(2008-4#2)
by participants##8##2##(1994-3#1)(1995-1#1)(2008-1#1)(2008-12#1)(2008-4#2)(2010-8#1)(2011-1#1)
by participating in##2##3##(1992-1#1)(2008-10#1)
by participating##3##2##(1992-1#1)(2008-10#1)(2008-9#1)
by particle bombardment and##2##4##(2008-10#2)
by particle bombardment##5##3##(2008-10#4)(2008-5#1)
by particle size##2##3##(2008-10#1)(2008-5#1)
by particle##9##2##(1997-2#1)(2008-10#5)(2008-5#2)(2010-11#1)
by partitioning##2##2##(1993-8#1)(2008-10#1)
by passage of##2##3##(1992-8#1)(2008-10#1)
by passage through##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
by passage##5##2##(1992-8#1)(1995-12#1)(2008-10#2)(2008-3#1)
by passing them##2##3##(2008-10#2)
by passing##11##2##(2008-10#9)(2008-11#1)(2008-12#1)
by passive##4##2##(1995-11#1)(2008-5#1)(2009-7#1)(2010-12#1)
by pathogen##2##2##(2008-10#2)
by pathogenic##3##2##(2008-10#2)(2013-1#1)
by pathogenicity assays##2##3##(2008-10#2)
by pathogenicity tests and##2##4##(2008-10#2)
by pathogenicity tests##3##3##(2008-10#3)
by pathogenicity##9##2##(2008-10#9)
by pathogens##2##2##(2008-10#1)(2011-10#1)
by pathological examination##2##3##(2008-10#1)(2012-12#1)
by patient##5##2##(1990-12#1)(1997-5#1)(2007-8#1)(2011-2#2)
by patients and##4##3##(1991-6#1)(1996-8#1)(2008-11#1)(2012-3#1)
by patients##11##2##(1991-12#1)(1991-6#1)(1996-2#1)(1996-8#1)(2008-11#2)(2010-10#2)(2012-3#2)(2013-8#1)
by paying##2##2##(1995-5#1)(2008-9#1)
by peer##2##2##(2008-11#1)(2013-1#1)
by people##4##2##(1993-12#1)(2008-10#2)(2012-3#1)
by pepstatin A##2##3##(1991-9#1)(1995-8#1)
by perceived##3##2##(2011-2#2)(2013-1#1)
by percent##2##2##(2008-10#1)(2013-1#1)
by performing a##2##3##(1991-3#1)(2008-10#1)
by performing##14##2##(1991-3#1)(2008-10#9)(2008-11#1)(2010-6#1)(2011-2#1)(2013-8#1)
by perfusing##2##2##(1997-2#1)(2008-10#1)
by periodate##4##2##(2008-10#4)
by periodic##2##2##(2008-10#2)
by periods at##2##3##(2008-10#2)
by peripheral##3##2##(1992-3#1)(1995-8#1)(2008-10#1)
by peritoneal##2##2##(2011-2#1)(2012-3#1)
by permanganate##2##2##(2008-10#2)
by peroxodisulfate##2##2##(2008-10#2)
by peroxynitrite##2##2##(2008-10#2)
by personal##2##2##(2008-12#1)(2013-1#1)
by persons##2##2##(2008-10#1)(2010-10#1)
by pertussis toxin##2##3##(1990-8#1)(1997-1#1)
by pertussis##3##2##(1990-8#1)(1992-9#1)(1997-1#1)
by pervaporation##2##2##(2008-10#2)
by phagocytes##2##2##(2008-10#1)(2008-12#1)
by pharmacies##2##2##(1990-2#1)(1995-1#1)
by pharmacological##2##2##(1995-11#1)(2010-12#1)
by phase##5##2##(1990-5#1)(1992-12#1)(2007-11#1)(2008-3#1)(2011-2#1)
by phenolic compounds##3##3##(2008-10#3)
by phenols##2##2##(2008-10#2)
by phenoxodiol##2##2##(2009-9#2)
by phenylephrine##4##2##(1991-6#2)(1994-3#2)
by phorbol 12-myristate 13-acetate (PMA)##2##5##(1994-11#1)(2008-11#1)
by phorbol ester in##2##4##(1994-6#1)(1997-1#1)
by phorbol ester##6##3##(1991-5#1)(1994-11#1)(1994-6#1)(1995-6#1)(1997-1#1)(2008-11#1)
by phorbol esters##2##3##(1993-8#1)(1996-2#1)
by phorbol myristate acetate##2##4##(1994-6#1)(2006-6#1)
by phorbol##12##2##(1991-5#1)(1993-8#1)(1994-11#2)(1994-6#2)(1995-6#1)(1996-2#1)(1997-1#1)(2006-6#1)(2008-11#2)
by phosphate##3##2##(1991-5#1)(2008-10#1)(2010-12#1)
by phospholipase C##3##3##(1993-6#2)(2008-11#1)
by phospholipase##4##2##(1993-6#2)(2008-11#2)
by phosphonic acid-imbedded polyurethane foam##2##5##(2008-10#2)
by phosphorylation##4##2##(1992-9#1)(1994-11#1)(1996-2#1)(1997-2#1)
by photochemically##2##2##(2008-10#1)(2008-11#1)
by photodynamic##2##2##(2012-2#2)
by photogenerated##2##2##(2008-10#1)(2009-11#1)
by photolysis##3##2##(1996-5#1)(2008-10#2)
by photometry##2##2##(2008-10#2)
by phylogenetic analyses of the##2##5##(2008-10#1)(2008-8#1)
by phylogenetic##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
by physical adsorption##2##3##(2008-10#2)
by physical agents##2##3##(1990-6#2)
by physical exercise##2##3##(2010-6#1)(2013-8#1)
by physical therapists##2##3##(1992-3#1)(2008-12#1)
by physical##12##2##(1990-6#2)(1992-3#1)(1997-2#1)(2008-10#4)(2008-12#1)(2010-6#1)(2010-7#1)(2013-8#1)
by physicians##7##2##(1991-8#2)(1993-3#1)(1994-1#1)(1997-3#1)(2008-12#1)(2013-1#1)
by phytoplasmas##2##2##(2008-10#2)
by placing the##2##3##(2008-3#1)(2011-1#1)
by placing##6##2##(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)
by plant##7##2##(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)
by plants##7##2##(2008-10#3)(2008-8#1)(2008-9#1)(2009-8#2)
by plaque##2##2##(2008-10#1)(2008-9#1)
by plasma##2##2##(2008-10#2)
by plasmid##2##2##(2008-8#1)(2011-1#1)
by plasticized##2##2##(2008-10#2)
by plate counts##2##3##(2008-10#2)
by plating##2##2##(2008-10#2)
by plotting the##4##3##(2008-10#4)
by point mutations##2##3##(1991-12#1)(2008-7#1)
by point##4##2##(1991-12#1)(1992-8#1)(2008-11#1)(2008-7#1)
by polarography##6##2##(2008-10#6)
by polishing##5##2##(2008-10#5)
by pollen##2##2##(2008-10#1)(2008-8#1)
by pollination##2##2##(2008-10#1)(2009-10#1)
by polyacrylamide gel electrophoresis##3##4##(2008-4#2)(2008-5#1)
by polyacrylamide##4##2##(1991-12#1)(2008-4#2)(2008-5#1)
by polyclonal antibodies##2##3##(1992-8#1)(1995-6#1)
by polyclonal##4##2##(1990-9#1)(1992-8#1)(1995-6#2)
by polymerase chain reaction (PCR) and##3##6##(2008-10#1)(2010-6#1)(2011-2#1)
by polymerase chain reaction (PCR) screening##2##6##(1996-12#1)(1997-2#1)
by polymerase chain reaction (PCR) using##2##6##(1996-12#1)(1996-8#1)
by polymerase chain reaction (PCR)##15##5##(1996-12#2)(1996-8#1)(1997-2#1)(2008-10#8)(2008-11#1)(2010-6#1)(2011-2#1)
by polymerase chain reaction amplification of##2##6##(2008-10#2)
by polymerase chain reaction amplification##4##5##(2008-10#4)
by polymerase chain reaction and##2##5##(2008-10#1)(2008-5#1)
by polymerase chain reaction in##2##5##(1996-3#1)(2008-10#1)
by polymerase chain reaction using##3##5##(2008-10#2)(2012-12#1)
by polymerase chain reaction##47##4##(1992-6#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(2008-10#29)(2008-11#2)(2008-5#2)(2009-8#2)(2010-6#2)(2011-2#2)(2012-12#2)
by polymerase chain##48##3##(1992-6#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#29)(2008-11#2)(2008-5#2)(2009-8#2)(2010-6#2)(2011-2#2)(2012-12#2)
by polyurethane##2##2##(2008-10#2)
by poor##3##2##(1991-9#1)(2008-10#1)(2012-12#1)
by population##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
by populations of##2##3##(2008-10#2)
by portal##2##2##(1991-11#2)
by positioning##3##2##(2008-10#1)(2013-1#2)
by positive##5##2##(1992-8#2)(2008-11#1)(2011-2#1)(2012-12#1)
by positron emission tomography (PET)##2##5##(1990-8#1)(1996-2#1)
by post##4##2##(2008-12#1)(2010-10#1)(2010-7#1)(2011-2#1)
by potassium hexacyanoferrate(III)##2##3##(2008-10#2)
by potassium periodate in##2##4##(2008-10#2)
by potassium periodate##5##3##(2008-10#5)
by potassium##9##2##(2008-10#9)
by potato##2##2##(2008-10#2)
by potential##4##2##(1992-12#1)(1996-12#1)(2008-10#2)
by potentiometric and##2##3##(2008-10#2)
by potentiometric titration##5##3##(2008-10#5)
by potentiometric titrations##2##3##(2008-10#2)
by potentiometric##16##2##(2008-10#16)
by potentiometry and##5##3##(2008-10#5)
by potentiometry##7##2##(2008-10#7)
by potocytosis##2##2##(1994-6#1)(1995-6#1)
by powder metallurgy##2##3##(2009-7#2)
by practising##2##2##(1996-6#1)(2008-12#1)
by practitioners##4##2##(1996-3#1)(2008-10#1)(2008-11#2)
by pre-treatment with genistein or daidzein##2##6##(2008-10#2)
by precipitation with##2##3##(2008-10#1)(2008-8#1)
by precipitation##5##2##(2008-10#4)(2008-8#1)
by precise##2##2##(2008-11#1)(2008-6#1)
by precolumn##2##2##(2008-10#1)(2008-5#1)
by preconcentration##4##2##(2008-10#4)
by predators and##2##3##(1997-7#1)(2008-8#1)
by predators as##2##3##(2012-3#2)
by predators##6##2##(1997-7#1)(2008-8#2)(2012-3#3)
by pregnant women##2##3##(2009-4#1)(2013-1#1)
by preincubation##2##2##(1995-11#1)(1997-1#1)
by preparative##3##2##(1995-6#1)(2008-10#1)(2008-5#1)
by presenting the##3##3##(1997-3#1)(2008-6#1)(2011-2#1)
by presenting##5##2##(1995-12#1)(1997-3#1)(2008-2#1)(2008-6#1)(2011-2#1)
by pressure##2##2##(1996-12#1)(2008-10#1)
by pressurized##2##2##(2008-10#2)
by pretreatment of the cells with##2##6##(1997-1#2)
by pretreatment of the##3##4##(1995-2#1)(1997-1#2)
by pretreatment of##5##3##(1995-2#1)(1997-1#2)(2008-11#1)(2011-2#1)
by pretreatment with the extracts##2##5##(2013-1#2)
by pretreatment with the##4##4##(1990-5#1)(1993-12#1)(2013-1#2)
by pretreatment with##7##3##(1990-5#1)(1993-12#1)(1993-6#1)(1994-3#1)(2012-2#1)(2013-1#2)
by pretreatment##14##2##(1990-5#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-2#1)(1997-1#2)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)(2013-1#2)
by preventing##9##2##(1990-5#1)(1990-7#1)(1995-2#1)(2008-11#1)(2008-5#2)(2009-12#1)(2011-2#1)(2012-3#1)
by prevention of##2##3##(1990-12#1)(2008-10#1)
by previous##5##2##(1995-2#1)(2008-10#2)(2011-2#2)
by previously##3##2##(2008-10#3)
by primary care##2##3##(1996-11#2)
by primary##5##2##(1990-9#1)(1993-11#1)(1994-6#1)(1996-11#2)
by primer##2##2##(1993-2#1)(2008-10#1)
by principal component analysis (PCA) and##5##6##(2008-10#5)
by principal component analysis (PCA)##7##5##(2008-10#7)
by principal component analysis##10##4##(2008-10#9)(2013-1#1)
by principal component##11##3##(2008-10#10)(2013-1#1)
by prior i##2##3##(1996-2#1)(1997-4#1)
by prior##10##2##(1994-8#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-4#1)
by private insurers##2##3##(1993-1#1)(1994-1#1)
by private##7##2##(1992-12#1)(1992-3#1)(1993-1#1)(1994-1#1)(1997-3#1)(1997-4#1)(2008-10#1)
by pro-choice##2##2##(1995-6#1)(1996-5#1)
by probing##3##2##(1991-9#1)(2008-10#1)(2008-6#1)
by problems##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
by procedure##2##2##(2008-10#2)
by processing of##2##3##(2007-11#1)(2008-3#1)
by processing##7##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)
by producing##4##2##(2008-10#3)(2008-7#1)
by products##2##2##(2008-10#2)
by professional##2##2##(1996-1#1)(2010-8#1)
by professionals##2##2##(2008-11#1)(2009-10#1)
by progesterone in normal##2##4##(1990-5#2)
by progesterone##3##2##(1990-5#2)(2008-8#1)
by programmed##2##2##(1995-12#1)(2008-10#1)
by progressive##6##2##(1992-12#1)(2008-1#1)(2008-4#2)(2012-3#1)(2013-7#1)
by prolonged##5##2##(1990-12#1)(1997-1#1)(2008-1#1)(2011-1#2)
by prolonging##2##2##(2008-11#1)(2011-3#1)
by promoter##2##2##(2008-9#1)(2011-1#1)
by promoting the##2##3##(1994-12#1)(2012-3#1)
by promoting##5##2##(1994-12#1)(1994-8#1)(2008-10#1)(2009-8#1)(2012-3#1)
by proper##2##2##(1995-12#1)(2008-10#1)
by proposing##2##2##(1996-3#1)(2008-10#1)
by protease##2##2##(2008-10#1)(2008-7#1)
by protecting##3##2##(1994-2#1)(2008-5#2)
by protein G##2##3##(1990-12#2)
by protein kinase C##8##4##(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-8#2)(2008-7#1)
by protein kinase##9##3##(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#2)(2008-7#1)
by protein kinases C and##2##5##(1995-6#1)(2011-2#1)
by protein##21##2##(1990-12#2)(1990-5#1)(1991-5#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#3)(1995-8#3)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
by proteins##3##2##(2008-10#3)
by proteolytic##3##2##(1994-11#1)(1995-8#1)(2008-11#1)
by providers##5##2##(1993-3#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-6#1)
by providing a##7##3##(1994-1#2)(2008-10#1)(2008-11#3)(2010-1#1)
by providing timely##2##3##(1996-1#1)(2008-7#1)
by providing##21##2##(1991-9#1)(1994-1#2)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)
by proximity##3##2##(2008-9#3)
by public health##2##3##(1996-2#1)(1996-3#1)
by public##3##2##(1991-3#1)(1996-2#1)(1996-3#1)
by pulmonary##3##2##(2009-5#1)(2012-12#1)(2013-1#1)
by pulse radiolysis##2##3##(2008-9#2)
by pulse##3##2##(1995-2#1)(2008-9#2)
by pulsed field gel electrophoresis##2##5##(2008-10#1)(2012-3#1)
by pulsed##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
by pulsed-field gel electrophoresis##6##4##(1993-12#1)(1996-12#1)(1997-2#2)(2008-10#2)
by pumping##3##2##(2008-2#1)(2008-3#1)(2010-6#1)
by puncturing the##2##3##(1996-3#1)(2008-11#1)
by pure##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
by purified##5##2##(1992-12#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
by purinergic agents##2##3##(1995-8#2)
by putting##2##2##(1992-2#1)(1995-3#1)
by q-PCR##2##2##(2008-10#2)
by qualitative##2##2##(2012-2#2)
by qualitatively##2##2##(2008-11#1)(2010-1#1)
by quantification of##2##3##(2008-10#1)(2008-12#1)
by quantifying the##5##3##(2008-10#4)(2011-2#1)
by quantitating the##3##3##(1994-5#1)(1995-2#1)(2006-6#1)
by quantitative PCR##3##3##(1993-6#1)(1995-2#1)(2008-2#1)
by quantitative polymerase chain reaction##2##5##(2008-10#1)(2013-8#1)
by quantitative real-time PCR##2##4##(2010-11#1)(2012-3#1)
by quantitative trait##2##3##(2008-10#1)(2008-9#1)
by quantitative##18##2##(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-9#2)(2010-11#1)(2012-3#1)(2013-8#1)
by quartz crystal microbalance##3##4##(2008-10#3)
by quasi-elastic light scattering##2##4##(2008-10#2)
by questionnaires##2##2##(2008-11#1)(2013-1#1)
by quinine##3##2##(2008-10#3)
by race in the##2##4##(1995-2#2)
by race##9##2##(1995-2#3)(2008-10#3)(2008-12#1)(2009-5#1)(2011-2#1)
by race/ethnicity##2##2##(2013-1#2)
by races 1##2##3##(2008-10#2)
by races##4##2##(2008-10#4)
by radial##2##2##(1990-2#1)(2011-2#1)
by radiation and##2##3##(1993-2#1)(2013-1#1)
by radiation therapy##3##3##(2008-1#1)(2008-7#1)(2013-8#1)
by radiation##8##2##(1993-2#1)(1993-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
by radical##5##2##(1990-6#1)(1994-6#2)(1996-5#1)(2013-8#1)
by radioimmunoassay##7##2##(1990-11#1)(1991-3#1)(1992-9#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-3#1)
by radiotherapy##6##2##(1990-12#1)(1990-6#2)(1991-8#1)(1991-9#1)(2010-11#1)
by rain##2##2##(2008-10#2)
by raising the##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
by raising##8##2##(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)
by random amplified polymorphic DNA (RAPD) analysis##3##7##(2008-10#3)
by random amplified polymorphic DNA (RAPD)##4##6##(2008-10#4)
by random amplified polymorphic DNA##6##5##(2008-10#6)
by random amplified##7##3##(2008-10#7)
by random##9##2##(2008-10#8)(2012-2#1)
by randomly##3##2##(2008-10#2)(2008-3#1)
by rapid##4##2##(1997-3#1)(2008-10#1)(2008-8#1)(2012-2#1)
by rat hepatic microsomes##3##4##(2011-1#3)
by rat liver##2##3##(1994-8#1)(1995-8#1)
by rat##13##2##(1990-8#1)(1991-9#1)(1993-8#1)(1994-8#2)(1995-8#1)(2008-10#2)(2008-11#1)(2011-1#3)(2013-1#1)
by rats##3##2##(1992-12#1)(1993-3#2)
by reacting with##3##3##(2008-10#2)(2008-5#1)
by reacting##7##2##(2008-10#5)(2008-5#1)(2010-4#1)
by reaction of##2##3##(1996-5#1)(2008-5#1)
by reaction with##13##3##(1993-8#1)(1994-5#1)(1997-1#1)(2008-10#10)
by reaction##17##2##(1993-8#1)(1994-5#1)(1996-5#1)(1997-1#1)(2008-10#12)(2008-5#1)
by reactive oxygen species (ROS)##3##5##(2008-10#1)(2008-5#1)(2009-8#1)
by real##2##2##(2008-11#1)(2011-2#1)
by real-time PCR##3##3##(2008-10#2)(2012-3#1)
by real-time polymerase chain reaction##2##5##(2008-10#1)(2010-6#1)
by real-time polymerase chain##3##4##(2008-10#1)(2008-5#1)(2010-6#1)
by real-time reverse transcription-polymerase chain reaction##2##6##(2008-10#1)(2013-1#1)
by real-time##9##2##(2008-10#5)(2008-5#1)(2010-6#1)(2012-3#1)(2013-1#1)
by recent##6##2##(1994-3#1)(1994-6#1)(1995-1#1)(1996-6#1)(2008-1#1)(2009-5#1)
by receptor##4##2##(1994-3#1)(1995-2#2)(2008-11#1)
by receptor-mediated##2##2##(1991-12#1)(2008-10#1)
by recognizing##2##2##(2008-8#1)(2009-10#1)
by recombinant adeno-associated viral##2##4##(2008-9#2)
by recombinant human##2##3##(2008-1#1)(2013-1#1)
by recombinant##11##2##(1995-5#1)(1997-8#3)(2008-1#2)(2008-11#1)(2008-9#3)(2013-1#1)
by reconstructive##2##2##(1990-9#1)(1992-5#1)
by recording emission fluorescence spectra between##2##6##(2008-10#2)
by recording the##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
by recording##11##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-7#2)
by recoveries of##2##3##(2008-10#2)
by recovery measurements##3##3##(2008-10#3)
by recovery test##2##3##(2008-10#2)
by recovery##5##2##(2008-10#5)
by recruiting##2##2##(2012-2#1)(2013-1#1)
by recurrent##3##2##(1996-5#1)(2008-7#1)(2010-6#1)
by reduced##6##2##(1991-5#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
by reducing the##15##3##(1990-2#1)(1991-3#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
by reducing##30##2##(1990-2#1)(1991-3#1)(1991-6#2)(1994-3#1)(1994-8#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#2)(2010-11#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
by reduction at -1##2##4##(2008-10#2)
by reduction of the##2##4##(1990-2#1)(2008-10#1)
by reduction of##4##3##(1990-2#1)(2008-10#3)
by reduction##13##2##(1990-2#1)(1995-8#1)(1996-5#4)(2008-10#6)(2012-2#1)
by reference methods##2##3##(2008-10#2)
by reference to##2##3##(2008-10#1)(2012-2#1)
by reference##4##2##(2008-10#3)(2012-2#1)
by reflecting##2##2##(2010-12#1)(2011-2#1)
by region##3##2##(1992-2#1)(2008-10#2)
by regression analysis##3##3##(2008-10#3)
by regression##5##2##(2008-10#4)(2011-1#1)
by regular##5##2##(1991-8#1)(2008-10#3)(2013-1#1)
by regulated##3##2##(1996-3#1)(2008-8#1)(2010-11#1)
by regulating the##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
by regulating##10##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
by regulation of##2##3##(2009-5#1)(2013-8#1)
by regulations##2##2##(1994-2#1)(2012-2#1)
by regulatory##2##2##(2008-11#1)(2009-6#1)
by related##2##2##(1992-7#1)(2009-10#1)
by relating##2##2##(1990-11#1)(2008-10#1)
by relative standard deviation##2##4##(2008-10#2)
by relative standard##3##3##(2008-10#3)
by relative##8##2##(2008-10#5)(2008-11#1)(2008-3#1)(2011-1#1)
by relatively##4##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-6#1)
by relaxing##2##2##(2008-8#1)(2008-9#1)
by release of##3##3##(1990-5#1)(1994-2#1)(1995-8#1)
by releasing the##2##3##(2008-11#1)(2011-2#1)
by releasing##5##2##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
by religious##4##2##(1996-9#1)(2008-12#1)(2009-6#1)(2012-12#1)
by remote##2##2##(1996-5#1)(2010-12#1)
by removal of the##2##4##(2008-11#1)(2010-10#1)
by removal of##8##3##(1991-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-10#2)(2012-3#2)
by removal##9##2##(1991-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-10#2)(2012-3#2)
by removing a##2##3##(2008-10#1)(2012-2#1)
by removing##7##2##(1993-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)
by renal##5##2##(1991-11#1)(1997-8#1)(2008-6#1)(2013-1#2)
by rep-PCR##3##2##(2008-10#3)
by repeat##2##2##(1993-9#1)(2008-7#1)
by repeated##6##2##(1994-9#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)
by repeating##2##2##(2008-10#1)(2012-3#1)
by repetitive##5##2##(1990-9#1)(2008-10#4)
by replacement of##4##3##(1990-12#1)(1991-5#1)(1992-3#1)(1993-1#1)
by replacing the##4##3##(1997-4#1)(2008-11#1)(2008-5#1)(2010-10#1)
by replacing##10##2##(1997-4#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
by repressing##2##2##(2011-2#1)(2013-1#1)
by reproductive##2##2##(1993-11#1)(2008-9#1)
by research##3##2##(1997-8#1)(2008-11#1)(2009-3#1)
by researchers at##2##3##(1997-2#1)(2008-10#1)
by researchers in##2##3##(2008-4#1)(2010-5#1)
by researchers##8##2##(1992-2#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-5#1)
by resistance is##2##3##(2008-10#1)(2008-8#1)
by resistance##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
by resistant##4##2##(2008-10#3)(2011-2#1)
by resonance##3##2##(1990-8#1)(2008-10#2)
by respiratory##2##2##(1996-3#1)(2012-3#1)
by response surface##3##3##(2008-10#2)(2012-3#1)
by response##4##2##(1990-12#1)(2008-10#2)(2012-3#1)
by restoring##3##2##(1993-12#1)(1993-3#1)(2010-12#1)
by restriction analysis of##3##4##(1996-3#1)(1996-6#1)(2008-10#1)
by restriction analysis##4##3##(1992-3#1)(1996-3#1)(1996-6#1)(2008-10#1)
by restriction enzyme analysis##2##4##(2008-10#2)
by restriction enzyme digestion##2##4##(2008-10#2)
by restriction enzyme##5##3##(2008-10#5)
by restriction enzyme-mediated integration (REMI)##2##5##(2008-10#2)
by restriction fragment length polymorphism (RFLP)##3##6##(2008-10#3)
by restriction fragment length polymorphism analysis of the internal transcribed spacer##2##11##(2008-10#2)
by restriction fragment length polymorphism analysis of##3##7##(2008-10#3)
by restriction fragment length polymorphism analysis##4##6##(2008-10#4)
by restriction fragment length polymorphism##11##5##(2008-10#10)(2008-9#1)
by restriction##22##2##(1992-3#1)(1996-3#1)(1996-6#1)(2008-10#18)(2008-9#1)
by results from##2##3##(1990-12#1)(2008-10#1)
by results##3##2##(1990-12#1)(1991-11#1)(2008-10#1)
by reticulocytes##2##2##(1996-2#2)
by retinal##2##2##(2010-1#1)(2011-1#1)
by retinoic acid##6##3##(1993-3#3)(1994-11#1)(2008-11#2)
by retrospective##2##2##(1994-3#1)(1995-5#1)
by retroviral##2##2##(2008-11#1)(2008-9#1)
by returning##2##2##(2008-1#1)(2010-8#1)
by reverse flow##2##3##(2008-10#2)
by reverse transcriptase polymerase chain reaction##3##6##(1996-12#1)(1997-1#1)(2011-2#1)
by reverse transcription and##2##4##(1993-8#1)(2011-2#1)
by reverse transcription##3##3##(1993-8#1)(2008-9#1)(2011-2#1)
by reverse transcription-PCR##2##3##(1995-8#1)(1996-12#1)
by reverse transcription-polymerase chain reaction (RT-PCR)##4##6##(2008-10#2)(2008-11#1)(2010-1#1)
by reverse transcription-polymerase chain reaction##7##5##(1995-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-1#1)
by reverse##22##2##(1990-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#2)
by reverse-flow injection##2##3##(2008-10#2)
by reverse-phase HPLC##2##3##(1994-5#1)(2008-10#1)
by reverse-phase##5##2##(1994-5#1)(2008-10#4)
by reverse-transcription polymerase chain reaction##2##5##(2008-10#2)
by reversed##2##2##(2008-10#2)
by reversed-phase HPLC##5##3##(1990-5#1)(1996-12#1)(2008-10#3)
by reversed-phase high performance liquid chromatography##4##6##(2008-10#3)(2008-11#1)
by reversed-phase high-performance liquid chromatography (RP-HPLC)##3##6##(2008-10#3)
by reversed-phase high-performance liquid chromatography##8##5##(1991-12#1)(1992-6#1)(2008-10#6)
by reversed-phase##19##2##(1990-5#1)(1991-12#1)(1992-6#1)(1996-12#1)(2008-10#13)(2008-11#1)(2008-5#1)
by reversible##3##2##(1993-6#1)(2008-4#1)(2009-10#1)
by reversing the flow##2##4##(2008-10#2)
by reviewing the##3##3##(2008-6#1)(2010-7#1)(2012-12#1)
by reviewing##5##2##(2008-4#1)(2008-6#1)(2010-7#1)(2012-12#2)
by rhodamine 6G##2##3##(2008-10#2)
by rhodamine##3##2##(2008-10#3)
by ribonuclease protection##2##3##(2008-10#2)
by risk##2##2##(1996-3#1)(2013-8#1)
by road##2##2##(2009-10#1)(2009-7#1)
by rotation of the beam splitter grating about the axis##2##10##(2008-3#2)
by rotation of the##4##4##(1992-12#1)(2008-3#3)
by running##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
by rupture##3##2##(1991-6#1)(2011-2#2)
by s##2##2##(1992-6#1)(1994-3#1)
by saline water##2##3##(2008-10#2)
by saline##3##2##(1997-2#1)(2008-10#2)
by salt stress##6##3##(1997-7#1)(1997-8#1)(2008-9#1)(2009-8#3)
by samarium iodide##2##3##(2008-10#2)
by sample##2##2##(2008-10#2)
by sampling the##3##3##(2008-10#2)(2008-7#1)
by sampling##16##2##(2008-10#11)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
by scaling##2##2##(2008-5#1)(2012-2#1)
by scanning and transmission electron microscopy##3##6##(2007-12#3)
by scanning and transmission electron##4##5##(2007-12#4)
by scanning electron microscopy (SEM) and##2##6##(2008-7#1)(2009-7#1)
by scanning electron microscopy (SEM)##6##5##(2008-10#3)(2008-7#1)(2009-7#1)(2013-1#1)
by scanning electron microscopy to##2##5##(2008-12#1)(2009-7#1)
by scanning electron microscopy##16##4##(1992-2#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#2)(2011-2#2)(2013-1#1)
by scanning electron##17##3##(1992-2#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#2)(2011-2#2)(2013-1#1)
by scanning the potential##3##4##(2008-10#3)
by scanning the##5##3##(2008-10#3)(2008-3#1)(2008-4#1)
by scanning##32##2##(1992-2#1)(2007-12#4)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#2)(2011-2#2)(2013-1#1)
by scientists##2##2##(1992-12#1)(1996-9#1)
by scintillation counting##2##3##(2008-11#1)(2008-8#1)
by screen-printing##2##2##(2008-10#2)
by screening a##2##3##(2008-8#1)(2008-9#1)
by screening with the##2##4##(1993-2#1)(1997-8#1)
by screening with##3##3##(1993-2#2)(1997-8#1)
by screening##12##2##(1990-2#1)(1991-3#1)(1993-2#2)(1995-12#1)(1996-11#1)(1997-4#1)(1997-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
by second##3##2##(1991-6#1)(2008-10#1)(2008-12#1)
by second-derivative##3##2##(1993-8#1)(2008-10#2)
by secondary##7##2##(1990-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#1)
by secreted##2##2##(2008-7#1)(2009-8#1)
by secretion of##2##3##(2008-7#1)(2009-12#1)
by sedimentation##2##2##(1993-8#1)(2008-10#1)
by seed and##2##3##(2008-10#2)
by seed##4##2##(2008-10#4)
by segmented flow injection-hydride generation atomic absorption spectrometry (SFI-HGAAS)##2##9##(2008-10#2)
by segmented##3##2##(2008-10#2)(2009-7#1)
by seizures##2##2##(1995-5#1)(2013-7#1)
by selected ion monitoring (SIM) method##2##6##(2008-10#2)
by selected ion monitoring (SIM)##3##5##(2008-10#3)
by selected ion monitoring##4##4##(2008-10#4)
by selected##7##2##(1996-12#1)(2008-10#5)(2008-12#1)
by selecting a##4##3##(2008-10#1)(2008-7#1)(2009-10#1)(2012-3#1)
by selecting the##2##3##(2008-10#1)(2013-8#1)
by selecting##10##2##(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
by selection of a##2##4##(2008-3#1)(2011-2#1)
by selection of##3##3##(2008-11#1)(2008-3#1)(2011-2#1)
by selection##10##2##(1995-2#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#2)
by selective and sequential elution with 0##2##7##(2008-10#2)
by selective##16##2##(1992-2#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-6#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2011-2#1)
by self-administered##2##2##(1993-2#1)(2013-1#1)
by semantic##3##2##(1996-2#1)(2011-1#2)
by semi-quantitative RT-PCR##2##3##(2008-8#1)(2008-9#1)
by semi-quantitative##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
by sensing##2##2##(2009-8#1)(2012-2#1)
by sensory##3##2##(1992-6#1)(1993-1#1)(2009-8#1)
by separate##2##2##(1997-7#1)(2008-10#1)
by separating##2##2##(2008-10#2)
by separation of##2##3##(2008-10#2)
by separation##3##2##(2008-10#3)
by sequence analysis of##4##4##(1993-12#1)(1993-2#1)(2008-10#2)
by sequence analysis##9##3##(1993-12#2)(1993-2#2)(2008-10#4)(2009-6#1)
by sequence##11##2##(1993-12#2)(1993-2#2)(2008-10#5)(2008-8#1)(2009-6#1)
by sequencing of##2##3##(1993-12#1)(2008-10#1)
by sequencing the##4##3##(1990-8#1)(1992-9#1)(2008-10#2)
by sequencing##9##2##(1990-8#1)(1992-9#1)(1993-12#1)(2008-10#4)(2008-12#1)(2008-8#1)
by sequential extraction##2##3##(2008-10#2)
by sequential injection analysis and##2##5##(2008-10#2)
by sequential injection analysis##11##4##(2008-10#11)
by sequential injection chromatography##2##4##(2008-10#2)
by sequential injection##16##3##(2008-10#16)
by sequential metal vapor elution analysis (SMVEA)##2##7##(2008-10#2)
by sequential metal vapor elution analysis##3##6##(2008-10#3)
by sequential##27##2##(1994-11#1)(2008-10#26)
by sera from##3##3##(1990-5#1)(2008-11#1)(2009-6#1)
by serial##4##2##(1994-8#1)(2008-10#2)(2008-2#1)
by serine##5##2##(1993-3#1)(1997-8#1)(2006-6#1)(2008-5#1)(2011-1#1)
by serological##4##2##(2008-10#3)(2011-2#1)
by serum##4##2##(1990-2#1)(1993-2#1)(1995-6#1)(2008-11#1)
by serving as##2##3##(2008-10#2)
by seven##5##2##(1997-4#1)(2008-10#1)(2008-8#1)(2010-10#1)(2013-8#1)
by several authors##2##3##(1993-11#1)(2008-3#1)
by several different##4##3##(1992-3#1)(1994-8#1)(2008-10#1)(2008-5#1)
by several factors##4##3##(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
by several groups##4##3##(1992-6#1)(1997-8#1)(2008-10#1)(2008-4#1)
by several mechanisms##4##3##(1990-11#1)(2008-5#1)(2008-6#1)(2009-3#1)
by several orders of magnitude##3##5##(1994-5#1)(2007-11#1)(2008-10#1)
by several species of##2##4##(2008-10#2)
by several strains of##3##4##(2008-10#3)
by several##60##2##(1990-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-1#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#19)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
by severe##5##2##(1990-9#1)(1997-3#1)(2008-7#1)(2010-6#1)(2013-8#1)
by sex and##3##3##(1995-12#1)(2008-7#1)(2013-8#1)
by sex##9##2##(1990-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1995-12#1)(2008-7#1)(2008-8#1)(2010-6#1)(2013-8#1)
by shaking with an##2##4##(2008-10#2)
by shaking##3##2##(2008-10#3)
by sharing##2##2##(2008-8#1)(2009-8#1)
by sharp##2##2##(2008-10#1)(2008-12#1)
by shifting the##5##3##(2008-10#2)(2008-3#2)(2011-2#1)
by shifting##6##2##(1995-6#1)(2008-10#2)(2008-3#2)(2011-2#1)
by short##7##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)
by shortening##2##2##(1997-4#1)(2008-10#1)
by siRNA##3##2##(2009-9#1)(2011-2#1)(2013-8#1)
by sigma##2##2##(1990-12#1)(1993-9#1)
by significant increases in##2##4##(1996-12#1)(2008-10#1)
by significant##7##2##(1996-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-1#1)
by silica gel##2##3##(2008-10#1)(2008-11#1)
by silver##7##2##(1992-8#1)(1995-12#1)(2008-10#5)
by similar##3##2##(1996-12#1)(2008-10#2)
by simple mechanical polishing##2##4##(2008-10#2)
by simple##18##2##(1994-5#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-9#1)(2010-7#1)
by simply polishing##4##3##(2008-10#4)
by simply##11##2##(2006-6#1)(2008-10#8)(2008-6#1)(2012-2#1)
by simulated sunlight##2##3##(2008-11#2)
by simulated##5##2##(1994-2#1)(2008-10#1)(2008-11#2)(2008-9#1)
by simulation##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
by simultaneous atomic absorption spectrometry##2##5##(2008-10#2)
by simultaneous##13##2##(1991-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
by simultaneously##3##2##(1994-3#1)(2008-11#2)
by single##21##2##(1995-6#1)(1997-6#1)(2008-10#15)(2008-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
by single-strand conformation polymorphism##2##4##(2008-10#2)
by single-sweep oscillopolarography##3##3##(2008-10#3)
by site-directed mutagenesis of##2##4##(1990-5#1)(1992-3#1)
by site-directed mutagenesis to##2##4##(1992-1#1)(2008-10#1)
by site-directed mutagenesis##13##3##(1990-5#1)(1991-5#1)(1992-1#2)(1992-3#2)(1992-6#1)(1994-5#2)(2008-10#1)(2008-9#3)
by six##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2010-11#1)
by size exclusion chromatography##4##4##(2008-10#3)(2011-2#1)
by size exclusion##5##3##(2008-10#4)(2011-2#1)
by size-exclusion chromatography##3##3##(1993-6#1)(1997-2#1)(2008-9#1)
by size-exclusion##4##2##(1993-6#1)(1997-2#1)(2008-10#1)(2008-9#1)
by skin##2##2##(1990-3#1)(1991-12#1)
by slab##2##2##(1995-6#1)(2008-10#1)
by slightly##2##2##(2008-10#2)
by slowing##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
by slurry sampling##4##3##(2008-10#4)
by slurry##7##2##(2008-10#7)
by small##12##2##(1990-8#1)(1991-1#1)(1992-8#1)(1993-12#1)(1995-11#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)
by soaking##2##2##(2008-10#1)(2013-1#1)
by social##3##2##(2011-2#2)(2012-3#1)
by society##2##2##(1993-12#1)(1993-6#1)
by sodium deoxycholate##2##3##(1993-8#1)(2008-10#1)
by sodium dodecyl sulfate polyacrylamide gel electrophoresis##2##7##(1990-10#1)(2012-2#1)
by sodium dodecyl sulfate##4##4##(1990-10#1)(2008-10#1)(2008-11#1)(2012-2#1)
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##5##6##(1990-10#1)(2008-10#3)(2008-11#1)
by sodium dodecyl##9##3##(1990-10#2)(2008-10#4)(2008-11#2)(2012-2#1)
by sodium sulfide##2##3##(2008-10#2)
by sodium##23##2##(1990-10#2)(1993-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-8#1)(2010-11#1)(2012-2#1)
by soil##8##2##(2008-10#7)(2013-8#1)
by sol-gel method##4##3##(2008-10#4)
by sol-gel technique##2##3##(2008-10#2)
by sol-gel##8##2##(2008-10#8)
by solid phase extraction (SPE) using##2##6##(2008-10#2)
by solid phase extraction (SPE)##3##5##(2008-10#3)
by solid phase extraction##6##4##(2008-10#6)
by solid phase microextraction##3##4##(2008-10#3)
by solid phase spectrophotometry##2##4##(2008-10#2)
by solid phase##13##3##(2008-10#13)
by solid sampling Zeeman atomic absorption spectrometry##2##7##(2008-10#2)
by solid sampling##4##3##(2008-10#4)
by solid state (13)C NMR spectroscopy##2##6##(2008-10#2)
by solid state bioprocessing##2##4##(1997-2#2)
by solid state##5##3##(1997-2#2)(2008-10#3)
by solid##26##2##(1997-2#2)(2008-10#24)
by solid-matrix##2##2##(2008-10#2)
by solid-phase extraction and gas chromatography-mass##2##6##(2008-10#2)
by solid-phase extraction and##5##4##(1992-11#1)(1997-2#1)(2008-10#3)
by solid-phase extraction with##3##4##(2008-10#3)
by solid-phase extraction##13##3##(1992-11#1)(1997-2#3)(2008-10#9)
by solid-phase microextraction (SPME)##4##4##(2008-10#4)
by solid-phase microextraction coupled##2##4##(2008-10#2)
by solid-phase microextraction##9##3##(2008-10#8)(2012-12#1)
by solid-phase##26##2##(1992-11#1)(1992-3#1)(1997-2#3)(2008-10#19)(2008-9#1)(2012-12#1)
by solid-state##2##2##(2010-12#1)(2011-2#1)
by soluble##2##2##(1997-7#1)(2013-1#1)
by solution calorimetry##3##3##(2008-10#3)
by solution##6##2##(1993-8#1)(1995-8#1)(2008-10#4)
by solvent extraction##5##3##(2008-10#4)(2008-5#1)
by solvent sublation##2##3##(2008-10#2)
by solvent##8##2##(2008-10#7)(2008-5#1)
by solving a##2##3##(2010-7#1)(2010-8#1)
by solving##4##2##(2008-10#1)(2010-10#1)(2010-7#1)(2010-8#1)
by some authors##2##3##(2008-7#1)(2013-1#1)
by some form of##2##4##(2008-11#1)(2010-11#1)
by some of##2##3##(1995-5#1)(2008-10#1)
by some proteases##2##3##(1995-3#2)
by some##29##2##(1990-12#1)(1994-3#1)(1995-3#2)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)(2012-2#2)(2013-1#1)(2013-7#1)
by sonication##4##2##(1993-12#1)(2008-10#3)
by soot in##2##3##(2008-3#2)
by sorption on a conical minicolumn packed with activated carbon (AC) at pH 5##2##14##(2008-10#2)
by sorption on a##4##4##(2008-10#4)
by sorption on##6##3##(2008-10#6)
by space##2##2##(2008-12#1)(2008-9#1)
by spatial##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
by specialist##3##2##(1997-8#1)(2009-6#1)(2009-8#1)
by specialists in##2##3##(1993-6#1)(1995-11#1)
by specialists##3##2##(1993-6#1)(1995-11#1)(2008-9#1)
by specialty##2##2##(1993-12#1)(2009-9#1)
by species##3##2##(2008-10#2)(2008-9#1)
by species-specific primers##3##3##(2008-10#3)
by specific and##2##3##(1991-5#1)(1996-12#1)
by specific##25##2##(1990-12#1)(1991-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#2)(2011-2#4)(2013-1#1)(2013-8#2)
by spectral##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
by spectrofluorimetry using##2##3##(2008-10#2)
by spectrofluorimetry##8##2##(2008-10#7)(2008-11#1)
by spectrometry##2##2##(2008-11#1)(2008-8#1)
by spectrophotometric and##2##3##(2008-10#2)
by spectrophotometric##6##2##(2008-10#5)(2009-8#1)
by spectrophotometry and##3##3##(2008-10#3)
by spectrophotometry##24##2##(2008-10#24)
by spectroscopic##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
by spending##2##2##(2008-11#1)(2009-8#1)
by spermine in the old##2##5##(1990-3#2)
by spermine in##3##3##(1990-3#3)
by spermine##7##2##(1990-3#5)(1991-5#2)
by spiking##7##2##(2008-10#7)
by spin##2##2##(2008-10#2)
by spontaneous##5##2##(1994-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
by spray##4##2##(2008-10#3)(2008-11#1)
by spring##2##2##(2008-12#2)
by sputtering##2##2##(2008-10#1)(2009-5#1)
by squamometry as they were in a##2##7##(2008-5#2)
by square wave adsorptive stripping voltammetry##5##6##(2008-10#5)
by square wave anodic stripping voltammetry##2##6##(2008-10#2)
by square wave cathodic stripping voltammetry##2##6##(2008-10#2)
by square wave voltammetry##2##4##(2008-10#2)
by square wave##12##3##(2008-10#12)
by square-wave and##2##3##(2008-10#2)
by square-wave anodic stripping voltammetry (SWASV)##2##6##(2008-10#2)
by square-wave anodic stripping voltammetry##3##5##(2008-10#3)
by square-wave anodic##4##3##(2008-10#4)
by square-wave##8##2##(2008-10#8)
by stabilization##2##2##(1994-9#1)(2012-2#1)
by stable##2##2##(1997-1#1)(2008-11#1)
by staff##2##2##(1993-1#1)(1997-3#1)
by stage##2##2##(1990-12#1)(2012-2#1)
by staining with a##3##4##(1990-12#1)(2008-11#1)(2008-5#1)
by staining with##6##3##(1990-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)
by staining##9##2##(1990-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#2)
by standard addition method##3##4##(2008-10#3)
by standard addition##5##3##(2008-10#5)
by standard additions##2##3##(2008-10#2)
by standard##18##2##(1994-5#1)(2008-10#12)(2008-11#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-3#1)
by state##4##2##(1995-12#1)(1997-1#1)(1997-3#1)(2008-11#1)
by statistical##5##2##(2008-10#4)(2008-8#1)
by steady##2##2##(2008-10#1)(2008-7#1)
by step##2##2##(1997-5#1)(2008-11#1)
by stepwise elution##2##3##(1995-11#1)(2008-10#1)
by stepwise##5##2##(1995-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
by steroids##2##2##(1990-11#1)(1992-5#1)
by stimulating##5##2##(1993-8#1)(1995-8#1)(1996-11#1)(2011-2#1)(2012-2#1)
by stimulation of##4##3##(1990-8#1)(1996-5#1)(1997-2#2)
by stimulation##8##2##(1990-8#2)(1996-11#1)(1996-5#1)(1997-2#2)(2008-10#1)(2009-12#1)
by stirring##2##2##(2008-10#1)(2008-5#1)
by stochastic effects##2##3##(2008-8#1)(2012-2#1)
by stochastic##5##2##(2008-10#1)(2008-8#2)(2010-7#1)(2012-2#1)
by stochasticity##2##2##(2008-8#2)
by storage##2##2##(1992-3#2)
by strain 89B61##2##3##(2008-10#2)
by strain 90-166##2##3##(2008-10#2)
by strain##14##2##(2008-10#12)(2009-1#1)(2009-8#1)
by strains of##3##3##(2008-10#1)(2011-2#2)
by strains##4##2##(2008-10#2)(2011-2#2)
by streptozotocin##2##2##(2010-11#1)(2011-2#1)
by stress##5##2##(1997-6#1)(2008-10#1)(2010-4#2)(2011-2#1)
by stripping voltammetry with a##2##5##(2008-10#2)
by stripping voltammetry##6##3##(2008-10#6)
by stripping##8##2##(2008-10#8)
by stromal cells##2##3##(2008-11#1)(2008-8#1)
by strong##4##2##(1990-5#1)(1995-6#1)(2008-9#1)(2010-10#1)
by structural defects##2##3##(1997-6#1)(2008-2#1)
by structural##7##2##(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-4#1)
by students and##3##3##(1997-2#1)(2008-11#2)
by students in##2##3##(2008-12#1)(2012-2#1)
by students##10##2##(1992-3#1)(1996-2#1)(1997-2#1)(2008-11#3)(2008-12#3)(2012-2#1)
by studies of##2##3##(1995-5#1)(2008-8#1)
by studies##7##2##(1994-8#1)(1995-5#1)(2008-10#2)(2008-8#2)(2011-2#1)
by studying the effect of##2##5##(1995-11#1)(2008-10#1)
by studying the##10##3##(1995-11#1)(1995-12#1)(1997-6#1)(2008-10#3)(2008-5#2)(2008-6#1)(2011-2#1)
by studying##17##2##(1993-12#1)(1995-11#1)(1995-12#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#1)
by subcutaneous administration of##2##4##(1995-2#1)(2012-2#1)
by subcutaneous injection##3##3##(2008-11#1)(2013-1#1)(2013-7#1)
by subcutaneous##6##2##(1995-2#1)(1996-2#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
by subsequent##4##2##(1991-3#1)(1991-6#1)(2008-10#2)
by substance P##2##3##(1995-11#1)(1997-4#1)
by substance##4##2##(1992-1#1)(1995-11#1)(1997-3#1)(1997-4#1)
by substituting the##2##3##(2008-10#1)(2012-3#1)
by substituting##3##2##(2008-10#2)(2012-3#1)
by substitution##2##2##(1994-11#1)(2008-7#1)
by substrate##2##2##(2008-10#1)(2012-2#1)
by subtle##2##2##(2008-5#1)(2009-11#1)
by subtracting##2##2##(2008-10#1)(2008-8#1)
by subtraction of a##2##4##(2008-3#2)
by subtraction##4##2##(1990-4#1)(2008-3#3)
by subtractive##2##2##(1995-11#1)(1995-12#1)
by successive##6##2##(1997-2#1)(2008-10#3)(2008-5#1)(2011-1#1)
by such factors as##2##4##(1990-2#1)(2013-1#1)
by such##13##2##(1990-2#1)(1992-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
by sucrose density gradient centrifugation##2##5##(1994-8#1)(1997-3#1)
by sucrose##3##2##(1990-11#1)(1994-8#1)(1997-3#1)
by sudden##2##2##(2008-10#1)(2011-2#1)
by suggesting that##3##3##(1994-12#1)(2008-12#1)(2009-12#1)
by suggesting##4##2##(1994-12#2)(2008-12#1)(2009-12#1)
by suitable##2##2##(2008-10#1)(2008-11#1)
by sulfate##2##2##(1992-3#1)(2008-3#1)
by summing##4##2##(1995-11#1)(2008-10#2)(2008-8#1)
by sun glint##2##3##(2008-3#2)
by sun##3##2##(2008-3#2)(2011-2#1)
by sunscreen##2##2##(2008-5#2)
by sunscreens##3##2##(2008-5#3)
by supercritical##5##2##(2008-10#4)(2013-1#1)
by superoxide##2##2##(1993-8#1)(2008-10#1)
by supersonic jet/multiphoton ionization/mass spectrometry##2##5##(2008-10#2)
by supplementation##2##2##(1991-12#1)(2008-12#1)
by suppressing##6##2##(1994-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-1#1)(2013-8#1)
by suppression##2##2##(2008-10#1)(2010-4#1)
by surface plasmon resonance##5##4##(2008-10#4)(2008-4#1)
by surface plasmon##6##3##(2008-10#4)(2008-4#1)(2011-2#1)
by surface##17##2##(1994-12#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2011-2#1)
by surface-enhanced Raman spectroscopy##2##4##(2008-10#2)
by surface-enhanced##3##2##(2008-10#3)
by surfactant-mediated##3##2##(2008-10#3)
by surgery##6##2##(1992-5#1)(1997-4#1)(2008-5#1)(2008-7#3)
by surgical##8##2##(1990-5#1)(1993-1#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
by suspending a##2##3##(2008-10#2)
by sustained##3##2##(1995-2#1)(2008-11#1)(2010-3#1)
by switching the##2##3##(2008-10#2)
by switching##3##2##(2008-10#2)(2008-8#1)
by symptoms##2##2##(1996-6#1)(2008-10#1)
by synchronous fluorescence##3##3##(2008-10#3)
by synchronous##6##2##(1993-8#1)(2008-10#5)
by synthesis of##2##3##(2008-10#1)(2008-9#1)
by synthesis##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
by synthetic##3##2##(1994-3#1)(2008-11#1)(2008-9#1)
by systemic##7##2##(1993-3#1)(1994-2#1)(2008-10#1)(2008-12#1)(2011-3#1)(2012-3#2)
by t##3##2##(2008-11#2)(2008-8#1)
by taking a##2##3##(1991-2#1)(2008-10#1)
by taking advantage of##4##4##(1995-3#1)(1996-1#1)(2008-10#2)
by taking into account##4##4##(2008-10#3)(2008-3#1)
by taking##17##2##(1991-2#1)(1992-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
by target##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
by targeting the##3##3##(2013-1#3)
by targeting##9##2##(1995-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)
by teachers##4##2##(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
by techniques##2##2##(2008-10#1)(2008-4#1)
by telephone##5##2##(1996-5#2)(2008-10#1)(2011-2#1)(2013-8#1)
by temperature##9##2##(2008-10#6)(2008-11#1)(2012-6#1)(2013-8#1)
by ten##3##2##(2008-10#2)(2010-8#1)
by terminal##3##2##(1992-12#1)(1997-7#1)(2008-9#1)
by termites##2##2##(2013-8#2)
by testing individual##2##3##(2008-10#2)
by testing the##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
by testing##16##2##(1992-5#1)(1994-3#1)(2008-10#10)(2008-9#1)(2010-8#1)(2013-8#2)
by testosterone##4##2##(1994-2#1)(1995-12#3)
by tetrachlorohydroquinone##3##2##(2009-3#3)
by tetracycline##2##2##(2008-10#1)(2013-1#1)
by that##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
by the &quot##3##3##(1990-5#1)(1996-11#1)(2008-8#1)
by the 1##3##3##(2008-10#2)(2008-3#1)
by the American Academy of Pediatrics##2##6##(2010-8#1)(2013-1#1)
by the American Heart Association and##2##6##(1996-6#1)(2010-9#1)
by the American##10##3##(1991-12#1)(1992-2#1)(1994-12#1)(1996-6#1)(2008-10#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#2)
by the Association of##2##4##(1995-12#1)(2008-10#1)
by the Association##3##3##(1990-6#1)(1995-12#1)(2008-10#1)
by the Authors##2##3##(1990-3#1)(1991-3#1)
by the Brazilian##2##3##(2008-10#1)(2011-2#1)
by the British##4##3##(2008-10#3)(2008-11#1)
by the Brn-3a##2##3##(1995-6#2)
by the Canadian##4##3##(1993-9#1)(1997-2#1)(2009-3#1)(2012-12#1)
by the Central##2##3##(2008-10#1)(2008-3#1)
by the Combination of##2##4##(2008-10#2)
by the D##2##3##(2008-10#2)
by the DNA##3##3##(1997-6#1)(2008-10#1)(2008-7#1)
by the DPPH##2##3##(2008-11#1)(2008-5#1)
by the Danish##2##3##(1990-12#1)(1997-3#1)
by the Department of##6##4##(1990-2#1)(1991-12#1)(1992-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
by the Dutch##2##3##(1994-12#1)(1996-8#1)
by the ELISA method##2##4##(2008-10#2)
by the ELISA##3##3##(2008-10#3)
by the European Commission##3##4##(2008-10#3)
by the European Society of Radiology##4##6##(2012-2#4)
by the European Society of##5##5##(2012-2#4)(2013-1#1)
by the European##14##3##(2008-10#8)(2008-3#1)(2012-2#4)(2013-1#1)
by the Federal##2##3##(1995-3#1)(2008-10#1)
by the Foundation for##2##4##(1994-3#1)(2008-10#1)
by the G##2##3##(1995-8#1)(2008-6#1)
by the HPLC method##2##4##(2008-10#1)(2009-8#1)
by the HPLC##3##3##(2008-10#2)(2009-8#1)
by the Health Care Financing Administration (HCFA)##3##7##(1994-12#1)(1995-12#1)(1997-3#1)
by the Health##4##3##(1994-1#1)(1994-12#1)(1995-12#1)(1997-3#1)
by the House##2##3##(1995-12#1)(1997-2#1)
by the Institut##3##3##(2008-10#2)(2010-1#1)
by the Institute of Medicine##2##5##(1996-5#1)(1997-2#1)
by the Institute of##3##4##(1995-2#1)(1996-5#1)(1997-2#1)
by the International##5##3##(1995-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2011-9#1)
by the Japanese##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
by the Joint Council of Governmental Public Health Agencies##2##9##(1996-3#2)
by the Joint##3##3##(1996-3#2)(2009-9#1)
by the Kirby-Bauer##2##3##(2008-7#1)(2013-8#1)
by the Ministry of Health##3##5##(1994-12#1)(2008-10#1)(2008-5#1)
by the Minnesota##2##3##(2010-1#1)(2012-12#1)
by the Nafion/MV modified##2##4##(2008-10#2)
by the National Health Service##2##5##(2008-11#2)
by the National Institute of##2##5##(1991-3#1)(2008-9#1)
by the National Institute##4##4##(1991-3#1)(1992-3#1)(2008-10#1)(2008-9#1)
by the National##12##3##(1991-3#1)(1992-1#1)(1992-3#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
by the New York##2##4##(1991-12#1)(1994-12#1)
by the New##3##3##(1991-12#1)(1994-12#1)(2012-12#1)
by the Norwegian##2##3##(1996-6#1)(2008-10#1)
by the Ontario Ministry of##2##5##(1991-2#1)(1995-3#1)
by the Ontario##3##3##(1991-2#1)(1993-3#1)(1995-3#1)
by the PCR##2##3##(1995-6#1)(2008-4#1)
by the Pan American Health Organization##2##6##(1994-9#1)(2013-1#1)
by the Physiotherapy Section##2##4##(1992-3#2)
by the Public Health##2##4##(1997-2#1)(2012-12#1)
by the Public##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
by the RNA##2##3##(1995-6#1)(2008-10#1)
by the South##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
by the State##2##3##(1995-6#1)(2011-2#1)
by the U##3##3##(1997-6#1)(2008-8#1)(2012-3#1)
by the US Environmental Protection Agency (EPA)##2##7##(2008-10#2)
by the US FDA##2##4##(2010-5#1)(2011-2#1)
by the US Food and Drug Administration (FDA) for##2##9##(2008-9#2)
by the US##11##3##(2008-10#3)(2008-5#1)(2008-9#2)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
by the US-8##2##3##(2008-10#2)
by the United States Environmental Protection Agency##2##7##(2008-9#2)
by the United States##5##4##(2008-10#2)(2008-9#2)(2012-3#1)
by the University of##2##4##(1993-6#1)(2008-11#1)
by the University##4##3##(1993-6#1)(2008-10#2)(2008-11#1)
by the WHO##2##3##(2009-6#1)(2012-2#1)
by the World Health Organisation (WHO)##2##6##(2008-10#1)(2012-2#1)
by the World Health Organization (WHO) as##2##7##(2009-6#1)(2013-1#1)
by the World Health Organization (WHO)##3##6##(2008-1#1)(2009-6#1)(2013-1#1)
by the World Health Organization##9##5##(1992-1#1)(1996-9#1)(2008-1#1)(2009-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
by the World Health##11##4##(1992-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
by the World Organisation for Animal Health##2##7##(2011-2#2)
by the World##13##3##(1992-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2009-6#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)
by the ability of the##2##5##(2008-11#1)(2011-2#1)
by the ability of##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
by the ability##4##3##(1995-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
by the above##2##3##(1995-5#1)(2008-10#1)
by the absence of the##2##5##(2007-12#1)(2008-11#1)
by the absence of##10##4##(1993-3#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)
by the academic##2##3##(1990-2#1)(1996-1#1)
by the acquisition of##2##4##(2009-6#1)(2012-3#1)
by the acquisition##3##3##(2008-10#1)(2009-6#1)(2012-3#1)
by the action of##4##4##(1993-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
by the active##2##3##(2008-8#1)(2013-7#1)
by the addition of EDTA##4##5##(2008-10#3)(2008-4#1)
by the addition of a nitrogen flow and##2##8##(2008-10#2)
by the addition of a##5##5##(2008-10#3)(2008-11#1)(2013-1#1)
by the addition of nitrite and##2##6##(2008-10#2)
by the addition of proteins##2##5##(2008-10#2)
by the addition of the##2##5##(2008-11#2)
by the addition of##59##4##(1992-2#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#26)(2008-11#12)(2008-4#1)(2008-7#3)(2008-8#2)(2009-7#2)(2012-2#2)(2012-3#1)(2013-1#2)
by the addition##60##3##(1992-2#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#26)(2008-11#13)(2008-4#1)(2008-7#3)(2008-8#2)(2009-7#2)(2012-2#2)(2012-3#1)(2013-1#2)
by the adjacent##3##3##(1996-5#2)(1997-3#1)
by the administration of##4##4##(1990-11#1)(2008-11#1)(2011-2#1)(2012-2#1)
by the age of##5##4##(1990-9#1)(1993-11#1)(1995-12#1)(1997-3#1)(2008-5#1)
by the aid of##2##4##(2008-10#1)(2008-11#1)
by the alkaline elution test##2##5##(1993-12#2)
by the altered##2##3##(1996-3#1)(2010-10#1)
by the ambient##2##3##(2008-6#1)(2010-7#1)
by the amount of##6##4##(1996-12#1)(2008-10#4)(2010-12#1)
by the analysis of a##2##5##(2008-10#2)
by the analysis of certified reference materials and##2##8##(2008-10#2)
by the analysis of certified reference materials##3##7##(2008-10#3)
by the analysis of the standard reference material##2##8##(2008-10#2)
by the analysis of the standard reference##3##7##(2008-10#3)
by the analysis of the##7##5##(1990-5#1)(2008-10#5)(2010-12#1)
by the analysis of##22##4##(1990-5#1)(2008-10#20)(2010-12#1)
by the analysis##25##3##(1990-5#1)(1992-12#1)(1996-12#1)(2008-10#20)(2008-8#1)(2010-12#1)
by the analyte##3##3##(2008-10#3)
by the aphid##3##3##(2008-10#3)
by the appearance of##4##4##(2008-10#3)(2008-3#1)
by the application of the##5##5##(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#1)
by the application of##12##4##(1994-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
by the application##13##3##(1994-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
by the applied##3##3##(2008-10#2)(2008-5#1)
by the assessment of##2##4##(2008-5#1)(2009-7#1)
by the association of##3##4##(2008-10#2)(2009-7#1)
by the association##4##3##(2008-10#2)(2009-4#1)(2009-7#1)
by the assumption of##2##4##(2008-12#1)(2008-3#1)
by the author##5##3##(1991-11#2)(1992-2#1)(1997-6#1)(2009-9#1)
by the authors##8##3##(1992-1#1)(1995-1#1)(2008-10#4)(2008-8#1)(2008-9#1)
by the autosampler##2##3##(2008-10#2)
by the availability of##5##4##(2008-10#2)(2008-8#1)(2013-1#2)
by the availability##6##3##(2008-10#3)(2008-8#1)(2013-1#2)
by the bacteria##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
by the bacterial##2##3##(1994-12#1)(1994-5#1)
by the bacterium Erwinia##2##4##(2008-10#2)
by the bacterium##4##3##(2008-10#4)
by the baculovirus-insect cell system##2##5##(2008-11#2)
by the beta##2##3##(1992-9#1)(1994-12#1)
by the beta-binomial##3##3##(2008-10#3)
by the binding of##6##4##(1993-6#1)(1994-5#1)(1996-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
by the binding##8##3##(1993-6#1)(1994-5#1)(1996-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)
by the biocatalytic##2##3##(2008-10#2)
by the biocontrol agent##3##4##(2008-10#3)
by the biocontrol agents##2##4##(2008-10#2)
by the biocontrol##6##3##(2008-10#6)
by the biosensor##3##3##(2008-10#3)
by the brain##2##3##(2008-11#2)
by the breakdown##2##3##(1991-5#1)(2008-11#1)
by the carrier##2##3##(1995-3#1)(2008-10#1)
by the catalytic##2##3##(1995-2#1)(2008-12#1)
by the cell##4##3##(1994-5#1)(2008-11#1)(2008-5#1)(2008-7#1)
by the cells##9##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-7#1)
by the cellular##2##3##(2008-9#1)(2011-2#1)
by the central##3##3##(1996-2#1)(2007-12#1)(2008-9#1)
by the change in##2##4##(1995-11#1)(2008-10#1)
by the change##4##3##(1992-1#1)(1995-11#1)(2008-10#1)(2008-3#1)
by the characteristics of the##2##5##(2008-10#1)(2009-6#1)
by the charge##3##3##(1991-5#1)(2008-10#2)
by the chelating##4##3##(2008-10#4)
by the chemical##2##3##(2008-10#1)(2008-2#1)
by the chromatographic##2##3##(2008-10#2)
by the classical##3##3##(2008-10#2)(2008-9#1)
by the clinical##3##3##(1991-12#1)(2013-1#2)
by the clinician##2##3##(2012-2#1)(2012-3#1)
by the clinicians##2##3##(1994-12#1)(2007-9#1)
by the column method##2##4##(2008-10#2)
by the combination of##6##4##(1993-6#1)(1995-12#1)(2008-10#2)(2008-8#1)(2012-3#1)
by the combined##6##3##(1997-4#1)(2008-10#3)(2010-4#1)(2011-2#1)
by the comet assay##2##4##(2010-5#2)
by the computer##2##3##(1995-12#1)(2008-10#1)
by the concentration of##3##4##(1990-6#1)(1991-12#1)(2008-10#1)
by the consumer##3##3##(2008-11#1)(2008-5#2)
by the control##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
by the conventional##5##3##(1993-12#1)(2008-10#4)
by the correlation##2##3##(1992-3#1)(2010-12#1)
by the corresponding##2##3##(2008-10#2)
by the current##3##3##(1992-8#1)(2008-3#1)(2008-9#1)
by the decision bits##2##4##(2008-3#2)
by the decrease##2##3##(2008-10#2)
by the degree of##5##4##(1990-3#1)(1991-5#1)(2008-10#2)(2008-11#1)
by the deletion of##2##4##(1993-6#1)(2008-10#1)
by the demonstration of##3##4##(1995-11#1)(1995-12#2)
by the dependence##2##3##(2008-10#2)
by the described##2##3##(2008-10#2)
by the detector##5##3##(2008-10#5)
by the determination of molybdenum##2##5##(2008-10#2)
by the determination of nitrite##2##5##(2008-10#1)(2008-11#1)
by the determination of the##2##5##(2008-10#2)
by the determination of##16##4##(1991-3#1)(2008-10#14)(2008-11#1)
by the developed##4##3##(2008-10#4)
by the development of a##2##5##(2008-10#1)(2008-12#1)
by the development of##8##4##(1992-9#1)(1994-3#1)(2008-10#1)(2008-12#1)(2010-3#1)(2011-3#1)(2012-3#1)(2013-8#1)
by the development##9##3##(1992-9#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-3#1)(2011-3#1)(2012-3#1)(2013-8#1)
by the difference between the##2##5##(1994-9#1)(2008-9#1)
by the difference between##3##4##(1994-9#1)(2008-10#1)(2008-9#1)
by the difference in##2##4##(1992-9#1)(2008-10#1)
by the difference##7##3##(1992-9#1)(1994-9#1)(2008-10#2)(2008-8#1)(2008-9#2)
by the different##10##3##(1990-5#1)(2008-10#7)(2008-12#1)(2010-9#1)
by the differential pulse voltammetry (DPV)##2##6##(2008-10#2)
by the differential##4##3##(1991-9#1)(2008-10#3)
by the digestion##2##3##(1993-8#1)(2008-10#1)
by the direct##5##3##(1992-12#1)(2008-10#3)(2008-11#1)
by the discovery##2##3##(1997-3#1)(2008-10#1)
by the disease##5##3##(1990-3#1)(2008-10#4)
by the dose-response##2##3##(2008-10#2)
by the dual-process##2##3##(2013-1#2)
by the effect of the##2##5##(2008-10#2)
by the effect of##4##4##(2008-10#3)(2013-1#1)
by the elderly##5##3##(1993-3#2)(1994-1#1)(1995-12#1)(1995-3#1)
by the electrochemical##3##3##(2008-10#3)
by the electronic##2##3##(2008-10#1)(2010-8#1)
by the electropolymerization of##2##4##(2008-10#2)
by the emerging##2##3##(2008-10#1)(2010-1#1)
by the end of the century##2##6##(1994-9#1)(1997-6#1)
by the end of the##10##5##(1991-12#1)(1994-2#1)(1994-9#1)(1997-6#1)(2008-10#5)(2008-11#1)
by the end of##17##4##(1990-12#1)(1991-12#1)(1994-2#1)(1994-9#1)(1996-1#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2011-3#1)(2012-2#2)
by the end##19##3##(1990-12#1)(1991-12#1)(1994-2#1)(1994-9#1)(1996-1#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-3#1)(2012-2#2)
by the endophyte##2##3##(2008-10#2)
by the environment##2##3##(1992-2#1)(2008-10#1)
by the enzymatic##3##3##(2008-10#2)(2008-7#1)
by the enzyme##3##3##(1994-3#1)(2008-10#1)(2008-5#1)
by the evaluation##2##3##(2012-2#1)(2013-1#1)
by the evolutionary##2##3##(2008-8#2)
by the example of##2##4##(1990-5#1)(2011-2#1)
by the excitation of##2##4##(2008-10#1)(2008-11#1)
by the excitation##3##3##(2008-10#2)(2008-11#1)
by the existence of##3##4##(1995-2#1)(2008-9#1)(2009-7#1)
by the exogenous##2##3##(1990-5#1)(2008-10#1)
by the expression of the##2##5##(1996-2#1)(2008-11#1)
by the expression of##3##4##(1993-6#1)(1996-2#1)(2008-11#1)
by the extraction##2##3##(2008-10#1)(2010-12#1)
by the fact that the##5##5##(1991-3#1)(1992-1#1)(2008-10#1)(2008-11#2)
by the fact that##15##4##(1991-3#1)(1992-1#1)(1992-12#1)(2008-10#3)(2008-11#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)
by the family##3##3##(1990-3#1)(1996-8#1)(2012-3#1)
by the femur##2##3##(2013-1#2)
by the ferric##2##3##(1997-7#1)(2008-11#1)
by the fiber##2##3##(2008-10#2)
by the finding that##2##4##(1994-2#1)(2008-10#1)
by the first##6##3##(1991-6#1)(1993-6#1)(1994-11#1)(2008-10#2)(2008-5#1)
by the fixed##2##3##(2008-10#2)
by the flow injection##2##4##(2008-10#2)
by the flow##3##3##(2008-10#2)(2008-11#1)
by the fluorescence quenching method##2##5##(2008-10#2)
by the following##4##3##(2008-11#2)(2008-5#1)(2013-8#1)
by the formation of a##2##5##(2008-10#2)
by the formation of##14##4##(1994-3#1)(1997-1#1)(2008-10#7)(2008-11#1)(2009-8#1)(2010-4#1)(2010-6#1)(2013-1#1)
by the formation##15##3##(1994-3#1)(1997-1#1)(2008-10#7)(2008-11#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
by the former##3##3##(1994-12#1)(2008-10#1)(2010-6#1)
by the four##3##3##(2008-10#3)
by the frequency##2##3##(1994-6#1)(2008-3#1)
by the functional state of the feeding apparatus##2##8##(2010-8#2)
by the functional##3##3##(2008-10#1)(2010-8#2)
by the fungal##2##3##(2008-10#2)
by the fungus but##2##4##(2008-10#1)(2008-11#1)
by the fungus##21##3##(2008-10#19)(2008-11#1)(2010-3#1)
by the fusion##2##3##(2008-11#1)(2008-8#1)
by the gas##3##3##(2008-10#1)(2008-3#2)
by the gene##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
by the general##3##3##(1997-2#1)(2008-1#1)(2013-1#1)
by the good fit of the##2##6##(2008-10#2)
by the good##4##3##(2008-10#4)
by the government##4##3##(1995-3#2)(1997-8#1)(2008-11#1)
by the gravimetric method##2##4##(1994-3#1)(2008-10#1)
by the greenhouse whitefly##2##4##(2008-10#2)
by the group##2##3##(2008-7#1)(2008-9#1)
by the head##3##3##(2008-10#3)
by the healthcare##2##3##(2009-6#2)
by the heat##2##3##(2008-10#2)
by the high##4##3##(2008-11#1)(2009-5#1)(2010-5#1)(2013-8#1)
by the highly##2##3##(1993-12#1)(2008-10#1)
by the hospital##4##3##(1991-6#1)(1994-1#2)(2008-10#1)
by the host##6##3##(2008-10#5)(2011-2#1)
by the human##9##3##(1993-3#1)(1995-12#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#1)
by the hybrid##2##3##(1993-9#1)(2012-3#1)
by the hydrogen peroxide##2##4##(2008-10#1)(2011-2#1)
by the hydrogen##3##3##(2008-10#2)(2011-2#1)
by the hydrolysis of##2##4##(2008-10#1)(2008-6#1)
by the i##2##3##(1995-11#1)(1996-2#1)
by the immobilization of##3##4##(2008-10#3)
by the immobilization##4##3##(2008-10#4)
by the immune##2##3##(1991-9#1)(2011-2#1)
by the immunohistochemical method##2##4##(1990-5#1)(2008-5#1)
by the in situ##2##4##(1996-12#1)(2008-10#1)
by the in##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
by the incident##2##3##(2008-10#2)
by the incorporation of##2##4##(2008-10#2)
by the increase of##2##4##(1990-12#1)(2008-10#1)
by the increase##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
by the increased##3##3##(2008-10#2)(2008-11#1)
by the increasing##2##3##(1992-3#1)(2008-8#1)
by the individual##2##3##(2008-11#1)(2010-6#1)
by the induction of##3##4##(2008-10#1)(2010-11#1)(2012-2#1)
by the induction##5##3##(2008-10#2)(2008-11#1)(2010-11#1)(2012-2#1)
by the infection##2##3##(2008-10#1)(2011-2#1)
by the information##2##3##(2009-5#1)(2011-2#1)
by the inhibition of the##2##5##(1995-11#1)(1995-6#1)
by the inhibition of##4##4##(1995-11#1)(1995-6#1)(2008-5#1)(2008-7#1)
by the inhibition##6##3##(1992-3#1)(1995-11#1)(1995-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
by the inhibitor of##2##4##(2008-8#1)(2013-8#1)
by the initial rate##2##4##(2008-10#2)
by the initial##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
by the injection of##2##4##(2008-10#1)(2008-3#1)
by the inner filter effect##2##5##(2008-10#2)
by the inoculum##2##3##(2008-10#2)
by the insertion of##2##4##(2008-10#2)
by the institution in##2##4##(1991-3#1)(2012-2#1)
by the interaction between##5##4##(1990-12#1)(1991-2#1)(2008-10#2)(2008-8#1)
by the interaction of##2##4##(2008-4#1)(2008-8#1)
by the interaction##8##3##(1990-12#1)(1991-2#1)(2008-10#2)(2008-4#2)(2008-8#2)
by the internal standard method##2##5##(1993-3#1)(2008-10#1)
by the internal standard##3##4##(1993-3#1)(2008-10#2)
by the intervention##2##3##(2008-12#2)
by the intracellular pathogen##2##4##(1995-2#1)(2009-8#1)
by the intracluster correlation##2##4##(1992-9#1)(2008-10#1)
by the introduction of a##3##5##(2008-10#3)
by the introduction of##8##4##(2008-10#5)(2008-3#1)(2010-7#1)(2013-1#1)
by the invading##2##3##(2008-10#2)
by the inverse##2##3##(2008-10#2)
by the isolates##2##3##(2008-10#2)
by the kidney##2##3##(1997-1#1)(2011-2#1)
by the laboratory##2##3##(2011-2#1)(2013-1#1)
by the lack of a##5##5##(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
by the lack of##12##4##(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)(2013-8#1)
by the large##3##3##(1997-7#1)(2008-10#1)(2008-7#1)
by the laser##2##3##(2008-3#2)
by the latter##4##3##(1991-8#1)(2008-10#2)(2008-5#1)
by the librarian##2##3##(1991-3#1)(1992-12#1)
by the limited##2##3##(2008-10#1)(2008-9#1)
by the linear regression##2##4##(2008-10#1)(2013-8#1)
by the linear##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
by the liver##3##3##(1991-7#1)(2012-2#1)(2013-7#1)
by the local##2##3##(1997-4#1)(2008-9#1)
by the logistic##3##3##(2008-10#2)(2008-7#1)
by the loss of##4##4##(1992-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
by the low##5##3##(2008-10#2)(2008-12#1)(2009-4#1)(2011-2#1)
by the magnetic field##3##4##(2008-8#2)(2008-9#1)
by the main##4##3##(1990-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
by the maintenance##2##3##(2008-11#2)
by the majority of##2##4##(2008-11#1)(2008-12#1)
by the manual##2##3##(1990-5#1)(2008-10#1)
by the manufacturer##3##3##(2008-10#3)
by the manufacturers##2##3##(2008-10#2)
by the mass spectrometer##2##4##(2008-10#2)
by the mass##4##3##(2008-10#2)(2008-11#1)(2010-8#1)
by the matrix effect##2##4##(2008-10#1)(2010-11#1)
by the matrix##5##3##(2008-10#4)(2010-11#1)
by the means of##2##4##(2011-2#2)
by the measurement of the##2##5##(2006-6#1)(2008-10#1)
by the measurement of##5##4##(2006-6#1)(2008-10#3)(2008-3#1)
by the media##2##3##(2010-2#2)
by the medical##3##3##(1991-3#1)(1993-6#1)(1993-8#1)
by the members of##2##4##(1997-8#1)(2009-8#1)
by the membrane##5##3##(2008-10#5)
by the metal##2##3##(1994-5#1)(2008-10#1)
by the method of##5##4##(2008-10#3)(2008-12#1)(2008-9#1)
by the method##12##3##(2008-10#9)(2008-12#1)(2008-3#1)(2008-9#1)
by the methods##2##3##(2008-10#2)
by the model##7##3##(1992-9#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)
by the models##2##3##(1995-3#1)(2008-9#1)
by the modification of##2##4##(2008-10#2)
by the modified Brdicka procedure##2##5##(2008-10#2)
by the modified##5##3##(2008-10#4)(2012-3#1)
by the monitoring of##2##4##(2008-10#2)
by the most##2##3##(2008-12#1)(2008-8#1)
by the mother##2##3##(2008-8#1)(2013-1#1)
by the much##2##3##(2008-10#1)(2009-8#1)
by the mutant##2##3##(2008-10#2)
by the national##4##3##(1994-12#1)(1994-6#1)(1995-12#1)(2011-2#1)
by the natural##3##3##(1990-12#1)(2008-10#1)(2008-9#1)
by the nature of the##2##5##(1994-8#1)(2008-10#1)
by the nature of##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
by the necrotrophic##2##3##(2008-10#2)
by the negative##3##3##(1990-5#1)(1991-3#1)(2008-10#1)
by the neonatal##2##3##(2008-11#2)
by the new##5##3##(1995-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
by the nitrogen##2##3##(1993-6#1)(2008-2#1)
by the non-linear##2##3##(2008-10#2)
by the nonpathogenic##2##3##(2008-10#2)
by the novel##2##3##(1995-5#1)(2011-3#1)
by the number of##9##4##(1991-2#1)(1993-12#1)(1997-3#1)(2008-10#3)(2008-9#1)(2012-3#1)(2013-8#1)
by the number##10##3##(1991-2#1)(1993-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
by the nurse##3##3##(2010-7#2)(2011-2#1)
by the nutritionists##2##3##(1991-2#2)
by the observation of##2##4##(1992-9#1)(1997-2#1)
by the observation##4##3##(1992-9#1)(1997-2#1)(2008-9#1)(2009-9#1)
by the occurrence of##3##4##(2008-10#2)(2008-7#1)
by the occurrence##4##3##(2008-10#2)(2008-7#1)(2012-12#1)
by the official##4##3##(2008-10#3)(2008-11#1)
by the on-line##3##3##(2008-10#3)
by the ongoing##2##3##(1997-6#1)(2013-1#1)
by the optical##2##3##(2008-3#1)(2009-5#1)
by the order of##2##4##(2008-10#1)(2008-8#1)
by the original##2##3##(2008-10#1)(2008-9#1)
by the other##4##3##(1994-8#1)(2008-10#3)
by the overwhelming##2##3##(2011-2#1)(2013-1#1)
by the oxidation of##5##4##(2008-10#5)
by the oxidation##6##3##(2008-10#6)
by the oxidative##3##3##(2008-10#3)
by the pH##3##3##(1994-5#1)(1995-6#1)(2008-10#1)
by the pathogen##11##3##(2008-10#11)
by the pathogens##2##3##(2008-10#2)
by the patient##6##3##(1990-11#1)(1993-11#1)(1994-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
by the paucity of##2##4##(1991-8#1)(2008-10#1)
by the peak##2##3##(2008-10#2)
by the percentage of##3##4##(1993-3#1)(2008-10#1)(2011-1#1)
by the performance of the##2##5##(2008-10#2)
by the peripheral##2##3##(1991-7#1)(1996-2#1)
by the perturbation##2##3##(2008-10#2)
by the pharmaceutical industry##2##4##(1996-2#1)(1997-5#1)
by the phase##2##3##(2008-3#2)
by the physician##4##3##(1993-8#1)(1996-9#1)(2010-7#2)
by the pineal hormone##2##4##(1995-9#1)(2008-5#1)
by the plant##2##3##(2008-10#1)(2008-11#1)
by the plant-pathogenic fungus##2##4##(2008-10#2)
by the polyhedrin promoter##2##4##(2008-11#2)
by the polymerase chain reaction (PCR)##2##6##(2008-10#1)(2008-9#1)
by the polymerase chain reaction##9##5##(1991-6#1)(1992-10#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
by the polyurethane##2##3##(2008-10#2)
by the positive##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
by the potent##2##3##(1994-8#1)(2012-2#1)
by the practitioner##2##3##(1997-4#1)(2008-4#1)
by the preparation##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
by the presence of a##3##5##(1995-12#1)(1995-6#1)(2011-2#1)
by the presence of other##4##5##(2008-10#4)
by the presence of the##3##5##(1990-5#1)(2008-11#1)(2012-12#1)
by the presence of##54##4##(1990-3#1)(1990-5#1)(1993-3#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#23)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#4)(2011-2#2)(2012-12#1)(2013-8#1)
by the presence or absence of##5##6##(1995-11#1)(2008-10#3)(2008-4#1)
by the presence##62##3##(1990-3#1)(1990-5#1)(1993-3#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#27)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-6#4)(2011-2#3)(2012-12#1)(2013-8#1)
by the present method##9##4##(1995-3#1)(2008-10#8)
by the present##15##3##(1995-3#1)(1996-2#1)(2008-10#13)
by the primary health##2##4##(1991-6#2)
by the primary##4##3##(1991-6#2)(1993-6#1)(2013-1#1)
by the product of##2##4##(1997-3#1)(2008-5#1)
by the production of##3##4##(1994-8#1)(2008-10#2)
by the program##2##3##(1993-3#1)(1996-2#1)
by the proportion of##2##4##(2008-8#1)(2008-9#1)
by the proportion##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
by the proposed method and by##2##6##(2008-10#2)
by the proposed method and the##2##6##(2008-10#2)
by the proposed method and##7##5##(2008-10#7)
by the proposed method are##2##5##(2008-10#2)
by the proposed method in##2##5##(2008-10#2)
by the proposed method were compared##2##6##(2008-10#2)
by the proposed method were##4##5##(2008-10#4)
by the proposed method##27##4##(2008-10#27)
by the proposed procedure##3##4##(2008-10#2)(2008-6#1)
by the proposed##48##3##(2008-10#45)(2008-3#1)(2008-6#1)(2009-10#1)
by the protein kinase##2##4##(1995-12#1)(1995-6#1)
by the protein phosphatase##2##4##(1993-8#1)(1994-11#1)
by the protein##7##3##(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-10#1)(2010-7#1)
by the quality of##2##4##(2013-1#2)
by the quantitative##2##3##(2008-10#2)
by the radiologist##2##3##(1991-3#1)(2012-2#1)
by the random##3##3##(2008-10#2)(2008-8#1)
by the range of##2##4##(1990-11#1)(2008-11#1)
by the rapid##5##3##(1995-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
by the rate of##5##4##(1997-1#1)(2008-7#1)(2008-9#1)(2010-11#2)
by the rate##7##3##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)
by the ratio of the##3##5##(1994-12#1)(2008-4#1)(2008-5#1)
by the ratio of##5##4##(1994-12#1)(2008-10#1)(2008-4#1)(2008-5#2)
by the reaction between##4##4##(2008-10#4)
by the reaction of##3##4##(1996-5#1)(2008-10#2)
by the reaction##10##3##(1993-8#1)(1996-5#1)(2008-10#8)
by the reagents##2##3##(1994-11#1)(2008-10#1)
by the recent##2##3##(2008-11#1)(2013-8#1)
by the recently##2##3##(1994-12#1)(2008-8#1)
by the receptor##2##3##(1992-10#1)(1994-12#1)
by the recombinant vaccinia virus##2##5##(2008-8#2)
by the recombinant##4##3##(2008-10#1)(2008-8#3)
by the recovery of##2##4##(2008-10#2)
by the recovery##3##3##(2008-10#3)
by the redox##2##3##(1992-8#1)(2008-10#1)
by the reduction of the##2##5##(2008-10#1)(2008-11#1)
by the reduction of##5##4##(2008-10#4)(2008-11#1)
by the reduction##6##3##(2008-10#4)(2008-11#1)(2008-9#1)
by the reference##7##3##(2008-10#7)
by the regression##2##3##(2008-10#1)(2008-9#1)
by the relative##5##3##(1994-12#1)(2008-10#2)(2008-9#1)(2010-12#1)
by the relatively##2##3##(2008-10#1)(2009-1#1)
by the release of##4##4##(1994-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
by the relevant##2##3##(2008-11#1)(2012-3#1)
by the removal of##2##4##(1992-3#1)(1995-11#1)
by the repeating##2##3##(1992-9#1)(2011-2#1)
by the resin phase##2##4##(2008-10#2)
by the resin##5##3##(2008-10#5)
by the resistant##2##3##(2008-10#1)(2008-11#1)
by the respective##3##3##(1991-2#1)(1993-6#1)(2008-10#1)
by the results of the##2##5##(1992-5#1)(2008-8#1)
by the results of##10##4##(1992-5#1)(1995-12#1)(1997-4#1)(2008-10#4)(2008-7#1)(2008-8#2)
by the reverse##2##3##(1997-7#1)(2008-10#1)
by the review##2##3##(1995-12#1)(2008-11#1)
by the right transradial approach##2##5##(2008-11#2)
by the risk##2##3##(1996-11#1)(2012-2#1)
by the same investigator##2##4##(2011-1#1)(2013-1#1)
by the same mechanism as##2##5##(1993-12#1)(2008-10#1)
by the same mechanism##3##4##(1993-12#1)(2008-10#1)(2011-2#1)
by the same##41##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-8#2)(1995-1#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#5)
by the scaling##2##3##(2008-5#1)(2008-8#1)
by the scarcity of##2##4##(2011-2#1)(2011-3#1)
by the screening##2##3##(1997-4#1)(2008-10#1)
by the second##8##3##(1991-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)
by the segregation of##2##4##(2008-10#2)
by the selection##3##3##(1997-9#1)(2008-10#1)(2008-11#1)
by the senior author##4##4##(1993-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
by the senior##5##3##(1993-12#2)(2008-9#1)(2012-3#1)(2013-1#1)
by the sequences##2##3##(1993-3#1)(1993-8#1)
by the sequential##3##3##(1995-2#1)(2008-10#1)(2008-12#1)
by the serological##2##3##(1995-12#1)(1997-8#1)
by the significantly##2##3##(2013-1#1)(2013-8#1)
by the simplest##2##3##(2008-11#1)(2008-8#1)
by the simplex method##2##4##(2008-10#2)
by the simultaneous##3##3##(1992-6#1)(2007-12#1)(2008-10#1)
by the single##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
by the size of the##4##5##(1996-6#1)(2008-10#1)(2010-5#1)(2011-2#1)
by the size##5##3##(1996-6#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
by the skin##3##3##(2008-5#3)
by the slope##3##3##(2008-10#3)
by the small##6##3##(1990-8#1)(1994-6#1)(2008-10#3)(2013-8#1)
by the so-called##2##3##(2007-12#1)(2008-10#1)
by the social##3##3##(2008-11#2)(2009-6#1)
by the software##2##3##(2008-9#1)(2012-3#1)
by the soilborne##4##3##(2008-10#4)
by the sol-gel##2##3##(2008-10#2)
by the solvent extraction method##2##5##(2008-10#2)
by the solvent##5##3##(1996-5#1)(2008-10#3)(2008-7#1)
by the somatostatin##2##3##(1995-2#1)(2012-3#1)
by the source##3##3##(2007-12#1)(2008-10#2)
by the species##2##3##(2008-10#2)
by the specific##5##3##(1990-12#1)(1995-8#1)(2008-10#3)
by the spectrometer autosampler##2##4##(2008-10#2)
by the spectrophotometric method##2##4##(2008-10#2)
by the spectrophotometric##3##3##(2008-10#3)
by the stable##2##3##(2008-7#1)(2013-8#1)
by the standard addition method##7##5##(2008-10#7)
by the standard addition##8##4##(2008-10#8)
by the standard additions method##2##5##(2008-10#2)
by the standard##16##3##(1992-12#1)(2008-10#14)(2008-11#1)
by the state##2##3##(1995-2#1)(1996-2#1)
by the stimulation##2##3##(1992-12#1)(2009-8#1)
by the stripping##2##3##(2008-10#2)
by the structural characterization##2##4##(2008-10#1)(2008-4#1)
by the students##4##3##(2008-11#2)(2010-10#1)(2013-1#1)
by the study of##3##4##(2008-10#3)
by the study##4##3##(1990-2#1)(2008-10#3)
by the subject##3##3##(2008-4#1)(2008-9#1)(2013-1#1)
by the substitution##2##3##(1993-12#1)(2008-11#1)
by the surfactant##2##3##(1997-2#1)(2008-10#1)
by the sustained##2##3##(1994-6#1)(1997-8#1)
by the synthesis of##2##4##(2008-10#2)
by the system##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
by the target##2##3##(2008-10#1)(2008-3#1)
by the term##2##3##(1993-8#2)
by the test##2##3##(1997-3#1)(2008-5#1)
by the thickness##2##3##(2008-10#2)
by the third##3##3##(1995-8#1)(1996-1#1)(2007-12#1)
by the three##5##3##(1995-11#1)(2008-10#4)
by the time##5##3##(1991-9#1)(1996-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
by the traditional technique##2##4##(2011-2#2)
by the traditional##5##3##(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#2)
by the treatment of##3##4##(2008-10#1)(2008-11#2)
by the treatment##4##3##(1996-12#1)(2008-10#1)(2008-11#2)
by the two methods##4##4##(2008-10#3)(2008-11#1)
by the two##21##3##(2008-10#12)(2008-11#3)(2008-3#2)(2008-8#2)(2008-9#1)(2012-5#1)
by the type##5##3##(1995-11#1)(2008-10#2)(2008-5#1)(2008-9#1)
by the univariate method##2##4##(2008-10#2)
by the univariate##3##3##(2008-10#3)
by the use of a##7##5##(2008-10#6)(2008-11#1)
by the use of attenuated total##2##6##(2008-10#2)
by the use of the##2##5##(2008-10#2)
by the use of##43##4##(1990-2#1)(1990-5#2)(1991-12#1)(1991-8#1)(1992-1#1)(1995-3#1)(1995-6#1)(2008-10#24)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
by the use##46##3##(1990-2#1)(1990-5#2)(1991-12#1)(1991-8#1)(1992-1#1)(1995-3#1)(1995-6#1)(2008-10#26)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
by the user##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
by the vascular##2##3##(2008-10#1)(2012-3#1)
by the vector##4##3##(2008-10#4)
by the whitefly##3##3##(2008-10#3)
by the wild-type##4##3##(1991-12#2)(2008-10#2)
by the year 2000##11##4##(1990-2#1)(1993-3#1)(1994-9#2)(1997-2#2)(1997-6#4)(2008-11#1)
by the year##13##3##(1990-2#1)(1993-3#1)(1994-9#3)(1997-2#2)(1997-6#4)(2008-11#1)(2009-10#1)
by the yeast##2##3##(1994-9#1)(1995-5#1)
by the##3403##2##(1990-11#10)(1990-12#9)(1990-2#12)(1990-3#8)(1990-5#19)(1990-6#3)(1990-8#4)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#15)(1991-2#15)(1991-3#18)(1991-5#8)(1991-6#8)(1991-7#2)(1991-8#6)(1991-9#5)(1992-1#11)(1992-10#2)(1992-11#3)(1992-12#15)(1992-2#12)(1992-3#15)(1992-4#4)(1992-5#5)(1992-6#10)(1992-8#4)(1992-9#8)(1993-1#2)(1993-11#5)(1993-12#20)(1993-2#12)(1993-3#22)(1993-6#20)(1993-8#26)(1993-9#5)(1994-1#7)(1994-11#15)(1994-12#28)(1994-2#10)(1994-3#17)(1994-5#20)(1994-6#6)(1994-8#16)(1994-9#10)(1995-1#7)(1995-11#18)(1995-12#30)(1995-2#23)(1995-3#12)(1995-5#4)(1995-6#24)(1995-8#13)(1995-9#3)(1996-1#9)(1996-11#5)(1996-12#16)(1996-2#20)(1996-3#9)(1996-5#18)(1996-6#11)(1996-8#4)(1996-9#3)(1997-1#14)(1997-2#24)(1997-3#15)(1997-4#9)(1997-5#3)(1997-6#9)(1997-7#8)(1997-8#13)(1997-9#1)(2006-6#1)(2007-11#3)(2007-12#17)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#1323)(2008-11#213)(2008-12#38)(2008-2#12)(2008-3#92)(2008-4#23)(2008-5#79)(2008-6#13)(2008-7#57)(2008-8#87)(2008-9#83)(2009-1#4)(2009-10#14)(2009-11#6)(2009-12#3)(2009-3#7)(2009-4#5)(2009-5#8)(2009-6#8)(2009-7#9)(2009-8#34)(2009-9#7)(2010-1#11)(2010-10#6)(2010-11#9)(2010-12#10)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#11)(2010-6#9)(2010-7#14)(2010-8#14)(2010-9#5)(2011-1#12)(2011-10#1)(2011-2#100)(2011-3#12)(2011-7#1)(2011-9#1)(2012-12#19)(2012-2#39)(2012-3#36)(2012-5#1)(2013-1#78)(2013-7#3)(2013-8#33)
by theanine##2##2##(2008-11#2)
by their enzymatic##2##3##(2008-11#2)
by their high##2##3##(2008-6#1)(2010-2#1)
by their interaction##2##3##(1990-5#1)(2008-10#1)
by their large##2##3##(1993-6#1)(2008-10#1)
by their specific##2##3##(2008-10#1)(2008-4#1)
by their##89##2##(1990-5#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#3)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-10#19)(2008-11#8)(2008-12#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#3)(2013-8#1)
by them##6##2##(1990-9#1)(1993-3#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-8#1)
by themselves##7##2##(2008-10#2)(2008-11#2)(2008-9#1)(2009-5#1)(2009-7#1)
by theoretical##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
by theory##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
by therapeutic##2##2##(2012-3#1)(2013-1#1)
by thermal lensing##4##3##(2008-10#4)
by thermal##14##2##(1995-8#1)(2008-10#12)(2008-11#1)
by thermogravimetric##2##2##(2008-10#2)
by thermolysin##5##2##(1993-8#1)(1994-5#4)
by these agents##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
by these bacteria##2##3##(2008-10#2)
by these cells##6##3##(1991-5#1)(1992-2#1)(2008-11#3)(2008-9#1)
by these factors##2##3##(2008-11#1)(2008-8#1)
by these genes##2##3##(2008-10#1)(2009-8#1)
by these groups##2##3##(1995-12#1)(2011-1#1)
by these methods##2##3##(2008-10#1)(2012-12#1)
by these procedures##2##3##(2008-10#1)(2008-9#1)
by these three##2##3##(2008-10#1)(2010-12#1)
by these two##8##3##(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#4)(2011-3#1)
by these viruses##2##3##(2008-11#1)(2013-1#1)
by these##90##2##(1990-11#1)(1991-3#2)(1991-5#2)(1992-2#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-7#1)(2008-10#24)(2008-11#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
by theta##2##2##(2008-10#1)(2010-7#1)
by thin layer chromatography and##2##5##(2008-10#1)(2008-11#1)
by thin layer chromatography##5##4##(2008-10#3)(2008-11#1)(2009-8#1)
by thiol##2##2##(1992-3#1)(1994-8#1)
by thiols##2##2##(1991-3#1)(2008-10#1)
by thiourea##2##2##(2008-10#1)(2011-2#1)
by third derivative spectrophotometry##2##4##(2008-10#2)
by third##3##2##(1995-2#1)(2008-10#2)
by thirteen##2##2##(1997-8#1)(2011-2#1)
by this analysis##2##3##(1992-2#1)(1995-3#1)
by this bacterium##2##3##(2008-10#2)
by this fungus##3##3##(2008-10#2)(2011-1#1)
by this in##2##3##(1995-2#1)(2008-11#1)
by this method are##3##4##(1992-4#1)(2008-10#2)
by this method were in good agreement with##2##8##(2008-10#2)
by this method were in##3##5##(2008-10#2)(2008-5#1)
by this method were##7##4##(2008-10#6)(2008-5#1)
by this method##31##3##(1990-2#1)(1992-4#2)(1994-11#1)(1997-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
by this new##2##3##(1996-2#1)(2008-10#1)
by this newly developed method##2##5##(2008-10#2)
by this pathogen##4##3##(2008-10#2)(2009-8#2)
by this procedure##7##3##(1995-10#1)(2008-10#5)(2008-6#1)
by this proposed##2##3##(2008-10#2)
by this protein##2##3##(1995-6#1)(2013-1#1)
by this route##2##3##(1993-11#1)(2011-2#1)
by this sensor##2##3##(2008-10#2)
by this strategy##2##3##(1993-12#1)(2013-1#1)
by this study##3##3##(1990-6#1)(1997-8#1)(2008-11#1)
by this system##2##3##(2008-10#1)(2011-2#1)
by this technique##4##3##(2008-10#2)(2008-2#1)(2011-3#1)
by this type of##2##4##(1990-8#1)(2008-3#1)
by this##134##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#2)(1997-1#2)(1997-8#1)(2007-12#2)(2008-10#61)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
by thoracoscopic##2##2##(1997-4#1)(2011-2#1)
by those genes##2##3##(2008-10#2)
by those who##3##3##(1990-6#1)(1994-1#1)(2009-4#1)
by those with##4##3##(1992-3#2)(1996-3#1)(2008-1#1)
by those##17##2##(1990-6#1)(1991-2#1)(1992-3#2)(1994-1#1)(1995-12#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-4#1)(2012-3#1)(2013-1#1)
by three different##3##3##(1992-3#1)(1996-5#1)(2008-10#1)
by three##31##2##(1990-6#1)(1991-12#1)(1992-3#1)(1993-6#1)(1994-3#2)(1995-8#1)(1996-5#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
by three-way##2##2##(2008-10#2)
by threonine##2##2##(1994-11#1)(1997-8#1)
by thrombin##5##2##(1991-9#2)(1992-4#1)(1995-11#1)(2008-10#1)
by thymic##2##2##(2008-8#1)(2012-12#1)
by time##5##2##(2008-10#2)(2010-2#1)(2013-1#2)
by time-resolved##2##2##(1990-8#1)(2008-10#1)
by time-varying magnetic fields##2##4##(1992-3#2)
by tinea##2##2##(2008-5#2)
by titration calorimetry##2##3##(1992-10#1)(2008-10#1)
by titration##3##2##(1992-10#1)(2008-10#2)
by toluidine blue O##2##4##(2008-10#2)
by topically##2##2##(2008-12#1)(2008-5#1)
by total##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
by traditional methods##2##3##(2008-10#1)(2008-9#1)
by traditional##15##2##(1993-2#1)(1993-9#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-9#3)(2010-8#1)(2013-8#1)
by trained##3##2##(2010-2#1)(2012-2#2)
by transcription##3##2##(1993-9#1)(2008-7#1)(2008-9#1)
by transcriptionally##2##2##(2008-11#1)(2013-1#1)
by transesophageal echocardiography (TEE)##2##4##(2008-7#1)(2011-2#1)
by transesophageal echocardiography##3##3##(2008-7#2)(2011-2#1)
by transfecting##6##2##(2008-11#4)(2008-8#1)(2008-9#1)
by transfection##3##2##(2008-11#3)
by transfer of the 2-deoxygalactosyl group from beta-galactosidase to##2##9##(2009-8#2)
by transfer of##4##3##(1991-3#1)(2008-10#1)(2009-8#2)
by transferring##4##2##(2008-10#2)(2008-9#2)
by transformation with##2##3##(2008-10#2)
by transforming##2##2##(2008-10#2)
by transient##4##2##(1992-8#1)(2008-11#1)(2011-3#1)(2013-1#1)
by translation##4##2##(2008-2#1)(2008-6#1)(2008-9#2)
by transmission electron microscopy and##3##5##(2008-10#2)(2009-11#1)
by transmission electron microscopy##10##4##(1997-3#1)(2008-10#6)(2008-12#1)(2008-5#1)(2009-11#1)
by transmission##12##2##(1997-3#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)
by treating##4##2##(1993-6#1)(1994-11#1)(1996-5#1)(2008-10#1)
by treatment of the hydroxide residue with##2##7##(2008-10#2)
by treatment of the##4##4##(1990-9#1)(2008-10#3)
by treatment of##7##3##(1990-9#1)(1994-11#1)(1994-5#1)(2008-10#4)
by treatment with 2%##2##4##(2008-10#1)(2008-11#1)
by treatment with the##2##4##(1991-12#1)(2012-2#1)
by treatment with##31##3##(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-2#1)(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#2)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
by treatment##41##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-3#1)(2008-10#8)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
by triangle##2##2##(2008-10#1)(2008-6#1)
by triple-antibody sandwich##2##3##(2008-10#2)
by trophic##2##2##(2008-7#2)
by trypsin digestion##2##3##(1990-2#1)(1990-5#1)
by trypsin##4##2##(1990-2#1)(1990-5#2)(1993-8#1)
by tryptophan and its analogue##2##5##(2008-11#2)
by tumor cells##4##3##(1990-12#1)(1990-6#1)(2008-5#1)(2008-9#1)
by tumor##10##2##(1990-12#1)(1990-6#1)(1992-1#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
by tumors##3##2##(2008-10#2)(2013-1#1)
by tumour##3##2##(2010-10#1)(2011-2#1)(2013-7#1)
by tungsten coil electrothermal atomic absorption spectrometry##5##7##(2008-10#5)
by tungsten##6##2##(2008-10#6)
by two case studies##3##4##(1995-2#1)(2008-10#2)
by two competing##2##3##(2008-10#1)(2008-8#1)
by two different##6##3##(1991-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
by two distinct##2##3##(1996-2#1)(2008-11#1)
by two genes##2##3##(1997-7#1)(2008-10#1)
by two independent reviewers##2##4##(1997-8#1)(2012-12#1)
by two independent##3##3##(1994-11#1)(1997-8#1)(2012-12#1)
by two major##4##3##(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#1)
by two methods##3##3##(2008-10#2)(2008-11#1)
by two types of##2##4##(1990-12#1)(2008-11#1)
by two##99##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#23)(2008-11#9)(2008-12#2)(2008-3#4)(2008-5#2)(2008-8#4)(2008-9#5)(2009-10#2)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
by two-dimensional NMR techniques##2##4##(1990-9#1)(2008-8#1)
by two-dimensional electrophoresis##2##3##(1996-8#1)(2008-4#1)
by two-dimensional gel electrophoresis##3##4##(1995-12#1)(2008-10#1)(2010-12#1)
by two-dimensional##10##2##(1990-9#2)(1993-9#1)(1995-12#2)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)
by two-photon##2##2##(2008-10#1)(2010-1#1)
by two-wave##2##2##(2008-3#2)
by type I##3##3##(1996-2#2)(2013-1#1)
by type of##4##3##(1994-12#1)(1996-3#1)(2008-11#1)(2009-3#1)
by type##12##2##(1994-12#1)(1994-2#1)(1996-2#4)(1996-3#1)(2008-11#1)(2008-7#1)(2009-3#1)(2013-1#1)(2013-8#1)
by typical##4##2##(1991-4#1)(2008-10#1)(2008-12#1)(2009-8#1)
by tyrosinase##2##2##(2008-10#1)(2008-5#1)
by ultrafiltration##4##2##(2008-10#3)(2012-2#1)
by ultrasonic nebulization##2##3##(2008-10#2)
by ultrasonic##8##2##(1993-2#2)(1994-9#1)(2008-10#5)
by ultrasonography##4##2##(1992-9#1)(1997-8#1)(2008-12#1)(2011-2#1)
by ultrasound in##3##3##(1993-8#1)(1997-3#1)(2012-3#1)
by ultrasound##12##2##(1993-8#1)(1994-12#1)(1994-5#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-9#1)(2012-3#2)(2013-8#1)
by ultrasound-assisted##2##2##(2008-10#2)
by ultrastructural##2##2##(1994-8#1)(2008-5#1)
by ultraviolet##5##2##(2008-10#2)(2008-3#1)(2008-5#2)
by ultraviolet-visible##2##2##(2008-10#2)
by understanding the##2##3##(2008-6#1)(2008-9#1)
by unfolding##2##2##(2008-10#1)(2008-9#1)
by unilateral##3##2##(1995-12#2)(2008-12#1)
by unique##2##2##(2008-10#2)
by univariate method##3##3##(2008-10#3)
by universities##2##2##(1993-3#1)(1997-3#1)
by unknown##2##2##(2008-1#1)(2008-10#1)
by unsaturated fatty acids##2##4##(1993-3#1)(1996-3#1)
by unweighted##3##2##(2008-10#3)
by up to 10%##2##4##(2008-3#2)
by up to a##2##4##(1995-12#1)(2008-11#1)
by up to##15##3##(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-7#1)
by upregulation of##2##3##(2009-12#1)(2013-1#1)
by urinary##2##2##(1993-12#1)(1994-3#1)
by us##8##2##(1991-3#1)(1991-5#1)(1995-6#1)(2008-10#4)(2008-9#1)
by use of a nonreciprocal##2##5##(2008-3#2)
by use of a single##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
by use of a##53##4##(1990-12#1)(1991-12#1)(1995-11#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#33)(2009-1#1)
by use of an adaptive##2##5##(2008-3#2)
by use of an##11##4##(2008-2#1)(2008-3#10)
by use of different##3##4##(2008-2#1)(2008-3#2)
by use of focused-ion-beam milling##2##5##(2008-3#2)
by use of standard##2##4##(2008-3#1)(2013-1#1)
by use of the##23##4##(2008-10#1)(2008-2#4)(2008-3#17)(2010-6#1)
by use of this##2##4##(2008-3#2)
by use of two##2##4##(2008-3#2)
by use of##177##3##(1990-12#1)(1991-12#1)(1991-9#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-11#6)(2007-12#9)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#16)(2008-3#109)(2008-4#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-11#1)(2010-6#3)(2010-7#1)(2011-2#1)(2013-1#2)
by using 0##2##3##(2008-10#2)
by using 1##3##3##(2008-10#3)
by using 18##2##3##(2008-10#2)
by using 5##3##3##(2008-10#3)
by using GUS##2##3##(2008-10#1)(2008-9#1)
by using N##2##3##(2008-10#2)
by using NIR##2##3##(2008-10#2)
by using NaCl##2##3##(2008-10#2)
by using PBMC and whole blood culture assays##2##8##(2011-2#2)
by using UV##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
by using a column containing Amberlite XAD-16 resin and##2##9##(2008-10#2)
by using a combination of##3##5##(2008-10#2)(2008-8#1)
by using a common spectrofluorometer##2##5##(2008-10#2)
by using a common##3##4##(2008-10#2)(2008-11#1)
by using a conventional##2##4##(2008-10#2)
by using a flow##2##4##(2008-10#2)
by using a high##3##4##(2008-10#2)(2008-11#1)
by using a new##2##4##(2008-10#2)
by using a newly##2##4##(1994-11#1)(2008-10#1)
by using a simple##2##4##(2008-10#2)
by using a specific##2##4##(1990-5#1)(1995-8#1)
by using a standard##3##4##(2008-10#3)
by using a system##2##4##(2008-2#1)(2008-5#1)
by using a validated##2##4##(2010-7#1)(2012-12#1)
by using a##111##3##(1990-5#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(2007-9#1)(2008-10#71)(2008-11#10)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-3#1)
by using an HPLC##2##4##(2008-10#2)
by using an acid##2##4##(2008-10#2)
by using an##24##3##(1995-2#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-2#1)
by using artificial neural##2##4##(2008-10#1)(2010-8#1)
by using both##3##3##(2008-10#2)(2008-8#1)
by using capillary##3##3##(2008-10#3)
by using conventional##2##3##(2008-10#1)(2008-11#1)
by using crystal##2##3##(2008-10#1)(2008-2#1)
by using cyclic##3##3##(2008-10#2)(2009-9#1)
by using different##5##3##(2008-10#3)(2008-12#1)(2008-7#1)
by using differential##3##3##(2008-10#2)(2010-12#1)
by using flow injection analysis##3##5##(2008-10#3)
by using fluorescence##2##3##(1994-5#1)(2008-10#1)
by using gel##2##3##(2008-8#2)
by using gelatin##2##3##(2008-10#2)
by using inductively coupled##2##4##(2008-10#2)
by using it as##2##4##(2008-10#1)(2008-12#1)
by using methylene blue##2##4##(2008-10#2)
by using multivariate calibration##2##4##(2008-10#2)
by using of##2##3##(2008-10#2)
by using optical and##2##4##(2008-5#1)(2009-7#1)
by using partial least squares##3##5##(2008-10#3)
by using partial##4##3##(2008-10#4)
by using polymerase chain##2##4##(2008-10#1)(2013-1#1)
by using principal component##2##4##(2008-10#1)(2008-11#1)
by using principal##3##3##(2008-10#2)(2008-11#1)
by using reference materials##2##4##(2008-10#2)
by using reference##3##3##(2008-10#2)(2008-2#1)
by using short##2##3##(2008-3#1)(2008-9#1)
by using silica gel loaded with##2##6##(2008-10#2)
by using silica gel##3##4##(2008-10#2)(2008-11#1)
by using sodium##2##3##(2008-10#2)
by using specific##2##3##(2008-8#1)(2011-3#1)
by using square wave voltammetry##2##5##(2008-10#2)
by using square wave##3##4##(2008-10#3)
by using standard##6##3##(1991-3#1)(2008-10#2)(2008-11#1)(2008-12#2)
by using such##2##3##(2008-7#1)(2013-8#1)
by using synthetic##2##3##(2008-10#1)(2008-11#1)
by using the method of##3##5##(2008-10#1)(2010-12#1)(2013-1#1)
by using the modified##3##4##(1996-12#1)(2008-11#1)(2008-3#1)
by using the proposed##3##4##(2008-10#3)
by using the##96##3##(1991-12#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#56)(2008-11#6)(2008-3#8)(2008-5#2)(2008-8#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
by using these##6##3##(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)
by using this##7##3##(1993-11#1)(1997-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
by using three##2##3##(2008-10#2)
by using two##6##3##(1992-4#1)(2008-10#4)(2008-11#1)
by using various##2##3##(2008-10#1)(2008-5#1)
by using yeast two-hybrid##2##4##(2008-9#2)
by using##603##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-3#2)(1991-9#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-5#2)(1995-12#3)(1995-2#6)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#2)(2006-6#1)(2007-9#1)(2008-10#365)(2008-11#37)(2008-12#9)(2008-2#5)(2008-3#19)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#28)(2008-9#13)(2009-1#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#7)(2011-1#2)(2011-2#10)(2011-3#4)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#5)
by utilising##3##2##(2008-10#2)(2008-12#1)
by utilizing a flow-through type##2##5##(2008-10#2)
by utilizing a##3##3##(2008-10#2)(2008-11#1)
by utilizing the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
by utilizing##15##2##(1991-3#1)(1991-7#1)(1993-9#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-7#2)
by vaccination with##2##3##(1995-2#1)(2008-8#1)
by vaccination##3##2##(1995-2#1)(1995-9#1)(2008-8#1)
by validated##2##2##(1991-2#1)(2010-7#1)
by variance##2##2##(2008-10#1)(2013-1#1)
by variation##2##2##(1993-11#1)(2009-7#1)
by variations in the##2##4##(1996-3#1)(2008-10#1)
by variations in##3##3##(1996-3#1)(2008-10#2)
by various factors##4##3##(2008-11#1)(2008-2#1)(2010-12#1)(2012-2#1)
by various investigators##3##3##(1995-2#1)(1996-12#1)(2008-4#1)
by various methods##2##3##(1995-11#1)(2008-10#1)
by various techniques and##2##4##(2008-10#2)
by various##42##2##(1990-2#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1996-12#1)(2007-11#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
by varying the amount of##2##5##(2008-10#2)
by varying the magnitude of the applied current##2##8##(2008-10#2)
by varying the##16##3##(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-6#1)
by varying##24##2##(1994-12#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-6#2)(2012-3#1)
by vascular##4##2##(1995-2#1)(2008-10#1)(2009-8#1)(2010-3#1)
by vector##2##2##(2008-10#2)
by vectors##3##2##(2008-10#3)
by velocity##2##2##(1993-5#1)(1993-8#1)
by venipuncture##2##2##(2010-11#1)(2011-2#1)
by ventral##2##2##(1993-6#1)(1996-2#1)
by ventricular##2##2##(2008-10#1)(2012-2#1)
by verbascoside##2##2##(2008-8#2)
by very##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
by vessel##2##2##(1992-9#1)(2010-9#1)
by viable##3##2##(2008-11#2)(2009-12#1)
by vibration of##2##3##(2007-12#1)(2008-3#1)
by vibration##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
by video-assisted thoracoscopic##2##3##(2007-8#1)(2013-7#1)
by viewing##2##2##(2008-8#1)(2008-9#1)
by viral##5##2##(1995-2#1)(2008-11#3)(2012-3#1)
by virtue of its##2##4##(1996-2#1)(2008-10#1)
by virtue of their##3##4##(1993-2#1)(2008-9#1)(2009-12#1)
by virtue of##7##3##(1993-2#1)(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)
by virulence##2##2##(2008-10#2)
by virus##5##2##(2008-10#1)(2008-11#2)(2008-9#1)(2013-1#1)
by visible light irradiation##2##4##(2009-3#2)
by visible##3##2##(2008-10#1)(2009-3#2)
by visual##7##2##(1990-8#1)(1991-2#1)(1996-11#1)(2008-10#3)(2008-11#1)
by visualization##2##2##(2008-10#1)(2011-2#1)
by visually estimating the##2##4##(2008-10#2)
by visually##3##2##(1990-8#1)(2008-10#2)
by vitamin E##2##3##(1992-9#1)(1994-5#1)
by vitamin##4##2##(1992-1#1)(1992-9#1)(1994-5#1)(2008-11#1)
by volatile##2##2##(2008-10#1)(2009-8#1)
by voltammetric##3##2##(2008-10#3)
by voltammetry##2##2##(2008-10#2)
by volume##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2009-7#2)
by volumetric Karl Fischer (KF) titration##2##6##(2008-10#2)
by volumetric Karl Fischer##3##4##(2008-10#3)
by volunteers##2##2##(1994-3#2)
by washing the##2##3##(2008-10#2)
by washing with##2##3##(2008-10#2)
by washing##4##2##(2008-10#4)
by water and##3##3##(1995-3#1)(2008-10#1)(2012-12#1)
by water##11##2##(1995-3#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
by wavelength##2##2##(2008-10#1)(2008-3#1)
by way of the##5##4##(1993-3#1)(2008-11#1)(2008-12#2)(2008-7#1)
by way of##18##3##(1992-9#1)(1993-3#2)(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-7#1)(2008-9#1)(2010-8#4)(2013-1#1)
by weather variables##2##3##(2008-10#1)(2012-3#1)
by week##3##2##(1991-3#1)(1992-8#1)(2011-2#1)
by weekly##2##2##(2008-10#1)(2008-5#1)
by weighing the##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
by weighing##5##2##(1994-3#1)(2008-10#3)(2008-12#1)
by weight status##2##3##(2011-2#2)
by weight##6##2##(1991-12#1)(1993-3#2)(2008-10#1)(2011-2#2)
by well##2##2##(2008-11#1)(2008-12#1)
by western blot##2##3##(2008-10#2)
by western blotting##4##3##(2008-10#1)(2008-11#2)(2012-12#1)
by western##8##2##(2008-10#5)(2008-11#2)(2012-12#1)
by wet##2##2##(2008-10#1)(2012-2#1)
by wheat##3##2##(1992-6#1)(2008-10#1)(2013-8#1)
by which a##7##3##(1994-11#1)(2008-11#2)(2008-2#1)(2010-10#1)(2010-5#1)(2010-7#1)
by which it##2##3##(1995-9#1)(2008-10#1)
by which the##20##3##(1990-8#1)(1991-2#1)(1993-2#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-4#1)(2013-1#1)
by which these##6##3##(1994-11#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
by which they##4##3##(1995-2#1)(2008-10#1)(2011-2#2)
by which this occurs##4##4##(1992-9#1)(2008-11#2)(2013-1#1)
by which this##8##3##(1992-9#1)(1996-1#1)(2008-11#3)(2008-4#1)(2010-1#1)(2013-1#1)
by which##135##2##(1990-11#1)(1990-5#2)(1990-8#2)(1991-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#3)(1994-8#1)(1995-12#3)(1995-2#4)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#24)(2008-11#14)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
by white##2##2##(2008-12#1)(2009-9#1)
by whiteflies##4##2##(2008-10#4)
by widespread##2##2##(2008-10#1)(2009-11#1)
by wild type##2##3##(2008-11#1)(2008-12#1)
by wild##3##2##(2008-11#2)(2008-12#1)
by wild-type##4##2##(1993-11#1)(2008-10#3)
by wind##5##2##(2008-10#2)(2008-11#2)(2010-1#1)
by wine##2##2##(2008-10#1)(2009-7#1)
by with##2##2##(2008-10#1)(2012-2#1)
by woody plants##2##3##(2008-9#2)
by woody##3##2##(2008-10#1)(2008-9#2)
by working in a##2##4##(1997-5#1)(2010-7#1)
by working in##3##3##(1997-5#1)(2008-10#1)(2010-7#1)
by wortmannin##3##2##(1994-11#1)(1995-8#1)(2008-11#1)
by wounding##2##2##(2008-10#2)
by xenobiotics##2##2##(1994-8#1)(2008-11#1)
by xi = gamma + 3##2##6##(2008-3#2)
by xuefu zhuyu decoction##2##4##(2013-8#2)
by yeast two-hybrid system##4##4##(2008-8#1)(2008-9#3)
by yeast##9##2##(1992-3#1)(1993-8#1)(2008-10#3)(2008-8#1)(2008-9#3)
by younger##2##2##(1990-6#1)(2008-5#1)
by zymography##2##2##(2010-3#1)(2013-8#1)
by##25206##1##(1990-10#11)(1990-11#76)(1990-12#90)(1990-2#68)(1990-3#48)(1990-4#2)(1990-5#146)(1990-6#47)(1990-7#10)(1990-8#66)(1990-9#53)(1991-1#37)(1991-10#8)(1991-11#32)(1991-12#86)(1991-2#73)(1991-3#106)(1991-4#5)(1991-5#113)(1991-6#53)(1991-7#18)(1991-8#41)(1991-9#46)(1992-1#40)(1992-10#13)(1992-11#17)(1992-12#109)(1992-2#59)(1992-3#124)(1992-4#25)(1992-5#23)(1992-6#82)(1992-7#3)(1992-8#45)(1992-9#55)(1993-1#45)(1993-11#45)(1993-12#116)(1993-2#76)(1993-3#146)(1993-5#3)(1993-6#121)(1993-8#169)(1993-9#52)(1994-1#40)(1994-11#136)(1994-12#100)(1994-2#86)(1994-3#109)(1994-5#124)(1994-6#42)(1994-8#174)(1994-9#37)(1995-1#27)(1995-10#2)(1995-11#135)(1995-12#189)(1995-2#193)(1995-3#68)(1995-5#55)(1995-6#171)(1995-8#144)(1995-9#29)(1996-1#41)(1996-11#40)(1996-12#145)(1996-2#184)(1996-3#78)(1996-5#102)(1996-6#46)(1996-8#24)(1996-9#21)(1997-1#133)(1997-2#153)(1997-3#111)(1997-4#55)(1997-5#17)(1997-6#49)(1997-7#68)(1997-8#121)(1997-9#11)(2006-6#22)(2007-11#34)(2007-12#131)(2007-8#16)(2007-9#5)(2008-1#71)(2008-10#9630)(2008-11#1584)(2008-12#327)(2008-2#163)(2008-3#611)(2008-4#191)(2008-5#551)(2008-6#119)(2008-7#467)(2008-8#708)(2008-9#645)(2009-1#26)(2009-10#91)(2009-11#48)(2009-12#63)(2009-2#2)(2009-3#41)(2009-4#20)(2009-5#48)(2009-6#57)(2009-7#97)(2009-8#196)(2009-9#43)(2010-1#83)(2010-10#67)(2010-11#76)(2010-12#85)(2010-2#24)(2010-3#33)(2010-4#72)(2010-5#58)(2010-6#63)(2010-7#81)(2010-8#107)(2010-9#23)(2011-1#101)(2011-10#11)(2011-2#743)(2011-3#83)(2011-7#2)(2011-9#4)(2012-12#130)(2012-2#344)(2012-3#289)(2012-4#8)(2012-5#6)(2012-6#4)(2012-7#4)(2012-9#1)(2013-1#510)(2013-3#1)(2013-7#27)(2013-8#296)
by-pass grafts##3##2##(2011-2#3)
by-pass##4##1##(1997-3#1)(2011-2#3)
by-product of##8##2##(1994-12#1)(1994-3#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)
by-product##14##1##(1994-12#1)(1994-3#2)(1996-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)
by-products in drinking water##3##4##(2008-10#3)
by-products in##4##2##(2008-10#4)
by-products##22##1##(1990-11#1)(2008-10#12)(2008-11#2)(2008-9#4)(2010-4#1)(2011-2#2)
bypass for##3##2##(2008-7#2)(2011-2#1)
bypass graft surgery##5##3##(1993-12#1)(1995-2#1)(2008-11#1)(2012-12#1)(2013-8#1)
bypass graft##9##2##(1992-11#1)(1993-12#1)(1994-12#1)(1995-2#1)(2008-11#2)(2008-12#1)(2012-12#1)(2013-8#1)
bypass grafting##11##2##(1993-12#1)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#2)(2012-3#2)(2013-1#3)
bypass in##4##2##(1990-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
bypass is a##2##3##(1993-3#2)
bypass is##4##2##(1993-3#2)(2008-7#2)
bypass operations##2##2##(1990-2#1)(1993-3#1)
bypass procedures in##2##3##(1997-6#2)
bypass surgery and##2##3##(2009-10#1)(2012-2#1)
bypass surgery is##2##3##(2008-11#1)(2011-3#1)
bypass surgery##17##2##(1990-2#1)(1990-6#1)(2006-6#1)(2008-11#3)(2009-10#1)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#5)(2012-5#1)
bypass trapped-flow analysis system##2##4##(2008-10#2)
bypass was##2##2##(2011-3#1)(2012-3#1)
bypass with##2##2##(2008-7#1)(2013-1#1)
bypass##94##1##(1990-2#2)(1990-6#2)(1990-9#1)(1992-1#2)(1992-11#1)(1993-12#2)(1993-3#5)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#2)(2006-6#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#3)(2011-2#7)(2011-3#6)(2012-12#2)(2012-2#2)(2012-3#12)(2012-5#3)(2013-1#6)(2013-8#2)
bypassed##2##1##(2008-11#1)(2012-2#1)
bypasses the##2##2##(1994-8#1)(2008-11#1)
bypasses##6##1##(1991-3#1)(1994-8#1)(2008-11#1)(2011-3#2)(2013-8#1)
bypassing the##2##2##(2008-11#1)(2008-5#1)
bypassing##4##1##(1992-12#1)(1994-5#1)(2008-11#1)(2008-5#1)
bypivacain##4##1##(2012-3#4)
byproduct##2##1##(2008-11#1)(2008-7#1)
byproducts##2##1##(2008-11#1)(2009-12#1)
byssochlamic acid and##2##3##(2010-3#2)
byssoidea##6##1##(2008-10#6)
bystander effects##4##2##(2008-7#4)
bystander##6##1##(1997-1#1)(2008-7#4)(2013-8#1)
bystanders##2##1##(1994-12#1)(1996-5#1)
bénéficié##2##1##(2011-2#1)(2013-1#1)
c =##8##2##(1992-11#1)(1992-12#1)(1992-9#1)(1996-5#1)(2008-11#1)(2008-8#3)
c and##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
c is##2##2##(1990-5#1)(2008-10#1)
c molecule with##2##3##(2008-10#2)
c oxidase subunit##2##3##(2008-10#1)(2010-4#1)
c oxidase##9##2##(1995-2#2)(1997-7#4)(2008-10#1)(2008-6#1)(2010-4#1)
c release##3##2##(2010-3#2)(2011-2#1)
c was##4##2##(2008-11#4)
c##148##1##(1990-5#3)(1990-7#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#7)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-11#5)(1994-2#5)(1994-3#2)(1994-5#5)(1995-2#2)(1996-12#2)(1996-2#15)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#12)(1997-7#4)(2008-10#28)(2008-11#12)(2008-6#1)(2008-7#1)(2008-8#7)(2009-9#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-8#11)(2011-2#5)(2012-2#1)(2013-1#1)
c(6A)##4##1##(2009-10#4)
c(L##6##1##(2008-10#6)
c(L)=0##4##1##(2008-10#4)
c(i)(r)##3##1##(2012-2#3)
c) the##2##2##(1991-6#1)(2008-7#1)
c) was##2##2##(2008-10#1)(2011-2#1)
c)##12##1##(1990-6#1)(1991-6#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
c-Abl##5##1##(1995-8#5)
c-DIV for##2##2##(2008-10#2)
c-DIV##6##1##(2008-10#6)
c-FLIP expression##2##2##(2012-2#2)
c-FLIP is##2##2##(2012-2#2)
c-FLIP##11##1##(2009-9#1)(2011-2#1)(2012-2#9)
c-FLIP(L) and c-FLIP(S)##2##3##(2012-2#2)
c-FLIP(L)##3##1##(2012-2#3)
c-Fos##3##1##(1992-12#2)(1996-12#1)
c-Ha-ras##5##1##(1990-12#2)(1992-8#1)(2008-11#2)
c-Jun N-terminal##2##2##(1995-2#1)(2010-12#1)
c-Jun and c-Fos##2##3##(1992-12#2)
c-Jun and##3##2##(1992-12#2)(1995-2#1)
c-Jun expression and c-Jun/AP-1##2##4##(1995-12#2)
c-Jun expression##3##2##(1995-12#2)(1996-12#1)
c-Jun in##3##2##(1995-2#2)(1996-12#1)
c-Jun##22##1##(1992-12#2)(1995-12#3)(1995-2#12)(1996-12#4)(2010-12#1)
c-Jun/AP-1 activity##2##2##(1995-12#2)
c-Jun/AP-1##3##1##(1995-12#3)
c-KIT or##2##2##(2013-1#2)
c-KIT##4##1##(2013-1#4)
c-Ki-ras gene##3##2##(1992-8#3)
c-Ki-ras##4##1##(1992-8#4)
c-Kit##3##1##(2010-8#2)(2013-1#1)
c-MYC##2##1##(2012-2#2)
c-Met receptor in##2##3##(2011-2#2)
c-Met receptor##5##2##(2011-2#5)
c-Met##6##1##(2011-2#6)
c-Mil##3##1##(1995-2#3)
c-Mil/Raf##4##1##(1995-2#4)
c-Mpl##4##1##(2008-8#4)
c-Myc directly##2##2##(2013-1#2)
c-Myc is a##2##3##(2008-11#1)(2013-1#1)
c-Myc##23##1##(1994-9#2)(1997-8#2)(2008-11#4)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#12)
c-Raf-1##3##1##(1995-2#3)
c-Rel##4##1##(1993-9#3)(1995-6#1)
c-abl##2##1##(1995-8#2)
c-erbA alpha gene##4##3##(1993-3#4)
c-erbA alpha##5##2##(1993-3#5)
c-erbB-2 gene product associates with catenins##2##6##(1994-11#2)
c-erbB-2 gene product##4##3##(1994-11#4)
c-erbB-2 protein was##2##3##(1993-1#2)
c-erbB-2 protein##6##2##(1993-1#5)(1994-12#1)
c-erbB-2##11##1##(1993-1#5)(1994-11#4)(1994-12#1)(1997-8#1)
c-fos and c-jun##2##3##(1991-5#1)(1996-12#1)
c-fos and##5##2##(1991-5#1)(1996-12#2)(2008-9#2)
c-fos expression and##2##3##(1994-11#1)(1996-12#1)
c-fos expression in##2##3##(1994-11#1)(1997-2#1)
c-fos expression##7##2##(1994-11#3)(1996-12#1)(1997-2#1)(1997-3#2)
c-fos in the##2##3##(1997-2#1)(1997-3#1)
c-fos mRNA##4##2##(1993-1#1)(1996-12#3)
c-fos##24##1##(1991-5#1)(1993-1#1)(1994-11#3)(1996-12#10)(1997-2#3)(1997-3#3)(2008-11#1)(2008-9#2)
c-jun AS cells##2##3##(2008-11#2)
c-jun AS##4##2##(2008-11#4)
c-jun AS-SEAP cells##2##3##(2008-11#2)
c-jun AS-SEAP##3##2##(2008-11#3)
c-jun gene##3##2##(1995-8#1)(2008-11#2)
c-jun oncogene##2##2##(1995-8#2)
c-jun##22##1##(1991-5#1)(1995-8#6)(1996-12#3)(2008-11#11)(2008-7#1)
c-kit##4##1##(2008-11#1)(2008-9#1)(2009-7#1)(2010-12#1)
c-met##5##1##(1995-8#5)
c-myb##3##1##(1990-6#3)
c-myc allele on the##3##4##(1993-2#3)
c-myc and##4##2##(1990-12#1)(2008-8#2)(2008-9#1)
c-myc gene was##3##3##(1993-2#1)(1993-3#1)(2008-8#1)
c-myc gene##14##2##(1993-2#2)(1993-3#6)(2008-11#3)(2008-8#3)
c-myc mRNA##2##2##(1990-12#2)
c-myc were##2##2##(1993-2#1)(2008-5#1)
c-myc##49##1##(1990-12#3)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#11)(1993-3#7)(1993-8#1)(1994-9#1)(1995-9#1)(1997-7#1)(2008-11#12)(2008-5#3)(2008-8#5)(2008-9#1)
c-sis/PDGF-B##2##1##(2008-9#2)
c-src##3##1##(1990-12#2)(2008-8#1)
c-type##3##1##(1994-11#2)(1994-5#1)
c/ml##3##1##(2008-11#3)
c1/c1 genotype##4##2##(2008-8#4)
c3 and##2##2##(1994-5#2)
c3##7##1##(1994-5#7)
cAA-AM1##3##1##(1997-7#3)
cADPR##2##1##(1994-11#2)
cAMP accumulation##3##2##(1995-6#1)(1995-8#1)(1997-2#1)
cAMP and Ca(2+) signaling pathways##2##5##(2008-11#2)
cAMP and##6##2##(1993-6#1)(1994-8#1)(1996-12#1)(2008-11#2)(2009-10#1)
cAMP as##2##2##(1995-11#1)(1995-8#1)
cAMP content##3##2##(1995-8#1)(1997-1#1)(2008-8#1)
cAMP elevation##2##2##(1994-6#2)
cAMP formation in##2##3##(1995-12#1)(1997-2#1)
cAMP formation##5##2##(1992-4#1)(1995-11#1)(1995-12#2)(1997-2#1)
cAMP generation in##2##3##(1991-3#1)(1995-8#1)
cAMP in##4##2##(1994-11#2)(1997-2#1)(2010-1#1)
cAMP level and##2##3##(1994-8#1)(1995-8#1)
cAMP level##7##2##(1994-11#1)(1994-8#1)(1995-8#1)(2008-8#4)
cAMP levels in##2##3##(1995-8#1)(2008-10#1)
cAMP levels##6##2##(1995-8#4)(2008-10#2)
cAMP or##2##2##(1997-2#1)(2008-11#1)
cAMP pathway##6##2##(2008-11#6)
cAMP production by##3##3##(1991-3#1)(1997-2#1)(1997-4#1)
cAMP response element-binding##2##3##(2008-7#1)(2012-3#1)
cAMP response##3##2##(1995-8#1)(2008-7#1)(2012-3#1)
cAMP signaling##2##2##(2008-11#2)
cAMP was##2##2##(1991-3#1)(1997-2#1)
cAMP##100##1##(1991-3#5)(1992-4#1)(1992-6#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#5)(1994-6#4)(1994-8#5)(1995-11#8)(1995-12#2)(1995-6#6)(1995-8#14)(1996-12#1)(1996-2#3)(1997-1#1)(1997-2#11)(1997-4#1)(2008-10#3)(2008-11#12)(2008-7#2)(2008-8#7)(2009-10#1)(2010-1#1)(2012-3#1)
cAMP-dependent protein kinase (PKA)##3##4##(1993-3#1)(1994-11#1)(1995-2#1)
cAMP-dependent protein kinase A (PKA)##2##5##(1994-8#1)(2008-10#1)
cAMP-dependent protein kinase##8##3##(1990-2#1)(1990-8#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#2)(2008-10#1)
cAMP-dependent##11##1##(1990-2#1)(1990-8#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-8#2)(1995-2#2)(2008-10#1)
cAMP-mediated##3##1##(1992-6#1)(1994-8#1)(2012-2#1)
cAMP-response##2##1##(1994-11#1)(1996-2#1)
cAMP-specific phosphodiesterase##2##2##(1994-6#1)(1994-8#1)
cAMP-specific##3##1##(1993-6#1)(1994-6#1)(1994-8#1)
cAMP/PKA##2##1##(2009-8#1)(2013-7#1)
cDNA and deduced amino acid##2##5##(1992-10#1)(2008-11#1)
cDNA and genomic clones##5##4##(1993-6#1)(1995-6#1)(1996-12#1)(2008-10#1)(2010-5#1)
cDNA and genomic##6##3##(1993-6#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#1)(2010-5#1)
cDNA and its##2##3##(1995-11#1)(2008-6#1)
cDNA and the##3##3##(1990-8#2)(1995-6#1)
cDNA and##23##2##(1990-8#2)(1992-10#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-8#2)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2010-5#1)
cDNA array##5##2##(2008-10#1)(2008-9#4)
cDNA arrays##2##2##(2008-9#2)
cDNA as a probe##4##4##(1993-6#2)(1994-11#1)(1995-6#1)
cDNA as a##5##3##(1993-6#2)(1994-11#1)(1995-6#1)(2008-9#1)
cDNA as probe##2##3##(1995-6#1)(1996-12#1)
cDNA as##8##2##(1993-6#2)(1994-11#1)(1995-6#2)(1996-12#1)(2008-9#2)
cDNA by##5##2##(1993-12#1)(1997-2#2)(2008-9#1)(2010-5#1)
cDNA clone UDPGTh2##2##3##(2008-11#2)
cDNA clone encoding a##3##4##(1993-9#1)(1996-12#1)(1997-1#1)
cDNA clone encoding##7##3##(1993-12#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-9#1)
cDNA clone for##2##3##(1991-5#1)(1992-10#1)
cDNA clone from##2##3##(1990-7#1)(1995-8#1)
cDNA clone is##2##3##(1991-9#1)(2008-8#1)
cDNA clone of##4##3##(1997-3#1)(2008-10#2)(2008-8#1)
cDNA clone was##2##3##(1995-8#1)(2008-10#1)
cDNA clone which is##2##4##(1994-11#1)(2008-8#1)
cDNA clone##42##2##(1990-2#1)(1990-7#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-10#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#4)(1994-6#1)(1995-6#2)(1995-8#4)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-9#1)(2008-10#5)(2008-11#4)(2008-8#5)
cDNA clones and##3##3##(1993-2#1)(2008-9#1)(2010-4#1)
cDNA clones coding for##2##4##(1993-6#1)(1997-2#1)
cDNA clones coding##3##3##(1993-6#1)(1997-2#1)(2008-8#1)
cDNA clones encoding##3##3##(1990-8#1)(1991-6#1)(1997-2#1)
cDNA clones from human##4##4##(1995-8#1)(1996-2#2)(1996-8#1)
cDNA clones of human cell line KG-1##2##7##(1995-8#1)(1996-2#1)
cDNA clones of##6##3##(1995-8#1)(1996-2#1)(2008-10#4)
cDNA clones were isolated##3##4##(1990-8#1)(1992-3#1)(2008-8#1)
cDNA clones were obtained##2##4##(1996-8#1)(1997-7#1)
cDNA clones were##11##3##(1990-8#1)(1991-12#1)(1992-3#1)(1996-2#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-8#1)(2008-9#3)
cDNA clones will##2##3##(1996-8#1)(2008-11#1)
cDNA clones##63##2##(1990-8#3)(1991-12#1)(1991-6#2)(1992-10#1)(1992-3#1)(1993-2#1)(1993-6#2)(1995-2#1)(1995-8#3)(1996-12#2)(1996-2#5)(1996-8#5)(1997-2#3)(1997-7#1)(1997-8#3)(2008-10#8)(2008-11#9)(2008-8#3)(2008-9#8)(2010-4#1)
cDNA cloning and sequencing##2##4##(1990-5#1)(2008-10#1)
cDNA cloning and##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
cDNA cloning of##4##3##(1992-8#1)(1993-3#1)(1994-11#1)(2008-11#1)
cDNA cloning##10##2##(1990-5#2)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
cDNA coding for the##2##4##(1995-8#1)(1996-2#1)
cDNA coding for##7##3##(1991-9#1)(1992-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-2#1)
cDNA coding##8##2##(1991-9#1)(1992-3#2)(1993-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-2#1)
cDNA contained##2##2##(1991-5#1)(1997-7#1)
cDNA copies##2##2##(2008-10#2)
cDNA copy##2##2##(2008-10#2)
cDNA differential bands##2##3##(2008-8#2)
cDNA differential##3##2##(2008-8#3)
cDNA encoded a##2##3##(1993-8#1)(2010-5#1)
cDNA encoded##4##2##(1993-8#1)(1995-8#1)(2008-6#1)(2010-5#1)
cDNA encodes##2##2##(1991-7#1)(2008-6#1)
cDNA encoding a protein##2##4##(1994-6#1)(2008-9#1)
cDNA encoding a##7##3##(1994-6#1)(1995-11#1)(1997-1#1)(2008-8#2)(2008-9#2)
cDNA encoding bovine##2##3##(1993-2#2)
cDNA encoding human##6##3##(1995-6#1)(2008-11#1)(2008-8#4)
cDNA encoding phytoene##2##3##(1995-2#2)
cDNA encoding the human##2##4##(1993-8#1)(2008-5#1)
cDNA encoding the##12##3##(1993-3#2)(1993-6#2)(1993-8#2)(1995-11#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-5#2)
cDNA encoding##42##2##(1990-5#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#2)(1994-11#2)(1994-6#1)(1995-11#2)(1995-2#3)(1995-6#3)(1995-8#1)(1996-12#1)(1997-1#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#6)(2008-9#2)
cDNA expression library was##2##4##(2008-8#1)(2008-9#1)
cDNA expression library##4##3##(2008-8#2)(2008-9#2)
cDNA expression##9##2##(1990-5#1)(1993-12#1)(1995-12#2)(1997-9#1)(2008-8#2)(2008-9#2)
cDNA for a##4##3##(1993-6#1)(1995-2#1)(1997-8#1)(2010-5#1)
cDNA for rat##2##3##(1990-8#1)(1996-12#1)
cDNA for the rat##2##4##(1994-11#1)(1995-2#1)
cDNA for the##5##3##(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-9#1)
cDNA for##20##2##(1990-5#1)(1990-8#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-5#1)(2010-5#1)
cDNA fragment encoding##2##3##(1997-7#2)
cDNA fragment of##2##3##(2008-10#1)(2008-8#1)
cDNA fragment was##3##3##(2008-8#2)(2010-1#1)
cDNA fragment##15##2##(1991-5#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-8#7)(2008-9#2)(2010-1#1)
cDNA fragments and##2##3##(1996-2#2)
cDNA fragments containing##2##3##(2008-10#1)(2008-8#1)
cDNA fragments were##2##3##(2008-8#2)
cDNA fragments##10##2##(1996-2#2)(2008-10#1)(2008-8#6)(2008-9#1)
cDNA from human##2##3##(1991-6#1)(1993-3#1)
cDNA from##9##2##(1991-5#1)(1991-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(2008-10#1)(2008-8#1)
cDNA in the##5##3##(1995-6#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
cDNA in##11##2##(1993-6#1)(1995-6#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#1)
cDNA insert##2##2##(1990-7#1)(2008-11#1)
cDNA into##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
cDNA is##8##2##(1993-2#1)(1993-6#1)(2008-8#5)(2008-9#1)
cDNA libraries of##3##3##(1995-6#1)(1997-2#2)
cDNA libraries##13##2##(1995-6#1)(1996-12#1)(1996-8#2)(1997-2#4)(1997-4#1)(1997-6#2)(2008-10#1)(2008-11#1)
cDNA library and##5##3##(1994-11#1)(1997-7#1)(2008-8#2)(2011-2#1)
cDNA library by##5##3##(1993-2#1)(2008-11#2)(2008-8#1)(2008-9#1)
cDNA library derived from##3##4##(1990-8#1)(1992-9#1)(1993-6#1)
cDNA library from##2##3##(1993-3#1)(1993-6#1)
cDNA library of##2##3##(1994-11#1)(1995-8#1)
cDNA library screening and##2##4##(1991-9#1)(1996-2#1)
cDNA library was constructed##2##4##(2008-9#1)(2010-5#1)
cDNA library was screened using##4##5##(1992-3#1)(1992-6#1)(2008-10#1)(2008-8#1)
cDNA library was screened##7##4##(1990-8#1)(1992-3#1)(1992-6#1)(1994-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
cDNA library was##11##3##(1990-8#1)(1992-3#1)(1992-6#1)(1994-11#2)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-5#1)
cDNA library with##4##3##(1997-7#1)(2008-2#1)(2008-8#1)(2008-9#1)
cDNA library##62##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#6)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#5)(1997-2#1)(1997-6#1)(1997-7#3)(1997-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#8)(2008-9#5)(2010-5#1)(2011-2#1)
cDNA microarray##2##2##(2008-10#1)(2009-10#1)
cDNA microarrays##3##2##(2008-4#2)(2008-8#1)
cDNA of a##3##3##(2008-8#2)(2008-9#1)
cDNA of human##2##3##(1994-11#1)(1997-2#1)
cDNA of the##2##3##(2008-10#1)(2008-12#1)
cDNA of##18##2##(1994-11#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-12#2)(2008-8#5)(2008-9#2)(2010-5#2)
cDNA or##2##2##(1991-7#1)(2008-11#1)
cDNA probe##7##2##(1990-2#1)(1991-6#1)(1993-2#1)(2008-10#4)
cDNA probes to##3##3##(1993-2#1)(2008-10#2)
cDNA probes##8##2##(1992-6#1)(1993-2#1)(1994-11#1)(2008-10#4)(2008-8#1)
cDNA sequence and##3##3##(1991-5#1)(1991-6#1)(1993-3#1)
cDNA sequence as a##2##4##(1992-10#1)(1993-2#1)
cDNA sequence for##3##3##(1992-10#1)(1993-6#1)(2008-10#1)
cDNA sequence of the##2##4##(1990-8#1)(1993-3#1)
cDNA sequence of##3##3##(1990-8#1)(1993-3#1)(2008-10#1)
cDNA sequence##23##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-10#3)(1993-2#1)(1993-3#2)(1993-6#2)(1994-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-9#2)(2008-10#3)(2008-11#1)(2008-4#1)
cDNA sequences##10##2##(1992-6#1)(1993-6#1)(1993-8#2)(1996-12#1)(1996-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-5#1)
cDNA sequencing##4##2##(1991-6#1)(1994-11#1)(1997-6#1)(2008-10#1)
cDNA species##2##2##(1993-8#1)(1996-2#1)
cDNA synthesis and##2##3##(2008-8#2)
cDNA synthesis##6##2##(1997-2#2)(2008-11#1)(2008-8#2)(2008-9#1)
cDNA thus##2##2##(1991-5#1)(1993-8#1)
cDNA to the##2##3##(1995-2#1)(1997-1#1)
cDNA to##4##2##(1992-8#1)(1995-2#1)(1997-1#1)(2008-5#1)
cDNA using##2##2##(2008-4#1)(2008-9#1)
cDNA was cloned and##2##4##(1995-2#1)(1996-12#1)
cDNA was cloned##4##3##(1995-2#1)(1996-12#1)(2008-9#2)
cDNA was determined##2##3##(1993-12#1)(1997-7#1)
cDNA was isolated##2##3##(1992-3#1)(1995-12#1)
cDNA was obtained##2##3##(2008-10#1)(2008-9#1)
cDNA was used##2##3##(1997-1#1)(2008-10#1)
cDNA was##26##2##(1990-8#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-7#2)(1997-9#1)(2008-10#3)(2008-8#2)(2008-9#5)(2010-5#1)
cDNA were##4##2##(1993-12#1)(1995-2#1)(2010-5#2)
cDNA which encodes##2##3##(1993-8#1)(1995-6#1)
cDNA which##3##2##(1991-9#1)(1993-8#1)(1995-6#1)
cDNA##633##1##(1990-2#2)(1990-5#7)(1990-7#2)(1990-8#14)(1991-12#2)(1991-5#14)(1991-6#9)(1991-7#3)(1991-9#7)(1992-10#7)(1992-3#7)(1992-6#6)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#9)(1993-2#19)(1993-3#9)(1993-6#23)(1993-8#14)(1993-9#1)(1994-11#31)(1994-12#3)(1994-6#2)(1994-8#1)(1995-11#5)(1995-12#9)(1995-2#16)(1995-6#25)(1995-8#13)(1996-12#18)(1996-2#20)(1996-3#2)(1996-8#11)(1997-1#4)(1997-2#14)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#19)(1997-8#7)(1997-9#7)(2008-10#55)(2008-11#36)(2008-12#3)(2008-2#3)(2008-4#8)(2008-5#6)(2008-6#6)(2008-8#71)(2008-9#47)(2009-10#3)(2010-1#1)(2010-4#1)(2010-5#14)(2011-10#1)(2011-2#1)(2011-3#1)(2013-1#1)
cDNA-derived hypovirus RNA##2##3##(2008-10#2)
cDNA-specific##2##1##(1993-12#1)(1995-11#1)
cDNAclones##2##1##(2008-11#2)
cDNAs and##3##2##(1993-12#1)(1997-7#1)(2008-11#1)
cDNAs corresponding to the##2##4##(1993-12#1)(2008-10#1)
cDNAs corresponding to##3##3##(1993-12#2)(2008-10#1)
cDNAs derived from##4##3##(1990-8#1)(1993-12#1)(2008-10#1)(2008-8#1)
cDNAs encoding the alpha and beta subunits of##2##8##(1993-2#2)
cDNAs encoding the##3##3##(1993-12#1)(1993-2#2)
cDNAs encoding##6##2##(1991-6#1)(1993-12#2)(1993-2#2)(1993-6#1)
cDNAs for the##3##3##(1995-2#1)(2008-11#1)(2010-5#1)
cDNAs from##3##2##(1992-10#1)(1997-8#1)(2008-11#1)
cDNAs of##6##2##(1994-11#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-8#2)
cDNAs representing##2##2##(1991-7#1)(2008-10#1)
cDNAs that##3##2##(1991-12#1)(1993-6#1)(2008-10#1)
cDNAs were##6##2##(1993-8#2)(1995-8#1)(1997-8#3)
cDNAs with##2##2##(2008-11#1)(2008-8#1)
cDNAs##72##1##(1990-8#2)(1991-12#3)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1993-12#12)(1993-2#2)(1993-6#3)(1993-8#2)(1994-11#5)(1995-12#1)(1995-2#1)(1995-8#3)(1997-2#3)(1997-7#3)(1997-8#5)(2008-10#5)(2008-11#9)(2008-8#7)(2009-10#1)(2010-5#1)
cELISA##3##1##(2008-10#2)(2011-2#1)
cFIX##4##1##(2008-9#4)
cGMP and##2##2##(1995-8#1)(1997-1#1)
cGMP in##2##2##(1995-2#1)(1995-8#1)
cGMP levels##2##2##(1995-2#1)(2008-7#1)
cGMP may##2##2##(1995-8#2)
cGMP production##2##2##(1995-2#1)(2008-11#1)
cGMP##19##1##(1993-8#1)(1995-2#6)(1995-8#7)(1997-1#1)(2008-11#2)(2008-7#1)(2009-10#1)
cGMP-binding activity in##2##3##(1995-8#2)
cGMP-binding activity##3##2##(1995-8#3)
cGMP-binding in##2##2##(1995-8#2)
cGMP-binding##9##1##(1995-8#9)
cGy##4##1##(1991-8#1)(2008-10#1)(2008-7#1)(2009-11#1)
cGy) and##2##2##(1993-9#2)
cGy) are##2##2##(1993-9#2)
cGy)##12##1##(1993-9#12)
cITP##2##1##(2008-10#2)
cLBP##3##1##(2013-1#3)
cM and##5##2##(1997-2#1)(2008-10#1)(2008-9#3)
cM away from the##2##4##(2008-10#1)(2012-3#1)
cM away##3##2##(2008-10#2)(2012-3#1)
cM from a##2##3##(2008-10#2)
cM from fzp(t)##2##3##(2008-9#2)
cM from##8##2##(1995-9#1)(2008-10#4)(2008-8#1)(2008-9#2)
cM in the##2##3##(2008-10#2)
cM to##2##2##(2008-9#2)
cM##35##1##(1995-9#1)(1997-2#2)(2008-10#20)(2008-12#1)(2008-8#1)(2008-9#8)(2012-3#2)
cM) and##7##2##(2008-10#7)
cM) in##3##2##(2008-10#3)
cM) to##2##2##(2008-10#2)
cM)##24##1##(2008-10#24)
cMOAT##2##1##(2008-11#2)
cPLA2##2##1##(1993-6#1)(1994-11#1)
cPTH-(1-34) and cPTH-(1-88)##2##3##(1991-3#2)
cPTH-(1-34)##3##1##(1991-3#3)
cPTH-(1-88)##3##1##(1991-3#3)
cRNA##3##1##(1995-2#1)(1996-12#1)(2008-10#1)
cTR##6##1##(1991-6#6)
cTnI in##2##2##(2008-10#1)(2010-12#1)
cTnI##10##1##(2008-10#5)(2010-12#5)
cZi DBS##3##2##(2012-3#3)
cZi##5##1##(2012-3#5)
c[actin]5/2##2##1##(1993-8#2)
ca##65##1##(1993-8#1)(1994-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(2008-10#48)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#2)(2010-10#2)(2011-2#1)(2012-9#1)
cabbage (Brassica oleracea var##2##4##(2008-10#2)
cabbage and##3##2##(2008-10#3)
cabbage butterfly##3##2##(1997-8#2)(2008-8#1)
cabbage##27##1##(1990-8#2)(1997-8#2)(2008-10#17)(2008-7#1)(2008-8#4)(2011-3#1)
cabergoline##4##1##(2008-7#4)
cabin fires##2##2##(1996-12#2)
cabin length##2##2##(1996-12#2)
cabin smoke control##2##3##(1996-12#2)
cabin ventilation##2##2##(1996-12#2)
cabin##18##1##(1996-12#16)(2008-1#2)
cabinet##2##1##(2008-10#1)(2008-11#1)
cable in##2##2##(2008-9#1)(2009-3#1)
cable##17##1##(2008-10#1)(2008-11#1)(2008-9#7)(2009-3#5)(2010-9#2)(2012-12#1)
cables##2##1##(2008-9#1)(2010-9#1)
cacao isolates##2##2##(2008-10#2)
cacao##10##1##(2008-10#10)
cacao)##2##1##(2008-10#2)
cachectic##2##1##(1996-3#1)(2008-5#1)
caches##3##1##(2008-3#2)(2008-9#1)
cachexia and xyloporosis##2##3##(2008-10#2)
cachexia and##4##2##(2008-10#3)(2012-2#1)
cachexia##8##1##(2008-10#6)(2012-2#1)(2013-8#1)
cacodylate buffer##2##2##(2008-10#1)(2008-5#1)
cacti##4##1##(2008-10#3)(2008-9#1)
cactophilic Drosophila mojavensis##3##3##(2008-8#2)(2008-9#1)
cactorum and P##2##3##(2008-10#2)
cactorum##16##1##(2008-10#16)
cactus##8##1##(2008-10#6)(2008-8#1)(2008-9#1)
cadaver of##2##2##(2007-11#1)(2013-1#1)
cadaver##10##1##(1994-1#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-3#1)(2012-3#1)(2013-1#1)
cadaveric dissection##2##2##(2011-2#2)
cadaveric specimens##2##2##(2011-2#2)
cadaveric study##2##2##(2008-9#1)(2011-2#1)
cadaveric##14##1##(2008-9#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#8)(2013-1#1)
cadaverine##5##1##(1994-8#1)(2008-10#3)(2008-5#1)
cadavers##6##1##(1995-11#1)(2008-12#3)(2009-1#1)(2012-3#1)
cadence##2##1##(2008-12#1)(2010-9#1)
cadmium (II) and##3##3##(2008-10#3)
cadmium (II)##6##2##(2008-10#6)
cadmium and copper determination in##2##5##(2008-10#2)
cadmium and copper##6##3##(2008-10#6)
cadmium and lead in##10##4##(2008-10#10)
cadmium and lead##14##3##(2008-10#14)
cadmium and mercury are##2##4##(1994-3#1)(2008-10#1)
cadmium and mercury##6##3##(1994-3#1)(2008-10#5)
cadmium and nickel in##2##4##(2008-10#2)
cadmium and nickel##6##3##(2008-10#5)(2009-12#1)
cadmium and##45##2##(1994-3#1)(1994-6#1)(2008-10#41)(2008-11#1)(2009-12#1)
cadmium are##3##2##(2008-10#3)
cadmium at##3##2##(2008-10#3)
cadmium by##3##2##(2008-10#3)
cadmium chloride##2##2##(1990-5#1)(2008-11#1)
cadmium complex##2##2##(2008-10#2)
cadmium concentration##2##2##(2008-10#2)
cadmium content in##2##3##(1993-12#1)(2008-10#1)
cadmium determination in##5##3##(2008-10#5)
cadmium determination##8##2##(2008-10#8)
cadmium from##3##2##(2008-10#3)
cadmium in drug samples by##2##5##(2008-10#2)
cadmium in seawater##2##3##(2008-10#2)
cadmium in the##4##3##(1993-12#1)(2008-10#2)(2008-12#1)
cadmium in##35##2##(1993-12#1)(2008-10#33)(2008-12#1)
cadmium ions##5##2##(2008-10#5)
cadmium is##3##2##(2008-10#3)
cadmium reductor##4##2##(2008-10#4)
cadmium salts##2##2##(2008-10#2)
cadmium using##3##2##(2008-10#3)
cadmium was##3##2##(2008-10#3)
cadmium were##3##2##(1993-12#1)(2008-10#2)
cadmium with##2##2##(2008-10#2)
cadmium##228##1##(1990-5#1)(1993-12#7)(1994-3#1)(1994-6#2)(2008-10#210)(2008-11#5)(2008-12#1)(2009-12#1)
cadmium(II) and zinc(II)##3##3##(1991-5#2)(2008-10#1)
cadmium(II) and##7##2##(1991-5#3)(2008-10#4)
cadmium(II) in aqueous##2##3##(2008-10#2)
cadmium(II) with##2##2##(2008-10#2)
cadmium(II)##34##1##(1991-5#4)(2008-10#30)
cadmium-induced lethality##2##2##(1993-12#2)
cadmium-induced##3##1##(1993-12#3)
caecal microflora##4##2##(1993-8#4)
caecal##7##1##(1993-8#5)(2008-5#2)
caeruloplasmin##2##1##(1993-2#2)
caesarean section##8##2##(1994-3#2)(2011-1#1)(2011-2#3)(2013-1#2)
caesarean sections##3##2##(1994-3#2)(2008-11#1)
caesarean##14##1##(1993-12#1)(1994-3#4)(1995-12#1)(2008-11#1)(2011-1#1)(2011-2#3)(2013-1#3)
cafeteria diet control##2##3##(2013-1#2)
cafeteria diet##6##2##(2013-1#6)
cafeteria##10##1##(1992-1#3)(1996-2#1)(2013-1#6)
caffeic acid and##3##3##(2008-10#2)(2013-1#1)
caffeic acid##18##2##(2008-10#9)(2008-11#5)(2008-5#1)(2013-1#3)
caffeic and quinic acids##3##4##(2008-11#3)
caffeic and##4##2##(2008-11#4)
caffeic##25##1##(2008-10#12)(2008-11#9)(2008-5#1)(2013-1#3)
caffeine (CF)##2##2##(2008-10#2)
caffeine and nicotine in##3##4##(2009-7#3)
caffeine and nicotine##4##3##(2009-7#4)
caffeine and non-steroidal anti-inflammatory drugs##2##5##(2008-10#2)
caffeine and##9##2##(2008-10#4)(2009-7#5)
caffeine in##7##2##(1995-8#1)(1996-5#1)(2008-10#5)
caffeine sensor##2##2##(2008-10#2)
caffeine solution was##2##3##(2008-10#2)
caffeine to##2##2##(1995-8#1)(2008-10#1)
caffeine##60##1##(1990-2#1)(1991-1#3)(1992-7#1)(1995-11#5)(1995-8#7)(1996-5#2)(2008-10#29)(2008-5#1)(2008-8#1)(2009-7#6)(2010-9#2)(2011-2#1)(2013-1#1)
café##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
caféine##2##1##(2013-1#2)
cagA-/vacA+##2##1##(2008-12#2)
cage compounds##2##2##(1996-5#2)
cage to##2##2##(2008-11#1)(2010-5#1)
cage##17##1##(1994-8#1)(1996-5#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-5#2)
caged with##3##2##(2008-10#3)
caged##9##1##(1995-2#1)(2008-10#4)(2008-8#1)(2009-3#2)(2010-4#1)
cages (PVC pipe##2##3##(2008-10#2)
cages were##4##2##(2008-10#4)
cages##16##1##(1993-6#1)(1996-3#1)(1996-5#3)(2008-10#10)(2008-7#1)
cajani##2##1##(2008-10#2)
cakes##6##1##(2012-2#6)
calamity##2##1##(2008-10#2)
calbindin##2##1##(1994-2#1)(2013-8#1)
calcaneal intraosseous lipoma##2##3##(2010-3#2)
calcaneal intraosseous lipomas##2##3##(2010-3#2)
calcaneal intraosseous##4##2##(2010-3#4)
calcaneal##8##1##(2010-3#7)(2012-2#1)
calcaneo-valgus foot##2##2##(2010-3#2)
calcaneo-valgus##3##1##(2010-3#3)
calcaneocuboid joint##2##2##(2009-10#2)
calcaneocuboid##3##1##(2009-10#2)(2012-2#1)
calcar loading and##2##3##(2009-4#2)
calcareous soil##3##2##(2012-6#2)(2012-9#1)
calcareous##9##1##(1990-11#1)(2012-6#5)(2012-9#3)
calcein##6##1##(1994-11#2)(2008-10#4)
calcemia levels##2##2##(1990-9#2)
calcific aortic##2##2##(2008-12#1)(2012-2#1)
calcific##5##1##(1992-2#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
calcification and##3##2##(1990-3#1)(2010-3#1)(2012-3#1)
calcification in##3##2##(2008-7#1)(2010-3#1)(2012-12#1)
calcification of the falx cerebri##2##5##(1997-3#2)
calcification of the##4##3##(1990-11#2)(1997-3#2)
calcification of##5##2##(1990-11#2)(1997-3#2)(2012-12#1)
calcification##25##1##(1990-11#3)(1990-3#1)(1990-6#1)(1991-9#1)(1997-3#2)(2008-7#2)(2009-1#2)(2010-3#2)(2010-6#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
calcifications within the##2##3##(2011-2#2)
calcifications##16##1##(1996-3#1)(1997-8#6)(2008-12#1)(2009-12#1)(2011-2#4)(2012-12#2)(2012-2#1)
calcified nodules##2##2##(2008-11#1)(2012-12#1)
calcified tissues##4##2##(1991-2#1)(2008-11#3)
calcified##19##1##(1991-2#1)(1991-3#1)(2008-10#1)(2008-11#5)(2009-7#2)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
calcifying##2##1##(1991-11#1)(1997-6#1)
calcination in##2##2##(2008-10#2)
calcination##3##1##(2008-10#3)
calcined at##3##2##(2008-10#3)
calcineurin##7##1##(1991-9#3)(2008-9#2)(2011-3#1)(2012-3#1)
calciotrophic hormones##4##2##(1990-11#4)
calcite##10##1##(1990-11#1)(2008-10#9)
calcitonin and##2##2##(1990-2#1)(1992-6#1)
calcitonin binding sites##2##3##(1990-2#2)
calcitonin gene##2##2##(1990-2#2)
calcitonin gene-related peptide (CGRP)##2##4##(1997-3#1)(1997-4#1)
calcitonin gene-related peptide##16##3##(1992-6#10)(1994-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(2013-8#1)
calcitonin gene-related##18##2##(1992-6#10)(1994-8#2)(1997-1#1)(1997-3#3)(1997-4#1)(2013-8#1)
calcitonin##35##1##(1990-2#8)(1990-9#1)(1992-6#15)(1994-8#2)(1997-1#1)(1997-3#3)(1997-4#2)(2008-4#2)(2013-8#1)
calcitonin/CGRP gene##2##2##(1992-6#2)
calcitonin/alpha-CGRP and beta-CGRP genes##3##4##(1992-6#3)
calcitonin/alpha-CGRP##6##1##(1992-6#6)
calcitriol##2##1##(1993-3#1)(2011-1#1)
calcium (0##2##2##(1993-11#1)(1994-3#1)
calcium (Ca)##3##2##(1995-8#1)(2011-1#2)
calcium (Ca2+)##2##2##(1991-1#1)(1996-12#1)
calcium alginate##2##2##(2008-5#1)(2013-1#1)
calcium and cadmium##3##3##(2008-10#3)
calcium and filamentous actin##2##4##(1994-6#2)
calcium and magnesium in water samples##2##6##(2008-10#2)
calcium and magnesium in##6##4##(2008-10#6)
calcium and magnesium ions##3##4##(2008-10#3)
calcium and magnesium##18##3##(1991-5#1)(2008-10#17)
calcium and pH##2##3##(1990-2#2)
calcium and phosphorus##2##3##(2008-10#1)(2013-1#1)
calcium and potassium##2##3##(1996-2#1)(2008-10#1)
calcium and##49##2##(1990-2#4)(1990-5#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#2)(1996-2#1)(1997-8#2)(2008-10#27)(2010-11#1)(2013-1#1)(2013-8#2)
calcium antagonists##7##2##(1990-6#1)(1991-8#2)(1995-12#1)(2008-10#1)(2008-7#2)
calcium are##2##2##(2008-10#1)(2009-8#1)
calcium ascorbate##2##2##(2008-5#2)
calcium binding to##2##3##(2008-10#1)(2013-8#1)
calcium binding##6##2##(2008-10#4)(2009-4#1)(2013-8#1)
calcium can##2##2##(1994-3#1)(2008-9#1)
calcium carbonate and##2##3##(2011-2#2)
calcium carbonate polymorphs##2##3##(2008-10#2)
calcium carbonate##19##2##(1990-11#1)(2008-10#9)(2008-7#1)(2011-2#7)(2012-12#1)
calcium channel antagonists##2##3##(1994-11#1)(2008-10#1)
calcium channel blocker##4##3##(1996-5#1)(2008-5#1)(2008-7#2)
calcium channel blockers (CCB)##2##4##(2008-10#1)(2008-7#1)
calcium channel blockers##11##3##(1994-8#1)(1996-6#2)(2008-10#3)(2008-11#3)(2008-7#1)(2012-12#1)
calcium channel##22##2##(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-5#1)(1996-6#2)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#3)(2012-12#2)(2013-1#1)
calcium channels##7##2##(1993-6#1)(1996-2#1)(1997-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
calcium chelator##2##2##(2008-10#1)(2008-8#1)
calcium chloride##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)
calcium concentration ([Ca2+]i)##3##3##(1990-5#1)(1992-6#2)
calcium concentration in biological##2##4##(2008-10#1)(2013-8#1)
calcium concentration in##8##3##(1992-6#1)(1994-11#1)(1995-2#1)(2008-10#4)(2013-8#1)
calcium concentration##23##2##(1990-5#1)(1991-12#1)(1992-6#3)(1994-11#1)(1994-3#3)(1995-2#2)(1995-8#3)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
calcium concentrations##4##2##(1993-6#1)(1994-8#1)(2009-8#1)(2011-2#1)
calcium content##2##2##(2008-10#2)
calcium flux##2##2##(1991-1#1)(2008-9#1)
calcium for##2##2##(2008-10#1)(2008-8#1)
calcium homeostasis##3##2##(2008-11#1)(2010-10#1)(2012-2#1)
calcium hydroxide##6##2##(2008-10#2)(2013-1#4)
calcium hydroxylapatite##4##2##(2008-10#4)
calcium in the##4##3##(1991-2#1)(1994-3#1)(2008-10#1)(2010-12#1)
calcium in##12##2##(1991-12#1)(1991-2#1)(1993-6#1)(1994-3#1)(2008-1#1)(2008-10#5)(2008-8#1)(2010-12#1)
calcium indicators##3##2##(1991-5#1)(2008-4#2)
calcium influx##3##2##(1994-11#1)(1994-5#1)(2010-5#1)
calcium ion##4##2##(1990-5#1)(1993-8#1)(2010-8#1)(2013-8#1)
calcium ionophore A23187##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
calcium ionophore##9##2##(1990-12#1)(1994-11#1)(1995-11#2)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)
calcium ions##10##2##(1995-11#2)(1995-8#2)(2008-10#5)(2008-9#1)
calcium levels were##2##3##(1991-8#1)(2008-10#1)
calcium levels##5##2##(1991-5#1)(1991-8#1)(1997-1#1)(2008-10#1)(2008-12#1)
calcium mobilization##5##2##(1990-5#2)(1990-8#1)(1995-2#1)(2008-9#1)
calcium oscillations in##2##3##(1994-11#2)
calcium oscillations##3##2##(1994-11#3)
calcium overload##2##2##(1991-2#1)(2011-2#1)
calcium oxalate stone formation##2##4##(1992-9#2)
calcium oxalate stone##3##3##(1991-12#1)(1992-9#2)
calcium oxalate##10##2##(1991-12#2)(1992-9#4)(1995-8#1)(2008-10#3)
calcium phosphate##3##2##(2008-10#2)(2008-2#1)
calcium release##3##2##(1993-8#1)(1994-11#1)(1994-8#1)
calcium removal##4##2##(2008-8#4)
calcium selective##2##2##(2008-10#2)
calcium signaling##2##2##(2008-11#1)(2009-6#1)
calcium signals##2##2##(1995-2#1)(1996-12#1)
calcium supplements##2##2##(2008-10#1)(2011-1#1)
calcium to##3##2##(1991-6#1)(1994-3#1)(2011-2#1)
calcium transients##2##2##(2008-8#2)
calcium uptake in##2##3##(1997-1#1)(2013-8#1)
calcium uptake##4##2##(1997-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
calcium were##2##2##(1995-8#1)(2008-10#1)
calcium with a single##2##4##(2008-10#2)
calcium with##4##2##(2008-10#4)
calcium##443##1##(1990-11#2)(1990-12#1)(1990-2#13)(1990-5#7)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#8)(1991-2#3)(1991-3#1)(1991-5#5)(1991-6#3)(1991-8#4)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#4)(1992-8#1)(1992-9#6)(1993-11#2)(1993-2#1)(1993-6#7)(1993-8#4)(1994-11#12)(1994-2#2)(1994-3#11)(1994-5#3)(1994-6#3)(1994-8#8)(1995-11#5)(1995-12#3)(1995-2#9)(1995-8#9)(1996-11#1)(1996-12#2)(1996-2#4)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#3)(1997-5#2)(1997-8#4)(2008-1#3)(2008-10#141)(2008-11#14)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#10)(2008-8#17)(2008-9#9)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#15)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#7)
calcium)##2##1##(2008-10#2)
calcium-based binders##3##2##(2012-12#3)
calcium-based##4##1##(2012-12#4)
calcium-binding protein##3##2##(2009-7#3)
calcium-binding##6##1##(1994-5#2)(1997-2#1)(2009-7#3)
calcium-channel blockers##6##2##(1994-8#1)(2008-11#1)(2008-7#2)(2009-6#2)
calcium-channel##7##1##(1994-8#1)(2008-11#2)(2008-7#2)(2009-6#2)
calcium-dependent##7##1##(1990-5#1)(1994-5#1)(1994-6#1)(1995-8#2)(2008-7#1)(2009-6#1)
calcium-independent##2##1##(1990-5#1)(1995-2#1)
calcium-mediated##2##1##(1994-11#1)(2011-2#1)
calcium-phosphate coating##2##2##(2009-7#2)
calcium-selective##3##1##(2008-10#3)
calcium-sensing receptor (CaSR)##2##3##(2008-11#2)
calcium-sensitive##2##1##(1994-2#1)(2008-10#1)
calcium/calmodulin-dependent kinase II##2##3##(1996-12#1)(2009-7#1)
calcium/calmodulin-dependent protein kinase II##7##4##(1995-2#2)(1996-2#3)(2008-8#2)
calcium/calmodulin-dependent protein kinase##8##3##(1990-8#1)(1995-2#2)(1996-2#3)(2008-8#2)
calcium/calmodulin-dependent signaling##2##2##(2008-10#2)
calcium/calmodulin-dependent##12##1##(1990-8#1)(1995-2#2)(1996-12#1)(1996-2#3)(2008-10#2)(2008-8#2)(2009-7#1)
calcium/phosphorus balance##2##2##(1991-11#2)
calculate the absorption##2##3##(2008-3#2)
calculate the##59##2##(1992-12#1)(1993-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#3)(2012-3#1)
calculate##89##1##(1991-11#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#32)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-8#2)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)
calculated SBLS spectra##2##3##(2008-2#2)
calculated a##3##2##(1992-9#1)(1995-2#1)(2008-3#1)
calculated after##3##2##(2007-8#1)(2008-10#1)(2009-5#1)
calculated and compared with##4##4##(2008-10#1)(2008-3#3)
calculated and compared##5##3##(2008-10#1)(2008-3#3)(2013-1#1)
calculated and discussed##2##3##(2008-10#2)
calculated and experimental##2##3##(2008-2#1)(2008-3#1)
calculated and the##7##3##(1994-8#1)(2008-10#4)(2008-3#1)(2013-8#1)
calculated and##30##2##(1994-8#1)(1995-3#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#7)(2011-2#2)(2013-1#1)(2013-8#1)
calculated are##2##2##(2008-10#1)(2012-2#1)
calculated as 3##2##3##(2008-10#1)(2011-2#1)
calculated as a function of##2##5##(2008-10#2)
calculated as a##3##3##(2008-10#2)(2008-5#1)
calculated as relative standard deviation (R##4##6##(2008-10#4)
calculated as the difference between total##2##6##(2008-10#2)
calculated as the difference between##4##5##(2008-10#4)
calculated as the difference##5##4##(2008-10#5)
calculated as the##8##3##(1991-6#1)(2008-10#6)(2008-7#1)
calculated as three times the standard deviation of the##2##9##(2008-10#2)
calculated as##29##2##(1991-6#1)(2008-10#21)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
calculated at##7##2##(2008-10#5)(2008-12#1)(2011-2#1)
calculated by difference##2##3##(2008-10#2)
calculated by the##9##3##(1992-12#1)(1993-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2011-3#1)
calculated by use of the##2##5##(2008-2#1)(2008-3#1)
calculated by use of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
calculated by using the##3##4##(2008-10#2)(2009-1#1)
calculated by##36##2##(1992-12#1)(1993-3#1)(1995-11#1)(2007-12#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2009-1#1)(2009-10#1)(2011-1#1)(2011-3#1)
calculated detection limit##3##3##(2008-10#3)
calculated detection limits##2##3##(2008-10#2)
calculated detection##5##2##(2008-10#5)
calculated for all##3##3##(2008-10#2)(2011-2#1)
calculated for each##10##3##(2008-10#7)(2010-3#1)(2011-2#1)(2013-1#1)
calculated for the##8##3##(1993-2#1)(1994-1#1)(2008-10#5)(2008-3#1)
calculated for##48##2##(1991-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-1#1)(1996-3#1)(1997-2#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#4)(2009-11#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
calculated from 10##2##3##(2008-10#2)
calculated from a##2##3##(2008-10#2)
calculated from kinetic data##2##4##(2008-10#2)
calculated from the difference##3##4##(2008-10#3)
calculated from the molecular##2##4##(2008-10#2)
calculated from the peak heights obtained##3##6##(2008-10#3)
calculated from the##35##3##(1992-2#1)(1995-3#1)(2008-10#23)(2008-11#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
calculated from##67##2##(1990-9#1)(1992-2#1)(1995-3#1)(1995-6#1)(2008-10#45)(2008-11#2)(2008-3#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-6#1)(2012-2#1)(2012-6#1)
calculated giving##2##2##(2008-10#2)
calculated in##8##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)(2012-12#2)
calculated molecular weight of##2##4##(1995-6#1)(2008-8#1)
calculated molecular##4##2##(1993-3#1)(1995-6#1)(1996-6#1)(2008-8#1)
calculated on a##2##3##(2008-10#1)(2008-9#1)
calculated on##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
calculated over##2##2##(2008-10#1)(2013-8#1)
calculated ratio##2##2##(2009-1#2)
calculated results##2##2##(2008-10#1)(2008-3#1)
calculated that##2##2##(2006-6#1)(2008-10#1)
calculated the##5##2##(1990-9#1)(1992-9#1)(1996-6#1)(2008-7#1)(2012-5#1)
calculated to be 0##2##4##(2008-10#2)
calculated to be 3##2##4##(2008-10#2)
calculated to be 4##3##4##(1993-1#1)(2008-10#2)
calculated to be##22##3##(1990-6#1)(1991-12#1)(1993-1#1)(1996-12#1)(1996-3#1)(2008-10#15)(2008-2#1)(2011-1#1)
calculated to evaluate the##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
calculated to##29##2##(1990-6#1)(1991-12#1)(1991-2#1)(1993-1#1)(1996-12#1)(1996-3#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#2)(2012-3#1)
calculated using the##13##3##(1992-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2011-2#1)(2011-3#1)
calculated using##26##2##(1992-12#2)(1994-12#1)(1994-9#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-8#2)(2009-3#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
calculated values derived##2##3##(2008-10#1)(2008-3#1)
calculated values of sensitivity##2##4##(2008-10#1)(2008-3#1)
calculated values of##3##3##(2008-10#1)(2008-3#2)
calculated values##5##2##(2008-10#2)(2008-3#3)
calculated with the##2##3##(2008-10#2)
calculated with##7##2##(2008-10#6)(2008-3#1)
calculated##504##1##(1990-11#1)(1990-5#3)(1990-6#1)(1990-9#4)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#4)(1993-1#1)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-2#1)(1997-4#2)(1997-5#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#269)(2008-11#14)(2008-12#5)(2008-2#10)(2008-3#43)(2008-5#5)(2008-7#6)(2008-8#7)(2008-9#4)(2009-1#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#17)(2011-3#3)(2012-12#7)(2012-2#4)(2012-3#4)(2012-5#1)(2012-6#1)(2013-1#5)(2013-8#7)
calculates the##3##2##(2008-10#2)(2008-7#1)
calculates##5##1##(1991-2#1)(2008-10#3)(2008-7#1)
calculating the average##3##3##(1993-3#1)(1996-8#1)(2008-10#1)
calculating the scattering##2##3##(2008-3#2)
calculating the##25##2##(1993-3#1)(1994-1#1)(1996-12#1)(1996-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#1)(2010-4#1)(2010-7#2)(2013-8#1)
calculating##43##1##(1991-3#1)(1992-12#1)(1993-3#1)(1994-1#1)(1995-9#1)(1996-12#1)(1996-8#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-8#1)(2010-4#1)(2010-7#2)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
calculation and##3##2##(2008-10#1)(2011-3#1)(2012-2#1)
calculation based on##2##3##(2008-5#1)(2010-10#1)
calculation is##3##2##(1996-6#1)(2007-12#1)(2008-12#1)
calculation method##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
calculation of a##3##3##(1992-12#1)(2008-10#2)
calculation of the minimum##2##4##(1996-3#1)(2008-10#1)
calculation of the##17##3##(1993-3#1)(1996-3#1)(1997-1#1)(2008-10#8)(2008-3#2)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
calculation of##43##2##(1992-12#1)(1993-3#1)(1994-9#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#23)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#2)(2013-1#2)
calculation results##2##2##(2008-10#1)(2013-1#1)
calculation skills in##2##3##(2008-11#2)
calculation skills##4##2##(2008-11#3)(2008-12#1)
calculation that##3##2##(1992-9#1)(2008-3#1)(2008-7#1)
calculation were##2##2##(1995-12#1)(2011-2#1)
calculation with##2##2##(1995-9#1)(2008-3#1)
calculation##98##1##(1992-12#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-12#2)(2008-10#33)(2008-11#6)(2008-12#8)(2008-2#4)(2008-3#12)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2010-10#1)(2010-12#2)(2011-2#4)(2011-3#2)(2012-2#1)(2013-1#4)
calculations and##2##2##(2008-10#2)
calculations are##4##2##(1996-5#1)(2008-10#2)(2009-5#1)
calculations at##2##2##(2008-10#1)(2008-12#1)
calculations can##2##2##(2008-11#1)(2008-3#1)
calculations confirm##2##2##(2008-6#1)(2009-5#1)
calculations for a##2##3##(2008-2#1)(2008-3#1)
calculations for##6##2##(2008-2#1)(2008-3#2)(2009-12#1)(2012-3#1)(2013-1#1)
calculations have been##2##3##(2008-11#1)(2008-3#1)
calculations indicate that the##2##4##(1991-6#1)(2008-2#1)
calculations indicate that##3##3##(1991-6#1)(2008-2#1)(2008-3#1)
calculations is not##2##3##(1996-5#1)(2008-3#1)
calculations is##3##2##(1996-5#1)(2008-11#1)(2008-3#1)
calculations made##2##2##(2008-10#2)
calculations of the##9##3##(1993-3#1)(1996-3#1)(2008-10#4)(2008-3#1)(2009-9#2)
calculations of##22##2##(1990-12#1)(1993-3#1)(1996-3#1)(2008-10#6)(2008-2#1)(2008-3#7)(2008-5#1)(2009-9#3)(2010-6#1)
calculations show that the##4##4##(2008-2#1)(2008-3#2)(2009-12#1)
calculations to##5##2##(2008-10#1)(2008-3#3)(2011-2#1)
calculations was##2##2##(2008-10#1)(2013-1#1)
calculations were##5##2##(1996-5#1)(2008-10#2)(2008-3#1)(2013-8#1)
calculations with##2##2##(2008-2#1)(2008-3#1)
calculations##123##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-9#1)(1993-3#3)(1994-5#1)(1996-3#1)(1996-5#6)(1997-6#1)(2008-10#40)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#26)(2008-5#1)(2008-6#1)(2009-12#3)(2009-5#3)(2009-7#1)(2009-9#3)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
calculator##5##1##(2008-11#5)
calculi and##2##2##(2008-1#1)(2008-10#1)
calculi##11##1##(1991-3#2)(1994-5#1)(1995-8#3)(2008-1#1)(2008-10#3)(2012-12#1)
calculus and##2##2##(2008-10#1)(2013-1#1)
calculus##7##1##(2008-10#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
caldesmon##7##1##(1993-8#1)(1994-5#6)
calendar instruments##4##2##(2010-1#4)
calendar time##3##2##(1992-9#1)(1994-9#1)(2008-8#1)
calendar year##4##2##(1991-2#1)(1995-12#1)(2012-2#1)(2013-1#1)
calendar years##3##2##(1991-2#2)(1994-6#1)
calendar##19##1##(1991-2#3)(1991-6#1)(1992-9#2)(1994-6#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-8#1)(2010-1#6)(2012-2#1)(2013-1#1)
calf serum##10##2##(1991-5#1)(1992-6#2)(1995-2#1)(2008-11#5)(2008-7#1)
calf spleen##2##2##(1994-8#2)
calf thymus DNA (ctDNA)##4##4##(2008-10#4)
calf thymus DNA and fish sperm DNA##2##7##(2008-10#2)
calf thymus DNA and##3##4##(2008-10#3)
calf thymus DNA##18##3##(1995-2#1)(2008-10#17)
calf thymus##19##2##(1995-2#1)(2008-10#18)
calf uterine##3##2##(1990-11#2)(1995-11#1)
calf##49##1##(1990-11#2)(1991-5#1)(1991-6#3)(1991-8#2)(1992-6#3)(1992-8#1)(1994-8#2)(1995-11#1)(1995-2#2)(1997-5#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)
calf-thymus DNA##2##2##(1991-5#2)
calgranulin##2##1##(2010-12#2)
caliber##4##1##(1992-1#1)(1993-1#1)(2008-9#2)
calibrate##8##1##(1990-2#1)(2008-10#1)(2008-3#2)(2008-9#2)(2009-12#1)(2012-2#1)
calibrated and##2##2##(2008-10#1)(2013-1#1)
calibrated by every 0##2##4##(2013-1#2)
calibrated by##4##2##(2008-10#2)(2013-1#2)
calibrated in the##3##3##(2008-10#3)
calibrated in##5##2##(2008-10#5)
calibrated with a##3##3##(2008-10#1)(2008-3#2)
calibrated with##5##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#2)
calibrated##35##1##(1990-2#1)(1993-3#1)(1993-6#1)(1997-2#2)(2006-6#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-3#4)(2008-5#1)(2009-11#1)(2009-12#1)(2012-2#1)(2013-1#3)
calibrating##4##1##(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#1)
calibration against aqueous standards##2##4##(2008-10#2)
calibration against aqueous##3##3##(2008-10#3)
calibration against##4##2##(2008-10#4)
calibration and shading correction##2##4##(2008-9#2)
calibration and##21##2##(2008-10#15)(2008-11#1)(2008-3#1)(2008-9#2)(2013-1#2)
calibration applied to##2##3##(2008-10#2)
calibration approach##4##2##(2008-10#4)
calibration approaches##4##2##(2008-10#3)(2009-12#1)
calibration are##2##2##(2008-10#2)
calibration by every 0##2##4##(2013-1#2)
calibration by##7##2##(2008-10#5)(2013-1#2)
calibration can be##3##3##(2008-10#2)(2008-3#1)
calibration curve and##2##3##(2008-10#2)
calibration curve by##5##3##(2008-10#4)(2008-9#1)
calibration curve for##6##3##(2008-10#6)
calibration curve in the range##3##5##(2008-10#3)
calibration curve in the##4##4##(2008-10#4)
calibration curve in##5##3##(2008-10#5)
calibration curve is linear from##2##5##(2008-10#2)
calibration curve is linear in the##2##6##(2008-10#2)
calibration curve is linear over a range of##3##8##(2008-10#3)
calibration curve is linear over the concentration range 0##3##9##(2008-10#3)
calibration curve is linear over the##4##6##(2008-10#4)
calibration curve is linear over##8##5##(2008-10#8)
calibration curve is linear##14##4##(2008-10#14)
calibration curve is##18##3##(2008-10#18)
calibration curve of##4##3##(2008-10#4)
calibration curve over the range of 0##2##7##(2008-10#2)
calibration curve systems##2##3##(2008-10#2)
calibration curve was 0##3##4##(2008-10#3)
calibration curve was constructed##2##4##(2008-10#2)
calibration curve was linear in the concentration range##2##8##(2008-10#2)
calibration curve was linear in the##4##6##(2008-10#4)
calibration curve was linear over the concentration range##5##8##(2008-10#5)
calibration curve was linear over the range 0##2##8##(2008-10#2)
calibration curve was linear over the range##4##7##(2008-10#4)
calibration curve was linear over the##9##6##(2008-10#9)
calibration curve was linear over##10##5##(2008-10#10)
calibration curve was linear##19##4##(2008-10#19)
calibration curve was obtained in##2##5##(2008-10#2)
calibration curve was obtained with##2##5##(2008-10#2)
calibration curve was obtained##6##4##(2008-10#6)
calibration curve was##36##3##(2008-10#35)(2012-2#1)
calibration curve with a##2##4##(2008-10#2)
calibration curve with##4##3##(2008-10#4)
calibration curve##106##2##(1991-5#1)(2008-10#102)(2008-9#1)(2012-2#1)(2013-8#1)
calibration curves are##3##3##(2008-10#3)
calibration curves for##3##3##(2008-10#3)
calibration curves in the##2##4##(2008-10#2)
calibration curves in##4##3##(2008-10#2)(2010-11#2)
calibration curves of##3##3##(2008-10#3)
calibration curves showed good##2##4##(2008-10#2)
calibration curves showed##3##3##(2008-10#3)
calibration curves were##12##3##(2008-10#12)
calibration curves##46##2##(2008-10#43)(2009-8#1)(2010-11#2)
calibration data##2##2##(2008-10#1)(2010-3#1)
calibration dependencies##2##2##(2008-10#2)
calibration equation##2##2##(2008-10#2)
calibration equations##2##2##(2008-10#2)
calibration established##2##2##(2008-10#2)
calibration experiments##2##2##(2008-10#1)(2008-3#1)
calibration for each##2##3##(2008-10#2)
calibration for the##8##3##(2008-10#5)(2008-2#2)(2008-9#1)
calibration for##13##2##(2008-10#7)(2008-11#1)(2008-2#3)(2008-9#2)
calibration function##4##2##(2008-10#4)
calibration graph for the determination of##2##6##(2008-10#2)
calibration graph for##7##3##(2008-10#7)
calibration graph is linear in the range of##4##8##(2008-10#4)
calibration graph is linear in the range##5##7##(2008-10#5)
calibration graph is linear over the range##3##7##(2008-10#3)
calibration graph is linear over the##4##6##(2008-10#4)
calibration graph is linear up to##2##6##(2008-10#2)
calibration graph is linear##11##4##(2008-10#11)
calibration graph is##17##3##(2008-10#17)
calibration graph was linear from##6##5##(2008-10#6)
calibration graph was linear in the range 0##3##8##(2008-10#3)
calibration graph was linear in the range of##4##8##(2008-10#4)
calibration graph was linear in the range##10##7##(2008-10#10)
calibration graph was linear in the##13##6##(2008-10#13)
calibration graph was linear over the range##4##7##(2008-10#4)
calibration graph was linear up to##4##6##(2008-10#4)
calibration graph was linear##28##4##(2008-10#28)
calibration graph was obtained over the##3##6##(2008-10#3)
calibration graph was obtained##14##4##(2008-10#14)
calibration graph was##44##3##(2008-10#44)
calibration graph##92##2##(2008-10#92)
calibration graphs based on##2##4##(2008-10#2)
calibration graphs obtained##2##3##(2008-10#2)
calibration graphs of##2##3##(2008-10#2)
calibration graphs were linear in the concentration ranges of##2##9##(2008-10#2)
calibration graphs were linear in the concentration##3##7##(2008-10#3)
calibration graphs were linear in the range of##3##8##(2008-10#3)
calibration graphs were linear in the##6##6##(2008-10#6)
calibration graphs were linear over the##2##6##(2008-10#2)
calibration graphs were linear##11##4##(2008-10#11)
calibration graphs were obtained in the range##2##7##(2008-10#2)
calibration graphs were obtained over the##3##6##(2008-10#3)
calibration graphs were obtained##10##4##(2008-10#10)
calibration graphs were##28##3##(2008-10#28)
calibration graphs with##2##3##(2008-10#2)
calibration graphs##55##2##(2008-10#55)
calibration has been##2##3##(2008-10#1)(2008-6#1)
calibration in the##6##3##(2008-10#6)
calibration in##12##2##(2008-10#12)
calibration is##6##2##(2008-10#4)(2008-6#1)(2010-3#1)
calibration line##4##2##(2008-10#4)
calibration lines##3##2##(2008-10#3)
calibration matrix was##3##3##(2008-10#3)
calibration matrix were##2##3##(2008-10#2)
calibration matrix##12##2##(2008-10#12)
calibration method based on##3##4##(2008-10#3)
calibration method is##3##3##(2008-10#3)
calibration method was##2##3##(2008-10#2)
calibration method with##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
calibration method##20##2##(2008-10#17)(2008-3#1)(2008-9#1)(2010-3#1)
calibration methodology##2##2##(2008-10#2)
calibration methods such as##2##4##(2008-10#2)
calibration methods to##3##3##(2008-10#3)
calibration methods##20##2##(2008-10#20)
calibration model for##3##3##(2008-10#3)
calibration model was obtained##2##4##(2008-10#2)
calibration model##23##2##(2008-10#23)
calibration models##8##2##(2008-10#8)
calibration of a dynamic surface tension detector##2##7##(2008-10#2)
calibration of a##5##3##(2008-10#5)
calibration of mixtures##2##3##(2008-10#2)
calibration of the##11##3##(1991-5#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-9#1)(2010-3#1)
calibration of##28##2##(1991-5#1)(2008-10#20)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-3#1)
calibration parameters##5##2##(1995-9#3)(2008-3#2)
calibration plot is##2##3##(2008-10#2)
calibration plot of##4##3##(2008-10#4)
calibration plot##12##2##(2008-10#12)
calibration plots are##2##3##(2008-10#2)
calibration plots for##4##3##(2008-10#4)
calibration plots##16##2##(2008-10#16)
calibration precision limits##2##3##(2008-10#2)
calibration procedure for##2##3##(2008-10#2)
calibration procedure##6##2##(2008-10#5)(2008-3#1)
calibration range for##2##3##(2008-10#2)
calibration range of##4##3##(2008-10#4)
calibration range was##7##3##(2008-10#7)
calibration range##27##2##(2008-10#26)(2009-8#1)
calibration ranges for##2##3##(1995-3#1)(2008-10#1)
calibration ranges##4##2##(1995-3#1)(2008-10#3)
calibration rate##2##2##(2013-1#2)
calibration recovery##3##2##(2008-10#3)
calibration samples##2##2##(2008-10#2)
calibration set and##2##3##(2008-10#2)
calibration set was composed##3##4##(2008-10#3)
calibration set was##5##3##(2008-10#5)
calibration set##13##2##(2008-10#13)
calibration slope of##2##3##(2008-10#2)
calibration solutions##4##2##(2008-10#4)
calibration standards##6##2##(2008-10#6)
calibration straight lines##2##3##(2008-10#2)
calibration strategy##2##2##(2008-10#2)
calibration technique##10##2##(2008-10#8)(2008-2#1)(2008-6#1)
calibration techniques##2##2##(2008-10#2)
calibration that##2##2##(2008-3#1)(2008-9#1)
calibration using a##2##3##(2008-10#2)
calibration using##3##2##(2008-10#3)
calibration was accomplished##2##3##(2008-10#2)
calibration was applied to##2##4##(2008-10#2)
calibration was obtained##3##3##(2008-10#3)
calibration was##17##2##(2008-10#16)(2008-7#1)
calibration with aqueous standards##2##4##(2008-10#2)
calibration with##9##2##(2008-10#8)(2008-6#1)
calibration without##2##2##(2008-10#2)
calibration##801##1##(1991-5#2)(1995-3#1)(1995-9#3)(2008-10#728)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#15)(2008-4#2)(2008-6#6)(2008-7#2)(2008-9#11)(2009-12#1)(2009-8#2)(2010-11#3)(2010-3#4)(2011-2#1)(2012-2#1)(2013-1#7)(2013-8#1)
calibration)##2##1##(2008-10#2)
calibrations for##3##2##(2008-10#3)
calibrations of##2##2##(2008-10#2)
calibrations were##4##2##(2008-10#4)
calibrations##26##1##(2008-10#23)(2008-2#1)(2008-3#1)(2012-2#1)
calibrator##6##1##(2008-10#6)
calibre##3##1##(1997-3#1)(2008-7#1)(2011-2#1)
calico mosaic virus##3##3##(2008-10#3)
california##6##1##(1990-11#1)(2008-10#5)
californica nuclear polyhedrosis virus##6##4##(1994-11#1)(1995-12#1)(2008-11#1)(2008-7#2)(2008-8#1)
californica##14##1##(1993-12#2)(1994-11#1)(1995-12#2)(1997-3#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)
californica)##3##1##(2008-10#2)(2008-7#1)
calix(6)arene##2##1##(2008-10#2)
calix[4]arene and##3##2##(2008-10#3)
calix[4]arene dibenzocrown##2##2##(2008-10#2)
calix[4]arene##16##1##(1996-5#2)(2008-10#14)
calix[4]arene/hydroxy-terminated silicone##2##2##(2008-10#2)
calix[4]arenes##3##1##(1996-5#2)(2008-10#1)
calix[4]crown ether-ester##2##2##(2008-10#2)
calix[4]crown-5-azacrown-5##2##1##(2008-10#2)
calix[6]arene tetraester I##2##3##(2008-10#2)
calix[6]arene tetraester##3##2##(2008-10#3)
calix[6]arene##4##1##(2008-10#4)
calixarene hydroxamic acid##2##3##(2008-10#2)
calixarene##5##1##(2008-10#5)
calixcrown ethers##2##2##(2008-10#2)
calixcrown##3##1##(2008-10#3)
call attention to the##2##4##(2008-11#1)(2008-12#1)
call backs##2##2##(2010-8#2)
call for a##2##3##(1997-1#1)(2008-10#1)
call for the##2##3##(2008-10#1)(2008-12#1)
call for##17##2##(1993-3#1)(1995-8#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2009-10#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
call has##2##2##(2008-8#1)(2008-9#1)
call the##2##2##(2008-7#1)(2012-12#1)
call to action##2##3##(1992-2#1)(2009-5#1)
call to##5##2##(1991-3#1)(1992-2#1)(2007-12#1)(2009-11#1)(2009-5#1)
call##53##1##(1991-3#1)(1992-2#1)(1993-3#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-1#1)(2010-2#3)(2010-8#3)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
called &quot##18##2##(1992-12#1)(1992-3#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2010-4#1)(2011-2#3)(2011-3#1)(2011-7#1)(2013-1#1)
called a##5##2##(2008-10#2)(2008-9#2)(2009-10#1)
called for##5##2##(2008-11#2)(2010-6#1)(2011-2#1)(2013-8#1)
called in##3##2##(1991-2#1)(2008-4#1)(2008-5#1)
called the##15##2##(1991-2#1)(1993-2#1)(1994-12#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)
called upon to develop##2##4##(2008-11#1)(2008-12#1)
called upon to##8##3##(1992-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)
called##170##1##(1990-5#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#33)(2008-11#10)(2008-12#4)(2008-3#2)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#9)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#13)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#6)
calli and##3##2##(2008-12#1)(2008-9#2)
calli of##2##2##(2008-12#1)(2008-9#1)
calli##9##1##(2008-12#2)(2008-8#2)(2008-9#5)
calligraphies and traditional Chinese paintings##2##5##(2008-10#2)
calling for##2##2##(1997-2#1)(2008-8#1)
calling##9##1##(1995-8#1)(1997-2#1)(2008-4#3)(2008-8#2)(2010-11#1)(2013-8#1)
callitrichid##2##1##(2012-3#2)
callose wall##2##2##(2011-2#2)
callose##9##1##(2008-10#7)(2011-2#2)
callose-enriched wall appositions##2##3##(2008-10#2)
calls and##2##2##(1992-8#1)(1994-8#1)
calls by##2##2##(2008-8#2)
calls for a##2##3##(1993-1#1)(1996-12#1)
calls for the##4##3##(1994-1#1)(2008-1#1)(2008-11#1)(2011-1#1)
calls for##17##2##(1991-3#1)(1993-1#1)(1994-1#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#1)
calls had##2##2##(2008-9#2)
calls in##2##2##(2008-8#1)(2011-2#1)
calls on the##2##3##(2008-11#1)(2010-11#1)
calls to##2##2##(1991-3#1)(2008-8#1)
calls##48##1##(1991-3#2)(1992-8#1)(1993-1#1)(1994-1#1)(1994-3#1)(1994-8#5)(1996-12#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-6#1)(2008-8#9)(2008-9#3)(2009-10#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
callus##17##1##(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#7)
calmagite##5##1##(2008-10#5)
calmodulin (CaM)##2##2##(1994-3#1)(2008-8#1)
calmodulin and##5##2##(1990-5#1)(1993-6#1)(1995-11#2)(2008-8#1)
calmodulin antagonists##3##2##(1995-2#1)(2008-10#2)
calmodulin binding##2##2##(1993-6#1)(2008-8#1)
calmodulin kinase##2##2##(1996-12#2)
calmodulin##40##1##(1990-5#2)(1991-8#1)(1991-9#1)(1993-6#9)(1994-3#2)(1995-11#4)(1995-2#2)(1995-8#1)(1996-12#2)(1997-2#3)(2008-10#5)(2008-7#1)(2008-8#6)(2010-3#1)
calmodulin-binding protein##2##2##(1994-5#2)
calmodulin-binding##5##1##(1990-5#1)(1993-9#1)(1994-5#2)(2008-8#1)
calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes##2##5##(1997-2#2)
calmodulin-dependent cyclic nucleotide phosphodiesterase##7##4##(1997-2#7)
calmodulin-dependent protein kinase II##2##4##(1993-6#1)(2008-10#1)
calmodulin-dependent protein kinase##5##3##(1993-6#1)(2008-10#1)(2008-8#3)
calmodulin-dependent##13##1##(1991-9#1)(1993-6#1)(1997-2#7)(2008-10#1)(2008-8#3)
calmodulin-like calcium-binding protein from##2##4##(2009-7#2)
calomel##7##1##(2008-10#7)
caloric and formula intake##2##4##(1991-12#2)
caloric intake and##2##3##(1992-12#1)(2008-10#1)
caloric intake##4##2##(1991-1#1)(1991-12#1)(1992-12#1)(2008-10#1)
caloric restriction##7##2##(2008-10#2)(2008-11#1)(2008-7#3)(2010-1#1)
caloric##16##1##(1991-1#1)(1991-12#3)(1992-12#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-9#1)(2010-1#1)(2012-2#1)
calorie diet##3##2##(2008-3#2)(2011-2#1)
calorie restriction##3##2##(2008-4#3)
calorie##14##1##(2008-10#1)(2008-3#7)(2008-4#5)(2011-2#1)
calories and##2##2##(2008-10#1)(2008-3#1)
calories##7##1##(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)
calorimeter##6##1##(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)
calorimetric method##2##2##(2008-10#2)
calorimetric techniques##2##2##(2008-10#1)(2011-1#1)
calorimetric##14##1##(1990-8#1)(1993-8#1)(1995-8#1)(1997-2#1)(2008-10#7)(2008-8#1)(2011-1#2)
calorimetry and##3##2##(2008-10#3)
calorimetry in##3##2##(2008-10#2)(2011-1#1)
calorimetry the##2##2##(1997-2#2)
calorimetry##33##1##(1990-8#1)(1991-5#1)(1992-10#2)(1993-8#3)(1994-5#1)(1997-2#3)(2008-10#11)(2008-11#2)(2008-5#3)(2008-8#1)(2009-3#1)(2011-1#3)(2011-2#1)
calpain 2##3##2##(2013-1#3)
calpain I##6##2##(1990-2#2)(1992-6#4)
calpain II##3##2##(1990-2#1)(1994-5#2)
calpain##25##1##(1990-2#7)(1992-12#6)(1992-6#4)(1994-5#3)(1996-8#1)(2008-11#1)(2013-1#3)
calpains##3##1##(1990-2#3)
calpastatin##4##1##(2008-11#4)
calphostin C##2##2##(1997-1#1)(2008-9#1)
calponin##6##1##(1993-6#5)(2008-11#1)
calreticulin glycosylation##3##2##(1994-11#3)
calreticulin##8##1##(1994-11#8)
calvaria##9##1##(1990-11#2)(2008-10#1)(2008-11#6)
calvarial##4##1##(1993-6#1)(2008-11#1)(2009-11#1)(2013-8#1)
calves and cows##2##3##(2013-1#2)
calves and##3##2##(2008-11#1)(2013-1#2)
calves by##2##2##(1991-3#1)(1996-11#1)
calves from##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
calves in##3##2##(1996-11#1)(1996-12#2)
calves of##4##2##(2012-12#2)(2012-2#2)
calves were##8##2##(1996-12#2)(1996-3#1)(1997-5#2)(2008-9#1)(2012-12#1)(2013-1#1)
calves##50##1##(1991-3#1)(1996-11#2)(1996-12#10)(1996-3#2)(1997-5#7)(2008-11#1)(2008-9#2)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#8)
calves)##2##1##(1996-12#2)
calyptras##2##1##(2008-10#2)
calyx##4##1##(2008-10#4)
camaldulensis##5##1##(2008-5#5)
cambial##2##1##(2008-10#2)
cambium##11##1##(2008-10#10)(2010-3#1)
cambogia in rats##2##3##(2012-2#2)
cambogia in##3##2##(2012-2#3)
cambogia##4##1##(2012-2#4)
came from the##4##3##(1993-8#1)(2008-10#3)
came from##15##2##(1992-12#1)(1993-8#1)(1994-6#1)(1997-9#1)(2008-10#8)(2008-12#1)(2010-5#1)(2013-8#1)
came in##4##2##(2008-11#1)(2008-5#1)(2010-8#2)
came into being##2##3##(2008-10#1)(2008-9#1)
came to our##2##3##(2008-5#1)(2013-1#1)
came to that of##3##4##(2011-2#3)
came to the##2##3##(2008-12#1)(2010-2#1)
came to##12##2##(1993-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
came##42##1##(1991-6#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-6#1)(1997-2#1)(1997-9#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#4)
camel##5##1##(1996-12#3)(2011-2#2)
camels and##3##2##(2011-2#3)
camels were##3##2##(1996-12#2)(2011-2#1)
camels##16##1##(1993-3#1)(1996-12#3)(2011-2#12)
camera and##3##2##(2008-2#2)(2008-7#1)
camera for##3##2##(2008-3#1)(2008-4#1)(2010-12#1)
camera is##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
camera to##4##2##(1996-3#1)(2008-11#1)(2010-3#1)(2012-2#1)
camera with##2##2##(1996-2#1)(2008-6#1)
camera##42##1##(1991-1#1)(1994-2#1)(1996-2#3)(1996-3#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-6#5)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#2)(2012-12#1)(2012-2#1)
cameras have##2##2##(2008-3#1)(2008-6#1)
cameras in##2##2##(1995-12#1)(2008-4#1)
cameras##14##1##(1990-12#1)(1995-12#1)(2008-3#1)(2008-4#2)(2008-6#8)(2012-2#1)
camp##5##1##(2008-12#2)(2008-7#2)(2010-9#1)
campaign and##2##2##(1992-2#1)(1995-3#1)
campaign for##3##2##(1990-3#1)(2008-11#1)(2012-2#1)
campaign to##7##2##(1992-2#1)(1997-6#2)(2008-1#2)(2008-11#1)(2012-2#1)
campaign was##3##2##(1997-1#1)(2010-1#1)(2013-1#1)
campaign will##2##2##(1994-1#1)(1997-6#1)
campaign with##2##2##(1995-5#1)(1997-6#1)
campaign##40##1##(1990-3#2)(1991-1#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#6)(1994-1#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#7)(2008-1#3)(2008-11#2)(2008-3#2)(2008-5#1)(2010-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
campaigns against##2##2##(1993-2#1)(2010-1#1)
campaigns in##4##2##(2010-1#3)(2011-2#1)
campaigns to##3##2##(2007-12#1)(2008-1#1)(2009-7#1)
campaigns##24##1##(1990-3#1)(1993-12#1)(1993-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-7#2)(2010-1#5)(2011-1#1)(2011-2#2)(2011-3#1)(2013-8#1)
campaniform sensilla##2##2##(2007-12#2)
campestris and##3##2##(2008-10#2)(2009-6#1)
campestris in Brassica Genomes##2##4##(2008-10#2)
campestris in Brassica##3##3##(2008-10#3)
campestris in##7##2##(2008-10#6)(2011-1#1)
campestris isolates##2##2##(2008-10#2)
campestris pathovars##4##2##(2008-10#4)
campestris pv##92##2##(2008-10#91)(2009-6#1)
campestris races##3##2##(2008-10#3)
campestris##125##1##(2008-10#120)(2009-6#2)(2011-1#2)(2012-2#1)
campestris)##2##1##(2008-10#1)(2011-1#1)
camphor##2##1##(2008-10#1)(2011-2#1)
campion)##2##1##(2008-8#2)
camps##5##1##(1994-9#1)(2008-7#3)(2013-1#1)
camptothecin stacking##2##2##(1993-8#2)
camptothecin##8##1##(1990-7#2)(1993-8#4)(1994-8#2)
camptothecin-induced##3##1##(1993-8#3)
campus##9##1##(1991-2#1)(1991-3#1)(1996-12#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
campuses##4##1##(2008-11#1)(2011-2#2)(2012-2#1)
campylobacteriosis##4##1##(2008-10#2)(2008-7#2)
campylobacters were##2##2##(1990-3#2)
campylobacters##3##1##(1990-3#3)
can a##4##2##(1993-5#1)(1994-12#1)(2008-9#1)(2009-7#1)
can accelerate the##3##3##(2008-10#2)(2010-8#1)
can accelerate##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)
can access##2##2##(1996-1#1)(2008-9#1)
can accommodate a##2##3##(2007-12#1)(2008-10#1)
can accommodate##6##2##(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)
can account for the##3##4##(1991-11#1)(2008-11#1)(2010-4#1)
can account for##6##3##(1991-11#1)(1991-6#1)(2008-11#2)(2008-8#1)(2010-4#1)
can account##7##2##(1991-11#1)(1991-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-4#1)
can accumulate##6##2##(1996-6#1)(2008-10#2)(2008-11#2)(2009-8#1)
can accurately predict##2##3##(2008-10#1)(2008-3#1)
can achieve##5##2##(1992-3#1)(1993-12#1)(1997-2#1)(2008-3#1)(2012-2#1)
can acquire##2##2##(1994-8#1)(2008-11#1)
can act as a##8##4##(2008-10#4)(2008-11#1)(2008-12#1)(2010-10#1)(2012-2#1)
can act as both##2##4##(1994-3#1)(2008-10#1)
can act as effective##2##4##(1995-2#1)(2010-7#1)
can act as##16##3##(1994-3#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-8#1)
can act to##3##3##(1994-11#1)(2008-8#1)(2013-7#1)
can act##25##2##(1994-11#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
can activate the##3##3##(1994-6#1)(1997-2#1)(1997-7#1)
can activate##10##2##(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
can add##3##2##(1991-3#1)(2008-9#1)(2009-7#1)
can address##2##2##(1991-1#1)(2008-10#1)
can adequately##2##2##(1997-3#1)(2008-10#1)
can adsorb##2##2##(2008-10#2)
can adversely affect##2##3##(2008-10#1)(2012-12#1)
can affect cell##2##3##(1996-12#1)(2011-2#1)
can affect the##12##3##(1991-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
can affect##29##2##(1991-2#1)(1993-3#1)(1994-8#1)(1996-12#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
can afford##3##2##(1993-12#1)(1994-12#1)(2009-8#1)
can aid in the##3##4##(1996-9#1)(1997-1#1)(2013-8#1)
can aid in##5##3##(1996-9#1)(1997-1#1)(1997-5#1)(2008-9#1)(2013-8#1)
can all be##2##3##(1992-3#1)(2008-8#1)
can all##4##2##(1992-3#1)(1997-2#1)(2008-8#1)(2012-2#1)
can alleviate the##2##3##(2008-3#1)(2012-2#1)
can alleviate##3##2##(2008-3#1)(2012-2#1)(2013-8#1)
can allow##4##2##(1995-3#1)(2008-10#1)(2008-11#1)(2009-1#1)
can also affect##2##3##(2012-2#1)(2013-8#1)
can also be a##2##4##(1994-3#1)(2008-10#1)
can also be adapted##3##4##(1990-12#1)(2008-4#2)
can also be applied to##5##5##(1992-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
can also be carried out in##2##6##(1996-5#2)
can also be determined##3##4##(2008-10#3)
can also be employed##2##4##(2010-7#1)(2012-3#1)
can also be induced##2##4##(1997-7#1)(2008-4#1)
can also be successfully##2##4##(2008-10#1)(2009-10#1)
can also be used as##3##5##(2008-10#2)(2008-4#1)
can also be used to determine##2##6##(1990-12#1)(2008-10#1)
can also be used to##10##5##(1990-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
can also be used##17##4##(1990-12#1)(2008-10#6)(2008-3#1)(2008-4#3)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
can also be##78##3##(1990-12#2)(1991-12#2)(1992-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-5#2)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-9#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
can also change the##2##4##(1997-1#1)(2008-10#1)
can also demonstrate##2##3##(2010-12#1)(2011-2#1)
can also influence##2##3##(2008-8#1)(2010-6#1)
can also interact##2##3##(1996-2#1)(2008-10#1)
can also occur##2##3##(2008-5#1)(2013-7#1)
can also produce##2##3##(1993-11#1)(2011-2#1)
can also provide##2##3##(2008-7#1)(2010-10#1)
can also##132##2##(1990-12#2)(1991-12#2)(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#2)(1997-3#1)(1997-6#2)(1997-7#1)(2007-12#3)(2008-10#31)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#7)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
can alter the##6##3##(2008-10#1)(2008-8#3)(2009-5#1)(2010-1#1)
can alter##9##2##(2008-10#1)(2008-3#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-1#1)
can alternatively be quantitatively adsorbed on##4##6##(2008-10#4)
can alternatively be quantitatively##5##4##(2008-10#5)
can always##2##2##(2008-8#1)(2010-10#1)
can and does occur##2##4##(2008-7#1)(2009-9#1)
can and##4##2##(1992-9#1)(2008-11#1)(2008-7#1)(2009-9#1)
can appear in##2##3##(1994-9#1)(2008-10#1)
can appear##4##2##(1991-11#1)(1991-8#1)(1994-9#1)(2008-10#1)
can arise from##2##3##(2008-11#1)(2012-2#1)
can arise when##2##3##(2008-11#1)(2009-9#1)
can arise##7##2##(2008-11#3)(2009-9#1)(2012-2#1)(2012-3#2)
can arrest##3##2##(2008-9#1)(2011-2#1)(2011-3#1)
can assemble##2##2##(1994-3#1)(2008-8#1)
can assist in the##2##4##(1995-2#1)(2012-12#1)
can assist in##3##3##(1995-2#1)(2009-7#1)(2012-12#1)
can assist the##3##3##(1993-2#1)(2008-12#1)(2010-10#1)
can assist##11##2##(1993-1#1)(1993-2#1)(1995-2#2)(2008-10#1)(2008-12#2)(2009-7#1)(2010-10#1)(2012-12#1)(2013-8#1)
can associate##2##2##(1995-6#1)(2012-2#1)
can augment##2##2##(2008-6#1)(2013-8#1)
can avoid##7##2##(1992-9#1)(1993-12#2)(1995-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
can be a challenging##2##4##(2008-10#2)
can be a powerful tool in##2##6##(2010-8#1)(2013-8#1)
can be a powerful##3##4##(1995-2#1)(2010-8#1)(2013-8#1)
can be a useful##3##4##(2008-10#1)(2009-9#1)(2010-6#1)
can be a valuable##2##4##(1992-1#1)(1993-2#1)
can be a##39##3##(1992-1#1)(1992-2#1)(1993-2#2)(1994-12#2)(1995-2#2)(1996-2#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
can be accessed##3##3##(2008-10#1)(2009-2#1)(2010-12#1)
can be accompanied by##2##4##(1994-9#1)(2008-8#1)
can be accomplished by##8##4##(1994-5#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#1)
can be accomplished##14##3##(1994-5#1)(1995-1#1)(1995-3#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#2)
can be accurately determined with##2##5##(2008-10#1)(2008-3#1)
can be accurately##5##3##(1990-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
can be achieved by using##2##5##(2008-10#2)
can be achieved by##11##4##(1990-9#1)(1993-9#1)(1997-7#1)(2008-10#5)(2009-3#1)(2009-6#1)(2013-8#1)
can be achieved even for##2##5##(2008-10#1)(2013-8#1)
can be achieved from##2##4##(2008-10#1)(2008-12#1)
can be achieved through##2##4##(2008-11#1)(2012-7#1)
can be achieved with##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
can be achieved##41##3##(1990-9#2)(1991-3#1)(1993-2#1)(1993-9#1)(1995-2#1)(1997-7#2)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-8#1)(2012-7#1)(2013-8#2)
can be acquired from##2##4##(2007-12#1)(2011-7#1)
can be acquired##6##3##(2007-12#1)(2008-10#4)(2011-7#1)
can be activated by##3##4##(1994-11#1)(1995-12#1)(1996-12#1)
can be activated##6##3##(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)
can be adapted for##2##4##(1994-3#1)(2008-4#1)
can be adapted to##5##4##(1990-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
can be adapted##8##3##(1990-5#1)(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)
can be added to##2##4##(2008-10#1)(2008-11#1)
can be added##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
can be adjusted by the##2##5##(2008-3#1)(2010-5#1)
can be adjusted by##3##4##(2008-10#1)(2008-3#1)(2010-5#1)
can be adjusted##4##3##(2008-10#1)(2008-3#2)(2010-5#1)
can be administered to##4##4##(1994-2#1)(1994-9#1)(2010-12#1)(2013-8#1)
can be adopted for the##2##5##(2008-10#2)
can be adopted##5##3##(1990-2#1)(2008-10#2)(2008-12#1)(2008-3#1)
can be adsorbed at the mercury electrode and yields a sensitive oscillopolarographic wave##2##13##(2008-10#2)
can be adsorbed at the mercury electrode and yields a sensitive##3##11##(2008-10#3)
can be adsorbed##5##3##(2008-10#5)
can be advanced##2##3##(2008-10#1)(2008-11#1)
can be affected by the##2##5##(2008-10#1)(2009-8#1)
can be affected by##4##4##(2008-10#2)(2008-11#1)(2009-8#1)
can be also used##2##4##(2008-10#1)(2010-8#1)
can be also##4##3##(2008-10#3)(2010-8#1)
can be altered by##2##4##(1990-2#1)(2008-6#1)
can be altered##4##3##(1990-2#1)(2008-3#1)(2008-6#1)(2008-9#1)
can be an effective##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
can be an efficient##2##4##(2008-10#1)(2010-11#1)
can be an important##5##4##(1993-1#1)(1993-3#1)(2008-10#2)(2011-1#1)
can be an##19##3##(1991-1#1)(1993-1#1)(1993-3#1)(1996-1#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
can be analysed directly##2##4##(2008-10#2)
can be analysed##3##3##(2008-10#3)
can be analyzed by##4##4##(1993-12#1)(2008-10#1)(2008-4#2)
can be analyzed with##2##4##(2008-10#1)(2008-9#1)
can be analyzed##17##3##(1993-12#2)(2008-10#10)(2008-4#3)(2008-9#2)
can be anticipated##2##3##(2008-10#1)(2013-1#1)
can be applicable to##2##4##(2008-10#2)
can be applied also##2##4##(1995-5#1)(2008-10#1)
can be applied by##2##4##(2008-10#1)(2013-8#1)
can be applied for any##2##5##(1994-8#1)(1995-6#1)
can be applied for##5##4##(1994-8#1)(1995-6#1)(2008-10#3)
can be applied in##9##4##(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
can be applied successfully to##2##5##(2008-10#1)(2008-11#1)
can be applied to any##3##5##(1995-2#1)(2008-4#1)(2008-9#1)
can be applied to determine##2##5##(2008-10#2)
can be applied to many##2##5##(2008-10#1)(2008-11#1)
can be applied to the##11##5##(1996-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)
can be applied to##33##4##(1993-12#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-2#1)(2012-3#1)
can be applied with##2##4##(2008-10#1)(2008-3#1)
can be applied##71##3##(1993-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
can be approximated##2##3##(2008-3#1)(2013-8#1)
can be as##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2013-8#1)
can be ascribed to the##3##5##(2008-10#1)(2008-3#1)(2009-9#1)
can be ascribed to##5##4##(2008-10#2)(2008-3#1)(2008-8#1)(2009-9#1)
can be assessed##5##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)
can be associated with##5##4##(1990-5#1)(2008-11#1)(2008-7#1)(2009-8#2)
can be assumed that##2##4##(2008-7#1)(2009-1#1)
can be assumed to##2##4##(2008-10#1)(2010-3#1)
can be assumed##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-3#1)
can be attained##6##3##(1992-3#1)(2008-10#3)(2008-11#1)(2009-3#1)
can be attributed to the difference in##2##7##(2008-9#1)(2012-2#1)
can be attributed to the##10##5##(1992-10#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-9#1)(2012-2#1)
can be attributed to##14##4##(1992-10#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2012-2#1)(2012-9#1)
can be avoided by##2##4##(1996-11#1)(2008-7#1)
can be avoided##10##3##(1990-5#1)(1992-3#1)(1993-2#1)(1994-3#2)(1996-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#1)
can be best##2##3##(2012-2#2)
can be better understood##2##4##(2008-11#1)(2013-1#1)
can be better##7##3##(1994-3#1)(2008-11#2)(2008-2#1)(2010-12#1)(2013-1#2)
can be both##2##3##(1990-2#1)(2008-10#1)
can be broadly##2##3##(2008-4#1)(2013-1#1)
can be broken##2##3##(2008-4#1)(2008-9#1)
can be calculated by##2##4##(2008-10#1)(2008-2#1)
can be calculated from##2##4##(2008-10#2)
can be calculated##6##3##(2008-10#4)(2008-2#1)(2011-3#1)
can be calibrated##3##3##(2008-10#2)(2008-3#1)
can be carried out in##4##5##(1994-2#1)(2008-10#2)(2008-2#1)
can be carried out on##2##5##(1993-12#1)(2008-10#1)
can be carried out##10##4##(1993-12#1)(1994-2#1)(2008-10#6)(2008-2#1)(2008-4#1)
can be categorized##2##3##(2010-5#1)(2013-1#1)
can be caused by a##2##5##(1992-1#1)(1994-12#1)
can be caused by##4##4##(1992-1#1)(1994-12#1)(2008-11#1)(2008-7#1)
can be challenging##3##3##(2008-10#1)(2010-6#1)(2012-2#1)
can be changed##2##3##(2008-11#1)(2008-9#1)
can be characterized as a##2##5##(2009-10#1)(2010-11#1)
can be characterized as##7##4##(2008-10#2)(2009-10#1)(2010-11#1)(2011-2#2)(2013-8#1)
can be characterized by##3##4##(1991-3#1)(2008-10#2)
can be characterized##10##3##(1991-3#1)(2008-10#4)(2009-10#1)(2010-11#1)(2011-2#2)(2013-8#1)
can be classified into##5##4##(1992-7#1)(2008-7#1)(2008-9#1)(2011-3#1)(2013-1#1)
can be classified##8##3##(1992-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-3#1)(2013-1#1)
can be clearly distinguished from##2##5##(1991-2#1)(2008-10#1)
can be clearly seen##2##4##(2008-3#1)(2012-2#1)
can be clearly##5##3##(1991-2#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
can be closed##2##3##(2008-11#2)
can be collected and##2##4##(2008-9#1)(2010-8#1)
can be combined##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
can be compared to##2##4##(2008-7#1)(2010-6#1)
can be compared##8##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-6#1)(2013-1#1)
can be compensated by##2##4##(2008-10#1)(2013-8#1)
can be compensated##3##3##(1991-2#1)(2008-10#1)(2013-8#1)
can be completed in##4##4##(1995-11#1)(2008-10#3)
can be completed##7##3##(1994-3#1)(1995-11#1)(2008-10#4)(2013-8#1)
can be completely##2##3##(2008-10#1)(2008-4#1)
can be complex##2##3##(1990-11#1)(2012-2#1)
can be concluded that##16##4##(1994-8#1)(1996-11#1)(1997-6#1)(2008-10#6)(2008-12#1)(2009-8#1)(2011-3#1)(2012-2#3)(2012-9#1)
can be concluded##18##3##(1994-12#1)(1994-8#1)(1996-11#1)(1997-6#1)(2008-10#6)(2008-12#1)(2009-8#1)(2011-3#1)(2012-2#3)(2012-9#1)(2013-1#1)
can be conducted in##2##4##(1991-9#1)(1993-3#1)
can be conducted using##2##4##(2008-10#1)(2008-5#1)
can be conducted##4##3##(1991-9#1)(1993-3#1)(2008-10#1)(2008-5#1)
can be confidently##2##3##(2012-2#1)(2013-1#1)
can be confirmed##3##3##(1991-3#1)(2011-2#1)(2012-12#1)
can be considerably##2##3##(1997-4#1)(2008-7#1)
can be considered an##3##4##(1993-3#1)(2008-10#1)(2008-11#1)
can be considered as a##4##5##(2008-11#1)(2009-11#1)(2011-2#2)
can be considered as an##2##5##(2008-10#2)
can be considered as##14##4##(2008-10#7)(2008-11#1)(2008-5#1)(2009-11#1)(2011-2#3)(2012-3#1)
can be considered in##3##4##(1994-9#1)(2008-5#1)(2011-2#1)
can be considered to be##2##5##(1992-11#1)(2008-5#1)
can be considered to##3##4##(1992-11#1)(2008-10#1)(2008-5#1)
can be considered##35##3##(1990-6#1)(1992-11#1)(1993-3#2)(1994-9#1)(1997-8#1)(2008-10#12)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-2#5)(2012-3#1)
can be constructed##3##3##(2008-10#2)(2008-2#1)
can be continuously##3##3##(2008-10#2)(2008-4#1)
can be controlled by##5##4##(1993-6#1)(2008-10#2)(2009-7#1)(2011-2#1)
can be controlled with##2##4##(2008-11#1)(2008-7#1)
can be controlled##11##3##(1993-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#2)
can be conveniently##2##3##(1996-2#1)(2008-4#1)
can be converted into##2##4##(1996-5#1)(2011-3#1)
can be converted##4##3##(1996-5#1)(2008-10#2)(2011-3#1)
can be corrected##2##3##(1996-2#1)(2008-10#1)
can be correlated with##2##4##(1996-12#1)(2008-9#1)
can be correlated##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
can be coupled with##2##4##(2008-10#2)
can be coupled##3##3##(2008-10#2)(2008-3#1)
can be created##2##3##(2008-4#1)(2013-1#1)
can be cultured in##2##4##(2008-11#1)(2012-2#1)
can be cultured##3##3##(2008-11#2)(2012-2#1)
can be curative##2##3##(1997-2#1)(2010-10#1)
can be cured##4##3##(1991-9#1)(1996-11#1)(2010-4#1)(2010-8#1)
can be decreased##4##3##(1997-8#1)(2008-11#1)(2008-5#1)(2012-3#1)
can be deduced##3##3##(2007-12#1)(2008-10#2)
can be defined as##3##4##(2008-4#1)(2008-8#1)(2012-12#1)
can be defined##6##3##(1993-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
can be degraded##2##3##(2008-10#1)(2011-2#1)
can be delivered to##2##4##(1993-9#1)(2010-7#1)
can be delivered##5##3##(1993-9#1)(1997-1#2)(2010-7#1)(2011-2#1)
can be demonstrated##4##3##(1990-3#1)(2008-4#1)(2012-2#2)
can be derived from the##2##5##(2008-11#1)(2008-7#1)
can be derived from##6##4##(1996-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
can be derived##10##3##(1996-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)
can be described as a##3##5##(1997-2#1)(1997-6#1)(2008-11#1)
can be described by a##4##5##(2008-10#3)(2008-7#1)
can be described by the##2##5##(1991-5#1)(2013-1#1)
can be described by##6##4##(1991-5#1)(2008-10#3)(2008-7#1)(2013-1#1)
can be described##10##3##(1991-5#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
can be designed##5##3##(2008-10#1)(2008-11#2)(2008-3#1)(2012-2#1)
can be desorbed with 2##2##5##(2008-10#2)
can be desorbed##3##3##(2008-10#2)(2008-7#1)
can be detected and determined using##2##6##(2008-10#1)(2008-11#1)
can be detected and##5##4##(2008-10#3)(2008-11#1)(2008-9#1)
can be detected at##2##4##(2008-10#2)
can be detected by##9##4##(1990-9#1)(2008-10#2)(2008-4#3)(2008-9#2)(2009-6#1)
can be detected in the##2##5##(2008-10#2)
can be detected in##8##4##(1993-12#1)(1993-8#1)(2007-11#1)(2008-10#3)(2008-8#1)(2010-1#1)
can be detected##40##3##(1990-9#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-8#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#18)(2008-11#2)(2008-4#3)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#1)(2010-1#1)(2012-2#1)(2012-3#1)
can be determined by the##2##5##(2008-10#1)(2008-3#1)
can be determined by##12##4##(1990-8#1)(1996-3#1)(2008-10#8)(2008-3#1)(2009-11#1)
can be determined directly##3##4##(2008-10#3)
can be determined in the presence of##3##7##(2008-10#3)
can be determined in the range of 0##3##8##(2008-10#3)
can be determined in the range##7##6##(2008-10#7)
can be determined in the##11##5##(2008-10#11)
can be determined in##19##4##(2008-10#18)(2008-11#1)
can be determined simultaneously in##2##5##(2008-10#2)
can be determined simultaneously with the concentration ratios of##2##9##(2008-10#2)
can be determined simultaneously##6##4##(2008-10#6)
can be determined using the##2##5##(2008-10#2)
can be determined using##3##4##(2008-10#3)
can be determined with##3##4##(2008-10#3)
can be determined##67##3##(1990-8#1)(1996-3#1)(2008-10#54)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-9#1)(2009-11#1)
can be detrimental to##2##4##(2008-12#1)(2008-8#1)
can be detrimental##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
can be developed by##2##4##(1997-4#1)(2008-10#1)
can be developed in##2##4##(1993-11#1)(2008-5#1)
can be developed##8##3##(1993-11#1)(1997-4#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#1)
can be diagnosed by##2##4##(1996-11#1)(2010-6#1)
can be diagnosed##3##3##(1996-11#1)(2009-1#1)(2010-6#1)
can be diagnostic##2##3##(2008-10#1)(2012-2#1)
can be differentiated by##2##4##(2008-10#1)(2012-3#1)
can be differentiated##5##3##(1996-11#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)
can be difficult because##2##4##(2008-10#1)(2010-7#1)
can be difficult to##3##4##(2010-12#1)(2012-2#1)(2013-1#1)
can be difficult##12##3##(1990-11#1)(1997-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
can be directly determined by##2##5##(1995-11#1)(2008-10#1)
can be directly determined##3##4##(1995-11#1)(2008-10#2)
can be directly used##2##4##(2008-10#2)
can be directly##8##3##(1995-11#1)(2008-1#1)(2008-10#5)(2012-3#1)
can be displayed##2##3##(2009-10#1)(2010-9#1)
can be dissociated from##2##4##(1995-6#1)(2013-8#1)
can be dissociated##4##3##(1993-6#1)(1995-6#1)(2008-8#1)(2013-8#1)
can be distinguished as##2##4##(2008-10#1)(2008-7#1)
can be distinguished by##2##4##(1993-9#1)(2008-10#1)
can be distinguished from each other##2##6##(2008-4#1)(2009-5#1)
can be distinguished from other##2##5##(2008-10#2)
can be distinguished from##4##4##(2008-10#2)(2008-4#1)(2009-5#1)
can be distinguished##17##3##(1993-9#1)(1996-9#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)
can be divided into four##2##5##(1997-8#1)(2009-8#1)
can be divided into the##3##5##(1990-5#1)(2008-10#2)
can be divided into three##2##5##(1997-8#1)(2008-12#1)
can be divided into two##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
can be divided into##18##4##(1990-5#1)(1995-12#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
can be divided##19##3##(1990-5#1)(1995-12#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2011-2#1)(2012-9#1)(2013-1#1)
can be done at##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
can be done by##3##4##(2008-10#3)
can be done in##3##4##(1994-8#1)(1997-1#1)(2008-10#1)
can be done with##2##4##(2008-10#1)(2008-9#1)
can be done without##2##4##(2008-10#1)(2010-10#1)
can be done##21##3##(1992-11#1)(1992-3#1)(1994-8#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)
can be downloaded##2##3##(2008-10#1)(2008-4#1)
can be drawn from the##4##5##(1991-12#1)(1993-12#1)(2008-11#1)(2008-12#1)
can be drawn from##7##4##(1991-12#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-12#1)
can be drawn on##2##4##(2007-11#1)(2008-11#1)
can be drawn##13##3##(1991-12#1)(1993-12#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#1)(2010-12#1)
can be driven by##2##4##(2008-9#1)(2010-1#1)
can be due to##2##4##(2008-10#1)(2008-8#1)
can be easily achieved##3##4##(2008-10#2)(2008-9#1)
can be easily adapted to the##2##6##(2008-10#1)(2008-12#1)
can be easily adapted to##3##5##(2008-10#2)(2008-12#1)
can be easily adapted##4##4##(2008-10#3)(2008-12#1)
can be easily and##2##4##(2008-10#1)(2012-3#1)
can be easily implemented##2##4##(2008-3#1)(2008-7#1)
can be easily monitored##2##4##(2007-12#1)(2008-10#1)
can be easily reduced on the##2##6##(2008-10#2)
can be easily regenerated##2##4##(2008-10#2)
can be easily##42##3##(1990-12#1)(1994-11#1)(1994-3#2)(2006-6#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
can be effective in##6##4##(1995-3#1)(2006-6#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
can be effective##7##3##(1995-3#1)(2006-6#1)(2008-10#2)(2010-4#1)(2011-2#1)(2013-1#1)
can be effectively##9##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
can be efficiently used for##2##5##(2008-11#1)(2008-4#1)
can be efficiently##4##3##(2008-11#2)(2008-4#1)(2011-1#1)
can be either##2##3##(2011-1#1)(2013-1#1)
can be elicited by##2##4##(1992-8#1)(2008-11#1)
can be eliminated by a##2##5##(2008-10#1)(2008-11#1)
can be eliminated by##5##4##(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)
can be eliminated##11##3##(1997-8#1)(2008-10#5)(2008-11#3)(2008-8#1)(2010-11#1)
can be elucidated##2##3##(2008-4#1)(2011-2#1)
can be eluted##2##3##(2008-10#2)
can be employed by##2##4##(1996-1#1)(2008-3#1)
can be employed for the##2##5##(2008-10#2)
can be employed for##5##4##(1992-5#1)(2008-10#3)(2008-12#1)
can be employed in##2##4##(2008-10#1)(2008-12#1)
can be employed to##4##4##(2008-11#1)(2008-8#1)(2009-5#1)(2010-11#1)
can be employed##17##3##(1992-5#1)(1993-6#1)(1996-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-5#1)(2010-11#1)
can be engineered to##2##4##(2010-7#1)(2011-2#1)
can be enhanced by La(3+)##2##5##(2008-10#2)
can be enhanced by the addition of##2##7##(2007-11#1)(2008-10#1)
can be enhanced by##4##4##(2007-11#1)(2008-10#3)
can be enhanced##8##3##(1994-12#1)(1995-1#1)(2007-11#1)(2008-10#4)(2012-3#1)
can be equally##2##3##(2008-11#1)(2011-2#1)
can be established between##2##4##(2008-10#1)(2008-9#1)
can be established##7##3##(1994-2#1)(2008-10#4)(2008-9#1)(2011-2#1)
can be estimated by##2##4##(2008-10#2)
can be estimated from##3##4##(2008-7#1)(2008-8#1)(2011-2#1)
can be estimated##9##3##(1992-2#1)(1992-6#1)(1992-9#1)(2008-10#2)(2008-7#1)(2008-8#2)(2011-2#1)
can be evaluated by##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
can be evaluated##10##3##(1996-3#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
can be evolutionarily stable##2##4##(2008-8#2)
can be excised##2##3##(1992-1#1)(2008-9#1)
can be expected in##2##4##(2008-10#1)(2013-8#1)
can be expected to##5##4##(1995-1#1)(2008-12#1)(2008-5#1)(2008-8#2)
can be expected when##2##4##(2008-10#1)(2012-7#1)
can be expected##15##3##(1995-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-7#1)(2013-8#1)
can be explained as##2##4##(2008-10#1)(2008-8#1)
can be explained by a##3##5##(1990-11#1)(1993-8#1)(2008-1#1)
can be explained by assuming that##2##6##(2008-10#1)(2008-11#1)
can be explained by the##4##5##(1996-5#1)(2008-3#1)(2010-1#1)(2010-10#1)
can be explained by##20##4##(1990-11#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-10#1)(2012-12#1)
can be explained in terms of##2##6##(1993-8#1)(2008-10#1)
can be explained through##2##4##(2008-1#1)(2008-10#1)
can be explained using##2##4##(2008-10#1)(2008-5#1)
can be explained##33##3##(1990-11#1)(1990-5#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-11#1)(1996-5#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#2)(2009-12#1)(2010-1#1)(2010-10#1)(2012-12#1)(2012-3#1)
can be exploited in##3##4##(2008-10#2)(2008-11#1)
can be exploited to reduce the##2##6##(2008-10#1)(2008-3#1)
can be exploited to##5##4##(2008-10#2)(2008-3#1)(2008-6#1)(2013-7#1)
can be exploited##9##3##(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-7#1)
can be expressed as##4##4##(2008-10#1)(2008-11#2)(2008-7#1)
can be expressed by##2##4##(2008-10#1)(2008-3#1)
can be expressed##10##3##(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
can be extended for##2##4##(1990-8#1)(2008-10#1)
can be extended to##6##4##(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
can be extended##12##3##(1990-8#1)(1996-3#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
can be extracted from the##2##5##(2008-10#1)(2008-11#1)
can be extracted from##3##4##(2008-10#1)(2008-11#1)(2010-11#1)
can be extracted##6##3##(2008-10#4)(2008-11#1)(2010-11#1)
can be extremely##2##3##(2008-2#1)(2008-8#1)
can be facilitated by##2##4##(1992-12#1)(2008-8#1)
can be facilitated##5##3##(1992-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
can be fitted##2##3##(1997-2#1)(2012-3#1)
can be followed by##2##4##(2008-10#1)(2008-11#1)
can be followed##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
can be formed##6##3##(1994-5#1)(1995-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
can be formulated##3##3##(2008-3#1)(2008-8#1)(2012-4#1)
can be found in the##4##5##(2008-10#3)(2009-11#1)
can be found in##12##4##(2008-10#6)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2011-2#2)
can be found##20##3##(1991-11#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2011-2#3)
can be fully##2##3##(1993-3#1)(2008-10#1)
can be further##11##3##(1994-3#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2009-12#1)(2009-8#1)(2010-11#1)
can be gained##2##3##(2008-11#1)(2008-9#1)
can be generated in##2##4##(2008-2#1)(2008-7#1)
can be generated##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)
can be given##2##3##(1995-5#1)(2008-9#1)
can be greatly enhanced by addition of##2##7##(2008-10#2)
can be greatly enhanced by quinine##2##6##(2008-10#2)
can be greatly enhanced by##5##5##(2008-10#5)
can be greatly improved##2##4##(2008-10#1)(2009-11#1)
can be greatly##8##3##(2008-10#6)(2008-4#1)(2009-11#1)
can be grouped as##2##4##(2008-10#1)(2012-2#1)
can be grouped##3##3##(2008-10#2)(2012-2#1)
can be helpful in##3##4##(1997-8#1)(2008-11#1)(2010-10#1)
can be helpful to##3##4##(2008-8#1)(2009-1#1)(2010-8#1)
can be helpful##8##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-8#1)(2012-2#1)
can be highly##3##3##(1993-12#1)(2008-3#1)(2008-8#1)
can be identified as##2##4##(1993-3#1)(2010-4#1)
can be identified by##3##4##(1993-6#1)(2008-10#1)(2008-11#1)
can be identified for the##2##5##(2008-10#1)(2009-12#1)
can be identified from the UV spectrum of a 1##2##10##(2008-10#2)
can be identified from the##3##5##(1995-12#1)(2008-10#2)
can be identified from##4##4##(1995-12#1)(2008-10#3)
can be identified in##2##4##(2007-12#1)(2008-10#1)
can be identified using##2##4##(1995-2#1)(2008-10#1)
can be identified##21##3##(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-4#1)
can be imaged##3##3##(2008-3#1)(2008-5#1)(2009-12#1)
can be implemented in##4##4##(2008-11#1)(2011-2#1)(2013-1#2)
can be implemented on##2##4##(1993-9#1)(2008-10#1)
can be implemented with##2##4##(2008-3#1)(2013-1#1)
can be implemented##14##3##(1993-9#1)(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#3)
can be improved by##9##4##(1992-2#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
can be improved upon##2##4##(1990-5#1)(2010-12#1)
can be improved using##2##4##(1992-12#1)(2008-11#1)
can be improved##19##3##(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
can be included##3##3##(2008-10#1)(2008-11#1)(2010-11#1)
can be incorporated into a##3##5##(1995-2#1)(2008-10#2)
can be incorporated into the##3##5##(1994-3#1)(2008-3#1)(2009-9#1)
can be incorporated into##10##4##(1994-3#1)(1995-2#1)(2008-10#3)(2008-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2012-3#1)
can be incorporated##11##3##(1994-3#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2012-3#1)
can be increased by##4##4##(1991-9#1)(2008-10#2)(2008-3#1)
can be increased significantly##3##4##(2008-10#2)(2008-3#1)
can be increased##9##3##(1991-9#1)(2008-10#5)(2008-2#1)(2008-3#2)
can be induced by a##3##5##(1993-3#1)(1994-12#1)(2008-11#1)
can be induced by##8##4##(1993-3#1)(1994-12#1)(1997-8#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-10#1)
can be induced to develop##2##5##(1993-6#1)(2008-10#1)
can be induced to differentiate into##2##6##(2008-11#2)
can be induced to##7##4##(1991-5#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#2)
can be induced##25##3##(1990-7#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1996-11#1)(1997-8#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-10#1)
can be infected##2##3##(1996-9#1)(2008-10#1)
can be inferred from the##2##5##(2008-3#1)(2008-5#1)
can be inferred from##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
can be influenced by the##2##5##(1996-12#1)(2008-9#1)
can be influenced by##8##4##(1992-6#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)
can be influenced##9##3##(1992-6#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)
can be inhibited by##2##4##(1996-2#1)(2013-8#1)
can be inhibited##3##3##(1996-2#1)(2008-8#1)(2013-8#1)
can be initiated by##2##4##(1992-9#1)(2012-3#1)
can be injured by##2##4##(2008-1#1)(2011-2#1)
can be inserted##2##3##(2010-9#1)(2013-1#1)
can be integrated with##2##4##(2008-10#2)
can be integrated##3##3##(2008-10#2)(2011-1#1)
can be interpreted as a##2##5##(1993-8#1)(2008-10#1)
can be interpreted as##4##4##(1991-2#1)(1993-8#1)(1995-3#1)(2008-10#1)
can be interpreted in terms of##2##6##(2008-10#2)
can be interpreted to##2##4##(1996-5#1)(2008-3#1)
can be interpreted##8##3##(1991-2#1)(1993-8#1)(1995-3#1)(1996-5#1)(2008-10#3)(2008-3#1)
can be interrogated##3##3##(2008-10#2)(2009-12#1)
can be investigated##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
can be isolated from##3##4##(2008-9#3)
can be isolated##6##3##(2008-10#2)(2008-4#1)(2008-9#3)
can be kept##2##3##(2008-10#1)(2008-3#1)
can be linked to##2##4##(1995-12#1)(2008-11#1)
can be loaded into##2##4##(2008-10#1)(2008-9#1)
can be loaded##3##3##(2008-10#2)(2008-9#1)
can be localized##2##3##(1997-1#1)(2008-5#1)
can be located##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
can be made by##2##4##(1992-5#1)(2008-5#1)
can be made for##2##4##(1997-5#1)(2008-11#1)
can be made in the##2##5##(1992-3#1)(2008-8#1)
can be made in##3##4##(1992-3#1)(2008-8#1)(2008-9#1)
can be made##21##3##(1991-1#1)(1992-3#1)(1992-5#1)(1994-9#1)(1996-3#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2012-12#1)(2013-1#1)
can be maintained in the##2##5##(2008-11#1)(2008-9#1)
can be maintained in##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
can be maintained##7##3##(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#2)
can be managed##4##3##(1992-2#1)(1994-2#1)(2008-10#1)(2009-10#1)
can be manipulated##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
can be mapped##2##3##(1990-5#1)(1996-8#1)
can be measured in##3##4##(2008-10#2)(2008-9#1)
can be measured with a##3##5##(2008-10#2)(2008-3#1)
can be measured with##6##4##(2008-10#3)(2008-3#3)
can be measured##20##3##(1992-12#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-9#2)(2009-8#1)(2012-3#1)
can be mediated##2##3##(1994-3#1)(2012-3#1)
can be met by##2##4##(2008-11#2)
can be minimized by##2##4##(2008-10#2)
can be minimized##7##3##(2008-10#3)(2008-4#1)(2011-2#1)(2012-2#2)
can be modeled##2##3##(2008-10#2)
can be modified##2##3##(2008-4#1)(2008-7#1)
can be modulated by##2##4##(2008-10#1)(2011-2#1)
can be modulated##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
can be monitored by measuring the##2##6##(2008-10#2)
can be monitored by##4##4##(2008-10#4)
can be monitored spectrophotometrically by measuring the decrease in##2##9##(2008-10#2)
can be monitored with##2##4##(1997-6#1)(2012-2#1)
can be monitored##13##3##(1997-6#1)(2008-10#8)(2008-7#1)(2009-8#1)(2012-2#2)
can be more##5##3##(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
can be neglected##2##3##(2008-3#2)
can be observed and##2##4##(2008-5#1)(2008-8#1)
can be observed at the##2##5##(2008-5#1)(2010-4#1)
can be observed at##5##4##(1990-5#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
can be observed in##3##4##(1997-6#1)(2008-10#1)(2008-11#1)
can be observed##22##3##(1990-5#2)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#1)
can be obtained by##13##4##(1993-3#1)(2008-10#7)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)
can be obtained from the##2##5##(2008-10#1)(2008-3#1)
can be obtained from##6##4##(2008-10#2)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)
can be obtained in##6##4##(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
can be obtained through a##2##5##(1994-12#1)(2008-12#1)
can be obtained through##3##4##(1994-12#1)(2008-12#1)(2008-9#1)
can be obtained using##2##4##(2008-10#1)(2008-2#1)
can be obtained with##4##4##(2008-11#1)(2008-2#1)(2009-5#1)(2013-8#1)
can be obtained##64##3##(1992-5#1)(1993-3#2)(1994-12#1)(1995-5#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-5#2)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#3)
can be of great##4##4##(2008-10#1)(2008-9#1)(2009-8#1)(2010-7#1)
can be of##15##3##(1992-5#1)(1993-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-9#2)(2009-8#1)(2010-7#1)(2012-2#1)
can be only##2##3##(1992-12#1)(2008-10#1)
can be operated##2##3##(2008-10#1)(2008-3#1)
can be optimized##3##3##(2008-3#2)(2008-5#1)
can be overcome by##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
can be overcome##5##3##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
can be part of##2##4##(2008-11#1)(2008-7#1)
can be partially##2##3##(1992-12#1)(1992-9#1)
can be particularly##2##3##(2010-10#1)(2011-2#1)
can be partly##2##3##(2008-10#1)(2009-12#1)
can be performed by##2##4##(2008-5#1)(2010-7#1)
can be performed in the##3##5##(2008-10#3)
can be performed in##9##4##(1991-3#1)(1992-12#1)(2008-10#5)(2008-11#1)(2012-3#1)
can be performed on##2##4##(2008-11#1)(2008-9#1)
can be performed safely##2##4##(1991-3#2)
can be performed to##3##4##(2008-11#2)(2008-3#1)
can be performed using##3##4##(2008-10#2)(2008-4#1)
can be performed with##5##4##(1990-2#1)(1992-3#1)(1995-1#1)(2008-3#1)(2008-7#1)
can be performed##38##3##(1990-2#1)(1991-3#4)(1992-12#1)(1992-3#1)(1992-9#1)(1995-1#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-10#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-3#1)
can be placed in##2##4##(2008-10#1)(2008-11#1)
can be placed##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
can be positive##2##3##(1995-12#1)(2009-7#1)
can be possible by##2##4##(2008-11#1)(2009-10#1)
can be predicted by##3##4##(1997-6#1)(2008-10#1)(2008-7#1)
can be predicted from the##3##5##(1997-2#1)(2008-10#1)(2008-3#1)
can be predicted from##5##4##(1993-6#1)(1997-2#1)(2008-10#2)(2008-3#1)
can be predicted##12##3##(1993-6#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
can be prepared in##4##4##(2008-10#1)(2008-11#2)(2008-4#1)
can be prepared##8##3##(2008-10#3)(2008-11#3)(2008-4#1)(2008-9#1)
can be present in##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
can be present##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)
can be prevented by##7##4##(1991-3#1)(1992-5#1)(1993-12#1)(1995-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
can be prevented##12##3##(1991-3#1)(1992-5#1)(1993-12#1)(1995-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
can be problematic##3##3##(2008-1#1)(2008-9#1)(2009-12#1)
can be processed in##2##4##(2008-10#1)(2008-3#1)
can be processed##5##3##(2008-10#3)(2008-3#1)(2012-2#1)
can be produced by##2##4##(1994-9#1)(2008-3#1)
can be produced##6##3##(1994-9#1)(2008-11#3)(2008-3#1)(2008-4#1)
can be promoted##3##3##(1997-7#1)(2008-9#1)(2011-1#1)
can be properly##2##3##(1993-8#1)(2008-10#1)
can be proposed##2##3##(1994-2#1)(2008-4#1)
can be provided##4##3##(1995-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
can be quantified by##2##4##(2008-10#1)(2008-4#1)
can be quantified using##2##4##(2008-10#1)(2011-2#1)
can be quantified with##4##4##(2008-10#3)(2008-5#1)
can be quantified##14##3##(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
can be quantitated##2##3##(2008-4#2)
can be quantitatively##4##3##(2008-10#4)
can be quite##3##3##(1994-3#1)(2008-5#1)(2010-10#1)
can be rapidly and easily##2##5##(2008-10#2)
can be rapidly##4##3##(2008-10#2)(2008-4#1)(2013-8#1)
can be rationalized##2##3##(1994-5#1)(2008-10#1)
can be reached##5##3##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
can be readily applied to##2##5##(2008-10#2)
can be readily determined##2##4##(2008-10#1)(2009-11#1)
can be readily##21##3##(1990-8#1)(1991-10#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-7#1)(2011-2#1)
can be realised##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
can be recognised##2##3##(2007-12#1)(2008-11#1)
can be recommended for clinical##2##5##(1993-2#2)
can be recommended for##6##4##(1993-2#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
can be recommended##7##3##(1993-2#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
can be recovered from##2##4##(2008-10#1)(2008-6#1)
can be recovered##6##3##(2008-10#3)(2008-3#1)(2008-6#1)(2012-12#1)
can be recruited##2##3##(2008-11#1)(2012-2#1)
can be reduced by##11##4##(1993-8#1)(1996-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2011-3#1)(2013-1#1)
can be reduced significantly##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
can be reduced to##2##4##(2008-10#1)(2010-8#1)
can be reduced##26##3##(1990-11#1)(1993-12#1)(1993-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#2)(2010-8#2)(2011-3#1)(2013-1#1)
can be regarded as a##2##5##(1994-2#1)(2008-10#1)
can be regarded as##7##4##(1994-2#1)(1995-11#1)(2007-12#1)(2008-10#3)(2011-2#1)
can be regenerated by simply polishing##2##6##(2008-10#2)
can be regenerated by simply##3##5##(2008-10#3)
can be regenerated by##6##4##(2008-10#6)
can be regenerated##8##3##(2008-10#8)
can be regulated by##6##4##(1995-11#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-3#1)
can be regulated##9##3##(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)
can be related to the##2##5##(1995-3#1)(2008-10#1)
can be related to##5##4##(1995-3#1)(2008-10#2)(2010-11#1)(2013-1#1)
can be related with##2##4##(2008-10#1)(2013-8#1)
can be related##7##3##(1995-3#1)(2008-10#3)(2010-11#1)(2013-1#1)(2013-8#1)
can be relatively##2##3##(2008-11#1)(2008-8#1)
can be reliably used##3##4##(1992-3#1)(1997-3#1)(2008-10#1)
can be reliably##4##3##(1992-3#1)(1997-3#1)(2008-10#1)(2008-11#1)
can be removed by##2##4##(2008-3#1)(2011-2#1)
can be removed from the##2##5##(2008-10#2)
can be removed from##3##4##(2008-10#2)(2009-9#1)
can be removed##8##3##(2008-10#3)(2008-11#2)(2008-3#1)(2009-9#1)(2011-2#1)
can be repaired by##2##4##(2008-8#1)(2008-9#1)
can be repeatedly##2##3##(2008-10#1)(2008-9#1)
can be replaced##2##3##(2008-10#1)(2008-11#1)
can be reported##2##3##(1994-9#1)(2008-3#1)
can be represented by##4##4##(1990-8#2)(2008-10#1)(2008-11#1)
can be represented##6##3##(1990-8#2)(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)
can be reproduced in vitro by##2##6##(1997-7#1)(2008-11#1)
can be reproduced in vitro##3##5##(1997-7#1)(2008-11#1)(2008-5#1)
can be reproduced##5##3##(1997-7#1)(2008-11#2)(2008-5#1)(2009-8#1)
can be resolved by##4##4##(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)
can be resolved##9##3##(1991-3#1)(1993-9#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)
can be restored by##3##4##(1990-5#1)(1996-3#1)(2008-4#1)
can be restored##7##3##(1990-5#1)(1994-8#1)(1996-3#1)(1997-7#1)(2008-4#1)(2008-9#1)(2011-2#1)
can be retrieved with##2##4##(2008-3#2)
can be retrieved##3##3##(2008-3#3)
can be reversed by##2##4##(1994-8#1)(2013-8#1)
can be reversed##3##3##(1994-8#1)(2013-7#1)(2013-8#1)
can be safely used##2##4##(2008-11#1)(2011-2#1)
can be safely##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#2)
can be said##3##3##(1990-2#1)(1992-2#1)(2011-2#1)
can be searched##2##3##(1991-2#1)(2008-3#1)
can be secreted##2##3##(2008-11#1)(2009-3#1)
can be seen as##2##4##(2008-12#1)(2011-2#1)
can be seen in the##2##5##(2008-11#1)(2011-2#1)
can be seen in##5##4##(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
can be seen##13##3##(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#2)(2011-2#2)(2012-2#1)
can be selected##3##3##(2008-10#2)(2008-11#1)
can be selectively##5##3##(1990-9#1)(2008-10#2)(2008-7#1)(2011-2#1)
can be sensitized##2##3##(2008-10#1)(2008-11#1)
can be separated by##4##4##(1996-2#1)(2008-10#2)(2008-11#1)
can be separated from##5##4##(2008-10#5)
can be separated in##2##4##(2008-10#2)
can be separated with high##2##5##(2008-10#2)
can be separated with##4##4##(2008-10#3)(2013-8#1)
can be separated##24##3##(1996-2#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-9#1)(2013-8#1)
can be seriously##2##3##(1995-12#1)(2008-11#1)
can be severe in##2##4##(2008-10#2)
can be severe##3##3##(2008-10#2)(2008-7#1)
can be shifted##2##3##(1991-3#1)(2008-3#1)
can be shown##2##3##(1991-5#1)(2009-12#1)
can be significantly reduced##2##4##(2008-10#1)(2008-7#1)
can be significantly##7##3##(2007-12#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-1#1)
can be simulated by##2##4##(2008-10#1)(2008-7#1)
can be simulated##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
can be simultaneously determined##2##4##(2008-10#2)
can be simultaneously##5##3##(1994-5#1)(2008-10#4)
can be solved with##2##4##(2008-3#1)(2008-7#1)
can be solved##7##3##(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-12#1)
can be specifically##2##3##(1996-12#1)(2011-2#1)
can be spectrophotometrically monitored at##2##5##(2008-10#2)
can be standardized##2##3##(2008-10#2)
can be stimulated by##2##4##(1990-5#1)(1993-12#1)
can be stored in##2##4##(2008-10#1)(2008-3#1)
can be stored##4##3##(1990-12#2)(2008-10#1)(2008-3#1)
can be strongly##2##3##(2008-10#1)(2008-8#1)
can be studied in##2##4##(2008-10#1)(2008-11#1)
can be studied##6##3##(2008-10#3)(2008-11#1)(2010-4#1)(2011-2#1)
can be subject to##2##4##(2008-10#2)
can be substantially##2##3##(1992-3#1)(2008-10#1)
can be successfully applied to the##3##6##(2008-10#3)
can be successfully applied to##4##5##(2008-10#3)(2008-3#1)
can be successfully applied##7##4##(2008-10#6)(2008-3#1)
can be successfully used for##2##5##(2008-10#1)(2011-2#1)
can be successfully used to##2##5##(2010-4#1)(2012-2#1)
can be successfully used##5##4##(2008-10#2)(2010-4#1)(2011-2#1)(2012-2#1)
can be successfully##17##3##(1997-8#1)(2008-10#9)(2008-3#1)(2009-12#1)(2010-4#1)(2011-2#3)(2012-2#1)
can be suggested##4##3##(1990-5#1)(1994-11#1)(2008-10#1)(2010-4#1)
can be summarized as follows##2##5##(1995-9#2)
can be summarized##3##3##(1995-9#2)(2008-7#1)
can be supported##2##3##(2008-11#2)
can be suppressed by##2##4##(2007-11#1)(2008-11#1)
can be synthesized##2##3##(1992-12#1)(1992-6#1)
can be tailored##2##3##(2007-11#1)(2009-7#1)
can be taken into account by considering##2##7##(2008-10#2)
can be taken into##3##4##(2008-10#2)(2010-5#1)
can be taken to##3##4##(1990-12#1)(1994-9#1)(2008-8#1)
can be taken##9##3##(1990-12#1)(1994-9#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-5#1)
can be targeted by##2##4##(2009-4#1)(2011-2#1)
can be targeted##3##3##(1997-7#1)(2009-4#1)(2011-2#1)
can be tested##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
can be the##7##3##(1997-3#1)(2008-10#3)(2008-12#1)(2010-6#1)(2012-2#1)
can be tolerated in considerable amounts##2##6##(2008-10#2)
can be tolerated##6##3##(1990-11#1)(2008-10#4)(2008-3#1)
can be traced to##2##4##(1994-12#1)(2008-10#1)
can be traced##3##3##(1994-12#1)(2008-10#1)(2009-6#1)
can be transferred to##2##4##(2008-10#2)
can be transferred##5##3##(2008-10#2)(2008-8#1)(2010-6#1)(2013-1#1)
can be transformed##3##3##(1994-12#1)(2008-7#1)(2013-8#1)
can be translated into##3##4##(1991-12#1)(2008-6#1)(2008-8#1)
can be translated##4##3##(1991-12#1)(2008-6#1)(2008-8#1)(2012-2#1)
can be transmitted from##2##4##(1990-9#1)(2008-10#1)
can be transmitted through##2##4##(1996-5#1)(2008-10#1)
can be transmitted##5##3##(1990-9#1)(1996-5#1)(2008-10#3)
can be transplanted##2##3##(2008-11#1)(2008-8#1)
can be transported##3##3##(2008-10#2)(2008-11#1)
can be treated as##3##4##(1990-9#1)(2008-10#1)(2008-3#1)
can be treated with##7##4##(1990-9#1)(1991-3#1)(1991-9#1)(1992-5#1)(1996-11#1)(2007-8#1)(2008-7#1)
can be treated##16##3##(1990-12#1)(1990-9#2)(1991-3#1)(1991-9#2)(1992-5#1)(1995-2#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)
can be triggered by##2##4##(1996-12#1)(2009-4#1)
can be tuned##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)
can be understood as a##2##5##(2008-10#1)(2008-6#1)
can be understood as##3##4##(2008-10#1)(2008-6#1)(2013-8#1)
can be understood##6##3##(1990-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
can be undertaken##2##3##(1992-9#1)(1993-12#1)
can be used as a guide##2##6##(2011-2#1)(2012-2#1)
can be used as a new##5##6##(2008-10#3)(2008-5#2)
can be used as a##35##5##(1996-3#1)(1997-8#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-2#2)(2013-1#2)
can be used as an aid##2##6##(1991-11#1)(2008-10#1)
can be used as an##12##5##(1990-5#1)(1991-11#1)(1993-9#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2011-2#1)
can be used as efficient##2##5##(2008-10#1)(2008-8#1)
can be used as the##3##5##(2008-10#2)(2013-8#1)
can be used as##67##4##(1990-5#1)(1991-11#1)(1993-9#1)(1994-11#1)(1996-3#1)(1997-8#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-2#2)(2012-2#5)(2013-1#4)(2013-8#1)
can be used by##5##4##(1991-1#1)(2008-12#2)(2009-6#1)(2009-8#1)
can be used directly for##2##5##(1995-6#1)(2008-10#1)
can be used directly##3##4##(1995-6#1)(2008-10#2)
can be used for at least 3 months without any considerable##3##11##(2008-10#3)
can be used for at least 3 months without any##5##10##(2008-10#5)
can be used for at least##12##6##(2008-10#12)
can be used for both##2##5##(2008-11#1)(2008-2#1)
can be used for determination of##2##6##(2008-10#2)
can be used for determining##2##5##(2008-10#2)
can be used for its determination##2##6##(2008-10#2)
can be used for more than##4##6##(2008-10#4)
can be used for purposes of##2##6##(1991-6#1)(1994-6#1)
can be used for rapid##2##5##(2008-10#1)(2008-4#1)
can be used for routine##2##5##(2008-10#1)(2008-12#1)
can be used for simultaneous##2##5##(2008-10#1)(2011-3#1)
can be used for the determination of##4##7##(2008-10#4)
can be used for the##24##5##(2008-10#20)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
can be used for##106##4##(1991-6#1)(1992-3#1)(1992-8#1)(1994-6#1)(1994-8#1)(1997-7#1)(2007-12#1)(2008-10#64)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-8#2)(2008-9#3)(2009-10#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
can be used in a##4##5##(2008-10#2)(2008-3#1)(2008-4#1)
can be used in clinical##2##5##(2010-8#1)(2011-1#1)
can be used in the pH range##5##7##(2008-10#5)
can be used in the##13##5##(2008-10#8)(2010-10#1)(2011-2#3)(2013-1#1)
can be used in##37##4##(1995-12#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-8#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#2)
can be used instead##2##4##(2008-10#2)
can be used on##3##4##(1997-4#1)(2008-2#1)(2013-8#1)
can be used over a##4##5##(2008-10#4)
can be used prior to##2##5##(2008-10#1)(2010-8#1)
can be used successfully##2##4##(2008-5#1)(2009-3#1)
can be used to accurately##2##5##(1994-3#1)(2008-10#1)
can be used to assess the##2##6##(2008-11#1)(2009-8#1)
can be used to assess##3##5##(2008-11#1)(2009-11#1)(2009-8#1)
can be used to calculate the##2##6##(2008-10#2)
can be used to characterize##4##5##(2008-11#1)(2008-3#2)(2008-9#1)
can be used to compare##2##5##(2008-10#1)(2008-9#1)
can be used to compute##2##5##(2008-4#1)(2008-8#1)
can be used to create##2##5##(2008-10#1)(2009-11#1)
can be used to define##2##5##(2008-10#1)(2008-11#1)
can be used to derive##2##5##(2008-10#1)(2008-9#1)
can be used to describe the##2##6##(2008-3#1)(2010-12#1)
can be used to describe##3##5##(2008-3#1)(2008-9#1)(2010-12#1)
can be used to detect##9##5##(2008-10#4)(2008-4#4)(2010-6#1)
can be used to determine the relevance of##2##8##(1996-2#1)(2008-10#1)
can be used to determine the##9##6##(1996-2#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)
can be used to determine##14##5##(1993-12#1)(1996-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
can be used to develop##2##5##(2008-11#1)(2012-2#1)
can be used to effectively##2##5##(2008-10#1)(2008-11#1)
can be used to enhance##2##5##(2008-11#1)(2008-3#1)
can be used to establish##2##5##(2008-10#1)(2008-11#1)
can be used to estimate the##3##6##(2008-10#3)
can be used to estimate##4##5##(2008-10#3)(2008-2#1)
can be used to evaluate the##3##6##(1991-1#1)(1997-8#1)(2008-10#1)
can be used to evaluate##4##5##(1991-1#1)(1997-8#1)(2008-10#2)
can be used to generate##3##5##(2008-1#1)(2011-3#1)(2012-2#1)
can be used to help##4##5##(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
can be used to identify the##2##6##(1995-2#1)(2008-10#1)
can be used to identify##8##5##(1993-3#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)
can be used to improve the##2##6##(1994-3#1)(2009-6#1)
can be used to inform##2##5##(1996-1#1)(2013-8#1)
can be used to investigate the##2##6##(1996-12#1)(2012-3#1)
can be used to monitor##2##5##(2008-10#1)(2008-4#1)
can be used to obtain##2##5##(2008-10#1)(2008-12#1)
can be used to overcome##2##5##(1996-3#1)(2012-2#1)
can be used to predict the##3##6##(1997-9#1)(2008-10#1)(2013-8#1)
can be used to predict##5##5##(1997-9#1)(2008-10#2)(2008-3#1)(2013-8#1)
can be used to produce##6##5##(2008-11#1)(2008-2#2)(2009-12#1)(2009-5#1)(2010-3#1)
can be used to quantitate##2##5##(1990-12#1)(2008-4#1)
can be used to reconstruct##2##5##(2008-3#1)(2010-6#1)
can be used to solve##3##5##(2008-11#1)(2009-12#1)(2010-7#1)
can be used to study the##2##6##(2008-10#1)(2008-4#1)
can be used to study##6##5##(1993-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-9#1)
can be used to test##4##5##(1995-6#1)(2008-1#1)(2008-10#1)(2012-3#1)
can be used to transfer##2##5##(1990-5#1)(2008-10#1)
can be used to treat##2##5##(1992-1#1)(1997-6#1)
can be used to##186##4##(1990-12#1)(1990-5#1)(1991-1#1)(1992-1#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#2)(1995-2#2)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#2)(1997-8#1)(1997-9#1)(2007-11#1)(2008-1#4)(2008-10#56)(2008-11#16)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#12)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#6)(2009-11#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#5)
can be used when##3##4##(2008-10#2)(2008-12#1)
can be used with##7##4##(1991-3#1)(1992-3#1)(2008-10#2)(2008-3#1)(2013-1#2)
can be used##464##3##(1990-12#2)(1990-5#2)(1991-1#2)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#186)(2008-11#28)(2008-12#11)(2008-2#8)(2008-3#19)(2008-4#24)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#12)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#15)(2011-3#2)(2012-12#2)(2012-2#12)(2012-3#5)(2013-1#15)(2013-8#9)
can be useful as##2##4##(2008-10#2)
can be useful for the##2##5##(2008-10#1)(2013-8#1)
can be useful for##7##4##(2008-10#4)(2008-2#1)(2012-3#1)(2013-8#1)
can be useful in##8##4##(1991-2#1)(1996-11#1)(1996-12#1)(2008-10#2)(2008-3#1)(2010-10#1)(2011-1#1)
can be useful to##5##4##(1992-2#1)(2008-10#1)(2008-4#2)(2011-2#1)
can be useful##25##3##(1991-2#1)(1992-2#1)(1994-8#1)(1996-11#1)(1996-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
can be utilized for##3##4##(1994-11#1)(2008-10#1)(2009-10#1)
can be utilized to##2##4##(2008-4#1)(2008-9#1)
can be utilized##10##3##(1994-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)
can be varied##2##3##(2008-11#1)(2008-3#1)
can be very useful##2##4##(2010-1#1)(2013-1#1)
can be very##8##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2012-12#1)(2013-1#1)
can be viewed as##3##4##(1991-3#1)(1993-12#1)(1994-12#1)
can be viewed##5##3##(1991-3#1)(1993-12#1)(1994-12#1)(2011-2#1)(2011-7#1)
can be virtually##2##3##(1991-3#1)(2011-2#1)
can be visualized##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)
can be well separated within##2##5##(2008-10#2)
can be well separated##3##4##(2008-10#3)
can be well##4##3##(2008-10#4)
can be written as a##2##5##(2008-10#1)(2013-1#1)
can be written as##3##4##(2008-10#2)(2013-1#1)
can be written##4##3##(2008-10#3)(2013-1#1)
can be##2891##2##(1990-11#6)(1990-12#10)(1990-2#6)(1990-3#1)(1990-5#15)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#7)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#8)(1991-3#18)(1991-5#4)(1991-6#1)(1991-9#7)(1992-1#8)(1992-10#2)(1992-11#5)(1992-12#10)(1992-2#10)(1992-3#10)(1992-4#1)(1992-5#7)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#16)(1993-2#10)(1993-3#12)(1993-6#10)(1993-8#8)(1993-9#6)(1994-11#5)(1994-12#12)(1994-2#11)(1994-3#19)(1994-5#10)(1994-6#1)(1994-8#8)(1994-9#7)(1995-1#6)(1995-11#6)(1995-12#13)(1995-2#17)(1995-3#5)(1995-5#3)(1995-6#5)(1995-9#3)(1996-1#8)(1996-11#10)(1996-12#12)(1996-2#7)(1996-3#11)(1996-5#5)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#8)(1997-2#9)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#11)(1997-7#10)(1997-8#13)(1997-9#1)(2006-6#2)(2007-11#10)(2007-12#13)(2007-8#3)(2008-1#16)(2008-10#983)(2008-11#214)(2008-12#44)(2008-2#31)(2008-3#124)(2008-4#88)(2008-5#46)(2008-6#24)(2008-7#68)(2008-8#76)(2008-9#100)(2009-1#3)(2009-10#9)(2009-11#12)(2009-12#18)(2009-2#2)(2009-3#7)(2009-4#3)(2009-5#8)(2009-6#7)(2009-7#7)(2009-8#24)(2009-9#6)(2010-1#7)(2010-10#11)(2010-11#11)(2010-12#15)(2010-3#6)(2010-4#11)(2010-5#9)(2010-6#16)(2010-7#10)(2010-8#21)(2010-9#3)(2011-1#12)(2011-10#1)(2011-2#102)(2011-3#8)(2011-7#3)(2012-12#12)(2012-2#56)(2012-3#30)(2012-4#1)(2012-7#2)(2012-9#3)(2013-1#64)(2013-7#3)(2013-8#43)
can become##6##2##(2008-10#2)(2008-11#3)(2013-1#1)
can begin##2##2##(1994-1#1)(2008-7#1)
can benefit from a##2##4##(1992-3#1)(1997-3#1)
can benefit from the##3##4##(1991-2#1)(1992-2#1)(2008-9#1)
can benefit from##10##3##(1991-2#1)(1992-2#1)(1992-3#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-9#2)(2011-2#1)(2013-8#1)
can best##5##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
can bind to the##6##4##(1993-8#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#2)
can bind to##10##3##(1990-9#1)(1993-8#1)(1994-5#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-8#3)
can bind##21##2##(1990-9#2)(1991-5#1)(1992-3#1)(1993-8#1)(1994-5#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#5)(2009-12#1)(2011-2#3)
can block##2##2##(2008-8#1)(2008-9#1)
can boost the##2##3##(2008-5#1)(2012-3#1)
can both##3##2##(2008-4#1)(2008-5#1)(2011-10#1)
can bring about##3##3##(1990-11#1)(2008-11#1)(2012-2#1)
can bring##5##2##(1990-11#1)(1996-3#1)(2008-11#1)(2008-12#1)(2012-2#1)
can build##2##2##(2010-10#1)(2013-1#1)
can carry##2##2##(2008-10#1)(2010-1#1)
can catalyze the##3##3##(1993-8#1)(2008-10#2)
can catalyze##4##2##(1993-8#1)(1994-5#1)(2008-10#2)
can cause a##4##3##(1990-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
can cause intrauterine##2##3##(1992-5#1)(2013-1#1)
can cause many##2##3##(1993-3#1)(2008-10#1)
can cause serious##2##3##(2008-11#1)(2010-7#1)
can cause severe##3##3##(1996-11#1)(2008-10#1)(2011-2#1)
can cause##66##2##(1990-2#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-12#1)(1996-11#2)(1997-2#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
can change the##2##3##(1994-3#1)(2012-3#1)
can change##5##2##(1994-3#1)(2008-11#1)(2008-8#1)(2012-3#2)
can coexist##3##2##(1995-5#1)(2008-8#1)(2008-9#1)
can come to##2##3##(2008-5#1)(2012-2#1)
can compensate##2##2##(1997-3#1)(2008-3#1)
can complement##2##2##(2008-5#1)(2008-8#1)
can complete##4##2##(2008-10#4)
can completely##2##2##(1995-5#1)(2008-3#1)
can complex with##2##3##(1991-5#1)(1994-5#1)
can complicate##2##2##(1995-3#1)(2012-3#1)
can conclude that##6##3##(1994-8#1)(2009-12#1)(2011-2#2)(2011-7#1)(2013-1#1)
can conclude##7##2##(1994-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2011-7#1)(2013-1#1)
can confer##3##2##(1993-8#1)(2008-9#1)(2013-8#1)
can considerably##3##2##(1997-8#1)(2008-11#1)(2008-3#1)
can contain##2##2##(2008-10#1)(2008-8#1)
can contaminate the##2##3##(2008-10#1)(2008-4#1)
can contract##2##2##(1995-12#1)(1996-2#1)
can contribute greatly to##2##4##(2010-6#2)
can contribute to the##8##4##(1990-6#1)(1991-3#1)(1994-12#1)(1997-7#1)(2008-11#1)(2009-7#1)(2010-8#1)(2011-3#1)
can contribute to##18##3##(1990-6#1)(1991-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)
can contribute##24##2##(1990-6#1)(1991-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-6#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
can control##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
can cooperate with##2##3##(1994-12#1)(2009-9#1)
can create a##3##3##(1993-2#1)(1997-3#1)(2008-5#1)
can create an##3##3##(1994-12#1)(2010-5#1)(2010-8#1)
can create##8##2##(1993-2#1)(1994-12#1)(1997-3#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)
can damage##2##2##(1992-9#1)(2008-10#1)
can deal with##2##3##(1995-12#1)(2008-10#1)
can decrease the##3##3##(2011-3#1)(2013-1#1)(2013-8#1)
can decrease##7##2##(1995-3#1)(2008-11#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
can defend##2##2##(2008-6#1)(2009-8#1)
can define##2##2##(1994-12#1)(2012-3#1)
can degrade##3##2##(2008-10#1)(2009-3#1)(2012-2#1)
can delay the evolution of##2##5##(1995-6#2)
can delay##4##2##(1990-5#1)(1995-6#2)(2008-9#1)
can deliver##2##2##(2008-7#1)(2011-2#1)
can destroy##2##2##(1994-9#1)(2008-11#1)
can detect##8##2##(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
can determine the##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)
can determine##6##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-2#1)
can detrimentally affect##3##3##(2008-11#1)(2010-11#1)(2013-1#1)
can develop at any##2##4##(1993-2#1)(2011-1#1)
can develop##12##2##(1993-2#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)
can differ in##2##3##(2008-10#1)(2008-8#1)
can differ##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
can differentiate into##2##3##(2008-7#2)
can differentiate##4##2##(2008-10#1)(2008-7#2)(2011-2#1)
can directly##6##2##(1991-5#1)(1992-1#1)(1997-1#1)(2008-11#1)(2009-3#1)(2011-2#1)
can discriminate between tastants##2##4##(2008-11#2)
can discriminate between##3##3##(2008-10#1)(2008-11#2)
can discriminate##4##2##(1991-5#1)(2008-10#1)(2008-11#2)
can distinguish the##2##3##(2008-10#1)(2008-9#1)
can distinguish##6##2##(2008-10#3)(2008-9#1)(2009-6#1)(2009-8#1)
can do to##3##3##(2008-12#2)(2008-6#1)
can do##6##2##(1992-8#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#1)
can dramatically##5##2##(1992-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
can drive the##2##3##(2008-9#1)(2009-9#1)
can drive##4##2##(1991-5#1)(2008-10#1)(2008-9#1)(2009-9#1)
can dynamically##2##2##(2008-11#1)(2008-12#1)
can easily and quickly label##2##5##(2008-10#2)
can easily be determined##2##4##(2007-12#1)(2008-10#1)
can easily be##15##3##(1990-2#1)(1990-9#1)(1994-3#1)(1996-5#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-3#1)(2010-1#1)
can easily##22##2##(1990-2#1)(1990-9#1)(1991-3#1)(1994-3#1)(1995-12#1)(1996-5#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-3#1)(2010-1#1)(2011-2#1)(2012-3#1)
can effectively communicate##2##3##(1992-2#1)(1994-2#1)
can effectively increase the##2##4##(2008-3#1)(2012-3#1)
can effectively inhibit##2##3##(2008-11#1)(2008-9#1)
can effectively suppress##2##3##(2008-3#1)(2008-9#1)
can effectively##17##2##(1992-2#1)(1994-2#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)
can efficiently##4##2##(2008-10#1)(2008-6#1)(2011-3#2)
can either enhance or##2##4##(2008-10#1)(2008-11#1)
can either##5##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
can elicit##3##2##(2008-11#1)(2008-9#1)(2012-2#1)
can eliminate the##4##3##(2008-10#2)(2008-3#1)(2011-1#1)
can eliminate##9##2##(1995-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
can emit##2##2##(2008-10#1)(2008-11#1)
can enable##3##2##(2008-11#1)(2012-2#2)
can engage in##2##3##(2008-11#1)(2013-1#1)
can enhance the##10##3##(1993-3#1)(2008-10#2)(2008-11#4)(2008-5#1)(2009-11#1)(2011-3#1)
can enhance##22##2##(1993-3#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-11#1)(2009-5#1)(2011-3#1)
can ensure the##3##3##(1992-2#1)(1993-2#1)(2008-3#1)
can enter##6##2##(1994-12#1)(1995-5#1)(2008-11#1)(2008-9#2)(2011-2#1)
can equally##2##2##(2008-11#1)(2010-10#1)
can estimate##2##2##(2008-10#1)(2008-4#1)
can evaluate##5##2##(2008-9#1)(2010-12#1)(2012-2#1)(2012-9#1)(2013-1#1)
can even lead to##2##4##(2008-10#1)(2008-5#1)
can even##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#3)
can evolve when##2##3##(2008-8#2)
can evolve##9##2##(2008-10#1)(2008-8#7)(2010-10#1)
can exert##2##2##(2008-10#1)(2009-3#1)
can exhibit##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2013-8#2)
can expect to spend##2##4##(2011-2#2)
can expect##6##2##(2008-3#2)(2009-9#1)(2011-2#2)(2013-1#1)
can experience##3##2##(1995-3#1)(2008-12#1)(2013-8#1)
can explain the##7##3##(1991-9#1)(2008-10#1)(2008-7#1)(2008-8#3)(2012-3#1)
can explain##10##2##(1991-9#1)(1996-3#1)(2008-10#2)(2008-7#1)(2008-8#3)(2011-2#1)(2012-3#1)
can exploit##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
can express##2##2##(1993-3#1)(2008-9#1)
can extend to##2##3##(1991-3#1)(2008-5#1)
can facilitate the learning and##2##5##(1997-2#1)(2008-11#1)
can facilitate the##5##3##(1995-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)
can facilitate##14##2##(1994-12#1)(1995-12#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2013-1#1)
can favour##3##2##(2008-10#1)(2010-10#1)(2012-12#1)
can find##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
can form a##5##3##(2008-10#3)(2008-8#2)
can form the 1##2##4##(2008-10#2)
can form the##3##3##(1994-12#1)(2008-10#2)
can form##13##2##(1990-2#1)(1994-12#1)(2008-10#7)(2008-8#2)(2008-9#1)(2011-2#1)
can function as##3##3##(1995-2#1)(2008-10#1)(2009-10#1)
can function##6##2##(1993-12#1)(1995-2#1)(2008-10#2)(2009-10#1)(2009-8#1)
can further##4##2##(1990-8#1)(2008-8#1)(2012-3#1)(2013-1#1)
can gain##6##2##(1996-3#1)(2008-6#1)(2008-8#3)(2010-4#1)
can generate##8##2##(1994-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)(2013-7#1)
can germinate##2##2##(2011-2#2)
can get##5##2##(1993-3#1)(1994-2#1)(1994-5#1)(2008-4#1)(2011-3#1)
can give a##4##3##(1993-6#1)(2008-10#2)(2008-6#1)
can give insights into the##2##5##(2010-7#1)(2012-3#1)
can give rise to##5##4##(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
can give the##2##3##(1993-12#1)(2008-10#1)
can give##25##2##(1990-5#1)(1993-12#1)(1993-6#1)(1994-2#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
can greatly alter the##2##4##(2008-9#1)(2012-3#1)
can greatly improve the##2##4##(2008-10#1)(2008-6#1)
can greatly##4##2##(2008-10#1)(2008-6#1)(2008-9#1)(2012-3#1)
can grow##5##2##(1990-5#1)(2008-11#1)(2009-10#1)(2009-6#1)(2009-8#1)
can hardly be##2##3##(2007-12#1)(2009-10#1)
can have a direct##2##4##(2008-10#1)(2011-2#1)
can have a significant impact on##2##6##(2008-3#1)(2012-2#1)
can have a significant##3##4##(2008-3#1)(2008-5#1)(2012-2#1)
can have a##16##3##(1992-12#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-9#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
can have an##4##3##(1992-1#1)(2008-8#1)(2012-2#2)
can have beneficial##2##3##(2008-7#2)
can have devastating##3##3##(2008-8#1)(2011-2#2)
can have the##2##3##(1995-5#1)(2012-3#1)
can have##51##2##(1992-1#1)(1992-12#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-8#2)(2011-2#4)(2012-2#6)(2012-3#1)(2013-1#3)
can help in the##2##4##(1990-2#1)(2010-8#1)
can help to##10##3##(1990-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-8#1)(2013-1#2)
can help us##2##3##(1991-6#1)(2008-10#1)
can help with##2##3##(1995-3#1)(2010-8#1)
can help##41##2##(1990-2#1)(1990-3#1)(1991-6#1)(1992-12#2)(1993-1#1)(1993-2#1)(1994-1#2)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-7#2)(2010-8#2)(2011-2#1)(2011-3#1)(2013-1#3)(2013-8#1)
can identify##6##2##(1997-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2013-1#1)
can impair the##3##3##(1991-12#1)(2008-10#2)
can impair##4##2##(1991-12#1)(2008-10#2)(2009-10#1)
can improve its##2##3##(2008-3#1)(2008-8#1)
can improve symptom control##2##4##(2010-12#1)(2011-2#1)
can improve the##11##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)
can improve##30##2##(1993-3#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#4)
can in turn##2##3##(2008-5#1)(2009-5#1)
can in##6##2##(1990-8#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#2)
can include##4##2##(1994-2#1)(2008-10#1)(2010-6#1)(2012-3#1)
can increase precision in##2##4##(1993-9#1)(2008-8#1)
can increase rapidly##2##3##(2008-10#1)(2008-8#1)
can increase the risk##2##4##(2011-2#1)(2012-2#1)
can increase the##8##3##(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-2#1)
can increase with##2##3##(2008-8#1)(2008-9#1)
can increase##31##2##(1991-11#1)(1993-9#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-8#5)(2008-9#3)(2009-12#1)(2009-6#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)
can indeed##2##2##(2009-11#1)(2009-8#1)
can indicate##4##2##(1995-11#1)(2008-10#3)
can induce an##2##3##(2008-11#1)(2013-1#1)
can induce apoptosis##2##3##(2008-8#1)(2008-9#1)
can induce formation of##2##4##(2008-6#1)(2011-2#1)
can induce systemic resistance in##2##5##(2008-10#2)
can induce systemic resistance##3##4##(2008-10#2)(2013-8#1)
can induce the production of##2##5##(2008-10#1)(2008-11#1)
can induce the##6##3##(1992-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)
can induce##41##2##(1992-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1997-7#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2011-2#4)(2012-5#1)(2013-1#1)(2013-8#2)
can infect##4##2##(2008-10#4)
can influence the outcome of##2##5##(2008-12#1)(2013-1#1)
can influence the process of myelination##2##6##(2008-5#2)
can influence the##13##3##(1991-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
can influence##32##2##(1990-8#1)(1991-2#1)(1994-12#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
can inform##2##2##(2008-11#1)(2013-8#1)
can inhibit the##3##3##(2008-8#3)
can inhibit##13##2##(1991-3#1)(1992-12#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#4)(2011-2#1)(2011-3#1)
can initiate##4##2##(1990-5#1)(2008-10#1)(2011-2#1)(2013-8#1)
can insure##2##2##(1991-12#1)(1993-2#1)
can interact with##5##3##(1994-3#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-9#1)
can interact##7##2##(1994-3#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-8#1)(2008-9#1)
can interfere with the##4##4##(1993-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
can interfere with##7##3##(1993-3#1)(2008-10#2)(2008-11#1)(2010-11#1)(2012-12#1)(2012-3#1)
can interfere##9##2##(1993-3#1)(2008-10#4)(2008-11#1)(2010-11#1)(2012-12#1)(2012-3#1)
can involve##5##2##(2008-1#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
can it##2##2##(1991-8#1)(2012-12#1)
can keep##3##2##(1993-2#1)(2008-11#1)(2008-9#1)
can lead to a##3##4##(2008-10#1)(2009-12#1)(2013-8#1)
can lead to biased##2##4##(2008-12#1)(2008-8#1)
can lead to chronic##2##4##(2008-7#1)(2011-2#1)
can lead to either##2##4##(2008-10#1)(2013-8#1)
can lead to increased##2##4##(2008-3#1)(2010-11#1)
can lead to more##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
can lead to positive##2##4##(2008-10#2)
can lead to serious##3##4##(1997-1#1)(2008-10#1)(2009-9#1)
can lead to significant##3##4##(2008-12#1)(2008-7#1)(2013-1#1)
can lead to the development and##2##6##(2008-10#1)(2008-8#1)
can lead to the development of##2##6##(2011-2#1)(2012-3#1)
can lead to the development##4##5##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
can lead to the##6##4##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
can lead to##66##3##(1990-6#1)(1992-9#1)(1997-1#1)(1997-5#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-1#1)(2009-12#2)(2009-3#2)(2009-9#1)(2010-11#2)(2010-7#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
can lead##68##2##(1990-6#1)(1992-9#1)(1995-3#1)(1997-1#1)(1997-5#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-1#1)(2009-12#2)(2009-3#2)(2009-9#1)(2010-11#2)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
can learn from##3##3##(1993-12#1)(1997-3#1)(2008-11#1)
can learn to##3##3##(1993-12#1)(1997-1#1)(2009-8#1)
can learn##8##2##(1993-12#4)(1997-1#1)(1997-3#1)(2008-11#1)(2009-8#1)
can limit##2##2##(1990-11#1)(2011-2#1)
can lower the##2##3##(2008-10#1)(2013-1#1)
can maintain a##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
can maintain##9##2##(1993-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#1)
can make a##4##3##(1992-12#1)(2008-11#1)(2008-6#1)(2010-7#1)
can make##17##2##(1991-3#1)(1992-12#1)(1993-12#1)(1994-1#1)(1995-3#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
can manifest##2##2##(1993-2#1)(2008-12#1)
can match##2##2##(2008-10#1)(2009-5#1)
can measure the##2##3##(1997-6#1)(2008-2#1)
can measure##5##2##(1997-6#1)(2008-2#1)(2008-9#1)(2009-9#1)(2013-7#1)
can mediate##3##2##(1994-5#1)(1997-7#1)(2011-2#1)
can meet the##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
can meet these requirements##2##4##(2008-10#1)(2008-5#1)
can meet##7##2##(1992-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
can mimic##6##2##(2008-10#2)(2009-1#1)(2009-9#1)(2012-2#1)(2012-3#1)
can minimize the##2##3##(2011-2#1)(2013-1#1)
can minimize##4##2##(1994-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
can moderate##2##2##(2008-10#1)(2008-12#1)
can modify the##3##3##(1990-6#1)(2008-7#1)(2011-2#1)
can modify##7##2##(1990-6#1)(1992-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
can modulate the##3##3##(1997-4#1)(2006-6#1)(2007-12#1)
can modulate##6##2##(1993-8#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#2)
can no longer be maintained##2##5##(2008-3#1)(2008-8#1)
can no longer be##4##4##(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
can no longer##6##3##(1997-5#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-5#1)
can not be considered##2##4##(2008-10#1)(2013-1#1)
can not be used##2##4##(2008-10#1)(2008-11#1)
can not be##17##3##(1993-1#1)(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#6)(2008-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
can not only##3##3##(2008-11#1)(2008-9#1)(2010-10#1)
can not##25##2##(1993-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-11#1)(2008-10#7)(2008-11#3)(2008-9#1)(2009-1#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
can now be treated##2##4##(1996-11#1)(1996-3#1)
can now be##14##3##(1990-11#1)(1990-12#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
can now##18##2##(1990-11#1)(1990-12#1)(1992-12#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
can obtain##5##2##(1994-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
can obviate the need for##2##5##(1991-11#1)(1997-8#1)
can obviously##2##2##(2008-9#2)
can occasionally##2##2##(1994-12#1)(1994-9#1)
can occur and##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
can occur as##2##3##(1994-2#1)(2008-9#1)
can occur at##2##3##(2008-10#1)(2011-2#1)
can occur even##2##3##(2008-8#1)(2011-2#1)
can occur in any##2##4##(2008-12#1)(2013-1#1)
can occur in the##2##4##(2008-3#1)(2010-9#1)
can occur in##9##3##(1991-3#1)(1995-5#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#1)
can occur only##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
can occur with##3##3##(1991-8#1)(2009-6#1)(2011-2#1)
can occur##47##2##(1991-3#1)(1991-8#1)(1992-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#10)(2012-12#1)(2013-1#2)
can offer##4##2##(1993-11#1)(1994-6#1)(1997-7#1)(2008-10#1)
can often be##4##3##(1991-6#1)(2008-4#1)(2009-9#1)(2013-1#1)
can often##9##2##(1991-6#1)(1993-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2013-1#1)
can only be achieved##2##4##(1994-12#1)(2008-7#1)
can only be obtained##2##4##(1995-2#1)(2008-11#1)
can only be##24##3##(1990-3#1)(1991-11#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)
can only##32##2##(1990-3#1)(1991-11#1)(1992-6#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
can operate in##2##3##(2008-9#1)(2010-7#1)
can operate##6##2##(2008-10#3)(2008-9#1)(2010-7#1)(2010-9#1)
can overcome##2##2##(1992-1#1)(1994-2#1)
can perform##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)
can persist##2##2##(2008-10#1)(2012-3#1)
can play a crucial role##2##5##(2008-10#1)(2008-11#1)
can play a key role in##2##6##(1995-2#1)(2010-4#1)
can play a pivotal role in##2##6##(2008-6#1)(2010-11#1)
can play a##9##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
can play an important role in reducing##2##7##(2011-2#1)(2012-2#1)
can play an important role in##7##6##(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
can play##18##2##(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
can pose a##3##3##(2010-1#1)(2011-2#1)(2013-1#1)
can possibly##3##2##(1993-6#1)(2008-10#1)(2012-3#1)
can potentially be##3##3##(2008-4#1)(2008-8#2)
can potentially##11##2##(2008-10#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#3)(2012-3#1)(2013-1#1)
can potentiate##2##2##(2008-11#1)(2010-4#1)
can predict the##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
can predict##9##2##(1991-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#2)(2013-1#2)
can prepare##3##2##(2007-12#1)(2008-11#1)(2008-12#1)
can present a##2##3##(2008-10#1)(2010-11#1)
can present as##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
can present in a##2##4##(2008-5#1)(2012-3#1)
can present with##2##3##(2008-11#1)(2013-1#1)
can present##9##2##(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
can prevent the##5##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)
can prevent##11##2##(1991-2#1)(1994-2#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-8#1)
can process##2##2##(2008-11#1)(2008-12#1)
can produce a##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
can produce##31##2##(1990-12#1)(1994-11#1)(1994-9#1)(1995-11#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#4)(2011-1#1)(2012-2#2)(2013-1#4)(2013-8#2)
can promote crop health##2##4##(2008-10#2)
can promote##9##2##(1994-8#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-6#1)(2013-8#1)
can protect##4##2##(2008-11#2)(2011-2#1)(2011-3#1)
can prove##2##2##(2008-10#1)(2010-7#1)
can provide a reliable##2##4##(2008-3#1)(2011-2#1)
can provide a useful##2##4##(2008-11#1)(2012-3#1)
can provide a valuable##2##4##(2008-9#1)(2009-12#1)
can provide a##16##3##(1993-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
can provide an excellent##2##4##(2008-12#1)(2013-1#1)
can provide an##7##3##(1994-3#1)(1996-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
can provide direct##2##3##(1994-3#1)(2012-3#1)
can provide important##3##3##(1993-3#1)(2008-10#1)(2013-1#1)
can provide information##4##3##(1993-2#1)(2008-10#1)(2010-12#1)(2013-1#1)
can provide insight into the##2##5##(2008-11#1)(2008-8#1)
can provide insights into##2##4##(2008-9#1)(2009-12#1)
can provide insights##3##3##(2008-9#1)(2009-10#1)(2009-12#1)
can provide satisfactory##2##3##(1993-2#1)(2008-10#1)
can provide the##3##3##(1990-11#1)(2009-7#1)(2012-2#1)
can provide valuable##3##3##(1995-1#1)(2008-10#1)(2008-4#1)
can provide##74##2##(1990-11#2)(1991-12#1)(1991-2#1)(1993-2#2)(1993-3#2)(1994-3#3)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#9)
can provoke##2##2##(2008-10#1)(2008-7#1)
can quantitatively##4##2##(2008-10#3)(2008-11#1)
can range##2##2##(2008-2#1)(2013-1#1)
can rapidly##4##2##(1995-2#1)(2008-10#2)(2008-6#1)
can reach high##2##3##(1991-1#1)(2008-10#1)
can reach##5##2##(1991-1#1)(2008-10#4)
can react with##8##3##(2008-10#8)
can react##9##2##(2008-10#8)(2011-2#1)
can read and write##2##4##(2008-4#1)(2008-9#1)
can readily be used to##3##5##(2008-4#2)(2008-9#1)
can readily be used##4##4##(2008-10#1)(2008-4#2)(2008-9#1)
can readily be##5##3##(2008-10#2)(2008-4#2)(2008-9#1)
can readily lead to##2##4##(2007-12#1)(2008-10#1)
can readily##8##2##(2007-12#1)(2008-10#3)(2008-4#2)(2008-9#1)(2010-4#1)
can recognize##6##2##(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)
can recover##3##2##(1995-5#1)(2008-7#1)(2013-8#1)
can reduce mortality##2##3##(1997-1#1)(2013-1#1)
can reduce or##2##3##(2008-5#1)(2009-10#1)
can reduce potato late blight severity##2##6##(2008-10#2)
can reduce the degree of##2##5##(1997-3#1)(2009-11#1)
can reduce the##13##3##(1992-9#1)(1995-5#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
can reduce##32##2##(1991-3#1)(1992-9#2)(1995-2#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
can reflect##2##2##(2008-8#1)(2013-8#1)
can regulate the##2##3##(1997-1#1)(2008-5#1)
can regulate##9##2##(1991-3#1)(1992-3#1)(1994-3#1)(1997-1#1)(2008-11#1)(2008-5#1)(2009-8#2)(2012-3#1)
can release##2##2##(2008-10#1)(2008-7#1)
can replace##5##2##(1990-8#1)(1991-11#1)(1994-1#1)(2008-3#1)(2012-2#1)
can represent##2##2##(2008-11#1)(2012-2#1)
can reproduce##2##2##(2008-11#1)(2008-8#1)
can require##2##2##(1994-8#1)(2010-6#1)
can resolve##5##2##(2008-10#3)(2008-2#1)(2008-9#1)
can respond to##3##3##(1992-12#1)(2008-8#1)(2008-9#1)
can result from a variety of##2##6##(2008-6#1)(2010-6#1)
can result from a##3##4##(2008-6#1)(2010-6#1)(2013-8#1)
can result from##6##3##(1996-2#1)(2008-6#1)(2010-6#1)(2011-2#2)(2013-8#1)
can result in a##3##4##(1991-6#1)(2008-10#1)(2008-9#1)
can result in enhanced##2##4##(2008-11#1)(2008-5#1)
can result in the##5##4##(1995-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
can result in##37##3##(1991-6#1)(1991-8#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2010-1#2)(2010-12#1)(2010-3#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
can result##43##2##(1991-6#1)(1991-8#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2010-1#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
can reveal##4##2##(1992-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
can reverse##3##2##(1997-2#1)(2008-8#1)(2013-8#1)
can rival##2##2##(2010-7#1)(2012-2#1)
can routinely be##2##3##(2008-10#1)(2008-8#1)
can safely##3##2##(2008-10#1)(2008-6#1)(2010-5#1)
can see that##2##3##(2008-11#2)
can selectively##3##2##(1990-11#1)(2008-10#2)
can serve as a##13##4##(1990-5#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#2)(2010-12#1)(2011-2#1)
can serve as an##3##4##(2008-11#1)(2008-9#1)(2009-12#1)
can serve as##25##3##(1990-5#1)(1991-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-6#1)(2008-9#3)(2009-12#1)(2010-12#1)(2011-2#2)(2012-12#1)
can serve to##2##3##(1991-12#1)(2011-2#1)
can serve##28##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-6#1)(2008-9#3)(2009-12#1)(2010-12#1)(2011-2#3)(2012-12#1)
can show that the##2##4##(2008-5#1)(2012-3#1)
can show that##3##3##(1992-9#1)(2008-5#1)(2012-3#1)
can show##5##2##(1992-9#1)(2008-5#2)(2011-2#1)(2012-3#1)
can significantly affect##2##3##(2008-10#2)
can significantly enhance the##2##4##(2008-6#1)(2013-1#1)
can significantly increase##2##3##(2008-10#1)(2008-8#1)
can significantly influence the##2##4##(1992-9#1)(2008-8#1)
can significantly influence##4##3##(1992-9#1)(2008-8#1)(2010-10#1)(2012-2#1)
can significantly reduce##2##3##(2010-9#1)(2011-2#1)
can significantly##17##2##(1992-9#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#3)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
can simplify##3##2##(2008-10#1)(2011-2#2)
can simply##2##2##(2008-11#1)(2008-9#1)
can simultaneously##4##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)
can slow##2##2##(1996-9#1)(2008-10#1)
can solve##2##2##(2008-10#1)(2008-6#1)
can sometimes be##7##3##(2008-10#2)(2009-6#1)(2011-2#2)(2013-1#2)
can speed##2##2##(2011-2#1)(2013-1#1)
can spend##2##2##(1995-6#1)(2008-9#1)
can spread from##2##3##(2008-10#1)(2011-2#1)
can spread##3##2##(2008-10#2)(2011-2#1)
can stabilize the##2##3##(1994-11#1)(2008-8#1)
can still be##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
can still##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
can stimulate the##4##3##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
can stimulate##11##2##(1991-5#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)
can substantially##2##2##(2008-10#1)(2012-3#1)
can substitute for##3##3##(1991-3#1)(1995-2#2)
can substitute##4##2##(1991-3#1)(1995-2#2)(2008-10#1)
can successfully##5##2##(1991-5#1)(1997-2#1)(2008-10#1)(2010-7#1)(2011-2#1)
can support##9##2##(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)(2010-12#1)
can suppress##6##2##(1990-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
can survive in##3##3##(2009-12#2)(2013-8#1)
can survive##8##2##(2007-12#1)(2008-10#3)(2008-9#1)(2009-12#2)(2013-8#1)
can sustain##2##2##(2008-8#1)(2010-7#1)
can take many##2##3##(1992-1#1)(2008-5#1)
can take place##4##3##(1991-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
can take to##3##3##(1995-1#1)(1997-2#1)(2011-2#1)
can take##16##2##(1991-2#1)(1992-1#1)(1993-11#1)(1994-12#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-9#1)(2009-9#1)(2011-2#1)
can target##2##2##(1995-6#1)(2008-12#1)
can the##3##2##(1990-6#1)(1995-12#1)(2008-9#1)
can then be used to##4##5##(2008-10#1)(2008-4#1)(2008-9#1)(2010-11#1)
can then be used##5##4##(2008-10#1)(2008-4#1)(2008-9#2)(2010-11#1)
can then be##18##3##(1990-11#1)(1992-3#1)(2007-12#1)(2008-10#6)(2008-4#3)(2008-9#3)(2009-10#1)(2010-11#1)(2012-3#1)
can then##22##2##(1990-11#1)(1992-3#1)(1995-2#1)(2007-12#1)(2008-10#6)(2008-4#3)(2008-8#2)(2008-9#3)(2009-10#1)(2010-11#1)(2012-2#1)(2012-3#1)
can therefore be used##2##4##(1995-11#1)(2008-10#1)
can therefore be##6##3##(1995-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-7#1)(2013-8#1)
can therefore##9##2##(1995-11#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2010-7#1)(2013-8#1)
can they##4##2##(1991-12#1)(1994-12#1)(2008-11#2)
can thus be##5##3##(2008-10#2)(2008-11#2)(2013-1#1)
can thus##9##2##(1990-12#1)(1995-8#1)(2008-10#2)(2008-11#3)(2008-9#1)(2013-1#1)
can transfer##2##2##(2008-10#1)(2008-11#1)
can translate into##3##3##(1991-5#1)(2008-10#1)(2013-1#1)
can trigger##4##2##(1997-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
can undergo##4##2##(1990-2#1)(1992-9#1)(1993-3#1)(2008-10#1)
can undermine##2##2##(1995-1#1)(2008-8#1)
can use to##4##3##(1995-1#1)(2008-12#1)(2008-3#1)(2009-3#1)
can use##14##2##(1994-2#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-11#1)(2011-2#1)
can usually be##2##3##(1990-12#1)(2008-2#1)
can utilize##2##2##(2008-11#1)(2009-6#1)
can vary from##2##3##(2008-10#1)(2008-12#1)
can vary##8##2##(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2013-8#1)
can we improve##2##3##(1992-5#1)(2012-2#1)
can we learn from##2##4##(1991-3#1)(1993-6#1)
can we learn##4##3##(1991-3#1)(1993-6#1)(2009-8#1)(2011-2#1)
can we##18##2##(1991-11#1)(1991-3#1)(1992-5#1)(1993-2#2)(1993-6#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-2#3)(2013-7#1)
can work together##2##3##(2013-1#1)(2013-8#1)
can work##6##2##(1991-2#1)(1993-12#1)(2008-6#1)(2011-3#1)(2013-1#1)(2013-8#1)
can yield##10##2##(1991-6#1)(1992-9#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2012-2#1)(2013-8#1)
can##5338##1##(1990-11#14)(1990-12#16)(1990-2#11)(1990-3#3)(1990-5#20)(1990-6#7)(1990-7#1)(1990-8#10)(1990-9#11)(1991-1#8)(1991-10#1)(1991-11#9)(1991-12#16)(1991-2#15)(1991-3#30)(1991-5#13)(1991-6#8)(1991-8#5)(1991-9#9)(1992-1#13)(1992-10#3)(1992-11#5)(1992-12#20)(1992-2#15)(1992-3#21)(1992-4#2)(1992-5#11)(1992-6#7)(1992-7#1)(1992-8#5)(1992-9#16)(1993-1#4)(1993-11#7)(1993-12#34)(1993-2#28)(1993-3#25)(1993-5#2)(1993-6#13)(1993-8#13)(1993-9#7)(1994-1#7)(1994-11#11)(1994-12#40)(1994-2#20)(1994-3#32)(1994-5#20)(1994-6#4)(1994-8#17)(1994-9#14)(1995-1#13)(1995-11#10)(1995-12#21)(1995-2#35)(1995-3#15)(1995-5#12)(1995-6#16)(1995-8#1)(1995-9#9)(1996-1#18)(1996-11#19)(1996-12#22)(1996-2#19)(1996-3#20)(1996-5#8)(1996-6#7)(1996-8#1)(1996-9#7)(1997-1#27)(1997-2#23)(1997-3#15)(1997-4#6)(1997-5#4)(1997-6#19)(1997-7#20)(1997-8#16)(1997-9#1)(2006-6#4)(2007-11#13)(2007-12#31)(2007-8#3)(2007-9#1)(2008-1#23)(2008-10#1410)(2008-11#399)(2008-12#86)(2008-2#46)(2008-3#186)(2008-4#125)(2008-5#105)(2008-6#58)(2008-7#116)(2008-8#253)(2008-9#202)(2009-1#7)(2009-10#26)(2009-11#16)(2009-12#31)(2009-2#2)(2009-3#14)(2009-4#5)(2009-5#14)(2009-6#16)(2009-7#16)(2009-8#51)(2009-9#20)(2010-1#19)(2010-10#28)(2010-11#26)(2010-12#32)(2010-3#8)(2010-4#25)(2010-5#15)(2010-6#27)(2010-7#30)(2010-8#31)(2010-9#10)(2011-1#20)(2011-10#3)(2011-2#237)(2011-3#24)(2011-7#4)(2012-12#31)(2012-2#121)(2012-3#90)(2012-4#1)(2012-5#3)(2012-7#2)(2012-9#4)(2013-1#159)(2013-7#11)(2013-8#90)
can't##7##1##(1994-2#1)(1995-12#1)(1995-2#1)(1997-6#1)(2008-6#1)(2008-9#1)(2009-10#1)
canadensis##3##1##(2008-10#2)(2010-3#1)
canadian##5##1##(2008-11#2)(2012-12#1)(2012-2#1)(2012-3#1)
canal and the##2##3##(1993-12#1)(2008-9#1)
canal and##9##2##(1993-12#1)(2008-10#2)(2008-9#2)(2011-2#1)(2012-3#2)(2013-1#1)
canal cell##2##2##(2007-12#2)
canal is##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
canal of##4##2##(2008-10#4)
canal on the##2##3##(2011-2#2)
canal was##2##2##(2008-7#1)(2013-1#1)
canal##64##1##(1991-2#1)(1991-3#1)(1993-12#1)(1996-12#1)(2007-11#1)(2007-12#5)(2008-10#7)(2008-12#2)(2008-7#5)(2008-9#9)(2009-3#1)(2011-2#8)(2011-7#1)(2012-12#3)(2012-3#2)(2013-1#15)(2013-7#1)
canal-wall##2##1##(2008-9#2)
canalicular transporters##2##2##(2008-11#2)
canalicular##11##1##(1993-3#2)(1995-2#2)(2008-11#7)
canaliculi##3##1##(1993-3#1)(2007-12#2)
canaliculus##4##1##(2008-10#2)(2009-6#1)(2013-8#1)
canalization and##2##2##(1993-1#1)(2008-8#1)
canalization##3##1##(1993-1#2)(2008-8#1)
canals and##2##2##(1994-12#1)(2008-10#1)
canals##14##1##(1994-12#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#2)(2012-3#2)(2013-1#1)
canariensis isolates##2##2##(2008-10#2)
canariensis##6##1##(2008-10#6)
canceled by##2##2##(2008-3#1)(2012-2#1)
canceled stimulatory actions of L-leucine and KIC on protein synthesis##2##10##(2008-11#2)
canceled the##3##2##(2008-11#3)
canceled##7##1##(2008-11#5)(2008-3#1)(2012-2#1)
cancelled##2##1##(1997-5#1)(2008-10#1)
cancellous bone##4##2##(2009-7#2)(2011-2#1)(2013-1#1)
cancellous screws##4##2##(2008-7#1)(2009-3#1)(2012-3#2)
cancellous##12##1##(1996-3#1)(2008-7#1)(2009-3#1)(2009-7#2)(2010-3#2)(2011-2#2)(2012-3#2)(2013-1#1)
cancer (CC)##2##2##(2008-11#2)
cancer (CRC)##5##2##(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
cancer (HNPCC)##2##2##(2009-12#2)
cancer HeLa cells##3##3##(2008-11#1)(2008-8#2)
cancer according to##2##3##(2008-10#1)(2011-2#1)
cancer after##5##2##(1991-2#1)(2008-12#3)(2012-12#1)
cancer among##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
cancer and other diseases##3##4##(1994-5#1)(2008-11#1)(2009-7#1)
cancer and other##5##3##(1993-3#1)(1994-5#1)(2008-11#2)(2009-7#1)
cancer and the##7##3##(1992-6#1)(1994-5#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-1#1)(2013-8#1)
cancer and their##4##3##(1994-3#1)(1995-2#1)(1996-3#1)(2013-1#1)
cancer and##90##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-9#4)(1991-12#3)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#4)(1992-6#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-3#1)(1994-12#1)(1994-3#2)(1994-5#3)(1995-2#2)(1996-3#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#4)
cancer are presented##2##3##(1992-2#1)(2010-11#1)
cancer are reported##2##3##(1991-6#1)(2007-8#1)
cancer are used to##2##4##(1991-3#1)(2008-4#1)
cancer are##14##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-12#1)(1996-11#2)(1997-8#1)(2007-8#1)(2008-4#1)(2009-5#1)(2010-11#1)(2012-3#2)
cancer as a##3##3##(1994-2#1)(2013-1#1)(2013-8#1)
cancer as##6##2##(1994-2#1)(2008-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
cancer at the##2##3##(1992-2#1)(2011-2#1)
cancer at##6##2##(1991-2#1)(1992-2#1)(1993-8#1)(2010-7#1)(2011-2#2)
cancer between##2##2##(1997-7#1)(2012-3#1)
cancer but##3##2##(1994-9#1)(2008-10#1)(2011-2#1)
cancer by using##2##3##(1995-9#1)(2010-6#1)
cancer by##8##2##(1991-6#1)(1991-7#1)(1992-2#1)(1995-9#1)(2008-7#1)(2010-6#1)(2011-3#1)(2013-7#1)
cancer can be##3##3##(1993-3#1)(2010-8#1)(2013-8#1)
cancer care##13##2##(2008-11#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-3#7)(2013-1#1)
cancer cases##12##2##(1991-2#1)(1995-12#3)(1997-3#1)(2008-12#2)(2008-5#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
cancer cell growth and##2##4##(2012-3#1)(2013-1#1)
cancer cell growth##4##3##(2008-11#2)(2012-3#1)(2013-1#1)
cancer cell invasion##2##3##(2008-11#2)
cancer cell line##18##3##(1990-11#1)(1990-5#1)(1993-3#1)(1995-12#1)(1997-2#2)(2008-11#4)(2008-8#3)(2008-9#2)(2010-12#1)(2011-1#1)(2013-1#1)
cancer cell lines and##3##4##(1997-7#1)(2008-11#1)(2009-4#1)
cancer cell lines is##2##4##(1994-8#1)(2008-11#1)
cancer cell lines that##3##4##(2008-11#3)
cancer cell lines was##2##4##(2008-11#1)(2013-1#1)
cancer cell lines##39##3##(1990-6#1)(1992-4#1)(1993-1#1)(1994-8#2)(1995-12#1)(1997-7#3)(2008-11#16)(2008-4#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#2)
cancer cell proliferation and##3##4##(2008-11#1)(2012-2#1)(2013-8#1)
cancer cell##81##2##(1990-11#1)(1990-5#1)(1990-6#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-8#2)(1995-12#2)(1997-2#2)(1997-7#3)(2008-11#28)(2008-4#1)(2008-8#4)(2008-9#7)(2009-4#2)(2010-1#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
cancer cells and##15##3##(1991-6#1)(2008-11#3)(2008-9#1)(2009-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
cancer cells by##2##3##(1997-7#1)(2008-11#1)
cancer cells have been##2##4##(1993-12#1)(2012-3#1)
cancer cells have##3##3##(1993-12#1)(2010-6#1)(2012-3#1)
cancer cells in culture##2##4##(1995-12#1)(2008-11#1)
cancer cells in vitro##3##4##(1994-8#1)(1997-7#1)(2013-1#1)
cancer cells in##12##3##(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1997-7#1)(2008-11#2)(2008-8#1)(2012-2#2)(2013-1#1)
cancer cells is##7##3##(1994-8#1)(2008-11#1)(2010-2#1)(2011-2#3)(2013-1#1)
cancer cells of##2##3##(2008-8#1)(2008-9#1)
cancer cells to##7##3##(2008-11#4)(2009-7#1)(2011-2#1)(2013-1#1)
cancer cells using##2##3##(2008-10#1)(2012-2#1)
cancer cells was##4##3##(1994-8#1)(2008-11#1)(2008-9#2)
cancer cells were##4##3##(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
cancer cells with##5##3##(1990-2#1)(1992-2#1)(2008-11#1)(2009-9#1)(2013-1#1)
cancer cells##153##2##(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#1)(1991-6#2)(1992-2#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#3)(1995-10#1)(1995-12#1)(1997-7#4)(2008-10#2)(2008-11#32)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#8)(2009-12#4)(2009-4#3)(2009-7#1)(2009-9#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#23)(2012-2#5)(2012-3#8)(2013-1#13)(2013-8#7)
cancer chemotherapy##7##2##(1994-9#1)(1995-3#1)(1995-6#1)(2008-11#3)(2008-7#1)
cancer continue to##2##3##(2008-11#1)(2010-11#1)
cancer continues to##2##3##(2010-12#1)(2010-8#1)
cancer control programs##5##3##(2011-3#5)
cancer control research and##2##4##(1997-1#2)
cancer control research##3##3##(1997-1#3)
cancer control##22##2##(1997-1#13)(2008-7#1)(2009-4#1)(2011-3#7)
cancer death##3##2##(1997-1#1)(2008-7#2)
cancer deaths in##3##3##(1991-3#1)(2008-7#1)(2009-12#1)
cancer deaths##7##2##(1991-3#2)(1997-1#1)(2008-7#1)(2009-12#1)(2011-3#1)(2013-1#1)
cancer detection##4##2##(1992-2#1)(2008-1#1)(2011-2#2)
cancer development##8##2##(1992-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cancer diagnosis and treatment##2##4##(2010-6#1)(2013-1#1)
cancer diagnosis##11##2##(1990-8#1)(1991-8#1)(1993-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
cancer drug resistance##2##3##(2013-1#2)
cancer drug##4##2##(2009-9#1)(2012-2#1)(2013-1#2)
cancer drugs##3##2##(2010-11#1)(2010-5#1)(2012-2#1)
cancer due to##2##3##(1990-8#1)(2008-11#1)
cancer during##5##2##(1994-9#1)(2008-10#1)(2013-1#3)
cancer epidemiology##3##2##(1995-9#1)(2008-11#1)(2011-3#1)
cancer epigenetics##2##2##(2009-4#2)
cancer family history##2##3##(2012-3#2)
cancer family##3##2##(1994-12#1)(2012-3#2)
cancer following##4##2##(1993-11#1)(1993-12#2)(2012-3#1)
cancer from##3##2##(1991-6#1)(2008-12#1)(2013-1#1)
cancer gene therapy##5##3##(1994-5#2)(2008-8#2)(2011-2#1)
cancer gene##7##2##(1994-5#2)(2008-10#1)(2008-8#2)(2011-2#2)
cancer has been##4##3##(1991-12#1)(1992-9#1)(2010-1#1)(2011-2#1)
cancer has##13##2##(1990-12#1)(1990-9#1)(1991-12#1)(1992-9#1)(1997-7#2)(2009-12#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)
cancer have been##2##3##(1996-11#1)(2010-6#1)
cancer have##8##2##(1996-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-6#1)
cancer imaging##6##2##(2008-1#2)(2008-2#4)
cancer immunotherapy##6##2##(2008-11#5)(2012-2#1)
cancer in a##8##3##(1990-6#1)(1992-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#2)(2012-12#1)
cancer in elderly##3##3##(1994-12#1)(2008-7#1)(2011-2#1)
cancer in males##4##3##(1990-8#1)(1994-12#1)(1997-7#2)
cancer in men##4##3##(2008-1#1)(2008-11#1)(2010-1#1)(2010-10#1)
cancer in patients with##4##4##(1994-12#1)(2008-12#3)
cancer in patients##6##3##(1994-12#1)(2008-12#3)(2011-2#1)(2012-12#1)
cancer in the United States##3##5##(1995-9#1)(2009-5#1)(2013-1#1)
cancer in the absence of the low dose##2##8##(2008-7#2)
cancer in the absence of##3##5##(1996-11#1)(2008-7#2)
cancer in the world##2##4##(2010-5#1)(2013-1#1)
cancer in the##18##3##(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#2)(1995-9#1)(1996-11#1)(1997-1#1)(2008-12#1)(2008-7#2)(2009-12#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
cancer in##86##2##(1990-6#4)(1990-8#2)(1990-9#4)(1991-2#1)(1991-3#1)(1991-6#3)(1992-12#2)(1992-2#1)(1993-1#2)(1993-11#1)(1994-12#4)(1994-6#1)(1994-8#1)(1995-9#2)(1996-11#1)(1997-1#1)(1997-7#3)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#6)(2008-7#3)(2008-8#3)(2009-12#1)(2009-5#1)(2010-1#3)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-2#9)(2012-12#2)(2012-3#3)(2013-1#6)(2013-8#1)
cancer incidence and##2##3##(1992-2#1)(2009-5#1)
cancer incidence in##4##3##(1996-3#2)(2011-2#1)(2012-12#1)
cancer incidence##12##2##(1991-3#1)(1992-2#1)(1996-3#4)(1997-3#2)(2009-5#1)(2011-2#1)(2011-3#1)(2012-12#1)
cancer includes##2##2##(1993-6#1)(2011-3#1)
cancer increased##2##2##(1997-7#1)(2011-3#1)
cancer initiation##3##2##(2009-12#1)(2011-2#1)(2012-3#1)
cancer invasion and metastasis##3##4##(2011-2#3)
cancer is a major##3##4##(2009-12#1)(2010-12#1)(2010-5#1)
cancer is a##9##3##(1990-6#1)(1991-9#1)(2008-11#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#3)
cancer is rare and##2##4##(2007-8#1)(2010-6#1)
cancer is the most common##2##5##(2010-12#1)(2012-3#1)
cancer is the most##3##4##(2008-5#1)(2010-12#1)(2012-3#1)
cancer is the second leading##2##5##(2008-1#1)(2009-5#1)
cancer is the second##3##4##(2008-1#1)(2009-5#1)(2010-8#1)
cancer is the##8##3##(2008-1#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-8#1)
cancer is used to##2##4##(1990-9#1)(1992-9#1)
cancer is##50##2##(1990-6#2)(1990-9#1)(1991-9#1)(1992-2#1)(1992-9#1)(1994-12#1)(1995-12#1)(1997-1#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#6)(2011-3#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
cancer lesions##3##2##(2008-10#2)(2011-2#1)
cancer mammae##2##2##(1991-2#1)(1992-5#1)
cancer management##3##2##(2010-12#1)(2010-8#1)(2012-3#1)
cancer may be##2##3##(1990-2#1)(2010-12#1)
cancer may##4##2##(1990-2#1)(1992-2#1)(2010-11#1)(2010-12#1)
cancer metastases##2##2##(1990-12#1)(2008-4#1)
cancer metastasis##4##2##(2008-1#1)(2008-7#1)(2008-9#1)(2010-7#1)
cancer model has##2##3##(2008-10#2)
cancer model##3##2##(2008-10#2)(2010-6#1)
cancer models##2##2##(2010-6#1)(2011-2#1)
cancer morbidity##2##2##(1995-2#1)(1997-1#1)
cancer mortality data##3##3##(2008-5#1)(2013-1#2)
cancer mortality in the##2##4##(1996-6#1)(1997-1#1)
cancer mortality in##5##3##(1990-8#1)(1991-12#1)(1994-2#1)(1996-6#1)(1997-1#1)
cancer mortality rate##3##3##(1993-12#1)(2012-12#1)(2013-1#1)
cancer mortality##28##2##(1990-8#4)(1991-12#2)(1993-12#2)(1994-2#2)(1996-6#1)(1997-1#2)(1997-7#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-7#1)(2010-1#2)(2010-11#1)(2012-12#1)(2013-1#3)(2013-8#1)
cancer observed##3##2##(1990-9#1)(1991-12#1)(2013-1#1)
cancer of the cervix##2##4##(1996-6#1)(2008-11#1)
cancer of the left##2##4##(1990-3#1)(2012-3#1)
cancer of the stomach##3##4##(1990-9#1)(1991-2#2)
cancer of the uterine cervix##3##5##(2008-11#1)(2009-11#2)
cancer of the##27##3##(1990-3#1)(1990-8#1)(1990-9#5)(1991-11#1)(1991-2#2)(1991-8#1)(1992-9#1)(1994-2#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-8#2)(2008-11#2)(2009-11#2)(2010-12#2)(2012-3#1)
cancer of##35##2##(1990-3#1)(1990-8#1)(1990-9#5)(1991-11#1)(1991-2#2)(1991-8#1)(1992-9#1)(1994-2#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-8#3)(2008-11#2)(2009-11#2)(2010-12#2)(2012-3#2)(2013-1#6)
cancer on##2##2##(2008-7#1)(2011-2#1)
cancer or benign##2##3##(1990-6#1)(1993-1#1)
cancer or##7##2##(1990-6#1)(1991-12#1)(1992-2#1)(1993-1#1)(2008-8#1)(2009-12#1)(2009-2#1)
cancer pain management##3##3##(2008-7#1)(2009-12#1)(2012-2#1)
cancer pain treatment##3##3##(1997-3#3)
cancer pain##20##2##(1997-3#4)(1997-5#1)(2008-7#8)(2009-12#1)(2012-2#6)
cancer patient##7##2##(1993-11#1)(1997-5#1)(2008-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
cancer patients after##4##3##(1994-12#3)(2008-10#1)
cancer patients and##9##3##(1990-12#1)(1992-2#1)(1993-11#1)(1994-3#1)(1995-2#1)(2008-11#1)(2010-5#1)(2011-2#2)
cancer patients in a##2##4##(2010-2#1)(2011-2#1)
cancer patients in an##2##4##(2008-10#1)(2012-2#1)
cancer patients in##9##3##(1990-6#2)(1993-1#1)(1994-8#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
cancer patients pretreated with 5-fluorouracil##2##5##(1992-12#2)
cancer patients pretreated with##3##4##(1992-12#2)(1994-8#1)
cancer patients receiving##2##3##(2009-11#1)(2011-2#1)
cancer patients treated with##2##4##(2009-11#1)(2009-5#1)
cancer patients were included in the##2##6##(2010-12#1)(2013-8#1)
cancer patients were##4##3##(1994-3#1)(2008-10#1)(2010-12#1)(2013-8#1)
cancer patients who##3##3##(1993-1#1)(2012-3#1)(2013-8#1)
cancer patients with bone metastases##2##5##(2011-2#2)
cancer patients with##9##3##(1992-12#1)(1993-11#1)(1994-3#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#2)(2013-8#1)
cancer patients##124##2##(1990-12#6)(1990-2#2)(1990-6#2)(1991-3#2)(1991-6#2)(1992-12#3)(1992-2#2)(1992-3#3)(1993-1#4)(1993-11#8)(1994-12#4)(1994-3#5)(1994-6#3)(1994-8#4)(1995-2#2)(1995-9#1)(1996-10#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#4)(2009-12#4)(2009-5#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-5#1)(2010-7#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#7)
cancer patients]##3##2##(1991-3#1)(2012-3#1)(2013-1#1)
cancer populations##2##2##(2009-4#1)(2012-2#1)
cancer precursors##2##2##(1994-1#1)(2011-2#1)
cancer prevention and control initiatives##2##5##(1996-2#1)(1997-1#1)
cancer prevention and control##3##4##(1996-2#1)(1997-1#2)
cancer prevention and##5##3##(1996-2#1)(1997-1#2)(2008-7#1)(2009-12#1)
cancer prevention programs##2##3##(1997-1#1)(2013-1#1)
cancer prevention##12##2##(1996-2#1)(1997-1#4)(1997-4#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-3#1)(2012-2#1)(2013-1#1)
cancer procedures##2##2##(1995-2#2)
cancer progression##4##2##(2011-2#2)(2012-2#1)(2013-1#1)
cancer received##2##2##(1990-12#1)(2008-10#1)
cancer registries##2##2##(1991-2#1)(2011-3#1)
cancer repression gene p53##2##4##(2008-10#2)
cancer research and##2##3##(2008-11#1)(2009-4#1)
cancer research are##2##3##(1990-2#1)(2008-11#1)
cancer research##11##2##(1990-2#2)(2008-11#2)(2009-12#1)(2009-4#6)
cancer risk among##3##3##(2008-12#1)(2010-6#1)(2011-2#1)
cancer risk and##4##3##(1993-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
cancer risk from##2##3##(2013-1#2)
cancer risk in##6##3##(1990-8#1)(1991-2#1)(1993-11#1)(1996-3#1)(2008-7#1)(2013-1#1)
cancer risk was##2##3##(1991-2#1)(1991-3#1)
cancer risk##33##2##(1990-6#2)(1990-8#2)(1991-2#2)(1991-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1995-6#1)(1995-9#4)(1996-3#2)(1997-8#2)(2008-11#2)(2008-12#1)(2008-7#2)(2010-6#2)(2011-2#2)(2012-3#2)(2013-1#3)
cancer samples##2##2##(2011-2#2)
cancer screening and##2##3##(2008-12#1)(2009-5#1)
cancer screening services##3##3##(1996-2#2)(1997-1#1)
cancer screening study##2##3##(1995-12#1)(2008-1#1)
cancer screening was##2##3##(1990-8#1)(2008-8#1)
cancer screening##37##2##(1990-2#1)(1990-8#1)(1992-2#2)(1994-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-9#3)(1996-2#2)(1997-1#4)(1997-2#1)(2008-1#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#4)(2010-8#2)(2011-2#2)(2012-12#4)(2013-1#1)(2013-8#1)
cancer should be##3##3##(1994-2#2)(2008-4#1)
cancer should##4##2##(1994-2#2)(2008-4#1)(2012-2#1)
cancer showed##2##2##(1994-2#1)(2008-8#1)
cancer sites##5##2##(1990-8#1)(1996-2#1)(2008-11#1)(2009-11#1)(2011-3#1)
cancer specific human##3##3##(2008-11#3)
cancer specific##5##2##(2008-11#5)
cancer specimens##5##2##(1993-8#3)(2011-2#1)(2013-1#1)
cancer stem cells (CSCs) are##2##5##(2009-9#1)(2011-2#1)
cancer stem cells##4##3##(2009-9#1)(2011-2#2)(2013-8#1)
cancer surgery##4##2##(1991-3#1)(1992-9#1)(2010-12#1)(2010-4#1)
cancer survivors##3##2##(2008-8#1)(2012-3#2)
cancer survivorship interventions##2##3##(2012-3#2)
cancer survivorship##5##2##(2012-3#5)
cancer susceptibility##5##2##(1994-9#2)(1995-12#1)(1996-10#1)(1997-7#1)
cancer syndromes##6##2##(1990-12#1)(2009-12#2)(2011-2#2)(2012-3#1)
cancer than##3##2##(1993-1#1)(2008-12#1)(2011-2#1)
cancer that##3##2##(2010-6#1)(2011-2#1)(2013-8#1)
cancer therapeutics##5##2##(2008-11#1)(2011-2#2)(2013-8#2)
cancer therapy##17##2##(1994-12#1)(1994-5#1)(2008-11#1)(2008-7#4)(2009-1#1)(2009-12#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
cancer through##3##2##(1991-12#1)(2008-5#1)(2009-12#1)
cancer tissue##5##2##(1990-2#1)(1993-1#1)(1993-11#1)(2009-4#1)(2012-3#1)
cancer tissues##9##2##(1991-12#2)(2008-10#3)(2008-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
cancer to##4##2##(1991-8#1)(1993-6#1)(2008-10#1)(2010-12#1)
cancer treatment and##2##3##(2008-7#1)(2011-2#1)
cancer treatment in##3##3##(2010-8#1)(2011-2#2)
cancer treatment is##2##3##(2009-9#1)(2011-2#1)
cancer treatment##21##2##(2008-11#3)(2008-12#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-9#3)(2010-8#1)(2011-2#5)(2013-1#1)
cancer treatments##3##2##(2008-7#1)(2013-1#2)
cancer using##4##2##(2008-6#1)(2009-12#1)(2009-2#1)(2013-8#1)
cancer vaccines##3##2##(2008-5#3)
cancer was##15##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#3)(1992-12#1)(1993-1#1)(1994-2#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-3#2)
cancer were analyzed##2##3##(1997-7#1)(2008-11#1)
cancer were observed##2##3##(1990-12#1)(1992-9#1)
cancer were treated with two types of regimens##2##8##(1997-7#2)
cancer were treated with##4##4##(1991-6#1)(1992-12#1)(1997-7#2)
cancer were treated##5##3##(1991-6#1)(1992-12#1)(1997-7#2)(2011-2#1)
cancer were##18##2##(1990-12#2)(1990-6#1)(1990-8#1)(1991-6#2)(1992-12#1)(1992-9#1)(1994-12#1)(1997-7#3)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#2)(2012-12#1)
cancer which##5##2##(1990-11#1)(1991-8#1)(2007-8#1)(2012-3#1)(2013-7#1)
cancer who are##2##3##(2008-7#1)(2011-2#1)
cancer who presented##2##3##(2010-6#1)(2013-1#1)
cancer who##8##2##(1997-7#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#2)
cancer with##17##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#2)(1992-2#1)(1993-1#1)(1993-2#1)(1997-3#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#2)
cancer xenografts in##3##3##(1997-7#1)(2008-8#1)(2013-1#1)
cancer xenografts##6##2##(1997-7#2)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
cancer##2072##1##(1990-11#6)(1990-12#31)(1990-2#14)(1990-3#3)(1990-5#5)(1990-6#20)(1990-8#30)(1990-9#27)(1991-11#1)(1991-12#16)(1991-2#16)(1991-3#17)(1991-6#31)(1991-7#6)(1991-8#22)(1991-9#1)(1992-10#1)(1992-12#17)(1992-2#22)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-9#13)(1993-1#34)(1993-11#43)(1993-12#7)(1993-2#5)(1993-3#5)(1993-6#2)(1993-8#5)(1993-9#6)(1994-1#1)(1994-11#3)(1994-12#28)(1994-2#14)(1994-3#11)(1994-5#9)(1994-6#8)(1994-8#15)(1994-9#9)(1995-10#3)(1995-12#14)(1995-2#9)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#26)(1996-10#5)(1996-11#9)(1996-2#7)(1996-3#11)(1996-5#1)(1996-6#2)(1997-1#35)(1997-2#4)(1997-3#10)(1997-4#4)(1997-5#3)(1997-7#33)(1997-8#15)(2007-11#2)(2007-8#8)(2008-1#23)(2008-10#60)(2008-11#142)(2008-12#23)(2008-2#11)(2008-4#23)(2008-5#31)(2008-6#5)(2008-7#74)(2008-8#32)(2008-9#25)(2009-1#3)(2009-10#1)(2009-11#9)(2009-12#38)(2009-2#4)(2009-3#4)(2009-4#35)(2009-5#26)(2009-6#4)(2009-7#5)(2009-8#2)(2009-9#12)(2010-1#11)(2010-10#8)(2010-11#19)(2010-12#39)(2010-2#11)(2010-3#1)(2010-4#4)(2010-5#8)(2010-6#22)(2010-7#12)(2010-8#21)(2010-9#2)(2011-1#8)(2011-2#198)(2011-3#28)(2012-12#21)(2012-2#47)(2012-3#82)(2013-1#134)(2013-7#8)(2013-8#68)
cancer)##4##1##(1991-8#1)(2008-12#1)(2010-12#1)(2010-6#1)
cancer--a##2##1##(1992-5#1)(2011-2#1)
cancer--the##2##1##(1997-7#1)(2012-3#1)
cancer-associated##5##1##(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#1)(2013-1#1)
cancer-causing##3##1##(1991-12#1)(2011-2#1)(2011-3#1)
cancer-cell##2##1##(2008-11#2)
cancer-related death##2##2##(2008-1#1)(2013-1#1)
cancer-related deaths##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
cancer-related##12##1##(1990-8#1)(2008-1#1)(2008-4#2)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
cancer-specific##3##1##(2008-11#1)(2009-9#1)(2011-2#1)
cancer?##2##1##(2011-2#2)
cancer]##24##1##(1990-11#1)(1990-9#3)(1991-6#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2011-1#2)(2011-2#1)(2011-3#2)(2012-3#1)(2013-8#1)
cancerous##7##1##(1990-6#1)(1991-6#1)(2008-11#1)(2008-5#1)(2009-10#2)(2011-2#1)
cancers and other##2##3##(2008-1#1)(2010-12#1)
cancers and##12##2##(1993-8#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
cancers are##5##2##(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#2)
cancers arising##2##2##(1991-6#1)(2012-2#1)
cancers develop##2##2##(2008-1#1)(2013-1#1)
cancers have been##2##3##(2008-4#1)(2011-2#1)
cancers in patients##2##3##(1995-11#1)(2012-3#1)
cancers in which telomerase##2##4##(2008-11#2)
cancers in##14##2##(1990-8#1)(1991-6#2)(1994-12#1)(1995-11#1)(2008-11#3)(2008-12#1)(2008-8#1)(2010-7#1)(2012-3#1)(2013-1#2)
cancers including##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
cancers is##5##2##(1993-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-4#1)
cancers may be##2##3##(1993-1#1)(1994-2#1)
cancers observed##2##2##(1991-2#1)(2010-1#1)
cancers of different##2##3##(2009-9#1)(2011-2#1)
cancers of the breast##3##4##(1992-5#1)(2008-11#1)(2008-4#1)
cancers of the##8##3##(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(2008-11#1)(2008-4#1)(2012-3#1)
cancers of##12##2##(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(1994-2#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-3#1)
cancers that##4##2##(1990-12#1)(1997-3#2)(2008-11#1)
cancers treated##2##2##(1993-11#1)(2011-2#1)
cancers was##2##2##(1990-12#1)(1994-12#1)
cancers were##9##2##(1990-2#1)(1991-2#2)(1991-3#1)(1993-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
cancers with##3##2##(1990-9#1)(1993-11#1)(2013-1#1)
cancers##199##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-8#6)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#8)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-1#3)(1993-11#5)(1993-2#1)(1993-8#2)(1994-12#3)(1994-2#3)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-9#2)(1997-2#1)(1997-3#2)(1997-7#5)(1997-8#1)(2007-8#2)(2008-1#5)(2008-10#4)(2008-11#11)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#30)(2011-3#4)(2012-12#5)(2012-2#4)(2012-3#6)(2013-1#17)(2013-7#3)(2013-8#2)
cancers)##2##1##(1994-8#1)(1995-12#1)
candida##6##1##(2008-10#4)(2008-6#2)
candidacy assessment##2##2##(2012-2#2)
candidacy for bilateral cochlear implants##2##5##(2012-2#2)
candidacy##9##1##(2008-9#1)(2012-2#8)
candidate for a##4##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
candidate for biological control of##2##5##(2008-10#2)
candidate for the##3##3##(1996-12#2)(2008-9#1)
candidate for this##2##3##(1992-6#1)(2008-10#1)
candidate for use##2##3##(1993-2#1)(2009-9#1)
candidate for##25##2##(1992-6#1)(1993-2#1)(1993-9#2)(1995-12#1)(1996-12#2)(1996-2#1)(1997-8#1)(2006-6#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)
candidate gene for##2##3##(2008-6#1)(2013-8#1)
candidate gene##11##2##(1990-12#1)(1992-3#1)(2008-10#1)(2008-6#1)(2009-10#2)(2010-11#1)(2010-5#1)(2012-3#2)(2013-8#1)
candidate genes for Batten disease##2##5##(1994-11#2)
candidate genes for##5##3##(1994-11#2)(1996-8#1)(2008-8#1)(2009-10#1)
candidate genes that##2##3##(2008-10#1)(2008-8#1)
candidate genes##27##2##(1994-11#2)(1996-8#3)(1997-2#1)(1997-8#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2010-5#2)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
candidate in##2##2##(2009-6#1)(2013-7#1)
candidate of##3##2##(1992-6#1)(2008-11#1)(2010-1#1)
candidate proteins for##2##3##(2008-7#1)(2009-10#1)
candidate strain##2##2##(2008-9#2)
candidate to##3##2##(2008-10#2)(2008-11#1)
candidate transcripts##2##2##(2009-10#1)(2013-8#1)
candidate tumor suppressor gene##3##4##(2008-9#1)(2009-9#2)
candidate vaccine##2##2##(1995-5#1)(2008-9#1)
candidate vaccines##2##2##(1995-5#2)
candidate##139##1##(1990-12#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#3)(1995-6#1)(1996-12#2)(1996-2#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-8#3)(2006-6#1)(2008-1#1)(2008-10#25)(2008-11#9)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#7)(2009-10#6)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-5#4)(2010-8#1)(2011-2#8)(2011-3#3)(2012-2#2)(2012-3#7)(2013-1#1)(2013-7#1)(2013-8#3)
candidates and##2##2##(1996-3#1)(2008-9#1)
candidates are##3##2##(2011-2#2)(2011-3#1)
candidates for the treatment of##2##5##(2011-1#1)(2013-1#1)
candidates for the##6##3##(1992-12#1)(1993-12#1)(1996-8#1)(2011-1#2)(2013-1#1)
candidates for vaginal hysterectomy##2##4##(1991-3#1)(1993-12#1)
candidates for##35##2##(1990-4#3)(1991-3#1)(1992-12#1)(1993-12#4)(1993-3#1)(1994-2#1)(1996-8#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
candidates to##5##2##(2008-7#2)(2010-11#1)(2012-12#1)(2012-3#1)
candidates who##2##2##(2012-12#1)(2012-2#1)
candidates##72##1##(1990-4#3)(1991-3#1)(1992-12#1)(1993-12#4)(1993-3#2)(1993-8#1)(1994-1#2)(1994-2#1)(1996-3#1)(1996-8#1)(2008-10#7)(2008-11#5)(2008-5#1)(2008-7#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#3)(2011-3#4)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#1)
candidiasis in##4##2##(2008-5#4)
candidiasis is##2##2##(2008-5#2)
candidiasis##22##1##(1990-3#1)(1991-2#1)(1997-1#1)(2008-5#16)(2011-2#1)(2012-3#2)
candidosis in##2##2##(2008-5#2)
candidosis##10##1##(2008-5#9)(2013-1#1)
candidum and microbivorous nematodes##2##4##(2008-10#2)
candidum##7##1##(2008-10#7)
cane##4##1##(2008-10#4)
canes##6##1##(2008-10#6)
canine cardiac Purkinje##2##3##(1992-3#1)(2010-4#1)
canine complement activation##2##3##(2008-10#2)
canine distemper virus##4##3##(2008-12#1)(2009-8#1)(2012-3#2)
canine heart##2##2##(2010-12#1)(2011-2#1)
canine myoblasts##2##2##(2008-11#2)
canine neutrophils and##2##3##(2008-10#2)
canine neutrophils##5##2##(2008-10#5)
canine pancreatic##2##2##(1991-10#1)(2012-3#1)
canine rabies in Colombia##2##4##(2011-2#2)
canine rabies##4##2##(2011-2#4)
canine thyroid carcinoma##2##3##(2012-3#2)
canine tracheal##3##2##(1994-11#3)
canine##82##1##(1990-5#3)(1991-10#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-11#3)(1994-12#2)(1994-8#2)(1995-2#2)(1996-12#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#3)(2009-8#4)(2010-12#1)(2010-4#2)(2011-2#12)(2012-2#1)(2012-3#12)(2013-1#6)
canines##11##1##(2008-10#3)(2009-8#1)(2012-3#3)(2013-1#4)
canis in a##2##3##(2011-2#2)
canis in##3##2##(2011-2#3)
canis##7##1##(2008-5#4)(2011-2#3)
canister##3##1##(1992-3#1)(1996-1#1)(2008-9#1)
canker and##2##2##(2008-10#2)
canker development in##3##3##(2008-10#3)
canker disease of##2##3##(2008-10#2)
canker disease##4##2##(2008-10#4)
canker in##2##2##(2008-10#2)
canker is##4##2##(2008-10#4)
canker of peach##2##3##(2008-10#2)
canker of##9##2##(2008-10#9)
canker pathogen##2##2##(2008-10#2)
canker resistance##3##2##(2008-10#3)
canker size##3##2##(2008-10#3)
canker that##2##2##(2008-10#2)
canker was##3##2##(2008-10#3)
canker##74##1##(2008-10#73)(2010-3#1)
cankered trees##3##2##(2008-10#3)
cankered##4##1##(2008-10#4)
cankers in##3##2##(2008-10#3)
cankers on##4##2##(2008-10#4)
cankers sampled##2##2##(2008-10#2)
cankers were##2##2##(2008-10#2)
cankers##28##1##(2008-10#27)(2010-3#1)
cannabidiol##5##1##(2010-10#5)
cannabina##3##1##(2008-10#3)
cannabinoid binding##3##2##(1996-2#3)
cannabinoid receptor##5##2##(1991-1#1)(1991-4#1)(1996-2#1)(1997-8#1)(2009-8#1)
cannabinoid receptors in##3##3##(1991-10#1)(1991-4#2)
cannabinoid receptors##4##2##(1991-10#1)(1991-4#3)
cannabinoid##18##1##(1991-1#2)(1991-10#1)(1991-4#4)(1996-2#5)(1997-8#1)(2009-12#2)(2009-8#2)(2010-10#1)
cannabinoids in##2##2##(2008-11#1)(2009-8#1)
cannabinoids##7##1##(1997-8#3)(2008-11#3)(2009-8#1)
cannabis and##2##2##(2013-8#2)
cannabis during##2##2##(2009-7#2)
cannabis is##2##2##(2008-1#1)(2013-8#1)
cannabis markets##2##2##(2008-12#2)
cannabis use during adolescence##2##4##(2009-7#1)(2013-8#1)
cannabis use on##2##3##(2009-7#1)(2013-8#1)
cannabis use##10##2##(2008-1#2)(2009-7#5)(2013-8#3)
cannabis users##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
cannabis##41##1##(1997-8#1)(2008-1#5)(2008-11#1)(2008-12#9)(2009-7#10)(2013-8#15)
cannabis-using boys##2##2##(2013-8#2)
canned##4##1##(2008-10#1)(2011-2#3)
cannibalism##2##1##(1991-12#1)(2009-10#1)
cannifolia starch##2##2##(2008-5#2)
cannot adequately##3##2##(2008-8#1)(2010-12#2)
cannot be achieved##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
cannot be applied##3##3##(1991-12#1)(2008-8#1)(2013-1#1)
cannot be attributed##2##3##(1990-8#1)(2011-2#1)
cannot be completely##2##3##(2008-7#1)(2008-8#1)
cannot be controlled##4##3##(1993-3#2)(1996-3#1)(2009-8#1)
cannot be distinguished by##2##4##(1993-8#1)(2008-11#1)
cannot be easily##2##3##(2008-10#1)(2008-3#1)
cannot be excluded##4##3##(1990-9#1)(1991-11#1)(1996-3#1)(2008-10#1)
cannot be expected##2##3##(2011-2#1)(2013-1#1)
cannot be explained by##5##4##(1995-6#1)(1995-8#1)(2009-8#1)(2012-3#1)(2013-1#1)
cannot be explained##12##3##(1992-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#1)
cannot be generalized##2##3##(2008-10#1)(2008-11#1)
cannot be ignored##4##3##(1994-2#1)(2008-11#1)(2008-12#1)(2008-8#1)
cannot be incorporated into the##2##5##(1993-1#1)(2008-3#1)
cannot be obtained##2##3##(2007-12#1)(2013-8#1)
cannot be performed##2##3##(2008-10#1)(2009-9#1)
cannot be recommended##4##3##(1991-6#1)(1997-2#1)(2011-2#1)(2013-1#1)
cannot be related to##3##4##(1994-8#1)(1995-5#1)(1995-6#1)
cannot be ruled out##2##4##(2007-11#1)(2008-11#1)
cannot be used for quantitative analysis##2##6##(2008-10#2)
cannot be used for##3##4##(2008-10#3)
cannot be used in##2##4##(2008-7#2)
cannot be used to##2##4##(2008-10#1)(2013-8#1)
cannot be used##10##3##(1991-12#1)(1992-3#1)(2008-10#4)(2008-7#2)(2010-5#1)(2013-8#1)
cannot be##156##2##(1990-2#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-3#3)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1997-2#3)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#24)(2008-11#13)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#10)(2008-9#2)(2009-10#1)(2009-12#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
cannot bind to the##2##4##(2008-8#2)
cannot bind to##3##3##(2008-8#2)(2008-9#1)
cannot discriminate##2##2##(2008-10#1)(2008-9#1)
cannot explain the##2##3##(2008-10#1)(2008-8#1)
cannot explain##4##2##(2008-10#1)(2008-8#1)(2010-10#1)(2012-2#1)
cannot grow##2##2##(2009-6#1)(2009-8#1)
cannot ignore##3##2##(2008-11#1)(2011-3#2)
cannot induce##2##2##(2008-11#1)(2010-3#1)
cannot move##2##2##(2008-10#1)(2008-8#1)
cannot perform##2##2##(1995-6#1)(2008-1#1)
cannot readily be##2##3##(1992-12#1)(1994-8#1)
cannot undergo the##2##3##(1995-6#1)(2009-5#1)
cannot yet be##2##3##(1991-11#1)(2008-10#1)
cannot##254##1##(1990-11#1)(1990-2#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#3)(1991-3#2)(1991-5#1)(1991-6#2)(1992-12#2)(1992-2#2)(1992-3#3)(1993-1#1)(1993-3#3)(1993-8#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-5#4)(1995-6#6)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#38)(2008-11#18)(2008-12#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#29)(2008-9#5)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#7)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#10)(2011-3#2)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#4)
cannula##8##1##(1991-3#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-3#1)
cannulated##3##1##(1997-1#1)(2008-12#1)(2012-2#1)
cannulation of the fallopian tube##2##5##(1992-1#2)
cannulation of the##4##3##(1992-1#2)(1992-12#2)
cannulation or##2##2##(2008-1#2)
cannulation##11##1##(1992-1#3)(1992-12#2)(2008-1#4)(2008-11#1)(2011-2#1)
canola meal##4##2##(2008-10#4)
canola##24##1##(2008-10#21)(2008-12#2)(2011-10#1)
canonical discriminant##2##2##(2008-10#2)
canonical##19##1##(1992-3#2)(1993-12#1)(1993-6#1)(1995-3#1)(1997-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
canopies##5##1##(2008-10#5)
canopy and##4##2##(2008-10#4)
canopy closure##8##2##(2008-10#8)
canopy reflectance were##2##3##(2008-10#2)
canopy reflectance##3##2##(2008-10#3)
canopy size and##3##3##(2008-10#3)
canopy size##5##2##(2008-10#5)
canopy spectra##2##2##(2008-10#2)
canopy was##3##2##(2008-10#3)
canopy##60##1##(1993-3#1)(2008-10#53)(2008-8#2)(2008-9#4)
cantaloupe and##3##2##(2008-10#3)
cantaloupe fruit##3##2##(2008-10#3)
cantaloupe roots##2##2##(2008-10#2)
cantaloupe##23##1##(2008-10#23)
canthaxanthin##6##1##(2008-12#2)(2013-8#4)
cantilever##6##1##(2008-10#2)(2010-7#3)(2012-2#1)
cantilevers##6##1##(2008-3#6)
canton##2##1##(1991-6#1)(1996-11#1)
cantonal##2##1##(1996-11#2)
cap and##2##2##(2008-10#1)(2008-11#1)
cap on##2##2##(1992-11#1)(1995-6#1)
cap site##2##2##(1992-3#1)(1995-6#1)
cap structure##7##2##(1997-2#3)(2008-10#4)
cap was##4##2##(2008-9#4)
cap##36##1##(1992-11#1)(1992-3#1)(1993-9#1)(1995-6#2)(1997-2#4)(2007-12#3)(2008-10#8)(2008-11#2)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#6)(2009-8#2)
capabilities and tomorrow's##2##3##(1993-3#2)
capabilities and##6##2##(1993-2#1)(1993-3#2)(2008-10#1)(2008-11#2)
capabilities are##3##2##(1991-3#1)(2008-10#1)(2008-3#1)
capabilities for##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
capabilities in##2##2##(2008-11#1)(2011-2#1)
capabilities of a##2##3##(1995-2#1)(2012-12#1)
capabilities of the two##2##4##(1997-2#1)(2008-10#1)
capabilities of the##6##3##(1997-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-7#1)
capabilities of##22##2##(1995-2#1)(1996-1#1)(1997-2#1)(2008-10#10)(2008-3#3)(2008-6#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-7#1)(2012-12#1)
capabilities to##2##2##(2008-10#1)(2008-8#1)
capabilities##73##1##(1991-1#1)(1991-12#2)(1991-3#1)(1992-12#2)(1993-2#1)(1993-3#2)(1994-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-10#21)(2008-11#7)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-7#1)(2011-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
capability and##3##2##(1992-10#1)(2008-10#1)(2008-11#1)
capability for##8##2##(1995-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-12#1)
capability in##3##2##(1994-5#1)(2008-4#1)(2008-7#1)
capability of detection##2##3##(2008-10#2)
capability of the method##2##4##(2008-10#1)(2009-7#1)
capability of the##17##3##(2008-10#11)(2008-3#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
capability of this##2##3##(2008-10#2)
capability of##44##2##(1993-2#1)(1993-8#1)(2008-10#26)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
capability than##3##2##(1990-11#1)(2010-10#1)(2012-2#1)
capability to metabolize##2##3##(2008-10#1)(2008-5#1)
capability to##17##2##(1990-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-7#1)(2012-2#1)(2013-1#1)
capability##111##1##(1990-11#1)(1990-2#2)(1991-1#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-12#1)(1997-3#1)(2008-10#41)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2011-7#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
capable of binding to##3##4##(2008-10#1)(2008-9#2)
capable of binding##7##3##(2008-10#2)(2008-8#1)(2008-9#3)(2009-8#1)
capable of causing both GLS##3##5##(2008-10#3)
capable of causing##9##3##(1993-9#1)(1997-8#1)(2006-6#1)(2008-10#5)(2008-11#1)
capable of converting##2##3##(1994-11#1)(2010-1#1)
capable of creating##3##3##(1996-12#1)(2008-3#1)(2009-7#1)
capable of detecting##13##3##(1994-11#1)(1995-3#1)(1996-12#1)(2008-10#8)(2008-9#1)(2011-2#1)
capable of determining##2##3##(1992-12#1)(2008-10#1)
capable of directly detecting##2##4##(2008-10#1)(2012-2#1)
capable of directly##4##3##(2007-12#1)(2008-10#2)(2012-2#1)
capable of discriminating##2##3##(2008-10#1)(2008-9#1)
capable of effectively##2##3##(1995-6#1)(2008-5#1)
capable of expressing##2##3##(1993-9#1)(2013-1#1)
capable of forming##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
capable of generating##6##3##(1995-2#1)(1995-6#1)(2008-10#3)(2008-3#1)
capable of handling##3##3##(2008-10#2)(2008-3#1)
capable of identifying##3##3##(2008-10#1)(2008-9#1)(2009-12#1)
capable of inducing a##2##4##(2008-10#2)
capable of inducing##7##3##(1991-12#1)(1994-11#1)(1995-12#1)(2008-10#3)(2008-5#1)
capable of infecting pistachio and##2##5##(2008-10#2)
capable of infecting##5##3##(2008-10#4)(2011-3#1)
capable of inhibiting##2##3##(2008-10#1)(2012-3#1)
capable of interacting with the##2##5##(1994-11#1)(1995-5#1)
capable of killing##2##3##(1993-12#1)(1995-2#1)
capable of liberating iron from transferrin##2##6##(2008-5#2)
capable of measuring##3##3##(1992-9#1)(2008-10#2)
capable of mediating the electron transfer to##3##7##(2008-10#3)
capable of metabolizing##2##3##(1990-11#1)(2012-2#1)
capable of mimicking the##2##4##(1995-2#1)(2012-2#1)
capable of neutralizing##2##3##(2008-10#2)
capable of penetrating##2##3##(2008-10#1)(2010-10#1)
capable of performing##2##3##(1992-6#1)(2008-10#1)
capable of predicting the##2##4##(2008-3#1)(2009-7#1)
capable of producing##6##3##(1993-9#1)(2008-10#3)(2008-11#1)(2008-9#1)
capable of providing##2##3##(1996-3#1)(2009-5#1)
capable of recognizing##2##3##(2008-10#1)(2010-11#1)
capable of recording##2##3##(2008-10#1)(2008-11#1)
capable of reliably##2##3##(2008-10#1)(2012-2#1)
capable of simultaneous##2##3##(2008-10#1)(2008-6#1)
capable of supporting##3##3##(1994-5#1)(2010-8#1)(2012-3#1)
capable of##246##2##(1990-11#1)(1990-2#3)(1990-5#2)(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-12#5)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#91)(2008-11#19)(2008-12#2)(2008-3#10)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#11)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#8)(2012-3#3)(2013-1#4)(2013-8#1)
capable to##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
capable##257##1##(1990-11#1)(1990-2#3)(1990-5#2)(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-12#5)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#92)(2008-11#25)(2008-12#3)(2008-3#10)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#11)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-2#8)(2012-3#3)(2013-1#4)(2013-8#1)
capacitance measurement##3##2##(2008-10#2)(2008-5#1)
capacitance response is not sensitive##2##5##(2008-10#2)
capacitance##19##1##(2008-10#11)(2008-11#4)(2008-5#3)(2012-2#1)
capacities and##3##2##(1994-3#1)(2008-10#2)
capacities are##3##2##(2007-12#1)(2008-10#2)
capacities at##2##2##(2008-10#1)(2008-11#1)
capacities for##6##2##(2008-10#4)(2008-11#1)(2012-7#1)
capacities of the resin for##2##5##(2008-10#2)
capacities of the resin##3##4##(2008-10#3)
capacities of the##10##3##(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)
capacities of##19##2##(1997-2#5)(2007-12#1)(2008-10#11)(2008-11#1)(2008-7#1)
capacities to##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
capacities were found##2##3##(2008-7#1)(2013-1#1)
capacities were##5##2##(2008-10#1)(2008-7#2)(2008-9#1)(2013-1#1)
capacities##60##1##(1993-12#1)(1994-3#1)(1996-2#1)(1997-2#5)(2007-12#2)(2008-10#30)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-7#1)(2011-2#1)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
capacitive##5##1##(2008-10#4)(2008-5#1)
capacitively coupled plasma torch##2##4##(2008-10#2)
capacitor##4##1##(2008-10#3)(2010-10#1)
capacitors##4##1##(2008-10#3)(2008-7#1)
capacity and resolution##3##3##(2008-10#1)(2008-4#2)
capacity and the##3##3##(2008-10#1)(2010-8#2)
capacity and##28##2##(1991-7#1)(1992-3#1)(1992-6#1)(1997-1#1)(2008-1#1)(2008-10#9)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-3#1)(2012-12#1)
capacity are##3##2##(2008-11#2)(2010-2#1)
capacity at##3##2##(1990-9#1)(2008-5#1)(2012-2#1)
capacity building##4##2##(1997-2#2)(1997-3#1)(2012-3#1)
capacity by##4##2##(1996-2#1)(2008-11#2)(2008-3#1)
capacity coefficients##2##2##(2008-10#2)
capacity decreased##2##2##(2008-10#1)(2008-11#1)
capacity factors##3##2##(2008-10#3)
capacity for data-based planning##2##4##(1997-1#2)
capacity for##28##2##(1990-5#1)(1995-1#1)(1996-11#1)(1996-3#1)(1997-1#2)(1997-2#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
capacity have##2##2##(2008-10#1)(2012-2#1)
capacity in rats##2##3##(2008-7#1)(2012-2#1)
capacity in the##2##3##(2008-11#1)(2009-3#1)
capacity in##16##2##(1997-2#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#2)
capacity is##6##2##(1991-8#1)(2008-10#1)(2008-5#2)(2009-12#1)(2012-3#1)
capacity of 0##2##3##(2008-10#2)
capacity of 10##2##3##(1992-6#1)(2008-10#1)
capacity of OAV##2##3##(1997-3#2)
capacity of a##4##3##(1995-8#1)(2008-11#1)(2008-7#1)(2010-10#1)
capacity of cells##2##3##(1990-3#1)(2008-11#1)
capacity of the membrane disks modified by##2##7##(2008-10#2)
capacity of the membrane disks modified##3##6##(2008-10#3)
capacity of the resin for##2##5##(2008-10#2)
capacity of the resin was##3##5##(2008-10#3)
capacity of the resin##6##4##(2008-10#6)
capacity of the##63##3##(1990-11#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-2#1)(2008-10#39)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#2)
capacity of these##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
capacity of##159##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-9#1)(2008-10#73)(2008-11#11)(2008-3#4)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#6)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
capacity on the##2##3##(2008-10#2)
capacity on##6##2##(2008-10#6)
capacity or##2##2##(1995-2#1)(2008-11#1)
capacity than##4##2##(2008-10#2)(2009-4#1)(2010-4#1)
capacity to differentiate##2##3##(1990-5#1)(2010-11#1)
capacity to produce##2##3##(1994-3#1)(1996-2#1)
capacity to support##2##3##(2008-11#1)(2008-4#1)
capacity to##55##2##(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#4)(1997-8#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
capacity using##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
capacity utilization##3##2##(2010-8#3)
capacity values##3##2##(2008-10#3)
capacity was##13##2##(1995-12#1)(2008-10#8)(2008-11#1)(2012-2#2)(2012-3#1)
capacity were##4##2##(1991-2#1)(1991-8#1)(1993-6#1)(2008-10#1)
capacity##509##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#1)(1991-8#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#5)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#5)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#3)(1997-1#4)(1997-2#6)(1997-3#9)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#3)(2008-10#190)(2008-11#38)(2008-12#5)(2008-3#7)(2008-4#4)(2008-5#15)(2008-6#1)(2008-7#14)(2008-8#8)(2008-9#13)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#4)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#9)(2010-11#5)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#6)(2011-1#6)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#15)(2012-3#9)(2012-8#1)(2013-1#10)(2013-7#3)(2013-8#3)
capacity) and##2##2##(2008-10#1)(2008-12#1)
capacity) equipped with a 25 mL##2##6##(2008-10#2)
capacity)##6##1##(1992-3#1)(2008-10#3)(2008-12#1)(2012-6#1)
capillaries and##3##2##(2008-10#2)(2008-7#1)
capillaries by##2##2##(2008-10#1)(2008-11#1)
capillaries can##2##2##(2008-10#2)
capillaries##31##1##(1997-1#1)(1997-2#4)(2008-10#17)(2008-11#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-4#1)
capillary HPLC##3##2##(2008-10#1)(2008-4#2)
capillary and a##2##3##(2008-10#2)
capillary and##9##2##(2008-10#9)
capillary at##4##2##(2008-10#4)
capillary by##2##2##(2008-10#1)(2008-2#1)
capillary column##11##2##(2008-10#9)(2008-5#1)(2009-8#1)
capillary columns##2##2##(2008-10#2)
capillary discharge##2##2##(2008-3#2)
capillary electrochromatography##7##2##(1997-2#2)(2008-10#5)
capillary electrophoresis (CE) for##2##4##(2008-10#2)
capillary electrophoresis (CE) has##2##4##(2008-10#2)
capillary electrophoresis (CE) method##4##4##(2008-10#4)
capillary electrophoresis (CE) separation##3##4##(2008-10#3)
capillary electrophoresis (CE) system##4##4##(1997-2#1)(2008-10#3)
capillary electrophoresis (CE)##28##3##(1997-2#1)(2008-10#26)(2010-7#1)
capillary electrophoresis (CE)-amperometric detection##2##4##(2008-10#2)
capillary electrophoresis detection##2##3##(2008-10#1)(2008-2#1)
capillary electrophoresis for the##2##4##(2008-10#1)(2008-5#1)
capillary electrophoresis for##4##3##(2008-10#3)(2008-5#1)
capillary electrophoresis in##3##3##(2008-10#2)(2008-12#1)
capillary electrophoresis is##3##3##(2008-10#3)
capillary electrophoresis method for the##4##5##(1997-2#1)(2008-10#3)
capillary electrophoresis method for##5##4##(1997-2#1)(2008-10#4)
capillary electrophoresis method##9##3##(1997-2#1)(2008-10#8)
capillary electrophoresis system with##2##4##(2008-10#2)
capillary electrophoresis system##6##3##(2008-10#6)
capillary electrophoresis to determine##2##4##(2008-10#2)
capillary electrophoresis to##7##3##(2008-10#7)
capillary electrophoresis using##4##3##(2008-10#4)
capillary electrophoresis with amperometric detection##4##5##(2008-10#4)
capillary electrophoresis with electrochemical detection##4##5##(2008-10#4)
capillary electrophoresis with electrochemical##6##4##(2008-10#6)
capillary electrophoresis with laser-induced##4##4##(2008-10#4)
capillary electrophoresis with wall-jet amperometric detection##2##6##(2008-10#2)
capillary electrophoresis with##23##3##(1997-2#1)(2008-10#22)
capillary electrophoresis##149##2##(1997-2#5)(2008-10#136)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#1)
capillary electrophoresis-tandem mass spectrometry##3##4##(1997-2#3)
capillary electrophoretic method was developed for the##2##7##(2008-10#2)
capillary electrophoretic method##3##3##(2008-10#3)
capillary electrophoretic separation##2##3##(1997-2#1)(2008-10#1)
capillary electrophoretic##10##2##(1997-2#1)(2008-10#9)
capillary gas chromatography with##2##4##(2008-10#2)
capillary gas chromatography##5##3##(2008-10#4)(2008-5#1)
capillary ion chromatograph##2##3##(2008-10#2)
capillary ion##3##2##(1997-2#1)(2008-10#2)
capillary isotachophoresis (CITP)##2##3##(2008-10#2)
capillary isotachophoresis##6##2##(2008-10#6)
capillary of a sampling arm assembly##3##6##(2008-10#3)
capillary of a##6##3##(2008-10#6)
capillary of##7##2##(2008-10#7)
capillary temperature##3##2##(2008-10#3)
capillary tube##3##2##(2008-10#1)(2008-2#2)
capillary wall##2##2##(1997-2#1)(2010-12#1)
capillary was selected##2##3##(2008-10#2)
capillary was##7##2##(2008-10#7)
capillary where##2##2##(1997-2#1)(2008-10#1)
capillary with##3##2##(2008-10#3)
capillary zone electrophoresis (CZE) with##2##5##(2008-10#2)
capillary zone electrophoresis (CZE)##11##4##(2008-10#11)
capillary zone electrophoresis method for the determination of##2##8##(2008-10#2)
capillary zone electrophoresis using##3##4##(2008-10#3)
capillary zone electrophoresis with amperometric detection##2##6##(2008-10#2)
capillary zone electrophoresis with##7##4##(2008-10#7)
capillary zone electrophoresis##51##3##(1992-12#2)(2008-10#49)
capillary##396##1##(1991-2#1)(1991-6#1)(1992-12#2)(1996-6#1)(1997-2#16)(2008-1#1)(2008-10#340)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#3)(2008-5#5)(2008-7#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
capillary-column liquid chromatography##2##3##(2008-10#2)
capital and##2##2##(1992-2#1)(2013-8#1)
capital asset management##3##3##(1994-3#3)
capital cost##2##2##(1991-2#1)(2008-10#1)
capital costs##4##2##(1992-2#2)(1993-1#1)(2008-10#1)
capital equipment##3##2##(1991-1#1)(1994-3#2)
capital funds##2##2##(1994-12#1)(2008-11#1)
capital payments##2##2##(1992-2#2)
capital##46##1##(1991-1#2)(1991-2#1)(1992-12#1)(1992-2#5)(1992-3#1)(1993-1#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#12)(1994-9#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-8#2)(2008-9#2)(2011-2#1)(2013-1#2)(2013-8#2)
capitalensis)##2##1##(2008-10#2)
capitalize on the##3##3##(1994-12#1)(1995-2#1)(2008-4#1)
capitalize on##7##2##(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(2008-4#1)(2010-9#1)(2011-2#1)
capitalizes on##2##2##(2008-10#1)(2012-2#1)
capitata##5##1##(2007-12#2)(2008-10#2)(2008-11#1)
capitata)##2##1##(2008-10#1)(2008-11#1)
capitated##6##1##(1995-12#1)(1995-2#2)(1995-3#1)(1996-3#1)(1997-2#1)
capitation and##3##2##(1993-3#1)(1997-1#2)
capitation arrangements##2##2##(1993-3#1)(1994-3#1)
capitation payments##6##2##(1993-3#1)(1994-2#1)(1997-1#4)
capitation rates for##2##3##(1991-2#2)
capitation rates##3##2##(1991-2#2)(1994-3#1)
capitation##25##1##(1991-2#2)(1992-2#1)(1993-3#6)(1994-2#1)(1994-3#4)(1995-2#2)(1997-1#7)(1997-2#1)(1997-3#1)
capitis##7##1##(2008-5#5)(2010-9#1)(2013-1#1)
capped RNA##3##2##(2008-10#1)(2011-2#2)
capped and uncapped##2##3##(2008-10#2)
capped with##2##2##(1992-6#1)(2008-10#1)
capped##11##1##(1992-6#1)(2008-10#8)(2011-2#2)
capping layer##3##2##(2009-5#3)
capping of the##3##3##(1991-6#1)(2008-10#1)(2012-2#1)
capping protein##2##2##(2010-12#2)
capping##13##1##(1991-6#1)(1992-2#1)(2008-10#2)(2009-5#3)(2010-12#2)(2011-2#1)(2012-2#3)
cappuccino and spire##2##3##(1994-9#2)
caproate##3##1##(2008-10#2)(2012-3#1)
caps of##2##2##(2007-12#2)
caps##8##1##(1992-8#1)(1995-2#1)(1997-7#1)(2007-12#4)(2008-10#1)
capsaicin had##2##2##(2008-8#1)(2011-2#1)
capsaicin on##6##2##(1992-6#1)(1993-11#2)(2008-11#1)(2009-9#1)(2011-2#1)
capsaicin pretreatment##3##2##(1992-6#2)(1997-4#1)
capsaicin treatment on##2##3##(1992-6#1)(2008-11#1)
capsaicin treatment##5##2##(1992-6#1)(1997-4#1)(2008-11#3)
capsaicin was##2##2##(1992-6#1)(2008-11#1)
capsaicin##44##1##(1992-6#9)(1993-11#3)(1997-4#5)(2008-10#2)(2008-11#17)(2008-8#2)(2009-9#3)(2011-2#2)(2013-1#1)
capsaicin-sensitive##4##1##(1992-6#2)(1997-4#2)
capsaicinoids##3##1##(2008-10#3)
capsaicins##2##1##(2008-10#2)
capsici and##2##2##(2008-10#2)
capsici in pepper##2##3##(2008-10#2)
capsici in##9##2##(2008-10#9)
capsici is a##2##3##(2008-10#2)
capsici isolates##2##2##(2008-10#2)
capsici was##2##2##(2008-10#2)
capsici##38##1##(2008-10#35)(2008-11#2)(2012-2#1)
capsid protein (CP)##3##3##(2008-10#3)
capsid protein (ORF##2##3##(2008-10#2)
capsid protein##17##2##(2008-1#1)(2008-10#13)(2008-8#1)(2009-7#1)(2009-8#1)
capsid shell##2##2##(1991-5#1)(2008-8#1)
capsid##33##1##(1991-5#2)(1995-2#3)(2008-1#1)(2008-10#18)(2008-5#1)(2008-8#5)(2009-7#2)(2009-8#1)
capstone course is##2##3##(1993-1#2)
capstone course##5##2##(1993-1#5)
capsular block syndrome##2##3##(2011-2#2)
capsular contracture##2##2##(1992-9#1)(2013-1#1)
capsular polysaccharide##3##2##(1990-12#1)(1997-3#1)(2008-5#1)
capsular##12##1##(1990-12#1)(1990-5#2)(1992-9#1)(1995-11#1)(1997-3#1)(2008-5#2)(2011-2#3)(2013-1#1)
capsulatum was##2##2##(2008-5#2)
capsulatum##7##1##(2008-5#7)
capsule and##2##2##(2008-12#1)(2013-1#1)
capsule endoscopy findings##2##3##(2011-2#2)
capsule endoscopy in##2##3##(2010-12#1)(2011-2#1)
capsule endoscopy##9##2##(2009-8#1)(2010-12#2)(2011-2#6)
capsule of the##2##3##(2011-2#1)(2012-2#1)
capsule of##5##2##(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)
capsule##46##1##(1990-11#1)(1991-8#1)(1996-12#2)(1997-3#1)(2008-10#5)(2008-12#6)(2008-5#1)(2008-7#4)(2009-8#1)(2010-12#2)(2011-2#15)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
capsules and##10##2##(2007-12#1)(2008-10#9)
capsules in##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
capsules##34##1##(1997-3#5)(2007-12#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
captive snakes##2##2##(1996-12#2)
captive##12##1##(1991-3#1)(1996-12#2)(1996-6#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)
captopril for##2##2##(1992-12#1)(2008-7#1)
captopril in##2##2##(1990-11#1)(2008-10#1)
captopril##27##1##(1990-11#5)(1992-11#1)(1992-12#1)(1993-2#1)(1994-5#5)(1995-8#1)(1996-2#3)(2008-10#7)(2008-7#3)
capture a##2##2##(1993-2#1)(2008-1#1)
capture and##7##2##(1990-12#1)(1991-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#1)
capture assay##3##2##(2008-4#3)
capture detection (GC-ECD)##2##3##(2008-10#2)
capture detection##8##2##(2008-10#8)
capture detector (ECD)##3##3##(2008-10#3)
capture detector (GC-ECD)##2##3##(2008-10#2)
capture detector##8##2##(2008-10#8)
capture in##2##2##(2008-9#1)(2010-8#1)
capture microdissection##3##2##(2008-4#3)
capture of##7##2##(1990-12#2)(1997-2#1)(2008-10#3)(2008-5#1)
capture potential##2##2##(2008-10#1)(2012-2#1)
capture rates##2##2##(2008-9#2)
capture the essence of##2##4##(2008-11#1)(2009-7#1)
capture the##15##2##(1990-12#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-8#1)
capture##95##1##(1990-12#4)(1991-2#1)(1993-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-1#3)(2008-10#31)(2008-11#5)(2008-3#2)(2008-4#7)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#8)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-7#1)(2010-8#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
captured and##2##2##(2008-12#1)(2008-4#1)
captured at##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
captured by the##2##3##(2011-2#2)
captured by##6##2##(1995-6#1)(2008-11#1)(2011-2#3)(2013-1#1)
captured in##7##2##(2008-10#3)(2008-12#1)(2010-12#1)(2010-8#2)
captured on##3##2##(2008-10#1)(2008-4#1)(2010-2#1)
captured##38##1##(1992-2#1)(1995-6#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-2#4)(2011-9#1)(2012-2#1)(2013-1#1)
captures the##4##2##(2008-10#1)(2009-10#1)(2010-7#1)(2012-2#1)
captures##9##1##(1992-11#1)(2008-10#2)(2008-8#1)(2009-10#2)(2010-7#1)(2012-2#1)(2012-3#1)
capturing a##2##2##(2008-11#1)(2011-2#1)
capturing##19##1##(1992-3#1)(1993-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-8#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-8#2)
caput##6##1##(1997-8#2)(2008-12#2)(2008-7#1)(2012-2#1)
car accidents##2##2##(1991-3#1)(2009-3#1)
car##11##1##(1991-3#1)(2008-10#3)(2008-11#3)(2009-3#1)(2010-12#1)(2013-1#2)
caractéristiques##3##1##(2008-11#1)(2013-1#2)
carazolol##4##1##(1995-11#4)
carbachol and the##2##3##(1994-8#1)(2008-10#1)
carbachol and##4##2##(1994-8#1)(1996-12#1)(2008-10#2)
carbachol stimulated accumulation of labeled IP4##2##6##(1997-1#2)
carbachol stimulated##4##2##(1996-12#1)(1997-1#3)
carbachol##27##1##(1994-11#1)(1994-8#9)(1996-12#6)(1997-1#5)(2008-10#5)(2008-11#1)
carbachol-##2##1##(1995-11#2)
carbachol-stimulated##4##1##(1995-2#1)(1997-1#3)
carbamate (mebendazole)##2##2##(2008-10#2)
carbamate##11##1##(1993-6#1)(2008-10#9)(2012-12#1)
carbamates in the##2##3##(2008-10#2)
carbamates in##5##2##(2008-10#5)
carbamates were##2##2##(2008-10#2)
carbamates##10##1##(2008-10#10)
carbamazepine and##2##2##(2008-10#2)
carbamazepine##9##1##(1997-4#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-3#1)
carbamyl phosphate synthetase (CPS)##2##4##(1990-7#2)
carbamyl phosphate synthetases##2##3##(1990-7#2)
carbamyl phosphate##4##2##(1990-7#4)
carbamylcholine chloride##4##2##(1995-8#4)
carbamylcholine##5##1##(1992-8#1)(1995-8#4)
carbapenem antibiotic##2##2##(2008-5#1)(2008-7#1)
carbaryl and benomyl##3##3##(2008-10#3)
carbaryl##18##1##(2008-10#18)
carbazole derivative##3##2##(2008-10#3)
carbazole##4##1##(2008-10#4)
carbendazim and##2##2##(2008-10#2)
carbendazim##7##1##(2008-10#7)
carbene complex##2##2##(2010-3#1)(2010-5#1)
carbene##3##1##(2010-3#1)(2010-5#1)(2010-7#1)
carbide##8##1##(2008-10#7)(2008-11#1)
carbinol##3##1##(2008-10#3)
carboCys##4##1##(2008-10#4)
carbocysteine##2##1##(2008-10#2)
carbodiimide and##2##2##(2008-10#2)
carbodiimide##6##1##(1997-2#1)(2008-10#5)
carbodiimide/glutaraldehyde##2##1##(2008-10#2)
carbofuran##8##1##(2008-10#8)
carbohydrate chain attached to Asn-39##2##5##(1990-5#2)
carbohydrate chain##4##2##(1990-5#4)
carbohydrate chains##2##2##(1990-5#1)(2008-11#1)
carbohydrate concentrations##3##2##(2008-10#3)
carbohydrate counting##2##2##(2011-2#2)
carbohydrate diet##2##2##(2008-3#2)
carbohydrate intake##2##2##(2008-4#1)(2013-1#1)
carbohydrate metabolism##7##2##(1994-8#1)(1997-6#1)(2008-10#3)(2010-1#1)(2012-3#1)
carbohydrate moieties##4##2##(1994-8#1)(1995-8#1)(2008-12#1)(2008-9#1)
carbohydrate moiety of##3##3##(1991-12#1)(1994-8#1)(2008-11#1)
carbohydrate moiety##5##2##(1991-12#2)(1994-8#1)(2006-6#1)(2008-11#1)
carbohydrate reserves##2##2##(2008-10#2)
carbohydrate source##2##2##(2008-10#2)
carbohydrate structure of##2##3##(1990-5#1)(1992-11#1)
carbohydrate structures##5##2##(1991-5#2)(1996-12#1)(2008-11#1)(2008-5#1)
carbohydrate##87##1##(1990-11#1)(1990-2#2)(1990-5#7)(1990-8#2)(1991-12#2)(1991-5#2)(1992-11#1)(1993-1#2)(1994-5#1)(1994-8#3)(1995-8#2)(1996-12#2)(1996-5#1)(1996-6#4)(1997-2#2)(1997-6#1)(2006-6#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#3)
carbohydrate-binding##3##1##(1994-8#1)(2009-3#2)
carbohydrate-derivatized##2##1##(1990-2#2)
carbohydrate-restricted diet##5##2##(2008-3#5)
carbohydrate-specific##2##1##(1990-2#1)(2008-11#1)
carbohydrates and##4##2##(1997-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
carbohydrates in##6##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-5#1)
carbohydrates is##2##2##(2008-7#2)
carbohydrates on##2##2##(1992-6#1)(1995-8#1)
carbohydrates were##2##2##(2008-10#1)(2008-9#1)
carbohydrates##44##1##(1992-6#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#2)(2008-10#13)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2010-8#1)(2011-2#1)(2012-5#2)(2013-1#2)
carbohydrates)##4##1##(2008-3#1)(2008-7#1)(2013-1#2)
carbon (%)##2##2##(2008-10#2)
carbon and a##2##3##(2008-10#2)
carbon and nitrogen contents##2##4##(2008-10#2)
carbon and nitrogen##8##3##(2008-10#7)(2008-11#1)
carbon and sulfur##2##3##(2010-11#2)
carbon and##31##2##(1996-12#1)(1996-3#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#3)
carbon atom and##2##3##(1991-3#1)(2008-10#1)
carbon atom positions##2##3##(2008-7#2)
carbon atom##8##2##(1991-3#2)(2008-10#4)(2008-7#2)
carbon atoms was##3##3##(2008-10#2)(2013-8#1)
carbon atoms##7##2##(1992-6#1)(2008-10#4)(2008-7#1)(2013-8#1)
carbon based##2##2##(2008-10#2)
carbon black##2##2##(2008-10#2)
carbon catabolite repression by sugars in the juice##2##8##(2008-10#2)
carbon catabolite repression by##3##4##(1993-12#1)(2008-10#2)
carbon catabolite repression##4##3##(1993-12#1)(2008-10#3)
carbon centers##2##2##(1996-5#2)
carbon ceramic electrode prepared by##2##5##(2008-10#2)
carbon ceramic electrode prepared with sol-gel technique##2##7##(2008-10#2)
carbon ceramic electrode prepared##4##4##(2008-10#4)
carbon ceramic electrode##10##3##(2008-10#10)
carbon ceramic##11##2##(2008-10#11)
carbon coated##2##2##(2008-10#1)(2012-12#1)
carbon composite electrode##3##3##(2008-10#3)
carbon composite##7##2##(2008-10#5)(2013-1#2)
carbon content of the##2##4##(2008-10#2)
carbon content of##3##3##(2008-10#2)(2012-9#1)
carbon content##4##2##(2008-10#3)(2012-9#1)
carbon dioxide (CO 2) laser##2##5##(1991-2#1)(1992-1#1)
carbon dioxide (CO(2))##4##3##(2008-11#1)(2009-6#1)(2012-2#1)(2012-3#1)
carbon dioxide (CO2)##2##3##(1996-12#2)
carbon dioxide and##3##3##(2008-10#3)
carbon dioxide extraction##3##3##(2008-10#3)
carbon dioxide from##2##3##(2008-10#1)(2008-11#1)
carbon dioxide in##4##3##(1993-12#1)(2008-10#3)
carbon dioxide laser##4##3##(1991-12#2)(1992-1#1)(1993-8#1)
carbon dioxide production##5##3##(2008-11#5)
carbon dioxide was##3##3##(2008-10#3)
carbon dioxide##75##2##(1991-12#2)(1991-2#1)(1992-1#2)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1996-12#2)(2008-10#42)(2008-11#10)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-4#2)(2012-2#1)(2012-3#2)
carbon disc electrode##5##3##(2008-10#5)
carbon disk electrode##4##3##(1990-12#1)(2008-10#3)
carbon disk##5##2##(1990-12#1)(2008-10#4)
carbon electrode (GCE) using##2##4##(2008-10#2)
carbon electrode (GCE)##15##3##(2008-10#15)
carbon electrode and its##2##4##(2008-10#2)
carbon electrode and##6##3##(2008-10#6)
carbon electrode can be##2##4##(2008-10#2)
carbon electrode for##2##3##(2008-10#2)
carbon electrode using##3##3##(2008-10#3)
carbon electrode was used##2##4##(2008-10#2)
carbon electrode was##6##3##(2008-10#6)
carbon electrode##119##2##(1990-12#1)(2008-10#118)
carbon electrodes (SPCEs)##3##3##(2008-10#3)
carbon electrodes for##2##3##(2008-10#1)(2013-1#1)
carbon electrodes have been##2##4##(2008-10#2)
carbon electrodes in##3##3##(2008-10#3)
carbon electrodes modified with##4##4##(2008-10#4)
carbon electrodes##36##2##(2008-10#34)(2013-1#2)
carbon felt##2##2##(2008-10#2)
carbon fiber microdisk electrode##3##4##(2008-10#3)
carbon fiber microelectrode##3##3##(2008-10#3)
carbon fiber microelectrodes##2##3##(2008-4#2)
carbon fiber nanoelectrodes##2##3##(2008-10#2)
carbon fiber ultramicroelectrode##2##3##(2008-10#2)
carbon fiber##15##2##(2008-10#13)(2008-4#2)
carbon fibers for SPME##2##4##(2008-10#2)
carbon fibers for##3##3##(2008-10#3)
carbon fibers##6##2##(2008-10#6)
carbon fibre##2##2##(2008-10#2)
carbon film electrodes##2##3##(2008-10#2)
carbon film##3##2##(2008-10#3)
carbon flux through##2##3##(2008-11#1)(2008-7#1)
carbon flux##6##2##(2008-11#1)(2008-7#2)(2008-8#1)(2013-1#2)
carbon in steels##2##3##(2008-10#2)
carbon in the##3##3##(2008-10#2)(2008-3#1)
carbon in##11##2##(2008-10#10)(2008-3#1)
carbon ink##2##2##(2008-10#2)
carbon is##2##2##(2008-10#1)(2008-3#1)
carbon isotope##3##2##(2008-10#3)
carbon loss##2##2##(2008-10#2)
carbon metabolism##6##2##(2008-10#1)(2008-7#2)(2008-9#1)(2012-7#2)
carbon modified##2##2##(2008-10#2)
carbon monoxide (CO)##2##3##(1990-5#1)(1996-12#1)
carbon monoxide and##2##3##(2008-10#1)(2008-11#1)
carbon monoxide poisoning##3##3##(1990-5#1)(2009-11#2)
carbon monoxide##16##2##(1990-5#2)(1991-3#1)(1993-8#2)(1995-2#1)(1996-12#2)(2008-10#3)(2008-11#1)(2009-11#2)(2010-10#1)(2010-12#1)
carbon nanotube (CNT)##3##3##(2008-10#1)(2008-7#1)(2009-11#1)
carbon nanotube##8##2##(2008-10#5)(2008-7#2)(2009-11#1)
carbon nanotubes (CNTs)##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
carbon nanotubes (MWNTs)##3##3##(2008-10#2)(2009-3#1)
carbon nanotubes and redox polymer##2##5##(2008-10#2)
carbon nanotubes and##3##3##(2008-10#3)
carbon nanotubes by##2##3##(2008-7#2)
carbon nanotubes film##2##3##(2008-10#2)
carbon nanotubes on##2##3##(2008-10#1)(2008-7#1)
carbon nanotubes were##2##3##(2008-10#1)(2011-2#1)
carbon nanotubes##47##2##(2008-10#29)(2008-7#7)(2009-10#2)(2009-3#2)(2010-4#1)(2010-7#1)(2011-2#4)(2013-1#1)
carbon or##2##2##(2008-10#2)
carbon particles##4##2##(2008-10#1)(2008-3#1)(2012-12#2)
carbon paste electrode (CPE)##10##4##(2008-10#10)
carbon paste electrode and##2##4##(2008-10#2)
carbon paste electrode for the##3##5##(2008-10#3)
carbon paste electrode for##8##4##(2008-10#8)
carbon paste electrode has been developed##3##6##(2008-10#3)
carbon paste electrode in the presence of##2##7##(2008-10#2)
carbon paste electrode in##3##4##(2008-10#3)
carbon paste electrode modified by silver nanoparticles##2##7##(2008-10#2)
carbon paste electrode modified by##3##5##(2008-10#3)
carbon paste electrode modified with##10##5##(2008-10#10)
carbon paste electrode modified##15##4##(2008-10#15)
carbon paste electrode using##3##4##(2008-10#3)
carbon paste electrode were##2##4##(2008-10#2)
carbon paste electrode##84##3##(2008-10#84)
carbon paste electrodes for##2##4##(2008-10#2)
carbon paste electrodes##11##3##(2008-10#11)
carbon paste##108##2##(2008-10#108)
carbon powder##5##2##(2008-10#5)
carbon present in the##2##4##(2008-10#1)(2008-3#1)
carbon screen-printed electrode##3##3##(2008-10#3)
carbon showed the##2##3##(2008-10#2)
carbon source##23##2##(1995-9#1)(2008-10#12)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
carbon sources in the##2##4##(1991-9#1)(1997-2#1)
carbon sources in##3##3##(1991-9#1)(1997-2#1)(2008-5#1)
carbon sources##9##2##(1991-9#2)(1996-12#1)(1997-2#1)(2008-10#2)(2008-5#2)(2011-1#1)
carbon spheres##2##2##(2008-3#2)
carbon substrate utilization##2##3##(2008-10#2)
carbon substrates##3##2##(2008-10#2)(2011-2#1)
carbon tetrachloride and##2##3##(2008-10#2)
carbon tetrachloride##10##2##(1992-6#1)(2008-10#6)(2009-8#1)(2010-2#1)(2013-1#1)
carbon to##3##2##(2008-10#3)
carbon were##3##2##(1993-8#1)(2008-10#2)
carbon##774##1##(1990-12#2)(1990-5#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-9#2)(1992-1#2)(1992-5#1)(1992-6#2)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#4)(1994-5#2)(1994-8#1)(1995-2#1)(1995-9#1)(1996-12#6)(1996-3#1)(1996-5#3)(1997-2#1)(2008-10#606)(2008-11#21)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-7#23)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#3)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#3)(2012-5#2)(2012-7#2)(2012-9#1)(2013-1#9)(2013-8#2)
carbon) and##2##2##(2008-10#2)
carbon)##3##1##(2008-10#3)
carbon-13 labeled modified##2##3##(2008-10#2)
carbon-13##5##1##(1992-12#1)(2008-10#4)
carbon-based##2##1##(2008-10#1)(2009-8#1)
carbon-paste##2##1##(2008-10#2)
carbon-supported##2##1##(2008-10#2)
carbon-working electrode##2##2##(2008-10#2)
carbon/nitrogen ratio##3##2##(2008-10#2)(2008-12#1)
carbon/nitrogen ratios##2##2##(2008-10#2)
carbon/nitrogen##5##1##(2008-10#4)(2008-12#1)
carbonaceous##4##1##(2008-10#3)(2008-12#1)
carbonate and##7##2##(2008-10#3)(2011-2#4)
carbonate apatite##2##2##(2008-10#2)
carbonate by##2##2##(2008-10#1)(2011-2#1)
carbonate complexes##3##2##(2008-10#3)
carbonate in##5##2##(2008-10#5)
carbonate ion##2##2##(2008-10#2)
carbonate or Tris##2##3##(2008-10#2)
carbonate selectivity##2##2##(2008-10#2)
carbonate species##2##2##(2008-10#2)
carbonate to##2##2##(2008-10#1)(2011-2#1)
carbonate##75##1##(1990-11#2)(1994-5#1)(1996-2#1)(2008-10#56)(2008-7#1)(2011-2#12)(2012-12#1)(2013-1#1)
carbonate)##4##1##(2008-10#4)
carbonate-selective##3##1##(2008-10#3)
carbonated##2##1##(2008-10#1)(2009-7#1)
carbonates##8##1##(1996-5#1)(2008-10#5)(2008-3#1)(2008-6#1)
carbonic anhydrase##5##2##(1993-1#2)(2009-3#2)(2013-8#1)
carbons##5##1##(1991-5#1)(1993-8#1)(2008-10#3)
carbonum##7##1##(2008-10#7)
carbonyl and##2##2##(2008-10#1)(2012-2#1)
carbonyl compounds##6##2##(1992-12#1)(2008-10#5)
carbonyl group at##3##3##(2008-11#1)(2011-3#1)(2012-2#1)
carbonyl group##7##2##(1995-6#1)(1996-5#1)(2008-10#2)(2008-11#1)(2011-3#1)(2012-2#1)
carbonyl groups of##2##3##(1996-5#1)(2009-7#1)
carbonyl groups on##2##3##(1995-5#1)(1996-5#1)
carbonyl groups##6##2##(1995-5#1)(1996-5#3)(2009-7#1)(2009-8#1)
carbonyl oxygen atom of##2##4##(1991-3#1)(1996-5#1)
carbonyl oxygen##5##2##(1991-3#2)(1996-5#3)
carbonyl##42##1##(1990-6#1)(1990-9#2)(1991-3#3)(1992-12#1)(1992-3#1)(1995-5#1)(1995-6#1)(1996-5#8)(2008-10#14)(2008-11#1)(2008-8#1)(2009-7#1)(2009-8#3)(2010-7#1)(2011-3#1)(2012-2#2)
carbonylation##2##1##(1996-5#1)(2010-12#1)
carbonyls##2##1##(1994-5#1)(2008-10#1)
carboplatin and##2##2##(1991-8#1)(2008-8#1)
carboplatin##10##1##(1991-8#2)(1993-2#1)(2008-10#5)(2008-7#1)(2008-8#1)
carbosilane dendrimer##2##2##(2008-10#2)
carboxamide##3##1##(1992-2#2)(1994-8#1)
carboxen-polydimethylsiloxane##2##1##(2008-10#1)(2009-8#1)
carboxin resistance##3##2##(2008-10#3)
carboxin-sensitive##2##1##(2008-10#2)
carboxy terminus##2##2##(1993-8#1)(1995-8#1)
carboxy-terminal tag##2##2##(2008-11#2)
carboxy-terminal##5##1##(1993-8#1)(1997-4#1)(2008-11#2)(2009-7#1)
carboxy-terminus##4##1##(1991-12#1)(1991-5#1)(1992-6#1)(1995-6#1)
carboxyarsenazo##2##1##(2008-10#2)
carboxyfluorescein (CF)##2##2##(2008-10#2)
carboxyfluorescein diacetate##2##2##(2008-11#1)(2008-9#1)
carboxyfluorescein##5##1##(2008-10#3)(2008-11#1)(2008-9#1)
carboxykinase and citric-acid-cycle dehydrogenases##2##4##(1991-3#2)
carboxykinase##6##1##(1991-3#2)(1994-8#1)(1996-2#1)(2008-12#2)
carboxyl and##3##2##(2008-10#2)(2009-7#1)
carboxyl group of xylanase##2##4##(1993-3#2)
carboxyl group##6##2##(1993-3#3)(2008-10#3)
carboxyl groups of##2##3##(2008-10#2)
carboxyl groups on the##2##4##(2008-10#2)
carboxyl groups##9##2##(1997-2#1)(2008-10#8)
carboxyl terminal##4##2##(1993-8#1)(1996-12#2)(2008-10#1)
carboxyl terminus of##3##3##(1992-8#1)(1996-12#1)(2012-2#1)
carboxyl terminus##10##2##(1992-7#1)(1992-8#1)(1992-9#3)(1995-6#1)(1996-12#1)(2008-11#2)(2012-2#1)
carboxyl##41##1##(1990-7#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-3#3)(1993-8#3)(1994-5#2)(1995-6#1)(1996-12#3)(1997-2#1)(2008-10#15)(2008-11#2)(2008-4#1)(2009-7#1)(2011-2#2)(2012-2#1)
carboxyl-terminal##5##1##(1991-12#1)(1994-11#1)(1995-6#2)(1997-8#1)
carboxylase##11##1##(1990-5#2)(1991-3#1)(1992-9#4)(1995-8#1)(2008-11#2)(2008-7#1)
carboxylase/oxygenase (Rubisco)##2##2##(1993-12#2)
carboxylate groups##5##2##(1991-5#2)(2008-10#3)
carboxylate matrices##3##2##(2008-7#3)
carboxylate moiety on the##2##4##(2008-10#2)
carboxylate##19##1##(1991-5#3)(1993-8#1)(2008-10#10)(2008-7#3)(2012-12#2)
carboxylated##4##1##(2008-10#4)
carboxylation efficiency##2##2##(2008-9#1)(2012-6#1)
carboxylation##4##1##(1992-9#1)(2008-9#1)(2012-5#1)(2012-6#1)
carboxylesterases##2##1##(1991-5#1)(1996-12#1)
carboxylic acid by##2##3##(2008-10#2)
carboxylic acid##16##2##(1991-9#1)(2008-10#13)(2009-8#1)(2010-4#1)
carboxylic acids and##2##3##(1997-2#1)(2008-10#1)
carboxylic acids are##2##3##(2008-10#1)(2011-1#1)
carboxylic acids by##2##3##(2008-10#1)(2011-1#1)
carboxylic acids##16##2##(1997-2#1)(2008-10#11)(2011-1#4)
carboxylic functional group##2##3##(2011-2#2)
carboxylic groups in##2##3##(2008-10#2)
carboxylic groups##5##2##(2008-10#5)
carboxylic##52##1##(1991-9#2)(1997-2#1)(2008-10#41)(2009-8#1)(2010-4#1)(2011-1#4)(2011-2#2)
carboxyltransferase##4##1##(1992-9#4)
carboxymethyl##4##1##(2008-10#3)(2008-7#1)
carboxymethylated chitosan##2##2##(2009-3#2)
carboxymethylated dextran##2##2##(2008-10#2)
carboxymethylated##4##1##(2008-10#2)(2009-3#2)
carboxymethylated-dextran##2##1##(2008-10#2)
carboxymethylcellulose (CMC)##4##2##(2008-10#2)(2009-3#1)(2011-2#1)
carboxypeptidase H##2##2##(1995-8#2)
carboxypeptidase M expression##2##3##(1995-6#2)
carboxypeptidase M##7##2##(1990-5#1)(1995-6#6)
carboxypeptidase##21##1##(1990-2#1)(1990-5#1)(1993-8#6)(1995-6#7)(1995-8#2)(2006-6#4)
carcase##2##1##(1997-5#2)
carcases with a fleece score of##2##6##(1997-5#2)
carcases with a##3##3##(1997-5#3)
carcases##10##1##(1990-3#1)(1990-9#2)(1997-5#7)
carcass##7##1##(2008-5#1)(2013-1#6)
carcasses##4##1##(2008-7#1)(2013-1#3)
carcinine##2##1##(2008-5#2)
carcinoembryonic antigen (CEA) gene family##2##5##(1990-5#1)(1992-6#1)
carcinoembryonic antigen (CEA)##5##3##(1990-5#1)(1992-6#1)(2008-10#1)(2008-11#2)
carcinoembryonic antigen and epithelial membrane antigen##2##6##(1991-12#1)(1992-2#1)
carcinoembryonic antigen and##4##3##(1991-12#1)(1992-2#1)(2008-11#1)(2008-7#1)
carcinoembryonic antigen##10##2##(1990-5#1)(1991-12#1)(1992-2#1)(1992-6#1)(2008-10#2)(2008-11#3)(2008-7#1)
carcinoembryonic##11##1##(1990-5#1)(1991-12#1)(1992-2#1)(1992-6#2)(2008-10#2)(2008-11#3)(2008-7#1)
carcinogen in##2##2##(1990-6#1)(1993-11#1)
carcinogen##11##1##(1990-6#1)(1993-11#3)(1993-8#1)(1994-11#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
carcinogenesis and##5##2##(1995-9#1)(2008-9#1)(2010-12#2)(2013-8#1)
carcinogenesis by##2##2##(1992-10#1)(2009-3#1)
carcinogenesis in the rat kidney##2##5##(1994-5#2)
carcinogenesis in##3##2##(1991-12#1)(1994-5#2)
carcinogenesis is##2##2##(1993-11#1)(2008-12#1)
carcinogenesis##42##1##(1990-6#2)(1991-12#1)(1991-6#1)(1992-10#1)(1993-11#2)(1993-12#1)(1994-5#3)(1995-11#1)(1995-2#1)(1995-9#7)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#2)
carcinogenic activity of##4##3##(1994-5#1)(2008-9#3)
carcinogenic potential##2##2##(1991-12#1)(2008-10#1)
carcinogenic##27##1##(1990-5#2)(1991-12#4)(1992-6#1)(1994-5#1)(1995-11#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-9#4)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
carcinogenicity of##7##2##(1991-12#5)(1992-9#1)(1993-8#1)
carcinogenicity##14##1##(1991-12#5)(1992-9#1)(1993-8#1)(2008-10#2)(2008-9#5)
carcinogens in##2##2##(1995-9#1)(2008-5#1)
carcinogens##17##1##(1991-12#1)(1991-5#1)(1992-6#2)(1995-2#1)(1995-9#1)(1997-2#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
carcinoid tumor##4##2##(1990-2#2)(1994-8#1)(2012-3#1)
carcinoid tumours##5##2##(1992-11#4)(2009-11#1)
carcinoid##29##1##(1990-2#3)(1990-5#1)(1992-11#6)(1992-5#1)(1994-8#2)(1997-1#1)(2009-11#1)(2009-5#1)(2010-2#3)(2011-2#7)(2012-2#1)(2012-3#2)
carcinoma (HCC) is##5##3##(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
carcinoma (HCC)##13##2##(1993-2#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-12#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
carcinoma (NSCLC)##2##2##(2008-11#1)(2013-1#1)
carcinoma HeLa cells##2##3##(2008-11#2)
carcinoma and in##2##3##(1992-5#1)(1994-8#1)
carcinoma and the##3##3##(1993-11#1)(1993-8#1)(2009-1#1)
carcinoma and##22##2##(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-1#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
carcinoma are##4##2##(1995-12#1)(2007-8#1)(2010-11#1)(2010-7#1)
carcinoma arising from##4##3##(2008-10#3)(2010-7#1)
carcinoma arising##6##2##(2008-10#3)(2010-7#1)(2013-8#2)
carcinoma breast##2##2##(2008-10#1)(2012-3#1)
carcinoma cases##3##2##(1990-12#1)(2008-1#1)(2011-2#1)
carcinoma cell line##7##3##(1994-8#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-8#1)(2008-9#1)
carcinoma cell lines##8##3##(1992-7#1)(1992-8#3)(1995-6#1)(1995-9#1)(2010-7#1)(2013-1#1)
carcinoma cell##22##2##(1991-2#2)(1992-7#1)(1992-8#3)(1994-8#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-2#1)(2008-11#3)(2008-8#2)(2008-9#2)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
carcinoma cells and##2##3##(1993-8#1)(2008-11#1)
carcinoma cells by##2##3##(1992-6#1)(1993-8#1)
carcinoma cells##21##2##(1992-6#2)(1992-8#1)(1993-8#4)(1994-8#1)(1995-12#1)(1995-2#2)(2008-11#4)(2008-9#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
carcinoma from##4##2##(2010-7#3)(2012-12#1)
carcinoma in 17##2##3##(1991-3#1)(1993-8#1)
carcinoma in a##8##3##(1990-6#2)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(2010-8#1)(2011-2#1)
carcinoma in situ##6##3##(1990-2#2)(1991-9#1)(1994-1#1)(1994-12#1)(1997-3#1)
carcinoma in the##3##3##(1990-8#1)(1994-12#1)(1995-12#1)
carcinoma in##29##2##(1990-2#2)(1990-6#2)(1990-8#2)(1991-3#2)(1991-9#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-12#1)(1997-3#1)(1997-7#1)(2010-8#1)(2011-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
carcinoma is a##2##3##(1997-5#1)(2009-10#1)
carcinoma is the most common##2##5##(2009-2#1)(2013-1#1)
carcinoma is##9##2##(1990-8#1)(1992-3#1)(1997-5#1)(2008-10#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-1#2)
carcinoma observed##2##2##(1990-3#1)(1990-6#1)
carcinoma of prostate##2##3##(1995-8#1)(2011-2#1)
carcinoma of the bladder##3##4##(1992-12#2)(2011-2#1)
carcinoma of the breast##2##4##(2012-3#2)
carcinoma of the cervix##5##4##(1990-8#3)(1991-3#1)(2012-3#1)
carcinoma of the cystic duct##2##5##(1992-9#2)
carcinoma of the endometrium##3##4##(1993-9#1)(2011-2#2)
carcinoma of the esophagus##2##4##(1993-8#2)
carcinoma of the gallbladder##3##4##(1991-12#2)(2012-3#1)
carcinoma of the head and neck##3##6##(1990-6#2)(2007-11#1)
carcinoma of the head##4##4##(1990-6#2)(1990-9#1)(2007-11#1)
carcinoma of the ovary##2##4##(1995-12#1)(1997-8#1)
carcinoma of the pancreas##3##4##(1990-9#2)(1991-3#1)
carcinoma of the parotid gland##2##5##(1991-6#2)
carcinoma of the skin##4##4##(1993-3#1)(2010-3#2)(2011-2#1)
carcinoma of the vulva##3##4##(1992-3#3)
carcinoma of the##65##3##(1990-3#1)(1990-6#2)(1990-8#3)(1990-9#4)(1991-12#2)(1991-3#2)(1991-6#5)(1992-12#4)(1992-2#4)(1992-3#3)(1992-5#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-12#1)(1995-10#1)(1995-12#1)(1995-8#2)(1996-3#1)(1997-5#1)(1997-8#2)(2007-11#1)(2008-1#1)(2009-10#1)(2009-5#3)(2010-3#2)(2011-2#4)(2012-3#4)(2013-1#1)
carcinoma of##72##2##(1990-3#1)(1990-6#2)(1990-8#3)(1990-9#4)(1991-12#2)(1991-3#2)(1991-6#5)(1992-12#4)(1992-2#4)(1992-3#3)(1992-5#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-12#1)(1995-10#1)(1995-12#1)(1995-8#3)(1996-3#1)(1997-5#1)(1997-8#2)(2007-11#1)(2008-1#1)(2009-10#1)(2009-5#3)(2010-11#2)(2010-3#2)(2011-2#5)(2012-3#4)(2013-1#4)
carcinoma on##2##2##(2009-6#1)(2012-3#1)
carcinoma or##4##2##(2009-1#1)(2010-12#1)(2010-7#1)(2012-3#1)
carcinoma patients##3##2##(1990-2#1)(1991-12#1)(2012-3#1)
carcinoma represents##2##2##(2008-1#1)(2009-1#1)
carcinoma stage##2##2##(1997-5#2)
carcinoma that##2##2##(1990-12#1)(2008-9#1)
carcinoma tissue##3##2##(1992-3#1)(1993-1#1)(2008-9#1)
carcinoma to##4##2##(1990-6#1)(1990-8#1)(1992-3#1)(2011-2#1)
carcinoma was found in##2##4##(1990-11#1)(2008-9#1)
carcinoma was found##3##3##(1990-11#1)(1990-6#1)(2008-9#1)
carcinoma was##7##2##(1990-11#1)(1990-6#1)(1991-8#1)(1992-9#1)(1993-8#1)(2008-9#1)(2011-2#1)
carcinoma were##3##2##(1991-6#1)(1991-8#1)(1992-12#1)
carcinoma with extensive osseous metaplasia##2##5##(1992-2#2)
carcinoma with##9##2##(1992-2#2)(1993-2#1)(1994-12#1)(2008-11#1)(2008-8#1)(2011-2#2)(2012-3#1)
carcinoma##462##1##(1990-11#3)(1990-12#7)(1990-2#7)(1990-3#4)(1990-6#12)(1990-8#7)(1990-9#7)(1991-12#3)(1991-2#6)(1991-3#5)(1991-6#8)(1991-8#12)(1991-9#3)(1992-12#6)(1992-2#7)(1992-3#9)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#2)(1993-2#5)(1993-3#1)(1993-8#12)(1993-9#3)(1994-1#2)(1994-12#20)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#8)(1995-10#1)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#8)(1997-5#5)(1997-7#1)(1997-8#8)(2007-11#1)(2007-8#2)(2008-1#9)(2008-10#18)(2008-11#22)(2008-12#4)(2008-7#1)(2008-8#7)(2008-9#16)(2009-1#5)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-8#3)(2010-11#3)(2010-12#10)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#8)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#36)(2012-12#1)(2012-2#4)(2012-3#22)(2013-1#29)(2013-7#3)(2013-8#11)
carcinoma)##2##1##(1994-3#1)(2013-1#1)
carcinoma-associated##2##1##(1990-8#1)(1994-2#1)
carcinoma?##2##1##(1990-8#1)(2011-2#1)
carcinoma]##7##1##(1990-3#1)(1993-6#1)(1996-8#1)(1997-5#1)(2011-3#1)(2012-3#2)
carcinomas and##10##2##(1990-12#1)(1992-8#1)(1994-12#1)(2008-11#1)(2011-2#5)(2012-3#1)
carcinomas are##4##2##(2011-2#3)(2012-3#1)
carcinomas by##2##2##(2008-12#1)(2011-2#1)
carcinomas in##6##2##(1994-12#2)(1996-10#1)(1997-3#1)(2008-9#1)(2011-2#1)
carcinomas may##3##2##(1990-6#1)(1994-11#1)(2009-12#1)
carcinomas of the lower lip##2##5##(1991-8#2)
carcinomas of the##6##3##(1991-8#3)(1997-2#1)(2012-3#2)
carcinomas of##7##2##(1990-2#1)(1991-8#3)(1997-2#1)(2012-3#2)
carcinomas was##2##2##(1992-8#1)(2012-3#1)
carcinomas were##2##2##(1991-12#1)(2011-2#1)
carcinomas with##3##2##(2011-2#3)
carcinomas##93##1##(1990-12#1)(1990-2#2)(1990-6#2)(1991-11#1)(1991-12#1)(1991-8#3)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#1)(1995-10#2)(1995-6#1)(1996-10#1)(1997-2#1)(1997-3#3)(1997-8#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#2)(2010-7#1)(2010-8#1)(2011-2#26)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#1)
carcinomas)##2##1##(1997-8#1)(2012-3#1)
carcinomatous component##2##2##(2009-3#1)(2011-2#1)
carcinomatous##5##1##(1990-11#1)(1991-6#1)(2009-3#1)(2011-2#2)
carcinosarcomas##2##1##(2011-2#2)
card is##2##2##(1994-2#2)
card##10##1##(1992-3#1)(1994-2#2)(1996-2#1)(1997-3#4)(2008-10#1)(2008-11#1)
cardiac CT##2##2##(2011-2#1)(2012-2#1)
cardiac MRI##3##2##(2008-3#1)(2012-12#1)(2012-2#1)
cardiac abnormalities##2##2##(1990-11#1)(2010-8#1)
cardiac amyloidosis##3##2##(1992-8#2)(2011-2#1)
cardiac and skeletal##3##3##(1995-2#3)
cardiac and##14##2##(1992-6#1)(1995-2#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-8#1)
cardiac anomalies##4##2##(2010-6#1)(2010-8#1)(2012-12#1)(2013-8#1)
cardiac arrest##14##2##(1990-12#3)(1990-9#2)(1994-6#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
cardiac arrhythmia##2##2##(2011-2#1)(2013-1#1)
cardiac arrhythmias##7##2##(1990-9#1)(1991-11#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
cardiac catheterization##4##2##(1994-3#1)(1995-12#1)(2011-2#2)
cardiac cell##2##2##(2008-10#1)(2008-7#1)
cardiac cells##6##2##(1996-2#2)(2008-7#4)
cardiac center##2##2##(1994-12#1)(2010-6#1)
cardiac computed tomography (CT)##2##4##(2008-12#1)(2012-2#1)
cardiac computed tomography##5##3##(2008-12#2)(2012-2#2)(2013-2#1)
cardiac contractility##4##2##(1996-3#1)(2008-9#2)(2010-4#1)
cardiac cycle##2##2##(2008-10#1)(2011-2#1)
cardiac damage##2##2##(2010-7#1)(2011-2#1)
cardiac death in young athletes##3##5##(2012-3#3)
cardiac death in young##4##4##(2008-12#1)(2012-3#3)
cardiac death##11##2##(2008-11#2)(2008-12#2)(2009-10#1)(2011-2#1)(2011-3#1)(2012-3#4)
cardiac defect##3##2##(2010-10#2)(2012-2#1)
cardiac defects##3##2##(1997-3#1)(2010-10#2)
cardiac differentiation##2##2##(1994-11#2)
cardiac disorders##2##2##(2008-7#1)(2010-8#1)
cardiac dysfunction##4##2##(2008-12#1)(2011-2#3)
cardiac electrophysiology##6##2##(1992-3#1)(2008-12#3)(2009-10#1)(2013-1#1)
cardiac enzymes##4##2##(2008-12#4)
cardiac events##6##2##(2008-11#2)(2008-5#1)(2010-12#2)(2012-2#1)
cardiac failure##8##2##(1996-3#1)(1996-6#2)(1996-9#1)(2008-10#2)(2008-11#1)(2010-5#1)
cardiac function and##2##3##(2011-2#2)
cardiac function in##3##3##(2008-10#1)(2011-2#2)
cardiac function##12##2##(1991-2#1)(1992-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#5)
cardiac health##2##2##(2008-11#1)(2010-8#1)
cardiac hypertrophy and##2##3##(2010-12#1)(2010-6#1)
cardiac hypertrophy in##2##3##(2008-12#1)(2011-2#1)
cardiac hypertrophy that##2##3##(2011-2#1)(2012-12#1)
cardiac hypertrophy##23##2##(1994-12#1)(2008-12#2)(2008-7#1)(2010-12#10)(2010-4#1)(2010-6#2)(2011-2#4)(2012-12#2)
cardiac imaging and##2##3##(2008-12#1)(2012-2#1)
cardiac imaging##3##2##(2008-12#1)(2012-2#2)
cardiac index##6##2##(1991-6#1)(1993-2#2)(2009-8#1)(2012-2#2)
cardiac insufficiency##2##2##(1991-6#2)
cardiac involvement##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
cardiac length and##2##3##(1993-12#2)
cardiac magnetic resonance imaging (MRI)##2##5##(2008-3#1)(2012-2#1)
cardiac magnetic resonance imaging##5##4##(2008-3#2)(2012-2#1)(2013-3#2)
cardiac magnetic resonance##6##3##(2008-3#3)(2012-2#1)(2013-3#2)
cardiac manifestation of##2##3##(1997-5#1)(2010-5#1)
cardiac manifestation##3##2##(1997-5#1)(2010-5#1)(2013-8#1)
cardiac markers##2##2##(2008-10#2)
cardiac muscle##9##2##(1991-5#2)(1992-3#1)(2008-10#2)(2010-7#2)(2012-12#1)(2012-3#1)
cardiac myocyte##2##2##(1994-11#1)(2008-10#1)
cardiac myocytes through##2##3##(1995-11#2)
cardiac myocytes##18##2##(1992-3#1)(1993-3#6)(1994-11#2)(1995-11#2)(1996-2#1)(2008-7#1)(2008-8#2)(2008-9#3)
cardiac myosin##2##2##(1992-3#1)(1996-8#1)
cardiac output and cardiac index were##2##6##(1991-6#1)(2012-2#1)
cardiac output and cardiac index##3##5##(1991-6#1)(2012-2#2)
cardiac output and##6##3##(1991-6#1)(2012-2#2)(2012-3#3)
cardiac output##14##2##(1991-6#1)(2008-12#3)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#2)(2012-3#4)(2013-1#1)
cardiac performance##2##2##(2008-10#1)(2011-2#1)
cardiac procedures##3##2##(1995-12#1)(1995-8#1)(2011-2#1)
cardiac referred pain##2##3##(2008-9#2)
cardiac rehabilitation##2##2##(2008-11#2)
cardiac resynchronisation##2##2##(2008-10#1)(2012-2#1)
cardiac resynchronization therapy##3##3##(2008-11#1)(2008-12#1)(2010-6#1)
cardiac risk##2##2##(2010-9#1)(2012-2#1)
cardiac surgery##16##2##(1991-3#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
cardiac surgery]##2##2##(2012-3#2)
cardiac surgical patients##3##3##(2008-12#3)
cardiac surgical##4##2##(1997-8#1)(2008-12#3)
cardiac sympathetic nerve##5##3##(2008-9#4)(2012-2#1)
cardiac sympathetic##7##2##(2008-9#4)(2012-2#3)
cardiac tamponade##2##2##(2008-11#1)(2013-1#1)
cardiac tissue##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
cardiac troponin I (cTnI)##3##4##(2008-10#2)(2010-12#1)
cardiac troponin I##7##3##(2008-10#4)(2010-12#2)(2010-6#1)
cardiac troponin##9##2##(1996-8#1)(2008-10#4)(2008-6#1)(2010-12#2)(2010-6#1)
cardiac valve##2##2##(1994-3#2)
cardiac##400##1##(1990-11#2)(1990-12#3)(1990-9#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#6)(1992-3#7)(1992-5#1)(1992-6#2)(1992-8#2)(1993-12#5)(1993-2#3)(1993-3#7)(1993-6#1)(1993-8#1)(1994-11#6)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-8#1)(1996-2#3)(1996-3#2)(1996-6#3)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#2)(2007-12#3)(2008-10#25)(2008-11#20)(2008-12#29)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#18)(2008-8#3)(2008-9#14)(2009-1#1)(2009-10#4)(2009-12#2)(2009-5#4)(2009-8#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#17)(2010-4#5)(2010-5#3)(2010-6#15)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#1)(2011-2#32)(2011-3#1)(2012-12#7)(2012-2#25)(2012-3#21)(2013-1#11)(2013-2#3)(2013-3#2)(2013-7#1)(2013-8#7)
cardiac-specific##6##1##(1994-11#2)(1995-2#1)(1995-6#1)(2011-2#1)(2012-12#1)
cardinal##7##1##(2008-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-6#1)(2011-2#2)
cardio-vascular##3##1##(2010-2#2)(2013-1#1)
cardiocytes impaired by##3##3##(2011-3#3)
cardiocytes##4##1##(2011-3#4)
cardiogenesis##3##1##(2008-11#1)(2008-9#2)
cardiogenic shock##5##2##(1990-9#1)(1996-3#1)(1997-5#1)(2008-11#1)(2013-8#1)
cardiogenic##7##1##(1990-9#1)(1996-3#1)(1997-5#1)(2007-8#1)(2008-11#1)(2013-1#1)(2013-8#1)
cardiogram##3##1##(2010-8#2)(2012-12#1)
cardiolipin##5##1##(1990-6#1)(1991-5#3)(2008-9#1)
cardiological##3##1##(1992-5#1)(2008-11#1)(2008-12#1)
cardiologists##7##1##(1993-12#1)(2008-11#2)(2008-3#1)(2010-1#1)(2011-2#1)(2012-12#1)
cardiology##12##1##(1991-2#1)(1991-6#1)(1996-3#1)(2006-6#1)(2008-11#4)(2008-12#1)(2008-7#1)(2009-6#1)(2013-8#1)
cardiology]##3##1##(1991-2#2)(1992-5#1)
cardiometabolic variables##2##2##(2012-12#2)
cardiometabolic##4##1##(2010-5#2)(2012-12#2)
cardiomyocyte development##2##2##(2008-11#2)
cardiomyocyte##5##1##(1996-2#1)(2008-11#2)(2008-5#1)(2008-7#1)
cardiomyocytes and##2##2##(2008-11#1)(2010-6#1)
cardiomyocytes from##2##2##(2008-11#2)
cardiomyocytes##24##1##(1992-9#1)(1994-3#2)(1994-8#1)(1995-11#1)(1996-2#3)(2008-11#5)(2008-7#6)(2010-12#3)(2010-6#2)
cardiomyopathies##3##1##(1994-3#1)(2008-10#1)(2009-10#1)
cardiomyopathy and##5##2##(2008-10#1)(2008-7#2)(2010-4#1)(2013-1#1)
cardiomyopathy have##2##2##(1993-2#1)(1994-12#1)
cardiomyopathy in##4##2##(1990-3#1)(2008-10#1)(2008-11#1)(2010-4#1)
cardiomyopathy is##3##2##(2008-7#2)(2013-1#1)
cardiomyopathy with##2##2##(1991-5#1)(2010-6#1)
cardiomyopathy##75##1##(1990-3#2)(1990-9#1)(1991-5#3)(1993-2#3)(1994-12#2)(1996-8#8)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-7#8)(2009-10#2)(2009-6#3)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2011-2#4)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#3)
cardiomyopathy)##4##1##(2008-10#1)(2008-8#1)(2011-2#2)
cardioplegia##4##1##(1991-3#4)
cardioprotection##2##1##(2010-12#2)
cardioprotective##5##1##(2008-10#1)(2009-8#1)(2010-8#1)(2012-3#2)
cardiopulmonary bypass (CPB)##3##3##(1995-12#1)(2012-2#1)(2013-8#1)
cardiopulmonary bypass and##2##3##(2013-1#2)
cardiopulmonary bypass for##2##3##(2008-7#1)(2011-2#1)
cardiopulmonary bypass##14##2##(1995-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
cardiopulmonary resuscitation##7##2##(1990-9#1)(1994-9#2)(1995-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
cardiopulmonary##27##1##(1990-9#1)(1994-9#2)(1995-11#1)(1995-12#2)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#2)(2010-4#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
cardiorespiratory efficiency##3##2##(2012-2#3)
cardiorespiratory##8##1##(2008-7#1)(2009-4#1)(2010-5#2)(2012-2#3)(2013-1#1)
cardiothoracic##2##1##(1993-12#1)(2013-1#1)
cardiotoxicity by##2##2##(2008-7#1)(2013-1#1)
cardiotoxicity##5##1##(2008-7#1)(2013-1#4)
cardiovascular and interventional radiology##2##4##(1993-3#2)
cardiovascular and metabolic##3##3##(1990-5#1)(2009-10#1)(2011-2#1)
cardiovascular and other##3##3##(2008-10#1)(2010-4#1)(2010-6#1)
cardiovascular and##16##2##(1990-5#1)(1991-1#1)(1992-12#1)(1993-3#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
cardiovascular anomalies##2##2##(2008-8#1)(2010-6#1)
cardiovascular autonomic neuropathy##2##3##(2012-2#2)
cardiovascular biomarkers##2##2##(2010-5#1)(2012-2#1)
cardiovascular complications##7##2##(1993-2#2)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
cardiovascular devices##2##2##(2010-6#2)
cardiovascular disease (CVD)##7##3##(2008-6#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#2)
cardiovascular disease and##7##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2013-1#1)(2013-7#1)
cardiovascular disease are##2##3##(1996-11#1)(2010-9#1)
cardiovascular disease in##4##3##(1993-12#1)(2008-7#1)(2009-1#1)(2009-12#1)
cardiovascular disease risk factors##3##4##(1991-6#2)(2008-7#1)
cardiovascular disease risk##6##3##(1991-6#2)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
cardiovascular disease##67##2##(1991-6#2)(1992-8#1)(1992-9#1)(1993-12#5)(1996-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-3#1)(2013-7#2)(2013-8#3)
cardiovascular diseases and##4##3##(2008-10#1)(2008-8#2)(2013-8#1)
cardiovascular diseases in##6##3##(1991-6#2)(2008-11#2)(2009-10#1)(2010-10#1)
cardiovascular diseases##27##2##(1991-6#2)(1993-11#1)(1995-2#2)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-8#2)(2009-10#1)(2009-12#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
cardiovascular disorders##3##2##(2010-6#1)(2012-3#2)
cardiovascular effects of cocaine and##2##5##(1991-1#1)(2010-11#1)
cardiovascular effects of##3##3##(1991-1#1)(2010-11#1)(2013-8#1)
cardiovascular effects##6##2##(1991-1#1)(1995-11#1)(2008-6#1)(2009-7#1)(2010-11#1)(2013-8#1)
cardiovascular events##16##2##(2009-1#1)(2010-1#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#4)
cardiovascular function##4##2##(1992-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
cardiovascular health##5##2##(2009-10#1)(2010-12#1)(2012-12#2)(2013-8#1)
cardiovascular morbidity and mortality##6##4##(2008-1#2)(2008-11#1)(2008-7#3)
cardiovascular morbidity and##7##3##(2008-1#3)(2008-11#1)(2008-7#3)
cardiovascular morbidity##8##2##(1993-11#1)(2008-1#3)(2008-11#1)(2008-7#3)
cardiovascular mortality##2##2##(2012-12#1)(2013-8#1)
cardiovascular parameters##2##2##(2012-3#1)(2013-8#1)
cardiovascular reactivity##6##2##(2012-2#6)
cardiovascular reflex tests and##2##4##(1994-3#2)
cardiovascular reflex tests##4##3##(1994-3#4)
cardiovascular response during dental##2##4##(1990-5#2)
cardiovascular response##3##2##(1990-5#3)
cardiovascular risk and##3##3##(2008-6#1)(2009-10#1)(2013-1#1)
cardiovascular risk factor##3##3##(1991-6#1)(1996-8#1)(2008-11#1)
cardiovascular risk factors##14##3##(1996-8#1)(2008-11#4)(2008-7#4)(2008-9#1)(2010-4#2)(2013-3#2)
cardiovascular risk in the##2##4##(2009-11#1)(2009-12#1)
cardiovascular risk in##3##3##(2009-11#1)(2009-12#1)(2010-12#1)
cardiovascular risk profile##2##3##(2010-4#1)(2011-2#1)
cardiovascular risk stratification##2##3##(2009-1#1)(2011-2#1)
cardiovascular risk##48##2##(1991-6#1)(1993-12#2)(1994-6#1)(1996-8#2)(2008-1#3)(2008-11#6)(2008-6#3)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-4#3)(2010-9#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#3)(2013-3#3)
cardiovascular risks##3##2##(2008-10#1)(2011-1#2)
cardiovascular surgery##3##2##(1994-3#1)(2008-8#2)
cardiovascular system##13##2##(2008-10#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
cardiovascular##309##1##(1990-2#1)(1990-5#4)(1991-1#2)(1991-6#5)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#8)(1993-2#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#5)(1994-6#1)(1995-11#1)(1995-2#2)(1996-11#3)(1996-8#2)(1997-5#1)(1997-8#2)(2007-8#1)(2008-1#9)(2008-10#11)(2008-11#21)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#9)(2008-7#15)(2008-8#7)(2008-9#5)(2009-1#3)(2009-10#12)(2009-11#1)(2009-12#6)(2009-6#2)(2009-7#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#1)(2010-4#10)(2010-5#3)(2010-6#10)(2010-7#1)(2010-9#4)(2011-1#5)(2011-2#14)(2012-12#6)(2012-2#20)(2012-3#9)(2013-1#17)(2013-3#4)(2013-7#3)(2013-8#20)
cardioversion using##2##2##(2008-10#2)
cardioversion##7##1##(2008-10#5)(2008-7#1)(2013-1#1)
cardioverter defibrillator##4##2##(2008-12#4)
cardioverter-defibrillator##3##1##(2008-12#3)
cards##10##1##(1997-2#2)(1997-3#4)(2008-10#2)(2008-11#1)(2008-3#1)
care Medicaid##4##2##(1991-3#1)(1997-2#3)
care about##3##2##(1991-2#1)(1995-12#1)(2008-7#1)
care across providers##2##3##(2012-3#2)
care across##5##2##(1993-2#1)(1997-1#1)(2010-12#1)(2012-3#2)
care administration and##2##3##(1991-12#1)(1994-3#1)
care administration##5##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(1996-2#1)
care administrators##12##2##(1992-2#4)(1992-3#1)(1993-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2009-4#1)(2009-8#1)
care after##2##2##(2008-12#1)(2012-12#1)
care agencies##3##2##(1994-1#1)(1995-3#2)
care among##6##2##(1996-2#1)(1996-3#1)(2008-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
care and access to##2##4##(2008-1#1)(2008-11#1)
care and access##3##3##(1995-1#1)(2008-1#1)(2008-11#1)
care and health systems##2##4##(1997-3#1)(2008-11#1)
care and health##4##3##(1992-1#1)(1995-2#1)(1997-3#1)(2008-11#1)
care and its##3##3##(1993-5#1)(1997-1#1)(2013-8#1)
care and other##3##3##(1991-12#1)(1995-1#1)(1996-12#1)
care and primary##2##3##(1997-3#1)(1997-5#1)
care and promote##2##3##(1996-2#1)(2008-11#1)
care and provide##2##3##(1994-12#1)(2008-3#1)
care and research##2##3##(1992-11#1)(2011-3#1)
care and service##2##3##(1995-2#1)(2008-11#1)
care and support##2##3##(2008-11#1)(2008-12#1)
care and that##2##3##(2008-11#1)(2013-1#1)
care and the##8##3##(1991-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-12#1)(2012-12#1)
care and to##2##3##(1994-3#1)(2008-10#1)
care and treatment##4##3##(1994-1#3)(2008-7#1)
care and##135##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#4)(1993-12#4)(1993-2#3)(1993-3#3)(1993-5#1)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#4)(1995-2#8)(1995-3#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#14)(2008-12#6)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#1)(2010-10#4)(2010-2#1)(2010-8#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#4)(2013-1#7)(2013-8#1)
care are discussed##2##3##(1992-2#1)(2011-1#1)
care are##17##2##(1991-3#2)(1992-2#1)(1992-3#1)(1994-1#2)(1995-3#1)(1997-3#2)(2008-11#2)(2009-11#1)(2009-5#1)(2010-12#2)(2011-1#2)
care areas##2##2##(1996-1#1)(2013-8#1)
care as a##5##3##(1996-2#1)(2008-4#1)(2009-11#1)(2010-7#1)(2011-7#1)
care as an##2##3##(1993-3#1)(2010-12#1)
care as well as##4##4##(1995-12#1)(1997-4#1)(2013-1#2)
care as##13##2##(1993-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-7#1)(2013-1#2)
care at a##2##3##(1992-1#1)(1993-3#1)
care at##5##2##(1992-1#1)(1993-3#1)(1997-2#1)(2008-12#1)(2013-1#1)
care based on the##2##4##(2008-11#1)(2012-3#1)
care be##2##2##(1991-2#1)(2008-11#1)
care benchmarking##2##2##(1994-12#2)
care benefits##4##2##(1994-2#1)(1995-12#1)(1995-3#1)(2008-6#1)
care by Medicare beneficiaries##2##4##(1993-12#1)(1994-1#1)
care by##10##2##(1991-12#2)(1992-3#1)(1993-12#2)(1994-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
care can be delivered##2##4##(2010-7#1)(2011-2#1)
care can be##7##3##(1994-2#1)(1994-3#1)(1995-12#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)
care can##14##2##(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#2)(1997-1#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
care case##3##2##(1991-2#1)(1994-3#1)(1995-2#1)
care center##5##2##(1991-3#1)(1996-1#1)(2007-8#1)(2008-10#1)(2012-12#1)
care centers]##2##2##(1994-6#1)(1996-2#1)
care centres##3##2##(1994-6#2)(1995-1#1)
care choices##3##2##(1991-9#1)(1997-3#1)(2008-4#1)
care companies##2##2##(1993-2#1)(2008-11#1)
care concerns##2##2##(1993-3#1)(2008-9#1)
care coordination##7##2##(1993-3#2)(1995-3#3)(1996-1#1)(2012-3#1)
care coordinators##2##2##(2008-3#2)
care cost containment##3##3##(1991-2#1)(1992-1#1)(1994-1#1)
care cost##4##2##(1991-2#1)(1992-1#1)(1994-1#1)(1994-2#1)
care costs and##10##3##(1994-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#1)(2008-11#4)
care costs##35##2##(1991-12#3)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#4)(1994-2#2)(1995-1#1)(1995-2#1)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#3)(2008-11#4)(2008-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
care courses##2##2##(2008-11#1)(2008-12#1)
care coverage for##2##3##(1995-2#1)(2008-11#1)
care coverage##3##2##(1995-2#1)(2008-11#2)
care crisis##3##2##(1997-3#2)(2009-6#1)
care delivered to##2##3##(1995-2#1)(2010-8#1)
care delivered##5##2##(1995-2#1)(1996-2#1)(2008-3#1)(2008-7#1)(2010-8#1)
care delivery and##4##3##(1993-2#1)(1995-2#1)(2008-11#1)(2008-6#1)
care delivery is##2##3##(1993-12#1)(1996-2#1)
care delivery systems##5##3##(1993-12#1)(1995-1#1)(1995-12#2)(1996-1#1)
care delivery##36##2##(1991-1#1)(1991-2#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-12#3)(1995-2#2)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(2008-11#3)(2008-6#1)(2010-12#2)(2010-8#3)(2012-3#2)
care demand##2##2##(1994-2#1)(1997-3#1)
care during the preoperative##2##4##(2012-3#2)
care during the##3##3##(1995-12#1)(2012-3#2)
care during##9##2##(1995-12#1)(1997-8#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-1#3)
care education##3##2##(2008-11#2)(2008-12#1)
care encounter##2##2##(1995-2#1)(1997-2#1)
care environment##15##2##(1991-12#1)(1991-2#1)(1991-3#2)(1993-12#1)(1993-3#3)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(2008-11#1)
care environments##3##2##(1994-2#1)(2008-11#1)(2010-10#1)
care executives are##2##3##(1996-2#1)(1996-3#1)
care executives##6##2##(1994-1#1)(1996-2#4)(1996-3#1)
care expenditures##14##2##(1991-2#1)(1992-1#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-2#2)(1995-3#1)(1996-3#1)(1997-3#1)(2008-11#2)(2012-2#1)
care experience and##2##3##(2012-2#2)
care experience##4##2##(1994-6#1)(1996-2#1)(2012-2#2)
care experienced##2##2##(1991-12#1)(1997-2#1)
care facilities can##2##3##(1991-12#1)(1993-12#1)
care facilities have##2##3##(1991-3#1)(1996-3#1)
care facilities in##5##3##(1992-2#1)(1994-12#1)(1997-1#1)(1997-2#1)(2008-12#1)
care facilities##22##2##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-8#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
care facility##9##2##(1991-1#1)(1991-12#2)(1991-2#3)(1994-3#1)(2008-12#1)(2009-3#1)
care financing##8##2##(1991-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)
care firms##2##2##(1991-3#1)(1996-12#1)
care following##2##2##(1994-3#1)(1994-5#1)
care for Medicare beneficiaries##3##4##(1992-12#1)(1993-12#1)(1995-12#1)
care for Medicare##4##3##(1992-12#1)(1993-12#1)(1995-12#1)(1995-3#1)
care for a##3##3##(1997-3#1)(2012-2#1)(2013-1#1)
care for adolescents##2##3##(1995-12#2)
care for all patients##2##4##(1992-3#1)(2008-3#1)
care for all##3##3##(1992-3#1)(1993-12#1)(2008-3#1)
care for cancer patients##3##4##(1990-6#1)(1996-2#1)(2009-12#1)
care for children and pregnant women##2##6##(1995-2#1)(2013-8#1)
care for children with##4##4##(1997-2#2)(2008-11#2)
care for children##9##3##(1995-2#1)(1996-12#1)(1997-2#2)(2008-11#2)(2012-2#2)(2013-8#1)
care for high-risk individuals##2##4##(2011-2#2)
care for older people##6##4##(2009-3#1)(2010-10#5)
care for older##7##3##(1994-2#1)(2009-3#1)(2010-10#5)
care for patients with##2##4##(2008-6#1)(2013-1#1)
care for patients##5##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
care for people with mental##3##5##(1997-8#1)(2008-11#2)
care for people with##4##4##(1997-8#1)(2008-11#2)(2012-3#1)
care for persons with##2##4##(1991-12#1)(1997-2#1)
care for special populations##2##4##(1996-2#1)(1997-2#1)
care for the elderly##5##4##(1991-2#2)(1991-3#1)(1992-2#1)(1993-2#1)
care for the frail elderly##2##5##(1993-1#1)(1993-3#1)
care for the##24##3##(1990-12#3)(1991-2#2)(1991-3#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-3#2)(1997-2#1)(2008-11#1)(2008-8#2)(2010-10#1)(2012-12#1)(2013-1#1)
care for young##2##3##(2011-2#1)(2013-1#1)
care for##119##2##(1990-12#3)(1990-6#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-9#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-9#1)(1997-2#7)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#15)(2008-12#2)(2008-3#2)(2008-6#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#6)(2010-5#1)(2010-7#1)(2010-9#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
care fraud##7##2##(1991-1#2)(1993-12#4)(1993-2#1)
care from the##3##3##(1994-12#1)(1994-9#1)(2009-12#1)
care from##5##2##(1991-12#1)(1994-12#1)(1994-9#1)(1997-1#1)(2009-12#1)
care graph##2##2##(2008-9#2)
care guidelines##2##2##(2008-11#2)
care has been##6##3##(1993-12#1)(1993-3#1)(1995-2#1)(1996-2#1)(2010-10#1)(2010-8#1)
care has led##2##3##(1991-3#1)(2008-11#1)
care has##14##2##(1991-3#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-12#1)(2010-10#2)(2010-8#1)
care have##4##2##(1994-12#1)(1997-3#1)(2008-11#1)(2010-8#1)
care health##3##2##(1994-9#1)(1995-1#1)(1995-12#1)
care hospital##15##2##(1993-12#1)(1994-12#1)(1997-3#1)(2008-11#2)(2010-10#2)(2010-11#2)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
care improvement##2##2##(1994-12#1)(2012-2#1)
care in a##4##3##(1993-2#1)(1995-12#1)(2008-10#1)(2013-8#1)
care in acute##2##3##(2008-11#1)(2008-3#1)
care in health##2##3##(1992-3#1)(1994-12#1)
care in intensive##2##3##(2010-12#1)(2012-3#1)
care in medical schools##2##4##(1993-11#1)(1997-3#1)
care in rural##2##3##(1996-3#1)(2008-11#1)
care in the United States##4##5##(1995-3#1)(1996-2#1)(1997-3#1)(2008-10#1)
care in the community##3##4##(1995-2#1)(2010-10#1)(2012-2#1)
care in the early##2##4##(1996-12#1)(2010-8#1)
care in the first##2##4##(1993-3#1)(2011-1#1)
care in the##42##3##(1990-6#1)(1991-1#2)(1991-11#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#4)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
care in##125##2##(1990-2#1)(1990-6#1)(1991-1#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#3)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#2)(1996-12#3)(1996-2#6)(1996-3#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#2)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#3)(2008-8#4)(2009-10#1)(2009-11#1)(2009-6#2)(2010-10#3)(2010-11#5)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#4)
care include##2##2##(1996-3#1)(2008-1#1)
care increases##2##2##(1992-2#1)(1993-1#1)
care indicators##12##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-11#1)
care industry and##2##3##(1991-1#1)(1997-1#1)
care industry##21##2##(1991-1#1)(1991-12#1)(1992-3#1)(1993-12#3)(1995-12#1)(1995-3#3)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-11#5)
care information##7##2##(1992-12#1)(1993-1#1)(1994-2#1)(1996-2#1)(1997-3#1)(2008-11#1)(2010-8#1)
care institutions and##4##3##(1992-3#1)(1993-1#1)(1993-12#1)(2008-11#1)
care institutions##9##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1997-1#1)(2008-11#1)(2010-8#1)
care insurance##4##2##(1993-3#3)(1996-5#1)
care interventions##2##2##(1993-12#1)(2008-11#1)
care into the##2##3##(1991-12#1)(2012-3#1)
care into##6##2##(1991-12#1)(1996-2#1)(2008-11#3)(2012-3#1)
care is a##5##3##(1991-12#1)(1993-3#1)(1997-4#1)(2008-11#1)(2008-12#1)
care is an##2##3##(1991-2#1)(1995-2#1)
care is examined##2##3##(1991-12#1)(2008-9#1)
care is financed##2##3##(1996-2#1)(1997-5#1)
care is required to##2##4##(2008-3#1)(2010-12#1)
care is reviewed##2##3##(1992-6#1)(1993-1#1)
care is taken to##2##4##(2008-10#1)(2008-11#1)
care is taken##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
care is##60##2##(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#2)(1993-3#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-8#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
care issues##2##2##(2008-11#1)(2008-6#1)
care management of patients with##2##5##(1995-11#1)(2012-2#1)
care management of##3##3##(1995-11#1)(2010-7#1)(2012-2#1)
care management##14##2##(1991-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-2#2)(1997-2#1)(2010-7#1)(2012-2#1)(2012-3#1)
care managers##4##2##(1991-3#1)(1994-1#1)(1996-2#1)(1997-2#1)
care market##4##2##(1991-1#1)(1994-12#1)(1997-1#1)(1997-2#1)
care may be##2##3##(1995-3#1)(2008-11#1)
care may##4##2##(1994-2#1)(1995-3#1)(2008-11#1)(2011-2#1)
care means to##2##3##(2008-11#1)(2010-10#1)
care measures##4##2##(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#1)
care medical##3##2##(2008-4#2)(2011-2#1)
care might##2##2##(1997-3#1)(2010-9#1)
care model##3##2##(1997-6#1)(2010-8#1)(2012-3#1)
care models##2##2##(1997-1#1)(2012-2#1)
care must be taken to##3##5##(1993-12#1)(2008-10#1)(2008-4#1)
care must be taken##4##4##(1993-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
care must be##5##3##(1992-1#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
care needs and##2##3##(1995-12#1)(2010-10#1)
care needs to be##3##4##(1996-12#1)(1996-8#1)(2012-12#1)
care needs##20##2##(1994-2#1)(1995-12#7)(1995-3#2)(1996-12#1)(1996-8#1)(1997-2#2)(2010-10#1)(2010-11#2)(2012-12#1)(2013-1#2)
care networks##3##2##(1995-2#2)(1996-12#1)
care nursery##4##2##(1993-3#2)(1995-1#2)
care nurses##2##2##(2008-12#1)(2010-10#1)
care nursing##5##2##(1990-2#1)(2008-11#3)(2010-10#1)
care of a##3##3##(2012-3#1)(2013-1#2)
care of an##2##3##(2008-11#1)(2012-3#1)
care of battered##2##3##(1995-5#2)
care of older people##6##4##(1995-3#1)(2010-10#5)
care of older##9##3##(1995-3#1)(2008-11#3)(2010-10#5)
care of patients with##6##4##(1991-6#1)(1995-11#1)(1997-4#2)(2008-1#2)
care of patients##7##3##(1991-6#1)(1995-11#1)(1997-4#2)(2008-1#2)(2008-11#1)
care of the dying##3##4##(1991-12#1)(2010-10#1)(2010-8#1)
care of the feet##3##4##(2013-1#3)
care of the older person##4##5##(2010-10#4)
care of the patient##2##4##(2008-11#1)(2012-3#1)
care of the##20##3##(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#5)(2010-8#1)(2012-3#1)(2013-1#5)
care of these patients##2##4##(2008-11#1)(2012-3#1)
care of##88##2##(1990-6#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#2)(1996-3#1)(1997-4#3)(1997-5#1)(2007-11#1)(2008-1#3)(2008-10#3)(2008-11#14)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#10)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-3#6)(2013-1#10)
care on a##2##3##(1993-1#1)(1997-2#1)
care on the##3##3##(1992-3#1)(1994-2#1)(1995-12#1)
care on##11##2##(1991-3#3)(1992-3#1)(1993-1#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-4#1)(2008-8#1)
care options##3##2##(1991-3#1)(1995-3#1)(1997-3#1)
care or##5##2##(1992-12#1)(2011-2#2)(2012-12#2)
care organization##11##2##(1990-6#1)(1991-2#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-12#1)(1996-1#2)(1997-3#1)(2010-10#1)
care organization's##3##2##(1994-1#1)(1994-2#1)(1995-1#1)
care organizations (MCOs)##3##3##(1994-12#1)(1996-2#1)(1997-2#1)
care organizations must##2##3##(1993-12#1)(1997-2#1)
care organizations need##2##3##(1995-2#1)(2010-7#1)
care organizations were##2##3##(1995-1#1)(2008-11#1)
care organizations##49##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-1#3)(1994-12#6)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#4)(1996-1#2)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#2)(2008-11#7)(2008-6#3)(2009-6#1)(2010-7#1)(2011-2#2)
care outcomes##2##2##(1995-3#2)
care partners##2##2##(1993-3#1)(1994-2#1)
care patients##6##2##(1990-2#3)(2008-7#2)(2011-2#1)
care personnel##4##2##(1990-2#1)(1991-12#1)(1994-5#1)(2008-7#1)
care physician##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)
care physician)##2##2##(1997-2#1)(2010-1#1)
care physicians and##4##3##(2008-11#1)(2008-6#1)(2011-1#2)
care physicians##12##2##(1991-3#1)(1993-6#1)(1994-12#1)(1996-11#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#2)(2012-2#1)
care physicians' perceptions of medication errors and error prevention and##2##10##(2011-1#2)
care physicians' perceptions of medication errors and error prevention##3##9##(2011-1#3)
care placements##3##2##(1991-1#1)(2008-11#2)
care plan##12##2##(1992-3#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-2#2)(2008-3#1)(2010-3#1)(2013-1#4)
care planning in##4##3##(2010-3#1)(2012-12#1)(2013-1#2)
care planning##9##2##(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#6)
care plans##17##2##(1994-2#1)(1995-12#5)(1995-3#1)(1996-12#1)(1997-2#4)(1997-3#1)(2008-11#1)(2008-12#1)(2013-1#2)
care policy and##2##3##(1991-1#1)(2008-11#1)
care policy as a##2##4##(1997-2#1)(2008-11#1)
care policy##13##2##(1991-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-2#4)(2008-11#2)(2009-3#1)
care practice##4##2##(1994-1#1)(1995-2#2)(2008-11#1)
care practices that##3##3##(1995-3#1)(2008-11#2)
care practices##7##2##(1995-3#1)(1997-7#1)(2008-11#3)(2012-3#1)(2013-1#1)
care practitioners##3##2##(1996-1#1)(2008-11#1)(2013-1#1)
care problems##3##2##(1997-1#1)(1997-8#1)(2011-2#1)
care products##10##2##(1992-11#2)(1997-4#1)(2008-10#1)(2008-5#6)
care professionals##21##2##(1991-2#3)(1992-12#1)(1992-3#1)(1993-1#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)
care program for##2##3##(1993-1#1)(1995-3#1)
care program##10##2##(1991-12#1)(1993-1#1)(1993-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-7#1)
care programs##13##2##(1991-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-11#1)
care provided by##3##3##(1992-1#1)(1996-1#1)(2013-1#1)
care provided to##7##3##(1991-3#1)(1992-1#1)(1994-3#1)(1996-2#2)(2008-3#1)(2010-8#1)
care provided##17##2##(1991-3#1)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#2)(1997-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-8#1)(2013-1#1)
care providers are##7##3##(1994-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2008-11#1)(2010-10#1)(2010-2#1)
care providers need to##3##4##(2008-10#1)(2010-4#1)(2012-3#1)
care providers##54##2##(1991-12#1)(1991-2#3)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#2)(1994-12#4)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#3)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#7)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
care providers)##2##2##(1995-2#1)(2009-10#1)
care provision##3##2##(2013-8#3)
care quality and##2##3##(2008-11#1)(2010-8#1)
care quality is##3##3##(1993-3#2)(2011-2#1)
care quality##25##2##(1991-3#2)(1993-3#5)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#2)(1997-2#1)(2008-11#1)(2010-8#3)(2011-2#1)
care reform and the##3##4##(1991-12#1)(1994-12#1)(1995-3#1)
care reform and##5##3##(1991-12#1)(1993-12#1)(1994-12#1)(1995-3#1)(2010-8#1)
care reform in the##4##4##(1993-12#1)(1995-12#1)(1996-6#1)(1997-3#1)
care reform in##6##3##(1993-12#1)(1995-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)
care reform is##2##3##(1994-2#1)(1996-1#1)
care reform##67##2##(1991-12#1)(1993-12#7)(1993-5#1)(1994-1#3)(1994-12#4)(1994-2#4)(1994-8#4)(1995-1#1)(1995-12#15)(1995-2#4)(1995-3#1)(1996-1#3)(1996-2#2)(1996-3#5)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-8#1)(2010-5#1)(2010-8#1)(2012-3#2)
care report##2##2##(1997-3#1)(2008-11#1)
care require##2##2##(1997-8#1)(2008-11#1)
care requires##2##2##(2010-12#1)(2010-4#1)
care research##3##2##(2008-1#1)(2009-4#2)
care risk management##2##3##(1997-2#2)
care risk##3##2##(1995-3#1)(1997-2#2)
care rose##2##2##(1991-12#1)(1992-12#1)
care sector##10##2##(1992-12#1)(1992-2#1)(1996-2#2)(2008-11#2)(2008-12#1)(2010-10#1)(2010-7#1)(2012-2#1)
care service delivery##2##3##(1995-2#1)(1995-3#1)
care service##4##2##(1994-2#1)(1995-2#1)(1995-3#1)(2008-11#1)
care services and##5##3##(1992-1#1)(1993-12#1)(1994-1#1)(1997-8#1)(2008-11#1)
care services for##3##3##(1991-2#1)(1993-3#1)(1997-8#1)
care services in##3##3##(1991-2#1)(1995-12#1)(2013-1#1)
care services is##2##3##(1993-3#1)(1997-2#1)
care services provided##2##3##(1991-3#1)(1994-12#1)
care services to the##2##4##(1991-1#1)(2008-7#1)
care services to##3##3##(1991-1#1)(1991-3#1)(2008-7#1)
care services##49##2##(1991-1#1)(1991-2#2)(1991-3#3)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#2)(1994-12#4)(1994-3#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-8#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-8#1)(2013-1#1)
care setting##22##2##(1992-2#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-2#1)(2008-11#4)(2008-12#1)(2008-4#1)(2009-11#1)(2010-1#2)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#2)
care settings##16##2##(1992-2#1)(1996-12#2)(1997-1#2)(2007-12#1)(2008-11#4)(2008-12#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-9#1)
care should be##2##3##(2008-9#1)(2011-2#1)
care spending##11##2##(1993-3#1)(1994-1#1)(1995-2#2)(1995-3#1)(1997-2#2)(1997-3#2)(2008-11#2)
care staff in##3##3##(2008-11#1)(2011-2#2)
care staff##9##2##(1994-6#1)(2008-11#2)(2010-10#1)(2010-11#1)(2011-2#4)
care strategy##2##2##(1994-2#1)(2013-1#1)
care supply##2##2##(1992-3#2)
care system and##9##3##(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-6#1)(2010-4#1)(2011-1#1)
care system has##2##3##(1995-3#1)(2008-11#1)
care system in##3##3##(1992-12#1)(1992-2#1)(1997-3#1)
care system##66##2##(1991-2#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1994-1#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#3)(1996-2#2)(1996-3#3)(1997-2#2)(1997-3#3)(1997-6#2)(2007-12#1)(2008-11#2)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
care systems and##2##3##(1995-12#1)(2012-2#1)
care systems##21##2##(1992-12#1)(1993-12#2)(1993-2#2)(1993-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-3#1)(1997-1#4)(2008-1#1)(2008-11#1)(2008-12#1)(2010-11#1)(2012-2#1)(2012-3#1)
care teaching##2##2##(2012-3#1)(2013-8#1)
care team design##4##3##(1994-2#3)(1995-2#1)
care team##21##2##(1993-12#1)(1994-2#5)(1995-11#1)(1995-2#5)(1996-2#1)(2008-11#2)(2008-7#2)(2009-9#2)(2010-10#1)(2010-4#1)
care teams which##2##3##(1994-2#2)
care teams##5##2##(1993-11#1)(1994-2#2)(1995-2#1)(2011-2#1)
care than##2##2##(1996-12#1)(1997-2#1)
care that##6##2##(1994-12#1)(1995-2#1)(1997-3#1)(2008-7#1)(2010-8#1)(2012-3#1)
care the##2##2##(1992-8#1)(1994-6#1)
care there##2##2##(1993-2#1)(1996-12#1)
care they##5##2##(1995-2#1)(1996-2#1)(2008-11#2)(2008-8#1)
care to a##3##3##(2008-11#1)(2009-5#1)(2010-9#1)
care to children and##2##4##(2008-11#1)(2010-4#1)
care to children##3##3##(2008-11#2)(2010-4#1)
care to older people##2##4##(2008-6#1)(2010-10#1)
care to people##3##3##(2011-1#2)(2012-3#1)
care to the##6##3##(2008-11#2)(2010-10#1)(2010-11#1)(2011-1#1)(2012-3#1)
care to their patients##2##4##(2008-11#1)(2012-3#1)
care to their##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
care to this##2##3##(2008-9#1)(2013-8#1)
care to##43##2##(1990-2#1)(1991-3#1)(1993-5#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-5#2)(2010-10#2)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#3)(2012-12#1)(2012-3#4)(2013-8#1)
care transitions##2##2##(2010-10#1)(2010-11#1)
care under the##3##3##(1993-12#1)(1996-2#2)
care under##7##2##(1992-2#1)(1993-12#1)(1995-12#1)(1996-2#3)(1997-2#1)
care unit##34##2##(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-2#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)
care units (ICUs)##2##3##(1991-2#1)(2011-2#1)
care units##21##2##(1991-2#2)(1994-3#2)(1996-12#1)(1996-2#2)(2007-8#2)(2008-10#1)(2008-11#5)(2010-12#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
care use by Hispanic adults##2##5##(1995-12#2)
care use in##2##3##(2009-6#1)(2010-8#1)
care use##9##2##(1995-12#2)(1997-3#1)(2009-6#1)(2010-8#1)(2012-3#1)(2013-1#3)
care using##2##2##(1993-12#1)(2008-7#1)
care utilization##10##2##(1994-2#1)(1996-2#3)(1997-1#2)(1997-2#1)(2009-5#1)(2013-1#2)
care was##8##2##(1992-1#1)(1993-2#1)(1995-2#2)(1997-8#1)(2008-11#1)(2010-1#1)(2011-1#1)
care were##9##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-2#1)(2008-11#1)(2009-3#1)
care which is##2##3##(1992-2#1)(1995-1#1)
care which##3##2##(1992-2#1)(1994-6#1)(1995-1#1)
care will be##2##3##(2010-10#1)(2011-2#1)
care will depend on##2##4##(1994-12#1)(1996-2#1)
care will##8##2##(1991-6#1)(1994-12#1)(1996-2#2)(2008-10#1)(2010-10#1)(2011-2#1)(2012-3#1)
care with##7##2##(1992-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-2#1)(2008-8#1)(2013-8#1)
care within a##3##3##(1996-1#1)(2008-11#1)(2013-8#1)
care within##4##2##(1996-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
care workers in##4##3##(1992-2#1)(1993-2#1)(1996-12#1)(2008-11#1)
care workers who##2##3##(1992-1#1)(2010-11#1)
care workers##18##2##(1992-1#1)(1992-2#2)(1993-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-11#5)(2010-11#3)(2011-2#1)
care would##2##2##(1993-1#1)(1994-12#1)
care##3010##1##(1990-11#2)(1990-12#3)(1990-2#11)(1990-3#3)(1990-6#9)(1990-9#1)(1991-1#33)(1991-11#3)(1991-12#42)(1991-2#52)(1991-3#54)(1991-6#6)(1991-8#2)(1991-9#4)(1992-1#25)(1992-11#5)(1992-12#29)(1992-2#55)(1992-3#40)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#27)(1993-11#6)(1993-12#82)(1993-2#38)(1993-3#79)(1993-5#4)(1993-6#3)(1993-9#4)(1994-1#58)(1994-12#82)(1994-2#70)(1994-3#63)(1994-5#2)(1994-6#16)(1994-8#7)(1994-9#7)(1995-1#27)(1995-11#7)(1995-12#100)(1995-2#100)(1995-3#57)(1995-5#7)(1995-6#5)(1995-8#2)(1996-1#51)(1996-11#7)(1996-12#27)(1996-2#100)(1996-3#57)(1996-5#3)(1996-6#2)(1996-8#14)(1996-9#4)(1997-1#54)(1997-2#103)(1997-3#69)(1997-4#16)(1997-5#13)(1997-6#6)(1997-7#5)(1997-8#24)(2007-11#1)(2007-12#3)(2007-8#5)(2007-9#1)(2008-1#16)(2008-10#37)(2008-11#267)(2008-12#57)(2008-3#19)(2008-4#18)(2008-5#21)(2008-6#22)(2008-7#28)(2008-8#39)(2008-9#17)(2009-1#3)(2009-10#5)(2009-11#8)(2009-12#7)(2009-3#9)(2009-4#8)(2009-5#15)(2009-6#5)(2009-7#1)(2009-8#3)(2009-9#8)(2010-1#6)(2010-10#75)(2010-11#23)(2010-12#16)(2010-2#6)(2010-3#4)(2010-4#16)(2010-5#3)(2010-6#1)(2010-7#10)(2010-8#43)(2010-9#13)(2011-1#26)(2011-2#62)(2011-3#3)(2011-7#2)(2012-12#27)(2012-2#36)(2012-3#83)(2013-1#104)(2013-8#33)
care&quot##4##1##(1991-2#1)(2008-11#1)(2008-5#1)(2012-3#1)
care's##3##1##(1994-2#1)(1997-7#1)(2008-6#1)
care)##3##1##(1995-3#1)(1997-8#1)(2008-8#1)
care-giver##2##1##(1992-3#1)(2008-7#1)
care?##12##1##(1991-2#1)(1991-3#3)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-11#1)(2013-1#1)
care]##40##1##(1990-9#1)(1991-6#2)(1991-9#1)(1993-11#3)(1993-2#4)(1993-3#2)(1993-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-11#2)(1995-5#1)(1996-11#1)(1996-3#3)(1996-6#3)(1997-3#1)(1997-5#2)(1997-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
cared for##9##2##(1991-1#1)(1991-11#1)(1994-6#1)(2008-11#3)(2008-3#1)(2010-11#1)(2011-2#1)
career development##4##2##(1991-1#1)(1994-3#2)(1997-2#1)
career in##4##2##(1992-1#1)(1993-11#1)(1994-12#2)
career##31##1##(1990-12#1)(1991-1#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-3#1)(1994-12#5)(1994-3#2)(1996-1#1)(1996-2#1)(1997-2#2)(1997-6#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-1#1)(2012-2#2)
careers in##3##2##(1992-7#1)(1992-8#1)(1996-3#1)
careers of##3##2##(1993-6#1)(1995-6#1)(2009-12#1)
careers##13##1##(1991-3#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-6#2)(1994-2#1)(1995-6#1)(1996-3#1)(2009-12#1)(2010-1#1)(2013-1#1)
careful and##2##2##(2008-11#1)(2012-3#1)
careful attention to##4##3##(1995-1#1)(2008-10#1)(2008-7#1)(2010-1#1)
careful attention##8##2##(1992-3#2)(1995-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)
careful consideration of##2##3##(2008-10#1)(2011-2#1)
careful consideration##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
careful examination of##2##3##(1993-11#1)(2010-10#1)
careful examination##3##2##(1993-11#1)(2010-10#1)(2010-6#1)
careful follow-up of##2##3##(1991-2#1)(2008-9#1)
careful follow-up##4##2##(1991-2#1)(1993-3#1)(2008-11#1)(2008-9#1)
careful history and##3##3##(1994-12#1)(2008-11#1)(2010-6#1)
careful interpretation of##2##3##(2009-8#1)(2011-2#1)
careful intraoperative##2##2##(1991-6#1)(2013-1#1)
careful planning in##2##3##(1994-12#1)(2011-2#1)
careful process design##2##3##(2008-11#1)(2011-2#1)
careful scrutiny##2##2##(2008-11#1)(2013-8#1)
careful selection of##3##3##(2008-4#1)(2012-12#1)(2013-1#1)
careful##79##1##(1990-3#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#2)(1994-12#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#3)
carefully and##2##2##(1996-3#1)(2006-5#1)
carefully chosen to##2##3##(2008-2#1)(2008-3#1)
carefully controlled##7##2##(2008-10#2)(2008-5#3)(2008-7#1)(2012-7#1)
carefully crafted##2##2##(2008-10#1)(2008-12#1)
carefully designed##3##2##(1991-12#1)(2008-5#2)
carefully evaluated##4##2##(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
carefully examined##2##2##(2008-10#1)(2008-11#1)
carefully monitor##2##2##(1992-11#1)(2008-11#1)
carefully selected##5##2##(1997-8#1)(2008-10#2)(2010-11#1)(2010-6#1)
carefully structured##2##2##(1995-2#1)(2008-7#1)
carefully studied##4##2##(2008-10#4)
carefully##81##1##(1990-5#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-5#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#7)(2008-7#6)(2008-9#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#1)
caregiver burden##2##2##(2009-5#1)(2013-8#1)
caregiver##16##1##(1992-2#1)(1992-3#1)(1994-3#1)(1996-3#1)(2008-6#1)(2008-7#1)(2009-5#3)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
caregivers and to##2##3##(2008-1#1)(2009-5#1)
caregivers and##7##2##(1997-8#1)(2008-1#1)(2008-7#1)(2009-5#2)(2013-1#2)
caregivers are##4##2##(1991-12#1)(1994-2#1)(2009-5#1)(2013-8#1)
caregivers express##2##2##(1992-3#2)
caregivers face##2##2##(2008-6#2)
caregivers for##2##2##(1995-2#1)(1996-3#1)
caregivers had##2##2##(1994-1#1)(2013-8#1)
caregivers in##2##2##(1992-3#1)(1993-11#1)
caregivers of children with AIDS##2##5##(2012-3#2)
caregivers of children with##4##4##(1994-1#1)(1995-2#1)(2012-3#2)
caregivers of dementia patients##2##4##(2008-6#2)
caregivers of patients with##2##4##(2011-2#1)(2013-8#1)
caregivers of the##2##3##(1992-1#1)(1992-3#1)
caregivers of##16##2##(1991-12#1)(1992-1#1)(1992-3#2)(1994-1#1)(1995-2#1)(2008-6#2)(2008-7#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
caregivers regarding##2##2##(1996-1#1)(2010-8#1)
caregivers who##2##2##(2008-7#1)(2010-10#1)
caregivers with##2##2##(2010-7#2)
caregivers##86##1##(1991-1#3)(1991-12#6)(1991-2#1)(1992-1#2)(1992-3#12)(1993-11#1)(1994-1#2)(1994-2#1)(1995-2#2)(1996-1#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-6#6)(2008-7#5)(2009-10#1)(2009-5#5)(2010-10#1)(2010-2#1)(2010-4#3)(2010-7#7)(2010-8#2)(2011-2#4)(2011-8#1)(2012-3#2)(2013-1#4)(2013-8#8)
caregivers'##2##1##(1991-12#1)(1992-3#1)
caregiving##21##1##(1991-12#1)(1992-3#2)(1994-1#1)(1994-3#1)(1995-1#2)(1996-1#2)(2008-6#3)(2008-7#3)(2010-7#1)(2012-2#5)
carer##6##1##(2008-11#1)(2008-12#3)(2009-6#1)(2011-1#1)
carers and service users##2##4##(2012-3#2)
carers and##3##2##(2008-12#1)(2012-3#2)
carers more##2##2##(2008-12#2)
carers##19##1##(1997-8#1)(2008-11#1)(2008-12#5)(2009-6#4)(2011-1#5)(2012-3#2)(2013-8#1)
cares##2##1##(1995-1#1)(2012-3#1)
caretakers##4##1##(1991-12#1)(2010-6#3)
cargo##4##1##(2008-11#1)(2009-8#1)(2011-2#2)
carica##2##1##(2008-10#2)
caries and##8##2##(1990-3#2)(1991-6#1)(2008-10#1)(2008-11#1)(2012-2#3)
caries is a##2##3##(1991-6#1)(2012-2#1)
caries##35##1##(1990-3#2)(1991-6#5)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2010-10#1)(2011-2#3)(2012-2#12)(2013-7#1)(2013-8#1)
caries-related factors##2##2##(2012-2#2)
caries-related##4##1##(2012-2#4)
carina##4##1##(2010-7#2)(2011-3#1)(2012-3#1)
carinata (BC genome)##2##3##(2008-10#2)
carinata##4##1##(2008-10#4)
caring and##4##2##(1990-6#1)(2008-12#1)(2008-8#1)(2012-3#1)
caring for a premature##2##4##(2011-2#2)
caring for a##4##3##(1992-3#1)(1997-8#1)(2011-2#2)
caring for older people##2##4##(2010-10#2)
caring for patients with##4##4##(2008-11#1)(2010-7#2)(2012-2#1)
caring for patients##8##3##(1994-2#1)(1997-2#1)(2008-11#1)(2010-7#2)(2010-8#1)(2012-2#1)(2013-8#1)
caring for the##3##3##(1991-3#1)(2008-11#2)
caring for their children##2##4##(1996-1#1)(2012-3#1)
caring for their##3##3##(1996-1#1)(2011-2#1)(2012-3#1)
caring for##30##2##(1991-3#1)(1992-3#2)(1994-2#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#8)(2010-10#2)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#1)
caring in the best interests of the child##2##8##(2010-9#2)
caring of##2##2##(1992-3#1)(2012-3#1)
caring role and##2##3##(2011-1#2)
caring role##3##2##(2011-1#3)
caring##53##1##(1990-6#1)(1991-3#1)(1992-1#1)(1992-3#3)(1994-2#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#13)(2008-12#3)(2008-5#1)(2008-8#1)(2010-10#4)(2010-11#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#4)(2013-8#2)
cariogenic##3##1##(2012-2#1)(2013-1#2)
carious lesions##2##2##(2011-2#1)(2012-2#1)
carious##6##1##(2008-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
cariously involved primary teeth##2##4##(2011-2#2)
carlavirus##2##1##(2008-10#1)(2008-9#1)
carlaviruses##2##1##(2008-10#1)(2008-9#1)
carmine##11##1##(1990-6#2)(1993-8#4)(2008-10#5)
carminic acid at##3##3##(2008-10#3)
carminic acid##8##2##(2008-10#8)
carmovirus##3##1##(2008-10#3)
carmustine##2##1##(2010-11#2)
carnation and##3##2##(2008-10#3)
carnation##9##1##(2008-10#9)
carnitine was##2##2##(1991-2#2)
carnitine##5##1##(1991-2#4)(2008-10#1)
carnivores##7##1##(1994-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#3)
carnivorous##4##1##(2008-5#1)(2008-8#2)(2009-8#1)
carolinensis##3##1##(2011-2#3)
carota L##4##2##(1994-11#1)(2008-8#2)(2008-9#1)
carotae##2##1##(2008-10#2)
carotenoid content was##2##3##(2008-10#1)(2008-12#1)
carotenoid content##3##2##(2008-10#2)(2008-12#1)
carotenoid##26##1##(1992-9#1)(1995-2#2)(2008-10#7)(2008-12#2)(2008-8#7)(2009-10#3)(2010-10#4)
carotenoids in##3##2##(1992-9#1)(2008-10#2)
carotenoids##15##1##(1992-9#5)(2008-10#4)(2008-12#3)(2011-2#2)(2013-8#1)
carotenoprotein complexes##2##2##(2008-12#2)
carotid and##6##2##(2008-11#2)(2008-4#1)(2009-12#1)(2011-2#1)(2013-8#1)
carotid arteries and##3##3##(1996-9#1)(2008-7#1)(2012-2#1)
carotid arteries were##2##3##(1996-9#1)(2008-7#1)
carotid arteries##10##2##(1996-9#2)(2008-7#3)(2011-2#4)(2012-2#1)
carotid artery and##2##3##(2011-2#1)(2013-8#1)
carotid artery aneurysm##2##3##(1992-5#1)(2008-7#1)
carotid artery in##2##3##(2008-7#2)
carotid artery intima-media thickness##2##4##(2010-10#1)(2013-8#1)
carotid artery is not##2##4##(1993-3#1)(2008-7#1)
carotid artery is##4##3##(1993-3#2)(2008-7#1)(2012-3#1)
carotid artery occlusion##2##3##(1996-12#1)(2008-7#1)
carotid artery stenosis##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
carotid artery was##3##3##(2008-7#2)(2008-9#1)
carotid artery##56##2##(1992-5#1)(1993-3#2)(1996-12#1)(1997-3#3)(1997-6#5)(1997-8#1)(2006-6#1)(2008-11#1)(2008-7#15)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#3)
carotid cavernous##3##2##(1996-6#1)(1996-9#1)(1997-3#1)
carotid disorders##2##2##(2011-3#2)
carotid endarterectomy##6##2##(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-7#1)
carotid intima-media thickness and brachial artery flow-mediated vasodilatation##2##8##(2008-11#2)
carotid intima-media thickness##3##3##(2008-11#3)
carotid plaque##2##2##(2008-8#1)(2010-9#1)
carotid smooth muscle##2##3##(1990-12#2)
carotid stenosis##6##2##(1993-1#1)(2008-11#1)(2008-8#3)(2011-2#1)
carotid stenting##2##2##(2008-11#2)
carotid surgery##2##2##(1990-9#1)(2011-3#1)
carotid system##2##2##(1996-9#2)
carotid##133##1##(1990-12#2)(1990-5#1)(1990-9#2)(1991-12#1)(1992-5#2)(1993-1#1)(1993-3#2)(1996-12#1)(1996-6#4)(1996-9#8)(1997-3#4)(1997-6#5)(1997-8#2)(2006-6#1)(2008-1#1)(2008-11#12)(2008-4#1)(2008-7#22)(2008-8#6)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-2#19)(2011-3#5)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#3)(2013-8#6)
carotid-subclavian bypass##2##2##(1993-3#1)(2008-7#1)
carotovora and##2##2##(2008-10#2)
carotovora subsp##8##2##(1990-5#2)(2008-10#6)
carotovora was##2##2##(2008-10#2)
carotovora##17##1##(1990-5#4)(2008-10#13)
carp Vg##2##2##(2008-10#2)
carp##25##1##(1990-8#2)(2008-10#5)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#2)(2010-5#7)(2010-8#1)
carpal instability##2##2##(2008-9#1)(2013-1#1)
carpal tunnel is##2##3##(2008-9#2)
carpal tunnel release##3##3##(2008-9#3)
carpal tunnel syndrome (CTS)##3##4##(2008-9#2)(2010-8#1)
carpal tunnel syndrome##10##3##(2008-12#4)(2008-9#4)(2010-8#2)
carpal tunnel##22##2##(1997-2#1)(2008-12#5)(2008-9#14)(2010-8#2)
carpal##29##1##(1997-2#1)(1997-3#1)(2008-12#5)(2008-9#18)(2010-8#2)(2013-1#2)
carpels##2##1##(1997-8#1)(2008-8#1)
carpenter##3##1##(2008-7#3)
carpi ulnaris##2##2##(2008-9#2)
carpi##4##1##(1996-6#1)(2008-12#1)(2008-9#2)
carpogenic germination of sclerotia##2##4##(2008-10#2)
carpogenic germination of##3##3##(2008-10#3)
carpogenic germination##7##2##(2008-10#7)
carpometacarpal joint##3##2##(2008-9#3)
carpometacarpal##4##1##(2008-9#4)
carpophila##2##1##(2008-10#2)
carrageenan##2##1##(2008-12#1)(2011-10#1)
carrageenan-induced##2##1##(1993-2#2)
carriage in the##2##3##(2008-5#1)(2013-1#1)
carriage in##5##2##(1996-8#1)(2008-5#1)(2013-1#3)
carriage of##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
carriage##11##1##(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2011-2#1)(2013-1#3)
carried a##6##2##(1995-6#1)(2008-10#3)(2008-8#1)(2008-9#1)
carried at##2##2##(1995-5#1)(2012-3#1)
carried by a##3##3##(2008-10#2)(2008-5#1)
carried by the##7##3##(1990-5#1)(1995-6#1)(1995-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)
carried by##21##2##(1990-5#1)(1993-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(2008-10#7)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-1#1)(2012-3#2)
carried in##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
carried on##3##2##(1991-3#1)(2008-10#2)
carried out a study##2##4##(2008-10#1)(2008-7#1)
carried out a##10##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
carried out according to##2##4##(1993-12#1)(2008-9#1)
carried out against##3##3##(2008-10#3)
carried out and the##2##4##(2008-10#1)(2012-3#1)
carried out and##6##3##(2008-10#4)(2008-5#1)(2012-3#1)
carried out as##5##3##(1990-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
carried out at a##2##4##(2008-10#2)
carried out at the##5##4##(1996-5#1)(1997-6#1)(2008-10#2)(2010-1#1)
carried out at##28##3##(1996-5#1)(1997-6#1)(2008-10#17)(2008-11#1)(2008-7#1)(2009-8#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
carried out between##2##3##(1991-8#1)(2011-2#1)
carried out by a##7##4##(2008-1#1)(2008-10#5)(2008-4#1)
carried out by applying##3##4##(2008-10#3)
carried out by means of a##2##6##(2007-11#1)(2011-2#1)
carried out by means of##5##5##(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-7#1)
carried out by the##15##4##(1990-12#1)(1990-3#1)(1994-12#1)(2008-10#9)(2008-7#1)(2009-10#1)(2012-2#1)
carried out by using##11##4##(2008-10#11)
carried out by##95##3##(1990-12#1)(1990-3#1)(1991-5#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#69)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-7#1)
carried out for six##2##4##(2008-10#2)
carried out for the determination of##2##6##(2008-10#2)
carried out for the##4##4##(1991-2#1)(2008-10#2)(2010-12#1)
carried out for##15##3##(1991-2#1)(1993-3#1)(2008-10#9)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#1)
carried out in a##18##4##(1994-2#1)(2008-10#15)(2008-11#1)(2013-1#1)
carried out in an##5##4##(2008-10#4)(2008-2#1)
carried out in aqueous##2##4##(2008-10#2)
carried out in cases of##2##5##(1994-2#1)(1996-3#1)
carried out in four##2##4##(1990-2#1)(2008-11#1)
carried out in its fluorescent band##2##6##(2008-10#2)
carried out in order to achieve the##2##7##(2008-10#2)
carried out in order to##8##5##(1994-5#1)(1994-6#1)(2008-10#6)
carried out in the U##2##5##(1990-6#1)(2008-5#1)
carried out in the field##2##5##(2008-10#1)(2008-7#1)
carried out in the presence of##4##6##(1996-5#1)(2008-10#2)(2011-2#1)
carried out in the##27##4##(1990-6#1)(1996-5#1)(1997-1#1)(2008-10#17)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#2)(2013-1#1)
carried out in##127##3##(1990-11#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-6#2)(1991-9#1)(1993-11#1)(1993-3#2)(1994-2#2)(1994-5#1)(1994-6#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#1)(2008-10#69)(2008-11#7)(2008-12#2)(2008-2#2)(2008-5#5)(2008-7#3)(2008-9#2)(2009-12#2)(2009-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#1)
carried out on a##10##4##(1992-5#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-12#1)
carried out on the##14##4##(2008-10#6)(2008-3#1)(2008-5#3)(2008-8#1)(2009-12#1)(2011-2#2)
carried out on##57##3##(1991-6#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-5#1)(2007-11#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2011-2#5)(2013-1#1)
carried out only##2##3##(2008-10#2)
carried out over the##3##4##(2008-10#3)
carried out over##6##3##(2008-10#3)(2008-8#1)(2011-1#1)(2011-2#1)
carried out the##9##3##(1991-8#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-3#1)
carried out through##6##3##(1996-1#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
carried out to assess##3##4##(1993-8#1)(1996-6#1)(2008-10#1)
carried out to clarify the##3##5##(2008-10#1)(2008-6#1)(2010-5#1)
carried out to confirm##2##4##(2008-10#1)(2010-12#1)
carried out to demonstrate##2##4##(2008-10#1)(2010-11#1)
carried out to determine the##9##5##(1994-3#1)(1996-12#1)(2008-10#3)(2008-5#1)(2011-2#2)(2013-1#1)
carried out to determine##12##4##(1994-3#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-7#2)(2011-2#2)(2013-1#1)
carried out to develop a##3##5##(2008-10#2)(2008-5#1)
carried out to evaluate the##4##5##(1990-2#1)(2008-10#1)(2008-12#2)
carried out to evaluate##5##4##(1990-11#1)(1990-2#1)(2008-10#1)(2008-12#2)
carried out to investigate the##4##5##(1991-6#1)(2008-10#1)(2008-12#1)(2008-5#1)
carried out to investigate##6##4##(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
carried out to study the##3##5##(1991-12#1)(1994-6#1)(2008-11#1)
carried out to study##4##4##(1991-12#1)(1994-6#1)(2008-10#1)(2008-11#1)
carried out to##57##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-6#1)(2008-10#21)(2008-11#3)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-1#2)(2013-8#1)
carried out under various##2##4##(2008-10#1)(2008-3#1)
carried out under##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)
carried out until the##2##4##(2008-10#2)
carried out until##4##3##(2008-10#2)(2008-7#1)(2010-11#1)
carried out using a##10##4##(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
carried out using an##4##4##(2008-10#3)(2010-3#1)
carried out using genetic##2##4##(2009-3#1)(2013-8#1)
carried out using the##6##4##(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)
carried out using these##2##4##(1991-5#1)(2010-7#1)
carried out using two##2##4##(2008-10#2)
carried out using##54##3##(1991-5#1)(1996-12#1)(2008-10#38)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-3#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
carried out via##2##3##(1996-2#1)(2010-11#1)
carried out with a##3##4##(2008-10#1)(2008-5#1)(2009-11#1)
carried out with respect to the##2##6##(1997-7#1)(2008-10#1)
carried out with the##6##4##(1997-3#1)(2008-10#3)(2008-2#1)(2010-4#1)
carried out with these##2##4##(2008-10#1)(2008-7#1)
carried out with##40##3##(1990-5#2)(1990-9#1)(1991-6#1)(1993-2#1)(1993-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#21)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-1#1)
carried out within the##3##4##(1990-3#1)(2008-10#1)(2008-3#1)
carried out within##4##3##(1990-3#1)(2008-10#1)(2008-3#1)(2010-7#1)
carried out without any##3##4##(2008-10#3)
carried out without##5##3##(2008-10#5)
carried out##688##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#3)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#7)(1991-8#4)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1995-12#2)(1995-9#1)(1996-1#1)(1996-12#6)(1996-2#3)(1996-3#2)(1996-5#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#3)(2008-1#1)(2008-10#367)(2008-11#20)(2008-12#9)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#30)(2008-6#3)(2008-7#16)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#5)(2009-3#3)(2009-7#1)(2009-8#2)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#3)(2011-1#4)(2011-2#26)(2011-3#2)(2012-12#8)(2012-2#7)(2012-3#16)(2012-7#1)(2013-1#10)(2013-8#6)
carried the##5##2##(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
carried to the##3##3##(2008-10#3)
carried to##5##2##(1997-8#1)(2008-10#4)
carried##756##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#3)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#7)(1991-8#4)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#7)(1993-6#2)(1993-8#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#7)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#3)(2007-11#3)(2008-1#1)(2008-10#390)(2008-11#22)(2008-12#9)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#32)(2008-6#3)(2008-7#18)(2008-8#4)(2008-9#10)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#3)(2009-7#1)(2009-8#3)(2010-1#5)(2010-10#2)(2010-11#5)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#3)(2011-1#4)(2011-2#26)(2011-3#2)(2012-12#8)(2012-2#8)(2012-3#21)(2012-7#1)(2013-1#11)(2013-8#7)
carrier and an##2##3##(2008-10#2)
carrier and##8##2##(1995-5#1)(2008-10#6)(2008-9#1)
carrier are##3##2##(2008-10#2)(2008-11#1)
carrier buffer##4##2##(2008-10#4)
carrier by##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
carrier concentration in the##2##4##(2008-10#1)(2008-3#1)
carrier concentration##4##2##(2008-10#3)(2008-3#1)
carrier containing##2##2##(2008-10#2)
carrier electrolyte##5##2##(1997-2#1)(2008-10#4)
carrier flow##3##2##(2008-10#3)
carrier for the##2##3##(1991-5#1)(2008-10#1)
carrier for##8##2##(1991-5#1)(1996-12#1)(2008-10#5)(2010-7#1)
carrier gas at a flow rate of##2##7##(2008-10#2)
carrier gas flow rate##5##4##(2008-10#5)
carrier gas flow##8##3##(2008-10#7)(2011-2#1)
carrier gas##19##2##(2008-10#17)(2008-7#1)(2011-2#1)
carrier generation##2##2##(2008-3#2)
carrier in a##3##3##(2008-10#2)(2008-5#1)
carrier in##12##2##(1995-6#1)(2008-10#9)(2008-5#1)(2012-12#1)
carrier into##2##2##(2008-10#2)
carrier is##2##2##(1991-5#1)(2008-10#1)
carrier material for##2##3##(2011-2#2)
carrier material##3##2##(2008-7#1)(2011-2#2)
carrier moiety##2##2##(1995-5#2)
carrier of##5##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-8#1)
carrier protein##12##2##(1990-5#1)(1992-4#3)(1994-8#1)(1995-6#4)(2008-11#1)(2008-4#1)(2008-5#1)
carrier proteins##3##2##(1995-6#1)(2008-5#2)
carrier solution##25##2##(2008-10#25)
carrier state##2##2##(1996-3#1)(1997-3#1)
carrier stream and##3##3##(2008-10#3)
carrier stream containing 0##2##4##(2008-10#2)
carrier stream containing##3##3##(2008-10#3)
carrier stream of##7##3##(2008-10#7)
carrier stream to##4##3##(2008-10#4)
carrier stream##34##2##(2008-10#34)
carrier system##2##2##(2008-10#1)(2008-5#1)
carrier that##2##2##(1995-5#1)(2008-10#1)
carrier to carrier transfer##5##4##(2008-11#5)
carrier to##9##2##(1991-5#1)(1993-11#1)(2008-10#2)(2008-11#5)
carrier transfer##6##2##(2008-11#5)(2009-11#1)
carrier type##2##2##(2008-7#2)
carrier was prepared##3##3##(2008-10#3)
carrier was##5##2##(2008-10#5)
carrier with##2##2##(2008-10#1)(2008-11#1)
carrier##269##1##(1990-5#1)(1991-12#1)(1991-5#4)(1992-3#1)(1992-4#3)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#5)(1995-6#6)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(2007-11#2)(2008-10#179)(2008-11#19)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#10)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#7)(2012-12#1)(2013-1#1)
carrier-mediated##5##1##(1991-5#1)(1992-3#2)(1994-8#1)(2011-3#1)
carriers and a##2##3##(2008-10#1)(2008-11#1)
carriers and##5##2##(1995-6#1)(2008-10#2)(2008-11#1)(2009-7#1)
carriers during##2##2##(2008-11#2)
carriers for##6##2##(2008-10#3)(2008-12#1)(2010-7#1)(2010-8#1)
carriers in a##2##3##(2008-11#1)(2011-2#1)
carriers in cell culture##2##4##(2008-11#2)
carriers in cesium ion selective electrodes##2##6##(2008-10#2)
carriers in plasticized##2##3##(2008-10#2)
carriers in##16##2##(2008-10#8)(2008-11#3)(2008-7#2)(2011-2#2)(2012-2#1)
carriers is##2##2##(2011-2#2)
carriers of##9##2##(1991-8#1)(1995-9#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#2)(2013-8#2)
carriers performed the##2##3##(2008-10#2)
carriers to##2##2##(1995-9#1)(2008-10#1)
carriers was##4##2##(2008-11#4)
carriers with##2##2##(2008-10#1)(2008-9#1)
carriers##111##1##(1990-3#1)(1991-8#1)(1993-11#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-3#1)(1996-5#1)(1997-1#3)(2008-10#40)(2008-11#24)(2008-12#1)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#9)(2011-8#1)(2012-2#3)(2013-8#3)
carries a high risk of severe##2##6##(1995-5#1)(2008-7#1)
carries a high##3##3##(1995-5#1)(2008-12#1)(2008-7#1)
carries a##9##2##(1995-5#1)(1996-12#1)(1996-2#1)(2008-12#1)(2008-7#2)(2009-9#1)(2010-6#1)(2013-1#1)
carries an##2##2##(1996-2#1)(2008-10#1)
carries both##2##2##(1997-6#1)(2008-10#1)
carries out##5##2##(1990-11#1)(2008-10#2)(2008-3#1)(2013-8#1)
carries the##7##2##(1995-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-3#1)(2013-1#1)
carries##39##1##(1990-11#1)(1992-3#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
carrot (Daucus carota)##2##3##(2008-10#2)
carrot (Daucus##3##2##(2008-10#2)(2008-9#1)
carrot motley##2##2##(2008-10#2)
carrot roots##3##2##(2008-10#3)
carrot somatic embryo##2##3##(2008-9#2)
carrot somatic##3##2##(2008-9#3)
carrot##25##1##(2008-10#19)(2008-8#1)(2008-9#5)
carrots##3##1##(2008-10#3)
carry a##10##2##(1992-6#1)(1994-12#1)(2008-10#5)(2008-12#1)(2008-8#1)(2013-1#1)
carry food to##2##3##(1993-6#2)
carry food##3##2##(1993-6#3)
carry out a##2##3##(2008-3#1)(2008-9#1)
carry out an##2##3##(2010-3#1)(2011-3#1)
carry out the##14##3##(1994-5#1)(1995-12#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-2#3)(2010-12#1)(2011-1#1)
carry out##41##2##(1990-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-7#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
carry the##8##2##(1991-3#1)(1993-6#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#1)
carry##87##1##(1990-2#1)(1991-3#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#4)(1994-1#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#27)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)
carry-to-leave when sated##2##3##(1993-6#2)
carrying a##22##2##(1993-12#1)(1993-9#1)(1995-5#1)(1997-3#2)(2008-10#8)(2008-11#1)(2008-9#3)(2009-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
carrying both##2##2##(2008-10#1)(2008-8#1)
carrying capacities##4##2##(2008-10#1)(2008-6#1)(2008-8#2)
carrying capacity for##2##3##(2008-10#2)
carrying capacity##9##2##(1997-3#1)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#1)
carrying multiple##2##2##(2008-10#1)(2008-9#1)
carrying out a##5##3##(1990-9#1)(2008-10#3)(2008-11#1)
carrying out the##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
carrying out##21##2##(1990-11#1)(1990-9#1)(1993-3#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
carrying the Vf gene##2##4##(2008-10#2)
carrying the Vf##3##3##(2008-10#3)
carrying the gene##3##3##(2008-10#2)(2008-11#1)
carrying the mutations##3##3##(1995-6#3)
carrying the resistance gene##2##4##(2008-10#2)
carrying the##39##2##(1990-11#1)(1990-5#1)(1993-2#1)(1993-6#2)(1994-11#1)(1995-2#1)(1995-5#2)(1995-6#3)(1997-3#2)(1997-4#1)(1997-8#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-8#1)(2010-1#2)(2010-6#1)
carrying these##2##2##(2007-12#1)(2008-10#1)
carrying##153##1##(1990-11#2)(1990-5#1)(1990-9#1)(1991-6#1)(1992-10#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#3)(1995-6#3)(1996-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#57)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#10)(2009-10#1)(2009-8#3)(2010-1#4)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#1)
carrying-to-eat##2##1##(1993-6#2)
carrying-to-leave##2##1##(1993-6#2)
carryover##4##1##(2008-10#4)
cars##5##1##(2008-10#1)(2008-11#3)(2010-11#1)
cart##2##1##(2010-7#1)(2011-2#1)
carthamin##6##1##(2008-11#6)
carthlicum##2##1##(2012-3#2)
cartilage and bone##7##3##(1991-5#2)(2007-11#3)(2008-7#1)(2011-2#1)
cartilage and##9##2##(1991-5#2)(2007-11#3)(2008-7#1)(2009-7#1)(2011-2#2)
cartilage cell cultures##2##3##(1990-11#2)
cartilage cells to##2##3##(1990-11#2)
cartilage cells##4##2##(1990-11#4)
cartilage damage##2##2##(2010-10#2)
cartilage defect##2##2##(2011-2#2)
cartilage degradation##2##2##(1993-2#1)(2011-2#1)
cartilage differentiation##2##2##(1994-11#1)(2008-11#1)
cartilage framework##2##2##(2009-1#2)
cartilage from##3##2##(1993-12#2)(2008-7#1)
cartilage in##2##2##(2012-2#1)(2012-3#1)
cartilage of##2##2##(1993-12#1)(2008-7#1)
cartilage or##2##2##(1997-6#1)(2008-11#1)
cartilage proteoglycan##2##2##(1991-5#1)(1993-2#1)
cartilage regeneration##2##2##(2010-10#1)(2012-3#1)
cartilage replacement##3##2##(2009-9#3)
cartilage rings##2##2##(1990-3#2)
cartilage tissue##2##2##(2008-11#1)(2008-7#1)
cartilage##75##1##(1990-11#7)(1990-3#2)(1991-5#5)(1993-12#3)(1993-2#5)(1994-11#1)(1994-6#1)(1997-6#1)(2007-11#3)(2008-1#1)(2008-11#7)(2008-12#2)(2008-7#6)(2008-9#1)(2009-1#3)(2009-7#1)(2009-9#5)(2010-10#4)(2010-12#1)(2011-2#9)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
cartilages##3##1##(1992-3#1)(2008-11#2)
cartilaginous##7##1##(1990-9#1)(2008-7#1)(2008-9#2)(2009-1#2)(2009-6#1)
cartridge and##3##2##(2008-10#3)
cartridge containing##2##2##(2008-10#2)
cartridge is##4##2##(2008-10#4)
cartridge to##2##2##(2008-10#2)
cartridge was##5##2##(2008-10#5)
cartridge##45##1##(1997-2#3)(2008-10#42)
cartridges and##6##2##(1993-2#1)(2008-10#5)
cartridges were##3##2##(2008-10#3)
cartridges with##3##2##(2008-10#3)
cartridges##28##1##(1992-11#1)(1993-2#1)(2008-10#25)(2008-11#1)
cartridges)##2##1##(2008-10#2)
carvacrol in##4##2##(2008-10#2)(2008-11#2)
carvacrol were##2##2##(2008-11#2)
carvacrol##18##1##(2008-10#3)(2008-11#13)(2008-12#2)
carvedilol and##2##2##(2010-4#2)
carvedilol##10##1##(2008-10#4)(2010-4#6)
carvone##2##1##(2008-10#2)
caryophyllene oxide##2##2##(2008-11#1)(2008-12#1)
caryophyllene##3##1##(2008-10#1)(2008-11#1)(2008-12#1)
caryopsis##3##1##(2008-10#3)
cas de##6##2##(2011-2#1)(2013-1#5)
cas pendant le##2##3##(2013-1#2)
cas##20##1##(2011-2#4)(2013-1#16)
cascade and##7##2##(1992-11#1)(1997-1#1)(2007-11#1)(2008-11#1)(2009-8#2)(2011-2#1)
cascade correlation networks##4##3##(2008-10#4)
cascade in##2##2##(1995-2#2)
cascade is##2##2##(2009-8#2)
cascade leading to##2##3##(1995-12#1)(2009-8#1)
cascade occurs##2##2##(1995-2#1)(2008-7#1)
cascade of events##3##3##(1992-9#1)(1993-8#1)(2009-9#1)
cascade of##10##2##(1992-9#1)(1993-8#1)(1994-6#2)(2008-10#2)(2009-9#1)(2012-2#2)(2012-3#1)
cascade system##3##2##(2008-3#2)(2008-6#1)
cascade##61##1##(1992-11#1)(1992-2#3)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-6#4)(1994-8#1)(1995-12#1)(1995-2#3)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#10)(2009-9#2)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
cascaded##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
cascades and##2##2##(2008-7#1)(2008-8#1)
cascades are##2##2##(1996-2#1)(2008-7#1)
cascades in##4##2##(1997-1#1)(2008-1#1)(2008-8#2)
cascades that##3##2##(1996-2#1)(2008-7#1)(2009-8#1)
cascades##27##1##(1996-2#3)(1997-1#2)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#4)(2008-8#7)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-2#2)
case - control study##4##4##(2008-11#4)
case B##2##2##(2013-1#2)
case also##3##2##(2008-10#1)(2009-3#1)(2009-8#1)
case analysis##2##2##(1996-1#1)(2008-11#1)
case and review of the literature##3##6##(2008-12#2)(2013-1#1)
case and review of the##5##5##(1990-5#1)(2008-12#2)(2010-5#1)(2013-1#1)
case and review of##7##4##(1990-5#1)(2008-12#3)(2008-7#1)(2010-5#1)(2013-1#1)
case and review##9##3##(1990-5#1)(2008-12#3)(2008-7#1)(2010-5#1)(2013-1#3)
case and that##2##3##(2008-7#1)(2008-9#1)
case and##23##2##(1990-5#1)(1994-12#1)(1994-9#1)(1996-3#2)(1997-3#1)(2008-12#4)(2008-5#1)(2008-7#4)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)
case are##3##2##(1990-9#1)(2008-10#1)(2011-2#1)
case as a##2##3##(1996-3#1)(2010-11#1)
case as##5##2##(1996-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-6#1)
case assumes that cells grow##2##5##(2008-7#2)
case because##3##2##(2008-12#1)(2008-7#1)(2008-8#1)
case by##3##2##(2008-10#1)(2008-8#2)
case control study##2##3##(2008-11#1)(2012-12#1)
case control##6##2##(1995-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-12#1)
case did the##3##3##(1991-8#1)(1997-8#1)(2008-9#1)
case each##4##2##(1996-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
case example##5##2##(1997-2#2)(2008-11#1)(2008-12#1)(2009-10#1)
case examples##2##2##(1997-2#1)(2008-6#1)
case fatality rates##3##3##(2011-2#2)(2013-8#1)
case for risk-based premiums in##2##5##(2008-7#2)
case for risk-based##3##3##(2008-7#3)
case for the##4##3##(1991-6#1)(1994-1#1)(2008-11#2)
case for##33##2##(1991-6#1)(1991-7#1)(1992-1#1)(1994-1#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-7#3)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#3)
case from##4##2##(1992-6#1)(1993-8#1)(1994-5#1)(2012-2#1)
case has been reported in##2##5##(2010-12#1)(2010-6#1)
case has been reported##3##4##(2010-12#1)(2010-6#1)(2013-1#1)
case has##8##2##(1991-3#2)(1993-1#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)
case highlights the##4##3##(2008-11#1)(2008-7#1)(2013-1#2)
case histories are##2##3##(1991-2#1)(1997-2#1)
case histories##4##2##(1991-2#1)(1996-11#1)(1997-2#1)(2011-7#1)
case history of a##4##4##(1991-8#1)(1992-2#1)(1994-12#1)(2012-12#1)
case history##8##2##(1991-8#1)(1992-2#1)(1993-2#1)(1994-12#1)(1997-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
case if##2##2##(1992-3#1)(1994-5#1)
case illustrates that##2##3##(1997-8#1)(2009-8#1)
case illustrates##5##2##(1997-3#1)(1997-8#1)(2008-7#1)(2009-8#1)(2011-2#1)
case in a##4##3##(2008-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
case in the##5##3##(1995-6#1)(1996-5#1)(2008-10#2)(2010-1#1)
case in which an##2##4##(2008-11#1)(2010-11#1)
case in which the##3##4##(2012-12#1)(2013-1#1)(2013-8#1)
case in which##10##3##(1992-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
case in##37##2##(1990-2#1)(1992-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
case is a##2##3##(2008-10#1)(2013-7#1)
case is considered##2##3##(2013-1#1)(2013-7#1)
case is described##2##3##(1991-3#1)(2008-10#1)
case is presented of##2##4##(1992-2#1)(2008-10#1)
case is presented##7##3##(1992-2#1)(1993-1#1)(2008-10#1)(2008-7#2)(2012-2#1)(2013-1#1)
case is reported of##3##4##(1990-6#2)(1991-3#1)
case is that##3##3##(1990-9#1)(2008-1#1)(2010-6#1)
case is the first##2##4##(2011-2#1)(2012-3#1)
case is the##3##3##(2011-2#2)(2012-3#1)
case is unusual##2##3##(2008-7#1)(2010-10#1)
case is##36##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-3#2)(1991-6#1)(1992-2#1)(1993-1#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-7#3)(2010-10#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
case it##2##2##(2008-1#1)(2008-11#1)
case management##20##2##(1991-12#3)(1992-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-3#2)(1997-2#5)(1997-3#1)(2009-11#1)(2010-6#1)
case managers##5##2##(1991-2#1)(1992-1#1)(1996-12#1)(1996-2#2)
case mix adjustment##5##3##(1994-1#1)(1995-2#4)
case mix and severity of illness##2##6##(1993-12#1)(1995-2#1)
case mix and##5##3##(1992-12#2)(1993-12#2)(1995-2#1)
case mix funding##4##3##(1991-12#1)(1995-2#3)
case mix indices##2##3##(1995-2#2)
case mix measurement using outpatient drug dispense##2##7##(1995-2#2)
case mix measurement##3##3##(1991-12#1)(1995-2#2)
case mix measures##2##3##(1995-2#2)
case mix##43##2##(1991-12#3)(1991-3#1)(1992-12#5)(1992-2#1)(1993-12#5)(1993-3#1)(1994-1#1)(1994-12#3)(1995-2#20)(1996-3#1)(2010-12#2)
case notes##2##2##(2008-1#1)(2008-11#1)
case of Achilles tendon rupture##2##5##(2010-3#2)
case of B##3##3##(2008-10#2)(2011-2#1)
case of IFPs##2##3##(2013-8#2)
case of Riedel's thyroiditis##2##4##(2008-12#2)
case of T-cell lymphoma##2##4##(1991-12#2)
case of a 12-year-old boy with##2##6##(2008-10#1)(2008-11#1)
case of a 16-year-old##3##4##(2010-1#1)(2012-3#1)(2013-1#1)
case of a 19-year-old female##2##5##(2008-7#1)(2012-12#1)
case of a 21-year-old##2##4##(1991-8#1)(2013-1#1)
case of a 35-year-old##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
case of a 41-year-old##2##4##(2012-3#2)
case of a 46-year-old##2##4##(2008-7#1)(2008-9#1)
case of a 49-year-old##2##4##(2008-7#1)(2013-1#1)
case of a 55-year-old##2##4##(2011-2#1)(2013-8#1)
case of a 60-year-old##2##4##(2008-7#1)(2009-1#1)
case of a 70-year-old##3##4##(2012-3#1)(2013-1#2)
case of a 72-year-old##3##4##(2008-12#1)(2008-7#1)(2010-6#1)
case of a 74-year-old##2##4##(2009-1#1)(2011-2#1)
case of a boy##2##4##(1995-5#1)(2012-12#1)
case of a cutaneous##2##4##(1990-8#1)(2010-6#1)
case of a female patient with##3##6##(1992-12#1)(2008-1#1)(2012-12#1)
case of a female patient##4##5##(1992-12#1)(2008-1#1)(2012-12#2)
case of a female##5##4##(1992-12#1)(2008-1#1)(2012-12#2)(2012-3#1)
case of a giant##3##4##(2008-12#1)(2012-12#1)(2013-1#1)
case of a large##2##4##(1992-5#1)(2011-2#1)
case of a male##2##4##(2011-2#1)(2012-12#1)
case of a patient with##5##5##(1990-8#1)(1991-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
case of a patient##10##4##(1990-8#1)(1991-11#1)(1993-6#2)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#2)
case of a young woman##2##5##(2008-7#1)(2010-12#1)
case of a young##5##4##(2008-7#1)(2010-12#1)(2012-2#2)(2013-8#1)
case of a##174##3##(1990-12#1)(1990-8#2)(1991-1#1)(1991-11#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-6#3)(1994-1#1)(1994-12#1)(1995-5#2)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#14)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#15)(2008-8#2)(2008-9#5)(2009-1#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-5#2)(2010-6#5)(2011-1#1)(2011-2#21)(2012-12#10)(2012-2#4)(2012-3#8)(2013-1#20)(2013-2#1)(2013-7#2)(2013-8#7)
case of acute##7##3##(1993-6#1)(2008-10#1)(2008-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
case of advanced genital##2##4##(2008-11#2)
case of advanced##3##3##(1997-6#1)(2008-11#2)
case of alveolar##2##3##(2010-11#1)(2011-2#1)
case of an infant##2##4##(1991-2#1)(2012-2#1)
case of an##21##3##(1990-6#1)(1991-2#1)(1992-12#1)(1994-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
case of bilateral##6##3##(1994-12#1)(2008-10#1)(2008-9#2)(2010-5#1)(2013-1#1)
case of bone##2##3##(2008-12#1)(2013-1#1)
case of both##3##3##(2008-10#2)(2013-1#1)
case of chronic granulomatous disease##2##5##(2013-1#2)
case of chronic##5##3##(2008-11#1)(2011-2#2)(2013-1#2)
case of complete##2##3##(2008-10#2)
case of congenital##4##3##(2008-12#1)(2010-11#1)(2010-9#1)(2012-3#1)
case of cutaneous##4##3##(2008-10#1)(2010-11#1)(2010-6#2)
case of diffuse##4##3##(2008-10#1)(2008-3#1)(2009-1#1)(2011-2#1)
case of early##3##3##(1990-8#1)(2008-9#1)(2011-2#1)
case of esophageal##2##3##(1997-8#1)(2010-6#1)
case of extracranial##2##3##(1992-5#1)(2008-7#1)
case of failure and##2##4##(2008-11#1)(2009-4#1)
case of faun tail##2##4##(2010-6#2)
case of fulminant amebic colitis##2##5##(2011-2#2)
case of gastric##3##3##(1992-9#2)(2009-8#1)
case of giant##4##3##(2008-12#1)(2008-7#1)(2009-3#1)(2012-3#1)
case of hereditary##2##3##(2010-6#1)(2012-3#1)
case of herniation of##2##4##(2009-4#1)(2011-2#1)
case of high-grade##2##3##(2011-2#1)(2013-1#1)
case of idiopathic##3##3##(1997-8#1)(2010-10#1)(2013-1#1)
case of inflammatory##2##3##(2010-6#2)
case of isolated##5##3##(2008-12#1)(2010-11#1)(2012-3#1)(2013-1#2)
case of laryngeal##2##3##(2012-3#1)(2013-1#1)
case of late##3##3##(1993-3#1)(2008-9#1)(2013-1#1)
case of left##2##3##(1997-3#1)(2008-12#1)
case of leukemia cutis at the site of a prior catheter insertion##2##12##(2010-6#2)
case of leukemia##3##3##(2010-6#2)(2011-2#1)
case of lung##2##3##(1994-12#1)(2011-2#1)
case of male##2##3##(2008-8#1)(2011-2#1)
case of malignant##2##3##(2008-7#1)(2010-1#1)
case of massive digestive hemorrhage##2##5##(1992-5#2)
case of medulloblastoma in##2##4##(2008-7#1)(2009-1#1)
case of membranous lipodystrophy observed in lichen amyloidosis##2##8##(2010-6#2)
case of meningitis##2##3##(2009-11#1)(2011-2#1)
case of multiple##2##3##(2008-7#1)(2013-1#1)
case of natural##2##3##(2008-10#1)(2012-12#1)
case of persistent##2##3##(2008-12#1)(2013-1#1)
case of pneumocephalus secondary to##2##5##(2008-7#2)
case of pneumocephalus##3##3##(2008-7#2)(2008-9#1)
case of primary##12##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#2)(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-3#1)(2013-8#1)
case of pulmonary##6##3##(2007-8#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#2)
case of reconstruction##2##3##(1990-3#1)(2009-4#1)
case of severe##6##3##(1991-11#1)(1991-6#1)(2007-12#1)(2013-1#2)(2013-8#1)
case of sexual abuse##2##4##(1996-11#2)
case of sexual##3##3##(1996-11#2)(2008-8#1)
case of small##3##3##(1991-6#1)(1992-12#1)(2008-10#1)
case of spontaneous hemocholecyst##2##4##(2013-1#2)
case of spontaneous##9##3##(1990-9#1)(1992-2#1)(2008-7#2)(2012-12#1)(2012-2#1)(2013-1#3)
case of such a lesion##2##5##(2008-7#1)(2010-7#1)
case of such a##3##4##(2008-7#1)(2010-7#1)(2012-2#1)
case of such##4##3##(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
case of supernumerary spleen##2##4##(1990-5#2)
case of surgical##2##3##(1990-5#1)(2012-3#1)
case of synchronous##2##3##(2008-10#1)(2009-1#1)
case of systemic lupus erythematosus##2##5##(2012-2#1)(2013-1#1)
case of the##50##3##(1990-11#1)(1991-11#1)(1991-5#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#22)(2008-11#4)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
case of this type##2##4##(1990-5#1)(2010-3#1)
case of this##3##3##(1990-5#1)(2010-3#1)(2012-3#1)
case of thyrotoxicosis##2##3##(2008-7#2)
case of unilateral##2##3##(2011-2#1)(2013-1#1)
case of unusual##2##3##(2008-7#1)(2010-1#1)
case of very long-term##2##4##(2011-2#2)
case of very##6##3##(2008-10#3)(2008-11#1)(2011-2#2)
case of##910##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#4)(1990-5#6)(1990-6#2)(1990-8#4)(1990-9#3)(1991-1#2)(1991-11#8)(1991-12#5)(1991-2#3)(1991-3#5)(1991-5#1)(1991-6#9)(1991-8#3)(1992-1#1)(1992-12#3)(1992-2#6)(1992-5#6)(1992-9#5)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#4)(1993-6#5)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#7)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#5)(1995-3#2)(1995-5#2)(1996-11#5)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#5)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#6)(2006-6#1)(2007-12#1)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#161)(2008-11#47)(2008-12#38)(2008-2#4)(2008-3#19)(2008-4#1)(2008-5#15)(2008-7#47)(2008-8#10)(2008-9#20)(2009-1#7)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#3)(2009-8#7)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#7)(2010-12#12)(2010-2#1)(2010-3#10)(2010-4#1)(2010-5#7)(2010-6#24)(2010-7#5)(2010-8#6)(2010-9#1)(2011-1#7)(2011-2#81)(2011-3#2)(2012-12#23)(2012-2#14)(2012-3#35)(2013-1#81)(2013-2#1)(2013-7#5)(2013-8#15)
case only##2##2##(2008-8#1)(2013-1#1)
case presented##2##2##(2008-12#1)(2013-1#1)
case rate##2##2##(1995-12#1)(1995-2#1)
case report and brief review of the literature##2##8##(2012-3#1)(2013-1#1)
case report and literature review##14##5##(2008-12#6)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#2)
case report and review of literature##7##6##(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
case report and review of the literature##13##7##(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
case report and review of##20##5##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#3)
case report and review##21##4##(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#3)
case report and##42##3##(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#9)(2008-7#1)(2008-8#2)(2008-9#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#5)(2012-3#3)(2013-1#7)(2013-8#2)
case report describes a##3##4##(2008-7#1)(2009-6#1)(2013-1#1)
case report describes##7##3##(2008-12#3)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)
case report illustrates the##2##4##(2008-11#1)(2012-3#1)
case report is##6##3##(2008-1#1)(2008-12#1)(2008-8#1)(2010-9#1)(2013-1#2)
case report of a##10##4##(1995-11#1)(2007-8#1)(2008-11#2)(2008-12#2)(2009-1#1)(2010-9#1)(2013-1#2)
case report of an##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
case report of##22##3##(1995-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#4)(2009-1#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-3#2)(2013-1#3)
case report with##3##3##(1994-8#1)(2012-3#1)(2013-1#1)
case report##227##2##(1990-12#3)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-6#2)(1991-8#2)(1992-12#2)(1992-2#7)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#1)(1996-9#2)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#10)(2008-12#28)(2008-7#2)(2008-8#5)(2008-9#9)(2009-1#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#4)(2010-5#2)(2010-7#5)(2010-9#3)(2011-1#6)(2011-2#25)(2011-3#2)(2012-12#12)(2012-2#3)(2012-3#16)(2013-1#31)(2013-8#5)
case report]##18##2##(1992-9#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#3)(2009-1#1)(2009-5#5)(2011-2#2)(2012-3#1)(2013-1#2)
case reports and##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
case reports##28##2##(1990-12#1)(1990-9#1)(1991-3#1)(1993-11#1)(1993-12#1)(1997-5#1)(2008-10#1)(2008-11#6)(2008-7#2)(2009-1#1)(2009-4#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#5)
case revealed##2##2##(2009-1#1)(2010-12#1)
case review##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
case series describes##2##3##(2008-12#1)(2013-1#1)
case series in##2##3##(2011-2#2)
case series of##2##3##(2008-10#1)(2013-1#1)
case series##30##2##(2008-10#2)(2008-12#5)(2009-6#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)
case should##2##2##(2008-11#1)(2013-8#1)
case showed##2##2##(2008-7#1)(2011-2#1)
case showing##2##2##(2008-12#1)(2011-2#1)
case studies as##3##3##(2008-11#2)(2013-1#1)
case studies in##2##3##(2008-11#1)(2008-12#1)
case studies of##4##3##(1991-12#1)(2008-11#3)
case studies##33##2##(1990-5#1)(1991-12#1)(1991-3#1)(1993-1#1)(1994-12#1)(1995-2#1)(1996-1#2)(2008-10#4)(2008-11#8)(2008-12#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-7#2)(2013-1#2)(2013-8#1)
case study approach##2##3##(1996-1#1)(2008-11#1)
case study as a teaching method##2##6##(2008-11#2)
case study data##2##3##(2008-11#2)
case study describes the##2##4##(2008-4#1)(2008-9#1)
case study describes##4##3##(2008-4#1)(2008-9#1)(2009-6#1)(2010-10#1)
case study for##2##3##(1997-3#1)(2008-10#1)
case study in##7##3##(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#2)(2010-10#1)(2012-12#1)
case study is to##2##4##(1993-1#1)(2012-12#1)
case study is##6##3##(1993-1#1)(1996-1#1)(2008-1#1)(2008-9#1)(2012-12#1)(2013-1#1)
case study of a##3##4##(1991-2#1)(1997-2#1)(2008-3#1)
case study of the effects##2##5##(1995-2#1)(2011-1#1)
case study of the##6##4##(1995-2#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)
case study of##22##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1995-2#1)(1996-3#1)(1997-2#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#1)
case study was##2##3##(2010-5#1)(2012-12#1)
case study##128##2##(1990-12#1)(1990-2#1)(1991-1#2)(1991-2#3)(1991-3#2)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#4)(1995-12#1)(1995-2#4)(1995-3#3)(1996-1#4)(1996-3#2)(1997-2#4)(1997-3#4)(2008-1#2)(2008-10#11)(2008-11#19)(2008-12#2)(2008-3#4)(2008-4#2)(2008-8#1)(2008-9#6)(2009-3#3)(2009-6#1)(2010-10#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#11)(2013-8#1)
case suggests that##2##3##(1990-6#1)(2010-6#1)
case that##11##2##(1993-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
case the##17##2##(1990-5#1)(1990-9#1)(1994-9#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-8#3)
case there is##2##3##(1995-5#1)(2008-3#1)
case there was##2##3##(1996-11#1)(2008-7#1)
case there##4##2##(1995-5#1)(1996-11#1)(2008-3#1)(2008-7#1)
case to##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
case treated##2##2##(1992-5#1)(2008-10#1)
case underscores the##2##3##(2008-10#1)(2012-2#1)
case using a##2##3##(1991-2#1)(2013-8#1)
case using##3##2##(1991-2#1)(2013-1#1)(2013-8#1)
case was reported in the##2##5##(1994-9#1)(1996-5#1)
case was##16##2##(1991-12#1)(1991-3#1)(1994-9#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#3)
case we##2##2##(2008-10#1)(2008-9#1)
case weights##2##2##(1991-12#1)(1995-12#1)
case where##7##2##(1995-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2012-12#1)
case with a##3##3##(1991-6#1)(2011-2#1)(2013-1#1)
case with review of##3##4##(2008-11#1)(2008-12#2)
case with##27##2##(1991-12#1)(1991-6#1)(1992-5#2)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
case##2124##1##(1990-11#5)(1990-12#11)(1990-2#4)(1990-3#10)(1990-5#9)(1990-6#10)(1990-8#7)(1990-9#9)(1991-1#8)(1991-11#11)(1991-12#22)(1991-2#16)(1991-3#18)(1991-5#1)(1991-6#17)(1991-7#1)(1991-8#11)(1992-1#4)(1992-11#1)(1992-12#19)(1992-2#19)(1992-3#4)(1992-5#10)(1992-6#1)(1992-9#6)(1993-1#10)(1993-11#2)(1993-12#12)(1993-2#10)(1993-3#7)(1993-6#7)(1993-8#3)(1993-9#1)(1994-1#9)(1994-11#1)(1994-12#17)(1994-2#3)(1994-3#8)(1994-5#4)(1994-6#6)(1994-8#4)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#7)(1995-12#12)(1995-2#30)(1995-3#9)(1995-5#4)(1995-6#5)(1995-9#1)(1996-1#7)(1996-11#11)(1996-12#1)(1996-2#5)(1996-3#12)(1996-5#5)(1996-6#3)(1996-8#1)(1996-9#6)(1997-2#18)(1997-3#14)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#13)(2006-6#1)(2007-12#2)(2007-8#8)(2007-9#2)(2008-1#17)(2008-10#263)(2008-11#135)(2008-12#100)(2008-2#6)(2008-3#32)(2008-4#5)(2008-5#20)(2008-6#6)(2008-7#91)(2008-8#35)(2008-9#54)(2009-1#14)(2009-10#9)(2009-11#6)(2009-12#4)(2009-3#9)(2009-4#5)(2009-5#10)(2009-6#4)(2009-8#14)(2009-9#3)(2010-1#8)(2010-10#12)(2010-11#17)(2010-12#27)(2010-2#4)(2010-3#18)(2010-4#3)(2010-5#14)(2010-6#33)(2010-7#15)(2010-8#9)(2010-9#6)(2011-1#19)(2011-2#159)(2011-3#4)(2011-7#1)(2012-12#55)(2012-2#32)(2012-3#72)(2013-1#189)(2013-2#1)(2013-7#10)(2013-8#39)
case)##11##1##(1990-6#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-1#1)(2010-11#1)
case-based##4##1##(1992-12#2)(2008-12#1)(2009-6#1)
case-by-case##5##1##(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#2)
case-control and##2##2##(1994-2#1)(2008-7#1)
case-control association study##2##3##(2008-9#1)(2011-2#1)
case-control data##2##2##(1992-9#1)(2008-7#1)
case-control studies##6##2##(1990-8#3)(1992-9#2)(1995-9#1)
case-control study of##2##3##(1992-9#1)(1996-3#1)
case-control study was##2##3##(1991-2#1)(2011-2#1)
case-control study##14##2##(1990-12#1)(1990-8#1)(1991-2#2)(1991-8#2)(1992-9#1)(1996-3#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
case-control##32##1##(1990-12#1)(1990-8#4)(1991-2#2)(1991-8#2)(1992-9#5)(1994-2#1)(1995-9#1)(1996-3#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
case-costing and##2##2##(1992-12#1)(1996-3#1)
case-counts##2##1##(2008-6#2)
case-management techniques and##2##3##(1995-3#2)
case-management techniques##3##2##(1995-3#3)
case-management##6##1##(1995-3#5)(1997-2#1)
case-mix classification##2##2##(1991-12#1)(1993-2#1)
case-mix groups##3##2##(1991-2#1)(1991-3#1)(1993-1#1)
case-mix indexes##2##2##(1992-12#1)(1993-1#1)
case-mix system##2##2##(1991-2#2)
case-mix##21##1##(1991-12#3)(1991-2#4)(1991-3#4)(1992-12#2)(1993-1#2)(1993-12#1)(1993-2#4)(1994-2#1)
case-report##2##1##(2011-2#1)(2011-3#1)
case-series##2##1##(1995-9#1)(2012-12#1)
case]##20##1##(1990-3#2)(1990-5#1)(1990-9#2)(1991-6#1)(1992-5#1)(1993-3#1)(1993-6#2)(1996-2#1)(1996-6#1)(2013-1#4)(2013-8#4)
casei##8##1##(1995-6#2)(2008-5#2)(2008-7#3)(2013-1#1)
casein hydrolyzate##2##2##(1997-2#2)
casein kinase I##5##3##(1993-6#2)(1993-8#1)(1994-11#2)
casein kinase II phosphorylation sites##2##5##(2008-8#1)(2008-9#1)
casein kinase II##9##3##(1990-12#2)(1993-8#3)(1994-11#1)(1997-7#1)(2008-8#1)(2008-9#1)
casein kinase##14##2##(1990-12#2)(1993-6#2)(1993-8#4)(1994-11#3)(1997-7#1)(2008-8#1)(2008-9#1)
casein kinase-II##2##2##(1993-2#2)
casein##27##1##(1990-12#2)(1993-2#2)(1993-6#2)(1993-8#4)(1994-11#3)(1996-6#1)(1997-2#2)(1997-7#1)(2008-10#7)(2008-8#1)(2008-9#1)(2012-2#1)
caseins by hydrophobic interaction chromatography##2##5##(2008-10#2)
caseins##5##1##(2008-10#5)
caseload##3##1##(1994-1#1)(1995-12#2)
cases (15%)##2##2##(1992-12#1)(2011-2#1)
cases (16##2##2##(2007-8#1)(2008-12#1)
cases (2##4##2##(1997-4#1)(2008-12#1)(2012-3#2)
cases (26##3##2##(2008-10#2)(2009-8#1)
cases (30##3##2##(1996-11#1)(2008-12#1)(2013-8#1)
cases (4##2##2##(1996-6#1)(2012-12#1)
cases (53##3##2##(2008-10#2)(2009-8#1)
cases (6%)##2##2##(1991-3#1)(1997-3#1)
cases a##3##2##(1997-8#1)(2006-6#1)(2008-10#1)
cases after##2##2##(1990-2#2)
cases among##2##2##(1995-12#1)(2013-8#1)
cases an##2##2##(1991-8#1)(2008-12#1)
cases and 1##2##3##(1995-12#1)(2011-2#1)
cases and 6069 controls##2##4##(2011-2#2)
cases and a review of##2##5##(2008-10#1)(2009-5#1)
cases and a##3##3##(1997-3#1)(2008-10#1)(2009-5#1)
cases and by##3##3##(1990-12#1)(2008-11#1)(2013-8#1)
cases and controls##9##3##(1990-8#2)(1991-7#1)(1992-9#1)(1996-12#1)(2008-10#1)(2011-2#3)
cases and is##2##3##(1996-3#1)(2008-10#1)
cases and may##2##3##(1990-6#1)(1995-3#1)
cases and reduced in one case##2##6##(2008-7#2)
cases and review of the literature##2##6##(1992-12#1)(2008-10#1)
cases and review of the literature]##2##6##(2012-3#1)(2013-1#1)
cases and review of the##4##5##(1992-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
cases and##77##2##(1990-12#1)(1990-6#3)(1990-8#3)(1991-1#2)(1991-11#1)(1991-7#1)(1991-8#1)(1992-12#3)(1992-5#1)(1992-9#3)(1993-1#1)(1993-2#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#7)(2009-10#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-3#5)(2013-1#3)(2013-8#1)
cases are diagnosed##2##3##(1994-3#1)(2008-12#1)
cases are due to##5##4##(1995-12#1)(2008-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
cases are mild##2##3##(2013-1#2)
cases are presented##2##3##(1996-12#1)(2008-5#1)
cases are reviewed##2##3##(1991-2#1)(2008-7#1)
cases are##36##2##(1991-2#1)(1991-8#1)(1992-9#1)(1993-1#1)(1994-3#1)(1995-12#2)(1996-11#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#6)
cases as##7##2##(1995-2#1)(2008-10#2)(2008-2#1)(2009-3#1)(2012-2#2)
cases associated with##3##3##(1991-12#1)(2008-5#1)(2008-7#1)
cases at##4##2##(1990-9#1)(1991-3#1)(1995-2#1)(2008-10#1)
cases but##6##2##(1990-6#1)(1993-6#1)(1996-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
cases by the##2##3##(1991-1#1)(2008-12#1)
cases by##14##2##(1990-12#1)(1991-1#1)(1991-11#2)(1992-12#1)(1992-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2013-1#1)(2013-8#1)
cases can be##2##3##(2008-12#1)(2012-12#1)
cases can##3##2##(2008-12#1)(2012-12#1)(2013-8#1)
cases caused##2##2##(1992-12#1)(2013-8#1)
cases classified##3##2##(1994-3#1)(2011-2#2)
cases collected##2##2##(2008-10#2)
cases compared to##3##3##(1990-8#1)(2008-3#1)(2011-2#1)
cases confirm##2##2##(2008-10#1)(2011-2#1)
cases could be analysed##2##4##(1991-8#2)
cases could##4##2##(1991-8#2)(2008-1#1)(2008-7#1)
cases described in##2##3##(1992-12#1)(1992-9#1)
cases detected##3##2##(1990-8#2)(2008-11#1)
cases diagnosed by##2##3##(1997-3#1)(2008-5#1)
cases diagnosed##4##2##(1997-3#1)(2008-5#1)(2012-12#1)(2012-3#1)
cases for##6##2##(1990-12#1)(1990-2#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
cases from the##3##3##(1995-11#1)(2013-1#1)(2013-8#1)
cases from##7##2##(1993-12#1)(1995-11#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
cases had an##3##3##(1991-11#1)(2008-7#1)(2011-2#1)
cases had##15##2##(1990-6#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-5#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-7#2)(2011-2#2)(2013-1#3)
cases has been##2##3##(2011-2#1)(2013-8#1)
cases has##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
cases have been described##3##4##(2009-6#1)(2013-1#2)
cases have been reported in the literature##3##7##(1990-12#1)(1996-11#1)(2013-1#1)
cases have been reported in the medical literature##2##8##(1990-8#1)(2013-1#1)
cases have been reported in the##7##6##(1990-12#1)(1990-8#1)(1996-11#1)(1997-8#1)(2010-6#1)(2013-1#2)
cases have been reported in##11##5##(1990-12#1)(1990-8#1)(1991-12#1)(1996-11#1)(1997-8#2)(2010-6#1)(2013-1#4)
cases have been reported so far##2##6##(2008-7#1)(2012-12#1)
cases have been reported to date##2##6##(2008-7#1)(2013-1#1)
cases have been reported##18##4##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1996-11#1)(1997-8#2)(2008-10#1)(2008-7#2)(2010-6#1)(2012-12#1)(2013-1#6)
cases have been##28##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-9#1)(1996-11#1)(1996-3#1)(1997-8#2)(2008-10#1)(2008-7#4)(2009-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#9)
cases have##34##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-9#1)(1996-11#1)(1996-3#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#4)(2009-6#1)(2009-9#1)(2010-6#3)(2010-8#1)(2012-12#1)(2013-1#10)
cases having##3##2##(1994-9#1)(1997-1#1)(2008-10#1)
cases in Thailand##2##3##(1995-12#2)
cases in order to##2##4##(2008-10#1)(2011-2#1)
cases in patients##6##3##(1992-9#1)(1995-5#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-3#1)
cases in the United States##2##5##(1996-3#1)(2013-1#1)
cases in the literature##2##4##(1997-3#1)(2008-7#1)
cases in the##12##3##(1993-12#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-12#1)(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
cases in which a##3##4##(1991-8#1)(2011-2#1)(2013-1#1)
cases in which one##2##4##(2008-10#2)
cases in which the##2##4##(2008-10#1)(2011-2#1)
cases in which##19##3##(1991-11#1)(1991-8#1)(1996-5#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-9#1)(2011-2#4)(2013-1#1)
cases in##60##2##(1991-11#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-9#2)(1995-12#3)(1995-5#1)(1996-11#3)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
cases involving##2##2##(1991-12#1)(2013-1#1)
cases is##15##2##(1990-9#1)(1992-9#2)(1994-12#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
cases it was##4##3##(1990-2#1)(1991-8#1)(2008-10#1)(2008-9#1)
cases it##8##2##(1990-2#1)(1991-6#1)(1991-8#1)(2008-10#2)(2008-3#2)(2008-9#1)
cases likely to##2##3##(1997-1#1)(2012-2#1)
cases may##2##2##(1996-11#1)(2008-11#1)
cases not##2##2##(1990-6#1)(1995-12#1)
cases occurred among##2##3##(1991-12#2)
cases occurred##3##2##(1991-12#2)(2012-12#1)
cases occurring##2##2##(1992-9#1)(2008-11#1)
cases of AIDS are##2##4##(1992-9#1)(1996-11#1)
cases of AIDS##4##3##(1992-9#1)(1996-11#1)(1997-6#2)
cases of HCC##2##3##(1993-2#1)(2008-11#1)
cases of HIV infection are##2##5##(1995-12#1)(1996-11#1)
cases of HIV##4##3##(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)
cases of HIV-1##2##3##(1992-9#1)(2008-5#1)
cases of SHLI##2##3##(2011-2#2)
cases of T1##2##3##(1990-6#1)(1991-6#1)
cases of a##2##3##(1994-2#1)(2008-7#1)
cases of acute##7##3##(1990-9#1)(2007-8#1)(2008-12#2)(2009-4#1)(2011-2#1)(2012-12#1)
cases of adrenal##2##3##(1993-3#2)
cases of breast##2##3##(1994-12#1)(2012-3#1)
cases of cerebral##2##3##(2008-7#1)(2009-9#1)
cases of chronic##2##3##(1993-6#1)(2012-12#1)
cases of cutaneous##2##3##(2008-11#1)(2010-6#1)
cases of deep##2##3##(2008-5#1)(2011-2#1)
cases of diffuse##2##3##(1991-12#1)(2008-3#1)
cases of ectopic##2##3##(2008-10#1)(2011-2#1)
cases of foetal##2##3##(1991-9#2)
cases of gastric##3##3##(1992-12#1)(1992-5#1)(1994-12#1)
cases of inflammatory##2##3##(1992-9#1)(1997-3#1)
cases of influenza##2##3##(2011-2#1)(2012-3#1)
cases of interstitial##2##3##(1996-12#1)(2012-12#1)
cases of invasive##2##3##(1994-2#2)
cases of large##3##3##(1991-6#1)(1994-2#1)(2008-7#1)
cases of linear alopecia##2##4##(2010-6#2)
cases of locally advanced breast cancer##2##6##(1991-8#2)
cases of malignant mesothelioma##2##4##(1991-12#2)
cases of malignant##6##3##(1991-12#2)(1993-6#1)(1995-12#1)(1997-5#1)(2012-3#1)
cases of nose plastic surgery##2##5##(1990-9#2)
cases of patients with##3##4##(1997-8#1)(2011-2#2)
cases of patients##4##3##(1997-8#1)(2011-2#2)(2013-1#1)
cases of petrous apex cholesteatoma presenting with double vision##2##9##(2011-2#2)
cases of petrous apex cholesteatoma##3##5##(2011-2#3)
cases of poisoning##2##3##(1990-9#1)(2008-12#1)
cases of primary##5##3##(1991-11#1)(2008-7#1)(2013-1#2)(2013-7#1)
cases of secondary##3##3##(1991-11#1)(1991-3#1)(2012-2#1)
cases of single##2##3##(1992-12#1)(2008-12#1)
cases of spontaneous##2##3##(1992-2#1)(2008-7#1)
cases of successful##2##3##(2008-10#1)(2011-3#1)
cases of such##2##3##(1997-8#1)(2011-2#1)
cases of surgically##2##3##(2008-7#1)(2012-2#1)
cases of suspected##2##3##(1990-6#1)(2011-1#1)
cases of the##5##3##(1997-8#1)(2008-10#2)(2013-8#2)
cases of this##2##3##(1996-9#1)(2008-10#1)
cases of trisomy##4##3##(2012-3#4)
cases of venous##2##3##(1990-3#1)(1996-11#1)
cases of##374##2##(1990-12#2)(1990-3#4)(1990-5#3)(1990-6#4)(1990-9#7)(1991-11#9)(1991-12#5)(1991-2#1)(1991-3#3)(1991-6#6)(1991-8#8)(1991-9#3)(1992-12#2)(1992-2#3)(1992-5#2)(1992-6#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-12#7)(1994-2#5)(1994-3#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#4)(1996-12#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-3#5)(1997-5#1)(1997-6#3)(1997-8#11)(2007-12#3)(2007-8#4)(2008-1#1)(2008-10#25)(2008-11#9)(2008-12#12)(2008-3#1)(2008-4#4)(2008-5#13)(2008-7#26)(2008-8#4)(2008-9#5)(2009-1#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#8)(2010-7#2)(2011-1#5)(2011-2#36)(2011-3#2)(2012-12#5)(2012-2#6)(2012-3#16)(2013-1#22)(2013-7#1)(2013-8#6)
cases only##3##2##(1991-11#1)(1996-5#1)(2011-2#1)
cases per year##4##3##(1992-2#1)(1992-9#1)(1996-11#1)(2010-8#1)
cases per##7##2##(1990-9#1)(1992-2#1)(1992-9#1)(1996-11#1)(1996-8#1)(1997-5#1)(2010-8#1)
cases provide##3##2##(1990-8#1)(2011-3#1)(2012-3#1)
cases published##2##2##(2009-3#1)(2011-2#1)
cases qualify##2##2##(1992-12#1)(2008-1#1)
cases received##2##2##(1991-9#1)(2008-12#1)
cases recorded##3##2##(1995-12#1)(1995-2#1)(2008-10#1)
cases registered in##2##3##(1992-5#1)(2013-8#1)
cases registered##3##2##(1991-2#1)(1992-5#1)(2013-8#1)
cases reported in the##3##4##(1997-8#1)(2011-2#1)(2013-8#1)
cases reported##6##2##(1994-9#1)(1996-1#1)(1997-8#1)(2011-2#2)(2013-8#1)
cases required##2##2##(1992-9#1)(2012-3#1)
cases showed##4##2##(1991-10#1)(2008-10#1)(2008-11#1)(2013-1#1)
cases studied##3##2##(1990-12#1)(1990-6#1)(1993-2#1)
cases suggest that##2##3##(1994-6#1)(2013-8#1)
cases than in##2##3##(1990-8#1)(2013-1#1)
cases than the##2##3##(1997-8#1)(2008-10#1)
cases than##8##2##(1990-8#2)(1993-12#2)(1997-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
cases that had##3##3##(2011-1#2)(2013-8#1)
cases that have##2##3##(1997-3#1)(2008-9#1)
cases that the##2##3##(1997-2#1)(1997-3#1)
cases that##18##2##(1993-12#1)(1995-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-1#1)(2008-12#1)(2008-6#2)(2008-9#1)(2009-1#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
cases the##41##2##(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-8#1)(1994-3#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)
cases there##2##2##(1992-5#1)(2007-11#1)
cases to##7##2##(1991-12#1)(2008-10#3)(2010-7#1)(2011-2#1)(2012-2#1)
cases treated##2##2##(2008-7#1)(2008-9#1)
cases two##2##2##(2008-10#2)
cases was##11##2##(1990-12#1)(1991-2#1)(1991-8#1)(1993-2#1)(1996-1#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-12#1)
cases we##2##2##(1996-3#1)(2013-1#1)
cases were also##2##3##(2009-8#1)(2012-12#1)
cases were examined##2##3##(1997-8#2)
cases were found##4##3##(1991-12#1)(1992-12#1)(2008-7#2)
cases were identified##3##3##(1996-11#1)(2008-7#1)(2013-8#1)
cases were managed##2##3##(2013-1#2)
cases were registered##2##3##(1991-11#1)(1991-6#1)
cases were reported in##2##4##(1996-8#1)(1997-3#1)
cases were reported##6##3##(1995-12#1)(1996-8#2)(1997-3#1)(1997-8#1)(2011-2#1)
cases were studied##3##3##(2011-2#2)(2012-12#1)
cases were treated##2##3##(1996-3#1)(2008-12#1)
cases were##62##2##(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#6)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#11)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#3)
cases when##6##2##(2008-10#2)(2008-5#1)(2008-9#2)(2012-3#1)
cases where only##2##3##(2008-12#1)(2008-8#1)
cases where the##6##3##(1990-9#1)(1993-1#1)(1996-11#1)(2008-10#2)(2008-9#1)
cases where there##3##3##(1996-5#1)(2008-11#1)(2011-2#1)
cases where##27##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-11#2)(1996-5#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
cases which##2##2##(1991-6#1)(2013-1#1)
cases with a##5##3##(1993-8#1)(1997-1#1)(2008-10#2)(2010-12#1)
cases with and without##3##4##(1995-2#1)(2008-2#1)(2012-2#1)
cases with and##4##3##(1990-8#1)(1995-2#1)(2008-2#1)(2012-2#1)
cases with eight variables for##2##5##(2008-10#2)
cases with the##3##3##(1992-9#1)(1997-8#1)(2012-3#1)
cases with##67##2##(1990-11#1)(1990-12#2)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#4)(1991-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-8#1)(1994-12#2)(1995-11#1)(1995-2#1)(1997-1#1)(1997-3#2)(1997-8#4)(2008-10#7)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-3#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#10)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
cases within##3##2##(1993-1#1)(1994-9#1)(2008-7#1)
cases without##5##2##(1993-3#1)(1995-11#1)(1995-3#1)(1997-8#1)(2013-1#1)
cases##1881##1##(1990-11#2)(1990-12#18)(1990-2#12)(1990-3#8)(1990-5#6)(1990-6#19)(1990-8#16)(1990-9#23)(1991-1#13)(1991-10#2)(1991-11#28)(1991-12#23)(1991-2#18)(1991-3#10)(1991-6#17)(1991-7#1)(1991-8#27)(1991-9#6)(1992-12#20)(1992-2#5)(1992-5#12)(1992-6#1)(1992-9#21)(1993-1#19)(1993-11#4)(1993-12#13)(1993-2#10)(1993-3#5)(1993-6#6)(1993-8#5)(1993-9#3)(1994-1#3)(1994-12#15)(1994-2#9)(1994-3#9)(1994-6#3)(1994-9#12)(1995-1#2)(1995-10#1)(1995-11#10)(1995-12#21)(1995-2#9)(1995-3#7)(1995-5#6)(1995-6#3)(1995-9#1)(1996-1#3)(1996-11#23)(1996-12#6)(1996-3#16)(1996-5#8)(1996-6#6)(1996-8#4)(1996-9#4)(1997-1#6)(1997-2#7)(1997-3#34)(1997-4#6)(1997-5#3)(1997-6#13)(1997-8#38)(2006-6#2)(2007-11#10)(2007-12#4)(2007-8#16)(2008-1#12)(2008-10#244)(2008-11#64)(2008-12#39)(2008-2#3)(2008-3#14)(2008-4#6)(2008-5#52)(2008-6#5)(2008-7#107)(2008-8#25)(2008-9#32)(2009-1#7)(2009-10#9)(2009-12#3)(2009-3#9)(2009-4#8)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#16)(2009-9#2)(2010-1#5)(2010-10#2)(2010-11#5)(2010-12#14)(2010-2#5)(2010-3#8)(2010-5#4)(2010-6#17)(2010-7#10)(2010-8#5)(2010-9#1)(2011-1#16)(2011-2#156)(2011-3#8)(2012-12#28)(2012-2#26)(2012-3#56)(2012-4#1)(2013-1#111)(2013-7#1)(2013-8#43)
cases) and##8##2##(1990-12#1)(1990-6#1)(1991-2#1)(1994-1#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
cases) of##2##2##(1991-12#1)(2010-7#1)
cases) or##2##2##(1994-2#1)(2008-11#1)
cases) were##4##2##(1990-2#1)(1993-12#1)(1996-6#1)(2008-5#1)
cases)##55##1##(1990-12#3)(1990-2#1)(1990-6#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1992-5#1)(1992-9#2)(1993-12#1)(1994-1#2)(1994-2#2)(1994-8#3)(1996-6#4)(1997-4#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#5)(2008-7#4)(2010-7#1)(2011-2#2)(2012-3#2)
cases]##33##1##(1990-2#2)(1990-3#2)(1990-9#1)(1991-11#3)(1991-3#1)(1991-6#1)(1992-5#3)(1993-3#1)(1993-6#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-5#1)(2007-8#2)(2008-11#1)(2009-1#4)(2009-5#4)(2011-2#1)(2013-1#2)
casework##9##1##(1995-11#1)(2008-10#2)(2008-12#6)
cash flow##6##2##(1991-9#1)(1993-12#2)(1996-2#2)(2008-11#1)
cash##9##1##(1991-9#1)(1992-8#1)(1993-12#2)(1993-3#1)(1996-2#2)(2008-10#1)(2008-11#1)
casks##2##1##(2008-10#2)
casokefamide##2##1##(1993-3#2)
caspase activation##5##2##(2008-11#4)(2008-9#1)
caspase activities##2##2##(2008-11#2)
caspase##14##1##(2008-11#9)(2008-9#1)(2011-2#2)(2012-2#2)
caspase-3 in##2##2##(2008-9#2)
caspase-3##10##1##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#3)(2011-2#1)(2011-3#2)(2013-7#1)
caspase-8##2##1##(2011-2#1)(2012-2#1)
caspase-dependent##2##1##(2008-10#1)(2011-2#1)
caspases##12##1##(2008-11#7)(2008-4#3)(2008-7#1)(2008-9#1)
cassava (Manihot esculenta)##2##3##(2008-10#2)
cassava genotypes##2##2##(2008-10#2)
cassava root rot##3##3##(2008-10#3)
cassava##15##1##(2008-10#15)
cassette into the##2##3##(1997-3#1)(2008-8#1)
cassette mutagenesis##2##2##(1994-5#1)(2008-8#1)
cassette was##3##2##(1993-9#1)(2008-11#1)(2013-1#1)
cassette##21##1##(1993-9#3)(1994-5#1)(1996-6#2)(1997-3#1)(2008-10#1)(2008-11#7)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
cassettes##4##1##(2008-11#3)(2008-9#1)
cassini##2##1##(2008-9#2)
cast in##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
cast iron##7##2##(2008-10#7)
cast membranes##5##2##(2008-11#5)
cast on##2##2##(2008-10#1)(2008-11#1)
cast##44##1##(1994-12#1)(1997-2#1)(2008-10#19)(2008-11#12)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
castaneum##6##1##(2008-12#3)(2008-9#1)(2012-2#2)
castanospermine##3##1##(1993-8#3)
castanospermine-treated cells##2##2##(1993-8#2)
caste determination##2##2##(2008-8#1)(2010-1#1)
caste##5##1##(2008-8#1)(2010-1#1)(2011-2#3)
castes##6##1##(2008-8#5)(2012-2#1)
casting a##3##2##(2008-10#1)(2008-5#2)
casting and LB methods##2##4##(2008-11#2)
casting and##3##2##(2008-11#2)(2008-9#1)
casting of##2##2##(2008-10#2)
casting##22##1##(2008-10#6)(2008-11#5)(2008-5#2)(2008-7#1)(2008-9#6)(2013-1#2)
castings##2##1##(2009-7#2)
castor##2##1##(2008-10#1)(2013-8#1)
castrated male##2##2##(2008-9#1)(2012-3#1)
castrated males##3##2##(1993-8#1)(1994-2#1)(1995-2#1)
castrated rat cells##2##3##(1996-2#2)
castrated rat##3##2##(1996-2#3)
castrated##13##1##(1990-11#1)(1993-8#1)(1994-2#2)(1995-2#1)(1996-2#3)(2008-10#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
castration and##2##2##(1994-2#2)
castration##9##1##(1991-5#1)(1993-8#1)(1994-2#4)(1995-2#2)(2009-10#1)
casts and##3##2##(2008-11#1)(2011-2#2)
casts##8##1##(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#3)(2013-8#1)
casual##12##1##(1991-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2011-2#1)(2012-2#1)(2012-3#1)
casualties##2##1##(1997-6#1)(2013-1#1)
cat dorsal##2##2##(1991-2#1)(2008-8#1)
cat with##2##2##(2012-3#2)
cat##31##1##(1990-11#1)(1990-5#4)(1990-6#1)(1991-10#3)(1991-2#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-12#1)(1995-1#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-8#6)(2008-9#2)(2012-3#3)(2013-1#1)
cat-86##6##1##(1991-9#6)
cat-scratch disease##4##2##(1991-4#4)
cat-scratch##5##1##(1991-4#5)
catabolic and##2##2##(2008-10#1)(2011-1#1)
catabolic##6##1##(2008-10#2)(2008-11#2)(2011-1#1)(2012-2#1)
catabolism of HDL apoA-I##2##4##(2008-6#2)
catabolism of hyaluronan##2##3##(2011-1#2)
catabolism of##12##2##(1990-2#1)(1991-9#1)(1994-8#1)(2008-11#1)(2008-6#5)(2011-1#3)
catabolism##19##1##(1990-2#2)(1991-9#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#5)(2008-8#1)(2011-1#4)(2011-2#1)
catabolite repression##6##2##(1993-12#1)(2008-10#5)
catabolized##2##1##(2008-10#1)(2008-4#1)
catacombs##2##1##(2008-10#1)(2011-2#1)
catalase activity##3##2##(2008-10#1)(2008-7#2)
catalase and reduced glutathione##2##4##(2012-2#2)
catalase and##5##2##(1995-8#1)(2008-10#2)(2012-2#2)
catalase catalyzes the degradation of##2##5##(2008-10#2)
catalase enzyme##3##2##(2008-10#3)
catalase was##2##2##(2008-10#2)
catalase##43##1##(1990-3#5)(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-6#5)(1995-8#4)(1997-7#2)(2008-10#16)(2008-7#3)(2012-2#2)(2013-1#1)
catalog of##3##2##(2008-9#3)
catalog##5##1##(2008-9#5)
catalogs##2##1##(1994-3#1)(2008-9#1)
catalogues##2##1##(1997-2#1)(2008-11#1)
catalyse the##3##2##(1997-7#1)(2008-10#2)
catalyse##5##1##(1997-7#1)(2008-10#3)(2011-1#1)
catalysed by the##4##3##(1997-1#1)(2008-10#2)(2011-1#1)
catalysed by##12##2##(1991-2#1)(1997-1#1)(2008-10#8)(2008-5#1)(2011-1#1)
catalysed##16##1##(1991-2#1)(1994-8#1)(1997-1#1)(2008-10#11)(2008-5#1)(2011-1#1)
catalyses the oxidation of##5##4##(2008-10#5)
catalyses the##9##2##(1993-8#1)(1996-2#1)(2008-10#6)(2008-11#1)
catalyses##12##1##(1990-5#1)(1993-8#1)(1995-12#1)(1996-2#1)(2008-10#6)(2008-11#1)(2011-1#1)
catalysis and##4##2##(1991-5#1)(1994-11#1)(1994-3#1)(1995-6#1)
catalysis of the periodate oxidation of##2##6##(2008-10#2)
catalysis of the##5##3##(1993-8#1)(1995-6#1)(2008-10#3)
catalysis of##10##2##(1993-8#1)(1995-6#1)(2008-10#7)(2008-8#1)
catalysis on the##3##3##(2008-10#3)
catalysis to##2##2##(1994-11#1)(2009-10#1)
catalysis using##2##2##(2008-10#1)(2012-2#1)
catalysis with a##2##3##(1991-5#1)(2008-10#1)
catalysis##49##1##(1990-12#1)(1991-5#3)(1991-7#1)(1993-8#5)(1994-11#2)(1994-3#1)(1995-2#1)(1995-6#4)(1997-8#2)(2008-10#19)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
catalyst and is##2##3##(2008-10#2)
catalyst and##9##2##(2008-10#8)(2008-12#1)
catalyst based on##2##3##(2008-11#1)(2010-8#1)
catalyst for the hydrolysis##2##4##(1993-8#1)(2008-10#1)
catalyst for the##6##3##(1993-8#1)(2008-10#5)
catalyst for##11##2##(1991-2#1)(1993-8#1)(1995-2#1)(2008-10#7)(2008-6#1)
catalyst has been##2##3##(2008-10#2)
catalyst in the##4##3##(1993-8#2)(2008-10#2)
catalyst in##6##2##(1993-8#2)(2008-10#3)(2011-2#1)
catalyst is##3##2##(2008-10#3)
catalyst with##2##2##(1996-5#1)(2008-10#1)
catalyst##79##1##(1991-2#1)(1993-8#3)(1995-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(2008-10#53)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-8#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
catalysts and##3##2##(2008-10#2)(2010-7#1)
catalysts are##3##2##(2008-10#1)(2008-11#2)
catalysts for##3##2##(2008-10#2)(2009-10#1)
catalysts to##3##2##(2008-10#1)(2008-11#1)(2009-9#1)
catalysts were##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
catalysts with##2##2##(2008-10#2)
catalysts##43##1##(1994-12#1)(1996-3#1)(1996-5#1)(2008-10#25)(2008-11#8)(2008-12#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-2#1)
catalytic Zn(II)##3##2##(1992-3#3)
catalytic action of##3##3##(2008-10#3)
catalytic action##6##2##(2008-10#6)
catalytic activities##5##2##(1993-2#1)(1993-8#1)(1994-5#1)(1997-3#2)
catalytic activity for the##2##4##(2008-10#1)(2008-12#1)
catalytic activity for##3##3##(2008-10#2)(2008-12#1)
catalytic activity in##2##3##(1993-8#1)(2008-10#1)
catalytic activity of Fe(III)-HNT##2##4##(2008-10#2)
catalytic activity of the##4##4##(2008-10#3)(2009-3#1)
catalytic activity of##19##3##(1990-8#1)(1997-8#1)(2008-10#14)(2009-3#2)(2012-2#1)
catalytic activity toward##2##3##(2008-10#2)
catalytic activity##46##2##(1990-8#1)(1991-7#1)(1992-6#1)(1993-8#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#2)(2012-2#1)
catalytic adsorptive stripping voltammetry (CAdSV)##2##5##(2008-10#2)
catalytic adsorptive stripping voltammetry##5##4##(2008-10#5)
catalytic adsorptive stripping##6##3##(2008-10#6)
catalytic adsorptive##8##2##(2008-10#8)
catalytic and##4##2##(1997-1#1)(2008-10#1)(2010-11#1)(2012-2#1)
catalytic antibodies##3##2##(1995-2#2)(2008-10#1)
catalytic chemiluminescent##2##2##(2008-10#2)
catalytic combustion##3##2##(2008-10#3)
catalytic converters##5##2##(2008-10#3)(2008-11#2)
catalytic current and##3##3##(2008-10#3)
catalytic current##9##2##(2008-10#9)
catalytic domain of##4##3##(1991-10#1)(1992-11#2)(2009-7#1)
catalytic domain##9##2##(1991-10#1)(1992-11#2)(1993-12#1)(1994-11#1)(1995-8#1)(1997-3#1)(2008-9#1)(2009-7#1)
catalytic domains##6##2##(1992-3#1)(1992-7#1)(1993-2#1)(1996-2#1)(1997-8#1)(2009-6#1)
catalytic effect of##19##3##(2008-10#19)
catalytic effect on the oxidation reaction of##2##7##(2008-10#2)
catalytic effect on the oxidation##8##5##(2008-10#8)
catalytic effect on the oxidative coupling of##2##7##(2008-10#2)
catalytic effect on the##13##4##(2008-10#13)
catalytic effect on##14##3##(2008-10#14)
catalytic effect##34##2##(2008-10#34)
catalytic effects on the##2##4##(2008-10#2)
catalytic effects##3##2##(2008-10#3)
catalytic efficiency##4##2##(1994-5#2)(2008-11#1)(2009-3#1)
catalytic function##6##2##(1990-5#1)(1992-6#3)(1996-2#1)(2008-9#1)
catalytic indicator##2##2##(2008-10#2)
catalytic kinetic spectrofluorimetric method##2##4##(2008-10#2)
catalytic kinetic spectrophotometric method##2##4##(2008-10#2)
catalytic kinetic##7##2##(2008-10#7)
catalytic mechanism##3##2##(1992-7#1)(1995-2#1)(1995-6#1)
catalytic mechanisms##2##2##(1993-8#1)(2008-4#1)
catalytic peaks on##2##3##(2008-10#2)
catalytic photometric##2##2##(2008-10#2)
catalytic process##2##2##(1994-5#1)(2008-10#1)
catalytic properties of##3##3##(1994-11#1)(2008-10#1)(2009-10#1)
catalytic properties##8##2##(1993-8#1)(1994-11#1)(1996-2#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-7#1)
catalytic rate constant##6##3##(1994-5#1)(2008-10#5)
catalytic rate##7##2##(1994-5#1)(2008-10#6)
catalytic reaction is##3##3##(2008-10#3)
catalytic reaction was##2##3##(2008-10#2)
catalytic reaction##11##2##(2008-10#11)
catalytic reduction##3##2##(2008-10#3)
catalytic sites##5##2##(1992-4#2)(1993-2#1)(1994-5#2)
catalytic spectrophotometric determination of##2##4##(2008-10#2)
catalytic spectrophotometric##6##2##(2008-10#6)
catalytic subunit (DNA-PKcs)##2##3##(1996-2#1)(2013-1#1)
catalytic subunit and##2##3##(1995-2#1)(2010-12#1)
catalytic subunit##21##2##(1992-9#7)(1994-5#1)(1995-11#2)(1995-2#4)(1995-6#1)(1995-8#1)(1996-2#2)(2008-11#1)(2010-12#1)(2013-1#1)
catalytic subunits of##2##3##(1992-6#2)
catalytic subunits##3##2##(1992-6#2)(1996-2#1)
catalytic surface for the##2##4##(2008-10#2)
catalytic surface##3##2##(2008-10#3)
catalytic triad of##2##3##(1992-3#1)(1995-2#1)
catalytic triad##3##2##(1992-3#2)(1995-2#1)
catalytic turnover##2##2##(2008-10#1)(2012-2#1)
catalytic##337##1##(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-3#8)(1992-4#3)(1992-6#7)(1992-7#2)(1992-9#7)(1993-12#1)(1993-2#4)(1993-8#7)(1993-9#2)(1994-11#2)(1994-5#11)(1995-11#2)(1995-2#10)(1995-3#1)(1995-6#9)(1995-8#2)(1996-12#1)(1996-2#9)(1996-5#2)(1997-1#1)(1997-3#3)(1997-7#1)(1997-8#2)(2008-10#187)(2008-11#11)(2008-12#2)(2008-4#4)(2008-5#1)(2008-9#3)(2009-10#1)(2009-3#3)(2009-6#1)(2009-7#4)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
catalytical##2##1##(2008-10#2)
catalytically active##5##2##(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)
catalytically reduced by##2##3##(2008-10#2)
catalytically##13##1##(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-11#1)
catalyze the##15##2##(1992-3#1)(1993-8#1)(2008-10#8)(2009-12#1)(2009-6#1)(2009-7#1)(2012-2#2)
catalyze##27##1##(1991-10#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2012-2#2)
catalyzed a##2##2##(1997-8#1)(2008-10#1)
catalyzed by a##4##3##(1990-10#1)(1993-12#1)(2010-3#1)(2012-2#1)
catalyzed by the##2##3##(1990-11#1)(2013-1#1)
catalyzed by##38##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-5#3)(1994-8#1)(1995-6#2)(2008-10#14)(2008-7#4)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#2)
catalyzed oxidation of##2##3##(2008-10#2)
catalyzed reaction##3##2##(2008-10#3)
catalyzed the formation of##2##4##(1991-9#1)(2008-10#1)
catalyzed the oxidation of##2##4##(2008-10#2)
catalyzed the##10##2##(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-5#1)(1997-8#1)(2008-10#4)
catalyzed##66##1##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-5#4)(1994-8#1)(1995-6#2)(1997-2#1)(1997-8#2)(2008-10#30)(2008-11#1)(2008-7#4)(2009-9#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-2#2)(2013-1#2)
catalyzes a##2##2##(1992-9#1)(1994-11#1)
catalyzes the conversion of##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
catalyzes the first step in##2##5##(1990-7#1)(1997-1#1)
catalyzes the oxidation##2##3##(2008-10#2)
catalyzes the##18##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-2#1)
catalyzes##28##1##(1990-11#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-8#2)(2008-10#7)(2008-11#1)(2008-8#2)(2009-7#1)(2011-2#1)
catalyzing the##8##2##(1992-10#1)(1992-6#2)(1994-11#1)(2008-10#1)(2008-7#2)(2008-9#1)
catalyzing##12##1##(1992-10#1)(1992-6#2)(1994-11#1)(2008-10#1)(2008-7#2)(2008-9#3)(2009-7#1)(2013-8#1)
catamenial##2##1##(1991-3#1)(2008-7#1)
cataract and##4##2##(2010-8#3)(2011-2#1)
cataract extractions##2##2##(1991-9#1)(1994-12#1)
cataract in a cynomolgus monkey##2##5##(2012-2#2)
cataract in##3##2##(2010-8#1)(2012-2#2)
cataract surgery##3##2##(1991-1#1)(1991-2#1)(2011-2#1)
cataract##23##1##(1991-1#1)(1991-2#1)(1991-9#1)(1992-9#1)(1994-12#1)(2009-1#1)(2010-8#7)(2011-2#6)(2012-2#3)(2013-1#1)
cataracts##3##1##(1991-9#1)(1992-2#1)(2011-2#1)
catarrhal##3##1##(1990-6#1)(2008-5#2)
catastrophe emissions##2##2##(2008-10#2)
catastrophe##3##1##(2008-10#2)(2008-11#1)
catastrophic haemorrhage##2##2##(1997-6#1)(2013-1#1)
catastrophic##10##1##(1993-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#2)
catch##9##1##(1991-9#1)(1992-8#1)(1995-1#1)(1995-3#1)(2008-10#2)(2008-7#2)(2008-8#1)
catch-up##3##1##(2008-11#1)(2013-1#2)
catching##3##1##(1990-6#1)(2008-7#1)(2010-7#1)
catchment##3##1##(1990-2#1)(2008-10#1)(2010-6#1)
catechin and catechol##2##3##(2011-1#2)
catechin and##4##2##(2008-10#2)(2011-1#2)
catechin or epicatechin##2##3##(1993-8#2)
catechin##10##1##(1993-8#4)(2008-10#2)(2008-11#1)(2009-8#1)(2011-1#2)
catechins and##2##2##(2008-10#1)(2009-8#1)
catechins in##3##2##(2008-10#3)
catechins was##2##2##(2008-10#1)(2008-11#1)
catechins##19##1##(2008-10#13)(2008-11#5)(2009-8#1)
catechol and pyrogallol##2##3##(2008-10#2)
catechol and##5##2##(2008-10#5)
catechol as##2##2##(2008-10#2)
catechol derivatives in##2##3##(2008-10#2)
catechol derivatives##6##2##(2008-10#6)
catechol has been##2##3##(2008-10#2)
catechol siderophore##4##2##(2008-10#4)
catechol to##2##2##(2008-10#2)
catechol was##3##2##(2008-10#3)
catechol were##2##2##(2008-10#2)
catechol within##2##2##(2008-10#2)
catechol##55##1##(2008-10#51)(2008-11#2)(2011-1#2)
catecholamine derivatives##2##2##(2008-10#2)
catecholamine secretion##2##2##(1994-5#1)(1995-11#1)
catecholamine##13##1##(1992-6#2)(1994-5#1)(1995-11#1)(1997-2#1)(2008-10#4)(2008-7#1)(2011-2#1)(2013-1#2)
catecholaminergic nerve##2##2##(1990-5#1)(2008-7#1)
catecholaminergic##9##1##(1990-5#1)(1994-2#3)(1995-12#1)(1996-5#1)(1997-2#2)(2008-7#1)
catecholamines and##8##2##(1991-1#1)(1994-3#2)(1995-11#1)(2008-10#4)
catecholamines in pharmaceutical preparations##2##4##(2008-10#2)
catecholamines in##9##2##(1997-2#2)(2008-10#6)(2008-7#1)
catecholamines##31##1##(1991-1#1)(1994-3#2)(1995-11#1)(1997-2#3)(1997-3#1)(2008-10#19)(2008-7#2)(2009-8#1)(2011-2#1)
catechols##4##1##(2008-10#4)
catechu L extract##3##3##(2008-5#3)
catechu L##5##2##(2008-5#5)
catechu##11##1##(2008-5#11)
categorical scale and##2##3##(2008-10#2)
categorical scale was used##2##4##(1997-8#2)
categorical scale##4##2##(1997-8#2)(2008-10#2)
categorical##13##1##(1995-12#1)(1997-8#2)(2008-10#3)(2008-11#2)(2008-7#1)(2009-4#1)(2013-1#2)(2013-8#1)
categories and##9##2##(1993-12#1)(2008-11#4)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
categories emerged from the##2##4##(2008-11#1)(2013-1#1)
categories emerged##4##2##(2008-11#2)(2013-1#2)
categories for##2##2##(2010-11#2)
categories in##5##2##(2008-10#1)(2008-2#2)(2008-5#1)(2012-2#1)
categories of host plants##2##4##(2008-10#2)
categories of host##3##3##(2008-10#3)
categories of the##4##3##(1994-12#2)(2008-11#2)
categories of##36##2##(1990-5#1)(1990-9#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-8#1)(1997-3#2)(2008-10#5)(2008-11#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
categories on##2##2##(1990-12#1)(1997-8#1)
categories significantly associated with repeat prescriptions were##2##7##(2008-11#2)
categories that##6##2##(1997-1#1)(2008-11#2)(2008-12#1)(2010-1#2)
categories to##2##2##(1997-1#1)(2012-2#1)
categories was##2##2##(2008-2#1)(2012-2#1)
categories were##4##2##(1991-12#1)(2008-10#2)(2013-1#1)
categories##158##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#4)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#4)(1994-1#1)(1994-12#5)(1994-3#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-8#1)(1997-1#3)(1997-3#2)(1997-8#1)(2008-10#23)(2008-11#23)(2008-12#6)(2008-2#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-1#6)(2010-10#1)(2010-11#2)(2010-12#3)(2010-8#1)(2011-1#2)(2011-2#18)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#5)(2013-8#2)
categorise##2##1##(2008-11#1)(2010-11#1)
categorised into##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
categorised##5##1##(1997-3#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-2#1)
categorization of the##2##3##(2008-10#1)(2008-11#1)
categorization of##8##2##(2008-10#1)(2008-11#3)(2008-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
categorization##22##1##(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#8)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-8#3)
categorize the##2##2##(2008-11#1)(2009-6#1)
categorize##6##1##(1995-2#2)(2008-11#1)(2008-8#1)(2009-6#1)(2012-3#1)
categorized as a##2##3##(2008-10#1)(2008-5#1)
categorized as either##2##3##(2013-1#2)
categorized as##13##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-11#1)(2013-1#3)
categorized based on##2##3##(2013-1#2)
categorized by thematic##2##3##(2010-10#1)(2012-3#1)
categorized by##4##2##(2008-1#1)(2010-10#1)(2012-3#1)(2013-3#1)
categorized into two##2##3##(1995-12#1)(2008-10#1)
categorized into##5##2##(1995-12#1)(2008-10#2)(2008-4#1)(2010-5#1)
categorized the##2##2##(2008-10#1)(2008-5#1)
categorized##34##1##(1991-11#1)(1995-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-3#1)
categorizes##2##1##(1995-2#1)(2012-2#1)
categorizing##2##1##(1992-9#1)(2008-8#1)
category and##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
category are##2##2##(1996-2#1)(1997-8#1)
category of##18##2##(1990-12#1)(1991-8#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#1)
category rating scale##2##3##(2012-2#2)
category##76##1##(1990-12#2)(1991-8#1)(1992-1#1)(1993-3#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#3)(1996-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#3)(2009-10#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-8#1)(2011-2#9)(2012-2#7)(2013-1#3)(2013-8#1)
catenation##2##1##(2008-10#2)
catering##2##1##(1997-7#1)(2007-12#1)
caterpillars##2##1##(1990-11#2)
catfish muscle##2##2##(2008-10#2)
catfish##3##1##(2008-10#3)
catgut##3##1##(1991-1#2)(2013-1#1)
cath lab##2##2##(2009-5#1)(2011-2#1)
cathepsin A##2##2##(2006-6#2)
cathepsin D gene##2##3##(1990-5#2)
cathepsin D##13##2##(1990-5#4)(1994-5#4)(1995-6#1)(1995-8#3)(2010-12#1)
cathepsin G and##3##3##(1993-3#1)(1994-5#2)
cathepsin G##9##2##(1993-3#1)(1994-5#4)(2008-6#1)(2008-7#3)
cathepsin L##2##2##(1995-6#2)
cathepsin##31##1##(1990-5#4)(1992-9#1)(1993-3#1)(1994-5#8)(1995-6#4)(1995-8#4)(2006-6#3)(2008-6#1)(2008-7#3)(2009-8#1)(2010-12#1)
cathepsins B and D##9##4##(1995-6#6)(1997-1#3)
catheter and##4##2##(1994-6#1)(2010-9#1)(2011-2#1)(2012-12#1)
catheter can be##2##3##(2008-11#1)(2011-2#1)
catheter drainage##3##2##(1990-11#1)(1997-8#1)(2008-10#1)
catheter has##2##2##(2008-11#1)(2011-2#1)
catheter immobilization##2##2##(2011-2#2)
catheter implantation##2##2##(2011-2#2)
catheter in the##2##3##(1997-3#1)(2013-1#1)
catheter in##4##2##(1990-8#1)(1997-3#1)(2011-2#1)(2013-1#1)
catheter insertion##5##2##(2010-6#3)(2012-12#1)(2012-2#1)
catheter is##3##2##(2008-7#1)(2011-2#2)
catheter material was##2##3##(2011-2#2)
catheter material were##2##3##(2011-2#2)
catheter material##6##2##(1996-12#1)(2011-2#5)
catheter of##2##2##(1996-3#1)(2013-1#1)
catheter on##2##2##(1993-6#1)(2008-10#1)
catheter removal##2##2##(2008-1#1)(2012-12#1)
catheter to##5##2##(1997-3#2)(2008-11#1)(2008-4#1)(2010-6#1)
catheter was introduced##2##3##(1990-2#1)(1997-6#1)
catheter was##8##2##(1990-2#1)(1997-6#1)(2008-10#1)(2008-7#2)(2011-2#3)
catheter##115##1##(1990-11#4)(1990-2#1)(1990-8#1)(1991-3#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#7)(1997-6#2)(1997-8#2)(2008-1#1)(2008-10#4)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2010-10#1)(2010-12#1)(2010-6#7)(2010-9#1)(2011-2#39)(2012-12#3)(2012-2#3)(2013-1#6)
catheter-based##2##1##(2010-6#1)(2013-1#1)
catheter-related##2##1##(2010-12#1)(2011-2#1)
catheterisation##5##1##(2008-7#2)(2010-10#2)(2012-2#1)
catheterizable channels##2##2##(2008-10#2)
catheterization##16##1##(1992-12#1)(1993-2#3)(1994-3#1)(1995-12#1)(2008-10#1)(2008-7#1)(2011-2#5)(2011-3#1)(2012-3#2)
catheterizations##6##1##(1993-2#4)(1997-3#1)(2010-6#1)
catheterized##2##1##(1995-12#1)(1997-8#1)
catheters and##3##2##(1997-6#1)(2011-2#2)
catheters are##2##2##(2009-5#1)(2011-2#1)
catheters in##2##2##(1990-11#1)(2011-2#1)
catheters##35##1##(1990-11#2)(1991-3#1)(1994-5#1)(1996-12#3)(1997-3#3)(1997-6#2)(2008-1#3)(2008-7#2)(2009-5#1)(2011-2#16)(2012-2#1)
cathodal##2##1##(1992-3#1)(2008-10#1)
cathode material##3##2##(2008-10#3)
cathode##17##1##(2008-10#16)(2008-11#1)
cathodic ECL##2##2##(2008-10#2)
cathodic adsorptive stripping voltammetry##2##4##(2008-10#2)
cathodic adsorptive stripping##5##3##(2008-10#5)
cathodic adsorptive##6##2##(2008-10#6)
cathodic and anodic##2##3##(2008-10#2)
cathodic differential pulse##2##3##(2008-10#2)
cathodic electrolyte##3##2##(2008-10#3)
cathodic peak at##3##3##(2008-10#3)
cathodic peak current##3##3##(2008-10#2)(2010-6#1)
cathodic peak was##2##3##(2008-10#2)
cathodic peak##11##2##(2008-10#10)(2010-6#1)
cathodic reduction##2##2##(2008-10#2)
cathodic scan##3##2##(2008-10#3)
cathodic stripping square-wave voltammetry##2##4##(2008-10#2)
cathodic stripping voltammetric##7##3##(2008-10#7)
cathodic stripping voltammetry (CSV)##2##4##(2008-10#2)
cathodic stripping voltammetry of##2##4##(2008-10#2)
cathodic stripping voltammetry using##3##4##(2008-10#3)
cathodic stripping voltammetry##28##3##(2008-10#28)
cathodic stripping##48##2##(2008-10#48)
cathodic##92##1##(2008-10#91)(2010-6#1)
cation and anion##2##3##(2008-10#1)(2008-7#1)
cation and##7##2##(1991-7#1)(1996-5#1)(2008-10#4)(2008-7#1)
cation complexes##2##2##(2008-10#2)
cation exchange chromatography##4##3##(2008-10#3)(2009-3#1)
cation exchange column##5##3##(2008-10#5)
cation exchange resin##3##3##(2008-10#3)
cation exchange##26##2##(1992-8#1)(2008-10#23)(2008-7#1)(2009-3#1)
cation exchanger##5##2##(1990-5#1)(2008-10#4)
cation in##2##2##(2008-10#1)(2008-6#1)
cation of onium salt N(1-carbaethoxypentadecyl)-trimethyl ammonium bromide##2##7##(2008-10#2)
cation of##4##2##(2008-10#4)
cation radical##2##2##(1996-5#1)(2008-10#1)
cation radii##2##2##(2008-10#2)
cation selective##2##2##(2008-10#2)
cation transport##2##2##(2008-10#1)(2008-8#1)
cation uptake##3##2##(1994-5#1)(2008-10#2)
cation with##2##2##(2008-10#2)
cation##127##1##(1990-2#4)(1990-5#1)(1991-7#2)(1991-9#1)(1992-8#1)(1994-5#1)(1996-5#2)(1997-2#1)(1997-3#1)(2008-10#103)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-3#1)(2012-2#1)
cation)##2##1##(2008-10#2)
cation-exchange resin##4##2##(2008-10#4)
cation-exchange##16##1##(2008-10#16)
cation-selective##5##1##(2008-10#4)(2009-8#1)
cationic additive and 5%##2##4##(2008-10#2)
cationic additive##4##2##(2008-10#4)
cationic amphiphiles##3##2##(2008-11#3)
cationic and anionic##2##3##(2008-10#2)
cationic and neutral##2##3##(1990-5#1)(2008-10#1)
cationic and non-ionic surfactants##2##4##(2008-10#2)
cationic and##8##2##(1990-5#1)(2008-10#7)
cationic arsenic compounds##2##3##(2008-10#2)
cationic arsenic##5##2##(2008-10#5)
cationic complex##2##2##(2008-10#2)
cationic dye##3##2##(2008-10#3)
cationic exchanger##3##2##(2008-10#3)
cationic lipid##2##2##(1995-2#2)
cationic lipid-mediated NGF gene transfection##2##5##(1996-12#2)
cationic lipid-mediated NGF##3##3##(1996-12#3)
cationic lipid-mediated##4##2##(1996-12#4)
cationic liposome##3##2##(2008-9#2)(2011-2#1)
cationic liposomes##2##2##(1994-5#2)
cationic micellar##5##2##(2008-10#5)
cationic peptide##2##2##(2008-10#1)(2008-11#1)
cationic polyelectrolyte##3##2##(2008-10#2)(2009-12#1)
cationic polymer##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
cationic polymers##4##2##(2008-5#4)
cationic porphyrin##2##2##(2008-10#2)
cationic resin##5##2##(2008-10#5)
cationic sites in##2##3##(2008-10#2)
cationic species##6##2##(2008-10#5)(2009-9#1)
cationic surfactant (cetyltrimethylammonium##2##3##(2008-10#2)
cationic surfactant##21##2##(2008-10#17)(2008-5#1)(2008-8#3)
cationic surfactants##7##2##(2008-10#6)(2008-5#1)
cationic templates##2##2##(2008-10#2)
cationic vesicle##2##2##(2008-11#2)
cationic##165##1##(1990-12#1)(1990-5#1)(1991-7#1)(1994-5#2)(1995-2#5)(1995-8#1)(1996-12#4)(1997-1#1)(2008-10#113)(2008-11#12)(2008-5#15)(2008-8#3)(2008-9#2)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)
cations (Ca##2##2##(2008-10#2)
cations (group##2##2##(2008-10#2)
cations and anions have been##2##5##(2008-10#2)
cations and anions in low##2##5##(2008-10#2)
cations and anions on the##2##5##(2008-10#2)
cations and anions on##3##4##(2008-10#3)
cations and anions were##2##4##(2008-10#2)
cations and anions##23##3##(2008-10#23)
cations and proteins##2##3##(2008-10#2)
cations and the##2##3##(2008-10#2)
cations and##36##2##(1993-6#1)(2008-10#35)
cations are##3##2##(1994-8#1)(2008-10#2)
cations as##2##2##(2008-10#2)
cations at##3##2##(2008-10#3)
cations but##3##2##(1990-5#2)(1993-6#1)
cations by##2##2##(2008-10#1)(2008-9#1)
cations can be##2##3##(2008-10#1)(2008-9#1)
cations could##2##2##(1990-5#1)(2008-10#1)
cations from##2##2##(2008-10#2)
cations have been##2##3##(2008-10#2)
cations in aqueous##2##3##(2008-10#2)
cations in the##4##3##(2008-10#3)(2011-2#1)
cations in##14##2##(2008-10#13)(2011-2#1)
cations interact##2##2##(2008-10#2)
cations into the##2##3##(2008-10#2)
cations into##3##2##(2008-10#3)
cations is##7##2##(2008-10#7)
cations like##2##2##(2008-10#2)
cations of##4##2##(2008-10#4)
cations on##3##2##(2008-10#3)
cations present in the##2##4##(2008-10#2)
cations such as##6##3##(1995-2#1)(1997-1#1)(2008-10#3)(2009-8#1)
cations using##3##2##(2008-10#3)
cations was##4##2##(2008-10#4)
cations were achieved##2##3##(2008-10#2)
cations were studied##2##3##(2008-10#1)(2008-9#1)
cations were##10##2##(2008-10#9)(2008-9#1)
cations which##2##2##(2008-10#2)
cations with##6##2##(2008-10#6)
cations##234##1##(1990-5#4)(1992-6#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-1#1)(2008-10#210)(2008-7#1)(2008-9#5)(2009-8#1)(2011-2#1)
cats (P = 0##2##4##(2013-8#2)
cats (P##3##2##(2013-8#3)
cats undergoing##2##2##(2012-3#2)
cats##37##1##(1990-11#2)(1993-1#2)(1996-11#1)(1996-2#1)(1996-6#2)(1997-2#1)(2008-4#1)(2008-8#4)(2012-3#15)(2013-8#8)
cattle and##4##2##(1991-8#1)(1992-12#1)(2010-7#1)(2011-2#1)
cattle from##3##2##(1996-12#3)
cattle herds##3##2##(2011-2#2)(2012-3#1)
cattle in##4##2##(1996-12#1)(1997-5#1)(2012-3#2)
cattle meat##3##2##(2010-4#3)
cattle tendons##6##2##(2008-5#6)
cattle to##3##2##(1990-3#1)(1996-12#1)(2011-2#1)
cattle trade routes##2##3##(2011-2#2)
cattle treated with##2##3##(1991-3#2)
cattle##73##1##(1990-3#4)(1990-6#1)(1990-9#1)(1991-3#5)(1991-8#2)(1992-12#1)(1993-2#1)(1995-9#2)(1996-12#8)(1996-3#2)(1996-6#1)(1997-5#2)(1997-7#2)(1997-9#1)(2008-10#4)(2008-5#6)(2008-8#1)(2010-1#3)(2010-10#1)(2010-4#7)(2010-7#1)(2011-2#10)(2012-3#5)(2013-1#2)
cattleya##3##1##(2008-8#3)
caucasian##2##1##(2008-5#1)(2012-3#1)
caucasoid##2##1##(1997-8#2)
caucasus##2##1##(2008-8#2)
cauda equina syndrome during third trimester of pregnancy##2##8##(2008-12#2)
cauda equina syndrome##4##3##(2008-12#3)(2012-3#1)
cauda##5##1##(2008-12#4)(2012-3#1)
caudal fin)##2##2##(2010-8#2)
caudal##20##1##(1990-3#1)(1990-5#1)(1990-9#1)(1993-3#1)(1996-5#2)(1997-3#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-9#1)(2010-8#3)(2012-3#2)(2013-8#1)
caudalis##3##1##(1990-9#1)(1997-2#1)(2008-9#1)
caudate nuclei##2##2##(2008-6#1)(2008-7#1)
caudate nucleus##5##2##(1996-12#1)(2008-10#1)(2008-7#3)
caudate putamen and##2##3##(1996-12#2)
caudate putamen##5##2##(1995-6#1)(1996-12#4)
caudate##15##1##(1991-4#1)(1995-6#1)(1996-12#5)(2008-10#1)(2008-6#1)(2008-7#6)
caudate-putamen may##2##2##(1993-6#2)
caudate-putamen##11##1##(1993-6#8)(2008-7#3)
caught##5##1##(1995-3#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-3#1)
cauliflower and##4##2##(2008-10#4)
cauliflower##32##1##(2008-10#32)
caulivora isolates##4##2##(2008-10#4)
caulivora##14##1##(2008-10#14)
causal agent has been##2##4##(2008-10#2)
causal agent has##4##3##(2008-10#4)
causal agent of Botryosphaeria panicle and shoot blight of pistachio##2##10##(2008-10#2)
causal agent of Fusarium##3##4##(2008-10#3)
causal agent of bacterial spot##2##5##(2008-10#2)
causal agent of bacterial##3##4##(2008-10#3)
causal agent of barley##2##4##(2008-10#2)
causal agent of brown rot of stone fruits##2##8##(2008-10#2)
causal agent of sudden oak death##3##6##(2008-10#3)
causal agent of tan spot of wheat##2##7##(2008-10#2)
causal agent of tan spot##4##5##(2008-10#4)
causal agent of the disease##3##5##(2008-10#3)
causal agent of this##3##4##(2008-10#3)
causal agent of white pine blister rust##2##7##(2008-10#2)
causal agent of##88##3##(1997-4#1)(2008-10#84)(2008-12#1)(2011-10#1)(2012-2#1)
causal agent##99##2##(1997-4#1)(2008-10#94)(2008-12#1)(2010-1#1)(2011-10#1)(2012-2#1)
causal agents of##7##3##(2008-10#6)(2010-5#1)
causal factor##2##2##(1995-6#1)(2007-12#1)
causal factors of##2##3##(2009-10#1)(2011-2#1)
causal interactions##2##2##(2008-11#2)
causal mechanisms##4##2##(1997-1#1)(2008-11#1)(2009-8#2)
causal modeling and##2##3##(1997-3#2)
causal modeling##3##2##(1997-3#3)
causal network##2##2##(2008-11#1)(2008-8#1)
causal networks##3##2##(2008-11#3)
causal organism##5##2##(2008-10#5)
causal relations##2##2##(2008-7#2)
causal relationship between##3##3##(1991-12#1)(1995-2#1)(2009-4#1)
causal relationship with##3##3##(2008-10#1)(2008-11#2)
causal relationship##7##2##(1991-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2009-4#1)
causal role in##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
causal role##4##2##(1990-5#1)(2008-10#1)(2011-2#2)
causal therapy##2##2##(1996-3#1)(2011-2#1)
causal##177##1##(1990-5#1)(1991-12#2)(1991-2#1)(1992-2#1)(1992-5#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-4#2)(2007-12#1)(2008-10#116)(2008-11#12)(2008-12#2)(2008-7#6)(2008-8#3)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#2)(2011-10#1)(2011-2#4)(2012-2#2)(2012-3#1)(2012-5#1)(2013-7#2)
causality##6##1##(1996-11#1)(2008-11#3)(2008-7#1)(2012-2#1)
causally associated with##2##3##(2008-10#1)(2013-1#1)
causally##6##1##(1992-9#1)(1994-6#1)(1996-11#1)(1997-1#1)(2008-10#1)(2013-1#1)
causation##3##1##(2008-7#1)(2013-1#1)(2013-7#1)
causative agent of##14##3##(1992-8#1)(2008-10#2)(2009-6#1)(2011-2#6)(2012-2#1)(2013-1#2)(2013-8#1)
causative agent##18##2##(1992-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-6#1)(2011-2#7)(2012-2#1)(2013-1#2)(2013-8#1)
causative agents of##2##3##(2008-11#1)(2008-12#1)
causative bacteria##2##2##(1991-8#1)(2006-6#1)
causative factor##3##2##(1997-4#1)(2008-10#1)(2009-9#1)
causative factors##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
causative organism##2##2##(1992-5#1)(2013-1#1)
causative role##2##2##(1995-6#1)(2008-11#1)
causative##45##1##(1991-2#1)(1991-8#1)(1992-5#2)(1992-8#1)(1995-2#1)(1995-6#1)(1997-4#1)(2006-6#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#1)
cause DNA damage##2##3##(1993-12#1)(2008-10#1)
cause DNA##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
cause a variety of##2##4##(2009-8#1)(2012-3#1)
cause a wide range of##2##5##(2009-8#1)(2011-2#1)
cause a wide variety of##2##5##(2008-6#1)(2011-1#1)
cause a wide##4##3##(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
cause a##33##2##(1990-2#1)(1991-12#1)(1991-5#1)(1994-12#2)(1995-8#1)(1996-6#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
cause alterations##3##2##(1997-6#1)(2008-12#1)(2008-5#1)
cause an##9##2##(1994-2#1)(1994-5#1)(1996-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2011-3#1)(2013-8#1)
cause and##7##2##(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#2)
cause bone##2##2##(1993-6#1)(2008-11#1)
cause both##2##2##(1996-11#1)(2013-8#1)
cause building-related##2##2##(1994-9#2)
cause cancer##2##2##(2008-11#1)(2013-1#1)
cause cell death##4##3##(2008-10#1)(2008-11#1)(2009-6#1)(2013-1#1)
cause changes in##3##3##(2006-6#1)(2008-12#1)(2008-8#1)
cause cranberry stem gall##3##4##(2008-10#3)
cause death##2##2##(2008-7#1)(2011-2#1)
cause different##3##2##(2008-10#1)(2012-2#1)(2012-7#1)
cause disease in##2##3##(2008-10#1)(2010-7#1)
cause disease on##3##3##(2008-10#3)
cause disease##8##2##(2008-10#6)(2010-7#1)(2012-2#1)
cause distress##2##2##(2008-7#1)(2011-2#1)
cause exclusion##2##2##(2008-8#1)(2008-9#1)
cause for concern##3##3##(1992-3#1)(1997-5#1)(2013-8#1)
cause for the##5##3##(1991-4#1)(2008-1#1)(2008-10#1)(2010-1#1)(2013-8#1)
cause for##25##2##(1991-4#1)(1992-3#1)(1995-12#1)(1997-3#1)(1997-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
cause harm##2##2##(1993-1#1)(2008-11#1)
cause in##5##2##(1990-6#1)(2008-10#2)(2008-12#1)(2009-3#1)
cause increased##2##2##(1997-3#1)(2008-9#1)
cause infection##5##2##(2008-10#5)
cause interference##2##2##(2008-10#1)(2008-8#1)
cause irreversible##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
cause is unknown##2##3##(1991-2#1)(2008-1#1)
cause is##9##2##(1991-2#1)(1996-6#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-10#1)(2011-2#2)(2013-1#1)
cause many##4##2##(1993-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
cause mild##2##2##(1992-3#1)(2008-10#1)
cause multiple##3##2##(2008-3#1)(2011-1#1)(2013-1#1)
cause neural##2##2##(1997-8#1)(2011-2#1)
cause of a##5##3##(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#2)
cause of acute##2##3##(1993-6#1)(2008-10#1)
cause of anthrax##2##3##(1992-12#1)(2011-2#1)
cause of cancer-related deaths##2##4##(2008-5#1)(2011-2#1)
cause of cancer-related##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
cause of chronic##4##3##(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
cause of death in Western##2##5##(2012-2#1)(2013-8#1)
cause of death in the##2##5##(2010-10#1)(2011-3#1)
cause of death in##10##4##(1993-9#1)(1994-5#1)(1995-2#1)(2008-1#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
cause of death of##2##4##(1990-6#1)(2011-2#1)
cause of death was##2##4##(1995-11#2)
cause of death##32##3##(1990-11#1)(1990-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-2#1)(1996-12#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
cause of dementia##2##3##(1996-11#1)(2008-7#1)
cause of dyspnoea in##2##4##(2010-10#2)
cause of dyspnoea##3##3##(2010-10#2)(2013-8#1)
cause of gastrointestinal##2##3##(2011-2#2)
cause of hair loss##2##4##(2008-5#2)
cause of human##3##3##(2008-4#1)(2010-10#1)(2011-2#1)
cause of intestinal obstruction##3##4##(2008-12#2)(2009-8#1)
cause of intracerebral##2##3##(2008-12#1)(2012-3#1)
cause of low back pain in##2##6##(2009-4#2)
cause of low##3##3##(2009-4#2)(2011-2#1)
cause of lower##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
cause of morbidity and mortality in##4##6##(1993-3#1)(2008-12#1)(2009-12#1)(2009-8#1)
cause of morbidity and mortality##7##5##(1993-3#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-2#1)
cause of morbidity in##2##4##(2008-2#1)(2011-2#1)
cause of morbidity##11##3##(1993-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-3#1)
cause of mortality##4##3##(2008-1#1)(2010-7#1)(2011-2#1)(2011-3#1)
cause of pulmonary##2##3##(2010-10#1)(2012-2#1)
cause of renal##2##3##(2008-1#1)(2008-10#1)
cause of respiratory##2##3##(1990-9#1)(2008-12#1)
cause of root rot##2##4##(2008-10#2)
cause of secondary hypertension##2##4##(2008-12#1)(2011-2#1)
cause of skin##3##3##(2008-5#1)(2011-2#2)
cause of spontaneous##2##3##(2012-3#1)(2013-7#1)
cause of the##16##3##(1990-6#1)(1995-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
cause of this##8##3##(1990-11#2)(1991-6#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)
cause of##289##2##(1990-11#3)(1990-6#2)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#3)(1991-7#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-3#2)(1997-6#2)(1997-8#1)(2008-1#10)(2008-10#27)(2008-11#12)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#6)(2008-7#16)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#6)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#37)(2011-3#3)(2012-12#4)(2012-2#13)(2012-3#13)(2013-1#23)(2013-7#1)(2013-8#5)
cause plant##2##2##(2008-10#2)
cause power##2##2##(2008-2#1)(2008-3#1)
cause removal of##2##3##(2008-6#1)(2008-7#1)
cause seedling blight##2##3##(2008-10#2)
cause serious##3##2##(2008-11#1)(2010-7#1)(2011-2#1)
cause severe##6##2##(1996-11#1)(2008-10#2)(2011-2#2)(2013-8#1)
cause significant changes in##2##4##(1996-12#1)(2008-10#1)
cause significant morbidity##2##3##(2008-7#2)
cause significant##10##2##(1996-12#1)(2008-10#5)(2008-7#2)(2010-9#1)(2013-8#1)
cause stroke##2##2##(1995-2#1)(2008-8#1)
cause such##3##2##(1991-8#1)(1996-3#1)(2011-2#1)
cause symptoms in##2##3##(2008-10#2)
cause symptoms##5##2##(2008-10#5)
cause systemic##2##2##(2008-12#1)(2008-8#1)
cause the airways to narrow##2##5##(1997-1#2)
cause the formation of##2##4##(2008-7#1)(2010-10#1)
cause the##18##2##(1993-2#1)(1993-6#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
cause this##2##2##(2008-5#1)(2008-8#1)
cause various##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
cause was##3##2##(1995-5#1)(2008-5#1)(2008-7#1)
cause yield##2##2##(2008-10#2)
cause##763##1##(1990-11#3)(1990-2#2)(1990-3#1)(1990-6#3)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#3)(1995-11#4)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#9)(1996-3#2)(1996-6#4)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#5)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2006-6#2)(2007-11#1)(2008-1#15)(2008-10#144)(2008-11#37)(2008-12#22)(2008-2#2)(2008-3#9)(2008-4#7)(2008-5#19)(2008-6#2)(2008-7#32)(2008-8#23)(2008-9#16)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#10)(2009-9#1)(2010-1#3)(2010-10#9)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#85)(2011-3#4)(2012-12#8)(2012-2#21)(2012-3#26)(2012-5#1)(2012-7#1)(2013-1#40)(2013-7#3)(2013-8#20)
cause-effect##2##1##(1991-3#1)(2011-2#1)
cause-specific survival##4##2##(1994-12#1)(2012-3#3)
cause-specific##5##1##(1994-12#1)(1997-1#1)(2012-3#3)
caused O2- production##4##3##(1996-2#4)
caused a 2##2##3##(1993-6#1)(1995-9#1)
caused a 5% depression on the signal##2##7##(2008-10#2)
caused a decrease in the##2##5##(2008-10#1)(2009-8#1)
caused a decrease in##6##4##(2008-10#2)(2008-11#2)(2009-8#2)
caused a dose-dependent increase in##3##5##(2006-6#1)(2008-10#1)(2008-5#1)
caused a dose-dependent##6##3##(1992-12#1)(1993-6#1)(1994-8#1)(2006-6#1)(2008-10#1)(2008-5#1)
caused a marked decrease in##2##5##(1994-8#1)(2008-7#1)
caused a marked##4##3##(1994-8#2)(2008-10#1)(2008-7#1)
caused a partial ATP recovery##2##5##(1994-8#2)
caused a rapid and##3##4##(1991-6#1)(1992-6#1)(1994-11#1)
caused a rapid##7##3##(1991-6#1)(1992-6#1)(1994-11#1)(1997-1#2)(2008-10#1)(2008-11#1)
caused a reduction in##2##4##(2008-5#1)(2011-2#1)
caused a significant decrease in##4##5##(1993-1#1)(1996-2#2)(2010-5#1)
caused a significant increase in##2##5##(2008-12#1)(2009-8#1)
caused a significant reduction in##2##5##(1994-6#1)(1996-2#1)
caused a significant reduction##3##4##(1993-1#1)(1994-6#1)(1996-2#1)
caused a significant##14##3##(1993-1#2)(1994-6#1)(1994-8#1)(1996-2#3)(2008-10#2)(2008-12#1)(2009-8#3)(2010-5#1)
caused a##79##2##(1990-5#1)(1990-6#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-6#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#7)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1997-1#2)(1997-7#2)(1997-8#1)(2006-6#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#5)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-1#1)
caused an increase in the##3##5##(2008-10#1)(2008-11#1)(2009-8#1)
caused an increase in##7##4##(1993-6#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)
caused an increase of##2##4##(2008-8#1)(2011-10#1)
caused an increase##10##3##(1993-6#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-10#1)(2013-1#1)
caused an##17##2##(1991-5#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-10#1)(2013-1#1)
caused by A##3##3##(2008-10#3)
caused by Alternaria alternata##3##4##(2008-10#3)
caused by B##3##3##(2008-10#2)(2008-12#1)
caused by Bipolaris sorokiniana##3##4##(2008-10#3)
caused by Blumeria graminis f##2##5##(2008-10#2)
caused by Botrytis cinerea##2##4##(2008-10#2)
caused by C##6##3##(2007-12#1)(2008-10#4)(2011-2#1)
caused by Cercospora zeae-maydis##2##4##(2008-10#2)
caused by Cercospora##3##3##(2008-10#3)
caused by Cochliobolus heterostrophus race O##2##6##(2008-10#2)
caused by Cochliobolus sativus##3##4##(2008-10#3)
caused by Cochliobolus##5##3##(2008-10#5)
caused by Colletotrichum##5##3##(2008-10#5)
caused by E##2##3##(2008-10#1)(2009-12#1)
caused by Erwinia amylovora##2##4##(2008-10#2)
caused by F##3##3##(2008-10#3)
caused by Fusarium graminearum##4##4##(2008-10#3)(2011-10#1)
caused by Fusarium oxysporum f##6##5##(2008-10#6)
caused by Fusarium##13##3##(2008-10#12)(2011-10#1)
caused by Magnaporthe grisea##3##4##(2008-10#2)(2009-10#1)
caused by Magnaporthe##4##3##(2008-10#2)(2009-10#1)(2012-2#1)
caused by Mycosphaerella citri##2##4##(2008-10#2)
caused by P##7##3##(2008-10#7)
caused by Penicillium expansum##3##4##(2008-10#3)
caused by Penicillium##4##3##(2008-10#3)(2011-2#1)
caused by Phytophthora infestans##2##4##(2008-10#1)(2009-6#1)
caused by Phytophthora ramorum##2##4##(2008-10#2)
caused by Phytophthora sojae is##2##5##(2008-10#2)
caused by Phytophthora##10##3##(2008-10#9)(2009-6#1)
caused by Pseudomonas syringae pv##5##5##(2008-10#5)
caused by Pseudomonas syringae##6##4##(2008-10#6)
caused by Puccinia coronata var##2##5##(2008-10#2)
caused by Puccinia coronata##3##4##(2008-10#3)
caused by Puccinia striiformis f##3##5##(2008-10#3)
caused by Puccinia striiformis##4##4##(2008-10#4)
caused by Puccinia triticina and P##2##6##(2008-10#2)
caused by Puccinia##12##3##(2008-10#12)
caused by Pythium spp##2##4##(2008-10#2)
caused by Pythium ultimum##3##4##(2008-10#3)
caused by Pythium##5##3##(2008-10#5)
caused by R##5##3##(2008-10#5)
caused by Rhizoctonia solani##2##4##(2008-10#2)
caused by Rhodotorula mucilaginosa in##2##5##(2009-11#2)
caused by S##3##3##(2008-10#2)(2010-12#1)
caused by SHLI##2##3##(2011-2#2)
caused by Sclerotinia sclerotiorum##3##4##(2008-10#3)
caused by Septoria passerinii##2##4##(2008-10#2)
caused by Septoria##4##3##(2008-10#4)
caused by Streptococcus##3##3##(1991-11#1)(2011-2#2)
caused by T##2##3##(2008-10#1)(2008-5#1)
caused by Trichophyton tonsurans##2##4##(2008-5#2)
caused by Tropheryma whippelii##2##4##(1996-8#2)
caused by Verticillium dahliae##2##4##(2008-10#2)
caused by Xanthomonas campestris pv##6##5##(2008-10#6)
caused by Xanthomonas oryzae pv##2##5##(2008-10#1)(2009-10#1)
caused by Xanthomonas##10##3##(2008-10#9)(2009-10#1)
caused by Xylella fastidiosa##2##4##(2008-10#2)
caused by a defect in the##2##6##(1994-11#1)(2008-12#1)
caused by a defect##3##4##(1994-11#1)(2008-12#1)(2013-1#1)
caused by a##50##3##(1990-11#1)(1992-1#2)(1993-3#1)(1994-11#1)(1994-12#2)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
caused by actinomycosis##2##3##(2008-1#1)(2013-8#1)
caused by air##2##3##(1995-5#1)(2008-11#1)
caused by an increase in##2##5##(2008-11#1)(2008-7#1)
caused by an##14##3##(1990-12#1)(1992-9#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
caused by at least##3##4##(2008-10#2)(2008-6#1)
caused by bacteria##2##3##(2008-12#1)(2011-2#1)
caused by bilateral##2##3##(1993-3#1)(2013-1#1)
caused by both##2##3##(2008-10#2)
caused by brain tumors##2##4##(2008-12#2)
caused by cell##2##3##(2008-11#1)(2012-2#1)
caused by chronic##2##3##(1990-3#1)(2008-10#1)
caused by delayed##2##3##(2008-12#1)(2012-3#1)
caused by differences in##3##4##(2008-10#2)(2011-2#1)
caused by different##5##3##(1990-9#1)(1991-7#1)(2008-10#2)(2008-5#1)
caused by dysfunctional communication between##2##5##(1990-12#2)
caused by either##3##3##(2008-10#3)
caused by higher##2##3##(2008-10#1)(2013-1#1)
caused by human##2##3##(1990-3#1)(2008-9#1)
caused by infection##2##3##(2011-2#1)(2013-8#1)
caused by infections##2##3##(1994-5#1)(1995-5#1)
caused by iron##2##3##(2008-10#1)(2012-2#1)
caused by local##2##3##(2008-9#1)(2011-2#1)
caused by low-frequency vibrations##2##4##(2008-3#2)
caused by malaria##2##3##(2012-12#2)
caused by maternal##2##3##(2011-2#1)(2012-3#1)
caused by members of the##2##5##(2008-10#2)
caused by mutations in the gene##2##6##(1990-5#1)(2011-1#1)
caused by mutations in the##4##5##(1990-5#1)(1997-1#1)(2011-1#1)(2013-8#1)
caused by mutations in##10##4##(1990-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
caused by mutations of##2##4##(1995-2#1)(1996-2#1)
caused by mutations##12##3##(1990-5#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
caused by nutrient depletion##2##4##(2008-7#2)
caused by rupture of##2##4##(1991-6#1)(2011-2#1)
caused by ruptured traumatic##2##4##(2008-12#2)
caused by several##2##3##(2008-10#1)(2008-7#1)
caused by some##2##3##(2008-10#2)
caused by structural##2##3##(2008-2#1)(2009-7#1)
caused by the absence of##3##5##(1993-9#1)(2008-11#1)(2011-2#1)
caused by the addition of##2##5##(2008-11#1)(2008-8#1)
caused by the ascomycete Mycosphaerella graminicola (anamorph Septoria tritici)##2##9##(2008-10#2)
caused by the ascomycete##3##4##(2008-10#3)
caused by the fungus Cercospora zeae-maydis##2##6##(2008-10#2)
caused by the fungus##13##4##(2008-10#12)(2010-3#1)
caused by the presence of##2##5##(1995-12#1)(2008-11#1)
caused by the presence##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
caused by the release of##2##5##(2008-7#1)(2013-8#1)
caused by the soilborne##2##4##(2008-10#2)
caused by the use##2##4##(2009-3#1)(2012-3#1)
caused by the##115##3##(1990-12#1)(1990-5#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#2)(1995-2#1)(1996-5#1)(2008-10#65)(2008-11#8)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-3#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#5)(2012-3#3)(2013-8#2)
caused by their##4##3##(2008-11#1)(2008-5#1)(2008-8#2)
caused by these##4##3##(2008-10#1)(2008-5#2)(2008-9#1)
caused by this##5##3##(1990-8#1)(2008-10#2)(2008-12#1)(2008-5#1)
caused by various##3##3##(1995-11#1)(2007-11#1)(2011-2#1)
caused by virus##2##3##(2008-11#1)(2008-9#1)
caused by##761##2##(1990-11#2)(1990-12#6)(1990-3#4)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#4)(1991-7#1)(1991-9#3)(1992-1#2)(1992-2#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#4)(1996-5#2)(1996-6#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#6)(1997-5#2)(1997-6#3)(2007-11#2)(2007-12#5)(2007-9#1)(2008-1#3)(2008-10#345)(2008-11#34)(2008-12#17)(2008-2#3)(2008-3#18)(2008-4#1)(2008-5#26)(2008-6#3)(2008-7#17)(2008-8#18)(2008-9#8)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#4)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#48)(2011-3#2)(2012-12#7)(2012-2#10)(2012-3#13)(2013-1#10)(2013-8#14)
caused changes in##2##3##(2008-10#1)(2009-8#1)
caused decreases in##2##3##(1994-2#1)(2008-11#1)
caused disease symptoms##3##3##(2008-10#3)
caused disease##6##2##(2008-10#6)
caused from##4##2##(1995-3#1)(2008-10#2)(2008-8#1)
caused galls on 10 to##2##5##(2008-10#2)
caused galls on##3##3##(2008-10#3)
caused higher##3##2##(2008-10#3)
caused lesions##2##2##(2008-10#1)(2008-5#1)
caused less disease on isoline##2##5##(2008-10#2)
caused less disease on##4##4##(2008-10#4)
caused less##6##2##(2008-1#1)(2008-10#5)
caused mainly by##3##3##(1991-6#1)(2008-3#1)(2013-8#1)
caused mainly##4##2##(1991-6#1)(2008-10#1)(2008-3#1)(2013-8#1)
caused more##2##2##(2008-10#1)(2013-8#1)
caused mortality##2##2##(1990-3#1)(2008-10#1)
caused much##2##2##(2008-10#1)(2008-11#1)
caused no##8##2##(1993-8#1)(1994-2#1)(1994-6#1)(2008-10#3)(2008-11#2)
caused only a small increase in##2##6##(1990-12#1)(2008-7#1)
caused only##5##2##(1990-12#1)(1996-5#1)(2008-10#2)(2008-7#1)
caused primarily by##5##3##(1991-5#1)(2008-10#2)(2008-3#1)(2011-1#1)
caused reduced##2##2##(2008-10#2)
caused reductions in##2##3##(2008-10#1)(2008-7#1)
caused reductions##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
caused severe##6##2##(1991-2#1)(1994-3#1)(2008-10#3)(2008-9#1)
caused significant cytotoxicity against dopaminergic##2##5##(2008-7#2)
caused significant disease on##2##4##(2008-10#2)
caused significant##11##2##(1992-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2013-8#1)
caused significantly less##2##3##(2008-10#2)
caused significantly##3##2##(2008-10#3)
caused similar##5##2##(2008-10#4)(2009-8#1)
caused some##2##2##(1996-12#1)(2008-10#1)
caused the significant##2##3##(2008-10#1)(2009-8#1)
caused the##15##2##(1991-3#1)(1994-9#1)(1995-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-8#1)
caused to##4##2##(1993-3#1)(2008-10#2)(2008-5#1)
caused typical##3##2##(2008-10#3)
caused very##2##2##(2008-10#2)
caused##1078##1##(1990-11#2)(1990-12#7)(1990-3#5)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#2)(1991-2#6)(1991-3#6)(1991-5#7)(1991-6#7)(1991-7#2)(1991-9#3)(1992-1#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#3)(1993-1#3)(1993-12#1)(1993-3#4)(1993-6#5)(1993-8#5)(1993-9#1)(1994-11#9)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#8)(1994-9#4)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#12)(1996-3#4)(1996-5#3)(1996-6#2)(1996-8#3)(1997-1#4)(1997-2#2)(1997-3#6)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#3)(2006-6#1)(2007-11#2)(2007-12#5)(2007-9#1)(2008-1#4)(2008-10#475)(2008-11#52)(2008-12#22)(2008-2#3)(2008-3#20)(2008-4#1)(2008-5#36)(2008-6#6)(2008-7#25)(2008-8#25)(2008-9#10)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#4)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#10)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#4)(2011-10#2)(2011-2#57)(2011-3#2)(2012-12#9)(2012-2#10)(2012-3#14)(2012-7#1)(2013-1#14)(2013-8#18)
causes Alternaria##3##2##(2008-10#3)
causes Fusarium head blight (FHB)##2##5##(2008-10#2)
causes Fusarium wilt##2##3##(2008-10#2)
causes Fusarium##4##2##(2008-10#4)
causes Septoria tritici blotch of##2##5##(2008-10#2)
causes a strong##2##3##(2008-10#2)
causes a##25##2##(1991-7#1)(1992-5#1)(1993-1#1)(1994-11#1)(1997-1#2)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
causes an enhancement##2##3##(2008-10#2)
causes an increase in the##2##5##(1994-5#1)(1997-7#1)
causes an##13##2##(1994-3#1)(1994-5#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
causes and consequences##2##3##(2008-8#1)(2010-7#1)
causes and##11##2##(1990-2#1)(1990-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-2#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-7#1)
causes are##3##2##(1997-3#1)(2008-9#1)(2009-3#1)
causes black##2##2##(2008-10#2)
causes brown rot##2##3##(2008-10#2)
causes brown##3##2##(2008-10#3)
causes changes in##2##3##(2008-9#1)(2009-7#1)
causes chronic##2##2##(2009-7#1)(2013-1#1)
causes damage##2##2##(2008-5#1)(2011-2#1)
causes defects##2##2##(2008-8#1)(2011-2#1)
causes for the##2##3##(2008-10#1)(2008-11#1)
causes for##12##2##(1996-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-3#1)
causes further##2##2##(1992-6#1)(2008-10#1)
causes in##2##2##(1996-12#1)(2012-3#1)
causes include trauma##2##3##(2008-10#2)
causes include##4##2##(1993-9#1)(2008-10#2)(2008-7#1)
causes increased##3##2##(1996-6#1)(2008-11#1)(2012-12#1)
causes it to##2##3##(1992-4#1)(2008-10#1)
causes no##4##2##(2008-10#3)(2008-11#1)
causes of acute pancreatitis##2##4##(2013-1#2)
causes of acute##3##3##(2007-12#1)(2013-1#2)
causes of cancer##2##3##(1994-2#1)(2009-12#1)
causes of death were##4##4##(1991-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
causes of death##9##3##(1991-12#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
causes of diabetes##2##3##(2008-1#2)
causes of disease##2##3##(1994-9#1)(2008-10#1)
causes of medication errors##2##4##(2011-1#2)
causes of morbidity and mortality in##2##6##(2008-10#1)(2011-2#1)
causes of morbidity and mortality##3##5##(2008-1#1)(2008-10#1)(2011-2#1)
causes of occupational asthma##2##4##(2008-10#2)
causes of primary##2##3##(1992-5#1)(2008-10#1)
causes of such##2##3##(2008-3#1)(2012-2#1)
causes of the##9##3##(1996-8#1)(1997-4#1)(2008-11#1)(2008-8#4)(2011-2#1)(2012-12#1)
causes of these##2##3##(1995-5#1)(2008-7#1)
causes of this##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
causes of variation##2##3##(2008-7#1)(2008-8#1)
causes of##101##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#1)(1992-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-9#1)(1995-12#2)(1995-5#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#7)(2008-10#8)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#8)(2008-8#6)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#6)
causes rapid##2##2##(2008-10#1)(2008-11#1)
causes root rot##2##3##(2008-10#2)
causes selective##2##2##(1990-5#1)(1996-3#1)
causes serious##2##2##(2008-10#2)
causes several##2##2##(2008-10#1)(2008-7#1)
causes severe##4##2##(2008-10#3)(2010-11#1)
causes significant##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
causes strong##2##2##(1995-6#1)(2006-6#1)
causes such as##3##3##(2008-8#1)(2011-2#1)(2011-3#1)
causes symptoms similar to##2##4##(2008-10#2)
causes the##18##2##(1992-12#1)(1993-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(2008-10#6)(2008-7#2)(2008-8#1)(2009-8#1)(2013-1#1)
causes them to##2##3##(1992-12#1)(2008-9#1)
causes thymic atrophy by##2##4##(2008-10#2)
causes thymic atrophy##3##3##(2008-10#3)
causes to##2##2##(2008-7#1)(2009-7#1)
causes yellowing and##2##3##(2008-10#2)
causes##432##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#3)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#9)(2008-10#114)(2008-11#20)(2008-12#8)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#18)(2008-8#10)(2008-9#9)(2009-10#3)(2009-12#2)(2009-3#3)(2009-7#5)(2009-8#6)(2010-1#1)(2010-10#2)(2010-11#8)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#9)(2011-2#28)(2011-3#3)(2012-12#4)(2012-2#8)(2012-3#7)(2012-7#1)(2013-1#15)(2013-7#1)(2013-8#2)
causing a change in##2##4##(2008-10#1)(2008-7#1)
causing a significant##2##3##(1991-3#1)(2008-10#1)
causing a##17##2##(1991-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)
causing an##5##2##(1993-12#1)(2008-10#3)(2008-5#1)
causing bacterial spot##2##3##(2008-10#2)
causing brown spot of##2##4##(2008-10#2)
causing degradation of##2##3##(2007-11#1)(2012-2#1)
causing direct##2##2##(2008-10#1)(2012-3#1)
causing disease in##2##3##(2008-10#1)(2008-12#1)
causing disease##5##2##(2008-10#4)(2008-12#1)
causing dwarfing and transmittable by A##2##6##(2008-10#2)
causing gray leaf spot of maize##2##6##(2008-10#2)
causing gray leaf spot##3##4##(2008-10#3)
causing head##2##2##(2008-10#2)
causing high##2##2##(2012-2#1)(2013-1#1)
causing it to##2##3##(1996-6#1)(2011-2#1)
causing more##3##2##(2008-10#2)(2013-8#1)
causing mosaic symptoms##2##3##(2008-10#2)
causing necrosis and##2##3##(2008-10#1)(2008-5#1)
causing neurological##2##2##(2007-8#1)(2012-12#1)
causing pain##2##2##(2010-1#1)(2010-12#1)
causing potato##3##2##(2008-10#3)
causing serious##4##2##(2008-10#1)(2008-7#3)
causing severe epidemics##2##3##(2008-10#2)
causing severe##3##2##(2008-10#2)(2008-12#1)
causing significant##6##2##(1993-9#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
causing spinal cord compression##2##4##(2008-7#1)(2012-3#1)
causing the##16##2##(1994-8#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#3)(2012-12#1)
causing yellowing##3##2##(2008-10#3)
causing##232##1##(1990-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-2#1)(1993-12#2)(1993-6#2)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-8#2)(1997-9#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#95)(2008-11#9)(2008-12#12)(2008-3#2)(2008-5#8)(2008-7#15)(2008-8#3)(2008-9#5)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
caustic##7##1##(2008-10#3)(2008-6#4)
caution and##3##2##(1997-1#1)(2008-9#1)(2011-1#1)
caution in##3##2##(2008-11#2)(2008-9#1)
caution is needed in##2##4##(1995-5#1)(2008-12#1)
caution is##4##2##(1992-6#1)(1995-5#1)(2008-10#1)(2008-12#1)
caution should be##3##3##(1993-2#1)(1993-6#1)(2013-8#1)
caution to##3##2##(2008-11#2)(2008-9#1)
caution when##2##2##(2008-10#1)(2008-8#1)
caution##34##1##(1991-12#1)(1991-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#4)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
cautionary##3##1##(2008-9#1)(2009-8#1)(2013-8#1)
cautioned the##2##2##(1995-6#1)(2008-10#1)
cautioned##4##1##(1995-6#1)(1996-3#1)(2008-10#1)(2013-1#1)
cautions##3##1##(1994-8#1)(2008-10#1)(2008-9#1)
cautious in##2##2##(2008-12#1)(2011-2#1)
cautious##5##1##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
cautiously##3##1##(1995-5#1)(1996-6#1)(2008-8#1)
cava and##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
cava##22##1##(1992-9#3)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#2)(2010-4#3)(2011-2#3)(2013-1#2)
caval reconstruction##2##2##(2013-1#2)
cave##5##1##(1995-6#1)(1996-3#1)(2008-10#1)(2011-2#2)
caveats##5##1##(1992-1#1)(1992-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
caveolae in##2##2##(1995-2#2)
caveolae may##3##2##(1995-2#2)(1995-6#1)
caveolae##16##1##(1995-2#14)(1995-6#2)
caveolin##17##1##(1995-2#5)(1995-6#11)(2012-2#1)
caveolin-1 is##2##2##(2010-1#2)
caveolin-1##7##1##(2010-1#7)
cavernomas##4##1##(1996-6#3)(2008-7#1)
cavernosa##4##1##(2008-10#3)(2013-1#1)
cavernous angiomas##2##2##(2008-7#2)
cavernous hemangiolymphangioma of the##2##4##(2008-10#2)
cavernous hemangiolymphangioma##3##2##(2008-10#3)
cavernous malformations away from##2##4##(2012-3#2)
cavernous malformations##3##2##(2012-3#3)
cavernous sinus##11##2##(1990-12#3)(1993-9#1)(2008-7#2)(2011-2#4)(2012-3#1)
cavernous##27##1##(1990-12#3)(1993-9#1)(1996-6#1)(1996-9#2)(1997-3#1)(2008-10#3)(2008-7#4)(2009-1#1)(2009-10#1)(2011-2#4)(2012-3#6)
caviomorph##2##1##(2012-2#2)
caviomorphs##2##1##(2012-2#2)
cavitated caries surfaces##2##3##(2012-2#2)
cavitated caries##4##2##(2012-2#4)
cavitated##5##1##(2012-2#5)
cavitation##3##1##(2008-5#1)(2012-5#1)(2013-8#1)
cavities for amalgam##2##3##(1990-9#2)
cavities in##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
cavities with suspended mirrors##2##4##(2008-3#2)
cavities##32##1##(1990-9#2)(1993-3#1)(1993-8#1)(1993-9#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#11)(2008-5#1)(2008-7#1)(2010-8#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
cavity a##2##2##(2008-3#1)(2012-3#1)
cavity and the##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
cavity and##19##2##(1990-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
cavity by use of an##2##5##(2008-2#1)(2008-3#1)
cavity configuration##2##2##(2008-2#1)(2008-3#1)
cavity design##3##2##(2008-3#3)
cavity detuning##2##2##(2007-12#1)(2008-3#1)
cavity for##5##2##(1996-5#1)(2008-3#3)(2008-9#1)
cavity in a##2##3##(2008-10#1)(2008-3#1)
cavity in##6##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#1)
cavity is used##2##3##(2008-2#1)(2008-3#1)
cavity is##8##2##(1990-5#1)(1991-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2012-12#1)(2013-1#1)
cavity length##2##2##(2007-12#1)(2008-3#1)
cavity made by the##2##4##(1996-5#1)(2008-7#1)
cavity of the##7##3##(1996-12#1)(2008-10#3)(2012-3#1)(2013-1#1)(2013-8#1)
cavity of##19##2##(1995-9#1)(1996-12#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
cavity or##3##2##(1991-6#1)(2008-10#1)(2008-9#1)
cavity preparation##2##2##(1991-2#1)(2008-7#1)
cavity rare diseases##2##3##(2011-7#2)
cavity rare##3##2##(2011-7#3)
cavity ring-down spectroscopy##2##3##(2010-7#2)
cavity ringdown spectroscopy##10##3##(2008-2#1)(2008-3#9)
cavity ringdown##13##2##(2008-2#1)(2008-3#12)
cavity that##3##2##(2008-10#1)(2008-3#2)
cavity to##3##2##(2008-10#1)(2008-3#2)
cavity was##5##2##(1991-3#1)(1996-3#1)(2008-10#1)(2008-9#1)(2009-8#1)
cavity were##4##2##(1995-9#1)(1997-8#1)(2008-10#1)(2008-3#1)
cavity with a##2##3##(2008-3#1)(2013-1#1)
cavity with##3##2##(1993-8#1)(2008-3#1)(2013-1#1)
cavity##213##1##(1990-2#3)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#3)(1997-3#1)(1997-4#1)(1997-8#2)(2007-12#5)(2008-1#3)(2008-10#23)(2008-11#4)(2008-12#7)(2008-2#17)(2008-3#65)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#5)(2009-10#1)(2009-8#2)(2010-12#3)(2010-7#2)(2011-2#3)(2011-7#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#18)(2013-7#1)(2013-8#1)
cavity's##2##1##(2008-3#2)
cavity)##2##1##(2008-10#1)(2011-2#1)
cavity-length modulation technique##2##3##(2008-2#2)
cavity-length##3##1##(2007-12#1)(2008-2#2)
cavity]##2##1##(1990-5#1)(1997-4#1)
cbiXJCDETLFGAcysG(A)cbiYbtuR##2##1##(2011-1#2)
cc##2##1##(2009-11#1)(2010-11#1)
cce_0567##2##1##(2009-7#2)
cdc7Δ##2##1##(2012-3#2)
ce##4##1##(2011-2#1)(2013-1#3)
cease to##2##2##(2008-11#1)(2012-2#1)
cease##7##1##(1991-11#1)(1991-2#1)(1997-3#1)(2008-11#1)(2009-6#1)(2010-2#1)(2012-2#1)
ceased to##2##2##(1994-9#1)(1995-3#1)
ceased##12##1##(1993-1#1)(1994-9#1)(1995-3#2)(2008-10#4)(2008-11#1)(2010-1#1)(2010-5#1)(2010-8#1)
ceases##5##1##(2008-11#2)(2008-12#1)(2008-6#1)(2012-3#1)
cecal impaction##3##2##(2013-8#3)
cecal ligation and puncture##2##4##(2012-3#2)
cecal ligation##3##2##(2012-3#3)
cecal volvulus##3##2##(2012-3#3)
cecal##11##1##(2012-3#6)(2013-8#5)
cecropin AD##2##2##(1994-5#2)
cecropin##8##1##(1994-5#4)(2008-10#2)(2008-8#2)
cecum##6##1##(2008-11#1)(2008-12#5)
cedar pollinosis##9##2##(2012-12#9)
cedar##15##1##(2008-10#1)(2012-12#14)
cefaclor##2##1##(2008-10#2)
cefadroxil monohydrate##3##2##(2008-10#3)
cefadroxil##14##1##(2008-10#14)
cefalexin##3##1##(2008-10#3)
cefazolin sodium##7##2##(2008-10#7)
cefazolin##11##1##(2008-10#9)(2008-12#1)(2011-2#1)
cefditoren pivoxil##2##2##(2011-2#2)
cefepime and##2##2##(2008-7#2)
cefepime##5##1##(2008-7#5)
cefixime##6##1##(2008-10#6)
cefotaxime and ceftriaxone##3##3##(2008-7#3)
cefotaxime and##5##2##(2008-12#1)(2008-7#3)(2011-2#1)
cefotaxime or##2##2##(2011-2#2)
cefotaxime##11##1##(2008-10#2)(2008-12#1)(2008-7#4)(2011-2#3)(2013-1#1)
cefpodoxime##2##1##(2010-6#1)(2011-2#1)
ceftazidime##7##1##(1991-3#2)(2008-10#3)(2008-7#2)
ceftibuten##4##1##(1994-8#4)
ceftriaxone in##2##2##(1990-5#2)
ceftriaxone##10##1##(1990-5#3)(1991-3#1)(2007-12#1)(2008-7#4)(2011-2#1)
ceiling effect##4##2##(2008-11#3)(2008-7#1)
ceiling effects##3##2##(2008-11#1)(2009-10#1)(2010-11#1)
ceiling level##2##2##(1996-12#2)
ceiling##12##1##(1993-9#1)(1996-12#2)(2008-11#4)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2013-7#1)
cel##2##1##(1996-12#1)(2008-11#1)
cel9-cel48 cluster##2##2##(2009-3#2)
celadonite##2##1##(2008-10#2)
celebrated for##2##2##(2008-11#1)(2010-1#1)
celebrated##3##1##(2008-11#1)(2010-1#1)(2013-1#1)
celecoxib in pharmaceutical formulation and human serum##2##7##(2008-10#2)
celecoxib in##3##2##(2008-10#3)
celecoxib##10##1##(2008-10#4)(2008-12#2)(2011-2#4)
celestial cues##4##2##(1994-3#4)
celestial##5##1##(1994-3#5)
celestine blue##2##2##(2008-10#2)
celiac artery##2##2##(2008-12#1)(2013-1#1)
celiac disease##11##2##(2008-10#2)(2008-12#2)(2011-2#3)(2012-12#2)(2013-8#2)
celiac##18##1##(2008-10#2)(2008-12#5)(2009-5#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
celibacy##2##1##(2008-11#1)(2008-12#1)
celiotomies##2##1##(1992-2#2)
cell (PFC) assay##3##3##(2008-10#2)(2008-4#1)
cell (PFC)##5##2##(1993-12#1)(2008-10#2)(2008-4#2)
cell ATP##2##2##(2008-11#2)
cell activation and cytokine##2##4##(2008-4#2)
cell activation and##3##3##(1995-11#1)(2008-4#2)
cell activation##22##2##(1994-11#2)(1995-11#5)(2008-11#1)(2008-4#4)(2008-9#1)(2009-8#1)(2012-3#7)(2013-1#1)
cell activity were##3##3##(2008-10#3)
cell activity##14##2##(1993-3#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-11#1)(2013-8#1)
cell adaptation##3##2##(2008-11#3)
cell adenosine deaminase##2##3##(1992-12#2)
cell adhesion and##7##3##(1994-11#1)(1994-5#1)(2008-11#1)(2008-9#2)(2009-10#1)(2010-6#1)
cell adhesion molecule##3##3##(1996-12#1)(2008-5#1)(2009-9#1)
cell adhesion to the##3##4##(2008-11#1)(2009-10#1)(2011-1#1)
cell adhesion to##6##3##(2008-11#1)(2009-10#2)(2009-3#2)(2011-1#1)
cell adhesion##36##2##(1993-6#2)(1994-11#2)(1994-5#1)(1996-12#1)(2008-1#2)(2008-11#9)(2008-3#1)(2008-5#1)(2008-9#3)(2009-10#3)(2009-3#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
cell after##5##2##(2008-10#2)(2008-11#3)
cell age##2##2##(1990-2#1)(1995-9#1)
cell aggregates of##2##3##(2008-10#2)
cell aggregates##5##2##(2007-12#1)(2008-10#4)
cell aggregation##2##2##(2008-10#2)
cell alone##3##2##(2008-11#3)
cell also##2##2##(1990-5#1)(1997-3#1)
cell analysis##7##2##(2007-12#1)(2008-11#2)(2008-4#2)(2009-12#2)
cell and T cell##2##4##(2008-4#1)(2013-1#1)
cell and a##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
cell and adsorptive polarographic determination of##3##6##(2008-10#3)
cell and in the##2##4##(2008-3#2)
cell and its content was determined by adsorptive polarography##2##9##(2008-10#2)
cell and its##6##3##(2008-10#3)(2008-11#1)(2009-3#1)(2009-5#1)
cell and molecular biology##2##4##(2008-4#1)(2008-9#1)
cell and squamous cell carcinomas of the face##2##8##(2012-3#2)
cell and the##10##3##(2008-10#7)(2008-3#1)(2008-9#2)
cell and tissue culture##2##4##(2008-11#1)(2011-3#1)
cell and tissue##5##3##(2008-11#2)(2008-9#1)(2011-3#1)(2013-8#1)
cell and##91##2##(1990-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-6#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#10)(2008-2#1)(2008-3#4)(2008-4#3)(2008-6#1)(2008-8#3)(2008-9#11)(2009-10#1)(2009-3#2)(2009-5#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
cell antigens##2##2##(1995-12#1)(2008-9#1)
cell apoptosis and##2##3##(2008-11#1)(2008-9#1)
cell apoptosis in human##2##4##(2008-9#2)
cell apoptosis in##4##3##(2008-9#2)(2009-12#1)(2010-1#1)
cell apoptosis##21##2##(2008-11#3)(2008-8#4)(2008-9#7)(2009-12#1)(2010-1#3)(2011-2#1)(2011-3#1)(2013-1#1)
cell are##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
cell areas##2##2##(1995-8#1)(2012-5#1)
cell as##2##2##(1994-8#1)(2008-10#1)
cell assay system##2##3##(1990-10#1)(1990-11#1)
cell assay##8##2##(1990-10#1)(1990-11#1)(2008-10#5)(2008-8#1)
cell assays##2##2##(1994-8#1)(2008-9#1)
cell assemblies##2##2##(1996-2#2)
cell assembly##2##2##(2008-10#2)
cell associated##2##2##(2008-11#1)(2012-12#1)
cell at a##3##3##(2008-10#2)(2009-8#1)
cell at##8##2##(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2009-8#1)
cell attachment and proliferation##2##4##(2008-5#1)(2012-5#1)
cell attachment and##4##3##(1995-6#1)(2008-5#1)(2009-12#1)(2012-5#1)
cell attachment sites in entactin##2##5##(1995-6#2)
cell attachment##16##2##(1992-3#2)(1995-6#5)(2008-5#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-9#1)(2012-2#1)(2012-5#3)
cell banks##4##2##(2008-11#3)(2012-3#1)
cell based on##4##3##(2008-10#2)(2008-3#2)
cell based##6##2##(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)
cell behavior##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
cell behaviour in continuous culture##2##5##(2008-11#2)
cell behaviour in##3##3##(2008-11#3)
cell behaviour##5##2##(2008-11#4)(2009-7#1)
cell binding##3##2##(1994-11#1)(2008-10#1)(2009-7#1)
cell bioassay systems##4##3##(2008-10#4)
cell bioassay##6##2##(1991-12#1)(1995-11#1)(2008-10#4)
cell biological##6##2##(1995-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
cell biologists##2##2##(2008-9#1)(2009-8#1)
cell biology and##4##3##(2008-11#3)(2009-12#1)
cell biology##19##2##(1991-2#1)(1995-5#1)(2008-10#1)(2008-11#8)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2012-2#2)(2012-3#1)
cell bodies and##3##3##(1996-12#1)(2007-12#1)(2008-7#1)
cell bodies in the##6##4##(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-9#1)
cell bodies of##2##3##(1990-5#1)(1997-3#1)
cell bodies##21##2##(1990-5#2)(1991-10#2)(1991-12#2)(1995-12#1)(1995-6#1)(1996-12#2)(1996-5#2)(1997-2#1)(1997-3#5)(2007-12#1)(2008-7#1)(2008-9#1)
cell body and##2##3##(2008-10#1)(2008-7#1)
cell body##10##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#6)(2013-1#1)
cell by a##2##3##(2008-10#2)
cell by##7##2##(2008-10#4)(2008-11#1)(2008-5#1)(2010-12#1)
cell cDNA library##2##3##(1993-2#1)(1995-12#1)
cell can be##2##3##(2008-10#1)(2008-9#1)
cell can##5##2##(1995-2#1)(2008-10#3)(2008-9#1)
cell cancers##2##2##(1997-7#1)(2011-2#1)
cell carcinoma (OSCC) has##2##4##(2010-12#1)(2012-3#1)
cell carcinoma (OSCC)##4##3##(2010-12#1)(2012-3#1)(2013-1#2)
cell carcinoma (RCC)##5##3##(1990-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
cell carcinoma (TCC)##2##3##(2008-10#1)(2012-3#1)
cell carcinoma and##9##3##(1991-8#2)(1993-8#1)(2008-10#2)(2008-11#2)(2010-12#1)(2013-8#1)
cell carcinoma arising from a##2##5##(2008-10#1)(2010-7#1)
cell carcinoma arising in##2##4##(2013-8#2)
cell carcinoma arising##4##3##(2008-10#1)(2010-7#1)(2013-8#2)
cell carcinoma cell##3##3##(2008-11#2)(2010-8#1)
cell carcinoma in##5##3##(1990-8#2)(2012-3#2)(2013-1#1)
cell carcinoma is##2##3##(1992-3#1)(2013-1#1)
cell carcinoma of the##13##4##(1990-6#1)(1991-6#1)(1992-12#3)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1997-5#1)(2007-11#1)(2009-5#1)(2013-1#1)
cell carcinoma of##15##3##(1990-6#1)(1991-6#1)(1992-12#3)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1997-5#1)(2007-11#1)(2009-5#1)(2013-1#3)
cell carcinoma##102##2##(1990-2#2)(1990-6#2)(1990-8#2)(1991-6#2)(1991-8#6)(1992-12#3)(1992-3#6)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1997-3#7)(1997-5#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-9#1)(2009-1#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#8)(2012-3#7)(2013-1#11)(2013-8#6)
cell carcinoma]##3##2##(2011-3#1)(2012-3#2)
cell carcinomas are##2##3##(2011-2#1)(2012-3#1)
cell carcinomas##15##2##(1991-11#1)(1991-8#1)(1992-3#1)(1993-9#1)(1997-3#3)(2009-4#1)(2010-8#1)(2011-2#2)(2012-3#4)
cell changes##4##2##(1991-11#1)(2008-10#2)(2013-1#1)
cell clones##16##2##(1992-2#1)(1993-8#1)(2008-11#10)(2008-4#2)(2008-5#1)(2008-9#1)
cell clusters##4##2##(1993-12#1)(1996-2#1)(2008-12#1)(2008-8#1)
cell colonies##5##2##(2008-11#4)(2008-8#1)
cell communication##4##2##(2008-5#4)
cell compartment##2##2##(2008-10#1)(2008-5#1)
cell components##6##2##(2007-12#1)(2009-8#3)(2013-1#2)
cell concentration and##2##3##(2008-11#2)
cell concentration in##2##3##(2008-11#1)(2008-7#1)
cell concentration of##3##3##(2008-11#2)(2008-7#1)
cell concentration over##2##3##(2008-11#1)(2008-7#1)
cell concentration was##2##3##(2008-11#2)
cell concentration##30##2##(2008-11#19)(2008-7#9)(2008-9#2)
cell concentrations##3##2##(2008-11#2)(2008-9#1)
cell configuration##2##2##(2008-10#2)
cell constants##2##2##(1992-11#1)(2008-8#1)
cell containing##2##2##(2008-10#1)(2008-2#1)
cell contains a##3##3##(2007-12#1)(2008-10#2)
cell contains##6##2##(1995-8#1)(2007-12#2)(2008-10#2)(2008-7#1)
cell content##2##2##(2008-10#1)(2011-2#1)
cell could##2##2##(2008-10#1)(2008-9#1)
cell count and##2##3##(1992-2#1)(2011-2#1)
cell count of the##2##4##(2008-11#1)(2011-2#1)
cell count of##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
cell count##15##2##(1992-2#2)(1995-11#1)(1996-8#1)(2008-11#2)(2008-7#2)(2009-8#1)(2011-2#4)(2013-1#2)
cell counting##6##2##(2008-11#5)(2008-9#1)
cell counts and##4##3##(1996-3#1)(2009-12#1)(2011-1#2)
cell counts in##3##3##(1991-11#2)(2008-11#1)
cell counts##16##2##(1991-11#2)(1993-3#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#4)
cell cultivation##5##2##(2008-11#5)
cell culture and viral##2##4##(2008-11#2)
cell culture and##8##3##(1997-7#1)(2008-11#6)(2012-3#1)
cell culture are discussed##2##4##(2008-11#1)(2008-7#1)
cell culture at##2##3##(2008-11#2)
cell culture conditions##3##3##(1993-12#1)(2008-11#2)
cell culture engineering##2##3##(2008-11#2)
cell culture experiments##3##3##(2008-11#1)(2008-5#2)
cell culture for##2##3##(2008-11#1)(2008-7#1)
cell culture in the##2##4##(2008-11#2)
cell culture in##4##3##(2008-11#3)(2008-7#1)
cell culture may be##2##4##(2008-11#1)(2008-4#1)
cell culture media##5##3##(1991-5#1)(2008-11#3)(2011-2#1)
cell culture medium##6##3##(1993-12#1)(2008-11#3)(2011-2#1)(2013-1#1)
cell culture model##2##3##(1995-9#1)(1996-12#1)
cell culture models##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
cell culture of##2##3##(2008-5#1)(2008-9#1)
cell culture process##3##3##(2008-11#3)
cell culture processes##8##3##(2008-11#8)
cell culture production##2##3##(2008-11#2)
cell culture samples##2##3##(2008-11#2)
cell culture supernatants##2##3##(1997-3#1)(2008-10#1)
cell culture system##6##3##(1992-3#2)(2008-10#1)(2008-11#3)
cell culture systems##4##3##(2008-11#4)
cell culture techniques##2##3##(2008-11#2)
cell culture using##3##3##(2008-11#2)(2008-7#1)
cell culture was##3##3##(2008-11#3)
cell culture were##3##3##(1994-2#1)(1996-2#1)(2008-11#1)
cell culture##171##2##(1991-5#1)(1992-3#2)(1993-12#2)(1994-2#3)(1995-9#1)(1996-12#1)(1996-2#2)(1997-3#2)(1997-7#1)(2008-10#4)(2008-11#116)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-12#2)(2011-2#6)(2012-2#5)(2012-3#1)(2013-1#3)
cell cultured##2##2##(2008-5#2)
cell cultures and##3##3##(2008-4#1)(2008-5#1)(2009-6#1)
cell cultures are##2##3##(2008-10#1)(2008-11#1)
cell cultures at##4##3##(2008-5#2)(2008-7#2)
cell cultures by##2##3##(2008-11#2)
cell cultures for##2##3##(2008-11#1)(2008-5#1)
cell cultures grown in##2##4##(2008-7#2)
cell cultures in##2##3##(2008-11#2)
cell cultures infected with##2##4##(2008-11#1)(2008-7#1)
cell cultures of##2##3##(2008-11#1)(2008-7#1)
cell cultures to##2##3##(1990-11#1)(2009-6#1)
cell cultures were##4##3##(1994-2#1)(2008-11#3)
cell cultures with##4##3##(1990-11#1)(1994-11#1)(1995-11#1)(2008-2#1)
cell cultures##108##2##(1990-11#4)(1990-4#1)(1990-5#1)(1991-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#5)(1995-12#2)(1996-12#3)(1996-2#3)(1997-1#1)(2008-10#1)(2008-11#57)(2008-2#2)(2008-4#2)(2008-5#8)(2008-7#10)(2009-6#2)(2011-2#1)(2013-1#1)
cell culturing##2##2##(2008-11#2)
cell cycle activity##2##3##(2008-9#1)(2012-3#1)
cell cycle after##2##3##(2008-11#2)
cell cycle analyses on##2##4##(2008-11#2)
cell cycle analyses##3##3##(2008-11#2)(2008-9#1)
cell cycle analysis in##2##4##(2008-11#1)(2008-9#1)
cell cycle analysis##9##3##(2008-11#5)(2008-9#4)
cell cycle and##5##3##(2008-11#4)(2011-2#1)
cell cycle arrest and##2##4##(1991-5#1)(2013-1#1)
cell cycle arrest at G1/S was##2##6##(1997-7#2)
cell cycle arrest at G1/S##3##5##(1997-7#3)
cell cycle arrest at##4##4##(1997-7#3)(2008-11#1)
cell cycle arrest##16##3##(1991-5#1)(1997-1#1)(1997-3#2)(1997-7#4)(2008-11#2)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
cell cycle control##2##3##(2008-9#1)(2011-2#1)
cell cycle distribution##2##3##(1997-1#1)(2008-11#1)
cell cycle is##2##3##(1993-9#1)(2011-2#1)
cell cycle phase##6##3##(2008-11#5)(2008-9#1)
cell cycle phases##5##3##(2008-11#5)
cell cycle progression and##5##4##(2008-11#3)(2009-6#1)(2012-2#1)
cell cycle progression in yeast##2##5##(1996-3#1)(2009-6#1)
cell cycle progression in##5##4##(1996-3#1)(1997-1#1)(2008-11#1)(2009-6#1)(2012-3#1)
cell cycle progression were##2##4##(1993-8#1)(1994-11#1)
cell cycle progression##25##3##(1991-5#1)(1992-10#1)(1993-8#1)(1994-11#2)(1995-9#2)(1996-3#1)(1997-1#1)(1997-7#1)(2008-11#5)(2008-9#2)(2009-6#2)(2011-2#1)(2012-2#2)(2012-3#3)
cell cycle reentry##2##3##(1994-9#2)
cell cycle regulation##5##3##(2008-10#1)(2008-11#1)(2009-8#2)(2011-2#1)
cell cycle regulators##2##3##(2012-2#2)
cell cycle related##2##3##(2008-11#2)
cell cycle status##2##3##(2008-11#1)(2008-9#1)
cell cycle was##2##3##(2008-11#1)(2008-8#1)
cell cycle##166##2##(1991-5#3)(1992-10#3)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-3#3)(1994-9#2)(1995-2#1)(1995-9#5)(1996-3#3)(1997-1#5)(1997-3#2)(1997-7#8)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#55)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#20)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#5)(2010-1#1)(2010-10#1)(2011-2#9)(2012-2#8)(2012-3#5)(2013-1#2)
cell cycle-dependent##2##2##(1995-8#1)(2008-8#1)
cell cytokines##2##2##(1996-12#1)(2008-10#1)
cell cytoplasm was##5##3##(2008-10#5)
cell cytoplasm##12##2##(1992-12#2)(2007-12#1)(2008-10#8)(2011-2#1)
cell cytoskeleton##3##2##(1993-6#1)(1994-5#1)(2009-10#1)
cell damage and##3##3##(1996-12#1)(2008-11#1)(2012-12#1)
cell damage##15##2##(1992-9#1)(1994-8#1)(1996-12#1)(1997-1#1)(2008-11#4)(2008-8#2)(2010-9#1)(2011-3#2)(2012-12#1)(2012-3#1)
cell death after##3##3##(1994-2#1)(2010-11#1)(2013-1#1)
cell death and the##2##4##(2009-8#1)(2011-2#1)
cell death and##10##3##(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#2)(2011-2#1)(2011-9#1)
cell death as a##2##4##(2008-11#1)(2009-8#1)
cell death by apoptosis##3##4##(2008-11#1)(2009-4#1)(2010-2#1)
cell death by##5##3##(2008-11#1)(2008-8#1)(2009-4#1)(2010-2#1)(2013-7#1)
cell death caused by##2##4##(2008-11#2)
cell death during the##2##4##(1994-2#1)(2008-11#1)
cell death during##3##3##(1994-2#1)(2008-11#1)(2008-4#1)
cell death has##2##3##(2008-9#1)(2012-2#1)
cell death in Parkinson's disease##3##5##(2008-7#3)
cell death in plants##2##4##(2008-10#1)(2009-8#1)
cell death in the##7##4##(1990-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
cell death in##22##3##(1990-5#1)(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-7#6)(2009-8#2)(2010-11#1)(2011-2#1)(2012-12#1)
cell death is##3##3##(2008-11#1)(2008-7#1)(2009-12#1)
cell death occurred##2##3##(2008-10#1)(2008-11#1)
cell death of the##2##4##(1995-8#1)(2008-11#1)
cell death of thymocytes##3##4##(2008-8#3)
cell death of tobacco cells via similar##2##7##(2009-6#2)
cell death of tobacco cells##3##5##(2009-6#3)
cell death of##10##3##(1995-8#1)(1996-12#1)(2008-11#1)(2008-8#3)(2009-3#1)(2009-6#3)
cell death or##3##3##(1996-12#1)(2008-11#1)(2008-4#1)
cell death pathways##2##3##(2008-11#1)(2009-8#1)
cell death under##2##3##(1994-11#1)(2008-11#1)
cell death was##3##3##(1994-11#1)(2008-10#2)
cell death##182##2##(1990-5#2)(1992-12#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#4)(1996-12#6)(1996-2#1)(1996-5#4)(1997-9#1)(2008-10#19)(2008-11#38)(2008-12#1)(2008-4#6)(2008-5#1)(2008-7#14)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#4)(2009-3#2)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#15)(2009-9#1)(2010-11#2)(2010-2#1)(2011-2#8)(2011-9#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)
cell debris##3##2##(1993-8#1)(2008-7#1)(2008-8#1)
cell degeneration##8##2##(1994-8#4)(2008-7#4)
cell degranulation##2##2##(1994-11#1)(2010-1#1)
cell delivery##2##2##(2010-6#1)(2012-3#1)
cell densities and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
cell densities in the##2##4##(2008-11#2)
cell densities in##3##3##(2008-11#2)(2008-7#1)
cell densities of##5##3##(2008-10#1)(2008-11#2)(2008-7#2)
cell densities##21##2##(1996-12#1)(2008-10#2)(2008-11#11)(2008-7#5)(2011-2#2)
cell density and##10##3##(2008-11#8)(2008-7#1)(2012-5#1)
cell density in##4##3##(1995-3#1)(2008-11#3)
cell density is##2##3##(1993-8#1)(2008-11#1)
cell density obtained##2##3##(2008-11#2)
cell density of 1##2##4##(2008-11#2)
cell density of##7##3##(2008-11#6)(2008-7#1)
cell density was##3##3##(2008-11#3)
cell density##74##2##(1993-8#2)(1995-3#1)(1996-12#1)(2008-11#60)(2008-7#5)(2009-7#1)(2011-1#1)(2011-2#2)(2012-5#1)
cell densityof##2##2##(2008-11#2)
cell development and##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
cell development can##2##3##(2008-4#1)(2012-2#1)
cell development##12##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-7#2)(2012-2#4)(2013-1#1)
cell diameter##3##2##(2008-11#3)
cell differentiation and##8##3##(1997-7#1)(2008-11#3)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
cell differentiation as##2##3##(2008-11#2)
cell differentiation by##2##3##(2008-11#2)
cell differentiation in the##2##4##(2008-11#1)(2008-5#1)
cell differentiation in vitro##2##4##(2008-11#2)
cell differentiation in##4##3##(2008-11#3)(2008-5#1)
cell differentiation into##2##3##(2008-11#1)(2013-1#1)
cell differentiation through##2##3##(1995-8#1)(2008-11#1)
cell differentiation##43##2##(1993-3#1)(1993-6#1)(1995-8#2)(1997-7#1)(2008-11#17)(2008-4#4)(2008-5#3)(2008-8#2)(2008-9#2)(2011-2#5)(2012-2#2)(2013-1#2)(2013-7#1)
cell disease##5##2##(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
cell disruption##2##2##(2008-10#2)
cell distribution in##2##3##(2008-11#1)(2008-7#1)
cell distribution##6##2##(2008-11#2)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
cell division and##2##3##(2008-5#1)(2011-2#1)
cell division in##3##3##(1993-8#1)(1996-12#1)(2008-11#1)
cell division occurred##2##3##(2008-10#1)(2008-11#1)
cell division was##2##3##(2008-10#1)(2008-11#1)
cell division##39##2##(1991-2#1)(1993-12#1)(1993-8#3)(1994-11#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#6)(2008-4#1)(2008-5#1)(2008-9#4)(2009-10#2)(2009-5#4)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
cell divisions##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
cell dose##2##2##(2010-11#2)
cell energy##2##2##(1992-12#1)(2008-10#1)
cell engineering strategies##3##3##(2008-11#3)
cell engineering##5##2##(2008-11#5)
cell enumeration##2##2##(2008-9#2)
cell envelope##4##2##(2008-5#2)(2011-2#1)(2013-1#1)
cell epitope##2##2##(1997-8#1)(2008-11#1)
cell epitopes##7##2##(1995-5#4)(2008-4#2)(2008-5#1)
cell equipped with##3##3##(2008-10#3)
cell expansion and##3##3##(2008-10#1)(2009-8#2)
cell expansion in##2##3##(2008-11#1)(2009-8#1)
cell expansion##6##2##(2008-10#1)(2008-11#1)(2009-8#4)
cell expression##2##2##(2008-11#2)
cell extracts by##2##3##(1992-6#1)(2008-10#1)
cell extracts from##2##3##(1994-8#1)(2008-9#1)
cell extracts were##2##3##(1990-5#1)(2008-6#1)
cell extracts##13##2##(1990-5#2)(1992-6#1)(1994-5#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-6#2)(2008-9#1)(2012-2#1)
cell fate decisions##4##3##(2008-11#2)(2009-12#1)(2009-8#1)
cell fate##10##2##(1993-6#1)(1994-12#1)(2008-11#5)(2009-12#1)(2009-8#1)(2010-11#1)
cell fates##3##2##(2009-12#2)(2009-8#1)
cell filling##2##2##(2008-4#1)(2012-2#1)
cell firing##4##2##(1994-2#2)(2008-11#2)
cell for slab optical waveguide##2##5##(2008-10#2)
cell for the determination of##2##5##(2008-10#2)
cell for the##4##3##(2008-10#3)(2008-11#1)
cell for use with##2##4##(2008-10#2)
cell for##22##2##(2008-10#15)(2008-11#3)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
cell fraction and##2##3##(2008-7#1)(2009-3#1)
cell fraction##8##2##(1990-5#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)
cell fractionation techniques##2##3##(1995-6#1)(2008-4#1)
cell fractionation##3##2##(1995-6#1)(2008-11#1)(2008-4#1)
cell from##2##2##(1997-3#1)(2013-7#1)
cell function and##2##3##(1992-12#1)(2008-10#1)
cell function in the##2##4##(2008-11#1)(2009-10#1)
cell function##17##2##(1992-12#2)(1992-6#1)(1995-2#1)(1995-5#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-10#1)(2009-8#2)(2011-2#1)(2013-1#1)
cell functions and##2##3##(1993-8#1)(2008-11#1)
cell functions including##2##3##(2008-5#1)(2009-8#1)
cell functions##11##2##(1993-12#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#2)(2012-3#1)
cell fusion and##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
cell fusion##10##2##(1991-5#2)(1993-3#1)(2008-11#4)(2008-8#1)(2008-9#1)(2009-8#1)
cell genomic##2##2##(2008-11#1)(2012-2#1)
cell granuloma##3##2##(1991-9#2)(2011-2#1)
cell group of##2##3##(1990-5#1)(1996-5#1)
cell group##5##2##(1990-5#3)(1996-5#1)(2008-8#1)
cell growth and antibody production##2##5##(2008-11#2)
cell growth and death##2##4##(2008-11#1)(2011-2#1)
cell growth and differentiation##4##4##(1994-6#1)(2008-10#1)(2008-11#2)
cell growth and neurite extension##2##5##(2008-11#2)
cell growth and product yield##2##5##(2008-11#1)(2008-7#1)
cell growth and proliferation##2##4##(1992-8#1)(2008-11#1)
cell growth and recombinant protein production##3##6##(2008-11#3)
cell growth and##42##3##(1992-8#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#20)(2008-7#3)(2008-9#1)(2009-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
cell growth as well as##2##5##(2008-11#1)(2011-2#1)
cell growth as##3##3##(2008-11#2)(2011-2#1)
cell growth at##4##3##(1990-11#2)(2008-11#2)
cell growth control##2##3##(2011-2#2)
cell growth factor##3##3##(1991-3#2)(2009-7#1)
cell growth in S##2##4##(1996-2#1)(1997-3#1)
cell growth in a biodegradable polymer##2##6##(2008-7#2)
cell growth in a##9##4##(2008-11#6)(2008-7#3)
cell growth in the##4##4##(2008-11#4)
cell growth in##27##3##(1996-2#2)(1997-3#1)(2008-11#18)(2008-7#3)(2008-9#1)(2012-3#1)(2013-1#1)
cell growth inhibition##3##3##(2008-11#3)
cell growth is##3##3##(2008-11#2)(2009-9#1)
cell growth of##3##3##(2008-11#3)
cell growth or##2##3##(1995-6#1)(1997-7#1)
cell growth promotion##2##3##(2008-11#2)
cell growth rate##4##3##(2008-11#3)(2008-7#1)
cell growth to##2##3##(1994-11#1)(2011-2#1)
cell growth was observed##2##4##(2008-11#2)
cell growth was##8##3##(2008-11#7)(2008-9#1)
cell growth with high##2##4##(2008-11#1)(2008-8#1)
cell growth with##4##3##(2008-11#3)(2008-8#1)
cell growth##198##2##(1990-11#2)(1990-5#2)(1990-6#1)(1991-12#1)(1991-3#4)(1991-5#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#4)(1997-1#2)(1997-3#2)(1997-7#3)(2008-10#1)(2008-11#109)(2008-7#11)(2008-8#1)(2008-9#7)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2011-1#1)(2011-2#10)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)
cell has a##2##3##(2007-12#1)(2012-3#1)
cell has been developed##2##4##(2008-10#2)
cell has been##5##3##(2008-10#5)
cell has##8##2##(2007-12#1)(2008-10#5)(2008-7#1)(2012-3#1)
cell hepatitis##3##2##(2008-5#3)
cell homogenates##3##2##(1993-8#1)(1995-11#1)(2008-11#1)
cell hybrid##2##2##(1994-11#1)(1997-2#1)
cell hybrids##2##2##(1995-2#1)(1997-9#1)
cell hyperplasia##2##2##(2011-2#1)(2012-2#1)
cell identification##2##2##(2008-9#2)
cell imaging##4##2##(2008-10#2)(2009-10#1)(2012-2#1)
cell in a##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
cell in the##10##3##(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)
cell in##17##2##(1996-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)
cell induced by##2##3##(2008-11#1)(2008-9#1)
cell infiltrates##4##2##(2008-10#1)(2013-1#3)
cell infiltration and##2##3##(2008-10#1)(2011-2#1)
cell infiltration##5##2##(2008-10#2)(2011-2#1)(2013-1#2)
cell injury##5##2##(1995-11#2)(1995-2#1)(2008-11#1)(2009-9#1)
cell integrity##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
cell interactions##2##2##(2008-11#1)(2012-4#1)
cell into##4##2##(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
cell invasion beneath mesothelial-cell##2##4##(2008-11#2)
cell invasion##11##2##(2008-11#9)(2012-2#1)(2013-8#1)
cell is a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
cell is designed##2##3##(2008-10#2)
cell is##25##2##(1993-8#1)(1995-9#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)
cell isolation##5##2##(2008-11#4)(2008-9#1)
cell killing of HL-60 cells by##2##6##(1993-8#2)
cell killing of HL-60 cells##3##5##(1993-8#3)
cell killing##11##2##(1991-5#1)(1993-8#4)(1995-8#3)(2008-11#1)(2008-8#1)(2008-9#1)
cell kinetics##4##2##(1993-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
cell layer##4##2##(2011-2#1)(2013-8#3)
cell layers of##3##3##(2008-10#3)
cell layers##8##2##(1994-11#1)(2008-10#6)(2009-10#1)
cell leukemia##9##2##(1992-6#1)(1997-5#1)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#2)
cell level in##2##3##(2007-12#1)(2008-6#1)
cell level##6##2##(2007-12#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-2#1)
cell line HUH7-ins##2##3##(2010-11#2)
cell line PC12##5##3##(2008-11#5)
cell line THP-1##2##3##(1993-6#1)(1995-6#1)
cell line allows for##2##4##(2008-11#2)
cell line and##10##3##(2008-10#1)(2008-11#8)(2008-9#1)
cell line by##5##3##(2008-11#3)(2008-4#1)(2008-9#1)
cell line capable##2##3##(2008-11#2)
cell line cross-contamination##3##3##(2008-11#3)
cell line derived from##4##4##(2008-10#1)(2008-11#2)(2008-9#1)
cell line development##3##3##(2008-11#3)
cell line expressing##2##3##(2008-11#2)
cell line for##4##3##(2008-11#2)(2008-9#1)(2012-2#1)
cell line from##4##3##(1995-11#2)(2008-11#1)(2013-1#1)
cell line had different##2##4##(2008-8#2)
cell line has##2##3##(2008-11#2)
cell line in##8##3##(2008-11#7)(2008-9#1)
cell line is a##2##4##(1990-5#1)(1994-12#1)
cell line is##7##3##(1990-5#2)(1994-12#1)(1997-1#1)(2008-11#3)
cell line named##2##3##(2008-11#2)
cell line of##7##3##(2008-10#1)(2008-11#6)
cell line producing##3##3##(1997-2#1)(2008-11#2)
cell line showed##2##3##(2008-10#1)(2011-2#1)
cell line stably##2##3##(2008-8#2)
cell line that was##2##4##(2008-11#1)(2011-2#1)
cell line that##5##3##(1990-7#1)(1993-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
cell line to##6##3##(1990-6#1)(1994-8#1)(2008-11#3)(2009-12#1)
cell line transfected with##4##4##(2008-11#2)(2008-4#1)(2008-7#1)
cell line under##2##3##(1993-8#1)(2008-11#1)
cell line used##2##3##(2008-11#2)
cell line using##2##3##(2008-11#2)
cell line was established##2##4##(2008-11#2)
cell line was examined##2##4##(1994-5#2)
cell line was##13##3##(1994-5#2)(2008-11#11)
cell line were##4##3##(2008-11#3)(2012-2#1)
cell line which##4##3##(1990-8#1)(2008-11#3)
cell line with a##2##4##(1996-12#1)(2008-11#1)
cell line with##6##3##(1994-12#1)(1996-12#1)(1997-1#1)(2008-11#3)
cell line##409##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#10)(1990-6#2)(1990-7#1)(1990-8#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#4)(1994-11#7)(1994-12#2)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#3)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-6#5)(1995-8#2)(1996-12#2)(1996-2#5)(1997-1#8)(1997-2#4)(1997-7#2)(1997-8#1)(1997-9#1)(2008-10#10)(2008-11#224)(2008-12#3)(2008-4#5)(2008-7#7)(2008-8#19)(2008-9#18)(2009-10#1)(2009-12#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-2#3)(2013-1#5)(2013-8#1)
cell line)##4##2##(1994-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
cell lineage of##3##3##(1995-2#1)(2007-12#1)(2012-3#1)
cell lineage##8##2##(1995-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-3#1)
cell lineages in##2##3##(1995-12#1)(1995-2#1)
cell lineages##12##2##(1990-5#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-6#2)(1997-7#1)(2008-11#1)(2008-4#1)(2013-8#1)
cell lines and have##2##4##(2008-11#2)
cell lines and primary##2##4##(1994-5#1)(1997-7#1)
cell lines and that##3##4##(2008-11#2)(2008-8#1)
cell lines and##22##3##(1994-5#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-11#12)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
cell lines are##7##3##(1992-4#1)(1992-6#1)(1995-12#1)(2008-11#3)(2008-4#1)
cell lines as##2##3##(2008-11#2)
cell lines by FISH##2##4##(2008-11#2)
cell lines by limiting dilution##2##5##(2008-11#1)(2008-9#1)
cell lines by##10##3##(1997-7#1)(2008-11#6)(2008-12#2)(2008-9#1)
cell lines can##3##3##(1990-5#1)(1997-7#1)(2008-11#1)
cell lines derived from##7##4##(1993-8#1)(1995-12#1)(2008-11#3)(2008-4#1)(2008-8#1)
cell lines differed##2##3##(2008-11#2)
cell lines during##3##3##(1992-8#1)(2008-11#1)(2008-7#1)
cell lines established##2##3##(1992-8#1)(2008-9#1)
cell lines examined##3##3##(1993-3#1)(1995-12#1)(2008-11#1)
cell lines following##2##3##(1996-12#1)(1997-7#1)
cell lines for##4##3##(2008-11#3)(2012-2#1)
cell lines from##5##3##(1992-6#1)(1995-2#1)(2008-11#2)(2008-9#1)
cell lines has##4##3##(1996-2#1)(2008-11#2)(2008-4#1)
cell lines have been widely used##2##6##(2008-11#2)
cell lines have been##4##4##(2008-11#4)
cell lines have##8##3##(2008-11#8)
cell lines in vitro and##2##5##(1995-6#1)(2008-4#1)
cell lines in vitro##3##4##(1995-6#1)(2008-4#1)(2011-3#1)
cell lines in##12##3##(1994-5#1)(1995-6#1)(1997-1#2)(2008-11#5)(2008-4#1)(2011-3#1)(2013-8#1)
cell lines is##3##3##(1994-8#1)(2008-11#2)
cell lines of##5##3##(1993-12#1)(1995-2#1)(2008-11#2)(2013-1#1)
cell lines on##2##3##(2008-11#1)(2008-7#1)
cell lines or##4##3##(1997-3#1)(2008-11#3)
cell lines secreting##2##3##(2008-10#1)(2008-11#1)
cell lines showed##2##3##(1992-8#1)(2008-11#1)
cell lines such as##2##4##(2008-11#2)
cell lines that are##3##4##(1992-7#1)(2008-11#2)
cell lines that##9##3##(1992-7#1)(1994-5#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#4)
cell lines to##6##3##(1992-6#1)(1993-8#1)(2008-11#3)(2008-9#1)
cell lines transfected with##2##4##(2008-11#1)(2008-9#1)
cell lines using##2##3##(2008-11#2)
cell lines was##6##3##(1990-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
cell lines were established##2##4##(1992-8#1)(2008-11#1)
cell lines were##15##3##(1991-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-8#1)(2008-11#6)(2008-9#1)
cell lines which##3##3##(1993-12#1)(1993-6#1)(2008-11#1)
cell lines with particular reference to##2##6##(1992-2#1)(2008-11#1)
cell lines with##7##3##(1992-2#1)(1995-6#1)(2008-11#3)(2008-8#1)(2012-2#1)
cell lines##415##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#4)(1990-8#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#3)(1992-4#4)(1992-6#5)(1992-7#1)(1992-8#9)(1993-1#1)(1993-12#3)(1993-3#5)(1993-6#7)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#4)(1995-12#12)(1995-2#6)(1995-3#1)(1995-6#5)(1995-9#1)(1996-12#2)(1996-2#3)(1997-1#3)(1997-3#1)(1997-7#9)(1997-8#3)(2008-10#6)(2008-11#199)(2008-12#3)(2008-2#1)(2008-4#8)(2008-7#4)(2008-8#13)(2008-9#25)(2009-12#1)(2009-4#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#9)(2013-1#6)(2013-8#3)
cell lipoma##3##2##(1990-12#3)
cell longevity and##2##3##(2008-11#2)
cell loss and##4##3##(2008-5#1)(2008-7#1)(2011-2#2)
cell loss by##2##3##(1994-11#1)(2010-11#1)
cell loss from##4##3##(2009-10#1)(2010-11#2)(2012-2#1)
cell loss##13##2##(1994-11#1)(1994-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-11#3)(2011-2#3)(2012-2#1)
cell lung cancer (NSCLC)##4##4##(1993-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
cell lung cancer##21##3##(1993-2#1)(1993-9#1)(1994-12#2)(1994-8#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-1#2)(2012-2#3)(2013-1#2)(2013-8#2)
cell lung carcinoma##5##3##(1994-8#2)(1996-12#2)(1997-5#1)
cell lung##29##2##(1993-2#1)(1993-9#1)(1994-12#2)(1994-8#3)(1996-12#2)(1996-2#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-1#2)(2012-2#4)(2013-1#3)(2013-8#2)
cell lymphoma in##2##3##(2009-1#1)(2009-7#1)
cell lymphoma is##3##3##(2009-8#3)
cell lymphoma of##3##3##(2009-8#2)(2013-1#1)
cell lymphoma##17##2##(2009-1#2)(2009-7#5)(2009-8#8)(2012-3#1)(2013-1#1)
cell lymphomas##6##2##(1993-9#1)(2008-9#2)(2009-8#1)(2013-1#2)
cell lysate was##2##3##(1994-11#1)(2010-11#1)
cell lysate##6##2##(1994-11#1)(2008-10#2)(2008-9#1)(2009-3#1)(2010-11#1)
cell lysates were##2##3##(2008-7#1)(2011-2#1)
cell lysates##8##2##(1991-9#1)(1992-10#1)(2008-4#1)(2008-7#4)(2011-2#1)
cell lysis##8##2##(1996-6#1)(2008-10#2)(2008-7#2)(2011-2#1)(2013-1#2)
cell made of glass##2##4##(2008-10#2)
cell made##3##2##(2008-10#3)
cell maintenance and##3##3##(2008-11#1)(2009-8#1)(2013-8#1)
cell marker##4##2##(2008-11#1)(2008-6#1)(2009-10#1)(2012-5#1)
cell markers##5##2##(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-5#1)
cell mass##8##2##(1997-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-6#1)(2011-2#1)(2013-8#1)
cell media##2##2##(2008-11#1)(2008-8#1)
cell mediated##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
cell membrane and##3##3##(2008-8#1)(2011-3#1)(2012-2#1)
cell membrane of##3##3##(1990-5#1)(2009-8#1)(2013-7#1)
cell membrane##40##2##(1990-12#2)(1990-2#2)(1990-5#1)(1991-5#2)(1993-11#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2009-9#2)(2011-3#2)(2012-2#2)(2013-7#1)(2013-8#1)
cell membranes was##2##3##(1993-6#1)(2008-9#1)
cell membranes##23##2##(1991-3#1)(1991-5#4)(1992-12#1)(1993-6#3)(1994-8#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-6#1)
cell metabolic##2##2##(2008-10#1)(2008-11#1)
cell metabolism and##2##3##(2008-7#1)(2013-1#1)
cell metabolism by##2##3##(2008-11#1)(2008-7#1)
cell metabolism##15##2##(2008-11#7)(2008-7#5)(2011-2#1)(2013-1#2)
cell migration have##2##3##(2011-2#2)
cell migration in##2##3##(2011-2#2)
cell migration##21##2##(1991-5#1)(1992-6#1)(1996-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-1#1)(2011-2#10)(2013-8#1)
cell mitogen##4##2##(1992-6#1)(1995-2#1)(2008-11#2)
cell mitosis##2##2##(2008-11#1)(2012-2#1)
cell model##2##2##(2008-11#2)
cell models##4##2##(2008-11#2)(2008-4#1)(2012-2#1)
cell monolayer##7##2##(1993-12#2)(2008-11#2)(2011-3#3)
cell monolayers##9##2##(2008-10#2)(2008-11#7)
cell morphology and##3##3##(2008-11#2)(2008-8#1)
cell morphology##11##2##(2008-11#6)(2008-8#2)(2008-9#2)(2011-2#1)
cell motility and##4##3##(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
cell motility##9##2##(2008-11#2)(2008-5#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
cell movement##4##2##(1996-2#1)(2009-10#3)
cell multiplication was observed##2##4##(2008-11#2)
cell multiplication##4##2##(2008-10#1)(2008-11#3)
cell myogenesis##2##2##(1993-3#2)
cell necrosis##6##2##(1992-5#1)(2008-10#3)(2008-11#1)(2011-10#1)
cell neuroendocrine carcinoma of##2##4##(2012-3#1)(2013-1#1)
cell neuroendocrine carcinoma##3##3##(2012-3#1)(2013-1#2)
cell neuroendocrine##4##2##(2012-3#1)(2013-1#3)
cell nodules were##2##3##(2008-11#2)
cell nodules##4##2##(2008-11#4)
cell nuclear antigen (PCNA)##4##4##(1994-12#1)(1994-8#1)(1995-6#1)(2011-2#1)
cell nuclear antigen##8##3##(1991-8#1)(1992-10#1)(1994-12#1)(1994-8#1)(1995-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
cell nuclear extracts##4##3##(1993-6#3)(1993-8#1)
cell nuclear##12##2##(1991-8#1)(1992-10#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
cell nuclei were##2##3##(1991-5#1)(2010-8#1)
cell nuclei##10##2##(1991-5#1)(1993-11#1)(1993-12#1)(1994-11#1)(2008-8#1)(2008-9#1)(2010-8#4)
cell nucleus##6##2##(1991-2#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
cell number and##5##3##(1991-6#1)(1995-2#1)(2008-11#2)(2008-7#1)
cell number##32##2##(1991-6#1)(1992-3#1)(1992-8#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-11#17)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2012-3#1)
cell numbers and##2##3##(2008-10#1)(2012-5#1)
cell numbers in##5##3##(1994-2#1)(1995-12#2)(2008-11#1)(2013-1#1)
cell numbers##19##2##(1994-2#1)(1995-12#2)(1995-3#1)(1995-8#1)(2008-10#2)(2008-11#5)(2008-7#2)(2011-2#3)(2012-5#1)(2013-1#1)
cell of the##6##3##(2008-10#3)(2008-3#1)(2008-6#1)(2012-2#1)
cell of##9##2##(2008-10#5)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#1)
cell on##2##2##(2008-10#1)(2008-8#1)
cell or##6##2##(1991-10#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)
cell origin##2##2##(1994-5#1)(2012-3#1)
cell output##2##2##(2008-11#2)
cell pH##2##2##(1995-8#2)
cell parameters##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)
cell passages##2##2##(2008-11#1)(2008-5#1)
cell phenotype##6##2##(2008-11#2)(2010-11#1)(2012-2#3)
cell phone##3##2##(2011-1#2)(2013-1#1)
cell physiology##6##2##(1994-11#1)(2008-11#3)(2011-2#2)
cell placed##2##2##(2008-10#2)
cell plasma membrane##2##3##(1991-3#1)(2011-3#1)
cell plasticity##2##2##(2008-11#2)
cell plate expansion during##2##4##(2009-10#2)
cell plate expansion##3##3##(2009-10#3)
cell polarity##5##2##(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#2)
cell pool##2##2##(2008-11#1)(2013-1#1)
cell pools##4##2##(2008-11#4)
cell population as a whole##2##5##(2008-11#2)
cell population as##3##3##(1995-9#1)(2008-11#2)
cell population in the##3##4##(1997-1#1)(2008-11#1)(2010-7#1)
cell population in##6##3##(1997-1#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
cell population is##2##3##(1990-12#1)(2008-11#1)
cell population that##2##3##(2008-7#1)(2012-12#1)
cell population was##2##3##(2008-11#1)(2008-7#1)
cell population were##2##3##(2008-11#1)(2012-4#1)
cell population##46##2##(1990-12#1)(1990-8#1)(1991-8#1)(1994-5#1)(1994-8#1)(1995-9#1)(1997-1#1)(2008-10#3)(2008-11#18)(2008-7#5)(2008-9#2)(2010-7#3)(2011-2#2)(2012-12#1)(2012-4#1)(2013-1#2)(2013-8#2)
cell populations and##2##3##(2008-11#1)(2013-1#1)
cell populations were##2##3##(1990-6#1)(1995-11#1)
cell populations with##2##3##(2008-11#2)
cell populations##27##2##(1990-6#1)(1991-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(2008-11#8)(2008-7#1)(2008-9#5)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
cell preparation##2##2##(2008-9#1)(2010-6#1)
cell preparations##3##2##(1994-6#1)(2008-4#2)
cell probe##2##2##(2008-11#2)
cell processes##4##2##(1994-11#1)(2008-11#1)(2008-6#1)(2010-7#1)
cell produced##2##2##(2008-11#2)
cell production##4##2##(2008-10#2)(2008-11#2)
cell progenitor activity in culture##2##5##(2008-4#2)
cell progenitor##4##2##(1995-6#1)(2008-4#2)(2010-10#1)
cell progenitors##4##2##(1995-6#1)(2008-4#3)
cell proliferation after##2##3##(1997-8#1)(2013-1#1)
cell proliferation and cell##2##4##(2008-11#1)(2008-9#1)
cell proliferation and differentiation were##2##5##(2008-9#1)(2012-2#1)
cell proliferation and differentiation##5##4##(1993-3#1)(1995-12#1)(2008-11#1)(2008-9#1)(2012-2#1)
cell proliferation and survival##2##4##(2013-1#1)(2013-8#1)
cell proliferation and the##2##4##(1992-3#1)(2008-11#1)
cell proliferation and transformation##2##4##(1994-9#1)(2008-11#1)
cell proliferation and##32##3##(1990-12#1)(1992-3#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1997-1#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-9#4)(2009-12#1)(2010-6#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
cell proliferation assay##2##3##(1993-8#1)(2008-11#1)
cell proliferation by##4##3##(1995-2#2)(2008-9#2)
cell proliferation during##2##3##(1994-3#1)(2008-11#1)
cell proliferation in##10##3##(1990-11#1)(1990-6#1)(1995-11#2)(1995-12#1)(1995-9#1)(2008-11#2)(2011-2#1)(2012-2#1)
cell proliferation induced by##2##4##(1990-12#1)(1994-9#1)
cell proliferation is##2##3##(2008-7#1)(2011-2#1)
cell proliferation of##4##3##(1997-1#1)(2008-11#3)
cell proliferation or##2##3##(1992-8#1)(2008-11#1)
cell proliferation rate##3##3##(1991-8#1)(2008-11#1)(2012-3#1)
cell proliferation was##2##3##(2008-11#1)(2012-3#1)
cell proliferation were##5##3##(2008-11#4)(2008-5#1)
cell proliferation##116##2##(1990-11#3)(1990-12#3)(1990-5#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-11#4)(1995-12#3)(1995-2#7)(1995-9#1)(1997-1#2)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#33)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#9)(2009-12#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#5)(2012-2#7)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
cell protein content##4##3##(1992-8#1)(1995-9#2)(2008-11#1)
cell protein per min##2##4##(1992-3#1)(2008-11#1)
cell protein##13##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-3#1)(1992-8#2)(1995-9#2)(2008-11#5)
cell proteins##2##2##(1993-6#1)(2008-12#1)
cell protoplasts##6##2##(2008-10#1)(2008-8#5)
cell ratio##2##2##(1990-12#1)(2008-10#1)
cell reaction##3##2##(2008-10#2)(2008-5#1)
cell reactivity##3##2##(2013-1#3)
cell receptor and##2##3##(1991-9#1)(2010-8#1)
cell receptor##12##2##(1991-9#1)(1994-3#1)(1995-8#1)(2007-12#1)(2008-11#4)(2008-4#2)(2009-8#1)(2010-8#1)
cell receptors##4##2##(1995-2#1)(2008-4#2)(2008-9#1)
cell recognition##2##2##(1990-8#1)(1995-5#1)
cell recovery and##2##3##(2008-11#2)
cell recovery##4##2##(2008-11#4)
cell recruitment to the##2##4##(2008-10#1)(2013-1#1)
cell regeneration##4##2##(2008-10#1)(2008-11#1)(2013-1#1)(2013-7#1)
cell replacement##2##2##(2008-11#2)
cell research is##2##3##(2008-11#1)(2008-9#1)
cell research will##2##3##(2008-10#1)(2008-11#1)
cell research##11##2##(2008-10#2)(2008-11#5)(2008-9#3)(2013-8#1)
cell response to##3##3##(2008-10#1)(2008-11#1)(2010-11#1)
cell response##12##2##(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#6)(2010-11#1)(2012-2#1)
cell responses in the##2##4##(1996-12#1)(2008-10#1)
cell responses in##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
cell responses to##3##3##(1990-5#1)(1997-8#1)(2008-4#1)
cell responses##15##2##(1990-5#1)(1993-6#1)(1995-5#3)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-6#1)(2012-3#1)
cell responsiveness to##2##3##(1990-11#1)(1990-5#1)
cell retention and##2##3##(2008-11#2)
cell retention##7##2##(2008-11#7)
cell samples##2##2##(1990-12#1)(2009-12#1)
cell sarcoma##3##2##(2011-2#1)(2013-1#2)
cell secretion##3##2##(1992-8#1)(1994-11#1)(2008-11#1)
cell seeding##4##2##(1990-6#1)(2008-11#2)(2009-12#1)
cell separation##8##2##(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2013-1#1)
cell shape and##5##3##(2008-11#1)(2009-8#1)(2011-2#2)(2012-2#1)
cell shape##14##2##(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-2#2)
cell signaling and##2##3##(2008-10#1)(2008-9#1)
cell signaling##9##2##(1991-9#1)(1994-11#1)(2008-1#1)(2008-10#2)(2008-9#2)(2011-2#2)
cell signalling##4##2##(1994-11#1)(2010-10#3)
cell size and##2##3##(2008-11#1)(2008-4#1)
cell size during##2##3##(1995-9#1)(2008-7#1)
cell size increase##2##3##(1995-9#2)
cell size of P##2##4##(2008-10#2)
cell size when##2##3##(2008-11#1)(2008-8#1)
cell size##27##2##(1995-9#4)(2008-10#4)(2008-11#8)(2008-4#2)(2008-7#7)(2008-8#1)(2013-1#1)
cell sizes in##2##3##(2008-11#1)(2011-2#1)
cell sizes##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
cell sorting##9##2##(1992-6#1)(2008-11#2)(2008-4#2)(2008-9#2)(2011-2#2)
cell source##2##2##(2008-11#2)
cell specific perfusion rates##3##4##(2008-11#3)
cell specific perfusion##4##3##(2008-11#4)
cell specific##12##2##(1992-9#1)(1995-11#1)(1995-3#1)(2008-11#8)(2008-4#1)
cell strain##4##2##(1991-2#4)
cell structure##3##2##(2008-7#1)(2008-9#1)(2009-10#1)
cell studies##2##2##(2008-11#1)(2012-2#1)
cell sublines##2##2##(2008-11#2)
cell subpopulation##2##2##(2008-11#1)(2011-2#1)
cell subpopulations##3##2##(1991-1#1)(2008-11#2)
cell subsets in the##2##4##(1993-8#1)(2012-2#1)
cell subsets in##3##3##(1993-8#1)(2008-9#1)(2012-2#1)
cell subsets using magnetic##2##4##(2008-4#2)
cell subsets##9##2##(1993-8#1)(1994-8#1)(2008-11#1)(2008-4#3)(2008-9#2)(2012-2#1)
cell suicide##2##2##(2008-11#1)(2008-9#1)
cell surface FcepsilonRI expression was observed in about##2##8##(2008-11#2)
cell surface FcepsilonRI expression##3##4##(2008-11#3)
cell surface IL-1 receptors##2##4##(1995-2#2)
cell surface IL-1##3##3##(1995-2#3)
cell surface and##3##3##(1995-2#1)(2008-11#1)(2008-4#1)
cell surface antigen##5##3##(2008-10#1)(2008-11#2)(2008-9#2)
cell surface antigens##2##3##(1995-6#1)(2008-9#1)
cell surface characteristics##2##3##(2008-12#1)(2008-5#1)
cell surface expression of FcepsilonRI on##2##6##(2008-11#2)
cell surface expression of FcepsilonRI##3##5##(2008-11#3)
cell surface expression of##5##4##(1997-9#1)(2008-11#4)
cell surface expression##6##3##(1997-9#1)(2008-10#1)(2008-11#4)
cell surface marker##2##3##(2008-11#2)
cell surface markers##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
cell surface molecules##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
cell surface of##6##3##(2008-10#2)(2008-11#3)(2008-5#1)
cell surface receptor##7##3##(1992-12#1)(1994-11#1)(1994-5#2)(1995-2#1)(1996-2#1)(2010-8#1)
cell surface receptors##8##3##(1994-11#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#2)(2009-9#1)(2011-2#1)
cell surface##107##2##(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#3)(1995-2#8)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#4)(1997-7#1)(1997-9#1)(2007-12#1)(2008-10#14)(2008-11#22)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-6#1)(2009-8#1)(2009-9#6)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)
cell surface-associated##2##2##(1996-12#2)
cell surfaces##6##2##(1995-2#2)(1995-5#1)(2008-5#1)(2008-8#1)(2009-8#1)
cell survival and##2##3##(2008-10#1)(2010-1#1)
cell survival in##3##3##(2008-10#1)(2008-11#2)
cell survival##19##2##(1993-8#2)(1994-2#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
cell suspension culture##2##3##(2008-9#1)(2009-6#1)
cell suspension is##2##3##(2008-11#1)(2008-8#1)
cell suspension##16##2##(1994-8#2)(2008-10#1)(2008-11#9)(2008-8#2)(2008-9#1)(2009-6#1)
cell suspensions##8##2##(1990-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)
cell system##14##2##(1992-3#1)(1997-1#2)(1997-7#1)(2008-10#1)(2008-11#5)(2008-4#2)(2008-7#2)
cell systems##7##2##(2008-11#6)(2013-8#1)
cell technology##3##2##(2008-11#3)
cell that##8##2##(1995-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
cell therapies##2##2##(2008-11#1)(2013-1#1)
cell therapy for##2##3##(1991-8#1)(2012-3#1)
cell therapy in##3##3##(1994-6#1)(2009-10#1)(2012-3#1)
cell therapy##18##2##(1991-8#1)(1994-6#6)(2008-10#1)(2008-11#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-3#2)(2012-4#1)(2013-1#1)
cell through##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
cell to be##2##3##(2008-10#2)
cell to cell##2##3##(1997-8#1)(2008-11#1)
cell to##21##2##(1992-9#1)(1993-3#2)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2013-8#1)
cell transfer##4##2##(2008-11#3)(2008-4#1)
cell transferrin##2##2##(1990-8#2)
cell transformation##2##2##(2008-11#2)
cell transplant##4##2##(2010-10#1)(2010-11#1)(2012-12#1)(2013-1#1)
cell transplantation for##2##3##(2010-10#1)(2012-12#1)
cell transplantation##24##2##(1997-8#1)(2008-10#1)(2008-11#5)(2008-7#1)(2010-10#3)(2010-11#6)(2011-2#2)(2012-12#4)(2013-1#1)
cell tumor of the salivary gland##2##6##(2009-3#2)
cell tumor of the##3##4##(2009-3#3)
cell tumor##10##2##(1993-3#1)(1994-6#1)(2007-12#2)(2009-3#3)(2010-12#1)(2011-2#1)(2012-3#1)
cell tumors of the##3##4##(1991-8#1)(2007-8#2)
cell tumors##5##2##(1991-8#1)(2007-8#2)(2011-2#1)(2012-12#1)
cell tumours is##2##3##(1990-2#1)(2008-2#1)
cell tumours##11##2##(1990-2#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-5#1)(2011-2#3)
cell type of##2##3##(2008-7#1)(2013-1#1)
cell type specific##3##3##(2008-11#2)(2009-8#1)
cell type##24##2##(1991-11#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#2)(2008-10#2)(2008-11#4)(2008-7#2)(2008-9#1)(2009-8#3)(2013-1#2)
cell type-specific##4##2##(1993-8#1)(1995-11#1)(1995-8#1)(2012-3#1)
cell types and##5##3##(1990-5#1)(2008-11#2)(2009-12#1)(2012-3#1)
cell types are##2##3##(2007-12#1)(2008-12#1)
cell types have been##2##4##(2008-11#1)(2012-3#1)
cell types in the##3##4##(2008-11#1)(2009-8#1)(2010-11#1)
cell types in##9##3##(1992-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-11#1)
cell types including##2##3##(2008-11#1)(2008-7#1)
cell types of the##2##4##(2008-10#1)(2009-10#1)
cell types of##4##3##(1995-6#1)(2008-10#1)(2008-11#1)(2009-10#1)
cell types such as##2##4##(2008-11#1)(2012-3#1)
cell types that are##2##4##(2008-10#1)(2011-2#1)
cell types that##3##3##(2008-10#2)(2011-2#1)
cell types##92##2##(1990-2#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-11#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#2)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#24)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#5)(2009-10#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-3#6)(2012-5#1)(2013-1#1)
cell uptake of##2##3##(1997-1#2)
cell using##4##2##(2008-10#4)
cell viabilities##2##2##(2008-11#2)
cell viability and##7##3##(1995-2#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2012-3#1)
cell viability has##2##3##(2008-11#1)(2013-1#1)
cell viability in##5##3##(2008-11#4)(2013-1#1)
cell viability of##4##3##(2008-11#2)(2010-10#1)(2012-3#1)
cell viability was##6##3##(2008-11#3)(2009-9#1)(2012-3#1)(2013-1#1)
cell viability##56##2##(1990-6#2)(1995-2#1)(1995-8#1)(1996-3#2)(2008-10#2)(2008-11#24)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
cell volume and##4##3##(1992-12#1)(1993-8#1)(2008-10#1)(2013-8#1)
cell volume was##2##3##(1992-12#1)(2008-7#1)
cell volume##12##2##(1992-12#5)(1992-8#2)(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
cell wall and##3##3##(2008-10#2)(2010-3#1)
cell wall components##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
cell wall degradation##2##3##(2008-10#1)(2011-10#1)
cell wall fortification of rice leaves##2##6##(2008-10#2)
cell wall glycoproteins##2##3##(2008-5#2)
cell wall materials##3##3##(2008-10#3)
cell wall of##3##3##(2008-10#2)(2008-5#1)
cell wall polymer##2##3##(1990-2#1)(2011-2#1)
cell wall strengthening##3##3##(2008-10#2)(2009-6#1)
cell wall thickness##2##3##(2008-10#2)
cell wall was##3##3##(2008-10#2)(2008-8#1)
cell wall##90##2##(1990-2#1)(1990-5#1)(1995-6#2)(1996-12#1)(2008-10#58)(2008-11#3)(2008-5#7)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#1)(2009-6#1)(2010-3#1)(2011-10#1)(2011-2#4)(2012-2#1)
cell wall-associated##3##2##(2008-10#3)
cell wall-degrading enzymes##2##3##(2008-10#2)
cell wall-degrading##3##2##(2008-10#3)
cell walls of##7##3##(2008-10#6)(2008-11#1)
cell walls were##2##3##(2008-10#2)
cell walls##33##2##(2008-10#29)(2008-11#1)(2009-10#1)(2011-2#2)
cell was observed for the##2##5##(2008-11#2)
cell was studied##2##3##(1993-8#1)(2008-9#1)
cell was##19##2##(1990-12#1)(1993-8#1)(2008-10#8)(2008-11#7)(2008-9#2)
cell were found to be##2##5##(1990-5#1)(2008-11#1)
cell were##11##2##(1990-5#1)(1996-8#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#1)
cell which was##2##3##(2008-10#1)(2008-11#1)
cell which##5##2##(1991-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
cell will##2##2##(2008-7#1)(2009-5#1)
cell with a##7##3##(2007-12#1)(2008-10#4)(2008-12#1)(2009-12#1)
cell with##20##2##(1990-8#1)(2007-12#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)
cell##5227##1##(1990-10#1)(1990-11#13)(1990-12#21)(1990-2#13)(1990-4#1)(1990-5#42)(1990-6#15)(1990-7#1)(1990-8#12)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#7)(1991-12#5)(1991-2#10)(1991-3#11)(1991-5#20)(1991-6#6)(1991-8#12)(1991-9#7)(1992-1#1)(1992-10#7)(1992-11#2)(1992-12#23)(1992-2#7)(1992-3#17)(1992-4#4)(1992-5#2)(1992-6#18)(1992-7#1)(1992-8#17)(1992-9#5)(1993-1#2)(1993-11#8)(1993-12#16)(1993-2#5)(1993-3#24)(1993-5#1)(1993-6#29)(1993-8#51)(1993-9#7)(1994-11#47)(1994-12#19)(1994-2#13)(1994-3#15)(1994-5#17)(1994-6#16)(1994-8#30)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#28)(1995-12#40)(1995-2#52)(1995-3#8)(1995-5#19)(1995-6#38)(1995-8#31)(1995-9#22)(1996-11#2)(1996-12#34)(1996-2#32)(1996-3#6)(1996-5#7)(1996-6#2)(1996-8#2)(1997-1#40)(1997-2#8)(1997-3#30)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#37)(1997-8#14)(1997-9#4)(2006-6#1)(2007-11#2)(2007-12#38)(2007-8#3)(2008-1#13)(2008-10#648)(2008-11#1615)(2008-12#28)(2008-2#17)(2008-3#25)(2008-4#105)(2008-5#80)(2008-6#12)(2008-7#175)(2008-8#132)(2008-9#271)(2009-1#8)(2009-10#35)(2009-11#2)(2009-12#29)(2009-3#16)(2009-4#6)(2009-5#12)(2009-6#23)(2009-7#17)(2009-8#77)(2009-9#18)(2010-1#12)(2010-10#14)(2010-11#23)(2010-12#13)(2010-2#3)(2010-3#5)(2010-4#2)(2010-5#6)(2010-6#11)(2010-7#9)(2010-8#14)(2010-9#4)(2011-1#16)(2011-10#2)(2011-2#192)(2011-3#17)(2011-9#1)(2012-12#17)(2012-2#106)(2012-3#71)(2012-4#4)(2012-5#14)(2013-1#130)(2013-7#12)(2013-8#41)
cell's##4##1##(2008-11#1)(2009-8#2)(2011-2#1)
cell(-1)##7##1##(2008-10#2)(2008-11#5)
cell) and##2##2##(2008-11#1)(2013-7#1)
cell)##12##1##(1990-5#1)(1993-6#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#1)(2013-7#1)
cell-##5##1##(1995-8#1)(1996-2#1)(2008-10#1)(2009-8#1)(2012-2#1)
cell-adhesion molecule L1##2##3##(2008-7#2)
cell-adhesion##3##1##(2008-7#3)
cell-associated##9##1##(1990-2#1)(1992-10#2)(1993-6#2)(2008-11#3)(2008-4#1)
cell-based assay##3##2##(2008-10#1)(2011-3#2)
cell-based systems##2##2##(2008-4#2)
cell-based##22##1##(1993-8#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-8#1)
cell-binding##2##1##(1994-11#1)(2010-5#1)
cell-bound##3##1##(1991-2#1)(2008-4#1)(2008-7#1)
cell-by-cell##2##1##(2008-9#2)
cell-cell and##2##2##(2008-7#1)(2009-7#1)
cell-cell communication##5##2##(1993-2#1)(2008-9#1)(2010-7#3)
cell-cell contact##2##2##(1995-2#1)(2009-8#1)
cell-cell fusion##2##2##(2009-8#2)
cell-cell interaction and##3##3##(2008-10#1)(2009-8#2)
cell-cell interaction##4##2##(2008-10#1)(2008-11#1)(2009-8#2)
cell-cell interactions##5##2##(1993-12#1)(1994-5#1)(1996-12#1)(2008-11#1)(2010-7#1)
cell-cell signaling##2##2##(2010-7#2)
cell-cell##28##1##(1993-12#1)(1993-2#1)(1994-5#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#7)(2010-7#6)
cell-cycle arrestable##2##2##(2008-11#2)
cell-cycle specific##2##2##(2008-11#2)
cell-cycle##15##1##(1993-9#1)(2008-10#1)(2008-11#9)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
cell-dependent##4##1##(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
cell-derived##8##1##(1995-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
cell-enriched##2##1##(1994-5#1)(2013-1#1)
cell-free expression screening##2##3##(2011-2#2)
cell-free extracts##2##2##(2008-8#1)(2008-9#1)
cell-free supernatant was##2##3##(2008-5#1)(2008-7#1)
cell-free system##12##2##(1990-5#2)(1991-5#1)(1991-8#1)(1993-8#2)(1995-6#1)(1996-2#1)(1997-7#2)(2008-10#1)(2008-8#1)
cell-free##32##1##(1990-5#2)(1991-5#1)(1991-8#1)(1993-8#2)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#3)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#5)
cell-laden microcarriers##2##2##(2008-11#2)
cell-like##8##1##(2008-11#3)(2008-7#2)(2009-5#1)(2012-5#1)(2013-1#1)
cell-lysates##2##1##(2008-7#2)
cell-mediated and##2##2##(1995-12#1)(1995-2#1)
cell-mediated delivery of TNF-alpha##2##4##(2013-1#2)
cell-mediated immune responses##3##3##(1995-2#1)(2012-12#1)(2013-8#1)
cell-mediated immune##5##2##(1995-2#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
cell-mediated immunity and##2##3##(2009-12#1)(2012-3#1)
cell-mediated immunity in##2##3##(1995-12#1)(2008-8#1)
cell-mediated immunity is##2##3##(2008-4#1)(2008-5#1)
cell-mediated immunity##11##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#2)(2012-3#1)
cell-mediated##28##1##(1991-12#1)(1994-11#1)(1994-5#1)(1995-12#2)(1995-2#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
cell-penetrating peptides##3##2##(2010-10#1)(2011-3#2)
cell-penetrating##4##1##(2010-10#1)(2011-3#3)
cell-retention##2##1##(2008-11#2)
cell-specific and##3##2##(1992-6#1)(2008-11#1)(2008-9#1)
cell-specific expression##2##2##(1995-11#1)(1995-8#1)
cell-specific manner and##2##3##(1994-5#1)(2009-8#1)
cell-specific##11##1##(1992-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
cell-surface antigens##3##2##(1990-12#2)(2008-4#1)
cell-surface expression of##2##3##(1993-6#2)
cell-surface##11##1##(1990-12#2)(1993-6#2)(1996-12#1)(2008-11#1)(2008-4#3)(2008-9#1)(2013-1#1)
cell-to-cell movement of##5##3##(2008-10#5)
cell-to-cell movement##7##2##(2008-10#7)
cell-to-cell##15##1##(2008-10#13)(2010-11#1)(2011-2#1)
cell-type##2##1##(1997-3#1)(2011-2#1)
cell-type-specific##3##1##(1995-2#1)(1995-8#1)(2012-12#1)
cell-wall##2##1##(2008-7#1)(2008-9#1)
cell/biomaterial interactions##2##2##(2008-11#2)
cell/biomaterial##3##1##(2008-11#2)(2011-3#1)
cellar##2##1##(2008-10#1)(2008-8#1)
cellline##2##1##(2008-11#2)
cellobiohydrolase I##2##2##(1993-8#2)
cellobiose##7##1##(1995-6#1)(2008-10#4)(2008-11#1)(2011-2#1)
cellophane##2##1##(2008-10#2)
cellproliferation##2##1##(2008-11#2)
cells (150 ppm) were##2##4##(2008-10#2)
cells (150 ppm)##3##3##(2008-10#3)
cells (150##4##2##(2008-10#4)
cells (APCs)##2##2##(1995-5#1)(2012-3#1)
cells (DCs)##9##2##(2008-10#1)(2008-11#3)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
cells (HSCs)##5##2##(1993-8#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-7#1)
cells (LCs)##2##2##(1996-12#1)(2007-12#1)
cells (MNCs)##3##2##(2008-11#2)(2008-9#1)
cells (MSCs)##5##2##(2008-11#2)(2008-9#1)(2009-10#1)(2010-8#1)
cells (NPCs)##2##2##(2008-7#1)(2013-7#1)
cells (OPCs)##2##2##(2008-7#1)(2012-4#1)
cells (PCs)##2##2##(1994-2#1)(2008-11#1)
cells (human##2##2##(1994-11#1)(2008-11#1)
cells (in beads)##2##3##(1994-3#2)
cells (in##3##2##(1994-3#2)(2008-4#1)
cells (r = 0##2##4##(1995-8#1)(2008-11#1)
cells (with##2##2##(1993-8#2)
cells -##2##2##(2008-11#2)
cells a##5##2##(2008-11#4)(2008-7#1)
cells according to##2##3##(2008-10#1)(2008-4#1)
cells across##4##2##(2008-11#2)(2009-8#1)(2012-2#1)
cells adapted to##3##3##(2008-11#3)
cells adapted##4##2##(2008-11#4)
cells adhering to##2##3##(2008-10#1)(2011-2#1)
cells adhesion##3##2##(2008-9#2)(2012-2#1)
cells adjacent to##2##3##(2008-10#2)
cells affected##2##2##(1995-2#1)(2008-11#1)
cells after the##2##3##(1991-5#1)(1995-3#1)
cells after##12##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#1)(1994-8#1)(1995-3#2)(1997-6#1)(2008-8#1)(2008-9#2)(2009-12#1)
cells against##5##2##(1991-5#1)(2008-11#3)(2011-2#1)
cells along with##2##3##(2008-4#1)(2008-8#1)
cells along##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
cells also##10##2##(1990-3#1)(1990-6#1)(1992-6#1)(1996-2#1)(2007-12#1)(2008-10#3)(2012-2#1)(2013-1#1)
cells and 3##2##3##(2008-9#1)(2010-1#1)
cells and a##9##3##(1992-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
cells and about##2##3##(2008-11#2)
cells and acted as a##2##5##(1995-2#1)(2008-5#1)
cells and also##2##3##(2008-11#2)
cells and an##3##3##(1992-2#1)(2008-5#1)(2013-1#1)
cells and are##4##3##(1995-11#1)(2009-10#1)(2009-6#1)(2011-2#1)
cells and can be##2##4##(2008-5#1)(2008-9#1)
cells and can##5##3##(1992-9#1)(1995-2#1)(2008-5#1)(2008-9#2)
cells and cell##7##3##(1991-5#1)(1993-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)
cells and cells##2##3##(1994-3#1)(2009-10#1)
cells and different##2##3##(2010-5#1)(2012-3#1)
cells and embryos##3##3##(1990-5#1)(2008-4#2)
cells and ependymal##2##3##(1991-7#1)(2008-12#1)
cells and few##2##3##(2008-5#2)
cells and fibroblasts##4##3##(1990-2#2)(1997-1#1)(1997-7#1)
cells and for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
cells and found##2##3##(1994-6#1)(2013-1#1)
cells and has##2##3##(2009-12#1)(2013-7#1)
cells and human##7##3##(1993-6#1)(1995-6#1)(2008-11#2)(2008-9#1)(2010-6#1)(2011-2#1)
cells and in##11##3##(1993-8#1)(1994-11#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
cells and its##5##3##(1994-5#1)(2008-11#2)(2009-8#1)(2010-12#1)
cells and macrophages##2##3##(2007-11#1)(2013-1#1)
cells and may be##2##4##(2008-8#1)(2008-9#1)
cells and normal##2##3##(1993-12#1)(2010-12#1)
cells and not##2##3##(1990-8#1)(2008-11#1)
cells and of##5##3##(1990-5#1)(1995-2#1)(2008-11#1)(2008-9#1)(2013-8#1)
cells and other##3##3##(1997-1#1)(2008-11#2)
cells and platelet aggregation##2##4##(1994-8#1)(2008-11#1)
cells and production of##2##4##(2008-11#1)(2011-2#1)
cells and proliferation##2##3##(2012-2#1)(2013-8#1)
cells and reduced##2##3##(1995-2#1)(2008-10#1)
cells and suggest that##3##4##(1994-6#1)(2008-8#1)(2013-1#1)
cells and suggest##4##3##(1994-3#1)(1994-6#1)(2008-8#1)(2013-1#1)
cells and syncytia##2##3##(1990-8#1)(2008-10#1)
cells and that the##2##4##(1995-2#1)(2008-11#1)
cells and that##7##3##(1990-5#1)(1993-8#1)(1995-2#2)(2008-11#1)(2008-5#1)(2008-8#1)
cells and the effects of##2##5##(1993-3#1)(1994-6#1)
cells and the##34##3##(1990-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-8#2)(2010-11#1)(2010-6#1)(2012-12#1)(2013-7#1)
cells and their differentiation##2##4##(1995-12#1)(2012-4#1)
cells and their##9##3##(1993-8#1)(1995-12#2)(1995-9#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-4#1)
cells and therefore##2##3##(2008-11#1)(2009-7#1)
cells and this##2##3##(1995-2#1)(1997-1#1)
cells and three##2##3##(2008-7#1)(2013-1#1)
cells and tissues##9##3##(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2010-11#1)(2012-2#1)(2013-1#1)
cells and to detect##2##4##(2008-11#1)(2008-9#1)
cells and to##3##3##(2008-11#1)(2008-9#1)(2009-10#1)
cells and used to##2##4##(1992-6#1)(2008-10#1)
cells and v-src-transformed NIH3T3 cells##2##5##(1997-1#2)
cells and was##5##3##(1993-9#1)(2008-10#1)(2008-11#3)
cells and were##2##3##(1992-8#1)(2008-10#1)
cells and whether##2##3##(2008-7#1)(2011-2#1)
cells and with##2##3##(1990-5#1)(2009-10#1)
cells and##421##2##(1990-12#3)(1990-2#3)(1990-5#7)(1990-8#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#5)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#10)(1995-5#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#1)(1997-1#6)(1997-2#1)(1997-3#3)(1997-7#2)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#37)(2008-11#80)(2008-12#6)(2008-3#1)(2008-4#10)(2008-5#10)(2008-7#14)(2008-8#20)(2008-9#25)(2009-10#8)(2009-12#3)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#3)(2010-11#2)(2010-12#3)(2010-3#3)(2010-5#3)(2010-6#3)(2011-2#17)(2011-3#1)(2012-12#7)(2012-2#8)(2012-3#6)(2012-4#1)(2013-1#15)(2013-7#4)(2013-8#9)
cells and/or##3##2##(2008-9#1)(2009-4#1)(2013-1#1)
cells appear to##2##3##(2008-11#1)(2008-7#1)
cells appear##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
cells appeared to be##2##4##(2008-11#1)(2011-2#1)
cells appeared to##3##3##(1997-3#1)(2008-11#1)(2011-2#1)
cells appeared##8##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
cells appears to be##2##4##(1997-1#1)(2008-11#1)
cells appears##3##2##(1997-1#1)(2008-11#2)
cells are a##4##3##(1994-5#1)(2008-4#1)(2008-9#2)
cells are activated by##2##4##(2009-7#1)(2011-2#1)
cells are activated##3##3##(2008-4#1)(2009-7#1)(2011-2#1)
cells are also##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
cells are being##2##3##(2008-11#1)(2008-9#1)
cells are capable of##5##4##(1990-2#1)(1994-11#1)(2008-11#1)(2008-9#1)(2010-6#1)
cells are cultured##2##3##(2008-11#2)
cells are derived from##2##4##(1995-6#1)(2008-11#1)
cells are discussed##4##3##(2008-11#3)(2008-4#1)
cells are grown##2##3##(2008-10#1)(2008-4#1)
cells are involved in##2##4##(2008-7#1)(2012-3#1)
cells are located##2##3##(1997-1#1)(2007-12#1)
cells are more##2##3##(2008-11#1)(2011-2#1)
cells are not##3##3##(2007-12#1)(2008-9#2)
cells are present in##2##4##(2008-11#2)
cells are present##3##3##(2008-11#2)(2010-3#1)
cells are presented##2##3##(2008-9#1)(2009-9#1)
cells are removed from the##2##5##(2008-11#2)
cells are responsible for##2##4##(1994-3#1)(2011-2#1)
cells are stimulated##4##3##(1990-12#1)(1991-5#1)(2008-4#1)(2010-10#1)
cells are suitable for##2##4##(2008-11#2)
cells are the##5##3##(2008-11#1)(2008-9#1)(2010-10#1)(2012-2#2)
cells are then##2##3##(1990-12#1)(2008-10#1)
cells are used##2##3##(2009-8#1)(2012-2#1)
cells are well##2##3##(1993-11#1)(2013-8#1)
cells are widely used##2##4##(2008-11#2)
cells are##137##2##(1990-12#3)(1990-2#1)(1991-5#3)(1992-6#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-7#1)(2007-12#5)(2008-10#5)(2008-11#35)(2008-2#1)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#16)(2009-10#2)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-3#1)(2010-6#2)(2011-2#9)(2012-2#3)(2012-3#1)(2013-8#1)
cells around the##2##3##(2008-10#1)(2012-3#1)
cells around##3##2##(2008-10#2)(2012-3#1)
cells arranged##2##2##(2008-8#1)(2010-12#1)
cells arrested##2##2##(1995-2#1)(2008-11#1)
cells as a##5##3##(1992-8#1)(1995-12#1)(1995-2#1)(2008-11#1)(2009-6#1)
cells as an##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)
cells as assessed by##2##4##(1995-12#1)(2008-11#1)
cells as compared to##2##4##(2008-11#2)
cells as compared##3##3##(1993-8#1)(2008-11#2)
cells as indicated by##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
cells as well as in##4##5##(1990-12#1)(1995-6#1)(2008-9#2)
cells as well as##13##4##(1990-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#4)
cells as##42##2##(1990-12#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-12#4)(1995-2#1)(1995-6#1)(2008-10#3)(2008-11#14)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
cells associated with the##2##4##(2008-10#1)(2008-7#1)
cells associated with##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
cells at 37 degrees C##3##5##(1991-2#1)(1993-8#1)(1995-2#1)
cells at a##5##3##(2008-10#1)(2008-11#3)(2008-9#1)
cells at all##2##3##(2008-10#1)(2008-11#1)
cells at any##2##3##(1993-9#1)(2008-11#1)
cells at different stages##2##4##(2008-9#1)(2009-10#1)
cells at different##3##3##(2008-11#1)(2008-9#1)(2009-10#1)
cells at high##2##3##(2008-11#2)
cells at the##6##3##(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)
cells at##38##2##(1990-11#1)(1991-2#2)(1992-9#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#7)(2008-11#17)(2008-8#1)(2008-9#3)(2009-10#1)
cells attached to the##2##4##(2008-11#2)
cells attached to##3##3##(2008-11#2)(2008-9#1)
cells attached##4##2##(2008-11#3)(2008-9#1)
cells based on##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
cells bearing##3##2##(1990-8#1)(1995-5#1)(2011-2#1)
cells became##6##2##(1995-2#1)(1995-3#1)(2008-11#3)(2008-8#1)
cells become##3##2##(1991-5#1)(1994-3#1)(1997-1#1)
cells before##3##2##(1991-5#1)(2008-10#1)(2012-12#1)
cells being in the##2##4##(1993-8#2)
cells being##3##2##(1993-8#2)(2012-2#1)
cells beneath##2##2##(2008-10#1)(2008-11#1)
cells beyond the midgut epithelia##2##5##(2008-10#2)
cells both in##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
cells both##6##2##(1990-12#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-10#1)
cells but also##3##3##(1995-6#1)(2008-11#1)(2008-9#1)
cells but not in##3##4##(1990-12#1)(1993-11#1)(2008-11#1)
cells but not##9##3##(1990-12#1)(1991-5#1)(1993-11#1)(1993-8#1)(1994-8#1)(2008-11#2)(2008-7#1)(2010-8#1)
cells but##19##2##(1990-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-3#1)(2008-11#5)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
cells by a##2##3##(1995-8#1)(2008-11#1)
cells by an##2##3##(1995-2#1)(2010-10#1)
cells by flow cytometry##3##4##(1996-6#1)(1997-7#1)(2008-9#1)
cells by homologous recombination##2##4##(2008-8#1)(2008-9#1)
cells by human NK cells##2##5##(2008-8#2)
cells by human##3##3##(1994-8#1)(2008-8#2)
cells by increasing##2##3##(1991-5#1)(1993-3#1)
cells by means of##2##4##(1995-6#1)(2008-10#1)
cells by releasing##2##3##(2008-11#1)(2008-5#1)
cells by the##9##3##(1992-6#1)(1993-8#1)(1995-8#1)(1997-1#1)(2008-11#3)(2008-5#1)(2012-2#1)
cells by using a##2##4##(1995-8#1)(2008-11#1)
cells by##119##2##(1990-11#1)(1990-8#1)(1991-5#2)(1992-2#1)(1992-4#1)(1992-6#3)(1993-11#1)(1993-3#1)(1993-8#4)(1994-11#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#5)(1995-6#2)(1995-8#5)(1996-2#1)(1996-6#1)(1997-1#3)(1997-7#3)(1997-8#1)(2008-10#9)(2008-11#33)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#12)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-4#1)(2013-7#1)(2013-8#1)
cells can be induced##2##4##(2008-11#2)
cells can be isolated from##2##5##(2008-9#2)
cells can be observed##2##4##(2008-11#1)(2008-8#1)
cells can be used##3##4##(2008-11#2)(2008-9#1)
cells can be##26##3##(1990-12#1)(1996-2#1)(1997-7#1)(2008-11#10)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#7)(2009-12#1)
cells can readily be used to##2##6##(2008-4#2)
cells can result in##2##4##(2008-11#1)(2008-5#1)
cells can stimulate##2##3##(2008-11#1)(2008-8#1)
cells can then##2##3##(2008-10#1)(2008-8#1)
cells can##44##2##(1990-12#2)(1990-2#1)(1993-3#1)(1994-2#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#12)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#8)(2009-12#3)(2013-1#1)
cells caused by##4##3##(1994-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
cells caused##6##2##(1994-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)
cells changed##2##2##(2008-11#1)(2011-2#1)
cells co-cultured with##3##3##(2008-11#1)(2009-7#2)
cells co-transfected with the##3##4##(1990-8#2)(2008-9#1)
cells co-transfected with##5##3##(1990-8#2)(1995-11#1)(1995-12#1)(2008-9#1)
cells compared to##5##3##(1992-9#1)(1993-3#1)(2007-12#1)(2008-11#2)
cells constitute a##2##3##(2008-11#2)
cells constitute##3##2##(2008-11#2)(2013-8#1)
cells constitutively##2##2##(1995-12#1)(2008-11#1)
cells contain a##3##3##(1990-11#1)(2007-12#2)
cells contain##7##2##(1990-11#1)(1990-5#1)(1992-10#1)(2007-12#3)(2008-7#1)
cells contained a##2##3##(1991-5#1)(2008-10#1)
cells contained##8##2##(1991-5#1)(1993-1#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-9#1)
cells containing##8##2##(1990-2#1)(1995-2#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-12#1)(2011-2#1)
cells contains##3##2##(1992-10#1)(2008-10#1)(2008-8#1)
cells contribute to##2##3##(1994-12#1)(2007-12#1)
cells correlated##2##2##(2008-7#1)(2013-1#1)
cells could also be##2##4##(2008-11#1)(2008-9#1)
cells could also##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
cells could be the##2##4##(2008-8#2)
cells could be##9##3##(1991-11#1)(1993-9#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)
cells could not##2##3##(2008-8#1)(2009-6#1)
cells could##23##2##(1991-11#1)(1993-9#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-8#5)(2008-9#3)(2009-12#2)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
cells cultivated in##2##3##(2008-11#2)
cells cultured in serum containing medium##3##6##(2008-11#3)
cells cultured in##11##3##(1992-8#2)(1994-3#2)(2008-11#6)(2010-6#1)
cells cultured on the##2##4##(2008-11#2)
cells cultured on##7##3##(1995-2#1)(2008-11#4)(2008-5#2)
cells cultured under##3##3##(1992-8#1)(2008-9#1)(2011-2#1)
cells cultured##24##2##(1992-8#3)(1994-3#2)(1995-2#1)(1997-1#1)(2008-11#12)(2008-5#2)(2008-9#1)(2010-6#1)(2011-2#1)
cells decreased##5##2##(1996-2#1)(2008-11#1)(2008-7#2)(2010-1#1)
cells demonstrated##7##2##(1993-3#1)(1994-2#1)(1997-3#1)(2008-11#4)
cells depend on##2##3##(2008-11#1)(2008-4#1)
cells depending on the##3##4##(1997-4#1)(2008-11#2)
cells derived from rat##2##4##(2008-11#2)
cells derived from the##4##4##(2008-11#2)(2008-7#1)(2008-9#1)
cells derived from##15##3##(1995-12#1)(2008-11#8)(2008-7#1)(2008-9#1)(2010-3#1)(2012-3#2)(2013-1#1)
cells derived##16##2##(1995-12#1)(2008-11#9)(2008-7#1)(2008-9#1)(2010-3#1)(2012-3#2)(2013-1#1)
cells develop##3##2##(2008-5#1)(2010-5#2)
cells developed##2##2##(2008-10#1)(2012-12#1)
cells did not express##2##4##(1991-2#1)(2008-11#1)
cells did not release##2##4##(1990-2#1)(2008-11#1)
cells did not##10##3##(1990-2#1)(1991-2#1)(1993-2#1)(1993-3#1)(2008-11#4)(2008-7#1)(2012-2#1)
cells did##12##2##(1990-2#1)(1991-2#1)(1993-2#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#4)(2008-7#1)(2012-2#1)
cells die by apoptosis##2##4##(1993-3#1)(2009-8#1)
cells die##4##2##(1993-3#1)(2008-11#1)(2009-8#1)(2010-3#1)
cells died##2##2##(2008-11#2)
cells differ in##2##3##(1992-2#1)(2008-11#1)
cells differentiated from##2##3##(2009-12#2)
cells differentiated##4##2##(1996-2#1)(2008-11#1)(2009-12#2)
cells directly##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
cells display the##3##3##(1994-8#2)(2008-11#1)
cells display##5##2##(1994-8#2)(2008-11#1)(2009-12#1)(2012-2#1)
cells displayed a##2##3##(2008-11#1)(2011-3#1)
cells displayed##9##2##(1997-3#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-3#1)
cells displaying##2##2##(1997-3#2)
cells do not##6##3##(1992-10#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-7#1)(2008-8#1)
cells do##7##2##(1990-11#1)(1992-10#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-7#1)(2008-8#1)
cells dropped##2##2##(2008-10#1)(2008-11#1)
cells during infection##2##3##(2008-10#1)(2008-5#1)
cells during##13##2##(1994-11#1)(1994-6#1)(1995-9#1)(2008-10#2)(2008-11#3)(2008-5#2)(2009-8#1)(2010-5#1)(2012-12#1)
cells either##3##2##(1994-11#1)(1996-2#1)(2008-9#1)
cells employing##2##2##(1995-6#1)(2008-11#1)
cells encapsulated in##3##3##(2008-11#2)(2008-5#1)
cells engineered to##2##3##(2008-11#2)
cells even##2##2##(1990-12#1)(2008-11#1)
cells examined##3##2##(1993-8#1)(2008-11#1)(2008-8#1)
cells exhibit a##2##3##(1994-2#1)(2008-7#1)
cells exhibit increased##2##3##(1992-6#1)(1992-8#1)
cells exhibit##9##2##(1992-6#1)(1992-8#1)(1994-2#1)(1995-9#1)(2008-7#1)(2008-9#2)(2010-10#1)(2013-1#1)
cells exhibited a decreased##2##4##(1991-5#1)(2008-11#1)
cells exhibited a##5##3##(1991-5#1)(1992-12#1)(2008-10#1)(2008-11#1)(2009-6#1)
cells exhibited##10##2##(1991-5#1)(1992-12#1)(2008-10#1)(2008-11#5)(2009-6#2)
cells exist##2##2##(2008-11#1)(2008-7#1)
cells exposed to a##3##4##(1990-2#1)(2008-11#1)(2008-9#1)
cells exposed to##13##3##(1990-11#1)(1990-2#2)(1992-12#1)(1992-6#1)(1994-3#1)(1995-6#1)(2008-11#2)(2008-7#1)(2008-9#2)(2009-3#1)
cells express##9##2##(1995-11#1)(1995-6#1)(2008-4#1)(2008-5#2)(2011-2#2)(2012-2#2)
cells expressed the##3##3##(2008-11#2)(2010-6#1)
cells expressed##11##2##(1992-3#1)(2008-11#7)(2008-6#1)(2010-6#2)
cells expressing SSTR1##2##3##(1995-2#2)
cells expressing glutamine synthetase##2##4##(2008-11#2)
cells expressing the##8##3##(1992-2#1)(1995-2#3)(1995-6#1)(1997-7#1)(2008-11#2)
cells expressing##27##2##(1992-2#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-2#6)(1995-6#1)(1996-2#1)(1997-7#1)(2008-11#11)(2008-9#2)(2013-1#1)
cells failed to##3##3##(1993-2#1)(2008-10#1)(2013-1#1)
cells following##4##2##(1990-5#1)(1992-9#1)(2008-11#1)(2013-1#1)
cells for apoptosis##3##3##(1995-2#2)(1996-12#1)
cells for cell##2##3##(2008-11#2)
cells for the##6##3##(2008-11#4)(2008-9#1)(2010-6#1)
cells for tissue##2##3##(2012-5#1)(2013-1#1)
cells for transplantation##2##3##(2008-11#2)
cells for##52##2##(1990-12#2)(1991-5#1)(1991-8#1)(1995-2#2)(1996-12#1)(1996-3#1)(2008-10#5)(2008-11#20)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#8)(2010-6#2)(2012-5#1)(2013-1#3)(2013-8#1)
cells form a##2##3##(1992-9#1)(2009-8#1)
cells form##3##2##(1992-9#1)(2008-7#1)(2009-8#1)
cells formed##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
cells forming##2##2##(1991-8#1)(2007-12#1)
cells frequently##2##2##(2008-10#1)(2008-11#1)
cells from a##3##3##(1991-9#1)(2008-4#1)(2009-8#1)
cells from adult mouse##2##4##(2008-11#2)
cells from death##2##3##(2008-11#1)(2008-9#1)
cells from different##2##3##(1990-5#1)(2012-3#1)
cells from human cord blood##3##5##(2008-9#3)
cells from human##4##3##(2008-8#1)(2008-9#3)
cells from mice##4##3##(2008-10#1)(2008-11#3)
cells from mouse##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
cells from other##2##3##(2008-11#1)(2013-8#1)
cells from patients with##2##4##(2008-9#1)(2011-2#1)
cells from pregnant rats##2##4##(1990-11#2)
cells from rat kidney##2##4##(1995-11#2)
cells from rat##6##3##(1990-2#1)(1995-11#2)(1995-8#2)(2012-4#1)
cells from small##2##3##(2008-11#1)(2008-4#1)
cells from the##22##3##(1992-6#1)(1993-6#1)(1994-11#1)(2007-12#3)(2008-10#2)(2008-11#6)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-8#1)
cells from umbilical##2##3##(1994-6#1)(2008-11#1)
cells from which##2##3##(1993-8#1)(2008-11#1)
cells from##127##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#3)(1995-2#1)(1995-8#2)(1996-2#1)(1997-7#2)(2007-12#3)(2008-10#7)(2008-11#35)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#11)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#6)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#4)
cells gave rise to##2##4##(2008-11#2)
cells generated##2##2##(1991-5#1)(1995-2#1)
cells grew##3##2##(2008-11#2)(2008-7#1)
cells grow##4##2##(2008-11#1)(2008-5#1)(2008-7#2)
cells growing in##2##3##(2008-11#2)
cells growing on##2##3##(2008-10#1)(2008-11#1)
cells growing##4##2##(2008-10#1)(2008-11#3)
cells grown at 0##2##4##(1991-11#2)
cells grown at##5##3##(1991-11#3)(2008-5#2)
cells grown in batch culture##2##5##(2008-11#2)
cells grown in culture##2##4##(1993-12#1)(2008-11#1)
cells grown in medium of low##2##6##(1991-11#2)
cells grown in serum-free suspension culture##4##6##(2008-11#4)
cells grown in serum-free##6##4##(2008-11#6)
cells grown in the absence##2##5##(1994-11#1)(2008-10#1)
cells grown in##24##3##(1990-6#1)(1991-11#2)(1993-12#1)(1994-11#1)(2008-10#1)(2008-11#18)
cells grown on##4##3##(1990-5#1)(2008-11#3)
cells grown under##2##3##(1997-1#1)(2008-11#1)
cells grown##37##2##(1990-5#1)(1990-6#1)(1991-11#5)(1993-12#1)(1994-11#1)(1997-1#1)(2008-10#1)(2008-11#24)(2008-5#2)
cells growth and##2##3##(2008-8#1)(2013-1#1)
cells growth##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
cells had a high##2##4##(2008-11#2)
cells had a##3##3##(2008-11#3)
cells had different##2##3##(1993-8#1)(2008-9#1)
cells had the##2##3##(1993-8#1)(2008-11#1)
cells had##16##2##(1990-6#1)(1993-8#2)(1994-8#2)(2008-11#9)(2008-9#2)
cells harboring##3##2##(1993-8#1)(1996-12#1)(2011-2#1)
cells harvested from##2##3##(1994-5#1)(2008-10#1)
cells harvested##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
cells has been demonstrated##2##4##(2008-5#1)(2008-8#1)
cells has been##8##3##(1990-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-1#1)
cells has##20##2##(1990-12#1)(1993-3#1)(2008-10#1)(2008-11#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#1)
cells have an##2##3##(1992-7#1)(2010-1#1)
cells have been shown to##2##5##(1993-12#1)(2008-11#1)
cells have been studied##2##4##(1994-11#1)(2008-11#1)
cells have been##16##3##(1990-7#1)(1991-2#1)(1993-12#1)(1994-11#1)(1997-8#1)(2008-11#9)(2008-8#1)(2012-3#1)
cells have the##2##3##(2008-11#2)
cells have##39##2##(1990-7#1)(1991-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1997-8#1)(2008-11#17)(2008-7#2)(2008-8#2)(2008-9#4)(2010-1#1)(2010-6#2)(2011-2#1)(2012-3#2)(2013-8#1)
cells having##2##2##(1991-11#1)(2008-4#1)
cells immobilized##2##2##(2008-11#2)
cells in a dose- and time-dependent manner##2##7##(2008-11#1)(2011-2#1)
cells in a dose-dependent manner##3##5##(1994-12#1)(2008-11#1)(2010-6#1)
cells in a##29##3##(1992-6#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-11#14)(2008-2#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
cells in all the##2##4##(2008-10#1)(2008-8#1)
cells in all##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
cells in an##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
cells in batch##3##3##(1995-9#1)(2008-11#1)(2012-3#1)
cells in bioreactor##2##3##(2008-11#2)
cells in both##4##3##(1993-8#1)(2008-9#1)(2010-1#1)(2010-11#1)
cells in culture as well as##2##6##(2008-11#1)(2008-9#1)
cells in culture##19##3##(1993-8#2)(1994-3#1)(1995-12#1)(2008-11#12)(2008-4#1)(2008-9#1)(2012-2#1)
cells in female nude mice##2##5##(1994-12#2)
cells in low serum or##2##5##(2008-11#2)
cells in monolayer culture##2##4##(2008-11#2)
cells in multi-well##2##3##(2008-11#2)
cells in nude mice##2##4##(1994-12#1)(2011-2#1)
cells in order to##2##4##(1993-3#1)(2008-11#1)
cells in other##2##3##(1994-2#1)(1997-3#1)
cells in primary culture##4##4##(1993-3#1)(1994-8#2)(2008-6#1)
cells in response to##5##4##(1992-12#1)(1992-2#1)(2008-10#1)(2009-3#1)(2010-10#1)
cells in serum-free##2##3##(2008-11#2)
cells in suspension culture##4##4##(1997-1#1)(2008-11#3)
cells in suspension##12##3##(1997-1#1)(2008-11#11)
cells in the CNS and PNS##2##6##(2008-7#2)
cells in the CNS##3##4##(2008-11#1)(2008-7#2)
cells in the G1##2##4##(1994-11#1)(2008-11#1)
cells in the absence of##4##5##(1993-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
cells in the adult##2##4##(2008-11#1)(2012-2#1)
cells in the bone marrow##3##5##(2008-10#1)(2010-6#2)
cells in the brain##4##4##(2008-7#1)(2012-2#3)
cells in the dermis and##2##5##(1996-12#1)(2010-6#1)
cells in the dermis##3##4##(1996-12#2)(2010-6#1)
cells in the developing##2##4##(1994-2#1)(2010-11#1)
cells in the exponential phase of growth##2##7##(1994-8#1)(2008-11#1)
cells in the hepatopancreas##2##4##(2008-6#1)(2008-7#1)
cells in the interstitium##2##4##(2009-10#2)
cells in the pancreas##2##4##(2008-11#1)(2010-11#1)
cells in the presence of##6##5##(1993-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)
cells in the process##2##4##(2008-6#1)(2013-8#1)
cells in the testis##4##4##(2008-7#2)(2009-10#1)(2012-2#1)
cells in the visual cortex##2##5##(1990-8#1)(1996-2#1)
cells in the##121##3##(1990-8#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-8#1)(1996-12#4)(1996-2#1)(1997-1#1)(1997-8#2)(2008-10#9)(2008-11#33)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#17)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-6#5)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
cells in tissue engineering protocols##2##5##(2008-11#2)
cells in tissue engineering##4##4##(2008-11#3)(2012-5#1)
cells in tissue##6##3##(1997-1#1)(2008-11#4)(2012-5#1)
cells in transgenic mice##2##4##(1995-2#1)(1995-6#1)
cells in transgenic##3##3##(1995-2#1)(1995-6#2)
cells in vitro and in vivo##3##6##(1994-11#1)(1994-5#1)(2013-8#1)
cells in vitro and##6##4##(1994-11#1)(1994-5#1)(2008-11#1)(2009-4#1)(2013-1#1)(2013-8#1)
cells in vitro##22##3##(1990-2#1)(1991-5#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1997-7#1)(2008-11#6)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
cells in vivo##3##3##(1992-11#1)(2008-9#1)(2012-2#1)
cells in which##2##3##(2010-10#1)(2011-2#1)
cells in##405##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#3)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#6)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#6)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#6)(1996-2#1)(1996-9#1)(1997-1#4)(1997-3#1)(1997-7#2)(1997-8#3)(2007-12#1)(2008-10#27)(2008-11#133)(2008-12#3)(2008-2#1)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#28)(2008-8#18)(2008-9#17)(2009-1#1)(2009-10#7)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#4)(2010-10#3)(2010-11#6)(2010-2#1)(2010-6#8)(2010-8#1)(2011-1#2)(2011-2#11)(2012-12#2)(2012-2#9)(2012-3#7)(2012-5#1)(2013-1#6)(2013-8#4)
cells including##4##2##(2008-10#1)(2008-11#3)
cells increased the##2##3##(2008-11#2)
cells increased##12##2##(1993-8#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#4)(2008-7#2)(2008-8#1)(2013-1#1)
cells increases with increasing##2##4##(2008-10#1)(2008-9#1)
cells increases##5##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
cells increasing##2##2##(2008-8#1)(2011-2#1)
cells incubated with the medium containing##2##6##(2008-11#2)
cells incubated with##3##3##(2008-11#3)
cells incubated##5##2##(1994-3#1)(2008-11#4)
cells indicating##2##2##(2009-4#1)(2012-3#1)
cells induced by the##2##4##(2010-12#1)(2012-12#1)
cells induced by##8##3##(1993-3#2)(1994-8#1)(2008-10#2)(2008-8#1)(2010-12#1)(2012-12#1)
cells induced##11##2##(1993-3#2)(1994-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
cells induces##5##2##(1990-5#1)(1994-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
cells infected with a baculovirus##2##5##(2008-11#2)
cells infected with a##5##4##(1993-8#1)(1997-3#1)(2008-11#2)(2008-7#1)
cells infected with re-virus showed##2##5##(1993-6#2)
cells infected with re-virus##3##4##(1993-6#3)
cells infected with the##2##4##(1994-11#1)(2011-3#1)
cells infected with wild-type##2##4##(1993-6#1)(2008-11#1)
cells infected with##17##3##(1993-6#5)(1993-8#1)(1994-11#1)(1997-3#1)(2008-11#5)(2008-7#2)(2008-8#1)(2011-3#1)
cells infected##18##2##(1993-6#5)(1993-8#1)(1994-11#1)(1997-3#1)(2008-11#6)(2008-7#2)(2008-8#1)(2011-3#1)
cells inhibited##3##2##(1992-7#1)(1994-11#2)
cells inhibits##2##2##(1995-6#1)(2010-1#1)
cells initially##2##2##(2008-10#1)(2008-11#1)
cells interact with##2##3##(1994-12#1)(2009-3#1)
cells into the##9##3##(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
cells into##30##2##(1993-6#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#9)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
cells involved in##5##3##(1992-12#1)(1993-1#1)(1994-5#1)(2007-12#1)(2008-10#1)
cells involves##2##2##(1990-5#1)(1995-2#1)
cells is a##4##3##(2008-11#2)(2008-5#1)(2008-9#1)
cells is associated with##2##4##(2011-2#2)
cells is based on the##3##5##(2008-2#1)(2008-9#2)
cells is controlled##3##3##(2008-4#1)(2009-12#1)(2012-2#1)
cells is described##2##3##(1990-12#1)(2008-11#1)
cells is discussed##2##3##(1997-3#1)(2008-4#1)
cells is highly##2##3##(1990-12#1)(2008-9#1)
cells is negatively##2##3##(1995-8#1)(2008-8#1)
cells is not a##2##4##(2008-9#1)(2013-1#1)
cells is not##8##3##(1994-6#1)(1995-6#2)(1996-2#1)(2008-9#2)(2012-3#1)(2013-1#1)
cells is performed##2##3##(2008-9#2)
cells is the##2##3##(2011-2#1)(2012-2#1)
cells is thought to##2##4##(2008-11#1)(2008-6#1)
cells is##93##2##(1990-12#5)(1990-5#1)(1990-8#2)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#20)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#12)(2009-10#1)(2009-12#1)(2009-6#1)(2010-2#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
cells isolated from the##2##4##(1990-11#1)(2009-9#1)
cells isolated from##10##3##(1990-11#2)(1990-6#1)(1991-5#1)(1995-12#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-9#1)(2013-1#1)
cells lack##4##2##(1995-6#2)(1996-2#2)
cells lacking##2##2##(1991-5#1)(1996-12#1)
cells leads to##2##3##(1995-6#1)(1997-1#1)
cells like##2##2##(2008-11#1)(2011-2#1)
cells lines##2##2##(2008-11#1)(2008-4#1)
cells lining the##2##3##(2011-2#1)(2013-1#1)
cells lining##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
cells loaded with##3##3##(1992-6#1)(1997-1#1)(2008-9#1)
cells lose##3##2##(1990-3#1)(1990-5#1)(2008-11#1)
cells loss##2##2##(2011-2#2)
cells lost##3##2##(1990-5#1)(2008-10#1)(2009-6#1)
cells mL-1##3##2##(2008-11#3)
cells maintain##2##2##(1990-5#2)
cells maintained on collagen gel##2##5##(1994-8#2)
cells maintained##6##2##(1994-3#1)(1994-8#3)(1995-2#1)(2011-2#1)
cells may be sufficient##2##4##(1994-5#1)(1997-8#1)
cells may be##10##3##(1990-8#1)(1993-8#1)(1994-5#1)(1997-8#1)(2008-11#3)(2009-9#1)(2010-11#1)(2012-12#1)
cells may have##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
cells may provide##2##3##(1994-8#1)(2008-11#1)
cells may##24##2##(1990-8#1)(1991-5#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-11#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2012-12#1)
cells mediate##2##2##(2008-11#1)(2008-7#1)
cells mediated by##2##3##(2008-10#1)(2008-11#1)
cells might be##3##3##(1997-1#1)(2008-11#1)(2011-2#1)
cells might##9##2##(1997-1#1)(1997-8#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
cells ml(-1) and##2##3##(2008-10#1)(2008-11#1)
cells ml(-1)##20##2##(2008-10#5)(2008-11#15)
cells ml(-1)) and##2##3##(2008-10#1)(2008-11#1)
cells ml(-1))##8##2##(2008-10#1)(2008-11#7)
cells more##3##2##(1993-8#1)(2010-10#1)(2013-8#1)
cells must##3##2##(2009-10#2)(2011-2#1)
cells not only##2##3##(2008-11#1)(2008-9#1)
cells not##4##2##(2008-11#2)(2008-9#1)(2010-11#1)
cells obtained from##3##3##(1992-2#1)(1997-1#1)(2008-4#1)
cells obtained##4##2##(1992-2#1)(1997-1#1)(2008-4#2)
cells occurred##3##2##(1990-2#1)(2008-10#1)(2010-6#1)
cells occurs##2##2##(1994-6#1)(2012-3#1)
cells of T##2##3##(2008-11#1)(2011-1#1)
cells of both##5##3##(1994-2#1)(1994-5#1)(1996-12#1)(2008-10#2)
cells of different scolopidia##2##4##(2008-7#2)
cells of different##5##3##(1997-8#1)(2008-11#1)(2008-7#2)(2008-8#1)
cells of healthy##2##3##(2008-11#2)
cells of interest##3##3##(2008-11#1)(2008-9#2)
cells of mice##2##3##(1997-8#1)(2011-2#1)
cells of patients##2##3##(1994-2#1)(1997-6#1)
cells of preantral##2##3##(2008-8#1)(2008-9#1)
cells of roots##2##3##(2008-10#1)(2008-9#1)
cells of strain##2##3##(2008-10#2)
cells of the conducting##2##4##(2013-1#2)
cells of the dorsal##3##4##(1991-7#1)(1996-12#1)(1996-2#1)
cells of the human##2##4##(2008-11#1)(2011-2#1)
cells of the immune system##2##5##(2008-4#2)
cells of the rat##2##4##(1990-5#1)(1995-2#1)
cells of the##69##3##(1990-5#1)(1991-7#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-6#2)(1996-9#1)(1997-5#2)(1997-7#2)(1997-8#2)(2007-12#3)(2008-10#7)(2008-11#10)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
cells of two##2##3##(1994-3#1)(2007-12#1)
cells of##188##2##(1990-2#2)(1990-5#1)(1991-11#1)(1991-7#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-2#3)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#3)(1996-12#5)(1996-2#3)(1996-6#3)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#6)(2007-12#6)(2008-1#1)(2008-10#34)(2008-11#23)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#12)(2009-10#1)(2009-12#1)(2010-1#2)(2010-5#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
cells on a##3##3##(1990-2#1)(2008-11#1)(2008-12#1)
cells on microcarriers##3##3##(2008-11#3)
cells on porous##2##3##(2008-11#2)
cells on some polymeric films##2##5##(2008-11#2)
cells on the##9##3##(1993-3#1)(2008-11#5)(2009-8#1)(2012-3#1)(2013-7#1)
cells on##43##2##(1990-2#2)(1992-6#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-9#2)(1997-1#1)(2008-10#1)(2008-11#23)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
cells only##3##2##(1997-1#1)(2008-7#2)
cells or the##3##3##(1995-12#1)(1995-2#1)(2008-11#1)
cells or their##2##3##(2008-11#1)(2008-6#1)
cells or##34##2##(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#2)(1995-12#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#7)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-10#1)(2011-2#3)
cells over the##2##3##(1991-5#1)(1995-8#1)
cells over##4##2##(1991-5#1)(1995-8#1)(2008-7#1)(2011-2#1)
cells overexpressing##9##2##(1994-11#1)(1995-2#1)(1995-6#2)(1997-7#1)(2008-11#1)(2008-8#3)
cells participate in##2##3##(2008-11#1)(2008-5#1)
cells per flower##3##3##(2008-10#3)
cells per g of tissue##2##5##(2008-10#2)
cells per gram of##2##4##(2008-10#1)(2008-11#1)
cells per ml##3##3##(2008-10#2)(2008-11#1)
cells per##17##2##(1994-8#1)(1995-3#1)(2008-10#9)(2008-11#4)(2008-5#1)(2010-6#1)
cells play##2##2##(2008-1#1)(2008-11#1)
cells possess##6##2##(1994-8#2)(1995-8#1)(2008-11#1)(2008-7#1)(2009-9#1)
cells possessed##2##2##(2008-5#1)(2008-6#1)
cells prepared from##2##3##(1995-11#1)(2008-11#1)
cells prepared##3##2##(1995-11#1)(2008-11#2)
cells present in##2##3##(2008-11#1)(2008-9#1)
cells present##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2012-3#1)
cells pretreated with##2##3##(1990-11#1)(1996-12#1)
cells previously##3##2##(1995-12#1)(2008-11#2)
cells prior to##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
cells produce##4##2##(1990-2#1)(1995-2#1)(1996-12#1)(2008-11#1)
cells produced##4##2##(2008-10#1)(2008-11#3)
cells producing the##2##3##(1993-2#1)(2008-7#1)
cells producing tissue##2##3##(2008-11#2)
cells producing##6##2##(1993-2#1)(2008-11#3)(2008-4#1)(2008-7#1)
cells proliferate and differentiate##2##4##(1995-12#1)(2010-3#1)
cells proliferate##4##2##(1995-12#1)(1995-2#1)(1997-1#1)(2010-3#1)
cells provide##3##2##(1993-3#1)(2008-11#2)
cells rather than##3##3##(1994-8#1)(1995-2#1)(2008-10#1)
cells reacted##2##2##(2008-11#1)(2011-1#1)
cells recovered from##2##3##(2008-10#1)(2012-2#1)
cells released##2##2##(1992-12#1)(2008-11#1)
cells remain##2##2##(1997-1#1)(2008-7#1)
cells remained on##2##3##(2008-11#2)
cells remained##5##2##(2008-11#4)(2010-11#1)
cells remains to be##2##4##(2008-11#1)(2009-8#1)
cells remains##6##2##(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
cells represents a##3##3##(1995-9#1)(2008-9#2)
cells requires##2##2##(2007-12#1)(2008-11#1)
cells resistant to##3##3##(1993-8#1)(1994-11#1)(2008-10#1)
cells respond to##2##3##(1996-2#1)(2008-11#1)
cells respond##4##2##(1996-2#1)(2008-11#3)
cells responded to##5##3##(1990-2#1)(1992-6#3)(2011-1#1)
cells responded##6##2##(1990-2#1)(1992-6#3)(2008-10#1)(2011-1#1)
cells responding to##3##3##(1992-6#2)(1994-2#1)
cells responsible for##2##3##(1994-11#1)(2009-8#1)
cells resulted in a##3##4##(1993-12#1)(1996-12#1)(2008-11#1)
cells resulted in##7##3##(1993-12#1)(1994-5#1)(1996-12#1)(1996-6#1)(2008-11#1)(2012-12#1)(2013-1#1)
cells resulting in##2##3##(2009-3#1)(2010-3#1)
cells resulting##3##2##(2008-9#1)(2009-3#1)(2010-3#1)
cells revealed a##3##3##(1990-8#1)(2008-5#1)(2012-2#1)
cells revealed that the##2##4##(1993-12#1)(2008-8#1)
cells revealed that##3##3##(1993-12#1)(2008-10#1)(2008-8#1)
cells revealed the##2##3##(2008-11#1)(2012-2#1)
cells revealed##12##2##(1990-8#1)(1991-5#1)(1991-7#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2012-2#2)
cells reveals##2##2##(2010-6#1)(2013-8#1)
cells secrete##4##2##(1994-11#1)(1995-5#1)(1997-7#1)(2013-8#1)
cells secreting##3##2##(2008-11#2)(2008-7#1)
cells seems##2##2##(1995-12#1)(2009-6#1)
cells selected##2##2##(1994-5#1)(2012-12#1)
cells sensitive to##3##3##(1995-12#1)(2008-8#1)(2013-1#1)
cells share a##2##3##(2007-12#1)(2008-9#1)
cells should be##3##3##(1991-3#1)(1995-12#1)(2008-10#1)
cells should##4##2##(1991-3#1)(1995-12#1)(2008-10#1)(2009-4#1)
cells show a##4##3##(1990-11#1)(1992-9#1)(2008-11#2)
cells show that##4##3##(1997-1#1)(2008-8#1)(2008-9#1)(2012-3#1)
cells show##13##2##(1990-11#1)(1992-9#1)(1997-1#1)(2008-11#4)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
cells showed a##6##3##(2008-11#5)(2011-1#1)
cells showed that the##3##4##(1995-6#1)(2008-11#1)(2009-8#1)
cells showed that##7##3##(1995-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)
cells showed the##3##3##(1993-8#1)(1994-8#1)(2008-11#1)
cells showed##33##2##(1990-5#1)(1992-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#13)(2008-12#1)(2008-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
cells showing an##2##3##(1990-2#1)(1992-6#1)
cells showing##6##2##(1990-11#1)(1990-2#1)(1992-6#1)(1994-6#1)(1997-3#2)
cells significantly##2##2##(2008-8#1)(2012-4#1)
cells similar to##2##3##(1997-7#1)(2011-2#1)
cells since##3##2##(1995-11#1)(2008-4#1)(2009-10#1)
cells situated##2##2##(1994-2#1)(1997-2#1)
cells so that##2##3##(2008-9#1)(2011-3#1)
cells specifically##2##2##(1993-6#1)(1997-7#1)
cells stably expressing##3##3##(1995-11#1)(2008-11#1)(2013-1#1)
cells stably##5##2##(1994-11#1)(1995-11#1)(2008-11#1)(2008-9#1)(2013-1#1)
cells stained##2##2##(2008-9#2)
cells stimulated with the##2##4##(1991-5#1)(2012-12#1)
cells stimulated with##3##3##(1991-5#1)(1995-11#1)(2012-12#1)
cells stimulated##4##2##(1991-5#1)(1995-11#1)(1995-2#1)(2012-12#1)
cells stopped##2##2##(2008-11#2)
cells studied##2##2##(2008-8#1)(2009-12#1)
cells subjected to hypoosmotic pressure##2##5##(2008-11#2)
cells subjected to##4##3##(2008-11#2)(2008-7#1)(2009-12#1)
cells such as platelets and##2##5##(2008-9#1)(2011-2#1)
cells such as##8##3##(1994-3#1)(1995-5#1)(2008-11#2)(2008-5#1)(2008-9#2)(2011-2#1)
cells suggested that##2##3##(1992-3#1)(1995-8#1)
cells suggested the##2##3##(1991-5#1)(1992-6#1)
cells suggested##5##2##(1991-5#1)(1992-3#1)(1992-6#1)(1995-8#1)(2008-8#1)
cells suggests that##2##3##(2009-9#1)(2011-2#1)
cells suggests##4##2##(1995-6#1)(2008-12#1)(2009-9#1)(2011-2#1)
cells supported##2##2##(1995-2#1)(2012-2#1)
cells surrounded##2##2##(2008-7#2)
cells surrounding##2##2##(1995-12#1)(2008-10#1)
cells survived##6##2##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)
cells surviving##3##2##(1996-12#1)(2008-10#1)(2012-3#1)
cells synthesize##2##2##(1997-1#1)(2013-1#1)
cells tested##2##2##(1994-3#1)(2008-10#1)
cells than in##4##3##(1990-6#1)(1992-8#1)(1997-8#1)(2008-11#1)
cells than those in##2##4##(2008-11#2)
cells than those##3##3##(2008-11#2)(2011-2#1)
cells than##11##2##(1990-6#1)(1992-8#1)(1997-8#1)(2008-11#6)(2011-2#1)(2012-3#1)
cells that are homozygous for##2##5##(1995-2#1)(2008-9#1)
cells that are in the##2##5##(1994-3#2)
cells that are##10##3##(1993-3#1)(1994-3#2)(1995-2#1)(2008-4#2)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
cells that can be##2##4##(2008-4#1)(2008-9#1)
cells that can##3##3##(2008-4#1)(2008-9#1)(2013-8#1)
cells that contained##4##3##(2008-11#4)
cells that could not##2##4##(2008-7#2)
cells that enable##2##3##(2010-11#1)(2013-8#1)
cells that express##3##3##(1993-12#1)(2008-7#1)(2011-1#1)
cells that have been##2##4##(2008-4#1)(2008-5#1)
cells that have##5##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
cells that is##2##3##(1997-7#1)(2013-1#1)
cells that responded to##2##4##(1992-6#1)(2008-10#1)
cells that responded##3##3##(1992-6#1)(2007-12#1)(2008-10#1)
cells that were##5##3##(1994-8#1)(2008-10#3)(2008-11#1)
cells that##76##2##(1991-5#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-7#2)(2007-12#3)(2008-10#8)(2008-11#8)(2008-4#6)(2008-5#1)(2008-7#5)(2008-9#6)(2009-12#1)(2009-5#1)(2010-11#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
cells themselves##2##2##(1992-2#1)(2008-11#1)
cells through the##3##3##(2008-11#2)(2009-8#1)
cells through their##2##3##(1995-2#1)(2008-8#1)
cells through##15##2##(1993-8#1)(1995-2#2)(1997-1#1)(2008-10#1)(2008-11#6)(2008-8#1)(2009-8#1)(2011-2#1)(2011-3#1)
cells throughout the##3##3##(1997-1#1)(2008-7#2)
cells to a##5##3##(1990-5#1)(2008-11#2)(2008-8#1)(2009-3#1)
cells to be##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
cells to cisplatin##2##3##(2008-9#2)
cells to growth in##2##4##(2008-11#2)
cells to high##3##3##(2008-11#3)
cells to induce##3##3##(2008-10#1)(2008-4#1)(2010-7#1)
cells to positively charged##3##4##(2008-10#3)
cells to produce##5##3##(2008-10#1)(2008-11#2)(2010-8#2)
cells to respond to##2##4##(2008-7#1)(2012-3#1)
cells to the##16##3##(1995-11#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#3)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
cells to these##2##3##(2008-11#2)
cells to undergo apoptosis##2##4##(1995-2#2)
cells to##158##2##(1990-11#2)(1990-2#2)(1990-5#3)(1991-7#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-5#2)(1995-11#1)(1995-2#4)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#19)(2008-11#48)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#7)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#4)(2010-7#1)(2010-8#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
cells together with##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
cells transfected with a##2##4##(1995-12#1)(2008-11#1)
cells transfected with each##2##4##(1995-8#2)
cells transfected with the##5##4##(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
cells transfected with##28##3##(1993-1#2)(1994-11#3)(1995-11#1)(1995-12#1)(1995-6#5)(1995-8#2)(1997-7#1)(1997-9#1)(2008-10#1)(2008-11#7)(2008-8#2)(2009-8#1)(2010-12#1)
cells transformed by##3##3##(1991-2#1)(1997-7#1)(2009-7#1)
cells transformed with##5##3##(1997-7#1)(2008-10#2)(2011-2#2)
cells transformed##8##2##(1991-2#1)(1997-7#2)(2008-10#2)(2009-7#1)(2011-2#2)
cells transplantation##2##2##(2011-3#1)(2013-8#1)
cells transplanted into##2##3##(2011-2#1)(2013-1#1)
cells transplanted##3##2##(1994-5#1)(2011-2#1)(2013-1#1)
cells treated by##4##3##(2008-11#3)(2013-8#1)
cells treated with 1##2##4##(1993-8#1)(2012-12#1)
cells treated with##27##3##(1992-3#1)(1993-8#1)(1994-8#1)(1995-8#8)(1997-1#1)(1997-4#4)(2008-11#8)(2008-9#1)(2012-12#1)(2013-8#1)
cells treated##31##2##(1992-3#1)(1993-8#1)(1994-8#1)(1995-8#8)(1997-1#1)(1997-4#4)(2008-11#11)(2008-9#1)(2012-12#1)(2013-8#2)
cells typically##2##2##(2010-6#2)
cells under both##2##3##(1995-11#1)(1997-1#1)
cells under the##3##3##(2008-11#2)(2008-8#1)
cells under##17##2##(1990-2#1)(1992-7#1)(1993-6#1)(1994-11#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-11#5)(2008-8#1)(2008-9#2)(2010-12#1)(2012-2#1)
cells upon##3##2##(1996-2#1)(2008-11#1)(2008-8#1)
cells used for the production of##2##6##(2008-11#2)
cells used for the##3##4##(2008-11#3)
cells used for##4##3##(1996-2#1)(2008-11#3)
cells used##6##2##(1996-2#1)(2008-11#3)(2008-4#1)(2010-6#1)
cells using a##7##3##(1990-2#1)(2008-11#4)(2008-9#1)(2010-8#1)
cells using the##6##3##(1993-12#1)(2008-11#2)(2008-4#1)(2008-8#1)(2013-1#1)
cells using##39##2##(1990-2#1)(1991-5#1)(1993-12#1)(1994-5#1)(1995-8#2)(2008-10#4)(2008-11#14)(2008-12#1)(2008-4#2)(2008-8#3)(2008-9#2)(2009-3#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
cells via a##2##3##(1993-8#1)(2008-11#1)
cells via the##2##3##(2008-11#1)(2008-8#1)
cells via##14##2##(1993-3#1)(1993-8#1)(2008-11#7)(2008-8#1)(2009-6#2)(2011-3#1)(2012-2#1)
cells was 4##2##3##(2008-12#1)(2011-2#1)
cells was about##3##3##(1997-1#1)(2008-11#2)
cells was also increased##2##4##(2008-11#1)(2011-2#1)
cells was also##9##3##(1994-11#1)(2008-11#3)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)
cells was completely blocked by##2##5##(1994-8#1)(2008-9#1)
cells was confirmed##2##3##(2008-11#1)(2008-8#1)
cells was detected by##2##4##(2008-9#1)(2010-1#1)
cells was detected##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
cells was determined by##3##4##(1994-8#1)(2008-11#2)
cells was determined##5##3##(1990-2#1)(1994-8#1)(2008-11#3)
cells was enhanced##2##3##(2008-11#2)
cells was examined##3##3##(1992-6#1)(1994-11#1)(2008-8#1)
cells was found to##4##4##(1990-5#1)(1990-6#1)(2008-11#2)
cells was found##5##3##(1990-5#1)(1990-6#1)(2008-11#3)
cells was increased##3##3##(1994-11#1)(1997-1#1)(2008-11#1)
cells was inhibited by##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
cells was investigated##5##3##(1994-11#2)(2008-11#3)
cells was not##2##3##(1997-1#1)(2008-11#1)
cells was observed in##2##4##(1994-3#1)(2010-11#1)
cells was observed##6##3##(1990-2#1)(1990-6#1)(1994-3#1)(1995-8#1)(2008-5#1)(2010-11#1)
cells was proportional to##2##4##(2008-11#2)
cells was reduced##2##3##(2008-11#1)(2008-8#1)
cells was shown##2##3##(2008-11#1)(2008-9#1)
cells was significantly##2##3##(1991-6#1)(2008-11#1)
cells was studied##2##3##(1994-11#1)(2008-8#1)
cells was successfully##2##3##(1995-12#1)(2008-11#1)
cells was##118##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#2)(1991-6#1)(1992-3#1)(1992-6#2)(1993-6#1)(1993-8#2)(1994-11#6)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#2)(1996-3#1)(1997-1#3)(2008-10#6)(2008-11#47)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#6)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#3)
cells were able to##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
cells were adapted to##2##4##(2008-11#2)
cells were adapted##3##3##(2008-11#3)
cells were affected##2##3##(1991-1#1)(2008-11#1)
cells were also##8##3##(1991-10#1)(1992-6#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
cells were amplified##2##3##(2008-11#2)
cells were analysed##2##3##(2008-11#1)(2013-1#1)
cells were assessed##3##3##(2008-11#2)(2010-6#1)
cells were both##2##3##(2008-11#1)(2010-6#1)
cells were cultivated in##3##4##(2008-11#3)
cells were cultured in the presence of##3##7##(2008-11#3)
cells were cultured in the##4##5##(2008-11#4)
cells were cultured in##10##4##(1996-2#1)(2008-11#8)(2012-4#1)
cells were cultured under##3##4##(2008-11#3)
cells were cultured##16##3##(1996-2#1)(2008-11#14)(2012-4#1)
cells were demonstrated##2##3##(1991-10#1)(2008-11#1)
cells were developed##2##3##(2008-10#1)(2008-9#1)
cells were either##3##3##(1995-8#1)(2008-11#1)(2008-6#1)
cells were examined by##2##4##(2008-11#2)
cells were examined##8##3##(1990-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(2008-11#4)
cells were exposed to ultrasound##2##5##(1993-8#1)(2008-8#1)
cells were exposed to##8##4##(1990-8#1)(1993-8#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
cells were exposed##9##3##(1990-8#1)(1993-12#1)(1993-8#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
cells were first grown##2##4##(2008-11#2)
cells were found in##4##4##(1990-2#1)(1994-2#1)(2008-5#1)(2008-8#1)
cells were found to be##3##5##(1994-8#1)(2008-7#1)(2008-8#1)
cells were found to##5##4##(1994-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
cells were found##14##3##(1990-2#1)(1990-9#1)(1994-2#1)(1994-8#1)(1997-3#1)(1997-4#1)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#2)
cells were grown in a##2##5##(2008-11#2)
cells were grown in##5##4##(2008-10#2)(2008-11#3)
cells were grown on##4##4##(1995-9#1)(2008-11#2)(2013-1#1)
cells were grown##12##3##(1993-8#1)(1995-9#1)(2008-10#2)(2008-11#6)(2011-2#1)(2013-1#1)
cells were identified by##2##4##(1997-3#1)(2008-5#1)
cells were increased##2##3##(2008-10#1)(2011-3#1)
cells were incubated for##2##4##(1995-11#1)(2012-3#1)
cells were incubated with##2##4##(1994-11#1)(2010-11#1)
cells were incubated##4##3##(1994-11#1)(1995-11#1)(2010-11#1)(2012-3#1)
cells were induced##2##3##(2008-9#1)(2013-1#1)
cells were infected with##2##4##(1997-3#1)(2011-3#1)
cells were injected##2##3##(2008-11#1)(2013-1#1)
cells were introduced##2##3##(2008-8#1)(2008-9#1)
cells were investigated##4##3##(2008-11#2)(2008-3#1)(2009-10#1)
cells were irradiated with##2##4##(2008-11#1)(2012-3#1)
cells were isolated from##3##4##(2008-11#2)(2008-6#1)
cells were more##5##3##(1994-2#1)(1994-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
cells were not##9##3##(1992-6#2)(1993-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-6#1)
cells were observed in##2##4##(2008-10#1)(2012-3#1)
cells were observed##6##3##(1991-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
cells were obtained##2##3##(2008-11#1)(2008-8#1)
cells were plated##2##3##(1992-6#1)(2013-1#1)
cells were seeded onto##2##4##(2008-11#1)(2012-4#1)
cells were seeded##3##3##(2008-11#2)(2012-4#1)
cells were seen##2##3##(1990-2#1)(2008-5#1)
cells were selected##3##3##(1993-2#1)(1997-8#1)(2008-11#1)
cells were shown to##4##4##(2008-11#2)(2008-8#1)(2013-1#1)
cells were significantly##2##3##(1995-11#1)(2008-9#1)
cells were similar to##2##4##(2008-5#1)(2008-6#1)
cells were stably##2##3##(1993-2#1)(1995-2#1)
cells were still##2##3##(2008-11#1)(2009-12#1)
cells were stimulated##2##3##(1995-8#1)(1997-1#1)
cells were studied##8##3##(1991-5#1)(1992-8#1)(1993-3#1)(2008-11#2)(2008-8#2)(2008-9#1)
cells were subjected to a##2##5##(2008-11#1)(2010-1#1)
cells were subjected to##4##4##(1992-6#1)(2008-11#2)(2010-1#1)
cells were susceptible to##2##4##(1995-2#1)(2008-11#1)
cells were the##2##3##(2008-8#1)(2008-9#1)
cells were then##4##3##(1990-8#1)(1994-5#1)(2008-11#1)(2008-12#1)
cells were transfected with##5##4##(1994-8#1)(2008-11#2)(2010-11#1)(2011-2#1)
cells were transfected##6##3##(1994-8#1)(2008-11#3)(2010-11#1)(2011-2#1)
cells were transferred##4##3##(2008-12#1)(2008-7#1)(2008-9#2)
cells were transformed##2##3##(2008-10#1)(2008-11#1)
cells were treated with##4##4##(1991-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
cells were treated##5##3##(1991-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
cells were typsinized and replated##2##5##(2008-11#2)
cells were used to##2##4##(2008-11#1)(2011-2#1)
cells were used##4##3##(1991-5#1)(1993-12#1)(2008-11#1)(2011-2#1)
cells were##327##2##(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#1)(1991-5#5)(1992-6#6)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-8#7)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#6)(1994-8#5)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#4)(1996-6#1)(1997-1#2)(1997-3#6)(1997-4#1)(1997-8#1)(2008-10#19)(2008-11#108)(2008-12#5)(2008-3#2)(2008-5#10)(2008-6#7)(2008-7#8)(2008-8#14)(2008-9#15)(2009-1#1)(2009-10#1)(2009-12#3)(2009-8#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-6#3)(2011-2#10)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#4)(2012-4#2)(2013-1#12)(2013-8#1)
cells when compared to##3##4##(2008-11#2)(2008-7#1)
cells when##9##2##(1991-3#1)(1995-2#1)(1996-2#1)(2008-11#4)(2008-7#2)
cells where it##2##3##(1997-2#1)(2008-11#1)
cells where##4##2##(1995-11#1)(1997-2#1)(2008-10#1)(2008-11#1)
cells which are##2##3##(2008-11#1)(2008-6#1)
cells which can##2##3##(2008-11#1)(2008-9#1)
cells which had##3##3##(1994-8#1)(2008-11#2)
cells which were##6##3##(1993-1#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
cells which##31##2##(1990-2#1)(1990-3#1)(1993-1#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#2)(1997-7#1)(2008-11#8)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#3)(2012-2#1)(2013-1#1)
cells while##2##2##(2008-11#1)(2010-11#1)
cells whose##2##2##(1994-11#1)(2008-11#1)
cells will be##3##3##(2008-11#2)(2010-12#1)
cells will##6##2##(1994-5#1)(2008-11#3)(2008-7#1)(2010-12#1)
cells with 1##3##3##(1995-12#2)(1995-8#1)
cells with 12-O-tetradecanoyl-phorbol-13-acetate##2##3##(1993-3#1)(1995-6#1)
cells with DNA damage##2##4##(1994-8#1)(2008-4#1)
cells with DNA##3##3##(1994-8#1)(2008-4#1)(2008-7#1)
cells with EGF##2##3##(1990-8#1)(1992-7#1)
cells with IL-1##2##3##(1990-12#1)(1995-6#1)
cells with a high efficiency##2##5##(1990-5#1)(2008-11#1)
cells with a high##3##4##(1990-5#1)(2008-11#2)
cells with a##21##3##(1990-5#1)(1993-6#1)(1993-8#2)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#9)(2008-7#2)(2008-9#3)
cells with an##6##3##(1994-8#1)(2008-10#1)(2008-11#3)(2008-9#1)
cells with different##3##3##(1990-8#1)(1997-7#1)(2008-11#1)
cells with high expression of CD133##2##6##(2009-9#2)
cells with high##5##3##(2008-11#2)(2008-7#1)(2009-9#2)
cells with increasing##2##3##(2008-10#1)(2008-11#1)
cells with nuclear##2##3##(2008-7#1)(2011-2#1)
cells with respect to##3##4##(1995-8#1)(2008-4#1)(2013-1#1)
cells with sodium##2##3##(2008-5#1)(2008-8#1)
cells with the##14##3##(1991-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1996-2#1)(2008-11#4)(2008-8#1)
cells with various##4##3##(2008-10#1)(2008-11#3)
cells with##192##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#6)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1997-1#4)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#13)(2008-11#59)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-7#9)(2008-8#5)(2008-9#12)(2009-5#1)(2009-9#2)(2010-1#2)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
cells within a##2##3##(1995-8#1)(2008-11#1)
cells within the##6##3##(1994-2#1)(2008-9#2)(2009-3#1)(2012-3#1)(2013-1#1)
cells within##14##2##(1994-2#1)(1995-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
cells without##7##2##(2008-10#1)(2008-11#3)(2008-7#1)(2011-2#2)
cells x day##4##3##(2008-11#4)
cells##6843##1##(1990-11#21)(1990-12#50)(1990-2#45)(1990-3#6)(1990-5#59)(1990-6#16)(1990-7#1)(1990-8#39)(1990-9#2)(1991-1#6)(1991-10#3)(1991-11#16)(1991-12#10)(1991-2#8)(1991-3#12)(1991-5#65)(1991-6#17)(1991-7#10)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#16)(1992-11#3)(1992-12#16)(1992-2#15)(1992-3#16)(1992-4#2)(1992-5#5)(1992-6#65)(1992-7#10)(1992-8#19)(1992-9#17)(1993-1#13)(1993-11#14)(1993-12#27)(1993-2#14)(1993-3#47)(1993-5#2)(1993-6#39)(1993-8#95)(1993-9#12)(1994-11#112)(1994-12#15)(1994-2#19)(1994-3#49)(1994-5#44)(1994-6#35)(1994-8#68)(1995-10#1)(1995-11#46)(1995-12#63)(1995-2#122)(1995-3#8)(1995-5#14)(1995-6#64)(1995-8#69)(1995-9#14)(1996-1#1)(1996-11#1)(1996-12#47)(1996-2#47)(1996-3#7)(1996-6#9)(1996-9#4)(1997-1#82)(1997-2#10)(1997-3#44)(1997-4#12)(1997-5#2)(1997-6#5)(1997-7#66)(1997-8#27)(1997-9#3)(2006-6#3)(2007-11#5)(2007-12#63)(2008-1#13)(2008-10#501)(2008-11#1838)(2008-12#46)(2008-2#13)(2008-3#6)(2008-4#124)(2008-5#121)(2008-6#41)(2008-7#238)(2008-8#249)(2008-9#404)(2009-1#4)(2009-10#43)(2009-11#1)(2009-12#42)(2009-3#28)(2009-4#10)(2009-5#4)(2009-6#26)(2009-7#16)(2009-8#50)(2009-9#25)(2010-1#33)(2010-10#16)(2010-11#41)(2010-12#18)(2010-2#5)(2010-3#16)(2010-4#2)(2010-5#17)(2010-6#41)(2010-7#7)(2010-8#16)(2010-9#1)(2011-1#12)(2011-2#245)(2011-3#21)(2012-10#1)(2012-12#44)(2012-2#105)(2012-3#78)(2012-4#9)(2012-5#7)(2013-1#151)(2013-7#16)(2013-8#76)
cells'##10##1##(2008-11#1)(2008-7#3)(2008-8#3)(2008-9#1)(2012-2#1)(2013-8#1)
cells(-1) day(-1)##2##2##(2008-11#2)
cells) and##7##2##(1992-5#1)(1992-6#1)(1996-12#1)(1997-1#1)(2008-11#1)(2009-10#1)(2013-8#1)
cells) are##4##2##(1997-4#1)(2008-10#1)(2008-7#1)(2012-2#1)
cells) or##3##2##(1993-6#1)(2008-7#2)
cells) was##2##2##(2008-5#1)(2008-7#1)
cells)##57##1##(1990-10#1)(1990-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#10)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#3)
cells/day##2##1##(2008-11#2)
cells/ml for##4##2##(2008-11#1)(2010-1#3)
cells/ml##15##1##(1996-8#1)(2008-10#1)(2008-11#8)(2008-7#2)(2010-1#3)
cells?##2##1##(2008-11#2)
cells]##4##1##(1990-11#1)(2010-12#1)(2011-3#1)(2013-8#1)
cellsgrowing in increased##2##3##(2008-11#2)
cellsin##3##1##(2008-11#2)(2008-8#1)
cellsshowed##2##1##(2008-11#2)
cellswas##2##1##(2008-11#2)
cellswere##3##1##(2008-11#3)
cellular DNA##8##2##(2008-11#3)(2008-7#1)(2008-9#3)(2012-2#1)
cellular RNA##3##2##(1995-12#1)(2008-4#1)(2008-9#1)
cellular accumulation##3##2##(1990-2#1)(1993-8#1)(2013-1#1)
cellular activation##4##2##(1992-12#1)(1995-6#2)(2008-9#1)
cellular activities##2##2##(2009-12#1)(2011-2#1)
cellular activity##4##2##(1991-2#1)(1992-11#1)(1994-8#1)(2008-11#1)
cellular adaptation##2##2##(1991-5#1)(2010-7#1)
cellular aging##5##2##(1990-3#3)(2008-7#1)(2011-2#1)
cellular and humoral immune responses##3##5##(2008-10#1)(2008-11#1)(2008-12#1)
cellular and humoral immune##4##4##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
cellular and humoral immunity##2##4##(2008-10#1)(2012-2#1)
cellular and humoral##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#2)
cellular and molecular levels##2##4##(2008-7#1)(2008-9#1)
cellular and molecular##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)
cellular and nuclear##2##3##(1990-3#1)(2008-7#1)
cellular and tissue##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
cellular and viral##4##3##(1995-2#1)(2008-11#2)(2010-1#1)
cellular and##27##2##(1990-3#1)(1995-2#1)(1997-2#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
cellular antigens##2##2##(1990-12#1)(1997-3#1)
cellular automata##3##2##(1994-2#1)(2008-11#2)
cellular binding##2##2##(1994-3#1)(1994-8#1)
cellular changes that##2##3##(2008-4#1)(2009-12#1)
cellular changes##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2012-12#1)
cellular characteristics##2##2##(2008-11#1)(2013-8#1)
cellular cholesterol##3##2##(1990-8#1)(1994-11#1)(2008-6#1)
cellular compartments##2##2##(1995-2#1)(2009-8#1)
cellular component##2##2##(2008-9#1)(2013-1#1)
cellular components##7##2##(1990-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
cellular composition##2##2##(1997-5#1)(2008-7#1)
cellular debris##2##2##(1992-12#1)(1994-6#1)
cellular delivery##2##2##(2012-12#1)(2013-1#1)
cellular differentiation##5##2##(1995-2#1)(2008-11#3)(2008-9#1)
cellular disorganization##2##2##(2008-10#2)
cellular distribution of##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
cellular elements##3##2##(1995-8#1)(2008-4#1)(2008-9#1)
cellular energy##2##2##(1994-8#1)(2011-2#1)
cellular environments##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
cellular enzyme##2##2##(2008-5#2)
cellular events such as##2##4##(2009-5#1)(2011-2#1)
cellular events##6##2##(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#3)
cellular expression of##2##3##(1996-12#1)(2009-3#1)
cellular expression##3##2##(1996-12#1)(2009-3#1)(2010-1#1)
cellular fatty acid##3##3##(2008-10#2)(2011-1#1)
cellular fatty##4##2##(2008-10#2)(2011-1#2)
cellular function##9##2##(1995-12#1)(1997-3#1)(2006-6#1)(2008-11#2)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
cellular functions of##3##3##(2008-11#1)(2009-8#1)(2010-12#1)
cellular functions##21##2##(1994-3#1)(1996-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
cellular genes which##2##3##(2008-8#2)
cellular genes##3##2##(2008-8#3)
cellular growth and##2##3##(1994-3#2)
cellular growth##8##2##(1993-11#1)(1994-11#1)(1994-3#2)(1994-8#1)(2008-12#1)(2008-7#1)(2011-2#1)
cellular health##2##2##(2011-2#2)
cellular immune response##3##3##(1990-12#1)(1991-12#1)(2009-12#1)
cellular immune responses against##2##4##(1995-5#1)(2011-2#1)
cellular immune responses##7##3##(1991-12#1)(1995-5#1)(2008-12#2)(2008-5#2)(2011-2#1)
cellular immune##11##2##(1990-12#1)(1991-12#2)(1995-5#1)(2008-12#2)(2008-5#2)(2009-12#1)(2011-2#1)(2013-8#1)
cellular immunity##4##2##(1995-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
cellular infiltrate##2##2##(2007-9#1)(2008-9#1)
cellular integrity##2##2##(1991-5#1)(1996-6#1)
cellular interactions##2##2##(2008-10#1)(2009-9#1)
cellular level##13##2##(1990-2#1)(1993-11#1)(1994-2#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-6#1)(2012-12#1)
cellular levels of##3##3##(1991-3#1)(1992-8#1)(1995-2#1)
cellular levels##5##2##(1991-3#1)(1992-8#1)(1995-2#1)(2008-4#2)
cellular life/death balance##2##3##(2012-2#2)
cellular localization of##2##3##(1991-10#1)(1996-6#1)
cellular markers##2##2##(2008-9#1)(2012-2#1)
cellular material##2##2##(1997-3#2)
cellular mechanism of##2##3##(2008-10#1)(2008-11#1)
cellular mechanism##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2009-8#2)
cellular mechanisms that##2##3##(1990-2#1)(2009-8#1)
cellular mechanisms##7##2##(1990-2#1)(1994-8#1)(2008-11#1)(2008-2#1)(2009-8#2)(2011-2#1)
cellular membrane##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
cellular membranes##3##2##(1994-5#1)(1995-6#1)(1997-7#1)
cellular metabolism##10##2##(1993-8#1)(2008-10#2)(2008-11#5)(2008-7#2)
cellular morphology##4##2##(1992-2#1)(1996-2#1)(2008-11#2)
cellular motions##2##2##(2008-11#2)
cellular or##4##2##(1991-12#1)(1994-6#1)(2008-11#1)(2009-8#1)
cellular organelles##4##2##(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)
cellular oxygen##2##2##(1992-5#1)(1997-1#1)
cellular pathways##2##2##(2008-7#1)(2011-2#1)
cellular patterns##2##2##(1991-8#1)(2009-5#1)
cellular phenotypes##2##2##(2008-11#1)(2008-7#1)
cellular physiology##3##2##(2008-7#1)(2009-8#1)(2011-2#1)
cellular plant pathogens##2##3##(2008-10#2)
cellular process that##2##3##(1994-12#1)(2009-8#1)
cellular process##3##2##(1994-12#1)(2008-9#1)(2009-8#1)
cellular processes in##3##3##(1995-2#1)(2008-1#1)(2009-6#1)
cellular processes such as##3##4##(2008-9#2)(2011-2#1)
cellular processes that##2##3##(2011-2#1)(2012-2#1)
cellular processes##30##2##(1995-2#3)(2008-1#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#2)(2009-8#3)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)
cellular productivity##3##2##(2008-11#3)
cellular proliferation in vitro##2##4##(2008-1#1)(2008-11#1)
cellular proliferation in##3##3##(2008-1#1)(2008-11#1)(2013-7#1)
cellular proliferation##14##2##(1994-11#1)(1994-3#1)(1996-2#1)(2008-1#2)(2008-11#3)(2008-5#1)(2013-1#2)(2013-7#2)(2013-8#1)
cellular protein##12##2##(1990-5#1)(1994-11#1)(1994-12#1)(1995-8#1)(1997-1#1)(2008-11#4)(2008-9#1)(2010-12#1)(2011-2#1)
cellular proteins##18##2##(1991-5#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-8#1)(1997-3#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)
cellular receptor##4##2##(1993-8#1)(1994-11#1)(1995-12#1)(2008-10#1)
cellular redox homeostasis##4##3##(1994-8#2)(2009-6#1)(2009-9#1)
cellular release of##2##3##(1995-11#1)(1995-2#1)
cellular respiration##3##2##(1997-1#1)(2008-10#1)(2008-5#1)
cellular response to DNA damage##2##5##(2011-2#2)
cellular response to##6##3##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
cellular response##9##2##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#5)(2012-2#1)
cellular responses of##2##3##(2008-11#1)(2008-5#1)
cellular responses to##3##3##(1992-3#1)(1997-8#1)(2008-7#1)
cellular responses##11##2##(1992-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2009-12#1)(2010-12#1)
cellular responsiveness to##2##3##(1995-12#1)(2008-4#1)
cellular senescence##7##2##(1997-7#1)(2008-11#4)(2012-3#2)
cellular sensitivity to##4##3##(1990-2#1)(1993-3#2)(1995-12#1)
cellular sensitivity##5##2##(1990-2#1)(1993-3#2)(1995-12#1)(2008-11#1)
cellular shape change##2##3##(2009-9#2)
cellular signaling##3##2##(2008-11#1)(2008-8#1)(2010-1#1)
cellular slime##2##2##(1995-6#1)(2008-8#1)
cellular stimulation##2##2##(1996-2#1)(2008-10#1)
cellular stress##3##2##(2011-2#1)(2012-2#2)
cellular substrate##2##2##(1997-1#1)(2008-11#1)
cellular substrates##2##2##(2008-11#1)(2008-7#1)
cellular survival##2##2##(2008-9#2)
cellular systems##4##2##(1992-3#1)(1996-12#1)(2008-11#1)(2011-2#1)
cellular targeting##2##2##(1990-11#1)(2011-2#1)
cellular targets##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
cellular therapies##5##2##(2008-11#1)(2008-4#1)(2013-1#3)
cellular therapy##4##2##(2008-11#1)(2012-3#1)(2013-1#2)
cellular toxicity##3##2##(1992-12#1)(2008-9#1)(2011-1#1)
cellular transformation##3##2##(2009-10#1)(2011-2#1)(2012-2#1)
cellular transport of##2##3##(2008-10#1)(2008-11#1)
cellular transport##3##2##(2008-10#1)(2008-11#2)
cellular vesicles##2##2##(1997-3#2)
cellular##655##1##(1990-11#2)(1990-12#5)(1990-2#7)(1990-3#4)(1990-5#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#7)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#7)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#10)(1994-9#1)(1995-11#4)(1995-12#7)(1995-2#14)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#5)(1995-9#1)(1996-12#2)(1996-2#6)(1996-6#2)(1996-8#1)(1997-1#6)(1997-2#3)(1997-3#15)(1997-5#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-9#3)(2008-1#6)(2008-10#52)(2008-11#108)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#21)(2008-5#14)(2008-6#2)(2008-7#29)(2008-8#7)(2008-9#35)(2009-10#3)(2009-12#7)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#21)(2009-9#6)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#3)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#45)(2011-3#2)(2012-12#5)(2012-2#19)(2012-3#9)(2013-1#23)(2013-7#3)(2013-8#8)
cellularity and##2##2##(2008-10#2)
cellularity##10##1##(1997-8#1)(2008-10#5)(2008-7#1)(2009-1#1)(2012-2#1)(2013-1#1)
cellulase activity##2##2##(2008-10#2)
cellulase##20##1##(1990-5#1)(1993-8#1)(2008-10#14)(2008-7#1)(2008-9#2)(2011-2#1)
cellulases##6##1##(1990-5#1)(2009-3#2)(2011-2#3)
cellulite##3##1##(2008-5#3)
cellulitis##10##1##(1991-8#5)(2007-12#1)(2008-7#1)(2013-1#3)
cellulolytic and##2##2##(2008-10#2)
cellulolytic##4##1##(1992-11#1)(2008-10#3)
cellulolyticus in##2##2##(2011-2#2)
cellulolyticus##6##1##(2011-2#6)
cellulose acetate (CA) membrane##2##4##(2008-10#2)
cellulose acetate##8##2##(1991-12#1)(2008-10#6)(2008-5#1)
cellulose and chitin##2##3##(2008-10#2)
cellulose and##7##2##(2008-10#5)(2008-9#1)(2011-2#1)
cellulose appeared##2##2##(2008-10#2)
cellulose binding domain##3##3##(2008-7#3)
cellulose carrier##2##2##(2008-10#1)(2008-7#1)
cellulose filters##2##2##(2008-10#2)
cellulose labeling##2##2##(2008-10#2)
cellulose matrix##2##2##(2008-10#2)
cellulose membrane##5##2##(2008-10#5)
cellulose nitrate membrane filter##2##4##(2008-10#2)
cellulose triacetate##3##2##(2008-10#3)
cellulose were tested##2##3##(2008-10#2)
cellulose were##3##2##(2008-10#3)
cellulose##99##1##(1991-11#1)(1991-12#1)(1992-12#1)(1992-7#1)(2008-10#66)(2008-11#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#4)(2013-1#2)(2013-8#2)
cellulose)##3##1##(1992-1#1)(2008-10#1)(2008-11#1)
cellulose-azure##5##1##(2008-10#5)
cellulosic##5##1##(1993-8#1)(2008-10#3)(2012-3#1)
cement and##5##2##(2008-10#2)(2011-2#2)(2013-1#1)
cement matrices##2##2##(2008-10#2)
cement##34##1##(1997-6#1)(2008-10#13)(2008-5#2)(2009-7#1)(2011-2#4)(2012-2#1)(2013-1#12)
cemented and##2##2##(2013-1#2)
cemented##9##1##(1993-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2012-2#1)(2013-1#4)
cementless total##2##2##(2009-3#1)(2009-4#1)
cementless##7##1##(1997-6#2)(2009-3#4)(2009-4#1)
cements##3##1##(2008-10#1)(2013-1#2)
cementum##2##1##(2013-1#2)
cenocepacia from banana##2##3##(2008-10#2)
cenocepacia isolates##2##2##(2008-10#2)
cenocepacia##7##1##(2008-10#7)
censored data linear regression##2##4##(1995-9#2)
censored data##6##2##(1995-12#1)(1995-9#3)(1997-3#1)(2008-10#1)
censored##13##1##(1992-9#3)(1995-12#2)(1995-9#3)(1997-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
censorship##2##1##(1996-5#2)
census data##3##2##(2008-1#1)(2008-8#1)(2011-2#1)
census divisions##2##2##(1994-1#1)(1996-3#1)
census##17##1##(1991-5#1)(1992-12#2)(1994-1#1)(1994-2#1)(1996-3#1)(2008-1#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)
censuses##3##1##(2008-8#2)(2008-9#1)
centenarians##21##1##(2008-7#16)(2012-12#5)
center and##4##2##(1992-2#1)(1993-8#1)(1994-12#1)(1997-2#1)
center experience##4##2##(2008-1#3)(2008-3#1)
center for##7##2##(1996-6#1)(1997-8#1)(2008-11#1)(2008-8#2)(2010-7#1)(2012-3#1)
center have been##2##3##(1990-9#1)(2008-10#1)
center in the##2##3##(2008-10#1)(2008-8#1)
center in##15##2##(1990-12#1)(1991-8#1)(1994-3#4)(1996-3#1)(2008-1#1)(2008-10#2)(2008-8#2)(2010-8#1)(2012-12#1)(2012-2#1)
center is##2##2##(2008-10#1)(2008-8#1)
center layer##4##2##(2013-8#4)
center of diversity##4##3##(2008-10#4)
center of origin##5##3##(2008-10#4)(2011-2#1)
center of the##16##3##(1993-8#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
center of this##2##3##(1993-8#1)(1995-2#1)
center of##41##2##(1991-2#1)(1991-3#1)(1993-8#2)(1995-2#1)(1996-3#1)(2008-10#13)(2008-11#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
center over##2##2##(1991-8#1)(2011-2#1)
center to##2##2##(2010-6#1)(2012-2#1)
center was##2##2##(1996-12#1)(2008-10#1)
center with##4##2##(1993-1#1)(2008-3#1)(2013-1#1)(2013-8#1)
center##172##1##(1990-12#1)(1990-2#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-8#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-8#5)(1994-12#1)(1994-3#8)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#2)(1996-12#2)(1996-3#3)(1996-6#1)(1997-1#3)(1997-2#2)(1997-8#1)(2007-8#1)(2007-9#4)(2008-1#7)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#12)(2008-5#3)(2008-7#3)(2008-8#11)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#8)
center's##2##1##(1993-2#1)(1996-12#1)
center]##15##1##(1991-11#1)(1993-3#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#3)(1997-5#1)
centered around the##3##3##(1996-1#1)(2008-10#2)
centered around##4##2##(1996-1#1)(2008-10#2)(2008-11#1)
centered at##7##2##(2008-10#3)(2008-2#1)(2008-3#2)(2009-5#1)
centered on the##5##3##(1993-12#1)(1994-9#1)(2008-11#1)(2008-2#1)(2010-7#1)
centered on##11##2##(1993-12#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#2)(2013-1#1)
centered##26##1##(1993-12#1)(1994-9#1)(1996-1#1)(1997-1#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-7#2)(2013-1#1)
centering##10##1##(1993-3#1)(2008-10#8)(2008-12#1)
centerpiece##3##1##(1996-3#1)(1996-5#1)(2011-2#1)
centers and other##2##3##(1994-3#1)(2008-11#1)
centers and##9##2##(1991-1#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2013-1#1)
centers for the##2##3##(2008-5#1)(2008-7#1)
centers for##5##2##(1991-1#1)(1997-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
centers in the##4##3##(2008-10#2)(2008-5#1)(2010-8#1)
centers in##13##2##(1994-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
centers is##2##2##(2008-11#2)
centers of##6##2##(1991-10#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
centers on##3##2##(1992-2#1)(2008-10#1)(2010-6#1)
centers to##5##2##(1991-12#1)(1996-1#1)(1996-5#1)(1997-2#1)(2008-1#1)
centers were##2##2##(2008-10#2)
centers which##2##2##(1994-2#1)(2009-9#1)
centers with##2##2##(1991-1#1)(1996-1#1)
centers##133##1##(1990-2#3)(1990-6#1)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#2)(1995-12#3)(1995-3#4)(1996-1#5)(1996-2#1)(1996-3#1)(1996-5#4)(1997-2#5)(1997-3#1)(1997-4#2)(2007-8#1)(2007-9#4)(2008-1#5)(2008-10#15)(2008-11#9)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-9#1)(2010-11#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#6)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
centers)##3##1##(1996-1#1)(2008-10#2)
centers]##3##1##(1994-6#2)(1996-2#1)
centimeter of##5##2##(2008-10#4)(2010-7#1)
centimeter##9##1##(1991-5#1)(2008-10#7)(2010-7#1)
centimeters##6##1##(1993-11#1)(1994-11#1)(1995-6#2)(2008-10#1)(2008-3#1)
centimorgan##4##1##(1994-9#2)(2008-10#2)
centimorgans (cM)##7##2##(2008-10#7)
centimorgans##14##1##(1994-9#1)(2008-10#13)
centractin##5##1##(1995-2#5)
central CRF##2##2##(1997-4#2)
central California##2##2##(2008-10#1)(2008-9#1)
central DI##4##2##(1997-8#4)
central ET-1##3##2##(1994-11#3)
central European##2##2##(1994-12#1)(2012-9#1)
central Florida##2##2##(1991-2#1)(2008-10#1)
central New York##4##3##(1991-3#1)(2008-10#3)
central United States##4##3##(2008-10#3)(2008-11#1)
central action of##2##3##(1992-6#1)(1996-12#1)
central action##3##2##(1992-6#1)(1996-12#1)(2011-2#1)
central administration##2##2##(1992-1#1)(1994-2#1)
central affective##2##2##(2013-8#2)
central and autonomic nervous##2##4##(2009-8#1)(2010-11#1)
central and northern##2##3##(2008-10#2)
central and peripheral immune function in##2##6##(2008-10#2)
central and peripheral neurons##3##4##(1996-12#3)
central and peripheral##9##3##(1993-5#1)(1996-12#4)(2008-10#2)(2008-7#1)(2013-8#1)
central and regional functions##2##4##(1990-11#2)
central and southern Somalia##2##4##(2011-2#2)
central and southern##4##3##(2008-10#2)(2011-2#2)
central and##20##2##(1990-11#2)(1993-5#1)(1996-12#4)(2007-12#1)(2008-10#6)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#2)(2013-8#1)
central area of##2##3##(2008-10#1)(2008-3#1)
central aspects##2##2##(1991-3#1)(2012-12#1)
central cell##10##2##(2007-12#2)(2008-11#2)(2008-9#6)
central cells##3##2##(2008-5#3)
central coast##2##2##(2008-10#2)
central complex##4##2##(2007-12#4)
central component of##2##3##(2012-2#1)(2013-8#1)
central component##4##2##(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
central composite design##16##3##(2008-10#14)(2008-11#2)
central composite designs##3##3##(2008-10#3)
central composite##21##2##(2008-10#18)(2008-11#3)
central control##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
central core##3##2##(1997-3#1)(2008-11#1)(2012-3#1)
central corneal##2##2##(2011-2#2)
central diabetes insipidus##3##3##(1997-8#1)(2011-1#2)
central domain##8##2##(2008-9#8)
central focus##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
central glucagon-like peptide-1##2##3##(1996-2#2)
central goal##2##2##(2008-8#1)(2011-2#1)
central highlands of Mexico##2##4##(2008-10#2)
central in##2##2##(2012-2#1)(2013-1#1)
central iran##2##2##(2013-1#2)
central islet necrosis##2##3##(2010-11#2)
central level##2##2##(1990-11#1)(2012-3#1)
central lumen##5##2##(2007-12#1)(2008-6#2)(2008-7#2)
central metabolism##5##2##(2008-11#1)(2008-7#4)
central metals##2##2##(2008-10#2)
central necrosis##2##2##(1990-12#1)(2008-10#1)
central nervous system (CNS)##26##4##(1991-12#2)(1991-2#1)(1994-2#1)(1996-12#3)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
central nervous system and##7##4##(1996-12#2)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
central nervous system involvement##2##4##(2008-10#1)(2008-7#1)
central nervous system lymphoma (PCNSL)##2##5##(2008-7#1)(2009-8#1)
central nervous system lymphoma##5##4##(1991-6#1)(1996-11#1)(2008-7#2)(2009-8#1)
central nervous system of##5##4##(1992-6#1)(1995-2#1)(1996-12#1)(1997-3#1)(2011-2#1)
central nervous system##119##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#9)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#13)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
central nervous##124##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#9)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#13)(2008-9#3)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
central nicotinic##2##2##(1996-2#2)
central nucleus of the##2##4##(1996-12#1)(2012-3#1)
central nucleus##4##2##(1992-6#1)(1996-12#1)(2012-3#2)
central obesity##2##2##(2008-10#1)(2008-6#1)
central or##4##2##(1990-11#1)(1994-12#1)(2008-7#1)(2010-7#1)
central pathophysiological##2##2##(2010-10#1)(2011-2#1)
central pattern generators##2##3##(2008-11#1)(2009-5#1)
central regulator of##2##3##(2008-9#1)(2013-1#1)
central retinal vein occlusion##2##4##(2011-2#2)
central retinal##4##2##(2011-2#3)(2013-7#1)
central role in the##7##4##(1993-3#1)(1995-6#1)(1997-1#1)(2008-1#1)(2008-10#1)(2011-2#2)
central role in##17##3##(1992-3#1)(1993-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
central role##29##2##(1991-5#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#3)(2010-11#1)(2011-2#4)(2011-3#1)(2013-1#1)(2013-8#1)
central sensitization##3##2##(2008-9#2)(2011-2#1)
central sulcus hemorrhage##2##3##(2013-1#2)
central sulcus##3##2##(2008-7#1)(2013-1#2)
central terminals##2##2##(1992-6#1)(1997-3#1)
central theme##4##2##(2008-11#2)(2009-7#1)(2010-5#1)
central to the##7##3##(1990-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
central to these##2##3##(1993-1#1)(1997-3#1)
central to##23##2##(1990-5#1)(1992-10#1)(1993-1#1)(1993-9#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-1#1)
central vein cannulation##2##3##(2008-1#2)
central vein stenosis##2##3##(2008-1#2)
central vein##4##2##(2008-1#4)
central veins##2##2##(1993-6#1)(2008-10#1)
central venous catheter##3##3##(2008-7#2)(2011-2#1)
central venous catheters##2##3##(2008-7#2)
central venous##9##2##(1990-3#1)(1990-9#1)(2008-7#5)(2011-2#1)(2011-3#1)
central visual##2##2##(2011-2#1)(2013-8#1)
central##550##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#6)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#2)(1994-8#2)(1995-12#4)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#18)(1996-2#9)(1996-3#1)(1997-1#3)(1997-2#5)(1997-3#7)(1997-4#7)(1997-7#2)(1997-8#7)(2007-12#15)(2008-1#9)(2008-10#94)(2008-11#35)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#12)(2008-6#4)(2008-7#32)(2008-8#11)(2008-9#28)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#7)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#35)(2011-3#3)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#9)(2012-9#1)(2013-1#22)(2013-7#3)(2013-8#14)
centralis##3##1##(2008-6#1)(2010-4#2)
centrality##3##1##(2010-7#1)(2013-1#2)
centralization of##2##2##(1997-8#1)(2011-2#1)
centralization##3##1##(1997-8#1)(2011-2#2)
centralized departments##2##2##(1996-1#2)
centralized##14##1##(1991-1#1)(1991-2#1)(1992-1#1)(1994-2#1)(1995-12#2)(1996-1#2)(1997-8#1)(2008-10#2)(2008-5#1)(2010-8#2)
centrally acting muscle relaxant##4##4##(1992-3#2)(1996-2#2)
centrally acting##6##2##(1992-3#2)(1992-6#1)(1996-2#2)(2012-3#1)
centrally##16##1##(1992-3#2)(1992-6#2)(1996-2#3)(2008-10#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-9#2)(2012-3#1)(2013-8#2)
centre and##2##2##(1995-10#1)(2013-1#1)
centre for health##2##3##(1996-6#1)(2008-11#1)
centre for##9##2##(1995-5#3)(1996-6#2)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
centre in##4##2##(1991-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
centre of the##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
centre of##11##2##(1993-2#1)(1993-9#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-7#1)
centre to##2##2##(1992-12#1)(2008-11#1)
centre with##2##2##(2010-10#2)
centre##57##1##(1990-9#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-12#1)(1995-5#5)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#4)(1997-4#2)(1997-7#2)(2007-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#4)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-7#1)(2013-1#5)(2013-8#1)
centre)##2##1##(1995-5#1)(2008-10#1)
centred at##2##2##(2008-10#2)
centred on the##2##3##(2008-10#1)(2011-2#1)
centred on##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-12#1)
centred##11##1##(2008-10#3)(2008-11#3)(2008-5#1)(2011-2#3)(2012-12#1)
centres and##5##2##(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
centres can##2##2##(2008-10#1)(2008-11#1)
centres for##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
centres have##2##2##(1994-6#1)(2008-11#1)
centres in the##2##3##(1991-2#1)(2008-11#1)
centres in##4##2##(1991-2#1)(2008-11#3)
centres of##2##2##(1990-5#1)(2008-1#1)
centres on the##2##3##(1995-1#1)(2008-11#1)
centres with##2##2##(2008-11#1)(2010-10#1)
centres##58##1##(1990-5#1)(1990-6#1)(1991-2#1)(1992-6#2)(1993-12#1)(1993-6#1)(1994-6#3)(1995-1#2)(1995-10#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-5#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#16)(2008-5#4)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#4)(2013-1#2)
centrifugal##8##1##(1990-2#1)(1992-1#2)(2008-2#2)(2009-12#1)(2011-2#1)(2013-1#1)
centrifugation and##9##2##(1992-12#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-5#2)(2011-2#1)
centrifugation at##2##2##(2008-10#1)(2008-5#1)
centrifugation for##2##2##(2008-10#1)(2008-9#1)
centrifugation of the##2##3##(2008-10#1)(2008-11#1)
centrifugation of##4##2##(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#1)
centrifugation on##2##2##(2008-10#1)(2008-11#1)
centrifugation or##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
centrifugation##53##1##(1990-2#1)(1992-12#1)(1993-8#4)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1997-3#3)(2008-10#17)(2008-11#7)(2008-4#2)(2008-5#6)(2008-8#1)(2008-9#4)(2011-2#2)
centrifuge##7##1##(1993-2#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)
centrifuged##4##1##(2008-10#2)(2008-11#1)(2008-9#1)
centrin genes##2##2##(2008-9#2)
centrin##4##1##(2008-9#4)
centrin-1##3##1##(2008-9#3)
centroid##3##1##(2008-3#1)(2008-5#1)(2010-4#1)
centroids##2##1##(2008-10#1)(2010-4#1)
centromere##8##1##(1996-3#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-8#1)(2012-3#1)
centromere-proximal##3##1##(1996-3#3)
centromeric to the color pigment##2##5##(1993-3#2)
centromeric##8##1##(1993-12#1)(1993-3#3)(1996-8#1)(1997-6#1)(2008-10#1)(2010-8#1)
centrosymmetric##4##1##(1992-8#1)(2008-10#1)(2008-3#2)
cents##3##1##(1994-1#2)(2008-8#1)
centuries##11##1##(1991-6#1)(1994-12#1)(2008-10#1)(2008-12#2)(2008-6#1)(2009-6#1)(2009-8#1)(2010-1#2)(2011-2#1)
century and the##2##3##(2008-10#1)(2008-11#1)
century and##7##2##(1994-9#1)(2008-10#2)(2008-11#1)(2010-1#1)(2012-12#1)(2012-3#1)
century as the##2##3##(1995-12#1)(2013-8#1)
century b##2##2##(2008-10#2)
century in##3##2##(1997-6#1)(2008-10#1)(2008-12#1)
century of research##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
century of##5##2##(1993-2#1)(2008-7#1)(2008-8#2)(2012-2#1)
century to##3##2##(1992-2#1)(2009-12#1)(2011-3#1)
century##149##1##(1990-12#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-11#3)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#2)(1997-1#5)(1997-2#1)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#2)(2007-12#2)(2008-10#20)(2008-11#7)(2008-12#12)(2008-2#1)(2008-4#6)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-12#3)(2009-5#1)(2009-8#4)(2010-1#12)(2010-10#1)(2010-5#1)(2011-2#8)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#3)
century)##2##1##(2008-10#1)(2008-9#1)
century?##3##1##(1994-3#1)(2008-11#1)(2012-3#1)
century]##3##1##(1993-11#1)(2008-11#2)
cepa L##2##2##(1993-12#1)(2008-10#1)
cepa##4##1##(1993-12#2)(2008-10#2)
cepacia 1324##3##2##(2008-10#3)
cepacia AMMDR1 on##2##3##(2008-10#2)
cepacia AMMDR1##10##2##(2008-10#10)
cepacia##22##1##(2008-10#20)(2008-7#2)
cephalexin##3##1##(1990-6#1)(2008-10#1)(2008-11#1)
cephalic##2##1##(2008-5#1)(2008-6#1)
cephalopod##6##1##(2008-7#3)(2009-8#1)(2011-2#2)
cephalopods##5##1##(2008-7#3)(2009-8#2)
cephalosporin C##2##2##(2011-1#2)
cephalosporin antibiotics##5##2##(2008-10#5)
cephalosporin##14##1##(1994-8#1)(2008-10#5)(2008-11#1)(2011-1#5)(2011-2#2)
cephalosporins##5##1##(2008-10#2)(2008-7#1)(2011-1#2)
ceramic glazes##3##2##(2008-10#3)
ceramic interpositional arthroplasty##2##3##(2010-11#2)
ceramic materials##4##2##(2008-10#3)(2012-2#1)
ceramic pieces##2##2##(2008-10#2)
ceramic processing##2##2##(2008-10#2)
ceramic shards##2##2##(2008-10#2)
ceramic##54##1##(1990-5#1)(1991-3#2)(2008-10#38)(2008-12#2)(2008-2#1)(2009-7#4)(2010-11#3)(2012-2#1)(2013-1#2)
ceramics##7##1##(2008-10#3)(2009-7#3)(2010-12#1)
ceramide 2##5##2##(2008-5#5)
ceramide 5 and hexadecanoic acid##2##5##(2008-5#2)
ceramide 5##5##2##(2008-5#5)
ceramide##31##1##(1994-5#5)(1995-12#1)(1996-2#1)(2008-10#1)(2008-5#21)(2008-7#1)(2011-2#1)
ceramides and##2##2##(1995-12#1)(2008-5#1)
ceramides##9##1##(1995-12#2)(2008-10#1)(2008-5#6)
cerasi##2##1##(2008-10#2)
cercosporin##4##1##(2008-10#4)
cereal and##2##2##(2008-10#2)
cereal crops##3##2##(2008-10#3)
cereal##21##1##(2008-10#13)(2008-8#1)(2008-9#1)(2009-8#2)(2010-1#2)(2011-2#1)(2012-3#1)
cerealis##5##1##(2008-10#5)
cereals and grasses##3##3##(2008-10#3)
cereals and##5##2##(2008-10#4)(2012-3#1)
cereals##25##1##(1991-12#4)(1991-6#1)(2008-10#10)(2008-11#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#3)(2012-3#1)(2013-8#1)
cerebellar and##2##2##(1997-3#1)(2012-3#1)
cerebellar artery##6##2##(2008-7#4)(2012-3#2)
cerebellar ataxia##7##2##(1995-6#1)(1997-8#1)(2008-7#2)(2011-2#2)(2013-1#1)
cerebellar blood flow##2##3##(1995-5#2)
cerebellar cortex of##2##3##(1995-8#1)(1997-2#1)
cerebellar cortex##10##2##(1992-6#1)(1995-2#1)(1995-8#3)(1997-2#2)(2012-2#1)(2013-8#2)
cerebellar degeneration##4##2##(1992-2#1)(1997-8#3)
cerebellar granule cells##3##3##(1996-12#1)(2008-9#2)
cerebellar lesion##2##2##(1993-3#1)(2013-1#1)
cerebellar symptoms##3##2##(2011-2#3)
cerebellar##77##1##(1992-2#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-2#2)(1995-11#1)(1995-2#1)(1995-5#4)(1995-6#1)(1995-8#4)(1996-12#3)(1996-2#1)(1997-2#4)(1997-3#1)(1997-8#4)(2008-7#14)(2008-9#2)(2009-1#1)(2009-8#1)(2011-2#8)(2012-2#2)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#6)
cerebellopontine angle (CPA)##2##3##(2011-2#1)(2012-3#1)
cerebellopontine angle##4##2##(1994-9#1)(2011-2#2)(2012-3#1)
cerebellum and##5##2##(1993-6#1)(1994-2#1)(1996-12#1)(2008-8#1)(2013-8#1)
cerebellum in##4##2##(1992-6#1)(1996-12#1)(2008-11#1)(2013-1#1)
cerebellum of the meander tail mutant mouse##2##7##(1992-9#2)
cerebellum of the##4##3##(1991-4#1)(1992-9#2)(1995-12#1)
cerebellum of##5##2##(1991-4#1)(1992-9#2)(1994-2#1)(1995-12#1)
cerebellum##51##1##(1990-5#1)(1991-1#3)(1991-4#2)(1992-6#1)(1992-9#2)(1993-6#1)(1993-8#3)(1994-2#3)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#3)(1996-12#11)(1996-2#2)(1997-2#2)(1997-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#5)(2013-8#1)
cerebral AVM##5##2##(1997-3#1)(2008-7#1)(2012-3#3)
cerebral AVMs##4##2##(1997-3#1)(2008-7#2)(2012-3#1)
cerebral abscess##3##2##(1996-3#1)(1996-6#1)(2008-7#1)
cerebral air embolism##3##3##(2008-7#3)
cerebral amyloid angiopathy##2##3##(1996-11#1)(2013-1#1)
cerebral amyloidosis##2##2##(2013-1#2)
cerebral and##3##2##(2008-5#1)(2009-9#1)(2011-2#1)
cerebral aneurysm after##2##3##(2008-7#1)(2013-1#1)
cerebral aneurysm##4##2##(1997-3#1)(2008-7#2)(2013-1#1)
cerebral aneurysms##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
cerebral angiography##2##2##(1997-6#1)(2008-7#1)
cerebral arteries##6##2##(1996-2#1)(1996-3#1)(1997-6#1)(2008-4#1)(2008-7#2)
cerebral arteriovenous malformation to##2##4##(2008-7#2)
cerebral arteriovenous malformation##6##3##(2008-7#6)
cerebral arteriovenous malformations (AVMs)##6##4##(1997-3#1)(2008-7#5)
cerebral arteriovenous malformations##12##3##(1996-3#1)(1997-3#2)(1997-6#1)(2008-7#8)
cerebral arteriovenous##21##2##(1996-3#3)(1997-3#3)(1997-6#1)(2008-7#14)
cerebral artery##32##2##(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-12#2)(2008-4#1)(2008-7#12)(2010-11#1)(2011-2#6)(2013-8#5)
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and the##2##11##(2008-8#1)(2010-12#1)
cerebral blood flow (CBF)##4##4##(2008-7#4)
cerebral blood flow in##2##4##(1995-5#1)(1996-6#1)
cerebral blood flow measurements##2##4##(1995-8#1)(1996-6#1)
cerebral blood flow##23##3##(1994-2#2)(1995-11#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#3)(1996-6#3)(2008-5#1)(2008-7#5)(2012-3#1)(2013-1#1)
cerebral cortex and##6##3##(1996-12#3)(2008-11#1)(2008-7#1)(2008-9#1)
cerebral cortex of##3##3##(1994-2#1)(1997-2#1)(2008-7#1)
cerebral cortex##32##2##(1991-4#1)(1993-6#1)(1994-2#1)(1995-11#2)(1996-12#5)(1997-2#5)(2008-10#1)(2008-11#8)(2008-7#5)(2008-9#1)(2011-2#2)
cerebral cortical##7##2##(1990-5#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-7#2)
cerebral edema and##2##3##(2009-8#1)(2010-1#1)
cerebral edema##3##2##(2009-8#1)(2010-1#2)
cerebral haemorrhage##4##2##(1997-3#1)(2008-7#3)
cerebral hemisphere##6##2##(2008-7#2)(2011-2#1)(2013-8#3)
cerebral hemispheres##5##2##(1996-2#1)(2008-7#2)(2011-2#2)
cerebral hemorrhage##3##2##(2007-9#1)(2012-12#1)(2013-8#1)
cerebral infarction##14##2##(1990-3#3)(1997-5#6)(2008-7#3)(2011-2#1)(2012-12#1)
cerebral infarcts and consequent focal neurologic deficits##2##7##(2011-2#2)
cerebral ischaemia##5##2##(2008-7#5)
cerebral ischemia##7##2##(1996-12#1)(1997-2#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
cerebral ischemic##2##2##(2009-11#1)(2013-1#1)
cerebral lesion##2##2##(1992-12#1)(2009-11#1)
cerebral lesions##3##2##(1996-11#1)(2008-12#1)(2008-7#1)
cerebral malaria##3##2##(2009-9#1)(2012-3#2)
cerebral manifestations##3##2##(2008-7#3)
cerebral metabolic##2##2##(1991-1#1)(1994-2#1)
cerebral metabolism##2##2##(1991-10#1)(1994-2#1)
cerebral microbleeds are associated with##2##5##(2008-8#2)
cerebral microbleeds in##2##3##(2008-8#1)(2012-2#1)
cerebral microbleeds##7##2##(2008-8#6)(2012-2#1)
cerebral mucormycosis##2##2##(2008-12#2)
cerebral oxygen utilization##2##3##(1990-5#2)
cerebral oxygen##3##2##(1990-5#2)(2008-7#1)
cerebral palsy##11##2##(1997-5#1)(2008-11#2)(2009-3#1)(2009-4#3)(2010-9#1)(2011-2#3)
cerebral perfusion##3##2##(1997-5#1)(2008-7#2)
cerebral recurrence##2##2##(1990-12#2)
cerebral sequelae##3##2##(1990-12#3)
cerebral stroke##3##2##(1996-6#1)(1996-9#1)(2013-8#1)
cerebral subdivisions##3##2##(1997-2#3)
cerebral tissue##3##2##(2008-7#1)(2008-8#1)(2010-1#1)
cerebral vascular##4##2##(1996-11#1)(2008-4#1)(2008-7#2)
cerebral veins##2##2##(2008-7#2)
cerebral white matter##5##3##(2008-7#2)(2008-8#1)(2010-12#2)
cerebral##349##1##(1990-11#1)(1990-12#5)(1990-3#5)(1990-5#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-6#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-2#16)(1994-3#1)(1994-8#1)(1995-11#5)(1995-2#1)(1995-5#5)(1995-8#1)(1996-11#7)(1996-12#9)(1996-2#8)(1996-3#9)(1996-6#10)(1996-9#2)(1997-2#10)(1997-3#11)(1997-4#1)(1997-5#8)(1997-6#4)(2007-9#1)(2008-10#1)(2008-11#12)(2008-12#8)(2008-4#3)(2008-5#3)(2008-7#90)(2008-8#10)(2008-9#1)(2009-1#1)(2009-11#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#5)(2010-11#1)(2010-12#4)(2010-9#1)(2011-2#25)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#10)(2013-8#12)
cerebri##3##1##(1997-3#2)(1997-8#1)
cerebri)##2##1##(1990-12#2)
cerebrocortical##2##1##(1996-2#1)(1997-1#1)
cerebroside elicitor##4##2##(2008-10#4)
cerebroside sulfate##3##2##(1993-8#3)
cerebroside##13##1##(1993-8#3)(2008-10#10)
cerebrospinal fluid (CSF) absorption##2##4##(1993-1#1)(2008-7#1)
cerebrospinal fluid (CSF) leak##3##4##(2008-7#1)(2011-2#2)
cerebrospinal fluid (CSF) leakage##2##4##(2008-12#1)(2012-3#1)
cerebrospinal fluid (CSF)##22##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#2)(1994-8#1)(1996-12#1)(2008-12#1)(2008-7#4)(2011-2#5)(2012-3#2)(2013-1#1)
cerebrospinal fluid fistula##2##3##(2008-12#1)(2008-7#1)
cerebrospinal fluid in##3##3##(1991-2#1)(1993-2#1)(2008-7#1)
cerebrospinal fluid leak##4##3##(2008-7#1)(2011-2#3)
cerebrospinal fluid leaks##2##3##(2011-2#2)
cerebrospinal fluid of##4##3##(1993-1#1)(2008-12#1)(2010-12#1)(2011-2#1)
cerebrospinal fluid##60##2##(1990-2#3)(1990-5#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-3#2)(1993-1#3)(1993-12#1)(1993-2#1)(1994-8#3)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#2)(2008-10#2)(2008-12#3)(2008-7#10)(2009-11#1)(2010-12#3)(2010-5#1)(2011-2#13)(2012-3#3)(2013-1#1)
cerebrospinal##63##1##(1990-2#3)(1990-5#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-3#2)(1993-1#3)(1993-12#1)(1993-2#1)(1994-8#3)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#2)(2008-10#2)(2008-12#3)(2008-7#10)(2009-11#1)(2010-12#3)(2010-5#1)(2011-2#13)(2012-3#3)(2013-1#4)
cerebrovascular accident##4##2##(1997-8#1)(2008-4#1)(2011-2#1)(2012-12#1)
cerebrovascular disease for##2##3##(2008-10#2)
cerebrovascular disease##7##2##(1996-2#1)(2008-10#2)(2008-7#2)(2008-8#2)
cerebrovascular lesions##3##2##(1991-6#2)(2008-7#1)
cerebrovascular risk factors##3##3##(1996-11#3)
cerebrovascular risk##4##2##(1996-11#3)(2011-2#1)
cerebrovascular##34##1##(1990-9#1)(1991-6#4)(1992-12#1)(1993-3#1)(1996-11#3)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2009-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)
cerebrum##5##1##(1990-5#1)(1990-7#1)(1994-11#1)(1996-12#1)(2008-11#1)
cereulide synthetase##2##2##(2011-2#2)
cereulide##6##1##(2011-2#6)
cereus and##3##2##(2011-1#1)(2011-2#2)
cereus group population##2##3##(2011-2#2)
cereus group##9##2##(2011-2#9)
cereus strain##3##2##(2008-10#1)(2011-2#2)
cereus strains##2##2##(2008-10#2)
cereus##39##1##(1992-3#4)(2008-10#6)(2010-12#2)(2011-1#2)(2011-2#25)
cerevisiae 4C##2##2##(2013-1#2)
cerevisiae AS##3##2##(2008-8#3)
cerevisiae GRF18##2##2##(2008-8#2)
cerevisiae and##6##2##(1991-5#1)(1995-2#1)(1996-3#2)(2008-4#1)(2008-7#1)
cerevisiae are##2##2##(1994-9#1)(1996-6#1)
cerevisiae by##3##2##(1993-9#1)(1997-6#1)(2008-8#1)
cerevisiae cells##4##2##(1993-12#1)(1993-8#1)(1995-9#1)(2008-4#1)
cerevisiae chromosome##10##2##(1993-12#1)(1994-9#2)(1995-12#2)(1995-9#1)(1996-3#3)(1996-6#1)
cerevisiae gene##3##2##(1996-6#1)(2012-3#2)
cerevisiae genes##3##2##(1991-2#1)(1993-2#1)(1996-3#1)
cerevisiae has two##2##3##(1997-7#2)
cerevisiae has##7##2##(1992-10#1)(1996-3#1)(1996-6#1)(1997-7#2)(2008-7#1)(2012-3#1)
cerevisiae hsp90##2##2##(1996-12#2)
cerevisiae in##3##2##(1993-12#1)(1996-12#1)(2011-1#1)
cerevisiae protein##2##2##(1996-6#2)
cerevisiae were##3##2##(1996-6#1)(1997-6#1)(2008-10#1)
cerevisiae##192##1##(1990-12#1)(1990-2#4)(1990-7#1)(1991-2#1)(1991-5#3)(1991-9#2)(1992-10#2)(1992-3#1)(1993-12#8)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#9)(1994-12#1)(1994-3#1)(1994-9#3)(1995-12#2)(1995-2#3)(1995-6#3)(1995-9#7)(1996-12#4)(1996-2#4)(1996-3#21)(1996-6#23)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#8)(1997-8#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#4)(2008-7#6)(2008-8#8)(2008-9#2)(2009-7#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#15)(2013-1#3)
cerevisiae)##4##1##(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
ceria-zirconia##5##1##(2008-10#5)
cerium phosphate (disodium)##2##3##(2008-10#2)
cerium phosphate##4##2##(2008-10#4)
cerium phosphates with##2##3##(2008-10#2)
cerium##16##1##(2008-10#14)(2008-7#1)(2012-2#1)
cerium(IV) and##2##2##(2008-10#2)
cerium(IV) in##5##2##(2008-10#5)
cerium(IV)##17##1##(2008-10#17)
cerivastatin and##2##2##(2008-10#2)
certain areas##3##2##(1990-8#1)(2011-2#1)(2013-8#1)
certain aspects of the##2##4##(2008-10#1)(2010-8#1)
certain aspects of##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
certain aspects##4##2##(2008-10#1)(2009-4#1)(2010-8#1)(2012-3#1)
certain assumptions##2##2##(2008-10#1)(2008-3#1)
certain cancers##4##2##(2008-1#1)(2008-2#1)(2008-8#1)(2011-1#1)
certain cases##2##2##(1991-2#1)(2008-10#1)
certain cell##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
certain cells##2##2##(1995-2#1)(2013-8#1)
certain changes##3##2##(1994-12#1)(2008-9#1)(2012-2#1)
certain characteristics##2##2##(2008-5#1)(2011-2#1)
certain circumstances##7##2##(1990-3#1)(1994-3#1)(1995-8#1)(2008-5#1)(2011-2#2)(2012-2#1)
certain combinations##2##2##(2008-10#2)
certain compounds##2##2##(1994-5#1)(2008-10#1)
certain conditions##11##2##(1991-5#1)(1994-6#1)(2008-10#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#1)
certain decisions##3##2##(2008-11#3)
certain diseases##4##2##(2008-10#3)(2013-1#1)
certain drugs on prescription have been distributed to patients by##2##10##(1990-2#2)
certain drugs##4##2##(1990-2#2)(2008-11#2)
certain environmental##4##2##(1993-2#1)(2008-10#2)(2012-3#1)
certain fatty acids##2##3##(1996-3#1)(2011-2#1)
certain individuals##2##2##(2008-10#1)(2008-7#1)
certain metal##3##2##(2008-10#3)
certain other##4##2##(1990-5#1)(2008-3#1)(2008-5#1)(2013-8#1)
certain peptides##2##2##(1994-5#2)
certain physiological##2##2##(2008-10#1)(2012-2#1)
certain population##2##2##(1990-12#1)(2011-2#1)
certain populations of##2##3##(1990-5#1)(2008-5#1)
certain questions##2##2##(2008-1#1)(2009-10#1)
certain rats##2##2##(1993-6#2)
certain regions##2##2##(2008-10#2)
certain requirements##2##2##(2008-10#1)(2009-8#1)
certain risk groups##2##3##(1990-3#1)(2013-1#1)
certain risk##3##2##(1990-3#1)(2008-10#1)(2013-1#1)
certain safety##2##2##(1993-2#1)(2008-11#1)
certain species##2##2##(2008-8#1)(2008-9#1)
certain specific##2##2##(2008-2#1)(2011-2#1)
certain subgroups##3##2##(1991-6#1)(2009-11#1)(2013-1#1)
certain that##2##2##(2008-11#1)(2008-9#1)
certain types of##7##3##(1992-9#1)(1994-9#1)(2008-10#1)(2008-11#3)(2009-8#1)
certain variables##2##2##(2008-10#2)
certain##369##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#3)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#4)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2008-1#3)(2008-10#86)(2008-11#32)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#15)(2008-7#14)(2008-8#12)(2008-9#15)(2009-10#4)(2009-11#1)(2009-12#5)(2009-4#1)(2009-6#1)(2009-8#6)(2010-1#5)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#25)(2011-3#1)(2012-2#5)(2012-3#5)(2013-1#9)(2013-8#10)
certainly##22##1##(1990-8#1)(1992-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2009-1#1)(2009-7#1)(2010-11#1)(2010-7#1)(2013-1#1)
certainty about future funding##2##4##(1995-3#2)
certainty##11##1##(1991-11#1)(1995-3#3)(1996-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
certificate in##2##2##(1994-12#1)(2008-11#1)
certificate of##4##2##(1991-3#1)(1994-12#1)(2008-11#1)(2011-2#1)
certificate values##2##2##(2008-10#2)
certificate##15##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-5#1)(1994-12#2)(2008-10#4)(2008-11#2)(2011-2#1)
certificated##2##1##(2008-10#1)(2013-8#1)
certificates##6##1##(1991-2#1)(2010-4#1)(2012-12#3)(2013-8#1)
certification and##3##2##(1993-12#1)(2008-10#1)(2012-12#1)
certification of##4##2##(1991-9#1)(2008-10#3)
certification program##2##2##(1996-3#1)(2009-8#1)
certification programs##2##2##(1994-12#1)(2008-10#1)
certification##29##1##(1991-1#1)(1991-9#1)(1993-12#3)(1994-12#4)(1996-3#1)(1997-2#2)(2008-10#10)(2008-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
certified and##8##2##(1992-3#1)(2008-10#6)(2013-1#1)
certified as##4##2##(1991-12#1)(1991-6#1)(1991-9#1)(2013-1#1)
certified biological reference materials##2##4##(2008-10#2)
certified contents##2##2##(2008-10#2)
certified for the##2##3##(2008-10#2)
certified for##6##2##(2008-10#5)(2012-12#1)
certified material##2##2##(2008-10#2)
certified materials##7##2##(2008-10#7)
certified nurse assistants##2##3##(2008-11#1)(2010-11#1)
certified nurse##3##2##(2008-11#1)(2010-11#2)
certified or##3##2##(2008-10#3)
certified range##3##2##(2008-10#3)
certified reference material (CRM)##2##4##(2008-10#2)
certified reference material (GBW##2##4##(2008-10#2)
certified reference material and##4##4##(2008-10#4)
certified reference material of##5##4##(2008-10#5)
certified reference material##32##3##(2008-10#32)
certified reference materials (CRMs)##6##4##(2008-10#6)
certified reference materials and of##2##5##(2008-10#2)
certified reference materials and##9##4##(2008-10#9)
certified reference materials are##2##4##(2008-10#2)
certified reference materials of##5##4##(2008-10#5)
certified reference materials were##2##4##(2008-10#2)
certified reference materials##56##3##(2008-10#56)
certified reference##99##2##(2008-10#99)
certified soil##2##2##(2008-10#2)
certified to provide##2##3##(1992-2#1)(1993-12#1)
certified value of##4##3##(2008-10#4)
certified value##17##2##(2008-10#17)
certified values at a 95% confidence level##2##7##(2008-10#2)
certified values at##4##3##(2008-10#4)
certified values in##4##3##(2008-10#4)
certified values of##4##3##(2008-10#4)
certified values##48##2##(2008-10#48)
certified water##3##2##(2008-10#3)
certified##249##1##(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(2008-10#233)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#2)(2011-2#1)(2012-12#1)(2013-1#2)
certifying##3##1##(1991-9#1)(1994-12#1)(2012-3#1)
cerulenin##3##1##(1995-6#2)(2009-8#1)
ceruletide##4##1##(1994-2#4)
ceruloplasmin##9##1##(1992-12#2)(2008-10#2)(2012-2#4)(2013-1#1)
cervical and thoracic spine##2##4##(2008-12#2)
cervical and thoracic##4##3##(2008-12#4)
cervical and##8##2##(1992-3#1)(2008-12#4)(2008-8#1)(2011-2#1)(2013-8#1)
cervical artery compromise##2##3##(2008-12#2)
cervical artery##3##2##(2008-12#3)
cervical artificial disc replacement (C-ADR)##4##5##(2012-12#4)
cervical artificial disc replacement##7##4##(2012-12#7)
cervical artificial##8##2##(2012-12#8)
cervical cancer and##2##3##(2008-1#1)(2008-10#1)
cervical cancer in the##2##4##(1991-6#1)(2013-1#1)
cervical cancer in##3##3##(1991-6#1)(2008-11#1)(2013-1#1)
cervical cancer screening##5##3##(1990-8#1)(1995-9#1)(1997-1#1)(1997-2#1)(2013-8#1)
cervical cancer##47##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-2#1)(1994-1#1)(1995-9#2)(1996-10#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2011-3#5)(2012-12#1)(2012-3#6)(2013-1#4)(2013-8#1)
cervical cancers##2##2##(1995-2#2)
cervical carcinogenesis##2##2##(1992-10#1)(1995-2#1)
cervical carcinoma##2##2##(1994-8#1)(2010-8#1)
cervical carotid##2##2##(2013-8#2)
cervical collar##2##2##(2010-8#2)
cervical cord injury##2##3##(2008-7#2)
cervical cord##3##2##(1997-6#1)(2008-7#2)
cervical cytology##2##2##(1990-12#1)(1994-1#1)
cervical decompression and fusion##2##4##(2008-7#1)(2012-12#1)
cervical disc##4##2##(2008-7#1)(2011-2#2)(2012-12#1)
cervical disk herniations##2##3##(1996-3#2)
cervical disk##3##2##(1990-9#1)(1996-3#2)
cervical dystonia##3##2##(2008-7#2)(2011-2#1)
cervical extension##2##2##(2008-12#2)
cervical flexion AROM##2##3##(2008-12#2)
cervical flexion in patients with neck pain##2##7##(2008-12#2)
cervical flexion##4##2##(2008-12#4)
cervical fusion##3##2##(2008-7#3)
cervical injury##2##2##(2008-7#2)
cervical internal carotid##2##3##(1996-6#1)(2013-8#1)
cervical intraepithelial neoplasia grade##2##4##(1994-2#1)(2013-1#1)
cervical intraepithelial neoplasia##12##3##(1991-2#4)(1994-12#2)(1994-2#1)(2011-2#2)(2012-3#1)(2013-1#2)
cervical lesions##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
cervical lymph##2##2##(1991-3#1)(1997-3#1)
cervical mass##2##2##(2011-2#2)
cervical oesophageal cancer##2##3##(2008-1#2)
cervical plate fixation##2##3##(2009-10#2)
cervical plate##4##2##(2009-10#4)
cervical plexus block##3##3##(2010-7#2)(2012-3#1)
cervical plexus##4##2##(2010-7#3)(2012-3#1)
cervical positional tolerance##2##3##(2008-12#2)
cervical radiculopathy and##2##3##(2008-7#2)
cervical radiculopathy##5##2##(2008-7#4)(2012-3#1)
cervical range of motion##2##4##(2008-12#2)
cervical screening##3##2##(1990-12#3)
cervical spinal cord##4##3##(2008-7#1)(2010-5#2)(2012-2#1)
cervical spinal##5##2##(2008-7#1)(2010-5#2)(2012-2#1)(2012-3#1)
cervical spine##30##2##(1995-11#1)(1997-4#1)(2008-12#4)(2009-3#3)(2010-12#3)(2011-2#6)(2012-12#6)(2012-3#3)(2013-1#3)
cervical stroma##2##2##(1992-2#1)(2011-2#1)
cervical tissue##2##2##(1991-2#1)(1992-2#1)
cervical total disc arthroplasty (C-ADR)##2##5##(2012-12#2)
cervical##272##1##(1990-12#5)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-2#12)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-2#4)(1992-3#4)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-9#2)(1996-10#2)(1996-2#1)(1996-3#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#4)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#1)(2008-11#9)(2008-12#29)(2008-4#2)(2008-7#22)(2008-8#3)(2009-10#4)(2009-2#1)(2009-3#3)(2010-11#1)(2010-12#6)(2010-3#1)(2010-5#3)(2010-7#3)(2010-8#5)(2010-9#1)(2011-2#20)(2011-3#5)(2012-12#28)(2012-2#1)(2012-3#22)(2013-1#18)(2013-8#6)
cervicitis##4##1##(2011-2#4)
cervicogenic headache##5##2##(2008-12#5)
cervicotomy##3##1##(2008-12#1)(2013-1#2)
cervix cancer##5##2##(1990-5#1)(1990-6#2)(1993-11#1)(2008-11#1)
cervix in##3##2##(1991-3#1)(1996-6#1)(2013-1#1)
cervix was##2##2##(1992-2#1)(2013-1#1)
cervix##27##1##(1990-5#1)(1990-6#3)(1990-8#3)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-6#1)(2008-11#3)(2009-11#2)(2012-3#1)(2013-1#5)
ces gene##2##2##(2011-2#2)
ces transcription##3##2##(2011-2#3)
ces##12##1##(2008-11#2)(2011-2#8)(2013-1#2)
cesarean delivery##2##2##(1997-1#1)(2013-1#1)
cesarean section##9##2##(1995-12#1)(1997-1#1)(1997-8#1)(2012-12#2)(2012-3#1)(2013-1#3)
cesarean##16##1##(1995-12#4)(1997-1#3)(1997-8#1)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#4)
cesium chloride##4##2##(2008-10#3)(2008-9#1)
cesium ion over##5##3##(2008-10#5)
cesium ion selective##4##3##(2008-10#4)
cesium ion##10##2##(2008-10#10)
cesium ion-selective electrodes based on##2##5##(2008-10#2)
cesium ion-selective##3##2##(2008-10#3)
cesium ions##3##2##(2008-10#3)
cesium selectivity##2##2##(2008-10#2)
cesium##38##1##(1993-8#1)(2007-12#1)(2008-10#30)(2008-3#5)(2008-9#1)
cessation activities##2##2##(2013-1#2)
cessation for adolescents##2##3##(2009-7#2)
cessation in##4##2##(1997-1#1)(2008-11#1)(2009-7#2)
cessation intervention practices##2##3##(2011-2#2)
cessation intervention##5##2##(2008-4#2)(2008-8#1)(2011-2#2)
cessation medication##2##2##(2013-1#2)
cessation of growth##2##3##(2008-11#1)(2008-7#1)
cessation of phospholipid##2##3##(1995-6#2)
cessation of##20##2##(1991-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1995-6#3)(1997-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-8#2)(2012-2#1)(2013-8#2)
cessation program##2##2##(2008-4#1)(2010-2#1)
cessation programs##2##2##(1991-12#1)(2012-2#1)
cessation rates##7##2##(2008-11#7)
cessation treatment##4##2##(2007-12#2)(2009-1#1)(2009-7#1)
cessation##84##1##(1991-11#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1995-3#1)(1995-6#3)(1997-1#1)(1997-3#1)(2007-12#4)(2008-1#1)(2008-11#11)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-7#7)(2009-9#2)(2010-2#6)(2010-8#2)(2011-2#7)(2012-2#2)(2013-1#15)(2013-8#2)
cetacean##2##1##(1996-6#1)(2012-2#1)
cetaceans##2##1##(2012-2#2)
cetyl trimethyl ammonium bromide##2##4##(2008-10#2)
cetyl##9##1##(2008-10#4)(2008-5#5)
cetylpyridine bromide##2##2##(2008-10#2)
cetylpyridinium bromide (CPB)##2##3##(2008-10#2)
cetylpyridinium chloride (CPC)##7##3##(2008-10#7)
cetylpyridinium chloride##17##2##(2008-10#17)
cetylpyridinium##25##1##(2008-10#25)
cetyltrimethylammonium bromide (CTAB)##10##3##(2008-10#10)
cetyltrimethylammonium bromide (CTMAB)##2##3##(2008-10#2)
cetyltrimethylammonium bromide##14##2##(2008-10#14)
cetyltrimethylammonium chloride (CTAC)##3##3##(2008-10#3)
cetyltrimethylammonium chloride##5##2##(2008-10#5)
cetyltrimethylammonium##21##1##(2008-10#21)
cfu##3##1##(2008-5#2)(2008-9#1)
cfu/cm(2)##2##1##(2011-2#2)
cfu/cm(2))##2##1##(2012-2#2)
cgs##5##1##(2008-10#5)
ch)##2##1##(2010-12#2)
chacoense##3##1##(2008-10#3)
chain and the##4##3##(1993-11#1)(1994-11#1)(2008-12#1)(2008-9#1)
chain and##16##2##(1993-11#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-9#2)(2009-7#1)(2010-12#1)
chain antibodies##3##2##(2008-10#2)(2009-3#1)
chain by##3##2##(1995-11#1)(2008-5#1)(2012-2#1)
chain constant region##4##3##(1997-8#2)(1997-9#2)
chain elongation##3##2##(1996-5#2)(2008-8#1)
chain expression##3##2##(1997-9#2)(2011-2#1)
chain extension##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
chain fatty acid##5##3##(1992-3#1)(1993-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
chain fatty acids##3##3##(1990-6#1)(2008-10#2)
chain fatty##8##2##(1990-6#1)(1992-3#1)(1993-8#1)(2008-10#3)(2008-5#1)(2008-7#1)
chain gene expression##5##3##(1992-3#4)(1994-12#1)
chain gene##13##2##(1991-2#2)(1992-3#5)(1994-12#1)(1995-2#1)(1997-5#1)(2008-11#2)(2008-9#1)
chain in##9##2##(1990-5#1)(1994-11#1)(1995-11#2)(2008-10#1)(2008-9#2)(2011-2#1)(2012-2#1)
chain interactions in##2##3##(2008-12#1)(2008-5#1)
chain is##2##2##(2008-10#1)(2011-2#1)
chain length is##3##3##(2008-11#3)
chain length of##3##3##(1993-8#1)(1994-5#1)(2009-3#1)
chain length##17##2##(1992-7#1)(1992-8#1)(1993-8#4)(1994-5#3)(2008-10#3)(2008-11#3)(2008-12#1)(2009-3#1)
chain lengths from##2##3##(1997-6#1)(2013-8#1)
chain lengths##5##2##(1994-11#1)(1997-6#2)(2008-10#1)(2013-8#1)
chain may##2##2##(1994-11#1)(2011-2#1)
chain models##3##2##(2008-12#2)(2008-8#1)
chain of bullfrog##2##3##(1997-7#2)
chain of the cofactor##3##4##(1994-5#3)
chain of the##7##3##(1993-8#1)(1994-5#3)(1996-12#1)(2008-10#1)(2008-9#1)
chain of##32##2##(1990-5#2)(1992-1#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#4)(1995-11#1)(1995-2#2)(1996-12#1)(1997-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-8#1)
chain reaction (PCR) amplification of##4##5##(1993-2#1)(2008-10#3)
chain reaction (PCR) amplification##7##4##(1993-2#1)(2008-10#6)
chain reaction (PCR) primers were designed##2##6##(2008-10#2)
chain reaction (PCR) primers were##3##5##(2008-10#3)
chain reaction (PCR) primers##4##4##(2008-10#4)
chain reaction (PCR) using##6##4##(1996-12#1)(1996-8#1)(2008-10#3)(2011-2#1)
chain reaction (PCR)##105##3##(1991-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(1996-12#3)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#79)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#3)
chain reaction (PCR)-based##8##3##(2008-10#8)
chain reaction (QRT-PCR)##2##3##(2008-10#2)
chain reaction (RT-PCR) and##6##4##(1994-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)
chain reaction (RT-PCR) on##2##4##(2008-10#1)(2008-5#1)
chain reaction (RT-PCR) was##4##4##(1994-11#1)(2008-10#3)
chain reaction (RT-PCR)##32##3##(1993-12#1)(1994-11#2)(1995-11#1)(1995-12#1)(1996-12#2)(1997-7#1)(2008-10#16)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-1#1)(2012-2#1)
chain reaction (rep-PCR)##9##3##(2008-10#9)
chain reaction amplification of the##3##5##(1993-8#1)(2008-10#2)
chain reaction amplification of##5##4##(1993-8#1)(2008-10#4)
chain reaction amplification##10##3##(1993-8#1)(1995-12#1)(2008-10#8)
chain reaction analysis##5##3##(1997-9#1)(2008-10#3)(2011-2#1)
chain reaction and Southern blot##2##5##(2008-10#2)
chain reaction and##18##3##(1990-8#1)(1994-12#1)(1995-12#1)(2008-10#11)(2008-5#1)(2011-2#2)(2013-1#1)
chain reaction assay##4##3##(1996-12#1)(2008-10#3)
chain reaction assays##10##3##(2008-10#10)
chain reaction detection##2##3##(2008-10#2)
chain reaction fingerprinting##2##3##(2008-10#2)
chain reaction for##5##3##(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
chain reaction in##6##3##(1996-3#1)(2008-10#2)(2013-1#3)
chain reaction of##5##3##(2008-10#4)(2011-2#1)
chain reaction primers##4##3##(2008-10#4)
chain reaction showed##3##3##(1994-11#1)(2008-10#1)(2009-8#1)
chain reaction to##5##3##(1996-12#1)(2008-11#2)(2011-2#2)
chain reaction using specific primers for##2##6##(1994-11#1)(2008-7#1)
chain reaction using##9##3##(1992-6#1)(1993-2#1)(1994-11#1)(1997-7#1)(2008-10#3)(2008-7#1)(2012-12#1)
chain reaction was used to##3##5##(1991-7#1)(1992-6#1)(2012-3#1)
chain reaction was##6##3##(1991-5#1)(1991-7#1)(1992-6#1)(1995-6#1)(2008-10#1)(2012-3#1)
chain reaction with##5##3##(1993-2#1)(1994-11#1)(2008-10#3)
chain reaction##371##2##(1990-2#1)(1990-8#2)(1991-1#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#4)(1992-8#1)(1993-12#3)(1993-2#6)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#6)(1995-6#1)(1996-11#1)(1996-12#7)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#4)(1997-8#1)(1997-9#1)(2008-10#239)(2008-11#9)(2008-12#1)(2008-4#2)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#4)(2009-6#2)(2009-8#2)(2010-1#1)(2010-4#1)(2010-6#4)(2011-2#15)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#2)
chain reaction)##2##2##(1993-12#1)(2008-5#1)
chain reaction-based detection of##2##4##(2008-10#1)(2008-9#1)
chain reaction-based##11##2##(1993-8#1)(2008-10#9)(2008-9#1)
chain reactions##6##2##(1993-8#1)(1997-4#1)(2008-10#4)
chain structure##2##2##(1997-2#1)(2008-10#1)
chain that##2##2##(1993-9#1)(2008-9#1)
chain transfer agent##2##3##(2008-12#2)
chain transfer##4##2##(2008-12#3)(2009-10#1)
chain with##2##2##(1993-2#1)(2008-10#1)
chain##747##1##(1990-12#3)(1990-2#1)(1990-5#7)(1990-6#1)(1990-8#3)(1991-1#1)(1991-2#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-2#4)(1992-3#9)(1992-4#2)(1992-6#9)(1992-7#1)(1992-8#4)(1993-11#5)(1993-12#4)(1993-2#8)(1993-3#1)(1993-6#4)(1993-8#23)(1993-9#4)(1994-1#1)(1994-11#20)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#12)(1994-9#3)(1995-1#1)(1995-11#8)(1995-12#7)(1995-2#6)(1995-6#6)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#9)(1996-3#1)(1996-5#4)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#9)(1997-9#9)(2008-10#313)(2008-11#26)(2008-12#21)(2008-4#6)(2008-5#13)(2008-6#2)(2008-7#5)(2008-8#15)(2008-9#24)(2009-1#1)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-6#4)(2009-7#6)(2009-8#6)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#4)(2010-8#1)(2011-1#1)(2011-2#26)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#11)(2013-8#14)
chain)##3##1##(1991-5#1)(1995-2#1)(2008-11#1)
chainreaction##2##1##(2008-11#2)
chains and##4##2##(1992-10#1)(2008-10#1)(2008-8#1)(2011-2#1)
chains are##8##2##(1993-9#3)(1995-2#2)(2008-9#2)(2009-7#1)
chains as##2##2##(1994-5#1)(2011-2#1)
chains by##3##2##(1991-5#1)(2008-8#1)(2008-9#1)
chains have##3##2##(1992-9#1)(1997-2#1)(2008-11#1)
chains in the##5##3##(1991-6#1)(1997-9#1)(2008-10#2)(2012-12#1)
chains in##8##2##(1991-6#1)(1993-9#2)(1995-6#1)(1997-9#1)(2008-10#2)(2012-12#1)
chains of a##2##3##(1990-8#1)(1994-11#1)
chains of the##3##3##(1994-11#1)(2008-11#1)(2008-5#1)
chains of##20##2##(1990-12#1)(1990-8#1)(1992-4#1)(1993-8#2)(1994-11#2)(1994-5#2)(1995-6#2)(2008-10#3)(2008-11#2)(2008-5#2)(2010-10#1)(2012-2#1)
chains on the##2##3##(1993-12#1)(2008-10#1)
chains that are##3##3##(1993-9#1)(1995-2#1)(2009-8#1)
chains that##4##2##(1993-9#1)(1995-2#1)(1997-9#1)(2009-8#1)
chains to##3##2##(1997-9#1)(2008-10#1)(2008-5#1)
chains were##5##2##(1993-11#1)(1993-6#1)(1993-8#1)(2008-11#1)(2013-8#1)
chains##138##1##(1990-12#2)(1990-5#1)(1990-8#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-6#1)(1993-8#4)(1993-9#10)(1994-11#4)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#6)(1995-6#5)(1996-5#1)(1997-2#3)(1997-9#5)(2008-10#19)(2008-11#12)(2008-12#2)(2008-5#6)(2008-7#1)(2008-8#9)(2008-9#7)(2009-3#1)(2009-7#2)(2009-8#2)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#3)
chair##6##1##(1995-6#1)(1996-5#1)(1996-8#1)(2008-11#1)(2010-4#1)(2013-8#1)
chair/twist-boat equilibrium##2##2##(1996-5#2)
chairman##2##1##(1995-12#1)(2008-11#1)
chairs##6##1##(2009-4#6)
chalazal##3##1##(2008-11#2)(2009-12#1)
chalcogenide glass membrane ion-selective electrode##2##5##(2008-10#2)
chalcogenide glass##8##2##(2008-10#8)
chalcogenide glasses##2##2##(1991-1#1)(2008-10#1)
chalcogenide##18##1##(1991-1#1)(2008-10#13)(2010-5#4)
chalcogenide-based##2##1##(2008-10#1)(2010-5#1)
chalcogramma##3##1##(2010-8#3)
chalcone synthase##2##2##(2008-10#1)(2008-9#1)
chalcone##5##1##(2008-10#4)(2008-9#1)
chalcones##2##1##(2008-10#1)(2011-3#1)
chalcophile elements##2##2##(2008-10#2)
challenge and##6##2##(1990-2#1)(1993-12#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#1)
challenge at##2##2##(2008-1#1)(2008-5#1)
challenge by##2##2##(1990-11#1)(1995-6#1)
challenge due to the##2##4##(2011-2#1)(2012-12#1)
challenge due to##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
challenge for a##2##3##(1991-11#1)(2008-12#1)
challenge for the##12##3##(1991-1#1)(1996-3#1)(2008-11#2)(2008-7#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
challenge for##37##2##(1991-1#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-5#1)(1995-12#1)(1996-1#1)(1996-3#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#1)(2008-7#2)(2009-6#1)(2009-7#1)(2010-5#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
challenge in a##3##3##(1994-12#1)(2008-11#1)(2013-1#1)
challenge in terms of##2##4##(1997-2#1)(2008-11#1)
challenge in the##4##3##(1996-3#1)(2008-12#1)(2011-2#1)(2012-3#1)
challenge in##22##2##(1992-2#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-12#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
challenge is to##4##3##(1991-11#1)(1993-2#1)(1994-2#1)(2008-12#1)
challenge is##7##2##(1991-11#1)(1993-2#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-12#1)(2009-12#1)
challenge of the##3##3##(1994-9#1)(2008-11#1)(2011-2#1)
challenge of##29##2##(1991-12#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
challenge test##4##2##(2008-5#1)(2012-3#3)
challenge that##2##2##(2008-10#1)(2012-3#1)
challenge the##10##2##(1995-2#1)(1996-5#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
challenge to the##7##3##(1992-1#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-6#1)(2010-7#1)(2012-2#1)
challenge to##31##2##(1991-3#1)(1992-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-6#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-2#3)(2012-3#2)(2013-1#2)
challenge was##5##2##(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
challenge which##2##2##(1996-12#2)
challenge with##14##2##(1990-2#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-2#2)(2008-10#6)(2009-6#1)
challenge##279##1##(1990-11#1)(1990-2#3)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#2)(1996-1#3)(1996-11#2)(1996-12#10)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#31)(2008-11#15)(2008-12#10)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#3)(2009-3#1)(2009-6#4)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2011-2#16)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#17)(2013-1#16)(2013-8#7)
challenge]##3##1##(1990-6#1)(1993-2#1)(1993-6#1)
challenged as##2##2##(2008-1#1)(2011-2#1)
challenged by##8##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2010-7#1)
challenged plants##2##2##(2008-10#2)
challenged to##4##2##(1990-6#1)(1995-12#1)(1997-2#1)(2008-12#1)
challenged with B##2##3##(2008-10#2)
challenged with PVX containing the##2##5##(2008-10#2)
challenged with a##2##3##(2008-10#1)(2008-9#1)
challenged with##18##2##(2008-1#1)(2008-10#13)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
challenged##50##1##(1990-6#1)(1993-12#1)(1995-12#2)(1995-5#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
challenges ahead##2##2##(1996-3#1)(2008-6#1)
challenges and opportunities##5##3##(2008-12#1)(2008-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
challenges and the##2##3##(1997-2#1)(2010-12#1)
challenges and##27##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-2#2)(1997-2#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2013-1#2)(2013-8#3)
challenges are##6##2##(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-6#1)
challenges associated with##5##3##(1994-12#1)(1996-1#2)(2008-11#1)(2008-12#1)
challenges exist##2##2##(1995-3#1)(2012-3#1)
challenges faced by##3##3##(1994-3#1)(2008-11#1)(2008-12#1)
challenges faced##5##2##(1994-3#1)(2008-11#1)(2008-12#1)(2009-11#1)(2013-1#1)
challenges facing the##3##3##(1991-1#1)(1996-3#1)(2013-1#1)
challenges facing##11##2##(1991-1#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-3#1)(2008-10#1)(2008-8#1)(2009-6#1)(2013-1#1)
challenges for the future##2##4##(2008-11#1)(2010-12#1)
challenges for the##5##3##(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-8#1)
challenges for##21##2##(1992-1#1)(1992-3#1)(1993-1#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-4#1)(2010-12#1)(2010-8#2)(2012-3#1)(2013-1#1)
challenges in a##2##3##(2010-10#1)(2013-8#1)
challenges in monitoring##2##3##(1996-2#1)(2009-6#1)
challenges in the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
challenges in##24##2##(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-10#1)(2010-4#1)(2010-5#2)(2011-2#4)(2012-2#1)(2013-8#2)
challenges include##2##2##(1996-2#1)(1997-2#1)
challenges involved##2##2##(1996-2#1)(2011-1#1)
challenges of the twenty-first century##2##5##(1994-2#1)(1997-1#1)
challenges of the##3##3##(1992-12#1)(1994-2#1)(1997-1#1)
challenges of##29##2##(1992-1#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1996-1#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-11#4)(2008-12#4)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
challenges related to##3##3##(2008-12#1)(2010-12#1)(2010-7#1)
challenges remain##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
challenges such as##2##3##(2008-9#1)(2012-12#1)
challenges that may##2##3##(2009-11#1)(2012-3#1)
challenges that##9##2##(1994-1#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-3#1)
challenges the##3##2##(2008-1#1)(2009-12#1)(2011-2#1)
challenges to the##4##3##(2008-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
challenges to##13##2##(1997-3#1)(2008-11#1)(2008-12#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
challenges were##2##2##(2008-1#1)(2008-11#1)
challenges with##3##2##(2009-10#1)(2010-11#1)(2013-8#1)
challenges##249##1##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#3)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#5)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#4)(1995-5#1)(1996-1#4)(1996-2#12)(1996-3#7)(1997-1#6)(1997-2#6)(1997-3#4)(1997-7#1)(2008-1#8)(2008-10#8)(2008-11#29)(2008-12#16)(2008-4#3)(2008-5#4)(2008-6#6)(2008-8#7)(2008-9#4)(2009-10#3)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#6)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#11)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#10)
challenging and##6##2##(1997-2#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-2#2)
challenging because##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
challenging clinical##3##2##(2008-11#1)(2009-9#1)(2010-6#1)
challenging for##3##2##(2008-11#1)(2008-12#1)(2010-7#1)
challenging problem in##2##3##(2008-10#1)(2008-7#1)
challenging problem##6##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-6#1)(2012-2#1)(2013-8#1)
challenging procedure##2##2##(2008-10#1)(2011-2#1)
challenging since##2##2##(2008-10#1)(2010-6#1)
challenging task##8##2##(1996-1#1)(2008-10#3)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)
challenging the##2##2##(2008-10#1)(2008-8#1)
challenging to##7##2##(1991-2#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
challenging##111##1##(1991-12#1)(1991-2#1)(1992-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#2)(2008-10#17)(2008-11#8)(2008-12#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#5)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#11)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#9)(2013-8#6)
chamber and the##2##3##(2008-10#1)(2008-11#1)
chamber and##11##2##(2008-10#9)(2008-11#2)
chamber experiments##7##2##(2008-10#7)
chamber for##3##2##(2008-10#2)(2008-5#1)
chamber in the##2##3##(2008-10#1)(2008-7#1)
chamber in##3##2##(2008-10#2)(2008-7#1)
chamber of a##2##3##(2008-10#1)(2008-9#1)
chamber of##6##2##(2008-10#3)(2008-11#2)(2008-9#1)
chamber or##2##2##(2008-10#1)(2011-1#1)
chamber through##2##2##(2008-10#2)
chamber was##6##2##(1992-6#1)(2008-10#2)(2008-11#2)(2009-9#1)
chamber with##4##2##(2008-10#3)(2013-1#1)
chamber##118##1##(1991-2#3)(1992-6#2)(1994-11#1)(1996-2#2)(1996-3#1)(2008-1#1)(2008-10#71)(2008-11#11)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#3)(2009-9#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#4)(2013-8#3)
chambers and##6##2##(1996-2#2)(2008-10#2)(2008-11#1)(2009-8#1)
chambers demonstrated that##2##3##(1994-9#1)(2008-10#1)
chambers for##2##2##(2008-10#1)(2012-9#1)
chambers of##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
chambers were##4##2##(1991-2#1)(1996-2#1)(2008-10#1)(2008-11#1)
chambers##37##1##(1990-5#1)(1991-2#1)(1994-9#1)(1996-2#3)(1997-1#1)(2006-6#1)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#1)(2013-8#1)
champagne##2##1##(2008-10#2)
champions##3##1##(2008-11#1)(2008-3#1)(2008-7#1)
chance and##2##2##(1990-6#1)(2008-10#1)
chance for##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
chance of survival##2##3##(1994-6#1)(2010-4#1)
chance of##17##2##(1994-12#1)(1994-6#1)(1995-12#1)(1995-6#3)(1997-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#2)(2010-8#2)(2011-2#2)(2013-1#1)
chance or##2##2##(2008-11#1)(2011-2#1)
chance to##10##2##(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2013-1#2)(2013-8#1)
chance##52##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-8#1)(1993-3#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-6#3)(1996-2#1)(1996-5#1)(1997-3#2)(1997-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#4)(2013-1#3)(2013-8#1)
chances for##5##2##(1991-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
chances of##5##2##(1993-8#1)(2008-11#1)(2008-7#1)(2013-8#2)
chances##12##1##(1991-2#1)(1992-3#1)(1993-8#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#2)
change activity##2##2##(1991-6#2)
change after##6##2##(1991-1#1)(1991-6#1)(2008-2#1)(2010-3#1)(2010-8#1)(2011-2#1)
change among##2##2##(1991-3#1)(2008-12#1)
change and that##2##3##(2008-11#1)(2010-11#1)
change and##21##2##(1991-12#1)(1992-12#1)(1996-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-2#1)
change are##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
change as a result of##2##5##(2009-12#1)(2012-3#1)
change as##5##2##(2008-11#2)(2008-8#1)(2009-12#1)(2012-3#1)
change at the##2##3##(2008-10#1)(2008-8#1)
change at##8##2##(1993-11#1)(1993-8#1)(2008-10#4)(2008-8#1)(2010-1#1)
change between##2##2##(1991-1#1)(2009-4#1)
change by##7##2##(1993-6#1)(1994-12#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-12#1)
change can be##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
change can##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
change caused by the##2##4##(1993-8#1)(2008-10#1)
change caused by##3##3##(1993-8#1)(2008-10#2)
change compared to the baseline##2##5##(2011-2#2)
change compared##3##2##(2008-10#1)(2011-2#2)
change could be##2##3##(2008-10#1)(2008-9#1)
change did not##2##3##(1994-12#1)(2008-10#1)
change due to##4##3##(1992-8#1)(2008-10#3)
change during the##3##3##(2008-9#1)(2009-10#1)(2011-1#1)
change during##10##2##(1995-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
change following##4##2##(2008-10#1)(2008-9#1)(2009-9#1)(2013-8#1)
change for the addition of the##2##6##(1990-8#2)
change for the##6##3##(1990-8#2)(1991-1#1)(1992-12#2)(1993-12#1)
change for##10##2##(1990-8#2)(1991-1#1)(1992-12#2)(1993-12#1)(1996-1#1)(2008-10#2)(2008-12#1)
change from a##3##3##(2009-8#1)(2010-8#1)(2011-2#1)
change from an##2##3##(1995-8#1)(2008-5#1)
change from baseline##2##3##(2012-2#1)(2013-1#1)
change from##22##2##(1990-8#1)(1991-3#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
change had##2##2##(1992-12#1)(2008-12#1)
change has##2##2##(2008-10#1)(2008-12#1)
change in BMI##4##3##(2010-8#3)(2013-1#1)
change in Medicare##2##3##(1991-2#1)(1992-12#1)
change in a##2##3##(1994-12#1)(1996-1#1)
change in absorbance##7##3##(2008-10#7)
change in average cell diameter##2##5##(2008-11#2)
change in average##4##3##(1992-12#1)(2008-11#3)
change in cell##2##3##(1993-8#1)(2008-11#1)
change in depression##2##3##(2010-1#2)
change in either##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
change in fluorescence intensity##3##4##(1995-11#1)(2008-10#2)
change in function##2##3##(1995-3#1)(2010-10#1)
change in health##2##3##(1996-2#1)(1997-8#1)
change in irrational beliefs##2##4##(2010-5#2)
change in its##2##3##(2008-10#1)(2008-11#1)
change in local##2##3##(1996-1#1)(2009-12#1)
change in opposite directions##2##4##(2008-8#1)(2008-9#1)
change in pH##2##3##(2008-10#1)(2009-12#1)
change in population size##2##4##(2008-8#2)
change in population##3##3##(2008-10#1)(2008-8#2)
change in potential##2##3##(2008-10#2)
change in practice##4##3##(2008-11#2)(2008-8#2)
change in response to##3##4##(1996-3#1)(2008-11#1)(2011-1#1)
change in response##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2011-1#1)
change in systemic level work##3##5##(2008-12#3)
change in the fluorescence##2##4##(2008-10#2)
change in the number of##5##5##(1990-6#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
change in the pulp chamber##2##5##(1991-2#2)
change in the relative##2##4##(1990-3#1)(2008-10#1)
change in the##100##3##(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-2#4)(1991-9#1)(1992-1#1)(1992-12#2)(1993-8#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#4)(1997-7#2)(2008-10#28)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2010-7#2)(2011-1#1)(2011-2#6)(2012-3#1)(2013-8#2)
change in their##3##3##(1993-12#1)(1995-2#1)(2008-10#1)
change in this##2##3##(1994-1#1)(2008-10#1)
change in##334##2##(1990-11#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#5)(1991-11#2)(1991-2#5)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#4)(1992-12#5)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#4)(1995-6#3)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-7#2)(1997-8#3)(2008-10#85)(2008-11#25)(2008-12#7)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#14)(2008-8#11)(2008-9#10)(2009-12#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#13)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#11)(2013-8#8)
change induced by##2##3##(1991-2#1)(2010-12#1)
change is the##2##3##(2008-10#1)(2008-9#1)
change is##18##2##(1993-3#1)(1994-1#1)(1994-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-7#1)
change it##2##2##(1991-1#1)(2012-9#1)
change its##2##2##(2008-11#1)(2010-10#1)
change led to##2##3##(2008-10#1)(2008-11#1)
change linearly##2##2##(2008-10#1)(2008-8#1)
change management##2##2##(2008-12#2)
change mediated by##2##3##(1994-2#1)(1995-2#1)
change must be##2##3##(1994-12#1)(1996-1#1)
change occurred following##2##3##(2008-7#1)(2013-1#1)
change occurred##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
change of alpha-naphtholphthalein in##2##4##(2008-10#2)
change of an##2##3##(1997-3#1)(2008-10#1)
change of the##23##3##(1991-2#1)(1991-5#1)(1993-2#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2012-3#1)
change of##84##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#2)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
change on the##2##3##(1993-2#1)(2008-10#1)
change on##7##2##(1991-5#1)(1993-2#1)(2008-10#1)(2008-11#3)(2009-11#1)
change or a##2##3##(2008-10#1)(2010-4#1)
change or##4##2##(2008-10#2)(2010-4#1)(2011-1#1)
change our understanding of##2##4##(2009-4#1)(2013-1#1)
change our##3##2##(2009-4#1)(2012-2#1)(2013-1#1)
change over##3##2##(1996-3#1)(2008-11#1)(2012-12#1)
change process##6##2##(1993-12#1)(1994-1#3)(2008-11#2)
change rate##2##2##(2008-10#1)(2008-7#1)
change resulted from the##2##4##(2008-10#1)(2008-8#1)
change that##3##2##(1993-2#1)(2008-5#1)(2008-8#1)
change the##43##2##(1990-11#1)(1991-1#2)(1992-4#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
change their##10##2##(1990-6#1)(1991-5#1)(1992-2#1)(1994-2#1)(2008-11#2)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)
change through the##2##3##(2008-8#1)(2008-9#1)
change through##5##2##(2008-10#2)(2008-8#1)(2008-9#2)
change to a##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
change to the##2##3##(1995-2#1)(2011-2#1)
change to##19##2##(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)
change under##2##2##(1992-10#1)(2008-10#1)
change was observed for the##2##5##(2009-1#1)(2011-2#1)
change was observed in the##2##5##(1991-5#1)(2010-5#1)
change was observed in##5##4##(1991-5#1)(1993-11#1)(1993-12#1)(2010-5#1)(2011-3#1)
change was observed##8##3##(1991-5#1)(1993-11#1)(1993-12#1)(2008-10#1)(2009-1#1)(2010-5#1)(2011-2#1)(2011-3#1)
change was##27##2##(1991-1#1)(1991-12#1)(1991-5#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-6#2)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-12#2)(2010-5#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-6#1)
change were##2##2##(2008-10#1)(2008-12#1)
change when##2##2##(2013-1#1)(2013-8#1)
change while##2##2##(2008-5#1)(2012-12#1)
change will not be##2##4##(1995-8#1)(1997-1#1)
change will##5##2##(1995-8#1)(1997-1#1)(1997-6#1)(2008-11#1)(2012-5#1)
change with age##2##3##(1990-3#1)(2008-5#1)
change with an##2##3##(2010-5#1)(2011-2#1)
change with respect to##3##4##(1991-3#1)(2008-10#2)
change with##18##2##(1990-3#1)(1991-3#1)(1993-5#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-8#2)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
change within the##2##3##(2008-5#1)(2008-6#1)
change within##6##2##(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2012-5#1)
change would##3##2##(2008-12#2)(2012-12#1)
change##1027##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#5)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#14)(1991-11#2)(1991-12#3)(1991-2#13)(1991-3#6)(1991-5#10)(1991-6#5)(1991-8#2)(1991-9#3)(1992-1#7)(1992-10#1)(1992-12#13)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#4)(1993-11#4)(1993-12#11)(1993-2#4)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#8)(1994-1#10)(1994-11#1)(1994-12#8)(1994-2#7)(1994-3#7)(1994-5#5)(1994-6#2)(1994-8#4)(1995-1#5)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#4)(1995-6#9)(1995-8#7)(1996-1#11)(1996-11#2)(1996-12#3)(1996-2#9)(1996-3#4)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#8)(1997-2#8)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#4)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#206)(2008-11#81)(2008-12#31)(2008-2#2)(2008-3#18)(2008-4#8)(2008-5#22)(2008-6#9)(2008-7#24)(2008-8#33)(2008-9#29)(2009-1#1)(2009-10#3)(2009-11#8)(2009-12#9)(2009-3#3)(2009-4#2)(2009-5#9)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#5)(2010-1#6)(2010-10#7)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#8)(2010-5#8)(2010-6#3)(2010-7#7)(2010-8#9)(2010-9#3)(2011-1#5)(2011-10#1)(2011-2#43)(2011-3#4)(2012-12#8)(2012-2#13)(2012-3#13)(2012-5#2)(2012-6#4)(2012-7#2)(2012-8#1)(2012-9#3)(2013-1#27)(2013-8#23)
change)##3##1##(1995-5#1)(2008-10#1)(2008-5#1)
changed after##2##2##(2008-10#1)(2008-11#1)
changed and##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-1#1)
changed as##2##2##(1992-6#1)(2008-11#1)
changed at##2##2##(2009-6#1)(2010-1#1)
changed by the##2##3##(2008-10#1)(2008-11#1)
changed by##7##2##(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)
changed considerably over the##2##4##(1997-8#1)(2011-2#1)
changed dramatically##2##2##(1990-6#1)(1996-3#1)
changed during long-term##2##3##(2008-11#1)(2013-1#1)
changed during##5##2##(1990-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
changed every##2##2##(2008-10#1)(2008-8#1)
changed from##11##2##(1993-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2012-12#1)
changed in a##2##3##(2008-10#1)(2008-8#1)
changed in the##4##3##(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
changed in##14##2##(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-1#1)
changed into##4##2##(2008-10#2)(2011-3#1)(2013-1#1)
changed little##4##2##(1991-9#1)(2008-10#2)(2008-2#1)
changed morphology##2##2##(1993-12#1)(2013-1#1)
changed on##2##2##(1996-6#1)(2012-2#1)
changed over time##3##3##(2008-10#2)(2011-2#1)
changed over##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
changed phenotype##2##2##(2008-10#2)
changed significantly##4##2##(1991-6#1)(2008-11#2)(2010-8#1)
changed substantially##2##2##(1991-3#1)(2012-2#1)
changed the way##2##3##(1995-1#1)(2010-8#1)
changed the##14##2##(1993-8#1)(1995-1#2)(1996-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)
changed their##5##2##(1990-6#2)(1994-3#1)(1994-8#1)(2008-11#1)
changed to a##3##3##(1991-6#1)(1997-3#1)(2008-10#1)
changed to alanine##2##3##(1994-5#1)(2008-9#1)
changed to phenotype##2##3##(2008-10#2)
changed to##19##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-5#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
changed when##2##2##(2008-10#1)(2008-8#1)
changed with##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
changed##181##1##(1990-3#1)(1990-6#4)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#4)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2008-10#39)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#8)(2009-12#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#3)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
changes affecting##2##2##(1992-2#1)(2008-11#1)
changes after##5##2##(1995-12#1)(2008-10#2)(2010-3#1)(2011-2#1)
changes among##2##2##(1990-3#1)(2008-12#1)
changes and the##4##3##(1991-3#1)(2008-11#1)(2008-5#1)(2013-8#1)
changes and their##3##3##(1990-6#1)(2008-9#1)(2009-8#1)
changes and##33##2##(1990-11#2)(1990-6#1)(1991-3#1)(1992-11#1)(1993-8#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-12#1)(2009-4#2)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
changes are poorly understood##2##4##(2008-5#1)(2012-2#1)
changes are##26##2##(1990-11#2)(1990-2#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-2#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
changes as a result of##2##5##(1993-8#1)(2013-7#1)
changes as a##3##3##(1993-8#1)(2008-10#1)(2013-7#1)
changes as compared##2##3##(1993-12#1)(2012-2#1)
changes as##9##2##(1993-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
changes associated with the##5##4##(1991-9#1)(1993-1#1)(1995-6#1)(2008-1#1)(2008-10#1)
changes associated with##12##3##(1991-9#1)(1993-1#1)(1995-6#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#4)(2010-10#1)(2012-12#1)
changes at the##4##3##(2008-10#1)(2008-8#2)(2012-3#1)
changes at##9##2##(2008-10#2)(2008-8#2)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
changes before##2##2##(1994-12#1)(2008-7#1)
changes between##5##2##(2008-10#1)(2008-11#1)(2009-10#1)(2009-7#1)(2012-2#1)
changes by##5##2##(1992-1#1)(2008-10#1)(2008-11#2)(2009-5#1)
changes can be detected##2##4##(1992-12#1)(2008-9#1)
changes can be##7##3##(1992-12#1)(1993-2#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
changes can##14##2##(1991-2#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2012-2#1)
changes caused by##3##3##(2008-10#2)(2012-3#1)
changes consistent with##2##3##(2008-10#1)(2008-7#1)
changes contributing to##2##3##(2008-3#1)(2009-9#1)
changes could be##3##3##(1993-1#1)(1997-8#1)(2011-2#1)
changes depending on##2##3##(2008-6#1)(2012-2#1)
changes due to##2##3##(2008-7#1)(2010-1#1)
changes during asexual reproduction##2##4##(2008-10#2)
changes during storage##2##3##(2008-10#1)(2011-2#1)
changes during the past##2##4##(2008-10#1)(2008-11#1)
changes during the##8##3##(1992-3#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-5#1)
changes during##20##2##(1992-3#2)(1993-8#1)(1994-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-5#1)(2013-8#1)
changes followed##2##2##(2011-2#1)(2012-2#1)
changes following##3##2##(2008-3#1)(2008-9#1)(2009-1#1)
changes for the##2##3##(1990-8#1)(2010-3#1)
changes for##5##2##(1990-8#1)(1995-2#1)(2010-1#1)(2010-3#1)(2011-2#1)
changes from baseline##3##3##(1993-1#1)(2011-2#2)
changes from the##2##3##(2008-11#1)(2013-8#1)
changes from##13##2##(1993-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#3)(2012-9#1)(2013-8#1)
changes have been##4##3##(1991-2#1)(1994-5#1)(1995-12#1)(1996-11#1)
changes have occurred in##2##4##(2008-10#1)(2008-11#1)
changes have##11##2##(1991-2#1)(1994-5#1)(1995-12#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-10#1)(2012-2#1)
changes in Medicare##3##3##(1991-1#1)(1994-1#1)(1995-3#1)
changes in a##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-3#1)
changes in action##2##3##(2008-11#2)
changes in adolescents' perceptions of##2##5##(2009-7#2)
changes in allele##2##3##(2010-4#1)(2012-3#1)
changes in allocation to##2##4##(2008-8#1)(2008-9#1)
changes in amino##2##3##(1990-12#1)(2012-8#1)
changes in apparent##2##3##(2008-9#1)(2009-11#1)
changes in arterial elasticity##2##4##(2013-8#2)
changes in average##2##3##(1992-12#1)(2008-9#1)
changes in blood coagulation##2##4##(1991-3#1)(2006-6#1)
changes in blood pressure##2##4##(1997-8#1)(2008-8#1)
changes in blood##5##3##(1991-3#1)(1997-8#1)(2006-6#1)(2008-8#1)(2013-1#1)
changes in body weight##2##4##(2008-3#1)(2008-4#1)
changes in body##3##3##(2008-3#1)(2008-4#1)(2009-8#1)
changes in both##5##3##(1991-6#1)(1993-8#1)(2008-3#1)(2008-8#1)(2012-2#1)
changes in brain##2##3##(2008-9#1)(2013-8#1)
changes in cell morphology##2##4##(2008-11#1)(2008-8#1)
changes in cell physiology##2##4##(1994-11#1)(2011-2#1)
changes in cell##10##3##(1994-11#1)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
changes in cerebral##2##3##(1994-2#1)(2013-1#1)
changes in complement activation##2##4##(2008-10#2)
changes in concentrations of##2##4##(1992-3#1)(2008-7#1)
changes in cytoskeletal##2##3##(1994-11#1)(2011-2#1)
changes in dietary habits##2##4##(2010-1#1)(2010-6#1)
changes in drug##2##3##(1997-1#1)(2008-1#1)
changes in eating##2##3##(2010-8#1)(2012-2#1)
changes in enthalpy##2##3##(1997-2#1)(2008-10#1)
changes in environmental##2##3##(2008-4#1)(2009-8#1)
changes in expression of##4##4##(1994-12#1)(1996-2#1)(2008-8#1)(2010-4#1)
changes in expression##7##3##(1994-12#1)(1996-2#1)(2008-11#1)(2008-8#2)(2010-4#1)(2012-2#1)
changes in food availability##2##4##(2008-9#2)
changes in food##3##3##(2008-9#3)
changes in free##2##3##(1991-6#1)(2010-4#1)
changes in function##2##3##(1994-5#1)(2008-10#1)
changes in gene expression and##2##5##(2007-12#1)(2010-1#1)
changes in gene expression are##2##5##(2008-7#1)(2010-5#1)
changes in gene expression in##4##5##(1996-12#1)(2008-8#1)(2010-10#1)(2011-2#1)
changes in gene expression##14##4##(1996-12#1)(1996-2#1)(2007-12#2)(2008-11#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)
changes in health care##2##4##(1991-2#1)(1994-3#1)
changes in health##3##3##(1991-2#1)(1994-3#1)(1996-3#1)
changes in heart rate##2##4##(2013-8#2)
changes in high##2##3##(1993-8#1)(2009-4#1)
changes in hospital##2##3##(2013-1#2)
changes in how##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
changes in human##3##3##(2011-2#2)(2013-1#1)
changes in immune function##3##4##(2008-10#3)
changes in immune##4##3##(2008-10#3)(2008-7#1)
changes in intracellular##3##3##(1994-2#1)(1994-3#1)(2008-11#1)
changes in its##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
changes in leptin##2##3##(2013-8#2)
changes in lipid##2##3##(2008-10#1)(2008-5#1)
changes in liver##2##3##(1994-6#1)(2011-2#1)
changes in local##3##3##(1994-2#1)(2008-10#1)(2011-2#1)
changes in membrane potential##2##4##(1997-1#1)(2008-9#1)
changes in membrane##3##3##(1997-1#1)(2008-9#2)
changes in metabolic control##2##4##(1994-12#2)
changes in mortality##2##3##(1990-8#1)(2008-9#1)
changes in organ##2##3##(2008-10#1)(2008-9#1)
changes in other##2##3##(1991-12#1)(2008-4#1)
changes in otherwise##2##3##(2008-11#1)(2012-2#1)
changes in pH##4##3##(1995-6#1)(2008-10#2)(2008-9#1)
changes in perfusion##2##3##(2008-11#2)
changes in phase##2##3##(2008-11#1)(2013-8#1)
changes in phenotype##2##3##(2008-10#1)(2010-4#1)
changes in physician payment##2##4##(1994-1#2)
changes in plant##2##3##(2008-10#1)(2008-8#1)
changes in plasma##4##3##(1991-2#1)(1997-2#1)(2008-7#2)
changes in population growth rate##2##5##(2008-8#2)
changes in population##6##3##(1991-2#1)(2008-10#1)(2008-12#1)(2008-8#3)
changes in preoperative##2##3##(2011-2#2)
changes in primary##2##3##(1993-2#1)(1996-12#1)
changes in protein##2##3##(2010-4#2)
changes in provider##2##3##(1994-12#1)(1997-1#1)
changes in rat##2##3##(2008-7#1)(2008-8#1)
changes in recent years##2##4##(1992-1#1)(2008-11#1)
changes in relative##2##3##(1994-9#1)(2008-10#1)
changes in response to##2##4##(1990-11#1)(1994-5#1)
changes in response##3##3##(1990-11#1)(1994-5#1)(2008-8#1)
changes in serotonergic signaling##2##4##(2012-3#2)
changes in serum##3##3##(1990-3#1)(2008-3#1)(2009-12#1)
changes in service##2##3##(1991-1#1)(2008-11#1)
changes in sialylation pattern of##3##5##(2008-11#3)
changes in smoking##2##3##(1992-2#1)(2013-1#1)
changes in social##2##3##(1996-12#1)(2012-12#1)
changes in spatial##2##3##(2008-10#1)(2008-9#1)
changes in spinal ganglion neurons##2##5##(2008-7#2)
changes in surface##2##3##(1991-3#1)(2008-10#1)
changes in synaptic##5##3##(1997-3#2)(2008-1#1)(2008-11#1)(2008-7#1)
changes in the actin cytoskeleton required for neurite formation##2##9##(1996-12#2)
changes in the activities of##2##5##(1990-3#2)
changes in the brain##2##4##(1996-12#1)(2013-1#1)
changes in the cell##2##4##(1992-2#1)(2008-9#1)
changes in the cerebellum##2##4##(2013-1#2)
changes in the composition of the##3##6##(2008-10#2)(2011-2#1)
changes in the composition##4##4##(2008-10#3)(2011-2#1)
changes in the criteria##2##4##(1992-3#1)(2008-8#1)
changes in the diffusion##2##4##(1997-6#1)(2008-7#1)
changes in the distribution of##2##5##(1992-12#1)(2012-12#1)
changes in the distribution##3##4##(1992-12#1)(2008-11#1)(2012-12#1)
changes in the environment##2##4##(1996-3#1)(2008-10#1)
changes in the expression of##2##5##(1994-3#1)(2008-10#1)
changes in the extracellular##2##4##(1994-8#1)(1995-11#1)
changes in the health care system##4##6##(1991-2#1)(1994-3#2)(2012-2#1)
changes in the health care##5##5##(1991-2#1)(1994-3#2)(1996-2#1)(2012-2#1)
changes in the human##2##4##(2010-8#2)
changes in the immune##2##4##(1991-2#1)(2008-7#1)
changes in the levels of##3##5##(1997-3#1)(2008-7#1)(2013-8#1)
changes in the list of reportable diseases##2##7##(1997-3#2)
changes in the liver##2##4##(1990-11#1)(1993-12#1)
changes in the neural##4##4##(1994-3#1)(2008-11#3)
changes in the oscillation amplitude##2##5##(2008-10#2)
changes in the overall##2##4##(1994-6#1)(2008-10#1)
changes in the proportion of##3##5##(2008-10#1)(2008-8#1)(2012-3#1)
changes in the protein##3##4##(1995-6#1)(2008-10#1)(2011-2#1)
changes in the radiometric##2##4##(2008-3#2)
changes in the rate of##4##5##(2008-8#2)(2008-9#1)(2012-3#1)
changes in the redox##2##4##(2008-10#2)
changes in the relative##2##4##(1990-3#1)(1994-9#1)
changes in the shape##2##4##(2008-10#1)(2009-12#1)
changes in the structure of##2##5##(1993-8#1)(2008-12#1)
changes in the structure##3##4##(1993-8#1)(2008-12#1)(2008-7#1)
changes in the transmission##2##4##(2008-10#1)(2008-3#1)
changes in the##265##3##(1990-11#3)(1990-3#3)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#4)(1992-9#3)(1993-1#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-6#3)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#5)(1997-5#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#50)(2008-11#18)(2008-12#3)(2008-2#2)(2008-3#8)(2008-5#9)(2008-7#9)(2008-8#8)(2008-9#6)(2009-10#1)(2009-12#5)(2009-5#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#15)(2012-12#2)(2012-2#4)(2012-3#5)(2012-9#1)(2013-1#12)(2013-7#1)(2013-8#3)
changes in their##5##3##(1994-12#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-8#1)
changes in these##5##3##(1996-2#1)(2008-10#2)(2011-2#1)(2013-8#1)
changes in this##2##3##(1996-2#1)(2008-12#1)
changes in virulence##2##3##(2008-10#2)
changes in viscosity and density##2##5##(2008-10#2)
changes in##835##2##(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#6)(1990-5#2)(1990-8#3)(1991-1#5)(1991-12#4)(1991-2#9)(1991-3#5)(1991-5#1)(1991-6#7)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#4)(1992-2#6)(1992-3#5)(1992-4#1)(1992-6#5)(1992-9#3)(1993-1#5)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#2)(1993-8#7)(1993-9#1)(1994-1#4)(1994-11#2)(1994-12#12)(1994-2#5)(1994-3#9)(1994-5#8)(1994-6#4)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#12)(1996-2#11)(1996-3#5)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#11)(1997-3#9)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2006-6#4)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#4)(2008-10#120)(2008-11#59)(2008-12#15)(2008-2#4)(2008-3#17)(2008-4#7)(2008-5#22)(2008-6#4)(2008-7#35)(2008-8#33)(2008-9#39)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#7)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#9)(2009-8#6)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#2)(2011-2#45)(2011-3#1)(2012-12#6)(2012-2#21)(2012-3#19)(2012-5#2)(2012-7#2)(2012-8#3)(2012-9#1)(2013-1#32)(2013-7#1)(2013-8#22)
changes including##7##2##(1992-1#1)(1994-11#1)(2008-10#3)(2008-7#1)(2012-12#1)
changes induced by##10##3##(1991-9#1)(1992-6#1)(2008-10#4)(2008-11#1)(2008-7#2)(2009-4#1)
changes induced in the##3##4##(1993-6#1)(1994-3#1)(2008-2#1)
changes induced##14##2##(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2009-4#1)
changes is##4##2##(1992-9#1)(2008-3#1)(2008-9#1)(2012-3#1)
changes its##2##2##(2008-12#1)(2013-1#1)
changes made in##2##3##(1994-1#1)(2008-10#1)
changes made##3##2##(1994-1#1)(2008-10#1)(2012-2#1)
changes may be##4##3##(1992-11#1)(1997-1#1)(2007-12#1)(2013-8#1)
changes may##6##2##(1992-11#1)(1994-1#1)(1997-1#1)(1997-3#1)(2007-12#1)(2013-8#1)
changes measured##2##2##(1996-12#1)(1996-2#1)
changes observed in the##2##4##(2008-10#1)(2011-2#1)
changes observed in##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
changes observed##9##2##(1991-12#1)(1994-5#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-5#1)
changes occur in##2##3##(2008-10#1)(2010-12#1)
changes occur##5##2##(2008-10#1)(2008-9#2)(2010-12#1)(2013-8#1)
changes occurred at##2##3##(2008-7#1)(2012-2#1)
changes occurred in##4##3##(1992-12#1)(2008-10#2)(2008-11#1)
changes occurred within the##2##4##(2008-10#2)
changes occurred within##3##3##(2008-10#3)
changes occurred##15##2##(1992-12#1)(1994-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)
changes occurring at the##2##4##(2008-11#1)(2008-5#1)
changes occurring at##3##3##(1991-3#1)(2008-11#1)(2008-5#1)
changes occurring in the##5##4##(1993-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
changes occurring in##6##3##(1993-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
changes occurring##13##2##(1991-3#1)(1993-12#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2010-12#1)
changes of albumin##2##3##(2008-10#2)
changes of blood vessels##2##4##(2010-1#1)(2011-2#1)
changes of collagen##2##3##(2008-7#1)(2012-3#1)
changes of human##2##3##(1993-8#1)(2008-11#1)
changes of pH##2##3##(2008-10#1)(2008-8#1)
changes of the##26##3##(1991-6#1)(1992-3#1)(1993-8#1)(1994-5#1)(1997-2#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-8#1)
changes of this##2##3##(1993-12#1)(1994-5#1)
changes of##99##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-3#1)(1994-5#2)(1995-11#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#26)(2008-11#5)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#5)(2009-3#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#7)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#5)
changes on the##6##3##(1990-8#1)(1992-1#1)(1995-12#1)(1996-3#1)(2008-10#2)
changes on##20##2##(1990-8#1)(1991-12#1)(1992-1#1)(1994-1#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-10#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
changes or##4##2##(2008-11#1)(2008-9#1)(2009-3#1)(2010-12#1)
changes over time##3##3##(1991-2#1)(1996-6#1)(2008-9#1)
changes over##5##2##(1991-2#1)(1996-6#1)(2008-9#1)(2010-6#1)(2011-2#1)
changes possibly##2##2##(2010-11#1)(2013-1#1)
changes resulting from##2##3##(2008-4#1)(2008-6#1)
changes seen in##2##3##(1994-12#1)(2008-4#1)
changes seen on##2##3##(1996-6#1)(1997-8#1)
changes seen##6##2##(1994-12#1)(1996-6#1)(1997-8#1)(2008-4#1)(2008-7#1)(2012-2#1)
changes should##2##2##(1996-1#1)(2010-3#1)
changes similar to those##2##4##(2008-5#2)
changes such as##3##3##(1993-2#1)(2008-10#2)
changes than##2##2##(2008-7#1)(2011-2#1)
changes that are occurring in##2##5##(1995-1#1)(1996-2#1)
changes that are##6##3##(1992-6#1)(1995-1#1)(1996-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
changes that can be##2##4##(2010-4#1)(2012-9#1)
changes that occur in##2##4##(2008-5#1)(2012-12#1)
changes that occur with puberty##2##5##(2010-4#2)
changes that occur##7##3##(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-4#2)(2012-12#1)
changes that were##2##3##(2008-10#1)(2008-5#1)
changes that##37##2##(1991-2#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-8#1)(1996-2#2)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-4#3)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-8#1)
changes the##8##2##(1990-5#1)(1993-12#1)(1994-5#1)(2008-10#3)(2010-11#1)(2011-2#1)
changes to the payment##2##4##(1992-2#1)(1996-3#1)
changes to the##10##3##(1991-6#1)(1992-2#1)(1993-1#1)(1993-2#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#2)
changes to##26##2##(1991-6#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-11#6)(2008-12#1)(2008-5#1)(2008-8#2)(2009-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
changes was##3##2##(1990-6#1)(1991-9#1)(2008-5#1)
changes were associated with the##2##5##(2008-10#1)(2008-9#1)
changes were associated with##4##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
changes were detected in##2##4##(1994-2#1)(1995-11#1)
changes were detected##3##3##(1994-2#1)(1995-11#1)(2008-10#1)
changes were found in the##2##5##(1993-12#1)(2008-7#1)
changes were found in##3##4##(1993-12#1)(2008-7#1)(2013-1#1)
changes were found##5##3##(1991-7#1)(1993-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
changes were not##2##3##(2010-12#1)(2011-1#1)
changes were noted in##3##4##(1996-12#1)(2011-2#1)(2012-3#1)
changes were observed at##2##4##(1993-8#1)(2009-8#1)
changes were observed in the##8##5##(1990-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(2009-12#1)(2009-8#1)
changes were observed in##13##4##(1990-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2013-1#2)
changes were observed##18##3##(1990-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#2)(2012-2#1)(2013-1#2)
changes were seen in##3##4##(1991-12#1)(2008-12#1)(2011-2#1)
changes were seen##5##3##(1991-12#1)(1995-11#1)(2008-12#1)(2010-3#1)(2011-2#1)
changes were used in##2##4##(2009-7#1)(2012-2#1)
changes were used##3##3##(2009-7#1)(2011-2#1)(2012-2#1)
changes were##68##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#5)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#3)
changes when##2##2##(2008-10#1)(2008-9#1)
changes which occur in##3##4##(1993-2#1)(1994-5#1)(2010-11#1)
changes which##7##2##(1991-11#1)(1993-2#2)(1994-5#1)(1995-8#1)(2010-11#1)(2012-2#1)
changes will##3##2##(1996-3#1)(2008-10#1)(2008-6#1)
changes with increasing##3##3##(1991-12#1)(1994-8#1)(2008-7#1)
changes with the##2##3##(2008-8#1)(2011-2#1)
changes with##16##2##(1991-12#1)(1993-1#1)(1994-8#1)(1995-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)
changes within##2##2##(2008-12#1)(2010-5#1)
changes##1696##1##(1990-11#9)(1990-12#2)(1990-2#3)(1990-3#8)(1990-5#5)(1990-6#3)(1990-8#6)(1990-9#2)(1991-1#6)(1991-11#2)(1991-12#10)(1991-2#17)(1991-3#11)(1991-5#6)(1991-6#10)(1991-7#1)(1991-8#1)(1991-9#7)(1992-1#8)(1992-11#2)(1992-12#10)(1992-2#12)(1992-3#11)(1992-4#1)(1992-6#9)(1992-9#5)(1993-1#12)(1993-12#8)(1993-2#9)(1993-3#5)(1993-6#6)(1993-8#17)(1993-9#1)(1994-1#8)(1994-11#3)(1994-12#17)(1994-2#9)(1994-3#15)(1994-5#21)(1994-6#4)(1994-8#9)(1994-9#5)(1995-1#4)(1995-11#8)(1995-12#11)(1995-2#8)(1995-3#6)(1995-5#1)(1995-6#7)(1995-8#8)(1996-1#3)(1996-11#3)(1996-12#19)(1996-2#19)(1996-3#12)(1996-6#8)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#16)(1997-3#14)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#6)(1997-9#1)(2006-6#4)(2007-11#2)(2007-12#10)(2007-8#2)(2008-1#6)(2008-10#247)(2008-11#108)(2008-12#33)(2008-2#7)(2008-3#30)(2008-4#13)(2008-5#48)(2008-6#10)(2008-7#81)(2008-8#48)(2008-9#71)(2009-1#4)(2009-10#6)(2009-11#2)(2009-12#10)(2009-3#4)(2009-4#7)(2009-5#3)(2009-6#5)(2009-7#15)(2009-8#18)(2009-9#4)(2010-1#8)(2010-10#7)(2010-11#8)(2010-12#8)(2010-2#1)(2010-3#6)(2010-4#14)(2010-5#3)(2010-6#6)(2010-7#4)(2010-8#10)(2010-9#6)(2011-1#5)(2011-2#87)(2011-3#5)(2011-7#1)(2012-12#17)(2012-2#49)(2012-3#37)(2012-5#5)(2012-7#2)(2012-8#3)(2012-9#5)(2013-1#66)(2013-7#3)(2013-8#40)
changes)##3##1##(2008-9#2)(2012-2#1)
changing and##2##2##(2008-11#1)(2008-12#1)
changing demographics##2##2##(2008-9#1)(2010-8#1)
changing environment##6##2##(1991-2#1)(1991-3#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-7#1)
changing environments##3##2##(1997-7#1)(2008-7#1)(2009-6#1)
changing field##2##2##(1991-12#1)(2013-8#1)
changing from##5##2##(1990-5#1)(1992-3#1)(1997-8#1)(2008-2#1)(2012-12#1)
changing health care environment##3##4##(1991-2#1)(1997-3#1)(2008-11#1)
changing health care##5##3##(1991-2#1)(1993-12#1)(1997-1#1)(1997-3#1)(2008-11#1)
changing health##6##2##(1991-2#1)(1992-1#1)(1993-12#1)(1997-1#1)(1997-3#1)(2008-11#1)
changing in##3##2##(1992-9#1)(2007-8#1)(2008-10#1)
changing market##2##2##(1992-2#1)(1994-2#1)
changing needs##2##2##(1992-1#1)(1995-5#1)
changing policy##2##2##(1997-8#1)(2008-11#1)
changing role of##2##3##(1997-5#1)(2008-11#1)
changing the##46##2##(1990-5#1)(1990-6#1)(1992-6#1)(1993-2#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#5)(2011-2#1)(2013-1#1)
changing their##2##2##(1996-2#1)(2008-11#1)
changing this##2##2##(1995-1#1)(1995-6#1)
changing times##2##2##(1991-1#1)(1991-3#1)
changing##173##1##(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-3#2)(1997-1#3)(1997-2#2)(1997-3#5)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#5)(2007-8#1)(2008-10#35)(2008-11#21)(2008-12#6)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-1#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#3)(2013-8#2)
channel and##8##2##(1995-8#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-12#1)
channel antagonists##3##2##(1994-11#2)(2008-10#1)
channel beta##2##2##(1994-12#1)(1996-12#1)
channel blockade##3##2##(1993-6#2)(2008-12#1)
channel blocker##9##2##(1990-5#1)(1995-11#1)(1996-5#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)
channel blockers and##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
channel blockers##16##2##(1990-8#1)(1994-8#1)(1995-11#2)(1996-2#1)(1996-6#2)(2008-10#4)(2008-11#3)(2008-7#1)(2012-12#1)
channel clusters##3##2##(2008-7#3)
channel complex##2##2##(1995-11#1)(1996-2#1)
channel domains##2##2##(2008-7#2)
channel for##5##2##(1990-11#1)(2008-10#2)(2008-12#1)(2012-2#1)
channel in##4##2##(1994-12#1)(1994-8#1)(2008-10#1)(2009-12#1)
channel is##6##2##(1994-5#1)(2008-10#2)(2008-2#1)(2009-10#1)(2009-8#1)
channel mRNA##3##2##(1996-12#3)
channel mRNAs##3##2##(1996-12#3)
channel of the##3##3##(1992-1#1)(2008-10#1)(2013-1#1)
channel of##5##2##(1992-1#1)(1997-8#1)(2008-10#2)(2013-1#1)
channel protein##4##2##(1991-12#1)(1997-2#2)(2010-12#1)
channel through##2##2##(1990-8#1)(2007-12#1)
channel walls##3##2##(2008-10#1)(2008-12#2)
channel was##4##2##(1996-12#1)(1997-2#1)(2008-10#1)(2013-1#1)
channel waveguide##2##2##(2008-2#2)
channel with##2##2##(2008-10#1)(2013-8#1)
channel##205##1##(1990-11#1)(1990-5#1)(1990-8#2)(1991-12#2)(1992-1#1)(1992-3#4)(1992-6#2)(1993-6#2)(1993-8#1)(1994-11#6)(1994-12#5)(1994-5#1)(1994-8#6)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#15)(1996-2#4)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#6)(1997-7#1)(1997-8#2)(2007-12#3)(2008-10#43)(2008-11#6)(2008-12#6)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#2)(2009-5#2)(2009-8#3)(2010-12#1)(2010-8#1)(2011-2#3)(2011-3#4)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#2)
channel&quot##2##1##(2011-2#2)
channel-forming##3##1##(1990-11#2)(1994-11#1)
channelopathies##5##1##(2008-7#1)(2012-2#1)(2012-3#3)
channels and the##2##3##(2008-9#1)(2010-4#1)
channels and##12##2##(1993-6#1)(1994-5#1)(1995-11#1)(2008-10#4)(2008-6#1)(2008-9#2)(2010-4#1)(2013-8#1)
channels are##6##2##(1995-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)
channels as a function of##2##5##(2008-2#1)(2008-3#1)
channels as##4##2##(2008-2#2)(2008-3#2)
channels from##2##2##(2008-11#1)(2008-8#1)
channels has##2##2##(2008-8#1)(2012-3#1)
channels have a##2##3##(2008-10#2)
channels have been##2##3##(2008-7#1)(2009-12#1)
channels have##5##2##(1994-12#1)(2008-10#2)(2008-7#1)(2009-12#1)
channels in the membrane##2##4##(1994-11#1)(2008-7#1)
channels in the##6##3##(1994-11#1)(1996-2#1)(2008-7#1)(2009-10#2)(2009-7#1)
channels in##22##2##(1990-8#1)(1991-9#1)(1992-9#1)(1994-11#6)(1994-12#1)(1996-2#2)(1997-7#1)(2008-3#1)(2008-7#1)(2009-10#4)(2009-7#1)(2011-2#1)(2012-2#1)
channels is##2##2##(1990-8#1)(2008-12#1)
channels of##4##2##(2008-10#1)(2008-8#1)(2009-10#1)(2010-4#1)
channels that##2##2##(2008-9#1)(2009-10#1)
channels were##6##2##(1994-11#1)(1997-2#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
channels##155##1##(1990-2#1)(1990-8#3)(1991-9#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#13)(1994-12#4)(1994-5#1)(1995-11#1)(1995-2#4)(1995-3#2)(1996-2#8)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#21)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#10)(2009-10#9)(2009-12#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
channels)##3##1##(2007-12#1)(2011-2#2)
chaos and oscillations##3##3##(2008-11#3)
chaos and##4##2##(2008-11#4)
chaos in##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
chaos##17##1##(1994-2#1)(1995-6#1)(2008-11#7)(2008-8#3)(2008-9#4)(2013-8#1)
chaotic dynamics in##2##3##(2008-11#2)
chaotic dynamics is##2##3##(2008-11#2)
chaotic dynamics##9##2##(1992-8#1)(2008-11#7)(2008-8#1)
chaotic oscillations##3##2##(2007-12#2)(2008-9#1)
chaotic regime##3##2##(2008-11#2)(2008-9#1)
chaotic##29##1##(1992-8#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#11)(2008-8#5)(2008-9#3)(2010-1#1)(2011-2#2)
chaotropic##3##1##(1990-2#1)(1991-3#1)(2008-10#1)
chaperone##11##1##(1997-4#3)(2008-7#4)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)
chaperones##6##1##(1995-2#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#2)
chaperoning##2##1##(2008-7#2)
chaplain visits##2##2##(2008-12#2)
chaplain##4##1##(1993-12#1)(2008-12#3)
chaplain's role in bioethical decision-making##2##5##(1994-12#2)
chaplains##3##1##(1994-12#2)(2009-11#1)
chapter discusses##3##2##(2010-8#1)(2011-2#2)
chapter##21##1##(1995-3#1)(2008-11#1)(2008-4#4)(2008-9#2)(2009-10#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#3)
chapters##5##1##(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#2)
character and##5##2##(2008-12#2)(2008-5#1)(2008-9#1)(2010-12#1)
character displacement##3##2##(2008-8#3)
character in the##3##3##(2007-12#3)
character information##2##2##(2013-1#2)
character of the##5##3##(1996-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
character of##22##2##(1992-12#1)(1994-5#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-3#1)(2012-3#2)
character##80##1##(1992-12#2)(1994-5#2)(1995-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#4)(2008-10#17)(2008-11#5)(2008-12#7)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#7)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-3#1)(2011-2#2)(2011-3#1)(2012-3#4)(2012-5#1)(2013-1#5)
characterisation and##6##2##(2008-10#5)(2012-2#1)
characterisation of the##9##3##(1993-12#1)(1993-2#1)(2008-10#5)(2008-11#1)(2008-8#1)
characterisation of this##2##3##(1995-11#1)(2008-10#1)
characterisation of##37##2##(1990-11#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-3#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-8#1)(2012-2#3)
characterisation##50##1##(1990-11#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-3#1)(2008-1#2)(2008-10#34)(2008-11#2)(2008-8#1)(2011-10#1)(2012-2#5)
characterise the##8##2##(1994-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-10#1)(2013-8#1)
characterise##17##1##(1994-11#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
characterised and##2##2##(2008-10#1)(2008-12#1)
characterised as##3##2##(2008-10#1)(2008-11#1)(2012-5#1)
characterised by a##3##3##(2008-10#2)(2011-2#1)
characterised by high##2##3##(2008-12#1)(2008-6#1)
characterised by low##2##3##(2008-10#2)
characterised by the##5##3##(1993-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
characterised by##37##2##(1991-3#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#1)
characterised in##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
characterised the##2##2##(1991-5#1)(1993-2#1)
characterised with##3##2##(2008-10#3)
characterised##73##1##(1991-2#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-2#2)(1993-3#1)(1994-12#1)(1995-12#1)(1996-12#4)(1996-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#5)(2008-12#2)(2008-6#1)(2008-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-5#1)(2013-7#1)(2013-8#1)
characterising the##5##2##(2008-10#5)
characterising##12##1##(2008-10#6)(2008-11#1)(2011-2#2)(2011-3#1)(2012-2#2)
characteristic airway dimensions##2##3##(2008-11#2)
characteristic autoantibodies##2##2##(1996-11#2)
characteristic band##2##2##(2008-10#1)(2008-12#1)
characteristic clinical##4##2##(2009-8#1)(2011-2#2)(2012-12#1)
characteristic concentration and##2##3##(2008-10#2)
characteristic concentration##5##2##(2008-10#5)
characteristic data of the electrochemical hydride generation and common hydride generation by NaBH(4) were compared##2##15##(2008-10#2)
characteristic disease##2##2##(2008-10#2)
characteristic feature of##2##3##(1996-11#1)(1997-8#1)
characteristic features of the##5##4##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
characteristic features of##12##3##(1990-11#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2010-7#1)(2013-1#1)
characteristic features##15##2##(1990-11#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-7#1)(2013-1#2)
characteristic for the##2##3##(2008-12#2)
characteristic for##16##2##(1995-8#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
characteristic ions##3##2##(2008-10#3)
characteristic mass of##7##3##(2008-10#7)
characteristic mass was##3##3##(2008-10#3)
characteristic mass##20##2##(2008-10#20)
characteristic masses##3##2##(2008-10#3)
characteristic of all##4##3##(1993-2#1)(2008-11#1)(2008-12#1)(2008-8#1)
characteristic of an##3##3##(1991-2#1)(2009-4#1)(2012-12#1)
characteristic of several##2##3##(1990-5#1)(2008-11#1)
characteristic of the hypersensitive response (HR)##2##6##(2008-10#2)
characteristic of the##25##3##(1990-10#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
characteristic of these##2##3##(1991-8#1)(2011-2#1)
characteristic of this##4##3##(1990-5#1)(1993-8#1)(1996-12#1)(2008-10#1)
characteristic of##99##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-8#2)(1994-5#1)(1995-12#2)(1995-2#2)(1996-12#2)(1996-3#1)(1997-2#1)(1997-7#2)(2007-12#1)(2008-10#30)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#6)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
characteristic pattern##2##2##(2008-5#1)(2011-2#1)
characteristic patterns##2##2##(2008-2#1)(2010-8#1)
characteristic peak##2##2##(2008-11#1)(2013-8#1)
characteristic peaks##4##2##(2008-10#4)
characteristic presenting symptoms##2##3##(2008-7#1)(2012-12#1)
characteristic properties##4##2##(1993-11#1)(2010-6#1)(2012-12#1)(2012-3#1)
characteristic signs and symptoms##2##4##(1997-8#2)
characteristic signs##3##2##(1997-8#2)(2012-12#1)
characteristic species evolved by the##2##5##(2008-10#2)
characteristic symptoms of##4##3##(2008-10#3)(2011-2#1)
characteristic symptoms##5##2##(2008-10#3)(2010-2#1)(2011-2#1)
characteristic that##3##2##(1992-2#1)(1995-1#1)(2008-5#1)
characteristic to the##2##3##(2008-5#1)(2011-2#1)
characteristic##329##1##(1990-10#1)(1990-11#3)(1990-3#1)(1990-5#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-11#3)(1996-12#4)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#5)(2007-12#3)(2008-1#2)(2008-10#121)(2008-11#16)(2008-12#7)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#13)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#5)(2010-10#4)(2010-2#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#17)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#9)(2013-8#6)
characteristic)##3##1##(2008-10#2)(2008-12#1)
characteristically##6##1##(1994-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-3#1)(2013-1#1)
characteristics among##2##2##(2008-10#1)(2013-8#1)
characteristics and educational##2##3##(1992-3#1)(2008-12#1)
characteristics and needs of##2##4##(1991-3#1)(2008-6#1)
characteristics and the##8##3##(1990-9#1)(1994-1#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-7#1)
characteristics and their##2##3##(2008-3#1)(2011-2#1)
characteristics and##81##2##(1990-11#1)(1990-9#1)(1991-3#2)(1992-11#1)(1992-12#2)(1992-3#1)(1993-2#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#17)(2008-11#6)(2008-12#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#4)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
characteristics are defined##2##3##(1991-2#1)(2008-3#1)
characteristics are not##2##3##(2008-10#1)(2008-11#1)
characteristics are##18##2##(1991-2#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-8#1)
characteristics as a##2##3##(1995-2#1)(2008-5#1)
characteristics as##7##2##(1991-5#1)(1995-2#2)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
characteristics associated with##6##3##(1992-2#1)(1993-6#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
characteristics at a##2##3##(2008-10#1)(2008-3#1)
characteristics between##2##2##(1990-8#1)(1995-3#1)
characteristics by##6##2##(2008-10#3)(2008-11#1)(2012-3#1)(2013-1#1)
characteristics compared##2##2##(2008-10#1)(2012-2#1)
characteristics did not##2##3##(2008-10#2)
characteristics evaluated were##2##3##(2008-10#2)
characteristics for the##4##3##(1995-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
characteristics for##9##2##(1995-11#1)(2007-12#1)(2008-10#6)(2008-8#1)
characteristics have been##6##3##(1993-3#1)(1994-9#1)(2008-10#2)(2009-4#1)(2012-2#1)
characteristics have##7##2##(1993-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2009-4#1)(2012-2#1)
characteristics in terms of##2##4##(2008-10#1)(2009-9#1)
characteristics in the##2##3##(2011-2#1)(2013-1#1)
characteristics in##16##2##(1995-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
characteristics including##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
characteristics is##4##2##(1994-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
characteristics make the##2##3##(2013-8#2)
characteristics make##5##2##(1990-3#1)(2013-1#1)(2013-8#3)
characteristics observed##2##2##(1993-12#1)(2008-10#1)
characteristics of 2##2##3##(1994-2#1)(2008-10#1)
characteristics of Chinese male batterers##2##5##(2009-5#2)
characteristics of a disparity detector##2##5##(1990-8#2)
characteristics of a fiber##2##4##(2008-2#1)(2008-3#1)
characteristics of a good##2##4##(2008-11#2)
characteristics of a novel##2##4##(2008-10#1)(2008-11#1)
characteristics of a##31##3##(1990-3#1)(1990-8#2)(1991-9#1)(1993-3#1)(1994-3#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
characteristics of an##3##3##(1993-3#1)(2008-10#2)
characteristics of apoptosis##2##3##(1995-12#1)(2008-7#1)
characteristics of both##2##3##(1996-1#1)(2011-2#1)
characteristics of cells##2##3##(2008-11#1)(2013-8#1)
characteristics of children##2##3##(2013-1#2)
characteristics of conventional##2##3##(2008-5#1)(2010-6#1)
characteristics of different##3##3##(1997-8#1)(2008-7#1)(2008-8#1)
characteristics of dry##2##3##(1997-2#1)(2008-9#1)
characteristics of each##2##3##(2008-10#1)(2008-3#1)
characteristics of enzyme##2##3##(2008-10#1)(2013-1#1)
characteristics of human##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
characteristics of meat##2##3##(2010-4#2)
characteristics of microcosmic and photosensitive damage on space structure of##2##10##(2008-8#2)
characteristics of native##2##3##(1994-5#1)(2008-10#1)
characteristics of our##2##3##(1996-3#1)(1997-2#1)
characteristics of patients hospitalized##2##4##(2012-12#2)
characteristics of patients##4##3##(2008-12#1)(2011-2#1)(2012-12#2)
characteristics of recombinant##2##3##(2008-11#2)
characteristics of several##5##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
characteristics of some##2##3##(2008-10#1)(2011-2#1)
characteristics of the aerosol##2##4##(1992-3#1)(2008-10#1)
characteristics of the cardiovascular system##2##5##(2008-10#2)
characteristics of the electrode##2##4##(2008-10#2)
characteristics of the health##2##4##(1993-12#1)(2008-12#1)
characteristics of the inclusion##2##4##(2008-10#2)
characteristics of the method##2##4##(2008-10#1)(2008-5#1)
characteristics of the predicted stimulus##2##5##(2013-8#2)
characteristics of the##131##3##(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-9#2)(1997-7#1)(2007-12#2)(2008-1#2)(2008-10#54)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-6#2)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#9)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
characteristics of these##8##3##(1994-12#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)
characteristics of this##12##3##(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
characteristics of viral quasispecies##3##4##(2013-8#3)
characteristics of##428##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#6)(1996-9#2)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#4)(2008-1#4)(2008-10#117)(2008-11#33)(2008-12#4)(2008-2#7)(2008-3#19)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#16)(2008-8#12)(2008-9#13)(2009-10#1)(2009-12#3)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#4)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#24)(2011-3#3)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#14)(2013-8#15)
characteristics on the##2##3##(2008-3#1)(2010-6#1)
characteristics on##8##2##(1991-3#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#2)
characteristics related##2##2##(2008-10#1)(2011-2#1)
characteristics such as sensitivity##2##4##(2008-10#2)
characteristics such as the##2##4##(2008-10#1)(2008-6#1)
characteristics such as##14##3##(1991-12#1)(1991-5#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-7#1)
characteristics suitable for##2##3##(2008-3#1)(2009-7#1)
characteristics than##2##2##(1992-3#1)(2009-7#1)
characteristics that are##3##3##(2008-10#2)(2008-2#1)
characteristics that can be##2##4##(2008-10#1)(2013-1#1)
characteristics that can##3##3##(2008-10#2)(2013-1#1)
characteristics that distinguish##2##3##(1996-3#1)(2008-7#1)
characteristics that##18##2##(1993-1#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
characteristics to the##2##3##(1993-8#1)(1994-3#1)
characteristics to##7##2##(1991-2#1)(1993-8#1)(1994-3#1)(2008-10#1)(2008-3#2)(2009-4#1)
characteristics was##8##2##(1990-2#2)(2008-10#2)(2008-11#1)(2008-3#1)(2012-12#2)
characteristics were examined##2##3##(1994-1#1)(2008-10#1)
characteristics were not##2##3##(1991-3#1)(2011-2#1)
characteristics were obtained##3##3##(2008-10#3)
characteristics were related to##2##4##(2008-7#1)(2009-7#1)
characteristics were studied##7##3##(2008-10#6)(2010-11#1)
characteristics were##31##2##(1991-3#1)(1994-1#1)(1995-3#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#1)
characteristics when##3##2##(2008-10#2)(2008-9#1)
characteristics with##8##2##(1994-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2012-2#1)
characteristics within the##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
characteristics within##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
characteristics##949##1##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#4)(1990-3#3)(1990-5#1)(1990-8#3)(1990-9#5)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#9)(1991-5#4)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#6)(1992-4#1)(1992-6#2)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#4)(1993-6#2)(1993-8#3)(1994-1#4)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#5)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#10)(1995-2#5)(1995-3#8)(1995-5#2)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#7)(1996-9#3)(1997-2#7)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#3)(2006-5#1)(2007-12#6)(2008-1#4)(2008-10#279)(2008-11#61)(2008-12#11)(2008-2#9)(2008-3#37)(2008-4#5)(2008-5#33)(2008-6#7)(2008-7#25)(2008-8#28)(2008-9#22)(2009-10#1)(2009-12#5)(2009-3#2)(2009-4#4)(2009-5#7)(2009-6#2)(2009-7#11)(2009-8#3)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#6)(2010-6#11)(2010-7#7)(2010-8#4)(2011-1#3)(2011-2#51)(2011-3#3)(2012-12#9)(2012-2#18)(2012-3#14)(2012-4#1)(2012-9#1)(2013-1#25)(2013-8#30)
characterization and application of a##2##5##(2008-11#2)
characterization and application##3##3##(2008-10#1)(2008-11#2)
characterization and##27##2##(1990-5#1)(1994-11#1)(1997-7#1)(2008-10#11)(2008-11#4)(2008-3#4)(2008-5#1)(2009-3#1)(2010-12#2)(2011-2#1)
characterization by##6##2##(2008-10#4)(2008-11#1)(2010-4#1)
characterization from##2##2##(1993-5#1)(2008-3#1)
characterization has##2##2##(2008-3#1)(2008-7#1)
characterization in##2##2##(2008-10#1)(2011-2#1)
characterization measurements##2##2##(2008-2#1)(2008-3#1)
characterization of Cryptococcus neoformans var##2##5##(2008-5#2)
characterization of a gene##2##4##(1993-12#1)(2012-3#1)
characterization of a new##7##4##(2008-10#5)(2008-8#1)(2011-2#1)
characterization of a novel##9##4##(1993-2#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-8#1)(2008-9#1)
characterization of a##57##3##(1990-2#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-7#1)(1997-8#2)(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
characterization of an##6##3##(1996-12#1)(1997-2#1)(2008-10#3)(2009-5#1)
characterization of biological##2##3##(2008-10#1)(2010-9#1)
characterization of cell##2##3##(1994-8#1)(2008-11#1)
characterization of focal liver lesions##2##5##(2010-12#2)
characterization of human##7##3##(1991-6#1)(1997-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
characterization of its##2##3##(2008-10#2)
characterization of new##4##3##(1993-12#1)(1995-5#1)(2008-10#1)(2010-4#1)
characterization of nuclear##2##3##(1991-2#1)(2008-9#1)
characterization of plasmid DNA##2##4##(2008-10#2)
characterization of polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
characterization of recombinant##3##3##(1991-9#1)(1995-11#1)(1995-6#1)
characterization of the human##2##4##(1991-5#1)(1995-11#1)
characterization of the rat##3##4##(1993-8#1)(1994-2#1)(1996-2#1)
characterization of the##76##3##(1990-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#3)(1995-11#2)(1995-2#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
characterization of their##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
characterization of these mutants##2##4##(2008-10#2)
characterization of these##6##3##(2008-10#2)(2008-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
characterization of this##2##3##(2008-10#2)
characterization of two##4##3##(1992-2#2)(1993-12#1)(2008-10#1)
characterization of##374##2##(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#3)(1991-9#3)(1992-12#1)(1992-2#3)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#4)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#5)(1996-12#3)(1996-2#2)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#3)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#126)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#14)(2008-5#12)(2008-6#1)(2008-7#1)(2008-8#14)(2008-9#13)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#4)(2013-8#8)
characterization revealed that##2##3##(1995-6#1)(2008-10#1)
characterization shows##2##2##(1992-5#1)(2008-3#1)
characterization studies##3##2##(2008-10#3)
characterization using##3##2##(1995-11#1)(2008-10#2)
characterization##479##1##(1990-11#3)(1990-2#3)(1990-5#3)(1990-8#1)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#3)(1991-9#3)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#3)(1994-2#1)(1994-5#4)(1994-8#3)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#6)(1996-12#4)(1996-2#2)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#3)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#171)(2008-11#22)(2008-12#2)(2008-2#4)(2008-3#20)(2008-4#17)(2008-5#14)(2008-6#1)(2008-7#2)(2008-8#15)(2008-9#14)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#1)(2010-4#4)(2010-5#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#13)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#8)(2013-8#10)
characterizations of the##2##3##(2007-11#1)(2008-9#1)
characterizations of##8##2##(2007-11#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-1#1)(2013-8#2)
characterizations##9##1##(2007-11#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-7#1)(2013-8#2)
characterize and##8##2##(1997-3#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2013-1#1)
characterize its##2##2##(1990-2#1)(2012-2#1)
characterize output##2##2##(1995-2#1)(2008-4#1)
characterize the effects of##4##4##(1994-2#1)(2008-10#2)(2008-11#1)
characterize the interaction of##2##4##(1991-5#1)(2012-2#1)
characterize the interaction##3##3##(1991-5#1)(2009-6#1)(2012-2#1)
characterize the performance of##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
characterize the sorption##2##3##(2008-10#2)
characterize the##96##2##(1990-5#1)(1990-7#1)(1991-5#2)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-1#1)(2008-10#39)(2008-11#7)(2008-12#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
characterize their##7##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-7#1)
characterize these##3##2##(1993-1#1)(1994-2#1)(1997-3#1)
characterize this process##2##3##(2008-7#1)(2009-8#1)
characterize this##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)
characterize##209##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-3#1)(1993-8#2)(1994-11#2)(1994-2#3)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#73)(2008-11#17)(2008-12#4)(2008-3#12)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#2)
characterized a##8##2##(1991-2#1)(1995-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)
characterized according to##2##3##(2008-8#1)(2012-3#1)
characterized after##2##2##(2008-10#1)(2011-1#1)
characterized and evaluated for##2##4##(2008-10#1)(2008-11#1)
characterized and optimized to##2##4##(2008-10#2)
characterized and used for##2##4##(1995-12#1)(2008-10#1)
characterized and##19##2##(1993-9#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-3#1)(2008-10#11)(2008-11#2)(2008-9#1)
characterized as a##8##3##(1992-3#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
characterized as being##2##3##(2008-10#1)(2008-9#1)
characterized as the##4##3##(1990-9#1)(1991-5#1)(1995-2#1)(2009-10#1)
characterized as##33##2##(1990-9#1)(1991-5#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-11#1)(1997-3#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
characterized at the##2##3##(2008-10#2)
characterized at##6##2##(1990-6#1)(1994-5#1)(2008-10#4)
characterized both##2##2##(1997-7#1)(2012-2#1)
characterized by FT-IR spectroscopy##2##4##(2008-10#2)
characterized by Fourier transform infrared##2##5##(2008-10#2)
characterized by IR##3##3##(2008-10#3)
characterized by UV-vis##2##3##(2008-10#2)
characterized by X-ray diffraction (XRD)##2##5##(2008-10#2)
characterized by X-ray diffraction##3##4##(1994-5#1)(2008-10#2)
characterized by X-ray##5##3##(1994-5#1)(2008-10#3)(2011-3#1)
characterized by a progressive##3##4##(1991-2#1)(2010-10#1)(2013-8#1)
characterized by a##45##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#2)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#3)
characterized by abnormal##2##3##(2009-8#1)(2011-2#1)
characterized by accumulation of##2##4##(2010-10#1)(2010-7#1)
characterized by an##19##3##(1992-3#1)(1994-12#1)(1994-5#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#1)
characterized by bilateral##2##3##(2009-3#1)(2010-9#1)
characterized by both##2##3##(1990-5#1)(2013-1#1)
characterized by central##2##3##(2008-10#2)
characterized by chronic##3##3##(1991-11#1)(2008-5#1)(2008-7#1)
characterized by different##2##3##(2008-2#1)(2012-3#1)
characterized by distinct##2##3##(2008-10#2)
characterized by elemental analysis##5##4##(2008-10#5)
characterized by elevated##2##3##(1994-5#1)(2011-2#1)
characterized by fever##2##3##(1994-9#1)(2009-11#1)
characterized by high##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)
characterized by higher##2##3##(1990-2#1)(2011-2#1)
characterized by highly##2##3##(1990-11#1)(2008-7#1)
characterized by increased##2##3##(1994-5#1)(2010-6#1)
characterized by infrared##3##3##(2008-10#2)(2008-5#1)
characterized by intense##2##3##(2008-5#2)
characterized by its##7##3##(1997-5#1)(2008-10#4)(2011-2#1)(2013-1#1)
characterized by low##2##3##(2008-10#1)(2010-4#1)
characterized by means of##3##4##(2008-10#3)
characterized by pathogenicity##4##3##(2008-10#4)
characterized by progressive##3##3##(2008-4#2)(2013-7#1)
characterized by recurrent##2##3##(2008-7#1)(2010-6#1)
characterized by scanning electron microscopy (SEM)##2##6##(2008-10#1)(2009-7#1)
characterized by sequence analysis and##2##5##(1993-12#1)(1993-2#1)
characterized by severe##2##3##(1997-3#1)(2008-7#1)
characterized by small##2##3##(2008-10#1)(2010-8#1)
characterized by spontaneous##2##3##(2008-9#1)(2012-3#1)
characterized by the absence of##2##5##(2007-12#1)(2008-7#1)
characterized by the formation##2##4##(2010-6#1)(2012-12#1)
characterized by the presence of##6##5##(1994-5#1)(2008-10#2)(2010-6#3)
characterized by the production of##2##5##(1994-8#1)(2008-10#1)
characterized by the##37##3##(1991-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-6#5)(2011-2#2)(2012-12#1)(2013-1#3)
characterized by their##3##3##(2008-10#3)
characterized by using##6##3##(2008-10#3)(2009-9#2)(2011-2#1)
characterized by various##5##3##(2008-10#5)
characterized by very##2##3##(1994-11#1)(2008-11#1)
characterized by##397##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#3)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#2)(1991-8#1)(1992-12#3)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#7)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#134)(2008-11#8)(2008-12#12)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#13)(2008-7#15)(2008-8#6)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#3)(2009-7#9)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#10)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#24)(2011-3#2)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#15)(2013-7#1)(2013-8#6)
characterized for mating type##2##4##(2008-10#2)
characterized for their##2##3##(2008-10#2)
characterized for##17##2##(1993-6#1)(1995-11#1)(2008-10#11)(2008-3#1)(2010-4#1)(2012-2#1)(2013-8#1)
characterized from##6##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#2)
characterized genes##2##2##(1997-6#1)(2008-10#1)
characterized here##2##2##(2008-10#2)
characterized in a##2##3##(1993-2#1)(2008-10#1)
characterized in terms of##5##4##(1990-11#1)(1996-2#1)(2008-10#2)(2008-5#1)
characterized in vitro##2##3##(2008-10#1)(2008-11#1)
characterized in##30##2##(1990-11#2)(1991-7#1)(1993-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
characterized mainly##2##2##(2008-7#2)
characterized on the basis of##4##5##(2008-10#4)
characterized on##6##2##(1992-6#1)(2008-10#4)(2013-1#1)
characterized over##2##2##(2008-10#1)(2013-8#1)
characterized plant##2##2##(1995-6#1)(2008-10#1)
characterized previously##3##2##(1995-6#1)(1997-8#1)(2008-10#1)
characterized primarily by##3##3##(2008-10#2)(2008-7#1)
characterized that##2##2##(1995-6#1)(2008-3#1)
characterized the gene expression##2##4##(1995-2#1)(2010-11#1)
characterized the##26##2##(1992-8#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#9)(2008-11#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
characterized through##3##2##(1995-12#1)(2008-10#1)(2008-5#1)
characterized to##4##2##(1994-5#1)(1997-9#1)(2011-3#1)(2012-12#1)
characterized two##2##2##(1993-8#1)(1997-8#1)
characterized using a##3##3##(2008-10#3)
characterized using infrared##2##3##(2008-10#1)(2008-5#1)
characterized using the##2##3##(1993-6#1)(2009-10#1)
characterized using##30##2##(1991-9#1)(1993-6#1)(1994-5#1)(2008-10#21)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2012-2#1)
characterized were##2##2##(1992-6#1)(2008-10#1)
characterized with amplified fragment length polymorphism##2##6##(2008-10#2)
characterized with respect to##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
characterized with##14##2##(1996-2#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
characterized##768##1##(1990-11#5)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#6)(1990-6#1)(1990-9#2)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#2)(1991-7#3)(1991-8#1)(1991-9#4)(1992-12#3)(1992-3#4)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#6)(1994-12#3)(1994-2#1)(1994-5#12)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#2)(1995-6#7)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#5)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#296)(2008-11#27)(2008-12#14)(2008-2#2)(2008-3#9)(2008-4#7)(2008-5#22)(2008-6#1)(2008-7#21)(2008-8#13)(2008-9#11)(2009-1#2)(2009-10#6)(2009-11#4)(2009-12#1)(2009-3#3)(2009-6#1)(2009-7#14)(2009-8#12)(2009-9#3)(2010-1#5)(2010-10#3)(2010-11#6)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#10)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#29)(2011-3#4)(2012-12#3)(2012-2#17)(2012-3#11)(2013-1#23)(2013-7#1)(2013-8#11)
characterizes the##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
characterizes##12##1##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
characterizing a##2##2##(1994-2#1)(2010-12#1)
characterizing disease##2##2##(2008-10#2)
characterizing interspecific associations##2##3##(2008-10#2)
characterizing the sorption##2##3##(2008-10#2)
characterizing the##19##2##(1992-1#1)(1995-2#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-3#2)
characterizing##48##1##(1992-1#1)(1992-3#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-3#2)
characters and##4##2##(1995-2#1)(1996-12#1)(2008-10#1)(2011-2#1)
characters are##6##2##(1995-2#1)(2008-11#2)(2008-7#1)(2009-8#1)(2010-3#1)
characters for##2##2##(2008-10#2)
characters in this##2##3##(1996-12#1)(2008-8#1)
characters in##6##2##(1995-2#2)(1996-12#1)(2007-12#1)(2008-8#1)(2011-2#1)
characters of##4##2##(2007-12#1)(2008-10#2)(2013-8#1)
characters on the##2##3##(2008-11#1)(2010-3#1)
characters##62##1##(1995-2#6)(1996-12#2)(2007-12#2)(2008-10#14)(2008-11#5)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#4)(2009-8#1)(2010-3#5)(2010-8#1)(2011-2#3)(2012-3#2)(2013-8#2)
characters'##3##1##(2008-11#3)
charantia##3##1##(2008-12#3)
charcoal##11##1##(2008-10#9)(2008-7#1)(2012-9#1)
charge (m/z)##2##2##(2008-10#2)
charge and the##3##3##(1996-6#1)(2008-10#1)(2008-9#1)
charge and##7##2##(1991-6#1)(1994-5#1)(1996-6#1)(2008-10#3)(2008-9#1)
charge at##2##2##(2011-1#1)(2011-2#1)
charge coupled device##2##3##(2008-10#2)
charge density as##2##3##(2008-10#1)(2009-8#1)
charge density of the##2##4##(2008-10#2)
charge density of##5##3##(2008-10#3)(2008-4#1)(2009-8#1)
charge density##14##2##(1991-5#2)(2008-10#7)(2008-4#1)(2008-9#1)(2009-8#3)
charge development##3##2##(2008-10#3)
charge distribution##4##2##(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#1)
charge for##2##2##(1991-11#1)(2008-9#1)
charge increased##2##2##(2008-11#2)
charge is##3##2##(2007-11#2)(2008-4#1)
charge of the##6##3##(1990-5#1)(1991-2#1)(1992-8#1)(1994-9#1)(2008-10#2)
charge of##17##2##(1990-5#1)(1991-2#1)(1992-8#1)(1994-9#1)(1995-2#1)(2008-10#4)(2008-11#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#3)
charge on##2##2##(1995-11#1)(2008-10#1)
charge or##2##2##(1996-12#1)(2008-10#1)
charge separation##3##2##(2008-8#2)(2011-2#1)
charge state##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
charge transfer complex##4##3##(2008-10#4)
charge transfer complexes##2##3##(2008-10#2)
charge transfer in##2##3##(1991-9#2)
charge transfer##18##2##(1991-9#2)(2008-10#15)(2013-1#1)
charge transport##2##2##(2008-10#1)(2008-7#1)
charge##148##1##(1990-12#2)(1990-5#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#2)(1992-8#1)(1993-1#1)(1993-6#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#64)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-8#4)(2010-1#1)(2010-6#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#2)(2013-1#8)
charge-based weights##2##2##(1993-1#2)
charge-coupled device (CCD)##3##3##(1991-2#1)(2008-1#1)(2008-10#1)
charge-coupled device##6##2##(1991-2#1)(2008-1#1)(2008-10#3)(2012-2#1)
charge-transfer complexes and##3##3##(1996-5#1)(2008-10#2)
charge-transfer complexes##4##2##(1996-5#1)(2008-10#3)
charge-transfer##11##1##(1992-1#1)(1996-5#1)(2008-10#9)
charged CE-beta-CD##2##2##(2008-10#2)
charged amino acids and##2##4##(1993-8#1)(1997-8#1)
charged amino acids##6##3##(1993-8#1)(1995-6#2)(1997-8#1)(2008-8#1)(2011-1#1)
charged by##3##2##(1995-1#1)(2008-10#1)(2009-10#1)
charged carriers##2##2##(2008-10#2)
charged chromoionophores##2##2##(2008-10#2)
charged complexes##5##2##(2008-10#5)
charged gold surfaces##2##3##(2008-10#2)
charged ligands##3##2##(1997-2#2)(2008-10#1)
charged membrane into##2##3##(2008-7#2)
charged membrane##4##2##(2008-11#1)(2008-7#3)
charged nylon##2##2##(2008-11#2)
charged residues of human##2##4##(1995-6#2)
charged residues within the##2##4##(2008-8#1)(2011-1#1)
charged residues##12##2##(1990-11#1)(1994-5#1)(1995-6#2)(1997-8#2)(1997-9#1)(2008-8#2)(2011-1#3)
charged surface##3##2##(1991-9#1)(2008-11#2)
charged surfaces##2##2##(2008-10#2)
charged that##4##2##(1995-12#2)(1995-6#2)
charged with the##2##3##(1994-12#1)(2012-3#1)
charged with##13##2##(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-5#2)(2008-11#2)(2012-3#2)(2013-1#2)
charged##138##1##(1990-11#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#8)(1995-8#1)(1996-5#3)(1997-2#4)(1997-8#4)(1997-9#1)(2008-10#60)(2008-11#8)(2008-7#5)(2008-8#3)(2009-1#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-7#2)(2011-1#6)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
charged-surface##5##1##(2008-11#5)
charges and Medicare##2##3##(1991-12#1)(1991-2#1)
charges and##5##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1996-1#1)
charges as##2##2##(1991-12#1)(2008-10#1)
charges for##3##2##(1991-1#2)(1992-1#1)
charges in##2##2##(1992-12#1)(2011-2#1)
charges of##5##2##(1994-2#1)(1995-12#1)(1996-5#1)(2008-10#2)
charges##53##1##(1990-12#1)(1991-1#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#2)(1993-1#2)(1993-12#6)(1994-1#1)(1994-2#2)(1995-12#2)(1995-2#2)(1996-1#1)(1996-5#1)(1997-6#1)(2008-10#10)(2008-11#1)(2009-8#2)(2010-7#1)(2011-2#1)
charging currents##2##2##(2008-10#2)
charging##6##1##(1995-6#2)(2008-10#3)(2012-2#1)
charitable care##3##2##(2008-11#3)
charitable##8##1##(1993-5#1)(1996-3#1)(1997-1#1)(2008-11#5)
charity care will##2##3##(1996-2#2)
charity care##11##2##(1992-3#3)(1996-2#4)(2008-11#4)
charity##15##1##(1992-3#4)(1995-6#1)(1996-2#5)(2008-11#5)
charred##2##1##(1992-12#1)(2012-9#1)
chart for##2##2##(1995-2#1)(2010-3#1)
chart review was performed of##2##5##(2008-9#1)(2011-2#1)
chart review was##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
chart review##8##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
chart##27##1##(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
chartarum##3##1##(2008-11#3)
charter##3##1##(1992-2#1)(2012-2#2)
charting##4##1##(1996-1#3)(2008-11#1)
charts and##2##2##(1993-3#1)(1994-1#1)
charts for##3##2##(1995-12#1)(2008-12#1)(2012-12#1)
charts of patients with##2##4##(1993-1#2)
charts that##2##2##(1997-3#1)(2008-10#1)
charts the##2##2##(2008-10#1)(2008-3#1)
charts##39##1##(1991-2#1)(1993-1#3)(1993-3#2)(1994-1#1)(1994-3#1)(1995-12#1)(1996-1#2)(1997-3#2)(2008-10#13)(2008-12#2)(2008-3#2)(2008-7#4)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
chase times##3##2##(1992-12#3)
chase##5##1##(1992-12#3)(1995-8#1)(2008-9#1)
chasmogamous##3##1##(2008-10#3)
chat##2##1##(2012-2#1)(2013-1#1)
cheap and easily available##2##4##(2008-10#2)
cheap and simple##2##3##(2008-10#2)
cheap and##8##2##(2008-10#8)
cheap to produce##2##3##(2008-8#1)(2011-2#1)
cheap to##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
cheap##24##1##(1990-2#1)(1993-3#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#2)
cheaper and##4##2##(1991-3#1)(2008-10#1)(2008-7#1)(2011-7#1)
cheaper to##2##2##(2008-12#1)(2011-7#1)
cheaper##15##1##(1991-3#2)(1995-11#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2011-7#2)
cheapest synonymous##2##2##(1993-11#2)
cheapest##3##1##(1993-11#2)(2008-10#1)
cheaply##2##1##(2008-10#2)
cheaters##2##1##(2008-8#1)(2008-9#1)
cheating##5##1##(2008-12#2)(2008-8#3)
check on##2##2##(1993-3#1)(2009-1#1)
check the##13##2##(1991-2#1)(2008-10#7)(2008-12#3)(2008-5#1)(2008-9#1)
check##40##1##(1991-2#1)(1991-3#1)(1993-3#1)(1994-12#1)(1996-5#1)(2008-10#17)(2008-11#2)(2008-12#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-1#1)(2012-7#1)(2013-1#2)
check-ups##2##1##(1993-5#1)(1993-6#1)
checkbites were##2##2##(1993-1#2)
checkbites##3##1##(1993-1#3)
checked by analyzing##2##3##(2008-10#2)
checked by applying it to##2##5##(2008-10#2)
checked by##24##2##(1995-9#1)(2008-10#22)(2008-3#1)
checked for the##5##3##(2008-10#5)
checked for##8##2##(2008-10#8)
checked in##4##2##(2008-10#2)(2010-3#1)(2011-2#1)
checked on the##2##3##(2008-10#2)
checked on##3##2##(2008-10#3)
checked the##3##2##(1997-7#1)(2008-10#2)
checked through##2##2##(2008-10#1)(2008-3#1)
checked using##4##2##(2008-10#4)
checked with##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
checked##71##1##(1990-8#1)(1995-12#1)(1995-9#1)(1997-7#1)(2008-10#54)(2008-11#1)(2008-3#3)(2008-5#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
checkerboard assay##2##2##(1994-8#1)(2009-6#1)
checkerboard##4##1##(1992-6#1)(1994-8#1)(2008-10#1)(2009-6#1)
checking the##2##2##(2012-2#1)(2013-1#1)
checking##7##1##(1993-12#1)(1995-2#1)(1995-9#1)(2008-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
checklist for##3##2##(1994-12#1)(2010-9#1)(2013-1#1)
checklist of##3##2##(1993-2#1)(1995-2#1)(2011-2#1)
checklist to##2##2##(1990-3#1)(2010-9#1)
checklist was##2##2##(2013-1#2)
checklist##16##1##(1990-3#1)(1993-2#1)(1994-12#1)(1995-2#1)(2010-9#2)(2011-2#3)(2013-1#7)
checkpoint control##2##2##(2009-6#1)(2013-1#1)
checkpoint##11##1##(2008-11#3)(2009-6#3)(2011-2#1)(2012-3#1)(2013-1#3)
checks and##2##2##(1991-3#1)(1994-12#1)
checks##10##1##(1991-3#1)(1994-12#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2010-9#1)
checkup##6##1##(1992-12#1)(2011-2#1)(2013-1#4)
cheek##14##1##(1993-2#1)(1994-3#1)(1995-9#1)(2008-5#11)
cheese with##2##2##(2008-10#1)(2012-2#1)
cheese##19##1##(1990-8#1)(2008-10#12)(2012-2#6)
cheeses##4##1##(2008-10#1)(2012-2#3)
chelate affinity chromatography##3##3##(1995-8#1)(1996-12#2)
chelate and##2##2##(2008-10#2)
chelate can##2##2##(2008-10#2)
chelate concentration##2##2##(2008-10#2)
chelate formed##2##2##(2008-10#2)
chelate is##7##2##(2008-10#7)
chelate of##3##2##(2008-10#3)
chelate on##2##2##(2008-10#2)
chelate was##3##2##(2008-10#3)
chelate which##2##2##(2008-10#2)
chelate with##8##2##(2008-10#8)
chelate##67##1##(1993-8#1)(1995-8#1)(1996-12#2)(2008-10#60)(2010-4#1)(2011-2#1)(2012-3#1)
chelates in##2##2##(2008-10#2)
chelates of Co(II)##2##3##(2008-10#2)
chelates of##4##2##(2008-10#4)
chelates was##3##2##(2008-10#3)
chelates were found##2##3##(2008-10#2)
chelates were injected##2##3##(2008-10#2)
chelates were investigated##2##3##(2008-10#2)
chelates were##11##2##(2008-10#11)
chelates with##6##2##(2008-10#6)
chelates##50##1##(1990-5#1)(2008-1#1)(2008-10#47)(2009-9#1)
chelating Sepharose beads##2##3##(2008-10#2)
chelating adsorbent##2##2##(2008-10#2)
chelating agent##13##2##(2008-10#13)
chelating agents##5##2##(1994-5#3)(2008-10#2)
chelating fiber is##2##3##(2008-10#2)
chelating fiber##9##2##(2008-10#9)
chelating groups##3##2##(2008-10#3)
chelating matrix##3##2##(2008-10#3)
chelating or reducing agents were##2##5##(1990-5#2)
chelating polymer##3##2##(2008-10#3)
chelating polymers##2##2##(2008-10#2)
chelating reagent##3##2##(2008-10#3)
chelating resin YPA(4) as both##2##5##(2008-10#2)
chelating resin having##2##3##(2008-10#2)
chelating resin is##3##3##(2008-10#3)
chelating resin was characterized by##2##5##(2008-10#2)
chelating resin was##6##3##(2008-10#6)
chelating resin with##3##3##(2008-10#3)
chelating resin##37##2##(2008-10#37)
chelating resins##6##2##(2008-10#6)
chelating##126##1##(1990-5#2)(1994-5#3)(2008-10#121)
chelation by##2##2##(1993-8#1)(2008-10#1)
chelation ion chromatography##2##3##(2008-10#2)
chelation of##3##2##(2008-10#3)
chelation with##2##2##(2008-10#2)
chelation##17##1##(1993-8#1)(1996-5#1)(2008-10#14)(2008-4#1)
chelatogen##2##1##(2008-10#2)
chelator##19##1##(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-8#3)(2011-2#1)
chelators##11##1##(1995-2#1)(2008-11#2)(2010-6#1)(2011-2#1)(2012-3#5)(2013-8#1)
chelerythrine and##4##2##(2008-10#4)
chelicerates##2##1##(2007-12#2)
chemical DNA sequencing##2##3##(1995-6#2)
chemical agents##5##2##(1990-8#1)(1992-4#1)(1996-12#1)(2008-11#1)(2010-7#1)
chemical alternatives to methyl bromide##2##5##(2008-10#2)
chemical alternatives##3##2##(2008-10#3)
chemical analyser##2##2##(2008-10#2)
chemical analysis and##2##3##(2008-10#2)
chemical analysis is##2##3##(2008-10#2)
chemical analysis of the##2##4##(2008-10#2)
chemical analysis of##7##3##(2008-10#7)
chemical analysis##35##2##(1994-5#1)(1995-5#1)(2008-10#27)(2010-7#4)(2013-8#2)
chemical and FI variables##3##4##(2008-10#3)
chemical and biochemical##2##3##(2008-10#1)(2010-7#1)
chemical and biological##5##3##(1990-8#1)(1994-12#1)(2008-10#2)(2010-7#1)
chemical and cultural measures##2##4##(2008-10#2)
chemical and environmental analysis##2##4##(2008-3#2)
chemical and enzymatic##2##3##(1997-2#2)
chemical and flow variables##3##4##(2008-10#3)
chemical and flow##4##3##(2008-10#4)
chemical and genetic##2##3##(2008-10#2)
chemical and instrumental variables##3##4##(2008-10#3)
chemical and instrumental##4##3##(2008-10#4)
chemical and physical properties of##2##5##(2008-10#1)(2010-7#1)
chemical and physical properties##4##4##(1995-11#1)(2008-10#1)(2010-7#2)
chemical and physical##11##3##(1995-11#1)(2008-10#6)(2008-2#1)(2008-5#1)(2010-7#2)
chemical and spectral##2##3##(2008-10#1)(2008-12#1)
chemical and thermal##2##3##(2008-10#1)(2009-12#1)
chemical and toxicological characteristics##2##4##(2008-5#2)
chemical and##60##2##(1990-8#1)(1994-12#1)(1995-11#1)(1997-2#2)(2008-10#38)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2009-10#1)(2009-12#1)(2009-7#1)(2010-4#1)(2010-7#4)
chemical barriers##2##2##(2008-10#2)
chemical behavior##2##2##(2008-10#2)
chemical bonds##2##2##(2008-10#1)(2008-5#1)
chemical characterisation##3##2##(2008-10#2)(2012-2#1)
chemical characteristics of##6##3##(2008-10#4)(2010-4#2)
chemical characteristics##9##2##(2008-10#5)(2008-11#1)(2009-8#1)(2010-4#2)
chemical characterization of##5##3##(2008-10#4)(2008-11#1)
chemical characterization##7##2##(1990-2#1)(2008-10#4)(2008-11#1)(2010-4#1)
chemical class&quot##2##2##(2008-10#2)
chemical classes##3##2##(2008-10#3)
chemical components of##3##3##(2012-3#1)(2013-8#2)
chemical components##5##2##(2008-10#1)(2011-3#1)(2012-3#1)(2013-8#2)
chemical composition of the##5##4##(1990-5#1)(1991-5#1)(2008-10#1)(2008-11#2)
chemical composition of##8##3##(1990-5#1)(1991-5#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-7#1)(2013-1#1)
chemical composition##19##2##(1990-5#1)(1991-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2009-7#2)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
chemical compositions##2##2##(2008-10#1)(2008-12#1)
chemical compounds that##2##3##(2008-12#1)(2008-5#1)
chemical compounds##3##2##(2008-12#1)(2008-5#1)(2013-1#1)
chemical conditions of##2##3##(2008-10#2)
chemical conditions##5##2##(2008-10#5)
chemical constituents of the##2##4##(2008-11#1)(2012-3#1)
chemical constituents of##6##3##(2008-11#1)(2012-2#1)(2012-3#2)(2013-8#2)
chemical constituents##8##2##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#2)(2013-8#3)
chemical control##9##2##(2008-10#9)
chemical conversion##2##2##(2008-10#1)(2008-7#1)
chemical corneal burn##3##3##(2010-10#3)
chemical data sets##3##3##(2008-10#3)
chemical data##6##2##(2008-10#6)
chemical degradation of##2##3##(2008-10#1)(2012-12#1)
chemical degradation##5##2##(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
chemical deposition##2##2##(2008-10#2)
chemical derivatization of##2##3##(2008-10#2)
chemical derivatization##4##2##(1994-5#1)(2008-10#3)
chemical differences##3##2##(2008-10#2)(2008-11#1)
chemical elements##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
chemical energy##3##2##(1993-9#1)(2008-8#1)(2009-10#1)
chemical entities##4##2##(1995-5#1)(2009-2#2)(2010-7#1)
chemical environment and##3##3##(2008-8#1)(2010-11#1)(2012-2#1)
chemical environment##6##2##(2008-10#3)(2008-8#1)(2010-11#1)(2012-2#1)
chemical equilibrium predictions##2##3##(2008-2#1)(2008-3#1)
chemical equilibrium##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
chemical etching##2##2##(2008-10#1)(2008-3#1)
chemical features##3##2##(2008-10#2)(2010-12#1)
chemical fixation##2##2##(2008-5#1)(2008-7#1)
chemical form of##2##3##(1994-5#1)(2008-10#1)
chemical form##3##2##(1994-5#1)(2008-10#2)
chemical forms of##2##3##(2008-10#2)
chemical forms##4##2##(2008-10#4)
chemical fungicides##2##2##(2008-10#2)
chemical groups##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
chemical imaging methods for the##2##5##(2008-10#2)
chemical imaging##4##2##(2008-10#4)
chemical in##2##2##(2008-9#2)
chemical indices##2##2##(2008-10#2)
chemical inducer##2##2##(2008-10#2)
chemical inducers##2##2##(1992-6#1)(2010-10#1)
chemical industries##2##2##(2008-11#1)(2012-2#1)
chemical industry##2##2##(2008-11#1)(2011-2#1)
chemical inhibitors##2##2##(2008-10#1)(2008-11#1)
chemical insult##2##2##(2008-5#1)(2010-7#1)
chemical interactions##2##2##(1991-3#1)(2008-5#1)
chemical interference##2##2##(2008-7#1)(2009-12#1)
chemical ionization##6##2##(2008-10#5)(2013-8#1)
chemical is##5##2##(2008-10#2)(2008-5#3)
chemical laboratories##2##2##(2008-10#2)
chemical mechanisms##2##2##(2008-10#1)(2009-8#1)
chemical method##4##2##(2008-10#3)(2008-4#1)
chemical methods##5##2##(2008-10#4)(2010-6#1)
chemical modification and##4##3##(1995-6#1)(2008-10#2)(2008-4#1)
chemical modification##14##2##(1992-6#1)(1993-6#1)(1993-8#1)(1995-6#1)(2008-10#9)(2008-4#1)
chemical modifications##4##2##(2008-10#3)(2013-1#1)
chemical modifier and##2##3##(2008-10#2)
chemical modifier for the##2##4##(2008-10#2)
chemical modifier for##4##3##(2008-10#4)
chemical modifier was##3##3##(2008-10#3)
chemical modifier##38##2##(2008-10#38)
chemical modifiers for##2##3##(2008-10#2)
chemical modifiers have been##2##4##(2008-10#2)
chemical modifiers##20##2##(2008-10#20)
chemical nature of the##3##4##(2008-11#3)
chemical nature of##5##3##(1993-8#1)(1996-12#1)(2008-11#3)
chemical nature##7##2##(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-5#1)
chemical or biological##2##3##(2008-11#1)(2010-7#1)
chemical or##7##2##(1990-5#1)(2008-10#2)(2008-11#2)(2010-7#2)
chemical orthogonality##3##2##(2009-3#3)
chemical oxygen demand (COD)##4##4##(2008-10#4)
chemical oxygen demand using##2##4##(2008-10#2)
chemical oxygen demand##8##3##(2008-10#8)
chemical parameters##5##2##(2008-10#3)(2008-2#1)(2013-8#1)
chemical procedures##5##2##(2008-10#5)
chemical processes##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
chemical properties of the##2##4##(1997-2#1)(2011-2#1)
chemical properties of##5##3##(1997-2#1)(2008-10#2)(2011-2#1)(2013-8#1)
chemical properties##17##2##(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-5#1)(2011-2#2)(2011-3#1)(2013-8#1)
chemical proteomics##2##2##(2009-7#2)
chemical reaction events##2##3##(1995-6#2)
chemical reaction##17##2##(1995-6#2)(2008-10#12)(2008-7#1)(2008-9#1)(2011-2#1)
chemical reactions in##2##3##(1995-6#1)(2008-10#1)
chemical reactions##9##2##(1995-6#2)(2008-10#4)(2008-5#1)(2008-7#1)(2010-7#1)
chemical reactivity and##2##3##(2008-10#2)
chemical reactivity##7##2##(2008-10#5)(2008-8#2)
chemical reagents##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
chemical reduction and##2##3##(2008-10#2)
chemical reduction method##4##3##(2012-2#4)
chemical reduction##8##2##(1990-8#2)(2008-10#2)(2012-2#4)
chemical relationships##2##2##(2008-9#1)(2013-1#1)
chemical sciences##3##2##(2008-10#1)(2010-7#2)
chemical selectivity of##2##3##(2008-10#1)(2009-10#1)
chemical sensing##2##2##(2008-10#2)
chemical sensor based on##3##4##(2008-10#3)
chemical sensor for##7##3##(2008-10#6)(2008-3#1)
chemical sensor##19##2##(2008-10#16)(2008-3#2)(2010-7#1)
chemical sensors and##4##3##(2008-10#4)
chemical sensors for##3##3##(2008-10#3)
chemical sensors##16##2##(2008-10#16)
chemical separation of Hf##3##4##(2008-10#3)
chemical separation of##4##3##(2008-10#4)
chemical separation##8##2##(2008-10#8)
chemical sequencing reactions##2##3##(1995-6#2)
chemical sequencing##4##2##(1990-5#1)(1995-6#3)
chemical shift assignments for the##4##5##(2009-7#4)
chemical shift assignments of##4##4##(2009-7#4)
chemical shift assignments##9##3##(2009-7#9)
chemical shift of##3##3##(2008-10#3)
chemical shift##22##2##(1993-3#1)(1994-5#2)(1996-5#1)(2008-10#5)(2008-9#1)(2009-7#9)(2010-7#1)(2012-2#2)
chemical shifts of the##2##4##(2008-10#2)
chemical shifts of##4##3##(2008-10#3)(2008-9#1)
chemical shifts##16##2##(1991-5#2)(1992-4#1)(1994-5#1)(1994-8#1)(2008-10#6)(2008-9#2)(2010-7#1)(2012-2#2)
chemical signals##2##2##(2008-10#2)
chemical signatures##2##2##(2008-10#2)
chemical speciation##3##2##(2008-10#3)
chemical species and##2##3##(2008-10#2)
chemical species in##2##3##(2008-10#1)(2008-3#1)
chemical species##11##2##(2008-10#8)(2008-3#3)
chemical specificity##2##2##(2009-3#1)(2010-7#1)
chemical stability of##2##3##(2008-10#2)
chemical stability##7##2##(1996-1#1)(2008-10#5)(2008-5#1)
chemical step##3##2##(1991-9#2)(2009-10#1)
chemical stimulation##2##2##(2012-2#2)
chemical stimuli##4##2##(2008-10#2)(2009-12#1)(2010-4#1)
chemical structure and##2##3##(1995-11#1)(2010-4#1)
chemical structure of##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
chemical structure##14##2##(1995-11#2)(2008-10#7)(2008-11#2)(2008-5#1)(2010-4#1)(2013-1#1)
chemical structures of the##2##4##(1996-12#1)(2011-3#1)
chemical structures of##3##3##(1996-12#1)(2008-10#1)(2011-3#1)
chemical structures##7##2##(1995-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2011-3#1)
chemical substances##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
chemical such as##2##3##(1995-11#1)(2008-11#1)
chemical suppression##2##2##(2008-10#1)(2008-8#1)
chemical synthesis of##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
chemical synthesis##7##2##(2008-10#2)(2008-11#1)(2008-4#1)(2009-5#1)(2011-1#1)(2011-2#1)
chemical system and##3##3##(2008-10#2)(2009-6#1)
chemical system##8##2##(2008-10#7)(2009-6#1)
chemical systems##3##2##(2008-10#3)
chemical techniques##3##2##(2008-10#2)(2010-7#1)
chemical treatment##7##2##(2008-10#4)(2008-6#2)(2012-2#1)
chemical treatments##2##2##(1990-2#1)(2009-7#1)
chemical vapor deposition and##2##4##(2008-10#2)
chemical vapor deposition##7##3##(2008-10#3)(2008-2#1)(2008-3#3)
chemical vapour##2##2##(2008-10#2)
chemical variables affecting the sensitivity of##2##6##(2008-10#2)
chemical variables affecting the##6##4##(2008-10#6)
chemical variables##13##2##(2008-10#13)
chemical warfare agent##4##3##(2008-11#4)
chemical warfare agents##5##3##(2008-10#1)(2008-11#4)
chemical warfare##9##2##(2008-10#1)(2008-11#8)
chemical yields##2##2##(2008-10#2)
chemical##940##1##(1990-2#2)(1990-5#3)(1990-8#5)(1991-3#3)(1991-5#5)(1991-9#4)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#4)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#7)(1994-8#2)(1994-9#3)(1995-11#6)(1995-2#1)(1995-5#2)(1995-6#11)(1995-9#1)(1996-1#1)(1996-12#4)(1996-5#1)(1997-2#3)(1997-6#1)(2007-12#3)(2008-10#559)(2008-11#41)(2008-12#7)(2008-2#6)(2008-3#16)(2008-4#7)(2008-5#30)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#11)(2009-10#4)(2009-12#3)(2009-2#2)(2009-3#5)(2009-5#2)(2009-6#4)(2009-7#17)(2009-8#3)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#1)(2010-4#8)(2010-6#1)(2010-7#27)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#5)(2012-12#2)(2012-2#17)(2012-3#4)(2013-1#13)(2013-8#17)
chemically active##2##2##(2008-10#1)(2008-11#1)
chemically and##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
chemically bonded##3##2##(2008-10#2)(2009-8#1)
chemically by##2##2##(1997-2#1)(2008-10#1)
chemically defined medium##4##3##(1993-6#1)(2008-11#1)(2008-5#2)
chemically defined##7##2##(1993-6#1)(2008-11#4)(2008-5#2)
chemically diverse##2##2##(2008-10#1)(2008-11#1)
chemically immobilized on the surface of##2##6##(2008-10#2)
chemically induced##5##2##(1990-6#1)(1995-11#2)(1995-9#1)(2013-1#1)
chemically linked##2##2##(1995-5#1)(2008-10#1)
chemically modified and unmodified##2##4##(2008-10#2)
chemically modified carbon paste electrode (CMCPE) for##2##7##(2008-10#2)
chemically modified carbon paste electrode##6##5##(2008-10#6)
chemically modified carbon##7##3##(2008-10#7)
chemically modified chloromethylated polystyrene-PAN##2##4##(2008-10#2)
chemically modified electrode (CME) was prepared##2##6##(2008-10#2)
chemically modified electrode (CME)##6##4##(2008-10#6)
chemically modified electrode exhibits##2##4##(2008-10#2)
chemically modified electrode was##3##4##(2008-10#3)
chemically modified electrode##19##3##(2008-10#19)
chemically modified electrodes##3##3##(2008-10#3)
chemically modified silica gel##3##4##(2008-10#3)
chemically modified with##5##3##(2008-10#5)
chemically modified##55##2##(2008-10#54)(2008-5#1)
chemically related##2##2##(2007-12#1)(2008-5#1)
chemically selective phases##2##3##(2008-10#2)
chemically sensitized##2##2##(2008-10#2)
chemically similar##3##2##(2008-10#3)
chemically synthesized##4##2##(1991-3#1)(1992-6#1)(1994-5#1)(1995-12#1)
chemically##123##1##(1990-6#1)(1991-3#1)(1992-6#1)(1993-6#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-9#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#83)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#2)(2012-2#1)(2013-1#1)
chemically-defined##4##1##(2008-11#4)
chemically-induced##2##1##(2008-7#1)(2011-2#1)
chemicals and##9##2##(1991-9#1)(2008-10#5)(2008-11#2)(2008-5#1)
chemicals are##5##2##(1993-3#1)(2008-10#2)(2008-11#1)(2012-2#1)
chemicals at##2##2##(2008-10#1)(2008-11#1)
chemicals by##3##2##(2008-10#2)(2008-11#1)
chemicals for##4##2##(2008-10#3)(2008-9#1)
chemicals from the##2##3##(1994-3#1)(2008-10#1)
chemicals from##3##2##(1994-3#1)(2008-10#2)
chemicals in the environment##2##4##(2008-11#2)
chemicals in the##8##3##(1991-12#1)(1993-3#2)(2008-10#1)(2008-11#3)(2011-2#1)
chemicals in##15##2##(1991-12#1)(1993-3#2)(1994-3#1)(2008-10#5)(2008-11#4)(2010-7#1)(2011-2#1)
chemicals investigated##2##2##(2008-10#2)
chemicals is##2##2##(2008-11#2)
chemicals on the##2##3##(2008-11#2)
chemicals on##3##2##(2008-10#1)(2008-11#2)
chemicals that##2##2##(2008-10#1)(2008-11#1)
chemicals to##2##2##(2008-10#1)(2008-11#1)
chemicals used##2##2##(1994-3#1)(2008-10#1)
chemicals was##2##2##(2008-10#1)(2008-11#1)
chemicals were##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
chemicals which##2##2##(2008-10#1)(2011-3#1)
chemicals with##3##2##(2008-10#3)
chemicals##138##1##(1991-12#1)(1991-9#1)(1992-1#2)(1993-3#3)(1994-3#4)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#2)(1997-3#1)(2008-10#56)(2008-11#39)(2008-5#7)(2008-7#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)
chemiluminescence (CL) detection##8##3##(2008-10#8)
chemiluminescence (CL) flow-injection method##2##4##(2008-10#2)
chemiluminescence (CL) flow-injection##3##3##(2008-10#3)
chemiluminescence (CL) method for the determination of##3##7##(2008-10#3)
chemiluminescence (CL) method for the##4##5##(2008-10#4)
chemiluminescence (CL) method for##5##4##(2008-10#5)
chemiluminescence (CL) method is proposed for the determination of##3##9##(2008-10#3)
chemiluminescence (CL) method is##4##4##(2008-10#4)
chemiluminescence (CL) method##11##3##(2008-10#11)
chemiluminescence (CL) reaction##4##3##(2008-10#4)
chemiluminescence (CL) system for##3##4##(2008-10#3)
chemiluminescence (CL) system##7##3##(2008-10#7)
chemiluminescence (CL) was##2##3##(2008-10#2)
chemiluminescence (CL)##53##2##(1991-2#1)(2008-10#50)(2008-5#1)(2013-8#1)
chemiluminescence (ECL)##3##2##(2008-10#1)(2012-2#2)
chemiluminescence analysis of##2##3##(2008-10#2)
chemiluminescence analysis##3##2##(2008-10#3)
chemiluminescence and##7##2##(2008-10#7)
chemiluminescence detection in##2##3##(2008-10#2)
chemiluminescence detection of##2##3##(2008-10#2)
chemiluminescence detection using##2##3##(2008-10#2)
chemiluminescence detection##34##2##(2008-10#33)(2008-5#1)
chemiluminescence detector##6##2##(2008-10#6)
chemiluminescence determination of##15##3##(2008-10#15)
chemiluminescence during##2##2##(2008-10#2)
chemiluminescence emission##4##2##(2008-10#4)
chemiluminescence for the##2##3##(2008-10#2)
chemiluminescence generated during##2##3##(2008-10#2)
chemiluminescence generated##3##2##(2008-10#3)
chemiluminescence immunoassay##2##2##(2008-10#2)
chemiluminescence in the##2##3##(2008-10#2)
chemiluminescence in##4##2##(2008-10#4)
chemiluminescence intensity##10##2##(2008-10#10)
chemiluminescence method for the determination of##2##6##(2008-10#2)
chemiluminescence method for##3##3##(2008-10#3)
chemiluminescence method is proposed for the determination of##2##8##(2008-10#2)
chemiluminescence method is##3##3##(2008-10#3)
chemiluminescence method##7##2##(2008-10#7)
chemiluminescence of##6##2##(2008-10#6)
chemiluminescence reaction of##5##3##(2008-10#5)
chemiluminescence reaction##12##2##(2008-10#12)
chemiluminescence system##5##2##(2008-10#5)
chemiluminescence systems##2##2##(2008-10#2)
chemiluminescence##229##1##(1991-2#1)(1995-8#1)(1996-12#1)(2008-10#215)(2008-5#3)(2010-7#2)(2012-2#4)(2013-8#2)
chemiluminescent (CL)##4##2##(2008-10#4)
chemiluminescent and##2##2##(2008-10#2)
chemiluminescent assay##6##2##(2008-10#6)
chemiluminescent behaviour##4##2##(2008-10#4)
chemiluminescent detection##7##2##(1995-6#1)(2008-10#6)
chemiluminescent determination of##3##3##(2008-10#3)
chemiluminescent method using flow injection is described for the determination of##3##11##(2008-10#3)
chemiluminescent method##5##2##(2008-10#5)
chemiluminescent polymer##2##2##(2008-10#2)
chemiluminescent reaction##4##2##(1995-6#1)(2008-10#2)(2010-11#1)
chemiluminescent reagent##2##2##(2008-10#2)
chemiluminescent sensor##2##2##(2008-10#2)
chemiluminescent substrates##2##2##(2008-10#2)
chemiluminescent##62##1##(1992-9#1)(1995-6#2)(1997-2#2)(2008-10#54)(2010-11#3)
chemiluminogenic##3##1##(2008-10#3)
chemiluminometric##5##1##(2008-10#5)
chemiluminscence##2##1##(2008-10#2)
chemiresistor##2##1##(2008-10#2)
chemisorption at##2##2##(2008-10#2)
chemisorption of##2##2##(2008-10#2)
chemisorption##7##1##(2008-10#6)(2013-1#1)
chemist##4##1##(1994-12#2)(2008-10#2)
chemistries##8##1##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#2)
chemistry -##2##2##(2008-11#2)
chemistry and##12##2##(1994-12#3)(2008-10#5)(2008-11#3)(2008-5#1)
chemistry are##2##2##(1994-12#1)(2008-10#1)
chemistry as##4##2##(1994-12#3)(2008-10#1)
chemistry by##2##2##(2008-10#1)(2010-7#1)
chemistry education in the United States##2##6##(1994-12#2)
chemistry for##2##2##(2008-10#1)(2008-4#1)
chemistry in##6##2##(1994-12#3)(1997-7#1)(2008-10#1)(2010-7#1)
chemistry is##10##2##(1994-12#2)(1996-5#1)(2008-10#4)(2008-4#1)(2010-7#2)
chemistry of the##4##3##(2008-10#4)
chemistry of##16##2##(2008-10#10)(2008-4#1)(2010-7#2)(2013-1#3)
chemistry to##5##2##(1994-12#1)(2008-10#3)(2011-2#1)
chemistry was##2##2##(1994-12#1)(2008-10#1)
chemistry with##2##2##(2008-4#1)(2010-7#1)
chemistry##165##1##(1992-11#1)(1993-12#1)(1994-12#24)(1996-1#1)(1996-5#1)(1997-7#1)(2008-10#80)(2008-11#8)(2008-3#1)(2008-4#5)(2008-5#5)(2009-6#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-7#20)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#5)
chemists and##2##2##(2008-10#1)(2010-11#1)
chemists##12##1##(1991-12#1)(1994-12#2)(2008-10#5)(2008-11#1)(2008-5#1)(2010-11#1)(2012-3#1)
chemo- and##2##2##(1992-12#1)(2008-11#1)
chemo-##3##1##(1990-12#1)(1992-12#1)(2008-11#1)
chemo-radiotherapy##5##1##(1990-6#3)(2011-3#2)
chemoanalyses results##2##2##(2008-10#2)
chemoattractant##7##1##(1994-11#2)(1995-6#1)(2008-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
chemoembolization for##2##2##(2013-1#1)(2013-7#1)
chemoembolization##4##1##(1997-8#1)(2008-10#1)(2013-1#1)(2013-7#1)
chemoendocrine##2##1##(1994-12#1)(1997-7#1)
chemokine receptor##3##2##(2011-2#1)(2013-1#2)
chemokine receptors##2##2##(2008-9#1)(2011-2#1)
chemokine##19##1##(1994-11#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-9#1)(2009-3#1)(2010-5#2)(2010-6#1)(2011-2#2)(2013-1#3)
chemokines and##2##2##(2008-1#1)(2012-3#1)
chemokines##6##1##(2008-1#1)(2008-10#1)(2009-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
chemometric analysis##3##2##(2008-10#3)
chemometric analytical##2##2##(2008-10#2)
chemometric approach##11##2##(2008-10#11)
chemometric approaches##2##2##(2008-10#2)
chemometric calibrations##2##2##(2008-10#2)
chemometric data##2##2##(2008-10#2)
chemometric method for##2##3##(2008-10#2)
chemometric method##7##2##(2008-10#7)
chemometric methods##8##2##(2008-10#8)
chemometric models##2##2##(2008-10#2)
chemometric resolution method##2##3##(2008-10#2)
chemometric resolution##3##2##(2008-10#3)
chemometric study##5##2##(2008-10#5)
chemometric technique##3##2##(2008-10#3)
chemometric techniques##7##2##(2008-10#7)
chemometric tools##2##2##(2008-10#2)
chemometric##72##1##(2008-10#72)
chemometrical optimization##2##2##(2008-10#2)
chemometrical##6##1##(2008-10#6)
chemometrics and##2##2##(2008-10#2)
chemometrics methods##3##2##(2008-10#3)
chemometrics modelling##2##2##(2008-10#2)
chemometrics##16##1##(2008-10#16)
chemopreventative properties of##2##3##(2010-1#2)
chemoprevention of prostate cancer##2##4##(1995-9#1)(2008-6#1)
chemoprevention of##6##2##(1995-9#3)(2008-6#1)(2011-2#1)(2013-1#1)
chemoprevention##12##1##(1995-9#3)(2008-12#2)(2008-6#2)(2009-12#1)(2009-5#1)(2011-2#2)(2013-1#1)
chemopreventive##7##1##(1995-9#1)(2008-10#1)(2009-12#1)(2009-3#2)(2011-2#2)
chemoradiation##4##1##(2008-10#3)(2010-12#1)
chemoradiotherapy##6##1##(1992-3#1)(2008-10#2)(2012-3#3)
chemoresistance##6##1##(1997-5#1)(2008-11#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
chemoselective##2##1##(2008-10#2)
chemosensitivity of##2##2##(1991-2#1)(1991-8#1)
chemosensitivity##6##1##(1991-2#2)(1991-8#1)(1997-7#1)(2008-11#2)
chemosensor for##2##2##(2008-10#2)
chemosensory##8##1##(2007-12#6)(2008-11#1)(2008-5#1)
chemostat culture##3##2##(2008-7#3)
chemostat cultures##2##2##(2008-11#1)(2008-7#1)
chemostat##9##1##(2008-11#1)(2008-7#7)(2011-2#1)
chemotactic N-formylamino acids##2##3##(2008-10#2)
chemotactic for##2##2##(1992-6#2)
chemotactic peptide##3##2##(1992-6#2)(1996-2#1)
chemotactic##15##1##(1992-6#6)(1994-11#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#3)(2010-5#1)(2010-8#1)
chemotactically##2##1##(1994-11#1)(2008-8#1)
chemotaxis of##3##2##(2008-10#1)(2010-8#2)
chemotaxis##21##1##(1992-9#1)(1994-11#5)(1994-5#1)(1995-6#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-8#2)(2013-8#1)
chemotherapeutic agents in##2##3##(2009-12#2)
chemotherapeutic agents were##2##3##(1997-7#1)(2013-1#1)
chemotherapeutic agents##17##2##(1990-2#1)(1997-1#1)(1997-7#2)(2008-10#1)(2008-11#4)(2008-7#1)(2009-12#2)(2012-2#3)(2013-1#2)
chemotherapeutic drug##2##2##(1997-7#1)(2008-10#1)
chemotherapeutic drugs##6##2##(1997-7#3)(2008-11#1)(2008-5#1)(2013-1#1)
chemotherapeutic regimens##2##2##(2008-1#1)(2008-7#1)
chemotherapeutic##36##1##(1990-2#1)(1991-2#1)(1992-2#1)(1997-1#1)(1997-7#7)(2008-1#1)(2008-10#2)(2008-11#6)(2008-5#1)(2008-7#2)(2009-12#2)(2009-3#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#2)
chemotherapy agents##8##2##(2008-8#7)(2013-1#1)
chemotherapy and radiation therapy##2##4##(1993-2#1)(2008-11#1)
chemotherapy and radiation##5##3##(1992-7#1)(1993-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
chemotherapy and##19##2##(1990-6#1)(1991-8#2)(1992-7#1)(1993-2#2)(1995-6#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-8#1)(2012-3#3)(2013-1#1)
chemotherapy are##2##2##(1994-2#1)(2011-1#1)
chemotherapy by##2##2##(2008-10#1)(2011-2#1)
chemotherapy combined with##3##3##(1994-6#1)(2011-2#1)(2012-3#1)
chemotherapy dose##2##2##(2008-7#2)
chemotherapy drug##2##2##(2008-8#1)(2009-12#1)
chemotherapy followed by##2##3##(2008-10#1)(2012-12#1)
chemotherapy for ovarian##2##3##(2012-12#1)(2013-1#1)
chemotherapy for##12##2##(1990-10#1)(1993-11#1)(1994-2#2)(2007-8#1)(2008-7#2)(2009-12#1)(2012-12#1)(2013-1#3)
chemotherapy in advanced##2##3##(1993-2#1)(1994-8#1)
chemotherapy in breast cancer##4##4##(1995-8#3)(2008-7#1)
chemotherapy in the treatment of##5##5##(1992-12#2)(1993-9#1)(1997-5#1)(2012-3#1)
chemotherapy in the##6##3##(1990-6#1)(1992-12#2)(1993-9#1)(1997-5#1)(2012-3#1)
chemotherapy in##26##2##(1990-2#1)(1990-6#1)(1991-9#1)(1992-12#4)(1992-2#3)(1993-2#1)(1993-9#1)(1994-8#1)(1995-8#3)(1997-3#2)(1997-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-2#2)(2012-3#1)(2013-1#1)
chemotherapy is##6##2##(1997-5#1)(2008-11#3)(2013-1#1)(2013-8#1)
chemotherapy of##4##2##(1991-11#1)(1991-3#1)(2010-2#1)(2011-2#1)
chemotherapy or##3##2##(2008-5#1)(2008-7#1)(2010-12#1)
chemotherapy regimen##2##2##(1990-6#1)(2008-8#1)
chemotherapy regimens##4##2##(1990-12#1)(2008-7#1)(2012-3#2)
chemotherapy to##2##2##(2012-3#2)
chemotherapy was significantly##2##3##(1993-11#1)(2010-2#1)
chemotherapy was##6##2##(1991-6#1)(1993-11#1)(1997-3#1)(2008-10#1)(2010-2#1)(2012-3#1)
chemotherapy were##7##2##(1991-2#1)(1991-8#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-3#1)
chemotherapy with cisplatin##2##3##(1992-12#1)(1994-12#1)
chemotherapy with##13##2##(1991-6#1)(1992-12#2)(1994-12#2)(1995-10#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-8#1)
chemotherapy##269##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#8)(1990-8#5)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#6)(1991-8#4)(1991-9#1)(1992-12#10)(1992-2#7)(1992-3#1)(1992-7#1)(1993-11#9)(1993-2#5)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-11#1)(1997-3#6)(1997-5#2)(1997-7#3)(2006-6#1)(2007-8#2)(2008-10#20)(2008-11#14)(2008-5#1)(2008-7#33)(2008-8#11)(2009-12#3)(2009-8#1)(2010-11#2)(2010-12#5)(2010-2#5)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#19)(2013-1#23)(2013-8#8)
chemotherapy-induced apoptosis##2##2##(2008-11#2)
chemotherapy-induced nausea and vomiting##4##4##(2008-7#1)(2010-12#3)
chemotherapy-induced##11##1##(2008-11#3)(2008-7#4)(2010-11#1)(2010-12#3)
cherry disease##3##2##(2008-10#3)
cherry fruit##4##2##(2008-10#4)
cherry red##2##2##(2010-8#1)(2011-2#1)
cherry tomatoes##2##2##(2008-2#2)
cherry trees##2##2##(2008-10#2)
cherry##32##1##(2008-10#27)(2008-2#2)(2008-9#1)(2010-8#1)(2011-2#1)
cherubism##2##1##(2009-3#2)
chest MDCT##2##2##(2011-2#2)
chest X-ray##9##2##(1990-6#1)(1991-12#3)(1997-3#1)(2009-9#1)(2010-11#1)(2013-1#2)
chest pain and##8##3##(1997-4#1)(2007-8#1)(2008-7#1)(2010-1#1)(2010-10#2)(2010-5#1)(2013-1#1)
chest pain center##3##3##(2008-3#3)
chest pain in##4##3##(1991-3#1)(2008-3#2)(2013-1#1)
chest pain patients in the ED##2##6##(2012-2#2)
chest pain patients in the emergency department##2##7##(2008-3#2)
chest pain patients in the##4##5##(2008-3#2)(2012-2#2)
chest pain patients in##5##4##(2008-3#3)(2012-2#2)
chest pain patients##6##3##(2008-3#4)(2012-2#2)
chest pain resulting from diffuse esophageal spasm and related disorders##2##10##(1992-6#2)
chest pain type##3##3##(2008-3#3)
chest pain##53##2##(1991-3#1)(1992-6#3)(1996-3#4)(1997-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#16)(2008-7#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#6)(2012-3#1)(2013-1#2)
chest physicians##2##2##(1995-2#1)(2008-7#1)
chest physiotherapy##2##2##(1991-2#1)(1997-3#1)
chest radiograph and##2##3##(2007-12#1)(2008-7#1)
chest radiograph##6##2##(1997-8#2)(2007-12#1)(2008-7#1)(2012-3#1)(2013-7#1)
chest radiography in the##2##4##(1997-8#1)(2011-2#1)
chest radiography in##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
chest radiography##4##2##(1997-8#2)(2011-2#1)(2012-2#1)
chest syndrome##2##2##(2013-1#2)
chest trauma##2##2##(2012-2#2)
chest wall and##2##3##(2010-6#1)(2010-9#1)
chest wall##10##2##(1990-6#1)(1991-12#3)(2009-1#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
chest x-ray reports##2##3##(2010-12#2)
chest x-ray##6##2##(2010-12#5)(2012-3#1)
chest##125##1##(1990-5#1)(1990-6#4)(1991-12#9)(1991-2#2)(1991-3#1)(1991-9#1)(1992-6#3)(1994-2#1)(1995-2#1)(1996-3#4)(1997-3#2)(1997-4#1)(1997-8#5)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#16)(2008-5#1)(2008-7#4)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#7)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-2#11)(2012-3#4)(2013-1#8)(2013-7#1)
chestnut blight##10##2##(2008-10#9)(2008-9#1)
chestnut##16##1##(2008-10#12)(2008-5#3)(2008-9#1)
chewing and##2##2##(2008-10#1)(2013-1#1)
chewing lice##4##2##(2011-2#4)
chewing##12##1##(1996-2#3)(2008-10#1)(2010-12#1)(2011-2#4)(2013-1#3)
chez la femme enceinte##2##4##(2013-1#2)
chez le##2##2##(2013-1#2)
chez un##3##2##(2013-1#3)
chez##10##1##(2008-11#1)(2013-1#9)
chi 2##2##2##(1990-9#1)(1996-3#1)
chi square##2##2##(1990-3#2)
chi##15##1##(1990-3#2)(1990-9#1)(1991-3#2)(1996-3#1)(2008-10#9)
chi(2)##4##1##(2008-10#3)(2008-3#1)
chi-square test##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
chi-square##5##1##(2008-10#1)(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
chia seed##2##2##(2011-2#2)
chiasm##2##1##(2008-7#1)(2012-3#1)
chick and##3##2##(1993-6#1)(1996-2#2)
chick brain##2##2##(1990-7#1)(1995-11#1)
chick embryo##2##2##(1990-8#1)(2008-11#1)
chick##26##1##(1990-7#2)(1990-8#1)(1993-12#1)(1993-6#2)(1995-11#1)(1995-12#2)(1996-2#6)(1997-1#4)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
chick-pea##2##1##(2008-10#2)
chicken PTH-(1-88)##6##2##(1991-3#6)
chicken anaemia agent##3##3##(1991-3#3)
chicken anaemia virus (CAV)##2##4##(2008-5#2)
chicken anaemia virus##4##3##(2008-5#4)
chicken anaemia##7##2##(1991-3#3)(2008-5#4)
chicken and##7##2##(1990-2#1)(1991-5#1)(1993-12#2)(2008-10#1)(2008-5#1)(2010-4#1)
chicken beta-actin promoter##2##3##(2008-11#1)(2008-9#1)
chicken brain membranes##3##3##(1993-6#3)
chicken brain##5##2##(1993-6#5)
chicken carcases##2##2##(1990-9#2)
chicken eggs##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
chicken embryo fibroblasts (CEF)##2##4##(1991-5#1)(2008-11#1)
chicken embryo fibroblasts and##2##4##(1991-5#1)(1993-6#1)
chicken embryo fibroblasts##4##3##(1991-5#2)(1993-6#1)(2008-11#1)
chicken embryo##8##2##(1991-5#2)(1993-6#1)(2008-11#1)(2008-12#2)(2011-1#2)
chicken embryonic##2##2##(2008-11#1)(2008-8#1)
chicken embryos##2##2##(2008-11#1)(2008-8#1)
chicken flocks##2##2##(2008-5#2)
chicken heart##3##2##(2008-5#1)(2008-8#2)
chicken hepatic##2##2##(1990-11#1)(2010-12#1)
chicken hybridoma##3##2##(2008-11#3)
chicken intestine##2##2##(2008-12#1)(2008-5#1)
chicken is##2##2##(2008-11#1)(2008-5#1)
chicken kidney cells##3##3##(1991-3#3)
chicken liver##6##2##(1990-11#1)(1993-12#3)(2008-10#2)
chicken manure##5##2##(2008-10#5)
chicken meat##2##2##(2008-10#1)(2011-2#1)
chicken nebulin##3##2##(2008-6#3)
chicken ovarian follicles##3##3##(2008-12#3)
chicken oviduct##2##2##(1990-8#2)
chicken respiratory viruses##2##3##(2013-8#2)
chicken respiratory##5##2##(2013-8#5)
chicken##166##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-8#2)(1990-9#2)(1991-3#15)(1991-5#6)(1991-6#4)(1992-6#2)(1993-12#7)(1993-2#4)(1993-6#7)(1993-8#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#3)(1997-9#9)(2008-10#15)(2008-11#14)(2008-12#9)(2008-4#1)(2008-5#23)(2008-6#4)(2008-8#7)(2008-9#4)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-8#5)
chickenpox##2##1##(1991-12#1)(2008-11#1)
chickens were##2##2##(2008-5#2)
chickens with##2##2##(2008-5#2)
chickens##32##1##(1991-9#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#22)(2008-8#3)
chickpea (Cicer arietinum)##2##3##(2008-10#2)
chickpea (Cicer##3##2##(2008-10#3)
chickpea and faba bean##2##4##(2008-10#2)
chickpea cultivar##4##2##(2008-10#4)
chickpea cultivars##2##2##(2008-10#2)
chickpea genotypes##2##2##(2008-10#2)
chickpea plants##2##2##(2008-10#2)
chickpea seed yield##2##3##(2008-10#2)
chickpea yield##2##2##(2008-10#2)
chickpea##39##1##(2008-10#39)
chickpeas##2##1##(2008-10#2)
chicks aged##2##2##(1990-3#2)
chicks at##2##2##(2008-12#1)(2008-5#1)
chicks from nests##2##3##(2008-8#2)
chicks from##3##2##(2008-5#1)(2008-8#2)
chicks inoculated with 2##2##4##(2008-5#2)
chicks learned to avoid##2##4##(2008-6#2)
chicks that##2##2##(2008-6#2)
chicks were##4##2##(1995-9#1)(2008-5#1)(2008-6#2)
chicks##48##1##(1990-3#3)(1991-3#2)(1992-9#1)(1995-9#1)(2008-12#4)(2008-5#16)(2008-6#15)(2008-8#3)(2008-9#1)(2011-2#2)
chicory (Cichorium##2##2##(2008-10#2)
chicory##3##1##(2008-10#3)
chief cells##13##2##(1994-8#6)(1995-8#7)
chief complaint of##6##3##(2008-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
chief county medical officers react more often##2##7##(1997-8#2)
chief##40##1##(1991-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#6)(1995-1#1)(1995-2#1)(1995-6#2)(1995-8#7)(1996-2#2)(1996-3#1)(1997-1#1)(1997-8#2)(2008-10#1)(2008-12#2)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#6)
chiefly in##3##2##(1990-12#1)(1992-6#1)(2008-4#1)
chiefly##7##1##(1990-12#1)(1990-2#1)(1992-6#1)(1995-5#1)(2008-4#1)(2008-6#2)
child abuse and##2##3##(2009-5#1)(2012-2#1)
child abuse##7##2##(1992-1#1)(1995-5#1)(2008-11#1)(2009-5#1)(2009-9#2)(2012-2#1)
child age##2##2##(1995-2#1)(2009-11#1)
child aged##2##2##(2008-9#1)(2010-3#1)
child an unhealthy diet##2##4##(2010-6#2)
child and adolescent##7##3##(1992-1#2)(1993-1#1)(1993-2#1)(2008-11#2)(2013-1#1)
child and youth##2##3##(2008-11#2)
child and##22##2##(1992-1#2)(1993-1#1)(1993-2#1)(1995-1#1)(1995-5#3)(2008-11#6)(2008-12#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
child behavior problems##2##3##(1995-2#1)(2009-11#1)
child behavior##3##2##(1995-2#2)(2009-11#1)
child care##9##2##(1990-2#1)(1995-5#2)(2008-11#1)(2009-10#1)(2009-4#2)(2012-3#2)
child development##13##2##(1995-1#1)(1996-9#3)(2008-11#4)(2009-9#1)(2011-1#2)(2012-2#1)(2013-8#1)
child distress##2##2##(1995-2#2)
child due to accidental oral ingestion##2##6##(1995-11#2)
child during##2##2##(1993-3#1)(2012-2#1)
child from##5##2##(1991-6#1)(1995-5#2)(2010-7#1)(2012-2#1)
child gender##2##2##(2009-11#1)(2010-6#1)
child has##2##2##(2008-11#1)(2010-3#1)
child health care##2##3##(1995-1#1)(2012-3#1)
child health input##2##3##(2008-11#2)
child health##19##2##(1991-11#1)(1991-3#1)(1994-6#2)(1995-1#2)(1995-12#2)(1996-12#1)(1997-2#1)(2008-11#7)(2009-6#1)(2012-3#1)
child in##4##2##(1995-5#2)(2008-11#1)(2010-6#1)
child is##7##2##(1993-12#1)(1995-5#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
child laborers##3##2##(1997-6#2)(2009-10#1)
child molester##2##2##(1996-5#2)
child obesity##2##2##(2012-2#1)(2013-8#1)
child on##2##2##(2008-11#2)
child or##2##2##(1995-2#1)(2011-2#1)
child perceptions##2##2##(2008-12#2)
child poverty by 50% by##2##5##(2008-11#2)
child poverty by##3##3##(2008-11#3)
child poverty##12##2##(2008-11#12)
child presented with##3##3##(2008-10#2)(2010-11#1)
child presenting with##2##3##(2008-11#1)(2011-2#1)
child presents with##2##3##(2008-10#1)(2008-11#1)
child psychiatric##2##2##(1991-2#1)(1993-1#1)
child psychiatry##5##2##(1996-6#1)(2008-11#4)
child social development and behavior##2##5##(2009-9#2)
child social development##3##3##(2009-9#3)
child to##6##2##(1994-3#1)(1995-5#1)(1996-2#2)(2010-9#1)(2011-2#1)
child under the age of##2##5##(2009-5#1)(2010-6#1)
child was##7##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-6#1)(2012-3#1)
child who is##2##3##(2008-9#1)(2010-9#1)
child who presented with##2##4##(2009-9#1)(2010-5#1)
child who presents with##4##4##(2006-5#3)(2010-6#1)
child who presents##6##3##(2006-5#5)(2010-6#1)
child who was treated surgically##2##5##(2011-2#1)(2013-1#1)
child who##12##2##(2006-5#5)(2008-9#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
child with a##4##3##(2008-10#1)(2008-9#2)(2010-1#1)
child with severe##2##3##(2008-10#1)(2008-9#1)
child with##30##2##(1992-6#1)(1993-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#6)(2010-1#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-2#1)(2012-12#1)(2012-3#1)
child##352##1##(1990-12#8)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#3)(1992-1#4)(1992-12#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#2)(1994-12#1)(1994-3#1)(1994-6#4)(1995-1#7)(1995-11#2)(1995-12#3)(1995-2#7)(1995-5#28)(1996-11#2)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-9#3)(1997-2#4)(1997-3#1)(1997-6#2)(1997-8#2)(2006-5#5)(2007-12#1)(2007-8#1)(2008-10#25)(2008-11#56)(2008-12#7)(2008-2#2)(2008-7#2)(2008-8#1)(2008-9#22)(2009-10#5)(2009-11#6)(2009-12#1)(2009-4#2)(2009-5#5)(2009-6#3)(2009-9#9)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#11)(2010-7#4)(2010-8#4)(2010-9#10)(2011-1#5)(2011-2#14)(2012-12#4)(2012-2#13)(2012-3#6)(2013-1#10)(2013-8#3)
child's diet##2##2##(2010-6#2)
child's medical##2##2##(1992-3#1)(1995-1#1)
child's##49##1##(1992-1#2)(1992-2#3)(1992-3#1)(1993-12#1)(1993-2#4)(1994-3#1)(1995-1#5)(1995-12#1)(1997-6#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-9#1)(2009-6#1)(2009-9#3)(2010-6#2)(2010-9#5)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)
child-rearing##2##1##(1995-1#1)(2008-11#1)
child]##2##1##(1993-5#1)(1996-9#1)
childbearing age##3##2##(1991-1#1)(2009-8#1)(2013-1#1)
childbearing women as well as##2##5##(1992-12#2)
childbearing women##4##2##(1992-12#3)(2013-1#1)
childbearing##15##1##(1990-2#1)(1991-1#1)(1992-12#3)(1995-1#1)(1997-3#1)(2007-8#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-8#1)(2013-1#3)
childbirth and##2##2##(2009-10#1)(2010-6#1)
childbirth as##2##2##(1995-1#2)
childbirth##10##1##(1993-3#1)(1995-1#4)(1995-12#1)(1995-6#1)(1997-1#1)(2009-10#1)(2010-6#1)
childhood acute lymphoblastic##2##3##(2008-11#1)(2010-11#1)
childhood acute##4##2##(2008-11#1)(2010-11#1)(2011-2#2)
childhood and adolescence##7##3##(1995-2#1)(1996-11#1)(2008-11#1)(2009-12#2)(2011-2#2)
childhood and adolescent##2##3##(2008-11#1)(2012-2#1)
childhood and adult life##2##4##(2008-10#1)(2009-8#1)
childhood and adult##3##3##(1990-12#1)(2008-10#1)(2009-8#1)
childhood and##23##2##(1990-12#1)(1990-6#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-12#3)(2009-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
childhood are##3##2##(2008-11#2)(2013-1#1)
childhood asthma##5##2##(2008-10#1)(2008-11#3)(2012-2#1)
childhood atopic dermatitis##2##3##(2013-1#2)
childhood diseases##2##2##(2008-8#1)(2008-9#1)
childhood immunization##3##2##(1995-5#1)(1996-12#2)
childhood immunizations##3##2##(1996-12#3)
childhood in##3##2##(1992-11#1)(2011-1#1)(2012-2#1)
childhood is##6##2##(1991-6#1)(1996-11#1)(2008-11#1)(2011-2#2)(2012-3#1)
childhood leukemia##2##2##(1991-3#2)
childhood malnutrition in Yemen##3##4##(2010-6#3)
childhood malnutrition in##4##3##(2010-6#4)
childhood malnutrition##5##2##(2010-6#5)
childhood obesity prevention##2##3##(2012-2#2)
childhood obesity##10##2##(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#7)
childhood trauma##2##2##(2013-8#2)
childhood##174##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-2#3)(1991-3#4)(1991-6#1)(1991-8#2)(1992-11#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1995-12#2)(1995-2#2)(1995-5#6)(1996-11#3)(1996-12#5)(1996-3#1)(1997-7#1)(1997-8#2)(2007-8#1)(2008-10#10)(2008-11#19)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#3)(2009-8#2)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#7)(2010-8#1)(2011-1#8)(2011-2#17)(2012-12#2)(2012-2#12)(2012-3#5)(2013-1#9)(2013-8#4)
childhood-onset##2##1##(2012-3#1)(2013-1#1)
childhood]##5##1##(1990-9#1)(1991-3#1)(1992-3#1)(1994-6#1)(2013-8#1)
childless##4##1##(1996-9#2)(2009-10#1)(2011-2#1)
children (aged##2##2##(2008-11#1)(2008-9#1)
children (mean age##2##3##(2010-1#1)(2013-1#1)
children -##3##2##(2008-11#3)
children after##5##2##(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)
children aged 2##3##3##(1995-3#1)(2008-9#1)(2012-2#1)
children aged from##2##3##(1991-9#1)(2010-11#1)
children aged less##2##3##(2010-6#1)(2012-12#1)
children aged##14##2##(1991-9#1)(1995-3#1)(1995-5#1)(2008-9#3)(2010-11#1)(2010-6#3)(2012-12#2)(2012-2#2)
children ages##2##2##(1991-8#2)
children and adolescences##2##3##(2012-3#2)
children and adolescents are##3##4##(2008-11#1)(2008-3#1)(2009-6#1)
children and adolescents in the##3##5##(2008-3#1)(2010-11#1)(2011-2#1)
children and adolescents in##5##4##(2008-3#1)(2009-7#1)(2010-11#1)(2011-2#2)
children and adolescents who##2##4##(2009-9#1)(2011-2#1)
children and adolescents with##7##4##(1995-12#1)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
children and adolescents##56##3##(1990-6#1)(1991-2#5)(1992-1#1)(1993-1#1)(1994-8#1)(1995-12#2)(1997-8#1)(2008-1#1)(2008-11#7)(2008-3#2)(2008-4#1)(2008-8#4)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#4)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)
children and adults with##4##4##(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)
children and adults##18##3##(1992-2#1)(1995-5#1)(1996-2#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2012-2#1)(2013-8#1)
children and child##2##3##(1997-6#1)(2008-11#1)
children and families##3##3##(1992-2#1)(1992-3#1)(2010-4#1)
children and its##3##3##(1995-5#1)(2011-2#1)(2012-3#1)
children and lowest in##2##4##(2009-7#2)
children and support##2##3##(2008-11#1)(2012-3#1)
children and the##3##3##(2010-5#1)(2011-2#1)(2013-1#1)
children and their families##10##4##(1994-1#1)(1995-3#2)(2008-11#5)(2010-12#1)(2011-1#1)
children and their parents##2##4##(1991-2#1)(2011-2#1)
children and their##15##3##(1991-2#1)(1992-2#1)(1994-1#1)(1995-3#2)(2008-11#6)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
children and to##4##3##(1990-12#1)(2008-11#2)(2010-5#1)
children and young adults##4##4##(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
children and young##5##3##(1991-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
children and##150##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#7)(1991-6#2)(1992-1#1)(1992-2#3)(1992-3#1)(1993-1#1)(1994-1#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#25)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#13)(2011-5#1)(2012-12#2)(2012-2#5)(2012-3#10)(2013-1#5)(2013-8#2)
children are born##2##3##(1990-6#1)(2008-11#1)
children are##21##2##(1990-6#1)(1994-2#1)(1994-6#2)(1995-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-11#4)(2008-12#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)
children as a##2##3##(2010-10#1)(2012-12#1)
children as##4##2##(1995-1#1)(1995-5#1)(2010-10#1)(2012-12#1)
children at risk for##4##4##(1994-1#1)(1996-12#1)(2009-7#1)(2009-9#1)
children at risk##6##3##(1991-12#1)(1994-1#1)(1996-12#1)(2008-12#1)(2009-7#1)(2009-9#1)
children at##12##2##(1991-12#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
children attending##2##2##(1991-8#1)(2011-2#1)
children below##3##2##(2008-1#1)(2008-12#1)(2008-5#1)
children born##4##2##(1991-11#1)(1994-3#1)(1996-9#1)(2013-1#1)
children but##3##2##(1990-5#1)(1994-2#1)(1995-8#1)
children can be##2##3##(2010-6#1)(2012-2#1)
children can##4##2##(2008-11#1)(2008-9#1)(2010-6#1)(2012-2#1)
children completed##4##2##(2008-3#1)(2009-4#1)(2010-7#1)(2010-8#1)
children demonstrated##2##2##(2012-2#2)
children did not##2##3##(2008-11#1)(2012-2#1)
children die each day from##2##5##(1990-2#2)
children die each day##4##4##(1990-2#4)
children do not##3##3##(2008-12#1)(2008-9#1)(2012-2#1)
children during the##2##3##(2010-2#1)(2013-1#1)
children during##4##2##(1992-2#1)(2010-2#1)(2012-3#1)(2013-1#1)
children eat a healthy diet##2##5##(2011-1#2)
children exhibited##3##2##(1991-8#1)(2008-12#2)
children for##2##2##(1995-1#1)(2010-10#1)
children from the##2##3##(2008-3#1)(2013-1#1)
children from##10##2##(1990-6#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-6#1)(2012-12#1)(2013-1#2)
children had been##2##3##(1997-6#1)(2008-9#1)
children had##6##2##(1994-6#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-7#1)
children has been##2##3##(2007-12#1)(2008-11#1)
children has##4##2##(1994-12#1)(2007-12#1)(2008-11#1)(2010-9#1)
children have been##2##3##(1991-3#1)(1993-12#1)
children have##4##2##(1991-3#1)(1993-12#1)(2008-11#2)
children hospitalized in##3##3##(1992-2#2)(2013-1#1)
children hospitalized##4##2##(1992-2#2)(2009-12#1)(2013-1#1)
children implanted with the Nucleus##2##5##(2008-9#2)
children implanted##3##2##(2008-9#3)
children in a##7##3##(1994-12#1)(2008-11#1)(2011-2#3)(2012-3#1)(2013-8#1)
children in the##11##3##(1994-9#1)(1995-3#1)(1996-11#1)(2008-3#2)(2008-9#2)(2010-11#1)(2010-6#1)(2012-12#1)(2012-2#1)
children in these##2##3##(1996-12#1)(2011-2#1)
children in this age group were##2##6##(1991-8#1)(1995-12#1)
children in this age group##3##5##(1991-8#1)(1995-12#1)(1997-1#1)
children in this study##2##4##(1992-2#1)(2008-10#1)
children in this##5##3##(1991-8#1)(1992-2#1)(1995-12#1)(1997-1#1)(2008-10#1)
children in urban poverty##2##4##(2013-1#2)
children in urban##3##3##(2008-10#1)(2013-1#2)
children in##66##2##(1990-11#1)(1990-2#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#4)(2008-3#2)(2008-6#1)(2008-9#3)(2009-9#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
children interrogation##2##2##(2011-2#2)
children is a##2##3##(2008-9#1)(2011-2#1)
children is an##2##3##(2008-12#1)(2011-2#1)
children is##12##2##(1991-12#1)(1994-8#1)(2008-12#2)(2008-9#2)(2009-9#1)(2010-6#1)(2011-2#3)(2013-1#1)
children less than##3##3##(1995-8#1)(1996-11#1)(2013-8#1)
children living in##4##3##(2008-11#2)(2011-2#1)(2013-8#1)
children may be##2##3##(1996-12#1)(2010-7#1)
children may##6##2##(1996-12#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#2)
children more##2##2##(1991-11#1)(2011-2#1)
children not##2##2##(1992-2#1)(2012-2#1)
children of these##2##3##(2008-9#1)(2010-8#1)
children of##16##2##(1991-11#1)(1994-6#1)(2008-11#5)(2008-9#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
children on##5##2##(2008-11#1)(2009-7#1)(2009-9#1)(2012-2#1)(2013-7#1)
children over##4##2##(1990-12#1)(1995-12#1)(1996-2#1)(2012-12#1)
children participated in##3##3##(2010-11#1)(2010-7#1)(2010-9#1)
children presenting with##2##3##(2008-11#1)(2013-7#1)
children presenting##3##2##(2008-11#2)(2013-7#1)
children protection##2##2##(2011-2#2)
children receiving##5##2##(1996-1#1)(2007-11#2)(2008-10#1)(2012-2#1)
children sequentially##2##2##(2008-9#1)(2012-2#1)
children should be##2##3##(1990-2#1)(2013-1#1)
children than in##2##3##(1994-12#1)(2011-2#1)
children the##3##2##(1996-11#1)(2008-11#1)(2011-1#1)
children they##2##2##(2008-10#1)(2009-9#1)
children to##14##2##(1991-2#3)(1994-9#1)(1995-5#1)(2008-4#1)(2008-8#1)(2008-9#4)(2009-10#1)(2012-2#1)(2013-1#1)
children treated with inhaled##3##4##(2007-11#3)
children treated with##7##3##(2007-11#5)(2010-1#1)(2010-12#1)
children treated##8##2##(1996-11#1)(2007-11#5)(2010-1#1)(2010-12#1)
children under 10 years of age##2##6##(2008-10#1)(2012-12#1)
children under five years##2##4##(2008-1#2)
children under five##3##3##(2008-1#2)(2008-2#1)
children under##15##2##(1990-12#1)(1994-9#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
children undergoing treatment##2##3##(1990-8#1)(2010-7#1)
children undergoing##5##2##(1990-8#1)(1991-2#1)(2008-9#1)(2010-7#1)(2011-2#1)
children used a##2##3##(2008-9#2)
children used both implants##2##4##(2012-2#2)
children used##5##2##(1994-6#1)(2008-9#2)(2012-2#2)
children using cochlear implants##4##4##(2008-9#4)
children using the Nucleus 24 cochlear implant##2##7##(2008-9#2)
children using the Nucleus##3##4##(2008-9#3)
children using##9##2##(2008-10#1)(2008-9#8)
children was##7##2##(1991-11#1)(1994-3#1)(1995-12#1)(2008-2#1)(2012-12#1)(2013-8#2)
children were##30##2##(1990-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1997-6#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-9#3)(2009-10#2)(2010-6#3)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
children who are##6##3##(1992-2#1)(1997-8#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#1)
children who clutter##5##3##(2011-1#5)
children who did not receive##2##5##(1994-6#1)(1995-1#1)
children who did##3##3##(1994-6#1)(1995-1#1)(2008-2#1)
children who had received cochlear implants##2##6##(2008-9#2)
children who had##4##3##(1994-6#1)(2008-9#2)(2013-7#1)
children who have complex and continuing##2##6##(2008-11#2)
children who have##4##3##(1994-9#1)(2008-11#2)(2008-2#1)
children who receive##3##3##(1994-6#2)(2010-4#1)
children who received##6##3##(1994-6#1)(2008-11#3)(2010-4#1)(2011-1#1)
children who stutter##2##3##(2008-2#2)
children who were##5##3##(1994-1#2)(1994-6#1)(1995-1#1)(2008-12#1)
children who##53##2##(1991-8#1)(1992-1#1)(1992-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-6#6)(1994-9#1)(1995-1#3)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-2#5)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#2)(2010-4#2)(2011-1#6)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
children whose parents##3##3##(1994-6#1)(2008-12#1)(2010-11#1)
children whose##5##2##(1994-6#1)(2008-12#2)(2010-11#1)(2011-2#1)
children with ADHD and##2##4##(2010-8#1)(2012-2#1)
children with ADHD##5##3##(1996-6#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
children with AIDS##5##3##(1995-6#2)(2012-3#3)
children with CAS##2##3##(2011-1#2)
children with CDGP##4##3##(2011-1#4)
children with English as an additional language##2##7##(2008-2#2)
children with IDDM##2##3##(1995-3#2)
children with SLI##3##3##(2011-1#3)
children with SLOS##2##3##(2010-7#2)
children with Waardenburg syndrome##3##4##(2008-9#3)
children with a##7##3##(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-7#1)(2013-7#1)
children with acute respiratory##3##4##(2013-8#3)
children with acute##5##3##(1994-5#1)(2008-1#1)(2013-8#3)
children with asthma##6##3##(1996-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2010-9#2)
children with cancer##8##3##(1995-2#1)(2008-11#1)(2008-5#1)(2010-7#1)(2010-9#2)(2012-2#2)
children with chronic illness##2##4##(1992-2#1)(1997-2#1)
children with chronic##5##3##(1992-2#1)(1997-2#3)(2011-2#1)
children with classic CAH##2##4##(2010-2#2)
children with classic##3##3##(2010-2#3)
children with cochlear implants##7##4##(2008-9#7)
children with complex##3##3##(2008-11#3)
children with congenital heart disease##2##5##(1990-11#1)(2008-11#1)
children with congenital##3##3##(1990-11#1)(1990-12#1)(2008-11#1)
children with developmental disorders##2##4##(1995-1#2)
children with developmental##3##3##(1995-1#2)(2012-2#1)
children with diabetes and##2##4##(1995-2#1)(2010-9#1)
children with diabetes mellitus##2##4##(1994-6#2)
children with diabetes##8##3##(1994-6#3)(1995-2#3)(1995-3#1)(2010-9#1)
children with disabilities##6##3##(1994-1#2)(1995-1#1)(1995-12#1)(1996-1#2)
children with failed##2##3##(2008-10#2)
children with intestinal malrotation##2##4##(2012-3#2)
children with learning difficulties##4##4##(2008-11#4)
children with learning disabilities##4##4##(2011-1#4)
children with learning##8##3##(2008-11#4)(2011-1#4)
children with mental retardation##2##4##(1993-3#2)
children with mild##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
children with moderate or severe asthma##2##6##(2008-11#2)
children with moderate##4##3##(1993-3#2)(2008-11#2)
children with no##2##3##(1995-1#1)(1996-1#1)
children with profound hearing loss and severe language delay##2##9##(2008-9#2)
children with recurrent##2##3##(2008-1#1)(2013-7#1)
children with respiratory##2##3##(1994-6#1)(1997-1#1)
children with special health care needs##6##6##(1995-12#4)(1995-3#2)
children with special health##7##4##(1994-3#1)(1995-12#4)(1995-3#2)
children with special needs##2##4##(1997-2#2)
children with special##9##3##(1994-3#1)(1995-12#4)(1995-3#2)(1997-2#2)
children with suspected##2##3##(1990-11#1)(2013-1#1)
children with##228##2##(1990-11#2)(1990-12#3)(1991-11#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#3)(1993-3#7)(1994-1#2)(1994-3#4)(1994-5#1)(1994-6#4)(1995-1#5)(1995-12#5)(1995-2#4)(1995-3#5)(1995-6#2)(1996-1#4)(1996-11#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#7)(2008-10#16)(2008-11#18)(2008-12#7)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#18)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#3)(2010-7#4)(2010-8#1)(2010-9#7)(2011-1#23)(2011-2#7)(2011-5#1)(2012-2#8)(2012-3#6)(2013-1#9)(2013-7#3)(2013-8#3)
children without##4##2##(1990-6#1)(1994-12#1)(1996-6#1)(2008-11#1)
children working in the##3##4##(2012-12#3)
children younger than three##2##4##(2008-11#2)
children##1316##1##(1990-11#7)(1990-12#11)(1990-2#11)(1990-5#1)(1990-6#5)(1990-8#2)(1990-9#1)(1991-11#5)(1991-12#9)(1991-2#16)(1991-3#1)(1991-6#14)(1991-8#7)(1991-9#4)(1992-1#2)(1992-11#2)(1992-2#14)(1992-3#6)(1992-5#1)(1992-7#1)(1993-1#2)(1993-12#1)(1993-2#4)(1993-3#11)(1993-9#1)(1994-1#10)(1994-12#13)(1994-2#4)(1994-3#9)(1994-5#1)(1994-6#30)(1994-8#2)(1994-9#6)(1995-1#20)(1995-12#15)(1995-2#11)(1995-3#13)(1995-5#19)(1995-6#2)(1995-8#5)(1996-1#11)(1996-11#8)(1996-12#11)(1996-2#6)(1996-3#4)(1996-6#3)(1996-8#1)(1996-9#5)(1997-1#6)(1997-2#11)(1997-3#3)(1997-4#3)(1997-6#5)(1997-8#9)(2007-11#10)(2007-12#5)(2008-1#24)(2008-10#68)(2008-11#138)(2008-12#46)(2008-2#12)(2008-3#8)(2008-4#9)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#8)(2008-9#88)(2009-1#1)(2009-10#9)(2009-11#1)(2009-12#8)(2009-3#11)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#14)(2009-8#2)(2009-9#14)(2010-1#6)(2010-10#5)(2010-11#12)(2010-12#4)(2010-2#5)(2010-4#3)(2010-5#6)(2010-6#15)(2010-7#19)(2010-8#6)(2010-9#16)(2011-1#46)(2011-2#86)(2011-5#2)(2012-12#29)(2012-2#60)(2012-3#36)(2013-1#50)(2013-7#9)(2013-8#21)
children's behavior##9##2##(1991-2#2)(1994-6#5)(2010-11#2)
children's early##3##2##(2008-11#1)(2011-2#2)
children's health##5##2##(1991-2#1)(2008-11#3)(2012-12#1)
children's healthy##2##2##(2010-5#1)(2011-2#1)
children's hospital##5##2##(1991-1#1)(1992-3#1)(2008-11#2)(2011-1#1)
children's mental health##5##3##(1993-1#1)(1994-3#1)(2010-12#3)
children's nursing##4##2##(2008-11#4)
children's perceptions of the classroom##2##5##(2008-12#2)
children's perceptions of##3##3##(2008-12#3)
children's perceptions##7##2##(2008-12#6)(2009-4#1)
children's recurrent pain##2##3##(2008-11#2)
children's social competence##3##3##(2010-11#3)
children's social##4##2##(2009-9#1)(2010-11#3)
children's speech##3##2##(2008-9#2)(2011-1#1)
children's teeth in##2##3##(1991-6#2)
children's temperament to##2##3##(2009-10#2)
children's usual##3##2##(1991-2#3)
children's well-being##3##2##(1995-1#2)(2010-1#1)
children's##119##1##(1990-2#3)(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#7)(1991-6#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-3#5)(1994-6#6)(1995-1#6)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-11#16)(2008-12#9)(2008-4#2)(2008-6#1)(2008-9#3)(2009-10#2)(2009-4#2)(2009-9#2)(2010-1#3)(2010-11#7)(2010-12#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
children) treated with##2##3##(2008-1#2)
children)##8##1##(2008-1#2)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
children?##7##1##(2008-11#5)(2008-9#1)(2012-2#1)
children]##16##1##(1990-11#2)(1990-6#1)(1991-2#2)(1991-6#1)(1992-5#1)(1994-6#1)(1995-5#2)(1996-11#2)(1996-6#1)(2008-11#1)(2009-5#1)(2012-3#1)
chile pepper##3##2##(2008-10#3)
chile##4##1##(2008-10#3)(2008-3#1)
chili powder##3##2##(2008-10#3)
chili##4##1##(2008-10#4)
chill accumulation##4##2##(2012-4#3)(2012-8#1)
chill##11##1##(1992-11#1)(2008-10#1)(2012-4#4)(2012-8#4)(2013-8#1)
chilled##3##1##(2008-10#2)(2011-2#1)
chilling temperatures##3##2##(2012-4#1)(2012-8#2)
chilling##12##1##(2008-5#1)(2012-4#8)(2012-8#3)
chills##2##1##(2007-12#2)
chilopods##2##1##(2007-12#2)
chimera##10##1##(1990-7#1)(1994-11#1)(1997-3#1)(2008-11#3)(2008-8#2)(2013-1#2)
chimeras were##2##2##(1997-8#1)(2009-6#1)
chimeras##10##1##(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#2)(2009-6#2)
chimeric antibody##3##2##(1994-12#1)(2008-11#2)
chimeric constructs##3##2##(1992-6#1)(2008-10#2)
chimeric gene##6##2##(1991-10#1)(1993-12#1)(1993-3#1)(1994-5#2)(2009-10#1)
chimeric mice##2##2##(2008-8#2)
chimeric virus##3##2##(1997-3#1)(2008-11#2)
chimeric##60##1##(1990-8#2)(1991-10#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#2)(1997-2#4)(1997-3#5)(1997-8#1)(1997-9#2)(2008-10#8)(2008-11#12)(2008-4#2)(2008-8#5)(2008-9#5)(2009-10#1)(2010-12#1)(2011-2#2)
chimiothérapie##2##1##(2013-1#2)
chimpanzee facial##2##2##(2008-11#2)
chimpanzee##6##1##(1991-12#1)(1993-8#1)(1997-6#1)(2008-11#2)(2010-5#1)
chimpanzees##3##1##(2008-11#2)(2013-1#1)
chin##11##1##(1992-12#1)(2008-5#5)(2011-2#1)(2012-2#1)(2012-3#3)
chinaï##3##1##(2008-10#3)
chinense##7##1##(2008-10#3)(2008-11#2)(2012-3#2)
chinensis (Lour##3##2##(2008-10#3)
chinensis##5##1##(2008-10#3)(2008-11#2)
chinese hamster ovary cells##2##4##(2008-11#1)(2011-2#1)
chinese hamster ovary##4##3##(1992-8#1)(2008-11#2)(2011-2#1)
chinese##6##1##(1992-8#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)
chip allows##2##2##(2008-10#1)(2008-12#1)
chip by##2##2##(2008-10#2)
chip design##2##2##(2008-4#1)(2012-3#1)
chip for##4##2##(2008-10#4)
chip has##2##2##(2008-10#1)(2008-5#1)
chip using a##2##3##(2008-10#2)
chip was used to##2##4##(2008-10#2)
chip was##6##2##(2008-10#4)(2008-12#2)
chip were##3##2##(2008-10#1)(2008-12#1)(2009-10#1)
chip with##3##2##(2008-10#2)(2013-1#1)
chip##59##1##(2008-10#43)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2012-3#2)(2013-1#1)
chips##13##1##(1994-1#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)
chiral HPLC##2##2##(1997-2#2)
chiral amino acids##3##3##(2008-10#3)
chiral center##2##2##(1997-2#1)(2008-10#1)
chiral discrimination##4##2##(2008-10#4)
chiral drugs##2##2##(1990-6#1)(2008-10#1)
chiral polyamines are##3##3##(2009-10#3)
chiral polyamines##6##2##(2009-10#6)
chiral recognition is##2##3##(1994-5#1)(2008-10#1)
chiral recognition##5##2##(1994-5#1)(2008-10#4)
chiral resolution##3##2##(2008-10#3)
chiral selector in##2##3##(2008-10#2)
chiral selector##13##2##(2008-10#13)
chiral separation of##2##3##(2008-10#2)
chiral separation##4##2##(2008-10#4)
chiral solvating agent##2##3##(2008-10#2)
chiral stationary phase (CSP) in##2##5##(2008-10#2)
chiral stationary phase (CSP)##4##4##(2008-10#4)
chiral stationary phase by##2##4##(2008-10#2)
chiral stationary phase##13##3##(2008-10#13)
chiral stationary phases##4##3##(2008-10#4)
chiral stationary##17##2##(2008-10#17)
chiral##99##1##(1990-6#1)(1992-11#1)(1994-5#1)(1994-8#3)(1995-6#4)(1996-5#3)(1997-2#5)(2008-10#68)(2009-10#9)(2010-6#1)(2011-1#1)(2011-2#2)
chirality##4##1##(2008-10#3)(2012-2#1)
chiropractic##2##1##(2008-12#2)
chirp of##2##2##(2008-3#2)
chirp##6##1##(2008-2#3)(2008-3#3)
chirped##3##1##(2008-3#3)
chirped-pulse amplification##2##2##(2008-2#2)
chirps##3##1##(2008-3#3)
chirurgicale##2##1##(2011-2#1)(2013-1#1)
chirurgie##3##1##(2011-2#3)
chit33 gene##3##2##(2008-10#3)
chitin affinity chromatography##2##3##(2008-10#2)
chitin in the##3##3##(2008-10#3)
chitin was##2##2##(2008-10#2)
chitin##34##1##(1992-12#1)(1992-8#1)(2008-10#30)(2011-2#2)
chitinase activity of##2##3##(2008-10#2)
chitinase activity##9##2##(2008-10#9)
chitinase and beta-1##6##3##(2008-10#6)
chitinase and##8##2##(2008-10#8)
chitinase##36##1##(2008-10#36)
chitinase-deficient##2##1##(2008-10#2)
chitinases and beta-1##3##3##(2008-10#3)
chitinases##10##1##(2008-10#10)
chitinolytic and##2##2##(2008-10#2)
chitinolytic enzymes##2##2##(2008-10#2)
chitinolytic fractions##2##2##(2008-10#2)
chitinolytic##8##1##(2008-10#7)(2008-5#1)
chitobiase gene##6##2##(1992-10#6)
chitobiase##13##1##(1992-10#13)
chitobiase-deficient##2##1##(1992-10#2)
chitosan against##2##2##(2008-5#2)
chitosan and##7##2##(2008-10#5)(2008-5#2)
chitosan are##2##2##(2008-10#2)
chitosan as##2##2##(2008-10#1)(2008-5#1)
chitosan for##2##2##(2008-10#2)
chitosan membranes##3##2##(2008-10#3)
chitosan solution##2##2##(2008-10#2)
chitosan to##2##2##(2008-10#1)(2008-5#1)
chitosan##68##1##(2008-10#49)(2008-5#14)(2009-3#3)(2009-7#2)
chitosan-entrapped carbon paste electrode (CCPE)##2##5##(2008-10#2)
chitosan-entrapped carbon paste electrode##3##4##(2008-10#3)
chitosan-modified##2##1##(2008-10#2)
chitosan-starch as##2##2##(2008-5#2)
chitwoodi and M##13##3##(2008-10#13)
chitwoodi or M##2##3##(2008-10#2)
chitwoodi##27##1##(2008-10#27)
chl##2##1##(1990-5#2)
chlamydial infections##2##2##(1995-12#1)(2009-8#1)
chlamydial##8##1##(1990-5#1)(1995-12#1)(2009-8#2)(2011-2#4)
chlamydiosis##2##1##(1992-2#1)(2008-5#1)
chlamydospore##3##1##(2008-10#3)
chlamydospores g(1) of soil##3##4##(2008-10#3)
chlamydospores of##3##2##(2008-10#3)
chlamydospores per gram of soil##4##5##(2008-10#4)
chlamydospores per gram of##6##4##(2008-10#6)
chlamydospores per##7##2##(2008-10#7)
chlamydospores that##2##2##(2008-10#2)
chlamydospores##23##1##(2008-10#22)(2010-3#1)
chloral hydrate##3##2##(1994-2#1)(1997-2#1)(2008-10#1)
chlorambucil##5##1##(2008-11#5)
chloramine-T (CAT)##2##2##(2008-10#2)
chloramine-T##4##1##(2008-10#4)
chloramphenicol acetyl transferase##2##3##(1994-11#1)(1997-7#1)
chloramphenicol acetyltransferase (CAT) gene##3##4##(1992-6#1)(1993-8#1)(1997-8#1)
chloramphenicol acetyltransferase (CAT)##6##3##(1992-6#1)(1993-8#1)(1995-2#1)(1997-8#1)(2008-4#1)(2008-7#1)
chloramphenicol acetyltransferase reporter##2##3##(1995-2#1)(1995-6#1)
chloramphenicol acetyltransferase##10##2##(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-2#2)(1995-6#1)(1997-8#1)(2008-4#1)(2008-7#1)
chloramphenicol to##2##2##(2008-10#2)
chloramphenicol##34##1##(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-2#2)(1995-6#2)(1996-8#1)(1997-7#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
chloranilate complex##3##2##(2008-10#3)
chloranilate##4##1##(2008-10#4)
chlorate in##5##2##(2008-10#5)
chlorate##26##1##(2008-10#26)
chlorate-resistant isolates##2##2##(2008-10#2)
chlorate-resistant sectors##2##2##(2008-10#2)
chlorate-resistant##7##1##(2008-10#7)
chlordimeform##3##1##(2008-10#3)
chlorhexidine##4##1##(2011-2#1)(2012-3#1)(2013-1#2)
chloride (BC)##2##2##(2008-10#2)
chloride (DDPC)##2##2##(2008-10#2)
chloride (INT)##2##2##(2008-10#2)
chloride (PVC)##9##2##(2008-10#9)
chloride and nitrate##3##3##(2008-10#3)
chloride and phosphate##3##3##(2008-10#3)
chloride and##30##2##(1990-5#1)(1994-8#1)(1995-8#1)(1996-6#1)(2008-10#24)(2008-11#1)(2008-7#1)
chloride anions##2##2##(2008-10#2)
chloride as a##3##3##(2008-10#3)
chloride as##7##2##(2008-10#7)
chloride at##3##2##(2008-10#3)
chloride buffer##4##2##(2008-10#4)
chloride channel blocker##2##3##(1990-5#1)(2008-9#1)
chloride channel##3##2##(1990-5#1)(2008-9#1)(2011-3#1)
chloride complex##2##2##(2008-10#2)
chloride concentration was##2##3##(2008-10#2)
chloride concentration##9##2##(2008-10#8)(2011-2#1)
chloride current##3##2##(1995-11#1)(2011-3#2)
chloride currents##3##2##(1995-11#2)(1995-2#1)
chloride determination by hydride generation gas phase molecular absorption spectrometry##2##10##(2008-10#2)
chloride determination##7##2##(2008-10#7)
chloride for##2##2##(2008-10#2)
chloride in a##2##3##(2008-10#2)
chloride in cigarettes##2##3##(2008-10#2)
chloride in the##5##3##(2008-10#3)(2008-7#1)(2011-2#1)
chloride in##21##2##(1992-11#1)(2008-10#17)(2008-7#2)(2011-2#1)
chloride into##2##2##(2008-10#2)
chloride ion##12##2##(1995-12#1)(2008-10#10)(2011-3#1)
chloride ions in##2##3##(2008-10#2)
chloride ions##8##2##(2008-10#7)(2009-8#1)
chloride is used as##2##4##(2008-10#2)
chloride is##5##2##(1994-5#1)(2008-10#4)
chloride media##4##2##(2008-10#4)
chloride membrane entrapped in a cellulose support##2##7##(2008-10#2)
chloride of##2##2##(2008-10#2)
chloride on microcrystalline naphthalene##2##4##(2008-10#2)
chloride on the##3##3##(1994-5#2)(2008-10#1)
chloride on##6##2##(1994-5#2)(2008-10#3)(2008-12#1)
chloride or##2##2##(1994-11#1)(1995-8#1)
chloride reactant ion##2##3##(2008-10#2)
chloride reactant ions##2##3##(2008-10#2)
chloride reactant##4##2##(2008-10#4)
chloride secretion##2##2##(1990-5#2)
chloride sodalites##3##2##(2008-10#3)
chloride solution was##2##3##(2008-10#2)
chloride solution##8##2##(1992-3#1)(2008-10#7)
chloride solutions##4##2##(2008-10#4)
chloride to##2##2##(2008-10#2)
chloride was added##2##3##(2008-10#2)
chloride was##7##2##(2008-10#7)
chloride were##3##2##(2008-10#2)(2008-11#1)
chloride with##7##2##(1994-5#1)(1996-5#1)(2008-10#5)
chloride##395##1##(1990-5#5)(1991-12#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-12#1)(1994-11#1)(1994-5#10)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-8#5)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#2)(2006-6#1)(2008-10#310)(2008-11#10)(2008-12#6)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#4)(2012-2#2)
chloride) (PVC) matrix##3##3##(2008-10#3)
chloride) (PVC) membrane electrode##3##4##(2008-10#3)
chloride) (PVC) membrane##6##3##(2008-10#6)
chloride) (PVC) membranes containing those deoxycholic##2##6##(2008-10#2)
chloride) (PVC) membranes##5##3##(2008-10#5)
chloride) (PVC)##19##2##(2008-10#19)
chloride) and##4##2##(2008-10#4)
chloride) membrane electrode##3##3##(2008-10#3)
chloride) membrane##14##2##(2008-10#14)
chloride) were##2##2##(1990-8#1)(2008-10#1)
chloride)##59##1##(1990-8#1)(2006-6#1)(2008-10#57)
chloride+zwitterionic##2##1##(2008-10#2)
chlorides and##3##2##(2008-10#3)
chlorides##11##1##(1992-11#1)(1996-5#1)(2008-10#7)(2010-8#2)
chlorinated biphenyls##5##2##(1993-12#3)(2008-10#2)
chlorinated hydrocarbons are##2##3##(2008-10#2)
chlorinated hydrocarbons##6##2##(2008-10#6)
chlorinated##29##1##(1993-12#4)(1994-3#1)(2008-10#21)(2008-11#1)(2011-1#2)
chlorination by-products##4##2##(2008-10#4)
chlorination##9##1##(2008-10#8)(2008-9#1)
chlorine and##4##2##(2008-10#3)(2009-8#1)
chlorine atom##2##2##(2008-5#2)
chlorine atoms##3##2##(2008-10#3)
chlorine dioxide in water##3##4##(2008-10#3)
chlorine dioxide in##6##3##(2008-10#6)
chlorine dioxide##11##2##(2008-10#11)
chlorine in##3##2##(2008-10#3)
chlorine is##2##2##(2008-10#2)
chlorine species##4##2##(2008-10#4)
chlorine to##2##2##(2008-10#2)
chlorine using##2##2##(2008-10#2)
chlorine was##2##2##(2008-10#2)
chlorine with##2##2##(2008-10#2)
chlorine##64##1##(1991-5#2)(1991-6#3)(1992-5#1)(1996-1#1)(2008-10#54)(2008-5#2)(2009-8#1)
chlorine-containing disinfectants##2##2##(2008-10#2)
chlorite##7##1##(2008-10#7)
chloro-organic##5##1##(2008-10#2)(2009-8#3)
chloroacetate##2##1##(1994-8#1)(2008-10#1)
chloroacetic acid##3##2##(2008-10#2)(2008-11#1)
chloroacetic acids##4##2##(2008-10#4)
chloroacetic##8##1##(2008-10#7)(2008-11#1)
chlorobenzene##6##1##(2008-10#6)
chlorocomplexes with##2##2##(2008-10#2)
chloroethylating species##3##2##(2010-11#3)
chlorofluorocarbon (CFC) propellants##3##3##(1992-3#2)(1996-1#1)
chlorofluorocarbon (CFC)##5##2##(1992-3#2)(1996-1#2)(1996-2#1)
chlorofluorocarbon##6##1##(1992-3#3)(1996-1#2)(1996-2#1)
chlorofluorocarbons (CFCs)##3##2##(1996-1#2)(1996-2#1)
chloroform and dichloromethane##3##3##(2008-10#3)
chloroform and##10##2##(2008-10#9)(2008-12#1)
chloroform as##4##2##(1991-8#1)(2008-10#3)
chloroform extraction##3##2##(2008-10#3)
chloroform phase##2##2##(2008-10#2)
chloroform solution of##2##3##(2008-10#2)
chloroform solution##4##2##(2008-10#4)
chloroform was##3##2##(1991-8#1)(2008-10#2)
chloroform with##2##2##(2008-10#2)
chloroform##86##1##(1991-8#3)(1993-8#1)(2008-10#75)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
chloroformate##8##1##(1996-5#1)(2008-10#7)
chloroformates##2##1##(2008-10#2)
chloroformic##3##1##(2008-10#3)
chlorogenic acid were##2##3##(2008-10#1)(2008-11#1)
chlorogenic acid##16##2##(2008-10#12)(2008-11#4)
chlorogenic##20##1##(2008-10#14)(2008-11#6)
chloroguaiacol##5##1##(2008-10#5)
chloromethylated##7##1##(2008-10#7)
chloronaphthalene##2##1##(2008-10#2)
chloropentamminecobalt(III) ion##2##2##(2008-10#2)
chloroperoxidase in the oxidation of##2##5##(1994-5#2)
chloroperoxidase##4##1##(1994-5#4)
chlorophenolicum##2##1##(2009-3#2)
chlorophenols and##2##2##(2008-10#2)
chlorophenols##12##1##(2008-10#12)
chlorophyll a retrieval##2##3##(2008-3#2)
chlorophyll a##8##2##(2008-10#1)(2008-12#1)(2008-3#5)(2008-8#1)
chlorophyll and##2##2##(2008-10#1)(2008-9#1)
chlorophyll concentration##2##2##(2008-9#1)(2012-9#1)
chlorophyll content##5##2##(2008-12#4)(2012-7#1)
chlorophyll contents##2##2##(2008-12#1)(2008-9#1)
chlorophyll fluorescence##2##2##(2008-10#1)(2008-8#1)
chlorophyll##41##1##(1995-2#1)(2008-10#9)(2008-11#2)(2008-12#7)(2008-3#6)(2008-8#3)(2008-9#7)(2009-10#1)(2009-7#1)(2010-6#1)(2012-7#1)(2012-9#2)
chlorophyll-a##2##1##(2008-10#1)(2008-3#1)
chlorophyll-related##2##1##(2008-11#2)
chlorophylls a##4##2##(2008-10#4)
chlorophylls##6##1##(2008-10#6)
chloropicrin##6##1##(2008-10#6)
chloroplast envelopes##3##2##(1994-11#3)
chloroplast genome##3##2##(2008-12#2)(2008-9#1)
chloroplast protein##2##2##(2008-1#1)(2008-9#1)
chloroplast repositioning##2##2##(2008-11#1)(2009-8#1)
chloroplast##33##1##(1990-5#1)(1991-2#1)(1991-6#2)(1992-8#1)(1994-11#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-8#3)(2008-9#2)(2009-7#2)(2009-8#2)(2010-10#1)(2012-3#5)
chloroplastic##2##1##(1997-7#1)(2008-8#1)
chloroplasts and##4##2##(1993-12#1)(2008-10#1)(2008-9#1)(2009-8#1)
chloroplasts##11##1##(1993-12#1)(1994-11#1)(1995-8#1)(2008-1#2)(2008-10#3)(2008-9#1)(2009-8#1)(2012-3#1)
chloropropyl and aminopropyl sol-gel##2##4##(2008-10#2)
chloropropyl bonded silica##2##3##(2008-10#2)
chloropropyl##4##1##(2008-10#4)
chloroquine##15##1##(1992-12#1)(1992-6#2)(1993-8#5)(1994-6#1)(1995-8#1)(2008-10#5)
chloroquine-induced myopathy##2##2##(1995-12#2)
chloroquine-induced##4##1##(1995-12#4)
chlorosis and##3##2##(2008-10#3)
chlorosis in##5##2##(2008-10#5)
chlorosis on##2##2##(2008-10#2)
chlorosis toxin##5##2##(2008-10#5)
chlorosis virus##7##2##(2008-10#7)
chlorosis##40##1##(2008-10#40)
chlorosis-inducing##2##1##(2008-10#2)
chlorosomes from the green##2##4##(1996-2#2)
chlorosomes##3##1##(1996-2#3)
chlorothalonil##4##1##(2008-10#4)
chlorothiazide##3##1##(2008-10#3)
chlorotic area##2##2##(2008-10#2)
chlorotic leaf areas##2##3##(2008-10#2)
chlorotic leaf##7##2##(2008-10#7)
chlorotic mottle virus##3##3##(2008-10#3)
chlorotic mottle##5##2##(2008-10#5)
chlorotic spot virus##5##3##(2008-10#5)
chlorotic streaks##5##2##(2008-10#5)
chlorotic stunt virus##6##3##(2008-10#6)
chlorotic##37##1##(2008-10#37)
chlorotriazines##2##1##(2008-10#2)
chlorphenamine##4##1##(2008-10#4)
chlorphenamine-imprinted polymer##2##2##(2008-10#2)
chlorpromazine hydrochloride##5##2##(2008-10#5)
chlorpromazine##10##1##(2008-10#10)
chlorpyrifos and##2##2##(2008-10#2)
chlorpyrifos##12##1##(2008-10#12)
chlorsulfuron##3##1##(2008-10#1)(2008-9#2)
chlortetracycline (CTC)##4##2##(2008-10#3)(2008-8#1)
chlortetracycline and##3##2##(2008-10#3)
chlortetracycline hydrochloride##4##2##(2008-10#4)
chlortetracycline in##3##2##(2008-10#3)
chlortetracycline were##2##2##(2008-10#2)
chlortetracycline##22##1##(2008-10#21)(2008-8#1)
chlorzoxazone and acetaminophen##2##3##(2008-10#2)
chlorzoxazone##5##1##(2008-10#5)
chocolate milk##2##2##(2008-10#2)
chocolate##6##1##(2008-10#4)(2008-12#1)(2009-3#1)
choice among##2##2##(1991-3#1)(2008-9#1)
choice and##8##2##(1991-3#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-6#1)(2011-2#1)
choice between##6##2##(1990-3#1)(1991-3#1)(1992-9#1)(1995-12#1)(1995-5#1)(2011-10#1)
choice due to##2##3##(2008-10#1)(2012-3#1)
choice for patients with##3##4##(1997-4#1)(2009-12#1)(2010-10#1)
choice for routine##2##3##(2008-10#2)
choice for the##5##3##(1996-2#1)(1997-2#1)(2008-2#1)(2008-8#1)(2013-1#1)
choice for##47##2##(1991-10#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)
choice has##3##2##(1996-2#1)(2008-10#1)(2013-1#1)
choice in evaluating##2##3##(2008-10#1)(2011-2#1)
choice in the##3##3##(1990-2#1)(2008-8#1)(2011-2#1)
choice in treating##2##3##(2011-2#1)(2012-3#1)
choice in##27##2##(1990-2#1)(1990-9#1)(1991-1#1)(1992-12#1)(1993-1#1)(1994-3#1)(1995-11#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#6)(2008-9#2)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)
choice is##7##2##(1992-9#1)(1994-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)
choice of a##6##3##(1991-6#1)(2008-3#1)(2008-9#2)(2010-12#1)(2010-3#1)
choice of an##2##3##(1990-3#1)(2008-8#1)
choice of antimicrobial##2##3##(2008-7#1)(2013-1#1)
choice of drug##2##3##(1997-1#1)(2009-8#1)
choice of health##2##3##(1992-3#1)(1997-3#1)
choice of mates##2##3##(2008-8#1)(2008-9#1)
choice of solvent##2##3##(2008-10#2)
choice of sowing date##2##4##(2008-10#2)
choice of specialty##3##3##(1991-6#2)(1993-6#1)
choice of the##13##3##(1990-2#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#4)(2011-2#2)(2012-12#2)(2013-1#1)
choice of therapy##3##3##(1992-2#2)(1993-11#1)
choice of##104##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-6#4)(1992-2#3)(1992-3#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-6#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-11#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#7)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-10#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)
choice paradigm##2##2##(1990-11#1)(1992-12#1)
choice reaction##2##2##(2008-7#2)
choice to##5##2##(1994-1#1)(1994-2#1)(2009-6#1)(2011-7#1)(2012-12#1)
choice was##3##2##(2008-10#1)(2009-3#1)(2012-12#1)
choice were examined by comparing##2##5##(2008-8#2)
choice were##3##2##(2008-8#2)(2008-9#1)
choice with##3##2##(1990-2#1)(2008-9#1)(2011-2#1)
choice##310##1##(1990-11#1)(1990-2#3)(1990-3#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#5)(1991-6#5)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#2)(1992-5#1)(1992-9#8)(1993-1#3)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#2)(1996-1#1)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#45)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#20)(2008-9#31)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#8)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#2)(2011-2#14)(2011-3#1)(2011-7#1)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#13)(2013-8#2)
choice)##2##1##(2008-7#1)(2009-6#1)
choice-offering##4##1##(2008-4#4)
choice]##2##1##(1992-3#2)
choices and##4##2##(1992-12#1)(2009-5#1)(2010-11#1)(2013-1#1)
choices are##4##2##(1991-9#1)(2008-8#2)(2013-1#1)
choices for##4##2##(1994-1#1)(2007-11#1)(2013-1#2)
choices of##5##2##(1993-12#1)(1997-3#1)(2008-8#2)(2009-8#1)
choices that##2##2##(1994-3#1)(1996-3#1)
choices##51##1##(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#4)(1997-1#1)(1997-3#6)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#4)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
choix##2##1##(2011-2#2)
cholangiocarcinoma##9##1##(1992-2#1)(2008-2#2)(2009-9#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
cholangiography##2##1##(1990-8#1)(2012-2#1)
cholangioscopy system##2##2##(2010-12#2)
cholangioscopy##3##1##(2010-12#3)
cholangitis and##3##2##(1997-8#1)(2013-1#2)
cholangitis##9##1##(1997-6#1)(1997-8#1)(2009-8#1)(2010-12#1)(2013-1#5)
cholate uptake##3##2##(1992-3#3)
cholate##6##1##(1992-3#6)
cholecalciferol and##3##2##(2008-5#3)
cholecystectomy and##2##2##(1993-3#1)(1995-12#1)
cholecystectomy complication##2##2##(2012-3#2)
cholecystectomy for##2##2##(1993-3#1)(1997-8#1)
cholecystectomy in bariatric##2##3##(1993-3#2)
cholecystectomy in##8##2##(1991-3#1)(1993-3#2)(1997-8#2)(2008-12#1)(2009-8#2)
cholecystectomy##36##1##(1990-9#1)(1991-1#1)(1991-3#4)(1992-9#1)(1993-3#7)(1995-12#1)(1997-8#5)(2008-12#4)(2008-8#1)(2009-8#3)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)
cholecystitis and##4##2##(1991-3#1)(1991-8#1)(1992-9#1)(1997-8#1)
cholecystitis##13##1##(1990-9#1)(1991-3#1)(1991-6#2)(1991-8#2)(1992-9#1)(1995-11#1)(1997-8#4)(2010-12#1)
cholecystitis]##2##1##(1990-9#1)(1997-8#1)
cholecystokinin (CCK)##5##2##(1992-8#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-7#1)
cholecystokinin (CCK)-B##2##2##(1995-12#1)(1996-2#1)
cholecystokinin##14##1##(1992-8#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-4#1)(2008-7#2)
choledochal cyst##2##2##(2009-9#2)
choledochal##4##1##(1990-8#1)(2009-9#3)
choledocholithiasis##4##1##(1990-5#1)(1997-8#1)(2009-9#2)
cholelithiasis##2##1##(1991-3#1)(1995-10#1)
cholera antitoxin##3##2##(2008-10#3)
cholera in##2##2##(1992-5#2)
cholera toxin B subunit##3##4##(2008-11#3)
cholera toxin##7##2##(1991-3#1)(1993-8#1)(1994-3#1)(1997-3#1)(2008-11#3)
cholera##18##1##(1991-3#1)(1992-5#5)(1993-8#1)(1994-3#1)(1997-3#1)(2008-10#3)(2008-11#3)(2012-3#2)(2013-1#1)
cholerae isolates##2##2##(2012-3#2)
cholerae##19##1##(1990-5#2)(1992-5#1)(1994-11#1)(2008-10#1)(2008-9#5)(2009-8#3)(2012-3#6)
cholestasis##5##1##(1992-5#1)(1993-3#3)(2008-5#1)
cholestatic##3##1##(1992-9#1)(1995-10#1)(2013-1#1)
cholesteatoma##15##1##(2008-9#3)(2011-2#12)
cholesteatomas##2##1##(2011-2#2)
cholesteric liquid crystals##2##3##(1995-6#1)(2008-7#1)
cholesterol accumulation and##2##3##(1990-8#1)(1991-5#1)
cholesterol accumulation##3##2##(1990-8#2)(1991-5#1)
cholesterol acyltransferase (ACAT)##2##3##(1994-8#2)
cholesterol acyltransferase (LCAT)##2##3##(1993-6#2)
cholesterol acyltransferase##7##2##(1991-12#1)(1993-6#2)(1993-8#2)(1994-8#2)
cholesterol and Brij((R))30##2##3##(2008-10#2)
cholesterol and plasma##2##3##(1990-8#1)(1991-2#1)
cholesterol and triglycerides were##2##4##(1990-8#2)
cholesterol and triglycerides##6##3##(1990-8#3)(1991-6#1)(1993-2#1)(2008-7#1)
cholesterol and##29##2##(1990-8#5)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#2)(1992-9#1)(1993-2#1)(1995-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
cholesterol are##3##2##(1994-5#1)(2012-2#2)
cholesterol as well as##2##4##(1992-11#1)(2012-2#1)
cholesterol as##3##2##(1992-11#1)(2012-2#2)
cholesterol biosensor##2##2##(2008-10#2)
cholesterol concentration with##2##3##(2008-10#2)
cholesterol concentration##5##2##(1991-6#1)(2008-10#4)
cholesterol concentrations##4##2##(1991-2#1)(1991-6#1)(2008-3#1)(2010-12#1)
cholesterol content of##2##3##(1990-8#1)(2008-6#1)
cholesterol content##4##2##(1990-8#2)(2008-10#1)(2008-6#1)
cholesterol did not##2##3##(2008-3#1)(2008-5#1)
cholesterol efflux##3##2##(1994-11#3)
cholesterol ester##2##2##(1992-12#2)
cholesterol esterification in##4##3##(1990-8#2)(1994-8#2)
cholesterol esterification##5##2##(1990-8#2)(1994-8#3)
cholesterol for##2##2##(1991-12#1)(1993-6#1)
cholesterol from##2##2##(1994-8#1)(2012-2#1)
cholesterol in##10##2##(1990-8#1)(1991-4#1)(2008-10#3)(2008-5#1)(2009-7#3)(2013-1#1)
cholesterol is##5##2##(1994-11#1)(1996-8#1)(2008-10#2)(2013-1#1)
cholesterol levels and##2##3##(1994-12#1)(2013-1#1)
cholesterol levels in##3##3##(1991-6#1)(1994-3#1)(2013-1#1)
cholesterol levels##15##2##(1991-6#2)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-11#1)(2008-10#1)(2010-12#1)(2013-1#5)
cholesterol lowering##4##2##(2008-1#1)(2008-4#1)(2010-12#1)(2013-8#1)
cholesterol metabolism and##2##3##(1993-3#1)(2008-10#1)
cholesterol metabolism##6##2##(1993-3#2)(1993-6#1)(1995-6#1)(2008-10#2)
cholesterol oxidase##3##2##(2008-10#3)
cholesterol ratio##3##2##(2008-3#2)(2008-5#1)
cholesterol removal##2##2##(2008-4#2)
cholesterol synthesis##3##2##(1991-5#1)(1991-6#1)(2012-2#1)
cholesterol to##2##2##(1991-2#1)(2008-10#1)
cholesterol transport into##2##3##(2012-2#2)
cholesterol transport##5##2##(1994-3#1)(2008-6#1)(2009-10#1)(2012-2#2)
cholesterol was##8##2##(1990-8#1)(1991-11#1)(1991-6#2)(2008-10#2)(2009-7#1)(2012-2#1)
cholesterol with##4##2##(2008-10#3)(2008-6#1)
cholesterol##251##1##(1990-8#17)(1991-11#6)(1991-12#5)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#11)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#2)(1994-11#7)(1994-12#3)(1994-3#3)(1994-5#6)(1994-8#7)(1994-9#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-8#1)(1997-2#2)(1997-8#1)(2008-1#2)(2008-10#50)(2008-11#2)(2008-12#4)(2008-3#10)(2008-4#6)(2008-5#6)(2008-6#7)(2008-7#4)(2009-10#1)(2009-7#6)(2010-12#6)(2010-3#1)(2010-7#2)(2011-2#3)(2012-2#16)(2013-1#16)(2013-8#4)
cholesterol&quot##2##1##(2013-8#2)
cholesterol-depleted##2##1##(1994-8#1)(2012-2#1)
cholesterol-lowering##6##1##(1991-6#1)(2008-4#1)(2010-7#1)(2012-2#3)
cholesteryl ester accumulation##2##3##(1990-8#1)(1994-11#1)
cholesteryl ester formation##2##3##(1990-8#1)(1991-5#1)
cholesteryl ester##7##2##(1990-8#2)(1991-5#1)(1994-11#1)(1995-8#1)(2009-8#2)
cholesteryl esters##2##2##(2009-8#2)
cholesteryl##10##1##(1990-8#3)(1991-5#1)(1994-11#1)(1995-8#1)(2009-8#4)
cholestyramine##3##1##(1991-2#2)(2008-10#1)
cholic##3##1##(2008-10#3)
choline acetyltransferase##5##2##(1993-3#1)(1996-12#3)(1996-2#1)
choline biosensor was##3##3##(2008-10#3)
choline biosensor##4##2##(2008-10#4)
choline chloride##2##2##(2008-11#2)
choline oxidase##4##2##(2008-10#4)
choline##25##1##(1991-5#2)(1993-3#1)(1994-3#1)(1996-12#4)(1996-2#1)(2008-10#12)(2008-11#2)(2008-7#1)(2010-6#1)
cholinergic and glutamatergic##2##3##(2008-7#2)
cholinergic and##4##2##(1991-7#1)(2008-7#2)(2013-8#1)
cholinergic assessment##2##2##(2011-1#2)
cholinergic mechanisms##2##2##(1996-2#1)(2008-11#1)
cholinergic neurons in the release of dopamine##2##7##(1997-2#2)
cholinergic neurons##11##2##(1991-12#2)(1991-9#1)(1996-12#3)(1997-2#3)(2008-5#2)
cholinergic system##4##2##(1991-9#1)(1994-8#1)(2010-8#2)
cholinergic systems##2##2##(1996-12#1)(2008-5#1)
cholinergic transmission and##2##3##(2008-8#1)(2011-1#1)
cholinergic transmission in##3##3##(2008-8#1)(2013-8#2)
cholinergic transmission##8##2##(2008-8#4)(2011-1#1)(2013-8#3)
cholinergic##56##1##(1990-5#1)(1991-12#2)(1991-7#2)(1991-9#3)(1992-6#1)(1992-8#3)(1994-8#3)(1996-12#6)(1996-2#1)(1997-1#1)(1997-2#3)(1997-4#1)(2008-11#3)(2008-5#4)(2008-7#3)(2008-8#5)(2010-1#1)(2010-8#2)(2011-1#3)(2012-12#1)(2013-1#1)(2013-8#6)
cholinergic-serotonergic##2##1##(1991-7#2)
cholinesterase##11##1##(1990-5#1)(2008-10#4)(2008-7#1)(2011-1#2)(2013-1#3)
cholinesterases##2##1##(2008-10#2)
chondral##4##1##(2011-2#4)
chondroblastic osteosarcoma##3##2##(2013-1#3)
chondroblastic##4##1##(2013-1#4)
chondrocyte culture##2##2##(2008-11#1)(2009-7#1)
chondrocyte##9##1##(1992-1#2)(2008-11#5)(2008-7#1)(2009-7#1)
chondrocytes and##4##2##(2008-11#2)(2011-2#1)(2012-4#1)
chondrocytes of##4##2##(1993-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
chondrocytes were##2##2##(2008-11#1)(2008-7#1)
chondrocytes##36##1##(1992-1#1)(1993-12#2)(1994-6#2)(2007-11#1)(2008-11#17)(2008-7#5)(2008-8#1)(2008-9#1)(2011-2#4)(2012-4#1)(2013-8#1)
chondrogenesis and##2##2##(1991-5#1)(2008-11#1)
chondrogenesis##7##1##(1991-5#2)(1994-11#2)(2008-11#3)
chondrogenic and osteogenic differentiation##2##4##(2008-11#2)
chondrogenic differentiation potential##2##3##(2008-11#2)
chondrogenic differentiation##9##2##(1994-11#1)(2008-11#8)
chondrogenic##16##1##(1994-11#1)(2008-11#15)
chondrosarcoma and##2##2##(2008-5#1)(2011-2#1)
chondrosarcoma of##3##2##(2008-5#2)(2008-7#1)
chondrosarcoma##14##1##(1993-2#1)(1997-8#1)(2008-5#4)(2008-7#2)(2009-1#1)(2010-3#1)(2011-2#4)
choose a##3##2##(1993-11#1)(2011-2#1)(2012-3#1)
choose between##2##2##(1992-2#1)(1994-9#1)
choose not to##3##3##(2008-12#1)(2013-1#2)
choose their##2##2##(1994-12#1)(2008-9#1)
choose to##3##2##(2008-4#1)(2010-4#2)
choose##31##1##(1992-2#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1997-2#2)(1997-3#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-4#2)(2011-2#2)(2012-3#3)(2013-1#2)
choosen##2##1##(2010-8#1)(2011-7#1)
chooses##3##1##(1994-12#1)(2008-9#1)(2013-8#1)
choosing a##2##2##(1991-2#1)(2008-8#1)
choosing friends##5##2##(2009-7#5)
choosing one##3##2##(1993-12#1)(2008-10#1)(2008-9#1)
choosing the##4##2##(1992-1#1)(2008-10#1)(2013-1#2)
choosing to##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
choosing##32##1##(1991-2#1)(1992-1#1)(1992-3#1)(1993-12#2)(1993-3#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#2)(2009-7#5)(2010-11#1)(2012-3#1)(2013-1#2)
chopstick##4##1##(2011-2#4)
chordoma##3##1##(2010-9#1)(2011-2#2)
chordotonal organ##2##2##(2008-7#2)
chorea and##3##2##(2008-5#1)(2008-7#1)(2011-10#1)
chorea in##3##2##(2008-7#1)(2011-10#2)
chorea was##2##2##(2011-10#2)
chorea##14##1##(2008-5#1)(2008-7#3)(2011-10#10)
choreographed##2##1##(2008-9#1)(2009-12#1)
chorioamnionitis##2##1##(2012-3#2)
choriocarcinoma cells##3##2##(1994-6#2)(2008-10#1)
chorion##11##1##(1990-11#1)(1993-1#1)(2008-12#8)(2012-3#1)
chorionic cells##2##2##(1993-6#2)
chorionic gonadotrophin##2##2##(1996-3#1)(2007-7#1)
chorionic gonadotropin (hCG)##3##3##(1995-8#1)(1997-1#1)(2011-1#1)
chorionic gonadotropin##5##2##(1995-8#3)(1997-1#1)(2011-1#1)
chorionic villus sampling##2##3##(1991-2#1)(2008-4#1)
chorionic##11##1##(1991-2#1)(1993-6#2)(1995-8#3)(1996-3#1)(1997-1#1)(2007-7#1)(2008-4#1)(2011-1#1)
choroid plexus##5##2##(1994-2#1)(1996-12#4)
choroid##13##1##(1994-2#1)(1996-12#4)(2008-5#1)(2011-7#3)(2012-3#1)(2013-1#3)
choroidal metastases##3##2##(1990-12#3)
choroidal neovascular membrane##3##3##(2010-10#2)(2010-9#1)
choroidal##13##1##(1990-12#3)(2010-1#1)(2010-10#3)(2010-9#1)(2011-7#1)(2013-1#4)
chose to##7##2##(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-6#1)(2013-8#1)
chose##16##1##(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-10#1)(2011-2#2)(2013-8#1)
chosen according to##2##3##(1992-3#1)(2008-10#1)
chosen and the##2##3##(2008-10#2)
chosen and##6##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
chosen as a model##2##4##(2008-10#1)(2008-7#1)
chosen as a##7##3##(2008-10#5)(2008-11#1)(2008-7#1)
chosen as model##3##3##(2008-10#3)
chosen as the##8##3##(2008-10#8)
chosen as##35##2##(1991-5#1)(1993-8#1)(1997-6#1)(2008-10#26)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#2)
chosen by the##2##3##(2008-11#1)(2008-4#1)
chosen by##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
chosen for each##3##3##(2008-10#1)(2008-3#1)(2009-2#1)
chosen for further##2##3##(1991-12#1)(2009-6#1)
chosen for the determination##2##4##(2008-10#2)
chosen for the##4##3##(2008-10#3)(2008-11#1)
chosen for this##3##3##(2008-10#2)(2008-11#1)
chosen for##19##2##(1991-12#1)(1992-2#1)(1996-8#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2009-2#1)(2009-6#1)(2011-2#1)(2013-1#1)
chosen from the##2##3##(2008-10#2)
chosen from##6##2##(2008-10#6)
chosen in##3##2##(1990-11#1)(2008-10#2)
chosen only##2##2##(1991-12#1)(2008-10#1)
chosen to be##4##3##(1995-5#1)(2008-10#2)(2008-2#1)
chosen to test##2##3##(1996-3#1)(2008-12#1)
chosen to##22##2##(1993-6#1)(1994-2#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-5#1)
chosen was##2##2##(1993-8#1)(2008-10#1)
chosen##151##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#2)(1991-5#1)(1992-2#1)(1992-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#78)(2008-11#13)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#4)(2011-3#2)(2013-1#3)(2013-8#3)
chroma##2##1##(2010-4#1)(2011-2#1)
chromaffin cells##14##2##(1990-5#3)(1992-6#3)(1994-5#2)(1994-8#1)(1995-11#3)(1997-7#2)
chromaffin granules##4##2##(1990-5#4)
chromaffin##18##1##(1990-5#7)(1992-6#3)(1994-5#2)(1994-8#1)(1995-11#3)(1997-7#2)
chromate buffer##2##2##(2008-10#2)
chromate ions##2##2##(2008-10#2)
chromate##10##1##(2008-10#10)
chromate(VI)##2##1##(2008-10#2)
chromatic##9##1##(1996-2#1)(2008-10#2)(2008-3#5)(2011-2#1)
chromaticity##3##1##(1996-2#1)(2008-3#2)
chromatid exchange (SCE)##2##3##(1990-6#1)(2008-11#1)
chromatid exchange##4##2##(1990-6#2)(1993-12#1)(2008-11#1)
chromatid segregation##2##2##(2008-11#1)(2012-2#1)
chromatid##13##1##(1990-6#2)(1993-12#2)(1997-7#2)(2008-11#5)(2012-2#1)(2013-1#1)
chromatin and##4##2##(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
chromatin clumping##2##2##(2008-7#2)
chromatin condensation and##2##3##(2008-7#2)
chromatin condensation##9##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#1)(2012-3#1)
chromatin immunoprecipitation assay##2##3##(2008-11#2)
chromatin immunoprecipitation##5##2##(2008-11#3)(2008-2#1)(2011-2#1)
chromatin in##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
chromatin modifier##2##2##(2009-8#2)
chromatin remodeling##5##2##(2009-8#1)(2011-2#3)(2011-9#1)
chromatin structure##7##2##(1994-5#2)(2007-12#1)(2008-9#1)(2011-2#3)
chromatin texture##2##2##(2010-8#2)
chromatin##75##1##(1990-2#3)(1992-12#1)(1994-5#3)(1995-2#1)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#8)(2008-8#6)(2008-9#4)(2009-12#1)(2009-8#4)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#12)(2011-9#2)(2012-2#1)(2012-3#2)(2013-1#2)
chromatin-associated##3##1##(1991-5#2)(1995-2#1)
chromatogram##8##1##(2008-10#7)(2013-1#1)
chromatograms and mass spectra##2##4##(2008-10#2)
chromatograms and##4##2##(2008-10#4)
chromatograms for the detection of the investigated##2##7##(2008-10#2)
chromatograms for##3##2##(2008-10#3)
chromatograms obtained##3##2##(2008-10#3)
chromatograms##19##1##(2008-10#19)
chromatograph##15##1##(2008-10#13)(2008-11#1)(2008-8#1)
chromatographed##4##1##(1997-2#1)(2008-10#3)
chromatographic analysis of##8##3##(2008-10#7)(2008-11#1)
chromatographic analysis##18##2##(1994-8#1)(2006-6#1)(2008-10#15)(2008-11#1)
chromatographic and##7##2##(1997-1#1)(2008-10#4)(2008-11#1)(2010-11#1)
chromatographic approach##2##2##(2008-10#2)
chromatographic behavior of some##3##4##(2008-10#3)
chromatographic behavior of##6##3##(2008-10#6)
chromatographic behavior##8##2##(2008-10#8)
chromatographic behaviors##2##2##(2008-10#2)
chromatographic characteristics##2##2##(2008-10#2)
chromatographic column is##2##3##(2008-10#2)
chromatographic column##9##2##(2008-10#9)
chromatographic columns##5##2##(2008-10#5)
chromatographic conditions were##3##3##(2008-10#3)
chromatographic conditions##8##2##(2008-10#8)
chromatographic data##5##2##(2008-10#5)
chromatographic detection##2##2##(2008-10#2)
chromatographic determination of##21##3##(1993-2#1)(1997-2#1)(2008-10#19)
chromatographic determination##25##2##(1993-2#1)(1997-2#1)(2008-10#23)
chromatographic elution##2##2##(2008-10#2)
chromatographic fractions##3##2##(2008-10#3)
chromatographic method for the determination of##3##6##(2008-10#3)
chromatographic method for the separation of##2##6##(2008-10#2)
chromatographic method for the simultaneous determination of##2##7##(2008-10#2)
chromatographic method for the simultaneous##3##5##(2008-10#3)
chromatographic method for the##10##4##(2008-10#10)
chromatographic method for##15##3##(1997-2#1)(2008-10#14)
chromatographic method has been developed##3##5##(2008-10#3)
chromatographic method of analysis of##2##5##(2008-10#2)
chromatographic method was##4##3##(1997-2#1)(2008-10#3)
chromatographic method with##2##3##(2008-10#2)
chromatographic method##37##2##(1996-12#1)(1997-2#3)(2008-10#32)(2012-2#1)
chromatographic methods for##2##3##(2010-7#1)(2012-12#1)
chromatographic methods##11##2##(2008-10#8)(2010-7#2)(2012-12#1)
chromatographic parameters##2##2##(1997-2#1)(2008-10#1)
chromatographic peak##2##2##(2008-10#2)
chromatographic peaks and##2##3##(2008-10#2)
chromatographic peaks##5##2##(2008-10#4)(2008-7#1)
chromatographic performance##2##2##(2008-10#2)
chromatographic probe##2##2##(2008-10#2)
chromatographic procedure##6##2##(2008-10#4)(2008-5#1)(2008-8#1)
chromatographic profiles##3##2##(2008-10#3)
chromatographic resolution##10##2##(2008-10#10)
chromatographic response function (CRF)##3##4##(2008-10#3)
chromatographic response##5##2##(2008-10#5)
chromatographic retention index of##2##4##(2008-10#2)
chromatographic retention indices of##2##4##(2008-10#2)
chromatographic retention indices##3##3##(2008-10#3)
chromatographic retention##7##2##(2008-10#7)
chromatographic run##6##2##(1997-2#1)(2008-10#5)
chromatographic separation and##2##3##(2008-10#2)
chromatographic separation of inorganic##2##4##(2008-10#2)
chromatographic separation of the##4##4##(2008-10#3)(2008-4#1)
chromatographic separation of##15##3##(2008-10#14)(2008-4#1)
chromatographic separation##32##2##(2008-10#31)(2008-4#1)
chromatographic separations##4##2##(2008-10#3)(2010-11#1)
chromatographic stationary phase##3##3##(2008-10#3)
chromatographic stationary##4##2##(2008-10#4)
chromatographic system##11##2##(2008-10#10)(2010-11#1)
chromatographic systems##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
chromatographic technique##3##2##(2008-10#3)
chromatographic techniques##6##2##(2008-10#2)(2008-11#1)(2010-11#1)(2010-4#1)(2011-2#1)
chromatographic##333##1##(1993-2#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#8)(2006-6#1)(2008-10#292)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#5)(2010-4#2)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
chromatographically##4##1##(1994-11#1)(2008-10#3)
chromatographies##5##1##(1990-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(2011-3#1)
chromatography (C(18))##2##2##(2008-10#2)
chromatography (GC)##19##2##(2008-10#18)(2008-5#1)
chromatography (HPLC)##82##2##(1992-11#1)(1995-3#1)(1997-2#1)(2008-10#69)(2008-11#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)
chromatography (IC)##11##2##(2008-10#11)
chromatography (MEKC)##10##2##(2008-10#9)(2010-7#1)
chromatography (R=0##3##2##(2008-10#3)
chromatography (SEC) with##3##3##(2008-10#3)
chromatography (SEC)##6##2##(1997-2#1)(2008-10#4)(2008-8#1)
chromatography (TLC)##3##2##(2008-10#2)(2008-4#1)
chromatography analysis of##3##3##(2008-10#3)
chromatography analysis##8##2##(2008-10#8)
chromatography and a##3##3##(1994-6#1)(2008-10#2)
chromatography and gel filtration##3##4##(1994-8#1)(1997-1#1)(2008-8#1)
chromatography and inductively coupled##2##4##(2008-10#2)
chromatography and mass spectrometry##2##4##(2008-1#1)(2008-10#1)
chromatography and preparative##3##3##(1990-2#1)(1991-9#1)(2012-2#1)
chromatography and the##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
chromatography and##59##2##(1990-2#1)(1991-9#1)(1992-11#1)(1992-6#3)(1993-8#1)(1994-6#1)(1994-8#2)(1997-1#1)(1997-2#3)(2008-1#1)(2008-10#35)(2008-11#2)(2008-8#3)(2011-1#1)(2011-3#1)(2012-2#2)
chromatography as a##2##3##(2008-10#1)(2008-11#1)
chromatography as##3##2##(2008-10#2)(2008-11#1)
chromatography at##2##2##(1992-12#1)(2008-9#1)
chromatography combined with##5##3##(2008-10#4)(2008-11#1)
chromatography coupled to##4##3##(2008-10#4)
chromatography coupled with chemiluminescence detection##2##5##(2008-10#2)
chromatography coupled with mass spectrometry##2##5##(2008-10#1)(2008-5#1)
chromatography coupled with mass##4##4##(2008-10#3)(2008-5#1)
chromatography coupled with##16##3##(1995-11#1)(2008-10#14)(2008-5#1)
chromatography coupled##22##2##(1995-11#1)(2008-10#20)(2008-5#1)
chromatography followed by##3##3##(1994-8#1)(1996-12#1)(2008-10#1)
chromatography for the analysis of##3##5##(2008-10#3)
chromatography for the determination of##4##5##(2008-10#3)(2009-8#1)
chromatography for the##13##3##(2008-10#12)(2009-8#1)
chromatography for##17##2##(2008-10#16)(2009-8#1)
chromatography fraction##2##2##(2008-10#2)
chromatography fractions##2##2##(2008-10#2)
chromatography has been##2##3##(2008-10#2)
chromatography has##3##2##(2008-10#2)(2008-11#1)
chromatography have been##2##3##(2008-10#2)
chromatography in the##3##3##(2008-10#2)(2012-2#1)
chromatography in##12##2##(1992-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(2008-10#5)(2008-9#1)(2010-11#1)(2012-2#1)
chromatography is an##2##3##(2008-10#2)
chromatography is##4##2##(2008-10#3)(2008-11#1)
chromatography mass spectrometry##2##3##(2008-10#2)
chromatography method for the##2##4##(1991-12#1)(2008-10#1)
chromatography method for##5##3##(1991-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
chromatography method##13##2##(1991-12#1)(1997-2#1)(2008-10#9)(2008-5#1)(2012-2#1)
chromatography of the##5##3##(1990-5#1)(1991-12#1)(1994-5#1)(2008-10#1)(2008-7#1)
chromatography of##13##2##(1990-5#1)(1991-12#1)(1994-5#1)(1997-3#1)(2008-10#6)(2008-5#1)(2008-7#2)
chromatography on DEAE cellulose##2##4##(2008-4#1)(2008-8#1)
chromatography on DEAE-Sepharose and##2##4##(1996-6#1)(2009-9#1)
chromatography on DEAE-Sepharose##3##3##(1991-12#1)(1996-6#1)(2009-9#1)
chromatography on a##7##3##(1990-11#1)(1991-12#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-4#1)
chromatography on##23##2##(1990-11#1)(1991-12#2)(1992-6#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-8#1)(2009-6#1)(2009-9#2)
chromatography or##2##2##(2008-10#1)(2008-9#1)
chromatography stationary phase##2##3##(2008-10#2)
chromatography study of##2##3##(2008-10#2)
chromatography techniques##2##2##(2008-1#1)(2008-10#1)
chromatography to the##2##3##(2008-10#2)
chromatography to##5##2##(1994-11#1)(2008-10#4)
chromatography under##2##2##(2008-10#2)
chromatography using a##3##3##(2008-10#2)(2009-8#1)
chromatography using##20##2##(1991-5#1)(1995-6#1)(2008-10#15)(2008-11#1)(2008-9#1)(2009-8#1)
chromatography was##6##2##(1992-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
chromatography were##2##2##(1993-6#1)(2008-10#1)
chromatography with UV##3##3##(2008-10#3)
chromatography with atomic##2##3##(2008-10#2)
chromatography with direct##2##3##(2008-10#2)
chromatography with electron capture detection##3##5##(2008-10#3)
chromatography with electron##5##3##(2008-10#5)
chromatography with on-line light scattering##2##5##(2008-4#2)
chromatography with on-line##3##3##(2008-10#1)(2008-4#2)
chromatography with pulsed amperometric detection##2##5##(1991-7#1)(1992-1#1)
chromatography with the##2##3##(2008-10#2)
chromatography with##74##2##(1991-7#2)(1992-1#1)(1993-2#1)(1995-6#1)(1997-2#1)(2008-10#61)(2008-11#1)(2008-4#2)(2008-5#3)(2009-8#1)
chromatography##784##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-5#2)(1990-8#3)(1991-12#6)(1991-3#2)(1991-5#2)(1991-7#3)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#8)(1993-1#1)(1993-2#1)(1993-6#4)(1993-8#4)(1993-9#2)(1994-11#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#4)(1995-11#3)(1995-12#1)(1995-3#1)(1995-6#5)(1995-8#1)(1996-12#4)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#13)(1997-3#1)(1997-7#2)(2007-12#1)(2008-1#2)(2008-10#557)(2008-11#26)(2008-12#1)(2008-4#10)(2008-5#17)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#11)(2009-3#4)(2009-6#2)(2009-8#8)(2009-9#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-7#6)(2011-1#3)(2011-2#5)(2011-3#1)(2012-2#6)(2013-1#1)
chromatography)##2##1##(2008-10#2)
chromatography-Fourier transform infrared##3##3##(1997-2#1)(2008-10#2)
chromatography-electron capture detection##2##3##(2008-10#2)
chromatography-electron capture##3##2##(2008-10#3)
chromatography-electrospray mass spectrometry##4##3##(2008-10#4)
chromatography-electrospray##10##1##(2008-10#8)(2008-8#2)
chromatography-high##4##1##(2008-10#4)
chromatography-hydride generation-atomic fluorescence spectrometry##2##4##(2008-10#2)
chromatography-hydride##3##1##(2008-10#3)
chromatography-mass spectrometry (GC-MS)##18##3##(1990-5#1)(2008-10#16)(2008-5#1)
chromatography-mass spectrometry##51##2##(1990-5#2)(1992-3#1)(1994-2#1)(1997-2#1)(2008-10#41)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
chromatography-mass##56##1##(1990-5#2)(1992-3#1)(1994-2#1)(1997-1#1)(1997-2#1)(2008-10#45)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
chromatography-olfactometry##3##1##(2008-10#3)
chromatography-tandem mass spectrometry##4##3##(2008-10#4)
chromatography/mass spectrometry##10##2##(1995-11#1)(2008-10#9)
chromatography/mass##11##1##(1995-11#1)(2008-10#10)
chromatography/sniffing port analysis##2##3##(2008-10#2)
chromatomembrane cell (CMC) was##3##4##(2008-10#3)
chromatomembrane cell and its##2##4##(2008-10#2)
chromatomembrane cell and##3##3##(2008-10#3)
chromatomembrane cell##12##2##(2008-10#12)
chromatomembrane cells##4##2##(2008-10#4)
chromatomembrane method##2##2##(2008-10#2)
chromatomembrane##19##1##(2008-10#19)
chromatophores##3##1##(2008-5#1)(2008-7#2)
chrome azurol S##2##3##(2008-10#2)
chrome##5##1##(2008-10#5)
chromic acid##2##2##(2008-10#2)
chromic##4##1##(1990-6#1)(2008-10#3)
chromium (III) species##3##3##(2008-10#3)
chromium (III)##10##2##(2008-10#10)
chromium (VI) in##3##3##(2008-10#3)
chromium (VI)##13##2##(2008-10#13)
chromium agents##2##2##(2008-10#2)
chromium and aluminium in human urine##2##6##(2008-10#2)
chromium and cobalt##2##3##(2008-10#2)
chromium and lead in drinking water by##2##7##(2008-10#2)
chromium and lead in##3##4##(2008-10#3)
chromium and##15##2##(2008-10#13)(2008-12#1)(2011-2#1)
chromium at##3##2##(2008-10#3)
chromium by##3##2##(2008-10#3)
chromium determination in##2##3##(2008-10#2)
chromium determination##4##2##(2008-10#4)
chromium has##2##2##(2008-10#2)
chromium in PACS-2##2##3##(2008-10#2)
chromium in heavy crude oil##2##5##(2008-10#2)
chromium in tanning sewage##2##4##(2008-10#2)
chromium in##40##2##(2008-10#40)
chromium isotope ratios##3##3##(2008-10#3)
chromium isotope##4##2##(2008-10#4)
chromium matrices##2##2##(2008-10#2)
chromium speciation##5##2##(2008-10#5)
chromium species in##3##3##(2008-10#3)
chromium species##11##2##(2008-10#11)
chromium using##3##2##(2008-10#3)
chromium was##9##2##(2008-10#9)
chromium with##3##2##(2008-10#3)
chromium##194##1##(2008-10#182)(2008-12#6)(2009-12#2)(2011-2#4)
chromium(III) and chromium(VI)##2##3##(2008-10#2)
chromium(III) by##2##2##(2008-10#2)
chromium(III) in##3##2##(2008-10#3)
chromium(III) propionate##2##2##(2008-10#2)
chromium(III)##16##1##(2008-10#16)
chromium(V) in##3##2##(2008-10#3)
chromium(V)##7##1##(2008-10#7)
chromium(VI) and its##2##3##(2008-10#2)
chromium(VI) and molybdenum(VI) in natural##2##5##(2008-10#2)
chromium(VI) and molybdenum(VI)##3##3##(2008-10#3)
chromium(VI) and##9##2##(2008-10#9)
chromium(VI) by##6##2##(2008-10#6)
chromium(VI) content##2##2##(2008-10#2)
chromium(VI) in electroplating baths##2##4##(2008-10#2)
chromium(VI) in##15##2##(2008-10#15)
chromium(VI) ion associates##2##3##(2008-10#2)
chromium(VI) ion##3##2##(2008-10#3)
chromium(VI) using##3##2##(2008-10#3)
chromium(VI)##68##1##(2008-10#68)
chromium(total)##2##1##(2008-10#2)
chromium-reducible##2##1##(2008-10#2)
chromogenic reagent for##6##3##(2008-10#6)
chromogenic reagent##24##2##(2008-10#24)
chromogenic reagents##3##2##(2008-10#3)
chromogenic substrate##3##2##(2008-10#2)(2008-9#1)
chromogenic system##2##2##(2008-10#2)
chromogenic##43##1##(1990-2#1)(1992-12#1)(1996-5#1)(2008-10#38)(2008-9#1)(2010-4#1)
chromogranin A##11##2##(1990-5#1)(1993-8#5)(2008-11#1)(2010-11#3)(2011-2#1)
chromogranin B and secretogranin II##2##5##(1992-12#2)
chromogranin B##7##2##(1992-12#7)
chromogranin##19##1##(1990-5#1)(1991-8#1)(1992-12#7)(1993-8#5)(2008-11#1)(2010-11#3)(2011-2#1)
chromoionophore##5##1##(2008-10#5)
chromoionophores and anion ionophores in solvent polymeric##2##7##(2008-10#2)
chromoionophores##5##1##(2008-10#5)
chromone derivatives##3##2##(2009-3#3)
chromone##4##1##(2009-3#3)(2010-6#1)
chromophobe renal cell carcinoma and small lymphocytic lymphoma##2##8##(2008-11#2)
chromophore and##3##2##(1991-3#1)(1994-5#1)(2008-10#1)
chromophore##36##1##(1991-3#2)(1994-5#4)(1996-5#1)(1997-2#1)(2008-10#16)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)(2012-2#2)
chromophores in##3##2##(2008-10#1)(2008-3#1)(2009-9#1)
chromophores on the##3##3##(1994-5#3)
chromophores##23##1##(1994-5#6)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#3)(2009-9#2)(2011-2#1)
chromophoric##2##1##(2008-10#1)(2008-2#1)
chromosomal DNA##6##2##(1990-12#1)(1993-9#2)(2009-6#1)(2009-7#1)(2011-2#1)
chromosomal aberrations and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
chromosomal aberrations##10##2##(1991-12#1)(1997-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-1#2)(2011-2#2)
chromosomal abnormalities and##2##3##(1990-8#1)(2010-1#1)
chromosomal abnormalities##6##2##(1990-8#1)(2010-1#1)(2012-3#4)
chromosomal analysis##3##2##(2012-3#3)
chromosomal and plasmid-borne cpe-carrying##2##4##(2011-2#2)
chromosomal and##4##2##(2011-2#2)(2012-2#1)(2013-1#1)
chromosomal blocks in##2##3##(2008-8#2)
chromosomal ends##2##2##(1993-12#1)(2008-11#1)
chromosomal fragile sites##2##3##(2011-2#2)
chromosomal gene cluster##2##3##(2008-10#1)(2011-1#1)
chromosomal gene transfer##2##3##(2008-10#2)
chromosomal gene##7##2##(1995-9#2)(2008-10#4)(2011-1#1)
chromosomal instability##2##2##(2008-10#2)
chromosomal inversion##4##2##(2008-10#1)(2008-7#3)
chromosomal localization##2##2##(1996-12#1)(2008-9#1)
chromosomal location of the##4##4##(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)
chromosomal location of##5##3##(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)
chromosomal location##6##2##(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
chromosomal locations of the##2##4##(2008-10#2)
chromosomal locations##3##2##(1997-6#1)(2008-10#2)
chromosomal looping##3##2##(2011-2#3)
chromosomal organization##4##2##(1996-12#1)(2009-10#2)(2010-5#1)
chromosomal protein##2##2##(1993-2#2)
chromosomal rearrangements##6##2##(2008-10#1)(2008-4#1)(2011-3#1)(2012-3#3)
chromosomal region##2##2##(1996-6#1)(2007-12#1)
chromosomal regions##6##2##(1997-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)
chromosomal segment##3##2##(1995-12#1)(2008-10#2)
chromosomal segmental duplications##2##3##(2009-10#2)
chromosomal segments##2##2##(1991-9#1)(2009-10#1)
chromosomal sequence##2##2##(1996-6#1)(2009-10#1)
chromosomal sequences##2##2##(1993-12#1)(2008-10#1)
chromosomal translocation##5##2##(1993-2#2)(2012-3#3)
chromosomal##142##1##(1990-12#1)(1990-3#2)(1990-8#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-10#1)(1993-12#2)(1993-2#4)(1993-6#2)(1993-9#2)(1994-2#1)(1995-12#1)(1995-9#2)(1996-12#3)(1996-6#2)(1997-2#4)(1997-6#1)(1997-8#2)(1997-9#1)(2007-12#1)(2008-10#21)(2008-11#5)(2008-12#6)(2008-2#1)(2008-4#3)(2008-7#5)(2008-8#9)(2008-9#3)(2009-10#6)(2009-6#1)(2009-7#3)(2010-1#4)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#14)(2011-3#2)(2012-2#1)(2012-3#16)(2013-1#1)
chromosome 1 and##2##3##(1995-8#1)(2008-10#1)
chromosome 1##11##2##(1995-8#3)(1997-8#1)(2008-10#4)(2008-9#1)(2009-10#1)(2012-3#1)
chromosome 10##2##2##(1996-12#1)(2012-3#1)
chromosome 11 by##2##3##(2008-10#2)
chromosome 11##8##2##(1995-5#1)(2008-10#3)(2008-11#1)(2008-8#3)
chromosome 11q13##3##2##(1997-7#1)(1997-8#2)
chromosome 12##6##2##(1996-12#2)(2008-10#4)
chromosome 13q12-13##2##2##(1994-9#2)
chromosome 16##4##2##(1993-12#2)(1994-11#1)(1997-2#1)
chromosome 17p13##2##2##(1993-11#1)(2008-8#1)
chromosome 1A##3##2##(2008-10#3)
chromosome 1B##4##2##(2008-10#4)
chromosome 1H##3##2##(2008-10#3)
chromosome 2 between##2##3##(2008-8#1)(2008-9#1)
chromosome 2##6##2##(1993-2#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
chromosome 21##6##2##(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-8#1)
chromosome 21q22##3##2##(1997-2#2)(1997-8#1)
chromosome 2q23##2##2##(2012-3#2)
chromosome 3##13##2##(1995-10#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-10#3)(2011-2#1)(2012-3#1)
chromosome 3(3H)##2##2##(2008-10#2)
chromosome 3H##5##2##(2008-10#5)
chromosome 4##16##2##(1994-11#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#2)(2009-10#6)(2012-3#2)
chromosome 4(4H)##2##2##(2008-10#2)
chromosome 4J##2##2##(2008-10#2)
chromosome 5 and##2##3##(1993-2#1)(2010-1#1)
chromosome 5##15##2##(1993-2#1)(1997-5#1)(1997-6#3)(1997-8#4)(2008-10#4)(2008-7#1)(2010-1#1)
chromosome 5(1H)##5##2##(2008-10#5)
chromosome 6##11##2##(1990-5#1)(1994-11#1)(1995-2#2)(1995-6#2)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
chromosome 7##7##2##(1990-8#1)(1996-6#3)(1997-2#1)(2008-9#1)(2009-10#1)
chromosome 7(5H)##4##2##(2008-10#4)
chromosome 7A##7##2##(2008-10#7)
chromosome 7D##2##2##(2008-10#2)
chromosome 8 and##4##3##(1996-12#1)(1997-7#1)(1997-8#1)(2010-1#1)
chromosome 8##8##2##(1993-2#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-8#1)(2008-9#2)(2010-1#1)
chromosome 9##2##2##(1996-12#1)(2011-2#1)
chromosome 9p21##2##2##(1997-7#2)
chromosome I##2##2##(1996-6#1)(1997-7#1)
chromosome II##4##2##(1993-12#1)(1996-6#2)(2012-3#1)
chromosome III##2##2##(1996-3#1)(2012-3#1)
chromosome IV of S##2##4##(1996-6#2)
chromosome IV of##3##3##(1996-3#1)(1996-6#2)
chromosome IV##8##2##(1996-3#1)(1996-6#5)(1997-8#1)(2012-3#1)
chromosome IX##3##2##(1995-9#1)(1996-3#2)
chromosome VI##7##2##(1995-12#2)(1997-6#5)
chromosome VII of Saccharomyces cerevisiae##2##5##(1995-9#1)(1996-3#1)
chromosome VII##8##2##(1995-9#2)(1996-3#3)(1996-6#3)
chromosome X reveals##2##3##(1995-9#1)(1996-6#1)
chromosome X##5##2##(1993-12#1)(1995-9#2)(1996-6#2)
chromosome XIV reveals##2##3##(1996-3#2)
chromosome XIV##6##2##(1995-9#2)(1996-3#3)(1996-6#1)
chromosome XV##2##2##(1996-3#1)(1996-6#1)
chromosome aberrations in##2##3##(2008-9#1)(2012-3#1)
chromosome aberrations##6##2##(1997-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-3#1)
chromosome analysis##2##2##(1997-3#1)(2008-9#1)
chromosome and##4##2##(2008-11#1)(2008-12#1)(2008-8#1)(2011-3#1)
chromosome arm 1S##2##3##(2012-3#2)
chromosome arm##6##2##(2008-10#3)(2012-3#3)
chromosome at##3##2##(1995-2#1)(2008-9#2)
chromosome band##2##2##(1997-7#1)(2011-3#1)
chromosome breakage in##2##3##(1997-3#1)(2012-3#1)
chromosome breakage is##2##3##(2012-3#2)
chromosome breakage##7##2##(1997-3#1)(2012-3#6)
chromosome copy number##3##3##(2009-7#1)(2012-3#2)
chromosome damage##2##2##(2008-11#1)(2013-8#1)
chromosome ends##2##2##(2008-11#2)
chromosome found##2##2##(2008-10#2)
chromosome in the##2##3##(2008-10#2)
chromosome in##7##2##(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)
chromosome is##2##2##(1995-5#1)(2008-4#1)
chromosome mapping##2##2##(2008-8#2)
chromosome number of##4##3##(1990-8#1)(2008-10#1)(2008-12#2)
chromosome number was##2##3##(2008-10#1)(2008-12#1)
chromosome number##9##2##(1990-8#1)(2008-10#2)(2008-12#4)(2009-12#1)(2012-3#1)
chromosome numbers vary##2##3##(2008-12#2)
chromosome numbers##8##2##(2008-10#3)(2008-12#3)(2009-12#1)(2012-3#1)
chromosome of##10##2##(1993-9#1)(1994-11#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#2)
chromosome painting##2##2##(2008-9#1)(2012-3#1)
chromosome pair and##2##3##(2008-12#2)
chromosome pair##4##2##(2008-12#3)(2010-5#1)
chromosome preparation##2##2##(2008-11#1)(2008-4#1)
chromosome regions##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
chromosome segments##2##2##(2008-8#1)(2012-3#1)
chromosome segregation##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
chromosome set##2##2##(2008-12#2)
chromosome sizes##2##2##(1997-2#1)(2008-10#1)
chromosome that##2##2##(1996-6#1)(2012-12#1)
chromosome transfer experiments##2##3##(1996-6#1)(2008-11#1)
chromosome translocations or##2##3##(1997-7#1)(2008-9#1)
chromosome translocations##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
chromosome was##2##2##(1993-2#1)(1997-7#1)
chromosome##510##1##(1990-3#2)(1990-5#1)(1990-8#2)(1991-10#1)(1991-5#1)(1991-6#1)(1993-11#2)(1993-12#8)(1993-2#6)(1993-9#2)(1994-11#5)(1994-12#3)(1994-9#6)(1995-10#1)(1995-12#3)(1995-2#4)(1995-5#3)(1995-6#6)(1995-8#7)(1995-9#8)(1996-12#12)(1996-2#4)(1996-3#13)(1996-6#27)(1996-8#6)(1997-2#11)(1997-3#7)(1997-5#1)(1997-6#10)(1997-7#13)(1997-8#19)(2007-12#3)(2008-10#114)(2008-11#17)(2008-12#27)(2008-2#1)(2008-4#7)(2008-7#4)(2008-8#29)(2008-9#26)(2009-10#13)(2009-12#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-5#6)(2010-8#4)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#35)(2013-1#1)(2013-8#3)
chromosome-specific##2##1##(2008-10#2)
chromosomes 1##8##2##(1995-5#1)(1996-12#1)(2008-10#2)(2008-8#3)(2008-9#1)
chromosomes 10 and 12##5##4##(1996-12#5)
chromosomes 10 and##6##3##(1996-12#6)
chromosomes 10##7##2##(1996-12#6)(2008-10#1)
chromosomes 2##3##2##(2008-10#3)
chromosomes 3##4##2##(2008-10#3)(2008-8#1)
chromosomes 8 and 9##4##4##(1996-12#4)
chromosomes II and IV##2##4##(1996-6#2)
chromosomes and their##2##3##(1990-3#1)(2010-5#1)
chromosomes and##11##2##(1990-3#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2012-3#1)
chromosomes are##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
chromosomes as##2##2##(2008-10#1)(2010-5#1)
chromosomes by##4##2##(2008-10#1)(2008-12#2)(2008-8#1)
chromosomes for##2##2##(2008-12#1)(2008-9#1)
chromosomes from##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)
chromosomes had a##2##3##(2008-12#2)
chromosomes has##2##2##(2008-11#1)(2008-12#1)
chromosomes in the##3##3##(1990-3#1)(2008-12#1)(2013-1#1)
chromosomes in##12##2##(1990-3#1)(1996-6#1)(2008-10#1)(2008-12#3)(2008-4#2)(2008-9#1)(2011-3#1)(2012-3#1)(2013-1#1)
chromosomes of the##3##3##(1997-6#1)(1997-8#1)(2008-12#1)
chromosomes of##11##2##(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#2)(2009-10#1)(2010-5#2)(2010-8#1)
chromosomes that##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
chromosomes was found##2##3##(2008-12#2)
chromosomes was##3##2##(2008-12#2)(2012-3#1)
chromosomes were##3##2##(1997-6#1)(2008-10#1)(2008-9#1)
chromosomes will##2##2##(1996-12#1)(2008-10#1)
chromosomes##207##1##(1990-3#3)(1990-5#2)(1992-12#1)(1993-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#14)(1996-3#2)(1996-6#4)(1996-8#1)(1997-2#5)(1997-3#1)(1997-6#6)(1997-8#1)(1997-9#2)(2007-12#3)(2008-10#32)(2008-11#11)(2008-12#30)(2008-4#7)(2008-7#4)(2008-8#11)(2008-9#19)(2009-10#1)(2009-12#3)(2009-7#1)(2010-1#2)(2010-5#10)(2010-8#2)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#10)(2013-1#4)
chromotropic acid (1##2##3##(2008-10#2)
chromotropic acid##13##2##(2008-10#13)
chronic (1##2##2##(2010-4#2)
chronic (8##2##2##(1991-9#1)(1994-2#1)
chronic Achilles tendinosis##3##3##(2009-10#2)(2010-3#1)
chronic B-lymphocytic leukemia##2##3##(1995-2#2)
chronic EtOH treatment##3##3##(2008-10#3)
chronic EtOH##5##2##(2008-10#5)
chronic H##4##2##(1997-1#4)
chronic HBV infection##2##3##(2009-8#2)
chronic HBV##5##2##(2009-8#3)(2013-1#1)(2013-8#1)
chronic HCV infection##2##3##(2009-8#1)(2013-1#1)
chronic HCV##3##2##(2009-8#1)(2013-1#2)
chronic TRZ##3##2##(1996-12#3)
chronic abdominal pain associated with##2##5##(1995-2#2)
chronic abscess##2##2##(1994-12#1)(2007-8#1)
chronic active hepatitis##3##3##(1993-5#1)(2009-8#2)
chronic active##5##2##(1993-5#1)(2008-5#1)(2009-12#1)(2009-8#2)
chronic administration##4##2##(1992-12#1)(1992-3#2)(2008-10#1)
chronic airway##2##2##(1994-12#1)(2008-7#1)
chronic and acute##4##3##(1991-11#1)(1993-11#1)(2008-5#1)(2012-12#1)
chronic and##7##2##(1991-11#2)(1993-11#1)(2008-5#1)(2009-12#1)(2012-12#1)(2013-1#1)
chronic angina##3##2##(2008-12#3)
chronic ankle pain##2##3##(2010-7#1)(2011-2#1)
chronic ankle##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
chronic bacterial prostatitis##3##3##(2008-10#3)
chronic bacterial##4##2##(2008-10#3)(2010-7#1)
chronic bronchitis##9##2##(1992-5#1)(1994-3#1)(1996-1#2)(1996-11#1)(1997-1#1)(1997-4#1)(2008-7#2)
chronic cancer pain##2##3##(2008-7#2)
chronic care and rehabilitation##3##4##(1993-12#3)
chronic care##6##2##(1992-1#1)(1992-2#1)(1993-12#4)
chronic cerebral hypoperfusion (CCH)##2##4##(2008-7#2)
chronic cerebral hypoperfusion##5##3##(2008-7#4)(2009-6#1)
chronic cerebral##6##2##(2008-7#5)(2009-6#1)
chronic cholecystitis##2##2##(1997-8#1)(2010-12#1)
chronic conditions that share##2##4##(2011-2#2)
chronic conditions##14##2##(1996-1#1)(1997-1#1)(1997-2#3)(2009-10#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
chronic degenerative##2##2##(2009-10#1)(2012-12#1)
chronic dialysis##2##2##(1993-9#1)(2008-1#1)
chronic diarrhea##3##2##(1991-8#2)(2013-1#1)
chronic disease of##2##3##(2008-10#1)(2012-3#1)
chronic disease prevention##2##3##(1997-1#1)(1997-2#1)
chronic disease risk factors##2##4##(1993-3#1)(2008-10#1)
chronic disease##25##2##(1993-11#2)(1993-3#3)(1993-9#1)(1994-5#1)(1994-6#1)(1995-3#1)(1997-1#1)(1997-2#2)(1997-8#2)(2007-8#1)(2008-10#3)(2010-1#4)(2011-2#1)(2012-2#1)(2012-3#1)
chronic diseases and##4##3##(1996-6#1)(2008-10#1)(2008-5#1)(2011-1#1)
chronic diseases in the elderly##2##5##(1991-3#1)(1997-8#1)
chronic diseases in##4##3##(1991-3#1)(1997-8#1)(2008-7#1)(2010-1#1)
chronic diseases including##2##3##(2008-10#1)(2008-6#1)
chronic diseases such as##2##4##(2008-11#1)(2013-1#1)
chronic diseases##29##2##(1991-2#1)(1991-3#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
chronic duodenal##2##2##(1992-11#1)(2008-12#1)
chronic ear##2##2##(2011-2#2)
chronic effect##2##2##(2010-12#1)(2013-1#1)
chronic effects##3##2##(1994-5#1)(1996-12#1)(2008-5#1)
chronic empyema##4##2##(2010-1#4)
chronic eosinophilic pneumonia##2##3##(1991-12#2)
chronic exposure to##6##3##(1991-4#2)(2008-10#2)(2008-7#1)(2013-1#1)
chronic exposure##8##2##(1991-4#2)(2008-10#2)(2008-7#2)(2009-7#1)(2013-1#1)
chronic fatigue syndrome##4##3##(1993-2#1)(2008-12#1)(2009-10#1)(2010-1#1)
chronic fatigue##9##2##(1993-2#1)(2008-10#4)(2008-12#1)(2009-10#1)(2010-1#1)(2013-1#1)
chronic fracture dislocation of the ankle##3##6##(2012-2#3)
chronic gastritis##3##2##(1990-11#1)(1996-6#1)(2009-8#1)
chronic granulomatous disease##4##3##(2007-8#1)(2012-12#1)(2013-1#2)
chronic granulomatous inflammation##2##3##(1990-3#2)
chronic granulomatous##9##2##(1990-3#2)(2007-8#2)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#2)
chronic headache##4##2##(1996-11#1)(1996-2#1)(2008-7#1)(2008-9#1)
chronic health##3##2##(1995-3#1)(2008-7#1)(2012-12#1)
chronic heart failure##7##3##(1991-6#1)(2008-7#1)(2009-10#3)(2012-2#1)(2013-8#1)
chronic heart##8##2##(1991-6#1)(2008-7#1)(2009-10#3)(2012-2#1)(2013-8#2)
chronic hemodialysis##3##2##(1991-6#1)(2008-1#2)
chronic hepatitis B virus (HBV) infection##3##6##(2008-10#1)(2009-12#1)(2009-8#1)
chronic hepatitis B virus (HBV)##4##5##(2008-10#1)(2009-12#1)(2009-8#2)
chronic hepatitis B##17##3##(1993-2#1)(1995-10#1)(2008-10#1)(2009-12#1)(2009-8#10)(2011-2#2)(2013-1#1)
chronic hepatitis C patients##2##4##(2009-8#1)(2013-7#1)
chronic hepatitis C virus infection##2##5##(2009-8#1)(2013-1#1)
chronic hepatitis C virus##3##4##(2009-8#2)(2013-1#1)
chronic hepatitis C##16##3##(2009-10#1)(2009-5#2)(2009-8#3)(2010-4#1)(2011-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
chronic hepatitis##38##2##(1993-2#1)(1995-10#2)(2008-10#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-8#15)(2010-4#1)(2011-2#4)(2013-1#7)(2013-7#1)(2013-8#2)
chronic hypoxia##3##2##(1996-12#1)(2010-11#1)(2010-4#1)
chronic if##2##2##(2008-7#1)(2013-1#1)
chronic illness and##2##3##(1997-2#1)(2010-10#1)
chronic illness##10##2##(1991-12#1)(1992-2#1)(1993-3#1)(1997-2#1)(2008-7#2)(2010-10#2)(2011-1#1)(2013-1#1)
chronic illnesses##5##2##(1993-3#4)(2008-11#1)
chronic in##2##2##(1991-5#1)(2013-1#1)
chronic infection##8##2##(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
chronic inflammation and##4##3##(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
chronic inflammation in##2##3##(2009-10#1)(2011-2#1)
chronic inflammation##18##2##(1991-3#1)(1997-8#1)(2008-4#1)(2009-1#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#2)(2013-8#2)
chronic inflammatory nonbacterial prostatitis##2##4##(2008-10#2)
chronic inflammatory process##3##3##(2008-1#1)(2010-6#1)(2013-1#1)
chronic inflammatory##15##2##(1994-5#2)(1997-8#1)(2008-1#1)(2008-10#3)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#3)
chronic interstitial##2##2##(2008-5#1)(2011-2#1)
chronic ischaemia##2##2##(2011-2#2)
chronic kidney disease (CKD)##4##4##(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#1)
chronic kidney disease##17##3##(2008-11#1)(2009-1#2)(2009-5#1)(2010-10#2)(2010-4#2)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)
chronic kidney##18##2##(2008-11#1)(2009-1#2)(2009-5#1)(2010-10#2)(2010-4#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)
chronic lateral##2##2##(1994-2#1)(1997-6#1)
chronic liver disease##13##3##(1991-11#1)(1991-8#1)(2008-1#2)(2008-10#1)(2009-8#5)(2010-12#1)(2013-1#2)
chronic liver##15##2##(1991-11#1)(1991-8#1)(2008-1#2)(2008-10#1)(2009-8#5)(2010-12#1)(2011-2#1)(2013-1#3)
chronic low back pain##5##4##(2010-1#1)(2012-12#2)(2013-1#2)
chronic lung disease##3##3##(1994-6#2)(2012-2#1)
chronic lung##5##2##(1994-3#1)(1994-6#2)(2012-2#2)
chronic lymphocytic leukemia##7##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-6#1)(2011-2#1)
chronic lymphocytic##8##2##(1991-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-6#1)(2011-2#1)
chronic motor##2##2##(2008-4#1)(2012-3#1)
chronic mucocutaneous##2##2##(2011-2#1)(2012-3#1)
chronic muscle pain##2##3##(1997-4#2)
chronic myelogenous leukemia##2##3##(1992-9#1)(2009-7#1)
chronic myeloid leukemia (CML)##2##4##(1990-2#1)(2010-11#1)
chronic myeloid leukemia##6##3##(1990-2#2)(1997-5#1)(2008-10#1)(2010-11#2)
chronic neutrophilic leukemia##2##3##(2009-8#2)
chronic nonmalignant pain##5##3##(2010-3#5)
chronic obstructive lung disease##2##4##(1995-2#1)(2008-7#1)
chronic obstructive lung disease]##2##4##(2008-1#2)
chronic obstructive lung##5##3##(1995-2#2)(2008-1#2)(2008-7#1)
chronic obstructive pulmonary disease (COPD) in##2##6##(1995-12#1)(2011-2#1)
chronic obstructive pulmonary disease (COPD)##13##5##(1992-3#1)(1995-12#1)(1996-1#2)(2008-1#1)(2010-10#1)(2011-2#4)(2012-12#1)(2013-8#2)
chronic obstructive pulmonary disease##24##4##(1992-3#1)(1995-12#2)(1996-1#2)(2007-12#1)(2008-1#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-8#2)
chronic obstructive pulmonary##29##3##(1992-3#1)(1993-11#1)(1995-12#2)(1996-1#2)(2007-12#1)(2008-1#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2011-2#10)(2012-12#1)(2012-2#1)(2013-8#3)
chronic obstructive##34##2##(1992-3#1)(1993-11#1)(1995-12#2)(1995-2#2)(1996-1#2)(2007-12#1)(2008-1#3)(2008-7#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2011-2#10)(2012-12#1)(2012-2#1)(2013-8#3)
chronic osteomyelitis##4##2##(2008-9#1)(2010-6#3)
chronic otitis media##2##3##(1990-3#1)(2008-9#1)
chronic otitis##3##2##(1990-3#1)(1991-3#1)(2008-9#1)
chronic pain and##2##3##(2008-11#1)(2012-3#1)
chronic pain in##2##3##(2008-12#1)(2010-4#1)
chronic pain patients##3##3##(1991-1#1)(2008-4#1)(2010-9#1)
chronic pain syndrome##4##3##(2008-4#2)(2009-11#1)(2012-3#1)
chronic pain syndromes##2##3##(2008-4#2)
chronic pain##26##2##(1991-1#1)(1997-8#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#7)(2008-9#1)(2009-11#2)(2010-3#1)(2010-4#1)(2010-9#1)(2012-3#3)(2013-1#2)
chronic pancreatitis##9##2##(1992-11#2)(2009-7#6)(2011-2#1)
chronic patients with##2##3##(2008-12#1)(2011-1#1)
chronic patients##4##2##(1997-2#1)(2008-12#1)(2011-1#1)(2012-12#1)
chronic pelvic##2##2##(1994-3#1)(2008-10#1)
chronic periodontitis and peri-implantitis##2##4##(2013-1#2)
chronic periodontitis##10##2##(2008-12#6)(2013-1#4)
chronic phase of##2##3##(2008-12#1)(2013-8#1)
chronic phase##3##2##(2008-12#2)(2013-8#1)
chronic pulmonary heart disease##2##4##(2011-2#2)
chronic pulmonary##3##2##(2010-5#1)(2011-2#2)
chronic pyelonephritis##3##2##(2011-2#3)
chronic relapsing##4##2##(1991-2#1)(1993-8#1)(2009-7#1)(2013-7#1)
chronic renal disease##7##3##(1994-3#1)(2008-1#2)(2008-10#3)(2011-2#1)
chronic renal failure (CRF)##3##4##(2008-1#2)(2011-2#1)
chronic renal failure and##2##4##(1993-3#1)(2008-12#1)
chronic renal failure in##2##4##(1995-5#1)(2008-1#1)
chronic renal failure who##2##4##(1993-2#1)(2013-1#1)
chronic renal failure##19##3##(1991-11#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-5#1)(2008-1#6)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
chronic renal failure]##2##3##(1997-2#1)(2008-10#1)
chronic renal insufficiency##4##3##(1993-3#1)(2011-2#2)(2011-3#1)
chronic renal##32##2##(1991-11#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-1#8)(2008-10#4)(2008-12#1)(2011-2#5)(2011-3#1)(2012-3#1)(2013-1#2)
chronic respiratory##2##2##(1992-3#1)(2012-2#1)
chronic rhinosinusitis##2##2##(2011-2#2)
chronic sclerosing dacryoadenitis with high level of IgG4##2##8##(2011-2#2)
chronic sclerosing dacryoadenitis with high level of##3##7##(2011-2#3)
chronic skin##4##2##(1991-6#1)(1997-8#1)(2012-3#2)
chronic sorrow##3##2##(2009-9#3)
chronic stress##3##2##(1991-1#1)(2008-11#2)
chronic subdural hematoma##3##3##(2008-7#3)
chronic suppurative lung disease##2##4##(1994-12#1)(1997-1#1)
chronic suppurative lung##4##3##(1994-12#3)(1997-1#1)
chronic suppurative##7##2##(1994-12#4)(1997-1#1)(2008-9#1)(2010-12#1)
chronic thromboembolic pulmonary hypertension##2##4##(2009-10#1)(2013-1#1)
chronic thromboembolic pulmonary##3##3##(2009-10#1)(2010-10#1)(2013-1#1)
chronic thromboembolic##4##2##(2009-10#1)(2010-10#2)(2013-1#1)
chronic total occlusion##5##3##(2008-11#3)(2008-12#2)
chronic total occlusions##4##3##(2008-11#1)(2008-12#3)
chronic total##9##2##(2008-11#4)(2008-12#5)
chronic treatment with vigabatrin##2##4##(1992-3#2)
chronic treatment with##6##3##(1992-3#2)(1997-1#1)(1997-2#1)(2010-6#1)(2013-1#1)
chronic treatment##8##2##(1992-3#2)(1994-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2010-6#1)(2013-1#1)
chronic uremia##2##2##(2010-3#1)(2011-2#1)
chronic use of##3##3##(1991-1#1)(2008-12#1)(2012-12#1)
chronic use##4##2##(1991-1#1)(2008-12#1)(2010-12#1)(2012-12#1)
chronic vasculitis mainly involving##2##4##(1997-8#2)
chronic venous disorders##3##3##(2010-7#3)
chronic venous insufficiency##3##3##(2013-1#3)
chronic venous##6##2##(2010-7#3)(2013-1#3)
chronic viral##2##2##(2007-12#1)(2010-5#1)
chronic whiplash##3##2##(2008-12#2)(2013-1#1)
chronic wounds##5##2##(2008-9#4)(2012-3#1)
chronic wrist pain##8##3##(2008-9#8)
chronic##864##1##(1990-11#1)(1990-2#3)(1990-3#5)(1991-1#6)(1991-11#4)(1991-12#3)(1991-2#6)(1991-3#5)(1991-4#3)(1991-5#1)(1991-6#6)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#6)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#4)(1993-2#3)(1993-3#13)(1993-5#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#7)(1994-3#7)(1994-5#8)(1994-6#5)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#8)(1995-3#2)(1995-5#1)(1996-1#5)(1996-11#2)(1996-12#10)(1996-2#3)(1996-6#3)(1997-1#12)(1997-2#12)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#2)(1997-8#12)(2007-11#1)(2007-12#2)(2007-8#7)(2008-1#17)(2008-10#50)(2008-11#23)(2008-12#32)(2008-2#1)(2008-3#1)(2008-4#15)(2008-5#13)(2008-6#2)(2008-7#35)(2008-9#25)(2009-1#4)(2009-10#12)(2009-11#3)(2009-12#5)(2009-5#3)(2009-6#2)(2009-7#14)(2009-8#32)(2009-9#4)(2010-1#12)(2010-10#10)(2010-11#4)(2010-12#18)(2010-2#2)(2010-3#10)(2010-4#8)(2010-5#3)(2010-6#6)(2010-7#10)(2010-9#3)(2011-1#6)(2011-2#78)(2011-3#2)(2012-12#12)(2012-2#20)(2012-3#29)(2012-5#4)(2013-1#67)(2013-7#6)(2013-8#18)
chronic)##2##1##(2008-11#2)
chronical##2##1##(1996-6#1)(2011-2#1)
chronically ill and##2##3##(1995-2#1)(2013-8#1)
chronically ill##3##2##(1995-2#1)(1996-12#1)(2013-8#1)
chronically implanted##2##2##(1994-8#1)(2008-11#1)
chronically mentally ill Medicaid beneficiaries##2##5##(1994-2#2)
chronically mentally ill Medicaid##3##4##(1994-2#3)
chronically mentally ill##5##3##(1992-1#1)(1994-2#3)(1997-2#1)
chronically obstructed coronary arteries##2##4##(1992-9#2)
chronically obstructed##3##2##(1992-9#2)(2013-1#1)
chronically stressed##2##2##(2008-11#2)
chronically treated##3##2##(1993-2#1)(1994-8#1)(2008-7#1)
chronically##41##1##(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#3)(1995-2#1)(1996-12#2)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#2)(2008-11#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
chronicity of##2##2##(2007-11#1)(2008-11#1)
chronicity##3##1##(2007-11#1)(2008-11#1)(2008-4#1)
chronicles##2##1##(2008-4#1)(2010-6#1)
chronoamperometric##3##1##(2008-10#3)
chronoamperometry##7##1##(2008-10#7)
chronocoulometry##3##1##(2008-10#3)
chronological##6##1##(2008-7#2)(2008-8#1)(2010-6#1)(2012-2#1)(2012-3#1)
chronology##5##1##(1993-12#1)(1996-11#1)(2008-10#3)
chronopharmacology##2##1##(2008-5#2)
chronopotentiometric##8##1##(2008-10#8)
chronopotentiometry##5##1##(2008-10#5)
chrysantha##2##1##(2009-8#2)
chrysanthemi##2##1##(2008-10#2)
chrysanthemum##5##1##(2008-10#5)
chrysemydis##2##1##(2008-9#2)
chrysene##7##1##(1994-5#1)(2008-10#6)
chrysosporium##12##1##(1990-12#2)(2008-11#2)(2008-6#3)(2008-7#2)(2009-9#3)
chrysotile and amosite##2##3##(1991-12#2)
chrysotile and##3##2##(1991-12#3)
chrysotile fibers were##2##3##(1991-12#2)
chrysotile fibers##3##2##(1991-12#3)
chrysotile##14##1##(1991-12#14)
chrysotile/tremolite##2##1##(1991-12#2)
chuanxiong and##2##2##(2012-3#1)(2013-8#1)
chum salmon##3##2##(1993-3#3)
chunks##2##1##(2010-4#2)
church##13##1##(1990-6#1)(1990-9#1)(1991-12#1)(2008-10#4)(2009-11#2)(2010-10#1)(2010-2#3)
churches##3##1##(2008-1#1)(2008-10#1)(2008-11#1)
chylomicron metabolism##2##2##(2008-10#2)
chylomicron production##2##2##(2008-10#2)
chylomicron##4##1##(2008-10#4)
chylomicrons and very low density lipoproteins##2##6##(1992-3#1)(1995-2#1)
chylomicrons##5##1##(1992-3#1)(1995-2#1)(2008-10#3)
chylothorax##3##1##(1990-9#2)(1991-11#1)
chymosin##5##1##(1995-6#1)(2008-7#4)
chymotrypsin##5##1##(1990-2#1)(1990-5#1)(1995-6#1)(2008-10#1)(2011-2#1)
chymotrypsin-like##2##1##(1994-5#1)(2008-5#1)
chymotryptic##2##1##(1992-4#1)(1993-8#1)
cicada##2##1##(2008-8#2)
cicadas##8##1##(2008-9#8)
ciceris and##5##2##(2008-10#5)
ciceris in##2##2##(2008-10#2)
ciceris isolates##2##2##(2008-10#2)
ciceris on##2##2##(2008-10#2)
ciceris race 5 in##2##4##(2008-10#2)
ciceris race 5##8##3##(2008-10#8)
ciceris race##10##2##(2008-10#10)
ciceris##30##1##(2008-10#30)
cichlid##4##1##(2008-5#1)(2010-8#3)
cichoracearum##3##1##(2008-10#3)
cichoric acid##2##2##(2008-10#2)
ciclesonide##3##1##(2008-8#3)
cider##3##1##(2008-10#3)
cigarette samples##3##2##(2008-10#3)
cigarette smoke and##3##3##(1993-8#1)(2008-1#1)(2008-5#1)
cigarette smoke##16##2##(1993-8#4)(2008-1#1)(2008-5#10)(2013-8#1)
cigarette smoking and##2##3##(1991-11#1)(2010-5#1)
cigarette smoking##21##2##(1991-11#1)(1991-12#3)(1992-6#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-12#3)(2008-7#2)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
cigarette use among peers and##2##5##(2013-1#2)
cigarette use among##3##3##(2013-1#3)
cigarette use##5##2##(1996-1#1)(2013-1#4)
cigarette##50##1##(1990-2#1)(1991-11#1)(1991-12#3)(1991-9#1)(1992-6#1)(1993-8#4)(1996-1#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#3)(2008-4#1)(2008-5#11)(2008-7#2)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#5)(2013-8#4)
cigarettes per day)##3##3##(1994-6#3)
cigarettes per##5##2##(1991-11#1)(1994-6#4)
cigarettes##25##1##(1991-11#2)(1991-12#1)(1991-9#2)(1993-11#1)(1993-2#1)(1994-6#4)(2008-10#3)(2009-11#1)(2009-5#1)(2009-7#4)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
cilia##6##1##(1996-9#1)(2008-9#1)(2013-1#4)
ciliary neurotrophic factor (CNTF)##2##4##(1990-5#1)(1996-2#1)
ciliary neurotrophic factor##3##3##(1990-5#1)(1996-2#2)
ciliary##13##1##(1990-5#1)(1992-8#4)(1995-11#1)(1996-2#2)(1997-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
ciliate##2##1##(2010-4#1)(2012-3#1)
ciliated cells##2##2##(1996-1#1)(2011-2#1)
ciliated##6##1##(1996-1#1)(2008-11#1)(2008-6#2)(2011-2#2)
cilicica##2##1##(2008-11#2)
cilium##9##1##(2008-7#2)(2013-1#7)
cimetidine##9##1##(2008-11#9)
cinchona-alkaloid##3##1##(2008-10#3)
cinchona-alkaloids##2##1##(2008-10#2)
cine and phase contrast##2##4##(2013-3#2)
cine computed tomographic##3##3##(2013-1#3)
cine##7##1##(2013-1#5)(2013-3#2)
cinerea and U##3##3##(2008-10#3)
cinerea and the##3##3##(2008-10#3)
cinerea and##14##2##(2008-10#13)(2008-5#1)
cinerea as##2##2##(2008-10#2)
cinerea by##5##2##(2008-10#5)
cinerea collected from##2##3##(2008-10#2)
cinerea colonies##2##2##(2008-10#2)
cinerea colonized##2##2##(2008-10#2)
cinerea conidia##6##2##(2008-10#6)
cinerea development##2##2##(2008-10#2)
cinerea during pathogen sporulation##2##4##(2008-10#2)
cinerea in##9##2##(2008-10#9)
cinerea infection##3##2##(2008-10#3)
cinerea inoculation##3##2##(2008-10#3)
cinerea is##2##2##(2008-10#2)
cinerea isolates##2##2##(2008-10#2)
cinerea on geranium##2##3##(2008-10#2)
cinerea on##11##2##(2008-10#11)
cinerea or##2##2##(2008-10#2)
cinerea was##11##2##(2008-10#11)
cinerea were subcultured##2##3##(2008-10#2)
cinerea were##5##2##(2008-10#5)
cinerea##178##1##(2008-10#173)(2008-5#1)(2008-8#2)(2009-6#1)(2011-10#1)
cinerea)##2##1##(2008-10#2)
cinereus##5##1##(2010-7#1)(2010-8#4)
cingulata capable of causing both GLS and bitter rot##2##9##(2008-10#2)
cingulata from the United States##2##5##(2008-10#2)
cingulata were##2##2##(2008-10#2)
cingulata##14##1##(2008-10#14)
cingulate cortex##6##2##(1994-3#1)(2008-11#3)(2009-10#1)(2013-8#1)
cingulate lesioned##2##2##(1994-3#2)
cingulate##13##1##(1994-3#4)(1996-2#1)(2008-11#5)(2009-10#1)(2013-8#2)
cinnabar and##2##2##(2008-5#2)
cinnabar##8##1##(2008-10#6)(2008-5#2)
cinnamate##4##1##(2008-5#2)(2011-1#2)
cinnamic acid derived cross-linker##2##4##(2010-4#2)
cinnamic acid##6##2##(2008-10#3)(2008-11#1)(2010-4#2)
cinnamic aldehyde##2##2##(2008-5#2)
cinnamic##9##1##(2008-10#4)(2008-11#1)(2008-5#2)(2010-4#2)
cinnamomi in##3##2##(2008-10#3)
cinnamomi##21##1##(2008-10#21)
cinnamyl alcohol dehydrogenase##2##3##(2008-10#2)
ciprofibrate##6##1##(1990-12#3)(1990-5#2)(1997-5#1)
ciprofloxacin 0##2##2##(2012-3#2)
ciprofloxacin and##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
ciprofloxacin hydrochloride and##2##3##(2008-10#2)
ciprofloxacin hydrochloride##3##2##(2008-10#3)
ciprofloxacin in##6##2##(2007-8#1)(2008-10#5)
ciprofloxacin##38##1##(1991-4#3)(2007-12#2)(2007-8#1)(2008-10#20)(2008-7#5)(2010-12#1)(2011-2#2)(2012-3#4)
circadian clock and##4##3##(1995-2#1)(2009-8#3)
circadian clock##8##2##(1995-2#3)(2009-8#5)
circadian clock-##2##2##(1995-2#2)
circadian pacemaker##4##2##(1994-2#3)(1996-2#1)
circadian phase##2##2##(2008-5#2)
circadian rhythm in##3##3##(1994-2#1)(1997-2#1)(2008-5#1)
circadian rhythm of##2##3##(1992-2#1)(2008-12#1)
circadian rhythm##12##2##(1992-2#1)(1993-6#1)(1994-2#1)(1995-11#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-5#3)(2011-2#1)
circadian rhythms and##2##3##(1996-2#1)(2013-1#1)
circadian rhythms##5##2##(1990-5#1)(1996-2#1)(2009-8#1)(2013-1#1)(2013-7#1)
circadian variation##2##2##(1997-2#1)(2008-11#1)
circadian##57##1##(1990-5#3)(1992-2#1)(1993-6#1)(1994-2#4)(1995-11#1)(1995-2#6)(1996-2#2)(1997-2#2)(2008-10#1)(2008-11#8)(2008-12#1)(2008-5#11)(2009-7#3)(2009-8#7)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#3)
circannual##2##1##(2008-11#2)
circasemiseptan##3##1##(2008-11#3)
circaseptan##6##1##(2008-11#6)
circinatum##2##1##(2008-10#2)
circle of##3##2##(1995-11#1)(2008-7#1)(2011-2#1)
circle##15##1##(1990-2#1)(1993-1#1)(1994-12#1)(1995-11#1)(1997-6#2)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#3)(2011-2#2)
circle)) of##3##2##(2008-10#3)
circles##2##1##(2008-10#1)(2013-8#1)
circovirus##3##1##(2008-5#3)
circuit and the##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
circuit and##9##2##(2008-10#3)(2008-11#3)(2010-8#1)(2010-9#1)(2012-2#1)
circuit for##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
circuit in##4##2##(2008-11#4)
circuit is##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
circuit of##2##2##(1996-12#1)(2008-11#1)
circuit or##2##2##(2008-10#1)(2011-2#1)
circuit support arm##2##3##(2011-2#2)
circuit that##2##2##(2008-10#1)(2008-3#1)
circuit to##2##2##(1995-12#1)(2009-5#1)
circuit##87##1##(1992-1#4)(1995-12#1)(1995-2#1)(1996-12#2)(1997-6#1)(2008-10#20)(2008-11#22)(2008-2#1)(2008-3#9)(2008-8#1)(2009-5#2)(2009-8#3)(2010-12#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-8#3)
circuitry that##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
circuitry underlying##4##2##(2008-11#4)
circuitry##28##1##(1992-6#1)(1994-8#2)(2008-10#1)(2008-11#10)(2008-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#7)
circuits and the##2##3##(1995-3#1)(2009-5#1)
circuits and##6##2##(1995-3#1)(2008-9#1)(2009-5#1)(2010-9#2)(2013-8#1)
circuits are##2##2##(1990-5#1)(2008-11#1)
circuits in the##2##3##(1990-5#1)(2013-8#1)
circuits is##2##2##(2008-11#1)(2013-8#1)
circuits of##3##2##(1994-8#1)(2007-12#1)(2008-11#1)
circuits that##4##2##(2008-11#2)(2009-9#1)(2013-8#1)
circuits##49##1##(1990-5#3)(1992-1#2)(1994-8#3)(1995-3#1)(2007-12#1)(2008-11#12)(2008-3#6)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-9#2)(2011-2#1)(2012-2#2)(2013-8#7)
circular Gaussian##2##2##(2008-2#1)(2008-6#1)
circular and linear##2##3##(1990-5#1)(2008-10#1)
circular aperture##2##2##(2008-2#1)(2008-3#1)
circular cylinder##2##2##(2008-2#1)(2008-3#1)
circular dichroism (CD)##4##3##(1990-5#1)(1995-2#1)(2008-10#2)
circular dichroism and##2##3##(1994-5#1)(2008-10#1)
circular dichroism in##2##3##(1992-8#1)(1993-8#1)
circular dichroism spectra##2##3##(1992-1#1)(2008-9#1)
circular dichroism##20##2##(1990-5#1)(1992-1#1)(1992-6#1)(1992-8#2)(1993-8#3)(1994-5#1)(1995-2#1)(2008-10#8)(2008-4#1)(2008-9#1)
circular lesions##2##2##(2008-10#1)(2008-12#1)
circular or##2##2##(2008-10#1)(2008-3#1)
circular single-stranded##2##2##(1995-2#1)(2008-10#1)
circular##76##1##(1990-5#2)(1991-2#1)(1992-1#1)(1992-6#2)(1992-8#2)(1993-6#1)(1993-8#3)(1994-11#1)(1994-5#1)(1995-2#2)(1996-6#1)(1997-3#1)(1997-4#3)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-7#2)(2011-2#2)
circularization##3##1##(1994-5#1)(1997-6#1)(2008-4#1)
circulate##3##1##(1991-5#1)(1997-2#1)(2013-8#1)
circulated##4##1##(2008-10#2)(2010-2#1)(2013-8#1)
circulating AFP mRNA in##2##4##(2008-10#2)
circulating AFP mRNA##6##3##(2008-10#6)
circulating antibody##2##2##(2006-6#1)(2012-2#1)
circulating blood##2##2##(2008-7#2)
circulating cells##2##2##(2008-11#1)(2010-8#1)
circulating factors##3##2##(1992-3#1)(2010-6#2)
circulating immune complexes##4##3##(1990-12#2)(1997-8#2)
circulating in the##3##3##(2008-3#1)(2008-7#1)(2012-3#1)
circulating in##5##2##(2008-3#2)(2008-7#1)(2012-3#1)(2013-8#1)
circulating leukocytes##2##2##(2008-9#1)(2013-1#1)
circulating levels##2##2##(1990-2#1)(1992-9#1)
circulating lipid and glucose levels##2##5##(2008-10#2)
circulating platelets##3##2##(2006-6#1)(2008-9#2)
circulating testosterone##2##2##(2008-8#1)(2008-9#1)
circulating##86##1##(1990-12#2)(1990-2#1)(1990-6#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-9#1)(1996-12#1)(1997-8#2)(2006-6#3)(2008-1#2)(2008-10#15)(2008-11#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
circulation and##7##2##(1994-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
circulation can##3##2##(1996-1#1)(1997-1#1)(2013-8#1)
circulation in##6##2##(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#2)(2010-3#1)
circulation may##2##2##(1990-8#1)(2013-8#1)
circulation of the##3##3##(2008-10#2)(2009-10#1)
circulation of##12##2##(1992-3#1)(1993-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2009-10#1)(2009-8#1)(2012-12#2)
circulation through##3##2##(2008-7#1)(2009-10#2)
circulation were##2##2##(2008-10#2)
circulation##82##1##(1990-8#1)(1992-3#3)(1993-3#1)(1993-6#1)(1994-1#1)(1994-8#2)(1996-1#4)(1996-11#1)(1996-3#2)(1997-1#6)(1997-2#2)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#3)(2009-10#4)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#8)(2013-1#1)(2013-8#5)
circulation)##3##1##(1990-9#1)(2011-1#2)
circulative transmission##2##2##(2008-10#2)
circulative##3##1##(2008-10#3)
circulatory arrest##3##2##(2013-1#3)
circulatory failure##3##2##(1992-5#1)(1996-3#1)(2008-5#1)
circulatory pattern##2##2##(1996-3#2)
circulatory support##5##2##(2008-11#1)(2009-10#1)(2010-6#3)
circulatory system##2##2##(2010-7#2)
circulatory##25##1##(1991-2#1)(1992-5#1)(1995-2#1)(1996-3#3)(2008-10#4)(2008-11#1)(2008-5#1)(2009-10#2)(2010-6#3)(2010-7#2)(2011-2#2)(2012-3#1)(2013-1#3)
circumcincta##2##1##(1996-12#2)
circumcision##5##1##(1991-8#3)(1997-4#1)(2008-10#1)
circumference and##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
circumference of the##2##3##(1991-11#1)(2013-1#1)
circumference##36##1##(1991-11#1)(1996-11#1)(1996-8#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-4#1)(2008-7#7)(2010-4#1)(2011-1#3)(2011-2#6)(2013-1#3)(2013-8#1)
circumferential wall##2##2##(1997-8#1)(2009-7#1)
circumferential##11##1##(1997-8#1)(2008-8#4)(2009-3#1)(2009-7#3)(2010-10#1)(2011-2#1)
circumflex artery##3##2##(2008-8#1)(2013-1#2)
circumflex##4##1##(2008-8#1)(2013-1#3)
circumpolar indigenous##4##2##(2013-1#4)
circumscribed##8##1##(1990-11#1)(1990-2#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2013-8#2)
circumstances (e##2##2##(2010-11#1)(2011-2#1)
circumstances and##4##2##(1991-3#1)(2008-10#1)(2009-8#1)(2013-1#1)
circumstances are##2##2##(2008-10#1)(2010-10#1)
circumstances in which##3##3##(1996-8#1)(2008-10#1)(2008-4#1)
circumstances in##4##2##(1996-5#1)(1996-8#1)(2008-10#1)(2008-4#1)
circumstances of##2##2##(2008-10#1)(2008-12#1)
circumstances that##2##2##(2008-11#1)(2012-12#1)
circumstances the##2##2##(1993-12#1)(2008-5#1)
circumstances under which##2##3##(2008-11#1)(2008-12#1)
circumstances where##4##2##(1991-12#1)(1992-9#1)(1993-12#1)(2008-10#1)
circumstances##68##1##(1990-3#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#4)(1994-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(2008-10#7)(2008-11#5)(2008-12#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
circumstantial constraints##2##2##(2008-12#2)
circumstantial evidence##2##2##(2008-10#2)
circumstantial##5##1##(1992-3#1)(2008-10#2)(2008-12#2)
circumvent the##7##2##(2008-10#3)(2010-1#1)(2010-3#1)(2012-2#1)(2012-3#1)
circumvent these problems##2##3##(1997-8#1)(2011-2#1)
circumvent##16##1##(1992-8#1)(1997-8#1)(2008-10#8)(2008-11#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
circumvented##2##1##(2008-10#2)
circumventing the##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
circumventing##5##1##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
circumvents the##3##2##(2007-12#1)(2008-10#1)(2010-5#1)
circumvents##5##1##(1991-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-5#1)
cirrhosis (Child's class##2##3##(2009-8#2)
cirrhosis and portal hypertension##3##4##(2009-8#2)(2010-10#1)
cirrhosis and##11##2##(1992-2#1)(1993-2#1)(2009-12#1)(2009-8#3)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
cirrhosis with##2##2##(2009-8#1)(2013-1#1)
cirrhosis##48##1##(1990-8#1)(1992-12#3)(1992-2#1)(1992-9#2)(1993-12#1)(1993-2#3)(1996-11#1)(1997-5#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-8#10)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-3#6)(2013-1#7)(2013-8#1)
cirrhosis]##2##1##(1991-11#1)(2009-1#1)
cirrhotic patient with ascites##2##4##(2011-2#2)
cirrhotic patient##3##2##(2011-2#3)
cirrhotic##9##1##(1993-3#1)(2009-8#3)(2010-12#2)(2011-2#3)
cirrhotics##11##1##(2009-8#2)(2012-3#9)
cirri##3##1##(2008-10#3)
cirrus cloud##3##2##(2008-3#3)
cirrus clouds##4##2##(2008-3#4)
cirrus##9##1##(2008-3#9)
cis element of##2##3##(2008-9#1)(2009-8#1)
cis elements##2##2##(2008-10#1)(2009-8#1)
cis isomers of##2##3##(1990-9#1)(1992-9#1)
cis isomers##3##2##(1990-9#1)(1992-9#1)(1995-6#1)
cis peptide bond##2##3##(2008-9#2)
cis regulatory##2##2##(2008-10#1)(2008-9#1)
cis##19##1##(1990-9#4)(1991-6#1)(1992-9#1)(1993-2#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-9#4)(2009-8#2)(2013-1#1)
cis- and##4##2##(1996-5#1)(2008-10#2)(2012-2#1)
cis-##6##1##(1993-6#1)(1995-2#1)(1996-5#1)(2008-10#2)(2012-2#1)
cis-aconitic##3##1##(1997-7#2)(2010-6#1)
cis-acting DNA##2##2##(1993-3#1)(1993-8#1)
cis-acting element in##2##3##(1993-6#1)(1995-6#1)
cis-acting element##6##2##(1993-6#1)(1995-6#2)(2008-8#2)(2012-2#1)
cis-acting elements were##2##3##(1991-6#1)(1993-12#1)
cis-acting elements##5##2##(1991-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(2008-10#1)
cis-acting##18##1##(1991-6#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1995-6#2)(2008-10#2)(2008-7#1)(2008-8#2)(2012-2#1)(2013-1#1)
cis-element##4##1##(1996-12#1)(2008-8#1)(2008-9#1)(2009-8#1)
cis-elements##3##1##(1993-12#2)(2008-9#1)
cis-flupenthixol##6##1##(1993-6#6)
cis-platin and##3##2##(1994-5#1)(2008-10#2)
cis-platin##7##1##(1994-5#3)(2008-10#4)
cis-regulatory elements##5##2##(2008-7#1)(2009-10#2)(2010-1#1)(2012-3#1)
cis-regulatory##9##1##(1994-11#1)(1995-2#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-1#1)(2012-3#2)
cis/trans##2##1##(1991-5#2)
cisapride and BRL 24924##3##4##(1990-5#3)
cisapride and##4##2##(1990-5#4)
cisapride##6##1##(1990-5#6)
cisatracurium and mivacurium##2##3##(2008-10#2)
cisatracurium##7##1##(2008-10#7)
cisplatin and radiotherapy##2##3##(1991-2#1)(1993-9#1)
cisplatin and##8##2##(1990-12#1)(1991-2#1)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(2008-10#1)
cisplatin in##4##2##(1991-6#1)(1991-8#1)(1993-8#2)
cisplatin infusion##2##2##(1990-12#2)
cisplatin nephrotoxicity##2##2##(1990-12#2)
cisplatin##46##1##(1990-12#10)(1990-6#1)(1991-2#2)(1991-6#2)(1991-8#2)(1992-12#2)(1993-1#1)(1993-2#3)(1993-8#4)(1993-9#1)(1994-12#1)(1995-10#2)(2008-10#9)(2008-11#2)(2008-9#2)(2013-1#2)
cisplatin-induced apoptosis##2##2##(1993-2#2)
cisplatin-induced##6##1##(1990-12#2)(1990-6#1)(1993-2#2)(2013-1#1)
cistern##6##1##(1993-1#3)(2011-2#1)(2012-3#2)
cisterna chyli##2##2##(2012-3#2)
cisterna##4##1##(2008-7#1)(2012-3#2)(2013-1#1)
cisternae##6##1##(2008-7#6)
cisternography##3##1##(2008-12#1)(2011-2#2)
cisterns##2##1##(2008-7#2)
cistron##6##1##(1993-12#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
cistrons##2##1##(1993-12#1)(2008-10#1)
cit##2##1##(1992-9#1)(1996-6#1)
citA##4##1##(1997-4#4)
citalopram and venlafaxine##2##3##(2012-2#2)
citalopram##10##1##(2008-7#1)(2009-7#1)(2012-2#3)(2012-3#5)
citation##9##1##(2008-10#1)(2008-9#1)(2009-11#1)(2010-12#3)(2013-1#3)
citations##11##1##(1994-3#1)(1996-2#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
cite##5##1##(1996-3#1)(2011-2#4)
cited as the most##2##4##(1996-2#1)(2008-11#1)
cited as##8##2##(1994-1#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2013-1#1)
cited in##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
cited ions in##2##3##(2008-10#2)
cited##24##1##(1993-3#1)(1994-1#1)(1996-2#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-3#1)(2013-1#1)
cites the##2##2##(1991-3#1)(1993-2#1)
cites##4##1##(1990-8#1)(1991-3#1)(1993-2#1)(1994-3#1)
cities and states##2##3##(1990-11#2)
cities and##5##2##(1990-11#2)(2008-10#1)(2008-11#1)(2010-1#1)
cities in##6##2##(1990-11#2)(2008-10#3)(2008-3#1)
cities of##5##2##(2008-10#2)(2012-12#2)(2013-8#1)
cities##33##1##(1990-11#5)(1991-1#1)(1994-2#1)(1995-3#1)(1997-6#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#1)(2010-1#1)(2010-10#1)(2012-12#2)(2013-1#1)(2013-8#1)
citing a##2##2##(1992-11#1)(1995-12#1)
citing##7##1##(1992-11#1)(1995-12#1)(2008-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)
citizen participation in health care policy reform##2##7##(1997-2#2)
citizen participation in##3##3##(1992-2#1)(1997-2#2)
citizen participation##4##2##(1992-2#1)(1993-3#1)(1997-2#2)
citizen##5##1##(1992-2#1)(1993-3#1)(1997-2#2)(1997-3#1)
citizens in##2##2##(1995-3#1)(2012-3#1)
citizens of##3##2##(2008-12#1)(2009-10#1)(2009-3#1)
citizens##13##1##(1992-12#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-2#1)(2008-12#1)(2009-10#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-3#1)
citrate (SC)##3##2##(2008-10#2)(2011-2#1)
citrate and l-lactate##2##3##(2008-10#2)
citrate and##5##2##(2008-10#5)
citrate at##2##2##(2012-2#2)
citrate buffer solution##2##3##(2008-10#2)
citrate buffer##4##2##(2008-10#4)
citrate ions##2##2##(1992-9#2)
citrate synthase gene##3##3##(1995-12#1)(1997-4#1)(1997-8#1)
citrate synthase of##2##3##(1997-4#2)
citrate synthase##9##2##(1995-12#1)(1997-4#4)(1997-8#3)(2008-7#1)
citrate##68##1##(1992-9#6)(1995-12#1)(1996-6#1)(1997-4#4)(1997-7#1)(1997-8#3)(2007-7#1)(2008-10#33)(2008-12#1)(2008-5#1)(2008-7#4)(2010-4#1)(2011-2#8)(2012-2#2)(2012-5#1)
citri and##3##2##(2008-10#3)
citri by##2##2##(2008-10#2)
citri causes##2##2##(2008-10#2)
citri in##5##2##(2008-10#5)
citri infection##2##2##(2008-10#2)
citri on##2##2##(2008-10#2)
citri population sizes##2##3##(2008-10#2)
citri population##3##2##(2008-10#3)
citri proteins##3##2##(2008-10#3)
citri to##3##2##(2008-10#3)
citri##69##1##(2008-10#69)
citri-infected shoots##3##2##(2008-10#3)
citri-infected##7##1##(2008-10#7)
citric acid was##4##3##(2008-10#4)
citric acid##34##2##(2008-10#28)(2013-1#6)
citric and gluconic##2##3##(2008-10#2)
citric##43##1##(2008-10#36)(2008-5#1)(2013-1#6)
citricarpa##5##1##(2008-10#5)
citricida##9##1##(2008-10#9)
citricola##2##1##(2008-10#1)(2010-3#1)
citrinin##8##1##(1993-12#8)
citrophthora in California##2##3##(2008-10#2)
citrulli was detected##2##3##(2008-10#2)
citrulli was##3##2##(2008-10#3)
citrulli##16##1##(2008-10#16)
citrulline##2##1##(1996-2#2)
citrumelo##4##1##(2008-10#4)
citrus and coffee##2##3##(2008-10#2)
citrus and noncitrus hosts##2##4##(2008-10#2)
citrus and##9##2##(2008-10#9)
citrus are##2##2##(2008-10#2)
citrus bacterial canker##2##3##(2008-10#2)
citrus bacterial##3##2##(2008-10#3)
citrus black rot##3##3##(2008-10#3)
citrus black##4##2##(2008-10#4)
citrus canker##6##2##(2008-10#6)
citrus cultivars##2##2##(2008-10#2)
citrus fruit##12##2##(2008-10#12)
citrus fruits##9##2##(2008-10#8)(2012-12#1)
citrus groves and##2##3##(2008-10#2)
citrus groves##4##2##(2008-10#3)(2013-8#1)
citrus in Florida##2##3##(2008-10#2)
citrus in##4##2##(2008-10#4)
citrus isolates##2##2##(2008-10#2)
citrus leaves##3##2##(2008-10#3)
citrus orchard##3##2##(2008-10#3)
citrus orchards##2##2##(2008-10#2)
citrus roots##3##2##(2008-10#3)
citrus species and##2##3##(2008-10#2)
citrus species##3##2##(2008-10#3)
citrus strains##3##2##(2008-10#3)
citrus trees##4##2##(2008-10#4)
citrus tristeza virus (CTV)##3##4##(2008-10#3)
citrus tristeza virus##9##3##(2008-10#9)
citrus tristeza##10##2##(2008-10#10)
citrus variegated chlorosis##4##3##(2008-10#4)
citrus viroids other than CEVd##2##5##(2008-10#2)
citrus viroids##7##2##(2008-10#7)
citrus##146##1##(2008-10#142)(2012-12#1)(2013-8#3)
city and a##2##3##(1997-6#1)(2008-11#1)
city and##4##2##(1997-6#1)(2008-11#1)(2012-12#1)(2013-1#1)
city in##2##2##(2008-12#1)(2010-9#1)
city of##21##2##(1991-6#1)(1994-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2009-10#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)
city were##2##2##(2008-12#1)(2013-1#1)
city##79##1##(1990-11#3)(1991-1#1)(1991-6#1)(1994-2#1)(1994-9#1)(1995-12#4)(1995-6#1)(1996-12#2)(1996-8#1)(1997-6#4)(2008-10#15)(2008-11#8)(2008-12#7)(2008-5#7)(2009-10#2)(2010-3#1)(2010-9#2)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)
city's##5##1##(1995-12#2)(1996-5#1)(1997-3#1)(2008-11#1)
civil penalty##2##2##(1996-5#2)
civil rights##2##2##(1996-1#1)(2008-11#1)
civil##11##1##(1994-3#2)(1994-9#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-6#1)(2008-11#2)(2012-3#1)
civilian##4##1##(1992-3#2)(1995-6#1)(2010-1#1)
civilians##2##1##(1992-12#1)(2010-7#1)
civilization##3##1##(1991-6#1)(1995-5#2)
cladding layer##2##2##(2008-10#1)(2008-3#1)
cladding modes##3##2##(2008-3#3)
cladding radius##2##2##(2008-3#2)
cladding##9##1##(2008-10#1)(2008-3#8)
clade IR-I##2##2##(2008-10#2)
clade and##4##2##(2008-10#4)
clade as##3##2##(2008-10#2)(2008-6#1)
clade in which the##2##4##(2008-10#2)
clade of##4##2##(2008-10#1)(2009-8#1)(2010-4#1)(2012-3#1)
clade that##2##2##(2008-10#1)(2008-8#1)
clade was##2##2##(2008-10#2)
clade were##3##2##(2008-10#3)
clade with##2##2##(2008-10#2)
clade##55##1##(2008-10#38)(2008-6#2)(2008-8#6)(2008-9#1)(2009-8#2)(2010-4#1)(2011-2#1)(2012-3#2)(2013-8#2)
clades based on##2##3##(2008-10#2)
clades of##3##2##(2008-10#2)(2009-8#1)
clades that##2##2##(2008-10#1)(2008-8#1)
clades##44##1##(2007-12#1)(2008-10#25)(2008-8#9)(2008-9#2)(2009-6#2)(2009-8#1)(2010-4#2)(2013-8#2)
cladistic##3##1##(2007-12#1)(2010-3#2)
cladograms##6##1##(2008-10#2)(2010-3#4)
claim for##3##2##(1995-6#1)(2008-10#1)(2012-3#1)
claim of##3##2##(1995-12#2)(1995-6#1)
claim that the##4##3##(1990-11#1)(1992-2#1)(1992-9#1)(2008-8#1)
claim that##12##2##(1990-11#1)(1992-2#1)(1992-9#1)(1995-6#1)(1996-5#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2013-8#1)
claim to have##2##3##(1995-11#1)(2008-12#1)
claim to##3##2##(1995-11#1)(2008-12#1)(2008-5#1)
claim##39##1##(1990-11#1)(1991-9#1)(1992-2#1)(1992-9#2)(1993-1#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-6#3)(1995-8#1)(1996-2#2)(1996-5#1)(1997-6#1)(2008-10#2)(2008-12#3)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-8#1)
claimed he##2##2##(1995-12#1)(1995-6#1)
claimed that the##2##3##(2008-10#1)(2010-3#1)
claimed that they##2##3##(1995-11#1)(2010-5#1)
claimed that##8##2##(1995-11#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-8#1)
claimed values by the##2##4##(2008-10#2)
claimed values##3##2##(2008-10#3)
claimed##26##1##(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1997-4#3)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#2)
claiming##2##1##(1995-2#1)(2008-7#1)
claims and##4##2##(1993-12#2)(1995-12#1)(2012-2#1)
claims cost##2##2##(1993-1#2)
claims data to##3##3##(1993-12#1)(1996-1#2)
claims data##12##2##(1991-1#1)(1992-2#1)(1993-12#1)(1995-1#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)(2009-9#1)(2013-1#1)
claims for##3##2##(1996-2#1)(2008-5#1)(2009-10#1)
claims in##2##2##(2008-5#1)(2010-3#1)
claims of##6##2##(1996-2#1)(1996-3#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-2#1)
claims that##2##2##(2008-5#1)(2010-4#1)
claims##64##1##(1991-1#1)(1992-2#3)(1993-1#2)(1993-12#3)(1994-12#1)(1994-2#5)(1994-6#1)(1995-1#4)(1995-12#3)(1995-6#1)(1996-1#2)(1996-2#5)(1996-3#1)(1997-1#3)(1997-2#3)(1997-3#1)(2008-11#2)(2008-5#5)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
clam##5##1##(2008-5#3)(2008-8#1)(2009-7#1)
clamp and tie##3##3##(2011-2#3)
clamp technique##3##2##(1994-11#1)(2008-8#2)
clamp##16##1##(1990-7#1)(1991-5#1)(1994-11#1)(1994-12#5)(1995-11#1)(2008-3#1)(2008-8#2)(2011-2#4)
clamping##5##1##(1992-9#1)(2008-7#1)(2011-2#2)(2013-1#1)
clams and##2##2##(2008-5#2)
clams##9##1##(2008-5#9)
clandestine##2##1##(1990-3#1)(2013-1#1)
clarification of##4##2##(1995-11#1)(1997-2#1)(2008-10#1)(2010-5#1)
clarification##14##1##(1990-9#1)(1991-12#2)(1994-1#2)(1995-11#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
clarified and##2##2##(2008-7#1)(2009-6#1)
clarified by##4##2##(1994-3#1)(1994-8#1)(2008-11#1)(2008-8#1)
clarified that##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-8#1)
clarified the##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
clarified##35##1##(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-3#2)(2008-10#9)(2008-11#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-10#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
clarifies and##2##2##(2008-12#1)(2008-8#1)
clarifies##4##1##(2008-11#1)(2008-12#2)(2008-8#1)
clarify its##2##2##(2008-10#1)(2010-11#1)
clarify the current##2##3##(2008-10#1)(2013-8#1)
clarify the role of##3##4##(2008-10#1)(2011-3#1)(2013-8#1)
clarify the role##4##3##(2008-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
clarify the situation##2##3##(2011-2#1)(2012-2#1)
clarify the##45##2##(1991-12#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-8#1)(1997-1#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
clarify whether##6##2##(1991-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#2)
clarify##69##1##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-8#1)(1997-9#1)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
clarifying the##7##2##(1994-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
clarifying##9##1##(1994-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
clarithromycin##7##1##(2008-10#6)(2010-12#1)
clarity and##4##2##(1996-1#1)(2008-12#1)(2008-9#1)(2013-8#1)
clarity is##2##2##(1997-1#1)(2008-12#1)
clarity of##3##2##(1990-12#2)(2009-5#1)
clarity to##2##2##(1990-8#1)(2008-11#1)
clarity##20##1##(1990-12#2)(1990-8#1)(1994-12#1)(1995-10#1)(1996-1#1)(1997-1#1)(2008-11#2)(2008-12#3)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-7#1)(2013-1#2)(2013-8#1)
clarkii clarkii##2##2##(2010-8#2)
clarkii##10##1##(2008-6#2)(2010-8#8)
clash of##2##2##(1992-11#1)(2009-8#1)
class 1 and class##2##4##(2007-12#1)(2008-10#1)
class 1##8##2##(1990-2#2)(1995-2#1)(2007-12#1)(2008-10#4)
class 2##3##2##(2008-10#3)
class 3##7##2##(1995-12#1)(2007-12#2)(2008-10#3)(2009-7#1)
class Archaeoglobi##2##2##(2011-2#2)
class B##2##2##(2009-8#2)
class I MHC##3##3##(1990-5#1)(1994-5#2)
class I and beta 2-microglobulin gene expression in##2##8##(1995-12#2)
class I and beta 2-microglobulin gene expression##4##7##(1995-12#4)
class I and class II##3##5##(1995-5#1)(2008-4#1)(2008-9#1)
class I and##9##3##(1995-12#4)(1995-5#1)(2008-4#1)(2008-9#2)(2011-2#1)
class I antigens##4##3##(1992-7#1)(1994-5#2)(2008-8#1)
class I expression##3##3##(1997-9#3)
class I heavy chain##3##4##(1997-9#2)(2008-4#1)
class I heavy##5##3##(1997-9#4)(2008-4#1)
class I mGluR##2##3##(1995-12#2)
class I molecules of##2##4##(1990-5#1)(2008-8#1)
class I molecules##11##3##(1990-5#2)(1995-2#1)(1995-5#1)(1997-9#1)(2008-11#1)(2008-4#1)(2008-8#4)
class I or##2##3##(2008-4#2)
class I##64##2##(1990-5#3)(1991-2#1)(1992-7#1)(1993-8#1)(1994-5#4)(1995-12#7)(1995-2#1)(1995-5#4)(1997-8#1)(1997-9#10)(2008-1#8)(2008-10#2)(2008-11#1)(2008-4#6)(2008-7#1)(2008-8#8)(2008-9#3)(2010-7#1)(2011-2#1)
class II MHC##6##3##(1993-3#6)
class II alleles##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
class II antigens##3##3##(1991-8#1)(1997-8#2)
class II genes##3##3##(1997-8#3)
class II molecules##5##3##(1995-12#1)(1995-5#2)(2008-5#1)(2008-8#1)
class II tetramers##2##3##(2008-9#2)
class II##34##2##(1991-11#1)(1991-8#1)(1992-3#1)(1993-3#6)(1995-12#2)(1995-5#3)(1997-8#8)(1997-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2012-12#1)(2013-1#2)
class II/III##2##2##(1992-3#2)
class III##6##2##(1992-3#2)(2007-12#2)(2008-10#1)(2008-7#1)
class IV chitinase##2##3##(2008-10#2)
class IV##3##2##(1995-8#1)(2008-10#2)
class action lawsuits##2##3##(2008-11#2)
class action##4##2##(2008-11#4)
class agonist##2##2##(1995-11#2)
class and##4##2##(1995-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
class composed of##2##3##(2008-11#2)
class health care##2##3##(1994-1#2)
class identity of a##2##4##(2008-10#2)
class identity of##3##3##(2008-10#3)
class in##3##2##(2008-11#1)(2011-2#2)
class of compounds##7##3##(1993-8#2)(1996-5#1)(2008-10#4)
class of drugs##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
class of models##2##3##(1995-5#1)(2013-8#1)
class of neutral##2##3##(2008-10#2)
class of proteins##3##3##(1995-2#1)(2008-11#1)(2008-4#1)
class of recA-like##2##3##(1995-6#2)
class of specific##2##3##(1991-5#1)(1995-2#1)
class of tests##2##3##(2008-10#2)
class of therapeutic##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
class of##123##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#25)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
class showing##2##2##(1993-1#2)
class size##2##2##(2008-11#1)(2013-1#1)
class was##2##2##(2008-10#1)(2012-3#1)
class##377##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#4)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-7#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#7)(1993-6#1)(1993-8#4)(1994-1#2)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#6)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#14)(1995-2#5)(1995-3#1)(1995-5#8)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#10)(1997-9#12)(2007-12#5)(2008-1#9)(2008-10#68)(2008-11#24)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#10)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#15)(2008-9#11)(2009-1#1)(2009-10#4)(2009-12#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#18)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#10)(2013-8#5)
classes according to the##2##4##(1995-11#1)(2013-1#1)
classes and##7##2##(1990-3#1)(1992-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
classes as a##2##3##(2008-10#2)
classes based on##2##3##(2008-7#1)(2009-10#1)
classes have##2##2##(2008-11#1)(2012-2#1)
classes in the##2##3##(1992-12#1)(2010-1#1)
classes in##5##2##(1992-12#1)(1995-1#1)(2008-10#1)(2008-11#1)(2010-1#1)
classes of CB agonists##2##4##(2009-12#2)
classes of compounds that##2##4##(2008-10#1)(2011-2#1)
classes of drugs##3##3##(2008-10#2)(2011-2#1)
classes of ionotropic##3##3##(1995-11#2)(2008-7#1)
classes of process startup problems##2##5##(2008-11#2)
classes of the##2##3##(2008-10#1)(2008-4#1)
classes of##75##2##(1992-9#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2008-10#16)(2008-11#11)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#3)(2010-3#2)(2010-7#2)(2011-2#3)(2012-12#1)(2013-8#1)
classes showed##2##2##(2008-10#2)
classes that##2##2##(2008-8#1)(2009-12#1)
classes were##2##2##(2008-10#1)(2008-12#1)
classes with##4##2##(1990-12#1)(2008-10#2)(2013-7#1)
classes##165##1##(1990-12#2)(1990-3#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#4)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#53)(2008-11#16)(2008-12#3)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#4)(2009-12#4)(2009-7#2)(2010-1#5)(2010-10#1)(2010-11#1)(2010-3#2)(2010-7#2)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
classic Kaposi's sarcoma##3##3##(1990-6#2)(1992-12#1)
classic method##2##2##(2008-10#1)(2010-7#1)
classic model##2##2##(2008-10#2)
classic##55##1##(1990-6#2)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-12#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-1#2)(2009-10#2)(2010-11#1)(2010-2#5)(2010-4#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#1)(2013-1#3)
classical HPLC##2##2##(2008-10#2)
classical and individual-based approaches##2##4##(2008-9#2)
classical and##4##2##(2008-5#1)(2008-9#2)(2012-2#1)
classical conditioning in##2##3##(1996-2#1)(2008-5#1)
classical conditioning##3##2##(1996-2#2)(2008-5#1)
classical group##2##2##(2008-5#2)
classical hypersensitive##3##2##(2008-10#3)
classical injection##2##2##(2008-10#2)
classical least squares (CLS)##6##4##(2008-10#6)
classical least squares##8##3##(2008-10#7)(2008-3#1)
classical least##9##2##(2008-10#8)(2008-3#1)
classical least-squares##3##2##(2008-10#3)
classical medical##2##2##(2010-7#1)(2013-8#1)
classical metapopulation##2##2##(2008-8#1)(2008-9#1)
classical methods##5##2##(2008-10#5)
classical model##2##2##(2009-5#1)(2013-8#1)
classical mutant strains##2##3##(2012-3#2)
classical or##2##2##(2010-5#1)(2012-3#1)
classical techniques##2##2##(2008-12#1)(2011-2#1)
classical##192##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-8#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-5#2)(1995-11#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#68)(2008-11#10)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#10)(2008-7#3)(2008-8#8)(2008-9#11)(2009-11#1)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#4)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#8)(2013-1#4)(2013-8#2)
classical&quot##3##1##(1990-8#2)(2008-8#1)
classically used to##2##3##(2008-7#1)(2011-2#1)
classically##9##1##(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
classification accuracy of##2##3##(2008-10#1)(2010-8#1)
classification accuracy##6##2##(2008-10#2)(2008-6#3)(2010-8#1)
classification and##18##2##(1990-2#1)(1990-3#1)(1992-3#1)(1994-12#1)(2008-10#5)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
classification approach##2##2##(2008-12#1)(2009-10#1)
classification are##2##2##(2008-11#1)(2009-10#1)
classification as##3##2##(2008-10#1)(2009-4#1)(2011-1#1)
classification based on the##2##4##(1997-3#1)(2008-10#1)
classification based on##7##3##(1997-3#1)(2008-10#4)(2008-5#1)(2008-8#1)
classification by##3##2##(2008-10#2)(2008-5#1)
classification capability##2##2##(2008-10#2)
classification for##7##2##(1991-12#1)(2008-10#3)(2010-12#1)(2010-7#1)(2013-8#1)
classification framework##3##2##(2008-10#3)
classification in the##4##3##(1993-12#2)(2008-10#2)
classification in##7##2##(1993-12#2)(2008-1#1)(2008-10#3)(2010-12#1)
classification is based on##3##4##(2008-5#2)(2011-3#1)
classification is##7##2##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2011-3#1)(2013-8#1)
classification lists##2##2##(2011-2#2)
classification methods##2##2##(2008-10#1)(2008-5#1)
classification of human##2##3##(2008-5#1)(2008-9#1)
classification of new##2##3##(2008-10#2)
classification of spontaneous intraventricular haemorrhage##2##5##(2008-7#2)
classification of tan spot##2##4##(2008-10#2)
classification of the samples##2##4##(2008-10#2)
classification of the##14##3##(1991-9#1)(1995-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
classification of this##2##3##(2010-12#1)(2013-1#1)
classification of tumor##2##3##(2009-12#1)(2009-6#1)
classification of##91##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-1#1)(1993-12#1)(1995-5#1)(1996-3#1)(1997-8#1)(2008-1#2)(2008-10#35)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#4)(2010-4#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
classification on##2##2##(1993-1#1)(1997-8#1)
classification probabilities##2##2##(2008-10#1)(2008-12#1)
classification rates##2##2##(2008-6#2)
classification scheme##4##2##(1996-6#1)(2008-10#2)(2011-2#1)
classification system and##2##3##(2008-10#1)(2011-2#1)
classification system for##5##3##(1991-9#1)(1992-2#1)(1994-3#2)(2008-12#1)
classification system has##2##3##(1990-11#1)(2011-2#1)
classification system of##3##3##(2008-12#2)(2008-4#1)
classification system##29##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-12#3)(1994-3#3)(1995-2#2)(1996-6#1)(2008-10#1)(2008-12#5)(2008-4#1)(2010-12#1)(2011-2#5)(2012-3#1)
classification systems for##2##3##(1993-12#1)(2011-2#1)
classification systems##10##2##(1993-12#2)(2007-12#1)(2008-11#1)(2008-12#1)(2010-9#2)(2011-2#3)
classification to##2##2##(2008-10#1)(2010-6#1)
classification tool##2##2##(1995-2#1)(2008-10#1)
classification was used##2##3##(1997-8#1)(2009-3#1)
classification was##7##2##(1991-2#1)(1991-9#1)(1997-8#1)(2008-10#3)(2009-3#1)
classification were##2##2##(2008-10#1)(2008-7#1)
classification with##2##2##(2008-10#1)(2013-8#1)
classification##333##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#5)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-1#3)(1993-11#1)(1993-12#6)(1993-2#1)(1993-9#1)(1994-12#5)(1994-3#3)(1995-1#1)(1995-2#3)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-8#6)(2007-12#1)(2008-1#3)(2008-10#100)(2008-11#6)(2008-12#13)(2008-4#4)(2008-5#11)(2008-6#7)(2008-7#13)(2008-8#3)(2008-9#3)(2009-10#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#2)(2010-1#1)(2010-10#3)(2010-12#8)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#1)(2011-2#26)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#10)(2013-8#11)
classifications are made##2##3##(2008-10#1)(2013-8#1)
classifications are##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
classifications of the##2##3##(2010-11#1)(2011-2#1)
classifications of##7##2##(2008-10#2)(2008-5#1)(2010-11#1)(2011-2#1)(2013-8#2)
classifications were##2##2##(2008-10#1)(2012-2#1)
classifications##32##1##(1991-9#1)(1996-1#1)(1997-1#1)(2008-10#8)(2008-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
classified according to the##11##4##(1991-8#1)(1993-12#1)(1997-8#1)(2008-10#4)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
classified according to##16##3##(1991-8#1)(1993-12#1)(1996-3#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
classified as a##2##3##(2007-8#1)(2008-10#1)
classified as being##2##3##(1997-2#1)(2011-2#1)
classified as having##2##3##(1993-1#1)(2010-3#1)
classified as overweight or obese##2##5##(2008-10#1)(2012-2#1)
classified as##60##2##(1990-11#1)(1990-8#1)(1991-6#1)(1992-5#1)(1993-1#2)(1993-8#1)(1994-12#1)(1994-3#1)(1996-3#2)(1997-2#2)(1997-8#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-6#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
classified by a##2##3##(1996-12#1)(2008-10#1)
classified by the##2##3##(2008-8#1)(2011-2#1)
classified by##12##2##(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
classified correctly##2##2##(2008-10#2)
classified in the##7##3##(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)
classified in##13##2##(1990-2#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-4#1)(2008-9#1)(2009-9#1)(2011-10#1)
classified into eight##2##3##(1997-3#1)(2008-12#1)
classified into four categories##2##4##(2009-12#1)(2011-2#1)
classified into four##6##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)
classified into one of##2##4##(1992-7#1)(2008-10#1)
classified into six##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
classified into the##5##3##(1996-2#1)(1997-6#1)(1997-8#1)(2008-11#1)(2011-3#1)
classified into three##6##3##(1990-12#1)(1997-6#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
classified into two##7##3##(1996-6#1)(1997-2#1)(2008-10#4)(2010-8#1)
classified into##49##2##(1990-12#1)(1992-7#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-6#3)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
classified with##3##2##(2008-10#2)(2008-7#1)
classified##187##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#3)(1991-6#1)(1991-8#1)(1992-5#1)(1992-7#1)(1993-1#3)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1997-2#3)(1997-3#1)(1997-6#2)(1997-8#3)(2007-8#1)(2008-1#1)(2008-10#60)(2008-11#6)(2008-12#7)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#9)(2008-8#1)(2008-9#4)(2009-10#3)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#3)(2010-8#3)(2011-10#1)(2011-2#13)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#3)
classifier##13##1##(2008-10#6)(2008-11#3)(2009-10#1)(2010-7#2)(2010-8#1)
classifiers##3##1##(2008-11#2)(2010-8#1)
classify the##5##2##(2008-10#3)(2008-11#1)(2010-8#1)
classify##40##1##(1991-8#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-4#1)(2008-10#20)(2008-11#2)(2008-4#1)(2008-5#4)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#2)(2013-1#1)
classifying##14##1##(1992-12#1)(1993-12#2)(1994-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
classmates##4##1##(2008-9#1)(2009-7#3)
classroom and##5##2##(2008-11#1)(2008-12#4)
classroom context##2##2##(2008-12#2)
classroom environment and##2##3##(2008-12#1)(2011-2#1)
classroom environment##6##2##(2008-12#4)(2011-2#2)
classroom organization##2##2##(2008-12#2)
classroom setting##3##2##(2008-11#2)(2011-1#1)
classroom##53##1##(1996-1#1)(2008-10#1)(2008-11#11)(2008-12#33)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#3)
classroom-based##2##1##(2008-11#1)(2008-12#1)
classrooms in Study##2##3##(2008-12#2)
classrooms of##2##2##(2011-2#2)
classrooms were##3##2##(2008-12#1)(2011-2#2)
classrooms##24##1##(2008-11#1)(2008-12#13)(2009-7#1)(2010-8#1)(2011-2#8)
classwide REMS for##2##3##(2013-1#2)
classwide REMS##3##2##(2013-1#3)
classwide##4##1##(2013-1#4)
clastogenic##2##1##(2008-11#1)(2010-1#1)
clathrin and##2##2##(1993-9#1)(2012-2#1)
clathrin##4##1##(1993-9#2)(2012-2#2)
clathrin-coated##2##1##(1995-6#1)(2009-6#1)
claudication##5##1##(1995-2#4)(2008-8#1)
clauses##2##1##(2008-11#2)
clavicles##2##1##(2011-1#1)(2013-1#1)
clavicular##4##1##(1993-3#1)(2009-1#1)(2011-1#1)(2012-2#1)
clavigerum population##2##2##(2008-10#2)
clavigerum populations##3##2##(2008-10#3)
clavigerum##8##1##(2008-10#8)
clavulanic acid by##2##3##(2008-10#1)(2011-2#1)
clavulanic acid##7##2##(1990-3#2)(2008-10#3)(2011-2#2)
claw of##2##2##(2011-2#2)
claw##6##1##(2010-3#1)(2011-2#5)
claws and##2##2##(1997-5#1)(2011-2#1)
claws of##2##2##(2011-2#2)
claws##6##1##(1997-5#1)(2011-2#5)
clay and##4##2##(2008-10#4)
clay content##2##2##(2008-10#2)
clay loam and##2##3##(2008-10#2)
clay loam or##2##3##(2008-10#2)
clay loam than##2##3##(2008-10#2)
clay loam##6##2##(2008-10#6)
clay minerals##2##2##(2008-10#2)
clay soil##2##2##(2008-10#2)
clay##36##1##(2008-10#34)(2009-7#2)
clays##5##1##(2008-10#5)
clean air##3##2##(1997-1#1)(2008-10#1)(2008-3#1)
clean and##5##2##(1997-5#1)(2008-10#3)(2012-2#1)
clean the##2##2##(2008-5#1)(2012-3#1)
clean up##9##2##(1996-5#1)(2008-10#8)
clean##45##1##(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#26)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
clean-up and##3##2##(2008-10#3)
clean-up and/or enrichment##3##3##(2008-10#3)
clean-up followed by##2##3##(2008-10#2)
clean-up of##3##2##(2008-10#2)(2008-11#1)
clean-up procedure##3##2##(2008-10#3)
clean-up procedures##3##2##(2008-10#3)
clean-up was##2##2##(2008-10#1)(2008-11#1)
clean-up##40##1##(1996-6#1)(1997-2#1)(2008-10#35)(2008-11#2)(2008-7#1)
cleaned and##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
cleaned with##3##2##(2008-10#1)(2009-6#2)
cleaned##12##1##(2008-10#5)(2008-11#1)(2008-7#1)(2009-6#4)(2013-1#1)
cleaned-up by##2##2##(2008-10#2)
cleaner sample##2##2##(2008-10#1)(2010-11#1)
cleaner##3##1##(2008-10#1)(2008-11#1)(2010-11#1)
cleaning of the electrode##2##4##(2008-10#2)
cleaning of the##3##3##(2008-10#3)
cleaning of##5##2##(2008-10#4)(2013-1#1)
cleaning or##3##2##(2008-10#2)(2008-11#1)
cleaning the##4##2##(2008-10#2)(2013-1#2)
cleaning##33##1##(2008-10#17)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#2)(2010-9#1)(2011-2#4)(2013-1#4)
cleanroom environments##3##2##(2012-2#3)
cleanroom##6##1##(2012-2#6)
cleansed##2##1##(2008-1#1)(2008-10#1)
cleansers##3##1##(2008-5#3)
cleansing agents in##2##3##(2013-1#2)
cleansing agents##5##2##(2013-1#5)
cleansing##16##1##(1991-12#1)(2008-5#9)(2013-1#6)
cleanup and##2##2##(2008-10#2)
cleanup of##3##2##(2008-10#3)
cleanup with##2##2##(2008-10#2)
cleanup##15##1##(2008-10#14)(2008-11#1)
cleanup/preconcentration##2##1##(2008-10#2)
clear and##5##2##(1990-11#1)(1993-12#1)(2008-11#1)(2008-3#1)(2010-3#1)
clear cell##2##2##(2011-2#1)(2013-1#1)
clear correlation between the##2##4##(2008-3#1)(2008-5#1)
clear correlation##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
clear cytoplasm##2##2##(1991-8#1)(2009-8#1)
clear dependence##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
clear diagnosis##2##2##(2011-1#2)
clear difference in##3##3##(1990-8#1)(1991-8#1)(2013-1#1)
clear difference##4##2##(1990-8#2)(1991-8#1)(2013-1#1)
clear distinction between##2##3##(1990-12#1)(2008-10#1)
clear evidence of##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
clear evidence that##4##3##(1993-3#1)(1996-3#1)(2008-8#1)(2013-1#1)
clear evidence##9##2##(1990-6#1)(1993-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#2)
clear explanation##3##2##(1994-8#1)(2008-9#1)(2011-2#1)
clear for##2##2##(2008-10#1)(2011-2#1)
clear functional##2##2##(2007-12#1)(2009-8#1)
clear holographic images##2##3##(2008-3#2)
clear if##2##2##(2008-11#1)(2013-1#1)
clear images##2##2##(2008-10#1)(2011-2#1)
clear indication of##3##3##(1992-3#1)(2008-9#1)(2012-2#1)
clear indication##4##2##(1992-3#1)(2008-10#1)(2008-9#1)(2012-2#1)
clear is##2##2##(2008-11#1)(2011-2#1)
clear margin and##2##3##(2008-7#1)(2013-1#1)
clear now##2##2##(2008-5#1)(2008-7#1)
clear pattern of##2##3##(2008-10#2)
clear pattern##3##2##(2008-10#2)(2008-5#1)
clear relationship between##3##3##(2008-10#1)(2008-5#2)
clear relationship to the##2##4##(1993-11#1)(2008-7#1)
clear relationship##5##2##(1993-11#1)(2008-10#1)(2008-5#2)(2008-7#1)
clear separation##2##2##(1990-12#1)(2008-11#1)
clear sky##2##2##(2007-12#1)(2008-3#1)
clear spaces##2##2##(2008-7#2)
clear that both##2##3##(1995-5#1)(2008-7#1)
clear that the##9##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
clear that there are##3##4##(1996-3#1)(2010-11#1)(2010-12#1)
clear that##37##2##(1995-11#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#6)(2012-12#1)(2012-3#1)
clear the##2##2##(1995-6#1)(2010-3#1)
clear understanding of the##3##4##(1997-1#1)(2010-3#1)(2011-2#1)
clear understanding of##5##3##(1997-1#1)(1997-2#1)(2010-3#1)(2011-1#1)(2011-2#1)
clear with##2##2##(2010-10#1)(2011-2#1)
clear##278##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#4)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-8#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#48)(2008-11#28)(2008-12#7)(2008-3#8)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#16)(2008-8#6)(2008-9#12)(2009-1#1)(2009-10#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#20)(2012-12#2)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#12)(2013-7#2)(2013-8#7)
clear-cut##10##1##(1991-2#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2013-1#1)(2013-8#1)
clearability##3##1##(1997-1#3)
clearance and##5##2##(1993-2#1)(1994-8#2)(2011-3#1)(2013-1#1)
clearance by##2##2##(1996-2#1)(1997-1#1)
clearance from the airways was##2##5##(1997-1#2)
clearance from the##3##3##(1993-8#1)(1997-1#2)
clearance from##4##2##(1992-10#1)(1993-8#1)(1997-1#2)
clearance in the##2##3##(1996-2#1)(2011-2#1)
clearance in##9##2##(1991-12#1)(1995-2#1)(1996-2#2)(1997-1#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)
clearance is##2##2##(1997-1#1)(1997-2#1)
clearance of the##2##3##(2013-1#1)(2013-8#1)
clearance of##14##2##(1991-1#1)(1992-2#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-1#2)(2008-10#1)(2008-6#2)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
clearance was achieved##2##3##(1991-3#1)(2007-8#1)
clearance was##3##2##(1991-3#1)(2007-8#1)(2011-2#1)
clearance##70##1##(1990-11#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-10#1)(1992-2#1)(1993-2#1)(1993-8#2)(1994-8#3)(1995-12#2)(1995-2#2)(1996-1#5)(1996-2#7)(1997-1#7)(1997-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-8#1)(2010-1#2)(2010-5#2)(2010-6#1)(2011-2#3)(2011-3#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
clearcut##2##1##(1992-12#1)(2013-8#1)
cleared from##3##2##(1991-12#1)(1994-5#1)(2009-3#1)
cleared##11##1##(1990-11#1)(1991-12#1)(1992-12#1)(1994-5#1)(1995-8#1)(1997-1#1)(2008-5#1)(2008-8#2)(2009-3#1)(2013-1#1)
clearer##8##1##(1991-1#1)(1992-9#1)(1996-3#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
clearest##2##1##(2008-11#1)(2008-9#1)
clearing##7##1##(1995-12#1)(1996-1#1)(2008-10#2)(2008-9#1)(2010-6#1)(2011-2#1)
clearinghouse##3##1##(1992-8#1)(1994-1#2)
clearinghouses and##2##2##(1996-3#2)
clearinghouses##3##1##(1996-3#3)
clearly a##2##2##(2008-9#1)(2012-12#1)
clearly affected##2##2##(1991-2#1)(2011-10#1)
clearly and##2##2##(2008-10#1)(2008-11#1)
clearly articulated##2##2##(2008-12#2)
clearly be##2##2##(2008-9#1)(2012-3#1)
clearly define##2##2##(2008-7#1)(2011-1#1)
clearly defined##8##2##(1995-12#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
clearly demonstrate that##6##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-3#1)
clearly demonstrate the##2##3##(2008-10#1)(2012-2#1)
clearly demonstrate##11##2##(1991-2#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-3#1)(2012-2#1)
clearly demonstrated by##2##3##(2008-10#1)(2013-1#1)
clearly demonstrated that##4##3##(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#1)
clearly demonstrated the##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
clearly demonstrated##12##2##(2008-10#5)(2008-11#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#2)
clearly demonstrates the##3##3##(2007-12#1)(2008-10#2)
clearly demonstrating that##2##3##(2008-10#1)(2008-11#1)
clearly different from##2##3##(2008-10#2)
clearly different##4##2##(2008-10#4)
clearly differentiated##3##2##(2008-10#3)
clearly distinct from##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
clearly distinct##4##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
clearly distinguishable##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
clearly distinguished from##3##3##(1991-2#1)(2008-10#1)(2008-6#1)
clearly distinguished##5##2##(1991-2#1)(1997-7#1)(2008-10#2)(2008-6#1)
clearly divided##2##2##(1992-11#1)(2008-10#1)
clearly established##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
clearly evident##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
clearly have##2##2##(2008-11#1)(2012-2#1)
clearly identifiable##2##2##(1995-1#1)(2010-6#1)
clearly identified##6##2##(1990-8#1)(1991-6#1)(2008-10#3)(2008-3#1)
clearly identify the##2##3##(2008-9#1)(2010-11#1)
clearly identify##3##2##(2008-10#1)(2008-9#1)(2010-11#1)
clearly improved##2##2##(2008-10#1)(2008-12#1)
clearly indicate that##4##3##(1997-1#1)(2008-10#2)(2013-1#1)
clearly indicate the##2##3##(2008-10#1)(2008-11#1)
clearly indicate##7##2##(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2013-1#1)
clearly indicated that##4##3##(1991-5#1)(2008-10#2)(2012-2#1)
clearly indicated##5##2##(1991-5#1)(2008-10#2)(2010-11#1)(2012-2#1)
clearly indicates the##2##3##(2008-11#1)(2008-6#1)
clearly into##2##2##(1995-12#1)(2008-10#1)
clearly linked##2##2##(2008-5#1)(2010-3#1)
clearly observed when the##2##4##(2008-11#1)(2008-2#1)
clearly observed##5##2##(2008-10#2)(2008-11#2)(2008-2#1)
clearly preferred##2##2##(1992-12#1)(2008-10#1)
clearly resolved##2##2##(2007-12#1)(2008-10#1)
clearly revealed the##2##3##(2008-10#1)(2008-11#1)
clearly revealed##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
clearly satisfies the typical requirements for control processes##2##8##(2008-10#2)
clearly seen##3##2##(2008-3#1)(2009-11#1)(2012-2#1)
clearly separated the##2##3##(2008-5#1)(2013-1#1)
clearly separated##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
clearly show that the##2##4##(1990-5#1)(2008-11#1)
clearly show that##5##3##(1990-5#1)(1991-9#1)(1994-5#1)(2008-11#1)(2008-7#1)
clearly show the##2##3##(2008-6#1)(2009-7#1)
clearly show##7##2##(1990-5#1)(1991-9#1)(1994-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-7#1)
clearly showed that the##4##4##(2008-10#2)(2008-5#1)(2008-7#1)
clearly showed that##7##3##(1993-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
clearly showed the##3##3##(1995-2#1)(2008-10#2)
clearly showed##12##2##(1993-11#1)(1995-2#1)(2008-10#7)(2008-5#1)(2008-7#1)(2011-2#1)
clearly showing##2##2##(2009-5#1)(2011-2#1)
clearly shown##2##2##(2008-9#1)(2013-1#1)
clearly shows that##4##3##(2008-10#2)(2008-11#1)(2009-8#1)
clearly shows##6##2##(1992-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2009-8#1)
clearly suggest that##2##3##(1993-1#1)(1997-8#1)
clearly suggested##2##2##(2008-10#1)(2010-6#1)
clearly that##4##2##(2008-10#1)(2008-5#2)(2008-9#1)
clearly visible##3##2##(2008-11#2)(2008-5#1)
clearly with##2##2##(1991-12#1)(2008-3#1)
clearly##264##1##(1990-11#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#81)(2008-11#29)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#6)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#11)(2011-3#2)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#7)(2013-8#1)
clears##3##1##(1991-6#1)(1995-6#1)(1997-1#1)
cleavable##4##1##(1990-2#1)(1990-5#1)(2008-12#1)(2009-3#1)
cleavage activity in##2##3##(2008-9#2)
cleavage activity##4##2##(1997-2#1)(2008-9#3)
cleavage and##6##2##(1990-11#2)(1990-2#1)(1993-8#1)(2008-9#1)(2013-1#1)
cleavage at the##2##3##(1993-8#1)(1996-2#1)
cleavage at##5##2##(1990-5#1)(1993-8#2)(1995-6#1)(1996-2#1)
cleavage by##3##2##(1991-3#1)(1992-4#1)(1994-8#1)
cleavage in##2##2##(1996-5#1)(2008-11#1)
cleavage occurs##4##2##(1994-9#2)(2008-4#2)
cleavage of a##4##3##(1995-6#1)(2008-11#2)(2008-7#1)
cleavage of the##12##3##(1994-11#1)(1994-8#1)(1995-8#1)(1996-5#2)(2008-10#3)(2008-12#1)(2008-8#2)(2009-8#1)
cleavage of##35##2##(1990-5#1)(1990-9#1)(1994-11#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-6#2)(1995-8#1)(1996-5#2)(1997-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#3)
cleavage pattern##2##2##(2008-4#2)
cleavage rates##2##2##(1995-6#1)(2008-9#1)
cleavage sequence##2##2##(1995-6#1)(2008-10#1)
cleavage site##8##2##(1991-10#2)(1991-6#3)(2008-10#2)(2008-5#1)
cleavage sites##6##2##(1990-7#1)(1991-9#1)(1993-6#1)(1993-8#1)(2008-11#1)(2008-8#1)
cleavage was##2##2##(1991-5#1)(2008-5#1)
cleavage##137##1##(1990-11#2)(1990-2#1)(1990-5#4)(1990-7#1)(1990-9#1)(1991-10#4)(1991-3#2)(1991-5#1)(1991-6#3)(1991-9#2)(1992-10#1)(1992-4#2)(1993-6#1)(1993-8#6)(1994-11#1)(1994-5#4)(1994-8#4)(1994-9#4)(1995-2#1)(1995-6#7)(1995-8#2)(1996-2#1)(1996-5#4)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#2)(2007-12#6)(2008-10#13)(2008-11#7)(2008-12#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#12)(2009-3#1)(2009-6#1)(2009-8#6)(2009-9#1)(2011-2#1)(2013-1#5)(2013-7#1)
cleave##10##1##(1991-10#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
cleaved by the##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
cleaved by##6##2##(1991-10#1)(1991-3#1)(1992-6#1)(1994-8#1)(2008-10#1)(2008-5#1)
cleaved to##2##2##(2008-4#1)(2009-6#1)
cleaved with##2##2##(1993-8#1)(1994-5#1)
cleaved##31##1##(1991-10#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#3)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#2)(2009-7#1)(2010-3#1)
cleaves the##2##2##(1994-5#1)(2008-4#1)
cleaves##13##1##(1991-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#2)(1995-3#1)(1995-8#2)(1996-12#1)(2008-11#1)(2008-4#1)(2009-6#1)
cleaving##7##1##(1992-4#1)(1992-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)
cleft cysts##3##2##(2008-7#2)(2012-3#1)
cleft lip and palate##6##4##(2008-10#1)(2011-2#2)(2013-1#3)
cleft lip##8##2##(1997-3#1)(2008-10#1)(2011-2#3)(2013-1#3)
cleft palate##2##2##(2012-12#2)
cleft##24##1##(1993-12#2)(1997-3#1)(2008-10#1)(2008-7#4)(2009-10#1)(2010-11#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#4)
clenbuterol and##2##2##(2010-6#2)
clenbuterol##21##1##(2008-10#11)(2010-12#1)(2010-6#9)
clenching effort##5##2##(2010-9#5)
clenching##7##1##(2010-6#2)(2010-9#5)
clergy##4##1##(2010-2#4)
clevelandii line##2##2##(2008-10#2)
clevelandii##10##1##(2008-10#10)
clever##2##1##(2008-1#1)(2008-8#1)
client and##2##2##(1993-12#1)(2009-6#1)
client group##4##2##(2008-11#3)(2008-7#1)
client groups and education settings##2##5##(2013-8#2)
client groups and##3##3##(2013-8#3)
client groups##4##2##(2013-8#4)
client screening##2##2##(1991-1#1)(1996-12#1)
client##40##1##(1991-1#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#3)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-11#6)(2008-12#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-4#1)(2012-2#1)(2012-3#3)(2013-8#6)
client-centered##2##1##(1992-3#1)(1996-3#1)
clientele##6##1##(1991-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2012-3#1)
clients and##7##2##(1991-1#1)(1995-3#1)(1996-3#2)(2009-6#1)(2010-5#1)(2010-9#1)
clients in##4##2##(1993-12#1)(1994-1#2)(1996-3#1)
clients who are##2##3##(2010-5#1)(2012-2#1)
clients with schizophrenia##2##3##(2013-8#2)
clients with##7##2##(1991-12#1)(1994-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#2)
clients##59##1##(1991-1#2)(1991-12#5)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#2)(1994-2#2)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-3#4)(1997-2#1)(2008-1#1)(2008-11#4)(2008-12#2)(2008-6#4)(2008-7#1)(2008-9#2)(2009-6#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#4)
clients'##2##1##(1991-1#1)(2008-11#1)
climacteric##5##1##(1992-12#2)(2008-11#3)
climate and##8##2##(2008-10#1)(2008-11#2)(2008-4#1)(2009-11#1)(2009-7#1)(2010-1#1)(2012-2#1)
climate change on##3##3##(2008-11#3)
climate change##22##2##(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#2)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-5#1)(2012-6#3)(2012-7#1)(2012-8#1)(2012-9#3)(2013-8#2)
climate changes##5##2##(2008-6#1)(2010-3#1)(2012-5#1)(2012-9#2)
climate conditions##3##2##(2012-2#1)(2012-9#2)
climate may##2##2##(1991-2#1)(2010-10#1)
climate of##5##2##(2008-10#2)(2008-11#1)(2012-3#1)(2012-5#1)
climate##92##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-2#2)(2008-10#16)(2008-11#13)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#5)(2012-6#4)(2012-7#5)(2012-8#1)(2012-9#12)(2013-8#2)
climates##13##1##(2008-10#7)(2008-8#1)(2010-3#2)(2010-5#1)(2012-4#1)(2012-9#1)
climatic area##3##2##(2008-10#3)
climatic conditions##5##2##(2008-10#4)(2008-8#1)
climatic factors##3##2##(2008-10#1)(2012-3#2)
climatic suitability##2##2##(2008-10#2)
climatic##25##1##(1990-8#1)(2008-10#11)(2008-8#3)(2008-9#1)(2010-3#3)(2010-8#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#1)
climatically sensitive##2##2##(2010-3#2)
climatically##5##1##(2008-10#2)(2010-3#3)
climbing##6##1##(1992-6#1)(1994-2#1)(2008-9#1)(2010-8#1)(2013-1#2)
clindamycin##5##1##(2007-11#4)(2011-2#1)
clinic and##2##2##(2008-11#1)(2009-10#1)
clinic are##2##2##(2010-8#1)(2011-3#1)
clinic as##3##2##(2008-11#2)(2008-7#1)
clinic because of##2##3##(1997-4#1)(2011-1#1)
clinic between##2##2##(2010-3#1)(2012-3#1)
clinic for##7##2##(1994-1#1)(2008-10#1)(2008-9#1)(2011-2#4)
clinic in##9##2##(1996-12#1)(2009-10#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
clinic network##3##2##(1994-1#2)(1996-3#1)
clinic of the##2##3##(2008-1#1)(2011-2#1)
clinic or##3##2##(1997-3#1)(2008-10#1)(2009-5#1)
clinic setting##3##2##(1993-12#2)(2011-7#1)
clinic staff##2##2##(1996-1#2)
clinic visits##2##2##(1991-1#1)(1995-12#1)
clinic were##4##2##(2008-3#1)(2009-5#1)(2009-9#1)(2011-1#1)
clinic with##2##2##(1995-2#1)(2008-11#1)
clinic##109##1##(1990-3#1)(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-2#2)(1994-1#5)(1995-12#2)(1995-2#5)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#11)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#3)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#15)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
clinic-based##5##1##(1996-5#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-1#1)
clinic]##2##1##(1996-11#1)(2009-5#1)
clinical (bio)chemistry##2##2##(1994-12#2)
clinical Stage##2##2##(1994-12#2)
clinical activities##2##2##(1994-12#1)(2008-11#1)
clinical activity##2##2##(2008-11#1)(2013-1#1)
clinical alterations##2##2##(2008-12#1)(2013-1#1)
clinical analysis##5##2##(1991-3#1)(2008-10#4)
clinical and academic##2##3##(2008-11#1)(2013-8#1)
clinical and administrative##2##3##(2010-8#2)
clinical and angiographic##2##3##(1994-9#1)(2008-11#1)
clinical and basic##3##3##(2008-3#1)(2009-12#1)(2011-7#1)
clinical and biological##6##3##(1997-8#1)(2008-10#1)(2008-7#2)(2010-6#1)(2011-2#1)
clinical and cytological##2##3##(1994-5#1)(1997-2#1)
clinical and diagnostic##3##3##(1990-9#1)(2010-10#2)
clinical and economic##2##3##(1997-2#1)(2008-6#1)
clinical and environmental##2##3##(2008-10#2)
clinical and experimental##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
clinical and functional outcomes##2##4##(2013-1#2)
clinical and functional results##2##4##(2013-1#2)
clinical and functional##4##3##(2013-1#4)
clinical and genetic##3##3##(1994-3#1)(2008-11#1)(2008-7#1)
clinical and haemodynamic##2##3##(2008-3#1)(2011-2#1)
clinical and histological features##2##4##(1991-11#1)(2008-7#1)
clinical and histological##4##3##(1991-11#1)(1991-8#1)(2008-7#1)(2013-1#1)
clinical and histopathological findings##2##4##(2008-4#1)(2010-6#1)
clinical and histopathological##3##3##(2008-1#1)(2008-4#1)(2010-6#1)
clinical and imaging##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
clinical and laboratory variables##2##4##(2011-1#2)
clinical and laboratory##8##3##(1992-9#1)(1994-12#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)
clinical and microbiological characteristics of##2##5##(2007-12#2)
clinical and microbiological##3##3##(2007-12#2)(2008-5#1)
clinical and morphological##3##3##(1997-6#1)(2009-8#1)(2011-2#1)
clinical and mycological cure##2##4##(2008-5#2)
clinical and mycological##3##3##(2008-5#3)
clinical and nonclinical##2##3##(1993-12#1)(1994-1#1)
clinical and parasitological signs##3##4##(2012-12#3)
clinical and pathologic##3##3##(1990-6#1)(1991-8#1)(1992-2#1)
clinical and pathological features of##3##5##(1991-12#1)(1991-6#1)(2010-11#1)
clinical and pathological features##4##4##(1991-12#1)(1991-6#1)(2010-11#1)(2012-2#1)
clinical and pathological##9##3##(1991-12#1)(1991-6#1)(1991-8#1)(1994-3#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)
clinical and radiographic outcomes##2##4##(2011-2#1)(2013-1#1)
clinical and radiographic##5##3##(2008-12#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
clinical and radiological examination##4##4##(1995-9#1)(2008-10#1)(2012-12#1)(2012-2#1)
clinical and radiological findings##3##4##(2012-12#3)
clinical and radiological##16##3##(1990-5#1)(1991-11#1)(1995-9#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)
clinical and research##2##3##(2008-6#1)(2010-8#1)
clinical and serologic##2##3##(1990-3#1)(2011-2#1)
clinical and theoretical##2##3##(2008-11#1)(2008-9#1)
clinical and therapeutic aspects of##2##5##(1990-9#1)(1992-5#1)
clinical and therapeutic##3##3##(1990-9#1)(1992-5#1)(1994-2#1)
clinical and##167##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-6#2)(1991-8#3)(1992-1#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-9#1)(1995-9#1)(1996-6#1)(1997-2#4)(1997-3#2)(1997-6#1)(1997-8#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#19)(2011-7#2)(2012-12#9)(2012-2#2)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#1)
clinical anemia in##2##3##(2012-3#2)
clinical appearance of##2##3##(2008-5#1)(2012-3#1)
clinical appearance##5##2##(1996-6#1)(2008-5#2)(2010-6#1)(2012-3#1)
clinical application of nursing##3##4##(1990-2#3)
clinical application of the##2##4##(2008-10#1)(2010-12#1)
clinical application of##11##3##(1990-2#3)(1991-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
clinical application##22##2##(1990-2#4)(1991-6#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-3#2)(2013-8#2)
clinical applications of##3##3##(2008-4#1)(2009-4#1)(2012-2#1)
clinical applications##19##2##(1997-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-7#2)(2012-2#4)(2013-8#1)
clinical areas##4##2##(2008-11#4)
clinical as well as##2##4##(1997-8#1)(2012-3#1)
clinical aspects and##2##3##(1991-2#1)(2008-1#1)
clinical aspects of##4##3##(1990-9#1)(1992-2#1)(2008-5#1)(2009-8#1)
clinical aspects##12##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1997-1#1)(2008-1#1)(2008-5#1)(2009-8#2)(2013-1#1)
clinical assessment and##2##3##(2008-12#1)(2008-5#1)
clinical assessment of##8##3##(1990-6#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-6#1)(2010-7#1)(2011-2#1)
clinical assessment##18##2##(1990-6#1)(1992-12#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#3)(2009-10#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
clinical audit##3##2##(2012-2#1)(2013-1#2)
clinical basis##2##2##(1990-3#1)(2012-3#1)
clinical behavior##4##2##(1997-7#1)(2008-12#1)(2008-8#1)(2013-1#1)
clinical behaviour##2##2##(2012-3#1)(2013-1#1)
clinical benefit of##4##3##(1997-7#2)(2008-10#1)(2008-8#1)
clinical benefit##12##2##(1996-3#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#1)
clinical benefits of##4##3##(2008-10#1)(2009-6#1)(2011-2#2)
clinical benefits##7##2##(2008-10#1)(2008-7#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#2)
clinical biochemistry exists##2##3##(1994-12#2)
clinical biochemistry in##2##3##(1994-12#2)
clinical biochemistry##22##2##(1994-12#19)(2008-5#3)
clinical biochemists##5##2##(1994-12#5)
clinical cardiac electrophysiology##3##3##(2008-12#3)
clinical care to##2##3##(2008-11#1)(2008-12#1)
clinical care##7##2##(1995-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#1)
clinical case is##2##3##(1991-3#1)(2013-1#1)
clinical case of##5##3##(1990-5#1)(1991-3#1)(2013-1#3)
clinical case##12##2##(1990-3#1)(1990-5#2)(1991-3#2)(2008-7#1)(2012-3#1)(2013-1#5)
clinical case]##6##2##(1990-3#1)(1990-5#1)(1992-5#1)(1993-3#1)(1993-6#2)
clinical cases of##3##3##(1993-3#1)(1993-6#1)(1995-9#1)
clinical cases##11##2##(1991-12#1)(1993-3#1)(1993-6#1)(1995-9#1)(1996-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
clinical cases]##2##2##(1990-2#1)(1993-3#1)
clinical challenge##4##2##(1993-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
clinical characteristics of##9##3##(1992-2#1)(1994-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#2)(2013-1#2)
clinical characteristics##19##2##(1992-2#1)(1994-12#1)(1995-10#1)(1995-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-6#1)(2011-2#5)(2012-3#2)(2013-1#2)
clinical chemist##2##2##(1994-12#2)
clinical chemistry and biochemical pathology##2##5##(1994-12#2)
clinical chemistry and##3##3##(1994-12#3)
clinical chemistry as##2##3##(1994-12#2)
clinical chemistry in##3##3##(1994-12#3)
clinical chemistry##22##2##(1994-12#21)(2008-10#1)
clinical chemists##3##2##(1991-12#1)(1994-12#2)
clinical cohort##2##2##(2007-12#2)
clinical competence##2##2##(2008-11#1)(2008-12#1)
clinical complications##2##2##(2009-10#1)(2012-12#1)
clinical concern##3##2##(1993-9#1)(2007-8#1)(2011-2#1)
clinical concerns##2##2##(1992-12#1)(2008-11#1)
clinical condition and##2##3##(1991-12#1)(2013-1#1)
clinical condition##12##2##(1990-5#1)(1991-12#1)(1991-3#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#3)(2013-1#1)
clinical conditions in##2##3##(1990-2#1)(1995-9#1)
clinical conditions##9##2##(1990-2#1)(1991-3#1)(1995-9#1)(2008-10#1)(2008-7#2)(2012-2#1)(2013-1#2)
clinical consequences##4##2##(1991-3#1)(2008-5#1)(2008-7#2)
clinical considerations##2##2##(1993-12#1)(2013-1#1)
clinical correlates##2##2##(2011-2#1)(2013-8#1)
clinical course and##4##3##(2008-7#1)(2008-9#1)(2012-12#2)
clinical course of patients with##2##5##(2008-7#1)(2010-11#1)
clinical course of##8##3##(1996-11#1)(1997-3#1)(1997-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
clinical course##33##2##(1992-12#1)(1994-6#1)(1996-11#2)(1997-3#4)(1997-5#2)(2008-12#1)(2008-7#5)(2008-9#2)(2010-1#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
clinical credibility and competence##2##4##(2008-11#2)
clinical credibility##4##2##(2008-11#4)
clinical criteria##6##2##(1990-8#1)(1991-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
clinical cure##3##2##(1992-6#1)(2008-5#1)(2010-5#1)
clinical data and##3##3##(1996-11#1)(1997-2#1)(2010-6#1)
clinical data are##2##3##(2008-2#1)(2012-2#1)
clinical data for##2##3##(2010-11#1)(2011-2#1)
clinical data##28##2##(1990-9#1)(1991-3#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2010-11#2)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
clinical decision making##3##3##(1992-12#1)(2010-11#1)(2010-12#1)
clinical decision support to##2##4##(1997-3#1)(2010-4#1)
clinical decision support##3##3##(1997-3#1)(2010-4#1)(2010-6#1)
clinical decision##10##2##(1991-1#1)(1992-12#1)(1997-3#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)
clinical decision-making and##2##3##(2008-11#1)(2013-1#1)
clinical decision-making in the##2##4##(2008-11#1)(2008-12#1)
clinical decision-making skills##2##3##(2008-11#1)(2012-2#1)
clinical decision-making##17##2##(2008-10#1)(2008-11#10)(2008-12#2)(2010-8#1)(2011-10#1)(2012-2#1)(2013-1#1)
clinical decisions regarding the##2##4##(2008-12#1)(2011-2#1)
clinical decisions##4##2##(1993-5#1)(2008-12#2)(2011-2#1)
clinical departments##2##2##(1991-3#1)(1992-1#1)
clinical depression##6##2##(1991-2#2)(2008-10#1)(2008-11#1)(2008-7#2)
clinical description##2##2##(1992-1#1)(2010-6#1)
clinical deterioration##2##2##(2012-3#1)(2013-8#1)
clinical development##6##2##(2008-10#1)(2008-8#2)(2010-10#1)(2010-11#2)
clinical diagnoses##2##2##(2012-2#1)(2013-1#1)
clinical diagnosis and##3##3##(1995-12#1)(2008-9#1)(2012-12#1)
clinical diagnosis of##6##3##(1992-12#1)(1996-11#1)(2008-7#1)(2011-2#1)(2011-7#1)(2012-12#1)
clinical diagnosis##16##2##(1990-3#1)(1991-6#1)(1992-12#1)(1995-12#1)(1996-11#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#2)
clinical diagnostic##3##2##(2008-4#1)(2008-5#1)(2010-12#1)
clinical dilemma##2##2##(1994-8#1)(2008-7#1)
clinical disease##5##2##(2008-10#1)(2008-2#1)(2008-5#2)(2009-1#1)
clinical diseases##2##2##(2008-10#1)(2010-12#1)
clinical disorder##2##2##(2008-4#1)(2012-3#1)
clinical documents##2##2##(2010-8#2)
clinical drug##2##2##(1991-3#1)(2010-5#1)
clinical education for undergraduate nurses##2##5##(2008-12#2)
clinical education##7##2##(2008-12#6)(2013-8#1)
clinical educators##3##2##(2008-11#1)(2008-12#2)
clinical effect##5##2##(1997-5#1)(2011-2#2)(2013-8#2)
clinical effectiveness of##4##3##(2008-7#2)(2011-2#1)(2012-3#1)
clinical effects and treatments##3##4##(2010-8#3)
clinical effects##9##2##(1990-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-8#3)(2011-2#2)
clinical efficacy and##2##3##(1990-3#1)(2013-8#1)
clinical efficacy of##4##3##(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
clinical efficacy##10##2##(1990-3#1)(1993-12#1)(1997-4#1)(2008-11#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
clinical endpoints##3##2##(2008-12#1)(2010-2#1)(2013-1#1)
clinical entity##13##2##(1991-6#1)(1996-11#1)(1997-2#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)
clinical environment##5##2##(2008-11#3)(2008-12#2)
clinical evaluation in##2##3##(1990-2#1)(1992-12#1)
clinical evaluation of##6##3##(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
clinical evaluation units##2##3##(1994-12#2)
clinical evaluation##23##2##(1990-2#1)(1990-3#1)(1992-12#1)(1993-2#1)(1994-12#2)(1995-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
clinical evidence of##3##3##(2008-10#2)(2011-2#1)
clinical evidence that##2##3##(1992-9#1)(2008-7#1)
clinical evidence##15##2##(1992-9#1)(2008-10#3)(2008-7#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
clinical examination and the##2##4##(2008-9#1)(2012-2#1)
clinical examination and##7##3##(1992-5#1)(1995-2#1)(1995-9#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
clinical examination##22##2##(1991-6#1)(1992-5#2)(1995-2#1)(1995-9#1)(1996-9#1)(2008-11#4)(2008-12#3)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#2)(2012-2#2)(2013-1#1)
clinical experience and##3##3##(2008-12#2)(2013-1#1)
clinical experience for##2##3##(2008-12#2)
clinical experience using##2##3##(2010-6#1)(2011-2#1)
clinical experience with##3##3##(2010-11#1)(2010-6#1)(2012-3#1)
clinical experience##19##2##(1991-2#1)(2008-1#1)(2008-11#5)(2008-12#5)(2009-4#1)(2010-11#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#1)
clinical experiences for##2##3##(2008-11#2)
clinical experiences##6##2##(2008-11#2)(2008-12#3)(2009-2#1)
clinical expertise##2##2##(2008-12#1)(2010-12#1)
clinical expression##3##2##(1997-5#1)(2010-1#1)(2011-2#1)
clinical factors##2##2##(2011-2#1)(2012-12#1)
clinical feature of##2##3##(1990-9#1)(2011-2#1)
clinical features and management of##2##5##(2010-5#1)(2012-3#1)
clinical features and##9##3##(1991-2#1)(1992-12#1)(2008-1#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-5#1)(2012-3#1)(2013-8#1)
clinical features in##2##3##(2008-7#1)(2010-11#1)
clinical features of the##2##4##(2008-5#1)(2008-7#1)
clinical features of##13##3##(1997-8#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#2)
clinical features were##2##3##(2008-1#1)(2008-12#1)
clinical features##41##2##(1990-12#1)(1991-2#1)(1992-12#1)(1993-6#1)(1997-8#2)(2007-8#1)(2008-1#3)(2008-12#3)(2008-5#1)(2008-7#6)(2008-9#2)(2009-12#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#1)(2013-8#1)
clinical finding##3##2##(2008-10#2)(2013-1#1)
clinical findings and##2##3##(1997-4#1)(2011-2#1)
clinical findings##15##2##(1993-2#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
clinical follow-up##5##2##(2009-8#1)(2011-1#3)(2012-12#1)
clinical forms of##6##3##(1993-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2012-3#1)
clinical forms##9##2##(1993-2#1)(2008-5#4)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
clinical gene therapy##2##3##(1994-5#1)(2008-8#1)
clinical grade##2##2##(2008-11#1)(2008-7#1)
clinical group##2##2##(2008-9#1)(2012-3#1)
clinical groups##2##2##(1995-5#2)
clinical guideline development##2##3##(1996-1#1)(2012-2#1)
clinical guideline for##2##3##(1996-1#1)(2010-9#1)
clinical guideline##4##2##(1996-1#2)(2010-9#1)(2012-2#1)
clinical guidelines##6##2##(1991-12#1)(1993-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
clinical health##2##2##(2008-12#2)
clinical history and##2##3##(1996-9#1)(2012-2#1)
clinical history##7##2##(1991-12#1)(1995-11#1)(1996-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
clinical illness##2##2##(1995-2#1)(2013-8#1)
clinical imaging##2##2##(2011-2#1)(2012-2#1)
clinical impact of##3##3##(2008-10#2)(2013-1#1)
clinical impact##4##2##(2008-10#2)(2009-8#1)(2013-1#1)
clinical implication##3##2##(2008-10#1)(2009-1#1)(2009-7#1)
clinical implications for##3##3##(2008-4#1)(2009-11#1)(2013-1#1)
clinical implications##17##2##(1995-2#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#3)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#3)
clinical importance of##3##3##(1997-8#1)(2008-5#1)(2008-6#1)
clinical importance##6##2##(1993-3#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-6#2)
clinical improvement and##2##3##(2010-7#1)(2013-1#1)
clinical improvement was observed##2##4##(2013-1#2)
clinical improvement##10##2##(1996-1#1)(1996-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#5)
clinical indications##4##2##(1992-3#1)(1995-5#1)(2008-8#1)(2012-2#1)
clinical information##13##2##(1991-12#1)(1991-3#1)(1993-2#1)(1997-5#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
clinical intervention##2##2##(1993-3#1)(2008-7#1)
clinical investigation##4##2##(1993-8#1)(2008-12#1)(2010-6#1)(2013-8#1)
clinical investigations##3##2##(1992-3#1)(2013-7#1)(2013-8#1)
clinical investigators##2##2##(1992-3#1)(1993-11#1)
clinical isolates from HIV-infected##2##4##(2008-5#2)
clinical isolates of C##2##4##(2008-5#2)
clinical isolates of Candida albicans##2##5##(2008-5#2)
clinical isolates of Candida##3##4##(2008-5#3)
clinical isolates of Pseudomonas aeruginosa##3##5##(2012-2#3)
clinical isolates of##12##3##(1995-2#1)(1997-8#1)(2008-5#6)(2008-7#1)(2012-2#3)
clinical isolates##22##2##(1995-2#1)(1997-3#1)(1997-8#2)(2008-5#10)(2008-7#2)(2010-6#1)(2011-2#1)(2012-2#4)
clinical issues##3##2##(1992-9#1)(2010-10#1)(2012-12#1)
clinical judgement##2##2##(2011-2#1)(2013-8#1)
clinical judgment and##2##3##(1993-12#1)(2008-1#1)
clinical judgment##4##2##(1993-12#1)(2007-9#1)(2008-1#1)(2008-6#1)
clinical knowledge##4##2##(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)
clinical laboratories##8##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)
clinical laboratory professionals##2##3##(1994-12#2)
clinical laboratory sciences##2##3##(1994-12#2)
clinical laboratory##24##2##(1993-1#1)(1994-1#2)(1994-12#12)(1997-4#1)(2008-10#4)(2008-12#1)(2008-9#2)(2011-2#1)
clinical lacunar syndrome##3##3##(2009-10#3)
clinical leaders##2##2##(1997-2#2)
clinical leadership##2##2##(1997-2#1)(2008-12#1)
clinical learning environment##6##3##(2008-11#1)(2008-12#5)
clinical learning environments##2##3##(2008-11#2)
clinical learning##18##2##(2008-11#8)(2008-12#10)
clinical level##3##2##(2008-11#2)(2008-7#1)
clinical literature and##2##3##(1993-12#1)(2012-2#1)
clinical literature##8##2##(1992-12#1)(1993-12#3)(2008-10#1)(2008-12#1)(2010-6#1)(2012-2#1)
clinical management and##2##3##(2011-1#1)(2013-1#1)
clinical management of patients##2##4##(2008-11#1)(2012-3#1)
clinical management of##9##3##(2008-11#2)(2008-4#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
clinical management##23##2##(2008-10#2)(2008-11#3)(2008-4#2)(2009-12#2)(2009-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
clinical manifestation##2##2##(1990-12#1)(1997-8#1)
clinical manifestations of##6##3##(1994-6#1)(2008-7#2)(2010-9#1)(2011-2#1)(2013-1#1)
clinical manifestations##18##2##(1991-11#1)(1991-3#2)(1994-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#4)(2010-9#1)(2011-2#2)(2013-1#3)
clinical markers of##2##3##(2012-12#1)(2013-1#1)
clinical markers##4##2##(2011-2#2)(2012-12#1)(2013-1#1)
clinical mastitis##4##2##(1990-6#1)(1992-2#1)(1996-8#2)
clinical medicine##11##2##(1992-12#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-6#3)(1995-8#1)(1997-7#1)(2011-3#2)
clinical notes##2##2##(1992-3#1)(2012-3#1)
clinical nurse##4##2##(2008-11#2)(2013-1#2)
clinical nurses##4##2##(1991-2#1)(2008-12#1)(2013-1#2)
clinical nursing diagnosis##3##3##(1990-2#3)
clinical nursing##8##2##(1990-2#3)(2008-11#1)(2008-12#4)
clinical observation##2##2##(2008-12#1)(2013-7#1)
clinical observations##4##2##(1991-12#1)(1991-2#1)(1993-3#1)(2008-6#1)
clinical oncology##8##2##(1994-6#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
clinical or##8##2##(1992-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#2)
clinical outcome at##2##3##(1995-11#1)(2008-7#1)
clinical outcome between the##2##4##(1997-3#1)(2011-2#1)
clinical outcome in patients##2##4##(2008-7#1)(2011-2#1)
clinical outcome in##4##3##(1995-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
clinical outcome is##2##3##(2011-2#1)(2013-1#1)
clinical outcome of##5##3##(2006-6#1)(2009-3#1)(2012-3#1)(2013-1#2)
clinical outcome##32##2##(1991-2#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-3#2)(2006-6#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
clinical outcomes and##4##3##(1994-1#1)(1997-1#1)(2008-11#1)(2012-3#1)
clinical outcomes in##2##3##(2011-2#1)(2013-1#1)
clinical outcomes of##3##3##(2008-10#1)(2009-7#2)
clinical outcomes##32##2##(1992-12#1)(1994-1#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#2)(2010-2#1)(2011-2#4)(2012-12#3)(2012-3#4)(2013-1#5)
clinical parameters##10##2##(2008-10#2)(2008-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
clinical pathology conference held by the##4##6##(2008-8#3)(2012-2#1)
clinical pathology##7##2##(1994-12#3)(2008-8#3)(2012-2#1)
clinical pathway##6##2##(2008-3#2)(2012-2#2)(2012-3#1)(2013-1#1)
clinical pathways##2##2##(2008-3#1)(2012-2#1)
clinical pattern##3##2##(1997-8#1)(2008-5#1)(2008-7#1)
clinical pediatric##2##2##(2010-8#1)(2011-2#1)
clinical penetrance##5##2##(2008-5#5)
clinical performance##3##2##(2008-1#1)(2010-8#1)(2011-7#1)
clinical perspective##3##2##(1997-8#1)(2008-11#2)
clinical perspectives##3##2##(1993-3#1)(2008-11#1)(2008-4#1)
clinical phase##2##2##(2006-6#1)(2008-10#1)
clinical phenotype##6##2##(1992-3#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
clinical picture of##2##3##(1990-3#1)(2008-7#1)
clinical picture##12##2##(1990-3#1)(1990-9#1)(1991-3#1)(1993-8#1)(1994-6#1)(1997-4#1)(1997-6#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
clinical placement settings##2##3##(2008-11#2)
clinical placement##19##2##(2008-11#7)(2008-12#11)(2013-8#1)
clinical placements in##2##3##(2008-11#1)(2008-12#1)
clinical placements##13##2##(2008-11#6)(2008-12#7)
clinical point of view##2##4##(2008-10#1)(2009-7#1)
clinical practice and outcomes##2##4##(1994-1#1)(2008-11#1)
clinical practice and research##3##4##(2008-6#1)(2010-11#1)(2012-2#1)
clinical practice and the##3##4##(2008-12#1)(2008-6#1)(2008-7#1)
clinical practice and##16##3##(1994-1#1)(1995-11#1)(2008-11#2)(2008-12#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-2#1)
clinical practice are##2##3##(1994-3#1)(2010-9#1)
clinical practice for##4##3##(1997-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
clinical practice guideline##2##3##(2010-8#1)(2012-3#1)
clinical practice guidelines##4##3##(1993-12#2)(1994-12#1)(1996-2#1)
clinical practice has##2##3##(2013-1#1)(2013-8#1)
clinical practice in the##2##4##(2008-11#1)(2010-11#1)
clinical practice in##6##3##(1993-3#1)(2008-11#1)(2010-11#1)(2010-12#1)(2013-1#2)
clinical practice is##6##3##(1994-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
clinical practice of##5##3##(1993-11#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-2#1)
clinical practice to##4##3##(1993-3#1)(2008-11#1)(2009-8#1)(2010-12#1)
clinical practice##162##2##(1991-2#1)(1991-3#2)(1992-12#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-11#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-8#2)(2007-8#1)(2008-10#5)(2008-11#32)(2008-12#10)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#12)(2010-11#5)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#8)(2013-8#2)
clinical practice]##6##2##(1991-3#1)(1993-5#1)(1997-5#1)(2009-5#1)(2012-3#1)(2013-1#1)
clinical predictors##2##2##(2008-7#1)(2012-2#1)
clinical presentation is##2##3##(1995-1#1)(2012-2#1)
clinical presentation of##5##3##(1990-12#1)(2008-11#1)(2009-10#1)(2011-2#2)
clinical presentation##27##2##(1990-12#1)(1990-5#1)(1990-9#1)(1995-1#1)(1996-3#2)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-7#1)(2009-10#1)(2009-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
clinical presentations##4##2##(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
clinical preventive services##3##3##(1995-12#2)(1996-2#1)
clinical preventive##5##2##(1995-12#3)(1996-2#1)(1997-2#1)
clinical problem in##2##3##(2010-12#2)
clinical problem##6##2##(1997-4#1)(2007-9#1)(2008-6#1)(2010-12#2)(2012-3#1)
clinical problems##7##2##(1991-12#1)(1993-12#1)(1993-9#1)(2008-7#1)(2010-10#1)(2010-6#1)(2013-1#1)
clinical process##3##2##(1993-3#1)(1995-3#1)(1997-3#1)
clinical processes##2##2##(1994-1#1)(1994-12#1)
clinical profile of##3##3##(2009-1#1)(2010-12#1)(2012-3#1)
clinical profile##6##2##(2009-1#1)(2009-11#1)(2010-12#1)(2010-5#1)(2012-3#2)
clinical profiles##3##2##(2011-2#1)(2012-3#2)
clinical progress##2##2##(2008-6#1)(2011-2#1)
clinical properties##2##2##(1991-6#1)(2010-9#1)
clinical protocol##2##2##(2008-5#1)(2010-7#1)
clinical protocols##2##2##(1993-11#1)(2008-11#1)
clinical purposes##2##2##(2010-11#1)(2013-8#1)
clinical range##2##2##(2008-10#1)(2010-10#1)
clinical reality##3##2##(2010-10#1)(2011-2#2)
clinical realm##2##2##(2010-10#1)(2013-7#1)
clinical reasoning##3##2##(2008-11#1)(2008-12#2)
clinical relevance of##2##3##(1991-12#1)(2008-10#1)
clinical relevant disease##2##3##(2010-11#2)
clinical report##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
clinical reports##5##2##(2011-2#3)(2011-7#1)(2013-7#1)
clinical research##21##2##(1994-12#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2010-11#2)(2010-8#3)(2010-9#1)(2012-12#1)(2013-1#1)
clinical resistance to##2##3##(2008-11#1)(2013-1#1)
clinical response to treatment##2##4##(1996-8#1)(2013-8#1)
clinical response##14##2##(1991-3#2)(1991-6#3)(1996-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
clinical responses to##2##3##(2012-3#2)
clinical responses##4##2##(1990-12#1)(1991-3#1)(2012-3#2)
clinical results and##2##3##(2008-7#1)(2013-1#1)
clinical results of##2##3##(2013-1#1)(2013-7#1)
clinical results##15##2##(1991-3#1)(1993-11#1)(1993-9#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-6#1)(2011-2#1)(2013-1#3)(2013-7#1)
clinical review##4##2##(2008-11#1)(2012-12#1)(2013-1#2)
clinical risk factors##2##3##(2012-12#1)(2013-8#1)
clinical role##5##2##(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
clinical routine##4##2##(1997-1#1)(2012-2#3)
clinical safety##2##2##(2007-11#1)(2011-3#1)
clinical sample##2##2##(1994-6#1)(1997-8#1)
clinical samples##10##2##(2008-10#3)(2008-5#3)(2013-1#1)(2013-8#3)
clinical scenarios##4##2##(2008-7#1)(2010-12#2)(2012-3#1)
clinical sciences##3##2##(1994-12#3)
clinical screening##3##2##(1990-2#1)(1991-12#1)(2008-10#1)
clinical sequelae##2##2##(2011-2#2)
clinical services to##2##3##(1994-3#1)(2008-11#1)
clinical services##7##2##(1991-10#1)(1994-3#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-4#1)
clinical setting and##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
clinical setting of##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
clinical setting##31##2##(1991-11#1)(1992-3#2)(1993-3#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#2)(2008-7#1)(2008-9#5)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
clinical settings##24##2##(1996-1#1)(2008-1#1)(2008-11#9)(2008-12#3)(2008-2#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#1)
clinical severity##2##2##(1995-2#1)(1997-6#1)
clinical sign##3##2##(1991-8#1)(2008-10#1)(2013-7#1)
clinical significance and##2##3##(2008-10#1)(2013-2#1)
clinical significance of##5##3##(2008-2#1)(2010-4#1)(2012-3#1)(2013-1#2)
clinical significance##15##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-3#2)(2013-1#5)(2013-2#1)
clinical signs and symptoms##5##4##(1992-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
clinical signs and##6##3##(1992-1#1)(1992-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
clinical signs associated with##2##4##(1990-3#1)(1991-8#1)
clinical signs of infective mononucleosis and##2##6##(2011-2#2)
clinical signs of##8##3##(1996-12#1)(2008-5#2)(2009-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
clinical signs##30##2##(1990-3#2)(1991-8#1)(1992-1#1)(1992-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-5#1)(2008-5#6)(2009-1#1)(2010-1#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#4)
clinical site availability##2##3##(2008-11#2)
clinical situation##6##2##(1990-2#1)(1990-9#1)(1992-3#1)(2008-11#1)(2008-4#1)(2013-1#1)
clinical situations##6##2##(1997-4#1)(2008-3#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
clinical skill##3##2##(2008-11#3)
clinical skills and##3##3##(1992-3#1)(1996-1#1)(2008-12#1)
clinical skills in##2##3##(2008-11#1)(2008-12#1)
clinical skills##10##2##(1992-3#2)(1996-1#1)(2008-11#4)(2008-12#3)
clinical specimens of##2##3##(2008-12#1)(2013-8#1)
clinical specimens##7##2##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-8#3)
clinical spectrum##6##2##(1995-1#1)(2008-4#1)(2008-7#2)(2012-3#1)(2013-1#1)
clinical staff##3##2##(1991-12#1)(1996-1#1)(2011-2#1)
clinical stage##5##2##(1990-8#1)(1990-9#1)(2008-1#2)(2012-3#1)
clinical stages I##2##3##(2008-1#2)
clinical stages##3##2##(2008-1#3)
clinical state##3##2##(1992-5#1)(1995-12#1)(1996-3#1)
clinical status and##2##3##(1995-5#1)(2013-1#1)
clinical status##8##2##(1995-11#1)(1995-5#1)(2008-7#1)(2009-5#2)(2011-2#1)(2013-1#2)
clinical strains##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
clinical studies and ADR reports##2##5##(2011-2#2)
clinical studies and##3##3##(1994-12#1)(2011-2#2)
clinical studies are necessary##2##4##(2011-2#1)(2013-8#1)
clinical studies are##6##3##(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
clinical studies as##2##3##(2010-8#1)(2012-5#1)
clinical studies has##2##3##(2008-7#1)(2009-10#1)
clinical studies have shown that##2##5##(2011-2#2)
clinical studies have##5##3##(1992-2#1)(1996-9#1)(2010-10#1)(2011-2#2)
clinical studies of##7##3##(1992-2#1)(1996-11#1)(2008-11#1)(2008-5#1)(2011-2#2)(2011-7#1)
clinical studies on##2##3##(2009-7#1)(2013-8#1)
clinical studies suggesting##2##3##(2008-7#1)(2009-3#1)
clinical studies to##2##3##(2008-10#1)(2013-8#1)
clinical studies using##2##3##(2008-3#1)(2013-8#1)
clinical studies with##2##3##(2010-5#1)(2013-8#1)
clinical studies##69##2##(1992-2#2)(1993-6#1)(1994-12#1)(1994-8#1)(1996-11#1)(1996-2#1)(1996-9#1)(2008-10#6)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#3)(2010-10#1)(2010-11#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-2#10)(2011-7#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#9)
clinical study on##3##3##(1990-5#1)(2011-2#1)(2013-1#1)
clinical study##22##2##(1990-5#2)(1992-12#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-5#3)(2009-12#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#2)
clinical subgroups with back pain and related disorders is offered##2##10##(2008-12#2)
clinical subgroups##3##2##(1995-12#1)(2008-12#2)
clinical success##6##2##(2007-11#1)(2008-11#1)(2008-7#3)(2011-2#1)
clinical supervision##4##2##(2008-11#3)(2008-4#1)
clinical support##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
clinical suspicion##4##2##(1997-2#1)(2009-11#1)(2011-2#1)(2013-1#1)
clinical symptom##3##2##(1996-9#1)(2008-12#1)(2011-2#1)
clinical symptoms and signs##2##4##(1995-2#1)(2008-10#1)
clinical symptoms and##6##3##(1995-2#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#2)
clinical symptoms are##2##3##(1991-6#1)(1997-1#1)
clinical symptoms of##5##3##(1997-1#1)(1997-3#1)(2008-12#1)(2010-8#1)(2013-8#1)
clinical symptoms were##3##3##(1990-2#1)(1990-9#1)(2008-5#1)
clinical symptoms##30##2##(1990-2#1)(1990-9#1)(1991-6#1)(1992-3#1)(1992-5#1)(1995-2#1)(1997-1#2)(1997-3#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
clinical syndrome##4##2##(2008-10#1)(2011-2#1)(2012-3#2)
clinical teaching and##2##3##(2008-11#1)(2008-12#1)
clinical teaching##4##2##(2008-11#3)(2008-12#1)
clinical testing of sunscreens##2##4##(2008-5#2)
clinical testing of##4##3##(1995-5#1)(1996-6#1)(2008-5#2)
clinical testing##8##2##(1995-5#1)(1996-2#1)(1996-6#1)(1997-6#1)(2008-4#1)(2008-5#2)(2013-8#1)
clinical tool for##3##3##(1993-12#2)(2008-10#1)
clinical tool##5##2##(1993-12#2)(1995-2#1)(2008-10#1)(2008-12#1)
clinical training and##2##3##(1996-1#1)(2008-10#1)
clinical training##3##2##(1996-1#1)(2008-10#1)(2012-2#1)
clinical translation##2##2##(2012-3#1)(2013-1#1)
clinical trial are##2##3##(1996-3#1)(2011-3#1)
clinical trial data##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
clinical trial evidence##2##3##(2008-6#1)(2008-7#1)
clinical trial for##3##3##(1994-5#1)(1995-9#1)(2010-10#1)
clinical trial information##2##3##(2009-2#1)(2013-1#1)
clinical trial is the##2##4##(1996-6#1)(2011-2#1)
clinical trial of##8##3##(1994-9#1)(2008-7#1)(2009-4#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
clinical trial on##2##3##(1993-5#1)(2013-1#1)
clinical trial was##4##3##(1991-2#1)(1991-3#1)(1996-1#1)(2010-8#1)
clinical trial with##2##3##(2008-6#1)(2013-1#1)
clinical trial##74##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-9#2)(1993-5#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-6#4)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-2#1)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#6)
clinical trials and other##2##4##(1996-3#1)(2008-11#1)
clinical trials and##11##3##(1990-9#1)(1992-2#1)(1995-9#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)
clinical trials are needed to##2##5##(2011-2#2)
clinical trials are##8##3##(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(2008-5#1)(2011-2#3)
clinical trials as##3##3##(2008-5#3)
clinical trials for##2##3##(2009-4#1)(2010-10#1)
clinical trials in oncology##2##4##(2009-12#1)(2010-1#1)
clinical trials in the##2##4##(2008-11#1)(2008-5#1)
clinical trials in##11##3##(1991-6#1)(1993-9#1)(1994-8#1)(2006-6#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-1#1)
clinical trials is##3##3##(1996-6#1)(2008-10#1)(2013-7#1)
clinical trials of##16##3##(1993-2#1)(1994-5#2)(1995-5#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
clinical trials should be##2##4##(2010-4#1)(2010-8#1)
clinical trials should##3##3##(1993-12#1)(2010-4#1)(2010-8#1)
clinical trials to##4##3##(2008-6#1)(2012-2#2)(2013-1#1)
clinical trials with##6##3##(1992-9#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-2#1)
clinical trials##165##2##(1990-9#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#5)(1995-5#2)(1995-9#1)(1996-3#4)(1996-6#8)(1996-9#1)(1997-3#1)(2006-6#1)(2008-10#5)(2008-11#18)(2008-12#1)(2008-5#13)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#7)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#4)(2010-8#3)(2011-1#1)(2011-2#6)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#1)
clinical type##2##2##(1993-11#1)(2013-1#1)
clinical units##4##2##(1995-12#4)
clinical use for##3##3##(1996-11#1)(2008-10#1)(2009-7#1)
clinical use in##7##3##(1991-9#1)(1994-12#1)(2007-11#1)(2008-10#1)(2009-12#1)(2011-2#1)(2011-3#1)
clinical use of the##2##4##(2008-12#1)(2010-6#1)
clinical use of##10##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-2#1)
clinical use##33##2##(1991-12#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-12#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#1)
clinical usefulness of##2##3##(2008-11#1)(2011-2#1)
clinical usefulness##4##2##(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
clinical uses##2##2##(2008-11#1)(2008-4#1)
clinical utility##4##2##(2009-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
clinical validation##4##2##(1996-2#1)(2008-1#1)(2010-5#1)(2012-2#1)
clinical value of##2##3##(2008-5#1)(2012-2#1)
clinical value##4##2##(2008-10#1)(2008-5#1)(2010-5#1)(2012-2#1)
clinical variables##2##2##(2007-12#1)(2013-8#1)
clinical work with##2##3##(1995-5#2)
clinical work##3##2##(1995-5#3)
clinical##2716##1##(1990-11#1)(1990-12#5)(1990-2#16)(1990-3#15)(1990-5#11)(1990-6#3)(1990-8#2)(1990-9#12)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#15)(1991-2#14)(1991-3#28)(1991-6#13)(1991-8#9)(1991-9#2)(1992-1#5)(1992-12#15)(1992-2#9)(1992-3#19)(1992-5#7)(1992-6#1)(1992-9#11)(1993-1#2)(1993-11#12)(1993-12#24)(1993-2#11)(1993-3#20)(1993-5#3)(1993-6#5)(1993-8#3)(1993-9#8)(1994-1#8)(1994-12#92)(1994-2#3)(1994-3#7)(1994-5#7)(1994-6#10)(1994-8#5)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#16)(1995-2#13)(1995-3#3)(1995-5#15)(1995-8#1)(1995-9#6)(1996-1#9)(1996-11#9)(1996-12#4)(1996-2#7)(1996-3#14)(1996-5#1)(1996-6#16)(1996-8#5)(1996-9#6)(1997-1#8)(1997-2#18)(1997-3#22)(1997-4#9)(1997-5#9)(1997-6#8)(1997-7#6)(1997-8#23)(2006-6#7)(2007-11#4)(2007-12#9)(2007-8#10)(2007-9#2)(2008-1#17)(2008-10#125)(2008-11#251)(2008-12#143)(2008-2#4)(2008-3#15)(2008-4#25)(2008-5#108)(2008-6#30)(2008-7#103)(2008-8#28)(2008-9#50)(2009-1#5)(2009-10#16)(2009-11#7)(2009-12#12)(2009-2#4)(2009-3#8)(2009-4#17)(2009-5#5)(2009-6#5)(2009-7#10)(2009-8#13)(2009-9#6)(2010-1#10)(2010-10#31)(2010-11#44)(2010-12#37)(2010-2#6)(2010-3#2)(2010-4#8)(2010-5#27)(2010-6#33)(2010-7#11)(2010-8#33)(2010-9#9)(2011-1#14)(2011-10#1)(2011-2#203)(2011-3#11)(2011-7#10)(2011-8#1)(2012-12#57)(2012-2#76)(2012-3#101)(2012-5#2)(2013-1#184)(2013-2#1)(2013-7#12)(2013-8#67)
clinical/diagnostic##2##1##(1991-12#2)
clinically acceptable##2##2##(1996-3#1)(2008-6#1)
clinically and histologically##2##3##(2010-12#1)(2011-2#1)
clinically and##15##2##(1992-2#1)(1995-12#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
clinically approved##3##2##(2011-2#1)(2011-3#1)(2012-3#1)
clinically as an##2##3##(2012-2#1)(2012-3#1)
clinically as##5##2##(1997-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
clinically based service limitation##2##4##(1993-12#2)
clinically based##3##2##(1993-12#2)(2008-12#1)
clinically by##5##2##(1991-2#1)(1995-5#1)(1997-8#1)(2008-5#2)
clinically defined##2##2##(1997-2#2)
clinically diagnosed##5##2##(1996-11#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-3#1)
clinically effective##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
clinically evaluated##3##2##(1992-2#1)(2008-11#1)(2011-3#1)
clinically evident##3##2##(1990-6#1)(1997-1#1)(2008-10#1)
clinically healthy##3##2##(1991-6#1)(2008-11#1)(2008-5#1)
clinically important differences##2##3##(1997-8#1)(2012-3#1)
clinically important##14##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
clinically in##2##2##(1992-5#1)(2008-8#1)
clinically inexperienced student therapists##2##4##(2012-2#2)
clinically irrelevant##2##2##(2008-11#2)
clinically meaningful improvements##2##3##(2008-12#2)
clinically meaningful##7##2##(1995-5#1)(2008-12#4)(2008-7#1)(2012-12#1)
clinically normal##4##2##(1992-5#1)(2008-5#2)(2010-9#1)
clinically proven##4##2##(1996-12#1)(2011-2#3)
clinically relevant##23##2##(1996-2#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#2)
clinically significant##13##2##(1992-6#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-1#1)(2009-3#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
clinically silent##2##2##(2010-12#1)(2011-2#1)
clinically similar##2##2##(1991-2#1)(2008-7#1)
clinically to##2##2##(2009-12#1)(2010-7#1)
clinically used##3##2##(2008-4#2)(2009-8#1)
clinically useful##14##2##(1990-9#1)(1991-12#1)(1992-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#1)
clinically validated##2##2##(2010-11#1)(2011-2#1)
clinically##216##1##(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-6#2)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#1)(1993-12#3)(1993-2#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-8#4)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#21)(2008-12#9)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#3)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#22)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#11)(2012-4#1)(2013-1#10)(2013-8#5)
clinician satisfaction##2##2##(2010-8#1)(2012-2#1)
clinician to obtain##2##3##(2010-12#1)(2013-1#1)
clinician to##7##2##(1991-2#1)(1994-12#1)(2007-9#1)(2008-12#2)(2010-12#1)(2013-1#1)
clinician##37##1##(1990-9#1)(1991-1#1)(1991-2#1)(1993-1#1)(1994-12#1)(1995-1#1)(1997-3#1)(2007-9#1)(2008-11#3)(2008-12#5)(2008-6#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#1)
clinician's##7##1##(1997-2#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-1#1)(2012-2#1)
clinicians and managers##3##3##(1994-1#1)(1997-1#1)(1997-4#1)
clinicians and researchers##2##3##(2008-12#1)(2008-7#1)
clinicians and##16##2##(1992-3#1)(1994-1#1)(1997-1#1)(1997-4#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2012-2#1)
clinicians better##2##2##(2008-11#1)(2013-1#1)
clinicians can##2##2##(2011-2#1)(2012-2#1)
clinicians have##3##2##(2008-12#1)(2008-4#1)(2011-2#1)
clinicians in the##3##3##(1996-6#1)(2007-9#1)(2008-7#1)
clinicians in##8##2##(1994-9#1)(1996-6#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
clinicians make##2##2##(1993-3#1)(2010-4#1)
clinicians must##2##2##(1993-2#1)(2008-2#1)
clinicians of##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
clinicians should##3##2##(2008-7#1)(2009-9#1)(2010-6#1)
clinicians to focus##2##3##(2010-5#1)(2011-2#1)
clinicians to##12##2##(1991-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
clinicians who##2##2##(2008-6#1)(2008-9#1)
clinicians with##3##2##(2008-11#2)(2008-8#1)
clinicians##114##1##(1990-6#1)(1991-1#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#14)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#6)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#8)(2013-8#1)
clinicians' beliefs about biological##2##4##(2010-4#2)
clinicians' confidence in##2##3##(2011-2#1)(2012-2#1)
clinicians'##5##1##(2010-4#2)(2011-2#1)(2012-2#2)
clinico-pathologic characteristics##2##2##(2008-10#2)
clinico-pathologic##7##1##(1991-6#1)(1991-8#2)(2008-10#3)(2013-8#1)
clinicochemical##2##1##(1993-2#2)
clinicopathologic features and##2##3##(2008-11#1)(2011-2#1)
clinicopathologic features of##2##3##(1994-6#1)(2010-1#1)
clinicopathologic features##4##2##(1994-6#1)(2008-11#1)(2010-1#1)(2011-2#1)
clinicopathologic##8##1##(1990-6#1)(1994-6#1)(2008-11#2)(2010-1#2)(2011-2#1)(2013-1#1)
clinicopathological##8##1##(1991-8#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-5#1)
clinics and hospitals##2##3##(1994-12#1)(1997-8#1)
clinics and##6##2##(1990-6#1)(1991-1#2)(1994-12#1)(1995-2#1)(1997-8#1)
clinics are##2##2##(1991-12#1)(2008-1#1)
clinics by##3##2##(1994-1#2)(1995-12#1)
clinics in the##2##3##(1991-6#1)(2008-11#1)
clinics in##5##2##(1990-3#1)(1991-6#1)(1996-12#1)(2008-11#1)(2013-1#1)
clinics were##2##2##(2008-10#1)(2008-12#1)
clinics##59##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#5)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#2)(1993-3#2)(1994-1#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-6#1)(1996-1#1)(1996-12#2)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-9#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#4)(2013-8#2)
clinics]##2##1##(1996-2#1)(2013-8#1)
clinique et##2##2##(2013-1#2)
clinique##4##1##(2013-1#4)
cliniques##2##1##(2011-2#2)
clinodactyly of the##2##3##(1997-3#2)
clip##5##1##(2008-1#1)(2008-12#4)
clipped or##2##2##(1995-11#1)(2008-7#1)
clipped##5##1##(1995-11#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)
clipping##10##1##(1995-11#1)(1996-9#3)(1997-3#1)(1997-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
clips were##2##2##(1997-5#1)(2008-12#1)
clips##7##1##(1997-5#2)(2008-12#4)(2012-2#1)
clivus##4##1##(2008-12#1)(2011-2#3)
cln2##2##1##(1991-5#2)
cloacae##10##1##(2007-11#1)(2008-11#1)(2008-9#4)(2010-6#3)(2011-2#1)
cloacal exstrophy##6##2##(2008-10#6)
cloacal samples##3##2##(1996-12#3)
cloacal sampling##2##2##(1996-12#2)
cloacal swab##2##2##(1996-12#2)
cloacal swabs##2##2##(2008-5#2)
cloacal##19##1##(1996-12#7)(2008-10#9)(2008-5#3)
clobutinol##2##1##(2008-10#2)
clock components##2##2##(2009-8#2)
clock##12##1##(1991-12#1)(1995-2#3)(1997-1#1)(2008-9#1)(2009-8#6)
clock- and phytochrome-regulated##2##3##(1995-2#2)
clock-##3##1##(1995-2#3)
clocks##2##1##(2008-11#1)(2009-7#1)
clofibrate##6##1##(1990-12#3)(1990-2#1)(1992-8#1)(2008-11#1)
clofibrate-inducible##2##1##(1992-8#2)
clogging##2##1##(2008-11#1)(2008-7#1)
clomipramine##2##1##(2008-10#2)
clonal disorder##2##2##(2010-1#1)(2013-1#1)
clonal diversity##2##2##(1997-8#1)(2012-3#1)
clonal endocrine pancreatic glucagon-secreting##2##4##(1994-11#2)
clonal expansion##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
clonal lineage##11##2##(2008-10#11)
clonal lineages of##3##3##(2008-10#3)
clonal lineages were identified in##2##5##(2008-10#2)
clonal lineages were identified##3##4##(2008-10#3)
clonal lineages were##4##3##(2008-10#4)
clonal lineages##21##2##(2008-10#21)
clonal or##2##2##(2008-10#1)(2008-9#1)
clonal population of##2##3##(2008-10#1)(2009-3#1)
clonal population##5##2##(2008-10#4)(2009-3#1)
clonal reproduction##3##2##(2008-10#2)(2008-9#1)
clonal variation##2##2##(2008-10#1)(2008-7#1)
clonal##88##1##(1993-12#1)(1993-3#1)(1994-11#2)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#56)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#6)(2009-3#1)(2009-8#1)(2010-1#2)(2011-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
clonality##6##1##(2008-10#3)(2008-5#3)
clonally propagated##2##2##(2008-10#2)
clonally related##2##2##(2008-10#1)(2008-9#1)
clonally##9##1##(1993-12#1)(2008-10#6)(2008-4#1)(2008-9#1)
clonazepam##2##1##(1997-4#1)(2008-10#1)
clone Y31##2##2##(1997-7#2)
clone analysis##2##2##(1993-2#1)(1995-6#1)
clone and the##2##3##(1991-12#1)(2008-8#1)
clone and##4##2##(1991-12#1)(1993-2#1)(1997-8#1)(2008-8#1)
clone as a##2##3##(1995-12#1)(2008-10#1)
clone contained a##2##3##(1993-8#1)(2008-8#1)
clone contained##4##2##(1993-8#2)(1997-9#1)(2008-8#1)
clone containing the##2##3##(1996-8#1)(1997-9#1)
clone containing##7##2##(1993-12#1)(1996-8#1)(1997-9#1)(2008-10#1)(2008-8#3)
clone contains a##2##3##(1993-12#1)(1994-11#1)
clone encoding the##2##3##(1990-5#1)(1995-6#1)
clone encoding##8##2##(1990-5#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-9#1)
clone from a##5##3##(1990-7#1)(1993-2#1)(1993-6#1)(1995-2#1)(1996-3#1)
clone from##7##2##(1990-7#1)(1993-2#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(2008-10#1)
clone had##2##2##(1995-8#1)(1997-8#1)
clone in##3##2##(1994-8#1)(2008-4#1)(2008-8#1)
clone inserts##2##2##(1991-5#1)(1997-8#1)
clone is##5##2##(1991-9#1)(1993-6#3)(2008-8#1)
clone of a##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
clone of an##2##3##(1997-3#1)(2008-10#1)
clone of the##2##3##(1993-6#1)(2008-10#1)
clone of##10##2##(1993-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)
clone recognized a##2##3##(1991-12#1)(1997-7#1)
clone recognized##3##2##(1991-12#2)(1997-7#1)
clone showed that the##2##4##(1994-11#1)(1995-2#1)
clone that contains##2##3##(1993-3#1)(2008-4#1)
clone that##4##2##(1993-3#1)(1995-2#1)(2008-10#1)(2008-4#1)
clone the##4##2##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
clone to##2##2##(1990-2#1)(1996-2#1)
clone was identified##2##3##(2008-8#2)
clone was isolated and##2##4##(1991-9#1)(1994-11#1)
clone was isolated from a##2##5##(1993-6#1)(1995-8#1)
clone was isolated##4##3##(1991-9#1)(1993-6#1)(1994-11#1)(1995-8#1)
clone was##19##2##(1990-2#1)(1991-9#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-11#5)(2008-8#5)(2008-9#1)
clone which##3##2##(1993-6#1)(1994-11#1)(2008-8#1)
clone with##3##2##(1993-3#1)(1994-8#1)(2008-11#1)
clone##195##1##(1990-2#4)(1990-5#4)(1990-7#2)(1991-12#3)(1991-5#5)(1991-7#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#1)(1993-12#8)(1993-2#5)(1993-3#3)(1993-6#8)(1993-8#3)(1993-9#1)(1994-11#11)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#5)(1995-6#3)(1995-8#7)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#8)(1997-8#4)(1997-9#3)(2008-10#20)(2008-11#25)(2008-4#4)(2008-7#1)(2008-8#20)(2008-9#11)(2009-6#1)(2010-11#1)(2013-8#1)
clone-corrected data##2##2##(2008-10#2)
clone-corrected##3##1##(2008-10#3)
cloned 4-cell embryos derived from##2##5##(2008-9#2)
cloned DNA##6##2##(1991-9#1)(2008-10#5)
cloned RAPD##2##2##(2008-10#2)
cloned a cDNA encoding##2##4##(1995-11#1)(2008-6#1)
cloned a cDNA##4##3##(1993-2#1)(1995-11#1)(2008-6#1)(2008-8#1)
cloned a##8##2##(1991-7#1)(1993-2#1)(1995-11#1)(1995-6#1)(1997-7#1)(2008-6#1)(2008-8#1)(2008-9#1)
cloned and analyzed##2##3##(2008-10#1)(2008-11#1)
cloned and characterized##6##3##(1995-2#1)(2008-10#3)(2008-8#1)(2011-1#1)
cloned and expressed in Escherichia coli##3##6##(1993-12#1)(1997-3#1)(2008-10#1)
cloned and its##2##3##(1997-7#2)
cloned and sequenced and##2##4##(1996-12#1)(2008-8#1)
cloned and sequenced the##5##4##(1993-9#1)(1994-11#1)(1995-6#1)(1997-7#1)(1997-8#1)
cloned and sequenced##39##3##(1991-6#1)(1992-6#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-7#2)(1997-8#1)(2008-10#16)(2008-5#1)(2008-8#3)(2008-9#1)(2013-1#1)
cloned and##66##2##(1990-5#1)(1991-6#1)(1992-10#2)(1992-6#1)(1993-12#4)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-7#4)(1997-8#1)(2008-10#23)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#2)(2011-1#1)(2013-1#1)
cloned between##2##2##(2008-8#1)(2009-3#1)
cloned by a##2##3##(1993-2#1)(2008-11#1)
cloned by polymerase chain reaction##2##5##(1996-8#1)(2008-10#1)
cloned by screening##3##3##(1997-4#1)(1997-8#1)(2008-8#1)
cloned by##13##2##(1991-6#1)(1991-9#1)(1993-2#1)(1994-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#3)
cloned cDNA##4##2##(1994-11#1)(2008-10#3)
cloned cDNAs##2##2##(2008-10#2)
cloned embryos##3##2##(2008-9#3)
cloned fragments##4##2##(1990-12#1)(2008-10#3)
cloned from a human##2##4##(1994-11#1)(1997-2#1)
cloned from a single##2##4##(1993-12#1)(2008-10#1)
cloned from a##7##3##(1993-12#1)(1994-11#2)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)
cloned from an##2##3##(1990-5#1)(1997-8#1)
cloned from human##2##3##(1995-6#2)
cloned from rice##2##3##(2008-8#2)
cloned from the##6##3##(1991-5#1)(1993-9#1)(2008-10#2)(2008-6#1)(2008-8#1)
cloned from##31##2##(1990-5#1)(1991-5#1)(1993-12#3)(1993-9#2)(1994-11#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#4)(2008-9#1)(2010-5#1)
cloned gene##5##2##(1992-1#1)(1997-2#1)(1997-7#1)(2008-4#1)(2008-8#1)
cloned human##4##2##(1993-8#1)(1995-11#1)(2008-11#1)(2008-4#1)
cloned in a##3##3##(1990-11#1)(1992-8#1)(1997-3#1)
cloned in the##4##3##(1994-12#1)(1995-11#1)(1995-8#1)(2008-9#1)
cloned in##15##2##(1990-11#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2010-10#1)
cloned into a plasmid vector##2##5##(1994-12#1)(2008-10#1)
cloned into a##8##3##(1990-5#1)(1993-12#1)(1993-6#2)(1994-12#1)(2008-10#3)
cloned into the##6##3##(1991-6#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-8#2)
cloned into various##2##3##(2008-11#1)(2008-9#1)
cloned into##30##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-6#2)(1993-9#1)(1994-12#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-8#6)(2008-9#4)(2010-6#1)(2013-1#1)
cloned mu-##2##2##(1995-11#2)
cloned probes##2##2##(2008-10#1)(2008-9#1)
cloned sequences##2##2##(1993-12#2)
cloned the##7##2##(1991-9#1)(1995-6#1)(1997-7#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)
cloned using##2##2##(1991-9#1)(2010-6#1)
cloned viral##2##2##(2008-10#2)
cloned##309##1##(1990-11#2)(1990-12#1)(1990-5#5)(1991-2#1)(1991-5#1)(1991-6#6)(1991-7#1)(1991-9#5)(1992-1#1)(1992-10#3)(1992-3#3)(1992-6#2)(1992-8#1)(1993-12#13)(1993-2#2)(1993-6#7)(1993-8#1)(1993-9#6)(1994-11#6)(1994-12#3)(1995-11#5)(1995-12#2)(1995-2#3)(1995-6#7)(1995-8#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#4)(1996-8#2)(1997-2#6)(1997-3#3)(1997-4#1)(1997-7#9)(1997-8#5)(2008-10#77)(2008-11#15)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#34)(2008-9#25)(2009-12#1)(2009-3#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#3)(2011-1#1)(2013-1#2)(2013-8#1)
clones and by##2##3##(1993-2#1)(1996-2#1)
clones and the##2##3##(1997-8#1)(2008-9#1)
clones and##16##2##(1993-2#1)(1993-3#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-6#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-4#1)
clones appeared##2##2##(1992-2#1)(1996-2#1)
clones are genes##3##3##(2008-9#3)
clones are##9##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#6)
clones contained##2##2##(1993-6#1)(2008-10#1)
clones containing##2##2##(1990-8#1)(1996-12#1)
clones corresponding to##3##3##(1993-6#1)(1995-2#1)(1997-2#1)
clones derived from##2##3##(1996-8#1)(2012-2#1)
clones expressing##2##2##(2008-11#2)
clones for##6##2##(1992-10#1)(1992-2#1)(2008-10#1)(2008-11#2)(2012-3#1)
clones from a##4##3##(1991-12#1)(2008-10#2)(2008-11#1)
clones from the##5##3##(2008-10#1)(2008-11#1)(2008-9#3)
clones from##20##2##(1991-12#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-8#1)(2008-10#5)(2008-11#3)(2008-9#4)(2009-10#1)
clones had##3##2##(1993-8#1)(1997-3#1)(2008-11#1)
clones has##2##2##(1993-6#1)(2008-10#1)
clones have been##2##3##(1997-8#1)(2010-10#1)
clones have##3##2##(1997-8#1)(2008-11#1)(2010-10#1)
clones hybridized##2##2##(2008-10#2)
clones in##6##2##(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-5#1)(2013-8#1)
clones mapped to##3##3##(1997-8#1)(2012-3#2)
clones obtained##2##2##(1997-3#1)(2008-10#1)
clones of RNA##2##3##(2008-10#1)(2008-9#1)
clones of a##2##3##(1991-5#1)(1996-12#1)
clones of the##3##3##(1993-6#1)(2008-10#2)
clones of##20##2##(1991-5#1)(1992-6#1)(1993-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-9#2)(2011-2#1)
clones on##2##2##(1993-12#1)(1996-12#1)
clones reported##2##2##(1993-12#1)(2008-11#1)
clones revealed##2##2##(1997-8#1)(2008-12#1)
clones showed##6##2##(2008-10#2)(2008-11#3)(2008-9#1)
clones spanning##2##2##(1990-8#1)(1996-12#1)
clones that##5##2##(1994-11#1)(1997-7#1)(2008-10#2)(2012-3#1)
clones to##3##2##(1996-8#1)(2008-10#1)(2008-11#1)
clones was##7##2##(1991-6#1)(1991-9#1)(2008-10#3)(2008-11#2)
clones were capable of##2##4##(2008-10#1)(2008-11#1)
clones were expressed##2##3##(1993-8#1)(1997-8#1)
clones were found to be##2##5##(1990-8#1)(1997-2#1)
clones were found to##4##4##(1990-8#1)(1997-2#1)(2008-11#1)(2008-8#1)
clones were found##5##3##(1990-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
clones were isolated from##4##4##(1991-9#1)(2008-8#3)
clones were isolated which##2##4##(1992-3#1)(1993-2#1)
clones were isolated##9##3##(1990-8#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1997-7#1)(2008-8#3)
clones were obtained by a##2##5##(1993-12#1)(1996-8#1)
clones were obtained by##3##4##(1993-12#1)(1996-8#1)(2008-9#1)
clones were obtained from##2##4##(1997-7#1)(2008-9#1)
clones were obtained##8##3##(1993-12#1)(1996-8#1)(1997-7#1)(2008-8#2)(2008-9#3)
clones were sequenced##3##3##(1991-12#1)(1996-2#1)(1997-3#1)
clones were successfully##2##3##(1996-2#1)(2008-8#1)
clones were then##2##3##(2008-10#2)
clones were##57##2##(1990-8#2)(1991-12#2)(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1996-12#2)(1996-2#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#2)(2008-10#10)(2008-11#4)(2008-8#8)(2008-9#8)(2010-10#1)(2012-3#1)
clones with an average insert size of##2##7##(1997-6#1)(2008-8#1)
clones with##6##2##(1996-12#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-8#2)
clones##346##1##(1990-12#1)(1990-5#1)(1990-8#8)(1991-12#4)(1991-5#1)(1991-6#3)(1991-9#2)(1992-10#1)(1992-2#4)(1992-3#1)(1992-6#2)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#9)(1993-8#7)(1994-11#2)(1994-5#2)(1995-2#1)(1995-6#4)(1995-8#4)(1996-12#11)(1996-2#12)(1996-6#4)(1996-8#8)(1997-2#9)(1997-3#4)(1997-6#3)(1997-7#4)(1997-8#20)(1997-9#1)(2007-12#1)(2008-10#76)(2008-11#48)(2008-12#1)(2008-4#6)(2008-5#1)(2008-8#17)(2008-9#32)(2009-10#2)(2010-10#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#6)(2013-8#2)
clones)##2##1##(1996-8#1)(2008-10#1)
clonidine and##2##2##(1990-11#1)(1997-4#1)
clonidine##6##1##(1990-11#1)(1997-4#4)(2008-10#1)
cloning and DNA##2##3##(1993-12#1)(2008-8#1)
cloning and characterization of##6##4##(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1997-8#1)(2010-5#1)
cloning and expression of##4##4##(1990-5#1)(1993-2#1)(1993-6#1)(2012-3#1)
cloning and expression##8##3##(1990-5#1)(1991-5#1)(1993-2#1)(1993-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
cloning and function##2##3##(2008-9#2)
cloning and sequence analysis of a##2##6##(1993-2#1)(1997-4#1)
cloning and sequence analysis of##3##5##(1991-5#1)(1993-2#1)(1997-4#1)
cloning and sequence##4##3##(1991-5#1)(1993-2#2)(1997-4#1)
cloning and sequencing of##3##4##(1993-3#1)(1995-6#1)(1997-1#1)
cloning and sequencing##7##3##(1990-5#1)(1993-3#1)(1995-6#1)(1997-1#1)(2008-10#2)(2011-2#1)
cloning and##36##2##(1990-5#2)(1991-5#2)(1991-9#1)(1992-3#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1995-6#2)(1997-1#1)(1997-4#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-8#3)(2008-9#3)(2010-5#1)(2011-2#1)(2012-3#1)
cloning method##3##2##(2008-11#1)(2008-4#2)
cloning of a novel##2##4##(1995-8#1)(1997-7#1)
cloning of a##8##3##(1993-12#1)(1993-3#1)(1993-8#2)(1995-8#1)(1996-3#1)(1997-7#1)(2008-9#1)
cloning of human##3##3##(1993-3#1)(1994-11#2)
cloning of the cDNA##2##4##(1995-2#1)(2008-8#1)
cloning of the genes##2##4##(1992-9#1)(2008-8#1)
cloning of the human##2##4##(1994-11#1)(1995-11#1)
cloning of the##20##3##(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)
cloning of this##5##3##(1992-8#1)(1994-11#1)(1995-12#1)(2008-10#1)(2012-3#1)
cloning of##60##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-8#3)(1994-11#8)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-7#2)(2008-10#6)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-12#1)(2009-8#1)(2011-1#1)(2012-3#1)
cloning sites##5##2##(1993-12#2)(1993-8#2)(2011-1#1)
cloning vector##4##2##(1993-8#1)(1995-8#1)(2008-9#1)(2011-1#1)
cloning was##3##2##(1993-12#1)(2008-8#1)(2010-6#1)
cloning##172##1##(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#11)(1993-2#9)(1993-3#6)(1993-6#2)(1993-8#9)(1994-11#8)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#5)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#2)(1997-9#1)(2008-10#15)(2008-11#11)(2008-2#1)(2008-4#11)(2008-7#2)(2008-8#15)(2008-9#14)(2009-12#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-1#4)(2011-2#2)(2012-3#3)
clonogenic##3##1##(2008-11#3)
clopidogrel and##4##2##(2006-6#1)(2008-3#1)(2011-2#2)
clopidogrel bisulphate##4##2##(2008-10#4)
clopidogrel##20##1##(2006-6#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-8#2)(2011-2#6)(2012-12#1)(2013-8#1)
cloramphenicol and##2##2##(2008-10#1)(2008-5#1)
cloramphenicol##3##1##(2008-10#2)(2008-5#1)
closantel##2##1##(1991-8#2)
close agreement##4##2##(2008-10#3)(2008-8#1)
close association between##3##3##(1993-1#1)(1997-1#1)(2008-10#1)
close association of##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
close association with##6##3##(1992-1#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-9#1)
close association##12##2##(1992-1#1)(1993-1#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-10#1)
close collaboration between##3##3##(1991-2#1)(2008-10#1)(2010-10#1)
close collaboration##5##2##(1991-2#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-2#1)
close connection with the##2##4##(1994-12#1)(2008-10#1)
close connection with##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
close connection##4##2##(1994-12#1)(2008-10#2)(2008-8#1)
close contact with##6##3##(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#2)
close contact##9##2##(1990-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#2)(2010-5#1)
close cooperation##2##2##(2010-7#1)(2011-4#1)
close correlation between the##2##4##(1996-12#1)(2008-12#1)
close correlation between##4##3##(1996-12#1)(2008-10#2)(2008-12#1)
close correlation with##3##3##(1996-3#1)(2008-11#1)(2008-3#1)
close correlation##10##2##(1990-9#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)
close enough to##2##3##(1994-5#1)(2008-10#1)
close enough##3##2##(1994-5#1)(2008-10#1)(2008-4#1)
close examination##2##2##(1997-2#1)(2008-8#1)
close follow-up##3##2##(1992-9#1)(1996-11#1)(1997-4#1)
close friends with##2##3##(2009-7#1)(2011-2#1)
close friends##3##2##(2009-7#2)(2011-2#1)
close look at##2##3##(2008-10#1)(2010-8#1)
close monitoring and##2##3##(2007-11#1)(2010-1#1)
close monitoring of visual function##2##5##(2013-1#2)
close monitoring##6##2##(2007-11#1)(2010-1#1)(2011-2#1)(2013-1#3)
close or##2##2##(2008-11#1)(2008-12#1)
close proximity of##2##3##(1994-5#1)(2013-1#1)
close proximity to the##2##4##(1994-5#1)(2008-10#1)
close proximity to##6##3##(1994-5#1)(2008-10#4)(2009-12#1)
close proximity##13##2##(1994-5#2)(1995-2#1)(2008-10#6)(2008-3#1)(2009-12#1)(2010-11#1)(2013-1#1)
close relation between##2##3##(1994-6#1)(2008-7#1)
close relationship between the##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
close relationship between##8##3##(1995-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)
close relationship of##3##3##(1996-8#1)(2008-10#1)(2008-5#1)
close relationship with##4##3##(1994-12#2)(2008-10#2)
close relationship##16##2##(1994-12#2)(1995-12#1)(1996-8#1)(2008-10#7)(2008-5#2)(2008-8#1)(2009-9#1)(2011-2#1)
close relationships among##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
close relationships##6##2##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-2#2)
close relative of##2##3##(2008-10#2)
close relative##3##2##(2008-10#2)(2008-8#1)
close relatives##7##2##(1990-11#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#2)
close the##4##2##(1992-3#1)(1993-2#1)(2008-11#1)(2010-10#1)
close to 0##2##3##(2008-10#1)(2008-6#1)
close to 1##3##3##(2008-10#3)
close to 100% for##3##4##(2008-10#2)(2008-5#1)
close to 100%##10##3##(2008-10#9)(2008-5#1)
close to 2%##2##3##(2008-10#2)
close to 7##2##3##(2008-10#1)(2008-5#1)
close to a##2##3##(1992-6#1)(2008-5#1)
close to each other##2##4##(2006-6#1)(2013-8#1)
close to its##2##3##(1991-9#1)(2008-10#1)
close to that of##3##4##(1995-11#1)(2008-10#1)(2008-5#1)
close to that##4##3##(1995-11#1)(2008-10#2)(2008-5#1)
close to the catalytic##2##4##(2009-7#1)(2011-1#1)
close to the##57##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#3)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-6#2)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-3#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
close to those of##3##4##(2008-8#1)(2009-5#1)(2009-7#1)
close to those##6##3##(2008-10#2)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)
close to##134##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-3#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1995-11#2)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#51)(2008-11#6)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#3)(2008-8#3)(2008-9#5)(2009-12#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
close together##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
close vicinity##3##2##(1994-8#1)(2007-12#1)(2012-3#1)
close##317##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-9#2)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#3)(1993-8#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#6)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#96)(2008-11#14)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#11)(2008-6#6)(2008-7#4)(2008-8#10)(2008-9#10)(2009-10#4)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-4#1)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#6)
close-proximity##3##1##(2009-5#3)
closed and##3##2##(1992-2#1)(2008-7#1)(2013-8#1)
closed colonies##2##2##(2012-3#2)
closed down##2##2##(1996-5#1)(1997-8#1)
closed head##2##2##(2008-11#1)(2012-3#1)
closed reduction and##2##3##(2013-7#2)
closed reduction of##3##3##(2011-2#1)(2013-7#2)
closed reduction##8##2##(2011-2#3)(2013-7#5)
closed shell##2##2##(1992-8#1)(2013-1#1)
closed system##4##2##(2008-10#4)
closed to##8##2##(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-8#1)
closed using##2##2##(1991-12#1)(1992-2#1)
closed vessel microwave##2##3##(2008-10#2)
closed vessel##4##2##(2008-10#4)
closed vessels##2##2##(2008-10#2)
closed with##2##2##(1993-2#1)(2008-10#1)
closed##98##1##(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#2)(2008-10#31)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-9#2)(2011-2#8)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#5)(2013-8#4)
closed-chamber##2##1##(2008-3#2)
closed-form##3##1##(2008-3#1)(2008-6#2)
closed-loop control##4##2##(2008-7#1)(2013-1#3)
closed-loop##6##1##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#3)
closely approximate##2##2##(1994-1#1)(2008-11#1)
closely associated with the##8##4##(1990-5#1)(1992-3#1)(1993-8#1)(2008-10#2)(2008-9#1)(2012-2#2)
closely associated with##16##3##(1990-5#1)(1992-3#1)(1993-8#2)(2008-10#4)(2008-8#2)(2008-9#3)(2009-6#1)(2012-2#2)
closely associated##18##2##(1990-5#1)(1992-3#1)(1993-8#2)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#3)(2009-6#1)(2012-2#2)(2012-3#1)
closely correlated with the##3##4##(1993-8#1)(1994-6#1)(2008-10#1)
closely correlated with##4##3##(1990-5#1)(1993-8#1)(1994-6#1)(2008-10#1)
closely correlated##5##2##(1990-5#1)(1992-5#1)(1993-8#1)(1994-6#1)(2008-10#1)
closely followed the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)
closely followed##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)
closely homologous##2##2##(1993-2#1)(1994-5#1)
closely linked to Rsp genes##2##5##(2008-10#2)
closely linked to the##4##4##(2008-10#3)(2012-5#1)
closely linked to##11##3##(2008-10#9)(2008-11#1)(2012-5#1)
closely linked with##2##3##(2008-11#1)(2008-8#1)
closely linked##21##2##(1995-6#1)(1997-8#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-8#1)(2012-5#1)
closely match those##2##3##(1992-9#1)(2009-7#1)
closely overlapping##2##2##(1991-1#1)(2008-10#1)
closely packed##2##2##(2008-10#1)(2008-12#1)
closely packing##2##2##(2008-10#2)
closely reflects the##2##3##(2011-2#2)
closely related fungi##2##3##(2008-10#1)(2008-5#1)
closely related isolates##2##3##(2008-10#1)(2011-2#1)
closely related species##9##3##(1991-5#1)(2008-10#4)(2008-8#3)(2012-3#1)
closely related to each other##5##5##(2008-10#3)(2008-8#1)(2011-2#1)
closely related to the##17##4##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-7#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
closely related to##70##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-7#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#3)(1997-8#1)(2007-12#1)(2008-10#33)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-7#1)(2010-10#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
closely related with the##2##4##(2008-10#1)(2012-3#1)
closely related##132##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-11#1)(1991-5#1)(1991-7#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#3)(1997-8#1)(2007-12#1)(2008-10#58)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#8)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-2#6)(2012-3#6)(2012-5#2)(2013-1#2)(2013-8#2)
closely resemble##5##2##(1994-3#1)(2008-11#2)(2008-7#1)(2009-8#1)
closely resembles that##2##3##(2007-12#1)(2008-5#1)
closely resembles##7##2##(1990-8#1)(1993-2#1)(1994-5#1)(2007-12#1)(2008-5#1)(2010-6#1)(2011-2#1)
closely similar to##3##3##(1994-5#1)(1997-7#1)(2008-6#1)
closely similar##6##2##(1994-5#1)(1997-7#1)(2008-4#1)(2008-6#1)(2008-9#2)
closely spaced##8##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-3#1)
closely surrounding the##2##3##(1991-10#1)(2008-10#1)
closely the##2##2##(1993-9#1)(2008-9#1)
closely tied to##3##3##(1992-3#1)(2008-8#1)(2010-11#1)
closely to##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
closely with##4##2##(1990-2#1)(2008-10#2)(2010-1#1)
closely##276##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#3)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-2#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-12#3)(1997-2#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#95)(2008-11#11)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#14)(2008-9#16)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#8)(2012-5#3)(2013-1#3)(2013-8#2)
closeness##4##1##(1996-5#1)(2010-9#2)(2013-1#1)
closer examination##2##2##(1993-12#1)(2008-10#1)
closer than##2##2##(2008-10#1)(2008-8#1)
closer the##2##2##(2011-2#1)(2012-2#1)
closer to the##4##3##(2008-5#1)(2008-6#1)(2010-10#1)(2010-5#1)
closer to##14##2##(1992-6#1)(1993-1#1)(1994-1#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-5#1)(2013-7#1)
closer##41##1##(1990-12#1)(1990-2#1)(1991-6#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-1#2)(1995-12#1)(1997-3#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
closes##4##1##(2008-3#1)(2009-8#2)(2010-9#1)
closest RGAP##2##2##(2008-10#2)
closest marker##2##2##(2008-10#2)
closest to the##5##3##(1995-12#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-9#1)
closest to##7##2##(1991-3#1)(1995-12#1)(2006-6#1)(2008-10#2)(2008-6#1)(2008-9#1)
closest##24##1##(1991-3#1)(1995-12#1)(2006-6#1)(2008-10#16)(2008-12#1)(2008-6#1)(2008-9#2)(2012-12#1)
closing of##2##2##(1991-8#1)(2009-10#1)
closing the protein inadequacy gap##2##5##(2012-2#2)
closing the##7##2##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#2)(2012-3#1)
closing time##2##2##(1997-2#1)(2009-8#1)
closing##18##1##(1991-8#1)(1992-3#2)(1993-12#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#2)(2012-2#2)(2012-3#1)
closterovirus associated with LChD##2##4##(2008-10#2)
closterovirus associated with##4##3##(2008-10#4)
closterovirus##11##1##(2008-10#11)
closteroviruses##12##1##(2008-10#12)
clostridia##7##1##(2011-2#7)
closure and##5##2##(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)
closure in the##2##3##(1995-6#1)(2012-6#1)
closure in##5##2##(1995-6#1)(2008-11#2)(2012-12#1)(2012-6#1)
closure is##4##2##(1991-2#1)(1992-1#1)(2008-10#1)(2013-8#1)
closure of a##2##3##(1997-8#1)(2008-11#1)
closure of fossa ovalis atrial septal##2##6##(2008-11#2)
closure of the anterior##3##4##(1991-1#2)(2011-1#1)
closure of the##15##3##(1991-1#2)(1991-12#1)(1995-6#1)(1996-6#1)(1997-3#1)(2008-11#1)(2009-8#4)(2011-1#1)(2011-2#2)(2012-12#1)
closure of##28##2##(1991-1#2)(1991-12#1)(1992-1#1)(1992-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2008-11#5)(2009-10#1)(2009-8#4)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)
closure using##2##2##(2008-11#1)(2011-2#1)
closure was##4##2##(1997-8#1)(2008-10#1)(2008-11#2)
closure with##3##2##(1991-12#1)(1992-1#1)(2011-2#1)
closure##104##1##(1991-1#2)(1991-12#2)(1991-2#2)(1992-1#3)(1992-12#1)(1992-2#3)(1995-6#2)(1996-3#3)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#6)(2007-12#1)(2008-10#15)(2008-11#18)(2008-7#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#4)(2010-6#1)(2011-1#1)(2011-2#11)(2012-12#4)(2012-3#6)(2012-6#1)(2013-1#3)(2013-8#1)
closure]##2##1##(1996-3#1)(2013-1#1)
closures##3##1##(1996-3#2)(2009-8#1)
clot formation##3##2##(1992-1#1)(2013-1#2)
clot lysis##3##2##(1994-3#1)(1994-5#1)(1995-6#1)
clot##11##1##(1992-1#3)(1994-3#1)(1994-5#1)(1995-6#2)(1997-3#1)(2011-2#1)(2013-1#2)
cloth##2##1##(2008-10#2)
clothes##9##1##(2009-12#1)(2011-1#3)(2012-12#1)(2012-3#4)
clothing and##2##2##(2010-4#1)(2011-2#1)
clothing of##2##2##(1990-3#1)(2008-10#1)
clothing##8##1##(1990-3#1)(1996-5#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#2)
clotrimazole 1% cream in##2##4##(2008-5#2)
clotrimazole##8##1##(2008-5#8)
clots##6##1##(1994-5#1)(2008-10#2)(2011-2#1)(2013-1#2)
clotting factor IX (hFIX)##2##4##(2008-8#2)
clotting factor IX##5##3##(1990-5#1)(2008-8#3)(2008-9#1)
clotting products##4##2##(1996-5#4)
clotting##13##1##(1990-5#1)(1996-5#4)(1997-3#1)(2008-8#3)(2008-9#2)(2011-2#2)
cloud and aerosol##2##3##(2008-3#2)
cloud and##3##2##(2008-3#3)
cloud optical depth##2##3##(2008-3#2)
cloud optical##5##2##(2008-2#2)(2008-3#3)
cloud point extraction of##2##4##(2008-10#2)
cloud point extraction##11##3##(2008-10#11)
cloud point temperature##3##3##(2008-10#3)
cloud point##17##2##(2008-10#17)
cloud water##4##2##(2008-10#4)
cloud##51##1##(1991-5#1)(1993-3#1)(1994-2#1)(2008-10#23)(2008-2#6)(2008-3#14)(2010-5#4)(2013-8#1)
cloud-free##2##1##(2008-11#1)(2008-3#1)
cloud-point extraction##3##2##(2008-10#3)
cloud-point temperature##2##2##(2008-10#2)
cloud-point##5##1##(2008-10#5)
clouds and##10##2##(1991-5#1)(2008-10#1)(2008-3#8)
clouds are##3##2##(2008-2#1)(2008-3#2)
clouds##31##1##(1991-5#4)(2008-10#2)(2008-2#3)(2008-3#22)
cloudy##5##1##(2008-10#4)(2008-2#1)
clover and##2##2##(2008-10#2)
clover proliferation##3##2##(2008-10#3)
clover yellow vein virus##2##4##(2008-10#2)
clover yellow vein##3##3##(2008-10#3)
clover##19##1##(1995-12#2)(2008-10#14)(2008-12#1)(2011-2#2)
clovers##4##1##(2008-10#1)(2011-2#3)
cloxacillin##2##1##(2008-10#1)(2008-11#1)
club##5##1##(2008-10#2)(2008-12#3)
clubroot##2##1##(2008-10#2)
clubs##4##1##(1994-3#2)(2008-12#2)
clue to##2##2##(2008-8#1)(2012-2#1)
clue##3##1##(2008-12#1)(2008-8#1)(2012-2#1)
clues about the##3##3##(1991-2#1)(2008-10#1)(2010-10#1)
clues about##5##2##(1991-2#1)(2008-10#2)(2008-11#1)(2010-10#1)
clues for##2##2##(1997-6#1)(2008-11#1)
clues into the##2##3##(2010-12#1)(2010-5#1)
clues to the##4##3##(1997-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
clues to##10##2##(1990-8#1)(1997-3#1)(2008-11#1)(2008-6#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-2#1)
clues##25##1##(1990-8#2)(1991-2#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-6#2)(2008-9#3)(2009-12#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-2#1)
clumped into##2##2##(1992-6#1)(2008-7#1)
clumped##4##1##(1992-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
clumping and##2##2##(2008-12#1)(2008-7#1)
clumping##7##1##(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-7#1)
clumps of##3##2##(1992-2#1)(2008-10#1)(2008-7#1)
clumps##11##1##(1992-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)
cluster analyses##3##2##(2008-10#3)
cluster analysis of##4##3##(2008-10#4)
cluster analysis with##2##3##(1990-5#1)(2008-10#1)
cluster analysis##28##2##(1990-5#1)(2008-10#26)(2008-11#1)
cluster and##6##2##(2008-10#4)(2010-10#1)(2013-1#1)
cluster as the##2##3##(2008-10#1)(2008-12#1)
cluster as##3##2##(2008-10#2)(2008-12#1)
cluster assignment##2##2##(2009-11#1)(2010-10#1)
cluster controlling##3##2##(2008-10#3)
cluster for##2##2##(2011-1#1)(2013-8#1)
cluster formation##3##2##(2008-10#2)(2008-12#1)
cluster from the##3##3##(2008-10#2)(2009-3#1)
cluster has been##2##3##(2008-6#1)(2008-8#1)
cluster in the##2##3##(1993-8#1)(2013-8#1)
cluster in##10##2##(1993-3#1)(1993-8#2)(1994-5#1)(2008-10#3)(2008-6#1)(2008-8#1)(2013-8#1)
cluster of##28##2##(1992-12#1)(1992-4#2)(1996-12#3)(1996-6#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2010-11#2)(2012-3#1)(2013-1#1)
cluster size##3##2##(2008-10#3)
cluster sizes##2##2##(2008-8#1)(2010-10#1)
cluster together in##2##3##(2008-10#1)(2011-2#1)
cluster together##5##2##(2008-10#3)(2009-10#1)(2011-2#1)
cluster types##2##2##(2013-1#2)
cluster was##4##2##(1996-6#1)(2008-10#3)
cluster were##2##2##(1994-5#1)(2008-10#1)
cluster##209##1##(1990-5#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#1)(1993-3#2)(1993-8#4)(1994-5#6)(1996-12#4)(1996-6#6)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#104)(2008-11#4)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#3)(2010-10#6)(2010-11#6)(2010-4#1)(2011-1#3)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#3)
cluster-correlate##3##1##(2013-1#3)
clustered and##2##2##(2010-4#1)(2012-2#1)
clustered around##2##2##(1990-5#1)(2008-10#1)
clustered in a##3##3##(2008-10#2)(2008-11#1)
clustered in the##3##3##(1993-2#1)(1997-6#1)(2008-10#1)
clustered in three##3##3##(2008-10#3)
clustered in##12##2##(1993-2#1)(1997-6#1)(2008-10#9)(2008-11#1)
clustered into three##3##3##(2008-10#3)
clustered into##8##2##(2008-10#7)(2013-8#1)
clustered separately##2##2##(2008-10#2)
clustered to##3##2##(2008-10#2)(2010-10#1)
clustered together and##3##3##(2008-10#3)
clustered together##7##2##(2008-10#6)(2009-5#1)
clustered with isolates##2##3##(2008-10#2)
clustered with members of X##2##5##(2008-10#2)
clustered with other##2##3##(2008-10#2)
clustered with phytoplasmas##2##3##(2008-10#2)
clustered with##16##2##(2008-10#16)
clustered within a##3##3##(1996-12#1)(1996-6#1)(2008-10#1)
clustered within##5##2##(1996-12#1)(1996-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
clustered##76##1##(1990-5#1)(1993-2#1)(1994-11#1)(1994-6#2)(1995-9#1)(1996-12#1)(1996-6#2)(1997-6#1)(2008-10#53)(2008-11#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
clustering algorithm##2##2##(2009-10#1)(2010-8#1)
clustering analysis##3##2##(2008-5#2)(2008-8#1)
clustering and decision tree analyses##2##5##(2008-10#2)
clustering and##4##2##(2008-10#3)(2008-4#1)
clustering of the##2##3##(1996-12#1)(2012-5#1)
clustering of##17##2##(1990-12#1)(1991-1#1)(1991-5#1)(1996-12#3)(2008-10#5)(2008-7#1)(2009-5#1)(2009-8#2)(2010-12#1)(2012-5#1)
clustering technique##2##2##(2010-8#1)(2011-2#1)
clustering##56##1##(1990-12#1)(1991-1#1)(1991-5#1)(1996-12#3)(2008-10#22)(2008-11#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-5#1)
clustering&quot##2##1##(2008-11#1)(2012-3#1)
clusters (I##2##2##(2008-10#2)
clusters and their##2##3##(2008-12#2)
clusters and##9##2##(2008-10#4)(2008-12#2)(2008-5#1)(2009-9#1)(2013-1#1)
clusters are##2##2##(2008-10#2)
clusters based on##2##3##(2008-10#2)
clusters consisting of##2##3##(1991-5#1)(2008-10#1)
clusters in the##5##3##(1993-12#1)(1993-8#1)(2008-7#1)(2013-1#2)
clusters in##11##2##(1993-12#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-7#1)(2010-10#3)(2013-1#3)
clusters is##2##2##(2008-8#1)(2010-8#1)
clusters mainly##2##2##(1996-2#1)(2008-10#1)
clusters of V##2##3##(2008-10#2)
clusters of different##2##3##(1995-12#1)(2008-11#1)
clusters of isolates##6##3##(2008-10#6)
clusters of##50##2##(1991-9#1)(1992-11#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-6#1)(1997-6#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-10#1)(2011-2#3)(2013-1#1)
clusters on the##2##3##(1995-6#1)(2008-10#1)
clusters that correlated with##2##4##(2008-10#2)
clusters that##5##2##(2008-10#4)(2010-5#1)
clusters were found##2##3##(2008-10#1)(2008-5#1)
clusters were identified##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
clusters were##7##2##(2008-10#4)(2008-5#1)(2011-2#1)(2013-1#1)
clusters##178##1##(1991-2#1)(1991-5#1)(1991-9#2)(1992-11#3)(1992-9#1)(1993-12#3)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-6#1)(2008-10#83)(2008-11#2)(2008-12#6)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#1)(2009-12#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#10)(2010-11#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-3#2)(2013-1#7)
clusters)##3##1##(2008-10#1)(2008-11#1)(2012-2#1)
clutch size and##2##3##(2008-9#2)
clutch size in bethylid wasps##2##5##(2008-9#2)
clutch size##13##2##(1991-5#1)(2008-11#1)(2008-8#1)(2008-9#10)
clutch thickness##4##2##(2008-9#4)
clutch##22##1##(1991-5#3)(2008-11#1)(2008-8#3)(2008-9#15)
clutches are##2##2##(2008-9#2)
clutches##14##1##(1991-5#3)(2008-9#11)
clutter##6##1##(2008-3#1)(2011-1#5)
cluttered##2##1##(2008-3#1)(2011-1#1)
cm (mean 3##2##3##(2013-1#2)
cm H(2)O)##2##2##(2010-7#2)
cm above the burner##2##4##(2008-3#2)
cm above the##3##3##(1992-9#1)(2008-3#2)
cm above##4##2##(1992-9#1)(2008-10#1)(2008-3#2)
cm and 1##2##3##(2010-9#1)(2013-1#1)
cm and##5##2##(1997-4#1)(2007-12#1)(2008-10#1)(2010-9#1)(2013-1#1)
cm below the##3##3##(2008-10#2)(2011-1#1)
cm below##4##2##(1992-9#1)(2008-10#2)(2011-1#1)
cm between rows and within rows##2##6##(2008-12#2)
cm between##3##2##(2008-10#1)(2008-12#2)
cm deep##2##2##(2008-10#2)
cm diameter##2##2##(1992-3#1)(2009-11#1)
cm for##2##2##(2008-10#2)
cm from the##4##3##(2008-10#4)
cm from##6##2##(2008-10#6)
cm in diameter##5##3##(1992-2#1)(1994-6#1)(2008-7#1)(2012-3#1)(2013-8#1)
cm in diameter)##2##3##(2008-10#1)(2012-3#1)
cm in size)##2##3##(2012-12#2)
cm in the##5##3##(2008-10#1)(2009-3#2)(2011-2#2)
cm in##24##2##(1992-2#1)(1994-6#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-3#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#3)
cm length and##2##3##(2008-10#2)
cm length capillary at##3##4##(2008-10#3)
cm length##6##2##(2008-10#6)
cm long separation channel at a separation voltage of##2##9##(2008-10#2)
cm long##7##2##(2008-10#6)(2013-8#1)
cm of##3##2##(2008-10#1)(2008-7#1)(2009-11#1)
cm or##2##2##(1991-3#1)(2010-6#1)
cm reaction coil was transported to the detector with an Ar flow##2##12##(2008-10#2)
cm s(-1)##3##2##(2008-10#3)
cm to the##2##3##(2008-10#1)(2011-2#1)
cm to##5##2##(1993-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
cm was##4##2##(1991-12#2)(2008-10#1)(2013-1#1)
cm x 0##2##3##(2008-10#2)
cm x##6##2##(2008-10#3)(2008-9#1)(2009-8#1)(2010-3#1)
cm##197##1##(1990-3#1)(1990-9#2)(1991-12#2)(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-3#2)(1994-6#1)(1996-2#2)(1997-1#2)(1997-4#3)(1997-8#3)(2007-12#1)(2008-1#4)(2008-10#76)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#4)(2009-11#5)(2009-2#2)(2009-3#2)(2009-5#1)(2009-8#2)(2010-12#1)(2010-3#2)(2010-6#3)(2010-7#3)(2010-9#2)(2011-1#4)(2011-2#5)(2012-12#7)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#4)
cm(-1) Hz(-1/2)##3##2##(2007-12#1)(2008-3#2)
cm(-1) and 1##2##3##(2008-10#2)
cm(-1) and the##3##3##(2008-10#3)
cm(-1) and##20##2##(2008-10#19)(2008-3#1)
cm(-1) at##14##2##(2008-10#13)(2010-12#1)
cm(-1) atm(-1) HWHM]##2##3##(2008-3#2)
cm(-1) band was used for the quantification of##2##8##(2008-10#2)
cm(-1) bands##2##2##(2008-10#2)
cm(-1) for##6##2##(2008-10#6)
cm(-1) in##4##2##(2008-10#3)(2008-2#1)
cm(-1) region##2##2##(2008-10#2)
cm(-1) was##2##2##(2008-3#1)(2013-8#1)
cm(-1) were##5##2##(2008-10#4)(2008-3#1)
cm(-1) with a##2##3##(2008-10#1)(2008-3#1)
cm(-1) with##4##2##(2008-10#1)(2008-3#2)(2008-8#1)
cm(-1)##121##1##(2007-12#1)(2008-10#92)(2008-11#2)(2008-2#3)(2008-3#19)(2008-8#2)(2010-12#1)(2013-8#1)
cm(-1)) and##3##2##(2008-10#3)
cm(-1))##22##1##(2007-12#2)(2008-10#11)(2008-3#7)(2008-5#1)(2012-12#1)
cm(-1)]##2##1##(2008-3#2)
cm(-2) and##3##2##(2008-10#1)(2008-5#1)(2011-3#1)
cm(-2) for##5##2##(2008-10#5)
cm(-2) is##3##2##(2008-10#1)(2008-5#2)
cm(-2) of##2##2##(2008-10#2)
cm(-2) respectively##2##2##(2008-10#2)
cm(-2) was##2##2##(2008-10#1)(2008-5#1)
cm(-2)##44##1##(2008-10#35)(2008-5#7)(2011-3#2)
cm(-2))##5##1##(2008-10#3)(2008-5#1)(2008-7#1)
cm(-3) in a##2##3##(2008-10#1)(2008-11#1)
cm(-3)##16##1##(2008-10#10)(2008-11#1)(2008-3#2)(2010-8#2)(2013-8#1)
cm(-3))##2##1##(2008-10#2)
cm(2) of leaf##2##3##(2008-10#1)(2008-5#1)
cm(2) of##3##2##(2008-10#1)(2008-5#2)
cm(2) s(-1)##3##2##(2008-10#2)(2008-3#1)
cm(2) s(-1))##4##2##(2008-10#4)
cm(2)##18##1##(2008-10#10)(2008-3#2)(2008-5#3)(2010-12#1)(2012-2#2)
cm(2))##5##1##(2008-10#4)(2008-5#1)
cm(2)/s (R=-0##2##2##(2008-7#2)
cm(2)/s in the##2##3##(2008-7#2)
cm(2)/s##5##1##(2008-7#5)
cm(3) fractions##2##2##(2008-10#2)
cm(3) min(-1)##3##2##(2008-10#3)
cm(3)##10##1##(2008-10#10)
cm(3))##3##1##(2008-10#2)(2008-11#1)
cm) and##6##2##(2008-10#1)(2008-12#2)(2010-9#1)(2011-2#1)(2013-1#1)
cm)##24##1##(1991-6#1)(1992-12#1)(1993-9#2)(2008-1#1)(2008-10#4)(2008-12#4)(2008-2#1)(2008-7#1)(2009-10#1)(2010-9#2)(2011-2#3)(2013-1#3)
cm/GW at##2##2##(2008-3#2)
cm/s##3##1##(1992-3#2)(1995-11#1)
cm2 or##4##2##(1996-1#4)
cm2##9##1##(1990-12#1)(1990-5#1)(1996-1#4)(2008-10#1)(2010-11#1)(2011-2#1)
cm3##2##1##(1992-2#1)(1997-4#1)
cmCs coated MWNTs##2##3##(2009-3#2)
cmCs##3##1##(2009-3#3)
cmk rpsA##2##2##(1997-2#2)
cmk##3##1##(1997-2#3)
cms-T cytoplasm##2##2##(2008-10#2)
cms-T##5##1##(2008-10#5)
cnidarian##2##1##(2008-7#1)(2009-8#1)
cnidarians##2##1##(2009-8#1)(2010-4#1)
co##4##1##(2008-11#1)(2009-8#1)(2010-11#1)(2012-2#1)
co-##3##1##(2008-11#3)
co-activator##5##1##(1995-6#1)(2008-10#1)(2011-2#1)(2013-1#2)
co-assemble with##2##2##(2008-1#1)(2008-8#1)
co-calibration##2##1##(2012-2#2)
co-chaperone##2##1##(2009-6#1)(2011-2#1)
co-culture conditions##2##2##(2008-11#2)
co-culture models##2##2##(2012-4#2)
co-culture of##3##2##(2008-11#3)
co-culture system##3##2##(2008-11#2)(2008-8#1)
co-culture systems##2##2##(1993-3#1)(2008-10#1)
co-culture##16##1##(1993-3#1)(2008-10#2)(2008-11#9)(2008-8#1)(2012-2#1)(2012-4#2)
co-cultured EC/HRP##3##2##(2012-4#3)
co-cultured in##2##2##(2008-10#1)(2012-4#1)
co-cultured on##2##2##(1996-12#2)
co-cultured with##6##2##(2008-11#2)(2008-12#1)(2008-7#1)(2009-7#2)
co-cultured##16##1##(1996-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#2)(2012-4#6)
co-cultures of##3##2##(2008-10#1)(2008-7#2)
co-cultures##4##1##(1994-2#1)(2008-10#1)(2008-7#2)
co-deposition of##2##2##(2008-10#2)
co-digestion##6##1##(2013-1#6)
co-disposal precipitates##2##2##(2008-10#2)
co-disposal##3##1##(2008-10#3)
co-eluted with##2##2##(2008-10#2)
co-eluted##3##1##(2008-10#3)
co-evolved with##2##2##(2008-6#1)(2013-8#1)
co-exist##4##1##(2008-10#2)(2012-5#1)(2013-1#1)
co-existence of##6##2##(1991-5#1)(1993-8#1)(1995-12#1)(1997-2#1)(2008-10#1)(2012-3#1)
co-existence##7##1##(1991-5#1)(1993-8#1)(1995-12#1)(1997-2#1)(2008-10#1)(2012-3#2)
co-existing##9##1##(1995-10#1)(2008-10#6)(2008-11#1)(2008-4#1)
co-express##2##1##(2007-12#1)(2012-2#1)
co-expressed in##3##2##(1993-12#1)(1994-11#1)(2009-10#1)
co-expressed with##3##2##(1997-7#1)(2008-2#1)(2008-8#1)
co-expressed##8##1##(1993-12#1)(1994-11#1)(1995-12#1)(1997-7#1)(2008-2#1)(2008-8#1)(2009-10#1)(2012-3#1)
co-expressing##2##1##(2007-12#1)(2008-11#1)
co-expression of##3##2##(2008-11#3)
co-expression##6##1##(1993-2#1)(1995-6#1)(1997-9#1)(2008-11#3)
co-extracted##3##1##(2008-10#3)
co-factor##5##1##(1997-1#1)(2008-10#2)(2011-2#1)(2013-1#1)
co-formulated##2##1##(2008-10#2)
co-immobilized on##3##2##(2008-10#3)
co-immobilized##6##1##(2008-10#6)
co-immunoprecipitates with##3##2##(1993-8#1)(1997-7#1)(2012-2#1)
co-immunoprecipitation##3##1##(1993-8#1)(2008-11#1)(2012-2#1)
co-incubation##2##1##(1995-11#1)(2008-11#1)
co-infecting##2##1##(2008-10#1)(2011-2#1)
co-infection was##2##2##(2008-10#1)(2011-2#1)
co-infection with##2##2##(2011-2#2)
co-infection##9##1##(2008-10#1)(2008-8#1)(2011-2#6)(2013-8#1)
co-infections by genotypes B and C##2##6##(2008-12#2)
co-infections##4##1##(2008-12#4)
co-injected with##3##2##(1992-6#1)(1993-12#1)(1995-12#1)
co-injection##5##1##(1991-12#1)(1993-12#1)(2008-12#2)(2010-5#1)
co-inoculated with##3##2##(2008-10#3)
co-inoculated##7##1##(2008-10#7)
co-inoculations##2##1##(2008-10#2)
co-leadership##2##1##(1995-12#2)
co-linear##2##1##(2011-1#2)
co-localization of##4##2##(1990-5#1)(2008-10#1)(2010-12#2)
co-localized in##2##2##(1990-5#1)(1995-6#1)
co-localized with the##2##3##(2008-10#1)(2012-2#1)
co-localized with##5##2##(1992-6#1)(2008-10#1)(2012-2#3)
co-localized##8##1##(1990-5#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-12#1)(2012-2#3)
co-morbid##3##1##(2008-1#2)(2012-12#1)
co-morbidities##3##1##(2011-3#2)(2013-1#1)
co-morbidity with##3##2##(1991-1#1)(2013-1#2)
co-morbidity##5##1##(1991-1#1)(2008-11#1)(2011-2#1)(2013-1#2)
co-occupancy##3##1##(2008-2#3)
co-occur##8##1##(2008-10#1)(2008-8#2)(2009-10#1)(2010-3#2)(2012-2#2)
co-occurred##2##1##(2008-12#1)(2012-3#1)
co-occurrence of##3##2##(2008-10#1)(2008-8#1)(2010-11#1)
co-occurrence##5##1##(2008-10#2)(2008-8#1)(2010-11#1)(2010-8#1)
co-occurring##9##1##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
co-operation##4##1##(1997-8#1)(2008-10#2)(2008-9#1)
co-operative##3##1##(1991-2#1)(2008-1#1)(2009-8#1)
co-ordination of##2##2##(1991-2#1)(1991-3#1)
co-ordination##5##1##(1991-2#1)(1991-3#1)(2008-11#1)(2008-12#1)(2008-5#1)
co-ordinator##2##1##(2008-11#1)(2008-12#1)
co-polymer trimethylamine microcarriers##3##3##(2008-11#3)
co-polymer##4##1##(2008-10#1)(2008-11#3)
co-precipitated##2##1##(2008-10#2)
co-precipitation##4##1##(2008-10#3)(2008-11#1)
co-prescription##2##1##(2011-2#2)
co-produced in##2##2##(1997-7#1)(2011-2#1)
co-produced##3##1##(1997-7#1)(2011-2#2)
co-provenance##2##1##(2008-10#2)
co-regulated genes##2##2##(2008-7#2)
co-regulated in##2##2##(2009-8#1)(2010-10#1)
co-regulated##5##1##(2008-10#1)(2008-7#2)(2009-8#1)(2010-10#1)
co-regulation of##2##2##(2009-8#1)(2012-3#1)
co-regulation##3##1##(1992-12#1)(2009-8#1)(2012-3#1)
co-researchers##3##1##(2008-11#2)(2008-12#1)
co-segregated##3##1##(2008-10#2)(2012-2#1)
co-solvent##4##1##(2008-10#4)
co-solvents##2##1##(2008-10#2)
co-stimulation##2##1##(2008-11#1)(2012-2#1)
co-stimulatory##4##1##(2007-11#1)(2008-10#2)(2012-3#1)
co-suppression##4##1##(2008-9#4)
co-surfactant##2##1##(2008-10#2)
co-transcription##2##1##(2011-2#1)(2013-1#1)
co-transfectant##2##1##(1994-12#1)(2008-11#1)
co-transfected with##6##2##(1990-8#2)(1995-11#1)(1995-12#1)(2008-11#1)(2008-9#1)
co-transfected##10##1##(1990-8#2)(1995-11#1)(1995-12#2)(1995-6#1)(2008-11#2)(2008-9#1)(2011-3#1)
co-transfection##3##1##(1995-6#1)(2008-8#1)(2011-3#1)
co-transformed plants##2##2##(2008-8#2)
co-treatment##2##1##(2008-11#1)(2011-2#1)
co-workers##4##1##(1992-1#1)(1995-12#1)(1996-5#1)(2008-10#1)
coabsorption system##2##2##(2008-10#2)
coaches##2##1##(2011-2#2)
coactivator##4##1##(2008-1#2)(2008-9#1)(2011-2#1)
coaggregation##5##1##(2008-5#5)
coaggregations##2##1##(2008-5#2)
coagulase-negative Staphylococcus##3##2##(1991-3#1)(2011-2#1)(2013-1#1)
coagulase-negative staphylococci##6##2##(1990-6#1)(2008-7#2)(2010-12#1)(2010-4#2)
coagulase-negative##11##1##(1990-6#1)(1991-3#2)(2008-7#2)(2009-6#1)(2010-12#1)(2010-4#2)(2011-2#1)(2013-1#1)
coagulating##3##1##(1993-12#1)(2008-12#1)(2008-9#1)
coagulation analysers##5##2##(2008-10#5)
coagulation and##4##2##(1992-12#1)(2010-12#1)(2010-3#2)
coagulation artifact##2##2##(1994-12#2)
coagulation disorders##2##2##(1991-3#2)
coagulation factor IX##3##3##(2008-8#2)(2008-9#1)
coagulation factor##8##2##(1992-12#1)(2008-11#2)(2008-8#4)(2008-9#1)
coagulation in##2##2##(2006-6#1)(2013-1#1)
coagulation occurred##2##2##(1992-1#1)(2011-2#1)
coagulation proteins##2##2##(2008-9#1)(2012-12#1)
coagulation system##2##2##(2010-8#1)(2013-1#1)
coagulation time##3##2##(2008-9#3)
coagulation waveform on##2##3##(1992-12#2)
coagulation waveform##3##2##(1992-12#3)
coagulation##63##1##(1990-11#1)(1991-3#3)(1991-9#4)(1992-1#2)(1992-12#5)(1994-12#2)(1995-2#1)(1995-3#3)(1996-8#1)(2006-6#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#5)(2010-12#1)(2010-3#4)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
coagulopathy##5##1##(1990-2#1)(2008-7#2)(2009-1#1)(2011-2#1)
coal analysis##2##2##(2008-10#2)
coal by ICP##2##3##(2008-10#2)
coal by##6##2##(2008-10#6)
coal fly ash and##4##4##(2008-10#4)
coal fly ash samples##3##4##(2008-10#3)
coal fly ash##7##3##(2008-10#7)
coal fly##8##2##(2008-10#8)
coal sample##2##2##(2008-10#2)
coal samples##5##2##(2008-10#5)
coal##43##1##(1997-5#1)(2008-10#41)(2013-8#1)
coal-fired power stations##2##3##(2008-10#2)
coalesce##3##1##(1993-5#1)(2009-10#1)(2011-2#1)
coalesced##2##1##(2008-10#2)
coalescence or##2##2##(2008-10#2)
coalescence##5##1##(2008-10#3)(2008-5#1)(2009-7#1)
coalescent##4##1##(2008-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
coalition building##2##2##(1994-12#1)(1997-1#1)
coalition of##4##2##(1994-12#1)(1996-3#1)(2008-5#1)(2008-8#1)
coalition##14##1##(1994-1#1)(1994-12#2)(1996-1#2)(1996-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-5#4)
coalitions##4##1##(1991-9#1)(1994-12#1)(2008-6#1)(2008-8#1)
coals##7##1##(2008-10#7)
coamplified with##2##2##(2008-10#2)
coanalgesics##2##1##(1997-3#2)
coarse coding or suppression##2##4##(2012-3#2)
coarse coding##4##2##(2012-3#4)
coarse##29##1##(1991-6#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#2)(2008-8#5)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-3#5)
coarser##4##1##(2008-10#1)(2008-5#1)(2008-8#2)
coast live oak##2##3##(2008-10#2)
coast of##6##2##(2008-10#3)(2010-8#2)(2012-12#1)
coast##22##1##(1990-11#2)(2008-10#14)(2008-11#2)(2010-8#2)(2012-12#1)(2013-8#1)
coastal California##3##2##(2008-10#3)
coastal and inland waters##3##4##(2008-3#3)
coastal and##5##2##(2008-10#1)(2008-3#3)(2010-8#1)
coastal areas of California##2##4##(2008-10#2)
coastal areas of##3##3##(2008-10#2)(2013-8#1)
coastal areas##4##2##(2008-10#2)(2012-5#1)(2013-8#1)
coastal regions##2##2##(2013-1#1)(2013-8#1)
coastal seawater##3##2##(2008-10#3)
coastal waters and##2##3##(2008-3#2)
coastal waters##9##2##(2008-10#4)(2008-12#1)(2008-3#3)(2010-4#1)
coastal##45##1##(1990-11#1)(2008-10#25)(2008-12#1)(2008-3#6)(2010-1#1)(2010-4#1)(2010-8#4)(2012-5#1)(2013-1#1)(2013-8#4)
coat color spotting##3##3##(1994-12#3)
coat color##6##2##(1994-12#4)(2008-8#1)(2010-4#1)
coat is##3##2##(2008-10#2)(2008-8#1)
coat of##2##2##(1994-11#1)(1995-2#1)
coat protein (CP) and##4##4##(2008-10#4)
coat protein (CP) coding region##2##5##(2008-10#2)
coat protein (CP) coding##3##4##(2008-10#3)
coat protein (CP) gene was amplified##2##6##(2008-10#2)
coat protein (CP) gene was##3##5##(2008-10#2)(2008-8#1)
coat protein (CP) gene##12##4##(2008-10#11)(2008-8#1)
coat protein (CP) of##2##4##(2008-10#2)
coat protein (CP)##24##3##(2008-10#23)(2008-8#1)
coat protein gene of##3##4##(2008-10#3)
coat protein gene##10##3##(2008-10#10)
coat protein genes##3##3##(2008-10#3)
coat protein in##2##3##(1997-3#1)(2008-10#1)
coat protein of##3##3##(2008-10#2)(2008-7#1)
coat protein##70##2##(1997-3#2)(2008-10#60)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2011-2#1)
coat proteins (CPs)##3##3##(2008-10#3)
coat proteins##7##2##(2008-10#5)(2009-6#1)(2011-2#1)
coat the##3##2##(1995-2#1)(2008-10#2)
coat##123##1##(1990-9#1)(1994-11#1)(1994-12#4)(1995-2#3)(1997-3#2)(2008-10#88)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#7)(2009-6#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#7)
coated GCE in##2##3##(2008-10#2)
coated GCE##4##2##(2008-10#4)
coated QCM##3##2##(2008-10#3)
coated amylose tris-(3##2##3##(2008-10#2)
coated by the osmiophilic material##2##5##(2008-10#2)
coated by##5##2##(2008-10#4)(2009-7#1)
coated capillary##5##2##(2008-10#5)
coated electrode##4##2##(2008-10#4)
coated electrodes##5##2##(2008-10#5)
coated glass##3##2##(2008-10#3)
coated glassy carbon electrode##6##4##(2008-10#6)
coated glassy carbon##7##3##(2008-10#7)
coated graphite##5##2##(2008-10#5)
coated membranes##2##2##(1993-9#1)(1995-2#1)
coated on a##3##3##(2008-10#2)(2008-3#1)
coated on glassy carbon##2##4##(2008-10#2)
coated on the surface of##2##5##(2008-10#2)
coated on the##4##3##(2008-10#4)
coated on##14##2##(2008-10#13)(2008-3#1)
coated plastic substrata##2##3##(1994-8#2)
coated sugar spheres##2##3##(2008-11#2)
coated superparamagnetic iron oxide nanoparticles##2##5##(2012-12#2)
coated vesicles##3##2##(1997-1#3)
coated wire electrodes##3##3##(2008-10#3)
coated with APDC##2##3##(2008-10#2)
coated with a##16##3##(1990-12#1)(2008-10#13)(2009-5#1)(2012-2#1)
coated with pipDTC##2##3##(2008-10#2)
coated with the##4##3##(2008-10#4)
coated with##60##2##(1990-12#4)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2009-5#1)(2009-8#1)(2012-2#2)
coated zirconia-magnesia chromatography##2##3##(2008-10#2)
coated zirconia-magnesia##3##2##(2008-10#3)
coated##186##1##(1990-12#4)(1990-9#1)(1991-3#1)(1993-9#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#1)(1997-1#3)(1997-2#1)(2008-10#138)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2012-12#2)(2012-2#2)
coating a##3##2##(2008-10#3)
coating and the##2##3##(2008-10#1)(2008-2#1)
coating and##5##2##(2008-10#4)(2008-2#1)
coating for resolving rhodamine B##2##5##(2008-10#2)
coating for##6##2##(2008-10#5)(2009-7#1)
coating is##3##2##(2008-10#2)(2008-3#1)
coating method##3##2##(2008-10#3)
coating of the##6##3##(1993-3#1)(2008-10#3)(2008-11#1)(2008-2#1)
coating of##14##2##(1993-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)
coating on the##5##3##(2008-10#3)(2008-5#1)(2009-7#1)
coating on##6##2##(2008-10#3)(2008-5#1)(2009-7#2)
coating solution##2##2##(2008-10#2)
coating the##3##2##(2008-10#2)(2008-3#1)
coating thickness##4##2##(2008-10#1)(2008-3#3)
coating was##5##2##(2008-10#5)
coating##101##1##(1993-3#1)(1995-2#1)(2008-10#75)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-7#3)(2010-4#1)(2010-7#1)
coating)##2##1##(2008-10#1)(2008-3#1)
coatings and##4##2##(2008-10#2)(2008-3#1)(2010-7#1)
coatings are##3##2##(2008-10#1)(2008-2#1)(2010-7#1)
coatings for##3##2##(2008-10#2)(2010-4#1)
coatings of##3##2##(2008-10#2)(2010-4#1)
coatings on a##2##3##(2008-10#1)(2010-4#1)
coatings on glassy carbon##2##4##(2008-10#2)
coatings on##9##2##(2008-10#7)(2008-3#1)(2010-4#1)
coatings onto glassy carbon##2##4##(2008-10#2)
coatings to##2##2##(2008-10#1)(2010-7#1)
coatings were##3##2##(2008-10#3)
coatings with##2##2##(2010-4#2)
coatings##62##1##(1997-2#1)(2008-10#36)(2008-2#1)(2008-3#9)(2008-7#1)(2009-8#1)(2010-4#10)(2010-7#3)
coatomer mutants##2##2##(1994-12#2)
coatomer##6##1##(1994-12#4)(2009-7#1)(2011-2#1)
coats##9##1##(2008-10#1)(2008-8#5)(2009-9#1)(2011-2#1)(2012-2#1)
coauthor##2##1##(1992-3#1)(1993-2#1)
coaxial##4##1##(1992-11#1)(2008-10#2)(2008-3#1)
cobalamin##4##1##(1992-9#1)(2011-1#3)
cobalt (II)##2##2##(2008-10#2)
cobalt and chromium in human urine##2##6##(2008-10#2)
cobalt and chromium##3##3##(2008-10#3)
cobalt and nickel by marine brown alga Sargassum sp##2##9##(2008-12#2)
cobalt and nickel##3##3##(2008-10#1)(2008-12#2)
cobalt and##10##2##(2008-10#7)(2008-11#1)(2008-12#2)
cobalt by##3##2##(2008-10#3)
cobalt determination in##3##3##(2008-10#3)
cobalt hexacyanoferrate##2##2##(2008-10#2)
cobalt in the##3##3##(2008-10#3)
cobalt in water samples by##2##5##(2008-10#2)
cobalt in water samples##3##4##(2008-10#3)
cobalt in##20##2##(2008-10#20)
cobalt metal##2##2##(2008-10#2)
cobalt was##2##2##(2008-10#2)
cobalt with nitroso-R-salt##3##3##(2008-10#3)
cobalt with##7##2##(2008-10#7)
cobalt##127##1##(1993-12#1)(2008-10#120)(2008-11#1)(2008-12#4)(2008-5#1)
cobalt(II) and nickel(II)##2##3##(2008-10#2)
cobalt(II) and##10##2##(2008-10#10)
cobalt(II) ions##2##2##(2008-10#2)
cobalt(II) was##3##2##(2008-10#3)
cobalt(II)##48##1##(2008-10#48)
cobalt(II)-hydrogen peroxide-hydrogencarbonate##2##2##(2008-10#2)
cobalt(III)##2##1##(2008-10#2)
cobalt-60##3##1##(1991-2#1)(2008-7#2)
cobalt-wire##4##1##(2008-10#4)
coblation for##2##2##(2010-3#2)
coca var##2##2##(2008-10#2)
coca##11##1##(2008-10#11)
coca-growing regions##2##2##(2008-10#2)
cocaethylene administration##2##2##(1996-12#2)
cocaethylene##7##1##(1996-12#7)
cocaine abuse in##2##3##(1991-1#2)
cocaine abuse##3##2##(1991-1#3)
cocaine addiction##3##2##(1991-1#1)(2008-11#1)(2009-7#1)
cocaine and opiate##3##3##(2010-11#3)
cocaine and##6##2##(1991-1#2)(2010-11#3)(2013-8#1)
cocaine dependence##2##2##(1991-1#1)(2008-11#1)
cocaine exposure##2##2##(1991-1#1)(1992-12#1)
cocaine in the##3##3##(1993-6#1)(2013-8#2)
cocaine in##5##2##(1991-1#1)(1993-6#1)(2013-8#3)
cocaine on##2##2##(1991-1#1)(1993-6#1)
cocaine self-administration by rhesus##2##4##(1991-1#2)
cocaine self-administration##5##2##(1991-1#2)(1993-6#2)(2009-7#1)
cocaine use##6##2##(1991-1#2)(1992-12#2)(2010-6#2)
cocaine##81##1##(1991-1#30)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#3)(1992-7#1)(1993-6#8)(1996-12#2)(2008-1#1)(2008-11#2)(2009-7#8)(2010-1#1)(2010-11#4)(2010-6#2)(2012-3#2)(2013-8#14)
cocamide DEA##2##2##(2008-5#2)
cocci##3##1##(1991-3#1)(1996-12#1)(2010-2#1)
coccidioidomycosis##3##1##(2008-5#2)(2011-2#1)
coccidiosis##2##1##(2008-5#2)
coccineus L##2##2##(2008-3#2)
coccineus##5##1##(2008-10#3)(2008-3#2)
coccodes isolates##4##2##(2008-10#4)
coccodes##19##1##(2008-10#19)
cochlea and##5##2##(2008-9#2)(2012-2#3)
cochlea##12##1##(2008-9#8)(2009-9#1)(2012-2#3)
cochleae##5##1##(2008-9#5)
cochlear hair cells##3##3##(2009-8#1)(2012-2#2)
cochlear implant candidates##2##3##(2008-9#2)
cochlear implant electrode##4##3##(2008-9#4)
cochlear implant experience##3##3##(2008-9#3)
cochlear implant patients##2##3##(2008-9#2)
cochlear implant programme##3##3##(2008-9#3)
cochlear implant recipients and##3##4##(2008-9#3)
cochlear implant recipients##6##3##(2008-9#5)(2012-2#1)
cochlear implant speech##2##3##(2008-9#2)
cochlear implant surgery##2##3##(2008-9#2)
cochlear implant system##5##3##(2008-9#5)
cochlear implant users##19##3##(2008-9#18)(2012-2#1)
cochlear implant wearers##2##3##(2008-9#2)
cochlear implant##101##2##(2008-9#95)(2011-2#1)(2012-2#4)(2013-1#1)
cochlear implantation in a##2##4##(2008-9#1)(2013-1#1)
cochlear implantation in##10##3##(2008-9#9)(2013-1#1)
cochlear implantation is##3##3##(2008-9#3)
cochlear implantation was##2##3##(2008-9#2)
cochlear implantation##48##2##(2008-9#45)(2012-2#2)(2013-1#1)
cochlear implanted##2##2##(2008-9#2)
cochlear implantees##2##2##(2008-9#2)
cochlear implants and##2##3##(2008-9#2)
cochlear implants have##2##3##(2008-9#1)(2012-2#1)
cochlear implants in##2##3##(2008-9#2)
cochlear implants##45##2##(2008-9#39)(2012-2#6)
cochlear models##2##2##(2012-2#2)
cochlear nerve##2##2##(2008-9#2)
cochlear nucleus complex##2##3##(2013-8#2)
cochlear nucleus##6##2##(1996-2#3)(2013-8#3)
cochlear##221##1##(1996-12#1)(1996-2#3)(2008-9#191)(2009-8#2)(2011-2#3)(2012-2#16)(2013-1#2)(2013-8#3)
cochleostomies##2##1##(2008-9#2)
cochleostomy and##2##2##(2008-9#2)
cochleostomy##6##1##(2008-9#6)
cochlioides cultures##2##2##(2008-10#2)
cochlioides##10##1##(2008-10#9)(2013-1#1)
cockatiel##3##1##(2008-5#3)
cockle##7##1##(1996-12#7)
cockroach##7##1##(1990-5#1)(1995-11#1)(2007-12#2)(2008-8#1)(2011-2#1)(2013-1#1)
cockroaches##2##1##(1995-11#1)(2007-12#1)
cocktail of##3##2##(2008-10#2)(2008-11#1)
cocktail##8##1##(2008-10#4)(2008-11#1)(2011-2#2)(2012-2#1)
cocoa##5##1##(2008-10#1)(2009-3#1)(2010-4#3)
cocoamidopropyl betaine##3##2##(2008-10#1)(2008-5#2)
coconut oil##3##2##(2008-10#1)(2013-1#2)
coconut##8##1##(2008-10#6)(2013-1#2)
cocultivation##5##1##(2008-10#5)
coculture system##7##2##(1995-2#1)(2008-11#3)(2008-5#3)
coculture##16##1##(1995-2#1)(2008-11#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)
cocultured##5##1##(1995-2#1)(1995-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
cocultures of##2##2##(1995-2#1)(2008-10#1)
cocultures##15##1##(1995-2#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)
coculturing with fullydifferentiated##2##3##(2008-11#2)
coculturing with##3##2##(2008-11#3)
coculturing##4##1##(2008-11#4)
cod Gadus morhua in##3##4##(2010-8#3)
cod Gadus morhua##6##3##(2010-8#6)
cod liver##2##2##(2008-10#1)(2011-2#1)
cod##9##1##(2008-10#2)(2010-8#6)(2011-2#1)
code and##2##2##(2008-3#2)
code compression##2##2##(2012-3#2)
code for a##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
code for the##2##3##(1990-5#1)(2008-3#1)
code for##16##2##(1990-5#4)(1993-6#4)(2008-10#2)(2008-11#1)(2008-3#3)(2011-2#1)(2013-8#1)
code is##4##2##(2008-3#3)(2013-8#1)
code of##2##2##(1997-5#1)(2013-8#1)
code to##2##2##(1991-3#1)(1992-2#1)
code##59##1##(1990-5#5)(1991-3#2)(1992-2#2)(1993-6#4)(1994-5#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#14)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#4)
code-related##2##1##(2013-1#2)
coded by sgcD##2##3##(2008-9#2)
coded by the##2##3##(1993-2#1)(2009-9#1)
coded by##4##2##(1993-2#1)(2008-9#2)(2009-9#1)
coded excitation##3##2##(2012-3#3)
coded for a##3##3##(1990-5#1)(2008-10#1)(2010-6#1)
coded for##7##2##(1990-5#2)(1994-11#2)(2008-10#1)(2008-7#1)(2010-6#1)
coded##27##1##(1990-5#2)(1993-2#1)(1994-11#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
codeine##5##1##(1990-8#2)(2008-10#2)(2008-6#1)
coders and non-coders##3##3##(2007-12#3)
coders and##4##2##(2007-12#4)
coders##9##1##(2007-12#9)
codes and##2##2##(1991-3#1)(2008-11#1)
codes for a protein##3##4##(1995-2#1)(2011-2#1)(2013-1#1)
codes for a##8##3##(1993-12#1)(1993-2#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
codes for the##6##3##(1991-9#1)(1993-12#1)(2008-10#3)(2008-7#1)
codes for##19##2##(1991-9#1)(1993-12#2)(1993-2#2)(1994-11#1)(1995-2#1)(1996-2#1)(1997-2#2)(1997-7#2)(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
codes in##2##2##(1997-3#1)(2008-3#1)
codes##36##1##(1991-3#4)(1991-9#1)(1993-12#3)(1993-2#2)(1994-11#1)(1995-2#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-7#2)(2008-10#5)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
codeswitching##2##1##(2011-2#2)
codifying##2##1##(2008-10#1)(2010-8#1)
coding and non-coding##3##3##(2007-12#1)(2010-7#1)(2011-2#1)
coding and noncoding sequences##2##4##(2008-10#1)(2008-4#1)
coding and suppression##2##3##(2012-3#2)
coding and##11##2##(1997-3#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#2)
coding for a##7##3##(1991-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(2008-10#1)(2008-8#1)
coding for an##2##3##(1993-2#1)(2008-11#1)
coding for proteins of##2##4##(2008-10#2)
coding for the##12##3##(1992-1#1)(1992-3#1)(1993-6#2)(1993-8#1)(1995-8#2)(1996-2#1)(1997-8#2)(2008-10#1)(2008-6#1)
coding for##50##2##(1990-3#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-2#4)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-8#2)(2006-6#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
coding in##3##2##(2008-11#3)
coding instructions##2##2##(2012-12#2)
coding of the##2##3##(1994-6#1)(2013-1#1)
coding of##6##2##(1990-5#1)(1994-6#1)(1996-2#1)(2008-11#2)(2013-1#1)
coding professionals##2##2##(2007-12#2)
coding region and##6##3##(1990-6#1)(1993-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
coding region assays##3##3##(2008-12#3)
coding region for the##2##4##(1990-7#1)(2008-10#1)
coding region for##3##3##(1990-7#2)(2008-10#1)
coding region of the##4##4##(1993-6#1)(1997-7#1)(1997-8#1)(2008-4#1)
coding region of##15##3##(1990-12#1)(1990-8#2)(1993-2#1)(1993-6#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#3)
coding region##60##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-5#1)(1992-6#1)(1993-12#1)(1993-2#3)(1993-6#4)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#6)(2008-4#1)(2008-8#5)(2008-9#2)(2010-5#1)(2010-7#2)(2013-1#3)(2013-8#2)
coding regions and##2##3##(1997-2#1)(2011-2#1)
coding regions are##2##3##(2008-9#1)(2010-7#1)
coding regions of the##3##4##(1993-6#1)(2010-7#1)(2013-8#1)
coding regions of##4##3##(1993-6#1)(2010-7#1)(2013-8#2)
coding regions were##2##3##(1991-9#1)(1995-12#1)
coding regions within the##2##4##(1995-12#1)(1996-12#1)
coding regions##19##2##(1991-9#1)(1993-6#2)(1995-12#3)(1996-12#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#1)(2013-8#2)
coding scheme##3##2##(2008-11#1)(2008-9#1)(2009-3#1)
coding sequence for##2##3##(1997-3#1)(2008-11#1)
coding sequence of this pseudogene is##2##6##(1993-2#1)(1994-11#1)
coding sequence of##7##3##(1992-10#1)(1993-2#2)(1994-11#1)(1997-8#1)(2008-8#2)
coding sequence was##4##3##(1993-12#1)(1997-2#1)(1997-4#1)(2008-8#1)
coding sequence##27##2##(1991-7#1)(1992-10#1)(1992-3#2)(1993-12#2)(1993-2#2)(1993-8#1)(1994-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#4)(2011-2#1)(2012-3#1)
coding sequences and##3##3##(1997-7#1)(2008-11#1)(2011-2#1)
coding sequences of##8##3##(1995-8#3)(1996-2#5)
coding sequences##15##2##(1995-12#2)(1995-8#3)(1996-2#5)(1997-7#1)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#1)
coding should be##2##3##(2010-8#1)(2012-12#1)
coding strand of##2##3##(1997-7#1)(2008-10#1)
coding system##2##2##(1992-2#1)(2008-11#1)
coding##264##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#5)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-12#6)(1993-2#10)(1993-6#10)(1993-8#2)(1993-9#1)(1994-11#3)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#8)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#6)(1996-12#3)(1996-2#11)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#11)(1997-8#5)(2006-6#1)(2007-12#8)(2008-10#19)(2008-11#22)(2008-12#9)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#13)(2008-9#11)(2009-10#1)(2009-12#1)(2009-3#1)(2010-5#1)(2010-7#6)(2010-8#3)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#7)(2012-2#2)(2012-3#8)(2013-1#8)(2013-8#4)
codominant##5##1##(1995-2#1)(2008-10#3)(2012-3#1)
codon 4##2##2##(1991-9#2)
codon and##3##2##(1993-12#1)(2008-9#1)(2011-3#1)
codon bias##3##2##(1993-8#1)(1996-3#1)(2008-10#1)
codon for##4##2##(1993-8#1)(2008-10#3)
codon of the c-Ki-ras##2##4##(1992-8#2)
codon of the##4##3##(1992-8#2)(1993-8#1)(2008-8#1)
codon of##6##2##(1992-8#2)(1993-8#1)(1997-7#1)(2008-8#2)
codon usage and##2##3##(2008-5#1)(2008-9#1)
codon usage of##2##3##(1991-7#1)(1997-8#1)
codon usage##6##2##(1991-7#1)(1997-8#3)(2008-5#1)(2008-9#1)
codon##52##1##(1990-8#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-6#1)(1992-8#3)(1993-11#2)(1993-12#3)(1993-8#3)(1994-11#3)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#3)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#4)(2010-6#1)(2011-3#1)(2013-1#1)
codons and##2##2##(1993-12#1)(1993-9#1)
codons was##2##2##(1996-3#1)(1996-8#1)
codons##26##1##(1991-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1995-12#1)(1996-3#2)(1996-6#2)(1996-8#4)(1997-8#2)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#1)(2011-3#1)
codons)##2##1##(1991-9#2)
coefficient (log##2##2##(1996-2#1)(2008-10#1)
coefficient (r##2##2##(2011-3#1)(2013-1#1)
coefficient 0##3##2##(2008-10#3)
coefficient =##2##2##(1990-12#1)(2008-10#1)
coefficient D##2##2##(2008-10#1)(2008-5#1)
coefficient R(2)##2##2##(2008-10#2)
coefficient and the##5##3##(2008-10#2)(2008-3#3)
coefficient and##17##2##(2008-10#11)(2008-3#3)(2008-9#1)(2009-11#1)(2010-1#1)
coefficient between##4##2##(1993-3#1)(2008-10#2)(2008-3#1)
coefficient for a##2##3##(2007-12#1)(2008-10#1)
coefficient for the##5##3##(1993-1#1)(2008-10#4)
coefficient for##13##2##(1991-5#1)(1993-1#1)(2007-12#1)(2008-10#9)(2008-3#1)
coefficient function##2##2##(2008-3#1)(2010-1#1)
coefficient in the##2##3##(2008-2#1)(2008-5#1)
coefficient in##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
coefficient is 0##4##3##(2008-10#4)
coefficient is##7##2##(2008-10#4)(2008-3#3)
coefficient measurements##3##2##(2008-10#3)
coefficient of 0##39##3##(2008-10#38)(2008-2#1)
coefficient of 3##2##3##(2008-10#2)
coefficient of determination##4##3##(2008-10#3)(2011-2#1)
coefficient of gene differentiation##3##4##(2008-10#3)
coefficient of genetic differentiation##2##4##(2008-10#2)
coefficient of the##14##3##(1990-5#2)(2008-10#9)(2008-2#1)(2008-3#1)(2010-4#1)
coefficient of variance##2##3##(1990-2#1)(2008-10#1)
coefficient of variation (CV)##4##4##(1990-12#1)(1993-2#1)(2008-10#1)(2008-8#1)
coefficient of variation for##3##4##(1990-2#1)(2008-10#2)
coefficient of variation is##2##4##(1992-3#1)(1996-3#1)
coefficient of variation of the##2##5##(2008-10#2)
coefficient of variation of##6##4##(2008-10#6)
coefficient of variation##27##3##(1990-12#1)(1990-2#1)(1990-9#1)(1992-3#2)(1993-2#1)(1996-3#1)(2008-10#15)(2008-5#2)(2008-8#1)(2010-8#1)(2012-2#1)
coefficient of##124##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-9#1)(1992-3#2)(1993-2#1)(1996-3#1)(1997-8#1)(2008-10#86)(2008-2#6)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
coefficient values##9##2##(1991-5#1)(2008-10#8)
coefficient was 0##7##3##(1990-12#1)(2008-10#5)(2008-3#1)
coefficient was##15##2##(1990-12#1)(1993-8#1)(2008-10#10)(2008-3#1)(2012-2#1)(2013-1#1)
coefficient were##5##2##(2008-10#4)(2008-11#1)
coefficient when##2##2##(1992-9#1)(2008-10#1)
coefficient##359##1##(1990-12#3)(1990-2#2)(1990-5#2)(1990-9#1)(1991-5#3)(1992-3#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#213)(2008-11#3)(2008-2#16)(2008-3#38)(2008-5#9)(2008-7#5)(2008-8#4)(2008-9#5)(2009-11#2)(2009-3#3)(2009-8#1)(2010-1#5)(2010-12#3)(2010-4#1)(2010-8#3)(2011-2#6)(2011-3#5)(2012-2#4)(2013-1#10)
coefficient)##3##1##(2008-10#3)
coefficient=0##3##1##(2008-10#3)
coefficients among##2##2##(2008-10#2)
coefficients and the##5##3##(1995-6#1)(2008-10#4)
coefficients and##14##2##(1995-6#1)(2008-10#10)(2008-3#1)(2008-5#1)(2010-10#1)
coefficients are##6##2##(2008-3#3)(2008-5#2)(2010-11#1)
coefficients at 355##2##3##(2008-3#2)
coefficients at##3##2##(2008-2#1)(2008-3#2)
coefficients determined##2##2##(2008-10#2)
coefficients equal##2##2##(2008-10#2)
coefficients estimated##2##2##(2008-10#2)
coefficients for the##6##3##(2008-10#4)(2008-12#1)(2008-5#1)
coefficients for##24##2##(1991-11#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)
coefficients from##2##2##(2008-10#2)
coefficients in the##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
coefficients in##6##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2013-1#1)
coefficients is##2##2##(2008-10#1)(2008-3#1)
coefficients obtained##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
coefficients of 0##3##3##(2008-10#3)
coefficients of a##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
coefficients of determination##5##3##(2008-10#5)
coefficients of the##11##3##(1990-5#2)(2008-10#8)(2008-3#1)
coefficients of these##2##3##(1995-9#1)(2008-10#1)
coefficients of variation are##3##4##(1991-2#1)(1996-3#1)(2008-10#1)
coefficients of variation for##2##4##(2008-10#1)(2008-5#1)
coefficients of variation of##2##4##(1996-3#1)(2008-10#1)
coefficients of variation were below##2##5##(2008-10#2)
coefficients of variation were##8##4##(2008-10#8)
coefficients of variation##24##3##(1990-11#1)(1991-2#1)(1996-3#3)(2008-10#17)(2008-5#1)(2008-9#1)
coefficients of variations##2##3##(2008-10#2)
coefficients of##90##2##(1990-11#1)(1990-5#3)(1991-2#1)(1995-9#1)(1996-3#3)(2008-10#63)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#3)(2008-9#1)(2010-4#1)(2011-2#1)
coefficients that are##2##3##(2008-2#1)(2010-1#1)
coefficients that##3##2##(2008-2#1)(2008-3#1)(2010-1#1)
coefficients to##2##2##(2008-10#2)
coefficients were calculated##2##3##(2008-10#2)
coefficients were determined##2##3##(1991-11#1)(2008-10#1)
coefficients were obtained##2##3##(2008-10#1)(2011-2#1)
coefficients were##20##2##(1991-11#1)(1992-3#1)(2008-10#14)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
coefficients with##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
coefficients##262##1##(1990-11#1)(1990-5#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-5#2)(1992-3#2)(1994-5#1)(1995-6#1)(1995-9#1)(1996-3#3)(1996-5#1)(1997-6#1)(2007-11#1)(2008-10#163)(2008-11#4)(2008-12#3)(2008-2#9)(2008-3#23)(2008-5#7)(2008-7#7)(2008-8#2)(2008-9#2)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#2)(2011-2#4)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
coeliac disease##9##2##(1990-11#2)(1991-12#2)(1992-12#3)(2008-10#1)(2008-8#1)
coeliac mucosal digestion of fraction 9##2##6##(1992-12#2)
coeliac##17##1##(1990-11#2)(1991-12#5)(1992-12#5)(2008-10#1)(2008-11#2)(2008-8#1)(2011-7#1)
coeliac-toxic##2##1##(1991-12#2)
coeliacs##2##1##(1991-12#2)
coeloconic sensilla of##2##3##(2008-7#2)
coelomic compartments##2##2##(2011-2#2)
coelomic fluid##6##2##(1990-5#1)(1995-8#5)
coelomic##10##1##(1990-5#1)(1995-8#5)(2008-5#1)(2011-2#3)
coeluting##2##1##(1997-2#1)(2008-4#1)
coenospermia##5##1##(2007-12#5)
coenzyme A##6##2##(1990-2#1)(1990-9#1)(1993-6#1)(1994-8#3)
coenzyme##22##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#3)(2008-10#8)(2013-1#1)(2013-8#3)
coenzyme-binding##2##1##(1991-5#2)
coenzymes##5##1##(2008-10#1)(2008-7#3)(2013-8#1)
coercion and##3##2##(1997-2#1)(2009-11#1)(2009-4#1)
coercion##8##1##(1997-2#1)(2008-11#2)(2009-11#1)(2009-4#3)(2012-2#1)
coercive##3##1##(2007-12#1)(2009-6#1)(2010-11#1)
coeruleum##4##1##(2008-10#4)
coethnic##2##1##(2011-2#2)
coevolution between host##2##3##(2008-10#1)(2008-8#1)
coevolution between##5##2##(2008-10#1)(2008-8#3)(2008-9#1)
coevolution can##2##2##(2008-8#1)(2008-9#1)
coevolution in##2##2##(2012-3#2)
coevolution of##3##2##(1995-5#1)(2008-8#2)
coevolution##23##1##(1995-5#1)(2008-10#4)(2008-8#12)(2008-9#4)(2012-3#2)
coevolutionary##7##1##(1995-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#2)
coevolve with##2##2##(2008-8#2)
coevolve##3##1##(2008-8#2)(2008-9#1)
coevolved##2##1##(2008-10#2)
coexist in##9##2##(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2012-3#1)
coexist with##2##2##(1995-5#1)(2013-1#1)
coexist##25##1##(1994-2#1)(1995-5#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#11)(2008-9#3)(2012-3#1)(2013-1#1)
coexisted system##2##2##(2008-10#2)
coexisted with##2##2##(2008-10#1)(2008-11#1)
coexisted##8##1##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
coexistence among##2##2##(2008-8#1)(2008-9#1)
coexistence and##2##2##(1994-5#1)(2008-8#1)
coexistence between##3##2##(2008-8#1)(2008-9#2)
coexistence can##2##2##(2008-8#1)(2008-9#1)
coexistence equilibrium##2##2##(2008-8#2)
coexistence in##4##2##(2008-8#3)(2008-9#1)
coexistence is possible##2##3##(2008-8#2)
coexistence of both##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
coexistence of competing species##2##4##(2008-8#2)
coexistence of multiple##2##3##(2008-8#1)(2012-2#1)
coexistence of##26##2##(1992-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-8#9)(2008-9#5)(2010-6#1)(2012-2#1)(2012-3#2)(2013-8#1)
coexistence requires##2##2##(2008-8#1)(2008-9#1)
coexistence##75##1##(1992-6#1)(1994-5#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-8#42)(2008-9#17)(2009-7#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-8#1)
coexistent proximal and distal##2##4##(1993-1#2)
coexistent proximal##3##2##(1993-1#3)
coexistent##14##1##(1992-3#1)(1993-1#3)(1993-8#1)(1994-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-11#1)(2009-7#2)
coexisting conditions##2##2##(1997-1#1)(2012-12#1)
coexisting electrolytes in the sample solution and##2##7##(2008-10#2)
coexisting ions##6##2##(2008-10#6)
coexisting junctions##2##2##(2012-2#2)
coexisting metal ions##4##3##(2008-10#4)
coexisting substances##2##2##(2008-10#2)
coexisting with##2##2##(2009-7#1)(2012-2#1)
coexisting##43##1##(1991-3#1)(1997-1#2)(2008-10#20)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
coexpress##2##1##(1995-5#1)(1996-12#1)
coexpressed in##2##2##(2008-11#1)(2009-6#1)
coexpressed with##4##2##(1995-11#1)(1996-12#1)(2008-11#2)
coexpressed##9##1##(1995-11#1)(1995-2#1)(1996-12#1)(2008-11#3)(2008-7#1)(2009-6#1)(2010-12#1)
coexpressing alpha##2##2##(1995-11#1)(1995-6#1)
coexpressing##7##1##(1993-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-7#1)
coexpression in##2##2##(1993-6#1)(2009-8#1)
coexpression of##3##2##(1993-6#1)(1995-11#1)(2008-9#1)
coexpression##5##1##(1993-6#2)(1995-11#1)(2008-9#1)(2009-8#1)
cofactor in##4##2##(1993-8#1)(1996-2#1)(2008-12#1)(2012-2#1)
cofactor requirements##2##2##(1993-8#2)
cofactor##19##1##(1990-5#1)(1990-9#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-8#3)(1994-11#1)(1994-5#4)(1996-2#1)(2008-11#1)(2008-12#1)(2009-3#1)(2012-2#2)
cofactors##11##1##(1990-5#1)(1991-9#1)(1993-8#1)(1995-6#1)(1996-6#1)(1997-7#1)(2008-2#1)(2011-2#2)(2012-2#1)(2013-8#1)
coffee and##6##2##(1993-11#1)(2008-10#5)
coffee beans##9##2##(2008-10#9)
coffee leaves##3##2##(2008-10#3)
coffee samples##2##2##(2008-10#2)
coffee varieties##4##2##(2008-10#4)
coffee##50##1##(1993-11#1)(2008-10#42)(2008-11#3)(2008-5#2)(2011-2#1)(2012-12#1)
coffee)##3##1##(2008-10#3)
coffees##3##1##(2008-10#3)
cofoundress associations##2##2##(2008-9#2)
cofoundress##3##1##(2008-9#3)
cognate protein##2##2##(1995-11#1)(1995-2#1)
cognate resistance##3##2##(2008-10#1)(2009-8#2)
cognate##25##1##(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#3)(1997-8#1)(1997-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#2)(2009-9#1)(2011-1#1)(2012-2#1)
cognition and##6##2##(2008-11#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
cognition in##3##2##(2008-4#1)(2009-10#1)(2009-8#1)
cognition##39##1##(1995-2#1)(1996-2#1)(2008-11#8)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#9)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#2)
cognitions##6##1##(1995-2#2)(2009-8#1)(2010-1#2)(2010-6#1)
cognitive abilities##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
cognitive ability in##2##3##(2009-8#2)
cognitive ability##4##2##(2008-11#1)(2009-4#1)(2009-8#2)
cognitive analysis##3##2##(2008-5#3)
cognitive and affective##2##3##(1991-2#1)(2008-11#1)
cognitive and behavioral##2##3##(2009-8#1)(2012-3#1)
cognitive and emotional##2##3##(1994-5#1)(2008-12#1)
cognitive and##18##2##(1991-2#1)(1994-5#1)(1996-11#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)
cognitive behavior therapy##2##3##(2012-2#2)
cognitive behavior##3##2##(2012-2#2)(2012-3#1)
cognitive behavioural##2##2##(1991-2#1)(2008-10#1)
cognitive decline and##2##3##(2009-8#1)(2013-8#1)
cognitive decline##9##2##(1991-1#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#2)(2013-8#1)
cognitive development and##3##3##(2008-11#2)(2012-2#1)
cognitive development##5##2##(2008-11#3)(2009-7#1)(2012-2#1)
cognitive flexibility##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
cognitive function is##2##3##(1993-11#1)(2011-2#1)
cognitive function##13##2##(1993-11#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
cognitive functioning##3##2##(1993-11#1)(2008-11#2)
cognitive functions##3##2##(2008-7#1)(2010-1#1)(2013-8#1)
cognitive growth fostering##3##3##(1990-12#3)
cognitive growth##4##2##(1990-12#3)(2009-10#1)
cognitive impairment (MCI)##2##3##(2008-6#1)(2009-10#1)
cognitive impairment and##2##3##(2012-12#1)(2013-8#1)
cognitive impairment in##4##3##(2008-6#1)(2009-10#1)(2009-6#1)(2013-8#1)
cognitive impairment is##2##3##(2008-2#1)(2012-2#1)
cognitive impairment##31##2##(2008-2#6)(2008-6#2)(2008-7#2)(2009-10#6)(2009-5#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#3)
cognitive impairments##5##2##(1991-1#1)(1991-7#1)(1993-3#1)(2008-12#1)(2012-3#1)
cognitive level##2##2##(2008-12#2)
cognitive levels##2##2##(2008-12#2)
cognitive performance##6##2##(1993-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
cognitive problems in##2##3##(1995-3#1)(2010-9#1)
cognitive problems##3##2##(1995-3#1)(2008-8#1)(2010-9#1)
cognitive process##2##2##(2008-11#1)(2008-12#1)
cognitive processes##4##2##(2008-5#2)(2009-10#1)(2011-1#1)
cognitive processing##2##2##(2008-11#1)(2012-3#1)
cognitive science##3##2##(1995-1#1)(2008-10#1)(2008-9#1)
cognitive skills##3##2##(2008-11#2)(2012-3#1)
cognitive status and##3##3##(2008-7#3)
cognitive status##4##2##(2008-7#3)(2012-3#1)
cognitive studies##2##2##(2008-11#1)(2010-7#1)
cognitive style and##2##3##(2010-10#1)(2012-3#1)
cognitive style was##2##3##(2010-1#1)(2012-3#1)
cognitive style##11##2##(2010-1#7)(2010-10#2)(2012-3#2)
cognitive tasks##3##2##(2009-8#2)(2010-1#1)
cognitive therapy##2##2##(1996-6#1)(2012-3#1)
cognitive##228##1##(1990-12#4)(1990-8#1)(1991-1#2)(1991-2#2)(1991-7#1)(1992-12#1)(1993-11#4)(1993-3#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#24)(2008-12#12)(2008-2#7)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#22)(2008-8#4)(2008-9#4)(2009-10#16)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#7)(2010-1#10)(2010-10#5)(2010-11#2)(2010-4#3)(2010-5#1)(2010-7#3)(2010-9#2)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#10)(2012-3#12)(2013-1#4)(2013-8#12)
cognitive-behavioral therapy##4##2##(2009-11#3)(2012-2#1)
cognitive-behavioral##6##1##(2009-11#3)(2009-6#1)(2012-2#1)(2013-1#1)
cognitive-behavioural##2##1##(1990-11#1)(2008-11#1)
cognitively impaired##5##2##(1993-2#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-7#1)
cognitively##6##1##(1993-2#1)(2008-1#1)(2008-12#2)(2010-11#1)(2010-7#1)
cognizant of##2##2##(1995-2#1)(1997-2#1)
cognizant##3##1##(1995-2#1)(1997-2#1)(2008-12#1)
cohabitation##2##1##(1990-2#1)(2011-2#1)
cohered structures##3##2##(1991-7#3)
cohered##6##1##(1991-7#6)
coherence and##2##2##(2007-12#1)(2008-12#1)
coherence in##2##2##(1993-3#1)(2012-3#1)
coherence length of##2##3##(2008-3#2)
coherence length##3##2##(2008-3#3)
coherence of##6##2##(1991-7#1)(2008-3#5)
coherence tomography (OCT) has##5##4##(2011-2#1)(2011-7#3)(2013-1#1)
coherence tomography (OCT)##12##3##(2008-5#1)(2011-2#1)(2011-7#8)(2013-1#2)
coherence tomography in##3##3##(2011-7#3)
coherence tomography##31##2##(2007-11#2)(2008-3#2)(2008-5#1)(2009-9#1)(2010-9#1)(2011-2#2)(2011-7#19)(2013-1#3)
coherence##58##1##(1991-7#2)(1991-9#1)(1993-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#17)(2008-5#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-2#2)(2011-7#19)(2012-3#1)(2013-1#3)
coherent DIAL##2##2##(2008-3#2)
coherent Doppler lidar##3##3##(2008-3#3)
coherent Doppler##4##2##(2008-3#4)
coherent and##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
coherent anti-Stokes Raman scattering##2##4##(2008-3#2)
coherent anti-Stokes Raman spectroscopy (CARS)##2##5##(2008-2#1)(2008-3#1)
coherent anti-Stokes Raman##4##3##(2008-2#1)(2008-3#3)
coherent anti-Stokes##5##2##(2008-2#1)(2008-3#4)
coherent anti-stokes Raman scattering for##2##5##(2008-3#2)
coherent anti-stokes Raman##3##3##(2008-2#1)(2008-3#2)
coherent beam##2##2##(2008-2#2)
coherent differential absorption lidar##2##4##(2008-3#2)
coherent image is##2##3##(2008-3#2)
coherent image##4##2##(2008-2#1)(2008-3#3)
coherent optical##2##2##(1992-11#1)(2008-3#1)
coherent##67##1##(1990-5#1)(1991-2#1)(1992-11#1)(1992-8#1)(1995-12#1)(2007-11#3)(2007-12#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#28)(2008-6#2)(2008-7#1)(2010-10#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#2)
cohesion##9##1##(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2010-8#3)
cohesive##6##1##(1994-12#1)(1997-5#1)(2007-11#1)(2009-8#1)(2013-1#2)
cohesiveness##4##1##(1991-12#1)(1996-3#1)(2008-5#1)(2010-8#1)
cohort had a mean##2##4##(2008-9#2)
cohort in##2##2##(2008-11#1)(2010-6#1)
cohort included##2##2##(1997-4#1)(2008-9#1)
cohort of 19 patients with##2##5##(2008-9#1)(2011-2#1)
cohort of patients with##2##4##(2011-2#1)(2012-3#1)
cohort of patients##4##3##(2011-2#2)(2012-12#1)(2012-3#1)
cohort of street-involved youth##2##4##(2013-1#2)
cohort of##40##2##(1991-12#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-9#1)(1996-3#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)
cohort studies##8##2##(1991-12#1)(1994-2#1)(1995-9#1)(1996-3#1)(2008-11#2)(2008-7#1)(2008-8#1)
cohort study of##4##3##(2007-12#1)(2008-11#1)(2008-8#1)(2012-3#1)
cohort study##19##2##(1991-1#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
cohort was##4##2##(2007-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
cohort##122##1##(1990-6#1)(1991-1#1)(1991-12#2)(1991-6#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-9#2)(1996-11#1)(1996-3#4)(1997-4#1)(1997-8#1)(2007-12#4)(2008-10#1)(2008-11#10)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#9)(2009-10#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#11)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#13)(2013-8#3)
cohorts born in the##2##4##(2011-2#2)
cohorts born##3##2##(2011-2#3)
cohorts of patients with bleeding esophageal varices##2##7##(2013-1#2)
cohorts of patients##3##3##(2013-1#3)
cohorts of students##3##3##(2008-11#2)(2013-1#1)
cohorts of##10##2##(2008-10#2)(2008-11#3)(2013-1#5)
cohorts were##2##2##(1990-2#1)(2011-2#1)
cohorts##32##1##(1990-2#1)(1994-2#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-7#4)(2008-8#1)(2009-8#1)(2011-2#6)(2013-1#6)
coil (GDC)##2##2##(1997-6#1)(2008-7#1)
coil and a##2##3##(2008-10#2)
coil and the##2##3##(2008-10#2)
coil and##12##2##(1992-3#1)(2008-10#10)(2008-7#1)
coil atomizer##6##2##(2008-10#6)
coil embolization##6##2##(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
coil in the##2##3##(1996-9#1)(2008-8#1)
coil length of##2##3##(2008-10#2)
coil length##9##2##(2008-10#9)
coil lifetime##2##2##(2008-10#2)
coil occlusion of##2##3##(1997-8#1)(2008-7#1)
coil occlusion##3##2##(1997-8#1)(2008-11#1)(2008-7#1)
coil of the##2##3##(2008-10#1)(2008-9#1)
coil of##4##2##(2008-10#3)(2008-9#1)
coil over##2##2##(1992-9#1)(2010-7#1)
coil placement##2##2##(1997-3#1)(2008-7#1)
coil positioning##2##2##(2010-7#2)
coil to##7##2##(2008-10#5)(2010-7#1)(2012-3#1)
coil was##6##2##(1996-9#1)(2008-10#5)
coil##126##1##(1992-3#3)(1992-9#1)(1996-2#1)(1996-9#2)(1997-3#5)(1997-6#1)(1997-8#2)(2008-10#82)(2008-11#2)(2008-12#1)(2008-7#6)(2008-8#2)(2008-9#1)(2010-7#7)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
coiled around##2##2##(2008-10#2)
coiled coil##3##2##(1992-9#1)(2011-1#1)(2011-2#1)
coiled high-birefringent fibers##3##3##(2008-2#3)
coiled reactor positioned at the output antenna of a domestic microwave oven at 700 W is##2##16##(2008-10#2)
coiled reactor positioned##3##3##(2008-10#3)
coiled reactor##4##2##(2008-10#4)
coiled##17##1##(1992-9#1)(1997-3#1)(2008-10#7)(2008-2#4)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
coiled-coil structure and##2##3##(1992-9#1)(1996-12#1)
coiled-coil##8##1##(1992-9#6)(1996-12#1)(2009-8#1)
coiling and##2##2##(2008-10#1)(2008-8#1)
coiling of##2##2##(2011-3#1)(2012-3#1)
coiling##8##1##(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)
coils is##2##2##(1997-8#2)
coils were##2##2##(1996-9#1)(2008-10#1)
coils##18##1##(1995-11#2)(1995-3#1)(1996-9#1)(1997-3#3)(1997-8#6)(2008-10#4)(2008-7#1)
coin##2##1##(1991-9#1)(2007-8#1)
coincide with the##3##3##(2008-10#2)(2010-8#1)
coincide with those of the##2##5##(1997-7#1)(2008-3#1)
coincide with those##3##3##(1997-7#1)(2008-10#1)(2008-3#1)
coincide with##11##2##(1997-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2010-8#1)(2011-2#1)
coincide##14##1##(1997-7#1)(2008-10#5)(2008-11#3)(2008-3#1)(2009-10#1)(2010-8#1)(2011-2#2)
coincided with a##3##3##(2008-11#2)(2008-8#1)
coincided with the increase##2##4##(2008-10#1)(2008-11#1)
coincided with the##16##3##(1993-8#1)(1996-1#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-8#1)(2013-1#1)
coincided with##29##2##(1990-6#1)(1993-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#9)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-8#1)(2011-2#1)(2013-1#1)
coincided##31##1##(1990-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#10)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-8#1)(2011-2#1)(2013-1#1)
coincidence##7##1##(1991-11#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-2#1)(2012-3#1)
coincident with an##2##3##(1991-12#1)(2010-8#1)
coincident with the##6##3##(1991-2#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-7#1)(2009-10#1)
coincident with##11##2##(1991-12#1)(1991-2#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)(2012-3#1)
coincident##16##1##(1991-12#1)(1991-2#1)(1992-12#1)(1994-6#1)(1995-2#2)(1997-1#1)(2008-10#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)(2012-3#1)
coincidental with##2##2##(2008-11#1)(2008-5#1)
coincidentally##2##1##(2008-7#1)(2008-9#1)
coincides with the##11##3##(1993-8#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2012-12#1)
coincides with##14##2##(1990-5#1)(1993-8#1)(1995-6#2)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#1)
coincides##18##1##(1990-5#1)(1993-8#1)(1995-6#2)(1995-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#2)(2012-12#1)
coinciding with##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
coined in##3##2##(2012-12#1)(2013-8#2)
coined##5##1##(1997-8#1)(2010-3#1)(2012-12#1)(2013-8#2)
coinfect##3##1##(1997-3#1)(2008-10#2)
coinfected with HIV##2##3##(2008-10#1)(2011-2#1)
coinfected with##3##2##(2008-10#2)(2011-2#1)
coinfected##8##1##(2008-10#5)(2008-11#1)(2008-7#1)(2011-2#1)
coinfecting##3##1##(2008-10#2)(2008-7#1)
coinfection with##3##2##(2008-10#2)(2008-7#1)
coinfection##12##1##(2008-10#7)(2008-7#4)(2011-2#1)
coinoculated into##2##2##(2008-10#2)
coinoculated with A1 + A2 sporangia of##2##7##(2008-10#2)
coinoculated with##11##2##(1995-2#1)(2008-10#10)
coinoculated##16##1##(1995-2#1)(2008-10#15)
coinoculation##2##1##(2008-10#2)
coioides##5##1##(2008-12#3)(2010-5#2)
col-36 and col-40##3##3##(1993-12#3)
col-36##4##1##(1993-12#4)
col-40##4##1##(1993-12#4)
colchicine and##2##2##(1993-6#1)(2008-8#1)
colchicine##6##1##(1990-2#1)(1993-6#1)(1995-11#1)(1995-2#1)(2008-11#1)(2008-8#1)
cold and dry air##2##4##(2012-3#2)
cold and##5##2##(1993-8#1)(2008-10#1)(2009-8#1)(2012-3#2)
cold chain##3##2##(1994-9#2)(2011-2#1)
cold in##2##2##(2008-7#1)(2012-3#1)
cold knife##3##2##(1994-12#3)
cold rolling with##2##3##(2013-8#2)
cold season##2##2##(2008-10#1)(2011-2#1)
cold storage##8##2##(2008-10#8)
cold stress##2##2##(2008-10#2)
cold vapor atomic absorption spectrometry (CV-AAS)##2##6##(2008-10#2)
cold vapor atomic absorption spectrometry (CVAAS)##2##6##(2008-10#2)
cold vapor atomic absorption spectrometry##8##5##(2008-10#8)
cold vapor atomic absorption##9##4##(2008-10#9)
cold vapor##13##2##(2008-10#13)
cold vapour atomic absorption spectrometry (CVAAS)##4##6##(2008-10#4)
cold vapour atomic absorption spectrometry##6##5##(2008-10#6)
cold vapour atomic absorption##8##4##(2008-10#8)
cold vapour atomic fluorescence##2##4##(2008-10#2)
cold vapour atomic##10##3##(2008-10#10)
cold vapour generation##2##3##(2008-10#2)
cold vapour##13##2##(2008-10#13)
cold##99##1##(1990-11#1)(1990-9#1)(1992-3#1)(1993-8#1)(1994-12#3)(1994-9#3)(1995-11#3)(2008-10#48)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#4)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#1)(2013-8#7)
cold&quot##2##1##(1997-2#2)
cold-exposed animals##2##2##(2008-7#2)
cold-exposed##3##1##(2008-7#3)
cold-hardiness strategies##3##2##(2008-8#3)
cold-shock response in mammalian cells##2##5##(2008-11#2)
cold-shock response in mammalian##3##4##(2008-11#3)
cold-shock##4##1##(2008-11#4)
cold-vapor atomic##2##2##(2008-10#2)
cold-vapor##3##1##(2008-10#3)
cold-vapour##2##1##(2008-10#2)
colds##5##1##(2008-10#2)(2008-7#3)
colectomy was performed##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
colectomy##5##1##(2008-12#1)(2009-12#2)(2011-2#1)(2013-1#1)
coleopteran and##2##2##(2008-10#2)
coleopteran##5##1##(2008-10#5)
coli B WP2 strains##2##4##(2008-9#2)
coli BL21 (DE3) cells##2##4##(1994-5#2)
coli BL21##3##2##(1994-5#2)(2013-1#1)
coli DNA polymerase I##2##4##(1997-8#1)(2008-4#1)
coli DNA polymerase III holoenzyme##2##5##(1992-3#1)(1994-12#1)
coli DNA polymerase##4##3##(1992-3#1)(1994-12#1)(1997-8#1)(2008-4#1)
coli DNA##5##2##(1992-3#2)(1994-12#1)(1997-8#1)(2008-4#1)
coli K-12 bacterial cells to##3##5##(2008-10#3)
coli K-12##17##2##(1991-11#2)(1993-9#1)(1996-12#6)(1996-6#3)(2008-10#4)(2009-6#1)
coli K1##3##2##(2009-12#3)
coli Nissle 1917##3##3##(2011-2#3)
coli Nissle##4##2##(2010-10#1)(2011-2#3)
coli O157##13##2##(1995-2#2)(1996-3#1)(2008-10#6)(2010-4#2)(2012-2#2)
coli O26##2##2##(1993-9#2)
coli RNA polymerase##3##3##(1995-2#2)(1995-6#1)
coli RecA and yeast RAD51 homolog##2##6##(1997-4#2)
coli RecA##3##2##(1997-4#2)(2008-4#1)
coli and Salmonella##2##3##(1990-5#1)(2011-1#1)
coli and purified to homogeneity##2##5##(1995-2#1)(2008-8#1)
coli and##26##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-3#3)(1993-6#1)(1993-9#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2011-1#3)(2011-2#2)(2012-2#2)
coli are##3##2##(1997-2#1)(1997-6#1)(2008-10#1)
coli beta-galactosidase##3##2##(1995-12#1)(1997-8#1)(2008-7#1)
coli by##4##2##(1991-5#1)(1993-9#1)(2008-11#1)(2009-6#1)
coli cell##2##2##(2008-10#1)(2008-7#1)
coli cells containing##2##3##(1995-2#1)(2008-10#1)
coli cells harboring##2##3##(1993-8#1)(1996-12#1)
coli cells##9##2##(1992-3#1)(1993-8#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
coli expression system##2##3##(1994-5#1)(1997-7#1)
coli extracts##2##2##(2008-4#2)
coli fldA##2##2##(1997-7#2)
coli genetic map)##2##3##(1992-9#2)
coli immobilized on sepiolite##4##4##(2008-10#4)
coli in##2##2##(1990-5#1)(2011-1#1)
coli inclusion bodies##2##3##(2008-4#2)
coli infection##2##2##(1996-8#1)(2011-2#1)
coli is##4##2##(1991-12#1)(1993-6#1)(2008-4#1)(2011-1#1)
coli lacZ gene##3##3##(1993-12#1)(1997-8#1)(2008-11#1)
coli lacZ##4##2##(1993-12#2)(1997-8#1)(2008-11#1)
coli outer membrane##2##3##(1990-11#1)(1997-8#1)
coli shuttle##2##2##(1993-12#1)(2008-8#1)
coli strain##5##2##(1993-8#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)
coli strains with##3##3##(1991-12#1)(1993-9#1)(2011-1#1)
coli strains##11##2##(1991-12#1)(1993-12#1)(1993-9#1)(2008-10#2)(2008-12#3)(2008-9#1)(2011-1#1)(2011-2#1)
coli tRNA(fMet) genes##2##3##(1995-6#2)
coli tRNA(fMet)##3##2##(1995-6#3)
coli to##5##2##(1993-12#1)(1996-12#1)(1997-3#1)(2008-4#1)(2009-3#1)
coli using##5##2##(1991-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(2008-7#1)
coli was##9##2##(1990-5#2)(1991-3#1)(1991-5#1)(1993-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
coli with a##3##3##(1991-9#1)(1993-8#1)(2008-7#1)
coli with##4##2##(1991-9#1)(1993-8#1)(2008-7#1)(2012-2#1)
coli##410##1##(1990-11#6)(1990-5#10)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-3#5)(1991-5#8)(1991-7#2)(1991-9#3)(1992-1#1)(1992-3#3)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#4)(1993-12#13)(1993-6#4)(1993-8#10)(1993-9#11)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#7)(1994-8#4)(1995-11#2)(1995-12#6)(1995-2#15)(1995-6#14)(1995-8#1)(1995-9#1)(1996-12#15)(1996-3#2)(1996-6#7)(1996-8#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#5)(1997-8#6)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#42)(2008-11#15)(2008-12#7)(2008-4#11)(2008-5#1)(2008-7#22)(2008-8#22)(2008-9#14)(2009-12#8)(2009-3#2)(2009-6#4)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#4)(2010-6#8)(2011-1#10)(2011-2#17)(2011-3#1)(2012-2#10)(2012-3#5)(2013-1#4)
coli)##5##1##(2008-10#3)(2012-2#2)
colic##3##1##(1990-11#1)(1997-4#1)(2008-10#1)
coliform##4##1##(2008-10#4)
coliforms##3##1##(1990-6#1)(2008-10#2)
colistin##2##1##(2008-10#2)
colitic mice##3##2##(2011-3#3)
colitis (UC)##3##2##(2009-12#1)(2010-12#1)(2011-2#1)
colitis and##2##2##(1992-6#1)(1995-8#1)
colitis caused by##3##3##(1990-5#1)(2010-6#2)
colitis in##3##2##(1992-6#1)(2008-4#1)(2010-12#1)
colitis is##2##2##(1990-5#1)(2013-1#1)
colitis were##2##2##(1995-10#1)(2011-3#1)
colitis##56##1##(1990-5#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-9#1)(1994-6#1)(1995-10#3)(1995-8#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#9)(2010-6#2)(2011-2#5)(2011-3#3)(2012-2#2)(2013-1#8)
colitis]##5##1##(1990-6#1)(1992-3#1)(1993-2#1)(2008-12#1)(2011-3#1)
collaborate with##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
collaborated to##3##2##(1991-2#1)(1997-2#1)(2008-11#1)
collaborating##2##1##(1991-9#1)(2008-5#1)
collaboration and##8##2##(1993-12#1)(2008-11#4)(2008-12#2)(2009-3#1)
collaboration between the##4##3##(1996-1#1)(2008-11#3)
collaboration between##17##2##(1991-2#2)(1993-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-9#1)(2010-10#1)(2011-2#1)
collaboration in developing##2##3##(2008-11#2)
collaboration in##3##2##(1992-3#1)(2008-11#2)
collaboration with other##2##3##(2008-11#2)
collaboration with the##9##3##(1991-6#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-1#1)(2011-3#1)
collaboration with##23##2##(1991-6#1)(1996-1#1)(1996-2#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2010-1#1)(2010-5#1)(2011-2#1)(2011-3#1)
collaboration##88##1##(1991-2#4)(1991-6#1)(1991-9#1)(1992-12#3)(1992-3#1)(1993-12#2)(1993-3#1)(1994-2#1)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#20)(2008-12#10)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#2)(2010-10#1)(2010-5#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
collaborations##6##1##(2008-11#1)(2009-11#2)(2009-3#1)(2010-10#1)(2013-8#1)
collaborative approach between##2##3##(2008-11#1)(2008-12#1)
collaborative approach##4##2##(1997-3#1)(2008-11#2)(2008-12#1)
collaborative effort by##2##3##(1996-12#1)(1997-1#1)
collaborative effort to##3##3##(1995-11#2)(2012-3#1)
collaborative effort##8##2##(1994-12#1)(1995-11#2)(1996-12#1)(1997-1#1)(1997-3#1)(2011-9#1)(2012-3#1)
collaborative efforts of##5##3##(1993-3#1)(1994-9#1)(1996-1#1)(2010-10#1)(2013-1#1)
collaborative efforts##7##2##(1993-3#1)(1994-3#1)(1994-9#1)(1996-1#1)(2009-9#1)(2010-10#1)(2013-1#1)
collaborative exercise##3##2##(2008-12#3)
collaborative learning##3##2##(2008-12#2)(2012-2#1)
collaborative practice##2##2##(2008-12#1)(2012-2#1)
collaborative relationship##2##2##(2008-11#1)(2008-4#1)
collaborative research##2##2##(2010-10#1)(2011-3#1)
collaborative structures to##2##3##(2008-11#2)
collaborative structures##3##2##(2008-10#1)(2008-11#2)
collaborative study was##2##3##(1997-7#1)(2008-10#1)
collaborative study##4##2##(1995-11#1)(1997-7#1)(2008-10#1)(2009-11#1)
collaborative venture##2##2##(1991-2#1)(2008-11#1)
collaborative work in##2##3##(1993-12#1)(2013-1#1)
collaborative work##8##2##(1993-12#4)(1994-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
collaborative working##3##2##(2008-11#3)
collaborative##86##1##(1991-2#2)(1993-1#1)(1993-12#6)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-11#3)(1996-1#3)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#15)(2008-12#11)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-3#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-2#1)(2011-3#1)(2011-9#3)(2012-2#4)(2012-3#2)(2013-1#6)
collaboratively##8##1##(1995-3#1)(2008-11#4)(2008-12#2)(2011-2#1)
collaboratives##2##1##(2013-1#2)
collaborators##3##1##(1994-9#1)(2008-12#1)(2008-5#1)
collagen I and III##3##4##(1995-12#1)(2011-2#2)
collagen I and##4##3##(1995-12#2)(2011-2#2)
collagen I fibrils##2##3##(1992-6#2)
collagen I##13##2##(1992-6#5)(1994-8#2)(1995-12#3)(2011-2#2)(2012-3#1)
collagen III##2##2##(1995-12#2)
collagen alpha 1 (IV)##2##4##(1994-12#2)
collagen alpha 1##4##3##(1994-12#4)
collagen alpha##5##2##(1990-5#1)(1994-12#4)
collagen and##6##2##(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)(2012-2#1)
collagen beads##3##2##(2008-11#3)
collagen biosynthesis##3##2##(1997-7#1)(2008-5#2)
collagen by##2##2##(1993-12#1)(1995-3#1)
collagen cDNA##2##2##(1992-3#1)(1997-7#1)
collagen cross-links##2##2##(1994-12#2)
collagen degradation##4##2##(2009-7#1)(2013-1#2)(2013-8#1)
collagen fiber##2##2##(2012-2#1)(2013-1#1)
collagen fibers##8##2##(1994-11#1)(2008-8#2)(2009-7#1)(2012-3#3)(2013-8#1)
collagen fibres types I and III in the##2##8##(2008-7#2)
collagen fibrils##5##2##(2008-1#1)(2008-7#4)
collagen film##2##2##(2008-10#2)
collagen formation##4##2##(1991-12#1)(1994-12#1)(2008-5#1)(2013-8#1)
collagen gel substrata##2##3##(1994-8#2)
collagen gel##10##2##(1994-11#2)(1994-8#6)(2008-11#1)(2012-3#1)
collagen gene expression in##2##4##(1992-8#1)(1994-12#1)
collagen gene##3##2##(1992-8#2)(1994-12#1)
collagen hydrogel##2##2##(2012-3#2)
collagen hydrolysate##5##2##(2008-5#5)
collagen in a##2##3##(2008-11#1)(2009-7#1)
collagen in the##3##3##(1992-6#1)(2008-5#1)(2008-9#1)
collagen in##10##2##(1990-8#1)(1992-6#1)(1993-3#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-12#1)
collagen is##2##2##(1992-6#1)(1997-7#1)
collagen network##6##2##(2008-5#2)(2008-7#2)(2009-10#2)
collagen of##3##2##(1992-6#1)(1997-7#1)(2008-11#1)
collagen promoter##2##2##(1991-5#2)
collagen scaffolds##4##2##(2009-7#4)
collagen solubility##2##2##(2010-4#2)
collagen synthesis and##2##3##(2008-5#2)
collagen synthesis in##2##3##(2008-5#2)
collagen synthesis##8##2##(2008-5#7)(2008-7#1)
collagen turnover##2##2##(1993-3#1)(2007-11#1)
collagen type I##8##3##(2008-11#5)(2008-5#3)
collagen type IV##4##3##(1992-6#2)(2008-11#2)
collagen type##14##2##(1992-6#2)(2008-11#8)(2008-5#4)
collagen was##3##2##(1993-3#1)(2008-9#1)(2009-7#1)
collagen##231##1##(1990-12#1)(1990-5#1)(1990-8#5)(1991-12#1)(1991-5#7)(1992-11#1)(1992-3#4)(1992-6#14)(1992-8#2)(1993-12#3)(1993-3#8)(1994-11#3)(1994-12#9)(1994-8#13)(1995-12#6)(1995-3#1)(1997-1#2)(1997-7#7)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#29)(2008-5#32)(2008-7#11)(2008-8#9)(2008-9#2)(2009-10#2)(2009-7#16)(2009-8#1)(2010-4#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#13)(2013-1#4)(2013-8#8)
collagen-blended membranes##3##2##(2008-11#3)
collagen-coated##6##1##(2008-11#6)
collagen-induced platelet##2##2##(2006-6#1)(2008-5#1)
collagen-induced##5##1##(2006-6#3)(2008-11#1)(2008-5#1)
collagen-like##2##1##(1990-8#1)(1993-3#1)
collagenase activity##2##2##(1994-3#2)
collagenase and##2##2##(2008-11#1)(2008-5#1)
collagenase secretion##2##2##(2008-11#2)
collagenase##20##1##(1991-5#1)(1993-3#1)(1994-3#7)(2008-11#5)(2008-5#2)(2008-8#4)
collagenous hydrolysates##2##2##(2008-5#2)
collagenous##10##1##(1990-8#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#2)
collagens and##5##2##(1992-8#1)(1997-7#1)(2008-5#3)
collagens##8##1##(1991-5#1)(1992-8#1)(1997-7#1)(2008-11#1)(2008-5#4)
collapse and##2##2##(2008-10#2)
collapse of the##10##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
collapse of##17##2##(1991-9#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#2)(2012-2#1)
collapse##36##1##(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1994-8#1)(1995-2#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#2)(2010-1#1)(2011-2#1)(2012-2#1)
collapsed replication forks##3##3##(2012-3#3)
collapsed##8##1##(2008-10#3)(2008-8#1)(2012-3#4)
collapses to##2##2##(1991-9#1)(2008-8#1)
collapses##3##1##(1991-9#1)(2008-10#1)(2008-8#1)
collapsing##5##1##(1991-3#1)(2008-10#1)(2008-12#1)(2009-10#1)(2011-2#1)
collar##11##1##(1991-8#1)(2008-10#2)(2008-12#1)(2008-8#2)(2010-3#1)(2010-8#2)(2011-2#1)(2013-1#1)
collared##2##1##(2008-8#1)(2008-9#1)
collars##2##1##(2008-8#1)(2010-8#1)
collated##2##1##(2008-12#1)(2012-2#1)
collateral ligament##3##2##(2009-7#1)(2012-2#2)
collateral##20##1##(1991-2#1)(1993-3#1)(1994-1#1)(1995-2#1)(1997-3#3)(1997-6#1)(1997-8#2)(2008-1#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-2#5)(2012-3#1)
collaterally sprout##2##2##(1997-3#2)
collaterals of the##2##3##(1996-5#1)(2008-11#1)
collaterals of##5##2##(1996-5#2)(1997-3#2)(2008-11#1)
collaterals##12##1##(1994-2#1)(1995-12#1)(1996-5#2)(1997-3#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)
collation of##2##2##(2008-10#1)(2008-11#1)
collation##3##1##(1993-12#1)(2008-10#1)(2008-11#1)
colleague##4##1##(2008-11#1)(2010-7#1)(2011-2#2)
colleagues and##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
colleagues have##2##2##(2010-11#1)(2012-2#1)
colleagues##28##1##(1990-6#1)(1991-6#1)(1994-12#2)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#5)(2013-1#2)
collect data##10##2##(1992-2#1)(1994-2#1)(1995-12#1)(2008-11#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
collect information##3##2##(1993-2#1)(2008-11#1)(2012-3#1)
collect the##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
collect##50##1##(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-10#8)(2008-11#10)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)
collected 5##2##2##(2008-10#1)(2008-12#1)
collected after##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
collected and analyzed##7##3##(1992-1#1)(2008-10#4)(2011-2#1)(2013-8#1)
collected and hemoglobin##2##3##(2011-2#1)(2012-5#1)
collected and preconcentrated##2##3##(2008-10#2)
collected and the##2##3##(2008-10#1)(2008-11#1)
collected and##28##2##(1992-1#1)(1994-2#1)(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)(2013-8#1)
collected around##2##2##(2008-10#2)
collected as##6##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-9#1)
collected at a##2##3##(2008-12#1)(2012-2#1)
collected at different times##2##4##(2008-8#1)(2008-9#1)
collected at different##5##3##(2008-10#1)(2008-8#2)(2008-9#1)(2011-3#1)
collected at each##2##3##(2008-10#1)(2008-3#1)
collected at harvest##2##3##(2008-10#2)
collected at the##4##3##(2008-10#3)(2008-5#1)
collected at various##2##3##(2008-1#1)(2008-10#1)
collected at##24##2##(1991-6#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
collected before and after the##2##5##(2008-12#1)(2013-1#1)
collected before##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
collected between##5##2##(2008-10#3)(2010-10#1)(2011-2#1)
collected by a##2##3##(2008-10#1)(2008-3#1)
collected by the##4##3##(1992-2#1)(1994-6#1)(2008-12#1)(2011-2#1)
collected by using a##2##4##(2008-10#1)(2011-2#1)
collected by##26##2##(1992-2#1)(1992-5#1)(1994-6#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#5)(2012-12#1)
collected data from##2##3##(2010-11#1)(2010-5#1)
collected data on##2##3##(2008-1#1)(2008-11#1)
collected data##17##2##(1992-1#1)(1994-1#1)(2008-1#1)(2008-10#6)(2008-11#3)(2010-11#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
collected during 1993##2##3##(1995-12#1)(2008-10#1)
collected during the last 50 years##2##6##(2008-10#2)
collected during the##8##3##(1991-12#2)(2008-10#2)(2008-12#1)(2008-9#1)(2010-8#1)(2011-1#1)
collected during##24##2##(1991-12#2)(1991-6#1)(1993-2#1)(1994-8#1)(1995-12#1)(2008-10#10)(2008-12#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
collected for each##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
collected for the##2##3##(1997-2#1)(2008-12#1)
collected for##16##2##(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#2)(2011-2#1)(2012-3#1)
collected from a##12##3##(1990-11#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)(2010-5#1)(2012-12#1)
collected from all##3##3##(2008-10#3)
collected from apple##2##3##(2008-10#2)
collected from both##3##3##(2008-10#2)(2008-12#1)
collected from citrus##2##3##(2008-10#2)
collected from commercial##2##3##(2008-10#2)
collected from common wheat in##2##5##(2008-10#2)
collected from cultivated potatoes##2##4##(2008-10#2)
collected from different host plant species##2##6##(2008-10#2)
collected from different##6##3##(2008-10#6)
collected from diseased##2##3##(2008-10#2)
collected from durum wheat##3##4##(2008-10#3)
collected from each##5##3##(2008-10#5)
collected from eight##2##3##(2008-10#2)
collected from five##4##3##(2008-10#4)
collected from four##3##3##(2008-10#2)(2011-2#1)
collected from local##2##3##(2008-12#1)(2013-1#1)
collected from naturally##2##3##(1996-12#1)(2008-10#1)
collected from patients##4##3##(1991-7#1)(2008-11#1)(2011-2#1)(2012-3#1)
collected from pistachio and other##2##5##(2008-10#2)
collected from potato##6##3##(2008-10#6)
collected from rice##2##3##(2008-10#1)(2013-8#1)
collected from seven##2##3##(2008-10#2)
collected from several##2##3##(2008-10#2)
collected from soybean##3##3##(2008-10#3)
collected from the commercial##2##4##(2008-10#2)
collected from the field##3##4##(2008-10#3)
collected from the##28##3##(2008-10#19)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#4)(2013-8#1)
collected from three##4##3##(2008-10#4)
collected from tomato##3##3##(2008-10#3)
collected from two##3##3##(2008-10#2)(2008-5#1)
collected from various##5##3##(2008-10#3)(2008-11#1)(2009-2#1)
collected from##241##2##(1990-11#1)(1991-2#1)(1991-7#1)(1993-12#1)(1994-1#1)(1994-9#1)(1995-8#1)(1996-12#2)(1996-2#1)(2008-10#169)(2008-11#7)(2008-12#12)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#7)(2013-8#6)
collected in 1993##2##3##(2008-10#1)(2011-2#1)
collected in 2002##2##3##(2008-10#2)
collected in a##15##3##(1990-6#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
collected in an urban##2##4##(2008-10#2)
collected in an##3##3##(2008-10#3)
collected in each##2##3##(1996-12#1)(2008-10#1)
collected in fractions##2##3##(2008-10#2)
collected in the field##2##4##(2008-10#2)
collected in the##25##3##(1990-12#1)(1996-12#1)(2008-10#20)(2010-8#2)(2013-1#1)
collected in three##2##3##(2008-10#2)
collected in two##3##3##(2008-10#2)(2008-11#1)
collected in##105##2##(1990-12#1)(1990-6#1)(1994-6#1)(1996-12#2)(1997-4#1)(2008-10#78)(2008-11#2)(2008-12#3)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)
collected information on##2##3##(2008-11#1)(2013-8#1)
collected information##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
collected monthly from##3##3##(2008-10#3)
collected near##4##2##(2008-10#4)
collected on a##3##3##(1997-2#1)(2008-10#2)
collected on the walls of a knotted##3##7##(2008-10#3)
collected on the##10##3##(2008-10#8)(2008-11#1)(2008-12#1)
collected on##30##2##(1993-6#1)(1994-6#1)(1996-3#1)(1997-2#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
collected over 2##2##3##(2008-10#1)(2010-8#1)
collected over a##6##3##(2008-10#4)(2012-12#1)(2012-2#1)
collected over the##2##3##(2008-10#2)
collected over##14##2##(1991-2#1)(2008-10#8)(2008-12#1)(2010-8#2)(2012-12#1)(2012-2#1)
collected randomly from##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
collected through a##2##3##(2008-11#1)(2008-7#1)
collected through the##2##3##(1995-9#1)(2012-3#1)
collected through##12##2##(1990-12#1)(1994-2#1)(1995-9#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-3#3)(2013-8#1)
collected up to##2##3##(1993-11#1)(2013-1#1)
collected using a##4##3##(2008-10#2)(2010-6#1)(2013-1#1)
collected using##9##2##(1996-3#1)(2008-10#4)(2008-11#1)(2010-6#1)(2013-1#2)
collected with a##2##3##(2008-10#1)(2010-9#1)
collected with##3##2##(2008-10#1)(2009-5#1)(2010-9#1)
collected worldwide##2##2##(2008-10#2)
collected##694##1##(1990-11#1)(1990-12#3)(1990-6#1)(1991-12#2)(1991-2#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#2)(1992-2#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#3)(1994-2#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#3)(1997-2#3)(1997-4#1)(2008-1#3)(2008-10#404)(2008-11#28)(2008-12#33)(2008-3#3)(2008-5#12)(2008-7#3)(2008-8#9)(2008-9#10)(2009-12#3)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#2)(2011-10#2)(2011-2#26)(2011-3#2)(2011-9#1)(2012-12#8)(2012-2#12)(2012-3#14)(2012-5#1)(2013-1#28)(2013-8#11)
collecting and##3##2##(1992-1#1)(1993-3#1)(2008-9#1)
collecting data##4##2##(1993-3#1)(2008-11#1)(2008-12#1)(2008-5#1)
collecting information on the##2##4##(1996-1#1)(2008-10#1)
collecting information on##3##3##(1996-1#1)(1996-2#1)(2008-10#1)
collecting information##4##2##(1996-1#1)(1996-2#1)(2008-10#1)(2011-2#1)
collecting services##3##2##(2008-12#3)
collecting system##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
collecting the##4##2##(2008-10#2)(2013-1#2)
collecting##45##1##(1992-1#1)(1993-3#2)(1996-1#1)(1996-12#1)(1996-2#2)(2008-10#13)(2008-11#5)(2008-12#4)(2008-2#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
collection and analysis of##3##4##(1993-3#1)(1995-12#1)(2008-10#1)
collection and analysis##6##3##(1993-3#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
collection and management##2##3##(2008-10#1)(2010-5#1)
collection and##23##2##(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
collection as##6##2##(2008-10#5)(2008-5#1)
collection by##3##2##(2008-10#3)
collection date##2##2##(2008-10#2)
collection efficiency##6##2##(2008-10#4)(2011-2#1)(2013-8#1)
collection for##3##2##(2008-11#2)(2010-6#1)
collection from##2##2##(2008-10#1)(2008-11#1)
collection in##5##2##(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#2)
collection includes##2##2##(2008-10#1)(2008-5#1)
collection methods##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
collection of P##3##3##(2008-10#3)
collection of airborne##3##3##(2008-10#3)
collection of boron##2##3##(2008-10#2)
collection of data##4##3##(1995-12#1)(1997-3#2)(2012-12#1)
collection of isolates##4##3##(2008-10#4)
collection of large##2##3##(2008-10#1)(2010-12#1)
collection of random##2##3##(2008-10#1)(2008-4#1)
collection of the##7##3##(2008-10#6)(2010-1#1)
collection of##99##2##(1990-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#3)(2008-10#59)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
collection or##2##2##(2008-10#1)(2010-6#1)
collection process##2##2##(2008-10#1)(2008-11#1)
collection strategies##2##2##(1995-2#1)(2008-6#1)
collection time##3##2##(2008-10#1)(2008-3#2)
collection using##2##2##(2008-10#2)
collection was undertaken##2##3##(2008-11#2)
collection was##7##2##(1990-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)
collection were##5##2##(2008-10#4)(2008-5#1)
collection##297##1##(1990-12#1)(1990-8#2)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#6)(1994-12#5)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#8)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#7)(2007-12#1)(2008-10#144)(2008-11#20)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#10)(2010-9#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
collection)##3##1##(2011-2#1)(2013-1#2)
collection/concentration of trace amounts of formaldehyde in air##2##8##(2008-10#2)
collection/concentration of##4##2##(2008-10#4)
collections from the##2##3##(2008-10#2)
collections from##9##2##(2008-10#9)
collections of##11##2##(1995-5#1)(2008-10#8)(2008-7#1)(2008-9#1)
collections were##3##2##(2008-10#3)
collections##54##1##(1991-3#1)(1995-5#1)(2008-10#36)(2008-11#4)(2008-7#1)(2008-9#1)(2009-9#3)(2010-1#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#3)
collective dynamics##2##2##(2009-8#1)(2012-2#1)
collective modes##2##2##(1992-8#1)(2009-8#1)
collective##27##1##(1990-5#1)(1991-11#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-1#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-8#3)(2010-10#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-2#3)
collectively called##2##2##(1992-10#1)(2009-11#1)
collectively known as##2##3##(2008-10#1)(2011-2#1)
collectively##23##1##(1991-1#1)(1992-10#1)(1994-6#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#4)(2012-3#1)
collector for##2##2##(2008-10#2)
collector##12##1##(2008-10#12)
collectors##3##1##(2008-10#1)(2008-5#1)(2010-8#1)
collects##3##1##(2008-10#1)(2008-11#2)
college classroom##2##2##(1996-1#1)(2011-1#1)
college graduates##3##2##(1991-3#1)(1995-2#1)(1997-2#1)
college group was higher than high school group##2##8##(1990-12#2)
college of##5##2##(1997-8#1)(2008-11#1)(2009-6#1)(2012-12#1)(2012-3#1)
college students have##2##3##(2008-11#1)(2013-8#1)
college students in##2##3##(2012-2#1)(2013-8#1)
college students to##2##3##(1992-7#1)(2008-12#1)
college students were##2##3##(1992-12#1)(2012-2#1)
college students##21##2##(1992-12#1)(1992-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-10#2)(2012-2#3)(2013-8#7)
college women resist sexual attacks##2##5##(2009-11#2)
college women##9##2##(2008-12#4)(2009-11#3)(2012-2#2)
college##64##1##(1990-12#2)(1991-3#1)(1992-1#3)(1992-12#1)(1992-3#1)(1992-7#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-8#1)(2008-11#9)(2008-12#5)(2008-4#1)(2008-5#3)(2009-11#3)(2009-3#1)(2009-6#1)(2010-1#2)(2010-10#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#9)
colleges in##2##2##(1992-1#1)(2008-12#1)
colleges##9##1##(1991-1#1)(1991-2#1)(1992-1#2)(2008-11#1)(2008-12#1)(2010-11#1)(2012-3#1)(2013-8#1)
collembola-biotest##3##1##(2008-11#3)
collembolans##2##1##(2008-10#2)
colletotrichum species##3##2##(2008-10#3)
colletotrichum##4##1##(2008-10#4)
colliculus##2##1##(1997-3#1)(2008-10#1)
colliding##2##1##(2008-9#2)
collimated ratemeter##2##2##(1996-2#2)
collimated##11##1##(1996-2#3)(2008-11#1)(2008-2#1)(2008-3#6)
collimating##2##1##(2008-2#1)(2008-3#1)
collimation##2##1##(1993-9#1)(2008-3#1)
collinear##7##1##(2008-10#6)(2008-3#1)
collinearity##2##1##(2008-10#1)(2008-7#1)
collision induced dissociation##2##3##(2008-10#2)
collision of##2##2##(1994-1#1)(2008-10#1)
collision rates##2##2##(2008-8#2)
collision##19##1##(1991-9#1)(1994-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-8#2)
collision-induced absorption##2##2##(2008-11#1)(2008-3#1)
collision-induced dissociation##4##2##(2008-10#3)(2011-1#1)
collision-induced##7##1##(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)
collisional deactivation of##2##3##(2008-2#2)
collisional##4##1##(1991-9#1)(2008-2#2)(2008-3#1)
collisions##10##1##(1990-12#1)(1992-8#2)(1994-2#1)(2007-12#2)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)
collocated##4##1##(2008-10#1)(2008-3#3)
colloid analysis by single particle inductively coupled plasma-mass spectrometry##2##9##(2008-10#2)
colloid analysis##3##2##(2008-10#3)
colloid cyst of the third ventricle##3##6##(2008-7#3)
colloid cyst##5##2##(2008-7#5)
colloid cysts##3##2##(2008-7#3)
colloid precipitate flotation##2##3##(2008-10#2)
colloid precipitate##3##2##(2008-10#3)
colloid resorption was##2##3##(2008-7#2)
colloid##24##1##(1990-6#1)(1994-2#1)(1997-1#1)(2008-10#10)(2008-2#1)(2008-7#10)
colloidal and particulate##2##3##(2008-10#2)
colloidal and##4##2##(2008-10#4)
colloidal chitin##2##2##(2008-10#2)
colloidal gold##4##2##(2008-10#2)(2010-6#1)(2011-2#1)
colloidal material##2##2##(2008-10#2)
colloidal particle in the plasma torch can be detected and measured##2##11##(2008-10#2)
colloidal particle##3##2##(2008-10#3)
colloidal particles##2##2##(2008-10#2)
colloidal semiconductor##3##2##(2008-10#1)(2008-8#2)
colloidal silver##2##2##(2008-10#2)
colloidal suspension##3##2##(2008-10#3)
colloidal##37##1##(1990-6#1)(1995-2#1)(1997-1#1)(2008-10#26)(2008-5#1)(2008-8#2)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)
colloidal-gold cysteamine-modified##2##2##(2008-10#2)
colloids in a single particle analysis mode##2##7##(2008-10#2)
colloids in##3##2##(2008-10#3)
colloids##12##1##(2008-10#10)(2008-2#1)(2011-2#1)
colloids)##2##1##(2008-10#2)
coloanal anastomosis##2##2##(2007-8#2)
colocalised##3##1##(1993-6#1)(1997-3#2)
colocalization of octopamine with##2##4##(1994-2#2)
colocalization of##4##2##(1994-2#2)(1997-2#1)(2011-2#1)
colocalization##8##1##(1994-2#2)(1997-2#1)(2008-11#1)(2010-5#2)(2011-2#2)
colocalized with##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
colocalized##7##1##(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2013-8#1)
colocalizes with##2##2##(1994-12#1)(1995-6#1)
colon (SW1222##2##2##(2008-11#2)
colon adenocarcinoma)##2##2##(2008-11#2)
colon and rectum##3##3##(1991-2#1)(1991-6#2)
colon and##9##2##(1991-2#1)(1991-6#2)(1994-12#1)(2008-11#1)(2008-12#2)(2010-6#1)(2012-2#1)
colon cancer cell lines##5##4##(1990-6#1)(1994-8#2)(1997-7#1)(2008-11#1)
colon cancer cell##7##3##(1990-6#1)(1993-3#1)(1994-8#2)(1997-2#1)(1997-7#1)(2008-11#1)
colon cancer cells##6##3##(1990-8#1)(1993-3#1)(1994-8#2)(2011-2#2)
colon cancer in##3##3##(1990-6#1)(1991-6#1)(2011-2#1)
colon cancer mortality rates##2##4##(1993-12#1)(2008-5#1)
colon cancer mortality##4##3##(1993-12#2)(2008-5#2)
colon cancer patients##2##3##(1992-12#1)(2012-3#1)
colon cancer##46##2##(1990-6#2)(1990-8#2)(1991-3#3)(1991-6#2)(1992-12#1)(1993-11#3)(1993-12#3)(1993-3#2)(1994-8#4)(1995-12#1)(1995-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#2)(2009-12#1)(2009-4#1)(2010-6#3)(2011-2#4)(2012-3#1)
colon cancers##2##2##(2008-1#2)
colon carcinogenesis##2##2##(1995-9#1)(2010-6#1)
colon carcinoma##5##2##(1990-8#1)(1994-8#1)(2008-11#1)(2008-9#2)
colon epithelial cells##2##3##(2010-1#2)
colon examinations##2##2##(1997-8#2)
colon lamina propria##3##3##(2008-11#3)
colon was##2##2##(2008-12#1)(2009-1#1)
colon##158##1##(1990-11#1)(1990-12#1)(1990-3#4)(1990-6#4)(1990-8#5)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#7)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#7)(1993-12#3)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-8#5)(1995-12#1)(1995-9#3)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#3)(2007-8#4)(2008-1#8)(2008-10#2)(2008-11#17)(2008-12#15)(2008-5#3)(2008-9#2)(2009-1#2)(2009-12#2)(2009-4#1)(2010-1#2)(2010-12#3)(2010-6#5)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#2)
colon/rectum##2##1##(1990-9#1)(1991-2#1)
colonial species was##2##3##(2008-8#2)
colonial##11##1##(2008-8#3)(2009-11#1)(2009-8#2)(2010-1#4)(2011-2#1)
coloniality and##2##2##(2008-9#2)
coloniality##7##1##(2008-9#7)
colonic carcinoma##2##2##(2009-1#2)
colonic cell line##2##3##(1994-3#2)
colonic diverticulitis##4##2##(2009-8#3)(2012-2#1)
colonic lipoma##2##2##(2008-10#2)
colonic mucosa##3##2##(2010-12#2)(2011-3#1)
colonic polyps and##2##3##(2009-1#1)(2012-3#1)
colonic##39##1##(1990-11#1)(1990-6#2)(1990-8#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-3#2)(1997-8#2)(2008-10#4)(2008-12#1)(2008-4#1)(2009-1#4)(2009-12#3)(2009-8#3)(2010-12#3)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#4)
colonies adjust##2##2##(2008-8#2)
colonies and##3##2##(1991-3#1)(2008-10#1)(2010-1#1)
colonies by##2##2##(2008-11#1)(2009-8#1)
colonies formed##4##2##(1995-2#1)(2008-10#2)(2008-11#1)
colonies from the##2##3##(2008-8#1)(2012-3#1)
colonies grown on##2##3##(2008-11#2)
colonies in##2##2##(2008-11#1)(2013-1#1)
colonies of the##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
colonies of##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
colonies on##5##2##(1993-12#1)(2008-10#3)(2008-11#1)
colonies per leaf##3##3##(2008-10#3)
colonies that##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
colonies was##5##2##(1997-3#1)(2008-10#4)
colonies were counted##2##3##(1994-11#1)(2008-10#1)
colonies were recovered from##2##4##(2008-10#2)
colonies were screened for their##2##5##(1990-5#1)(2012-2#1)
colonies were##11##2##(1990-5#1)(1994-11#1)(1997-8#1)(2008-10#5)(2008-8#1)(2008-9#1)(2012-2#1)
colonies##105##1##(1990-5#1)(1990-8#1)(1991-3#1)(1991-9#1)(1993-12#2)(1993-8#1)(1994-11#3)(1994-8#1)(1995-2#1)(1997-3#5)(1997-8#1)(2008-10#38)(2008-11#8)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#17)(2008-9#7)(2009-6#1)(2009-8#3)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
colonisation of the##2##3##(2006-6#1)(2008-11#1)
colonisation##4##1##(2006-6#2)(2008-11#1)(2011-2#1)
colonization and infection of##2##4##(2008-10#1)(2011-2#1)
colonization and infection##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
colonization and##16##2##(2008-10#10)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
colonization as##2##2##(2008-10#2)
colonization at##2##2##(2008-10#2)
colonization by both##3##3##(2008-10#3)
colonization by the fungus##2##4##(2008-10#2)
colonization by the##7##3##(2008-10#6)(2008-5#1)
colonization by##27##2##(2008-10#26)(2008-5#1)
colonization in the##2##3##(2008-10#2)
colonization in##10##2##(2007-12#1)(2008-10#9)
colonization is##2##2##(2008-11#1)(2008-9#1)
colonization occurred##2##2##(2008-10#2)
colonization of apple##2##3##(2008-10#2)
colonization of dead##2##3##(2008-10#2)
colonization of leaf##2##3##(2008-10#2)
colonization of leaves##2##3##(2008-10#2)
colonization of plant roots##2##4##(2008-10#2)
colonization of potato##2##3##(2008-10#2)
colonization of roots by##2##4##(2008-10#2)
colonization of roots##5##3##(2008-10#5)
colonization of the host##3##4##(2008-10#3)
colonization of the root##2##4##(2008-10#2)
colonization of the##11##3##(2008-10#10)(2011-1#1)
colonization of tomato##3##3##(2008-10#3)
colonization of wounds##2##3##(2008-10#2)
colonization of##60##2##(1991-3#1)(2008-10#55)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
colonization on the##2##3##(2008-10#1)(2008-12#1)
colonization on##5##2##(2008-10#4)(2008-12#1)
colonization probabilities##4##2##(2008-8#4)
colonization probability##2##2##(2008-8#2)
colonization strategies##3##2##(2008-10#3)
colonization was observed##2##3##(2008-10#2)
colonization was##14##2##(2008-10#13)(2009-6#1)
colonization were##4##2##(2008-10#4)
colonization when##2##2##(2008-10#2)
colonization with##3##2##(1991-3#1)(2008-10#2)
colonization##230##1##(1991-3#2)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#176)(2008-11#5)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#21)(2008-9#3)(2009-12#1)(2009-6#1)(2009-8#4)(2010-5#1)(2011-1#2)(2011-2#3)(2013-1#1)
colonizations##2##1##(2008-10#1)(2008-2#1)
colonize agronomic crops##2##3##(2008-10#2)
colonize the##6##2##(2008-10#5)(2011-1#1)
colonize##21##1##(2008-10#16)(2008-8#2)(2011-1#1)(2011-2#2)
colonized a##2##2##(2008-10#2)
colonized by S##2##3##(1991-3#2)
colonized by the pathogen##2##4##(2008-10#2)
colonized by the##6##3##(2008-10#6)
colonized by##29##2##(1991-3#3)(1995-8#1)(2008-10#25)
colonized flowers that opened##2##4##(2008-10#2)
colonized roots##2##2##(2008-10#2)
colonized senesced leaves##2##3##(2008-10#2)
colonized the host##2##3##(2008-10#2)
colonized the##10##2##(2008-10#10)
colonized##76##1##(1991-3#3)(1995-8#1)(2008-10#71)(2008-9#1)
colonizer and successor species##3##4##(2008-9#3)
colonizer##6##1##(2008-10#2)(2008-9#3)(2011-2#1)
colonizers##7##1##(2008-5#6)(2008-8#1)
colonizes##4##1##(2008-10#4)
colonizing##8##1##(2008-10#3)(2008-5#1)(2008-8#3)(2011-2#1)
colonoscopy##13##1##(1995-10#3)(2008-1#4)(2008-10#1)(2009-1#1)(2012-3#4)
colons##3##1##(2008-11#2)(2008-4#1)
colony and##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
colony counting method##3##3##(2008-10#3)
colony counts##6##2##(1996-12#1)(2008-10#3)(2008-11#1)(2013-8#1)
colony density##5##2##(2008-10#5)
colony development##2##2##(2008-10#2)
colony diameter##2##2##(2008-10#2)
colony formation assay##2##3##(1994-8#1)(2008-11#1)
colony formation of##2##3##(1990-2#2)
colony formation on##2##3##(1993-12#1)(2008-8#1)
colony formation##9##2##(1990-12#2)(1990-2#2)(1993-12#1)(1994-8#1)(2008-11#2)(2008-8#1)
colony forming ability##2##3##(2008-8#2)
colony forming units##4##3##(1996-12#1)(2008-10#2)(2008-5#1)
colony forming##7##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)
colony growth##7##2##(1993-9#1)(1994-8#1)(2008-10#4)(2008-8#1)
colony hybridization##4##2##(1996-12#1)(2008-10#3)
colony in##3##2##(2008-5#2)(2008-6#1)
colony morphologies##2##2##(2008-10#1)(2013-1#1)
colony morphology##7##2##(2008-10#5)(2008-11#1)(2013-1#1)
colony productivity##2##2##(2008-8#2)
colony size##7##2##(2008-10#2)(2008-9#5)
colony staining##2##2##(2008-10#1)(2008-11#1)
colony stimulating factor##3##3##(1991-5#1)(1992-3#1)(2008-11#1)
colony stimulating##5##2##(1991-5#1)(1992-3#1)(1995-12#2)(2008-11#1)
colony##128##1##(1990-12#2)(1990-2#2)(1990-5#1)(1991-5#1)(1992-1#3)(1992-3#1)(1993-12#1)(1993-9#1)(1994-8#2)(1995-12#2)(1995-6#2)(1996-12#4)(1996-6#1)(2008-10#46)(2008-11#13)(2008-2#3)(2008-5#4)(2008-6#6)(2008-7#1)(2008-8#11)(2008-9#10)(2009-6#1)(2009-8#1)(2010-4#1)(2012-2#1)(2012-5#2)(2013-1#2)(2013-8#3)
colony)##2##1##(1996-2#1)(2013-8#1)
colony-forming units##4##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
colony-forming##7##1##(1993-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
colony-stimulating factor (GM-CSF)##2##3##(1995-6#1)(2008-4#1)
colony-stimulating factor##13##2##(1993-11#1)(1994-12#1)(1995-6#1)(2008-11#5)(2008-4#1)(2009-7#2)(2010-6#1)(2012-3#1)
colony-stimulating##17##1##(1991-6#1)(1992-10#1)(1993-11#2)(1994-12#1)(1995-6#1)(2008-11#5)(2008-4#1)(2008-7#1)(2009-7#2)(2010-6#1)(2012-3#1)
colophony##3##1##(1997-2#3)
color Doppler##7##2##(1995-3#6)(2010-12#1)
color and granularity##2##3##(2011-2#2)
color and##9##2##(1994-12#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#2)
color are##2##2##(2008-3#1)(2009-7#1)
color change##5##2##(1996-5#1)(2008-10#2)(2008-11#1)(2010-4#1)
color charge transfer complex##3##4##(2008-10#3)
color forming##2##2##(2008-10#2)
color in the##2##3##(2008-10#2)
color in##3##2##(1994-12#1)(2008-10#2)
color intensity of the##2##4##(2008-10#2)
color intensity of##4##3##(2008-10#4)
color is##4##2##(2008-10#1)(2008-3#1)(2010-4#2)
color of##10##2##(1996-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
color or##2##2##(2008-10#1)(2009-12#1)
color parameters##2##2##(2010-4#1)(2011-2#1)
color pigment gene cluster##2##4##(1993-3#2)
color pigment gene##3##3##(1993-3#3)
color pigment##4##2##(1993-3#4)
color reaction##7##2##(2008-10#7)
color reproduction##2##2##(2008-3#2)
color##137##1##(1991-2#1)(1993-1#1)(1993-3#4)(1993-8#1)(1994-12#5)(1994-5#1)(1995-3#6)(1995-6#1)(1996-12#1)(1996-5#2)(2008-10#53)(2008-11#2)(2008-3#14)(2008-5#3)(2008-6#12)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#5)(2010-7#1)(2011-1#1)(2011-2#4)(2013-1#4)
color&quot##2##1##(2008-10#1)(2008-9#1)
color-coded##2##1##(1996-3#1)(2008-3#1)
colorants in##5##2##(2008-10#4)(2008-5#1)
colorants were##2##2##(2008-10#1)(2008-5#1)
colorants##16##1##(2008-10#11)(2008-5#5)
coloration in the##2##3##(2008-6#1)(2008-8#1)
coloration in##3##2##(2008-5#1)(2008-6#1)(2008-8#1)
coloration of##2##2##(2008-10#1)(2012-3#1)
coloration##16##1##(2008-10#3)(2008-5#2)(2008-6#3)(2008-8#4)(2012-3#4)
colorectal adenocarcinoma##4##2##(1991-12#1)(2008-11#1)(2009-12#1)(2012-12#1)
colorectal and##2##2##(1991-12#1)(2011-2#1)
colorectal cancer (CRC)##4##3##(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
colorectal cancer are##2##3##(1991-3#1)(1997-8#1)
colorectal cancer in the##3##4##(1991-3#1)(1991-6#1)(2010-6#1)
colorectal cancer patients##5##3##(1990-2#1)(1990-6#1)(1992-12#1)(1997-8#2)
colorectal cancer resistant to fluorouracil##2##5##(1990-2#2)
colorectal cancer screening##2##3##(1995-9#1)(2010-8#1)
colorectal cancer syndromes##2##3##(2009-12#2)
colorectal cancer was##2##3##(1991-6#1)(1994-2#1)
colorectal cancer##71##2##(1990-12#3)(1990-2#3)(1990-6#2)(1991-12#1)(1991-3#3)(1991-6#2)(1992-12#1)(1992-2#2)(1993-12#2)(1993-3#2)(1994-2#3)(1994-6#1)(1995-10#1)(1995-5#1)(1995-9#2)(1997-4#1)(1997-8#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-12#7)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#8)(2012-3#5)(2013-1#3)
colorectal carcinoma##8##2##(1990-2#1)(1992-12#1)(1995-12#1)(1995-6#1)(2009-12#2)(2011-2#1)(2012-12#1)
colorectal carcinomas##3##2##(1991-12#1)(1992-5#1)(1994-2#1)
colorectal endometriosis##2##2##(2013-1#2)
colorectal neoplasms##2##2##(1992-5#2)
colorectal surgery using a##2##4##(1992-9#1)(2013-1#1)
colorectal surgery##5##2##(1992-9#1)(2013-1#4)
colorectal tumors##2##2##(2008-10#1)(2008-11#1)
colorectal##119##1##(1990-12#3)(1990-2#4)(1990-6#2)(1991-12#4)(1991-3#4)(1991-6#2)(1992-12#2)(1992-2#2)(1992-5#3)(1992-9#2)(1993-12#2)(1993-3#4)(1994-2#4)(1994-6#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-9#3)(1997-4#1)(1997-8#5)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#1)(2009-12#11)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-6#4)(2010-8#1)(2011-2#10)(2012-12#2)(2012-3#7)(2013-1#10)
colored complex with##4##3##(2008-10#4)
colored complex##10##2##(2008-10#10)
colored compound##3##2##(2008-10#3)
colored microspheres##2##2##(2008-10#2)
colored species##2##2##(2008-10#2)
colored##41##1##(1990-2#1)(2008-10#34)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#3)
colorimeter##3##1##(2008-10#3)
colorimetric and##2##2##(2008-10#2)
colorimetric assay##6##2##(1991-12#1)(2008-10#2)(2008-11#2)(2009-12#1)
colorimetric detection of##3##3##(1992-9#1)(2008-10#2)
colorimetric detection##8##2##(1992-9#1)(1997-8#1)(2008-10#6)
colorimetric determination of##4##3##(2008-10#4)
colorimetric determination##7##2##(2008-10#7)
colorimetric flow##3##2##(2008-10#3)
colorimetric method and##2##3##(2008-10#2)
colorimetric method for the##2##4##(1992-12#1)(2008-10#1)
colorimetric method for##3##3##(1992-12#1)(2008-10#2)
colorimetric method using##2##3##(2008-10#2)
colorimetric method##19##2##(1992-12#1)(1994-3#2)(2008-10#14)(2009-8#1)(2011-3#1)
colorimetric methods##2##2##(2008-10#1)(2008-5#1)
colorimetric reaction##3##2##(2008-10#2)(2008-12#1)
colorimetric reagent##5##2##(2008-10#5)
colorimetric##78##1##(1991-12#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-3#3)(1997-8#1)(2008-10#57)(2008-11#3)(2008-12#1)(2008-5#4)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-3#1)
colorimetrically##2##1##(2008-10#2)
colorimetry##10##1##(2008-10#9)(2008-5#1)
coloring reagents##2##2##(2008-10#2)
coloring##5##1##(2008-10#2)(2008-5#3)
colorless##11##1##(2008-10#7)(2008-11#1)(2008-5#1)(2009-10#2)
colors##13##1##(2008-3#1)(2008-6#4)(2008-8#1)(2008-9#3)(2009-10#1)(2012-2#3)
colostomy##2##1##(1993-6#1)(2013-8#1)
colostrum##6##1##(1991-11#1)(2012-2#5)
colour and##3##2##(2008-10#2)(2012-2#1)
colour bleaching of methylene blue (MB) in##2##7##(2008-10#2)
colour bleaching##3##2##(2008-10#3)
colour change##2##2##(2008-10#2)
colour developed##2##2##(1990-12#1)(2008-5#1)
colour development##2##2##(2008-10#2)
colour intensity of the##2##4##(2008-10#2)
colour intensity of##3##3##(2008-10#3)
colour intensity##4##2##(2008-10#4)
colour of the solution##2##4##(2008-10#2)
colour of the##6##3##(2008-10#5)(2010-4#1)
colour of##9##2##(2008-10#6)(2008-5#1)(2010-4#1)(2013-1#1)
colour on##2##2##(1990-9#1)(2008-10#1)
colour reaction##3##2##(2008-10#3)
colour reactions##2##2##(2008-10#2)
colour systems##2##2##(2008-10#2)
colour was measured##2##3##(2008-10#1)(2008-5#1)
colour was##3##2##(2008-10#2)(2008-5#1)
colour##79##1##(1990-12#3)(1990-9#1)(1991-6#1)(1992-5#1)(2008-10#40)(2008-12#1)(2008-5#17)(2008-7#2)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#3)
colour-coded IR imaging##2##3##(2008-7#2)
colour-coded##3##1##(1996-3#1)(2008-7#2)
coloured complex formed##2##3##(2008-10#2)
coloured complex##6##2##(2008-10#6)
coloured hair##4##2##(2008-5#3)(2011-1#1)
coloured product##2##2##(2008-10#2)
coloured products##3##2##(2008-10#2)(2011-1#1)
coloured##38##1##(1991-6#1)(1993-8#1)(1996-6#1)(2008-10#27)(2008-5#5)(2011-1#3)
colourimetric##3##1##(2008-10#3)
colouring##3##1##(2008-10#1)(2008-5#2)
colourless##5##1##(2008-10#4)(2011-2#1)
colours##9##1##(1993-8#1)(2008-10#2)(2008-5#5)(2011-1#1)
colposcopic##4##1##(1991-1#1)(1992-3#1)(2008-4#1)(2012-3#1)
colposcopy directed biopsy##4##3##(2008-11#4)
colposcopy directed cytology and##2##4##(2008-11#2)
colposcopy directed cytology##3##3##(2008-11#3)
colposcopy directed##8##2##(2008-11#8)
colposcopy##17##1##(1990-6#1)(1992-3#3)(1994-1#1)(1994-2#1)(2008-11#10)(2012-3#1)
colposuspension##2##1##(1994-3#2)
columbia##4##1##(2008-10#1)(2009-3#2)(2013-1#1)
columella##3##1##(2008-10#1)(2008-11#1)(2009-8#1)
column (150mm x##2##3##(2008-10#2)
column (250 mm##2##3##(1997-2#1)(2008-10#1)
column and a mobile phase of##3##6##(2008-10#3)
column and a##8##3##(2008-10#8)
column and an##2##3##(2008-10#2)
column and detected##2##3##(2008-10#2)
column and determined##6##3##(2008-10#6)
column and subsequently##2##3##(2008-10#2)
column and##42##2##(1992-9#1)(1993-11#1)(2008-10#34)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#2)
column are##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
column as a stationary phase##2##5##(2008-10#2)
column as##4##2##(2008-10#3)(2008-11#1)
column at##2##2##(2008-10#2)
column before##2##2##(2008-10#2)
column by##4##2##(1995-11#1)(2008-10#3)
column capacity##2##2##(2008-10#2)
column chromatographies##2##2##(1990-11#1)(1992-8#1)
column chromatography and##3##3##(2008-8#1)(2011-3#1)(2012-2#1)
column chromatography on##2##3##(2008-8#1)(2009-6#1)
column chromatography using##2##3##(2008-10#1)(2008-11#1)
column chromatography##21##2##(1990-11#1)(1991-12#1)(1996-5#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-2#1)
column coated with##3##3##(2008-10#2)(2008-5#1)
column conditioning##2##2##(2008-10#2)
column containing##6##2##(2008-10#6)
column could be used##2##4##(2008-10#2)
column could be##4##3##(2008-10#4)
column could##6##2##(2008-10#6)
column filled with Amberlite##2##4##(2008-10#2)
column filled with##3##3##(2008-10#3)
column filled##4##2##(2008-10#4)
column followed by##3##3##(1990-2#1)(1992-12#1)(2008-10#1)
column for separation and##2##4##(2008-10#2)
column for the##4##3##(2008-10#4)
column for##10##2##(2008-10#9)(2011-2#1)
column from##2##2##(2008-10#1)(2008-3#1)
column has been developed##2##4##(2008-10#2)
column has##3##2##(2008-10#3)
column in patients with##2##4##(2008-7#1)(2011-2#1)
column in the##2##3##(2008-10#2)
column in##8##2##(2008-10#6)(2008-7#1)(2011-2#1)
column is##13##2##(2008-10#6)(2008-11#1)(2008-3#5)(2009-9#1)
column length##4##2##(2008-10#4)
column lengthening##4##2##(2009-10#4)
column maintained at##2##3##(2008-10#2)
column material was##2##3##(2008-10#2)
column material##4##2##(2008-10#4)
column method and##2##3##(2008-10#2)
column method##8##2##(2008-10#8)
column of##8##2##(2008-10#7)(2008-4#1)
column operation##5##2##(2008-10#5)
column or##2##2##(2008-10#2)
column packed with 0##2##4##(2008-10#2)
column packed with a##2##4##(2008-10#2)
column packed with iminodiacetate resin##2##5##(2008-10#2)
column packed with##17##3##(2008-10#15)(2008-11#1)(2008-7#1)
column placed##2##2##(2008-10#2)
column preconcentration and##2##3##(2008-10#2)
column preconcentration of##2##3##(2008-10#2)
column preconcentration##8##2##(2008-10#8)
column prior to##3##3##(1997-2#1)(2008-10#2)
column recovery##2##2##(2008-10#2)
column separation and preconcentration##2##4##(2008-10#2)
column separation##3##2##(2008-10#3)
column stationary phase##2##3##(2008-10#2)
column supercritical fluid chromatographic##2##4##(2008-10#2)
column supercritical fluid##8##3##(2008-10#8)
column switching##3##2##(1992-11#1)(2008-10#2)
column system for##2##3##(2008-10#2)
column system using##2##3##(1990-11#1)(2008-10#1)
column system was##3##3##(2008-10#3)
column system##9##2##(1990-11#1)(2008-10#8)
column technique##5##2##(2008-10#5)
column techniques##4##2##(2008-10#4)
column temperature##12##2##(2008-10#12)
column to##5##2##(2008-10#4)(2008-11#1)
column used##2##2##(2008-10#2)
column using a mixture of 0##2##6##(2008-10#2)
column using a##4##3##(2008-10#4)
column using anti-solamargine monoclonal antibody##2##5##(2008-11#2)
column using##13##2##(2008-10#10)(2008-11#3)
column was able to##2##4##(2008-10#2)
column was used##2##3##(2008-10#2)
column was##26##2##(1992-6#1)(2008-10#24)(2008-11#1)
column were##3##2##(2008-10#3)
column where##2##2##(2008-10#2)
column which is##2##3##(2008-10#1)(2008-5#1)
column which##3##2##(2008-10#2)(2008-5#1)
column with 0##4##3##(1990-12#1)(2008-10#3)
column with a gradient##2##4##(2008-10#2)
column with a mobile phase##3##5##(2008-10#3)
column with a##8##3##(2008-10#8)
column with gradient elution##3##4##(2008-10#3)
column with the mobile phase##2##5##(2008-10#1)(2011-3#1)
column with##34##2##(1990-12#1)(1991-11#1)(2008-10#29)(2008-11#1)(2008-9#1)(2011-3#1)
column##606##1##(1990-11#3)(1990-12#2)(1990-2#2)(1991-11#1)(1991-12#2)(1991-5#2)(1991-7#2)(1991-8#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1996-5#1)(1997-2#8)(2008-10#467)(2008-11#17)(2008-12#2)(2008-2#1)(2008-3#18)(2008-4#5)(2008-5#8)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#4)(2009-6#1)(2009-8#4)(2009-9#1)(2010-4#1)(2011-2#8)(2011-3#3)(2012-2#3)(2013-1#2)
column)##2##1##(2008-10#2)
column-FIA system##2##2##(2008-10#2)
column-switching technique##2##2##(1992-11#2)
column-switching techniques##2##2##(1992-11#1)(2008-10#1)
column-switching##8##1##(1992-11#3)(2008-10#5)
columnar and layered##2##3##(2007-12#2)
columnar and##3##2##(2007-12#3)
columnar liquid##2##2##(2008-7#2)
columnar##16##1##(1990-6#1)(1991-2#2)(2007-12#3)(2008-2#1)(2008-3#2)(2008-7#4)(2008-8#1)(2009-10#1)(2010-4#1)
columnare##7##1##(2008-9#3)(2013-1#4)
columns and##6##2##(1990-11#1)(1997-2#1)(2008-10#3)(2008-3#1)
columns are##2##2##(2008-11#1)(2008-3#1)
columns at##2##2##(1992-6#1)(2008-10#1)
columns for the##2##3##(1997-2#1)(2008-10#1)
columns for##7##2##(1997-2#2)(2008-10#4)(2008-3#1)
columns has been##3##3##(2008-10#2)(2008-11#1)
columns have##2##2##(2008-10#2)
columns in##5##2##(2008-10#1)(2008-11#4)
columns is##2##2##(1997-2#1)(2008-10#1)
columns may##2##2##(2008-11#2)
columns of##3##2##(1994-1#1)(2008-10#1)(2008-3#1)
columns packed with##2##3##(2008-10#2)
columns to##2##2##(2008-10#1)(2008-3#1)
columns were tested and similar##2##5##(2008-10#2)
columns were tested##3##3##(2008-10#3)
columns were##7##2##(2008-10#7)
columns with##6##2##(1996-2#1)(2008-10#3)(2008-3#2)
columns##113##1##(1990-11#1)(1991-5#1)(1992-6#2)(1992-7#1)(1994-1#1)(1994-11#1)(1995-3#1)(1996-2#1)(1997-2#4)(1997-3#2)(2008-10#74)(2008-11#9)(2008-3#10)(2008-4#3)(2011-2#1)(2013-1#1)
colymycin M and##2##3##(2008-10#2)
com##4##1##(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
com)##2##1##(2010-7#1)(2011-2#1)
com/locate/withdrawalpolicy)##6##1##(2008-10#3)(2008-11#3)
coma##13##1##(1991-11#1)(1991-12#1)(2008-11#1)(2008-3#1)(2008-7#4)(2009-8#2)(2011-1#1)(2012-12#1)(2013-1#1)
coma)##2##1##(1997-2#2)
comatose##2##1##(2008-7#2)
comb##4##1##(2008-3#2)(2011-2#1)(2012-3#1)
combability and##2##2##(2008-5#2)
combat##27##1##(1990-11#1)(1991-2#1)(1991-6#1)(1994-2#1)(1994-3#1)(1996-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#4)(2012-2#5)(2013-1#3)
combi 40+##2##2##(2008-9#2)
combi##4##1##(2008-9#4)
combination antifungal therapy##2##3##(2011-2#2)
combination between##2##2##(2008-7#1)(2008-9#1)
combination chemotherapy in##3##3##(1992-12#2)(1993-2#1)
combination chemotherapy##8##2##(1991-6#2)(1992-12#2)(1993-2#1)(1993-8#1)(1997-7#1)(2008-10#1)
combination for the##3##3##(1997-2#1)(2008-10#1)(2009-12#1)
combination for##5##2##(1996-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
combination has##4##2##(1995-5#1)(2008-4#1)(2009-10#1)(2010-2#1)
combination in the##2##3##(2008-10#1)(2009-8#1)
combination in##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2009-8#1)
combination is##3##2##(1995-5#1)(2008-3#1)(2011-1#1)
combination may##2##2##(2008-8#1)(2011-2#1)
combination of DTPA and BHT showed##2##6##(2008-5#2)
combination of DTPA and BHT##3##5##(2008-5#3)
combination of Nep1 and P##3##5##(2008-10#3)
combination of V(H)-gp130 and##2##4##(2008-11#2)
combination of a##13##3##(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-3#1)
combination of agents##2##3##(2011-2#2)
combination of all##2##3##(2011-2#1)(2013-8#1)
combination of an##3##3##(2008-10#1)(2008-5#1)(2011-10#1)
combination of attenuated total##2##4##(2008-10#1)(2008-5#1)
combination of both methods##2##4##(2008-10#1)(2011-2#1)
combination of both##9##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
combination of diverse##2##3##(2008-10#1)(2010-6#1)
combination of flow injection##3##4##(2008-10#3)
combination of functional##2##3##(2012-2#2)
combination of heparin##2##3##(2008-10#1)(2011-2#1)
combination of high heritability and low reproductive success##2##8##(2012-3#2)
combination of high##4##3##(2008-10#1)(2008-12#1)(2012-3#2)
combination of low pH and QCT##2##6##(1994-8#2)
combination of low pH and##3##5##(1994-8#3)
combination of nurses##2##3##(2008-11#2)
combination of on-line##2##3##(2008-10#2)
combination of recombinant##2##3##(1991-9#1)(1995-2#1)
combination of reverse transcription##2##4##(1995-12#1)(2008-10#1)
combination of several##2##3##(1991-5#1)(2011-2#1)
combination of such##2##3##(1991-12#1)(2008-10#1)
combination of techniques##2##3##(2008-10#1)(2008-12#1)
combination of the two##4##4##(1996-3#1)(2008-7#1)(2012-5#1)(2012-6#1)
combination of the##37##3##(1992-3#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#1)(2013-8#2)
combination of these techniques##2##4##(2008-9#1)(2010-11#1)
combination of these##11##3##(1990-8#1)(1991-6#1)(1992-12#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-11#1)
combination of these)##2##3##(1991-8#1)(2010-8#1)
combination of three##3##3##(2008-10#3)
combination of two##7##3##(2008-10#4)(2008-2#1)(2008-4#1)(2012-3#1)
combination of unique##2##3##(2008-10#1)(2010-5#1)
combination of##387##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-6#1)(1993-8#3)(1994-3#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-7#1)(1997-8#4)(1997-9#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#112)(2008-11#22)(2008-12#5)(2008-2#3)(2008-3#12)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#15)(2008-8#13)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#7)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#20)(2011-3#3)(2012-12#1)(2012-2#5)(2012-3#10)(2012-5#1)(2012-6#1)(2012-9#1)(2013-1#7)(2013-8#8)
combination pharmacological##2##2##(2013-1#2)
combination products##2##2##(1995-5#2)
combination regimens##3##2##(2008-6#1)(2011-2#2)
combination therapy in pulmonary arterial hypertension##2##6##(2010-10#2)
combination therapy in##3##3##(2010-10#3)
combination therapy may be##2##4##(1997-7#1)(2010-10#1)
combination therapy with##3##3##(2011-2#2)(2013-1#1)
combination therapy##19##2##(1996-11#1)(1997-5#2)(1997-7#1)(2008-10#2)(2010-10#6)(2010-11#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
combination treatment##2##2##(1997-5#1)(2013-1#1)
combination vaccine##3##2##(1995-5#3)
combination vaccines##9##2##(1995-5#9)
combination was##6##2##(2008-10#3)(2009-8#1)(2010-12#1)(2012-2#1)
combination with a##21##3##(1994-5#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
combination with conventional##2##3##(2008-3#1)(2011-2#1)
combination with high##2##3##(2008-10#1)(2008-9#1)
combination with other##5##3##(1994-9#1)(1995-2#1)(1996-9#1)(2008-11#1)(2008-3#1)
combination with the##15##3##(1990-8#1)(1992-1#1)(1994-2#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)
combination with##149##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(2006-6#1)(2008-10#50)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#6)(2009-3#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#6)(2013-8#3)
combination would##2##2##(2008-10#1)(2010-12#1)
combination##713##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#3)(1990-8#4)(1990-9#3)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#6)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#4)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#6)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#2)(1995-11#5)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#23)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#3)(1997-7#4)(1997-8#4)(1997-9#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#198)(2008-11#37)(2008-12#10)(2008-2#4)(2008-3#19)(2008-4#6)(2008-5#19)(2008-6#2)(2008-7#21)(2008-8#21)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-6#2)(2009-7#2)(2009-8#9)(2009-9#1)(2010-1#4)(2010-10#9)(2010-11#9)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#40)(2011-3#5)(2012-12#1)(2012-2#11)(2012-3#17)(2012-5#2)(2012-6#2)(2012-7#2)(2012-9#2)(2013-1#24)(2013-8#11)
combination)##2##1##(2011-2#1)(2012-3#1)
combinations among the##2##3##(2008-10#1)(2008-9#1)
combinations among##3##2##(2008-10#2)(2008-9#1)
combinations and##6##2##(2008-10#3)(2008-12#1)(2009-12#1)(2011-2#1)
combinations by##2##2##(2008-10#1)(2008-11#1)
combinations containing##2##2##(2008-10#2)
combinations in the##2##3##(2008-10#1)(2008-12#1)
combinations in##5##2##(1991-1#1)(2008-10#3)(2008-12#1)
combinations of four##2##3##(2008-10#2)
combinations of genes##2##3##(1997-7#1)(2008-8#1)
combinations of parameters##2##3##(2008-8#1)(2008-9#1)
combinations of temperature##3##3##(2008-10#2)(2012-4#1)
combinations of the original##2##4##(2008-10#2)
combinations of the##12##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
combinations of these##6##3##(1993-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
combinations of treatments##2##3##(2008-10#1)(2009-8#1)
combinations of two##2##3##(2008-10#2)
combinations of##92##2##(1991-5#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1996-12#2)(1996-2#2)(1997-7#1)(2008-10#30)(2008-11#3)(2008-12#2)(2008-3#5)(2008-5#4)(2008-8#8)(2008-9#9)(2009-12#1)(2009-8#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#3)
combinations on##2##2##(2008-12#1)(2012-3#1)
combinations that##3##2##(2008-10#2)(2012-3#1)
combinations was##2##2##(2008-10#1)(2008-8#1)
combinations were##3##2##(2008-10#3)
combinations with##3##2##(1993-11#1)(2008-10#1)(2008-4#1)
combinations##192##1##(1991-1#1)(1991-5#1)(1993-1#1)(1993-11#3)(1993-8#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#4)(1996-3#1)(1997-1#1)(1997-7#2)(2008-10#79)(2008-11#9)(2008-12#5)(2008-3#7)(2008-4#2)(2008-5#5)(2008-8#12)(2008-9#12)(2009-12#2)(2009-8#3)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#4)(2012-3#5)(2012-4#1)(2013-1#6)(2013-8#3)
combinations)##2##1##(2008-10#2)
combinatorial chemistry##3##2##(1997-7#1)(2008-10#1)(2008-4#1)
combinatorial interactions##2##2##(1996-3#1)(2009-12#1)
combinatorial libraries##2##2##(2008-4#2)
combinatorial library##2##2##(2008-4#1)(2011-2#1)
combinatorial phage display##2##3##(2008-4#1)(2012-2#1)
combinatorial##28##1##(1996-3#1)(1997-7#1)(1997-9#1)(2008-1#2)(2008-10#3)(2008-4#6)(2008-7#1)(2009-10#1)(2009-12#2)(2009-8#1)(2010-4#1)(2011-2#5)(2012-2#1)(2013-1#2)
combinatorially##2##1##(1991-9#1)(2009-6#1)
combine a##3##2##(1995-5#1)(2008-3#1)(2012-12#1)
combine high##2##2##(2008-10#2)
combine the advantages of##2##4##(2008-8#1)(2013-1#1)
combine the##7##2##(1995-5#1)(2008-10#2)(2008-11#1)(2008-8#2)(2013-1#1)
combine their##2##2##(1993-2#1)(2011-1#1)
combine this##2##2##(2010-4#1)(2013-1#1)
combine to##2##2##(1997-3#1)(2012-2#1)
combine##39##1##(1993-11#1)(1993-2#1)(1995-3#1)(1995-5#3)(1996-3#1)(1996-6#2)(1997-3#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-1#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
combined 24-hr##2##2##(1996-3#2)
combined action of##3##3##(2008-10#2)(2008-11#1)
combined activity##2##2##(1995-12#1)(2008-10#1)
combined administration of##3##3##(1996-2#1)(1997-4#1)(2011-2#1)
combined aerobic and resistance##2##4##(2013-1#2)
combined and##6##2##(1991-6#1)(2008-10#4)(2012-3#1)
combined anesthesia##4##2##(2012-3#4)
combined anterior/posterior surgical approach##2##4##(2012-3#2)
combined application of##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
combined approach##5##2##(1990-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
combined chemometric##2##2##(2008-10#2)
combined compression algorithm##2##3##(2013-8#2)
combined data set##5##3##(2008-10#4)(2008-11#1)
combined data##10##2##(2008-10#8)(2008-11#1)(2010-4#1)
combined effects of##8##3##(1990-5#1)(2008-10#6)(2008-11#1)
combined efficacy of##2##3##(2008-4#1)(2013-8#1)
combined endpoint##2##2##(1992-9#2)
combined exercise training group##2##4##(2013-1#2)
combined exercise##3##2##(2013-1#2)(2013-8#1)
combined exposure##3##2##(1993-8#3)
combined for##3##2##(2008-10#2)(2008-9#1)
combined gemcitabine##2##2##(2008-10#2)
combined in a##2##3##(2008-10#1)(2008-3#1)
combined in the##3##3##(2008-10#2)(2008-3#1)
combined in##10##2##(1992-9#1)(2008-10#5)(2008-12#1)(2008-3#2)(2009-3#1)
combined influence of##2##3##(2008-10#1)(2010-1#1)
combined lateral##2##2##(2011-2#2)
combined measurements##2##2##(2008-3#1)(2008-6#1)
combined method of##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
combined method##4##2##(2008-10#1)(2012-3#1)(2013-1#2)
combined molecular##2##2##(2008-10#1)(2012-3#1)
combined phase##2##2##(1991-3#1)(2012-2#1)
combined procedure##4##2##(2008-10#1)(2008-11#2)(2009-8#1)
combined program##2##2##(1995-3#1)(1996-12#1)
combined results##4##2##(1992-3#1)(1995-11#1)(2008-10#1)(2011-2#1)
combined serotonin/norepinephrine reuptake inhibitor##2##4##(2008-4#2)
combined species densities##3##3##(2008-8#3)
combined supra- and infratentorial##3##4##(2008-7#3)
combined surgery and##2##3##(2008-11#1)(2013-1#1)
combined the advantages of##2##4##(2008-10#2)
combined the use of##3##4##(2008-10#3)
combined the##12##2##(2008-10#8)(2008-8#1)(2012-3#2)(2013-1#1)
combined to##8##2##(1994-11#1)(2007-11#1)(2008-10#4)(2008-8#1)(2009-11#1)
combined training##3##2##(2013-8#3)
combined treatment for##2##3##(1996-3#1)(2007-8#1)
combined treatment of##2##3##(2008-5#1)(2013-1#1)
combined treatment with##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
combined treatment##13##2##(1992-3#1)(1996-3#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-6#3)(2013-1#2)
combined use of##10##3##(1993-2#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
combined use##11##2##(1993-2#1)(1997-7#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
combined vaccine##2##2##(1995-5#2)
combined vaccines##3##2##(1995-5#3)
combined with HPLC##2##3##(2008-10#1)(2008-8#1)
combined with a##25##3##(1990-11#1)(1992-3#1)(1995-12#1)(2008-10#9)(2008-3#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-2#1)
combined with an##3##3##(2008-10#3)
combined with atomic##2##3##(2008-10#2)
combined with corticosteroid##2##3##(2008-1#2)
combined with each other##2##4##(2010-4#1)(2013-1#1)
combined with electrothermal##2##3##(2008-10#2)
combined with flow injection analysis##2##5##(2008-10#2)
combined with flow-injection##3##3##(2008-10#3)
combined with gas##2##3##(2008-10#2)
combined with good##2##3##(1993-2#1)(2008-10#1)
combined with inductively coupled plasma mass spectrometry##2##7##(2008-10#2)
combined with ion##2##3##(2008-10#1)(2008-11#1)
combined with other##6##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-6#1)(2011-2#1)
combined with radiotherapy##2##3##(1997-3#1)(2012-3#1)
combined with solid-phase extraction##2##4##(2008-10#2)
combined with solid-phase##4##3##(2008-10#4)
combined with tandem##2##3##(2008-10#1)(2011-3#1)
combined with the presence of##2##5##(1995-2#1)(2008-10#1)
combined with the sensitivity of##2##5##(2008-10#2)
combined with the##34##3##(1994-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-1#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
combined with tissue plasminogen activator##2##5##(2008-7#2)
combined with various##2##3##(2008-10#2)
combined with##228##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#2)(1997-3#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#97)(2008-11#6)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#7)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-2#4)(2012-3#7)(2012-7#1)(2013-1#7)(2013-2#1)(2013-8#6)
combined##587##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-5#1)(1992-9#5)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#8)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#5)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#3)(2008-10#201)(2008-11#22)(2008-12#6)(2008-2#5)(2008-3#13)(2008-4#7)(2008-5#5)(2008-6#5)(2008-7#11)(2008-8#14)(2008-9#18)(2009-11#2)(2009-12#3)(2009-3#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#4)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#23)(2011-3#3)(2012-12#3)(2012-2#12)(2012-3#28)(2012-6#4)(2012-7#1)(2013-1#29)(2013-2#2)(2013-7#1)(2013-8#18)
combined&quot##2##1##(2008-10#2)
combines a##6##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-6#1)
combines an##3##2##(2008-10#2)(2008-2#1)
combines both##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
combines the##11##2##(1993-3#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
combines with##2##2##(2008-10#2)
combines##58##1##(1991-5#1)(1992-11#1)(1993-2#1)(1993-3#1)(2007-12#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#4)(2009-12#1)(2009-5#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
combing force measurements##2##3##(2008-5#2)
combing##7##1##(2008-5#3)(2008-6#1)(2008-9#3)
combining a##5##2##(2007-12#1)(2008-10#4)
combining ability##2##2##(2008-10#2)
combining biocontrol##2##2##(2008-10#2)
combining both##3##2##(1997-6#1)(2008-3#1)(2009-9#1)
combining data##2##2##(2008-11#1)(2011-2#1)
combining different##2##2##(1997-6#1)(2012-3#1)
combining mindfulness##2##2##(2013-1#2)
combining of##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
combining several##2##2##(1992-1#1)(2008-2#1)
combining the two##2##3##(2008-10#1)(2010-11#1)
combining the##14##2##(1995-2#1)(1995-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-11#1)(2012-2#2)
combining them##2##2##(2008-10#1)(2012-2#1)
combining these##2##2##(2008-7#1)(2012-2#1)
combining with##3##2##(2008-10#2)(2008-9#1)
combining##100##1##(1990-3#1)(1990-5#1)(1992-1#1)(1993-1#1)(1993-2#1)(1994-2#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-6#2)(2007-12#1)(2008-10#37)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#7)
combustion diagnostics##2##2##(2008-3#2)
combustion gases##2##2##(1996-12#2)
combustion method##2##2##(2008-10#2)
combustion of the sample##2##4##(2008-10#2)
combustion of##5##2##(2008-10#4)(2008-11#1)
combustion products are##2##3##(1996-12#2)
combustion products##5##2##(1996-12#5)
combustion to##2##2##(2008-10#1)(2008-11#1)
combustion##53##1##(1996-12#15)(2008-10#17)(2008-11#5)(2008-2#4)(2008-3#11)(2010-7#1)
come a long way##3##4##(1991-1#1)(2008-10#1)(2009-10#1)
come a##4##2##(1991-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
come back##2##2##(1993-2#1)(2010-9#1)
come from the##3##3##(2007-12#1)(2008-10#2)
come from##18##2##(1993-12#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
come in##3##2##(1995-11#1)(2010-8#1)(2012-12#1)
come into contact with##2##4##(1997-2#1)(2008-10#1)
come into##7##2##(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)
come of##2##2##(1992-1#1)(2008-11#1)
come to a##3##3##(1993-6#1)(1997-5#1)(2012-2#1)
come to the##3##3##(1992-5#1)(1995-6#1)(2012-2#1)
come to##22##2##(1991-1#1)(1992-5#1)(1993-1#1)(1993-6#1)(1995-1#1)(1995-11#1)(1995-6#2)(1997-5#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-10#1)(2012-2#3)
come together##2##2##(2009-10#1)(2010-11#1)
come with##2##2##(1991-12#1)(2008-10#1)
come##89##1##(1991-1#3)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-11#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#9)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
comes a##2##2##(2008-3#1)(2008-9#1)
comes from and##2##3##(2008-10#1)(2011-2#1)
comes from the##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
comes from##11##2##(1991-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
comes in contact with the##2##5##(2008-10#2)
comes in##4##2##(1995-2#1)(2008-10#2)(2009-9#1)
comes the##2##2##(1997-3#1)(2009-12#1)
comes to the##2##3##(1995-2#1)(1996-3#1)
comes to##7##2##(1991-3#1)(1994-12#1)(1995-2#1)(1996-3#2)(1996-9#1)(1997-6#1)
comes##33##1##(1991-12#1)(1991-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2011-2#1)
comet Shoemaker-Levy 9##2##3##(1995-6#2)
comet##18##1##(1995-6#2)(2008-10#4)(2010-5#4)(2010-8#7)(2013-1#1)
comfort in##5##2##(1996-9#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
comfort level##2##2##(1995-1#1)(2008-9#1)
comfort##21##1##(1995-1#1)(1996-9#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#5)(2013-8#1)
comfortable with##5##2##(1995-2#1)(1996-5#1)(1997-2#1)(2011-2#2)
comfortable##18##1##(1991-2#1)(1992-2#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-9#5)(2009-5#1)(2011-2#4)(2013-1#1)
comigrated with the single P##2##5##(2008-10#2)
comigrated with##4##2##(1992-12#1)(2008-10#3)
comigrated##5##1##(1992-12#1)(1995-6#1)(2008-10#3)
comigrating##2##1##(2008-10#2)
coming from different##2##3##(1990-3#1)(2008-10#1)
coming from the same##2##4##(2013-1#2)
coming from the##9##3##(1994-3#1)(2008-10#4)(2009-10#1)(2012-3#1)(2013-1#2)
coming from##20##2##(1990-3#1)(1992-3#1)(1994-3#1)(1996-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#2)
coming into contact with##2##4##(1995-2#1)(2010-1#1)
coming of age##2##3##(2008-12#1)(2010-5#1)
coming of##3##2##(2008-12#1)(2010-1#1)(2010-5#1)
coming to##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
coming years##2##2##(1996-1#1)(2012-3#1)
coming##42##1##(1990-3#1)(1991-3#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-1#4)(1997-8#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-1#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
commandments of##2##2##(1995-3#1)(2009-9#1)
commandments##4##1##(1995-3#1)(2008-12#2)(2009-9#1)
commands##3##1##(2011-1#1)(2011-2#2)
comme##3##1##(2008-11#1)(2008-5#1)(2013-1#1)
commence##3##1##(1992-9#1)(1994-9#1)(2008-11#1)
commenced##9##1##(1990-9#1)(1991-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
commencement of##3##2##(2008-6#1)(2008-7#1)(2009-6#1)
commences##2##1##(2008-7#1)(2012-2#1)
commencing##3##1##(1991-11#1)(1996-12#1)(2008-11#1)
commensal##11##1##(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#4)
commensals##2##1##(2011-2#2)
commensurate with##2##2##(2008-10#1)(2011-2#1)
commensurate##4##1##(1994-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
comment on the##4##3##(1993-12#1)(1995-3#1)(2008-3#1)(2008-5#1)
comment on##10##2##(1991-12#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-9#1)
comment##33##1##(1991-12#1)(1993-12#1)(1993-3#1)(1995-3#2)(1996-2#1)(2008-1#1)(2008-11#12)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-7#1)(2010-9#1)(2012-3#1)(2013-8#3)
commentary calls for##2##3##(1996-12#1)(2008-11#1)
commentary discusses the##2##3##(2008-10#1)(2013-1#1)
commentary discusses##3##2##(1996-2#1)(2008-10#1)(2013-1#1)
commentary on##2##2##(2008-6#1)(2008-9#1)
commentary##28##1##(1992-3#1)(1994-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-5#1)(2012-2#2)(2013-1#2)
commented##5##1##(1991-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
comments about##2##2##(1992-3#1)(2008-10#1)
comments on the##4##3##(1994-6#1)(1996-1#1)(1996-12#1)(1996-6#1)
comments on##12##2##(1994-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#2)(2012-3#1)
comments##24##1##(1991-3#1)(1992-11#1)(1992-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
commercial Calimyrna##2##2##(2008-10#2)
commercial TxD##2##2##(2008-10#2)
commercial agriculture##2##2##(2008-10#2)
commercial and##6##2##(1991-12#1)(2008-10#3)(2008-11#2)
commercial apple orchard##2##3##(2008-10#2)
commercial applications##2##2##(2008-3#1)(2011-2#1)
commercial citrus plantings##3##3##(2008-10#3)
commercial citrus##4##2##(2008-10#4)
commercial cosmetics##2##2##(2008-5#2)
commercial cultivars##3##2##(2008-10#3)
commercial devices##5##2##(2008-10#5)
commercial drinking##4##2##(2008-10#4)
commercial fields in##3##3##(2008-10#3)
commercial fields##7##2##(2008-10#7)
commercial formulations of##2##3##(2008-10#2)
commercial formulations using##2##3##(2008-10#2)
commercial formulations##13##2##(2008-10#13)
commercial fruit juices##2##3##(2008-10#2)
commercial glucose##2##2##(2008-10#2)
commercial greenhouse##3##2##(2008-10#3)
commercial greenhouses##4##2##(2008-10#4)
commercial harvest##3##2##(2008-10#2)(2011-2#1)
commercial herbal shampoos##3##3##(2008-5#3)
commercial honey samples##3##3##(2008-10#3)
commercial hybrid##2##2##(2008-10#1)(2008-8#1)
commercial hybrids##2##2##(2008-10#2)
commercial image analysis system##2##4##(2008-10#2)
commercial jet##2##2##(1995-3#2)
commercial kit##2##2##(2008-10#2)
commercial lettuce##2##2##(2008-10#2)
commercial mineral waters##2##3##(2008-10#2)
commercial or##3##2##(2008-10#1)(2008-4#2)
commercial orchards##4##2##(2008-10#4)
commercial pharmaceutical preparations##4##3##(2008-10#4)
commercial pharmaceutical products##2##3##(2008-10#2)
commercial pharmaceutical##8##2##(2008-10#8)
commercial pharmaceuticals##2##2##(2008-10#2)
commercial pistachio orchards in##2##4##(2008-10#2)
commercial pistachio orchards##3##3##(2008-10#3)
commercial plant activators##2##3##(2008-10#2)
commercial potato fields in##2##4##(2008-10#2)
commercial potato##5##2##(2008-10#5)
commercial product##2##2##(2008-10#2)
commercial production of##3##3##(2008-10#2)(2008-11#1)
commercial production##4##2##(2008-10#3)(2008-11#1)
commercial products##7##2##(2008-10#5)(2011-1#1)(2012-2#1)
commercial reagents##2##2##(2008-10#2)
commercial sample##2##2##(2008-10#2)
commercial samples of##4##3##(2008-10#3)(2008-5#1)
commercial samples##12##2##(2008-10#10)(2008-5#2)
commercial seed##2##2##(2008-10#2)
commercial software##4##2##(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)
commercial sources##2##2##(2008-5#1)(2013-1#1)
commercial storage##2##2##(2008-10#2)
commercial strawberry fields in##2##4##(2008-10#2)
commercial tea##2##2##(2008-10#2)
commercial wines##2##2##(2008-10#2)
commercial##383##1##(1990-3#2)(1990-6#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#2)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#281)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#20)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-7#2)(2012-12#1)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#2)
commercialized##7##1##(1992-11#1)(2008-10#3)(2008-11#1)(2010-12#1)(2012-3#1)
commercially available InGaAs/InP avalanche photodiodes##3##5##(2008-3#3)
commercially available enzyme-linked immunosorbent##2##4##(2008-10#2)
commercially available formulations##2##3##(2008-10#1)(2008-5#1)
commercially available immunochemistry##3##3##(2008-10#3)
commercially available instrument##2##3##(2008-10#1)(2008-9#1)
commercially available pharmaceutical##2##3##(2008-10#2)
commercially available products##3##3##(2008-10#2)(2008-5#1)
commercially available reagents##2##3##(2008-10#1)(2008-9#1)
commercially available##108##2##(1991-12#2)(1991-3#2)(1992-2#1)(1993-3#1)(1996-5#1)(2008-10#63)(2008-11#5)(2008-12#1)(2008-3#7)(2008-4#4)(2008-5#9)(2008-7#1)(2008-9#5)(2009-11#1)(2012-2#1)(2013-1#4)
commercially grown##2##2##(2008-10#1)(2011-10#1)
commercially important##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
commercially pure titanium##3##3##(2008-11#1)(2009-7#1)(2013-1#1)
commercially relevant##2##2##(2008-11#1)(2011-1#1)
commercially used##2##2##(2008-10#2)
commercially viable##2##2##(2012-2#2)
commercially##139##1##(1991-12#2)(1991-3#2)(1992-2#1)(1993-3#1)(1994-12#1)(1996-5#1)(2008-10#75)(2008-11#8)(2008-12#2)(2008-3#8)(2008-4#4)(2008-5#9)(2008-7#1)(2008-9#5)(2009-11#1)(2009-7#1)(2010-4#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-2#5)(2013-1#6)
commercially-available##2##1##(2008-10#1)(2012-2#1)
comminuted##3##1##(2008-12#2)(2011-2#1)
commission##2##1##(2008-10#1)(2008-11#1)
commissioned by the##2##3##(1991-2#1)(2008-11#1)
commissioned##5##1##(1991-2#1)(1993-12#1)(1994-12#1)(1996-1#1)(2008-11#1)
commissions##5##1##(1993-3#1)(1996-1#1)(1997-2#2)(2009-5#1)
commissural##3##1##(1991-2#1)(1997-2#1)(2008-8#1)
commissure##3##1##(1993-3#1)(2007-12#2)
commit##2##1##(2008-10#1)(2011-2#1)
commitment and##2##2##(1993-12#1)(2008-9#1)
commitment for##2##2##(1996-1#1)(2012-2#1)
commitment in##2##2##(1994-12#1)(2008-11#1)
commitment is##2##2##(1996-1#1)(2008-11#1)
commitment of##3##2##(1994-9#1)(2008-11#1)(2012-3#1)
commitment on##2##2##(1994-1#1)(1996-5#1)
commitment regarding##2##2##(2008-11#1)(2013-1#1)
commitment to a##2##3##(1993-2#1)(1997-3#1)
commitment to quality##2##3##(1994-1#1)(1995-2#1)
commitment to the##4##3##(1991-2#1)(1995-2#1)(2008-11#1)(2012-2#1)
commitment to##19##2##(1991-2#1)(1992-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#2)(1995-2#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#2)(2008-6#1)(2012-2#1)
commitment##52##1##(1990-5#1)(1991-2#1)(1992-1#1)(1993-12#2)(1993-2#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-9#1)(1995-2#2)(1996-1#7)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(2008-11#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
commitments##4##1##(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)
committed relationship##2##2##(2012-2#2)
committed to the##2##3##(1992-1#1)(1994-12#1)
committed to##12##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-11#1)(2012-2#1)(2012-3#1)
committed##24##1##(1990-8#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-5#1)(2008-11#2)(2008-4#1)(2012-12#1)(2012-2#4)(2012-3#1)
committee and##2##2##(1996-2#1)(2012-2#1)
committee for##3##2##(1993-3#1)(1994-12#1)(1995-12#1)
committee of##3##2##(1997-3#1)(2008-10#1)(2012-12#1)
committee on##3##2##(1993-6#1)(1996-3#1)(2008-3#1)
committee##29##1##(1991-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#3)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#3)(2012-12#1)(2012-2#2)
committees and##5##2##(1990-3#1)(1994-12#1)(1996-1#1)(1997-2#1)(2012-2#1)
committees##24##1##(1990-2#1)(1990-3#1)(1991-2#2)(1991-3#2)(1993-3#1)(1994-12#2)(1995-1#1)(1995-5#1)(1996-1#2)(1997-2#2)(1997-3#1)(2008-10#5)(2011-2#1)(2012-2#1)(2012-3#1)
committing suicide##3##2##(1993-9#2)(2008-12#1)
committing##5##1##(1991-3#1)(1993-9#2)(2008-12#1)(2008-7#1)
commodities##4##1##(2008-10#3)(2010-7#1)
commodity##6##1##(2008-1#1)(2008-10#3)(2008-6#1)(2010-7#1)
common 5'##2##2##(1993-12#1)(2008-8#1)
common additives##2##2##(2008-10#2)
common alleles##2##2##(1997-3#1)(2008-10#1)
common alpha subunit##2##3##(1995-8#2)
common among the##2##3##(2008-10#1)(2011-1#1)
common among##8##2##(1996-11#1)(1997-4#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-3#2)
common analytical methods##3##3##(2008-10#3)
common ancestor##8##2##(1997-6#1)(2008-10#4)(2009-6#1)(2010-4#1)(2012-3#1)
common and comet##3##3##(2010-8#3)
common and destructive##2##3##(2008-10#2)
common and often##2##3##(2008-9#1)(2010-7#1)
common and specific##2##3##(2012-2#2)
common and that##2##3##(2008-10#1)(2008-11#1)
common and usually##2##3##(2008-11#1)(2008-8#1)
common and##40##2##(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#2)(2010-10#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#4)(2011-2#3)(2012-2#6)(2012-5#1)(2013-1#2)
common anions and##2##3##(2008-10#2)
common anions##3##2##(2008-10#3)
common approach##3##2##(2008-11#2)(2013-1#1)
common bean (Phaseolus vulgaris) plants##2##5##(2008-10#2)
common bean (Phaseolus vulgaris)##9##4##(2008-10#9)
common bean (Phaseolus##11##3##(2008-10#9)(2008-12#2)
common bean gene##2##3##(2008-10#2)
common bean##34##2##(2008-10#31)(2008-12#2)(2013-8#1)
common beans##3##2##(2008-10#1)(2013-8#2)
common belief that##2##3##(1990-12#1)(2008-5#1)
common benign##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
common bile duct stones##2##4##(1997-8#2)
common bile duct##14##3##(1990-5#2)(1990-9#3)(1991-3#2)(1996-11#1)(1997-8#2)(2009-9#2)(2010-12#1)(2013-1#1)
common breast##2##2##(1992-9#1)(1993-1#1)
common cancers##3##2##(1990-8#1)(2008-8#1)(2012-2#1)
common carotid artery##4##3##(1996-12#1)(2008-7#3)
common carotid##6##2##(1996-12#1)(1997-8#1)(2008-7#4)
common cations and anions##2##4##(2008-10#2)
common cations##4##2##(2008-10#4)
common cause of##25##3##(1993-9#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
common causes of##8##3##(1990-3#1)(1990-6#1)(1997-8#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
common characteristics of##2##3##(2008-10#1)(2011-2#1)
common characteristics##5##2##(1992-11#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
common childhood illness##2##3##(2008-11#1)(2010-2#1)
common childhood##3##2##(2008-11#1)(2008-9#1)(2010-2#1)
common chronic##4##2##(1991-2#1)(2008-9#1)(2010-11#1)(2011-1#1)
common clinical##7##2##(1991-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)
common cold##7##2##(1992-3#1)(2008-10#4)(2012-3#1)(2013-8#1)
common complaint##3##2##(1990-6#1)(2008-5#1)(2008-9#1)
common complication of##2##3##(1991-6#1)(2011-2#1)
common complication##3##2##(1991-6#1)(2008-9#1)(2011-2#1)
common complications of##2##3##(2009-1#1)(2010-8#1)
common complications##3##2##(1991-2#1)(2009-1#1)(2010-8#1)
common conditions##4##2##(1991-12#1)(2008-11#1)(2008-4#1)(2012-12#1)
common denominator##2##2##(2008-11#1)(2008-8#1)
common disease of the##2##4##(2008-11#1)(2010-12#1)
common disease##7##2##(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
common diseases##3##2##(1997-3#1)(2009-12#1)(2013-1#1)
common disorder##4##2##(1995-2#1)(1997-8#1)(2008-9#1)(2009-6#1)
common duct##2##2##(1990-5#1)(2007-12#1)
common dural##2##2##(2012-3#2)
common during##2##2##(2008-10#1)(2008-12#1)
common elements of##2##3##(2012-2#2)
common elements##5##2##(1991-5#1)(2008-10#1)(2008-4#1)(2012-2#2)
common excipients##5##2##(2008-10#5)
common factor##3##2##(2008-1#1)(2008-11#1)(2012-2#1)
common factors##3##2##(2012-2#3)
common feature of the##2##4##(1995-6#1)(2008-11#1)
common feature of these##2##4##(1991-3#1)(2008-11#1)
common feature of##13##3##(1991-10#1)(1991-3#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-5#1)
common feature##14##2##(1991-10#1)(1991-3#1)(1993-12#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-5#1)
common features of##4##3##(2008-1#1)(2008-12#2)(2009-8#1)
common features##6##2##(2008-1#1)(2008-10#1)(2008-12#2)(2009-8#1)(2010-10#1)
common fibular nerve palsy##2##4##(2012-3#2)
common fibular##3##2##(2012-3#3)
common finding in##5##3##(1996-6#1)(2008-7#2)(2009-8#1)(2012-2#1)
common finding##6##2##(1996-6#1)(2008-7#2)(2009-8#1)(2012-2#2)
common findings during##2##3##(2009-8#1)(2011-2#1)
common findings##4##2##(1997-3#1)(2009-8#1)(2009-9#1)(2011-2#1)
common fixed point##4##3##(2011-2#4)
common for##2##2##(1992-3#1)(2008-8#1)
common genetic variation##2##3##(2011-2#1)(2012-2#1)
common genetic##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
common goal of##2##3##(1991-2#1)(1992-1#1)
common goal##3##2##(1991-2#1)(1992-1#1)(2008-10#1)
common ground##3##2##(1994-12#1)(2008-9#2)
common haplotypes##5##2##(2008-10#3)(2008-2#1)(2008-6#1)
common herbicide##2##2##(2008-10#1)(2008-11#1)
common human##2##2##(1994-5#1)(2009-3#1)
common iliac artery##3##3##(2006-6#1)(2011-2#2)
common imaging##2##2##(2008-1#1)(2012-2#1)
common in both##2##3##(2008-10#1)(2012-3#1)
common in children##2##3##(2011-2#2)
common in infants##2##3##(2006-5#1)(2012-12#1)
common in patients with##2##4##(2010-12#1)(2010-6#1)
common in patients##4##3##(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)
common in the##18##3##(1990-12#1)(1991-6#1)(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#2)
common in##82##2##(1990-12#1)(1991-11#1)(1991-6#1)(1993-12#2)(1994-12#1)(1995-3#1)(1997-3#2)(1997-8#1)(2006-5#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#4)(2008-5#4)(2008-7#5)(2008-8#7)(2008-9#2)(2009-1#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#3)
common injuries##3##2##(1990-2#1)(2010-12#1)(2013-1#1)
common injury##2##2##(2010-1#2)
common inorganic##2##2##(2008-10#2)
common interferents##3##2##(2008-10#3)
common interfering species##2##3##(2008-10#2)
common interfering##4##2##(2008-10#4)
common ions##13##2##(2008-10#13)
common laboratory##2##2##(1996-6#1)(2008-4#1)
common law##3##2##(1990-11#1)(1995-12#2)
common maize##2##2##(2012-2#2)
common mechanism is##2##3##(1994-8#1)(2011-2#1)
common mechanism of##2##3##(1994-5#1)(2010-1#1)
common mechanism##9##2##(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)
common medical##2##2##(1997-8#1)(2008-1#1)
common mental##2##2##(2008-11#1)(2010-5#1)
common metal ions##2##3##(2008-10#2)
common method##4##2##(2008-10#2)(2008-4#1)(2012-2#1)
common methods##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
common misconceptions##2##2##(1997-1#1)(2011-2#1)
common modes of##2##3##(2008-11#1)(2008-9#1)
common molecular##2##2##(2011-2#2)
common mosaic##8##2##(2008-10#8)
common movement##2##2##(2008-7#1)(2009-9#1)
common mutation in##3##3##(1990-8#1)(1997-3#1)(2008-7#1)
common name##2##2##(2008-10#1)(2012-2#1)
common nosocomial bacterial##2##3##(2013-8#2)
common occurrence##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)
common of##2##2##(2008-11#1)(2008-5#1)
common ones##2##2##(2008-10#1)(2008-9#1)
common organic and inorganic anions##2##5##(2008-10#2)
common organic##3##2##(2008-10#3)
common pathways##2##2##(1993-12#1)(2011-2#1)
common patterns##2##2##(1991-5#1)(2011-2#1)
common pharmaceutical##3##2##(2008-10#3)
common pitfalls in##2##3##(1993-1#1)(1995-2#1)
common practice among##2##3##(1991-6#1)(1996-11#1)
common practice##6##2##(1991-6#1)(1996-11#1)(2008-10#3)(2012-2#1)
common presenting##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
common primary##5##2##(2008-2#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
common problem##9##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
common problems##4##2##(2008-10#1)(2008-4#1)(2008-9#2)
common procedure for##2##3##(1992-5#1)(2008-10#1)
common procedure##3##2##(1991-5#1)(1992-5#1)(2008-10#1)
common processes##3##2##(1993-6#1)(2008-9#1)(2012-2#1)
common reason for##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
common reason##4##2##(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
common reasons for##4##3##(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
common region (CR) sequences of##2##5##(2008-10#2)
common region of##2##3##(1990-11#1)(2008-10#1)
common region##6##2##(1990-11#1)(2008-10#5)
common response curve##2##3##(1995-9#2)
common response##3##2##(1995-9#2)(2010-4#1)
common risk##2##2##(2011-2#1)(2012-12#1)
common rust##4##2##(2008-10#4)
common scab##3##2##(2008-10#3)
common sense##3##2##(1994-2#1)(2008-1#1)(2010-4#1)
common sequence motif##2##3##(1995-6#2)
common side##4##2##(1996-8#1)(2008-4#2)(2013-1#1)
common site of##2##3##(2008-1#1)(2011-2#1)
common spectrophotometric##3##2##(2008-10#3)
common target##3##2##(1991-9#2)(2013-1#1)
common terms##2##2##(2008-4#1)(2008-9#1)
common than##4##2##(2008-8#2)(2011-2#2)
common themes##5##2##(1993-3#1)(2008-11#1)(2008-12#1)(2009-9#1)(2011-1#1)
common to a##2##3##(2008-4#1)(2011-2#1)
common to all raters##3##4##(2012-2#3)
common to all three##2##4##(1991-7#1)(1996-1#1)
common to all##7##3##(1991-7#1)(1996-1#1)(2008-10#1)(2012-2#4)
common to both##8##3##(1991-5#1)(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#3)(2008-11#1)
common to other##2##3##(2008-1#1)(2008-5#1)
common to the two##2##4##(2008-10#1)(2008-2#1)
common to the##5##3##(1995-11#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-2#1)
common to##43##2##(1990-7#1)(1991-5#2)(1991-7#1)(1993-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#4)
common type##9##2##(1993-6#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
common types of cancer##2##4##(1990-8#1)(2010-10#1)
common types of##5##3##(1990-8#1)(1995-5#1)(2010-10#1)(2013-1#2)
common types##7##2##(1990-8#1)(1995-5#1)(2010-10#1)(2012-3#1)(2013-1#3)
common use##2##2##(1995-12#1)(2012-2#1)
common wheat from##3##3##(2008-10#3)
common wheat##18##2##(2008-10#15)(2008-8#3)
common with##6##2##(1993-11#3)(2008-10#1)(2008-4#1)(2012-3#1)
common within##3##2##(2008-10#2)(2012-3#1)
common yet##2##2##(2008-10#1)(2013-8#1)
common##1269##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#6)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#6)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#5)(1991-5#7)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#4)(1992-7#1)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#9)(1993-2#4)(1993-3#2)(1993-6#5)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#2)(1995-1#3)(1995-11#2)(1995-12#9)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#4)(1995-9#4)(1996-1#3)(1996-11#4)(1996-12#7)(1996-2#4)(1996-3#1)(1996-6#3)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#16)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#13)(1997-9#1)(2006-5#1)(2006-6#2)(2007-12#9)(2007-8#2)(2008-1#12)(2008-10#336)(2008-11#56)(2008-12#29)(2008-2#6)(2008-3#9)(2008-4#23)(2008-5#20)(2008-6#7)(2008-7#35)(2008-8#38)(2008-9#44)(2009-1#4)(2009-10#4)(2009-12#10)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#15)(2009-9#6)(2010-1#6)(2010-10#9)(2010-11#6)(2010-12#17)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#8)(2010-6#6)(2010-7#5)(2010-8#12)(2010-9#2)(2011-1#8)(2011-2#75)(2011-3#1)(2011-4#3)(2012-12#11)(2012-2#60)(2012-3#41)(2012-5#2)(2013-1#57)(2013-7#2)(2013-8#23)
commonalities and differences##2##3##(2010-10#1)(2011-2#1)
commonalities##4##1##(1994-12#1)(2008-9#1)(2010-10#1)(2011-2#1)
commoner than##2##2##(2008-1#1)(2008-8#1)
commoner##4##1##(1996-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
commonest cause##2##2##(2008-1#1)(2008-10#1)
commonest##21##1##(1990-6#1)(1997-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-11#1)(2010-11#1)(2012-3#3)(2013-1#1)
commonly accepted##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
commonly adopted##4##2##(2008-3#1)(2009-11#1)(2009-7#1)(2013-1#1)
commonly affected##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
commonly associated metal ions##2##4##(2008-10#2)
commonly associated with the##2##4##(2008-10#2)
commonly associated with##7##3##(1991-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
commonly associated##11##2##(1991-4#1)(2008-10#5)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
commonly been##2##2##(2008-5#1)(2008-7#1)
commonly caused by##2##3##(2008-7#1)(2011-2#1)
commonly considered##2##2##(2008-10#1)(2012-7#1)
commonly employed in##2##3##(2008-11#1)(2008-5#1)
commonly employed##8##2##(1992-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)
commonly encountered in##3##3##(2008-10#2)(2011-2#1)
commonly encountered##5##2##(2008-10#2)(2011-1#2)(2011-2#1)
commonly found in the##3##4##(1991-1#1)(1997-3#1)(2011-2#1)
commonly found in##14##3##(1991-1#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-1#1)
commonly found on##3##3##(2008-10#3)
commonly found##22##2##(1991-1#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-9#1)(2009-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
commonly grown##2##2##(2008-10#2)
commonly in the##7##3##(1993-6#1)(2008-10#1)(2008-12#2)(2008-9#1)(2011-2#2)
commonly in##13##2##(1993-6#1)(2008-10#2)(2008-12#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-1#1)(2011-2#2)
commonly involved##3##2##(2009-9#1)(2010-12#1)(2013-1#1)
commonly isolated##5##2##(2008-10#5)
commonly known as##5##3##(2007-12#1)(2008-10#2)(2009-3#1)(2012-12#1)
commonly known##6##2##(2007-12#1)(2008-10#2)(2009-3#1)(2011-2#1)(2012-12#1)
commonly observed in##4##3##(1994-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
commonly observed##9##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)
commonly occur in##4##3##(1997-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
commonly occur##5##2##(1997-8#1)(2008-10#1)(2008-9#1)(2009-12#1)(2013-1#1)
commonly occurring##3##2##(1993-2#1)(2008-10#1)(2012-3#1)
commonly on##3##2##(1991-2#1)(2008-10#2)
commonly performed##8##2##(1992-2#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
commonly prescribed for##2##3##(2010-12#1)(2012-12#1)
commonly prescribed##6##2##(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#3)
commonly present in the##2##4##(2008-10#2)
commonly present in##6##3##(2008-10#6)
commonly present##7##2##(2008-10#6)(2008-11#1)
commonly recorded processes of##2##4##(1994-12#2)
commonly recovered##2##2##(2008-10#2)
commonly referred to as##5##4##(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
commonly reported##9##2##(1991-2#1)(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#3)
commonly seen in##7##3##(2008-10#2)(2008-12#2)(2009-1#1)(2012-2#1)(2012-3#1)
commonly seen##10##2##(1992-12#1)(2008-10#2)(2008-12#2)(2009-1#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
commonly studied##2##2##(1996-3#1)(2006-6#1)
commonly thought to##2##3##(1991-7#1)(2008-9#1)
commonly thought##3##2##(1991-7#1)(2008-3#1)(2008-9#1)
commonly used as a##6##4##(1992-11#1)(2008-10#3)(2008-11#1)(2008-7#1)
commonly used as##9##3##(1992-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
commonly used drugs##2##3##(1994-12#1)(2008-11#1)
commonly used dural sealing techniques##2##5##(2012-3#2)
commonly used for the##2##4##(2008-10#2)
commonly used for##12##3##(1992-3#1)(2008-10#5)(2008-11#3)(2008-9#1)(2010-1#1)(2010-11#1)
commonly used in cytometry##2##4##(2008-9#2)
commonly used in the analysis of##3##6##(1990-2#1)(2008-4#1)(2008-6#1)
commonly used in the##7##4##(1990-2#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#1)
commonly used in##24##3##(1990-2#1)(1993-12#2)(1994-6#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#6)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
commonly used methods##4##3##(2008-10#2)(2008-2#1)(2008-9#1)
commonly used surfactants##2##3##(1996-1#1)(2008-10#1)
commonly used to##10##3##(1994-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#3)(2012-5#1)
commonly used##131##2##(1990-2#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#46)(2008-11#8)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#12)(2009-12#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#3)
commonly##392##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#2)(1994-12#5)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#3)(1997-2#2)(1997-3#1)(1997-8#2)(2006-6#2)(2007-12#1)(2008-1#2)(2008-10#123)(2008-11#21)(2008-12#10)(2008-2#1)(2008-3#7)(2008-4#8)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#10)(2008-9#22)(2009-1#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#25)(2011-3#1)(2012-12#3)(2012-2#10)(2012-3#20)(2012-5#1)(2012-7#1)(2013-1#14)(2013-3#1)(2013-8#5)
commonplace in##2##2##(2008-11#1)(2008-9#1)
commonplace##7##1##(1991-3#1)(1992-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
commonsense##2##1##(1993-12#1)(1995-3#1)
communal activities##2##2##(2008-11#2)
communal##4##1##(2008-11#4)
commune##7##1##(1996-6#1)(2008-10#6)
communicable disease surveillance##4##3##(1997-3#3)(2008-1#1)
communicable disease##6##2##(1991-8#1)(1997-3#4)(2008-1#1)
communicable diseases##2##2##(1996-6#2)
communicable##8##1##(1991-8#1)(1996-6#2)(1997-3#4)(2008-1#1)
communicate effectively##2##2##(1997-2#1)(2008-11#1)
communicate the##4##2##(1992-2#1)(2008-5#1)(2013-1#2)
communicate with the##2##3##(2008-10#1)(2011-2#1)
communicate with##6##2##(1995-12#1)(1996-2#1)(2008-10#1)(2008-7#2)(2011-2#1)
communicate##32##1##(1992-2#2)(1993-2#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#4)(2013-8#1)
communicated to the##2##3##(1996-11#1)(2008-7#1)
communicated with##2##2##(2008-10#1)(2013-1#1)
communicated##9##1##(1990-8#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-7#2)(2010-11#1)(2012-12#1)(2013-1#1)
communicates##2##1##(1990-6#1)(2008-10#1)
communicating science##2##2##(2013-1#2)
communicating their##2##2##(2011-1#1)(2013-1#1)
communicating with patients##3##3##(2008-11#1)(2013-8#2)
communicating with people##2##3##(2013-8#2)
communicating with##7##2##(2008-11#2)(2012-2#1)(2013-8#4)
communicating##36##1##(1992-3#1)(1992-6#1)(1993-2#2)(1995-2#1)(1996-3#2)(1997-3#3)(2008-11#2)(2008-7#7)(2009-5#1)(2010-4#5)(2011-1#1)(2012-2#2)(2013-1#4)(2013-8#4)
communication about##4##2##(2008-10#2)(2008-3#1)(2010-4#1)
communication among##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2010-8#1)
communication and##19##2##(1994-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
communication are##2##2##(1992-3#1)(2010-11#1)
communication as the##2##3##(2010-7#1)(2013-8#1)
communication as##3##2##(2008-9#1)(2010-7#1)(2013-8#1)
communication between parents and##3##4##(1990-12#1)(2008-11#1)(2013-1#1)
communication between patients##2##3##(2011-1#1)(2013-1#1)
communication between the model student family and the delinquent adolescent##2##10##(1990-12#2)
communication between the##4##3##(1990-12#3)(2008-10#1)
communication between##34##2##(1990-12#4)(1993-9#1)(1994-2#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#2)(2010-12#3)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
communication bottleneck##2##2##(2008-3#2)
communication difficulties##2##2##(2008-7#1)(2010-4#1)
communication in##7##2##(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
communication is to##2##3##(1992-2#1)(2012-12#1)
communication is##5##2##(1990-9#1)(1991-12#1)(1992-2#1)(2008-5#1)(2012-12#1)
communication mode##2##2##(2008-9#2)
communication networks##2##2##(2008-3#1)(2008-6#1)
communication of##5##2##(1990-12#2)(2008-11#1)(2009-5#1)(2010-4#1)
communication related impairments##7##3##(2011-1#7)
communication reports##2##2##(1990-12#1)(2008-10#1)
communication skills and##4##3##(1992-3#1)(2008-11#1)(2008-12#2)
communication skills program for##2##4##(2008-12#2)
communication skills##20##2##(1992-2#1)(1992-3#1)(1997-3#1)(2008-11#5)(2008-12#5)(2008-9#1)(2010-10#1)(2012-2#4)(2012-3#1)
communication strategies##2##2##(1997-2#1)(2012-2#1)
communication system##4##2##(1990-12#2)(2008-3#1)(2010-11#1)
communication systems##4##2##(1997-8#1)(2007-11#1)(2008-11#1)(2008-2#1)
communication that##2##2##(1994-11#1)(2008-11#1)
communication through##2##2##(2008-11#2)
communication with children##2##3##(1990-12#1)(2008-11#1)
communication with the##4##3##(2011-2#1)(2013-1#2)(2013-8#1)
communication with##14##2##(1990-12#3)(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#2)(2013-8#2)
communication##258##1##(1990-12#15)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#2)(1992-3#3)(1993-2#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#35)(2008-12#12)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#18)(2009-10#3)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#4)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#5)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#11)(2011-2#7)(2012-12#1)(2012-2#8)(2012-3#5)(2013-1#14)(2013-8#13)
communication]##2##1##(1991-8#1)(2012-3#1)
communications and information##2##3##(1995-12#1)(2008-3#1)
communications and##3##2##(1995-12#1)(1997-1#1)(2008-3#1)
communications between##3##2##(1994-3#1)(2008-7#1)(2010-2#1)
communications can##3##2##(1993-2#1)(1994-1#2)
communications with##2##2##(1996-11#1)(2008-10#1)
communications##26##1##(1992-1#1)(1993-12#1)(1993-2#2)(1994-1#3)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-11#1)(1997-1#1)(1997-3#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-5#1)(2012-3#1)
communicative hand gestures and object-directed hand movements##2##7##(2008-11#2)
communicative hand gestures and##3##4##(2008-11#3)
communicative hand gestures##4##3##(2008-11#4)
communicative intent##2##2##(2008-11#2)
communicative##10##1##(2008-11#6)(2008-12#1)(2008-4#1)(2010-5#1)(2011-1#1)
communis##11##1##(1993-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#5)(2013-1#1)(2013-8#1)
communis)##2##1##(2008-10#1)(2009-10#1)
communities and community##2##3##(2008-1#1)(2010-4#1)
communities and##15##2##(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-9#2)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
communities are##2##2##(2008-10#1)(2008-9#1)
communities from##3##2##(2008-10#1)(2008-8#1)(2010-1#1)
communities have##5##2##(1996-3#1)(2008-9#2)(2012-2#1)(2012-6#1)
communities in Canada##2##3##(1995-1#1)(1996-3#1)
communities in the##3##3##(1995-3#1)(2008-10#1)(2009-8#1)
communities in which different##2##4##(2008-8#2)
communities in which##6##3##(1995-3#1)(1996-3#2)(2008-8#2)(2012-2#1)
communities in##21##2##(1994-9#1)(1995-1#1)(1995-3#2)(1996-3#3)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-8#3)(2009-8#2)(2010-9#1)(2012-2#1)(2013-1#1)
communities is##2##2##(2008-8#1)(2010-9#1)
communities of##12##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#3)(2009-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
communities residing in##4##3##(2008-10#1)(2012-12#3)
communities than##2##2##(2008-9#1)(2009-8#1)
communities that##2##2##(2008-11#1)(2011-2#1)
communities to##2##2##(1997-1#1)(2008-10#1)
communities under##2##2##(1995-3#1)(2009-8#1)
communities using##2##2##(2008-8#1)(2008-9#1)
communities were##3##2##(2008-10#3)
communities where##2##2##(2009-10#1)(2011-2#1)
communities with##2##2##(2008-10#1)(2008-11#1)
communities##187##1##(1991-2#2)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#6)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#6)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2008-1#4)(2008-10#26)(2008-11#9)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#22)(2008-9#21)(2009-10#1)(2009-6#3)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#7)(2011-1#1)(2011-2#14)(2012-12#4)(2012-2#9)(2012-3#1)(2012-6#1)(2013-1#11)
community agencies##2##2##(2012-2#2)
community and health##2##3##(1991-2#1)(1996-2#1)
community and institutional residents##2##4##(1995-3#2)
community and the##3##3##(1994-1#2)(1995-3#1)
community and##29##2##(1991-2#1)(1992-12#1)(1994-1#3)(1995-1#1)(1995-2#1)(1995-3#3)(1996-2#1)(1996-3#2)(2008-10#4)(2008-11#4)(2008-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
community approach##3##2##(1992-1#2)(2013-1#1)
community are##3##2##(1993-6#1)(2010-10#1)(2013-1#1)
community as##2##2##(2008-8#2)
community assessment##2##2##(2008-1#1)(2008-12#1)
community at large##2##3##(1992-12#1)(2008-7#1)
community based care##2##3##(2008-12#2)
community based nursing##2##3##(2008-12#2)
community based##11##2##(1991-2#1)(1993-12#1)(2008-1#1)(2008-12#6)(2013-1#1)(2013-7#1)
community benefit##2##2##(1993-1#1)(1993-12#1)
community benefits##3##2##(1996-2#1)(2008-11#2)
community building##2##2##(1991-2#2)
community by##3##2##(1992-1#1)(2008-8#2)
community can##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
community care##7##2##(1994-1#1)(1997-8#1)(2010-10#5)
community characteristics##2##2##(2008-11#1)(2008-9#1)
community composition##4##2##(2008-10#1)(2010-6#3)
community configurations##2##2##(2008-9#2)
community contexts##3##2##(2010-7#2)(2010-9#1)
community continues to##2##3##(2011-2#1)(2012-2#1)
community dwelling##5##2##(2008-1#1)(2008-12#3)(2011-2#1)
community dynamics##5##2##(2008-8#3)(2008-9#2)
community engagement strategies##2##3##(2012-2#2)
community engagement##6##2##(2012-2#6)
community experience##2##2##(1996-11#1)(2011-2#1)
community for##3##2##(1995-1#1)(2008-1#1)(2008-12#1)
community groups##2##2##(1996-1#1)(1996-2#1)
community has##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
community health care##4##3##(1991-3#1)(1992-2#1)(1995-1#1)(2008-11#1)
community health center##4##3##(1990-9#1)(2008-1#2)(2008-12#1)
community health centers##2##3##(1997-2#2)
community health information##4##3##(1996-1#3)(2013-1#1)
community health##31##2##(1990-9#3)(1991-2#1)(1991-3#1)(1992-2#1)(1995-1#1)(1996-1#6)(1996-11#2)(1996-2#1)(1997-2#7)(1997-3#1)(2008-1#3)(2008-11#1)(2008-12#1)(2009-5#1)(2013-1#1)
community hospital and##2##3##(1991-3#1)(2008-11#1)
community hospital statistics##4##3##(1991-2#1)(1992-2#1)(1994-12#1)(1996-2#1)
community hospital##12##2##(1991-2#1)(1991-3#1)(1992-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-11#1)(2009-2#1)(2011-2#2)
community hospitals##5##2##(1990-6#1)(1991-3#1)(2008-3#2)(2011-2#1)
community in South##2##3##(2008-11#1)(2011-2#1)
community in the##4##3##(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#1)
community in##17##2##(1990-2#1)(1995-12#1)(1997-1#2)(1997-4#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-6#1)(2010-6#3)(2011-2#1)(2013-1#2)
community integration##2##2##(1996-1#1)(1997-1#1)
community is##4##2##(2008-1#1)(2008-6#1)(2008-8#1)(2010-10#1)
community level##10##2##(1994-8#1)(1996-12#1)(1996-3#2)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#3)
community meetings##2##2##(1997-1#1)(2009-4#1)
community members##5##2##(1991-2#1)(2008-9#2)(2012-12#1)(2012-2#1)
community mental health teams##2##4##(2008-12#2)
community mental health##13##3##(1992-1#1)(1993-1#1)(1996-1#3)(1997-1#1)(1997-3#4)(2008-12#2)(2010-4#1)
community needs##2##2##(1994-1#1)(2008-12#1)
community nurses##4##2##(1996-2#2)(2008-11#1)(2012-12#1)
community nursing students##2##3##(2008-11#2)
community of research and practice is##2##6##(2010-10#2)
community of research and practice##4##5##(2010-10#4)
community of the##3##3##(1993-12#1)(1994-1#1)(2008-10#1)
community of##15##2##(1993-12#1)(1994-1#1)(1994-3#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-10#4)(2013-1#1)
community or hospital##2##3##(1992-2#1)(2008-11#1)
community organization##2##2##(2008-8#2)
community organizations##2##2##(1997-2#1)(2008-1#1)
community participation##2##2##(1992-1#1)(1992-12#1)
community pharmacies in##2##3##(2008-11#1)(2012-2#1)
community pharmacies##4##2##(2008-11#3)(2012-2#1)
community pharmacists in##3##3##(2011-1#3)
community pharmacists##12##2##(2008-11#1)(2011-1#9)(2013-1#2)
community physicians##2##2##(1997-8#2)
community resident##3##2##(1991-1#1)(2008-10#2)
community residents##7##2##(1995-3#4)(1997-1#3)
community resources##4##2##(1996-1#1)(1996-3#1)(2008-11#1)(2009-5#1)
community sample of##3##3##(1992-1#1)(2010-11#1)(2013-1#1)
community sample##5##2##(1992-1#1)(2010-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
community services##3##2##(1991-1#1)(1992-1#1)(1996-3#1)
community setting##7##2##(1991-1#1)(2008-1#1)(2008-11#3)(2011-2#1)(2012-12#1)
community settings##4##2##(1994-2#1)(1997-1#1)(2008-8#1)(2011-2#1)
community stability##2##2##(2008-9#2)
community structure and##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
community structure##14##2##(2008-10#3)(2008-8#6)(2008-9#4)(2012-3#1)
community structures##2##2##(2008-10#2)
community study##2##2##(2009-11#1)(2011-2#1)
community support##2##2##(2008-12#1)(2009-6#1)
community to##3##2##(1992-1#1)(2009-10#1)(2009-5#1)
community treatment##2##2##(1994-1#1)(2008-6#1)
community violence exposure##2##3##(2009-12#2)
community violence##3##2##(2009-12#3)
community was##2##2##(2008-10#1)(2010-9#1)
community were##3##2##(1996-1#1)(2008-10#1)(2008-12#1)
community with##5##2##(2008-1#1)(2008-11#1)(2008-8#2)(2011-2#1)
community##570##1##(1990-2#1)(1990-6#1)(1990-9#5)(1991-1#6)(1991-12#2)(1991-2#10)(1991-3#5)(1992-1#10)(1992-12#3)(1992-2#3)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#16)(1994-12#4)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#3)(1995-12#3)(1995-2#3)(1995-3#10)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#17)(1996-11#6)(1996-12#2)(1996-2#10)(1996-3#13)(1997-1#12)(1997-2#19)(1997-3#7)(1997-4#1)(1997-8#3)(2008-1#20)(2008-10#39)(2008-11#44)(2008-12#28)(2008-3#2)(2008-5#1)(2008-6#6)(2008-7#7)(2008-8#36)(2008-9#26)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#9)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#1)(2010-10#12)(2010-11#2)(2010-4#3)(2010-5#1)(2010-6#7)(2010-7#10)(2010-8#3)(2010-9#6)(2011-1#10)(2011-2#20)(2012-12#9)(2012-2#18)(2012-3#3)(2012-6#1)(2013-1#24)(2013-7#1)(2013-8#2)
community's##4##1##(1992-12#1)(2008-12#1)(2011-2#1)(2013-8#1)
community-acquired pneumonia in##3##3##(1992-5#1)(2008-10#1)(2010-5#1)
community-acquired##5##1##(1992-5#2)(2008-10#1)(2010-5#1)(2011-2#1)
community-associated methicillin-resistant##3##2##(2008-10#1)(2008-11#2)
community-based care##2##2##(1993-2#1)(1995-3#1)
community-based drug abuse treatment##2##4##(2008-6#2)
community-based intervention##2##2##(2008-11#1)(2010-10#1)
community-based prevention##2##2##(1995-3#2)
community-based primary prevention programs##2##4##(1995-3#2)
community-based primary prevention##3##3##(1995-3#3)
community-based primary##4##2##(1995-3#3)(2008-4#1)
community-based quality improvement initiative##2##4##(2013-1#2)
community-based reports##3##2##(2008-7#2)(2013-1#1)
community-based sample##4##2##(2008-11#2)(2008-7#1)(2009-9#1)
community-based study##4##2##(2007-12#1)(2008-7#2)(2013-8#1)
community-based##62##1##(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#7)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#3)(2008-7#5)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#8)(2013-8#1)
community-dwelling elders##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#2)
community-dwelling##6##1##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#2)
community-level patterns##2##2##(2008-8#2)
community-level##10##1##(1995-2#1)(2008-8#2)(2008-9#2)(2009-6#2)(2013-1#3)
community-wide effort##2##2##(1994-12#1)(1996-1#1)
community-wide report card##2##3##(1997-3#2)
community-wide report##3##2##(1997-3#3)
community-wide##9##1##(1992-12#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-3#4)(2008-8#1)
communitywide##4##1##(2013-1#4)
commutator##2##1##(2008-10#2)
commuting##2##1##(1993-5#1)(2008-10#1)
comorbid conditions##3##2##(2010-7#1)(2013-1#1)(2013-8#1)
comorbid diagnoses##2##2##(2012-2#2)
comorbid psychiatric disorders##2##3##(2008-6#2)
comorbid psychiatric##4##2##(2008-6#2)(2008-7#1)(2012-2#1)
comorbid##19##1##(2008-6#2)(2008-7#2)(2008-8#1)(2009-5#2)(2009-9#1)(2010-7#1)(2011-10#3)(2012-2#5)(2013-1#1)(2013-8#1)
comorbidities and##2##2##(2013-1#2)
comorbidities of##2##2##(2011-2#1)(2013-1#1)
comorbidities##28##1##(2008-10#1)(2008-12#1)(2008-7#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-6#2)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#6)
comorbidity in##2##2##(1991-1#1)(2008-6#1)
comorbidity##13##1##(1991-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#3)
comovirus##2##1##(1995-12#2)
compact and##10##2##(1991-7#1)(1994-2#1)(2008-10#5)(2008-3#2)(2013-1#1)
compact arrangement of##2##3##(1995-8#1)(1996-6#1)
compact film##4##2##(2008-10#4)
compact in##2##2##(1997-1#1)(2008-7#1)
compact optical system##2##3##(2008-3#2)
compact##74##1##(1991-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(2008-10#33)(2008-12#1)(2008-2#2)(2008-3#16)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2011-2#2)(2013-1#1)
compacta##7##1##(1991-12#1)(1996-12#2)(2008-5#2)(2008-7#1)(2013-7#1)
compaction in##2##2##(1997-3#1)(2008-7#1)
compaction##3##1##(1997-3#1)(2008-10#1)(2008-7#1)
compactness of the##2##3##(2008-10#1)(2008-5#1)
companies and##6##2##(1993-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2010-5#1)
companies are##6##2##(1991-3#1)(1996-5#2)(2008-11#1)(2008-5#1)(2010-8#1)
companies have##3##2##(1993-12#1)(2008-11#1)(2008-5#1)
companies in the##3##3##(1990-2#1)(1993-3#1)(2008-10#1)
companies in##4##2##(1990-2#1)(1993-3#1)(1994-3#1)(2008-10#1)
companies that##3##2##(1993-3#1)(2008-11#2)
companies were##2##2##(2008-11#2)
companies##58##1##(1990-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1994-3#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-5#5)(1997-8#1)(2008-10#6)(2008-11#16)(2008-12#1)(2008-5#3)(2008-7#1)(2010-5#2)(2010-7#2)(2010-8#2)(2011-2#1)(2012-12#2)(2013-1#1)
companies'##3##1##(1992-5#1)(1996-5#1)(1996-8#1)
companion animals##3##2##(2011-2#2)(2013-1#1)
companion##10##1##(1991-2#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-12#1)(2008-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
company has##4##2##(2008-10#1)(2008-5#2)(2010-9#1)
company of##2##2##(1992-11#1)(2010-4#1)
company##33##1##(1992-11#1)(1992-12#1)(1993-12#3)(1993-3#1)(1995-1#2)(1996-2#1)(1996-5#1)(1997-1#1)(2008-10#3)(2008-11#6)(2008-5#5)(2008-8#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
company's##6##1##(1990-2#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
comparability of##8##2##(1990-6#1)(2008-10#6)(2012-2#1)
comparability##12##1##(1990-6#1)(2008-10#9)(2009-10#1)(2012-2#1)
comparable amounts of##2##3##(2009-6#1)(2009-7#1)
comparable between##3##2##(2008-10#2)(2008-12#1)
comparable for##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
comparable in terms of##4##4##(1993-11#1)(2008-11#1)(2012-12#2)
comparable in the##4##3##(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
comparable in##11##2##(1993-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#2)(2012-2#1)
comparable or##3##2##(2008-10#2)(2008-11#1)
comparable results to##3##3##(2008-10#2)(2010-12#1)
comparable results with those obtained##2##5##(2008-10#2)
comparable results with##3##3##(2008-10#2)(2008-7#1)
comparable results##10##2##(2008-10#7)(2008-11#1)(2008-7#1)(2010-12#1)
comparable to a##2##3##(2008-10#1)(2010-5#1)
comparable to that in##6##4##(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-3#1)
comparable to that obtained##2##4##(2008-10#1)(2008-11#1)
comparable to that of the##4##5##(1993-6#1)(1994-2#1)(2008-10#1)(2008-5#1)
comparable to that of##12##4##(1990-5#1)(1993-6#1)(1994-2#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-5#1)
comparable to that##24##3##(1990-5#1)(1993-6#1)(1994-2#1)(1995-11#1)(1996-5#1)(1997-4#2)(2008-10#7)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-3#1)
comparable to the##16##3##(1991-3#1)(1993-1#1)(1995-5#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
comparable to those achieved##2##4##(1993-6#1)(2008-10#1)
comparable to those determined##2##4##(2008-10#2)
comparable to those found##2##4##(1990-2#1)(2008-10#1)
comparable to those obtained by##3##5##(2008-10#3)
comparable to those obtained with the##2##6##(2008-10#2)
comparable to those obtained with##4##5##(2008-10#4)
comparable to those obtained##10##4##(2008-10#10)
comparable to those of the##2##5##(2008-10#1)(2008-6#1)
comparable to those of##6##4##(1991-2#1)(2008-10#4)(2008-6#1)
comparable to those reported in##2##5##(2008-10#2)
comparable to those reported##3##4##(2008-10#3)
comparable to those##34##3##(1990-2#1)(1991-2#1)(1993-6#1)(1995-6#1)(2008-10#26)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
comparable to##109##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#3)(1993-6#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#2)(2008-10#52)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
comparable values for##2##3##(1991-6#1)(2008-5#1)
comparable values##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
comparable with or##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
comparable with respect to##2##4##(2008-10#2)
comparable with that of##13##4##(1990-8#1)(1991-3#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
comparable with that##14##3##(1990-8#1)(1991-3#1)(1993-1#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
comparable with the##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2013-8#1)
comparable with those obtained by the##2##6##(2008-10#2)
comparable with those obtained by##7##5##(2008-10#6)(2008-3#1)
comparable with those obtained##9##4##(2008-10#8)(2008-3#1)
comparable with those of##2##4##(2008-7#1)(2013-8#1)
comparable with those##15##3##(1991-3#1)(2008-10#10)(2008-3#1)(2008-7#1)(2009-8#1)(2013-8#1)
comparable with##50##2##(1990-2#1)(1990-8#1)(1991-3#2)(1993-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-3#7)(2008-5#3)(2008-7#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
comparable##275##1##(1990-2#2)(1990-3#2)(1990-5#2)(1990-8#1)(1991-2#1)(1991-3#4)(1991-6#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#4)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(2007-12#3)(2008-10#110)(2008-11#26)(2008-12#3)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#6)(2011-7#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#3)
comparably to##3##2##(2008-10#1)(2009-8#1)(2012-3#1)
comparably##7##1##(1994-6#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#1)(2012-3#1)
comparative analyses##3##2##(2008-10#2)(2009-8#1)
comparative analysis is##2##3##(2008-10#1)(2012-2#1)
comparative analysis of##11##3##(1993-6#1)(1993-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
comparative analysis##25##2##(1991-6#1)(1993-6#1)(1993-9#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#2)
comparative and##5##2##(2008-11#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
comparative approach##2##2##(2009-8#1)(2012-3#1)
comparative assessment of##2##3##(2009-10#1)(2013-1#1)
comparative assessment##3##2##(2008-11#1)(2009-10#1)(2013-1#1)
comparative data##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
comparative effectiveness##2##2##(2008-10#1)(2008-7#1)
comparative epidemiology##2##2##(2008-10#2)
comparative evaluation of##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
comparative genetic##2##2##(2008-10#1)(2008-12#1)
comparative genome##2##2##(1995-2#1)(2008-8#1)
comparative genomic analysis##2##3##(2008-7#1)(2009-10#1)
comparative genomic hybridization (CGH)##3##4##(2008-9#1)(2012-3#2)
comparative genomic hybridization##5##3##(2008-4#1)(2008-9#1)(2012-3#3)
comparative genomic##7##2##(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-3#3)
comparative genomics##4##2##(2008-8#1)(2011-2#1)(2012-3#2)
comparative method##7##2##(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)
comparative methods##2##2##(2008-10#1)(2008-8#1)
comparative molecular field analysis (CoMFA)##2##5##(2010-12#1)(2011-2#1)
comparative molecular##3##2##(2010-12#1)(2011-2#2)
comparative performance##2##2##(2008-10#2)
comparative perspective##3##2##(1995-2#1)(2009-8#2)
comparative proteomics##2##2##(2010-12#2)
comparative purposes##2##2##(2008-10#2)
comparative sequence analysis##2##3##(1997-6#1)(2008-10#1)
comparative studies of##3##3##(2008-2#1)(2008-9#1)(2010-5#1)
comparative studies with##6##3##(1997-8#1)(2008-10#2)(2008-11#2)(2012-12#1)
comparative studies##17##2##(1997-8#1)(2006-6#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-9#1)(2010-5#1)(2012-12#1)
comparative study for the##2##4##(1993-3#1)(2008-10#1)
comparative study in##3##3##(2008-1#1)(2008-10#2)
comparative study of the##7##4##(1993-6#1)(1997-6#1)(2008-10#4)(2008-9#1)
comparative study of##23##3##(1993-6#1)(1996-2#1)(1997-6#1)(2008-10#11)(2008-11#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-10#1)(2010-3#1)(2013-1#2)
comparative study on##6##3##(1990-12#1)(1990-9#2)(2008-10#1)(2010-12#1)(2010-6#1)
comparative study was##4##3##(2008-10#4)
comparative study##54##2##(1990-12#1)(1990-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
comparative study]##2##2##(1991-3#1)(1994-6#1)
comparative value of##2##3##(2012-3#1)(2013-1#1)
comparative value##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
comparative##219##1##(1990-12#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#3)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#68)(2008-11#17)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#12)(2008-9#9)(2009-10#3)(2009-3#1)(2009-6#1)(2009-8#6)(2010-10#1)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#2)(2012-2#3)(2012-3#13)(2013-1#8)(2013-8#2)
comparatively higher##2##2##(2008-10#1)(2010-7#1)
comparatively little##3##2##(2009-6#1)(2010-12#1)(2012-2#1)
comparatively##20##1##(1992-9#1)(1993-3#1)(1995-3#1)(2008-10#5)(2008-3#1)(2008-9#2)(2009-6#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
comparator##8##1##(2008-11#1)(2008-5#4)(2012-3#2)(2013-1#1)
compare a##2##2##(2008-8#1)(2008-9#1)
compare both##4##2##(1992-1#1)(1994-5#1)(2008-11#1)(2010-8#1)
compare fairly well with data obtained using##2##7##(2008-10#2)
compare favorably to##2##3##(1992-2#1)(2008-11#1)
compare favorably with those obtained##4##5##(2008-10#4)
compare favorably with##8##3##(2008-10#5)(2008-3#2)(2008-9#1)
compare favorably##10##2##(1992-2#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-9#1)
compare favourably with##2##3##(2008-10#2)
compare favourably##3##2##(2008-10#3)
compare gene expression##2##3##(2008-11#2)
compare our##4##2##(1994-3#2)(2008-7#1)(2011-2#1)
compare the effectiveness of##2##4##(2008-10#1)(2013-1#1)
compare the effects of##2##4##(2008-11#1)(2012-5#1)
compare the results obtained with##2##5##(2008-10#1)(2013-1#1)
compare the results obtained##3##4##(2008-10#2)(2013-1#1)
compare the results of##3##4##(1996-1#1)(2008-5#1)(2013-1#1)
compare the results##11##3##(1991-3#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#2)
compare the size##2##3##(1996-3#1)(2008-10#1)
compare the temporal##2##3##(2006-6#1)(2008-10#1)
compare the##105##2##(1991-12#2)(1991-3#1)(1993-1#1)(1993-12#2)(1994-12#1)(1994-3#2)(1994-6#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-3#1)(1997-8#1)(2006-6#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#15)(2013-8#3)
compare them to##2##3##(1991-7#1)(2008-11#1)
compare them with##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
compare them##6##2##(1991-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
compare these##7##2##(1996-2#1)(2008-11#1)(2008-3#2)(2008-9#1)(2011-1#2)
compare three##2##2##(2008-10#1)(2008-8#1)
compare to##4##2##(1995-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
compare two##5##2##(1994-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
compare very##2##2##(2008-10#2)
compare well with the##2##4##(1990-8#1)(2008-10#1)
compare well with those##2##4##(2008-10#2)
compare well with##4##3##(1990-8#1)(2008-10#3)
compare well##5##2##(1990-8#1)(2008-10#4)
compare with##6##2##(1994-1#1)(2008-10#2)(2008-11#1)(2012-3#2)
compare##261##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#3)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1997-3#3)(1997-8#3)(2006-6#1)(2008-10#58)(2008-11#14)(2008-12#4)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#12)(2008-9#10)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#13)(2012-12#2)(2012-2#3)(2012-3#11)(2012-5#1)(2013-1#24)(2013-8#6)
compared a##3##2##(1995-11#1)(2009-11#1)(2012-12#1)
compared according to the##3##4##(2008-10#3)
compared according to##5##3##(2008-10#3)(2008-7#1)(2013-1#1)
compared across##2##2##(1993-2#1)(2013-1#1)
compared among##7##2##(1995-6#1)(2007-12#1)(2008-10#4)(2012-2#1)
compared and contrasted##3##3##(2008-10#2)(2008-5#1)
compared and the##3##3##(2008-10#2)(2008-11#1)
compared and##17##2##(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#1)
compared as##3##2##(2008-10#2)(2008-9#1)
compared at##4##2##(1995-2#1)(2008-10#1)(2008-3#2)
compared between the two groups##2##5##(2011-2#1)(2012-2#1)
compared between the##5##3##(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
compared between##16##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#3)(2012-2#2)(2012-5#1)(2013-1#2)
compared both##2##2##(2008-10#2)
compared by use of##2##4##(1991-12#1)(2007-12#1)
compared by##10##2##(1991-12#1)(1991-8#1)(1993-2#1)(1993-3#1)(2007-12#1)(2008-10#4)(2013-1#1)
compared favorably to##4##3##(1993-12#1)(2008-10#2)(2008-9#1)
compared favorably with##2##3##(2008-10#2)
compared favorably##6##2##(1993-12#1)(2008-10#4)(2008-9#1)
compared favourably with the##2##4##(2008-10#2)
compared for a##3##3##(1995-11#1)(1995-2#1)(2008-10#1)
compared for each##2##3##(2008-10#1)(2011-2#1)
compared for the##8##3##(1996-12#1)(2008-10#6)(2013-1#1)
compared for##31##2##(1990-8#1)(1991-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#2)
compared in a##3##3##(1995-9#1)(2008-10#1)(2008-5#1)
compared in terms of##4##4##(2008-10#3)(2008-3#1)
compared in the##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
compared in##31##2##(1991-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-12#2)(1997-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
compared it with##4##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
compared on the basis of##3##5##(2008-10#2)(2011-2#1)
compared on##8##2##(2008-10#4)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)
compared rates of##2##3##(2008-5#2)
compared responses##2##2##(2008-9#1)(2009-8#1)
compared sequences##3##2##(1996-6#3)
compared statistically with those obtained##2##5##(2008-10#1)(2008-11#1)
compared statistically##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
compared the effects of##6##4##(1991-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(2009-8#1)(2010-1#1)
compared the efficacy and##2##4##(1993-1#1)(2008-10#1)
compared the efficacy##3##3##(1993-1#1)(2008-10#1)(2012-3#1)
compared the power of the##2##5##(1996-3#2)
compared the results of##3##4##(2008-11#1)(2009-3#1)(2011-2#1)
compared the results##8##3##(2008-10#2)(2008-11#2)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
compared the two##2##3##(1996-1#1)(2008-10#1)
compared the yield##2##3##(2008-10#2)
compared the##64##2##(1990-12#1)(1991-12#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#2)
compared their##4##2##(1990-5#1)(1995-12#2)(2008-3#1)
compared these##4##2##(2008-3#1)(2012-12#1)(2013-8#2)
compared three##2##2##(2008-10#1)(2008-11#1)
compared to 0##3##3##(1993-8#1)(2008-10#1)(2008-8#1)
compared to 1##5##3##(1994-11#1)(2008-10#1)(2008-11#3)
compared to A7##2##3##(2008-11#2)
compared to European##2##3##(2008-1#1)(2010-10#1)
compared to SD rats and##4##5##(1996-12#4)
compared to SD rats##6##4##(1996-12#6)
compared to a bare capillary##2##5##(1997-2#2)
compared to a bare##3##4##(1997-2#2)(2008-10#1)
compared to a group of##2##5##(1994-2#1)(2008-5#1)
compared to a##23##3##(1991-6#1)(1994-2#1)(1997-2#2)(2008-10#8)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
compared to an##5##3##(1997-1#1)(2008-10#2)(2008-5#1)(2012-2#1)
compared to analogous##2##3##(1994-5#1)(2008-10#1)
compared to aqueous##2##3##(2008-10#2)
compared to bare metal stents##3##5##(2008-11#2)(2008-12#1)
compared to baseline)##2##3##(2011-2#1)(2013-1#1)
compared to cells##2##3##(1992-8#1)(2008-11#1)
compared to commercial##2##3##(2008-10#2)
compared to control cultures##2##4##(1995-12#1)(2008-11#1)
compared to control##16##3##(1993-2#1)(1993-6#1)(1994-3#1)(1995-12#3)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#2)(2013-1#1)
compared to controls##13##3##(1990-11#1)(1990-5#1)(1990-8#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
compared to conventional##9##3##(1994-3#1)(2008-10#4)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
compared to glass##2##3##(2008-10#2)
compared to group##3##3##(2008-11#1)(2009-3#2)
compared to healthy##4##3##(1993-2#1)(2009-6#1)(2009-8#1)(2013-1#1)
compared to human##2##3##(2008-11#1)(2008-6#1)
compared to individual##3##3##(2008-10#1)(2008-11#2)
compared to its##4##3##(2008-11#2)(2009-8#1)(2013-8#1)
compared to manual##2##3##(2008-10#1)(2010-8#1)
compared to many##2##3##(2008-10#1)(2008-5#1)
compared to non-obese##2##3##(2012-2#2)
compared to non-tolerant##2##3##(2008-12#1)(2011-10#1)
compared to normal##7##3##(1992-8#1)(1993-11#2)(2008-5#1)(2009-1#2)(2011-2#1)
compared to older##2##3##(2008-5#1)(2008-7#1)
compared to one##2##3##(2008-5#1)(2008-9#1)
compared to other##24##3##(1990-11#1)(1996-6#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)
compared to pH 4 and 6##2##6##(2008-5#2)
compared to pH##3##3##(2008-5#2)(2013-1#1)
compared to parental##2##3##(1994-11#1)(1994-8#1)
compared to patients##3##3##(2008-10#1)(2010-2#1)(2013-1#1)
compared to rats fed##2##4##(1993-12#1)(2013-1#1)
compared to saline##3##3##(1993-1#1)(1995-12#1)(1995-2#1)
compared to sham##3##3##(1993-6#1)(1995-11#1)(1996-12#1)
compared to simple##2##3##(2008-4#1)(2008-7#1)
compared to standard##4##3##(1990-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
compared to subjects##2##3##(2008-1#1)(2012-3#1)
compared to tasks##2##3##(2008-11#1)(2009-7#1)
compared to that in##4##4##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
compared to that obtained##3##4##(1992-12#1)(2008-11#1)(2008-6#1)
compared to that of a##2##5##(2008-10#1)(2008-7#1)
compared to that of control##2##5##(2008-10#1)(2008-11#1)
compared to that of the##5##5##(1990-5#1)(1994-2#1)(1997-7#1)(2008-10#1)(2011-2#1)
compared to that of##23##4##(1990-5#1)(1991-3#1)(1993-1#1)(1993-8#1)(1994-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-7#2)(2010-10#1)(2011-2#1)
compared to that##33##3##(1990-5#1)(1991-3#1)(1992-12#2)(1993-1#1)(1993-8#1)(1994-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)
compared to the ELISA##2##4##(2008-10#2)
compared to the GC-HRMS##2##4##(2008-10#2)
compared to the USA##2##4##(2009-4#2)
compared to the acid-washed PM 1648##2##6##(2008-10#2)
compared to the alphanumeric##2##4##(2010-8#2)
compared to the baseline##3##4##(2011-2#2)(2013-1#1)
compared to the control PFS##2##5##(2008-11#2)
compared to the control group##5##5##(1994-8#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
compared to the control##14##4##(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-6#2)
compared to the conventional method##2##5##(2008-11#2)
compared to the conventional##5##4##(2008-10#1)(2008-11#3)(2008-4#1)
compared to the direct##2##4##(2008-10#1)(2008-5#1)
compared to the expected##2##4##(1993-8#1)(1994-12#1)
compared to the flat##2##4##(1991-2#1)(1995-2#1)
compared to the levels in the control group##2##8##(2009-12#1)(2011-1#1)
compared to the negative##2##4##(1990-6#1)(2009-8#1)
compared to the normal##3##4##(1994-9#1)(2008-7#1)(2011-3#1)
compared to the other##8##4##(1991-3#1)(1995-1#1)(2008-10#5)(2009-11#1)
compared to the reference method##2##5##(2008-10#2)
compared to the reference##4##4##(2008-10#3)(2008-12#1)
compared to the retinol deficient group##2##6##(1994-8#2)
compared to the single##2##4##(2008-10#1)(2013-1#1)
compared to the standard##4##4##(2008-10#1)(2008-11#2)(2008-7#1)
compared to the static##2##4##(2008-11#1)(2013-8#1)
compared to the traditional##2##4##(2008-10#1)(2008-3#1)
compared to the untreated##2##4##(1995-12#1)(2008-5#1)
compared to the usual##2##4##(2008-10#1)(2008-3#1)
compared to the values##2##4##(2008-5#1)(2011-2#1)
compared to the wild-type##2##4##(1996-12#1)(2008-10#1)
compared to the youngest##2##4##(1996-2#1)(2008-10#1)
compared to the zero##2##4##(1994-8#1)(2008-10#1)
compared to the##220##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#3)(1991-3#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-3#3)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#60)(2008-11#24)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#9)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-12#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-2#5)(2012-3#1)(2012-6#2)(2012-9#1)(2013-1#3)(2013-8#1)
compared to their control##2##4##(1991-5#1)(2012-2#1)
compared to their##11##3##(1991-2#1)(1991-5#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
compared to those from##2##4##(2008-10#1)(2008-11#1)
compared to those in Group##2##5##(2011-1#1)(2011-2#1)
compared to those in the##2##5##(2011-1#1)(2012-5#1)
compared to those in##5##4##(2008-10#1)(2011-1#2)(2011-2#1)(2012-5#1)
compared to those obtained by the##3##6##(2008-10#3)
compared to those obtained by##6##5##(2008-10#6)
compared to those obtained with##3##5##(2008-10#3)
compared to those obtained##11##4##(2008-10#11)
compared to those of##12##4##(1990-5#1)(1990-9#1)(1994-5#1)(2008-10#3)(2010-4#2)(2011-2#2)(2012-3#1)(2013-8#1)
compared to those with##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
compared to those without##5##4##(2008-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
compared to those##54##3##(1990-5#1)(1990-9#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-12#1)(2008-10#24)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
compared to traditional##2##3##(2008-10#1)(2011-2#1)
compared to tumors##2##3##(1993-11#2)
compared to untreated##3##3##(2008-10#1)(2008-11#2)
compared to what##2##3##(2008-11#1)(2008-5#1)
compared to wild type##2##4##(1997-7#1)(2009-8#1)
compared to wild-type##3##3##(2009-10#1)(2011-2#2)
compared to young##2##3##(2008-7#1)(2013-7#1)
compared to younger##2##3##(1996-2#1)(2008-7#1)
compared to##829##2##(1990-11#5)(1990-12#1)(1990-5#6)(1990-6#2)(1990-8#3)(1990-9#1)(1991-12#5)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#4)(1992-12#4)(1992-3#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-1#9)(1993-11#7)(1993-12#2)(1993-2#5)(1993-3#2)(1993-6#3)(1993-8#4)(1993-9#2)(1994-1#3)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#4)(1994-5#6)(1994-8#9)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#14)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#1)(1997-7#4)(1997-8#4)(2007-12#6)(2007-8#1)(2008-1#3)(2008-10#183)(2008-11#98)(2008-12#13)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#31)(2008-6#3)(2008-7#30)(2008-8#14)(2008-9#21)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#10)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#7)(2010-9#4)(2011-1#4)(2011-10#1)(2011-2#37)(2011-3#1)(2011-7#1)(2012-12#6)(2012-2#24)(2012-3#17)(2012-5#3)(2012-6#2)(2012-9#2)(2013-1#28)(2013-7#4)(2013-8#18)
compared two groups##2##3##(2009-3#1)(2012-2#1)
compared two##4##2##(2008-3#1)(2008-4#1)(2009-3#1)(2012-2#1)
compared under##2##2##(2008-10#2)
compared using##16##2##(1995-12#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#1)
compared very##2##2##(2008-10#2)
compared well with the results##2##5##(2008-10#2)
compared well with the##4##4##(2008-10#4)
compared well with those obtained by##4##6##(2008-10#4)
compared well with those obtained##5##5##(2008-10#5)
compared well with those##8##4##(2008-10#8)
compared well with##13##3##(2008-10#13)
compared well##14##2##(2008-10#14)
compared when##3##2##(2008-8#1)(2008-9#1)(2011-3#1)
compared with 'incorrect' and##3##4##(2008-11#3)
compared with 0##6##3##(2008-10#2)(2009-3#2)(2013-1#2)
compared with 2##3##3##(2009-12#1)(2010-12#1)(2013-1#1)
compared with 24##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
compared with 25##2##3##(1993-12#1)(2008-10#1)
compared with 4##4##3##(2008-10#2)(2012-3#2)
compared with 6##2##3##(2008-11#1)(2013-1#1)
compared with ACDF##3##3##(2012-12#3)
compared with CS and NC participants##2##6##(2008-11#2)
compared with CS##3##3##(2008-10#1)(2008-11#2)
compared with P##4##3##(2008-10#4)
compared with a control group##3##5##(1991-2#1)(2008-10#1)(2013-1#1)
compared with a control##4##4##(1991-2#1)(2008-10#2)(2013-1#1)
compared with a conventional##2##4##(2008-10#1)(2008-12#1)
compared with a new single compound##2##6##(2008-11#2)
compared with a similar##2##4##(2008-10#2)
compared with a standard##2##4##(2008-10#2)
compared with a traditional##2##4##(2008-10#1)(2008-5#1)
compared with a##40##3##(1991-2#2)(1991-8#1)(1995-11#1)(1997-1#1)(2007-12#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#3)
compared with an##4##3##(1991-7#1)(2008-10#3)
compared with bare##2##3##(2008-10#2)
compared with baseline##4##3##(2011-2#2)(2013-1#2)
compared with best##2##3##(2010-12#1)(2013-1#1)
compared with both##2##3##(2008-3#1)(2013-8#1)
compared with brief pulse##2##4##(2012-12#2)
compared with classical##2##3##(2008-10#1)(2008-3#1)
compared with column technique##2##4##(2008-10#2)
compared with control plants##2##4##(2008-10#2)
compared with control##14##3##(1993-12#1)(1995-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
compared with controls##9##3##(1994-8#1)(1995-12#1)(1995-3#1)(2008-10#3)(2008-7#1)(2011-2#2)
compared with conventional treatments##2##4##(1997-5#1)(2008-6#1)
compared with conventional##12##3##(1997-5#1)(2008-10#9)(2008-6#1)(2008-8#1)
compared with data from##4##4##(1993-6#1)(2008-10#2)(2012-2#1)
compared with data##6##3##(1993-6#1)(2008-1#1)(2008-10#3)(2012-2#1)
compared with different##2##3##(2008-2#1)(2013-1#1)
compared with each other##6##4##(2008-10#4)(2008-11#1)(2008-12#1)
compared with experimental##3##3##(2008-2#1)(2008-3#2)
compared with free##2##3##(2008-10#2)
compared with full term infants##2##5##(2011-2#2)
compared with full term##3##4##(2011-2#3)
compared with furrow irrigation##2##4##(2008-10#2)
compared with gene##2##3##(2008-10#1)(2012-3#1)
compared with group##2##3##(2008-9#1)(2010-7#1)
compared with growth##2##3##(2008-10#1)(2011-2#1)
compared with healthy controls##2##4##(1997-8#1)(2008-10#1)
compared with healthy##3##3##(1991-7#1)(1997-8#1)(2008-10#1)
compared with high##2##3##(2008-10#1)(2012-12#1)
compared with in##3##3##(1990-11#1)(2008-10#2)
compared with inductively coupled##2##4##(2008-10#2)
compared with isolates from 'Minneola'##2##5##(2008-10#2)
compared with isolates from##3##4##(2008-10#3)
compared with its##2##3##(1994-3#1)(2008-5#1)
compared with matched##2##3##(2010-12#2)
compared with measurements##2##3##(2008-2#1)(2008-3#1)
compared with men##2##3##(1991-7#1)(2008-4#1)
compared with no##3##3##(2008-10#2)(2012-12#1)
compared with non-Medicare##2##3##(1991-12#1)(1994-12#1)
compared with nontreated controls##2##4##(2008-10#2)
compared with normal##4##3##(1993-6#1)(1995-5#1)(2008-7#1)(2012-2#1)
compared with one##3##3##(1991-2#1)(2008-10#2)
compared with only##2##3##(1993-1#1)(2008-8#1)
compared with other resistant##2##4##(2008-10#2)
compared with other##25##3##(1990-12#1)(1990-6#1)(1993-11#1)(1994-1#1)(1995-3#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
compared with others##2##3##(1991-5#1)(2008-10#1)
compared with pH##3##3##(2008-10#3)
compared with patients with##3##4##(2011-2#2)(2012-3#1)
compared with patients##8##3##(1995-2#1)(1996-3#2)(1997-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
compared with plants##2##3##(2008-10#2)
compared with positive control##2##4##(2008-10#1)(2008-11#1)
compared with previous##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
compared with primary##2##3##(2011-2#1)(2012-3#1)
compared with reference##2##3##(2008-10#2)
compared with regard to##2##4##(2008-7#1)(2011-10#1)
compared with results obtained with##2##5##(2006-6#1)(2008-10#1)
compared with results obtained##3##4##(2006-6#1)(2008-10#2)
compared with results##5##3##(2006-6#1)(2008-10#3)(2011-2#1)
compared with seedlings##2##3##(2008-10#2)
compared with similar##2##3##(1996-3#1)(2008-11#1)
compared with single##3##3##(2008-10#3)
compared with single-level##2##3##(2012-12#2)
compared with standard##5##3##(1993-12#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
compared with susceptible ones##3##4##(2008-10#2)(2008-12#1)
compared with that at##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
compared with that in the##2##5##(2008-10#1)(2011-3#1)
compared with that in##13##4##(2008-10#7)(2008-11#2)(2008-2#1)(2008-8#1)(2009-6#1)(2011-3#1)
compared with that observed in##2##5##(1996-12#1)(2008-10#1)
compared with that observed##4##4##(1996-12#1)(2008-10#2)(2008-11#1)
compared with that of a conventional##2##6##(2007-12#1)(2008-10#1)
compared with that of a##5##5##(1996-2#1)(2007-12#1)(2008-10#2)(2012-2#1)
compared with that of other##2##5##(2008-10#1)(2008-3#1)
compared with that of the##13##5##(1991-12#1)(1991-2#1)(1992-6#1)(2007-12#1)(2008-10#4)(2008-8#1)(2008-9#2)(2010-4#1)(2013-1#1)
compared with that of##45##4##(1991-12#1)(1991-2#1)(1992-6#2)(1993-11#1)(1995-6#1)(1996-2#1)(2006-6#1)(2007-12#2)(2008-10#21)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-9#1)(2010-4#2)(2012-2#1)(2012-3#1)(2013-1#1)
compared with that on##2##4##(2008-10#2)
compared with that reported in the literature##2##7##(1991-2#1)(1991-3#1)
compared with that##80##3##(1991-12#1)(1991-2#2)(1991-3#1)(1992-6#2)(1993-1#1)(1993-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(2006-6#1)(2007-12#2)(2008-10#36)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-6#3)(2009-9#1)(2010-4#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
compared with the CP##2##4##(2008-10#2)
compared with the Kjeldahl##2##4##(2008-10#2)
compared with the Marquardt-Levenberg##2##4##(2008-2#2)
compared with the baseline##2##4##(2008-10#1)(2008-7#1)
compared with the control group##4##5##(1994-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
compared with the control treatment##2##5##(2008-10#2)
compared with the control##17##4##(1993-1#1)(1994-3#1)(2008-10#9)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)
compared with the controls##3##4##(2008-10#3)
compared with the conventional##4##4##(2008-10#3)(2008-9#1)
compared with the corresponding##4##4##(1995-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
compared with the current##2##4##(1996-1#2)
compared with the data obtained##2##5##(2008-10#1)(2013-1#1)
compared with the effect of##2##5##(1996-2#1)(2008-10#1)
compared with the findings##3##4##(1991-2#1)(1997-8#1)(2008-11#1)
compared with the first##2##4##(1996-12#1)(2011-2#1)
compared with the high##2##4##(2008-10#1)(2008-9#1)
compared with the normal##4##4##(1991-2#1)(1996-2#1)(2010-10#1)(2011-3#1)
compared with the number of##2##5##(1993-6#1)(1995-2#1)
compared with the other two##3##5##(2008-10#2)(2010-6#1)
compared with the other##9##4##(2008-10#6)(2008-8#1)(2010-6#1)(2011-2#1)
compared with the parental strain##2##5##(2008-10#2)
compared with the placebo group##2##5##(2009-8#1)(2012-2#1)
compared with the reference##5##4##(2008-10#3)(2008-11#1)(2013-8#1)
compared with the results obtained by##2##6##(2008-10#2)
compared with the results obtained##5##5##(2008-10#5)
compared with the results of the##2##6##(2008-10#1)(2008-3#1)
compared with the results of##6##5##(1996-11#1)(2008-10#1)(2008-3#3)(2011-2#1)
compared with the results##12##4##(1996-11#1)(2008-10#7)(2008-3#3)(2011-2#1)
compared with the standard##5##4##(1996-3#1)(2008-10#4)
compared with the susceptible##2##4##(2008-10#2)
compared with the total##2##4##(2008-3#1)(2010-4#1)
compared with the traditional##2##4##(2008-2#1)(2010-12#1)
compared with the usual##3##4##(2008-10#2)(2008-3#1)
compared with the value obtained##2##5##(1995-6#1)(2008-11#1)
compared with the values obtained##2##5##(2008-10#2)
compared with the vehicle##2##4##(2010-1#1)(2013-8#1)
compared with the wild-type strain##3##5##(2008-10#3)
compared with the##278##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-10#1)(1992-2#3)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#1)(1997-8#3)(2008-10#128)(2008-11#5)(2008-2#7)(2008-3#19)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#18)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#6)
compared with their##8##3##(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-6#1)(2013-1#1)
compared with those determined##3##4##(1990-9#1)(2008-10#2)
compared with those from##4##4##(2008-10#2)(2008-11#1)(2008-8#1)
compared with those in the##3##5##(2008-10#1)(2008-11#1)(2012-12#1)
compared with those in##10##4##(1995-11#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2012-12#2)
compared with those obtained by high performance liquid chromatography (HPLC)##2##10##(2008-10#2)
compared with those obtained by the##4##6##(2008-10#4)
compared with those obtained by##15##5##(2008-10#13)(2008-3#1)(2008-5#1)
compared with those obtained from##4##5##(2008-10#4)
compared with those obtained using##6##5##(1995-6#1)(2008-10#5)
compared with those obtained with a##2##6##(2008-10#1)(2008-3#1)
compared with those obtained with the##2##6##(2008-10#2)
compared with those obtained with##8##5##(2008-10#7)(2008-3#1)
compared with those obtained##34##4##(1995-6#1)(2008-10#30)(2008-3#2)(2008-5#1)
compared with those of a##3##5##(1994-8#1)(2008-10#2)
compared with those of other##5##5##(2008-10#3)(2008-3#2)
compared with those of the##9##5##(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)
compared with those of##42##4##(1990-5#1)(1991-3#1)(1993-11#1)(1994-8#1)(1996-3#1)(2008-10#25)(2008-11#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)
compared with those reported##2##4##(2008-10#2)
compared with those with##4##4##(2008-10#2)(2010-4#1)(2012-12#1)
compared with those##121##3##(1990-5#1)(1990-9#1)(1991-3#1)(1992-1#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-3#2)(2008-10#80)(2008-11#8)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#3)
compared with untreated##4##3##(1993-8#1)(1995-2#1)(2008-12#1)(2010-11#1)
compared with values##3##3##(2008-3#2)(2011-2#1)
compared with water##3##3##(2008-10#3)
compared with wild-type##5##3##(1996-2#1)(2008-10#3)(2012-12#1)
compared with women##2##3##(1991-11#1)(2010-6#1)
compared with young ones##2##4##(1990-5#1)(2008-7#1)
compared with young##4##3##(1990-5#1)(1996-2#1)(2008-7#2)
compared with##1101##2##(1990-11#1)(1990-12#5)(1990-5#3)(1990-6#1)(1990-9#5)(1991-11#2)(1991-12#3)(1991-2#9)(1991-3#4)(1991-5#1)(1991-7#3)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#3)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#5)(1993-11#4)(1993-12#4)(1993-2#4)(1993-6#3)(1993-8#4)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#5)(1994-6#1)(1994-8#5)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#5)(1995-5#1)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#6)(1996-2#10)(1996-3#7)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#7)(2006-6#3)(2007-11#1)(2007-12#4)(2008-1#4)(2008-10#489)(2008-11#57)(2008-12#11)(2008-2#16)(2008-3#49)(2008-4#1)(2008-5#18)(2008-6#4)(2008-7#21)(2008-8#17)(2008-9#18)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#7)(2010-10#2)(2010-11#1)(2010-12#10)(2010-4#5)(2010-6#5)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#52)(2011-3#4)(2012-12#20)(2012-2#11)(2012-3#23)(2013-1#32)(2013-7#1)(2013-8#14)
compared##2412##1##(1990-11#6)(1990-12#8)(1990-5#10)(1990-6#4)(1990-8#4)(1990-9#6)(1991-1#2)(1991-11#3)(1991-12#11)(1991-2#15)(1991-3#8)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#6)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#7)(1992-2#4)(1992-3#1)(1992-5#2)(1992-6#4)(1992-8#5)(1992-9#3)(1993-1#17)(1993-11#14)(1993-12#8)(1993-2#12)(1993-3#5)(1993-6#7)(1993-8#9)(1993-9#3)(1994-1#6)(1994-11#8)(1994-12#6)(1994-2#8)(1994-3#12)(1994-5#7)(1994-6#1)(1994-8#15)(1994-9#2)(1995-1#4)(1995-11#9)(1995-12#18)(1995-2#14)(1995-3#8)(1995-5#3)(1995-6#8)(1995-8#2)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#24)(1996-2#13)(1996-3#11)(1996-6#6)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#11)(1997-3#7)(1997-4#2)(1997-5#2)(1997-7#9)(1997-8#13)(2006-6#3)(2007-11#1)(2007-12#13)(2007-8#1)(2008-1#7)(2008-10#869)(2008-11#184)(2008-12#30)(2008-2#22)(2008-3#75)(2008-4#10)(2008-5#64)(2008-6#10)(2008-7#62)(2008-8#40)(2008-9#51)(2009-1#2)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#1)(2009-3#11)(2009-4#5)(2009-5#2)(2009-6#7)(2009-7#12)(2009-8#11)(2009-9#2)(2010-1#9)(2010-10#6)(2010-11#1)(2010-12#16)(2010-2#1)(2010-3#4)(2010-4#10)(2010-5#2)(2010-6#8)(2010-7#7)(2010-8#13)(2010-9#6)(2011-1#7)(2011-10#2)(2011-2#104)(2011-3#6)(2011-7#2)(2012-12#34)(2012-2#45)(2012-3#49)(2012-4#1)(2012-5#4)(2012-6#2)(2012-9#3)(2013-1#76)(2013-7#5)(2013-8#38)
compares favorably with that##2##4##(2008-10#1)(2008-3#1)
compares favorably##3##2##(2008-10#2)(2008-3#1)
compares favourably with##3##3##(1991-9#1)(2008-10#1)(2008-7#1)
compares the##15##2##(1991-12#1)(1993-12#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-12#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-2#1)
compares##37##1##(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
comparing CHM##2##2##(2008-10#2)
comparing and##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
comparing apples##2##2##(2008-12#1)(2008-8#1)
comparing both##2##2##(1997-7#1)(2012-12#1)
comparing clinical##2##2##(2008-11#1)(2013-1#1)
comparing different##2##2##(2009-8#1)(2010-5#1)
comparing gene##2##2##(2008-4#1)(2010-4#1)
comparing it with##5##3##(1990-2#1)(1996-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
comparing long-term##2##2##(2008-10#1)(2012-12#1)
comparing multilevel C-ADR with##2##4##(2012-12#2)
comparing multilevel##3##2##(2012-12#3)
comparing patients##2##2##(1997-3#1)(2012-12#1)
comparing results##3##2##(2008-10#2)(2008-8#1)
comparing the result of##2##4##(2008-10#1)(2008-3#1)
comparing the results with those##2##5##(2008-10#1)(2010-11#1)
comparing the results with##5##4##(2008-10#4)(2010-11#1)
comparing the results##8##3##(1996-3#1)(2008-10#6)(2010-11#1)
comparing the two##2##3##(1992-12#1)(1996-1#1)
comparing the##70##2##(1990-2#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-6#1)(2008-10#32)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#3)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
comparing their##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
comparing them with##3##3##(2008-10#2)(2011-3#1)
comparing to patients##2##3##(2011-2#1)(2012-3#1)
comparing to##5##2##(2008-10#2)(2011-2#2)(2012-3#1)
comparing two##3##2##(1993-1#1)(2008-4#1)(2011-2#1)
comparing with standard##2##3##(2008-10#1)(2012-2#1)
comparing with the##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
comparing with##11##2##(1993-3#1)(2008-10#5)(2008-5#2)(2008-8#1)(2010-6#1)(2012-2#1)
comparing##202##1##(1990-2#2)(1990-7#1)(1991-3#3)(1992-1#1)(1992-12#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#3)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#2)(2007-12#1)(2008-10#70)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#8)(2008-8#12)(2008-9#8)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-6#2)(2011-2#3)(2011-3#3)(2012-12#9)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
comparison among##5##2##(2008-10#2)(2008-6#1)(2009-11#1)(2011-2#1)
comparison analysis##2##2##(2008-10#2)
comparison and##8##2##(1993-2#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2013-8#1)
comparison at##2##2##(1991-3#1)(2008-11#1)
comparison between a##2##3##(2008-10#1)(2011-2#1)
comparison between different##2##3##(1991-11#1)(2008-10#1)
comparison between measured##2##3##(2008-2#1)(2008-3#1)
comparison between patients with##2##4##(1997-5#1)(2013-1#1)
comparison between the two##2##4##(1991-6#1)(2008-11#1)
comparison between the##9##3##(1991-6#1)(1992-5#1)(1994-5#1)(2008-10#4)(2008-11#1)(2010-4#1)
comparison between two##2##3##(1996-3#1)(2013-8#1)
comparison between##42##2##(1990-2#1)(1991-11#1)(1991-6#1)(1992-5#1)(1994-2#1)(1994-5#1)(1996-3#1)(1997-5#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-4#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
comparison group##5##2##(1992-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-11#1)
comparison in##4##2##(1994-6#1)(2008-10#1)(2008-3#1)(2010-4#1)
comparison is##12##2##(1994-9#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
comparison of a##4##3##(1992-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
comparison of amino acid sequences of##2##6##(2008-10#1)(2008-8#1)
comparison of amino##3##3##(2008-10#1)(2008-8#2)
comparison of benefits##2##3##(1992-3#1)(2008-5#1)
comparison of both##2##3##(1991-6#1)(1995-12#1)
comparison of gene##2##3##(1996-12#1)(2008-10#1)
comparison of measurements##2##3##(2008-2#1)(2008-3#1)
comparison of results##3##3##(2008-10#2)(2008-11#1)
comparison of that##2##3##(2008-10#1)(2008-3#1)
comparison of the analytical##2##4##(2008-10#2)
comparison of the deduced##3##4##(1993-6#2)(2008-10#1)
comparison of the electrochemical##2##4##(2008-10#2)
comparison of the performance of##2##5##(2008-10#2)
comparison of the results of##2##5##(2008-10#1)(2008-5#1)
comparison of the results with those##2##6##(2008-10#2)
comparison of the results##5##4##(2008-10#3)(2008-5#1)(2009-9#1)
comparison of the two##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
comparison of the##69##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-6#3)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-8#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-12#1)(2013-1#1)
comparison of their##2##3##(2008-10#2)
comparison of these##4##3##(2008-10#2)(2008-3#1)(2012-7#1)
comparison of three##2##3##(2008-10#1)(2012-2#1)
comparison of two different##2##4##(1992-9#1)(2008-10#1)
comparison of two##15##3##(1991-1#1)(1992-3#1)(1992-9#1)(1994-9#3)(1996-6#1)(2008-10#3)(2008-3#2)(2011-1#1)(2012-12#1)(2012-2#1)
comparison of various##2##3##(2008-10#2)
comparison of##236##2##(1990-6#1)(1990-8#1)(1991-1#3)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#80)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-7#1)(2012-9#2)(2013-1#4)(2013-8#4)
comparison permits##2##2##(1997-2#1)(2008-7#1)
comparison purposes##2##2##(2008-10#2)
comparison revealed that##2##3##(2008-9#1)(2012-12#1)
comparison showed that##2##3##(1991-6#1)(2008-8#1)
comparison study##6##2##(1992-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-1#1)
comparison to a##2##3##(2008-10#1)(2013-8#1)
comparison to the control group##2##5##(2009-12#1)(2012-3#1)
comparison to the control##3##4##(2008-12#1)(2009-12#1)(2012-3#1)
comparison to the##30##3##(1990-2#1)(1990-9#1)(1991-6#1)(1994-3#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
comparison to those##6##3##(2008-10#5)(2013-1#1)
comparison to##96##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-3#1)(1997-2#2)(2007-12#1)(2008-10#35)(2008-11#10)(2008-12#6)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
comparison was made between##3##4##(1994-3#1)(2008-10#1)(2011-2#1)
comparison was made of##2##4##(1991-3#1)(1996-12#1)
comparison was made##8##3##(1991-3#1)(1994-3#1)(1996-12#1)(2008-10#4)(2011-2#1)
comparison was##12##2##(1991-3#1)(1994-3#1)(1996-12#1)(2008-10#6)(2010-6#1)(2010-9#1)(2011-2#1)
comparison were##6##2##(2008-10#2)(2008-3#1)(2008-5#2)(2011-2#1)
comparison with 3##2##3##(1995-8#1)(2008-10#1)
comparison with a reference##2##4##(2008-10#2)
comparison with a##8##3##(2008-10#6)(2008-3#1)(2008-8#1)
comparison with clinical##2##3##(2008-11#1)(2011-2#1)
comparison with commercial##2##3##(2008-10#1)(2008-5#1)
comparison with control##2##3##(1995-12#1)(2008-12#1)
comparison with modern##2##3##(2013-1#2)
comparison with other##10##3##(1996-3#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-5#1)
comparison with results##2##3##(2008-11#1)(2008-3#1)
comparison with some##3##3##(2008-10#3)
comparison with that in##2##4##(2008-8#2)
comparison with that of##7##4##(1995-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)
comparison with that##12##3##(1995-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#5)(2008-9#1)
comparison with the control group##2##5##(1993-3#1)(2008-10#1)
comparison with the control##4##4##(1993-3#2)(2008-10#1)(2008-12#1)
comparison with the reference##2##4##(2008-10#2)
comparison with the sequences in protein and EST databases and analysis with computer programs for gene modeling##2##17##(1997-6#1)(1997-8#1)
comparison with the standard##2##4##(2008-10#1)(2008-11#1)
comparison with the##55##3##(1991-2#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#25)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#3)
comparison with those##4##3##(1995-8#1)(1997-8#1)(2008-10#1)(2008-8#1)
comparison with##209##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#2)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#83)(2008-11#19)(2008-12#8)(2008-3#9)(2008-5#5)(2008-7#2)(2008-8#10)(2008-9#2)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#10)(2011-3#1)(2012-2#1)(2012-5#1)(2013-1#4)
comparison##737##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#5)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#6)(1991-5#2)(1991-6#6)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#6)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#6)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#5)(1996-5#1)(1996-6#3)(1996-8#3)(1997-1#1)(1997-2#8)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#5)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#264)(2008-11#51)(2008-12#20)(2008-2#5)(2008-3#25)(2008-4#4)(2008-5#21)(2008-6#2)(2008-7#11)(2008-8#18)(2008-9#13)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#1)(2011-2#23)(2011-3#2)(2012-12#4)(2012-2#12)(2012-3#6)(2012-5#1)(2012-7#1)(2012-9#2)(2013-1#19)(2013-7#1)(2013-8#9)
comparisons across##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
comparisons among##4##2##(2008-10#2)(2008-11#1)(2010-12#1)
comparisons and##9##2##(1991-2#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-11#1)
comparisons are##2##2##(1991-3#1)(2009-7#1)
comparisons between the##2##3##(2008-10#1)(2013-1#1)
comparisons between##10##2##(1991-11#1)(1995-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
comparisons but also##2##3##(2008-10#1)(2013-8#1)
comparisons indicate that##2##3##(1993-6#1)(2008-10#1)
comparisons indicate##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
comparisons of the##3##3##(2008-10#2)(2009-7#1)
comparisons of##26##2##(1995-2#3)(2007-12#1)(2008-10#9)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#2)
comparisons revealed that##6##3##(2008-10#3)(2008-4#1)(2009-7#1)(2012-2#1)
comparisons revealed##7##2##(1997-7#1)(2008-10#3)(2008-4#1)(2009-7#1)(2012-2#1)
comparisons to national##4##3##(1994-3#4)
comparisons to other##2##3##(2008-8#1)(2011-2#1)
comparisons to##10##2##(1994-3#4)(2008-8#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
comparisons using##3##2##(2008-10#1)(2008-9#1)(2010-1#1)
comparisons were made##2##3##(2008-10#2)
comparisons with a##3##3##(1992-4#1)(2008-3#2)
comparisons with the##3##3##(1992-4#1)(1995-12#1)(2008-11#1)
comparisons with##10##2##(1992-4#2)(1994-3#1)(1995-12#1)(1996-1#1)(2008-11#1)(2008-3#3)(2008-7#1)
comparisons within##2##2##(1991-12#1)(2008-10#1)
comparisons##150##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-4#2)(1992-6#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-3#5)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#7)(1996-1#2)(1996-3#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-12#3)(2008-1#2)(2008-10#48)(2008-11#4)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#7)(2008-9#6)(2009-11#1)(2009-12#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-8#2)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
compartment in##3##2##(1991-5#1)(1993-6#1)(2008-11#1)
compartment of a##2##3##(2008-10#1)(2008-7#1)
compartment of the##4##3##(1992-3#1)(2008-10#1)(2008-12#1)(2009-10#1)
compartment of##7##2##(1992-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-10#1)
compartment syndrome##4##2##(2009-1#4)
compartment to##2##2##(1995-11#1)(2009-9#1)
compartment##47##1##(1990-12#1)(1991-5#1)(1992-10#1)(1992-3#2)(1993-2#2)(1993-6#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-2#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#4)(2009-10#1)(2009-9#1)(2010-11#3)(2011-2#4)(2012-2#3)(2013-1#1)
compartmental models##2##2##(1995-12#1)(2008-11#1)
compartmental##8##1##(1992-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2013-8#1)
compartmentalization of##9##2##(1994-8#1)(1997-3#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
compartmentalization##12##1##(1994-11#1)(1994-8#1)(1997-3#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)
compartmentalized##6##1##(1994-11#1)(1995-2#1)(2008-10#2)(2008-7#1)(2009-8#1)
compartmentation of##3##2##(1995-8#1)(1996-6#1)(2012-7#1)
compartments and##2##2##(2008-10#1)(2012-2#1)
compartments are##2##2##(2008-10#1)(2011-2#1)
compartments in##3##2##(1994-6#1)(1995-2#1)(2008-11#1)
compartments of the##2##3##(2008-10#1)(2008-7#1)
compartments of##6##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
compartments##44##1##(1990-5#1)(1992-10#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-2#3)(1995-8#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-8#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#2)
compartments)##2##1##(2009-10#1)(2011-2#1)
compassionate##3##1##(1991-2#1)(2008-10#1)(2008-11#1)
compatibility and##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
compatibility between##4##2##(2008-10#1)(2008-9#1)(2009-3#1)(2013-1#1)
compatibility group##8##2##(2008-10#8)
compatibility groups##19##2##(2008-10#19)
compatibility in##2##2##(2008-10#2)
compatibility of a##2##3##(2009-12#1)(2012-3#1)
compatibility of the##5##3##(1993-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
compatibility of wax and oil##2##5##(2008-5#2)
compatibility of##19##2##(1993-8#1)(2008-10#4)(2008-3#1)(2008-5#4)(2009-12#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#1)
compatibility rate##2##2##(2013-1#2)
compatibility tests##3##2##(1997-5#1)(2008-10#2)
compatibility to##2##2##(1995-5#1)(2008-10#1)
compatibility type##4##2##(2008-10#4)
compatibility with##5##2##(2008-10#3)(2008-11#1)(2013-1#1)
compatibility##97##1##(1993-8#1)(1995-5#1)(1997-5#1)(2008-10#61)(2008-11#1)(2008-3#2)(2008-5#8)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-3#3)(2013-1#7)(2013-8#1)
compatible (i##2##2##(2008-10#2)
compatible and##3##2##(2008-10#2)(2008-5#1)
compatible hosts##3##2##(2008-10#3)
compatible interaction##3##2##(2008-10#3)
compatible solutes##2##2##(2012-7#2)
compatible with a##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
compatible with all##3##3##(1990-12#1)(2008-10#1)(2008-9#1)
compatible with the hypothesis##2##4##(1991-2#1)(2011-2#1)
compatible with the##13##3##(1990-8#1)(1991-2#1)(2008-10#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
compatible with##55##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-8#2)(1992-2#1)(1992-9#1)(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-3#3)(2013-1#2)
compatible##98##1##(1990-12#1)(1990-8#1)(1991-2#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-8#1)(1995-6#1)(1997-3#1)(2007-12#1)(2008-10#46)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#5)(2009-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#6)(2011-7#1)(2012-2#1)(2012-3#4)(2012-7#2)(2013-1#2)
compel##3##1##(1994-2#1)(1996-12#1)(2008-12#1)
compelled to##2##2##(1991-2#1)(2008-6#1)
compelling business##2##2##(1997-1#2)
compelling evidence that##4##3##(2008-2#1)(2009-8#1)(2011-2#2)
compelling evidence##8##2##(1995-3#1)(1996-12#1)(2007-12#1)(2008-2#1)(2009-8#1)(2011-2#2)(2013-8#1)
compelling##20##1##(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-1#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
compensate for the##14##3##(1994-12#1)(1994-5#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
compensate for their##2##3##(2008-11#1)(2012-2#1)
compensate for##23##2##(1994-12#1)(1994-5#2)(1995-8#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-3#4)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
compensate##31##1##(1990-11#1)(1993-11#1)(1994-12#1)(1994-5#2)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-3#5)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
compensated by an##2##3##(2008-7#1)(2013-8#1)
compensated by##9##2##(1995-5#1)(1995-6#1)(2008-10#3)(2008-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
compensated cirrhosis##2##2##(2013-1#2)
compensated for by##5##3##(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
compensated for##7##2##(2008-10#2)(2008-3#2)(2008-8#1)(2008-9#1)(2013-1#1)
compensated state##3##2##(1991-2#3)
compensated with##2##2##(1991-2#1)(1996-3#1)
compensated##33##1##(1991-2#6)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-10#8)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-7#1)(2013-1#4)(2013-8#1)
compensating for the##2##3##(1995-3#1)(2008-3#1)
compensating for##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
compensating##6##1##(1995-3#1)(1997-3#1)(2008-10#3)(2008-3#1)
compensation and##4##2##(2008-10#1)(2008-3#1)(2012-2#1)(2013-8#1)
compensation for##4##2##(1994-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
compensation in##4##2##(1991-2#2)(2008-10#1)(2008-3#1)
compensation is##8##2##(1993-3#1)(1995-1#1)(2008-3#2)(2008-9#2)(2013-8#2)
compensation of##5##2##(1991-12#1)(1991-2#2)(2008-2#1)(2008-3#1)
compensation systems##3##2##(1994-12#1)(1997-1#1)(2008-2#1)
compensation with##3##2##(2008-10#1)(2008-3#2)
compensation##96##1##(1991-12#1)(1991-2#8)(1991-3#1)(1992-2#1)(1993-1#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#4)(1995-2#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(2007-11#1)(2008-10#10)(2008-11#7)(2008-2#4)(2008-3#15)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#14)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#6)
compensatory homeostasis##5##2##(2012-2#5)
compensatory β-cell##2##2##(2010-11#2)
compensatory##28##1##(1994-5#1)(1994-8#2)(1995-6#1)(2008-10#4)(2008-11#1)(2008-8#2)(2009-1#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
compete for the##2##3##(1991-5#1)(1995-6#1)
compete for##18##2##(1991-3#1)(1991-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#5)(2008-9#1)
compete in##3##2##(1997-1#1)(2008-11#1)(2008-8#1)
compete with##13##2##(1990-8#1)(1993-3#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-11#2)(2009-3#1)(2009-7#1)(2010-1#1)(2012-2#1)(2013-7#1)
compete##45##1##(1990-8#1)(1991-3#1)(1991-5#1)(1993-3#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#2)(1997-1#1)(1997-2#2)(2006-6#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#1)(2009-3#1)(2009-7#1)(2010-1#1)(2012-2#1)(2013-7#1)
competed for##3##2##(1993-6#2)(1993-8#1)
competed with##3##2##(1993-3#1)(2008-10#1)(2008-8#1)
competed##8##1##(1990-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1996-12#1)(2008-10#1)(2008-8#1)
competence and confidence##3##3##(2008-11#2)(2008-12#1)
competence and##13##2##(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#4)(2009-7#2)(2010-11#2)
competence in##10##2##(1992-2#1)(1992-3#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2012-3#1)(2013-1#1)
competence is##4##2##(1994-12#1)(2008-12#3)
competence of the##2##3##(1993-8#1)(1996-2#1)
competence of##9##2##(1993-8#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#2)
competence that##2##2##(1993-6#1)(2008-1#1)
competence to##3##2##(2008-11#2)(2009-6#1)
competence##81##1##(1990-6#1)(1991-6#2)(1992-2#2)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-6#1)(1995-2#1)(1996-2#2)(1997-8#2)(2007-12#1)(2008-1#3)(2008-10#5)(2008-11#21)(2008-12#14)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#4)(2010-11#3)(2011-2#1)(2012-3#3)(2013-1#3)
competencies are##2##2##(2008-11#1)(2013-1#1)
competencies in##2##2##(2008-12#2)
competencies##21##1##(1992-1#1)(1992-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(2007-12#2)(2008-11#1)(2008-12#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
competency assessment##2##2##(2008-11#2)
competency of##3##2##(2008-10#1)(2008-11#1)(2010-3#1)
competency##20##1##(1991-2#1)(1994-1#1)(1995-2#1)(1996-1#1)(2007-12#4)(2008-10#2)(2008-11#4)(2008-12#2)(2008-8#2)(2010-3#1)(2011-2#1)
competency-based assessment##2##2##(2008-11#2)
competency-based##4##1##(2008-11#4)
competent and##3##2##(1992-3#1)(2008-11#2)
competent care##2##2##(1994-12#1)(2010-8#1)
competent for##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
competent nursing##3##2##(1991-2#1)(2008-12#2)
competent practitioners##4##2##(2008-11#2)(2008-12#2)
competent to##2##2##(1994-3#1)(2008-12#1)
competent##37##1##(1991-2#1)(1991-9#1)(1992-3#2)(1994-11#2)(1994-12#2)(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#9)(2008-5#2)(2010-11#1)(2010-8#1)(2013-8#1)
competes with##2##2##(1995-6#1)(2008-10#1)
competes##3##1##(1995-6#1)(2006-6#1)(2008-10#1)
competing anions##2##2##(2013-1#2)
competing demands##3##2##(2008-11#2)(2008-12#1)
competing for##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
competing in##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
competing plant pathogens##2##3##(2008-10#2)
competing species##12##2##(2008-8#10)(2008-9#2)
competing with##2##2##(1991-3#1)(2008-8#1)
competing##62##1##(1990-6#1)(1991-2#1)(1991-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-9#1)(1997-2#1)(2007-11#3)(2007-12#3)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#17)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#2)(2010-9#1)(2011-2#1)(2013-1#3)
competition among##6##2##(1991-3#1)(1992-2#1)(1994-1#1)(1994-2#1)(2008-8#1)(2008-9#1)
competition and predation##2##3##(2008-8#1)(2008-9#1)
competition and the##2##3##(2008-4#1)(2008-9#1)
competition and##22##2##(1991-3#1)(1992-12#1)(1995-2#2)(1996-2#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-8#6)(2008-9#4)(2009-1#1)(2009-7#1)
competition are##5##2##(2008-11#2)(2008-9#3)
competition assays##3##2##(1993-6#1)(2012-2#1)(2012-3#1)
competition between relatives##3##3##(2009-10#3)
competition between species##2##3##(2008-8#2)
competition between the##3##3##(1993-8#1)(1996-12#1)(2008-10#1)
competition between##20##2##(1993-8#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#3)(2010-11#1)
competition could be##2##3##(1997-2#1)(2008-8#1)
competition could##4##2##(1997-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
competition data##2##2##(1997-2#1)(2010-11#1)
competition dialysis assay##2##3##(2008-4#2)
competition dialysis##3##2##(2008-4#3)
competition experiments##2##2##(1995-12#1)(1996-3#1)
competition for nutrients##4##3##(2008-10#4)
competition for resources##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
competition for space##2##3##(2008-10#1)(2008-9#1)
competition for territories##2##3##(2008-8#2)
competition for the##2##3##(2008-11#1)(2008-8#1)
competition for##26##2##(1993-1#1)(1993-2#1)(1996-1#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#8)(2008-9#4)(2009-4#1)
competition from indigenous##2##3##(2008-10#2)
competition in the##2##3##(2008-11#1)(2013-8#1)
competition in##13##2##(1992-2#1)(1995-2#1)(1997-2#1)(2008-11#1)(2008-8#5)(2008-9#2)(2009-6#1)(2013-8#1)
competition is##5##2##(2008-8#4)(2008-9#1)
competition leads to##2##3##(2008-8#1)(2008-9#1)
competition may##2##2##(2008-9#1)(2009-10#1)
competition models##2##2##(2008-8#2)
competition occurred##2##2##(2008-10#1)(2008-9#1)
competition of##4##2##(2008-10#3)(2008-7#1)
competition on##5##2##(1991-3#1)(2008-11#2)(2008-12#1)(2008-8#1)
competition was##3##2##(2008-8#3)
competition will##2##2##(1997-3#1)(2013-8#1)
competition with##11##2##(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#4)(2010-8#1)
competition##245##1##(1991-1#1)(1991-3#3)(1992-12#2)(1992-2#4)(1992-3#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#3)(1994-2#1)(1995-12#1)(1995-2#6)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#4)(1997-3#2)(2008-1#1)(2008-10#32)(2008-11#17)(2008-12#2)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#74)(2008-9#47)(2009-1#1)(2009-10#7)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#5)
competition)##3##1##(2008-8#2)(2008-9#1)
competition-colonization models##3##2##(2008-8#3)
competition-colonization trade-off##4##2##(2008-8#4)
competition-colonization##8##1##(2008-8#8)
competition?##3##1##(1991-2#1)(2008-8#1)(2013-8#1)
competitions##4##1##(1993-3#1)(2009-8#1)(2011-2#2)
competitive ELISA##7##2##(1990-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-4#1)
competitive Langmuir##2##2##(2008-10#2)
competitive ability of##2##3##(2008-12#1)(2008-9#1)
competitive ability##10##2##(2008-10#1)(2008-12#1)(2008-8#5)(2008-9#3)
competitive adsorption##3##2##(2008-10#3)
competitive and##4##2##(2008-10#1)(2008-8#1)(2009-7#1)(2013-8#1)
competitive anions##2##2##(2008-10#2)
competitive assay##3##2##(2008-10#3)
competitive binding##6##2##(1990-5#1)(1992-3#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#1)
competitive dominance##2##2##(2008-8#1)(2008-9#1)
competitive effects##3##2##(2008-10#2)(2008-9#1)
competitive employment##2##2##(1993-3#2)
competitive enzyme-linked immunosorbent assay (ELISA)##2##5##(2008-10#2)
competitive enzyme-linked immunosorbent assay##6##4##(1991-9#2)(2008-10#3)(2011-2#1)
competitive enzyme-linked immunosorbent##7##3##(1991-9#2)(2008-10#3)(2011-2#2)
competitive exclusion of##2##3##(2008-10#2)
competitive exclusion##8##2##(1995-9#1)(2008-10#4)(2008-8#2)(2008-9#1)
competitive immune##2##2##(2008-10#2)
competitive immunoassay for##2##3##(2008-10#2)
competitive immunoassay##6##2##(2008-10#6)
competitive immunoreaction##2##2##(2008-10#2)
competitive inhibition of##2##3##(1992-12#1)(2008-11#1)
competitive inhibition##6##2##(1992-12#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-5#1)
competitive inhibitor##2##2##(1993-8#1)(2008-10#1)
competitive inhibitors of##3##3##(1991-5#1)(1992-12#1)(1994-5#1)
competitive inhibitors##5##2##(1991-5#2)(1991-9#1)(1992-12#1)(1994-5#1)
competitive interactions##7##2##(2008-10#3)(2008-8#3)(2010-8#1)
competitive market##2##2##(1991-3#1)(1994-12#1)
competitive polymerase chain reaction##3##4##(1995-12#1)(2008-10#2)
competitive reaction##4##2##(2008-10#4)
competitive sport participation##2##3##(2009-7#1)(2010-1#1)
competitive strategies for##2##3##(1996-1#1)(1997-1#1)
competitive substrate colonization##2##3##(2008-10#2)
competitive type##3##2##(1993-3#1)(2008-10#2)
competitive with the##2##3##(1996-5#1)(2008-10#1)
competitive with##3##2##(1994-5#1)(1996-5#1)(2008-10#1)
competitive##204##1##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#3)(1991-5#3)(1991-9#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-8#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-12#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#78)(2008-11#14)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#28)(2008-9#9)(2009-3#1)(2009-7#5)(2010-1#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
competitive-type immunoassay##2##2##(2008-10#2)
competitively exclude##2##2##(2008-10#1)(2008-8#1)
competitively inhibited##5##2##(1990-8#1)(1994-5#1)(1995-8#1)(1996-2#1)(2008-8#1)
competitively##17##1##(1990-8#1)(1991-3#1)(1991-9#1)(1994-5#2)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#4)(2008-9#1)(2011-2#1)
competitiveness##3##1##(1995-2#1)(2008-10#1)(2013-1#1)
competitor and##2##2##(1996-3#1)(2008-8#1)
competitor for##2##2##(2008-10#1)(2012-12#1)
competitor has a##2##3##(2008-8#2)
competitor is##2##2##(2008-8#1)(2008-9#1)
competitor of##2##2##(1995-2#1)(2008-10#1)
competitor##25##1##(1991-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#4)(2008-8#14)(2008-9#2)(2012-12#1)
competitors for##4##2##(2008-8#4)
competitors to##2##2##(1993-1#1)(2008-8#1)
competitors##28##1##(1990-12#1)(1993-1#1)(1993-3#1)(2008-8#21)(2008-9#3)(2009-10#1)
compilation of##4##2##(1992-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
compilation##7##1##(1992-2#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-7#1)
compile##4##1##(1996-12#1)(2008-9#1)(2010-9#1)(2013-1#1)
compiled and##2##2##(1993-2#1)(2008-10#1)
compiled codons##2##2##(2008-11#2)
compiled from##2##2##(2008-5#1)(2008-7#1)
compiled##17##1##(1991-6#1)(1991-8#1)(1993-12#1)(1993-2#3)(2008-10#3)(2008-11#5)(2008-5#1)(2008-7#1)(2012-12#1)
compiling##2##1##(2008-11#2)
complain##4##1##(1993-12#2)(1993-3#1)(1997-4#1)
complained of pain in the##2##5##(2008-8#1)(2009-1#1)
complained of severe pain##2##4##(2008-12#1)(2012-3#1)
complained of##14##2##(1990-12#1)(1991-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2009-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
complained##17##1##(1990-12#1)(1991-11#1)(1992-6#1)(1995-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
complaining of##4##2##(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
complaining##5##1##(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
complaint in##2##2##(2008-11#1)(2008-5#1)
complaint of##10##2##(2007-8#1)(2008-12#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
complaint with the##2##3##(1995-6#1)(1996-5#1)
complaint##20##1##(1990-6#1)(1995-12#1)(1995-6#1)(1996-5#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
complaints and##3##2##(1990-3#1)(1990-9#1)(2008-7#1)
complaints in##2##2##(1990-3#1)(2008-10#1)
complaints may##2##2##(1990-11#1)(2009-11#1)
complaints of##11##2##(1994-3#1)(2008-10#1)(2008-12#2)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
complaints##51##1##(1990-11#1)(1990-3#3)(1990-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-3#3)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-12#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
complement a##3##2##(1996-3#1)(1996-6#1)(2009-8#1)
complement activation##5##2##(2008-10#5)
complement and##3##2##(1993-3#1)(2008-4#1)(2011-2#1)
complement each other to##2##4##(1997-3#1)(2013-8#1)
complement factor H##2##3##(1997-9#1)(2009-6#1)
complement factor##3##2##(1991-3#1)(1997-9#1)(2009-6#1)
complement fixation##3##2##(1992-5#1)(2008-1#1)(2008-5#1)
complement in##2##2##(1993-3#1)(2008-7#1)
complement of##8##2##(1992-8#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)
complement pathways##2##2##(1993-11#2)
complement receptor##2##2##(1994-6#1)(1997-3#1)
complement receptors##2##2##(2008-10#2)
complement system##3##2##(1991-2#1)(2008-10#1)(2009-6#1)
complement the##9##2##(1993-12#1)(1994-12#1)(2008-10#4)(2008-8#1)(2010-5#1)(2010-8#1)
complement those##2##2##(2008-10#1)(2010-5#1)
complement to the##2##3##(1993-3#1)(2008-11#1)
complement to##9##2##(1990-3#1)(1993-3#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
complement##89##1##(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#2)(1992-5#1)(1992-8#1)(1993-11#4)(1993-12#3)(1993-3#4)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-3#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
complement-dependent##2##1##(1997-5#1)(2011-2#1)
complement-mediated##2##1##(1995-5#1)(2008-10#1)
complementarity of##2##2##(1991-2#1)(1994-5#1)
complementarity to##2##2##(1993-12#1)(2008-8#1)
complementarity##9##1##(1991-2#1)(1993-12#2)(1994-5#2)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
complementary DNA (cDNA)##3##3##(2008-10#2)(2008-9#1)
complementary DNA clones##2##3##(2008-10#2)
complementary DNA##12##2##(1990-5#1)(1991-5#2)(1994-12#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-9#1)
complementary DNAs##3##2##(1991-5#1)(1994-11#2)
complementary and alternative medicine (CAM)##2##5##(2008-10#2)
complementary and alternative medicine##7##4##(2008-10#4)(2009-5#1)(2009-6#2)
complementary and alternative##9##3##(1991-3#1)(2008-10#4)(2008-11#1)(2009-5#1)(2009-6#2)
complementary and##11##2##(1991-3#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-5#1)(2009-6#2)(2012-3#1)
complementary feeding practices and behaviours##2##5##(2010-6#2)
complementary feeding##3##2##(2010-6#3)
complementary information##2##2##(1994-12#1)(2008-10#1)
complementary log-log##2##2##(2008-10#2)
complementary method to HRMS for##2##5##(2008-10#2)
complementary method to##3##3##(2008-10#3)
complementary method##4##2##(2008-10#3)(2012-2#1)
complementary oligonucleotides##2##2##(1993-6#1)(2008-10#1)
complementary sense##3##2##(2008-9#3)
complementary sequence##2##2##(1995-12#1)(2008-10#1)
complementary sequences##3##2##(2008-10#2)(2008-4#1)
complementary strand##4##2##(2008-10#3)(2008-4#1)
complementary strands##2##2##(1997-6#1)(2008-10#1)
complementary target##9##2##(2008-10#8)(2008-9#1)
complementary technique##2##2##(1996-3#1)(2008-10#1)
complementary to a##2##3##(1997-7#2)
complementary to the target##2##4##(2008-10#2)
complementary to the##6##3##(2008-10#4)(2008-4#1)(2008-9#1)
complementary to##21##2##(1996-8#1)(1997-7#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-2#2)
complementary##145##1##(1990-5#1)(1991-3#1)(1991-5#4)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-7#2)(2008-10#67)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#6)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#9)(2009-5#1)(2009-6#2)(2009-8#1)(2010-6#5)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
complementation groups##2##2##(1996-3#2)
complementation of a##2##3##(1993-9#1)(1995-9#1)
complementation of##6##2##(1992-5#1)(1993-9#1)(1995-9#1)(1996-2#1)(1996-3#1)(2008-10#1)
complementation system##2##2##(2008-8#2)
complementation using##2##2##(1995-12#1)(2008-9#1)
complementation was##2##2##(1997-7#1)(2008-10#1)
complementation with##2##2##(1995-2#1)(2008-11#1)
complementation##28##1##(1992-5#1)(1993-9#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#3)(1997-7#1)(2008-10#7)(2008-11#1)(2008-8#3)(2008-9#3)(2009-10#1)
complemented by the wild-type##2##4##(1991-12#2)
complemented by the##3##3##(1991-12#2)(2011-2#1)
complemented by##8##2##(1991-12#2)(1995-6#1)(1997-7#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)
complemented the##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
complemented with a##2##3##(2008-11#1)(2009-8#1)
complemented##18##1##(1991-12#2)(1995-2#1)(1995-6#1)(1997-7#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)
complementing##7##1##(1996-6#1)(2008-10#1)(2008-11#3)(2008-9#1)(2011-3#1)
complements##6##1##(1995-6#1)(1997-7#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-8#1)
complete DNA##2##2##(2008-10#1)(2012-3#1)
complete NMR chemical shift assignments##3##5##(2009-7#3)
complete a##8##2##(1990-11#1)(1992-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2010-8#1)(2013-7#1)(2013-8#1)
complete absence of Ce(IV) and##2##5##(2008-10#2)
complete absence of##10##3##(1992-5#1)(1993-12#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#4)(2013-1#1)
complete absence##11##2##(1992-5#1)(1993-12#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2013-1#1)
complete analysis of##3##3##(1991-1#1)(2008-10#2)
complete analysis##6##2##(1991-1#1)(2008-10#5)
complete and accurate##2##3##(2010-5#1)(2010-8#1)
complete and##10##2##(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
complete assessment##2##2##(2008-4#1)(2008-9#1)
complete assignment##2##2##(2009-7#1)(2013-1#1)
complete backbone##2##2##(2009-7#2)
complete blood count##2##3##(2008-10#1)(2013-1#1)
complete by##2##2##(1994-11#1)(2008-11#1)
complete cDNA##2##2##(1993-8#1)(2010-5#1)
complete clinical##2##2##(1997-8#1)(2011-2#1)
complete closure##3##2##(1997-8#3)
complete control of##2##3##(2008-10#1)(2010-12#1)
complete control##4##2##(2008-10#2)(2008-8#1)(2010-12#1)
complete cure##4##2##(2008-7#2)(2011-2#1)(2013-7#1)
complete denture##4##2##(2013-1#4)
complete dentures##4##2##(2011-7#1)(2013-1#3)
complete digestion of samples##2##4##(2008-10#2)
complete digestion##3##2##(1996-2#1)(2008-10#2)
complete dissolution of##2##3##(1995-8#1)(2008-10#1)
complete dissolution##3##2##(1995-8#1)(2008-10#2)
complete elimination of##2##3##(2008-11#1)(2008-7#1)
complete elution of##2##3##(2008-10#2)
complete elution##3##2##(2008-10#3)
complete emergence##2##2##(2008-10#2)
complete eradication of##2##3##(2010-12#1)(2011-2#1)
complete excision of CIN or worse##2##6##(1994-2#2)
complete excision of the##2##4##(2012-3#1)(2013-1#1)
complete excision of##4##3##(1994-2#2)(2012-3#1)(2013-1#1)
complete explanation of##2##3##(1990-12#1)(2008-11#1)
complete extraction of##3##3##(2008-10#3)
complete extraction##4##2##(2008-10#4)
complete functional##2##2##(1993-6#1)(2008-7#1)
complete fusion##2##2##(1991-5#2)
complete gene##3##2##(1993-8#1)(2008-9#1)(2010-5#1)
complete genome of##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
complete genome sequence of the##3##5##(2008-9#1)(2011-2#2)
complete genome sequence of##11##4##(2008-10#1)(2008-9#1)(2011-2#8)(2013-8#1)
complete genome sequence##33##3##(2008-10#1)(2008-9#2)(2011-2#28)(2013-8#2)
complete genome sequences##4##3##(2008-10#2)(2008-4#2)
complete genome##42##2##(2008-10#5)(2008-4#2)(2008-8#2)(2008-9#2)(2011-2#28)(2012-3#1)(2013-8#2)
complete genomes##2##2##(2008-10#1)(2008-8#1)
complete genomic sequence of##2##4##(2008-10#1)(2008-8#1)
complete genomic##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
complete in##9##2##(1991-8#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-8#1)
complete inactivation##2##2##(1990-2#1)(2011-2#1)
complete internal transcribed spacer (ITS) region##3##6##(2008-10#3)
complete interruption of##2##3##(1993-3#1)(2012-2#1)
complete its life cycle##2##4##(2008-10#1)(2012-2#1)
complete linkage##2##2##(2008-8#1)(2012-2#1)
complete list of##3##3##(1991-8#1)(1996-12#1)(2010-3#1)
complete loss of the##2##4##(2008-12#1)(2013-1#1)
complete loss of##10##3##(1993-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
complete medical history##2##3##(1995-5#1)(2012-5#1)
complete medical##3##2##(1993-12#1)(1995-5#1)(2012-5#1)
complete mineralization##2##2##(1995-11#1)(2008-10#1)
complete mitochondrial##2##2##(2008-5#1)(2008-6#1)
complete nucleotide sequence of a##6##5##(1993-3#1)(1995-9#1)(1996-6#1)(1997-4#1)(2008-10#2)
complete nucleotide sequence of the##7##5##(1992-3#1)(1993-2#1)(1995-6#1)(1997-7#1)(2008-10#3)
complete nucleotide sequence of##18##4##(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#7)(2008-8#1)
complete nucleotide sequence##20##3##(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#8)(2008-8#1)
complete nucleotide sequences of##4##4##(2008-10#3)(2013-8#1)
complete nucleotide##27##2##(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#12)(2008-8#1)(2013-8#1)
complete obliteration##4##2##(2008-7#4)
complete open reading frame##3##4##(1993-3#1)(2008-8#2)
complete open reading frames##3##4##(1995-12#1)(1995-9#2)
complete open reading##6##3##(1993-3#1)(1995-12#1)(1995-9#2)(2008-8#2)
complete or incomplete##2##3##(2008-10#1)(2008-12#1)
complete or partial##3##3##(1991-6#1)(2008-12#1)(2010-5#1)
complete or##5##2##(1991-6#1)(2008-10#1)(2008-12#2)(2010-5#1)
complete pathologic##2##2##(1990-12#1)(2008-10#1)
complete picture of the##2##4##(2008-10#1)(2010-4#1)
complete picture##4##2##(2008-10#1)(2009-8#2)(2010-4#1)
complete procedure##4##2##(2008-10#2)(2010-7#2)
complete protection##3##2##(1990-6#1)(1996-12#1)(2008-9#1)
complete radiological##2##2##(2008-7#1)(2010-5#1)
complete recovery of##4##3##(1991-11#1)(1991-2#1)(2008-10#2)
complete recovery##7##2##(1991-11#1)(1991-2#1)(1991-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
complete regression of##2##3##(1990-3#1)(1990-6#1)
complete regression##3##2##(1990-3#1)(1990-6#1)(1992-2#1)
complete remission (CR)##2##3##(2008-10#2)
complete remission in##2##3##(2008-8#1)(2012-3#1)
complete remission##17##2##(1990-6#1)(1990-8#2)(1991-2#2)(1991-6#1)(1991-8#1)(2008-10#4)(2008-8#1)(2011-2#1)(2012-3#3)(2013-1#1)
complete removal of##5##3##(1994-11#1)(1995-6#1)(2008-10#2)(2011-1#1)
complete resection##6##2##(1990-8#1)(1992-12#1)(2011-2#3)(2012-12#1)
complete resistance against##2##3##(2008-10#2)
complete resistance to##9##3##(2008-10#9)
complete resistance##14##2##(2008-10#14)
complete resolution of the##2##4##(2008-7#1)(2009-6#1)
complete resolution of##8##3##(2008-10#1)(2008-7#3)(2009-6#1)(2010-5#1)(2010-9#1)(2012-3#1)
complete resolution##9##2##(1992-12#1)(2008-10#1)(2008-7#3)(2009-6#1)(2010-5#1)(2010-9#1)(2012-3#1)
complete response at##2##3##(1991-8#1)(1994-1#1)
complete response##9##2##(1990-12#1)(1990-6#1)(1991-8#1)(1994-1#1)(1997-7#1)(2012-3#4)
complete separation of the##3##4##(1990-12#2)(2008-10#1)
complete separation of##7##3##(1990-12#2)(1997-2#1)(2008-10#4)
complete separation##8##2##(1990-12#2)(1997-2#1)(2008-10#5)
complete sequence of the##4##4##(1993-2#1)(2008-10#2)(2008-8#1)
complete sequence of##11##3##(1993-2#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#2)(2010-5#1)
complete sequence specific##2##3##(2008-9#1)(2009-7#1)
complete sequence##16##2##(1993-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-5#1)(2011-2#1)
complete sequences##2##2##(2008-10#1)(2012-3#1)
complete set of##4##3##(1996-12#1)(1997-7#1)(2008-6#1)(2012-3#1)
complete suppression of##2##3##(2008-10#2)
complete thallium##2##2##(1991-12#1)(2008-10#1)
complete the##18##2##(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#1)
complete their##2##2##(1991-2#1)(1996-3#1)
complete tumor resection##2##3##(2011-2#1)(2012-3#1)
complete tumor##4##2##(1991-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
complete understanding of the##4##4##(1996-12#1)(2008-4#1)(2010-4#1)(2011-2#1)
complete understanding of##5##3##(1996-12#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#1)
complete within##2##2##(1990-2#1)(2008-10#1)
complete##640##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#7)(1991-5#4)(1991-6#4)(1991-8#7)(1992-1#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#6)(1993-2#4)(1993-3#4)(1993-6#3)(1993-8#3)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#6)(1995-8#6)(1995-9#4)(1996-1#2)(1996-12#6)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#9)(1997-8#6)(2007-11#1)(2007-12#3)(2008-10#173)(2008-11#27)(2008-12#7)(2008-3#4)(2008-4#9)(2008-5#3)(2008-6#4)(2008-7#25)(2008-8#27)(2008-9#19)(2009-10#1)(2009-12#2)(2009-6#2)(2009-7#10)(2009-8#3)(2010-12#3)(2010-3#2)(2010-4#4)(2010-5#8)(2010-6#2)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#53)(2011-3#2)(2011-7#2)(2012-12#3)(2012-2#6)(2012-3#26)(2012-5#1)(2013-1#22)(2013-7#4)(2013-8#8)
completed 3##2##2##(2010-6#1)(2012-12#1)
completed a questionnaire that##2##4##(2008-11#1)(2013-1#1)
completed a questionnaire##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
completed a survey##2##3##(2010-11#1)(2010-8#1)
completed a##21##2##(1996-5#1)(1997-2#1)(2008-11#6)(2008-7#1)(2008-9#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
completed an electronic##2##3##(2010-10#1)(2012-3#1)
completed an##8##2##(1991-9#1)(1992-12#1)(2008-1#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
completed and##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
completed as part of##3##4##(2008-11#1)(2013-1#2)
completed as##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
completed both##3##2##(1994-12#1)(1997-2#1)(2011-2#1)
completed by the##4##3##(2008-10#2)(2008-12#1)(2009-8#1)
completed by##11##2##(1996-1#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-1#1)
completed genome sequence of a member of the family##2##9##(2011-2#2)
completed genome sequence of a member of the##4##8##(2011-2#4)
completed genome sequence of a member##5##6##(2011-2#5)
completed genome sequence of a##6##5##(2011-2#6)
completed genome sequence of the family##5##6##(2011-2#5)
completed genome sequence of the##8##5##(2011-2#8)
completed genome sequence of##14##4##(2011-2#14)
completed genome sequence##17##3##(2011-2#17)
completed in less than##2##4##(1995-11#1)(2008-10#1)
completed in##21##2##(1995-11#1)(1996-1#1)(1996-5#1)(1997-3#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
completed measures of##5##3##(2008-11#1)(2008-4#1)(2009-7#1)(2010-11#1)(2010-7#1)
completed online##2##2##(2008-12#1)(2013-1#1)
completed questionnaires##5##2##(2008-10#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
completed surveys##4##2##(1996-3#1)(2009-5#1)(2012-12#1)(2013-1#1)
completed the study##3##3##(2007-12#1)(2008-3#2)
completed the##21##2##(1994-3#2)(1996-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
completed their##3##2##(1996-3#1)(2008-11#1)(2008-7#1)
completed three##2##2##(2010-8#1)(2013-8#1)
completed to##3##2##(1991-12#1)(2008-10#1)(2012-12#1)
completed treatment##2##2##(1993-1#1)(1996-3#1)
completed two##2##2##(1994-3#1)(2008-7#1)
completed under##2##2##(2008-10#1)(2011-2#1)
completed with a##2##3##(1992-12#1)(2013-1#1)
completed with##8##2##(1992-12#1)(1996-2#1)(1997-6#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
completed within 5##2##3##(2008-10#2)
completed within##8##2##(1992-2#1)(2008-10#6)(2008-5#1)
completed without##2##2##(1994-2#1)(2008-10#1)
completed##225##1##(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#2)(1994-3#6)(1995-1#2)(1995-11#1)(1995-12#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#38)(2008-11#18)(2008-12#6)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#7)(2008-8#7)(2008-9#4)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#25)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#13)(2013-8#8)
completely abolished the##2##3##(1993-6#1)(1996-2#1)
completely abolished##12##2##(1990-5#1)(1990-9#1)(1993-6#1)(1993-8#1)(1995-11#1)(1996-2#2)(1997-7#1)(1997-8#1)(2008-11#2)(2008-7#1)
completely abrogated##2##2##(1994-6#1)(2013-1#1)
completely absent##2##2##(2010-8#1)(2011-2#1)
completely accurate##2##2##(2009-12#1)(2010-12#1)
completely after##2##2##(2008-7#1)(2013-1#1)
completely and##2##2##(1996-11#1)(2008-10#1)
completely asymmetric competition##2##3##(2008-8#2)
completely asymptomatic##2##2##(2008-5#1)(2011-2#1)
completely avoided##2##2##(2008-7#1)(2011-2#1)
completely blocked by the##2##4##(1995-6#1)(2008-8#1)
completely blocked by##6##3##(1994-8#1)(1995-6#1)(2008-8#2)(2008-9#1)(2012-2#1)
completely blocked the increase in##2##5##(1990-7#1)(1992-12#1)
completely blocked the##3##3##(1990-7#1)(1992-12#1)(2011-2#1)
completely blocked##15##2##(1990-11#1)(1990-7#1)(1992-12#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)
completely by##4##2##(1993-1#1)(1997-1#1)(2008-10#2)
completely conserved##2##2##(1990-11#1)(1993-12#1)
completely depleted##3##2##(1995-6#1)(2008-11#1)(2013-8#1)
completely developed##2##2##(2008-12#1)(2011-1#1)
completely different from##3##3##(1997-6#1)(2008-11#1)(2012-3#1)
completely different##5##2##(1997-6#1)(2008-10#2)(2008-11#1)(2012-3#1)
completely disappeared##3##2##(1990-8#1)(2008-7#1)(2011-2#1)
completely eliminated##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
completely elucidated##4##2##(2008-10#2)(2009-12#1)(2010-7#1)
completely from the##2##3##(2008-10#1)(2008-9#1)
completely from##3##2##(2008-10#2)(2008-9#1)
completely in the##2##3##(2008-10#1)(2009-10#1)
completely in##3##2##(2008-10#2)(2009-10#1)
completely inhibited lipolytic activity##2##4##(2010-10#2)
completely inhibited the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
completely inhibited##10##2##(1995-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#2)(2011-2#1)
completely lost##2##2##(2008-10#1)(2008-9#1)
completely natural##3##2##(2008-5#3)
completely new##4##2##(1994-2#1)(2008-10#1)(2008-11#2)
completely occluded##2##2##(1996-9#1)(1997-3#1)
completely on##2##2##(1991-5#1)(2013-1#1)
completely or##2##2##(1995-8#1)(2008-10#1)
completely overlapped##2##2##(1993-2#1)(2008-8#1)
completely oxidized##2##2##(1995-2#1)(2008-10#1)
completely prevent##2##2##(1997-3#1)(2008-10#1)
completely prevented the##2##3##(1996-2#1)(2008-11#1)
completely prevented##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
completely prevents##3##2##(2008-8#1)(2013-1#2)
completely removed##3##2##(2008-10#2)(2008-5#1)
completely replacing##2##2##(1993-8#1)(1996-9#1)
completely resected##4##2##(1993-9#1)(2008-7#1)(2009-5#1)(2012-2#1)
completely resistant##3##2##(2008-10#3)
completely resolved##2##2##(2008-11#1)(2010-2#1)
completely reversed this##2##3##(1991-2#2)
completely reversed##5##2##(1991-2#2)(2008-5#1)(2008-9#2)
completely reversible##3##2##(1993-1#1)(2008-8#1)(2013-1#1)
completely separated from##2##3##(2008-10#2)
completely separated##7##2##(1997-6#1)(2008-10#6)
completely sequenced##7##2##(1997-7#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)
completely serum-free##2##2##(2008-11#2)
completely suppressed##6##2##(1994-8#1)(1996-5#1)(2008-10#2)(2008-6#1)(2012-2#1)
completely wilted##2##2##(2008-10#2)
completely within##2##2##(2007-12#1)(2008-5#1)
completely##324##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-12#3)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#3)(1993-8#3)(1993-9#2)(1994-12#1)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#7)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#2)(1997-3#2)(1997-6#2)(1997-7#4)(1997-8#2)(2006-5#1)(2007-12#2)(2008-10#88)(2008-11#23)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#13)(2008-8#10)(2008-9#9)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#4)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#5)
completeness and##2##2##(2010-5#1)(2013-7#1)
completeness of##3##2##(2008-10#1)(2008-12#1)(2010-8#1)
completeness##8##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-5#1)(2010-8#1)(2013-7#1)
completes the##4##2##(1992-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
completes##7##1##(1992-3#1)(1993-5#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
completesmall bowel obstruction##2##3##(2009-8#2)
completing Koch's postulates##2##3##(2008-10#2)
completing the##8##2##(1990-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-9#1)(2010-10#1)(2011-2#1)
completing##17##1##(1990-11#1)(1991-8#1)(1994-12#1)(2008-10#3)(2008-11#5)(2008-12#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
completion and##2##2##(2008-11#2)
completion in##2##2##(1994-3#1)(2008-5#1)
completion of a##2##3##(2008-10#1)(2013-8#1)
completion of an##4##3##(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
completion of chemotherapy##2##3##(1991-6#1)(1991-8#1)
completion of the##18##3##(1991-11#1)(1993-9#1)(1994-12#1)(1995-6#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
completion of therapy##2##3##(1991-6#1)(1996-3#1)
completion of##46##2##(1990-12#1)(1991-11#1)(1991-6#2)(1991-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-3#2)(1997-7#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
completion rate was##2##3##(2011-2#2)
completion rates##2##2##(1996-12#1)(2008-6#1)
completion##65##1##(1990-12#1)(1991-11#1)(1991-6#2)(1991-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#2)(1996-3#3)(1997-7#1)(2008-10#6)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
complex (MHC)##7##2##(1990-5#1)(1995-12#1)(1995-2#1)(1997-9#2)(2008-1#1)(2008-9#1)
complex (TAT)##2##2##(1991-3#1)(2010-3#1)
complex Gaussian statistics##2##3##(2008-3#2)
complex I activity##2##3##(2008-7#2)
complex I##4##2##(1993-12#1)(2008-7#3)
complex IV##2##2##(1990-2#1)(1994-11#1)
complex a##2##2##(2008-10#1)(2012-2#1)
complex activity##2##2##(2009-8#2)
complex and a##2##3##(2008-10#1)(2011-2#1)
complex and are##2##3##(2012-2#2)
complex and confusing##2##3##(1992-3#1)(2012-2#1)
complex and continuing health needs##2##5##(2008-11#2)
complex and continuing##3##3##(2008-11#3)
complex and determination of##3##4##(2008-10#3)
complex and its application##2##4##(2008-10#2)
complex and its##6##3##(1994-11#1)(2008-10#4)(2012-3#1)
complex and naphthalene was dissolved with 5 ml of dimethylformamide (DMF) and the metal##2##14##(2008-10#2)
complex and naphthalene was dissolved with 5 ml of##3##9##(2008-10#3)
complex and the##6##3##(2008-10#4)(2011-2#1)(2012-3#1)
complex and therefore##2##3##(1995-12#1)(2008-9#1)
complex and##82##2##(1992-12#1)(1992-3#3)(1994-11#2)(1994-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(2008-10#31)(2008-11#5)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-7#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#3)(2012-3#3)
complex anions##3##2##(2008-10#3)
complex architecture##2##2##(2007-12#1)(2011-2#1)
complex are examined using##2##4##(2008-10#2)
complex are##13##2##(1993-8#1)(1995-2#1)(1995-6#2)(2008-10#8)(2009-10#1)
complex as a##3##3##(2008-10#2)(2012-2#1)
complex as carrier##2##3##(2008-10#2)
complex as the##2##3##(2008-10#1)(2008-2#1)
complex as well as the##3##5##(2007-12#1)(2008-10#2)
complex as well##4##3##(2007-12#1)(2008-10#3)
complex as##20##2##(2007-12#1)(2008-10#15)(2008-2#1)(2008-5#1)(2012-2#2)
complex at a##2##3##(2008-10#2)
complex at pH 5##2##4##(1992-4#1)(2008-10#1)
complex at pH##3##3##(1992-4#1)(2008-10#2)
complex at the##2##3##(2008-10#1)(2012-12#1)
complex at##17##2##(1992-4#1)(1994-5#1)(2008-10#13)(2008-3#1)(2012-12#1)
complex behavior##3##2##(2008-10#1)(2009-3#1)(2009-8#1)
complex between the drug##2##4##(2008-10#2)
complex between the##4##3##(1995-2#1)(2008-10#2)(2009-7#1)
complex between##13##2##(1994-5#1)(1995-2#1)(2008-10#10)(2009-7#1)
complex biological process##2##3##(2009-10#1)(2013-8#1)
complex biological systems##2##3##(2009-3#1)(2013-8#1)
complex biological##10##2##(1993-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-9#1)(2013-8#2)
complex brain networks##2##3##(2009-8#2)
complex but##3##2##(1991-7#1)(2008-10#2)
complex by the##3##3##(2007-12#1)(2008-10#2)
complex by using##2##3##(2008-10#2)
complex by##12##2##(1992-8#1)(1997-2#1)(2007-12#1)(2008-10#9)
complex can alternatively be quantitatively adsorbed on##2##7##(2008-10#2)
complex can alternatively be quantitatively##3##5##(2008-10#3)
complex can be adsorbed##2##4##(2008-10#2)
complex can be##4##3##(2008-10#4)
complex can##9##2##(2008-10#9)
complex carbohydrates##6##2##(1995-2#1)(1997-2#1)(1997-8#2)(2008-3#1)(2008-5#1)
complex case of##2##3##(2008-10#1)(2013-1#1)
complex case##3##2##(2008-10#1)(2013-1#2)
complex cases##2##2##(2008-12#1)(2009-3#1)
complex cellular##4##2##(2008-10#1)(2008-4#1)(2009-8#1)(2012-2#1)
complex chemical##3##2##(1991-3#1)(2008-10#2)
complex clinical##2##2##(2008-4#1)(2008-7#1)
complex composite is##2##3##(2008-10#2)
complex composite##4##2##(2008-10#4)
complex composition##2##2##(2008-10#2)
complex compounds##2##2##(2008-10#2)
complex consisting of##2##3##(2008-4#2)
complex containing##5##2##(1994-3#2)(1995-2#1)(2008-9#1)(2010-10#1)
complex could be##2##3##(1990-5#1)(1993-8#1)
complex could##4##2##(1990-5#1)(1993-8#3)
complex diseases##4##2##(2008-11#1)(2009-4#1)(2010-12#1)(2011-3#1)
complex disorders##2##2##(2010-5#1)(2011-2#1)
complex displayed a##2##3##(1994-11#1)(2008-10#1)
complex during##3##2##(1992-3#1)(2011-2#1)(2013-1#1)
complex dynamics##3##2##(2008-10#1)(2008-8#2)
complex eluted with##2##3##(1992-6#1)(2008-10#1)
complex eluted##3##2##(1992-6#1)(2008-10#2)
complex environmental##4##2##(2008-10#3)(2008-11#1)
complex extracted##2##2##(2008-10#2)
complex extraction##2##2##(2008-10#2)
complex films on##2##3##(2008-10#2)
complex fistulas##2##2##(2010-12#2)
complex food##2##2##(2008-10#2)
complex for the##4##3##(2008-10#4)
complex for##8##2##(2008-10#7)(2008-12#1)
complex form##2##2##(1994-11#1)(2008-10#1)
complex formation between##10##3##(2008-10#9)(2008-7#1)
complex formation constants##5##3##(2008-10#5)
complex formation equilibria are##2##4##(2008-10#2)
complex formation equilibria##3##3##(2008-10#3)
complex formation in the##2##4##(1995-6#1)(2008-10#1)
complex formation in##4##3##(1995-6#1)(2008-10#3)
complex formation is##2##3##(2008-10#2)
complex formation of##9##3##(2008-10#9)
complex formation reaction##3##3##(2008-10#3)
complex formation reactions##2##3##(2008-10#2)
complex formation was##4##3##(2008-10#4)
complex formation with##6##3##(1995-6#1)(1997-7#1)(2008-10#4)
complex formation##69##2##(1995-6#3)(1997-7#1)(2008-10#60)(2008-7#1)(2009-7#1)(2009-8#1)(2012-3#1)(2013-1#1)
complex formed between##9##3##(1994-5#2)(2008-10#7)
complex formed in the##2##4##(2008-10#2)
complex formed in##3##3##(2008-10#3)
complex formed is monitored spectrophotometrically##2##5##(2008-10#2)
complex formed is##3##3##(2008-10#3)
complex formed##21##2##(1994-5#2)(2008-10#19)
complex from the##2##3##(1996-2#1)(2008-10#1)
complex from##8##2##(1993-12#1)(1995-2#1)(1996-2#1)(2008-10#4)(2010-8#1)
complex function##2##2##(2008-11#1)(2008-3#1)
complex genetic##3##2##(2008-8#1)(2009-10#1)(2009-3#1)
complex genome##2##2##(1992-6#1)(2012-3#1)
complex had the##2##3##(1993-8#1)(2008-10#1)
complex had##4##2##(1993-8#1)(2008-10#2)(2008-8#1)
complex has been investigated by##2##5##(1993-8#1)(2008-10#1)
complex has been##6##3##(1993-8#1)(1994-5#1)(2008-10#4)
complex has##7##2##(1993-8#1)(1994-5#1)(2008-10#5)
complex have##2##2##(1991-12#1)(2009-8#1)
complex having##2##2##(2008-10#2)
complex health##2##2##(1994-3#1)(2008-11#1)
complex heterozygotes##2##2##(2008-12#2)
complex history##3##2##(2008-12#1)(2010-10#1)(2012-2#1)
complex immune##2##2##(1996-11#1)(2012-3#1)
complex impedance##3##2##(2008-10#3)
complex in a##3##3##(2008-10#2)(2008-12#1)
complex in an##2##3##(2008-10#2)
complex in aqueous##2##3##(2008-10#2)
complex in chloroform##2##3##(2008-10#2)
complex in solution##2##3##(2008-10#2)
complex in the##12##3##(1994-5#1)(1994-9#1)(1995-6#1)(2008-10#5)(2008-5#1)(2009-6#1)(2009-7#1)(2010-4#1)
complex in this##2##3##(2008-10#1)(2012-2#1)
complex in##43##2##(1991-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-10#25)(2008-12#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
complex industrial##2##2##(2008-10#1)(2013-1#1)
complex interaction between##4##3##(1992-9#1)(2010-12#1)(2010-8#1)(2013-1#1)
complex interaction of##2##3##(2008-11#2)
complex interaction##7##2##(1992-9#1)(2008-10#1)(2008-11#2)(2010-12#1)(2010-8#1)(2013-1#1)
complex interactions between##4##3##(1991-6#1)(2008-1#1)(2008-5#1)(2008-7#1)
complex interactions of##3##3##(1992-5#1)(1993-8#1)(2011-2#1)
complex interactions##10##2##(1991-6#1)(1992-5#1)(1993-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#2)
complex invasive therapies##2##3##(2008-11#2)
complex ion##6##2##(1992-9#1)(2008-10#5)
complex ionic matrices##2##3##(2008-10#2)
complex is 1##3##3##(2008-10#3)
complex is at##2##3##(2008-10#2)
complex is extracted##2##3##(2008-10#2)
complex is formed and##2##4##(2008-10#2)
complex is formed##3##3##(2008-10#3)
complex is measured at##2##4##(2008-10#2)
complex is monitored at##2##4##(2008-10#2)
complex is monitored##3##3##(2008-10#3)
complex is oxidized##2##3##(2008-10#2)
complex is quantitatively##2##3##(2008-10#2)
complex is then##4##3##(2008-10#4)
complex is##59##2##(1991-3#5)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-8#1)(2008-10#44)(2008-4#1)(2008-7#1)(2012-3#2)
complex issues##2##2##(1996-3#1)(1997-2#1)
complex karyotypes in##2##3##(2010-1#2)
complex lesions##2##2##(2011-2#2)
complex material##2##2##(2008-10#1)(2008-2#1)
complex materials##2##2##(2008-10#2)
complex matrices and##2##3##(2008-10#1)(2008-5#1)
complex matrices with##2##3##(2008-10#2)
complex matrices##21##2##(2008-10#18)(2008-5#2)(2010-11#1)
complex matrix##4##2##(2008-10#3)(2009-10#1)
complex may##2##2##(1996-2#1)(1997-7#1)
complex mechanism##2##2##(2009-8#1)(2010-3#1)
complex medical##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
complex mixture of##6##3##(1992-6#1)(1996-12#1)(2008-10#3)(2008-4#1)
complex mixture##11##2##(1992-6#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-4#2)
complex mixtures and##2##3##(2008-10#1)(2008-5#1)
complex mixtures of##2##3##(2008-4#2)
complex mixtures##9##2##(2008-1#1)(2008-10#4)(2008-4#2)(2008-5#1)(2009-7#1)
complex models##3##2##(1992-11#1)(2008-8#1)(2011-2#1)
complex modified##3##2##(2008-10#3)
complex molecular##2##2##(2008-11#1)(2009-4#1)
complex movements##2##2##(2008-7#2)
complex nature of##4##3##(2008-10#3)(2008-11#1)
complex needs##6##2##(1992-2#2)(2008-11#3)(2009-11#1)
complex odontoma##3##2##(2013-1#3)
complex of banana##3##3##(2008-10#3)
complex of the##5##3##(1995-8#1)(2008-10#3)(2008-6#1)
complex of zinc##2##3##(2008-10#2)
complex of##77##2##(1991-3#1)(1992-4#1)(1992-9#1)(1993-8#8)(1993-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-10#48)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-5#1)
complex oligosaccharides##2##2##(2008-5#1)(2012-2#1)
complex on a hanging mercury drop electrode##2##7##(2008-10#2)
complex on a##4##3##(2008-10#4)
complex on activated carbon##2##4##(2008-10#2)
complex on amberlite##2##3##(2008-10#2)
complex on microcrystalline naphthalene##2##4##(2008-10#2)
complex on the##2##3##(2008-10#2)
complex on to##2##3##(2008-10#2)
complex on##19##2##(2008-10#19)
complex onto a##3##3##(2008-10#3)
complex onto##7##2##(2008-10#7)
complex organisms##2##2##(2010-9#2)
complex organization##4##2##(1994-11#1)(1995-3#1)(1997-7#1)(2012-3#1)
complex oxalate-Alizarin Red##2##3##(2008-10#2)
complex pathotypes##4##2##(2008-10#4)
complex pattern of##4##3##(1992-1#1)(2008-10#2)(2011-2#1)
complex pattern##7##2##(1992-1#1)(1993-2#1)(2008-10#2)(2008-11#2)(2011-2#1)
complex phosphorylation##2##2##(2012-3#2)
complex problems##2##2##(2008-11#1)(2008-12#1)
complex procedure##2##2##(2008-10#1)(2008-11#1)
complex procedures##2##2##(1992-9#1)(2011-2#1)
complex process##12##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#2)(2011-2#3)(2013-1#1)
complex processes##2##2##(2008-11#1)(2013-8#1)
complex race##2##2##(2008-10#1)(2008-8#1)
complex reaction##2##2##(2008-10#1)(2010-1#1)
complex refractive index##5##3##(2008-10#1)(2008-3#4)
complex refractive##9##2##(2008-10#1)(2008-3#8)
complex regional##2##2##(2008-12#1)(2008-7#1)
complex regulation##2##2##(2011-1#1)(2013-8#1)
complex regulatory##4##2##(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
complex relationship between##4##3##(2008-11#1)(2009-11#1)(2011-2#2)
complex relationship##6##2##(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#3)
complex relationships##4##2##(1997-3#1)(2008-10#2)(2008-11#1)
complex retained on##2##3##(2008-10#2)
complex revealed by##2##3##(2011-2#1)(2012-3#1)
complex role##2##2##(1992-8#1)(2008-10#1)
complex sample##4##2##(2008-10#4)
complex samples##10##2##(2008-10#10)
complex set of##2##3##(1993-8#1)(1994-12#1)
complex showed that##2##3##(2008-10#1)(2008-9#1)
complex showed##4##2##(1995-11#1)(2008-10#2)(2008-9#1)
complex shows##2##2##(2008-10#2)
complex signaling##2##2##(2008-9#1)(2009-8#1)
complex social behavior##3##3##(2008-10#2)(2008-11#1)
complex social##4##2##(2008-10#2)(2008-11#2)
complex spatial##3##2##(2008-8#2)(2011-7#1)
complex species formed##3##3##(2008-10#3)
complex species##13##2##(2008-10#13)
complex spectral##2##2##(2007-11#1)(2008-10#1)
complex stability constants for##2##4##(2008-10#2)
complex stability constants##3##3##(2008-10#3)
complex stability##5##2##(2008-10#4)(2011-2#1)
complex structure and##3##3##(1993-8#1)(2007-12#1)(2010-11#1)
complex structure of##2##3##(1995-9#1)(2012-2#1)
complex structure##10##2##(1991-12#1)(1993-8#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-11#1)(2012-2#2)
complex structures in the##2##4##(2011-1#1)(2013-8#1)
complex structures##4##2##(1990-11#1)(1991-12#1)(2011-1#1)(2013-8#1)
complex synthetic##3##2##(2008-10#3)
complex system##7##2##(1990-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
complex systems##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
complex task##2##2##(2012-2#2)
complex than##4##2##(2008-10#3)(2008-9#1)
complex that is required for##2##5##(1995-2#1)(2008-9#1)
complex that is required##3##4##(1995-2#1)(2008-5#1)(2008-9#1)
complex that is##5##3##(1995-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
complex that##15##2##(1992-9#1)(1994-3#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
complex the##2##2##(2008-10#2)
complex therapy in##2##3##(2007-11#1)(2011-3#1)
complex therapy##3##2##(2007-11#2)(2011-3#1)
complex to form##2##3##(2008-10#1)(2008-11#1)
complex to the##3##3##(1991-12#1)(2009-7#1)(2012-2#1)
complex to##16##2##(1991-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
complex together with##4##3##(1995-2#1)(2008-10#3)
complex using##2##2##(1992-9#1)(2008-10#1)
complex was 1##3##3##(2008-10#3)
complex was accumulated##2##3##(2008-10#2)
complex was evaluated##2##3##(2008-10#2)
complex was formed##4##3##(1995-11#1)(2008-10#3)
complex was from 5##2##4##(2008-10#2)
complex was from##3##3##(2008-10#3)
complex was observed at##2##4##(2008-10#2)
complex was observed##4##3##(1995-11#1)(2007-12#1)(2008-10#2)
complex was tested##2##3##(2008-10#2)
complex was used##2##3##(2008-10#2)
complex was##54##2##(1990-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#2)(1995-6#1)(2007-12#1)(2008-10#43)(2011-2#1)
complex were##11##2##(1991-3#1)(1991-5#2)(2008-10#5)(2008-12#1)(2011-2#1)(2012-12#1)
complex when the##2##3##(2008-10#1)(2008-8#1)
complex when##4##2##(2008-10#3)(2008-8#1)
complex which has a##2##4##(2008-10#2)
complex which has##3##3##(2008-10#3)
complex which is##2##3##(2008-10#2)
complex which##7##2##(1995-12#1)(2008-10#6)
complex with 1##4##3##(2008-10#4)
complex with a suitable absorption at##2##6##(2008-10#2)
complex with a##11##3##(1990-12#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#7)
complex with absorption maximum at##2##5##(2008-10#2)
complex with an##2##3##(2008-10#2)
complex with the##4##3##(1991-5#1)(1992-3#1)(2008-10#1)(2008-8#1)
complex with##79##2##(1990-12#1)(1991-5#2)(1992-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#2)(1997-1#1)(2007-12#1)(2008-10#58)(2008-5#1)(2008-8#2)(2009-7#3)(2010-5#1)(2012-2#2)(2012-3#1)
complex##1849##1##(1990-11#6)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#8)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#15)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#3)(1992-5#1)(1992-6#8)(1992-8#2)(1992-9#8)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#30)(1993-9#6)(1994-1#1)(1994-11#15)(1994-12#5)(1994-2#4)(1994-3#7)(1994-5#19)(1994-8#3)(1994-9#4)(1995-11#8)(1995-12#9)(1995-2#25)(1995-3#5)(1995-5#1)(1995-6#12)(1995-8#6)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#6)(1996-3#5)(1997-1#9)(1997-2#6)(1997-3#7)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#4)(1997-9#3)(2006-6#1)(2007-11#5)(2007-12#12)(2008-1#6)(2008-10#899)(2008-11#74)(2008-12#19)(2008-2#3)(2008-3#21)(2008-4#16)(2008-5#26)(2008-6#7)(2008-7#29)(2008-8#28)(2008-9#37)(2009-1#2)(2009-10#8)(2009-11#2)(2009-12#5)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#13)(2009-8#23)(2010-1#8)(2010-10#4)(2010-11#9)(2010-12#9)(2010-3#6)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#8)(2010-8#9)(2010-9#4)(2011-1#4)(2011-2#61)(2011-3#3)(2011-7#1)(2012-12#8)(2012-2#44)(2012-3#33)(2012-4#1)(2013-1#34)(2013-8#18)
complex)##4##1##(1990-5#1)(2008-10#2)(2012-6#1)
complex-coupled distributed-feedback laser##2##3##(2008-3#2)
complex-coupled##4##1##(2008-3#4)
complex-formation equilibria of##2##3##(2008-10#2)
complex-formation##6##1##(2008-10#6)
complex-forming##3##1##(2008-10#3)
complex-type##3##1##(1994-5#3)
complexant reactions##2##2##(2008-10#2)
complexant##4##1##(2008-10#4)
complexants##2##1##(2008-10#2)
complexation and solvent extraction##2##4##(2008-10#2)
complexation and##7##2##(2008-10#7)
complexation behavior of##2##3##(2008-10#2)
complexation behavior##3##2##(2008-10#3)
complexation between##6##2##(2008-10#6)
complexation by the##2##3##(2008-10#2)
complexation by##5##2##(2008-10#5)
complexation constant##2##2##(2008-10#2)
complexation constants##7##2##(2008-10#7)
complexation equilibria##5##2##(2008-10#5)
complexation in water##3##3##(2008-10#3)
complexation in##5##2##(2008-10#5)
complexation mechanism was##2##3##(2008-10#2)
complexation of metal##2##3##(2008-10#2)
complexation of the##4##3##(2008-10#4)
complexation of##23##2##(2008-10#22)(2008-12#1)
complexation reaction between##2##3##(2008-10#2)
complexation reaction of Cu(II) with##3##5##(2008-10#3)
complexation reaction of##4##3##(2008-10#4)
complexation reaction##12##2##(2008-10#12)
complexation reactions##3##2##(2008-10#3)
complexation was##2##2##(2008-10#1)(2013-1#1)
complexation with ammonium##4##3##(2008-10#4)
complexation with two high molecular weight poly(acrylic acids)##2##8##(2008-10#2)
complexation with two##3##3##(2008-10#3)
complexation with##24##2##(2008-10#23)(2013-1#1)
complexation##135##1##(2008-10#130)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#2)
complexed by##3##2##(2008-10#3)
complexed to##2##2##(1994-5#1)(2008-10#1)
complexed with O##2##3##(2008-10#2)
complexed with the##3##3##(1994-3#1)(1995-8#1)(2008-10#1)
complexed with##27##2##(1990-12#1)(1991-12#1)(1991-3#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#19)
complexed##43##1##(1990-12#1)(1991-12#1)(1991-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#33)
complexes and the##2##3##(2008-10#2)
complexes and##21##2##(1993-11#1)(1996-5#1)(1997-8#1)(2008-10#14)(2008-5#1)(2008-7#1)(2008-9#1)(2011-3#1)
complexes are formed at##2##4##(2008-10#2)
complexes are formed in##2##4##(2008-10#2)
complexes are formed##5##3##(2008-10#5)
complexes are then##2##3##(2008-10#2)
complexes are##30##2##(1994-5#1)(1995-8#2)(1996-2#1)(2008-10#24)(2008-2#1)(2009-8#1)
complexes as well as##2##4##(2008-10#2)
complexes as##6##2##(2008-10#5)(2008-5#1)
complexes at##5##2##(1995-8#1)(1996-2#1)(2008-10#3)
complexes between##9##2##(1995-6#1)(1996-3#1)(2008-10#6)(2011-2#1)
complexes by capillary##2##3##(2008-10#2)
complexes by the##2##3##(2008-10#2)
complexes by##13##2##(1995-8#2)(2008-10#10)(2010-3#1)
complexes can be##2##3##(1997-7#1)(2008-4#1)
complexes containing##8##2##(2008-10#4)(2008-11#2)(2008-12#1)(2009-9#1)
complexes exhibit a##2##3##(2008-10#2)
complexes exhibit##4##2##(1994-5#1)(2008-10#3)
complexes extracted into##2##3##(2008-10#2)
complexes for##3##2##(2008-10#1)(2013-8#2)
complexes formed at##2##3##(1997-3#1)(2008-10#1)
complexes formed between##5##3##(2008-10#5)
complexes formed by##3##3##(2008-10#3)
complexes formed in solution##2##4##(2008-10#2)
complexes formed in the##4##4##(1993-3#1)(1995-8#1)(2008-10#2)
complexes formed in##7##3##(1993-3#1)(1995-8#1)(1997-3#1)(2008-10#4)
complexes formed with##2##3##(1995-6#1)(2008-10#1)
complexes formed##23##2##(1993-3#1)(1995-6#2)(1995-8#1)(1997-3#2)(2008-10#17)
complexes from##3##2##(2008-10#3)
complexes have been determined##3##4##(1992-9#1)(2008-10#2)
complexes have been##11##3##(1992-9#1)(1994-5#1)(2008-10#9)
complexes have##13##2##(1992-9#1)(1993-8#1)(1994-5#1)(2008-10#10)
complexes in human##2##3##(1995-8#1)(2008-10#1)
complexes in the presence of##2##5##(2008-10#2)
complexes in the##10##3##(1994-5#1)(2008-10#9)
complexes in vivo##3##3##(1995-6#1)(2010-11#2)
complexes in which a##2##4##(2008-10#1)(2010-7#1)
complexes in##36##2##(1992-9#3)(1994-5#1)(1995-6#1)(1995-8#2)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-2#1)
complexes involved in the oxidative phosphorylation##2##6##(1990-2#2)
complexes is##10##2##(1993-8#1)(1995-8#1)(2008-10#7)(2011-2#1)
complexes may##2##2##(1993-8#1)(2012-12#1)
complexes of Cu(II)##2##3##(2008-10#2)
complexes of inosine##2##3##(2008-10#2)
complexes of lanthanides##2##3##(2008-10#2)
complexes of some##2##3##(2008-10#2)
complexes of the##3##3##(1997-3#1)(2008-10#2)
complexes of##53##2##(1992-4#1)(1993-8#2)(1997-3#2)(2008-10#46)(2008-11#1)(2008-12#1)
complexes on a##3##3##(2008-10#3)
complexes on the##2##3##(2008-10#2)
complexes on##10##2##(2008-10#10)
complexes or##3##2##(1994-5#1)(2008-10#1)(2008-4#1)
complexes resulting##2##2##(2008-10#1)(2012-3#1)
complexes show##2##2##(2008-10#1)(2008-5#1)
complexes studied##6##2##(1993-8#1)(2008-10#4)(2010-7#1)
complexes that are##2##3##(2008-4#1)(2009-10#1)
complexes that##6##2##(1997-3#2)(2008-4#1)(2009-10#1)(2010-10#1)(2012-3#1)
complexes the##2##2##(2008-10#2)
complexes to##3##2##(1997-1#1)(2008-10#1)(2013-8#1)
complexes using the##3##3##(2008-10#3)
complexes using##5##2##(2008-10#4)(2008-2#1)
complexes was studied potentiometrically##2##4##(2008-10#2)
complexes was studied##4##3##(2008-10#4)
complexes was##10##2##(1995-11#1)(2008-10#9)
complexes were determined at 25 degrees C##3##7##(2008-10#3)
complexes were determined by##2##4##(2008-10#2)
complexes were determined##11##3##(2008-10#11)
complexes were found to##2##4##(2008-10#2)
complexes were stable##2##3##(2008-10#2)
complexes were used##2##3##(2008-10#2)
complexes were##33##2##(1994-5#1)(2008-10#30)(2008-11#2)
complexes which##5##2##(1991-5#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-5#1)
complexes with a##3##3##(2008-10#3)
complexes with and##2##3##(1991-9#1)(2008-10#1)
complexes with carboxylic ligands##2##4##(2008-10#2)
complexes with different##3##3##(2008-10#2)(2010-11#1)
complexes with inorganic##2##3##(2008-10#2)
complexes with some##3##3##(2008-10#2)(2010-11#1)
complexes with the##9##3##(2008-10#8)(2009-10#1)
complexes with##76##2##(1990-11#1)(1990-12#1)(1991-9#1)(1993-8#2)(1997-1#1)(2008-10#62)(2008-5#1)(2009-10#1)(2009-8#1)(2010-11#4)(2012-3#1)
complexes##585##1##(1990-11#1)(1990-12#2)(1990-2#2)(1991-2#1)(1991-5#1)(1991-9#4)(1992-4#4)(1992-6#1)(1992-9#5)(1993-11#1)(1993-3#1)(1993-8#12)(1994-11#1)(1994-12#1)(1994-5#10)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#11)(1996-2#4)(1996-3#2)(1996-5#2)(1997-1#3)(1997-3#8)(1997-7#3)(1997-8#2)(2008-10#407)(2008-11#10)(2008-12#5)(2008-2#3)(2008-4#7)(2008-5#6)(2008-7#4)(2008-9#3)(2009-10#3)(2009-8#5)(2009-9#4)(2010-10#1)(2010-11#8)(2010-3#1)(2010-6#1)(2010-7#6)(2011-2#7)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#3)(2013-8#4)
complexes)##3##1##(2007-12#1)(2008-10#2)
complexing ability of##2##3##(2008-10#2)
complexing agent and##2##3##(2008-10#2)
complexing agent for##2##3##(2008-10#2)
complexing agent##23##2##(2008-10#23)
complexing agent)##3##2##(2008-10#3)
complexing agents##11##2##(2008-10#11)
complexing ligands##2##2##(2008-10#2)
complexing of##2##2##(2008-10#2)
complexing power##2##2##(2008-10#2)
complexing properties of##5##3##(2008-10#5)
complexing properties##8##2##(2008-10#8)
complexing reaction##2##2##(2008-10#2)
complexing reagent##4##2##(2008-10#4)
complexing with##3##2##(2008-10#3)
complexing##70##1##(2008-10#68)(2008-5#1)(2008-9#1)
complexities involved##2##2##(1994-1#2)
complexities of the##2##3##(2008-12#1)(2011-2#1)
complexities of##6##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
complexities that##2##2##(2008-4#1)(2008-8#1)
complexities##13##1##(1992-1#1)(1994-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#2)(2009-5#1)(2011-2#1)(2013-8#1)
complexity and##11##2##(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#2)
complexity in##4##2##(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
complexity of different##2##3##(1997-6#1)(2008-4#1)
complexity of resistance##2##3##(2008-10#2)
complexity of the##30##3##(1992-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-5#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
complexity of##62##2##(1991-6#1)(1992-1#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-5#1)(1996-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#5)(2013-1#2)(2013-8#1)
complexity was##3##2##(2008-10#2)(2008-11#1)
complexity##130##1##(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#24)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-2#11)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#3)
complexometric titration##2##2##(2008-10#2)
complexometric titrations##2##2##(2008-10#2)
complexometric##8##1##(2008-10#8)
complexone##3##1##(2008-10#3)
compliance and##6##2##(1991-11#1)(1994-1#1)(1995-12#1)(1996-11#1)(2008-10#1)(2012-3#1)
compliance in the##2##3##(1993-11#1)(1997-2#1)
compliance in##4##2##(1993-11#1)(1997-2#1)(1997-4#1)(2013-8#1)
compliance is often##2##3##(1993-11#2)
compliance is##7##2##(1993-11#5)(2008-9#1)(2012-3#1)
compliance issues##2##2##(2010-12#1)(2012-2#1)
compliance of the##2##3##(1996-3#1)(2012-3#1)
compliance of##6##2##(1993-11#1)(1994-8#1)(1996-3#1)(2008-10#1)(2010-4#1)(2012-3#1)
compliance on##2##2##(1996-3#1)(2009-11#1)
compliance to##2##2##(1992-11#1)(2008-7#1)
compliance was##3##2##(1991-6#1)(2008-3#1)(2013-7#1)
compliance with instructions on how to use the##2##8##(1990-2#2)
compliance with pharmacotherapy##2##3##(1993-11#2)
compliance with the##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
compliance with this##2##3##(1991-12#1)(1996-2#1)
compliance with##26##2##(1990-2#2)(1991-12#2)(1993-11#3)(1994-5#1)(1996-2#1)(1997-5#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
compliance##95##1##(1990-2#2)(1991-11#2)(1991-12#3)(1991-6#1)(1992-11#1)(1992-3#1)(1993-11#13)(1993-3#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-3#3)(1997-2#4)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
compliances##2##1##(1991-3#1)(2012-2#1)
compliant##5##1##(1993-1#1)(2008-11#3)(2010-4#1)
complicate the##5##2##(1997-4#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
complicate##12##1##(1995-3#1)(1996-11#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
complicated by a##3##3##(2008-2#1)(2010-1#2)
complicated by the##6##3##(1995-2#1)(1997-3#1)(2008-11#1)(2008-8#2)(2009-5#1)
complicated by##44##2##(1990-12#1)(1990-9#1)(1991-6#1)(1994-1#2)(1995-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#8)(2013-8#3)
complicated cellular##3##2##(2008-11#1)(2008-4#2)
complicated chemical##2##2##(2008-10#1)(2009-6#1)
complicated disease##3##2##(1997-8#1)(2010-12#1)(2013-8#1)
complicated malaria##3##2##(2012-12#3)
complicated or##2##2##(1995-6#1)(2010-12#1)
complicated process##3##2##(2008-7#1)(2009-10#1)(2012-2#1)
complicated structural component##2##3##(2013-8#2)
complicated structure##2##2##(2008-3#1)(2010-12#1)
complicated with##4##2##(2008-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
complicated##126##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#3)(1992-11#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-1#2)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-6#1)(2011-2#8)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#7)
complicates the##2##2##(1995-3#1)(2010-5#1)
complicates##10##1##(1995-3#1)(2008-10#3)(2008-12#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
complicating lumbar##2##2##(2012-12#2)
complicating##14##1##(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-12#2)(2013-1#3)
complication after##5##2##(2008-1#1)(2008-12#2)(2011-2#1)(2012-2#1)
complication and##3##2##(2013-1#3)
complication associated with##3##3##(2009-7#1)(2011-2#1)(2012-12#1)
complication following##5##2##(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)
complication in the##4##3##(2008-1#1)(2009-8#1)(2013-1#2)
complication in##13##2##(2008-1#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
complication is##9##2##(1990-5#1)(1991-3#1)(1992-3#1)(1997-8#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#2)
complication may##2##2##(2008-7#1)(2013-1#1)
complication occurred##3##2##(1997-3#1)(2013-1#2)
complication of HIV##2##3##(1996-3#1)(2008-1#1)
complication of a##2##3##(2011-2#1)(2012-2#1)
complication of an##2##3##(2009-1#1)(2010-5#1)
complication of chronic##2##3##(2008-1#1)(2011-2#1)
complication of laparoscopic##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
complication of the##4##3##(1991-8#1)(2011-2#2)(2012-12#1)
complication of this##2##3##(1991-3#1)(2008-7#1)
complication of total##2##3##(2013-1#2)
complication of##67##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#2)(1993-1#1)(1995-10#1)(1995-12#1)(1996-3#1)(2008-1#2)(2008-10#1)(2008-12#4)(2008-2#1)(2008-7#4)(2008-9#1)(2009-1#2)(2009-7#1)(2009-9#3)(2010-10#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#14)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#4)
complication rate in##3##3##(2008-9#1)(2010-3#1)(2012-3#1)
complication rate of##3##3##(1996-9#1)(2012-3#1)(2013-1#1)
complication rate was##3##3##(1993-6#1)(2007-8#1)(2011-2#1)
complication rate##21##2##(1991-3#1)(1993-12#1)(1993-6#2)(1995-1#2)(1996-9#1)(1997-6#1)(2007-8#1)(2008-9#1)(2010-3#1)(2011-2#3)(2012-3#4)(2013-1#3)
complication rates in##2##3##(2011-2#2)
complication rates of##2##3##(1994-8#1)(2008-8#1)
complication rates##14##2##(1994-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#2)
complication that may##2##3##(2011-2#1)(2013-1#1)
complication that##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
complication was##3##2##(2008-10#1)(2008-7#1)(2011-3#1)
complication##210##1##(1990-3#1)(1990-5#2)(1991-11#1)(1991-3#5)(1991-6#1)(1991-8#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-6#2)(1994-3#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-12#2)(1996-3#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#11)(2008-2#1)(2008-5#1)(2008-7#11)(2008-8#3)(2008-9#4)(2009-1#4)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#38)(2011-3#3)(2012-12#12)(2012-2#6)(2012-3#20)(2013-1#26)(2013-8#1)
complications after heart surgery##2##4##(1997-3#2)
complications after##9##2##(1997-3#2)(2007-11#1)(2007-8#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#1)
complications and in##2##3##(1994-12#1)(2009-3#1)
complications and mortality##2##3##(2011-2#1)(2013-8#1)
complications and surgical##3##3##(2008-11#2)(2013-1#1)
complications and##32##2##(1990-11#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1996-3#1)(2007-8#1)(2008-11#4)(2008-7#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
complications are associated with##2##4##(2010-10#1)(2011-3#1)
complications are##11##2##(1991-9#1)(2008-7#1)(2010-10#2)(2010-7#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-1#1)
complications arising from##2##3##(2008-11#1)(2008-7#1)
complications arising##3##2##(2008-11#1)(2008-7#1)(2011-3#1)
complications as well##2##3##(1990-9#1)(1996-3#1)
complications as##4##2##(1990-9#1)(1996-3#1)(2008-7#1)(2011-2#1)
complications associated with this##2##4##(2009-12#1)(2012-12#1)
complications associated with##9##3##(1990-11#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
complications but##6##2##(1995-12#1)(2008-12#1)(2011-2#3)(2013-1#1)
complications by##3##2##(2009-5#1)(2010-12#1)(2013-1#1)
complications can##2##2##(2011-2#2)
complications compared with##2##3##(2010-12#1)(2012-3#1)
complications due to##5##3##(1990-11#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
complications during##5##2##(1991-6#1)(1996-6#1)(1997-6#1)(2012-12#2)
complications following##3##2##(1995-12#1)(2008-5#1)(2012-3#1)
complications from the##2##3##(2008-12#1)(2012-3#1)
complications from##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
complications in children##3##3##(1994-6#2)(2011-2#1)
complications in patients##2##3##(2009-5#1)(2010-12#1)
complications in the##5##3##(1991-9#1)(1992-12#1)(1993-9#1)(2007-8#1)(2013-1#1)
complications in these##2##3##(1990-2#1)(1996-9#1)
complications in##32##2##(1990-11#1)(1990-2#1)(1990-9#3)(1991-9#2)(1992-12#1)(1993-9#1)(1994-6#2)(1995-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#3)
complications included##2##2##(2008-7#1)(2008-9#1)
complications including##4##2##(2008-7#1)(2011-3#1)(2012-12#1)(2013-1#1)
complications is##2##2##(1991-9#1)(2008-7#1)
complications may##3##2##(1994-5#1)(1997-8#1)(2012-3#1)
complications occurred in##5##3##(1991-2#1)(2008-11#1)(2009-3#1)(2013-1#1)(2013-8#1)
complications occurred##10##2##(1991-2#1)(1994-9#1)(1995-11#1)(1995-8#1)(2007-11#1)(2008-11#1)(2009-3#1)(2013-1#2)(2013-8#1)
complications of Crohn disease##2##4##(1997-8#2)
complications of diabetes##3##3##(2008-1#3)
complications of lung##2##3##(2011-3#2)
complications of the##3##3##(1990-5#1)(1991-11#1)(2008-1#1)
complications of this##2##3##(1993-8#1)(1994-6#1)
complications of##50##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-8#2)(2008-1#6)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
complications or##7##2##(1993-11#1)(2010-1#1)(2010-12#2)(2012-3#1)(2013-1#2)
complications related to the##3##4##(1991-6#1)(1997-3#1)(2008-9#1)
complications related to##5##3##(1990-5#1)(1991-6#1)(1993-3#1)(1997-3#1)(2008-9#1)
complications such as##16##3##(1990-11#1)(1995-11#1)(1996-11#1)(1996-9#1)(2007-12#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-3#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
complications than##4##2##(1991-6#1)(2009-3#1)(2013-1#2)
complications that are##2##3##(1990-3#1)(2008-3#1)
complications that can##2##3##(1991-3#1)(2010-12#1)
complications that have##2##3##(1994-6#1)(2009-3#1)
complications that may##2##3##(2012-2#2)
complications that##11##2##(1990-3#1)(1991-3#1)(1994-6#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-2#2)(2013-1#2)
complications the##2##2##(1996-3#1)(2011-3#1)
complications was##8##2##(1991-8#1)(1992-12#2)(2008-9#2)(2010-3#1)(2012-3#2)
complications were encountered##2##3##(1991-2#1)(2008-9#1)
complications were evaluated##3##3##(2008-9#1)(2009-8#1)(2013-1#1)
complications were noted in##2##4##(1992-1#1)(2013-1#1)
complications were noted##4##3##(1990-8#1)(1992-1#1)(1994-2#1)(2013-1#1)
complications were observed##5##3##(1990-3#1)(1994-12#1)(1995-1#1)(2008-7#1)(2013-1#1)
complications were##24##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#5)
complications with a##2##3##(1992-5#1)(2011-2#1)
complications with##5##2##(1990-3#1)(1992-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
complications##527##1##(1990-11#9)(1990-2#1)(1990-3#6)(1990-5#3)(1990-8#1)(1990-9#6)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#3)(1991-6#6)(1991-8#2)(1991-9#5)(1992-1#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#6)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#5)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#6)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#8)(1996-12#1)(1996-2#3)(1996-3#6)(1996-6#2)(1996-9#4)(1997-3#5)(1997-6#2)(1997-8#5)(2007-11#3)(2007-12#1)(2007-8#7)(2008-1#12)(2008-10#7)(2008-11#16)(2008-12#8)(2008-3#2)(2008-5#3)(2008-7#31)(2008-8#1)(2008-9#16)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#6)(2009-5#3)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#16)(2010-3#3)(2010-6#1)(2010-7#6)(2010-8#1)(2011-2#47)(2011-3#20)(2012-12#20)(2012-2#15)(2012-3#30)(2013-1#77)(2013-7#1)(2013-8#7)
complications--in##2##1##(2011-2#2)
complied with##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
complies with##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
compliment##3##1##(1993-12#2)(2011-2#1)
complimentary##2##1##(2008-11#1)(2008-2#1)
comply with the##5##3##(1995-2#1)(2008-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
comply with##13##2##(1991-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-8#1)(2011-2#1)(2013-1#1)
comply##14##1##(1991-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)(2013-1#1)
compomer##4##1##(2008-5#1)(2011-2#2)(2013-1#1)
component A##4##2##(1991-12#2)(2008-9#2)
component analysis (PCA)##30##3##(2008-10#30)
component analysis and cluster analysis##4##5##(2008-10#4)
component analysis and##11##3##(2008-10#6)(2008-11#1)(2009-11#1)(2011-2#1)(2013-8#2)
component analysis##78##2##(2008-10#60)(2008-11#3)(2008-4#1)(2009-11#1)(2010-10#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#2)
component and partial least##2##4##(2008-10#2)
component and the##2##3##(2008-10#2)
component and##12##2##(2008-10#8)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)
component cells##2##2##(1992-6#2)
component characters##2##2##(2008-8#2)
component coatings##2##2##(2008-10#2)
component equilibrium constants##3##3##(2008-10#3)
component factor analysis##2##3##(2008-10#1)(2008-11#1)
component failures##2##2##(1990-11#1)(2011-2#1)
component for the##4##3##(1994-3#1)(1996-12#1)(2012-2#2)
component for##8##2##(1994-3#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#2)
component in an##2##3##(1992-8#1)(2008-3#1)
component in the##18##3##(1990-11#1)(1990-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#1)(2013-8#1)
component in##46##2##(1990-11#2)(1990-12#1)(1990-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#2)(1994-5#1)(1995-2#1)(2008-10#6)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-8#2)
component is a major##2##4##(1994-5#1)(2008-12#1)
component is a##3##3##(1992-9#1)(1994-5#1)(2008-12#1)
component is the##3##3##(2008-10#1)(2008-8#1)(2009-4#1)
component is##11##2##(1990-7#1)(1991-2#1)(1992-9#1)(1994-5#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)
component model##2##2##(2008-10#1)(2013-1#1)
component number##2##2##(2008-10#2)
component of a larger##2##4##(2008-12#1)(2010-10#1)
component of a##9##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)
component of an##3##3##(1996-3#1)(2008-5#1)(2013-8#1)
component of both##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
component of cluster##2##3##(2008-10#2)
component of comprehensive##2##3##(1992-1#1)(2013-1#1)
component of human telomerase##2##4##(2008-11#1)(2008-9#1)
component of human##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
component of many##3##3##(2008-10#2)(2012-2#1)
component of more than##2##4##(2008-10#1)(2013-8#1)
component of the LE model##2##5##(2008-10#2)
component of the human##2##4##(2011-2#2)
component of the immune system##2##5##(1990-9#1)(2012-2#1)
component of the protein##3##4##(1991-5#1)(1995-2#1)(1997-7#1)
component of the rat##2##4##(1990-5#1)(1992-3#1)
component of the system##2##4##(2008-10#2)
component of the transcription factor##2##5##(1993-9#1)(2008-10#1)
component of the##91##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#2)(1993-9#2)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#4)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-2#5)(2013-1#2)
component of this##5##3##(1993-9#1)(2008-10#2)(2008-9#1)(2011-1#1)
component of##202##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#4)(1992-6#4)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#4)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#5)(1996-3#2)(1997-2#1)(1997-3#5)(1997-7#2)(1997-8#2)(1997-9#1)(2007-12#1)(2008-10#45)(2008-11#19)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#9)(2008-7#7)(2008-8#5)(2008-9#7)(2009-1#1)(2009-11#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#8)(2011-7#1)(2012-2#8)(2012-3#2)(2013-1#5)(2013-8#5)
component on the##2##3##(2008-10#2)
component parts##2##2##(1997-1#1)(2013-1#1)
component present in##2##3##(1993-3#1)(1995-6#1)
component proteins##3##2##(1992-12#1)(1992-9#1)(2012-3#1)
component pure stands (P = 0##3##6##(2008-10#3)
component pure stands##4##3##(2008-10#4)
component regression##16##2##(2008-10#16)
component responsible for##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
component spectral##2##2##(2008-10#2)
component that##3##2##(1996-12#1)(2008-11#1)(2009-12#1)
component to##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
component was##6##2##(1991-8#1)(1995-3#1)(1995-6#1)(2008-8#1)(2009-1#1)(2013-1#1)
component were##4##2##(1997-3#1)(2008-10#1)(2012-2#1)(2013-8#1)
component with a##3##3##(2008-10#2)(2008-11#1)
component with##5##2##(1995-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
component within##3##2##(2008-11#2)(2013-1#1)
component##612##1##(1990-11#7)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#3)(1992-12#4)(1992-3#4)(1992-6#7)(1992-8#1)(1992-9#5)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#6)(1994-8#1)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#3)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#4)(1997-1#2)(1997-2#3)(1997-3#9)(1997-7#3)(1997-8#2)(1997-9#1)(2007-12#2)(2008-10#214)(2008-11#46)(2008-12#6)(2008-2#1)(2008-3#13)(2008-4#3)(2008-5#18)(2008-7#10)(2008-8#26)(2008-9#16)(2009-1#4)(2009-10#3)(2009-11#3)(2009-12#1)(2009-3#3)(2009-4#5)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#17)(2011-3#1)(2011-7#1)(2012-2#13)(2012-3#11)(2013-1#18)(2013-8#16)
component)##3##1##(2008-10#2)(2008-8#1)
components against the##2##3##(2008-10#1)(2008-11#1)
components against##4##2##(2008-10#1)(2008-11#2)(2011-3#1)
components also##2##2##(1996-12#1)(2008-10#1)
components analysis (PCA)##6##3##(2008-10#5)(2010-7#1)
components analysis##16##2##(1992-1#1)(2008-10#13)(2010-7#1)(2012-2#1)
components and the##3##3##(2008-10#2)(2008-11#1)
components and their##3##3##(2008-10#1)(2009-10#1)(2010-7#1)
components and##24##2##(1990-11#1)(1994-9#1)(2008-10#12)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#2)
components are##23##2##(1990-11#1)(1991-1#1)(1993-3#1)(1994-11#1)(1995-5#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-8#1)(2009-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
components as a##2##3##(2008-7#1)(2009-12#1)
components as well as##2##4##(2008-11#2)
components as##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2009-12#1)
components at the##2##3##(2009-10#1)(2010-9#1)
components at##4##2##(2008-10#1)(2008-3#1)(2009-10#1)(2010-9#1)
components by##7##2##(1995-5#1)(2008-10#3)(2008-11#1)(2009-7#1)(2010-7#1)
components can be##2##3##(2008-8#1)(2011-2#1)
components can##5##2##(2008-8#2)(2009-8#1)(2010-1#1)(2011-2#1)
components caused##2##2##(2008-10#1)(2011-2#1)
components could##2##2##(2008-10#1)(2008-5#1)
components for the##2##3##(2008-8#1)(2009-8#1)
components for##15##2##(1996-5#1)(1997-3#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
components found##2##2##(2008-10#2)
components from the##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
components from##6##2##(1995-3#1)(2008-10#3)(2008-11#2)
components had##2##2##(2011-2#2)
components have been##2##3##(2008-5#1)(2009-4#1)
components in a##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
components in the##14##3##(1996-6#1)(2008-10#7)(2008-3#1)(2009-8#1)(2010-1#1)(2013-1#2)(2013-8#1)
components in this##2##3##(2008-8#1)(2009-12#1)
components in##51##2##(1992-11#2)(1993-12#1)(1994-5#1)(1995-5#2)(1996-6#1)(1997-3#1)(2008-10#25)(2008-11#4)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2013-1#2)(2013-8#2)
components including##2##2##(1991-12#1)(2010-6#1)
components into the##2##3##(2008-7#1)(2013-8#1)
components involved in##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
components is##9##2##(1992-9#1)(1995-3#1)(2008-10#5)(2009-8#2)
components isolated##2##2##(2011-3#2)
components may be##2##3##(2008-11#1)(2008-9#1)
components may##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
components named##2##2##(1993-8#1)(2008-8#1)
components of DEJ##2##3##(2008-5#2)
components of a comprehensive##2##4##(1996-2#1)(2011-2#1)
components of a##12##3##(1993-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
components of aggressiveness##4##3##(2008-10#4)
components of any##2##3##(1997-3#1)(2008-12#1)
components of essential##2##3##(2008-10#1)(2012-3#1)
components of fitness##2##3##(2008-9#2)
components of hospital care##2##4##(1991-3#2)
components of movement##2##3##(1990-5#2)
components of partial resistance##4##4##(2008-10#4)
components of plant##2##3##(2008-10#1)(2008-8#1)
components of primary inoculum dispersal##2##5##(2008-10#2)
components of skin##2##3##(2008-5#2)
components of support##2##3##(1994-3#1)(1996-3#1)
components of the cell##2##4##(2008-11#1)(2008-9#1)
components of the health##2##4##(1991-3#1)(1993-3#1)
components of the host##2##4##(2009-8#1)(2010-1#1)
components of the immune system##2##5##(2008-10#2)
components of the intervention##2##4##(2008-4#1)(2008-8#1)
components of the metabolic syndrome##4##5##(2008-1#2)(2008-11#1)(2010-5#1)
components of the program##2##4##(1996-3#1)(1997-1#1)
components of the##101##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#3)(2008-10#28)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#2)(2009-12#1)(2009-4#1)(2009-8#4)(2010-1#2)(2010-2#1)(2010-5#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
components of these##5##3##(1996-12#1)(1996-2#1)(2008-10#2)(2008-8#1)
components of this##4##3##(1993-8#1)(1995-2#1)(2008-12#1)(2008-5#1)
components of variance##2##3##(1996-3#1)(2008-10#1)
components of##249##2##(1990-11#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#3)(1991-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#4)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#2)(2008-1#3)(2008-10#69)(2008-11#15)(2008-12#6)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#15)(2008-9#8)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#4)(2010-1#3)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#10)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
components on the##5##3##(1991-2#1)(2008-11#3)(2011-2#1)
components on##12##2##(1991-2#2)(2008-10#3)(2008-11#4)(2011-2#1)(2011-3#1)(2013-1#1)
components or##2##2##(2008-8#1)(2013-1#1)
components present in the##2##4##(2008-1#1)(2008-10#1)
components present in##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
components rather than##2##3##(2008-11#1)(2008-3#1)
components required for##2##3##(2008-10#1)(2013-1#1)
components resulted in##2##3##(2008-10#1)(2009-8#1)
components such as collagen and##2##5##(2008-5#1)(2012-2#1)
components such as##7##3##(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
components that are##2##3##(2010-5#1)(2013-8#1)
components that##9##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
components to##2##2##(2008-10#1)(2009-7#1)
components was investigated##2##3##(2008-10#1)(2008-9#1)
components was##10##2##(2008-10#6)(2008-5#1)(2008-9#1)(2013-1#2)
components were infectious by biolistic inoculation to##2##7##(2008-10#2)
components were measured##2##3##(2008-10#2)
components were obtained##2##3##(2008-10#1)(2008-8#1)
components were##23##2##(1991-12#1)(1991-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2013-1#3)(2013-8#1)
components with##7##2##(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#2)(2009-6#1)
components##793##1##(1990-11#4)(1990-2#1)(1990-5#3)(1990-8#1)(1991-1#2)(1991-12#7)(1991-2#4)(1991-3#6)(1991-5#2)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#7)(1996-1#2)(1996-11#1)(1996-12#9)(1996-2#5)(1996-3#4)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#7)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-12#2)(2008-1#5)(2008-10#269)(2008-11#70)(2008-12#10)(2008-2#5)(2008-3#24)(2008-4#5)(2008-5#22)(2008-6#6)(2008-7#17)(2008-8#44)(2008-9#22)(2009-1#1)(2009-10#9)(2009-12#7)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#4)(2009-8#14)(2010-1#5)(2010-11#3)(2010-2#1)(2010-5#3)(2010-6#3)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#33)(2011-3#10)(2012-12#1)(2012-2#11)(2012-3#7)(2013-1#26)(2013-7#1)(2013-8#12)
components)##3##1##(2008-10#1)(2008-7#1)(2012-12#1)
compose##3##1##(2008-10#3)
composed by##7##2##(2007-12#1)(2008-10#5)(2011-2#1)
composed mainly of##4##3##(1994-5#1)(1995-6#1)(2008-12#1)(2010-8#1)
composed of 0##2##3##(2008-10#2)
composed of 18##3##3##(1993-3#1)(1994-11#1)(2008-10#1)
composed of a mass of##2##5##(2008-10#1)(2008-5#1)
composed of a##22##3##(1992-1#1)(1993-12#1)(1993-8#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2013-1#1)
composed of alpha##2##3##(1995-11#1)(2008-11#1)
composed of alternating##2##3##(1996-2#1)(2008-10#1)
composed of an##3##3##(2008-10#1)(2011-2#2)
composed of different##2##3##(1997-7#1)(2008-12#1)
composed of directly repeated half-sites##2##5##(1995-8#2)
composed of fibrous##2##3##(2010-5#1)(2011-2#1)
composed of four##4##3##(1993-6#1)(2008-12#2)(2008-5#1)
composed of human##2##3##(1990-8#1)(2008-11#1)
composed of keratinocytes##2##3##(2008-5#2)
composed of one##2##3##(2007-12#1)(2008-10#1)
composed of the##11##3##(1990-5#2)(1994-5#2)(2008-5#1)(2008-6#1)(2008-8#2)(2010-4#1)(2010-6#1)(2013-1#1)
composed of three##5##3##(2008-8#1)(2009-6#1)(2009-7#1)(2010-8#2)
composed of two##9##3##(1994-5#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
composed of##186##2##(1990-11#1)(1990-12#1)(1990-5#5)(1990-6#1)(1990-8#2)(1991-8#2)(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#5)(2008-10#49)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#3)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
composed the##2##2##(2008-10#1)(2008-8#1)
composed##205##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#2)(1991-8#2)(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#4)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#7)(2008-10#58)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#11)(2008-9#3)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
composer##2##1##(2013-1#2)
composing gratings##2##2##(2008-8#2)
composing the##3##2##(2008-10#3)
composing##10##1##(1991-6#1)(2008-10#5)(2008-12#1)(2008-8#2)(2011-2#1)
composite Nd##2##2##(2008-2#2)
composite OWG with 10nm##2##4##(2008-10#2)
composite OWG##5##2##(2008-10#5)
composite Tm##2##2##(2008-2#2)
composite as##4##2##(2008-10#4)
composite biosensors##3##2##(2008-10#3)
composite body part##2##3##(2008-9#2)
composite design##18##2##(2008-10#15)(2008-11#2)(2011-2#1)
composite designs##4##2##(2008-10#4)
composite electrode##7##2##(2008-10#7)
composite electrodes##6##2##(2008-10#6)
composite fiber##2##2##(2008-11#2)
composite film##7##2##(2008-10#6)(2013-1#1)
composite films##4##2##(2008-10#3)(2013-1#1)
composite graft##4##2##(2008-12#1)(2008-9#2)(2012-2#1)
composite hydrogel##3##2##(2009-7#3)
composite interval mapping##6##3##(2008-10#6)
composite is reported##2##3##(2008-10#2)
composite is##4##2##(2008-10#4)
composite material films##2##3##(2008-10#2)
composite material##10##2##(2008-10#7)(2009-7#3)
composite materials##3##2##(2008-10#1)(2009-7#2)
composite matrix##5##2##(2008-10#5)
composite modified##2##2##(2008-10#2)
composite of##5##2##(2008-10#1)(2008-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
composite optical waveguide##2##3##(2008-10#2)
composite optical waveguides##2##3##(2008-10#2)
composite optical##4##2##(2008-10#4)
composite resin##4##2##(2013-1#4)
composite resins##2##2##(1990-9#1)(2013-1#1)
composite restorations##2##2##(1990-9#1)(2013-1#1)
composite thin films##2##3##(2008-10#2)
composite was##2##2##(2008-10#2)
composite with##2##2##(2008-10#2)
composite##200##1##(1990-9#2)(1991-6#1)(1992-6#1)(2008-10#127)(2008-11#8)(2008-12#1)(2008-2#7)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#11)(2010-2#1)(2011-2#6)(2012-2#4)(2013-1#11)
composites are##2##2##(2009-11#1)(2010-4#1)
composites as##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
composites in##2##2##(2010-4#1)(2013-1#1)
composites of##4##2##(2008-10#1)(2008-8#1)(2009-7#1)(2010-4#1)
composites subjected to different periods of accelerated artificial aging##2##9##(2013-1#2)
composites were obtained##2##3##(2010-4#2)
composites were##4##2##(1990-2#1)(2009-7#1)(2010-4#2)
composites##39##1##(1990-2#2)(1997-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#3)(2009-7#7)(2010-10#1)(2010-4#10)(2011-2#2)(2013-1#8)
composition analysis of##2##3##(1997-2#1)(2008-11#1)
composition analysis##4##2##(1997-2#2)(2008-10#1)(2008-11#1)
composition and concentration##2##3##(1990-2#1)(2010-11#1)
composition and content##2##3##(2009-8#1)(2012-8#1)
composition and fatty acid profiles##2##5##(2010-11#1)(2011-2#1)
composition and fatty acid##3##4##(2010-11#2)(2011-2#1)
composition and function##3##3##(2008-5#1)(2009-6#1)(2012-2#1)
composition and in##2##3##(1994-3#1)(2008-11#1)
composition and inflammation##3##3##(2011-2#3)
composition and pH##2##3##(2008-10#2)
composition and size##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
composition and the##2##3##(2008-10#2)
composition and##67##2##(1990-2#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#3)(2010-4#1)(2011-2#6)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#2)
composition as a##2##3##(2010-10#1)(2012-9#1)
composition as##3##2##(1991-12#1)(2010-10#1)(2012-9#1)
composition between##5##2##(2008-10#2)(2008-11#1)(2011-2#2)
composition changes##2##2##(2008-7#1)(2008-9#1)
composition has also been##2##4##(2008-10#1)(2008-11#1)
composition has##3##2##(2008-10#1)(2008-11#1)(2010-9#1)
composition in the##2##3##(2008-10#1)(2008-12#1)
composition in##11##2##(1990-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2010-6#1)(2012-2#3)
composition is known##2##3##(2008-10#1)(2008-2#1)
composition is##7##2##(2008-10#4)(2008-2#1)(2009-7#1)(2012-2#1)
composition of a##5##3##(1990-9#1)(2008-10#2)(2008-8#1)(2009-8#1)
composition of different##2##3##(2008-10#1)(2008-11#1)
composition of organic##2##3##(1991-7#1)(2008-11#1)
composition of populations of##2##4##(2008-10#2)
composition of populations##3##3##(2008-10#2)(2008-8#1)
composition of sequence variants##2##4##(2008-10#2)
composition of the affected areas##2##5##(2011-2#2)
composition of the bacterial##2##4##(2008-10#2)
composition of the complex##3##4##(2008-10#3)
composition of the essential oil of##2##6##(2008-11#2)
composition of the essential##3##4##(2008-11#3)
composition of the extracted##2##4##(2008-10#2)
composition of the human##2##4##(1990-8#1)(2011-2#1)
composition of the population##2##4##(2008-10#1)(2008-9#1)
composition of the##71##3##(1990-5#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-9#1)(1993-8#1)(1996-3#1)(2008-10#37)(2008-11#5)(2008-8#5)(2008-9#4)(2010-1#1)(2010-4#2)(2011-2#5)
composition of these##3##3##(2008-11#2)(2010-7#1)
composition of various##2##3##(2008-10#2)
composition of##181##2##(1990-5#4)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-9#1)(1993-8#1)(1994-2#2)(1994-3#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-7#1)(2008-10#84)(2008-11#12)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#9)(2008-9#7)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-10#1)(2010-4#2)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#10)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#2)
composition on the##6##3##(2008-10#4)(2008-11#1)(2011-2#1)
composition on##9##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
composition range##2##2##(2008-10#2)
composition ratio##3##2##(2008-10#3)
composition that##2##2##(2008-9#1)(2010-4#1)
composition to##8##2##(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)
composition was##10##2##(1997-8#1)(2008-10#5)(2008-11#2)(2008-8#1)(2009-8#1)
composition were##7##2##(2008-10#4)(2008-5#1)(2011-2#1)(2012-8#1)
composition with a##2##3##(1994-8#1)(2008-12#1)
composition with##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
composition##489##1##(1990-12#1)(1990-2#1)(1990-5#5)(1990-8#4)(1990-9#1)(1991-10#1)(1991-12#8)(1991-2#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#5)(1992-7#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#4)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#214)(2008-11#33)(2008-12#4)(2008-2#3)(2008-3#13)(2008-4#2)(2008-5#14)(2008-7#2)(2008-8#13)(2008-9#10)(2009-10#1)(2009-6#2)(2009-7#6)(2009-8#6)(2010-1#4)(2010-10#2)(2010-11#3)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#6)(2010-9#2)(2011-1#3)(2011-2#29)(2012-2#13)(2012-3#6)(2012-8#4)(2012-9#1)(2013-1#8)(2013-8#5)
compositional analysis##2##2##(1994-11#1)(2008-4#1)
compositional data##2##2##(2008-10#1)(2008-5#1)
compositional differences##2##2##(2008-10#2)
compositional##13##1##(1992-6#2)(1993-3#1)(1994-11#1)(2008-10#4)(2008-2#3)(2008-4#1)(2008-5#1)
compositionally##2##1##(2008-10#1)(2009-5#1)
compositions and##2##2##(2008-11#1)(2013-8#1)
compositions based on##2##3##(2008-10#1)(2008-5#1)
compositions for##3##2##(2008-10#2)(2013-1#1)
compositions of the##4##3##(2008-10#4)
compositions of##17##2##(1990-5#1)(1990-9#1)(1995-3#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-8#1)(2011-10#1)
compositions to##3##2##(2008-11#1)(2012-2#2)
compositions were##2##2##(2008-10#2)
compositions##57##1##(1990-5#1)(1990-9#1)(1992-3#1)(1993-3#1)(1995-3#2)(2008-10#28)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-4#1)(2011-10#1)(2012-2#4)(2013-1#2)(2013-8#2)
compost amendments##2##2##(2008-10#2)
compost and##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
compost mix##9##2##(2008-10#9)
compost samples##2##2##(2008-10#2)
compost tea##7##2##(2008-10#7)
compost to##2##2##(2008-10#2)
compost was##3##2##(2008-10#3)
compost water extract##3##3##(2008-10#3)
compost water##4##2##(2008-10#4)
compost##57##1##(2008-10#52)(2008-11#1)(2008-12#3)(2013-8#1)
compost-amended media##2##2##(2008-10#2)
compost-amended mix##2##2##(2008-10#2)
compost-amended potting mix##2##3##(2008-10#2)
compost-amended potting##3##2##(2008-10#3)
compost-amended##9##1##(2008-10#9)
composted cotton-gin trash##3##3##(2008-10#3)
composted pine bark##2##3##(2008-10#2)
composted swine##2##2##(2008-10#2)
composted##16##1##(2008-10#16)
composting##7##1##(2008-10#4)(2008-12#3)
composts that##2##2##(2008-10#2)
composts with##2##2##(2008-10#2)
composts##7##1##(2008-10#7)
compound 1##4##2##(2008-10#1)(2008-11#2)(2010-6#1)
compound analysis##2##2##(2008-10#2)
compound and used##2##3##(2008-10#2)
compound and##8##2##(2008-10#7)(2008-11#1)
compound at a##2##3##(2008-10#1)(2008-11#1)
compound content##2##2##(2008-10#1)(2008-11#1)
compound could##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
compound exhibits a##2##3##(2008-10#1)(2008-11#1)
compound exhibits##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
compound eye##3##2##(2007-12#3)
compound fertilizer##3##2##(2008-10#3)
compound for the##2##3##(2008-10#1)(2008-11#1)
compound for##8##2##(2007-11#1)(2008-10#4)(2008-11#2)(2008-5#1)
compound found in the##2##4##(2008-10#1)(2012-2#1)
compound from##4##2##(1991-5#1)(1992-12#1)(2008-10#2)
compound has been##3##3##(1990-8#1)(1992-12#1)(2008-10#1)
compound has##5##2##(1990-8#1)(1992-12#1)(2008-10#2)(2008-5#1)
compound in the##3##3##(1990-8#1)(2008-10#2)
compound in##15##2##(1990-8#1)(2008-10#9)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)
compound is##12##2##(1993-12#1)(1996-5#1)(1997-6#2)(2008-10#4)(2008-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
compound of##3##2##(2008-10#3)
compound parabolic concentrator##3##3##(2013-8#3)
compound separately##2##2##(2008-10#2)
compound that interferes with##2##4##(1997-6#1)(2008-10#1)
compound that is##2##3##(1996-2#1)(2008-8#1)
compound that##14##2##(1990-5#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-5#2)(2008-8#3)(2009-8#1)(2011-3#1)(2012-2#1)
compound to##7##2##(1993-1#1)(2008-10#4)(2008-11#1)(2008-5#1)
compound transgenic mice##2##3##(2013-1#2)
compound used for its determination##2##5##(1997-2#2)
compound used##3##2##(1997-2#2)(2008-10#1)
compound using##2##2##(2008-10#1)(2010-11#1)
compound was##16##2##(1992-12#1)(2008-10#11)(2008-11#1)(2009-6#1)(2010-11#1)(2012-2#1)
compound were##2##2##(2008-10#2)
compound with a##2##3##(2008-10#1)(2008-11#1)
compound with##9##2##(2008-10#6)(2008-11#2)(2009-4#1)
compound within##2##2##(2008-10#1)(2009-8#1)
compound##327##1##(1990-12#2)(1990-5#1)(1990-8#5)(1991-2#1)(1991-5#3)(1992-10#1)(1992-12#4)(1992-9#1)(1993-1#2)(1993-12#2)(1993-6#1)(1993-8#4)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#5)(1997-1#2)(1997-2#2)(1997-6#3)(1997-8#1)(2007-11#1)(2007-12#4)(2008-10#175)(2008-11#29)(2008-12#1)(2008-3#2)(2008-5#14)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-8#3)(2010-11#3)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#8)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#4)
compound's##2##1##(2008-10#1)(2008-5#1)
compound)##2##1##(2008-10#2)
compound-US pairings##2##2##(2008-5#2)
compound-specific##5##1##(2008-10#2)(2008-11#1)(2010-3#2)
compounded if##2##2##(2010-12#1)(2010-7#1)
compounded##3##1##(2008-10#1)(2010-12#1)(2010-7#1)
compounds (CALUX TEQ values are##2##5##(2008-10#2)
compounds 1 and 2##3##4##(2008-10#1)(2008-11#2)
compounds 1##5##2##(1994-2#1)(2008-10#1)(2008-11#2)(2010-6#1)
compounds 1-3##3##2##(2008-11#2)(2011-3#1)
compounds against##3##2##(2008-10#2)(2011-3#1)
compounds also##6##2##(1991-3#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)
compounds and by##2##3##(1994-5#1)(1996-5#1)
compounds and the##7##3##(2008-10#5)(2011-1#1)(2012-12#1)
compounds and their##3##3##(2008-10#2)(2008-11#1)
compounds and to##2##3##(2008-10#1)(2012-3#1)
compounds and##55##2##(1990-7#1)(1994-5#2)(1996-5#1)(2008-10#39)(2008-11#3)(2008-5#1)(2009-8#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
compounds are##33##2##(1996-5#1)(2006-6#1)(2008-10#20)(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
compounds as well as##3##4##(1993-12#1)(2008-10#2)
compounds as##21##2##(1993-12#1)(1993-8#1)(1994-8#1)(2008-10#13)(2008-11#3)(2011-1#1)(2012-3#1)
compounds at a##2##3##(2008-10#1)(2011-2#1)
compounds at##12##2##(1993-12#1)(2008-10#9)(2011-2#1)(2011-3#1)
compounds belonged to##2##3##(2008-10#1)(2012-2#1)
compounds but##3##2##(2008-10#3)
compounds by capillary electrophoresis##3##4##(2008-10#3)
compounds by the##2##3##(2008-10#2)
compounds by##22##2##(1990-10#1)(2008-10#21)
compounds can be##6##3##(2008-10#4)(2008-5#1)(2011-3#1)
compounds can##7##2##(2008-10#4)(2008-11#1)(2008-5#1)(2011-3#1)
compounds combined with##2##3##(2008-10#2)
compounds commonly##2##2##(2008-10#2)
compounds containing one##2##3##(1996-5#1)(2008-10#1)
compounds containing the##2##3##(1991-6#1)(2008-10#1)
compounds containing##6##2##(1991-6#1)(1996-5#1)(2008-10#4)
compounds could be##3##3##(2008-10#2)(2009-12#1)
compounds could##8##2##(2008-10#4)(2008-11#1)(2009-12#1)(2010-5#2)
compounds derived from##4##3##(1996-5#1)(2008-11#1)(2011-3#2)
compounds detected in##3##3##(2008-10#3)
compounds detected##5##2##(2008-10#4)(2011-2#1)
compounds directly into##2##3##(2008-10#2)
compounds emitted by##3##3##(2008-10#1)(2009-8#1)(2011-10#1)
compounds except##3##2##(1994-8#1)(2008-10#2)
compounds exhibited##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
compounds extracted##2##2##(2008-10#2)
compounds for the##2##3##(2008-10#1)(2008-11#1)
compounds for their##2##3##(1991-1#1)(1993-12#1)
compounds for##9##2##(1991-1#2)(1993-12#1)(2008-10#5)(2008-11#1)
compounds found in the##2##4##(2008-10#1)(2010-11#1)
compounds found in##4##3##(2008-10#2)(2010-11#1)(2011-2#1)
compounds found##6##2##(1997-2#1)(2008-10#3)(2010-11#1)(2011-2#1)
compounds from the##5##3##(2008-10#2)(2008-11#2)(2009-8#1)
compounds from##30##2##(1996-5#1)(2008-10#19)(2008-11#4)(2009-8#1)(2010-3#1)(2011-2#1)(2011-3#2)(2013-1#1)
compounds had a##2##3##(2008-11#1)(2011-2#1)
compounds had##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
compounds has been##7##3##(1994-5#1)(2008-10#6)
compounds has##9##2##(1994-5#1)(2008-10#7)(2008-11#1)
compounds have also##2##3##(2008-10#1)(2012-3#1)
compounds have been##10##3##(2008-10#8)(2010-11#1)(2012-2#1)
compounds have##15##2##(1994-3#1)(2008-10#10)(2008-5#1)(2010-11#1)(2012-2#1)(2012-3#1)
compounds having a##3##3##(1991-5#2)(2008-11#1)
compounds having the##2##3##(1992-12#1)(2008-11#1)
compounds having##8##2##(1991-5#2)(1992-12#1)(2008-10#2)(2008-11#2)(2008-5#1)
compounds identified##2##2##(2008-10#1)(2010-7#1)
compounds in air##3##3##(2008-10#2)(2013-1#1)
compounds in biological##2##3##(2008-10#2)
compounds in commercial##3##3##(2008-10#3)
compounds in cooked beef meat##2##5##(2008-10#2)
compounds in different##2##3##(2008-10#1)(2008-5#1)
compounds in environmental##2##3##(2008-10#2)
compounds in human##2##3##(2008-10#2)
compounds in landfill##3##3##(2008-10#3)
compounds in samples containing##2##4##(2008-10#1)(2009-8#1)
compounds in samples##3##3##(2008-10#2)(2009-8#1)
compounds in synthetic##2##3##(2008-10#2)
compounds in the environment##3##4##(2008-10#2)(2010-5#1)
compounds in the##22##3##(1991-1#1)(1994-5#1)(1997-4#1)(2008-10#15)(2008-11#3)(2010-5#1)
compounds in their##3##3##(2008-10#2)(2008-5#1)
compounds in wastewater from##2##4##(2008-10#2)
compounds in wastewater##3##3##(2008-10#3)
compounds in water and##2##4##(2008-10#2)
compounds in water samples##3##4##(2008-10#3)
compounds in water with a##2##5##(2008-10#2)
compounds in water##8##3##(2008-10#8)
compounds in##133##2##(1991-1#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-5#1)(1997-4#1)(2008-10#105)(2008-11#5)(2008-5#5)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-8#3)(2013-1#3)
compounds including##5##2##(2008-10#5)
compounds into##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
compounds investigated##4##2##(2008-10#3)(2008-11#1)
compounds is also##2##3##(2008-10#1)(2013-1#1)
compounds is of great##2##4##(2008-10#2)
compounds is of##3##3##(2008-10#3)
compounds is reported##2##3##(2008-10#2)
compounds is##17##2##(1997-4#1)(2008-10#12)(2008-6#1)(2008-7#1)(2013-1#2)
compounds made##2##2##(2008-10#2)
compounds may also##2##3##(1993-2#1)(1997-4#1)
compounds may##4##2##(1991-5#1)(1993-2#1)(1997-4#1)(2008-5#1)
compounds normally##2##2##(2008-10#2)
compounds obtained##2##2##(2008-10#2)
compounds of interest##2##3##(2008-10#2)
compounds of the##3##3##(1994-8#1)(2008-10#1)(2008-12#1)
compounds of two commercial Irish beef meats##2##7##(2008-10#2)
compounds of which##2##3##(2008-10#1)(2011-2#1)
compounds of wine##2##3##(2008-10#2)
compounds of##21##2##(1991-5#1)(1994-8#1)(2008-10#14)(2008-11#1)(2008-12#2)(2010-12#1)(2011-2#1)
compounds on the##7##3##(1994-5#1)(2008-10#5)(2008-11#1)
compounds on##15##2##(1990-11#1)(1994-5#1)(2008-10#9)(2008-11#4)
compounds or##6##2##(1991-6#1)(2008-10#5)
compounds possess##2##2##(2008-10#1)(2011-3#1)
compounds present in the##5##4##(2008-10#5)
compounds present in##11##3##(2008-10#11)
compounds present##12##2##(2008-10#12)
compounds prior to##2##3##(2008-10#2)
compounds produced in##2##3##(2008-10#2)
compounds produced##4##2##(2008-10#3)(2008-5#1)
compounds range from##2##3##(2008-10#1)(2008-11#1)
compounds responsible for the discolouration and##2##6##(2008-10#2)
compounds responsible for the discolouration##3##5##(2008-10#3)
compounds seemed to##2##3##(2008-10#1)(2008-7#1)
compounds should be##2##3##(2008-10#2)
compounds show##2##2##(2008-5#1)(2011-3#1)
compounds showed an##2##3##(2008-10#1)(2012-2#1)
compounds showed##7##2##(2008-10#3)(2008-11#3)(2012-2#1)
compounds spiked##2##2##(2008-10#1)(2011-2#1)
compounds studied were##2##3##(2008-10#2)
compounds studied##8##2##(1994-5#1)(1994-8#1)(2008-10#6)
compounds such as##11##3##(1992-9#1)(2008-10#10)
compounds tested##5##2##(1990-12#1)(1994-11#1)(1994-8#1)(2008-10#1)(2009-8#1)
compounds than##2##2##(2008-10#2)
compounds that are##2##3##(2008-10#1)(2008-12#1)
compounds that have been used as##2##6##(2008-10#1)(2010-4#1)
compounds that have##4##3##(2008-10#1)(2008-5#1)(2010-10#1)(2010-4#1)
compounds that inhibit##3##3##(2008-10#3)
compounds that may##2##3##(2008-10#1)(2009-12#1)
compounds that were##3##3##(2008-10#3)
compounds that##29##2##(1994-3#1)(2008-10#18)(2008-12#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-2#4)
compounds to##14##2##(1992-8#1)(1995-8#1)(2008-10#9)(2008-11#2)(2008-5#1)
compounds using the inside needle capillary adsorption trap##2##8##(2008-10#2)
compounds using the##4##3##(2008-10#4)
compounds using##7##2##(2008-10#7)
compounds was determined##3##3##(2008-10#2)(2012-2#1)
compounds was observed##3##3##(2008-10#2)(2008-11#1)
compounds was performed##2##3##(2008-10#2)
compounds was tested##2##3##(2008-10#2)
compounds was##27##2##(2008-10#23)(2008-11#3)(2012-2#1)
compounds were also##3##3##(2008-10#3)
compounds were compared with##2##4##(1992-10#1)(2008-11#1)
compounds were designed and synthesized##2##5##(2008-11#1)(2011-3#1)
compounds were detected by##2##4##(2008-10#2)
compounds were detected in##2##4##(2008-10#2)
compounds were detected##4##3##(2008-10#4)
compounds were determined by##2##4##(2008-5#1)(2009-8#1)
compounds were determined in##2##4##(2008-10#2)
compounds were determined##4##3##(2008-10#2)(2008-5#1)(2009-8#1)
compounds were evaluated##2##3##(2008-11#1)(2008-8#1)
compounds were examined##2##3##(2008-10#1)(2009-4#1)
compounds were extracted from##2##4##(2008-10#2)
compounds were extracted##3##3##(2008-10#3)
compounds were formed##2##3##(1991-5#1)(1994-9#1)
compounds were found to be##2##5##(2008-10#1)(2008-5#1)
compounds were found to##4##4##(2008-10#1)(2008-5#1)(2011-3#1)(2012-2#1)
compounds were investigated##2##3##(2008-10#1)(2011-2#1)
compounds were isolated and purified from##2##6##(2008-10#1)(2008-12#1)
compounds were isolated by##2##4##(2008-10#1)(2008-11#1)
compounds were isolated from##3##4##(2008-10#3)
compounds were isolated##9##3##(2008-10#7)(2008-11#1)(2008-12#1)
compounds were measured##3##3##(1993-1#1)(2008-11#2)
compounds were present at##2##4##(2008-10#1)(2011-3#1)
compounds were screened##2##3##(2011-3#2)
compounds were separated##2##3##(2008-10#2)
compounds were studied##3##3##(1996-5#1)(2008-10#2)
compounds were tested for##3##4##(2008-11#1)(2008-5#1)(2011-3#1)
compounds were tested##5##3##(1994-11#1)(2008-11#1)(2008-5#2)(2011-3#1)
compounds were##93##2##(1990-11#1)(1991-5#2)(1992-10#1)(1992-8#2)(1993-1#1)(1993-12#2)(1994-11#1)(1994-9#1)(1996-5#1)(2008-10#48)(2008-11#11)(2008-12#1)(2008-5#5)(2008-8#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2011-3#7)(2012-2#1)
compounds when##2##2##(2008-10#1)(2009-8#1)
compounds which are##4##3##(1991-2#1)(1994-5#1)(1994-8#1)(2008-10#1)
compounds which##10##2##(1991-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-10#4)(2008-5#1)(2012-2#1)
compounds whose##3##2##(1991-5#1)(2008-10#1)(2011-3#1)
compounds with a##3##3##(1994-3#1)(2008-10#1)(2008-5#1)
compounds with affinity for##2##4##(2008-10#2)
compounds with affinity##3##3##(2008-10#3)
compounds with anti-inflammatory##2##3##(2008-10#2)
compounds with different##4##3##(1993-12#1)(1995-11#1)(2008-10#2)
compounds with high##2##3##(2008-11#1)(2008-5#1)
compounds with##37##2##(1991-5#2)(1993-12#1)(1994-3#1)(1995-11#1)(2008-10#19)(2008-11#3)(2008-5#3)(2009-6#1)(2011-1#1)(2011-2#1)(2011-3#4)
compounds without##2##2##(2008-10#2)
compounds##1296##1##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#3)(1991-2#1)(1991-3#2)(1991-5#13)(1991-6#6)(1992-10#1)(1992-12#5)(1992-3#4)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#8)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#7)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#13)(1994-8#11)(1994-9#1)(1995-11#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#13)(1997-2#2)(1997-4#5)(1997-8#1)(2006-6#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#834)(2008-11#90)(2008-12#7)(2008-3#5)(2008-5#34)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#3)(2009-8#15)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#11)(2011-10#3)(2011-2#33)(2011-3#30)(2012-12#4)(2012-2#11)(2012-3#6)(2012-8#3)(2013-1#10)(2013-8#4)
compounds)##7##1##(2008-10#6)(2008-11#1)
comprehended##3##1##(1993-1#1)(2009-4#1)(2012-3#1)
comprehenders##3##1##(2013-1#3)
comprehension and##3##2##(1997-3#1)(2008-1#1)(2012-3#1)
comprehension of quality indicators##2##4##(1997-3#2)
comprehension of the##4##3##(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
comprehension of##12##2##(1997-3#3)(2007-8#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
comprehension processes##3##2##(2012-3#3)
comprehension##38##1##(1997-3#7)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#5)(2013-1#4)
comprehensive analysis of the##2##4##(1996-8#1)(1997-6#1)
comprehensive analysis of##7##3##(1992-1#1)(1995-8#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-4#1)(2010-11#1)
comprehensive and##7##2##(1995-2#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-8#1)(2013-1#1)
comprehensive approach##5##2##(1992-12#1)(1995-12#1)(1997-2#1)(2011-2#1)(2013-8#1)
comprehensive assessment of##3##3##(2009-10#1)(2010-12#1)(2011-2#1)
comprehensive assessment##6##2##(1994-1#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
comprehensive breast cancer screening services##2##5##(1996-2#2)
comprehensive care and##2##3##(2008-7#1)(2012-3#1)
comprehensive care for##2##3##(1992-3#1)(1994-2#1)
comprehensive care##8##2##(1992-3#1)(1994-2#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#2)
comprehensive characterization of##2##3##(2012-2#1)(2013-8#1)
comprehensive clinical##2##2##(2008-12#1)(2010-10#1)
comprehensive computerized system##2##3##(2013-1#2)
comprehensive data##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
comprehensive evaluation of##4##3##(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)
comprehensive evaluation##5##2##(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
comprehensive explanation of##2##3##(2008-11#1)(2013-8#1)
comprehensive health care reform##2##4##(1994-12#1)(1994-8#1)
comprehensive health##6##2##(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)
comprehensive human linkage map##2##4##(1994-9#2)
comprehensive information on##2##3##(1991-12#1)(2008-3#1)
comprehensive information##3##2##(1991-12#1)(2008-1#1)(2008-3#1)
comprehensive list of##2##3##(1995-1#1)(2008-9#1)
comprehensive medical##2##2##(1993-3#1)(2008-7#1)
comprehensive model of##3##3##(2009-8#1)(2010-5#1)(2010-8#1)
comprehensive model##6##2##(1992-9#2)(2009-8#1)(2010-5#1)(2010-8#1)(2013-1#1)
comprehensive public health##2##3##(1997-1#2)
comprehensive review of the literature##2##5##(2008-10#1)(2012-2#1)
comprehensive review of the##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
comprehensive review of##5##3##(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#2)
comprehensive review##8##2##(1997-2#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
comprehensive screening##3##2##(1996-2#1)(1997-1#1)(2008-10#1)
comprehensive study of the##2##4##(2008-10#1)(2009-3#1)
comprehensive study of##3##3##(2008-10#2)(2009-3#1)
comprehensive study##4##2##(2008-10#2)(2009-3#1)(2013-1#1)
comprehensive two-dimensional gas##2##3##(2008-10#2)
comprehensive understanding of##2##3##(2012-3#1)(2013-1#1)
comprehensive way##2##2##(1994-1#1)(1995-5#1)
comprehensive##221##1##(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#4)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#2)(1994-1#4)(1994-12#3)(1994-2#3)(1994-3#3)(1994-8#2)(1994-9#3)(1995-1#3)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#5)(1996-3#1)(1996-8#2)(1997-1#3)(1997-2#5)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#5)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#6)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#9)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2011-7#2)(2011-8#1)(2012-2#6)(2012-3#4)(2013-1#18)(2013-8#5)
comprehensively assess the##2##3##(2008-10#1)(2012-3#1)
comprehensively assess##3##2##(2008-10#2)(2012-3#1)
comprehensively studied##2##2##(1993-2#1)(2008-10#1)
comprehensively##11##1##(1993-2#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#2)(2010-11#1)(2012-3#1)
comprehensiveness of information##2##3##(2008-12#1)(2011-1#1)
comprehensiveness of##6##2##(2008-12#2)(2011-1#4)
comprehensiveness##8##1##(2008-12#4)(2011-1#4)
compress##2##1##(2008-10#1)(2011-2#1)
compressa##3##1##(2011-2#3)
compressed air##3##2##(1991-12#1)(1996-3#2)
compressed because##2##2##(1992-12#2)
compressed pulses##2##2##(2007-11#1)(2007-12#1)
compressed##13##1##(1991-12#1)(1991-3#1)(1992-12#2)(1996-3#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
compresses##3##1##(2011-2#2)(2013-1#1)
compressibility d(ln##2##2##(1991-5#2)
compressibility##7##1##(1991-5#3)(2008-10#4)
compressible##3##1##(2007-11#1)(2008-10#1)(2008-5#1)
compressing the##6##2##(1997-8#1)(2008-10#1)(2012-2#3)(2013-8#1)
compression algorithm##3##2##(2013-8#3)
compression and the##2##3##(2008-10#1)(2013-8#1)
compression and##10##2##(1990-3#1)(2008-10#4)(2008-5#1)(2009-7#1)(2010-7#1)(2013-8#2)
compression arithmetic##2##2##(2012-3#2)
compression at the##2##3##(2011-2#1)(2012-12#1)
compression by##4##2##(2008-7#1)(2012-3#1)(2013-1#2)
compression effect##3##2##(2013-8#3)
compression from##2##2##(2007-12#1)(2009-1#1)
compression in##7##2##(1992-12#1)(1996-6#1)(2007-12#1)(2008-7#2)(2009-5#1)(2012-2#1)
compression is##2##2##(2010-1#1)(2010-7#1)
compression neuropathy##3##2##(2008-12#1)(2008-9#1)(2009-5#1)
compression of the recurrent motor branch##2##6##(2008-9#2)
compression of the trigeminal##2##4##(2008-7#1)(2011-2#1)
compression of the##12##3##(1992-12#1)(1992-9#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-9#4)(2011-2#2)
compression of##19##2##(1992-12#1)(1992-9#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-9#4)(2009-7#1)(2010-7#1)(2011-2#2)
compression or##2##2##(2010-10#1)(2011-2#1)
compression tests##2##2##(2009-7#1)(2013-1#1)
compression##114##1##(1990-3#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-12#6)(1992-9#1)(1993-3#1)(1993-9#1)(1995-3#1)(1996-6#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#8)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#9)(2008-9#9)(2009-1#1)(2009-3#1)(2009-5#2)(2009-7#7)(2010-1#1)(2010-10#1)(2010-12#2)(2010-7#3)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#10)(2013-1#4)(2013-8#12)
compression)##2##1##(2008-7#1)(2010-1#1)
compressions##2##1##(1991-11#1)(2009-10#1)
compressive Young's##2##2##(2009-7#2)
compressive and##2##2##(2009-7#1)(2011-3#1)
compressive stress##2##2##(2008-3#1)(2009-7#1)
compressive##13##1##(1991-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#6)(2011-2#2)(2011-3#1)
compressor##3##1##(1995-3#1)(2008-2#1)(2012-3#1)
comprise 4% of##2##3##(1993-12#1)(2013-1#1)
comprise a family of##2##4##(1995-12#1)(2008-10#1)
comprise a##10##2##(1991-7#1)(1993-2#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2011-2#1)
comprise the##6##2##(2008-10#2)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
comprise##44##1##(1991-11#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-11#2)(1995-12#3)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-4#1)(2009-10#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
comprised a set of three-way solenoid valves##2##7##(2008-10#2)
comprised a##7##2##(2008-10#6)(2008-5#1)
comprised all##2##2##(2008-10#1)(2008-11#1)
comprised between##5##2##(2007-12#1)(2008-10#4)
comprised four##3##2##(2008-10#1)(2008-6#1)(2010-10#1)
comprised negative##2##2##(2013-1#2)
comprised of a##8##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
comprised of either##2##3##(2008-10#1)(2013-8#1)
comprised of the##2##3##(2008-10#1)(2013-8#1)
comprised of##39##2##(1990-12#1)(1990-8#1)(1992-4#1)(1994-1#1)(1996-3#1)(1997-9#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#3)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
comprised six##3##2##(2008-10#2)(2008-6#1)
comprised the##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
comprised three##2##2##(2008-10#1)(2012-6#1)
comprised##96##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-4#1)(1994-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#37)(2008-11#7)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-9#3)(2009-11#1)(2009-6#2)(2010-10#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#4)
comprises a##7##2##(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#2)
comprises an##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
comprises of##4##2##(1997-8#1)(2008-10#2)(2009-9#1)
comprises several##2##2##(2008-11#1)(2012-3#1)
comprises the##5##2##(1993-2#1)(1995-6#1)(2008-10#1)(2008-11#2)
comprises two##3##2##(1996-2#1)(2008-10#1)(2012-2#1)
comprises##48##1##(1993-12#1)(1993-2#1)(1995-1#1)(1995-5#2)(1995-6#1)(1996-2#1)(1997-3#2)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
comprising a##10##2##(1994-12#1)(1995-12#1)(1996-11#1)(1997-2#1)(2008-10#4)(2008-8#1)(2010-1#1)
comprising an##2##2##(1995-2#1)(2008-10#1)
comprising isolates##2##2##(2008-10#2)
comprising of##6##2##(2008-10#1)(2008-7#1)(2009-12#1)(2010-10#2)(2010-6#1)
comprising the##7##2##(1990-8#1)(1995-12#1)(2008-10#4)(2008-7#1)
comprising two##3##2##(1997-8#1)(2007-12#1)(2008-10#1)
comprising##81##1##(1990-8#1)(1991-6#2)(1992-4#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#2)(1996-11#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-1#2)(2010-10#2)(2010-6#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
compromise between the##3##3##(2008-10#2)(2008-3#1)
compromise between##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
compromise in##3##2##(1997-1#1)(2008-10#1)(2012-2#1)
compromise of##2##2##(2008-10#1)(2009-7#1)
compromise on##2##2##(2008-11#1)(2009-9#1)
compromise the##4##2##(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)
compromise was##2##2##(2008-12#1)(2012-2#1)
compromise##40##1##(1993-12#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#4)(2013-1#3)(2013-8#2)
compromised by##5##2##(1993-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-4#1)
compromised in##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
compromised##37##1##(1993-1#5)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#2)(2012-2#4)(2013-1#1)
compromises##3##1##(1993-11#1)(1996-3#1)(2013-1#1)
compromising the##4##2##(1992-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
compromising##9##1##(1992-2#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-10#1)(2012-2#2)
compulsory health insurance##2##3##(1994-2#1)(2013-8#1)
compulsory treatment of allegedly mentally disordered persons within the community##2##10##(1994-1#2)
compulsory##10##1##(1991-6#1)(1994-1#3)(1994-12#2)(1994-2#1)(1996-1#1)(2008-11#1)(2013-8#1)
computation of the##2##3##(2008-10#1)(2008-12#1)
computation of##8##2##(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2011-2#1)
computation time##2##2##(2008-3#2)
computation##24##1##(1990-11#1)(2008-10#6)(2008-12#1)(2008-3#8)(2008-4#1)(2008-6#1)(2009-12#2)(2011-2#1)(2012-3#1)(2013-8#2)
computational and##2##2##(1992-9#1)(2012-2#1)
computational approaches have been developed##2##5##(2011-2#1)(2011-3#1)
computational approaches to##2##3##(2008-7#2)
computational approaches##5##2##(2008-11#1)(2008-7#2)(2011-2#1)(2011-3#1)
computational efficiency##2##2##(2008-3#1)(2008-6#1)
computational fluid dynamic simulation##2##4##(2008-11#1)(2008-3#1)
computational fluid dynamic##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
computational fluid dynamics##2##3##(2008-11#2)
computational fluid##5##2##(2008-11#3)(2008-3#1)(2013-1#1)
computational method of##2##3##(2008-3#1)(2010-10#1)
computational methods##2##2##(1992-9#1)(2008-7#1)
computational model of the##2##4##(2008-11#1)(2013-1#1)
computational model of##5##3##(2008-11#3)(2013-1#1)(2013-8#1)
computational model##11##2##(2008-11#6)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
computational modeling##3##2##(1990-8#1)(2008-11#1)(2013-8#1)
computational models that##2##3##(2008-11#1)(2008-4#1)
computational models##7##2##(2008-11#4)(2008-4#1)(2009-5#1)(2010-10#1)
computational program##2##2##(2008-10#2)
computational strategy##3##2##(2008-10#2)(2008-3#1)
computational studies##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
computational##88##1##(1990-11#1)(1990-5#1)(1990-8#1)(1992-9#2)(2008-10#9)(2008-11#17)(2008-2#1)(2008-3#7)(2008-4#3)(2008-6#3)(2008-7#7)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#3)(2010-11#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#4)
computationally efficient##2##2##(2009-8#1)(2012-3#1)
computationally##10##1##(2008-11#3)(2008-8#2)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
computations for a##2##3##(2008-3#2)
computations for##4##2##(2008-10#1)(2008-3#3)
computations##16##1##(1990-8#2)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-8#1)
compute and##2##2##(1995-9#1)(2008-4#1)
compute the##12##2##(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-3#1)
compute##21##1##(1995-9#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-6#4)(2008-7#3)(2008-8#1)(2009-3#1)(2011-3#1)
computed and##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
computed by##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
computed for##3##2##(1993-1#1)(2008-10#1)(2010-12#1)
computed from a##2##3##(1993-12#1)(2008-3#1)
computed from the##6##3##(2008-10#1)(2008-3#3)(2012-3#1)(2013-1#1)
computed from##13##2##(1990-11#1)(1993-12#1)(2008-10#3)(2008-3#4)(2008-5#1)(2012-3#1)(2012-5#1)(2013-1#1)
computed in##2##2##(2008-10#1)(2008-7#1)
computed to##2##2##(2008-9#1)(2012-2#1)
computed tomographic (CT) scan##4##4##(2008-7#3)(2012-3#1)
computed tomographic (CT)##5##3##(2008-7#4)(2012-3#1)
computed tomographic images##2##3##(2011-2#1)(2013-1#1)
computed tomographic scans##2##3##(1993-6#1)(2011-2#1)
computed tomographic##18##2##(1993-6#1)(1997-5#1)(2008-7#4)(2009-10#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#6)
computed tomography (CT) and##5##4##(2008-9#1)(2011-2#1)(2012-2#3)
computed tomography (CT) is##2##4##(2008-7#1)(2012-3#1)
computed tomography (CT) or##3##4##(2009-3#1)(2010-1#1)(2013-1#1)
computed tomography (CT) scan showed##2##5##(2008-7#1)(2010-1#1)
computed tomography (CT) scan was##2##5##(2009-8#1)(2012-3#1)
computed tomography (CT) scan##8##4##(2008-12#1)(2008-7#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
computed tomography (CT) scans##3##4##(2008-7#2)(2011-2#1)
computed tomography (CT)##33##3##(1991-3#1)(2008-12#3)(2008-7#5)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-7#1)(2011-2#5)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#1)
computed tomography (MDCT) in##3##4##(2008-12#1)(2011-2#2)
computed tomography (MDCT)##4##3##(2008-12#1)(2011-2#2)(2012-2#1)
computed tomography and magnetic resonance imaging##4##6##(1990-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
computed tomography and##11##3##(1990-12#1)(1991-11#1)(2007-9#1)(2008-2#1)(2008-7#2)(2010-10#1)(2010-3#1)(2011-2#3)
computed tomography angiography in##2##4##(2008-11#1)(2011-2#1)
computed tomography angiography##12##3##(2008-11#3)(2008-12#5)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
computed tomography are##2##3##(2008-7#1)(2012-2#1)
computed tomography in patients with##2##5##(2008-12#1)(2012-2#1)
computed tomography in the##2##4##(2008-7#1)(2012-2#1)
computed tomography in##7##3##(1994-1#1)(2008-12#2)(2008-7#1)(2012-2#2)(2013-2#1)
computed tomography or magnetic resonance imaging##2##6##(1997-8#1)(2010-12#1)
computed tomography or magnetic resonance##3##5##(1997-8#1)(2010-12#1)(2011-2#1)
computed tomography or##4##3##(1997-4#1)(1997-8#1)(2010-12#1)(2011-2#1)
computed tomography scan##6##3##(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
computed tomography scans##3##3##(2008-11#1)(2008-7#2)
computed tomography showed##2##3##(1990-3#1)(2011-2#1)
computed tomography to detect the##2##5##(2008-10#1)(2009-10#1)
computed tomography##127##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1994-1#2)(1995-5#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#14)(2008-2#2)(2008-7#13)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#3)(2010-10#4)(2010-12#5)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#22)(2012-12#3)(2012-2#18)(2012-3#3)(2013-1#7)(2013-2#1)(2013-7#1)(2013-8#2)
computed with##3##2##(2008-3#2)(2010-7#1)
computed##200##1##(1990-11#1)(1990-12#2)(1990-3#2)(1991-11#1)(1991-12#2)(1991-3#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#2)(1995-5#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#15)(2008-2#2)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#19)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#2)(2010-1#3)(2010-10#4)(2010-12#6)(2010-3#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#25)(2012-12#3)(2012-2#21)(2012-3#6)(2012-5#1)(2013-1#15)(2013-2#1)(2013-7#1)(2013-8#2)
computer age##2##2##(1996-2#1)(2008-10#1)
computer aided##2##2##(2008-10#1)(2013-8#1)
computer analysis of##2##3##(2008-10#1)(2009-11#1)
computer and information literacy##2##4##(2008-11#2)
computer and##7##2##(1995-12#1)(1997-2#1)(2008-11#3)(2009-12#1)(2012-12#1)
computer applications##3##2##(1992-12#2)(1996-2#1)
computer assisted##3##2##(2008-11#2)(2008-12#1)
computer code##2##2##(2008-3#2)
computer controlled##4##2##(2008-10#3)(2011-2#1)
computer database##2##2##(2008-1#1)(2013-1#1)
computer for##3##2##(1995-5#1)(2008-10#1)(2008-7#1)
computer leases##3##2##(1993-2#3)
computer literacy##6##2##(1992-12#1)(1996-1#5)
computer model##2##2##(2010-5#1)(2012-2#1)
computer modeling##2##2##(1995-2#1)(1996-12#1)
computer program for##2##3##(1995-9#1)(2008-10#1)
computer program with##2##3##(2008-3#1)(2013-1#1)
computer program##28##2##(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#3)(1995-9#1)(1997-2#2)(1997-6#1)(2008-10#12)(2008-11#1)(2008-3#3)(2008-9#1)(2013-1#1)
computer programs##7##2##(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-4#1)(2013-1#1)
computer resources##2##2##(2008-3#2)
computer search of##4##3##(1990-2#1)(1995-8#1)(1996-2#1)(2008-8#1)
computer simulation##13##2##(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#2)
computer simulations of##3##3##(1995-3#1)(2008-3#1)(2010-3#1)
computer simulations##9##2##(1995-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#2)(2010-3#1)
computer skills##2##2##(1992-12#1)(2008-12#1)
computer software that##2##3##(1992-12#1)(2012-2#1)
computer software##9##2##(1992-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#4)(2012-2#1)
computer system##5##2##(1993-2#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
computer systems##2##2##(2008-11#1)(2008-9#1)
computer technology##3##2##(2008-12#1)(2008-9#2)
computer tomography (CT)##2##3##(2011-2#1)(2012-2#1)
computer tomography##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
computer vision##4##2##(2008-6#1)(2012-3#3)
computer##206##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#7)(1993-1#1)(1993-2#5)(1993-3#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#4)(1997-2#5)(1997-3#1)(1997-6#4)(1997-8#1)(2007-11#3)(2007-8#1)(2008-1#3)(2008-10#47)(2008-11#16)(2008-12#5)(2008-2#2)(2008-3#16)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#8)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#5)(2013-8#1)
computer-aided##6##1##(1997-8#1)(2008-10#2)(2008-11#1)(2011-2#2)
computer-animated##5##1##(2008-10#1)(2008-11#4)
computer-assisted image analysis##3##3##(2008-10#2)(2009-10#1)
computer-assisted self-interview##3##2##(2013-1#3)
computer-assisted##11##1##(1994-12#1)(2008-10#5)(2008-11#1)(2009-10#1)(2013-1#3)
computer-based journal##3##2##(1994-6#3)
computer-based methods##2##2##(2008-10#2)
computer-based tool##2##2##(2008-10#1)(2008-12#1)
computer-based##18##1##(1990-12#1)(1992-2#2)(1994-2#1)(1994-6#5)(2008-10#4)(2008-11#2)(2008-12#2)(2011-2#1)
computer-controlled environmental chamber##3##3##(2008-10#3)
computer-controlled##13##1##(2008-10#10)(2008-2#1)(2008-3#2)
computer-generated holograms##2##2##(2008-3#2)
computer-graphic animations##2##2##(2010-9#2)
computer-guided##3##1##(2008-11#1)(2008-8#2)
computer-intensive##2##1##(2008-10#2)
computerised##10##1##(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-2#1)
computerized clinical##2##2##(2008-7#1)(2013-1#1)
computerized freezing milling technique##2##4##(2012-3#2)
computerized image analysis##2##3##(2008-12#1)(2008-5#1)
computerized image##3##2##(1992-9#1)(2008-12#1)(2008-5#1)
computerized medical records##2##3##(2008-11#2)
computerized medical##4##2##(1994-6#1)(2008-11#2)(2010-8#1)
computerized patient##3##2##(1994-3#1)(2008-11#1)(2012-3#1)
computerized pharmacy##2##2##(2008-11#2)
computerized system for##2##3##(2013-1#2)
computerized system##3##2##(2013-1#3)
computerized tomography showed##2##3##(1997-3#1)(2008-12#1)
computerized tomography##13##2##(1990-6#1)(1991-12#1)(1991-3#1)(1997-3#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-3#1)(2011-2#2)(2013-1#2)
computerized##63##1##(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#3)(1992-9#2)(1993-11#1)(1994-3#5)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#2)(1997-3#1)(2008-10#2)(2008-11#8)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#8)
computers and##3##2##(1994-3#1)(1996-2#1)(2008-12#1)
computers in##2##2##(2008-11#1)(2009-9#1)
computers to##3##2##(1994-3#1)(2012-2#1)(2013-1#1)
computers##18##1##(1993-1#1)(1994-3#2)(1996-1#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#1)(2009-9#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
computing and##2##2##(1996-2#2)
computing the##16##2##(1990-2#1)(1992-9#2)(1994-1#1)(2008-10#1)(2008-3#6)(2008-6#1)(2009-3#1)(2009-7#1)(2011-3#1)(2012-3#1)
computing##29##1##(1990-11#1)(1990-2#1)(1992-9#2)(1994-1#1)(1995-9#1)(1996-2#2)(1997-3#1)(2008-10#5)(2008-3#7)(2008-6#1)(2009-3#1)(2009-7#1)(2010-8#2)(2011-3#1)(2012-3#1)(2013-1#1)
concanavalin A &gt##2##3##(1995-11#2)
concanavalin A (Con A)##5##4##(1990-6#1)(1994-11#1)(1995-2#1)(2008-10#2)
concanavalin A and##2##3##(1995-11#1)(2008-10#1)
concanavalin A##16##2##(1990-6#1)(1993-8#1)(1994-11#1)(1995-11#8)(1995-12#1)(1995-2#1)(2008-10#3)
concanavalin##18##1##(1990-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#8)(1995-12#1)(1995-2#1)(2008-10#4)
concatemers##2##1##(1993-6#2)
concatenated##4##1##(2007-11#1)(2008-10#1)(2012-3#1)(2013-8#1)
concave##12##1##(1996-5#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
concealed##7##1##(2007-12#1)(2008-10#5)(2008-11#1)
concealing##2##1##(2008-3#1)(2013-1#1)
concealment##4##1##(2007-12#1)(2008-10#2)(2010-11#1)
conceded##3##1##(1995-6#1)(2008-8#2)
conceivable that the##2##3##(1995-6#1)(1997-8#1)
conceivable that##5##2##(1995-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-10#1)
conceived and##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
conceived to##3##2##(2008-11#2)(2013-1#1)
conceived##15##1##(1991-12#1)(1991-2#1)(1994-3#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
concentrate and##2##2##(2008-10#1)(2008-3#1)
concentrate in the##3##3##(1990-12#1)(2010-4#1)(2011-2#1)
concentrate is##2##2##(2008-10#2)
concentrate on##4##2##(2008-10#1)(2008-11#1)(2009-7#1)(2013-8#1)
concentrate their##2##2##(1990-12#1)(1991-12#1)
concentrate##49##1##(1990-12#2)(1991-12#1)(1997-7#2)(2008-10#25)(2008-11#3)(2008-3#6)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-4#3)(2011-2#1)(2012-2#1)(2013-8#1)
concentrated H(2)SO(4)##3##2##(2008-10#3)
concentrated HCl and##3##3##(2008-10#3)
concentrated HCl##5##2##(2008-10#5)
concentrated about##2##2##(2008-10#1)(2008-12#1)
concentrated and##3##2##(2008-10#2)(2008-11#1)
concentrated as##3##2##(2008-10#3)
concentrated at the##2##3##(2008-9#1)(2009-8#1)
concentrated at##3##2##(2008-9#1)(2009-10#1)(2009-8#1)
concentrated by the##3##3##(1996-12#1)(2008-10#2)
concentrated by##12##2##(1992-11#1)(1996-12#1)(2008-10#9)(2012-2#1)
concentrated collagen hydrogels at 5 mg/ml##2##6##(2012-3#2)
concentrated collagen hydrogels##3##3##(2012-3#3)
concentrated emulsion and suspension instability analysis##2##6##(2008-10#2)
concentrated hydrochloric acid##4##3##(2008-10#4)
concentrated hydrochloric##5##2##(2008-10#5)
concentrated hydrofluoric acid##3##3##(2008-10#3)
concentrated in a##2##3##(1994-3#1)(2008-10#1)
concentrated in the##7##3##(1991-12#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
concentrated in##16##2##(1990-5#1)(1991-12#1)(1992-6#1)(1993-6#1)(1994-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)
concentrated inocula##3##2##(2008-10#3)
concentrated nitric acid##6##3##(2008-10#6)
concentrated nitric##7##2##(2008-10#7)
concentrated on the##2##3##(1994-2#1)(2008-10#1)
concentrated on##5##2##(1994-2#1)(2008-10#3)(2012-12#1)
concentrated samples##2##2##(2008-10#2)
concentrated solutions of##2##3##(2008-10#1)(2008-9#1)
concentrated solutions##3##2##(2008-10#2)(2008-9#1)
concentrated sulfuric acid##3##3##(2008-10#3)
concentrated sulphuric acid##3##3##(2008-10#3)
concentrated to##2##2##(2008-10#1)(2010-10#1)
concentrated tomato pasta##2##3##(2008-10#2)
concentrated within##2##2##(1996-6#1)(2008-3#1)
concentrated##142##1##(1990-5#2)(1991-11#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(2008-10#96)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#4)
concentrates and##3##2##(2008-10#3)
concentrates for hemodialysis##2##3##(2008-10#2)
concentrates on the##2##3##(2008-2#1)(2008-9#1)
concentrates on##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
concentrates##20##1##(1993-6#1)(2008-10#12)(2008-2#1)(2008-9#1)(2010-11#1)(2010-4#4)
concentrating by the##2##3##(2008-10#2)
concentrating on their##2##3##(1991-2#1)(2008-11#1)
concentrating on##5##2##(1991-2#1)(1994-1#1)(2008-11#2)(2008-4#1)
concentrating##16##1##(1991-2#1)(1993-12#1)(1994-1#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2011-2#1)
concentration &lt##2##2##(2008-10#1)(2008-7#1)
concentration (&lt##2##2##(1992-9#1)(2008-10#1)
concentration (0##3##2##(1994-11#1)(2008-10#1)(2012-3#1)
concentration (10##2##2##(2008-10#1)(2008-7#1)
concentration (2##2##2##(2008-11#1)(2008-5#1)
concentration (CMC) of##2##3##(2008-10#2)
concentration ([Ca(2+)](i)) in##2##3##(2008-8#1)(2008-9#1)
concentration ([Ca(2+)](i))##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
concentration ([Ca2+]i)##5##2##(1990-5#1)(1992-6#2)(1994-6#1)(1995-11#1)
concentration 1##3##2##(2008-10#2)(2008-5#1)
concentration 10##2##2##(1993-1#1)(2008-10#1)
concentration achieved##3##2##(1992-9#1)(2008-11#1)(2008-12#1)
concentration after##2##2##(2008-7#2)
concentration along with##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
concentration also##2##2##(1993-3#1)(2008-7#1)
concentration and a##4##3##(2008-10#4)
concentration and determination of##3##4##(2008-10#3)
concentration and its##3##3##(2008-10#2)(2008-5#1)
concentration and pH of##3##4##(2008-10#3)
concentration and pH##9##3##(1994-11#1)(2008-10#8)
concentration and production##2##3##(2008-11#2)
concentration and separation of##3##4##(2008-10#3)
concentration and temperature on the##2##5##(2008-10#2)
concentration and temperature on##3##4##(2008-10#3)
concentration and temperature##6##3##(2008-10#5)(2008-3#1)
concentration and the##19##3##(2008-10#14)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)(2013-1#1)
concentration and time##3##3##(1994-6#1)(2008-10#2)
concentration and volume of##4##4##(2008-10#4)
concentration and##132##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-6#1)(1992-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-3#3)(2008-10#87)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-10#1)(2011-2#2)(2013-1#3)(2013-8#1)
concentration are##4##2##(2008-10#3)(2011-2#1)
concentration as##7##2##(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2010-1#1)
concentration at a##2##3##(1997-2#1)(2008-7#1)
concentration at the##4##3##(2008-10#2)(2008-9#1)(2012-9#1)
concentration at which##2##3##(2008-10#2)
concentration at##20##2##(1991-7#1)(1992-12#1)(1993-1#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-9#1)
concentration below##3##2##(1993-6#1)(2008-10#2)
concentration between 0##3##3##(2008-10#3)
concentration between##10##2##(1992-12#1)(1995-3#1)(2008-10#8)
concentration but##3##2##(1990-3#1)(1990-5#1)(2008-10#1)
concentration by the##2##3##(2008-10#1)(2008-12#1)
concentration by##8##2##(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)
concentration can be##7##3##(2008-10#5)(2008-11#2)
concentration can##8##2##(2008-10#6)(2008-11#2)
concentration change of##2##3##(2008-10#2)
concentration change##5##2##(2008-10#3)(2008-7#1)(2008-9#1)
concentration compared##2##2##(2008-10#1)(2013-8#1)
concentration conditions##5##2##(2008-10#1)(2008-9#4)
concentration correlated##2##2##(1992-9#1)(2011-2#1)
concentration could be##3##3##(2008-10#2)(2008-11#1)
concentration could##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
concentration data##2##2##(2008-10#2)
concentration decreased##3##2##(2008-10#1)(2008-11#2)
concentration decreases##2##2##(2008-10#1)(2008-12#1)
concentration dependence of##2##3##(1995-6#1)(2008-10#1)
concentration dependence##4##2##(1995-6#1)(2008-10#3)
concentration dependent increase in##2##4##(1993-6#1)(2008-10#1)
concentration dependent##13##2##(1990-5#1)(1993-6#1)(1994-8#1)(2008-10#7)(2008-7#1)(2012-2#1)(2013-8#1)
concentration depending on the##2##4##(2008-10#1)(2008-11#1)
concentration depending on##3##3##(2008-10#2)(2008-11#1)
concentration detection##3##2##(2008-10#2)(2008-3#1)
concentration determination##2##2##(1992-8#1)(2008-3#1)
concentration determined##2##2##(2008-10#1)(2008-7#1)
concentration did not##3##3##(1996-8#1)(2008-11#1)(2008-7#1)
concentration distribution of the##2##4##(2008-10#2)
concentration distribution of##3##3##(2008-10#3)
concentration distribution##5##2##(2008-10#3)(2008-3#2)
concentration during##5##2##(1990-3#1)(1992-9#1)(1997-6#1)(2008-11#1)(2008-3#1)
concentration effects on##2##3##(2008-10#1)(2008-7#1)
concentration enhanced##2##2##(2008-10#2)
concentration enhancement##2##2##(2008-10#2)
concentration factor was##2##3##(2008-10#2)
concentration factor##7##2##(2008-10#7)
concentration for each##3##3##(1992-9#1)(2008-10#1)(2008-7#1)
concentration for the##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
concentration for##20##2##(1992-9#1)(1993-8#1)(1994-5#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-5#1)(2008-7#3)
concentration from 0##3##3##(2008-10#2)(2008-8#1)
concentration from 1##4##3##(2008-10#3)(2008-11#1)
concentration from##20##2##(1990-3#1)(2008-10#13)(2008-11#3)(2008-5#1)(2008-8#1)(2009-6#1)
concentration giving a signal equal to three times the standard deviation of the##2##13##(2008-10#2)
concentration giving a signal equal to three times##3##8##(2008-10#3)
concentration giving##4##2##(1990-5#1)(2008-10#3)
concentration gradient shell##3##3##(2012-2#3)
concentration gradient##12##2##(2008-10#8)(2009-9#1)(2012-2#3)
concentration gradients##3##2##(2008-10#3)
concentration groups##3##2##(2008-9#3)
concentration had a##2##3##(2011-2#1)(2013-1#1)
concentration had##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
concentration has been##5##3##(2008-10#3)(2008-3#1)(2008-6#1)
concentration has##8##2##(2008-10#6)(2008-3#1)(2008-6#1)
concentration have been##3##3##(2008-10#3)
concentration in a##12##3##(2008-10#8)(2008-11#1)(2008-3#2)(2008-9#1)
concentration in aqueous##2##3##(2008-10#1)(2008-12#1)
concentration in biological##3##3##(2008-10#2)(2013-8#1)
concentration in blood##2##3##(1991-2#1)(1996-3#1)
concentration in both the##2##4##(2008-10#1)(2011-2#1)
concentration in erythrocytes##2##3##(1990-2#1)(1991-2#1)
concentration in grain and##2##4##(2008-10#2)
concentration in grain##4##3##(2008-10#4)
concentration in kernels of##2##4##(2008-10#2)
concentration in solution##2##3##(2008-10#2)
concentration in the blood##2##4##(1990-12#1)(2008-10#1)
concentration in the culture##2##4##(2008-11#1)(2008-7#1)
concentration in the extract##2##4##(2008-10#2)
concentration in the liquid##2##4##(2008-10#2)
concentration in the medium##2##4##(1993-12#1)(2011-1#1)
concentration in the mobile phase##2##5##(2008-10#2)
concentration in the organic##2##4##(2008-10#2)
concentration in the plants##2##4##(2008-10#2)
concentration in the plasma##2##4##(1992-9#1)(2008-10#1)
concentration in the range 0##4##5##(2008-10#4)
concentration in the range 1-10##2##5##(2008-10#2)
concentration in the range of 0##6##6##(2008-10#6)
concentration in the range of 2##2##6##(2008-10#2)
concentration in the range of 5##2##6##(2008-10#2)
concentration in the range of##14##5##(2008-10#14)
concentration in the range##27##4##(2008-10#27)
concentration in the sample##3##4##(2008-10#3)
concentration in the##95##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-9#3)(1993-12#1)(1994-5#1)(2008-10#71)(2008-11#3)(2008-3#2)(2008-7#7)(2011-1#1)(2011-10#1)
concentration in upper phase is much higher than that of##2##10##(2008-10#2)
concentration in water##2##3##(2008-10#2)
concentration in waters##2##3##(2008-10#2)
concentration in##197##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-2#4)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-10#125)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#9)(2008-8#3)(2008-9#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#2)(2013-8#1)
concentration increased to##2##3##(1993-3#1)(2008-11#1)
concentration increased##7##2##(1990-3#1)(1990-9#1)(1993-3#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
concentration increases##4##2##(2008-10#3)(2009-8#1)
concentration induced##3##2##(1994-3#1)(1995-8#1)(2008-8#1)
concentration interval##2##2##(2008-10#2)
concentration is associated with the##2##5##(2008-10#1)(2010-4#1)
concentration is determined##2##3##(2008-10#1)(2008-3#1)
concentration is linear##3##3##(2008-10#3)
concentration is lower##2##3##(1996-8#1)(2008-10#1)
concentration is not##2##3##(2008-10#1)(2009-10#1)
concentration is presented##2##3##(2008-10#1)(2008-3#1)
concentration is##39##2##(1990-12#1)(1994-2#1)(1996-8#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)
concentration leads to##2##3##(2008-3#1)(2008-7#1)
concentration level and exposure time##2##5##(2008-10#2)
concentration level and##3##3##(2008-10#3)
concentration level of 0##2##4##(2008-10#2)
concentration level of 1##2##4##(2008-10#2)
concentration level of 5##2##4##(2008-10#1)(2009-8#1)
concentration level of##13##3##(2008-10#11)(2008-11#1)(2009-8#1)
concentration level##25##2##(2008-10#22)(2008-11#1)(2009-8#2)
concentration levels and##4##3##(2008-10#4)
concentration levels between##4##3##(2008-10#4)
concentration levels by##2##3##(2008-10#2)
concentration levels from 3##2##4##(2008-10#2)
concentration levels from##5##3##(2008-10#4)(2011-2#1)
concentration levels in the##2##4##(2008-10#2)
concentration levels in##3##3##(2008-10#3)
concentration levels of the##2##4##(2008-10#2)
concentration levels of##9##3##(2008-10#8)(2008-11#1)
concentration levels##56##2##(2008-10#51)(2008-11#1)(2008-5#2)(2011-2#1)(2011-3#1)
concentration limit of detection##4##4##(1997-2#2)(2008-10#2)
concentration limit of##5##3##(1997-2#2)(2008-10#3)
concentration limits##2##2##(2008-10#1)(2008-11#1)
concentration may be##3##3##(1993-11#1)(2008-7#1)(2011-2#1)
concentration means##2##2##(2008-10#2)
concentration measured##5##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
concentration measurement##3##2##(2008-10#1)(2008-3#2)
concentration measurements are##3##3##(2008-10#2)(2008-3#1)
concentration measurements in a##2##4##(2008-2#1)(2008-3#1)
concentration measurements of##2##3##(2008-10#1)(2008-11#1)
concentration measurements##12##2##(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)
concentration method##2##2##(2008-10#2)
concentration obtained in##2##3##(2008-10#1)(2011-2#1)
concentration obtained##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
concentration of 0##15##3##(2008-10#11)(2008-11#2)(2008-7#1)(2011-1#1)
concentration of 1##21##3##(1995-11#2)(1997-1#1)(2008-10#6)(2008-11#6)(2008-3#1)(2008-5#3)(2008-7#1)(2012-3#1)
concentration of 10 muM##2##4##(2008-10#1)(2008-11#1)
concentration of 10##9##3##(1992-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2012-2#1)
concentration of 100##6##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#2)
concentration of 2##10##3##(2008-10#7)(2008-12#1)(2008-5#1)(2010-12#1)
concentration of 20##3##3##(2008-10#2)(2008-11#1)
concentration of 25##3##3##(2008-10#1)(2010-1#1)(2012-3#1)
concentration of 250##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
concentration of 3##6##3##(1990-5#2)(2008-10#2)(2008-11#1)(2011-1#1)
concentration of 4##4##3##(2008-10#3)(2008-11#1)
concentration of 40μg/ml##2##3##(2012-3#2)
concentration of 5##10##3##(1990-11#1)(2008-10#8)(2008-5#1)
concentration of 50##3##3##(2008-10#1)(2010-3#1)(2012-3#1)
concentration of 6##4##3##(1990-6#1)(2008-10#2)(2008-7#1)
concentration of 60##2##3##(2008-10#1)(2011-2#1)
concentration of DETA##2##3##(2008-10#2)
concentration of Fe(II)##2##3##(2008-10#2)
concentration of H(2)O(2) in the range##2##6##(2008-10#2)
concentration of H(2)O(2)##4##3##(2008-10#4)
concentration of MeOH##2##3##(2008-10#2)
concentration of NO in##2##4##(1993-8#1)(2008-10#1)
concentration of NO##3##3##(1993-8#1)(2008-10#2)
concentration of NaCl##2##3##(1990-5#1)(2008-10#1)
concentration of PIBs/ml was obtained##2##5##(2008-11#2)
concentration of Triton##2##3##(2008-10#2)
concentration of VB(2)##2##3##(2008-10#2)
concentration of a##9##3##(1993-12#1)(2008-10#7)(2008-9#1)
concentration of about 0##2##4##(2008-10#2)
concentration of acid##3##3##(2008-10#3)
concentration of an##2##3##(2008-11#1)(2011-2#1)
concentration of analyte##3##3##(2008-10#3)
concentration of approximately##5##3##(1993-8#1)(2008-11#3)(2008-8#1)
concentration of arsenic##2##3##(2008-10#2)
concentration of ascorbic acid##4##4##(2008-10#4)
concentration of buffer##2##3##(2008-10#2)
concentration of calcium and##2##4##(2008-10#1)(2013-1#1)
concentration of calcium##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
concentration of cobalt(II)##2##3##(2008-10#2)
concentration of dopamine in the range of##2##7##(2008-10#2)
concentration of effluent##2##3##(2008-10#1)(2008-12#1)
concentration of electrolyte##2##3##(2008-10#2)
concentration of eluent##2##3##(2008-10#2)
concentration of elution solution##2##4##(2008-10#2)
concentration of extract##2##3##(2008-12#2)
concentration of ferritin in##2##4##(1993-11#1)(2008-10#1)
concentration of free##5##3##(2008-10#3)(2011-2#1)(2013-8#1)
concentration of glucose##3##3##(2008-10#2)(2008-11#1)
concentration of glutamine##2##3##(2008-11#2)
concentration of hormones##4##3##(1997-4#1)(2008-8#3)
concentration of hydrogen##3##3##(2008-10#3)
concentration of internal##2##3##(2008-10#2)
concentration of intracellular##2##3##(1993-3#1)(2008-10#1)
concentration of iron and##2##4##(1996-2#1)(2008-10#1)
concentration of iron##5##3##(1996-2#2)(2008-10#3)
concentration of l-cysteine##3##3##(2008-10#3)
concentration of melatonin##2##3##(2008-10#1)(2011-2#1)
concentration of mercury##2##3##(2008-10#2)
concentration of metal ions##4##4##(2008-10#4)
concentration of metal##6##3##(2008-10#6)
concentration of modifier##2##3##(2008-10#2)
concentration of nitrite##4##3##(2008-10#4)
concentration of proteins in##2##4##(2008-10#1)(2011-2#1)
concentration of proteins##3##3##(2008-10#2)(2011-2#1)
concentration of serum##3##3##(1995-5#1)(2008-11#1)(2008-8#1)
concentration of some##2##3##(2008-10#1)(2008-12#1)
concentration of styrene##2##3##(2008-10#2)
concentration of substrate##2##3##(2008-7#2)
concentration of sulfur##2##3##(2008-10#2)
concentration of the analyte##3##4##(2008-10#3)
concentration of the dissolved ligand##2##5##(2008-10#2)
concentration of the ligand##2##4##(2008-10#2)
concentration of the metal ions##2##5##(2008-10#2)
concentration of the sample##2##4##(2008-10#2)
concentration of the solute##2##4##(2008-10#2)
concentration of the solution##2##4##(1995-3#1)(1996-3#1)
concentration of the##82##3##(1991-5#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#2)(1996-3#1)(2008-10#56)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
concentration of these##5##3##(1994-8#2)(2008-10#2)(2012-2#1)
concentration of total##3##3##(2008-10#2)(2008-11#1)
concentration of trace elements##2##4##(2008-10#2)
concentration of trace##3##3##(2008-10#3)
concentration of vanadium in##2##4##(2008-10#2)
concentration of vanadium##6##3##(1990-5#1)(2008-10#5)
concentration of various##2##3##(2008-10#1)(2013-8#1)
concentration of##756##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#2)(1993-1#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#5)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#4)(1994-8#5)(1995-11#4)(1995-2#2)(1995-3#4)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#6)(1996-3#1)(1997-1#3)(1997-2#1)(1997-4#3)(1997-5#1)(2007-11#1)(2008-10#454)(2008-11#48)(2008-12#17)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#16)(2008-6#2)(2008-7#15)(2008-8#15)(2008-9#14)(2009-12#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#14)(2011-3#1)(2012-2#9)(2012-3#6)(2013-1#8)(2013-8#5)
concentration on the##11##3##(1992-6#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)
concentration on##25##2##(1992-6#1)(1994-2#1)(1996-12#1)(1997-4#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-3#1)
concentration only##2##2##(1992-10#1)(2008-10#1)
concentration or a##2##3##(2008-7#2)
concentration or##4##2##(1991-2#1)(2008-10#1)(2008-7#2)
concentration over the range of##2##5##(2008-10#1)(2008-11#1)
concentration over the range##3##4##(2008-10#2)(2008-11#1)
concentration over the##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
concentration over##8##2##(2008-10#4)(2008-11#2)(2008-7#2)
concentration plot##3##2##(2008-10#3)
concentration present in##2##3##(2008-10#1)(2008-11#1)
concentration profile of##2##3##(2008-10#2)
concentration profile##4##2##(1993-2#1)(1996-3#1)(2008-10#2)
concentration profiles of the##2##4##(2008-10#1)(2008-11#1)
concentration profiles of##5##3##(2008-10#2)(2008-11#2)(2008-3#1)
concentration profiles were##2##3##(2008-10#1)(2008-3#1)
concentration profiles##11##2##(1997-2#1)(2008-10#4)(2008-11#3)(2008-3#3)
concentration range (1##10##3##(2008-10#10)
concentration range 0##25##3##(2008-10#25)
concentration range 1##9##3##(2008-10#9)
concentration range 2##6##3##(2008-10#6)
concentration range 3##2##3##(2008-10#2)
concentration range 5##6##3##(2008-10#6)
concentration range and##4##3##(1990-12#1)(2008-10#3)
concentration range between##5##3##(2008-10#5)
concentration range for the##2##4##(2008-10#2)
concentration range for##3##3##(2008-10#3)
concentration range from 0 to##2##5##(2008-10#2)
concentration range from 0##4##4##(2008-10#4)
concentration range from 1##4##4##(2008-10#4)
concentration range from 5##7##4##(2008-10#7)
concentration range from##33##3##(2008-10#33)
concentration range is##3##3##(1990-12#1)(2008-10#2)
concentration range of 0##29##4##(2008-10#28)(2011-3#1)
concentration range of 0-2##2##4##(2008-10#2)
concentration range of 1##11##4##(1995-11#1)(2008-10#10)
concentration range of 2##5##4##(2008-10#5)
concentration range of 3##2##4##(2008-10#2)
concentration range of 5##5##4##(2008-10#5)
concentration range of 7##2##4##(2008-10#2)
concentration range of linear##2##4##(2008-10#2)
concentration range of the##3##4##(1995-2#1)(2008-10#2)
concentration range of two orders of magnitude##2##7##(2008-10#2)
concentration range of##107##3##(1995-11#1)(1995-2#1)(2008-10#101)(2008-11#1)(2011-3#2)(2013-1#1)
concentration range over which##2##4##(2008-10#2)
concentration range was##8##3##(2008-10#7)(2011-2#1)
concentration range##329##2##(1990-12#4)(1990-2#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-10#309)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#2)(2013-1#1)
concentration ranged from##2##3##(2008-5#2)
concentration ranges are##2##3##(2008-10#2)
concentration ranges for the##4##4##(2008-10#4)
concentration ranges for##5##3##(2008-10#5)
concentration ranges of##10##3##(2008-10#9)(2008-7#1)
concentration ranges to##2##3##(2008-10#2)
concentration ranges##49##2##(1995-8#1)(2008-10#45)(2008-11#1)(2008-7#1)(2012-2#1)
concentration ratio and varied pH##2##5##(2008-10#2)
concentration ratio of##3##3##(2008-10#3)
concentration ratio##8##2##(2008-10#7)(2008-7#1)
concentration ratios of Fe(II)##2##4##(2008-10#2)
concentration ratios of##6##3##(2008-10#6)
concentration ratios##9##2##(2008-10#9)
concentration reached##4##2##(2008-10#1)(2008-5#1)(2008-7#2)
concentration reduced the##2##3##(2008-10#1)(2008-7#1)
concentration represent##2##2##(2008-11#1)(2009-7#1)
concentration required for##2##3##(2008-10#2)
concentration required##3##2##(1997-5#1)(2008-10#2)
concentration results in##2##3##(2008-10#2)
concentration samples##2##2##(2008-10#1)(2009-11#1)
concentration should##2##2##(2008-10#2)
concentration step##2##2##(2008-10#2)
concentration such##2##2##(2008-10#1)(2008-8#1)
concentration technique##2##2##(2008-10#2)
concentration than the##2##3##(2008-10#1)(2011-2#1)
concentration than##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
concentration that##4##2##(2008-10#3)(2008-8#1)
concentration time curve##2##3##(1996-3#1)(2008-12#1)
concentration to##7##2##(1990-2#1)(2008-10#3)(2008-11#2)(2008-7#1)
concentration up to##8##3##(1992-12#1)(1994-11#1)(2008-10#4)(2008-7#1)(2011-2#1)
concentration used##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
concentration using a##2##3##(2008-10#1)(2008-11#1)
concentration using##5##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
concentration value##2##2##(2008-10#1)(2008-11#1)
concentration values of##3##3##(2008-10#3)
concentration values##11##2##(2008-10#7)(2008-9#3)(2013-1#1)
concentration versus time curve (AUC)##2##5##(2008-6#1)(2008-7#1)
concentration versus time##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
concentration versus##5##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
concentration was 1##2##3##(2008-10#2)
concentration was decreased##2##3##(2008-10#1)(2008-11#1)
concentration was determined##7##3##(1990-5#1)(2008-10#5)(2008-3#1)
concentration was found in##2##4##(2008-10#1)(2008-11#1)
concentration was found to be##2##5##(1992-9#1)(2008-10#1)
concentration was found##5##3##(1992-9#1)(2008-10#2)(2008-11#2)
concentration was increased##5##3##(1990-5#1)(1997-2#1)(2008-10#2)(2008-11#1)
concentration was less than##2##4##(2008-10#1)(2008-7#1)
concentration was measured by##2##4##(2008-10#1)(2010-4#1)
concentration was measured##4##3##(2008-10#2)(2008-12#1)(2010-4#1)
concentration was obtained in the range##3##6##(2008-10#2)(2008-12#1)
concentration was obtained##4##3##(2008-10#3)(2008-12#1)
concentration was only##2##3##(1991-5#1)(2008-11#1)
concentration was significantly higher in##2##5##(2008-10#1)(2011-2#1)
concentration was significantly higher##3##4##(2008-10#2)(2011-2#1)
concentration was##81##2##(1990-3#1)(1990-5#2)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-8#2)(1996-8#1)(1997-2#1)(2008-10#45)(2008-11#10)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
concentration were found for##2##4##(2008-10#2)
concentration were investigated in##2##4##(1995-2#1)(2008-10#1)
concentration were linear##2##3##(2008-10#2)
concentration were obtained with##3##4##(2008-10#3)
concentration were obtained##6##3##(2008-10#4)(2010-12#1)(2013-8#1)
concentration were studied##2##3##(2008-10#2)
concentration were##23##2##(1995-2#1)(2008-10#18)(2008-3#1)(2008-7#1)(2010-12#1)(2013-8#1)
concentration which##7##2##(1992-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-7#1)
concentration will##3##2##(1993-12#1)(2008-7#1)(2008-8#1)
concentration with an##4##3##(1994-8#1)(2008-10#1)(2008-6#1)(2011-10#1)
concentration with the##3##3##(2007-12#1)(2008-10#2)
concentration with##16##2##(1994-8#1)(2007-12#1)(2008-10#11)(2008-3#1)(2008-6#1)(2011-10#1)
concentration within the##2##3##(2008-10#2)
concentration within##4##2##(1996-2#1)(2008-10#2)(2008-11#1)
concentration##2743##1##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#9)(1990-3#8)(1990-5#18)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#3)(1991-11#2)(1991-12#11)(1991-2#4)(1991-3#2)(1991-5#11)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#9)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#9)(1992-8#3)(1992-9#14)(1993-1#8)(1993-11#3)(1993-12#5)(1993-2#7)(1993-3#9)(1993-6#5)(1993-8#13)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#4)(1994-5#7)(1994-6#6)(1994-8#10)(1995-11#10)(1995-12#1)(1995-2#7)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#11)(1996-12#6)(1996-2#10)(1996-3#11)(1996-5#1)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#7)(1997-4#4)(1997-5#2)(1997-6#2)(2007-11#1)(2007-12#2)(2008-10#1726)(2008-11#166)(2008-12#37)(2008-2#8)(2008-3#59)(2008-4#5)(2008-5#54)(2008-6#7)(2008-7#88)(2008-8#34)(2008-9#44)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#4)(2009-7#3)(2009-8#11)(2009-9#1)(2010-1#4)(2010-10#5)(2010-11#5)(2010-12#6)(2010-3#5)(2010-4#6)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-10#3)(2011-2#41)(2011-3#5)(2012-12#2)(2012-2#24)(2012-3#10)(2012-9#2)(2013-1#19)(2013-8#18)
concentration) and##2##2##(2008-10#1)(2008-11#1)
concentration) of##2##2##(2008-5#1)(2011-3#1)
concentration) were##3##2##(2008-10#3)
concentration)##18##1##(2008-10#12)(2008-11#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-3#1)
concentration-based##2##1##(2008-10#1)(2012-2#1)
concentration-dependent fashion##2##2##(1990-5#1)(1993-11#1)
concentration-dependent increase in##2##3##(1996-12#1)(2008-10#1)
concentration-dependent manner##17##2##(1990-5#1)(1991-6#1)(1992-6#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-11#2)(1997-1#2)(2008-11#1)(2008-9#1)(2009-3#1)
concentration-dependent##34##1##(1990-5#2)(1991-6#1)(1992-1#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#3)(1994-5#1)(1995-11#4)(1996-12#1)(1997-1#2)(1997-4#3)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)
concentration-dependently##2##1##(1994-11#1)(1997-4#1)
concentration-function approach##2##2##(2012-2#2)
concentration-response relationships##2##2##(1991-1#1)(2008-10#1)
concentration-response##4##1##(1991-1#1)(1992-8#1)(2008-10#2)
concentrations &gt##3##2##(1994-8#1)(1995-8#1)(2008-10#1)
concentrations &lt##2##2##(1996-12#1)(2008-10#1)
concentrations (&gt##3##2##(1994-11#1)(2008-7#1)(2009-6#1)
concentrations (&lt##2##2##(2008-10#2)
concentrations (0##12##2##(1990-5#1)(1995-12#1)(2006-6#1)(2008-10#4)(2008-12#2)(2008-5#2)(2012-2#1)
concentrations (1##5##2##(1990-2#1)(1991-5#1)(2008-10#1)(2008-3#1)(2010-5#1)
concentrations (10##2##2##(2008-10#2)
concentrations (3##3##2##(2008-10#3)
concentrations (up to##2##3##(2008-10#1)(2008-5#1)
concentrations 0##2##2##(2008-10#2)
concentrations above##6##2##(1990-6#1)(1994-6#1)(2008-10#2)(2008-9#1)(2010-10#1)
concentrations after##5##2##(2008-10#3)(2008-11#1)(2012-3#1)
concentrations also##2##2##(1990-5#1)(2008-10#1)
concentrations and pH##3##3##(2008-10#3)
concentrations and personal exposure##2##4##(2008-11#2)
concentrations and the effect of##2##5##(2008-5#1)(2013-8#1)
concentrations and the##7##3##(1992-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2013-8#1)
concentrations and volumes##2##3##(2008-10#2)
concentrations and##55##2##(1991-12#2)(1992-11#1)(1992-3#1)(1993-2#1)(1994-12#1)(2008-10#28)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
concentrations are higher for materials with##2##6##(1996-12#2)
concentrations are##24##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1995-2#1)(1996-12#3)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-2#2)
concentrations as low as 0##4##5##(2008-10#2)(2008-11#2)
concentrations as low as##8##4##(2008-10#6)(2008-11#2)
concentrations as well as##2##4##(2008-8#1)(2010-11#1)
concentrations as##19##2##(1993-12#1)(2008-10#10)(2008-11#5)(2008-8#1)(2010-11#1)(2012-2#1)
concentrations at##3##2##(2008-10#2)(2011-2#1)
concentrations below 2##2##3##(2008-11#1)(2012-12#1)
concentrations below##5##2##(2008-10#3)(2008-11#1)(2012-12#1)
concentrations between 0##8##3##(2008-10#7)(2009-6#1)
concentrations between##19##2##(1992-12#2)(1994-8#1)(2008-10#13)(2008-11#2)(2009-6#1)
concentrations but##4##2##(1990-5#1)(2009-3#1)(2010-12#1)(2011-1#1)
concentrations by##8##2##(1993-2#1)(2008-10#5)(2008-11#1)(2011-2#1)
concentrations can be##3##3##(2008-10#2)(2008-11#1)
concentrations can##5##2##(1992-12#1)(1996-12#1)(2008-10#2)(2008-11#1)
concentrations correlated##2##2##(1990-2#1)(1994-11#1)
concentrations could be##3##3##(1994-8#1)(2008-10#1)(2009-5#1)
concentrations decreased##4##2##(2008-10#2)(2008-11#2)
concentrations determined##2##2##(2008-10#1)(2008-2#1)
concentrations did not##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
concentrations down to##2##3##(2008-10#2)
concentrations for##15##2##(2008-10#11)(2008-11#2)(2011-3#1)(2013-1#1)
concentrations found in##3##3##(2008-10#2)(2008-7#1)
concentrations found were##2##3##(2008-10#2)
concentrations found##7##2##(2008-10#6)(2008-7#1)
concentrations from 0##7##3##(1993-6#2)(2008-10#2)(2008-11#2)(2008-7#1)
concentrations from##13##2##(1993-6#2)(1994-11#1)(1994-8#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-7#1)
concentrations greater than 0##2##4##(2008-10#2)
concentrations greater than##6##3##(2008-10#5)(2008-5#1)
concentrations had##2##2##(2008-10#1)(2012-7#1)
concentrations has##2##2##(1992-7#1)(2008-10#1)
concentrations have been##2##3##(2008-10#2)
concentrations have##3##2##(1995-5#1)(2008-10#2)
concentrations higher than 1##2##4##(2008-10#2)
concentrations higher than those##2##4##(2008-10#1)(2008-11#1)
concentrations higher than##7##3##(1991-5#1)(2008-10#3)(2008-11#1)(2008-7#2)
concentrations in a##7##3##(1996-12#1)(2008-10#5)(2008-7#1)
concentrations in humans##3##3##(1991-1#1)(2010-11#2)
concentrations in patients with##4##4##(1990-2#1)(1992-11#2)(2008-3#1)
concentrations in response to##2##4##(1995-8#1)(2010-10#1)
concentrations in seawater##2##3##(2008-10#2)
concentrations in serum##3##3##(1992-11#1)(1993-2#1)(2008-10#1)
concentrations in some##2##3##(1991-12#1)(2008-10#1)
concentrations in the range 0##2##5##(2008-10#2)
concentrations in the range of##2##5##(2008-10#2)
concentrations in the range##7##4##(2008-10#6)(2008-11#1)
concentrations in the samples were##2##5##(2008-10#2)
concentrations in the samples##3##4##(2008-10#3)
concentrations in the##49##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#31)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#2)
concentrations in various##2##3##(2008-10#1)(2008-5#1)
concentrations in water samples##3##4##(2008-10#3)
concentrations in water##4##3##(2008-10#4)
concentrations in##141##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-5#1)(1992-11#3)(1992-12#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-2#1)(1994-8#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-1#1)(2008-10#74)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#5)(2008-9#1)(2009-7#2)(2010-10#1)(2010-11#2)(2011-3#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#1)
concentrations increased in the##2##4##(1992-2#1)(2013-1#1)
concentrations increased significantly##3##3##(1994-12#1)(2012-2#1)(2013-8#1)
concentrations increased##9##2##(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
concentrations is##3##2##(2008-10#2)(2008-3#1)
concentrations levels##2##2##(2008-10#1)(2008-5#1)
concentrations may##2##2##(2008-10#1)(2010-7#1)
concentrations obtained##5##2##(2008-10#4)(2008-5#1)
concentrations of 0##7##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)
concentrations of 1##3##3##(1994-5#1)(2008-10#2)
concentrations of 100##2##3##(2008-10#2)
concentrations of 2##6##3##(2008-10#3)(2008-12#2)(2008-3#1)
concentrations of 5##3##3##(1994-5#2)(2008-10#1)
concentrations of CO2 and##2##4##(1993-6#1)(1995-8#1)
concentrations of CaO##2##3##(2013-1#2)
concentrations of IL-2##2##3##(2008-11#1)(2008-7#1)
concentrations of LIF##2##3##(2008-11#2)
concentrations of NOM##2##3##(2008-11#2)
concentrations of PEG##2##3##(2008-12#1)(2011-2#1)
concentrations of PGRs##2##3##(2008-12#2)
concentrations of T3##2##3##(1994-11#1)(2008-10#1)
concentrations of a##3##3##(2008-10#3)
concentrations of acetylcholine##4##3##(1994-8#3)(1995-11#1)
concentrations of adenosine or the##2##5##(1994-6#2)
concentrations of airborne##2##3##(2008-10#2)
concentrations of alkali##2##3##(2008-10#2)
concentrations of all##3##3##(1991-8#1)(1996-1#1)(2009-8#1)
concentrations of aluminium##3##3##(2008-10#3)
concentrations of antiendometrial antibodies##2##4##(1995-2#2)
concentrations of calcium and##2##4##(1992-9#1)(2008-10#1)
concentrations of calcium##3##3##(1992-9#1)(1997-5#1)(2008-10#1)
concentrations of chromium and##2##4##(2008-10#1)(2008-12#1)
concentrations of chromium##3##3##(2008-10#2)(2008-12#1)
concentrations of citrinin##2##3##(1993-12#2)
concentrations of copper##3##3##(1992-12#1)(2008-10#2)
concentrations of ethanol##2##3##(1992-7#2)
concentrations of glucose##6##3##(1990-5#1)(1991-2#1)(1994-8#1)(2008-11#2)(2008-7#1)
concentrations of hepatic##2##3##(1990-5#1)(1994-8#1)
concentrations of high-density lipoprotein (HDL)##2##5##(2008-6#2)
concentrations of hydrogen##2##3##(1992-12#1)(2008-10#1)
concentrations of iron and##2##4##(2008-10#1)(2013-8#1)
concentrations of iron##3##3##(2008-10#2)(2013-8#1)
concentrations of less than##2##4##(1997-4#1)(2008-10#1)
concentrations of metal ions##2##4##(2008-10#2)
concentrations of metal##3##3##(2008-10#3)
concentrations of metallothionein##2##3##(1990-5#2)
concentrations of metals##4##3##(2008-10#3)(2013-1#1)
concentrations of methotrexate##2##3##(2008-11#2)
concentrations of naproxen##2##3##(2008-10#2)
concentrations of natriuretic peptides##2##4##(2009-5#2)
concentrations of nitrite##2##3##(2008-10#2)
concentrations of organic solvents##2##4##(2008-10#1)(2011-2#1)
concentrations of organic##3##3##(2008-10#2)(2011-2#1)
concentrations of other##2##3##(1990-2#1)(2008-10#1)
concentrations of phorbol ester##2##4##(1992-8#1)(2008-11#1)
concentrations of phosphate##2##3##(2008-10#2)
concentrations of seed extract##2##4##(2012-2#2)
concentrations of several##2##3##(2008-10#1)(2012-3#1)
concentrations of sodium chloride##2##4##(1994-5#1)(2008-12#1)
concentrations of sodium##4##3##(1994-5#1)(2008-10#1)(2008-12#1)(2013-1#1)
concentrations of specific##2##3##(2009-9#1)(2011-2#1)
concentrations of the analyte##2##4##(2008-10#2)
concentrations of the analytes in##2##5##(2008-10#2)
concentrations of the analytes##4##4##(2008-10#4)
concentrations of the antifungals##2##4##(2008-5#2)
concentrations of the elements##3##4##(2008-10#3)
concentrations of the products of incomplete combustion##2##7##(1996-12#2)
concentrations of the three##2##4##(2008-10#2)
concentrations of the##64##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#39)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#2)(2011-1#1)
concentrations of these drugs##2##4##(2008-10#2)
concentrations of these##10##3##(1990-7#1)(1993-6#1)(2008-10#7)(2008-11#1)
concentrations of thiobarbituric acid reactive substances##2##6##(1992-3#2)
concentrations of this##2##3##(1991-6#1)(2008-10#1)
concentrations of##489##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#6)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#4)(1992-3#5)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-2#2)(1994-5#8)(1994-6#2)(1994-8#7)(1995-11#3)(1995-12#1)(1995-2#4)(1995-8#5)(1996-1#2)(1996-12#4)(1996-2#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#3)(2008-10#233)(2008-11#44)(2008-12#9)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#1)(2008-9#3)(2009-5#3)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-8#3)(2011-1#1)(2011-2#10)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#6)(2012-7#1)(2012-9#1)(2013-1#7)(2013-8#2)
concentrations on##2##2##(2008-10#2)
concentrations or the##2##3##(2008-10#1)(2008-3#1)
concentrations or##5##2##(2008-10#3)(2008-3#1)(2013-8#1)
concentrations over##2##2##(2008-10#1)(2008-11#1)
concentrations possible in##2##3##(2008-10#1)(2012-2#1)
concentrations ranged between##2##3##(2008-10#1)(2011-2#1)
concentrations ranged from##3##3##(2008-10#3)
concentrations ranged##6##2##(2008-10#5)(2011-2#1)
concentrations ranging from 0##3##4##(1993-12#1)(1997-8#1)(2008-11#1)
concentrations ranging from 1##3##4##(2008-10#2)(2008-11#1)
concentrations ranging from 4##2##4##(2008-10#2)
concentrations ranging from##15##3##(1993-12#1)(1997-8#1)(2008-10#10)(2008-11#3)
concentrations showed significant##2##3##(1995-8#1)(2008-7#1)
concentrations showed##4##2##(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
concentrations studied##3##2##(1994-8#1)(2008-10#2)
concentrations tested##3##2##(2008-10#1)(2008-11#2)
concentrations than in##2##3##(1994-3#1)(2013-8#1)
concentrations than##5##2##(1993-2#1)(1994-3#1)(1997-3#1)(2008-11#1)(2013-8#1)
concentrations that are##2##3##(2008-10#1)(2013-1#1)
concentrations that##10##2##(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#4)(2011-1#1)(2011-3#1)(2013-1#1)
concentrations to##5##2##(2008-10#4)(2008-9#1)
concentrations up to##12##3##(2008-10#12)
concentrations used in the##2##4##(2008-10#2)
concentrations used##5##2##(2008-10#3)(2008-11#2)
concentrations was between##2##3##(2008-10#2)
concentrations was##7##2##(2008-10#5)(2008-11#1)(2008-8#1)
concentrations were analyzed##2##3##(1990-12#1)(2008-10#1)
concentrations were detected##2##3##(2008-10#2)
concentrations were determined by##2##4##(2008-2#1)(2009-8#1)
concentrations were determined in##2##4##(2008-10#2)
concentrations were determined##9##3##(1991-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-8#1)(2010-8#1)
concentrations were found##3##3##(1990-2#1)(2008-10#2)
concentrations were higher##2##3##(2008-10#1)(2013-8#1)
concentrations were in general##2##4##(2008-10#1)(2008-2#1)
concentrations were increased##2##3##(1994-8#1)(2008-10#1)
concentrations were investigated in##2##4##(1993-1#1)(2008-10#1)
concentrations were measured in##2##4##(1994-2#1)(2008-10#1)
concentrations were measured using##2##4##(1993-2#1)(2009-8#1)
concentrations were measured##6##3##(1993-2#1)(1994-2#1)(2008-10#2)(2009-8#1)(2013-8#1)
concentrations were obtained##2##3##(2008-10#2)
concentrations were significantly##3##3##(1993-2#2)(2008-10#1)
concentrations were similar in##2##4##(1991-12#1)(2008-10#1)
concentrations were similar to##2##4##(1994-12#1)(2008-10#1)
concentrations were similar##4##3##(1991-12#1)(1994-12#1)(2008-10#2)
concentrations were studied##2##3##(1995-8#1)(2008-10#1)
concentrations were##79##2##(1990-12#2)(1990-2#1)(1990-5#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-8#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
concentrations which##3##2##(1993-6#1)(1994-3#1)(1996-1#1)
concentrations with##6##2##(2008-10#5)(2012-12#1)
concentrations##1429##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#13)(1990-3#5)(1990-5#18)(1990-6#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#13)(1991-2#7)(1991-3#2)(1991-5#8)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#6)(1992-12#9)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#2)(1993-1#5)(1993-11#2)(1993-12#5)(1993-2#13)(1993-3#2)(1993-6#6)(1993-8#9)(1994-11#11)(1994-12#4)(1994-2#5)(1994-3#4)(1994-5#10)(1994-6#3)(1994-8#23)(1995-11#4)(1995-12#2)(1995-2#7)(1995-5#2)(1995-8#12)(1996-1#4)(1996-12#17)(1996-2#7)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#1)(1997-8#5)(2006-6#1)(2007-12#1)(2008-10#684)(2008-11#112)(2008-12#25)(2008-2#7)(2008-3#26)(2008-4#4)(2008-5#28)(2008-6#6)(2008-7#34)(2008-8#7)(2008-9#10)(2009-3#3)(2009-5#4)(2009-6#2)(2009-7#6)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#7)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#3)(2010-8#8)(2011-1#5)(2011-10#2)(2011-2#22)(2011-3#7)(2012-12#3)(2012-2#22)(2012-3#13)(2012-5#4)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#22)(2013-8#11)
concentrations) and##2##2##(2008-10#1)(2013-8#1)
concentrations)##10##1##(2008-10#6)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
concentrator##4##1##(2008-10#1)(2013-8#3)
concentric##7##1##(1991-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
concentrically##2##1##(2008-10#2)
concept analysis##3##2##(2008-11#1)(2013-1#2)
concept and the##2##3##(1995-2#1)(2009-12#1)
concept and##15##2##(1994-3#2)(1995-2#1)(2008-10#3)(2008-5#1)(2009-12#1)(2009-5#1)(2010-6#2)(2010-8#1)(2012-2#2)(2013-8#1)
concept based on the##2##4##(2008-10#1)(2008-11#1)
concept based on##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
concept behind##2##2##(2008-10#1)(2011-2#1)
concept for the##2##3##(2008-10#1)(2010-10#1)
concept for##8##2##(1992-12#1)(1997-6#2)(2008-10#3)(2010-10#1)(2011-2#1)
concept has been##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
concept has##4##2##(1992-1#1)(1992-12#1)(2008-10#1)(2013-8#1)
concept in the##2##3##(1992-12#1)(2010-7#1)
concept in##11##2##(1991-12#1)(1992-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-7#1)(2012-2#1)
concept is based on the##2##5##(2008-10#1)(2008-2#1)
concept is that##2##3##(1992-2#1)(2008-3#1)
concept is the##2##3##(1995-2#1)(2010-4#1)
concept is##13##2##(1992-2#1)(1995-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)
concept mapping##3##2##(2008-11#1)(2008-12#2)
concept maps##4##2##(2008-12#4)
concept of &quot##5##3##(1992-3#2)(1995-5#1)(1997-1#1)(2012-2#1)
concept of a##8##3##(1990-3#1)(1991-1#1)(1992-2#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-9#1)
concept of an##3##3##(1994-11#1)(1997-8#1)(2008-10#1)
concept of childhood##2##3##(1995-5#2)
concept of ice-like-water capture&quot##2##4##(2008-5#2)
concept of mentorship##2##3##(2008-11#2)
concept of mixed##3##3##(2008-10#1)(2012-2#2)
concept of nursing advocacy##2##4##(2009-12#2)
concept of rehabilitation##2##3##(2010-10#1)(2013-1#1)
concept of residual confounding##2##4##(1992-9#2)
concept of self##2##3##(2008-11#1)(2010-8#1)
concept of stewardship##3##3##(2012-2#3)
concept of the limbic system##2##5##(1992-12#2)
concept of the##10##3##(1992-12#2)(1993-1#1)(1996-9#1)(1997-6#1)(2007-8#1)(2008-12#1)(2009-5#3)
concept of##126##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-9#2)(1993-1#2)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-5#4)(1996-1#2)(1996-3#1)(1996-6#2)(1996-9#2)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#5)(2008-3#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#2)(2009-5#3)(2009-6#1)(2009-7#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#2)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#11)(2012-3#3)(2013-1#6)
concept presented##3##2##(1991-3#1)(2012-2#2)
concept that can##2##3##(2008-3#1)(2010-6#1)
concept that##18##2##(1995-2#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#1)(2013-8#1)
concept to##3##2##(1993-12#2)(1994-12#1)
concept was##3##2##(2008-10#2)(2008-9#1)
concept which##2##2##(2008-12#1)(2009-5#1)
concept##288##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#2)(1992-9#3)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#4)(1995-6#1)(1996-1#3)(1996-3#1)(1996-6#2)(1996-9#2)(1997-1#4)(1997-3#2)(1997-6#4)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#56)(2008-11#16)(2008-12#14)(2008-2#1)(2008-3#9)(2008-5#5)(2008-7#9)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#3)(2009-12#3)(2009-5#7)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#6)(2011-1#1)(2011-2#8)(2011-9#1)(2012-12#1)(2012-2#17)(2012-3#4)(2013-1#12)(2013-8#3)
conception and##2##2##(2008-10#1)(2010-11#1)
conception of the##3##3##(1992-1#1)(2009-10#1)(2012-2#1)
conception of##4##2##(1992-1#1)(1992-3#1)(2009-10#1)(2012-2#1)
conception rate in Japanese Black cows##2##6##(2013-1#2)
conception rate##3##2##(2013-1#3)
conception##26##1##(1990-6#1)(1990-9#1)(1992-1#1)(1992-3#1)(1994-3#1)(1994-9#1)(1996-9#2)(2008-10#3)(2008-11#1)(2009-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
conceptions of##7##2##(1995-3#3)(1996-6#1)(2008-5#1)(2010-5#1)(2013-8#1)
conceptions##10##1##(1995-3#3)(1996-6#1)(2008-5#1)(2010-5#1)(2012-12#1)(2013-8#3)
concepts about##2##2##(2008-10#1)(2011-2#1)
concepts and##13##2##(1993-12#1)(1994-2#1)(1996-3#2)(1997-2#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
concepts are##5##2##(1996-2#1)(2008-10#1)(2008-9#1)(2009-11#1)(2010-10#1)
concepts for##4##2##(1990-6#1)(1994-12#1)(2008-10#1)(2010-7#1)
concepts from##2##2##(2012-3#2)
concepts have##2##2##(2008-10#1)(2009-5#1)
concepts in forest pathology##2##4##(2008-10#2)
concepts in the##2##3##(1993-11#1)(2008-11#1)
concepts in##10##2##(1992-1#1)(1993-11#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-12#1)(2013-1#1)
concepts into##2##2##(2008-12#1)(2008-5#1)
concepts of self-organization##2##3##(2008-9#2)
concepts of##29##2##(1993-12#1)(1993-3#2)(1994-3#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
concepts presented in##2##3##(2008-10#1)(2013-1#1)
concepts regarding##3##2##(1994-8#1)(1997-1#1)(2009-6#1)
concepts such as##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
concepts that##3##2##(1997-3#1)(2008-11#1)(2012-3#1)
concepts to##3##2##(1991-3#1)(2008-9#1)(2012-3#1)
concepts##119##1##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#4)(1993-11#1)(1993-12#2)(1993-3#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#9)(2008-12#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#2)
conceptual advances##2##2##(2008-8#2)
conceptual and practical##2##3##(1997-1#1)(1997-2#1)
conceptual and##7##2##(1995-3#1)(1997-1#1)(1997-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2012-2#1)
conceptual applications employed in this technology set are provided by way of illustration##4##13##(2010-8#4)
conceptual basis##2##2##(2008-7#1)(2008-8#1)
conceptual categories##2##2##(1991-2#1)(2008-11#1)
conceptual change##3##2##(2011-2#3)
conceptual framework for##4##3##(1997-3#1)(2008-11#1)(2008-8#1)(2010-8#1)
conceptual framework##11##2##(1992-3#1)(1993-2#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-12#2)(2008-8#1)(2010-8#1)(2012-2#1)
conceptual issues##2##2##(1996-2#1)(2009-7#1)
conceptual skills##2##2##(1996-3#2)
conceptual work##2##2##(1995-5#1)(1997-3#1)
conceptual##66##1##(1990-12#1)(1991-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-10#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-10#2)(2010-8#5)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
conceptualisation of clinical decision-making##2##4##(2008-11#2)
conceptualisation of##3##2##(2008-11#3)
conceptualization##4##1##(1992-3#2)(1997-1#1)(2008-11#1)
conceptualizations##3##1##(2008-2#1)(2009-9#2)
conceptualize##2##1##(2010-4#1)(2013-1#1)
conceptually##7##1##(1993-1#2)(2008-10#1)(2008-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
concern about AIDS as an epidemic##2##6##(1992-2#2)
concern about the possibility of##2##5##(1992-12#1)(2008-11#1)
concern about the##7##3##(1992-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-8#1)
concern about##15##2##(1990-6#1)(1991-3#1)(1992-12#1)(1992-2#2)(1994-2#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
concern among##3##2##(1992-2#1)(2008-11#1)(2010-12#1)
concern and##4##2##(1990-12#1)(1991-1#1)(2008-11#1)(2010-1#1)
concern are##3##2##(2008-11#2)(2008-2#1)
concern as##3##2##(1991-3#1)(2008-10#1)(2010-11#1)
concern at##2##2##(2008-11#1)(2010-8#1)
concern because##3##2##(1994-2#1)(2007-12#1)(2008-8#1)
concern for the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
concern for their children's well-being##2##5##(1995-1#2)
concern for##16##2##(1992-2#1)(1994-2#1)(1995-1#2)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
concern in the##5##3##(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
concern in##16##2##(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
concern is##9##2##(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)
concern of##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
concern on the##3##3##(1990-2#1)(1993-3#1)(2009-3#1)
concern on##4##2##(1990-2#1)(1993-3#1)(1996-1#1)(2009-3#1)
concern over##2##2##(2008-10#1)(2013-1#1)
concern regarding##2##2##(1992-1#1)(2008-7#1)
concern that##7##2##(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-11#1)
concern the##3##2##(1992-12#1)(2008-8#1)(2012-2#1)
concern to##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
concern was the##2##3##(2009-10#1)(2011-2#1)
concern was##7##2##(1997-2#1)(2008-10#2)(2009-10#2)(2011-2#2)
concern with##2##2##(1995-1#1)(1996-2#1)
concern##155##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-8#1)(1993-3#2)(1993-9#1)(1994-2#3)(1995-1#3)(1996-1#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#18)(2008-12#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#2)(2009-3#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#3)
concerned about the##2##3##(1992-3#2)
concerned about their##3##3##(1991-2#1)(2008-1#1)(2013-8#1)
concerned about##13##2##(1991-2#2)(1992-3#2)(1993-11#1)(1993-3#1)(1995-6#2)(1996-5#1)(2008-1#1)(2008-8#1)(2013-8#2)
concerned that##3##2##(1996-5#1)(2008-1#1)(2010-5#1)
concerned the##2##2##(2008-10#2)
concerned with the relationship between##2##5##(1992-3#1)(2011-2#1)
concerned with the##13##3##(1991-2#2)(1992-3#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)
concerned with##27##2##(1991-2#2)(1992-1#1)(1992-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-2#1)(2012-12#1)
concerned##66##1##(1991-2#5)(1991-6#1)(1992-1#1)(1992-3#3)(1993-11#2)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#4)(1996-5#2)(1997-4#1)(1997-8#2)(2008-1#2)(2008-10#7)(2008-11#9)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2010-1#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#2)
concerning Treg##2##2##(2013-8#2)
concerning a##4##2##(2008-5#1)(2008-7#2)(2010-6#1)
concerning carboxylate and inorganic anions##2##5##(2008-10#2)
concerning health care##2##3##(1993-12#1)(2008-11#1)
concerning its##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
concerning oral##2##2##(1990-6#1)(2008-1#1)
concerning quality##2##2##(1992-3#1)(1995-3#1)
concerning risk##2##2##(2008-11#1)(2010-11#1)
concerning the application of##2##4##(2008-10#1)(2011-2#1)
concerning the interaction between##2##4##(2008-10#1)(2008-5#1)
concerning the management of##2##4##(1994-12#1)(2012-3#1)
concerning the mechanisms of##2##4##(2008-10#1)(2008-11#1)
concerning the origin of##2##4##(2009-6#1)(2010-1#1)
concerning the performance##2##3##(2008-10#1)(2008-11#1)
concerning the role of##2##4##(1997-8#1)(2008-12#1)
concerning the treatment##2##3##(1994-6#1)(1996-11#1)
concerning the##77##2##(1990-3#1)(1991-2#2)(1992-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-10#18)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
concerning their##6##2##(1995-1#1)(1995-12#1)(1997-6#1)(2008-11#1)(2008-7#1)(2010-7#1)
concerning these##3##2##(1990-6#1)(1991-3#1)(2010-11#1)
concerning this##2##2##(2008-7#1)(2013-8#1)
concerning two##3##2##(1991-2#1)(1997-2#1)(2008-3#1)
concerning what##2##2##(2008-11#1)(2012-2#1)
concerning##200##1##(1990-11#2)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#6)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#35)(2008-11#21)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#4)(2010-11#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#7)(2012-2#4)(2012-3#6)(2013-1#9)(2013-8#7)
concerns about the costs of##2##5##(1992-1#1)(2008-11#1)
concerns about the##8##3##(1992-1#1)(1995-1#1)(1996-12#1)(2008-11#3)(2008-12#2)
concerns about##19##2##(1992-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(2008-11#4)(2008-12#2)(2008-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
concerns and##11##2##(1991-2#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#1)
concerns are##3##2##(1995-1#1)(2008-5#1)(2008-8#1)
concerns for##4##2##(1993-12#1)(2012-2#1)(2012-3#2)
concerns have##3##2##(2008-11#1)(2010-7#1)(2012-2#1)
concerns highlighted by the##2##4##(2008-11#1)(2010-5#1)
concerns of##6##2##(1992-2#1)(1993-12#1)(1993-3#1)(1994-9#1)(1996-5#1)(2008-7#1)
concerns over##4##2##(1996-2#1)(2008-10#1)(2010-8#1)(2012-3#1)
concerns raised by##3##3##(1991-12#1)(1991-3#1)(2008-11#1)
concerns raised##4##2##(1991-12#1)(1991-3#1)(2008-11#1)(2008-3#1)
concerns regarding the##4##3##(1993-3#1)(1996-12#1)(2008-11#1)(2013-1#1)
concerns regarding##8##2##(1993-3#1)(1996-12#1)(2008-11#3)(2008-7#1)(2011-1#1)(2013-1#1)
concerns that are##2##3##(1993-3#1)(2008-7#1)
concerns that##7##2##(1992-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-11#1)
concerns the##6##2##(1991-2#1)(1992-3#1)(1996-1#1)(1996-3#1)(2008-10#2)
concerns were##2##2##(2008-12#2)
concerns with##3##2##(1995-12#1)(2008-10#1)(2012-2#1)
concerns##152##1##(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#6)(1994-1#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#4)(1995-12#1)(1995-2#4)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#17)(2008-12#12)(2008-3#2)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#3)
concerted effort to##2##3##(1991-1#1)(1996-12#1)
concerted effort##5##2##(1991-1#1)(1991-3#1)(1996-12#1)(2012-2#1)(2013-8#1)
concerted##11##1##(1991-1#1)(1991-3#1)(1991-9#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
concise and##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
concise overview of##2##3##(2008-11#1)(2010-9#1)
concise overview##5##2##(2008-10#3)(2008-11#1)(2010-9#1)
concise##16##1##(2008-10#5)(2008-11#3)(2008-7#1)(2008-9#3)(2010-5#1)(2010-9#1)(2011-3#1)(2013-1#1)
conclude by##11##2##(1990-9#1)(1993-3#1)(1994-1#2)(1996-2#1)(2008-8#2)(2011-2#1)(2012-2#2)(2013-8#1)
conclude from these##2##3##(2008-10#2)
conclude from##4##2##(1991-8#1)(2008-10#2)(2008-8#1)
conclude that a##6##3##(1994-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#2)
conclude that an##2##3##(1995-2#1)(2011-2#1)
conclude that both##2##3##(1992-9#1)(2008-8#1)
conclude that oospores##2##3##(2008-10#2)
conclude that systemic##2##3##(2008-10#2)
conclude that the##51##3##(1990-5#1)(1990-9#1)(1991-12#3)(1991-5#1)(1992-12#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-9#1)
conclude that there are##3##4##(1994-2#1)(2008-10#1)(2008-9#1)
conclude that there is a##3##5##(2008-10#1)(2013-1#2)
conclude that there is##4##4##(2008-10#1)(2011-2#1)(2013-1#2)
conclude that there##8##3##(1994-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
conclude that these##5##3##(1990-2#1)(1991-2#1)(1993-6#1)(1997-2#1)(2008-10#1)
conclude that this##3##3##(1991-2#1)(2008-11#1)(2013-8#1)
conclude that with##2##3##(1991-3#1)(2009-10#1)
conclude that##242##2##(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#4)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#4)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#1)(1997-7#2)(1997-8#3)(2006-6#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#42)(2008-11#16)(2008-12#1)(2008-3#5)(2008-5#3)(2008-7#12)(2008-8#11)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#10)(2011-7#1)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#8)(2013-8#2)
conclude the##2##2##(1994-5#1)(2008-11#1)
conclude with##6##2##(1994-3#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-2#2)
conclude##277##1##(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#4)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#5)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#1)(1997-7#2)(1997-8#3)(2006-6#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#47)(2008-11#18)(2008-12#2)(2008-3#5)(2008-5#4)(2008-7#13)(2008-8#14)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#12)(2011-7#1)(2012-2#6)(2012-3#5)(2012-5#1)(2013-1#9)(2013-8#3)
concluded from this##2##3##(2008-6#1)(2010-2#1)
concluded from##4##2##(2008-12#1)(2008-6#1)(2010-2#1)(2011-2#1)
concluded that a##5##3##(1997-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-1#1)
concluded that an##2##3##(1996-6#1)(2008-12#1)
concluded that at##3##3##(1995-12#1)(2008-10#2)
concluded that for##3##3##(1990-3#1)(2008-10#1)(2008-11#1)
concluded that in##2##3##(1994-2#1)(2010-9#1)
concluded that it is##4##4##(1997-6#1)(2008-11#1)(2008-8#1)(2013-1#1)
concluded that it##6##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)(2013-1#1)
concluded that the##58##3##(1990-2#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#1)(1993-11#1)(1993-8#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#17)(2008-11#5)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
concluded that there##2##3##(2008-10#1)(2009-3#1)
concluded that this##3##3##(1996-8#1)(2008-5#1)(2009-7#1)
concluded that##209##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-6#2)(1997-8#4)(1997-9#1)(2008-10#48)(2008-11#14)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#3)(2009-8#2)(2010-10#2)(2010-4#1)(2010-9#1)(2011-2#7)(2011-3#1)(2012-2#5)(2012-3#4)(2012-9#1)(2013-1#8)(2013-8#2)
concluded the##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
concluded to##2##2##(2008-10#2)
concluded##229##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-9#2)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-6#2)(1997-8#5)(1997-9#1)(2008-10#53)(2008-11#14)(2008-12#6)(2008-2#1)(2008-3#2)(2008-5#12)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#3)(2009-8#3)(2010-10#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#9)(2011-3#1)(2012-2#5)(2012-3#4)(2012-9#1)(2013-1#10)(2013-8#2)
concludes by discussing##3##3##(1996-2#1)(2008-11#1)(2008-12#1)
concludes by##10##2##(1992-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#4)(2008-12#1)(2008-8#1)
concludes that the##5##3##(1990-8#1)(1991-2#1)(1997-2#1)(2008-11#1)(2012-3#1)
concludes that##19##2##(1990-8#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1996-12#1)(1997-2#3)(2008-11#2)(2010-8#2)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
concludes with a discussion of how##2##6##(2008-11#1)(2008-9#1)
concludes with a discussion of the##4##6##(1995-3#1)(2008-12#1)(2010-5#1)(2012-2#1)
concludes with a discussion of##6##5##(1995-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-5#1)(2012-2#1)
concludes with a##7##3##(1995-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-5#1)(2012-2#2)
concludes with recommendations##2##3##(1995-12#1)(2008-11#1)
concludes with some thoughts##2##4##(2010-11#2)
concludes with some##5##3##(1996-6#1)(2008-5#1)(2009-3#1)(2010-11#2)
concludes with##23##2##(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-2#2)
concludes##54##1##(1990-8#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#5)(1997-3#1)(2008-11#8)(2008-12#4)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
concluding that the##2##3##(2008-10#1)(2008-11#1)
concluding that##5##2##(2008-10#3)(2008-11#1)(2012-3#1)
concluding with##3##2##(2008-11#1)(2008-6#1)(2013-8#1)
concluding##13##1##(1991-2#1)(1994-3#1)(2008-10#6)(2008-11#2)(2008-6#1)(2012-3#1)(2013-8#1)
conclusion is that the##5##4##(2008-10#1)(2008-7#1)(2009-7#1)(2010-4#1)(2012-3#1)
conclusion is that##13##3##(1990-12#1)(1990-2#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-4#1)(2012-3#2)
conclusion is##16##2##(1990-12#1)(1990-2#1)(1994-3#1)(1994-9#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-4#1)(2012-3#3)
conclusion of the##5##3##(1997-3#1)(2008-11#2)(2013-1#1)(2013-8#1)
conclusion of##11##2##(1992-3#2)(1994-1#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#2)(2009-6#1)(2013-1#1)(2013-8#1)
conclusion that the##10##3##(1992-9#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
conclusion that##28##2##(1990-12#1)(1990-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-3#1)(1995-12#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
conclusion##236##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#6)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-1#4)(2008-10#33)(2008-11#16)(2008-12#7)(2008-3#4)(2008-5#13)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-6#3)(2011-2#19)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#8)(2013-1#18)(2013-8#8)
conclusions about the##3##3##(1995-5#1)(2009-12#1)(2010-9#1)
conclusions about##8##2##(1995-5#1)(1996-6#1)(2008-10#2)(2009-10#1)(2009-12#1)(2010-3#1)(2010-9#1)
conclusions and##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
conclusions are##4##2##(1990-6#1)(2008-10#1)(2008-8#1)(2009-8#1)
conclusions can be drawn from the##2##6##(1993-12#1)(2008-11#1)
conclusions can be drawn from##4##5##(1993-12#1)(2008-10#1)(2008-11#1)(2010-12#1)
conclusions can be drawn##6##4##(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
conclusions can be##7##3##(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)
conclusions drawn from##3##3##(2008-8#1)(2010-7#1)(2011-2#1)
conclusions for##3##2##(1991-12#1)(2008-5#1)(2010-12#1)
conclusions from##2##2##(1991-1#1)(1994-12#1)
conclusions is##2##2##(1990-12#1)(1993-12#1)
conclusions may##2##2##(1992-3#1)(2013-1#1)
conclusions of an earlier##2##4##(1993-12#1)(2008-9#1)
conclusions of the##2##3##(1993-3#1)(2008-12#1)
conclusions of##7##2##(1991-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(2008-12#1)(2008-9#1)
conclusions that can be drawn##2##5##(2008-10#1)(2008-12#1)
conclusions were drawn##2##3##(2008-10#1)(2013-1#1)
conclusions were##5##2##(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
conclusions##80##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#3)
conclusive evidence that##2##3##(1995-2#1)(2008-10#1)
conclusive evidence##5##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)
conclusive##15##1##(1993-12#1)(1993-2#1)(1995-2#1)(1997-4#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
conclusively demonstrated##2##2##(2008-11#1)(2008-5#1)
conclusively that##2##2##(1997-1#1)(2008-10#1)
conclusively##9##1##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-8#1)
concolor)##3##1##(1996-12#1)(2008-10#1)(2013-1#1)
concomitant AR##3##2##(2012-12#3)
concomitant HD##2##2##(2011-2#2)
concomitant PC or BCP mutations##2##5##(2013-1#2)
concomitant changes##2##2##(1994-6#1)(1996-2#1)
concomitant chemoradiation##2##2##(2008-10#2)
concomitant increase##2##2##(1994-11#1)(1996-2#1)
concomitant ions were studied##2##4##(2008-10#2)
concomitant ions##4##2##(2008-10#4)
concomitant lesions##2##2##(2009-9#1)(2011-2#1)
concomitant presence of two anomalous##2##5##(2008-9#2)
concomitant reduction##2##2##(1994-3#1)(2008-10#1)
concomitant use##3##2##(2008-10#2)(2011-2#1)
concomitant with the##2##3##(1994-8#1)(2010-4#1)
concomitant with##13##2##(1991-5#1)(1992-6#1)(1994-8#1)(1995-1#1)(1996-12#1)(2008-10#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
concomitant##101##1##(1990-9#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#3)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-2#1)(1997-5#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#7)(2012-2#3)(2013-1#4)(2013-8#6)
concomitantly decreased##2##2##(1994-8#1)(2013-8#1)
concomitantly with the##2##3##(2008-9#1)(2013-1#1)
concomitantly with##8##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-9#1)(2011-2#1)(2013-1#1)
concomitantly##25##1##(1991-8#2)(1992-12#1)(1993-1#1)(1993-12#1)(1994-8#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
concomitants##5##1##(2008-10#4)(2008-11#1)
concordance between the##2##3##(2008-10#1)(2012-3#1)
concordance between##7##2##(1991-2#1)(1995-12#1)(2008-10#3)(2008-8#1)(2012-3#1)
concordance with##2##2##(2012-2#1)(2013-1#1)
concordance##19##1##(1990-8#1)(1991-2#1)(1995-12#2)(2008-10#4)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
concordant with##2##2##(2008-10#2)
concordant##5##1##(2008-10#2)(2008-7#1)(2011-2#2)
concrete words##2##2##(1991-2#1)(1996-2#1)
concrete##11##1##(1991-2#1)(1993-3#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#3)(2010-1#1)(2013-1#1)
concurrence##3##1##(1990-11#1)(2012-12#1)(2012-3#1)
concurrent chemo-radiotherapy##2##2##(1990-6#1)(2011-3#1)
concurrent chemoradiotherapy##4##2##(2008-10#1)(2012-3#3)
concurrent infection##2##2##(2009-8#2)
concurrent measurement##2##2##(2008-10#1)(2012-12#1)
concurrent partnerships##3##2##(2011-2#3)
concurrent sexual partnerships##3##3##(2011-2#3)
concurrent treatment##2##2##(2008-10#1)(2008-11#1)
concurrent validity##2##2##(2012-2#2)
concurrent##66##1##(1990-5#1)(1990-6#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-11#1)(1996-11#1)(1997-1#1)(1997-5#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-8#5)(2010-10#1)(2010-4#1)(2011-10#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#4)(2013-8#3)
concurrently and##2##2##(2008-12#1)(2009-10#1)
concurrently##17##1##(1993-12#1)(1995-5#1)(1995-8#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2013-7#1)
concussion complicated by##2##3##(2010-1#2)
concussion##10##1##(2008-6#1)(2010-1#5)(2012-3#2)(2013-1#2)
concussions##4##1##(2010-1#2)(2013-1#2)
condemned##2##1##(1995-12#1)(2011-2#1)
condensate##4##1##(1992-11#1)(2008-10#1)(2010-5#2)
condensates##4##1##(2008-10#3)(2008-3#1)
condensation and##6##2##(1991-3#1)(1995-8#1)(2008-10#1)(2008-7#3)
condensation growth##2##2##(2013-1#2)
condensation of the##3##3##(1992-3#1)(2008-10#1)(2011-1#1)
condensation of##15##2##(1991-3#1)(1992-12#1)(1992-3#2)(1993-8#1)(2008-10#5)(2008-11#1)(2008-7#2)(2011-1#1)(2011-3#1)
condensation reaction of##2##3##(2008-10#1)(2008-7#1)
condensation reaction##6##2##(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)
condensation reactions##3##2##(2008-10#2)(2008-7#1)
condensation technique##2##2##(1991-3#1)(2013-1#1)
condensation##57##1##(1991-3#3)(1992-12#2)(1992-3#2)(1993-8#1)(1995-8#1)(1996-5#1)(2007-12#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#12)(2008-8#3)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#4)
condense##3##1##(1996-5#2)(2008-7#1)
condensed chromatin##2##2##(1990-2#1)(2008-7#1)
condensed chromosomes##2##2##(1995-2#1)(2008-7#1)
condensed phase##4##2##(2008-10#4)
condensed tannin##4##2##(2008-10#3)(2011-2#1)
condensed tannins##2##2##(1993-8#1)(2008-10#1)
condensed##27##1##(1990-2#1)(1991-9#1)(1993-8#1)(1995-2#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)
condenses##2##1##(2007-12#1)(2008-7#1)
condensing##4##1##(1996-5#1)(2008-10#2)(2008-7#1)
condition affecting##2##2##(2011-2#1)(2012-12#1)
condition and its##3##3##(1992-5#1)(2010-12#1)(2011-2#1)
condition and the##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
condition and##32##2##(1991-12#2)(1992-5#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#4)
condition are##4##2##(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
condition by##2##2##(2008-10#1)(2008-2#1)
condition can be##2##3##(2008-10#1)(2008-3#1)
condition can##5##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-7#1)
condition characterized by##5##3##(2008-5#2)(2009-7#1)(2010-1#1)(2011-2#1)
condition commonly##2##2##(2012-2#1)(2013-1#1)
condition dependent##2##2##(2008-8#2)
condition during the##3##3##(1994-6#1)(2011-2#1)(2012-2#1)
condition for the##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)
condition for##16##2##(1992-9#1)(1994-12#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
condition from##2##2##(2008-11#1)(2008-8#1)
condition has been##2##3##(2008-10#1)(2011-1#1)
condition has##5##2##(1995-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2011-1#1)
condition improved##2##2##(2008-12#1)(2011-2#1)
condition in our##2##3##(2010-11#1)(2012-3#1)
condition in the##5##3##(2008-10#2)(2011-2#2)(2011-3#1)
condition in which the##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
condition in which##8##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2013-1#1)
condition in##22##2##(1994-3#1)(1996-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
condition is usually##2##3##(2008-10#1)(2011-2#1)
condition is##21##2##(1990-9#1)(1992-5#1)(1993-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-3#1)(2013-1#1)
condition known##2##2##(1997-2#1)(2008-5#1)
condition may be##2##3##(2008-7#1)(2013-1#1)
condition may##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
condition occurs##2##2##(1996-12#1)(2008-8#1)
condition of Icelandic cod Gadus morhua##2##6##(2010-8#2)
condition of the baby##2##4##(2008-11#1)(2012-3#1)
condition of the patient##2##4##(1990-6#1)(1991-3#1)
condition of the skin##2##4##(1990-6#1)(1996-12#1)
condition of the##12##3##(1990-6#2)(1991-3#2)(1996-12#1)(1997-5#1)(2008-11#1)(2008-6#1)(2010-8#1)(2012-3#2)(2013-1#1)
condition of##43##2##(1990-6#2)(1991-2#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#4)(2011-2#3)(2012-3#4)(2013-1#2)(2013-8#3)
condition or##3##2##(2008-9#1)(2009-10#1)(2010-12#1)
condition resistance##2##2##(2008-10#2)
condition should be##2##3##(1991-6#1)(2008-4#1)
condition should##4##2##(1991-6#1)(2008-12#1)(2008-4#1)(2008-5#1)
condition showing the##2##3##(2008-11#2)
condition than##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
condition that has##3##3##(2008-8#1)(2009-1#1)(2012-2#1)
condition that occurs##2##3##(1992-5#1)(2013-1#1)
condition that##10##2##(1992-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
condition the##5##2##(2008-10#3)(2009-5#1)(2009-7#1)
condition they##2##2##(2008-10#2)
condition using##2##2##(2008-10#1)(2008-5#1)
condition was obtained##2##3##(2008-10#2)
condition was##17##2##(1995-12#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
condition were##5##2##(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-8#1)
condition which##2##2##(1995-12#1)(2013-1#1)
condition who##2##2##(2008-9#1)(2012-3#1)
condition with a##2##3##(2008-11#1)(2012-3#1)
condition with##9##2##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
condition##492##1##(1990-12#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-9#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#5)(1994-3#2)(1994-6#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-6#4)(1996-11#4)(1996-12#2)(1996-2#3)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#1)(1997-8#5)(2007-12#4)(2007-8#1)(2008-1#5)(2008-10#83)(2008-11#27)(2008-12#13)(2008-2#4)(2008-3#14)(2008-4#14)(2008-5#19)(2008-6#2)(2008-7#13)(2008-8#16)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#5)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#4)(2010-10#4)(2010-11#5)(2010-12#5)(2010-2#1)(2010-5#8)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#6)(2011-2#34)(2011-3#2)(2011-7#1)(2012-12#4)(2012-2#9)(2012-3#22)(2013-1#37)(2013-7#1)(2013-8#14)
condition')##2##1##(2008-11#2)
condition) or##2##2##(2013-1#1)(2013-8#1)
condition)##5##1##(2012-3#1)(2013-1#2)(2013-8#2)
condition-dependent ornaments##2##2##(2008-8#2)
condition-dependent##3##1##(2008-8#3)
condition-specific performance measures##3##3##(1997-3#3)
condition-specific##5##1##(1994-2#1)(1997-3#3)(2010-10#1)
condition]##2##1##(2011-2#1)(2013-8#1)
conditional confidence limits on##2##4##(1995-9#2)
conditional confidence limits##3##3##(1995-9#3)
conditional discrimination##3##2##(1992-12#2)(1993-3#1)
conditional formation##2##2##(2008-10#2)
conditional gene##3##2##(2008-11#1)(2008-9#2)
conditional on the##2##3##(2008-10#1)(2011-2#1)
conditional on##3##2##(2008-10#1)(2011-2#2)
conditional stability constants##6##3##(2008-10#6)
conditional stability##7##2##(2008-10#7)
conditional##56##1##(1992-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-9#6)(1996-3#2)(1997-3#1)(2008-10#18)(2008-11#5)(2008-5#2)(2008-8#1)(2008-9#5)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#3)(2013-1#1)
conditionally##9##1##(1993-8#2)(1994-9#1)(2008-11#2)(2008-7#1)(2012-2#2)(2012-3#1)
conditioned by a single dominant gene##2##6##(2008-10#2)
conditioned by a single dominant##3##5##(2008-10#3)
conditioned by a single##4##4##(2008-10#4)
conditioned by the##2##3##(2008-10#2)
conditioned by##12##2##(1991-5#1)(2008-10#9)(2008-11#1)(2012-3#1)
conditioned in##2##2##(2008-10#2)
conditioned media of##2##3##(1994-11#1)(1995-11#1)
conditioned media##5##2##(1994-11#1)(1995-11#1)(1997-7#1)(2008-11#1)(2012-4#1)
conditioned medium at##2##3##(2008-11#2)
conditioned medium##17##2##(1990-11#1)(1992-8#1)(1994-3#1)(1995-2#1)(1997-1#2)(2008-11#11)
conditioned place preference##3##3##(1993-6#2)(1994-2#1)
conditioned reinforcement and##2##3##(1993-6#2)
conditioned reinforcement##5##2##(1993-6#5)
conditioned reinforcer##2##2##(1993-6#2)
conditioned response##2##2##(1996-2#1)(2008-5#1)
conditioned stimulus##5##2##(1996-2#1)(1996-5#1)(1997-7#2)(2008-5#1)
conditioned taste aversion##3##3##(1991-1#1)(2008-5#2)
conditioned the##2##2##(2008-10#2)
conditioned to##2##2##(2008-10#1)(2008-11#1)
conditioned upon##2##2##(1991-2#1)(2008-11#1)
conditioned##86##1##(1990-11#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-6#10)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-2#3)(1996-5#2)(1997-1#2)(1997-7#5)(2008-10#21)(2008-11#17)(2008-4#1)(2008-5#8)(2008-8#1)(2009-3#1)(2009-8#1)(2012-3#1)(2012-4#1)(2013-1#1)
conditioner##2##1##(2008-10#1)(2008-5#1)
conditioners##6##1##(2008-10#2)(2008-5#2)(2013-1#2)
conditioning and##3##2##(2008-10#2)(2008-11#1)
conditioning chemotherapy##2##2##(2008-7#1)(2012-12#1)
conditioning effects##4##2##(2008-5#4)
conditioning of the##4##3##(1994-8#1)(2008-10#2)(2008-5#1)
conditioning of##6##2##(1994-8#1)(2008-10#4)(2008-5#1)
conditioning on##2##2##(2008-7#2)
conditioning procedures##2##2##(1995-5#1)(2008-5#1)
conditioning resistance to##2##3##(2008-10#2)
conditioning the hypersensitive reaction##2##4##(2008-10#2)
conditioning the##3##2##(2008-10#3)
conditioning##66##1##(1992-12#2)(1993-1#1)(1994-8#3)(1995-5#1)(1996-2#2)(1997-7#5)(2008-10#22)(2008-11#9)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#3)(2012-12#1)(2013-1#1)
conditions (0##3##2##(2008-10#3)
conditions (2##2##2##(1995-8#1)(2008-10#1)
conditions (5##2##2##(1992-8#1)(2008-10#1)
conditions (e##2##2##(2008-9#2)
conditions (high##2##2##(1992-3#1)(1993-8#1)
conditions (i##4##2##(2008-10#3)(2013-1#1)
conditions (number of##2##3##(2008-10#2)
conditions (pH##7##2##(1991-7#1)(2008-10#5)(2010-7#1)
conditions a pKa##2##3##(2008-10#2)
conditions a##5##2##(2008-10#5)
conditions affecting the##2##3##(1992-9#1)(2008-10#1)
conditions affecting##6##2##(1992-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
conditions allow##2##2##(2008-10#2)
conditions also##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
conditions and a##2##3##(1997-5#1)(2008-10#1)
conditions and by##2##3##(2008-10#2)
conditions and compared to##2##4##(2008-5#1)(2008-8#1)
conditions and compared##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
conditions and fibre##2##3##(2008-10#2)
conditions and have##2##3##(2008-10#1)(2009-1#1)
conditions and in##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
conditions and on##2##3##(2008-3#1)(2010-7#1)
conditions and other##2##3##(2008-10#1)(2012-2#1)
conditions and pathological##2##3##(1990-9#1)(2006-6#1)
conditions and the##13##3##(1990-5#1)(1991-2#1)(2008-10#9)(2010-8#1)(2013-1#1)
conditions and their##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)
conditions and to##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
conditions and with##2##3##(2008-10#1)(2008-11#1)
conditions and##105##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-5#2)(1993-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#49)(2008-11#8)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-7#2)
conditions applied##3##2##(2008-4#2)(2012-9#1)
conditions are determined##2##3##(2008-10#2)
conditions are established##2##3##(2008-10#2)
conditions are found to be##2##5##(2008-10#2)
conditions are optimized##2##3##(2008-10#2)
conditions are presented##3##3##(1995-12#1)(1997-2#1)(2008-3#1)
conditions are the##2##3##(2009-9#1)(2013-8#1)
conditions are##52##2##(1992-12#1)(1993-12#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-6#1)(2008-10#26)(2008-11#5)(2008-3#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-8#1)
conditions as well as##5##4##(1994-1#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
conditions as##16##2##(1994-1#1)(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
conditions associated with##7##3##(1995-2#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-1#1)(2013-1#1)(2013-8#1)
conditions at room temperature##3##4##(2008-10#2)(2013-8#1)
conditions at##17##2##(2008-10#11)(2008-12#2)(2008-3#1)(2008-4#2)(2013-8#1)
conditions both##2##2##(2008-10#2)
conditions but in##2##3##(2008-10#2)
conditions but##4##2##(1991-5#1)(2008-10#3)
conditions by means of##2##4##(1993-2#1)(2008-10#1)
conditions by the##2##3##(1991-12#1)(1997-7#1)
conditions by##9##2##(1991-12#1)(1993-2#1)(1993-8#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-9#1)
conditions can be##2##3##(2008-11#1)(2008-7#1)
conditions can##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
conditions characterized by##2##3##(1993-3#1)(2008-10#1)
conditions considered##2##2##(1997-3#1)(2008-3#1)
conditions could##2##2##(2008-10#1)(2008-5#1)
conditions described##2##2##(1997-2#1)(2008-10#1)
conditions detected##2##2##(2008-11#1)(2008-8#1)
conditions developed##3##2##(2008-10#3)
conditions during##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
conditions employed##8##2##(2008-10#7)(2008-9#1)
conditions established##3##2##(2008-10#3)
conditions even##2##2##(2008-10#1)(2008-7#1)
conditions for a##2##3##(2008-11#1)(2008-12#1)
conditions for both the##2##4##(2008-10#2)
conditions for both##5##3##(1997-4#1)(2008-10#4)
conditions for determination of##4##4##(2008-10#4)
conditions for determination##6##3##(2008-10#6)
conditions for determining##5##3##(2008-10#5)
conditions for each##2##3##(2008-10#1)(2008-4#1)
conditions for infection##2##3##(2008-10#2)
conditions for its##2##3##(2008-10#2)
conditions for maintaining##5##3##(2008-11#5)
conditions for maximum##2##3##(2008-11#1)(2012-2#1)
conditions for metal##2##3##(2008-10#2)
conditions for sample##4##3##(2008-10#4)
conditions for separation and##2##4##(2008-10#2)
conditions for separation of##3##4##(2008-10#3)
conditions for separation##6##3##(2008-10#6)
conditions for sequential##2##3##(2008-10#2)
conditions for successful##3##3##(2008-11#2)(2008-9#1)
conditions for the CL##3##4##(2008-10#3)
conditions for the analysis of##2##5##(2008-10#2)
conditions for the determination of##7##5##(2008-10#7)
conditions for the extraction of##2##5##(2008-10#2)
conditions for the formation of the##2##6##(2008-10#2)
conditions for the formation of##3##5##(2008-10#3)
conditions for the reaction##2##4##(2008-10#2)
conditions for the separation of the##2##6##(2008-10#2)
conditions for the separation of##5##5##(2008-10#5)
conditions for the##60##3##(1990-9#1)(1997-2#1)(2008-10#50)(2008-11#4)(2008-9#2)(2011-1#1)(2011-2#1)
conditions for which##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
conditions for##203##2##(1990-2#1)(1990-9#1)(1993-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(2008-10#131)(2008-11#23)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#7)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
conditions found##3##2##(1997-2#1)(2008-10#2)
conditions from##3##2##(2008-10#2)(2008-3#1)
conditions has been##5##3##(1993-8#1)(2008-10#2)(2008-7#1)(2012-3#1)
conditions has##6##2##(1993-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2012-3#1)
conditions have been established##3##4##(2008-10#3)
conditions have been optimized##3##4##(2008-10#3)
conditions have been##10##3##(1991-2#1)(1991-3#1)(1991-6#1)(2008-10#7)
conditions have##11##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-5#1)(2008-10#7)
conditions if##2##2##(2008-10#1)(2008-4#1)
conditions in order to##3##4##(2008-10#2)(2008-7#1)
conditions in the##13##3##(2007-12#1)(2008-10#7)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
conditions in their##2##3##(2008-7#1)(2011-2#1)
conditions in vivo##2##3##(2008-5#2)
conditions in which the##2##4##(2008-7#1)(2008-8#1)
conditions in which##6##3##(1993-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
conditions in##53##2##(1990-2#1)(1990-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#19)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#3)(2010-4#1)(2010-9#1)(2011-2#5)(2012-12#1)(2013-8#1)
conditions include##2##2##(1996-6#1)(2008-10#1)
conditions including heat##2##3##(2008-10#1)(2011-2#1)
conditions including##11##2##(1992-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-6#1)(2011-2#1)(2013-1#1)
conditions involving##2##2##(1994-8#1)(1996-6#1)
conditions is described##2##3##(2008-10#2)
conditions is##14##2##(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#2)(2012-7#1)
conditions it##3##2##(1994-5#2)(2008-12#1)
conditions leading to##3##3##(1997-6#1)(2008-5#1)(2013-1#1)
conditions may##2##2##(2008-10#2)
conditions might##2##2##(2008-10#1)(2008-4#1)
conditions obtained##5##2##(2008-10#4)(2008-11#1)
conditions of a##3##3##(2008-10#2)(2008-3#1)
conditions of an##2##3##(2008-10#2)
conditions of ischemic heart disease##2##5##(2012-3#2)
conditions of ischemic heart##3##4##(2012-3#3)
conditions of low ionic strength##2##5##(1994-5#1)(2011-2#1)
conditions of low##3##3##(1994-5#1)(2008-10#1)(2011-2#1)
conditions of partial##2##3##(1996-2#1)(2011-2#1)
conditions of production##3##3##(2008-11#1)(2012-2#2)
conditions of temperature##2##3##(2008-10#2)
conditions of the system##2##4##(2008-10#2)
conditions of the##23##3##(1997-2#1)(1997-8#1)(2008-10#15)(2008-3#1)(2008-5#2)(2008-7#1)(2010-6#1)(2013-8#1)
conditions of these##6##3##(2008-10#1)(2008-9#4)(2009-12#1)
conditions of this##5##3##(1990-6#1)(1992-4#1)(2008-10#1)(2008-9#1)(2013-1#1)
conditions of##140##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-8#1)(2008-10#62)(2008-11#4)(2008-3#6)(2008-5#3)(2008-7#2)(2008-9#9)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-6#1)(2010-7#4)(2010-9#1)(2011-2#8)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#1)
conditions on functional properties##2##4##(1991-2#1)(2010-4#1)
conditions on the##6##3##(2008-10#4)(2008-5#1)(2008-7#1)
conditions on##22##2##(1991-2#1)(1995-11#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)
conditions only##3##2##(2008-10#1)(2008-11#2)
conditions or in the##2##4##(2008-10#1)(2013-1#1)
conditions or##8##2##(1997-2#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#2)
conditions over a##2##3##(1993-6#1)(2008-8#1)
conditions over##4##2##(1993-6#1)(2008-8#2)(2012-3#1)
conditions recovered##2##2##(2008-10#1)(2011-1#1)
conditions reported##2##2##(1994-6#1)(2009-11#1)
conditions required for##3##3##(2008-10#2)(2008-9#1)
conditions required##5##2##(2008-10#4)(2008-9#1)
conditions requiring##2##2##(2008-1#1)(2011-2#1)
conditions resistance##2##2##(2008-10#2)
conditions resulted in##3##3##(1990-5#1)(1992-12#1)(2008-3#1)
conditions revealed##2##2##(1990-9#1)(2013-8#1)
conditions selected##3##2##(2008-10#3)
conditions show that##2##3##(2008-12#1)(2010-10#1)
conditions showed##3##2##(1997-1#1)(2008-10#1)(2009-11#1)
conditions similar to those##3##4##(1990-11#1)(2008-10#2)
conditions studied##2##2##(2008-11#1)(2008-7#1)
conditions such as pH##8##4##(2008-10#8)
conditions such as##24##3##(1992-2#1)(1994-11#1)(1995-1#1)(2008-10#13)(2008-4#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
conditions tested##5##2##(2008-10#2)(2008-11#3)
conditions than##2##2##(2008-10#2)
conditions that are##4##3##(1990-2#1)(2008-11#1)(2013-1#1)(2013-8#1)
conditions that can##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
conditions that favour##2##3##(1991-5#1)(1997-4#1)
conditions that lead##2##3##(2008-10#2)
conditions that the##3##3##(1991-12#1)(1992-5#1)(1996-8#1)
conditions that were##2##3##(1996-12#1)(2008-10#1)
conditions that##37##2##(1990-2#2)(1991-12#1)(1991-5#2)(1992-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#8)(2008-11#6)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#3)
conditions the linear##4##3##(2008-10#4)
conditions the##17##2##(1993-3#1)(1994-2#1)(2008-10#13)(2008-9#1)(2013-8#1)
conditions through##2##2##(2008-10#1)(2008-11#1)
conditions to be used in##2##5##(2008-10#1)(2008-4#1)
conditions to be##4##3##(2008-10#2)(2008-4#1)(2013-8#1)
conditions to the##3##3##(2008-10#3)
conditions to##23##2##(1990-12#1)(1997-2#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
conditions triggering##2##2##(2006-6#1)(2011-2#1)
conditions under which the##2##4##(2012-2#1)(2013-8#1)
conditions under which##12##3##(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#5)(2010-10#1)(2012-2#1)(2013-8#1)
conditions used##6##2##(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#3)
conditions using the##2##3##(2008-10#2)
conditions using##4##2##(2008-10#4)
conditions was 0##2##3##(2008-10#2)
conditions was evaluated##2##3##(1996-12#1)(2008-10#1)
conditions was studied##2##3##(2010-11#1)(2013-8#1)
conditions was##19##2##(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#11)(2008-11#2)(2010-11#1)(2011-2#1)(2013-8#1)
conditions were 1##2##3##(2008-10#2)
conditions were achieved##2##3##(2008-10#2)
conditions were also##2##3##(2008-10#1)(2011-3#1)
conditions were applied##3##3##(2008-10#2)(2012-8#1)
conditions were chosen##2##3##(2008-10#2)
conditions were conducted##2##3##(2008-10#2)
conditions were determined##4##3##(2008-10#2)(2008-11#2)
conditions were established##5##3##(2008-10#5)
conditions were evaluated##5##3##(1991-5#1)(2008-10#4)
conditions were found for##2##4##(2008-10#2)
conditions were found to be##6##5##(2008-10#6)
conditions were found to##7##4##(2008-10#7)
conditions were found##11##3##(2008-10#11)
conditions were investigated##7##3##(2008-10#6)(2009-12#1)
conditions were not##2##3##(2008-10#1)(2008-7#1)
conditions were obtained##3##3##(2008-10#3)
conditions were optimised##4##3##(2008-10#4)
conditions were optimized by##2##4##(2008-10#2)
conditions were optimized for the##2##5##(2008-10#2)
conditions were optimized for##5##4##(2008-10#4)(2010-5#1)
conditions were optimized##13##3##(2008-10#11)(2010-5#1)(2013-8#1)
conditions were selected##2##3##(2008-10#2)
conditions were studied by##2##4##(2008-10#2)
conditions were studied##5##3##(2008-10#5)
conditions were tested##2##3##(2008-10#2)
conditions were used##2##3##(2008-11#1)(2010-4#1)
conditions were##126##2##(1990-9#1)(1991-5#1)(2008-10#103)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-8#1)(2013-8#1)
conditions when##5##2##(2008-10#2)(2008-9#1)(2009-10#1)(2009-7#1)
conditions where the##2##3##(1993-6#1)(1994-5#1)
conditions where##10##2##(1992-3#1)(1992-7#1)(1993-6#1)(1994-5#1)(1994-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-2#1)
conditions which##6##2##(2008-10#1)(2008-11#2)(2008-12#1)(2012-3#1)(2013-1#1)
conditions will##2##2##(2008-5#1)(2008-7#1)
conditions with a##2##3##(2008-10#1)(2008-7#1)
conditions with an##2##3##(2008-10#2)
conditions with the##3##3##(1991-3#1)(1996-5#1)(2011-10#1)
conditions with##16##2##(1991-2#1)(1991-3#1)(1994-9#1)(1996-5#1)(2008-10#8)(2008-3#1)(2008-7#1)(2008-9#1)(2011-10#1)
conditions within##2##2##(2008-11#2)
conditions##2324##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#13)(1990-5#5)(1990-6#2)(1990-8#3)(1990-9#4)(1991-11#1)(1991-12#6)(1991-2#7)(1991-3#7)(1991-5#10)(1991-6#3)(1991-7#1)(1992-10#1)(1992-12#6)(1992-2#3)(1992-3#10)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#7)(1993-2#5)(1993-3#8)(1993-6#4)(1993-8#13)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#4)(1994-6#5)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#6)(1995-12#5)(1995-2#11)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#8)(1995-9#4)(1996-1#2)(1996-12#12)(1996-2#14)(1996-3#1)(1996-5#7)(1996-6#5)(1996-8#1)(1997-1#9)(1997-2#23)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#1)(1997-8#3)(2006-6#6)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#1157)(2008-11#160)(2008-12#21)(2008-2#11)(2008-3#41)(2008-4#20)(2008-5#41)(2008-6#16)(2008-7#72)(2008-8#58)(2008-9#52)(2009-1#2)(2009-10#15)(2009-11#6)(2009-12#10)(2009-3#2)(2009-5#2)(2009-6#3)(2009-7#8)(2009-8#4)(2009-9#5)(2010-1#8)(2010-10#11)(2010-11#7)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#4)(2010-7#11)(2010-8#5)(2010-9#4)(2011-1#8)(2011-10#2)(2011-2#65)(2011-3#4)(2011-7#1)(2011-9#1)(2012-12#9)(2012-2#30)(2012-3#23)(2012-4#2)(2012-5#1)(2012-7#3)(2012-8#1)(2012-9#2)(2013-1#44)(2013-7#2)(2013-8#32)
conditions)##3##1##(1991-5#1)(2008-10#1)(2011-1#1)
condom and personal lubricant samples##2##5##(2008-10#2)
condom and personal##3##3##(2008-10#3)
condom use and other##2##4##(1997-6#1)(2008-1#1)
condom use##9##2##(1992-2#1)(1995-12#1)(1997-6#1)(2008-1#2)(2008-11#2)(2011-2#1)(2012-2#1)
condom##22##1##(1992-2#2)(1995-12#2)(1997-6#3)(2008-1#2)(2008-10#5)(2008-11#6)(2011-2#1)(2012-2#1)
condoms##20##1##(1990-6#3)(1997-6#4)(2008-11#1)(2008-4#4)(2008-8#1)(2009-5#1)(2010-7#3)(2011-2#1)(2013-1#2)
conducive for##4##2##(1997-2#1)(2008-10#3)
conducive soil##4##2##(2008-10#4)
conducive to downy mildew development##2##5##(2008-10#2)
conducive to ectoparasitic nematode damage on##2##6##(2008-10#2)
conducive to sporulation##2##3##(2008-10#2)
conducive to the##3##3##(2008-10#2)(2012-3#1)
conducive to##17##2##(1993-2#1)(1994-12#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
conducive##29##1##(1993-2#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-10#21)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
conduct a systematic review##2##4##(2013-1#1)(2013-8#1)
conduct a##8##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
conduct and##5##2##(2008-10#1)(2009-7#1)(2010-5#2)(2012-2#1)
conduct of a##2##3##(1992-2#1)(2008-11#1)
conduct of##8##2##(1992-2#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-4#1)
conduct problems##5##2##(2008-12#1)(2009-7#4)
conduct research##2##2##(2008-1#1)(2008-12#1)
conduct the##3##2##(2008-10#2)(2013-8#1)
conduct this##2##2##(2007-12#1)(2008-10#1)
conduct##59##1##(1991-2#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#6)(2010-5#4)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
conductance in##2##2##(1994-3#1)(2008-10#1)
conductance level##3##2##(2008-7#3)
conductance of##6##2##(1994-11#1)(1994-12#1)(2008-10#1)(2009-8#2)(2011-2#1)
conductance or conversion factors for##2##5##(2008-11#2)
conductance##40##1##(1991-3#1)(1991-5#1)(1994-11#3)(1994-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(2008-10#10)(2008-11#3)(2008-5#4)(2008-7#5)(2009-8#6)(2011-2#1)(2011-3#1)(2012-7#1)
conducted a pilot##2##3##(2008-12#1)(2010-11#1)
conducted a retrospective##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
conducted a study##2##3##(2008-3#1)(2009-6#1)
conducted a##35##2##(1993-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
conducted across##2##2##(2008-8#1)(2013-8#1)
conducted after##2##2##(2008-10#1)(2013-1#1)
conducted among the##2##3##(1997-3#1)(2012-3#1)
conducted among##3##2##(1997-3#1)(2008-12#1)(2012-3#1)
conducted an##2##2##(1994-12#1)(2008-3#1)
conducted at 25 degrees C##2##5##(2008-10#1)(2009-7#1)
conducted at the##10##3##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
conducted at two##3##3##(2008-10#2)(2008-11#1)
conducted at##25##2##(1991-11#1)(1994-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
conducted between##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
conducted both##3##2##(1991-1#1)(2008-11#1)(2010-12#1)
conducted by a##2##3##(1993-3#1)(2008-10#1)
conducted by the##6##3##(1991-6#1)(1993-3#1)(1994-12#1)(1995-6#1)(2008-10#2)
conducted by##26##2##(1990-12#1)(1991-6#1)(1993-3#3)(1994-12#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#2)(2012-2#1)(2012-3#1)
conducted during##5##2##(1995-11#1)(2007-9#1)(2008-10#3)
conducted for the##3##3##(1992-1#1)(2008-10#1)(2012-2#1)
conducted for##8##2##(1992-1#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-12#1)(2009-5#1)(2012-2#1)
conducted from##5##2##(2008-10#3)(2009-12#1)(2013-7#1)
conducted in 1989##2##3##(1991-3#1)(1994-3#1)
conducted in a##13##3##(1990-11#1)(1993-3#1)(1996-6#1)(2008-10#3)(2008-11#2)(2009-12#1)(2009-5#1)(2011-2#2)(2012-2#1)
conducted in an##3##3##(2008-10#2)(2008-12#1)
conducted in field##2##3##(2008-10#2)
conducted in hot##2##3##(2013-8#2)
conducted in order to##3##4##(1997-6#1)(2008-10#1)(2012-3#1)
conducted in the past##2##4##(2007-12#1)(2008-11#1)
conducted in the##13##3##(1990-8#1)(1992-2#1)(1993-8#1)(1994-9#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-11#1)
conducted in this##2##3##(1993-1#1)(2008-4#1)
conducted in two##2##3##(1994-9#1)(2008-10#1)
conducted in##119##2##(1990-11#1)(1990-3#1)(1990-8#2)(1991-2#1)(1991-3#2)(1991-9#2)(1992-2#1)(1993-1#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-9#2)(1995-12#1)(1996-1#3)(1996-6#1)(1996-9#1)(1997-6#3)(1997-7#1)(2007-12#1)(2008-1#4)(2008-10#35)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#5)(2013-8#4)
conducted on a##4##3##(1991-7#1)(2008-2#1)(2011-2#1)(2012-5#1)
conducted on samples##2##3##(2008-10#2)
conducted on the##7##3##(1990-12#1)(2008-10#2)(2008-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
conducted on##36##2##(1990-12#1)(1991-7#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#4)
conducted over a##2##3##(2008-10#1)(2008-5#1)
conducted over##5##2##(1990-6#1)(2008-10#2)(2008-11#1)(2008-5#1)
conducted pre-##3##2##(2010-7#1)(2013-1#2)
conducted semistructured interviews with##3##4##(2010-11#1)(2010-8#1)(2013-1#1)
conducted the##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
conducted this study##2##3##(2010-7#1)(2011-2#1)
conducted to assess the##5##4##(2008-10#4)(2012-12#1)
conducted to assess##8##3##(2008-10#5)(2008-12#1)(2010-8#1)(2012-12#1)
conducted to determine if##4##4##(1992-3#2)(2008-10#2)
conducted to determine the relative##2##5##(2008-10#2)
conducted to determine the##10##4##(1995-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2010-11#1)(2011-2#1)
conducted to determine whether##4##4##(1995-8#1)(2008-10#2)(2008-7#1)
conducted to determine##22##3##(1991-5#1)(1992-3#2)(1995-1#1)(1995-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#2)
conducted to establish##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
conducted to evaluate the effects of##2##6##(2008-10#1)(2010-4#1)
conducted to evaluate the##9##4##(2008-10#4)(2008-11#1)(2008-6#1)(2010-12#1)(2010-4#1)(2012-2#1)
conducted to evaluate##11##3##(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#1)(2012-2#1)
conducted to examine the##4##4##(2008-10#1)(2008-11#2)(2008-12#1)
conducted to examine whether##2##4##(1995-9#1)(2008-11#1)
conducted to examine##6##3##(1995-9#1)(2008-10#1)(2008-11#3)(2008-12#1)
conducted to further##2##3##(2008-10#1)(2010-8#1)
conducted to identify the##3##4##(1995-10#1)(2008-10#2)
conducted to identify##9##3##(1995-10#1)(1997-1#1)(2008-10#4)(2010-11#1)(2013-1#2)
conducted to investigate the effects of##3##6##(1992-2#1)(2008-10#1)(2011-2#1)
conducted to investigate the##8##4##(1992-2#1)(2008-10#2)(2008-12#2)(2008-6#1)(2011-2#2)
conducted to test the##3##4##(1991-2#1)(2008-10#1)(2012-2#1)
conducted to test##5##3##(1991-2#1)(2008-10#2)(2008-11#1)(2012-2#1)
conducted to##108##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#2)(1995-1#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-2#2)(1997-1#1)(2008-10#37)(2008-11#9)(2008-12#10)(2008-5#2)(2008-6#3)(2008-7#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-8#3)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)
conducted under the auspices of the##2##6##(1994-12#1)(2008-11#1)
conducted under the##4##3##(1994-12#1)(2008-10#1)(2008-11#2)
conducted under##5##2##(1994-12#1)(2008-10#2)(2008-11#2)
conducted using a##9##3##(1991-12#1)(1992-3#1)(1994-8#1)(2008-10#2)(2008-7#1)(2010-8#1)(2013-1#2)
conducted using the##2##3##(2008-5#1)(2013-1#1)
conducted using##28##2##(1991-12#1)(1992-3#1)(1994-8#1)(1996-2#2)(2008-10#10)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
conducted with a##3##3##(1997-3#1)(2008-12#1)(2008-5#1)
conducted with the##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
conducted with##30##2##(1995-1#1)(1996-1#1)(1997-3#2)(2008-10#6)(2008-12#3)(2008-5#4)(2008-9#2)(2009-5#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-8#1)(2012-3#2)(2013-1#2)(2013-8#1)
conducted##549##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#3)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#2)(1993-3#5)(1993-8#1)(1994-1#1)(1994-12#5)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#5)(1996-2#7)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#1)(2007-12#2)(2007-9#1)(2008-1#5)(2008-10#161)(2008-11#37)(2008-12#23)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#15)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#3)(2009-12#3)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#5)(2009-9#1)(2010-10#4)(2010-11#7)(2010-12#3)(2010-2#3)(2010-4#2)(2010-6#3)(2010-7#5)(2010-8#9)(2010-9#2)(2011-1#3)(2011-2#26)(2011-3#1)(2012-12#6)(2012-2#14)(2012-3#15)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#37)(2013-7#1)(2013-8#11)
conductimetric##4##1##(2008-10#3)(2008-5#1)
conducting a##9##2##(1992-12#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
conducting and non-conducting##2##3##(2008-10#1)(2008-7#1)
conducting and##7##2##(2008-10#4)(2008-7#1)(2010-5#1)(2012-3#1)
conducting canal##2##2##(2007-12#2)
conducting polymer layer##3##3##(2008-10#3)
conducting polymer solid contact##2##4##(2008-10#2)
conducting polymer##16##2##(2008-10#16)
conducting polymers##3##2##(1990-8#1)(2008-10#2)
conducting polypyrrole##3##2##(2008-10#3)
conducting research##2##2##(2010-11#1)(2010-9#1)
conducting studies##4##2##(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
conducting the##5##2##(2008-10#2)(2008-5#1)(2009-11#1)(2012-2#1)
conducting this##2##2##(1996-1#1)(2008-10#1)
conducting##98##1##(1990-8#1)(1991-12#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-3#2)(2007-12#2)(2008-1#1)(2008-10#40)(2008-11#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#7)
conduction and##2##2##(2008-11#1)(2010-7#1)
conduction band of CdS##2##4##(2008-8#2)
conduction defects##2##2##(1995-1#1)(2010-7#1)
conduction in##2##2##(2008-10#1)(2010-12#1)
conduction mechanism##2##2##(1991-3#2)
conduction studies and electromyography##2##4##(2012-2#1)(2012-3#1)
conduction##25##1##(1991-3#2)(1992-6#2)(1994-3#1)(1995-1#1)(1997-3#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-12#2)(2010-7#5)(2012-2#1)(2012-3#1)
conductive carbon##2##2##(2008-10#1)(2013-1#1)
conductive films##3##2##(2008-10#3)
conductive polymer##2##2##(2008-10#2)
conductive##12##1##(2008-10#11)(2013-1#1)
conductivities##3##1##(2008-10#2)(2008-3#1)
conductivity and##9##2##(2008-10#5)(2008-11#2)(2012-5#1)(2013-1#1)
conductivity detection##4##2##(2008-10#4)
conductivity detector##4##2##(2008-10#4)
conductivity measurement##2##2##(2008-10#1)(2009-10#1)
conductivity measurements##2##2##(2008-10#2)
conductivity media##2##2##(2008-11#2)
conductivity of the##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
conductivity of##10##2##(1992-8#1)(2008-10#6)(2008-3#2)(2013-1#1)
conductivity##52##1##(1991-9#1)(1992-8#1)(1996-5#1)(2008-10#37)(2008-11#4)(2008-3#3)(2009-10#1)(2009-8#1)(2012-5#1)(2013-1#2)
conductometric titration data##2##3##(2008-10#2)
conductometric titration##4##2##(2008-10#4)
conductometric##9##1##(2008-10#9)
conductometry##4##1##(2008-10#4)
conductor was##2##2##(2008-10#2)
conductor##5##1##(2008-10#5)
conductors##2##1##(1992-8#1)(1996-5#1)
conducts##2##1##(1992-3#1)(2010-12#1)
conduit for##2##2##(1992-8#1)(2008-1#1)
conduit##7##1##(1992-8#1)(2007-12#2)(2008-1#1)(2008-10#2)(2013-1#1)
conduits##4##1##(2008-10#4)
condylar cartilage from##2##3##(1993-12#2)
condylar cartilage##3##2##(1993-12#2)(1994-6#1)
condylar position##2##2##(1993-1#2)
condylar process##2##2##(2008-7#2)
condylar##14##1##(1992-3#1)(1993-1#2)(1993-12#2)(1994-6#3)(1996-9#1)(2008-10#1)(2008-7#2)(2013-1#2)
condyle##9##1##(1993-1#1)(2008-7#1)(2011-2#1)(2013-1#6)
condylomata acuminata##2##2##(1994-1#1)(2013-1#1)
cone beam computed tomography##3##4##(2009-12#1)(2013-1#2)
cone beam##4##2##(2009-12#1)(2009-3#1)(2013-1#2)
cone##26##1##(1991-1#3)(1991-2#1)(1992-2#1)(1993-12#1)(1994-2#5)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2013-1#5)
cone-shaped##2##1##(1996-5#1)(2011-1#1)
coneflower (Echinacea purpurea)##3##3##(2008-10#3)
coneflower##4##1##(2008-10#4)
cones and##2##2##(2008-10#1)(2008-8#1)
cones##14##1##(1992-2#1)(1993-12#1)(1994-2#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-8#5)
confabulation##3##1##(2008-7#3)
confectionery sunflower##3##2##(2008-10#3)
confederation##2##1##(1991-3#1)(2008-11#1)
confer a##8##2##(1993-11#1)(1993-2#1)(1993-8#1)(1994-9#1)(2008-10#2)(2008-11#1)(2011-2#1)
confer protection##2##2##(1995-5#1)(2009-10#1)
confer resistance in##2##3##(2008-10#2)
confer resistance to##7##3##(1997-7#1)(2008-10#5)(2013-1#1)
confer resistance##10##2##(1997-7#1)(2008-10#8)(2013-1#1)
confer the##2##2##(2008-5#1)(2008-7#1)
confer##50##1##(1990-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-8#3)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#19)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-2#1)(2011-2#2)(2013-1#3)(2013-8#1)
conference evaluation##2##2##(2012-2#2)
conference for student##2##3##(1991-1#1)(2008-11#1)
conference in##5##2##(1992-3#1)(1994-1#1)(1995-12#1)(2008-12#1)(2012-2#1)
conference on the##2##3##(1994-6#1)(1995-3#1)
conference on##8##2##(1990-2#1)(1991-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-2#2)(2008-11#1)
conference was##4##2##(1995-3#1)(1995-6#1)(2008-3#1)(2010-5#1)
conference##71##1##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-12#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#3)(1995-6#1)(1995-9#2)(1996-12#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#2)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#1)(2008-8#3)(2009-5#4)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#4)(2010-5#3)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#1)
conferences##11##1##(1990-6#1)(1991-3#1)(1993-12#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-4#1)(2012-2#1)
conferred a##2##2##(2008-10#1)(2012-12#1)
conferred by a single gene##2##5##(2008-10#2)
conferred by a single##4##4##(2008-10#4)
conferred by a##6##3##(1995-2#1)(2008-10#5)
conferred by the##4##3##(2008-10#4)
conferred by##24##2##(1992-8#1)(1993-2#1)(1995-2#1)(2008-10#16)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
conferred complete##2##2##(2008-10#2)
conferred on##2##2##(1995-2#1)(2008-10#1)
conferred protection against##2##3##(2008-10#1)(2011-2#1)
conferred resistance to##4##3##(2008-10#4)
conferred resistance##7##2##(2008-10#7)
conferred the##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
conferred##56##1##(1992-12#1)(1992-8#1)(1993-2#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#1)(2008-10#34)(2008-11#3)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
conferring a##2##2##(1994-9#1)(2010-12#1)
conferring resistance to##9##3##(2008-10#9)
conferring resistance##13##2##(2008-10#13)
conferring##33##1##(1994-9#1)(1996-2#1)(2008-10#22)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
confers a high level of##2##5##(2008-10#2)
confers a high##3##3##(1994-9#1)(2008-10#2)
confers a##7##2##(1992-8#1)(1994-9#1)(2008-10#3)(2008-9#1)(2010-8#1)
confers resistance to##8##3##(2008-10#7)(2008-11#1)
confers resistance##10##2##(2008-10#9)(2008-11#1)
confers the##2##2##(1994-12#1)(2013-8#1)
confers to##2##2##(2010-10#1)(2013-1#1)
confers##39##1##(1992-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-3#1)(2008-10#22)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
confidence and competence##2##3##(2008-11#2)
confidence and##6##2##(2008-11#3)(2008-12#3)
confidence can##2##2##(1991-12#1)(2008-9#1)
confidence in beef##2##3##(1996-3#1)(1996-6#1)
confidence in the##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
confidence in their##4##3##(1996-1#1)(2008-11#1)(2008-9#1)(2012-2#1)
confidence in##27##2##(1996-1#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-9#2)(2009-10#1)(2010-8#3)(2011-2#1)(2012-2#3)
confidence interval (CI)##4##3##(2011-2#2)(2012-12#1)(2012-3#1)
confidence interval 0##4##3##(1990-6#1)(1991-8#2)(2010-6#1)
confidence interval [CI]##5##3##(1993-12#1)(2010-10#1)(2010-4#3)
confidence interval for theta##3##4##(1996-3#3)
confidence interval for##7##3##(1991-2#1)(1996-3#5)(2008-10#1)
confidence interval of##5##3##(1991-7#1)(2008-10#2)(2010-3#1)(2013-1#1)
confidence interval##47##2##(1990-6#1)(1991-11#2)(1991-2#2)(1991-7#1)(1991-8#2)(1993-12#1)(1995-9#1)(1996-3#6)(1997-3#1)(2008-10#9)(2008-11#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#7)
confidence intervals for the##2##4##(2008-10#2)
confidence intervals for##4##3##(1994-9#1)(2008-10#3)
confidence intervals##27##2##(1990-2#1)(1994-9#2)(1995-5#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#6)(2013-8#1)
confidence is##4##2##(2008-11#2)(2011-1#1)(2012-2#1)
confidence level of 95%##2##4##(2008-10#2)
confidence level##53##2##(1995-9#1)(2008-10#52)
confidence level)##5##2##(2008-10#5)
confidence limit##3##2##(1991-5#1)(2008-10#2)
confidence limits##14##2##(1990-6#1)(1994-3#2)(1994-9#1)(1995-9#3)(1997-3#2)(2008-10#3)(2013-1#2)
confidence of##3##2##(2008-11#3)
confidence that the##2##3##(1991-12#1)(2008-1#1)
confidence that##3##2##(1991-12#1)(2008-1#1)(2008-10#1)
confidence to##4##2##(2008-3#1)(2012-2#3)
confidence was##2##2##(2008-10#1)(2008-11#1)
confidence##249##1##(1990-2#1)(1990-3#1)(1990-6#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#2)(1993-12#1)(1994-3#2)(1994-9#3)(1995-3#2)(1995-5#1)(1995-9#5)(1996-1#1)(1996-3#8)(1996-6#1)(1997-3#3)(2008-1#2)(2008-10#106)(2008-11#23)(2008-12#16)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#10)(2013-8#1)
confidence)##2##1##(2008-10#2)
confident that the##2##3##(1996-5#1)(2008-10#1)
confident that##3##2##(1996-1#1)(1996-5#1)(2008-10#1)
confident they##2##2##(2010-8#2)
confident##13##1##(1996-1#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#3)(2009-10#1)(2010-8#2)(2013-7#1)
confidential##2##1##(1995-6#1)(2008-9#1)
confidentiality and##2##2##(1990-2#1)(2008-11#1)
confidentiality breaches##2##2##(2007-12#2)
confidentiality of##2##2##(1993-3#1)(1997-5#1)
confidentiality##15##1##(1990-2#1)(1993-3#1)(1995-12#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-8#2)
confidently and##2##2##(2008-11#2)
confidently##9##1##(2008-1#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
configural processing##3##2##(2008-11#3)
configural##8##1##(2008-11#8)
configuration allows the##3##3##(2008-10#2)(2008-3#1)
configuration and##6##2##(1991-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2013-1#1)
configuration for##5##2##(2007-11#1)(2008-10#2)(2008-3#2)
configuration in##4##2##(1994-2#1)(2008-5#1)(2009-3#1)(2009-7#1)
configuration is##6##2##(1995-5#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-3#1)
configuration of the device##2##4##(2008-10#1)(2008-11#1)
configuration of the##8##3##(1993-3#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)(2013-1#1)
configuration of##19##2##(1991-10#1)(1991-6#1)(1993-3#1)(1994-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2012-2#1)(2013-1#1)
configuration on##2##2##(2008-10#1)(2009-10#1)
configuration to##2##2##(2008-10#1)(2008-11#1)
configuration with a##3##3##(2008-10#1)(2008-3#2)
configuration with##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
configuration##123##1##(1990-8#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-5#3)(2007-11#5)(2007-12#1)(2008-10#35)(2008-11#8)(2008-2#8)(2008-3#22)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)
configurations and##3##2##(1991-1#2)(1997-6#1)
configurations are##3##2##(2008-2#1)(2008-3#2)
configurations in##4##2##(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#1)
configurations of the##3##3##(1995-2#1)(1996-5#1)(2008-10#1)
configurations of##7##2##(1995-11#1)(1995-2#1)(1996-1#1)(1996-5#1)(2008-10#2)(2008-8#1)
configurations on the##2##3##(2008-10#1)(2008-9#1)
configurations on##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
configurations that##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
configurations were##4##2##(2007-11#1)(2008-10#2)(2009-3#1)
configurations with##2##2##(2007-12#1)(2008-10#1)
configurations##55##1##(1991-1#3)(1992-12#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-5#2)(1996-1#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#2)(2009-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
configure a##2##2##(2008-10#1)(2009-11#1)
configured##4##1##(1991-5#1)(1993-12#1)(2008-10#2)
confined in##3##2##(2008-10#2)(2012-2#1)
confined to a##4##3##(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)
confined to the##14##3##(1990-9#1)(1991-11#1)(1994-12#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#3)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
confined to##31##2##(1990-3#1)(1990-9#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-8#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
confined##44##1##(1990-3#1)(1990-9#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-8#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
confinement in##3##2##(1991-6#1)(2008-10#1)(2008-7#1)
confinement of the##2##3##(2008-10#1)(2008-3#1)
confinement##14##1##(1991-6#1)(1991-9#1)(1993-5#1)(2007-11#1)(2008-10#2)(2008-3#5)(2008-5#1)(2008-7#1)(2009-7#1)
confines the##2##2##(2008-11#2)
confines##6##1##(2008-10#3)(2008-11#3)
confining##4##1##(2008-10#2)(2008-5#1)(2010-4#1)
confirm and extend##2##3##(1994-3#1)(2008-10#1)
confirm and##3##2##(1994-3#1)(2008-10#2)
confirm earlier##2##2##(1993-2#1)(2008-10#1)
confirm its##6##2##(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
confirm previous##2##2##(1991-2#1)(2008-6#1)
confirm previously reported##2##3##(2008-6#1)(2011-2#1)
confirm some##2##2##(1991-8#1)(2008-8#1)
confirm that a##2##3##(1994-11#1)(2010-1#1)
confirm that the##13##3##(1990-8#1)(1993-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
confirm that there##2##3##(1991-6#1)(2008-5#1)
confirm that##39##2##(1990-2#1)(1990-8#2)(1990-9#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
confirm the association of##2##4##(1996-8#1)(2008-10#1)
confirm the existence of##2##4##(2008-11#1)(2010-2#1)
confirm the importance of##2##4##(2008-10#2)
confirm the important role of##2##5##(1995-12#1)(2008-10#1)
confirm the important##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
confirm the presence of##5##4##(1990-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
confirm the##76##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#18)(2008-11#7)(2008-12#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
confirm their##4##2##(1991-3#1)(2008-10#3)
confirm these results##2##3##(1996-12#1)(2011-2#1)
confirm these##8##2##(1996-12#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#3)
confirm this finding##2##3##(1994-11#1)(2008-8#1)
confirm this##6##2##(1991-11#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
confirm##183##1##(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-6#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#44)(2008-11#11)(2008-12#3)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#15)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#3)
confirmation and##3##2##(2008-10#1)(2008-4#1)(2012-12#1)
confirmation by##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
confirmation from##3##2##(1990-8#1)(2008-10#1)(2009-8#1)
confirmation of the##7##3##(1991-2#1)(1992-3#1)(2008-2#1)(2008-4#2)(2011-2#2)
confirmation of##18##2##(1991-2#1)(1992-3#2)(1995-11#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#3)(2013-1#1)
confirmation was##2##2##(2008-1#1)(2008-10#1)
confirmation##37##1##(1990-8#1)(1991-2#1)(1991-3#1)(1992-3#2)(1995-11#1)(1996-3#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-4#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)
confirmatory factor analysis##2##3##(2008-11#1)(2010-1#1)
confirmatory factor##3##2##(2008-11#2)(2010-1#1)
confirmatory testing##3##2##(1997-2#1)(2009-3#2)
confirmatory##20##1##(1997-2#2)(2008-10#5)(2008-11#3)(2008-5#2)(2009-3#2)(2010-1#1)(2012-2#3)(2013-1#2)
confirmatory&quot##2##1##(1997-2#2)
confirmed a##10##2##(1994-3#1)(1994-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
confirmed an##5##2##(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
confirmed and characterized##2##3##(2008-10#1)(2008-9#1)
confirmed and extended##2##3##(2008-10#2)
confirmed and##9##2##(1993-8#1)(1995-3#1)(2008-10#5)(2008-9#1)(2011-2#1)
confirmed as##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
confirmed at histological examination##2##4##(2011-2#2)
confirmed at the##2##3##(2008-10#2)
confirmed at##6##2##(2008-10#4)(2011-2#2)
confirmed by Northern blot##2##4##(1993-3#1)(2008-9#1)
confirmed by PCR##2##3##(2008-10#1)(2008-8#1)
confirmed by Southern##2##3##(2008-10#1)(2008-11#1)
confirmed by Western##2##3##(2008-11#1)(2011-2#1)
confirmed by X-ray photoelectron spectroscopy (XPS)##2##6##(2008-10#2)
confirmed by X-ray##3##3##(1996-5#1)(2008-10#2)
confirmed by a##5##3##(1992-1#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
confirmed by an##4##3##(2008-10#1)(2008-7#1)(2009-1#1)(2012-3#1)
confirmed by analysing##2##3##(2008-10#2)
confirmed by biopsy##2##3##(2011-2#2)
confirmed by elemental##2##3##(2008-10#2)
confirmed by immunochemical##2##3##(1996-2#1)(1997-2#1)
confirmed by polymerase chain reaction##4##5##(2008-10#3)(2012-12#1)
confirmed by scanning##2##3##(2008-10#1)(2011-2#1)
confirmed by sequence analysis of##2##5##(1993-12#1)(2008-10#1)
confirmed by sequencing##2##3##(2008-10#1)(2008-8#1)
confirmed by the results of##3##5##(1997-4#1)(2008-10#1)(2008-8#1)
confirmed by the##27##3##(1990-3#1)(1990-6#1)(1991-5#1)(1995-6#1)(1996-5#1)(1997-1#2)(1997-4#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#2)(2013-1#1)
confirmed by##183##2##(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#1)(1996-2#2)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#73)(2008-11#15)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#2)(2009-11#1)(2009-12#2)(2010-11#2)(2010-12#3)(2011-1#1)(2011-2#14)(2011-3#1)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#4)
confirmed clinically##2##2##(1992-5#1)(2012-3#1)
confirmed experimentally##3##2##(1996-2#1)(2008-10#1)(2008-7#1)
confirmed for the##4##3##(2008-10#1)(2008-11#1)(2009-6#1)(2010-3#1)
confirmed for##11##2##(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-6#1)(2010-3#2)(2012-3#2)
confirmed in a##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
confirmed in the##6##3##(1992-2#1)(1995-11#1)(2008-10#4)
confirmed in##25##2##(1992-2#1)(1993-12#1)(1995-11#1)(1997-9#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-9#1)(2011-2#3)(2012-3#1)
confirmed it to be##2##4##(2012-2#1)(2013-1#1)
confirmed its##3##2##(2008-10#1)(2008-9#1)(2009-1#1)
confirmed on##3##2##(2008-11#1)(2013-7#1)(2013-8#1)
confirmed only##2##2##(1991-3#1)(2008-10#1)
confirmed our hypothesis##2##3##(2010-8#1)(2013-8#1)
confirmed our previous findings##2##4##(1994-8#1)(1996-12#1)
confirmed our##4##2##(1994-8#1)(1996-12#1)(2010-8#1)(2013-8#1)
confirmed previous##2##2##(2007-12#1)(2008-10#1)
confirmed subdivision##2##2##(2008-10#2)
confirmed that all##2##3##(2008-10#1)(2011-1#1)
confirmed that the expression of##2##5##(1997-7#1)(2008-10#1)
confirmed that the##20##3##(1991-9#1)(1993-12#1)(1995-6#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-8#2)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
confirmed that they were##2##4##(1997-8#1)(2008-10#1)
confirmed that this##2##3##(1990-8#1)(1995-11#1)
confirmed that##82##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-10#26)(2008-11#4)(2008-12#3)(2008-2#1)(2008-5#1)(2008-8#6)(2008-9#3)(2009-7#1)(2009-8#1)(2010-1#3)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#2)
confirmed the close relationship of##2##5##(2008-10#1)(2008-5#1)
confirmed the diagnosis as##2##4##(2010-12#1)(2013-8#1)
confirmed the diagnosis of##9##4##(1994-9#1)(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#3)
confirmed the diagnosis##14##3##(1991-8#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
confirmed the existence of##3##4##(1993-2#1)(2008-10#1)(2008-11#1)
confirmed the formation of##2##4##(2011-2#2)
confirmed the high##3##3##(1993-11#1)(2008-10#2)
confirmed the potential##2##3##(2010-6#1)(2012-12#1)
confirmed the presence of the##3##5##(1992-6#1)(2008-10#1)(2009-9#1)
confirmed the presence of##11##4##(1992-6#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-9#1)(2010-4#1)
confirmed the presence##12##3##(1992-6#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)
confirmed the specificity of the##2##5##(2008-10#2)
confirmed the validity of the##2##5##(2010-8#1)(2011-2#1)
confirmed the validity of##3##4##(2008-3#1)(2010-8#1)(2011-2#1)
confirmed the##93##2##(1991-8#1)(1992-6#1)(1993-11#2)(1993-2#1)(1994-2#1)(1994-9#1)(1995-11#2)(1997-2#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#31)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#2)(2009-9#1)(2010-10#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
confirmed their##2##2##(2008-10#1)(2010-6#1)
confirmed these results and##2##4##(1992-6#1)(1993-8#1)
confirmed these results##3##3##(1992-6#1)(1993-8#1)(2008-10#1)
confirmed these##6##2##(1992-6#1)(1993-8#1)(2008-10#3)(2008-3#1)
confirmed this##2##2##(1994-8#1)(2008-10#1)
confirmed through##4##2##(1995-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
confirmed to be in##2##4##(2009-3#1)(2013-1#1)
confirmed to be##10##3##(1997-1#1)(2008-10#5)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#1)
confirmed to have##2##3##(2008-11#1)(2009-7#1)
confirmed to##17##2##(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2012-3#1)(2013-1#2)
confirmed using a##2##3##(2008-10#1)(2008-5#1)
confirmed using##7##2##(1990-6#1)(1994-6#1)(2008-10#3)(2008-5#1)(2011-2#1)
confirmed with##13##2##(1993-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-12#2)(2010-5#1)(2011-3#2)(2012-12#1)
confirmed##600##1##(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#5)(1990-8#4)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#8)(1994-9#1)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#1)(1995-6#5)(1995-8#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#5)(1997-9#1)(2006-6#1)(2007-12#4)(2007-8#1)(2008-1#4)(2008-10#200)(2008-11#30)(2008-12#13)(2008-2#1)(2008-3#6)(2008-5#9)(2008-7#12)(2008-8#17)(2008-9#11)(2009-1#4)(2009-10#1)(2009-11#2)(2009-12#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#47)(2011-3#3)(2012-12#12)(2012-2#11)(2012-3#16)(2013-1#21)(2013-7#1)(2013-8#7)
confirming its##2##2##(2008-3#1)(2012-6#1)
confirming previous##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
confirming that##9##2##(1997-3#1)(2007-12#1)(2008-10#4)(2008-7#2)(2012-6#1)
confirming the diagnosis of##2##4##(1990-8#1)(2013-1#1)
confirming the diagnosis##3##3##(1990-8#1)(2008-12#1)(2013-1#1)
confirming the validity of##3##4##(1990-9#1)(2008-10#2)
confirming the##29##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1994-5#1)(1994-6#2)(2008-10#11)(2008-12#1)(2008-3#2)(2008-8#1)(2009-10#1)(2011-2#3)(2013-1#2)
confirming##59##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-11#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-1#4)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#3)(2012-2#1)(2012-6#2)(2013-1#3)
confirms our##3##2##(1993-2#1)(2008-3#1)(2012-3#1)
confirms that the##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
confirms that there##2##3##(2008-10#1)(2008-2#1)
confirms that##14##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1994-1#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
confirms the need##2##3##(2009-8#1)(2012-3#1)
confirms the##21##2##(1991-3#2)(1991-6#2)(1992-5#1)(1995-2#1)(1996-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#4)(2009-8#1)(2012-3#2)
confirms##46##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#2)(1992-5#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#5)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)
conflict and academic achievement##2##4##(2010-1#2)
conflict and the##2##3##(2008-8#1)(2008-9#1)
conflict and##15##2##(1990-2#4)(1996-12#1)(2008-8#4)(2008-9#1)(2010-1#5)
conflict between##5##2##(1993-12#1)(2008-8#1)(2010-10#1)(2010-7#1)(2013-1#1)
conflict is##4##2##(1995-5#1)(2008-8#1)(2009-9#1)(2010-1#1)
conflict of interest##3##3##(2008-12#1)(2008-9#1)(2013-8#1)
conflict of##5##2##(1996-3#1)(1997-8#1)(2008-12#1)(2008-9#1)(2013-8#1)
conflict on##2##2##(2009-9#1)(2012-3#1)
conflict over reproductive allocation##5##4##(2008-8#5)
conflict over sex##2##3##(2008-8#2)
conflict over the##2##3##(2008-8#1)(2012-3#1)
conflict over##17##2##(2008-8#13)(2008-9#3)(2012-3#1)
conflict resolution##3##2##(1993-12#1)(2011-2#2)
conflict with parents##3##3##(2009-7#2)(2013-1#1)
conflict with##9##2##(1994-6#1)(1995-2#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#2)(2011-2#1)(2013-1#1)
conflict##97##1##(1990-2#5)(1992-1#1)(1992-3#1)(1993-12#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-8#31)(2008-9#9)(2009-7#2)(2009-9#12)(2010-1#10)(2010-10#1)(2010-7#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
conflicting results##8##2##(1997-1#1)(2008-11#1)(2009-12#1)(2010-5#1)(2011-2#3)(2012-3#1)
conflicting##21##1##(1993-8#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
conflicts between the##2##3##(2008-4#1)(2010-10#1)
conflicts between##3##2##(2008-4#1)(2008-8#1)(2010-10#1)
conflicts in##2##2##(2008-10#1)(2008-8#1)
conflicts of interest##3##3##(2008-9#1)(2009-4#2)
conflicts##15##1##(2008-10#1)(2008-4#1)(2008-8#5)(2008-9#2)(2009-4#3)(2010-10#1)(2010-11#1)(2011-3#1)
confluence of the##2##3##(1992-4#1)(2008-10#1)
confluence of##3##2##(1992-4#1)(2008-10#1)(2010-8#1)
confluence point##2##2##(2008-10#2)
confluence##15##1##(1992-4#1)(1995-2#1)(1995-3#1)(2008-10#4)(2008-11#7)(2010-8#1)
confluency##4##1##(2008-11#4)
confluent cultures##2##2##(2008-11#2)
confluent monolayers##2##2##(1992-12#1)(2008-11#1)
confluent##16##1##(1991-5#2)(1992-12#1)(1992-3#1)(1994-6#1)(2008-10#4)(2008-11#4)(2011-2#1)(2012-12#1)(2013-1#1)
confluent-phase cells##2##2##(1995-12#2)
confluent-phase##3##1##(1995-12#3)
confocal and##2##2##(2008-10#1)(2008-9#1)
confocal fluorescence##2##2##(2008-11#1)(2009-8#1)
confocal laser microscopy##2##3##(2007-12#1)(2008-5#1)
confocal laser scanning microscopy##6##4##(2008-10#1)(2008-11#2)(2008-8#2)(2010-8#1)
confocal laser scanning##8##3##(2008-10#1)(2008-11#2)(2008-8#3)(2008-9#1)(2010-8#1)
confocal laser##10##2##(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#1)(2010-8#1)
confocal microscope##6##2##(2007-12#1)(2008-2#3)(2009-6#1)(2011-2#1)
confocal microscopic##2##2##(1994-9#1)(2008-11#1)
confocal microscopy and##2##3##(2008-11#1)(2010-10#1)
confocal microscopy##21##2##(1997-1#1)(2007-12#2)(2008-10#2)(2008-11#10)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)
confocal scanning##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
confocal unstable resonator##2##3##(2008-3#2)
confocal unstable##4##2##(2008-3#4)
confocal##62##1##(1994-9#1)(1997-1#1)(2007-11#3)(2007-12#4)(2008-10#6)(2008-11#15)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#7)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
conform to the##4##3##(1995-8#1)(1996-6#1)(2008-11#1)(2010-6#1)
conform to##10##2##(1991-12#1)(1994-3#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-6#1)(2012-2#1)
conform##12##1##(1990-11#1)(1990-5#1)(1991-12#1)(1994-3#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-6#1)(2012-2#1)
conformation and##9##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-3#2)
conformation by##2##2##(1990-5#1)(1992-6#1)
conformation decreased##2##2##(2008-8#2)
conformation of the pocket region##2##5##(2008-8#2)
conformation of the##19##3##(1992-4#1)(1993-3#2)(1994-5#1)(2008-10#4)(2008-2#1)(2008-8#6)(2008-9#2)(2011-2#1)(2012-2#1)
conformation of##40##2##(1990-5#1)(1991-5#1)(1992-4#1)(1993-3#2)(1994-5#1)(1995-6#3)(1996-2#1)(1997-2#2)(2008-10#10)(2008-2#1)(2008-8#10)(2008-9#3)(2011-2#1)(2012-2#3)
conformation polymorphism (SSCP) analysis of##2##5##(2008-10#2)
conformation polymorphism (SSCP) analysis##3##4##(2008-10#3)
conformation polymorphism (SSCP)##4##3##(2008-10#3)(2008-8#1)
conformation polymorphism analysis of##2##4##(2008-10#1)(2011-2#1)
conformation polymorphism analysis##3##3##(1991-12#1)(2008-10#1)(2011-2#1)
conformation polymorphism##8##2##(1991-12#1)(2008-10#5)(2008-8#1)(2011-2#1)
conformation that##3##2##(1993-8#1)(1994-5#1)(1995-6#1)
conformation were examined##2##3##(2008-10#1)(2008-9#1)
conformation##115##1##(1990-3#1)(1990-5#2)(1991-12#1)(1991-5#7)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-3#3)(1993-8#3)(1994-5#4)(1995-2#1)(1995-6#9)(1995-8#2)(1996-2#2)(1997-2#2)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#23)(2008-9#7)(2009-3#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#3)(2013-8#1)
conformation(s)##2##1##(1993-8#2)
conformational change in the##3##4##(1990-8#1)(1995-6#1)(2008-5#1)
conformational change in##4##3##(1990-8#1)(1991-5#1)(1995-6#1)(2008-5#1)
conformational change of G(o)alpha##3##4##(2008-9#3)
conformational change of##6##3##(2008-11#1)(2008-9#3)(2009-3#2)
conformational change##22##2##(1990-8#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-6#5)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#3)(2009-5#2)
conformational changes in the##5##4##(1992-6#1)(1994-5#1)(1995-6#2)(2009-7#1)
conformational changes in##7##3##(1992-6#1)(1994-5#1)(1995-2#1)(1995-6#2)(2009-7#1)(2013-8#1)
conformational changes of the##4##4##(1994-5#1)(2008-9#1)(2009-3#1)(2013-8#1)
conformational changes of##8##3##(1993-8#1)(1994-5#1)(2008-10#3)(2008-9#1)(2009-3#1)(2013-8#1)
conformational changes##21##2##(1991-9#1)(1992-6#2)(1993-8#1)(1994-5#2)(1995-2#1)(1995-6#3)(2008-10#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-7#2)(2013-8#3)
conformational dynamics##2##2##(1992-6#1)(2009-5#1)
conformational flexibility##2##2##(1995-11#1)(1995-8#1)
conformational mobility##2##2##(1992-6#1)(2008-10#1)
conformational polymorphisms##2##2##(1994-12#1)(2008-12#1)
conformational properties##3##2##(1993-8#2)(1994-5#1)
conformational restriction##2##2##(2008-10#1)(2008-8#1)
conformational states##3##2##(1996-2#1)(2008-4#1)(2010-10#1)
conformational study on##2##3##(1993-3#1)(2008-10#1)
conformational##92##1##(1990-5#1)(1990-8#1)(1991-5#4)(1991-9#1)(1992-6#5)(1993-3#2)(1993-8#5)(1994-11#1)(1994-12#1)(1994-5#4)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#9)(1995-8#2)(1996-2#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#4)(2009-3#4)(2009-5#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#2)(2012-2#3)(2013-1#1)(2013-8#3)
conformationally##4##1##(1994-11#1)(1995-8#1)(1996-2#1)(2008-5#1)
conformations of##5##2##(1990-5#1)(1991-5#1)(2008-8#2)(2013-8#1)
conformations##23##1##(1990-5#1)(1990-8#1)(1991-3#2)(1991-5#2)(1995-11#2)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#2)
conformed to the##2##3##(1997-4#1)(2008-10#1)
conformed to##3##2##(1997-4#1)(2008-10#1)(2008-5#1)
conformed##4##1##(1997-4#1)(2008-10#2)(2008-5#1)
conformer##4##1##(1996-2#3)(2008-8#1)
conformers##5##1##(1993-8#2)(1994-5#1)(1996-5#1)(2008-12#1)
conforming to##2##2##(2008-1#1)(2008-11#1)
conformity##2##1##(2008-10#2)
conforms to the##2##3##(2008-10#2)
conforms to##4##2##(2008-10#3)(2008-9#1)
conforms##5##1##(2008-10#3)(2008-3#1)(2008-9#1)
confound the##3##2##(1993-11#1)(2008-10#1)(2010-4#1)
confound##5##1##(1993-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)
confounded by##4##2##(1994-9#1)(2008-10#2)(2010-10#1)
confounded##6##1##(1994-9#1)(2008-10#3)(2008-8#1)(2010-10#1)
confounders##8##1##(1997-3#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-5#1)(2013-1#3)
confounding and##2##2##(1992-9#1)(2008-7#1)
confounding effect of##2##3##(1992-9#1)(1995-12#1)
confounding effects##2##2##(1997-1#1)(2008-9#1)
confounding factors are##2##3##(1991-12#1)(2008-6#1)
confounding factors that##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
confounding factors##15##2##(1991-12#2)(1996-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#4)(2010-11#1)(2012-12#1)(2013-1#2)
confounding variables are##2##3##(1992-3#1)(2008-12#1)
confounding variables##6##2##(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#1)(2008-12#1)(2010-6#1)
confounding##42##1##(1990-8#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#8)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2010-1#4)(2010-11#1)(2010-5#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#2)
confounds##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
confront##6##1##(1990-12#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-6#1)
confrontation##3##1##(1996-2#1)(2012-3#2)
confronted by##3##2##(1992-2#1)(1996-2#1)(2008-10#1)
confronted with##8##2##(1990-11#1)(1992-1#1)(1993-11#1)(2007-11#1)(2008-7#1)(2010-3#1)(2010-7#1)(2011-3#1)
confronted##12##1##(1990-11#1)(1992-1#1)(1992-2#1)(1993-11#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-7#1)(2011-3#1)
confronting##4##1##(1992-2#1)(1994-12#2)(2013-1#1)
confused with##7##2##(1997-3#1)(1997-4#1)(1997-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)
confused##12##1##(1991-12#1)(1992-1#1)(1992-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#3)
confusing##10##1##(1991-3#2)(1992-3#1)(1995-3#1)(1997-1#1)(2008-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
confusion and##6##2##(1997-3#1)(2008-4#1)(2008-7#2)(2013-1#2)
confusion in the literature##2##4##(1994-8#1)(2008-10#1)
confusion in the##3##3##(1994-8#1)(1995-3#1)(2008-10#1)
confusion in this##2##3##(1997-3#1)(2008-11#1)
confusion in##9##2##(1994-8#1)(1995-3#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
confusion with other##2##3##(1991-2#1)(2011-2#1)
confusion##34##1##(1991-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-3#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#5)(2009-1#1)(2010-10#1)(2011-2#1)(2012-3#2)(2013-1#3)
confusional##2##1##(1991-8#1)(2009-5#1)
congener profiles##2##2##(2008-10#2)
congener##8##1##(2008-10#8)
congeneric##4##1##(2008-10#3)(2010-8#1)
congeners were##3##2##(2008-10#2)(2008-11#1)
congeners with##2##2##(1993-12#1)(2008-10#1)
congeners##20##1##(1993-1#1)(1993-12#1)(1995-11#3)(2008-10#11)(2008-11#3)(2010-2#1)
congenic lines##2##2##(2012-3#2)
congenic##3##1##(1993-3#1)(2012-3#2)
congenita##4##1##(1992-3#2)(2008-11#2)
congenital adrenal hyperplasia##3##3##(2008-4#1)(2010-2#1)(2012-3#1)
congenital adrenal##4##2##(2008-4#1)(2010-2#1)(2011-1#1)(2012-3#1)
congenital and acquired##4##3##(2009-12#1)(2009-3#1)(2012-2#2)
congenital anomalies in##2##3##(2008-11#2)
congenital anomalies##17##2##(1991-6#1)(1997-3#5)(2008-11#10)(2012-12#1)
congenital anomaly##6##2##(1991-8#1)(2008-11#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-3#1)
congenital aphakia##2##2##(2010-9#2)
congenital defect##2##2##(2008-10#1)(2012-3#1)
congenital diaphragmatic hernia##3##3##(2008-11#2)(2012-3#1)
congenital diaphragmatic##4##2##(2008-11#2)(2012-3#2)
congenital heart defects##3##3##(1997-8#2)(2012-2#1)
congenital heart disease in##2##4##(2008-11#1)(2013-8#1)
congenital heart disease##26##3##(1990-11#1)(1993-12#1)(2008-10#2)(2008-11#3)(2009-10#5)(2010-10#2)(2010-6#2)(2010-9#3)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
congenital heart##31##2##(1990-11#2)(1992-5#1)(1993-12#1)(1997-8#2)(2008-10#2)(2008-11#3)(2009-10#5)(2010-10#2)(2010-6#2)(2010-9#3)(2011-2#1)(2012-2#4)(2012-3#2)(2013-8#1)
congenital hypothyroidism##5##2##(2008-4#1)(2011-1#4)
congenital limb deformity##3##3##(2009-3#3)
congenital malformations is##2##3##(1995-12#1)(2008-11#1)
congenital malformations##15##2##(1995-12#1)(2008-10#1)(2008-11#3)(2008-7#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
congenital or##4##2##(1991-6#1)(1992-5#1)(1996-11#1)(2010-6#1)
congenital small bowel##2##3##(2012-3#2)
congenital splenic cyst##4##3##(1997-8#4)
congenital venous##2##2##(2010-11#2)
congenital##166##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-9#6)(1991-6#2)(1991-8#1)(1992-5#3)(1993-12#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-12#2)(1996-11#1)(1997-3#6)(1997-6#1)(1997-8#8)(2008-10#8)(2008-11#21)(2008-12#1)(2008-4#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#5)(2009-12#1)(2009-3#11)(2009-8#1)(2010-10#3)(2010-11#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#8)(2011-2#4)(2012-12#2)(2012-2#14)(2012-3#13)(2013-1#3)(2013-8#1)
congenitally##2##1##(2008-10#1)(2008-5#1)
congestion##2##1##(2011-2#1)(2013-7#1)
congestive cardiac failure from##2##4##(1996-3#1)(1996-6#1)
congestive cardiac failure##4##3##(1996-3#1)(1996-6#2)(2010-5#1)
congestive heart failure##14##3##(1990-9#2)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)(2012-3#2)
congestive heart##15##2##(1990-9#2)(1994-2#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)(2012-3#2)
congestive##20##1##(1990-3#1)(1990-9#2)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)(2010-5#1)(2012-3#2)
conglutin##2##1##(2008-10#2)
congress was##2##2##(2010-11#2)
congress##4##1##(1993-12#1)(1996-12#1)(2010-11#2)
congresses##6##1##(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(2008-11#1)(2011-4#1)
congressional##2##1##(1992-12#1)(1995-12#1)
congressionally mandated##2##2##(1991-1#1)(1991-3#1)
congruence between##2##2##(2012-2#1)(2012-3#1)
congruence in end-of-life treatment preferences##2##5##(2010-4#2)
congruence with##2##2##(2008-12#1)(2010-4#1)
congruence##7##1##(2008-12#1)(2010-12#1)(2010-4#3)(2012-2#1)(2012-3#1)
congruency##2##1##(2012-2#1)(2013-8#1)
congruent with##4##2##(1991-12#1)(2008-10#2)(2008-8#1)
congruent##15##1##(1990-12#1)(1991-12#1)(1991-5#1)(2007-12#2)(2008-10#6)(2008-8#2)(2013-8#2)
congruity##2##1##(2012-3#2)
congénitales##2##1##(2013-1#2)
conic##2##1##(2008-3#1)(2008-5#1)
conical##10##1##(1993-5#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-8#1)
conically sculpted tips##3##3##(1995-2#3)
conically sculpted##5##2##(1995-2#5)
conidia and appressoria##4##3##(2008-10#4)
conidia and ascospores##2##3##(2008-10#1)(2010-3#1)
conidia and##16##2##(2008-10#15)(2010-3#1)
conidia are##2##2##(2008-10#2)
conidia at##2##2##(2008-10#2)
conidia can##2##2##(2008-10#2)
conidia contributed##2##2##(2008-10#2)
conidia deposited on##2##3##(2008-10#2)
conidia formed##2##2##(2008-10#2)
conidia from##8##2##(2008-10#8)
conidia germinated in##2##3##(2008-10#2)
conidia germinated##10##2##(2008-10#10)
conidia germination##6##2##(2008-10#6)
conidia in rainwater##2##3##(2008-10#2)
conidia in the##2##3##(2008-10#2)
conidia in##8##2##(2008-10#8)
conidia initiated germination##2##3##(2008-10#2)
conidia of B##2##3##(2008-10#2)
conidia of C##2##3##(2008-10#2)
conidia of F##2##3##(2008-10#2)
conidia of M##2##3##(2008-10#2)
conidia of P##2##3##(2008-10#2)
conidia of S##2##3##(2008-10#2)
conidia of the##3##3##(2008-10#3)
conidia of##23##2##(2008-10#22)(2008-5#1)
conidia on leaves and coverslips##2##5##(2008-10#2)
conidia on the##2##3##(2008-10#2)
conidia on##10##2##(2008-10#10)
conidia or germinating conidia of##2##5##(2008-10#2)
conidia or##6##2##(2008-10#6)
conidia per ml##4##3##(2008-10#4)
conidia per ml) at intervals of##2##6##(2008-10#2)
conidia per ml) of##2##4##(2008-10#2)
conidia per ml)##5##3##(2008-10#5)
conidia per##12##2##(2008-10#12)
conidia produced in##3##3##(2008-10#3)
conidia produced##5##2##(2008-10#5)
conidia production##5##2##(2008-10#4)(2008-5#1)
conidia reduced##2##2##(2008-10#2)
conidia stored at -20 degrees C##2##6##(2008-10#2)
conidia than##2##2##(2008-10#2)
conidia that##2##2##(2008-10#2)
conidia to##4##2##(2008-10#4)
conidia treated with##2##3##(2008-10#2)
conidia was##6##2##(2008-10#5)(2008-5#1)
conidia were##11##2##(2008-10#11)
conidia with appressoria##3##3##(2008-10#3)
conidia with##7##2##(2008-10#7)
conidia##234##1##(2008-10#229)(2008-5#3)(2009-8#1)(2010-3#1)
conidia/ml for F##2##3##(2008-10#2)
conidia/ml were##2##2##(2008-10#2)
conidia/ml##5##1##(2008-10#5)
conidial germ tubes##2##3##(2008-10#2)
conidial germ##3##2##(2008-10#3)
conidial germination and appressorium formation##3##5##(2008-10#3)
conidial germination and##7##3##(2008-10#7)
conidial germination in##2##3##(2008-10#2)
conidial germination of##2##3##(2008-10#2)
conidial germination was##2##3##(2008-10#2)
conidial germination##25##2##(2008-10#25)
conidial inoculations##4##2##(2008-10#4)
conidial inoculum from##2##3##(2008-10#2)
conidial inoculum##3##2##(2008-10#3)
conidial morphology##2##2##(2008-10#2)
conidial suspension of##4##3##(2008-10#4)
conidial suspension##9##2##(2008-10#9)
conidial suspensions of##4##3##(2008-10#4)
conidial suspensions##7##2##(2008-10#7)
conidial##65##1##(2008-10#65)
conidiation is##2##2##(2008-10#2)
conidiation was##2##2##(2008-10#2)
conidiation##9##1##(2008-10#9)
conidiophores##4##1##(2008-10#4)
conidium germination##2##2##(2008-10#2)
conifer species##2##2##(2008-10#2)
conifer##14##1##(2008-10#9)(2008-11#1)(2008-8#3)(2011-10#1)
conifers##10##1##(2008-10#5)(2009-8#3)(2010-10#1)(2010-5#1)
conization by##3##2##(1992-2#1)(1992-3#2)
conization in##2##2##(1991-1#1)(1994-12#1)
conization##11##1##(1991-1#3)(1992-2#2)(1992-3#2)(1994-12#3)(2012-3#1)
conjecture of##2##2##(2008-12#1)(2008-8#1)
conjecture##6##1##(2008-12#1)(2008-8#2)(2009-10#1)(2010-11#1)(2013-8#1)
conjectures##2##1##(2008-8#1)(2013-1#1)
conjoined twins##3##2##(2008-10#1)(2010-7#2)
conjoined##5##1##(2008-10#1)(2010-7#3)(2013-1#1)
conjugal##2##1##(1992-7#1)(2008-8#1)
conjugate and##6##2##(1994-11#1)(2008-10#3)(2008-11#1)(2008-7#1)
conjugate as signal generator##3##4##(2008-7#3)
conjugate as##4##2##(2008-10#1)(2008-7#3)
conjugate base##2##2##(2008-10#2)
conjugate formation was enhanced by##2##5##(2006-6#2)
conjugate formation##10##2##(2006-6#10)
conjugate gradient algorithm in##2##4##(2010-8#2)
conjugate gradient algorithm##3##3##(2010-8#3)
conjugate gradient##4##2##(2008-8#1)(2010-8#3)
conjugate is the##2##3##(2008-10#1)(2008-11#1)
conjugate is##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
conjugate of##5##2##(1990-8#1)(2008-10#3)(2008-11#1)
conjugate to the##3##3##(2008-10#3)
conjugate vaccination##2##2##(1995-5#2)
conjugate vaccine##4##2##(1995-5#1)(1997-3#1)(2008-10#1)(2013-1#1)
conjugate vaccines##4##2##(1994-9#1)(1995-5#1)(2007-11#1)(2008-10#1)
conjugate was determined by matrix-assisted laser desorption/ionization##2##7##(2008-11#2)
conjugate was##8##2##(2008-10#6)(2008-11#2)
conjugate were determined##2##3##(2008-10#1)(2008-11#1)
conjugate were##3##2##(2008-10#2)(2008-11#1)
conjugate with##2##2##(2008-10#1)(2008-11#1)
conjugate##95##1##(1990-12#2)(1990-8#5)(1994-11#3)(1994-9#1)(1995-5#5)(1996-5#3)(1997-3#1)(2006-6#11)(2007-11#2)(2008-10#35)(2008-11#9)(2008-3#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-4#2)(2010-8#3)(2013-1#1)
conjugated and unconjugated##2##3##(2008-11#1)(2009-5#1)
conjugated and##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
conjugated bile acids were##3##4##(1993-2#3)
conjugated bile acids##5##3##(1993-2#5)
conjugated bile##6##2##(1992-3#1)(1993-2#5)
conjugated dienes##8##2##(1992-3#3)(2009-8#5)
conjugated to a##2##3##(2008-4#1)(2008-9#1)
conjugated to the##2##3##(2008-10#2)
conjugated to##19##2##(1990-12#3)(1991-5#1)(1995-5#1)(1997-3#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-2#1)
conjugated with bovine serum albumin##2##5##(2008-10#1)(2008-5#1)
conjugated with horseradish peroxidase##2##4##(1996-12#1)(2008-10#1)
conjugated with##19##2##(1994-5#1)(1995-3#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#2)
conjugated##78##1##(1990-12#4)(1991-2#1)(1991-5#4)(1992-3#4)(1993-2#5)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-3#1)(2008-10#23)(2008-11#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-5#1)(2009-8#5)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
conjugates of the##2##3##(1991-5#1)(1995-11#1)
conjugates of##7##2##(1990-8#1)(1991-5#1)(1993-11#1)(1994-11#1)(1995-11#1)(2008-10#2)
conjugates##29##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#2)(1993-11#1)(1994-11#4)(1995-11#1)(1997-1#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-4#5)(2008-5#1)(2008-9#1)(2011-2#1)
conjugating##7##1##(1995-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-7#2)
conjugation in##2##2##(2008-10#1)(2008-2#1)
conjugation to##3##2##(1997-1#1)(2008-10#2)
conjugation##16##1##(1997-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-9#2)
conjugative##2##1##(2008-10#1)(2008-8#1)
conjunction with a##16##3##(1992-9#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
conjunction with the##18##3##(1994-3#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
conjunction with##95##2##(1990-3#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#37)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-2#3)(2013-1#1)
conjunction##98##1##(1990-3#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#38)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-2#3)(2013-1#1)(2013-8#1)
conjunctiva##3##1##(2008-11#1)(2010-10#2)
conjunctival petechiae##2##2##(1995-11#2)
conjunctival swabs from##2##3##(2011-2#2)
conjunctival##9##1##(1991-8#1)(1995-11#3)(2008-11#2)(2011-2#2)(2012-3#1)
conjunctivitis##4##1##(1991-2#1)(2008-1#1)(2012-3#1)(2013-8#1)
connect the##2##2##(2008-7#1)(2013-1#1)
connect to the##2##3##(1996-9#1)(2008-5#1)
connect to##5##2##(1996-9#1)(2007-12#1)(2008-5#1)(2009-7#1)(2012-2#1)
connect with##2##2##(2008-8#2)
connect##14##1##(1996-9#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
connected by a##2##3##(2008-10#1)(2011-2#1)
connected by##7##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
connected in series##4##3##(2008-10#4)
connected to a UV detector##2##5##(2008-10#2)
connected to a##10##3##(2008-10#8)(2009-1#1)(2010-7#1)
connected to the##12##3##(1990-6#1)(1994-6#1)(2008-10#3)(2008-8#2)(2008-9#1)(2010-10#1)(2012-2#1)(2012-5#1)(2013-8#1)
connected to##37##2##(1990-6#1)(1991-2#1)(1994-6#2)(2008-10#16)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2010-10#1)(2010-7#1)(2012-2#2)(2012-5#1)(2013-8#1)
connected with the sample##2##4##(2008-10#2)
connected with the##11##3##(1995-3#1)(1996-5#1)(2008-10#4)(2008-11#3)(2008-3#1)(2009-8#1)
connected with##33##2##(1990-2#1)(1990-6#1)(1991-9#1)(1994-2#1)(1995-3#1)(1996-5#1)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2012-8#1)(2013-1#1)
connected##102##1##(1990-2#1)(1990-6#2)(1991-2#1)(1991-9#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-3#2)(1996-5#1)(2007-8#1)(2008-10#34)(2008-11#14)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-1#1)(2009-3#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2012-5#1)(2012-8#1)(2013-1#2)(2013-8#2)
connectedness and##5##2##(2008-9#1)(2010-10#3)(2010-11#1)
connectedness##10##1##(1993-8#1)(2008-9#2)(2010-10#5)(2010-11#2)
connecting peptides##4##2##(2008-10#3)(2008-9#1)
connecting the##5##2##(1992-10#1)(1994-5#1)(2008-5#2)(2008-7#1)
connecting##27##1##(1992-10#1)(1992-6#1)(1994-5#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#6)(2009-9#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-3#1)
connection between the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
connection between##13##2##(1991-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
connection by##2##2##(2007-8#1)(2008-11#1)
connection could be##2##3##(2008-10#1)(2008-12#1)
connection data##6##2##(1995-5#6)
connection of the##2##3##(2008-3#1)(2011-1#1)
connection of##5##2##(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)
connection to##6##2##(2008-11#3)(2010-7#1)(2010-8#1)(2011-2#1)
connection with the##7##3##(1990-2#1)(1991-3#1)(1994-12#1)(2008-10#3)(2008-2#1)
connection with##18##2##(1990-2#1)(1991-3#1)(1993-6#1)(1994-12#1)(1996-6#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)
connection##71##1##(1990-11#1)(1990-2#1)(1991-2#2)(1991-3#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#6)(1996-2#1)(1996-6#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#2)
connectional##2##1##(1995-5#2)
connections among##3##2##(2008-11#2)(2013-1#1)
connections and prosocial norms##3##4##(2013-1#3)
connections and##5##2##(2008-11#1)(2009-5#1)(2013-1#3)
connections between research and practice##2##5##(2010-10#2)
connections between the##4##3##(1995-11#1)(2008-12#1)(2012-5#1)(2013-1#1)
connections between##15##2##(1992-5#1)(1995-11#1)(1995-5#2)(1996-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-8#2)(2010-10#2)(2012-5#1)(2013-1#1)
connections have been##2##3##(1993-6#1)(2008-11#1)
connections in the##2##3##(1996-2#1)(2011-2#1)
connections in##4##2##(1996-2#1)(2009-8#1)(2011-2#2)
connections of the##3##3##(1991-6#1)(1997-3#2)
connections of##6##2##(1991-6#1)(1996-2#1)(1997-3#3)(2008-11#1)
connections that##2##2##(1997-2#1)(2008-11#1)
connections to family and peers##2##5##(2013-1#2)
connections to##5##2##(1996-2#1)(2007-12#1)(2008-8#1)(2013-1#2)
connections with the##3##3##(1993-6#1)(1997-3#1)(2013-8#1)
connections with##6##2##(1993-6#1)(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
connections within a##2##3##(2008-11#2)
connections within the##2##3##(1997-3#2)
connections within##4##2##(1997-3#2)(2008-11#2)
connections##84##1##(1991-5#1)(1991-6#1)(1992-5#1)(1993-6#2)(1995-11#1)(1995-5#2)(1996-2#4)(1997-2#1)(1997-3#7)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#22)(2008-12#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#8)(2010-10#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-5#1)(2013-1#11)(2013-8#1)
connective tissue and##2##3##(2008-12#1)(2013-1#1)
connective tissue disease##5##3##(1991-11#1)(1997-4#1)(2012-2#2)(2012-3#1)
connective tissue diseases]##2##3##(1993-2#1)(1995-5#1)
connective tissue##33##2##(1990-2#1)(1991-11#1)(1993-2#1)(1995-5#3)(1996-2#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-3#3)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#5)
connective tissues and##3##3##(1993-3#1)(2008-11#1)(2011-2#1)
connective tissues##6##2##(1990-2#2)(1993-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
connective##40##1##(1990-2#3)(1991-11#1)(1993-2#1)(1993-3#1)(1995-5#3)(1996-2#1)(1997-4#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-3#3)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#7)
connectivity and##2##2##(1992-6#1)(2012-12#1)
connectivity between the##2##3##(2008-11#1)(2013-1#1)
connectivity data##2##2##(1995-5#2)
connectivity in##2##2##(2008-1#1)(2012-2#1)
connectivity of##2##2##(2012-3#1)(2013-8#1)
connectivity##28##1##(1992-6#1)(1994-3#1)(1995-5#4)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
connector##6##1##(2008-10#2)(2008-11#1)(2010-9#3)
connectors##4##1##(2010-9#1)(2011-1#2)(2011-2#1)
connects a##2##2##(2008-10#1)(2009-5#1)
connects to the##2##3##(1996-9#1)(2008-9#1)
connects##12##1##(1996-1#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)
conotoxin present in##2##3##(2008-12#2)
cons of changing##2##3##(2008-11#2)
cons of##10##2##(1992-1#1)(1996-6#1)(2008-11#3)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
cons##14##1##(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
conscientious##6##1##(1991-3#1)(2008-11#1)(2011-2#4)
conscious state##2##2##(2008-7#2)
conscious##17##1##(1992-3#1)(1993-1#1)(1994-2#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-12#1)(2008-11#2)(2008-7#2)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#2)
consciously##2##1##(1997-3#1)(2010-12#1)
consciousness and##6##2##(1991-11#1)(1997-3#1)(2008-11#1)(2009-8#1)(2010-6#1)(2012-2#1)
consciousness is##4##2##(1995-8#1)(2008-11#3)
consciousness##30##1##(1990-9#1)(1991-11#1)(1992-6#2)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#8)(2008-7#1)(2009-11#1)(2009-8#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#3)
consecutive admissions##2##2##(1992-12#1)(2008-11#1)
consecutive aromatic residues in the##2##5##(2008-11#2)
consecutive aromatic##3##2##(2008-11#3)
consecutive cases of##2##3##(1996-3#1)(2008-10#1)
consecutive cases##4##2##(1993-2#1)(1996-3#1)(2008-10#1)(2012-3#1)
consecutive chest pain patients##2##4##(2008-3#2)
consecutive cohort##2##2##(1994-3#1)(2012-2#1)
consecutive days##8##2##(1991-2#1)(2008-10#3)(2008-11#1)(2011-2#2)(2012-2#1)
consecutive injections of##2##3##(1996-12#1)(2008-10#1)
consecutive layers##2##2##(1992-9#1)(2008-3#1)
consecutive measurements and##2##3##(2008-10#2)
consecutive measurements of##3##3##(2008-10#3)
consecutive measurements##6##2##(2008-10#6)
consecutive patients from##2##3##(2010-12#1)(2011-2#1)
consecutive patients presenting with##2##4##(1995-10#1)(2013-1#1)
consecutive patients who##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
consecutive patients with chronic##2##4##(2012-12#1)(2013-1#1)
consecutive patients with##14##3##(1990-6#2)(1991-2#1)(1991-8#1)(2008-9#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
consecutive patients##37##2##(1990-12#1)(1990-3#1)(1990-6#3)(1991-2#1)(1991-8#1)(1995-10#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#2)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)
consecutive reactions##2##2##(2008-10#2)
consecutive series of##8##3##(1990-12#1)(1990-8#1)(1991-8#1)(1997-8#1)(2008-9#1)(2010-11#1)(2012-5#1)(2013-1#1)
consecutive weeks##2##2##(2008-10#2)
consecutive years##8##2##(1991-8#1)(2008-10#4)(2008-5#2)(2013-1#1)
consecutive##172##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-6#3)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1995-10#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#39)(2008-11#7)(2008-12#2)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#6)(2009-3#2)(2009-5#2)(2010-1#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-7#1)(2012-12#3)(2012-2#6)(2012-3#6)(2012-5#2)(2013-1#9)(2013-8#1)
consecutively admitted##2##2##(1997-3#1)(2011-2#1)
consecutively##12##1##(1990-9#1)(1993-8#1)(1994-5#1)(1996-8#1)(1997-3#1)(2008-10#4)(2008-11#1)(2010-12#1)(2011-2#1)
consensual##2##1##(2008-11#1)(2011-2#1)
consensus (ERIC)##3##2##(2008-10#3)
consensus about the##2##3##(1997-1#1)(2009-6#1)
consensus among##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
consensus and##3##2##(1997-3#1)(2008-10#1)(2009-7#1)
consensus as to##2##3##(1993-1#1)(2008-10#1)
consensus binding##2##2##(1995-6#1)(1995-8#1)
consensus has been##2##3##(1995-2#1)(2012-12#1)
consensus has##3##2##(1995-2#1)(2012-12#1)(2013-8#1)
consensus in the##2##3##(2008-10#1)(2012-2#1)
consensus is now emerging on##2##5##(2008-8#2)
consensus is##4##2##(1996-6#1)(2008-8#2)(2011-2#1)
consensus of the##2##3##(2009-5#1)(2011-2#1)
consensus of##3##2##(2008-11#1)(2009-5#1)(2011-2#1)
consensus on the##3##3##(1994-2#1)(2008-11#1)(2012-12#1)
consensus on##13##2##(1994-2#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-9#1)(2012-12#1)(2013-1#3)(2013-8#1)
consensus primers##2##2##(2008-10#1)(2008-9#1)
consensus recommendations##2##2##(2008-3#1)(2008-9#1)
consensus regarding the optimal##2##4##(1994-12#1)(1995-5#1)
consensus regarding the##3##3##(1994-12#1)(1995-5#1)(2008-11#1)
consensus regarding##4##2##(1994-12#1)(1995-5#1)(2008-11#1)(2013-8#1)
consensus sequence for##2##3##(1993-6#1)(1997-8#1)
consensus sequence of##7##3##(1990-8#1)(1991-12#1)(1996-6#1)(2008-10#1)(2008-8#2)(2009-8#1)
consensus sequence##23##2##(1990-8#1)(1991-12#1)(1991-5#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)
consensus sequences##5##2##(1991-6#1)(1993-12#2)(1993-6#1)(1994-11#1)
consensus statement on##3##3##(1993-3#1)(2009-8#2)
consensus statement##7##2##(1993-3#1)(1995-5#1)(2008-6#2)(2009-8#2)(2013-1#1)
consensus statements##3##2##(2011-2#3)
consensus that##3##2##(1993-12#1)(1997-3#2)
consensus values##3##2##(2008-10#3)
consensus##152##1##(1990-8#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-12#8)(1993-2#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#24)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-2#1)(2010-9#1)(2011-2#7)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#14)(2013-8#3)
consent and##2##2##(1993-3#1)(2012-12#1)
consent for##2##2##(1994-12#1)(1997-6#1)
consent form##4##2##(2009-4#2)(2012-3#1)(2013-1#1)
consent of the##2##3##(2011-2#1)(2012-3#1)
consent of##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
consent regarding the##2##3##(1991-3#1)(1995-9#1)
consent to donation of##2##4##(1993-2#2)
consent to research##2##3##(1995-2#1)(2010-11#1)
consent to##13##2##(1992-1#1)(1993-2#2)(1994-1#1)(1995-2#1)(2008-1#1)(2008-11#2)(2009-6#2)(2010-11#2)(2012-3#1)
consent##59##1##(1991-3#2)(1992-1#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#4)(1995-2#6)(1995-9#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-6#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#7)(2009-6#2)(2009-9#1)(2010-11#5)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#1)
consent'##2##1##(2009-9#2)
consenting##2##1##(2010-7#1)(2013-1#1)
consequence is##2##2##(2010-10#1)(2013-8#1)
consequence of a##6##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
consequence of an##2##3##(2008-10#2)
consequence of the##14##3##(1990-11#1)(1990-2#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
consequence of this##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
consequence of which##2##3##(2008-11#1)(2013-1#1)
consequence of##75##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#2)(1993-8#1)(1994-3#1)(1994-5#2)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#7)(2013-8#1)
consequence that##2##2##(2011-2#1)(2013-1#1)
consequence##120##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#2)(1993-8#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#31)(2008-11#12)(2008-12#2)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#2)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#10)(2013-8#3)
consequences and##5##2##(1990-11#1)(1992-5#1)(1997-4#1)(2008-11#1)(2010-10#1)
consequences are##2##2##(2008-10#1)(2008-5#1)
consequences associated with##3##3##(2008-1#1)(2008-6#1)(2009-5#1)
consequences due to##2##3##(2010-7#1)(2011-2#1)
consequences for adult##2##3##(2008-4#1)(2012-2#1)
consequences for many##2##3##(2010-11#1)(2012-2#1)
consequences for the##8##3##(1992-2#1)(1994-11#1)(1997-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)
consequences for##28##2##(1992-2#1)(1993-2#1)(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#6)(2008-9#3)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
consequences in##5##2##(1991-2#2)(2008-3#1)(2010-8#1)(2011-2#1)
consequences of a##3##3##(1993-11#1)(2008-7#1)(2009-12#1)
consequences of asymmetric dispersal rates##2##5##(2008-8#2)
consequences of organized violence##2##4##(1990-6#2)
consequences of paediatric##2##3##(2008-11#1)(2008-9#1)
consequences of pain##2##3##(2008-11#2)
consequences of sexual abuse##2##4##(2010-10#2)
consequences of sexual##3##3##(2010-10#2)(2012-3#1)
consequences of the##8##3##(1990-11#1)(1990-12#1)(1993-3#2)(2008-10#1)(2008-11#2)(2010-10#1)
consequences of their##3##3##(2008-11#1)(2010-1#1)(2010-9#1)
consequences of these##3##3##(1994-2#1)(2008-5#1)(2012-2#1)
consequences of this behavior##2##4##(2008-11#1)(2013-1#1)
consequences of this##5##3##(2008-11#2)(2008-8#1)(2013-1#1)(2013-8#1)
consequences of##110##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1991-1#1)(1991-2#1)(1991-7#2)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#16)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#19)(2008-9#3)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
consequences on##4##2##(1995-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
consequences that cause##2##3##(2008-11#1)(2008-7#1)
consequences that##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
consequences to##3##2##(1992-12#1)(2012-2#1)(2013-8#1)
consequences##214##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-1#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2008-1#5)(2008-10#13)(2008-11#25)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#27)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#6)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#11)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#7)(2013-8#5)
consequent reduction in##2##3##(1995-12#1)(2008-10#1)
consequent##26##1##(1991-6#1)(1992-2#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#3)(2013-1#3)(2013-8#1)
consequential##3##1##(2009-8#1)(2011-2#1)(2013-1#1)
consequently a##2##2##(2008-3#1)(2008-5#1)
consequently the##6##2##(1997-7#1)(2008-10#3)(2008-5#1)(2009-7#1)
consequently##61##1##(1992-3#1)(1994-1#1)(1995-2#1)(1995-5#1)(1996-2#2)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-4#1)(2013-1#2)
conservation and management##4##3##(2008-8#2)(2012-3#1)(2013-1#1)
conservation and##8##2##(1994-11#1)(2008-8#3)(2008-9#2)(2012-3#1)(2013-1#1)
conservation between##5##2##(1991-12#1)(1993-12#1)(1993-6#1)(2008-11#1)(2012-3#1)
conservation in##5##2##(1990-2#1)(1993-8#1)(2008-11#1)(2008-7#1)(2010-7#1)
conservation is##2##2##(1994-12#1)(2008-9#1)
conservation management##2##2##(2008-8#1)(2013-1#1)
conservation of the##5##3##(1991-6#1)(1993-12#1)(1993-2#1)(2008-8#1)(2009-9#1)
conservation of this##2##3##(1993-12#1)(1993-6#1)
conservation of##25##2##(1991-6#2)(1991-7#1)(1992-6#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#3)(2009-9#1)(2010-11#1)(2013-1#2)(2013-8#1)
conservation state of##4##3##(2008-10#4)
conservation was##2##2##(1993-2#1)(1994-11#1)
conservation##88##1##(1990-2#2)(1991-12#1)(1991-6#3)(1991-7#1)(1992-1#1)(1992-2#3)(1992-6#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#7)(2009-9#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
conservative amino acid##3##3##(1993-6#1)(2008-9#2)
conservative and##2##2##(1997-6#1)(2012-2#1)
conservative care##2##2##(2009-12#1)(2013-1#1)
conservative estimate##2##2##(1991-12#1)(2008-10#1)
conservative group##2##2##(2013-1#2)
conservative management of##2##3##(1993-9#1)(2013-1#1)
conservative management##11##2##(1993-9#1)(2008-10#1)(2011-2#1)(2013-1#8)
conservative measures##2##2##(2009-11#1)(2012-12#1)
conservative revision&quot##2##2##(2009-4#2)
conservative stems##2##2##(2009-4#2)
conservative surgery##4##2##(1995-5#1)(2010-12#2)(2011-2#1)
conservative therapy##4##2##(1997-1#1)(1997-3#1)(2011-3#1)(2013-1#1)
conservative treatment for##2##3##(2010-3#1)(2013-1#1)
conservative treatment of##2##3##(1994-3#1)(2013-1#1)
conservative treatment with##3##3##(1991-3#1)(1997-6#1)(2013-1#1)
conservative treatment##23##2##(1990-9#1)(1991-3#2)(1993-11#1)(1993-2#1)(1994-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#6)
conservative treatments##2##2##(2011-2#1)(2013-1#1)
conservative##107##1##(1990-9#2)(1991-12#1)(1991-3#2)(1991-6#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#3)(1993-9#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#2)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#5)(2009-11#2)(2009-12#1)(2009-4#5)(2009-5#1)(2010-12#4)(2010-3#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#24)
conservatively treated##3##2##(1992-1#1)(2008-7#1)(2011-2#1)
conservatively with##3##2##(2010-5#1)(2013-1#1)(2013-8#1)
conservatively##23##1##(1991-12#1)(1992-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#4)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#5)(2013-8#1)
conservatrice##2##1##(2011-2#2)
conserve natural##2##2##(2010-4#1)(2010-7#1)
conserve##6##1##(1991-5#1)(1992-2#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)
conserved Arg##2##2##(2008-8#2)
conserved among the##3##3##(1996-8#1)(2008-10#1)(2008-5#1)
conserved among##12##2##(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1995-2#1)(1996-8#1)(2008-10#3)(2008-5#1)
conserved and##10##2##(1993-6#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
conserved between the two##2##4##(1991-6#1)(2012-3#1)
conserved between the##4##3##(1991-5#1)(1991-6#1)(2012-2#1)(2012-3#1)
conserved between##9##2##(1991-12#1)(1991-5#1)(1991-6#1)(1995-2#1)(2008-10#1)(2012-2#2)(2012-3#2)
conserved cysteine##3##2##(1991-9#1)(1992-10#1)(1994-11#1)
conserved domain##2##2##(1993-12#1)(1993-8#1)
conserved domains of##2##3##(1997-2#1)(2008-10#1)
conserved domains##3##2##(1997-2#1)(2008-10#2)
conserved during evolution##2##3##(1995-9#1)(1997-2#1)
conserved during##4##2##(1992-12#1)(1995-9#1)(1997-2#1)(2008-9#1)
conserved for##4##2##(1992-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
conserved gene##2##2##(2008-10#1)(2009-10#1)
conserved in all##3##3##(1993-9#1)(1994-5#1)(1995-2#1)
conserved in both##2##3##(1994-5#1)(1997-9#1)
conserved in many##2##3##(1996-12#1)(2008-8#1)
conserved in the porcine##2##4##(1995-8#1)(2012-2#1)
conserved in the##4##3##(1994-11#1)(1995-6#1)(1995-8#1)(2012-2#1)
conserved in##22##2##(1992-6#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-5#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-4#2)(2012-2#2)
conserved motif##4##2##(1995-2#1)(1995-6#1)(2008-10#1)(2008-8#1)
conserved motifs of the##2##4##(2008-10#2)
conserved motifs of##3##3##(2008-10#3)
conserved motifs##6##2##(2008-10#6)
conserved protein##4##2##(1997-1#1)(1997-7#1)(2008-8#1)(2009-8#1)
conserved proteins##4##2##(1994-6#1)(2008-11#1)(2008-9#1)(2013-8#1)
conserved region of##4##3##(1990-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
conserved region##12##2##(1990-11#1)(1992-6#1)(1994-11#3)(1994-5#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2013-1#1)
conserved regions are##2##3##(1995-6#1)(2008-9#1)
conserved regions of the##3##4##(1995-2#1)(2008-10#1)(2008-9#1)
conserved regions of##5##3##(1995-2#1)(1995-6#1)(2008-10#2)(2008-9#1)
conserved regions##12##2##(1991-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-6#2)(1997-7#1)(2008-10#2)(2008-9#2)
conserved regulatory##3##2##(1995-2#2)(2008-11#1)
conserved residues in the##2##4##(1992-3#1)(1997-8#1)
conserved residues##6##2##(1991-5#1)(1992-3#2)(1993-2#1)(1995-8#1)(1997-8#1)
conserved sequence##5##2##(1993-12#1)(1993-3#1)(1995-2#1)(1995-6#1)(2008-10#1)
conserved sequences##8##2##(1993-2#1)(1994-11#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#1)(2013-8#1)
conserved structural##2##2##(2013-1#2)
conserved through##2##2##(1990-5#1)(2008-10#1)
conserved throughout evolution##4##3##(1993-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
conserved throughout##5##2##(1993-12#1)(1997-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
conserved with##2##2##(1993-6#1)(2008-6#1)
conserved within##2##2##(1992-6#1)(2008-8#1)
conserved##250##1##(1990-11#1)(1990-5#1)(1991-12#2)(1991-5#3)(1991-6#4)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#4)(1992-9#1)(1993-12#13)(1993-2#5)(1993-3#2)(1993-6#5)(1993-8#4)(1993-9#3)(1994-11#10)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1995-2#13)(1995-6#13)(1995-8#4)(1995-9#1)(1996-12#4)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-7#6)(1997-8#2)(1997-9#6)(2007-11#1)(2008-10#43)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#6)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#7)(2012-3#4)(2013-1#6)(2013-8#4)
conserving the##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
conserving##11##1##(1994-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#3)(2012-2#2)
consider a##14##2##(1990-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-8#4)
consider as they develop##2##4##(1993-1#1)(2008-10#1)
consider before##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
consider both##2##2##(2008-10#1)(2008-8#1)
consider how the##2##3##(2008-10#1)(2008-8#1)
consider how##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
consider in detail##2##3##(2008-10#1)(2008-12#1)
consider in##7##2##(1993-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)
consider it##3##2##(1991-2#1)(2008-7#2)
consider pain##2##2##(1993-2#2)
consider possible##2##2##(2008-10#1)(2012-2#1)
consider relevant##2##2##(2008-9#1)(2011-1#1)
consider some of the##2##4##(2008-11#1)(2012-3#1)
consider some##4##2##(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
consider that a##2##3##(2008-5#1)(2008-7#1)
consider that for a##3##4##(2008-10#3)
consider that##15##2##(1994-12#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-11#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-8#1)
consider the role##2##3##(1992-3#1)(2013-8#1)
consider the support##2##3##(1992-3#1)(2010-5#1)
consider the##50##2##(1991-3#1)(1992-3#2)(1995-5#1)(1996-1#3)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#4)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#4)
consider their##4##2##(1994-5#1)(1996-1#1)(2008-11#1)(2011-1#1)
consider this##2##2##(2008-7#1)(2012-3#1)
consider two##2##2##(2012-2#1)(2013-8#1)
consider using##2##2##(1992-3#1)(1993-1#1)
consider whether##2##2##(2008-12#1)(2009-6#1)
consider##215##1##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#3)(1993-1#4)(1993-12#3)(1993-2#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1996-1#4)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#17)(2008-12#6)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#12)(2008-9#4)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#9)(2011-3#2)(2012-2#10)(2012-3#9)(2013-1#9)(2013-8#12)
considerable amounts##5##2##(2008-10#4)(2011-2#1)
considerable and##2##2##(1992-2#1)(2009-7#1)
considerable attention has been##2##4##(2008-10#1)(2009-3#1)
considerable attention##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
considerable body of##2##3##(2008-9#1)(2010-10#1)
considerable challenges##2##2##(2008-11#1)(2010-5#1)
considerable change##4##2##(1995-8#1)(2008-10#2)(2008-11#1)
considerable clinical##3##2##(1992-9#1)(2008-11#1)(2008-7#1)
considerable concern##2##2##(1995-1#1)(2008-11#1)
considerable decrease##2##2##(1993-3#1)(1994-8#1)
considerable differences between##2##3##(1990-9#1)(1997-8#1)
considerable differences##4##2##(1990-9#1)(1997-8#1)(2008-10#2)
considerable experimental##2##2##(2008-3#1)(2008-7#1)
considerable financial##2##2##(1997-5#1)(2008-11#1)
considerable genetic##2##2##(2008-10#2)
considerable heterogeneity##5##2##(1990-8#1)(1993-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
considerable homology##3##2##(1995-11#1)(1996-3#1)(2008-5#1)
considerable improvement of the##2##4##(1990-9#1)(2008-10#1)
considerable improvement##4##2##(1990-11#1)(1990-9#1)(2008-10#1)(2008-11#1)
considerable information##2##2##(2008-10#1)(2013-1#1)
considerable interest because of##2##4##(1993-1#1)(2008-3#1)
considerable interest in##2##3##(2008-10#1)(2008-5#1)
considerable interest##6##2##(1993-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-1#1)
considerable morbidity and##2##3##(2007-12#1)(2011-2#1)
considerable morbidity##3##2##(2007-12#1)(2011-2#1)(2012-3#1)
considerable opportunity##2##2##(2008-11#1)(2013-1#1)
considerable overlap##2##2##(1994-12#1)(1997-8#1)
considerable percentage##2##2##(2008-10#1)(2013-1#1)
considerable potential##3##2##(1994-1#1)(1996-2#1)(2008-12#1)
considerable power to##2##3##(2008-9#1)(2012-3#1)
considerable progress##2##2##(2008-11#1)(2008-9#1)
considerable promise for##2##3##(1991-2#1)(2008-10#1)
considerable promise##3##2##(1991-2#1)(2008-10#1)(2012-3#1)
considerable proportion of##2##3##(2008-10#1)(2008-9#1)
considerable reduction in##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
considerable reduction of the##3##4##(1991-2#1)(2008-10#1)(2008-11#1)
considerable reduction##7##2##(1991-2#1)(2008-10#3)(2008-11#2)(2008-3#1)
considerable research has##2##3##(1993-3#1)(1995-1#1)
considerable risk##2##2##(1991-3#1)(2012-2#1)
considerable success##3##2##(1993-3#1)(1996-6#1)(2013-1#1)
considerable time##2##2##(1990-3#1)(1994-3#1)
considerable variability in##3##3##(1997-5#1)(2008-10#1)(2008-9#1)
considerable variation in##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
considerable variation##8##2##(1995-11#1)(1996-3#1)(2008-10#3)(2011-2#1)(2013-1#2)
considerable variations##2##2##(2009-7#1)(2011-2#1)
considerable yield##2##2##(2008-10#2)
considerable##225##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#2)(1992-1#2)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-5#2)(1997-8#2)(2007-12#2)(2008-10#59)(2008-11#20)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#10)(2009-1#2)(2009-10#2)(2009-3#1)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#2)(2010-3#1)(2010-5#3)(2010-9#1)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#8)(2012-5#1)(2013-1#11)
considerably affected the##2##3##(2008-10#2)
considerably among the##2##3##(2008-10#2)
considerably among##3##2##(2008-10#2)(2008-7#1)
considerably and##2##2##(2008-10#1)(2008-9#1)
considerably different##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
considerably enlarged##2##2##(2008-5#1)(2008-7#1)
considerably from##2##2##(2008-10#1)(2008-7#1)
considerably higher in##2##3##(1992-8#1)(2013-1#1)
considerably higher levels##2##3##(2009-10#1)(2012-12#1)
considerably higher##11##2##(1992-8#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#1)(2012-12#1)(2013-1#1)
considerably improved the##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
considerably improved##4##2##(1997-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
considerably in##7##2##(1991-3#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-8#1)
considerably increased##2##2##(1994-11#1)(2008-5#1)
considerably less potent##2##3##(1992-6#1)(1994-11#1)
considerably less##9##2##(1991-12#1)(1992-6#1)(1994-11#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-10#1)(2011-2#1)
considerably lower##6##2##(1990-6#1)(1991-8#1)(1996-3#1)(2008-10#3)
considerably more##8##2##(1992-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2012-3#1)
considerably over the past##2##4##(1997-1#1)(2011-2#1)
considerably over the##3##3##(1997-1#1)(1997-8#1)(2011-2#1)
considerably slower##2##2##(2008-10#1)(2008-11#1)
considerably smaller##2##2##(2008-10#2)
considerably to##3##2##(1991-5#1)(1996-2#1)(2008-10#1)
considerably##128##1##(1990-12#1)(1990-6#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#4)(2008-10#33)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
consideration by the##3##3##(1994-12#1)(1995-12#1)(2008-11#1)
consideration for##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#2)(2011-2#1)
consideration in the design and##2##5##(1991-1#1)(2013-8#1)
consideration in the##5##3##(1991-1#1)(1991-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
consideration in##10##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(2008-10#2)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
consideration is##2##2##(1992-3#1)(1992-9#1)
consideration needs to be given to##2##6##(2008-5#1)(2011-1#1)
consideration of a##2##3##(1995-6#1)(1997-2#1)
consideration of clinical##2##3##(1992-9#1)(2013-1#1)
consideration of how##2##3##(1996-6#1)(2008-8#1)
consideration of other##2##3##(1993-2#1)(2011-2#1)
consideration of the##12##3##(1992-2#1)(1993-3#1)(1995-11#1)(2008-10#4)(2008-3#1)(2009-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
consideration of##46##2##(1991-2#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-6#3)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
consideration on##2##2##(1990-6#1)(2011-2#1)
consideration should be given to##2##5##(1997-2#1)(2011-1#1)
consideration when##5##2##(1993-2#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
consideration##108##1##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1992-2#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-1#1)(1997-2#2)(2008-10#17)(2008-11#5)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-6#5)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#2)
considerations about the##2##3##(2008-10#1)(2008-5#1)
considerations and##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2011-7#1)
considerations are##3##2##(1993-11#1)(1995-5#1)(2010-8#1)
considerations for the##3##3##(1992-3#1)(2008-1#1)(2008-6#1)
considerations for##15##2##(1992-3#2)(1993-1#1)(1994-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#2)
considerations in the##6##3##(1991-6#1)(1992-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(2010-6#1)
considerations in##20##2##(1991-6#1)(1992-2#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
considerations of##9##2##(1995-3#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-8#1)(2013-1#1)
considerations on##4##2##(1990-3#1)(1990-9#1)(1992-12#1)(2012-3#1)
considerations regarding the##2##3##(1995-5#1)(2008-10#1)
considerations such as##2##3##(2008-10#1)(2009-12#1)
considerations that##4##2##(2008-4#2)(2008-9#1)(2013-1#1)
considerations to##4##2##(1991-6#1)(1997-1#1)(2008-11#1)(2011-1#1)
considerations##127##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-6#3)(1992-12#3)(1992-2#1)(1992-3#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#3)(1997-1#2)(1997-2#2)(1997-4#1)(2008-1#2)(2008-10#19)(2008-11#9)(2008-12#4)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-3#4)(2013-1#8)
considerations]##3##1##(1990-9#1)(1991-6#1)(2012-3#1)
considered a major##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
considered a rare##2##3##(2008-1#1)(2008-10#1)
considered a suitable##2##3##(1993-1#1)(1995-5#1)
considered a valid##3##3##(1991-6#1)(2010-12#1)(2011-3#1)
considered a##66##2##(1991-6#1)(1992-12#1)(1993-1#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2009-10#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#1)
considered an important##2##3##(2008-10#1)(2008-8#1)
considered an##21##2##(1990-6#1)(1991-12#1)(1993-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
considered and discussed##4##3##(2008-10#3)(2010-1#1)
considered and##13##2##(2008-10#8)(2008-11#2)(2008-9#1)(2010-1#1)(2010-5#1)
considered appropriate##3##2##(2010-12#3)
considered are##4##2##(1992-1#1)(2008-10#2)(2008-11#1)
considered as &quot##2##3##(2011-2#1)(2013-8#1)
considered as a form of##2##5##(2008-9#1)(2011-1#1)
considered as a potential##2##4##(2009-11#1)(2011-2#1)
considered as a##31##3##(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)
considered as an alternative to##3##5##(2008-10#1)(2011-2#2)
considered as an alternative##4##4##(1991-1#1)(2008-10#1)(2011-2#2)
considered as an important##3##4##(2008-11#1)(2008-4#1)(2010-6#1)
considered as an##15##3##(1991-1#1)(1991-2#1)(1992-9#1)(1994-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
considered as factors##2##3##(2008-10#2)
considered as part of the##2##5##(1994-12#1)(1994-6#1)
considered as possible##2##3##(1992-9#1)(2008-11#1)
considered as the first step##2##5##(2008-10#1)(2012-2#1)
considered as the main##2##4##(2007-8#1)(2008-10#1)
considered as the##10##3##(2007-8#1)(2008-10#7)(2008-11#1)(2012-2#1)
considered as##107##2##(1990-8#1)(1991-1#1)(1991-2#2)(1991-6#1)(1992-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-6#1)(2007-12#3)(2007-8#2)(2008-10#36)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-8#1)
considered at the##2##3##(1996-1#1)(2012-6#1)
considered at##5##2##(1996-1#1)(2008-11#1)(2009-7#1)(2009-8#1)(2012-6#1)
considered by##11##2##(1993-11#2)(1993-12#1)(1994-1#1)(2008-10#1)(2008-3#1)(2008-7#3)(2011-2#1)(2013-1#1)
considered clinically##2##2##(2008-10#1)(2013-1#1)
considered essential##2##2##(1992-12#1)(2013-1#1)
considered for a##4##3##(1993-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
considered for comparison##2##3##(2008-10#2)
considered for##24##2##(1993-11#1)(1995-2#1)(2006-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#2)
considered if##4##2##(1996-6#1)(1997-3#1)(2009-12#1)(2011-2#1)
considered in all##2##3##(2008-10#1)(2012-12#1)
considered in order to##3##4##(1992-9#1)(2008-10#2)
considered in relation to##3##4##(2008-10#2)(2012-12#1)
considered in terms of##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
considered in the##23##3##(1992-3#1)(1993-3#1)(1996-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-8#2)
considered in this##2##3##(2008-10#1)(2011-2#1)
considered in##74##2##(1990-3#1)(1991-8#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-2#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#2)(2009-8#3)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#3)(2013-8#2)
considered it##2##2##(2008-10#1)(2009-10#1)
considered metal ions in##4##4##(2008-10#4)
considered more##2##2##(2009-4#1)(2009-6#1)
considered normal##3##2##(2008-7#1)(2010-1#1)(2012-2#1)
considered of##2##2##(2011-2#1)(2012-3#1)
considered one##2##2##(2008-10#1)(2008-9#1)
considered only##3##2##(2008-10#1)(2011-2#1)(2012-4#1)
considered regarding##2##2##(2008-8#1)(2011-2#1)
considered representative##2##2##(1990-11#1)(2011-2#1)
considered safe##4##2##(1991-12#1)(2010-12#2)(2013-1#1)
considered significant##5##2##(1995-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
considered suitable for making##2##4##(1992-2#1)(2008-10#1)
considered that the##7##3##(1995-12#1)(1996-3#1)(2008-10#2)(2008-6#1)(2011-2#1)(2013-1#1)
considered that##14##2##(1994-11#1)(1995-12#1)(1996-3#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-9#2)(2009-7#1)(2011-2#1)(2013-1#1)
considered the gold##2##3##(2010-1#1)(2011-2#1)
considered the most important##2##4##(2008-10#2)
considered the most##5##3##(1993-12#2)(2008-10#3)
considered the##22##2##(1991-2#1)(1992-2#1)(1993-12#2)(1997-1#1)(2008-10#9)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-12#2)(2011-2#1)
considered to arise##2##3##(2008-10#1)(2011-1#1)
considered to be a##15##4##(1990-11#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
considered to be caused by##2##5##(2008-11#1)(2011-2#1)
considered to be derived from##2##5##(1995-8#1)(2012-2#1)
considered to be due to##2##5##(2008-10#1)(2008-7#1)
considered to be important for##2##5##(1994-8#1)(2008-11#1)
considered to be related to##2##5##(2008-9#1)(2012-3#1)
considered to be the##6##4##(1994-6#1)(2008-4#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-7#1)
considered to be very##2##4##(1992-11#1)(2008-11#1)
considered to be##66##3##(1990-11#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(2008-10#8)(2008-11#11)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#9)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#6)
considered to belong to##2##4##(2008-10#2)
considered to form##2##3##(2008-10#1)(2012-2#1)
considered to have##5##3##(1993-2#1)(1995-11#1)(1996-9#1)(2008-5#1)(2010-3#1)
considered to play##3##3##(1996-12#1)(2008-11#1)(2011-2#1)
considered to represent##2##3##(2008-10#1)(2008-11#1)
considered to result from##2##4##(1994-11#1)(2008-10#1)
considered to##97##2##(1990-11#1)(1991-3#2)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(2008-10#15)(2008-11#15)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#11)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#6)
considered together##2##2##(2011-10#1)(2011-2#1)
considered useful##2##2##(1990-6#1)(1997-1#1)
considered were##3##2##(2008-10#2)(2011-2#1)
considered when##23##2##(1993-2#2)(1993-6#1)(1994-5#1)(1995-1#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
considered with##4##2##(1993-1#1)(2008-10#2)(2009-10#1)
considered##805##1##(1990-11#2)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#4)(1991-6#3)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#6)(1992-3#2)(1992-6#1)(1992-9#5)(1993-1#4)(1993-11#4)(1993-12#4)(1993-2#5)(1993-3#4)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#6)(1995-2#5)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#5)(2006-5#1)(2007-12#5)(2007-8#3)(2008-1#6)(2008-10#211)(2008-11#48)(2008-12#19)(2008-2#2)(2008-3#11)(2008-4#4)(2008-5#18)(2008-6#3)(2008-7#25)(2008-8#13)(2008-9#16)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#6)(2009-7#5)(2009-8#7)(2010-1#7)(2010-10#3)(2010-11#7)(2010-12#14)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#67)(2011-3#2)(2012-12#12)(2012-2#14)(2012-3#16)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#2)(2012-8#1)(2013-1#28)(2013-7#4)(2013-8#19)
considering a##2##2##(2008-10#1)(2008-11#1)
considering differences##2##2##(2008-10#1)(2010-8#1)
considering how the##2##3##(2008-10#1)(2008-3#1)
considering only##2##2##(1997-6#1)(2008-9#1)
considering some##2##2##(2008-10#1)(2008-8#1)
considering that the##2##3##(2008-10#1)(2011-2#1)
considering that##3##2##(2008-10#2)(2011-2#1)
considering the complexity of the##2##5##(2008-10#2)
considering the##31##2##(1991-1#1)(1992-8#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
considering their##2##2##(1997-9#1)(2008-8#1)
considering them##2##2##(1995-5#1)(2013-8#1)
considering##103##1##(1991-1#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#3)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#6)(2008-9#2)(2009-3#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
considers a##2##2##(1995-9#1)(2008-10#1)
considers some of the##2##4##(2008-11#2)
considers the##22##2##(1990-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1994-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-1#2)
considers whether##2##2##(2008-12#1)(2011-2#1)
considers##50##1##(1990-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-3#1)(2008-10#11)(2008-11#6)(2008-12#4)(2008-4#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
consist of a##12##3##(1992-3#1)(1993-12#1)(1993-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)
consist of multiple##2##3##(1994-9#1)(2012-3#1)
consist of several##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
consist of the##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
consist of two##6##3##(1991-10#1)(1992-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)
consist of##52##2##(1991-10#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-9#2)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)
consist##55##1##(1990-2#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-9#2)(1995-6#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)
consisted either of##2##3##(1990-3#1)(2008-10#1)
consisted in##2##2##(2008-10#1)(2008-7#1)
consisted mainly of##2##3##(2008-11#2)
consisted of 1##2##3##(2008-10#1)(2010-1#1)
consisted of 10##2##3##(2008-10#1)(2013-1#1)
consisted of 119##2##3##(1995-6#1)(2013-8#1)
consisted of 2##3##3##(1990-2#1)(2008-10#1)(2010-1#1)
consisted of 20 ascosporic isolates##2##5##(2008-10#2)
consisted of 20##3##3##(2008-10#2)(2012-3#1)
consisted of 30##2##3##(1995-1#1)(2007-8#1)
consisted of 34##2##3##(2011-2#2)
consisted of 35##2##3##(2011-2#1)(2012-12#1)
consisted of 4##2##3##(2008-8#1)(2013-8#1)
consisted of 50##2##3##(1991-2#1)(1995-11#1)
consisted of 53 patients##2##4##(1994-3#1)(2011-2#1)
consisted of 53##3##3##(1994-3#1)(2011-2#1)(2012-2#1)
consisted of 8##3##3##(2008-10#1)(2009-5#1)(2012-3#1)
consisted of a mixture of##2##5##(2008-10#2)
consisted of a##21##3##(1991-5#1)(1992-3#1)(2008-10#11)(2008-7#3)(2009-11#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
consisted of an##7##3##(1992-3#1)(1993-3#1)(2008-10#4)(2008-3#1)
consisted of early##2##3##(2008-12#1)(2008-5#1)
consisted of five##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
consisted of only one##2##4##(2008-10#2)
consisted of the##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
consisted of three##6##3##(1990-3#1)(1993-12#1)(1995-12#1)(2008-10#2)(2008-11#1)
consisted of two##6##3##(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)
consisted of various##2##3##(1993-9#1)(2008-12#1)
consisted of##171##2##(1990-2#2)(1990-3#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#3)(1997-5#1)(1997-7#1)(2007-8#1)(2008-10#51)(2008-11#7)(2008-12#8)(2008-3#3)(2008-5#7)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#4)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#3)
consisted##183##1##(1990-2#2)(1990-3#3)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#3)(1997-5#1)(1997-7#1)(2007-8#1)(2008-10#57)(2008-11#9)(2008-12#8)(2008-3#3)(2008-5#7)(2008-7#8)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#4)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#7)(2013-8#3)
consistency across##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
consistency and##5##2##(2008-10#2)(2008-11#2)(2010-7#1)
consistency as##3##2##(2008-10#1)(2013-1#2)
consistency coefficient##2##2##(2011-2#2)
consistency in##6##2##(1993-2#1)(2008-11#2)(2008-12#1)(2010-1#1)(2011-2#1)
consistency of the##6##3##(1992-9#1)(1995-5#1)(2008-10#2)(2008-11#1)(2009-11#1)
consistency of##14##2##(1992-9#1)(1994-2#1)(1995-5#1)(2008-10#5)(2008-11#3)(2008-9#1)(2009-11#1)(2011-2#1)
consistency with the##2##3##(2008-10#1)(2008-11#1)
consistency with##4##2##(1992-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
consistency##66##1##(1992-9#2)(1993-2#1)(1994-2#1)(1995-5#4)(1996-12#2)(2008-10#13)(2008-11#11)(2008-12#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2010-1#2)(2010-11#2)(2010-7#2)(2011-2#5)(2012-2#1)(2013-1#7)(2013-8#1)
consistent across##3##2##(2008-10#2)(2013-8#1)
consistent among##4##2##(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)
consistent and reliable##2##3##(2008-10#2)
consistent and##13##2##(1990-12#1)(1990-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2013-1#1)
consistent association##2##2##(1990-12#1)(2008-10#1)
consistent between##3##2##(2008-10#3)
consistent differences##3##2##(1991-5#1)(2009-11#1)(2009-4#1)
consistent effects##2##2##(2008-10#2)
consistent for##2##2##(1990-2#1)(2010-8#1)
consistent improvement##2##2##(2008-7#1)(2012-2#1)
consistent in##7##2##(1993-8#1)(2008-10#4)(2008-11#1)(2010-12#1)
consistent levels of##2##3##(2008-10#1)(2008-8#1)
consistent or##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
consistent pattern of##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
consistent pattern##6##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-6#1)(2012-2#1)
consistent protective effect##2##3##(1994-2#2)
consistent results##3##2##(2008-10#2)(2008-11#1)
consistent with Elsevier Policy on Article Withdrawal (http##3##8##(2008-10#1)(2008-11#2)
consistent with Elsevier Policy on Article Withdrawal##4##7##(2008-10#1)(2008-11#3)
consistent with a 1##2##4##(2008-10#2)
consistent with a model##2##4##(1995-2#1)(2008-10#1)
consistent with a role for##3##5##(1990-3#1)(1993-12#1)(1996-12#1)
consistent with a role##5##4##(1990-3#1)(1993-12#1)(1996-12#1)(2009-10#1)(2012-3#1)
consistent with a scenario of##2##5##(2008-10#2)
consistent with a##40##3##(1990-3#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
consistent with an##6##3##(1990-8#1)(1995-12#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
consistent with both##2##3##(2008-10#1)(2008-11#1)
consistent with current##4##3##(2008-10#1)(2008-3#2)(2008-4#1)
consistent with earlier##2##3##(2008-10#2)
consistent with experimental results##2##4##(2013-1#2)
consistent with experimental##4##3##(2008-12#1)(2010-10#1)(2013-1#2)
consistent with observed##2##3##(2008-5#1)(2008-9#1)
consistent with other##4##3##(1991-6#1)(1996-12#1)(1997-9#1)(2008-12#1)
consistent with our##4##3##(1992-3#1)(1996-2#1)(2008-10#1)(2008-3#1)
consistent with previous findings##2##4##(2008-7#1)(2011-2#1)
consistent with previous##9##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)
consistent with previously reported results##2##5##(2008-10#1)(2012-2#1)
consistent with previously reported##3##4##(2008-10#2)(2012-2#1)
consistent with random mating##3##4##(2008-10#3)
consistent with recent##3##3##(1990-5#1)(1995-11#1)(2008-9#1)
consistent with results##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
consistent with that of##3##4##(2008-10#3)
consistent with that##5##3##(1994-2#1)(2008-10#4)
consistent with the experimental##2##4##(1995-6#1)(1996-5#1)
consistent with the hypothesis of a##2##6##(2008-10#2)
consistent with the hypothesis of##5##5##(2008-10#4)(2013-8#1)
consistent with the hypothesis that the##6##6##(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)
consistent with the hypothesis that##18##5##(1993-12#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)
consistent with the hypothesis##23##4##(1993-12#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
consistent with the idea that the##2##6##(1990-10#1)(2009-10#1)
consistent with the idea that##3##5##(1990-10#1)(2008-10#1)(2009-10#1)
consistent with the idea##4##4##(1990-10#1)(2008-10#2)(2009-10#1)
consistent with the limited##2##4##(2008-8#1)(2009-8#1)
consistent with the observed##2##4##(2008-10#1)(2008-8#1)
consistent with the presence of##2##5##(1993-1#1)(2008-5#1)
consistent with the reference##2##4##(2008-10#2)
consistent with the reported##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
consistent with the results of Western blotting##2##7##(2008-9#2)
consistent with the##127##3##(1990-10#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#35)(2008-11#6)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#11)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
consistent with their##2##3##(1993-11#1)(2012-3#1)
consistent with theoretical##2##3##(2008-9#1)(2012-3#1)
consistent with these##3##3##(2008-10#2)(2012-3#1)
consistent with this hypothesis##2##4##(1990-5#1)(2008-10#1)
consistent with this##5##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-4#1)
consistent with those of##4##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
consistent with those##9##3##(1993-3#1)(1994-5#1)(2008-10#5)(2008-11#1)(2008-2#1)
consistent with variations in the##2##5##(2008-9#1)(2011-2#1)
consistent with##353##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#6)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#4)(1993-6#2)(1993-8#6)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#6)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#5)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#6)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#2)(2007-12#4)(2008-10#97)(2008-11#21)(2008-12#4)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#18)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#2)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#12)(2013-1#12)(2013-8#4)
consistent##504##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#7)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#5)(1993-6#2)(1993-8#7)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#6)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#7)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#2)(2007-12#4)(2008-1#1)(2008-10#146)(2008-11#33)(2008-12#6)(2008-2#4)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#7)(2008-7#11)(2008-8#21)(2008-9#16)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#16)(2012-12#1)(2012-2#7)(2012-3#15)(2013-1#18)(2013-8#6)
consistently and significantly##3##3##(1997-2#1)(2008-10#2)
consistently and##4##2##(1997-2#1)(2008-10#3)
consistently associated with##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
consistently associated##5##2##(1994-3#1)(2008-10#2)(2012-12#1)(2013-1#1)
consistently detected##6##2##(2008-10#4)(2008-9#1)(2012-3#1)
consistently different##2##2##(2008-10#2)
consistently during##2##2##(2008-7#2)
consistently good##2##2##(2008-10#1)(2008-12#1)
consistently has##2##2##(2008-11#1)(2008-12#1)
consistently higher than##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
consistently higher##6##2##(1996-5#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-3#1)
consistently identified##3##2##(2008-10#2)(2009-7#1)
consistently in##5##2##(2008-10#2)(2008-3#1)(2010-1#1)(2012-3#1)
consistently increased##2##2##(2008-10#2)
consistently isolated from##3##3##(2008-10#3)
consistently less than##2##3##(2008-10#1)(2012-2#1)
consistently look##2##2##(2010-10#2)
consistently more##2##2##(2008-10#1)(2008-12#1)
consistently observed##6##2##(1995-5#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
consistently predicted to##2##3##(1990-5#2)
consistently produced##3##2##(2008-10#2)(2012-12#1)
consistently reduced##3##2##(2008-10#2)(2008-11#1)
consistently reported##2##2##(2008-6#1)(2012-12#1)
consistently suppress##3##2##(2008-10#3)
consistently suppressed##2##2##(2008-10#2)
consistently with##2##2##(2008-10#2)
consistently##148##1##(1990-5#2)(1990-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#2)(1993-8#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#73)(2008-11#10)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#6)(2009-7#1)(2010-1#1)(2010-10#4)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#2)
consisting in##2##2##(2008-10#1)(2008-7#1)
consisting mainly of##3##3##(1992-12#1)(2008-5#1)(2008-7#1)
consisting of 10##4##3##(2008-10#3)(2008-8#1)
consisting of 14##2##3##(1991-5#1)(2008-10#1)
consisting of 243##2##3##(1990-11#1)(2008-10#1)
consisting of 340 amino acid residues##2##6##(1995-6#1)(1995-8#1)
consisting of a##23##3##(1990-2#1)(1993-2#1)(1993-6#1)(1994-11#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2009-3#1)(2011-2#1)(2013-1#2)
consisting of an##2##3##(2008-10#2)
consisting of either##2##3##(2008-10#1)(2008-9#1)
consisting of four##2##3##(1993-2#1)(2008-11#1)
consisting of multiple##2##3##(2009-9#1)(2012-2#1)
consisting of one##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
consisting of only##3##3##(2008-10#2)(2008-7#1)
consisting of six##2##3##(2008-11#1)(2008-3#1)
consisting of the##18##3##(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#9)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#1)
consisting of three##9##3##(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)
consisting of two##6##3##(1995-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#2)
consisting of##204##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1992-6#1)(1993-11#1)(1993-2#4)(1993-6#1)(1993-8#2)(1994-11#3)(1994-5#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#5)(2008-10#74)(2008-11#13)(2008-12#6)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#5)(2009-3#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#2)
consisting##214##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#4)(1993-6#1)(1993-8#2)(1994-11#3)(1994-5#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#5)(2008-10#77)(2008-11#14)(2008-12#6)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#5)(2009-11#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#2)
consists in the##4##3##(1991-11#1)(2008-10#3)
consists in##12##2##(1991-11#1)(1994-5#1)(2008-10#4)(2008-2#2)(2008-3#2)(2011-3#1)(2013-8#1)
consists of 15##2##3##(1995-8#1)(2011-2#1)
consists of 7##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
consists of a large##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
consists of a set of##2##5##(2008-11#1)(2008-6#1)
consists of a single##2##4##(2008-11#1)(2008-12#1)
consists of a##42##3##(1991-2#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-1#1)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
consists of about##2##3##(2007-12#1)(2013-8#1)
consists of an##9##3##(1992-9#1)(1994-5#1)(1996-8#1)(2008-10#4)(2008-11#1)(2010-6#1)
consists of monoterpene hydrocarbons##2##4##(2008-11#2)
consists of multiple##2##3##(2008-2#1)(2009-12#1)
consists of several##2##3##(2007-12#1)(2013-1#1)
consists of six##2##3##(2008-12#1)(2010-7#1)
consists of the##9##3##(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
consists of three major##2##4##(1997-8#1)(2008-10#1)
consists of three##7##3##(1991-2#1)(1995-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
consists of two##20##3##(1994-5#1)(1995-2#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#1)
consists of##213##2##(1990-5#1)(1990-9#2)(1991-2#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#48)(2008-11#18)(2008-12#8)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#3)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#5)
consists##229##1##(1990-5#1)(1990-9#2)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#3)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#54)(2008-11#19)(2008-12#8)(2008-2#6)(2008-3#13)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#3)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#6)
consolidate##3##1##(1997-3#1)(2008-10#1)(2008-11#1)
consolidated##5##1##(1995-6#1)(1996-12#1)(2007-12#1)(2009-3#1)(2013-1#1)
consolidation CCRT##2##2##(2008-10#2)
consolidation chemotherapy##2##2##(2008-10#2)
consolidation docetaxel##2##2##(2008-10#2)
consolidation of##3##2##(2008-11#1)(2009-10#1)(2009-7#1)
consolidation##21##1##(1994-8#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-2#3)(2013-8#1)
consommation de Tramadol##3##3##(2013-1#3)
consommation##5##1##(2013-1#5)
consortia##4##1##(1992-3#1)(2008-10#1)(2008-7#1)(2011-1#1)
consortium of##7##2##(1991-1#1)(1993-2#1)(1996-1#1)(1997-1#1)(2008-11#2)(2008-7#1)
consortium##15##1##(1991-1#1)(1993-12#2)(1993-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-7#1)(2010-5#2)(2010-8#1)(2012-12#1)
conspecific attraction##2##2##(2008-8#1)(2008-9#1)
conspecific brood parasitism##2##3##(2008-8#2)
conspecific brood##4##2##(2008-8#4)
conspecific females##2##2##(2008-8#1)(2008-9#1)
conspecific males##2##2##(2008-8#1)(2008-9#1)
conspecific sperm##3##2##(2008-8#3)
conspecific strains##2##2##(2008-10#1)(2008-5#1)
conspecific##27##1##(1994-8#1)(1995-12#1)(2008-10#4)(2008-5#1)(2008-8#14)(2008-9#3)(2009-6#1)(2009-8#1)(2010-8#1)
conspecifics##4##1##(1994-8#1)(1995-12#1)(2008-8#1)(2008-9#1)
conspicuous with##2##2##(2008-5#1)(2008-7#1)
conspicuous##18##1##(1990-9#1)(1997-4#2)(2008-10#7)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-8#1)
conspicuously##2##1##(2008-5#1)(2008-8#1)
conspurcata##3##1##(2008-12#3)
constant (K)##3##2##(2008-10#3)
constant K(m)##3##2##(2008-10#3)
constant RH##2##2##(2008-10#2)
constant across##2##2##(2008-10#1)(2008-7#1)
constant and the##2##3##(1993-3#1)(2008-10#1)
constant and##15##2##(1993-1#1)(1993-3#1)(1994-5#1)(2008-10#11)(2008-11#1)
constant at##11##2##(1993-3#1)(1993-8#1)(1996-2#1)(2008-10#6)(2008-6#1)(2008-7#1)
constant between the##2##3##(2008-10#2)
constant between##4##2##(1995-9#1)(2008-10#3)
constant cell##2##2##(2008-11#1)(2008-5#1)
constant comparative method##3##3##(2008-11#2)(2008-12#1)
constant concentration of##2##3##(2008-10#2)
constant concentration##3##2##(2008-10#3)
constant current coulometric titration method##2##5##(2008-10#2)
constant current stripping analysis##2##4##(2008-10#2)
constant current stripping##3##3##(2008-10#3)
constant current##12##2##(2008-10#11)(2010-1#1)
constant darkness##4##2##(1994-8#1)(1995-11#1)(2008-5#2)
constant depth film fermentor (CDFF)##2##5##(2008-9#2)
constant domain##3##2##(1993-6#2)(2008-10#1)
constant during the##4##3##(1992-12#1)(2008-10#2)(2008-11#1)
constant during##6##2##(1990-12#1)(1992-12#1)(2008-10#3)(2008-11#1)
constant flow##3##2##(2008-10#3)
constant for a##2##3##(1997-2#1)(2008-10#1)
constant for the reaction of##2##5##(1994-5#1)(2008-10#1)
constant for the reaction##3##4##(1994-5#1)(2008-10#2)
constant for the two##2##4##(2008-10#2)
constant for the##16##3##(1990-5#1)(1991-5#1)(1992-3#1)(1994-5#1)(1995-8#1)(1996-5#1)(2008-10#8)(2008-7#1)(2008-8#1)
constant for##32##2##(1990-5#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)
constant from the##2##3##(2008-11#1)(2013-1#1)
constant growth##2##2##(1997-6#1)(2011-2#1)
constant in##7##2##(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
constant incidence##2##2##(1994-9#1)(1995-12#1)
constant ionic medium##4##3##(2008-10#4)
constant ionic strength##4##3##(2008-10#4)
constant ionic##8##2##(2008-10#8)
constant is##5##2##(1993-8#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
constant light##3##2##(1995-11#1)(2008-10#1)(2008-5#1)
constant obtained##2##2##(2008-10#1)(2008-7#1)
constant of 0##2##3##(1995-6#1)(2008-10#1)
constant of 2##2##3##(2008-10#2)
constant of 4##2##3##(2008-10#2)
constant of a##3##3##(2008-10#3)
constant of the 1st antibody##2##5##(2008-10#2)
constant of the complex##4##4##(2008-10#3)(2008-11#1)
constant of the inclusion complex of##2##6##(2008-10#2)
constant of the##29##3##(1993-8#2)(1995-6#1)(1996-3#1)(2008-10#24)(2008-11#1)
constant of##82##2##(1990-5#1)(1990-8#1)(1993-8#4)(1995-3#1)(1995-6#3)(1996-3#1)(2008-10#65)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
constant on the##2##3##(1996-5#1)(2008-10#1)
constant on##3##2##(1996-5#1)(2008-10#2)
constant or##4##2##(2008-10#2)(2008-9#1)(2012-4#1)
constant osmotic pressure##2##3##(2008-11#2)
constant over the##3##3##(1994-6#1)(2007-12#1)(2008-6#1)
constant over##6##2##(1994-6#1)(2007-12#1)(2008-10#3)(2008-6#1)
constant potential##5##2##(2008-10#5)
constant rate##4##2##(2008-10#3)(2008-11#1)
constant ratio##5##2##(1992-9#1)(2008-10#3)(2009-8#1)
constant region##6##2##(1997-8#2)(1997-9#2)(2008-4#2)
constant stimuli method##2##3##(1990-11#2)
constant stimuli##6##2##(1990-11#6)
constant temperature in the##2##4##(2008-10#1)(2008-9#1)
constant temperature##7##2##(1997-2#1)(2008-10#5)(2008-9#1)
constant temperatures of##3##3##(2008-10#3)
constant temperatures##7##2##(2008-10#6)(2008-8#1)
constant the##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
constant through##2##2##(1997-7#1)(2008-10#1)
constant throughout the course of the##2##6##(1992-6#1)(2008-7#1)
constant to##4##2##(1991-5#1)(2008-10#2)(2013-1#1)
constant total##3##2##(2008-10#3)
constant value at##2##3##(1990-5#1)(2008-10#1)
constant value of##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
constant value##9##2##(1990-5#1)(2008-10#4)(2008-11#1)(2008-2#2)(2009-7#1)
constant values of##2##3##(2008-10#2)
constant values##9##2##(2008-10#9)
constant was calculated##2##3##(2008-10#2)
constant was determined to be##2##5##(2008-10#2)
constant was determined##4##3##(2008-10#4)
constant was##10##2##(1993-8#1)(2008-10#9)
constant were##5##2##(2008-10#4)(2008-8#1)
constant with##2##2##(2008-10#1)(2008-5#1)
constant##563##1##(1990-11#7)(1990-12#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#4)(1993-6#2)(1993-8#12)(1994-1#1)(1994-12#1)(1994-5#6)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-8#1)(1997-2#3)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#2)(2007-12#5)(2008-10#326)(2008-11#26)(2008-12#4)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#23)(2008-8#9)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#3)(2012-3#6)(2012-4#1)(2012-8#1)(2013-1#5)(2013-8#1)
constant(s) of##2##2##(2008-10#2)
constant)##5##1##(2007-12#1)(2008-10#3)(2008-7#1)
constant-current##3##1##(2008-10#2)(2008-3#1)
constant-energy synchronous##2##2##(2008-10#2)
constantly being##2##2##(2008-10#1)(2011-2#1)
constantly##26##1##(1991-2#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
constants (K(ex)##2##2##(2008-10#2)
constants (K(ex))##3##2##(2008-10#3)
constants (logK(ex))##2##2##(2008-10#2)
constants (pK(a)) of##2##3##(2008-10#2)
constants a##2##2##(2008-10#1)(2008-8#1)
constants and the##2##3##(1995-3#1)(2008-10#1)
constants and their##2##3##(2008-10#2)
constants and##22##2##(1995-3#1)(2008-10#19)(2008-3#1)(2011-2#1)
constants are evaluated##2##3##(1990-8#1)(2008-10#1)
constants are##10##2##(1990-8#1)(1992-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)
constants at##4##2##(2008-10#4)
constants by##5##2##(1995-8#1)(2008-10#4)
constants calculated##2##2##(1995-6#1)(2008-10#1)
constants determination of##2##3##(2008-10#2)
constants determination##4##2##(2008-10#4)
constants determined by##2##3##(2008-10#2)
constants for a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
constants for the##7##3##(1993-8#1)(2008-10#5)(2008-5#1)
constants for##35##2##(1993-8#1)(1993-9#1)(1994-8#1)(1995-6#1)(1996-5#1)(2008-10#24)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)
constants from##4##2##(2008-10#3)(2008-7#1)
constants has##2##2##(2008-10#2)
constants in##7##2##(1992-4#1)(2008-10#6)
constants is developed##2##3##(2008-10#2)
constants is##3##2##(2008-10#3)
constants obtained by this method##2##5##(1992-4#1)(2008-5#1)
constants obtained by##4##3##(1992-4#1)(2008-10#2)(2008-5#1)
constants obtained##8##2##(1992-4#1)(2008-10#6)(2008-5#1)
constants of 1##2##3##(2008-10#2)
constants of carbonate##2##3##(2008-10#2)
constants of complexes##6##3##(2008-10#6)
constants of five##2##3##(2008-10#2)
constants of some##5##3##(1993-1#1)(2008-10#4)
constants of the above##2##4##(2008-10#2)
constants of the complexes##4##4##(2008-10#4)
constants of the##42##3##(1993-8#1)(1994-8#1)(2008-10#37)(2008-2#1)(2008-8#1)(2008-9#1)
constants of these##3##3##(1992-9#1)(2008-10#2)
constants of##130##2##(1990-9#1)(1991-5#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#111)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)
constants than##2##2##(2008-10#2)
constants that##2##2##(2008-10#2)
constants used##2##2##(2008-3#2)
constants was##2##2##(2008-10#1)(2008-5#1)
constants were also##2##3##(2008-10#2)
constants were calculated##5##3##(2008-10#5)
constants were determined##4##3##(2008-10#3)(2008-9#1)
constants were found to be##5##5##(2008-10#5)
constants were found##6##3##(2008-10#6)
constants were obtained##3##3##(2008-10#3)
constants were##29##2##(1991-5#1)(1993-1#1)(2008-10#26)(2008-9#1)
constants with##2##2##(2008-10#2)
constants##429##1##(1990-8#2)(1990-9#2)(1991-3#1)(1991-5#6)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#7)(1992-9#1)(1993-1#3)(1993-8#3)(1993-9#1)(1994-5#4)(1994-8#4)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#343)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#6)(2008-7#4)(2008-8#5)(2008-9#3)(2009-8#1)(2011-1#1)(2011-2#1)
constellation of##6##2##(2008-10#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
constellations of fit##2##3##(2009-10#2)
constellations of##3##2##(2009-10#2)(2009-12#1)
constellations##5##1##(2009-10#4)(2009-12#1)
constipation in the adult##2##4##(1993-6#2)
constipation with##2##2##(2008-10#1)(2011-2#1)
constipation##11##1##(1990-11#1)(1991-8#1)(1992-3#1)(1993-6#2)(1994-3#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)
constituent of the##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
constituent of##9##2##(1990-8#1)(1992-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2012-2#1)
constituent proteins##2##2##(2008-5#1)(2009-7#1)
constituent##35##1##(1990-8#1)(1992-12#1)(1993-11#1)(1997-8#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
constituents and##4##2##(2008-10#2)(2008-5#1)(2011-3#1)
constituents are##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
constituents by##2##2##(2008-10#2)
constituents from the##2##3##(2008-10#1)(2013-8#1)
constituents from##6##2##(2008-10#2)(2008-3#1)(2011-2#1)(2013-8#2)
constituents in the##3##3##(2008-10#2)(2013-8#1)
constituents in##10##2##(2008-10#6)(2008-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
constituents of medicinal##2##3##(2008-11#1)(2012-2#1)
constituents of the##9##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
constituents of##24##2##(1997-2#1)(2008-10#7)(2008-11#3)(2008-12#2)(2009-8#2)(2010-10#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
constituents such as##2##3##(2008-10#1)(2010-11#1)
constituents that##2##2##(1995-9#1)(2008-10#1)
constituents was##2##2##(2008-10#2)
constituents were##5##2##(2008-10#3)(2008-11#2)
constituents##99##1##(1990-2#1)(1990-5#1)(1994-8#1)(1995-6#2)(1995-9#1)(1996-9#1)(1997-2#1)(2008-10#43)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
constitute a class of##2##4##(2008-10#1)(2012-3#1)
constitute a large##2##3##(2009-10#1)(2012-2#1)
constitute a major##2##3##(2008-10#1)(2008-11#1)
constitute a new##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
constitute a##38##2##(1990-5#2)(1990-8#1)(1991-5#1)(1992-12#1)(1994-9#1)(1996-2#1)(1997-1#2)(1997-7#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-6#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
constitute about##2##2##(1990-6#1)(2013-1#1)
constitute an important##2##3##(1992-8#1)(2011-2#1)
constitute an##6##2##(1992-8#1)(1995-2#1)(1996-1#1)(2008-4#1)(2011-2#1)(2013-8#1)
constitute good##2##2##(2008-2#1)(2010-10#1)
constitute one of the##2##4##(1990-11#1)(1994-2#1)
constitute one##3##2##(1990-11#1)(1994-2#1)(2011-2#1)
constitute the##23##2##(1991-6#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-8#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#3)(2012-2#2)(2013-8#1)
constitute##93##1##(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#2)(1997-1#2)(1997-7#1)(1997-8#2)(2008-10#21)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#4)(2009-4#1)(2010-10#1)(2011-2#5)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
constituted a##5##2##(1993-1#1)(1995-6#1)(2008-10#2)(2013-1#1)
constituted an##2##2##(2008-10#2)
constituted by a##2##3##(1993-11#1)(2008-10#1)
constituted by an##2##3##(2008-10#2)
constituted by##14##2##(1993-11#1)(2008-10#5)(2009-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
constituted of##2##2##(2008-5#1)(2008-9#1)
constituted the##5##2##(1993-1#1)(2008-10#1)(2009-7#1)(2010-1#1)(2011-1#1)
constituted##36##1##(1990-5#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-5#1)(2008-10#11)(2008-5#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
constitutes a good##3##3##(2008-11#1)(2010-10#1)(2012-2#1)
constitutes a significant##2##3##(2008-11#1)(2009-8#1)
constitutes a##23##2##(1991-2#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-8#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
constitutes an##8##2##(2008-10#1)(2008-8#1)(2010-12#3)(2011-2#1)(2012-3#1)(2013-1#1)
constitutes less than 1% of##2##5##(2008-5#1)(2013-7#1)
constitutes the first##4##3##(2008-10#3)(2013-8#1)
constitutes the highest##2##3##(2008-10#1)(2012-7#1)
constitutes the##17##2##(1990-11#1)(1991-11#1)(2007-12#1)(2008-10#7)(2008-8#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-7#1)(2013-8#2)
constitutes##66##1##(1990-11#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#2)(2007-12#1)(2008-10#13)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#4)(2011-2#3)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#4)
constituting a##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
constituting the##3##2##(1994-6#1)(2008-11#1)(2008-7#1)
constituting##9##1##(1994-6#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)
constitution of the##2##3##(2008-10#1)(2008-11#1)
constitution of##3##2##(2008-10#2)(2008-11#1)
constitution##5##1##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
constitutional descriptors##2##2##(2008-10#2)
constitutional symptoms##2##2##(2008-9#1)(2011-2#1)
constitutional##17##1##(1995-10#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(2008-10#2)(2008-9#1)(2011-1#2)(2011-2#2)(2012-12#2)
constitutions##2##1##(2008-11#1)(2008-12#1)
constitutive and inducible##3##3##(1992-12#1)(1994-8#1)(2008-11#1)
constitutive and##7##2##(1992-12#1)(1994-8#1)(1995-12#1)(1995-9#1)(2008-11#1)(2008-8#2)
constitutive blast secretion of##2##4##(2006-6#2)
constitutive cytokine secretion##2##3##(2006-6#2)
constitutive expression and##3##3##(1994-6#1)(1995-11#1)(2009-3#1)
constitutive expression of the##2##4##(1997-8#2)
constitutive expression of##4##3##(1995-11#1)(1997-8#2)(2008-10#1)
constitutive expression##8##2##(1994-6#1)(1995-11#2)(1997-8#2)(2008-10#1)(2008-7#1)(2009-3#1)
constitutive levels##2##2##(1990-5#1)(2008-10#1)
constitutive or##2##2##(2008-11#1)(2010-12#1)
constitutive promoter##2##2##(2008-10#2)
constitutive resistance##2##2##(2008-8#2)
constitutive secretory vesicles##2##3##(1992-12#2)
constitutive secretory##4##2##(1992-12#4)
constitutive##66##1##(1990-5#1)(1991-9#2)(1992-12#8)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-9#1)(1997-8#2)(2006-6#5)(2008-10#9)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#6)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2013-1#6)
constitutively activated##3##2##(1997-7#1)(2009-7#1)(2011-2#1)
constitutively express##3##2##(1993-12#1)(1993-6#1)(2008-11#1)
constitutively expressed##6##2##(1995-11#1)(1995-6#2)(1997-7#1)(2008-7#1)(2008-8#1)
constitutively phosphorylated##2##2##(1995-6#1)(2013-1#1)
constitutively##30##1##(1992-12#1)(1993-12#2)(1993-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-6#6)(1997-7#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-10#1)(2011-2#1)(2013-1#2)
constrain the evolution of##2##4##(2008-8#2)
constrain the##3##2##(2008-11#1)(2008-8#2)
constrain##8##1##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-3#1)
constrained DET##2##2##(2008-10#2)
constrained by a##2##3##(2008-10#1)(2008-8#1)
constrained by##8##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)
constrained compression##2##2##(2009-7#2)
constrained##28##1##(1992-4#1)(1996-3#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-7#3)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#1)
constraining##3##1##(2008-11#2)(2008-8#1)
constrains##3##1##(1995-2#1)(2008-9#1)(2009-6#1)
constraint in the##2##3##(2008-10#1)(2011-2#1)
constraint in##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
constraint on activity##3##3##(2008-10#1)(2008-8#2)
constraint on##8##2##(2008-10#3)(2008-3#1)(2008-8#3)(2013-1#1)
constraint to##2##2##(2008-10#1)(2012-2#1)
constraint##41##1##(1994-9#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-8#11)(2008-9#5)(2009-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#4)
constraint&quot##2##1##(2008-8#1)(2012-3#1)
constraints and##9##2##(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#1)
constraints are##2##2##(1992-2#1)(2008-8#1)
constraints can##2##2##(2008-7#1)(2008-8#1)
constraints in##2##2##(1994-5#1)(2008-8#1)
constraints of the##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
constraints of##7##2##(2008-10#3)(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
constraints on the##4##3##(1991-5#1)(1994-5#1)(1994-8#1)(2008-9#1)
constraints on##11##2##(1991-5#2)(1994-5#1)(1994-8#1)(2008-8#3)(2008-9#2)(2009-8#2)
constraints that##3##2##(1994-12#1)(2008-11#1)(2012-2#1)
constraints to##2##2##(2008-10#1)(2008-9#1)
constraints were##2##2##(1994-5#1)(2008-8#1)
constraints##110##1##(1990-8#1)(1991-5#4)(1992-2#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-5#8)(1994-8#1)(1996-2#2)(2008-10#10)(2008-11#12)(2008-12#5)(2008-3#1)(2008-4#1)(2008-7#8)(2008-8#23)(2008-9#8)(2009-10#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)
constricted##3##1##(1993-1#1)(2013-1#2)
constriction of##2##2##(1994-9#1)(2013-8#1)
constriction##8##1##(1994-9#1)(1995-12#2)(2008-10#2)(2013-1#1)(2013-8#2)
construct a recombinant##3##3##(1992-3#1)(2008-11#1)(2008-8#1)
construct a simple##2##3##(2008-10#1)(2008-8#1)
construct a##31##2##(1992-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-6#1)(2008-10#9)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2010-10#1)(2011-1#1)(2011-3#1)(2012-2#1)
construct an##6##2##(1997-2#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-5#1)
construct and##4##2##(1995-6#1)(2008-10#1)(2008-8#1)(2011-1#1)
construct containing##3##2##(1994-2#1)(1996-3#1)(2008-10#1)
construct for##2##2##(1994-1#1)(2008-10#1)
construct in##5##2##(2008-10#1)(2008-11#2)(2009-3#1)(2012-2#1)
construct into##2##2##(1995-2#1)(2008-10#1)
construct it##2##2##(2008-11#1)(2008-9#1)
construct of##4##2##(1991-12#1)(1993-3#1)(2009-10#1)(2013-1#1)
construct or##2##2##(1996-12#1)(2008-11#1)
construct that is##2##3##(2008-11#1)(2012-3#1)
construct that##4##2##(1993-2#1)(2008-11#1)(2009-7#1)(2012-3#1)
construct the##6##2##(2008-10#4)(2008-8#2)
construct validity of##2##3##(2007-12#1)(2009-12#1)
construct validity##4##2##(1996-2#1)(2007-12#1)(2009-12#1)(2010-7#1)
construct was##6##2##(1993-12#1)(2008-11#1)(2008-8#2)(2008-9#1)(2013-1#1)
construct with##2##2##(2012-2#2)
construct##157##1##(1991-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-8#2)(1997-9#1)(2007-12#1)(2008-10#36)(2008-11#18)(2008-12#3)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#13)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#6)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#1)
constructed a mathematical model##2##4##(2008-11#1)(2008-9#1)
constructed a new##3##3##(1996-2#1)(2008-11#1)(2008-8#1)
constructed a novel##2##3##(2008-11#1)(2008-3#1)
constructed a series of##3##4##(1991-6#1)(1997-2#1)(2008-11#1)
constructed a##31##2##(1991-6#2)(1993-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#7)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-1#1)(2012-3#2)
constructed an##3##2##(1992-9#1)(2008-10#1)(2008-3#1)
constructed and a##2##3##(2008-8#1)(2008-9#1)
constructed and analyzed##2##3##(1997-3#1)(2008-10#1)
constructed and evaluated##3##3##(2008-10#2)(2013-1#1)
constructed and tested##5##3##(2008-10#3)(2008-3#2)
constructed and the##2##3##(1992-3#1)(2008-10#1)
constructed and transferred into##2##4##(2008-8#1)(2008-9#1)
constructed and used to##2##4##(2008-10#1)(2008-8#1)
constructed and##40##2##(1991-7#1)(1992-3#1)(1995-6#1)(1997-3#1)(2008-10#15)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#8)(2008-9#4)(2010-1#1)(2011-2#1)(2013-1#1)
constructed as a##3##3##(2008-10#2)(2011-2#1)
constructed as##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
constructed at##4##2##(2008-10#3)(2008-11#1)
constructed based on##3##3##(1995-6#1)(2008-10#1)(2008-12#1)
constructed by means of##2##4##(2008-10#1)(2008-8#1)
constructed by using##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-3#1)
constructed by##41##2##(1993-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2010-4#1)(2011-3#2)(2012-2#1)
constructed for the##6##3##(2008-10#5)(2008-11#1)
constructed for##21##2##(1993-12#1)(1993-6#1)(1995-9#1)(1997-6#1)(2007-12#1)(2008-10#10)(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-12#1)
constructed from a##4##3##(2007-11#1)(2008-10#3)
constructed from six QbD elements plus a communication/training team##2##9##(2012-2#2)
constructed from the##5##3##(1995-2#1)(2008-10#2)(2010-8#1)(2012-2#1)
constructed from##28##2##(1991-6#1)(1992-9#1)(1995-2#1)(1997-6#1)(2007-11#1)(2008-10#12)(2008-3#2)(2008-9#2)(2010-8#2)(2011-2#1)(2012-2#3)(2013-1#1)
constructed in the##2##3##(1993-2#1)(2008-10#1)
constructed in##11##2##(1993-2#1)(1994-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
constructed of blends##2##3##(2009-7#2)
constructed of##7##2##(2008-10#2)(2009-11#2)(2009-7#2)(2011-2#1)
constructed on the basis of##2##5##(1994-5#1)(2008-10#1)
constructed on##3##2##(1994-5#1)(2008-10#2)
constructed physical map##2##3##(1997-6#1)(2008-10#1)
constructed that##2##2##(2009-5#1)(2011-2#1)
constructed the##2##2##(1995-6#1)(2008-9#1)
constructed three##2##2##(1992-5#1)(2008-9#1)
constructed to determine##2##3##(1991-1#1)(2008-9#1)
constructed to##16##2##(1991-1#1)(1993-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#3)
constructed using the##7##3##(1993-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)
constructed using##23##2##(1991-5#1)(1993-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
constructed was##2##2##(2008-10#2)
constructed were##2##2##(2008-10#1)(2008-11#1)
constructed wetland##3##2##(2013-1#3)
constructed which##2##2##(1997-6#1)(2011-1#1)
constructed with a##3##3##(1990-9#1)(2008-10#2)
constructed with the##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
constructed with##14##2##(1990-9#1)(1997-8#1)(2008-10#9)(2008-8#1)(2008-9#2)
constructed##355##1##(1990-9#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-5#1)(1991-6#4)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#3)(1994-5#2)(1995-12#1)(1995-2#2)(1995-6#6)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#5)(1996-3#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#6)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#1)(2008-10#117)(2008-11#30)(2008-12#4)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#36)(2008-9#28)(2009-10#2)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-1#4)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#10)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
constructing a##7##2##(1994-12#1)(2008-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
constructing an##2##2##(1994-12#1)(2008-10#1)
constructing recombinant##2##2##(1992-9#1)(1993-2#1)
constructing##30##1##(1992-9#1)(1993-2#1)(1994-12#2)(1996-3#1)(1997-6#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
construction and performance##3##3##(2008-10#3)
construction and use of##2##4##(1993-9#1)(1997-1#1)
construction and use##3##3##(1993-9#1)(1997-1#1)(2008-10#1)
construction and##23##2##(1990-8#1)(1993-9#2)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-4#1)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
construction as##2##2##(1992-12#1)(2008-10#1)
construction cost##3##2##(1991-2#1)(1992-2#2)
construction in##4##2##(2008-10#3)(2008-9#1)
construction industry##3##2##(1991-12#3)
construction of a variety of##2##5##(1993-2#1)(2013-8#1)
construction of a##29##3##(1990-8#1)(1991-5#2)(1993-2#1)(1995-5#1)(1996-8#1)(1997-8#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#1)(2008-9#2)(2010-5#1)(2012-3#1)(2013-8#1)
construction of an##2##3##(2008-11#1)(2013-8#1)
construction of deletion mutants##2##4##(1993-2#1)(1994-8#1)
construction of immuno-PCR gene probe##2##5##(2008-8#2)
construction of the##14##3##(1996-5#1)(1996-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-3#1)
construction of##83##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-6#1)(1993-2#4)(1994-8#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#2)(1997-8#1)(2008-10#31)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#5)(2008-9#3)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
construction or##2##2##(1991-12#1)(1994-3#1)
construction was##2##2##(1996-5#1)(2013-1#1)
construction workers who##2##3##(1995-12#2)
construction workers##3##2##(1995-12#2)(2009-10#1)
construction##164##1##(1990-5#1)(1990-8#2)(1991-12#9)(1991-2#4)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#3)(1993-2#4)(1993-9#2)(1994-3#2)(1994-8#1)(1995-12#4)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#54)(2008-11#15)(2008-12#1)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
constructions of##2##2##(2008-11#1)(2010-2#1)
constructions##5##1##(2008-11#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)
constructive##4##1##(2008-11#1)(2008-12#1)(2010-7#1)(2013-8#1)
constructivist##3##1##(2008-12#3)
constructs and##2##2##(2010-11#1)(2013-1#1)
constructs are##2##2##(2008-4#1)(2012-2#1)
constructs as##2##2##(2008-11#1)(2009-10#1)
constructs between##2##2##(1992-6#1)(1993-3#1)
constructs carrying##2##2##(1994-11#1)(2011-1#1)
constructs have##2##2##(1993-3#1)(1994-2#1)
constructs in##6##2##(1993-8#1)(1995-6#1)(2008-11#2)(2008-8#1)(2012-2#1)
constructs of the##2##3##(1992-1#1)(2008-10#1)
constructs of##6##2##(1992-1#1)(2008-10#3)(2008-11#2)
constructs should be##2##3##(1993-12#1)(2008-12#1)
constructs were##4##2##(1993-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
constructs with##2##2##(2010-7#1)(2013-1#1)
constructs##65##1##(1991-7#1)(1992-1#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-2#1)(1995-2#1)(1995-6#2)(1997-1#1)(2008-10#7)(2008-11#11)(2008-12#2)(2008-4#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#6)
consult for##2##2##(2008-5#1)(2009-1#1)
consult##6##1##(2008-11#1)(2008-5#1)(2009-1#1)(2009-4#1)(2010-11#1)(2013-1#1)
consultant to##2##2##(1990-3#1)(1992-12#1)
consultant##11##1##(1990-2#1)(1990-3#2)(1992-12#2)(1996-2#1)(1996-5#1)(2008-11#1)(2012-3#1)(2013-8#2)
consultants and##2##2##(1990-3#1)(2013-8#1)
consultants in paediatrics##2##3##(1990-3#2)
consultants##9##1##(1990-3#3)(1993-1#1)(1994-12#1)(2008-11#1)(2012-2#1)(2013-8#2)
consultation and##3##2##(1992-2#1)(2008-11#1)(2011-2#1)
consultation in##2##2##(2008-10#1)(2013-1#1)
consultation oceurring##2##2##(2013-8#2)
consultation on##2##2##(1993-5#1)(1994-1#1)
consultation services for##2##3##(1991-12#1)(1994-1#1)
consultation services##3##2##(1991-12#1)(1994-1#2)
consultation with##4##2##(1996-5#1)(2008-1#1)(2008-11#1)(2008-12#1)
consultation##44##1##(1991-12#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-5#2)(1994-1#3)(1994-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#5)(2008-10#2)(2008-11#7)(2008-12#1)(2009-1#1)(2009-6#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-8#4)
consultations in##4##2##(1990-12#1)(1993-3#1)(2011-2#1)(2013-8#1)
consultations with##2##2##(1991-2#1)(2008-8#1)
consultations##13##1##(1990-12#1)(1991-11#1)(1991-2#1)(1993-3#1)(1994-6#2)(1995-5#1)(1996-11#1)(2008-1#2)(2008-8#1)(2011-2#1)(2013-8#1)
consulted##7##1##(1990-6#1)(1995-1#1)(1996-6#2)(1997-4#1)(2010-7#1)(2011-2#1)
consulting##5##1##(1991-1#1)(1993-2#1)(1993-5#1)(1994-1#1)(1995-5#1)
consumable##2##1##(2008-10#1)(2008-11#1)
consume the##2##2##(1995-12#1)(2012-2#1)
consume them##2##2##(2008-10#1)(2008-8#1)
consume##10##1##(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
consumed a##2##2##(2008-7#1)(2010-8#1)
consumed an average of##2##4##(2008-9#2)
consumed by a factor of 6##2##6##(2008-10#2)
consumed by a factor of##3##5##(2008-10#3)
consumed by##10##2##(1990-3#1)(1992-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2012-2#1)(2013-8#1)
consumed during##2##2##(1995-6#1)(2008-10#1)
consumed in the##3##3##(2008-10#2)(2008-7#1)
consumed in##7##2##(2008-10#4)(2008-11#1)(2008-7#1)(2009-7#1)
consumed or##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
consumed oxygen##2##2##(2008-10#2)
consumed per determination##3##3##(2008-10#3)
consumed per##4##2##(1995-11#1)(2008-10#3)
consumed##62##1##(1990-3#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#5)(2008-9#5)(2009-7#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
consumer academic##2##2##(2008-11#2)
consumer and##4##2##(1991-3#1)(2008-11#1)(2008-9#1)(2013-8#1)
consumer awareness##2##2##(1993-1#1)(2013-1#1)
consumer behavior##2##2##(1993-12#2)
consumer choice##4##2##(1993-1#1)(1994-2#1)(1996-2#1)(1997-3#1)
consumer consumption##3##2##(2009-8#1)(2010-10#2)
consumer demand##3##2##(1994-3#2)(2010-7#1)
consumer engagement behaviors##2##3##(2013-1#2)
consumer engagement##7##2##(2013-1#7)
consumer health information##4##3##(1993-1#3)(1997-3#1)
consumer health##8##2##(1993-1#3)(1997-3#3)(2009-5#1)(2009-7#1)
consumer information##6##2##(1997-3#6)
consumer involvement in##3##3##(1994-1#1)(1995-2#2)
consumer medication information##2##3##(2011-1#2)
consumer participation##2##2##(1997-3#1)(2008-11#1)
consumer participation&quot##2##2##(1997-3#2)
consumer population##2##2##(1997-3#1)(2008-8#1)
consumer preferences##2##2##(2011-2#1)(2013-1#1)
consumer satisfaction ratings##2##3##(1997-3#2)
consumer satisfaction##6##2##(1994-12#1)(1996-2#3)(1997-3#2)
consumer species##5##2##(2008-8#3)(2008-9#2)
consumer survey##2##2##(1996-2#1)(1997-3#1)
consumer surveys##2##2##(1996-2#1)(1997-2#1)
consumer##116##1##(1991-3#2)(1992-1#1)(1993-1#5)(1993-12#2)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#3)(1995-2#3)(1996-12#1)(1996-2#8)(1997-2#1)(1997-3#26)(2007-12#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-5#9)(2008-8#11)(2008-9#5)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2013-1#9)(2013-8#1)
consumer's perspective##2##2##(1997-2#1)(2008-5#1)
consumer's##4##1##(1997-2#1)(2008-10#1)(2008-5#2)
consumer-independent processing##3##2##(2008-12#3)
consumer-oriented##2##1##(1991-2#1)(1994-12#1)
consumer-resource##3##1##(2008-8#1)(2008-9#2)
consumer/survivor involvement##2##2##(1997-3#2)
consumer/survivor participation##2##2##(1997-3#2)
consumer/survivor##4##1##(1997-3#4)
consumers and##6##2##(1994-2#1)(1995-1#1)(1996-2#1)(2008-11#1)(2008-8#1)(2010-7#1)
consumers are##2##2##(1997-3#1)(2008-8#1)
consumers as##2##2##(1995-1#1)(2013-1#1)
consumers in##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
consumers of##4##2##(1992-1#1)(2008-10#1)(2010-8#1)(2013-1#1)
consumers to##5##2##(1993-3#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-9#1)
consumers who are##2##3##(1993-3#1)(1995-1#1)
consumers who##5##2##(1993-3#1)(1995-1#2)(1997-3#1)(2008-8#1)
consumers with##3##2##(1991-12#1)(1997-3#1)(2008-5#1)
consumers##73##1##(1991-12#1)(1991-2#1)(1992-1#1)(1993-3#2)(1994-2#1)(1994-3#2)(1995-1#7)(1995-2#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#13)(2007-12#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#7)(2008-8#6)(2008-9#1)(2010-1#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#7)
consumers' valuation of GAP##2##4##(2013-1#2)
consumers' valuation of##3##3##(2013-1#3)
consumers'##6##1##(1997-3#1)(2011-1#2)(2013-1#3)
consumers/survivors##3##1##(1997-3#3)
consumes##5##1##(2008-10#4)(2008-8#1)
consuming a##2##2##(1997-6#1)(2008-3#1)
consuming and##4##2##(2008-10#3)(2011-2#1)
consuming##36##1##(1990-2#1)(1993-8#1)(1994-1#1)(1997-6#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-3#2)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)
consumption (p = 0##3##4##(2011-2#3)
consumption (p##4##2##(2009-5#1)(2011-2#3)
consumption affects##2##2##(1996-2#1)(2012-2#1)
consumption among##2##2##(1991-12#1)(1994-5#1)
consumption and allows##2##3##(2008-10#1)(2009-8#1)
consumption and lactate##4##3##(2008-11#3)(2008-7#1)
consumption and the##3##3##(2008-10#2)(2008-11#1)
consumption and waste##3##3##(2008-10#2)(2008-11#1)
consumption and##30##2##(1990-8#1)(1991-8#1)(2008-10#10)(2008-11#10)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#1)(2010-7#1)(2012-2#1)
consumption are##4##2##(2008-10#2)(2008-7#1)(2010-10#1)
consumption as##2##2##(2008-10#1)(2008-12#1)
consumption by##9##2##(1991-12#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#4)
consumption can##2##2##(2008-11#1)(2012-2#1)
consumption during the##2##3##(2008-10#1)(2008-7#1)
consumption during##4##2##(2008-10#2)(2008-7#1)(2010-6#1)
consumption have been##2##3##(2009-12#1)(2009-7#1)
consumption in a##3##3##(1993-3#1)(1997-1#1)(2008-7#1)
consumption in the##4##3##(1990-8#2)(1995-6#1)(1997-1#1)
consumption in##18##2##(1990-8#3)(1993-3#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-1#2)(2008-10#1)(2008-11#2)(2008-7#2)(2009-1#1)(2009-8#1)(2011-1#1)
consumption is usually##2##3##(1995-11#1)(2008-10#1)
consumption is##6##2##(1994-6#1)(1995-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
consumption of 0##2##3##(2008-10#2)
consumption of reagents##2##3##(2008-10#2)
consumption of sample and reagents##2##5##(2008-10#2)
consumption of sugar-sweetened beverages##2##4##(2011-2#2)
consumption of the probiotic##2##4##(2013-1#2)
consumption of the##3##3##(2008-10#1)(2013-1#2)
consumption of vegetables##2##3##(2008-10#1)(2011-2#1)
consumption of##52##2##(1990-8#2)(1991-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-2#2)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#2)(2010-8#3)(2011-2#8)(2012-12#1)(2012-2#2)(2013-1#4)
consumption on##5##2##(1992-9#1)(1996-2#1)(2012-2#2)(2013-1#1)
consumption rate of##2##3##(2008-7#1)(2013-1#1)
consumption rate##9##2##(2008-11#5)(2008-7#2)(2008-8#1)(2013-1#1)
consumption rates of##2##3##(2008-11#1)(2008-9#1)
consumption rates##7##2##(2008-11#2)(2008-7#4)(2008-9#1)
consumption to##2##2##(1994-2#1)(2013-1#1)
consumption was associated with##2##4##(2009-5#2)
consumption was reduced##2##3##(2008-10#2)
consumption was##12##2##(2008-1#1)(2008-10#7)(2008-11#2)(2009-5#2)
consumption with##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
consumption##273##1##(1990-8#9)(1990-9#1)(1991-12#3)(1991-3#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1995-1#1)(1995-11#3)(1995-2#2)(1995-6#1)(1996-2#4)(1996-3#1)(1996-6#1)(1997-1#4)(2007-12#1)(2008-1#3)(2008-10#75)(2008-11#44)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#20)(2008-8#5)(2008-9#5)(2009-1#1)(2009-12#1)(2009-5#3)(2009-7#4)(2009-8#2)(2010-10#2)(2010-11#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#14)(2012-12#1)(2012-2#12)(2013-1#10)(2013-8#7)
consumption)##2##1##(2008-11#1)(2013-8#1)
consumption]##3##1##(1990-9#1)(1997-2#2)
consumptions of##2##2##(1990-8#1)(2008-10#1)
consumptive##3##1##(2008-10#2)(2008-7#1)
contact activity##2##2##(2008-11#2)
contact allergens##3##2##(2008-5#3)
contact and##7##2##(1990-9#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
contact angle and##2##3##(1997-1#1)(2009-7#1)
contact angle of##2##3##(2008-11#1)(2012-2#1)
contact angle##9##2##(1997-1#1)(2008-11#1)(2008-7#2)(2009-7#4)(2012-2#1)
contact are##3##2##(1997-6#1)(1997-9#1)(2008-7#1)
contact area##6##2##(2013-1#6)
contact areas were determined##2##4##(2013-1#2)
contact areas##4##2##(2009-8#2)(2013-1#2)
contact between the##7##3##(1993-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
contact between##16##2##(1990-12#1)(1993-3#1)(1994-3#1)(1997-5#1)(2007-12#1)(2008-10#7)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
contact dermatitis due to##2##4##(2008-5#1)(2012-3#1)
contact dermatitis##8##2##(1997-2#1)(2008-5#5)(2012-3#2)
contact electrodes were##2##3##(2008-10#2)
contact electrodes##6##2##(2008-10#6)
contact forces##2##2##(2008-12#1)(2011-2#1)
contact from##2##2##(2008-10#1)(2011-2#1)
contact in##3##2##(1994-5#1)(1997-3#1)(2008-6#1)
contact influences##2##2##(2008-11#2)
contact inhibition##6##2##(1992-3#1)(1995-2#2)(2008-11#3)
contact investigations##2##2##(2008-10#1)(2010-5#1)
contact is##2##2##(2010-12#1)(2011-2#1)
contact lens##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2011-7#1)
contact lenses##5##2##(1993-11#3)(2011-2#2)
contact loading##3##2##(2011-2#3)
contact mode##2##2##(1995-2#1)(2008-10#1)
contact model##2##2##(2012-4#2)
contact on##2##2##(1992-3#1)(2008-10#1)
contact prostheses##3##2##(2009-1#3)
contact sensitization##2##2##(2008-10#2)
contact sensitizers##4##2##(2008-10#4)
contact shift pattern##2##3##(1994-5#2)
contact site##3##2##(1991-3#1)(1994-5#1)(2008-10#1)
contact sites##2##2##(1991-3#1)(2012-2#1)
contact surface##6##2##(2008-10#2)(2013-1#4)
contact the##3##2##(1991-9#1)(2008-7#1)(2010-6#1)
contact time of the##2##4##(2008-10#2)
contact time of##4##3##(2008-10#4)
contact time##12##2##(2008-10#9)(2009-7#1)(2011-1#1)(2011-2#1)
contact to##2##2##(1995-11#1)(1997-8#1)
contact was##3##2##(1995-2#2)(2012-3#1)
contact were##3##2##(1992-9#1)(2008-10#2)
contact with a##5##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)
contact with other##2##3##(1992-5#1)(2010-1#1)
contact with the antagonist##3##4##(2008-10#3)
contact with the basement membrane##2##5##(2009-10#2)
contact with the enzyme solution##2##5##(2008-10#2)
contact with the skin##2##4##(1992-3#1)(2008-10#1)
contact with the##31##3##(1991-11#1)(1992-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-8#1)(2009-10#3)(2009-5#1)
contact with water##2##3##(2008-10#2)
contact with##86##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-5#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-9#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#33)(2008-11#7)(2008-12#3)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#3)(2009-5#3)(2009-6#1)(2010-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
contact##314##1##(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#2)(1992-3#3)(1992-5#1)(1992-9#1)(1993-1#4)(1993-11#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#6)(1994-6#4)(1994-8#1)(1995-1#1)(1995-11#5)(1995-12#1)(1995-2#10)(1995-9#1)(1996-1#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#2)(2007-12#5)(2007-8#1)(2008-10#105)(2008-11#17)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#15)(2008-6#2)(2008-7#9)(2008-8#3)(2009-1#4)(2009-10#3)(2009-5#3)(2009-6#2)(2009-7#7)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#2)(2010-5#2)(2010-6#2)(2011-1#2)(2011-2#17)(2011-7#1)(2012-2#5)(2012-3#4)(2012-4#2)(2013-1#14)(2013-8#2)
contacted the##3##2##(1991-9#1)(1992-3#1)(2012-3#1)
contacted with##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
contacted##12##1##(1991-9#1)(1992-3#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
contacting with##2##2##(2008-10#1)(2008-8#1)
contacting##9##1##(1991-9#1)(1996-6#1)(2008-10#3)(2008-8#1)(2012-3#3)
contacts between the##4##3##(1994-3#1)(2008-6#2)(2008-7#1)
contacts between##6##2##(1992-12#1)(1992-9#1)(1994-3#1)(2008-6#2)(2008-7#1)
contacts from##2##2##(2011-1#1)(2013-8#1)
contacts in##2##2##(1994-6#1)(1995-1#1)
contacts is##3##2##(1992-9#1)(1996-11#1)(2008-10#1)
contacts of asbestos##2##3##(1991-12#2)
contacts of##3##2##(1991-12#2)(2012-2#1)
contacts to##2##2##(2010-7#1)(2012-2#1)
contacts with##2##2##(1994-6#1)(2013-8#1)
contacts##44##1##(1991-12#3)(1991-3#1)(1992-12#2)(1992-4#1)(1992-9#2)(1994-3#1)(1994-6#3)(1995-1#1)(1995-5#1)(1996-11#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#4)(2008-6#3)(2008-7#4)(2008-9#2)(2010-5#3)(2010-7#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
contacts)##2##1##(2008-10#1)(2008-9#1)
contagion##6##1##(2008-10#1)(2008-11#1)(2012-2#2)(2013-8#2)
contagious##2##1##(1990-6#1)(2011-2#1)
contain a number of##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
contain a specific##4##3##(1990-11#1)(1990-5#2)(1994-8#1)
contain a variety of##2##4##(1997-8#1)(2008-9#1)
contain a##38##2##(1990-11#2)(1990-5#4)(1991-6#1)(1992-12#1)(1993-12#2)(1993-6#2)(1993-9#1)(1994-8#1)(1995-12#2)(1995-6#2)(1996-12#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-8#1)(2011-1#2)(2011-2#2)
contain an##5##2##(1991-2#1)(1995-3#1)(2008-10#1)(2008-9#1)(2012-2#1)
contain at least three##2##4##(2008-10#1)(2008-9#1)
contain at least two##2##4##(1992-10#1)(2008-10#1)
contain at least##5##3##(1992-10#1)(2008-10#3)(2008-9#1)
contain different##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
contain either##2##2##(1995-5#1)(2008-5#1)
contain electron##2##2##(2008-7#2)
contain glycine##2##2##(1994-2#1)(1997-2#1)
contain high levels of##2##4##(2008-10#1)(2008-5#1)
contain high##5##2##(2008-10#1)(2008-5#2)(2010-11#1)(2012-2#1)
contain item-writing flaws##2##3##(2008-12#2)
contain many##2##2##(2008-2#1)(2008-7#1)
contain more than one##2##4##(2008-10#1)(2008-8#1)
contain more##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
contain multiple##2##2##(2008-3#1)(2008-8#1)
contain one or##2##3##(1996-12#1)(1996-5#1)
contain one##3##2##(1996-12#1)(1996-5#1)(2008-9#1)
contain only##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
contain organic##3##2##(2008-10#2)(2008-11#1)
contain secretory##2##2##(2007-12#1)(2008-7#1)
contain several##3##2##(1993-6#1)(1995-6#1)(2008-10#1)
contain short##2##2##(1997-7#1)(2008-10#1)
contain some##2##2##(1997-3#1)(2006-6#1)
contain the pathogen##2##3##(2008-10#2)
contain the##28##2##(1990-12#1)(1991-12#2)(1991-5#2)(1991-9#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-9#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
contain two##6##2##(1993-8#2)(1993-9#1)(1994-11#1)(2007-12#1)(2008-8#1)
contain various##2##2##(1997-3#1)(2008-10#1)
contain##282##1##(1990-11#2)(1990-12#1)(1990-5#8)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#2)(1992-6#1)(1993-12#3)(1993-2#1)(1993-6#8)(1993-8#5)(1993-9#3)(1994-11#3)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1996-1#2)(1996-12#6)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#2)(2006-6#1)(2007-12#8)(2008-1#1)(2008-10#59)(2008-11#16)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#9)(2008-8#9)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#5)
contained &gt##2##2##(1997-2#1)(2008-10#1)
contained 0##2##2##(1992-11#1)(1997-2#1)
contained 6##2##2##(2011-3#1)(2013-8#1)
contained a higher##2##3##(1997-2#1)(2009-10#1)
contained a mixture of##3##4##(1990-9#1)(1997-2#1)(2008-10#1)
contained a number of##2##4##(1996-3#1)(2008-10#1)
contained a sequence##2##3##(1997-8#1)(2008-10#1)
contained a single open reading frame##2##6##(1997-7#1)(2008-10#1)
contained a single##8##3##(1995-2#1)(1997-7#1)(2008-10#6)
contained a##50##2##(1990-9#1)(1991-5#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#26)(2008-8#2)(2009-10#1)(2009-8#1)(2010-5#1)(2013-8#1)
contained about##2##2##(1990-10#1)(1991-6#1)
contained all of the##2##4##(1990-7#1)(2008-10#1)
contained all##5##2##(1990-7#1)(1991-5#1)(1997-7#1)(1997-8#1)(2008-10#1)
contained an internal standard##2##4##(2008-10#2)
contained an open reading frame of##2##6##(1996-3#1)(1997-9#1)
contained an open reading frame##4##5##(1990-5#1)(1993-12#1)(1996-3#1)(1997-9#1)
contained an##12##2##(1990-5#1)(1991-5#1)(1993-11#1)(1993-12#2)(1995-2#1)(1996-3#1)(1997-9#1)(2008-10#4)
contained at least##3##3##(1993-1#1)(1996-12#2)
contained both##5##2##(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)
contained clusters of isolates of the same##2##7##(2008-10#2)
contained dense##2##2##(2008-10#2)
contained gamma-aminobutyric acid##2##3##(1997-3#2)
contained gene##2##2##(2008-10#1)(2009-10#1)
contained glycine##2##2##(1997-3#2)
contained high levels of##3##4##(2008-10#1)(2008-11#2)
contained high##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
contained higher##2##2##(2008-10#1)(2010-5#1)
contained in a##9##3##(1990-12#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-7#1)
contained in the##16##3##(1990-5#1)(1990-9#1)(1994-11#1)(1994-3#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-5#2)(2009-8#1)
contained in##47##2##(1990-12#1)(1990-5#2)(1990-9#1)(1991-2#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-8#1)(1997-2#2)(1997-8#1)(2008-10#21)(2008-11#1)(2008-3#2)(2008-5#4)(2008-7#2)(2009-8#1)
contained isolates from##3##3##(2008-10#3)
contained isolates of##2##3##(2008-10#2)
contained isolates##5##2##(2008-10#5)
contained less##3##2##(2008-10#3)
contained more than##2##3##(2008-10#1)(2008-8#1)
contained more##5##2##(1994-2#1)(2008-10#2)(2008-8#1)(2013-8#1)
contained no detectable##3##3##(1991-12#1)(2008-11#2)
contained no##7##2##(1991-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-2#1)(2011-1#1)
contained numerous##2##2##(2008-10#1)(2011-2#1)
contained oncogenic##2##2##(1994-1#2)
contained only##7##2##(1997-2#1)(2008-10#6)
contained plasmids##2##2##(2008-10#2)
contained predominantly##2##2##(1997-2#1)(2008-10#1)
contained race##2##2##(2008-10#2)
contained sequences of##2##3##(2008-10#2)
contained several##2##2##(1993-12#1)(1997-7#1)
contained some##2##2##(1992-10#1)(2008-8#1)
contained the same##3##3##(2008-10#2)(2008-5#1)
contained the##32##2##(1992-10#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-8#3)
contained three##4##2##(1997-8#1)(2008-10#2)(2008-5#1)
contained two##5##2##(1991-9#1)(2008-10#4)
contained various##2##2##(1996-6#1)(2008-10#1)
contained within a##4##3##(1995-2#1)(2009-10#1)(2010-11#1)(2012-2#1)
contained within the##5##3##(1993-12#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-11#1)
contained within##13##2##(1993-12#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-2#2)(1995-6#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-11#1)(2012-2#1)
contained##390##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#5)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#5)(1994-1#2)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#3)(1995-11#4)(1995-12#4)(1995-2#5)(1995-6#4)(1995-8#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#10)(1997-3#5)(1997-4#1)(1997-7#5)(1997-8#5)(1997-9#1)(2007-12#2)(2008-10#163)(2008-11#20)(2008-12#7)(2008-3#3)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#1)(2009-10#3)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#5)
container##6##1##(1993-6#1)(2008-10#3)(2008-3#1)(2011-2#1)
containers##19##1##(1990-3#1)(2008-10#13)(2008-11#2)(2009-7#1)(2011-2#2)
containing 0##63##2##(1990-12#1)(1991-12#1)(1992-6#1)(2008-10#48)(2008-12#2)(2008-5#2)(2008-9#6)(2011-2#1)(2013-1#1)
containing 1##14##2##(1991-12#1)(1996-12#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
containing 1%##4##2##(1997-1#1)(2008-10#2)(2008-8#1)
containing 10 mM##3##3##(1997-1#1)(2008-10#2)
containing 10##9##2##(1993-1#1)(1995-8#1)(1997-1#1)(2008-10#4)(2008-5#2)
containing 10%##7##2##(2008-11#5)(2008-5#1)(2013-1#1)
containing 100##4##2##(2008-10#3)(2008-5#1)
containing 10mM##2##2##(2008-10#2)
containing 2##12##2##(1991-7#1)(2008-10#10)(2009-3#1)
containing 2%##3##2##(2008-10#2)(2011-2#1)
containing 20##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
containing 20%##3##2##(2008-10#1)(2008-5#2)
containing 20mugl(-1) of Cu(II)##2##4##(2008-10#2)
containing 3##3##2##(1994-5#1)(2008-10#2)
containing 30##2##2##(1994-5#1)(2008-12#1)
containing 4##3##2##(2008-10#2)(2012-2#1)
containing 40% (v/v)##2##3##(2008-10#2)
containing 5 mM##4##3##(2008-10#2)(2008-11#2)
containing 5##9##2##(1994-11#1)(1994-5#1)(2008-10#5)(2008-11#2)
containing 5% DEET (w/w)##2##4##(2008-5#2)
containing 5%##4##2##(2008-10#1)(2008-5#3)
containing 50##2##2##(2008-10#2)
containing 6##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
containing 7##3##2##(2008-10#2)(2008-11#1)
containing 70%##2##2##(1993-12#1)(2008-10#1)
containing 8##7##2##(2008-10#3)(2011-2#4)
containing AA##2##2##(2008-10#1)(2008-5#1)
containing As##2##2##(2008-10#2)
containing B##2##2##(2008-10#2)
containing Cu(II)##2##2##(2008-10#2)
containing EDTA##2##2##(2008-10#2)
containing HNO(3)##2##2##(2008-10#2)
containing L(1)##2##2##(2008-10#2)
containing N-acetylglucosamine or sialic acid##2##5##(2008-11#2)
containing Ni(II)##2##2##(1993-8#1)(2008-10#1)
containing ODN##3##2##(2008-10#3)
containing a 0##2##3##(1997-3#1)(2008-11#1)
containing a CWP##2##3##(2008-10#2)
containing a functional##2##3##(2008-11#1)(2008-5#1)
containing a human##2##3##(2008-10#1)(2010-1#1)
containing a large number of##2##5##(1995-5#1)(2012-2#1)
containing a large##3##3##(1995-5#1)(2008-10#1)(2012-2#1)
containing a lipophilic##3##3##(2008-10#3)
containing a mixture of##2##4##(2008-10#2)
containing a single##4##3##(2008-10#4)
containing a##100##2##(1990-8#1)(1992-6#1)(1993-2#1)(1993-9#3)(1994-11#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#55)(2008-11#7)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
containing acetic acid-sodium acetate buffer (pH##3##6##(2008-10#3)
containing acetic##4##2##(2008-10#4)
containing acetonitrile##2##2##(2008-10#2)
containing air sample matrix##2##4##(2008-10#2)
containing all##4##2##(2008-10#4)
containing alpha-nitroso-beta-naphthol as##2##3##(2008-10#2)
containing ammonium##2##2##(2008-10#2)
containing an open reading frame##2##5##(1995-6#1)(2008-9#1)
containing an##16##2##(1995-2#1)(1995-6#2)(1995-8#1)(1996-5#2)(1997-4#1)(2008-10#8)(2008-9#1)
containing as##3##2##(2008-10#3)
containing at least##2##3##(2008-7#1)(2010-10#1)
containing between##3##2##(2008-10#2)(2008-9#1)
containing both the##2##3##(2008-10#1)(2008-11#1)
containing both##16##2##(1994-11#1)(1996-3#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-5#1)(2011-2#1)
containing cells##2##2##(2008-11#1)(2011-2#1)
containing chromogranin##2##2##(1990-5#1)(1992-12#1)
containing compounds##2##2##(2008-10#2)
containing corn##2##2##(2008-10#2)
containing covalently bound##2##3##(2008-10#2)
containing data on##2##3##(2008-11#1)(2011-2#1)
containing different concentrations of##4##4##(2008-10#4)
containing different##15##2##(1991-7#1)(1995-2#1)(2008-10#12)(2008-8#1)
containing either##12##2##(1996-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#4)(2010-8#1)
containing equimolar##2##2##(2008-10#1)(2008-5#1)
containing fetal calf serum (FCS)##2##5##(2008-11#1)(2008-7#1)
containing fetal calf serum##5##4##(1992-6#1)(2008-11#3)(2008-7#1)
containing five##2##2##(1991-7#1)(1995-8#1)
containing glucose##2##2##(2008-10#2)
containing high concentrations of##3##4##(2008-10#3)
containing high levels of##2##4##(2008-10#2)
containing high##9##2##(2008-10#8)(2009-8#1)
containing human##6##2##(1996-6#1)(2008-11#2)(2008-8#1)(2012-3#2)
containing hydrogen##2##2##(2008-10#2)
containing immobilized##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
containing ionophores##2##2##(2008-10#2)
containing lacZ gene in##2##4##(2008-11#2)
containing lacZ##3##2##(2008-11#2)(2008-8#1)
containing large##3##2##(2008-10#2)(2008-6#1)
containing less##2##2##(1991-6#1)(2008-10#1)
containing low##3##2##(2008-10#3)
containing medium##8##2##(2008-11#7)(2008-12#1)
containing moniliformin##2##2##(2008-5#2)
containing monovalent and divalent##2##4##(2008-10#1)(2011-2#1)
containing more than##5##3##(1991-12#1)(1993-11#1)(2007-12#2)(2008-10#1)
containing multiple copies of##2##4##(1995-5#1)(2008-10#1)
containing multiple##7##2##(1991-6#1)(1995-5#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
containing nitrate##2##2##(2008-10#1)(2008-11#1)
containing no##8##2##(1990-5#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)
containing numerous##5##2##(1991-12#1)(2011-2#1)(2013-8#3)
containing one or both##2##4##(1995-11#1)(2008-10#1)
containing one or##4##3##(1995-11#1)(1996-5#1)(2008-10#2)
containing one##7##2##(1995-11#1)(1996-5#1)(2008-10#4)(2008-11#1)
containing only##13##2##(1991-5#1)(1993-8#1)(2008-10#6)(2008-11#4)(2008-6#1)
containing organic##2##2##(2008-10#1)(2008-11#1)
containing other##4##2##(1994-5#1)(2008-10#3)
containing paracetamol##2##2##(2008-10#2)
containing particles##2##2##(1993-2#1)(2008-10#1)
containing peptide##2##2##(1990-8#1)(1992-12#1)
containing perfect##2##2##(2008-10#1)(2008-9#1)
containing peroxidase##2##2##(2008-10#1)(2008-5#1)
containing phosphate##2##2##(2008-10#2)
containing phosphorus##2##2##(1995-11#1)(2008-10#1)
containing potassium##2##2##(2008-10#2)
containing product##2##2##(2008-10#1)(2010-5#1)
containing proline##2##2##(1994-11#2)
containing protein##4##2##(1991-12#1)(2008-7#1)(2009-10#1)(2013-8#1)
containing proteins##2##2##(2008-11#1)(2011-2#1)
containing pyrrole##2##2##(2008-10#2)
containing reference##2##2##(2008-10#2)
containing relatively high concentrations of##2##5##(1996-1#1)(2012-12#1)
containing relatively high##3##3##(1996-1#1)(2008-10#1)(2012-12#1)
containing sample##2##2##(2008-10#2)
containing sequences##4##2##(1993-8#1)(1994-3#1)(2008-11#1)(2008-9#1)
containing serum##3##2##(2008-11#2)(2013-8#1)
containing several##4##2##(1995-2#1)(2008-10#2)(2008-7#1)
containing single##3##2##(1995-6#1)(2008-10#2)
containing site 8 O-acetylated sialomucins##2##5##(1990-2#2)
containing small##2##2##(1990-6#1)(2010-4#1)
containing sodium##3##2##(2008-10#3)
containing substances##2##2##(2008-7#1)(2009-9#1)
containing sulfur##2##2##(2008-10#1)(2008-11#1)
containing suspended##2##2##(2008-10#2)
containing ten##2##2##(2008-10#2)
containing tetra-butylammonium perchlorate##2##3##(2008-10#2)
containing the 5'-upstream region of##2##5##(1996-3#2)
containing the HIV-1##2##3##(2008-11#2)
containing the Kunitz-type protease inhibitor (KPI) insert##2##7##(1996-12#2)
containing the N##2##3##(2008-10#2)
containing the RGD sequence##2##4##(1994-11#2)
containing the TPR##2##3##(1996-2#1)(1997-7#1)
containing the analyte##2##3##(2008-10#2)
containing the anions##2##3##(2008-10#2)
containing the chicken##2##3##(1997-9#1)(2008-11#1)
containing the complete##2##3##(1993-2#1)(2012-3#1)
containing the consensus##2##3##(2008-8#1)(2009-6#1)
containing the entire##2##3##(1990-2#1)(1996-8#1)
containing the extract##2##3##(2008-5#2)
containing the growth##2##3##(1992-2#1)(1995-1#1)
containing the purine units##2##4##(2008-10#2)
containing the putative##2##3##(2008-10#1)(2008-9#1)
containing the synthetic##2##3##(2008-10#1)(2008-5#1)
containing the target##2##3##(2008-10#1)(2008-8#1)
containing the##164##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#5)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-8#3)(1997-2#2)(1997-3#3)(1997-7#3)(1997-8#3)(1997-9#2)(2007-12#2)(2008-10#55)(2008-11#15)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#5)(2009-6#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
containing these##8##2##(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-4#1)(2010-10#1)
containing this##2##2##(2008-10#1)(2008-11#1)
containing three##7##2##(1996-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
containing two##4##2##(1993-2#1)(1993-8#1)(1994-12#1)(2011-2#1)
containing up to##6##3##(2008-10#6)
containing uracil##2##2##(1992-3#2)
containing various organic and inorganic substances##2##6##(2008-10#1)(2008-11#1)
containing various##8##2##(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2012-7#1)
containing varying concentrations of##2##4##(2008-10#1)(2008-11#1)
containing varying##5##2##(2008-10#4)(2008-11#1)
containing yellow##2##2##(2008-8#1)(2012-12#1)
containing##1392##1##(1990-11#3)(1990-12#4)(1990-2#4)(1990-5#8)(1990-6#5)(1990-7#1)(1990-8#5)(1991-12#7)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1991-7#6)(1991-9#1)(1992-10#1)(1992-12#6)(1992-2#2)(1992-3#4)(1992-6#5)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#5)(1993-6#6)(1993-8#13)(1993-9#5)(1994-11#9)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#12)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#14)(1995-3#1)(1995-5#4)(1995-6#10)(1995-8#7)(1996-1#2)(1996-12#9)(1996-2#4)(1996-3#4)(1996-5#4)(1996-6#4)(1996-8#5)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#1)(1997-6#4)(1997-7#6)(1997-8#8)(1997-9#3)(2007-12#11)(2008-10#723)(2008-11#105)(2008-12#11)(2008-2#4)(2008-3#4)(2008-4#8)(2008-5#63)(2008-6#4)(2008-7#14)(2008-8#37)(2008-9#32)(2009-10#1)(2009-12#3)(2009-3#1)(2009-6#3)(2009-7#6)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#27)(2011-3#2)(2012-12#5)(2012-2#8)(2012-3#7)(2012-7#1)(2013-1#19)(2013-8#8)
containment measures##4##2##(2008-11#1)(2011-2#2)(2011-3#1)
containment on##3##2##(1991-3#1)(1992-1#1)(2008-9#1)
containment##39##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#3)(1993-5#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-9#6)(2011-2#2)(2011-3#1)(2013-1#2)
contains 1##2##2##(1994-5#1)(2007-12#1)
contains 12##3##2##(2008-10#2)(2010-4#1)
contains a 1##2##3##(1993-12#1)(2008-10#1)
contains a highly conserved##2##4##(1993-12#1)(2008-8#1)
contains a non-heme##2##3##(1991-12#2)
contains a number of##2##4##(2008-4#1)(2012-2#1)
contains a single##2##3##(1993-3#1)(2008-10#1)
contains a small##3##3##(1996-3#1)(2007-12#1)(2013-8#1)
contains a##58##2##(1990-11#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#3)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#2)(1995-2#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-3#2)(2008-4#2)(2008-8#5)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
contains about##2##2##(1995-8#1)(2008-10#1)
contains all##4##2##(1990-11#1)(1991-9#1)(1995-2#1)(1997-7#1)
contains an N-terminal##2##3##(1991-6#1)(1993-12#1)
contains an open reading frame (ORF)##2##6##(1994-12#1)(2008-10#1)
contains an open reading frame encoding##2##6##(1995-6#1)(2008-5#1)
contains an open reading frame of##3##6##(1993-2#2)(1995-6#1)
contains an open reading frame##7##5##(1993-2#2)(1994-12#1)(1995-6#2)(2008-10#1)(2008-5#1)
contains an##18##2##(1991-2#1)(1991-6#1)(1992-4#1)(1993-12#2)(1993-2#2)(1994-12#1)(1995-6#3)(1997-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
contains approximately##4##2##(1991-5#1)(2009-3#2)(2010-1#1)
contains at least one##2##4##(1990-11#1)(1994-11#1)
contains at least##6##3##(1990-11#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#1)
contains cysteines##2##2##(1990-5#1)(1993-2#1)
contains five##3##2##(1994-11#1)(1995-6#1)(2008-8#1)
contains four##8##2##(1990-12#1)(1993-2#1)(1994-11#2)(1995-6#1)(2008-10#2)(2008-5#1)
contains information about##3##3##(2007-12#1)(2008-3#2)
contains information##4##2##(2007-12#1)(2008-3#2)(2008-4#1)
contains lipids##2##2##(2008-5#1)(2013-1#1)
contains many##2##2##(2008-10#1)(2008-3#1)
contains more##2##2##(1991-12#1)(2008-5#1)
contains multiple##4##2##(2008-10#2)(2012-12#1)(2013-1#1)
contains new##2##2##(1991-12#1)(1991-2#1)
contains no##3##2##(1993-2#1)(1993-6#1)(1997-3#1)
contains one##7##2##(1993-8#1)(1995-6#1)(1997-2#1)(2008-8#2)(2008-9#2)
contains only##4##2##(1990-5#1)(2008-3#2)(2008-9#1)
contains other##2##2##(1996-9#1)(2008-11#1)
contains potential##2##2##(1992-10#1)(1994-11#1)
contains protocols##3##2##(2008-1#1)(2008-9#2)
contains sequences##2##2##(1993-12#1)(2010-7#1)
contains several##10##2##(1993-2#2)(1993-3#1)(1993-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
contains supplementary material##12##3##(2010-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
contains ten##2##2##(1993-3#1)(1996-3#1)
contains the first##2##3##(1991-5#1)(1993-12#1)
contains the high affinity binding region of GIP and is a potent inhibitor of##2##14##(1997-4#2)
contains the##43##2##(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1994-8#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-9#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-5#1)(2010-7#1)
contains three##8##2##(1992-4#1)(1995-6#1)(1996-6#1)(1997-8#1)(2008-11#1)(2008-3#2)(2008-8#1)
contains two##11##2##(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-8#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2012-2#1)
contains##343##1##(1990-11#4)(1990-12#1)(1990-5#2)(1991-12#6)(1991-2#2)(1991-3#2)(1991-5#6)(1991-6#2)(1991-9#3)(1992-10#3)(1992-12#3)(1992-3#2)(1992-4#3)(1992-6#1)(1993-1#3)(1993-11#1)(1993-12#11)(1993-2#11)(1993-3#6)(1993-6#7)(1993-8#3)(1993-9#1)(1994-11#9)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-6#9)(1995-8#5)(1995-9#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-6#4)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#4)(1997-4#2)(1997-7#3)(1997-8#1)(1997-9#1)(2007-12#7)(2008-1#2)(2008-10#49)(2008-11#17)(2008-2#1)(2008-3#13)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#19)(2008-9#11)(2009-10#1)(2009-3#3)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2011-2#12)(2012-12#1)(2012-2#10)(2012-3#5)(2013-1#3)(2013-8#5)
contaminant elements of##2##3##(2008-10#2)
contaminant elements##3##2##(2008-10#3)
contaminant of##3##2##(1991-3#1)(1993-12#1)(1997-3#1)
contaminant trichloroethylene##2##2##(2008-10#2)
contaminant##21##1##(1991-3#1)(1993-12#1)(1997-3#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)
contaminant-free##2##1##(2008-10#2)
contaminant-specific##3##1##(2008-10#3)
contaminants and##4##2##(1991-3#1)(2008-10#2)(2008-11#1)
contaminants from the##2##3##(2008-10#2)
contaminants from##5##2##(1994-3#1)(2008-10#4)
contaminants in foods##3##3##(1994-3#2)(2011-2#1)
contaminants in soil##2##3##(2008-10#1)(2008-11#1)
contaminants in the environment##2##4##(2008-10#2)
contaminants in the##4##3##(1994-3#1)(2008-10#3)
contaminants in water##2##3##(2008-10#2)
contaminants in##20##2##(1994-3#3)(2008-10#10)(2008-11#4)(2008-5#1)(2011-2#2)
contaminants of the##2##3##(2008-10#1)(2008-11#1)
contaminants of##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
contaminants##57##1##(1991-3#2)(1994-3#7)(2008-10#28)(2008-11#14)(2008-5#2)(2008-9#1)(2011-2#3)
contaminate food and##2##3##(2008-10#1)(2010-7#1)
contaminate the grain with mycotoxins##2##5##(2008-10#2)
contaminate the##3##2##(2008-10#2)(2008-4#1)
contaminate##7##1##(2008-10#3)(2008-11#2)(2008-4#1)(2010-7#1)
contaminated and##2##2##(1990-3#1)(1994-3#1)
contaminated by the##3##3##(2008-10#1)(2008-11#2)
contaminated by##6##2##(2008-10#2)(2008-11#3)(2008-3#1)
contaminated clotting products##2##3##(1996-5#2)
contaminated environments##3##2##(2008-10#1)(2011-1#2)
contaminated samples##2##2##(2008-10#2)
contaminated site##3##2##(2008-10#2)(2008-11#1)
contaminated soil samples##2##3##(2008-10#2)
contaminated soil##10##2##(2008-10#8)(2008-11#2)
contaminated soils from##2##3##(2008-10#2)
contaminated soils##8##2##(2008-10#7)(2008-12#1)
contaminated water##4##2##(2008-10#3)(2008-3#1)
contaminated with##17##2##(1991-12#2)(1997-5#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
contaminated##100##1##(1990-10#1)(1990-3#1)(1991-12#2)(1994-3#1)(1996-5#2)(1997-5#1)(2007-12#1)(2008-10#55)(2008-11#20)(2008-12#4)(2008-3#4)(2008-9#1)(2010-3#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
contaminating organisms##2##2##(2008-10#1)(2008-5#1)
contaminating##11##1##(1993-8#1)(1995-6#1)(1997-3#2)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#2)
contamination and##8##2##(1994-3#1)(2007-12#1)(2008-10#5)(2012-2#1)
contamination are##3##2##(1994-3#1)(2008-10#2)
contamination as well##2##3##(2008-10#2)
contamination at##2##2##(1991-12#1)(1997-5#1)
contamination by##10##2##(2008-10#7)(2008-11#3)
contamination during##3##2##(2008-10#3)
contamination for##3##2##(2008-10#3)
contamination from the##2##3##(1991-12#1)(1997-5#1)
contamination from##4##2##(1991-12#1)(1997-5#1)(2008-11#1)(2008-3#1)
contamination has##2##2##(2008-10#1)(2008-3#1)
contamination in soil##2##3##(2008-10#2)
contamination in the##6##3##(2008-10#4)(2011-2#1)(2013-8#1)
contamination in##19##2##(1994-11#1)(2008-10#10)(2008-11#3)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
contamination is less than##2##4##(2008-10#1)(2008-3#1)
contamination is##3##2##(2008-10#2)(2008-3#1)
contamination levels##4##2##(2008-10#1)(2008-11#3)
contamination occurred##2##2##(2008-10#2)
contamination of a##2##3##(2008-11#1)(2012-2#1)
contamination of cell cultures##2##4##(2008-11#2)
contamination of soil with##2##4##(2008-10#2)
contamination of soil##4##3##(2008-10#4)
contamination of the##10##3##(1991-12#1)(1995-6#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
contamination of##42##2##(1991-11#1)(1991-12#1)(1991-3#1)(1994-3#1)(1995-6#1)(1997-5#1)(2007-12#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-5#3)(2008-7#2)(2011-2#2)(2012-2#1)
contamination on the##2##3##(1991-5#1)(2008-10#1)
contamination on##6##2##(1991-5#1)(2008-10#3)(2008-3#1)(2009-6#1)
contamination or##7##2##(1990-2#1)(1994-3#1)(2008-10#2)(2008-11#1)(2010-7#1)(2011-2#1)
contamination resulted in##2##3##(2008-10#2)
contamination risk##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
contamination should##2##2##(2008-10#2)
contamination sources##2##2##(2008-10#2)
contamination was##3##2##(1995-6#1)(2008-10#1)(2008-12#1)
contamination with##2##2##(2010-7#1)(2011-2#1)
contamination##212##1##(1990-11#1)(1990-2#2)(1991-11#1)(1991-12#5)(1991-3#2)(1991-5#2)(1994-11#1)(1994-3#4)(1995-6#2)(1996-9#1)(1997-5#4)(2007-12#2)(2008-10#106)(2008-11#30)(2008-12#5)(2008-3#5)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#2)(2010-7#2)(2011-10#1)(2011-2#6)(2012-2#11)(2012-3#1)(2013-1#3)(2013-8#1)
contamination)##2##1##(2008-10#1)(2011-2#1)
contaminations as well as##2##4##(2008-11#2)
contaminations as##3##2##(2008-11#3)
contaminations in a##2##3##(2008-11#2)
contaminations in animal cell##2##4##(2008-11#2)
contaminations in##7##2##(2008-10#2)(2008-11#5)
contaminations of##2##2##(2008-11#2)
contaminations##18##1##(2008-10#3)(2008-11#15)
contemplated##3##1##(2010-6#1)(2011-2#1)(2012-12#1)
contemplating##3##1##(1991-1#1)(2008-11#1)(2013-1#1)
contemplation##6##1##(2008-11#1)(2008-4#4)(2010-2#1)
contemporaneous##2##1##(1991-2#1)(2011-3#1)
contemporarily##3##1##(1992-12#1)(2008-10#1)(2008-3#1)
contemporary healthcare##4##2##(2008-7#1)(2009-8#2)(2010-10#1)
contemporary isolates##3##2##(2008-10#2)(2008-7#1)
contemporary literature##4##2##(2008-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
contemporary theories of##2##3##(2008-5#1)(2009-10#1)
contemporary##56##1##(1990-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#9)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#3)(2010-1#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#2)(2013-8#1)
contend##2##1##(2008-1#1)(2010-12#1)
contended that##3##2##(1995-6#1)(2008-11#2)
contends that the##2##3##(1995-12#1)(1996-5#1)
contends that##5##2##(1993-12#1)(1995-12#1)(1996-5#2)(2008-11#1)
content (0##3##2##(2008-10#3)
content (fructose plus glucose concentrations) in the concentration range from##2##10##(2008-10#2)
content analysis of##4##3##(1994-1#1)(2008-10#1)(2008-9#1)(2009-10#1)
content analysis was##2##3##(2008-11#1)(2008-12#1)
content analysis##28##2##(1994-1#1)(1996-1#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-5#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#4)(2010-8#1)
content and a##2##3##(1994-8#1)(2008-10#1)
content and disease##2##3##(2008-10#2)
content and pH##2##3##(2008-10#1)(2010-3#1)
content and quality##2##3##(1993-1#1)(2008-10#1)
content and salary##2##3##(1991-3#1)(1995-1#1)
content and structure##2##3##(1996-3#1)(2009-12#1)
content and the##7##3##(1993-1#1)(1994-11#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
content and##94##2##(1991-3#1)(1992-9#1)(1993-1#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-3#2)(2008-10#22)(2008-11#8)(2008-12#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#11)(2009-12#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-7#2)(2013-8#2)
content areas##3##2##(1993-3#2)(1996-2#1)
content as a##2##3##(1994-12#1)(2008-10#1)
content as well as##2##4##(1995-5#1)(2009-11#1)
content as##4##2##(1994-12#1)(1995-5#1)(2008-10#1)(2009-11#1)
content but##2##2##(1995-11#1)(2008-5#1)
content by##10##2##(1992-3#1)(2008-10#7)(2008-11#1)(2008-6#1)
content can be##2##3##(2008-10#2)
content could##2##2##(1990-10#1)(2008-10#1)
content decreased##5##2##(2010-4#2)(2011-2#2)(2013-1#1)
content decreases##2##2##(1991-9#1)(2008-11#1)
content determination##4##2##(2008-10#4)
content determined##3##2##(2008-10#3)
content during##3##2##(1994-6#1)(2008-4#1)(2012-2#1)
content for##3##2##(2008-10#2)(2012-2#1)
content from##2##2##(2008-10#2)
content has##2##2##(1994-12#1)(2008-10#1)
content higher than##2##3##(2008-10#1)(2010-4#1)
content in 704##2##3##(2008-12#2)
content in a##4##3##(1994-3#1)(2008-10#3)
content in commercially available##2##4##(2008-10#2)
content in different##3##3##(2008-10#2)(2012-2#1)
content in food##3##3##(2008-10#3)
content in natural water by graphite furnace atomic absorption spectrometry after collection as##2##13##(2008-10#2)
content in natural waters##2##4##(2008-10#2)
content in natural##4##3##(2008-10#4)
content in periwinkles infected with##2##5##(2008-10#2)
content in real##2##3##(2008-10#2)
content in sample##2##3##(2008-10#1)(2008-12#1)
content in some##2##3##(2008-10#2)
content in the brain##2##4##(2008-6#2)
content in the leaves##2##4##(2008-12#1)(2011-10#1)
content in the umbilical cord##2##5##(2009-8#2)
content in the##28##3##(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#3)(2009-8#2)(2011-10#1)(2011-2#1)(2013-1#1)
content in##130##2##(1990-2#1)(1991-12#2)(1991-6#1)(1993-1#1)(1993-12#2)(1994-3#2)(1994-8#1)(1995-8#1)(1996-12#3)(1997-2#1)(2008-10#73)(2008-11#4)(2008-12#8)(2008-5#5)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#7)(2011-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#5)
content increased##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
content is a##2##3##(1995-9#1)(2008-9#1)
content is low##2##3##(2008-10#1)(2008-5#1)
content is##16##2##(1995-9#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-9#3)(2013-8#1)
content of 0##2##3##(2008-10#1)(2008-11#1)
content of NaCl##2##3##(2008-10#2)
content of a number of##2##5##(2008-10#2)
content of a##8##3##(1995-9#1)(2008-10#5)(2010-12#1)(2011-2#1)
content of both the##2##4##(2008-6#1)(2013-1#1)
content of both##5##3##(1994-2#1)(1995-5#1)(1995-6#1)(2008-6#1)(2013-1#1)
content of each##2##3##(1995-5#1)(2008-10#1)
content of free##3##3##(2008-5#1)(2013-7#2)
content of lead in##2##4##(2008-10#2)
content of lead##3##3##(2008-10#3)
content of leaves##2##3##(2008-10#2)
content of malondialdehyde##2##3##(2008-12#1)(2009-8#1)
content of primary##2##3##(1997-3#1)(2008-5#1)
content of protected##2##3##(2008-10#2)
content of raw##2##3##(2010-4#2)
content of serum phospholipids##2##4##(2008-3#2)
content of some##3##3##(2008-10#3)
content of the fume is determined by##2##7##(2008-10#2)
content of the fume##3##4##(2008-10#3)
content of the isolated##2##4##(1996-12#1)(2008-10#1)
content of the##47##3##(1990-8#1)(1991-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#24)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-3#1)(2013-8#1)
content of these##2##3##(2008-10#1)(2013-8#1)
content of vanadium in the##2##5##(2008-10#2)
content of vanadium in##3##4##(2008-10#3)
content of water##2##3##(2008-10#2)
content of wheat##2##3##(2008-10#2)
content of wine##2##3##(2008-10#2)
content of##257##2##(1990-5#2)(1990-8#1)(1991-12#3)(1991-2#1)(1991-6#2)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#3)(1994-6#2)(1994-8#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(2008-10#120)(2008-11#14)(2008-12#10)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#3)(2012-8#3)(2012-9#1)(2013-1#10)(2013-7#2)(2013-8#2)
content on##4##2##(1995-11#1)(1997-2#1)(2008-10#1)(2010-5#1)
content than##3##2##(2008-10#1)(2008-3#1)(2012-6#1)
content to a##2##3##(1990-8#1)(2010-2#1)
content to##5##2##(1990-2#1)(1990-8#1)(1993-3#1)(2008-9#1)(2010-2#1)
content uniformity##2##2##(2008-10#2)
content using##2##2##(2008-10#1)(2008-9#1)
content validity##2##2##(2010-11#1)(2010-9#1)
content was calculated##2##3##(2008-10#2)
content was determined by adsorptive polarography##3##6##(2008-10#3)
content was determined by##6##4##(2008-10#5)(2012-2#1)
content was established##2##3##(2008-10#2)
content was observed##3##3##(2008-10#2)(2008-11#1)
content was##30##2##(1990-6#1)(1993-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
content were found##2##3##(2008-10#1)(2008-7#1)
content were##11##2##(1996-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)
content which was##2##3##(1992-8#1)(1996-12#1)
content with##3##2##(1991-12#1)(2008-10#1)(2009-12#1)
content##927##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-11#2)(1991-12#7)(1991-2#1)(1991-3#2)(1991-6#4)(1991-9#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#5)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#8)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#8)(1994-5#3)(1994-6#5)(1994-8#9)(1995-1#1)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#10)(1996-2#5)(1996-3#3)(1996-5#1)(1997-1#3)(1997-2#6)(1997-3#7)(1997-5#1)(1997-6#1)(2008-10#409)(2008-11#56)(2008-12#37)(2008-3#5)(2008-4#3)(2008-5#32)(2008-6#8)(2008-7#8)(2008-8#8)(2008-9#33)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#3)(2009-8#15)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#11)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-10#2)(2011-2#20)(2011-3#3)(2012-12#4)(2012-2#15)(2012-3#4)(2012-6#1)(2012-7#5)(2012-8#6)(2012-9#2)(2013-1#26)(2013-7#4)(2013-8#11)
content) and##2##2##(1995-11#1)(2012-6#1)
content)##10##1##(1995-11#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-8#1)(2010-4#1)(2012-6#1)
content-free##2##1##(2008-11#2)
contention that the##3##3##(1995-12#1)(1996-12#1)(1996-5#1)
contention that##7##2##(1995-12#1)(1996-12#1)(1996-5#2)(2008-9#1)(2009-7#1)(2011-2#1)
contention##8##1##(1995-12#1)(1996-12#1)(1996-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
contentious##7##1##(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)
contents and##12##2##(1991-11#1)(1992-12#1)(2008-10#5)(2008-8#3)(2008-9#1)(2012-3#1)
contents are##3##2##(1994-12#1)(2008-12#2)
contents decreased##2##2##(2008-12#1)(2008-9#1)
contents in geological##3##3##(2013-8#3)
contents in human##3##3##(1990-2#1)(2008-10#2)
contents in pharmaceutical formulations##2##4##(2008-10#2)
contents in pharmaceutical##3##3##(2008-10#3)
contents in the##5##3##(2008-10#4)(2009-8#1)
contents in##34##2##(1990-2#2)(1991-12#1)(2008-10#24)(2008-11#1)(2009-8#1)(2013-8#5)
contents into##2##2##(1994-12#1)(2009-4#1)
contents of CK##2##3##(2011-3#2)
contents of such##2##3##(2008-10#2)
contents of the skin##2##4##(2008-10#1)(2008-5#1)
contents of the##16##3##(1992-12#2)(1995-5#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
contents of these##2##3##(2008-10#2)
contents of three##2##3##(2008-10#2)
contents of##58##2##(1990-2#1)(1990-3#1)(1992-12#3)(1994-5#1)(1995-5#1)(1996-12#1)(2008-10#41)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2011-3#2)(2013-8#1)
contents ranged from##2##3##(2008-10#2)
contents were determined##2##3##(2008-10#2)
contents were estimated by##2##4##(2008-10#2)
contents were found##2##3##(2008-10#1)(2012-3#1)
contents were##13##2##(1993-3#1)(1993-8#1)(2008-10#10)(2012-3#1)
contents##181##1##(1990-2#3)(1990-3#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#8)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-3#1)(2008-10#106)(2008-11#10)(2008-12#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#3)(2009-8#1)(2011-3#3)(2012-2#2)(2012-3#4)(2013-8#7)
contest##4##1##(2008-8#1)(2009-10#1)(2012-3#2)
contested##3##1##(1996-5#1)(2008-7#1)(2010-10#1)
context and the##2##3##(2008-11#1)(2008-12#1)
context and##8##2##(1996-3#1)(2008-11#1)(2008-12#2)(2009-9#1)(2010-10#1)(2010-7#1)(2013-1#1)
context are##2##2##(2008-10#1)(2008-9#1)
context as##3##2##(1996-3#1)(2008-10#2)
context for##7##2##(1993-2#1)(2008-11#2)(2008-8#2)(2010-11#1)(2013-1#1)
context in the##2##3##(1997-7#1)(2008-11#1)
context in which##3##3##(1992-1#1)(2009-6#1)(2012-3#1)
context in##7##2##(1992-1#1)(1997-7#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-3#1)
context is##7##2##(1993-1#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
context of a single##2##4##(1991-11#1)(2008-11#1)
context of a##12##3##(1991-11#1)(1996-2#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-2#1)(2012-2#1)
context of health##3##3##(1994-2#1)(2008-7#1)(2009-6#1)
context of increasing##2##3##(2008-12#1)(2008-7#1)
context of protein##2##3##(2008-10#1)(2011-2#1)
context of the suicidal##2##4##(2010-6#2)
context of the##29##3##(1991-3#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-6#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
context of their##3##3##(1993-1#1)(2010-10#1)(2012-2#1)
context of these##2##3##(2008-3#1)(2012-2#1)
context of this##2##3##(2008-10#1)(2008-12#1)
context of##152##2##(1991-1#1)(1991-11#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#3)(1994-5#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#13)(2008-11#18)(2008-12#5)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#2)(2012-2#9)(2012-3#4)(2012-8#1)(2013-1#1)(2013-8#6)
context that##2##2##(2008-12#1)(2012-3#1)
context to##3##2##(1995-1#1)(2008-12#1)(2010-8#1)
context was##2##2##(2008-10#1)(2013-1#1)
context when##2##2##(2010-10#1)(2012-3#1)
context##296##1##(1990-11#1)(1991-1#1)(1991-11#3)(1991-3#2)(1991-6#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#5)(1994-5#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-2#2)(1996-3#5)(1997-1#3)(1997-3#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#27)(2008-11#31)(2008-12#13)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#13)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#2)(2009-6#6)(2009-7#4)(2009-8#9)(2009-9#2)(2010-1#4)(2010-10#7)(2010-11#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#1)(2011-2#14)(2011-7#1)(2012-12#3)(2012-2#13)(2012-3#10)(2012-7#1)(2012-8#1)(2013-1#10)(2013-7#1)(2013-8#8)
context-dependent##4##1##(2008-8#1)(2009-6#1)(2012-2#1)(2012-3#1)
context-sensitive##4##1##(2008-11#1)(2009-12#3)
contexts in the##2##3##(2008-12#1)(2012-3#1)
contexts in which##2##3##(2013-1#2)
contexts in##4##2##(2008-12#1)(2012-3#1)(2013-1#2)
contexts of##7##2##(2008-10#1)(2008-11#1)(2008-12#2)(2009-7#1)(2010-12#1)(2011-2#1)
contexts such as##2##3##(2008-10#1)(2012-2#1)
contexts##51##1##(1991-1#1)(1992-12#1)(1993-1#1)(1994-1#1)(2008-10#4)(2008-11#5)(2008-12#6)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#5)(2010-1#2)(2010-12#2)(2010-7#2)(2010-9#5)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
contextual factors##6##2##(2008-11#1)(2009-7#1)(2012-2#4)
contextual##24##1##(1993-12#2)(1996-2#1)(2008-11#4)(2008-12#1)(2009-7#1)(2010-10#4)(2010-12#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#3)
contextual-level##2##1##(2009-6#2)
contextualize##2##1##(2008-12#1)(2012-2#1)
contextualized##2##1##(2010-10#1)(2013-8#1)
contextualizes##2##1##(2008-11#1)(2012-2#1)
contig map encompassing##2##3##(1997-8#2)
contig map##7##2##(1996-12#1)(1996-2#1)(1997-8#5)
contig##17##1##(1994-11#2)(1995-12#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-8#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
contigs which covered a total length of##2##7##(1997-2#2)
contigs which##3##2##(1995-6#1)(1997-2#2)
contigs##13##1##(1994-11#1)(1995-6#4)(1996-6#2)(1997-2#3)(2008-9#1)(2010-4#1)(2011-2#1)
contiguous genomic sequence##2##3##(1995-12#1)(1997-9#1)
contiguous quadrats##3##2##(2008-10#3)
contiguous sequence of##2##3##(1995-8#1)(1996-12#1)
contiguous with the##2##3##(1994-5#1)(2011-2#1)
contiguous##26##1##(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-3#3)(1997-9#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
continence##4##1##(1993-6#2)(2008-10#2)
continent urinary##3##2##(2008-10#3)
continent##15##1##(2008-10#12)(2008-12#1)(2010-5#2)
continent)##2##1##(2008-9#2)
continental North America##2##3##(2008-10#2)
continental North##3##2##(2008-10#3)
continental margin##2##2##(2008-10#2)
continental scale##2##2##(2008-10#2)
continental shelf##2##2##(2010-8#2)
continental##17##1##(1995-6#1)(2008-10#9)(2008-2#1)(2008-8#1)(2010-8#3)(2011-2#1)(2013-8#1)
continents and##3##2##(2008-10#2)(2013-8#1)
continents##23##1##(2008-10#17)(2008-12#2)(2010-5#1)(2012-3#2)(2013-8#1)
contingencies associated with##2##3##(1991-12#1)(2010-10#1)
contingencies##3##1##(1991-12#1)(2010-10#1)(2010-4#1)
contingency##4##1##(1997-2#1)(2008-10#1)(2010-10#1)(2011-2#1)
contingent on##4##2##(1991-1#1)(1995-2#1)(2008-8#1)(2008-9#1)
contingent##6##1##(1991-1#1)(1993-6#1)(1995-2#1)(2008-8#1)(2008-9#1)(2009-9#1)
continual reassessment##3##2##(1994-9#2)(2008-7#1)
continual##8##1##(1994-9#2)(2008-10#1)(2008-7#3)(2009-8#1)(2010-11#1)
continually##10##1##(1994-3#2)(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
continuation of the##2##3##(1997-7#1)(2009-5#1)
continuation of##6##2##(1992-2#1)(1997-7#1)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)
continuation##11##1##(1992-2#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
continue the##2##2##(2008-12#1)(2008-8#1)
continue to be a##5##4##(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)
continue to be##21##3##(1992-1#1)(1995-3#1)(1997-1#2)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-4#1)(2010-6#1)(2012-3#2)(2013-1#1)
continue to decrease##2##3##(2008-11#1)(2011-2#1)
continue to develop##4##3##(1995-3#1)(2008-11#1)(2008-12#1)(2013-1#1)
continue to evolve##2##3##(2008-6#1)(2013-1#1)
continue to exist##2##3##(1995-12#1)(1997-3#1)
continue to grow##4##3##(1993-1#1)(2008-11#1)(2008-9#2)
continue to increase in the##2##5##(1994-6#1)(2011-2#1)
continue to increase##5##3##(1994-6#1)(2008-10#1)(2010-11#1)(2011-2#2)
continue to rise##2##3##(1992-2#1)(1994-12#1)
continue to##105##2##(1990-11#1)(1990-3#2)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#7)(2008-11#17)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-4#2)(2009-5#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-3#3)(2012-6#1)(2013-1#8)(2013-8#3)
continue##146##1##(1990-11#1)(1990-3#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#12)(2008-11#20)(2008-12#6)(2008-4#2)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#1)(2009-4#2)(2009-5#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#5)(2011-7#1)(2012-12#2)(2012-3#3)(2012-6#1)(2013-1#10)(2013-8#3)
continued at##5##2##(1990-2#1)(1994-1#1)(1997-4#1)(2008-10#1)(2011-1#1)
continued development##2##2##(2008-10#1)(2008-11#1)
continued focus##2##2##(2008-9#1)(2010-1#1)
continued for##11##2##(1990-9#1)(1992-11#1)(1994-9#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#2)(2011-2#1)(2011-3#1)
continued growth in##3##3##(1995-1#1)(2011-1#1)(2011-7#1)
continued growth##5##2##(1991-1#1)(1995-1#1)(2008-11#1)(2011-1#1)(2011-7#1)
continued in##3##2##(2010-5#1)(2011-1#1)(2013-8#1)
continued need to##2##3##(2008-11#1)(2010-12#1)
continued need##3##2##(1996-1#1)(2008-11#1)(2010-12#1)
continued on##2##2##(2008-7#1)(2008-9#1)
continued research##2##2##(2010-12#1)(2011-2#1)
continued smoking##2##2##(2008-11#1)(2010-2#1)
continued the##2##2##(2008-10#1)(2010-11#1)
continued to be##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#2)
continued to decline##2##3##(2008-10#1)(2010-10#1)
continued to evolve##2##3##(1994-12#1)(2011-2#1)
continued to grow##4##3##(1991-12#1)(2008-10#1)(2011-1#1)(2012-2#1)
continued to have a##2##4##(2010-1#1)(2011-2#1)
continued to have##6##3##(1997-3#2)(2007-12#1)(2008-10#1)(2010-1#1)(2011-2#1)
continued to increase##4##3##(1991-2#1)(1996-2#1)(2008-10#2)
continued to rise##2##3##(1996-3#1)(2013-8#1)
continued to show##2##3##(1993-1#1)(1995-12#1)
continued to##39##2##(1991-12#1)(1991-2#2)(1991-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
continued until##4##2##(1994-8#1)(2008-10#2)(2010-1#1)
continued use of##2##3##(1992-3#1)(2011-2#1)
continued with##5##2##(1991-3#1)(2010-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
continued##142##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#20)(2008-11#12)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#6)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#3)
continues in##2##2##(1996-2#1)(2009-10#1)
continues regarding the##2##3##(2008-4#1)(2008-7#1)
continues to be a major##2##5##(2008-10#1)(2010-10#1)
continues to be a significant problem##2##6##(1996-12#1)(2008-4#1)
continues to be a##9##4##(1991-12#1)(1992-1#1)(1993-6#1)(1996-12#1)(2008-10#2)(2008-4#1)(2009-9#1)(2010-10#1)
continues to be##20##3##(1991-12#1)(1992-1#1)(1993-6#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2012-3#1)
continues to emerge##3##3##(1996-5#1)(2011-1#1)(2013-1#1)
continues to evolve##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
continues to expand##2##3##(1996-3#1)(2013-1#1)
continues to have##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
continues to increase##5##3##(1995-3#1)(1997-7#1)(2010-6#1)(2010-8#1)(2011-1#1)
continues to represent a##2##4##(2008-7#1)(2010-6#1)
continues to rise##2##3##(1994-12#1)(2012-2#1)
continues to##58##2##(1991-12#1)(1992-1#1)(1993-6#1)(1994-12#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
continues##79##1##(1991-12#1)(1992-1#1)(1993-6#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#2)(2011-7#1)(2012-2#4)(2012-3#3)(2012-6#1)(2013-1#3)(2013-8#1)
continuing care retirement##4##3##(1991-2#1)(1993-2#1)(1994-2#2)
continuing disparities##2##2##(1994-12#1)(2008-1#1)
continuing education and##3##3##(1993-11#1)(2008-6#1)(2013-1#1)
continuing education in##2##3##(1994-12#1)(1997-5#1)
continuing education##27##2##(1991-2#2)(1992-1#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-12#7)(1997-5#1)(1997-8#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#3)(2013-8#1)
continuing efforts to##2##3##(1994-2#1)(1996-2#1)
continuing medical education##3##3##(2008-1#1)(2008-8#2)
continuing physiological needs##2##3##(2008-11#2)
continuing professional development##2##3##(2008-11#1)(2008-12#1)
continuing professional##3##2##(2008-11#2)(2008-12#1)
continuing to##6##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2011-2#1)
continuing##90##1##(1990-6#1)(1991-1#1)(1991-2#3)(1992-1#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#1)(1994-1#2)(1994-12#8)(1994-2#3)(1994-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#7)(2008-11#12)(2008-12#4)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
continuity and##5##2##(1993-1#1)(1996-1#1)(2008-11#1)(2010-4#1)(2012-3#1)
continuity cases##3##2##(1993-1#3)
continuity in the##3##3##(2008-10#1)(2009-1#1)(2009-8#1)
continuity of care##8##3##(1993-1#4)(1994-3#2)(1996-3#2)
continuity of medication management during##2##5##(2012-12#2)
continuity of medication management##3##4##(2012-12#3)
continuity of##19##2##(1993-1#4)(1993-8#1)(1994-3#2)(1995-3#1)(1996-3#2)(2008-11#4)(2010-8#1)(2012-12#3)(2012-2#1)
continuity with##2##2##(1995-2#1)(2009-10#1)
continuity##49##1##(1991-6#1)(1993-1#10)(1993-8#1)(1994-3#4)(1994-8#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#3)(1996-3#2)(2008-10#3)(2008-11#6)(2008-6#1)(2009-1#1)(2009-10#1)(2009-3#2)(2009-8#1)(2010-4#1)(2010-8#1)(2012-12#3)(2012-2#2)(2012-3#1)
continuity&quot##2##1##(1993-1#1)(2009-1#1)
continuous addition of##3##3##(2008-10#3)
continuous agitation##2##2##(2008-11#2)
continuous ambulatory peritoneal dialysis (CAPD)##2##5##(1995-12#1)(2008-10#1)
continuous ambulatory peritoneal dialysis##3##4##(1995-12#1)(2008-10#2)
continuous ambulatory peritoneál dialysis##3##4##(1997-8#3)
continuous ambulatory##7##2##(1995-12#1)(1995-2#1)(1997-8#3)(2008-10#2)
continuous analysis##6##2##(2008-10#6)
continuous and##18##2##(1991-2#1)(1991-9#1)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)(2013-1#1)
continuous bed##3##2##(2008-11#3)
continuous beer fermentation##3##3##(2008-10#3)
continuous cell lines##2##3##(1992-6#1)(2008-11#1)
continuous cell##4##2##(1992-6#1)(2008-11#2)(2011-2#1)
continuous covariates##2##2##(2008-10#1)(2013-1#1)
continuous culture and##2##3##(2008-11#2)
continuous culture mode##2##3##(2008-11#2)
continuous culture of##3##3##(2008-11#2)(2008-7#1)
continuous culture##13##2##(2008-11#12)(2008-7#1)
continuous cultures##2##2##(2008-11#2)
continuous derivatisation##2##2##(2008-10#2)
continuous determination of##2##3##(2008-10#2)
continuous education##4##2##(1994-12#2)(2009-11#1)(2010-10#1)
continuous evaporation##2##2##(2008-10#2)
continuous exposure##3##2##(1992-1#1)(2008-11#1)(2008-12#1)
continuous expression##2##2##(1997-7#1)(2008-8#1)
continuous flow analysis (CFA)##2##4##(2008-10#2)
continuous flow analysis##5##3##(2008-10#5)
continuous flow hydride generation##2##4##(2008-10#2)
continuous flow system##9##3##(2008-10#9)
continuous flow##46##2##(2008-10#41)(2008-11#2)(2008-7#1)(2010-6#1)(2011-2#1)
continuous glucose monitoring (CGM)##2##4##(2012-4#2)
continuous glucose monitoring system##2##4##(2008-1#1)(2012-5#1)
continuous glucose monitoring##4##3##(2008-1#1)(2012-4#2)(2012-5#1)
continuous glucose##5##2##(1995-8#1)(2008-1#1)(2012-4#2)(2012-5#1)
continuous hybridoma##4##2##(2008-11#3)(2008-7#1)
continuous hydride generation##3##3##(2008-10#3)
continuous illumination##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
continuous improvement##5##2##(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-2#1)
continuous increase##3##2##(1996-12#2)(2008-1#1)
continuous infusion of##2##3##(1994-12#1)(2012-3#1)
continuous infusion##4##2##(1990-12#1)(1994-12#1)(2012-3#2)
continuous intravenous infusion##2##3##(1990-8#1)(2010-11#1)
continuous intravenous##3##2##(1990-8#1)(2010-10#1)(2010-11#1)
continuous light##2##2##(2008-10#2)
continuous maize##2##2##(2008-10#1)(2008-12#1)
continuous measurements of##3##3##(2008-10#2)(2008-3#1)
continuous measurements##5##2##(2008-10#4)(2008-3#1)
continuous mode##5##2##(2008-10#5)
continuous monitoring of##8##3##(1997-1#1)(2008-10#5)(2011-2#2)
continuous monitoring##9##2##(1997-1#1)(2008-10#6)(2011-2#2)
continuous operation##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
continuous or##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
continuous perfusion mode##2##3##(2008-11#2)
continuous perfusion##5##2##(2008-11#5)
continuous phase##2##2##(2008-10#1)(2008-5#1)
continuous precipitation-dissolution flow system##3##4##(2008-10#3)
continuous prisoner's dilemma##2##3##(2008-8#2)
continuous production of MnP##2##4##(2008-7#2)
continuous production of##3##3##(2008-11#1)(2008-7#2)
continuous production##4##2##(2008-11#2)(2008-7#2)
continuous quality improvement (CQI)##3##4##(1993-3#1)(1994-1#1)(1994-2#1)
continuous quality improvement in the##2##5##(1993-3#1)(1994-2#1)
continuous quality improvement in##3##4##(1993-3#1)(1994-2#1)(1996-1#1)
continuous quality improvement##17##3##(1993-12#1)(1993-3#2)(1994-1#4)(1994-12#1)(1994-2#3)(1994-3#3)(1995-2#1)(1996-1#1)(1997-1#1)
continuous quality##18##2##(1993-12#1)(1993-3#3)(1994-1#4)(1994-12#1)(1994-2#3)(1994-3#3)(1995-2#1)(1996-1#1)(1997-1#1)
continuous quantitative##2##2##(2008-10#2)
continuous reagent addition##2##3##(2008-10#2)
continuous relief##3##2##(2008-3#3)
continuous sampling##2##2##(2008-10#1)(2012-7#1)
continuous titration based on a flow ratiometry##2##7##(2008-10#2)
continuous titration##3##2##(2008-10#3)
continuous treatment##2##2##(1991-6#1)(1995-2#1)
continuous ultrasound assisted dissolution##2##4##(2008-10#2)
continuous use##5##2##(2008-10#5)
continuous variation of##2##3##(2008-10#2)
continuous wave CO2 laser##2##4##(1996-1#2)
continuous wave and##2##3##(1990-8#1)(2008-3#1)
continuous wave lasers##2##3##(1991-3#1)(2008-3#1)
continuous wave##13##2##(1990-8#1)(1991-3#1)(1992-1#1)(1996-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)
continuous wavelet transform##2##3##(2008-10#2)
continuous wetness##6##2##(2008-10#6)
continuous##496##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#2)(1991-2#1)(1991-3#5)(1991-6#1)(1991-9#2)(1992-1#5)(1992-12#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-1#5)(1994-12#6)(1994-2#5)(1994-3#5)(1994-5#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#6)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#2)(1996-6#1)(1997-1#3)(1997-2#2)(1997-7#1)(1997-8#4)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#4)(2008-10#218)(2008-11#58)(2008-12#8)(2008-2#2)(2008-3#15)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-5#3)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#11)(2012-2#2)(2012-3#2)(2012-4#2)(2012-5#1)(2012-7#1)(2013-1#10)(2013-8#9)
continuous-flow dialysis##2##2##(2008-10#2)
continuous-flow extraction##2##2##(2008-10#2)
continuous-flow manifold##2##2##(2008-10#2)
continuous-flow pumps##2##2##(2010-6#2)
continuous-flow system##4##2##(2008-10#3)(2008-7#1)
continuous-flow##25##1##(2008-1#1)(2008-10#19)(2008-7#1)(2010-6#4)
continuous-time##2##1##(2008-10#1)(2008-8#1)
continuous-wave CO2##3##2##(2008-2#1)(2008-3#2)
continuous-wave Cr(4+)##2##2##(2008-3#2)
continuous-wave cavity ringdown spectroscopy##2##4##(2008-3#2)
continuous-wave laser##4##2##(2008-2#2)(2008-3#2)
continuous-wave##36##1##(2007-11#1)(2007-12#2)(2008-2#7)(2008-3#26)
continuously and##5##2##(2008-10#1)(2008-7#1)(2009-7#1)(2012-3#2)
continuously changing##2##2##(2008-10#1)(2008-11#1)
continuously during##2##2##(1994-12#1)(2013-1#1)
continuously flowing##3##2##(2008-10#3)
continuously for##2##2##(1993-12#1)(2008-11#1)
continuously from##2##2##(2008-11#1)(2008-8#1)
continuously in##3##2##(1997-7#1)(2008-8#1)(2011-2#1)
continuously monitored##6##2##(2008-10#4)(2008-11#1)(2008-4#1)
continuously perfused##2##2##(1991-3#1)(2008-11#1)
continuously stable##2##2##(2008-9#2)
continuously throughout the##2##3##(2008-9#1)(2012-2#1)
continuously throughout##3##2##(2008-7#1)(2008-9#1)(2012-2#1)
continuously to the##2##3##(2008-10#1)(2008-11#1)
continuously to##4##2##(2008-10#2)(2008-11#1)(2010-10#1)
continuously tunable##4##2##(2008-2#2)(2008-3#2)
continuously##105##1##(1991-11#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#39)(2008-11#14)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#4)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
continuum in##2##2##(2010-2#1)(2013-1#1)
continuum model##2##2##(2008-4#1)(2011-3#1)
continuum of care for##2##4##(1994-12#2)
continuum of care##6##3##(1991-1#1)(1991-12#1)(1992-1#1)(1994-12#3)
continuum of##18##2##(1991-1#1)(1991-12#1)(1992-1#2)(1992-3#2)(1994-12#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#1)(2011-2#1)
continuum##40##1##(1991-1#1)(1991-12#1)(1992-1#2)(1992-3#2)(1994-12#3)(1995-12#1)(1995-2#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#2)
contortus in##2##2##(1991-8#2)
contortus on##2##2##(1991-8#1)(1996-12#1)
contortus##6##1##(1991-8#4)(1996-12#1)(2012-2#1)
contour maps##2##2##(2008-10#1)(2011-2#1)
contour plots of##3##3##(2008-10#2)(2010-12#1)
contour plots##4##2##(2008-10#3)(2010-12#1)
contour##15##1##(1991-2#3)(2008-10#7)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
contoured##2##1##(2009-2#1)(2011-2#1)
contouring protocol for PET/CT treatment planning##2##6##(2009-2#2)
contouring protocol##5##2##(2009-2#5)
contouring##8##1##(2009-2#7)(2013-1#1)
contours of##2##2##(2008-5#1)(2008-8#1)
contours##4##1##(2008-10#1)(2008-5#1)(2008-8#2)
contraband##4##1##(2008-10#4)
contraception and##2##2##(1991-1#1)(2008-11#1)
contraception##15##1##(1991-1#2)(1994-8#1)(1996-3#1)(2008-11#2)(2009-12#1)(2011-2#3)(2013-1#5)
contraceptive counseling##4##2##(2013-1#4)
contraceptive gel##3##2##(1996-9#3)
contraceptive implant users##2##3##(2011-2#2)
contraceptive implants##2##2##(2011-2#2)
contraceptive method##4##2##(1994-8#1)(2013-1#3)
contraceptive methods##2##2##(1990-6#1)(1994-8#1)
contraceptive pill##3##2##(1997-6#1)(2010-1#1)(2012-3#1)
contraceptive use##5##2##(1990-6#1)(1991-3#1)(2008-8#1)(2013-1#2)
contraceptive##38##1##(1990-12#1)(1990-6#3)(1991-3#1)(1994-8#3)(1996-9#3)(1997-6#2)(2008-10#2)(2008-11#2)(2008-8#2)(2010-1#1)(2011-2#5)(2012-3#1)(2013-1#12)
contraceptives and their##2##3##(1990-6#1)(2011-3#1)
contraceptives and##4##2##(1990-6#1)(2008-10#1)(2011-3#1)(2012-12#1)
contraceptives in##2##2##(1990-6#1)(2012-2#1)
contraceptives##25##1##(1990-12#1)(1990-6#5)(1991-2#1)(1991-8#1)(1996-11#1)(1996-6#3)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#1)
contract and##3##2##(1992-1#1)(1992-4#1)(2008-11#1)
contract with##4##2##(1992-11#1)(1992-3#1)(1996-2#1)(2008-11#1)
contract##35##1##(1990-3#2)(1991-3#1)(1992-1#5)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-12#2)(1995-1#1)(1995-12#1)(1996-12#1)(1996-2#2)(2008-10#2)(2008-11#7)(2008-5#1)(2009-1#2)(2010-11#1)(2011-1#1)(2011-2#1)
contracted the##3##2##(1996-5#1)(2008-11#1)(2008-12#1)
contracted##16##1##(1993-3#1)(1995-6#1)(1996-12#1)(1996-5#3)(2008-11#4)(2008-12#1)(2008-9#2)(2010-1#1)(2010-11#1)(2013-1#1)
contractile action##2##2##(1990-8#1)(1997-4#1)
contractile activity##3##2##(1994-11#1)(1997-4#1)(2013-1#1)
contractile protein##2##2##(2008-11#1)(2010-6#1)
contractile response##2##2##(1990-5#1)(1991-5#1)
contractile responses##2##2##(1990-5#1)(2013-8#1)
contractile##24##1##(1990-5#2)(1990-8#1)(1991-5#2)(1991-6#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-2#1)(1997-4#3)(2008-11#2)(2008-12#2)(2008-7#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-8#2)
contractility##10##1##(1996-3#2)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#2)(2010-4#1)(2013-1#1)
contracting for##2##2##(1991-3#2)
contracting with##3##2##(1992-11#1)(1995-2#1)(1996-2#1)
contracting##17##1##(1991-3#3)(1992-11#2)(1992-12#1)(1992-2#1)(1994-12#3)(1995-12#1)(1995-2#1)(1996-2#3)(1997-3#1)(2010-10#1)
contraction and##3##2##(1994-9#1)(2008-10#1)(2009-8#1)
contraction by##2##2##(2008-12#1)(2008-5#1)
contraction in##2##2##(1997-4#1)(2010-6#1)
contraction is##2##2##(1994-8#1)(2008-10#1)
contraction of airway smooth muscle##2##5##(1997-1#1)(2010-1#1)
contraction of collagen gel##2##4##(1994-11#2)
contraction of ileum##2##3##(2008-12#2)
contraction of the##9##3##(1990-2#1)(1993-3#1)(1995-2#1)(2007-12#1)(2008-10#3)(2013-1#2)
contraction of##21##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-3#2)(1994-11#2)(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-7#1)(2010-1#1)(2010-6#1)(2013-1#2)
contraction was##2##2##(2011-2#1)(2012-3#1)
contraction were##2##2##(1997-4#1)(2010-9#1)
contraction##63##1##(1990-2#1)(1990-5#1)(1990-8#2)(1991-5#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-3#3)(1993-8#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-4#3)(2007-12#2)(2008-10#5)(2008-12#5)(2008-5#1)(2008-7#4)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-6#3)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
contractions and##2##2##(1996-2#1)(1997-4#1)
contractions in##3##2##(1990-2#1)(2008-7#1)(2008-9#1)
contractions of the##3##3##(1992-3#1)(1997-4#1)(2008-12#1)
contractions of##5##2##(1991-5#2)(1992-3#1)(1997-4#1)(2008-12#1)
contractions##29##1##(1990-2#1)(1991-5#2)(1992-3#5)(1992-8#2)(1993-3#2)(1996-2#1)(1997-4#6)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-10#1)(2012-2#1)(2013-8#2)
contractors##3##1##(1993-1#1)(1994-3#1)(1996-2#1)
contracts and##2##2##(1996-3#1)(1997-4#1)
contracts in##2##2##(2008-11#1)(2008-7#1)
contracts with##2##2##(1997-1#1)(1997-2#1)
contracts##24##1##(1991-1#1)(1996-3#1)(1997-1#3)(1997-2#2)(1997-4#1)(2008-11#12)(2008-7#1)(2008-9#3)
contracts?##2##1##(1992-2#1)(2008-11#1)
contractual##4##1##(1991-12#1)(1991-2#1)(2008-11#1)(2009-3#1)
contracture and##2##2##(2008-7#1)(2013-1#1)
contracture in##2##2##(1992-9#1)(1997-5#1)
contracture##9##1##(1992-9#2)(1997-5#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-1#2)
contractures##3##1##(2008-10#1)(2008-9#1)(2013-1#1)
contradict##2##1##(2008-10#2)
contradicting##2##1##(2010-8#1)(2012-3#1)
contradiction##4##1##(2008-10#1)(2008-3#1)(2008-8#2)
contradictions of##2##2##(1991-3#1)(1996-6#1)
contradictions##8##1##(1991-3#2)(1996-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-3#1)
contradictory and##3##2##(1997-8#1)(2008-9#1)(2012-2#1)
contradictory results##2##2##(2008-10#1)(2009-10#1)
contradictory##16##1##(1990-9#1)(1993-3#1)(1994-8#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-9#2)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
contradicts the##2##2##(2008-8#1)(2011-2#1)
contradicts##4##1##(2008-8#2)(2008-9#1)(2011-2#1)
contraindicated in##3##2##(1995-2#1)(2008-7#1)(2012-3#1)
contraindicated or when there is a strong suspicion of vasospasm as a dominant mechanism in angina##2##16##(2008-3#2)
contraindicated or##3##2##(2008-3#2)(2012-12#1)
contraindicated##15##1##(1995-2#1)(1996-3#1)(2008-3#3)(2008-7#2)(2009-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
contraindication for##2##2##(2013-1#2)
contraindication##5##1##(1994-8#1)(2011-2#2)(2013-1#2)
contraindications and##2##2##(1996-9#1)(2013-8#1)
contraindications to##3##2##(1991-2#1)(2011-3#1)(2013-8#1)
contraindications##14##1##(1991-2#1)(1993-12#1)(1996-12#1)(1996-9#1)(2008-11#2)(2011-2#2)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#2)
contralateral SHM##3##2##(2011-2#3)
contralateral breast##2##2##(1994-12#1)(2008-10#1)
contralateral eye##2##2##(1990-12#1)(2010-10#1)
contralateral knee##2##2##(2008-8#1)(2013-1#1)
contralateral metachronous breast##2##3##(1990-8#2)
contralateral metachronous##3##2##(1990-12#1)(1990-8#2)
contralateral ovary was##2##3##(1992-3#2)
contralateral primary##2##2##(1990-8#1)(2008-11#1)
contralateral surgery##3##2##(2010-7#1)(2013-1#2)
contralateral testis##2##2##(2008-10#2)
contralateral to the cortical stimulus site##2##6##(1990-9#2)
contralateral##58##1##(1990-12#2)(1990-8#3)(1990-9#3)(1991-2#1)(1992-3#2)(1993-3#4)(1994-12#1)(1994-2#2)(1996-12#2)(1996-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-2#6)(2013-1#7)(2013-8#1)
contrary to previous##2##3##(1992-3#1)(2010-8#1)
contrary to the view##2##4##(2013-8#2)
contrary to the##3##3##(2008-9#1)(2013-8#2)
contrary to##14##2##(1992-3#1)(1993-1#1)(1994-11#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2010-8#1)(2013-8#2)
contrary##56##1##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-3#1)(1993-1#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-2#1)(1995-12#1)(1995-2#2)(1997-1#1)(1997-8#1)(2008-10#8)(2008-11#5)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#3)
contrast agent can##2##3##(2010-12#2)
contrast agent##6##2##(2010-12#3)(2012-12#1)(2012-2#1)(2013-8#1)
contrast agents are##2##3##(2010-9#2)
contrast agents##11##2##(2008-1#1)(2008-3#1)(2010-12#2)(2010-9#5)(2012-3#2)
contrast and the##2##3##(2008-3#1)(2008-9#1)
contrast and##8##2##(1994-9#1)(1997-8#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-12#1)
contrast between##7##2##(2008-10#1)(2008-6#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#1)
contrast echocardiography]##2##2##(2008-9#1)(2013-8#1)
contrast enhancement##4##2##(2007-11#1)(2012-2#2)(2013-1#1)
contrast material administration##2##3##(2008-12#1)(2011-2#1)
contrast material##3##2##(2008-12#1)(2011-2#2)
contrast mechanism##3##2##(2008-5#1)(2010-8#1)(2012-12#1)
contrast media##7##2##(1991-1#1)(1991-9#1)(1992-3#1)(1997-8#2)(2008-12#1)(2012-2#1)
contrast medium and##2##3##(1992-12#1)(2008-1#1)
contrast medium##7##2##(1990-11#1)(1992-12#2)(1996-9#1)(2008-1#1)(2009-1#1)(2011-2#1)
contrast of the##3##3##(2008-3#3)
contrast of##6##2##(2007-11#1)(2008-3#3)(2008-6#1)(2009-10#1)
contrast over##2##2##(2012-2#2)
contrast parameter##2##2##(2008-6#2)
contrast ratio of##2##3##(2008-3#2)
contrast ratio##4##2##(2008-3#3)(2010-1#1)
contrast sensitivity##2##2##(2008-7#2)
contrast the##7##2##(1994-1#1)(1996-12#2)(2008-11#1)(2008-9#1)(2012-2#1)(2013-8#1)
contrast to a##4##3##(1990-10#1)(1992-10#1)(1992-12#1)(2008-10#1)
contrast to controls##3##3##(1996-12#1)(2008-7#1)(2010-7#1)
contrast to conventional##2##3##(2008-5#1)(2009-7#1)
contrast to earlier##3##3##(1993-6#1)(2008-5#1)(2008-8#1)
contrast to its##2##3##(1991-6#1)(1997-7#1)
contrast to other##7##3##(1995-6#1)(1996-5#1)(2008-11#2)(2009-6#1)(2009-7#1)(2010-9#1)
contrast to previous reports##2##4##(1993-6#1)(2008-10#1)
contrast to previous##5##3##(1993-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
contrast to the other##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
contrast to the##56##3##(1990-10#1)(1991-5#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#12)(2008-11#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-6#1)(2009-8#1)(2011-2#1)(2011-9#1)(2012-12#1)(2013-2#1)
contrast to their##2##3##(1993-6#1)(2008-10#1)
contrast to this##3##3##(1992-4#1)(1997-3#1)(2012-3#1)
contrast to what##2##3##(2008-12#1)(2008-5#1)
contrast to##169##2##(1990-10#2)(1990-2#1)(1990-5#1)(1991-5#3)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-6#5)(1993-8#4)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#35)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#3)(2009-12#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-7#1)(2010-9#1)(2011-2#5)(2011-9#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-2#1)(2013-8#2)
contrast with the##4##3##(1992-12#1)(2008-10#3)
contrast with##18##2##(1990-2#1)(1992-12#1)(1996-2#1)(1996-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)(2010-3#1)
contrast##712##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#3)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#4)(1991-5#7)(1991-6#2)(1991-9#2)(1992-10#1)(1992-12#6)(1992-3#6)(1992-4#1)(1992-6#4)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#8)(1993-8#7)(1993-9#1)(1994-1#2)(1994-11#8)(1994-12#1)(1994-2#6)(1994-5#8)(1994-6#2)(1994-8#5)(1994-9#2)(1995-11#7)(1995-12#2)(1995-2#17)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#5)(1996-11#1)(1996-12#12)(1996-2#10)(1996-5#4)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#6)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#9)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#165)(2008-11#50)(2008-12#5)(2008-2#1)(2008-3#13)(2008-4#3)(2008-5#19)(2008-6#7)(2008-7#23)(2008-8#31)(2008-9#18)(2009-1#1)(2009-10#3)(2009-12#3)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#9)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#7)(2011-2#18)(2011-9#1)(2012-12#8)(2012-2#23)(2012-3#14)(2012-7#1)(2013-1#11)(2013-2#1)(2013-3#2)(2013-8#9)
contrast-enhanced CT##5##2##(2013-1#5)
contrast-enhanced MR mammography##4##3##(1997-8#4)
contrast-enhanced MRI##2##2##(2008-1#1)(2010-12#1)
contrast-enhanced US##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
contrast-enhanced computed tomography##3##3##(2008-1#1)(2010-12#1)(2013-1#1)
contrast-enhanced harmonic US##2##3##(2010-12#2)
contrast-enhanced ultrasound##2##2##(2010-12#1)(2012-2#1)
contrast-enhanced##27##1##(1997-8#5)(2008-1#3)(2010-12#7)(2012-2#4)(2013-1#7)(2013-8#1)
contrasted with the##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
contrasted with##10##2##(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
contrasted##17##1##(1992-1#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
contrasting effects##2##2##(1993-8#1)(2008-8#1)
contrasting environments##2##2##(2008-8#1)(2008-9#1)
contrasting results##2##2##(2013-1#1)(2013-8#1)
contrasting##23##1##(1991-2#1)(1993-8#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#5)(2008-9#3)(2009-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
contrasts in##2##2##(2008-10#2)
contrasts the##2##2##(1994-2#1)(2008-10#1)
contrasts with##9##2##(1990-5#1)(1995-12#1)(1996-2#1)(2006-6#1)(2008-7#1)(2008-8#3)(2012-3#1)
contrasts##30##1##(1990-5#1)(1991-2#1)(1991-5#1)(1994-2#1)(1995-12#1)(1996-2#1)(2006-6#1)(2008-10#9)(2008-7#1)(2008-8#9)(2008-9#2)(2012-2#1)(2012-3#1)
contribute considerably to##2##3##(1991-5#1)(1996-2#1)
contribute greatly to##4##3##(2008-11#1)(2010-6#2)(2012-3#1)
contribute in##3##2##(1994-3#1)(2008-10#1)(2012-3#1)
contribute more to##2##3##(2008-10#2)
contribute significantly to the##6##4##(1995-2#1)(1996-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
contribute significantly to##10##3##(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
contribute significantly##12##2##(1992-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
contribute the##2##2##(2008-9#1)(2012-3#1)
contribute to a##13##3##(1994-12#1)(1994-8#1)(2008-10#6)(2008-11#2)(2009-10#1)(2010-9#1)(2012-3#1)
contribute to an##2##3##(2008-11#1)(2008-9#1)
contribute to cellular homeostasis##2##4##(1991-5#1)(1994-12#1)
contribute to disease##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
contribute to greater##2##3##(1994-2#1)(2008-12#1)
contribute to initial##2##3##(2008-10#1)(2008-8#1)
contribute to its##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
contribute to many##2##3##(2008-4#1)(2010-12#1)
contribute to reducing##2##3##(2008-10#1)(2013-8#1)
contribute to resistance in##2##4##(2008-10#2)
contribute to resistance##3##3##(2008-10#3)
contribute to specific##2##3##(2008-10#1)(2010-1#1)
contribute to the ability to##2##5##(1994-3#1)(2008-9#1)
contribute to the development of a##3##6##(1995-1#1)(2008-10#2)
contribute to the development of##8##5##(1991-12#1)(1994-11#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2012-2#1)
contribute to the formation of##3##5##(1994-2#1)(2009-8#1)(2010-5#1)
contribute to the increased##2##4##(2011-2#1)(2012-2#1)
contribute to the lower##2##4##(2008-11#2)
contribute to the onset##2##4##(2008-7#1)(2011-2#1)
contribute to the overall##2##4##(2008-10#1)(2011-2#1)
contribute to the reduction##2##4##(2008-10#1)(2012-3#1)
contribute to the understanding of the##3##6##(2008-10#1)(2010-5#1)(2012-3#1)
contribute to the understanding of##6##5##(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)
contribute to the##119##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#2)(1995-6#1)(1996-12#4)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#20)(2008-11#10)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#2)(2009-3#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#1)
contribute to this##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
contribute to tumor development##2##4##(2009-4#1)(2013-8#1)
contribute to understanding##4##3##(2008-11#2)(2009-12#1)(2012-9#1)
contribute to##253##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-3#2)(1991-5#2)(1992-12#1)(1992-4#1)(1992-6#3)(1992-9#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1996-12#7)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#43)(2008-11#24)(2008-12#8)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#13)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2010-9#3)(2011-2#12)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#10)(2012-3#7)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#7)
contribute##293##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#3)(1991-3#2)(1991-5#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-6#3)(1996-1#1)(1996-12#8)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#48)(2008-11#26)(2008-12#8)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#15)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#4)(2011-2#13)(2011-3#1)(2011-7#2)(2012-12#2)(2012-2#11)(2012-3#11)(2012-9#1)(2013-1#6)(2013-7#1)(2013-8#7)
contributed by the##4##3##(2008-10#4)
contributed by##7##2##(2008-10#6)(2008-9#1)
contributed significant##2##2##(2008-10#2)
contributed significantly to##3##3##(1993-2#1)(1997-2#1)(2008-10#1)
contributed the resistance##2##3##(2008-10#2)
contributed the##3##2##(2008-10#2)(2008-8#1)
contributed to a##3##3##(2008-12#1)(2012-3#1)(2013-1#1)
contributed to higher##2##3##(2008-10#2)
contributed to the development of##4##5##(1996-1#1)(2008-12#2)(2011-10#1)
contributed to the##41##3##(1991-12#1)(1991-2#1)(1991-6#1)(1994-11#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-5#2)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-8#1)
contributed to##76##2##(1991-12#1)(1991-2#2)(1991-6#1)(1992-2#1)(1994-11#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#4)(2008-5#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#1)
contributed##105##1##(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#30)(2008-11#5)(2008-12#4)(2008-2#1)(2008-5#2)(2008-8#6)(2008-9#2)(2009-10#1)(2009-7#2)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#2)(2013-8#1)
contributes half of the##2##4##(2008-3#1)(2008-8#1)
contributes significantly to the##3##4##(1993-6#1)(2008-10#1)(2012-3#1)
contributes significantly to##4##3##(1993-6#1)(1995-6#1)(2008-10#1)(2012-3#1)
contributes to a##2##3##(2008-10#1)(2010-11#1)
contributes to higher##2##3##(2008-11#1)(2012-2#1)
contributes to the development of##2##5##(1991-12#1)(2008-11#1)
contributes to the##21##3##(1991-12#2)(1994-11#1)(1994-3#1)(1995-2#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
contributes to##60##2##(1991-12#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
contributes##74##1##(1991-12#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
contributing factor to the##2##4##(2008-10#1)(2010-5#1)
contributing factor to##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
contributing factors##7##2##(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#2)(2012-2#1)
contributing most to the##2##4##(2008-11#1)(2008-5#1)
contributing to a##2##3##(2008-10#1)(2011-2#1)
contributing to health##2##3##(2008-1#1)(2008-7#1)
contributing to the##21##3##(1991-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2011-2#1)(2012-3#2)
contributing to##54##2##(1991-5#2)(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#2)(2009-12#1)(2009-9#2)(2010-10#1)(2011-2#5)(2011-3#1)(2012-3#6)(2013-1#1)
contributing towards##3##2##(1994-11#1)(2008-11#1)(2008-5#1)
contributing##77##1##(1991-5#2)(1994-11#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-1#2)(2008-10#17)(2008-11#8)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#2)(2009-12#1)(2009-9#2)(2010-10#1)(2010-5#1)(2011-2#9)(2011-3#1)(2012-2#2)(2012-3#6)(2013-1#1)
contribution and##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
contribution by##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
contribution from##12##2##(1995-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2009-4#1)(2010-7#1)(2013-1#2)
contribution in the##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
contribution of an##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
contribution of each##7##3##(1992-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)
contribution of such##2##3##(2008-10#1)(2008-12#1)
contribution of the##11##3##(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#2)(2009-6#1)(2010-4#1)
contribution of these##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
contribution of this##2##3##(2007-12#1)(2008-10#1)
contribution of various##2##3##(1993-12#1)(1995-5#1)
contribution of##101##2##(1990-12#1)(1992-1#1)(1992-12#2)(1993-1#2)(1993-12#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#26)(2008-11#10)(2008-12#8)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#3)(2009-12#1)(2009-4#1)(2009-6#3)(2010-1#1)(2010-11#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
contribution to health##2##3##(2008-11#1)(2008-12#1)
contribution to the signal##2##4##(2008-3#1)(2010-7#1)
contribution to the total##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
contribution to the understanding of##2##5##(1993-11#1)(2008-9#1)
contribution to the##24##3##(1990-5#1)(1991-1#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
contribution to##53##2##(1990-5#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#8)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#2)
contribution was##2##2##(2008-10#1)(2008-7#1)
contribution##209##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#46)(2008-11#19)(2008-12#12)(2008-2#3)(2008-3#16)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#1)(2009-4#2)(2009-6#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#8)
contributions and##2##2##(2012-3#2)
contributions from##3##2##(1992-3#1)(2008-11#1)(2008-3#1)
contributions in##2##2##(2008-10#1)(2013-8#1)
contributions of a methylene group##2##5##(2008-10#2)
contributions of a##3##3##(2008-10#2)(2008-9#1)
contributions of both##2##3##(2008-10#2)
contributions of the##3##3##(1997-8#1)(2008-10#2)
contributions of##32##2##(1992-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-9#1)(1996-2#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
contributions on##2##2##(2008-10#1)(2013-8#1)
contributions to the##10##3##(1996-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2010-1#1)(2013-1#1)
contributions to##26##2##(1991-9#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
contributions##90##1##(1991-9#1)(1992-12#1)(1992-3#2)(1993-2#3)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-2#2)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#2)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#3)
contributor to the##4##3##(1994-8#1)(2008-1#1)(2008-10#1)(2010-12#1)
contributor to##10##2##(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-9#1)(2012-12#1)
contributor##12##1##(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-12#1)(2011-3#1)(2011-9#1)(2012-12#1)
contributors to the##2##3##(2008-3#1)(2008-8#1)
contributors to##8##2##(2008-10#3)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#2)
contributors##12##1##(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-7#1)(2011-2#2)
contributory factors##2##2##(2008-1#1)(2008-9#1)
contributory##6##1##(2008-1#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
control (e##2##2##(2008-10#1)(2013-8#1)
control Medicare##2##2##(1993-12#1)(2012-3#1)
control NS/0 cells##2##3##(2008-11#2)
control abilities##4##2##(2011-2#4)
control access##2##2##(1996-1#1)(2012-2#1)
control actions of##2##3##(2008-8#1)(2012-12#1)
control activities##2##2##(1997-1#1)(2013-8#1)
control activity##4##2##(2008-10#3)(2008-8#1)
control adolescents##2##2##(2008-11#1)(2013-1#1)
control after##4##2##(1990-6#1)(1993-9#1)(1994-12#1)(2008-5#1)
control agent##12##2##(2008-10#10)(2008-5#1)(2010-10#1)
control agents##18##2##(2008-10#16)(2008-8#1)(2010-7#1)
control analysis##7##2##(2008-10#5)(2011-2#1)(2012-2#1)
control and HKD##2##3##(1991-5#2)
control and MCT-treated rats##2##4##(1994-5#2)
control and a##2##3##(2008-12#1)(2013-1#1)
control and experimental##2##3##(2008-11#1)(2010-9#1)
control and that##2##3##(2008-10#1)(2008-7#1)
control and the##4##3##(1995-11#1)(2008-5#1)(2011-3#1)(2013-8#1)
control and treated##3##3##(2008-10#1)(2008-12#1)(2009-11#1)
control and treatment##3##3##(1993-9#1)(2008-11#2)
control and##110##2##(1991-12#3)(1991-3#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#2)(1996-10#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-7#1)(2008-10#19)(2008-11#9)(2008-12#6)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#9)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-9#3)(2011-2#2)(2011-3#4)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#3)
control animals##13##2##(1990-12#1)(1992-1#3)(1993-6#1)(1994-2#1)(1995-11#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
control are##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
control at the##2##3##(1997-1#1)(2011-2#1)
control at##13##2##(1995-12#1)(1997-1#1)(1997-3#1)(2008-10#5)(2009-10#3)(2011-2#1)(2012-5#1)
control between##2##2##(1994-12#1)(2008-5#1)
control blood##2##2##(1993-2#1)(2010-10#1)
control by##15##2##(1993-6#1)(1993-9#1)(1996-3#1)(1996-5#1)(2008-10#8)(2008-11#2)(2008-5#1)
control can be##3##3##(1996-11#1)(2008-10#2)
control can##4##2##(1996-11#1)(2008-10#2)(2008-5#1)
control cell growth##2##3##(2008-11#2)
control cell line##3##3##(2008-11#2)(2011-2#1)
control cell##9##2##(1990-8#1)(2008-11#4)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
control cells in##2##3##(2008-11#1)(2008-8#1)
control cells##26##2##(1991-5#1)(1993-1#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(2008-11#13)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2011-2#1)
control center data##2##3##(2010-8#2)
control charting##3##2##(1996-1#3)
control charts##10##2##(1993-3#2)(1996-1#1)(2008-10#7)
control children##2##2##(2008-2#1)(2010-8#1)
control condition##8##2##(1992-12#1)(2008-12#1)(2008-4#2)(2009-9#1)(2010-10#1)(2012-2#1)(2013-8#1)
control conditions##3##2##(1993-8#1)(2008-11#2)
control costs##2##2##(1995-1#1)(1995-12#1)
control could##2##2##(2008-10#1)(2011-2#1)
control counterparts##2##2##(1991-5#1)(2008-12#1)
control counties##2##2##(1991-3#2)
control cream##2##2##(2008-5#2)
control culture##3##2##(2008-11#3)
control cultures##8##2##(1995-12#1)(1995-8#2)(2008-11#5)
control data##2##2##(2008-10#1)(2009-10#1)
control devices##6##2##(2009-12#4)(2010-1#2)
control diet##3##2##(1993-12#1)(2008-11#2)
control discs##2##2##(2012-3#2)
control during##3##2##(1993-12#1)(2010-8#1)(2012-2#1)
control efficacy##6##2##(2008-10#6)
control efforts##2##2##(1997-1#1)(2010-1#1)
control elements##3##2##(1993-12#1)(1993-2#1)(2008-9#1)
control experiment##2##2##(2008-10#1)(2008-9#1)
control experiments##3##2##(1990-5#1)(2008-11#1)(2008-7#1)
control failure##2##2##(2008-10#2)
control fibroblasts##2##2##(1995-12#1)(1996-12#1)
control flies##3##2##(1995-6#3)
control following##2##2##(1993-9#1)(1995-12#1)
control for the##4##3##(1993-2#1)(2008-9#1)(2012-2#1)(2012-3#1)
control for these##2##3##(2008-10#2)
control for##18##2##(1993-2#1)(1994-1#1)(1996-2#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-9#1)(2009-7#1)(2012-2#2)(2012-3#1)
control fruits##2##2##(2008-10#2)
control gene expression##2##3##(2008-10#2)
control goats##2##2##(1996-12#2)
control group (P &lt##3##4##(1994-3#1)(2011-3#1)(2012-3#1)
control group and##5##3##(1991-12#1)(1992-12#1)(1993-3#1)(2007-8#1)(2008-12#1)
control group in##4##3##(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)
control group included##3##3##(2011-2#2)(2013-1#1)
control group of##7##3##(1994-12#1)(1996-3#1)(2008-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
control group underwent##2##3##(2008-11#1)(2008-8#1)
control group was treated with##2##5##(2013-1#2)
control group was##10##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-3#1)(2013-1#2)
control group were##2##3##(2010-1#1)(2013-8#1)
control group with##3##3##(1992-2#1)(2008-9#2)
control group##161##2##(1990-11#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#2)(1994-12#4)(1994-3#3)(1994-5#1)(1994-8#4)(1996-2#1)(1996-3#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#16)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-1#1)(2009-12#7)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#4)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#16)(2011-3#7)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#20)(2013-8#2)
control group)##2##2##(1991-8#1)(2013-1#1)
control groups at##2##3##(2008-9#2)
control groups in both studies##3##5##(2008-9#3)
control groups of rats##2##4##(2011-2#2)
control groups showed##2##3##(1993-3#1)(2009-6#1)
control groups throughout both studies##2##5##(2008-9#2)
control groups throughout##3##3##(2008-9#3)
control groups##39##2##(1991-12#1)(1991-6#1)(1993-12#1)(1993-3#3)(1995-11#1)(1995-12#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#15)(2009-6#1)(2010-10#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
control growth##5##2##(2008-11#2)(2008-7#1)(2009-5#1)(2011-2#1)
control has##2##2##(2008-10#1)(2013-8#1)
control have been##5##3##(1997-7#1)(2008-10#2)(2008-11#1)(2013-1#1)
control have##7##2##(1997-2#1)(1997-7#2)(2008-10#2)(2008-11#1)(2013-1#1)
control in a##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2010-7#1)
control in diagnostic##2##3##(1993-8#1)(2008-4#1)
control in livestock##2##3##(1997-7#2)
control in mice##2##3##(2008-4#1)(2011-2#1)
control in patients with type 2##2##6##(2011-2#1)(2012-5#1)
control in patients with##4##4##(2011-2#1)(2012-12#1)(2012-5#1)(2013-8#1)
control in the field##2##4##(2008-10#2)
control in the##15##3##(1990-6#1)(1995-6#1)(1997-1#1)(2006-5#1)(2008-10#6)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
control in this##2##3##(1997-8#1)(2008-10#1)
control in type 2 diabetic##3##5##(2011-2#2)(2012-3#1)
control in##88##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-7#2)(1997-8#1)(2006-5#1)(2008-10#25)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#2)(2013-8#2)
control individuals##5##2##(1992-11#2)(1997-3#1)(1997-7#1)(2009-6#1)
control initiatives##3##2##(1996-2#1)(1997-1#2)
control is a##2##3##(1994-12#1)(1997-7#1)
control is the##2##3##(2008-8#1)(2012-12#1)
control is##20##2##(1992-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-8#3)(2008-9#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
control issues##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
control its##2##2##(2007-12#1)(2011-2#1)
control larvae##4##2##(2008-7#4)
control leaves##2##2##(2008-10#2)
control levels by##2##3##(1995-12#1)(2013-8#1)
control levels##6##2##(1994-5#1)(1995-12#1)(1996-12#2)(2010-5#1)(2013-8#1)
control light##3##2##(2008-3#3)
control link nurse##3##3##(2008-11#3)
control link##4##2##(2008-11#4)
control many##2##2##(2009-8#1)(2010-10#1)
control material##4##2##(2008-10#4)
control may##2##2##(2010-12#1)(2011-3#1)
control measure##6##2##(2008-10#4)(2011-2#2)
control measures and##3##3##(1996-1#1)(1997-7#1)(2013-8#1)
control measures for##3##3##(2008-10#2)(2011-2#1)
control measures that##2##3##(2010-1#1)(2011-2#1)
control measures to##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
control measures were##2##3##(2008-10#1)(2008-12#1)
control measures##34##2##(1994-6#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-7#2)(2008-10#13)(2008-12#2)(2009-6#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
control mechanism##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
control mechanisms##4##2##(1995-8#1)(1996-5#1)(2008-11#1)(2008-8#1)
control medium##2##2##(1990-5#1)(2008-11#1)
control method##5##2##(2008-10#3)(2013-8#2)
control methods##8##2##(1991-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2012-2#3)
control mice##14##2##(1990-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(1997-2#3)(1997-3#1)(2008-12#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-7#1)
control microbial##2##2##(2008-5#1)(2011-1#1)
control monkeys##2##2##(1994-3#2)
control necessary##2##2##(1997-5#1)(2009-8#1)
control obtained##2##2##(2008-10#1)(2013-1#1)
control of Botrytis##2##3##(2008-10#2)
control of P##2##3##(2008-10#2)
control of Phytophthora##2##3##(2008-10#2)
control of R##2##3##(2008-10#2)
control of S##2##3##(2008-10#2)
control of SV40##2##3##(2008-11#2)
control of a##11##3##(1992-10#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
control of all##2##3##(2008-10#1)(2011-2#1)
control of asthma##2##3##(2008-11#1)(2008-7#1)
control of avirulence toward##2##4##(2008-10#2)
control of avirulence##4##3##(2008-10#4)
control of biological##2##3##(1992-12#1)(2008-9#1)
control of black rot##3##4##(2008-10#3)
control of blood pressure##3##4##(1993-11#1)(1993-2#1)(2008-1#1)
control of blood##4##3##(1993-11#1)(1993-2#1)(2008-1#1)(2008-7#1)
control of blue##2##3##(2008-10#2)
control of both##2##3##(1991-8#1)(2012-2#1)
control of cell growth##2##4##(2008-11#2)
control of cell##6##3##(1997-1#1)(2008-11#3)(2008-9#1)(2009-8#1)
control of cellular##2##3##(1996-2#2)
control of crown##2##3##(2008-10#2)
control of drug##2##3##(1994-2#1)(2013-8#1)
control of fire blight##4##4##(2008-10#4)
control of fruit infection##2##4##(2008-10#2)
control of fruit##3##3##(2008-10#3)
control of hybridoma cells##2##4##(2008-11#2)
control of leaf spot on tall fescue (Festuca arundinacea)##2##9##(2008-10#2)
control of leaf spot##3##4##(2008-10#3)
control of leaf##5##3##(2008-10#5)
control of many##3##3##(2008-10#2)(2008-8#1)
control of pathogenic##3##3##(1994-11#1)(2008-10#2)
control of plant##4##3##(2008-10#4)
control of postharvest##5##3##(2008-10#5)
control of quantitative##2##3##(2008-10#1)(2009-10#1)
control of resistance to##3##4##(2008-10#3)
control of rice blast##2##4##(2008-10#2)
control of ruminants##2##3##(1997-7#2)
control of soilborne pathogens##2##4##(2008-10#2)
control of soilborne plant pathogens##3##5##(2008-10#3)
control of soilborne##5##3##(2008-10#5)
control of the disease in##2##5##(1991-8#1)(2008-10#1)
control of the disease##7##4##(1991-8#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-3#1)
control of the process##2##4##(1996-1#1)(2008-7#1)
control of the##87##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
control of these##2##3##(2011-2#2)
control of this disease##3##4##(2008-10#3)
control of this##5##3##(2008-10#3)(2008-9#2)
control of transcription##2##3##(1995-6#1)(2012-2#1)
control of ventricular response##2##4##(2008-7#2)
control of##411##2##(1990-11#2)(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#4)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#5)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#6)(1996-3#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#9)(2007-12#2)(2008-1#4)(2008-10#143)(2008-11#26)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#6)(2008-7#18)(2008-8#14)(2008-9#15)(2009-10#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#2)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-10#2)(2011-2#19)(2011-3#2)(2012-12#1)(2012-2#10)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#8)
control ones##2##2##(1991-5#1)(1991-6#1)
control or##15##2##(1991-5#1)(1995-1#1)(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-9#1)(2010-7#1)(2012-2#1)
control outcomes##2##2##(2012-3#1)(2013-8#1)
control over behaviour##4##3##(1993-6#4)
control over the placement of##2##5##(2009-10#2)
control over the release##2##4##(2008-12#2)
control over the##11##3##(1991-2#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-8#1)(2009-10#2)(2011-2#1)
control over their##3##3##(1992-1#1)(1995-1#1)(1996-1#1)
control over##28##2##(1991-2#1)(1992-1#1)(1993-3#1)(1993-6#4)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#5)(2008-8#2)(2009-10#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#1)
control patients##5##2##(1997-3#1)(2008-8#3)(2013-1#1)
control period##2##2##(2008-10#2)
control plant##3##2##(2008-10#2)(2009-8#1)
control plants##13##2##(2008-10#12)(2011-10#1)
control plots##6##2##(2008-10#6)
control points##2##2##(2011-2#2)
control policies##3##2##(2008-10#2)(2010-1#1)
control population##3##2##(2008-11#2)(2009-10#1)
control populations##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
control potential##2##2##(2008-10#2)
control practices##6##2##(1997-7#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
control procedures##2##2##(2008-11#1)(2008-9#1)
control processes##3##2##(2008-10#3)
control product##3##2##(1990-6#1)(2008-11#2)
control program and##2##3##(1994-12#1)(2008-11#1)
control program##3##2##(1994-12#1)(2008-11#1)(2008-9#1)
control programme##2##2##(2013-8#2)
control programmes##3##2##(1995-9#1)(1997-7#1)(2011-2#1)
control programs##8##2##(2011-2#1)(2011-3#5)(2012-12#1)(2013-1#1)
control purposes##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
control rats##20##2##(1991-12#1)(1991-5#1)(1992-3#1)(1993-6#2)(1994-11#1)(1994-5#2)(1994-8#1)(1995-11#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#2)
control region##11##2##(2008-12#9)(2008-8#2)
control resistance##2##2##(2008-10#2)
control sample##2##2##(2008-10#1)(2008-9#1)
control samples##5##2##(1997-2#1)(2008-10#2)(2009-6#1)(2012-2#1)
control schemes##2##2##(1997-7#1)(2008-10#1)
control science##3##2##(1997-1#2)(2010-1#1)
control sequences##2##2##(1993-9#1)(2011-2#1)
control serum##3##2##(2008-10#2)(2008-6#1)
control signals##2##2##(1990-5#1)(2008-11#1)
control site##4##2##(2008-10#2)(2008-5#2)
control standard##2##2##(2008-10#1)(2009-6#1)
control strategies and##2##3##(2008-10#1)(2008-11#1)
control strategies are discussed##2##4##(2008-10#1)(2011-2#1)
control strategies for##3##3##(2008-10#2)(2008-11#1)
control strategies to##2##3##(2008-10#1)(2008-11#1)
control strategies##15##2##(1991-8#1)(2008-10#8)(2008-11#3)(2010-11#1)(2011-2#2)
control strategy##12##2##(1997-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
control study##8##2##(2008-11#5)(2012-12#1)(2013-1#2)
control subjects were##2##3##(1997-8#1)(2008-7#1)
control subjects##34##2##(1990-12#1)(1991-12#2)(1992-12#1)(1992-3#1)(1995-5#9)(1996-12#1)(1997-8#4)(2008-10#2)(2008-12#1)(2008-7#4)(2009-10#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
control subjects)##2##2##(1995-5#2)
control success##2##2##(2008-8#2)
control system##10##2##(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#2)(2011-2#2)(2013-8#2)
control systems is##2##3##(2008-10#1)(2009-5#1)
control systems##6##2##(2008-10#2)(2009-5#2)(2011-2#1)(2012-2#1)
control than##2##2##(2008-10#1)(2008-8#1)
control that##4##2##(1994-1#1)(1997-7#1)(2008-10#1)(2008-12#1)
control the expression of##3##4##(1994-5#1)(1996-3#1)(2013-1#1)
control the##71##2##(1992-10#1)(1992-12#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#1)(2008-10#18)(2008-11#9)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#3)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#2)
control their##4##2##(1994-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
control to##8##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#2)(2012-2#1)
control tomato plants##2##3##(2008-10#2)
control treatment##8##2##(2008-10#7)(2010-9#1)
control treatments##2##2##(2008-10#2)
control trees##2##2##(2008-10#2)
control trial##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
control used##2##2##(1996-12#1)(2008-10#1)
control using##3##2##(2009-1#1)(2009-9#1)(2011-2#1)
control value##4##2##(1990-11#1)(1992-6#1)(1993-1#1)(1997-2#1)
control values for##2##3##(1997-2#1)(2009-11#1)
control values##9##2##(1990-5#1)(1991-5#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-8#1)(1997-2#1)(2009-11#1)(2013-1#1)
control vectors##3##2##(2008-11#3)
control was achieved##3##3##(1991-8#1)(1997-4#1)(2008-10#1)
control was##17##2##(1991-8#2)(1992-1#1)(1994-11#1)(1997-4#1)(2007-11#2)(2008-10#7)(2011-2#1)(2013-1#2)
control were found to##2##4##(2008-7#1)(2011-1#1)
control were##7##2##(1993-9#1)(1995-2#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-1#1)
control when weather supported##2##4##(2008-10#2)
control when##3##2##(2008-10#2)(2013-1#1)
control which##2##2##(1990-12#1)(1997-7#1)
control with##7##2##(1994-9#1)(1996-12#1)(2008-10#2)(2008-3#1)(2010-4#2)
control without##2##2##(2008-11#1)(2012-12#1)
control##2418##1##(1990-11#5)(1990-12#9)(1990-3#2)(1990-5#6)(1990-6#5)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#11)(1991-2#5)(1991-3#9)(1991-5#10)(1991-6#2)(1991-8#10)(1991-9#1)(1992-1#6)(1992-10#2)(1992-11#2)(1992-12#10)(1992-2#4)(1992-3#4)(1992-6#3)(1992-8#1)(1992-9#4)(1993-1#6)(1993-11#1)(1993-12#12)(1993-2#7)(1993-3#17)(1993-6#20)(1993-8#9)(1993-9#10)(1994-1#5)(1994-11#13)(1994-12#18)(1994-2#6)(1994-3#12)(1994-5#10)(1994-6#8)(1994-8#13)(1994-9#2)(1995-1#7)(1995-11#7)(1995-12#14)(1995-2#12)(1995-3#4)(1995-5#14)(1995-6#9)(1995-8#6)(1995-9#3)(1996-1#13)(1996-10#2)(1996-11#5)(1996-12#23)(1996-2#15)(1996-3#8)(1996-5#6)(1997-1#25)(1997-2#14)(1997-3#11)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#36)(1997-8#7)(2006-5#1)(2006-6#1)(2007-11#5)(2007-12#6)(2007-8#2)(2008-1#10)(2008-10#648)(2008-11#186)(2008-12#64)(2008-2#6)(2008-3#24)(2008-4#6)(2008-5#53)(2008-6#8)(2008-7#73)(2008-8#65)(2008-9#78)(2009-1#3)(2009-10#16)(2009-11#4)(2009-12#19)(2009-3#2)(2009-4#3)(2009-5#8)(2009-6#14)(2009-7#8)(2009-8#21)(2009-9#3)(2010-1#13)(2010-10#9)(2010-11#13)(2010-12#17)(2010-2#1)(2010-3#3)(2010-4#11)(2010-5#7)(2010-6#4)(2010-7#17)(2010-8#10)(2010-9#6)(2011-1#18)(2011-10#3)(2011-2#137)(2011-3#24)(2011-9#2)(2012-12#14)(2012-2#53)(2012-3#37)(2012-4#3)(2012-5#4)(2012-6#4)(2012-8#1)(2013-1#87)(2013-7#4)(2013-8#47)
control) and##2##2##(2011-2#1)(2013-1#1)
control) was##2##2##(2008-10#2)
control)##24##1##(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-10#10)(2008-11#3)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
control]##3##1##(1997-4#1)(2012-3#1)(2013-1#1)
controllability##3##1##(2008-11#2)(2012-3#1)
controllable##13##1##(1992-2#2)(1996-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-12#1)(2009-3#2)(2011-1#1)(2012-2#1)
controlled analgesia##2##2##(1992-2#1)(2012-3#1)
controlled and##10##2##(1994-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
controlled at the##2##3##(1997-1#1)(2008-7#1)
controlled at##7##2##(1991-6#1)(1997-1#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)
controlled by a complex##2##4##(1994-12#1)(2008-4#1)
controlled by a personal computer##2##5##(2008-10#2)
controlled by a single gene##2##5##(2008-10#2)
controlled by a single##11##4##(2008-10#9)(2008-5#1)(2008-9#1)
controlled by a##32##3##(1990-5#1)(1990-9#1)(1991-3#1)(1994-12#2)(1995-2#2)(2008-10#22)(2008-4#1)(2008-5#1)(2008-9#1)
controlled by different##2##3##(2008-10#1)(2008-9#1)
controlled by its##3##3##(1995-2#1)(1996-3#1)(2008-9#1)
controlled by operating##3##3##(2008-7#3)
controlled by single##2##3##(2008-10#1)(2008-8#1)
controlled by specific##2##3##(2008-7#1)(2010-8#1)
controlled by the##19##3##(1990-11#2)(1993-8#1)(1994-2#1)(1996-2#2)(1997-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
controlled by two##4##3##(2008-10#2)(2008-9#1)(2010-4#1)
controlled by varying the##2##4##(2008-10#1)(2009-7#1)
controlled by##129##2##(1990-11#3)(1990-5#3)(1990-6#1)(1990-9#1)(1991-3#1)(1991-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#1)(2008-10#54)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#8)(2009-12#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-8#1)
controlled carefully##2##2##(2008-10#1)(2013-8#1)
controlled clinical trial##4##3##(2008-10#1)(2010-5#2)(2013-1#1)
controlled clinical trials##6##3##(1991-6#1)(1993-2#1)(1995-12#1)(2010-11#1)(2010-4#1)(2012-3#1)
controlled clinical##11##2##(1991-6#1)(1993-2#1)(1995-12#1)(2008-10#2)(2010-11#1)(2010-4#1)(2010-5#2)(2012-3#1)(2013-1#1)
controlled conditions##24##2##(1993-8#1)(2008-10#18)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#1)(2013-8#1)
controlled cross##2##2##(2008-10#2)
controlled during##2##2##(2008-10#1)(2011-1#1)
controlled environment experiments##2##3##(2008-10#2)
controlled environment studies##3##3##(2008-10#3)
controlled environment##16##2##(2008-10#14)(2008-5#1)(2012-4#1)
controlled environmental conditions##6##3##(2008-10#5)(2008-11#1)
controlled environmental##7##2##(2008-10#6)(2008-11#1)
controlled experimental##2##2##(2008-10#1)(2010-7#1)
controlled expression of##3##3##(1997-8#2)(2008-11#1)
controlled for##2##2##(2008-10#1)(2008-11#1)
controlled growth##2##2##(2008-10#1)(2009-8#1)
controlled human##2##2##(2008-5#1)(2011-2#1)
controlled in order to##2##4##(2008-10#2)
controlled in part by##2##4##(1992-9#1)(2008-5#1)
controlled in##10##2##(1990-6#1)(1992-9#1)(1995-12#1)(1997-8#2)(2008-10#3)(2008-3#1)(2008-5#1)
controlled laboratory experiments##2##3##(2008-10#2)
controlled manner##2##2##(2008-7#1)(2009-12#1)
controlled medium##2##2##(2008-10#1)(2008-11#1)
controlled molecular weight##2##3##(2009-10#2)
controlled or##5##2##(1992-3#1)(1993-3#1)(2008-7#1)(2010-1#1)(2012-2#1)
controlled phase composition##2##3##(2009-7#2)
controlled phase##3##2##(2008-8#1)(2009-7#2)
controlled pilot study##2##3##(2009-11#2)
controlled pilot##3##2##(2009-11#2)(2010-10#1)
controlled pore##9##2##(2008-10#9)
controlled process##3##2##(2008-10#2)(2011-2#1)
controlled prospective studies##2##3##(1996-11#1)(1997-5#1)
controlled prospective##3##2##(1991-3#1)(1996-11#1)(1997-5#1)
controlled rate##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
controlled release of##4##3##(2008-10#2)(2008-5#1)(2010-4#1)
controlled release##5##2##(2008-10#2)(2008-5#1)(2009-12#1)(2010-4#1)
controlled resistance to##3##3##(2008-10#3)
controlled solid-phase microextraction##2##3##(2008-10#2)
controlled studies##7##2##(1991-2#1)(1994-6#1)(1997-4#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
controlled study of##2##3##(2008-10#1)(2010-9#1)
controlled study was to investigate the##2##6##(1997-3#1)(2009-12#1)
controlled study##10##2##(1991-7#1)(1997-3#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2009-12#1)(2010-9#1)
controlled substances##2##2##(1992-1#1)(2012-12#1)
controlled the##6##2##(2008-10#4)(2008-7#1)(2012-6#1)
controlled through the##2##3##(2008-10#2)
controlled to##3##2##(1995-11#1)(2008-11#1)(2008-5#1)
controlled trial of##10##3##(1990-6#1)(1991-12#1)(1992-3#1)(1997-7#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
controlled trial was##2##3##(2013-1#2)
controlled trial##34##2##(1990-6#1)(1991-12#1)(1992-3#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-4#1)(2008-8#4)(2009-12#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#14)
controlled trials (RCTs)##4##3##(1993-12#1)(2008-10#2)(2011-2#1)
controlled trials are##2##3##(2009-7#2)
controlled trials in##2##3##(1993-12#1)(2008-11#1)
controlled trials of##4##3##(1991-10#1)(2008-10#1)(2009-9#1)(2010-10#1)
controlled trials##33##2##(1991-10#1)(1993-12#5)(1994-6#1)(1994-9#2)(1995-2#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#4)
controlled under##2##2##(1990-12#1)(2008-10#1)
controlled via the##2##3##(2010-4#1)(2012-2#1)
controlled via##4##2##(1992-12#1)(2008-12#1)(2010-4#1)(2012-2#1)
controlled with##9##2##(1994-12#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#1)(2013-1#1)
controlled##548##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#5)(1990-6#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#7)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-6#2)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#6)(2007-11#1)(2008-1#1)(2008-10#192)(2008-11#29)(2008-12#9)(2008-3#10)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#18)(2008-8#13)(2008-9#10)(2009-10#3)(2009-11#2)(2009-12#9)(2009-3#1)(2009-5#4)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#24)(2012-12#4)(2012-2#10)(2012-3#9)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#27)(2013-8#3)
controlled-environment##3##1##(2008-10#3)
controlled-pore glass##2##2##(2008-10#2)
controlled-pore##3##1##(2008-10#3)
controlled-release##3##1##(1993-1#3)
controller is##2##2##(1997-2#1)(2008-3#1)
controller output voltage##2##3##(2008-10#2)
controller output##5##2##(2008-10#5)
controller voltage##3##2##(2008-10#3)
controller##22##1##(1997-2#4)(2008-10#14)(2008-3#2)(2012-3#1)(2013-1#1)
controlling and monitoring the effective bioload on the outside of the gloves##2##12##(2012-2#2)
controlling and##4##2##(2008-10#2)(2012-2#2)
controlling cell##2##2##(2008-11#1)(2009-6#1)
controlling costs##2##2##(1992-1#1)(1995-6#1)
controlling expenditures##3##2##(1992-2#1)(1994-3#1)(2008-11#1)
controlling factor##2##2##(2008-10#1)(2012-2#1)
controlling for demographic##4##3##(2010-12#1)(2012-3#1)(2013-1#2)
controlling for other##2##3##(2008-11#1)(2008-12#1)
controlling for the##4##3##(1995-12#1)(2008-11#1)(2008-8#1)(2010-1#1)
controlling for##29##2##(1992-1#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#2)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
controlling genes##2##2##(2008-11#1)(2010-1#1)
controlling pain##2##2##(2008-10#1)(2010-11#1)
controlling parameters##2##2##(2008-10#1)(2008-3#1)
controlling prices##2##2##(1994-1#2)
controlling spikelet differentiation##2##3##(2008-9#2)
controlling the levels of##3##4##(1992-12#2)(2009-10#1)
controlling the##42##2##(1991-12#1)(1992-12#2)(1995-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
controlling this##2##2##(2008-10#1)(2010-8#1)
controlling##208##1##(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#55)(2008-11#15)(2008-12#3)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#6)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-2#9)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#9)(2013-8#5)
controls (P &lt##2##3##(2010-12#1)(2012-3#1)
controls (P##4##2##(1995-12#1)(2010-12#1)(2012-3#2)
controls (P&lt##2##2##(1997-8#1)(2009-3#1)
controls (mycelium##2##2##(2008-10#2)
controls (n =##2##3##(1990-8#1)(2010-7#1)
controls (p = 0##2##4##(2008-10#2)
controls (p##3##2##(1996-11#1)(2008-10#2)
controls actin##2##2##(2012-2#1)(2013-8#1)
controls after##2##2##(1994-3#1)(2008-10#1)
controls and##21##2##(1991-1#1)(1991-12#2)(1995-12#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
controls are##3##2##(1992-9#1)(2009-8#1)(2011-2#1)
controls as##2##2##(1994-12#1)(1995-8#1)
controls at##6##2##(1995-6#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
controls cell##2##2##(1995-12#1)(2009-7#1)
controls for the##2##3##(2008-10#1)(2008-9#1)
controls for##8##2##(1992-12#1)(1997-9#1)(2008-10#3)(2008-5#1)(2008-9#2)
controls from##4##2##(1992-11#2)(1997-8#1)(2009-10#1)
controls had##2##2##(2011-1#1)(2013-1#1)
controls in the##2##3##(2008-11#1)(2008-9#1)
controls in##15##2##(1990-8#3)(1995-2#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#2)
controls of##2##2##(2008-10#1)(2008-8#1)
controls on the DOF##2##4##(2010-8#2)
controls on the##5##3##(2008-10#1)(2008-11#1)(2010-8#2)(2012-3#1)
controls on##7##2##(2008-10#1)(2008-11#1)(2010-8#2)(2012-3#1)(2013-1#2)
controls that##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
controls the##12##2##(1997-2#1)(1997-8#1)(2008-10#5)(2008-8#2)(2009-8#1)(2012-2#1)(2012-3#1)
controls to##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)
controls was##2##2##(1994-12#1)(2008-10#1)
controls were evaluated##2##3##(1991-12#1)(1996-11#1)
controls were##14##2##(1991-11#1)(1991-12#1)(1991-7#1)(1993-3#2)(1996-11#1)(1997-3#1)(2008-12#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)
controls who had##2##3##(1994-12#1)(2008-11#1)
controls with##5##2##(1993-2#1)(1996-11#1)(1996-2#1)(2008-11#1)(2010-4#1)
controls##457##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#9)(1991-1#1)(1991-11#1)(1991-12#10)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#1)(1992-9#3)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#6)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#7)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#3)(1996-11#4)(1996-12#6)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-8#7)(1997-9#1)(2006-6#1)(2007-12#1)(2008-10#96)(2008-11#31)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#13)(2008-6#2)(2008-7#36)(2008-8#8)(2008-9#16)(2009-10#4)(2009-12#1)(2009-3#2)(2009-6#4)(2009-7#4)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#31)(2012-12#2)(2012-2#8)(2012-3#14)(2012-5#1)(2012-7#1)(2013-1#18)(2013-8#6)
controls)##12##1##(1990-8#1)(1993-3#1)(1994-2#2)(1996-12#1)(2008-10#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
controversa and T##5##3##(2008-10#5)
controversa populations##2##2##(2008-10#2)
controversa##8##1##(2008-10#8)
controversial and##5##2##(2008-7#1)(2011-2#3)(2013-1#1)
controversial in##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
controversial issue##4##2##(1994-1#2)(2008-11#1)(2010-12#1)
controversial issues##6##2##(1991-3#1)(1995-3#1)(2008-1#2)(2010-5#1)(2013-1#1)
controversial views##2##2##(1993-12#1)(2008-11#1)
controversial##67##1##(1990-3#1)(1990-5#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-7#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#3)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
controversially##2##1##(1995-3#1)(2008-5#1)
controversies are##3##2##(1994-12#1)(2008-11#1)(2008-7#1)
controversies in##5##2##(1991-8#1)(1995-12#1)(2010-11#2)(2013-8#1)
controversies surrounding##3##2##(2008-11#3)
controversies that##3##2##(2008-11#2)(2013-8#1)
controversies##24##1##(1991-8#1)(1993-3#1)(1994-12#1)(1995-12#1)(2008-11#10)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-8#2)
controversy about the##2##3##(1990-9#1)(2008-10#1)
controversy about##4##2##(1990-9#1)(2008-10#1)(2010-11#1)(2011-2#1)
controversy and##5##2##(1991-5#1)(2009-10#1)(2010-11#1)(2012-12#1)(2013-8#1)
controversy over the##2##3##(2008-11#1)(2008-9#1)
controversy regarding the##2##3##(1995-11#1)(2008-7#1)
controversy surrounding the##2##3##(2010-7#1)(2010-8#1)
controversy##32##1##(1990-9#1)(1991-5#1)(1992-9#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-5#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
contusion##4##1##(1991-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
contusions were##2##2##(2008-7#2)
contusions##4##1##(2008-7#3)(2010-1#1)
conundrum##3##1##(2008-1#1)(2008-12#1)(2008-8#1)
conus medullaris##6##2##(1991-11#2)(2008-7#3)(2009-5#1)
convection in##2##2##(1992-8#1)(1995-6#1)
convection##7##1##(1992-8#1)(1995-6#1)(2008-10#2)(2009-10#2)(2009-8#1)
convective gas##2##2##(1997-2#2)
convective motion##2##2##(1992-8#1)(2008-3#1)
convective term##2##2##(2013-8#2)
convective##14##1##(1992-3#1)(1992-8#1)(1997-2#2)(2008-10#3)(2008-2#1)(2008-3#4)(2013-8#2)
convened##3##1##(2008-3#1)(2010-12#1)(2011-2#1)
convenience and##4##2##(1990-12#1)(2008-3#1)(2008-8#1)(2013-8#1)
convenience sample of##12##3##(1993-2#1)(1993-3#1)(2008-12#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
convenience sampling##2##2##(2011-2#1)(2013-8#1)
convenience##27##1##(1990-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(2008-12#3)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
convenient and rapid##3##3##(2008-10#2)(2008-4#1)
convenient and##9##2##(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
convenient for the##2##3##(2008-10#2)
convenient for##5##2##(1993-12#1)(2008-10#4)
convenient in##2##2##(2008-10#2)
convenient method for the determination of##2##6##(2008-10#2)
convenient method for the##3##4##(1990-12#1)(2008-10#2)
convenient method for##4##3##(1990-12#1)(2008-10#3)
convenient method##8##2##(1990-12#1)(2008-10#4)(2008-11#2)(2008-9#1)
convenient procedure##2##2##(2008-10#1)(2008-11#1)
convenient to##3##2##(2008-10#2)(2008-11#1)
convenient##80##1##(1990-12#1)(1990-5#1)(1990-8#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-1#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#10)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
conveniently and##2##2##(1996-2#1)(2008-10#1)
conveniently by##2##2##(2008-10#1)(2012-12#1)
conveniently##11##1##(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2012-12#1)
convention##5##1##(1992-12#1)(2008-10#2)(2008-12#1)(2012-2#1)
conventional CD4 T cells##2##4##(2012-12#1)(2013-8#1)
conventional CT##2##2##(1995-11#1)(2013-1#1)
conventional DNA##2##2##(1990-8#1)(2008-10#1)
conventional ISE##2##2##(2008-10#2)
conventional K(+)-doped##2##2##(2008-10#2)
conventional NSAIDs##2##2##(2008-10#1)(2011-2#1)
conventional ODS##2##2##(2008-10#2)
conventional RT-PCR##2##2##(2013-8#2)
conventional Soxhlet extraction##2##3##(2008-10#2)
conventional Soxhlet##4##2##(2008-10#4)
conventional T-flask and spinner flask cultures##2##6##(2008-11#2)
conventional acid digestion##2##3##(2008-10#2)
conventional acid##3##2##(1997-1#1)(2008-10#2)
conventional agents##2##2##(2008-8#2)
conventional analytical##3##2##(2008-10#2)(2008-9#1)
conventional and##14##2##(1993-3#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-2#1)
conventional approach##2##2##(2008-11#1)(2008-7#1)
conventional assays##2##2##(2009-12#2)
conventional bacteriological##2##2##(2008-9#1)(2010-6#1)
conventional batch##2##2##(2008-10#2)
conventional chemical sequencing##2##3##(1990-5#1)(1995-6#1)
conventional chemotherapeutic##2##2##(2009-12#1)(2013-8#1)
conventional clinical##2##2##(2008-11#1)(2010-8#1)
conventional complete dentures##2##3##(2013-1#2)
conventional electrode##2##2##(2008-10#2)
conventional electron##3##2##(1993-9#1)(2008-5#1)(2008-8#1)
conventional extraction##5##2##(2008-10#5)
conventional filtration##3##2##(2008-10#3)
conventional flame atomic absorption spectrometry##2##5##(2008-10#2)
conventional fluorescence##2##2##(2008-10#2)
conventional glass-ionomer restorative material##2##4##(2009-7#2)
conventional glass-ionomer##4##2##(2009-7#4)
conventional gold##2##2##(2008-10#2)
conventional heating##3##2##(2008-10#2)(2008-5#1)
conventional ion-selective electrodes##3##3##(2008-10#3)
conventional light##2##2##(2008-10#2)
conventional liquid-liquid extraction##2##3##(2008-10#2)
conventional lung function##2##3##(1997-2#2)
conventional management##2##2##(2008-10#1)(2008-7#1)
conventional medical##2##2##(2008-11#1)(2010-10#1)
conventional method of##2##3##(2008-10#1)(2008-11#1)
conventional method##15##2##(2008-10#8)(2008-11#3)(2008-12#2)(2008-8#1)(2010-6#1)
conventional methods for##3##3##(2008-10#2)(2012-2#1)
conventional methods##17##2##(1994-3#1)(1994-8#1)(2008-10#7)(2008-11#2)(2008-5#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
conventional nebulization##4##2##(2008-10#4)
conventional one##2##2##(2008-3#2)
conventional one-way alphanumeric##2##3##(2010-8#2)
conventional plots##4##2##(2008-10#4)
conventional procedure##6##2##(2008-10#4)(2011-2#1)(2011-3#1)
conventional quick dry##2##3##(2008-5#2)
conventional radiography##4##2##(2008-2#1)(2011-2#1)(2013-1#2)
conventional risk factors##2##3##(2008-8#1)(2010-9#1)
conventional risk##3##2##(2008-8#1)(2010-9#2)
conventional solid phase##2##3##(2008-10#2)
conventional solvent extraction##2##3##(2008-10#2)
conventional spectrophotometric##2##2##(2008-10#1)(2008-3#1)
conventional static##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
conventional stationary##2##2##(2008-11#1)(2008-5#1)
conventional technique##5##2##(1994-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2011-7#1)
conventional techniques##5##2##(1994-3#1)(1997-7#1)(2008-10#2)(2008-11#1)
conventional terminal##2##2##(1994-12#1)(2008-10#1)
conventional tests for##2##3##(1992-9#1)(1994-9#1)
conventional therapy##5##2##(1993-11#1)(1994-6#1)(2011-2#2)(2012-12#1)
conventional tillage##13##2##(2008-10#13)
conventional treatment##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
conventional vaccinology approaches##2##3##(2010-8#2)
conventional ventilation##3##2##(1994-6#3)
conventional well##2##2##(2013-1#2)
conventional wisdom##2##2##(2008-9#1)(2010-10#1)
conventional##541##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#4)(2008-1#3)(2008-10#241)(2008-11#37)(2008-12#6)(2008-2#3)(2008-3#20)(2008-4#2)(2008-5#16)(2008-6#6)(2008-7#9)(2008-8#5)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#8)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#9)(2010-9#4)(2011-1#2)(2011-2#21)(2011-3#1)(2011-7#4)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#6)
conventional-till fields (P = 0##2##5##(2008-10#2)
conventional-till fields##4##2##(2008-10#4)
conventionally tilled plots##2##3##(2008-10#2)
conventionally tilled##3##2##(2008-10#3)
conventionally used##2##2##(2008-10#2)
conventionally##21##1##(2008-10#15)(2008-11#2)(2008-12#1)(2008-9#1)(2010-5#1)(2013-1#1)
converge on##3##2##(2008-9#1)(2009-6#1)(2010-6#1)
converge to##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
converge##9##1##(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-6#1)(2013-1#1)
converged##3##1##(1997-1#1)(1997-8#1)(2008-9#1)
convergence in##2##2##(2009-10#1)(2011-2#1)
convergence of##6##2##(1991-12#1)(1992-9#1)(1996-3#1)(2009-3#1)(2012-3#1)(2013-8#1)
convergence to the global##2##4##(2008-10#1)(2008-8#1)
convergence to the##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
convergence to##6##2##(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#2)
convergence##30##1##(1991-12#1)(1992-9#1)(1995-2#1)(1996-3#1)(2007-12#3)(2008-10#6)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
convergent evolution in##2##3##(2011-2#2)
convergent evolution##6##2##(2008-9#1)(2009-6#1)(2011-2#4)
convergent##15##1##(1997-7#1)(2008-10#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#4)
convergently##2##1##(2008-10#1)(2009-8#1)
converges##2##1##(1997-2#1)(2009-7#1)
converging research##3##2##(2011-2#3)
converging##5##1##(2008-3#1)(2011-2#4)
conversation with##2##2##(2010-7#1)(2012-3#1)
conversation##8##1##(2008-11#2)(2008-12#1)(2008-6#1)(2010-7#1)(2012-3#1)(2013-1#2)
conversational##2##1##(2008-9#1)(2011-2#1)
conversations##4##1##(1995-12#1)(2008-12#1)(2008-9#1)(2009-6#1)
converse##2##1##(1990-8#1)(2008-8#1)
conversely##3##1##(2008-8#1)(2010-10#1)(2013-1#1)
conversion and##8##2##(1990-6#1)(1994-8#1)(1995-9#1)(2008-10#3)(2008-3#1)(2011-1#1)
conversion by use of the photorefractive##2##6##(2008-2#1)(2008-3#1)
conversion decreased##2##2##(2008-7#2)
conversion efficiencies##3##2##(2008-3#2)(2011-2#1)
conversion efficiency is##3##3##(2007-12#2)(2008-8#1)
conversion efficiency of##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
conversion efficiency##15##2##(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#3)(2010-1#1)
conversion factor##2##2##(2008-10#2)
conversion factors##3##2##(1992-2#1)(2008-11#2)
conversion from##4##2##(1994-3#1)(1997-8#1)(2008-10#1)(2011-2#1)
conversion in##3##2##(1993-12#1)(1994-3#1)(2007-12#1)
conversion into##7##2##(1991-7#1)(2008-10#5)(2008-11#1)
conversion is##5##2##(1992-8#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-7#1)
conversion of Cr(III) to Cr(VI)##2##5##(2008-10#2)
conversion of D##2##3##(1995-3#2)
conversion of Se(VI) in##2##4##(2008-10#2)
conversion of Se(VI) to Se(IV)##2##5##(2008-10#2)
conversion of Se(VI)##5##3##(2008-10#5)
conversion of the##16##3##(1991-5#1)(1992-12#1)(1994-5#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)
conversion of##98##2##(1990-10#1)(1990-11#2)(1990-8#1)(1991-5#2)(1992-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-3#4)(1995-6#2)(1995-8#4)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#2)(2008-10#40)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#2)(2010-1#2)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
conversion process##3##2##(1993-2#1)(2008-10#1)(2008-6#1)
conversion rate of##2##3##(1995-12#1)(2008-7#1)
conversion rate##4##2##(1995-12#3)(2008-7#1)
conversion rates##2##2##(2008-7#1)(2013-1#1)
conversion ratio##4##2##(2008-12#2)(2008-5#2)
conversion ratios##2##2##(2008-12#1)(2008-5#1)
conversion to the##5##3##(1996-5#2)(2007-12#1)(2008-10#1)(2008-12#1)
conversion to##22##2##(1990-10#1)(1990-9#1)(1992-10#1)(1996-3#1)(1996-5#2)(2007-12#2)(2008-10#4)(2008-12#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#1)
conversion was observed##2##3##(1990-12#1)(2008-10#1)
conversion was##5##2##(1990-12#1)(2008-10#3)(2008-5#1)
conversion##223##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-5#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#5)(1995-6#2)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-12#9)(2008-10#67)(2008-11#4)(2008-12#10)(2008-2#6)(2008-3#13)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#6)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
conversions and##2##2##(2008-11#1)(2013-8#1)
conversions in##2##2##(2009-4#1)(2011-1#1)
conversions##10##1##(1993-12#1)(1995-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
convert##23##1##(1991-5#1)(1993-12#3)(1995-11#1)(1995-12#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-5#1)(2011-2#1)(2013-1#2)
convertase subtilisin/kexin type 9##2##4##(2013-1#2)
convertase subtilisin/kexin##3##2##(2008-6#1)(2013-1#2)
convertase##6##1##(1993-2#2)(2008-4#1)(2008-6#1)(2013-1#2)
converted by##2##2##(1991-5#1)(2008-10#1)
converted coherent image##2##3##(2008-3#2)
converted in the##2##3##(2008-10#1)(2008-8#1)
converted in##3##2##(1996-5#1)(2008-10#1)(2008-8#1)
converted into a##4##3##(1997-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
converted into the##3##3##(1990-12#1)(2008-10#2)
converted into##19##2##(1990-12#1)(1993-12#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
converted to a sequence characterized amplified region (SCAR)##2##8##(2008-10#2)
converted to a##9##3##(1992-8#2)(1993-8#1)(2008-10#5)(2011-2#1)
converted to its##2##3##(2008-10#2)
converted to laparotomy##3##3##(1994-2#1)(1995-3#1)(1996-1#1)
converted to their respective##2##4##(2008-7#1)(2010-5#1)
converted to their##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
converted to##55##2##(1991-5#1)(1992-8#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-5#1)(2008-10#31)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
converted##94##1##(1990-12#1)(1990-5#2)(1991-10#1)(1991-5#2)(1992-8#2)(1993-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#3)(1997-3#1)(2008-10#49)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
converter based on##2##3##(2008-10#1)(2008-2#1)
converter##9##1##(2008-10#7)(2008-2#1)(2008-3#1)
converters##6##1##(2008-10#3)(2008-11#2)(2008-3#1)
converting enzyme (ACE)##3##3##(1993-12#1)(2008-1#1)(2008-7#1)
converting enzyme##6##2##(1991-3#1)(1993-12#2)(1996-6#1)(2008-1#1)(2008-7#1)
converting it to ADP##2##4##(2013-1#2)
converting it to##3##3##(1995-2#1)(2013-1#2)
converting the##2##2##(2008-10#1)(2008-8#1)
converting to##2##2##(2008-5#1)(2012-12#1)
converting##23##1##(1991-3#1)(1993-12#2)(1994-11#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
converts a##2##2##(2008-3#2)
converts the##2##2##(1997-1#1)(2008-10#1)
converts##11##1##(1990-11#1)(1992-8#1)(1997-1#1)(2008-10#5)(2008-3#2)(2012-2#1)
convex toward the##2##3##(1997-8#2)
convex##17##1##(1992-3#1)(1996-5#2)(1997-8#2)(2007-8#1)(2008-10#1)(2008-3#4)(2008-6#2)(2008-8#1)(2012-2#2)(2013-1#1)
convexity measure##8##2##(2008-6#8)
convexity##13##1##(1992-2#1)(2008-6#12)
convey##9##1##(1992-12#1)(1992-2#1)(1993-2#1)(1997-3#1)(1997-4#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-3#1)
conveyed##4##1##(2008-11#2)(2009-8#1)(2011-2#1)
conveying Liq pH##2##3##(2011-3#2)
conveying the##2##2##(1997-3#1)(2008-11#1)
conveying##6##1##(1994-8#1)(1997-3#1)(2008-11#1)(2011-3#3)
conveys##3##1##(2008-11#1)(2009-10#1)(2011-1#1)
convicted of sexual offenses##2##4##(1992-9#1)(1996-5#1)
convicted of##3##2##(1991-2#1)(1992-9#1)(1996-5#1)
convicted prostitute##2##2##(1992-9#2)
convicted##7##1##(1991-2#1)(1992-9#3)(1995-12#1)(1996-5#2)
conviction##3##1##(1992-9#2)(2013-8#1)
convictions##4##1##(1990-6#1)(1991-2#1)(2008-11#1)(2008-12#1)
convince##3##1##(1990-3#1)(1992-8#1)(1997-7#1)
convinced that##2##2##(1996-2#1)(2011-2#1)
convinced##5##1##(1995-1#1)(1996-1#1)(1996-2#1)(2010-1#1)(2011-2#1)
convincing evidence of##2##3##(1990-11#1)(1992-2#1)
convincing evidence that##4##3##(1990-12#1)(1992-9#1)(1995-11#1)(2010-1#1)
convincing evidence##8##2##(1990-11#1)(1990-12#1)(1992-2#1)(1992-9#1)(1995-11#1)(2008-10#1)(2010-1#1)(2011-2#1)
convincing for##2##2##(2012-12#1)(2013-8#1)
convincing##19##1##(1990-11#1)(1990-12#1)(1991-3#1)(1992-2#1)(1992-9#1)(1994-1#1)(1995-11#1)(2008-10#2)(2008-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
convincingly demonstrated##2##2##(2010-11#1)(2013-1#1)
convincingly##4##1##(1991-12#1)(1993-12#1)(2010-11#1)(2013-1#1)
convoluted##2##1##(2007-12#1)(2008-10#1)
convolution of the##2##3##(2008-10#1)(2008-3#1)
convolution##5##1##(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
convulsion##2##1##(2010-8#1)(2013-1#1)
convulsions##8##1##(1991-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(2010-1#1)(2010-7#1)(2011-1#2)
convulsive activity and##2##3##(2008-11#1)(2010-1#1)
convulsive##5##1##(2008-11#2)(2010-1#1)(2013-1#2)
conyzoides##3##1##(2008-10#3)
cooked beef meat##3##3##(2008-10#3)
cooked beef##7##2##(2008-10#4)(2010-4#3)
cooked frankfurters##2##2##(2010-4#2)
cooked meat products##2##3##(2010-4#2)
cooked meat##3##2##(2010-4#3)
cooked##18##1##(1997-2#3)(2008-10#6)(2010-4#8)(2011-2#1)
cooking loss##2##2##(2010-4#2)
cooking losses##2##2##(2010-4#2)
cooking##8##1##(1997-3#1)(2009-8#1)(2010-4#5)(2010-5#1)
cool diamonds##2##2##(1990-11#2)
cool##16##1##(1990-11#2)(1994-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2012-7#1)
cool-season##2##1##(2008-10#1)(2008-8#1)
cooled##13##1##(1991-2#1)(1992-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2012-2#1)
cooler##8##1##(2008-10#6)(2008-8#1)(2012-4#1)
cooling and##3##2##(2008-10#2)(2008-3#1)
cooling effluents##2##2##(2008-10#2)
cooling of the##2##3##(1991-2#1)(2008-10#1)
cooling of##4##2##(1991-2#1)(1992-8#1)(1995-3#1)(2008-10#1)
cooling##42##1##(1991-2#1)(1992-1#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-3#3)(1996-8#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#1)(2009-1#1)(2009-11#2)(2010-1#3)(2011-2#1)
cooperate in##2##2##(1997-3#1)(2011-2#1)
cooperate to##2##2##(1993-12#1)(1995-8#1)
cooperate with##7##2##(1990-2#1)(1994-12#1)(1996-2#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)
cooperate##13##1##(1990-2#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-2#2)(1997-3#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)
cooperated##2##1##(1993-2#1)(2008-11#1)
cooperates with##2##2##(2012-2#2)
cooperating with##3##2##(1997-4#2)(2008-11#1)
cooperating##4##1##(1997-4#2)(2008-11#1)(2008-8#1)
cooperation and##3##2##(2008-10#2)(2010-4#1)
cooperation between##9##2##(1993-6#1)(1995-11#1)(2008-8#2)(2009-8#1)(2011-1#1)(2011-4#1)(2012-12#1)(2012-3#1)
cooperation from##2##2##(2008-8#1)(2010-9#1)
cooperation in##5##2##(1993-11#1)(1993-12#1)(2008-12#1)(2008-8#2)
cooperation is##2##2##(2008-8#1)(2012-3#1)
cooperation of the##2##3##(1991-3#1)(2008-10#1)
cooperation of##3##2##(1991-3#1)(2008-10#1)(2008-11#1)
cooperation with community pharmacists##2##4##(2011-1#2)
cooperation with other##2##3##(1994-6#1)(2013-1#1)
cooperation with the##3##3##(1993-2#1)(1993-6#1)(2008-10#1)
cooperation with##14##2##(1993-2#2)(1993-6#1)(1994-6#1)(1996-6#1)(1997-1#1)(2008-10#1)(2009-10#1)(2010-7#3)(2011-1#2)(2013-1#1)
cooperation##62##1##(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-6#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#18)(2009-10#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-7#3)(2010-9#1)(2011-1#3)(2011-4#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
cooperative amplification##2##2##(1997-6#2)
cooperative binding##2##2##(1990-11#1)(2008-10#1)
cooperative breeding in##3##3##(2008-8#3)
cooperative breeding##8##2##(2008-8#8)
cooperative effort##2##2##(1991-2#1)(1996-1#1)
cooperative interactions##3##2##(2008-10#2)(2008-8#1)
cooperative nature##2##2##(1992-9#1)(1995-6#1)
cooperative tendencies##2##2##(2008-8#2)
cooperative##55##1##(1990-11#1)(1990-8#1)(1991-2#3)(1991-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#2)(1997-6#3)(2008-10#6)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#17)(2008-9#1)(2009-8#2)(2010-5#1)
cooperatively##7##1##(1995-2#2)(1997-7#1)(2008-12#1)(2008-9#3)
cooperativity in O2 binding##3##4##(1991-10#3)
cooperativity in##4##2##(1991-10#3)(1997-2#1)
cooperativity##13##1##(1990-8#1)(1991-10#4)(1993-8#1)(1994-5#3)(1997-2#1)(2008-10#2)(2012-2#1)
cooperators##2##1##(2008-8#1)(2012-3#1)
coordinate frames##2##2##(1990-5#2)
coordinate the##7##2##(1992-1#1)(1992-2#1)(2008-10#1)(2009-10#1)(2009-6#1)(2012-2#2)
coordinate##33##1##(1990-5#2)(1991-5#2)(1991-7#1)(1992-1#1)(1992-2#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#2)(1997-2#1)(1997-7#2)(2008-10#5)(2008-11#1)(2008-3#4)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-7#1)(2012-2#2)
coordinated by the##2##3##(1991-3#1)(2008-10#1)
coordinated by##3##2##(1991-3#1)(2008-10#1)(2009-5#1)
coordinated to##2##2##(2008-10#2)
coordinated with##3##2##(1994-12#1)(1995-6#1)(2011-2#1)
coordinated##43##1##(1991-3#1)(1992-1#2)(1993-6#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#2)(1997-3#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)
coordinately##3##1##(1991-5#1)(2008-10#1)(2008-11#1)
coordinates and##3##2##(2008-3#2)(2008-6#1)
coordinates are based on the##2##5##(1990-5#2)
coordinates of the##2##3##(1992-4#1)(2009-2#1)
coordinates of##3##2##(1991-6#1)(1992-4#1)(2009-2#1)
coordinates the##2##2##(1993-12#1)(2008-11#1)
coordinates with the##3##3##(2008-10#2)(2013-1#1)
coordinates with##5##2##(2008-10#2)(2008-9#1)(2010-7#1)(2013-1#1)
coordinates##33##1##(1990-5#2)(1991-6#1)(1992-2#1)(1992-4#2)(1993-12#1)(1993-8#1)(1993-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#9)(2008-6#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
coordinating the operation of##2##4##(1996-1#1)(2008-10#1)
coordinating the##5##2##(1994-1#2)(1996-1#1)(2008-10#2)
coordinating##17##1##(1992-6#1)(1994-1#2)(1994-5#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-2#2)(2008-10#4)(2009-9#1)(2010-4#1)(2012-2#1)
coordination and##6##2##(1993-3#1)(1994-8#1)(1996-1#1)(2008-11#1)(2008-12#1)(2011-3#1)
coordination in##3##2##(1994-5#1)(2009-1#1)(2009-8#1)
coordination of the##3##3##(1993-8#1)(2008-10#2)
coordination of##17##2##(1992-1#1)(1993-8#1)(1994-3#2)(1995-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
coordination was##3##2##(1995-3#1)(1997-2#1)(2008-9#1)
coordination with##3##2##(1996-2#1)(2008-10#2)
coordination##68##1##(1992-1#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#4)(1996-1#2)(1996-2#1)(1997-1#2)(1997-2#2)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-8#2)(2008-9#2)(2009-1#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#3)(2013-1#3)(2013-7#1)
coordinator##6##1##(1991-2#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#2)
coordinators##8##1##(1991-2#1)(1996-12#1)(2008-3#3)(2009-4#1)(2011-2#1)(2011-3#1)
copayments##2##1##(1991-3#1)(1995-1#1)
cope and##2##2##(1995-9#1)(2013-8#1)
cope with the##4##3##(1993-1#1)(2008-10#1)(2008-11#2)
cope with their##2##3##(1993-3#1)(1995-9#1)
cope with##19##2##(1993-1#1)(1993-3#1)(1994-12#1)(1995-9#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#2)(2013-8#1)
cope##28##1##(1993-1#1)(1993-3#1)(1994-12#1)(1995-9#2)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#3)(2011-2#2)(2013-8#2)
copepods##2##1##(2010-8#1)(2011-2#1)
cophenetic correlation##2##2##(2008-5#2)
copied##2##1##(2008-9#1)(2009-10#1)
copies in##3##2##(1990-6#1)(2008-10#1)(2013-8#1)
copies mul(-1)##2##2##(2008-10#2)
copies of the##19##3##(1992-8#1)(1993-12#1)(1994-11#1)(1996-12#1)(1996-6#1)(1997-2#3)(1997-7#1)(2008-10#7)(2008-8#1)(2009-10#1)(2012-12#1)
copies of these##2##3##(2008-10#1)(2008-5#1)
copies of this##4##3##(2008-10#4)
copies of##36##2##(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#3)(1997-7#1)(1997-8#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
copies per cell##2##3##(1991-2#1)(1993-8#1)
copies per##3##2##(1991-2#1)(1993-8#1)(2009-8#1)
copies##60##1##(1990-6#1)(1991-2#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#3)(1997-7#3)(1997-8#1)(2008-10#21)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#4)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
copies)##2##1##(2008-10#2)
coping (hesitation to report pain##2##5##(2010-11#2)
coping and anxiety##2##3##(1995-1#2)
coping and##5##2##(1995-1#2)(2008-11#1)(2008-12#1)(2009-7#1)
coping are##2##2##(1997-8#1)(2012-2#1)
coping skills##4##2##(1992-2#1)(2010-11#1)(2013-1#2)
coping strategies and##2##3##(1995-9#1)(2008-11#1)
coping strategies employed in##2##4##(2008-1#1)(2008-11#1)
coping strategies##14##2##(1991-1#1)(1992-3#1)(1995-9#1)(2008-1#2)(2008-11#8)(2008-8#1)
coping strategy##2##2##(2008-11#1)(2008-12#1)
coping styles##6##2##(2008-12#1)(2009-11#3)(2009-7#2)
coping was associated with##2##4##(2009-5#2)
coping with the##2##3##(1996-9#1)(2008-10#1)
coping with##6##2##(1991-1#1)(1991-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
coping##89##1##(1991-1#3)(1991-12#2)(1991-2#1)(1992-2#1)(1992-3#1)(1995-1#8)(1995-9#1)(1996-9#1)(1997-8#1)(2008-1#3)(2008-10#1)(2008-11#16)(2008-12#10)(2008-4#2)(2008-8#1)(2009-11#8)(2009-12#2)(2009-5#2)(2009-7#6)(2010-1#1)(2010-11#4)(2010-4#4)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#3)
copious##2##1##(1990-5#1)(2008-9#1)
coplanar##3##1##(2008-10#3)
copolymer and##2##2##(2008-10#2)
copolymer of##2##2##(2008-11#1)(2008-5#1)
copolymer with##2##2##(2008-10#1)(2008-12#1)
copolymer##28##1##(2008-10#15)(2008-11#6)(2008-12#2)(2008-5#2)(2009-7#1)(2010-4#2)
copolymerization of tau with tubulin and actin filaments##2##8##(1993-6#2)
copolymerization of##7##2##(1993-6#2)(2007-12#1)(2008-10#4)
copolymerization##8##1##(1993-6#2)(2007-12#1)(2008-10#4)(2009-10#1)
copolymers of##4##2##(2008-5#2)(2009-10#2)
copolymers##9##1##(2008-10#2)(2008-5#3)(2009-10#3)(2013-1#1)
copper (II)##4##2##(2008-10#4)
copper and 0##3##3##(2008-10#3)
copper and aluminium in##2##4##(1992-3#2)
copper and aluminium##3##3##(1992-3#3)
copper and cadmium##5##3##(2008-10#5)
copper and iron##12##3##(2008-10#12)
copper and lead in soils##2##5##(2008-10#2)
copper and lead in##4##4##(2008-10#4)
copper and lead##6##3##(2008-10#6)
copper and manganese in biological materials and##2##7##(2008-10#2)
copper and manganese##5##3##(2008-10#5)
copper and mercury ions##5##4##(2008-10#5)
copper and mercury##6##3##(2008-10#6)
copper and zinc##7##3##(1992-3#1)(2008-10#6)
copper and##68##2##(1992-12#1)(1992-3#4)(1993-2#1)(2008-10#60)(2008-8#1)(2013-8#1)
copper are##3##2##(1992-12#1)(2008-10#2)
copper as##2##2##(2008-10#2)
copper at##7##2##(2008-10#7)
copper by flame atomic absorption spectrometry##2##6##(2008-10#2)
copper by flame##3##3##(2008-10#3)
copper by##13##2##(2008-10#12)(2008-8#1)
copper can be##2##3##(2008-10#2)
copper complex##3##2##(2008-10#3)
copper complexes##3##2##(2008-10#3)
copper concentration in serum##2##4##(1993-2#2)
copper concentration of##2##3##(2008-10#1)(2008-11#1)
copper concentration##5##2##(1993-2#2)(2008-10#1)(2008-11#1)(2008-5#1)
copper concentrations in the range##2##5##(2008-10#2)
copper concentrations in the##3##4##(1990-5#1)(2008-10#2)
copper concentrations in##4##3##(1990-5#1)(2008-10#3)
copper concentrations##8##2##(1990-5#1)(2008-10#6)(2008-12#1)
copper content##2##2##(2008-10#2)
copper deficiency is##3##3##(2012-2#3)
copper deficiency##5##2##(2008-12#1)(2012-2#4)
copper determination by##3##3##(2008-10#3)
copper determination in natural##2##4##(2008-10#2)
copper determination in##11##3##(2008-10#11)
copper determination##17##2##(2008-10#17)
copper electrode in##2##3##(2008-10#2)
copper electrodes##3##2##(2008-10#3)
copper filter##2##2##(1997-8#2)
copper filtration##2##2##(1997-8#2)
copper formed##2##2##(2008-10#2)
copper from##4##2##(2008-10#4)
copper has been##2##3##(2008-10#2)
copper hexacyanoferrate##2##2##(2008-10#2)
copper hydroxide/mancozeb##2##2##(2008-10#2)
copper in aqueous##2##3##(2008-10#2)
copper in river water##3##4##(2008-10#3)
copper in river waters##3##4##(2008-10#3)
copper in river##6##3##(2008-10#6)
copper in##45##2##(2008-10#45)
copper ion##4##2##(2008-10#4)
copper ions##17##2##(2008-10#16)(2008-5#1)
copper mass##2##2##(2008-10#2)
copper matrices##2##2##(2008-10#2)
copper microparticles##2##2##(2008-10#2)
copper on##4##2##(2008-10#3)(2008-12#1)
copper oxide and glucose oxidase##2##5##(2008-10#2)
copper oxide##7##2##(1993-5#1)(2008-10#4)(2008-2#2)
copper phosphate##2##2##(2008-10#2)
copper recovery##2##2##(2008-10#2)
copper resistance##3##2##(2008-10#3)
copper solid amalgam electrode##2##4##(2008-10#2)
copper solid amalgam##4##3##(2008-10#4)
copper solutions##2##2##(2008-10#2)
copper sulfate (CuSO(4))##2##3##(2008-10#1)(2008-11#1)
copper sulfate##5##2##(2008-10#3)(2008-11#2)
copper using##3##2##(2008-10#3)
copper was##8##2##(1990-8#1)(2008-10#6)(2008-5#1)
copper were##5##2##(2008-10#5)
copper which##2##2##(2008-10#2)
copper wire##3##2##(2008-10#3)
copper with detection limits##2##4##(2008-10#2)
copper with detection##3##3##(2008-10#3)
copper with the##2##3##(2008-10#2)
copper with##10##2##(2008-10#10)
copper##465##1##(1990-5#4)(1990-8#3)(1992-12#3)(1992-3#5)(1993-2#3)(1993-5#1)(1997-8#5)(2008-10#398)(2008-11#4)(2008-12#6)(2008-2#3)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#4)(2009-12#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#11)(2013-1#1)(2013-7#1)(2013-8#2)
copper(I) chloride##3##2##(2008-10#3)
copper(I)##6##1##(2008-10#6)
copper(I)oxide##2##1##(2008-10#2)
copper(II) and cadmium(II)##3##3##(2008-10#3)
copper(II) and cobalt(II)##2##3##(2008-10#2)
copper(II) and nickel(II) in##3##4##(2008-10#3)
copper(II) and##19##2##(2008-10#19)
copper(II) ion##5##2##(2008-10#5)
copper(II) ions##9##2##(2008-10#9)
copper(II) is##3##2##(2008-10#3)
copper(II) phosphate##2##2##(2008-10#2)
copper(II) using octadecyl silica membrane disks modified by##2##8##(2008-10#2)
copper(II) using##3##2##(2008-10#3)
copper(II) was##3##2##(2008-10#3)
copper(II) with a##2##3##(2008-10#2)
copper(II) with##5##2##(2008-10#5)
copper(II)##112##1##(2008-10#111)(2008-12#1)
copper(II)-neocuproine reagent in##2##3##(2008-10#2)
copper(II)-neocuproine##3##1##(2008-10#3)
copper(II)-sensitive membrane##2##2##(2008-10#2)
copper)##3##1##(2008-10#2)(2010-4#1)
copper-modified##3##1##(2008-10#3)
copper-protein complex##2##2##(2008-10#2)
copper-protein complexes##3##2##(2008-10#3)
copper-protein##5##1##(2008-10#5)
copper-resistant strains##2##2##(2008-10#2)
copper-resistant##5##1##(2008-10#5)
copper-sensitive##3##1##(2008-10#3)
copper-smelting site##2##2##(2008-10#2)
copperised cadmium reductor column##3##4##(2008-10#3)
copperised cadmium##4##2##(2008-10#4)
copperized##2##1##(2008-10#2)
coprecipitated in##2##2##(1996-2#1)(2008-10#1)
coprecipitated with##2##2##(2008-10#2)
coprecipitated##6##1##(1996-2#1)(2008-10#5)
coprecipitation of##2##2##(2008-10#2)
coprecipitation##13##1##(2008-10#13)
copropagating##2##1##(2007-11#2)
coprophilous##2##1##(2008-11#2)
coproporphyrin##2##1##(2008-10#2)
coptisine##4##1##(2008-11#4)
copulation##7##1##(2007-12#1)(2008-11#2)(2008-6#1)(2008-8#2)(2013-8#1)
copulatory##3##1##(2008-11#1)(2011-2#2)
copurifies with##2##2##(1992-6#1)(1995-2#1)
copy number alterations##3##3##(2008-9#3)
copy number and##6##3##(1995-11#1)(1997-6#1)(2008-11#2)(2008-8#1)(2010-10#1)
copy number in##2##3##(1993-12#1)(2012-3#1)
copy number of##6##3##(1991-7#1)(2008-10#3)(2008-11#1)(2010-5#1)
copy number plasmid##2##3##(2008-10#2)
copy number##36##2##(1991-7#1)(1991-9#1)(1993-12#1)(1993-9#1)(1995-11#1)(1997-6#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#3)(2010-10#2)(2010-5#1)(2011-2#3)(2012-3#5)
copy numbers##3##2##(1993-9#1)(2008-10#1)(2009-10#1)
copy of the##10##3##(1993-3#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#3)
copy of##16##2##(1991-3#1)(1993-3#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2012-3#5)
copy on##2##2##(1993-2#1)(2012-3#1)
copy the mate choice of##3##5##(2008-9#1)(2009-6#2)
copy their##2##2##(1990-2#2)
copy##86##1##(1990-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#2)(1995-11#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-5#1)(2008-8#7)(2008-9#5)(2009-10#3)(2009-6#3)(2009-7#3)(2010-10#2)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#11)
cor pulmonale##3##2##(1991-11#1)(2012-12#2)
cor##5##1##(1991-11#1)(2008-10#1)(2008-12#1)(2012-12#2)
coracoid##4##1##(2013-1#4)
coral bleaching##3##2##(2008-9#1)(2012-2#2)
coral family##2##2##(2008-6#2)
coral goby Gobiodon erythrospilus##2##4##(2010-8#2)
coral reef bleaching##2##3##(2008-9#2)
coral reef##3##2##(2008-9#2)(2013-1#1)
coral reefs##2##2##(2008-3#1)(2008-9#1)
coral##18##1##(1993-2#1)(2008-3#2)(2008-6#2)(2008-9#4)(2010-5#1)(2010-8#3)(2011-2#1)(2012-2#3)(2013-1#1)
coral-reef##3##1##(2010-8#3)
coralliilyticus/neptunius-like isolate##2##2##(2009-6#2)
corals##10##1##(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#2)(2012-2#2)
cord and##16##2##(1990-11#2)(1992-1#1)(1992-12#1)(1995-12#2)(1996-12#1)(1996-2#2)(1997-6#1)(2008-7#4)(2013-7#1)(2013-8#1)
cord blood CD34(+) cells##3##4##(2008-8#3)
cord blood by##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
cord blood cells##3##3##(2008-11#3)
cord blood contains##2##3##(2008-11#1)(2008-9#1)
cord blood is##2##3##(2008-11#1)(2008-9#1)
cord blood samples##3##3##(2008-10#3)
cord blood transplantation##3##3##(2008-11#1)(2013-1#2)
cord blood unit##2##3##(2010-11#2)
cord blood units##2##3##(2010-11#2)
cord blood##48##2##(2008-10#5)(2008-11#19)(2008-4#1)(2008-8#5)(2008-9#9)(2010-11#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
cord compression##15##2##(1991-9#2)(1992-12#4)(1993-9#1)(2008-12#1)(2008-7#5)(2012-3#2)
cord injury##13##2##(1991-12#1)(1993-2#1)(2008-10#1)(2008-7#5)(2012-2#1)(2013-1#4)
cord of the##2##3##(1991-4#1)(1997-2#1)
cord of##6##2##(1991-4#1)(1997-2#4)(1997-3#1)
cord signal changes##2##3##(2012-12#2)
cord signal##4##2##(2012-12#4)
cord stricture##2##2##(2008-11#2)
cord were##2##2##(1991-5#1)(2008-7#1)
cord##230##1##(1990-11#3)(1990-5#3)(1991-12#1)(1991-4#1)(1991-5#5)(1991-6#7)(1991-9#2)(1992-1#2)(1992-12#5)(1992-6#1)(1993-2#2)(1993-6#1)(1993-9#3)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#3)(1995-2#1)(1996-12#5)(1996-2#7)(1996-5#3)(1996-9#1)(1997-2#5)(1997-3#5)(1997-6#3)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#29)(2008-12#4)(2008-4#3)(2008-5#1)(2008-7#31)(2008-8#5)(2008-9#12)(2009-11#1)(2009-5#1)(2009-8#7)(2010-11#8)(2010-12#4)(2010-5#3)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#6)(2012-2#2)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#1)
cord-blood##2##1##(2012-2#2)
cordata Thunb##3##2##(2008-10#3)
cordata##6##1##(2008-10#6)
cords##15##1##(1990-6#1)(1995-12#1)(2007-12#1)(2008-11#2)(2008-5#1)(2010-11#2)(2011-1#2)(2011-2#5)
core and##7##2##(1992-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-9#1)
core antigen##2##2##(1995-5#1)(1996-12#1)
core binding factor I (Cbfa I)##2##6##(2008-11#2)
core binding##3##2##(1993-2#1)(2008-11#2)
core biopsy##4##2##(2010-11#1)(2011-2#2)(2012-2#1)
core clinical skills##2##3##(2008-12#2)
core coding region##2##3##(2013-1#2)
core consists of##2##3##(1995-2#1)(1995-3#1)
core functions of public health##4##5##(1995-12#2)(1996-1#1)(1996-3#1)
core functions##12##2##(1995-12#4)(1996-1#1)(1996-2#2)(1996-3#3)(1997-2#2)
core genome##2##2##(2011-2#2)
core in##2##2##(1992-3#1)(2008-10#1)
core ischemic##2##2##(1997-2#2)
core like particles##2##3##(1996-12#2)
core microcapsules##6##2##(2008-11#6)
core of the##13##3##(1994-5#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-3#1)
core of##27##2##(1990-3#1)(1991-2#2)(1993-2#1)(1993-3#1)(1994-5#1)(2008-10#8)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
core particle##2##2##(1995-2#1)(1996-12#1)
core peptide##2##2##(1993-1#1)(1995-2#1)
core promoter##3##2##(1995-2#1)(2012-2#1)(2013-1#1)
core protein##8##2##(1990-2#1)(1991-5#1)(1992-1#2)(1995-5#1)(2008-11#2)(2008-8#1)
core proteins##2##2##(1997-9#1)(2008-5#1)
core public health functions##4##4##(1996-2#3)(1996-3#1)
core public health##7##3##(1995-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#1)
core region##6##2##(1995-2#1)(1997-3#1)(2008-5#1)(2008-7#1)(2008-8#2)
core sequence##4##2##(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
core set of##2##3##(2008-10#2)
core structure##2##2##(1994-5#1)(2008-11#1)
core temperature##8##2##(1992-3#3)(2008-5#3)(2010-7#1)(2011-2#1)
core##228##1##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#3)(1992-3#10)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-5#2)(1995-12#5)(1995-2#11)(1995-3#4)(1995-5#2)(1995-6#3)(1996-1#1)(1996-12#5)(1996-2#7)(1996-3#4)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-9#2)(2008-1#1)(2008-10#41)(2008-11#23)(2008-12#7)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#13)(2008-9#1)(2009-12#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#2)
core&quot##2##1##(1995-3#1)(2009-10#1)
core)##2##1##(1992-3#1)(2010-6#1)
core-doped rod##2##2##(2008-2#2)
core-doped##4##1##(2008-2#4)
core-needle biopsy##2##2##(2012-2#2)
core/shell particles##2##2##(2008-11#2)
cores from##2##2##(2008-10#1)(2013-8#1)
cores of the##3##3##(2008-10#1)(2010-6#1)(2013-8#1)
cores of##9##2##(1990-5#1)(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-8#1)
cores were##3##2##(2008-10#1)(2013-8#2)
cores##23##1##(1990-5#1)(1991-12#1)(1995-3#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2013-8#4)
corkscrew-shaped vessels##2##2##(1997-8#2)
corms of##3##2##(2008-10#3)
corms##4##1##(2008-10#3)(2008-12#1)
corn (Zea mays L##2##4##(2008-10#2)
corn (Zea mays)##3##3##(2008-10#3)
corn (Zea##5##2##(2008-10#5)
corn and soybean##3##3##(2008-10#3)
corn and##7##2##(2008-10#7)
corn borer##6##2##(1995-6#2)(2008-10#2)(2008-7#2)
corn fiber##3##2##(2008-11#1)(2013-1#2)
corn flea beetles ranged from 0##2##6##(2008-10#2)
corn flea beetles##7##3##(2008-10#7)
corn flea##8##2##(2008-10#8)
corn genotypes##4##2##(2008-10#4)
corn grits and green coffee beans ranged##2##7##(2008-10#2)
corn grits##4##2##(2008-10#4)
corn kernels##4##2##(2008-10#4)
corn lines##2##2##(2008-10#2)
corn meal agar##3##3##(2008-10#2)(2008-5#1)
corn oil##7##2##(2008-10#4)(2008-3#2)(2009-5#1)
corn plants##2##2##(2008-10#2)
corn plots##2##2##(2008-10#2)
corn rust##2##2##(2008-10#2)
corn starch##2##2##(2008-5#2)
corn stover##2##2##(2011-2#2)
corn trypsin inhibitor##2##3##(2008-10#2)
corn##115##1##(1995-3#1)(1995-6#2)(2008-10#92)(2008-11#2)(2008-3#2)(2008-5#5)(2008-7#3)(2008-8#2)(2009-5#1)(2009-8#1)(2011-2#2)(2013-1#2)
corn)##2##1##(2008-10#2)
corn-growing season##2##2##(2008-10#2)
cornea are##2##2##(2008-3#1)(2010-1#1)
cornea retention##4##2##(2011-3#4)
cornea##19##1##(1993-12#1)(2008-11#3)(2008-3#1)(2010-1#1)(2010-10#2)(2010-8#1)(2011-2#2)(2011-3#5)(2011-7#1)(2012-3#1)(2013-1#1)
corneal endothelial cell##2##3##(2011-2#1)(2013-1#1)
corneal endothelial cells##3##3##(2008-11#2)(2011-2#1)
corneal endothelial##6##2##(2008-11#3)(2011-2#2)(2013-1#1)
corneal epithelia##2##2##(2008-11#2)
corneal epithelium##2##2##(2008-11#1)(2011-2#1)
corneal thickness##2##2##(2011-2#2)
corneal transplantation##2##2##(2010-1#2)
corneal##42##1##(1991-8#1)(2008-11#7)(2010-1#2)(2010-10#8)(2011-2#16)(2011-3#1)(2011-7#1)(2012-3#3)(2013-1#3)
corneas##2##1##(2011-2#1)(2013-1#1)
corneocyte envelope##2##2##(2008-5#2)
corneocyte##6##1##(2008-5#6)
corneocytes on the##2##3##(2008-5#2)
corneocytes##12##1##(2008-5#11)(2011-2#1)
corneodesmolysis##4##1##(2008-5#4)
corneodesmosomal##3##1##(2008-5#3)
corneodesmosomes##4##1##(2008-5#4)
corneometer##5##1##(2008-5#5)
corneosomes##2##1##(2008-5#2)
corneosurfametry##3##1##(2008-5#3)
corneous##2##1##(2011-2#2)
corner of the##3##3##(1990-3#1)(2008-10#1)(2011-2#1)
corner of##5##2##(1990-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
corner##6##1##(1990-3#1)(1996-5#1)(2008-10#2)(2008-8#1)(2011-2#1)
cornerstone of##9##2##(1994-3#1)(1995-3#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)(2012-2#1)
cornerstone##10##1##(1994-3#1)(1995-3#1)(1996-11#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)(2012-2#1)
cornerstones of##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
corneum (SC) lipid##2##3##(2008-10#1)(2008-5#1)
corneum (SC)##7##2##(2008-10#1)(2008-5#6)
corneum barrier##3##2##(2008-5#3)
corneum cohesion##2##2##(2008-5#2)
corneum##78##1##(2008-10#3)(2008-5#75)
cornified envelope##2##2##(1994-3#1)(2008-5#1)
cornified##6##1##(1994-3#1)(2008-5#4)(2011-2#1)
cornmeal agar##4##2##(2008-10#4)
cornuarietis##7##1##(2008-11#7)
corollary is##2##2##(1991-5#1)(2009-8#1)
corona discharge ion mobility spectrometry##4##5##(2008-10#4)
corona discharge##5##2##(2008-10#5)
corona discharges##2##2##(2008-3#2)
corona##7##1##(2008-10#5)(2008-3#2)
coronal and root caries##2##4##(2008-1#1)(2008-5#1)
coronal and##3##2##(1995-5#1)(2008-1#1)(2008-5#1)
coronal##13##1##(1995-5#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#5)
coronally##2##1##(2013-1#2)
coronaria ischaemia##2##2##(2008-10#2)
coronary and peripheral##2##3##(2011-2#1)(2013-8#1)
coronary and##3##2##(2010-9#1)(2011-2#1)(2013-8#1)
coronary aneurysm##3##2##(2008-11#3)
coronary angiography and angioplasty##2##4##(2011-2#2)
coronary angiography and interventions##2##4##(2011-2#2)
coronary angiography and##7##3##(1992-9#1)(2009-10#1)(2011-2#5)
coronary angiography##19##2##(1992-9#1)(2008-10#1)(2008-11#2)(2009-10#3)(2009-11#1)(2011-2#9)(2012-2#1)(2013-1#1)
coronary angioplasty##10##2##(1992-9#2)(1993-12#1)(1995-2#1)(2008-11#2)(2008-5#2)(2008-8#1)(2013-8#1)
coronary arterial##3##2##(1992-11#1)(1994-11#1)(2013-2#1)
coronary arteries and##2##3##(1994-11#1)(2008-10#1)
coronary arteries in conditions of ischemic heart##2##7##(2012-3#2)
coronary arteries in##3##3##(2012-3#3)
coronary arteries were##3##3##(1994-11#1)(2012-3#2)
coronary arteries##20##2##(1991-12#1)(1991-3#1)(1992-6#1)(1992-9#2)(1994-11#4)(1997-8#2)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#5)
coronary artery aneurysms##2##3##(2008-11#1)(2011-2#1)
coronary artery bypass graft (CABG)##2##5##(1994-12#1)(2008-12#1)
coronary artery bypass graft surgery##3##5##(1995-2#1)(2008-11#1)(2012-12#1)
coronary artery bypass graft##7##4##(1992-11#1)(1994-12#1)(1995-2#1)(2008-11#2)(2008-12#1)(2012-12#1)
coronary artery bypass grafting##8##4##(1993-12#1)(2008-11#1)(2008-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
coronary artery bypass surgery##6##4##(1990-2#1)(2006-6#1)(2008-11#3)(2012-12#1)
coronary artery bypass##24##3##(1990-2#2)(1992-11#1)(1993-12#1)(1994-12#1)(1995-2#1)(2006-6#1)(2008-11#6)(2008-12#2)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#1)
coronary artery disease (CAD)##5##4##(1997-8#1)(2008-10#1)(2009-10#1)(2012-2#1)(2013-8#1)
coronary artery disease (n =##2##5##(2008-11#2)
coronary artery disease are##3##4##(2008-11#2)(2008-7#1)
coronary artery disease mortality##3##4##(2010-2#3)
coronary artery disease##40##3##(1990-3#1)(1992-9#1)(1993-2#1)(1995-3#1)(1996-6#1)(1997-8#2)(2008-10#1)(2008-11#10)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#1)(2010-2#4)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
coronary artery disease]##2##3##(2008-9#1)(2013-8#1)
coronary artery from the pulmonary##2##5##(2008-12#1)(2013-8#1)
coronary artery lesion##2##3##(1997-8#2)
coronary artery spasm and##2##4##(2008-7#2)
coronary artery spasm##4##3##(2008-7#4)
coronary artery stenosis##4##3##(2009-10#1)(2011-2#2)(2013-1#1)
coronary artery surgery##2##3##(2008-12#2)
coronary artery##107##2##(1990-2#2)(1990-3#1)(1990-8#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-3#1)(1997-8#4)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#22)(2008-12#10)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2010-12#1)(2010-2#4)(2010-5#1)(2010-9#1)(2011-2#11)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-2#4)(2013-7#1)(2013-8#3)
coronary bifurcation##2##2##(2008-11#1)(2013-1#1)
coronary bypass surgery with extracorporeal##2##5##(2012-3#2)
coronary bypass surgery##3##3##(2012-3#3)
coronary bypass##6##2##(1995-3#1)(2008-8#1)(2012-3#3)(2013-1#1)
coronary care##4##2##(2007-8#2)(2008-3#1)(2012-2#1)
coronary disease##5##2##(1993-3#1)(1995-12#1)(1996-11#1)(2007-8#1)(2011-2#1)
coronary endothelial##2##2##(1992-9#1)(2012-3#1)
coronary flow##2##2##(1992-6#1)(2008-12#1)
coronary heart disease (CHD)##3##4##(2008-11#1)(2008-6#1)(2012-2#1)
coronary heart disease and##5##4##(1993-12#2)(1993-2#1)(2008-12#1)(2008-8#1)
coronary heart disease in##4##4##(1996-8#2)(2008-12#2)
coronary heart disease is##2##4##(1991-2#1)(1993-2#1)
coronary heart disease##38##3##(1991-12#2)(1991-2#1)(1991-6#3)(1991-8#1)(1992-5#1)(1993-12#2)(1993-2#3)(1996-8#2)(2008-11#3)(2008-12#7)(2008-3#1)(2008-6#2)(2008-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#3)(2013-1#1)
coronary heart diseases##2##3##(1995-12#1)(2013-1#1)
coronary heart##40##2##(1991-12#2)(1991-2#1)(1991-6#3)(1991-8#1)(1992-5#1)(1993-12#2)(1993-2#3)(1995-12#1)(1996-8#2)(2008-11#3)(2008-12#7)(2008-3#1)(2008-6#2)(2008-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#3)(2013-1#2)
coronary interventions in the United States##2##6##(2011-2#2)
coronary interventions##8##2##(2008-11#2)(2011-2#6)
coronary lesion##2##2##(2008-11#1)(2011-2#1)
coronary lesions##2##2##(2008-11#1)(2010-12#1)
coronary procedures##5##2##(2011-2#5)
coronary revascularization##3##2##(2008-12#2)(2008-5#1)
coronary risk factors##2##3##(1991-3#1)(2010-7#1)
coronary risk##3##2##(1991-3#1)(1993-2#1)(2010-7#1)
coronary stent##5##2##(2011-2#5)
coronary stents##2##2##(2009-7#1)(2011-2#1)
coronary surgery##2##2##(2013-8#2)
coronary syndrome (ACS)##2##3##(2010-4#1)(2012-2#1)
coronary syndrome##28##2##(2008-11#9)(2008-3#10)(2008-7#1)(2009-10#1)(2010-4#2)(2011-2#4)(2012-2#1)
coronary syndromes##25##2##(2008-11#1)(2008-3#13)(2008-9#1)(2009-10#3)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#4)
coronary vascular smooth muscle cells##3##5##(1990-8#2)(1994-11#1)
coronary##376##1##(1990-2#2)(1990-3#1)(1990-8#4)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#5)(1991-6#3)(1991-8#1)(1992-11#2)(1992-5#2)(1992-6#2)(1992-9#10)(1993-12#4)(1993-2#5)(1993-3#1)(1994-11#6)(1994-12#1)(1995-12#2)(1995-2#3)(1995-3#2)(1996-11#1)(1996-6#2)(1996-8#3)(1997-3#1)(1997-8#6)(2006-6#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#51)(2008-12#25)(2008-3#26)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#14)(2009-11#3)(2009-12#3)(2009-5#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-9#4)(2011-2#59)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#22)(2013-1#11)(2013-2#6)(2013-7#1)(2013-8#13)
coronata f##3##2##(2008-10#3)
coronata in##2##2##(2008-10#2)
coronata var##3##2##(2008-10#3)
coronata##9##1##(2008-10#9)
coronatine gene expression##2##3##(2008-10#2)
coronatine##5##1##(2008-10#5)
coronoid process##5##2##(1991-2#1)(2008-7#2)(2011-2#1)(2012-3#1)
coronoid-maxillary space##3##2##(1991-2#3)
corpora allata##2##2##(1995-11#2)
corpora cavernosa##3##2##(2008-10#3)
corpora lutea (CL)##2##3##(2008-8#1)(2008-9#1)
corpora lutea##7##2##(1992-3#2)(1992-9#1)(1995-12#1)(2008-8#2)(2008-9#1)
corpora##14##1##(1992-3#2)(1992-9#1)(1995-11#2)(1995-12#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)
corporal punishment##2##2##(1995-5#1)(2008-11#1)
corporal##4##1##(1990-3#1)(1995-5#1)(2008-11#1)(2013-8#1)
corporate##11##1##(1991-3#1)(1993-1#2)(1993-12#2)(1997-1#1)(2008-10#1)(2008-11#2)(2009-10#1)(2013-1#1)
corporation##2##1##(1992-2#1)(1993-12#1)
corporations##5##1##(1992-11#1)(1993-3#1)(1997-3#1)(1997-6#1)(2008-10#1)
corporis gladiatorum presenting as a##2##5##(2012-3#2)
corporis gladiatorum##3##2##(2012-3#3)
corporis##5##1##(2008-5#2)(2012-3#3)
corpus allatum##2##2##(1995-11#2)
corpus callosum##4##2##(1996-12#1)(1996-2#1)(2008-7#1)(2011-2#1)
corpus luteum##5##2##(1992-9#1)(1995-12#1)(2008-9#2)(2010-3#1)
corpus of##2##2##(1994-1#1)(2008-11#1)
corpus striatum##2##2##(1997-2#2)
corpus##21##1##(1992-9#1)(1994-1#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
corpuscles##2##1##(2008-12#1)(2010-7#1)
correct classification of##2##3##(2008-10#1)(2012-3#1)
correct classification##6##2##(2008-10#5)(2012-3#1)
correct classifications##2##2##(2008-10#2)
correct determination of##2##3##(2008-10#1)(2012-12#1)
correct diagnosis and##4##3##(1990-9#1)(1991-3#1)(2011-2#1)(2012-3#1)
correct diagnosis of the##3##4##(1991-2#1)(2010-10#1)(2013-1#1)
correct diagnosis of##4##3##(1991-2#1)(2010-10#1)(2011-2#1)(2013-1#1)
correct diagnosis##20##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1995-1#1)(1997-5#1)(2008-11#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
correct dosage##2##2##(2008-10#1)(2008-12#1)
correct for##9##2##(1991-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-8#1)
correct identification##2##2##(2008-10#2)
correct information##2##2##(2009-12#1)(2011-2#1)
correct patient##2##2##(1995-2#1)(2012-2#1)
correct prediction of##2##3##(2008-10#2)
correct prediction rate##2##3##(2010-8#2)
correct prediction##4##2##(2008-10#2)(2010-8#2)
correct responses##5##2##(1991-2#1)(1993-3#2)(2008-11#1)(2013-8#1)
correct routes##2##2##(1992-12#2)
correct splicing##2##2##(1995-6#1)(2008-8#1)
correct the##10##2##(1992-8#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2010-1#1)(2012-2#1)
correct tours##2##2##(1992-12#2)
correct use of##4##3##(1991-6#1)(1993-8#1)(2008-11#1)(2008-9#1)
correct##183##1##(1990-11#3)(1990-3#1)(1990-5#1)(1990-9#2)(1991-2#2)(1991-3#3)(1991-6#3)(1992-12#4)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-1#2)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#36)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#9)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#16)(2009-12#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#3)
correctable##4##1##(2008-11#1)(2008-3#1)(2008-7#2)
corrected age##2##2##(1993-12#1)(2012-12#1)
corrected by##8##2##(1996-2#1)(1997-4#1)(2008-10#3)(2008-7#2)(2013-1#1)
corrected for the##2##3##(1991-5#1)(2008-10#1)
corrected for##12##2##(1991-5#1)(1991-8#1)(1996-12#3)(2008-10#5)(2008-11#1)(2008-9#1)
corrected to##3##2##(1996-6#1)(2008-3#1)(2008-9#1)
corrected using a baseline##2##4##(2008-10#2)
corrected visual acuity of##2##4##(2010-10#1)(2011-2#1)
corrected visual acuity##4##3##(2010-10#1)(2011-2#3)
corrected visual##5##2##(2010-10#1)(2011-2#3)(2012-3#1)
corrected with a##2##3##(2008-10#2)
corrected with##5##2##(2008-10#4)(2008-9#1)
corrected##53##1##(1991-5#2)(1991-8#1)(1993-12#1)(1994-8#1)(1996-12#3)(1996-2#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-7#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
correcting method for##2##3##(2013-8#2)
correcting the##3##2##(2008-3#3)
correcting##13##1##(2008-10#2)(2008-3#4)(2008-4#1)(2008-5#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-8#2)
correction algorithm##3##2##(2008-3#3)
correction and##6##2##(2008-10#5)(2012-2#1)
correction factor##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
correction factors##4##2##(2008-10#3)(2008-9#1)
correction for##10##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2011-2#2)(2012-12#1)(2013-1#1)
correction in the##3##3##(2008-3#1)(2012-2#1)(2013-7#1)
correction in##7##2##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
correction is##2##2##(2008-3#1)(2010-11#1)
correction method is##2##3##(2008-10#1)(2013-8#1)
correction method##7##2##(2008-10#3)(2008-3#1)(2013-8#3)
correction of instrumental line-shape distortions##2##5##(2008-3#2)
correction of the##9##3##(1992-5#1)(1994-3#1)(1995-9#1)(1997-1#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
correction of##36##2##(1992-5#1)(1993-11#1)(1994-3#1)(1995-9#1)(1997-1#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#1)
correction procedures##2##2##(2008-10#2)
correction to##2##2##(2008-3#1)(2013-7#1)
correction##148##1##(1990-12#1)(1992-5#1)(1993-11#1)(1994-3#3)(1995-9#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#52)(2008-11#1)(2008-12#3)(2008-2#7)(2008-3#23)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-7#2)(2010-10#1)(2010-11#2)(2010-3#1)(2010-7#1)(2011-2#5)(2012-12#3)(2012-2#7)(2013-1#2)(2013-7#2)(2013-8#8)
correctional##2##1##(2008-11#1)(2010-6#1)
corrections are##2##2##(1995-5#1)(2008-2#1)
corrections for##3##2##(2008-10#1)(2008-3#2)
corrections of##2##2##(2008-3#2)
corrections were##2##2##(1996-5#1)(2008-10#1)
corrections##17##1##(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-10#5)(2008-2#3)(2008-3#4)(2010-6#1)
corrective action##2##2##(1993-1#1)(2012-2#1)
corrective effect of sorbinil on##2##5##(1994-8#2)
corrective##11##1##(1992-9#2)(1993-1#1)(1994-8#2)(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#2)
correctly classified##11##2##(1991-12#1)(2008-10#8)(2008-7#2)
correctly identified##11##2##(1993-2#1)(1995-12#1)(1997-6#1)(2008-10#3)(2008-11#2)(2009-5#1)(2012-2#1)(2013-1#1)
correctly is##2##2##(2008-11#1)(2008-2#1)
correctly predicted##9##2##(1994-3#1)(1995-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
correctly processed##2##2##(1993-6#1)(1995-6#1)
correctly the##4##2##(1991-9#1)(2008-10#2)(2008-2#1)
correctly##85##1##(1990-11#1)(1990-5#1)(1991-12#2)(1991-9#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#3)(1996-6#2)(1996-8#1)(1997-6#1)(2008-10#24)(2008-11#7)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#6)(2008-8#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#1)
correctness and##2##2##(2008-11#2)
correctness of the##2##3##(2007-8#1)(2008-10#1)
correctness##9##1##(2007-8#1)(2008-10#2)(2008-11#6)
corrector##5##1##(2008-10#3)(2013-1#2)
corrects the article on p##13##5##(2008-11#3)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
corrects the article##15##3##(2008-11#3)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
corrects##17##1##(1995-2#1)(2008-11#3)(2008-2#1)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
correlate of##3##2##(1995-5#1)(1997-3#1)(2008-12#1)
correlate the##2##2##(1993-8#1)(2012-9#1)
correlate them with##3##3##(2008-12#1)(2011-2#1)(2012-4#1)
correlate this##3##2##(2008-10#2)(2008-11#1)
correlate to the##2##3##(2012-2#2)
correlate to##7##2##(2008-12#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#3)
correlate well with##4##3##(1997-6#1)(2008-10#1)(2010-10#1)(2010-5#1)
correlate with age##2##3##(2008-7#2)
correlate with better##2##3##(2011-2#1)(2013-8#1)
correlate with disease##2##3##(2008-10#1)(2013-1#1)
correlate with the##16##3##(1991-12#2)(1991-6#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
correlate with##62##2##(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1993-3#1)(1993-9#1)(1994-2#2)(1995-12#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
correlate##110##1##(1990-11#1)(1990-2#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#4)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#4)(2012-3#4)(2012-4#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#3)
correlated (P &lt##2##3##(2008-10#2)
correlated (P##3##2##(2008-10#3)
correlated (r = 0##2##4##(1992-12#1)(2008-10#1)
correlated between the##2##3##(2008-11#1)(2013-8#1)
correlated between##5##2##(1990-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
correlated closely with##2##3##(1990-2#1)(2008-10#1)
correlated closely##3##2##(1990-2#2)(2008-10#1)
correlated expression of##2##3##(1993-6#1)(2008-4#1)
correlated highly with##2##3##(2008-10#1)(2013-1#1)
correlated in##7##2##(1990-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#2)
correlated independently##2##2##(2008-9#1)(2013-8#1)
correlated negatively with##3##3##(1992-9#1)(1995-8#2)
correlated negatively##5##2##(1992-9#1)(1995-8#2)(2008-4#1)(2008-7#1)
correlated positively with the##3##4##(1995-8#1)(2013-8#2)
correlated positively with##14##3##(1990-2#1)(1995-8#1)(2008-10#2)(2008-8#1)(2010-8#2)(2011-10#1)(2011-2#2)(2013-1#2)(2013-8#2)
correlated positively##15##2##(1990-2#1)(1995-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#2)(2011-10#1)(2011-2#2)(2013-1#2)(2013-8#2)
correlated response to selection##2##4##(2008-8#2)
correlated response##3##2##(2008-8#3)
correlated responses to##2##3##(2008-8#2)
correlated responses##3##2##(2008-8#3)
correlated significantly with##9##3##(1991-2#1)(1993-12#1)(1994-11#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-4#1)(2013-8#2)
correlated significantly##10##2##(1991-2#1)(1993-12#1)(1994-11#1)(2006-6#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-4#1)(2013-8#2)
correlated strongly with##5##3##(1993-2#2)(2008-10#1)(2008-11#1)(2012-4#1)
correlated to a##3##3##(1993-3#1)(2008-10#1)(2011-2#1)
correlated to cell##2##3##(2008-11#2)
correlated to the##18##3##(1990-2#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-5#1)(1994-6#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-10#1)
correlated to##42##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-6#1)(1996-12#1)(2008-10#22)(2008-11#3)(2008-7#4)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
correlated well with the##6##4##(1991-12#1)(2008-1#1)(2008-10#2)(2008-11#2)
correlated well with their estrogen receptor content##2##7##(2008-11#2)
correlated well with##18##3##(1991-12#1)(1991-2#1)(1992-11#1)(2008-1#2)(2008-10#6)(2008-11#4)(2009-12#1)(2010-6#1)(2011-2#1)
correlated well##19##2##(1991-12#1)(1991-2#1)(1992-11#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-5#1)(2009-12#1)(2010-6#1)(2011-2#1)
correlated with a decrease##2##4##(2008-10#1)(2008-7#1)
correlated with a##12##3##(1991-6#1)(1993-8#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-10#4)(2008-7#1)(2008-8#1)(2013-8#1)
correlated with age##2##3##(1994-6#1)(2013-1#1)
correlated with an##5##3##(1991-8#1)(1993-11#1)(1997-1#1)(2008-10#1)(2008-7#1)
correlated with changes in##2##4##(2008-9#1)(2012-7#1)
correlated with differences##2##3##(2008-10#2)
correlated with disease##2##3##(2008-10#2)
correlated with each other##2##4##(2008-10#2)
correlated with geographic##4##3##(2008-10#3)(2012-3#1)
correlated with hepatic##2##3##(1990-5#1)(2013-8#1)
correlated with hexose sugars##2##4##(2011-2#2)
correlated with high##2##3##(1994-2#1)(2008-10#1)
correlated with host density##2##4##(2008-10#2)
correlated with host##3##3##(2008-10#3)
correlated with incidence##2##3##(2008-10#2)
correlated with increased blood##2##4##(2008-11#1)(2011-2#1)
correlated with increased##7##3##(2008-10#1)(2008-11#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
correlated with low disease severity soils##2##6##(2008-10#2)
correlated with maximum##2##3##(2008-10#2)
correlated with plant##3##3##(2008-10#3)
correlated with plasma##2##3##(1992-9#1)(1994-12#1)
correlated with poor##2##3##(2008-11#1)(2013-1#1)
correlated with reduced##2##3##(2008-10#1)(2013-1#1)
correlated with resistance##2##3##(2008-10#2)
correlated with sucrose and##2##4##(2011-2#2)
correlated with temperature##2##3##(2008-10#2)
correlated with the amount of##4##5##(1991-12#1)(1996-9#1)(2008-10#2)
correlated with the degree of##4##5##(1991-7#1)(2008-10#1)(2008-2#1)(2012-5#1)
correlated with the duration of##2##5##(1991-12#1)(2008-10#1)
correlated with the level of##2##5##(1997-3#1)(2008-10#1)
correlated with the minimum##2##4##(2008-10#1)(2013-8#1)
correlated with the number of##2##5##(1990-2#1)(2008-10#1)
correlated with the severity of##3##5##(1997-5#1)(1997-8#1)(2008-10#1)
correlated with the##93##3##(1990-2#2)(1991-12#3)(1991-5#1)(1991-6#2)(1991-7#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#2)(1995-11#2)(1995-8#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#30)(2008-11#3)(2008-2#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#2)(2013-1#2)(2013-8#2)
correlated with their ability to##2##5##(1993-8#1)(2008-10#1)
correlated with their##5##3##(1993-8#1)(1995-11#1)(2008-10#2)(2008-9#1)
correlated with those##2##3##(2008-10#2)
correlated with villous height##2##4##(2013-1#2)
correlated with virulence##3##3##(2008-10#3)
correlated with##334##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#4)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#4)(1994-8#2)(1995-11#4)(1995-2#1)(1995-3#2)(1995-8#2)(1996-12#6)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2007-12#2)(2008-1#1)(2008-10#140)(2008-11#8)(2008-12#1)(2008-2#1)(2008-7#7)(2008-8#9)(2008-9#13)(2009-10#2)(2009-11#2)(2009-3#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-10#2)(2011-2#13)(2011-9#1)(2012-12#3)(2012-2#6)(2012-3#11)(2012-5#3)(2012-7#1)(2013-1#11)(2013-8#7)
correlated##525##1##(1990-12#1)(1990-2#6)(1990-5#2)(1990-8#3)(1990-9#1)(1991-12#6)(1991-2#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#5)(1994-8#2)(1995-11#5)(1995-2#1)(1995-3#3)(1995-8#5)(1995-9#1)(1996-12#7)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#4)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#205)(2008-11#20)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#17)(2008-8#25)(2008-9#18)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#4)(2011-10#3)(2011-2#19)(2011-9#1)(2012-12#3)(2012-2#7)(2012-3#12)(2012-4#2)(2012-5#3)(2012-7#1)(2013-1#17)(2013-8#14)
correlates best with##2##3##(2008-11#1)(2008-7#1)
correlates in##4##2##(1993-3#1)(2008-8#1)(2013-8#2)
correlates of protection against##2##4##(1995-5#2)
correlates of the##2##3##(2008-11#1)(2009-8#1)
correlates of##26##2##(1991-1#1)(1991-6#1)(1992-11#1)(1994-2#2)(1995-3#1)(1995-5#2)(2008-11#2)(2008-12#1)(2008-8#2)(2009-5#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#7)(2013-8#1)
correlates to##2##2##(1994-2#1)(2013-8#1)
correlates well with##4##3##(1992-9#1)(2008-10#2)(2008-11#1)
correlates well##5##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-3#1)
correlates were##2##2##(1994-12#1)(2009-5#1)
correlates with a##5##3##(1997-7#1)(2008-7#1)(2009-3#1)(2009-9#1)(2013-1#1)
correlates with cell##2##3##(1995-9#1)(2008-11#1)
correlates with increased##3##3##(2009-8#2)(2013-1#1)
correlates with resistance##2##3##(2008-10#1)(2008-5#1)
correlates with the##9##3##(1990-12#1)(1993-12#1)(1995-6#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)
correlates with##46##2##(1990-12#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#3)(2009-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#6)
correlates##101##1##(1990-12#1)(1991-1#1)(1991-6#2)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#8)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#14)(2013-8#4)
correlating the##4##2##(2008-10#2)(2008-3#1)(2010-12#1)
correlating with##3##2##(1991-12#1)(1991-2#1)(1993-6#1)
correlating##15##1##(1991-12#1)(1991-2#1)(1991-3#1)(1993-6#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-12#1)
correlation (R =##2##3##(2008-10#2)
correlation (r = 0##6##4##(1994-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
correlation (r =##7##3##(1994-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
correlation (r=0##3##2##(2008-10#3)
correlation among##4##2##(1994-8#1)(2008-10#2)(2008-12#1)
correlation analysis##11##2##(2008-10#7)(2010-4#1)(2010-8#3)
correlation and##8##2##(2008-10#4)(2011-1#1)(2013-8#3)
correlation as##2##2##(2008-10#1)(2012-12#1)
correlation being##2##2##(1990-9#1)(1996-3#1)
correlation between DNA content and##2##5##(1994-12#1)(2008-9#1)
correlation between DNA##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
correlation between WB##2##3##(2008-10#2)
correlation between chronic##2##3##(2009-8#1)(2013-8#1)
correlation between clinical##2##3##(1997-7#1)(2011-2#1)
correlation between disease##2##3##(2008-10#2)
correlation between electrical and mechanical asynchrony in##2##7##(2008-10#2)
correlation between experimental##2##3##(2008-10#2)
correlation between genetic##4##3##(2008-10#4)
correlation between growth##2##3##(2008-10#1)(2008-12#1)
correlation between in vitro and in vivo##2##7##(1992-6#1)(2008-5#1)
correlation between preoperative weight change and postoperative##2##7##(2010-8#2)
correlation between real##2##3##(2007-8#1)(2008-10#1)
correlation between repeated##3##3##(1996-3#2)(2009-12#1)
correlation between results##2##3##(2008-10#2)
correlation between serum##3##3##(1991-12#1)(2011-2#2)
correlation between the degree of##2##5##(2008-12#1)(2010-12#1)
correlation between the in vitro##2##5##(2008-5#2)
correlation between the increase in##2##5##(1994-5#1)(1996-12#1)
correlation between the level of##2##5##(2008-10#1)(2011-1#1)
correlation between the two##2##4##(1995-5#1)(2008-3#1)
correlation between the##64##3##(1990-2#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#4)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#3)
correlation between these##2##3##(1994-5#1)(2011-2#1)
correlation between those##2##3##(1991-6#1)(2008-5#1)
correlation between##225##2##(1990-2#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1995-2#1)(1995-5#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#76)(2008-11#6)(2008-12#4)(2008-3#5)(2008-5#11)(2008-7#3)(2008-8#8)(2008-9#10)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#15)(2012-12#1)(2012-3#4)(2012-6#1)(2012-8#1)(2013-1#7)(2013-8#5)
correlation can be##3##3##(2008-10#2)(2008-9#1)
correlation coefficient (r) of 0##2##5##(2008-10#2)
correlation coefficient (r)##5##3##(2008-10#4)(2011-2#1)
correlation coefficient 0##2##3##(2008-10#2)
correlation coefficient and##3##3##(2008-10#3)
correlation coefficient between##2##3##(1993-3#1)(2008-10#1)
correlation coefficient for##2##3##(2008-10#2)
correlation coefficient of 0##35##4##(2008-10#35)
correlation coefficient of linear regression##3##5##(2008-10#3)
correlation coefficient of##43##3##(2008-10#40)(2008-7#1)(2010-8#1)(2013-1#1)
correlation coefficient was 0##5##4##(1990-12#1)(2008-10#4)
correlation coefficient was##7##3##(1990-12#1)(2008-10#5)(2012-2#1)
correlation coefficient##93##2##(1990-12#1)(1992-9#1)(1993-3#1)(2008-10#75)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-8#2)(2011-2#1)(2011-3#3)(2012-2#1)(2013-1#3)
correlation coefficients and##2##3##(2008-10#1)(2008-5#1)
correlation coefficients between##4##3##(1991-12#1)(2008-10#3)
correlation coefficients for##2##3##(2008-10#1)(2008-12#1)
correlation coefficients of 0##2##4##(2008-10#2)
correlation coefficients of##3##3##(2008-10#3)
correlation coefficients were 0##2##4##(2008-10#2)
correlation coefficients were##5##3##(2008-10#5)
correlation coefficients##32##2##(1991-12#1)(1992-3#1)(2008-10#25)(2008-12#3)(2008-5#1)(2010-12#1)
correlation compared##2##2##(2008-10#1)(2008-9#1)
correlation existed between##2##3##(2008-10#1)(2008-12#1)
correlation existed##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
correlation factor of 0##2##4##(2008-10#2)
correlation factor##5##2##(2008-10#5)
correlation for##4##2##(2008-10#3)(2008-3#1)
correlation in the##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
correlation in##9##2##(1994-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
correlation is##5##2##(2008-10#2)(2008-3#1)(2012-2#2)
correlation matrix##2##2##(2008-10#1)(2010-11#1)
correlation may##3##2##(2008-10#1)(2008-12#2)
correlation of 0##2##3##(2008-10#2)
correlation of disease status of##3##5##(2008-10#3)
correlation of the##8##3##(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
correlation of##40##2##(1990-2#1)(1992-3#1)(1994-3#1)(1995-3#1)(1995-9#1)(1996-6#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
correlation spectra##2##2##(2008-2#1)(2012-2#1)
correlation spectroscopy##10##2##(1990-5#1)(1997-6#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2013-1#1)
correlation spectrum##2##2##(2008-8#2)
correlation structures##3##2##(1992-9#1)(2010-1#1)(2013-8#1)
correlation tests##2##2##(1994-3#1)(2011-2#1)
correlation time##3##2##(2008-10#3)
correlation to the##6##3##(1990-12#2)(2008-10#2)(2008-11#1)(2009-8#1)
correlation to##8##2##(1990-12#2)(2008-10#2)(2008-11#2)(2009-8#1)(2012-2#1)
correlation value was##2##3##(2008-10#2)
correlation value##3##2##(2008-10#3)
correlation was established between the##2##5##(2008-10#2)
correlation was established##3##3##(2008-10#3)
correlation was found between the##15##5##(1990-12#1)(1992-2#1)(1996-11#1)(1997-6#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-9#1)(2013-1#1)
correlation was found between##27##4##(1990-12#2)(1992-12#1)(1992-2#1)(1993-1#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-7#3)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
correlation was found with##4##4##(1990-2#1)(1991-12#1)(1992-2#1)(2008-7#1)
correlation was found##33##3##(1990-12#2)(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#2)(1993-1#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-6#1)(2008-10#8)(2008-11#3)(2008-7#4)(2008-9#1)(2009-4#1)(2011-2#2)(2013-1#1)
correlation was observed between the##6##5##(1994-6#1)(2008-10#4)(2008-7#1)
correlation was observed between##11##4##(1991-6#1)(1994-6#1)(1995-12#1)(2008-10#5)(2008-5#2)(2008-7#1)
correlation was observed##12##3##(1991-6#1)(1994-6#1)(1995-12#1)(1995-6#1)(2008-10#5)(2008-5#2)(2008-7#1)
correlation was obtained between##2##4##(1993-2#1)(2008-10#1)
correlation was obtained##3##3##(1993-2#1)(2008-10#2)
correlation was##59##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-6#1)(2008-10#21)(2008-11#3)(2008-5#2)(2008-7#6)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
correlation with age##4##3##(1990-2#1)(1996-3#1)(2008-7#1)(2011-2#1)
correlation with disease##2##3##(1990-12#1)(2008-10#1)
correlation with each other##2##4##(2008-7#1)(2013-8#1)
correlation with glycemic status##2##4##(2012-2#2)
correlation with plasma##2##3##(1996-8#2)
correlation with the obliteration rate##2##5##(2008-7#2)
correlation with the##23##3##(1990-12#1)(1991-11#2)(1991-12#1)(1991-2#1)(2006-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2010-6#1)(2013-1#1)
correlation with##71##2##(1990-12#2)(1990-2#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-10#1)(1996-3#1)(1996-8#2)(2006-6#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
correlation##725##1##(1990-12#7)(1990-2#4)(1990-4#1)(1990-5#4)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-6#5)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-6#1)(1992-9#4)(1993-1#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#6)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#5)(1997-7#3)(1997-8#3)(2006-6#2)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#321)(2008-11#24)(2008-12#14)(2008-2#5)(2008-3#17)(2008-5#18)(2008-7#17)(2008-8#20)(2008-9#19)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#6)(2010-4#3)(2010-6#2)(2010-8#11)(2011-1#5)(2011-2#33)(2011-3#3)(2012-12#2)(2012-2#16)(2012-3#8)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#16)(2013-8#12)
correlation)##2##1##(1996-1#1)(2012-2#1)
correlational study##2##2##(2010-10#1)(2010-11#1)
correlational##8##1##(1991-3#1)(2008-8#1)(2010-10#1)(2010-11#2)(2011-1#1)(2012-3#1)(2013-1#1)
correlations among different##2##3##(2008-10#2)
correlations among twig##2##3##(2008-9#2)
correlations among##8##2##(2008-10#3)(2008-9#2)(2009-11#1)(2012-3#2)
correlations and##3##2##(2008-9#1)(2009-12#1)(2013-1#1)
correlations between disease##2##3##(2008-10#2)
correlations between the##11##3##(1992-2#1)(2008-10#5)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
correlations between##51##2##(1992-2#1)(1995-2#1)(2008-10#16)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#2)(2009-11#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-12#1)(2012-3#4)(2012-4#1)(2013-1#1)(2013-8#1)
correlations existed between the##2##4##(2008-10#1)(2013-1#1)
correlations for##2##2##(2008-10#1)(2008-9#1)
correlations in the##4##3##(2008-8#1)(2008-9#1)(2009-6#1)(2013-8#1)
correlations in##7##2##(2008-8#1)(2008-9#3)(2009-6#1)(2012-3#1)(2013-8#1)
correlations of##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
correlations were demonstrated between the expression of##2##7##(2011-3#2)
correlations were found between##5##4##(1990-8#1)(1993-2#1)(2008-10#2)(2011-1#1)
correlations were found##7##3##(1990-8#1)(1993-2#1)(2008-10#3)(2008-7#1)(2011-1#1)
correlations were observed between##3##4##(2008-10#2)(2008-8#1)
correlations were obtained##2##3##(2008-10#2)
correlations were##22##2##(1990-8#1)(1993-2#1)(2008-10#9)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#3)(2011-10#1)(2011-3#2)
correlations with the##2##3##(2008-11#1)(2010-10#1)
correlations with##11##2##(1992-3#1)(1993-2#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-10#1)(2011-1#2)
correlations##139##1##(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-2#3)(1992-3#1)(1993-2#3)(1994-5#1)(1994-8#2)(1995-2#1)(1996-12#1)(2008-10#38)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#17)(2009-10#2)(2009-11#3)(2009-12#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-8#1)(2011-1#7)(2011-10#2)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#9)(2012-4#1)(2013-1#4)(2013-8#4)
correlationship between##2##2##(2012-2#2)
correlationship##3##1##(2012-2#3)
correlative study##2##2##(2009-11#1)(2010-5#1)
correlative##13##1##(2008-10#4)(2008-9#1)(2009-11#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-2#2)
correlator##4##1##(2008-3#4)
correspond to a##8##3##(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)
correspond to known##3##3##(1995-9#1)(2008-10#1)(2008-11#1)
correspond to several##2##3##(2008-11#1)(2008-8#1)
correspond to the##21##3##(1992-6#1)(1994-9#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)
correspond to those previously reported##2##5##(2008-10#2)
correspond to those##3##3##(1994-5#1)(2008-10#2)
correspond to##74##2##(1990-5#2)(1991-11#2)(1991-7#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-9#4)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#27)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#4)(2008-8#4)(2008-9#2)(2009-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
correspond with the##3##3##(1992-1#1)(2008-10#1)(2009-10#1)
correspond with##5##2##(1992-1#1)(2008-10#2)(2009-10#1)(2012-3#1)
correspond##82##1##(1990-5#2)(1991-11#2)(1991-7#1)(1992-1#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-9#4)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#32)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#2)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
corresponded to a##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
corresponded to the degree of##2##5##(2008-10#1)(2008-11#1)
corresponded to the##10##3##(1990-5#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)
corresponded to##47##2##(1990-5#1)(1995-8#1)(1997-2#1)(2008-10#23)(2008-11#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#5)
corresponded well with##2##3##(2008-7#1)(2008-8#1)
corresponded well##3##2##(2008-7#1)(2008-8#1)(2010-3#1)
corresponded with the##2##3##(2008-10#1)(2008-12#1)
corresponded with##7##2##(1996-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
corresponded##64##1##(1990-5#1)(1992-12#1)(1995-8#1)(1996-12#2)(1997-2#1)(2008-10#27)(2008-11#8)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2010-3#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
correspondence analysis##10##2##(2008-10#8)(2008-5#2)
correspondence between the##2##3##(2008-10#1)(2012-12#1)
correspondence between##6##2##(1991-12#1)(1993-12#1)(2008-10#2)(2008-12#1)(2012-12#1)
correspondence with##3##2##(2008-10#3)
correspondence##30##1##(1991-12#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-1#3)
correspondences##3##1##(2008-6#2)(2008-8#1)
corresponding absorption##2##2##(2008-10#1)(2008-3#1)
corresponding aldehyde##2##2##(2008-10#2)
corresponding amino acid##2##3##(2008-10#1)(2008-6#1)
corresponding antibodies##2##2##(2008-10#2)
corresponding antigen##2##2##(2008-8#2)
corresponding avirulence gene##3##3##(2008-10#3)
corresponding avirulence##4##2##(2008-10#4)
corresponding binding##2##2##(1992-10#1)(2008-10#1)
corresponding complex##2##2##(2008-10#1)(2008-11#1)
corresponding controls##3##2##(1995-8#1)(1996-2#1)(2006-6#1)
corresponding detection limits##3##3##(2008-10#3)
corresponding detection##4##2##(2008-10#4)
corresponding gene##8##2##(1993-2#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#1)
corresponding genes##7##2##(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
corresponding groups##2##2##(2008-10#1)(2008-5#1)
corresponding high##2##2##(2008-10#2)
corresponding increase in##5##3##(1991-3#1)(1993-6#1)(1996-2#1)(1997-3#1)(2008-5#1)
corresponding increase##6##2##(1991-3#1)(1993-6#1)(1996-2#1)(1997-3#1)(2008-5#1)(2011-2#1)
corresponding increases##2##2##(1995-2#1)(2011-10#1)
corresponding measures##2##2##(2009-10#1)(2009-7#1)
corresponding nontransgenic##2##2##(2008-10#2)
corresponding normal##2##2##(1992-3#1)(2009-10#1)
corresponding observations##2##2##(2008-11#1)(2013-1#1)
corresponding rates##2##2##(2008-11#1)(2012-2#1)
corresponding reference##2##2##(2008-10#1)(2008-12#1)
corresponding regions of##2##3##(2008-10#1)(2013-8#1)
corresponding residues##2##2##(1992-4#2)
corresponding resistance gene##2##3##(2008-10#2)
corresponding results##3##2##(2008-10#1)(2008-3#2)
corresponding thermodynamic##2##2##(2008-10#2)
corresponding to 0##2##3##(2008-10#1)(2010-12#1)
corresponding to 1##2##3##(2008-10#2)
corresponding to 3##2##3##(2008-10#1)(2013-1#1)
corresponding to a##17##3##(1990-2#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
corresponding to about##2##3##(1995-11#1)(2008-10#1)
corresponding to an estimated delta Ka##2##6##(1995-2#2)
corresponding to an estimated##3##4##(1991-11#1)(1995-2#2)
corresponding to an##7##3##(1991-11#1)(1995-2#2)(2008-10#2)(2008-3#1)(2008-5#1)
corresponding to both##2##3##(2008-10#2)
corresponding to each##6##3##(2008-10#4)(2008-11#1)(2008-3#1)
corresponding to its##2##3##(2008-5#1)(2013-1#1)
corresponding to residues##6##3##(1992-4#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(2008-8#1)
corresponding to some##2##3##(2008-10#2)
corresponding to the 28##3##4##(1996-12#3)
corresponding to the 40##3##4##(1996-12#3)
corresponding to the equivalence point was sensed##2##7##(2008-10#2)
corresponding to the four##2##4##(2008-10#2)
corresponding to the maximum##2##4##(2008-10#2)
corresponding to the previously##2##4##(2008-10#2)
corresponding to the putative##2##4##(1993-2#1)(1994-5#1)
corresponding to the reduction of##2##5##(2008-10#2)
corresponding to the##80##3##(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-5#2)(1995-2#3)(1995-6#1)(1996-12#6)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#37)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
corresponding to these##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
corresponding to three times the standard deviation of##4##8##(2008-10#4)
corresponding to three##5##3##(1991-9#1)(2008-10#4)
corresponding to two##2##3##(2008-10#2)
corresponding to various##2##3##(1992-6#1)(2008-10#1)
corresponding to##218##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#3)(1994-6#1)(1995-11#2)(1995-2#8)(1995-6#1)(1995-8#1)(1996-12#7)(1996-6#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#3)(2008-10#102)(2008-11#6)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#3)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-2#3)(2012-3#1)(2012-5#1)(2012-8#1)(2013-1#4)(2013-8#3)
corresponding values for##5##3##(1993-8#1)(2008-10#2)(2008-7#1)(2010-4#1)
corresponding values##11##2##(1993-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)
corresponding with the##2##3##(1993-8#1)(2007-12#1)
corresponding with##3##2##(1993-8#1)(2007-12#1)(2008-10#1)
corresponding##540##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#5)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#4)(1993-8#6)(1994-11#2)(1994-12#1)(1994-5#4)(1994-6#1)(1994-8#2)(1995-11#3)(1995-2#10)(1995-6#4)(1995-8#4)(1995-9#2)(1996-12#7)(1996-2#5)(1996-3#1)(1996-5#12)(1996-6#4)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#5)(1997-7#2)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#230)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#13)(2008-4#3)(2008-5#15)(2008-6#3)(2008-7#7)(2008-8#16)(2008-9#7)(2009-10#7)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#2)(2010-12#5)(2010-4#1)(2010-6#5)(2010-7#3)(2010-8#1)(2011-1#4)(2011-10#2)(2011-2#16)(2011-3#1)(2012-2#6)(2012-3#4)(2012-5#1)(2012-8#2)(2013-1#8)(2013-8#10)
correspondingly##9##1##(1993-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#3)(2009-11#1)
corresponds to a##10##3##(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-7#1)
corresponds to an increase of##2##5##(2008-3#1)(2011-2#1)
corresponds to an##5##3##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
corresponds to approximately##2##3##(1991-11#1)(2008-10#1)
corresponds to that of##2##4##(2008-11#1)(2011-2#1)
corresponds to the##24##3##(1990-8#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-5#1)(1996-2#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
corresponds to two##2##3##(2008-3#1)(2008-8#1)
corresponds to##61##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-1#2)(2007-12#1)(2008-10#18)(2008-11#3)(2008-2#3)(2008-3#10)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#3)(2013-1#3)
corresponds##65##1##(1990-5#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-1#2)(1997-2#1)(2007-12#1)(2008-10#19)(2008-11#3)(2008-2#4)(2008-3#10)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#3)(2013-1#4)
corridors##3##1##(2008-9#3)
corroborate the##2##2##(1997-3#1)(2008-11#1)
corroborate this##2##2##(2008-12#1)(2013-8#1)
corroborate##9##1##(1997-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-7#2)(2013-8#1)
corroborated by##10##2##(1991-6#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-8#1)
corroborated the##3##2##(2008-10#2)(2009-8#1)
corroborated##20##1##(1991-6#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-8#1)(2009-8#1)(2011-1#1)
corroborates the##2##2##(2008-10#2)
corroborates##4##1##(2008-10#3)(2008-8#1)
corrole##2##1##(2008-10#2)
corrosion and##3##2##(2008-10#2)(2008-11#1)
corrosion##20##1##(2008-10#8)(2008-11#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#4)
corrosive##3##1##(2008-10#2)(2008-11#1)
corrugated##2##1##(2007-12#2)
cortex (areas##2##2##(1994-3#1)(2013-8#1)
cortex (mPFC)##2##2##(2008-11#2)
cortex after##2##2##(1996-12#1)(2008-11#1)
cortex and hippocampus##6##3##(1993-3#1)(1994-2#2)(1996-12#1)(1996-2#1)(2013-8#1)
cortex and the##5##3##(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
cortex and##32##2##(1993-3#1)(1994-2#4)(1995-6#1)(1995-8#1)(1996-12#5)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-7#1)(2013-8#3)
cortex as a##2##3##(1995-8#1)(2008-11#1)
cortex as##3##2##(1995-8#1)(2008-11#1)(2008-7#1)
cortex but not in the##2##5##(1990-5#1)(2008-11#1)
cortex but not##3##3##(1990-5#1)(1993-3#1)(2008-11#1)
cortex by##2##2##(1990-12#1)(2012-2#1)
cortex excitability##2##2##(2010-7#1)(2011-2#1)
cortex from##3##2##(1994-3#1)(2008-11#1)(2011-2#1)
cortex in##6##2##(1990-5#1)(1991-6#1)(1997-2#1)(2009-10#1)(2010-7#2)
cortex is##3##2##(1990-8#1)(2008-11#1)(2009-10#1)
cortex neurons##3##2##(1991-6#2)(1995-8#1)
cortex of Wistar##2##3##(1995-8#1)(2008-10#1)
cortex of the##8##3##(1992-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
cortex of##27##2##(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#2)(1997-2#2)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
cortex on##2##2##(1993-6#1)(2011-2#1)
cortex or##3##2##(1993-6#2)(2008-7#1)
cortex was##2##2##(1997-2#1)(2008-11#1)
cortex were##6##2##(1990-8#1)(1993-6#1)(1996-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
cortex which##2##2##(1993-6#1)(2008-11#1)
cortex##317##1##(1990-11#3)(1990-12#1)(1990-5#6)(1990-8#3)(1990-9#1)(1991-4#2)(1991-5#1)(1991-6#5)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-6#7)(1994-12#1)(1994-2#11)(1994-3#7)(1994-5#1)(1994-8#7)(1995-11#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#4)(1996-12#17)(1996-2#15)(1996-5#2)(1996-6#1)(1997-2#19)(1997-3#3)(1997-5#1)(2008-10#24)(2008-11#56)(2008-12#1)(2008-4#2)(2008-5#6)(2008-7#15)(2008-8#9)(2008-9#4)(2009-10#7)(2009-9#1)(2010-12#1)(2010-4#3)(2010-7#20)(2011-1#1)(2011-2#11)(2012-2#5)(2013-1#5)(2013-8#15)
cortex's##2##1##(2011-3#2)
cortexin##5##1##(2010-4#5)
cortical Lbs##3##2##(2008-7#3)
cortical activation during##2##3##(2008-11#2)
cortical activation##5##2##(1994-3#2)(1996-2#1)(2008-11#2)
cortical activity and##2##3##(1992-12#1)(2010-7#1)
cortical activity##7##2##(1992-12#1)(2008-11#4)(2010-7#1)(2013-8#1)
cortical allograft##5##2##(2011-2#5)
cortical and hippocampal##3##3##(1994-2#2)(2013-8#1)
cortical and stelar cells of##2##5##(2008-9#2)
cortical and stelar cells##3##4##(2008-9#3)
cortical and subcortical##3##3##(2008-11#3)
cortical and##16##2##(1991-10#3)(1994-2#2)(1995-11#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-9#3)(2013-8#1)
cortical area##4##2##(1991-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
cortical areas##7##2##(1990-8#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-8#2)(2009-10#1)
cortical atrophy##3##2##(2008-7#1)(2011-1#2)
cortical bone is##3##3##(1996-3#1)(2009-7#2)
cortical bone##14##2##(1996-3#2)(2007-8#1)(2008-10#1)(2008-9#1)(2009-7#7)(2012-3#1)(2013-1#1)
cortical cell##3##2##(2008-10#3)
cortical cells in##5##3##(2008-10#2)(2008-8#3)
cortical cells of##5##3##(2008-10#4)(2011-2#1)
cortical cells##30##2##(1990-8#2)(1996-12#1)(1996-2#3)(2008-10#15)(2008-11#4)(2008-8#3)(2008-9#1)(2011-2#1)
cortical circuits##2##2##(2008-11#1)(2011-2#1)
cortical control##2##2##(1993-3#2)
cortical layers##2##2##(1994-2#1)(2008-10#1)
cortical lesion##3##2##(1991-2#1)(2008-4#1)(2008-7#1)
cortical lesions##2##2##(1996-2#1)(2008-4#1)
cortical levels of##2##3##(1990-5#1)(1996-12#1)
cortical membranes##4##2##(1990-5#1)(1993-6#2)(1996-2#1)
cortical network##3##2##(1995-5#1)(2009-8#2)
cortical neurons in##3##3##(1995-12#1)(1997-2#1)(2008-11#1)
cortical neurons to##2##3##(1995-12#1)(1996-2#1)
cortical neurons##10##2##(1994-2#1)(1995-12#2)(1996-2#1)(1997-2#2)(2008-11#3)(2008-7#1)
cortical or##2##2##(1993-6#1)(1995-11#1)
cortical parenchyma##2##2##(2008-10#2)
cortical processing##2##2##(1996-2#1)(2008-11#1)
cortical region##6##2##(1990-11#1)(1996-2#1)(2008-11#2)(2010-7#2)
cortical regions##7##2##(1991-10#1)(1996-12#2)(2008-11#2)(2012-2#1)(2013-8#1)
cortical screws##2##2##(2013-1#2)
cortical slices##3##2##(1994-5#2)(1997-1#1)
cortical stimulation##4##2##(2009-9#1)(2010-7#2)(2011-2#1)
cortical structures##3##2##(1991-10#1)(2008-11#1)(2009-7#1)
cortical thickness##6##2##(1997-3#1)(2013-1#5)
cortical tissue and##2##3##(1996-12#1)(2008-10#1)
cortical tissue##3##2##(1996-12#1)(2008-10#2)
cortical tissues##2##2##(2008-10#1)(2008-12#1)
cortical##244##1##(1990-11#1)(1990-12#1)(1990-5#5)(1990-8#4)(1990-9#2)(1991-10#6)(1991-2#2)(1991-3#1)(1991-8#1)(1992-12#1)(1993-3#2)(1993-6#4)(1994-11#1)(1994-2#6)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#5)(1996-12#10)(1996-2#11)(1996-3#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#1)(2007-8#1)(2008-10#28)(2008-11#33)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#20)(2008-8#5)(2008-9#5)(2009-10#1)(2009-5#2)(2009-7#8)(2009-8#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#9)(2010-9#1)(2011-1#2)(2011-2#11)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#7)
cortically##2##1##(1990-9#1)(2011-2#1)
cortices##12##1##(1996-12#3)(1997-2#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-7#2)(2013-8#1)
cortico-hippocampal circuits##2##2##(2013-8#2)
cortico-striatal##2##1##(1996-2#1)(2009-7#1)
corticoid##3##1##(1996-6#1)(1997-2#1)(2010-12#1)
corticoids##2##1##(2010-12#1)(2011-2#1)
corticopontine projections##2##2##(2008-11#2)
corticopontine##3##1##(2008-11#3)
corticosteroid in##2##2##(2008-1#1)(2009-5#1)
corticosteroid therapy##4##2##(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
corticosteroid##24##1##(1991-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-5#1)(2007-11#1)(2008-1#2)(2008-11#7)(2008-7#2)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#2)
corticosteroids and##4##2##(2008-11#2)(2008-5#1)(2012-3#1)
corticosteroids are##6##2##(2007-11#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
corticosteroids has##2##2##(1997-5#1)(2007-11#1)
corticosteroids may##2##2##(1993-9#1)(2007-11#1)
corticosteroids or##2##2##(2013-1#1)(2013-8#1)
corticosteroids should##2##2##(2007-11#2)
corticosteroids##55##1##(1992-3#1)(1993-11#1)(1993-9#1)(1997-1#1)(1997-5#2)(1997-8#1)(2007-11#14)(2008-1#1)(2008-11#9)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#1)(2010-5#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#5)(2013-1#1)(2013-8#1)
corticosterone and##3##2##(1994-2#1)(1996-12#1)(2008-4#1)
corticosterone concentrations##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
corticosterone levels##2##2##(1995-12#1)(2008-10#1)
corticosterone to 11-dehydrocorticosterone##2##3##(1990-11#2)
corticosterone##27##1##(1990-11#4)(1990-5#1)(1994-2#1)(1995-12#1)(1996-12#5)(1997-2#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
corticotrophin-releasing##2##1##(1997-4#1)(2008-4#1)
corticotropin releasing##2##2##(1990-12#1)(1992-6#1)
corticotropin##4##1##(1990-12#1)(1992-6#1)(1995-12#1)(1995-2#1)
corticotropin-releasing factor (CRF)##2##3##(1996-12#1)(2008-4#1)
corticotropin-releasing factor##3##2##(1996-12#1)(2008-4#2)
corticotropin-releasing hormone##5##2##(1990-5#1)(1991-10#1)(1995-12#1)(2008-11#1)(2008-6#1)
corticotropin-releasing##10##1##(1990-5#2)(1991-10#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-4#3)(2008-6#1)
cortisectomies##2##1##(2012-3#2)
cortisol and##6##2##(1990-12#1)(1991-6#1)(2011-1#2)(2012-3#1)(2013-1#1)
cortisol level##3##2##(2011-2#3)
cortisol levels increased after##2##4##(2008-6#2)
cortisol levels##7##2##(2008-6#6)(2011-2#1)
cortisol##54##1##(1990-11#1)(1990-12#4)(1990-5#2)(1991-6#2)(1995-11#3)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#4)(2008-6#8)(2010-2#3)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
cortisol)##2##1##(1997-1#1)(2012-2#1)
cortisone##2##1##(2008-10#2)
coryli##2##1##(2008-10#2)
corymbifera##3##1##(2008-5#3)
cos region##2##2##(1990-11#2)
cos##6##1##(1990-11#4)(1996-2#2)
cos-containing##2##1##(1990-11#2)
cosegregated##2##1##(2008-10#2)
cosine of the##3##3##(2008-10#1)(2008-3#2)
cosmesis##6##1##(1991-2#1)(1994-6#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
cosmetic and functional results##3##4##(1991-9#1)(2008-10#1)(2008-9#1)
cosmetic and functional##4##3##(1991-9#1)(2008-10#1)(2008-9#1)(2013-1#1)
cosmetic and pharmaceutical##2##3##(2008-10#1)(2008-5#1)
cosmetic and##10##2##(1991-9#1)(2008-10#3)(2008-5#3)(2008-9#1)(2012-3#1)(2013-1#1)
cosmetic applications##2##2##(2008-5#2)
cosmetic effect##3##2##(2012-12#2)(2013-1#1)
cosmetic efficacy##2##2##(2008-5#2)
cosmetic emulsions##2##2##(2008-5#2)
cosmetic facial surgery##2##3##(2008-7#2)
cosmetic formulation##4##2##(2008-5#4)
cosmetic formulations##11##2##(2008-5#11)
cosmetic industry##5##2##(2008-5#4)(2008-9#1)
cosmetic ingredient##5##2##(2008-5#5)
cosmetic ingredients##6##2##(2008-5#6)
cosmetic materials##3##2##(2008-5#3)
cosmetic or pharmaceutical##2##3##(2008-5#2)
cosmetic or##3##2##(2008-5#3)
cosmetic outcome and##2##3##(1993-9#1)(2011-2#1)
cosmetic outcomes##2##2##(2012-12#2)
cosmetic preparations##3##2##(2008-10#1)(2008-5#1)(2009-9#1)
cosmetic product##5##2##(2008-10#1)(2008-5#4)
cosmetic products##22##2##(2008-10#3)(2008-5#19)
cosmetic properties##2##2##(2008-5#2)
cosmetic result##4##2##(1991-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
cosmetic results##5##2##(1991-2#2)(2008-7#1)(2011-2#1)(2013-1#1)
cosmetic samples##2##2##(2008-10#1)(2008-5#1)
cosmetic use##2##2##(2008-5#2)
cosmetic vehicle used##2##3##(2008-5#2)
cosmetic##148##1##(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1993-9#1)(1994-12#1)(2008-10#14)(2008-11#1)(2008-5#104)(2008-7#3)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-3#1)(2013-1#4)(2013-8#2)
cosmetically##4##1##(2008-11#1)(2008-5#3)
cosmetics and##3##2##(2008-5#3)
cosmetics as##2##2##(2008-10#2)
cosmetics have been##2##3##(2008-5#2)
cosmetics using##2##2##(2008-5#2)
cosmetics##54##1##(2008-10#5)(2008-11#1)(2008-5#48)
cosmetology##3##1##(2008-5#3)
cosmid clone##6##2##(1995-8#1)(1996-2#2)(1996-3#1)(1997-9#1)(2008-10#1)
cosmid clones from##2##3##(1994-11#1)(2008-10#1)
cosmid clones##3##2##(1994-11#1)(1996-6#1)(2008-10#1)
cosmid contigs##2##2##(1994-11#1)(1997-2#1)
cosmid library##5##2##(1990-11#1)(1993-12#1)(1994-11#1)(1996-8#1)(1997-7#1)
cosmid vector##2##2##(1996-2#2)
cosmid##26##1##(1990-11#1)(1993-12#2)(1993-3#1)(1994-11#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#4)(1996-3#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-7#2)(1997-9#2)(2008-10#2)
cosmids were##2##2##(1990-11#1)(1997-7#1)
cosmids##4##1##(1990-11#1)(1993-12#1)(1996-6#1)(1997-7#1)
cosmogenesis and##2##2##(2013-1#2)
cosmopolitan##4##1##(2008-10#2)(2008-12#1)(2011-2#1)
cost accounting##4##2##(1993-1#1)(1993-2#2)(1995-12#1)
cost analysis##2##2##(1997-2#1)(2008-10#1)
cost and effectiveness##2##3##(1992-5#1)(1993-12#1)
cost and performance##2##3##(1995-2#1)(2008-7#1)
cost and quality##2##3##(2009-8#1)(2012-3#1)
cost and the##2##3##(1992-12#1)(1992-5#1)
cost and##35##2##(1992-11#1)(1992-12#2)(1992-5#2)(1993-12#1)(1993-3#1)(1994-3#2)(1995-2#1)(1996-3#1)(1997-2#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
cost associated with the##2##4##(2008-7#1)(2008-8#1)
cost associated with##5##3##(2008-10#1)(2008-7#2)(2008-8#2)
cost at the##2##3##(2008-8#2)
cost comparison and patient satisfaction##2##5##(1997-2#2)
cost comparison##3##2##(1997-2#3)
cost containment and##4##3##(1994-12#1)(1995-3#1)(1996-2#1)(2008-11#1)
cost containment has##2##3##(1992-1#1)(1994-1#1)
cost containment in##2##3##(1992-1#1)(1995-12#1)
cost containment##24##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#3)(1993-5#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(2008-11#4)(2013-1#1)
cost control##5##2##(1993-8#1)(1994-2#1)(1995-1#1)(1997-2#1)(2008-11#1)
cost data##2##2##(1991-12#1)(1993-1#1)
cost effective##28##2##(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1996-11#1)(1996-8#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-7#1)(2011-2#4)(2012-2#2)
cost effectiveness of##5##3##(1992-2#1)(1995-2#1)(2010-2#1)(2011-2#1)(2012-12#1)
cost effectiveness##9##2##(1992-2#1)(1995-1#1)(1995-2#1)(2008-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
cost efficiency and##2##3##(2008-11#1)(2012-2#1)
cost efficiency##3##2##(1996-3#1)(2008-11#1)(2012-2#1)
cost efficient##2##2##(1991-1#1)(2008-10#1)
cost experience##3##2##(1993-1#3)
cost for the##2##3##(2008-10#2)
cost for##6##2##(1991-1#1)(1991-12#1)(1991-3#1)(2008-10#3)
cost function##2##2##(1992-12#1)(2008-9#1)
cost growth##5##2##(1991-12#1)(1992-12#2)(1993-3#1)(1997-2#1)
cost in##6##2##(1994-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)
cost increases##2##2##(1992-12#2)
cost incurred by##2##3##(1995-1#1)(2011-2#1)
cost index##2##2##(1992-2#1)(1994-1#1)
cost is##4##2##(2008-8#1)(2008-9#3)
cost less than##2##3##(1994-2#1)(1997-2#1)
cost less##4##2##(1992-11#1)(1994-2#2)(1997-2#1)
cost of Medicare##2##3##(1993-1#1)(1995-3#1)
cost of a##8##3##(1995-1#2)(1996-2#1)(2008-8#2)(2010-8#1)(2012-12#1)(2012-2#1)
cost of analysis##2##3##(2008-10#2)
cost of care##6##3##(1992-3#1)(1994-3#1)(1996-1#1)(2008-11#1)(2008-8#1)(2012-2#1)
cost of each of##2##4##(1993-12#1)(1995-12#1)
cost of goods##2##3##(2008-10#1)(2008-11#1)
cost of health care##2##4##(1994-12#1)(2013-8#1)
cost of home##2##3##(1995-2#1)(1995-3#1)
cost of parasitism in##2##4##(2008-8#2)
cost of parasitism##3##3##(2008-8#3)
cost of reproduction##3##3##(2008-8#2)(2008-9#1)
cost of the burden of##2##5##(2012-12#2)
cost of the##10##3##(1992-12#2)(1993-1#1)(1996-5#1)(2008-10#3)(2008-11#1)(2012-12#2)
cost of treatment##2##3##(1990-12#1)(2013-1#1)
cost of unnecessary virulence##2##4##(2008-10#2)
cost of##111##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-12#4)(1992-3#1)(1992-5#1)(1993-1#4)(1993-12#3)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#10)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#13)(2008-9#5)(2009-9#1)(2010-5#1)(2010-8#2)(2012-12#5)(2012-2#2)(2013-1#1)(2013-8#1)
cost on##2##2##(2008-11#1)(2008-8#1)
cost per case##5##3##(1992-12#4)(1996-3#1)
cost per square foot##2##4##(1991-2#1)(1992-2#1)
cost per visit##2##3##(1995-12#1)(1995-3#1)
cost per##18##2##(1991-2#1)(1992-12#4)(1992-2#1)(1992-5#1)(1993-1#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-11#2)(2009-8#4)
cost reduction##3##2##(1994-3#2)(1997-2#1)
cost savings for##2##3##(1995-2#1)(1997-2#1)
cost savings in##2##3##(1991-1#1)(2008-11#1)
cost savings##16##2##(1991-1#1)(1991-12#1)(1992-2#2)(1993-12#1)(1995-2#2)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2013-1#1)
cost shares##3##2##(1994-1#3)
cost sharing##3##2##(1992-2#1)(1993-12#1)(1994-3#1)
cost structure##2##2##(2008-11#2)
cost to society##2##3##(1996-2#1)(2008-11#1)
cost to the##2##3##(2008-10#1)(2008-11#1)
cost to##10##2##(1991-2#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2012-3#1)
cost was NOK##2##3##(1995-2#1)(1997-4#1)
cost was##3##2##(1995-2#1)(1997-4#1)(2012-12#1)
cost##493##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-9#2)(1991-1#6)(1991-12#7)(1991-2#10)(1991-3#5)(1992-1#4)(1992-11#3)(1992-12#24)(1992-2#8)(1992-3#5)(1992-5#4)(1993-1#12)(1993-12#7)(1993-2#5)(1993-3#6)(1993-5#1)(1993-8#1)(1994-1#8)(1994-12#4)(1994-2#10)(1994-3#8)(1994-9#3)(1995-1#7)(1995-12#7)(1995-2#13)(1995-3#6)(1995-5#4)(1995-6#1)(1996-1#3)(1996-11#3)(1996-2#4)(1996-3#6)(1996-5#1)(1996-8#1)(1997-1#4)(1997-2#17)(1997-3#1)(1997-4#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#78)(2008-11#46)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#8)(2008-8#28)(2008-9#19)(2009-1#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#7)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-2#9)(2011-7#1)(2012-12#9)(2012-2#7)(2012-3#7)(2013-1#8)(2013-8#4)
cost)##3##1##(1993-3#1)(2008-10#1)(2008-7#1)
cost-based weights##3##2##(1993-1#3)
cost-based##4##1##(1991-1#1)(1993-1#3)
cost-benefit analysis##2##2##(1991-12#1)(2009-12#1)
cost-benefit ratio##3##2##(1996-11#1)(2008-7#1)(2009-4#1)
cost-benefit##10##1##(1991-12#1)(1994-6#1)(1996-11#1)(2008-7#1)(2009-12#1)(2009-4#3)(2009-8#1)(2010-8#1)
cost-containment acts##2##2##(1992-1#2)
cost-containment##11##1##(1992-1#2)(1992-2#2)(1993-3#2)(1994-1#2)(1994-2#1)(1996-2#1)(1997-5#1)
cost-control##2##1##(1992-2#1)(1994-2#1)
cost-effective and##5##2##(1996-1#1)(2008-10#2)(2008-9#1)(2012-3#1)
cost-effective manner##3##2##(1993-12#1)(1993-9#1)(2008-7#1)
cost-effective production##2##2##(2008-11#2)
cost-effective use of##2##3##(1996-11#1)(1997-3#1)
cost-effective way to##4##3##(1994-3#2)(2008-11#1)(2011-2#1)
cost-effective way##6##2##(1994-3#2)(1997-7#1)(2008-11#1)(2010-8#1)(2011-2#1)
cost-effective##58##1##(1991-1#1)(1991-12#1)(1992-2#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-2#3)(1994-3#4)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)
cost-effectiveness analysis##3##2##(1997-1#1)(2009-8#1)(2012-12#1)
cost-effectiveness evaluations##2##2##(2008-2#2)
cost-effectiveness of enzyme replacement therapy (ERT) for the##2##8##(2012-12#2)
cost-effectiveness of##11##2##(1994-9#1)(1996-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-9#1)(2011-2#1)(2012-12#2)
cost-effectiveness studies##2##2##(1995-12#1)(2008-10#1)
cost-effectiveness##33##1##(1992-1#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-6#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-9#1)(2009-8#3)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#4)(2013-1#1)
cost-efficient##6##1##(1992-12#1)(1995-1#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-5#1)
cost-savings##2##1##(1992-12#1)(1992-2#1)
cost-sharing##3##1##(1997-2#1)(2010-5#2)
cost/benefit analysis##2##2##(1994-3#1)(2008-10#1)
cost/benefit ratio##3##2##(1991-3#1)(1992-2#2)
cost/benefit##6##1##(1991-3#2)(1992-2#2)(1994-3#1)(2008-10#1)
costal margin##2##2##(1991-12#1)(2011-1#1)
costal##3##1##(1991-12#1)(2009-1#1)(2011-1#1)
costimulatory molecules##8##2##(2007-12#5)(2008-10#1)(2008-11#2)
costimulatory##11##1##(2007-12#6)(2008-10#1)(2008-11#3)(2008-9#1)
costing##4##1##(1995-12#1)(2007-12#1)(2008-1#1)(2012-12#1)
costly and##6##2##(1995-5#1)(2008-10#2)(2008-8#2)(2013-1#1)
costly equipment##3##2##(1990-11#1)(2012-2#2)
costly to##5##2##(1993-3#1)(2008-10#1)(2008-8#1)(2008-9#2)
costly##44##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-2#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#7)(2010-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
costs DM##2##2##(1996-11#1)(1997-4#1)
costs about##2##2##(1990-2#1)(1997-4#1)
costs across##3##2##(1991-3#1)(1992-12#1)(2008-8#1)
costs among##3##2##(1992-12#1)(1995-2#1)(1997-1#1)
costs and benefits of##4##4##(1991-2#1)(2008-12#1)(2008-6#1)(2009-4#1)
costs and benefits##6##3##(1991-2#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-4#1)
costs and increased##2##3##(2010-12#1)(2012-12#1)
costs and quality##2##3##(1992-2#1)(1995-2#1)
costs and the##2##3##(2008-11#1)(2008-9#1)
costs and utilization##2##3##(1993-1#1)(1996-12#1)
costs and##52##2##(1991-1#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#2)(2008-10#4)(2008-11#6)(2008-12#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-2#2)(2012-12#2)(2013-1#1)
costs are high##2##3##(2008-8#2)
costs are##9##2##(1992-2#1)(1994-2#1)(1997-2#1)(2008-11#2)(2008-8#4)
costs as##2##2##(1994-12#1)(2008-10#1)
costs associated with##12##3##(1993-3#1)(1994-2#1)(1996-1#1)(1997-1#1)(1997-2#3)(2008-10#2)(2008-11#1)(2010-5#1)(2013-1#1)
costs by##6##2##(1991-12#1)(1991-9#1)(1994-3#1)(1996-1#1)(2008-10#1)(2008-11#1)
costs can be##2##3##(1997-2#1)(2008-11#1)
costs can##3##2##(1996-11#1)(1997-2#1)(2008-11#1)
costs for the##3##3##(1995-3#1)(1997-4#1)(2008-8#1)
costs for##10##2##(1991-3#1)(1995-3#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
costs have##3##2##(1992-2#1)(1996-3#1)(2008-11#1)
costs in a##2##3##(1994-2#1)(2008-9#1)
costs in the##3##3##(1991-6#1)(1993-1#1)(2011-2#1)
costs in##20##2##(1991-6#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#2)(1994-6#1)(1995-2#1)(1996-3#2)(2008-10#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-12#1)
costs incurred by##2##3##(1991-3#1)(2010-8#1)
costs incurred##3##2##(1991-3#1)(2010-8#2)
costs involved##2##2##(1994-12#1)(2008-10#1)
costs may##2##2##(1994-12#1)(1995-11#1)
costs of health care##2##4##(1993-12#1)(2008-11#1)
costs of health##3##3##(1993-12#1)(1993-2#1)(2008-11#1)
costs of plasticity##2##3##(2008-8#2)
costs of reproduction for##2##4##(2008-9#2)
costs of reproduction##5##3##(2008-9#5)
costs of the##6##3##(1990-8#1)(1990-9#1)(1992-12#1)(2008-10#2)(2008-11#1)
costs of##84##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-3#3)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1997-1#2)(1997-2#1)(2008-10#9)(2008-11#9)(2008-2#1)(2008-7#1)(2008-8#15)(2008-9#14)(2009-4#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
costs on##3##2##(1991-12#1)(1995-12#1)(2008-8#1)
costs or##2##2##(1991-1#1)(1991-12#1)
costs per##3##2##(1994-1#1)(2008-7#1)(2012-12#1)
costs through##2##2##(1997-2#1)(1997-3#1)
costs to society##2##3##(1995-11#1)(1997-4#1)
costs to##5##2##(1995-1#1)(1995-11#1)(1995-6#1)(1997-4#1)(2008-11#1)
costs was##3##2##(1994-1#1)(2008-11#1)(2011-2#1)
costs were##7##2##(1991-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-7#1)(2012-12#1)
costs##405##1##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-1#6)(1991-12#15)(1991-2#3)(1991-3#5)(1991-6#3)(1991-9#4)(1992-1#4)(1992-12#14)(1992-2#10)(1992-3#3)(1992-5#2)(1993-1#5)(1993-12#5)(1993-2#4)(1993-3#5)(1994-1#5)(1994-12#8)(1994-2#9)(1994-3#5)(1994-6#1)(1994-9#1)(1995-1#15)(1995-11#3)(1995-12#6)(1995-2#10)(1995-3#6)(1995-6#4)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#6)(1996-3#16)(1997-1#8)(1997-2#13)(1997-3#2)(1997-4#6)(2008-10#27)(2008-11#35)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#6)(2008-8#33)(2008-9#22)(2009-1#1)(2009-11#1)(2009-12#2)(2009-4#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-2#7)(2011-7#1)(2012-12#10)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#5)
costs?##2##1##(1997-4#1)(2013-1#1)
cosubstrate##4##1##(2008-10#4)
cosurfactant##3##1##(2008-10#1)(2008-5#2)
cotransfected##3##1##(1990-5#1)(1995-6#1)(2008-9#1)
cotransfection of##4##2##(1993-2#1)(1993-8#1)(1995-2#2)
cotransfection##7##1##(1993-2#1)(1993-8#2)(1995-2#2)(2008-11#2)
cotransformed with##2##2##(2008-10#1)(2008-9#1)
cotransporter##2##1##(2008-11#1)(2008-7#1)
cotransporting green##2##2##(2008-11#2)
cotransporting##3##1##(2008-11#3)
cotrimoxazole and##3##2##(2008-11#2)(2008-12#1)
cotrimoxazole##11##1##(2007-12#2)(2008-11#7)(2008-12#1)(2012-3#1)
cotton (Gossypium hirsutum)##3##3##(2008-10#2)(2008-9#1)
cotton (Gossypium##4##2##(2008-10#3)(2008-9#1)
cotton and olive##2##3##(2008-10#2)
cotton and##7##2##(2008-10#7)
cotton fiber##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
cotton fibers##2##2##(2008-9#2)
cotton fields##2##2##(2008-10#1)(2008-12#1)
cotton fruit##2##2##(1993-3#2)
cotton in##2##2##(2008-10#2)
cotton leaf curl##2##3##(2008-10#1)(2008-9#1)
cotton leaves##2##2##(2008-10#1)(2008-9#1)
cotton roots##5##2##(2008-10#5)
cotton seedling disease##2##3##(2008-10#2)
cotton seedlings##2##2##(2008-8#2)
cotton swab was##2##3##(2008-10#2)
cotton swab##4##2##(2008-10#3)(2011-2#1)
cotton terpenoid production##2##3##(2008-10#2)
cotton were##2##2##(2008-10#2)
cotton wilt disease##3##3##(2008-12#3)
cotton##87##1##(1993-3#2)(2008-10#64)(2008-12#5)(2008-5#1)(2008-8#5)(2008-9#8)(2011-2#1)(2013-8#1)
cotton-gin trash##6##2##(2008-10#6)
cotton-tipped applicator##2##2##(1992-1#2)
cottonball##5##1##(2008-10#5)
cottonseed##9##1##(2008-10#9)
cottonwood##2##1##(2008-10#1)(2009-8#1)
cotyledon petiole was##2##3##(2008-10#2)
cotyledon##14##1##(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#6)
cotyledonary node##2##2##(2008-10#1)(2008-12#1)
cotyledonary##8##1##(2008-10#3)(2008-12#2)(2013-8#3)
cotyledons and##3##2##(2008-10#3)
cotyledons with##2##2##(2008-10#2)
cotyledons##20##1##(1990-5#2)(2008-10#14)(2008-8#1)(2009-8#2)(2013-8#1)
cough and##2##2##(2008-1#1)(2008-12#1)
cough with##2##2##(2008-1#1)(2008-7#1)
cough##28##1##(1991-8#1)(1992-5#1)(1995-5#1)(1996-2#1)(1997-1#2)(1997-8#2)(2007-12#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#1)(2012-3#2)(2013-1#1)
coughing##9##1##(1990-3#1)(1991-11#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-6#1)(2008-12#1)(2013-8#1)
could accelerate the##2##3##(2008-10#2)
could accommodate##3##2##(1993-8#2)(2008-10#1)
could account for##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
could accurately##2##2##(2008-10#1)(2009-10#1)
could achieve##4##2##(1993-1#1)(2008-10#1)(2009-8#1)(2010-8#1)
could act as##3##3##(1994-8#1)(2008-11#1)(2008-9#1)
could act##5##2##(1994-8#1)(2008-11#1)(2008-5#2)(2008-9#1)
could activate##2##2##(1993-8#1)(1995-8#1)
could affect the performance of##3##5##(2008-10#3)
could affect the##10##3##(1990-5#1)(2008-10#7)(2008-8#1)(2011-2#1)
could affect##16##2##(1990-5#1)(2008-10#7)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
could allow##3##2##(2008-10#1)(2008-5#2)
could already##2##2##(2008-11#1)(2008-7#1)
could also affect the##3##4##(1996-2#1)(2010-5#1)(2013-1#1)
could also affect##4##3##(1996-2#1)(2008-8#1)(2010-5#1)(2013-1#1)
could also be applied to##2##5##(2008-10#1)(2010-5#1)
could also be considered##2##4##(1992-6#1)(2011-1#1)
could also be detected in##2##5##(2008-11#1)(2008-9#1)
could also be detected##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
could also be involved##2##4##(2008-10#1)(2012-3#1)
could also be used to##2##5##(2008-10#2)
could also be used##3##4##(2008-10#2)(2008-11#1)
could also be##28##3##(1992-6#1)(1995-2#1)(1995-6#1)(2008-10#10)(2008-11#4)(2008-8#2)(2008-9#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
could also contribute to##2##4##(2008-10#2)
could also##48##2##(1992-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#14)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-8#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
could alter##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
could amplify##3##2##(1993-12#1)(2008-8#1)(2012-2#1)
could apply to##2##3##(2008-11#1)(2011-2#1)
could assist##2##2##(2008-11#1)(2010-3#1)
could augment the##2##3##(2008-11#1)(2008-8#1)
could be a good##2##4##(2008-12#1)(2011-2#1)
could be a key##2##4##(2008-10#1)(2009-8#1)
could be a promising##2##4##(2008-10#1)(2008-8#1)
could be a useful##3##4##(2008-10#3)
could be a##36##3##(1990-11#1)(1991-2#1)(1991-3#1)(1993-1#1)(1996-3#1)(1996-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-8#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
could be accomplished##2##3##(2008-10#1)(2008-11#1)
could be accounted for by##3##5##(1995-6#1)(2008-10#1)(2009-5#1)
could be achieved by##4##4##(1990-2#1)(1996-2#1)(2008-10#1)(2012-2#1)
could be achieved using##3##4##(2008-10#1)(2008-12#1)(2009-12#1)
could be achieved with##3##4##(2008-10#2)(2011-2#1)
could be achieved##17##3##(1990-2#1)(1996-2#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#1)(2012-2#1)
could be acquired##2##3##(2008-10#2)
could be activated by##2##4##(1993-8#1)(2008-9#1)
could be adapted to##2##4##(2008-10#1)(2008-12#1)
could be adopted##2##3##(2008-10#1)(2008-11#1)
could be amplified by##2##4##(2008-10#1)(2008-11#1)
could be an effective means of##2##6##(1993-11#1)(2008-5#1)
could be an effective##3##4##(1993-11#1)(2008-5#1)(2012-3#1)
could be an##9##3##(1993-11#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
could be analysed##3##3##(1991-8#2)(2008-10#1)
could be analyzed in##2##4##(2008-10#2)
could be analyzed##3##3##(2008-10#3)
could be applied in##3##4##(2008-10#2)(2008-3#1)
could be applied successfully to the determination of the investigated##2##10##(2008-10#2)
could be applied successfully to the##3##6##(2008-10#3)
could be applied to the determination##2##6##(2008-10#2)
could be applied to the##3##5##(2008-10#3)
could be applied to##7##4##(1993-12#1)(2008-10#6)
could be applied##18##3##(1993-12#1)(2008-10#15)(2008-3#1)(2008-6#1)
could be as##2##3##(1997-6#1)(2012-12#1)
could be asked##2##3##(2008-11#1)(2010-10#1)
could be assigned to##2##4##(2008-10#2)
could be assigned##4##3##(2008-10#4)
could be associated with##2##4##(2008-10#1)(2011-10#1)
could be associated##3##3##(2008-10#2)(2011-10#1)
could be attained##4##3##(2008-10#4)
could be attributed to##7##4##(1995-12#1)(1997-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)
could be attributed##8##3##(1995-12#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)
could be avoided##2##3##(2008-11#1)(2008-7#1)
could be based on##3##4##(1992-2#1)(2008-5#1)(2008-9#1)
could be beneficial##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
could be characterized by##3##4##(1996-3#1)(2008-10#1)(2008-3#1)
could be characterized##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
could be classified as##2##4##(1990-11#1)(2009-10#1)
could be classified into two##2##5##(1997-2#1)(2008-10#1)
could be classified into##5##4##(1996-6#1)(1997-2#1)(2008-10#3)
could be classified##9##3##(1990-11#1)(1996-6#1)(1997-2#1)(2008-10#4)(2009-10#1)(2011-10#1)
could be combined##2##3##(2008-10#2)
could be compared with##2##4##(2008-10#2)
could be completed in##4##4##(2008-10#4)
could be completed##5##3##(2008-10#5)
could be completely##4##3##(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
could be concentrated by##2##4##(2008-10#2)
could be confirmed##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
could be considered a##3##4##(1995-12#1)(2011-2#1)(2012-12#1)
could be considered as a##2##5##(2008-10#2)
could be considered as##3##4##(2008-10#2)(2012-2#1)
could be considered##12##3##(1995-12#1)(2008-10#4)(2008-12#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
could be constructed and##2##4##(2008-10#1)(2008-5#1)
could be controlled##2##3##(2008-10#1)(2009-12#1)
could be correlated with the##3##5##(1992-6#1)(1995-11#1)(2007-12#1)
could be correlated##4##3##(1992-6#1)(1995-11#1)(2007-12#1)(2008-7#1)
could be crucial##3##3##(2009-6#1)(2011-2#1)(2012-5#1)
could be demonstrated##5##3##(1992-9#1)(1993-1#1)(1994-8#1)(1995-2#1)(1996-11#1)
could be derived##3##3##(2008-10#2)(2011-3#1)
could be described by a##2##5##(2008-10#1)(2008-7#1)
could be described##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
could be detected by##3##4##(1994-9#1)(2008-10#2)
could be detected in the##10##5##(1990-5#1)(1993-6#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-8#3)
could be detected in##26##4##(1990-5#1)(1993-6#1)(1994-12#1)(1995-6#1)(2008-10#11)(2008-11#1)(2008-5#3)(2008-8#5)(2012-2#1)(2013-1#1)
could be detected throughout##2##4##(2008-9#1)(2013-8#1)
could be detected with##2##4##(2008-10#2)
could be detected##58##3##(1990-5#1)(1991-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#23)(2008-11#1)(2008-5#4)(2008-6#1)(2008-8#7)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#3)
could be determined by the method##2##6##(2008-10#2)
could be determined by the##3##5##(2008-10#3)
could be determined by##6##4##(2008-10#5)(2008-11#1)
could be determined in the##5##5##(2008-10#5)
could be determined in##11##4##(1992-5#1)(2008-10#10)
could be determined over the##2##5##(2008-10#2)
could be determined simultaneously with##2##5##(2008-10#2)
could be determined with a 90%##2##6##(2008-10#2)
could be determined with a##3##5##(2008-10#3)
could be determined with##6##4##(2008-10#6)
could be determined##40##3##(1991-5#1)(1992-12#1)(1992-5#1)(2008-10#35)(2008-11#2)
could be developed##6##3##(2008-10#4)(2008-11#1)(2011-3#1)
could be differentiated##2##3##(2008-10#2)
could be directly##2##3##(1993-12#1)(2008-10#1)
could be discriminated##2##3##(2008-10#2)
could be distinguished##2##3##(1993-8#1)(2008-8#1)
could be divided into two##4##5##(2008-10#3)(2008-5#1)
could be divided into##5##4##(1995-11#1)(2008-10#3)(2008-5#1)
could be divided##6##3##(1995-11#1)(1996-12#1)(2008-10#3)(2008-5#1)
could be done to##2##4##(1996-8#1)(2008-9#1)
could be done##4##3##(1991-1#1)(1996-8#1)(2008-10#1)(2008-9#1)
could be due to the##5##5##(1992-9#1)(1996-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
could be due to##14##4##(1992-9#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
could be easily achieved##2##4##(2008-10#2)
could be easily separated##2##4##(2008-10#2)
could be easily##17##3##(2008-10#14)(2008-11#1)(2008-12#1)(2013-1#1)
could be effective##2##3##(2008-10#1)(2013-1#1)
could be efficiently##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
could be eliminated by the##2##5##(2008-10#1)(2008-7#1)
could be eliminated by##5##4##(2008-10#3)(2008-3#1)(2008-7#1)
could be eliminated##7##3##(1996-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
could be eluted##4##3##(2008-10#4)
could be employed##3##3##(2008-10#2)(2008-2#1)
could be enhanced by##5##4##(1996-2#1)(2008-10#2)(2008-11#1)(2009-7#1)
could be enhanced##6##3##(1996-2#1)(2008-10#2)(2008-11#2)(2009-7#1)
could be established##7##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)
could be estimated##2##3##(2008-10#2)
could be evaluated##3##3##(1990-3#1)(1991-8#1)(2008-5#1)
could be explained by a##3##5##(2008-10#3)
could be explained by the##3##5##(2008-10#1)(2008-11#2)
could be explained by##10##4##(1993-1#1)(1995-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-7#1)
could be explained##13##3##(1991-3#1)(1993-1#1)(1995-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2009-7#1)
could be exploited##3##3##(2008-10#2)(2011-2#1)
could be expressed##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
could be extracted##2##3##(2008-10#2)
could be facilitated##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
could be followed up##2##4##(1997-2#1)(2008-7#1)
could be followed##3##3##(1995-12#1)(1997-2#1)(2008-7#1)
could be formed##3##3##(2008-10#2)(2008-7#1)
could be found between##2##4##(1990-6#1)(2008-10#1)
could be found in##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
could be found##13##3##(1990-6#1)(1992-12#1)(1993-6#1)(1995-11#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#1)(2011-2#1)(2013-7#1)
could be functionally##2##3##(2008-10#1)(2010-1#1)
could be further divided into##2##5##(2008-10#2)
could be further##5##3##(2008-10#4)(2013-1#1)
could be greatly enhanced by##2##5##(2008-10#2)
could be greatly enhanced##3##4##(2008-10#3)
could be grouped into two##2##5##(2008-10#2)
could be grouped into##3##4##(1991-2#1)(2008-10#2)
could be helpful for##2##4##(2008-5#1)(2012-2#1)
could be helpful##3##3##(1997-3#1)(2008-5#1)(2012-2#1)
could be identified with##2##4##(1991-11#1)(1997-6#1)
could be identified##10##3##(1991-11#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#1)
could be important for the##2##5##(2008-5#1)(2009-6#1)
could be important in the##2##5##(2008-10#1)(2011-2#1)
could be important in##3##4##(2008-10#1)(2010-4#1)(2011-2#1)
could be important##6##3##(2008-10#2)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#1)
could be improved by##2##4##(1996-12#1)(1996-9#1)
could be improved##8##3##(1996-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2009-3#1)(2013-8#1)
could be incorporated into##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
could be incorporated##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2013-8#1)
could be increased##3##3##(1993-12#1)(2008-10#1)(2008-8#1)
could be indicative##2##3##(2008-10#1)(2010-7#1)
could be induced##2##3##(1994-2#1)(2008-7#1)
could be inferred##4##3##(2008-11#2)(2008-8#1)(2010-6#1)
could be inhibited by##5##4##(1995-11#1)(1995-2#1)(1996-12#1)(2008-11#1)(2010-3#1)
could be inhibited##7##3##(1991-5#1)(1995-11#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-5#1)(2010-3#1)
could be interpreted##4##3##(1994-5#1)(2008-10#1)(2008-5#2)
could be involved in the##3##5##(1995-2#1)(2008-10#1)(2009-8#1)
could be involved in##5##4##(1995-2#1)(2008-10#2)(2008-7#1)(2009-8#1)
could be involved##6##3##(1995-2#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#1)
could be isolated##3##3##(1996-6#1)(2008-5#1)(2012-2#1)
could be labeled##2##3##(1991-3#1)(2011-2#1)
could be less##2##3##(2008-10#1)(2008-9#1)
could be made##7##3##(1990-2#1)(1991-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)
could be maintained##3##3##(1993-9#1)(2008-10#1)(2008-7#1)
could be manipulated##2##3##(2008-10#1)(2009-12#1)
could be measured##3##3##(2008-10#3)
could be modified by##3##4##(1993-12#1)(2008-5#1)(2011-2#1)
could be modulated##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
could be monitored by##2##4##(1994-5#1)(2008-10#1)
could be monitored##5##3##(1994-5#1)(2008-10#4)
could be more##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)
could be observed in##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
could be observed##17##3##(1993-1#1)(1996-9#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#2)(2010-6#2)(2012-2#1)
could be obtained by##2##4##(2008-10#1)(2008-5#1)
could be obtained in##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
could be obtained using##2##4##(2008-10#1)(2008-5#1)
could be obtained when##2##4##(2008-10#1)(2008-12#1)
could be obtained##22##3##(1994-12#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-5#2)(2009-11#1)(2011-1#1)(2011-2#1)
could be of great##2##4##(2008-8#1)(2010-7#1)
could be of##6##3##(1991-9#1)(1994-8#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)
could be offered##2##3##(2011-2#1)(2013-1#1)
could be one of the##2##5##(1995-12#1)(2008-10#1)
could be one##3##3##(1995-12#1)(2008-10#1)(2010-10#1)
could be operated under physiological conditions (0##2##7##(2008-10#2)
could be overcome by##2##4##(2008-10#1)(2008-11#1)
could be partially##2##3##(2007-12#1)(2008-6#1)
could be performed in 1 min##2##6##(2008-10#2)
could be performed in 1##3##5##(2008-10#3)
could be performed in##5##4##(2008-10#5)
could be performed with the ratio 1##2##7##(2008-10#2)
could be performed##10##3##(2008-10#8)(2008-11#1)(2011-2#1)
could be placed##2##3##(2008-10#1)(2008-5#1)
could be predicted##5##3##(2008-10#3)(2008-9#1)(2010-11#1)
could be prepared##3##3##(2008-10#3)
could be present##2##3##(2008-10#1)(2008-11#1)
could be presented##2##3##(2008-12#1)(2008-9#1)
could be preserved##2##3##(2008-10#1)(2012-3#1)
could be prevented##3##3##(2008-11#1)(2008-5#1)(2010-11#1)
could be produced by##2##4##(1995-6#1)(2008-9#1)
could be provided##2##3##(2008-10#2)
could be quantified##2##3##(2008-10#2)
could be quantitatively adsorbed##2##4##(2008-10#2)
could be quantitatively##5##3##(2008-10#5)
could be readily##3##3##(2008-10#3)
could be recognized##2##3##(2008-9#1)(2011-2#1)
could be recorded##4##3##(1996-6#1)(2008-10#2)(2013-1#1)
could be reduced with##2##4##(1996-1#1)(2008-7#1)
could be reduced##7##3##(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-2#1)
could be regenerated by##2##4##(2008-10#2)
could be regenerated##3##3##(2008-10#3)
could be related to the##4##5##(1990-5#1)(1993-3#1)(1993-8#1)(2010-10#1)
could be related to##7##4##(1990-5#1)(1993-3#1)(1993-8#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)
could be related##8##3##(1990-5#1)(1990-8#1)(1993-3#1)(1993-8#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)
could be relevant##3##3##(1994-8#1)(2008-7#1)(2012-2#1)
could be reliably##2##3##(2008-10#1)(2008-12#1)
could be removed by##3##4##(1993-6#1)(1993-8#1)(2008-10#1)
could be replaced by##2##4##(2008-10#1)(2011-2#1)
could be reproduced with a##2##5##(1992-3#1)(2008-10#1)
could be required##2##3##(2008-10#1)(2013-1#1)
could be resolved##2##3##(2008-10#1)(2009-12#1)
could be responsible for##2##4##(2008-10#1)(2012-3#1)
could be reused##5##3##(2008-10#5)
could be reversed##3##3##(1990-6#1)(1993-8#1)(2013-8#1)
could be safely##2##3##(1995-1#1)(2008-12#1)
could be satisfactorily##2##3##(2008-10#2)
could be seen##5##3##(2008-10#3)(2008-12#1)(2013-1#1)
could be separated from##2##4##(2008-10#2)
could be separated into three##2##5##(1992-11#1)(2008-10#1)
could be separated into##3##4##(1992-11#1)(2008-10#2)
could be separated##9##3##(1992-11#1)(2008-10#8)
could be serious##2##3##(2008-12#1)(2012-12#1)
could be shown that##2##4##(1997-1#1)(2008-10#1)
could be shown##6##3##(1993-2#1)(1995-12#1)(1997-1#2)(2008-10#2)
could be significantly##2##3##(2008-5#1)(2008-9#1)
could be strongly##2##3##(2008-10#1)(2011-2#1)
could be substituted for standard LPA##2##6##(2011-2#2)
could be successfully##3##3##(2008-10#3)
could be suitable for the routine control analysis##2##8##(2008-10#2)
could be suppressed by##3##4##(1993-8#1)(2008-10#1)(2008-9#1)
could be that##2##3##(1997-7#1)(2013-8#1)
could be the result of##2##5##(2008-10#1)(2008-9#1)
could be the##12##3##(1992-12#1)(1994-11#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
could be to##2##3##(2008-7#1)(2011-2#1)
could be tolerated##3##3##(2008-10#3)
could be traced back to##2##5##(2008-10#2)
could be traced##4##3##(2008-10#4)
could be transferred##2##3##(2008-11#1)(2008-8#1)
could be transmitted##3##3##(2008-10#2)(2008-9#1)
could be treated##2##3##(2008-10#1)(2008-9#1)
could be used as a new##2##6##(2008-5#1)(2008-9#1)
could be used as a##18##5##(1993-2#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2011-3#1)(2013-8#3)
could be used as an##4##5##(2008-10#2)(2008-11#1)(2008-5#1)
could be used as##33##4##(1993-2#1)(1995-5#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-5#3)(2008-8#2)(2008-9#2)(2010-12#2)(2010-6#1)(2011-2#1)(2011-3#1)(2013-8#3)
could be used by##2##4##(2009-3#1)(2013-1#1)
could be used for at least##2##6##(2008-10#2)
could be used for more than##3##6##(2008-10#3)
could be used for the determination of##6##7##(2008-10#6)
could be used for the##10##5##(1993-1#1)(2008-10#8)(2009-3#1)
could be used for##26##4##(1992-1#1)(1993-1#1)(1995-2#1)(2008-10#18)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)
could be used in a pH range of 3##2##9##(2008-10#2)
could be used in a pH range of##6##8##(2008-10#6)
could be used in the##5##5##(1990-2#1)(2008-10#3)(2013-1#1)
could be used in##14##4##(1990-2#1)(2008-10#11)(2008-11#1)(2013-1#1)
could be used to detect##5##5##(2008-10#5)
could be used to determine##6##5##(2008-10#5)(2008-11#1)
could be used to enhance##2##5##(2008-11#1)(2012-2#1)
could be used to monitor##2##5##(2008-10#1)(2008-11#1)
could be used to##38##4##(1991-12#1)(1993-6#1)(1995-8#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
could be used##121##3##(1990-2#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-2#2)(1993-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#63)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#3)
could be useful for##4##4##(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
could be useful in##5##4##(1991-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-4#1)
could be useful to##2##4##(2008-10#2)
could be useful##11##3##(1991-8#1)(1995-2#1)(2008-10#4)(2008-11#2)(2009-11#1)(2010-4#1)(2011-2#1)
could be very##2##3##(2008-10#1)(2009-5#1)
could be visualized by##2##4##(2008-10#1)(2008-8#1)
could be well##3##3##(2008-10#3)
could be##1095##2##(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#4)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#5)(1991-5#4)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#5)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#4)(1993-6#6)(1993-8#10)(1993-9#3)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#6)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#6)(1995-2#9)(1995-3#3)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#3)(1996-6#3)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#5)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2007-12#2)(2007-9#1)(2008-1#3)(2008-10#489)(2008-11#70)(2008-12#20)(2008-2#2)(2008-3#8)(2008-5#46)(2008-6#3)(2008-7#22)(2008-8#33)(2008-9#26)(2009-10#2)(2009-11#3)(2009-12#5)(2009-3#5)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#7)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#6)(2010-7#4)(2011-1#6)(2011-10#2)(2011-2#41)(2011-3#4)(2012-12#7)(2012-2#19)(2012-3#6)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#13)
could become##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#2)
could benefit from##7##3##(1991-2#1)(1992-11#1)(1993-2#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-7#1)
could best##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
could bind to##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
could bind##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2010-12#1)
could block the##2##3##(1994-8#1)(2008-8#1)
could block##5##2##(1993-8#1)(1994-8#1)(1995-12#1)(2008-8#2)
could cause##7##2##(1995-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)
could change##4##2##(1996-5#1)(2008-9#1)(2009-7#1)(2012-3#1)
could clearly##2##2##(2008-11#1)(2011-3#1)
could complement##2##2##(1997-3#1)(2008-1#1)
could compromise##2##2##(2011-2#1)(2012-2#1)
could contain##2##2##(1994-2#1)(1995-12#1)
could contribute to the##6##4##(1994-11#1)(1994-2#1)(2008-10#3)(2008-5#1)
could contribute to##7##3##(1994-11#1)(1994-2#1)(1997-2#1)(2008-10#3)(2008-5#1)
could contribute##9##2##(1994-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-5#1)
could decrease the##3##3##(2008-1#1)(2008-11#1)(2013-8#1)
could decrease##4##2##(1994-2#1)(2008-1#1)(2008-11#1)(2013-8#1)
could degrade##2##2##(2008-10#2)
could detect no##2##3##(1995-12#1)(2008-9#1)
could detect##15##2##(1993-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#9)(2008-9#1)(2011-3#1)
could determine the##3##3##(1995-11#1)(2008-10#2)
could determine##4##2##(1995-11#1)(2008-10#2)(2008-11#1)
could develop##2##2##(2008-10#1)(2008-5#1)
could differentiate##2##2##(2008-10#1)(2008-12#1)
could directly##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
could discriminate##2##2##(2008-10#2)
could distinguish##4##2##(2008-10#2)(2008-9#1)(2010-12#1)
could drastically##2##2##(1994-3#1)(2013-1#1)
could easily be##4##3##(2008-10#1)(2008-11#1)(2012-3#2)
could easily##11##2##(1992-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-1#1)(2012-12#2)(2012-3#2)
could effectively##7##2##(2008-10#5)(2008-5#1)(2013-1#1)
could elicit##3##2##(1996-2#1)(2011-2#2)
could encode a##2##3##(1990-11#1)(2008-10#1)
could encourage##2##2##(2008-12#2)
could enhance the sensitivity##2##4##(2008-10#2)
could enhance the##5##3##(2008-10#4)(2008-11#1)
could enhance##7##2##(1995-8#1)(2008-10#4)(2008-11#1)(2012-2#1)
could exist##2##2##(2008-10#2)
could explain the##6##3##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
could explain their##2##3##(2011-10#1)(2011-2#1)
could explain##14##2##(1993-6#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-10#1)(2011-2#1)(2012-3#1)
could facilitate the##3##3##(1996-12#1)(2010-12#1)(2012-3#1)
could facilitate##6##2##(1996-12#1)(1996-9#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-3#1)
could find##2##2##(1993-11#1)(2008-12#1)
could fit##2##2##(2008-10#1)(2010-11#1)
could form##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
could further##2##2##(2008-10#1)(2008-9#1)
could generate##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
could give##3##2##(2008-10#2)(2010-10#1)
could greatly improve the##2##4##(2008-10#1)(2010-8#1)
could greatly##4##2##(2008-10#2)(2009-6#1)(2010-8#1)
could grow##3##2##(2008-11#1)(2008-5#1)(2010-6#1)
could have a##6##3##(1997-5#1)(2008-10#1)(2008-7#1)(2012-2#2)(2013-8#1)
could have been##5##3##(1990-5#1)(1997-3#1)(2008-11#1)(2010-1#1)(2010-4#1)
could have##35##2##(1990-5#1)(1991-1#1)(1993-12#1)(1994-9#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-5#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#2)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#5)(2013-1#2)(2013-8#1)
could help to improve##2##4##(2008-10#1)(2012-8#1)
could help to##5##3##(2008-10#1)(2012-12#3)(2012-8#1)
could help us##2##3##(1993-12#1)(2011-2#1)
could help##16##2##(1993-12#1)(1994-12#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-8#1)(2013-1#2)(2013-8#1)
could improve the##8##3##(2008-1#1)(2008-10#4)(2008-11#1)(2009-6#1)(2013-1#1)
could improve##14##2##(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#1)
could include##2##2##(2008-10#1)(2011-2#1)
could increase the##8##3##(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
could increase##14##2##(1993-8#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
could induce the##2##3##(2008-8#2)
could induce##18##2##(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#4)(2008-9#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
could infect##2##2##(2008-10#2)
could influence the##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
could influence##11##2##(1992-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2011-2#2)(2012-3#1)(2013-1#1)
could inhibit the##6##3##(1991-3#1)(1996-2#1)(2008-8#2)(2008-9#2)
could inhibit##10##2##(1991-3#1)(1996-2#1)(2008-11#3)(2008-8#2)(2008-9#3)
could interact with##4##3##(1996-2#1)(2008-10#2)(2008-11#1)
could interact##5##2##(1996-2#1)(2008-10#2)(2008-11#1)(2013-8#1)
could interfere##2##2##(1997-7#1)(2008-10#1)
could invade##2##2##(2008-10#2)
could jeopardize##2##2##(1994-1#1)(2013-1#1)
could lead to a##5##4##(1990-8#1)(2008-10#1)(2011-2#2)(2013-1#1)
could lead to better##2##4##(2008-11#1)(2010-10#1)
could lead to improved##2##4##(2008-10#1)(2008-3#1)
could lead to new##4##4##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
could lead to the##5##4##(1996-12#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
could lead to##33##3##(1990-8#1)(1992-8#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#7)(2012-2#2)(2013-1#2)(2013-8#1)
could lead##35##2##(1990-8#1)(1992-8#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#7)(2012-2#2)(2013-1#2)(2013-8#1)
could limit the##2##3##(2008-10#1)(2008-8#1)
could measure##2##2##(2008-10#1)(2012-3#1)
could modify the##5##3##(1992-2#1)(2011-10#1)(2011-2#3)
could name the##2##3##(2008-11#1)(2008-5#1)
could name##3##2##(1993-12#1)(2008-11#1)(2008-5#1)
could neutralize the##2##3##(1993-3#1)(2008-8#1)
could not be accounted for by##2##6##(1990-10#1)(2011-2#1)
could not be ascribed##2##4##(2008-11#1)(2009-6#1)
could not be attributed to##2##5##(1993-6#1)(2008-7#1)
could not be confirmed##2##4##(2008-12#1)(2012-2#1)
could not be demonstrated in##2##5##(1990-11#1)(1994-11#1)
could not be demonstrated##4##4##(1990-11#1)(1994-11#1)(2008-10#2)
could not be detected by##3##5##(1991-3#1)(1996-12#1)(2008-10#1)
could not be detected in##3##5##(1995-6#1)(2009-8#1)(2011-2#1)
could not be detected##8##4##(1991-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
could not be determined##2##4##(2008-10#2)
could not be distinguished from##2##5##(2008-10#2)
could not be distinguished##4##4##(2008-10#4)
could not be excluded##2##4##(2008-7#1)(2009-12#1)
could not be explained in##2##5##(1990-8#2)
could not be explained##4##4##(1990-8#2)(2008-8#1)(2012-2#1)
could not be forced to##2##5##(1996-5#2)
could not be further##2##4##(2008-10#2)
could not be grouped##2##4##(2008-10#2)
could not be identified##6##4##(1994-8#1)(2008-10#4)(2008-7#1)
could not be isolated##2##4##(1990-8#1)(1996-6#1)
could not be observed##2##4##(2007-12#1)(2008-10#1)
could not be obtained##2##4##(2008-10#1)(2008-2#1)
could not be used to##2##5##(2008-7#1)(2012-2#1)
could not be used##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
could not be##95##3##(1990-10#1)(1990-11#1)(1990-8#3)(1991-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#2)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#36)(2008-11#5)(2008-12#3)(2008-2#1)(2008-7#10)(2008-8#3)(2009-12#1)(2009-6#1)(2009-8#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#4)
could not detect large##2##4##(1993-8#1)(2008-11#1)
could not detect##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)
could not distinguish##2##3##(1994-9#1)(2008-10#1)
could not encode##2##3##(1993-2#1)(2008-10#1)
could not find a##2##4##(2008-8#1)(2013-8#1)
could not find##3##3##(2008-8#1)(2012-3#1)(2013-8#1)
could not have##2##3##(2009-3#1)(2010-5#1)
could not interact with##2##4##(2008-8#1)(2008-9#1)
could not prove##2##3##(1990-2#1)(1995-6#1)
could not recover the##2##4##(2008-8#2)
could not##166##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-3#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#5)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#53)(2008-11#10)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#13)(2008-8#12)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#1)(2013-8#2)
could observe##2##2##(2008-11#1)(2008-12#1)
could obtain##2##2##(1995-12#1)(2008-11#1)
could obviously##2##2##(2008-10#1)(2008-8#1)
could occur from##2##3##(1991-12#1)(2008-9#1)
could occur in the##2##4##(1995-6#1)(2008-12#1)
could occur in##3##3##(1995-6#1)(2008-10#1)(2008-12#1)
could occur##12##2##(1990-5#1)(1991-12#1)(1995-12#1)(1995-6#1)(2008-10#5)(2008-12#1)(2008-9#1)(2013-1#1)
could only be##6##3##(1990-3#1)(1993-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)
could only##9##2##(1990-3#1)(1993-8#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-5#2)
could otherwise##3##2##(1992-3#1)(2008-8#2)
could play a role in the##2##6##(1996-12#1)(2008-8#1)
could play a role in##4##5##(1994-11#1)(1994-8#1)(1996-12#1)(2008-8#1)
could play a##7##3##(1994-11#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-8#1)
could play an important role in##2##6##(1997-7#1)(2008-10#1)
could play an important##3##4##(1997-7#1)(2008-10#2)
could play##10##2##(1994-11#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-8#1)(2009-6#1)(2010-8#1)
could possibly be used##2##4##(2008-11#1)(2008-3#1)
could possibly be##4##3##(1990-5#1)(1993-11#1)(2008-11#1)(2008-3#1)
could possibly##5##2##(1990-12#1)(1990-5#1)(1993-11#1)(2008-11#1)(2008-3#1)
could potentially be involved in the host infection process##2##9##(2010-10#2)
could potentially be##7##3##(2008-10#1)(2008-11#1)(2010-10#2)(2011-2#1)(2013-1#2)
could potentially##15##2##(1990-5#1)(1994-5#1)(2008-10#5)(2008-11#1)(2009-7#1)(2009-8#1)(2010-10#2)(2011-2#1)(2013-1#2)
could predict##2##2##(2011-2#1)(2013-1#1)
could present##2##2##(2008-10#1)(2010-12#1)
could prevent the##2##3##(2008-9#1)(2009-8#1)
could prevent##6##2##(1991-5#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#2)
could produce##6##2##(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)
could promote the##4##3##(1992-12#1)(2008-8#2)(2013-1#1)
could promote##5##2##(1992-12#1)(1993-6#1)(2008-8#2)(2013-1#1)
could protect##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
could prove##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
could provide a##5##3##(1990-5#1)(1996-2#1)(1997-2#1)(2008-11#2)
could provide an alternative##2##4##(2008-10#1)(2008-9#1)
could provide an##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
could provide##22##2##(1990-5#1)(1991-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#2)
could quench##2##2##(2008-10#2)
could raise a##2##3##(1994-12#1)(2011-2#1)
could range from##2##3##(2008-10#2)
could rapidly##2##2##(1997-6#1)(2008-9#1)
could reach##10##2##(1997-6#1)(2008-10#5)(2008-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
could react with##2##3##(2008-10#2)
could readily##4##2##(1990-3#1)(1992-8#1)(2008-5#1)(2008-8#1)
could recognize##4##2##(1997-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
could recover##3##2##(1990-5#1)(2008-10#2)
could reduce the##4##3##(1997-3#1)(2008-3#1)(2008-9#1)(2010-12#1)
could reduce##9##2##(1995-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2013-8#1)
could reflect##3##2##(1992-12#1)(1992-2#1)(2008-10#1)
could represent a##4##3##(1996-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
could represent##7##2##(1993-1#1)(1996-11#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
could restore##2##2##(1991-7#1)(2008-8#1)
could result from##4##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-9#1)
could result in a##3##4##(1996-9#1)(2008-10#1)(2008-11#1)
could result in the##2##4##(2008-10#1)(2008-9#1)
could result in##15##3##(1993-8#1)(1996-12#1)(1996-9#1)(2008-10#3)(2008-11#2)(2008-9#3)(2009-9#1)(2011-2#3)
could result##19##2##(1993-8#1)(1993-9#1)(1996-12#1)(1996-9#1)(2008-10#4)(2008-11#3)(2008-9#4)(2009-9#1)(2011-2#3)
could reveal##2##2##(2008-10#1)(2011-2#1)
could selectively##2##2##(1990-11#1)(2012-3#1)
could serve as a##10##4##(1991-9#1)(1993-1#1)(1993-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2013-1#1)
could serve as the##2##4##(2008-11#1)(2013-8#1)
could serve as##16##3##(1991-3#1)(1991-9#1)(1993-1#1)(1993-8#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
could serve to##2##3##(2010-8#1)(2012-3#1)
could serve##20##2##(1991-3#1)(1991-9#1)(1993-1#1)(1993-8#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
could show a##3##3##(2008-5#2)(2009-12#1)
could show that the##3##4##(1997-7#1)(2008-11#2)
could show that##4##3##(1997-7#1)(2008-11#2)(2009-6#1)
could show##8##2##(1996-8#1)(1997-7#1)(2008-11#2)(2008-5#2)(2009-12#1)(2009-6#1)
could significantly decrease##2##3##(2008-9#1)(2012-2#1)
could significantly inhibit##2##3##(2008-8#1)(2008-9#1)
could significantly reduce##2##3##(1995-8#1)(1996-3#1)
could significantly##9##2##(1995-8#1)(1996-3#1)(2008-11#1)(2008-8#1)(2008-9#4)(2012-2#1)
could specifically##3##2##(1990-5#1)(2008-10#2)
could spread in##2##3##(2008-10#1)(2008-8#1)
could stably##2##2##(2008-9#1)(2013-8#1)
could still##3##2##(1996-2#1)(1996-8#1)(2008-8#1)
could stimulate the##2##3##(2008-7#1)(2012-3#1)
could stimulate##4##2##(1995-6#1)(2008-11#1)(2008-7#1)(2012-3#1)
could strengthen##2##2##(2010-7#1)(2013-8#1)
could strongly##2##2##(2008-8#1)(2011-1#1)
could successfully##2##2##(2008-10#2)
could suggest that##2##3##(2008-5#1)(2011-2#1)
could supply##2##2##(2008-5#1)(2011-3#1)
could take##2##2##(1991-3#1)(2008-10#1)
could then be##4##3##(2008-10#3)(2013-1#1)
could therefore be##4##3##(1990-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
could therefore##7##2##(1990-8#1)(2008-10#4)(2010-12#1)(2011-2#1)
could thus be##2##3##(2008-11#1)(2012-2#1)
could thus serve as##2##4##(1992-6#1)(2008-11#1)
could thus##8##2##(1992-6#1)(1993-8#1)(2008-11#2)(2008-5#2)(2008-6#1)(2012-2#1)
could trans-replicate##2##2##(2008-10#2)
could transfer##2##2##(1990-2#1)(2008-8#1)
could transmit##2##2##(2008-10#1)(2012-3#1)
could treat##2##2##(1996-2#1)(1997-3#1)
could use some standard##2##4##(2013-1#2)
could use##6##2##(1997-2#1)(2008-8#1)(2008-9#1)(2013-1#3)
could well##2##2##(2008-10#2)
could work##2##2##(1997-2#1)(2008-10#1)
could yield##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
could##2195##1##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#13)(1990-6#3)(1990-8#6)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#11)(1991-5#5)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#9)(1992-2#8)(1992-3#5)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#3)(1993-1#9)(1993-11#3)(1993-12#11)(1993-2#6)(1993-3#5)(1993-6#11)(1993-8#25)(1993-9#4)(1994-1#3)(1994-11#4)(1994-12#8)(1994-2#7)(1994-3#5)(1994-5#7)(1994-6#2)(1994-8#11)(1994-9#4)(1995-1#1)(1995-11#6)(1995-12#14)(1995-2#14)(1995-3#3)(1995-5#2)(1995-6#14)(1995-8#9)(1996-1#4)(1996-11#2)(1996-12#19)(1996-2#18)(1996-3#7)(1996-5#4)(1996-6#4)(1996-8#4)(1996-9#7)(1997-1#7)(1997-2#13)(1997-3#15)(1997-5#2)(1997-6#6)(1997-7#6)(1997-8#5)(2007-11#2)(2007-12#4)(2007-9#1)(2008-1#12)(2008-10#763)(2008-11#173)(2008-12#37)(2008-2#4)(2008-3#17)(2008-4#2)(2008-5#74)(2008-6#8)(2008-7#47)(2008-8#102)(2008-9#85)(2009-10#4)(2009-11#3)(2009-12#11)(2009-3#6)(2009-4#1)(2009-5#3)(2009-6#12)(2009-7#7)(2009-8#12)(2009-9#3)(2010-1#7)(2010-10#12)(2010-11#4)(2010-12#12)(2010-3#4)(2010-4#3)(2010-5#8)(2010-6#7)(2010-7#9)(2010-8#6)(2010-9#2)(2011-1#10)(2011-10#4)(2011-2#96)(2011-3#10)(2011-7#1)(2012-12#15)(2012-2#49)(2012-3#22)(2012-5#2)(2012-8#1)(2013-1#53)(2013-7#3)(2013-8#33)
couldn't happen##2##2##(1991-12#1)(1995-12#1)
couldn't##3##1##(1991-12#1)(1995-12#1)(2010-6#1)
coulombic interactions between##2##3##(1991-11#1)(2008-10#1)
coulombic interactions##4##2##(1991-11#1)(2008-10#3)
coulombic##5##1##(1991-11#1)(1996-5#1)(2008-10#3)
coulometric detection##2##2##(2008-10#2)
coulometric iodimetric##2##2##(2008-10#2)
coulometric method##2##2##(2008-10#2)
coulometric titration method##3##3##(2008-10#3)
coulometric titration of##3##3##(2008-10#3)
coulometric titration with the anodically generated chlorine##2##7##(2008-10#2)
coulometric titration##11##2##(2008-10#11)
coulometric##28##1##(2008-10#27)(2009-8#1)
coulometrically##2##1##(2008-10#2)
coumaphos##4##1##(2008-10#4)
coumarin##12##1##(1990-6#2)(1991-11#1)(1994-3#1)(2008-10#4)(2008-11#4)
coumarinic compound formation##2##3##(2008-10#2)
coumarins##6##1##(1990-6#1)(2008-10#1)(2008-11#3)(2011-3#1)
coumestrol##6##1##(1995-11#5)(2008-10#1)
council##2##1##(1995-6#1)(2009-12#1)
councils##4##1##(1997-8#3)(2008-11#1)
counsel and##2##2##(1993-12#1)(2013-1#1)
counsel##11##1##(1990-6#1)(1991-1#1)(1993-12#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-11#2)(2009-9#1)(2013-1#2)
counseled##2##1##(2008-11#1)(2008-3#1)
counseling and testing##2##3##(2013-1#2)
counseling and##12##2##(1994-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-11#1)(2011-2#1)(2013-1#5)(2013-8#1)
counseling as##2##2##(1995-6#1)(1997-3#1)
counseling by##2##2##(1996-5#1)(2008-7#1)
counseling for##2##2##(1997-4#1)(2008-4#1)
counseling in##2##2##(1995-11#1)(2010-1#1)
counseling or##2##2##(2008-4#1)(2013-1#1)
counseling programs##2##2##(1997-3#2)
counseling psychology##2##2##(2010-12#2)
counseling to##3##2##(1997-2#1)(2008-4#1)(2013-1#1)
counseling was##2##2##(2008-4#1)(2013-1#1)
counseling##73##1##(1991-1#2)(1991-6#1)(1993-1#1)(1994-3#1)(1995-11#1)(1995-6#2)(1995-9#1)(1996-5#7)(1997-2#3)(1997-3#5)(1997-4#3)(1997-8#1)(2008-11#5)(2008-4#7)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#2)
counselling and##2##2##(2008-11#1)(2008-7#1)
counselling##17##1##(1996-11#1)(1996-6#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#7)
counsellors##3##1##(2010-9#3)
counselors##10##1##(1996-5#1)(2008-12#4)(2008-6#2)(2010-11#3)
count and morphology##2##3##(2008-12#1)(2011-2#1)
count and##8##2##(1991-2#1)(1992-2#1)(2008-10#2)(2008-12#1)(2009-5#1)(2011-2#2)
count in##4##2##(2006-6#1)(2011-2#3)
count of##6##2##(1992-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
count rate##2##2##(1996-12#1)(2008-3#1)
count rates##2##2##(2008-11#1)(2008-3#1)
count than##2##2##(1993-12#1)(1996-8#1)
count was##2##2##(2007-12#2)
count##75##1##(1991-11#1)(1991-12#1)(1991-2#1)(1992-2#6)(1993-12#1)(1995-11#1)(1996-12#1)(1996-8#2)(1997-5#1)(2006-6#3)(2007-12#2)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#1)(2011-2#14)(2012-3#1)(2013-1#4)(2013-8#2)
countable##3##1##(2008-10#2)(2012-2#1)
counted after##2##2##(2008-10#1)(2008-12#1)
counted in##4##2##(1991-11#1)(2008-11#1)(2008-8#1)(2012-2#1)
counted##18##1##(1991-11#1)(1992-12#1)(1994-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#2)
counter and reference##2##3##(2008-10#2)
counter and##3##2##(2008-10#3)
counter anion##3##2##(2008-10#3)
counter electrode and a##2##4##(2008-10#2)
counter electrode##4##2##(2008-10#4)
counter ion##4##2##(2008-10#4)
counter##35##1##(1993-11#1)(1993-2#1)(1994-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-5#1)(2010-4#1)(2013-1#1)
counter-current chromatography##2##2##(2008-10#2)
counter-ion##4##1##(1997-2#2)(2008-10#2)
counter-terrorist##2##1##(2008-10#2)
counteract the##6##2##(1990-9#1)(1992-3#1)(1995-2#1)(2008-10#2)(2008-6#1)
counteract##11##1##(1990-9#1)(1992-3#1)(1994-12#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2012-4#1)
counteracted the##3##2##(1994-8#1)(2008-11#2)
counteracted##8##1##(1992-11#1)(1993-1#1)(1994-8#1)(2008-10#1)(2008-11#2)(2013-1#1)(2013-8#1)
counteracting##4##1##(2008-10#3)(2008-8#1)
counteractive##2##1##(2009-12#1)(2012-2#1)
counteracts##4##1##(2008-11#2)(2008-9#1)(2012-2#1)
counterarguments##2##1##(2008-8#2)
counterbalance order II##3##3##(2013-8#3)
counterbalance order##5##2##(2013-8#5)
counterbalanced##6##1##(1992-12#1)(1992-6#1)(1995-12#1)(2007-11#1)(2013-8#2)
countercurrent gas flow rate##3##4##(2008-10#3)
countercurrent gas flow rates##2##4##(2008-10#2)
countercurrent gas flow##5##3##(2008-10#5)
countercurrent gas##6##2##(2008-10#6)
countered by##2##2##(1991-12#1)(2008-8#1)
counterexample to##2##2##(2008-8#2)
counterexample##3##1##(2008-12#1)(2008-8#2)
counterflow##5##1##(1996-12#1)(2008-2#1)(2008-3#3)
counterintuitive result##2##2##(2008-10#1)(2008-8#1)
counterintuitive##7##1##(2008-10#1)(2008-8#4)(2008-9#2)
counterion##9##1##(1997-2#3)(2008-10#6)
counterions##2##1##(2008-10#2)
countermeasure##2##1##(2013-1#1)(2013-8#1)
countermeasures may be##2##3##(2010-7#2)
countermeasures##3##1##(2008-11#1)(2010-7#2)
counterpart and##2##2##(2010-12#1)(2011-2#1)
counterpart in##2##2##(1993-8#1)(2008-10#1)
counterpart of##2##2##(1994-11#1)(2013-1#1)
counterpart with##2##2##(1994-11#1)(2009-5#1)
counterpart##24##1##(1993-8#2)(1994-11#2)(1994-8#1)(1995-12#1)(1997-7#3)(2008-10#4)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
counterparts and##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
counterparts in the##2##3##(1996-12#1)(2008-7#1)
counterparts in##6##2##(1996-12#1)(1996-3#1)(2008-11#3)(2008-7#1)
counterparts of##3##2##(1992-1#1)(2008-10#2)
counterparts##54##1##(1991-5#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-11#1)(1994-2#2)(1995-9#1)(1996-12#1)(1996-3#2)(1997-7#1)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
counterpropagating pumps##2##2##(2007-11#2)
counterpropagating##3##1##(2007-11#3)
counterregulatory##2##1##(1997-2#1)(2010-2#1)
counterselected##2##1##(2008-10#1)(2008-11#1)
counties and##2##2##(1991-1#1)(2008-10#1)
counties are##4##2##(1991-3#1)(1991-6#1)(1996-3#2)
counties during the##2##3##(1991-3#1)(1997-3#1)
counties in##8##2##(1991-3#1)(1991-6#1)(1996-3#2)(2008-10#3)(2012-12#1)
counties of California##3##3##(2008-10#3)
counties of##5##2##(1995-5#1)(1997-3#1)(2008-10#3)
counties were##2##2##(1994-1#1)(2008-10#1)
counties with##4##2##(1991-3#3)(2008-10#1)
counties##52##1##(1991-1#1)(1991-11#2)(1991-3#9)(1991-6#6)(1992-2#1)(1993-1#1)(1994-1#2)(1994-2#1)(1995-2#1)(1995-5#1)(1996-3#8)(1997-3#3)(2008-10#13)(2010-10#1)(2012-12#2)
counties]##2##1##(1991-6#2)
counting and##4##2##(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
counting method##5##2##(1993-2#1)(2008-10#3)(2008-9#1)
counting methods##2##2##(2008-11#1)(2011-2#1)
counting of##2##2##(2008-4#1)(2008-9#1)
counting task##3##2##(2013-8#3)
counting the##3##2##(1997-6#1)(1997-8#1)(2008-10#1)
counting##60##1##(1993-2#1)(1993-8#1)(1996-1#1)(1997-6#1)(1997-8#1)(2008-10#15)(2008-11#9)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#5)(2009-8#2)(2010-10#1)(2011-2#6)(2013-1#1)(2013-8#6)
countries affected##2##2##(1990-12#1)(2013-8#1)
countries and among##2##3##(2008-10#1)(2011-2#1)
countries and##18##2##(1993-11#1)(1993-12#1)(1993-2#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#2)(2009-8#1)(2010-6#1)(2011-2#4)(2012-2#1)
countries are##9##2##(1990-11#1)(1990-12#1)(1990-2#1)(1992-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
countries around the globe##2##4##(2008-10#1)(2013-1#1)
countries around the##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
countries as##4##2##(1990-6#1)(1997-7#1)(2008-11#1)(2008-5#1)
countries because of##2##3##(2008-10#1)(2012-2#1)
countries because##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
countries for##4##2##(1990-6#1)(1992-6#1)(1993-3#1)(2008-10#1)
countries from##3##2##(1994-5#1)(2011-2#1)(2013-8#1)
countries has##3##2##(1992-1#1)(2008-1#1)(2012-2#1)
countries have been##2##3##(1996-9#1)(1997-8#1)
countries have##7##2##(1990-6#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-7#1)
countries in Europe##3##3##(1995-3#1)(2011-2#2)
countries in order to##2##4##(1991-6#1)(2010-12#1)
countries in the##5##3##(1994-12#1)(1997-8#1)(2008-12#1)(2010-12#1)(2012-2#1)
countries in##13##2##(1991-6#1)(1993-3#1)(1994-12#1)(1995-3#1)(1997-8#1)(2008-12#1)(2008-5#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-2#1)
countries including##2##2##(1996-2#1)(2008-1#1)
countries involved##2##2##(1990-6#1)(1997-8#1)
countries is low##2##3##(1990-11#1)(1991-6#1)
countries is##6##2##(1990-11#1)(1991-11#1)(1991-6#1)(1993-2#1)(2008-11#1)(2012-2#1)
countries like##2##2##(1992-5#1)(2011-2#1)
countries mortality##2##2##(2008-11#1)(2011-2#1)
countries of origin##3##3##(2008-10#2)(2013-1#1)
countries of the##3##3##(1993-2#1)(2008-10#1)(2011-2#1)
countries of##10##2##(1993-2#1)(2008-10#6)(2008-11#1)(2011-2#1)(2013-1#1)
countries or##5##2##(1994-1#1)(2008-10#2)(2008-11#1)(2008-2#1)
countries such as##2##3##(2008-10#1)(2010-12#1)
countries that##3##2##(1993-2#1)(2010-11#1)(2011-2#1)
countries to##5##2##(1993-2#1)(1993-3#1)(2008-10#1)(2008-11#2)
countries were##2##2##(2008-10#1)(2008-11#1)
countries where the##2##3##(1995-3#1)(2013-1#1)
countries where##7##2##(1990-6#1)(1993-3#1)(1995-3#1)(1997-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
countries with##7##2##(1990-12#2)(1994-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2012-12#1)
countries##361##1##(1990-11#6)(1990-12#6)(1990-2#3)(1990-3#1)(1990-6#6)(1990-8#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#5)(1992-6#7)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#13)(1993-3#7)(1993-6#1)(1994-1#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#5)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-9#2)(1997-1#1)(1997-6#2)(1997-7#4)(1997-8#8)(2007-12#1)(2008-1#12)(2008-10#51)(2008-11#33)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#5)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#13)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#8)(2011-1#2)(2011-2#29)(2011-3#2)(2011-4#3)(2012-12#5)(2012-2#14)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#5)
countries)##6##1##(2008-10#1)(2011-2#1)(2013-8#4)
countries]##3##1##(1991-6#1)(2011-3#1)(2013-1#1)
country and##4##2##(1993-2#1)(1996-1#1)(2012-3#1)(2013-1#1)
country for##2##2##(1996-1#1)(2008-12#1)
country in##3##2##(1994-9#1)(1997-6#1)(2009-10#1)
country is##5##2##(1994-1#2)(1995-1#1)(1997-6#1)(2008-11#1)
country of origin##2##3##(1994-2#1)(2008-10#1)
country of##4##2##(1994-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
country to##3##2##(1993-2#1)(1994-1#1)(2008-11#1)
country was##2##2##(2008-10#1)(2011-2#1)
country where##3##2##(1997-6#1)(2008-10#2)
country with##2##2##(1995-5#1)(2008-10#1)
country##111##1##(1990-9#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#5)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#3)(1995-1#2)(1995-12#4)(1995-2#2)(1995-5#3)(1995-6#1)(1996-1#3)(1996-11#2)(1996-3#2)(1997-2#1)(1997-6#7)(1997-8#3)(2008-10#18)(2008-11#5)(2008-12#2)(2008-7#1)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
country's##5##1##(1995-12#1)(1997-6#1)(2008-11#1)(2008-4#1)(2012-12#1)
counts after##2##2##(2008-10#1)(2012-2#1)
counts and the##3##3##(1997-5#1)(2010-3#1)(2011-2#1)
counts and##15##2##(1996-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(2008-10#2)(2008-11#2)(2009-12#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-4#1)
counts for most compounds##2##4##(2008-10#2)
counts for most##3##3##(2008-10#3)
counts for##4##2##(2008-10#3)(2008-11#1)
counts from##2##2##(2008-10#1)(2008-3#1)
counts in the##5##3##(1996-12#1)(2008-10#3)(2013-1#1)
counts in##9##2##(1991-11#2)(1996-12#1)(2008-10#4)(2008-11#1)(2013-1#1)
counts increased##2##2##(2008-10#2)
counts of##16##2##(1995-12#2)(1996-12#1)(1996-3#1)(1996-5#2)(2008-10#2)(2008-11#2)(2009-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
counts on##5##2##(1997-5#1)(2008-10#2)(2008-8#1)(2013-1#1)
counts only##2##2##(1996-12#1)(2008-9#1)
counts ranged from##2##3##(2008-10#2)
counts were##13##2##(1997-5#1)(2008-10#4)(2008-11#1)(2008-9#2)(2009-11#1)(2010-3#1)(2011-9#1)(2012-2#1)(2013-8#1)
counts##126##1##(1990-10#4)(1991-11#2)(1991-3#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#2)(1996-12#7)(1996-3#3)(1996-5#4)(1997-5#3)(2008-10#38)(2008-11#10)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#3)(2009-8#1)(2010-3#3)(2011-1#4)(2011-2#6)(2011-9#1)(2012-2#6)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#2)
county health departments in Kansas##2##5##(1995-3#2)
county health departments in##3##4##(1995-3#3)
county health departments##4##3##(1995-3#3)(1996-12#1)
county health##5##2##(1995-3#4)(1996-12#1)
county hospitals##2##2##(1991-2#1)(1991-6#1)
county of##2##2##(1991-1#1)(2011-2#1)
county population density##3##3##(1993-1#1)(1996-3#1)(2009-7#1)
county population size##2##3##(1991-3#1)(1992-12#1)
county population##5##2##(1991-3#1)(1992-12#1)(1993-1#1)(1996-3#1)(2009-7#1)
county##35##1##(1990-11#1)(1991-1#2)(1991-2#1)(1991-3#5)(1991-6#3)(1992-12#1)(1992-2#1)(1993-1#2)(1993-6#1)(1994-6#1)(1995-3#4)(1996-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#3)(2008-11#1)(2008-12#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)
county's##2##1##(1992-2#1)(2008-11#1)
couple at about -0##2##4##(2008-10#2)
couple of##6##2##(1997-2#1)(2008-10#3)(2009-12#1)(2012-2#1)
couple therapy and relationship education##3##5##(2012-2#3)
couple therapy outcome##2##3##(2012-2#2)
couple therapy##13##2##(2012-2#13)
couple to##2##2##(1992-3#1)(2010-7#1)
couple with a sequential injection hydride generation##2##7##(2008-10#2)
couple with##4##2##(2008-10#4)
couple##62##1##(1990-6#1)(1992-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(2008-10#28)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#19)
couple's##2##1##(2012-2#2)
couple-based##2##1##(2012-2#2)
coupled by##2##2##(1993-9#1)(2008-10#1)
coupled chitosan##2##2##(2008-10#2)
coupled column##2##2##(2008-10#2)
coupled dissolution/diffusion model##2##3##(2008-10#2)
coupled enzyme##4##2##(2008-10#4)
coupled in situ##2##3##(2008-10#2)
coupled in##4##2##(2008-10#3)(2011-2#1)
coupled into##2##2##(2008-2#1)(2008-3#1)
coupled on-line with##3##3##(2008-10#3)
coupled on-line##4##2##(2008-10#4)
coupled online##2##2##(2008-10#1)(2010-11#1)
coupled plasma atomic emission spectrometric##2##5##(2008-10#2)
coupled plasma atomic emission spectrometry (ETV-ICP-AES)##2##6##(2008-10#2)
coupled plasma atomic emission spectrometry (ICP-AES)##12##6##(2008-10#12)
coupled plasma atomic emission spectrometry##48##5##(1992-3#1)(2008-10#47)
coupled plasma atomic emission##61##4##(1992-3#1)(2008-10#60)
coupled plasma atomic##63##3##(1992-3#1)(2008-10#62)
coupled plasma mass spectrometry (ICP-MS) is##2##6##(2008-10#2)
coupled plasma mass spectrometry (ICP-MS)##23##5##(2008-10#23)
coupled plasma mass spectrometry##70##4##(2008-10#67)(2010-11#3)
coupled plasma mass##75##3##(2008-10#72)(2010-11#3)
coupled plasma optical emission spectrometry (ICP OES)##2##7##(2008-10#2)
coupled plasma optical emission spectrometry (ICP-OES) was##2##7##(2008-10#2)
coupled plasma optical emission spectrometry (ICP-OES)##10##6##(2008-10#10)
coupled plasma optical emission spectrometry##22##5##(2008-10#22)
coupled plasma optical emission spectroscopy##2##5##(2011-2#2)
coupled plasma optical emission##25##4##(2008-10#23)(2011-2#2)
coupled plasma time-of-flight mass##2##4##(2008-10#2)
coupled plasma##185##2##(1992-3#2)(2008-10#178)(2010-11#3)(2011-2#2)
coupled plasma-mass spectrometry##16##3##(2008-10#16)
coupled plasma-mass##19##2##(2008-10#19)
coupled receptor (such as##2##4##(1997-2#2)
coupled receptors##4##2##(1997-1#1)(2008-11#1)(2008-7#1)(2009-3#1)
coupled system##3##2##(2008-10#2)(2013-8#1)
coupled techniques##2##2##(2008-10#2)
coupled to HPLC##3##3##(2008-10#3)
coupled to a direct extraction device##2##6##(2008-10#2)
coupled to a flame atomic absorption spectrometer##3##7##(2008-10#3)
coupled to a##27##3##(1991-5#1)(1993-8#1)(1995-2#1)(1997-1#1)(2008-10#18)(2008-11#1)(2008-2#1)(2009-10#1)(2010-9#1)(2013-1#1)
coupled to an##4##3##(2008-10#3)(2008-3#1)
coupled to atomic##2##3##(2008-10#2)
coupled to electrothermal atomic absorption##2##5##(2008-10#2)
coupled to flame atomic absorption spectrophotometry##2##6##(2008-10#2)
coupled to flame atomic absorption##3##5##(2008-10#3)
coupled to geographical information systems##2##5##(2008-10#2)
coupled to high##2##3##(2008-10#2)
coupled to inductively coupled plasma optical emission spectrometry##2##8##(2008-10#2)
coupled to inductively coupled plasma##3##5##(2008-10#3)
coupled to multivariate calibration##2##4##(2008-10#2)
coupled to multivariate##3##3##(2008-10#3)
coupled to quadrupole time-of-flight##2##4##(2008-10#2)
coupled to the flow##2##4##(2008-10#2)
coupled to the##7##3##(2008-10#7)
coupled to##109##2##(1990-5#1)(1991-5#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#2)(1994-6#1)(1995-12#1)(1995-2#1)(1997-1#2)(1997-8#1)(2008-10#78)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2010-7#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
coupled with Franz cell##2##4##(2008-10#2)
coupled with a flame ionization detector##2##6##(2008-10#1)(2008-11#1)
coupled with a flame##3##4##(2008-10#2)(2008-11#1)
coupled with a flow injection##2##5##(2008-10#2)
coupled with a##26##3##(1994-1#1)(1996-12#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
coupled with amperometric detection##2##4##(2008-10#2)
coupled with an##8##3##(1994-12#1)(1994-5#1)(2008-10#5)(2010-12#1)
coupled with atomic fluorescence##2##4##(2008-10#2)
coupled with capillary electrophoresis##2##4##(2008-10#2)
coupled with capillary##3##3##(2008-10#3)
coupled with catalytic##2##3##(2008-10#2)
coupled with colorimetric detection##2##4##(2008-10#2)
coupled with diode array##2##4##(2008-10#2)
coupled with flame atomic absorption spectrometry (FAAS)##2##7##(2008-10#2)
coupled with flame atomic absorption spectrometry for##2##7##(2008-10#2)
coupled with flame atomic absorption spectrometry##4##6##(2008-10#4)
coupled with flow injection##2##4##(2008-10#2)
coupled with fluorimetric detection##4##4##(2008-10#4)
coupled with gas chromatography-mass spectrometry (GC-MS)##2##6##(2008-10#2)
coupled with gas chromatography-mass spectrometry##3##5##(2008-10#3)
coupled with gas##5##3##(2008-10#5)
coupled with high-performance liquid chromatography (HPLC)##2##6##(2008-10#2)
coupled with high-performance liquid chromatography##4##5##(2008-10#4)
coupled with inductively coupled##2##4##(2008-10#1)(2010-11#1)
coupled with mass spectrometry and##2##5##(2008-5#1)(2012-2#1)
coupled with mass spectrometry##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
coupled with mass##7##3##(2008-1#1)(2008-10#4)(2008-5#1)(2012-2#1)
coupled with microdialysis##2##3##(2008-10#2)
coupled with on-line##3##3##(2008-10#3)
coupled with the##13##3##(1995-11#2)(1995-5#1)(1997-8#1)(2008-10#8)(2009-6#1)
coupled with##160##2##(1991-7#2)(1992-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-11#3)(1995-5#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#116)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-5#1)(2013-1#2)
coupled##590##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#3)(1991-7#2)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#3)(1997-2#2)(1997-7#2)(1997-8#2)(2008-1#2)(2008-10#467)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#6)(2010-10#1)(2010-11#7)(2010-12#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#3)
coupled-mode theory##2##2##(2007-12#1)(2008-2#1)
coupled-mode##5##1##(2007-12#2)(2008-2#1)(2008-3#2)
coupled-wave equations##3##2##(2007-12#1)(2008-3#2)
coupler##15##1##(2007-11#1)(2008-2#9)(2008-3#4)(2008-8#1)
couplers##7##1##(1990-3#1)(2008-2#3)(2008-3#3)
couples are##2##2##(1996-9#1)(2008-11#1)
couples in##3##2##(2011-2#2)(2012-2#1)
couples relationship education##2##3##(2012-2#2)
couples the##2##2##(2008-3#1)(2013-8#1)
couples to##3##2##(1997-2#1)(2010-7#2)
couples with##5##2##(1993-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
couples##39##1##(1993-8#2)(1996-9#5)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-7#2)(2011-2#5)(2012-2#10)(2013-1#1)(2013-8#1)
coupling a##5##2##(2008-10#5)
coupling among##2##2##(1995-11#1)(2007-11#1)
coupling and##7##2##(1997-1#1)(2008-10#3)(2008-3#2)(2009-5#1)
coupling between the##6##3##(1993-8#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
coupling between##15##2##(1992-3#1)(1993-8#1)(1994-6#2)(1995-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-8#1)
coupling coefficient##3##2##(2008-3#3)
coupling constants##8##2##(1991-5#1)(1992-4#6)(1994-5#1)
coupling efficiency of##2##3##(2008-2#1)(2008-3#1)
coupling efficiency##4##2##(2008-2#2)(2008-3#2)
coupling impairment##2##2##(2010-7#2)
coupling in##7##2##(2008-3#2)(2009-11#2)(2010-7#1)(2013-8#2)
coupling is##4##2##(2008-3#2)(2010-7#1)(2013-8#1)
coupling loss of##2##3##(2008-2#2)
coupling method##2##2##(1990-2#1)(2008-10#1)
coupling of N-phenyl-p-phenylenediamine with N##2##5##(2008-10#2)
coupling of a##3##3##(1997-2#1)(2008-10#2)
coupling of an##4##3##(2008-10#3)(2008-3#1)
coupling of capillary##2##3##(2008-10#2)
coupling of flow##2##3##(2008-10#2)
coupling of power##2##3##(2008-3#2)
coupling of the##5##3##(1993-3#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-3#1)
coupling of##45##2##(1993-3#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#28)(2008-3#5)(2008-4#1)(2009-5#1)(2012-2#2)(2013-1#2)
coupling phase##5##2##(2008-10#5)
coupling reaction of##4##3##(2008-10#4)
coupling reaction##9##2##(1996-5#1)(2008-10#6)(2008-4#2)
coupling terms##2##2##(2008-3#1)(2013-8#1)
coupling the##5##2##(2008-10#3)(2008-4#2)
coupling through##2##2##(1996-6#1)(2010-11#1)
coupling to##8##2##(1992-11#1)(1992-9#1)(1993-8#1)(1997-7#1)(2008-10#1)(2008-3#2)(2009-5#1)
coupling were##2##2##(1990-2#1)(2008-10#1)
coupling with the##2##3##(2008-10#1)(2008-12#1)
coupling with##13##2##(2008-10#11)(2008-12#1)(2009-5#1)
coupling##227##1##(1990-2#2)(1991-5#1)(1992-11#1)(1992-3#2)(1992-4#6)(1992-9#1)(1993-3#1)(1993-8#3)(1994-5#2)(1994-6#2)(1995-11#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#100)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#34)(2008-4#12)(2008-8#1)(2008-9#2)(2009-11#2)(2009-3#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#4)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#8)
coupling&quot##2##1##(1991-9#1)(1993-5#1)
couplings are##2##2##(2008-11#1)(2008-5#1)
couplings##6##1##(2008-10#1)(2008-11#2)(2008-5#2)(2013-8#1)
coupons##8##1##(2013-8#8)
courage##3##1##(1994-1#1)(2008-11#1)(2008-7#1)
course and a##2##3##(2008-12#1)(2008-9#1)
course and outcome of##2##4##(2011-1#1)(2013-1#1)
course and the##2##3##(2008-11#1)(2010-4#1)
course and##25##2##(1997-3#1)(1997-5#1)(1997-8#1)(2008-11#7)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)
course are##2##2##(1992-1#1)(1993-1#1)
course at a##2##3##(2008-11#1)(2013-1#1)
course at##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
course content##2##2##(1994-12#1)(2011-1#1)
course for nurses##2##3##(2008-11#2)
course for##8##2##(1992-1#1)(1995-2#1)(2008-11#5)(2008-7#1)
course from##2##2##(1997-3#1)(2008-10#1)
course had##3##2##(1996-1#1)(2008-11#2)
course in a##2##3##(1996-2#1)(2010-10#1)
course in the##5##3##(1993-6#1)(1997-5#1)(2008-11#2)(2011-2#1)
course in##15##2##(1991-6#1)(1993-6#2)(1996-2#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2010-10#1)(2011-2#1)
course is##9##2##(1991-12#1)(1993-1#2)(1996-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#1)
course management systems that foster##2##5##(2008-12#2)
course management##3##2##(2008-12#3)
course of action##2##3##(1997-2#1)(2008-11#1)
course of acute##2##3##(2008-7#1)(2013-1#1)
course of an##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
course of changes in##3##4##(1997-3#1)(2009-11#1)(2013-1#1)
course of changes##4##3##(1997-3#1)(2009-11#1)(2013-1#2)
course of chronic##3##3##(2010-1#1)(2011-2#1)(2013-7#1)
course of our##2##3##(1990-6#1)(2008-11#1)
course of pregnancy and labor in patients##2##7##(2012-3#2)
course of pregnancy and labor##3##5##(2012-3#3)
course of pregnancy##7##3##(1995-12#1)(2012-3#6)
course of the disease##13##4##(1990-6#1)(1991-6#1)(1993-12#1)(1996-6#1)(1997-8#1)(2007-8#2)(2008-2#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)
course of the experiment##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
course of the study##2##4##(1993-1#1)(2008-10#1)
course of the##61##3##(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-5#3)(1996-6#3)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#2)(2008-10#12)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
course of this##5##3##(1996-11#1)(2008-10#2)(2009-8#1)(2011-2#1)
course of treatment##10##3##(1991-12#1)(1991-6#1)(1996-11#1)(1996-9#1)(2008-12#2)(2008-4#1)(2009-11#1)(2012-2#1)(2013-8#1)
course of##241##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#4)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#3)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#4)(1996-9#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#1)(2007-8#2)(2008-10#34)(2008-11#19)(2008-12#9)(2008-2#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#2)(2008-9#5)(2009-11#4)(2009-12#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#14)(2013-7#1)(2013-8#5)
course offerings##2##2##(1992-3#1)(1997-2#1)
course on##5##2##(2008-11#5)
course or##2##2##(1992-9#1)(2011-2#1)
course studies##3##2##(1993-8#1)(1995-12#1)(2008-11#1)
course that##2##2##(1991-3#1)(2010-10#1)
course to the##2##3##(1996-6#1)(2009-8#1)
course to##8##2##(1994-12#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#1)
course was uneventful##5##3##(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
course was##13##2##(1990-8#1)(1992-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#3)
course work##2##2##(1997-3#1)(2008-12#1)
course##501##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#6)(1990-8#2)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#3)(1991-8#2)(1992-1#2)(1992-12#1)(1992-3#3)(1992-6#2)(1992-7#1)(1992-9#2)(1993-1#7)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#4)(1994-12#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-11#5)(1996-2#3)(1996-3#3)(1996-5#3)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#12)(1997-4#2)(1997-5#3)(1997-6#2)(1997-8#2)(1997-9#1)(2007-8#2)(2008-1#2)(2008-10#43)(2008-11#92)(2008-12#27)(2008-2#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#24)(2008-8#2)(2008-9#8)(2009-10#5)(2009-11#4)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#4)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#8)(2010-4#1)(2010-6#1)(2010-7#3)(2010-9#2)(2011-1#6)(2011-2#38)(2011-3#1)(2012-12#3)(2012-2#10)(2012-3#13)(2013-1#26)(2013-7#3)(2013-8#12)
course)##2##1##(2008-11#1)(2008-8#1)
courses and##2##2##(1991-6#1)(1994-12#1)
courses for##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
courses in##13##2##(1991-2#2)(1992-1#1)(1994-1#2)(1996-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)
courses is##2##2##(1994-12#1)(2008-12#1)
courses of the##2##3##(2008-11#1)(2008-8#1)
courses of these##2##3##(1995-6#1)(2008-11#1)
courses of##16##2##(1990-6#2)(1994-12#1)(1994-2#1)(1995-6#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-8#1)(2011-2#2)(2013-1#1)
courses on##2##2##(1992-12#1)(2011-2#1)
courses were##3##2##(1990-9#1)(1992-12#1)(1993-2#1)
courses##87##1##(1990-12#7)(1990-6#2)(1990-9#1)(1991-2#4)(1991-6#1)(1992-1#1)(1992-12#2)(1993-2#1)(1994-1#2)(1994-12#8)(1994-2#1)(1995-6#1)(1996-1#4)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#13)(2008-12#8)(2008-5#1)(2008-8#1)(2010-11#1)(2010-9#1)(2011-2#5)(2012-12#1)(2013-1#9)(2013-2#1)
court affirmed##2##2##(1995-12#1)(1995-6#1)
court concluded that##2##3##(1990-11#1)(1990-2#1)
court files##2##2##(1992-9#2)
court had##2##2##(1995-6#1)(1997-6#1)
court rejected the##2##3##(1995-6#1)(1996-5#1)
court ruling##2##2##(1995-12#1)(1995-6#1)
court rulings##2##2##(1992-11#1)(1994-1#1)
court to##2##2##(1995-5#1)(2011-2#1)
court##63##1##(1990-11#6)(1990-2#2)(1991-1#1)(1992-11#1)(1992-9#2)(1993-12#2)(1994-1#1)(1994-12#1)(1995-12#8)(1995-2#3)(1995-5#1)(1995-6#8)(1996-5#6)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#3)(2008-10#5)(2008-11#4)(2008-12#2)(2011-2#4)
court's decision##2##2##(1993-12#1)(1995-6#1)
court's##5##1##(1993-12#1)(1995-6#2)(1996-5#1)(1997-6#1)
courts have##2##2##(1993-12#2)
courts of##2##2##(2008-10#1)(2012-2#1)
courts##17##1##(1990-11#1)(1993-12#2)(1993-9#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(2008-10#5)(2008-6#1)(2010-6#1)(2012-2#1)
courtship behavior##2##2##(2008-8#1)(2013-8#1)
courtship##8##1##(2008-8#5)(2008-9#1)(2013-8#2)
covalent affinity chromatography with thiol-disulphide##2##5##(2008-10#2)
covalent affinity chromatography##3##3##(2008-10#3)
covalent attachment of##4##3##(1994-5#1)(1995-6#1)(2008-5#1)(2013-1#1)
covalent attachment##7##2##(1994-5#1)(1995-6#1)(2008-10#3)(2008-5#1)(2013-1#1)
covalent binding of##5##3##(1990-7#1)(1994-5#1)(2008-10#2)(2012-12#1)
covalent bonding##2##2##(2008-10#1)(2009-9#1)
covalent grafting##3##2##(2008-10#3)
covalent immobilization of DNA##2##4##(2008-10#2)
covalent immobilization of##6##3##(2008-10#6)
covalent immobilization on##2##3##(2008-10#2)
covalent immobilization##10##2##(2008-10#10)
covalent linkage##4##2##(1992-6#1)(2008-10#2)(2008-11#1)
covalent modification##2##2##(1994-5#1)(2008-4#1)
covalent##46##1##(1990-7#1)(1991-3#1)(1992-6#1)(1993-8#1)(1994-5#3)(1995-6#1)(1997-1#1)(2008-10#31)(2008-11#1)(2008-4#1)(2008-5#1)(2009-9#1)(2012-12#1)(2013-1#1)
covalently attached to##4##3##(1991-3#1)(1993-8#1)(1995-3#1)(2008-10#1)
covalently attached##5##2##(1991-3#1)(1993-8#1)(1995-3#1)(2008-10#2)
covalently bond##2##2##(2008-10#2)
covalently bonded to##2##3##(2008-10#2)
covalently bonded##4##2##(2008-10#4)
covalently bound to a##2##4##(2008-10#2)
covalently bound to the##2##4##(1991-3#1)(2008-10#1)
covalently bound to##8##3##(1990-2#1)(1991-3#1)(1993-6#1)(2008-10#5)
covalently bound##17##2##(1990-2#1)(1991-3#2)(1993-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(2008-10#10)
covalently conjugated##2##2##(2008-10#1)(2008-8#1)
covalently immobilized on a##2##4##(2008-10#2)
covalently immobilized on##4##3##(1997-2#1)(2008-10#3)
covalently immobilized onto##2##3##(2008-10#2)
covalently immobilized##10##2##(1995-3#1)(1997-2#1)(2008-10#8)
covalently linked to##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
covalently linked##9##2##(1990-8#1)(1993-8#1)(1994-11#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
covalently to##2##2##(1991-8#1)(2008-10#1)
covalently##65##1##(1990-2#3)(1990-8#1)(1991-3#3)(1991-8#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-5#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#39)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)
covariables##4##1##(1992-9#1)(1995-9#3)
covariance analysis##2##2##(2008-10#2)
covariance between##2##2##(1997-7#1)(2008-8#1)
covariance functions##2##2##(2008-2#2)
covariance matrices##3##2##(2009-4#1)(2013-1#2)
covariance matrix##6##2##(2008-2#2)(2009-12#1)(2009-4#3)
covariance structure##2##2##(1992-9#1)(2013-1#1)
covariance##26##1##(1992-9#2)(1997-7#1)(2008-10#3)(2008-2#4)(2008-3#1)(2008-8#3)(2009-12#1)(2009-4#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
covariances##4##1##(2008-8#4)
covariate models##2##2##(1992-9#2)
covariate values##2##2##(1992-9#2)
covariate##8##1##(1992-9#4)(1994-8#1)(2009-12#1)(2013-1#1)(2013-8#1)
covariates##16##1##(1990-8#1)(1995-12#1)(2008-10#3)(2008-12#1)(2009-12#1)(2010-11#1)(2010-12#2)(2011-2#3)(2013-1#3)
covariation between##2##2##(2008-10#1)(2008-8#1)
covariation in##3##2##(2008-10#1)(2008-8#2)
covariation##7##1##(2008-10#3)(2008-8#4)
cover a##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
cover and##4##2##(2008-12#1)(2008-8#2)(2008-9#1)
cover by##2##2##(2008-10#2)
cover crop and##2##3##(2008-10#2)
cover crop on##2##3##(2008-10#2)
cover crop##8##2##(2008-10#8)
cover different##2##2##(1995-3#1)(2008-10#1)
cover for the##2##3##(2008-9#2)
cover in##3##2##(1990-3#1)(2008-8#1)(2008-9#1)
cover of##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
cover other##2##2##(1991-2#1)(2012-2#1)
cover the##13##2##(1990-2#1)(1992-3#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
cover was##2##2##(2008-10#1)(2008-7#1)
cover with##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
cover##85##1##(1990-2#1)(1990-3#1)(1991-2#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-3#3)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#23)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#13)(2009-10#1)(2009-8#2)(2010-4#1)(2010-7#1)(2011-2#6)(2012-2#2)(2012-3#1)
coverage among##3##2##(1992-2#2)(2013-1#1)
coverage and attitudes of primary care staff in Australia##2##9##(2011-2#2)
coverage and##11##2##(1992-2#1)(1993-3#2)(1996-12#1)(2008-10#1)(2010-4#1)(2010-6#1)(2011-2#2)(2011-3#1)(2013-1#1)
coverage are##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
coverage by##2##2##(2008-10#1)(2008-11#1)
coverage data##3##2##(1996-12#2)(2008-10#1)
coverage for the##2##3##(1995-2#1)(2013-8#1)
coverage for these##2##3##(1994-3#1)(2012-2#1)
coverage for##16##2##(1992-1#1)(1992-2#1)(1993-3#2)(1994-1#1)(1994-3#1)(1995-12#4)(1995-2#1)(2008-11#1)(2012-12#1)(2012-2#2)(2013-8#1)
coverage has increased##2##3##(1994-9#1)(2012-12#1)
coverage has##4##2##(1991-2#1)(1994-9#1)(2008-11#1)(2012-12#1)
coverage have##2##2##(1996-3#1)(2008-7#1)
coverage in##8##2##(1996-12#3)(2008-10#1)(2008-5#1)(2011-2#2)(2012-12#1)
coverage is##2##2##(1996-12#1)(2009-11#1)
coverage of the##9##3##(1991-1#1)(1992-2#1)(1993-9#1)(2008-11#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
coverage of##21##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#3)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
coverage on##5##2##(1995-1#1)(2008-10#3)(2013-1#1)
coverage probability##7##2##(1995-9#1)(2008-10#6)
coverage than##2##2##(2009-10#1)(2011-2#1)
coverage to##9##2##(1992-2#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-3#1)(1996-5#1)(2008-11#1)(2008-9#1)
coverage was##5##2##(1996-12#1)(2008-10#1)(2008-8#1)(2010-7#1)(2012-12#1)
coverage##177##1##(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#2)(1992-1#1)(1992-2#7)(1993-3#5)(1993-9#1)(1994-1#3)(1994-2#1)(1994-3#6)(1994-8#1)(1994-9#1)(1995-1#7)(1995-12#9)(1995-2#2)(1995-3#4)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#11)(1996-2#1)(1996-3#3)(1996-5#2)(2008-10#27)(2008-11#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#2)(2009-11#1)(2009-3#2)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#3)(2011-2#16)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#9)(2013-8#1)
covered a range of##2##4##(1994-12#1)(2008-10#1)
covered a wide##2##3##(2008-10#1)(2012-2#1)
covered a##8##2##(1994-12#1)(1997-2#3)(2008-10#3)(2012-2#1)
covered and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
covered by Medicaid##3##3##(1992-2#1)(1994-3#1)(1996-2#1)
covered by a##4##3##(2008-10#3)(2008-3#1)
covered by the##2##3##(1996-12#1)(2008-5#1)
covered by##29##2##(1992-2#2)(1993-1#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-3#5)(2008-5#1)(2008-7#1)(2011-2#2)
covered in this review include##2##5##(2008-10#1)(2012-12#1)
covered in this review##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
covered in this##6##3##(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
covered in##9##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#2)(2012-2#1)
covered include##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
covered smut##5##2##(2008-10#5)
covered stent##3##2##(2008-12#1)(2010-5#2)
covered the##7##2##(1995-2#1)(2008-1#1)(2008-10#3)(2008-9#1)(2013-8#1)
covered with a##11##3##(2008-10#9)(2008-12#1)(2008-7#1)
covered with an##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
covered with##31##2##(1997-2#2)(2008-10#15)(2008-11#2)(2008-12#3)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
covered##133##1##(1991-1#3)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#3)(1993-1#2)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-12#2)(1996-2#2)(1997-2#5)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#50)(2008-11#9)(2008-12#4)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#5)(2010-11#1)(2010-5#2)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
covering a wide range of##2##5##(2008-10#1)(2009-10#1)
covering a wide##4##3##(2008-10#1)(2008-9#1)(2009-10#1)(2012-5#1)
covering a##9##2##(1991-6#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-5#1)
covering all##2##2##(1997-3#1)(2008-10#1)
covering and##2##2##(2008-5#1)(2013-1#1)
covering different##4##2##(2008-10#3)(2008-5#1)
covering expenditures for various types of medical services and products and their sources of funding from 1960 to##2##18##(1995-3#1)(1997-3#1)
covering most##2##2##(2008-10#1)(2009-4#1)
covering the entire##2##3##(2008-11#1)(2008-8#1)
covering the##22##2##(1990-12#1)(1991-2#1)(1992-3#1)(1995-6#1)(1996-11#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2013-8#1)
covering##78##1##(1990-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-12#1)(1997-2#1)(1997-3#3)(1997-8#1)(2008-10#20)(2008-11#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-5#1)(2012-9#1)(2013-1#2)(2013-8#2)
covers a##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
covers about##2##2##(1993-2#1)(1995-6#1)
covers such##2##2##(2008-9#1)(2013-8#1)
covers the##15##2##(1995-12#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-3#1)
covers##43##1##(1993-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-9#5)(2010-10#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
coverslips were sprayed with##3##4##(2008-10#3)
coverslips##8##1##(2008-10#6)(2008-11#2)
covert##3##1##(1994-3#1)(2008-11#1)(2010-5#1)
cow milk samples##2##3##(2008-10#2)
cow milk##9##2##(2008-10#5)(2013-1#4)
cow tracheal epithelium##2##3##(1995-11#2)
cow##19##1##(1990-6#1)(1991-8#1)(1995-11#2)(2008-10#7)(2008-12#1)(2012-3#2)(2013-1#5)
cow's milk and##2##3##(2008-10#2)
cow's milk##4##2##(1991-6#1)(2008-10#3)
cow's##5##1##(1991-6#1)(2008-10#4)
cowpea cultivars##4##2##(2008-12#4)
cowpea leaves##4##2##(2008-10#4)
cowpea##14##1##(2008-10#10)(2008-12#4)
cows and a calf##2##4##(1991-8#2)
cows and##4##2##(1991-8#2)(1992-2#1)(2012-3#1)
cows fed a trehalose-supplemented diet##3##5##(2013-1#3)
cows fed a##4##3##(2013-1#4)
cows in##5##2##(1990-6#2)(1995-9#1)(2008-12#1)(2012-3#1)
cows were used##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
cows were##5##2##(1992-2#1)(2008-9#1)(2011-2#1)(2013-1#2)
cows with suppurative##2##3##(1991-8#2)
cows##40##1##(1990-6#3)(1990-9#1)(1991-8#4)(1992-12#1)(1992-2#2)(1993-6#1)(1995-9#1)(1996-8#5)(1997-4#1)(2008-12#1)(2008-9#2)(2011-2#2)(2012-3#4)(2013-1#12)
cox##4##1##(2008-10#4)
cox14 mutants##2##2##(1995-6#2)
coxI and II##2##3##(2008-10#2)
coxI and##3##2##(2008-10#3)
coxII##4##1##(2008-10#4)
coxal glands##2##2##(2007-12#2)
coxarthrosis##3##1##(1997-6#1)(2013-1#2)
coxsackie B virus##2##3##(2011-3#2)
cpSRP43##2##1##(2009-7#2)
cpe-positive##4##1##(2011-2#4)
cpxyl1##2##1##(2008-10#2)
cr(4+)##3##1##(2008-2#1)(2008-3#2)
crab apple blossoms##3##3##(2008-10#3)
crab apple flowers were##2##4##(2008-10#2)
crab apple flowers##3##3##(2008-10#3)
crab apple##8##2##(2008-10#8)
crab species##2##2##(2008-10#1)(2008-7#1)
crab##19##1##(1994-11#4)(2008-10#10)(2008-12#2)(2008-7#3)
crabgrass##3##1##(2008-10#3)
crabs##5##1##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)
crack behaviour##2##2##(2009-7#2)
crack cocaine##2##2##(2008-1#1)(2010-1#1)
crack injection##2##2##(2008-1#2)
crack patterns##2##2##(2009-7#2)
crack propagation##3##2##(2009-7#3)
crack##18##1##(1991-12#1)(2008-1#3)(2008-10#1)(2009-7#12)(2010-1#1)
cracking##6##1##(2008-10#5)(2008-5#1)
cracks##2##1##(2008-10#1)(2009-5#1)
cranberry cultivars##2##2##(2008-10#2)
cranberry plants##3##2##(2008-10#3)
cranberry stem gall and##2##4##(2008-10#2)
cranberry stem gall##5##3##(2008-10#5)
cranberry##14##1##(2008-10#13)(2011-1#1)
cranial and##2##2##(2008-10#1)(2008-7#1)
cranial base##3##2##(2011-2#3)
cranial blood vessels and##2##4##(1994-9#1)(2008-9#1)
cranial chondrosarcoma##3##2##(2011-2#3)
cranial fossa##4##2##(2008-12#1)(2008-7#1)(2009-9#1)(2011-2#1)
cranial nerve palsies##8##3##(1996-9#2)(2008-7#4)(2011-2#2)
cranial nerve##13##2##(1996-12#1)(1996-9#3)(2007-12#1)(2008-7#5)(2011-2#3)
cranial nerves are##2##3##(2008-1#1)(2012-3#1)
cranial nerves##14##2##(1991-3#1)(1993-9#1)(1996-12#1)(2008-1#5)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
cranial neuropathies##2##2##(1993-9#1)(2008-11#1)
cranial surgery##4##2##(2011-2#1)(2012-3#3)
cranial tibial translation##2##3##(2012-3#2)
cranial tibial##3##2##(1996-6#1)(2012-3#2)
cranial##66##1##(1990-5#1)(1991-3#1)(1993-9#2)(1994-9#1)(1996-11#2)(1996-12#2)(1996-6#2)(1996-9#3)(1997-4#1)(2007-12#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#9)(2008-9#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-2#19)(2012-3#8)(2013-1#1)(2013-8#1)
craniectomy##4##1##(2011-2#2)(2013-1#1)(2013-8#1)
craniocervical junction##5##2##(2011-2#5)
craniocervical##7##1##(2011-2#5)(2012-12#1)(2013-1#1)
craniofacial##13##1##(2008-12#1)(2008-9#3)(2010-6#6)(2011-2#1)(2013-1#2)
craniopharyngioma##10##1##(1993-9#1)(1995-5#2)(2008-7#4)(2011-2#3)
craniopharyngiomas##5##1##(2008-7#4)(2011-2#1)
cranioplasty##4##1##(2011-2#4)
craniosynostosis and##3##2##(2011-1#3)
craniotomies##2##1##(2008-7#1)(2011-2#1)
craniotomy and##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
craniotomy approach##2##2##(2011-2#1)(2013-1#1)
craniotomy for##2##2##(2011-2#1)(2012-3#1)
craniotomy with##4##2##(1990-12#1)(1995-11#1)(2008-7#2)
craniotomy##26##1##(1990-12#4)(1995-11#1)(2008-7#9)(2010-7#1)(2011-2#6)(2012-3#3)(2013-1#1)(2013-8#1)
craniovertebral junction##2##2##(2008-7#1)(2013-1#1)
crashes##3##1##(1997-3#1)(2008-8#1)(2008-9#1)
crassa and##5##2##(2008-10#1)(2009-6#1)(2010-7#2)(2012-3#1)
crassa##19##1##(1993-12#1)(1995-2#3)(1996-6#1)(1997-4#1)(2008-10#3)(2008-8#2)(2009-6#1)(2010-7#3)(2012-3#4)
crassipes##3##1##(2008-10#1)(2012-2#1)(2012-3#1)
crater##3##1##(1990-11#1)(2008-10#1)(2008-3#1)
craters##2##1##(1991-2#1)(2008-10#1)
craving##4##1##(1991-1#1)(1997-5#1)(2008-6#1)(2010-1#1)
crayfish Astacus leptodactylus##2##3##(2008-7#2)
crayfish##8##1##(2007-12#1)(2008-10#1)(2008-12#2)(2008-6#2)(2008-7#2)
cream and##6##2##(1990-9#1)(2008-5#5)
cream containing##4##2##(2008-10#1)(2008-5#3)
cream formulations##2##2##(2008-5#2)
cream in##4##2##(2008-10#1)(2008-5#3)
cream was##3##2##(2008-5#2)(2011-2#1)
cream with a##2##3##(2008-5#2)
cream##46##1##(1990-9#3)(2008-10#5)(2008-5#32)(2011-2#5)(2013-7#1)
creaminess##3##1##(2008-5#3)
creams and##2##2##(2008-5#2)
creams cause##2##2##(2008-5#2)
creams##23##1##(2008-10#2)(2008-5#19)(2008-8#1)(2011-2#1)
creams/lotions##2##1##(2008-5#2)
create &quot##2##2##(2011-2#2)
create a common##2##3##(1996-1#1)(2011-2#1)
create a more##2##3##(1994-12#1)(1996-1#1)
create a positive##2##3##(2008-7#1)(2010-10#1)
create a single##2##3##(1995-6#1)(2009-11#1)
create a##37##2##(1991-1#1)(1992-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-6#1)(1996-1#3)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2011-2#1)(2011-9#2)(2013-1#3)(2013-8#1)
create an##11##2##(1994-12#1)(1996-3#1)(1996-5#1)(1997-3#2)(2008-10#2)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#1)
create any conditions that##2##4##(1990-2#2)
create genetic##2##2##(2008-11#1)(2008-9#1)
create new##4##2##(1996-3#1)(1997-3#1)(2008-10#1)(2010-4#1)
create spatial##2##2##(2008-8#1)(2008-9#1)
create the##9##2##(1991-2#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)
create##132##1##(1990-2#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-11#1)(1992-12#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-9#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#4)(1996-3#3)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-6#1)(2007-12#1)(2008-10#15)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#1)(2009-7#1)(2010-10#3)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#5)(2011-9#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#2)
created a##16##2##(1991-2#1)(1992-1#1)(1993-12#1)(1994-6#1)(1995-1#1)(2008-10#1)(2008-9#1)(2009-10#2)(2009-6#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
created an##3##2##(1996-9#2)(2008-10#1)
created and##11##2##(1994-1#1)(1994-3#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
created by the##5##3##(2008-10#2)(2008-3#2)(2010-7#1)
created by##20##2##(1991-3#1)(1996-9#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2010-7#1)(2011-2#2)
created for##4##2##(2008-10#1)(2008-11#2)(2010-6#1)
created from##7##2##(1991-12#1)(1996-3#1)(2008-10#3)(2012-2#1)(2013-1#1)
created in the##2##3##(2008-3#1)(2008-7#1)
created in##10##2##(1996-1#1)(2006-6#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
created skill (adjusted OR 0##2##5##(2008-10#2)
created skill##3##2##(2008-10#3)
created that##5##2##(1994-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-6#1)
created the##6##2##(1991-6#1)(1995-6#1)(1997-1#1)(1997-6#1)(2010-6#1)(2011-2#1)
created through##3##2##(1997-3#1)(2008-9#2)
created to##10##2##(1992-2#1)(1993-9#1)(1994-1#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-6#1)(2013-1#1)
created using a##3##3##(1992-1#1)(2008-10#1)(2010-10#1)
created using##5##2##(1992-1#1)(2008-10#2)(2008-5#1)(2010-10#1)
created with##2##2##(2011-3#1)(2011-9#1)
created##151##1##(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-3#2)(1996-5#1)(1996-9#3)(1997-1#1)(1997-3#2)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#28)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-10#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#3)(2010-9#1)(2011-2#9)(2011-3#2)(2011-9#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#1)
creates a##12##2##(1992-3#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-3#1)
creates an##4##2##(1994-12#1)(2008-11#1)(2008-8#1)(2013-8#1)
creates new##3##2##(1995-6#1)(2011-2#2)
creates the##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
creates two##2##2##(2008-3#2)
creates##39##1##(1992-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-6#2)(1997-8#1)(2008-10#3)(2008-11#6)(2008-3#4)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
creatinase##2##1##(1990-2#1)(2008-10#1)
creatine and creatinine##3##3##(2008-10#3)
creatine and##4##2##(2008-10#4)
creatine kinase (CK)##5##3##(1990-11#1)(1990-2#1)(1994-12#2)(2011-2#1)
creatine kinase and##2##3##(1993-3#1)(2008-10#1)
creatine kinase in##2##3##(1990-2#1)(1995-8#1)
creatine kinase##16##2##(1990-11#1)(1990-2#2)(1992-3#1)(1993-3#1)(1994-12#2)(1995-8#2)(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)
creatine kinase-MB##4##2##(2008-3#3)(2011-2#1)
creatine phosphokinase##2##2##(2011-2#1)(2013-1#1)
creatine##32##1##(1990-11#1)(1990-2#5)(1992-3#2)(1993-3#1)(1994-12#3)(1995-8#2)(1997-3#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#3)(2013-1#1)
creating a##23##2##(1991-6#1)(1992-4#1)(1993-12#1)(1995-12#3)(1995-3#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-3#2)
creating an##3##2##(1994-3#1)(2008-12#1)(2013-8#1)
creating more##2##2##(1996-1#1)(2008-11#1)
creating new##3##2##(1992-11#1)(1996-1#1)(1997-2#1)
creating opportunities##2##2##(1993-6#1)(1997-3#1)
creating the##6##2##(1990-5#1)(1992-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
creating##72##1##(1990-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-3#3)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#5)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-8#2)
creatinine &gt##2##2##(2012-3#2)
creatinine (r = 0##2##4##(1995-11#1)(2011-2#1)
creatinine (r =##3##3##(1995-11#2)(2011-2#1)
creatinine and urea##2##3##(1995-3#1)(2008-10#1)
creatinine and##7##2##(1991-12#1)(1994-12#1)(1995-11#1)(1995-3#1)(2008-10#2)(2013-8#1)
creatinine concentration##2##2##(2008-10#2)
creatinine concentrations##2##2##(2008-10#2)
creatinine deiminase##5##2##(1991-12#2)(1995-3#1)(2008-10#2)
creatinine in urine##4##3##(2008-10#4)
creatinine in##7##2##(1991-12#1)(2008-10#5)(2012-3#1)
creatinine levels##5##2##(1992-3#1)(1993-2#1)(2008-10#2)(2012-3#1)
creatinine of##2##2##(2012-3#1)(2013-8#1)
creatinine ratio##3##2##(1991-12#1)(2013-1#2)
creatinine sensitive##3##2##(2008-10#3)
creatinine##87##1##(1990-12#1)(1991-12#6)(1992-3#1)(1993-2#1)(1994-12#1)(1995-11#4)(1995-3#6)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#35)(2008-7#5)(2009-6#1)(2011-2#5)(2012-2#1)(2012-3#6)(2013-1#6)(2013-8#2)
creatinine)##2##1##(1997-2#1)(2008-10#1)
creation and##2##2##(1992-1#1)(2012-3#1)
creation of a##14##3##(1991-3#1)(1992-1#1)(1994-5#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-3#1)
creation of new##5##3##(1991-7#1)(1997-6#1)(2008-10#1)(2008-11#2)
creation of the##3##3##(2008-3#1)(2010-1#1)(2010-9#1)
creation of##49##2##(1991-3#1)(1991-7#1)(1992-1#2)(1993-6#1)(1994-5#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(2008-10#9)(2008-11#9)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
creation##56##1##(1991-3#1)(1991-7#1)(1992-1#3)(1993-6#1)(1994-5#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(2008-10#9)(2008-11#9)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#2)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
creative and##3##2##(1992-1#1)(1992-12#1)(2007-8#1)
creative financing##2##2##(1993-2#2)
creative ideas##2##2##(1996-1#1)(1997-2#1)
creative##29##1##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-12#1)(1995-1#3)(1996-1#1)(1996-3#1)(1997-1#2)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
creativity and innovation##2##3##(1995-1#2)
creativity and##5##2##(1992-1#1)(1995-1#3)(2008-11#1)
creativity##11##1##(1991-3#1)(1992-1#1)(1995-1#6)(2008-11#2)(2009-10#1)
credence to the##2##3##(1992-3#1)(1996-1#1)
credence##4##1##(1992-3#1)(1996-1#2)(2008-10#1)
credentialing for##2##2##(1991-2#1)(2012-2#1)
credentialing##13##1##(1991-12#3)(1991-2#1)(1994-3#3)(1995-12#1)(1995-2#1)(1996-3#2)(1997-2#1)(2012-2#1)
credentials##3##1##(1992-3#3)
credibility and##3##2##(1990-2#1)(2008-11#2)
credibility interval##2##2##(2008-11#1)(2011-2#1)
credibility##16##1##(1990-2#1)(1993-12#1)(2008-11#7)(2008-12#1)(2011-2#3)(2013-1#3)
credible##8##1##(1993-12#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2013-1#1)
credit enhancement##2##2##(1991-9#2)
credit for##2##2##(1993-11#1)(1993-12#1)
credit##12##1##(1991-12#4)(1991-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1997-2#1)(2008-11#1)
creep loading##2##2##(2009-7#2)
creep##8##1##(2008-5#1)(2009-7#4)(2009-9#3)
creeping bentgrass##10##2##(2008-10#10)
creeping thistle##2##2##(2008-10#2)
creeping##16##1##(1994-8#2)(1997-4#1)(2008-10#13)
crenata##3##1##(2008-10#3)
creosote##2##1##(2008-10#2)
crest autograft##2##2##(2008-7#1)(2012-3#1)
crest##14##1##(1991-6#1)(1997-3#1)(2008-7#2)(2009-10#3)(2009-9#3)(2010-3#1)(2010-6#1)(2010-8#1)(2012-3#1)
crests##4##1##(2008-9#4)
cresyl violet##2##2##(1996-12#1)(2008-10#1)
cresyl##4##1##(1996-12#1)(2008-10#3)
crevice spawning##2##2##(2010-8#2)
crevice##5##1##(1992-4#2)(2008-10#1)(2010-8#2)
crevices##5##1##(2008-10#3)(2010-8#1)(2011-2#1)
crewmembers##3##1##(1996-12#3)
cribriform plate##3##2##(2008-11#1)(2011-2#2)
cribriform##4##1##(2008-11#1)(2011-2#2)(2013-8#1)
cricket##4##1##(2008-5#3)(2008-6#1)
crickets##4##1##(2008-8#2)(2008-9#1)(2012-3#1)
crime in##2##2##(1996-11#1)(2011-2#1)
crime prevention##2##2##(1991-1#1)(1992-12#1)
crime scene##3##2##(2008-10#2)(2008-12#1)
crime scenes##4##2##(2008-10#4)
crime##33##1##(1991-1#2)(1991-12#1)(1992-12#2)(1992-2#2)(1993-12#1)(1993-2#1)(1994-12#3)(1995-12#1)(1996-11#1)(1996-12#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#3)(2009-7#2)(2010-7#1)(2011-2#1)
crimes##9##1##(1991-2#1)(1993-2#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#1)
criminal justice supervision##2##3##(2008-6#2)
criminal justice##11##2##(1996-1#4)(2008-11#4)(2008-6#3)
criminal proceedings##3##2##(2011-2#3)
criminal transmission##2##2##(1996-5#2)
criminal##37##1##(1991-1#1)(1991-2#3)(1992-1#1)(1993-12#2)(1993-3#1)(1994-3#2)(1995-12#1)(1996-1#5)(1996-5#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-6#4)(2010-6#1)(2011-2#4)(2013-8#2)
criminalization of##2##2##(1994-2#1)(1996-1#1)
criminalization##3##1##(1994-2#1)(1996-1#2)
crinkle##2##1##(2008-10#2)
crise convulsive##2##2##(2013-1#2)
crises and##2##2##(2013-1#2)
crises convulsives##3##2##(2013-1#3)
crises##11##1##(1994-3#2)(1995-1#1)(2008-10#1)(2009-9#2)(2013-1#5)
crisis and##5##2##(1996-8#1)(1997-3#1)(2009-6#2)(2013-1#1)
crisis as##2##2##(2008-10#1)(2013-8#1)
crisis centre for children##3##4##(1995-5#3)
crisis for##2##2##(1995-1#1)(1996-3#1)
crisis in##7##2##(1997-5#1)(2008-11#1)(2008-6#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-1#1)
crisis management##2##2##(1992-1#1)(2008-7#1)
crisis##45##1##(1990-2#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#3)(1996-3#1)(1996-8#1)(1997-3#2)(1997-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#6)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#3)
crispa##2##1##(2008-10#2)
crispbread##2##1##(1991-6#2)
cristae##3##1##(2008-12#1)(2008-7#2)
criteria (sensitivity##2##2##(1997-8#2)
criteria after##2##2##(2013-1#2)
criteria alone##2##2##(1997-2#1)(2008-5#1)
criteria and standards##2##3##(1991-3#2)
criteria and##27##2##(1991-3#2)(1992-3#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#1)
criteria are##12##2##(1990-9#1)(1997-8#2)(2008-12#1)(2008-6#1)(2009-6#1)(2010-2#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
criteria as##2##2##(1995-3#1)(2011-2#1)
criteria can be##2##3##(1990-8#1)(2008-3#1)
criteria can##3##2##(1990-8#1)(2008-11#1)(2008-3#1)
criteria defined by the##2##4##(1991-11#1)(2011-2#1)
criteria for &quot##2##3##(1997-8#1)(2011-2#1)
criteria for a##3##3##(1991-1#1)(2008-12#1)(2008-8#1)
criteria for distinguishing##2##3##(2008-9#1)(2010-5#1)
criteria for identifying##2##3##(2008-7#1)(2013-1#1)
criteria for major depressive disorder (MDD)##2##6##(2011-2#1)(2012-3#1)
criteria for major depressive disorder##4##5##(2011-2#3)(2012-3#1)
criteria for major##5##3##(2011-2#4)(2012-3#1)
criteria for selecting the##2##4##(1990-5#1)(2008-3#1)
criteria for the##7##3##(1994-2#1)(1997-5#1)(1997-8#2)(2008-11#1)(2010-12#1)(2011-2#1)
criteria for##93##2##(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#5)(2008-10#10)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2010-12#3)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)
criteria have been##2##3##(2012-3#1)(2013-1#1)
criteria have##6##2##(1994-2#1)(1997-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
criteria in##8##2##(1994-9#1)(1997-8#1)(2008-7#1)(2010-12#1)(2011-2#3)(2013-1#1)
criteria included##3##2##(1997-1#1)(2009-8#1)(2010-2#1)
criteria is##4##2##(1997-8#1)(2008-3#1)(2011-2#1)(2012-2#1)
criteria of choice##3##3##(1990-3#1)(1992-9#1)(2008-8#1)
criteria of the##4##3##(1990-6#1)(1991-2#1)(2008-7#1)(2011-3#1)
criteria of##28##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-6#1)(1996-11#1)(1996-3#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
criteria regarding##2##2##(2008-11#1)(2012-3#1)
criteria should be##2##3##(1991-2#1)(1992-12#1)
criteria should##3##2##(1991-2#1)(1992-12#1)(2010-12#1)
criteria such as##4##3##(2008-10#3)(2008-5#1)
criteria that##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
criteria to##9##2##(2008-10#4)(2008-4#1)(2010-1#1)(2011-2#1)(2012-2#2)
criteria used to identify candidates for EPOF##2##7##(1993-12#2)
criteria used to##3##3##(1993-12#2)(1996-3#1)
criteria used##6##2##(1993-12#2)(1996-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
criteria was##2##2##(1996-6#1)(2012-2#1)
criteria were developed##2##3##(2008-10#1)(2010-12#1)
criteria were##15##2##(1996-11#1)(2008-10#3)(2008-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
criteria will##2##2##(1994-8#1)(2011-2#1)
criteria##396##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#5)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#26)(2008-1#1)(2008-10#41)(2008-11#19)(2008-12#5)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#8)(2008-6#8)(2008-7#15)(2008-8#5)(2008-9#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#7)(2010-2#7)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#45)(2011-3#4)(2011-7#1)(2012-12#11)(2012-2#19)(2012-3#13)(2013-1#26)(2013-8#5)
criteria)##3##1##(1997-8#1)(2008-10#1)(2013-1#1)
criterion and##4##2##(1993-3#1)(1995-3#1)(2008-10#1)(2012-3#1)
criterion are##2##2##(1996-3#1)(2008-10#1)
criterion for the##4##3##(1996-11#1)(2008-10#2)(2009-8#1)
criterion for##11##2##(1996-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-9#1)(2013-1#2)
criterion is based##2##3##(2008-3#1)(2008-8#1)
criterion is##6##2##(1996-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-3#1)
criterion lists##2##2##(2008-12#2)
criterion of##8##2##(1991-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(2008-10#1)(2010-2#3)
criterion that##2##2##(2008-10#1)(2008-3#1)
criterion to##4##2##(2008-10#3)(2011-2#1)
criterion was##2##2##(1991-2#1)(2008-10#1)
criterion##74##1##(1991-2#2)(1993-1#1)(1993-3#2)(1993-8#2)(1994-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#22)(2008-12#3)(2008-3#3)(2008-5#2)(2008-6#7)(2008-8#3)(2009-8#1)(2010-2#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#4)(2012-9#1)(2013-1#6)
criterion)##4##1##(2008-10#4)
criterium##2##1##(2008-10#1)(2009-12#1)
critical DGPS failure##2##3##(2009-10#2)
critical access hospital##2##3##(2008-11#1)(2012-2#1)
critical access##4##2##(2008-11#3)(2012-2#1)
critical action research##2##3##(2008-11#2)
critical amino acid residues##2##4##(1997-8#1)(2008-9#1)
critical amino acid##4##3##(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
critical analysis of the##4##4##(1992-1#1)(1997-5#1)(2008-11#1)(2009-10#1)
critical analysis of##8##3##(1991-6#1)(1992-1#1)(1995-1#1)(1997-5#1)(2008-11#2)(2008-3#1)(2009-10#1)
critical and##6##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-9#1)
critical appraisal skills##3##3##(2008-11#2)(2008-12#1)
critical appraisal##6##2##(2008-11#4)(2008-12#1)(2012-3#1)
critical area##2##2##(1991-3#2)
critical areas##3##2##(1993-12#1)(1997-3#1)(2008-11#1)
critical aspects of##3##3##(1994-2#1)(2008-9#2)
critical care nursing##2##3##(2008-11#2)
critical care placements##2##3##(2008-11#2)
critical care##16##2##(1994-3#1)(1996-2#2)(1996-3#1)(1997-2#1)(2008-11#5)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
critical comparison of##3##3##(1992-3#1)(2008-10#2)
critical comparison##4##2##(1992-3#1)(2008-10#3)
critical components of##4##3##(1996-2#1)(2009-10#1)(2011-2#1)(2013-7#1)
critical components##5##2##(1996-2#1)(2009-10#1)(2011-2#2)(2013-7#1)
critical design##2##2##(1995-5#1)(2012-2#1)
critical differences in the##2##4##(1994-12#1)(2009-9#1)
critical elements of##2##3##(2008-11#1)(2008-9#1)
critical elements##3##2##(1993-12#1)(2008-11#1)(2008-9#1)
critical evaluation of the##3##4##(1990-5#1)(1990-9#1)(1995-3#1)
critical evaluation of##9##3##(1990-5#1)(1990-9#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2013-8#2)
critical evaluation##10##2##(1990-5#1)(1990-9#1)(1992-12#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2013-8#2)
critical examination of the##4##4##(1991-12#1)(2008-10#2)(2008-11#1)
critical examination of##5##3##(1991-12#1)(2008-10#3)(2008-11#1)
critical exposure dose##2##3##(2008-10#2)
critical factors##6##2##(2008-10#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-3#1)
critical for its##4##3##(1993-8#1)(1995-2#1)(2008-10#1)(2008-9#1)
critical for the activation##2##4##(2008-10#1)(2008-9#1)
critical for the induction of##2##5##(2008-11#1)(2008-12#1)
critical for the##16##3##(2008-10#4)(2008-11#3)(2008-12#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-7#1)(2012-2#1)(2013-1#2)
critical for their##2##3##(2011-2#1)(2012-7#1)
critical for##63##2##(1991-12#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-8#2)(1994-1#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#1)(1997-7#1)(1997-9#1)(2008-10#9)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-4#1)(2009-8#4)(2010-10#1)(2010-7#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-4#1)(2012-7#1)(2013-1#3)(2013-8#1)
critical function##2##2##(1993-12#1)(2013-1#1)
critical health##2##2##(1997-3#1)(2010-8#1)
critical illness##3##2##(2008-6#1)(2012-3#2)
critical importance##8##2##(1990-6#1)(1991-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2012-2#1)(2013-8#1)
critical in the##2##3##(1995-8#1)(2008-10#1)
critical in##7##2##(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2012-2#1)
critical incident##5##2##(2008-11#1)(2008-12#1)(2010-10#2)(2013-1#1)
critical incidents##5##2##(2008-11#4)(2012-3#1)
critical information##2##2##(2008-11#1)(2010-4#1)
critical issues##6##2##(1995-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#2)
critical level##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
critical levels##2##2##(2008-10#1)(2008-11#1)
critical micellar concentration##3##3##(2008-10#2)(2010-11#1)
critical micelle concentration##6##3##(2008-10#6)
critical need to##2##3##(1995-3#1)(2010-7#1)
critical need##4##2##(1995-3#1)(2009-8#1)(2010-7#1)(2012-2#1)
critical number of##2##3##(2008-8#1)(2010-7#1)
critical of the##2##3##(1994-12#1)(2013-8#1)
critical parameters##5##2##(2008-10#2)(2008-4#1)(2008-5#1)(2012-3#1)
critical patch size effects##3##4##(2008-8#3)
critical patch size##4##3##(2008-8#4)
critical paths##2##2##(1993-3#2)
critical period##4##2##(2008-10#1)(2012-2#3)
critical periods##2##2##(2008-10#1)(2010-7#1)
critical players##2##2##(1995-6#1)(2009-3#1)
critical points##4##2##(1997-2#2)(2008-6#1)(2009-3#1)
critical process##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
critical region##3##2##(1996-12#1)(1997-2#1)(1997-3#1)
critical review of the literature##3##5##(2008-11#1)(2012-3#1)(2013-1#1)
critical review of the##5##4##(1993-3#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
critical review of##12##3##(1992-3#1)(1993-12#1)(1993-3#1)(2008-10#2)(2008-11#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
critical review##15##2##(1992-3#1)(1993-12#1)(1993-3#1)(2008-10#2)(2008-11#3)(2009-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
critical role in##33##3##(1990-11#1)(1990-5#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#2)(1997-2#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
critical role of##7##3##(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-1#1)
critical role##47##2##(1990-11#1)(1990-5#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#3)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#7)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
critical size##3##2##(1994-5#1)(2008-7#2)
critical step for##2##3##(2008-11#1)(2011-2#1)
critical step in the##3##4##(1995-8#1)(2008-10#1)(2008-11#1)
critical step in##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
critical step##8##2##(1995-8#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
critical steps and##2##3##(2008-4#1)(2008-9#1)
critical steps##4##2##(1996-5#1)(2008-4#1)(2008-8#1)(2008-9#1)
critical surface tension (gamma(c))##2##4##(2008-5#2)
critical surface tension##3##3##(2008-5#3)
critical temperature##2##2##(2008-8#1)(2012-2#1)
critical thinking and##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
critical thinking in nursing##3##4##(2008-12#3)
critical thinking in##5##3##(2008-11#1)(2008-12#4)
critical thinking skills in nurse prescribers##2##6##(2008-12#2)
critical thinking skills in##3##4##(2008-11#1)(2008-12#2)
critical thinking skills##5##3##(2008-11#3)(2008-12#2)
critical thinking##33##2##(2008-11#20)(2008-12#11)(2008-8#1)(2012-2#1)
critical threshold##5##2##(2008-8#2)(2010-10#3)
critical time for##2##3##(2008-10#2)
critical to the success of##3##5##(1994-12#1)(2011-2#2)
critical to the##12##3##(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#3)(2013-8#1)
critical to##39##2##(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
critical wavelength##6##2##(2008-5#6)
critical##614##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#8)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#3)(1994-12#4)(1994-2#6)(1994-3#2)(1994-5#3)(1994-6#1)(1995-1#2)(1995-2#7)(1995-3#2)(1995-5#6)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#3)(1996-12#5)(1996-2#6)(1996-3#3)(1996-5#3)(1997-1#2)(1997-2#10)(1997-3#5)(1997-5#1)(1997-7#2)(1997-8#1)(1997-9#1)(2007-12#2)(2008-10#78)(2008-11#91)(2008-12#21)(2008-2#2)(2008-3#4)(2008-4#8)(2008-5#15)(2008-6#5)(2008-7#13)(2008-8#26)(2008-9#21)(2009-10#12)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#3)(2009-6#2)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#10)(2010-11#2)(2010-12#2)(2010-4#4)(2010-6#1)(2010-7#9)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#31)(2011-3#1)(2011-7#1)(2012-2#26)(2012-3#13)(2012-4#1)(2012-7#1)(2013-1#19)(2013-7#2)(2013-8#10)
critical&quot##3##1##(2008-11#2)(2009-7#1)
critically analysed##3##2##(2008-10#1)(2008-11#2)
critically appraise the##2##3##(1991-2#1)(2008-12#1)
critically appraised##5##2##(2008-1#1)(2008-10#2)(2008-11#2)
critically compared##3##2##(2008-10#3)
critically depends on##2##3##(2010-7#1)(2011-2#1)
critically discuss##2##2##(2009-12#1)(2013-1#1)
critically discussed##4##2##(2008-10#3)(2008-9#1)
critically endangered##3##2##(2010-8#1)(2013-1#2)
critically evaluated##4##2##(1994-6#1)(2008-10#2)(2013-1#1)
critically examined##3##2##(2008-10#2)(2008-3#1)
critically examines##2##2##(2008-11#1)(2010-8#1)
critically ill patients and##3##4##(2008-11#1)(2010-8#1)(2013-1#1)
critically ill patients##10##3##(1991-3#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
critically ill##18##2##(1991-3#1)(1991-6#1)(1994-6#1)(2008-11#2)(2008-5#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
critically important##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)
critically involved in##2##3##(1997-7#1)(2013-8#1)
critically on the##3##3##(2008-6#2)(2008-8#1)
critically review the##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
critically review##4##2##(2008-10#1)(2008-11#1)(2009-7#1)(2010-1#1)
critically reviewed in##2##3##(2008-10#1)(2012-3#1)
critically reviewed##5##2##(2008-10#3)(2011-1#1)(2012-3#1)
critically##90##1##(1991-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1994-6#2)(1997-7#1)(2008-1#1)(2008-10#23)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#3)(2010-8#4)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#2)
criticism and##2##2##(2008-10#1)(2008-5#1)
criticism of##3##2##(1993-12#1)(1995-12#1)(2009-11#1)
criticism than##2##2##(1997-8#1)(2011-2#1)
criticism##17##1##(1990-11#1)(1990-3#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-11#3)(2011-2#2)(2013-1#2)
criticized for not##2##3##(1994-12#1)(1996-2#1)
criticized for##4##2##(1994-12#1)(1996-2#2)(2008-8#1)
criticized##10##1##(1991-1#1)(1994-12#1)(1996-1#1)(1996-2#2)(2008-10#1)(2008-8#1)(2009-5#1)(2009-6#1)(2013-1#1)
critics##4##1##(1994-12#1)(1995-12#1)(2008-11#1)(2011-2#1)
critique of##4##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-3#1)
critique##7##1##(1992-1#1)(1993-6#1)(1994-12#2)(2008-11#1)(2008-12#1)(2008-3#1)
critères de##2##2##(2013-1#2)
crocea##2##1##(2008-5#2)
crocin##3##1##(2008-11#3)
cromoglycate##3##1##(1997-1#1)(2008-10#2)
cromolyn##2##1##(1995-12#1)(2008-11#1)
crop and##8##2##(2008-10#6)(2008-8#2)
crop anthesis##3##2##(2008-10#3)
crop by##2##2##(2008-10#2)
crop edges##2##2##(2013-1#2)
crop growth stage##2##3##(2008-10#2)
crop growth##3##2##(2008-10#3)
crop health##3##2##(2008-10#3)
crop in the field##2##4##(2008-10#2)
crop in the##5##3##(2008-10#4)(2010-10#1)
crop in##9##2##(2008-10#6)(2010-10#2)(2013-8#1)
crop is##3##2##(2008-10#3)
crop management practices such as##2##5##(2008-10#2)
crop management##3##2##(2008-10#2)(2008-12#1)
crop of##2##2##(1991-11#1)(2008-10#1)
crop or##3##2##(2008-10#3)
crop pathogens##2##2##(2008-10#2)
crop pests##2##2##(2008-8#1)(2009-8#1)
crop plants in##2##3##(2008-11#1)(2008-12#1)
crop plants##6##2##(2008-10#2)(2008-11#3)(2008-12#1)
crop production systems##2##3##(2008-10#2)
crop production##6##2##(2008-10#5)(2012-2#1)
crop productivity of##2##3##(2010-10#2)
crop productivity##4##2##(2008-10#1)(2009-8#1)(2010-10#2)
crop protection decision making##2##4##(2008-10#2)
crop protection technologies based on##2##5##(2008-10#2)
crop protection##10##2##(2008-10#10)
crop rotation and##3##3##(2008-12#3)
crop rotation in##2##3##(2008-12#2)
crop rotation##17##2##(2008-10#7)(2008-12#10)
crop seasons##2##2##(2008-10#2)
crop species##5##2##(2008-10#3)(2012-2#2)
crop was##3##2##(2008-10#3)
crop yield##2##2##(2008-10#2)
crop yields##2##2##(2010-10#1)(2010-7#1)
crop##173##1##(1991-11#1)(2007-8#1)(2008-10#119)(2008-11#5)(2008-12#14)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-10#10)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#1)
crop-host availability##2##2##(2008-10#2)
crop-production##2##1##(2008-10#2)
cropped to##4##2##(2008-10#4)
cropped##6##1##(2008-10#6)
cropping areas##2##2##(2008-10#2)
cropping frequency##2##2##(2008-10#2)
cropping in the##2##3##(2008-10#1)(2013-8#1)
cropping period##2##2##(2008-10#2)
cropping periods##3##2##(2008-10#3)
cropping season##4##2##(2008-10#4)
cropping seasons##4##2##(2008-10#3)(2008-12#1)
cropping sequence##3##2##(2008-10#3)
cropping sequences##2##2##(2008-10#2)
cropping systems##4##2##(2008-10#3)(2008-5#1)
cropping##39##1##(2008-10#34)(2008-12#1)(2008-5#1)(2010-7#1)(2012-4#1)(2013-8#1)
crops and weeds##2##3##(2008-10#2)
crops and##12##2##(2008-10#9)(2011-2#1)(2013-1#1)(2013-8#1)
crops are planted##2##3##(2008-10#2)
crops are##3##2##(2008-10#3)
crops from##2##2##(2008-10#2)
crops in the##4##3##(2008-10#4)
crops in##16##2##(2008-10#13)(2008-6#1)(2012-2#1)(2013-1#1)
crops of##3##2##(2008-10#3)
crops such as##5##3##(2008-10#5)
crops was##3##2##(2008-10#3)
crops were grown##2##3##(2008-10#2)
crops were##6##2##(2008-10#6)
crops with##4##2##(2008-10#4)
crops worldwide##4##2##(2008-10#4)
crops##142##1##(2008-10#121)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-10#4)(2011-2#5)(2012-2#1)(2013-1#2)(2013-8#3)
cross LB x##2##3##(2008-10#2)
cross MiA##2##2##(2008-10#2)
cross between a##5##3##(2008-10#4)(2012-3#1)
cross between the resistant##4##4##(2008-10#4)
cross between the##10##3##(2008-10#10)
cross between two##2##3##(2008-10#2)
cross between##38##2##(1996-12#1)(2008-10#31)(2008-9#2)(2009-10#1)(2012-3#3)
cross correlation##3##2##(2008-2#1)(2010-8#2)
cross country##2##2##(1992-6#2)
cross court and down the line##2##6##(2011-2#2)
cross education may##2##3##(2013-8#2)
cross education##4##2##(2013-8#4)
cross inoculated##2##2##(2008-10#2)
cross of##10##2##(2008-10#10)
cross pathogenicity of##2##3##(2008-10#2)
cross pathogenicity##3##2##(2008-10#3)
cross polarization##2##2##(2008-10#2)
cross protection against##2##3##(2008-10#2)
cross protection##9##2##(2008-10#9)
cross reaction was##2##3##(2008-5#1)(2010-4#1)
cross reactions##3##2##(1996-11#1)(2008-10#1)(2008-5#1)
cross reactivity##5##2##(1992-9#2)(2008-10#2)(2008-8#1)
cross resistance##4##2##(2008-10#1)(2008-11#2)(2009-8#1)
cross section and##2##3##(2008-3#2)
cross section for##3##3##(2008-2#1)(2008-3#2)
cross section of##6##3##(1997-3#1)(2007-11#1)(2007-12#1)(2008-3#3)
cross section##23##2##(1993-5#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#16)
cross sectional study##2##3##(2008-7#1)(2011-2#1)
cross sectional##4##2##(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
cross sections have##2##3##(2008-2#1)(2008-3#1)
cross sections of the##2##4##(2008-3#1)(2011-2#1)
cross sections of##3##3##(2008-3#1)(2009-7#1)(2011-2#1)
cross sections##13##2##(2008-2#3)(2008-3#7)(2008-5#1)(2009-7#1)(2011-2#1)
cross sensitivity##3##2##(2008-10#3)
cross talk between##3##3##(2008-3#1)(2013-1#2)
cross talk##9##2##(2008-3#5)(2009-12#1)(2011-2#1)(2013-1#2)
cross the blood-labyrinth barrier into endolymph##2##6##(2009-8#1)(2012-2#1)
cross the blood-labyrinth barrier##3##4##(2009-8#2)(2012-2#1)
cross the##9##2##(2008-10#3)(2008-11#1)(2009-8#3)(2011-2#1)(2012-2#1)
cross validation##6##2##(2008-10#6)
cross was made between##2##4##(2008-10#1)(2008-8#1)
cross was##3##2##(2008-10#2)(2008-8#1)
cross##229##1##(1990-8#1)(1992-12#1)(1992-6#2)(1992-9#2)(1993-2#1)(1993-5#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#120)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#29)(2008-5#5)(2008-7#1)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#5)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#7)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#5)
cross-boundary##2##1##(2008-12#1)(2008-8#1)
cross-bridge##3##1##(1992-3#1)(2008-8#1)(2009-6#1)
cross-connectors##2##1##(2012-3#2)
cross-contamination of##2##2##(2008-10#2)
cross-contamination##13##1##(1991-12#1)(1994-11#1)(2008-10#3)(2008-11#8)
cross-correlation analysis##2##2##(1997-6#1)(2008-9#1)
cross-correlation dynamic light-scattering##3##3##(2008-3#3)
cross-correlation##10##1##(1994-11#1)(1997-6#1)(2008-10#1)(2008-3#5)(2008-9#1)(2012-2#1)
cross-coupling reactions of##2##3##(1996-5#1)(2010-8#1)
cross-coupling##3##1##(1996-5#1)(2009-5#1)(2010-8#1)
cross-cultural research##2##2##(2008-11#1)(2008-12#1)
cross-cultural##9##1##(2008-1#5)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
cross-cutting##2##1##(1994-2#1)(2012-2#1)
cross-disciplinary##4##1##(2008-11#1)(2013-8#3)
cross-flow##3##1##(2008-10#2)(2008-11#1)
cross-fostered##2##1##(2008-8#2)
cross-hybridization##2##1##(2008-10#1)(2012-2#1)
cross-infection##2##1##(2008-10#1)(2011-2#1)
cross-lagged##3##1##(2009-7#2)(2010-10#1)
cross-leg flap##2##2##(2012-12#2)
cross-link##5##1##(2008-11#3)(2008-4#1)(2010-4#1)
cross-linkages##4##1##(2008-10#4)
cross-linked acrylic acid##2##3##(2008-5#2)
cross-linked by##3##2##(1990-5#1)(1995-3#1)(2008-10#1)
cross-linked chitosan##2##2##(2008-10#2)
cross-linked phyllosilicates##2##2##(2008-6#2)
cross-linked polyacrylic acid polymers##4##4##(2008-5#4)
cross-linked to##2##2##(1995-11#1)(2013-8#1)
cross-linked with##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
cross-linked##36##1##(1990-5#1)(1990-8#2)(1991-12#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-6#3)(2008-10#12)(2008-2#1)(2008-5#6)(2008-6#3)(2010-4#1)(2010-8#2)(2013-8#1)
cross-linker##7##1##(2008-10#3)(2010-4#4)
cross-linking agent##4##2##(2008-10#4)
cross-linking and##2##2##(1995-6#1)(2008-8#1)
cross-linking experiments##2##2##(1995-12#2)
cross-linking of##5##2##(1995-6#2)(2008-10#1)(2008-5#2)
cross-linking reagent##2##2##(1995-6#1)(2008-6#1)
cross-linking with glutaraldehyde##5##3##(2008-10#5)
cross-linking with##6##2##(2008-10#6)
cross-linking##44##1##(1993-6#1)(1993-8#1)(1995-12#2)(1995-6#5)(2008-10#18)(2008-11#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-4#2)(2012-2#1)(2013-1#1)
cross-links##16##1##(1990-8#1)(1992-6#2)(1994-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#6)(2010-4#1)
cross-match before##2##2##(1997-5#2)
cross-matched##2##1##(2008-11#1)(2011-2#1)
cross-matching##7##1##(1997-5#2)(2011-2#4)(2011-3#1)
cross-membrane potential##2##2##(2008-10#2)
cross-modal##6##1##(2008-5#3)(2008-8#3)
cross-national##4##1##(1993-2#2)(1996-2#1)(2012-2#1)
cross-over##3##1##(1991-8#1)(1993-1#1)(1994-12#1)
cross-polarization##3##1##(2008-10#2)(2008-3#1)
cross-protection##6##1##(2008-10#1)(2008-8#3)(2011-2#2)
cross-react with##3##2##(1992-6#1)(1997-1#1)(2008-4#1)
cross-react##4##1##(1992-6#1)(1995-6#1)(1997-1#1)(2008-4#1)
cross-reacted with##7##2##(1993-12#1)(1993-2#1)(1995-12#1)(1996-2#1)(2008-10#3)
cross-reacted##10##1##(1993-12#1)(1993-2#2)(1995-12#1)(1996-2#1)(2008-10#5)
cross-reaction of##3##2##(1991-12#1)(2008-11#2)
cross-reaction was observed##2##3##(2008-11#1)(2010-4#1)
cross-reaction with##2##2##(2008-10#1)(2013-8#1)
cross-reaction##9##1##(1991-12#1)(2008-10#1)(2008-11#5)(2010-4#1)(2013-8#1)
cross-reactions##2##1##(2008-10#2)
cross-reactive epitopes##2##2##(2008-5#2)
cross-reactive##8##1##(1992-6#1)(2008-10#1)(2008-11#1)(2008-5#4)(2011-2#1)
cross-reactivities##2##1##(2008-10#2)
cross-reactivity against##2##2##(2008-10#1)(2009-12#1)
cross-reactivity between##2##2##(2008-4#1)(2011-2#1)
cross-reactivity for##2##2##(2008-10#2)
cross-reactivity of##2##2##(2008-10#1)(2008-11#1)
cross-reactivity to##2##2##(1995-11#1)(2008-10#1)
cross-reactivity was##2##2##(2008-10#2)
cross-reactivity with##3##2##(1990-11#1)(1992-3#1)(2008-10#1)
cross-reactivity##22##1##(1990-11#1)(1992-3#1)(1995-11#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#1)
cross-reactivity)##2##1##(2008-10#2)
cross-reacts with##2##2##(1993-9#1)(1997-1#1)
cross-resistance to##3##2##(2008-5#1)(2013-1#2)
cross-resistance##9##1##(2008-10#3)(2008-5#2)(2008-7#1)(2013-1#3)
cross-resistant to camptothecin##2##3##(1994-8#2)
cross-resistant to##7##2##(1991-3#1)(1994-8#3)(2008-5#3)
cross-section##6##1##(1997-3#1)(2007-12#2)(2008-10#2)(2011-2#1)
cross-sectional and##2##2##(1995-2#1)(2012-3#1)
cross-sectional area of the##2##4##(2010-12#1)(2013-8#1)
cross-sectional area##7##2##(2008-10#1)(2008-11#1)(2009-3#2)(2010-12#1)(2013-3#1)(2013-8#1)
cross-sectional data##2##2##(2011-2#2)
cross-sectional design##3##2##(2010-2#1)(2012-5#1)(2013-8#1)
cross-sectional imaging##6##2##(1997-6#1)(2008-2#2)(2012-2#2)(2013-1#1)
cross-sectional mortality##2##2##(2011-2#2)
cross-sectional sample##2##2##(2008-3#1)(2010-3#1)
cross-sectional studies##2##2##(1994-3#1)(2012-2#1)
cross-sectional study of##4##3##(1996-1#1)(2008-7#1)(2009-5#1)(2011-2#1)
cross-sectional study was carried out##3##5##(2008-7#1)(2011-2#2)
cross-sectional study was conducted##3##4##(2008-10#1)(2009-5#1)(2012-2#1)
cross-sectional study was performed##2##4##(2008-10#1)(2013-1#1)
cross-sectional study was##8##3##(2008-10#2)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
cross-sectional study with##3##3##(2010-3#1)(2010-9#1)(2012-12#1)
cross-sectional study##37##2##(1996-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#2)(2010-10#5)(2010-11#1)(2010-3#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
cross-sectional survey##7##2##(1997-3#1)(2008-11#2)(2008-9#2)(2011-1#1)(2011-2#1)
cross-sectional##97##1##(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#14)(2012-12#6)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#11)(2013-3#1)(2013-8#4)
cross-sections of##3##2##(2008-11#2)(2011-2#1)
cross-sections##7##1##(2008-10#2)(2008-11#3)(2008-5#1)(2011-2#1)
cross-sensitivity##3##1##(2008-10#3)
cross-sibling influences##2##2##(2011-2#2)
cross-species##6##1##(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)(2013-1#2)
cross-talk between the##3##3##(1997-1#1)(2008-10#1)(2009-10#1)
cross-talk between##7##2##(1996-2#1)(1997-1#1)(2008-10#1)(2009-10#3)(2009-6#1)
cross-talk##10##1##(1996-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2009-10#3)(2009-6#1)(2009-8#1)(2012-2#1)
cross-validated##3##1##(2009-3#2)(2011-2#1)
cross-validation method##5##2##(2008-10#5)
cross-validation##15##1##(2008-10#11)(2008-12#1)(2009-7#1)(2010-8#1)(2011-3#1)
crossbred##2##1##(2012-2#2)
crossbreeding##2##1##(1994-12#1)(2008-5#1)
crossbridges##4##1##(1995-2#4)
crossed gratings##2##2##(2008-3#2)
crossed to##3##2##(2008-10#3)
crossed with a##3##3##(2008-10#3)
crossed with##14##2##(2008-10#13)(2013-8#1)
crossed##33##1##(2008-10#23)(2008-3#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-7#1)(2012-3#1)(2013-8#1)
crosses between Columbia and##2##4##(2008-10#2)
crosses between resistant and susceptible##2##5##(2008-10#2)
crosses between resistant##4##3##(2008-10#4)
crosses between##18##2##(2008-10#16)(2008-8#1)(2012-3#1)
crosses in##3##2##(2008-12#1)(2009-10#1)(2012-3#1)
crosses indicated##2##2##(2008-10#2)
crosses involving##3##2##(2008-10#3)
crosses of##12##2##(2008-10#10)(2009-12#2)
crosses the##2##2##(1994-5#1)(2008-10#1)
crosses were made between##2##4##(2008-10#2)
crosses were made##3##3##(2008-10#3)
crosses were performed##2##3##(2008-10#2)
crosses were##11##2##(2008-10#11)
crosses with##4##2##(2008-10#4)
crosses##91##1##(1994-5#1)(1994-8#1)(1994-9#1)(2008-10#74)(2008-12#3)(2008-8#2)(2009-10#2)(2009-12#3)(2012-3#4)
crosses)##2##1##(2008-10#1)(2008-8#1)
crossing for##4##2##(1994-3#2)(1995-12#1)(1997-3#1)
crossing method##2##2##(2008-10#2)
crossing the##4##2##(1992-2#1)(2008-10#2)(2008-11#1)
crossing to##2##2##(1994-3#1)(2008-8#1)
crossing##34##1##(1992-2#1)(1993-8#1)(1994-3#6)(1995-12#1)(1995-6#1)(1997-3#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#2)
crossings##4##1##(1993-8#1)(2008-3#1)(2008-6#2)
crosslink formation##3##2##(2008-10#3)
crosslink under##2##2##(1993-8#2)
crosslink##9##1##(1993-8#2)(2008-10#5)(2009-9#1)(2010-11#1)
crosslinked fibers##3##2##(1995-2#3)
crosslinked to##3##2##(1993-3#1)(1993-8#1)(1995-2#1)
crosslinked with glutaraldehyde##2##3##(2008-10#1)(2008-5#1)
crosslinked with##4##2##(2008-10#3)(2008-5#1)
crosslinked##23##1##(1993-3#1)(1993-8#1)(1995-2#5)(2008-10#12)(2008-11#1)(2008-5#2)(2010-6#1)
crosslinker##2##1##(1995-2#1)(2008-10#1)
crosslinking density##2##2##(2010-6#2)
crosslinking of##4##2##(1995-2#3)(2012-2#1)
crosslinking##14##1##(1993-8#1)(1995-2#4)(2008-10#4)(2008-9#1)(2009-7#1)(2010-6#2)(2012-2#1)
crosslinks##3##1##(1990-8#1)(1995-8#1)(2008-10#1)
crossover study##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
crossover trial##2##2##(1993-11#1)(2012-2#1)
crossover##13##1##(1993-11#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-7#2)(2008-9#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
crossroad##2##1##(1995-2#1)(2008-11#1)
crosstalk between##4##2##(2011-2#1)(2012-2#2)(2013-7#1)
crosstalk from cAMP pathway##2##4##(2008-11#2)
crosstalk##12##1##(2008-11#4)(2008-5#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-7#1)
crotoxyphos and chlorfenvinphos in##2##4##(2008-10#2)
croup##4##1##(2008-11#3)(2008-8#1)
crowded plant populations are##2##4##(2008-8#2)
crowded plant populations##3##3##(2008-8#3)
crowded##16##1##(1991-12#1)(1996-3#1)(2008-11#2)(2008-8#3)(2008-9#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
crowding out##2##2##(1992-3#2)
crowding##7##1##(1992-3#2)(1993-2#1)(2008-9#1)(2009-8#2)(2012-12#1)
crown and root rot of poinsettia##2##6##(2008-10#2)
crown and root rot of tomato##2##6##(2008-10#2)
crown and root rot of##7##5##(2008-10#7)
crown and root rot##13##4##(2008-10#13)
crown and##15##2##(2008-10#15)
crown ether ring##2##3##(2008-10#2)
crown ether##15##2##(1996-5#1)(2008-10#14)
crown ethers##13##2##(2008-10#13)
crown gall##6##2##(2008-10#5)(2011-2#1)
crown of##4##2##(2008-10#1)(2009-8#1)(2013-1#2)
crown rot##7##2##(2008-10#7)
crown rust resistance gene##3##4##(2008-10#3)
crown rust resistance genes##2##4##(2008-10#2)
crown rust resistance in##4##4##(2008-10#4)
crown rust resistance##15##3##(2008-10#15)
crown rust##21##2##(2008-10#21)
crown size##2##2##(2008-9#2)
crown##112##1##(1990-5#1)(1996-5#1)(2008-10#92)(2008-9#3)(2009-8#1)(2011-2#3)(2013-1#11)
crown-rump length##2##2##(1993-12#2)
crown/implant failures##2##2##(2013-1#2)
crowns were##4##2##(2008-10#2)(2013-1#2)
crowns##17##1##(1990-12#1)(1995-9#1)(2008-10#8)(2013-1#7)
crucial and##2##2##(1996-2#1)(2008-11#1)
crucial for survival##2##3##(2008-12#1)(2009-6#1)
crucial for their##2##3##(1991-2#1)(2009-7#1)
crucial for##34##2##(1991-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#2)(2009-7#1)(2009-8#4)(2010-11#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
crucial in the##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
crucial in##11##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#2)
crucial role in the development of##2##6##(2011-2#1)(2013-1#1)
crucial role in the##9##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#1)
crucial role in##20##3##(1993-8#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
crucial role of##7##3##(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)
crucial role##32##2##(1992-10#1)(1993-8#1)(1994-3#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
crucial roles in##4##3##(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
crucial step in##2##3##(2008-9#1)(2009-8#1)
crucial to the development of##2##5##(2008-11#2)
crucial to the##5##3##(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#1)
crucial to##21##2##(1991-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#3)(2012-2#4)(2012-3#2)
crucial##171##1##(1991-12#2)(1991-2#1)(1992-10#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#4)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#18)(2008-11#15)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#7)(2009-10#4)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#7)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#13)(2011-3#1)(2012-2#10)(2012-3#6)(2012-5#1)(2013-1#9)(2013-8#2)
crucially##2##1##(1994-8#1)(2010-9#1)
crucian carp##8##2##(2008-6#1)(2008-8#1)(2010-5#5)(2010-8#1)
cruciate ligament injuries##2##3##(1990-6#2)
cruciate ligament reconstruction##8##3##(2008-11#3)(2012-2#1)(2013-1#4)
cruciate ligament##23##2##(1990-6#2)(1997-8#2)(2008-11#3)(2009-1#1)(2009-7#1)(2012-2#2)(2012-3#1)(2013-1#11)
crucifer isolates##4##2##(2008-10#4)
crucifer##6##1##(2008-10#6)
cruciferous hosts##5##2##(2008-10#5)
cruciferous plants##3##2##(2008-10#3)
cruciferous##11##1##(2008-10#11)
crucifers##3##1##(2008-10#3)
crude and##2##2##(2008-10#1)(2012-2#1)
crude antigen##2##2##(1996-12#1)(2008-10#1)
crude cell##3##2##(1994-5#1)(2008-10#1)(2012-2#1)
crude cells##2##2##(2008-12#2)
crude culture filtrate and partially purified chlorosis toxin##2##8##(2008-10#2)
crude enzyme##2##2##(2008-6#1)(2010-3#1)
crude ether##2##2##(2008-10#2)
crude extract and##3##3##(2008-11#3)
crude extract of##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
crude extract##12##2##(2008-10#6)(2008-11#5)(2008-12#1)
crude extracts of##3##3##(2008-10#2)(2008-11#1)
crude extracts##7##2##(1995-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-3#1)
crude methanol##2##2##(2008-12#2)
crude oil and##2##3##(2008-10#2)
crude oil refinery wastewater##2##4##(2008-10#2)
crude oil samples##2##3##(2008-10#2)
crude oil##23##2##(2008-10#23)
crude oils##7##2##(2008-10#7)
crude soil extracts##2##3##(2008-10#2)
crude##98##1##(1990-2#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#3)(1996-12#2)(1996-5#1)(1997-7#1)(2008-10#53)(2008-11#10)(2008-12#6)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#3)(2011-2#1)(2012-2#3)(2013-1#1)
crudes##2##1##(2008-10#2)
cruel##2##1##(1993-9#1)(1995-5#1)
cruentata##4##1##(2008-8#4)
cruise##2##1##(2008-10#2)
crural##4##1##(1997-8#1)(2009-9#1)(2011-2#1)(2011-3#1)
crush##3##1##(1991-11#2)(2008-9#1)
crushed##10##1##(2008-10#8)(2013-1#2)
crushing##4##1##(1991-11#1)(2008-10#1)(2008-12#2)
crust##3##1##(2008-10#2)(2013-8#1)
crustacean species##2##2##(1994-11#1)(2008-6#1)
crustacean##9##1##(1990-2#2)(1994-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
crustaceans##11##1##(2007-12#4)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)
cruzi##5##1##(1996-12#3)(2007-12#2)
cry##5##1##(1992-1#1)(1993-6#2)(2008-8#1)(2012-2#1)
cry1Ab gene##5##2##(2008-9#5)
cry1Ab##7##1##(2008-10#1)(2008-9#6)
cryIA(b)##2##1##(2008-10#2)
cryIVB transcription##2##2##(1993-12#2)
cryIVB##6##1##(1993-12#6)
crying##2##1##(2010-4#1)(2011-2#1)
cryo-transmission electron##2##2##(2008-5#2)
cryoablation##2##1##(2011-2#2)
cryofocussing##3##1##(2008-10#3)
cryogel membrane##2##2##(2008-10#2)
cryogenic trap##3##2##(2008-10#3)
cryogenic##11##1##(2008-10#10)(2008-11#1)
cryogenically##2##1##(2008-10#1)(2008-11#1)
cryoglobulinemia##3##1##(2013-1#3)
cryoinjury##2##1##(2010-6#2)
cryopreservation##11##1##(1996-3#1)(1996-8#2)(1997-7#1)(2008-11#4)(2008-9#2)(2011-2#1)
cryopreserved##4##1##(1996-3#1)(2008-11#2)(2008-9#1)
cryoresponsive##3##1##(2008-11#3)
cryostat##3##1##(2008-10#2)(2008-4#1)
cryosurgery##3##1##(1992-1#2)(1996-8#1)
cryptic species##7##2##(2008-10#5)(2010-1#1)(2012-3#1)
cryptic##17##1##(1995-6#1)(1996-12#1)(2008-10#6)(2008-11#2)(2009-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#3)
cryptica##5##1##(2008-10#1)(2010-11#4)
cryptococcal meningitis##3##2##(2011-2#3)
cryptococcosis and##2##2##(2012-3#2)
cryptococcosis in##3##2##(2008-5#3)
cryptococcosis##10##1##(2008-10#1)(2008-5#7)(2012-3#2)
cryptogein-treated tobacco plants##2##3##(2008-10#2)
cryptogenic stroke##2##2##(2008-11#1)(2008-7#1)
cryptogenic##4##1##(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)
cryptorchidism and inguinal hernia##2##4##(2008-10#2)
cryptorchidism##5##1##(2008-10#5)
cryptosporidiosis in##2##2##(1996-12#1)(2008-5#1)
cryptosporidiosis##9##1##(1992-2#1)(1996-11#1)(1996-12#4)(2008-5#2)(2011-2#1)
cryptoviolin##2##1##(1994-5#2)
crystal and a##2##3##(1992-8#1)(2008-2#1)
crystal and the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
crystal and##11##2##(1992-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
crystal as the##2##3##(2008-3#2)
crystal as##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
crystal at##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
crystal by##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
crystal films##2##2##(2008-10#1)(2009-5#1)
crystal for##3##2##(2007-12#2)(2008-10#1)
crystal form I##3##3##(2008-8#3)
crystal form II##2##3##(2008-8#2)
crystal form of##2##3##(1993-8#1)(2008-10#1)
crystal form##12##2##(1992-9#1)(1993-8#1)(2008-10#1)(2008-8#6)(2008-9#3)
crystal forms##3##2##(2008-8#3)
crystal has been##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
crystal has##5##2##(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
crystal in the##2##3##(2008-10#1)(2008-7#1)
crystal in##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2013-8#1)
crystal is##3##2##(1996-5#1)(2008-10#2)
crystal methamphetamine use##2##3##(2013-1#2)
crystal microbalance##27##2##(2008-10#27)
crystal orientation##2##2##(2008-3#2)
crystal packing##2##2##(1993-8#1)(2010-4#1)
crystal properties##2##2##(2008-3#2)
crystal protein-encoding##2##2##(1993-12#2)
crystal sensor array##2##3##(2008-10#2)
crystal size##3##2##(2008-3#1)(2013-8#2)
crystal structure for##2##3##(1994-5#1)(1997-9#1)
crystal structure of a##2##4##(2013-8#2)
crystal structure of allophycocyanin from red algaePorphyra yezoensis##2##8##(2008-8#2)
crystal structure of allophycocyanin from##3##5##(2008-8#3)
crystal structure of the trp##2##5##(1994-3#2)
crystal structure of the##6##4##(1994-12#1)(1994-3#2)(1995-2#1)(2008-8#1)(2013-8#1)
crystal structure of##21##3##(1992-4#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-2#1)(1995-8#1)(2008-8#4)(2008-9#1)(2012-2#2)(2013-8#3)
crystal structure was##2##3##(1992-12#1)(1996-5#1)
crystal structure##33##2##(1991-3#1)(1992-12#2)(1992-4#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#4)(1995-2#1)(1995-8#1)(1996-5#2)(1997-9#1)(2008-8#5)(2008-9#2)(2011-1#1)(2012-2#2)(2013-8#4)
crystal structures of homologous##2##4##(1994-5#2)
crystal structures of##6##3##(1994-5#3)(1996-5#1)(2008-10#1)(2009-8#1)
crystal temperature##3##2##(2007-12#1)(2008-3#2)
crystal to##3##2##(2008-2#2)(2008-3#1)
crystal violet (CV)##2##3##(2008-10#2)
crystal violet and##2##3##(2008-10#2)
crystal violet by##2##3##(2008-10#2)
crystal violet##19##2##(2008-10#17)(2008-11#1)(2008-9#1)
crystal was##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
crystal were measured##2##3##(2008-2#1)(2008-3#1)
crystal with##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
crystal##303##1##(1991-3#1)(1992-12#2)(1992-4#3)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-5#1)(1993-8#4)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#8)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#5)(1997-7#4)(1997-9#1)(2007-11#4)(2007-12#16)(2008-10#99)(2008-11#2)(2008-2#27)(2008-3#60)(2008-5#1)(2008-7#4)(2008-8#16)(2008-9#6)(2009-5#4)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#9)
crystallin##2##1##(1991-6#1)(1993-6#1)
crystalline and cross-linked glucose##2##4##(2008-10#2)
crystalline and##3##2##(2008-10#3)
crystalline silica##3##2##(2008-10#1)(2009-12#2)
crystalline##40##1##(1990-2#1)(1990-3#1)(1990-9#1)(1992-3#1)(1992-9#3)(1993-8#1)(1996-5#3)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#2)(2010-12#1)(2011-3#1)(2012-2#1)
crystallinity##4##1##(2008-7#1)(2010-12#1)(2013-8#2)
crystallisation of##2##2##(1992-9#1)(2008-10#1)
crystallisation##5##1##(1992-9#1)(2008-10#4)
crystallite##2##1##(2009-11#1)(2010-4#1)
crystallites##2##1##(2008-10#2)
crystallization and##2##2##(1995-8#1)(2008-8#1)
crystallization of##2##2##(2008-5#2)
crystallization##9##1##(1995-8#1)(2008-10#4)(2008-5#2)(2008-8#1)(2013-8#1)
crystallized in##4##2##(2008-8#1)(2008-9#3)
crystallized##7##1##(1991-3#1)(1992-4#1)(1996-5#1)(2008-8#1)(2008-9#3)
crystallographic asymmetric unit##2##3##(1992-9#1)(2008-8#1)
crystallographic##19##1##(1990-11#1)(1991-12#2)(1991-3#1)(1992-4#1)(1992-9#1)(1993-8#3)(2008-10#1)(2008-3#1)(2008-8#3)(2008-9#3)(2011-2#1)(2011-3#1)
crystals are##4##2##(1992-9#1)(1995-6#1)(2008-3#1)(2012-2#1)
crystals by##3##2##(2008-10#1)(2008-3#2)
crystals diffract##2##2##(2008-8#2)
crystals have##3##2##(1992-9#2)(2008-9#1)
crystals in##3##2##(2008-10#1)(2008-3#2)
crystals of potassium titanyl phosphate##2##5##(2008-10#2)
crystals of the##3##3##(1992-11#1)(1993-8#1)(2008-10#1)
crystals of##10##2##(1992-11#1)(1992-9#1)(1993-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)
crystals were##3##2##(2008-10#2)(2008-9#1)
crystals##83##1##(1991-11#2)(1992-11#2)(1992-4#1)(1992-8#2)(1992-9#8)(1993-8#1)(1995-3#2)(1995-6#4)(2007-11#2)(2008-10#12)(2008-11#1)(2008-2#5)(2008-3#23)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-5#1)(2009-7#1)(2012-2#1)(2013-8#1)
ctDNA##7##1##(2008-10#7)
ctr-EGR-Xa was##2##2##(1994-5#2)
ctr-EGR-Xa##3##1##(1994-5#3)
cube##2##1##(2008-10#1)(2008-2#1)
cube-corner##3##1##(2008-3#3)
cubense race four##2##3##(2008-10#2)
cubense suggests that##2##3##(2008-10#2)
cubense##14##1##(2008-10#14)
cubensis isolate##2##2##(2008-10#2)
cubensis##13##1##(2008-10#13)
cubes##2##1##(2008-3#1)(2008-6#1)
cubic simplex##2##2##(2008-5#2)
cubic##16##1##(1991-5#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-3#4)(2008-5#4)(2010-3#2)(2010-7#1)
cubital tunnel syndrome##5##3##(2008-12#1)(2008-9#4)
cubitus##2##1##(2009-3#1)(2013-1#1)
cuboidal##2##1##(2008-11#1)(2013-1#1)
cucumber (Cucumis sativus)##4##3##(2008-10#4)
cucumber (Cucumis##5##2##(2008-10#5)
cucumber and##3##2##(2008-10#3)
cucumber crop##2##2##(2008-10#2)
cucumber leaves##4##2##(2008-10#4)
cucumber mosaic cucumovirus (CMV)##2##4##(2008-10#2)
cucumber mosaic cucumovirus##3##3##(2008-10#3)
cucumber mosaic virus (CMV) was##2##5##(2008-10#2)
cucumber mosaic virus (CMV)##4##4##(2008-10#3)(2012-2#1)
cucumber mosaic virus in##2##4##(2008-10#2)
cucumber mosaic virus##10##3##(2008-10#9)(2012-2#1)
cucumber mosaic##13##2##(2008-10#12)(2012-2#1)
cucumber pathogens##4##2##(2008-10#4)
cucumber plants##5##2##(2008-10#5)
cucumber seedlings##3##2##(2008-10#3)
cucumber##77##1##(2008-10#73)(2008-12#1)(2012-2#1)(2013-8#2)
cucumbers##2##1##(2008-10#2)
cucumerinum##4##1##(2008-10#4)
cucumeris)##2##1##(2008-10#2)
cucumovirus##4##1##(2008-10#4)
cucurbit crops##2##2##(2013-8#2)
cucurbit hosts##5##2##(2008-10#5)
cucurbit wilt##2##2##(2008-10#2)
cucurbit yellow stunting disorder virus##3##5##(2008-10#3)
cucurbit yellow vine disease (CYVD)##2##5##(2008-10#2)
cucurbit yellow##5##2##(2008-10#5)
cucurbit##20##1##(2008-10#18)(2013-8#2)
cucurbit-infecting Tobamoviruses##2##2##(2008-10#2)
cucurbit-infecting tobamovirus##2##2##(2008-10#2)
cucurbit-infecting##6##1##(2008-10#6)
cucurbitae PG isozymes##2##3##(2008-10#2)
cucurbitae in##2##2##(2008-10#2)
cucurbitae##9##1##(2008-10#8)(2013-8#1)
cucurbits in##2##2##(2008-10#1)(2013-8#1)
cucurbits##17##1##(2008-10#15)(2013-8#2)
cue and##2##2##(1990-12#1)(2009-8#1)
cue for##2##2##(2008-10#1)(2012-2#1)
cue in##2##2##(1990-12#1)(2008-8#1)
cue levels##2##2##(2013-8#2)
cue was##2##2##(2008-11#1)(2013-8#1)
cue##26##1##(1990-12#4)(2008-10#1)(2008-11#3)(2008-8#5)(2009-6#1)(2009-8#3)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#6)
cue'##2##1##(2008-9#2)
cue-based##4##1##(2007-12#3)(2008-8#1)
cue-paced foot##2##2##(2013-8#2)
cued word generation##2##3##(1996-2#2)
cued##8##1##(1996-2#2)(2008-11#2)(2010-5#4)
cues and##4##2##(2009-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
cues can be##2##3##(2008-6#1)(2008-9#1)
cues of##2##2##(2010-8#2)
cues operate##2##2##(2013-8#2)
cues that##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
cues to##7##2##(2008-11#3)(2008-7#1)(2008-9#1)(2009-10#2)
cues were##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
cues##71##1##(1990-11#1)(1990-12#1)(1991-2#1)(1993-6#2)(1994-3#5)(1994-8#2)(2008-10#1)(2008-11#9)(2008-4#1)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#3)(2009-8#5)(2010-10#3)(2010-8#6)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#9)
cuff of##2##2##(1993-1#1)(2011-2#1)
cuff##15##1##(1991-12#5)(1993-1#1)(1995-1#1)(2008-12#1)(2009-2#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
cuisines##3##1##(2012-2#3)
culinary##6##1##(1994-3#1)(2008-10#1)(2008-12#1)(2012-2#3)
cull##3##1##(1996-3#1)(2008-10#2)
culminate##2##1##(2008-8#1)(2010-9#1)
culminated in##2##2##(2008-11#2)
culminating in the##2##3##(1995-6#1)(2008-7#1)
culminating in##3##2##(1994-6#1)(1995-6#1)(2008-7#1)
culmorum##23##1##(2008-10#23)
culmorum-inoculated##2##1##(2008-10#2)
culprit##2##1##(2010-9#1)(2011-2#1)
cultivar AB 136##3##3##(2008-10#3)
cultivar also##2##2##(2008-10#2)
cultivar and geographical region##2##4##(2008-10#2)
cultivar and geographical##3##3##(2008-10#3)
cultivar and##13##2##(2008-10#12)(2011-10#1)
cultivar had##2##2##(2008-10#2)
cultivar in##2##2##(2008-10#2)
cultivar mixtures##6##2##(2008-10#6)
cultivar of##7##2##(2008-10#7)
cultivar on##3##2##(2008-10#3)
cultivar resistance##3##2##(2008-10#2)(2011-10#1)
cultivar specificity##3##2##(2008-10#3)
cultivar susceptibility##2##2##(2008-10#2)
cultivar susceptible to both##2##4##(2008-10#2)
cultivar was##8##2##(2008-10#8)
cultivar with##3##2##(2008-10#3)
cultivar##179##1##(2008-10#171)(2008-12#1)(2008-9#1)(2011-10#4)(2011-2#1)(2012-2#1)
cultivar-preferential infection by the two genotypes##2##6##(2008-10#2)
cultivars accumulated more mycotoxins##2##4##(2008-10#2)
cultivars after##2##2##(2008-10#2)
cultivars against##2##2##(2008-10#2)
cultivars also##2##2##(2008-10#2)
cultivars and in##4##3##(2008-10#4)
cultivars and isolates##2##3##(2008-10#2)
cultivars and selections##3##3##(2008-10#3)
cultivars and##29##2##(2008-10#27)(2011-2#1)(2013-8#1)
cultivars are##6##2##(2008-10#4)(2008-8#1)(2011-10#1)
cultivars at##4##2##(2008-10#3)(2011-2#1)
cultivars based on##2##3##(2008-10#2)
cultivars by##4##2##(2008-10#3)(2011-2#1)
cultivars carrying##2##2##(2008-10#2)
cultivars containing##2##2##(2008-10#2)
cultivars differing in their##2##4##(2008-10#2)
cultivars differing in##4##3##(2008-10#3)(2008-12#1)
cultivars for##3##2##(2008-10#2)(2009-8#1)
cultivars from the##2##3##(2008-10#2)
cultivars from##5##2##(2008-10#5)
cultivars had##4##2##(2008-10#4)
cultivars have##3##2##(2008-10#3)
cultivars in the greenhouse##2##4##(2008-10#2)
cultivars in the##4##3##(2008-10#4)
cultivars in##11##2##(2008-10#11)
cultivars is##3##2##(2008-10#2)(2008-8#1)
cultivars like##2##2##(2008-10#2)
cultivars of Brassica##2##3##(2008-10#1)(2011-1#1)
cultivars of both##3##3##(2008-10#3)
cultivars of rice##2##3##(2008-10#2)
cultivars of soybean with##2##4##(2008-10#2)
cultivars of soybean##3##3##(2008-10#3)
cultivars of wheat##4##3##(2008-10#4)
cultivars of##27##2##(2008-10#25)(2008-12#1)(2011-1#1)
cultivars or##2##2##(2008-10#2)
cultivars representing##2##2##(2008-10#2)
cultivars resistant to##3##3##(2008-10#3)
cultivars showed##3##2##(2008-10#2)(2011-2#1)
cultivars such as##2##3##(2008-10#2)
cultivars tested were susceptible to##2##5##(2008-10#2)
cultivars tested##6##2##(2008-10#6)
cultivars than in##3##3##(2008-10#3)
cultivars that##6##2##(2008-10#5)(2009-10#1)
cultivars to##4##2##(2008-10#4)
cultivars used##2##2##(2008-10#1)(2008-9#1)
cultivars using##2##2##(2008-10#2)
cultivars was##8##2##(2008-10#8)
cultivars were analyzed##2##3##(2008-10#2)
cultivars were crossed with##2##4##(2008-10#2)
cultivars were evaluated using race##2##5##(2008-10#2)
cultivars were grown##2##3##(2008-10#2)
cultivars were inoculated##2##3##(2008-10#1)(2011-10#1)
cultivars were used as##2##4##(2008-10#1)(2008-12#1)
cultivars were##36##2##(2008-10#32)(2008-12#2)(2011-10#1)(2012-4#1)
cultivars while##2##2##(2008-10#2)
cultivars with different levels of##2##5##(2008-10#2)
cultivars with different##4##3##(2008-10#4)
cultivars with lower##2##3##(2008-10#2)
cultivars with##19##2##(2008-10#17)(2011-10#1)(2012-4#1)
cultivars##413##1##(2008-10#363)(2008-12#14)(2008-8#5)(2008-9#2)(2009-10#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-10#11)(2011-2#9)(2012-4#3)(2013-8#1)
cultivars)##2##1##(2008-10#2)
cultivate##4##1##(2008-11#2)(2008-12#1)(2013-1#1)
cultivated and##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
cultivated areas##2##2##(2008-10#2)
cultivated durum##2##2##(2008-10#2)
cultivated for##2##2##(2008-11#1)(2011-3#1)
cultivated in a##7##3##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)
cultivated in continuous##2##3##(2008-11#1)(2008-12#1)
cultivated in the presence of##2##5##(2008-11#2)
cultivated in the##3##3##(2008-11#3)
cultivated in vitro##2##3##(2008-10#2)
cultivated in##24##2##(2008-10#7)(2008-11#12)(2008-12#1)(2008-5#2)(2008-7#2)
cultivated potatoes in the##2##4##(2008-10#2)
cultivated potatoes##5##2##(2008-10#5)
cultivated rice##5##2##(2009-10#5)
cultivated with##3##2##(2008-10#2)(2008-11#1)
cultivated##88##1##(1993-2#1)(1994-11#1)(1996-1#1)(2008-10#41)(2008-11#20)(2008-12#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#5)(2010-10#1)(2011-3#1)(2012-3#1)(2013-8#4)
cultivating the##2##2##(2008-10#1)(2008-11#1)
cultivating##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
cultivation and##10##2##(2008-10#2)(2008-11#6)(2008-7#1)(2010-7#1)
cultivation conditions##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2013-1#1)
cultivation in the##2##3##(2008-10#1)(2008-11#1)
cultivation in##8##2##(1991-12#1)(2008-10#2)(2008-11#4)(2008-7#1)
cultivation of a##5##3##(2008-11#5)
cultivation of recombinant##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
cultivation of##27##2##(1994-3#1)(1997-7#1)(2008-10#3)(2008-11#17)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
cultivation on##2##2##(2008-10#1)(2008-11#1)
cultivation period##2##2##(2008-11#1)(2011-2#1)
cultivation system##2##2##(2008-11#2)
cultivation temperature##3##2##(2008-11#2)(2011-2#1)
cultivation time##2##2##(2008-10#1)(2008-7#1)
cultivation under##2##2##(2008-11#2)
cultivation vessels##2##2##(2008-11#2)
cultivation was##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
cultivation with##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
cultivation##129##1##(1991-12#1)(1994-3#1)(1995-12#1)(1997-2#2)(1997-7#1)(2008-1#1)(2008-10#25)(2008-11#79)(2008-12#1)(2008-5#1)(2008-7#7)(2008-9#1)(2010-11#2)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
cultivations in##2##2##(2008-10#1)(2008-11#1)
cultivations##10##1##(1993-6#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-7#1)(2011-2#1)
culturable bacteria##4##2##(2008-10#4)
culturable##13##1##(2008-10#10)(2008-7#2)(2008-9#1)
cultural adaptation##2##2##(2013-1#2)
cultural and linguistic##3##3##(1997-2#1)(2013-1#2)
cultural and political##2##3##(2008-1#1)(2008-11#1)
cultural and##10##2##(1997-1#1)(1997-2#1)(2008-1#2)(2008-11#2)(2008-12#1)(2009-10#1)(2013-1#2)
cultural appropriateness##2##2##(2010-4#2)
cultural aspects##3##2##(1993-11#1)(2011-2#1)(2012-12#1)
cultural awareness##2##2##(2008-11#2)
cultural beliefs##5##2##(2009-10#5)
cultural change process##2##3##(1994-1#2)
cultural change##3##2##(1994-1#2)(2008-11#1)
cultural competence in##2##3##(2008-1#1)(2008-12#1)
cultural competence##5##2##(2008-1#2)(2008-11#1)(2008-12#2)
cultural dimensions##2##2##(1997-3#1)(2012-12#1)
cultural diversity issues##2##3##(1997-2#2)
cultural diversity##8##2##(1996-1#2)(1997-2#2)(2008-11#2)(2012-12#1)(2012-2#1)
cultural heritage##5##2##(2008-10#4)(2008-11#1)
cultural influences##2##2##(2008-1#2)
cultural issues##3##2##(1995-1#1)(2008-1#2)
cultural needs##2##2##(2008-1#1)(2008-11#1)
cultural norms##2##2##(2008-1#1)(2008-11#1)
cultural objects##2##2##(2008-10#2)
cultural orientations were##2##3##(2011-2#2)
cultural orientations##3##2##(2011-2#3)
cultural perspectives##2##2##(2009-6#2)
cultural practices have##2##3##(2008-10#2)
cultural practices##5##2##(2008-1#1)(2008-10#4)
cultural values and##2##3##(2008-1#1)(2013-8#1)
cultural values##6##2##(2008-1#3)(2008-11#1)(2009-10#1)(2013-8#1)
cultural##135##1##(1990-3#1)(1991-11#1)(1993-11#1)(1994-1#2)(1995-1#2)(1995-12#1)(1995-5#1)(1996-1#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#1)(2008-1#18)(2008-10#23)(2008-11#17)(2008-12#7)(2008-5#2)(2008-8#1)(2009-10#10)(2009-3#1)(2009-6#2)(2010-1#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#4)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#1)
culturally appropriate care##2##3##(2013-8#2)
culturally appropriate##5##2##(2008-6#1)(2010-9#1)(2011-1#1)(2013-8#2)
culturally competent##2##2##(1997-2#1)(2010-8#1)
culturally diverse##5##2##(1997-2#2)(2008-1#1)(2008-7#1)(2012-2#1)
culturally relevant##3##2##(1992-2#1)(2009-5#1)(2012-3#1)
culturally sensitive##4##2##(2008-1#1)(2008-9#1)(2010-9#1)(2011-1#1)
culturally##28##1##(1992-2#1)(1997-2#4)(2008-1#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#2)
culture additive##2##2##(2008-11#2)
culture also##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
culture and from##2##3##(2008-11#1)(2012-2#1)
culture and gender##2##3##(2008-11#1)(2011-2#1)
culture and in##3##3##(1993-12#1)(1997-7#1)(2008-10#1)
culture and the##7##3##(1997-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2012-2#1)
culture and##50##2##(1993-11#2)(1993-12#1)(1994-1#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#7)(2008-11#22)(2008-12#3)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#1)
culture are##4##2##(1992-5#1)(2008-11#2)(2008-7#1)
culture as the##2##3##(2008-11#1)(2008-5#1)
culture as##5##2##(2008-11#2)(2008-5#1)(2008-9#1)(2010-8#1)
culture assay##2##2##(2008-11#1)(2011-2#1)
culture assays##4##2##(2008-5#1)(2008-9#1)(2011-2#2)
culture at 37 degrees C##2##5##(1995-2#1)(2008-11#1)
culture at a##2##3##(2008-10#1)(2008-11#1)
culture at the##3##3##(1995-8#1)(2008-11#1)(2008-5#1)
culture at##8##2##(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-5#1)
culture broth of Hericium erinaceus##2##5##(2008-11#2)
culture broth##3##2##(2008-11#2)(2008-6#1)
culture but##3##2##(1994-1#1)(1995-6#1)(2008-10#1)
culture by##7##2##(2008-10#1)(2008-11#5)(2008-12#1)
culture collections##4##2##(2008-10#4)
culture condition##6##2##(2008-11#5)(2008-5#1)
culture conditions and##4##3##(1991-5#1)(2008-10#1)(2008-11#1)(2011-1#1)
culture conditions for maintaining##2##4##(2008-11#2)
culture conditions for##6##3##(2008-11#6)
culture conditions that##2##3##(1996-12#1)(2008-11#1)
culture conditions to##2##3##(2008-11#2)
culture conditions were##2##3##(2008-11#1)(2010-5#1)
culture conditions##31##2##(1990-12#1)(1991-5#1)(1993-12#1)(1996-12#2)(2008-10#2)(2008-11#19)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)
culture confirmed##2##2##(2008-1#1)(2008-11#1)
culture could be##2##3##(2008-11#1)(2008-7#1)
culture could##4##2##(2008-11#3)(2008-7#1)
culture did not##3##3##(2008-10#1)(2008-11#2)
culture dish##4##2##(2008-11#4)
culture dishes##3##2##(1995-11#1)(2008-11#2)
culture engineering##3##2##(2008-11#3)
culture exhibited##2##2##(2008-11#1)(2009-6#1)
culture experiment##3##2##(1996-2#1)(1996-8#1)(2008-8#1)
culture experiments##6##2##(1990-12#1)(2008-11#2)(2008-5#3)
culture filtrate of RC-2##3##4##(2008-10#3)
culture filtrate of##5##3##(2008-10#5)
culture filtrate##11##2##(2008-10#10)(2008-8#1)
culture filtrates of##6##3##(2008-10#5)(2008-11#1)
culture filtrates##12##2##(2008-10#11)(2008-11#1)
culture flasks##2##2##(2008-11#2)
culture fluid##2##2##(1995-2#1)(2008-10#1)
culture fluids##2##2##(1995-2#1)(2008-10#1)
culture for##12##2##(2008-10#2)(2008-11#8)(2008-7#1)(2008-9#1)
culture has been##2##3##(2008-11#1)(2008-9#1)
culture in a##2##3##(1995-2#1)(2008-11#1)
culture in the##4##3##(2008-11#3)(2008-6#1)
culture in##21##2##(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#12)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
culture is##11##2##(2008-11#5)(2008-4#1)(2008-8#2)(2010-6#1)(2012-2#2)
culture material##4##2##(2008-5#4)
culture matrix##3##2##(2008-11#1)(2011-2#2)
culture may be##4##3##(2008-11#2)(2008-4#2)
culture may##5##2##(1991-2#1)(2008-11#2)(2008-4#2)
culture media was##2##3##(2008-10#1)(2008-11#1)
culture media##32##2##(1991-5#1)(1992-5#1)(1992-8#1)(1996-12#2)(2008-10#10)(2008-11#10)(2008-6#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-8#1)
culture medium and##5##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
culture medium composition##2##3##(2008-11#2)
culture medium of##5##3##(1995-12#1)(1995-6#1)(1997-1#1)(2009-3#2)
culture medium was##5##3##(1994-8#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#1)
culture medium##69##2##(1990-8#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#28)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2010-10#1)(2010-4#1)(2011-2#3)(2013-1#2)
culture method##6##2##(2008-11#1)(2008-12#1)(2009-6#1)(2012-2#3)
culture methodology##2##2##(2008-11#2)
culture methods##2##2##(2008-10#1)(2008-7#1)
culture mode##5##2##(2008-11#5)
culture model##5##2##(1995-9#2)(1996-12#1)(2008-5#1)(2009-3#1)
culture modes##2##2##(2008-11#2)
culture of CHO##2##3##(2008-11#2)
culture of Chinese hamster ovary cells##2##6##(2008-11#2)
culture of Chinese hamster ovary##3##5##(2008-11#3)
culture of a##2##3##(2008-11#1)(2008-7#1)
culture of human hematopoietic cells##3##5##(2008-11#3)
culture of human##5##3##(2008-11#4)(2008-9#1)
culture of mammalian cells##2##4##(2008-11#2)
culture of rat##2##3##(2008-11#1)(2008-9#1)
culture of recombinant##2##3##(2008-7#2)
culture of the##7##3##(1994-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-6#1)(2012-3#1)
culture of##73##2##(1991-2#1)(1993-8#2)(1994-1#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#1)(2008-10#3)(2008-11#40)(2008-2#1)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-12#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
culture on##5##2##(2008-11#3)(2008-8#1)(2009-11#1)
culture or##7##2##(2008-10#2)(2008-11#3)(2009-4#1)(2011-2#1)
culture parameters##2##2##(2008-11#2)
culture period##10##2##(2008-11#10)
culture plate##3##2##(2008-10#2)(2008-8#1)
culture plates##6##2##(2008-10#1)(2008-11#4)(2011-2#1)
culture procedure##2##2##(2008-4#2)
culture process##6##2##(2008-11#5)(2008-9#1)
culture processes##9##2##(2008-11#9)
culture production##3##2##(2008-11#3)
culture redox potential##2##3##(2008-11#2)
culture results##4##2##(2008-11#2)(2012-2#1)(2013-1#1)
culture samples##4##2##(2008-11#3)(2010-6#1)
culture showed##2##2##(2008-11#2)
culture solution##4##2##(2010-3#4)
culture supernatant##8##2##(1990-8#1)(1992-12#1)(1993-9#1)(2008-10#2)(2008-11#3)
culture supernatants##10##2##(1990-12#1)(1990-2#1)(1995-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2011-3#1)
culture supernates##2##2##(2008-7#2)
culture surface##2##2##(2008-11#1)(2012-5#1)
culture system for##4##3##(2008-10#1)(2008-11#2)(2009-12#1)
culture system of##2##3##(2008-11#1)(2012-12#1)
culture system was##2##3##(2008-11#1)(2008-8#1)
culture system were##2##3##(1992-3#1)(2008-10#1)
culture system with##2##3##(2008-10#1)(2008-11#1)
culture system##34##2##(1990-10#1)(1992-3#2)(1993-12#1)(2008-10#5)(2008-11#16)(2008-7#2)(2008-8#1)(2009-12#3)(2010-6#1)(2012-12#1)(2012-2#1)
culture systems##14##2##(2008-11#8)(2008-5#1)(2008-8#2)(2009-8#1)(2012-3#2)
culture technique##3##2##(2008-10#1)(2008-11#2)
culture techniques##3##2##(2008-11#2)(2008-7#1)
culture technologies##2##2##(2008-11#1)(2011-3#1)
culture technology##2##2##(2008-11#2)
culture temperature##4##2##(2008-11#3)(2008-7#1)
culture than##2##2##(2008-11#2)
culture the##4##2##(1992-5#2)(2008-10#1)(2008-11#1)
culture time##2##2##(1993-8#1)(2008-11#1)
culture to##8##2##(2008-10#2)(2008-11#5)(2011-2#1)
culture under##6##2##(2008-10#1)(2008-11#5)
culture using a##2##3##(2008-11#1)(2008-7#1)
culture using##8##2##(2008-11#6)(2008-7#2)
culture viability##2##2##(2008-11#2)
culture volume##3##2##(2008-11#2)(2008-7#1)
culture was##23##2##(1996-8#1)(2008-11#14)(2008-6#2)(2008-7#4)(2008-8#1)(2011-2#1)
culture were compared##2##3##(2008-11#2)
culture were studied##2##3##(1996-2#1)(2008-11#1)
culture were##8##2##(1994-2#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#4)
culture where##2##2##(2008-11#1)(2008-7#1)
culture with##9##2##(1996-12#1)(1997-1#1)(2008-11#6)(2010-6#1)
culture without##2##2##(2008-11#2)
culture##1122##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-8#3)(1991-11#1)(1991-2#2)(1991-5#3)(1992-12#1)(1992-3#2)(1992-5#4)(1992-6#1)(1992-8#2)(1993-11#4)(1993-12#7)(1993-3#3)(1993-6#2)(1993-8#5)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-6#1)(1994-8#7)(1995-11#3)(1995-12#7)(1995-2#8)(1995-3#3)(1995-6#3)(1995-8#6)(1995-9#2)(1996-1#1)(1996-12#11)(1996-2#3)(1996-6#1)(1996-8#2)(1997-1#7)(1997-3#5)(1997-7#3)(2006-6#1)(2008-1#2)(2008-10#119)(2008-11#585)(2008-12#11)(2008-2#3)(2008-4#14)(2008-5#25)(2008-6#6)(2008-7#52)(2008-8#24)(2008-9#26)(2009-10#2)(2009-11#1)(2009-12#8)(2009-3#5)(2009-4#1)(2009-6#6)(2009-7#3)(2009-8#3)(2010-10#3)(2010-11#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#28)(2011-3#2)(2012-12#1)(2012-2#18)(2012-3#9)(2012-5#2)(2013-1#11)(2013-8#3)
culture)##2##1##(2008-5#1)(2008-9#1)
culture-based##3##1##(1991-9#1)(2008-10#1)(2011-2#1)
culture-dependent##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
culture-derived##2##1##(2008-10#1)(2008-11#1)
culture-independent##4##1##(2008-10#2)(2011-2#1)(2012-2#1)
culture-negative##5##1##(1993-12#1)(1993-2#1)(1996-11#2)(2011-2#1)
culture-positive##4##1##(2008-10#1)(2010-6#3)
cultured and##5##2##(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#2)
cultured animal cells##2##3##(2008-4#1)(2008-9#1)
cultured at##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
cultured bovine aortic endothelial cells##4##5##(1990-12#2)(1991-5#1)(1993-8#1)
cultured cell##3##2##(1993-8#1)(1995-6#1)(2008-8#1)
cultured cells in##2##3##(1992-12#1)(2008-11#1)
cultured cells of##2##3##(2008-10#1)(2008-11#1)
cultured cells were##3##3##(2008-11#1)(2008-6#1)(2009-12#1)
cultured cells with##3##3##(1994-11#1)(1995-12#1)(2008-4#1)
cultured cells##40##2##(1990-12#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#2)(2008-1#1)(2008-10#4)(2008-11#17)(2008-4#2)(2008-6#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
cultured cumulus##2##2##(2008-9#2)
cultured fibroblasts##6##2##(1990-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(2008-4#1)(2008-5#1)
cultured for 6 days##2##4##(1995-8#2)
cultured for##8##2##(1993-3#1)(1995-11#1)(1995-8#2)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
cultured from the##3##3##(1991-3#1)(1997-1#1)(2008-5#1)
cultured from##6##2##(1991-2#1)(1991-3#1)(1997-1#2)(2008-5#1)(2013-8#1)
cultured guinea pig chief cells##2##5##(1995-8#2)
cultured hippocampal neurons by##2##4##(1995-2#1)(1996-12#1)
cultured hippocampal neurons##4##3##(1995-2#1)(1996-12#1)(1997-7#2)
cultured human cells##2##3##(1994-3#1)(2008-11#1)
cultured human osteoblast-like cells##2##4##(2008-11#2)
cultured human skin fibroblasts were##2##5##(2008-5#2)
cultured human skin fibroblasts##6##4##(1991-12#1)(2008-5#5)
cultured human##24##2##(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#1)(1993-3#1)(1994-3#2)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#5)(2008-5#7)
cultured in HG##3##3##(1992-8#3)
cultured in MS##2##3##(2008-12#2)
cultured in a##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
cultured in an##2##3##(2008-11#1)(2008-4#1)
cultured in both suspension and monolayer##2##6##(2008-11#2)
cultured in monolayer##4##3##(2008-11#3)(2008-5#1)
cultured in serum-free medium##2##4##(2008-11#2)
cultured in suspension##5##3##(2008-11#5)
cultured in the medium containing##2##5##(2008-11#2)
cultured in the presence of##7##5##(2008-11#5)(2008-4#1)(2011-3#1)
cultured in the##13##3##(2008-11#10)(2008-4#1)(2011-3#1)(2012-2#1)
cultured in vitro##4##3##(2008-4#1)(2008-7#1)(2008-9#1)(2010-6#1)
cultured in##75##2##(1992-8#4)(1993-12#1)(1994-3#2)(1995-8#1)(1996-2#1)(2006-6#1)(2008-10#2)(2008-11#39)(2008-12#3)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-4#2)(2013-1#1)
cultured mammalian cells##4##3##(1991-5#1)(2008-1#1)(2008-4#1)(2008-9#1)
cultured myoblasts##2##2##(1997-1#2)
cultured neonatal rat##3##3##(1993-3#1)(1995-11#2)
cultured neonatal##4##2##(1993-3#1)(1993-6#1)(1995-11#2)
cultured neurons##3##2##(2008-11#2)(2012-2#1)
cultured on a##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
cultured on the##5##3##(1993-3#1)(2008-11#4)
cultured on##27##2##(1993-3#2)(1995-2#1)(2008-10#2)(2008-11#15)(2008-5#3)(2008-7#1)(2008-9#2)(2012-5#1)
cultured osteoblast##2##2##(2008-11#2)
cultured primary##3##2##(1996-12#1)(2011-2#1)(2013-1#1)
cultured rat##9##2##(1990-12#1)(1992-6#1)(1993-8#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-7#1)
cultured shoot##2##2##(2008-8#2)
cultured skin fibroblasts##2##3##(1995-8#1)(2008-5#1)
cultured spermatogenic cysts##2##3##(2012-2#2)
cultured together##2##2##(2006-6#1)(2008-10#1)
cultured under##8##2##(1992-8#1)(2008-11#4)(2008-9#1)(2011-2#1)(2012-4#1)
cultured with the##2##3##(2008-11#1)(2011-3#1)
cultured with##15##2##(1993-3#2)(1993-8#1)(1995-12#1)(2008-11#7)(2008-6#1)(2011-3#1)(2013-1#1)(2013-8#1)
cultured##347##1##(1990-12#4)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#6)(1992-12#1)(1992-6#3)(1992-8#5)(1993-12#3)(1993-3#11)(1993-6#2)(1993-8#5)(1994-11#6)(1994-12#1)(1994-3#5)(1994-6#1)(1994-8#1)(1995-11#8)(1995-12#6)(1995-2#2)(1995-6#2)(1995-8#6)(1996-12#3)(1996-2#5)(1997-1#7)(1997-3#1)(1997-7#2)(2006-6#2)(2008-1#2)(2008-10#18)(2008-11#113)(2008-12#3)(2008-2#1)(2008-4#9)(2008-5#18)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#15)(2009-12#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#10)(2011-3#2)(2012-2#6)(2012-3#1)(2012-4#3)(2012-5#2)(2013-1#8)(2013-8#2)
culturedin##2##1##(2008-11#1)(2008-8#1)
cultures and organotypic slices##2##4##(2009-9#2)
cultures and##24##2##(2008-10#5)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#2)(2010-8#2)(2011-2#1)(2012-3#1)
cultures are##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
cultures as##2##2##(2011-1#1)(2012-4#1)
cultures at 37 degrees C##2##5##(1995-12#1)(2008-5#1)
cultures at the##3##3##(2008-11#1)(2008-7#2)
cultures at##9##2##(1995-12#1)(2008-11#3)(2008-5#2)(2008-7#3)
cultures but##2##2##(1992-3#1)(2008-11#1)
cultures by##8##2##(1995-8#1)(2008-10#1)(2008-11#5)(2010-8#1)
cultures can##2##2##(2008-11#2)
cultures carrying##2##2##(2008-7#2)
cultures compared to##2##3##(1995-12#1)(2013-1#1)
cultures containing##2##2##(2008-11#1)(2008-8#1)
cultures for##8##2##(2008-11#2)(2008-5#4)(2009-1#1)(2012-3#1)
cultures from##7##2##(1993-12#1)(2008-11#3)(2008-5#2)(2010-8#1)
cultures grown in##4##3##(2008-11#1)(2008-7#3)
cultures grown##5##2##(2008-11#1)(2008-7#4)
cultures has##2##2##(2008-11#1)(2008-6#1)
cultures have been##2##3##(2008-11#2)
cultures in order to##2##4##(2008-11#1)(2008-7#1)
cultures in the##2##3##(2008-10#1)(2008-11#1)
cultures in which##2##3##(2008-10#1)(2008-11#1)
cultures in##17##2##(1993-2#1)(2008-10#2)(2008-11#10)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
cultures incubated##3##2##(2008-11#3)
cultures infected##3##2##(2008-11#2)(2008-7#1)
cultures is##5##2##(1995-9#1)(2008-11#3)(2008-7#1)
cultures obtained from##3##3##(1990-8#1)(1995-11#1)(2010-6#1)
cultures of a##3##3##(2008-11#3)
cultures of human##6##3##(1991-5#1)(1993-3#2)(2008-11#3)
cultures of mouse##4##3##(1990-5#1)(1994-2#2)(2008-11#1)
cultures of porcine##2##3##(1995-12#1)(2008-11#1)
cultures of rat hepatocytes##2##4##(1990-5#1)(2008-11#1)
cultures of rat##4##3##(1990-5#1)(1995-11#1)(2008-11#1)(2008-7#1)
cultures of the##10##3##(1993-9#1)(1994-8#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2011-2#1)
cultures of##78##2##(1990-12#1)(1990-5#2)(1991-5#3)(1992-3#2)(1992-6#1)(1993-3#2)(1993-9#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-8#2)(1996-2#3)(1997-3#1)(2008-10#9)(2008-11#29)(2008-4#1)(2008-5#1)(2008-7#5)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
cultures on##2##2##(1995-9#1)(2008-10#1)
cultures or##2##2##(2008-10#1)(2008-11#1)
cultures remained##2##2##(2008-11#1)(2008-5#1)
cultures represent##2##2##(2008-11#2)
cultures showed a##2##3##(1993-8#1)(2011-2#1)
cultures showed##3##2##(1993-8#1)(2008-11#1)(2011-2#1)
cultures stimulated with##2##3##(1994-8#1)(1995-12#1)
cultures that were##2##3##(2007-12#1)(2008-10#1)
cultures that##5##2##(2007-12#1)(2008-10#2)(2008-11#2)
cultures to 1##2##3##(1990-11#1)(1994-3#1)
cultures to##8##2##(1990-11#1)(1994-3#1)(2008-11#1)(2009-6#1)(2010-4#2)(2010-6#1)(2013-1#1)
cultures treated with##2##3##(2008-10#1)(2008-7#1)
cultures using##4##2##(2008-11#4)
cultures was more##2##3##(1995-12#1)(2008-10#1)
cultures was##11##2##(1994-3#1)(1995-12#1)(2008-10#4)(2008-11#4)(2013-1#1)
cultures were negative##2##3##(2007-12#1)(2008-5#1)
cultures were obtained##2##3##(2007-12#1)(2008-7#1)
cultures were positive for##2##4##(2013-1#2)
cultures were positive##4##3##(2008-5#2)(2013-1#2)
cultures were prepared from##2##4##(1994-2#1)(2008-5#1)
cultures were##37##2##(1993-8#1)(1994-2#1)(1995-12#1)(1996-2#1)(2007-12#2)(2008-10#6)(2008-11#14)(2008-12#1)(2008-5#4)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#2)
cultures which##2##2##(1995-11#1)(2008-11#1)
cultures with a##2##3##(2008-10#1)(2008-2#1)
cultures with elevated Fis##2##4##(2008-7#2)
cultures with##20##2##(1990-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#9)(2008-2#1)(2008-7#2)(2011-1#1)(2013-1#1)
cultures##579##1##(1990-11#6)(1990-12#1)(1990-4#1)(1990-5#5)(1990-8#2)(1991-5#5)(1992-3#5)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#7)(1994-3#5)(1994-8#2)(1995-1#1)(1995-11#7)(1995-12#11)(1995-6#2)(1995-8#4)(1995-9#2)(1996-12#4)(1996-2#10)(1997-1#2)(1997-3#1)(1997-8#1)(2007-12#3)(2008-10#61)(2008-11#268)(2008-12#2)(2008-2#2)(2008-4#7)(2008-5#27)(2008-6#1)(2008-7#33)(2008-8#1)(2008-9#6)(2009-1#1)(2009-12#3)(2009-6#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-4#3)(2010-6#5)(2010-8#9)(2010-9#1)(2011-1#3)(2011-2#9)(2012-2#6)(2012-3#4)(2012-4#4)(2013-1#11)(2013-8#5)
cultures)##5##1##(2008-10#2)(2008-11#3)
culturing of##4##2##(1996-12#1)(2008-11#3)
culturing porcine##2##2##(1992-8#1)(2008-11#1)
culturing the cells##2##3##(1993-8#1)(2008-11#1)
culturing the##3##2##(1993-8#1)(2008-11#1)(2008-8#1)
culturing##26##1##(1992-5#1)(1992-8#1)(1993-8#1)(1996-12#1)(2008-11#14)(2008-4#1)(2008-8#1)(2008-9#4)(2010-6#1)(2011-2#1)
cumana##3##1##(2008-10#3)
cumbersome and##2##2##(1991-3#1)(2008-12#1)
cumbersome##11##1##(1991-3#1)(1992-8#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
cumulant##2##1##(2008-2#1)(2013-8#1)
cumulative bleeding##2##2##(2008-7#2)
cumulative disease incidence between##2##4##(2008-10#2)
cumulative dose of##2##3##(1991-6#1)(2011-2#1)
cumulative effect##3##2##(2008-10#1)(2010-10#1)(2012-12#1)
cumulative effects of##4##3##(2008-12#1)(2008-6#1)(2008-8#1)(2012-5#1)
cumulative effects##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-5#1)
cumulative genetic##2##2##(1995-12#1)(2010-10#1)
cumulative incidence##3##2##(2008-11#3)
cumulative mortality##2##2##(2008-10#1)(2011-2#1)
cumulative precipitation##2##2##(2008-10#2)
cumulative risk##2##2##(1992-2#1)(2009-10#1)
cumulative spore deposition##2##3##(2008-10#2)
cumulative##90##1##(1990-12#1)(1991-6#1)(1992-2#1)(1992-9#3)(1993-11#1)(1995-12#1)(1995-9#1)(2008-10#30)(2008-11#8)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#4)(2011-3#3)(2012-12#2)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#1)
cumulatively##2##1##(1994-11#1)(2009-8#1)
cumulus cells##3##2##(2008-9#2)(2013-1#1)
cumulus##7##1##(2008-3#1)(2008-9#3)(2013-1#3)
cup##10##1##(1991-1#1)(2008-10#6)(2012-2#1)(2012-3#1)(2013-1#1)
cupferron##4##1##(2008-10#4)
cupric oxide##2##2##(2013-1#2)
cupric##6##1##(2008-10#3)(2013-1#2)(2013-8#1)
cuprolinic##2##1##(1993-12#2)
cuprorivaite (Egyptian blue)##2##3##(2008-10#2)
cups##8##1##(1996-3#1)(2008-10#7)
curable##6##1##(1993-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-7#2)
curative resection##2##2##(2011-2#2)
curative surgery##4##2##(1996-11#1)(1997-7#1)(1997-8#2)
curative therapies##2##2##(2008-5#1)(2013-1#1)
curative treatment for##2##3##(1997-8#1)(2012-3#1)
curative treatment of colorectal liver metastases##2##6##(2012-3#2)
curative treatment##5##2##(1996-11#1)(1997-8#1)(2012-3#3)
curative##32##1##(1990-11#1)(1992-12#1)(1992-6#2)(1993-3#1)(1993-9#1)(1994-2#1)(1996-11#2)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#4)(2008-1#1)(2008-5#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
curators##2##1##(2008-4#2)
curcumin and##2##2##(1994-8#1)(2008-10#1)
curcumin or turmeric##3##3##(1994-8#3)
curcumin was##3##2##(2011-2#3)
curcumin##20##1##(1994-8#4)(2008-10#3)(2008-11#5)(2011-2#7)(2012-3#1)
curcumin-induced##3##1##(2011-2#3)
cure for AIDS##2##3##(1995-12#1)(1995-6#1)
cure for##4##2##(1995-12#1)(1995-6#1)(2008-10#1)(2010-11#1)
cure in about##2##3##(2010-12#1)(2011-2#1)
cure in##5##2##(2008-5#2)(2010-12#1)(2011-2#2)
cure of##6##2##(1991-1#1)(1991-5#1)(1992-12#1)(1996-3#1)(2008-5#1)(2011-2#1)
cure rate##3##2##(2008-1#1)(2008-7#2)
cure rates##2##2##(1992-6#1)(2010-6#1)
cure the##2##2##(2011-2#1)(2012-3#1)
cure to##2##2##(2010-11#2)
cure##51##1##(1991-1#1)(1991-5#1)(1992-12#2)(1992-6#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-5#4)(2008-7#8)(2008-8#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#5)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)
cured after##2##2##(2008-10#1)(2013-1#1)
cured by##6##2##(1995-6#1)(1996-11#1)(1996-9#2)(2007-8#1)(2011-2#1)
cured in##2##2##(1994-9#1)(2010-8#1)
cured of the##2##3##(2008-10#2)
cured of##4##2##(2008-1#1)(2008-10#2)(2012-12#1)
cured or improved##2##3##(1994-9#1)(2008-5#1)
cured or##4##2##(1994-9#1)(2008-5#1)(2010-4#1)(2010-6#1)
cured with##4##2##(1991-9#1)(2008-7#1)(2011-2#1)(2011-3#1)
cured##36##1##(1991-9#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-9#3)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-5#4)(2008-7#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#1)
cures##3##1##(1995-10#1)(2008-5#1)(2010-1#1)
curettage and##2##2##(2010-3#1)(2012-12#1)
curettage##9##1##(1992-12#1)(1992-2#1)(1993-12#1)(1995-3#1)(1995-8#2)(2009-4#1)(2010-3#1)(2012-12#1)
curette##5##1##(1992-12#3)(1992-2#1)(2008-12#1)
curettes##2##1##(1992-12#1)(2010-3#1)
curing##8##1##(1991-9#1)(2008-10#4)(2011-2#2)(2013-1#1)
curiosity##3##1##(1996-11#1)(2008-5#1)(2009-10#1)
curious about##2##2##(2008-12#1)(2009-9#1)
curious##3##1##(2008-12#1)(2009-9#1)(2011-2#1)
curl##67##1##(2008-10#64)(2008-9#2)(2010-1#1)
curled##4##1##(2008-10#4)
curly top virus (BCTV)##2##4##(2008-10#2)
curly top virus##13##3##(2008-10#13)
curly top##14##2##(2008-10#14)
currency##5##1##(1992-3#1)(2008-11#2)(2008-8#1)(2008-9#1)
current &quot##2##2##(2008-10#1)(2012-2#1)
current HIV##2##2##(1997-6#1)(2008-4#1)
current analysis##2##2##(1994-6#1)(2010-12#1)
current and emerging##2##3##(2008-10#1)(2008-6#1)
current and former##2##3##(1995-12#1)(2010-8#1)
current and future directions##2##4##(2008-11#1)(2008-12#1)
current and future##9##3##(1994-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#1)(2009-9#1)(2010-5#1)(2013-1#1)
current and potential##4##3##(1994-12#1)(1996-3#1)(1997-1#1)(2008-11#1)
current and the##4##3##(2008-10#4)
current and##41##2##(1992-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-6#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-3#1)(2013-1#1)
current applications##3##2##(1993-12#2)(2008-11#1)
current approaches to##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
current approaches##5##2##(1997-1#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)
current article##2##2##(2011-2#1)(2013-8#1)
current as##2##2##(2008-10#1)(2008-3#1)
current asthma##2##2##(2008-10#2)
current at##3##2##(2008-10#3)
current body##2##2##(2008-12#1)(2009-8#1)
current by##4##2##(1992-12#1)(1995-11#1)(2008-10#1)(2008-8#1)
current case##3##2##(2008-12#1)(2010-10#1)(2013-1#1)
current challenges##3##2##(1994-2#1)(2008-11#1)(2010-7#1)
current clinical##4##2##(2008-11#1)(2008-2#1)(2010-5#1)(2012-2#1)
current coders##2##2##(2007-12#2)
current concepts of##2##3##(2008-7#1)(2013-1#1)
current concepts##3##2##(1997-1#1)(2008-7#1)(2013-1#1)
current data regarding##2##3##(1997-2#1)(2010-6#1)
current data##7##2##(1997-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#2)(2013-8#1)
current debate##2##2##(2008-10#1)(2008-11#1)
current debates##3##2##(1997-2#1)(2010-4#1)(2010-8#1)
current demands##2##2##(1997-2#1)(2008-12#1)
current density##6##2##(2008-10#4)(2008-11#1)(2009-10#1)
current drop##2##2##(2008-10#2)
current epidemiological##2##2##(2008-10#1)(2008-11#1)
current events##2##2##(2011-2#2)
current evidence##8##2##(2008-11#2)(2008-5#1)(2010-1#1)(2010-3#1)(2012-2#1)(2013-1#2)
current experimental##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
current federal##2##2##(1991-2#1)(2010-9#1)
current findings##4##2##(2008-10#1)(2009-10#1)(2013-8#2)
current for the##2##3##(2008-10#2)
current for##5##2##(2008-10#5)
current formulations##2##2##(1992-3#1)(1996-1#1)
current government and professional##2##4##(2008-11#1)(2008-12#1)
current guidelines##3##2##(2008-11#1)(2009-10#1)(2010-12#1)
current had##4##2##(2008-10#4)
current health care##2##3##(1996-3#1)(1997-3#1)
current health##6##2##(1993-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-7#1)
current hospital##2##2##(1991-1#1)(1992-2#1)
current hypotheses##3##2##(2008-10#1)(2011-1#2)
current ideas##2##2##(1993-6#1)(2008-3#1)
current in##3##2##(1993-12#1)(2008-10#1)(2013-1#1)
current increased##3##2##(2008-10#3)
current insights##2##2##(2011-2#2)
current interest##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
current is##17##2##(2008-10#16)(2008-8#1)
current issues##5##2##(1990-2#1)(1993-2#1)(1996-6#1)(2008-11#1)(2012-2#1)
current knowledge about##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
current knowledge of the##4##4##(1996-3#1)(2008-5#1)(2008-7#2)
current knowledge of##8##3##(1996-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#1)
current knowledge on the##4##4##(2008-1#1)(2008-5#1)(2009-4#1)(2011-7#1)
current knowledge on##8##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2011-7#1)
current knowledge regarding##2##3##(2008-11#1)(2012-2#1)
current knowledge##25##2##(1996-3#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#3)
current lack of##2##3##(2010-5#1)(2012-2#1)
current laws and practices continue##2##5##(1993-3#1)(1996-2#1)
current levels##2##2##(1997-2#1)(2008-9#1)
current limitations##2##2##(2008-10#1)(2008-3#1)
current literature and##3##3##(2012-2#1)(2013-1#2)
current literature on the##2##4##(1995-12#1)(2008-11#1)
current literature on##3##3##(1995-12#1)(2008-11#1)(2011-2#1)
current literature##16##2##(1995-12#1)(1997-8#1)(2008-11#2)(2008-7#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
current management of##2##3##(2008-1#1)(2013-1#1)
current management##6##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-6#1)(2013-1#1)
current medical##3##2##(1992-8#1)(2008-10#1)(2008-7#1)
current medication##2##2##(2010-1#1)(2011-1#1)
current members of##2##3##(1996-3#2)
current methodology##2##2##(2008-10#1)(2008-6#1)
current methods for##2##3##(2008-11#1)(2011-3#1)
current methods of##3##3##(1997-7#1)(2008-11#2)
current methods##9##2##(1997-7#1)(2008-11#4)(2008-12#1)(2008-8#1)(2011-3#1)(2013-1#1)
current model##2##2##(2008-4#1)(2011-2#1)
current models##2##2##(1995-5#1)(2013-8#1)
current noninvasive##2##2##(2010-11#1)(2013-1#1)
current nursing##3##2##(1991-2#1)(2008-12#2)
current obtained##4##2##(2008-10#4)
current of glucose##2##3##(2008-10#2)
current of the##6##3##(2008-10#5)(2012-3#1)
current of##26##2##(2008-10#21)(2008-3#1)(2008-8#1)(2010-7#1)(2011-3#1)(2012-3#1)
current on##2##2##(2008-10#1)(2009-12#1)
current opinions##2##2##(2008-10#1)(2012-3#1)
current or##5##2##(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
current paper##5##2##(1997-3#1)(2010-10#1)(2010-3#1)(2012-2#2)
current perspectives##3##2##(1991-2#1)(2008-11#1)(2010-8#1)
current plasma##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
current policy##7##2##(1995-6#1)(1996-2#3)(2008-11#1)(2011-1#1)(2012-3#1)
current political##2##2##(2008-11#2)
current practice and##2##3##(2008-11#1)(2008-7#1)
current practice in##2##3##(2008-10#1)(2008-7#1)
current practice of##4##3##(1991-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
current practice##14##2##(1991-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
current practices##2##2##(1996-2#1)(2013-8#1)
current problems##3##2##(1991-2#1)(1997-8#1)(2008-10#1)
current progress##2##2##(1990-11#1)(2011-3#1)
current pulse##3##2##(2008-10#2)(2008-3#1)
current recommendations##8##2##(1995-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2009-5#1)(2010-7#1)
current reproduction##6##2##(2008-8#6)
current research##11##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2012-2#2)
current response##8##2##(2008-10#7)(2009-10#1)
current responses##2##2##(1996-2#1)(2008-10#1)
current results##4##2##(2007-12#1)(2008-10#1)(2010-12#1)(2010-6#1)
current review##4##2##(2008-10#1)(2010-1#1)(2012-2#1)(2013-8#1)
current risk-reducing##2##2##(1993-12#2)
current sample##2##2##(2008-10#1)(2012-2#1)
current scientific evidence##2##3##(2011-2#1)(2013-1#1)
current scientific##4##2##(1994-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
current service##2##2##(1991-3#1)(1994-1#1)
current signals##4##2##(2008-10#4)
current situation##3##2##(1991-11#1)(1991-3#1)(2012-12#1)
current smokers##3##2##(1994-6#1)(1996-3#1)(2008-11#1)
current smoking##2##2##(1992-6#1)(2013-1#1)
current standard##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
current state of the art##2##5##(1994-8#1)(2008-10#1)
current state of the##6##4##(1994-8#1)(1994-9#1)(1997-4#1)(2008-10#1)(2009-5#1)(2009-7#1)
current state of##21##3##(1994-8#1)(1994-9#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#2)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
current state##24##2##(1994-8#1)(1994-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#2)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
current state-of-the-art##2##2##(1991-1#1)(2011-7#1)
current status and future##2##4##(1997-3#1)(2012-3#1)
current status and##4##3##(1995-1#1)(1997-3#1)(2011-7#1)(2012-3#1)
current status of the##2##4##(1997-3#2)
current status of##18##3##(1994-12#1)(1997-3#2)(2008-10#2)(2008-11#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-7#1)(2012-12#1)(2013-1#3)(2013-8#1)
current status##28##2##(1994-12#1)(1995-1#1)(1997-3#4)(2008-10#2)(2008-11#2)(2008-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-7#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
current stimulation##6##2##(2008-11#1)(2010-7#3)(2012-2#2)
current studies##7##2##(1993-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-12#1)
current study was##5##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#2)
current study##51##2##(1995-2#1)(2008-10#12)(2008-11#6)(2008-5#3)(2009-10#1)(2009-7#2)(2010-1#2)(2010-11#1)(2010-6#3)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#5)
current surgical##2##2##(1997-8#1)(2008-11#1)
current system of radiation protection##2##5##(2008-12#2)
current system##4##2##(1992-3#1)(2008-12#2)(2008-6#1)
current technology##2##2##(2008-11#1)(2011-1#1)
current theories of##3##3##(1997-6#1)(2008-10#1)(2010-9#1)
current theories##4##2##(1997-6#1)(2008-10#2)(2010-9#1)
current theory##4##2##(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)
current therapies##2##2##(2012-2#1)(2013-1#1)
current therapy##2##2##(2008-11#1)(2010-1#1)
current thinking##2##2##(2009-8#1)(2010-11#1)
current through##3##2##(2008-9#2)(2009-5#1)
current to##2##2##(2008-10#2)
current treatment strategies##2##3##(2008-11#1)(2010-12#1)
current treatment##4##2##(1995-12#1)(2008-11#2)(2010-12#1)
current trends in##3##3##(1993-1#1)(1996-3#1)(2012-7#1)
current trends##4##2##(1993-1#1)(1995-1#1)(1996-3#1)(2012-7#1)
current understanding of the##5##4##(2008-7#2)(2009-12#1)(2012-2#1)(2013-8#1)
current understanding of##11##3##(2008-10#3)(2008-11#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
current usage and##2##3##(2008-11#1)(2012-2#1)
current use of##5##3##(2008-11#2)(2008-4#1)(2011-2#1)(2013-8#1)
current versus concentration##2##3##(2008-10#2)
current was proportional to the concentration of##2##7##(2008-10#2)
current was##13##2##(1990-5#1)(1992-8#1)(1993-3#1)(2008-10#8)(2008-12#1)(2011-2#1)
current with##6##2##(1991-5#1)(2008-10#4)(2008-7#1)
current work##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)
current##1030##1##(1990-11#2)(1990-2#2)(1990-5#4)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#7)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#9)(1992-2#4)(1992-3#5)(1992-6#2)(1992-8#6)(1993-1#3)(1993-12#5)(1993-2#3)(1993-3#5)(1993-6#2)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#8)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1996-1#7)(1996-12#3)(1996-2#10)(1996-3#10)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#7)(1997-2#6)(1997-3#12)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2007-12#4)(2008-1#7)(2008-10#285)(2008-11#86)(2008-12#25)(2008-2#3)(2008-3#21)(2008-4#12)(2008-5#11)(2008-6#8)(2008-7#21)(2008-8#26)(2008-9#15)(2009-1#2)(2009-10#8)(2009-12#5)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#8)(2009-8#4)(2009-9#2)(2010-1#8)(2010-10#9)(2010-11#6)(2010-12#16)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#10)(2010-6#11)(2010-7#9)(2010-8#6)(2010-9#6)(2011-1#7)(2011-2#35)(2011-3#7)(2011-7#4)(2012-12#7)(2012-2#41)(2012-3#26)(2012-7#1)(2013-1#32)(2013-8#26)
current)##4##1##(2008-10#3)(2008-8#1)
current-potential response##2##2##(2008-10#2)
current-voltage##2##1##(2008-7#1)(2010-7#1)
currently accepted##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
currently approved##2##2##(2008-10#1)(2010-12#1)
currently available clinical data##2##4##(2010-11#1)(2013-1#1)
currently available for the##3##4##(2008-11#1)(2008-5#1)(2009-1#1)
currently available for##6##3##(2008-11#1)(2008-2#1)(2008-5#1)(2009-1#1)(2010-3#1)(2011-2#1)
currently available in##2##3##(1992-1#1)(2008-10#1)
currently available is##2##3##(1992-12#1)(1994-9#1)
currently available methods##2##3##(2008-10#1)(2011-3#1)
currently available to##2##3##(1994-2#1)(2008-10#1)
currently available##43##2##(1992-1#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-3#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
currently being developed##2##3##(2008-10#1)(2008-9#1)
currently being implemented##2##3##(2008-11#1)(2008-12#1)
currently being used##6##3##(1990-2#1)(1994-2#1)(2008-10#2)(2010-12#1)(2010-6#1)
currently being##26##2##(1990-2#1)(1992-2#1)(1992-3#1)(1994-2#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-3#2)(2013-1#1)(2013-8#1)
currently causing##2##2##(1993-12#1)(2008-10#1)
currently comprise##3##2##(1994-3#2)(2009-10#1)
currently considered##2##2##(2008-10#1)(2011-2#1)
currently depressed adolescents##2##3##(2008-11#2)
currently employed##8##2##(1991-12#2)(2008-10#4)(2008-11#1)(2012-2#1)
currently found##2##2##(2008-10#1)(2008-11#1)
currently in clinical trials##2##4##(1993-8#1)(2009-4#1)
currently in clinical use or in clinical trials##2##8##(2008-5#2)
currently in clinical##4##3##(1993-8#1)(2008-5#2)(2009-4#1)
currently in use##2##3##(2008-10#1)(2009-7#1)
currently in##15##2##(1993-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2009-4#1)(2009-7#1)(2010-1#1)(2011-2#1)
currently is##2##2##(2008-10#2)
currently known##2##2##(2009-8#1)(2012-2#1)
currently limiting the##2##3##(2008-7#1)(2013-8#1)
currently much##2##2##(2008-10#1)(2008-8#1)
currently no##5##2##(1996-1#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
currently not##6##2##(1992-12#1)(2008-1#1)(2011-2#2)(2011-3#1)(2012-3#1)
currently of##2##2##(1997-7#1)(2008-10#1)
currently on the##2##3##(1997-2#1)(2009-6#1)
currently the most##5##3##(1991-3#1)(1996-1#2)(2008-10#2)
currently the##7##2##(1991-3#1)(1996-1#2)(2008-10#2)(2011-2#1)(2013-1#1)
currently under development##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
currently under##8##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-3#1)(2011-3#1)(2013-1#1)
currently unknown##3##2##(1995-6#1)(1997-1#1)(2010-10#1)
currently use##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
currently used for##5##3##(1992-12#1)(2008-10#1)(2010-11#2)(2010-7#1)
currently used in the##2##4##(2008-10#2)
currently used in##8##3##(1994-8#1)(2008-10#3)(2008-7#1)(2010-1#1)(2010-11#1)(2012-3#1)
currently used toxicity##2##3##(2008-10#2)
currently used##30##2##(1992-12#1)(1994-1#1)(1994-8#1)(1995-2#1)(2008-10#11)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
currently well##2##2##(2008-10#1)(2011-2#1)
currently##283##1##(1990-2#1)(1990-6#2)(1991-1#1)(1991-12#3)(1991-3#1)(1991-8#1)(1992-1#2)(1992-12#4)(1992-2#3)(1992-3#1)(1993-12#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#5)(1996-2#4)(1996-3#1)(1997-1#2)(1997-2#3)(1997-3#5)(1997-5#1)(1997-6#2)(1997-7#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#56)(2008-11#28)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#7)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#2)(2011-1#2)(2011-2#18)(2011-3#7)(2012-12#2)(2012-2#11)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#2)
currents and the##2##3##(2008-10#1)(2008-8#1)
currents and##9##2##(1991-2#1)(2008-10#6)(2008-8#2)
currents are##6##2##(2008-10#5)(2008-11#1)
currents as well as##2##4##(1992-8#1)(2008-10#1)
currents at##2##2##(1997-2#1)(2009-7#1)
currents by ATPgammaS##2##3##(1996-2#2)
currents by##4##2##(1992-8#1)(1996-2#2)(2013-1#1)
currents evoked by##2##3##(1995-11#2)
currents evoked##5##2##(1995-11#3)(1997-2#2)
currents had##2##2##(1995-2#1)(2008-10#1)
currents in##9##2##(1992-8#2)(1993-3#2)(1995-2#1)(1996-2#1)(2008-10#1)(2009-10#1)(2010-12#1)
currents measured at##2##3##(2008-10#2)
currents of##7##2##(1995-2#1)(1996-2#2)(2008-10#4)
currents on the##2##3##(2008-10#1)(2009-12#1)
currents similar to those##2##4##(2008-10#1)(2011-2#1)
currents than##3##2##(1991-2#1)(2008-10#2)
currents through##2##2##(1995-11#1)(2013-1#1)
currents to##2##2##(1992-3#1)(2008-10#1)
currents were observed##2##3##(1993-3#1)(2008-10#1)
currents were##8##2##(1993-3#1)(1994-11#1)(2008-10#6)
currents##115##1##(1991-2#2)(1992-3#1)(1992-8#5)(1993-3#4)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#10)(1995-2#5)(1996-12#1)(1996-2#7)(1996-5#1)(1997-2#3)(2008-10#47)(2008-11#5)(2008-3#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#3)(2009-7#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
curricula and##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
curricula in the##2##3##(1997-3#1)(2008-12#1)
curricula in##3##2##(1997-3#1)(2008-12#2)
curricula of##3##2##(1996-1#1)(2008-11#1)(2011-2#1)
curricula##35##1##(1991-1#1)(1994-1#1)(1994-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#2)(2008-10#1)(2008-11#10)(2008-12#10)(2011-2#4)(2012-3#1)
curricular##8##1##(1996-2#3)(1997-3#1)(2008-11#1)(2009-8#1)(2012-2#2)
curriculum and##5##2##(1996-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
curriculum based on##2##3##(1992-1#1)(2008-12#1)
curriculum change##2##2##(1996-3#1)(2009-8#1)
curriculum content##2##2##(1996-3#2)
curriculum design##2##2##(2008-11#1)(2008-12#1)
curriculum development##3##2##(2008-11#2)(2009-8#1)
curriculum for##2##2##(2008-11#1)(2008-12#1)
curriculum has##4##2##(2008-11#3)(2013-1#1)
curriculum in##4##2##(1994-3#1)(2008-11#1)(2013-1#2)
curriculum inquiry and##2##3##(1993-2#2)
curriculum is a##2##3##(2008-11#1)(2011-2#1)
curriculum is##6##2##(1993-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
curriculum of Greek medical schools##2##5##(2011-2#2)
curriculum of##6##2##(1996-8#1)(2009-6#1)(2011-2#4)
curriculum planning##2##2##(2008-12#2)
curriculum was##2##2##(2008-11#2)
curriculum##125##1##(1991-1#1)(1992-1#1)(1992-3#1)(1993-1#5)(1993-2#6)(1994-1#2)(1994-12#5)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#5)(1996-8#1)(1997-2#2)(1997-3#3)(2008-1#1)(2008-10#7)(2008-11#38)(2008-12#20)(2008-3#2)(2009-6#1)(2009-8#2)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#3)
curse of##3##2##(1991-9#1)(2008-7#1)(2013-1#1)
curse##4##1##(1991-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
curtail##3##1##(1996-2#1)(2008-10#2)
curtailed##4##1##(1993-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
curtailing##3##1##(1992-8#1)(2008-2#1)(2008-8#1)
curtovirus##6##1##(2008-10#6)
curtoviruses##2##1##(2008-10#2)
curvature and##4##2##(1997-2#1)(2012-2#1)(2013-1#2)
curvature of rice root##2##4##(2008-9#2)
curvature of the##2##3##(2008-3#1)(2013-1#1)
curvature of##6##2##(2008-2#1)(2008-3#1)(2008-9#3)(2013-1#1)
curvature##25##1##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-9#5)(2009-2#3)(2009-9#1)(2012-2#3)(2013-1#5)
curvatures##2##1##(2008-3#1)(2008-9#1)
curvatus##4##1##(1996-6#4)
curve (AUC) of##2##3##(2008-7#1)(2012-3#1)
curve (AUC)##5##2##(1994-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
curve analyses##5##2##(2008-12#1)(2009-7#1)(2012-12#1)(2012-2#2)
curve analysis##4##2##(2008-10#3)(2009-11#1)
curve and the##2##3##(2008-10#2)
curve and##14##2##(1994-9#1)(2007-8#1)(2008-10#8)(2008-7#1)(2008-9#2)(2013-1#1)
curve as##2##2##(1995-3#1)(2008-10#1)
curve based on##2##3##(2008-10#1)(2013-1#1)
curve by##7##2##(1997-2#1)(2008-10#5)(2008-9#1)
curve covered##2##2##(2008-10#2)
curve fitting##6##2##(2008-10#6)
curve for the##2##3##(1995-8#1)(2008-10#1)
curve for##19##2##(1990-11#1)(1995-8#2)(1996-2#2)(2008-10#11)(2008-11#1)(2011-2#2)
curve from 1##2##3##(2008-10#2)
curve from##4##2##(1994-12#1)(2008-10#2)(2008-12#1)
curve in the##6##3##(2008-10#5)(2009-10#1)
curve in##10##2##(1995-3#1)(2008-10#7)(2009-10#1)(2012-2#1)
curve is linear in the range##2##6##(2008-10#2)
curve is linear in the##3##5##(2008-10#3)
curve is linear over the concentration range##4##7##(2008-10#4)
curve is linear over the##5##5##(2008-10#5)
curve is linear over##9##4##(2008-10#9)
curve is linear##16##3##(2008-10#16)
curve is##27##2##(1995-9#1)(2008-10#24)(2008-11#1)(2008-6#1)
curve method##2##2##(2008-10#2)
curve obtained by##2##3##(2008-10#2)
curve obtained in the##2##4##(2007-8#1)(2008-10#1)
curve obtained##5##2##(2007-8#1)(2008-10#4)
curve of the##4##3##(2007-8#1)(2008-10#3)
curve of##19##2##(1992-8#1)(2007-8#1)(2008-10#11)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
curve over##3##2##(2008-10#3)
curve resolution methods##2##3##(2008-10#2)
curve resolution##3##2##(2008-10#3)
curve shape##2##2##(1995-9#1)(2008-11#1)
curve techniques##2##2##(2008-10#1)(2013-1#1)
curve that##2##2##(2008-10#1)(2008-6#1)
curve to##4##2##(1994-11#1)(1996-3#1)(1997-2#1)(2008-10#1)
curve was affected mainly by initial conditions##2##7##(2008-10#2)
curve was found##2##3##(2008-7#1)(2012-2#1)
curve was linear from##3##4##(2008-10#3)
curve was linear in the concentration range of##2##8##(2008-10#2)
curve was linear in the concentration range##3##7##(2008-10#3)
curve was linear in the##6##5##(2008-10#6)
curve was linear##23##3##(2008-10#23)
curve was obtained##7##3##(2008-10#7)
curve was##56##2##(2008-10#53)(2008-7#2)(2012-2#1)
curve with##6##2##(2008-10#6)
curve##330##1##(1990-11#1)(1991-5#1)(1992-8#3)(1992-9#1)(1994-11#3)(1994-12#2)(1994-9#3)(1995-3#6)(1995-8#3)(1995-9#2)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#2)(2007-8#8)(2008-10#229)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#3)(2009-7#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#2)
curve) of##2##2##(2008-10#1)(2010-8#1)
curve)##5##1##(2008-10#3)(2010-10#1)(2010-8#1)
curved##10##1##(2008-10#2)(2008-2#1)(2008-3#5)(2009-5#1)(2011-2#1)
curves and##7##2##(2007-8#1)(2008-10#4)(2008-5#1)(2013-8#1)
curves are##11##2##(1994-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2009-7#1)
curves between##3##2##(2008-10#1)(2008-7#1)(2009-3#1)
curves corresponded##2##2##(2008-7#1)(2008-8#1)
curves drawn with zero-to-peak values##2##5##(2008-10#2)
curves for the##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
curves for##18##2##(1993-8#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-7#4)(2012-2#1)
curves in##6##2##(2008-10#4)(2010-11#2)
curves obtained##6##2##(1996-2#1)(2008-10#2)(2008-5#1)(2011-2#2)
curves of##18##2##(1992-12#1)(1993-1#2)(1995-1#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-5#2)
curves showed##5##2##(2008-10#4)(2011-2#1)
curves to a##2##3##(2008-5#1)(2008-7#1)
curves to##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
curves using##2##2##(2008-10#2)
curves were constructed##3##3##(2008-10#3)
curves were drawn##2##3##(2008-10#2)
curves were generated for##2##4##(2008-10#2)
curves were linear in##4##4##(2008-10#4)
curves were linear##9##3##(2008-10#9)
curves were obtained for##3##4##(2008-10#3)
curves were obtained in##2##4##(2008-10#1)(2008-7#1)
curves were obtained##7##3##(2008-10#6)(2008-7#1)
curves were##37##2##(1997-8#1)(2008-10#31)(2008-11#1)(2008-7#2)(2013-1#1)(2013-8#1)
curves with the##2##3##(1995-3#1)(2008-7#1)
curves with##5##2##(1995-3#1)(2008-10#3)(2008-7#1)
curves##214##1##(1991-2#1)(1992-12#1)(1992-9#1)(1993-1#2)(1993-8#2)(1994-11#1)(1994-5#1)(1995-1#2)(1995-3#3)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#134)(2008-11#6)(2008-2#2)(2008-3#1)(2008-5#12)(2008-7#11)(2008-8#4)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#3)
curves)##2##1##(2008-10#2)
curvilinear relationship##2##2##(2008-10#1)(2008-7#1)
curvilinear##5##1##(1991-7#1)(2008-10#1)(2008-6#1)(2008-7#2)
cushions##3##1##(2008-10#2)(2009-3#1)
custodial work##3##2##(1991-12#3)
custodial workers##2##2##(1991-12#2)
custodial##6##1##(1991-12#6)
custodians of the##2##3##(1991-12#1)(2010-4#1)
custodians##6##1##(1991-12#5)(2010-4#1)
custody##7##1##(2008-1#1)(2010-1#6)
custom made##3##2##(2008-10#1)(2013-1#2)
custom software##2##2##(2008-10#1)(2012-2#1)
custom##19##1##(1992-3#1)(1993-9#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#3)
custom-designed##3##1##(2008-3#1)(2009-9#1)(2012-2#1)
custom-made##3##1##(2008-10#3)
customary charges##2##2##(1991-12#2)
customary##4##1##(1991-12#2)(1991-2#1)(2008-10#1)
customer satisfaction##3##2##(1991-2#1)(1992-1#1)(1994-3#1)
customer service##6##2##(1991-1#1)(1993-1#1)(1995-1#3)(1995-12#1)
customer value##2##2##(1994-12#1)(2013-8#1)
customer##25##1##(1991-1#1)(1991-2#1)(1992-1#3)(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#4)(1994-3#2)(1995-1#3)(1995-12#1)(1996-1#2)(2008-11#1)(2013-8#1)
customer-supplier dialogue##2##2##(1994-3#2)
customer-supplier##3##1##(1994-1#1)(1994-3#2)
customers and##2##2##(1994-12#2)
customers with special needs##2##4##(2012-3#2)
customers##22##1##(1992-1#1)(1992-3#1)(1993-1#2)(1993-12#1)(1994-1#4)(1994-12#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#1)(2012-3#2)
customers'##7##1##(1992-1#4)(1993-12#1)(1994-2#1)(1994-3#1)
customisable##2##1##(2011-3#2)
customize##3##1##(1993-11#1)(1996-1#1)(2008-10#1)
customized##6##1##(1993-1#1)(2008-10#2)(2008-5#1)(2011-7#1)(2013-1#1)
customs##2##1##(2008-11#1)(2011-2#1)
cut across##2##2##(2008-3#1)(2010-12#1)
cut and##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
cut as##2##2##(2007-12#1)(2008-10#1)
cut at the##5##3##(2007-12#1)(2008-3#1)(2008-9#3)
cut costs##2##2##(1997-1#1)(2008-9#1)
cut down##2##2##(2008-10#1)(2011-2#1)
cut from##4##2##(2009-7#1)(2010-4#2)(2011-2#1)
cut in##2##2##(2008-10#1)(2008-9#1)
cut null##2##2##(2008-9#2)
cut off##7##2##(1993-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
cut scores##5##2##(2008-12#2)(2012-2#3)
cut to##2##2##(2008-11#1)(2011-3#1)
cut##71##1##(1990-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(2007-12#2)(2008-10#9)(2008-11#3)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#11)(2009-6#1)(2009-7#2)(2010-12#1)(2010-4#3)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#1)
cut-flower roses##2##2##(2008-10#2)
cut-flower##3##1##(2008-10#3)
cut-off points##3##2##(1992-12#1)(1995-9#1)(2008-10#1)
cut-off value##4##2##(1992-11#1)(1996-12#1)(2010-5#1)(2012-3#1)
cut-off values for##2##3##(2011-1#2)
cut-off values##5##2##(1994-12#1)(1994-3#1)(2011-1#3)
cut-off##21##1##(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-12#1)(2008-10#5)(2008-6#1)(2010-5#1)(2011-1#3)(2012-3#1)(2013-1#2)
cut-offs##2##1##(1997-2#1)(2008-10#1)
cutaneous ageing##2##2##(2008-5#2)
cutaneous allodynia##2##2##(2008-9#2)
cutaneous and##2##2##(2008-5#1)(2013-1#1)
cutaneous angiomyolipoma##3##2##(2010-6#3)
cutaneous candidosis##3##2##(2008-5#3)
cutaneous homeostasis##2##2##(2008-5#1)(2012-2#1)
cutaneous infections##2##2##(2008-5#1)(2012-3#1)
cutaneous involvement##2##2##(1990-8#1)(2010-6#1)
cutaneous lesions##8##2##(2008-5#5)(2012-3#2)(2013-8#1)
cutaneous lymphoma##3##2##(2008-5#3)
cutaneous manifestation##2##2##(2010-6#1)(2013-1#1)
cutaneous melanoma##5##2##(1996-6#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-2#1)
cutaneous melanomas##3##2##(1994-6#1)(2009-4#2)
cutaneous metastases from##2##3##(1990-8#1)(2010-6#1)
cutaneous metastases##8##2##(1990-8#1)(2010-6#3)(2013-8#4)
cutaneous metastasis##2##2##(2010-11#1)(2010-6#1)
cutaneous nerve##4##2##(1997-3#1)(2008-9#3)
cutaneous or##2##2##(1997-3#1)(2012-3#1)
cutaneous pigmentation##2##2##(1995-2#2)
cutaneous vasculitis##2##2##(1997-4#1)(2008-8#1)
cutaneous##126##1##(1990-6#1)(1990-8#2)(1990-9#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#2)(1996-11#2)(1996-6#1)(1997-3#3)(1997-4#1)(2008-10#5)(2008-11#1)(2008-5#37)(2008-7#2)(2008-8#3)(2008-9#7)(2009-1#1)(2009-4#3)(2009-8#1)(2010-11#1)(2010-6#15)(2011-2#4)(2012-2#4)(2012-3#10)(2013-1#4)(2013-8#7)
cutanée##2##1##(2008-5#1)(2013-1#1)
cuticle Col##2##2##(1993-12#2)
cuticle and wax##2##3##(2008-10#2)
cuticle and##8##2##(2008-10#6)(2008-7#1)(2008-9#1)
cuticle components##2##2##(2009-8#2)
cuticle degradation##2##2##(2008-10#1)(2008-7#1)
cuticle was##2##2##(2008-10#2)
cuticle##42##1##(1993-12#4)(2007-12#4)(2008-10#17)(2008-5#2)(2008-7#10)(2008-9#1)(2009-8#4)
cuticular fingers##2##2##(2008-7#2)
cuticular hydrocarbons##9##2##(2008-9#5)(2012-3#3)(2013-8#1)
cuticular wax##2##2##(2008-10#2)
cuticular##26##1##(2007-12#8)(2008-10#3)(2008-5#2)(2008-7#2)(2008-9#6)(2012-3#3)(2013-8#2)
cutinase family##2##2##(2009-6#2)
cutinase in##2##2##(2008-10#1)(2008-7#1)
cutinase##9##1##(1995-3#1)(2008-10#1)(2008-7#5)(2009-6#2)
cutis as the##2##3##(2010-6#2)
cutis is##4##2##(2010-6#4)
cutis laxa##2##2##(2008-5#1)(2008-7#1)
cutis##11##1##(2008-5#1)(2008-7#1)(2010-6#9)
cutoff in microstructured optical fibers##2##5##(2007-11#2)
cutoff of##3##2##(1997-2#1)(1997-4#1)(2008-10#1)
cutoff point##4##2##(2008-11#1)(2012-2#3)
cutoff points##2##2##(2012-3#2)
cutoff##17##1##(1993-11#1)(1997-2#1)(1997-4#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2011-3#1)(2012-2#3)(2012-3#2)
cutoffs for##2##2##(2012-3#2)
cutoffs##3##1##(2008-12#1)(2012-3#2)
cutpoint##2##1##(2008-10#2)
cuts and##2##2##(1996-3#1)(2008-11#1)
cuts in##4##2##(1995-5#1)(1997-2#1)(2008-11#1)(2013-8#1)
cuts##20##1##(1991-9#1)(1992-12#1)(1993-5#1)(1995-12#1)(1995-5#2)(1996-3#1)(1996-5#2)(1997-2#1)(2008-11#3)(2008-3#3)(2008-5#1)(2009-3#1)(2013-1#1)(2013-8#1)
cutthroat trout##2##2##(2010-8#2)
cutting##17##1##(1990-9#1)(1992-6#1)(1994-1#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#2)(2011-2#2)
cutting-edge##2##1##(1997-1#1)(2012-2#1)
cuttings (physiological age##2##3##(2008-10#2)
cuttings of##2##2##(1990-8#1)(2008-10#1)
cuttings was##2##2##(2008-10#2)
cuttings were##2##2##(2008-10#2)
cuttings##12##1##(1990-8#1)(2008-10#10)(2012-4#1)
cuvette##4##1##(2008-10#4)
cuvettes##2##1##(2008-10#2)
cv##204##1##(1990-5#1)(1995-6#2)(1996-12#1)(2008-10#187)(2008-11#1)(2008-12#3)(2008-8#2)(2008-9#7)
cvs##43##1##(2008-10#43)
cw CO(2) laser##2##3##(2008-3#2)
cw CO(2)##3##2##(2008-3#3)
cw and pulsed##2##3##(2008-2#1)(2008-3#1)
cw laser##10##2##(2008-2#4)(2008-3#6)
cw output power##2##3##(2008-2#2)
cw photothermal##2##2##(2008-3#2)
cw power performance##2##3##(2008-2#2)
cw##40##1##(2007-11#2)(2007-12#2)(2008-2#14)(2008-3#22)
cyanate##2##1##(2008-10#2)
cyanex##4##1##(2008-10#4)
cyanide activity in##2##3##(2008-10#2)
cyanide and##4##2##(2008-10#4)
cyanide complexes##2##2##(1993-8#1)(2008-10#1)
cyanide concentration##2##2##(2008-10#2)
cyanide gas is##2##3##(2008-10#2)
cyanide gas##5##2##(2008-10#5)
cyanide in##3##2##(2008-10#3)
cyanide insensitive Acyl CoA oxidase##2##5##(1990-12#2)
cyanide ion##3##2##(2008-10#3)
cyanide is##3##2##(2008-10#3)
cyanide or##2##2##(1993-8#1)(2008-11#1)
cyanide solution##2##2##(2008-10#2)
cyanide was##2##2##(2008-10#2)
cyanide with##4##2##(2008-10#4)
cyanide##69##1##(1990-12#2)(1991-5#1)(1992-12#2)(1993-8#4)(1994-5#2)(1996-12#1)(2008-10#55)(2008-11#1)(2008-7#1)
cyanides##3##1##(2008-10#3)
cyanine R##2##2##(2008-10#2)
cyanine dye##3##2##(2008-10#3)
cyanine dyes##2##2##(2008-10#2)
cyanine##11##1##(2008-10#11)
cyano propyl stationary phase##4##4##(2008-10#4)
cyano propyl stationary##5##3##(2008-10#5)
cyano##8##1##(1996-5#1)(2008-10#7)
cyanoacrylate##4##1##(2008-10#1)(2008-5#2)(2008-7#1)
cyanobacteria##10##1##(1990-11#2)(1996-12#1)(2008-10#4)(2009-4#1)(2011-2#1)(2013-1#1)
cyanobacterial##14##1##(1990-11#3)(1994-6#2)(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
cyanobacterium Anabaena sp##2##3##(2008-8#2)
cyanobacterium Anabaena##3##2##(2008-11#1)(2008-8#2)
cyanobacterium Synechococcus sp##2##3##(1996-6#2)
cyanobacterium Synechococcus##3##2##(1996-6#2)(2013-1#1)
cyanobacterium Synechocystis sp##5##3##(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)
cyanobacterium##16##1##(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-6#4)(2008-11#1)(2008-8#3)(2013-1#1)
cyanocopolymer##3##1##(2008-10#3)
cyanogen bromide peptide##2##3##(1990-8#1)(2008-10#1)
cyanogen bromide##6##2##(1990-5#2)(1990-8#1)(1994-5#1)(2008-10#1)(2008-9#1)
cyanogen##7##1##(1990-5#2)(1990-8#1)(1994-5#1)(2008-10#1)(2008-9#1)(2010-4#1)
cyanopropyl##2##1##(2008-10#2)
cyanthiwigin##4##1##(2009-12#4)
cyanthiwigins##2##1##(2009-12#2)
cycad toxicity##2##2##(1994-11#2)
cycad##6##1##(1994-11#6)
cyclamate by an##2##3##(2008-10#2)
cyclamate in the##2##3##(2008-10#2)
cyclamate##5##1##(2008-10#5)
cyclamen leaves##2##2##(2008-10#2)
cyclamen##7##1##(2008-10#7)
cyclandelate##7##1##(1994-8#7)
cyclase activation##2##2##(1993-6#1)(1994-8#1)
cyclase activities##2##2##(1995-11#1)(1997-7#1)
cyclase activity in##4##3##(1990-8#2)(1994-11#1)(1994-3#1)
cyclase activity##9##2##(1990-8#4)(1992-6#1)(1994-11#3)(1994-3#1)
cyclase in##3##2##(1995-2#1)(1997-1#2)
cyclase##38##1##(1990-8#5)(1992-6#1)(1993-6#3)(1994-11#3)(1994-3#1)(1994-8#3)(1995-11#7)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#3)(1997-2#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)
cycle analysis##12##2##(1997-1#1)(2008-11#5)(2008-9#6)
cycle and mating behavior of Zygotylenchus guevarai##2##7##(2008-12#2)
cycle and the##3##3##(2008-10#2)(2011-3#1)
cycle and##21##2##(1994-5#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-5#1)(2008-9#1)(2010-1#2)(2011-2#2)(2011-3#2)(2012-3#1)
cycle are##4##2##(1992-3#1)(2008-10#1)(2008-2#1)(2011-3#1)
cycle arrest##19##2##(1991-5#1)(1997-1#1)(1997-3#2)(1997-7#5)(2008-11#4)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
cycle as##2##2##(1993-8#1)(2008-10#1)
cycle based on##2##3##(2009-9#1)(2010-7#1)
cycle by##3##2##(1994-3#1)(1997-1#1)(2012-2#1)
cycle caused##2##2##(2008-10#1)(2008-2#1)
cycle control##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
cycle during##3##2##(2008-7#1)(2009-8#1)(2012-3#1)
cycle frequency##3##2##(2010-4#3)
cycle from##2##2##(1994-3#1)(2008-12#1)
cycle genes##4##2##(2008-10#3)(2010-7#1)
cycle has##3##2##(1995-2#1)(1996-2#1)(2013-1#1)
cycle in the##3##3##(1996-3#1)(2008-10#1)(2012-2#1)
cycle in##16##2##(1990-5#1)(1993-8#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-8#1)
cycle is##5##2##(1993-9#1)(2008-1#1)(2008-10#2)(2011-2#1)
cycle may##2##2##(1993-11#1)(2008-10#1)
cycle of the seminiferous epithelium##3##5##(2009-10#3)
cycle of the##15##3##(1991-9#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-6#2)(2009-10#3)(2011-2#1)(2013-8#1)
cycle of##46##2##(1991-9#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2010-1#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
cycle on##3##2##(2008-11#1)(2012-2#2)
cycle phase##8##2##(2008-11#7)(2008-9#1)
cycle ratio##4##2##(2008-3#4)
cycle that##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
cycle threshold##2##2##(2008-10#2)
cycle time of##3##3##(2008-10#1)(2008-11#2)
cycle time##5##2##(1993-12#1)(2008-10#2)(2008-11#2)
cycle transition##2##2##(2008-9#1)(2011-2#1)
cycle was##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
cycle with##2##2##(2008-10#1)(2011-2#1)
cycle##451##1##(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#3)(1992-2#1)(1992-3#3)(1992-8#3)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#4)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#3)(1995-6#1)(1995-9#5)(1996-2#1)(1996-3#3)(1997-1#6)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#10)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#74)(2008-11#78)(2008-12#5)(2008-2#2)(2008-3#9)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#16)(2008-8#12)(2008-9#34)(2009-10#9)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#4)(2010-10#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#4)(2011-2#16)(2011-3#4)(2012-12#3)(2012-2#20)(2012-3#13)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#9)(2013-8#4)
cycler##3##1##(2008-4#1)(2011-2#2)
cycles and##3##2##(1994-3#1)(2008-10#1)(2008-3#1)
cycles are##2##2##(2008-10#2)
cycles during##2##2##(1991-2#1)(2010-8#1)
cycles in##2##2##(2011-2#1)(2012-12#1)
cycles of chemotherapy##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
cycles of selection##3##3##(2008-10#3)
cycles of the##2##3##(2008-11#1)(2012-2#1)
cycles of wetting and drying of##2##6##(2008-10#2)
cycles of##50##2##(1990-6#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1997-3#1)(2008-10#26)(2008-11#4)(2008-9#1)(2009-10#2)(2009-12#2)(2009-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)
cycles over##2##2##(2008-10#2)
cycles to##2##2##(1990-5#1)(2008-3#1)
cycles using##3##2##(2008-10#2)(2008-5#1)
cycles was##3##2##(1992-2#1)(2008-6#1)(2008-7#1)
cycles were##3##2##(2008-10#2)(2013-1#1)
cycles without##3##2##(2008-10#3)
cycles##131##1##(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-5#1)(1994-11#1)(1994-3#1)(1995-11#2)(1995-5#1)(1997-3#1)(2007-7#1)(2008-10#60)(2008-11#8)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#3)(2009-12#3)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
cycles)##6##1##(1990-6#1)(1991-11#1)(1997-7#1)(2008-10#3)
cyclic AMP (cAMP)##2##3##(1997-2#1)(2008-10#1)
cyclic AMP accumulation##4##3##(1994-2#2)(1996-12#2)
cyclic AMP and##2##3##(1993-6#1)(1995-11#1)
cyclic AMP content##2##3##(1995-11#2)
cyclic AMP production##3##3##(1995-11#3)
cyclic AMP response##2##3##(1995-8#1)(1997-2#1)
cyclic AMP##34##2##(1993-6#3)(1993-8#1)(1994-11#2)(1994-2#5)(1994-6#2)(1995-11#10)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-1#1)(1997-2#2)(1997-4#1)(2008-10#2)
cyclic AMP-dependent protein kinase##3##4##(1993-8#2)(1995-11#1)
cyclic AMP-responsive element binding protein (CREB)##2##6##(1996-12#2)
cyclic GMP##3##2##(1994-11#1)(1995-11#2)
cyclic adenosine monophosphate (cAMP)##2##4##(1994-8#1)(1995-8#1)
cyclic adenosine monophosphate##3##3##(1994-8#1)(1995-8#1)(2009-3#1)
cyclic and square wave voltammetry##2##5##(2008-10#2)
cyclic and square-wave voltammetry##3##4##(2008-10#3)
cyclic and##8##2##(2008-10#8)
cyclic batch operating mode##2##4##(2008-11#2)
cyclic gas exchange##2##3##(2010-4#2)
cyclic hypoxia##3##2##(2010-4#3)
cyclic ketals##2##2##(2008-5#2)
cyclic loading##4##2##(2009-3#2)(2009-7#2)
cyclic nucleotide phosphodiesterase isozyme##4##4##(1993-6#1)(1997-2#3)
cyclic nucleotide phosphodiesterase##8##3##(1993-6#1)(1997-2#7)
cyclic nucleotide##9##2##(1993-6#1)(1997-2#7)(2009-10#1)
cyclic peptide##2##2##(1992-3#1)(2008-10#1)
cyclic process##2##2##(2008-10#1)(2009-10#1)
cyclic strain##5##2##(1994-11#5)
cyclic succession##3##2##(2008-9#3)
cyclic tetrapeptide derivatives as neutral ionophores##2##6##(2008-10#2)
cyclic tetrapeptide##3##2##(2008-10#3)
cyclic tetrathioethers##2##2##(2008-10#2)
cyclic voltammetric studies##2##3##(2009-9#2)
cyclic voltammetric technique for##2##4##(2008-10#2)
cyclic voltammetric##11##2##(2008-10#9)(2009-9#2)
cyclic voltammetry (CV) and differential pulse voltammetry##2##7##(2008-10#2)
cyclic voltammetry (CV) and##8##4##(2008-10#8)
cyclic voltammetry (CV)##18##3##(2008-10#18)
cyclic voltammetry and differential pulse##3##5##(2008-10#3)
cyclic voltammetry and##14##3##(2008-10#13)(2013-1#1)
cyclic voltammetry as a function of##2##6##(2008-10#2)
cyclic voltammetry at a##4##4##(2008-10#4)
cyclic voltammetry at##5##3##(2008-10#5)
cyclic voltammetry with##2##3##(2008-4#1)(2009-9#1)
cyclic voltammetry##77##2##(2008-10#73)(2008-4#2)(2009-9#1)(2013-1#1)
cyclic voltammograms were##2##3##(2008-10#2)
cyclic voltammograms##9##2##(1996-5#1)(2008-10#8)
cyclic##254##1##(1990-11#1)(1990-5#2)(1990-8#2)(1990-9#1)(1992-3#1)(1992-4#2)(1993-6#7)(1993-8#5)(1994-11#12)(1994-2#5)(1994-6#2)(1994-8#1)(1995-11#14)(1995-12#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-12#4)(1996-5#2)(1997-1#1)(1997-2#10)(1997-4#1)(2008-10#126)(2008-11#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#4)(2009-3#3)(2009-7#5)(2009-8#5)(2009-9#4)(2010-4#6)(2011-2#1)(2013-1#1)(2013-7#2)
cyclical parthenogen##2##2##(2012-3#2)
cyclical##9##1##(1994-8#1)(2008-11#4)(2008-9#1)(2012-2#1)(2012-3#2)
cyclin A##2##2##(1994-11#1)(2011-2#1)
cyclin D1##4##2##(2010-1#2)(2013-1#2)
cyclin D1-Cdk4 complexes##2##3##(1997-7#2)
cyclin D2 gene##2##3##(1997-8#2)
cyclin D2 mRNA##2##3##(1997-8#2)
cyclin D2##8##2##(1997-8#8)
cyclin##26##1##(1992-10#2)(1993-9#1)(1994-11#6)(1997-1#1)(1997-7#2)(1997-8#8)(2008-9#1)(2010-1#2)(2011-2#1)(2013-1#2)
cyclin-dependent kinase 4##2##3##(1993-3#2)
cyclin-dependent kinase inhibitor##3##3##(2008-11#2)(2008-5#1)
cyclin-dependent kinase##12##2##(1993-3#2)(1994-11#1)(1997-1#1)(1997-7#1)(2008-11#3)(2008-5#1)(2011-2#1)(2012-3#2)
cyclin-dependent##14##1##(1993-3#2)(1994-11#2)(1997-1#1)(1997-7#1)(2008-11#3)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
cycling at##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
cycling cells from##2##3##(2008-11#2)
cycling cells##5##2##(2008-11#5)
cycling exercise bout##2##3##(2013-8#2)
cycling experiment##3##2##(2008-10#3)
cycling of the##2##3##(2008-10#2)
cycling of##7##2##(1990-8#1)(2008-10#4)(2008-11#1)(2008-7#1)
cycling the##2##2##(2008-10#2)
cycling##48##1##(1990-8#1)(1992-8#2)(1995-12#1)(1997-1#1)(2008-10#17)(2008-11#7)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-9#1)(2011-2#5)(2013-1#3)(2013-8#5)
cyclins##6##1##(1993-9#1)(2008-11#1)(2008-7#1)(2009-8#2)(2012-2#1)
cyclists##5##1##(1990-6#3)(2011-2#2)
cyclization to##2##2##(2008-10#2)
cyclization##9##1##(1992-6#1)(1996-5#5)(2008-10#2)(2008-8#1)
cyclized to the##2##3##(1996-5#2)
cyclized to##3##2##(1996-5#2)(2011-1#1)
cyclo-1##5##1##(2008-10#5)
cyclo-decapeptide##2##1##(2011-2#2)
cycloaddition of##4##2##(1996-5#4)
cycloaddition with##4##2##(1996-5#4)
cycloaddition##13##1##(1996-5#13)
cycloadditions##4##1##(1996-5#3)(2008-8#1)
cycloadduct was##2##2##(1996-5#2)
cycloadduct##6##1##(1996-5#6)
cycloadducts##4##1##(1996-5#4)
cyclocondensation##2##1##(2012-2#1)(2012-3#1)
cyclodextrin##14##1##(2008-10#13)(2008-5#1)
cyclodextrin-mediated capillary##2##2##(2008-10#2)
cyclodextrins were##2##2##(2008-10#2)
cyclodextrins with##2##2##(2008-10#2)
cyclodextrins##18##1##(2008-10#18)
cyclohexane##11##1##(2008-10#11)
cyclohexanone and##2##2##(2008-10#2)
cyclohexanone##7##1##(2008-10#7)
cycloheximide (CHX)##2##2##(2008-11#2)
cycloheximide and actinomycin D##2##4##(1995-12#1)(2008-11#1)
cycloheximide and##4##2##(1991-5#1)(1995-12#1)(2008-11#1)(2011-3#1)
cycloheximide##18##1##(1991-5#3)(1992-8#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-1#2)(2008-10#3)(2008-11#4)(2011-3#1)
cyclohexyl##3##1##(1995-11#2)(2008-10#1)
cyclohexyldiamine tetraacetic acid##2##3##(2008-10#2)
cyclooxygenase activity##2##2##(1992-3#2)
cyclooxygenase in##3##2##(1993-11#1)(2008-11#2)
cyclooxygenase or##2##2##(1995-11#1)(2008-11#1)
cyclooxygenase##19##1##(1992-3#2)(1993-11#1)(1994-5#3)(1995-11#1)(1996-12#2)(1997-1#1)(2008-10#1)(2008-11#6)(2008-5#1)(2012-2#1)
cyclooxygenase-2##7##1##(1997-1#2)(2008-10#3)(2012-2#1)(2013-1#1)
cyclopalladated amine complexes##2##3##(2008-10#2)
cyclopentadiene##2##1##(1996-5#2)
cyclopentadienylnickel(II) thiolato Schiff base##2##4##(2008-10#2)
cyclophilin##3##1##(1991-9#2)(2010-12#1)
cyclophosphamide and ifosphamide in##2##4##(2008-10#2)
cyclophosphamide and ifosphamide##3##3##(2008-10#3)
cyclophosphamide and##8##2##(1996-6#1)(2008-1#1)(2008-10#4)(2008-5#1)(2012-12#1)
cyclophosphamide in##3##2##(1997-8#1)(2008-1#2)
cyclophosphamide or##3##2##(1995-5#1)(2008-10#2)
cyclophosphamide##39##1##(1990-12#1)(1991-8#2)(1993-2#3)(1995-12#1)(1995-5#1)(1996-6#1)(1997-7#1)(1997-8#2)(2008-1#4)(2008-10#9)(2008-12#2)(2008-5#2)(2008-7#3)(2010-12#1)(2012-12#1)(2012-3#3)(2013-8#2)
cycloplegic##2##1##(2010-1#1)(2013-7#1)
cyclopropanated quinolizine species were##2##4##(2008-11#2)
cyclopropane##3##1##(2008-10#3)
cyclosporin A##5##2##(1991-9#1)(1994-8#1)(2008-11#1)(2011-2#1)(2011-3#1)
cyclosporin##9##1##(1991-9#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-3#2)
cyclosporine A and##3##3##(2008-10#3)
cyclosporine A##8##2##(1992-12#1)(1994-8#1)(2008-10#5)(2011-3#1)
cyclosporine##16##1##(1992-12#1)(1992-3#1)(1994-6#1)(1994-8#1)(2008-10#6)(2008-5#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#2)
cyclosporine-treated rats##3##2##(1992-3#3)
cyclotron##3##1##(1990-12#1)(1990-6#1)(1994-2#1)
cylinder coordinates##3##2##(2008-3#3)
cylinder is arbitrarily located and arbitrarily oriented##2##7##(2008-2#1)(2008-3#1)
cylinder is##3##2##(2008-2#1)(2008-3#2)
cylinder with##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
cylinder##38##1##(1991-12#1)(2007-12#1)(2008-10#9)(2008-2#5)(2008-3#11)(2008-7#1)(2009-2#7)(2013-1#3)
cylinders are##2##2##(2008-2#1)(2009-2#1)
cylinders##20##1##(1996-2#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-7#1)(2009-2#8)
cylindrical containers##2##2##(2008-11#1)(2011-2#1)
cylindrical impactor##3##2##(2008-10#3)
cylindrical##39##1##(1992-12#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#13)(2008-6#2)(2010-7#1)(2011-2#1)
cylindroids were##2##2##(2008-11#2)
cylindroids##4##1##(2008-11#4)
cymbalariae##3##1##(2012-3#3)
cymiazole##2##1##(2008-10#2)
cymosum##2##1##(2008-11#2)
cymoxanil##2##1##(2008-10#2)
cynomolgus monkey##3##2##(2012-2#3)
cynomolgus##6##1##(1997-8#1)(2008-10#2)(2012-2#3)
cypermethrin and##4##2##(2008-10#4)
cyprinacea##3##1##(2008-12#3)
cyst and egg##4##3##(2008-10#4)
cyst and##15##2##(1991-11#1)(1991-8#1)(2007-12#2)(2008-10#5)(2008-12#2)(2009-10#2)(2011-2#1)(2013-1#1)
cyst cavity##3##2##(1992-3#2)(1997-8#1)
cyst cells##5##2##(2012-2#5)
cyst disease##2##2##(2010-12#1)(2011-2#1)
cyst fluid##3##2##(1994-2#1)(2008-12#2)
cyst fluids##3##2##(1993-1#3)
cyst growth##2##2##(2013-1#2)
cyst in a##5##3##(1995-12#1)(1997-8#1)(2008-10#1)(2012-12#2)
cyst in the##3##3##(2008-12#1)(2010-11#1)(2010-12#1)
cyst in##10##2##(1995-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#2)(2013-8#1)
cyst into the##2##3##(1991-8#1)(2008-12#1)
cyst is##4##2##(2008-12#1)(2012-2#1)(2013-1#2)
cyst may##2##2##(2008-12#1)(2013-8#1)
cyst nematode##11##2##(2008-10#8)(2008-12#3)
cyst nematodes##3##2##(2008-10#2)(2008-12#1)
cyst of small##2##3##(2013-1#2)
cyst of the liver##2##4##(1991-3#1)(1991-8#1)
cyst of the liver--a case report##2##6##(2008-12#2)
cyst of the third ventricle##4##5##(2008-7#4)
cyst of the##17##3##(1991-3#3)(1991-8#1)(2007-8#1)(2008-12#2)(2008-7#6)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)
cyst of##21##2##(1991-3#4)(1991-8#1)(2007-8#1)(2008-12#2)(2008-7#6)(2008-9#1)(2009-1#1)(2010-11#1)(2011-2#1)(2013-1#3)
cyst populations##2##2##(2008-10#2)
cyst rupture##4##2##(1996-3#4)
cyst size##4##2##(2008-7#4)
cyst type##4##2##(1997-8#4)
cyst wall##3##2##(1992-3#1)(2008-12#1)(2008-7#1)
cyst was##3##2##(1992-3#1)(1997-8#1)(2008-7#1)
cyst with##4##2##(1997-8#2)(2008-7#1)(2013-1#1)
cyst##179##1##(1990-6#1)(1991-11#3)(1991-3#4)(1991-8#4)(1992-3#5)(1993-1#3)(1994-2#1)(1995-12#3)(1996-3#4)(1997-8#13)(2007-12#2)(2007-8#2)(2008-10#25)(2008-12#16)(2008-7#19)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#5)(2010-11#2)(2010-12#3)(2010-7#1)(2011-2#5)(2012-12#5)(2012-2#14)(2012-3#2)(2013-1#24)(2013-8#4)
cystadenocarcinoma##4##1##(1990-6#3)(2010-12#1)
cystadenoma of boundary malignancy in a##2##6##(2008-11#2)
cystadenoma##3##1##(2008-11#2)(2010-12#1)
cystathionine beta-synthase##5##2##(1995-2#5)
cystathionine##7##1##(1990-8#1)(1995-2#6)
cystatin C and##2##3##(2010-12#1)(2010-4#1)
cystatin C concentration##3##3##(2010-4#3)
cystatin C##8##2##(2010-12#1)(2010-4#5)(2013-1#2)
cysteamine-modified carbon paste electrodes##2##4##(2008-10#2)
cysteamine-modified##3##1##(2008-10#3)
cystectomy and##2##2##(1996-3#1)(2008-10#1)
cystectomy or##2##2##(1996-3#1)(2011-2#1)
cystectomy was performed##2##3##(1992-3#1)(1996-3#1)
cystectomy with##2##2##(1991-8#1)(2011-2#1)
cystectomy##13##1##(1990-6#1)(1990-9#1)(1991-8#1)(1992-3#1)(1993-3#1)(1996-3#4)(2008-10#2)(2011-2#2)
cysteine (Cys)##4##2##(2008-10#4)
cysteine and cystine##2##3##(2008-10#2)
cysteine and penicillamine##3##3##(2008-10#3)
cysteine and##13##2##(2008-10#10)(2009-8#1)(2010-11#1)(2011-3#1)
cysteine in a##2##3##(2008-10#2)
cysteine in human plasma##2##4##(2008-10#2)
cysteine in human##4##3##(2008-10#4)
cysteine in##11##2##(1993-8#1)(2008-10#10)
cysteine methyl ester##2##3##(2008-10#2)
cysteine proteases##5##2##(1995-6#1)(2008-11#1)(2008-4#2)(2008-7#1)
cysteine proteinases##2##2##(2008-10#2)
cysteine residue##6##2##(1990-2#2)(1990-5#1)(1991-9#1)(1993-8#1)(1995-6#1)
cysteine residues in##3##3##(1993-8#1)(1997-7#1)(2008-10#1)
cysteine residues##15##2##(1990-11#1)(1990-2#1)(1992-10#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#2)(1997-7#1)(2008-10#1)(2011-2#2)
cysteine with##4##2##(2008-10#4)
cysteine##126##1##(1990-11#1)(1990-2#3)(1990-5#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-6#1)(1993-8#7)(1993-9#2)(1994-11#5)(1995-6#2)(1997-7#1)(2008-10#83)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#2)(2011-2#2)(2011-3#1)(2012-2#1)
cysteine-1##2##1##(1994-11#2)
cysteine-223##2##1##(1992-3#2)
cysteine-rich EGF##2##2##(1995-6#2)
cysteine-rich domain##2##2##(2008-10#1)(2008-8#1)
cysteine-rich proteins##2##2##(2011-2#1)(2013-7#1)
cysteine-rich region##2##2##(1991-9#1)(1995-2#1)
cysteine-rich##14##1##(1991-9#1)(1994-11#2)(1995-2#1)(1995-6#3)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-7#1)
cysteines have##2##2##(1993-8#1)(1994-11#1)
cysteines##9##1##(1990-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#5)
cysteinyl##3##1##(1991-5#2)(1993-6#1)
cysteinylglycine##2##1##(2008-10#2)
cystemustine##2##1##(2008-5#2)
cystic and##3##2##(1992-12#1)(1997-8#1)(2013-1#1)
cystic breast##2##2##(2008-12#2)
cystic craniopharyngiomas##3##2##(2008-7#3)
cystic disease##3##2##(1993-1#1)(1997-8#2)
cystic duct##10##2##(1992-9#5)(2008-12#3)(2010-12#2)
cystic fibrosis (CF)##3##3##(1997-1#1)(2011-3#2)
cystic fibrosis patients##2##3##(1990-4#1)(2012-3#1)
cystic fibrosis##24##2##(1990-4#1)(1991-12#3)(1991-2#4)(1991-8#1)(1994-12#1)(1997-1#2)(1997-8#1)(2008-10#1)(2009-1#1)(2011-3#5)(2012-2#1)(2012-3#2)(2013-7#1)
cystic hypoglossal schwannoma with##2##4##(2011-2#2)
cystic hypoglossal##3##2##(2011-2#3)
cystic kidneys##2##2##(1997-5#1)(2008-10#1)
cystic lesion##6##2##(1992-2#1)(2008-10#2)(2008-5#2)(2013-1#1)
cystic lesions of##2##3##(2008-7#1)(2010-11#1)
cystic lesions##5##2##(2008-7#2)(2010-11#1)(2012-2#1)(2013-8#1)
cystic mass in the##2##4##(2011-2#1)(2013-8#1)
cystic mass with##3##3##(1990-6#1)(2011-2#1)(2012-12#1)
cystic mass##7##2##(1990-6#1)(2011-2#2)(2012-12#2)(2013-8#2)
cystic teratoma##5##2##(2013-8#5)
cystic##108##1##(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#3)(1991-2#7)(1991-8#1)(1992-12#1)(1992-2#2)(1992-9#5)(1993-1#1)(1994-12#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#5)(2008-1#1)(2008-10#5)(2008-12#9)(2008-5#3)(2008-7#8)(2009-1#1)(2009-3#3)(2010-11#1)(2010-12#2)(2011-2#11)(2011-3#5)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#11)
cystica##3##1##(2011-2#3)
cystine and##3##2##(2008-10#2)(2008-11#1)
cystine was##2##2##(2008-10#2)
cystine##23##1##(1990-5#3)(2008-10#11)(2008-11#8)(2008-4#1)
cystitis##10##1##(2008-10#2)(2008-12#3)(2009-1#1)(2012-3#4)
cystoadenocarcinoma##2##1##(2008-12#2)
cystocele##3##1##(1994-3#1)(2010-11#1)(2011-2#1)
cystocoele##4##1##(2011-2#4)
cystography##2##1##(2008-10#1)(2013-1#1)
cystomas of intestinal type##3##4##(1990-2#3)
cystomas of intestinal##4##3##(1990-2#4)
cystomas of##5##2##(1990-2#5)
cystomas##11##1##(1990-2#11)
cystometric studies##2##2##(2008-7#2)
cystometric##3##1##(1993-2#1)(2008-7#2)
cystosarcoma phyllodes are##2##3##(2011-3#2)
cystosarcoma phyllodes##4##2##(2011-3#4)
cystosarcoma##5##1##(2008-10#1)(2011-3#4)
cystoscopy##8##1##(2008-10#5)(2011-2#1)(2012-12#1)(2012-2#1)
cystospores##2##1##(2008-10#2)
cystourethrogram##4##1##(2008-10#4)
cysts and##3##2##(1993-1#1)(2008-10#2)
cysts are##8##2##(1991-6#1)(1993-1#1)(2008-10#1)(2008-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
cysts arising##2##2##(2010-12#1)(2013-1#1)
cysts associated with ectopic##2##4##(2013-1#2)
cysts have been##2##3##(2008-7#1)(2013-1#1)
cysts have##4##2##(1995-12#1)(2008-7#1)(2013-1#2)
cysts in##8##2##(2007-12#1)(2008-10#3)(2008-7#1)(2012-2#3)
cysts is##3##2##(1991-6#1)(2008-10#1)(2012-2#1)
cysts isolated from##2##3##(2008-10#2)
cysts lined by##2##3##(2008-12#2)
cysts lined##3##2##(2008-12#2)(2013-1#1)
cysts may##2##2##(1993-1#1)(2008-12#1)
cysts of the orbit##2##4##(2011-2#2)
cysts of the##5##3##(1992-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
cysts of##9##2##(1992-5#1)(2008-10#1)(2008-7#2)(2009-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
cysts on##2##2##(2008-7#1)(2012-2#1)
cysts that##2##2##(2008-10#1)(2012-2#1)
cysts was##3##2##(2008-10#1)(2012-2#2)
cysts were##9##2##(1990-6#1)(1995-12#1)(2008-7#2)(2010-11#1)(2010-12#1)(2012-2#2)(2012-3#1)
cysts when compared to##2##4##(1993-1#1)(1995-12#1)
cysts with##2##2##(1993-1#1)(2008-7#1)
cysts##118##1##(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-5#1)(1993-1#5)(1995-12#4)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#4)(2008-7#21)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#17)(2012-3#2)(2013-1#18)(2013-8#4)
cysts)##2##1##(1991-2#1)(1993-1#1)
cyt c##3##2##(2011-2#3)
cytidine##7##1##(1994-5#2)(1997-2#1)(2008-10#4)
cytisine##3##1##(2008-10#3)
cytoarchitecture and##2##2##(1994-3#1)(1994-9#1)
cytoarchitecture in the##3##3##(1992-9#2)(2013-8#1)
cytoarchitecture##6##1##(1992-9#2)(1994-3#1)(1994-9#1)(2008-11#1)(2013-8#1)
cytobrush##4##1##(1992-1#4)
cytochalasin B##4##2##(1994-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
cytochemical analysis##2##2##(2008-10#1)(2008-9#1)
cytochemical##16##1##(1993-11#2)(1993-12#1)(2008-10#8)(2008-7#3)(2008-9#1)(2009-12#1)
cytochemically##2##1##(2008-10#2)
cytochemistry##6##1##(2008-10#3)(2008-8#2)(2009-12#1)
cytochrome C##2##2##(2008-9#1)(2009-8#1)
cytochrome P-450 monooxygenase##2##3##(1991-5#1)(1992-3#1)
cytochrome P-450 reductase##2##3##(1995-8#1)(2008-11#1)
cytochrome P-450##12##2##(1991-5#2)(1992-3#2)(1994-2#1)(1995-8#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
cytochrome P-450cam##5##2##(1994-5#5)
cytochrome P450 3A4 activity##2##4##(2008-10#2)
cytochrome P450 IA2##2##3##(1990-5#2)
cytochrome P450##26##2##(1990-5#3)(1991-9#1)(1992-8#3)(1994-11#1)(1994-5#3)(1994-8#1)(1996-3#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#2)(2011-1#1)
cytochrome P450-dependent monooxygenases##2##3##(2008-11#1)(2009-8#1)
cytochrome P450-dependent##4##2##(1991-8#1)(1992-8#1)(2008-11#1)(2009-8#1)
cytochrome P4502E1##2##2##(2008-8#2)
cytochrome P450sccK201E##2##2##(2008-10#2)
cytochrome b 561##2##3##(2009-9#2)
cytochrome b gene##5##3##(2008-10#3)(2008-6#1)(2010-4#1)
cytochrome b##9##2##(2008-10#4)(2008-6#2)(2009-9#2)(2010-4#1)
cytochrome b5##2##2##(1992-6#2)
cytochrome b558##5##2##(1993-8#5)
cytochrome b561##2##2##(2009-9#2)
cytochrome c (cyt c)##2##4##(2008-10#1)(2011-2#1)
cytochrome c nitrite reductase##3##4##(1994-11#2)(2011-2#1)
cytochrome c oxidase##7##3##(1995-2#2)(1997-7#3)(2008-6#1)(2010-4#1)
cytochrome c release##2##3##(2010-3#2)
cytochrome c##21##2##(1993-6#1)(1994-11#2)(1995-2#2)(1997-7#3)(2008-10#6)(2008-6#1)(2008-7#1)(2010-3#2)(2010-4#1)(2011-2#2)
cytochrome c3##5##2##(1994-5#5)
cytochrome oxidase II##4##3##(2008-10#2)(2008-8#2)
cytochrome oxidase activity##2##3##(1995-6#1)(2008-7#1)
cytochrome oxidase subunit##2##3##(1990-5#1)(1993-2#1)
cytochrome oxidase##17##2##(1990-5#1)(1993-2#2)(1995-6#7)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)
cytochrome subunit##5##2##(1993-8#4)(1994-11#1)
cytochrome##140##1##(1990-5#5)(1991-5#2)(1991-8#1)(1991-9#3)(1992-3#2)(1992-6#2)(1992-8#4)(1993-2#2)(1993-6#1)(1993-8#9)(1994-11#5)(1994-2#1)(1994-5#17)(1994-8#1)(1995-2#2)(1995-6#7)(1995-8#3)(1996-3#1)(1997-2#2)(1997-7#3)(2008-10#21)(2008-11#7)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-8#2)(2009-9#6)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#2)
cytochrome-c reductase##2##2##(1995-8#2)
cytochromes c3##2##2##(1994-5#2)
cytochromes##5##1##(1994-5#4)(1995-6#1)
cytocompatibility of##3##2##(2009-7#2)(2013-8#1)
cytocompatibility##4##1##(2009-7#3)(2013-8#1)
cytogenetic analysis##3##2##(2008-9#1)(2012-3#2)
cytogenetic and##2##2##(2010-1#1)(2010-5#1)
cytogenetic damage##2##2##(2008-9#1)(2013-8#1)
cytogenetic data on##2##3##(2008-12#2)
cytogenetic diagnosis##7##2##(2008-11#4)(2012-3#3)
cytogenetic##28##1##(1990-8#1)(1993-8#2)(1997-4#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-7#1)(2008-9#2)(2010-1#2)(2010-5#1)(2012-3#7)(2013-1#1)(2013-8#2)
cytogenetics laboratory##4##2##(1997-3#3)(2008-11#1)
cytogenetics##17##1##(1997-3#3)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#8)(2009-8#1)(2010-1#1)
cytoglobin##5##1##(2010-11#5)
cytokeratin and##2##2##(2008-7#1)(2012-2#1)
cytokeratin##11##1##(1991-12#1)(1994-8#2)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2012-2#1)
cytokeratins##4##1##(1994-8#2)(2010-12#1)(2011-2#1)
cytokine action##3##2##(1996-12#2)(1996-2#1)
cytokine and chemokine##2##3##(2008-10#1)(2009-3#1)
cytokine and##10##2##(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#2)(2009-3#1)(2009-7#1)(2011-2#2)(2012-2#1)
cytokine expression##2##2##(2008-10#1)(2009-8#1)
cytokine gene##2##2##(2008-1#1)(2008-11#1)
cytokine genes##3##2##(1994-5#1)(2008-4#1)(2008-9#1)
cytokine levels in##3##3##(1996-12#2)(2008-10#1)
cytokine levels##7##2##(1996-12#4)(2008-10#1)(2009-9#1)(2010-12#1)
cytokine network##2##2##(1991-2#1)(1995-12#1)
cytokine producing cells##4##3##(2008-11#4)
cytokine producing##5##2##(2008-11#5)
cytokine production in##6##3##(2008-10#3)(2008-4#2)(2010-12#1)
cytokine production##30##2##(1991-2#1)(1996-12#1)(2008-10#13)(2008-11#2)(2008-4#8)(2009-6#1)(2010-12#2)(2012-2#1)(2013-8#1)
cytokine receptors and##4##3##(2008-4#1)(2008-9#2)(2009-12#1)
cytokine receptors##5##2##(1996-2#1)(2008-4#1)(2008-9#2)(2009-12#1)
cytokine responses in##2##3##(2008-11#1)(2008-9#1)
cytokine responses##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
cytokine secretion from##2##3##(2008-11#2)
cytokine secretion patterns##2##3##(1997-8#1)(2008-10#1)
cytokine secretion##18##2##(1997-8#1)(2006-6#3)(2008-10#3)(2008-11#4)(2008-4#6)(2011-2#1)
cytokine##134##1##(1990-12#1)(1991-2#2)(1993-8#2)(1994-11#2)(1994-5#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#9)(1996-2#7)(1997-3#1)(1997-8#1)(2006-6#3)(2007-11#1)(2008-1#1)(2008-10#22)(2008-11#16)(2008-4#24)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#3)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#4)(2013-1#3)(2013-8#4)
cytokine-dependent##3##1##(1990-12#1)(2006-6#2)
cytokine-induced##3##1##(1995-11#2)(2011-1#1)
cytokines and##17##2##(1993-11#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-11#1)(2012-2#2)(2013-1#2)
cytokines are##4##2##(1992-3#1)(2008-10#1)(2008-4#2)
cytokines as well as##2##4##(2008-4#1)(2008-7#1)
cytokines in##6##2##(1996-12#4)(2008-10#1)(2008-4#1)
cytokines including##4##2##(1996-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
cytokines interleukin##2##2##(1992-3#1)(1996-2#1)
cytokines may##2##2##(1996-12#1)(2012-2#1)
cytokines or glucose##2##3##(2010-11#2)
cytokines or##3##2##(2008-11#1)(2010-11#2)
cytokines produced by##2##3##(2008-11#1)(2008-9#1)
cytokines released##3##2##(1996-2#1)(1997-1#1)(2008-7#1)
cytokines such as##3##3##(2008-11#2)(2008-4#1)
cytokines to##4##2##(1996-12#1)(1996-2#1)(2008-11#1)(2012-3#1)
cytokines was##2##2##(1997-1#1)(2011-2#1)
cytokines were##2##2##(1996-12#1)(2012-2#1)
cytokines##132##1##(1990-8#1)(1991-5#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-12#2)(1995-5#1)(1996-12#10)(1996-2#9)(1997-1#2)(1997-8#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#12)(2008-4#12)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-5#1)(2011-2#12)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#2)
cytokinesis in##5##2##(2009-10#5)
cytokinesis##23##1##(1994-11#1)(2008-11#3)(2009-10#9)(2009-12#1)(2009-8#5)(2009-9#1)(2011-1#2)(2013-1#1)
cytokinin and auxin##2##3##(2008-10#2)
cytokinin and##3##2##(2008-10#3)
cytokinin##12##1##(2008-10#3)(2008-12#1)(2008-7#4)(2009-8#4)
cytokinins##2##1##(2008-11#1)(2009-8#1)
cytologic##6##1##(1992-1#1)(1992-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2009-1#1)
cytological and biochemical parameters##2##4##(2011-10#2)
cytological and biochemical##3##3##(2011-10#3)
cytological and##5##2##(2008-10#1)(2011-10#3)(2011-2#1)
cytological characteristics##2##2##(2007-12#1)(2010-12#1)
cytological diagnosis of##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
cytological diagnosis##4##2##(1997-2#2)(2008-10#1)(2011-2#1)
cytological diagnostics of##2##3##(2013-1#2)
cytological events##3##2##(2008-10#3)
cytological features##2##2##(2008-7#1)(2009-10#1)
cytological observations##2##2##(2008-10#2)
cytological samples##2##2##(1993-11#1)(2011-2#1)
cytological##41##1##(1990-2#1)(1991-6#1)(1993-11#1)(1994-5#1)(1997-2#5)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-12#1)(2011-10#4)(2011-2#3)(2012-12#1)(2013-1#2)
cytologically positive##2##2##(1990-2#2)
cytologically##5##1##(1990-2#3)(2008-10#1)(2011-2#1)
cytology and##8##2##(1990-2#1)(1994-1#1)(2008-11#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
cytology findings##2##2##(2008-10#1)(2008-11#1)
cytology in the##2##3##(1990-6#1)(2012-3#1)
cytology in##3##2##(1990-6#1)(2012-3#1)(2013-8#1)
cytology of##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
cytology reports##2##2##(2012-12#2)
cytology screening##2##2##(1990-12#1)(2012-12#1)
cytology were##2##2##(1990-12#1)(1994-1#1)
cytology##48##1##(1990-12#2)(1990-2#1)(1990-6#2)(1994-1#5)(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#2)(2010-8#1)(2011-2#2)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
cytolytic activity##3##2##(1994-5#1)(2008-10#2)
cytolytic##9##1##(1993-3#2)(1994-5#1)(2008-10#4)(2008-5#1)(2008-6#1)
cytomegalovirus (CMV)##6##2##(1995-12#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
cytomegalovirus immediate early##2##3##(1993-8#1)(2008-11#1)
cytomegalovirus infection##3##2##(1997-3#1)(2008-4#1)(2011-2#1)
cytomegalovirus promoter##3##2##(2008-11#3)
cytomegalovirus##22##1##(1993-8#2)(1995-12#1)(1996-12#2)(1997-3#2)(1997-8#1)(2008-11#6)(2008-4#2)(2008-8#1)(2008-9#3)(2011-2#1)(2012-12#1)
cytometer##19##1##(2006-6#1)(2008-11#2)(2008-4#1)(2008-9#15)
cytometers##7##1##(2008-4#1)(2008-9#6)
cytometric analysis of##15##3##(1994-3#1)(2008-11#1)(2008-4#1)(2008-9#11)(2012-3#1)
cytometric analysis##28##2##(1993-2#1)(1994-3#1)(2008-11#6)(2008-4#1)(2008-8#1)(2008-9#15)(2009-12#2)(2012-3#1)
cytometric data##2##2##(2008-10#1)(2008-11#1)
cytometric detection of##2##3##(2008-9#1)(2010-1#1)
cytometric detection##3##2##(2008-10#1)(2008-9#1)(2010-1#1)
cytometric determination of##3##3##(2008-9#3)
cytometric platelet cross-matching##2##3##(2011-2#2)
cytometric platelet##3##2##(2011-2#3)
cytometric##75##1##(1990-12#4)(1993-1#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-9#2)(2006-6#2)(2008-10#3)(2008-11#9)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#36)(2009-12#2)(2010-1#2)(2011-2#3)(2012-3#1)
cytometry analysis##6##2##(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-9#1)
cytometry and##14##2##(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#7)(2010-7#1)(2011-2#1)
cytometry can##2##2##(2008-11#1)(2008-9#1)
cytometry has##6##2##(2008-9#6)
cytometry have##2##2##(2008-9#2)
cytometry of apoptosis##2##3##(2008-9#2)
cytometry of##4##2##(2008-9#4)
cytometry revealed##2##2##(1994-8#1)(2008-11#1)
cytometry to##5##2##(1992-12#1)(2006-6#1)(2008-11#1)(2008-9#2)
cytometry using##2##2##(2008-9#2)
cytometry was##2##2##(1991-6#1)(2008-11#1)
cytometry with##2##2##(1993-8#1)(2008-9#1)
cytometry##179##1##(1990-8#1)(1991-6#2)(1992-12#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-8#1)(1995-8#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-6#3)(2008-10#4)(2008-11#17)(2008-4#12)(2008-7#7)(2008-8#3)(2008-9#102)(2009-12#1)(2009-6#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
cytopathic effect of##2##3##(2008-11#2)
cytopathic effect##5##2##(1993-2#1)(2008-11#3)(2011-3#1)
cytopathic effects##3##2##(2008-11#2)(2008-5#1)
cytopathic##10##1##(1993-2#1)(2008-11#6)(2008-5#2)(2011-3#1)
cytopathological##3##1##(2008-10#3)
cytopenias##2##1##(2008-11#2)
cytoplasm and##15##2##(1994-6#1)(2008-10#4)(2008-11#1)(2009-10#1)(2009-6#1)(2009-8#1)(2011-2#4)(2012-2#2)
cytoplasm disorganization and##2##3##(2008-10#2)
cytoplasm disorganization##3##2##(2008-10#3)
cytoplasm during##2##2##(2008-8#1)(2008-9#1)
cytoplasm in##2##2##(2006-6#1)(2008-10#1)
cytoplasm is##2##2##(1992-6#1)(2008-12#1)
cytoplasm leaves to##2##3##(2008-10#2)
cytoplasm of infected cells##2##4##(2008-10#1)(2009-7#1)
cytoplasm of some##2##3##(1997-2#2)
cytoplasm of the##9##3##(1991-2#1)(1992-2#1)(1995-5#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)
cytoplasm of##35##2##(1991-11#2)(1991-2#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1997-2#2)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
cytoplasm to##3##2##(1991-2#2)(2012-2#1)
cytoplasm was##9##2##(1994-6#1)(2008-10#5)(2008-8#2)(2008-9#1)
cytoplasm were##2##2##(2008-10#2)
cytoplasm##152##1##(1990-5#1)(1991-11#4)(1991-2#4)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#2)(1997-2#2)(1997-4#1)(1997-8#2)(2006-6#2)(2007-12#5)(2008-10#42)(2008-11#12)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#11)(2008-9#7)(2009-10#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-4#1)(2010-6#1)(2011-2#8)(2012-2#5)(2012-7#2)(2013-1#2)(2013-8#1)
cytoplasmic Ca(2+)##2##2##(2006-6#1)(2013-1#1)
cytoplasmic Ca2+##4##2##(1992-6#1)(1994-11#2)(1995-11#1)
cytoplasmic and mitochondrial##3##3##(1992-10#2)(1993-2#1)
cytoplasmic and nuclear loci##3##4##(2008-9#3)
cytoplasmic and##6##2##(1992-10#2)(1993-2#1)(2008-9#3)
cytoplasmic blebbing##2##2##(2008-11#1)(2009-12#1)
cytoplasmic domain of##3##3##(1991-6#1)(1993-12#1)(1995-2#1)
cytoplasmic domain##7##2##(1991-6#1)(1993-12#1)(1995-2#1)(2008-11#2)(2008-5#1)(2013-1#1)
cytoplasmic domains of##2##3##(1994-12#1)(2008-11#1)
cytoplasmic inclusion bodies##2##3##(2008-10#1)(2011-2#1)
cytoplasmic inclusion##3##2##(2008-10#2)(2011-2#1)
cytoplasmic inclusions in##2##3##(1993-12#1)(2008-7#1)
cytoplasmic inclusions##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
cytoplasmic incompatibility (CI)##2##3##(2008-8#2)
cytoplasmic incompatibility##4##2##(2008-8#3)(2008-9#1)
cytoplasmic irradiation##4##2##(2008-8#4)
cytoplasmic kinases##2##2##(2008-4#1)(2009-10#1)
cytoplasmic localization##2##2##(1993-6#1)(1996-2#1)
cytoplasmic loop##4##2##(1992-3#3)(2009-6#1)
cytoplasmic male##2##2##(2008-8#1)(2008-9#1)
cytoplasmic membrane and##4##3##(1991-10#2)(1997-8#1)(2011-2#1)
cytoplasmic membrane##8##2##(1991-10#2)(1991-5#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
cytoplasmic polyanions##2##2##(1991-11#2)
cytoplasmic probe##2##2##(1991-5#2)
cytoplasmic processes##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
cytoplasmic protein##3##2##(1992-9#1)(1993-8#1)(1994-11#1)
cytoplasmic receptor domain##3##3##(1997-7#3)
cytoplasmic receptor##4##2##(1997-7#3)(2008-4#1)
cytoplasmic region of human CD45##2##5##(1994-6#2)
cytoplasmic streaming in##2##3##(1994-9#1)(2008-11#1)
cytoplasmic tail##3##2##(2008-9#3)
cytoplasmic vacuolization##5##2##(2008-9#5)
cytoplasmic vesicles##2##2##(2008-10#2)
cytoplasmic##155##1##(1990-8#2)(1991-10#2)(1991-11#8)(1991-12#1)(1991-2#1)(1991-5#7)(1991-6#1)(1992-10#5)(1992-3#3)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-2#4)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-7#5)(1997-8#1)(2006-6#2)(2008-10#14)(2008-11#10)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#9)(2008-8#10)(2008-9#18)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#6)(2011-3#1)(2013-1#4)(2013-8#1)
cytoprotection##2##1##(1994-8#1)(2013-7#1)
cytoprotective action##2##2##(1996-2#1)(2013-7#1)
cytoprotective##8##1##(1995-3#1)(1996-2#1)(2008-11#1)(2010-10#2)(2012-2#1)(2013-7#2)
cytosine methylation##2##2##(2009-10#1)(2011-2#1)
cytosine##11##1##(1991-12#1)(1991-2#1)(1993-9#1)(1997-2#2)(2008-10#3)(2008-8#1)(2009-10#1)(2011-2#1)
cytosines of##2##2##(2009-10#2)
cytoskeletal components##2##2##(2008-11#1)(2009-8#1)
cytoskeletal elements##2##2##(1997-1#1)(2009-10#1)
cytoskeletal fraction##4##2##(1997-2#4)
cytoskeletal protein##3##2##(2008-7#1)(2008-8#1)(2010-5#1)
cytoskeletal proteins##3##2##(1996-12#1)(1996-2#1)(2009-8#1)
cytoskeletal structures##2##2##(2008-11#1)(2008-7#1)
cytoskeletal##23##1##(1993-6#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#4)(2008-11#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#3)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#1)
cytoskeleton and##3##2##(1990-5#1)(1996-2#1)(2008-11#1)
cytoskeleton is essential for##2##4##(2008-11#1)(2009-9#1)
cytoskeleton is##3##2##(2008-11#1)(2009-9#1)(2011-2#1)
cytoskeleton of##3##2##(1995-2#1)(2009-10#2)
cytoskeleton plays a##2##3##(2008-11#1)(2012-2#1)
cytoskeleton##41##1##(1990-5#1)(1993-6#3)(1994-5#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-2#3)(1997-7#1)(2008-11#11)(2008-8#1)(2008-9#3)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2011-2#1)(2011-3#1)(2012-2#1)
cytoskeleton-associated##2##1##(1995-9#1)(2008-9#1)
cytosol and membrane##2##3##(1993-8#1)(2008-11#1)
cytosol and##10##2##(1990-2#1)(1990-5#2)(1990-8#1)(1991-5#1)(1993-3#1)(1993-8#2)(2008-11#2)
cytosol fraction##5##2##(1990-11#2)(1992-6#1)(2008-10#2)
cytosol to nucleus##3##3##(2008-8#1)(2008-9#2)
cytosol to##7##2##(1992-12#1)(1992-6#1)(1997-1#1)(2008-8#1)(2008-9#2)(2011-2#1)
cytosol##48##1##(1990-11#4)(1990-2#1)(1990-5#5)(1990-8#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-3#3)(1993-8#4)(1994-5#1)(1995-9#1)(1997-1#1)(1997-4#1)(1997-7#2)(2008-10#5)(2008-11#3)(2008-8#1)(2008-9#3)(2010-10#1)(2011-2#3)(2013-1#1)
cytosolic 3##5##2##(1990-11#3)(1991-5#2)
cytosolic Ca(2+) concentration##2##3##(2008-11#1)(2008-7#1)
cytosolic Ca2+ concentration##2##3##(1994-8#1)(1995-11#1)
cytosolic Ca2+##10##2##(1991-5#1)(1992-4#1)(1994-8#1)(1995-11#2)(1996-2#5)
cytosolic NADH levels##3##3##(1994-8#2)(2009-9#1)
cytosolic NADH##6##2##(1994-8#4)(2009-9#2)
cytosolic activity##2##2##(1991-5#1)(1995-9#1)
cytosolic and##2##2##(1993-8#1)(2008-11#1)
cytosolic calcium concentration##2##3##(1990-5#1)(1994-11#1)
cytosolic calcium##5##2##(1990-2#1)(1990-5#1)(1994-11#1)(2008-9#1)(2009-12#1)
cytosolic components##2##2##(1991-5#1)(1993-8#1)
cytosolic domain of the KDR##2##5##(1994-11#2)
cytosolic domain##3##2##(1994-11#2)(1996-2#1)
cytosolic fractions##3##2##(1990-5#1)(1996-2#2)
cytosolic free Ca2+##3##3##(1990-2#1)(1995-11#1)(1997-1#1)
cytosolic free calcium concentration##2##4##(1992-6#2)
cytosolic free calcium levels##2##4##(1991-5#1)(1997-1#1)
cytosolic free calcium##4##3##(1991-5#1)(1992-6#2)(1997-1#1)
cytosolic free##8##2##(1990-2#1)(1991-5#1)(1992-6#2)(1995-11#1)(1997-1#2)(2008-11#1)
cytosolic or##2##2##(1996-11#1)(2008-11#1)
cytosolic peptides##3##2##(1996-2#3)
cytosolic phospholipase A2##10##3##(1993-6#2)(1994-11#2)(1995-11#6)
cytosolic proteins##3##2##(1992-12#3)
cytosolic purine 5'-nucleotidase##3##3##(1994-11#3)
cytosolic subfraction##2##2##(1995-2#2)
cytosolic transport##3##2##(1994-6#3)
cytosolic##109##1##(1990-11#6)(1990-2#2)(1990-5#6)(1991-2#1)(1991-5#9)(1991-8#2)(1992-12#4)(1992-4#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#9)(1994-2#1)(1994-6#3)(1994-8#6)(1995-11#10)(1995-2#2)(1995-9#1)(1996-11#1)(1996-2#11)(1996-3#2)(1997-1#2)(2007-12#2)(2008-10#1)(2008-11#6)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#3)(2010-5#1)(2011-2#1)(2013-1#1)
cytosols metabolized [3H]DHT##2##3##(1990-11#2)
cytosols##7##1##(1990-11#6)(2008-10#1)
cytostatic drugs##2##2##(1991-8#2)
cytostatic production phase is established##2##5##(2008-7#2)
cytostatic##14##1##(1990-6#1)(1991-8#4)(1993-11#1)(1997-4#1)(2008-7#6)(2009-12#1)
cytotoxic T cells (150 ppm)##2##5##(2008-10#2)
cytotoxic T cells##4##3##(2008-10#3)(2008-8#1)
cytotoxic T lymphocyte (CTL)##2##4##(2011-2#1)(2013-1#1)
cytotoxic T lymphocyte##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
cytotoxic T lymphocytes (CTL)##2##4##(2008-11#2)
cytotoxic T lymphocytes##5##3##(1995-5#1)(2008-11#4)
cytotoxic T##13##2##(1995-5#1)(2008-10#3)(2008-11#4)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
cytotoxic activities of##2##3##(2008-11#1)(2013-1#1)
cytotoxic activities##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
cytotoxic activity against##3##3##(2008-11#2)(2010-6#1)
cytotoxic activity of##4##3##(1990-12#4)
cytotoxic activity##12##2##(1990-12#5)(1996-12#1)(2008-11#3)(2008-4#1)(2010-6#1)(2011-2#1)
cytotoxic agents##8##2##(1997-8#1)(2008-11#3)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
cytotoxic analogs of luteinizing hormone-releasing hormone##2##6##(1993-1#2)
cytotoxic and cytogenetic##2##3##(1993-8#2)
cytotoxic and##8##2##(1993-8#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
cytotoxic at##2##2##(1994-8#1)(2011-2#1)
cytotoxic chemotherapy##4##2##(1997-5#1)(2008-11#1)(2008-7#1)(2012-3#1)
cytotoxic drugs##7##2##(1991-8#1)(2008-11#2)(2009-1#1)(2009-12#1)(2013-1#2)
cytotoxic effect of##3##3##(1996-3#1)(2008-11#1)(2010-12#1)
cytotoxic effect##9##2##(1990-2#1)(1995-8#1)(1996-3#1)(2008-11#2)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
cytotoxic effects of##8##3##(1990-5#1)(2008-11#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
cytotoxic effects on##2##3##(2008-11#1)(2009-12#1)
cytotoxic effects##11##2##(1990-5#1)(2008-11#4)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
cytotoxic for cells##2##3##(1990-8#1)(2013-8#1)
cytotoxic in##2##2##(1993-8#1)(2013-1#1)
cytotoxic property##2##2##(1994-3#1)(2008-11#1)
cytotoxic radicals##2##2##(1993-1#2)
cytotoxic response in##2##3##(1995-8#1)(2008-11#1)
cytotoxic response##3##2##(1992-10#1)(1995-8#1)(2008-11#1)
cytotoxic therapy##2##2##(2009-12#1)(2013-1#1)
cytotoxic to##3##2##(2008-9#1)(2010-1#1)(2012-3#1)
cytotoxic##132##1##(1990-12#6)(1990-2#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-7#1)(1993-1#7)(1993-8#3)(1994-3#1)(1994-8#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#33)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#4)(2009-9#2)(2010-1#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#2)
cytotoxicities##2##1##(2008-8#1)(2013-1#1)
cytotoxicity against K562##3##3##(1994-3#1)(2008-11#2)
cytotoxicity against##11##2##(1994-3#2)(1997-7#1)(2008-11#4)(2008-7#2)(2011-3#2)
cytotoxicity and the##2##3##(2008-11#1)(2008-8#1)
cytotoxicity and##8##2##(1994-8#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-8#2)
cytotoxicity assay##2##2##(1990-12#1)(2008-11#1)
cytotoxicity assays using the##2##4##(1997-2#1)(2008-8#1)
cytotoxicity assays##3##2##(1997-2#1)(2008-8#1)(2009-12#1)
cytotoxicity at##2##2##(2008-11#1)(2011-1#1)
cytotoxicity by##2##2##(1990-2#1)(2008-11#1)
cytotoxicity in##11##2##(1990-2#2)(1994-8#2)(1995-8#1)(2008-11#2)(2008-7#1)(2009-3#1)(2009-9#1)(2013-1#1)
cytotoxicity is##2##2##(1992-8#1)(1993-3#1)
cytotoxicity of the##8##3##(2008-11#3)(2008-5#1)(2008-8#3)(2008-9#1)
cytotoxicity of##21##2##(1990-5#1)(1991-5#1)(2008-10#1)(2008-11#7)(2008-5#1)(2008-8#6)(2008-9#1)(2009-12#2)(2013-1#1)
cytotoxicity on##2##2##(2008-10#1)(2008-11#1)
cytotoxicity studies##2##2##(2008-11#2)
cytotoxicity test##3##2##(2008-11#3)
cytotoxicity testing##2##2##(2008-11#2)
cytotoxicity tests##2##2##(2008-11#2)
cytotoxicity than##3##2##(1996-12#1)(2008-11#1)(2011-2#1)
cytotoxicity to##2##2##(1997-7#1)(2008-8#1)
cytotoxicity toward##3##2##(1994-8#2)(2012-2#1)
cytotoxicity was##2##2##(1993-1#1)(1995-8#1)
cytotoxicity##120##1##(1990-12#1)(1990-2#3)(1990-5#1)(1991-5#1)(1992-7#4)(1992-8#1)(1993-1#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-8#11)(1995-8#4)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-1#1)(2008-10#5)(2008-11#38)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#11)(2008-9#1)(2009-12#3)(2009-3#1)(2009-9#1)(2010-3#1)(2011-1#3)(2011-2#5)(2011-3#4)(2012-2#1)(2013-1#3)
cytotoxin production by Serratia marcescens##2##5##(1996-12#2)
cytotoxin production##3##2##(1996-12#3)
cytotoxin##4##1##(1996-12#4)
cytotoxins##2##1##(2011-2#1)(2013-8#1)
d 1##4##2##(1992-12#3)(2008-8#1)
d after the##3##3##(2010-12#1)(2013-1#2)
d after##9##2##(2008-8#5)(2008-9#1)(2010-12#1)(2013-1#2)
d and##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
d deficiency##2##2##(2011-1#2)
d elivery of##2##3##(2008-11#2)
d treatment##2##2##(2008-11#1)(2011-1#1)
d##103##1##(1992-12#5)(1992-6#4)(1993-2#1)(1996-2#2)(2008-10#42)(2008-11#6)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#11)(2008-9#7)(2009-3#2)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)
d&lt##3##1##(1995-3#1)(2008-10#2)
d'##3##1##(1991-2#3)
d'autres##2##1##(2013-1#2)
d'hypertension##2##1##(2011-2#1)(2013-1#1)
d'origine##2##1##(2008-10#1)(2011-2#1)
d'un phéochromocytome##2##2##(2011-2#2)
d'un##13##1##(2011-2#4)(2013-1#9)
d'une##11##1##(2008-11#1)(2008-5#1)(2011-2#4)(2013-1#5)
d(-1))##2##1##(2008-9#1)(2009-8#1)
d(33)##2##1##(2007-11#1)(2009-5#1)
d(AG/CT)n##2##1##(1996-8#2)
d(CCG/CGG)n##2##1##(1996-8#2)
d(TACGTA)##3##1##(1991-5#3)
d) and##2##2##(2008-10#1)(2011-2#1)
d)##10##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
d- and l-tryptophan##2##3##(2008-10#2)
d- and##3##2##(2008-10#3)
d-##4##1##(2008-10#4)
d-1##2##1##(2008-11#2)
d-LDH paste electrode##2##3##(2008-10#2)
d-LDH##3##1##(2008-10#3)
d-ROMs and PON1 activity##2##4##(2012-12#2)
d-Ser##2##1##(2008-10#2)
d-Tagatose##3##1##(2008-5#3)
d-amphetamine##2##1##(1990-9#1)(1991-1#1)
d-glucosamine##4##1##(2008-10#4)
d-glucose##2##1##(2008-10#1)(2008-5#1)
d-lactate##3##1##(2008-10#3)
d-lactic acid##7##2##(2008-10#5)(2008-11#2)
d-penicillamine in##2##2##(2008-10#2)
d-penicillamine##4##1##(2008-10#4)
d-ribose##2##1##(2011-1#2)
d-sorbitol##8##1##(2008-10#1)(2008-5#7)
d-tagatose was##2##2##(2008-5#2)
d-tagatose##14##1##(2008-5#14)
d-thyroxine##2##1##(2008-10#2)
dAMP hydroxyl##2##2##(2008-8#2)
dAMP##5##1##(2008-8#4)(2008-9#1)
dAVS##5##1##(1996-9#5)
dAdo##2##1##(1995-6#2)
dB (A)##3##2##(2011-2#3)
dB MHz(-1)##2##2##(2008-7#2)
dB MHz(-1))##2##2##(2008-7#2)
dB SNR##2##2##(2008-9#2)
dB for##3##2##(2008-3#3)
dB was##2##2##(2007-11#1)(2008-2#1)
dB were##2##2##(2008-2#1)(2009-5#1)
dB x##2##2##(2008-3#2)
dB##35##1##(1995-12#1)(2007-11#1)(2008-2#4)(2008-3#10)(2008-7#5)(2008-8#1)(2008-9#3)(2009-5#3)(2011-2#3)(2013-8#4)
dB) and##2##2##(2008-3#2)
dB)##5##1##(2008-3#5)
dB/0##4##1##(2010-8#4)
dQTL##5##1##(2008-10#5)
dRLh cells##2##2##(1991-5#2)
dRTA##5##1##(2008-1#5)
dTMP synthase##3##2##(1992-8#3)
dTMP##4##1##(1992-8#4)
dThd and##2##2##(1995-6#2)
da Vinci##2##2##(1991-3#1)(2008-10#1)
da##3##1##(1991-3#1)(2008-10#1)(2010-1#1)
dacryoadenitis##4##1##(2011-2#4)
dactyloides and##2##2##(2008-10#2)
dactyloides##4##1##(2008-10#4)
dactylon##4##1##(2008-10#4)
dahlia violet##2##2##(2008-10#2)
dahlia##4##1##(2008-10#3)(2008-12#1)
dahliae and V##2##3##(2008-10#2)
dahliae and##6##2##(2008-10#5)(2008-12#1)
dahliae by##3##2##(2008-10#3)
dahliae from cruciferous##2##3##(2008-10#2)
dahliae from noncruciferous hosts##2##4##(2008-10#2)
dahliae from##4##2##(2008-10#4)
dahliae in the##4##3##(2008-10#3)(2008-12#1)
dahliae in##10##2##(2008-10#9)(2008-12#1)
dahliae inoculum and##3##3##(2008-10#3)
dahliae isolates from artichoke##2##4##(2008-10#2)
dahliae isolates from##5##3##(2008-10#5)
dahliae isolates was##2##3##(2008-10#2)
dahliae isolates within##2##3##(2008-10#2)
dahliae isolates##10##2##(2008-10#10)
dahliae on##2##2##(2008-10#2)
dahliae was##3##2##(2008-10#3)
dahliae##86##1##(2008-10#83)(2008-12#3)
dahliae-infested plots##3##2##(2008-10#3)
dahliae-infested##4##1##(2008-10#4)
daidzein by##2##2##(2008-10#1)(2010-1#1)
daidzein in##2##2##(2008-10#2)
daidzein to equol##2##3##(2010-1#2)
daidzein##17##1##(2008-10#11)(2010-1#6)
daidzin##6##1##(2008-11#6)
daily activities##9##2##(1992-3#1)(2008-11#2)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)
daily and##8##2##(2008-10#3)(2008-11#4)(2008-8#1)
daily census##2##2##(1992-12#2)
daily clinical practice##5##3##(2011-2#4)(2013-8#1)
daily diet##2##2##(2008-10#1)(2013-8#1)
daily dietary##2##2##(1991-6#1)(2008-10#1)
daily dosage was##2##3##(2011-2#2)
daily dosage##3##2##(2007-11#1)(2011-2#2)
daily dose of##7##3##(1990-11#3)(1990-12#1)(1990-2#1)(1994-6#1)(2013-1#1)
daily dose##12##2##(1990-11#4)(1990-12#1)(1990-2#1)(1991-11#1)(1994-6#1)(2008-11#2)(2013-1#2)
daily doses of##5##3##(2008-7#1)(2008-9#4)
daily doses##10##2##(1991-2#1)(2008-11#2)(2008-7#1)(2008-9#6)
daily dosing##2##2##(2008-9#1)(2012-2#1)
daily during##2##2##(1991-11#1)(1993-3#1)
daily for 15##2##3##(2008-10#1)(2012-3#1)
daily for##11##2##(1993-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
daily in the morning##2##4##(2007-11#1)(2008-10#1)
daily in##5##2##(1993-2#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
daily infection##2##2##(2008-10#2)
daily injections of##2##3##(1990-12#1)(1997-2#1)
daily injections##3##2##(1990-12#1)(1997-2#1)(2012-4#1)
daily intake of##9##3##(1991-11#1)(1994-2#1)(2008-10#4)(2011-2#2)(2013-1#1)
daily intake##10##2##(1991-11#1)(1994-2#1)(2008-10#4)(2008-9#1)(2011-2#2)(2013-1#1)
daily intakes##2##2##(2008-10#1)(2011-2#1)
daily is##2##2##(1996-11#1)(1997-8#1)
daily life##14##2##(2008-11#2)(2008-12#2)(2008-7#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
daily living##16##2##(1991-12#1)(1992-12#1)(1993-3#1)(1995-2#2)(2008-11#1)(2008-7#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
daily meals##2##2##(2008-10#2)
daily mean temperature##2##3##(2008-10#2)
daily mortality##3##2##(1997-1#3)
daily nutrient##2##2##(2008-7#1)(2013-1#1)
daily pain##3##2##(2008-7#3)
daily practice##10##2##(1993-11#1)(1993-3#1)(1997-4#1)(2008-11#3)(2008-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
daily restraint##2##2##(1994-2#2)
daily smokers##2##2##(1990-2#1)(1990-6#1)
daily smoking##3##2##(1991-11#1)(1991-6#1)(2013-1#1)
daily sperm production##2##3##(1992-12#2)
daily spiritual experiences##2##3##(2009-11#2)
daily spiritual##4##2##(2009-11#4)
daily temperature##2##2##(2008-10#2)
daily temperatures##2##2##(2008-10#1)(2012-2#1)
daily use of##2##3##(2008-8#1)(2012-2#1)
daily use##4##2##(1991-9#1)(2008-8#1)(2012-2#1)(2013-1#1)
daily variations##3##2##(2008-5#3)
daily was##3##2##(1996-1#1)(2007-11#1)(2008-5#1)
daily with##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
daily work##2##2##(1994-1#1)(2013-1#1)
daily##302##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#2)(1990-6#1)(1991-1#2)(1991-11#5)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#6)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#5)(1994-6#2)(1995-1#1)(1995-2#2)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#4)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#4)(2007-12#1)(2008-10#48)(2008-11#24)(2008-12#6)(2008-3#4)(2008-5#9)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#16)(2009-1#1)(2009-11#6)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-2#22)(2011-9#1)(2012-12#1)(2012-2#11)(2012-3#3)(2012-4#1)(2013-1#16)(2013-8#6)
daily) or##2##2##(1996-2#1)(2013-1#1)
daily)##9##1##(1992-11#1)(1992-12#1)(1992-5#1)(1996-11#1)(1996-2#1)(2008-1#1)(2009-11#1)(2013-1#2)
dairy calves of the north-western zone of the Bogota##2##9##(2012-12#2)
dairy calves##3##2##(1997-5#1)(2012-12#2)
dairy cows fed a##2##4##(2013-1#2)
dairy cows##3##2##(1996-8#1)(2013-1#2)
dairy dessert##3##2##(2011-2#3)
dairy farms##3##2##(2012-12#2)(2012-3#1)
dairy goats##4##2##(1996-12#1)(2008-12#2)(2008-9#1)
dairy herds in the southern Netherlands##2##6##(1996-8#2)
dairy herds##6##2##(1990-6#1)(1992-2#1)(1995-9#1)(1996-8#2)(2012-3#1)
dairy products##5##2##(2008-10#3)(2011-2#1)(2012-2#1)
dairy streams##2##2##(2012-2#2)
dairy##49##1##(1990-6#1)(1992-2#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-8#3)(1997-5#2)(2008-10#6)(2008-12#2)(2008-9#1)(2009-11#1)(2011-2#5)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#6)
daisy modes the##2##3##(2007-11#2)
daisy modes##3##2##(2007-11#3)
daisy##6##1##(2007-11#4)(2008-10#2)
daltons##2##1##(1993-3#1)(2008-10#1)
dam water##2##2##(2008-10#2)
dam##6##1##(2008-10#3)(2008-12#2)(2008-4#1)
damage and a##2##3##(1996-3#1)(2012-3#1)
damage and apoptosis##2##3##(2012-12#1)(2013-7#1)
damage and the##4##3##(1994-8#1)(2008-11#2)(2009-6#1)
damage and##38##2##(1990-12#1)(1993-2#1)(1994-8#3)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(2008-10#4)(2008-11#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
damage at##5##2##(2008-11#2)(2008-7#1)(2008-8#1)(2013-8#1)
damage by##7##2##(1992-9#1)(1994-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
damage can be##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
damage can##4##2##(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
damage caused by##5##3##(1990-7#1)(2008-10#2)(2008-12#1)(2011-2#1)
damage caused to##2##3##(2008-10#1)(2008-5#1)
damage caused##7##2##(1990-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)
damage during##6##2##(1991-9#1)(1992-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
damage from##3##2##(2008-10#2)(2012-3#1)
damage in both##2##3##(2008-10#1)(2011-2#1)
damage in children##3##3##(2011-2#3)
damage in the##8##3##(1992-6#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-9#1)
damage in##39##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-6#1)(1992-9#1)(1995-6#2)(1996-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#8)(2012-2#1)(2012-4#2)(2013-1#1)(2013-7#1)
damage induced by##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
damage is##11##2##(2008-10#1)(2008-3#3)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
damage markers##2##2##(2009-8#1)(2012-3#1)
damage may##2##2##(1995-8#1)(2008-9#1)
damage measured##2##2##(2008-10#1)(2010-5#1)
damage morphologies##2##2##(2008-3#2)
damage observed##2##2##(1994-8#1)(2008-11#1)
damage occurred##2##2##(2008-10#1)(2008-3#1)
damage of DNA##2##3##(2008-10#1)(2008-11#1)
damage of the##3##3##(1997-8#1)(2008-10#2)
damage of##9##2##(1992-9#1)(1997-8#1)(2008-10#4)(2008-11#1)(2009-6#1)(2011-2#1)
damage on##5##2##(1993-3#1)(2008-10#2)(2008-8#2)
damage produced##2##2##(2008-10#1)(2013-1#1)
damage rather than##2##3##(2008-5#1)(2011-2#1)
damage resulting in##2##3##(2008-4#1)(2008-5#1)
damage resulting##3##2##(1997-8#1)(2008-4#1)(2008-5#1)
damage that can##2##3##(2010-9#1)(2011-2#1)
damage the##7##2##(1990-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-4#1)(2008-10#1)(2011-2#1)
damage threshold is##2##3##(2008-10#1)(2008-3#1)
damage threshold of##2##3##(2008-3#2)
damage threshold##9##2##(2008-10#5)(2008-3#3)(2013-8#1)
damage thresholds##2##2##(2008-3#2)
damage to DNA##2##3##(2008-10#2)
damage to the cells##2##4##(2008-11#1)(2008-6#1)
damage to the##18##3##(1992-12#1)(1993-2#1)(1994-11#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2012-12#1)
damage to##50##2##(1991-2#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
damage using##2##2##(1994-6#1)(2008-10#1)
damage was observed in##2##4##(1995-8#1)(2008-10#1)
damage was observed##3##3##(1995-8#1)(2008-10#2)
damage was##11##2##(1994-8#2)(1995-11#1)(1995-8#1)(2008-10#4)(2008-5#1)(2010-5#1)(2013-1#1)
damage were##2##2##(2008-10#1)(2012-3#1)
damage when##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
damage with##5##2##(1992-12#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
damage##443##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#5)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#7)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-8#2)(2008-10#91)(2008-11#35)(2008-12#3)(2008-3#20)(2008-4#8)(2008-5#14)(2008-6#1)(2008-7#12)(2008-8#14)(2008-9#18)(2009-1#5)(2009-10#2)(2009-12#3)(2009-5#1)(2009-6#5)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#33)(2011-3#2)(2011-7#2)(2012-12#3)(2012-2#6)(2012-3#8)(2012-4#3)(2013-1#21)(2013-7#2)(2013-8#12)
damage-induced##2##1##(2008-9#1)(2013-8#1)
damaged DNA##2##2##(1993-3#1)(2008-8#1)
damaged and apoptotic cells##3##4##(1995-2#3)
damaged and undamaged plants had equal##2##6##(2008-8#2)
damaged and##6##2##(1995-2#3)(2008-10#1)(2008-8#2)
damaged at##2##2##(2008-11#1)(2013-1#1)
damaged by the##2##3##(2008-10#1)(2008-8#1)
damaged by##8##2##(1990-5#1)(2008-10#3)(2008-7#1)(2008-8#2)(2012-2#1)
damaged cells##6##2##(2008-10#1)(2008-11#1)(2008-7#2)(2010-10#1)(2013-7#1)
damaged hairs##2##2##(2008-5#2)
damaged in##3##2##(2008-10#1)(2009-1#1)(2011-2#1)
damaged neurons##2##2##(1997-2#1)(2008-7#1)
damaged plants##4##2##(2008-8#4)
damaged tissues##2##2##(2008-11#1)(2010-8#1)
damaged##69##1##(1990-11#2)(1990-5#1)(1990-7#1)(1991-2#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-2#4)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#12)(2008-11#6)(2008-5#2)(2008-7#4)(2008-8#9)(2008-9#4)(2009-1#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
damages for##2##2##(1995-12#1)(1996-5#1)
damages induced by##2##3##(1990-6#1)(2009-8#1)
damages of##2##2##(2011-2#1)(2011-3#1)
damages##32##1##(1990-11#1)(1990-6#1)(1992-11#1)(1993-12#1)(1993-8#1)(1995-12#6)(1995-6#3)(1995-8#1)(1996-5#2)(2008-10#4)(2009-12#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#2)
damaging agents##7##2##(2008-10#1)(2008-7#6)
damaging effects of##3##3##(2008-8#1)(2010-5#1)(2013-8#1)
damaging to##2##2##(2008-10#2)
damaging##27##1##(2008-10#10)(2008-11#2)(2008-7#6)(2008-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-8#1)
damped response##2##2##(2008-10#2)
damped##3##1##(2008-10#2)(2008-3#1)
damper system##2##2##(2008-11#2)
damper##3##1##(1997-3#1)(2008-11#2)
damping-off and##2##2##(2008-10#2)
damping-off in##3##2##(2008-10#3)
damping-off of cucumber##3##3##(2008-10#3)
damping-off of radish##2##3##(2008-10#2)
damping-off of sugar beet##2##4##(2008-10#2)
damping-off of##13##2##(2008-10#13)
damping-off was not##2##3##(2008-10#2)
damping-off was##6##2##(2008-10#6)
damping-off##38##1##(2008-10#38)
dams##4##1##(2008-10#4)
damselfish##3##1##(2008-5#3)
damselfly##3##1##(2008-8#2)(2012-3#1)
dance##4##1##(2007-12#1)(2009-1#1)(2009-3#2)
dances##5##1##(2008-11#1)(2010-6#4)
dander##2##1##(1994-9#2)
dandruff##6##1##(2008-5#6)
danger of##11##2##(1990-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-11#1)(1997-4#1)(2008-10#2)(2008-11#1)(2011-2#1)
danger to human##2##3##(2008-10#1)(2013-8#1)
danger##22##1##(1990-11#2)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-11#1)(1997-4#1)(2008-10#7)(2008-11#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-8#1)
dangerous and##2##2##(1991-6#1)(2008-8#1)
dangerous for##2##2##(1994-6#1)(2008-11#1)
dangerous goods##4##2##(2009-10#4)
dangerous to life##3##3##(1996-12#1)(2011-2#2)
dangerous with##2##2##(2012-3#2)
dangerous##30##1##(1990-5#1)(1991-6#1)(1991-8#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#3)(2009-10#4)(2009-6#1)(2010-9#1)(2011-2#4)(2012-3#3)
dangers##9##1##(1992-2#1)(1992-3#1)(1996-11#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-9#1)(2010-5#1)(2013-1#1)
danofloxacin##3##1##(1991-3#3)
dans la littérature médicale##2##4##(2011-2#1)(2013-1#1)
dans la##5##2##(2008-11#1)(2011-2#1)(2013-1#3)
dans##12##1##(2008-11#1)(2008-5#2)(2011-2#2)(2013-1#7)
dansyl amino##2##2##(2008-10#2)
dansyl chloride##3##2##(2008-10#3)
dansyl fluorescence##3##2##(1994-5#1)(2008-10#2)
dansyl peptides##2##2##(1994-5#2)
dansyl tetrapeptide is##2##3##(1994-5#2)
dansyl tripeptides##2##2##(1994-5#2)
dansyl##23##1##(1994-5#12)(2008-10#11)
dansyl-C6-choline##3##1##(1994-5#3)
dansyl-phenylalanine and -sarcosine##2##3##(2008-10#2)
dansyl-threonine##2##1##(2008-10#2)
daptomycin##4##1##(2009-6#1)(2010-6#1)(2011-2#2)
dark and##4##2##(2007-12#1)(2008-10#2)(2008-12#1)
dark brown##5##2##(2008-10#4)(2010-6#1)
dark count##2##2##(2008-3#2)
dark cycle##2##2##(1994-8#1)(1995-11#1)
dark for##3##2##(2008-10#3)
dark green##4##2##(2008-10#1)(2013-8#3)
dark respiration##2##2##(2008-10#2)
dark side##2##2##(1996-1#1)(2008-11#1)
dark toxicity##2##2##(2008-11#2)
dark vegetation covered by atmospheric aerosols##2##6##(2008-3#2)
dark vegetation##3##2##(2008-3#3)
dark##89##1##(1991-5#4)(1993-6#1)(1994-2#1)(1994-8#1)(1995-11#3)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#2)(2007-12#2)(2008-10#31)(2008-11#7)(2008-12#4)(2008-3#12)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#4)
dark-eyed juncos (Junco hyemalis)##2##4##(2008-8#2)
dark-skinned##5##1##(2008-11#3)(2008-5#1)(2011-2#1)
darkened##2##1##(2008-10#2)
darkening##2##1##(2008-5#1)(2008-8#1)
darker##5##1##(1992-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2010-4#1)
darkness and##3##2##(2008-10#3)
darkness at##2##2##(2008-10#1)(2008-12#1)
darkness##18##1##(1994-8#1)(1995-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)
darlingi from##2##2##(2012-12#2)
darlingi##8##1##(2012-12#8)
dasatinib##10##1##(2012-2#6)(2013-1#4)
data (Experiment##2##2##(2013-1#2)
data (a##3##2##(1992-12#1)(1993-12#1)(2013-1#1)
data (e##3##2##(2008-1#1)(2008-9#1)(2013-1#1)
data (i##2##2##(2013-1#2)
data a##2##2##(1997-8#1)(2008-10#1)
data about the##4##3##(2008-10#1)(2008-12#1)(2009-5#1)(2012-3#1)
data about##10##2##(1990-3#1)(1996-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
data access##2##2##(1997-3#1)(1997-7#1)
data acquired##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
data acquisition and##3##3##(2008-10#2)(2008-11#1)
data acquisition##12##2##(1996-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2010-11#1)
data after##2##2##(2011-2#1)(2012-3#1)
data allowed##3##2##(1995-1#1)(2008-10#1)(2008-8#1)
data alone##2##2##(1997-6#1)(2008-11#1)
data along##2##2##(2008-12#1)(2010-8#1)
data also indicate that##2##4##(1993-6#1)(1994-5#1)
data also showed##2##3##(1992-9#1)(2008-5#1)
data also suggest that##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
data also##21##2##(1992-3#1)(1992-9#1)(1993-6#1)(1994-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#1)
data analyses##2##2##(1995-3#1)(1996-12#1)
data analysis and interpretation##2##4##(1996-6#1)(2008-9#1)
data analysis and##11##3##(1991-12#1)(1994-2#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
data analysis in##2##3##(2008-11#1)(2008-12#1)
data analysis of the Michelson Interferometer for Passive Atmospheric Sounding##2##10##(2008-3#2)
data analysis of##4##3##(2008-10#1)(2008-3#2)(2009-6#1)
data analysis was##4##3##(2008-6#2)(2008-7#1)(2010-12#1)
data analysis##64##2##(1991-12#1)(1993-9#1)(1994-2#1)(1996-6#1)(1997-3#2)(2008-10#20)(2008-11#4)(2008-12#4)(2008-3#7)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-2#1)
data and a##3##3##(2008-3#1)(2010-5#1)(2012-3#1)
data and analysis of##2##4##(1995-2#1)(2012-12#1)
data and analysis##3##3##(1995-2#1)(1996-1#1)(2012-12#1)
data and compare##2##3##(2008-3#1)(2009-8#1)
data and information##2##3##(1996-2#1)(2008-12#1)
data and methods##2##3##(1992-3#1)(2006-6#1)
data and model##2##3##(2008-6#1)(2008-7#1)
data and multivariate##3##3##(1992-1#1)(2008-10#2)
data and the##8##3##(1995-12#1)(1995-5#1)(1996-11#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
data and their##2##3##(2009-4#1)(2013-8#1)
data and to##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
data and trapping##2##3##(1996-5#1)(2008-10#1)
data and were used to##2##5##(2008-7#1)(2013-1#1)
data and were##3##3##(1994-12#1)(2008-7#1)(2013-1#1)
data and##124##2##(1990-5#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#29)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#5)(2013-8#4)
data are also presented##3##4##(1991-2#1)(2008-10#2)
data are also##4##3##(1990-5#1)(1991-2#1)(2008-10#2)
data are analyzed##3##3##(1994-2#1)(2008-10#1)(2008-2#1)
data are available for##2##4##(2008-11#1)(2008-7#1)
data are available from##2##4##(1990-3#1)(2011-2#1)
data are available##17##3##(1990-3#1)(1992-6#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
data are being##2##3##(1994-2#2)
data are collected##3##3##(1996-3#1)(2008-10#1)(2008-9#1)
data are compatible with##2##4##(2008-10#1)(2008-8#1)
data are consistent with the hypothesis that##2##7##(2008-10#1)(2008-8#1)
data are consistent with the##5##5##(1994-3#1)(1997-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
data are consistent with##11##4##(1991-5#1)(1992-6#1)(1993-8#1)(1994-3#1)(1997-9#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)
data are consistent##12##3##(1991-5#1)(1992-6#1)(1993-8#1)(1994-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
data are critical##2##3##(1997-3#1)(2013-1#1)
data are discussed##3##3##(1994-2#1)(2008-10#1)(2009-4#1)
data are not##4##3##(1991-12#1)(2008-10#1)(2010-7#1)(2011-3#1)
data are presented##6##3##(1991-3#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)
data are processed##3##3##(2008-10#2)(2008-3#1)
data are required##2##3##(2008-10#1)(2010-11#1)
data are subsequently##2##3##(2008-11#1)(2008-5#1)
data are used to##3##4##(1995-2#1)(2009-11#1)(2013-1#1)
data are used##6##3##(1995-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-8#1)(2013-1#1)
data are##119##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-6#2)(1993-8#1)(1994-1#2)(1994-2#4)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#1)(1997-9#1)(2008-10#28)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
data arrays##2##2##(2008-10#2)
data as a##4##3##(2008-10#1)(2008-5#1)(2013-1#2)
data as well as##5##4##(1991-3#1)(1996-3#1)(2008-3#1)(2010-5#1)(2013-8#1)
data as##15##2##(1991-3#1)(1994-9#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#2)(2013-8#1)
data assessment##2##2##(1994-3#1)(2008-11#1)
data associated with##2##3##(2008-10#2)
data at the##2##3##(2008-10#1)(2008-2#1)
data at##12##2##(1990-8#1)(1993-3#2)(2008-10#5)(2008-11#1)(2008-2#1)(2010-3#1)(2013-1#1)
data available from the##3##4##(1993-8#1)(2008-10#1)(2010-6#1)
data available on the##2##4##(1994-12#1)(2008-12#1)
data available on##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
data available##14##2##(1990-9#1)(1993-8#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2010-6#1)(2012-12#2)(2013-8#1)
data bank##3##2##(1995-11#2)(2008-10#1)
data banks##5##2##(1995-2#1)(1995-9#1)(2008-10#1)(2008-4#1)(2008-5#1)
data base##11##2##(1991-2#2)(1993-12#3)(1994-3#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
data based on the##2##4##(2008-10#1)(2008-9#1)
data based on##5##3##(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)
data bases##8##2##(1993-3#1)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
data basis##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
data be##3##2##(1992-3#1)(1993-11#1)(1993-12#1)
data being##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)
data between##2##2##(2008-11#1)(2013-1#1)
data by##17##2##(1992-2#1)(2008-10#8)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#1)(2011-9#1)(2012-3#1)(2013-1#2)
data calculated using##2##3##(2008-10#1)(2013-8#1)
data can be obtained##2##4##(2008-10#2)
data can be used to##3##5##(2008-1#1)(2008-11#1)(2010-6#1)
data can be used##5##4##(2008-1#1)(2008-11#1)(2010-6#1)(2010-8#1)(2011-1#1)
data can be##13##3##(1991-2#1)(1993-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)
data can##20##2##(1991-2#1)(1993-12#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)
data capture##6##2##(1997-3#1)(2008-11#1)(2009-3#1)(2010-8#3)
data clearly##3##2##(1996-12#1)(2010-11#1)(2012-2#1)
data collected by the##2##4##(1992-2#1)(1994-6#1)
data collected from a##3##4##(1996-2#1)(2008-10#2)
data collected from##12##3##(1994-9#1)(1996-2#1)(2008-10#7)(2012-12#1)(2013-1#1)(2013-8#1)
data collected in a##2##4##(1997-4#1)(2009-8#1)
data collected in##6##3##(1997-4#1)(2008-10#3)(2009-8#1)(2012-3#1)
data collected over a##2##4##(2008-10#1)(2012-12#1)
data collected through##3##3##(1990-12#1)(2008-11#1)(2011-2#1)
data collected##32##2##(1990-12#1)(1992-2#2)(1994-6#2)(1994-9#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#13)(2008-11#1)(2008-12#2)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
data collection and analysis##3##4##(1994-3#1)(2008-11#1)(2012-2#1)
data collection and##8##3##(1994-12#1)(1994-3#1)(1995-1#1)(1997-3#1)(2008-11#1)(2010-5#1)(2012-12#1)(2012-2#1)
data collection are##2##3##(1992-1#1)(2008-8#1)
data collection interface##2##3##(2010-8#2)
data collection is##2##3##(1993-3#1)(1994-12#1)
data collection methods##2##3##(1995-2#1)(2012-2#1)
data collection system##2##3##(1991-8#1)(1993-3#1)
data collection time##2##3##(2008-3#2)
data collection was##3##3##(1990-12#1)(2008-11#1)(2011-2#1)
data collection##58##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-12#1)(1993-3#4)(1994-12#4)(1994-3#1)(1995-1#1)(1995-2#6)(1997-2#1)(1997-3#4)(2007-12#1)(2008-10#1)(2008-11#6)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#7)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
data compared##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
data compression and visualization##2##4##(2008-10#2)
data compression and##3##3##(2008-10#3)
data compression##4##2##(2008-10#3)(2013-8#1)
data concerning the##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
data concerning##9##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#2)(2013-8#2)
data confirm that##7##3##(1990-8#1)(1991-6#1)(1994-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
data confirm the##2##3##(2007-8#1)(2008-10#1)
data confirm##9##2##(1990-8#1)(1991-6#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
data confirmed that##2##3##(2008-12#1)(2008-9#1)
data confirmed##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
data content##2##2##(1997-3#1)(2010-5#1)
data corresponding to the##2##4##(2008-10#2)
data corresponding to##4##3##(2008-10#4)
data could be obtained##2##4##(2008-10#1)(2011-2#1)
data could##4##2##(1994-9#1)(1997-3#1)(2008-10#1)(2011-2#1)
data covering##2##2##(2008-10#1)(2009-10#1)
data currently##3##2##(1997-2#1)(2011-3#1)(2012-2#1)
data demonstrate a##2##3##(1992-7#1)(2009-10#1)
data demonstrate that the##2##4##(2008-10#1)(2008-11#1)
data demonstrate that##19##3##(1992-6#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2009-6#2)(2012-5#1)(2013-8#1)
data demonstrate the##5##3##(1990-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
data demonstrate##27##2##(1990-11#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#2)(2011-2#1)(2012-5#1)(2013-8#1)
data demonstrated that the##2##4##(2008-10#2)
data demonstrated that##6##3##(1996-12#1)(2008-10#3)(2011-2#1)(2011-3#1)
data demonstrated##7##2##(1996-12#1)(1996-6#1)(2008-10#3)(2011-2#1)(2011-3#1)
data demonstrating##4##2##(2008-3#1)(2010-5#1)(2011-2#2)
data derived from##7##3##(1993-12#1)(1995-5#1)(1996-11#1)(2008-10#2)(2008-11#1)(2010-10#1)
data derived##8##2##(1993-12#1)(1995-5#1)(1996-11#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-8#1)
data described in the##2##4##(2008-10#1)(2013-1#1)
data describing##3##2##(2008-10#1)(2010-10#2)
data detection##2##2##(2008-3#1)(2012-3#1)
data directly##2##2##(2008-10#1)(2008-4#1)
data do not support##3##4##(1997-5#1)(2008-8#1)(2011-2#1)
data do not##9##3##(1993-6#1)(1997-5#1)(2008-10#2)(2008-8#2)(2009-4#1)(2011-2#2)
data entry##2##2##(1994-2#1)(2013-1#1)
data evaluation##3##2##(2008-10#2)(2008-11#1)
data exchange as swift and##2##5##(1995-12#1)(1996-1#1)
data exists##3##2##(2008-4#1)(2013-1#2)
data extracted##3##2##(1991-2#1)(1993-12#1)(2013-1#1)
data fields##2##2##(2008-11#1)(2010-8#1)
data file##2##2##(2008-4#1)(2008-9#1)
data files##7##2##(1997-2#2)(2008-11#1)(2008-9#4)
data followed##3##2##(2008-10#3)
data for a##5##3##(1994-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
data for all##2##3##(1995-1#1)(2013-1#1)
data for dioxins and##2##4##(2008-10#2)
data for each##3##3##(1992-9#1)(2008-11#1)(2009-11#1)
data for penile##2##3##(2011-1#2)
data for populations of##2##4##(2008-10#1)(2008-8#1)
data for six##2##3##(1992-7#1)(2008-10#1)
data for some##3##3##(2008-10#3)
data for the calibration plots showed good linear relationship with r(2)=0##2##11##(2008-10#2)
data for the determination of the##2##6##(2008-10#2)
data for the determination of##4##5##(2008-10#4)
data for the first##2##4##(1991-10#1)(2010-6#1)
data for the##22##3##(1991-10#1)(1993-3#2)(1996-2#1)(2008-10#14)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
data for these##2##3##(1997-2#1)(2008-10#1)
data for this study##2##4##(1996-1#1)(2010-7#1)
data for##120##2##(1990-2#1)(1991-10#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2008-1#1)(2008-10#44)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#6)(2008-9#1)(2009-11#2)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
data found in the literature##2##5##(1990-9#1)(2008-7#1)
data found##3##2##(1990-9#1)(2008-10#1)(2008-7#1)
data from 1##2##3##(2008-8#1)(2010-5#1)
data from a group of##2##5##(2008-10#1)(2010-12#1)
data from a sample of##3##5##(1995-2#1)(1997-4#1)(2008-12#1)
data from a##27##3##(1991-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
data from all##4##3##(2008-10#3)(2008-11#1)
data from an##6##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)
data from both##3##3##(2008-10#1)(2008-3#1)(2010-1#1)
data from clinical##2##3##(1995-5#1)(2013-8#1)
data from computer-based journals##2##4##(1994-6#2)
data from different##4##3##(1994-9#1)(2008-10#1)(2008-7#1)(2011-1#1)
data from field##2##3##(2008-10#1)(2008-9#1)
data from four##3##3##(1993-12#1)(2008-10#2)
data from many##2##3##(1994-2#1)(2008-7#1)
data from more##2##3##(2008-10#1)(2009-11#1)
data from multiple##2##3##(2010-10#1)(2010-4#1)
data from natural populations##2##4##(2008-9#1)(2012-3#1)
data from non-fused and non-pi-complexed pentafulvenes##2##6##(2008-10#2)
data from other##3##3##(1996-3#1)(2008-3#1)(2008-5#1)
data from patients##2##3##(2010-11#1)(2011-2#1)
data from previous##2##3##(2008-10#1)(2011-2#1)
data from prospective##2##3##(2009-7#1)(2011-2#1)
data from the Medicare Current Beneficiary Survey (MCBS)##3##8##(1995-12#2)(1997-2#1)
data from the Medicare##6##4##(1993-1#1)(1993-3#1)(1995-12#2)(1995-2#1)(1997-2#1)
data from the National Health Interview Survey##2##7##(1995-12#1)(1996-5#1)
data from the National Health##3##5##(1995-12#1)(1996-5#1)(2010-12#1)
data from the National Longitudinal Study of Adolescent Health##2##9##(2009-7#1)(2013-8#1)
data from the National##7##4##(1995-12#1)(1996-5#1)(1997-3#1)(2009-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
data from the first##2##4##(1994-1#1)(2008-10#1)
data from the literature##2##4##(1991-12#1)(2012-3#1)
data from the ongoing##2##4##(2008-5#1)(2012-2#1)
data from the##76##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#4)(1995-12#3)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(2008-10#11)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#2)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#1)
data from these##2##3##(2008-3#1)(2012-3#1)
data from this study##3##4##(2008-1#1)(2008-10#2)
data from this##4##3##(1996-3#1)(2008-1#1)(2008-10#2)
data from two##5##3##(1992-2#1)(2008-8#1)(2009-10#1)(2009-11#1)(2012-3#1)
data from various##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
data from##268##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-1#4)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1994-1#2)(1994-2#2)(1994-3#3)(1994-6#6)(1994-9#2)(1995-12#3)(1995-2#2)(1995-5#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#2)(1997-4#1)(2008-1#2)(2008-10#54)(2008-11#18)(2008-12#4)(2008-2#1)(2008-3#10)(2008-5#3)(2008-7#5)(2008-8#12)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#19)(2011-3#1)(2011-7#1)(2011-8#1)(2011-9#1)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#6)(2013-8#4)
data further##2##2##(1990-2#1)(2008-11#1)
data generated from##3##3##(2008-10#2)(2008-4#1)
data generated##11##2##(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)
data had##3##2##(1997-3#1)(2008-3#1)(2009-6#1)
data handling##3##2##(2008-4#1)(2011-2#2)
data has been##6##3##(1995-12#1)(2008-10#2)(2009-12#1)(2009-3#1)(2010-8#1)
data has##17##2##(1993-12#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#2)(2010-1#1)(2010-8#1)(2011-3#1)(2013-1#1)
data have been investigated##2##4##(1994-6#1)(2008-10#1)
data have been processed##3##4##(1997-5#1)(2008-10#2)
data have been##21##3##(1991-3#1)(1994-6#1)(1997-5#1)(2008-10#12)(2008-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
data have implications##2##3##(2010-6#1)(2012-3#1)
data have to##2##3##(2008-10#1)(2009-4#1)
data have##37##2##(1991-12#1)(1991-3#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-2#1)(1997-5#1)(2008-1#2)(2008-10#14)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)
data highlight a##2##3##(2008-10#1)(2012-2#1)
data highlight the##2##3##(2013-1#1)(2013-8#1)
data highlight##5##2##(1993-3#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
data identified##3##2##(2008-10#2)(2012-2#1)
data illustrate##2##2##(1995-6#1)(2010-8#1)
data illustrated that##2##3##(2008-10#1)(2008-11#1)
data implicate##2##2##(1995-11#1)(1997-2#1)
data in a##8##3##(1995-12#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-3#1)
data in multiwavelength mode##2##4##(2008-10#2)
data in order to##4##4##(2008-10#2)(2008-11#2)
data in our##2##3##(1997-8#1)(2008-11#1)
data in the literature##3##4##(1990-6#1)(1991-12#1)(2008-10#1)
data in the##15##3##(1990-6#1)(1991-12#1)(1993-9#1)(1995-12#1)(2008-10#4)(2008-3#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)
data in this##3##3##(1992-1#1)(2010-2#1)(2013-1#1)
data in##66##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-9#1)(1995-12#2)(1995-5#1)(1996-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
data included##3##2##(1997-3#1)(2008-7#1)(2012-5#1)
data indicate a##3##3##(1992-2#1)(1995-6#1)(2008-10#1)
data indicate that a##4##4##(1994-5#1)(1995-12#1)(2008-10#1)(2008-4#1)
data indicate that the##17##4##(1990-8#2)(1995-12#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#1)
data indicate that##78##3##(1990-12#1)(1990-8#2)(1991-1#1)(1991-12#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#2)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#15)(2008-11#6)(2008-3#1)(2008-4#1)(2008-7#7)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
data indicate the##2##3##(1997-6#1)(2008-10#1)
data indicate##89##2##(1990-12#1)(1990-8#2)(1991-1#1)(1991-12#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#2)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#17)(2008-11#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
data indicated a##2##3##(1993-3#1)(2008-10#1)
data indicated that the##3##4##(2008-10#3)
data indicated that##13##3##(1990-7#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#6)(2008-11#2)(2010-8#1)
data indicated the presence of two##2##6##(1994-3#1)(2008-10#1)
data indicated##19##2##(1990-7#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-2#1)(2008-10#9)(2008-11#2)(2010-8#1)
data indicates that the##3##4##(1994-5#1)(2008-10#1)(2008-7#1)
data indicates that##5##3##(1994-2#1)(1994-5#1)(2008-10#2)(2008-7#1)
data indicating##2##2##(2009-12#1)(2011-2#1)
data integration##2##2##(2011-3#1)(2012-3#1)
data interpretation##5##2##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#2)
data into##8##2##(1997-3#2)(2008-10#2)(2008-11#1)(2008-6#1)(2010-9#1)(2012-12#1)
data is available##2##3##(2009-7#1)(2010-10#1)
data is described##2##3##(1995-12#1)(1997-1#1)
data is presented##3##3##(2008-10#3)
data is studied##2##3##(1995-12#1)(2008-10#1)
data is##37##2##(1990-2#1)(1991-9#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1997-1#1)(2008-10#12)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-10#1)(2013-1#1)(2013-8#1)
data it##3##2##(1991-12#1)(1996-3#1)(2008-11#1)
data linking##2##2##(2008-10#1)(2009-8#1)
data management##8##2##(1994-2#1)(1994-3#1)(1997-1#1)(2008-2#1)(2010-11#1)(2010-5#2)(2010-8#1)
data matrices##4##2##(1995-5#1)(2008-10#2)(2012-2#1)
data matrix##5##2##(2008-10#4)(2008-5#1)
data may be used##2##4##(2008-12#1)(2009-12#1)
data may be##4##3##(2008-11#1)(2008-12#1)(2009-12#1)(2013-8#1)
data may have##2##3##(2011-2#1)(2013-8#1)
data may##11##2##(1992-8#1)(1993-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
data measured at##2##3##(2008-10#2)
data measured by##3##3##(2008-10#2)(2008-11#1)
data measured##9##2##(2008-10#5)(2008-11#1)(2008-3#2)(2010-1#1)
data mining method##2##3##(2008-10#1)(2010-8#1)
data mining##9##2##(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#2)(2010-10#1)(2010-8#2)
data model##2##2##(1997-3#2)
data monitoring##3##2##(1996-6#2)(2011-2#1)
data necessary for##2##3##(2008-10#1)(2008-12#1)
data needs##2##2##(1991-2#1)(1994-2#1)
data not##2##2##(2008-7#1)(2008-9#1)
data obtained are##2##3##(2008-10#2)
data obtained at##3##3##(2008-2#1)(2011-1#1)(2013-1#1)
data obtained by the##4##4##(2008-10#3)(2012-12#1)
data obtained by##16##3##(1995-3#1)(2008-10#14)(2012-12#1)
data obtained for##2##3##(2008-10#2)
data obtained from a##2##4##(2008-10#1)(2012-2#1)
data obtained from this##2##4##(2008-10#2)
data obtained from##20##3##(1994-5#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2012-2#1)
data obtained in##6##3##(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
data obtained on solutions containing##2##5##(2008-10#2)
data obtained on##3##3##(1993-8#1)(2008-10#2)
data obtained using the##4##4##(2008-10#4)
data obtained using##7##3##(2008-10#7)
data obtained with different##2##4##(2008-10#1)(2008-11#1)
data obtained with##7##3##(1993-3#1)(2008-10#3)(2008-11#3)
data obtained##79##2##(1991-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#44)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
data of a##3##3##(1991-3#1)(2008-10#2)
data of all##2##3##(2008-5#1)(2013-8#1)
data of both##2##3##(2008-10#1)(2008-2#1)
data of different##2##3##(2008-11#1)(2008-7#1)
data of the##24##3##(1995-12#1)(1997-8#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-9#2)(2010-8#1)(2011-3#1)(2013-1#2)
data of##71##2##(1991-3#2)(1991-5#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-12#3)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-9#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
data on health##3##3##(1995-3#1)(1997-3#1)(2008-9#1)
data on its##2##3##(2008-11#1)(2010-12#1)
data on renal##2##3##(2008-1#2)
data on the diagnostic##2##4##(2008-12#2)
data on the effect of##2##5##(2009-8#1)(2011-2#1)
data on the##49##3##(1991-12#1)(1991-3#3)(1991-8#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
data on their##5##3##(1996-3#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
data on this##2##3##(1992-3#1)(2008-12#1)
data on which##2##3##(2010-11#1)(2011-8#1)
data on##161##2##(1990-8#1)(1991-12#1)(1991-3#5)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-12#4)(1995-2#1)(1995-3#2)(1996-2#2)(1996-3#3)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-1#4)(2008-10#20)(2008-11#15)(2008-12#7)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#8)(2008-9#7)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#10)(2011-3#1)(2011-8#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#1)
data or##5##2##(1990-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
data patterns and##2##3##(2008-10#1)(2012-2#1)
data patterns##5##2##(1994-9#1)(2008-10#2)(2012-2#2)
data point to##2##3##(2008-7#1)(2011-2#1)
data points##15##2##(2008-10#7)(2008-2#1)(2008-4#5)(2008-5#1)(2013-8#1)
data presented in##2##3##(1993-12#1)(2008-12#1)
data presented##10##2##(1993-12#1)(1996-2#1)(2008-10#5)(2008-12#1)(2012-3#2)
data pretreatment##2##2##(2008-10#2)
data processed by##2##3##(2008-10#2)
data processing##12##2##(1993-3#1)(1995-5#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-8#1)
data proved##2##2##(2008-10#1)(2008-9#1)
data provide a##3##3##(2008-11#1)(2012-5#1)(2013-1#1)
data provide direct evidence##2##4##(2008-7#1)(2009-8#1)
data provide evidence for##3##4##(1993-12#1)(1995-11#1)(2008-10#1)
data provide evidence that##3##4##(1995-8#1)(2008-10#1)(2008-9#1)
data provide evidence##8##3##(1993-12#1)(1995-11#1)(1995-8#2)(2008-10#2)(2008-9#1)(2013-1#1)
data provide the first##4##4##(1994-5#1)(2008-10#2)(2010-11#1)
data provide##27##2##(1990-8#1)(1992-1#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-8#2)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-11#1)(2012-2#1)(2012-5#1)(2013-1#2)
data provided##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
data provides##4##2##(1995-5#1)(2010-3#1)(2012-3#1)(2013-1#1)
data published##3##2##(2008-10#2)(2012-3#1)
data quality##7##2##(2008-10#2)(2008-3#1)(2010-1#3)(2010-7#1)
data received from##2##3##(2008-10#1)(2008-11#1)
data recorded during##2##3##(2008-11#1)(2010-8#1)
data recorded##6##2##(2008-10#2)(2008-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
data reduction and analysis##2##4##(2008-2#1)(2008-3#1)
data refer to##2##3##(2008-10#1)(2008-12#1)
data reflect##2##2##(1991-12#1)(2011-2#1)
data regarding the##9##3##(2008-10#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#4)(2013-8#1)
data regarding##15##2##(1997-2#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
data related to##4##3##(1991-2#1)(1997-3#1)(2008-10#2)
data relating to##2##3##(1991-8#1)(1993-11#1)
data represents a##2##3##(2008-10#1)(2008-11#1)
data require##2##2##(2008-10#1)(2013-1#1)
data requirements##2##2##(2011-2#1)(2013-1#1)
data requires##2##2##(2008-11#1)(2008-4#1)
data reveal that##7##3##(1990-11#1)(1994-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
data reveal##10##2##(1990-11#1)(1994-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)
data revealed a##3##3##(2008-10#2)(2012-2#1)
data revealed that##5##3##(2008-10#3)(2008-11#1)(2009-10#1)
data revealed three##2##3##(2008-10#1)(2008-5#1)
data revealed##15##2##(2008-10#8)(2008-11#2)(2008-5#2)(2009-10#1)(2010-2#1)(2012-2#1)
data reviewed##2##2##(2008-7#1)(2013-1#1)
data separated isolates##2##3##(2008-10#2)
data set and##2##3##(2008-10#2)
data set are##2##3##(1990-2#1)(2008-8#1)
data set clustered in three groups according to the three types of plants##2##13##(2008-10#2)
data set of the##3##4##(1995-12#1)(2008-10#2)
data set of##6##3##(1995-12#1)(2008-10#5)
data set##51##2##(1990-2#1)(1994-12#1)(1995-12#1)(1995-9#1)(1997-6#1)(2008-10#34)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)
data sets and##5##3##(2008-10#3)(2008-7#1)(2012-2#1)
data sets at the leaflet##2##5##(2008-10#2)
data sets at the##4##4##(2008-10#4)
data sets for##2##3##(1996-2#1)(2012-2#1)
data sets from##3##3##(2008-10#2)(2008-11#1)
data sets of##2##3##(2008-10#1)(2010-11#1)
data sets reveals##2##3##(2010-10#1)(2010-7#1)
data sets using##3##3##(2008-10#2)(2008-6#1)
data sets was##2##3##(2008-10#2)
data sets were##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
data sets##71##2##(1995-9#1)(1996-2#1)(2008-10#43)(2008-11#6)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2012-2#2)(2012-3#1)(2013-1#1)
data sharing##3##2##(1995-3#1)(1996-3#1)(2011-2#1)
data should be##2##3##(1997-5#1)(2008-10#1)
data should##3##2##(1997-1#1)(1997-5#1)(2008-10#1)
data show a##2##3##(1994-12#1)(2008-11#1)
data show that the##7##4##(1993-1#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
data show that these##2##4##(1993-2#1)(2008-10#1)
data show that##34##3##(1990-5#2)(1991-3#1)(1992-12#1)(1993-1#2)(1993-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(2007-11#1)(2008-10#6)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-1#1)
data show##40##2##(1990-5#2)(1991-3#1)(1991-6#1)(1992-12#1)(1993-1#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#3)(2013-1#1)
data showed a##2##3##(2008-1#1)(2008-10#1)
data showed that the##2##4##(2008-11#1)(2008-9#1)
data showed that##13##3##(1993-1#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
data showed##18##2##(1991-3#1)(1993-1#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
data showing##3##2##(2008-11#1)(2008-7#1)(2009-8#1)
data shows that the##2##4##(1991-8#1)(2008-11#1)
data shows that##3##3##(1991-8#1)(2008-11#2)
data shows##4##2##(1991-8#1)(2008-11#2)(2008-12#1)
data so##2##2##(2008-10#2)
data sources to##2##3##(1991-3#1)(2009-10#1)
data sources were used##2##4##(1995-1#1)(1996-2#1)
data sources##9##2##(1991-2#2)(1991-3#1)(1995-1#1)(1996-2#2)(2008-12#1)(2009-10#1)(2009-11#1)
data standards##3##2##(1997-3#1)(2008-7#1)(2010-8#1)
data storage##6##2##(2007-12#1)(2008-3#4)(2008-7#1)
data strongly##2##2##(1996-5#1)(1997-7#1)
data structure##8##2##(1995-5#1)(2008-10#4)(2008-6#2)(2010-5#1)
data such as##3##3##(2008-10#1)(2008-4#1)(2010-1#1)
data such##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-1#1)
data suggest a##4##3##(1994-3#1)(1995-6#1)(2008-5#1)(2012-2#1)
data suggest that P##2##4##(2008-10#1)(2008-12#1)
data suggest that a##4##4##(1995-2#1)(2008-10#2)(2012-3#1)
data suggest that both##2##4##(1997-2#1)(2013-1#1)
data suggest that certain##2##4##(2008-10#1)(2008-11#1)
data suggest that not##2##4##(1992-3#1)(2008-12#1)
data suggest that the ability##2##5##(1992-10#1)(2008-10#1)
data suggest that the##33##4##(1990-11#1)(1990-2#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-5#2)(2008-9#2)(2011-2#2)(2012-3#1)(2013-7#1)
data suggest that there##2##4##(2008-10#1)(2008-11#1)
data suggest that this##3##4##(1990-11#1)(1996-12#1)(2012-3#1)
data suggest that##140##3##(1990-11#2)(1990-2#2)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#6)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-6#3)(1996-11#1)(1996-12#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#27)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-10#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#1)
data suggest the##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
data suggest##155##2##(1990-11#2)(1990-2#2)(1990-5#3)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#6)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#4)(1996-11#1)(1996-12#4)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#29)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-10#1)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#2)(2013-7#1)
data suggested that the##2##4##(2008-11#1)(2008-12#1)
data suggested that##8##3##(1990-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)(2012-12#1)
data suggested##11##2##(1990-6#1)(1991-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
data suggests that the##2##4##(2008-5#1)(2011-1#1)
data suggests that##6##3##(1994-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)
data suggests##9##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
data support a##3##3##(1993-12#1)(2008-10#1)(2013-1#1)
data support the hypothesis that##5##5##(1992-6#1)(1997-3#1)(2007-12#1)(2008-10#2)
data support the##8##3##(1992-6#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
data support##13##2##(1992-6#1)(1993-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
data supporting##2##2##(1994-1#1)(2008-11#1)
data supports##2##2##(2008-10#1)(2012-2#1)
data surrounding the##2##3##(1997-6#1)(2008-7#1)
data systems##8##2##(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#3)
data that can be##2##4##(2008-10#1)(2011-2#1)
data that demonstrate##2##3##(2008-11#1)(2008-7#1)
data that the##4##3##(1990-5#1)(2008-10#1)(2008-11#2)
data that will##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
data that##36##2##(1990-5#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(2008-10#5)(2008-11#7)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#6)(2013-1#1)
data the##3##2##(1997-4#1)(2008-2#1)(2010-11#1)
data there##2##2##(1995-5#1)(2008-7#1)
data they##2##2##(1994-12#1)(2012-2#1)
data through##5##2##(1997-1#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
data to an unstructured##3##4##(2013-1#3)
data to an##4##3##(2008-10#1)(2013-1#3)
data to be##3##3##(2007-12#1)(2008-10#2)
data to estimate the##2##4##(1992-12#1)(2008-7#1)
data to estimate##4##3##(1992-12#1)(2008-10#2)(2008-7#1)
data to evaluate##3##3##(1993-1#1)(1996-3#1)(2010-6#1)
data to examine##4##3##(1996-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
data to identify##3##3##(1997-3#1)(2008-12#1)(2010-1#1)
data to inform##4##3##(1997-3#1)(2008-11#1)(2008-12#1)(2010-10#1)
data to monitor##2##3##(1993-12#1)(1994-1#1)
data to obtain##2##3##(1996-12#1)(2008-10#1)
data to pathotype 1##2##4##(2008-10#2)
data to predict##2##3##(2008-8#1)(2009-8#1)
data to support##2##3##(2008-10#1)(2008-5#1)
data to the##4##3##(2008-10#2)(2008-2#1)(2010-4#1)
data to##81##2##(1991-2#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#1)(1994-9#1)(1995-2#3)(1996-1#2)(1996-12#3)(1996-3#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#5)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#9)(2013-8#1)
data together with##3##3##(1990-2#1)(2008-7#1)(2013-1#1)
data transformations have##2##3##(2008-10#2)
data transformations##3##2##(2008-10#3)
data treatment##4##2##(2008-10#4)
data types##2##2##(2008-11#1)(2011-2#1)
data typically##2##2##(2008-1#1)(2008-8#1)
data used in this##2##4##(2008-10#2)
data used in##3##3##(1997-2#1)(2008-10#2)
data used##6##2##(1994-12#1)(1997-2#1)(2008-10#3)(2008-8#1)
data using a##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
data using an##2##3##(1992-3#1)(2009-8#1)
data using principal component analysis (PCA)##2##6##(2008-10#2)
data using the##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
data using##23##2##(1992-2#1)(1992-3#1)(1996-1#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
data via##2##2##(2010-7#1)(2012-3#1)
data was analysed##3##3##(2011-2#1)(2012-2#2)
data was analyzed##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
data was collected by##2##4##(2011-2#2)
data was collected##3##3##(1991-2#1)(2011-2#2)
data was obtained##2##3##(2008-10#1)(2008-11#1)
data was performed##2##3##(2008-10#1)(2008-12#1)
data was used to##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
data was used##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
data was##48##2##(1991-2#2)(1995-8#1)(1996-1#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#2)(2008-7#2)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#5)
data we##5##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
data were acquired using##2##4##(2008-10#1)(2012-3#1)
data were acquired##3##3##(2008-10#2)(2012-3#1)
data were also##4##3##(1991-3#1)(2008-10#2)(2008-2#1)
data were analysed by##2##4##(2008-10#1)(2009-6#1)
data were analysed##4##3##(2008-10#2)(2008-9#1)(2009-6#1)
data were analyzed by##2##4##(1990-2#1)(2013-1#1)
data were analyzed in terms of##2##6##(2008-10#2)
data were analyzed##10##3##(1990-2#1)(1990-6#1)(1995-12#1)(2008-10#2)(2008-12#1)(2009-10#1)(2013-1#2)(2013-8#1)
data were available##2##3##(2008-12#1)(2012-3#1)
data were collected at##2##4##(2008-5#1)(2010-1#1)
data were collected by##2##4##(2008-11#1)(2009-12#1)
data were collected for##2##4##(2008-10#1)(2008-5#1)
data were collected from##3##4##(1993-12#1)(2010-11#1)(2013-1#1)
data were collected to##2##4##(2008-7#1)(2008-8#1)
data were collected using##3##4##(2008-11#1)(2013-1#2)
data were collected##24##3##(1993-12#1)(1993-6#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#5)
data were compared to##2##4##(1991-12#1)(2008-9#1)
data were compared with##3##4##(2008-10#2)(2008-12#1)
data were compared##5##3##(1991-12#1)(2008-10#2)(2008-12#1)(2008-9#1)
data were consistent with##2##4##(1991-8#1)(2008-10#1)
data were evaluated by##2##4##(2008-10#2)
data were extracted##2##3##(2013-1#2)
data were fitted to##2##4##(2008-10#1)(2008-11#1)
data were fitted##3##3##(2008-10#2)(2008-11#1)
data were generated##2##3##(2008-10#1)(2008-3#1)
data were in##2##3##(2008-10#1)(2008-12#1)
data were not##2##3##(2008-10#2)
data were obtained for##3##4##(1991-1#1)(2008-10#1)(2013-1#1)
data were obtained from##4##4##(1990-2#1)(1990-8#1)(1995-12#1)(2011-1#1)
data were obtained##10##3##(1990-2#1)(1990-8#1)(1991-1#1)(1995-12#1)(2008-10#3)(2008-3#1)(2011-1#1)(2013-1#1)
data were processed by##2##4##(2008-10#2)
data were processed##3##3##(2008-10#3)
data were recorded##4##3##(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
data were subjected to##2##4##(2008-10#1)(2013-1#1)
data were taken from##2##4##(1996-11#1)(2008-10#1)
data were then##4##3##(2008-10#2)(2009-12#1)(2011-2#1)
data were used to##12##4##(1991-1#1)(2008-10#7)(2008-8#1)(2009-8#2)(2011-2#1)
data were used##13##3##(1991-1#1)(2008-10#7)(2008-8#1)(2009-8#2)(2010-10#1)(2011-2#1)
data were##133##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-12#3)(1996-11#1)(1996-12#1)(1996-8#1)(2008-1#1)(2008-10#51)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#5)(2013-1#13)(2013-8#1)
data when##2##2##(2008-10#1)(2008-8#1)
data which##5##2##(1992-12#1)(2008-10#1)(2008-12#1)(2010-12#1)(2013-8#1)
data will be##3##3##(1996-3#1)(1997-3#1)(2008-4#1)
data will##7##2##(1996-3#1)(1997-3#1)(2008-10#1)(2008-4#1)(2010-8#1)(2010-9#1)(2011-3#1)
data with a##5##3##(2008-10#1)(2008-2#1)(2008-7#2)(2009-6#1)
data with the##4##3##(1994-3#1)(1995-5#1)(2008-11#2)
data with these##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
data with##33##2##(1990-5#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-9#2)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
data would##2##2##(2008-10#1)(2008-11#1)
data##3689##1##(1990-11#7)(1990-12#5)(1990-2#9)(1990-3#4)(1990-5#12)(1990-6#3)(1990-7#1)(1990-8#11)(1990-9#9)(1991-1#6)(1991-10#1)(1991-11#4)(1991-12#22)(1991-2#18)(1991-3#17)(1991-5#6)(1991-6#4)(1991-7#1)(1991-8#6)(1991-9#2)(1992-1#9)(1992-10#1)(1992-11#1)(1992-12#10)(1992-2#16)(1992-3#13)(1992-5#1)(1992-6#9)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#13)(1993-11#4)(1993-12#21)(1993-2#8)(1993-3#28)(1993-6#7)(1993-8#13)(1993-9#5)(1994-1#14)(1994-11#8)(1994-12#14)(1994-2#24)(1994-3#18)(1994-5#12)(1994-6#14)(1994-8#3)(1994-9#17)(1995-1#8)(1995-11#8)(1995-12#44)(1995-2#30)(1995-3#8)(1995-5#23)(1995-6#12)(1995-8#7)(1995-9#21)(1996-1#15)(1996-11#7)(1996-12#19)(1996-2#26)(1996-3#23)(1996-5#4)(1996-6#8)(1996-8#1)(1997-1#11)(1997-2#41)(1997-3#53)(1997-4#4)(1997-5#5)(1997-6#11)(1997-7#5)(1997-8#12)(1997-9#1)(2006-6#1)(2007-11#5)(2007-12#17)(2007-8#2)(2007-9#1)(2008-1#25)(2008-10#1009)(2008-11#254)(2008-12#65)(2008-2#24)(2008-3#122)(2008-4#50)(2008-5#59)(2008-6#24)(2008-7#103)(2008-8#94)(2008-9#78)(2009-1#1)(2009-10#29)(2009-11#13)(2009-12#12)(2009-3#8)(2009-4#13)(2009-5#8)(2009-6#11)(2009-7#12)(2009-8#24)(2009-9#5)(2010-1#17)(2010-10#34)(2010-11#21)(2010-12#18)(2010-2#6)(2010-3#9)(2010-4#9)(2010-5#16)(2010-6#12)(2010-7#17)(2010-8#44)(2010-9#4)(2011-1#10)(2011-10#1)(2011-2#152)(2011-3#19)(2011-7#2)(2011-8#2)(2011-9#4)(2012-12#25)(2012-2#56)(2012-3#76)(2012-5#4)(2013-1#147)(2013-7#5)(2013-8#59)
data)##5##1##(1995-9#1)(2008-10#1)(2008-9#1)(2010-11#1)(2013-8#1)
data-acquisition system##2##2##(2008-10#2)
data-acquisition##3##1##(2008-10#3)
data-based planning##4##2##(1996-2#1)(1997-1#3)
data-based##8##1##(1996-2#1)(1997-1#7)
data-driven approach to##2##3##(1996-2#1)(2013-8#1)
data-driven##6##1##(1996-2#1)(2008-6#1)(2010-10#1)(2011-8#1)(2012-2#1)(2013-8#1)
data-processing system##2##2##(2008-2#1)(2008-3#1)
data-processing##3##1##(2008-2#1)(2008-3#2)
data?##2##1##(1994-2#1)(2008-7#1)
databanks##2##1##(1992-1#1)(1995-9#1)
database (http##2##2##(2011-2#2)
database and the##2##3##(2010-12#1)(2010-5#1)
database and##14##2##(1991-12#1)(1994-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)
database application##2##2##(2008-11#2)
database are##3##2##(1991-3#1)(2008-3#1)(2010-5#1)
database consists of##2##3##(2008-4#1)(2009-2#1)
database designed to##2##3##(1991-12#1)(2008-4#1)
database for the##4##3##(2008-1#1)(2008-11#1)(2008-3#1)(2012-12#1)
database for##13##2##(1991-11#1)(1994-9#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-5#1)(2012-12#1)
database in##3##2##(2008-11#1)(2010-5#2)
database is##8##2##(1991-12#1)(1991-3#1)(1993-1#1)(2008-10#1)(2008-3#1)(2009-2#2)(2012-3#1)
database management software##3##3##(1991-3#1)(1992-3#2)
database management##8##2##(1991-3#2)(1992-3#3)(2008-9#2)(2010-8#1)
database matching##3##2##(1991-6#1)(2008-4#2)
database of natural##2##3##(2008-6#1)(2009-2#1)
database of##13##2##(1992-3#1)(1993-8#1)(1997-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
database on##2##2##(2008-10#1)(2008-12#1)
database search##2##2##(2008-4#1)(2013-1#1)
database system##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2011-3#2)
database that##5##2##(2008-10#1)(2008-9#1)(2010-5#2)(2012-3#1)
database to##6##2##(2008-1#1)(2008-11#2)(2008-9#1)(2012-3#1)(2013-1#1)
database using##2##2##(2008-1#1)(2008-10#1)
database was##5##2##(2008-10#1)(2008-11#2)(2012-3#1)(2013-1#1)
database##198##1##(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#7)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#5)(1993-1#4)(1993-8#1)(1994-11#1)(1994-12#3)(1994-9#1)(1995-12#4)(1995-9#1)(1996-3#4)(1996-8#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#22)(2008-11#18)(2008-12#9)(2008-3#4)(2008-4#15)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#12)(2009-10#4)(2009-2#4)(2010-12#4)(2010-4#1)(2010-5#10)(2010-7#3)(2010-8#4)(2011-2#5)(2011-3#2)(2012-12#5)(2012-2#1)(2012-3#7)(2013-1#5)
databases and##13##2##(1997-6#1)(1997-8#1)(2008-10#3)(2008-2#1)(2010-11#1)(2010-2#1)(2011-4#1)(2012-12#3)(2013-8#1)
databases for##5##2##(1994-3#1)(2008-1#1)(2008-9#1)(2013-1#2)
databases in order to##2##4##(2008-11#1)(2008-4#1)
databases in##5##2##(1995-5#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-4#1)
databases indicated##3##2##(1995-8#1)(1996-2#1)(2008-5#1)
databases of##3##2##(2008-11#1)(2008-9#1)(2012-12#1)
databases that contain##2##3##(2008-3#1)(2009-10#1)
databases to##3##2##(2008-10#1)(2010-8#1)(2012-12#1)
databases was##2##2##(2008-12#1)(2013-1#1)
databases were searched for##4##4##(1994-3#1)(2009-10#1)(2009-7#1)(2012-3#1)
databases were##7##2##(1994-3#1)(1996-6#1)(2009-10#1)(2009-7#1)(2012-3#1)(2013-1#2)
databases with##2##2##(1991-12#1)(2008-9#1)
databases##111##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-3#3)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-9#6)(2009-10#9)(2009-7#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#5)(2011-4#1)(2012-12#9)(2012-3#3)(2013-1#11)(2013-8#2)
datafiles##3##1##(1995-12#3)
dataset and##2##2##(2008-4#1)(2010-7#1)
dataset in##2##2##(2010-8#1)(2012-3#1)
dataset of##3##2##(1991-11#1)(2010-3#1)(2013-1#1)
dataset with##2##2##(2010-11#1)(2012-2#1)
dataset##24##1##(1991-11#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-3#1)(2010-7#4)(2010-8#1)(2012-2#1)(2012-3#5)(2013-1#1)
datasets from##2##2##(2008-6#2)
datasets to##2##2##(2008-3#1)(2011-2#1)
datasets with##2##2##(2008-12#1)(2008-6#1)
datasets##25##1##(1995-5#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#4)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
date and##4##2##(2008-10#2)(2008-7#1)(2009-6#1)
date back to##2##3##(2008-5#1)(2012-3#1)
date for the##7##3##(1996-1#1)(2011-2#6)
date for##10##2##(1996-1#1)(2008-10#1)(2010-8#1)(2011-2#6)(2012-12#1)
date from##4##2##(2008-10#3)(2008-2#1)
date in##4##2##(1996-3#1)(2008-10#3)
date most studies have##2##4##(2008-7#1)(2011-2#1)
date most##4##2##(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
date no##2##2##(2008-12#1)(2008-5#1)
date of first##4##3##(1990-8#1)(1991-11#1)(2008-12#1)(2008-7#1)
date of infection##2##3##(1992-9#1)(2008-10#1)
date of inoculation##2##3##(2008-10#2)
date of sowing##2##3##(2008-10#2)
date of the##3##3##(1997-5#1)(2008-10#1)(2013-1#1)
date of##27##2##(1990-8#1)(1991-11#1)(1991-12#1)(1992-9#1)(1996-3#1)(1997-5#1)(2008-10#14)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2012-12#1)(2013-1#2)
date on##6##2##(2008-10#4)(2008-4#1)(2012-2#1)
date the##4##2##(2008-10#2)(2010-7#1)(2013-8#1)
date there##3##2##(1992-2#1)(2008-7#1)(2008-9#1)
date with##2##2##(2008-7#1)(2011-2#1)
date##222##1##(1990-11#2)(1990-12#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-9#1)(2007-11#1)(2008-10#69)(2008-11#7)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#24)(2011-7#1)(2012-12#5)(2012-2#3)(2012-3#8)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#2)
dated##2##1##(2008-10#2)
dates and##2##2##(1991-11#1)(2008-10#1)
dates back to##2##3##(2008-12#1)(2008-6#1)
dates back##3##2##(2008-12#1)(2008-6#1)(2009-8#1)
dates##24##1##(1991-11#1)(1996-12#1)(2008-10#17)(2008-12#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-8#1)
dating back to the##3##4##(2008-10#1)(2009-10#1)(2009-8#1)
dating back to##4##3##(2008-10#1)(2009-10#1)(2009-8#1)(2010-5#1)
dating for##2##2##(2008-10#2)
dating##11##1##(1997-3#1)(2008-10#5)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#1)
dauci and A##2##3##(2008-10#2)
dauci##7##1##(2008-10#7)
daughter and##2##2##(1991-12#1)(1995-9#1)
daughter cell##3##2##(1995-9#1)(2009-12#1)(2009-8#1)
daughter cells##3##2##(1995-9#1)(2008-11#1)(2008-9#1)
daughter##17##1##(1991-12#1)(1994-11#1)(1995-12#1)(1995-9#3)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-8#1)
daughters##14##1##(1995-1#1)(1995-2#1)(1997-2#1)(2008-5#1)(2008-8#1)(2011-1#7)(2011-2#1)(2012-3#1)
daunomycin and##2##2##(2008-10#1)(2008-7#1)
daunomycin##15##1##(1990-2#2)(2008-10#8)(2008-11#1)(2008-7#4)
daunorubicin##3##1##(1991-2#1)(1993-11#1)(1994-5#1)
daunting##4##1##(1995-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
dawn of a new era##2##5##(2009-5#1)(2011-2#1)
dawn of##3##2##(2009-5#1)(2011-2#1)(2013-7#1)
dawn##4##1##(2008-10#1)(2009-5#1)(2011-2#1)(2013-7#1)
day 0##5##2##(2008-10#3)(2010-7#2)
day 1##16##2##(1991-8#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-6#2)(2012-2#1)(2013-1#1)
day 10##5##2##(1994-2#3)(2010-7#1)(2013-1#1)
day 11##3##2##(1995-2#1)(1997-7#1)(2009-6#1)
day 12##4##2##(1995-12#2)(2008-10#1)(2008-7#1)
day 14 after##2##3##(2006-6#1)(2011-2#1)
day 14##6##2##(2006-6#2)(2008-11#1)(2008-8#2)(2011-2#1)
day 16##2##2##(1993-12#1)(2013-1#1)
day 17##3##2##(1995-12#1)(2008-11#1)(2008-7#1)
day 18##6##2##(1993-3#1)(2008-10#3)(2008-11#1)(2008-9#1)
day 2 and##2##3##(1994-8#1)(2012-12#1)
day 2 to day##3##4##(2008-7#1)(2008-8#1)(2010-7#1)
day 2##8##2##(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#2)(2012-12#1)
day 20##6##2##(1993-12#1)(1995-12#3)(1996-12#1)(2011-1#1)
day 21 and##2##3##(1996-12#1)(2008-11#1)
day 21##5##2##(1996-12#1)(2006-6#1)(2008-11#1)(2008-5#1)(2012-3#1)
day 3##13##2##(1991-5#1)(1993-8#1)(1994-2#3)(1994-8#1)(2008-11#1)(2008-9#2)(2010-10#2)(2011-2#2)
day 4 in##2##3##(1994-5#1)(2012-3#1)
day 4 of##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
day 4##11##2##(1994-5#2)(1995-11#1)(1996-2#1)(2008-10#1)(2008-9#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#1)
day 5 after##2##3##(2008-11#1)(2008-7#1)
day 5##6##2##(1994-2#2)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#1)
day 50##4##2##(1995-12#1)(2006-6#1)(2008-10#2)
day 6 of##2##3##(1993-8#1)(2008-11#1)
day 6##5##2##(1993-8#1)(2008-11#1)(2010-7#2)(2012-12#1)
day 7 and##2##3##(1995-12#1)(1996-12#1)
day 7##11##2##(1994-5#2)(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
day 8 of gestation##2##4##(1993-12#2)
day 8##6##2##(1993-12#2)(2008-12#1)(2008-7#1)(2008-8#2)
day after the##3##3##(2007-12#1)(2012-3#2)
day after##12##2##(1990-12#1)(1991-2#1)(1992-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#2)
day and night sample##2##4##(2008-10#2)
day and night##6##3##(2008-10#4)(2008-2#2)
day and##22##2##(1990-12#1)(1991-1#1)(1992-3#1)(1995-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-12#3)(2010-8#1)(2011-2#1)
day as##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
day at##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
day by##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
day can##2##2##(2008-11#1)(2008-7#1)
day care##16##2##(1991-1#2)(1992-3#1)(1994-3#3)(1994-6#7)(1997-2#1)(1997-5#1)(2010-3#1)
day during##2##2##(2008-10#1)(2010-12#1)
day for 5##2##3##(2007-8#1)(2008-7#1)
day for##14##2##(1990-2#1)(1990-9#2)(1992-3#1)(1994-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2013-1#2)
day hospital for rehabilitation##2##4##(2008-7#2)
day hospital##8##2##(1993-2#2)(2008-7#6)
day in the##3##3##(1997-6#1)(2008-10#1)(2009-10#1)
day in##12##2##(1994-8#1)(1995-8#1)(1996-12#2)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-6#2)
day is##2##2##(2008-10#1)(2013-8#1)
day length##2##2##(2008-8#2)
day lengths##2##2##(2008-10#1)(2008-8#1)
day of life##11##3##(1991-2#1)(1993-12#2)(2008-10#2)(2011-1#2)(2011-2#2)(2012-3#2)
day of storage##2##3##(2008-10#2)
day of surgery##3##3##(1997-7#1)(2012-2#2)
day of the##8##3##(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)
day of treatment##2##3##(1996-12#1)(2008-10#1)
day of##51##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-12#3)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)
day old##4##2##(1996-12#1)(2008-12#2)(2008-8#1)
day on##3##2##(1992-3#1)(1995-3#1)(2013-8#1)
day or##3##2##(1991-9#1)(2008-10#1)(2008-12#1)
day period##2##2##(2008-10#1)(2008-12#1)
day prior##3##2##(2008-10#2)(2011-2#1)
day programs##2##2##(1993-2#2)
day shifts##4##2##(2010-6#4)
day surgery##8##2##(1990-2#2)(1995-1#3)(1995-2#1)(1996-3#1)(2012-3#1)
day that##2##2##(1993-1#1)(2008-10#1)
day the##3##2##(2008-12#1)(2009-8#1)(2013-1#1)
day to##6##2##(1991-2#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-5#2)
day was##9##2##(1994-6#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
day were##3##2##(1991-11#1)(1997-2#1)(2008-10#1)
day with##3##2##(1990-9#1)(2008-5#1)(2010-12#1)
day##532##1##(1990-12#5)(1990-2#6)(1990-5#4)(1990-9#4)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-3#5)(1992-5#1)(1992-6#1)(1993-1#3)(1993-12#7)(1993-2#5)(1993-3#4)(1993-6#1)(1993-8#2)(1994-12#3)(1994-2#11)(1994-3#5)(1994-5#4)(1994-6#10)(1994-8#6)(1995-1#3)(1995-11#2)(1995-12#11)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#11)(1996-2#2)(1996-3#2)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#4)(2006-6#5)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#85)(2008-11#37)(2008-12#23)(2008-2#2)(2008-3#3)(2008-5#15)(2008-7#26)(2008-8#15)(2008-9#8)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#5)(2010-12#10)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#14)(2010-7#13)(2010-8#7)(2010-9#1)(2011-1#6)(2011-2#21)(2011-9#1)(2012-12#6)(2012-2#7)(2012-3#15)(2012-5#1)(2013-1#18)(2013-8#7)
day(-1)##13##1##(2008-10#2)(2008-11#11)
day(-1))##6##1##(2008-10#1)(2008-11#1)(2010-5#2)(2010-7#1)(2013-8#1)
day) as##2##2##(1992-12#1)(2011-2#1)
day) to##2##2##(1992-12#1)(2008-12#1)
day)##19##1##(1992-11#1)(1992-12#2)(1994-6#3)(1997-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
day-night changes##2##2##(1995-11#1)(2008-5#1)
day-to-day operations##3##2##(1997-1#2)(1997-2#1)
day-to-day##14##1##(1994-3#1)(1997-1#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
day/night care##2##2##(1995-12#2)
day]##2##1##(1990-11#1)(1993-3#1)
daycare centres##2##2##(2007-12#2)
daycare##5##1##(2007-12#3)(2008-11#1)(2010-6#1)
daylight##4##1##(2008-10#4)
days (Group##2##2##(2010-12#2)
days (P &lt##2##3##(1994-3#1)(2009-11#1)
days (range##5##2##(1990-12#2)(2011-2#2)(2012-3#1)
days 0##5##2##(1995-12#2)(2008-10#1)(2008-5#1)(2008-7#1)
days 1 and##2##3##(2008-10#1)(2010-6#1)
days 1##5##2##(2008-10#2)(2009-12#1)(2010-6#2)
days 12##2##2##(1995-12#1)(1996-12#1)
days 14 and 21##6##4##(2008-5#6)
days 14 and##7##3##(2008-10#1)(2008-5#6)
days 4##3##2##(1994-5#1)(2008-5#1)(2010-7#1)
days a##4##2##(1995-2#1)(2008-9#2)(2013-1#1)
days across trials##2##3##(2008-10#2)
days after NGF gene transfection in##2##6##(1996-12#1)(1996-2#1)
days after a##2##3##(1996-5#1)(2010-12#1)
days after addition##2##3##(2008-10#1)(2008-11#1)
days after anthesis##4##3##(2008-10#3)(2008-9#1)
days after birth)##2##3##(1995-12#2)
days after budbreak##2##3##(2008-10#2)
days after emergence##2##3##(2008-10#2)
days after implantation##2##3##(1990-8#1)(2008-10#1)
days after inoculation and##2##4##(2008-10#2)
days after inoculation on##2##4##(2008-10#2)
days after inoculation with the pathogen##3##6##(2008-10#3)
days after inoculation with##5##4##(2008-10#5)
days after inoculation##44##3##(2008-10#42)(2008-5#1)(2008-8#1)
days after inoculation)##2##3##(2008-10#2)
days after planting##7##3##(2008-10#7)
days after pollination##3##3##(2008-10#3)
days after spraying##2##3##(2008-10#2)
days after surgery##5##3##(2010-10#1)(2011-2#3)(2012-12#1)
days after the last##2##4##(1996-12#1)(2010-12#1)
days after the##21##3##(1990-9#1)(1995-11#3)(1995-8#1)(1996-12#3)(1996-9#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
days after transplantation##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
days after treatment##8##3##(1990-10#2)(1992-1#2)(2008-10#3)(2011-2#1)
days after##167##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-9#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#89)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#10)(2012-12#1)(2012-3#3)(2013-1#5)(2013-8#2)
days and the##2##3##(1991-5#1)(1991-6#1)
days and then##5##3##(1991-2#1)(2008-10#2)(2008-11#2)
days and was##3##3##(1997-3#1)(2008-11#1)(2010-5#1)
days and##41##2##(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#10)(2008-11#8)(2008-5#2)(2008-8#1)(2010-1#1)(2010-11#1)(2010-5#2)(2011-2#4)(2012-3#1)(2013-1#2)
days as##2##2##(2008-10#1)(2008-11#1)
days at 20 degrees C##3##5##(2008-10#2)(2008-12#1)
days at 5 degrees C##2##5##(2008-10#2)
days at a dose of##2##5##(1994-3#1)(2008-11#1)
days at a##3##3##(1994-3#1)(2008-11#2)
days at##21##2##(1994-3#1)(1995-8#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-5#1)
days before the onset of##2##5##(2007-12#2)
days before the##3##3##(2007-12#2)(2008-10#1)
days before##11##2##(1995-12#1)(2007-12#2)(2008-10#3)(2008-11#1)(2009-6#1)(2010-8#1)(2011-2#2)
days by##3##2##(2008-10#2)(2008-12#1)
days decreased##2##2##(1990-12#1)(1997-2#1)
days during##5##2##(1990-12#1)(1995-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
days each week##2##3##(2011-2#1)(2012-12#1)
days following inoculation##2##3##(2008-10#2)
days following##7##2##(1996-12#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)
days for##11##2##(1991-3#1)(1997-4#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)
days from the##3##3##(1990-12#1)(2008-10#1)(2013-1#1)
days from##4##2##(1990-12#1)(2008-10#2)(2013-1#1)
days in culture##3##3##(1995-8#1)(2008-11#1)(2012-3#1)
days in the##6##3##(1995-2#1)(1995-8#1)(2008-10#3)(2008-11#1)
days in##32##2##(1990-3#1)(1992-2#1)(1995-2#1)(1995-5#1)(1995-8#2)(1997-3#1)(1997-4#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
days is##2##2##(2008-10#1)(2010-12#1)
days later##23##2##(1991-2#1)(1993-1#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-5#2)(2010-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
days of age##13##3##(1996-2#1)(1996-5#1)(2006-5#2)(2008-12#2)(2008-5#2)(2008-8#1)(2012-2#2)(2013-1#2)
days of cell isolation##2##4##(2008-11#2)
days of cultivation##2##3##(2008-11#2)
days of culture##4##3##(2008-11#3)(2008-8#1)
days of each##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
days of exposure to##2##4##(2008-10#2)
days of exposure##9##3##(1995-3#2)(2008-10#4)(2008-12#2)(2008-9#1)
days of incubation##7##3##(2008-10#2)(2008-11#4)(2008-5#1)
days of inoculation##2##3##(2008-10#2)
days of storage in##2##4##(2008-10#1)(2008-5#1)
days of the##9##3##(1993-11#2)(1995-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-2#1)
days of treatment##6##3##(1995-2#1)(1995-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
days of##98##2##(1991-1#1)(1992-12#2)(1993-11#2)(1993-2#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-5#2)(2007-12#2)(2007-8#1)(2008-10#23)(2008-11#15)(2008-12#5)(2008-2#1)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#1)
days old##6##2##(1996-2#1)(2008-10#3)(2008-12#2)
days old)##3##2##(2008-10#3)
days on a##2##3##(1993-3#2)
days on average)##2##3##(2011-2#2)
days on##10##2##(1993-3#2)(1996-11#1)(2007-12#2)(2008-10#2)(2011-2#2)(2013-1#1)
days or more##2##3##(2008-10#2)
days or weeks##2##3##(2008-5#1)(2013-1#1)
days or##14##2##(1991-3#1)(1994-3#1)(1995-8#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
days per week##6##3##(2008-10#1)(2008-9#2)(2013-1#3)
days per##7##2##(2008-10#2)(2008-9#2)(2013-1#3)
days post inoculation##2##3##(2008-10#2)
days post##9##2##(1996-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)
days post-infection##2##2##(2008-11#1)(2009-6#1)
days post-infestation##2##2##(1996-12#2)
days post-inoculation##6##2##(2008-5#4)(2010-10#2)
days post-transfection##3##2##(2008-11#1)(2011-2#2)
days postinfection##2##2##(2008-10#1)(2008-5#1)
days postinoculation (dpi)##3##3##(2008-10#3)
days postinoculation##8##2##(2008-10#8)
days postlesion and##2##3##(1997-3#2)
days postlesion##10##2##(1993-6#1)(1997-3#9)
days postoperatively##3##2##(1993-1#1)(2008-12#1)(2011-2#1)
days prior to inoculation##2##4##(2008-10#2)
days prior to##16##3##(1995-12#1)(1996-12#5)(2008-10#7)(2008-11#2)(2008-8#1)
days respectively##2##2##(1990-2#1)(1996-12#1)
days resulted in##2##3##(2008-10#2)
days than##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
days the##3##2##(2010-12#1)(2012-2#1)(2012-3#1)
days to anthesis in##2##4##(2008-10#2)
days to anthesis##4##3##(2008-10#4)
days to be##2##3##(2008-11#2)
days to complete##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
days to##25##2##(1991-3#1)(1996-9#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-5#1)(2008-9#1)(2009-12#1)(2010-4#1)(2013-1#2)
days total exposure) produced##2##4##(2008-10#2)
days treatment with##2##3##(1994-3#1)(1995-12#1)
days treatment##5##2##(1991-12#1)(1994-3#1)(1995-12#1)(2008-5#2)
days under##4##2##(1995-11#1)(2008-10#3)
days using a##3##3##(2008-10#1)(2008-11#2)
days was found##2##3##(2008-8#1)(2012-12#1)
days was##8##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-8#1)(2012-12#1)
days were##6##2##(1990-9#1)(2008-11#1)(2008-12#2)(2010-6#1)(2011-2#1)
days when##5##2##(1993-2#1)(2008-10#3)(2008-11#1)
days with infection##2##3##(2008-10#2)
days with##11##2##(1994-3#1)(2008-10#7)(2008-12#2)(2012-3#1)
days without##3##2##(2008-10#2)(2011-2#1)
days##1058##1##(1990-10#2)(1990-11#3)(1990-12#15)(1990-2#7)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#5)(1991-3#7)(1991-4#1)(1991-5#2)(1991-6#4)(1992-1#2)(1992-12#6)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#2)(1993-6#6)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#8)(1994-5#5)(1994-6#2)(1994-8#1)(1995-11#8)(1995-12#14)(1995-2#11)(1995-3#7)(1995-5#2)(1995-6#1)(1995-8#9)(1996-11#1)(1996-12#23)(1996-2#7)(1996-3#8)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#16)(1997-4#3)(1997-5#2)(1997-8#2)(1997-9#1)(2006-5#2)(2006-6#1)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#360)(2008-11#85)(2008-12#37)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#42)(2008-6#3)(2008-7#28)(2008-8#16)(2008-9#13)(2009-10#1)(2009-11#4)(2009-12#4)(2009-3#3)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#11)(2010-3#1)(2010-4#2)(2010-5#6)(2010-6#6)(2010-7#2)(2010-8#5)(2011-2#56)(2011-3#1)(2012-12#8)(2012-2#11)(2012-3#23)(2013-1#45)(2013-7#1)(2013-8#9)
days'##8##1##(1996-12#1)(2007-12#1)(2008-11#2)(2008-5#3)(2011-2#1)
days) after##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
days) and##5##2##(1996-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
days) in##2##2##(1995-2#1)(2008-10#1)
days) of##2##2##(1997-8#1)(2008-10#1)
days) on##2##2##(2008-10#1)(2008-12#1)
days) or##2##2##(2008-10#1)(2008-11#1)
days) was##4##2##(1994-3#1)(1997-8#1)(2007-8#1)(2013-8#1)
days)##66##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-2#3)(1994-3#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#3)(1996-2#4)(1997-8#2)(2007-8#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-3#2)(2013-8#2)
days/cm in the##2##3##(2009-3#2)
daytime RH##2##2##(2008-10#2)
daytime functioning##3##2##(2010-7#3)
daytime sleepiness##2##2##(2008-7#1)(2010-7#1)
daytime temperature##5##2##(2012-7#5)
daytime temperatures##2##2##(2008-10#2)
daytime##31##1##(1996-3#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-7#5)(2010-8#1)(2012-5#2)(2012-6#1)(2012-7#5)(2013-7#1)
db/+ mice##3##2##(2012-3#3)
db/+##4##1##(2012-3#4)
db/db and##3##2##(1994-11#1)(2012-3#2)
db/db mice##7##2##(2012-3#6)(2013-1#1)
db/db##15##1##(1994-11#1)(2012-3#13)(2013-1#1)
dbcGMP##2##1##(1995-8#2)
dc field##2##2##(1995-12#1)(2008-3#1)
dc##5##1##(1995-12#1)(2008-10#1)(2008-3#3)
dcmB##2##1##(1993-9#2)
dcrB##4##1##(1993-9#4)
ddC##2##1##(1994-11#1)(2008-11#1)
ddT##2##1##(1991-3#2)
ddY mice##3##2##(2010-11#3)
de Barquisimeto'##2##2##(2008-5#2)
de LA##2##2##(2013-1#2)
de Montaigne##2##2##(2012-3#2)
de Tramadol et de##2##4##(2013-1#2)
de Tramadol et##3##3##(2013-1#3)
de Tramadol##6##2##(2013-1#6)
de ces##2##2##(2013-1#2)
de décès##2##2##(2009-10#1)(2013-1#1)
de glissement&quot##4##2##(2010-6#4)
de kyste##2##2##(2011-2#1)(2013-1#1)
de l'octyl##2##2##(2008-5#2)
de la grossesse##4##3##(2011-2#1)(2013-1#3)
de la leucémie aiguë##3##4##(2013-1#3)
de la varicelle##3##3##(2013-1#3)
de la##37##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#5)(2011-2#5)(2011-3#3)(2013-1#21)
de novo adipogenesis##2##3##(2008-11#2)
de novo mutation##3##3##(1991-12#1)(1993-2#1)(1994-11#1)
de novo protein synthesis##2##4##(1995-12#1)(2008-11#1)
de novo synthesis of##5##4##(1990-5#1)(1993-11#1)(1994-8#1)(1995-12#1)(2011-1#1)
de novo synthesis##6##3##(1990-5#1)(1993-11#1)(1994-8#1)(1995-12#1)(2008-10#1)(2011-1#1)
de novo##39##2##(1990-5#1)(1990-7#1)(1991-12#1)(1993-11#2)(1993-12#3)(1993-2#2)(1994-11#3)(1994-6#1)(1994-8#2)(1995-12#2)(1995-6#1)(1997-1#1)(1997-3#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#2)(2008-9#1)(2010-1#2)(2011-1#1)(2013-8#1)
de pointes##2##2##(1991-8#1)(2013-1#1)
de traitement##2##2##(2011-2#1)(2013-1#1)
de##277##1##(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-2#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1994-11#3)(1994-6#1)(1994-8#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-5#1)(2008-10#39)(2008-11#16)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#36)(2008-7#4)(2008-9#2)(2009-10#9)(2010-1#6)(2010-10#1)(2010-5#1)(2010-6#4)(2011-1#1)(2011-2#21)(2011-3#3)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#84)(2013-8#2)
de-ionized water##3##2##(2008-10#2)(2009-5#1)
deacetylase##9##1##(1991-5#4)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
deacetylation##6##1##(1991-5#2)(1996-5#1)(2008-10#2)(2013-8#1)
deactivate##2##1##(2009-8#1)(2010-1#1)
deactivated##2##1##(2008-10#1)(2013-8#1)
deactivation of##4##2##(1990-6#1)(2008-2#2)(2008-5#1)
deactivation##8##1##(1990-6#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-2#2)(2008-5#1)(2013-1#1)
deacylated##2##1##(1990-5#1)(2008-10#1)
dead and##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
dead bodies##2##2##(2011-2#2)
dead cell##2##2##(2008-11#1)(2008-9#1)
dead cells##6##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)
dead cyclamen leaf tissue##2##4##(2008-10#2)
dead leaves##2##2##(2008-10#2)
dead space##6##2##(1991-12#5)(2012-2#1)
dead tits##2##2##(2008-5#2)
dead wood##3##2##(2008-10#3)
dead##70##1##(1990-9#1)(1991-11#1)(1991-12#5)(1995-11#1)(1996-11#1)(1997-3#2)(2007-12#2)(2008-10#26)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#3)(2010-3#1)(2010-5#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
dead-in-shell turkey embryos##3##3##(2008-5#3)
deadline##2##1##(1991-11#1)(1996-1#1)
deadly##6##1##(1992-2#1)(2008-10#1)(2010-1#1)(2010-5#1)(2012-2#1)(2012-3#1)
deaf and hard of hearing students##3##6##(2011-2#3)
deaf and hard of hearing##6##5##(2011-2#6)
deaf children and##3##3##(2008-9#2)(2011-2#1)
deaf children##9##2##(2008-9#7)(2011-2#2)
deaf or hard of hearing##2##5##(2011-2#2)
deaf signing##2##2##(2012-2#2)
deaf students##2##2##(2011-2#2)
deaf##40##1##(2008-9#16)(2011-2#17)(2012-2#5)(2012-3#2)
deafened adult##3##2##(2008-9#3)
deafened adults##5##2##(2008-9#5)
deafened children##2##2##(2008-9#2)
deafened patients##2##2##(2008-9#2)
deafened users##2##2##(2008-9#2)
deafened##15##1##(2008-9#15)
deafferentation##2##1##(1996-12#1)(1996-2#1)
deafferented##3##1##(1991-2#2)(1997-3#1)
deafness and##4##2##(2008-7#1)(2008-9#2)(2011-1#1)
deafness in##2##2##(2008-9#1)(2011-2#1)
deafness##36##1##(1990-3#1)(1994-9#7)(1997-3#1)(2008-11#1)(2008-7#1)(2008-9#17)(2009-8#1)(2011-1#4)(2011-2#3)
deal of##19##2##(1991-1#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
deal with a##3##3##(2008-3#2)(2010-10#1)
deal with the problem##2##4##(2008-10#1)(2012-3#1)
deal with the problems of##2##5##(1993-2#1)(1994-2#1)
deal with the##12##3##(1992-3#1)(1993-2#1)(1994-2#1)(1995-6#1)(1995-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-5#1)(2012-3#1)
deal with these##5##3##(1995-12#1)(1996-1#1)(2008-11#2)(2010-10#1)
deal with##49##2##(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#2)
deal##80##1##(1991-1#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-10#12)(2008-11#8)(2008-12#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
dealing with an##4##3##(1991-6#1)(1992-1#1)(2008-10#1)(2010-3#1)
dealing with plant##2##3##(2008-9#2)
dealing with the##13##3##(1992-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(2008-10#5)(2008-11#2)(2012-2#1)(2013-8#1)
dealing with them##2##3##(1992-2#1)(1996-6#1)
dealing with##49##2##(1991-6#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#2)(2008-9#6)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#2)
dealing##54##1##(1991-6#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-12#3)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#2)(2008-9#6)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#2)
deals with a##5##3##(1995-12#1)(2008-10#3)(2008-9#1)
deals with the##21##3##(1991-6#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#2)(2009-7#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
deals with##38##2##(1991-6#1)(1995-11#1)(1995-12#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
deals##42##1##(1991-6#1)(1995-11#1)(1995-12#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2009-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
dealt with by##2##3##(1996-2#1)(1996-6#1)
dealt with the##5##3##(1990-3#1)(1995-11#1)(2008-11#1)(2008-12#1)(2008-5#1)
dealt with##22##2##(1990-3#1)(1991-3#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#1)
dealt##23##1##(1990-3#1)(1991-3#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#1)
deaminase in acute##2##3##(1991-2#1)(1991-3#1)
deaminase##13##1##(1991-2#1)(1991-3#1)(1992-12#2)(1993-12#1)(1994-5#3)(1995-9#2)(2008-1#1)(2008-10#1)(2011-2#1)
deaminated##2##1##(2008-10#2)
dean of##2##2##(1990-6#1)(2008-10#1)
dearth of evidence##2##3##(2010-12#1)(2012-2#1)
dearth of##9##2##(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#1)(2010-1#1)(2010-12#1)(2012-2#1)
death after##4##2##(1994-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
death among##4##2##(1991-11#1)(1991-3#1)(1992-6#1)(2013-1#1)
death and the##4##3##(1994-2#1)(1995-2#1)(2009-8#1)(2011-2#1)
death and##33##2##(1990-11#1)(1991-11#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#4)(1996-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#2)(2010-1#1)(2010-9#1)(2011-2#3)(2011-9#1)(2012-3#1)
death are##4##2##(2008-10#1)(2010-8#2)(2013-1#1)
death as a##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
death at##2##2##(2008-10#1)(2012-2#1)
death but##2##2##(1995-2#1)(1996-5#1)
death by##11##2##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-7#1)
death caused by##5##3##(1991-9#1)(2008-10#2)(2008-11#2)
death certificates##4##2##(1991-2#1)(2010-4#1)(2012-12#1)(2013-8#1)
death donors##2##2##(2011-3#2)
death during the##4##3##(1994-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
death during##5##2##(1994-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
death following##4##2##(1996-12#1)(2008-7#2)(2010-12#1)
death for##2##2##(1991-3#1)(2008-11#1)
death from cardiovascular##3##3##(2008-11#1)(2010-12#1)(2011-2#1)
death from##8##2##(1995-12#2)(1997-7#1)(1997-8#1)(2008-11#2)(2010-12#1)(2011-2#1)
death in a##4##3##(1991-11#1)(2008-12#1)(2009-6#1)(2013-7#1)
death in patients with##3##4##(1993-9#1)(1996-11#1)(2011-2#1)
death in patients##4##3##(1993-9#1)(1996-11#1)(2008-11#1)(2011-2#1)
death in the general##2##4##(2008-7#2)
death in the##18##3##(1990-5#1)(1994-8#1)(1995-12#1)(1996-12#3)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2011-3#1)
death in##69##2##(1990-11#2)(1990-5#1)(1991-11#3)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#3)(1997-6#1)(2008-1#3)(2008-10#4)(2008-11#6)(2008-12#5)(2008-7#8)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
death induced by##3##3##(2008-11#2)(2008-7#1)
death is a##2##3##(1996-6#1)(2008-10#1)
death is##10##2##(1995-1#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)
death machinery##3##2##(2008-11#2)(2009-3#1)
death mechanism##2##2##(2008-11#1)(2012-3#1)
death occurred##6##2##(1991-6#1)(1992-2#1)(1997-8#1)(2008-10#2)(2008-11#1)
death occurs##2##2##(1996-11#1)(2010-1#1)
death of plants##3##3##(2008-10#3)
death of the##5##3##(1994-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
death of##42##2##(1990-6#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-12#2)(1997-7#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-8#4)(2009-3#1)(2009-5#2)(2009-6#3)(2009-8#1)(2010-8#1)(2010-9#2)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
death on the##2##3##(2008-12#1)(2010-9#1)
death or##6##2##(1991-2#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
death pathways##4##2##(2008-11#3)(2009-8#1)
death phase##3##2##(2008-11#3)
death programme##3##2##(2008-11#3)
death rate##14##2##(1990-11#1)(1990-9#1)(1992-5#1)(1997-1#1)(1997-7#2)(2008-11#4)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
death rates##8##2##(1993-1#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
death receptors##2##2##(2008-4#2)
death signals##2##2##(2009-8#1)(2011-2#1)
death syndrome (SDS) of soybean##2##5##(2008-10#2)
death syndrome has##2##3##(1991-9#1)(2008-10#1)
death syndrome##17##2##(1991-11#5)(1991-9#3)(1993-12#2)(2008-10#6)(2009-8#1)
death than##2##2##(1991-12#1)(2008-11#1)
death was determined##2##3##(1994-2#1)(1995-11#1)
death was##14##2##(1990-11#1)(1990-9#1)(1991-2#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-6#2)(2008-10#2)(2008-11#1)(2011-2#2)
death which##2##2##(2008-5#1)(2013-8#1)
death with##4##2##(1990-6#1)(1992-1#1)(1997-3#1)(2008-12#1)
death within 2##2##3##(1997-3#1)(2009-12#1)
death##593##1##(1990-11#6)(1990-5#2)(1990-6#3)(1990-9#3)(1991-11#10)(1991-12#4)(1991-2#7)(1991-3#2)(1991-6#1)(1991-9#4)(1992-1#4)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-2#6)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#6)(1995-12#8)(1995-2#12)(1995-3#1)(1995-5#2)(1995-6#7)(1995-8#5)(1996-11#4)(1996-12#11)(1996-2#1)(1996-5#5)(1996-6#5)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#7)(1997-8#3)(1997-9#1)(2007-12#1)(2007-8#1)(2008-1#6)(2008-10#59)(2008-11#71)(2008-12#13)(2008-3#1)(2008-4#10)(2008-5#4)(2008-7#42)(2008-8#18)(2008-9#10)(2009-10#9)(2009-12#5)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#7)(2009-7#3)(2009-8#19)(2009-9#1)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#5)(2011-1#1)(2011-2#35)(2011-3#6)(2011-9#2)(2012-12#9)(2012-2#8)(2012-3#14)(2012-7#1)(2013-1#20)(2013-7#2)(2013-8#6)
death'##3##1##(1995-3#1)(2010-10#2)
death)##7##1##(1992-6#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-6#1)(2008-10#1)(2011-2#1)
death-inducing##2##1##(2008-11#1)(2012-2#1)
death?##4##1##(1995-1#1)(2011-2#2)(2012-3#1)
death]##5##1##(1990-11#1)(1991-9#1)(1996-6#1)(2008-11#1)(2009-5#1)
deaths among##4##2##(1991-12#1)(2008-7#1)(2011-3#1)(2013-1#1)
deaths and##6##2##(1996-12#1)(1997-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
deaths are##2##2##(2008-11#1)(2010-8#1)
deaths at##5##2##(1991-3#1)(1992-6#2)(2013-8#2)
deaths due to##3##3##(1992-6#1)(2008-7#1)(2008-9#1)
deaths from##8##2##(1992-6#2)(1995-3#1)(1997-6#1)(1997-7#2)(2008-11#1)(2008-8#1)
deaths have##2##2##(2008-4#1)(2008-8#1)
deaths in developed##2##3##(1992-6#1)(2011-3#1)
deaths in the##2##3##(1991-3#1)(2012-2#1)
deaths in##16##2##(1991-12#1)(1991-3#2)(1991-9#1)(1992-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2011-3#1)(2012-2#1)
deaths occurred##3##2##(1991-3#1)(1997-8#1)(2013-1#1)
deaths per year##2##3##(1997-1#1)(2012-2#1)
deaths were due to##2##4##(2012-3#1)(2013-1#1)
deaths were##7##2##(1992-6#1)(1993-2#1)(2008-9#1)(2012-3#2)(2013-1#2)
deaths##109##1##(1990-5#1)(1990-6#1)(1991-12#3)(1991-3#5)(1991-9#1)(1992-6#9)(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#3)(1996-6#1)(1997-1#2)(1997-2#4)(1997-6#3)(1997-7#3)(1997-8#2)(2008-1#2)(2008-10#1)(2008-11#10)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#6)(2011-3#4)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
debaryanum##2##1##(2008-10#2)
debatable##4##1##(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
debate about the##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
debate about##7##2##(1990-6#1)(1992-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
debate and##3##2##(2008-11#1)(2008-12#1)(2010-7#1)
debate concerning##2##2##(1990-6#1)(2008-11#1)
debate for##2##2##(2008-11#1)(2008-9#1)
debate in Russia and##2##4##(1997-1#2)
debate in the##2##3##(1995-2#1)(2008-11#1)
debate in##6##2##(1995-2#1)(1997-1#2)(2008-11#2)(2008-7#1)
debate on how##2##3##(2008-11#1)(2010-11#1)
debate on the##5##3##(1993-2#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-3#1)
debate on##15##2##(1991-1#1)(1991-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-6#1)(2008-10#2)(2008-11#2)(2009-10#1)(2010-11#1)(2011-2#1)(2012-3#2)
debate over##8##2##(1993-12#1)(1994-3#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-8#2)(2013-1#1)
debate regarding the##3##3##(1997-1#1)(2008-6#1)(2009-10#1)
debate surrounding##4##2##(1990-6#1)(2008-11#2)(2008-12#1)
debate##86##1##(1990-6#3)(1991-1#1)(1991-3#2)(1992-2#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-5#2)(2008-10#2)(2008-11#17)(2008-12#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-7#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
debated by##2##2##(1996-2#1)(1996-3#1)
debated##15##1##(1991-9#1)(1993-3#2)(1995-5#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-8#4)(2009-4#1)(2009-8#1)(2010-1#1)
debates in##2##2##(1994-3#1)(2012-3#1)
debates on##2##2##(2008-12#1)(2010-8#1)
debates over##3##2##(1994-8#1)(2012-2#2)
debates##14##1##(1994-3#1)(1994-8#2)(1997-2#1)(2008-11#1)(2008-12#2)(2010-1#1)(2010-4#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
debilitated elderly##2##2##(2008-7#2)
debilitated patients##2##2##(2008-7#1)(2013-8#1)
debilitated##5##1##(2008-7#4)(2013-8#1)
debilitating##7##1##(1994-3#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-1#1)(2012-3#1)
debonding##2##1##(2009-11#1)(2009-7#1)
debridement and##2##2##(2008-7#1)(2009-10#1)
debridement of the##2##3##(1991-6#1)(2011-2#1)
debridement of##4##2##(1991-6#1)(2010-6#1)(2011-2#2)
debridement##12##1##(1991-6#1)(1995-2#1)(2007-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-6#4)(2011-2#2)
debriefing and##2##2##(2008-11#2)
debriefing##5##1##(2008-11#4)(2008-8#1)
debris and##4##2##(1992-12#1)(2008-10#3)
debris collected##2##2##(2008-10#2)
debris of##4##2##(2008-10#1)(2013-8#3)
debris##39##1##(1992-12#1)(1993-8#1)(1994-6#1)(2008-10#22)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2012-12#2)(2012-3#1)(2013-8#3)
debrisoquine##2##1##(2008-10#2)
debt financing##2##2##(2008-11#2)
debt##13##1##(1990-2#2)(1994-2#1)(1996-2#1)(1996-3#1)(2008-11#5)(2010-7#1)(2013-1#2)
debut of##2##2##(1990-9#1)(2013-1#1)
debut##6##1##(1990-9#3)(2008-7#1)(2013-1#1)(2013-8#1)
debutants##2##1##(2010-1#2)
decade ago##4##2##(2009-3#1)(2010-7#1)(2012-2#2)
decade and##9##2##(1992-1#1)(2008-10#6)(2008-11#1)(2012-2#1)
decade at##2##2##(2008-10#2)
decade due to the##2##4##(1990-12#1)(2008-10#1)
decade for##3##2##(1997-7#1)(2008-10#2)
decade has brought##2##3##(1993-1#1)(2012-3#1)
decade has##5##2##(1993-1#1)(1994-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
decade in the##2##3##(2008-10#2)
decade in##5##2##(2008-10#4)(2011-3#1)
decade it##2##2##(1995-2#1)(2008-5#1)
decade of change##2##3##(1992-3#1)(1993-1#1)
decade of##17##2##(1990-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(2008-10#7)(2011-2#1)(2012-2#1)(2013-1#1)
decade there has been a##2##5##(2007-12#1)(2009-7#1)
decade there has been##5##4##(1991-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-7#1)
decade##190##1##(1990-11#1)(1990-12#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#3)(2007-12#2)(2008-10#62)(2008-11#12)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#3)(2009-9#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-2#6)(2012-3#3)(2013-1#7)(2013-3#1)(2013-7#1)(2013-8#2)
decade)##6##1##(2008-10#6)
decades after the##2##3##(2008-7#2)
decades ago##4##2##(2008-10#1)(2010-5#1)(2011-1#1)(2013-8#1)
decades and##7##2##(1994-12#1)(2008-10#4)(2010-5#1)(2012-12#1)
decades as##2##2##(2008-10#1)(2013-8#1)
decades has##2##2##(2008-4#1)(2011-2#1)
decades have seen##2##3##(2010-11#1)(2013-8#1)
decades have##4##2##(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
decades in##4##2##(1995-1#1)(2008-7#1)(2011-3#1)(2012-2#1)
decades now##2##2##(2008-11#1)(2013-7#1)
decades of life##2##3##(2011-2#1)(2013-7#1)
decades of research##5##3##(2008-12#1)(2008-6#1)(2008-8#1)(2012-2#2)
decades of the 20th century##2##5##(2008-10#1)(2011-7#1)
decades of the##4##3##(2008-10#1)(2010-1#1)(2011-2#1)(2011-7#1)
decades of##18##2##(2008-10#2)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#2)(2011-7#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
decades there has been a##2##5##(1995-1#1)(2011-2#1)
decades there##3##2##(1994-2#1)(1995-1#1)(2011-2#1)
decades to##2##2##(2008-11#1)(2013-8#1)
decades##143##1##(1991-5#1)(1992-12#2)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#22)(2008-11#10)(2008-12#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#17)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#9)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#6)
decamer##3##1##(1993-8#1)(2008-10#2)
decapeptide PS-SCL##2##2##(2008-4#2)
decapitating fly##2##2##(2007-12#2)
decapitation##2##1##(2008-10#2)
decapod crustaceans##3##2##(2007-12#2)(2008-7#1)
decapods##8##1##(2007-12#8)
decarbonylation##2##1##(2008-10#2)
decarboxylase (HDC)##2##2##(1997-1#1)(2008-11#1)
decarboxylase and##4##2##(1992-9#1)(1995-8#1)(2008-10#1)(2011-2#1)
decarboxylase gene##3##2##(1992-8#2)(1997-1#1)
decarboxylase##29##1##(1992-8#5)(1992-9#3)(1993-8#2)(1995-6#1)(1995-8#2)(1996-12#2)(1997-1#2)(1997-3#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
decarboxylation of##2##2##(1993-8#1)(2008-10#1)
decarboxylation##8##1##(1993-8#4)(2008-10#2)(2008-6#2)
decaurelia##2##1##(2008-12#2)
decay and##2##2##(2008-10#2)
decay at##2##2##(2008-10#2)
decay development##4##2##(2008-10#4)
decay in##7##2##(2008-10#3)(2008-3#1)(2009-6#3)
decay is##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
decay kinetics##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
decay of the##5##3##(1992-12#1)(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
decay of##17##2##(1991-12#1)(1992-12#2)(1994-2#1)(1995-2#1)(2006-6#1)(2008-10#6)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
decay symptoms##2##2##(2008-10#2)
decay time##2##2##(2008-10#1)(2009-8#1)
decay was##2##2##(2008-10#2)
decay##77##1##(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#2)(1994-2#1)(1995-2#1)(2006-6#1)(2007-12#3)(2008-10#39)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#2)(2009-10#1)(2009-6#3)(2009-8#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)
decayed tissue and##2##3##(2008-10#2)
decayed##8##1##(2008-10#6)(2008-8#1)(2008-9#1)
decaying##10##1##(2008-10#6)(2010-1#1)(2011-2#3)
decays##13##1##(1990-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(2008-10#4)(2008-2#2)(2008-5#2)
deceased cancer patients##2##3##(1993-11#2)
deceased##9##1##(1992-3#1)(1993-11#2)(1993-2#1)(1994-2#1)(1997-3#1)(2011-2#1)(2013-1#2)
deceit##3##1##(1995-5#1)(2008-12#1)(2008-9#1)
deceived by##2##2##(1993-11#1)(1995-5#1)
deceived##3##1##(1993-11#1)(1995-5#1)(1997-4#1)
decelerated##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
deceleration##4##1##(2011-1#1)(2013-8#3)
decent##2##1##(2008-1#1)(2008-10#1)
decentralization of the##2##3##(2008-1#1)(2012-12#1)
decentralization of##3##2##(2008-1#1)(2012-12#1)(2012-3#1)
decentralization status of the##2##4##(2012-12#2)
decentralization##12##1##(1992-5#1)(1993-1#1)(2008-1#1)(2012-12#4)(2012-3#5)
decentralized management##2##2##(1992-12#1)(1995-12#1)
decentralized##12##1##(1992-1#1)(1992-12#2)(1993-6#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-12#1)(2008-10#3)
deceptive##2##1##(2011-2#1)(2013-1#1)
decide on the##3##3##(1995-2#1)(2008-10#1)(2009-8#1)
decide on##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
decide the##3##2##(2008-10#1)(2008-11#1)(2013-7#1)
decide to##2##2##(1995-6#1)(2008-7#1)
decide whether to##4##3##(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
decide whether##11##2##(1990-11#1)(1993-2#1)(1995-11#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
decide##26##1##(1990-11#1)(1993-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(2006-6#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
decided by the##2##3##(1994-2#1)(2008-8#1)
decided by##4##2##(1994-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
decided not to##3##3##(1990-9#1)(1996-3#1)(2010-11#1)
decided that the##5##3##(1991-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-11#1)
decided that##8##2##(1991-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2011-4#1)
decided to study##2##3##(2008-12#1)(2013-7#1)
decided to##14##2##(1990-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-11#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-8#1)(2010-11#1)(2012-3#1)(2013-7#1)
decided##40##1##(1990-6#1)(1990-9#1)(1991-6#3)(1993-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-11#2)(2010-5#1)(2011-2#1)(2011-3#2)(2011-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
decides##4##1##(1991-9#1)(1993-6#1)(1994-12#1)(2008-11#1)
deciding the##3##2##(1994-2#1)(1996-1#1)(2008-8#1)
deciding when##2##2##(2008-12#1)(2012-2#1)
deciding which##2##2##(2008-10#1)(2008-4#1)
deciding##13##1##(1994-2#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
decidua and##2##2##(1990-11#1)(2012-3#1)
decidua##4##1##(1990-11#1)(2008-10#2)(2012-3#1)
decidualization##2##1##(2012-3#2)
deciduous oak##2##2##(2012-9#2)
deciduous##6##1##(2008-11#1)(2008-9#1)(2012-9#2)(2013-1#1)(2013-8#1)
decim##2##1##(2008-9#2)
deciphering molecular##2##2##(2008-10#1)(2011-2#1)
deciphering the##4##2##(1997-6#1)(2008-10#1)(2010-8#1)(2013-1#1)
deciphering##10##1##(1997-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
decision about whether to##2##4##(2008-10#1)(2008-8#1)
decision about##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
decision analysis model##2##3##(2012-3#2)
decision analysis##4##2##(1994-6#1)(2009-4#1)(2012-3#2)
decision and detection limits are##2##5##(1995-9#2)
decision and detection limits##3##4##(1995-9#3)
decision and##4##2##(1995-9#3)(2010-8#1)
decision by##3##2##(1994-1#2)(2012-3#1)
decision for##6##2##(1991-12#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
decision in##4##2##(1991-12#1)(1993-12#1)(1994-3#1)(1995-6#1)
decision is##4##2##(1996-6#1)(2008-4#1)(2010-11#1)(2012-2#1)
decision limit##2##2##(2008-10#2)
decision makers and##2##3##(1993-1#1)(2008-10#1)
decision makers##9##2##(1993-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#1)(2010-12#1)(2010-4#1)(2012-12#1)
decision making and##7##3##(1992-3#1)(1993-3#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
decision making by##3##3##(1994-3#1)(2010-8#1)(2012-3#1)
decision making for outpatient chemotherapy in Japanese##2##7##(2010-2#2)
decision making for##5##3##(1992-3#1)(1993-12#1)(2010-2#2)(2011-2#1)
decision making in##6##3##(2008-10#3)(2009-10#2)(2010-11#1)
decision making related to##2##4##(2008-11#1)(2010-11#1)
decision making##56##2##(1990-3#1)(1992-12#1)(1992-3#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#3)(1995-3#2)(1996-2#3)(1996-6#3)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#4)(2008-12#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-11#4)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
decision of the##2##3##(1993-1#1)(1997-8#1)
decision of##9##2##(1993-1#1)(1993-11#1)(1997-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)
decision on##3##2##(2008-10#2)(2009-12#1)
decision process##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
decision processes##2##2##(2009-3#1)(2009-7#1)
decision rules##2##2##(2008-11#1)(2011-2#1)
decision support for##2##3##(2008-10#1)(2011-2#1)
decision support in##2##3##(1994-2#1)(2008-11#1)
decision support system for##2##4##(2008-10#1)(2010-8#1)
decision support system##3##3##(2008-10#2)(2010-8#1)
decision support systems##3##3##(1997-3#1)(2010-8#1)(2011-2#1)
decision support to##4##3##(1995-2#1)(1997-3#2)(2010-4#1)
decision support tool##3##3##(2008-10#1)(2009-6#1)(2010-8#1)
decision support##22##2##(1994-2#2)(1995-2#1)(1997-3#3)(2008-10#5)(2008-11#1)(2009-6#1)(2010-4#1)(2010-6#1)(2010-8#5)(2011-2#2)
decision threshold##3##2##(2008-10#3)
decision to leave##2##3##(2008-9#2)
decision to##24##2##(1991-3#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-6#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#4)(2009-6#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-3#3)(2013-1#1)
decision tree##4##2##(2008-10#3)(2012-3#1)
decision##234##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#6)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#9)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#5)(1995-9#3)(1996-1#3)(1996-2#5)(1996-5#1)(1996-6#5)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-8#1)(2008-10#34)(2008-11#13)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#8)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#7)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#12)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#15)(2013-1#8)
decision-makers##5##1##(2008-10#1)(2008-11#1)(2009-3#2)(2010-5#1)
decision-making ability##2##2##(1992-2#1)(2008-9#1)
decision-making and##4##2##(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
decision-making in the##3##3##(2008-11#1)(2008-12#1)(2011-7#1)
decision-making is##2##2##(2008-10#1)(2008-4#1)
decision-making process##8##2##(1993-1#1)(2008-12#3)(2008-9#1)(2009-1#1)(2009-10#1)(2011-2#1)
decision-making roles##2##2##(1996-1#1)(2010-8#1)
decision-making skills##4##2##(1992-2#1)(1993-2#1)(2008-11#1)(2012-2#1)
decision-making##77##1##(1992-2#2)(1993-1#1)(1993-2#2)(1994-12#3)(1996-1#2)(1996-3#1)(1997-2#1)(2008-10#4)(2008-11#17)(2008-12#6)(2008-4#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#6)(2011-10#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
decisional capacity##3##2##(2009-4#3)
decisional##8##1##(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#4)
decisional-balance##3##1##(2010-2#3)
decisionmaking styles##2##2##(1997-3#2)
decisionmaking##7##1##(1992-2#1)(1997-3#6)
decisions about health##2##3##(1993-12#1)(2008-7#1)
decisions about the##2##3##(2008-12#1)(2011-3#1)
decisions about##15##2##(1993-12#3)(1994-9#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
decisions and the##2##3##(1991-1#1)(1995-2#1)
decisions and##6##2##(1991-1#1)(1992-2#1)(1995-2#1)(1996-6#1)(1997-3#1)(2008-10#1)
decisions are based##2##3##(1997-3#1)(2008-8#1)
decisions are##9##2##(1992-5#1)(1993-1#1)(1997-3#1)(2008-8#1)(2009-12#2)(2011-2#2)(2012-12#1)
decisions based on##3##3##(1992-2#1)(2008-10#1)(2010-7#1)
decisions by##2##2##(2008-10#1)(2010-8#1)
decisions concerning the##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
decisions concerning##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
decisions during##2##2##(1992-2#1)(2008-11#1)
decisions for##8##2##(1995-12#2)(1996-1#1)(2008-10#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
decisions in the##5##3##(1995-3#1)(2008-11#1)(2010-12#1)(2010-5#1)(2012-12#1)
decisions in##12##2##(1993-5#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-8#1)(2008-11#1)(2010-10#1)(2010-12#2)(2010-5#1)(2012-12#1)(2013-1#1)
decisions is##4##2##(1991-1#1)(1991-3#1)(1997-3#1)(2008-11#1)
decisions on##3##2##(2009-6#2)(2010-8#1)
decisions regarding##6##2##(2008-12#1)(2009-5#1)(2010-1#1)(2011-2#1)(2011-8#1)(2012-2#1)
decisions such as##2##3##(1994-3#1)(2009-8#1)
decisions that##2##2##(1990-6#1)(1996-3#1)
decisions to adopt##3##3##(1997-1#1)(2010-11#2)
decisions to##9##2##(1994-3#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#2)
decisions under risk conditions##2##4##(2009-10#2)
decisions under##4##2##(2009-10#4)
decisions was##2##2##(2008-10#1)(2008-11#1)
decisions were made##2##3##(1994-12#1)(2008-10#1)
decisions when##2##2##(1993-3#1)(1994-9#1)
decisions which##2##2##(1996-1#1)(2010-9#1)
decisions with##3##2##(2008-10#1)(2008-12#1)(2009-9#1)
decisions##173##1##(1990-6#1)(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#3)(1992-5#1)(1993-1#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#6)(1994-12#3)(1994-3#3)(1994-6#1)(1994-9#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-6#1)(1996-1#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-3#6)(2008-1#2)(2008-10#13)(2008-11#14)(2008-12#4)(2008-4#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#4)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-2#4)(2011-3#1)(2011-8#1)(2012-12#6)(2012-2#8)(2012-3#1)(2013-1#2)(2013-8#1)
decisive for##2##2##(2008-10#1)(2008-3#1)
decisive role in the##3##4##(2008-10#2)(2008-9#1)
decisive role in##4##3##(2008-10#2)(2008-9#1)(2012-2#1)
decisive##16##1##(1990-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
decitabine##2##1##(2013-8#2)
declaration##2##1##(1990-3#1)(2009-10#1)
declare##2##1##(1992-3#1)(2008-10#1)
declared by##2##2##(2008-10#2)
declared##38##1##(1991-3#1)(1995-9#1)(1996-11#1)(2008-10#6)(2008-5#1)(2010-11#1)(2011-1#25)(2011-2#2)
declares##2##1##(1995-12#1)(2009-4#1)
declaring##3##1##(1996-5#1)(2008-10#1)(2008-7#1)
decline and##7##2##(2008-10#2)(2008-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2013-8#1)
decline below the##2##3##(2008-8#1)(2011-2#1)
decline during##2##2##(1990-3#1)(2008-7#1)
decline in bacterial##2##3##(2008-10#1)(2013-1#1)
decline in the number of##2##5##(1991-3#1)(2008-10#1)
decline in the rate of##2##5##(2008-9#1)(2013-1#1)
decline in the##14##3##(1990-6#1)(1991-3#1)(1991-7#1)(1996-12#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
decline in##58##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-3#1)(2008-10#7)(2008-11#4)(2008-7#5)(2008-8#2)(2008-9#3)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#1)
decline is##2##2##(1994-8#1)(2008-10#1)
decline occurring##2##2##(2008-10#2)
decline of cell##2##3##(2008-11#2)
decline of the##2##3##(2008-10#2)
decline of##17##2##(1994-6#1)(1995-3#1)(1995-5#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-12#1)(2010-8#1)(2012-7#3)(2013-1#1)
decline phase##2##2##(2008-11#2)
decline syndrome##2##2##(2008-10#1)(2010-3#1)
decline to##3##2##(1990-7#1)(1991-2#1)(1994-6#1)
decline was##6##2##(2008-10#1)(2008-11#2)(2008-7#2)(2013-1#1)
decline with age##3##3##(1991-8#1)(2008-10#1)(2008-9#1)
decline with increasing##3##3##(1990-2#1)(2008-11#1)(2008-8#1)
decline with##8##2##(1990-2#1)(1991-1#1)(1991-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
decline##165##1##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-2#3)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-6#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2008-10#32)(2008-11#16)(2008-6#1)(2008-7#19)(2008-8#9)(2008-9#7)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#4)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2012-7#4)(2013-1#10)(2013-7#1)(2013-8#2)
declined after##2##2##(1995-5#1)(2008-10#1)
declined and##2##2##(2010-8#1)(2011-2#1)
declined as##3##2##(2008-10#2)(2008-11#1)
declined at##2##2##(1992-8#1)(2008-10#1)
declined by##3##2##(1993-1#1)(2008-10#1)(2013-1#1)
declined during the course of##2##5##(2008-7#2)
declined during the##6##3##(1990-5#1)(1990-6#1)(2008-11#2)(2008-7#2)
declined during##7##2##(1990-5#1)(1990-6#1)(2008-11#2)(2008-7#2)(2013-1#1)
declined from##8##2##(1991-2#3)(1993-3#1)(2009-7#1)(2013-8#3)
declined gradually##2##2##(2008-10#1)(2013-8#1)
declined in the##2##3##(2008-10#1)(2011-2#1)
declined in##6##2##(1993-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
declined linearly with##4##3##(1993-8#1)(2008-10#2)(2008-7#1)
declined markedly##2##2##(2008-10#1)(2011-2#1)
declined over successive spawnings##2##4##(2010-8#2)
declined over time##3##3##(2008-11#1)(2010-5#1)(2011-2#1)
declined over##6##2##(1990-6#1)(2008-11#1)(2010-5#1)(2010-8#2)(2011-2#1)
declined progressively##2##2##(1994-12#1)(2008-10#1)
declined rapidly after##2##3##(1996-1#1)(2008-10#1)
declined rapidly through##2##3##(1992-6#1)(2008-10#1)
declined rapidly##6##2##(1992-6#1)(1996-1#1)(2008-10#4)
declined significantly##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-5#1)
declined somewhat##2##2##(1991-3#1)(2008-10#1)
declined steadily during##2##3##(1990-5#1)(1993-12#1)
declined steadily##3##2##(1990-5#2)(1993-12#1)
declined to near zero as the pH##2##7##(2008-10#2)
declined to the##2##3##(2008-10#2)
declined to##10##2##(1990-5#1)(1997-2#1)(2008-10#7)(2011-2#1)
declined until##2##2##(2008-10#2)
declined with##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
declined##111##1##(1990-5#4)(1990-6#3)(1991-11#1)(1991-2#4)(1991-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#2)(1994-12#3)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-5#1)(2008-10#35)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-7#1)(2010-5#1)(2010-8#4)(2011-2#7)(2012-2#1)(2012-5#1)(2013-1#3)(2013-8#5)
declines in##13##2##(1993-12#1)(1993-6#1)(1994-3#1)(1995-12#1)(1997-1#1)(2008-10#3)(2008-8#2)(2011-2#3)
declines with age##2##3##(1990-3#1)(2008-7#1)
declines with increasing##2##3##(2008-8#2)
declines with##6##2##(1990-3#1)(2007-11#1)(2008-7#2)(2008-8#2)
declines##32##1##(1990-3#1)(1991-3#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#3)(2008-8#7)(2011-2#3)
declining land cover##2##3##(2011-2#2)
declining mobility##4##2##(2008-7#4)
declining or##2##2##(2010-3#1)(2010-7#1)
declining##37##1##(1990-3#1)(1991-12#1)(1991-3#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-6#2)(1997-1#1)(2008-10#5)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-2#1)
decoction##8##1##(2008-10#2)(2012-3#1)(2013-8#5)
decoction]##2##1##(2012-3#2)
decoded##2##1##(2012-2#1)(2012-3#1)
decoders##3##1##(2008-3#3)
decoding the##2##2##(2009-10#1)(2013-8#1)
decoding##7##1##(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
decoloration##3##1##(2008-10#1)(2008-11#2)
decolorization##2##1##(2008-10#2)
decolourization capacity##2##2##(2011-1#2)
decolourization##3##1##(2011-1#3)
decompensated##5##1##(2009-8#1)(2011-2#2)(2012-3#2)
decompensation##7##1##(1990-3#1)(1991-2#1)(1994-12#1)(1995-11#1)(2008-4#1)(2009-8#2)
decomposable##2##1##(2008-11#1)(2009-12#1)
decompose the##2##2##(2008-10#1)(2011-2#1)
decompose##11##1##(2008-10#8)(2008-11#1)(2008-8#1)(2011-2#1)
decomposed Sphagnum peat##2##3##(2008-10#2)
decomposed by##3##2##(2008-10#3)
decomposed into a##2##3##(2008-10#2)
decomposed into##3##2##(1992-12#1)(2008-10#2)
decomposed using##2##2##(2008-10#1)(2013-1#1)
decomposed##19##1##(1992-12#1)(1995-11#1)(2008-10#14)(2008-11#1)(2011-2#1)(2013-1#1)
decomposes##3##1##(2008-10#2)(2008-5#1)
decomposing##5##1##(2008-10#4)(2008-11#1)
decomposition and##9##2##(2008-10#4)(2008-4#1)(2009-7#1)(2010-4#2)(2010-8#1)
decomposition at##2##2##(2008-10#1)(2008-11#1)
decomposition in##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
decomposition is##5##2##(1994-8#1)(2008-10#3)(2008-11#1)
decomposition method for##2##3##(2008-10#2)
decomposition method##5##2##(2008-10#5)
decomposition of a##4##3##(2008-10#3)(2013-8#1)
decomposition of soil##3##3##(2008-10#2)(2013-8#1)
decomposition of the data##2##4##(2008-10#1)(2008-6#1)
decomposition of the organic##2##4##(2008-10#2)
decomposition of the##14##3##(1992-12#1)(1994-8#1)(2008-10#9)(2008-3#1)(2008-6#1)(2009-7#1)
decomposition of##41##2##(1992-12#1)(1993-2#1)(1993-8#1)(1994-8#2)(2008-10#27)(2008-3#2)(2008-6#1)(2009-11#1)(2009-7#2)(2013-8#3)
decomposition to##2##2##(2008-10#2)
decomposition##118##1##(1990-8#1)(1992-12#2)(1993-2#1)(1993-8#1)(1994-8#3)(2008-10#76)(2008-11#7)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#3)(2010-10#1)(2010-3#2)(2010-4#4)(2010-8#1)(2011-2#4)(2013-8#3)
decompressed##2##1##(2008-7#2)
decompression and extension of fusion##2##5##(2012-3#2)
decompression and neurolysis##2##3##(2013-1#2)
decompression and posterior##2##3##(2008-12#2)
decompression and##12##2##(2008-12#2)(2008-7#2)(2009-8#1)(2012-12#2)(2012-3#2)(2013-1#3)
decompression for##5##2##(2008-7#2)(2011-2#2)(2013-1#1)
decompression is##4##2##(2008-7#1)(2011-2#2)(2012-12#1)
decompression of the spine##2##4##(2008-7#2)
decompression of the##4##3##(2008-12#1)(2008-7#3)
decompression##43##1##(1991-6#3)(2008-12#3)(2008-7#13)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#1)
decompressive hemicraniectomy##2##2##(2012-3#2)
decompressive surgery##2##2##(1991-9#1)(2012-12#1)
decompressive##5##1##(1991-9#1)(2010-11#1)(2012-12#1)(2012-3#2)
decondensed##2##1##(2008-9#2)
decontaminating##2##1##(2008-10#1)(2012-2#1)
decontamination of##2##2##(2008-10#1)(2008-11#1)
decontamination##8##1##(2008-10#4)(2008-11#2)(2008-9#1)(2013-1#1)
deconvolution for##2##2##(2008-10#1)(2011-2#1)
deconvolution method##2##2##(2008-10#2)
deconvolution of##3##2##(2008-10#3)
deconvolution was##3##2##(2008-10#2)(2008-2#1)
deconvolution##17##1##(2008-10#11)(2008-2#1)(2008-3#3)(2008-4#1)(2011-2#1)
deconvolved##4##1##(2008-10#2)(2008-3#2)
decorated with##2##2##(1991-5#1)(2008-5#1)
decorated##5##1##(1991-5#1)(1992-3#2)(2008-10#1)(2008-5#1)
decoration##4##1##(1995-2#1)(2008-10#3)
decorative##2##1##(2008-10#1)(2008-5#1)
decouple the##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
decoupled##2##1##(2008-9#1)(2010-10#1)
decoupling of##2##2##(2008-8#1)(2008-9#1)
decoupling##4##1##(1992-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
decoy##4##1##(2008-10#2)(2008-11#1)(2009-8#1)
decrease (increase) of##2##3##(2008-10#2)
decrease after##2##2##(1991-6#1)(2010-5#1)
decrease and the##2##3##(2008-10#1)(2008-11#1)
decrease and##5##2##(1997-3#1)(2008-10#3)(2008-11#1)
decrease as the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
decrease as##6##2##(1990-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
decrease at##3##2##(1992-7#2)(2008-11#1)
decrease blood##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
decrease during##4##2##(1994-5#1)(2010-12#1)(2012-3#1)(2013-8#1)
decrease for##4##2##(1990-5#1)(2008-10#3)
decrease from##2##2##(2008-3#1)(2008-8#1)
decrease in ST1##2##3##(2013-8#2)
decrease in absorbance of BG##2##5##(2008-10#2)
decrease in absorbance of the##2##5##(2008-10#2)
decrease in absorbance of##8##4##(2008-10#8)
decrease in absorbance##10##3##(2008-10#10)
decrease in activity##3##3##(2008-10#2)(2008-7#1)
decrease in an##2##3##(2008-10#2)
decrease in blood pressure##2##4##(1994-11#1)(1995-11#1)
decrease in both##4##3##(1994-12#1)(1996-2#1)(1997-1#1)(2013-7#1)
decrease in cell multiplication##2##4##(2008-11#2)
decrease in cell numbers##2##4##(2008-11#1)(2011-2#1)
decrease in cell##9##3##(1993-8#1)(1994-11#1)(1995-3#1)(2008-10#1)(2008-11#4)(2011-2#1)
decrease in color intensity of##2##5##(2008-10#2)
decrease in colour intensity of##2##5##(2008-10#2)
decrease in growth rate##2##4##(2008-11#1)(2013-8#1)
decrease in in vitro##2##4##(1990-12#1)(1993-1#1)
decrease in length of##2##4##(1993-2#1)(1994-12#1)
decrease in mean##2##3##(2008-7#1)(2008-9#1)
decrease in number of##2##4##(2008-10#1)(2008-5#1)
decrease in platelet##2##3##(2006-6#1)(2008-10#1)
decrease in resolution##2##3##(2008-10#2)
decrease in spasticity##2##3##(2010-9#1)(2011-2#1)
decrease in species richness##2##4##(2008-8#2)
decrease in the ability of##2##5##(2008-10#1)(2008-5#1)
decrease in the absorbance of the##4##6##(2008-10#4)
decrease in the absorbance of##6##5##(2008-10#6)
decrease in the absorbance##7##4##(2008-10#7)
decrease in the amount of##2##5##(1990-7#1)(2008-10#1)
decrease in the amount##3##4##(1990-7#1)(1995-8#1)(2008-10#1)
decrease in the cell##2##4##(2008-11#2)
decrease in the extraction time of##2##6##(2008-10#2)
decrease in the number of##6##5##(1993-6#1)(1993-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#1)
decrease in the number##7##4##(1993-6#1)(1993-8#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#1)
decrease in the order##2##4##(1990-9#1)(2008-10#1)
decrease in the value##2##4##(2010-4#1)(2012-2#1)
decrease in the##106##3##(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-8#7)(1995-8#2)(1996-11#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#38)(2008-11#7)(2008-12#2)(2008-3#1)(2008-5#5)(2008-7#4)(2009-12#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
decrease in total##6##3##(1991-6#1)(1992-2#1)(1993-6#1)(2008-11#1)(2008-12#1)(2009-8#1)
decrease in unsaturation##2##3##(2008-10#2)
decrease in urine DPD##2##4##(2008-10#2)
decrease in viable##2##3##(2008-10#1)(2008-7#1)
decrease in##359##2##(1990-11#2)(1990-12#5)(1990-3#2)(1990-5#3)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#4)(1992-1#1)(1992-2#3)(1992-6#4)(1992-8#3)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#10)(1994-5#3)(1994-6#1)(1994-8#9)(1995-11#4)(1995-12#2)(1995-3#1)(1995-8#4)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-6#2)(2007-12#2)(2008-1#2)(2008-10#99)(2008-11#35)(2008-12#10)(2008-3#3)(2008-4#1)(2008-5#10)(2008-7#13)(2008-8#4)(2008-9#4)(2009-11#3)(2009-12#1)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-10#1)(2011-2#16)(2012-2#6)(2012-3#6)(2013-1#5)(2013-7#3)(2013-8#10)
decrease is##7##2##(2008-10#5)(2008-11#1)(2013-1#1)
decrease level of##2##3##(2008-8#1)(2012-3#1)
decrease monotonically##2##2##(2008-11#1)(2008-3#1)
decrease occurred in##3##3##(2008-10#3)
decrease of peak current##2##4##(2008-10#2)
decrease of the diastolic##2##4##(1996-6#2)
decrease of the peak current##2##5##(2008-10#2)
decrease of the##27##3##(1991-2#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-6#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)
decrease of viability##3##3##(2008-11#3)
decrease of##99##2##(1990-9#1)(1991-2#1)(1992-6#3)(1993-1#1)(1994-2#1)(1994-8#4)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#3)(1997-5#1)(2008-1#1)(2008-10#40)(2008-11#9)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#7)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2011-2#5)(2012-3#2)(2013-1#1)
decrease on##2##2##(2008-10#1)(2009-12#1)
decrease or##3##2##(2008-10#2)(2008-8#1)
decrease over##2##2##(2008-10#1)(2008-3#1)
decrease patient##2##2##(1994-12#1)(2012-2#1)
decrease risk##2##2##(2011-2#1)(2013-1#1)
decrease sensitivity##2##2##(2009-12#1)(2011-2#1)
decrease serum##2##2##(2010-11#1)(2011-2#1)
decrease sexual risk behaviors##2##4##(2008-4#1)(2010-7#1)
decrease significantly##2##2##(2009-5#1)(2012-3#1)
decrease the efficiency of##2##4##(2008-8#1)(2008-9#1)
decrease the incidence of##3##4##(1993-3#1)(2011-2#1)(2013-1#1)
decrease the incidence##4##3##(1993-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
decrease the risk of##5##4##(1991-2#1)(2008-12#1)(2008-4#1)(2008-6#1)(2013-1#1)
decrease the##57##2##(1990-12#1)(1990-5#2)(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
decrease their##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
decrease to##4##2##(1994-2#1)(2008-10#2)(2012-2#1)
decrease was observed##2##3##(1993-12#1)(1995-2#1)
decrease was##13##2##(1990-11#1)(1990-2#1)(1991-5#1)(1993-12#1)(1994-3#1)(1995-2#2)(1996-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
decrease with increasing##7##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
decrease with the increase of##2##5##(2008-10#1)(2009-7#1)
decrease with the##3##3##(1993-12#1)(2008-10#1)(2009-7#1)
decrease with##18##2##(1993-12#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-4#1)(2012-3#1)
decrease##714##1##(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#2)(1990-5#10)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#6)(1991-8#2)(1992-1#1)(1992-2#3)(1992-3#1)(1992-6#8)(1992-7#2)(1992-8#4)(1993-1#5)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#13)(1994-5#5)(1994-6#1)(1994-8#13)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#5)(1996-11#3)(1996-12#6)(1996-2#8)(1996-3#5)(1996-6#4)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#2)(2006-6#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#4)(2008-10#198)(2008-11#64)(2008-12#16)(2008-2#1)(2008-3#10)(2008-4#4)(2008-5#17)(2008-6#2)(2008-7#21)(2008-8#26)(2008-9#9)(2009-10#1)(2009-11#4)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#8)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#35)(2011-3#1)(2011-7#1)(2012-2#15)(2012-3#16)(2012-5#1)(2013-1#13)(2013-7#3)(2013-8#16)
decrease)##3##1##(2008-10#2)(2013-7#1)
decreased (p &lt##3##3##(2008-11#1)(2008-12#1)(2013-8#1)
decreased (p##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
decreased CL intensity was linear##2##5##(2008-10#2)
decreased CL intensity##3##3##(2008-10#3)
decreased TdR kinase activity in##2##5##(1992-8#2)
decreased activity##2##2##(1993-3#1)(1997-7#1)
decreased after the##2##3##(1996-2#1)(2008-10#1)
decreased after##16##2##(1991-6#1)(1994-2#1)(1994-8#2)(1995-12#3)(1996-2#2)(2008-10#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
decreased again##2##2##(2008-8#2)
decreased and the##5##3##(2008-10#2)(2008-12#1)(2008-8#1)(2013-8#1)
decreased and##15##2##(1991-12#1)(1991-8#1)(1993-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-2#2)(2013-8#1)
decreased appetite and##2##3##(2011-1#1)(2011-2#1)
decreased appetite##3##2##(2011-1#1)(2011-2#2)
decreased as a function of##2##5##(1995-8#1)(2008-10#1)
decreased as a##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
decreased as temperature##2##3##(2008-10#2)
decreased as the##8##3##(1993-3#1)(2008-10#4)(2008-11#2)(2011-3#1)
decreased as##20##2##(1993-3#1)(1995-8#1)(2008-10#11)(2008-11#4)(2008-9#1)(2011-2#1)(2011-3#1)
decreased at all##2##3##(1995-12#1)(2008-10#1)
decreased at higher##2##3##(2008-10#1)(2008-11#1)
decreased at##12##2##(1994-5#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
decreased attention in##2##3##(2008-11#2)
decreased attention##3##2##(2008-11#3)
decreased bone##2##2##(2010-10#2)
decreased both##3##2##(1996-5#1)(2013-1#2)
decreased but##2##2##(1990-3#1)(2008-11#1)
decreased by 10%##2##3##(1991-6#1)(1996-11#1)
decreased by 40%##2##3##(2008-10#1)(2008-11#1)
decreased by BBR treatment##2##4##(2012-3#2)
decreased by a factor of##2##5##(1995-2#1)(2008-10#1)
decreased by a##5##3##(1995-2#2)(2008-10#2)(2008-7#1)
decreased by approximately##2##3##(2008-10#1)(2008-5#1)
decreased by the##3##3##(1990-5#1)(1994-6#1)(2008-10#1)
decreased by##57##2##(1990-5#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-1#2)(1993-3#1)(1994-5#1)(1994-6#1)(1995-2#2)(1996-11#2)(1997-8#1)(2008-10#16)(2008-11#4)(2008-5#2)(2008-7#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#5)(2012-6#1)(2013-1#1)(2013-8#1)
decreased cardiac##2##2##(1994-5#1)(2012-3#1)
decreased catabolism of##2##3##(2008-6#2)
decreased cognitive##2##2##(1993-11#1)(2008-1#1)
decreased compared with##3##3##(1995-6#2)(2009-6#1)
decreased compared##4##2##(1993-1#1)(1995-6#2)(2009-6#1)
decreased compliance##2##2##(2012-3#1)(2013-1#1)
decreased correspondingly##2##2##(1996-11#1)(2008-10#1)
decreased during the##7##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#2)(2013-1#1)
decreased during##21##2##(1990-5#1)(1991-9#1)(1993-1#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
decreased exponentially with increasing##2##4##(2008-10#2)
decreased exponentially with##3##3##(2008-10#3)
decreased expression of##3##3##(2008-10#1)(2011-2#2)
decreased following annuloplasty from##2##4##(2008-10#2)
decreased following##3##2##(2008-10#2)(2008-11#1)
decreased for##3##2##(1991-9#1)(2008-10#2)
decreased from 1##2##3##(1990-5#1)(2008-10#1)
decreased from 2##3##3##(2008-7#2)(2009-11#1)
decreased from a##2##3##(2008-1#1)(2008-7#1)
decreased from the baseline of##2##5##(2008-7#2)
decreased from the##4##3##(2008-5#1)(2008-7#2)(2013-8#1)
decreased from##32##2##(1990-11#1)(1990-5#1)(1991-6#2)(1993-8#1)(1996-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#6)(2009-11#1)(2009-7#1)(2010-4#1)(2013-1#2)(2013-8#1)
decreased gradually as the##2##4##(2008-10#1)(2008-12#1)
decreased gradually in##2##3##(1995-8#1)(2013-8#1)
decreased gradually with##2##3##(1995-8#1)(2008-9#1)
decreased gradually##9##2##(1995-8#2)(2008-10#2)(2008-12#1)(2008-9#2)(2012-12#1)(2013-8#1)
decreased in a##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
decreased in both groups##3##4##(2009-3#1)(2013-1#1)(2013-8#1)
decreased in both##5##3##(1993-8#1)(2008-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
decreased in cells##2##3##(1993-3#1)(1995-6#1)
decreased in comparison to##2##4##(2008-10#1)(2008-8#1)
decreased in comparison##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
decreased in diabetic liver##2##4##(1993-3#2)
decreased in intensity##2##3##(2008-10#2)
decreased in midbrain and##2##4##(1997-2#2)
decreased in the order##4##4##(2008-5#3)(2013-1#1)
decreased in the presence of##3##5##(2008-10#3)
decreased in the##18##3##(1992-3#1)(1996-12#1)(2008-10#8)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2013-1#2)
decreased in this##2##3##(2008-10#1)(2008-11#1)
decreased in##74##2##(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#4)(1993-8#1)(1994-2#2)(1995-6#1)(1996-12#1)(1997-2#2)(1997-7#1)(2007-11#1)(2008-10#21)(2008-11#8)(2008-12#4)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#5)(2009-3#1)(2009-6#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
decreased insulin##2##2##(1991-7#1)(1993-2#1)
decreased levels of##6##3##(1994-8#1)(1995-2#1)(1997-2#1)(2008-1#2)(2008-11#1)
decreased lung##2##2##(2009-9#1)(2012-2#1)
decreased markedly##2##2##(1993-12#1)(2008-10#1)
decreased maternal age##5##3##(1997-3#5)
decreased more##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
decreased need##2##2##(2008-10#1)(2011-2#1)
decreased on##5##2##(1994-2#1)(2008-10#2)(2008-8#1)(2010-5#1)
decreased only in##2##3##(1994-2#1)(2008-7#1)
decreased or##4##2##(1991-6#1)(1993-1#1)(1993-8#1)(2008-10#1)
decreased over time##4##3##(2008-10#3)(2009-7#1)
decreased over##6##2##(2008-10#3)(2009-7#1)(2010-10#1)(2012-3#1)
decreased pain##2##2##(2009-12#1)(2013-1#1)
decreased potency in the##2##4##(1991-1#2)
decreased progressively##3##2##(1993-3#1)(1996-12#1)(2010-4#1)
decreased rapidly##6##2##(1991-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
decreased response to##4##3##(1990-11#1)(2008-11#3)
decreased risk of##7##3##(1992-9#1)(1996-9#1)(2009-11#1)(2010-1#2)(2011-2#1)(2013-1#1)
decreased risk##8##2##(1992-9#1)(1996-9#1)(2009-11#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
decreased serum leptin##2##3##(2008-9#1)(2013-8#1)
decreased serum##4##2##(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
decreased sharply##3##2##(2008-10#3)
decreased sialylation##2##2##(2008-7#2)
decreased significantly at##3##3##(1995-2#1)(2010-5#1)(2011-2#1)
decreased significantly by##2##3##(2008-10#1)(2008-11#1)
decreased significantly during##2##3##(2008-10#1)(2012-3#1)
decreased significantly in the##2##4##(2008-8#1)(2009-12#1)
decreased significantly in##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
decreased significantly with##3##3##(1990-3#2)(2008-9#1)
decreased significantly##29##2##(1990-3#2)(1994-3#1)(1995-2#1)(1996-2#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#1)
decreased specific##2##2##(2008-11#2)
decreased strength##2##2##(2013-1#2)
decreased substantially##2##2##(1996-12#1)(2008-10#1)
decreased survival##2##2##(2009-1#1)(2012-3#1)
decreased the ADP-ribosylation of##2##4##(1990-3#2)
decreased the activity of##2##4##(1991-5#1)(1994-8#1)
decreased the degree of##2##4##(2008-10#1)(2008-8#1)
decreased the duration of##2##4##(1997-2#1)(2008-5#1)
decreased the formation of##2##4##(1993-3#1)(2008-11#1)
decreased the frequency of##2##4##(1997-3#1)(2008-11#1)
decreased the number of##2##4##(1994-8#1)(2008-10#1)
decreased the platelet deposition##2##4##(2006-6#2)
decreased the production of ROS by mitochondria from##2##8##(1994-5#2)
decreased the rate of##2##4##(1994-8#1)(2008-11#1)
decreased the##74##2##(1990-3#3)(1991-11#1)(1991-5#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#4)(1994-8#6)(1995-11#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(2006-6#2)(2008-10#13)(2008-11#9)(2008-12#4)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
decreased their##2##2##(2008-10#1)(2008-3#1)
decreased through##2##2##(1992-5#2)
decreased to##19##2##(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2011-2#1)(2012-3#1)
decreased under##2##2##(2008-11#2)
decreased until##4##2##(1991-8#1)(1996-12#2)(2008-7#1)
decreased upon##4##2##(2008-10#2)(2008-11#2)
decreased when the##2##3##(2008-10#1)(2008-9#1)
decreased when##7##2##(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
decreased whereas##3##2##(1991-12#1)(1997-2#1)(2008-11#1)
decreased with age in##3##4##(1990-3#2)(2008-7#1)
decreased with age##7##3##(1990-12#1)(1990-3#2)(2008-11#1)(2008-7#1)(2012-3#1)(2013-3#1)
decreased with an increase in##2##5##(2008-10#1)(2008-11#1)
decreased with distance from the##2##5##(2008-10#2)
decreased with increase in##3##4##(2008-10#3)
decreased with increased##4##3##(2008-10#2)(2010-4#1)(2013-1#1)
decreased with increasing mu##2##4##(2008-10#2)
decreased with increasing soil temperature and##2##6##(2008-10#2)
decreased with increasing temperature##3##4##(2008-10#2)(2008-9#1)
decreased with increasing##24##3##(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)
decreased with the age##2##4##(2008-10#1)(2008-7#1)
decreased with the##6##3##(1994-8#2)(2008-10#2)(2008-11#1)(2008-7#1)
decreased with##58##2##(1990-12#1)(1990-3#2)(1993-3#1)(1994-8#2)(2008-10#30)(2008-11#6)(2008-12#2)(2008-2#1)(2008-7#4)(2008-9#2)(2009-10#1)(2010-4#1)(2010-6#1)(2012-3#2)(2013-1#1)(2013-3#1)
decreased##875##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#8)(1990-5#4)(1990-6#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#6)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#6)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#14)(1993-6#1)(1993-8#9)(1994-11#2)(1994-12#3)(1994-2#8)(1994-3#1)(1994-5#11)(1994-6#3)(1994-8#12)(1995-11#4)(1995-12#8)(1995-2#9)(1995-3#1)(1995-6#4)(1995-8#8)(1996-11#4)(1996-12#7)(1996-2#9)(1996-5#2)(1996-6#2)(1996-9#1)(1997-2#8)(1997-3#11)(1997-6#2)(1997-7#2)(1997-8#2)(2006-6#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#6)(2008-10#212)(2008-11#91)(2008-12#22)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#22)(2008-6#7)(2008-7#36)(2008-8#22)(2008-9#34)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#1)(2009-6#6)(2009-7#3)(2009-8#4)(2009-9#4)(2010-1#5)(2010-10#6)(2010-11#2)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#33)(2011-3#4)(2012-12#5)(2012-2#16)(2012-3#18)(2012-6#1)(2012-7#2)(2013-1#37)(2013-3#1)(2013-8#8)
decreasein##2##1##(2008-11#2)
decreases NGC-3'##2##2##(1993-12#2)
decreases after##2##2##(2008-12#1)(2011-2#1)
decreases as the##3##3##(1991-2#1)(1996-3#1)(2008-10#1)
decreases as##4##2##(1991-2#1)(1993-12#1)(1996-3#1)(2008-10#1)
decreases by##3##2##(1991-5#1)(2008-10#1)(2010-8#1)
decreases exponentially with time##2##4##(2008-10#1)(2009-11#1)
decreases exponentially with##3##3##(2008-10#2)(2009-11#1)
decreases for##2##2##(2008-5#1)(2009-5#1)
decreases in 2-oxoglutarate levels##2##4##(1991-3#2)
decreases in morphine levels in##2##5##(1997-2#2)
decreases in morphine##3##3##(1997-2#3)
decreases in the##14##3##(1993-6#2)(1994-2#1)(1994-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-5#1)(2012-12#1)
decreases in##50##2##(1991-3#2)(1993-6#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-2#4)(2007-11#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
decreases linearly with increasing osmolarity##2##5##(1991-11#2)
decreases markedly##2##2##(1994-8#1)(2008-9#1)
decreases of##2##2##(1990-10#1)(2008-5#1)
decreases pain##2##2##(2009-12#1)(2013-1#1)
decreases significantly##2##2##(1991-3#1)(2012-3#1)
decreases the risk of##6##4##(2007-8#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
decreases the##24##2##(1990-9#1)(1993-12#2)(1993-6#1)(1994-5#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-7#3)(2008-8#2)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
decreases their##2##2##(1997-1#1)(2013-1#1)
decreases to##2##2##(2008-10#1)(2008-8#1)
decreases viral##2##2##(1995-5#1)(2010-12#1)
decreases with an increase in##3##5##(1997-2#1)(2008-3#1)(2008-8#1)
decreases with increasing temperature##2##4##(1993-8#1)(2009-7#1)
decreases with increasing##9##3##(1991-11#1)(1993-8#2)(1997-6#1)(2008-10#3)(2009-7#1)(2012-2#1)
decreases with temperature##2##3##(2008-10#2)
decreases with the##2##3##(2008-10#1)(2009-7#1)
decreases with##23##2##(1991-11#1)(1991-9#1)(1993-8#2)(1997-2#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2009-7#2)(2012-2#1)(2013-1#1)
decreases##204##1##(1990-10#1)(1990-12#1)(1990-9#1)(1991-11#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-6#5)(1993-8#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#6)(1997-2#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#42)(2008-11#6)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#9)(2008-7#9)(2008-8#15)(2008-9#7)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#2)
decreasing and##2##2##(2008-10#1)(2012-3#1)
decreasing in##10##2##(1990-3#1)(1992-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2010-12#1)(2010-6#1)
decreasing its##3##2##(1990-5#1)(2008-10#2)
decreasing levels of##2##3##(2008-10#1)(2009-8#1)
decreasing of the##3##3##(2008-10#2)(2008-9#1)
decreasing of##8##2##(2008-10#3)(2008-12#1)(2008-9#1)(2012-3#3)
decreasing pH##2##2##(2008-10#1)(2008-5#1)
decreasing risks of##2##3##(2008-10#1)(2011-2#1)
decreasing the peak current obtained proportionally to the increase of its concentration##2##12##(2008-10#2)
decreasing the peak current obtained##3##5##(2008-10#3)
decreasing the peak##4##3##(2008-10#4)
decreasing the risk##4##3##(1992-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
decreasing the##26##2##(1990-5#1)(1992-1#1)(1993-9#1)(1996-9#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
decreasing with##2##2##(2008-10#2)
decreasing##130##1##(1990-3#1)(1990-5#2)(1991-3#1)(1992-1#1)(1992-2#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#9)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#6)(2009-8#3)(2010-1#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#8)(2013-1#1)(2013-8#1)
decree##2##1##(1990-3#1)(1995-12#1)
decrement of##4##2##(2008-10#3)(2012-3#1)
decrement##7##1##(1994-3#1)(2008-10#3)(2008-5#1)(2012-3#2)
decubitus##2##1##(1993-6#2)
decyclopropylated degradation product##3##3##(2008-10#3)
decyl polyglucoside##2##2##(2008-5#2)
decyl)##2##1##(2008-10#2)
dedicated for##2##2##(2008-1#1)(2008-10#1)
dedicated to the##4##3##(2008-10#1)(2008-11#1)(2009-9#1)(2011-1#1)
dedicated to##17##2##(1993-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
dedicated##37##1##(1991-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
dedication##2##1##(1993-12#1)(2012-3#1)
dedifferentiate##4##1##(2008-11#2)(2008-9#2)
dedifferentiated##3##1##(2008-11#1)(2011-2#2)
dedifferentiation of the##2##3##(2008-11#2)
dedifferentiation of##3##2##(2008-11#3)
dedifferentiation##8##1##(2008-11#8)
deduce##10##1##(1993-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-7#1)
deduced aa sequence##4##3##(1990-11#1)(1993-12#2)(1993-6#1)
deduced aa##5##2##(1990-11#1)(1993-12#2)(1993-6#2)
deduced amino acid (aa) sequence##3##5##(1991-6#1)(1993-12#1)(1993-6#1)
deduced amino acid sequence is##2##5##(1993-3#1)(1996-6#1)
deduced amino acid sequence of##3##5##(1993-2#1)(2008-11#1)(2008-8#1)
deduced amino acid sequence revealed##2##5##(1997-4#1)(1997-7#1)
deduced amino acid sequence shows a high##2##7##(1993-2#1)(1995-11#1)
deduced amino acid sequence shows##3##5##(1993-12#1)(1993-2#1)(1995-11#1)
deduced amino acid sequence was##3##5##(1992-3#1)(1996-12#1)(1997-2#1)
deduced amino acid sequence##21##4##(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#1)
deduced amino acid sequences are##2##5##(1992-10#1)(2008-8#1)
deduced amino acid sequences of the##2##6##(1993-12#1)(2008-10#1)
deduced amino acid sequences of##5##5##(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(2008-10#1)
deduced amino acid sequences##11##4##(1990-5#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
deduced amino acid##36##3##(1990-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(1995-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-8#4)(2008-9#2)
deduced amino##37##2##(1990-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(1995-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-8#4)(2008-9#3)
deduced amino-acid##3##2##(1994-11#2)(2008-8#1)
deduced by analysis of cDNA clones from human cell line KG-1##3##11##(1995-8#1)(1996-2#2)
deduced by##6##2##(1995-8#1)(1996-2#2)(2008-10#3)
deduced for##2##2##(1993-9#1)(2008-10#1)
deduced from the cDNA##2##4##(1991-5#1)(1992-10#1)
deduced from the nucleotide sequence##2##5##(1990-8#1)(1997-6#1)
deduced from the##16##3##(1990-5#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-6#1)(1995-6#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)
deduced from##26##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
deduced primary structure of##2##4##(1991-6#1)(1992-3#1)
deduced primary structure##3##3##(1991-6#1)(1992-3#1)(1995-6#1)
deduced primary##4##2##(1991-6#1)(1992-3#1)(1993-9#1)(1995-6#1)
deduced protein of##2##3##(1993-2#1)(2008-8#1)
deduced protein##7##2##(1993-2#1)(1997-9#1)(2008-8#5)
deduced sequence of the##2##4##(1993-3#1)(1995-6#1)
deduced sequence##4##2##(1992-8#1)(1992-9#1)(1993-3#1)(1995-6#1)
deduced that the##3##3##(2008-10#2)(2011-2#1)
deduced that##6##2##(1993-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
deduced to##4##2##(1994-5#1)(1996-12#1)(2008-10#1)(2008-8#1)
deduced##124##1##(1990-11#1)(1990-5#2)(1990-8#1)(1991-5#2)(1991-6#2)(1992-10#2)(1992-3#2)(1992-8#2)(1992-9#4)(1993-12#6)(1993-2#7)(1993-3#2)(1993-6#7)(1993-8#1)(1993-9#3)(1994-11#4)(1994-3#1)(1994-5#2)(1995-11#1)(1995-6#4)(1995-8#3)(1996-12#2)(1996-2#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-9#1)(2007-12#1)(2008-10#20)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#14)(2008-9#3)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
deducing the##3##2##(2008-10#2)(2008-3#1)
deducing##4##1##(2008-10#3)(2008-3#1)
deductive##4##1##(1997-9#1)(2009-8#1)(2010-10#1)(2013-1#1)
deemed clinically##2##2##(1996-11#1)(2013-1#1)
deemed to be##3##3##(1993-3#1)(2008-12#1)(2009-4#1)
deemed##19##1##(1993-3#1)(1995-11#1)(1996-1#1)(1996-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#2)(2009-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
deep brain stimulation (DBS)##2##4##(2010-12#1)(2012-3#1)
deep brain stimulation##3##3##(2010-12#1)(2012-2#1)(2012-3#1)
deep breathing##9##2##(1994-3#1)(2012-2#8)
deep dyslexia##2##2##(1996-2#2)
deep hypothermic circulatory arrest##2##4##(2013-1#2)
deep infection##2##2##(1991-9#2)
deep inferior epigastric perforator##2##4##(2013-1#2)
deep inferior epigastric##3##3##(2013-1#3)
deep inside the##2##3##(1995-3#1)(2007-12#1)
deep inspiration##2##2##(2009-11#1)(2011-2#1)
deep layer##2##2##(2008-11#1)(2008-7#1)
deep learning##3##2##(2008-11#2)(2011-1#1)
deep mycoses##3##2##(2008-5#3)
deep ocean##2##2##(1990-8#1)(2012-2#1)
deep squat##3##2##(2011-2#3)
deep vein thrombosis##4##3##(2007-12#1)(2009-1#1)(2010-1#1)(2012-2#1)
deep vein##6##2##(2007-12#1)(2009-1#1)(2010-1#2)(2011-3#1)(2012-2#1)
deep venous thrombosis and pulmonary embolism##2##6##(2012-3#1)(2013-1#1)
deep venous thrombosis##9##3##(1996-6#1)(1997-3#1)(2008-8#4)(2012-3#2)(2013-1#1)
deep vibrissal##2##2##(2011-2#2)
deep waters##2##2##(2008-3#1)(2008-8#1)
deep wounds##2##2##(2008-11#2)
deep##126##1##(1990-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-5#1)(1994-3#2)(1995-3#3)(1996-2#2)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#4)(2008-10#14)(2008-11#8)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#9)(2011-3#2)(2012-2#13)(2012-3#3)(2013-1#12)(2013-8#5)
deep)##2##1##(2008-10#2)
deep-UV laser system##2##3##(2008-3#2)
deep-UV##4##1##(2008-3#4)
deep-inspiration breath-hold##3##2##(2009-11#3)
deep-sea fish cells##4##3##(2008-11#4)
deep-sea fish##6##2##(2008-11#6)
deep-sea hydrothermal##2##2##(1995-3#1)(2008-10#1)
deep-sea##8##1##(1995-3#1)(2008-10#1)(2008-11#6)
deepen##2##1##(1994-12#1)(2008-10#1)
deeper insight into##2##3##(1993-8#1)(2008-4#1)
deeper insight##4##2##(1993-8#1)(2008-10#1)(2008-4#1)(2013-8#1)
deeper insights##2##2##(2009-8#1)(2012-2#1)
deeper layers##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
deeper understanding of the##2##4##(2007-11#1)(2008-11#1)
deeper understanding of##7##3##(2007-11#1)(2008-11#2)(2008-8#1)(2010-7#1)(2010-9#1)(2012-12#1)
deeper##35##1##(1990-5#1)(1990-6#1)(1993-11#1)(1993-8#1)(1995-3#1)(1995-6#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
deeply embedded##2##2##(1990-5#1)(1991-5#1)
deeply rooted##4##2##(1995-5#1)(2008-10#2)(2008-11#1)
deeply##18##1##(1990-5#1)(1991-3#1)(1991-5#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
deer resistance is##2##3##(2008-8#2)
deer resistance##3##2##(2008-8#3)
deer##8##1##(2008-10#1)(2008-7#1)(2008-8#6)
defatted##6##1##(2008-10#5)(2008-11#1)
defatting##3##1##(2008-10#1)(2008-4#1)(2008-5#1)
default mode network##2##3##(2013-8#2)
default##9##1##(1994-2#1)(2008-4#1)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#4)
defeat##3##1##(1997-6#1)(2008-10#2)
defeated##8##1##(1995-6#1)(1996-5#1)(2008-10#5)(2009-10#1)
defect and##7##2##(2008-1#1)(2008-11#2)(2008-12#1)(2009-8#1)(2010-10#1)(2011-2#1)
defect by##2##2##(1997-1#1)(2008-11#1)
defect in the##14##3##(1990-5#2)(1994-11#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
defect in##26##2##(1990-5#4)(1994-11#1)(1994-12#2)(1995-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
defect is##5##2##(1996-12#1)(1997-7#1)(2008-7#1)(2008-9#1)(2013-8#1)
defect of a##3##3##(1993-9#1)(2013-1#2)
defect of the##3##3##(1995-6#1)(2009-8#1)(2013-1#1)
defect of##13##2##(1993-3#1)(1993-6#1)(1993-9#1)(1995-6#2)(1996-6#1)(1997-3#1)(2008-11#1)(2009-8#1)(2010-7#1)(2013-1#3)
defect on the##2##3##(2008-12#1)(2011-2#1)
defect on##3##2##(2008-12#1)(2008-9#1)(2011-2#1)
defect sites##2##2##(2008-10#2)
defect was reconstructed##2##3##(2008-9#1)(2011-2#1)
defect was repaired##3##3##(2008-12#2)(2012-3#1)
defect was##12##2##(1990-5#1)(1991-2#1)(1996-6#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-3#1)
defect with##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
defect##126##1##(1990-12#2)(1990-5#7)(1991-2#2)(1991-5#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#4)(1995-2#1)(1995-6#3)(1996-12#2)(1996-6#2)(1997-1#2)(1997-3#3)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#13)(2008-12#6)(2008-3#2)(2008-4#1)(2008-7#8)(2008-8#1)(2008-9#9)(2009-12#1)(2009-8#3)(2010-10#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#12)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
defective RNAs in##2##3##(2008-10#2)
defective RNAs##3##2##(2008-10#3)
defective hearing##2##2##(1990-12#2)
defective herpes simplex virus##3##4##(1996-12#2)(2008-11#1)
defective in##9##2##(1991-12#1)(1994-2#1)(1996-3#3)(1997-7#1)(2008-10#1)(2009-6#1)(2011-2#1)
defective interfering (DI)##2##3##(2008-10#2)
defective##55##1##(1990-11#1)(1990-12#2)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-12#2)(1996-3#3)(1997-1#2)(1997-6#1)(1997-7#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)
defects and##11##2##(1994-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-3#1)(2008-7#1)(2010-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
defects are##4##2##(1996-2#1)(1997-8#1)(2008-9#1)(2009-10#1)
defects associated##2##2##(2008-10#1)(2013-8#1)
defects by##2##2##(2012-12#1)(2012-3#1)
defects identified through##2##3##(2012-12#2)
defects identified##3##2##(2012-12#3)
defects in DNA##2##3##(1996-2#1)(2009-4#1)
defects in the##13##3##(1991-7#1)(1994-12#2)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
defects in##47##2##(1991-2#2)(1991-7#1)(1993-5#1)(1993-9#1)(1994-12#3)(1995-2#2)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-3#3)(2013-1#2)(2013-8#1)
defects may##2##2##(2008-9#1)(2010-10#1)
defects of the##4##3##(1990-5#1)(2008-6#1)(2008-9#1)(2010-6#1)
defects of##11##2##(1990-5#1)(1993-3#1)(1996-6#1)(1997-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#2)(2011-2#1)(2012-3#1)
defects present in PCOS##2##4##(2008-4#2)
defects such as##2##3##(1997-3#1)(2008-3#1)
defects that##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
defects were##4##2##(2008-3#1)(2010-12#1)(2012-12#1)(2012-3#1)
defects which##2##2##(1994-5#1)(2010-10#1)
defects##174##1##(1990-11#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-5#3)(1993-3#2)(1993-5#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#2)(1995-1#1)(1995-2#2)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#3)(1997-6#2)(1997-8#6)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-2#1)(2008-3#9)(2008-4#2)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#9)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#13)(2012-2#5)(2012-3#10)(2013-1#5)(2013-8#2)
defects)##3##1##(1997-3#1)(2008-10#1)(2010-10#1)
defects]##2##1##(1990-11#1)(2009-5#1)
defence against##2##2##(1990-9#1)(2012-2#1)
defence and##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
defence mechanisms##2##2##(2008-10#1)(2011-10#1)
defence of##2##2##(2008-7#1)(2012-2#1)
defence##14##1##(1990-9#1)(2008-10#1)(2008-7#2)(2009-6#1)(2011-10#3)(2011-2#1)(2012-2#3)(2012-6#1)(2013-1#1)
defend against##2##2##(2008-6#2)
defend the##2##2##(2008-7#1)(2008-9#1)
defend themselves against##3##3##(1993-3#1)(2009-8#1)(2011-10#1)
defend themselves##4##2##(1993-3#1)(2008-10#1)(2009-8#1)(2011-10#1)
defend##10##1##(1993-3#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#1)(2011-10#1)
defending the##2##2##(1995-6#1)(2008-8#1)
defending##7##1##(1991-1#1)(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-2#1)
defends the##2##2##(1991-3#1)(2011-2#1)
defense against fungal pathogens##2##4##(2008-10#1)(2011-2#1)
defense against infection##2##3##(2008-10#1)(2008-9#1)
defense against##20##2##(1990-11#1)(1993-12#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#2)
defense and development##2##3##(2009-8#2)
defense and##9##2##(1992-12#1)(2008-8#4)(2009-8#2)(2010-11#1)(2011-2#1)
defense are##2##2##(2008-10#1)(2008-9#1)
defense authorization bill##2##3##(1995-6#1)(1996-5#1)
defense bill##3##2##(1995-6#2)(1996-5#1)
defense gene##5##2##(2008-10#3)(2008-8#2)
defense genes##3##2##(2008-10#3)
defense in##3##2##(1993-2#1)(1996-12#1)(2008-10#1)
defense is##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
defense mechanism of##3##3##(2008-10#3)
defense mechanism##6##2##(2008-10#5)(2012-3#1)
defense mechanisms to##2##3##(2008-10#1)(2009-6#1)
defense mechanisms##13##2##(2008-10#9)(2008-5#1)(2009-6#1)(2009-9#1)(2011-2#1)
defense of##5##2##(1991-1#1)(1993-12#1)(1994-3#1)(2008-11#1)(2010-4#1)
defense reaction)##2##2##(2008-10#2)
defense reactions and##2##3##(2008-10#2)
defense reactions in##2##3##(2008-10#2)
defense reactions##11##2##(2008-10#11)
defense response##23##2##(2008-10#19)(2008-9#4)
defense responses against##3##3##(2008-10#2)(2008-9#1)
defense responses in##3##3##(2008-10#3)
defense responses to##2##3##(2008-10#2)
defense responses##18##2##(2008-10#17)(2008-9#1)
defense sprays##3##2##(2008-10#3)
defense strategies against##2##3##(2008-10#1)(2010-7#1)
defense strategies##4##2##(1991-3#1)(2008-10#1)(2009-8#1)(2010-7#1)
defense system##9##2##(1992-10#1)(1992-12#2)(1996-5#1)(2008-10#2)(2008-12#1)(2009-6#1)(2013-1#1)
defense systems##2##2##(2008-10#1)(2009-8#1)
defense##208##1##(1990-11#1)(1991-1#2)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#8)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-6#3)(1996-12#1)(1996-5#4)(1997-2#2)(2007-12#2)(2008-10#101)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#17)(2008-9#20)(2009-10#3)(2009-6#3)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#3)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#1)
defense)##2##1##(2008-7#1)(2008-8#1)
defense-associated##2##1##(2008-10#2)
defense-related genes##3##2##(2008-10#3)
defense-related##8##1##(2008-10#7)(2009-8#1)
defense-responsive genes##3##2##(2008-9#3)
defenses against##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
defenses and##3##2##(1993-2#2)(2008-9#1)
defenses##27##1##(1992-3#1)(1993-2#2)(1996-12#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#11)(2009-8#3)(2012-2#1)
defensive and##2##2##(2010-11#1)(2012-3#1)
defensive behavior##3##2##(1992-1#1)(2007-12#2)
defensive##21##1##(1992-1#2)(1992-12#2)(1993-3#1)(1994-5#1)(1994-8#1)(1997-3#1)(2007-12#6)(2008-11#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-3#2)
deference to##2##2##(2009-11#2)
defiance##4##1##(2008-12#4)
defibrillation##2##1##(2010-9#1)(2011-2#1)
defibrillator##8##1##(2008-12#4)(2009-10#1)(2010-9#2)(2011-2#1)
deficiencies and##2##2##(1996-2#1)(2013-1#1)
deficiencies are##2##2##(1996-2#1)(1997-8#1)
deficiencies in the##3##3##(1992-9#1)(1997-2#1)(2008-11#1)
deficiencies in##9##2##(1991-10#1)(1991-12#1)(1992-9#2)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)
deficiencies that##2##2##(2008-10#1)(2010-12#1)
deficiencies##32##1##(1990-6#1)(1991-10#1)(1991-12#1)(1992-9#4)(1993-6#1)(1995-11#1)(1996-2#3)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#2)(2009-12#1)(2010-12#1)(2011-2#2)(2013-1#4)
deficiency (GHD)##2##2##(2011-1#1)(2012-3#1)
deficiency among##4##2##(1991-8#2)(1997-3#1)(2012-3#1)
deficiency and##13##2##(1991-2#1)(1992-9#1)(1994-8#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-8#1)
deficiency anemia##2##2##(1991-6#1)(1994-6#1)
deficiency are##2##2##(1990-8#1)(2011-1#1)
deficiency at##2##2##(2008-8#1)(2012-3#1)
deficiency can cause##2##3##(2008-6#1)(2009-8#1)
deficiency disease##2##2##(2008-10#1)(2008-12#1)
deficiency has been##2##3##(2011-2#1)(2013-8#1)
deficiency has##4##2##(2011-2#1)(2012-2#2)(2013-8#1)
deficiency in the##9##3##(1990-5#1)(1992-9#1)(1993-3#1)(1996-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
deficiency in##23##2##(1990-5#1)(1992-9#2)(1993-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-8#1)(2010-2#1)(2011-1#3)(2013-1#3)(2013-8#1)
deficiency is associated with##3##4##(2011-2#1)(2012-2#1)(2012-3#1)
deficiency is not##2##3##(1991-9#1)(2012-2#1)
deficiency is##13##2##(1990-8#1)(1991-9#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
deficiency may be##4##3##(1992-9#1)(1994-5#1)(1996-2#1)(2007-12#1)
deficiency of the##6##3##(1990-8#1)(1991-7#1)(1992-12#1)(2006-6#1)(2008-8#1)(2012-12#1)
deficiency of##21##2##(1990-8#1)(1990-9#1)(1991-7#2)(1992-12#2)(1993-2#1)(1993-3#1)(1995-8#1)(1997-7#1)(2006-6#2)(2008-11#1)(2008-4#1)(2008-8#2)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
deficiency or##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
deficiency reduces##2##2##(2013-1#2)
deficiency results in##2##3##(1995-11#1)(2008-12#1)
deficiency rickets##2##2##(2011-1#2)
deficiency syndrome##3##2##(1996-11#1)(2011-2#1)(2013-1#1)
deficiency type##3##2##(2008-4#1)(2011-1#1)(2012-12#1)
deficiency was##5##2##(1993-3#1)(1994-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
deficiency with##2##2##(2011-1#1)(2012-2#1)
deficiency##211##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-9#6)(1993-12#2)(1993-2#1)(1993-3#4)(1994-11#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#3)(2006-6#2)(2007-12#5)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#5)(2008-12#5)(2008-4#10)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#2)(2009-8#5)(2010-10#2)(2010-11#1)(2010-2#3)(2011-1#14)(2011-2#8)(2012-12#3)(2012-2#18)(2012-3#11)(2013-1#11)(2013-7#2)(2013-8#8)
deficient and##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
deficient diets##2##2##(1994-5#2)
deficient for##2##2##(2008-11#1)(2012-3#1)
deficient in the##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
deficient in##20##2##(1990-8#1)(1993-12#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#10)(2008-7#2)(2008-9#1)(2009-8#1)
deficient mice##3##2##(2008-6#2)(2008-7#1)
deficient mutants##2##2##(1997-7#1)(2008-7#1)
deficient or##3##2##(1993-12#1)(2008-6#1)(2012-2#1)
deficient rats##4##2##(1994-5#2)(1994-8#1)(1995-11#1)
deficient transferrin##3##2##(1993-12#2)(1997-2#1)
deficient##73##1##(1990-11#1)(1990-8#1)(1993-12#4)(1993-2#1)(1994-3#1)(1994-5#6)(1994-8#7)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#2)(2006-6#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-6#4)(2008-7#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#3)
deficit and##7##2##(2008-10#2)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)
deficit disorder##2##2##(1995-1#1)(2008-11#1)
deficit for contralateral##2##3##(2009-10#2)
deficit hyperactivity disorder (ADHD)##2##4##(1996-6#1)(2009-9#1)
deficit hyperactivity disorder##8##3##(1996-6#1)(2008-11#2)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)
deficit hyperactivity##9##2##(1996-6#1)(2008-11#3)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)
deficit in the##5##3##(1997-2#1)(2008-11#2)(2008-7#2)
deficit in##13##2##(1991-7#1)(1993-2#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-11#4)(2008-7#2)(2011-2#1)
deficit or##2##2##(1996-3#1)(2010-5#1)
deficit regime##2##2##(2008-10#2)
deficit was##5##2##(1997-2#2)(2008-7#1)(2011-2#2)
deficit##92##1##(1990-12#1)(1990-9#1)(1991-7#3)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2008-10#8)(2008-11#8)(2008-12#3)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#10)(2012-12#3)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#1)
deficit/hyperactivity disorder in##2##3##(1997-8#2)
deficit/hyperactivity disorder##7##2##(1997-8#5)(2011-2#2)
deficit/hyperactivity##8##1##(1997-8#6)(2011-2#2)
deficits and##5##2##(1994-8#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)
deficits are##4##2##(1991-2#1)(1993-12#1)(2011-2#1)(2012-2#1)
deficits due to##2##3##(1995-11#1)(2008-7#1)
deficits following##2##2##(1993-3#1)(2009-10#1)
deficits have been##2##3##(2008-7#1)(2011-1#1)
deficits in these##2##3##(1992-12#1)(1996-2#1)
deficits in##27##2##(1991-2#1)(1992-12#2)(1993-12#1)(1994-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#5)(2013-1#2)
deficits on##4##2##(1993-3#2)(2011-2#1)(2012-2#1)
deficits to##2##2##(1991-3#1)(2012-3#1)
deficits##108##1##(1990-11#1)(1991-2#8)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-12#3)(1993-3#4)(1994-12#1)(1994-8#5)(1995-11#2)(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#5)(2008-12#4)(2008-2#1)(2008-4#1)(2008-7#9)(2008-9#1)(2009-10#5)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#4)(2011-2#5)(2011-7#1)(2012-2#9)(2012-3#8)(2012-9#1)(2013-1#5)
define a##10##2##(1990-8#1)(1992-12#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
define and##4##2##(1997-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
define best##2##2##(2008-12#1)(2013-1#1)
define its##3##2##(1994-12#1)(1994-3#1)(2008-10#1)
define the clinical##3##3##(1991-6#1)(2011-2#1)(2012-3#1)
define the effect of##2##4##(1995-2#1)(1997-7#1)
define the molecular##2##3##(2010-1#2)
define the risk##2##3##(2011-3#1)(2012-3#1)
define the role of##4##4##(1990-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
define the role##5##3##(1990-12#1)(1992-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
define the specific##2##3##(2010-1#1)(2013-1#1)
define the term##3##3##(2012-12#1)(2013-1#2)
define the##60##2##(1990-12#2)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-9#1)(1994-2#2)(1994-6#1)(1995-2#3)(1996-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
define two##2##2##(2010-3#1)(2010-4#1)
define which##2##2##(1996-3#1)(2011-2#1)
define##132##1##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-6#1)(1992-9#2)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#4)(1996-11#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#4)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#4)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#8)(2013-1#8)(2013-8#2)
defined a##3##2##(1992-9#1)(1997-7#1)(2012-2#1)
defined and reproducible##2##3##(2008-7#2)
defined and##18##2##(1990-2#1)(1991-12#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
defined as &quot##2##3##(1991-3#1)(2012-3#1)
defined as a##16##3##(1994-1#1)(1995-12#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
defined as an##6##3##(1993-6#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
defined as the concentration##2##4##(2008-10#2)
defined as the difference between##2##5##(1991-11#1)(2009-11#1)
defined as the ratio of the##3##6##(2008-10#1)(2008-11#1)(2008-3#1)
defined as the ratio##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
defined as the##27##3##(1991-11#1)(1991-9#1)(1992-1#1)(1993-12#1)(1995-12#1)(1995-5#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-11#1)(2011-2#2)(2012-2#1)
defined as those##2##3##(2008-8#1)(2012-12#1)
defined as three times the standard deviation of##2##8##(2008-10#2)
defined as##84##2##(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#4)(2012-4#1)(2013-1#2)(2013-7#1)
defined at the##2##3##(2010-6#1)(2013-1#1)
defined at##5##2##(2008-10#2)(2008-7#1)(2010-6#1)(2013-1#1)
defined by a##2##3##(2008-10#1)(2008-5#1)
defined by its##2##3##(2008-8#1)(2010-6#1)
defined by the##13##3##(1991-11#1)(1994-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#2)
defined by their##2##3##(1994-2#1)(1995-8#1)
defined by##53##2##(1990-12#1)(1991-1#1)(1991-11#1)(1994-11#2)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#5)(2009-12#1)(2010-1#1)(2010-11#1)(2010-6#2)(2010-8#2)(2011-2#2)(2012-3#3)
defined criteria##2##2##(2008-11#1)(2009-8#1)
defined daily##2##2##(2008-11#2)
defined for##5##2##(1995-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-3#1)
defined here as##2##3##(2008-6#1)(2013-1#1)
defined in a##2##3##(2008-10#1)(2008-11#1)
defined in the##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
defined in this##4##3##(1993-12#1)(2008-10#2)(2010-8#1)
defined in##21##2##(1993-12#1)(1993-3#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
defined mixtures of##3##3##(2008-12#2)(2008-9#1)
defined on the##2##3##(1992-9#1)(1994-12#1)
defined pattern##2##2##(1994-9#1)(2008-10#1)
defined peak##2##2##(2008-10#1)(2013-8#1)
defined populations##3##2##(1996-3#1)(2008-10#1)(2013-1#1)
defined prognostic factors##2##3##(1997-8#2)
defined protein-free##5##2##(2008-11#5)
defined that##2##2##(2008-3#1)(2010-10#1)
defined the##4##2##(1990-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
defined time##4##2##(2012-2#2)(2012-3#1)(2013-1#1)
defined to be##2##3##(2008-11#1)(2009-3#1)
defined using the##2##3##(1997-6#1)(2013-1#1)
defined using##3##2##(1997-6#1)(2010-11#1)(2013-1#1)
defined volume##2##2##(2008-10#2)
defined##398##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#3)(1991-11#5)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-9#2)(1993-12#4)(1993-3#2)(1993-6#4)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#9)(1995-2#3)(1995-5#3)(1995-6#4)(1995-8#5)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2006-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#72)(2008-11#37)(2008-12#9)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#7)(2008-7#16)(2008-8#15)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-5#2)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#19)(2011-3#1)(2012-12#1)(2012-2#15)(2012-3#10)(2012-4#1)(2013-1#11)(2013-7#1)(2013-8#3)
defines a new##2##3##(2008-10#1)(2008-5#1)
defines a##8##2##(1993-8#1)(1994-2#1)(1995-3#1)(2008-10#3)(2008-5#1)(2013-1#1)
defines migraine##2##2##(2008-9#2)
defines the##13##2##(1991-2#1)(1993-3#1)(1996-2#1)(1996-3#3)(1997-3#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)
defines##36##1##(1991-1#1)(1991-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#4)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
defining a##4##2##(1991-7#1)(1993-12#1)(2008-10#1)(2012-2#1)
defining the role of##2##4##(2008-2#1)(2010-5#1)
defining the roles of##2##4##(1995-3#1)(2011-1#1)
defining the##21##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
defining##67##1##(1990-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#3)
definite advantage##2##2##(1997-8#1)(2008-7#1)
definite##20##1##(1991-6#1)(1995-3#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
definitely##7##1##(1995-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
definition and the##2##3##(1991-1#1)(2008-10#1)
definition and##13##2##(1991-1#2)(1991-12#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2012-3#1)(2013-1#4)
definition for##2##2##(2008-6#1)(2012-2#1)
definition in##2##2##(1992-12#1)(1992-9#1)
definition is proposed##2##3##(1992-3#1)(2008-10#1)
definition is##7##2##(1992-3#1)(2008-10#1)(2012-3#1)(2013-1#4)
definition of &quot##2##3##(1996-6#1)(2008-7#1)
definition of CS##4##3##(2013-1#4)
definition of HC##2##3##(2008-10#2)
definition of a##2##3##(2008-10#1)(2011-2#1)
definition of the##15##3##(1992-5#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-6#1)(2010-7#1)(2012-2#2)
definition of##55##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-2#1)(1996-11#1)(1996-2#2)(1996-6#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#5)
definition##108##1##(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#3)(1993-1#1)(1993-2#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-11#2)(1996-2#4)(1996-3#1)(1996-6#1)(1996-9#1)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#4)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#3)(2013-1#17)
definitions and##7##2##(1992-3#2)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
definitions of the##4##3##(1993-1#1)(2008-1#2)(2011-2#1)
definitions of##20##2##(1993-1#1)(1994-12#1)(1995-1#1)(1996-11#1)(1996-6#1)(2008-1#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#2)(2013-1#2)
definitions##52##1##(1990-6#1)(1991-2#1)(1992-12#1)(1992-3#3)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#2)(1996-11#1)(1996-6#1)(1997-3#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)
definitive clinical##2##2##(1990-3#1)(2012-12#1)
definitive conclusions##3##2##(1990-12#1)(1992-12#1)(2009-10#1)
definitive concurrent chemoradiotherapy##2##3##(2012-3#2)
definitive diagnosis of##2##3##(1997-8#1)(2008-5#1)
definitive diagnosis##11##2##(1993-6#1)(1997-8#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
definitive diagnostic##3##2##(2008-12#1)(2010-12#1)(2013-1#1)
definitive evidence of##2##3##(2008-10#1)(2010-12#1)
definitive evidence##4##2##(1992-9#1)(2008-10#1)(2010-12#1)(2011-2#1)
definitive treatment##7##2##(1991-6#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#2)
definitive##70##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-8#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-4#1)(2010-12#4)(2010-2#1)(2010-5#1)(2011-2#10)(2012-12#1)(2012-3#5)(2013-1#4)(2013-8#2)
definitively##4##1##(1993-12#1)(2006-6#1)(2008-10#1)(2008-11#1)
deflated to##2##2##(1992-9#1)(1997-6#1)
deflation##2##1##(1992-9#1)(2008-7#1)
deflection angles##2##2##(2008-3#2)
deflection is##2##2##(2008-10#1)(2008-2#1)
deflection signals##2##2##(2008-3#2)
deflection##16##1##(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#11)
defocusing##3##1##(1992-12#1)(2007-12#1)(2008-3#1)
defoliating##2##1##(2008-10#2)
defoliation##6##1##(2008-10#6)
deforestation##2##1##(2008-12#1)(2011-2#1)
deform##4##1##(2008-5#1)(2009-7#2)(2010-8#1)
deformable##4##1##(2009-12#1)(2012-3#3)
deformans is##2##2##(2008-10#2)
deformans##8##1##(2008-10#8)
deformation and##4##2##(1997-5#1)(2008-3#2)(2009-7#1)
deformation disease##2##2##(2008-10#2)
deformation index##2##2##(2008-8#1)(2008-9#1)
deformation of the##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
deformation of##7##2##(2008-10#1)(2008-3#2)(2008-8#1)(2009-7#3)
deformation rates larger than##2##4##(2009-7#2)
deformation rates##3##2##(2009-7#3)
deformation##40##1##(1997-5#1)(2008-10#7)(2008-11#1)(2008-3#9)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#10)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
deformations as##2##2##(2008-3#2)
deformations of##5##2##(2008-3#5)
deformations##16##1##(2008-3#11)(2008-6#1)(2009-7#2)(2009-9#1)(2011-2#1)
deformed##9##1##(1992-8#1)(2008-10#1)(2008-3#4)(2008-5#1)(2009-7#1)(2010-5#1)
deforming##2##1##(1991-3#1)(2008-10#1)
deformities in##2##2##(2012-12#1)(2012-2#1)
deformities##15##1##(1990-9#1)(1991-6#1)(1997-6#2)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#1)
deformity and##5##2##(1991-8#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-3#1)
deformity can be effectively##2##4##(2008-8#1)(2008-9#1)
deformity in the thoracolumbar##2##4##(2008-8#2)
deformity in the##4##3##(2008-7#1)(2008-8#2)(2010-3#1)
deformity in##11##2##(1997-3#2)(2008-7#1)(2008-8#2)(2009-3#3)(2010-3#1)(2012-3#2)
deformity of##2##2##(2008-9#1)(2010-3#1)
deformity with##3##2##(2012-2#2)(2013-8#1)
deformity##54##1##(1991-8#1)(1997-3#2)(2008-10#1)(2008-12#5)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#3)(2009-3#5)(2010-11#3)(2010-3#2)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#3)(2013-8#2)
defrosting at room temperature##2##4##(2010-4#2)
defrosting at##4##2##(2010-4#4)
defrosting in the##2##3##(2010-4#2)
defrosting practices of ground beef##2##5##(2010-4#2)
defrosting practices##5##2##(2010-4#5)
defrosting##12##1##(2010-4#12)
deg##4##1##(2008-3#4)
deg-1 gene##2##2##(1990-5#2)
degeneracy##3##1##(1995-5#1)(2008-3#1)(2008-8#1)
degeneracy-split azimuthal modes##2##3##(2008-2#2)
degenerate four-wave mixing##2##3##(2008-3#2)
degenerate or necrotic lymphoblasts##2##4##(2008-5#2)
degenerate primers is##2##3##(2008-10#2)
degenerate primers that##2##3##(2008-10#2)
degenerate primers were##2##3##(2008-10#2)
degenerate primers##14##2##(1993-2#1)(1996-8#1)(1997-7#1)(2008-10#11)
degenerate##30##1##(1992-12#1)(1993-2#1)(1993-8#1)(1995-5#1)(1996-8#2)(1997-7#1)(2007-12#1)(2008-10#13)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#3)(2010-3#1)
degenerated##5##1##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
degenerating##3##1##(2008-11#2)(2011-2#1)
degeneration and##7##2##(1992-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
degeneration by##2##2##(1995-2#1)(2011-2#1)
degeneration in the##2##3##(2008-5#1)(2008-9#1)
degeneration in##7##2##(1995-8#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
degeneration induced by##4##3##(1994-8#3)(2008-7#1)
degeneration is##4##2##(1991-11#1)(1997-3#1)(1997-8#1)(2010-12#1)
degeneration of the##7##3##(1990-5#1)(1997-5#1)(2008-4#1)(2008-9#2)(2010-5#1)(2011-2#1)
degeneration of##14##2##(1990-5#4)(1997-5#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#3)(2010-5#1)(2011-2#1)
degeneration or##2##2##(2011-2#2)
degeneration##101##1##(1990-5#4)(1991-11#1)(1992-2#1)(1994-8#5)(1995-2#1)(1995-8#2)(1996-2#1)(1996-6#1)(1997-3#4)(1997-5#1)(1997-8#3)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#9)(2008-9#6)(2009-12#1)(2009-3#2)(2010-12#4)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#24)(2011-7#2)(2011-9#1)(2012-2#2)(2012-3#6)(2013-1#4)(2013-7#1)
degenerative and##3##2##(1993-2#1)(1994-5#2)
degenerative changes in the##3##4##(2006-6#1)(2011-2#1)(2012-12#1)
degenerative changes in##6##3##(1997-3#3)(2006-6#1)(2011-2#1)(2012-12#1)
degenerative changes##11##2##(1992-12#1)(1997-3#5)(1997-6#1)(2006-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
degenerative dementias##2##2##(2008-7#2)
degenerative disc disease and lumbar instability##2##6##(2011-2#2)
degenerative disc disease##9##3##(2008-7#1)(2011-2#3)(2012-12#2)(2012-3#3)
degenerative disc##11##2##(2008-7#1)(2011-2#4)(2012-12#3)(2012-3#3)
degenerative disease##2##2##(2012-12#1)(2013-8#1)
degenerative diseases of the##2##4##(2008-7#1)(2012-2#1)
degenerative diseases##10##2##(1992-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
degenerative disk##2##2##(2009-3#1)(2013-8#1)
degenerative effects##2##2##(1991-11#1)(2011-2#1)
degenerative##63##1##(1991-11#1)(1992-12#1)(1992-9#1)(1993-2#2)(1994-5#2)(1997-3#5)(1997-6#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-10#1)(2010-3#1)(2011-2#10)(2012-12#6)(2012-2#1)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
deglycosylated##3##1##(1990-8#1)(1991-12#1)(1997-2#1)
deglycosylation##3##1##(1993-1#2)(1993-8#1)
degradability##2##1##(2008-7#1)(2010-3#1)
degradable##3##1##(2008-10#1)(2008-11#1)(2008-12#1)
degradant##2##1##(2008-10#1)(2008-11#1)
degradation and can##2##3##(2008-11#1)(2012-2#1)
degradation and##16##2##(1994-8#1)(1996-12#2)(1997-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#2)
degradation are##3##2##(1997-2#1)(2008-10#1)(2012-3#1)
degradation at##2##2##(2008-10#2)
degradation by##12##2##(1993-3#1)(1994-11#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
degradation can##2##2##(2008-10#2)
degradation during##4##2##(1997-2#1)(2008-10#1)(2008-7#1)(2011-10#1)
degradation in the##5##3##(1991-6#1)(1995-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
degradation in##14##2##(1991-6#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-2#1)
degradation is##5##2##(1992-12#1)(2008-10#2)(2008-11#2)
degradation may##2##2##(2008-10#1)(2011-10#1)
degradation of 2##2##3##(2008-10#2)
degradation of IRS-1 in vitro##2##5##(1995-8#2)
degradation of a##3##3##(2008-11#2)(2013-1#1)
degradation of both##2##3##(2008-10#1)(2009-7#1)
degradation of host##2##3##(2008-10#2)
degradation of l-ascorbic acid##7##4##(2008-10#7)
degradation of the pesticides##2##4##(2008-11#2)
degradation of the##25##3##(1990-9#1)(1991-5#1)(1992-12#1)(1994-2#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2011-2#2)(2013-8#1)
degradation of##108##2##(1990-5#2)(1990-9#1)(1991-5#2)(1992-10#1)(1992-12#3)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-6#2)(1995-8#5)(1996-8#1)(1997-1#1)(2007-11#1)(2008-10#38)(2008-11#10)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-7#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
degradation on##2##2##(2008-7#1)(2012-3#1)
degradation or##5##2##(1990-5#1)(1996-11#1)(1997-4#1)(2008-11#1)(2012-2#1)
degradation pathway##5##2##(1992-12#1)(2008-10#1)(2009-7#1)(2010-4#2)
degradation process##3##2##(2008-10#2)(2009-11#1)
degradation processes of##2##3##(2008-10#2)
degradation product in##4##3##(2008-10#4)
degradation product of##4##3##(2008-10#4)
degradation product were detected##2##4##(2008-10#2)
degradation product were##4##3##(2008-10#4)
degradation product##23##2##(1991-5#1)(2008-10#21)(2008-5#1)
degradation product)##2##2##(2008-10#2)
degradation products are##2##3##(2008-10#2)
degradation products have been##2##4##(2008-10#2)
degradation products have##3##3##(2008-10#3)
degradation products in##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
degradation products of##3##3##(2008-10#2)(2010-5#1)
degradation products##38##2##(1997-2#1)(2008-10#29)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
degradation rates##4##2##(2008-10#1)(2008-11#2)(2010-10#1)
degradation reactions##2##2##(2008-11#1)(2010-4#1)
degradation than##2##2##(1992-8#1)(2008-10#1)
degradation was##7##2##(1990-8#1)(2008-10#2)(2008-7#2)(2010-4#1)(2012-2#1)
degradation were##3##2##(1997-1#1)(2011-2#1)(2011-3#1)
degradation##369##1##(1990-11#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-5#3)(1991-6#2)(1992-10#1)(1992-12#6)(1992-8#1)(1993-2#2)(1993-3#2)(1993-8#3)(1994-11#4)(1994-2#1)(1994-5#4)(1994-8#4)(1995-2#4)(1995-5#1)(1995-6#4)(1995-8#7)(1996-11#1)(1996-12#2)(1996-8#1)(1997-1#4)(1997-2#3)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#141)(2008-11#30)(2008-3#11)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#17)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#7)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#6)(2010-5#1)(2011-1#3)(2011-10#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#13)(2012-3#5)(2013-1#9)(2013-8#7)
degradation)##4##1##(2008-10#1)(2010-10#1)(2012-2#2)
degradative##2##1##(1995-8#1)(2008-7#1)
degrade the##4##2##(2008-10#2)(2010-3#1)(2011-2#1)
degrade##26##1##(1990-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#2)(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)
degraded and##2##2##(2008-10#1)(2008-11#1)
degraded by the##2##3##(1993-3#1)(2012-2#1)
degraded by##11##2##(1992-3#1)(1993-3#1)(1993-6#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#1)
degraded in the##4##3##(1995-2#2)(2008-10#1)(2008-11#1)
degraded in##6##2##(1995-2#2)(2008-10#2)(2008-11#2)
degraded when##2##2##(2008-11#1)(2008-5#1)
degraded with##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
degraded within##2##2##(1995-2#1)(2008-10#1)
degraded##55##1##(1992-3#1)(1993-3#1)(1993-6#3)(1994-8#1)(1995-11#1)(1995-2#4)(1995-6#2)(2006-6#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)
degrades##3##1##(1994-8#1)(2008-10#1)(2008-11#1)
degrading##11##1##(1992-3#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)
degranulation and##2##2##(2009-6#1)(2010-1#1)
degranulation of##2##2##(1994-11#2)
degranulation##9##1##(1994-11#3)(1994-2#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-1#1)(2013-1#1)
degree and##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
degree at##2##2##(2008-12#1)(2008-9#1)
degree days##5##2##(2008-10#4)(2008-8#1)
degree days)##2##2##(2008-10#1)(2008-8#1)
degree for##3##2##(1992-1#1)(2008-10#1)(2008-11#1)
degree hours##4##2##(2008-10#4)
degree in##5##2##(1991-12#1)(1991-2#1)(1993-11#1)(2008-10#2)
degree of aggregation of sclerotia##2##5##(2008-10#2)
degree of aggregation of##3##4##(2008-10#3)
degree of aggregation##6##3##(1992-9#1)(2008-10#3)(2008-11#1)(2008-8#1)
degree of agreement##4##3##(1992-12#1)(1993-3#1)(1995-1#1)(2008-5#1)
degree of alteration of consciousness during##2##6##(2013-8#2)
degree of apoptosis##2##3##(1995-2#1)(2011-2#1)
degree of association##2##3##(2008-10#2)
degree of carotid artery narrowing##2##5##(2011-2#2)
degree of carotid artery##3##4##(2011-2#3)
degree of cellular##3##3##(1990-12#1)(2008-11#2)
degree of change##2##3##(2008-10#1)(2008-11#1)
degree of conservation##2##3##(1991-6#1)(1993-12#1)
degree of conversion##2##3##(2013-1#2)
degree of coupling##3##3##(2008-4#1)(2008-9#1)(2011-1#1)
degree of differentiation##3##3##(2008-11#1)(2011-2#2)
degree of disease control##3##4##(2008-10#3)
degree of disease##4##3##(1997-8#1)(2008-10#3)
degree of genetic diversity and##2##5##(2008-10#2)
degree of genetic diversity##6##4##(2008-10#6)
degree of genetic##10##3##(2008-10#9)(2008-8#1)
degree of heterogeneity of##2##4##(2008-10#2)
degree of heterogeneity##5##3##(2008-10#5)
degree of homology##7##3##(1992-8#1)(1993-2#2)(1994-11#1)(1996-3#1)(1997-1#1)(2008-10#1)
degree of host specificity##3##4##(2008-10#3)
degree of impairment##3##3##(1991-1#1)(1991-2#1)(1995-3#1)
degree of infection##3##3##(2008-10#3)
degree of methylation##2##3##(2008-10#1)(2011-2#1)
degree of order of the##3##5##(2008-5#3)
degree of order of##4##4##(2008-5#4)
degree of order##5##3##(2008-5#5)
degree of parental investment##2##4##(2008-9#2)
degree of polarization##4##3##(2008-2#1)(2008-3#3)
degree of polymerization##3##3##(1990-6#1)(2008-10#2)
degree of proceeding of individual##2##5##(2008-10#2)
degree of protection##4##3##(1991-2#1)(2008-10#1)(2012-2#2)
degree of protonation of##3##4##(2008-10#3)
degree of pulmonary##2##3##(1997-3#1)(2012-3#1)
degree of recovery is##2##4##(2008-7#2)
degree of recovery##3##3##(2008-10#1)(2008-7#2)
degree of reduction##2##3##(2008-10#2)
degree of resistance##3##3##(2008-10#3)
degree of selectivity##3##3##(2008-10#3)
degree of sensitivity##5##3##(2008-10#5)
degree of sexual transmission##2##4##(2008-9#2)
degree of similarity##7##3##(1993-2#2)(1993-9#1)(2008-10#2)(2008-4#1)(2012-2#1)
degree of size##3##3##(2008-10#1)(2008-8#2)
degree of specialization##3##3##(2008-8#3)
degree of spectral overlap##2##4##(2008-10#2)
degree of stenosis##2##3##(1993-8#1)(2011-2#1)
degree of structural##4##3##(1991-6#1)(1992-6#1)(1997-2#1)(2013-1#1)
degree of substitution##3##3##(2008-10#1)(2011-2#2)
degree of the##8##3##(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
degree of tolerance##3##3##(2008-10#3)
degree of uncertainty##2##3##(2008-10#1)(2009-11#1)
degree of variability in##3##4##(2008-10#1)(2008-8#1)(2009-11#1)
degree of variability##5##3##(1991-12#1)(2008-10#2)(2008-8#1)(2009-11#1)
degree of##416##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#4)(1991-6#4)(1991-7#3)(1991-8#1)(1992-1#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#4)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#8)(1997-6#2)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#122)(2008-11#21)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#17)(2008-6#2)(2008-7#14)(2008-8#21)(2008-9#14)(2009-10#1)(2009-11#2)(2009-5#1)(2009-7#3)(2009-8#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-10#1)(2011-2#18)(2012-12#2)(2012-2#5)(2012-3#3)(2012-5#1)(2012-6#1)(2013-1#14)(2013-8#5)
degree on the##2##3##(1997-6#1)(2008-10#1)
degree on##4##2##(1997-6#1)(2008-10#2)(2008-11#1)
degree program##4##2##(1997-2#1)(2008-11#1)(2008-12#2)
degree than##6##2##(1991-6#2)(1993-8#1)(1995-11#1)(2008-10#1)(2010-3#1)
degree with##3##2##(1994-12#1)(1994-6#1)(1994-8#1)
degree##534##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#4)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#2)(1991-5#4)(1991-6#6)(1991-7#3)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#5)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-2#3)(1996-3#5)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#5)(1997-3#10)(1997-6#3)(1997-7#1)(1997-8#2)(2007-11#1)(2008-1#2)(2008-10#146)(2008-11#33)(2008-12#9)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#21)(2008-6#4)(2008-7#16)(2008-8#26)(2008-9#18)(2009-10#1)(2009-11#3)(2009-5#1)(2009-7#4)(2009-8#6)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-10#1)(2011-2#21)(2012-12#2)(2012-2#6)(2012-3#6)(2012-5#1)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#5)
degree-day intervals##2##2##(2008-10#2)
degree-day##6##1##(2008-10#5)(2008-12#1)
degree-days and##2##2##(2008-10#2)
degree-days##4##1##(2008-10#4)
degree-hours##3##1##(2008-10#3)
degrees &lt##2##2##(2008-2#1)(2008-3#1)
degrees (SD##2##2##(2008-12#2)
degrees ) and##2##3##(2008-10#1)(2008-9#1)
degrees ) for the##3##4##(2008-10#1)(2008-12#2)
degrees ) for##4##3##(2008-10#2)(2008-12#2)
degrees )##12##2##(2008-10#6)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#1)
degrees C (generally##2##3##(2008-10#2)
degrees C after##4##3##(2008-10#3)(2013-8#1)
degrees C and 0##3##4##(2008-10#3)
degrees C and 30##2##4##(2008-10#1)(2010-4#1)
degrees C and 37 degrees C##2##6##(2008-5#2)
degrees C and 37 degrees##4##5##(2008-10#2)(2008-5#2)
degrees C and 500##2##4##(2008-10#2)
degrees C and a##4##4##(2008-10#3)(2008-3#1)
degrees C and at##4##4##(2008-10#4)
degrees C and in##5##4##(2008-10#4)(2008-11#1)
degrees C and ionic strength##3##5##(2008-10#3)
degrees C and ionic##4##4##(1995-2#1)(2008-10#3)
degrees C and pH 5##2##5##(1994-5#1)(2008-10#1)
degrees C and pH 7##2##5##(2008-10#1)(2008-5#1)
degrees C and pH##8##4##(1994-5#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-6#2)
degrees C and pressures##2##4##(2008-10#2)
degrees C and relative humidity##2##5##(2008-10#2)
degrees C and the##5##4##(1992-3#1)(2008-10#3)(2008-11#1)
degrees C and then##3##4##(2008-10#2)(2013-8#1)
degrees C and was##3##4##(2008-10#3)
degrees C and##121##3##(1990-12#1)(1990-2#1)(1991-5#2)(1992-3#1)(1992-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#83)(2008-11#7)(2008-12#3)(2008-3#2)(2008-5#5)(2008-6#3)(2009-3#1)(2010-1#1)(2010-4#3)(2011-2#1)(2013-8#1)
degrees C at pH##3##4##(2008-10#3)
degrees C at relative humidities &gt##2##6##(2008-10#2)
degrees C at##11##3##(1990-11#1)(1996-12#2)(2008-10#8)
degrees C before##2##3##(2008-10#1)(2008-11#1)
degrees C but not at##6##5##(1991-2#1)(2008-10#5)
degrees C but##9##3##(1991-2#3)(2008-10#6)
degrees C compared with that##2##5##(2008-10#1)(2008-7#1)
degrees C compared with##4##4##(2008-10#3)(2008-7#1)
degrees C compared##5##3##(2008-10#3)(2008-11#1)(2008-7#1)
degrees C did not##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
degrees C during##4##3##(2008-10#4)
degrees C followed by##5##4##(1996-5#3)(2008-10#2)
degrees C for 1 h or after##2##7##(2008-2#2)
degrees C for 1 h##4##5##(2008-10#2)(2008-2#2)
degrees C for 1##6##4##(2008-10#4)(2008-2#2)
degrees C for 10##2##4##(1994-8#1)(2008-10#1)
degrees C for 12 h##2##5##(2008-10#1)(2009-11#1)
degrees C for 12##3##4##(2008-10#2)(2009-11#1)
degrees C for 2 h##2##5##(2008-10#1)(2008-6#1)
degrees C for 2##6##4##(1992-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
degrees C for 20##2##4##(2008-10#2)
degrees C for 24 h##3##5##(2008-10#2)(2008-9#1)
degrees C for 24##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
degrees C for 3##2##4##(2008-10#2)
degrees C for 30 min##3##5##(2008-10#2)(2008-7#1)
degrees C for 30##4##4##(2008-10#3)(2008-7#1)
degrees C for 4##2##4##(1995-2#1)(2008-10#1)
degrees C for 6 weeks##2##5##(2008-10#1)(2008-5#1)
degrees C for 6##3##4##(2008-10#2)(2008-5#1)
degrees C for 60 min##4##5##(2008-10#4)
degrees C for 7##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
degrees C for Cd##3##4##(2008-10#3)
degrees C for Pb##2##4##(2008-10#2)
degrees C for a##2##4##(2008-10#2)
degrees C for an##2##4##(2008-10#2)
degrees C for both##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
degrees C for infection of##2##5##(2008-10#2)
degrees C for more than##2##5##(2008-2#1)(2008-9#1)
degrees C for one##2##4##(2008-11#1)(2008-5#1)
degrees C for over##2##4##(2008-11#1)(2008-2#1)
degrees C for##101##3##(1990-12#1)(1991-11#1)(1992-6#1)(1993-8#1)(1994-8#3)(1995-2#1)(1996-5#1)(1997-2#2)(2008-10#64)(2008-11#7)(2008-12#1)(2008-2#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2010-4#4)
degrees C from##2##3##(2008-10#2)
degrees C gave the##2##4##(1996-5#1)(2008-10#1)
degrees C has been##2##4##(1991-5#1)(2008-10#1)
degrees C in a##3##4##(2008-10#3)
degrees C in the dark##3##5##(2008-10#3)
degrees C in the presence##2##5##(1990-5#1)(1995-11#1)
degrees C in the range of##2##6##(2008-10#2)
degrees C in the##13##4##(1990-5#1)(1995-11#1)(2008-10#8)(2008-11#1)(2010-4#1)(2013-8#1)
degrees C in##31##3##(1990-5#1)(1991-5#1)(1995-11#1)(1995-6#1)(2008-10#21)(2008-11#1)(2008-12#1)(2010-4#3)(2013-8#1)
degrees C indicating##2##3##(2008-11#1)(2008-12#1)
degrees C is##8##3##(1991-3#1)(1993-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-8#1)
degrees C night/day)##2##3##(2008-10#2)
degrees C on the##2##4##(2008-10#2)
degrees C on##3##3##(1993-12#1)(2008-10#2)
degrees C or##6##3##(2008-10#5)(2008-8#1)
degrees C resulted in##2##4##(1995-2#1)(2008-10#1)
degrees C than at##2##4##(1991-5#1)(2008-10#1)
degrees C than##3##3##(1991-5#1)(2008-10#2)
degrees C the##6##3##(2008-10#4)(2008-11#1)(2010-4#1)
degrees C to##6##3##(2008-10#3)(2008-11#2)(2008-12#1)
degrees C under continuous wetness##2##5##(2008-10#2)
degrees C under##8##3##(1994-8#1)(2008-10#5)(2008-11#2)
degrees C using##2##3##(2008-10#2)
degrees C was the best##2##5##(2008-10#1)(2008-5#1)
degrees C was##15##3##(2008-10#11)(2008-5#2)(2010-4#1)(2011-2#1)
degrees C were obtained##3##4##(2008-10#3)
degrees C were##16##3##(1992-3#1)(1993-8#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)
degrees C when##2##3##(2008-11#2)
degrees C while##2##3##(2008-10#1)(2008-5#1)
degrees C with a##4##4##(2008-10#4)
degrees C with an##2##4##(2008-10#1)(2008-2#1)
degrees C with the##2##4##(2008-10#1)(2008-9#1)
degrees C with##11##3##(1994-3#1)(2008-10#8)(2008-2#1)(2008-9#1)
degrees C without any##3##4##(2008-10#2)(2008-11#1)
degrees C without##4##3##(2008-10#3)(2008-11#1)
degrees C##993##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#7)(1991-3#1)(1991-5#9)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#11)(1993-9#4)(1994-3#1)(1994-5#3)(1994-8#5)(1995-11#1)(1995-12#3)(1995-2#4)(1995-6#4)(1995-8#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#7)(1996-6#1)(1997-1#2)(1997-2#7)(1997-7#1)(1997-8#3)(2007-12#7)(2008-10#687)(2008-11#52)(2008-12#18)(2008-2#10)(2008-3#4)(2008-5#37)(2008-6#6)(2008-7#12)(2008-8#8)(2008-9#7)(2009-11#1)(2009-3#2)(2009-7#4)(2009-8#3)(2010-1#2)(2010-4#16)(2011-2#4)(2013-8#5)
degrees C) and the##2##4##(2008-10#2)
degrees C) and##17##3##(1990-12#1)(1992-3#1)(1992-6#1)(1996-12#1)(2008-10#11)(2008-5#1)(2009-5#1)
degrees C) during##2##3##(2008-10#1)(2008-8#1)
degrees C) for##5##3##(1994-12#1)(2008-10#3)(2008-5#1)
degrees C) had##2##3##(2008-10#1)(2010-4#1)
degrees C) has been##2##4##(2008-10#2)
degrees C) in##2##3##(2008-10#2)
degrees C) of##3##3##(1992-3#1)(2008-10#2)
degrees C) or##2##3##(2008-10#2)
degrees C)##99##2##(1990-12#1)(1991-5#1)(1992-3#2)(1992-6#1)(1994-12#1)(1996-12#2)(2008-10#72)(2008-11#6)(2008-5#3)(2008-7#4)(2008-8#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-4#1)
degrees C-grown C##5##3##(2008-5#5)
degrees C-grown cells##2##3##(2008-5#2)
degrees C-grown##7##2##(2008-5#7)
degrees Celsius for##2##3##(2008-8#2)
degrees Cmin(-1)##2##2##(2008-10#2)
degrees N##4##2##(2008-10#2)(2008-3#2)
degrees W##2##2##(2008-10#1)(2008-3#1)
degrees W)##3##2##(2008-10#2)(2008-3#1)
degrees and 30+/-1 degrees##2##4##(2008-10#2)
degrees and the##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
degrees and##19##2##(1993-8#1)(1995-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-3#1)(2011-2#2)(2012-3#1)
degrees compared with##2##3##(2013-1#2)
degrees external##2##2##(2007-12#1)(2013-1#1)
degrees for bond angles##3##4##(1992-4#1)(2008-8#1)(2008-9#1)
degrees for controls##2##3##(2013-1#2)
degrees for the##2##3##(1994-5#1)(2008-9#1)
degrees for##14##2##(1992-4#1)(1994-5#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-3#4)(2008-8#1)(2008-9#2)(2013-1#2)
degrees from##2##2##(1993-11#1)(2008-3#1)
degrees in the##2##3##(1994-12#1)(2008-9#1)
degrees in##6##2##(1990-3#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-9#2)
degrees is##2##2##(1993-1#1)(2008-3#1)
degrees of experience##2##3##(1997-2#1)(2008-11#1)
degrees of freedom##8##3##(1990-8#1)(1992-8#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
degrees of knee flexion##2##4##(2009-3#1)(2013-1#1)
degrees of similarity##3##3##(1995-12#1)(1997-7#1)(2008-10#1)
degrees of##60##2##(1990-8#1)(1991-6#2)(1991-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-3#1)(1997-7#2)(2008-10#15)(2008-11#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2011-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
degrees off the zenith##2##4##(2008-3#2)
degrees respectively##2##2##(2008-8#1)(2012-3#1)
degrees than at##2##3##(2008-11#2)
degrees to##5##2##(1991-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)
degrees under##2##2##(2013-1#2)
degrees with respect to the##2##5##(2008-2#1)(2008-3#1)
degrees##1377##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#9)(1991-3#3)(1991-5#10)(1991-6#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-3#6)(1992-4#3)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#24)(1993-9#4)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#8)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#10)(1997-3#5)(1997-6#1)(1997-7#3)(1997-8#4)(2007-12#9)(2008-10#825)(2008-11#68)(2008-12#26)(2008-2#20)(2008-3#41)(2008-5#49)(2008-6#6)(2008-7#19)(2008-8#26)(2008-9#22)(2009-11#1)(2009-3#7)(2009-5#2)(2009-7#5)(2009-8#3)(2010-1#3)(2010-4#17)(2010-8#1)(2011-2#16)(2011-3#1)(2012-2#1)(2012-3#6)(2013-1#12)(2013-8#6)
degrees)##2##1##(1991-3#1)(2013-1#1)
degrees/s)##2##1##(2011-2#2)
dehalogenase##8##1##(2009-3#1)(2011-1#7)
dehalogenases with##2##2##(2011-1#2)
dehalogenases##6##1##(2011-1#6)
dehalogenation##2##1##(2008-11#2)
dehiscence##6##1##(1991-2#2)(1992-9#1)(2008-7#3)
dehiscent##4##1##(2008-10#1)(2011-2#3)
dehydratase##3##1##(1993-12#1)(2008-10#2)
dehydrated cowpea leaves##3##3##(2008-10#3)
dehydrated##7##1##(2008-10#5)(2008-9#2)
dehydration and##5##2##(1991-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
dehydration##21##1##(1990-2#1)(1991-6#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#3)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
dehydroalanine##3##1##(1994-5#3)
dehydroascorbate##3##1##(2008-11#1)(2009-9#2)
dehydroascorbic acid##7##2##(1993-3#2)(2008-10#5)
dehydrodimers of ferulic acid##3##4##(2008-10#3)
dehydroepiandrosterone##2##1##(1996-2#2)
dehydrogenase (EC 1##2##3##(1993-8#1)(1994-11#1)
dehydrogenase (GDH)##2##2##(1993-9#1)(2008-11#1)
dehydrogenase (LDH)##9##2##(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(2008-10#2)(2008-11#3)
dehydrogenase (SDH)##3##2##(2008-11#1)(2009-7#1)(2012-2#1)
dehydrogenase A##2##2##(2008-9#2)
dehydrogenase activities##3##2##(1996-2#1)(2008-11#2)
dehydrogenase activity and##3##3##(1990-11#1)(1993-3#1)(1995-6#1)
dehydrogenase activity was##2##3##(1990-11#1)(2012-2#1)
dehydrogenase activity##17##2##(1990-11#4)(1993-3#2)(1994-11#1)(1995-6#2)(2008-11#3)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#2)
dehydrogenase and##15##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2013-1#2)
dehydrogenase deficiency##5##2##(1990-2#1)(1990-8#1)(1991-2#1)(2007-12#1)(2008-4#1)
dehydrogenase from##5##2##(1990-11#1)(1990-5#1)(1994-11#1)(2008-4#1)(2008-9#1)
dehydrogenase gene##2##2##(1994-11#1)(2008-8#1)
dehydrogenase in the##3##3##(1990-11#1)(1990-5#1)(2008-11#1)
dehydrogenase in##9##2##(1990-11#1)(1990-5#1)(1991-3#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-11#1)
dehydrogenase reactor##2##2##(2008-10#2)
dehydrogenase was purified##2##3##(1990-11#2)
dehydrogenase was##6##2##(1990-11#2)(1994-8#2)(1997-1#1)(2008-10#1)
dehydrogenase##180##1##(1990-10#2)(1990-11#11)(1990-2#1)(1990-5#3)(1990-8#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1992-1#5)(1992-11#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-2#3)(1993-3#4)(1993-8#2)(1993-9#1)(1994-11#6)(1994-2#1)(1994-5#5)(1994-6#1)(1994-8#6)(1995-11#6)(1995-3#1)(1995-6#5)(1996-12#1)(1996-2#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-8#2)(2007-12#2)(2008-10#29)(2008-11#25)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#4)(2009-7#1)(2009-9#1)(2010-12#4)(2011-2#2)(2012-2#4)(2013-1#3)(2013-8#1)
dehydrogenase) and##2##2##(1995-6#1)(2008-10#1)
dehydrogenase)##4##1##(1994-8#1)(1995-6#1)(2008-10#1)(2008-8#1)
dehydrogenase-encoding gene##4##2##(1991-6#1)(1993-6#2)(1993-9#1)
dehydrogenases##10##1##(1991-3#2)(1991-5#3)(1993-3#1)(1994-11#1)(1995-8#1)(2008-10#1)(2012-5#1)
dei##2##1##(2010-1#2)
deiminase was##2##2##(1991-12#2)
deiminase##9##1##(1991-12#5)(1995-3#1)(2008-10#3)
deionised water##5##2##(2008-10#5)
deionized water and##2##3##(2008-10#2)
deionized water##12##2##(2008-10#9)(2008-3#1)(2009-7#1)(2013-1#1)
deionized##14##1##(2008-10#11)(2008-3#1)(2009-7#1)(2013-1#1)
del##8##1##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
del/del##2##1##(2013-8#2)
delamination##4##1##(2007-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
delay (time from##2##3##(1990-12#2)
delay CS##4##2##(2008-5#4)
delay and diffusion##4##3##(2013-8#4)
delay and##14##2##(1990-12#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#1)(2012-12#1)(2013-8#5)
delay between##3##2##(1991-2#1)(1997-4#1)(2008-12#1)
delay for the##2##3##(1997-2#1)(2013-8#1)
delay for##3##2##(1997-2#1)(2010-11#1)(2013-8#1)
delay in diagnosis##2##3##(1990-12#1)(2013-1#1)
delay in the##7##3##(1994-6#1)(2007-11#1)(2008-10#1)(2010-11#1)(2013-1#2)(2013-8#1)
delay in##37##2##(1990-12#4)(1991-2#1)(1991-8#1)(1992-3#1)(1994-3#1)(1994-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
delay line##3##2##(2008-3#3)
delay may##2##2##(1990-12#1)(1996-3#1)
delay of##20##2##(1991-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#1)(2010-6#1)(2011-1#2)(2012-12#2)(2012-6#1)
delay or##4##2##(1990-5#1)(1996-6#1)(2008-10#1)(2011-2#1)
delay the##10##2##(1995-12#1)(1995-6#2)(1996-3#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
delay time and##4##3##(2008-10#4)
delay time##8##2##(2008-10#6)(2008-3#1)(2010-9#1)
delay was##10##2##(1990-12#4)(1991-2#1)(1994-3#1)(1997-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
delay##197##1##(1990-12#15)(1990-5#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-8#2)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#4)(1996-6#2)(1996-9#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#30)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#8)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#3)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#8)(2012-12#7)(2012-3#1)(2012-6#1)(2012-7#1)(2013-1#8)(2013-8#15)
delay-line##2##1##(2008-3#2)
delayed Wallerian degeneration##3##3##(1997-3#3)
delayed alternation in##2##3##(1994-8#2)
delayed alternation##7##2##(1991-2#2)(1994-8#4)(2008-8#1)
delayed and prolonged##2##3##(1997-3#1)(2013-8#1)
delayed and##6##2##(1997-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
delayed apoptosis##2##2##(2008-11#2)
delayed as##2##2##(1991-2#1)(2009-8#1)
delayed because##2##2##(1992-2#1)(1997-8#1)
delayed complications##2##2##(1994-12#1)(1996-1#1)
delayed diagnosis##4##2##(1996-3#1)(2008-11#1)(2010-12#2)
delayed disease onset##2##3##(2008-10#2)
delayed dispersal##6##2##(2008-8#6)
delayed for##6##2##(1990-12#1)(1991-6#1)(1992-12#1)(2008-10#2)(2010-11#1)
delayed gastric emptying##2##3##(1990-12#1)(1997-4#1)
delayed hypersensitivity##2##2##(2008-5#1)(2008-7#1)
delayed in the##2##3##(1997-3#1)(2012-12#1)
delayed in##11##2##(1991-9#1)(1997-3#1)(2008-10#3)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
delayed loading##3##2##(2013-1#3)
delayed migration##2##2##(2008-12#2)
delayed model)##2##2##(2013-8#2)
delayed neuronal death##2##3##(1996-12#2)
delayed non-matching-to-sample##3##2##(1993-3#3)
delayed onset##2##2##(1997-2#1)(2011-2#1)
delayed operation##2##2##(1997-8#1)(2008-7#1)
delayed phase##2##2##(1997-8#1)(2013-1#1)
delayed progression##2##2##(2010-1#2)
delayed referral##2##2##(2008-1#1)(2008-11#1)
delayed the time##2##3##(2008-10#2)
delayed the##6##2##(1996-3#1)(2008-10#2)(2008-7#1)(2011-2#2)
delayed treatment##2##2##(1991-6#1)(2008-9#1)
delayed union##2##2##(2013-1#2)
delayed with##2##2##(1997-4#1)(2012-3#1)
delayed word recall##2##3##(2008-7#2)
delayed##198##1##(1990-12#2)(1990-5#1)(1990-6#1)(1991-1#2)(1991-2#4)(1991-6#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#6)(1994-12#1)(1994-8#5)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#2)(1997-3#7)(1997-4#2)(1997-8#6)(2008-1#1)(2008-10#31)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#10)(2008-8#11)(2008-9#4)(2009-10#1)(2009-4#1)(2009-8#5)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#11)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#13)(2013-8#8)
delayed-type hypersensitivity##3##2##(1995-12#1)(2008-10#2)
delayed-type##4##1##(1995-12#2)(2008-10#2)
delaying disease##2##2##(2008-10#1)(2010-11#1)
delaying the##3##2##(2008-10#1)(2010-12#2)
delaying##17##1##(1995-1#1)(2008-10#6)(2008-7#2)(2008-9#1)(2010-11#2)(2010-12#2)(2010-9#2)(2012-12#1)
delays and##2##2##(1993-3#1)(2013-8#1)
delays are##3##2##(1992-12#1)(2008-3#2)
delays in the##4##3##(1997-2#1)(2008-10#1)(2008-3#1)(2009-8#1)
delays in##6##2##(1997-2#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
delays of##2##2##(1993-3#1)(2008-10#1)
delays##35##1##(1991-11#1)(1992-12#1)(1993-3#3)(1994-8#2)(1997-2#3)(1997-8#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
delegates##3##1##(1994-9#1)(2008-11#1)(2008-5#1)
delegations##2##1##(1992-11#1)(1995-6#1)
deletants and chimeras##3##3##(2008-8#3)
deletants##5##1##(2008-8#5)
delete##2##1##(2008-10#1)(2008-8#1)
deleted and##3##2##(1994-11#1)(1996-6#1)(2009-8#1)
deleted in##6##2##(1997-2#1)(1997-3#1)(1997-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
deleted regions##2##2##(2008-10#1)(2011-2#1)
deleted##33##1##(1991-10#1)(1991-5#1)(1993-6#1)(1994-11#1)(1995-2#2)(1995-8#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-7#5)(2008-10#5)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
deleterious at the##2##3##(2008-8#2)
deleterious effect on##2##3##(1997-5#1)(2008-11#1)
deleterious effect##4##2##(1997-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
deleterious effects of##4##3##(1991-6#1)(2008-1#1)(2008-11#1)(2008-4#1)
deleterious effects on##6##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
deleterious effects##11##2##(1991-6#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)
deleterious mutations##3##2##(1997-7#2)(2008-8#1)
deleterious sequelae##2##2##(2011-2#1)(2012-12#1)
deleterious to##2##2##(1991-9#1)(2008-8#1)
deleterious##36##1##(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#2)(1994-2#1)(1997-5#1)(1997-7#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-6#1)(2011-2#4)(2012-12#1)
deleting##4##1##(1993-2#1)(1995-2#1)(2008-10#1)(2008-11#1)
deletion analysis of##3##3##(1995-6#1)(2008-7#1)(2008-8#1)
deletion and##8##2##(1993-6#1)(1994-11#2)(1997-3#1)(2008-9#2)(2009-8#1)(2011-2#1)
deletion at##3##2##(1996-12#2)(1997-3#1)
deletion in the##4##3##(1993-2#2)(2008-10#2)
deletion in##8##2##(1993-12#1)(1993-2#2)(1997-2#1)(1997-3#1)(2008-10#2)(2012-12#1)
deletion is##2##2##(1996-2#1)(2012-12#1)
deletion lines were##2##3##(2008-10#2)
deletion mutant of heterogeneous nuclear ribonucleoprotein##2##6##(2008-8#2)
deletion mutant##13##2##(1993-8#1)(1997-1#1)(1997-3#2)(2008-10#1)(2008-8#4)(2011-2#1)(2012-2#1)(2012-3#2)
deletion mutants of##2##3##(1992-6#1)(2008-10#1)
deletion mutants that##2##3##(2008-7#1)(2012-3#1)
deletion mutants##12##2##(1992-6#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-3#2)(2008-10#2)(2008-7#1)(2012-3#2)
deletion mutation##3##2##(1997-3#2)(2008-10#1)
deletion of 6q21-q23##2##3##(1997-3#2)
deletion of a##3##3##(1993-6#1)(1996-12#1)(2011-1#1)
deletion of the RGD sequence##2##5##(1995-6#2)
deletion of the##8##3##(1995-6#3)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#1)
deletion of##30##2##(1990-5#1)(1991-6#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-6#3)(1996-12#2)(1996-6#1)(1997-3#8)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#2)(2011-1#1)(2012-2#1)
deletion or##4##2##(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
deletion syndrome##3##2##(1997-3#2)(2012-12#1)
deletion was##2##2##(1994-11#1)(1996-12#1)
deletion##142##1##(1990-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-6#3)(1993-8#5)(1994-11#6)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#5)(1995-8#2)(1996-12#8)(1996-2#4)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#27)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#14)(2008-4#2)(2008-7#3)(2008-8#7)(2008-9#8)(2009-8#1)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#2)(2012-3#6)(2013-8#4)
deletions and##3##2##(1993-2#1)(2008-11#1)(2012-3#1)
deletions are##2##2##(1993-2#1)(1997-3#1)
deletions from a##2##3##(1993-9#1)(1996-12#1)
deletions from the##3##3##(1996-12#2)(1997-3#1)
deletions from##5##2##(1993-9#1)(1996-12#3)(1997-3#1)
deletions in the##2##3##(2008-11#1)(2011-2#1)
deletions in##11##2##(1993-12#1)(1993-3#1)(1994-11#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#2)(2011-2#1)
deletions is##3##2##(1997-3#2)(1997-7#1)
deletions of the mitochondrial DNA in##2##6##(1994-11#2)
deletions of the##4##3##(1994-11#2)(2008-10#1)(2009-8#1)
deletions of##10##2##(1991-5#1)(1992-10#1)(1993-12#1)(1994-11#2)(1997-3#1)(2008-10#2)(2008-9#1)(2009-8#1)
deletions or##2##2##(2008-11#1)(2012-3#1)
deletions within the##2##3##(2008-10#1)(2011-2#1)
deletions##77##1##(1990-8#1)(1991-5#2)(1992-10#1)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#1)(1993-9#1)(1994-11#4)(1995-6#1)(1995-8#2)(1996-12#6)(1997-3#15)(1997-7#3)(2008-10#4)(2008-11#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#4)(2010-1#1)(2011-2#3)(2011-3#1)(2012-3#5)
deleyianum is a##2##3##(1994-11#1)(2011-2#1)
deleyianum##5##1##(1994-11#2)(2011-2#3)
deliberate posterior hysterotomy##2##3##(2011-2#2)
deliberate##10##1##(1992-3#2)(2008-10#1)(2008-11#2)(2008-7#1)(2010-3#1)(2011-2#2)(2013-8#1)
deliberately##8##1##(1995-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-5#1)(2010-3#1)
deliberations##3##1##(1994-12#1)(2008-11#1)(2012-2#1)
delicisoa cells under osmotic stress##2##5##(2008-9#2)
delicisoa##3##1##(2008-9#3)
delimit##4##1##(1994-2#1)(2008-10#2)(2008-4#1)
delimitation##4##1##(2009-6#1)(2012-3#3)
delimited##5##1##(1992-1#1)(1996-6#1)(2008-10#1)(2009-10#2)
delineate the##6##2##(1990-6#1)(1994-5#1)(1995-2#2)(2008-9#1)(2012-2#1)
delineate##11##1##(1990-6#1)(1992-12#1)(1994-2#1)(1994-5#1)(1995-2#2)(2008-10#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-1#1)
delineated by the##2##3##(2008-5#1)(2009-11#1)
delineated on the##2##3##(1993-6#1)(1996-2#1)
delineated##17##1##(1993-3#1)(1993-6#1)(1995-8#1)(1996-2#1)(2008-10#8)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2013-8#1)
delineates the##3##2##(1997-3#1)(2008-4#1)(2009-5#1)
delineates##4##1##(1994-2#1)(1997-3#1)(2008-4#1)(2009-5#1)
delineating the##2##2##(2008-7#1)(2009-1#1)
delineating##3##1##(2008-10#1)(2008-7#1)(2009-1#1)
delineation of the##3##3##(2008-10#1)(2008-7#1)(2009-11#1)
delineation of##7##2##(1996-3#1)(2008-10#1)(2008-7#1)(2009-11#2)(2010-5#1)(2012-2#1)
delineation##13##1##(1996-3#1)(2008-10#1)(2008-7#1)(2009-11#6)(2009-2#1)(2010-5#1)(2012-2#2)
delinquency##4##1##(1990-12#2)(2009-7#2)
delinquent behavior for##2##3##(2009-7#2)
delinquent behavior is##2##3##(1990-12#2)
delinquent behavior##7##2##(1990-12#2)(2008-11#1)(2009-7#4)
delinquent group showed##2##3##(1990-12#2)
delinquent group##3##2##(1990-12#3)
delinquent##17##1##(1990-12#9)(2008-11#1)(2009-7#7)
delipidated protein##2##2##(1990-5#1)(1994-11#1)
delipidated##6##1##(1990-5#1)(1994-11#1)(1995-8#4)
delipidation##2##1##(1990-5#1)(1995-8#1)
delirious##3##1##(2009-7#1)(2011-2#2)
delirium during##2##2##(2010-10#1)(2013-1#1)
delirium in##4##2##(2010-10#2)(2012-12#1)(2013-1#1)
delirium prevention##2##2##(2010-10#2)
delirium protocol was##2##3##(2010-10#2)
delirium protocol##3##2##(2010-10#3)
delirium therapy##2##2##(2011-2#2)
delirium was##2##2##(2011-2#1)(2013-1#1)
delirium##41##1##(2008-7#1)(2009-5#1)(2010-1#3)(2010-10#16)(2011-2#5)(2012-12#2)(2013-1#13)
deliver a wider range of##2##5##(1994-12#1)(2008-10#1)
deliver a##6##2##(1994-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-10#1)(2011-2#1)
deliver and##3##2##(2008-7#1)(2008-8#1)(2010-10#1)
deliver high quality##2##3##(1993-12#1)(1997-1#1)
deliver high##3##2##(1993-12#1)(1997-1#2)
deliver patient##2##2##(2008-10#1)(2008-11#1)
deliver the##7##2##(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-12#1)
deliver##69##1##(1991-1#2)(1992-1#1)(1992-12#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1996-1#2)(1996-2#2)(1996-9#1)(1997-1#3)(1997-3#1)(2008-10#3)(2008-11#11)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2009-10#3)(2009-11#1)(2009-2#1)(2010-10#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
delivered a viable infant##2##4##(1991-2#1)(2013-1#1)
delivered as##2##2##(2008-3#1)(2011-2#1)
delivered at the##2##3##(1994-1#1)(1997-2#1)
delivered at##10##2##(1990-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1997-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
delivered beam##2##2##(2008-3#2)
delivered by a##8##3##(1991-2#1)(1992-3#1)(1995-2#1)(2008-10#3)(2008-11#1)(2011-3#1)
delivered by dental hygienists as part of a patient's regularly scheduled cleaning visit##2##13##(2008-4#2)
delivered by##27##2##(1991-2#1)(1992-3#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-5#1)(2009-8#3)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
delivered dose of##2##3##(1996-2#1)(1997-1#1)
delivered dose##4##2##(1996-2#2)(1997-1#1)(2008-7#1)
delivered during##3##2##(1990-3#1)(1994-2#1)(2013-1#1)
delivered from a##2##3##(2007-11#1)(2008-5#1)
delivered from the Diskus##2##4##(1996-2#2)
delivered from the##4##3##(1995-3#1)(1996-2#2)(1997-2#1)
delivered from##6##2##(1995-3#1)(1996-2#2)(1997-2#1)(2007-11#1)(2008-5#1)
delivered in a##2##3##(1995-5#1)(1996-3#1)
delivered in the##2##3##(1996-2#1)(2010-8#1)
delivered in##9##2##(1992-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
delivered into the##2##3##(1997-1#1)(2008-10#1)
delivered into##6##2##(1997-1#1)(2008-10#3)(2008-11#1)(2009-8#1)
delivered this##2##2##(1994-1#1)(2013-8#1)
delivered through##3##2##(2008-8#1)(2009-8#1)(2011-2#1)
delivered to a##2##3##(1993-9#1)(2013-1#1)
delivered to patients##2##3##(1995-2#1)(2010-7#1)
delivered to the respiratory tract##2##5##(1994-12#1)(1996-3#1)
delivered to the##11##3##(1994-12#3)(1996-3#1)(1997-2#1)(2008-3#1)(2008-5#4)(2011-2#1)
delivered to##22##2##(1993-9#1)(1994-12#3)(1995-2#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
delivered via##4##2##(1996-3#1)(1997-1#1)(2012-3#1)(2013-1#1)
delivered with##2##2##(2008-11#1)(2008-7#1)
delivered##145##1##(1990-12#3)(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#2)(1993-3#2)(1993-9#1)(1994-1#2)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-2#7)(1996-3#3)(1997-1#4)(1997-2#7)(1997-3#1)(1997-8#3)(2007-11#1)(2008-10#10)(2008-11#13)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#12)(2013-8#3)
deliveries in##2##2##(1995-12#1)(2011-2#1)
deliveries were##2##2##(1995-12#1)(2008-5#1)
deliveries##20##1##(1990-3#3)(1991-3#1)(1992-2#1)(1993-3#1)(1994-3#3)(1995-12#4)(1996-2#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
delivering CFTR gene##2##3##(2011-3#2)
delivering a##5##2##(1992-3#1)(1994-12#1)(1996-2#1)(2008-5#1)(2013-8#1)
delivering energy##2##2##(2008-9#2)
delivering optimal##2##2##(2008-6#1)(2013-1#1)
delivering the##2##2##(1991-12#1)(2008-11#1)
delivering##36##1##(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#2)(1996-1#2)(1996-12#1)(1996-2#4)(1997-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-3#2)(2012-2#1)(2013-1#2)(2013-8#1)
delivers the##4##2##(1991-12#1)(2008-10#2)(2012-3#1)
delivers##14##1##(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-2#3)(2012-3#2)
delivery allow##2##2##(2008-1#1)(2008-11#1)
delivery and evaluation of##2##4##(2008-12#2)
delivery and financing##2##3##(1992-3#1)(1993-2#1)
delivery and utilization##2##3##(1995-5#1)(2010-11#1)
delivery and##35##2##(1991-3#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#3)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#2)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#2)
delivery approach##3##2##(1995-1#1)(1995-3#1)(2010-5#1)
delivery are##4##2##(1992-3#2)(1993-3#1)(2008-5#1)
delivery at term##2##3##(2013-1#2)
delivery at##3##2##(2013-1#3)
delivery by##4##2##(1995-3#1)(1996-2#1)(2012-2#1)(2013-1#1)
delivery depends on the##2##4##(1996-2#1)(2008-5#1)
delivery efficiency##4##2##(1994-2#1)(1997-3#1)(2008-10#2)
delivery from##2##2##(1997-1#1)(2011-2#1)
delivery in the##2##3##(2008-10#1)(2008-11#1)
delivery in##11##2##(1993-1#1)(1995-10#1)(1996-3#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#2)
delivery into##4##2##(2008-11#3)(2010-6#1)
delivery is##3##2##(1993-12#1)(1996-2#1)(2008-11#1)
delivery methods##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
delivery of DNA##4##3##(1994-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
delivery of TNF-alpha##4##3##(2013-1#4)
delivery of a##8##3##(2008-11#3)(2010-5#1)(2010-8#2)(2011-2#1)(2012-3#1)
delivery of an##5##3##(2008-12#1)(2008-3#1)(2008-5#2)(2010-8#1)
delivery of care##3##3##(1992-2#1)(2008-11#1)(2013-1#1)
delivery of clinical##2##3##(1992-3#1)(1996-2#1)
delivery of health care services##2##5##(1994-12#1)(1996-2#1)
delivery of health care##3##4##(1992-1#1)(1994-12#1)(1996-2#1)
delivery of health##5##3##(1992-1#1)(1993-2#1)(1994-12#1)(1996-2#1)(2009-3#1)
delivery of nebulized insulin##2##4##(1996-3#2)
delivery of oxygen##2##3##(2008-9#1)(2011-2#1)
delivery of services to##2##4##(2008-11#1)(2009-6#1)
delivery of services##4##3##(1997-2#2)(2008-11#1)(2009-6#1)
delivery of the active##2##4##(2008-5#2)
delivery of the##8##3##(1990-6#1)(1994-3#1)(2008-10#2)(2008-3#1)(2008-5#2)(2013-1#1)
delivery of this##2##3##(2008-12#1)(2008-6#1)
delivery of##108##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#3)(1995-1#2)(1995-12#1)(1995-3#4)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#2)(1997-1#2)(1997-2#4)(2008-10#4)(2008-11#13)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-3#2)(2013-1#6)
delivery structures##2##2##(1994-1#1)(1995-3#1)
delivery system and##2##3##(1995-12#1)(2008-7#1)
delivery system for##5##3##(1992-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
delivery system in##2##3##(1993-1#1)(1995-2#1)
delivery system is##2##3##(2008-5#1)(2010-12#1)
delivery system to##2##3##(1992-3#1)(1996-1#1)
delivery system using##2##3##(2008-11#1)(2008-8#1)
delivery system##54##2##(1991-1#1)(1991-12#1)(1992-1#2)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#5)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
delivery systems for##6##3##(1992-3#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2009-10#1)
delivery systems of##3##3##(1993-2#1)(1996-1#2)
delivery systems that##3##3##(1993-12#1)(1994-2#1)(1995-12#1)
delivery systems to##2##3##(1992-3#1)(1993-12#1)
delivery systems##45##2##(1992-3#2)(1993-12#3)(1993-2#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-1#7)(1996-2#3)(1996-3#3)(1997-1#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2012-2#2)(2012-3#1)
delivery systems?##2##2##(1996-1#2)
delivery techniques##2##2##(1992-2#1)(2008-11#1)
delivery through##2##2##(1994-1#1)(2011-2#1)
delivery to the##9##3##(1996-3#2)(2008-10#2)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
delivery to##21##2##(1996-3#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#4)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
delivery vector for##2##3##(2008-9#1)(2011-2#1)
delivery vehicles##3##2##(2010-8#1)(2012-12#1)(2013-1#1)
delivery was##2##2##(2008-11#1)(2008-8#1)
delivery were##3##2##(1993-1#1)(1995-5#1)(2011-1#1)
delivery with##2##2##(1995-2#1)(2008-11#1)
delivery##470##1##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#3)(1992-1#5)(1992-12#1)(1992-2#6)(1992-3#14)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#6)(1993-3#4)(1993-6#1)(1994-1#8)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#6)(1994-5#5)(1995-1#4)(1995-10#1)(1995-12#9)(1995-2#6)(1995-3#12)(1995-5#6)(1995-9#1)(1996-1#18)(1996-11#3)(1996-12#3)(1996-2#14)(1996-3#16)(1996-6#1)(1997-1#19)(1997-2#10)(1997-3#2)(2007-12#5)(2008-1#2)(2008-10#21)(2008-11#50)(2008-12#10)(2008-3#7)(2008-4#8)(2008-5#16)(2008-6#3)(2008-7#14)(2008-8#13)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-4#1)(2010-5#3)(2010-6#7)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#2)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#12)(2012-3#15)(2013-1#19)(2013-8#3)
delocalized##3##1##(1994-5#2)(2008-10#1)
delta 1-opioid receptor agonist##2##4##(1996-2#2)
delta 14##3##2##(1993-8#3)
delta 14)##2##2##(1993-8#2)
delta 2-opioid receptor##2##3##(1996-2#2)
delta 9##2##2##(1991-12#2)
delta 9-tetrahydrocannabinol##4##2##(1991-10#1)(1991-4#2)(1996-2#1)
delta G degrees values##2##4##(1993-8#2)
delta G degrees##5##3##(1992-3#1)(1993-8#4)
delta G##7##2##(1992-3#1)(1993-8#5)(2011-3#1)
delta H##2##2##(1993-8#1)(1994-5#1)
delta Ka values##2##3##(1995-2#2)
delta Ka##5##2##(1995-2#5)
delta and epsilon##3##3##(2008-8#3)
delta and gamma##2##3##(2008-8#2)
delta and##10##2##(1995-2#1)(1995-6#1)(2008-8#5)(2010-1#1)(2013-8#2)
delta antigens##2##2##(1994-11#2)
delta kappa = kappa##2##4##(1990-5#2)
delta kappa##5##2##(1990-5#5)
delta opioid receptor##3##3##(1992-3#1)(1995-6#1)(2008-11#1)
delta opioid##6##2##(1992-3#1)(1995-6#1)(2008-11#1)(2009-7#3)
delta receptor##2##2##(1992-3#1)(1995-6#1)
delta sleep-inducing##2##2##(1990-5#2)
delta virus##4##2##(1991-8#1)(1994-11#2)(2009-8#1)
delta##123##1##(1990-5#7)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#5)(1991-4#3)(1991-8#1)(1992-11#1)(1992-3#4)(1992-8#2)(1992-9#9)(1993-6#2)(1993-8#19)(1994-11#5)(1994-12#1)(1994-5#1)(1995-2#6)(1995-3#2)(1995-6#3)(1996-12#2)(1996-2#6)(1996-3#4)(1996-6#1)(1996-9#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-8#8)(2009-7#4)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-3#1)(2013-8#4)
delta- and kappa-opioid receptors were 4##2##6##(1995-11#2)
delta- and kappa-opioid receptors##5##4##(1995-11#5)
delta-9 desaturase##2##2##(1996-6#2)
delta-9 fatty acid desaturase##2##4##(1996-6#2)
delta-9##4##1##(1996-6#4)
delta-opioid receptors##3##2##(1993-3#1)(1996-2#2)
delta-opioid##5##1##(1992-3#1)(1993-3#1)(1996-2#2)(2009-7#1)
delta-tocopherol##2##1##(2008-10#1)(2008-5#1)
deltamethrin in##3##2##(2008-10#3)
deltamethrin##14##1##(2008-10#13)(2012-12#1)
deltoid group##2##2##(2010-4#2)
deltoid ligament##2##2##(2009-3#2)
deltoid muscle and the##2##4##(2010-4#1)(2010-6#1)
deltoid muscle##4##2##(2009-3#1)(2010-4#2)(2010-6#1)
deltoid##11##1##(1997-6#1)(2008-12#1)(2009-3#4)(2010-4#4)(2010-6#1)
deltoidae##3##1##(2008-10#3)
deltoides and##2##2##(2008-10#2)
deltoides##15##1##(2008-10#15)
delusional##3##1##(2008-4#1)(2011-2#2)
delusions##3##1##(2008-4#1)(2011-2#1)(2013-8#1)
demand a more##2##3##(1996-3#1)(2010-10#1)
demand a##5##2##(1992-2#1)(1993-12#1)(1996-3#1)(2010-10#1)(2011-2#1)
demand and##4##2##(1992-9#1)(1994-12#1)(1995-2#1)(2008-11#1)
demand are##3##2##(1992-1#1)(1995-2#1)(2008-11#1)
demand for health care services##2##5##(1992-2#1)(1995-2#1)
demand for health care##3##4##(1992-2#1)(1995-2#1)(1997-8#1)
demand for health##5##3##(1992-2#1)(1994-6#1)(1995-2#1)(1997-8#1)(2012-3#1)
demand for waste collecting services##2##5##(2008-12#2)
demand for##46##2##(1990-6#2)(1990-9#1)(1992-2#3)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-6#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
demand from##2##2##(2011-2#1)(2013-8#1)
demand in##2##2##(1994-2#1)(2008-7#1)
demand of##5##2##(1990-2#1)(1991-1#1)(2008-9#2)(2012-3#1)
demand on##5##2##(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-6#1)
demand that##2##2##(2008-3#1)(2013-1#1)
demand##130##1##(1990-2#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-2#4)(1992-3#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-9#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#7)(1996-11#1)(1996-2#2)(1996-3#2)(1997-3#2)(1997-6#1)(1997-8#3)(2006-6#1)(2008-10#22)(2008-11#10)(2008-12#4)(2008-3#3)(2008-6#1)(2008-7#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-7#3)(2011-2#5)(2011-7#1)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#1)
demanded by##3##2##(1990-11#1)(1991-3#1)(2008-3#1)
demanded##7##1##(1990-11#1)(1991-2#1)(1991-3#1)(1996-5#1)(2008-10#2)(2008-3#1)
demanding and##2##2##(2008-12#1)(2008-9#1)
demanding##21##1##(1991-12#1)(1991-2#1)(1993-12#2)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
demands a##3##2##(1994-2#1)(2008-1#1)(2009-11#1)
demands and##4##2##(1991-1#1)(1994-12#1)(1997-2#1)(2009-10#1)
demands are##2##2##(1995-2#1)(1996-2#1)
demands for##10##2##(1993-11#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2013-1#2)
demands in##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2010-7#1)
demands of the##4##3##(1993-12#1)(1994-2#1)(2008-10#1)(2009-10#1)
demands of##12##2##(1993-12#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-7#1)(2012-3#2)
demands on##7##2##(1991-2#1)(1992-2#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-3#1)
demands placed on##2##3##(1994-1#1)(2008-10#1)
demands that##3##2##(1992-3#1)(1995-12#1)(2008-11#1)
demands##78##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#5)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-1#1)(1996-2#2)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#16)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-7#2)(2012-3#3)(2013-1#3)
demarcated##3##1##(2008-10#1)(2010-6#1)(2012-12#1)
deme##7##1##(2008-10#1)(2008-9#6)
demembranated Orychophragmus violaceus sperm##2##4##(2008-9#2)
demembranated##3##1##(2008-9#3)
demembraned sperms##2##2##(2008-8#2)
demented PD##3##2##(2008-7#3)
demented and non-demented##3##3##(2008-7#3)
demented and##4##2##(2008-7#4)
demented patients##6##2##(2008-7#6)
demented##22##1##(1990-9#1)(2008-7#21)
dementia and##9##2##(2008-11#1)(2008-7#5)(2010-10#1)(2010-11#1)(2013-8#1)
dementia are##2##2##(1992-3#1)(2008-5#1)
dementia can##2##2##(2008-7#1)(2013-8#1)
dementia care##2##2##(2013-8#2)
dementia group##2##2##(2008-7#2)
dementia in Parkinson's disease##2##4##(2008-7#2)
dementia in the elderly##2##4##(2008-7#2)
dementia in the##4##3##(2008-7#2)(2013-1#1)(2013-8#1)
dementia in##12##2##(1995-12#1)(2008-7#7)(2012-3#1)(2013-1#2)(2013-8#1)
dementia is##2##2##(1996-11#1)(2013-8#1)
dementia of the Alzheimer type##2##5##(1996-11#1)(2008-7#1)
dementia of the##3##3##(1996-11#1)(2008-6#1)(2008-7#1)
dementia of##4##2##(1996-11#1)(2008-6#2)(2008-7#1)
dementia or##3##2##(2008-7#2)(2012-12#1)
dementia patients##4##2##(2008-6#3)(2008-8#1)
dementia that is##2##3##(2008-7#1)(2011-1#1)
dementia was##4##2##(2008-7#4)
dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies##2##10##(2008-7#2)
dementia with Lewy bodies and multiple system atrophy##3##8##(2008-7#3)
dementia with Lewy bodies##4##4##(2008-7#4)
dementia with##6##2##(2008-7#4)(2009-8#1)(2013-1#1)
dementia##125##1##(1990-11#2)(1991-1#2)(1991-3#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1995-12#3)(1996-11#12)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#7)(2008-7#56)(2008-8#2)(2009-8#1)(2010-10#3)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#9)
dementias##3##1##(1993-2#1)(2008-7#2)
demerits of the##2##3##(2008-10#2)
demerits of##3##2##(2008-10#3)
demes of high mean fitness##2##5##(2008-9#2)
demes of high##3##3##(2008-9#3)
demes of lower mean fitness##2##5##(2008-9#2)
demes of##5##2##(2008-9#5)
demes##10##1##(2008-10#1)(2008-9#9)
demetalization##3##1##(2008-10#3)
demethylase##4##1##(1991-5#3)(2009-7#1)
demethylation inhibitor fungicides##3##3##(2008-10#3)
demethylation inhibitor##4##2##(2008-10#4)
demethylation of the##2##3##(1993-8#1)(2011-2#1)
demethylation of##4##2##(1992-3#1)(1993-8#2)(2011-2#1)
demethylation##14##1##(1992-3#3)(1993-8#2)(2008-10#7)(2008-9#1)(2011-2#1)
demineralized bone matrix##2##3##(1991-5#2)
demineralized##4##1##(1991-5#2)(2008-11#1)(2012-12#1)
demise##10##1##(2008-11#2)(2008-12#1)(2009-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
demissum##3##1##(2008-10#3)
democracy##3##1##(1995-5#1)(1997-7#1)(2008-7#1)
demodulated##2##1##(2008-10#1)(2008-3#1)
demodulation##2##1##(2008-3#2)
demographic and clinical##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
demographic and medical factors##2##4##(1994-12#2)
demographic and medical##3##3##(1994-12#2)(2007-12#1)
demographic and##11##2##(1994-12#2)(2007-12#2)(2008-11#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
demographic basis of population regulation##2##5##(2008-8#2)
demographic basis of##4##3##(2008-8#4)
demographic changes##2##2##(1996-3#1)(2008-3#1)
demographic characteristics of##2##3##(1992-1#1)(1992-12#1)
demographic characteristics were##2##3##(2008-7#1)(2011-2#1)
demographic characteristics##8##2##(1992-1#1)(1992-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-3#1)
demographic context##2##2##(1997-5#1)(2008-8#1)
demographic data##7##2##(1992-3#1)(2007-12#1)(2008-9#1)(2010-1#1)(2010-10#1)(2012-12#1)(2013-1#1)
demographic factors##4##2##(1993-2#1)(2008-9#1)(2012-12#1)(2013-1#1)
demographic mechanisms##2##2##(2008-8#2)
demographic or##2##2##(1994-12#1)(2008-8#1)
demographic parameters##3##2##(2008-8#2)(2010-7#1)
demographic profile##2##2##(1991-1#1)(1995-2#1)
demographic questionnaire##2##2##(2010-8#1)(2010-9#1)
demographic risk was##2##3##(2009-10#2)
demographic risk##5##2##(2009-10#4)(2010-2#1)
demographic variables were##3##3##(1995-1#1)(2012-12#1)(2012-2#1)
demographic variables##13##2##(1995-1#2)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
demographic variance##2##2##(2008-9#2)
demographic##100##1##(1990-12#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#3)(1995-1#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-5#1)(2007-12#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#16)(2008-9#10)(2009-10#4)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#4)(2013-8#2)
demographics and##4##2##(1992-12#1)(1997-2#1)(2011-2#2)
demographics##16##1##(1992-1#1)(1992-12#1)(1992-2#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#4)(2013-1#1)
demography##5##1##(2008-8#4)(2011-2#1)
demonstrable in##3##2##(1992-3#1)(2008-5#1)(2013-1#1)
demonstrable##13##1##(1991-3#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-4#1)(2008-5#4)(2013-1#1)
demonstrate a method##2##3##(2008-2#1)(2011-2#1)
demonstrate a new##4##3##(2008-2#4)
demonstrate a novel##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2012-2#2)
demonstrate a significant##2##3##(2008-3#1)(2008-5#1)
demonstrate a strong##2##3##(1993-12#1)(2009-7#1)
demonstrate a##46##2##(1990-12#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-11#2)(2008-2#7)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-11#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#3)(2012-3#1)
demonstrate an##9##2##(1995-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2013-8#1)
demonstrate and##2##2##(1990-11#1)(2008-3#1)
demonstrate any##3##2##(1990-12#1)(2009-10#1)(2011-1#1)
demonstrate by##2##2##(1991-7#1)(1997-7#1)
demonstrate different effects of##2##4##(2008-10#1)(2008-11#1)
demonstrate for the first time that##2##6##(2008-10#1)(2013-8#1)
demonstrate for the first time the##2##6##(1994-6#1)(2013-1#1)
demonstrate for the first time##5##5##(1994-6#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
demonstrate high##2##2##(2008-6#1)(2008-9#1)
demonstrate how to##3##3##(2008-3#1)(2008-4#1)(2008-6#1)
demonstrate how##18##2##(1992-2#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#1)(2013-1#1)
demonstrate in##2##2##(2008-12#1)(2009-7#1)
demonstrate its##6##2##(2008-10#2)(2008-3#1)(2008-8#1)(2009-9#1)(2012-2#1)
demonstrate potential##2##2##(2008-10#1)(2008-7#1)
demonstrate significant changes##2##3##(2008-7#1)(2012-2#1)
demonstrate that a large##2##4##(2007-12#1)(2009-6#1)
demonstrate that a##9##3##(1990-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)(2009-6#2)(2013-8#1)
demonstrate that an##4##3##(1995-3#1)(2008-11#1)(2008-2#1)(2012-3#1)
demonstrate that both##8##3##(1995-2#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-7#2)
demonstrate that even##3##3##(1991-12#1)(2008-7#1)(2010-4#1)
demonstrate that exposure to##3##4##(2008-10#2)(2013-1#1)
demonstrate that in the absence of##2##6##(1991-5#1)(1992-3#1)
demonstrate that in##3##3##(1990-5#1)(1991-5#1)(1992-3#1)
demonstrate that it is possible to##3##6##(2008-10#1)(2008-11#1)(2008-7#1)
demonstrate that it is##5##4##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
demonstrate that it##6##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
demonstrate that some##3##3##(1991-3#1)(2008-5#1)(2008-8#1)
demonstrate that specific##2##3##(1991-12#1)(2008-11#1)
demonstrate that such##2##3##(2007-12#1)(2008-8#1)
demonstrate that the##64##3##(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#3)(1996-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(2008-10#12)(2008-11#9)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
demonstrate that there is##2##4##(1992-3#1)(2010-8#1)
demonstrate that there##3##3##(1991-2#1)(1992-3#1)(2010-8#1)
demonstrate that these##5##3##(2007-12#1)(2008-10#3)(2010-7#1)
demonstrate that this##5##3##(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
demonstrate that##293##2##(1990-12#1)(1990-5#2)(1990-8#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-5#1)(1991-9#1)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#5)(1995-2#10)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1996-12#4)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-9#1)(2007-12#4)(2008-10#58)(2008-11#28)(2008-12#4)(2008-2#4)(2008-3#6)(2008-5#12)(2008-7#15)(2008-8#12)(2008-9#4)(2009-10#2)(2009-11#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#5)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#7)(2012-5#1)(2013-1#13)(2013-8#7)
demonstrate the ability of##2##4##(2008-10#1)(2008-4#1)
demonstrate the ability##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
demonstrate the advantage of##2##4##(2008-10#1)(2008-7#1)
demonstrate the applicability of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
demonstrate the applicability##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
demonstrate the application##2##3##(2008-4#1)(2008-9#1)
demonstrate the capabilities of this##2##5##(2008-3#1)(2008-6#1)
demonstrate the capability of the##2##5##(2008-10#2)
demonstrate the capability of##3##4##(2008-10#2)(2008-3#1)
demonstrate the capability##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
demonstrate the effect of##2##4##(2008-3#1)(2008-7#1)
demonstrate the effect##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
demonstrate the effectiveness##2##3##(2008-10#1)(2008-6#1)
demonstrate the effects of##3##4##(1995-5#1)(2008-3#1)(2011-2#1)
demonstrate the existence of a##2##5##(1990-8#1)(1995-2#1)
demonstrate the feasibility of the##6##5##(2008-10#3)(2008-11#1)(2008-3#2)
demonstrate the feasibility of##12##4##(2008-10#8)(2008-11#1)(2008-3#2)(2013-1#1)
demonstrate the feasibility##13##3##(2008-10#9)(2008-11#1)(2008-3#2)(2013-1#1)
demonstrate the great##2##3##(2008-10#1)(2008-2#1)
demonstrate the high##3##3##(2008-10#2)(2008-2#1)
demonstrate the importance of the##2##5##(1993-3#1)(2008-12#1)
demonstrate the importance of##5##4##(1993-3#1)(1995-9#1)(2008-10#1)(2008-12#1)(2010-7#1)
demonstrate the important role of##2##5##(1995-8#1)(2011-2#1)
demonstrate the method##2##3##(2008-3#1)(2008-6#1)
demonstrate the need##2##3##(1997-1#1)(2008-11#1)
demonstrate the performance of the##3##5##(2008-10#3)
demonstrate the positive##2##3##(2008-11#2)
demonstrate the potential of this##2##5##(1995-8#1)(2008-3#1)
demonstrate the potential of##6##4##(1995-8#1)(2008-10#2)(2008-3#1)(2009-5#1)(2012-2#1)
demonstrate the potential##9##3##(1995-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-5#1)(2012-2#1)
demonstrate the presence of##3##4##(1990-11#1)(1990-12#1)(1996-2#1)
demonstrate the suitability of the##2##5##(2008-10#2)
demonstrate the suitability of##3##4##(2008-10#2)(2010-8#1)
demonstrate the use of a##2##5##(2007-12#1)(2008-3#1)
demonstrate the use of##7##4##(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
demonstrate the utility of the##2##5##(2008-5#1)(2012-2#1)
demonstrate the utility of##10##4##(1990-5#1)(1991-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2012-2#2)
demonstrate the validity and##2##4##(2007-12#1)(2008-10#1)
demonstrate the##157##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#3)(2008-10#49)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#15)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#5)
demonstrate##648##1##(1990-11#3)(1990-12#4)(1990-5#5)(1990-8#3)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#4)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-12#7)(1995-2#15)(1995-3#1)(1995-5#6)(1995-6#5)(1995-8#4)(1995-9#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2007-11#6)(2007-12#13)(2008-1#1)(2008-10#134)(2008-11#53)(2008-12#9)(2008-2#18)(2008-3#37)(2008-4#3)(2008-5#23)(2008-6#8)(2008-7#25)(2008-8#23)(2008-9#12)(2009-10#5)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#19)(2012-3#12)(2012-5#1)(2013-1#23)(2013-8#9)
demonstrated a broad##2##3##(1997-6#1)(2008-5#1)
demonstrated a high##3##3##(2008-10#2)(2010-11#1)
demonstrated a large##2##3##(2011-2#2)
demonstrated a low##2##3##(1992-3#1)(2008-5#1)
demonstrated a significant##6##3##(1990-2#1)(1997-3#1)(2006-6#1)(2008-5#1)(2013-1#2)
demonstrated a statistically significant##2##4##(2008-12#1)(2013-1#1)
demonstrated a strong association##2##4##(2008-8#1)(2011-2#1)
demonstrated a strong##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
demonstrated a wide##2##3##(1996-12#1)(2009-4#1)
demonstrated a##81##2##(1990-2#3)(1991-11#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-7#2)(2006-6#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)
demonstrated after##3##2##(1995-12#1)(2012-3#1)(2013-8#1)
demonstrated an##4##2##(1992-3#1)(1992-9#1)(2008-7#1)(2012-3#1)
demonstrated and##9##2##(1992-12#1)(2008-10#6)(2008-5#1)(2008-9#1)
demonstrated as a##2##3##(2008-10#2)
demonstrated as##7##2##(1990-8#1)(2008-10#4)(2008-4#1)(2008-7#1)
demonstrated at##3##2##(1992-4#1)(2008-10#1)(2012-3#1)
demonstrated between the##3##3##(1993-2#1)(2011-3#2)
demonstrated between##4##2##(1993-2#1)(2009-8#1)(2011-3#2)
demonstrated both##4##2##(2008-10#2)(2008-2#1)(2011-2#1)
demonstrated by application##3##3##(2008-10#2)(2008-3#1)
demonstrated by determining##2##3##(2008-10#2)
demonstrated by means of##2##4##(2008-10#1)(2008-5#1)
demonstrated by the determination of##3##5##(2008-10#3)
demonstrated by the recovery##2##4##(2008-10#2)
demonstrated by the results of##2##5##(2008-10#1)(2008-8#1)
demonstrated by the##16##3##(1993-6#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
demonstrated by use of##3##4##(2007-11#1)(2008-3#2)
demonstrated by##96##2##(1991-3#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-12#1)(1997-1#1)(2007-11#2)(2008-10#52)(2008-11#4)(2008-3#7)(2008-5#4)(2008-8#2)(2008-9#1)(2009-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
demonstrated clinically##3##2##(2008-12#1)(2008-5#1)(2009-3#1)
demonstrated complete resolution of##2##4##(2009-6#1)(2010-5#1)
demonstrated complete##3##2##(2008-7#1)(2009-6#1)(2010-5#1)
demonstrated deletions##2##2##(1997-3#2)
demonstrated effects on##2##3##(2008-10#1)(2008-9#1)
demonstrated excellent##5##2##(2008-10#3)(2011-2#1)(2012-3#1)
demonstrated experimentally##4##2##(2008-10#1)(2008-3#2)(2012-2#1)
demonstrated for the first time that the##2##7##(2008-10#1)(2012-2#1)
demonstrated for the first time that##4##6##(2008-10#2)(2008-9#1)(2012-2#1)
demonstrated for the first time##8##5##(1993-3#1)(2007-11#1)(2008-10#4)(2008-9#1)(2012-2#1)
demonstrated for the##16##3##(1992-9#1)(1993-3#1)(2007-11#1)(2008-10#11)(2008-9#1)(2012-2#1)
demonstrated for##26##2##(1991-5#1)(1992-9#1)(1993-3#1)(1997-2#1)(2007-11#1)(2008-10#18)(2008-3#1)(2008-9#1)(2012-2#1)
demonstrated from##2##2##(1991-1#1)(2008-10#1)
demonstrated general statistical differences in##2##5##(2013-1#2)
demonstrated good##7##2##(2008-10#4)(2008-5#1)(2008-7#1)(2010-8#1)
demonstrated here for##2##3##(1993-2#1)(2012-2#1)
demonstrated here##3##2##(1990-11#1)(1993-2#1)(2012-2#1)
demonstrated high levels of##2##4##(1991-2#1)(2008-10#1)
demonstrated high##9##2##(1991-2#1)(1996-1#1)(2008-10#2)(2008-5#2)(2010-9#1)(2013-1#2)
demonstrated how##2##2##(2008-11#1)(2010-8#1)
demonstrated improved##2##2##(2008-7#1)(2008-9#1)
demonstrated in a##9##3##(1990-11#1)(2008-10#5)(2008-4#1)(2009-6#1)(2009-9#1)
demonstrated in the presence of a##2##6##(1991-5#2)
demonstrated in the##16##3##(1991-10#2)(1991-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2008-10#6)(2008-11#1)
demonstrated in this study##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
demonstrated in this##8##3##(1990-11#1)(1995-3#1)(2008-10#3)(2008-5#1)(2008-9#1)(2013-1#1)
demonstrated in vivo##2##3##(1994-2#1)(1994-8#1)
demonstrated in##74##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-5#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#22)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
demonstrated inhibitory##2##2##(1996-2#1)(2010-8#1)
demonstrated less##2##2##(1995-1#1)(2008-9#1)
demonstrated long-term stability and reproducibility with relative standard deviations of less than##2##12##(2008-10#2)
demonstrated modest##2##2##(2012-3#1)(2013-1#1)
demonstrated more##2##2##(2008-5#1)(2009-3#1)
demonstrated no significant differences##2##4##(1991-3#1)(2012-2#1)
demonstrated no significant##4##3##(1991-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrated no##5##2##(1991-3#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrated on the##4##3##(1990-12#1)(1996-3#1)(2008-10#2)
demonstrated on##10##2##(1990-12#1)(1993-1#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-3#1)
demonstrated over##3##2##(2008-10#2)(2009-8#1)
demonstrated previously##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
demonstrated significant##15##2##(1991-2#1)(1993-3#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
demonstrated some##2##2##(2008-10#1)(2008-11#1)
demonstrated statistically significant##2##3##(1993-1#1)(2011-2#1)
demonstrated statistically##3##2##(1993-1#1)(2008-5#1)(2011-2#1)
demonstrated that Tid1##2##3##(2011-2#2)
demonstrated that a number of##2##5##(2008-1#1)(2008-5#1)
demonstrated that a##7##3##(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)
demonstrated that all##5##3##(1993-8#1)(2008-10#2)(2009-8#1)(2013-1#1)
demonstrated that an##7##3##(1993-11#1)(1995-5#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-1#1)(2012-3#1)
demonstrated that both##7##3##(1994-5#1)(2008-10#4)(2008-11#2)
demonstrated that even##2##3##(2008-10#1)(2011-2#1)
demonstrated that exogenous##2##3##(2008-9#1)(2010-8#1)
demonstrated that expression of##2##4##(1996-12#1)(2009-8#1)
demonstrated that in##5##3##(1997-2#1)(2007-12#1)(2008-5#1)(2009-3#1)(2010-1#1)
demonstrated that induction of the##2##5##(2008-10#2)
demonstrated that it is##5##4##(2008-10#1)(2008-11#1)(2008-12#2)(2012-2#1)
demonstrated that it##6##3##(2008-10#2)(2008-11#1)(2008-12#2)(2012-2#1)
demonstrated that most##2##3##(2008-10#2)
demonstrated that only the##3##4##(2008-10#2)(2008-7#1)
demonstrated that only##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
demonstrated that our##2##3##(2008-10#1)(2012-2#1)
demonstrated that protein##3##3##(2008-10#1)(2008-9#1)(2011-3#1)
demonstrated that several##2##3##(1993-8#1)(2009-3#1)
demonstrated that some##2##3##(2009-8#1)(2011-1#1)
demonstrated that the expression of##2##5##(2008-8#1)(2013-1#1)
demonstrated that the expression##3##4##(2008-8#2)(2013-1#1)
demonstrated that the factors##2##4##(2008-10#2)
demonstrated that the level of##2##5##(2008-10#1)(2013-8#1)
demonstrated that the proposed##3##4##(2008-10#3)
demonstrated that the set of##2##5##(2008-11#1)(2013-1#1)
demonstrated that the visual##2##4##(1991-2#1)(2008-8#1)
demonstrated that the##107##3##(1991-2#1)(1991-5#2)(1994-1#1)(1994-11#2)(1994-2#1)(1994-8#2)(1995-6#1)(1995-8#1)(1997-2#1)(2006-6#1)(2008-10#39)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#8)(2009-3#1)(2009-7#1)(2009-8#4)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
demonstrated that there##3##3##(1990-5#1)(2008-11#1)(2010-1#1)
demonstrated that these##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
demonstrated that they##3##3##(2008-1#1)(2008-11#1)(2010-3#1)
demonstrated that this laser##2##4##(2008-3#1)(2009-5#1)
demonstrated that this##20##3##(1996-2#2)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
demonstrated that two##3##3##(1994-2#1)(1995-6#1)(2011-2#1)
demonstrated that with the##2##4##(2008-10#2)
demonstrated that with##3##3##(2008-10#2)(2008-5#1)
demonstrated that##388##2##(1990-12#1)(1990-4#2)(1990-5#3)(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-12#5)(1996-2#4)(1997-1#3)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#103)(2008-11#34)(2008-12#6)(2008-3#6)(2008-5#15)(2008-6#3)(2008-7#8)(2008-8#19)(2008-9#21)(2009-10#1)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#11)(2010-1#5)(2010-11#3)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#23)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#3)
demonstrated the ability of##2##4##(2008-10#1)(2008-5#1)
demonstrated the best##2##3##(2012-2#1)(2013-1#1)
demonstrated the effectiveness of##2##4##(2008-10#1)(2012-2#1)
demonstrated the efficacy of##3##4##(1992-1#1)(2008-5#1)(2012-12#1)
demonstrated the existence of##2##4##(2008-11#1)(2009-1#1)
demonstrated the expression of##2##4##(1995-8#1)(2011-2#1)
demonstrated the feasibility of##5##4##(1990-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
demonstrated the feasibility##6##3##(1990-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
demonstrated the importance of##2##4##(2008-10#1)(2010-11#1)
demonstrated the need for##2##4##(1997-6#1)(2008-10#1)
demonstrated the potential use of treating##2##6##(2008-9#2)
demonstrated the potential##3##3##(2008-9#2)(2010-12#1)
demonstrated the presence of a##2##5##(1995-11#1)(2008-8#1)
demonstrated the presence of##9##4##(1990-2#1)(1990-8#1)(1991-6#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
demonstrated the suitability of the##2##5##(1997-6#1)(2008-10#1)
demonstrated the utility of##3##4##(2007-12#1)(2008-10#1)(2010-12#1)
demonstrated the##86##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#1)(1993-11#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-3#2)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
demonstrated through##2##2##(2008-3#1)(2009-5#1)
demonstrated to be a##6##4##(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)
demonstrated to be an essential component of##2##7##(1991-6#1)(1992-1#1)
demonstrated to be an##3##4##(1991-6#1)(1992-1#1)(2008-10#1)
demonstrated to be##31##3##(1991-6#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-7#2)(2008-10#13)(2008-11#4)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
demonstrated to have##5##3##(1993-6#1)(1995-2#1)(2009-3#1)(2013-1#1)(2013-7#1)
demonstrated to promote the##3##4##(2008-10#2)(2012-2#1)
demonstrated to##50##2##(1991-6#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-6#2)(1993-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-7#2)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
demonstrated two##2##2##(2008-10#1)(2008-3#1)
demonstrated using a##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)
demonstrated using##14##2##(1990-5#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2010-11#1)(2012-2#1)
demonstrated when##3##2##(2008-10#2)(2008-7#1)
demonstrated with an##2##3##(1995-2#1)(2008-3#1)
demonstrated with the##3##3##(1990-8#1)(2008-10#2)
demonstrated with##15##2##(1990-8#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-3#5)(2009-8#1)(2010-12#2)
demonstrated##1250##1##(1990-11#5)(1990-12#4)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#3)(1991-5#7)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#8)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#5)(1992-9#3)(1993-1#5)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#8)(1993-6#4)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#7)(1994-12#1)(1994-2#6)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#7)(1994-9#1)(1995-1#2)(1995-11#5)(1995-12#6)(1995-2#8)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#4)(1996-1#4)(1996-11#4)(1996-12#9)(1996-2#7)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#6)(1997-2#9)(1997-3#8)(1997-6#6)(1997-7#5)(1997-8#2)(2006-6#2)(2007-11#7)(2007-12#8)(2007-8#1)(2008-1#3)(2008-10#355)(2008-11#82)(2008-12#16)(2008-2#10)(2008-3#52)(2008-4#3)(2008-5#59)(2008-6#7)(2008-7#33)(2008-8#33)(2008-9#38)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#13)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#15)(2009-9#1)(2010-1#8)(2010-10#1)(2010-11#6)(2010-12#12)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#7)(2010-9#5)(2011-1#2)(2011-2#58)(2011-3#4)(2012-12#10)(2012-2#28)(2012-3#15)(2013-1#45)(2013-7#3)(2013-8#9)
demonstrates a##16##2##(1990-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#5)(2010-1#1)(2010-4#1)(2013-1#1)
demonstrates good##2##2##(2008-10#1)(2008-9#1)
demonstrates how the##2##3##(1995-1#1)(2008-11#1)
demonstrates how to##2##3##(2008-4#2)
demonstrates how##6##2##(1995-1#1)(1995-12#1)(2008-11#1)(2008-4#2)(2013-1#1)
demonstrates that a##3##3##(1993-2#1)(2008-8#1)(2012-12#1)
demonstrates that an##2##3##(1993-12#1)(1995-2#1)
demonstrates that it is##2##4##(2008-10#1)(2012-3#1)
demonstrates that it##3##3##(1994-8#1)(2008-10#1)(2012-3#1)
demonstrates that the##14##3##(1991-2#1)(1991-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-8#1)
demonstrates that there is##2##4##(2008-9#1)(2013-1#1)
demonstrates that there##4##3##(2008-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
demonstrates that these##2##3##(2010-10#1)(2012-2#1)
demonstrates that this##4##3##(1992-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
demonstrates that##81##2##(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#3)(1996-12#1)(2007-11#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#5)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
demonstrates the feasibility of##2##4##(2008-11#1)(2012-3#1)
demonstrates the importance of##2##4##(2009-5#1)(2012-2#1)
demonstrates the possibility of##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
demonstrates the potential##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
demonstrates the use of##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
demonstrates the utility of##3##4##(2008-9#1)(2009-8#1)(2011-2#1)
demonstrates the value of##2##4##(2008-11#1)(2008-12#1)
demonstrates the##47##2##(1990-11#1)(1990-5#1)(1992-1#1)(1993-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
demonstrates##167##1##(1990-11#2)(1990-5#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#3)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#34)(2008-11#13)(2008-12#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#8)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#1)
demonstrating a##7##2##(1992-8#1)(1992-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2012-3#1)(2012-7#1)
demonstrating equivalence##2##2##(2008-10#2)
demonstrating that it is##2##4##(1993-9#1)(1995-6#1)
demonstrating that it##3##3##(1993-9#1)(1995-6#1)(2008-3#1)
demonstrating that the##9##3##(1993-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-3#1)
demonstrating that##54##2##(1990-11#1)(1991-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-2#3)(1995-6#2)(1997-3#1)(1997-7#2)(2008-10#11)(2008-11#7)(2008-12#2)(2008-3#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
demonstrating the effectiveness of##2##4##(2008-10#1)(2008-3#1)
demonstrating the efficiency##2##3##(1995-1#1)(2008-10#1)
demonstrating the feasibility of##3##4##(1990-5#1)(2008-10#1)(2011-2#1)
demonstrating the potential##2##3##(2008-10#1)(2011-2#1)
demonstrating the presence of##2##4##(1996-8#1)(2008-10#1)
demonstrating the utility of##2##4##(2008-11#1)(2012-2#1)
demonstrating the validity of##2##4##(2008-10#1)(2008-3#1)
demonstrating the##33##2##(1990-12#1)(1990-2#1)(1990-5#1)(1995-1#1)(1996-2#1)(1996-8#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
demonstrating##120##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-1#1)(1995-2#3)(1995-6#3)(1996-2#1)(1996-8#1)(1997-3#1)(1997-7#2)(2008-10#32)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#3)(2013-8#1)
demonstration in##2##2##(1995-3#1)(2013-1#1)
demonstration is##2##2##(2008-3#1)(2012-12#1)
demonstration model##2##2##(1996-1#1)(2008-10#1)
demonstration of a##3##3##(1993-9#1)(2007-12#1)(2008-7#1)
demonstration of increased##2##3##(2008-9#1)(2012-2#1)
demonstration of the##11##3##(1994-12#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
demonstration of this##2##3##(2008-10#1)(2008-2#1)
demonstration of##42##2##(1990-5#1)(1990-8#1)(1991-3#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#3)(1996-1#1)(1996-2#1)(2007-12#3)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2011-2#4)(2012-2#1)(2012-3#1)
demonstration project##3##2##(1992-1#1)(1995-3#1)(1996-2#1)
demonstration projects##2##2##(1996-12#1)(2010-10#1)
demonstration that##7##2##(1995-12#1)(1997-2#1)(2008-10#4)(2009-5#1)
demonstration##77##1##(1990-5#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#4)(1995-3#3)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
demonstrations##10##1##(1991-2#2)(1992-1#1)(1993-12#2)(1994-12#1)(1994-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
demyelinating disease of the central nervous system##2##7##(2011-2#1)(2012-3#1)
demyelinating disease of the##3##4##(1995-2#1)(2011-2#1)(2012-3#1)
demyelinating disease##4##2##(1995-12#1)(1995-2#1)(2011-2#1)(2012-3#1)
demyelinating polyneuropathy##4##2##(2008-7#2)(2012-3#2)
demyelinating##16##1##(1995-12#5)(1995-2#1)(2007-8#1)(2008-2#1)(2008-7#3)(2011-2#2)(2012-3#3)
demyelination and##2##2##(2010-12#1)(2011-2#1)
demyelination##8##1##(1995-12#1)(2008-11#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-2#1)
denaturant##5##1##(1992-8#1)(1997-2#1)(2008-10#3)
denaturation of##5##2##(1993-8#1)(1994-11#1)(1994-5#1)(2008-7#2)
denaturation procedures##2##2##(2008-10#2)
denaturation step##2##2##(2008-10#1)(2008-9#1)
denaturation##30##1##(1990-12#1)(1991-5#3)(1992-10#1)(1993-8#2)(1994-11#1)(1994-5#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#8)
denatured DNA##6##2##(1994-8#1)(2008-10#5)
denatured proteins##4##2##(1990-5#1)(2008-10#3)
denatured##27##1##(1990-5#3)(1991-5#2)(1992-8#1)(1994-8#1)(1995-3#1)(2008-10#17)(2008-8#1)(2009-9#1)
denaturing conditions##5##2##(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)
denaturing gradient gel electrophoresis (DGGE)##4##5##(2008-10#1)(2008-9#2)(2010-6#1)
denaturing gradient gel electrophoresis##5##4##(2008-10#2)(2008-9#2)(2010-6#1)
denaturing polyacrylamide##2##2##(2008-11#1)(2008-2#1)
denaturing##20##1##(1992-6#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#3)(2010-11#1)(2010-6#1)
dende##2##1##(2008-10#2)
dendrimer##7##1##(2008-10#7)
dendrimer-like polyamidoamine##2##2##(2008-10#2)
dendrimers##6##1##(1996-5#6)
dendrite of the##2##3##(1997-7#1)(2008-7#1)
dendrite##9##1##(1994-2#1)(1995-8#1)(1997-7#1)(2007-12#2)(2008-11#3)(2008-7#1)
dendrites and##3##2##(1995-8#1)(1997-3#1)(2008-11#1)
dendrites of##2##2##(1997-3#1)(2008-10#1)
dendrites##13##1##(1994-2#3)(1995-8#1)(1997-2#1)(1997-3#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)
dendritic arbors##3##2##(1994-2#3)
dendritic cell and##2##3##(2008-10#1)(2013-1#1)
dendritic cell##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#2)
dendritic cells (DC)##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
dendritic cells (DCs) in the##2##5##(2008-11#2)
dendritic cells (DCs)##7##3##(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#2)(2012-3#1)
dendritic cells and##4##3##(2008-10#1)(2008-9#3)
dendritic cells from mice##3##4##(2008-11#3)
dendritic cells from##5##3##(2008-11#4)(2012-2#1)
dendritic cells##37##2##(1997-2#1)(2008-10#3)(2008-11#12)(2008-6#1)(2008-8#6)(2008-9#7)(2009-12#1)(2011-2#4)(2012-2#1)(2012-3#1)
dendritic injury##3##2##(2008-7#3)
dendritic morphology##3##2##(2008-10#1)(2013-1#2)
dendritic spine##2##2##(1995-8#1)(2009-9#1)
dendritic spines##3##2##(1995-8#2)(2008-11#1)
dendritic transport of β-actin mRNA##2##5##(2012-2#2)
dendritic tree##3##2##(1994-2#2)(2008-11#1)
dendritic##82##1##(1990-5#1)(1994-2#5)(1995-8#3)(1997-2#2)(2007-12#1)(2008-10#11)(2008-11#16)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#7)(2009-12#1)(2009-8#2)(2009-9#1)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#7)
dendrogram##7##1##(2008-10#7)
denervated muscle##2##2##(2008-8#1)(2011-2#1)
denervated neuropil##8##2##(1997-3#8)
denervated##17##1##(1995-11#1)(1997-3#12)(2007-8#2)(2008-8#1)(2011-2#1)
denervation on##2##2##(1990-5#1)(2008-8#1)
denervation##11##1##(1990-5#1)(2007-8#3)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#3)(2013-8#1)
dengue and##2##2##(2012-12#2)
dengue in##2##2##(2011-2#1)(2012-12#1)
dengue transmission##2##2##(2011-2#2)
dengue##21##1##(2011-2#12)(2011-3#3)(2012-12#4)(2013-8#2)
dengue-III virus D9964##2##3##(2013-8#2)
denial and##4##2##(2008-4#3)(2010-11#1)
denial of##4##2##(1990-6#1)(1991-12#1)(2008-4#2)
denial##9##1##(1990-6#1)(1991-12#1)(2008-4#6)(2010-11#1)
denied that##2##2##(1993-3#1)(1995-6#1)
denied##13##1##(1992-12#1)(1993-3#1)(1995-12#4)(1995-6#2)(1996-5#1)(2007-12#1)(2010-10#1)(2010-8#1)(2013-1#1)
denies##4##1##(1991-3#1)(1991-9#1)(1996-5#1)(1997-7#1)
denitrificans##3##1##(1992-3#2)(2008-6#1)
denoising##2##1##(2008-10#1)(2009-8#1)
denominated##2##1##(1991-2#1)(2013-8#1)
denomination of##2##2##(2008-10#1)(2011-2#1)
denominator in##2##2##(2008-11#1)(2011-2#1)
denominator##8##1##(1992-12#1)(1995-3#1)(1996-2#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
denote the##2##2##(2008-10#2)
denote##4##1##(1996-8#1)(2008-10#3)
denoted as##2##2##(2008-10#1)(2012-2#1)
denoted##3##1##(2008-10#1)(2012-2#1)(2013-8#1)
denotes the##2##2##(2008-10#2)
dense aggregates##2##2##(2007-12#1)(2008-10#1)
dense and##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
dense granules##3##2##(1990-5#1)(2007-12#1)(2008-5#1)
dense in##2##2##(1992-3#1)(2007-12#1)
dense network##2##2##(1997-1#1)(2008-9#1)
dense population of##2##3##(2008-11#1)(2008-5#1)
dense##66##1##(1990-5#1)(1991-2#1)(1992-3#2)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-12#7)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#7)(2008-5#8)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
dense-core secretory granules##2##3##(1992-2#1)(1997-7#1)
densely packed##5##2##(2008-7#3)(2008-8#1)(2009-7#1)
densely populated pig##2##3##(2011-2#2)
densely populated##3##2##(2008-5#1)(2011-2#2)
densely##14##1##(1994-2#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-7#1)(2010-7#1)(2011-2#2)(2012-2#1)
denser##3##1##(2008-10#2)(2011-2#1)
densities and the##3##3##(1994-2#1)(1995-11#1)(2008-8#1)
densities and##17##2##(1994-2#2)(1995-11#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#1)
densities at the site of##2##5##(1992-12#1)(2008-10#1)
densities at##4##2##(1992-12#1)(2008-10#3)
densities between the##2##3##(2008-10#1)(2010-8#1)
densities between##3##2##(2008-10#2)(2010-8#1)
densities for##4##2##(2008-11#1)(2008-7#2)(2008-8#1)
densities in the field##2##4##(2008-10#1)(2008-9#1)
densities in the##6##3##(1996-12#1)(2008-10#2)(2008-11#2)(2008-9#1)
densities in##10##2##(1996-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)
densities observed##2##2##(2008-10#1)(2011-2#1)
densities of 2##2##3##(2008-10#2)
densities of H##6##3##(2008-10#6)
densities of fluorescent pseudomonads##2##4##(2008-10#2)
densities of four##2##3##(2008-10#2)
densities of indigenous 2##2##4##(2008-10#2)
densities of the pathogen##3##4##(2008-10#3)
densities of the##4##3##(2008-10#4)
densities of##46##2##(1994-2#2)(1994-5#1)(2008-10#31)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#3)(2010-6#1)(2013-1#1)(2013-8#1)
densities on##4##2##(2008-10#3)(2010-10#1)
densities revealed##2##2##(2008-10#1)(2010-7#1)
densities that##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
densities was observed##2##3##(2008-10#2)
densities were lower##2##3##(2008-10#2)
densities were##12##2##(1997-2#1)(2008-10#7)(2008-11#2)(2008-7#1)(2008-9#1)
densities##189##1##(1991-5#1)(1992-12#1)(1992-3#1)(1994-2#6)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#3)(1997-2#2)(1997-3#1)(2008-10#96)(2008-11#16)(2008-2#1)(2008-3#5)(2008-7#13)(2008-8#17)(2008-9#9)(2009-12#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#2)
densitometric##7##1##(1997-2#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)
densitometry and##2##2##(2009-3#1)(2011-2#1)
densitometry##9##1##(1990-5#1)(1990-6#1)(1996-2#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-3#1)(2011-2#1)
density (PSD)##4##2##(1996-12#2)(2008-11#1)(2010-8#1)
density also##2##2##(1991-5#1)(2008-10#1)
density and distribution##2##3##(2009-6#1)(2013-8#1)
density and the##6##3##(1991-11#1)(2008-10#5)
density and to##2##3##(2008-9#2)
density and total##2##3##(2008-10#1)(2008-9#1)
density and##69##2##(1991-11#2)(1993-1#1)(1994-9#1)(1995-2#3)(2007-8#1)(2008-10#27)(2008-11#15)(2008-3#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-6#1)(2010-10#1)(2011-1#1)(2012-5#1)(2013-1#1)(2013-8#1)
density are##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
density as a result of##3##5##(2008-10#1)(2008-9#2)
density as a##4##3##(2008-10#2)(2008-9#2)
density as##6##2##(1997-3#1)(2008-10#2)(2008-9#2)(2009-8#1)
density at least##2##3##(2008-10#1)(2008-11#1)
density at the##4##3##(1992-12#2)(2008-11#1)(2008-7#1)
density at which##2##3##(2008-9#2)
density at##11##2##(1992-12#2)(1995-2#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-9#2)
density being##2##2##(1993-8#1)(2012-2#1)
density but the##2##3##(2008-10#2)
density but##6##2##(2008-10#4)(2008-11#1)(2008-9#1)
density by##3##2##(1991-11#1)(1994-5#1)(2008-3#1)
density can##2##2##(1991-11#1)(2008-8#1)
density compared##2##2##(2008-11#1)(2008-9#1)
density culture##3##2##(2008-11#3)
density decreased##2##2##(2008-10#1)(2008-11#1)
density dependence in##4##3##(2008-8#4)
density dependence##15##2##(2008-10#1)(2008-8#12)(2008-9#2)
density dependent##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
density determinations##2##2##(2008-8#2)
density did not##3##3##(2008-10#2)(2008-8#1)
density distribution of##2##3##(2008-10#1)(2008-3#1)
density distribution##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
density distributions##2##2##(2008-3#1)(2008-7#1)
density during##2##2##(2008-10#2)
density fluctuations##2##2##(2008-3#2)
density for the##2##3##(1994-5#1)(2008-9#1)
density for##3##2##(1994-5#1)(2008-3#1)(2008-9#1)
density fractionation##2##2##(2008-11#2)
density from##2##2##(1991-3#1)(2008-10#1)
density function##3##2##(2008-3#2)(2008-8#1)
density functional##2##2##(2008-10#2)
density gradient centrifugation##8##3##(1993-8#2)(1994-8#2)(1997-3#1)(2008-9#2)(2011-2#1)
density gradient##12##2##(1993-8#2)(1994-8#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#3)(2010-12#1)(2011-2#1)
density gradients##3##2##(1995-6#2)(2008-4#1)
density in the##13##3##(1991-3#1)(1995-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
density in##34##2##(1991-11#2)(1991-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
density increased##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
density is##9##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2010-7#1)(2013-8#1)
density lipoprotein ligated cholesterol##3##4##(1991-11#3)
density lipoprotein receptor##8##3##(1991-2#2)(1993-3#2)(1994-9#1)(1995-2#2)(1995-6#1)
density lipoprotein##35##2##(1991-11#3)(1991-12#1)(1991-2#2)(1991-5#2)(1992-5#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-6#3)(1995-8#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)
density matrix##2##2##(2007-12#1)(2008-3#1)
density may##2##2##(1991-5#1)(2008-8#1)
density measurement##2##2##(1994-12#1)(2008-10#1)
density measurements##6##2##(2008-10#4)(2008-3#1)(2008-8#1)
density of 0##2##3##(1994-9#1)(2008-10#1)
density of 1##3##3##(2008-10#1)(2008-11#2)
density of a##3##3##(2008-11#1)(2008-7#2)
density of each aerosol component##2##5##(2008-3#2)
density of hares was##2##4##(2013-1#2)
density of infectious##3##3##(2008-10#1)(2008-8#2)
density of nematode-trapping fungi##2##4##(2008-10#2)
density of shift-multiplexed holographic memory##2##5##(2008-3#2)
density of strain##3##3##(2008-10#3)
density of the pathogen##3##4##(2008-10#3)
density of the##26##3##(1990-5#1)(1994-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2013-8#1)
density of zinc##2##3##(2008-10#2)
density of##131##2##(1990-11#1)(1990-5#1)(1993-2#1)(1993-9#3)(1994-2#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#52)(2008-11#16)(2008-12#1)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#7)(2008-9#5)(2009-11#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
density on the##8##3##(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#3)(2008-5#1)
density on##17##2##(1994-5#1)(1995-2#1)(2008-10#8)(2008-11#6)(2008-5#1)
density only##2##2##(2008-8#1)(2013-1#1)
density or##8##2##(1991-5#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
density perfusion cultures of##2##4##(2008-11#2)
density perfusion##6##2##(2008-11#6)
density polyethylene##4##2##(2008-10#2)(2009-3#2)
density profile##2##2##(1992-9#1)(1996-12#1)
density profiles##4##2##(1992-9#1)(1996-12#1)(2008-3#2)
density regulation##8##2##(2008-8#5)(2008-9#3)
density relationships##2##2##(2008-10#2)
density required##2##2##(2008-10#1)(2008-11#1)
density than##2##2##(2008-11#1)(2011-2#1)
density to##6##2##(1992-12#1)(1996-8#2)(2008-10#3)
density values##2##2##(1991-11#1)(2008-11#1)
density was high##2##3##(1996-2#1)(2008-10#1)
density was over 10(7)##2##4##(2008-11#2)
density was significantly##2##3##(2008-10#1)(2008-9#1)
density was##23##2##(1991-11#2)(1995-6#1)(1996-2#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#1)
density were##2##2##(2008-10#1)(2008-11#1)
density when##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
density with an##2##3##(2008-10#2)
density with##3##2##(2008-10#2)(2008-12#1)
density within##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
density##772##1##(1990-11#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#17)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#8)(1992-1#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#6)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#7)(1994-8#5)(1994-9#4)(1995-2#9)(1995-3#3)(1995-6#9)(1995-8#11)(1996-12#7)(1996-2#2)(1996-3#2)(1996-8#2)(1997-3#4)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#233)(2008-11#108)(2008-12#5)(2008-2#3)(2008-3#45)(2008-4#4)(2008-5#10)(2008-7#26)(2008-8#58)(2008-9#44)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#3)(2010-3#5)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#16)(2012-12#1)(2012-2#6)(2012-3#4)(2012-5#2)(2013-1#7)(2013-8#11)
density) and##2##2##(2008-10#1)(2008-9#1)
density)##7##1##(1991-11#1)(2008-10#3)(2008-8#1)(2008-9#2)
density-dependent manner##3##2##(1993-8#1)(1995-2#1)(2008-10#1)
density-dependent##17##1##(1990-6#1)(1993-8#3)(1995-2#1)(2008-10#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-6#1)
density-gradient##3##1##(2008-11#1)(2008-7#1)(2008-8#1)
density-independent mortality##3##2##(2008-8#3)
density-independent##4##1##(2008-8#4)
density-mediated indirect##2##2##(2008-9#2)
density-mediated##3##1##(2008-9#3)
density-viscosity##2##1##(2008-10#2)
dent##2##1##(2008-10#2)
dental abnormalities##2##2##(1995-9#1)(2011-1#1)
dental amalgams##2##2##(2008-10#2)
dental and##2##2##(2013-1#2)
dental applications##3##2##(2008-7#1)(2010-10#1)(2012-4#1)
dental biofilms of##3##3##(2013-1#3)
dental care##5##2##(1995-6#1)(2008-5#1)(2012-3#2)(2013-1#1)
dental caries and##2##3##(1991-6#1)(2012-2#1)
dental caries##10##2##(1991-6#3)(2008-7#3)(2011-2#1)(2012-2#2)(2013-7#1)
dental clinics##2##2##(1991-6#1)(2008-1#1)
dental education##6##2##(1993-1#1)(2008-8#4)(2013-1#1)
dental fear##3##2##(1993-1#3)
dental hard-tissue##2##2##(2008-7#2)
dental health##2##2##(1994-6#1)(2008-7#1)
dental home##3##2##(2011-2#3)
dental hygienists who reported that they##2##6##(1993-1#2)
dental hygienists##6##2##(1993-1#4)(2008-4#2)
dental implant removal torque##2##4##(2009-7#2)
dental implant surgery##3##3##(2013-1#3)
dental implant##10##2##(1996-3#1)(2009-7#4)(2011-7#1)(2013-1#4)
dental implants and##2##3##(2009-7#1)(2010-5#1)
dental implants using##2##3##(2012-12#1)(2013-1#1)
dental implants##13##2##(2009-7#3)(2010-5#1)(2011-7#1)(2012-12#1)(2013-1#7)
dental journals##3##2##(2013-1#3)
dental office##4##2##(1994-12#1)(2008-1#2)(2008-4#1)
dental patient##2##2##(1993-1#1)(2008-1#1)
dental patients##6##2##(1993-1#1)(1994-12#1)(2008-1#1)(2008-5#2)(2012-3#1)
dental plaque##2##2##(2008-5#1)(2011-2#1)
dental practice##2##2##(1990-9#1)(2008-1#1)
dental practitioner##4##2##(2008-1#3)(2011-2#1)
dental practitioners##4##2##(2008-1#3)(2011-2#1)
dental restorative materials##5##3##(2009-7#1)(2011-2#4)
dental school##2##2##(2008-11#1)(2013-8#1)
dental services##2##2##(1995-12#1)(2008-11#1)
dental students##4##2##(2013-1#4)
dental tissue engineering and##2##4##(2013-1#2)
dental tissue##3##2##(1990-9#1)(2013-1#2)
dental tissues##2##2##(1991-2#1)(1994-3#1)
dental treatment##2##2##(2008-5#1)(2011-2#1)
dental work##2##2##(1993-1#2)
dental##196##1##(1990-2#1)(1990-5#3)(1990-9#2)(1991-2#2)(1991-3#1)(1991-6#5)(1993-1#17)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-9#2)(1996-3#3)(1997-2#1)(1997-3#1)(2008-1#13)(2008-10#8)(2008-11#5)(2008-4#3)(2008-5#6)(2008-7#15)(2008-8#4)(2009-7#10)(2010-10#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#16)(2011-7#3)(2012-12#4)(2012-2#8)(2012-3#6)(2012-4#1)(2013-1#43)(2013-7#1)(2013-8#1)
dentate fast waves##2##3##(1994-8#2)
dentate fast##3##2##(1994-8#3)
dentate granule cells##3##3##(1990-5#2)(1996-12#1)
dentate gyrus of the##2##4##(1995-12#1)(2008-11#1)
dentate gyrus of##5##3##(1994-8#2)(1995-12#2)(2008-11#1)
dentate gyrus##20##2##(1990-5#2)(1994-2#1)(1994-8#3)(1995-12#2)(1996-12#6)(2008-11#4)(2008-7#1)(2013-8#1)
dentate##34##1##(1990-5#4)(1991-10#1)(1991-7#1)(1994-2#1)(1994-8#6)(1995-12#2)(1996-12#7)(2008-1#2)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#2)(2013-7#1)(2013-8#1)
dentifrice containing##4##2##(2011-2#3)(2013-1#1)
dentifrice##8##1##(2011-2#5)(2013-1#3)
dentigerous cyst##2##2##(2013-1#2)
dentigerous##4##1##(2013-1#4)
dentin and##2##2##(1991-2#1)(2008-7#1)
dentin hypersensitivity##6##2##(2011-2#6)
dentin regeneration##2##2##(2013-1#2)
dentin##26##1##(1990-2#2)(1991-2#2)(2008-7#1)(2010-10#2)(2011-2#10)(2012-12#3)(2013-1#6)
dentine##2##1##(2008-11#1)(2013-1#1)
dentist##7##1##(1995-6#3)(2008-11#1)(2011-2#2)(2012-12#1)
dentistry and##2##2##(1995-6#1)(2009-7#1)
dentistry in##5##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1993-3#1)
dentistry##27##1##(1990-2#1)(1990-3#3)(1990-5#1)(1990-9#2)(1991-2#1)(1993-1#1)(1993-3#2)(1995-6#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
dentists are##3##2##(1994-12#2)(2008-11#1)
dentists in Fiji##2##3##(2008-1#2)
dentists in##3##2##(2008-1#2)(2013-1#1)
dentists should##2##2##(2008-7#1)(2012-12#1)
dentists##21##1##(1993-1#1)(1994-12#3)(1995-6#1)(1997-2#1)(2008-1#4)(2008-11#4)(2008-7#2)(2010-5#1)(2012-12#2)(2013-1#2)
dentition examinations##2##2##(2012-2#2)
dentition##7##1##(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#4)
denture cleansing##2##2##(2013-1#2)
denture wearers##2##2##(2008-7#1)(2013-1#1)
denture##22##1##(1991-2#1)(2008-7#1)(2013-1#20)
dentures##7##1##(2008-7#1)(2011-7#1)(2013-1#5)
denuded oocytes##2##2##(2013-1#2)
denuded##4##1##(1994-11#1)(2008-1#1)(2013-1#2)
denuder is##2##2##(2008-10#2)
denuder##7##1##(2008-10#7)
denuder-based##3##1##(2008-10#3)
denutrition##2##1##(2008-7#2)
deny##5##1##(1991-2#1)(1994-12#1)(1995-6#1)(1997-2#1)(2009-11#1)
denying the##2##2##(1995-6#1)(2009-10#1)
denying##4##1##(1995-12#1)(1995-6#1)(1996-5#1)(2009-10#1)
deodorancy benefits over and above##2##5##(2008-5#2)
deodorancy##4##1##(2008-5#4)
deodorant products##2##2##(2008-5#2)
deodorant systems##2##2##(2008-5#2)
deodorant##14##1##(2008-5#13)(2012-3#1)
deoxycholate##9##1##(1993-8#1)(2008-10#8)
deoxycholic acid##2##2##(2008-10#2)
deoxycholic amides/cholanes##2##2##(2008-10#2)
deoxycholic##6##1##(2008-10#6)
deoxycorticosterone##3##1##(1990-11#1)(2013-8#2)
deoxygenation of the##3##3##(2008-10#3)
deoxygenation##9##1##(1996-5#2)(2008-10#7)
deoxynivalenol (DON)##9##2##(2008-10#9)
deoxynivalenol accumulation##2##2##(2008-10#2)
deoxynivalenol##16##1##(2008-10#16)
deoxynucleosides##2##1##(1990-11#1)(2008-4#1)
deoxynucleotide radical cations##4##3##(2008-9#4)
deoxynucleotide##6##1##(2008-8#1)(2008-9#5)
deoxyribonucleic acid##3##2##(2008-10#3)
deoxyribonucleoside phosphoramidites##2##2##(2008-4#2)
deoxyribonucleoside##3##1##(2008-4#2)(2008-9#1)
deoxyribose##3##1##(1991-3#1)(2008-10#1)(2008-9#1)
departed from##2##2##(2008-10#1)(2010-8#1)
departed##3##1##(2008-10#1)(2010-8#1)(2013-8#1)
department (ED)##7##2##(2008-11#2)(2009-6#2)(2010-8#1)(2011-9#1)(2012-2#1)
department and##2##2##(1996-1#1)(2008-11#1)
department at##2##2##(1996-1#1)(2011-2#1)
department can be##2##3##(1992-1#1)(2009-11#1)
department has##3##2##(1993-2#1)(1996-1#1)(2008-3#1)
department in##10##2##(1991-11#1)(1994-3#1)(1997-4#1)(2008-1#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
department is##2##2##(1993-3#1)(1994-12#1)
department of##12##2##(1991-11#2)(1991-3#1)(1993-3#1)(1995-2#2)(1997-4#1)(2008-10#2)(2013-1#2)(2013-8#1)
department to##2##2##(1996-1#1)(2008-11#1)
department will##2##2##(1991-2#1)(1993-12#1)
department with a##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
department with##8##2##(2008-12#1)(2008-3#3)(2009-9#1)(2011-2#2)(2013-1#1)
department##156##1##(1990-11#1)(1990-12#4)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-5#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#5)(1994-8#1)(1995-1#1)(1995-12#5)(1995-2#2)(1995-5#1)(1996-1#5)(1996-11#1)(1996-12#5)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-8#1)(2006-5#2)(2008-1#1)(2008-10#3)(2008-11#18)(2008-12#7)(2008-3#9)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#3)(2009-9#2)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#9)(2011-9#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
department]##3##1##(1991-11#1)(2009-1#2)
departmental portfolio##5##2##(2008-12#5)
departmental##11##1##(1991-12#1)(1992-1#1)(1992-12#1)(1993-1#1)(1994-3#1)(2008-12#5)(2011-2#1)
departments a##2##2##(1996-1#1)(1997-1#1)
departments and##10##2##(1991-3#1)(1992-1#1)(1992-12#1)(1994-1#1)(1996-3#1)(2008-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
departments at##3##2##(1991-11#1)(1993-6#1)(2008-10#1)
departments have##4##2##(1996-1#2)(1997-3#1)(2012-3#1)
departments is##2##2##(1991-11#1)(1997-8#1)
departments of general##2##3##(1993-11#1)(2013-8#1)
departments of public health##2##4##(1997-2#2)
departments of##9##2##(1990-6#1)(1992-1#1)(1993-11#1)(1997-2#2)(1997-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
departments to##4##2##(1996-12#1)(2008-10#1)(2012-2#1)(2013-8#1)
departments with##2##2##(1991-3#1)(2009-9#1)
departments##98##1##(1990-3#2)(1990-6#2)(1990-9#3)(1991-1#1)(1991-11#3)(1991-2#1)(1991-3#4)(1992-1#3)(1992-12#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#5)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#3)(1996-1#7)(1996-12#3)(1996-2#5)(1996-3#4)(1997-1#5)(1997-2#7)(1997-3#3)(1997-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-7#2)(2009-9#1)(2011-2#1)(2011-9#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
departs from##2##2##(2008-10#1)(2008-5#1)
departs##3##1##(1991-12#1)(2008-10#1)(2008-5#1)
departure from##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
departure##9##1##(1993-2#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)
departures from##2##2##(2008-10#2)
departures##3##1##(1990-8#1)(2008-10#2)
depend more##2##2##(1996-3#1)(2009-7#1)
depend on a##4##3##(1994-2#1)(1995-6#1)(2008-10#1)(2012-3#1)
depend on its##3##3##(2008-8#1)(2009-7#1)(2013-1#1)
depend on sex##2##3##(2008-9#1)(2012-3#1)
depend on the ability of##2##5##(1994-12#1)(2008-10#1)
depend on the availability of##3##5##(1991-1#1)(2008-10#1)(2008-9#1)
depend on the chemical##2##4##(1996-12#1)(2008-11#1)
depend on the clinical##2##4##(1990-2#1)(2008-9#1)
depend on the existence##2##4##(1994-2#1)(2008-8#1)
depend on the nature##2##4##(1994-11#1)(2008-10#1)
depend on the presence of##2##5##(1994-11#1)(2008-12#1)
depend on the##59##3##(1990-2#1)(1991-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-1#2)(1997-7#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#5)(2009-8#1)(2009-9#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-3#1)(2013-1#1)
depend on whether##2##3##(1996-2#1)(2008-9#1)
depend on##114##2##(1990-2#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#16)(2008-9#10)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
depend strongly on##2##3##(2008-11#1)(2008-3#1)
depend upon the##4##3##(1991-2#1)(1992-2#1)(1993-3#1)(2008-7#1)
depend upon##6##2##(1991-2#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-12#1)(2008-7#1)
depend##139##1##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#22)(2008-11#7)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#19)(2008-9#10)(2009-11#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
dependable##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
dependant##4##1##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
depended on both the##2##4##(2008-8#1)(2011-2#1)
depended on soil##2##3##(2008-10#1)(2012-6#1)
depended on the applied##2##4##(2008-10#2)
depended on the strain##2##4##(2008-11#1)(2008-5#1)
depended on the##30##3##(1991-5#2)(1991-6#1)(1993-6#1)(1996-2#1)(1997-1#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2011-2#2)(2012-12#1)
depended on##44##2##(1991-5#3)(1991-6#2)(1993-6#3)(1994-12#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)
depended primarily##2##2##(2008-10#2)
depended##52##1##(1991-5#3)(1991-6#2)(1993-6#3)(1994-12#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#18)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)
dependence and##11##2##(1990-6#1)(1991-1#1)(1992-8#1)(1994-8#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)
dependence between the absorbance##2##4##(2008-10#2)
dependence between the##4##3##(2007-11#1)(2008-10#3)
dependence between##8##2##(2007-11#1)(2008-10#6)(2009-7#1)
dependence in ADLs##2##3##(2008-7#2)
dependence in a##2##3##(2008-3#1)(2008-8#1)
dependence in the##3##3##(1992-1#1)(2008-3#1)(2008-8#1)
dependence in##18##2##(1991-1#4)(1992-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-7#3)(2008-8#4)(2011-2#1)
dependence is##3##2##(1990-6#1)(2008-10#1)(2013-8#1)
dependence of fluorescence##2##3##(2008-3#2)
dependence of the enzyme##2##4##(1990-5#1)(1997-6#1)
dependence of the fluorescence##2##4##(1995-6#1)(2008-3#1)
dependence of the rate##2##4##(1993-8#1)(2008-10#1)
dependence of the##51##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-8#3)(1995-11#2)(1995-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#17)(2008-2#5)(2008-3#12)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)
dependence of their##2##3##(2008-10#1)(2008-11#1)
dependence of this##3##3##(1990-5#1)(2008-10#1)(2008-2#1)
dependence of uptake rate in##2##5##(2008-10#2)
dependence of##105##2##(1990-5#3)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-8#4)(1995-11#2)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#39)(2008-11#1)(2008-2#8)(2008-3#19)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2012-2#2)(2012-6#1)
dependence on the##15##3##(1993-8#1)(1997-6#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)
dependence on##37##2##(1993-8#2)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
dependence similar to##2##3##(2008-2#2)
dependence to##2##2##(2008-10#1)(2013-8#1)
dependence was linear##3##3##(1992-3#1)(2008-10#2)
dependence was##5##2##(1992-3#1)(2008-10#3)(2008-3#1)
dependence##265##1##(1990-10#1)(1990-5#3)(1990-6#2)(1990-8#2)(1991-1#9)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1993-8#6)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#82)(2008-11#5)(2008-2#14)(2008-3#36)(2008-5#3)(2008-6#6)(2008-7#6)(2008-8#18)(2008-9#2)(2009-10#2)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2011-2#4)(2012-2#5)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#5)
dependence)##3##1##(2008-10#2)(2008-11#1)
dependences of##2##2##(2008-10#2)
dependences##3##1##(1996-12#1)(2008-10#2)
dependencies of##2##2##(1993-8#1)(2008-8#1)
dependencies##10##1##(1991-1#1)(1993-8#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2010-10#1)
dependency and##2##2##(1994-3#1)(2008-10#1)
dependency is##3##2##(1997-7#1)(2008-9#1)(2013-8#1)
dependency of the##2##3##(1997-2#1)(2008-11#1)
dependency of##6##2##(1990-2#1)(1997-2#1)(2008-11#2)(2008-5#1)(2011-2#1)
dependency##33##1##(1990-2#1)(1991-1#1)(1992-2#1)(1993-3#1)(1994-3#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
dependent and independent##2##3##(1993-12#1)(2008-7#1)
dependent and occurs##2##3##(1994-8#1)(2008-7#1)
dependent and##15##2##(1992-5#1)(1993-12#1)(1994-8#2)(2008-10#5)(2008-11#1)(2008-7#3)(2011-1#1)(2012-3#1)
dependent changes in##3##3##(1993-3#1)(2008-11#2)
dependent diabetes mellitus##7##3##(1992-5#1)(1994-12#2)(2008-11#2)(2008-7#2)
dependent diabetes##8##2##(1992-5#1)(1994-12#2)(2008-11#3)(2008-7#2)
dependent for##2##2##(1994-8#1)(2008-9#1)
dependent investigation of##2##3##(2008-10#2)
dependent manner##12##2##(1990-5#1)(1991-2#1)(1994-11#1)(1994-3#1)(2008-11#2)(2008-5#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
dependent mechanisms##2##2##(2008-11#1)(2012-2#1)
dependent not only on the presence of light but also on its direction of incidence##2##15##(1991-2#2)
dependent not only on##3##4##(1991-2#2)(1997-8#1)
dependent on a##4##3##(1994-6#1)(1994-8#1)(1996-6#1)(2008-8#1)
dependent on age##3##3##(1992-2#1)(1994-9#1)(2011-3#1)
dependent on both##4##3##(1995-3#1)(1995-5#1)(1996-12#1)(2008-7#1)
dependent on protein synthesis##2##4##(1990-11#1)(1995-12#1)
dependent on protein##3##3##(1990-11#1)(1991-5#1)(1995-12#1)
dependent on solution##2##3##(2008-10#2)
dependent on the UGT2B17 genotype##2##5##(2013-8#2)
dependent on the amount of##4##5##(2008-10#1)(2008-11#2)(2008-5#1)
dependent on the bacterial##2##4##(2008-10#1)(2011-2#1)
dependent on the concentration of##4##5##(2008-10#3)(2012-2#1)
dependent on the fraction of##2##5##(1994-5#1)(2008-10#1)
dependent on the level of##2##5##(2008-10#1)(2008-11#1)
dependent on the nature of the##3##6##(1994-5#1)(2008-10#2)
dependent on the nature of##4##5##(1993-3#1)(1994-5#1)(2008-10#2)
dependent on the pH##2##4##(1991-5#1)(2008-10#1)
dependent on the presence of##5##5##(1991-3#1)(1991-5#1)(1993-6#1)(2008-10#1)(2008-11#1)
dependent on the time of day##2##6##(2009-8#2)
dependent on the use of##2##5##(2008-10#2)
dependent on the##106##3##(1990-2#2)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#2)(1992-6#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-5#2)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#38)(2008-11#9)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-8#3)
dependent on wind##2##3##(2008-10#1)(2008-5#1)
dependent on##209##2##(1990-11#2)(1990-2#2)(1990-8#2)(1990-9#1)(1991-3#1)(1991-5#4)(1991-6#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-12#1)(2008-10#61)(2008-11#16)(2008-12#2)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-9#1)(2013-8#5)
dependent pathway##3##2##(1990-12#1)(1992-8#1)(2013-1#1)
dependent patients##3##2##(1992-12#2)(2009-7#1)
dependent pattern##2##2##(1993-3#1)(2013-1#1)
dependent plasticity##2##2##(2008-11#1)(2009-8#1)
dependent protein kinase##2##3##(1997-2#2)
dependent protein##3##2##(1997-2#2)(2012-2#1)
dependent signaling##2##2##(1997-2#1)(1997-7#1)
dependent upon the presence of##2##5##(1993-12#1)(2012-2#1)
dependent upon the presence##3##4##(1993-12#1)(2008-5#1)(2012-2#1)
dependent upon the##22##3##(1990-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-5#2)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
dependent upon##44##2##(1990-3#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-1#2)(2008-10#10)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
dependent variable##5##2##(1992-1#1)(2008-10#3)(2010-1#1)
dependent variables##7##2##(1995-12#2)(2008-10#1)(2008-11#2)(2010-4#1)(2012-2#1)
dependent virus##5##2##(2008-10#5)
dependent##437##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#6)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#5)(1993-8#2)(1994-1#2)(1994-11#5)(1994-12#2)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#2)(1995-5#4)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#4)(1997-2#4)(1997-3#2)(1997-7#5)(1997-8#3)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#112)(2008-11#41)(2008-12#6)(2008-3#8)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#15)(2008-8#10)(2008-9#7)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#7)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#10)(2012-3#3)(2012-9#1)(2013-1#4)(2013-8#7)
dependently on##2##2##(2008-10#1)(2008-12#1)
dependently##6##1##(1994-2#1)(1995-11#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
depending mainly on the##2##4##(1997-5#1)(2008-11#1)
depending mainly on##3##3##(1997-5#1)(2008-10#1)(2008-11#1)
depending of the##2##3##(2008-10#1)(2011-2#1)
depending on cell##2##3##(2008-11#1)(2009-8#1)
depending on different##2##3##(2008-10#1)(2011-2#1)
depending on how##2##3##(2008-11#1)(2008-12#1)
depending on its##4##3##(1996-3#1)(2008-10#2)(2010-11#1)
depending on pH##2##3##(2008-10#2)
depending on specific##2##3##(2011-1#1)(2013-8#1)
depending on the actual##2##4##(2006-6#1)(2008-10#1)
depending on the cell##3##4##(1993-8#1)(2008-11#1)(2008-9#1)
depending on the characteristics of the##2##6##(2008-10#1)(2011-2#1)
depending on the experimental##2##4##(1996-6#1)(2008-10#1)
depending on the medium##2##4##(2008-10#2)
depending on the metal##3##4##(2008-10#2)(2010-11#1)
depending on the method used##2##5##(2008-10#2)
depending on the nature of the##2##6##(2008-10#1)(2008-8#1)
depending on the nature##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
depending on the outcome##2##4##(2010-12#1)(2013-1#1)
depending on the polarization##2##4##(2008-3#2)
depending on the presence of##3##5##(1991-9#1)(2008-5#1)(2010-5#1)
depending on the reaction##2##4##(1996-5#1)(2008-10#1)
depending on the sample##2##4##(2008-10#2)
depending on the size of##2##5##(2008-10#1)(2008-7#1)
depending on the type of##4##5##(1997-2#1)(2008-11#1)(2008-12#1)(2008-6#1)
depending on the##159##3##(1991-12#1)(1991-9#2)(1993-11#1)(1993-3#1)(1993-8#4)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-10#64)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#4)(2009-11#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#4)
depending on their##9##3##(1995-1#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)
depending on whether##2##3##(1991-12#1)(2008-5#1)
depending on##220##2##(1991-12#2)(1991-3#1)(1991-9#2)(1993-11#1)(1993-3#1)(1993-8#4)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#84)(2008-11#17)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#4)(2009-1#1)(2009-11#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#7)
depending upon the nature##2##4##(1991-3#1)(2008-11#1)
depending upon the##9##3##(1991-3#1)(1992-2#1)(1993-8#1)(2008-10#2)(2008-11#2)(2010-6#1)(2010-7#1)
depending upon##12##2##(1991-3#1)(1992-2#1)(1993-8#1)(2008-10#4)(2008-11#3)(2010-6#1)(2010-7#1)
depending##242##1##(1990-2#1)(1991-12#2)(1991-3#2)(1991-9#2)(1992-2#1)(1993-11#1)(1993-3#1)(1993-8#5)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#90)(2008-11#22)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#8)(2008-9#4)(2009-1#1)(2009-11#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#7)
depends both on##2##3##(1992-6#1)(2008-10#1)
depends largely on##2##3##(1990-5#1)(2008-7#1)
depends mainly on the##3##4##(2008-10#1)(2008-3#2)
depends mainly on##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
depends not only on##2##4##(1997-6#1)(2013-1#1)
depends on a##4##3##(1990-11#1)(1993-6#1)(2007-8#1)(2008-3#1)
depends on both the##3##4##(1995-3#1)(2008-10#1)(2008-8#1)
depends on both##6##3##(1994-8#1)(1995-3#1)(2008-10#2)(2008-8#1)(2013-8#1)
depends on early##2##3##(1994-1#1)(2009-1#1)
depends on effective##2##3##(2006-6#1)(2011-2#1)
depends on how##2##3##(1993-3#1)(2008-4#1)
depends on our##2##3##(1993-3#1)(2010-4#1)
depends on stressor controllability and##2##5##(2008-11#2)
depends on the amount and##2##5##(2008-10#1)(2008-5#1)
depends on the amount##3##4##(2008-10#2)(2008-5#1)
depends on the chemical##2##4##(2008-10#1)(2008-3#1)
depends on the concentration and##3##5##(2008-10#3)
depends on the concentration##4##4##(2008-10#4)
depends on the degree of##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
depends on the degree##4##4##(2008-10#1)(2008-8#2)(2011-2#1)
depends on the magnitude of the##2##6##(2008-10#1)(2008-8#1)
depends on the presence##4##4##(1993-8#1)(1994-6#1)(1997-8#1)(2008-8#1)
depends on the size of##3##5##(1996-3#1)(2010-5#1)(2011-2#1)
depends on the specific##3##4##(1996-2#1)(2008-11#1)(2008-7#1)
depends on the stage of##2##5##(1993-2#1)(2008-7#1)
depends on the##109##3##(1990-5#1)(1991-3#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-10#34)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#13)(2008-9#2)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#2)
depends on two##2##3##(1995-3#1)(2008-10#1)
depends on whether##2##3##(2008-11#1)(2008-8#1)
depends on which##3##3##(1992-12#1)(1997-1#1)(2010-12#1)
depends on##196##2##(1990-11#1)(1990-5#2)(1991-3#1)(1992-1#1)(1992-12#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#53)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#21)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#10)(2011-3#2)(2012-2#1)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#3)(2013-8#5)
depends only on##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
depends only##5##2##(1990-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)
depends sensitively on the##2##4##(2008-10#1)(2008-3#1)
depends significantly on##2##3##(2008-12#1)(2008-3#1)
depends significantly##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
depends upon the##12##3##(1990-2#1)(1994-9#1)(2008-10#6)(2008-11#2)(2009-10#1)(2010-8#1)
depends upon##17##2##(1990-2#1)(1991-5#1)(1994-12#1)(1994-9#1)(2008-10#8)(2008-11#3)(2009-10#1)(2010-8#1)
depends##249##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#75)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#15)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#23)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#3)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#10)(2011-3#2)(2012-2#1)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#5)(2013-8#5)
depersonalization##2##1##(2008-10#1)(2008-11#1)
dephosphorylated by MBP##2##3##(1993-6#2)
dephosphorylated##7##1##(1992-6#1)(1993-6#3)(1996-2#1)(1996-6#1)(2013-1#1)
dephosphorylation of MLC20 in##2##4##(1994-11#2)
dephosphorylation of MLC20##3##3##(1994-11#3)
dephosphorylation of the##2##3##(1994-11#1)(1996-2#1)
dephosphorylation of##13##2##(1992-9#1)(1993-6#1)(1994-11#5)(1996-2#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
dephosphorylation##22##1##(1992-9#1)(1993-6#2)(1994-11#5)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#6)(2008-7#1)(2008-8#1)(2012-2#2)(2013-8#1)
depict the##8##2##(1991-1#1)(2008-3#1)(2010-10#1)(2010-12#3)(2012-2#1)(2012-3#1)
depict##10##1##(1991-1#1)(2008-3#1)(2010-10#1)(2010-12#3)(2012-12#1)(2012-2#2)(2012-3#1)
depicted a##2##2##(2011-2#1)(2013-1#1)
depicted by##2##2##(2010-1#1)(2010-12#1)
depicted##8##1##(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
depicting the##3##2##(2008-10#2)(2008-7#1)
depicting##7##1##(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
depiction of the##2##3##(2012-2#2)
depiction of##5##2##(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#2)
depicts the##3##2##(1990-11#1)(2008-12#1)(2008-7#1)
depigmentation on the##2##3##(2010-6#1)(2013-1#1)
depigmentation##7##1##(1994-12#1)(2010-6#4)(2011-2#1)(2013-1#1)
depigmenting activity##2##2##(2008-5#2)
depigmenting##3##1##(2008-5#3)
depilatory##3##1##(2008-5#3)
deplete the##2##2##(1991-12#1)(2008-9#1)
deplete##5##1##(1991-12#1)(1995-12#1)(2008-12#1)(2008-9#1)(2009-9#1)
depleted from the##2##3##(2007-12#1)(2008-11#1)
depleted in##4##2##(1990-5#1)(2008-11#1)(2008-7#1)(2010-3#1)
depleted of##4##2##(1992-10#1)(1995-6#1)(1997-4#1)(2008-12#1)
depleted##32##1##(1990-5#1)(1991-3#2)(1992-10#1)(1993-12#1)(1995-6#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-3#2)(2010-5#1)(2012-3#2)(2013-8#3)
depletes##2##1##(1997-1#1)(2008-8#1)
depleting##3##1##(1996-1#1)(2008-11#1)(2012-2#1)
depletion and##5##2##(1991-6#1)(1992-9#1)(1994-8#2)(1996-1#1)
depletion in the##4##3##(1991-5#1)(2008-10#2)(2008-7#1)
depletion in##7##2##(1991-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)
depletion is##2##2##(1991-6#1)(1996-2#1)
depletion of the##6##3##(1991-6#1)(1993-2#1)(1994-8#1)(2008-7#2)(2009-8#1)
depletion of##31##2##(1990-12#2)(1991-3#1)(1991-6#1)(1993-2#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#4)(2009-8#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)
depletion on the viability of human##2##6##(2008-7#2)
depletion on##5##2##(1997-2#1)(2008-12#1)(2008-7#2)(2009-8#1)
depletion##81##1##(1990-12#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#3)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-8#4)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)(2008-10#9)(2008-11#9)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#15)(2008-9#2)(2009-6#3)(2009-8#5)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
depletions##2##1##(1994-2#2)
deploy##6##1##(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
deployed in##3##2##(2008-10#3)
deployed##13##1##(1995-6#1)(1997-2#1)(2008-10#9)(2008-11#1)(2011-3#1)
deploying##4##1##(1994-2#1)(2008-10#2)(2010-11#1)
deployment in##2##2##(2008-10#2)
deployment of resistant cultivars##3##4##(2008-10#3)
deployment of resistant##5##3##(2008-10#5)
deployment of##15##2##(2008-10#10)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
deployment##25##1##(2008-10#16)(2008-11#3)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
deployments##3##1##(2008-10#3)
depolarisation##4##1##(2008-11#3)(2010-8#1)
depolarization and##2##2##(2008-10#2)
depolarization on##2##2##(1997-1#1)(2008-3#1)
depolarization was##2##2##(1994-2#1)(2008-10#1)
depolarization##26##1##(1990-8#1)(1992-3#1)(1993-1#1)(1994-2#3)(1996-2#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#7)(2009-8#1)(2010-11#1)(2010-8#1)
depolarized##4##1##(1990-8#2)(1994-2#1)(2008-10#1)
depolarizer##8##1##(2008-10#3)(2008-2#3)(2008-3#2)
depolarizing##5##1##(1993-3#1)(1994-2#2)(1995-12#1)(2008-3#1)
depolymerase##3##1##(2008-10#3)
depolymerisation of##2##2##(1993-6#1)(2008-10#1)
depolymerisation##4##1##(1993-6#2)(2008-10#2)
depolymerization of##2##2##(1994-11#1)(2008-11#1)
depolymerization##5##1##(1994-11#1)(1994-6#1)(2008-11#2)(2011-1#1)
deposit in##2##2##(1997-1#1)(2013-8#1)
deposit of##3##2##(1995-12#1)(2008-10#2)
deposit##21##1##(1994-12#1)(1995-12#2)(1997-1#1)(2008-10#11)(2008-4#1)(2008-5#3)(2008-7#1)(2013-8#1)
deposited as##4##2##(2008-10#4)
deposited at##4##2##(2008-10#3)(2008-3#1)
deposited by##5##2##(1992-3#1)(2008-10#3)(2008-2#1)
deposited in the airways##2##4##(1994-2#1)(1997-1#1)
deposited in the alveolar region##2##5##(1992-12#1)(1995-12#1)
deposited in the##13##3##(1992-12#1)(1994-12#2)(1994-2#1)(1995-12#2)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
deposited in##17##2##(1992-12#1)(1994-12#2)(1994-2#1)(1995-12#2)(1996-3#1)(1996-8#1)(1997-1#1)(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#1)(2013-8#1)
deposited on a##5##3##(2008-10#3)(2008-3#2)
deposited on glass##3##3##(2008-10#3)
deposited on the electrode##2##4##(2008-10#2)
deposited on the##14##3##(2008-10#13)(2009-5#1)
deposited on##32##2##(1996-3#1)(2008-10#26)(2008-11#1)(2008-3#2)(2008-8#1)(2009-5#1)
deposited onto glassy carbon##3##4##(2008-10#3)
deposited onto the##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
deposited onto##9##2##(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)
deposited with##4##2##(1996-9#1)(1997-1#1)(2008-10#2)
deposited##102##1##(1992-12#1)(1992-3#1)(1994-12#2)(1994-2#1)(1995-12#2)(1996-3#3)(1996-8#1)(1996-9#2)(1997-1#2)(2008-1#1)(2008-10#65)(2008-11#3)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
depositing a##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
deposition and##11##2##(1993-8#1)(1997-1#1)(2008-10#4)(2008-11#1)(2009-8#1)(2012-2#2)(2013-8#1)
deposition are##2##2##(1992-3#1)(2008-11#1)
deposition at##3##2##(2006-6#1)(2008-10#2)
deposition during##3##2##(2008-10#1)(2008-11#2)
deposition in the##6##3##(1992-2#1)(1996-12#1)(2008-10#1)(2008-11#2)(2009-6#1)
deposition in##12##2##(1991-1#1)(1992-2#1)(1992-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#3)(2009-6#1)(2009-8#1)
deposition is##9##2##(1992-3#1)(1997-1#2)(2008-11#1)(2008-3#1)(2010-4#1)(2012-2#2)(2013-1#1)
deposition mode##2##2##(1994-12#2)
deposition of a##3##3##(2008-10#2)(2008-9#1)
deposition of cadmium##2##3##(2008-10#2)
deposition of copper##2##3##(2008-10#2)
deposition of gold on the##2##5##(2008-10#2)
deposition of hygroscopic##2##3##(1994-12#1)(2013-1#1)
deposition of inhaled##2##3##(1992-3#1)(1994-12#1)
deposition of lignin##2##3##(2008-10#2)
deposition of the##3##3##(2008-10#2)(2008-7#1)
deposition of two layers of##2##5##(2008-10#2)
deposition of##55##2##(1991-12#1)(1992-12#1)(1992-3#2)(1994-12#3)(1995-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#31)(2008-11#2)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
deposition on a##2##3##(2008-10#1)(2012-2#1)
deposition on the mercury##2##4##(2008-10#2)
deposition on the##4##3##(2008-10#3)(2008-11#1)
deposition on##9##2##(2008-10#7)(2008-11#1)(2012-2#1)
deposition patterns##5##2##(1994-2#1)(1996-12#1)(2008-10#3)
deposition potential##2##2##(2008-10#2)
deposition solutions##3##2##(2008-10#3)
deposition studies##2##2##(1997-1#2)
deposition technique##5##2##(2008-10#2)(2008-3#3)
deposition temperature##2##2##(2009-11#2)
deposition than##2##2##(1996-12#1)(2008-11#1)
deposition time##6##2##(2008-10#6)
deposition was##4##2##(1994-9#1)(2008-10#3)
deposition were##5##2##(1993-2#1)(2008-10#3)(2008-11#1)
deposition with##3##2##(2008-11#2)(2010-3#1)
deposition within the##2##3##(1996-2#1)(2008-10#1)
deposition##232##1##(1991-1#1)(1991-10#1)(1991-12#6)(1992-12#1)(1992-2#1)(1992-3#6)(1992-9#1)(1993-2#2)(1993-8#1)(1994-12#7)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-12#7)(1996-2#1)(1996-3#1)(1997-1#6)(1997-8#1)(2006-6#3)(2008-10#93)(2008-11#27)(2008-2#3)(2008-3#9)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#3)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-3#1)(2010-4#3)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#8)(2013-1#4)(2013-8#4)
deposition)##4##1##(2008-10#4)
depositions##4##1##(2013-1#4)
deposits and##2##2##(1992-6#1)(2008-10#1)
deposits in the##2##3##(2012-12#2)
deposits in##5##2##(1992-12#1)(1994-11#1)(2008-6#1)(2012-12#2)
deposits of##4##2##(1994-11#1)(2008-10#2)(2013-7#1)
deposits on the##3##3##(1990-2#1)(2008-10#2)
deposits were##4##2##(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
deposits##41##1##(1990-2#1)(1992-12#1)(1992-6#1)(1994-11#4)(1994-5#1)(1995-3#3)(1996-6#2)(2007-12#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-7#1)(2012-12#2)(2013-1#1)(2013-7#1)
deprenyl##5##1##(2009-12#5)
depress##3##1##(2008-11#1)(2008-9#1)(2013-8#1)
depressed PD patients##2##3##(2008-7#2)
depressed adolescents##7##2##(1993-2#2)(2008-11#5)
depressed and##6##2##(1996-6#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-2#1)
depressed cancer patients##3##3##(2009-11#3)
depressed children and adolescents##2##4##(1991-2#2)
depressed in##3##2##(1994-5#1)(2007-11#1)(2011-1#1)
depressed mood##4##2##(2008-12#3)(2009-11#1)
depressed patients are##2##3##(1995-5#1)(2008-11#1)
depressed patients##8##2##(1995-5#1)(2008-11#1)(2008-7#2)(2010-7#2)(2011-2#1)(2012-3#1)
depressed the##3##2##(1996-2#1)(2008-11#1)(2008-9#1)
depressed##72##1##(1990-12#1)(1991-2#2)(1992-12#1)(1993-2#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#8)(2008-12#8)(2008-4#4)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#1)(2009-11#4)(2009-7#2)(2010-2#2)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
depresses##2##1##(1990-3#1)(2008-8#1)
depression among##3##2##(2008-11#1)(2008-12#1)(2010-4#1)
depression and anxiety##3##3##(2008-11#2)(2008-7#1)
depression and hostility##3##3##(2008-4#3)
depression and should be considered##2##5##(1993-1#1)(2008-11#1)
depression and the##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
depression and##37##2##(1993-1#1)(1993-12#1)(1995-2#1)(1996-11#1)(1996-6#2)(2007-12#1)(2008-11#8)(2008-12#4)(2008-4#4)(2008-7#2)(2008-9#2)(2010-2#1)(2010-4#1)(2010-7#3)(2011-3#2)(2012-2#3)
depression as a##2##3##(2008-8#1)(2011-10#1)
depression but##2##2##(2010-10#1)(2010-2#1)
depression care##3##2##(2012-2#3)
depression for##2##2##(2011-2#1)(2013-8#1)
depression group##4##2##(2010-5#1)(2011-2#3)
depression has##2##2##(2009-12#1)(2010-10#1)
depression in the##2##3##(2008-10#1)(2008-4#1)
depression in##16##2##(1992-12#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
depression is a##2##3##(2008-10#1)(2008-7#1)
depression is associated with increased##2##5##(2008-11#1)(2010-12#1)
depression is##8##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2010-12#1)
depression may##2##2##(2008-4#1)(2010-12#1)
depression model##3##2##(2013-1#2)(2013-8#1)
depression of cardiac contractility induced by##2##6##(2008-9#2)
depression of##9##2##(1992-8#1)(1994-5#1)(1996-3#1)(2008-5#2)(2008-9#2)(2010-6#1)(2013-8#1)
depression or##3##2##(2007-12#1)(2008-12#1)(2010-7#1)
depression over##2##2##(2008-9#1)(2010-1#1)
depression scale##2##2##(2008-7#1)(2010-1#1)
depression scores##4##2##(2008-12#2)(2008-4#1)(2010-7#1)
depression was##4##2##(2008-10#2)(2010-2#1)(2010-7#1)
depression were observed##2##3##(1991-1#1)(2008-8#1)
depression were##4##2##(1991-1#1)(1996-2#1)(2008-12#1)(2008-8#1)
depression with##3##2##(2008-7#2)(2012-2#1)
depression##274##1##(1991-1#2)(1991-10#1)(1991-2#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-7#7)(1997-8#1)(2007-12#5)(2008-10#9)(2008-11#22)(2008-12#16)(2008-4#17)(2008-5#2)(2008-6#7)(2008-7#30)(2008-8#13)(2008-9#8)(2009-11#4)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#8)(2010-10#2)(2010-12#3)(2010-2#9)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#10)(2011-10#2)(2011-2#7)(2011-3#2)(2012-12#3)(2012-2#14)(2012-3#6)(2013-1#11)(2013-8#13)
depression)##2##1##(2008-4#1)(2008-7#1)
depression]##7##1##(1997-3#2)(1997-8#1)(2011-3#2)(2013-1#1)(2013-8#1)
depressions##4##1##(1991-5#1)(2008-10#1)(2008-4#1)(2013-8#1)
depressive disorder##10##2##(2008-4#2)(2009-8#1)(2011-2#5)(2012-3#1)(2013-1#1)
depressive disorders##2##2##(2008-10#1)(2010-5#1)
depressive mood##2##2##(1995-2#1)(2011-2#1)
depressive or##2##2##(1992-2#1)(2010-5#1)
depressive symptomatology##3##2##(2008-7#2)(2013-8#1)
depressive symptoms and##4##3##(2009-7#2)(2010-10#1)(2010-4#1)
depressive symptoms in##3##3##(2008-8#1)(2013-1#1)(2013-8#1)
depressive symptoms##25##2##(2007-12#2)(2008-11#1)(2008-7#2)(2008-8#2)(2009-7#5)(2010-1#2)(2010-10#4)(2010-4#2)(2013-1#4)(2013-8#1)
depressive##61##1##(1991-11#1)(1991-6#1)(1992-1#1)(1992-2#2)(1993-12#1)(1995-12#2)(1995-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#4)(2008-8#2)(2009-7#6)(2009-8#1)(2010-1#2)(2010-10#4)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#3)(2011-2#7)(2012-3#2)(2013-1#6)(2013-8#3)
depressor##2##1##(2008-11#1)(2008-9#1)
deprivation and##5##2##(1994-2#2)(2008-10#1)(2008-11#1)(2013-8#1)
deprivation of##8##2##(1992-12#1)(1992-3#1)(1993-9#1)(1997-2#1)(2008-10#1)(2008-11#2)(2009-6#1)
deprivation resulted in##2##3##(1990-12#1)(1997-2#1)
deprivation##43##1##(1990-12#2)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-9#1)(1994-2#2)(1997-2#4)(2008-10#2)(2008-11#5)(2008-5#2)(2008-7#5)(2008-9#1)(2009-6#1)(2009-9#1)(2010-6#1)(2010-9#3)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
deprived of L-arginine or##2##4##(1990-12#2)
deprived of L-arginine##4##3##(1990-12#4)
deprived of##10##2##(1990-12#6)(1995-12#1)(1997-2#1)(2008-11#1)(2008-4#1)
deprived##12##1##(1990-12#6)(1995-12#1)(1997-2#1)(2008-11#1)(2008-4#1)(2012-2#2)
deprotection and##2##2##(1996-5#1)(2008-4#1)
deprotection##10##1##(1992-12#1)(1996-5#4)(2008-4#4)(2008-8#1)
deproteinized##3##1##(2008-10#3)
deprotonated##5##1##(1992-3#1)(1993-8#1)(2008-10#2)(2008-4#1)
deprotonation of the##4##3##(1990-5#1)(2008-10#3)
deprotonation of##5##2##(1990-5#1)(2008-10#4)
deprotonation##9##1##(1990-5#2)(2008-10#7)
depth and##6##2##(1993-1#1)(1993-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
depth distribution##2##2##(2008-10#1)(2013-8#1)
depth imaging optical coherence tomography##3##5##(2011-7#2)(2013-1#1)
depth in##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
depth information##3##2##(1990-8#1)(2007-11#1)(2008-3#1)
depth of field##2##3##(2008-10#1)(2008-3#1)
depth of insertion##2##3##(2008-10#1)(2008-9#1)
depth of the##9##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#3)(2013-1#1)
depth of wear##3##3##(2008-8#3)
depth of##40##2##(1990-11#1)(1992-8#1)(1993-1#3)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#1)(2008-8#4)(2008-9#1)(2010-8#2)(2011-2#4)(2012-8#1)(2013-1#3)(2013-8#2)
depth profile##4##2##(2008-3#4)
depth profiles of##2##3##(2008-10#2)
depth relief##2##2##(2008-10#2)
depth where##2##2##(2008-10#1)(2008-3#1)
depth##138##1##(1990-11#1)(1990-8#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#4)(1993-12#1)(1995-2#1)(1996-2#4)(2007-11#1)(2007-12#1)(2008-10#36)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#23)(2008-5#4)(2008-7#2)(2008-8#6)(2008-9#3)(2009-11#3)(2009-5#1)(2010-3#1)(2010-8#2)(2011-2#6)(2011-7#2)(2012-3#1)(2012-8#1)(2013-1#7)(2013-8#3)
depth)##2##1##(2008-10#1)(2008-3#1)
depths and##2##2##(2008-10#2)
depths of 0 to 60 cm than##2##7##(2008-10#2)
depths of 0 to##3##4##(2008-10#3)
depths of 60 to 120 cm##2##6##(2008-10#2)
depths of##10##2##(1990-8#1)(1995-6#1)(2008-10#7)(2013-8#1)
depths##25##1##(1990-8#1)(1995-6#1)(2008-10#16)(2008-2#2)(2008-3#1)(2008-8#1)(2012-2#1)(2013-8#2)
depurination of##3##2##(2008-10#3)
depurination##4##1##(2008-10#4)
dequalinium chloride##2##2##(2008-10#2)
dequalinium##3##1##(2008-10#3)
dequeened colony##3##2##(2008-6#3)
deranged##2##1##(1994-11#1)(2013-1#1)
derangement##2##1##(2008-10#1)(2008-6#1)
derangements in##2##2##(2008-11#1)(2011-2#1)
derangements##5##1##(2008-11#1)(2008-6#2)(2011-2#1)(2012-12#1)
deregulated expression of##2##3##(1994-11#1)(2011-2#1)
deregulated##5##1##(1993-2#1)(1994-11#1)(2008-9#1)(2009-3#1)(2011-2#1)
deregulation of##4##2##(2008-8#1)(2009-4#1)(2011-2#2)
deregulation##7##1##(2008-8#2)(2009-4#3)(2011-2#2)
derepression of##2##2##(2011-2#2)
derepression##5##1##(2008-7#1)(2011-1#1)(2011-2#3)
derivates##3##1##(2008-10#1)(2011-1#1)(2011-2#1)
derivation of a##2##3##(1995-9#1)(2008-11#1)
derivation of the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
derivation of##13##2##(1995-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2012-4#1)
derivation##32##1##(1990-9#2)(1992-9#1)(1995-9#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#3)(2009-2#1)(2011-2#3)(2012-4#1)
derivatisation reaction##3##2##(2008-10#3)
derivatisation##13##1##(1990-12#1)(2008-10#12)
derivatised carbon##2##2##(2008-10#2)
derivatised##3##1##(2008-10#3)
derivatising##2##1##(2008-10#2)
derivative (HpD)##2##2##(1990-6#1)(2008-7#1)
derivative and##4##2##(2008-10#3)(2012-3#1)
derivative containing##2##2##(1992-12#1)(2008-10#1)
derivative formed##2##2##(1991-3#1)(2008-11#1)
derivative from##5##2##(1992-6#1)(2008-10#3)(2011-3#1)
derivative has##2##2##(1995-6#1)(2008-10#1)
derivative in##2##2##(2008-10#2)
derivative is##2##2##(1992-4#1)(2008-10#1)
derivative linear##2##2##(2008-10#2)
derivative of heparin##2##3##(1997-1#2)
derivative of the##7##3##(1992-6#1)(2008-10#5)(2008-3#1)
derivative of##29##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-6#2)(1994-5#1)(1995-8#1)(1996-2#1)(1997-1#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
derivative ratio methods##2##3##(2008-10#2)
derivative reduction##2##2##(2008-10#2)
derivative signals##2##2##(2008-10#2)
derivative spectra is##2##3##(2008-10#2)
derivative spectra of##4##3##(2008-10#4)
derivative spectra were##2##3##(2008-10#2)
derivative spectra##13##2##(2008-10#13)
derivative spectral##2##2##(2008-10#2)
derivative spectrophotometric determination of##4##4##(2008-10#4)
derivative spectrophotometric method for##2##4##(2008-10#2)
derivative spectrophotometric method using##2##4##(2008-10#2)
derivative spectrophotometric method##8##3##(2008-10#8)
derivative spectrophotometric##17##2##(2008-10#17)
derivative spectrophotometry has##2##3##(2008-10#2)
derivative spectrophotometry in##3##3##(2008-10#3)
derivative spectrophotometry using##2##3##(2008-10#2)
derivative spectrophotometry##27##2##(2008-10#27)
derivative spectroscopy##3##2##(2008-10#3)
derivative synchronous##2##2##(2008-10#2)
derivative that##4##2##(1993-12#1)(2008-10#2)(2008-3#1)
derivative to the##2##3##(2008-10#2)
derivative to##5##2##(2008-10#4)(2008-3#1)
derivative was then##2##3##(1997-2#1)(2008-10#1)
derivative was##5##2##(1997-2#1)(2008-10#4)
derivative were##2##2##(2008-10#1)(2008-5#1)
derivative which##3##2##(1996-5#1)(2008-10#2)
derivative with##2##2##(2008-10#1)(2008-7#1)
derivative##270##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-12#4)(1992-4#1)(1992-6#5)(1993-12#3)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#4)(1997-1#3)(1997-2#2)(2007-12#1)(2008-10#204)(2008-11#5)(2008-3#5)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
derivative)##2##1##(1993-6#1)(2008-10#1)
derivatives and the##3##3##(1997-2#1)(2008-10#2)
derivatives and##9##2##(1996-5#1)(1997-2#1)(2008-10#5)(2008-5#1)(2011-2#1)
derivatives are##13##2##(1991-12#1)(1993-11#1)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
derivatives as neutral ionophores##3##4##(2008-10#3)
derivatives as##15##2##(1992-12#1)(1993-1#1)(2008-10#8)(2008-11#1)(2011-3#2)(2012-3#1)(2013-1#1)
derivatives by a##2##3##(2008-10#2)
derivatives by high-performance liquid chromatography##2##5##(2008-10#2)
derivatives by##8##2##(2008-10#6)(2008-9#1)(2009-3#1)
derivatives can be##2##3##(2008-10#2)
derivatives can##4##2##(2008-10#3)(2008-11#1)
derivatives for##4##2##(1992-4#1)(2008-10#1)(2008-11#1)(2012-2#1)
derivatives from##5##2##(1992-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
derivatives have been##2##3##(2008-10#1)(2008-11#1)
derivatives in pharmaceutical preparations##2##4##(2008-10#2)
derivatives in pharmaceutical##3##3##(2008-10#3)
derivatives in the presence of##2##5##(2008-10#2)
derivatives in the##3##3##(1992-10#1)(2008-10#2)
derivatives in##25##2##(1992-10#2)(2008-10#20)(2008-11#2)(2011-2#1)
derivatives is##5##2##(1996-5#1)(2008-10#3)(2008-3#1)
derivatives of caffeic acid##2##4##(2013-1#2)
derivatives of quercetin and##2##4##(2008-10#1)(2008-5#1)
derivatives of the three##2##4##(2008-12#1)(2008-9#1)
derivatives of the##8##3##(1993-1#1)(1993-9#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
derivatives of##47##2##(1991-5#2)(1992-12#4)(1993-1#2)(1993-12#1)(1993-9#1)(1994-5#1)(1994-8#2)(1997-3#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
derivatives on the##2##3##(1993-8#1)(2008-10#1)
derivatives on##8##2##(1993-6#1)(1993-8#1)(2008-10#4)(2008-11#1)(2008-5#1)
derivatives such as##3##3##(1990-11#1)(2008-11#1)(2012-3#1)
derivatives to be used##2##4##(1993-12#1)(2008-10#1)
derivatives to##3##2##(1993-12#1)(2008-10#2)
derivatives using##5##2##(2008-10#4)(2009-8#1)
derivatives was##9##2##(1992-10#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-3#2)
derivatives were designed and synthesized##2##5##(2008-10#1)(2011-3#1)
derivatives were determined##2##3##(1997-2#1)(2008-10#1)
derivatives were prepared##3##3##(1992-12#1)(2008-10#1)(2008-9#1)
derivatives were synthesized##3##3##(1993-1#1)(1993-8#1)(2008-5#1)
derivatives were##26##2##(1992-12#1)(1992-8#1)(1993-1#1)(1993-8#2)(1994-5#1)(1997-2#1)(2008-10#9)(2008-11#4)(2008-5#2)(2008-9#1)(2010-1#1)(2011-3#1)(2013-1#1)
derivatives with the##2##3##(1995-11#2)
derivatives with##10##2##(1993-11#1)(1994-5#1)(1995-11#2)(2008-10#2)(2008-11#2)(2008-7#1)(2011-3#1)
derivatives##354##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-6#2)(1992-10#3)(1992-12#12)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#4)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#8)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#6)(1994-8#2)(1995-11#3)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#7)(1997-2#4)(1997-3#3)(2006-6#1)(2008-10#163)(2008-11#36)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#15)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#8)(2009-3#3)(2009-8#4)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#7)(2011-3#5)(2012-2#4)(2012-3#5)(2013-1#6)
derivatives]##3##1##(1993-11#1)(2011-3#2)
derivatization after reduction of##2##4##(2008-10#2)
derivatization and##6##2##(2008-10#5)(2008-5#1)
derivatization by##4##2##(2008-10#4)
derivatization conditions##2##2##(2008-10#2)
derivatization has been##2##3##(2008-10#2)
derivatization is##2##2##(2008-10#2)
derivatization method##4##2##(2008-10#4)
derivatization methods##3##2##(2008-10#3)
derivatization of the##3##3##(2008-10#3)
derivatization of##16##2##(2008-10#16)
derivatization procedure##4##2##(2008-10#4)
derivatization procedures##3##2##(2008-10#3)
derivatization processes##2##2##(2008-10#2)
derivatization reaction##7##2##(2008-10#7)
derivatization reactions##2##2##(2008-10#2)
derivatization reagent##7##2##(2008-10#7)
derivatization reagents for##2##3##(2008-10#1)(2008-11#1)
derivatization reagents##4##2##(2008-10#3)(2008-11#1)
derivatization was##2##2##(2008-10#2)
derivatization with (S)-(-)-alpha-methylbenzyl isocyanate##2##4##(2008-11#2)
derivatization with thiols##2##3##(2008-11#2)
derivatization with##18##2##(1991-12#2)(1993-2#1)(2008-10#9)(2008-11#5)(2008-5#1)
derivatization##130##1##(1991-12#2)(1993-2#1)(1994-5#1)(2008-10#118)(2008-11#6)(2008-5#2)
derivatized denatured proteins##2##3##(2008-10#2)
derivatized with##10##2##(1990-2#1)(1997-2#1)(2008-10#7)(2008-11#1)
derivatized##24##1##(1990-2#1)(1990-5#1)(1992-6#1)(1997-2#1)(2008-10#17)(2008-11#1)(2008-7#1)(2011-3#1)
derivatizing agent##3##2##(2008-10#3)
derivatizing reagent##6##2##(2008-10#6)
derivatizing##10##1##(2008-10#10)
derive a simple##2##3##(2008-10#1)(2008-8#1)
derive a##12##2##(2007-12#2)(2008-10#4)(2008-8#3)(2008-9#1)(2011-2#1)(2011-3#1)
derive and##2##2##(2008-2#2)
derive from##7##2##(1993-12#1)(1993-2#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2013-8#1)
derive general##2##2##(2008-5#1)(2008-9#1)
derive the##12##2##(1992-9#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#2)(2012-2#1)(2013-8#2)
derive##65##1##(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1997-3#2)(2007-12#4)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-8#10)(2008-9#4)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#4)
derived a##3##2##(1995-8#1)(1997-8#1)(2008-10#1)
derived alleles##2##2##(2012-3#2)
derived and##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2010-7#1)
derived by use of##3##4##(2008-3#3)
derived by##15##2##(1991-5#1)(1997-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
derived cell##2##2##(2008-11#1)(2013-1#1)
derived cells##4##2##(1997-8#1)(2008-11#1)(2008-9#1)(2011-1#1)
derived compounds##2##2##(2008-10#1)(2008-11#1)
derived deletions is##2##3##(1997-3#2)
derived deletions##7##2##(1997-3#7)
derived factors##2##2##(1993-6#1)(2013-7#1)
derived for the##5##3##(2008-10#2)(2008-3#1)(2013-8#2)
derived for these##2##3##(2008-11#1)(2008-9#1)
derived for##12##2##(1994-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-9#1)(2013-8#2)
derived from 1##2##3##(1996-8#1)(2008-10#1)
derived from 5##2##3##(2008-5#1)(2008-9#1)
derived from BALB/c##2##3##(2008-11#1)(2008-8#1)
derived from Chinese##3##3##(2008-5#2)(2008-7#1)
derived from FRET##2##3##(2008-10#2)
derived from Langmuir isotherm##2##4##(2008-10#2)
derived from R##2##3##(1995-12#2)
derived from a common##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
derived from a cross between a##2##6##(2008-10#2)
derived from a cross between the##2##6##(2008-10#2)
derived from a cross between##7##5##(2008-10#7)
derived from a cross of##2##5##(2008-10#2)
derived from a cross##10##4##(2008-10#10)
derived from a novel##3##4##(1990-8#1)(1996-5#1)(2008-4#1)
derived from a single##3##4##(1996-2#1)(2008-10#1)(2008-8#1)
derived from a subgroup##2##4##(2008-10#2)
derived from a##41##3##(1990-8#1)(1993-6#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#22)(2008-11#3)(2008-4#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)
derived from all##3##3##(2008-10#3)
derived from an adult##2##4##(2008-9#2)
derived from an##7##3##(1993-8#1)(2008-3#1)(2008-9#3)(2009-8#1)(2013-8#1)
derived from bacterial##2##3##(2008-10#1)(2010-7#1)
derived from both##3##3##(1990-8#1)(2008-10#1)(2012-3#1)
derived from cDNA clones##2##4##(2008-10#2)
derived from cDNA##3##3##(1995-2#1)(2008-10#2)
derived from contaminating##2##3##(2008-10#1)(2011-2#1)
derived from crosses between the resistant##2##6##(2008-10#2)
derived from crosses between##4##4##(2008-10#4)
derived from crosses##5##3##(2008-10#5)
derived from crossing##2##3##(2008-10#2)
derived from different##4##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
derived from each##2##3##(2008-10#2)
derived from either##2##3##(2008-10#2)
derived from existing##2##3##(2008-3#1)(2009-10#1)
derived from fertilized##2##3##(2008-10#1)(2008-11#1)
derived from individual##2##3##(1995-12#1)(2010-7#1)
derived from its##2##3##(2008-10#1)(2008-12#1)
derived from mouse##2##3##(2008-11#1)(2010-3#1)
derived from natural##3##3##(2008-11#1)(2008-5#2)
derived from neural##2##3##(1997-4#1)(2011-2#1)
derived from one##2##3##(2008-10#1)(2011-2#1)
derived from parent##3##3##(2008-10#3)
derived from patients##2##3##(2008-10#2)
derived from plants##3##3##(2008-10#1)(2008-11#2)
derived from rat##3##3##(1994-8#1)(2008-11#2)
derived from small-scale##2##3##(2008-12#1)(2010-10#1)
derived from specific##2##3##(2008-11#1)(2008-2#1)
derived from strain AT##2##4##(2008-10#2)
derived from strain##4##3##(2008-10#4)
derived from structural##2##3##(2010-2#1)(2010-7#1)
derived from studies##2##3##(2009-11#1)(2009-8#1)
derived from the cross between##5##5##(2008-10#4)(2012-3#1)
derived from the cross##13##4##(2008-10#12)(2012-3#1)
derived from the same##4##4##(2008-10#2)(2009-1#1)(2012-2#1)
derived from the##103##3##(1990-12#1)(1990-5#4)(1991-10#2)(1991-12#1)(1991-5#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-6#1)(1997-2#3)(1997-8#1)(2008-10#40)(2008-11#8)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-8#2)
derived from these##6##3##(1995-2#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-4#1)
derived from this region of##2##5##(1995-6#1)(2008-10#1)
derived from this region##3##4##(1993-3#1)(1995-6#1)(2008-10#1)
derived from this##4##3##(1993-3#1)(1994-11#1)(1995-6#1)(2008-10#1)
derived from three##3##3##(2008-10#2)(2010-3#1)
derived from two##5##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
derived from various##3##3##(1993-8#1)(2008-9#1)(2010-10#1)
derived from wild-type##2##3##(2008-10#2)
derived from##496##2##(1990-12#1)(1990-5#6)(1990-7#1)(1990-8#3)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#2)(1994-11#9)(1994-12#2)(1994-3#3)(1994-5#3)(1994-8#2)(1995-1#1)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#175)(2008-11#58)(2008-12#7)(2008-2#4)(2008-3#8)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#16)(2008-9#13)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#3)(2009-6#4)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-7#5)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#3)(2012-2#5)(2012-3#13)(2012-4#1)(2013-1#7)(2013-8#4)
derived growth##2##2##(2008-9#1)(2013-1#1)
derived in the##3##3##(2008-10#1)(2008-11#2)
derived in##6##2##(2008-10#1)(2008-11#3)(2008-3#2)
derived neurotrophic factor##2##3##(2009-8#1)(2013-1#1)
derived on the basis of##2##5##(1995-9#1)(1996-3#1)
derived peptide##2##2##(2008-10#1)(2008-5#1)
derived that##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
derived the##2##2##(2008-3#1)(2012-2#1)
derived through##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
derived to##7##2##(2008-10#3)(2008-3#3)(2013-1#1)
derived treatment##2##2##(2008-6#2)
derived with##2##2##(2008-10#2)
derived##721##1##(1990-11#1)(1990-12#2)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#5)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#2)(1992-9#2)(1993-1#2)(1993-12#5)(1993-2#1)(1993-3#5)(1993-6#5)(1993-8#3)(1994-11#9)(1994-12#4)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#4)(1995-3#2)(1995-5#5)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#6)(1997-3#10)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#3)(1997-9#1)(2007-11#2)(2007-12#7)(2008-1#2)(2008-10#231)(2008-11#79)(2008-12#8)(2008-2#9)(2008-3#36)(2008-4#8)(2008-5#15)(2008-6#4)(2008-7#11)(2008-8#22)(2008-9#17)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#1)(2009-6#5)(2009-7#1)(2009-8#6)(2010-1#2)(2010-10#4)(2010-11#4)(2010-2#1)(2010-3#3)(2010-4#5)(2010-6#1)(2010-7#7)(2010-8#4)(2011-1#3)(2011-2#9)(2011-3#5)(2012-2#9)(2012-3#20)(2012-4#1)(2013-1#15)(2013-7#1)(2013-8#8)
derivedfrom##2##1##(2008-11#2)
derives from a##2##3##(1991-5#1)(2013-8#1)
derives from##3##2##(1991-5#1)(2010-10#1)(2013-8#1)
derives its##2##2##(2008-10#1)(2008-3#1)
derives##10##1##(1991-5#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-8#1)(2010-10#1)(2013-8#1)
deriving from the##3##3##(2008-10#3)
deriving from##6##2##(2008-10#5)(2012-3#1)
deriving##11##1##(2008-10#7)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
dermal and skin##2##3##(2008-5#2)
dermal and##6##2##(2008-5#4)(2008-9#1)(2013-8#1)
dermal application for 26 weeks##2##5##(2008-9#2)
dermal application for 26##3##4##(2008-9#3)
dermal equivalent model##2##3##(2008-5#2)
dermal equivalent##3##2##(2008-5#3)
dermal exposure##2##2##(2008-10#1)(2008-5#1)
dermal fibroblasts##3##2##(1990-5#2)(2008-5#1)
dermal plates##2##2##(2008-7#2)
dermal studies##2##2##(2008-9#2)
dermal##47##1##(1990-5#2)(1990-6#1)(1992-12#1)(1993-3#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-5#17)(2008-7#3)(2008-9#10)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
dermally##5##1##(2008-9#5)
dermaseptin b and##3##3##(1994-5#3)
dermaseptin b##6##2##(1994-5#6)
dermaseptin##7##1##(1994-5#7)
dermaseptins##2##1##(1993-3#2)
dermatan sulfate proteoglycan-II##2##3##(1992-10#2)
dermatan sulfate##3##2##(1992-10#2)(1992-12#1)
dermatitidis was##2##2##(2008-5#1)(2013-8#1)
dermatitidis##4##1##(2008-5#3)(2013-8#1)
dermatitis and##4##2##(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
dermatitis in##3##2##(1996-6#1)(2013-1#2)
dermatitis of##2##2##(1991-2#1)(2008-5#1)
dermatitis seborrhoeica##5##2##(2008-5#5)
dermatitis##39##1##(1991-2#5)(1991-3#1)(1996-6#2)(1997-2#1)(2008-11#1)(2008-5#18)(2011-2#3)(2012-3#3)(2013-1#5)
dermatologic##4##1##(2010-6#1)(2011-2#3)
dermatological##8##1##(1992-6#1)(2008-5#4)(2008-8#3)
dermatologist##2##1##(1991-6#1)(2008-5#1)
dermatologists##5##1##(1997-8#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)
dermatology and##2##2##(1991-6#1)(2008-5#1)
dermatology##3##1##(1991-6#1)(2008-5#1)(2012-3#1)
dermatome##2##1##(1994-12#2)
dermatomyositis##4##1##(1995-5#1)(2009-6#1)(2011-2#2)
dermatophyte##4##1##(2008-5#4)
dermatophytes##4##1##(2008-5#3)(2012-3#1)
dermatophytosis##3##1##(2008-5#3)
dermatoses##7##1##(2008-5#1)(2011-2#5)(2013-1#1)
dermis and epidermis##2##3##(1996-12#1)(2008-5#1)
dermis and##5##2##(1996-12#1)(2008-5#3)(2010-6#1)
dermis is##2##2##(1994-12#1)(2008-9#1)
dermis or##2##2##(2008-5#1)(2010-6#1)
dermis##34##1##(1994-12#1)(1996-12#7)(2008-11#1)(2008-12#1)(2008-5#11)(2008-9#4)(2010-6#7)(2012-2#1)(2012-3#1)
dermoid cysts of##2##3##(2011-2#1)(2013-8#1)
dermoid##4##1##(2011-2#3)(2013-8#1)
dermopathy##2##1##(2008-1#1)(2011-2#1)
des complications##2##2##(2013-1#2)
des crises convulsives##2##3##(2013-1#2)
des enfants##2##2##(2008-11#2)
des malformations##2##2##(2011-2#2)
des##39##1##(1996-11#1)(2008-10#3)(2008-11#7)(2008-5#1)(2009-10#2)(2011-2#7)(2013-1#18)
desacetyl-alpha-MSH##5##1##(2008-6#5)
desaturase gene##3##2##(1996-6#2)(2010-4#1)
desaturase##12##1##(1991-12#3)(1995-2#1)(1996-6#4)(2010-10#2)(2010-4#1)(2013-1#1)
desaturation##6##1##(1991-12#1)(1993-1#5)
descend##2##1##(2008-10#1)(2013-1#1)
descendants and##2##2##(2007-12#2)
descendants##6##1##(1995-6#1)(2007-12#3)(2008-10#2)
descending aorta##6##2##(1997-8#1)(2008-11#1)(2012-2#2)(2012-3#2)
descending colon##2##2##(2008-11#1)(2011-2#1)
descending mediastinitis##3##2##(2013-1#3)
descending necrotizing mediastinitis##2##3##(2008-12#2)
descending thoracic aorta and##2##4##(1997-8#1)(2013-3#1)
descending thoracic aorta##3##3##(1997-8#2)(2013-3#1)
descending thoracic##7##2##(1997-8#3)(2008-10#1)(2013-3#3)
descending##29##1##(1997-8#4)(2008-10#2)(2008-11#5)(2008-12#2)(2008-7#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-3#3)
descent and##2##2##(2008-5#1)(2013-1#1)
descent from a cross between##2##5##(2008-10#2)
descent##15##1##(1997-7#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
describe a case of a##6##5##(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
describe a case of primary##3##5##(1990-2#1)(1991-6#1)(1992-9#1)
describe a case of##22##4##(1990-2#1)(1991-6#2)(1992-9#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
describe a case##23##3##(1990-2#1)(1991-6#2)(1992-9#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
describe a hypothetical##2##3##(2009-10#1)(2012-2#1)
describe a method for##3##4##(1991-11#1)(1993-8#1)(2011-2#1)
describe a method of##2##4##(2008-12#1)(2011-7#1)
describe a method##10##3##(1990-12#1)(1991-11#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-3#3)(2011-2#1)(2011-7#1)
describe a minimally invasive##2##4##(2011-2#1)(2012-2#1)
describe a new##7##3##(1990-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
describe a novel##7##3##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-12#1)(2010-11#1)
describe a patient with a##2##5##(2008-7#1)(2012-3#1)
describe a patient with##5##4##(1990-9#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
describe a patient##6##3##(1990-9#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
describe a simple##5##3##(1990-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)
describe a technique##2##3##(1992-12#1)(2013-1#1)
describe a##127##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#2)(1991-11#1)(1991-3#1)(1991-6#2)(1992-12#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#2)(1997-2#2)(1997-3#1)(2007-11#1)(2008-10#8)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#6)(2013-8#3)
describe an automated##2##3##(2008-10#2)
describe an##21##2##(1991-6#1)(1994-9#1)(1995-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2009-5#1)(2010-3#1)(2011-2#4)(2012-3#2)(2013-1#1)
describe and compare the##2##4##(2008-10#1)(2011-2#1)
describe and##6##2##(1992-12#2)(2008-10#2)(2008-11#1)(2011-2#1)
describe current##2##2##(2008-1#1)(2010-7#1)
describe design##2##2##(2008-10#1)(2008-2#1)
describe diseases##2##2##(2008-10#1)(2013-1#1)
describe for the first time##2##5##(2008-10#1)(2012-2#1)
describe gene delivery to normal##2##5##(2008-4#2)
describe how the##5##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-9#2)
describe how to##7##3##(2008-10#1)(2008-4#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
describe how##24##2##(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#2)(2008-9#3)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
describe in##5##2##(1995-1#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
describe its##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
describe methods for##2##3##(2008-4#1)(2008-9#1)
describe methods##3##2##(2008-4#1)(2008-9#2)
describe one such##2##3##(2008-11#1)(2008-8#1)
describe our##8##2##(1997-3#1)(1997-9#1)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)
describe results from##2##3##(1997-3#1)(2012-3#1)
describe several##2##2##(2008-3#1)(2011-2#1)
describe some of the##3##4##(2008-3#1)(2008-5#1)(2010-7#1)
describe some of##4##3##(1991-3#1)(2008-3#1)(2008-5#1)(2010-7#1)
describe some##6##2##(1991-3#1)(2008-3#2)(2008-5#1)(2010-7#1)(2013-8#1)
describe that##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
describe the CT##2##3##(2012-12#1)(2012-2#1)
describe the analysis##2##3##(1993-2#1)(2008-9#1)
describe the application of##5##4##(2008-10#1)(2012-3#1)(2013-1#3)
describe the approaches##2##3##(1997-2#1)(2013-1#1)
describe the basic features of##3##5##(2008-3#1)(2011-2#2)
describe the basic##4##3##(2008-3#1)(2011-2#3)
describe the benefits##2##3##(2011-2#1)(2012-2#1)
describe the case of a##3##5##(1990-8#1)(1993-6#1)(2010-1#1)
describe the case of an##3##5##(1994-9#1)(2008-7#1)(2011-2#1)
describe the case of##7##4##(1990-8#1)(1993-6#1)(1994-9#1)(2008-7#1)(2010-1#1)(2011-2#2)
describe the case##8##3##(1990-8#1)(1991-8#1)(1993-6#1)(1994-9#1)(2008-7#1)(2010-1#1)(2011-2#2)
describe the characteristics of##2##4##(2008-9#1)(2013-1#1)
describe the clinical##8##3##(1991-8#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
describe the construction of a##4##5##(1990-8#1)(2008-11#1)(2008-9#1)(2012-3#1)
describe the construction of##5##4##(1990-8#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-3#1)
describe the design##3##3##(2008-10#2)(2008-4#1)
describe the development of the##2##5##(1996-11#1)(1996-2#1)
describe the development of##4##4##(1996-11#1)(1996-12#1)(1996-2#1)(2008-2#1)
describe the development##5##3##(1996-11#1)(1996-12#1)(1996-2#1)(2008-2#1)(2008-3#1)
describe the existence of##2##4##(1993-12#1)(2008-10#1)
describe the first##4##3##(1996-8#1)(2008-5#1)(2008-9#1)(2011-1#1)
describe the genetic##2##3##(2012-3#1)(2013-8#1)
describe the implementation##3##3##(2008-10#1)(2013-1#2)
describe the importance of##2##4##(1993-2#1)(2009-6#1)
describe the in vitro##2##4##(2008-11#2)
describe the in##3##3##(2008-11#2)(2012-12#1)
describe the main##5##3##(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#2)
describe the organization##2##3##(2008-11#1)(2013-8#1)
describe the process of##2##4##(2008-3#1)(2013-1#1)
describe the process##3##3##(1994-3#1)(2008-3#1)(2013-1#1)
describe the results of##5##4##(2008-2#1)(2008-6#1)(2008-8#2)(2013-8#1)
describe the role of##2##4##(1992-1#1)(2013-1#1)
describe the screening##2##3##(2008-10#1)(2012-3#1)
describe the severity of the##2##5##(1997-2#2)
describe the steps##2##3##(1993-1#1)(2011-2#1)
describe the structure of##2##4##(2008-12#1)(2008-3#1)
describe the structure##3##3##(1994-1#1)(2008-12#1)(2008-3#1)
describe the synthesis of##2##4##(2008-4#1)(2009-10#1)
describe the type of##2##4##(2008-10#1)(2011-2#1)
describe the type##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
describe the unique##2##3##(2012-2#1)(2013-8#1)
describe the use of##5##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
describe the##262##2##(1990-11#1)(1990-5#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-7#1)(2007-12#1)(2008-10#30)(2008-11#20)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#10)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#34)(2011-3#1)(2012-12#6)(2012-2#9)(2012-3#8)(2012-4#1)(2013-1#20)(2013-8#6)
describe their##9##2##(1993-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-5#1)(2012-2#1)
describe these##3##2##(2009-12#1)(2009-6#1)(2010-10#1)
describe this##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
describe two cases##3##3##(1993-6#1)(2011-2#1)(2013-1#1)
describe two##11##2##(1991-11#1)(1993-6#1)(1996-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
describe various##2##2##(1997-2#1)(2008-7#1)
describe##626##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#3)(1991-8#2)(1992-1#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#7)(1993-1#4)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#2)(1993-6#5)(1993-8#2)(1994-1#3)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#6)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#7)(1997-3#5)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#74)(2008-11#43)(2008-12#10)(2008-2#10)(2008-3#34)(2008-4#19)(2008-5#8)(2008-6#7)(2008-7#21)(2008-8#7)(2008-9#24)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#12)(2010-8#3)(2010-9#3)(2011-1#3)(2011-2#56)(2011-3#3)(2011-7#2)(2012-12#10)(2012-2#25)(2012-3#17)(2012-4#1)(2013-1#39)(2013-8#11)
described PCR assay##2##3##(2008-10#2)
described PCR##3##2##(2008-10#3)
described a##6##2##(1991-2#1)(1991-8#1)(1992-8#1)(2008-10#2)(2013-1#1)
described about##2##2##(2008-10#1)(2008-5#1)
described above##6##2##(1995-12#1)(1996-1#1)(1996-2#2)(2008-7#1)(2011-2#1)
described according to##2##3##(1995-3#1)(2009-1#1)
described along with##4##3##(2008-4#2)(2008-9#1)(2009-12#1)
described an##5##2##(1990-8#1)(1994-5#1)(2008-11#2)(2011-2#1)
described and discussed in##2##4##(2008-10#1)(2008-11#1)
described and discussed##6##3##(1990-9#1)(1995-11#1)(2008-10#3)(2008-11#1)
described and evaluated##3##3##(2008-10#3)
described and illustrated##4##3##(2007-12#1)(2008-10#2)(2011-7#1)
described and the##7##3##(1990-9#1)(1994-2#1)(1995-9#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-4#1)
described and their##4##3##(2007-12#1)(2008-10#2)(2010-12#1)
described and used for##2##4##(2008-10#2)
described and used##3##3##(1996-2#1)(2008-10#2)
described and##48##2##(1990-12#1)(1990-9#3)(1991-3#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-8#1)(2007-12#2)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#1)(2011-7#1)(2013-1#1)
described are##2##2##(2008-4#1)(2008-9#1)
described as &quot##3##3##(2008-10#1)(2009-9#1)(2012-12#1)
described as a new##2##4##(2008-10#1)(2011-1#1)
described as a##19##3##(1991-3#1)(1991-5#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)
described as an##2##3##(2008-4#1)(2009-8#1)
described as the##2##3##(1996-12#1)(2010-9#1)
described as well##5##3##(2008-10#4)(2008-3#1)
described as##49##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#2)
described based on the adsorption of the##2##7##(2008-10#2)
described based on the use of##2##6##(2008-10#2)
described based on the##6##4##(2008-10#6)
described based on##8##3##(2008-10#8)
described based##9##2##(1997-8#1)(2008-10#8)
described before##3##2##(2008-10#2)(2008-11#1)
described by A##2##3##(1993-11#1)(2012-3#1)
described by a Langmuir##2##4##(2008-10#2)
described by a##19##3##(1994-5#1)(1995-8#1)(1996-2#1)(2008-10#11)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)
described by our##2##3##(2008-11#1)(2010-12#1)
described by the Gompertz model##2##5##(2008-10#2)
described by the##22##3##(1990-5#1)(1991-5#1)(1992-2#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
described by using##3##3##(2008-10#3)
described by##86##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-2#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#31)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
described can be applied##2##4##(2008-9#2)
described can be##3##3##(2008-5#1)(2008-9#2)
described case##2##2##(1990-9#1)(2008-10#1)
described could##2##2##(2008-10#1)(2008-5#1)
described earlier##4##2##(1995-2#1)(2008-11#1)(2008-3#1)(2008-7#1)
described elsewhere##5##2##(1995-2#1)(2008-10#1)(2008-4#3)
described for determination of##3##4##(2008-10#3)
described for other##3##3##(2007-12#1)(2008-5#1)(2013-8#1)
described for rat##2##3##(2008-11#2)
described for the analysis of##3##5##(2008-10#3)
described for the determination of fluoride##2##6##(2008-10#2)
described for the determination of##51##5##(2008-10#51)
described for the direct##5##4##(2008-10#5)
described for the first time in##3##6##(2008-10#1)(2010-1#1)(2011-2#1)
described for the first time##8##5##(2008-10#6)(2010-1#1)(2011-2#1)
described for the rapid##2##4##(2008-10#2)
described for the simultaneous##4##4##(2008-10#4)
described for the##101##3##(1990-5#1)(1994-11#1)(1994-9#1)(2007-12#1)(2008-10#91)(2008-2#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#1)
described for this##4##3##(2007-12#1)(2008-10#2)(2013-1#1)
described for##162##2##(1990-12#1)(1990-5#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(2007-12#4)(2008-1#1)(2008-10#109)(2008-11#5)(2008-2#1)(2008-4#10)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#1)(2010-1#1)(2010-4#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-8#1)
described from the##3##3##(1990-3#1)(2008-5#1)(2011-2#1)
described from##4##2##(1990-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
described here also##2##3##(2008-11#1)(2008-4#1)
described here as##2##3##(2008-10#1)(2010-3#1)
described here is##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
described here##44##2##(1991-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-3#1)(1997-3#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-4#8)(2008-5#2)(2008-9#1)(2009-4#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
described herein##11##2##(1994-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-4#2)(2011-1#1)
described how the##2##3##(1995-12#1)(2009-12#1)
described how##3##2##(1995-12#1)(2008-12#1)(2009-12#1)
described in Japan##3##3##(2008-10#2)(2010-10#1)
described in a##11##3##(1990-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2010-10#1)(2011-2#1)
described in any##2##3##(1995-6#1)(1995-8#1)
described in association with##2##4##(1997-8#1)(2008-7#1)
described in detail in##2##4##(2008-10#1)(2011-2#1)
described in detail##10##3##(1994-12#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
described in literature##3##3##(1992-9#1)(1996-3#1)(2008-10#1)
described in other##5##3##(1990-5#1)(2008-10#1)(2008-7#2)(2011-2#1)
described in patients##2##3##(2010-12#1)(2012-3#1)
described in the literature##14##4##(1992-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
described in the present##2##4##(2008-10#1)(2008-11#1)
described in the##39##3##(1992-12#1)(1994-5#1)(1995-3#1)(1997-3#1)(1997-6#1)(2008-10#12)(2008-11#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#1)
described in this article##7##4##(1991-12#1)(1991-2#1)(1992-1#1)(1996-2#2)(1997-3#1)(2011-2#1)
described in this paper are##2##5##(1992-9#1)(1997-2#1)
described in this paper##15##4##(1990-2#1)(1992-9#1)(1996-12#1)(1997-2#2)(2008-10#7)(2008-11#1)(2008-12#1)(2013-7#1)
described in this report##3##4##(1995-2#1)(2008-11#1)(2011-2#1)
described in this study##4##4##(2008-10#2)(2011-2#2)
described in this unit is##3##5##(2008-4#3)
described in this unit##22##4##(2008-2#1)(2008-4#18)(2008-9#3)
described in this work##2##4##(2008-10#2)
described in this##58##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-9#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#19)(2008-9#3)(2011-2#4)(2013-1#1)(2013-7#1)
described in which##3##3##(1994-5#1)(2008-10#2)
described in##191##2##(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-9#2)(1994-12#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#3)(2008-10#49)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#28)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#2)
described is##7##2##(1990-2#1)(2008-10#4)(2008-11#2)
described method##5##2##(1990-9#1)(2008-10#2)(2009-8#1)(2013-8#1)
described of##4##2##(1991-3#1)(1992-12#2)(2009-10#1)
described on the##2##3##(1995-8#1)(2008-10#1)
described on##4##2##(1992-10#1)(1995-8#1)(2008-10#1)(2012-2#1)
described only in##2##3##(1990-9#1)(2008-10#1)
described previously##5##2##(1994-11#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-12#1)
described procedures##2##2##(2008-10#2)
described so far in the##3##5##(2008-10#1)(2008-5#1)(2013-1#1)
described so far##6##3##(1991-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
described species##4##2##(2008-10#3)(2010-10#1)
described specific##2##2##(1996-1#1)(2010-9#1)
described technique##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
described that##15##2##(1994-5#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2010-6#1)(2012-2#1)(2013-1#1)
described the association##2##3##(2008-7#1)(2013-1#1)
described the disease##3##3##(2008-10#3)
described the##28##2##(1990-3#1)(1991-3#1)(1994-5#1)(1995-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)
described their##3##2##(2008-9#1)(2010-1#1)(2012-12#1)
described to be##4##3##(1993-6#1)(1997-7#1)(2010-5#1)(2013-8#1)
described to##14##2##(1993-6#1)(1994-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-11#1)(2010-5#1)(2010-8#2)(2013-8#2)
described two##2##2##(1993-3#1)(2011-2#1)
described using a##2##3##(2008-10#2)
described using##4##2##(2008-10#3)(2012-12#1)
described well by##3##3##(1991-3#1)(2008-10#2)
described which##11##2##(1990-2#1)(1991-2#1)(1992-9#1)(1993-2#1)(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
described with the##3##3##(2008-3#1)(2013-1#2)
described with##13##2##(1991-6#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#2)
described within the##2##3##(2008-1#1)(2008-11#1)
described within##3##2##(2008-1#1)(2008-11#1)(2009-3#1)
described##1532##1##(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#3)(1990-5#7)(1990-6#2)(1990-8#2)(1990-9#7)(1991-1#1)(1991-12#3)(1991-2#6)(1991-3#8)(1991-5#5)(1991-6#5)(1991-7#1)(1991-8#2)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#9)(1992-2#5)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#6)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#8)(1994-3#4)(1994-5#8)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#16)(1995-2#6)(1995-3#5)(1995-6#7)(1995-8#3)(1995-9#4)(1996-1#6)(1996-11#3)(1996-12#2)(1996-2#9)(1996-3#6)(1996-5#6)(1996-6#4)(1996-8#1)(1997-1#4)(1997-2#6)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#8)(2007-11#1)(2007-12#8)(2008-1#5)(2008-10#692)(2008-11#77)(2008-12#29)(2008-2#13)(2008-3#39)(2008-4#86)(2008-5#22)(2008-6#5)(2008-7#27)(2008-8#10)(2008-9#27)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#7)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#5)(2010-10#7)(2010-11#8)(2010-12#6)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#10)(2011-10#2)(2011-2#48)(2011-3#5)(2011-7#3)(2012-12#5)(2012-2#13)(2012-3#15)(2012-4#1)(2013-1#27)(2013-7#2)(2013-8#13)
describes a case of##6##4##(1990-9#1)(1994-12#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
describes a case##8##3##(1990-9#1)(1994-12#1)(2008-10#1)(2008-11#2)(2012-3#1)(2013-1#2)
describes a fast and sensitive##2##5##(2008-10#1)(2008-9#1)
describes a fast and##3##4##(2008-10#2)(2008-9#1)
describes a method for the##4##5##(2008-10#2)(2008-11#1)(2008-9#1)
describes a method for##11##4##(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#5)
describes a method##13##3##(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-9#6)
describes a model##2##3##(1997-1#1)(2008-9#1)
describes a new##4##3##(2008-10#4)
describes a newly developed##4##4##(2008-10#4)
describes a novel##5##3##(2008-10#1)(2008-11#3)(2009-7#1)
describes a pregnant patient##2##4##(2009-6#1)(2013-1#1)
describes a procedure for##2##4##(2008-10#1)(2008-9#1)
describes a procedure##5##3##(2008-10#4)(2008-9#1)
describes a set of##2##4##(2008-1#1)(2008-9#1)
describes a simple and##3##4##(2008-10#2)(2008-9#1)
describes a##120##2##(1990-12#1)(1990-9#2)(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-2#2)(1996-3#1)(1997-1#2)(1997-2#2)(2008-1#2)(2008-10#30)(2008-11#11)(2008-12#3)(2008-4#9)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#18)(2009-6#3)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#9)
describes an analytical method for the determination of##2##8##(2008-10#2)
describes an analytical method for##3##5##(2008-10#3)
describes an analytical##4##3##(2008-10#4)
describes an evaluation##2##3##(2008-11#2)
describes an in##2##3##(1991-12#1)(2008-1#1)
describes an innovative##3##3##(2008-11#1)(2008-12#2)
describes an##28##2##(1990-11#1)(1991-12#1)(1992-2#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-4#3)(2008-5#1)(2008-9#2)(2013-1#3)
describes considerations##2##2##(2008-4#1)(2010-7#1)
describes development##2##2##(2008-10#2)
describes different##2##2##(2008-4#1)(2013-1#1)
describes experimental##2##2##(2008-10#1)(2008-4#1)
describes for the first time##2##5##(2008-10#1)(2008-6#1)
describes how a##2##3##(2008-12#1)(2010-10#1)
describes how an##2##3##(1997-2#1)(2008-11#1)
describes how it##2##3##(1996-1#1)(2008-11#1)
describes how the##4##3##(1991-2#1)(1997-2#1)(2008-4#1)(2009-8#1)
describes how to##5##3##(1991-12#1)(2008-4#4)
describes how##23##2##(1991-12#1)(1991-2#1)(1992-2#1)(1994-1#1)(1996-1#1)(1997-2#2)(2008-11#5)(2008-12#2)(2008-4#6)(2009-12#1)(2009-8#1)(2010-10#1)
describes immunocytochemical##2##2##(2007-12#1)(2008-9#1)
describes in detail the##4##4##(1996-6#1)(1997-3#1)(2008-4#1)(2008-9#1)
describes in detail##5##3##(1996-6#1)(1997-3#1)(2008-4#1)(2008-9#2)
describes in##8##2##(1994-3#1)(1996-6#1)(1997-3#1)(2008-4#1)(2008-9#2)(2009-7#1)(2013-1#1)
describes its##4##2##(1992-1#1)(1995-3#1)(2008-6#1)(2013-1#1)
describes one##7##2##(1992-12#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-12#2)(2008-9#1)
describes procedures##6##2##(2008-11#1)(2008-4#2)(2008-9#3)
describes recent##5##2##(2008-10#4)(2011-2#1)
describes several##4##2##(1997-3#1)(2008-4#2)(2008-9#1)
describes simple##2##2##(2008-4#1)(2008-9#1)
describes some characteristics##2##3##(1997-3#1)(2011-2#1)
describes some of the##2##4##(1991-2#1)(2013-1#1)
describes some##7##2##(1991-2#1)(1994-12#1)(1997-3#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
describes staining##2##2##(2008-4#1)(2008-9#1)
describes the application of##3##4##(1993-2#1)(2008-10#2)
describes the binding##2##3##(1996-2#1)(2008-10#1)
describes the clinical##2##3##(1992-5#1)(2012-2#1)
describes the components of##2##4##(1993-3#1)(2008-4#1)
describes the construction and##2##4##(2008-10#1)(2008-4#1)
describes the construction##3##3##(2008-10#2)(2008-4#1)
describes the data##2##3##(2008-10#1)(2008-11#1)
describes the determination of##4##4##(2008-10#3)(2008-9#1)
describes the development and application of##2##6##(2008-10#2)
describes the development and##3##4##(2008-10#3)
describes the development of a##6##5##(1996-3#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-2#1)
describes the development of##11##4##(1996-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2010-8#1)(2012-2#1)(2013-1#1)
describes the development##17##3##(1996-3#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
describes the dynamics of##2##4##(2008-8#2)
describes the effect##2##3##(2008-1#1)(2008-9#1)
describes the effects of##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
describes the experimental##3##3##(2008-10#3)
describes the first##2##3##(1991-5#1)(2008-11#1)
describes the isolation of##4##4##(1994-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
describes the isolation##5##3##(1994-11#1)(2008-10#1)(2008-4#2)(2008-9#1)
describes the potential##2##3##(2008-7#1)(2011-2#1)
describes the preparation##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
describes the process of##3##4##(1995-2#1)(2008-11#1)(2010-6#1)
describes the process##6##3##(1995-2#1)(2008-1#1)(2008-11#2)(2010-5#1)(2010-6#1)
describes the quantitative##2##3##(2008-5#1)(2009-5#1)
describes the relation between##2##4##(1991-6#1)(2010-10#1)
describes the results of a##2##5##(1997-7#1)(2008-10#1)
describes the results##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
describes the role of##2##4##(2008-11#2)
describes the strategic planning process used##2##6##(1991-2#1)(1994-2#1)
describes the structure##2##3##(1997-2#1)(2008-12#1)
describes the successful##2##3##(2008-10#2)
describes the surgical##2##3##(1992-1#1)(2008-4#1)
describes the synthesis of##2##4##(2008-4#2)
describes the synthesis##4##3##(2008-4#4)
describes the use of a##5##5##(1992-1#1)(1995-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
describes the use of the##3##5##(1996-9#1)(2008-4#2)
describes the use of##18##4##(1992-1#1)(1994-2#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(2008-10#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
describes the##261##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-7#2)(2008-1#7)(2008-10#58)(2008-11#23)(2008-12#11)(2008-2#1)(2008-3#3)(2008-4#28)(2008-5#6)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#17)(2009-5#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-5#4)(2010-6#2)(2010-8#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#4)
describes these##3##2##(2008-11#1)(2010-1#1)(2011-3#1)
describes this##3##2##(2008-11#2)(2008-7#1)
describes three cases of##2##4##(2008-10#1)(2013-1#1)
describes three##5##2##(1993-11#1)(2008-10#1)(2008-9#1)(2013-1#2)
describes two basic##2##3##(2008-9#2)
describes two##10##2##(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#3)(2010-1#1)(2010-6#1)
describes various##2##2##(1991-1#1)(2008-11#1)
describes##634##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#6)(1991-5#1)(1991-6#1)(1992-1#3)(1992-12#3)(1992-2#5)(1992-3#3)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#5)(1994-1#3)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#2)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#6)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#7)(1996-6#3)(1996-9#1)(1997-1#3)(1997-2#8)(1997-3#8)(1997-7#2)(2007-12#1)(2008-1#13)(2008-10#117)(2008-11#56)(2008-12#25)(2008-2#2)(2008-3#4)(2008-4#87)(2008-5#9)(2008-6#9)(2008-7#16)(2008-8#5)(2008-9#68)(2009-12#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#1)(2011-2#14)(2011-3#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#25)(2013-7#2)(2013-8#5)
describing a##4##2##(1992-2#1)(2010-7#2)(2011-2#1)
describing how##2##2##(2008-10#1)(2008-7#1)
describing the spatial##2##3##(2008-10#1)(2010-10#1)
describing the##33##2##(1991-3#1)(1993-8#1)(1994-12#1)(1997-1#1)(2008-10#9)(2008-11#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-8#2)
describing their##4##2##(2008-10#1)(2008-12#1)(2010-9#1)(2012-2#1)
describing this##2##2##(2008-10#1)(2008-3#1)
describing##98##1##(1991-2#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#2)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#23)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#9)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#5)(2010-11#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#4)
description and##4##2##(2008-12#1)(2008-2#1)(2013-1#2)
description for the##3##3##(1992-1#1)(2008-3#1)(2008-7#1)
description is##3##2##(2008-5#1)(2008-7#1)(2010-10#1)
description of a##6##3##(1996-1#1)(1996-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#1)
description of one##2##3##(2008-12#1)(2008-4#1)
description of sequence variants in##2##5##(2008-4#2)
description of the electrode response##2##5##(2008-10#2)
description of the main##2##4##(2007-12#1)(2008-11#1)
description of the system##2##4##(2010-12#1)(2012-3#1)
description of the##52##3##(1990-12#1)(1991-11#1)(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#3)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
description of their##2##3##(2008-10#1)(2011-7#1)
description of this##3##3##(2011-2#2)(2012-3#1)
description of##121##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#4)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#18)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#6)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#5)(2009-6#1)(2009-7#3)(2010-10#4)(2010-12#2)(2010-5#2)(2010-7#1)(2011-2#5)(2011-7#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
description##149##1##(1990-12#1)(1991-11#1)(1991-12#2)(1991-2#2)(1992-1#5)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#18)(2008-11#7)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#5)(2009-6#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#6)(2010-12#2)(2010-5#2)(2010-6#1)(2010-7#3)(2011-2#7)(2011-7#2)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#3)
descriptions for##2##2##(2008-4#1)(2008-9#1)
descriptions of how##2##3##(2008-11#2)
descriptions of the##5##3##(1996-3#1)(2008-10#1)(2008-11#3)
descriptions of##18##2##(1993-2#1)(1996-3#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-8#1)(2008-9#1)(2013-8#1)
descriptions##29##1##(1992-1#1)(1993-2#1)(1994-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2013-8#1)
descriptive analysis##3##2##(2008-10#1)(2011-2#2)
descriptive and##5##2##(1993-3#1)(1997-4#1)(2009-12#1)(2010-4#1)(2013-1#1)
descriptive cross-sectional study with##2##4##(2010-9#1)(2012-12#1)
descriptive cross-sectional study##4##3##(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
descriptive data##3##2##(1993-3#1)(2008-11#1)(2008-7#1)
descriptive information on##2##3##(1994-2#1)(1997-2#1)
descriptive information##4##2##(1993-12#1)(1994-2#1)(1995-3#1)(1997-2#1)
descriptive methods##2##2##(2008-10#1)(2010-1#1)
descriptive overview of##2##3##(2013-1#2)
descriptive phenomenological study##2##3##(2008-11#1)(2010-11#1)
descriptive qualitative study##2##3##(2010-10#1)(2013-1#1)
descriptive statistics##4##2##(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
descriptive study of##5##3##(1994-6#1)(2007-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
descriptive study to##2##3##(2010-6#1)(2012-12#1)
descriptive study was##2##3##(2010-11#1)(2012-3#1)
descriptive study##23##2##(1994-6#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#2)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
descriptive survey##4##2##(1992-1#1)(2008-12#1)(2010-10#1)(2010-8#1)
descriptive##102##1##(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#8)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-1#2)(2010-10#6)(2010-11#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-2#7)(2012-12#12)(2012-2#2)(2012-3#7)(2013-1#10)(2013-8#1)
descriptor##5##1##(2008-10#3)(2011-2#2)
descriptors and##2##2##(2008-10#1)(2009-3#1)
descriptors as##2##2##(2008-10#1)(2009-8#1)
descriptors of dyspnea##4##3##(2008-10#4)
descriptors of##7##2##(2008-10#7)
descriptors was##2##2##(2008-10#2)
descriptors were##5##2##(2008-10#3)(2008-12#1)(2008-5#1)
descriptors##39##1##(1997-2#1)(2008-10#29)(2008-12#1)(2008-5#4)(2009-3#2)(2009-8#1)(2011-3#1)
desensitization of the angiotensin receptors##2##5##(1994-2#2)
desensitization of the##3##3##(1994-2#2)(2008-10#1)
desensitization of##6##2##(1994-2#2)(2008-10#1)(2008-8#1)(2009-7#1)(2012-3#1)
desensitization##18##1##(1994-2#2)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#8)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
desensitizations##4##1##(2008-8#4)
desensitized##3##1##(1995-8#1)(1997-1#1)(2008-8#1)
desensitizing dentifrice##4##2##(2011-2#4)
desensitizing toothpastes##2##2##(2011-2#2)
desensitizing##8##1##(2011-2#8)
desert##11##1##(1996-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-8#2)(2009-6#1)(2013-1#1)
deserted ducklings##2##2##(2008-9#2)
deserted##3##1##(2008-9#3)
desertion##6##1##(2008-8#3)(2008-9#3)
deserve##8##1##(1993-1#1)(1993-12#1)(1994-12#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
deserves further##2##2##(1991-6#1)(2012-3#1)
deserves##6##1##(1990-12#1)(1991-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
desethylatrazine (DEA)##2##2##(2008-10#2)
desethylatrazine##3##1##(2008-10#3)
desferrioxamine and##2##2##(2008-10#1)(2008-11#1)
desferrioxamine mesylate and lisinopril##2##4##(2008-10#2)
desferrioxamine##8##1##(1993-2#2)(2008-10#5)(2008-11#1)
desialylation of##2##2##(2008-11#1)(2008-7#1)
desialylation##5##1##(2008-11#3)(2008-7#2)
desiccation of##3##2##(2008-10#2)(2008-11#1)
desiccation##9##1##(1992-12#2)(2008-10#4)(2008-11#1)(2008-8#2)
design a##7##2##(1992-3#2)(1993-12#1)(2008-10#3)(2008-5#1)
design also##2##2##(2008-10#1)(2012-3#1)
design and a central composite design##2##6##(2008-10#2)
design and a##4##3##(2008-10#3)(2013-1#1)
design and analysis##2##3##(1995-5#1)(1996-6#1)
design and business##2##3##(2012-3#2)
design and construction##2##3##(2008-10#1)(2011-2#1)
design and delivery##2##3##(1995-5#1)(2013-8#1)
design and development of##2##4##(2008-10#1)(2008-12#1)
design and evaluation of##2##4##(2008-3#1)(2013-8#1)
design and evaluation##3##3##(1997-3#1)(2008-3#1)(2013-8#1)
design and fabrication of##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
design and implementation##8##3##(1991-1#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2010-11#2)(2012-2#1)
design and operation##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
design and performance##4##3##(2008-10#1)(2008-3#2)(2010-8#1)
design and renovation of##2##4##(2012-3#2)
design and the##12##3##(1993-1#1)(1994-9#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
design and##103##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#4)(1997-2#1)(1997-3#2)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#8)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#2)(2009-9#1)(2010-11#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#7)(2013-1#3)(2013-8#4)
design applied##2##2##(2008-10#1)(2011-1#1)
design approach was##2##3##(2008-10#1)(2008-11#1)
design approach##6##2##(2008-10#4)(2008-11#1)(2009-7#1)
design at##4##2##(1995-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
design can be##2##3##(2008-10#1)(2010-8#1)
design can##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
design characteristics and##2##3##(2008-12#1)(2010-1#1)
design considerations##3##2##(2008-10#1)(2008-11#2)
design features##2##2##(1996-12#1)(2012-3#1)
design firms##2##2##(1992-2#1)(1997-3#1)
design for a##4##3##(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
design for optimization##3##3##(2008-10#3)
design for the##3##3##(2008-10#1)(2013-1#2)
design for two component mixtures##2##5##(2008-10#2)
design for##22##2##(1992-9#1)(1995-2#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#1)(2013-1#3)
design has##3##2##(2008-12#1)(2008-8#1)(2011-2#1)
design have##3##2##(1997-1#1)(2008-10#1)(2008-3#1)
design in the##3##3##(2008-10#2)(2013-1#1)
design in##14##2##(1994-12#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2010-8#1)(2013-1#1)
design involving##2##2##(1993-8#1)(2008-10#1)
design is based on##3##4##(1994-1#1)(1994-3#1)(2011-2#1)
design is presented##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
design is used for the##3##5##(2008-10#3)
design is used##4##3##(2008-10#3)(2008-11#1)
design is##23##2##(1993-3#1)(1994-1#1)(1994-3#1)(1995-9#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
design issues##3##2##(1991-1#1)(2008-2#1)(2008-3#1)
design may##2##2##(2011-2#2)
design method##5##2##(2008-10#2)(2008-3#1)(2010-8#1)(2012-3#1)
design more##2##2##(2011-2#1)(2013-1#1)
design of a##14##3##(1994-3#2)(1996-6#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#1)
design of an##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
design of clinical trials of##2##5##(1995-5#1)(2008-8#1)
design of clinical trials##3##4##(1995-5#1)(2008-8#1)(2010-11#1)
design of diffractive##2##3##(2008-3#2)
design of effective##2##3##(2011-2#2)
design of experiments&quot##2##3##(2008-10#2)
design of imaging##2##3##(2011-2#1)(2013-8#1)
design of such##3##3##(1994-9#1)(2008-3#1)(2008-9#1)
design of the system##3##4##(2008-10#1)(2008-2#1)(2012-3#1)
design of the##20##3##(1992-2#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-3#1)
design of##117##2##(1990-8#1)(1992-2#1)(1992-3#1)(1992-9#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-5#2)(1996-6#1)(1997-3#1)(1997-6#1)(2007-11#2)(2008-10#28)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#3)
design on##3##2##(2008-10#3)
design parameters##4##2##(1993-1#1)(1995-5#1)(2008-2#1)(2008-3#1)
design principles##6##2##(1994-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)
design study##4##2##(2008-10#2)(2010-7#2)
design that##6##2##(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-3#1)
design the trial to##2##4##(1995-5#2)
design the##9##2##(1995-5#2)(2008-10#3)(2008-6#1)(2010-11#1)(2010-8#1)(2012-2#1)
design to detect##2##3##(2008-10#2)
design to##12##2##(1996-3#1)(1997-1#1)(2008-10#6)(2008-12#1)(2009-8#1)(2011-2#2)
design was applied##3##3##(2008-10#2)(2008-11#1)
design was employed##4##3##(2008-10#2)(2008-12#1)(2013-1#1)
design was proposed##2##3##(2008-10#2)
design was used for##3##4##(2008-10#3)
design was used to determine the##2##6##(2008-10#1)(2011-2#1)
design was used to determine##3##5##(2008-10#2)(2011-2#1)
design was used to##11##4##(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#2)
design was used##19##3##(1996-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
design was##40##2##(1994-3#1)(1996-1#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#2)(2008-5#1)(2008-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
design were used##2##3##(2008-10#2)
design were##3##2##(2008-10#2)(2008-2#1)
design with a##2##3##(2008-10#1)(2010-4#1)
design with three##2##3##(2008-10#2)
design with##12##2##(2008-10#7)(2008-3#1)(2010-4#2)(2012-2#1)(2013-1#1)
design##768##1##(1990-11#1)(1990-8#1)(1991-1#3)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#4)(1992-3#4)(1992-9#8)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#5)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#9)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#5)(1995-5#8)(1995-6#1)(1995-9#1)(1996-1#5)(1996-12#4)(1996-2#3)(1996-3#4)(1996-6#5)(1997-1#2)(1997-2#3)(1997-3#6)(1997-6#3)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#236)(2008-11#39)(2008-12#16)(2008-2#14)(2008-3#50)(2008-4#6)(2008-5#13)(2008-6#2)(2008-7#14)(2008-8#9)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#8)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#7)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#9)(2010-9#1)(2011-1#6)(2011-2#35)(2011-3#4)(2011-9#1)(2012-12#16)(2012-2#25)(2012-3#23)(2012-5#1)(2013-1#39)(2013-8#18)
design)##4##1##(2007-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
designate##4##1##(1991-3#1)(1993-6#1)(1994-11#1)(2008-9#1)
designated as Lr46##2##3##(2008-10#2)
designated as the##2##3##(2008-10#2)
designated as##49##2##(1990-11#1)(1992-3#1)(1993-9#1)(1994-5#3)(1996-2#1)(1996-6#1)(1997-8#1)(2008-10#22)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#7)(2009-8#1)(2010-3#1)(2010-5#1)
designated beet##2##2##(2008-10#2)
designated species##2##2##(2008-10#2)
designated this##2##2##(1995-11#1)(1995-3#1)
designated##151##1##(1990-11#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-5#4)(1995-11#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#3)(1997-7#1)(1997-8#2)(2008-10#82)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#12)(2009-10#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)
designates##2##1##(2012-12#2)
designation##5##1##(1992-5#1)(2008-10#3)(2008-5#1)
designations##3##1##(2008-10#2)(2010-6#1)
designed a##8##2##(1990-12#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2013-1#1)
designed according to the##3##4##(2008-10#1)(2008-8#2)
designed according to##5##3##(1993-6#1)(2008-10#1)(2008-8#2)(2008-9#1)
designed an##2##2##(2008-12#1)(2011-2#1)
designed and built##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
designed and constructed##3##3##(1997-6#1)(2008-10#2)
designed and developed##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
designed and fabricated##3##3##(2008-10#1)(2008-3#2)
designed and implemented##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
designed and synthesized as##2##4##(2008-11#1)(2008-8#1)
designed and synthesized for##2##4##(2008-10#1)(2012-12#1)
designed and synthesized##13##3##(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)(2010-6#1)(2011-3#3)(2012-12#1)
designed and tested##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
designed and##45##2##(1997-6#1)(2008-10#15)(2008-11#5)(2008-2#2)(2008-3#6)(2008-6#1)(2008-8#3)(2008-9#2)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-3#1)(2013-1#1)
designed around##2##2##(2008-10#1)(2008-8#1)
designed as a##4##3##(2008-11#1)(2008-3#1)(2010-3#1)(2013-1#1)
designed as##8##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)(2009-12#1)(2010-3#1)(2013-1#1)
designed based on the##4##4##(1993-8#1)(2008-10#3)
designed based on##6##3##(1993-8#1)(2008-10#5)
designed by an##2##3##(2008-11#1)(2010-10#1)
designed by##6##2##(2008-10#3)(2008-11#1)(2008-3#1)(2010-10#1)
designed for both##2##3##(2008-10#2)
designed for spark##2##3##(2008-10#2)
designed for specific##2##3##(2008-10#1)(2009-12#1)
designed for the purpose of##2##5##(2008-10#1)(2008-2#1)
designed for the##12##3##(1991-1#2)(1992-1#1)(1995-3#1)(2008-10#6)(2008-2#1)(2008-3#1)
designed for this study##2##4##(1992-2#1)(2008-5#1)
designed for use in##2##4##(2009-7#1)(2010-11#1)
designed for use##3##3##(2008-4#1)(2009-7#1)(2010-11#1)
designed for##55##2##(1991-1#2)(1991-2#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-9#1)(1995-3#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#1)
designed from the##4##3##(2008-10#3)(2008-8#1)
designed from##10##2##(1993-12#1)(1996-8#1)(2007-12#1)(2008-10#6)(2008-8#1)
designed in##5##2##(2008-10#3)(2010-4#1)(2012-2#1)
designed on the##2##3##(1993-8#1)(2010-4#1)
designed so##3##2##(2008-5#1)(2008-9#1)(2010-8#1)
designed specifically for##3##3##(2008-10#2)(2008-11#1)
designed specifically to##3##3##(2008-10#1)(2009-10#1)(2012-2#1)
designed specifically##6##2##(2008-10#3)(2008-11#1)(2009-10#1)(2012-2#1)
designed that##3##2##(2008-10#2)(2008-3#1)
designed the##2##2##(2008-7#1)(2010-11#1)
designed this study to##2##4##(1996-2#1)(2013-7#1)
designed to allow##4##3##(1997-6#1)(2008-3#1)(2008-4#2)
designed to amplify##5##3##(2008-10#5)
designed to assess the##3##4##(2008-11#1)(2009-4#1)(2011-2#1)
designed to assess##8##3##(1994-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#2)
designed to be##8##3##(1995-2#1)(1996-2#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-7#1)
designed to better##2##3##(2008-10#1)(2012-3#1)
designed to change the##2##4##(1994-1#1)(2008-10#1)
designed to detect the##2##4##(2008-10#1)(2008-9#1)
designed to detect##7##3##(2008-10#4)(2008-4#1)(2008-9#1)(2012-2#1)
designed to determine the##4##4##(1990-5#1)(1993-3#1)(2008-3#1)(2012-3#1)
designed to determine##8##3##(1990-5#1)(1993-3#1)(1994-2#1)(1994-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
designed to elicit##2##3##(2008-11#1)(2009-10#1)
designed to encourage##2##3##(2008-11#2)
designed to enhance##2##3##(2008-11#1)(2008-7#1)
designed to ensure##3##3##(1993-1#1)(2008-10#1)(2013-1#1)
designed to evaluate a##2##4##(1996-1#1)(2008-11#1)
designed to evaluate the effects of##2##6##(2008-5#1)(2011-2#1)
designed to evaluate the##9##4##(1990-12#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
designed to evaluate##12##3##(1990-12#1)(1995-8#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
designed to explore##2##3##(2010-8#1)(2011-2#1)
designed to facilitate##4##3##(1992-2#1)(1992-6#1)(2008-10#1)(2008-11#1)
designed to further##2##3##(1993-3#1)(2008-12#1)
designed to generate##3##3##(1993-12#2)(2008-11#1)
designed to help##6##3##(1994-3#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-2#1)
designed to identify##2##3##(2008-10#2)
designed to improve the##2##4##(1993-3#1)(2013-1#1)
designed to improve##10##3##(1991-12#1)(1993-3#1)(1997-2#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
designed to increase##4##3##(1993-3#1)(1996-1#2)(2012-2#1)
designed to investigate the influence of##4##6##(2008-11#2)(2011-2#2)
designed to investigate the##11##4##(2008-10#2)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#4)(2012-12#1)
designed to investigate##12##3##(2008-10#2)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#5)(2012-12#1)
designed to maintain##2##3##(2008-9#2)
designed to measure the##3##4##(2008-3#2)(2008-5#1)
designed to measure##6##3##(1996-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-3#1)
designed to meet the needs of##2##6##(1996-2#1)(1997-1#1)
designed to meet the##4##4##(1991-12#1)(1996-2#1)(1997-1#1)(2008-10#1)
designed to minimize##2##3##(1993-3#1)(2011-2#1)
designed to perform the##2##4##(2008-10#1)(2008-11#1)
designed to perform##5##3##(2008-10#4)(2008-11#1)
designed to permit##2##3##(1993-12#1)(2008-4#1)
designed to produce##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
designed to promote##4##3##(2008-11#1)(2008-12#2)(2013-1#1)
designed to protect##2##3##(2008-11#1)(2008-4#1)
designed to provide##4##3##(1994-1#1)(2008-11#1)(2008-3#1)(2011-2#1)
designed to reduce the incidence of##2##6##(1991-12#1)(2011-2#1)
designed to reduce the##3##4##(1991-12#1)(2008-9#1)(2011-2#1)
designed to reduce##4##3##(1991-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
designed to see##2##3##(2008-11#1)(2012-3#1)
designed to simulate the##2##4##(2008-3#1)(2008-9#1)
designed to stimulate##4##3##(1991-12#1)(2008-9#1)(2010-1#1)(2012-3#1)
designed to study##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
designed to support##2##3##(1995-2#1)(2008-11#1)
designed to take##2##3##(2008-10#1)(2008-9#1)
designed to target##2##3##(2008-10#2)
designed to test the effects of the##2##7##(1992-1#1)(2008-10#1)
designed to test the##4##4##(1992-1#1)(1997-8#1)(2008-10#2)
designed to test##5##3##(1991-12#1)(1992-1#1)(1997-8#1)(2008-10#2)
designed to##249##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#7)(1991-3#2)(1992-1#2)(1992-2#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#6)(1993-3#5)(1993-6#3)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-9#2)(1995-2#5)(1995-3#1)(1995-8#1)(1996-1#3)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#45)(2008-11#25)(2008-12#7)(2008-3#10)(2008-4#11)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#12)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-2#15)(2012-12#3)(2012-2#7)(2012-3#8)(2013-1#8)(2013-8#2)
designed two##2##2##(1993-12#1)(2008-10#1)
designed using##6##2##(2008-10#4)(2013-1#1)(2013-8#1)
designed with a##3##3##(1992-1#1)(2008-11#1)(2008-3#1)
designed with the##2##3##(1996-1#1)(2013-1#1)
designed with##11##2##(1992-1#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2009-10#1)(2013-1#1)
designed within the##2##3##(2008-10#1)(2008-3#1)
designed##533##1##(1990-12#2)(1990-5#1)(1991-1#3)(1991-12#10)(1991-2#1)(1991-3#2)(1992-1#4)(1992-12#1)(1992-2#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#8)(1993-2#2)(1993-3#5)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#5)(1994-9#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#4)(1996-2#7)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#5)(2008-10#157)(2008-11#41)(2008-12#9)(2008-2#4)(2008-3#30)(2008-4#13)(2008-5#11)(2008-6#2)(2008-7#9)(2008-8#11)(2008-9#24)(2009-10#3)(2009-11#2)(2009-12#3)(2009-4#1)(2009-7#4)(2009-8#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#3)(2011-2#21)(2011-3#4)(2012-12#4)(2012-2#10)(2012-3#11)(2013-1#17)(2013-7#1)(2013-8#8)
designer drinks##2##2##(1997-5#2)
designer##7##1##(1992-12#1)(1997-4#1)(1997-5#2)(2010-7#1)(2012-3#2)
designers and##2##2##(2008-3#1)(2012-3#1)
designers##3##1##(2008-3#1)(2011-2#1)(2012-3#1)
designing a##12##2##(1994-3#2)(1995-9#1)(1997-2#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-8#3)(2011-2#1)(2012-12#1)
designing an##3##2##(2008-4#1)(2010-8#1)(2013-8#1)
designing and implementing##2##3##(2008-12#1)(2010-8#1)
designing and##5##2##(1994-3#1)(2008-12#2)(2008-3#1)(2010-8#1)
designing decision##2##2##(2008-10#1)(2010-8#1)
designing successful##2##2##(2008-10#2)
designing the##3##2##(2008-10#1)(2008-4#1)(2010-11#1)
designing these##2##2##(1997-3#1)(2008-6#1)
designing##62##1##(1992-3#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-3#3)(1995-2#1)(1995-5#1)(1995-9#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#6)(2008-6#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-8#6)(2011-2#3)(2011-3#1)(2012-12#1)(2013-8#2)
designs and##5##2##(2008-10#3)(2008-12#1)(2013-1#1)
designs are described##2##3##(2008-10#1)(2008-2#1)
designs are##10##2##(1992-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)
designs for##7##2##(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
designs have been##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
designs have##6##2##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)
designs in##2##2##(2008-10#2)
designs may be##2##3##(2008-10#1)(2008-11#1)
designs may##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
designs of##2##2##(2008-10#1)(2012-12#1)
designs that##2##2##(1996-3#1)(2011-2#1)
designs to##4##2##(1993-2#1)(2009-10#1)(2012-2#1)(2013-1#1)
designs were##3##2##(2008-10#2)(2012-2#1)
designs with##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
designs##108##1##(1992-9#2)(1993-2#1)(1994-9#2)(1995-2#3)(1995-9#1)(1996-3#2)(1997-1#1)(1997-3#2)(2007-12#1)(2008-10#45)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2009-10#1)(2009-7#2)(2010-11#1)(2010-5#1)(2011-2#7)(2012-12#1)(2012-2#4)(2013-1#4)
desipramine in the##2##3##(1990-5#1)(1991-1#1)
desipramine in##4##2##(1990-5#2)(1991-1#2)
desipramine##10##1##(1990-5#3)(1991-1#3)(2008-10#4)
desirability function##3##2##(2008-10#3)
desirability of##5##2##(1992-2#2)(2008-3#1)(2009-3#2)
desirability##10##1##(1990-6#1)(1992-2#2)(1994-1#1)(2008-10#3)(2008-3#1)(2009-3#2)
desirable and##4##2##(1993-1#1)(1995-2#1)(1996-3#1)(1996-6#1)
desirable characteristics##3##2##(2008-10#1)(2008-12#1)(2009-7#1)
desirable for##3##2##(2008-10#3)
desirable inverse growth associated production behavior##2##6##(2008-11#2)
desirable level##2##2##(2008-11#1)(2012-2#1)
desirable properties##4##2##(2008-11#1)(2008-6#2)(2013-1#1)
desirable to##13##2##(1997-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
desirable##66##1##(1991-6#1)(1992-1#2)(1993-1#2)(1993-2#1)(1993-3#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#11)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#2)
desire for##5##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
desire to understand##2##3##(2009-6#1)(2010-5#1)
desire to##8##2##(1994-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
desire##20##1##(1993-1#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
desired by##2##2##(1996-6#1)(2008-5#1)
desired characteristics and uses##2##4##(1993-2#2)
desired characteristics and##3##3##(1993-2#3)
desired characteristics##4##2##(1990-8#1)(1993-2#3)
desired for##2##2##(1995-5#1)(2008-10#1)
desired friends##3##2##(2009-7#3)
desired in##2##2##(2008-5#1)(2013-8#1)
desired levels of##2##3##(2008-10#2)
desired products##3##2##(2008-10#1)(2008-4#1)(2009-12#1)
desired quality##2##2##(2008-10#1)(2012-2#1)
desired##81##1##(1990-8#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-10#21)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-7#3)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
desires##3##1##(2010-10#2)(2012-3#1)
desiring to##2##2##(1994-12#1)(1994-2#1)
desisobutyryl-ciclesonide##3##1##(2008-8#3)
desisopropylatrazine (DIA)##2##2##(2008-10#2)
desktop##2##1##(2008-10#1)(2008-6#1)
desmetryne at##2##2##(2008-10#2)
desmetryne in##2##2##(2008-10#2)
desmetryne##6##1##(2008-10#6)
desmin##3##1##(2008-11#1)(2010-12#1)(2010-6#1)
desmoid tumors##4##2##(1997-8#2)(2011-2#1)(2012-3#1)
desmoid##6##1##(1997-8#2)(2008-12#1)(2009-12#1)(2011-2#1)(2012-3#1)
desmoids have a##2##3##(1997-8#2)
desmoids##6##1##(1997-8#6)
desmoplastic medulloblastomas##2##2##(1991-2#2)
desmoplastic##3##1##(1991-2#3)
desmosome##3##1##(2012-2#3)
desmosome-like junctions##2##2##(2009-10#2)
desmosome-like##3##1##(2009-10#3)
desmosomes and##4##2##(2008-12#1)(2008-7#2)(2012-2#1)
desolvation##5##1##(2008-10#5)
desorb the analyte##2##3##(2008-10#2)
desorb##5##1##(2008-10#5)
desorbed in the##4##3##(2008-10#2)(2008-7#2)
desorbed quantitatively with##2##3##(2008-10#2)
desorbed with##6##2##(2008-10#6)
desorbed##20##1##(2008-10#17)(2008-7#2)(2011-2#1)
desorption and##2##2##(2008-10#2)
desorption from##2##2##(1994-2#1)(2008-10#1)
desorption into a##2##3##(2008-10#2)
desorption mass spectrometry##2##3##(1990-8#1)(2008-10#1)
desorption of analytes##2##3##(2008-10#2)
desorption of the##5##3##(2008-10#5)
desorption of##13##2##(1991-9#1)(2008-10#10)(2009-12#1)(2010-4#1)
desorption procedure##2##2##(2008-10#2)
desorption time##2##2##(2008-10#2)
desorption##56##1##(1990-8#1)(1991-9#2)(1994-2#1)(2008-10#48)(2008-5#1)(2008-8#1)(2009-12#1)(2010-4#1)
desperately##2##1##(1995-1#1)(2008-1#1)
despite a##11##2##(1996-11#2)(1996-5#1)(2008-10#4)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
despite being on##2##3##(2008-11#1)(2013-1#1)
despite being##8##2##(1992-9#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
despite evidence that##2##3##(2008-11#2)
despite extensive##3##2##(2008-10#1)(2008-7#2)
despite having##2##2##(2010-8#1)(2011-2#1)
despite high##3##2##(2008-12#1)(2008-8#1)(2010-10#1)
despite intensive##3##2##(2008-10#2)(2013-8#1)
despite its##9##2##(1997-6#1)(2008-10#2)(2008-11#3)(2009-1#2)(2011-1#1)
despite negative##2##2##(1992-2#1)(2012-3#1)
despite no##2##2##(2010-7#1)(2012-3#1)
despite normal levels of##2##4##(2012-3#2)
despite of##3##2##(2009-6#1)(2011-1#1)(2011-3#1)
despite significant##2##2##(1993-3#1)(2012-2#1)
despite some##3##2##(1994-5#1)(2008-7#1)(2010-2#1)
despite the abundance of##2##4##(2008-10#1)(2009-6#1)
despite the clear##2##3##(1995-12#1)(2008-8#1)
despite the current##2##3##(2012-2#1)(2013-1#1)
despite the fact that the##2##5##(2008-10#1)(2010-6#1)
despite the fact that they##2##5##(2008-10#2)
despite the fact that##10##4##(1995-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
despite the high##2##3##(2011-2#1)(2013-1#1)
despite the lack of evidence##2##5##(2008-11#1)(2008-12#1)
despite the lack of##5##4##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
despite the presence of##5##4##(1990-5#1)(1995-2#1)(2008-10#1)(2008-7#1)(2009-10#1)
despite the##69##2##(1990-3#1)(1990-5#2)(1993-1#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#16)(2008-11#14)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#4)(2009-10#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#2)
despite their large##2##3##(2008-8#1)(2012-3#1)
despite their##8##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
despite these##3##2##(2009-10#1)(2011-2#1)(2013-1#1)
despite this##2##2##(1997-5#1)(2011-2#1)
despite##206##1##(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-11#3)(1996-2#2)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#32)(2008-11#27)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#8)(2008-9#4)(2009-1#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#11)(2011-3#2)(2012-2#7)(2012-3#9)(2012-5#1)(2013-1#8)(2013-8#7)
desquamation process##2##2##(2008-5#2)
desquamation##14##1##(1994-12#1)(2008-5#12)(2012-3#1)
destabilization of the##2##3##(1997-6#1)(2008-5#1)
destabilization##6##1##(1995-2#1)(1997-3#1)(1997-6#1)(2008-5#1)(2010-6#1)(2011-2#1)
destabilized by##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
destabilized the##2##2##(1993-8#2)
destabilized##8##1##(1993-8#3)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
destabilizes##2##1##(1997-2#1)(2008-9#1)
destabilizing##11##1##(1990-5#1)(1991-1#1)(1992-3#1)(1993-8#2)(2008-10#1)(2008-8#2)(2008-9#2)(2012-3#1)
destination##2##1##(2008-11#1)(2010-6#1)
destined for##3##2##(2008-10#2)(2008-11#1)
destined##4##1##(2008-10#2)(2008-11#1)(2009-4#1)
destroy the##7##2##(1994-9#1)(1997-6#1)(2008-10#3)(2008-11#1)(2010-1#1)
destroy##11##1##(1992-1#1)(1994-1#1)(1994-9#1)(1996-1#1)(1997-6#1)(2008-10#3)(2008-11#2)(2010-1#1)
destroyed by##3##2##(2008-10#2)(2008-12#1)
destroyed in##2##2##(1990-5#1)(1993-1#1)
destroyed the##3##2##(1990-5#1)(2008-10#1)(2013-8#1)
destroyed##17##1##(1990-5#3)(1991-3#1)(1991-5#1)(1993-1#1)(1994-8#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
destroying##3##1##(1990-5#1)(2010-4#1)(2011-2#1)
destroys the##3##2##(1997-5#1)(2008-11#1)(2012-3#1)
destroys##6##1##(1996-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
destructans isolates##3##2##(2008-10#3)
destructans were##2##2##(2008-10#2)
destructans##18##1##(2008-10#18)
destruction and##8##2##(2008-12#1)(2009-7#1)(2010-6#2)(2011-2#2)(2012-3#2)
destruction in##2##2##(2007-11#1)(2008-7#1)
destruction is##2##2##(2008-8#1)(2011-2#1)
destruction of malignant cells by##2##5##(2008-5#1)(2008-7#1)
destruction of the##12##3##(1990-12#1)(1990-5#1)(1993-3#1)(1997-5#1)(2008-10#1)(2008-4#3)(2009-8#2)(2010-11#1)(2011-2#1)
destruction of##36##2##(1990-12#1)(1990-2#1)(1990-5#2)(1993-3#2)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#1)(2013-1#2)
destruction##73##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1992-12#1)(1993-3#2)(1993-9#1)(1996-3#1)(1997-2#1)(1997-5#3)(2007-11#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-7#1)(2009-8#5)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2011-2#11)(2012-12#1)(2012-3#3)(2013-1#2)
destructiva##2##1##(2008-10#2)
destructive disease of##7##3##(2008-10#7)
destructive disease##9##2##(2008-10#9)
destructive pathogen##2##2##(2008-10#2)
destructive##43##1##(1990-6#1)(1991-2#2)(1996-3#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-5#1)(2008-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
desufflation##3##1##(2012-3#3)
desynchronization##2##1##(2008-5#1)(2013-8#1)
detach from##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
detach the##2##2##(2008-11#2)
detach##9##1##(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#3)
detachable balloon##2##2##(1996-9#1)(1997-3#1)
detachable coil##3##2##(1996-9#1)(1997-3#1)(1997-6#1)
detachable coils##3##2##(1995-11#1)(1997-3#1)(2008-7#1)
detachable##10##1##(1995-11#1)(1996-9#2)(1997-3#3)(1997-6#1)(2008-10#1)(2008-7#2)
detached by exposure to##2##4##(2008-11#2)
detached by##3##2##(2008-11#3)
detached crab apple##3##3##(2008-10#3)
detached flowers##5##2##(2008-10#5)
detached from the##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
detached from##6##2##(2008-10#2)(2008-11#3)(2011-2#1)
detached leaf##5##2##(2008-10#3)(2008-8#2)
detached leaflets and##2##3##(2008-10#2)
detached leaflets of##2##3##(2008-10#2)
detached leaflets##5##2##(2008-10#5)
detached leaves of##2##3##(2008-10#2)
detached leaves##7##2##(2008-10#7)
detached##50##1##(1994-2#1)(1997-6#1)(1997-7#1)(2008-10#36)(2008-11#7)(2008-8#2)(2011-2#1)(2013-1#1)
detached-leaf##2##1##(2008-10#2)
detachment associated with##3##3##(2013-1#2)(2013-8#1)
detachment of##5##2##(1990-9#1)(1991-3#1)(2007-12#1)(2008-11#2)
detachment##22##1##(1990-9#1)(1991-2#1)(1991-3#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#8)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
detail a##3##2##(1995-8#1)(2008-10#2)
detail and##12##2##(1995-1#1)(2008-1#1)(2008-10#6)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)
detail for##2##2##(1992-12#1)(1997-2#1)
detail in a##3##3##(2008-10#2)(2008-8#1)
detail in the##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
detail in##8##2##(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
detail of##3##2##(2008-7#1)(2009-5#1)(2011-2#1)
detail on##2##2##(2008-12#1)(2008-6#1)
detail the##17##2##(1991-6#1)(1995-5#1)(1996-6#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
detail to##8##2##(1994-5#1)(2008-10#6)(2008-11#1)
detail using##2##2##(2008-10#2)
detail##193##1##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#95)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#8)(2009-4#1)(2009-5#1)(2009-8#3)(2010-4#2)(2010-6#1)(2011-2#9)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
detailed analysis of the##6##4##(1995-12#1)(2008-1#1)(2008-3#2)(2008-7#1)(2009-10#1)
detailed analysis of##13##3##(1993-2#1)(1994-1#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-10#1)(2010-1#1)(2013-1#1)
detailed analysis##14##2##(1993-2#1)(1994-1#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2013-1#1)
detailed and##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
detailed biochemical##2##2##(1992-6#1)(2012-2#1)
detailed characterization of##3##3##(2008-3#1)(2008-5#1)(2009-5#1)
detailed chemical##2##2##(1995-5#1)(2008-3#1)
detailed comparison between##3##3##(1994-5#1)(2008-10#1)(2008-2#1)
detailed comparison##5##2##(1994-5#1)(2008-10#3)(2008-2#1)
detailed data on##2##3##(1996-3#1)(2011-3#1)
detailed data##4##2##(1990-3#1)(1996-3#1)(2009-3#1)(2011-3#1)
detailed description of the##4##4##(1996-6#1)(2008-7#1)(2008-9#1)(2010-12#1)
detailed description of##9##3##(1996-1#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)
detailed descriptions##2##2##(2008-11#1)(2008-9#1)
detailed design##5##2##(1996-1#1)(1996-3#1)(2012-2#2)(2013-1#1)
detailed examination of the##2##4##(1997-3#1)(1997-8#1)
detailed examination of##4##3##(1997-3#1)(1997-8#1)(2008-7#1)(2009-8#1)
detailed experimental##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
detailed exploration##2##2##(2009-12#1)(2012-2#1)
detailed history##2##2##(2009-12#1)(2013-8#1)
detailed information about the##3##4##(2008-2#1)(2010-10#1)(2011-2#1)
detailed information about##4##3##(2008-2#1)(2010-10#1)(2011-2#2)
detailed information on##2##3##(1991-8#1)(2008-9#1)
detailed information##11##2##(1991-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2011-3#1)
detailed instructions on##2##3##(1992-12#1)(2008-4#1)
detailed instructions##3##2##(1992-12#1)(2008-4#1)(2013-1#1)
detailed investigation##2##2##(2008-10#1)(2011-3#1)
detailed knowledge of the##2##4##(1992-9#1)(1997-3#1)
detailed knowledge of##5##3##(1992-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
detailed mechanism##2##2##(2008-9#1)(2009-6#1)
detailed medical##2##2##(2008-11#1)(2011-2#1)
detailed method for##3##3##(2008-4#1)(2008-9#2)
detailed molecular##3##2##(1997-6#1)(2010-12#2)
detailed protocols for##3##3##(2008-9#3)
detailed protocols##6##2##(2008-2#1)(2008-4#1)(2008-9#4)
detailed reviews##2##2##(1993-12#1)(2008-6#1)
detailed studies of##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
detailed studies##7##2##(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)
detailed study of##12##3##(2008-10#8)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#1)
detailed study##14##2##(1991-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2009-12#1)(2010-4#1)(2011-2#1)
detailed understanding of the##4##4##(2008-10#1)(2008-3#1)(2009-7#1)(2010-12#1)
detailed understanding of##5##3##(2008-10#1)(2008-3#1)(2009-12#1)(2009-7#1)(2010-12#1)
detailed unit##4##2##(2008-9#4)
detailed##236##1##(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-10#1)(1995-12#2)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#2)(1996-3#5)(1996-6#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#3)(2007-12#1)(2008-1#2)(2008-10#32)(2008-11#15)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#11)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#27)(2009-10#1)(2009-11#1)(2009-12#7)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#5)(2010-3#3)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#7)(2011-3#3)(2011-7#2)(2012-12#2)(2012-2#6)(2013-1#7)(2013-8#4)
detailing##7##1##(1996-1#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#1)(2012-2#1)
details about##2##2##(1992-3#1)(2008-4#1)
details and##4##2##(1991-6#1)(2008-10#1)(2008-12#1)(2008-9#1)
details are##6##2##(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
details for##5##2##(2008-4#3)(2008-9#1)(2011-1#1)
details how##2##2##(2008-9#1)(2010-5#1)
details of the##18##3##(1990-11#1)(1992-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)
details of these##2##3##(2008-11#1)(2010-11#1)
details of##44##2##(1990-11#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-3#3)(2013-8#2)
details on the##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
details on##6##2##(1994-12#1)(2008-10#2)(2008-11#2)(2008-9#1)
details some of##2##3##(1995-1#1)(2008-4#1)
details that##2##2##(2007-12#1)(2008-11#1)
details the##15##2##(1991-1#1)(1992-1#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#2)(2010-7#1)
details##125##1##(1990-11#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(2007-12#3)(2008-10#13)(2008-11#10)(2008-12#4)(2008-3#1)(2008-4#16)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#13)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#3)(2013-8#2)
detainees in police custody in London##2##6##(2010-1#2)
detainees in police custody##4##4##(2010-1#4)
detainees##5##1##(2010-1#5)
detect P##5##2##(2008-10#4)(2008-12#1)
detect a##10##2##(1992-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
detect all##3##2##(1996-12#1)(2008-10#2)
detect and identify##2##3##(2008-10#1)(2008-3#1)
detect and quantify##11##3##(2008-10#10)(2008-5#1)
detect and##29##2##(1991-6#1)(1993-2#1)(1994-3#1)(1997-2#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#2)(2013-8#1)
detect any changes##2##3##(2008-7#1)(2008-9#1)
detect any of##2##3##(2008-10#2)
detect any##12##2##(1993-2#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
detect both##4##2##(2008-10#3)(2008-4#1)
detect breast##2##2##(2010-6#1)(2012-2#1)
detect differences in the##2##4##(1996-2#1)(2008-10#1)
detect differences##3##2##(1996-2#1)(2008-10#2)
detect dopamine in##2##3##(2008-10#2)
detect early##2##2##(2008-10#1)(2010-6#1)
detect malignant##2##2##(1997-7#1)(2010-12#1)
detect microbial##4##2##(2008-11#2)(2012-2#2)
detect potential##2##2##(2008-11#2)
detect target##2##2##(2008-10#1)(2008-4#1)
detect the pathogen##2##3##(2008-10#2)
detect the presence##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
detect the##52##2##(1991-12#2)(1991-5#1)(1995-6#1)(1996-12#1)(2008-10#29)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
detect these##4##2##(1995-10#1)(2007-12#1)(2008-10#2)
detect this kind of##2##4##(1993-3#1)(2008-10#1)
detect##376##1##(1990-3#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-6#1)(1996-12#5)(1996-2#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#172)(2008-11#19)(2008-12#4)(2008-2#1)(2008-3#8)(2008-4#11)(2008-5#11)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#14)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#3)(2011-2#10)(2011-3#3)(2012-12#1)(2012-2#13)(2012-3#4)(2013-1#8)(2013-8#3)
detect-to-protect##2##1##(2010-7#2)
detectability of##4##2##(2008-10#3)(2008-3#1)
detectability##12##1##(1990-12#1)(2008-10#7)(2008-3#3)(2008-5#1)
detectable activity##3##2##(1994-8#1)(2009-6#2)
detectable amount of##4##3##(1992-6#1)(1996-5#2)(2007-12#1)
detectable amounts##2##2##(1990-11#1)(2008-10#1)
detectable and##3##2##(2008-10#3)
detectable at##5##2##(1997-5#1)(2008-10#2)(2012-3#1)(2013-1#1)
detectable by##10##2##(1992-6#1)(1994-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
detectable change##3##2##(1991-5#1)(2008-8#1)(2008-9#1)
detectable depurination##2##2##(2008-10#2)
detectable during##2##2##(1996-12#1)(2011-2#1)
detectable for##2##2##(2008-10#1)(2008-3#1)
detectable in the sera##2##4##(1991-5#1)(1994-3#1)
detectable in the##6##3##(1991-5#1)(1994-11#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)
detectable in##18##2##(1990-12#1)(1991-5#1)(1994-11#3)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-7#1)
detectable levels of##7##3##(1992-10#1)(1993-9#2)(2008-10#1)(2008-11#2)(2008-5#1)
detectable levels##10##2##(1992-10#1)(1993-12#1)(1993-9#2)(1996-12#1)(2008-10#2)(2008-11#2)(2008-5#1)
detectable populations##7##2##(2008-10#7)
detectable signal##4##2##(1996-12#1)(2008-10#1)(2008-9#2)
detectable##154##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#3)(1993-12#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#5)(1996-5#4)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#55)(2008-11#7)(2008-3#5)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#6)(2009-6#2)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
detectably##2##1##(1991-12#1)(2008-9#1)
detected 2##2##2##(2008-10#1)(2011-2#1)
detected 30##2##2##(1996-12#1)(2008-10#1)
detected 4##2##2##(1993-8#1)(2008-10#1)
detected DNA##2##2##(2008-10#2)
detected PLRV##2##2##(2008-10#2)
detected a##17##2##(1992-6#1)(1992-8#1)(1993-3#1)(1993-9#1)(1997-2#1)(1997-7#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
detected after##9##2##(1995-11#1)(1995-5#1)(1996-2#1)(2008-10#4)(2010-11#1)(2011-2#1)
detected among all##3##3##(2008-10#3)
detected among isolates##3##3##(2008-10#3)
detected among the##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
detected among##18##2##(2008-10#15)(2008-12#1)(2010-8#1)(2011-2#1)
detected amperometrically##2##2##(2008-10#2)
detected and quantified##2##3##(2008-10#2)
detected and the##2##3##(2008-10#1)(2008-9#1)
detected and##22##2##(1995-6#1)(1996-12#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)
detected are##2##2##(2008-10#2)
detected as a##2##3##(1993-8#1)(2008-10#1)
detected as early as##4##4##(1993-3#1)(2008-10#2)(2009-7#1)
detected as nitrite##2##3##(2008-10#2)
detected as##25##2##(1990-8#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#14)(2008-9#2)(2009-6#1)(2009-7#1)(2013-1#1)
detected at a level##2##4##(2008-10#2)
detected at a##3##3##(2008-10#2)(2009-5#1)
detected at all##4##3##(1990-9#1)(1995-11#1)(2008-10#2)
detected at any##2##3##(2008-5#1)(2008-6#1)
detected at baseline##2##3##(2013-1#2)
detected at low##2##3##(1996-12#1)(2008-10#1)
detected at pH##2##3##(2008-10#1)(2008-5#1)
detected at the##9##3##(1991-12#1)(1992-3#2)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)
detected at##60##2##(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-3#2)(1993-6#1)(1993-8#1)(1995-11#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#31)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
detected before the##2##3##(2008-10#2)
detected before##4##2##(2008-10#3)(2008-5#1)
detected between the##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
detected between##12##2##(2008-10#7)(2008-11#1)(2008-8#2)(2008-9#1)(2012-2#1)
detected both##5##2##(1990-5#1)(1991-5#1)(1995-6#1)(2008-10#1)(2011-2#1)
detected but##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
detected by PCR##2##3##(2008-10#1)(2010-1#1)
detected by UV##3##3##(2008-10#3)
detected by Western blot##5##4##(2008-8#2)(2008-9#2)(2012-2#1)
detected by Western##6##3##(2008-8#2)(2008-9#2)(2012-2#1)(2012-3#1)
detected by a##8##3##(2008-10#5)(2008-7#1)(2010-12#1)(2013-1#1)
detected by an##5##3##(1995-3#1)(2008-10#4)
detected by both##2##3##(2008-10#2)
detected by conventional##2##3##(1995-11#1)(2012-12#1)
detected by direct##4##3##(2008-10#2)(2012-2#1)(2012-3#1)
detected by protein##2##3##(1990-12#1)(2008-10#1)
detected by radioimmunoassay##2##3##(1995-12#1)(1996-12#1)
detected by screening##2##3##(1990-2#1)(1995-12#1)
detected by sequence analysis##2##4##(2008-10#1)(2009-6#1)
detected by the method##4##4##(2008-10#4)
detected by the##22##3##(1990-5#1)(1997-4#1)(2008-10#14)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
detected by these##3##3##(1991-3#1)(2008-10#1)(2012-12#1)
detected by this##2##3##(2008-10#1)(2008-3#1)
detected by using##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
detected by virtue of##2##4##(2008-10#1)(2008-9#1)
detected by##170##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(1997-9#1)(2008-10#76)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#18)(2009-10#1)(2009-6#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#2)(2013-8#2)
detected compounds##2##2##(2008-10#2)
detected consistently in##2##3##(2008-10#2)
detected consistently##3##2##(2008-10#3)
detected differences##2##2##(2008-10#2)
detected down to##2##3##(2008-10#1)(2013-8#1)
detected during the##3##3##(2008-10#3)
detected during##5##2##(1991-12#1)(1996-3#1)(2008-10#3)
detected early##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
detected either by##2##3##(2008-10#1)(2008-4#1)
detected either##5##2##(2006-6#1)(2008-10#3)(2008-4#1)
detected even in##2##3##(2008-10#2)
detected even##3##2##(2008-10#3)
detected for the##4##3##(2008-10#3)(2011-2#1)
detected for##20##2##(1995-2#1)(1995-5#1)(1997-6#1)(2008-10#12)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
detected from the##4##3##(2008-10#4)
detected from##14##2##(1996-6#1)(2008-10#9)(2008-11#1)(2008-8#1)(2009-5#1)(2013-1#1)
detected in 1##2##3##(2008-10#1)(2012-3#1)
detected in 18##2##3##(1996-6#1)(2009-8#1)
detected in 21##2##3##(2009-8#1)(2013-1#1)
detected in a##8##3##(1993-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-1#1)
detected in all the##2##4##(2008-11#1)(2008-8#1)
detected in all##10##3##(1990-12#1)(1993-12#1)(2008-10#6)(2008-11#1)(2008-8#1)
detected in an##2##3##(2008-10#2)
detected in both##10##3##(1991-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-9#1)(2013-1#1)
detected in brain##2##3##(2008-8#1)(2011-2#1)
detected in cell##2##3##(1995-2#1)(2008-11#1)
detected in cells##2##3##(1995-6#1)(1995-8#1)
detected in culture##2##3##(2008-10#2)
detected in differentiating##2##3##(2008-8#2)
detected in environmental##2##3##(2008-10#2)
detected in four##2##3##(2008-10#1)(2008-5#1)
detected in guttation fluid from systemically infected##2##7##(2008-10#2)
detected in human##5##3##(1990-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(2008-10#1)
detected in individual##2##3##(2008-10#1)(2012-2#1)
detected in infected##2##3##(2008-10#2)
detected in leaf##2##3##(2008-10#2)
detected in leukemic cells##2##4##(1995-2#1)(2008-9#1)
detected in mouse##2##3##(2008-10#1)(2013-1#1)
detected in one##3##3##(2008-10#2)(2011-2#1)
detected in other##4##3##(2008-10#2)(2008-8#1)(2010-11#1)
detected in patients with##2##4##(1992-3#1)(2009-8#1)
detected in patients##4##3##(1991-2#1)(1992-3#1)(1994-5#1)(2009-8#1)
detected in plasma##2##3##(2008-11#1)(2008-8#1)
detected in progeny tubers##2##4##(2008-10#2)
detected in roots of##2##4##(2008-10#2)
detected in samples from##2##4##(2008-10#1)(2011-2#1)
detected in samples##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
detected in seed##2##3##(2008-10#2)
detected in six##2##3##(1990-8#1)(1996-12#1)
detected in some##6##3##(1996-12#2)(2008-10#3)(2008-7#1)
detected in stage##2##3##(1997-7#1)(2012-2#1)
detected in susceptible##2##3##(2008-10#2)
detected in the brain##3##4##(1994-2#1)(1996-12#1)(2009-7#1)
detected in the first##2##4##(1990-5#1)(2008-10#1)
detected in the gut##2##4##(2008-10#2)
detected in the hemolymph##4##4##(2008-10#4)
detected in the liver##2##4##(2008-10#1)(2011-3#1)
detected in the serum##2##4##(1995-2#1)(2008-5#1)
detected in the##120##3##(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#53)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#6)(2008-9#1)(2009-1#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
detected in their##3##3##(1995-12#1)(1996-12#1)(2008-10#1)
detected in these##6##3##(1995-11#1)(2008-10#4)(2008-5#1)
detected in this study##2##4##(1991-12#1)(2008-10#1)
detected in this##5##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
detected in tissue##2##3##(2008-10#2)
detected in various##4##3##(1993-8#1)(1994-8#1)(1995-6#1)(2008-10#1)
detected in##435##2##(1990-12#2)(1990-2#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#1)(1994-8#5)(1995-11#3)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#6)(1995-8#4)(1996-12#14)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#1)(2008-10#205)(2008-11#17)(2008-12#7)(2008-2#1)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#3)(2008-8#19)(2008-9#9)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#5)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#4)(2010-8#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#11)(2013-7#2)(2013-8#2)
detected incidentally during routine##2##4##(1997-3#1)(2008-11#1)
detected incidentally##3##2##(1997-3#1)(2008-11#2)
detected indirectly##2##2##(2008-10#1)(2008-4#1)
detected is##2##2##(2008-11#1)(2009-5#1)
detected more##2##2##(2008-10#1)(2008-8#1)
detected on a##2##3##(2008-10#1)(2008-9#1)
detected on glassy carbon electrode surface at##2##7##(2008-10#2)
detected on glassy carbon electrode##3##5##(2008-10#3)
detected on the##3##3##(1994-6#1)(2008-10#2)
detected on##26##2##(1994-11#1)(1994-6#1)(1997-8#1)(2008-10#16)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
detected only in##5##3##(1996-12#1)(1997-8#1)(2008-10#3)
detected only##8##2##(1996-12#1)(1997-8#1)(2008-10#5)(2012-3#1)
detected over##3##2##(2008-10#3)
detected polymorphisms in##2##3##(2008-10#2)
detected powers##2##2##(2008-3#2)
detected significant##3##2##(1996-12#1)(2008-10#2)
detected significantly##2##2##(2008-10#1)(2008-12#1)
detected spectrophotometrically at##3##3##(2008-10#3)
detected spectrophotometrically##6##2##(2008-10#6)
detected the DNA##2##3##(2008-10#1)(2008-11#1)
detected the presence of##3##4##(1993-2#1)(2008-10#2)
detected the virus in##2##4##(2008-10#2)
detected the virus##3##3##(2008-10#3)
detected the##24##2##(1993-11#1)(1993-2#1)(1993-3#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-8#1)
detected through##2##2##(2008-10#1)(2012-3#1)
detected throughout the year##2##4##(2008-10#1)(2013-8#1)
detected throughout the##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
detected throughout##4##2##(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
detected to##5##2##(1994-12#1)(2008-10#1)(2008-9#1)(2013-1#2)
detected using a##9##3##(1997-8#1)(2008-10#8)
detected using all three##2##4##(2008-10#2)
detected using the##3##3##(2008-10#2)(2008-9#1)
detected using##25##2##(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-4#1)(2008-9#2)(2009-7#1)(2012-2#1)
detected were##3##2##(2008-10#2)(2013-1#1)
detected when##11##2##(1991-3#1)(1993-12#1)(2006-6#1)(2008-10#6)(2008-5#1)(2010-10#1)
detected with PCR##2##3##(1997-8#1)(2008-10#1)
detected with a##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
detected with the recovery of 90##2##6##(2008-10#2)
detected with the##10##3##(1991-3#1)(1993-8#1)(1995-2#1)(2008-10#7)
detected with##41##2##(1991-12#1)(1991-3#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-2#1)(1997-7#1)(1997-8#2)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#1)
detected within the##4##3##(2008-10#3)(2008-7#1)
detected within##11##2##(1993-3#1)(1995-2#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
detected##1334##1##(1990-11#2)(1990-12#5)(1990-2#2)(1990-5#7)(1990-8#5)(1990-9#3)(1991-12#6)(1991-2#2)(1991-3#4)(1991-5#5)(1991-6#2)(1991-7#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#8)(1993-5#1)(1993-6#5)(1993-8#7)(1993-9#3)(1994-1#1)(1994-11#11)(1994-12#4)(1994-2#8)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#1)(1995-11#9)(1995-12#9)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#8)(1995-8#5)(1995-9#2)(1996-11#1)(1996-12#27)(1996-2#4)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#7)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#6)(1997-8#13)(1997-9#2)(2006-6#2)(2007-11#2)(2007-12#4)(2008-10#655)(2008-11#48)(2008-12#24)(2008-2#4)(2008-3#13)(2008-4#10)(2008-5#36)(2008-6#4)(2008-7#12)(2008-8#40)(2008-9#44)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#7)(2010-1#6)(2010-10#2)(2010-11#3)(2010-12#5)(2010-4#1)(2010-5#6)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#29)(2011-3#5)(2012-12#10)(2012-2#22)(2012-3#22)(2012-6#1)(2012-7#1)(2013-1#27)(2013-7#2)(2013-8#13)
detecting DNA##3##2##(2008-10#3)
detecting a##4##2##(2008-10#3)(2008-4#1)
detecting and##6##2##(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
detecting as little as##2##4##(2008-10#2)
detecting hydroxyl radicals##2##3##(2008-10#2)
detecting the presence of##3##4##(1995-12#1)(2008-2#1)(2009-1#1)
detecting the##16##2##(1995-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-1#1)(2009-12#1)(2011-2#1)(2012-3#1)
detecting trace##2##2##(2008-10#1)(2010-7#1)
detecting##156##1##(1990-12#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-8#1)(2007-12#1)(2008-1#2)(2008-10#72)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
detection (2##2##2##(2008-10#2)
detection (AD) system##2##3##(2008-10#2)
detection (AD)##3##2##(2008-10#3)
detection (GC-EAD)##2##2##(2008-10#2)
detection (GC-MS)##2##2##(2008-10#2)
detection (HPLC-ECD)##2##2##(2008-10#1)(2008-5#1)
detection and analysis of##2##4##(2008-10#1)(2008-2#1)
detection and by##2##3##(1997-2#1)(2012-3#1)
detection and characterization of##7##4##(2008-10#2)(2008-4#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)
detection and characterization##10##3##(2008-10#3)(2008-3#1)(2008-4#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#1)
detection and differentiation of##2##4##(2008-10#2)
detection and discrimination##2##3##(2008-10#2)
detection and identification of##6##4##(2008-10#5)(2008-3#1)
detection and identification##7##3##(2008-10#6)(2008-3#1)
detection and intervention##5##3##(2008-11#1)(2009-6#1)(2010-10#2)(2012-2#1)
detection and isolation##2##3##(1996-12#1)(2008-4#1)
detection and quantification limits were##3##5##(2008-10#3)
detection and quantification limits##10##4##(2008-10#10)
detection and quantification of##9##4##(2008-10#8)(2010-7#1)
detection and quantification were##2##4##(2008-10#2)
detection and quantification##25##3##(2008-10#24)(2010-7#1)
detection and quantitation of##3##4##(1990-12#1)(2008-4#1)(2013-8#1)
detection and quantitation##7##3##(1990-12#1)(2008-10#4)(2008-4#1)(2013-8#1)
detection and quantitative##2##3##(2008-10#1)(2008-9#1)
detection and relative quantitation of##2##5##(2008-10#2)
detection and relative##5##3##(2008-10#5)
detection and spectrophotometric##2##3##(2008-10#2)
detection and staging of pancreatic##2##5##(2008-1#2)
detection and the##6##3##(2008-10#4)(2008-11#1)(2008-3#1)
detection and treatment of##2##4##(2008-4#1)(2012-2#1)
detection and treatment##5##3##(1995-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-2#1)
detection and##152##2##(1990-12#1)(1990-6#1)(1992-1#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-1#3)(2008-10#94)(2008-11#5)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#6)(2010-5#1)(2010-7#3)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-8#1)
detection are the##2##3##(2010-7#1)(2010-8#1)
detection are##14##2##(1997-2#1)(2008-10#10)(2009-5#1)(2010-7#1)(2010-8#1)
detection as well as##2##4##(2008-10#2)
detection as##7##2##(2008-10#6)(2011-2#1)
detection at 254 nm##2##4##(2008-10#1)(2009-8#1)
detection at 310 nm##2##4##(2008-10#1)(2008-5#1)
detection at a##6##3##(2008-10#6)
detection at anodized boron-doped diamond##2##5##(2008-10#2)
detection at anodized##3##3##(2008-10#3)
detection at the##5##3##(2008-10#4)(2008-11#1)
detection at##56##2##(1997-2#2)(2008-10#47)(2008-11#1)(2008-3#2)(2008-5#2)(2009-8#1)(2013-1#1)
detection bandwidth##4##2##(2008-3#3)(2009-5#1)
detection based on a##3##4##(2008-10#2)(2008-3#1)
detection based on##7##3##(2008-10#4)(2008-2#1)(2008-3#1)(2009-5#1)
detection being##2##2##(2008-10#2)
detection by PCR in##2##4##(2008-10#2)
detection by an##2##3##(2008-10#2)
detection by inductively coupled plasma mass spectrometry##4##7##(2008-10#4)
detection by##28##2##(1993-8#1)(1995-12#1)(2008-10#22)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#1)
detection capabilities##3##2##(2008-10#2)(2010-4#1)
detection capability##2##2##(2008-10#1)(2012-12#1)
detection cell##12##2##(2008-10#12)
detection channels##2##2##(2007-11#1)(2008-3#1)
detection combined with##3##3##(2008-10#3)
detection conditions were##2##3##(2008-10#2)
detection could##2##2##(2008-10#2)
detection current##2##2##(2008-10#2)
detection data##2##2##(2008-10#2)
detection efficiency##2##2##(2008-10#1)(2008-9#1)
detection electrode##3##2##(2008-10#3)
detection for each##3##3##(2008-10#3)
detection for ethanol##2##3##(2008-10#2)
detection for liquid##2##3##(2008-10#2)
detection for the analysis of chelerythrine and sanguinarine##2##8##(2008-10#2)
detection for the determination of##3##5##(2008-10#3)
detection for the##13##3##(1997-2#1)(2008-10#11)(2010-11#1)
detection for##64##2##(1991-7#2)(1997-2#2)(2008-10#55)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)
detection frequency of P##4##4##(2008-10#4)
detection frequency##6##2##(2008-10#6)
detection from##5##2##(2008-10#4)(2012-2#1)
detection has been developed for the determination of##3##8##(2008-10#3)
detection has been developed for the##4##6##(2008-10#4)
detection has been developed##7##4##(2008-10#7)
detection has been##11##3##(2008-10#11)
detection has##15##2##(1997-6#1)(2008-10#14)
detection have been##7##3##(2008-10#7)
detection have##8##2##(2008-10#8)
detection in a##4##3##(2008-10#4)
detection in an##2##3##(2007-11#1)(2008-10#1)
detection in flow analysis systems##2##5##(2008-10#2)
detection in flow analysis##3##4##(2008-10#3)
detection in flow##4##3##(2008-10#4)
detection in the presence of##3##5##(2008-10#2)(2008-9#1)
detection in the##24##3##(2008-10#17)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
detection in urine##3##3##(2008-10#3)
detection in##68##2##(1993-6#1)(2007-11#1)(2008-10#45)(2008-11#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#2)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
detection is 0##8##3##(2008-10#8)
detection is 2##5##3##(2008-10#5)
detection is described for the##2##5##(2008-10#2)
detection is described##6##3##(2008-10#6)
detection is presented##2##3##(2008-10#2)
detection is proposed##5##3##(2008-10#5)
detection is##54##2##(1993-2#1)(1997-2#1)(2008-10#43)(2008-3#4)(2008-9#1)(2009-1#1)(2010-7#1)(2013-1#2)
detection level##2##2##(2008-10#2)
detection limit (0##5##3##(2008-10#5)
detection limit (1##2##3##(2008-10#2)
detection limit (3 s)##2##4##(2008-10#2)
detection limit (3##8##3##(1991-12#1)(2008-10#7)
detection limit (3s) of##2##4##(2008-10#2)
detection limit (3s)##3##3##(2008-10#3)
detection limit (3sigma##2##3##(2008-10#2)
detection limit (3sigma) in##3##4##(2008-10#3)
detection limit (3sigma) is##2##4##(2008-10#2)
detection limit (3sigma) of 0##8##5##(2008-10#8)
detection limit (3sigma) of##14##4##(2008-10#14)
detection limit (3sigma) was##4##4##(2008-10#4)
detection limit (3sigma)##25##3##(2008-10#25)
detection limit (DL)##4##3##(2008-10#4)
detection limit (S/N=3) of##5##4##(2008-10#5)
detection limit (S/N=3)##12##3##(2008-10#12)
detection limit (as##2##3##(2008-10#2)
detection limit (log##3##3##(2008-10#3)
detection limit (signal-to-noise ratio##2##4##(2008-10#1)(2008-3#1)
detection limit (signal-to-noise##3##3##(2008-10#2)(2008-3#1)
detection limit (signal/noise##2##3##(2008-10#2)
detection limit 0##6##3##(2008-10#6)
detection limit 1##4##3##(2008-10#4)
detection limit achieved##2##3##(2008-10#2)
detection limit and precision##2##4##(2008-10#2)
detection limit and the##8##4##(2008-10#8)
detection limit and##22##3##(2008-10#22)
detection limit are##2##3##(2008-10#2)
detection limit could##2##3##(2008-10#2)
detection limit down to##2##4##(2008-10#2)
detection limit for the##6##4##(2008-10#6)
detection limit for trichlorfon##2##4##(2008-10#2)
detection limit for##37##3##(2008-10#36)(2008-12#1)
detection limit in##3##3##(2008-10#2)(2008-3#1)
detection limit is 0##24##4##(2008-10#24)
detection limit is 1##6##4##(2008-10#6)
detection limit is 2##6##4##(2008-10#6)
detection limit is 5##4##4##(2008-10#4)
detection limit is 6##2##4##(2008-10#2)
detection limit is##67##3##(2008-10#67)
detection limit obtained was 4##2##5##(2008-10#2)
detection limit obtained##4##3##(2008-10#3)(2008-3#1)
detection limit of 0##104##4##(1992-11#1)(2007-12#1)(2008-10#98)(2008-11#3)(2010-4#1)
detection limit of 1 muM##3##5##(2008-10#3)
detection limit of 1##51##4##(2008-10#48)(2008-11#1)(2008-2#1)(2008-3#1)
detection limit of 10##4##4##(2008-10#3)(2008-11#1)
detection limit of 12 mug l(-1)##2##6##(2008-10#2)
detection limit of 2##19##4##(2008-10#19)
detection limit of 20 ng ml(-1)##2##6##(2008-10#2)
detection limit of 20##5##4##(2008-10#5)
detection limit of 3##10##4##(2008-10#10)
detection limit of 32##2##4##(2008-10#2)
detection limit of 4##15##4##(2008-10#15)
detection limit of 5##9##4##(2008-10#9)
detection limit of 6##10##4##(2008-10#10)
detection limit of 7##3##4##(2008-10#3)
detection limit of 8##7##4##(2008-10#7)
detection limit of Cu(II)##2##4##(2008-10#2)
detection limit of about##3##4##(2008-10#3)
detection limit of the method##9##5##(2008-10#9)
detection limit of the##24##4##(2008-10#22)(2008-12#1)(2013-8#1)
detection limit of this method was##4##6##(1990-2#1)(2008-10#2)(2008-11#1)
detection limit of this method##7##5##(1990-2#1)(2008-10#5)(2008-11#1)
detection limit of this##9##4##(1990-2#1)(1995-11#1)(2008-10#6)(2008-11#1)
detection limit of##361##3##(1990-2#1)(1992-11#1)(1995-11#1)(2007-12#1)(2008-10#344)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-8#2)
detection limit to##2##3##(2008-10#2)
detection limit using##2##3##(2008-10#2)
detection limit was 0##26##4##(2008-10#26)
detection limit was 1##8##4##(2008-10#8)
detection limit was 10##2##4##(2008-10#2)
detection limit was 2##7##4##(2008-10#7)
detection limit was 20##2##4##(2008-10#2)
detection limit was 3##4##4##(2008-10#4)
detection limit was 4##3##4##(1990-12#1)(2008-10#2)
detection limit was 5##3##4##(2008-10#3)
detection limit was calculated##2##4##(2008-10#2)
detection limit was determined##4##4##(2008-10#4)
detection limit was estimated as 0##3##6##(2008-10#3)
detection limit was estimated##6##4##(2008-10#5)(2008-3#1)
detection limit was found to##4##5##(2008-10#4)
detection limit was improved to##2##5##(2008-10#2)
detection limit was lower##3##4##(2008-10#3)
detection limit was##106##3##(1990-12#1)(2008-10#104)(2008-3#1)
detection limit were##5##3##(2008-10#5)
detection limit##809##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-11#1)(1995-11#1)(2007-12#1)(2008-10#783)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2010-4#1)(2013-8#2)
detection limit) and##2##3##(2008-10#1)(2008-2#1)
detection limit)##3##2##(2008-10#2)(2008-2#1)
detection limits (0##4##3##(2008-10#4)
detection limits (3sigma) of##3##4##(2008-10#3)
detection limits (3sigma) were##3##4##(2008-10#3)
detection limits (3sigma)##10##3##(2008-10#10)
detection limits (DL)##4##3##(2008-10#4)
detection limits (LOD)##3##3##(2008-10#3)
detection limits (S/N=3) are##3##4##(2008-10#3)
detection limits (S/N=3) of##4##4##(2008-10#4)
detection limits (S/N=3) ranged from 0##2##6##(2008-10#2)
detection limits (S/N=3)##13##3##(2008-10#13)
detection limits achieved were##2##4##(2008-10#2)
detection limits achieved##5##3##(2008-10#5)
detection limits and the##2##4##(2008-10#2)
detection limits and##12##3##(2008-10#11)(2008-3#1)
detection limits are 0##6##4##(2008-10#6)
detection limits are 1##3##4##(2008-10#3)
detection limits are 3##2##4##(2008-10#2)
detection limits are##20##3##(1995-9#2)(2008-10#18)
detection limits being##2##3##(2008-10#2)
detection limits for the##4##4##(2008-10#4)
detection limits for##35##3##(1995-9#2)(1997-2#1)(2008-10#31)(2008-3#1)
detection limits in the range##2##5##(2008-10#2)
detection limits in the##3##4##(2008-10#3)
detection limits in##5##3##(2008-10#5)
detection limits obtained were##2##4##(2008-10#2)
detection limits obtained##6##3##(2008-10#6)
detection limits of 0##17##4##(2008-10#17)
detection limits of 1##2##4##(2008-10#2)
detection limits of 2##2##4##(2008-10#2)
detection limits of 7##3##4##(2008-10#3)
detection limits of about##2##4##(2008-10#2)
detection limits of the method##3##5##(2008-10#3)
detection limits of the##12##4##(2008-10#12)
detection limits of this##2##4##(2008-10#2)
detection limits of##73##3##(2008-10#73)
detection limits on##2##3##(2008-10#2)
detection limits range##2##3##(2008-10#1)(2012-2#1)
detection limits ranged from##2##4##(2008-10#2)
detection limits ranging from 0##3##5##(2008-10#3)
detection limits ranging from 2##2##5##(2008-10#2)
detection limits ranging from##6##4##(2008-10#6)
detection limits under##2##3##(2008-10#2)
detection limits were 0##11##4##(2008-10#11)
detection limits were 10##2##4##(2008-10#2)
detection limits were 7##2##4##(2008-10#2)
detection limits were found to be##6##6##(2008-10#6)
detection limits were in the##2##5##(2008-10#2)
detection limits were##50##3##(2008-10#49)(2011-2#1)
detection limits##333##2##(1995-9#4)(1997-2#1)(2008-10#322)(2008-3#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
detection method for##8##3##(2008-10#7)(2008-11#1)
detection method is##2##3##(2008-11#1)(2008-9#1)
detection method of##2##3##(2008-10#2)
detection method provides##2##3##(1993-1#1)(2008-10#1)
detection method##25##2##(1993-1#1)(1997-8#1)(2008-10#18)(2008-11#3)(2008-9#2)
detection methods and##3##3##(2008-10#2)(2008-11#1)
detection methods are##2##3##(2008-10#1)(2008-4#1)
detection methods##21##2##(2008-10#13)(2008-11#3)(2008-4#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-1#1)
detection mode##3##2##(2008-10#3)
detection modes##5##2##(2008-10#5)
detection of 0##15##3##(2008-10#15)
detection of 1##5##3##(2008-10#5)
detection of 2##2##3##(2008-10#2)
detection of ASPV##2##3##(2008-10#2)
detection of BrdU##2##3##(2008-9#2)
detection of Cu(2+)##2##3##(2008-10#2)
detection of DNA fragmentation##2##4##(1995-12#1)(2008-10#1)
detection of DNA hybridization##3##4##(2008-10#3)
detection of DNA strand##3##4##(2008-10#2)(2008-9#1)
detection of DNA##13##3##(1995-12#1)(2008-10#11)(2008-9#1)
detection of E##2##3##(2008-10#2)
detection of Escherichia coli O157##3##5##(2008-10#3)
detection of Escherichia coliform##2##4##(2008-10#2)
detection of Escherichia##5##3##(2008-10#5)
detection of HRP##2##3##(2008-10#2)
detection of M##2##3##(2008-10#1)(2008-5#1)
detection of NADH##4##3##(1992-9#1)(2008-10#3)
detection of NO##6##3##(2008-10#3)(2008-3#2)(2010-7#1)
detection of P##10##3##(2008-10#10)
detection of Phytophthora##4##3##(2008-10#4)
detection of Pseudomonas##2##3##(2008-10#2)
detection of Renibacterium salmoninarum##2##4##(2009-6#2)
detection of V##2##3##(2008-10#1)(2008-9#1)
detection of a single-base##2##4##(2008-10#2)
detection of a virus##2##4##(2008-10#2)
detection of a##25##3##(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#13)(2008-3#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-7#1)(2011-2#2)
detection of alkaline phosphatase activity##2##5##(2008-10#2)
detection of alkaline phosphatase##3##4##(2008-10#3)
detection of all##3##3##(2008-10#3)
detection of alleles##2##3##(2008-10#2)
detection of an##3##3##(2008-10#3)
detection of anions##2##3##(2008-10#2)
detection of antibodies class G##2##5##(2013-1#2)
detection of antibodies##7##3##(1990-12#3)(1991-3#2)(2013-1#2)
detection of any##2##3##(2008-5#1)(2013-1#1)
detection of arsenic using flow-injection hydride generation following sorbent extraction preconcentration##2##11##(2008-10#2)
detection of arsenic##3##3##(2008-10#3)
detection of as##2##3##(2008-9#1)(2010-4#1)
detection of ascorbate##2##3##(2008-10#2)
detection of begomoviruses##3##3##(2008-10#3)
detection of beryllium##2##3##(2008-10#2)
detection of cancer cells##2##4##(2008-11#2)
detection of cancer##3##3##(1990-6#1)(2008-11#2)
detection of carbohydrates##2##3##(2008-10#2)
detection of changes in##2##4##(2006-6#1)(2008-7#1)
detection of colorectal##2##3##(1995-12#1)(2008-1#1)
detection of common##2##3##(2008-10#1)(2013-8#1)
detection of congenital##2##3##(1993-12#1)(1994-9#1)
detection of different##4##3##(2008-10#4)
detection of disease##2##3##(2008-6#1)(2012-2#1)
detection of dye labelled DNA##2##5##(2008-10#2)
detection of explosives##5##3##(2008-10#5)
detection of fluorescence##2##3##(2010-12#2)
detection of four##2##3##(2008-10#2)
detection of gas##2##3##(2008-10#1)(2008-3#1)
detection of hantavirus antibodies##2##4##(2008-10#2)
detection of hantavirus##3##3##(2008-10#3)
detection of heavy##2##3##(2008-10#1)(2011-2#1)
detection of homologous##2##3##(2008-10#1)(2008-11#1)
detection of human heart fatty-acid binding protein##2##7##(2008-10#2)
detection of human##3##3##(1992-6#1)(2008-10#2)
detection of hydrazine##4##3##(2008-10#4)
detection of hydrogen peroxide##4##4##(2008-10#4)
detection of hydrogen##5##3##(2008-10#5)
detection of influenza##2##3##(2011-2#2)
detection of melatonin##2##3##(2008-10#2)
detection of metal##2##3##(2008-10#1)(2010-11#1)
detection of microorganisms in##2##4##(2011-2#2)
detection of monovalent##2##3##(2008-10#2)
detection of multiple##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
detection of nine grapevine viruses##2##5##(2008-10#2)
detection of nitric oxide##5##4##(2008-10#4)(2008-3#1)
detection of nitrogen##2##3##(2008-10#1)(2008-2#1)
detection of objects in##2##4##(2008-3#2)
detection of organic##2##3##(2008-10#2)
detection of organophosphorus##2##3##(2008-10#2)
detection of other##3##3##(2008-10#2)(2012-2#1)
detection of paraoxon##4##3##(2008-10#4)
detection of pathogens##2##3##(2008-10#1)(2011-2#1)
detection of phosphate##2##3##(2008-10#2)
detection of phosphorylated##3##3##(2008-9#3)
detection of phytoplasma in##2##4##(2008-10#2)
detection of plant viruses##4##4##(2008-10#3)(2008-9#1)
detection of plant##6##3##(2007-12#1)(2008-10#4)(2008-9#1)
detection of proteins##2##3##(2008-10#1)(2009-3#1)
detection of rhizomania##2##3##(2008-10#2)
detection of several##3##3##(2008-10#2)(2009-3#1)
detection of significant##2##3##(2010-5#1)(2012-2#1)
detection of single##4##3##(1997-7#1)(2008-10#1)(2008-9#1)(2010-8#1)
detection of some organic##2##4##(2008-10#2)
detection of some##3##3##(2008-10#3)
detection of sulfide##2##3##(2008-10#2)
detection of surface and intracellular antigens##2##6##(1990-12#2)
detection of synthetic pyrethroids containing##2##5##(2008-10#2)
detection of the DNA##2##4##(2008-10#1)(2013-1#1)
detection of the hybridization##2##4##(2008-10#2)
detection of the pathogen##3##4##(2008-10#3)
detection of the three##3##4##(2008-10#3)
detection of the virus in##2##5##(2008-10#2)
detection of the##87##3##(1990-12#2)(1994-12#1)(2007-12#1)(2008-10#65)(2008-11#2)(2008-3#5)(2008-5#1)(2008-9#1)(2009-12#3)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
detection of these##5##3##(2008-10#5)
detection of thiols##2##3##(2008-10#2)
detection of this##3##3##(2008-10#2)(2008-11#1)
detection of three##2##3##(2008-10#2)
detection of toxic compounds##2##4##(2008-10#1)(2008-11#1)
detection of trace##9##3##(2008-10#9)
detection of trinitrotoluene##2##3##(2008-10#2)
detection of two##4##3##(2008-10#3)(2013-8#1)
detection of uric acid##2##4##(2008-10#2)
detection of weak analytical##2##4##(2008-10#2)
detection of whole##2##3##(2008-10#1)(2008-5#1)
detection of##821##2##(1990-12#13)(1990-2#2)(1990-6#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#4)(1992-10#1)(1992-11#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#6)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#2)(1997-8#2)(2006-6#1)(2007-12#5)(2008-1#4)(2008-10#516)(2008-11#18)(2008-12#5)(2008-2#8)(2008-3#24)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#27)(2009-1#1)(2009-12#4)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#5)(2010-12#6)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#3)(2010-8#4)(2011-1#1)(2011-2#19)(2011-7#2)(2012-12#2)(2012-2#11)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#7)
detection on##4##2##(2008-10#3)(2009-9#1)
detection or##2##2##(2010-12#1)(2012-2#1)
detection potential was##2##3##(2008-10#2)
detection potential##8##2##(2008-10#8)
detection power##2##2##(2008-10#2)
detection processes##6##2##(2008-10#5)(2008-3#1)
detection provided by##3##3##(2008-10#3)
detection provided##5##2##(2008-10#5)
detection range of##3##3##(1992-12#1)(2008-10#2)
detection range##6##2##(1992-12#1)(2008-10#5)
detection rate of##3##3##(1994-1#1)(2010-12#1)(2013-8#1)
detection rate##6##2##(1994-1#1)(1997-4#2)(2008-10#1)(2010-12#1)(2013-8#1)
detection rates of##2##3##(2008-2#1)(2011-7#1)
detection rates##3##2##(2008-2#1)(2010-12#1)(2011-7#1)
detection reagents##2##2##(2008-10#2)
detection scheme for##4##3##(2008-10#4)
detection scheme is##2##3##(2008-10#1)(2012-2#1)
detection scheme##13##2##(2008-10#8)(2008-2#3)(2012-2#2)
detection selectivity##2##2##(1997-6#1)(2008-10#1)
detection sensitivity and##2##3##(2008-10#1)(2012-12#1)
detection sensitivity is##3##3##(2008-10#2)(2008-3#1)
detection sensitivity of##3##3##(2008-10#2)(2008-3#1)
detection sensitivity##14##2##(2008-10#9)(2008-2#1)(2008-3#3)(2012-12#1)
detection statistics##2##2##(2008-3#2)
detection step##2##2##(2008-10#2)
detection strategies is##2##3##(2008-10#2)
detection strategies##4##2##(2008-10#4)
detection system for##4##3##(1997-2#1)(2008-10#2)(2010-7#1)
detection system is##2##3##(2008-10#2)
detection system of##2##3##(2008-10#1)(2008-9#1)
detection system using##2##3##(2008-10#1)(2008-9#1)
detection system was##2##3##(2008-10#2)
detection system with##2##3##(2008-10#2)
detection system##34##2##(1997-2#1)(2008-10#27)(2008-3#3)(2008-9#2)(2010-7#1)
detection systems based on##3##4##(2008-10#2)(2008-3#1)
detection systems##14##2##(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#2)
detection task##2##2##(2008-11#1)(2008-9#1)
detection teams##3##2##(2011-1#3)
detection technique is##2##3##(2008-10#2)
detection technique##11##2##(2008-10#11)
detection techniques##7##2##(1994-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-3#1)
detection test##6##2##(2008-10#5)(2008-9#1)
detection tests##2##2##(1991-3#1)(2008-9#1)
detection than##3##2##(2008-10#2)(2008-5#1)
detection threshold##2##2##(2008-3#1)(2008-7#1)
detection to the##2##3##(1996-2#1)(2008-10#1)
detection to##9##2##(1996-2#1)(2007-12#1)(2008-10#6)(2008-3#1)
detection using a##5##3##(2008-10#3)(2008-9#1)(2012-2#1)
detection using the##3##3##(2008-10#2)(2012-2#1)
detection using##19##2##(2008-10#14)(2008-5#1)(2008-9#1)(2009-5#1)(2012-2#2)
detection via##3##2##(2008-10#3)
detection was 0##10##3##(2008-10#10)
detection was accomplished by##2##4##(2008-10#2)
detection was achieved at##2##4##(2008-10#2)
detection was achieved##3##3##(2008-10#3)
detection was also studied##2##4##(2008-10#2)
detection was applied to the determination of##2##7##(2008-10#2)
detection was applied##3##3##(2008-10#3)
detection was at##3##3##(2008-10#3)
detection was based on the##3##5##(2008-10#3)
detection was carried out at##2##5##(2008-10#2)
detection was carried out using##2##5##(2008-10#1)(2011-2#1)
detection was carried out##5##4##(2008-10#4)(2011-2#1)
detection was described##2##3##(2008-10#2)
detection was developed for the rapid separation and##2##8##(2008-10#2)
detection was developed for the##3##5##(2008-10#3)
detection was developed##9##3##(2008-10#9)
detection was employed##2##3##(2008-10#2)
detection was established##2##3##(2008-10#2)
detection was evaluated##3##3##(2008-10#3)
detection was fabricated##2##3##(2008-10#2)
detection was investigated##2##3##(2008-10#2)
detection was obtained##2##3##(2008-10#2)
detection was performed##8##3##(2008-10#8)
detection was##97##2##(1997-2#1)(2008-10#93)(2009-5#1)(2011-2#1)(2011-3#1)
detection wavelength##4##2##(2008-10#4)
detection were 0##4##3##(2008-10#4)
detection were investigated##5##3##(2008-10#5)
detection were##32##2##(2008-10#32)
detection when##3##2##(2008-3#2)(2009-6#1)
detection will be##2##3##(2008-10#1)(2008-3#1)
detection will##4##2##(2008-10#2)(2008-3#2)
detection with a##7##3##(2007-12#1)(2008-10#4)(2008-5#2)
detection with an##4##3##(1995-2#1)(1997-2#1)(2008-10#2)
detection with##25##2##(1990-8#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#16)(2008-5#2)(2008-9#2)(2013-8#1)
detection without##2##2##(2008-10#1)(2013-8#1)
detection##3611##1##(1990-12#16)(1990-2#3)(1990-6#2)(1990-8#6)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#6)(1991-7#5)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#2)(1995-9#5)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#18)(1997-3#2)(1997-4#2)(1997-6#5)(1997-7#2)(1997-8#6)(2006-6#1)(2007-11#2)(2007-12#12)(2008-1#9)(2008-10#2887)(2008-11#50)(2008-12#9)(2008-2#24)(2008-3#98)(2008-4#16)(2008-5#21)(2008-6#5)(2008-7#12)(2008-8#5)(2008-9#55)(2009-1#3)(2009-12#7)(2009-3#4)(2009-4#4)(2009-5#9)(2009-6#6)(2009-7#1)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#11)(2010-12#21)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#8)(2010-7#15)(2010-8#8)(2010-9#1)(2011-1#6)(2011-2#35)(2011-3#1)(2011-7#4)(2012-12#4)(2012-2#30)(2012-3#10)(2012-8#1)(2013-1#18)(2013-7#1)(2013-8#17)
detection)##6##1##(1993-8#1)(2008-10#5)
detection/identification##2##1##(2008-10#1)(2008-9#1)
detections of##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
detections##13##1##(2008-10#11)(2008-3#1)(2010-7#1)
detectivity##2##1##(2008-2#1)(2008-3#1)
detector and a##7##3##(2008-10#6)(2008-2#1)
detector and##15##2##(1990-8#1)(2008-10#12)(2008-2#1)(2011-3#1)
detector are##4##2##(2008-10#4)
detector as a##3##3##(2008-10#3)
detector as##4##2##(2008-10#3)(2008-3#1)
detector at a##3##3##(2008-10#3)
detector at##5##2##(2008-10#5)
detector based on##5##3##(2008-10#5)
detector cell##3##2##(2008-10#3)
detector dogs##4##2##(2008-10#4)
detector due to the##2##4##(2008-10#2)
detector electrode##2##2##(2008-10#2)
detector for a##2##3##(2008-10#2)
detector for capillary electrophoresis##4##4##(2008-10#4)
detector for liquid chromatography##2##4##(2008-10#2)
detector for the determination of##7##5##(2008-10#6)(2009-8#1)
detector for the##16##3##(2008-10#14)(2008-2#1)(2009-8#1)
detector for time-resolved##2##3##(2008-11#2)
detector for##45##2##(2008-10#39)(2008-11#2)(2008-2#1)(2008-3#1)(2009-8#1)(2013-1#1)
detector has been developed##2##4##(2008-3#1)(2013-1#1)
detector has been##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
detector has##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
detector in a sequential injection analysis system##2##7##(2008-10#2)
detector in a##3##3##(2008-10#3)
detector in##10##2##(2008-10#10)
detector is described##2##3##(2008-10#2)
detector is developed##2##3##(2008-10#2)
detector is used##3##3##(2008-10#2)(2008-3#1)
detector is##17##2##(2008-10#14)(2008-3#3)
detector on##2##2##(2008-10#2)
detector response at##2##3##(2008-10#2)
detector response is##3##3##(2008-10#2)(2008-3#1)
detector response##11##2##(2008-10#8)(2008-3#1)(2010-3#2)
detector showed good sensitivity##2##4##(2008-10#2)
detector showed##4##2##(2008-10#4)
detector that##2##2##(1990-8#1)(2008-10#1)
detector to##2##2##(2008-10#2)
detector was developed for##3##4##(2008-10#3)
detector was developed##4##3##(1990-8#1)(2008-10#3)
detector was used##4##3##(2008-10#3)(2008-2#1)
detector was##12##2##(1990-8#1)(2008-10#10)(2008-2#1)
detector were##4##2##(2008-10#4)
detector with a##5##3##(2008-10#4)(2008-2#1)
detector with an##4##3##(2008-10#4)
detector with##10##2##(2008-10#9)(2008-2#1)
detector##377##1##(1990-12#1)(1990-8#5)(2007-12#1)(2008-10#328)(2008-11#5)(2008-2#6)(2008-3#16)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-3#3)(2011-2#1)(2011-3#1)(2013-1#3)
detector)##4##1##(2008-10#2)(2008-3#1)(2008-5#1)
detectors and##2##2##(2008-3#1)(2008-4#1)
detectors are##2##2##(2008-10#1)(2010-3#1)
detectors for flow##2##3##(2008-10#2)
detectors for##11##2##(2008-10#11)
detectors in##2##2##(2008-10#2)
detectors proved to##2##3##(2008-10#2)
detectors were used##2##3##(2008-10#2)
detectors with##3##2##(2008-10#1)(2008-3#2)
detectors##48##1##(1990-8#1)(2008-10#33)(2008-11#1)(2008-3#7)(2008-4#3)(2008-9#1)(2009-5#1)(2010-3#1)
detects the##6##2##(1993-2#1)(2008-10#5)
detects##20##1##(1993-2#1)(1997-2#1)(2008-1#2)(2008-10#8)(2008-11#1)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
deter##3##1##(1993-12#1)(2008-10#1)(2012-2#1)
detergent and##2##2##(2008-4#2)
detergent##20##1##(1990-5#1)(1991-10#1)(1994-8#1)(1997-7#1)(2008-10#3)(2008-4#4)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#4)(2013-1#1)
detergent-based##2##1##(2008-5#1)(2008-9#1)
detergents and##4##2##(1990-2#1)(2008-10#2)(2008-5#1)
detergents##17##1##(1990-2#1)(1990-5#1)(1991-5#1)(1992-7#1)(1994-8#1)(2008-10#9)(2008-4#1)(2008-5#1)(2012-2#1)
deteriorate in##2##2##(1995-12#1)(2008-10#1)
deteriorate##5##1##(1993-3#1)(1995-12#1)(2008-10#2)(2012-2#1)
deteriorated##6##1##(1995-12#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)
deteriorates##2##1##(2010-4#1)(2013-1#1)
deteriorating environmental conditions over##2##4##(2008-8#2)
deteriorating the##2##2##(2008-10#2)
deteriorating##8##1##(2008-10#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
deterioration and##3##2##(2008-7#1)(2010-7#1)(2011-2#1)
deterioration in the##3##3##(2008-7#1)(2010-10#1)(2011-2#1)
deterioration in##10##2##(1996-9#1)(2008-10#2)(2008-7#2)(2008-9#2)(2010-10#1)(2011-2#1)(2012-2#1)
deterioration of the##3##3##(1992-6#1)(1993-2#1)(2008-10#1)
deterioration of##14##2##(1991-2#1)(1991-8#2)(1992-6#1)(1993-2#1)(1997-8#1)(2008-10#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2013-7#1)
deterioration##49##1##(1991-2#1)(1991-8#2)(1992-6#1)(1993-2#1)(1996-9#1)(1997-8#1)(2008-10#14)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
determinability range##2##2##(2008-10#2)
determinable ranges##2##2##(2008-10#2)
determinable##5##1##(1992-5#1)(2008-10#4)
determinant for the##2##3##(1994-11#1)(2008-10#1)
determinant for##3##2##(1994-11#1)(2008-10#2)
determinant in the##2##3##(2008-10#2)
determinant in##4##2##(2008-10#4)
determinant of the durability of resistance##2##6##(2008-10#2)
determinant of the number##2##4##(1993-3#1)(2007-12#1)
determinant of the##9##3##(1992-2#1)(1993-3#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-8#1)
determinant of##32##2##(1990-12#1)(1990-8#1)(1992-2#1)(1992-9#1)(1993-3#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-7#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
determinant##47##1##(1990-12#2)(1990-8#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#14)(2008-11#4)(2008-5#2)(2008-7#1)(2009-7#3)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
determinants and##2##2##(2008-10#1)(2008-8#1)
determinants for##6##2##(1993-5#1)(1994-6#1)(1996-3#1)(2008-10#1)(2013-1#2)
determinants in##4##2##(1993-12#1)(2008-10#2)(2008-4#1)
determinants of the##5##3##(1995-11#1)(1997-4#1)(2008-10#1)(2011-1#1)(2011-3#1)
determinants of##45##2##(1990-12#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-1#2)(1997-4#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
determinants were##2##2##(2008-10#2)
determinants##86##1##(1990-12#1)(1991-3#1)(1991-8#2)(1992-12#2)(1992-2#2)(1992-9#1)(1993-1#2)(1993-12#2)(1993-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-3#3)(1997-1#2)(1997-4#1)(1997-9#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#3)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#1)
determinate##4##1##(2008-10#2)(2011-2#1)(2012-12#1)
determination (0##2##2##(2008-10#2)
determination (accuracy##2##2##(2008-10#2)
determination after##4##2##(2008-10#4)
determination and monitoring of##2##4##(2008-10#2)
determination and speciation of##4##4##(2008-10#4)
determination and speciation##5##3##(2008-10#5)
determination and the##4##3##(2008-10#4)
determination and##30##2##(1993-2#1)(1993-8#1)(1994-1#1)(2008-10#26)(2010-11#1)
determination are##5##2##(2008-10#5)
determination as well##2##3##(2008-10#2)
determination as##4##2##(2008-10#4)
determination at a##2##3##(2008-10#2)
determination at low##2##3##(2008-10#2)
determination at pH##2##3##(2008-10#2)
determination at the##3##3##(2008-10#3)
determination at##15##2##(2008-10#15)
determination based on the##3##4##(2008-10#3)
determination based on##5##3##(2008-10#5)
determination between##3##2##(2008-10#3)
determination by FAAS in##2##4##(2008-10#2)
determination by FAAS##4##3##(2008-10#4)
determination by atomic absorption spectrometry##2##5##(2008-10#2)
determination by atomic absorption##3##4##(2008-10#3)
determination by atomic##4##3##(2008-10#4)
determination by cold vapour atomic absorption spectrometry##3##7##(2008-10#3)
determination by cold##4##3##(2008-10#4)
determination by differential pulse##2##4##(2008-10#2)
determination by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
determination by electrothermal##3##3##(2008-10#3)
determination by energy dispersive X-ray fluorescence##2##6##(2008-10#2)
determination by flame atomic absorption spectrometry (FAAS)##4##7##(2008-10#4)
determination by flame atomic absorption spectrometry##17##6##(2008-10#17)
determination by flame atomic##19##4##(2008-10#19)
determination by flow injection##3##4##(2008-10#3)
determination by flow##4##3##(2008-10#4)
determination by flow-injection##2##3##(2008-10#2)
determination by graphite furnace atomic absorption spectrometry##4##7##(2008-10#4)
determination by inductively coupled plasma atomic emission spectrometry##6##8##(2008-10#6)
determination by inductively coupled plasma atomic emission##7##7##(2008-10#7)
determination by inductively coupled plasma optical emission spectrometry##3##8##(2008-10#3)
determination by inductively coupled plasma##11##5##(2008-10#11)
determination by inductively coupled plasma-atomic emission spectrometry##2##7##(2008-10#2)
determination by inductively coupled##13##4##(2008-10#13)
determination by solid##2##3##(2008-10#2)
determination by the proposed method##3##5##(2008-10#3)
determination by the##5##3##(2008-10#4)(2008-11#1)
determination by using##2##3##(2008-10#2)
determination by##107##2##(1993-8#1)(2008-10#104)(2008-11#1)(2008-5#1)
determination can be performed in the range of 0##2##9##(2008-10#2)
determination can be##5##3##(2008-10#5)
determination could be##2##3##(2008-10#1)(2008-5#1)
determination directly##2##2##(2008-10#2)
determination for##13##2##(1992-5#2)(2008-10#9)(2008-11#1)(2010-7#1)
determination from##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
determination has been##4##3##(2008-10#4)
determination has##5##2##(2008-10#5)
determination in a##9##3##(2008-10#9)
determination in air##2##3##(2008-10#2)
determination in alloys##2##3##(2008-10#2)
determination in animal##3##3##(2008-10#3)
determination in aqueous##4##3##(2008-10#4)
determination in biological samples##3##4##(2008-10#3)
determination in biological##4##3##(2008-10#4)
determination in blood##4##3##(2008-10#4)
determination in certified reference materials##2##5##(2008-10#2)
determination in drinks##3##3##(2008-10#3)
determination in drugs##2##3##(2008-10#2)
determination in edible seaweed##2##4##(2008-10#2)
determination in edible##3##3##(2008-10#3)
determination in environmental samples by##2##5##(2008-10#2)
determination in environmental samples##4##4##(2008-10#4)
determination in environmental##7##3##(2008-10#7)
determination in food##3##3##(2008-10#3)
determination in geological samples by##2##5##(2008-10#2)
determination in honey##2##3##(2008-10#2)
determination in human urine##3##4##(2008-10#3)
determination in human##4##3##(2008-10#4)
determination in milk samples##2##4##(2008-10#2)
determination in natural water samples##2##5##(2008-10#2)
determination in natural water##3##4##(2008-10#3)
determination in natural waters##4##4##(2008-10#4)
determination in natural##10##3##(2008-10#10)
determination in pharmaceutical preparations##2##4##(2008-10#2)
determination in pharmaceutical samples##2##4##(2008-10#2)
determination in pharmaceutical##6##3##(2008-10#6)
determination in plant##2##3##(2008-10#2)
determination in real samples##2##4##(2008-10#2)
determination in river##2##3##(2008-10#2)
determination in sediment##2##3##(2008-10#2)
determination in sediments##2##3##(2008-10#2)
determination in serum##2##3##(2008-10#2)
determination in standard##2##3##(2008-10#2)
determination in the concentration range##2##5##(2008-10#2)
determination in the concentration##3##4##(2008-10#3)
determination in the presence of##6##5##(2008-10#6)
determination in the range##3##4##(2008-10#3)
determination in the##22##3##(2008-10#22)
determination in urine by##2##4##(2008-10#2)
determination in urine samples##2##4##(2008-10#2)
determination in urine##9##3##(2008-10#9)
determination in various samples##2##4##(2008-10#2)
determination in various##5##3##(2008-10#5)
determination in water samples##5##4##(2008-10#5)
determination in water##7##3##(2008-10#7)
determination in wines##2##3##(2008-10#2)
determination in##226##2##(1992-5#1)(1992-8#1)(1995-9#1)(2008-10#218)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)
determination is 2##2##3##(2008-10#2)
determination is based on a##2##5##(2008-10#2)
determination is based on the##9##5##(2008-10#9)
determination is based on##14##4##(2008-10#13)(2010-6#1)
determination is developed##2##3##(2008-10#2)
determination is not##2##3##(1993-2#1)(2008-10#1)
determination is performed##2##3##(2008-10#2)
determination is presented##2##3##(2008-10#2)
determination is##40##2##(1993-2#1)(2008-10#37)(2008-5#1)(2010-6#1)
determination limit of##3##3##(2008-10#3)
determination limit was##6##3##(2008-10#6)
determination limit##13##2##(2008-10#13)
determination limits##5##2##(2008-10#5)
determination method for##9##3##(2008-10#9)
determination method of##4##3##(2008-10#4)
determination method##19##2##(2008-10#19)
determination methods of##2##3##(2008-10#2)
determination methods##3##2##(2008-10#3)
determination of 0##11##3##(2008-10#11)
determination of 1##4##3##(2008-10#4)
determination of 1-naphthylacetic acid##2##4##(2008-10#2)
determination of 10##2##3##(2008-10#2)
determination of 19##3##3##(2008-10#3)
determination of 2##3##3##(2008-10#3)
determination of 2-(thiocyanomethylthiol)benzothiazole##2##3##(2008-10#2)
determination of 2-mercaptopyrimidines##2##3##(2008-10#2)
determination of 3##2##3##(2008-10#2)
determination of 4-aminophenol##3##3##(2008-10#3)
determination of 5-hydroxymethylfurfural##2##3##(2008-10#2)
determination of 50##4##3##(2008-10#4)
determination of 6-mercaptopurine##3##3##(2008-10#3)
determination of AA##2##3##(2008-10#2)
determination of Ag##5##3##(2008-10#5)
determination of Ag(I)##3##3##(2008-10#3)
determination of Al in##2##4##(2008-10#2)
determination of Al##6##3##(2008-10#6)
determination of Al(3+)##2##3##(2008-10#2)
determination of Al(III) and Fe(III) in post-hemodialysis fluids##2##8##(2008-10#2)
determination of Al(III) and Fe(III) in##3##6##(2008-10#3)
determination of As##14##3##(2008-10#14)
determination of As(III) and As(V) in##2##6##(2008-10#2)
determination of As(III) and As(V)##3##5##(2008-10#3)
determination of As(III) in##5##4##(2008-10#5)
determination of As(III)##11##3##(2008-10#11)
determination of AsA##2##3##(2008-10#2)
determination of Bi##5##3##(2008-10#5)
determination of COD##3##3##(2008-10#3)
determination of Captopril in##3##4##(2008-10#3)
determination of Captopril##5##3##(2008-10#5)
determination of Cd and##4##4##(2008-10#4)
determination of Cd##13##3##(2008-10#13)
determination of Cd(2+)##2##3##(2008-10#2)
determination of Cd(II)##4##3##(2008-10#4)
determination of Ce##2##3##(2008-10#2)
determination of Co##4##3##(2008-10#4)
determination of Co(II)##6##3##(2008-10#6)
determination of Cr(III) and Cr(VI) in##4##6##(2008-10#4)
determination of Cr(III) and##5##4##(2008-10#5)
determination of Cr(III)##11##3##(2008-10#11)
determination of Cr(VI) and Cr(III)##2##5##(2008-10#2)
determination of Cr(VI) in##2##4##(2008-10#2)
determination of Cr(VI)##5##3##(2008-10#5)
determination of Cu and##4##4##(2008-10#4)
determination of Cu##10##3##(2008-10#10)
determination of Cu(II) in##6##4##(2008-10#6)
determination of Cu(II)##9##3##(2008-10#9)
determination of Cypermethrin and Chlorpyrifos##2##5##(2008-10#2)
determination of DES##2##3##(2008-10#2)
determination of DNA content##2##4##(2008-9#2)
determination of DNA##5##3##(2008-10#2)(2008-9#3)
determination of Eu##2##3##(2008-10#2)
determination of Fe and V in##2##6##(2008-10#2)
determination of Fe and##6##4##(2008-10#5)(2013-8#1)
determination of Fe##9##3##(2008-10#8)(2013-8#1)
determination of Fe(3+)##2##3##(2008-10#2)
determination of Fe(II) and Fe(III) in pharmaceutical products##2##8##(2008-10#2)
determination of Fe(II) and Fe(III) in##3##6##(2008-10#3)
determination of Fe(II) and Fe(III)##7##5##(2008-10#7)
determination of Fe(II) and##8##4##(2008-10#8)
determination of Fe(II)##12##3##(2008-10#12)
determination of Fe(III) and Fe(II)##3##5##(2008-10#3)
determination of Fe(III) and##4##4##(2008-10#4)
determination of Fe(III) in the presence of Fe(II)##3##8##(2008-10#3)
determination of Fe(III) in the##4##5##(2008-10#4)
determination of Fe(III)##8##3##(2008-10#8)
determination of GSH in##2##4##(2008-10#2)
determination of GSH##3##3##(2008-10#3)
determination of H(2)O(2) in##4##4##(2008-10#4)
determination of H(2)O(2)##9##3##(2008-10#9)
determination of Hexythiazox in pesticide formulations##2##6##(2008-10#2)
determination of Hg in water##2##5##(2008-10#2)
determination of Hg in##5##4##(2008-10#5)
determination of Hg##6##3##(2008-10#6)
determination of Hg(II) in water samples##2##6##(2008-10#2)
determination of Hg(II) in##6##4##(2008-10#6)
determination of Hg(II)##10##3##(2008-10#10)
determination of Imatinib##2##3##(2008-10#2)
determination of L-dopa##2##3##(2008-10#2)
determination of Losartan and Valsartan in##2##6##(2008-10#2)
determination of MT in##2##4##(2008-10#2)
determination of Mancozeb in##2##4##(2008-10#2)
determination of Mn##2##3##(2008-10#2)
determination of Mo in##2##4##(2008-10#2)
determination of Mo##5##3##(2008-10#5)
determination of Mo(VI)##2##3##(2008-10#2)
determination of N-nitrosoamines##2##3##(2008-10#2)
determination of NO##3##3##(2008-10#3)
determination of Ni and Cr##2##5##(2008-10#2)
determination of Ni in##2##4##(2008-10#2)
determination of Ni##6##3##(2008-10#6)
determination of Ni(II) and Co(II)##3##5##(2008-10#3)
determination of PAHs##2##3##(2008-10#1)(2008-11#1)
determination of PCP##2##3##(2008-10#2)
determination of Pb##6##3##(2008-10#6)
determination of Pb(2+) and Cd(2+)##3##5##(2008-10#3)
determination of Pb(2+)##5##3##(2008-10#5)
determination of R-timolol in S-timolol maleate##2##6##(2008-10#2)
determination of Ru (III)##2##4##(2008-10#2)
determination of Sb(III) and Bi(III)##3##5##(2008-10#3)
determination of Sb(III) and Sb(V)##2##5##(2008-10#2)
determination of Sb(III) and##5##4##(2008-10#5)
determination of Sb(III) in Sb(III)/Sb(V) binary mixtures##2##7##(2008-10#2)
determination of Sb(III) in##4##4##(2008-10#4)
determination of Sb(III)##9##3##(2008-10#9)
determination of Se##10##3##(2008-10#10)
determination of Se(IV) and Se(VI)##2##5##(2008-10#2)
determination of Se(IV)##7##3##(2008-10#7)
determination of TAM in##2##4##(2008-10#2)
determination of Tween 80##2##4##(2008-10#2)
determination of V(V) and Al(III)##2##5##(2008-10#2)
determination of V(V) and##4##4##(2008-10#4)
determination of V(V) in##2##4##(2008-10#2)
determination of V(V)##7##3##(2008-10#7)
determination of VOCs in##2##4##(2008-10#2)
determination of Vitamin D(3) and 25-OH-D(3) in##2##7##(2008-10#2)
determination of Vitamin D(3) and##4##5##(2008-10#4)
determination of Vitamin##5##3##(2008-10#5)
determination of W(VI)##3##3##(2008-10#3)
determination of Ziram##3##3##(2008-10#3)
determination of Zn(2+) and Pb(2+)##2##5##(2008-10#2)
determination of Zn(2+)##3##3##(2008-10#3)
determination of Zr##2##3##(2008-10#2)
determination of Zr(IV) and Hf(IV)##2##5##(2008-10#2)
determination of a##16##3##(1994-3#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
determination of acetaminophen##3##3##(2008-10#3)
determination of acetylsalicylic acid (ASA)##2##5##(2008-10#2)
determination of acetylsalicylic acid##4##4##(2008-10#4)
determination of acid dissociation constants##3##5##(2008-10#3)
determination of acid numbers##2##4##(2008-10#2)
determination of acid values in oilseeds without titration##2##8##(2008-10#2)
determination of acid volatile sulfide in river sediments##2##8##(2008-10#2)
determination of acid volatile sulfide##3##5##(2008-10#3)
determination of acid volatile##4##4##(2008-10#4)
determination of acid##11##3##(2008-10#11)
determination of acidity constants##3##4##(2008-10#3)
determination of acrivastine in capsules##2##5##(2008-10#2)
determination of acrivastine in##3##4##(2008-10#3)
determination of acrivastine##4##3##(2008-10#4)
determination of active##3##3##(2008-10#3)
determination of acylglycerols##2##3##(2009-8#2)
determination of adenine in##2##4##(2008-10#2)
determination of airborne carbamates in##2##5##(2008-10#2)
determination of airborne##3##3##(2008-10#3)
determination of albumin and immunoglobulin G##2##6##(2008-10#2)
determination of albumin and##3##4##(2008-10#3)
determination of aldehydes##2##3##(2008-10#2)
determination of aliphatic amines in##3##5##(2008-10#3)
determination of aliphatic amines##6##4##(2008-10#6)
determination of aliphatic##7##3##(2008-10#7)
determination of alkaline phosphatase##2##4##(2008-10#2)
determination of alkaline##3##3##(2008-10#3)
determination of all three##2##4##(2008-10#2)
determination of all##7##3##(2008-10#7)
determination of alpha-glycerophosphate##2##3##(2008-10#2)
determination of aluminium##7##3##(2008-10#7)
determination of aluminum in drinking water##2##6##(2008-10#2)
determination of aluminum in##3##4##(2008-10#3)
determination of aluminum##5##3##(2008-10#5)
determination of ambroxol hydrochloride and doxycycline in pharmaceutical preparations##2##9##(2008-10#2)
determination of amiloride##2##3##(2008-10#2)
determination of amino acids##4##4##(2008-10#4)
determination of aminocaproic acid in pharmaceutical formulations##2##7##(2008-10#2)
determination of aminomethylbenzoic acid and aminophylline##2##6##(2008-10#2)
determination of aminomethylbenzoic acid##3##4##(2008-10#3)
determination of ammonia in##4##4##(2008-10#4)
determination of ammonia##7##3##(1995-3#2)(2008-10#5)
determination of ammonium and##4##4##(2008-10#4)
determination of ammonium in##2##4##(2008-10#2)
determination of ammonium##12##3##(2008-10#12)
determination of amphetamine##3##3##(2008-10#3)
determination of ampicillin and tetracycline in milk by##2##8##(2008-10#2)
determination of analyte ions##2##4##(2008-10#2)
determination of analytes in##3##4##(2008-10#3)
determination of analytes##4##3##(2008-10#4)
determination of andrographolide##2##3##(2008-10#2)
determination of anionic surfactants##4##4##(2008-10#4)
determination of anionic##6##3##(2008-10#6)
determination of anions##4##3##(2008-10#4)
determination of antimony in pharmaceuticals##3##5##(2008-10#3)
determination of antimony in##7##4##(2008-10#7)
determination of antimony##15##3##(2008-10#15)
determination of antimony(III) and antimony(V)##2##5##(2008-10#2)
determination of antimony(III) in##2##4##(2008-10#2)
determination of antimony(III)##4##3##(2008-10#4)
determination of arsenic (As)##2##4##(2008-10#2)
determination of arsenic in essential##2##5##(2008-10#2)
determination of arsenic in##10##4##(2008-10#10)
determination of arsenic species in##2##5##(2008-10#2)
determination of arsenic##20##3##(2008-10#20)
determination of ascorbic acid (AA)##3##5##(2008-10#3)
determination of ascorbic acid (AsA)##2##5##(2008-10#2)
determination of ascorbic acid and##2##5##(2008-10#2)
determination of ascorbic acid by the##2##6##(2008-10#2)
determination of ascorbic acid in pharmaceutical##2##6##(2008-10#2)
determination of ascorbic acid in##7##5##(2008-10#7)
determination of ascorbic acid using##3##5##(2008-10#3)
determination of ascorbic acid was##2##5##(2008-10#2)
determination of ascorbic acid with##2##5##(2008-10#2)
determination of ascorbic acid##32##4##(2008-10#32)
determination of astemizole##2##3##(2008-10#2)
determination of atrazine in##5##4##(2008-10#5)
determination of atrazine##7##3##(2008-10#7)
determination of azithromycin##2##3##(2008-10#2)
determination of barbituric acid##2##4##(2008-10#2)
determination of benzo[a]pyrene in##3##4##(2008-10#3)
determination of benzo[a]pyrene##5##3##(2008-10#5)
determination of benzoyl peroxide##3##4##(2008-10#3)
determination of beryllium##3##3##(2008-10#3)
determination of binary mixtures##2##4##(2008-10#2)
determination of biochemical oxygen demand##2##5##(2008-10#2)
determination of biochemical##3##3##(2008-10#3)
determination of biogenic amines##3##4##(2008-10#3)
determination of bismuth in water##2##5##(2008-10#2)
determination of bismuth in##9##4##(2008-10#9)
determination of bismuth##13##3##(2008-10#13)
determination of bismuth(III)##2##3##(2008-10#2)
determination of bisphenol A##2##4##(2008-10#1)(2009-8#1)
determination of bone##2##3##(1991-11#2)
determination of boron in ceramic materials##2##6##(2008-10#2)
determination of boron in plants##3##5##(2008-10#3)
determination of boron in soil##2##5##(2008-10#2)
determination of boron in##7##4##(2008-10#7)
determination of boron##12##3##(2008-10#12)
determination of both analytes in##3##5##(2008-10#3)
determination of both analytes##5##4##(2008-10#5)
determination of both metals##2##4##(2008-10#2)
determination of both##18##3##(1991-2#1)(1992-11#1)(2008-10#16)
determination of bromate##2##3##(2008-10#2)
determination of bromide in##5##4##(2008-10#5)
determination of bromide ion in a developer##2##7##(2008-10#2)
determination of bromide##12##3##(2008-10#12)
determination of cadmium and copper##2##5##(2008-10#2)
determination of cadmium and lead in table salt samples##2##9##(2008-10#2)
determination of cadmium and lead in##4##6##(2008-10#4)
determination of cadmium and lead##7##5##(2008-10#7)
determination of cadmium and zinc##2##5##(2008-10#2)
determination of cadmium and##11##4##(2008-10#11)
determination of cadmium in mussels##2##5##(2008-10#2)
determination of cadmium in urine##2##5##(2008-10#2)
determination of cadmium in##13##4##(2008-10#13)
determination of cadmium using##2##4##(2008-10#2)
determination of cadmium##33##3##(2008-10#33)
determination of caffeine##4##3##(2008-10#4)
determination of calcium and magnesium in natural waters##2##8##(2008-10#2)
determination of calcium and magnesium in##3##6##(2008-10#3)
determination of calcium and magnesium##5##5##(2008-10#5)
determination of calcium and##8##4##(2008-10#8)
determination of calcium in##2##4##(2008-10#2)
determination of calcium##17##3##(2008-10#17)
determination of captopril##3##3##(2008-10#3)
determination of carbaryl##4##3##(2008-10#4)
determination of carbofuran##3##3##(2008-10#3)
determination of carbon in uranium carbide##2##6##(2008-10#2)
determination of carbon##5##3##(2008-10#5)
determination of carp vitellogenin (Vg)##2##5##(2008-10#2)
determination of carp vitellogenin##3##4##(2008-10#3)
determination of carvedilol##2##3##(2008-10#2)
determination of catecholamines in##2##4##(2008-10#2)
determination of catecholamines##3##3##(2008-10#3)
determination of cationic surfactants##2##4##(2008-10#2)
determination of cationic##4##3##(2008-10#4)
determination of cefixime##3##3##(2008-10#3)
determination of cefminox in##2##4##(2008-10#2)
determination of cell##2##3##(2008-11#2)
determination of certain##3##3##(2008-10#3)
determination of cetylpyridinium##3##3##(2008-10#3)
determination of chemical oxygen demand##3##5##(2008-10#3)
determination of chlorate##3##3##(2008-10#3)
determination of chloride in##5##4##(2008-10#5)
determination of chloride##13##3##(2008-10#13)
determination of chlorine dioxide in##2##5##(2008-10#2)
determination of chlorine##3##3##(2008-10#3)
determination of chlorophylls##2##3##(2008-10#2)
determination of chloroquine##2##3##(2008-10#2)
determination of chlorpromazine##2##3##(2008-10#2)
determination of chlortetracycline##2##3##(2008-10#2)
determination of cholesterol##2##3##(2008-10#2)
determination of chromium (VI)##3##4##(2008-10#3)
determination of chromium in##7##4##(2008-10#7)
determination of chromium naphthenate in gasoline by flame##2##8##(2008-10#2)
determination of chromium species##2##4##(2008-10#2)
determination of chromium##21##3##(2008-10#21)
determination of chromium(VI) and##2##4##(2008-10#2)
determination of chromium(VI) in##7##4##(2008-10#7)
determination of chromium(VI)##11##3##(2008-10#11)
determination of cis-platin##2##3##(2008-10#2)
determination of cisatracurium##2##3##(2008-10#2)
determination of citric acid##2##4##(2008-10#2)
determination of cobalt and##3##4##(2008-10#3)
determination of cobalt in water samples##2##6##(2008-10#2)
determination of cobalt in##10##4##(2008-10#10)
determination of cobalt##29##3##(2008-10#29)
determination of cobalt(II) and##2##4##(2008-10#2)
determination of cobalt(II)##3##3##(2008-10#3)
determination of compounds##2##3##(2008-10#2)
determination of copper and cadmium##2##5##(2008-10#2)
determination of copper and iron in##3##6##(2008-10#3)
determination of copper and iron##6##5##(2008-10#6)
determination of copper and lead in seawater##2##7##(2008-10#2)
determination of copper and##14##4##(2008-10#14)
determination of copper at##4##4##(2008-10#4)
determination of copper by##6##4##(2008-10#6)
determination of copper in natural waters##2##6##(2008-10#2)
determination of copper in soft drink##2##6##(2008-10#2)
determination of copper in the presence of##2##7##(2008-10#2)
determination of copper in the##3##5##(2008-10#3)
determination of copper in water samples##4##6##(2008-10#4)
determination of copper in##23##4##(2008-10#23)
determination of copper with detection##2##5##(2008-10#2)
determination of copper##67##3##(2008-10#67)
determination of copper(II) based on its##2##6##(2008-10#2)
determination of copper(II) based on##3##5##(2008-10#3)
determination of copper(II) by##3##4##(2008-10#3)
determination of copper(II) in##3##4##(2008-10#3)
determination of copper(II)##18##3##(2008-10#18)
determination of creatine and creatinine##2##5##(2008-10#2)
determination of creatinine in urine##2##5##(2008-10#2)
determination of creatinine##3##3##(2008-10#3)
determination of cyanide as contaminant in pralidoxime mesylate##2##8##(2008-10#2)
determination of cyanide##10##3##(2008-10#10)
determination of cyclamate##2##3##(2008-10#2)
determination of cyclophosphamide and ifosphamide##2##5##(2008-10#2)
determination of cypermethrin and deltamethrin in emulsifiable concentrate formulations##2##9##(2008-10#2)
determination of cysteine (Cys)##2##4##(2008-10#2)
determination of cysteine and penicillamine##2##5##(2008-10#2)
determination of cysteine and##3##4##(2008-10#3)
determination of cysteine on flow injection system##2##7##(2008-10#2)
determination of cysteine##12##3##(2008-10#12)
determination of deltamethrin##2##3##(2008-10#2)
determination of desferrioxamine##2##3##(2008-10#2)
determination of dichlorvos pesticide##2##4##(2008-10#2)
determination of diclofenac in##2##4##(2008-10#2)
determination of different##8##3##(2008-10#8)
determination of dihydralazine sulfate##2##4##(2008-10#2)
determination of dioxins in##2##4##(2008-10#2)
determination of diphenhydramine##2##3##(2008-10#2)
determination of dipyridamole##2##3##(2008-10#2)
determination of dissolved chromium species##2##5##(2008-10#2)
determination of dissolved organic phosphorus##2##5##(2008-10#2)
determination of dissolved oxygen in##2##5##(2008-10#2)
determination of dissolved oxygen##3##4##(2008-10#3)
determination of dissolved##12##3##(2008-10#12)
determination of dopamine in injection and urine##2##7##(2008-10#2)
determination of dopamine in injection##3##5##(2008-10#3)
determination of dopamine in##4##4##(2008-10#4)
determination of dopamine##10##3##(2008-10#10)
determination of doxycycline##4##3##(2008-10#4)
determination of doxylamine succinate in pharmaceuticals##2##6##(2008-10#2)
determination of doxylamine succinate##3##4##(2008-10#3)
determination of each##2##3##(2008-10#2)
determination of eight##6##3##(2008-10#6)
determination of environmental##2##3##(2008-10#2)
determination of enzymatically generated hydrogen peroxide##2##6##(2008-10#2)
determination of ephedrine##2##3##(2008-10#2)
determination of epinephrine in##2##4##(2008-10#2)
determination of epinephrine##5##3##(2008-10#5)
determination of ethanol and glycerol in wines##2##7##(2008-10#2)
determination of ethanol##7##3##(2008-10#7)
determination of europium##3##3##(2008-10#3)
determination of famotidine in urine##2##5##(2008-10#2)
determination of famotidine##3##3##(2008-10#3)
determination of ferbam##3##3##(2008-10#3)
determination of five##3##3##(2008-10#3)
determination of flavonoids in##2##4##(2008-10#2)
determination of fluoride in plant samples##2##6##(2008-10#2)
determination of fluoride in##5##4##(2008-10#5)
determination of fluoride ion##5##4##(2008-10#5)
determination of fluoride with ion-selective electrode##2##6##(2008-10#2)
determination of fluoride##14##3##(2008-10#14)
determination of fluoxetine in pharmaceuticals and biological fluids##2##8##(2008-10#2)
determination of fluoxetine##3##3##(2008-10#3)
determination of fluphenazine##2##3##(2008-10#2)
determination of formaldehyde in##3##4##(2008-10#3)
determination of formaldehyde##4##3##(2008-10#4)
determination of four anti-dandruff agents##2##5##(2008-5#2)
determination of four##10##3##(2008-10#8)(2008-5#2)
determination of free cyanide##2##4##(2008-10#2)
determination of free##11##3##(1993-2#1)(2008-10#10)
determination of furosemide and triamterene##2##5##(2008-10#2)
determination of gallium by##2##4##(2008-10#2)
determination of gallium##4##3##(2008-10#4)
determination of gallium(III) and indium(III)##2##5##(2008-10#2)
determination of garenoxacin in##2##4##(2008-10#2)
determination of gentamycin is##2##4##(2008-10#2)
determination of gentamycin##3##3##(2008-10#3)
determination of gestodene##2##3##(2011-3#2)
determination of glucose in human serum##2##6##(2008-10#2)
determination of glucose in soluble coffee##2##6##(2008-10#2)
determination of glucose in##11##4##(2008-10#11)
determination of glucose was##2##4##(2008-10#2)
determination of glucose##18##3##(2008-10#18)
determination of glutathione##3##3##(2008-10#3)
determination of glycerol##2##3##(2008-10#2)
determination of heavy metals in##3##5##(2008-10#3)
determination of hemoglobin##4##3##(2008-10#4)
determination of hexachlorobenzene##2##3##(2008-10#2)
determination of histamine##2##3##(2008-10#2)
determination of histidine##2##3##(1995-3#1)(2008-10#1)
determination of homocysteine##3##3##(2008-10#3)
determination of hydrazine and phenylhydrazine##3##5##(2008-10#3)
determination of hydrazine##14##3##(2008-10#14)
determination of hydrogen peroxide was##2##5##(2008-10#2)
determination of hydrogen peroxide##18##4##(2008-10#18)
determination of hydrogen##19##3##(2008-10#19)
determination of hydroquinone in##4##4##(2008-10#4)
determination of hydroquinone##7##3##(2008-10#7)
determination of hydroxyl radical##2##4##(2008-10#2)
determination of hydroxyl##3##3##(2008-10#3)
determination of ibuprofen in the presence of beta-CD##2##8##(2008-10#2)
determination of ibuprofen in##3##4##(2008-10#3)
determination of imidacloprid##2##3##(2008-10#2)
determination of indium##3##3##(2008-10#3)
determination of individual##4##3##(2008-10#4)
determination of indomethacin and acemethacin by differential pulse adsorptive stripping voltammetry##2##11##(2008-10#2)
determination of indomethacin##3##3##(2008-10#3)
determination of inorganic and##2##4##(2008-10#2)
determination of inorganic arsenic##3##4##(2008-10#3)
determination of inorganic cations##2##4##(2008-10#2)
determination of inorganic##14##3##(2008-10#14)
determination of inosine nucleoside in nucleotides##2##6##(2008-10#2)
determination of inosine##3##3##(2008-10#3)
determination of iodate and iodide in table##2##7##(2008-10#2)
determination of iodate and iodide##3##5##(2008-10#3)
determination of iodate##6##3##(2008-10#6)
determination of iodide ion in##2##5##(2008-10#2)
determination of iodide##9##3##(2008-10#9)
determination of iodine##3##3##(2008-10#3)
determination of iridium##3##3##(2008-10#3)
determination of iridium(IV)##3##3##(2008-10#3)
determination of iron and chromium in steel alloys##3##8##(2008-10#3)
determination of iron and vanadium##2##5##(2008-10#2)
determination of iron and zinc in##2##6##(2008-10#2)
determination of iron and zinc##3##5##(2008-10#3)
determination of iron and##10##4##(2008-10#10)
determination of iron in##10##4##(2008-10#10)
determination of iron with##2##4##(2008-10#2)
determination of iron##32##3##(2008-10#32)
determination of iron(III) and##4##4##(2008-10#4)
determination of iron(III) in##2##4##(2008-10#2)
determination of iron(III)##7##3##(2008-10#7)
determination of iron(III)-dimethyldithiocarbamate (ferbam)##2##4##(2008-10#2)
determination of isoniazid##3##3##(2008-10#3)
determination of isoproterenol##2##3##(2008-10#2)
determination of l-ascorbic acid##4##4##(2008-10#4)
determination of l-cysteine and l-cystine##2##5##(2008-10#2)
determination of l-phenylalanine##2##3##(2008-10#2)
determination of lactic acid in##4##5##(2008-10#4)
determination of lanthanide##2##3##(2008-10#2)
determination of lanthanides##2##3##(2008-10#2)
determination of lead and copper##2##5##(2008-10#2)
determination of lead and tin##2##5##(2008-10#2)
determination of lead and##6##4##(2008-10#6)
determination of lead by##2##4##(2008-10#2)
determination of lead extracted by acetic acid from glazed ceramic surfaces by flow injection##2##14##(2008-10#2)
determination of lead in foods with##2##6##(2008-10#2)
determination of lead in natural##2##5##(2008-10#2)
determination of lead in soil and water samples##2##8##(2008-10#2)
determination of lead in vegetables with##2##6##(2008-10#2)
determination of lead in water samples##2##6##(2008-10#2)
determination of lead in water##3##5##(2008-10#3)
determination of lead in##33##4##(2008-10#33)
determination of lead with Arsenazo III##2##6##(2008-10#2)
determination of lead with##3##4##(2008-10#3)
determination of lead##56##3##(2008-10#56)
determination of lead(II) and cadmium(II)##2##5##(2008-10#2)
determination of lead(II) in##2##4##(2008-10#2)
determination of lead(II) with a 1##2##6##(2008-10#2)
determination of lead(II)##10##3##(2008-10#10)
determination of levofloxacin in##2##4##(2008-10#2)
determination of linoleate hydroperoxide##2##4##(2008-10#2)
determination of lithium##3##3##(2008-10#3)
determination of low concentrations of##2##5##(2008-10#2)
determination of low##9##3##(2008-10#9)
determination of magnesium in urine and##2##6##(2008-10#2)
determination of magnesium in##3##4##(2008-10#3)
determination of magnesium##7##3##(2008-10#7)
determination of maleic hydrazide##2##4##(2008-10#2)
determination of maltol in beverages##3##5##(2008-10#3)
determination of manganese and selenium in serum by##2##8##(2008-10#2)
determination of manganese and zinc in##3##6##(2008-10#3)
determination of manganese and##5##4##(2008-10#5)
determination of manganese in##7##4##(2008-10#7)
determination of manganese oxide content of Portland cement and cement raw meal##2##12##(2008-10#2)
determination of manganese##18##3##(2008-10#18)
determination of manganese(II) in##2##4##(2008-10#2)
determination of manganese(II)##8##3##(2008-10#8)
determination of mebendazole and pyrantel pamoate from tablets##2##8##(2008-10#2)
determination of mequitazine in human plasma##2##6##(2008-10#2)
determination of mercury in##4##4##(2008-10#4)
determination of mercury##11##3##(2008-10#11)
determination of mercury(II) and##2##4##(2008-10#2)
determination of mercury(II)##8##3##(2008-10#8)
determination of metal ions##5##4##(2008-10#5)
determination of metal##8##3##(2008-10#7)(2010-11#1)
determination of metallothionein##2##3##(2008-10#2)
determination of metals in##7##4##(2008-10#7)
determination of metals##8##3##(2008-10#8)
determination of methamidophos using##2##4##(2008-10#2)
determination of methanol##2##3##(2008-10#2)
determination of metoclopramide and tetracaine hydrochloride##2##6##(2008-10#2)
determination of metoclopramide hydrochloride##4##4##(2008-10#4)
determination of metoclopramide in##2##4##(2008-10#2)
determination of metoclopramide##10##3##(2008-10#10)
determination of metrifonate in##2##4##(2008-10#2)
determination of metrifonate##3##3##(2008-10#3)
determination of metronidazole at a##2##5##(2008-10#2)
determination of metronidazole##5##3##(2008-10#5)
determination of minoxidil##3##3##(2008-10#3)
determination of mixtures of##2##4##(2008-10#2)
determination of mixtures##3##3##(2008-10#3)
determination of molybdenum and copper##3##5##(2008-10#3)
determination of molybdenum and##4##4##(2008-10#4)
determination of molybdenum in##8##4##(2008-10#8)
determination of molybdenum with Alizarin Red S##2##7##(2008-10#2)
determination of molybdenum##20##3##(2008-10#20)
determination of molybdenum(VI) and tungsten(VI)##2##5##(2008-10#2)
determination of molybdenum(VI)##4##3##(2008-10#4)
determination of morphine##3##3##(2008-10#3)
determination of mug l(-1)##2##4##(2008-10#2)
determination of nalidixic acid and##2##5##(2008-10#2)
determination of nalidixic acid##3##4##(2008-10#3)
determination of nanogram##4##3##(2008-10#4)
determination of naphazoline nitrate and methylparaben##2##6##(2008-10#2)
determination of naproxen##6##3##(2008-10#6)
determination of natural##3##3##(2008-10#3)
determination of neostigmine in##2##4##(2008-10#2)
determination of neostigmine##3##3##(2008-10#3)
determination of nickel and##3##4##(2008-10#3)
determination of nickel has been##2##5##(2008-10#2)
determination of nickel in natural water samples##2##7##(2008-10#2)
determination of nickel in natural##3##5##(2008-10#3)
determination of nickel in##17##4##(2008-10#17)
determination of nickel##29##3##(2008-10#29)
determination of nitrate and##3##4##(2008-10#3)
determination of nitrate in vegetables##2##5##(2008-10#2)
determination of nitrate in##6##4##(2008-10#6)
determination of nitrate##11##3##(2008-10#11)
determination of nitric oxide##3##4##(2008-10#3)
determination of nitrite and nitrate in water##3##7##(2008-10#3)
determination of nitrite and nitrate in##6##6##(2008-10#6)
determination of nitrite and nitrate##12##5##(2008-10#12)
determination of nitrite based on its catalytic effect on the##2##10##(2008-10#2)
determination of nitrite in##11##4##(2008-10#11)
determination of nitrite ion in##2##5##(2008-10#2)
determination of nitrite ion using##2##5##(2008-10#2)
determination of nitrite ion##4##4##(2008-10#4)
determination of nitrite using##2##4##(2008-10#2)
determination of nitrite##39##3##(2008-10#38)(2008-11#1)
determination of nitroaniline isomers by##2##5##(2008-10#2)
determination of nitroaniline isomers##3##4##(2008-10#3)
determination of nitroaniline##5##3##(2008-10#5)
determination of nitrogen oxides in the air##2##7##(2008-10#2)
determination of nitrogen oxides##3##4##(2008-10#3)
determination of nitrogen##4##3##(2008-10#4)
determination of non-ionic surfactants##2##4##(2008-10#2)
determination of noradrenaline and##2##4##(2008-10#2)
determination of novalgin##2##3##(2008-10#2)
determination of nucleic acids##5##4##(2008-10#5)
determination of nucleic##6##3##(2008-10#6)
determination of numerous##2##3##(2008-10#2)
determination of ochratoxin A in##2##5##(2008-10#2)
determination of ofloxacin in##3##4##(2008-10#3)
determination of ofloxacin##4##3##(2008-10#4)
determination of organic dye mixtures by using##2##7##(2008-10#2)
determination of organic mercury##2##4##(2008-10#2)
determination of organic##6##3##(2008-10#6)
determination of organophosphorus pesticides in water and fruit juice with##2##10##(2008-10#2)
determination of organophosphorus pesticides##3##4##(2008-10#3)
determination of organophosphorus##4##3##(2008-10#4)
determination of organotin##2##3##(2008-10#2)
determination of orthophosphate and total inorganic phosphates in detergents##2##9##(2008-10#2)
determination of orthophosphate and total##3##5##(2008-10#3)
determination of orthophosphate in##3##4##(2008-10#3)
determination of orthophosphate##6##3##(2008-10#6)
determination of other##3##3##(2008-10#3)
determination of oxalate in urine##2##5##(2008-10#2)
determination of oxalate##5##3##(2008-10#5)
determination of oxidizable##4##3##(2008-10#4)
determination of oxychlorine species##2##4##(2008-10#2)
determination of p-aminobenzoic acid##2##4##(2008-10#2)
determination of palladium in airborne particulate matter##2##7##(2008-10#2)
determination of palladium in##5##4##(2008-10#5)
determination of palladium##7##3##(2008-10#7)
determination of palladium(II)##7##3##(2008-10#7)
determination of panaxynol in a##2##5##(2008-10#2)
determination of panaxynol in##3##4##(2008-10#3)
determination of paracetamol in pharmaceutical formulations##2##6##(2008-10#2)
determination of paracetamol in pharmaceuticals##3##5##(2008-10#3)
determination of paracetamol in##8##4##(2008-10#8)
determination of paracetamol##10##3##(2008-10#10)
determination of paraquat in##5##4##(2008-10#5)
determination of paraquat##11##3##(2008-10#11)
determination of partition coefficients of##3##5##(2008-10#3)
determination of partition coefficients##4##4##(2008-10#4)
determination of perchlorate in complex##2##5##(2008-10#2)
determination of perchlorate in##4##4##(2008-10#4)
determination of perchlorate##8##3##(2008-10#8)
determination of periodate and iodate##3##5##(2008-10#3)
determination of periodate##4##3##(2008-10#4)
determination of periodate-bromate and iodate-bromate mixtures##2##6##(2008-10#2)
determination of periodate-bromate and iodate-bromate##3##5##(2008-10#3)
determination of pesticides in##2##4##(2008-10#2)
determination of pharmaceuticals in##2##4##(2008-10#2)
determination of phenol##4##3##(2008-10#4)
determination of phenolic compounds and##2##5##(2008-10#2)
determination of phenolic compounds##3##4##(2008-10#3)
determination of phenolic##4##3##(2008-10#4)
determination of phenols in##2##4##(2008-10#2)
determination of phenols##5##3##(2008-10#5)
determination of phenothiazines##2##3##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical dosage forms##2##8##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical preparations##2##7##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical##4##6##(2008-10#4)
determination of phenylmercury##2##3##(2008-10#2)
determination of phenytoin in capsules and plasma##2##7##(2008-10#2)
determination of phosphate and silicate##2##5##(2008-10#2)
determination of phosphate and##4##4##(2008-10#4)
determination of phosphate in##3##4##(2008-10#3)
determination of phosphate##10##3##(2008-10#10)
determination of phosphorus by##3##4##(2008-10#3)
determination of phosphorus in##2##4##(2008-10#2)
determination of phosphorus species in environmental matrices##2##7##(2008-10#2)
determination of phosphorus species in##3##5##(2008-10#3)
determination of phosphorus species##4##4##(2008-10#4)
determination of phosphorus##12##3##(2008-10#12)
determination of piroxicam in##2##4##(2008-10#2)
determination of piroxicam##4##3##(2008-10#4)
determination of plaque##2##3##(2008-7#1)(2010-9#1)
determination of platinum##8##3##(2008-10#8)
determination of pollutants in##2##4##(2008-10#2)
determination of polycyclic aromatic hydrocarbons (PAHs)##3##6##(2008-10#3)
determination of polycyclic aromatic hydrocarbons##6##5##(2008-10#6)
determination of polyphenols in##2##4##(2008-10#2)
determination of potassium ions##2##4##(2008-10#2)
determination of potassium##4##3##(2008-10#4)
determination of praseodymium in##3##4##(2008-10#3)
determination of primary##3##3##(2008-10#3)
determination of procaine hydrochloride##4##4##(2008-10#4)
determination of propacetamol##2##3##(2008-10#2)
determination of propiverine and##2##4##(2008-10#2)
determination of propranolol and pindolol##3##5##(2008-10#3)
determination of protein##7##3##(1990-12#1)(2008-10#5)(2008-4#1)
determination of proteins in human serum##2##6##(2008-10#2)
determination of proteins in##3##4##(2008-10#3)
determination of proteins##8##3##(2008-10#8)
determination of pseudoephedrine hydrochloride and diphenhydramine hydrochloride in cough syrup##2##10##(2008-10#2)
determination of pseudoephedrine##3##3##(2008-10#3)
determination of pyridoxine hydrochloride in##2##5##(2008-10#2)
determination of pyridoxine hydrochloride##3##4##(2008-10#3)
determination of pyrogallol compounds##2##4##(2008-10#2)
determination of pyrogallol##3##3##(2008-10#3)
determination of quinalphos in##2##4##(2008-10#2)
determination of quinine##3##3##(2008-10#3)
determination of rare##3##3##(2008-10#3)
determination of recombinant##2##3##(2008-10#1)(2010-6#1)
determination of reduced glutathione##2##4##(2008-10#2)
determination of reducing sugars##2##4##(2008-10#2)
determination of relative##2##3##(2008-10#1)(2008-5#1)
determination of residual##2##3##(2008-10#1)(2008-9#1)
determination of rifampicin and isoniazid in##2##6##(2008-10#2)
determination of rubidate##3##3##(2008-10#3)
determination of ruthenium##6##3##(2008-10#6)
determination of rutin in##3##4##(2008-10#3)
determination of rutin##4##3##(2008-10#4)
determination of salbutamol##3##3##(2008-10#3)
determination of salicylamide##2##3##(2008-10#2)
determination of salicylate in##2##4##(2008-10#2)
determination of salicylic acid##2##4##(2008-10#2)
determination of salsalate in##3##4##(2008-10#3)
determination of salsalate##4##3##(2008-10#4)
determination of seawater##2##3##(2008-10#2)
determination of selenium (IV)##2##4##(2008-10#2)
determination of selenium in##5##4##(2008-10#5)
determination of selenium##13##3##(2008-10#13)
determination of selenium(IV) and##4##4##(2008-10#4)
determination of selenium(IV)##6##3##(2008-10#6)
determination of semicarbazide and hydrazine##3##5##(2008-10#3)
determination of semicarbazide##5##3##(2008-10#5)
determination of serum cholesterol##2##4##(1991-6#1)(2008-10#1)
determination of seven##2##3##(2008-10#2)
determination of several##8##3##(2008-10#8)
determination of silicon##3##3##(2008-10#3)
determination of silver in##6##4##(2008-10#6)
determination of silver##11##3##(2008-10#11)
determination of silver(I)##5##3##(2008-10#5)
determination of small amounts of##3##5##(2008-10#3)
determination of small##4##3##(2008-10#4)
determination of sodium cyclamate##2##4##(2008-10#2)
determination of sodium impurities in##2##5##(2008-10#2)
determination of sodium percarbonate##2##4##(2008-10#2)
determination of sodium##10##3##(2008-10#10)
determination of some anions##2##4##(2008-10#2)
determination of some metals##3##4##(2008-10#3)
determination of some##20##3##(2008-10#20)
determination of spironolactone and canrenone in urine##2##7##(2008-10#2)
determination of stability constants of##3##5##(2008-10#3)
determination of stability constants##6##4##(2008-10#6)
determination of stachyose##2##3##(2008-10#2)
determination of starch in food##2##5##(2008-10#2)
determination of stoichiometry and association##2##5##(2008-10#2)
determination of sub-nanogram##2##3##(2008-10#2)
determination of sucrose in beet root##2##6##(2008-10#2)
determination of sucrose in##4##4##(2008-10#4)
determination of sucrose##5##3##(2008-10#5)
determination of sulfamonomethoxine##2##3##(2008-10#2)
determination of sulfate ion##2##4##(2008-10#2)
determination of sulfate##3##3##(2008-10#3)
determination of sulfide in##6##4##(2008-10#6)
determination of sulfide##11##3##(2008-10#11)
determination of sulfite and sulfide##2##5##(2008-10#2)
determination of sulfite in food##2##5##(2008-10#2)
determination of sulfite in sugar and sulfur dioxide in air##2##10##(2008-10#2)
determination of sulfite in##5##4##(2008-10#5)
determination of sulfite##10##3##(2008-10#10)
determination of sulfonamide##2##3##(2008-10#1)(2009-8#1)
determination of sulfonamides in##3##4##(2008-10#3)
determination of sulfur dioxide##2##4##(2008-10#2)
determination of sulfur##3##3##(2008-10#3)
determination of sulphate in soil solutions##2##6##(2008-10#2)
determination of sulphate in##3##4##(2008-10#3)
determination of sulphide##2##3##(2008-10#2)
determination of tannic acid##2##4##(2008-10#2)
determination of taurine in##2##4##(2008-10#2)
determination of terbinafine and##2##4##(2008-10#2)
determination of terbinafine##3##3##(2008-10#3)
determination of ternary mixtures##2##4##(2008-10#2)
determination of tetracycline##2##3##(2008-10#2)
determination of thallium in##2##4##(1991-12#1)(2008-10#1)
determination of thallium##8##3##(1991-12#3)(2008-10#5)
determination of thallium(I)##2##3##(2008-10#2)
determination of the active##4##4##(2008-10#2)(2008-8#1)(2010-9#1)
determination of the amount of##2##5##(2008-10#2)
determination of the colorants tartrazine##2##5##(2008-10#2)
determination of the colorants##3##4##(2008-10#3)
determination of the components of##2##5##(2008-10#2)
determination of the composition##2##4##(2008-10#2)
determination of the concentration of##6##5##(2008-10#5)(2008-11#1)
determination of the concentration##7##4##(2008-10#6)(2008-11#1)
determination of the content of##2##5##(2008-10#2)
determination of the drug in##8##5##(2008-10#8)
determination of the drug##10##4##(2008-10#10)
determination of the entire genome##3##5##(1996-6#3)
determination of the growth##2##4##(2008-11#2)
determination of the levels of##3##5##(2008-10#2)(2011-2#1)
determination of the pesticide##4##4##(2008-10#4)
determination of the rare##2##4##(2008-10#2)
determination of the real##2##4##(2008-10#2)
determination of the relative##2##4##(2008-3#1)(2008-5#1)
determination of the stability constants##2##5##(2008-10#2)
determination of the stability##4##4##(2008-10#4)
determination of the synthetic antioxidant butylated hydroxyanisole##2##7##(2008-10#2)
determination of the target##2##4##(2008-10#2)
determination of the time##2##4##(1995-12#1)(2008-10#1)
determination of the total amount of##3##6##(2008-10#3)
determination of the total##9##4##(2008-10#8)(2008-11#1)
determination of the two##4##4##(2008-10#4)
determination of the##245##3##(1990-12#3)(1991-11#1)(1991-5#1)(1991-7#1)(1993-1#1)(1993-2#1)(1993-5#3)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(2008-10#190)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#3)(2008-5#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
determination of their##4##3##(1990-12#1)(1995-6#1)(2008-10#2)
determination of these compounds##8##4##(2008-10#8)
determination of these metal ions in##4##6##(2008-10#4)
determination of these metal ions##5##5##(2008-10#5)
determination of these metals##3##4##(2008-10#3)
determination of these pesticides in##2##5##(2008-10#2)
determination of these##42##3##(2008-10#42)
determination of thiamine in pharmaceutical formulations##2##6##(2008-10#2)
determination of thiamine in pharmaceutical##3##5##(2008-10#3)
determination of thiamine##6##3##(2008-10#6)
determination of thiocyanate##2##3##(2008-10#2)
determination of this compound##3##4##(2008-10#3)
determination of this element##2##4##(2008-10#2)
determination of this metal##2##4##(2008-10#2)
determination of this##12##3##(2008-10#11)(2011-2#1)
determination of thorium and rare earth##2##6##(2008-10#2)
determination of thorium and##3##4##(2008-10#3)
determination of thorium##6##3##(2008-10#6)
determination of three##14##3##(2008-10#14)
determination of tin and nickel in##2##6##(2008-10#2)
determination of tin in##4##4##(2008-10#4)
determination of tin##11##3##(2008-10#11)
determination of tolnaftate##2##3##(2008-10#2)
determination of total As##2##4##(2008-10#2)
determination of total amount of nitrite and nitrate##2##8##(2008-10#2)
determination of total and##3##4##(2008-10#3)
determination of total arsenic in##2##5##(2008-10#2)
determination of total arsenic##4##4##(2008-10#4)
determination of total chromium in##3##5##(2008-10#3)
determination of total inorganic carbon##2##5##(2008-10#2)
determination of total inorganic##4##4##(2008-10#4)
determination of total iron##3##4##(2008-10#3)
determination of total mercury##5##4##(2008-10#5)
determination of total phosphorus##3##4##(2008-10#3)
determination of total polyphenol##2##4##(2008-10#2)
determination of total protein in human serum##2##7##(2008-10#2)
determination of total proteins##2##4##(2008-10#2)
determination of total sulfur##4##4##(2008-10#4)
determination of total##58##3##(1991-11#1)(2008-10#57)
determination of toxic##4##3##(2008-10#4)
determination of toxicologically relevant arsenic##2##5##(2008-10#2)
determination of trace aluminum##3##4##(2008-10#3)
determination of trace amount of cobalt in##2##7##(2008-10#2)
determination of trace amount of##19##5##(2008-10#19)
determination of trace amount##20##4##(2008-10#20)
determination of trace amounts of Se(IV) in##2##7##(2008-10#2)
determination of trace amounts of cadmium in##2##7##(2008-10#2)
determination of trace amounts of cadmium##3##6##(2008-10#3)
determination of trace amounts of cobalt##2##6##(2008-10#2)
determination of trace amounts of copper and iron##2##8##(2008-10#2)
determination of trace amounts of copper##4##6##(2008-10#4)
determination of trace amounts of iodide##2##6##(2008-10#2)
determination of trace amounts of iron##2##6##(2008-10#2)
determination of trace amounts of lead##3##6##(2008-10#3)
determination of trace amounts of nitrite##3##6##(2008-10#3)
determination of trace amounts of selenium##2##6##(2008-10#2)
determination of trace amounts of zinc##2##6##(2008-10#2)
determination of trace amounts of##72##5##(2008-10#72)
determination of trace arsenic##2##4##(2008-10#2)
determination of trace copper##2##4##(2008-10#2)
determination of trace elements in##8##5##(2008-10#7)(2011-2#1)
determination of trace elements##14##4##(2008-10#13)(2011-2#1)
determination of trace lead in water after##2##7##(2008-10#2)
determination of trace lead##3##4##(2008-10#3)
determination of trace level of##2##5##(2008-10#2)
determination of trace levels of germanium##2##6##(2008-10#2)
determination of trace levels of##14##5##(2008-10#14)
determination of trace manganese in##2##5##(2008-10#2)
determination of trace manganese##6##4##(2008-10#6)
determination of trace mercury##4##4##(2008-10#4)
determination of trace metals by##3##5##(2008-10#3)
determination of trace metals in##6##5##(2008-10#6)
determination of trace metals##11##4##(2008-10#11)
determination of trace molybdenum##3##4##(2008-10#3)
determination of trace nitrite in food products with##2##8##(2008-10#2)
determination of trace nitrite in##3##5##(2008-10#3)
determination of trace or##2##4##(2008-10#2)
determination of trace oxyhalides and haloacetic acids##2##7##(2008-10#2)
determination of trace sulfur dioxide##2##5##(2008-10#2)
determination of trace water in organic solvents##2##7##(2008-10#2)
determination of trace##205##3##(2008-10#203)(2011-2#2)
determination of traces of##11##4##(2008-10#11)
determination of trans-beta-carotene in##2##4##(2008-10#2)
determination of triiodide##2##3##(2008-10#2)
determination of tungsten##7##3##(2008-10#7)
determination of two##9##3##(2008-10#9)
determination of ultra trace amounts of##6##6##(2008-10#6)
determination of ultra trace##8##4##(2008-10#8)
determination of ultra-trace levels of##2##5##(2008-10#2)
determination of ultra-trace##6##3##(2008-10#6)
determination of uranium in##6##4##(2008-10#6)
determination of uranium##11##3##(2008-10#11)
determination of urea in##3##4##(2008-10#3)
determination of urea##6##3##(2008-10#6)
determination of uric acid (UA)##2##5##(2008-10#2)
determination of uric acid and creatinine in urine##2##8##(2008-10#2)
determination of uric acid in##6##5##(2008-10#6)
determination of uric acid##14##4##(2008-10#14)
determination of uric##15##3##(2008-10#15)
determination of urinary##2##3##(2008-10#2)
determination of vanadium and its application to##2##7##(2008-10#2)
determination of vanadium and##3##4##(2008-10#3)
determination of vanadium in high saline##2##6##(2008-10#2)
determination of vanadium in natural waters##2##6##(2008-10#2)
determination of vanadium in petroleum oils and mineral ore samples##2##10##(2008-10#2)
determination of vanadium in##15##4##(2008-10#15)
determination of vanadium##26##3##(2008-10#26)
determination of vanadium(IV) and total vanadium##2##6##(2008-10#2)
determination of vanadium(V)##3##3##(2008-10#3)
determination of vancomycin and##2##4##(2008-10#2)
determination of vanillin and##2##4##(2008-10#2)
determination of vanillin##4##3##(2008-10#4)
determination of various##3##3##(2008-10#3)
determination of very##3##3##(1990-12#1)(2008-10#2)
determination of vitamin C in pharmaceutical preparations##2##7##(2008-10#2)
determination of vitamin C##3##4##(2008-10#3)
determination of vitamin K(1)##2##4##(2008-10#2)
determination of vitamin##7##3##(2008-10#7)
determination of volatile chlorination by-products in drinking water##2##8##(2008-10#2)
determination of volatile compounds in##2##5##(2008-10#2)
determination of volatile##7##3##(2008-10#7)
determination of water##2##3##(2008-10#2)
determination of water-soluble##3##3##(2008-10#3)
determination of wear metals in used##2##6##(2008-10#2)
determination of whether##2##3##(2008-3#1)(2008-9#1)
determination of withanolide##2##3##(2012-2#2)
determination of zinc and nickel in aqueous##2##7##(2008-10#2)
determination of zinc and nickel##3##5##(2008-10#3)
determination of zinc and##5##4##(2008-10#5)
determination of zinc in standard alloys##2##6##(2008-10#2)
determination of zinc in##8##4##(2008-10#8)
determination of zinc##22##3##(1992-3#1)(2008-10#21)
determination of zirconium##2##3##(2008-10#2)
determination of zirconium(IV)##3##3##(2008-10#3)
determination of##3697##2##(1990-12#10)(1990-2#2)(1990-5#1)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#4)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#4)(1993-5#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#3497)(2008-11#21)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#17)(2008-7#6)(2008-8#2)(2008-9#10)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#11)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#7)(2011-3#3)(2012-12#1)(2012-2#5)(2012-4#1)(2013-1#3)(2013-8#3)
determination on the##2##3##(2008-10#1)(2009-8#1)
determination on##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
determination or##4##2##(2008-10#3)(2010-5#1)
determination per hour##3##3##(2008-10#3)
determination range of##3##3##(2008-10#3)
determination range##7##2##(2008-10#7)
determination results##3##2##(2008-10#3)
determination since##2##2##(2008-10#2)
determination system##3##2##(2008-10#3)
determination that##2##2##(2008-10#1)(2008-8#1)
determination the##3##2##(2008-10#1)(2010-8#2)
determination to##3##2##(2008-10#2)(2010-10#1)
determination using##13##2##(2008-10#10)(2008-9#1)(2009-7#1)(2009-8#1)
determination via##2##2##(2008-10#1)(2008-8#1)
determination was also##2##3##(2008-10#2)
determination was based on the##3##5##(2008-10#3)
determination was carried out by##2##5##(2008-10#2)
determination was carried out##4##4##(2008-10#4)
determination was found to be##2##5##(2008-10#2)
determination was investigated##3##3##(2008-10#3)
determination was performed##4##3##(2008-10#4)
determination was##49##2##(1994-2#1)(2008-10#46)(2008-11#1)(2008-5#1)
determination were studied##2##3##(2008-10#2)
determination were##17##2##(2008-10#16)(2008-5#1)
determination with a##2##3##(2008-10#2)
determination with atomic absorption spectrometry##2##5##(2008-10#2)
determination with the##3##3##(2008-10#2)(2008-11#1)
determination with##15##2##(2008-10#14)(2008-11#1)
determination without titration##2##3##(2008-10#2)
determination without##4##2##(2008-10#4)
determination##4604##1##(1990-11#1)(1990-12#10)(1990-2#2)(1990-5#1)(1991-11#5)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#8)(1993-5#3)(1993-8#3)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-6#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#6)(1997-7#2)(1997-8#1)(2006-6#1)(2008-10#4324)(2008-11#29)(2008-12#6)(2008-2#6)(2008-3#13)(2008-4#2)(2008-5#27)(2008-7#8)(2008-8#7)(2008-9#14)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#13)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#11)(2011-3#3)(2012-12#3)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#4)
determination)##4##1##(2008-10#4)
determinations and##2##2##(2008-10#2)
determinations are##3##2##(2008-10#3)
determinations as##2##2##(1990-2#1)(2008-10#1)
determinations at the##5##3##(2008-10#5)
determinations at trace levels##2##4##(2008-10#2)
determinations at##10##2##(2008-10#10)
determinations by##6##2##(2008-10#5)(2008-8#1)
determinations can be##2##3##(1993-3#1)(2008-10#1)
determinations for##4##2##(2008-10#3)(2008-5#1)
determinations h(-1)##2##2##(2008-10#2)
determinations have##4##2##(2008-10#4)
determinations in environmental samples##2##4##(2008-10#2)
determinations in the##5##3##(2008-10#5)
determinations in water##3##3##(2008-10#3)
determinations in##18##2##(1993-2#1)(2008-10#17)
determinations is##2##2##(2008-10#2)
determinations of 0##6##3##(2008-10#6)
determinations of 1##5##3##(2008-10#5)
determinations of 2##3##3##(2008-10#3)
determinations of 5##3##3##(2008-10#3)
determinations of As(III)##2##3##(2008-10#2)
determinations of a##3##3##(2008-10#3)
determinations of cobalt(II) and hydrogen peroxide##2##6##(2008-10#2)
determinations of metal binding##2##4##(2010-11#2)
determinations of oxygen##2##3##(2008-10#1)(2008-11#1)
determinations of the##3##3##(1997-2#1)(2008-10#2)
determinations of trace##3##3##(2008-10#3)
determinations of##87##2##(1997-2#1)(2008-10#79)(2008-11#1)(2008-5#2)(2008-7#1)(2010-11#3)
determinations on##3##2##(2008-10#3)
determinations per h were##2##4##(2008-10#2)
determinations per h##3##3##(2008-10#3)
determinations per hour and##2##4##(2008-10#2)
determinations per hour##12##3##(2008-10#12)
determinations per##16##2##(2008-10#16)
determinations using##3##2##(2008-10#3)
determinations was##3##2##(2008-10#3)
determinations were##12##2##(2008-10#11)(2008-5#1)
determinations with##3##2##(2008-10#3)
determinations##229##1##(1990-2#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-1#2)(2008-10#205)(2008-11#2)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#3)(2011-2#1)
determine BPA##2##2##(2008-10#1)(2009-8#1)
determine a##7##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#2)(2013-1#1)
determine and##3##2##(2008-10#1)(2009-8#1)(2010-8#1)
determine cysteine##2##2##(2008-10#2)
determine dopamine##2##2##(2008-10#2)
determine how these##2##3##(1990-5#1)(2008-10#1)
determine how##25##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-2#1)(1995-5#1)(1996-1#1)(2007-12#3)(2008-10#9)(2008-11#3)(2010-1#1)
determine if a##5##3##(1992-3#1)(1996-6#1)(1997-3#1)(2008-12#1)(2008-9#1)
determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals##2##24##(2008-11#2)
determine if the##19##3##(1990-2#1)(1991-2#1)(1992-2#1)(1994-2#1)(1994-6#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#2)(2013-8#1)
determine if there is##3##4##(2010-1#1)(2012-12#1)(2012-3#1)
determine if there##5##3##(1994-12#1)(2008-10#1)(2010-1#1)(2012-12#1)(2012-3#1)
determine if this##3##3##(1994-8#1)(2008-10#1)(2012-7#1)
determine if##77##2##(1990-2#1)(1991-2#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#3)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#3)(1997-5#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#2)
determine in##2##2##(2008-4#1)(2009-8#1)
determine insensitivity##2##2##(2008-10#2)
determine its effect on##2##4##(1993-6#1)(2008-10#1)
determine its##6##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2012-3#2)
determine risk##2##2##(2009-10#1)(2012-2#1)
determine that the##3##3##(1994-11#1)(2008-11#1)(2008-3#1)
determine that##6##2##(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
determine the ability of##3##4##(2008-11#1)(2008-9#1)(2012-3#1)
determine the amount of##6##4##(2008-10#6)
determine the apparent##4##3##(2008-10#4)
determine the association##2##3##(2012-3#1)(2013-8#1)
determine the concentration of##10##4##(1991-12#1)(2008-10#8)(2008-9#1)
determine the concentrations of##2##4##(2008-10#2)
determine the contribution of##3##4##(1992-1#1)(2008-3#1)(2009-10#1)
determine the development of##2##4##(2011-2#1)(2013-1#1)
determine the distribution of##2##4##(1995-9#1)(2008-10#1)
determine the effect of different##2##5##(2008-12#1)(2013-1#1)
determine the effect of mismatches on##2##6##(1995-12#2)
determine the effect of the##3##5##(1997-1#1)(2008-8#1)(2013-1#1)
determine the effect of##24##4##(1991-8#1)(1995-12#2)(1997-1#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#2)(2013-1#2)
determine the effect##26##3##(1991-8#1)(1995-12#2)(1997-1#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#2)(2013-1#2)
determine the effectiveness of##2##4##(1990-6#1)(2012-12#1)
determine the effectiveness##3##3##(1990-6#1)(2012-12#1)(2013-1#1)
determine the effects of##18##4##(1990-5#1)(1994-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
determine the efficacy of##2##4##(1994-3#1)(2010-5#1)
determine the efficiency of##2##4##(2008-10#1)(2010-7#1)
determine the extent of##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
determine the extent##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
determine the feasibility##2##3##(2010-10#1)(2011-2#1)
determine the frequency of##3##4##(1995-1#1)(2008-11#1)(2008-9#1)
determine the genetic structure of##3##5##(2008-10#3)
determine the genetic##7##3##(2008-10#7)
determine the identity and##3##4##(2008-10#1)(2012-2#2)
determine the identity##4##3##(1992-9#1)(2008-10#1)(2012-2#2)
determine the impact of##6##4##(1993-2#1)(1994-3#1)(1995-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
determine the importance of##2##4##(2008-10#1)(2008-7#1)
determine the incidence of##3##4##(1991-11#1)(2012-3#1)(2013-1#1)
determine the incidence##4##3##(1991-11#1)(2012-3#1)(2013-1#2)
determine the influence of##11##4##(1996-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#4)
determine the knowledge and##2##4##(2009-10#1)(2009-5#1)
determine the level of##5##4##(1993-3#1)(1994-6#1)(2008-10#1)(2010-1#1)(2013-8#1)
determine the location##2##3##(2008-10#1)(2010-12#1)
determine the locations of##2##4##(1990-9#1)(2008-11#1)
determine the long-term##3##3##(1996-12#1)(2008-11#1)(2008-8#1)
determine the magnitude of##2##4##(1997-3#1)(2007-11#1)
determine the maximum##2##3##(2008-3#1)(2012-2#1)
determine the mechanism##2##3##(2008-10#1)(2013-1#1)
determine the molecular##2##3##(2008-10#1)(2008-11#1)
determine the overall##5##3##(2008-10#3)(2008-12#1)(2009-5#1)
determine the phase##2##3##(1990-6#1)(2012-2#1)
determine the prevalence of##11##4##(1996-12#1)(2008-10#1)(2008-12#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
determine the rate of##2##4##(1991-3#1)(2013-8#1)
determine the rate##5##3##(1991-3#1)(2008-10#2)(2013-1#1)(2013-8#1)
determine the regions##2##3##(1993-12#1)(1993-3#1)
determine the relationship between##6##4##(2008-10#4)(2008-12#2)
determine the relationship##7##3##(2008-10#4)(2008-12#2)(2011-1#1)
determine the relative##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
determine the spectral##2##3##(2008-10#2)
determine the success of##2##4##(2012-3#1)(2013-8#1)
determine the susceptibility to##2##4##(1997-8#1)(2013-8#1)
determine the time##2##3##(2008-11#1)(2008-6#1)
determine the##538##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#5)(1993-8#3)(1994-1#2)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#4)(1994-6#1)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#204)(2008-11#20)(2008-12#17)(2008-2#7)(2008-3#18)(2008-4#6)(2008-5#13)(2008-6#4)(2008-7#8)(2008-8#9)(2008-9#17)(2009-10#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#18)(2012-12#5)(2012-2#12)(2012-3#10)(2012-6#1)(2013-1#28)(2013-3#1)(2013-8#12)
determine their##30##2##(1990-5#1)(1991-2#1)(1995-10#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#1)
determine these metal ions##2##4##(2008-10#2)
determine these##4##2##(2008-10#4)
determine this##3##2##(1993-12#1)(2008-10#1)(2008-2#1)
determine to what extent##3##4##(1997-8#1)(2008-10#1)(2011-1#1)
determine total##3##2##(2008-10#3)
determine trace elements##2##3##(2008-10#2)
determine trace##6##2##(2008-10#6)
determine when##3##2##(1992-12#1)(2008-10#1)(2008-12#1)
determine whether Bcl-2 antagonists##2##4##(2009-12#2)
determine whether a##4##3##(1996-6#1)(2008-11#1)(2008-9#1)(2009-12#1)
determine whether the##20##3##(1990-5#1)(1990-8#1)(1992-10#1)(1993-6#1)(1993-8#1)(1995-5#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2011-2#1)
determine whether this##5##3##(1991-8#1)(1993-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
determine whether##109##2##(1990-5#3)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#19)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#3)(2010-2#1)(2010-7#2)(2011-2#7)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#2)
determine which##17##2##(1991-6#1)(1994-2#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
determine with##2##2##(2008-10#1)(2008-12#1)
determine##1193##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#8)(1990-6#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#7)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#4)(1992-5#1)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#6)(1993-3#6)(1993-6#4)(1993-8#7)(1993-9#2)(1994-1#2)(1994-11#5)(1994-12#8)(1994-2#5)(1994-3#8)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-12#7)(1996-2#2)(1996-3#5)(1996-5#2)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#6)(2007-11#2)(2007-12#8)(2007-8#1)(2008-1#4)(2008-10#521)(2008-11#52)(2008-12#27)(2008-2#12)(2008-3#23)(2008-4#12)(2008-5#26)(2008-6#8)(2008-7#18)(2008-8#17)(2008-9#28)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#7)(2009-8#8)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#6)(2011-1#4)(2011-2#39)(2012-12#8)(2012-2#21)(2012-3#18)(2012-5#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#41)(2013-3#1)(2013-7#3)(2013-8#19)
determined 'off line'##2##3##(2008-10#2)
determined a##3##2##(1993-2#1)(2008-10#1)(2008-8#1)
determined according to a##2##4##(1997-6#1)(2008-10#1)
determined according to the##6##4##(1997-8#1)(2008-10#2)(2008-5#2)(2009-7#1)
determined according to##10##3##(1997-6#1)(1997-8#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-7#1)
determined across##2##2##(2008-10#2)
determined after a##2##3##(2008-10#2)
determined after##13##2##(1990-2#1)(1990-8#1)(2008-10#11)
determined also##2##2##(2008-10#2)
determined and analysed##2##3##(1996-3#1)(2008-8#1)
determined and analyzed##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
determined and compared##9##3##(1990-9#1)(1997-2#1)(2008-10#5)(2008-11#1)(2011-2#1)
determined and the##6##3##(2008-10#5)(2010-8#1)
determined and their##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
determined and##46##2##(1990-9#1)(1991-5#1)(1993-3#1)(1993-9#1)(1995-6#1)(1996-3#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#2)
determined as a function of the##2##6##(1991-11#1)(2008-5#1)
determined as a function of##5##5##(1991-11#1)(2008-10#2)(2008-2#1)(2008-5#1)
determined as the ratio##2##4##(1996-1#1)(2008-10#1)
determined as the##5##3##(1992-12#1)(1996-1#1)(2008-10#2)(2009-8#1)
determined as##36##2##(1990-5#1)(1991-11#1)(1992-12#1)(1994-8#1)(1996-1#1)(2008-10#23)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2009-8#1)
determined at 1##2##3##(1991-3#1)(2008-3#1)
determined at 2##6##3##(1993-8#1)(1994-12#1)(1995-8#1)(2008-10#2)(2008-8#1)
determined at 25 degrees C and##2##6##(2008-10#2)
determined at 25 degrees C by##2##6##(2008-10#2)
determined at 25 degrees C##9##5##(2008-10#9)
determined at different##3##3##(2008-10#3)
determined at the##3##3##(2008-10#2)(2008-7#1)
determined at##41##2##(1991-3#1)(1993-8#1)(1994-12#1)(1995-8#2)(2008-10#30)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-4#1)
determined based on triple-resonance experiments with##2##6##(2009-7#2)
determined based on##9##3##(2008-10#6)(2009-3#1)(2009-7#2)
determined but##2##2##(1995-9#1)(2012-3#1)
determined by AAS##2##3##(2008-10#2)
determined by FAAS##3##3##(2008-10#3)
determined by HPLC##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)
determined by ICP-AES##2##3##(2008-10#2)
determined by ICP-MS##2##3##(2008-10#2)
determined by Northern##2##3##(1993-3#1)(2008-6#1)
determined by RIA##2##3##(2008-7#1)(2008-9#1)
determined by RP-HPLC##2##3##(2008-10#1)(2012-2#1)
determined by SDS-PAGE##2##3##(1995-11#1)(2008-11#1)
determined by TCA and by##2##5##(2008-10#2)
determined by X-ray crystallography##2##4##(1992-4#1)(2008-10#1)
determined by X-ray##3##3##(1992-4#1)(1996-5#1)(2008-10#1)
determined by a##24##3##(1990-5#1)(1993-2#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-9#1)
determined by amino acid analysis##2##5##(1992-6#1)(1995-3#1)
determined by an##5##3##(2008-10#4)(2008-5#1)
determined by analysis of##2##4##(2008-10#1)(2008-9#1)
determined by analyzing##2##3##(2008-10#1)(2012-3#1)
determined by anodic stripping##2##4##(2008-10#2)
determined by anodic##3##3##(2008-10#3)
determined by applying##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
determined by atomic absorption##6##4##(1994-11#1)(2008-10#5)
determined by atomic##7##3##(1994-11#1)(2008-10#6)
determined by both the##2##4##(1993-11#1)(2008-10#1)
determined by both##5##3##(1992-3#1)(1993-11#1)(2008-10#3)
determined by capillary##3##3##(2008-10#3)
determined by chemical##2##3##(1993-8#1)(2010-4#1)
determined by differential pulse polarography##3##5##(2008-10#3)
determined by differential##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
determined by direct##6##3##(1997-2#1)(2008-10#5)
determined by electrothermal atomic absorption spectrometry (ETAAS)##4##7##(2008-10#4)
determined by electrothermal atomic absorption spectrometry##7##6##(2008-10#7)
determined by enzyme-linked immunosorbent assay##2##5##(1990-5#1)(2010-4#1)
determined by external##2##3##(1996-1#1)(2008-10#1)
determined by fitting the data##2##5##(1990-8#1)(2010-4#1)
determined by fitting the##3##4##(1990-8#1)(2008-10#1)(2010-4#1)
determined by flame atomic absorption spectrometry (FAAS)##6##7##(2008-10#6)
determined by flame atomic absorption spectrometry##8##6##(2008-10#8)
determined by flame atomic absorption##10##5##(2008-10#10)
determined by flame atomic##11##4##(2008-10#11)
determined by flame##12##3##(2008-10#12)
determined by flow##3##3##(2008-10#2)(2008-9#1)
determined by gas##3##3##(1992-3#1)(2008-10#1)(2009-8#1)
determined by graphite furnace atomic absorption spectrometry (GFAAS)##3##8##(2008-10#3)
determined by graphite furnace atomic absorption spectrometry##5##7##(2008-10#5)
determined by high-resolution##2##3##(1994-5#1)(2008-10#1)
determined by hydride##2##3##(2008-10#2)
determined by in vitro##2##4##(1995-6#1)(2008-7#1)
determined by inductively coupled plasma atomic emission spectrometry##2##8##(2008-10#2)
determined by inductively coupled plasma##4##5##(2008-10#4)
determined by inductively coupled##6##4##(2008-10#6)
determined by inductively##7##3##(2008-10#7)
determined by mass##2##3##(1993-8#2)
determined by matrix-assisted laser desorption/ionization time of flight mass spectrometry##2##10##(2008-11#2)
determined by matrix-assisted laser desorption/ionization##4##5##(2008-11#4)
determined by matrix-assisted##5##3##(2008-11#5)
determined by means of##6##4##(2008-10#3)(2008-3#1)(2008-8#1)(2012-2#1)
determined by measuring the##6##4##(1994-3#1)(2008-10#4)(2008-4#1)
determined by nuclear magnetic resonance##2##5##(1994-5#1)(2008-10#1)
determined by protein##2##3##(1994-8#1)(1995-6#1)
determined by sequencing##2##3##(1992-9#1)(2008-10#1)
determined by size exclusion chromatography##2##5##(2008-10#1)(2011-2#1)
determined by sodium dodecyl sulfate##2##5##(2008-10#1)(2008-11#1)
determined by sodium dodecyl##5##4##(2008-10#4)(2008-11#1)
determined by solution calorimetry in##2##5##(2008-10#2)
determined by solution##3##3##(1995-8#1)(2008-10#2)
determined by spectrophotometry##3##3##(2008-10#3)
determined by spiking##2##3##(2008-10#2)
determined by standard##3##3##(1994-5#1)(2008-10#2)
determined by studying the##2##4##(1997-6#1)(2008-10#1)
determined by the difference##2##4##(2008-10#1)(2008-8#1)
determined by the distribution##2##4##(1991-5#1)(2008-10#1)
determined by the first##2##4##(1993-6#1)(2008-10#1)
determined by the interaction##2##4##(2008-8#2)
determined by the measurement of##2##5##(2008-10#1)(2008-3#1)
determined by the presence##2##4##(1994-8#1)(1995-11#1)
determined by the proposed method##3##5##(2008-10#3)
determined by the proposed##4##4##(2008-10#4)
determined by the##101##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-8#3)(1995-11#2)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#48)(2008-11#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#6)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#5)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
determined by their##4##3##(1992-9#1)(1995-8#1)(2008-8#1)(2009-7#1)
determined by this method##3##4##(2008-10#3)
determined by this##5##3##(2008-10#5)
determined by using the##4##4##(2008-10#3)(2010-11#1)
determined by using##11##3##(2008-10#10)(2010-11#1)
determined by##542##2##(1990-12#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#5)(1991-12#2)(1991-2#1)(1991-5#2)(1992-1#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#4)(1993-6#2)(1993-8#4)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-8#5)(1995-11#5)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#305)(2008-11#20)(2008-12#3)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#6)(2008-8#21)(2008-9#8)(2009-11#3)(2009-5#2)(2009-7#2)(2009-8#8)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#6)(2010-5#1)(2010-6#5)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#5)(2013-8#2)
determined directly from the##2##4##(2008-10#1)(2008-11#1)
determined directly from##3##3##(2008-10#1)(2008-11#2)
determined directly in##3##3##(2008-10#3)
determined directly##12##2##(2008-10#10)(2008-11#2)
determined disease##3##2##(2008-10#2)(2012-3#1)
determined exclusively by##2##3##(2008-10#2)
determined experimentally##3##2##(2008-3#1)(2008-7#1)(2013-1#1)
determined fluorimetrically##2##2##(2008-10#2)
determined for all##2##3##(2008-10#1)(2009-7#1)
determined for both##3##3##(2008-10#1)(2008-12#1)(2010-1#1)
determined for each##10##3##(1993-12#1)(2008-10#7)(2011-2#1)(2012-12#1)
determined for seven##2##3##(1994-9#1)(2008-10#1)
determined for the##10##3##(1990-5#1)(1992-9#2)(1993-12#1)(1993-3#1)(1995-8#1)(2008-10#2)(2008-8#1)(2009-10#1)
determined for##49##2##(1990-5#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-5#1)(1994-9#1)(1995-8#2)(1996-2#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
determined from cDNA clones##2##4##(2008-10#2)
determined from each of##2##4##(2008-10#2)
determined from the##20##3##(1990-11#1)(1991-11#1)(1996-5#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-3#1)(2009-8#1)(2009-9#1)(2011-2#1)
determined from their##2##3##(2008-10#2)
determined from##54##2##(1990-11#1)(1991-11#1)(1991-2#1)(1991-9#1)(1993-12#1)(1994-5#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#33)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#1)(2011-2#1)
determined if##2##2##(2007-12#1)(2008-10#1)
determined in a single##2##4##(2008-10#2)
determined in a##9##3##(2008-10#8)(2008-3#1)
determined in adult rats##2##4##(1992-12#1)(1994-2#1)
determined in all##3##3##(1995-3#1)(2008-10#2)
determined in aqueous##4##3##(2008-10#4)
determined in different ionic media##2##5##(2008-10#2)
determined in different##5##3##(2008-10#4)(2013-1#1)
determined in four##2##3##(2008-10#1)(2013-3#1)
determined in human##2##3##(2008-10#2)
determined in one##2##3##(1993-6#1)(2008-10#1)
determined in order to##3##4##(2008-10#2)(2012-2#1)
determined in pharmaceutical##2##3##(2008-10#2)
determined in relation to##2##4##(1992-6#1)(1996-3#1)
determined in river##2##3##(2008-10#2)
determined in samples##2##3##(1991-2#1)(2008-10#1)
determined in serum##2##3##(2008-10#2)
determined in solutions##2##3##(2008-10#2)
determined in standard##3##3##(2008-10#3)
determined in the concentration range of##2##6##(2008-10#2)
determined in the concentration range##4##5##(2008-10#4)
determined in the concentration##5##4##(2008-10#5)
determined in the field##2##4##(2008-10#2)
determined in the linear range##2##5##(2008-10#2)
determined in the presence of##10##5##(1994-5#1)(1995-12#1)(2008-10#8)
determined in the range of 0##4##6##(2008-10#4)
determined in the range of##5##5##(2008-10#4)(2008-11#1)
determined in the range##9##4##(2008-10#8)(2008-11#1)
determined in the same##2##4##(1994-11#1)(2008-10#1)
determined in the##42##3##(1994-11#1)(1994-5#1)(1995-12#1)(2008-10#35)(2008-11#2)(2008-3#1)(2009-8#1)
determined in vitro##2##3##(1991-12#1)(2008-10#1)
determined in vivo##2##3##(1990-6#1)(2006-6#1)
determined in water##3##3##(2008-10#3)
determined in##188##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#1)(2006-6#1)(2008-10#127)(2008-11#5)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-3#1)(2010-9#2)(2011-2#2)(2012-2#3)(2012-4#1)(2013-1#2)(2013-3#1)
determined independently##2##2##(2008-10#2)
determined mainly by##4##3##(1995-8#1)(2008-10#3)
determined measuring the absorbance at##3##5##(2008-10#3)
determined more by##2##3##(2009-6#1)(2009-8#1)
determined nucleotide sequences of the##2##5##(1997-7#1)(2008-6#1)
determined on a##2##3##(2008-10#2)
determined on the##5##3##(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-3#1)
determined on##13##2##(1990-6#1)(1994-12#1)(1997-8#1)(2008-10#6)(2008-11#1)(2009-3#1)(2011-2#1)(2013-7#1)
determined on-line##2##2##(2008-10#2)
determined only by the##2##4##(1991-12#1)(2008-9#1)
determined only##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
determined over the##3##3##(2008-10#3)
determined over##9##2##(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)
determined potentiometrically##4##2##(2008-10#4)
determined primarily by##3##3##(2008-10#1)(2008-8#2)
determined satisfactorily##4##2##(2008-10#4)
determined similarly##6##2##(2008-10#6)
determined simultaneously by##2##3##(2008-10#2)
determined simultaneously with##7##3##(2008-10#7)
determined simultaneously##15##2##(2008-10#15)
determined spectrophotometrically as##2##3##(2008-10#2)
determined spectrophotometrically at##3##3##(2008-10#3)
determined spectrophotometrically by##2##3##(2008-10#2)
determined spectrophotometrically##11##2##(2008-10#11)
determined successfully##2##2##(2008-10#2)
determined that the##12##3##(1991-4#1)(1992-9#1)(1993-12#1)(1997-2#1)(2008-10#4)(2008-3#2)(2010-11#1)(2013-8#1)
determined that##32##2##(1990-11#1)(1991-4#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#10)(2008-3#4)(2008-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
determined the complete nucleotide sequence of a##2##7##(1995-9#1)(1997-4#1)
determined the complete nucleotide sequence##3##5##(1995-8#1)(1995-9#1)(1997-4#1)
determined the complete##4##3##(1993-2#1)(1995-8#1)(1995-9#1)(1997-4#1)
determined the critical##2##3##(1993-8#1)(2008-10#1)
determined the expression##2##3##(2008-11#1)(2013-8#1)
determined the onset of##2##4##(2008-10#2)
determined the optimal##2##3##(2008-7#1)(2012-3#1)
determined the##52##2##(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1995-12#1)(1995-8#2)(1995-9#1)(1996-2#2)(1997-3#1)(1997-4#1)(2008-10#14)(2008-11#5)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#1)
determined their##2##2##(1993-6#1)(2008-10#1)
determined through##7##2##(2007-9#1)(2008-10#4)(2008-8#1)(2008-9#1)
determined to be 0##10##4##(2008-10#7)(2008-3#1)(2008-8#1)(2011-2#1)
determined to be 1##2##4##(2008-10#1)(2008-11#1)
determined to be 5##2##4##(1997-2#1)(2008-10#1)
determined to be Pd(MQ)(2)##2##4##(2008-10#2)
determined to be at##4##4##(1991-5#1)(2008-10#1)(2008-11#1)(2009-2#1)
determined to be##70##3##(1990-8#1)(1991-5#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#48)(2008-11#3)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-11#1)(2010-6#2)(2011-2#1)
determined to contain##2##3##(2008-10#1)(2008-9#1)
determined to##84##2##(1990-8#1)(1991-5#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#56)(2008-11#5)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-11#1)(2010-6#2)(2011-2#2)(2012-2#1)
determined under controlled conditions##2##4##(2008-10#2)
determined under##6##2##(1990-9#1)(1993-12#1)(1994-1#1)(2008-10#3)
determined using a##9##3##(1991-2#1)(2008-10#5)(2010-12#1)(2011-2#1)(2013-8#1)
determined using flow##2##3##(1993-8#1)(2008-10#1)
determined using the samples collected by##2##6##(2008-10#2)
determined using the##17##3##(2008-10#14)(2008-12#1)(2008-9#1)(2013-1#1)
determined using this##3##3##(2008-10#3)
determined using##79##2##(1990-5#1)(1991-2#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-5#2)(2008-10#46)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
determined values##6##2##(2008-10#6)
determined via##2##2##(2008-10#1)(2008-11#1)
determined was##2##2##(2008-10#2)
determined were##4##2##(1993-2#1)(2008-10#3)
determined whether the##4##3##(1994-8#1)(1996-3#1)(2008-11#1)(2008-8#1)
determined whether this##2##3##(1995-8#1)(2010-8#1)
determined whether##13##2##(1993-3#1)(1994-8#1)(1995-8#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-8#1)
determined which##5##2##(1997-7#1)(2008-10#1)(2011-2#1)(2013-1#2)
determined with a relative error##2##5##(2008-10#2)
determined with a relative##3##4##(2008-10#3)
determined with a##11##3##(2008-10#9)(2008-3#2)
determined with high accuracy##3##4##(2008-10#3)
determined with numerical##2##3##(2008-10#1)(2008-3#1)
determined with recovery##2##3##(2008-10#2)
determined with satisfactory results##5##4##(2008-10#5)
determined with satisfactory##6##3##(2008-10#6)
determined with the relative##2##4##(2008-10#2)
determined with the use of##2##5##(2008-10#2)
determined with the##10##3##(2008-10#8)(2008-8#1)(2009-8#1)
determined with this method##2##4##(2008-10#2)
determined with##63##2##(1990-12#1)(1990-5#1)(1993-8#1)(1996-8#1)(2008-10#52)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-8#1)
determined within##3##2##(2008-10#3)
determined without##7##2##(1992-4#1)(2008-10#6)
determined##1897##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#12)(1990-6#3)(1990-8#7)(1990-9#6)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#9)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#4)(1992-5#1)(1992-6#4)(1992-7#1)(1992-9#8)(1993-1#3)(1993-11#2)(1993-12#9)(1993-2#9)(1993-3#7)(1993-6#5)(1993-8#14)(1993-9#3)(1994-1#1)(1994-11#6)(1994-12#4)(1994-2#5)(1994-3#3)(1994-5#16)(1994-8#10)(1994-9#1)(1995-1#1)(1995-11#9)(1995-12#6)(1995-2#6)(1995-3#2)(1995-6#4)(1995-8#10)(1995-9#2)(1996-1#2)(1996-12#4)(1996-2#6)(1996-3#6)(1996-5#2)(1996-6#1)(1996-8#7)(1997-1#2)(1997-2#15)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#10)(2006-6#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1091)(2008-11#73)(2008-12#19)(2008-2#9)(2008-3#39)(2008-4#5)(2008-5#28)(2008-6#7)(2008-7#29)(2008-8#53)(2008-9#25)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#8)(2009-8#16)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#4)(2010-12#4)(2010-3#2)(2010-4#11)(2010-5#1)(2010-6#10)(2010-8#6)(2010-9#3)(2011-1#3)(2011-2#35)(2011-3#2)(2012-12#3)(2012-2#13)(2012-3#19)(2012-4#1)(2012-5#1)(2012-9#1)(2013-1#25)(2013-3#1)(2013-7#1)(2013-8#11)
determinedin##2##1##(2008-11#2)
determines a##2##2##(2008-10#1)(2013-8#1)
determines its##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
determines the level of##2##4##(1993-11#1)(2008-10#1)
determines the need for##2##4##(2008-11#1)(2011-2#1)
determines the number of##2##4##(2008-10#1)(2012-2#1)
determines the##24##2##(1990-6#1)(1993-11#1)(1995-11#1)(1995-9#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
determines##49##1##(1990-6#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
determining Cu(2+)##2##2##(2008-10#2)
determining NO() in##2##3##(2008-10#2)
determining a##2##2##(2011-2#1)(2013-8#1)
determining an##3##2##(1992-12#1)(2008-9#1)(2011-2#1)
determining gene##2##2##(1994-11#1)(2008-11#1)
determining how##3##2##(1993-2#2)(2010-5#1)
determining if##5##2##(2008-10#2)(2008-4#1)(2010-8#2)
determining mercury##2##2##(2008-10#2)
determining phosphate ion##2##3##(2008-10#2)
determining risk for##2##3##(2008-11#1)(2008-4#1)
determining the ability of##2##4##(1995-8#1)(2008-5#1)
determining the activity##2##3##(2008-10#1)(2008-11#1)
determining the amount of##2##4##(2008-10#2)
determining the diagnosis##2##3##(1990-2#1)(2008-12#1)
determining the extraction##2##3##(2008-10#2)
determining the genetic structure of##2##5##(2008-10#2)
determining the presence of##2##4##(2008-10#1)(2008-5#1)
determining the quality of##2##4##(2008-9#1)(2009-1#1)
determining the relative##3##3##(2008-10#2)(2008-8#1)
determining the value of##2##4##(1996-11#1)(2008-8#1)
determining the##133##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-11#2)(1996-5#2)(1997-7#1)(1997-8#1)(2008-10#45)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#11)(2008-9#3)(2009-1#1)(2009-10#1)(2009-7#1)(2009-8#4)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#2)
determining their##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
determining what##2##2##(2008-4#1)(2010-8#1)
determining whether a##2##3##(1993-1#1)(2008-8#1)
determining whether or not##2##4##(1995-2#1)(2008-7#1)
determining whether##9##2##(1993-1#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-7#2)(2008-8#1)(2010-10#1)
determining which##5##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
determining##332##1##(1990-2#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-8#2)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#149)(2008-11#24)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#8)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#19)(2008-9#9)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#2)
determinism and##2##2##(2008-12#1)(2008-8#1)
determinism##9##1##(2008-1#1)(2008-12#4)(2008-8#1)(2012-2#3)
deterministic dynamics##2##2##(2009-8#2)
deterministic model##3##2##(2008-10#1)(2008-8#2)
deterministic models##2##2##(1996-3#1)(2008-8#1)
deterministic##24##1##(1993-11#1)(1995-6#1)(1996-3#2)(2008-10#2)(2008-7#1)(2008-8#6)(2008-9#3)(2009-12#1)(2009-8#3)(2011-2#3)(2012-2#1)
deterrent##3##1##(1991-12#1)(1994-5#1)(2008-10#1)
deterrents##3##1##(2008-8#3)
detoxification enzymes##2##2##(2008-8#2)
detoxification of##5##2##(2008-10#2)(2008-11#2)(2011-1#1)
detoxification##24##1##(1991-1#1)(1995-11#2)(2008-10#6)(2008-11#7)(2008-7#2)(2008-8#2)(2009-8#1)(2010-5#1)(2011-1#1)(2012-3#1)
detoxified##4##1##(1996-2#1)(2008-11#1)(2011-1#1)(2012-2#1)
detoxify##4##1##(1994-11#1)(2009-9#1)(2010-5#1)(2011-1#1)
detriment##2##1##(2008-12#1)(2008-3#1)
detrimental effect of##5##3##(1995-5#1)(2008-10#2)(2008-11#1)(2012-7#1)
detrimental effect on##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-1#1)
detrimental effect##9##2##(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-1#1)(2012-7#1)
detrimental effects of##3##3##(1996-12#1)(2010-1#1)(2011-1#1)
detrimental effects on the##4##4##(1991-3#1)(2008-10#1)(2013-1#2)
detrimental effects on##8##3##(1991-3#3)(2008-10#2)(2009-10#1)(2013-1#2)
detrimental effects##15##2##(1991-3#3)(1993-1#1)(1996-12#1)(2008-10#3)(2008-7#1)(2009-10#1)(2010-1#1)(2011-1#1)(2012-7#1)(2013-1#2)
detrimental for##2##2##(2008-11#1)(2008-7#1)
detrimental impact on##2##3##(1996-3#1)(1997-3#1)
detrimental to the##3##3##(2008-12#1)(2008-8#1)(2013-8#1)
detrimental to##7##2##(1992-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-8#2)(2013-8#1)
detrimental##49##1##(1991-3#3)(1992-2#1)(1993-1#1)(1994-2#1)(1995-5#1)(1996-12#2)(1996-3#2)(1997-3#1)(2008-10#9)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-9#1)(2010-1#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-3#1)(2012-7#2)(2013-1#2)(2013-8#1)
detrusor##4##1##(2008-10#3)(2008-7#1)
detubularization##2##1##(1996-3#2)
detumescence##2##1##(2008-10#1)(2013-8#1)
detuning##6##1##(2007-12#1)(2008-3#5)
deuterated##3##1##(1996-5#1)(2008-3#1)(2008-5#1)
deuterium##15##1##(1991-3#2)(1992-4#1)(1992-6#3)(1993-8#2)(1996-5#1)(2008-10#3)(2008-3#3)
deux##4##1##(2013-1#4)
devascularization##2##1##(1997-6#1)(2008-9#1)
devastating complication following##2##3##(2008-8#1)(2009-3#1)
devastating complication##3##2##(2008-8#1)(2009-3#1)(2011-2#1)
devastating disease##9##2##(2008-10#5)(2008-11#2)(2008-7#1)(2012-2#1)
devastating diseases##3##2##(1997-7#1)(2008-10#2)
devastating##34##1##(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-7#3)(2008-8#2)(2009-3#1)(2010-3#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#1)
devazepide##3##1##(1993-6#2)(1996-2#1)
develop &quot##2##2##(1995-3#1)(2008-7#1)
develop AIDS##2##2##(1995-12#1)(1996-5#1)
develop a culture##2##3##(2008-11#1)(2013-8#1)
develop a fully automated##2##4##(2008-10#2)
develop a fully##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
develop a method for##3##4##(2008-10#1)(2009-8#1)(2012-4#1)
develop a model##4##3##(1996-3#1)(2008-10#1)(2008-8#2)
develop a new##10##3##(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)
develop a novel##3##3##(2008-10#2)(2012-3#1)
develop a practical##2##3##(2008-7#1)(2012-3#1)
develop a simple##9##3##(2008-10#5)(2008-11#1)(2008-5#2)(2013-1#1)
develop a specific##2##3##(2008-10#1)(2008-8#1)
develop a##129##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#2)(1994-12#2)(1994-5#1)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#4)(1997-2#2)(1997-6#1)(2008-10#31)(2008-11#16)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#6)(2013-8#4)
develop after##2##2##(1992-1#1)(2010-11#1)
develop amphetamine##2##2##(1993-6#2)
develop an approach for##2##4##(1997-2#1)(2008-8#1)
develop an##37##2##(1991-9#1)(1993-3#2)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#4)(2010-8#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
develop and analyze a##2##4##(2008-9#2)
develop and implement a new##2##5##(1996-1#1)(2012-3#1)
develop and implement a##5##4##(1991-12#1)(1995-2#1)(1996-1#1)(2012-3#1)(2013-1#1)
develop and implement##7##3##(1991-12#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
develop and##28##2##(1991-12#1)(1991-3#1)(1995-2#1)(1996-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
develop as##3##2##(2008-6#1)(2009-12#1)(2011-2#1)
develop at##3##2##(1993-2#1)(1996-9#1)(2011-1#1)
develop both##2##2##(2008-12#1)(2008-8#1)
develop disease##2##2##(2008-10#2)
develop during##2##2##(2008-10#1)(2011-2#1)
develop effective##4##2##(1996-3#1)(2008-10#2)(2008-12#1)
develop from##3##2##(1995-8#1)(2008-10#1)(2008-11#1)
develop in the##3##3##(2008-10#2)(2011-2#1)
develop in##15##2##(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
develop models##2##2##(2008-10#1)(2008-9#1)
develop more effective##2##3##(2008-10#1)(2011-2#1)
develop more##9##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#3)
develop multiple##2##2##(2008-8#1)(2012-3#1)
develop new##11##2##(1992-3#1)(1994-5#1)(2008-10#3)(2008-11#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)
develop normally##2##2##(1993-12#1)(2008-11#1)
develop novel##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
develop nurses##2##2##(2008-11#1)(2008-12#1)
develop of##2##2##(2008-11#1)(2011-2#1)
develop on the##2##3##(2008-10#2)
develop on##4##2##(2008-10#3)(2012-2#1)
develop secondary##4##2##(2008-10#2)(2009-8#1)(2011-2#1)
develop severe##4##2##(1991-6#1)(1993-11#1)(1995-12#1)(2013-1#1)
develop strategies for##3##3##(2008-10#1)(2008-11#1)(2010-11#1)
develop strategies##4##2##(2008-10#2)(2008-11#1)(2010-11#1)
develop symptoms##2##2##(2008-10#2)
develop the##23##2##(1991-1#1)(1993-3#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
develop their##6##2##(2008-1#1)(2008-11#2)(2008-12#1)(2010-10#1)(2013-1#1)
develop very##2##2##(2008-10#2)
develop##554##1##(1990-12#2)(1990-5#1)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#3)(1992-2#2)(1992-3#3)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#8)(1993-6#3)(1994-1#1)(1994-12#3)(1994-3#5)(1994-5#4)(1994-9#1)(1995-1#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#4)(1996-3#6)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#4)(2006-6#1)(2007-12#2)(2008-1#5)(2008-10#130)(2008-11#57)(2008-12#22)(2008-2#1)(2008-3#8)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#12)(2008-8#23)(2008-9#14)(2009-11#1)(2009-12#3)(2009-3#1)(2009-6#4)(2009-7#2)(2009-8#5)(2010-1#3)(2010-10#3)(2010-11#3)(2010-12#6)(2010-3#2)(2010-5#4)(2010-6#3)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#3)(2011-10#1)(2011-2#23)(2011-3#1)(2012-12#2)(2012-2#19)(2012-3#7)(2012-4#1)(2013-1#21)(2013-8#12)
developed MWP##2##2##(2008-10#2)
developed STR##2##2##(1995-11#1)(2008-12#1)
developed a comprehensive##2##3##(1995-3#1)(2013-1#1)
developed a computational model##3##4##(2010-7#1)(2012-2#1)(2013-8#1)
developed a concept of##2##4##(2008-7#1)(2012-2#1)
developed a fast##2##3##(2008-10#1)(2008-11#1)
developed a highly##3##3##(2008-10#1)(2013-1#2)
developed a method for##2##4##(2008-10#1)(2008-5#1)
developed a method to##3##4##(2008-11#1)(2008-8#1)(2009-12#1)
developed a method##8##3##(1995-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
developed a model##2##3##(1995-1#1)(2013-1#1)
developed a new method for the determination of##2##8##(2008-10#2)
developed a new method for##4##5##(2008-10#3)(2008-2#1)
developed a new##13##3##(1991-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2009-8#1)
developed a novel##7##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-6#1)(2013-1#1)
developed a procedure to##2##4##(2008-10#1)(2012-2#1)
developed a rapid and##2##4##(2008-10#1)(2008-11#1)
developed a rapid##3##3##(2008-10#1)(2008-11#2)
developed a real-time##2##3##(2008-10#1)(2008-8#1)
developed a sensitive##3##3##(1993-12#1)(1997-7#1)(2008-5#1)
developed a set of##2##4##(2009-8#1)(2010-8#1)
developed a simple##5##3##(1994-11#1)(2008-10#1)(2008-11#2)(2008-3#1)
developed a sudden##2##3##(2007-12#1)(2011-2#1)
developed a systemic##2##3##(1997-8#1)(2013-1#1)
developed a##161##2##(1991-12#2)(1991-3#1)(1991-8#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#32)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#14)(2013-8#3)
developed acute##2##2##(1996-3#1)(2012-12#1)
developed after##4##2##(1991-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
developed allows##2##2##(2008-10#2)
developed also##2##2##(1995-5#1)(2009-10#1)
developed an acute##4##3##(1992-12#1)(2008-3#1)(2009-3#1)(2010-3#1)
developed an approach to##2##4##(1994-2#1)(2008-10#1)
developed an in vitro##3##4##(1994-12#1)(2008-11#1)(2008-5#1)
developed an infection##2##3##(2008-10#2)
developed an##35##2##(1992-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-1#1)
developed analytical##4##2##(2008-10#3)(2010-5#1)
developed and a##2##3##(1992-1#1)(2008-10#1)
developed and applied to##3##4##(2008-10#3)
developed and applied##7##3##(2008-10#6)(2008-7#1)
developed and characterized##2##3##(2008-11#2)
developed and conducted##2##3##(2010-10#1)(2013-1#1)
developed and developing##2##3##(1997-7#1)(2012-3#1)
developed and evaluated##4##3##(2008-10#2)(2008-3#1)(2009-6#1)
developed and implemented##8##3##(1996-12#1)(2008-10#1)(2008-12#2)(2010-11#1)(2010-5#1)(2013-1#2)
developed and optimized##6##3##(1997-2#1)(2008-10#5)
developed and successfully##2##3##(1991-1#1)(2008-10#1)
developed and tested for the##2##5##(2008-10#2)
developed and tested for##3##4##(2008-10#3)
developed and tested##12##3##(1993-3#1)(1997-5#1)(2008-10#9)(2008-3#1)
developed and the##3##3##(2008-10#3)
developed and used for the##3##5##(2008-10#2)(2008-7#1)
developed and used for##5##4##(2008-10#4)(2008-7#1)
developed and used to##7##4##(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)
developed and used##14##3##(2008-10#10)(2008-11#1)(2008-7#2)(2008-8#1)
developed and utilized##3##3##(2008-10#2)(2008-12#1)
developed and validated##14##3##(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
developed and##117##2##(1991-1#1)(1991-2#2)(1992-1#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#2)(1997-5#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#62)(2008-11#7)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#5)(2013-8#1)
developed antibodies##2##2##(1995-9#1)(1996-2#1)
developed approach##2##2##(2008-10#1)(2010-8#1)
developed as a##11##3##(1994-3#1)(2008-10#5)(2008-12#1)(2008-8#1)(2010-5#1)(2011-3#1)(2013-1#1)
developed as an alternative to##4##5##(1997-2#1)(2008-5#1)(2009-4#1)(2012-12#1)
developed as an alternative##5##4##(1997-2#1)(2008-5#1)(2009-4#1)(2010-4#1)(2012-12#1)
developed as an##9##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-12#1)
developed as##24##2##(1993-12#1)(1994-3#1)(1997-2#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
developed assay##2##2##(1990-2#1)(1994-11#1)
developed at the##4##3##(1991-2#1)(2008-10#1)(2008-12#1)(2008-9#1)
developed at##13##2##(1991-2#1)(1994-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
developed based on a##4##4##(2008-10#4)
developed based on the##9##4##(2008-10#8)(2008-8#1)
developed based on##29##3##(1993-3#2)(1995-12#1)(2008-10#23)(2008-12#1)(2008-8#1)(2013-1#1)
developed based upon##2##3##(1992-3#1)(2008-10#1)
developed based##32##2##(1992-3#1)(1993-3#2)(1995-12#1)(2008-10#24)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
developed between##2##2##(1991-6#1)(2008-7#1)
developed biosensor##2##2##(2008-10#2)
developed both##2##2##(2011-2#1)(2013-1#1)
developed breast##2##2##(2008-5#2)
developed by C##2##3##(2008-10#2)
developed by a##8##3##(1995-2#1)(1997-3#1)(2008-10#4)(2008-3#1)(2010-12#1)
developed by the use of a##2##6##(2008-10#2)
developed by the##19##3##(1990-12#1)(1991-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
developed by using a##3##4##(2008-10#3)
developed by using##7##3##(2008-10#7)
developed by##92##2##(1990-12#2)(1990-8#1)(1991-2#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#50)(2008-11#4)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
developed can be##2##3##(2008-10#2)
developed capsular##2##2##(2011-2#1)(2013-1#1)
developed chelating matrix##2##3##(2008-10#2)
developed countries##31##2##(1992-6#7)(1996-1#1)(1997-7#1)(2008-11#5)(2008-3#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#3)(2012-3#1)
developed device##2##2##(2010-8#2)
developed diabetes##2##2##(1994-12#1)(2008-7#1)
developed during the##2##3##(2008-10#2)
developed electrode##2##2##(2008-10#2)
developed flow injection##2##3##(2008-10#2)
developed flow##4##2##(2008-10#4)
developed following##2##2##(1994-2#1)(2008-10#1)
developed for a new##2##4##(2008-10#1)(2008-11#1)
developed for a##8##3##(1993-12#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)
developed for analysis of##4##4##(2008-10#3)(2012-12#1)
developed for application##2##3##(2008-10#2)
developed for both##3##3##(2008-10#2)(2008-3#1)
developed for detecting##4##3##(1995-11#1)(2008-10#3)
developed for detection##3##3##(2008-10#3)
developed for determination of trace amounts of##2##7##(2008-10#2)
developed for determination of trace##3##5##(2008-10#3)
developed for determination of##17##4##(2008-10#17)
developed for easy##2##3##(2008-10#2)
developed for mercury speciation##2##4##(2008-10#2)
developed for monitoring##3##3##(2008-10#3)
developed for quantitative determination of##2##5##(2008-10#2)
developed for quantitative##3##3##(2008-10#3)
developed for rapid and##2##4##(2008-10#2)
developed for simultaneous determination of##6##5##(2008-10#6)
developed for simultaneous##10##3##(2008-10#10)
developed for the analysis of##7##5##(2008-10#7)
developed for the detection of##8##5##(1990-12#1)(2008-10#7)
developed for the detection##9##4##(1990-12#1)(2008-10#8)
developed for the determination of carbon##2##6##(2008-10#2)
developed for the determination of copper##2##6##(2008-10#2)
developed for the determination of dissolved##2##6##(2008-10#2)
developed for the determination of hydrogen##2##6##(2008-10#2)
developed for the determination of proteins##2##6##(2008-10#2)
developed for the determination of some##2##6##(2008-10#2)
developed for the determination of the##5##6##(2008-10#5)
developed for the determination of trace amounts of##4##8##(2008-10#4)
developed for the determination of trace##11##6##(2008-10#11)
developed for the determination of tungsten##2##6##(2008-10#2)
developed for the determination of##87##5##(2008-10#84)(2008-11#1)(2008-3#1)(2011-3#1)
developed for the determination##88##4##(2008-10#85)(2008-11#1)(2008-3#1)(2011-3#1)
developed for the direct determination of##6##6##(2008-10#6)
developed for the direct##8##4##(2008-10#8)
developed for the extraction of##3##5##(2008-10#3)
developed for the first time##2##5##(2008-10#1)(2008-7#1)
developed for the identification and##2##5##(2008-10#1)(2011-2#1)
developed for the identification##3##4##(2008-10#2)(2011-2#1)
developed for the isolation of##2##5##(2008-11#1)(2009-12#1)
developed for the on-line determination of##3##6##(2008-10#3)
developed for the on-line##4##4##(2008-10#4)
developed for the preconcentration##2##4##(2008-10#2)
developed for the prediction of##2##5##(1996-12#1)(2008-10#1)
developed for the quantification of##2##5##(2008-10#2)
developed for the quantitative determination of##5##6##(2008-10#5)
developed for the rapid and sensitive determination of##2##8##(2008-10#2)
developed for the rapid and##3##5##(2008-10#3)
developed for the rapid##6##4##(2008-10#6)
developed for the sensitive##2##4##(2008-10#2)
developed for the separation and determination of##4##7##(2008-10#4)
developed for the separation and##5##5##(2008-10#5)
developed for the separation of##4##5##(2008-10#4)
developed for the separation##9##4##(2008-10#9)
developed for the simultaneous determination of##11##6##(2008-10#11)
developed for the simultaneous##17##4##(2008-10#16)(2008-5#1)
developed for the spectrophotometric##3##4##(2008-10#3)
developed for the treatment of##2##5##(2008-10#2)
developed for the##226##3##(1990-12#1)(1994-2#1)(1996-12#1)(2008-10#199)(2008-11#9)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)(2009-5#1)(2010-6#1)(2011-2#1)(2011-3#1)
developed for this purpose##2##4##(2008-10#1)(2008-3#1)
developed for this##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
developed for trace##4##3##(2008-10#4)
developed for use in##5##4##(1994-9#1)(1997-1#1)(2008-10#1)(2008-9#1)(2009-10#1)
developed for##401##2##(1990-12#1)(1990-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#318)(2008-11#15)(2008-12#1)(2008-3#15)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#4)(2009-10#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#1)
developed from a cross between the resistant##2##7##(2008-10#2)
developed from a cross between the##3##6##(2008-10#3)
developed from a cross between##5##5##(2008-10#4)(2008-9#1)
developed from a##9##3##(1995-2#1)(1997-8#1)(2008-10#6)(2008-9#1)
developed from the##6##3##(1997-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
developed from##33##2##(1991-2#1)(1995-2#1)(1997-8#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
developed has##2##2##(2008-10#1)(2008-5#1)
developed here##3##2##(2008-10#2)(2008-8#1)
developed high##2##2##(1995-2#1)(2008-10#1)
developed his##2##2##(2008-10#1)(2011-2#1)
developed if##2##2##(2008-6#1)(2010-11#1)
developed in a##9##3##(1991-11#2)(1994-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-10#1)
developed in combination with##2##4##(2008-10#2)
developed in order to##14##4##(1990-2#1)(1991-3#1)(1993-11#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2010-7#1)
developed in our laboratory##6##4##(1993-1#1)(2008-10#4)(2008-9#1)
developed in our##7##3##(1993-1#1)(2008-10#4)(2008-9#2)
developed in previous##2##3##(2008-10#2)
developed in the present##2##4##(2008-10#2)
developed in the range##2##4##(2008-10#2)
developed in the##22##3##(1991-6#1)(1995-3#1)(1996-1#1)(2008-10#13)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)
developed in this paper##5##4##(2008-10#5)
developed in this study have##2##5##(2008-10#1)(2009-8#1)
developed in this study to determine##2##6##(2008-10#2)
developed in this study##11##4##(2008-10#10)(2009-8#1)
developed in this work##9##4##(2008-10#8)(2011-2#1)
developed in this##28##3##(1993-1#1)(2008-10#24)(2008-8#1)(2009-8#1)(2011-2#1)
developed in which##7##3##(1992-3#1)(2008-10#2)(2008-11#2)(2008-3#2)
developed in##131##2##(1990-2#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-1#2)(1993-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-1#2)(1996-12#1)(2008-1#1)(2008-10#72)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-3#4)
developed into a##3##3##(2008-10#2)(2008-11#1)
developed into##4##2##(1994-12#1)(2008-10#2)(2008-11#1)
developed is based on##2##4##(2008-10#2)
developed is##7##2##(2008-10#7)
developed leaf curling##2##3##(2008-10#2)
developed local##3##2##(1991-6#1)(1994-12#1)(2008-1#1)
developed low##2##2##(2012-3#1)(2013-1#1)
developed may##2##2##(2008-10#2)
developed method for the##2##4##(2008-10#2)
developed method for##7##3##(2008-10#7)
developed method has been##5##4##(2008-10#5)
developed method is##8##3##(2008-10#8)
developed method provides##2##3##(2008-10#1)(2012-12#1)
developed method was##34##3##(2008-10#33)(2008-11#1)
developed method##89##2##(2008-10#86)(2008-11#2)(2012-12#1)
developed methodology was##4##3##(2008-10#4)
developed methodology##13##2##(2008-10#11)(2011-2#2)
developed methods of##2##3##(2008-10#1)(2010-1#1)
developed methods were##6##3##(2008-10#6)
developed methods##9##2##(2008-10#7)(2010-1#1)(2012-3#1)
developed more slowly##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
developed more##8##2##(1993-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)(2011-1#1)
developed multiple##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
developed multiplex##3##2##(1995-11#1)(2008-10#2)
developed new##3##2##(2008-10#2)(2008-8#1)
developed of##2##2##(2008-10#1)(2010-10#1)
developed on the basis of##3##5##(2008-10#2)(2008-3#1)
developed on the##6##3##(2008-10#3)(2008-3#2)(2010-6#1)
developed on##10##2##(2008-10#6)(2008-11#1)(2008-3#2)(2010-6#1)
developed only in##2##3##(1997-8#1)(2008-10#1)
developed only##3##2##(1997-8#1)(2008-10#2)
developed over the past##2##4##(1992-3#1)(2008-4#1)
developed over the##4##3##(1992-1#1)(1992-3#1)(2008-4#1)(2008-7#1)
developed over##9##2##(1992-1#1)(1992-3#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
developed per##2##2##(2008-10#1)(2013-1#1)
developed previously##5##2##(1990-12#1)(2008-10#4)
developed procedure was##4##3##(2008-10#4)
developed procedure##16##2##(2008-10#16)
developed pulmonary##2##2##(2010-7#1)(2013-1#1)
developed rapid##4##2##(2008-10#4)
developed rapidly##2##2##(2008-10#1)(2010-6#1)
developed renal##2##2##(1994-5#1)(2013-1#1)
developed resin matrix##2##3##(2008-10#2)
developed resin##4##2##(2008-10#4)
developed respiratory##3##2##(2010-12#1)(2010-7#1)(2013-1#1)
developed several##2##2##(1995-12#1)(2008-10#1)
developed severe powdery mildew##2##4##(2008-10#2)
developed severe##6##2##(1994-6#1)(2008-10#3)(2011-1#1)(2013-1#1)
developed signs##2##2##(2008-7#1)(2013-1#1)
developed so far##2##3##(1996-12#1)(2008-10#1)
developed so##3##2##(1996-12#1)(2008-10#2)
developed specifically to##2##3##(2008-10#1)(2008-11#1)
developed symptoms##2##2##(2008-10#2)
developed system##9##2##(2008-10#7)(2010-10#1)(2010-8#1)
developed systemic resistance to##2##4##(2008-10#2)
developed systemic##4##2##(2008-10#3)(2013-8#1)
developed technique##3##2##(2008-10#2)(2008-9#1)
developed that can##2##3##(2008-10#1)(2008-2#1)
developed that included##3##3##(1997-1#1)(2010-7#1)(2012-12#1)
developed that##30##2##(1990-8#1)(1994-12#2)(1996-1#1)(1997-1#2)(2008-10#12)(2008-2#1)(2008-3#3)(2008-7#1)(2009-6#1)(2010-7#1)(2012-12#2)(2012-2#3)
developed the ability to##2##4##(1997-6#1)(2008-9#1)
developed the##10##2##(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-5#1)
developed these##2##2##(2008-7#1)(2011-2#1)
developed through##5##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
developed to account for##2##4##(1992-3#1)(2008-10#1)
developed to acquire##2##3##(2008-10#1)(2008-11#1)
developed to assess the##2##4##(2008-2#1)(2010-9#1)
developed to assess##6##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-9#1)
developed to be##3##3##(1994-3#1)(2008-11#1)(2008-12#1)
developed to date##3##3##(1995-2#1)(2008-10#1)(2008-12#1)
developed to detect the##4##4##(1991-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
developed to detect##9##3##(1991-12#1)(2008-10#6)(2008-11#1)(2013-1#1)
developed to determine the concentration of##2##6##(2008-10#2)
developed to determine the##7##4##(2008-10#6)(2011-2#1)
developed to determine##22##3##(2008-10#21)(2011-2#1)
developed to ensure##2##3##(2008-3#1)(2012-2#1)
developed to estimate##2##3##(1994-9#1)(2008-10#1)
developed to examine##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)
developed to guide the##2##4##(2008-10#1)(2010-7#1)
developed to guide##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
developed to identify and##2##4##(2008-10#1)(2010-4#1)
developed to identify##4##3##(1992-12#1)(1994-2#1)(2008-10#1)(2010-4#1)
developed to meet##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
developed to predict the##5##4##(1991-12#1)(2008-10#3)(2010-4#1)
developed to predict##7##3##(1991-12#1)(1992-3#1)(2008-10#4)(2010-4#1)
developed to provide a##3##4##(1996-2#1)(2008-10#1)(2008-8#1)
developed to provide##5##3##(1996-2#1)(2008-10#2)(2008-8#1)(2012-2#1)
developed to quantify the##2##4##(2008-10#2)
developed to quantify##5##3##(2008-10#5)
developed to quantitate the##2##4##(1991-9#1)(1992-12#1)
developed to separate##5##3##(2008-10#3)(2008-3#1)(2011-1#1)
developed to simulate##3##3##(2008-10#2)(2008-5#1)
developed to solve the##2##4##(2008-10#1)(2008-3#1)
developed to solve##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
developed to study the##9##4##(2008-10#5)(2008-11#2)(2008-2#1)(2011-2#1)
developed to study##11##3##(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#2)(2011-2#1)
developed to the##2##3##(1992-3#1)(1995-8#1)
developed to##193##2##(1991-12#2)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#93)(2008-11#16)(2008-12#7)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
developed transfection##2##2##(2008-11#2)
developed transient##2##2##(1990-6#1)(2010-3#1)
developed tumors##2##2##(2008-10#2)
developed two##7##2##(1993-6#1)(2008-10#3)(2008-8#2)(2012-2#1)
developed under##3##2##(1996-11#1)(2008-10#1)(2012-2#1)
developed using a##4##3##(2008-10#4)
developed using the##2##3##(2008-10#2)
developed using##42##2##(1990-2#1)(1992-6#1)(2008-10#36)(2008-11#1)(2009-10#1)(2010-10#1)(2013-1#1)
developed via##2##2##(1992-2#1)(2008-10#1)
developed was used##2##3##(2008-10#2)
developed was##9##2##(1990-12#1)(2008-10#8)
developed were##4##2##(2008-10#4)
developed when##2##2##(2008-10#2)
developed which##11##2##(1993-3#1)(1995-1#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2009-10#1)(2009-12#1)
developed with a##6##3##(2008-10#2)(2008-11#3)(2009-7#1)
developed with the aim##2##4##(2008-10#2)
developed with the##6##3##(1990-2#1)(2008-10#4)(2008-11#1)
developed with##28##2##(1990-2#1)(1994-5#1)(2008-10#18)(2008-11#4)(2008-12#1)(2009-12#1)(2009-7#1)(2012-3#1)
developed within the##2##3##(2008-10#1)(2008-11#1)
developed within##5##2##(2008-10#3)(2008-11#1)(2012-5#1)
developed##2480##1##(1990-12#6)(1990-2#6)(1990-3#2)(1990-6#5)(1990-8#2)(1990-9#2)(1991-1#3)(1991-11#3)(1991-12#5)(1991-2#10)(1991-3#4)(1991-6#4)(1991-8#3)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#8)(1992-2#2)(1992-3#10)(1992-5#1)(1992-6#8)(1992-9#1)(1993-1#6)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#7)(1993-6#3)(1993-8#4)(1994-1#1)(1994-11#6)(1994-12#15)(1994-2#6)(1994-3#9)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#2)(1995-11#3)(1995-12#12)(1995-2#11)(1995-3#4)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#2)(1996-1#9)(1996-11#5)(1996-12#9)(1996-2#6)(1996-3#9)(1996-5#3)(1996-6#2)(1997-1#5)(1997-2#8)(1997-3#7)(1997-4#1)(1997-5#6)(1997-6#5)(1997-7#5)(1997-8#10)(2007-11#3)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#1395)(2008-11#126)(2008-12#35)(2008-2#7)(2008-3#65)(2008-4#12)(2008-5#47)(2008-6#9)(2008-7#54)(2008-8#23)(2008-9#32)(2009-10#8)(2009-11#2)(2009-12#10)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#5)(2009-7#4)(2009-8#11)(2009-9#1)(2010-1#6)(2010-10#10)(2010-11#7)(2010-12#9)(2010-3#3)(2010-4#6)(2010-5#7)(2010-6#7)(2010-7#17)(2010-8#11)(2010-9#1)(2011-1#10)(2011-2#65)(2011-3#10)(2011-7#1)(2012-12#16)(2012-2#22)(2012-3#27)(2012-5#2)(2013-1#51)(2013-8#16)
developer sample##2##2##(2008-10#2)
developer##10##1##(1994-1#1)(2008-10#9)
developers of##2##2##(1994-1#1)(2008-10#1)
developers##5##1##(1994-1#1)(1995-2#1)(2008-10#3)
developing Drosophila##3##2##(1993-12#1)(1993-8#1)(2008-9#1)
developing a forecasting system##2##4##(2008-10#2)
developing a more##4##3##(2008-11#1)(2008-5#1)(2010-5#1)(2010-8#1)
developing a##48##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-8#1)(2012-2#2)(2013-1#2)(2013-8#2)
developing an effective##3##3##(1995-1#1)(2009-12#1)(2011-2#1)
developing an##13##2##(1995-1#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-7#2)(2011-2#1)(2012-12#1)
developing and developed countries##2##4##(2010-10#1)(2011-2#1)
developing and implementing##5##3##(1992-2#1)(1994-2#1)(2008-11#2)(2011-1#1)
developing and monitoring##2##3##(1997-2#1)(2008-11#1)
developing and##21##2##(1991-7#1)(1992-2#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
developing bolls##3##2##(2008-10#3)
developing brain##4##2##(1994-2#1)(1995-12#2)(1996-2#1)
developing breast cancer than##2##4##(1993-1#1)(2008-12#1)
developing breast cancer##7##3##(1991-2#1)(1993-1#1)(1995-9#1)(2008-12#2)(2012-3#2)
developing cardiovascular##2##2##(2008-10#1)(2012-2#1)
developing clinical##3##2##(1993-12#1)(2008-11#1)(2008-5#1)
developing clinically##2##2##(2008-11#1)(2013-1#1)
developing cotton##2##2##(1993-3#1)(2008-9#1)
developing countries and##3##3##(2010-6#1)(2011-2#2)
developing countries must##2##3##(1993-3#1)(2010-12#1)
developing countries where##2##3##(1993-3#1)(1997-8#1)
developing countries##52##2##(1990-12#1)(1990-2#1)(1991-6#2)(1991-8#1)(1992-5#1)(1993-3#3)(1994-12#1)(1994-9#2)(1996-12#1)(1996-3#1)(1997-7#3)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-7#1)(2008-8#1)(2010-12#5)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
developing diabetes##2##2##(2008-1#1)(2012-5#1)
developing educational##2##2##(1996-1#1)(2008-11#1)
developing effective##3##2##(1997-3#1)(2008-10#2)
developing from infected##2##3##(2008-10#2)
developing from##7##2##(2008-10#4)(2008-8#1)(2013-1#2)
developing germ cells must##2##4##(2009-10#2)
developing germ cells##5##3##(2009-10#3)(2012-2#2)
developing germ tubes##3##3##(2008-10#3)
developing germ##8##2##(2008-10#3)(2009-10#3)(2012-2#2)
developing in a##2##3##(2008-9#1)(2011-2#1)
developing in situ##2##3##(1993-5#1)(2008-8#1)
developing in vitro##2##3##(2009-12#2)
developing in##11##2##(1993-5#1)(1994-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-12#3)(2011-2#1)(2013-1#1)
developing limb##5##2##(2008-11#4)(2009-3#1)
developing linguistic##2##2##(2010-8#2)
developing mouse##2##2##(1994-2#1)(2008-5#1)
developing new##7##2##(1997-3#1)(2008-10#4)(2011-3#1)(2012-3#1)
developing novel##2##2##(2008-11#1)(2009-1#1)
developing on##2##2##(1990-8#1)(2008-8#1)
developing oocytes of##2##3##(2008-7#2)
developing resistance##2##2##(2008-10#1)(2013-8#1)
developing skin##3##2##(1991-6#1)(2008-5#1)(2012-3#1)
developing solution##7##2##(2008-10#7)
developing systems##2##2##(2008-10#1)(2008-3#1)
developing the##21##2##(1992-9#2)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)
developing their##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
developing tranilast##2##2##(2008-5#2)
developing two##2##2##(2008-8#1)(2011-2#1)
developing ways to##2##3##(1994-12#1)(1996-9#1)
developing world##9##2##(1997-7#4)(2008-12#1)(2010-12#1)(2011-2#1)(2013-8#2)
developing##536##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#5)(1991-7#3)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-9#3)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#7)(1993-5#1)(1993-8#2)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#6)(1994-5#1)(1994-8#1)(1994-9#6)(1995-1#2)(1995-12#7)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#5)(1996-3#5)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#9)(1997-6#1)(1997-7#8)(1997-8#1)(1997-9#2)(2007-12#5)(2008-1#5)(2008-10#92)(2008-11#57)(2008-12#23)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#11)(2008-6#5)(2008-7#13)(2008-8#15)(2008-9#12)(2009-1#2)(2009-10#7)(2009-12#7)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#9)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#2)(2011-2#18)(2011-3#4)(2011-8#1)(2012-12#5)(2012-2#11)(2012-3#18)(2012-5#1)(2013-1#19)(2013-7#1)(2013-8#10)
development -##2##2##(2008-11#1)(2013-1#1)
development activities##2##2##(1996-3#1)(2008-11#1)
development after##3##2##(1996-9#2)(2010-5#1)
development also##2##2##(2009-8#1)(2011-2#1)
development among##2##2##(2008-10#2)
development and a##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
development and application##3##3##(2008-10#2)(2011-2#1)
development and delivery of##2##4##(2008-12#2)
development and delivery##3##3##(2008-12#3)
development and differentiation##2##3##(1995-8#1)(2008-8#1)
development and expansion##2##3##(2008-10#1)(2009-4#1)
development and for##4##3##(1997-7#1)(2008-5#1)(2009-3#1)(2009-8#1)
development and function##2##3##(2010-11#1)(2010-7#1)
development and functional##2##3##(2008-8#2)
development and germination##2##3##(1995-6#1)(2008-10#1)
development and growth of##2##4##(2008-10#2)
development and implementation of a##3##5##(1993-3#2)(2012-2#1)
development and implementation of##10##4##(1992-1#1)(1993-3#2)(1994-2#2)(2008-11#3)(2012-2#1)(2013-1#1)
development and implementation##12##3##(1992-1#1)(1993-3#2)(1994-2#3)(2008-11#4)(2012-2#1)(2013-1#1)
development and in##4##3##(1994-2#1)(1994-3#1)(2008-7#1)(2009-8#1)
development and integrity##2##3##(2012-12#2)
development and its##2##3##(2008-10#1)(2013-8#1)
development and learning##2##3##(2008-11#2)
development and maintenance of##4##4##(1993-8#1)(2008-12#1)(2008-4#1)(2011-2#1)
development and maintenance##5##3##(1993-8#1)(2008-12#1)(2008-4#1)(2011-2#2)
development and maturation of##2##4##(1992-12#1)(2008-10#1)
development and optimization of##2##4##(2008-10#2)
development and physiology##2##3##(2008-8#1)(2011-2#1)
development and plant##2##3##(2008-10#1)(2008-9#1)
development and preliminary##2##3##(2008-10#1)(2010-6#1)
development and production of##2##4##(1995-5#1)(2008-12#1)
development and production##3##3##(1992-12#1)(1995-5#1)(2008-12#1)
development and repair##2##3##(1994-3#1)(2007-8#1)
development and spermatogenesis##2##3##(2009-10#1)(2012-2#1)
development and stress responses##2##4##(2009-10#1)(2009-6#1)
development and stress##5##3##(2009-10#3)(2009-6#1)(2009-8#1)
development and survival of##2##4##(1993-3#1)(2011-2#1)
development and testing of a##2##5##(1996-2#1)(2008-10#1)
development and testing##3##3##(1996-2#1)(2008-10#1)(2013-1#1)
development and the##9##3##(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
development and to##4##3##(1994-1#1)(1994-3#1)(1996-12#1)(2012-2#1)
development and use of##6##4##(1992-1#1)(1993-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
development and use##7##3##(1992-1#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
development and validation of##4##4##(2008-10#1)(2008-5#2)(2008-7#1)
development and validation##7##3##(2008-10#2)(2008-5#2)(2008-7#2)(2010-11#1)
development and##239##2##(1990-3#2)(1992-1#2)(1992-12#4)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#3)(1994-2#4)(1994-3#5)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#48)(2008-11#24)(2008-12#14)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#9)(2008-9#5)(2009-10#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#6)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#12)(2011-8#1)(2012-12#2)(2012-2#9)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#10)(2013-8#4)
development are##7##2##(1993-9#2)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
development as a##3##3##(2008-11#2)(2009-9#1)
development as well as##3##4##(2008-10#1)(2009-10#2)
development as##9##2##(1995-11#1)(2008-10#2)(2008-11#2)(2009-10#2)(2009-9#1)(2012-3#1)
development at##6##2##(1990-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-3#1)
development based on##3##3##(1994-2#1)(2008-10#1)(2010-11#1)
development based##4##2##(1994-2#1)(2008-10#2)(2010-11#1)
development because##2##2##(1993-9#1)(2008-10#1)
development between##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
development by the##2##3##(2008-10#1)(2012-2#1)
development by##20##2##(2008-10#6)(2008-5#10)(2009-8#1)(2011-2#1)(2012-2#2)
development can##4##2##(1994-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
development caused by##2##3##(2008-10#2)
development during adolescence##3##3##(2008-11#3)
development during the##2##3##(2008-10#1)(2008-11#1)
development during##9##2##(2008-10#2)(2008-11#4)(2011-1#1)(2013-1#2)
development efforts##2##2##(1992-12#1)(1994-1#1)
development following##2##2##(2008-10#1)(2008-9#1)
development for medical##2##3##(2009-10#1)(2009-12#1)
development for the##7##3##(1991-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2011-2#1)
development for##24##2##(1991-3#1)(1991-5#1)(1994-1#1)(1997-1#1)(2008-10#5)(2008-11#6)(2008-3#1)(2009-10#1)(2009-12#2)(2011-1#2)(2011-2#1)(2013-1#2)
development from##3##2##(2008-10#2)(2011-2#1)
development has been##2##3##(2008-11#1)(2013-1#1)
development has##8##2##(1994-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-8#1)(2013-1#1)
development have##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
development in Drosophila##2##3##(2009-7#1)(2012-2#1)
development in New##2##3##(1991-2#1)(2008-10#1)
development in a##9##3##(1992-12#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#1)(2012-3#1)
development in children##2##3##(2008-9#1)(2013-1#1)
development in relation to the##2##5##(2008-11#2)
development in the field of##2##5##(2008-3#1)(2010-8#1)
development in the##22##3##(1994-3#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#3)(2009-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
development in this area##4##4##(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)
development in vitro##2##3##(2008-10#1)(2008-9#1)
development in vivo##2##3##(2008-10#1)(2008-11#1)
development in##103##2##(1990-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#24)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#9)(2009-10#2)(2009-7#3)(2009-8#2)(2010-10#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
development include##4##2##(1994-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
development initiatives##2##2##(1992-1#1)(2008-10#1)
development instrument##3##2##(2008-11#2)(2013-8#1)
development into##2##2##(1992-1#1)(2010-9#1)
development is a##3##3##(1993-2#1)(2008-10#1)(2010-12#1)
development is##27##2##(1993-2#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#1)
development may##7##2##(1992-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-1#1)
development needs##2##2##(1994-1#1)(2012-2#1)
development of ARM##2##3##(2011-2#2)
development of ASD##2##3##(2012-12#1)(2012-3#1)
development of Drosophila melanogaster##2##4##(1997-8#2)
development of P##2##3##(2008-10#2)
development of a catalytic##2##4##(2008-10#1)(2010-6#1)
development of a comprehensive##2##4##(1995-3#1)(1997-8#1)
development of a highly sensitive##2##5##(2008-10#2)
development of a highly##3##4##(2008-10#2)(2008-3#1)
development of a hybrid artificial liver##2##6##(2008-11#2)
development of a method for the determination of##2##8##(2008-10#2)
development of a new##11##4##(1996-3#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-5#1)(2010-1#1)
development of a process##2##4##(2008-10#1)(2008-11#1)
development of a solid##2##4##(2008-10#2)
development of a##133##3##(1991-9#1)(1992-1#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#6)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2008-1#2)(2008-10#51)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-6#1)(2010-8#2)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
development of accurate##2##3##(2008-10#2)
development of an integrated##3##4##(1992-3#1)(2008-10#2)
development of an optical biosensor based on##2##7##(2008-10#2)
development of an##32##3##(1990-12#1)(1990-2#1)(1991-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-3#3)(2008-8#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#3)
development of analytical methods for##3##5##(2008-10#3)
development of analytical##5##3##(2008-10#4)(2011-2#1)
development of anti-HIV-1 drugs##2##4##(2011-2#2)
development of anti-nuclear##2##3##(2008-10#2)
development of appropriate##2##3##(1995-12#1)(2011-2#1)
development of atherosclerosis and##2##4##(1995-8#1)(2012-2#1)
development of atherosclerosis##4##3##(1995-8#1)(2008-1#1)(2012-2#1)(2012-3#1)
development of autoimmunity##4##3##(2008-10#2)(2010-5#2)
development of both##5##3##(1991-8#1)(1992-12#1)(2008-10#2)(2010-10#1)
development of brown rot##2##4##(2008-10#2)
development of brown##3##3##(2008-10#3)
development of cancer##3##3##(1990-12#1)(2008-11#1)(2011-3#1)
development of cardiovascular disease##2##4##(2008-7#2)
development of cardiovascular##3##3##(2008-7#2)(2013-7#1)
development of children##5##3##(2008-11#2)(2010-1#1)(2012-3#1)(2013-1#1)
development of chronic kidney disease (CKD)##2##6##(2009-1#1)(2010-10#1)
development of chronic##6##3##(1994-6#1)(2008-10#1)(2009-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
development of clinical placements##2##4##(2008-11#1)(2008-12#1)
development of clinical##10##3##(1993-12#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-12#1)(2013-8#2)
development of dementia##2##3##(1995-12#1)(2013-1#1)
development of diabetes##2##3##(2011-2#1)(2013-7#1)
development of different##2##3##(2008-10#1)(2010-8#1)
development of disease##2##3##(2008-10#2)
development of drugs##2##3##(2009-12#1)(2012-2#1)
development of effective##3##3##(2008-10#1)(2008-4#1)(2011-1#1)
development of entomology##2##3##(2010-1#2)
development of fusarium##2##3##(2008-10#2)
development of genetic##2##3##(2008-10#1)(2008-4#1)
development of health##2##3##(1992-1#1)(2008-11#1)
development of heart##2##3##(2008-7#1)(2008-8#1)
development of high##2##3##(2008-10#1)(2010-4#1)
development of human##2##3##(1991-3#1)(1994-12#1)
development of improved##4##3##(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
development of infants##2##3##(1992-12#1)(1994-6#1)
development of infection##2##3##(2008-10#2)
development of insulin resistance##3##4##(2008-9#1)(2010-12#1)(2012-5#1)
development of integrated##2##3##(1996-3#1)(1997-3#1)
development of latent##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
development of lung##2##3##(1991-2#1)(1994-6#1)
development of macular degeneration##2##4##(2011-2#2)
development of medical##5##3##(1993-2#1)(2010-1#1)(2011-2#1)(2012-3#2)
development of methods##2##3##(2008-10#1)(2010-7#1)
development of molecular##3##3##(2008-10#3)
development of more effective##2##4##(1993-12#1)(2009-12#1)
development of more specific##2##4##(2010-11#1)(2012-2#1)
development of more##12##3##(1993-12#1)(1994-5#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-2#2)
development of mouse##2##3##(2008-11#2)
development of multiple##4##3##(1996-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
development of neurodegenerative##2##3##(1994-11#1)(2008-11#1)
development of new##38##3##(1991-12#1)(1992-1#1)(1993-3#1)(1994-1#1)(1994-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#1)(2011-10#1)(2011-2#1)
development of novel anti-HIV-1##2##4##(2011-2#1)(2011-3#1)
development of novel##16##3##(2008-10#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
development of one##3##3##(1992-1#1)(2008-10#2)
development of ontogenic resistance##2##4##(2008-10#2)
development of phasic and tonic inhibition##2##6##(2011-2#2)
development of populations##2##3##(2008-10#2)
development of powdery mildew on##2##5##(2008-10#2)
development of products##2##3##(2008-11#1)(2008-5#1)
development of pulmonary edema##2##4##(1994-8#1)(2008-11#1)
development of pulmonary##3##3##(1994-8#1)(2008-11#1)(2009-5#1)
development of rapid##4##3##(2008-10#3)(2008-8#1)
development of rat##2##3##(1996-2#1)(2008-11#1)
development of reflective skills##2##4##(2008-11#1)(2008-12#1)
development of reflective##3##3##(2008-11#1)(2008-12#2)
development of renal##2##3##(2010-11#1)(2013-1#1)
development of rust##2##3##(2008-10#2)
development of severe dengue##2##4##(2011-2#2)
development of skin cancer##2##4##(1991-6#1)(2011-2#1)
development of skin##3##3##(1991-6#1)(2011-2#2)
development of social##2##3##(2008-11#1)(2008-12#1)
development of specific##8##3##(1994-1#1)(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#1)
development of stem##2##3##(2008-10#1)(2008-11#1)
development of strategies for##3##4##(1994-3#1)(2013-1#2)
development of strategies##4##3##(1994-3#1)(2010-11#1)(2013-1#2)
development of successful##2##3##(1996-11#1)(2008-10#1)
development of such##4##3##(1995-3#1)(1996-11#1)(2008-10#1)(2012-2#1)
development of synthetic##2##3##(2008-7#1)(2009-5#1)
development of technologies##2##3##(1995-5#1)(2010-7#1)
development of the cultivation of a bone marrow stromal cell line##2##11##(2008-11#2)
development of the disease##2##4##(2010-10#1)(2013-1#1)
development of the nervous system##3##5##(1994-11#1)(2007-12#2)
development of the pathogen##2##4##(2008-10#2)
development of the polycystic ovary syndrome##2##6##(2008-4#2)
development of the role##2##4##(2008-11#1)(2008-12#1)
development of the skill of reflection##2##6##(2008-11#2)
development of the vesico-ureteric junction##2##5##(2008-10#2)
development of the##102##3##(1991-3#2)(1991-9#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-6#1)(2007-12#2)(2008-10#20)(2008-11#10)(2008-12#8)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#1)
development of therapeutic##4##3##(1990-6#1)(2008-11#1)(2008-4#1)(2009-6#1)
development of these##9##3##(1990-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#2)(2011-2#1)(2011-7#1)
development of this##13##3##(1994-6#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2013-8#1)
development of two##4##3##(1994-12#1)(2008-10#2)(2008-5#1)
development of type##3##3##(1996-11#1)(2008-1#1)(2008-11#1)
development of user-friendly##2##3##(1991-3#1)(2008-10#1)
development of young##3##3##(1997-2#1)(2009-9#1)(2010-10#1)
development of##1164##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1991-1#3)(1991-12#4)(1991-2#5)(1991-3#5)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#7)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#11)(1993-2#1)(1993-3#6)(1993-6#1)(1994-1#4)(1994-11#4)(1994-12#13)(1994-2#5)(1994-3#10)(1994-5#2)(1994-6#5)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#4)(1995-5#7)(1995-6#1)(1995-8#6)(1995-9#1)(1996-1#3)(1996-11#7)(1996-12#7)(1996-2#10)(1996-3#11)(1996-6#2)(1996-8#1)(1997-1#6)(1997-2#9)(1997-3#9)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#11)(2006-6#2)(2007-12#4)(2008-1#10)(2008-10#272)(2008-11#114)(2008-12#41)(2008-2#2)(2008-3#11)(2008-4#16)(2008-5#22)(2008-6#2)(2008-7#21)(2008-8#17)(2008-9#27)(2009-1#5)(2009-10#4)(2009-12#8)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#8)(2009-7#10)(2009-8#7)(2009-9#2)(2010-1#11)(2010-10#7)(2010-11#14)(2010-12#17)(2010-3#1)(2010-4#3)(2010-5#7)(2010-6#4)(2010-7#12)(2010-8#7)(2010-9#4)(2011-1#6)(2011-10#3)(2011-2#66)(2011-3#11)(2011-7#5)(2012-12#13)(2012-2#32)(2012-3#32)(2012-4#1)(2012-5#2)(2013-1#33)(2013-7#3)(2013-8#17)
development officer##2##2##(1991-1#1)(1993-1#1)
development on grape##2##3##(2008-10#2)
development on the##2##3##(2008-10#1)(2009-5#1)
development on##21##2##(2008-10#16)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
development or##5##2##(2008-11#1)(2008-9#2)(2011-2#1)(2011-8#1)
development over time##3##3##(2008-10#3)
development over##5##2##(2008-10#4)(2008-11#1)
development period##2##2##(2008-7#1)(2010-8#1)
development perspective##2##2##(1993-12#1)(2008-11#1)
development process##6##2##(1994-3#2)(1995-12#1)(1997-2#1)(2008-5#1)(2009-7#1)
development processes##2##2##(2008-10#1)(2012-3#1)
development programs##8##2##(1992-1#1)(1994-1#2)(1995-1#2)(1995-5#1)(1996-3#1)(2011-2#1)
development project##2##2##(2008-11#2)
development rate of##2##3##(2008-10#1)(2008-9#1)
development should##2##2##(1991-3#1)(2008-8#1)
development stage##3##2##(1995-3#1)(2008-10#2)
development stages##2##2##(1993-6#1)(2008-10#1)
development strategy##2##2##(2010-10#2)
development that can##2##3##(1994-12#1)(2008-10#1)
development that has##2##3##(1994-8#1)(2008-11#1)
development that##7##2##(1991-1#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-11#2)(2010-11#1)
development through##3##2##(1994-3#1)(2009-9#1)(2012-2#1)
development time##5##2##(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)
development times for##3##3##(2008-10#3)
development times##4##2##(2008-10#3)(2008-11#1)
development to##8##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
development under##2##2##(2008-10#1)(2009-10#1)
development using##4##2##(1997-2#1)(2008-10#2)(2012-2#1)
development was greater at##2##4##(2008-10#2)
development was positively##2##3##(2008-10#2)
development was related##2##3##(2008-10#1)(2009-8#1)
development was similar##2##3##(2008-10#2)
development was##22##2##(1990-5#1)(1996-1#1)(2008-10#15)(2008-9#2)(2009-8#1)(2011-1#1)(2012-2#1)
development we##2##2##(1996-2#1)(2013-8#1)
development were also##2##3##(2008-3#1)(2011-2#1)
development were evaluated##3##3##(2008-10#2)(2011-1#1)
development were investigated using##2##4##(2008-10#2)
development were more sensitive to##2##5##(2008-11#1)(2008-12#1)
development were##14##2##(1991-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#2)(2011-2#1)
development when##4##2##(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)
development whilst##2##2##(2008-11#1)(2008-5#1)
development with##5##2##(1992-3#1)(2008-10#1)(2008-9#1)(2009-3#1)(2012-9#1)
development within##2##2##(2008-10#1)(2010-9#1)
development work##4##2##(2008-7#1)(2010-9#3)
development##2407##1##(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#3)(1990-5#5)(1990-6#3)(1991-1#8)(1991-12#5)(1991-2#10)(1991-3#7)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#13)(1992-12#15)(1992-2#3)(1992-3#4)(1992-6#5)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#14)(1993-2#8)(1993-3#12)(1993-6#4)(1993-8#1)(1993-9#3)(1994-1#19)(1994-11#7)(1994-12#16)(1994-2#17)(1994-3#24)(1994-5#2)(1994-6#6)(1994-8#9)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#11)(1995-2#14)(1995-3#7)(1995-5#10)(1995-6#3)(1995-8#13)(1995-9#3)(1996-1#9)(1996-11#7)(1996-12#14)(1996-2#20)(1996-3#17)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#11)(1997-2#12)(1997-3#14)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#12)(1997-8#15)(2006-6#3)(2007-12#13)(2007-8#1)(2008-1#16)(2008-10#583)(2008-11#256)(2008-12#74)(2008-2#4)(2008-3#19)(2008-4#24)(2008-5#50)(2008-6#7)(2008-7#37)(2008-8#48)(2008-9#87)(2009-1#6)(2009-10#18)(2009-11#1)(2009-12#11)(2009-3#5)(2009-4#4)(2009-5#9)(2009-6#14)(2009-7#19)(2009-8#40)(2009-9#11)(2010-1#13)(2010-10#16)(2010-11#25)(2010-12#23)(2010-3#4)(2010-4#5)(2010-5#19)(2010-6#8)(2010-7#21)(2010-8#16)(2010-9#10)(2011-1#19)(2011-10#3)(2011-2#116)(2011-3#12)(2011-7#5)(2011-8#2)(2012-12#17)(2012-2#74)(2012-3#56)(2012-4#2)(2012-5#3)(2012-9#1)(2013-1#69)(2013-7#4)(2013-8#35)
development)##2##1##(2008-10#1)(2013-8#1)
development?##5##1##(1991-3#1)(1995-3#1)(2008-11#2)(2011-2#1)
development]##2##1##(1991-6#1)(1992-5#1)
developmental and##10##2##(1997-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
developmental anomaly##2##2##(1991-6#1)(2013-1#1)
developmental biology##6##2##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)
developmental change##2##2##(2010-8#1)(2010-9#1)
developmental changes in##5##3##(2007-12#1)(2008-11#3)(2009-7#1)
developmental changes##6##2##(2007-12#2)(2008-11#3)(2009-7#1)
developmental decisions##2##2##(2009-8#2)
developmental defects##2##2##(1994-12#1)(2012-3#1)
developmental delay and##2##3##(2008-11#1)(2012-12#1)
developmental delay##11##2##(1992-12#1)(1994-6#1)(1996-9#1)(1997-3#4)(2008-11#1)(2011-2#1)(2012-12#2)
developmental delays##2##2##(1992-12#1)(2012-3#1)
developmental differences between##2##3##(2008-10#1)(2008-11#1)
developmental differences##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
developmental disabilities##3##2##(1993-3#2)(2010-10#1)
developmental disorders##7##2##(1995-1#2)(2008-11#1)(2012-2#1)(2013-8#3)
developmental dynamics##2##2##(2011-2#2)
developmental dyslexia##3##2##(2012-2#2)(2013-8#1)
developmental dysplasia of hip##2##4##(2013-7#2)
developmental events##4##2##(1995-11#1)(2008-10#1)(2008-9#2)
developmental exposure to##2##3##(2008-10#2)
developmental exposure##3##2##(2008-10#2)(2012-3#1)
developmental expression of##3##3##(1993-3#1)(2008-8#2)
developmental expression##4##2##(1993-12#1)(1993-3#1)(2008-8#2)
developmental fate##2##2##(2008-8#1)(2010-4#1)
developmental history##2##2##(1997-8#1)(2008-6#1)
developmental in##2##2##(1990-3#1)(1991-12#1)
developmental increase##2##2##(2011-2#2)
developmental instability##3##2##(2008-8#2)(2008-9#1)
developmental needs##2##2##(1991-12#1)(2008-11#1)
developmental outcomes##3##2##(1995-1#1)(2009-11#1)(2010-1#1)
developmental pathways##2##2##(2008-12#1)(2008-8#1)
developmental pattern##2##2##(2008-11#2)
developmental patterning##2##2##(2009-8#2)
developmental patterns of the##2##4##(2008-5#1)(2008-8#1)
developmental patterns##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
developmental period##4##2##(1992-12#1)(2007-12#1)(2009-11#1)(2009-8#1)
developmental periods##4##2##(2009-11#2)(2009-7#1)(2011-2#1)
developmental phase##2##2##(2008-10#1)(2008-9#1)
developmental potential##4##2##(2008-11#1)(2008-9#3)
developmental process##3##2##(1997-1#1)(2008-8#2)
developmental processes of##2##3##(2008-8#1)(2011-2#1)
developmental processes##6##2##(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-3#1)
developmental program##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
developmental programs##2##2##(2008-9#1)(2009-8#1)
developmental prosopagnosics##3##2##(2008-11#3)
developmental risk##2##2##(1991-12#1)(1992-12#1)
developmental role##2##2##(1995-2#1)(2009-8#1)
developmental sequences##3##2##(2008-9#3)
developmental stage of##2##3##(2008-10#1)(2010-4#1)
developmental stage##8##2##(1993-9#1)(1997-6#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-4#1)
developmental stages and##2##3##(2008-10#2)
developmental stages in##2##3##(1994-9#1)(2008-11#1)
developmental stages of##6##3##(1997-6#2)(2008-10#3)(2011-2#1)
developmental stages##31##2##(1993-3#1)(1994-9#1)(1997-1#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-8#3)(2009-10#1)(2011-2#3)
developmental thresholds##3##2##(2008-8#3)
developmental time##5##2##(1990-5#1)(2008-12#1)(2008-8#3)
developmental toxicity of citrinin##2##4##(1993-12#2)
developmental toxicity##6##2##(1993-12#2)(2010-1#3)(2011-2#1)
developmental toxin##2##2##(1993-12#2)
developmental trajectories##3##2##(2008-11#2)(2012-12#1)
developmental##268##1##(1990-3#1)(1990-5#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-3#1)(1993-12#7)(1993-3#4)(1993-6#1)(1993-9#2)(1994-1#3)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#6)(1997-6#3)(1997-7#1)(1997-8#3)(1997-9#1)(2007-12#4)(2008-10#26)(2008-11#34)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#28)(2008-9#19)(2009-10#1)(2009-11#4)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#10)(2010-1#6)(2010-10#1)(2010-4#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-2#15)(2012-12#7)(2012-2#8)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#5)
developmentally appropriate##2##2##(2008-9#1)(2011-1#1)
developmentally disabled##3##2##(1997-6#1)(2008-12#2)
developmentally regulated##12##2##(1991-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-8#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-3#1)
developmentally##28##1##(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-11#2)(1995-2#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
developments and future directions##2##4##(1991-2#1)(2013-8#1)
developments and##12##2##(1991-2#1)(2008-10#7)(2008-11#1)(2011-2#1)(2013-8#2)
developments are##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
developments concerning##2##2##(1995-3#1)(2008-11#1)
developments for##2##2##(1991-2#1)(2009-6#1)
developments have##4##2##(1992-1#1)(2007-12#1)(2008-6#1)(2010-10#1)
developments in both##2##3##(2008-11#1)(2008-9#1)
developments in clinical##2##3##(2008-11#1)(2008-12#1)
developments in molecular##2##3##(2011-1#1)(2011-2#1)
developments in the application of##3##5##(1995-3#1)(2008-10#2)
developments in the field of##6##5##(1994-9#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-9#1)(2013-8#1)
developments in the field##7##4##(1994-9#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-7#1)(2010-9#1)(2013-8#1)
developments in the treatment of##3##5##(2008-6#1)(2009-7#1)(2013-8#1)
developments in the##26##3##(1992-1#1)(1992-11#1)(1994-9#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-9#1)(2013-8#3)
developments in these##2##3##(2008-11#2)
developments in this field##2##4##(2008-10#1)(2010-7#1)
developments in this##5##3##(1995-2#1)(2008-10#1)(2008-7#1)(2010-7#1)(2013-8#1)
developments in##78##2##(1990-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#12)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-8#5)
developments of##9##2##(2008-10#4)(2008-11#1)(2008-7#1)(2012-2#2)(2013-8#1)
developments on##3##2##(2008-10#2)(2009-8#1)
developments regarding##3##2##(2009-10#1)(2011-2#1)(2011-7#1)
developments that have##2##3##(2008-2#1)(2009-6#1)
developments that##4##2##(2008-11#1)(2008-2#1)(2009-6#1)(2010-7#1)
developments with##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
developments##151##1##(1990-8#1)(1991-2#3)(1992-1#2)(1992-11#2)(1992-12#1)(1993-1#1)(1993-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-3#2)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#39)(2008-11#20)(2008-12#5)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#2)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#5)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#6)(2012-3#1)(2013-8#8)
develops a##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2012-3#1)
develops as a result of##2##5##(2009-10#1)(2012-2#1)
develops by##3##2##(2011-2#2)(2012-3#1)
develops gene-for-gene interactions with##2##4##(2008-10#2)
develops in the##2##3##(2011-2#1)(2012-2#1)
develops in##7##2##(1991-2#1)(1997-7#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)
develops on##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
develops when##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
develops##54##1##(1991-2#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#1)
deviance##4##1##(1994-9#2)(1996-3#1)(2009-12#1)
deviant stimuli##2##2##(2008-8#1)(2013-8#1)
deviant##5##1##(2008-12#1)(2008-8#1)(2010-1#1)(2013-8#2)
deviate##4##1##(2008-10#2)(2008-3#1)(2010-3#1)
deviated from the##3##3##(1997-8#1)(2008-10#2)
deviated from##5##2##(1997-8#1)(2008-10#3)(2008-8#1)
deviated##9##1##(1997-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
deviates more##2##2##(2008-10#1)(2008-8#1)
deviates##4##1##(2008-10#1)(2008-8#2)(2012-2#1)
deviation (S##6##2##(2008-10#6)
deviation [SD]##2##2##(2010-3#1)(2013-1#1)
deviation between##6##2##(2008-10#4)(2008-3#1)(2013-8#1)
deviation from additivity##2##3##(1992-12#1)(2008-10#1)
deviation from the##6##3##(1995-6#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
deviation from##13##2##(1992-12#1)(1992-4#2)(1995-6#1)(2008-10#4)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
deviation in the##4##3##(2008-10#3)(2008-3#1)
deviation in##10##2##(2008-10#8)(2008-3#1)(2013-1#1)
deviation is 0##2##3##(2008-10#1)(2008-9#1)
deviation is##21##2##(2008-10#20)(2008-9#1)
deviation less than##3##3##(2008-10#3)
deviation lower than##3##3##(2008-10#3)
deviation observed##2##2##(2009-2#2)
deviation of 0##11##3##(2008-10#9)(2008-3#1)(2009-2#1)
deviation of 1##18##3##(2008-10#17)(2008-2#1)
deviation of the##37##3##(1996-5#1)(2008-10#29)(2008-3#7)
deviation of##150##2##(1996-5#1)(1996-8#1)(1997-6#1)(2008-10#134)(2008-2#1)(2008-3#9)(2008-8#1)(2009-2#1)(2010-12#1)
deviation##511##1##(1992-12#1)(1992-4#2)(1994-5#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-11#3)(2008-10#448)(2008-11#1)(2008-2#1)(2008-3#16)(2008-8#3)(2008-9#3)(2009-2#4)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#4)
deviations are##3##2##(2008-10#2)(2008-3#1)
deviations being##2##2##(1993-8#1)(2008-1#1)
deviations between##2##2##(2008-10#2)
deviations from ideal##3##3##(1993-8#1)(2008-10#1)(2008-8#1)
deviations from the##3##3##(2008-2#1)(2008-8#1)(2008-9#1)
deviations from##11##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#3)(2008-9#1)(2013-8#1)
deviations in the##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
deviations in##6##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2013-1#1)
deviations lower than##2##3##(2008-10#2)
deviations obtained for##3##3##(2008-10#3)
deviations of 0##3##3##(2008-10#2)(2008-9#1)
deviations of 1##2##3##(1994-5#1)(2008-10#1)
deviations of##37##2##(1992-1#1)(1994-5#1)(2008-10#33)(2008-12#1)(2008-9#1)
deviations were lower than 3##2##5##(2008-10#2)
deviations were lower than##4##4##(2008-10#4)
deviations were##27##2##(2008-10#25)(2011-2#2)
deviations##167##1##(1992-1#1)(1993-8#2)(1994-5#1)(1997-2#1)(2008-1#1)(2008-10#133)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-8#4)(2008-9#2)(2010-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
device and its##2##3##(2008-10#2)
device and the##2##3##(1997-2#1)(2012-3#1)
device and##15##2##(1993-12#1)(1995-1#1)(1997-2#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)
device are##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
device available##2##2##(1996-1#1)(2008-10#1)
device based on plastic optical fibers##2##6##(2008-3#2)
device based on##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)
device by##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
device can##4##2##(1993-2#1)(1996-9#1)(2008-10#1)(2010-1#1)
device capable of##3##3##(2008-10#2)(2011-2#1)
device closure##5##2##(2008-11#5)
device consisted of a##2##4##(2008-10#1)(2008-7#1)
device consists of a##3##4##(1991-2#1)(2008-10#2)
device consists of##5##3##(1991-2#1)(2007-11#1)(2008-10#2)(2008-3#1)
device embolization##2##2##(2008-11#2)
device failures##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
device for measuring phase retardance##2##5##(2008-3#2)
device for the##2##3##(2008-10#1)(2009-3#1)
device for##26##2##(1996-1#1)(1996-12#2)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
device has been developed##2##4##(2008-10#2)
device has been##6##3##(2008-10#4)(2008-3#1)(2008-5#1)
device has##9##2##(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)
device implantation##2##2##(2009-10#1)(2010-6#1)
device in a##6##3##(2008-10#1)(2008-9#1)(2010-12#1)(2010-6#2)(2013-1#1)
device in the treatment of##2##5##(1996-1#1)(2011-2#1)
device in the##6##3##(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#1)
device in##16##2##(1996-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-6#3)(2010-7#1)(2011-2#1)(2013-1#1)
device is presented##3##3##(1995-1#1)(2008-3#2)
device is used##3##3##(2007-12#1)(2008-3#1)(2010-1#1)
device is##18##2##(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#2)(2010-1#2)(2010-6#1)(2010-8#1)(2012-3#1)
device must be##3##3##(1996-2#2)(2012-3#1)
device on##2##2##(2008-9#1)(2012-3#1)
device performed##2##2##(2010-6#1)(2011-2#1)
device prepared##3##2##(2008-10#3)
device reporting##2##2##(1993-3#2)
device that##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-10#1)
device therapy for##2##3##(2009-10#1)(2010-6#1)
device therapy##3##2##(2009-10#2)(2010-6#1)
device to the##2##3##(2008-10#1)(2008-11#1)
device to##12##2##(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
device use##3##2##(2008-9#1)(2012-2#2)
device used##2##2##(1997-2#1)(2009-5#1)
device using##2##2##(2008-10#2)
device was used##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
device was##14##2##(1994-9#1)(2008-10#5)(2008-11#1)(2008-9#3)(2009-7#1)(2010-1#1)(2012-2#1)(2013-1#1)
device were##2##2##(2008-10#1)(2008-9#1)
device which##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
device will be##2##3##(1992-3#1)(2008-5#1)
device with an##2##3##(2008-3#1)(2010-7#1)
device with##3##2##(2007-11#1)(2008-3#1)(2010-7#1)
device##380##1##(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-3#3)(1996-1#4)(1996-12#2)(1996-2#6)(1996-9#1)(1997-2#5)(2006-6#1)(2007-11#8)(2007-12#6)(2008-1#2)(2008-10#99)(2008-11#38)(2008-12#2)(2008-2#5)(2008-3#30)(2008-5#9)(2008-6#1)(2008-7#7)(2008-9#16)(2009-10#7)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#6)(2009-6#2)(2009-7#3)(2010-1#11)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#9)(2010-7#10)(2010-8#6)(2011-1#2)(2011-2#13)(2011-7#1)(2012-12#6)(2012-2#8)(2012-3#8)(2013-1#17)(2013-8#2)
device-related##2##1##(1993-3#1)(2010-12#1)
devices and##11##2##(1993-12#1)(1997-1#1)(2008-10#3)(2008-7#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-2#1)
devices are##16##2##(1991-3#1)(1993-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)
devices as##4##2##(2008-10#1)(2009-12#1)(2009-7#1)(2012-12#1)
devices based on##6##3##(2008-10#1)(2008-7#3)(2012-3#2)
devices but also##2##3##(2008-6#1)(2012-2#1)
devices but##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
devices by##2##2##(1997-1#1)(2008-10#1)
devices can##2##2##(1992-3#1)(2008-10#1)
devices explanted from##2##3##(2012-12#2)
devices for the##4##3##(2009-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
devices for##22##2##(1992-2#1)(1992-3#1)(1997-1#2)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
devices has been##2##3##(2008-10#1)(2010-7#1)
devices have been developed##2##4##(2008-9#1)(2009-12#1)
devices have been##4##3##(1994-2#1)(2008-7#1)(2008-9#1)(2009-12#1)
devices have##6##2##(1991-12#1)(1994-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)
devices in the##2##3##(2008-10#1)(2009-12#1)
devices in##10##2##(2008-10#3)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
devices is##8##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-6#2)(2012-3#1)
devices may##2##2##(2008-6#1)(2008-9#1)
devices on##4##2##(2008-10#1)(2009-12#1)(2013-1#2)
devices such as##5##3##(1996-2#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-8#1)
devices that are##2##3##(2010-6#1)(2010-7#1)
devices that##13##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
devices to##4##2##(1992-3#1)(2008-10#2)(2008-3#1)
devices were developed##2##3##(1996-2#1)(2009-12#1)
devices were##8##2##(1993-12#1)(1996-2#1)(2008-10#3)(2008-9#2)(2009-12#1)
devices will##2##2##(1997-1#2)
devices with different##2##3##(2008-10#2)
devices with##7##2##(1993-12#1)(1997-1#1)(2008-10#3)(2009-12#1)(2010-7#1)
devices##257##1##(1991-12#1)(1991-3#3)(1992-2#1)(1992-3#6)(1993-12#4)(1993-6#1)(1994-2#1)(1995-3#2)(1996-2#6)(1997-1#8)(2007-11#2)(2007-12#1)(2008-10#63)(2008-11#14)(2008-12#1)(2008-2#2)(2008-3#11)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#10)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-6#17)(2010-7#7)(2010-8#6)(2011-1#2)(2011-2#13)(2011-7#1)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#10)(2013-8#1)
devices)##3##1##(2010-1#2)(2011-2#1)
deviennent##2##1##(2008-11#2)
devise and implement##2##3##(1993-2#1)(1994-1#1)
devise##8##1##(1993-2#1)(1994-1#1)(2008-10#2)(2008-11#2)(2013-1#2)
devised a##6##2##(1996-1#1)(1997-1#1)(2008-10#2)(2008-6#1)(2008-7#1)
devised and##3##2##(1996-8#1)(2008-10#2)
devised by##3##2##(1990-8#1)(2008-10#1)(2008-4#1)
devised for##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
devised to##4##2##(1993-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
devised##35##1##(1990-8#1)(1992-11#1)(1993-2#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
devising a##2##2##(1996-5#1)(2008-10#1)
devising##4##1##(1996-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
devoid of the##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
devoid of##22##2##(1990-5#1)(1990-8#1)(1991-12#1)(1993-8#2)(1994-5#2)(1995-2#1)(1995-8#1)(1996-1#2)(1996-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)
devolution of##3##2##(1992-1#1)(1997-2#1)(2012-3#1)
devolution##6##1##(1992-1#1)(1997-2#4)(2012-3#1)
devolved##2##1##(1997-5#1)(2008-11#1)
devote##6##1##(1991-12#1)(1994-1#1)(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
devoted to the study of##2##5##(2010-11#1)(2010-5#1)
devoted to the##7##3##(1996-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-5#1)
devoted to##22##2##(1991-2#1)(1993-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-5#1)(2012-3#1)
devoted##25##1##(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2012-3#1)
devoured by##2##2##(2008-9#1)(2009-10#1)
dew period##7##2##(2008-10#7)
dew##17##1##(2008-10#17)
dewatered sewage sludge##2##3##(2008-12#2)
dewatered sludge##2##2##(2008-12#2)
dewatered##4##1##(2008-12#4)
dexamethasone (DEX)##3##2##(2008-10#1)(2008-11#2)
dexamethasone and aspirin##2##3##(1993-3#2)
dexamethasone and##8##2##(1990-3#1)(1993-3#2)(1994-3#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)
dexamethasone for##2##2##(2008-11#1)(2012-2#1)
dexamethasone induced ulcer model##2##4##(2012-2#2)
dexamethasone induced##3##2##(1991-5#1)(2012-2#2)
dexamethasone on##3##2##(1994-3#1)(1994-8#1)(2010-12#1)
dexamethasone or##3##2##(1994-3#1)(1995-8#1)(1997-1#1)
dexamethasone treatment##2##2##(1995-12#1)(2008-10#1)
dexamethasone##51##1##(1990-11#2)(1990-3#2)(1990-6#1)(1991-5#3)(1993-12#2)(1993-3#4)(1994-3#5)(1994-8#1)(1995-11#1)(1995-12#3)(1995-8#2)(1997-1#3)(2008-10#7)(2008-11#10)(2010-12#2)(2012-2#3)
dexamethasone-dependent##2##1##(1991-5#1)(1994-3#1)
dexamethasone-induced##2##1##(2012-2#2)
dexrazoxane##7##1##(2008-11#7)
dextra##2##1##(2008-11#1)(2011-3#1)
dextran amines##2##2##(1996-5#1)(1997-3#1)
dextran sulphate##2##2##(1990-12#1)(2006-6#1)
dextran##14##1##(1990-12#1)(1990-5#1)(1996-5#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2011-2#1)
dextransulphate##3##1##(2008-11#3)
dextromethorphan##5##1##(1996-2#4)(2010-9#1)
dextrose agar##13##2##(2008-10#12)(2008-5#1)
dextrose broth##5##2##(2008-10#4)(2008-5#1)
dextrose##22##1##(2008-10#17)(2008-5#3)(2011-2#2)
dhfr##2##1##(2008-11#2)
dhn1##2##1##(2008-9#2)
dhod##4##1##(1993-2#4)
di##3##1##(2008-10#1)(2008-4#2)
di- and tri-)##2##3##(2008-10#2)
di- and tri-methylation##3##3##(2009-10#3)
di- and tri-nucleotides##2##3##(2012-3#2)
di- and##13##2##(1995-6#1)(1996-5#1)(2008-10#6)(2009-10#3)(2012-3#2)
di-##16##1##(1995-6#1)(1996-5#1)(2008-10#8)(2008-11#1)(2009-10#3)(2012-3#2)
di-(2-ethylhexyl) phosphoric acid##2##3##(2008-10#2)
di-(2-ethylhexyl)##3##1##(2008-10#3)
di-2-pyridyl ketone##2##2##(2008-10#2)
di-2-thienyl ketone p-nitrophenylhydrazone (DSKNPH)##2##4##(2008-10#2)
di-2-thienyl ketone##3##2##(2008-10#3)
di-hydroxylated##2##1##(2011-1#2)
di-n-butyltin compounds##2##2##(1993-12#2)
di-n-butyltin##3##1##(1993-12#3)
di-substituted##2##1##(2008-10#2)
diabesity##2##1##(2013-8#2)
diabetes among##2##2##(1994-12#1)(2008-1#1)
diabetes and cardiovascular disease##2##4##(2008-11#1)(2009-6#1)
diabetes and cardiovascular##3##3##(2008-11#1)(2009-6#1)(2010-10#1)
diabetes and its##3##3##(2008-1#1)(2010-9#2)
diabetes and##29##2##(1991-8#1)(1994-12#1)(1994-6#1)(1995-2#2)(1997-4#1)(2008-1#4)(2008-11#3)(2009-12#1)(2009-6#1)(2010-10#3)(2010-9#3)(2011-2#1)(2012-3#1)(2012-4#1)(2012-5#1)(2013-1#1)(2013-8#3)
diabetes are##2##2##(2008-1#1)(2008-8#1)
diabetes by##2##2##(2011-2#1)(2012-3#1)
diabetes can##3##2##(1996-11#1)(2008-1#1)(2008-10#1)
diabetes care##3##2##(1994-12#1)(2009-6#1)(2012-2#1)
diabetes dataset##2##2##(2010-7#2)
diabetes disease##3##2##(2010-7#3)
diabetes duration##2##2##(1995-2#1)(1997-8#1)
diabetes for more than 16 years##2##6##(2013-1#2)
diabetes from##2##2##(2008-6#1)(2011-2#1)
diabetes group##3##2##(1996-11#2)(2008-12#1)
diabetes groups##2##2##(1996-11#1)(2008-12#1)
diabetes has##5##2##(1996-11#1)(2008-3#2)(2012-5#1)(2013-7#1)
diabetes have##4##2##(1994-12#1)(1996-11#1)(2008-1#1)(2010-10#1)
diabetes in China##2##3##(2010-10#2)
diabetes in Indian population##2##4##(2012-2#2)
diabetes in Kin-Hu##2##3##(1994-12#2)
diabetes in Zucker diabetic fatty##2##5##(2008-4#2)
diabetes in children##2##3##(2008-11#1)(2009-12#1)
diabetes in the##2##3##(1994-12#1)(2009-12#1)
diabetes in##24##2##(1994-12#7)(1996-11#1)(2008-1#4)(2008-11#2)(2008-4#2)(2009-12#2)(2009-5#1)(2010-10#3)(2012-2#2)
diabetes insipidus##10##2##(1994-11#2)(1997-8#2)(2008-4#2)(2008-7#1)(2011-1#2)(2012-3#1)
diabetes is##8##2##(1996-11#1)(2008-1#2)(2008-10#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-2#1)
diabetes may##4##2##(1993-3#1)(2008-1#1)(2010-10#1)(2010-9#1)
diabetes mellitus (DM)##2##3##(2011-1#1)(2012-5#1)
diabetes mellitus (IDDM)##3##3##(1995-3#1)(2008-11#1)(2011-2#1)
diabetes mellitus (NIDDM)##5##3##(1991-7#1)(1992-9#1)(2008-11#1)(2008-7#2)
diabetes mellitus and##11##3##(1992-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#4)
diabetes mellitus are##2##3##(2013-1#2)
diabetes mellitus in##6##3##(1994-6#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-11#1)
diabetes mellitus is##2##3##(1996-11#1)(2010-12#1)
diabetes mellitus or##4##3##(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#1)
diabetes mellitus type 2##2##4##(1993-11#1)(1993-2#1)
diabetes mellitus type##3##3##(1993-11#1)(1993-2#1)(2011-2#1)
diabetes mellitus was##3##3##(1992-12#1)(1994-6#1)(2008-10#1)
diabetes mellitus were##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
diabetes mellitus##119##2##(1990-2#1)(1991-12#1)(1991-7#2)(1992-12#5)(1992-5#1)(1992-9#2)(1993-11#1)(1993-2#1)(1994-11#2)(1994-12#4)(1994-6#3)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#3)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#1)(2008-1#5)(2008-10#8)(2008-11#13)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#8)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#5)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#13)(2013-8#2)
diabetes mellitus]##2##2##(1994-6#1)(2013-1#1)
diabetes on rat liver and heart tissues##2##7##(2008-10#2)
diabetes on rat##3##3##(1994-11#1)(2008-10#2)
diabetes on##11##2##(1994-11#2)(2008-1#2)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#2)
diabetes patients##6##2##(1995-11#1)(2008-1#2)(2008-11#1)(2011-2#2)
diabetes risk##2##2##(2010-10#1)(2010-5#1)
diabetes was##2##2##(2008-7#1)(2012-3#1)
diabetes##460##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#5)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#3)(1993-3#3)(1993-8#1)(1994-11#7)(1994-12#23)(1994-6#7)(1994-8#3)(1995-11#1)(1995-2#6)(1995-3#2)(1995-5#1)(1995-8#3)(1995-9#1)(1996-11#20)(1996-2#1)(1996-3#1)(1997-3#2)(1997-4#2)(1997-8#4)(2007-12#1)(2007-8#1)(2008-1#43)(2008-10#26)(2008-11#24)(2008-12#6)(2008-3#11)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#2)(2008-9#4)(2009-1#3)(2009-12#5)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#4)(2010-10#34)(2010-11#6)(2010-12#5)(2010-4#3)(2010-5#4)(2010-7#6)(2010-9#6)(2011-1#9)(2011-2#25)(2011-3#7)(2012-12#1)(2012-2#13)(2012-3#15)(2012-4#6)(2012-5#10)(2013-1#25)(2013-7#4)(2013-8#8)
diabetes)##3##1##(2008-4#1)(2011-2#1)(2012-4#1)
diabetes-associated T-cell##2##2##(1995-2#2)
diabetes-extract group##3##2##(2008-12#3)
diabetes?##3##1##(1992-12#1)(2010-12#1)(2012-5#1)
diabetes]##4##1##(1994-6#1)(1995-11#1)(1996-11#1)(2009-5#1)
diabetic (NOD)##3##2##(1995-2#1)(2008-10#1)(2010-11#1)
diabetic and##4##2##(1994-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
diabetic by##2##2##(2008-10#2)
diabetic cardiomyopathy##2##2##(1994-12#2)
diabetic complications##6##2##(1996-2#1)(2008-1#2)(2010-12#1)(2012-3#1)(2013-1#1)
diabetic conditions##2##2##(1993-8#1)(1994-8#1)
diabetic control##3##2##(1996-11#1)(2012-5#1)(2013-1#1)
diabetic decompensation##2##2##(1990-3#1)(1994-12#1)
diabetic elderly##2##2##(2008-12#2)
diabetic emergencies##3##2##(1994-12#3)
diabetic foot##4##2##(2011-2#1)(2012-2#2)(2013-1#1)
diabetic hepatocytes##3##2##(1994-8#3)
diabetic ketoacidosis##3##2##(2011-1#3)
diabetic liver##4##2##(1993-3#3)(2008-10#1)
diabetic macular##4##2##(2011-2#2)(2011-7#2)
diabetic mice##3##2##(1994-11#1)(2010-11#1)(2011-2#1)
diabetic nephropathy and##3##3##(1997-5#1)(1997-8#1)(2011-2#1)
diabetic nephropathy##17##2##(1991-11#1)(1994-3#3)(1997-5#1)(1997-8#3)(2008-1#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#1)
diabetic patient is##2##3##(2008-7#1)(2013-7#1)
diabetic patient##7##2##(1993-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
diabetic patients and identify##2##4##(2012-3#1)(2012-4#1)
diabetic patients and##6##3##(1993-2#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)(2012-4#1)
diabetic patients than##2##3##(1993-2#1)(2008-1#1)
diabetic patients with##6##3##(1991-12#1)(1993-2#1)(1995-2#1)(1997-8#1)(2011-2#1)(2013-1#1)
diabetic patients without overt##2##4##(2011-2#2)
diabetic patients##55##2##(1990-5#1)(1991-12#2)(1991-6#2)(1993-11#2)(1993-2#6)(1994-12#1)(1995-2#1)(1997-8#1)(2008-1#8)(2008-10#2)(2008-11#1)(2010-10#2)(2010-12#1)(2011-2#11)(2012-2#5)(2012-3#2)(2012-4#3)(2013-1#3)(2013-8#1)
diabetic peripheral neuropathy##2##3##(2007-7#1)(2008-9#1)
diabetic peripheral##3##2##(2007-7#1)(2008-9#2)
diabetic population##2##2##(2008-8#1)(2012-2#1)
diabetic rats received##2##3##(2008-12#1)(2012-3#1)
diabetic rats##16##2##(1994-11#1)(1994-12#2)(1994-8#2)(2008-10#2)(2008-12#3)(2011-3#2)(2012-12#1)(2012-3#2)(2013-8#1)
diabetic rats]##3##2##(2010-12#1)(2011-3#1)(2013-8#1)
diabetic retinopathy##14##2##(1991-9#1)(1995-9#3)(1996-8#1)(2008-5#1)(2010-10#6)(2011-2#2)
diabetic subjects##4##2##(1994-12#3)(2008-1#1)
diabetic tissues##2##2##(1993-3#1)(2008-10#1)
diabetic##229##1##(1990-3#3)(1990-5#1)(1991-11#1)(1991-12#3)(1991-6#3)(1991-9#1)(1992-6#1)(1993-11#4)(1993-2#6)(1993-3#4)(1993-8#3)(1994-11#4)(1994-12#17)(1994-3#3)(1994-8#7)(1995-2#2)(1995-9#3)(1996-11#1)(1996-2#3)(1996-8#1)(1997-5#1)(1997-8#5)(2007-7#1)(2008-1#17)(2008-10#16)(2008-11#2)(2008-12#7)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#8)(2010-11#2)(2010-12#3)(2011-1#3)(2011-2#28)(2011-3#6)(2011-7#2)(2012-12#2)(2012-2#12)(2012-3#10)(2012-4#5)(2012-5#2)(2013-1#11)(2013-7#2)(2013-8#4)
diabetics in##2##2##(1991-12#1)(1992-11#1)
diabetics##14##1##(1991-12#1)(1992-11#1)(1995-2#1)(1997-4#1)(2008-7#5)(2012-2#4)(2012-3#1)
diabetogenic##4##1##(1995-2#1)(2008-10#1)(2008-11#2)
diacetate##7##1##(1993-12#2)(2008-10#2)(2008-11#2)(2008-9#1)
diacetyl##4##1##(2008-6#4)
diacetylactis##2##1##(2008-6#2)
diacetyldioxime modified carbon paste electrode##2##5##(2008-10#2)
diacetyldioxime##4##1##(2008-10#4)
diacylated compounds##2##2##(1996-5#2)
diacylglycerol acyltransferase##2##2##(1990-5#2)
diacylglycerol and##3##2##(1991-3#2)(2008-11#1)
diacylglycerol or##2##2##(1990-5#1)(1994-5#1)
diacylglycerol##18##1##(1990-5#3)(1991-3#2)(1991-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#6)(1997-2#1)(2008-10#1)(2008-11#1)
diacylglycerol-containing membranes##2##2##(1994-5#2)
diadromous##2##1##(2010-8#2)
diafiltration##8##1##(2008-10#2)(2011-2#6)
diagenesis##2##1##(2013-8#2)
diagnosable##3##1##(2008-11#1)(2012-2#2)
diagnose a##2##2##(1991-12#1)(2008-10#1)
diagnose and treat##3##3##(1995-5#1)(2008-8#1)(2011-2#1)
diagnose and##8##2##(1995-5#1)(1997-1#1)(2008-10#2)(2008-8#1)(2011-2#2)(2013-8#1)
diagnose in##2##2##(2009-10#1)(2010-10#1)
diagnose##50##1##(1990-6#1)(1991-12#1)(1992-12#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2008-10#9)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#6)(2012-3#3)(2013-1#2)(2013-8#1)
diagnosed according to##2##3##(1997-8#1)(2008-7#1)
diagnosed acute##3##2##(2008-11#1)(2009-1#1)(2013-1#1)
diagnosed among##2##2##(2008-11#1)(2013-1#1)
diagnosed and treated##4##3##(2008-1#1)(2010-10#1)(2012-3#1)(2013-8#1)
diagnosed and##14##2##(1990-6#1)(1991-2#2)(1996-6#1)(2007-12#1)(2008-1#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
diagnosed as having a##3##4##(1996-9#1)(2008-7#1)(2011-2#1)
diagnosed as having##12##3##(1991-11#1)(1991-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(2008-7#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#1)
diagnosed as##27##2##(1991-11#2)(1991-12#1)(1991-4#1)(1991-9#1)(1995-2#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-7#2)(2010-2#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
diagnosed at an early##2##4##(2008-7#1)(2008-9#1)
diagnosed at an##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
diagnosed at##11##2##(1990-9#1)(1994-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2012-3#3)(2013-1#1)
diagnosed based on##2##3##(1994-12#1)(2013-1#1)
diagnosed before the##2##3##(1997-5#1)(2009-8#1)
diagnosed before##4##2##(1994-3#1)(1996-11#1)(1997-5#1)(2009-8#1)
diagnosed between##2##2##(1993-2#1)(2008-1#1)
diagnosed by ultrasound in##2##4##(1997-3#1)(2012-3#1)
diagnosed by ultrasound##4##3##(1994-5#1)(1996-11#1)(1997-3#1)(2012-3#1)
diagnosed by##19##2##(1991-6#1)(1994-3#1)(1994-5#1)(1996-11#1)(1997-3#2)(2007-8#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)
diagnosed diabetes mellitus##2##3##(2013-1#2)
diagnosed during##3##2##(1994-12#1)(1997-8#1)(2009-1#1)
diagnosed for##2##2##(1994-2#1)(2009-1#1)
diagnosed from##2##2##(1992-9#1)(2011-2#1)
diagnosed in 13##2##3##(1991-8#1)(2012-3#1)
diagnosed in a##3##3##(1991-3#1)(1995-11#1)(1997-5#1)
diagnosed in the##9##3##(1990-2#1)(1995-12#1)(2008-1#2)(2008-5#1)(2010-12#1)(2012-3#3)
diagnosed in##38##2##(1990-2#1)(1990-3#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#1)
diagnosed of##3##2##(2009-8#1)(2013-1#2)
diagnosed on fine needle aspiration##2##5##(2008-7#1)(2010-11#1)
diagnosed on the basis of##3##5##(1995-12#1)(2008-11#1)(2012-3#1)
diagnosed on##6##2##(1995-12#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-2#1)(2012-3#1)
diagnosed patients##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
diagnosed than##2##2##(1991-2#1)(2009-10#1)
diagnosed this##4##2##(2009-1#1)(2010-6#2)(2011-2#1)
diagnosed to have##5##3##(1991-2#1)(1997-8#1)(2008-12#1)(2008-3#1)(2012-2#1)
diagnosed to##6##2##(1991-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)
diagnosed type##2##2##(2009-8#1)(2011-2#1)
diagnosed with CRPS I##2##4##(2008-12#2)
diagnosed with a##4##3##(1995-12#1)(2008-1#1)(2008-11#1)(2012-12#1)
diagnosed with cancer##2##3##(2012-3#1)(2013-1#1)
diagnosed with glioblastoma##3##3##(2012-3#3)
diagnosed with the##4##3##(2008-10#1)(2013-1#2)(2013-8#1)
diagnosed with##71##2##(1991-7#1)(1993-12#1)(1993-2#2)(1994-1#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#11)(2012-12#3)(2012-3#10)(2013-1#8)(2013-8#2)
diagnosed##305##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#3)(1995-2#2)(1996-11#5)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-3#6)(1997-5#4)(1997-8#10)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#16)(2008-11#15)(2008-12#8)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#1)(2009-1#4)(2009-10#3)(2009-12#1)(2009-6#1)(2009-8#4)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#6)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#2)(2011-2#35)(2011-3#1)(2011-5#1)(2012-12#7)(2012-2#5)(2012-3#26)(2013-1#27)(2013-8#4)
diagnoses ICD##2##2##(1990-12#2)
diagnoses and drugs##2##3##(2008-11#2)
diagnoses and treatment are##2##4##(1990-12#1)(1994-9#1)
diagnoses and##11##2##(1990-12#1)(1994-9#1)(1997-3#1)(2008-11#3)(2012-12#1)(2012-2#1)(2013-1#3)
diagnoses for##3##2##(1991-1#1)(2008-7#1)(2012-3#1)
diagnoses from##2##2##(1994-6#2)
diagnoses in the##3##3##(1993-12#1)(1995-12#1)(2008-11#1)
diagnoses in##7##2##(1993-12#1)(1994-2#1)(1995-12#1)(2008-11#1)(2012-3#1)(2013-1#2)
diagnoses is##2##2##(2011-2#1)(2012-3#1)
diagnoses made##2##2##(1993-3#1)(1994-6#1)
diagnoses of##9##2##(1990-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-3#1)(2011-2#1)(2013-1#2)
diagnoses or##2##2##(2008-11#1)(2009-10#1)
diagnoses were##9##2##(1990-8#1)(1994-3#1)(1996-2#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)
diagnoses##102##1##(1990-12#5)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#3)(2008-10#4)(2008-11#11)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#15)
diagnosing##27##1##(1990-9#1)(1991-6#1)(1991-8#2)(1993-2#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#5)(2012-3#1)
diagnosis ICD##2##2##(1990-12#2)
diagnosis among##2##2##(1990-2#1)(2008-12#1)
diagnosis and a##2##3##(1991-11#1)(2011-2#1)
diagnosis and adequate##2##3##(1990-9#1)(2009-1#1)
diagnosis and allows##2##3##(1993-11#1)(2008-12#1)
diagnosis and appropriate##2##3##(2010-1#1)(2013-1#1)
diagnosis and classification of##2##4##(2008-10#1)(2012-2#1)
diagnosis and clinical management##2##4##(2008-4#1)(2012-12#1)
diagnosis and follow-up of##6##4##(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#3)
diagnosis and help##2##3##(2008-12#1)(2013-1#1)
diagnosis and management of##25##4##(1992-5#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#3)(2011-2#4)(2011-7#5)(2013-8#1)
diagnosis and management##35##3##(1992-5#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#3)(2010-9#1)(2011-2#7)(2011-7#5)(2013-8#1)
diagnosis and monitoring of##5##4##(1992-3#1)(1997-7#1)(2008-5#1)(2012-2#1)(2013-1#1)
diagnosis and proper##2##3##(2010-11#1)(2013-8#1)
diagnosis and recommendations##3##3##(1995-1#3)
diagnosis and surgical planning##2##4##(2008-7#1)(2011-2#1)
diagnosis and surgical##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
diagnosis and the start of treatment##2##6##(2012-12#2)
diagnosis and the##8##3##(1991-3#1)(1993-6#1)(2010-12#2)(2011-2#1)(2012-12#2)(2013-1#1)
diagnosis and therapeutic##4##3##(1997-4#1)(2008-12#2)(2012-2#1)
diagnosis and therapy of##3##4##(1992-5#1)(2011-2#1)(2012-3#1)
diagnosis and therapy##13##3##(1990-9#1)(1992-5#1)(1993-2#1)(1993-6#1)(1995-12#1)(1997-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#3)(2012-3#1)
diagnosis and treatment in##5##4##(1990-3#1)(2008-12#2)(2012-12#2)
diagnosis and treatment is##3##4##(2008-12#1)(2008-7#1)(2011-2#1)
diagnosis and treatment of the##2##5##(1993-2#1)(2008-4#1)
diagnosis and treatment of##27##4##(1990-9#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-12#2)(2010-8#1)(2011-2#3)(2011-7#2)(2012-12#1)(2012-3#1)(2013-1#4)
diagnosis and treatment##54##3##(1990-3#1)(1990-6#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#9)(2011-7#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#6)
diagnosis and treatment]##4##3##(1992-5#1)(1993-2#1)(1996-6#1)(2013-1#1)
diagnosis and##215##2##(1990-12#1)(1990-3#3)(1990-6#1)(1990-9#4)(1991-11#1)(1991-3#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#6)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-6#2)(1993-8#1)(1994-2#1)(1994-6#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#17)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#6)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#29)(2011-7#7)(2012-12#13)(2012-2#8)(2012-3#4)(2013-1#18)(2013-7#1)(2013-8#4)
diagnosis are based##2##3##(2008-9#1)(2013-1#1)
diagnosis are discussed##3##3##(1997-8#1)(2008-11#1)(2012-3#1)
diagnosis are##18##2##(1990-2#2)(1990-9#2)(1991-8#1)(1994-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
diagnosis as##5##2##(1991-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
diagnosis at##2##2##(1991-9#1)(2012-2#1)
diagnosis based on##2##3##(1996-12#1)(2008-10#1)
diagnosis based##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
diagnosis between##7##2##(2009-8#1)(2010-12#4)(2012-3#1)(2013-1#1)
diagnosis by##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
diagnosis can be##4##3##(1992-5#1)(2008-5#1)(2010-7#1)(2012-12#1)
diagnosis can##6##2##(1992-5#1)(1994-12#1)(2008-5#1)(2010-7#1)(2010-8#1)(2012-12#1)
diagnosis codes##2##2##(1991-3#1)(1993-12#1)
diagnosis could be##2##3##(1991-9#1)(1992-12#1)
diagnosis could not be##3##4##(2008-12#2)(2011-1#1)
diagnosis could##6##2##(1991-9#1)(1992-12#1)(1996-12#1)(2008-12#2)(2011-1#1)
diagnosis difficult##2##2##(1991-8#1)(2009-1#1)
diagnosis for##12##2##(2008-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
diagnosis has been##5##3##(1990-9#1)(1993-2#1)(2013-1#3)
diagnosis has to be##2##4##(2008-7#1)(2009-12#1)
diagnosis has##11##2##(1990-9#1)(1991-11#1)(1993-2#2)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#4)
diagnosis in a##4##3##(2008-10#1)(2008-11#1)(2010-6#1)(2012-3#1)
diagnosis in most cases##3##4##(2012-2#2)(2012-3#1)
diagnosis in the identification of the numerical chromosomal abnormalities##2##9##(2012-3#2)
diagnosis in the##3##3##(2008-10#1)(2012-3#2)
diagnosis in##33##2##(1990-12#2)(1990-2#1)(1991-2#1)(1992-1#2)(1996-11#2)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#5)
diagnosis is based on##2##4##(1993-2#1)(2013-1#1)
diagnosis is based##4##3##(1993-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
diagnosis is crucial##2##3##(2008-12#1)(2011-2#1)
diagnosis is difficult##2##3##(1993-6#1)(2012-12#1)
diagnosis is discussed##2##3##(1990-12#2)
diagnosis is essential##2##3##(1993-6#1)(2010-5#1)
diagnosis is established##2##3##(1990-12#1)(2013-1#1)
diagnosis is important##2##3##(2010-8#1)(2013-8#1)
diagnosis is made##3##3##(1990-3#1)(2008-7#1)(2013-1#1)
diagnosis is more##2##3##(1993-2#1)(2008-5#1)
diagnosis is often difficult##2##4##(1993-2#1)(2008-5#1)
diagnosis is very##2##3##(1990-2#1)(2010-11#1)
diagnosis is##44##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-9#1)(1993-2#3)(1993-6#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
diagnosis may##5##2##(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#2)
diagnosis method##2##2##(2008-10#2)
diagnosis must be##3##3##(1994-8#1)(1997-8#1)(2012-12#1)
diagnosis of &quot##2##3##(1991-12#1)(2008-12#1)
diagnosis of ADHD##2##3##(2008-9#1)(2011-2#1)
diagnosis of ASD##2##3##(2012-3#2)
diagnosis of Alzheimer's##2##3##(1996-11#1)(2013-1#1)
diagnosis of DR-ILD##2##3##(2011-2#2)
diagnosis of FA##2##3##(2008-4#2)
diagnosis of Lyme##2##3##(1997-3#1)(2008-10#1)
diagnosis of M##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
diagnosis of Newcastle disease##2##4##(2008-5#2)
diagnosis of P##2##3##(2008-10#1)(2011-2#1)
diagnosis of Schönlein-Henoch##2##3##(1997-8#2)
diagnosis of Steinert's dystrophy##2##4##(2013-1#2)
diagnosis of TA##2##3##(1997-8#2)
diagnosis of Takayasu arteritis##2##4##(1997-8#2)
diagnosis of a##14##3##(1991-11#1)(2008-11#1)(2008-7#2)(2009-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
diagnosis of acute##5##3##(1994-9#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
diagnosis of an##6##3##(2008-10#1)(2008-12#1)(2012-12#1)(2012-3#2)(2013-1#1)
diagnosis of appendiceal Crohn's disease##2##5##(2011-2#2)
diagnosis of autoimmune hepatitis##2##4##(1996-11#2)
diagnosis of bacterial##2##3##(1997-4#1)(2008-10#1)
diagnosis of bone##2##3##(1994-12#1)(2010-11#1)
diagnosis of brain##2##3##(2009-11#2)
diagnosis of breast##2##3##(1990-6#1)(2008-4#1)
diagnosis of cervical##3##3##(2008-11#2)(2013-1#1)
diagnosis of chronic##3##3##(1993-5#1)(2008-12#1)(2010-10#1)
diagnosis of dementia##5##3##(1996-11#3)(2008-7#1)(2012-12#1)
diagnosis of dyslexia##2##3##(2008-11#2)
diagnosis of early##3##3##(1990-9#1)(1991-12#1)(2008-5#1)
diagnosis of endometrial##2##3##(1995-3#1)(2013-1#1)
diagnosis of gastric##3##3##(1992-9#2)(2008-12#1)
diagnosis of hepatoblastoma##2##3##(2011-1#2)
diagnosis of infection in##2##4##(2008-10#2)
diagnosis of inflammatory##2##3##(2008-7#1)(2013-1#1)
diagnosis of intestinal obstruction##2##4##(2013-1#2)
diagnosis of left##2##3##(2012-2#1)(2013-1#1)
diagnosis of many##3##3##(1990-9#1)(2008-5#1)(2011-7#1)
diagnosis of oesophageal##2##3##(2008-1#1)(2008-11#1)
diagnosis of pelvic-peritoneal tuberculosis##2##4##(2008-10#2)
diagnosis of primary##3##3##(2008-12#1)(2013-1#2)
diagnosis of prostate cancer##2##4##(2009-12#1)(2011-2#1)
diagnosis of prostatic##3##3##(1991-2#2)(1991-7#1)
diagnosis of pulmonary embolism##3##4##(1991-11#3)
diagnosis of pulmonary##5##3##(1991-11#3)(1997-3#1)(2008-10#1)
diagnosis of rectal##2##3##(2013-1#1)(2013-8#1)
diagnosis of renal tumor##2##4##(2008-10#2)
diagnosis of renal##5##3##(1990-9#1)(2008-10#3)(2011-2#1)
diagnosis of significant##2##3##(1991-3#1)(2008-11#1)
diagnosis of such##2##3##(2013-1#1)(2013-8#1)
diagnosis of the Brugada syndrome##2##5##(2008-12#2)
diagnosis of the disease##2##4##(1991-2#1)(2011-2#1)
diagnosis of the underlying cause##2##5##(2010-10#2)
diagnosis of the##16##3##(1990-3#1)(1991-2#1)(1997-3#1)(2008-12#2)(2008-9#1)(2010-10#2)(2010-6#1)(2011-2#4)(2012-3#1)(2013-1#2)
diagnosis of these##4##3##(1990-5#1)(2008-5#1)(2011-2#1)(2012-2#1)
diagnosis of this disorder##2##4##(2008-8#1)(2011-2#1)
diagnosis of this##7##3##(1991-3#1)(1997-4#1)(1997-8#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnosis of tuberculosis##3##3##(1990-6#1)(2008-12#1)(2013-1#1)
diagnosis of urinary##2##3##(1997-2#1)(2008-10#1)
diagnosis of viral##2##3##(2008-11#1)(2013-8#1)
diagnosis of##397##2##(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#5)(1991-10#1)(1991-11#5)(1991-12#3)(1991-2#4)(1991-3#7)(1991-6#2)(1991-7#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#4)(1992-9#2)(1993-2#2)(1993-3#2)(1993-5#2)(1994-1#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#10)(1996-12#1)(1996-3#2)(1996-8#1)(1997-2#3)(1997-3#7)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#10)(2007-12#1)(2008-1#4)(2008-10#30)(2008-11#16)(2008-12#13)(2008-3#1)(2008-4#3)(2008-5#13)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#6)(2009-1#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-5#1)(2010-6#7)(2010-7#3)(2010-8#3)(2011-1#4)(2011-2#50)(2011-3#1)(2011-7#2)(2012-12#14)(2012-2#12)(2012-3#18)(2013-1#40)(2013-7#1)(2013-8#9)
diagnosis or##8##2##(1991-1#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-10#1)(2011-2#1)
diagnosis requires##2##2##(1992-2#1)(2011-2#1)
diagnosis should##3##2##(1990-3#1)(2010-12#1)(2013-1#1)
diagnosis taking##2##2##(2009-9#1)(2013-1#1)
diagnosis that##2##2##(1995-6#1)(2008-3#1)
diagnosis to be##2##3##(1992-9#1)(2008-10#1)
diagnosis to##8##2##(1990-12#1)(1991-11#1)(1992-9#1)(1993-3#1)(1995-2#1)(2008-10#2)(2010-11#1)
diagnosis today##2##2##(1997-8#2)
diagnosis was based on##4##4##(2008-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
diagnosis was confirmed by##4##4##(1990-3#1)(2008-10#1)(2008-7#1)(2009-11#1)
diagnosis was confirmed##8##3##(1990-3#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
diagnosis was delayed##2##3##(2009-4#1)(2010-11#1)
diagnosis was made##6##3##(1997-2#1)(1997-5#1)(2009-1#1)(2010-12#1)(2012-3#2)
diagnosis was not##2##3##(1990-12#1)(2008-7#1)
diagnosis was##56##2##(1990-12#2)(1990-3#4)(1991-8#1)(1992-12#1)(1993-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#5)(2009-1#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-5#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-3#6)(2013-1#1)(2013-8#2)
diagnosis when##5##2##(1996-12#1)(2008-1#1)(2012-3#2)(2013-8#1)
diagnosis with##3##2##(2008-11#1)(2011-2#2)
diagnosis##1179##1##(1990-11#2)(1990-12#17)(1990-2#11)(1990-3#14)(1990-5#3)(1990-6#7)(1990-8#3)(1990-9#14)(1991-1#1)(1991-10#1)(1991-11#9)(1991-12#6)(1991-2#8)(1991-3#11)(1991-6#10)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#2)(1992-12#7)(1992-2#4)(1992-3#4)(1992-5#17)(1992-9#6)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#12)(1993-3#4)(1993-5#2)(1993-6#5)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#6)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#3)(1995-9#1)(1996-11#16)(1996-12#4)(1996-2#2)(1996-3#4)(1996-6#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#10)(1997-4#6)(1997-5#3)(1997-7#4)(1997-8#24)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#60)(2008-11#38)(2008-12#48)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#29)(2008-6#4)(2008-7#40)(2008-8#3)(2008-9#11)(2009-1#7)(2009-10#1)(2009-11#7)(2009-12#4)(2009-3#1)(2009-4#4)(2009-5#5)(2009-7#1)(2009-8#10)(2009-9#7)(2010-1#6)(2010-10#10)(2010-11#10)(2010-12#36)(2010-2#1)(2010-3#8)(2010-4#1)(2010-5#8)(2010-6#16)(2010-7#10)(2010-8#12)(2010-9#2)(2011-1#14)(2011-2#127)(2011-3#3)(2011-7#10)(2012-12#58)(2012-2#37)(2012-3#54)(2013-1#88)(2013-7#2)(2013-8#27)
diagnosis-related group (DRG)##3##3##(1991-3#1)(1992-12#1)(1995-2#1)
diagnosis-related group weights##2##3##(1991-1#1)(1993-1#1)
diagnosis-related group##9##2##(1991-1#3)(1991-3#2)(1992-12#1)(1992-2#1)(1993-1#1)(1995-2#1)
diagnosis-related groups (DRGs)##8##3##(1991-12#1)(1992-12#1)(1992-2#2)(1994-12#3)(1995-3#1)
diagnosis-related groups to##2##3##(1991-12#1)(1994-12#1)
diagnosis-related groups##19##2##(1991-1#2)(1991-12#2)(1991-3#2)(1992-12#1)(1992-2#3)(1993-1#1)(1993-12#2)(1994-12#5)(1995-3#1)
diagnosis-related##28##1##(1991-1#5)(1991-12#2)(1991-3#4)(1992-12#2)(1992-2#4)(1993-1#2)(1993-12#2)(1994-12#5)(1995-2#1)(1995-3#1)
diagnosis?##7##1##(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(2007-12#2)(2010-10#1)
diagnosis]##7##1##(1990-11#1)(1990-2#1)(1992-2#1)(1996-11#2)(1997-2#1)(2013-1#1)
diagnosisof##2##1##(2009-8#2)
diagnostic accuracy and##2##3##(1991-3#1)(2012-3#1)
diagnostic accuracy of the technique##2##5##(1995-11#1)(2010-12#1)
diagnostic accuracy of##8##3##(1995-11#1)(2008-12#2)(2009-11#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
diagnostic accuracy##26##2##(1991-3#1)(1995-11#2)(1997-8#2)(2008-10#1)(2008-12#4)(2008-7#3)(2009-11#1)(2010-12#1)(2010-5#1)(2011-3#2)(2012-2#2)(2012-3#2)(2013-1#4)
diagnostic agreement##2##2##(1995-12#1)(2011-2#1)
diagnostic and interventional procedures##2##4##(2011-2#2)
diagnostic and management##4##3##(2008-10#1)(2008-9#1)(2010-8#1)(2013-1#1)
diagnostic and nondiagnostic##2##3##(2008-11#2)
diagnostic and prognostic##7##3##(1991-2#1)(1991-6#1)(2009-9#1)(2010-5#2)(2011-2#1)(2011-3#1)
diagnostic and therapeutic challenges##2##4##(2008-12#1)(2013-1#1)
diagnostic and therapeutic strategies##3##4##(2010-11#1)(2011-2#1)(2013-8#1)
diagnostic and therapeutic##15##3##(1990-12#1)(1993-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
diagnostic and treatment options##2##4##(2011-2#1)(2013-1#1)
diagnostic and treatment##6##3##(1993-9#1)(1994-2#1)(2011-2#2)(2013-1#2)
diagnostic and##44##2##(1990-12#1)(1991-2#1)(1991-6#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-2#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
diagnostic angiography##3##2##(1997-6#1)(2008-11#1)(2009-8#1)
diagnostic applications in##2##3##(2008-10#2)
diagnostic applications##6##2##(1990-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-12#1)
diagnostic approach for##2##3##(2008-3#1)(2012-3#1)
diagnostic approach##7##2##(1992-9#1)(1994-6#2)(2008-1#1)(2008-3#1)(2010-5#1)(2012-3#1)
diagnostic as well as##2##4##(1990-9#1)(2012-2#1)
diagnostic assays to##2##3##(2008-10#2)
diagnostic assays##4##2##(2008-10#3)(2011-2#1)
diagnostic assessment in##2##3##(2008-7#1)(2011-2#1)
diagnostic biomarkers##2##2##(2010-12#1)(2011-2#1)
diagnostic categories that##2##3##(1997-1#1)(2010-1#1)
diagnostic categories##5##2##(1997-1#2)(2008-11#2)(2010-1#1)
diagnostic category##2##2##(2011-2#1)(2012-2#1)
diagnostic challenge##6##2##(2009-10#1)(2009-8#1)(2011-2#2)(2011-3#1)(2013-1#1)
diagnostic challenges##2##2##(2011-2#1)(2013-1#1)
diagnostic characteristics##3##2##(1993-2#1)(2012-12#2)
diagnostic considerations##2##2##(1997-2#1)(1997-4#1)
diagnostic coverage##2##2##(2012-12#2)
diagnostic criteria and##4##3##(1997-8#1)(2009-11#1)(2011-2#1)(2012-2#1)
diagnostic criteria are##2##3##(1990-9#1)(2011-2#1)
diagnostic criteria for TS##2##4##(2008-7#2)
diagnostic criteria for##11##3##(2008-11#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
diagnostic criteria##29##2##(1990-9#1)(1991-8#1)(1991-9#1)(1994-12#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#8)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
diagnostic de##4##2##(2013-1#4)
diagnostic delay##5##2##(1990-12#4)(2008-10#1)
diagnostic difficulties##4##2##(1992-5#1)(2008-11#1)(2010-12#1)(2013-1#1)
diagnostic dilemma##6##2##(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#3)
diagnostic errors##2##2##(2008-4#1)(2013-1#1)
diagnostic evaluation of##3##3##(1991-12#1)(1992-12#1)(2011-2#1)
diagnostic evaluation##8##2##(1991-12#1)(1992-12#1)(2007-9#1)(2008-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
diagnostic examination##2##2##(1990-6#1)(1997-8#1)
diagnostic examinations##2##2##(1997-2#1)(1997-8#1)
diagnostic features##3##2##(2011-2#3)
diagnostic findings##3##2##(2008-12#1)(2010-10#1)(2013-1#1)
diagnostic follow-up##2##2##(1990-9#1)(2008-4#1)
diagnostic for##8##2##(1996-8#1)(2008-10#4)(2008-3#2)(2011-1#1)
diagnostic groups##6##2##(1991-11#2)(2010-5#4)
diagnostic imaging##6##2##(1991-1#2)(1997-6#1)(2010-6#1)(2012-12#1)(2012-2#1)
diagnostic importance##2##2##(1991-8#1)(2008-10#1)
diagnostic information##2##2##(1995-11#1)(1997-1#1)
diagnostic injections##2##2##(2008-9#2)
diagnostic interval##3##2##(1991-8#3)
diagnostic interview##2##2##(2010-8#1)(2011-2#1)
diagnostic investigations##2##2##(1991-3#1)(2008-7#1)
diagnostic labels##2##2##(1995-1#1)(1997-4#1)
diagnostic laboratories are##2##3##(2008-10#2)
diagnostic laboratories##3##2##(2008-10#2)(2008-7#1)
diagnostic laboratory##3##2##(2008-4#1)(2011-2#2)
diagnostic laparoscopy##3##2##(1993-1#1)(1994-3#1)(2013-1#1)
diagnostic marker of##2##3##(2008-10#1)(2013-7#1)
diagnostic marker##4##2##(2008-10#1)(2009-3#1)(2010-11#1)(2013-7#1)
diagnostic markers##2##2##(2013-8#2)
diagnostic means##2##2##(1992-12#1)(1993-3#1)
diagnostic method for##2##3##(2008-10#1)(2011-2#1)
diagnostic method##14##2##(1990-9#1)(1991-2#1)(1996-11#1)(1997-2#1)(2008-10#3)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)
diagnostic methods and##2##3##(1990-9#1)(2008-11#1)
diagnostic methods for##2##3##(1990-9#1)(2010-5#1)
diagnostic methods##12##2##(1990-9#3)(1992-6#1)(1992-9#1)(1994-6#1)(1994-9#1)(2008-11#1)(2010-5#1)(2011-2#2)(2013-1#1)
diagnostic network##3##2##(2012-12#3)
diagnostic of##2##2##(2008-10#1)(2008-5#1)
diagnostic or therapeutic##3##3##(1990-12#1)(1991-9#1)(2010-6#1)
diagnostic or##5##2##(1990-12#1)(1990-2#1)(1991-9#1)(2008-11#1)(2010-6#1)
diagnostic pitfalls##2##2##(2011-2#1)(2012-2#1)
diagnostic potential##5##2##(1997-6#2)(2008-10#1)(2008-7#1)(2013-8#1)
diagnostic problems##5##2##(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
diagnostic procedure##6##2##(1990-9#1)(1991-8#1)(2007-12#1)(2008-10#2)(2012-12#1)
diagnostic procedures and##2##3##(1997-5#1)(2008-12#1)
diagnostic procedures##21##2##(1990-9#3)(1992-3#2)(1993-12#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)
diagnostic sensitivity##4##2##(1993-2#1)(1996-12#1)(2008-10#1)(2010-12#1)
diagnostic specificity##2##2##(1996-12#1)(2008-10#1)
diagnostic strategy##2##2##(2008-3#1)(2011-2#1)
diagnostic system##4##2##(2008-10#2)(2008-2#1)(2010-6#1)
diagnostic technique##4##2##(2008-10#2)(2009-9#1)(2012-12#1)
diagnostic techniques##7##2##(1991-2#1)(1992-9#1)(1997-3#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
diagnostic technologies##2##2##(1993-12#2)
diagnostic test characteristics##2##3##(2012-12#2)
diagnostic test for##2##3##(2008-10#1)(2008-7#1)
diagnostic test##7##2##(2008-10#3)(2008-7#1)(2012-12#2)(2013-1#1)
diagnostic testing##3##2##(1997-3#1)(2008-4#2)
diagnostic tests##16##2##(1991-2#1)(1993-1#1)(1993-3#2)(2008-10#1)(2008-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
diagnostic tool for##3##3##(2008-10#2)(2008-11#1)
diagnostic tool in the evaluation of##2##6##(2008-12#1)(2008-9#1)
diagnostic tool in the##4##4##(2008-12#2)(2008-9#1)(2011-1#1)
diagnostic tool in##8##3##(1991-12#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-9#2)(2011-1#1)
diagnostic tool to##2##3##(2008-10#1)(2008-3#1)
diagnostic tool##20##2##(1991-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#4)(2009-12#1)(2009-9#1)(2011-1#1)
diagnostic tools are##2##3##(1991-3#1)(2013-8#1)
diagnostic tools for##2##3##(2008-10#1)(2012-12#1)
diagnostic tools##15##2##(1990-3#1)(1991-3#1)(1992-9#1)(1994-3#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-8#2)
diagnostic ultrasound##2##2##(1994-6#1)(1996-3#1)
diagnostic uncertainty##3##2##(2008-12#2)(2013-1#1)
diagnostic use##2##2##(1993-11#1)(2008-11#1)
diagnostic utility of##4##3##(2008-12#3)(2008-9#1)
diagnostic value of##4##3##(1991-3#1)(1991-6#1)(1996-3#1)(2007-11#1)
diagnostic value##6##2##(1991-3#1)(1991-6#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-3#1)
diagnostic work up##2##3##(1992-6#1)(2008-10#1)
diagnostic work##4##2##(1992-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
diagnostic work-up##5##2##(1997-3#1)(2010-10#3)(2012-2#1)
diagnostic workup##3##2##(1992-1#1)(1994-9#1)(2012-2#1)
diagnostic yield of##4##3##(1992-11#1)(2010-12#1)(2011-2#2)
diagnostic yield was##2##3##(2011-2#2)
diagnostic yield##10##2##(1992-11#1)(1997-8#1)(2010-12#1)(2011-2#6)(2013-8#1)
diagnostic##563##1##(1990-12#6)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#1)(1990-9#13)(1991-1#2)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#5)(1991-6#6)(1991-8#7)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#4)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#6)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#4)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#5)(1997-8#13)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#66)(2008-11#23)(2008-12#17)(2008-2#3)(2008-3#10)(2008-4#7)(2008-5#4)(2008-7#15)(2008-8#1)(2008-9#14)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#9)(2010-3#1)(2010-5#10)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#57)(2011-3#6)(2011-7#1)(2012-12#21)(2012-2#19)(2012-3#15)(2013-1#41)(2013-7#1)(2013-8#13)
diagnostic/therapeutic##2##1##(2008-10#2)
diagnostically##7##1##(1996-12#1)(1997-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
diagnostics and therapy##4##3##(1994-3#2)(1997-7#1)(2008-5#1)
diagnostics and##8##2##(1994-3#2)(1996-6#1)(1997-7#1)(2008-11#1)(2008-5#2)(2013-1#1)
diagnostics are##3##2##(1995-5#1)(1995-9#1)(2008-2#1)
diagnostics in##2##2##(2008-3#1)(2009-4#1)
diagnostics of malignant##2##3##(2013-1#2)
diagnostics of the##2##3##(1990-5#1)(2013-1#1)
diagnostics of##10##2##(1990-5#1)(1993-2#1)(2007-11#1)(2011-2#1)(2011-3#1)(2013-1#4)(2013-8#1)
diagnostics##52##1##(1990-5#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-5#1)(1995-9#1)(1996-6#1)(1997-4#1)(1997-7#2)(2007-11#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-4#1)(2010-7#1)(2010-8#2)(2011-2#7)(2011-3#1)(2013-1#6)(2013-8#2)
diagnostique##2##1##(2011-2#1)(2013-1#1)
diagnostiquées##3##1##(2011-2#2)(2013-1#1)
diagonal##2##1##(2008-8#1)(2008-9#1)
diagram of the##2##3##(2008-3#1)(2012-2#1)
diagram of##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
diagram##11##1##(1994-3#1)(2008-10#5)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#1)
diagrams and##3##2##(1996-1#1)(2008-10#2)
diagrams for##3##2##(1991-9#1)(2008-10#2)
diagrams of the##2##3##(2008-10#2)
diagrams of##6##2##(1993-8#1)(2008-10#4)(2008-5#1)
diagrams##23##1##(1991-9#1)(1993-2#1)(1993-8#1)(1996-1#4)(2008-10#12)(2008-5#1)(2008-9#1)(2010-7#1)(2012-7#1)
dial##2##1##(2008-10#1)(2013-1#1)
dialdehyde##5##1##(1991-5#1)(1993-8#1)(2008-10#2)(2013-1#1)
dialectical##2##1##(2010-10#1)(2012-3#1)
dialog##2##1##(2009-11#1)(2012-2#1)
dialogue between##2##2##(1994-1#1)(2008-5#1)
dialogue in the##2##3##(2011-2#1)(2012-3#1)
dialogue with##4##2##(1996-11#1)(2008-12#2)(2013-8#1)
dialogue##14##1##(1991-1#1)(1994-1#1)(1994-3#2)(1996-11#1)(1997-3#1)(2008-12#2)(2008-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
dialogues##2##1##(2012-3#1)(2013-1#1)
dialysate##11##1##(2008-10#8)(2011-2#3)
dialysed patients##2##2##(1994-5#1)(1997-8#1)
dialysed##4##1##(1994-5#1)(1994-8#1)(1997-8#1)(2008-10#1)
dialyser##4##1##(2008-10#4)
dialysis (PD)##5##2##(2011-2#5)
dialysis and##5##2##(1990-5#1)(2008-10#2)(2010-7#1)(2011-2#1)
dialysis concentrate##3##2##(2008-10#3)
dialysis concentrates##4##2##(2008-10#4)
dialysis during##2##2##(2008-10#2)
dialysis for the##2##3##(2008-10#2)
dialysis for##4##2##(1996-2#1)(2008-10#2)(2013-8#1)
dialysis in patients with##2##4##(2008-10#1)(2011-2#1)
dialysis in the##2##3##(2008-10#1)(2008-12#1)
dialysis in##5##2##(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)
dialysis is##7##2##(1997-5#1)(2008-10#4)(2008-4#1)(2011-2#1)
dialysis membrane##3##2##(2008-10#2)(2008-7#1)
dialysis membrane)##2##2##(2008-10#2)
dialysis method##4##2##(1994-11#1)(2008-10#2)(2011-2#1)
dialysis of##2##2##(2008-1#1)(2008-10#1)
dialysis patient##2##2##(1993-9#1)(2011-2#1)
dialysis patients##15##2##(1990-2#1)(1994-5#1)(1995-1#1)(2008-1#4)(2008-10#1)(2011-2#5)(2013-1#2)
dialysis probe##2##2##(1997-2#2)
dialysis process##2##2##(2008-10#1)(2008-12#1)
dialysis solution##3##2##(2008-10#1)(2011-2#2)
dialysis solutions##5##2##(2008-10#2)(2011-2#3)
dialysis technique##2##2##(2008-10#1)(2011-2#1)
dialysis therapy##3##2##(2011-2#3)
dialysis treatment##4##2##(1994-5#2)(2008-1#1)(2011-2#1)
dialysis unit##4##2##(1996-12#1)(2008-10#3)
dialysis vintage##2##2##(2011-2#2)
dialysis was##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
dialysis with##2##2##(1994-8#1)(2011-2#1)
dialysis##173##1##(1990-2#2)(1990-5#1)(1990-6#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#6)(1994-8#1)(1995-1#1)(1995-12#8)(1996-12#2)(1996-2#2)(1997-2#2)(1997-5#1)(1997-8#3)(2008-1#13)(2008-10#61)(2008-11#2)(2008-12#4)(2008-4#4)(2008-5#7)(2008-7#1)(2010-7#1)(2011-2#40)(2013-1#4)(2013-8#1)
dialysis)##2##1##(2012-3#1)(2013-8#1)
dialytic##2##1##(2008-1#1)(2008-11#1)
dialyzates##3##1##(2008-10#3)
dialyzed##5##1##(1994-8#1)(2008-10#3)(2011-2#1)
diamagnetic##3##1##(1994-5#1)(2008-9#1)(2012-2#1)
diameter &lt##2##2##(1997-1#1)(2008-3#1)
diameter and 20##2##3##(2008-10#1)(2008-8#1)
diameter and a##2##3##(2008-11#1)(2008-2#1)
diameter and the##2##3##(2009-7#1)(2011-2#1)
diameter and##25##2##(1991-12#1)(1995-3#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#2)(2009-11#1)(2009-7#3)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
diameter as##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
diameter between##3##2##(1997-3#1)(2008-3#1)(2013-1#1)
diameter by##2##2##(2008-10#1)(2009-1#1)
diameter carbon disc electrode positioned opposite the outlet of capillary##2##10##(2008-10#2)
diameter carbon disc electrode##3##4##(2008-10#3)
diameter during the##2##3##(2008-11#2)
diameter gold##2##2##(2008-10#2)
diameter in##7##2##(1994-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2013-1#1)
diameter is##2##2##(2008-10#2)
diameter of 0##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
diameter of 3##2##3##(2012-2#1)(2013-1#1)
diameter of the##11##3##(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#2)(2013-1#2)
diameter of##43##2##(1990-8#1)(1990-9#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-12#4)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#2)(2008-7#2)(2008-8#2)(2010-6#1)(2011-2#1)(2012-2#5)(2013-1#6)
diameter size##2##2##(2008-10#1)(2008-5#1)
diameter stems##2##2##(2008-10#2)
diameter that##2##2##(2008-3#1)(2009-10#1)
diameter using##2##2##(2008-5#1)(2010-5#1)
diameter was##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
diameter were##5##2##(1992-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
diameter with##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2012-3#1)
diameter##234##1##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#2)(1992-3#1)(1993-12#1)(1994-2#3)(1994-6#1)(1995-12#6)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#6)(2007-12#8)(2008-10#67)(2008-11#14)(2008-12#5)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#9)(2008-7#7)(2008-8#6)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#5)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#6)(2012-3#4)(2013-1#19)(2013-8#2)
diameter) in##2##2##(2008-10#1)(2008-11#1)
diameter) was##2##2##(1991-2#1)(2008-10#1)
diameter) were##3##2##(2008-10#2)(2013-1#1)
diameter)##24##1##(1991-2#1)(1996-1#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-5#2)(2008-9#1)(2012-3#1)(2013-1#1)
diameters and##2##2##(2009-2#1)(2009-7#1)
diameters of##6##2##(1997-4#1)(2008-10#4)(2011-2#1)
diameters were##3##2##(2008-7#2)(2009-2#1)
diameters##30##1##(1990-6#1)(1993-12#2)(1993-2#1)(1995-3#1)(1996-2#1)(1997-4#2)(2007-12#1)(2008-10#5)(2008-3#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#2)(2009-7#1)(2010-9#1)(2011-2#4)
diameters)##2##1##(2008-11#1)(2011-2#1)
diametral tensile strength##2##3##(2009-7#2)
diamide##3##1##(2008-10#2)(2011-2#1)
diamide-substituted##2##1##(2008-10#2)
diamides##8##1##(2008-10#8)
diamine (MSOPD)##2##2##(2008-10#2)
diamine hydrochloride in##2##3##(2008-10#2)
diamine oxidase##3##2##(2008-10#3)
diamine##19##1##(2008-10#14)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
diamines##3##1##(2008-10#3)
diamino##2##1##(1996-5#1)(2008-10#1)
diaminobenzidine##4##1##(1990-12#1)(1992-3#1)(2008-10#1)(2008-9#1)
diamond (BDD) electrode##2##3##(2008-10#2)
diamond (BDD)##3##2##(2008-10#3)
diamond 1mum##2##2##(2008-10#2)
diamond electrode##7##2##(2008-10#7)
diamond films##4##2##(2008-10#4)
diamond##41##1##(1991-5#1)(2008-10#36)(2008-3#4)
diamonds##3##1##(1990-11#3)
dianthi in##2##2##(2008-10#2)
dianthi##12##1##(2008-10#12)
diapause##5##1##(1995-11#1)(2008-8#4)
diaphorase##3##1##(1995-11#1)(1995-8#1)(2008-11#1)
diaphragm and##4##2##(1990-2#1)(1995-8#1)(2010-9#1)(2012-2#1)
diaphragm is##3##2##(2010-5#2)(2012-3#1)
diaphragm##25##1##(1990-2#2)(1990-5#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-8#1)(1995-8#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-5#4)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
diaphragm-free##3##1##(2008-10#3)
diaphragmatic hernia is##2##3##(2008-7#1)(2012-3#1)
diaphragmatic hernia##5##2##(2008-11#2)(2008-7#1)(2012-3#2)
diaphragmatic##9##1##(2008-11#2)(2008-7#1)(2009-4#1)(2010-5#1)(2012-3#4)
diaphyseal##4##1##(1996-3#1)(2009-4#1)(2009-7#1)(2011-2#1)
diaries##4##1##(2008-12#2)(2008-7#2)
diarrhea and##4##2##(1990-2#1)(2007-12#1)(2011-2#2)
diarrhea from##2##2##(1991-3#1)(1992-12#1)
diarrhea in##4##2##(1991-3#1)(1992-12#1)(2013-1#2)
diarrhea##41##1##(1990-2#1)(1991-3#3)(1991-6#1)(1991-8#8)(1992-12#3)(1993-8#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-9#1)(2009-11#1)(2010-12#3)(2011-2#6)(2013-1#5)
diarrheal illness##2##2##(2008-7#1)(2012-3#1)
diarrheal##5##1##(1997-6#1)(2008-10#1)(2008-7#1)(2012-3#2)
diarrhoea and##4##2##(1995-10#1)(1996-12#1)(2008-12#1)(2008-5#1)
diarrhoea in##2##2##(1997-8#1)(2008-8#1)
diarrhoea##13##1##(1991-3#1)(1991-8#1)(1995-10#1)(1996-12#1)(1997-5#2)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)
diarrhoeal##2##1##(2008-10#1)(2011-2#1)
diary##7##1##(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-3#1)(2011-2#1)
diarylamines##2##1##(1996-5#2)
diarylazobisphenol modified##2##2##(2008-10#2)
diastereomeric##5##1##(1991-5#1)(1996-5#2)(2008-11#1)(2008-8#1)
diastereoselective##3##1##(1996-5#3)
diastereoselectivity##3##1##(1996-5#3)
diastolic arterial blood pressure##3##4##(2007-8#1)(2011-2#1)(2012-3#1)
diastolic blood pressure##14##3##(1990-11#1)(1990-5#1)(1992-12#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-7#1)(2011-1#1)(2012-2#2)
diastolic blood##16##2##(1990-11#1)(1990-5#1)(1992-12#1)(1993-2#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-7#1)(2011-1#1)(2012-2#2)
diastolic dysfunction##3##2##(2010-4#1)(2011-2#1)(2012-12#1)
diastolic function##3##2##(1991-2#1)(2010-4#1)(2013-1#1)
diastolic pressure##3##2##(1994-6#1)(1996-3#2)
diastolic velocities##2##2##(1996-6#2)
diastolic velocity##3##2##(1996-6#2)(2013-8#1)
diastolic##50##1##(1990-11#1)(1990-5#1)(1991-2#1)(1992-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1996-3#4)(1996-6#4)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-4#3)(2010-7#3)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
diatom Cyclotella cryptica##2##3##(2010-11#2)
diatomaceous##2##1##(2007-12#1)(2008-12#1)
diatoms##4##1##(2008-3#1)(2009-4#1)(2009-8#1)(2012-2#1)
diaza-18-crown-6 ligands##2##2##(2008-10#2)
diaza-18-crown-6##4##1##(2008-10#4)
diazacrown##3##1##(2008-10#3)
diazadibenzocrown##2##1##(2008-10#2)
diazepam (0##2##2##(2008-11#1)(2012-3#1)
diazepam and prazepam##4##3##(2008-10#4)
diazepam and##6##2##(1991-1#1)(2008-10#5)
diazepam on##2##2##(2013-1#2)
diazepam##19##1##(1990-6#1)(1991-1#1)(1995-11#1)(2008-10#6)(2008-11#2)(2012-2#1)(2012-3#2)(2013-1#5)
diazepam-insensitive##5##1##(1995-11#5)
diazinon in##2##2##(2008-10#2)
diazinon##12##1##(2008-10#12)
diazo coupling reaction##2##3##(2008-10#2)
diazoamino p-azobenzene##2##2##(2008-10#2)
diazomethane and##2##2##(2008-10#2)
diazomethane##5##1##(2008-10#5)
diazonium salt##2##2##(2008-10#2)
diazonium##3##1##(2008-10#3)
diazotisation of##2##2##(2008-10#2)
diazotisation##4##1##(2008-10#4)
diazotized##3##1##(2008-10#3)
dibenzo 18 crown 6##2##4##(2008-10#2)
dibenzo##3##1##(2008-10#3)
dibenzo-18-crown-6 incorporated##2##2##(2008-10#2)
dibenzo-18-crown-6 or##2##2##(2008-10#2)
dibenzo-18-crown-6##11##1##(2008-10#11)
dibenzo-p-dioxins##8##1##(2008-10#7)(2008-11#1)
dibenzo[3n+2]crown-n##2##1##(2008-10#2)
dibenzofuran##2##1##(1993-12#1)(2008-10#1)
dibenzofurans##6##1##(1994-3#1)(2008-10#4)(2008-11#1)
dibenzothiophene##2##1##(1993-12#1)(2008-10#1)
diblock copolymer films prepared by the Langmuir-Blodgett##2##7##(2008-11#2)
diblock copolymer##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
diblock##7##1##(2008-10#3)(2008-11#2)(2008-12#2)
dibromo-##2##1##(2008-10#2)
dibromo-p-methyl-bromosulfonazo##2##1##(2008-10#2)
dibromo-p-methyl-carboxysulfonazo##2##1##(2008-10#2)
dibromo-p-methyl-methylsulfonazo##2##1##(2008-10#2)
dibromodicyanobutane##3##1##(2008-5#3)
dibutyl phthalate (DBP)##3##3##(2008-10#3)
dibutyl phthalate as##2##3##(2008-10#2)
dibutyl phthalate##6##2##(2008-10#6)
dibutyl##8##1##(2008-10#8)
dibutylphthalate (DBP)##2##2##(2008-10#2)
dibutylphthalate##5##1##(2008-10#5)
dibutyltin dichloride (DBTC)##2##3##(2008-10#2)
dibutyltin dichloride##3##2##(2008-10#3)
dibutyltin##4##1##(2008-10#3)(2008-4#1)
dibutyrate##2##1##(1994-8#1)(1995-8#1)
dibutyryl cAMP##4##2##(1991-3#1)(1993-8#1)(1995-11#1)(1996-2#1)
dibutyryl cyclic##2##2##(1994-11#1)(1995-11#1)
dibutyryl##8##1##(1991-3#1)(1993-8#1)(1994-11#1)(1995-11#2)(1995-8#2)(1996-2#1)
dicarboximide##3##1##(2008-10#3)
dicarboximide-resistant##2##1##(2008-10#2)
dicarboximides##2##1##(2008-10#2)
dicarboxylate ligands##3##2##(2008-10#3)
dicarboxylic acid##4##2##(1995-11#1)(2008-10#2)(2012-2#1)
dicarboxylic##7##1##(1995-11#1)(2008-10#5)(2012-2#1)
dichloride (DBTC)##3##2##(1993-12#1)(2008-10#2)
dichloride was##2##2##(1992-1#1)(2008-11#1)
dichloride##11##1##(1992-1#2)(1993-12#1)(2008-10#4)(2008-11#4)
dichloroacetic acid exposure##2##3##(2008-9#2)
dichloroacetic acid for 26##4##4##(2008-9#4)
dichloroacetic acid for##5##3##(2008-9#5)
dichloroacetic acid in##8##3##(2008-10#1)(2008-9#7)
dichloroacetic acid##21##2##(2008-10#3)(2008-9#18)
dichloroacetic##24##1##(2008-10#4)(2008-9#20)
dichlorobromomethane##2##1##(2008-10#2)
dichloroethane##2##1##(2008-10#2)
dichlorofluorescein (DCF)##2##2##(2008-10#1)(2008-11#1)
dichlorofluorescein##4##1##(2008-10#3)(2008-11#1)
dichloroisocyanurate##3##1##(2008-10#3)
dichloromethane and chloroform##2##3##(2008-10#2)
dichloromethane and##9##2##(2008-10#9)
dichloromethane as##2##2##(2008-10#2)
dichloromethane has been studied##2##4##(2008-10#2)
dichloromethane in##2##2##(2008-10#2)
dichloromethane was##2##2##(2008-10#2)
dichloromethane##39##1##(2008-10#33)(2008-11#5)(2008-5#1)
dichlorprop##2##1##(2008-11#2)
dichlorvos##13##1##(1997-5#2)(2008-10#11)
dichotomous##4##1##(1996-2#1)(1997-8#1)(2009-12#1)(2010-3#1)
dichotomy between##2##2##(2008-6#1)(2009-8#1)
dichotomy##8##1##(1990-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)
dichroic##4##1##(1995-6#1)(2008-10#1)(2008-3#2)
dichroism (CD) spectroscopy##2##3##(1994-5#1)(1995-2#1)
dichroism (CD)##6##2##(1990-5#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-4#1)
dichroism in##3##2##(1992-8#1)(1993-5#1)(1993-8#1)
dichroism##33##1##(1990-5#1)(1992-1#1)(1992-6#1)(1992-8#2)(1993-5#1)(1993-8#3)(1994-5#4)(1995-2#2)(1997-6#1)(2008-10#11)(2008-3#2)(2008-4#2)(2008-9#1)(2012-2#1)
dichromate##5##1##(2008-10#5)
dichromated gelatin##3##2##(2008-3#3)
dicistronic configuration##2##2##(2008-11#2)
dicistronic expression plasmids##2##3##(1993-6#2)
dicistronic expression##4##2##(1993-6#2)(2008-7#2)
dicistronic##9##1##(1993-6#2)(1994-6#1)(1997-8#2)(2008-11#2)(2008-7#2)
diclofenac and##3##2##(2008-10#2)(2011-2#1)
diclofenac at##2##2##(1990-9#1)(2008-12#1)
diclofenac in pharmaceutical preparations by##3##5##(2008-10#3)
diclofenac in pharmaceutical preparations##4##4##(2008-10#4)
diclofenac in pharmaceutical##5##3##(2008-10#5)
diclofenac in the presence of##3##5##(2008-10#3)
diclofenac in the##4##3##(2008-10#4)
diclofenac in##12##2##(2008-10#12)
diclofenac sodium and##2##3##(2008-10#2)
diclofenac sodium##5##2##(1991-3#1)(2008-10#4)
diclofenac##34##1##(1990-9#3)(1991-3#1)(2008-10#23)(2008-11#2)(2008-12#1)(2011-2#4)
dicoccoides##3##1##(2008-10#3)
dicot##4##1##(1991-6#1)(2008-10#2)(2013-8#1)
dicot-infecting##2##1##(2008-10#2)
dicots (Arabidopsis##2##2##(2008-9#1)(2009-10#1)
dicots##6##1##(1991-6#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-5#1)
dicotyledenous##2##1##(2008-9#2)
dicrotophos##2##1##(2008-10#2)
dictate the##2##2##(1995-1#1)(2012-12#1)
dictate##5##1##(1994-2#1)(1995-1#1)(2008-10#2)(2012-12#1)
dictated by##3##2##(1992-2#1)(1996-12#1)(2011-1#1)
dictated##5##1##(1992-2#1)(1996-12#1)(2008-12#1)(2011-1#1)(2013-8#1)
dictates the##2##2##(2008-10#1)(2008-4#1)
dicyano complex##3##2##(2008-10#3)
dicyclohexano-18-crown-6##5##1##(2008-10#5)
did a##3##2##(2008-11#1)(2008-7#1)(2013-7#1)
did affect the##3##3##(2008-10#2)(2008-11#1)
did affect##4##2##(2008-10#2)(2008-11#1)(2009-8#1)
did appear##2##2##(2008-11#1)(2008-12#1)
did cause##2##2##(1997-8#1)(2008-10#1)
did consent to##2##3##(2009-6#2)
did correlate with##2##3##(2008-9#2)
did correlate##3##2##(2008-9#2)(2012-12#1)
did develop##3##2##(1997-3#1)(2008-10#2)
did differ##2##2##(1995-5#1)(2008-8#1)
did have##4##2##(1992-12#1)(1993-8#1)(2008-11#1)(2008-9#1)
did improve##2##2##(2008-9#1)(2013-1#1)
did increase##2##2##(2008-10#1)(2010-6#1)
did not account for the##3##5##(1996-12#1)(2008-6#1)(2013-8#1)
did not account for##5##4##(1996-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
did not accumulate##2##3##(1995-6#1)(2008-10#1)
did not achieve statistical significance##2##5##(2008-7#2)
did not achieve##3##3##(2008-10#1)(2008-7#2)
did not act##3##3##(2008-10#1)(2008-8#2)
did not affect bacterial##2##4##(2008-10#1)(2012-2#1)
did not affect either##2##4##(1997-4#1)(2008-10#1)
did not affect root##2##4##(2008-10#2)
did not affect the efficacy of##2##6##(2008-10#2)
did not affect the expression##3##5##(2008-6#1)(2008-8#2)
did not affect the life span of##2##7##(1993-8#1)(2008-7#1)
did not affect the survival of##2##6##(2008-10#1)(2009-10#1)
did not affect the##52##4##(1991-2#1)(1991-8#1)(1992-3#1)(1993-8#2)(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#21)(2008-11#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
did not affect this##2##4##(1994-8#1)(2008-11#1)
did not affect##95##3##(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-8#2)(1994-12#1)(1994-8#2)(1995-11#4)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#2)(2006-6#1)(2008-10#36)(2008-11#9)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-5#1)(2013-1#3)
did not allow the##2##4##(2008-10#2)
did not allow us to##3##5##(2008-10#2)(2008-7#1)
did not allow##6##3##(2008-10#5)(2008-7#1)
did not alter the##14##4##(1990-3#1)(1990-5#1)(1991-10#1)(1995-11#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2009-9#1)
did not alter##25##3##(1990-3#1)(1990-5#1)(1991-10#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-8#2)(2009-9#1)(2010-6#1)(2012-2#1)
did not always##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
did not amplify DNA from##2##5##(2008-10#2)
did not amplify DNA##3##4##(2008-10#2)(2009-6#1)
did not amplify##6##3##(2008-10#4)(2008-11#1)(2009-6#1)
did not appear to##16##4##(1990-7#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-9#3)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
did not appear##20##3##(1990-7#1)(1991-12#1)(1995-12#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-9#3)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
did not apply to##3##4##(1995-2#2)(1996-5#1)
did not become##3##3##(1993-12#1)(2008-10#2)
did not catalyze##2##3##(1996-2#1)(2008-10#1)
did not cause any##3##4##(1990-2#1)(2008-10#1)(2013-1#1)
did not cause cell death##2##5##(2008-10#1)(2013-1#1)
did not cause##18##3##(1990-2#1)(1994-11#1)(1996-6#1)(2008-10#10)(2008-12#1)(2008-5#1)(2013-1#2)(2013-8#1)
did not change after##3##4##(1991-6#1)(2010-3#1)(2011-2#1)
did not change during##3##4##(2008-5#1)(2011-2#1)(2013-8#1)
did not change following##2##4##(2008-10#1)(2009-9#1)
did not change in the control##2##6##(2008-10#1)(2011-2#1)
did not change in the##3##5##(2008-10#1)(2011-2#2)
did not change in##5##4##(2008-10#1)(2008-11#1)(2011-10#1)(2011-2#2)
did not change over##2##4##(1996-3#1)(2008-11#1)
did not change significantly during the##2##6##(1997-2#1)(2011-1#1)
did not change significantly in either##2##6##(1994-2#1)(2008-3#1)
did not change significantly##7##4##(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
did not change the##8##4##(1990-11#1)(1992-4#1)(1994-6#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-12#1)
did not change with##2##4##(1990-3#1)(2008-10#1)
did not change##48##3##(1990-11#1)(1990-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
did not colonize##2##3##(2008-10#2)
did not compete##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
did not completely##3##3##(1991-5#1)(1994-9#1)(2008-10#1)
did not consent##2##3##(1995-12#1)(2012-3#1)
did not consider##3##3##(1996-1#1)(1997-2#1)(2008-10#1)
did not consistently affect##3##4##(2008-10#3)
did not consistently suppress##2##4##(2008-10#2)
did not consistently##7##3##(2008-10#7)
did not contain the##4##4##(1996-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
did not contain##7##3##(1996-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
did not continue##2##3##(1993-11#1)(2008-11#1)
did not control##2##3##(2008-10#2)
did not correlate well with##2##5##(2008-10#1)(2010-10#1)
did not correlate with the##6##5##(1991-12#2)(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
did not correlate with##15##4##(1991-12#2)(1991-2#1)(1994-2#1)(1995-12#1)(1996-8#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#2)(2013-1#1)(2013-8#1)
did not correlate##23##3##(1991-12#2)(1991-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-9#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
did not correspond to##3##4##(2008-10#3)
did not decline with age##2##5##(1991-8#1)(2008-10#1)
did not decline##3##3##(1991-8#1)(2008-10#2)
did not decrease GR##2##4##(1994-2#2)
did not decrease##9##3##(1994-2#2)(1996-2#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-5#1)
did not demonstrate##6##3##(1991-3#1)(2008-12#1)(2009-10#1)(2010-10#1)(2012-3#1)(2013-8#1)
did not detect any##4##4##(2008-10#2)(2008-7#1)(2008-9#1)
did not detect differences##2##4##(2008-10#2)
did not detect##9##3##(1990-5#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-9#1)
did not develop in##3##4##(1996-12#1)(2008-10#2)
did not develop##7##3##(1996-12#1)(2008-10#4)(2008-12#1)(2012-2#1)
did not differ among##3##4##(2008-10#3)
did not differ between the##5##5##(1993-3#1)(2008-10#2)(2013-1#1)(2013-8#1)
did not differ between##14##4##(1993-12#1)(1993-3#1)(1996-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-6#1)(2010-1#1)(2013-1#1)(2013-8#3)
did not differ by##3##4##(1997-2#1)(2008-10#1)(2012-2#1)
did not differ from control##3##5##(1993-6#1)(1995-12#1)(2008-10#1)
did not differ from the##2##5##(2008-11#1)(2010-1#1)
did not differ from##10##4##(1993-6#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#1)(2010-1#1)
did not differ in##12##4##(1991-3#1)(1991-7#1)(1993-2#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-9#1)(2010-8#1)(2013-8#1)
did not differ significantly (P##2##5##(2008-10#2)
did not differ significantly between the##2##6##(2009-10#1)(2011-2#1)
did not differ significantly between##6##5##(2008-10#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
did not differ significantly for##2##5##(2008-10#2)
did not differ significantly from that of##2##7##(1994-2#1)(2008-10#1)
did not differ significantly from the##2##6##(2008-10#2)
did not differ significantly from##7##5##(1994-2#1)(1996-2#1)(1996-3#1)(2008-10#4)
did not differ significantly##26##4##(1993-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(2008-10#14)(2008-7#2)(2009-10#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
did not differ##74##3##(1991-3#1)(1991-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
did not differentiate##3##3##(2008-10#2)(2008-8#1)
did not diminish##2##3##(2008-9#1)(2012-2#1)
did not directly##2##3##(2008-11#1)(2008-7#1)
did not discriminate##2##3##(1994-8#1)(2011-10#1)
did not distinguish##2##3##(2008-10#1)(2008-6#1)
did not disturb##2##3##(2008-6#1)(2012-3#1)
did not elicit##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
did not enhance##4##3##(2008-10#3)(2012-2#1)
did not exceed 1##2##4##(2008-10#1)(2008-7#1)
did not exceed##11##3##(1990-11#1)(1994-12#1)(2008-10#7)(2008-7#1)(2011-1#1)
did not exert##2##3##(2008-10#1)(2013-1#1)
did not exhibit any##2##4##(1997-3#1)(2011-2#1)
did not exhibit##10##3##(1991-3#1)(1997-3#1)(2008-10#5)(2008-5#1)(2008-7#1)(2011-2#1)
did not exist##2##3##(1990-3#1)(2008-10#1)
did not explain##2##3##(2008-8#2)
did not express the##2##4##(1991-2#1)(2008-11#1)
did not express##5##3##(1991-2#1)(2008-11#3)(2013-1#1)
did not extend to##2##4##(2008-10#1)(2010-8#1)
did not find##9##3##(1990-3#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)
did not fit##3##3##(2008-10#2)(2013-1#1)
did not follow the##2##4##(2010-11#1)(2013-1#1)
did not form##6##3##(2008-10#5)(2008-11#1)
did not further##3##3##(1996-2#1)(2008-10#1)(2012-2#1)
did not germinate##2##3##(2008-10#1)(2010-10#1)
did not give##2##3##(2008-10#2)
did not greatly##2##3##(2008-10#1)(2008-11#1)
did not grow##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
did not have a##6##4##(1993-12#1)(1995-12#2)(2008-11#1)(2011-2#1)(2012-12#1)
did not have an##3##4##(1995-8#1)(2008-10#1)(2008-12#1)
did not have any effect on the##2##7##(1994-5#1)(2008-10#1)
did not have any significant effect on the##2##8##(1995-3#1)(2008-10#1)
did not have any##7##4##(1990-12#1)(1994-5#1)(1995-3#1)(2008-10#4)
did not have significant effect on##2##6##(2008-10#1)(2013-1#1)
did not have significant effects on##2##6##(2008-10#1)(2008-9#1)
did not have significant##4##4##(2008-10#2)(2008-9#1)(2013-1#1)
did not have##37##3##(1990-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-8#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#3)
did not hybridize with##2##4##(2008-10#2)
did not hybridize##3##3##(2008-10#3)
did not hydrolyze##2##3##(1990-2#1)(1995-6#1)
did not identify##4##3##(1990-6#1)(1991-12#1)(2008-10#1)(2013-8#1)
did not improve and##2##4##(2008-5#1)(2011-2#1)
did not improve significantly##3##4##(2008-10#2)(2008-7#1)
did not improve the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
did not improve##17##3##(1996-12#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
did not include##2##3##(2008-11#1)(2013-8#1)
did not increase the##9##4##(1990-11#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#2)(2009-6#1)(2012-2#1)
did not increase with##2##4##(1995-2#1)(2010-8#1)
did not increase##27##3##(1990-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-8#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
did not induce significant##2##4##(1996-12#1)(2008-10#1)
did not induce the##2##4##(1990-5#1)(2008-10#1)
did not induce##20##3##(1990-5#2)(1992-8#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#8)(2008-11#3)(2008-8#1)
did not influence the##12##4##(1990-8#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2010-4#1)(2013-1#1)
did not influence##20##3##(1990-8#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2010-1#1)(2010-4#1)(2010-8#1)(2013-1#3)
did not infringe##2##3##(1993-9#1)(1995-6#1)
did not inhibit germination##2##4##(2008-10#2)
did not inhibit the##2##4##(2008-10#2)
did not inhibit##14##3##(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-3#1)(2006-6#1)(2008-10#6)(2010-4#1)
did not interfere in##2##4##(2008-10#2)
did not interfere the##3##4##(2008-10#3)
did not interfere with the assay##2##6##(2008-10#2)
did not interfere with the response##2##6##(2008-10#2)
did not interfere with the##13##5##(1990-12#1)(1997-2#1)(2008-10#10)(2008-8#1)
did not interfere with##20##4##(1990-12#1)(1991-5#1)(1997-2#1)(2008-10#14)(2008-8#1)(2010-8#1)(2013-8#1)
did not interfere##28##3##(1990-12#1)(1991-5#1)(1997-2#1)(2008-10#22)(2008-8#1)(2010-8#1)(2013-8#1)
did not know whether##2##4##(1995-1#1)(2008-10#1)
did not know##5##3##(1995-1#1)(2008-10#2)(2012-12#1)(2013-1#1)
did not lead to##5##4##(2008-10#1)(2008-11#3)(2010-5#1)
did not lose##2##3##(2008-10#2)
did not make##2##3##(1994-9#1)(2012-12#1)
did not match the##2##4##(2012-12#1)(2013-1#1)
did not match##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
did not mediate the##2##4##(1990-7#1)(2010-11#1)
did not meet##3##3##(1991-8#1)(1997-7#1)(2008-7#1)
did not modify the##4##4##(1994-3#1)(2008-10#2)(2009-7#1)
did not modify##7##3##(1994-3#1)(1995-2#1)(1997-2#1)(2008-10#3)(2009-7#1)
did not need##2##3##(2008-10#1)(2008-11#1)
did not observe##2##3##(2012-12#1)(2013-1#1)
did not obtain##2##3##(1995-12#1)(2008-11#1)
did not occur after##2##4##(1994-8#1)(1995-8#1)
did not occur at##2##4##(2008-10#2)
did not occur in##2##4##(1990-3#1)(1990-9#1)
did not occur##15##3##(1990-3#1)(1990-9#1)(1991-8#1)(1992-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-10#6)(2008-5#1)(2013-8#1)
did not pass##2##3##(1991-1#1)(2008-10#1)
did not perform any##3##4##(2008-2#1)(2009-1#1)(2009-3#1)
did not perform##4##3##(2008-10#1)(2008-2#1)(2009-1#1)(2009-3#1)
did not play a role in##2##6##(1990-7#1)(2008-10#1)
did not possess##3##3##(2008-10#2)(2008-8#1)
did not potentiate the##2##4##(1996-2#1)(2008-5#1)
did not predict skew##2##4##(2008-9#2)
did not predict##13##3##(1995-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#3)(2013-1#1)
did not present##6##3##(2008-10#3)(2010-6#1)(2012-3#1)(2013-1#1)
did not prevent##8##3##(1994-5#2)(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#1)
did not produce the##2##4##(2008-10#2)
did not produce##16##3##(1991-7#1)(1993-6#1)(2008-10#11)(2008-4#1)(2008-5#1)(2013-1#1)
did not promote the##2##4##(2008-10#1)(2008-11#1)
did not promote##5##3##(2008-10#1)(2008-11#4)
did not prove##3##3##(1996-3#1)(2008-10#1)(2008-4#1)
did not provide any##2##4##(2008-10#1)(2013-1#1)
did not provide##8##3##(2008-10#6)(2008-11#1)(2013-1#1)
did not reach statistical significance##3##5##(1991-2#1)(1994-12#1)(2008-7#1)
did not reach##7##3##(1991-2#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
did not react with other##2##5##(1996-12#1)(2008-11#1)
did not react with##11##4##(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-5#1)
did not react##12##3##(1990-8#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-5#1)
did not receive any treatment##3##5##(2008-5#1)(2008-7#1)(2012-3#1)
did not receive this intervention##2##5##(1995-1#2)
did not receive##10##3##(1993-1#1)(1994-6#1)(1995-1#2)(1997-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-8#1)
did not recover##3##3##(1991-9#1)(2008-7#1)(2013-8#1)
did not reduce disease##2##4##(2008-10#2)
did not reduce the severity of##2##6##(2008-10#2)
did not reduce the##5##4##(1994-8#1)(2008-10#3)(2010-1#1)
did not reduce##14##3##(1994-5#1)(1994-8#1)(2008-10#9)(2008-11#1)(2008-8#1)(2010-1#1)
did not report##5##3##(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
did not reproduce##2##3##(2008-10#1)(2013-1#1)
did not require any##4##4##(2008-10#4)
did not require##9##3##(2006-6#1)(2008-10#7)(2013-1#1)
did not respond to##8##4##(1990-12#1)(1990-2#1)(1991-11#1)(1994-12#1)(2008-10#1)(2008-6#1)(2012-12#1)(2013-8#1)
did not result in##14##4##(1992-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#5)(2008-7#1)(2009-6#1)(2011-2#1)
did not return##2##3##(2011-2#2)
did not reveal a close correlation between##2##7##(2008-10#1)(2008-12#1)
did not reveal any increase in##2##6##(1997-7#1)(2008-6#1)
did not reveal any##9##4##(1993-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
did not reveal##19##3##(1993-6#1)(1997-7#1)(1997-8#1)(1997-9#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
did not seem to##5##4##(1991-6#1)(1992-1#1)(1994-3#1)(2008-10#1)(2008-11#1)
did not separate##2##3##(1995-6#1)(2008-10#1)
did not show a significant similarity to any other gene##2##10##(1996-12#2)
did not show a##6##4##(1996-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
did not show any alteration##2##5##(2008-11#1)(2009-10#1)
did not show any change##2##5##(2011-2#1)(2013-8#1)
did not show any significant differences##2##6##(1994-5#1)(2008-10#1)
did not show any significant##7##5##(1994-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
did not show any##25##4##(1990-2#2)(1992-6#1)(1994-5#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
did not show significant##2##4##(2008-10#1)(2012-2#1)
did not show similar##2##4##(2008-5#1)(2012-8#1)
did not show the##2##4##(2008-11#1)(2008-7#1)
did not show##53##3##(1990-2#2)(1991-5#1)(1992-12#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#1)(2013-8#2)
did not significantly affect the##2##5##(1997-7#1)(2010-8#1)
did not significantly affect##3##4##(1997-7#1)(2008-10#1)(2010-8#1)
did not significantly alter either##2##5##(1993-6#1)(1997-4#1)
did not significantly alter##6##4##(1991-3#1)(1993-11#1)(1993-6#1)(1995-11#2)(1997-4#1)
did not significantly change##3##4##(1994-5#1)(2008-2#2)
did not significantly differ##3##4##(1995-12#1)(2008-10#1)(2012-12#1)
did not significantly##25##3##(1991-2#1)(1991-3#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-11#2)(1995-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2009-6#1)(2010-1#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
did not spread##2##3##(2008-10#2)
did not stimulate##2##3##(2008-10#2)
did not suffer##2##3##(2008-10#1)(2008-7#1)
did not support the##4##4##(1990-2#1)(2008-10#2)(2008-9#1)
did not support##6##3##(1990-2#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-9#1)
did not suppress##3##3##(2008-10#2)(2008-11#1)
did not survive##2##3##(2008-10#1)(2011-2#1)
did not take##3##3##(2008-10#1)(2009-6#1)(2012-2#1)
did not undergo##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
did not use##4##3##(2008-1#1)(2012-2#1)(2013-1#2)
did not vary by age##2##5##(1997-2#1)(2010-11#1)
did not vary by##3##4##(1997-2#1)(2008-10#1)(2010-11#1)
did not vary significantly##3##4##(1996-1#1)(2008-8#2)
did not vary with##2##4##(2008-5#1)(2008-8#1)
did not vary##10##3##(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-4#1)(2010-11#1)
did not violate the##2##4##(1996-5#1)(1996-9#1)
did not yield##2##3##(2008-10#1)(2013-1#1)
did not##1218##2##(1990-11#4)(1990-12#5)(1990-2#10)(1990-3#6)(1990-5#5)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#5)(1991-5#6)(1991-6#3)(1991-7#2)(1991-8#7)(1991-9#1)(1992-1#3)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#9)(1993-8#11)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#7)(1994-3#5)(1994-5#10)(1994-6#2)(1994-8#12)(1994-9#2)(1995-1#3)(1995-11#10)(1995-12#22)(1995-2#11)(1995-3#1)(1995-6#9)(1995-8#5)(1996-1#3)(1996-12#10)(1996-2#14)(1996-3#4)(1996-5#3)(1996-6#3)(1996-8#5)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#6)(1997-4#4)(1997-6#1)(1997-7#5)(1997-8#10)(1997-9#2)(2006-6#4)(2007-12#1)(2008-1#3)(2008-10#405)(2008-11#83)(2008-12#20)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#31)(2008-6#9)(2008-7#35)(2008-8#27)(2008-9#22)(2009-1#2)(2009-10#5)(2009-11#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#8)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#6)(2010-10#4)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#6)(2010-7#5)(2010-8#11)(2010-9#1)(2011-1#6)(2011-10#3)(2011-2#42)(2012-12#13)(2012-2#24)(2012-3#15)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#46)(2013-8#22)
did provide##3##2##(2008-10#2)(2008-12#1)
did react with##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
did show##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
did so in##2##3##(2010-1#1)(2012-12#1)
did so##4##2##(2008-11#1)(2010-1#1)(2012-12#1)(2012-2#1)
did the##31##2##(1990-5#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-4#1)(1995-12#1)(1997-3#1)(1997-4#2)(1997-8#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-2#1)
did their##3##2##(1993-12#1)(1997-3#1)(2008-10#1)
did they##4##2##(1995-8#1)(1996-1#1)(2008-10#2)
did well##2##2##(2008-7#1)(2011-1#1)
did##1444##1##(1990-11#5)(1990-12#5)(1990-2#10)(1990-3#6)(1990-5#8)(1990-6#4)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#6)(1991-3#6)(1991-5#6)(1991-6#4)(1991-7#2)(1991-8#8)(1991-9#1)(1992-1#4)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#6)(1992-8#1)(1993-1#4)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#5)(1993-6#9)(1993-8#13)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#5)(1994-2#7)(1994-3#5)(1994-5#10)(1994-6#2)(1994-8#13)(1994-9#2)(1995-1#3)(1995-11#11)(1995-12#24)(1995-2#14)(1995-3#2)(1995-5#1)(1995-6#9)(1995-8#6)(1996-1#4)(1996-11#1)(1996-12#13)(1996-2#15)(1996-3#4)(1996-5#3)(1996-6#8)(1996-8#5)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#9)(1997-4#7)(1997-6#1)(1997-7#5)(1997-8#13)(1997-9#2)(2006-6#6)(2007-12#1)(2008-1#3)(2008-10#478)(2008-11#102)(2008-12#25)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#36)(2008-6#11)(2008-7#38)(2008-8#35)(2008-9#34)(2009-1#3)(2009-10#6)(2009-11#3)(2009-3#3)(2009-4#5)(2009-5#1)(2009-6#10)(2009-7#3)(2009-8#3)(2009-9#6)(2010-1#7)(2010-10#4)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#7)(2010-7#5)(2010-8#11)(2010-9#2)(2011-1#7)(2011-10#3)(2011-2#46)(2012-12#16)(2012-2#27)(2012-3#15)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#47)(2013-7#1)(2013-8#24)
didactic and##3##2##(1991-2#1)(1996-2#1)(2008-1#1)
didactic##7##1##(1991-2#1)(1993-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
didactics##2##1##(2011-2#1)(2011-7#1)
didn't have##2##2##(2008-12#1)(2013-8#1)
didn't##6##1##(1993-12#1)(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#1)(2013-8#1)
didodecyldimethylammonium bromide (DDAB)##2##3##(2008-10#2)
didodecyldimethylammonium bromide##3##2##(2008-10#3)
die before##2##2##(2008-10#1)(2008-8#1)
die by apoptosis##3##3##(1993-3#1)(2008-7#1)(2009-8#1)
die by##4##2##(1993-3#1)(2008-11#1)(2008-7#1)(2009-8#1)
die for##2##2##(1996-12#1)(2008-8#1)
die in##5##2##(1990-6#2)(1991-8#1)(2008-11#1)(2010-8#1)
die of##2##2##(2008-11#1)(2008-7#1)
die##43##1##(1990-2#4)(1990-6#2)(1991-8#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)
dieback is##3##2##(2008-10#3)
dieback symptoms##3##2##(2008-10#3)
dieback##14##1##(2008-10#14)
died 3##2##2##(2009-3#1)(2010-3#1)
died 8##2##2##(1994-6#1)(2008-10#1)
died after##5##2##(1991-8#1)(1995-9#1)(1996-6#1)(2008-11#1)(2013-1#1)
died at the age of##2##5##(2008-7#1)(2013-1#1)
died at##4##2##(1991-8#1)(1997-3#1)(2008-7#1)(2013-1#1)
died before##2##2##(2008-10#1)(2008-9#1)
died due to##2##3##(2011-2#1)(2011-3#1)
died during the##6##3##(1993-2#1)(1997-4#2)(2008-11#1)(2011-3#1)(2013-1#1)
died during##9##2##(1991-7#1)(1993-2#1)(1997-4#2)(2008-10#2)(2008-11#1)(2011-3#1)(2013-1#1)
died from their##2##3##(1997-4#1)(2010-12#1)
died from##13##2##(1994-3#1)(1994-9#1)(1995-6#1)(1996-11#3)(1996-6#1)(1997-4#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
died in##5##2##(1991-8#1)(1996-8#1)(2007-11#1)(2008-10#1)(2012-12#1)
died of##17##2##(1990-6#3)(1991-12#1)(1992-12#1)(1994-12#2)(1994-3#1)(1995-11#1)(1997-3#2)(1997-6#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)
died on the##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
died on##5##2##(1992-3#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-3#1)
died or##3##2##(1996-6#1)(2008-9#1)(2011-3#1)
died prematurely##2##2##(2008-10#1)(2008-9#1)
died soon##2##2##(1992-6#1)(1993-12#1)
died suddenly##2##2##(1991-9#1)(2012-12#1)
died within 5##2##3##(1995-2#2)
died within##11##2##(1990-9#1)(1994-12#1)(1994-5#1)(1995-2#4)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
died##131##1##(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-9#1)(1996-11#3)(1996-5#1)(1996-6#4)(1996-8#1)(1997-3#3)(1997-4#4)(1997-6#1)(1997-8#4)(2007-11#1)(2008-10#11)(2008-11#6)(2008-5#1)(2008-7#10)(2008-9#3)(2009-1#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#8)(2011-3#3)(2012-12#4)(2012-3#7)(2013-1#5)(2013-8#1)
dieffenbachiae##4##1##(2008-10#4)
dieldrin and##2##2##(2008-10#2)
dieldrin##6##1##(2008-10#6)
dielectric and##2##2##(2007-12#1)(2013-1#1)
dielectric constant of the##2##4##(2008-10#2)
dielectric constant##7##2##(2008-10#5)(2008-4#1)(2013-1#1)
dielectric constants##8##2##(2008-10#6)(2008-3#1)(2008-4#1)
dielectric cylindrical##2##2##(2008-3#2)
dielectric function##2##2##(2008-3#2)
dielectric mirrors##2##2##(2008-2#2)
dielectric particles##2##2##(2008-3#2)
dielectric properties##3##2##(2008-10#1)(2009-9#1)(2010-12#1)
dielectric surfaces##2##2##(2013-8#2)
dielectric##51##1##(1993-5#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-2#4)(2008-3#15)(2008-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2013-1#4)(2013-8#3)
dielectrically##2##1##(2008-10#2)
dielectrics##3##1##(2008-3#3)
diencephalic##5##1##(1991-10#1)(1993-8#1)(1994-8#1)(2008-7#2)
diencephalon##3##1##(1993-8#1)(1995-12#1)(2008-6#1)
diene##9##1##(1991-5#2)(1994-5#1)(1996-5#1)(2008-10#5)
dienes##10##1##(1992-3#3)(1996-5#1)(2008-8#1)(2009-8#5)
dienophile##2##1##(1996-5#2)
dienophiles##4##1##(1996-5#4)
dies##2##1##(2008-10#1)(2009-9#1)
diesel fuel##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
diesel fuels##5##2##(2008-10#3)(2008-11#2)
diesel oil and white oil##2##5##(2008-10#2)
diesel oil##4##2##(2008-10#2)(2009-8#2)
diesel##20##1##(2008-10#13)(2008-11#4)(2008-3#1)(2009-8#2)
diester substituted calix[4]arene##2##3##(2008-10#2)
diet (&lt##2##2##(2008-3#2)
diet and T-2 toxin##2##4##(2011-2#2)
diet and cancer##2##3##(1990-8#2)
diet and other##2##3##(1994-3#1)(2009-5#1)
diet and physical##2##3##(2013-8#2)
diet and##30##2##(1990-12#1)(1990-6#1)(1990-8#4)(1991-12#1)(1994-12#1)(1994-3#1)(1997-5#1)(2008-10#5)(2008-3#2)(2009-5#2)(2009-8#1)(2010-12#2)(2010-6#1)(2011-2#4)(2012-2#1)(2013-8#2)
diet as##3##2##(2008-3#2)(2011-2#1)
diet breadth##5##2##(2008-9#4)(2012-3#1)
diet changes##2##2##(2008-9#1)(2010-8#1)
diet comprised foods rich in##2##5##(2010-6#2)
diet containing##5##2##(1991-12#1)(1991-6#1)(1993-12#1)(2008-10#1)(2008-11#1)
diet control group##2##3##(2013-1#2)
diet control##3##2##(2013-1#3)
diet for##7##2##(1991-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2013-1#1)(2013-8#1)
diet have##2##2##(1990-8#1)(2008-3#1)
diet improved the##2##3##(2008-10#1)(2010-4#1)
diet in##6##2##(1991-2#2)(1991-6#1)(1993-5#1)(2008-10#1)(2008-3#1)
diet induced##3##2##(2008-10#1)(2013-1#2)
diet is##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
diet lacking##2##2##(1995-11#1)(2008-11#1)
diet may##2##2##(2011-2#2)
diet of##8##2##(1990-3#1)(1994-8#1)(2008-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
diet on performance##2##3##(2013-8#2)
diet on the##2##3##(2008-3#2)
diet on##8##2##(1996-12#1)(2008-10#1)(2008-3#2)(2010-10#1)(2011-2#1)(2013-8#2)
diet only##2##2##(1994-12#1)(2013-1#1)
diet or##3##2##(1993-12#2)(2010-10#1)
diet quality of##2##3##(2011-2#2)
diet quality##5##2##(2011-2#4)(2013-1#1)
diet significantly##3##2##(1996-12#1)(2010-6#1)(2013-1#1)
diet supplemented with##2##3##(1991-2#1)(2013-1#1)
diet that##4##2##(1997-1#1)(2008-3#2)(2011-2#1)
diet to##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
diet was##7##2##(2008-3#1)(2013-1#2)(2013-8#4)
diet were##2##2##(1995-8#1)(2008-10#1)
diet with##2##2##(1990-3#1)(2008-3#1)
diet##264##1##(1990-12#1)(1990-3#2)(1990-6#3)(1990-8#8)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#10)(1991-5#1)(1991-6#4)(1993-11#1)(1993-12#5)(1993-2#1)(1993-5#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#3)(1997-1#3)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#25)(2008-11#6)(2008-3#38)(2008-7#5)(2008-9#11)(2009-5#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#2)(2010-6#9)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#32)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#26)(2013-7#1)(2013-8#15)
diet)##5##1##(2008-11#2)(2012-2#1)(2013-1#2)
diet-induced hypercholesterolemia##2##2##(1995-2#2)
diet-induced##3##1##(1995-2#2)(2008-4#1)
dietary adherence##2##2##(2008-4#2)
dietary and pharmacological##2##3##(1991-2#2)
dietary and physical activity##2##4##(2012-2#1)(2013-8#1)
dietary and##5##2##(1991-2#2)(1992-9#1)(2012-2#1)(2013-8#1)
dietary behaviors##2##2##(1997-1#1)(2012-2#1)
dietary boron##3##2##(1990-3#3)
dietary change##2##2##(1991-12#1)(1997-1#1)
dietary changes##5##2##(1990-6#3)(2010-8#1)(2012-2#1)
dietary compounds##2##2##(2008-10#2)
dietary counselling##2##2##(1996-11#1)(2011-2#1)
dietary deoxynivalenol##2##2##(2008-10#2)
dietary factors##5##2##(1994-2#2)(2008-10#1)(2009-8#1)(2011-2#1)
dietary fat and##2##3##(1994-2#1)(2013-1#1)
dietary fat intake##2##3##(1994-12#1)(2008-4#1)
dietary fat restriction##2##3##(2008-4#2)
dietary fat##7##2##(1994-12#1)(1994-2#2)(2008-4#3)(2013-1#1)
dietary fiber and##2##3##(2011-2#2)
dietary fiber from##3##3##(1993-11#3)
dietary fiber##9##2##(1993-11#5)(2010-1#1)(2010-8#1)(2011-2#2)
dietary guidelines##3##2##(2009-5#2)(2012-2#1)
dietary habits of##2##3##(1990-8#1)(2011-2#1)
dietary habits##10##2##(1990-8#2)(1993-11#1)(1993-9#1)(2010-1#1)(2010-6#3)(2011-2#2)
dietary intake##8##2##(1991-2#1)(1992-9#1)(1993-12#1)(2008-10#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
dietary intervention##2##2##(1996-11#1)(2009-5#1)
dietary level##2##2##(1993-12#1)(2008-11#1)
dietary macronutrients##2##2##(1996-12#1)(2008-3#1)
dietary modification##2##2##(2009-5#1)(2010-1#1)
dietary nucleotides##4##2##(2008-11#4)
dietary oxalate##2##2##(2012-2#2)
dietary patterns##4##2##(1990-8#1)(2010-6#3)
dietary potassium loading##2##3##(1991-5#2)
dietary protein##4##2##(1994-3#2)(2008-3#2)
dietary protocols##2##2##(2008-3#2)
dietary recommendations##2##2##(2008-4#1)(2010-1#1)
dietary restriction##3##2##(1992-2#1)(2008-7#2)
dietary sources##2##2##(2008-10#1)(2012-12#1)
dietary supplement##3##2##(1991-6#1)(2008-10#2)
dietary supplements and##2##3##(2008-10#1)(2010-3#1)
dietary supplements##4##2##(2008-10#1)(2008-8#1)(2010-3#1)(2011-2#1)
dietary threonine##3##2##(1997-8#3)
dietary treatment and insulin##2##4##(1996-11#2)
dietary treatment##3##2##(1996-11#2)(2010-10#1)
dietary##173##1##(1990-3#3)(1990-6#4)(1990-8#4)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#3)(1991-8#1)(1992-2#1)(1992-9#2)(1993-11#8)(1993-12#3)(1993-9#1)(1994-12#1)(1994-2#5)(1994-3#2)(1994-8#1)(1995-9#2)(1996-11#4)(1996-12#1)(1997-1#2)(1997-7#1)(1997-8#4)(2008-10#18)(2008-11#6)(2008-3#7)(2008-4#6)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#6)(2009-8#3)(2010-1#7)(2010-10#1)(2010-3#1)(2010-6#8)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#13)(2012-12#1)(2012-2#16)(2013-1#6)(2013-8#4)
diethanolamine##2##1##(2008-10#1)(2008-11#1)
diethanolamine-typed dendrimer##4##2##(2008-10#4)
diethyl 2##2##2##(2012-3#2)
diethyl dithiophosphate##4##2##(2008-10#4)
diethyl ether##8##2##(1997-2#1)(2008-10#5)(2008-11#2)
diethyl##20##1##(1997-2#1)(2008-10#10)(2008-11#3)(2008-5#1)(2010-5#1)(2012-3#4)
diethylacetal##6##1##(1990-12#6)
diethylamine##3##1##(2008-10#3)
diethylaminoethyl##2##1##(2008-10#2)
diethylaminoethyldextran##2##1##(2008-11#2)
diethyldithiocarbamate (DDTC)##3##2##(2008-10#3)
diethyldithiocarbamate##16##1##(2008-10#16)
diethylenetriamine with##2##2##(2008-10#2)
diethylenetriamine##9##1##(2008-10#9)
diethylenetriaminepentaacetic acid (DTPA)##2##3##(2008-10#1)(2008-5#1)
diethylstilbestrol##3##1##(2008-10#2)(2010-9#1)
diethylstilboestrol and vinblastine##2##3##(2011-1#2)
dietitian in##3##2##(1993-12#3)
dietitian##7##1##(1992-12#1)(1993-12#5)(2010-9#1)
dietitians##5##1##(1992-12#1)(1993-12#4)
diets and##2##2##(2008-10#1)(2008-11#1)
diets containing##3##2##(1995-8#1)(2008-5#1)(2013-1#1)
diets for##3##2##(1993-11#1)(1994-5#1)(1996-12#1)
diets had##2##2##(1994-5#1)(2008-4#1)
diets in the##3##3##(2008-10#1)(2008-3#2)
diets of##2##2##(2008-3#1)(2011-2#1)
diets on##2##2##(1996-12#1)(2008-4#1)
diets that##2##2##(1993-11#1)(2008-9#1)
diets##57##1##(1992-9#1)(1993-11#5)(1993-12#1)(1993-6#2)(1994-5#2)(1995-8#1)(1996-12#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#15)(2008-4#3)(2008-5#1)(2008-9#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
difenoconazole##3##1##(2008-10#3)
diferric transferrin##3##2##(1994-3#3)
diferulic acid##2##2##(2008-10#2)
differ according to##2##3##(2008-11#1)(2013-1#1)
differ across##2##2##(1994-1#1)(1996-3#1)
differ among plant##2##3##(2008-10#2)
differ among##6##2##(1996-5#1)(2008-10#4)(2009-10#1)
differ at##2##2##(1995-12#1)(2010-10#1)
differ based on##2##3##(2009-9#1)(2012-12#1)
differ between##24##2##(1991-11#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-12#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#3)
differ by their##2##3##(2008-8#1)(2013-8#1)
differ by##10##2##(1997-2#1)(1997-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
differ considerably##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
differ for##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
differ from that of the##2##5##(2008-10#1)(2008-3#1)
differ from that of##3##4##(2008-10#2)(2008-3#1)
differ from that##5##3##(2008-10#2)(2008-3#1)(2011-2#2)
differ from the##8##3##(1991-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-1#1)(2011-2#1)
differ from those of the##2##5##(2008-7#1)(2008-8#1)
differ from those of##4##4##(1996-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
differ from those##6##3##(1996-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
differ from##41##2##(1990-5#1)(1991-5#1)(1991-8#2)(1993-6#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#8)
differ fundamentally from##2##3##(1997-2#1)(2010-8#1)
differ greatly##2##2##(2008-8#1)(2012-3#1)
differ in a##2##3##(1995-2#1)(2008-10#1)
differ in both##2##3##(2008-11#1)(2008-4#1)
differ in host##2##3##(2008-10#1)(2008-8#1)
differ in pathogenicity##2##3##(2008-10#2)
differ in the##9##3##(1990-6#1)(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
differ in their abilities to##3##5##(1996-12#1)(1996-2#1)(2009-12#1)
differ in their##29##3##(1993-1#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-8#4)(2008-9#1)(2009-12#2)(2010-8#1)(2013-1#1)(2013-8#1)
differ in virulence##2##3##(2008-10#2)
differ in##77##2##(1990-11#1)(1990-6#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#6)(2009-1#1)(2009-12#2)(2009-9#1)(2010-8#1)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#3)
differ markedly##3##2##(2008-11#2)(2008-2#1)
differ only at##2##3##(1991-11#1)(2008-9#1)
differ only##3##2##(1991-11#1)(2008-5#1)(2008-9#1)
differ significantly for##3##3##(1991-12#1)(2008-10#2)
differ significantly from the##4##4##(1997-2#1)(2008-10#3)
differ significantly from those##3##4##(1996-3#1)(2008-8#2)
differ significantly from##12##3##(1994-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-8#2)(2012-3#1)
differ significantly in##3##3##(2008-12#1)(2013-1#1)(2013-8#1)
differ significantly##36##2##(1991-12#1)(1993-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#15)(2008-12#1)(2008-7#2)(2008-8#3)(2009-10#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
differ substantially from##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
differ substantially##6##2##(1994-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
differ widely in their##2##4##(2008-10#1)(2008-5#1)
differ widely in##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
differ widely##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
differ with##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
differ##258##1##(1990-11#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#1)(1994-1#2)(1994-2#2)(1994-5#1)(1995-10#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#7)(1996-2#2)(1996-3#4)(1996-5#1)(1996-8#1)(1997-2#3)(1997-8#1)(1997-9#1)(2007-12#2)(2008-10#66)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#8)(2008-8#19)(2008-9#13)(2009-1#1)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#11)(2012-12#3)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#6)(2013-8#8)
differed about##2##2##(2012-3#2)
differed according to the##2##4##(2008-10#2)
differed according to##3##3##(2008-10#2)(2011-2#1)
differed among the##4##3##(1992-3#1)(2008-10#2)(2012-3#1)
differed among##9##2##(1992-3#1)(2008-10#4)(2008-8#2)(2012-3#1)(2012-6#1)
differed at##2##2##(2008-10#2)
differed between the two##2##4##(1991-11#1)(2008-11#1)
differed between the##5##3##(1991-11#1)(2008-11#2)(2008-8#1)(2011-2#1)
differed between##12##2##(1991-11#1)(1994-5#1)(2008-10#1)(2008-11#5)(2008-8#2)(2011-2#1)(2013-8#1)
differed by##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#1)
differed clearly from##2##3##(2008-10#1)(2008-7#1)
differed considerably##3##2##(2008-10#1)(2008-7#2)
differed from that##3##3##(2008-11#1)(2008-8#1)(2012-12#1)
differed from the##10##3##(1992-12#1)(1993-8#1)(1994-2#1)(2008-10#3)(2008-7#2)(2008-8#1)(2012-3#1)
differed from those of##3##4##(2008-10#3)
differed from##21##2##(1990-8#1)(1992-12#1)(1993-8#1)(1994-2#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#3)(2012-12#1)(2012-3#2)
differed in quantity between##2##4##(2008-8#2)
differed in the number of##2##5##(2008-10#1)(2010-1#1)
differed in the##7##3##(2008-10#4)(2008-9#1)(2010-1#1)(2010-4#1)
differed in their ability to##5##5##(2008-10#5)
differed in their##16##3##(2008-10#9)(2008-11#3)(2008-5#1)(2008-8#1)(2009-10#1)(2010-5#1)
differed in##40##2##(1993-12#1)(1993-8#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#5)(2008-9#2)(2009-10#1)(2010-1#2)(2010-4#1)(2010-5#1)
differed markedly##3##2##(1993-6#1)(1994-8#1)(2012-3#1)
differed significantly (P##2##3##(1990-11#1)(2008-10#1)
differed significantly between the##3##4##(1997-7#2)(2008-8#1)
differed significantly between##4##3##(1997-7#2)(2008-10#1)(2008-8#1)
differed significantly for##2##3##(2008-10#2)
differed significantly from##5##3##(1994-5#1)(2008-10#1)(2009-4#1)(2009-9#1)(2013-8#1)
differed significantly in##2##3##(2008-10#2)
differed significantly##22##2##(1990-11#1)(1994-5#1)(1997-7#2)(2008-10#12)(2008-8#1)(2009-4#1)(2009-7#1)(2009-9#2)(2013-8#1)
differed slightly##2##2##(2008-10#2)
differed somewhat##2##2##(1990-12#1)(2011-2#1)
differed with##3##2##(1995-5#1)(2008-10#1)(2008-12#1)
differed##147##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-5#1)(1997-7#3)(2008-10#60)(2008-11#11)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#6)(2008-8#13)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#3)(2012-12#2)(2012-3#7)(2012-6#1)(2013-8#3)
difference (P##2##2##(2011-2#1)(2013-1#1)
difference Fourier##3##2##(1991-3#1)(2008-8#1)(2008-9#1)
difference among##7##2##(1991-1#1)(1994-3#1)(2008-10#3)(2011-2#1)(2013-1#1)
difference and##4##2##(1990-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
difference as##2##2##(1992-12#1)(2008-11#1)
difference at the 95%##4##4##(2008-10#4)
difference at##9##2##(2008-10#9)
difference being##3##2##(1991-11#1)(1994-2#1)(1996-6#1)
difference between groups##4##3##(2008-12#1)(2012-3#1)(2013-1#2)
difference between the groups##4##4##(1991-2#1)(2008-3#1)(2008-7#2)
difference between the mutant and##2##5##(2008-10#2)
difference between the two groups##3##5##(2008-12#1)(2008-7#1)(2011-2#1)
difference between the two##19##4##(1991-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2011-2#1)
difference between the##84##3##(1990-2#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#3)(1997-9#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-11#1)(2009-6#1)(2009-7#2)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-8#1)
difference between transgenic##2##3##(2008-10#1)(2008-12#1)
difference between two treatments##2##4##(1995-9#2)
difference between two##4##3##(1995-9#2)(2008-10#1)(2011-2#1)
difference between##157##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-12#3)(1996-3#1)(1996-6#1)(1997-8#3)(1997-9#1)(2007-12#1)(2008-10#47)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#8)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#2)
difference can##2##2##(2011-2#1)(2012-3#1)
difference could be##2##3##(2008-10#1)(2008-8#1)
difference emerged in##2##3##(1990-8#2)
difference equations##2##2##(2008-8#1)(2009-8#1)
difference for##6##2##(2008-10#2)(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#1)
difference frequency generation##2##3##(2008-2#1)(2008-3#1)
difference frequency##3##2##(2008-2#2)(2008-3#1)
difference from##2##2##(2008-10#1)(2008-8#1)
difference in H##2##3##(2008-10#1)(2008-12#1)
difference in HR##3##3##(2013-8#3)
difference in age##2##3##(2008-1#1)(2009-12#1)
difference in average##3##3##(2008-9#1)(2010-10#1)(2012-3#1)
difference in effect##2##3##(2008-11#1)(2010-4#1)
difference in length of##2##4##(1997-4#2)
difference in log K(ex) for two cations (one of each type) with the same number of carbon atoms was about##2##20##(2008-10#2)
difference in log K(ex)##3##4##(2008-10#3)
difference in morphology##2##3##(2012-2#1)(2013-1#1)
difference in outcome##2##3##(1995-11#1)(2012-3#1)
difference in plasma##2##3##(1990-8#1)(1993-2#1)
difference in production of##2##4##(2008-10#1)(2008-12#1)
difference in proportions##2##3##(1992-9#1)(2013-1#1)
difference in resistance to##2##4##(2008-10#1)(2011-2#1)
difference in sensitivity was##2##4##(1997-8#1)(2008-10#1)
difference in sensitivity##3##3##(1997-8#1)(2008-10#1)(2012-6#1)
difference in smoking prevalence##2##4##(1994-6#1)(2011-2#1)
difference in survival##4##3##(1990-6#1)(1990-8#1)(1991-8#1)(1992-12#1)
difference in terms of##2##4##(2008-11#1)(2011-2#1)
difference in the clinical##2##4##(1997-3#1)(2013-1#1)
difference in the frequency of##2##5##(2011-2#1)(2013-1#1)
difference in the incidence of##2##5##(2011-2#1)(2013-1#1)
difference in the nucleotide##2##4##(2013-8#2)
difference in the number of##2##5##(1997-6#1)(2008-11#1)
difference in the pattern of##2##5##(2008-10#1)(2008-11#1)
difference in the prevalence of##2##5##(1996-12#1)(2008-7#1)
difference in the rate of##4##5##(2008-10#3)(2013-1#1)
difference in the rates##2##4##(1992-12#1)(2008-10#1)
difference in the size of##2##5##(2008-9#1)(2012-3#1)
difference in the##78##3##(1990-6#1)(1990-8#1)(1991-2#2)(1992-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#20)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#4)
difference in their##4##3##(1993-12#1)(1996-6#1)(1997-6#1)(2012-3#1)
difference in##242##2##(1990-11#2)(1990-12#2)(1990-6#4)(1990-8#3)(1991-2#2)(1991-8#2)(1992-12#4)(1992-3#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#49)(2008-11#21)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#8)(2008-8#4)(2008-9#7)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#18)(2012-12#1)(2012-2#3)(2012-3#12)(2012-6#1)(2013-1#9)(2013-8#9)
difference is the presence of##2##5##(2008-5#1)(2012-3#1)
difference is##11##2##(1991-11#1)(1991-8#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-8#3)(2011-2#1)(2012-3#1)
difference may##2##2##(1994-12#1)(2008-11#1)
difference observed between##2##3##(2008-12#1)(2008-8#1)
difference observed was##2##3##(1996-12#1)(2013-1#1)
difference observed##5##2##(1996-12#1)(2008-12#1)(2008-8#1)(2013-1#2)
difference of the chemical##2##4##(2008-10#2)
difference of the##10##3##(2008-10#5)(2008-3#2)(2008-7#2)(2008-9#1)
difference of##38##2##(1990-12#1)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#7)(2008-11#5)(2008-3#6)(2008-7#3)(2008-8#1)(2008-9#5)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
difference on##2##2##(2008-10#1)(2008-11#1)
difference or ratio##2##3##(1995-5#2)
difference or##4##2##(1995-5#3)(2008-1#1)
difference regarding the##2##3##(1995-12#1)(1997-3#1)
difference regarding##3##2##(1995-12#1)(1997-3#1)(2010-1#1)
difference spectra##3##2##(1990-8#1)(1994-5#1)(2008-10#1)
difference spectrum##3##2##(1993-8#1)(1994-5#1)(2008-3#1)
difference that##2##2##(2008-10#1)(2008-11#1)
difference to##5##2##(2008-10#2)(2008-11#2)(2013-8#1)
difference was detected between##2##4##(2008-11#1)(2008-8#1)
difference was found between the##6##5##(1992-2#1)(1993-2#1)(2008-12#1)(2010-8#1)(2011-2#2)
difference was found between##12##4##(1990-8#1)(1992-2#1)(1993-2#1)(2008-10#3)(2008-12#2)(2010-8#1)(2011-2#3)
difference was found in the##2##5##(1996-2#1)(2008-10#1)
difference was found in##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
difference was found##21##3##(1990-8#1)(1992-2#1)(1993-2#1)(1994-3#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-7#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
difference was more pronounced in##2##5##(1993-2#1)(1995-5#1)
difference was not significant##3##4##(2008-10#2)(2013-1#1)
difference was not##7##3##(2008-10#2)(2009-3#2)(2010-12#1)(2011-1#1)(2013-1#1)
difference was observed between##3##4##(2008-10#2)(2008-5#1)
difference was observed in the##2##5##(2009-11#1)(2011-2#1)
difference was observed in##3##4##(2008-7#1)(2009-11#1)(2011-2#1)
difference was observed##10##3##(1993-1#1)(1993-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)
difference was seen between##2##4##(2008-5#2)
difference was seen##4##3##(1991-2#1)(1991-6#1)(2008-5#2)
difference was statistically significant (p##2##5##(2011-2#1)(2013-1#1)
difference was statistically significant##7##4##(1996-12#1)(2009-6#1)(2011-2#4)(2013-1#1)
difference was##64##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-5#1)(2008-10#13)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#2)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#8)(2013-1#5)(2013-8#2)
difference when##2##2##(2008-11#1)(2008-9#1)
difference within##2##2##(2008-10#1)(2013-8#1)
difference##692##1##(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#1)(1990-6#5)(1990-8#7)(1991-1#1)(1991-11#3)(1991-2#6)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#4)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#6)(1993-3#2)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#5)(1994-6#2)(1994-9#3)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#10)(1995-8#2)(1995-9#3)(1996-12#7)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#4)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(1997-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#162)(2008-11#47)(2008-12#20)(2008-2#5)(2008-3#24)(2008-4#2)(2008-5#15)(2008-7#24)(2008-8#25)(2008-9#24)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-6#3)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#7)(2010-6#2)(2010-7#7)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#41)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#20)(2012-6#1)(2013-1#27)(2013-8#21)
difference)##2##1##(2008-3#1)(2011-2#1)
difference-frequency generation##2##2##(2007-12#1)(2008-2#1)
difference-frequency mixing of##2##3##(2007-12#1)(2008-3#1)
difference-frequency mixing##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
difference-frequency##9##1##(2007-12#2)(2008-2#5)(2008-3#2)
difference?##3##1##(1991-2#1)(1997-3#1)(2013-1#1)
differences (P &lt##4##3##(2008-10#2)(2008-5#2)
differences (p &lt##2##3##(2011-2#2)
differences across##7##2##(1994-12#1)(1995-3#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
differences among individuals within##2##4##(2008-10#1)(2012-7#1)
differences among isolates##4##3##(2008-10#4)
differences among populations##2##3##(2008-10#2)
differences among the three groups##2##5##(1993-1#1)(2013-8#1)
differences among the##8##3##(1993-1#1)(2008-10#5)(2012-3#1)(2013-8#1)
differences among##41##2##(1991-1#1)(1991-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-3#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-8#3)(2009-1#1)(2011-2#1)(2012-3#2)(2012-7#1)(2013-8#1)
differences and similarities##4##3##(2008-7#2)(2009-12#1)(2009-7#1)
differences and##22##2##(1991-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-7#1)(2012-2#2)
differences are observed between the##2##5##(1992-4#1)(2008-10#1)
differences are##15##2##(1991-3#1)(1992-4#1)(1993-6#2)(1994-1#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
differences associated with##2##3##(2009-5#1)(2013-1#1)
differences at##4##2##(1993-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
differences between groups were##2##4##(1994-3#1)(2011-2#1)
differences between groups##8##3##(1994-3#1)(2009-3#1)(2009-7#1)(2011-2#2)(2013-1#3)
differences between healthy##2##3##(2008-10#1)(2009-8#1)
differences between normal##2##3##(2008-7#1)(2013-1#1)
differences between practising and non-practising##2##5##(1993-1#2)
differences between the clinical##3##4##(1994-6#1)(1995-5#1)(2008-1#1)
differences between the effects of##2##5##(1993-6#1)(1995-5#1)
differences between the methods##2##4##(2008-10#2)
differences between the two groups were observed##2##7##(1992-12#1)(2013-1#1)
differences between the two groups##7##5##(1992-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#2)
differences between the two##19##4##(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#2)(1993-6#1)(1993-8#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#2)(2013-8#1)
differences between the##67##3##(1991-3#1)(1991-6#2)(1991-9#2)(1992-12#2)(1993-6#2)(1993-8#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-5#2)(1995-8#1)(2008-1#3)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#2)(2010-1#2)(2011-2#2)(2013-1#2)(2013-8#2)
differences between them##2##3##(2008-10#1)(2009-11#1)
differences between these two##4##4##(2008-10#2)(2008-5#1)(2012-12#1)
differences between these##9##3##(1993-1#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-8#1)
differences between those##2##3##(1994-2#1)(2012-12#1)
differences between##207##2##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#3)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-2#2)(1993-6#2)(1993-8#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-12#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-12#1)(2008-1#5)(2008-10#50)(2008-11#10)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#4)(2009-1#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#9)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#11)(2013-8#3)
differences by race##3##3##(1995-2#2)(2009-5#1)
differences by##7##2##(1993-11#1)(1994-2#2)(1995-2#2)(2008-12#1)(2009-5#1)
differences can##3##2##(1991-12#1)(1991-6#1)(2010-8#1)
differences correlate with##2##3##(1997-2#1)(2013-8#1)
differences could be observed##2##4##(1993-1#1)(2008-10#1)
differences could be##4##3##(1993-1#1)(2008-10#1)(2013-1#2)
differences did not##2##3##(1993-8#1)(2008-5#1)
differences do##2##2##(1992-2#1)(2010-10#1)
differences emerged for##2##3##(2008-12#1)(2009-11#1)
differences exist between##3##3##(2012-3#2)(2013-8#1)
differences exist in the##3##4##(1994-5#1)(2007-12#1)(2008-11#1)
differences exist in##4##3##(1994-5#1)(1996-12#1)(2007-12#1)(2008-11#1)
differences exist##8##2##(1994-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#2)(2013-8#1)
differences for##6##2##(1994-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
differences found##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
differences from the##3##3##(1991-9#1)(1997-3#1)(2008-10#1)
differences from##7##2##(1991-9#1)(1992-12#1)(1995-5#1)(1997-2#2)(1997-3#1)(2008-10#1)
differences have been##4##3##(2008-10#1)(2008-5#2)(2008-8#1)
differences have##6##2##(2008-10#2)(2008-5#2)(2008-8#2)
differences in CVD##2##3##(2010-12#1)(2011-1#1)
differences in DNA##2##3##(2008-10#1)(2008-11#1)
differences in RGR##2##3##(2008-8#2)
differences in a##3##3##(1994-5#1)(1996-3#1)(2008-10#1)
differences in activity were##2##4##(1995-8#1)(2008-8#1)
differences in aggressiveness on##2##4##(2008-10#2)
differences in aggressiveness##5##3##(2008-10#5)
differences in allele frequencies##3##4##(2008-10#2)(2008-8#1)
differences in allele##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
differences in allelic##2##3##(2008-10#1)(2012-3#1)
differences in amino##2##3##(2008-5#1)(2012-8#1)
differences in basal##2##3##(2008-11#2)
differences in bleeding##2##3##(2009-3#2)
differences in both##2##3##(1996-3#1)(2008-12#1)
differences in cardiovascular##2##3##(2010-6#1)(2011-1#1)
differences in community##2##3##(2008-8#1)(2008-9#1)
differences in complex##2##3##(2008-10#1)(2008-11#1)
differences in composition of##2##4##(2008-10#1)(2012-8#1)
differences in composition##3##3##(2008-10#2)(2012-8#1)
differences in depressive symptoms##3##4##(2009-7#2)(2010-4#1)
differences in development in##2##4##(2008-9#2)
differences in disease severity##3##4##(2008-10#3)
differences in disease##4##3##(2008-10#4)
differences in disease-induced root##2##4##(2008-10#2)
differences in diversity##2##3##(2008-10#1)(2008-8#1)
differences in eccrine sweat and skin surface pH##2##8##(2008-5#2)
differences in expression##2##3##(2008-11#1)(2011-2#1)
differences in gender##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
differences in genetic##2##3##(2008-12#1)(2011-2#1)
differences in growth##3##3##(1997-3#1)(2008-10#1)(2010-8#1)
differences in health care##2##4##(1993-2#1)(1996-2#1)
differences in health##9##3##(1993-2#1)(1996-2#1)(2008-7#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
differences in immune function##2##4##(2008-9#2)
differences in immune##5##3##(2008-8#1)(2008-9#4)
differences in infection##2##3##(2008-10#2)
differences in isolates##3##3##(2008-10#3)
differences in life histories##2##4##(2008-10#1)(2008-8#1)
differences in major depressive disorder##2##5##(2008-4#2)
differences in major##4##3##(1992-4#1)(2008-4#3)
differences in mean##2##3##(2008-10#1)(2008-12#1)
differences in parasitism##2##3##(2008-9#2)
differences in pathogenicity##2##3##(2008-10#2)
differences in patient##2##3##(1995-12#1)(2008-7#1)
differences in platelet##2##3##(1991-12#1)(2010-3#1)
differences in prevalence##4##3##(1996-12#1)(2011-1#1)(2012-2#2)
differences in relative##2##3##(2008-10#1)(2008-11#1)
differences in reported##2##3##(1994-1#1)(2008-4#1)
differences in sampling##2##3##(2008-10#1)(2013-8#1)
differences in sensitivity##3##3##(2008-10#2)(2011-2#1)
differences in severity of##3##4##(1993-12#1)(2008-10#1)(2008-12#1)
differences in size##3##3##(1996-12#1)(2008-4#1)(2008-8#1)
differences in smoking abstinence##2##4##(2010-11#2)
differences in social##2##3##(1994-3#1)(2008-11#1)
differences in spatial ability##2##4##(2008-11#2)
differences in spore##2##3##(2008-10#2)
differences in stress##2##3##(2009-7#1)(2013-1#1)
differences in survival rates##2##4##(1990-8#1)(2008-9#1)
differences in survival##3##3##(1990-8#1)(2008-10#1)(2008-9#1)
differences in susceptibility##3##3##(2008-10#2)(2011-3#1)
differences in terms of##3##4##(2008-10#1)(2013-8#2)
differences in the chemical##2##4##(1991-5#1)(1997-2#1)
differences in the distribution of##3##5##(2008-9#1)(2009-10#1)(2011-2#1)
differences in the expression of##2##5##(1996-12#1)(2008-9#1)
differences in the fibre type composition between the left and right muscle##2##12##(2011-2#2)
differences in the frequencies of mtDNA haplotypes##2##7##(2008-10#2)
differences in the frequency of##4##5##(2008-10#2)(2011-2#1)(2012-3#1)
differences in the incidence of##3##5##(1990-6#1)(1991-11#1)(2008-10#1)
differences in the number##2##4##(1993-3#1)(2008-10#1)
differences in the rates of##5##5##(1994-2#1)(1996-2#1)(2008-10#2)(2013-1#1)
differences in the relationship between##2##5##(2008-10#1)(2010-1#1)
differences in the relationship##3##4##(2008-10#1)(2008-2#1)(2010-1#1)
differences in the response##2##4##(1990-6#1)(1996-12#1)
differences in the three groups##2##5##(1994-12#1)(2008-10#1)
differences in the timing of##2##5##(2008-11#2)
differences in the two##2##4##(2008-8#1)(2008-9#1)
differences in the type of##2##5##(2008-10#1)(2010-5#1)
differences in the##161##3##(1990-5#1)(1990-6#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#3)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#40)(2008-11#13)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#4)
differences in their##13##3##(1995-11#1)(2008-10#8)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
differences in these##3##3##(2008-10#1)(2008-8#1)(2010-7#1)
differences in this##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
differences in tissue##2##3##(1992-9#1)(2008-5#1)
differences in treatment##2##3##(1991-1#1)(2008-4#1)
differences in use##2##3##(1994-2#1)(2008-12#1)
differences in virulence and##2##4##(2008-10#2)
differences in virulence were##2##4##(2008-10#2)
differences in virulence##6##3##(2008-10#6)
differences in weight##3##3##(1991-2#1)(2008-12#1)(2013-8#1)
differences in yield##2##3##(2008-10#2)
differences in##597##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#4)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#3)(1993-6#2)(1994-1#2)(1994-12#3)(1994-2#6)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#8)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#8)(1996-2#3)(1996-3#4)(1997-1#1)(1997-2#4)(1997-3#4)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#1)(2008-1#1)(2008-10#159)(2008-11#41)(2008-12#20)(2008-2#4)(2008-3#7)(2008-4#13)(2008-5#17)(2008-7#11)(2008-8#30)(2008-9#23)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-7#7)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#6)(2011-10#2)(2011-2#18)(2011-3#1)(2012-12#3)(2012-2#8)(2012-3#9)(2012-5#4)(2012-8#2)(2013-1#20)(2013-8#15)
differences is##2##2##(1997-3#1)(2008-10#1)
differences may be related to the##2##6##(1997-7#1)(2008-7#1)
differences may be##6##3##(1997-7#2)(2008-10#2)(2008-7#1)(2013-1#1)
differences may##9##2##(1994-2#1)(1995-5#1)(1997-7#2)(2008-10#3)(2008-7#1)(2013-1#1)
differences might##2##2##(1991-5#1)(2012-3#1)
differences observable in##2##3##(2008-5#2)
differences observed between##3##3##(1993-8#1)(2008-5#1)(2011-2#1)
differences observed in the##2##4##(2008-10#2)
differences observed in##5##3##(1997-9#1)(2008-10#2)(2011-2#1)(2013-8#1)
differences observed were##2##3##(1991-2#1)(2011-3#1)
differences observed##12##2##(1991-2#1)(1993-8#1)(1997-9#1)(2008-10#4)(2008-5#1)(2011-2#2)(2011-3#1)(2013-8#1)
differences occurred##4##2##(1997-8#1)(2008-10#3)
differences of the##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
differences of##20##2##(1990-9#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-8#1)
differences on##8##2##(1994-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2012-2#1)(2013-8#1)
differences related to##2##3##(1995-11#1)(2013-1#1)
differences seem to be##2##4##(1993-11#1)(2008-10#1)
differences that##2##2##(1993-2#1)(2008-8#1)
differences to##4##2##(1992-7#1)(2008-10#1)(2008-4#1)(2010-11#1)
differences were also##4##3##(1993-1#1)(2008-9#1)(2009-12#1)(2010-1#1)
differences were detected##2##3##(2008-12#1)(2013-8#1)
differences were found among the##2##5##(1993-2#1)(2008-10#1)
differences were found among##6##4##(1993-2#1)(2008-10#4)(2012-3#1)
differences were found between the##5##5##(1992-3#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
differences were found between##13##4##(1992-3#1)(1993-11#1)(1993-2#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-3#1)(2013-1#1)
differences were found for##2##4##(2008-12#1)(2012-12#1)
differences were found in the##2##5##(2008-10#1)(2008-7#1)
differences were found in##12##4##(1992-12#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
differences were found##38##3##(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#2)(1996-1#1)(1997-3#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#2)
differences were not found##2##4##(2008-10#1)(2008-8#1)
differences were not statistically significant##3##5##(2008-1#1)(2008-10#1)(2013-8#1)
differences were not##7##3##(1992-2#1)(2008-1#1)(2008-10#3)(2008-8#1)(2013-8#1)
differences were noted##4##3##(1994-1#1)(1997-7#1)(2008-10#1)(2008-5#1)
differences were observed between the##5##5##(1994-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
differences were observed between##8##4##(1994-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)
differences were observed for##2##4##(2008-10#2)
differences were observed in the##4##5##(1992-6#1)(1995-11#1)(2008-10#1)(2012-3#1)
differences were observed in##11##4##(1992-6#1)(1994-5#1)(1995-11#1)(2008-10#3)(2008-6#2)(2010-3#1)(2010-6#1)(2012-3#1)
differences were observed##28##3##(1992-6#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-11#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-6#2)(2008-7#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
differences were obtained in##2##4##(1994-8#1)(2008-8#1)
differences were seen in##4##4##(2008-10#1)(2008-12#1)(2008-5#2)
differences were seen##5##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#2)
differences were##110##2##(1990-5#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-1#2)(1994-2#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#43)(2008-11#3)(2008-12#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#2)
differences when##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
differences with regard to##3##4##(1992-12#1)(1994-6#1)(2011-1#1)
differences with##7##2##(1991-6#2)(1992-12#1)(1994-3#1)(1994-6#1)(2008-8#1)(2011-1#1)
differences within the##4##3##(2008-10#2)(2008-5#1)(2010-10#1)
differences within##7##2##(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
differences##1291##1##(1990-11#4)(1990-2#2)(1990-5#3)(1990-6#2)(1990-8#5)(1990-9#2)(1991-1#2)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#4)(1991-5#4)(1991-6#8)(1991-7#1)(1991-8#3)(1991-9#6)(1992-12#9)(1992-2#8)(1992-3#4)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#8)(1993-11#4)(1993-12#7)(1993-2#13)(1993-3#6)(1993-6#8)(1993-8#5)(1994-1#5)(1994-12#6)(1994-2#15)(1994-3#4)(1994-5#11)(1994-6#3)(1994-8#8)(1994-9#1)(1995-1#4)(1995-11#7)(1995-12#10)(1995-2#12)(1995-3#4)(1995-5#6)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#6)(1996-12#12)(1996-2#5)(1996-3#4)(1996-5#1)(1997-1#1)(1997-2#7)(1997-3#9)(1997-5#1)(1997-6#1)(1997-7#8)(1997-8#6)(1997-9#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#7)(2008-10#340)(2008-11#69)(2008-12#37)(2008-2#8)(2008-3#17)(2008-4#19)(2008-5#45)(2008-6#5)(2008-7#29)(2008-8#60)(2008-9#37)(2009-1#2)(2009-10#4)(2009-11#8)(2009-12#5)(2009-3#5)(2009-4#3)(2009-5#6)(2009-7#11)(2009-8#6)(2009-9#1)(2010-1#7)(2010-10#6)(2010-11#6)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#8)(2011-10#2)(2011-2#44)(2011-3#4)(2012-12#9)(2012-2#22)(2012-3#28)(2012-4#1)(2012-5#6)(2012-7#1)(2012-8#2)(2013-1#48)(2013-8#30)
differences)##2##1##(1997-5#1)(2008-11#1)
different (P = 0##3##4##(2008-10#3)
different (P##5##2##(2008-10#5)
different CL##2##2##(2008-10#2)
different DNA##5##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
different German##2##2##(2008-12#2)
different HIV##2##2##(2008-5#2)
different HIV-1 subtypes##2##3##(2013-1#2)
different IGS types##2##3##(2008-10#2)
different VCGs##4##2##(2008-10#4)
different across##3##2##(2008-10#2)(2011-2#1)
different aetiology##2##2##(2008-10#1)(2011-2#1)
different affinities for##2##3##(1990-11#1)(1990-12#1)
different age groups of##2##4##(1993-9#1)(2008-9#1)
different age groups##8##3##(1993-9#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
different age##11##2##(1990-6#1)(1993-9#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
different ages##17##2##(1990-5#1)(1991-9#1)(1993-12#1)(1994-2#1)(1995-6#2)(1997-9#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)
different agonists##2##2##(1995-12#1)(2009-12#1)
different alternatives##3##2##(2008-10#2)(2013-1#1)
different amino acid##2##3##(2008-10#1)(2011-1#1)
different amino##4##2##(2008-10#3)(2011-1#1)
different among the##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)
different among##11##2##(2008-10#5)(2008-7#1)(2008-9#3)(2010-4#1)(2010-7#1)
different amounts of these##2##4##(2008-10#2)
different amounts of##16##3##(1997-7#1)(2008-10#14)(2012-8#1)
different amounts##17##2##(1997-7#1)(2008-10#15)(2012-8#1)
different analytes##5##2##(2008-10#5)
different analytical methods for##2##4##(2008-10#2)
different analytical methods##7##3##(2008-10#6)(2008-11#1)
different analytical##11##2##(2008-10#8)(2008-11#2)(2008-6#1)
different and##7##2##(1994-11#1)(2008-10#3)(2008-4#2)(2010-6#1)
different anions##5##2##(1993-12#2)(2008-10#3)
different antibiotics##3##2##(1991-1#1)(1996-11#1)(2012-3#1)
different antibodies##2##2##(1994-12#1)(2009-3#1)
different anticancer##2##2##(2008-11#1)(2010-11#1)
different applications##6##2##(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2013-8#1)
different approaches for##3##3##(2008-10#2)(2013-1#1)
different approaches to##3##3##(1991-6#1)(2008-12#1)(2008-9#1)
different approaches##15##2##(1991-6#2)(1995-12#1)(1995-5#1)(2008-10#5)(2008-12#2)(2008-9#1)(2013-1#3)
different areas of##10##3##(2008-10#6)(2008-11#2)(2009-10#1)(2013-1#1)
different areas##13##2##(1992-12#1)(1994-6#1)(2008-10#6)(2008-11#2)(2009-10#1)(2013-1#2)
different arsenic##3##2##(2008-10#2)(2008-11#1)
different artificial##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
different aspects of the##3##4##(1996-2#1)(2008-10#1)(2013-1#1)
different aspects of##16##3##(1994-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
different aspects##18##2##(1994-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
different assay##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
different assays##4##2##(2008-10#1)(2011-1#1)(2013-1#2)
different at##4##2##(2008-10#1)(2008-11#2)(2008-8#1)
different atomic##2##2##(2008-2#2)
different auxin##2##2##(2008-12#2)
different average##2##2##(2008-10#2)
different batches of##3##3##(2008-10#2)(2008-11#1)
different batches##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
different behavioral##4##2##(1991-2#1)(2008-5#2)(2008-8#1)
different behaviors in##2##3##(2012-2#1)(2013-1#1)
different behaviors##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
different behaviour of##2##3##(1992-2#1)(2008-10#1)
different behaviour##4##2##(1992-2#1)(2008-10#3)
different between the 2 groups##2##5##(1991-11#1)(2012-3#1)
different between the two groups##2##5##(2007-12#1)(2008-10#1)
different between the two##3##4##(2007-12#1)(2008-10#2)
different between the##11##3##(1991-11#1)(2007-12#1)(2008-10#7)(2008-7#1)(2012-3#1)
different between##29##2##(1990-3#1)(1990-5#1)(1991-11#1)(1993-11#1)(1994-5#1)(1996-12#1)(2007-12#1)(2008-10#13)(2008-7#1)(2011-2#2)(2012-3#4)(2013-8#2)
different binding##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
different biochemical##2##2##(1994-5#1)(2008-11#1)
different biological samples##2##3##(2008-10#2)
different biological##3##2##(2008-10#2)(2008-8#1)
different bioluminescence inhibition##2##3##(2008-10#2)
different blood##2##2##(2008-10#2)
different bloom##2##2##(2008-10#2)
different botanical origins##2##3##(2008-10#2)
different botanical##3##2##(2008-10#2)(2013-8#1)
different brain areas##3##3##(1995-11#1)(1996-2#1)(2009-10#1)
different brain##6##2##(1990-5#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-6#1)(2009-10#1)
different brands of##3##3##(2008-10#3)
different brands##5##2##(2008-10#5)
different buffer media##3##3##(2008-10#3)
different buffer##5##2##(2008-10#5)
different buffers##2##2##(2008-10#2)
different but##4##2##(1994-11#1)(2008-10#2)(2008-8#1)
different calibration##4##2##(2008-10#4)
different carbon sources##2##3##(2008-10#1)(2008-5#1)
different carbon##3##2##(2008-10#2)(2008-5#1)
different cases##2##2##(2008-3#1)(2008-9#1)
different categories##2##2##(1990-9#1)(2012-2#1)
different cationic##2##2##(2008-10#1)(2008-5#1)
different cations and anions##2##4##(2008-10#2)
different causes of##2##3##(1993-11#1)(2008-10#1)
different cell lines##4##3##(2008-11#4)
different cell types in##3##4##(2008-2#1)(2008-4#1)(2009-8#1)
different cell types##10##3##(1994-11#1)(1995-11#1)(1997-7#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#2)(2009-8#1)
different cell##24##2##(1994-11#1)(1995-11#1)(1995-9#1)(1997-7#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2012-3#1)
different cells##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
different cellular##6##2##(2008-11#1)(2008-9#1)(2009-7#1)(2009-8#2)(2012-2#1)
different changes in##2##3##(2008-10#1)(2013-8#1)
different changes##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
different characteristics##2##2##(1992-3#1)(2013-8#1)
different characters##2##2##(2008-10#1)(2008-11#1)
different chemical structures##3##3##(1995-11#1)(2008-10#2)
different chemical##15##2##(1993-8#1)(1995-11#1)(2008-10#11)(2008-11#1)(2008-6#1)
different chromatographic##2##2##(2008-10#1)(2010-11#1)
different chromosomal##2##2##(2008-10#1)(2008-7#1)
different chromosomes##2##2##(2008-11#1)(2008-9#1)
different classes of chemotherapeutic##2##4##(1997-7#2)
different classes of##14##3##(1997-3#1)(1997-6#1)(1997-7#2)(2008-10#5)(2009-12#2)(2010-3#2)(2012-12#1)
different classes##18##2##(1997-3#1)(1997-6#1)(1997-7#2)(2008-10#9)(2009-12#2)(2010-3#2)(2012-12#1)
different classrooms##2##2##(2008-12#2)
different climatic##2##2##(2008-10#1)(2012-9#1)
different clinical##12##2##(1996-3#1)(1997-8#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
different clusters##2##2##(2008-10#1)(2011-2#1)
different coloured charge-transfer complexes and radicals were developed##2##8##(2008-10#2)
different combinations of the##2##4##(2008-3#1)(2008-9#1)
different combinations of three##2##4##(2008-10#1)(2008-12#1)
different combinations of##10##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-4#1)
different combinations##12##2##(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-4#1)
different commercial devices##4##3##(2008-10#4)
different commercial formulations##2##3##(2008-10#2)
different commercial##12##2##(2008-10#12)
different commercially available##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
different community##2##2##(2008-10#1)(2008-9#1)
different complex##3##2##(2008-10#3)
different components of cow milk##3##5##(2008-10#3)
different components of the##3##4##(1993-3#1)(2008-10#1)(2008-8#1)
different components of##8##3##(1993-3#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-10#1)
different components##12##2##(1993-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#1)
different compositions##3##2##(2008-10#3)
different compounds##5##2##(1994-5#1)(2008-10#3)(2011-2#1)
different computational##2##2##(2008-8#1)(2011-2#1)
different concentration levels##4##3##(2008-10#3)(2011-2#1)
different concentration of##4##3##(2008-10#4)
different concentration ranges##2##3##(1995-8#1)(2008-10#1)
different concentration ratios of##3##4##(2008-10#3)
different concentration##14##2##(1995-8#1)(2008-10#12)(2011-2#1)
different concentrations and##2##3##(2008-10#1)(2013-1#1)
different concentrations of aluminum tetrasulfophthalocyanines##2##5##(2012-3#2)
different concentrations of the##4##4##(1997-2#1)(2008-10#3)
different concentrations of##27##3##(1993-8#1)(1997-2#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#3)
different concentrations was##2##3##(2008-11#1)(2008-8#1)
different concentrations##40##2##(1993-8#1)(1997-2#1)(1997-8#1)(2008-10#20)(2008-11#2)(2008-12#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#2)(2013-1#5)
different conclusions##2##2##(1991-2#1)(2008-3#1)
different conditions##13##2##(1993-12#1)(2008-10#5)(2008-7#3)(2009-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
different configurations##4##2##(1992-12#1)(2008-10#2)(2008-9#1)
different constitutive models##2##3##(2013-1#2)
different contents##2##2##(2008-10#2)
different continents##6##2##(2008-10#3)(2008-12#1)(2012-3#1)(2013-8#1)
different control##2##2##(2008-10#1)(2008-8#1)
different correction##2##2##(2008-10#1)(2008-9#1)
different cosmetic##2##2##(2008-5#2)
different countries##13##2##(1990-11#1)(1992-3#1)(2008-10#1)(2008-11#5)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
different criteria##4##2##(1993-6#1)(2008-10#3)
different crystal##2##2##(2008-10#1)(2008-3#1)
different cultivars##3##2##(2008-10#2)(2011-1#1)
different cultural##3##2##(2008-1#1)(2008-10#1)(2008-12#1)
different culture##4##2##(1996-12#1)(2008-11#2)(2008-8#1)
different cultures##5##2##(2008-11#1)(2010-4#1)(2010-8#3)
different cytokines##3##2##(2006-6#1)(2008-10#1)(2012-3#1)
different data##3##2##(2008-10#2)(2008-11#1)
different days of##4##3##(1993-11#2)(2008-10#2)
different days##8##2##(1990-12#1)(1993-11#2)(2008-1#1)(2008-10#3)(2008-6#1)
different definitions##3##2##(2008-1#1)(2008-8#1)(2012-2#1)
different degrees of##11##3##(1991-7#1)(1994-11#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
different degrees##18##2##(1991-7#1)(1994-11#1)(1994-5#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2011-3#1)(2012-3#1)
different demographic histories##2##3##(2012-3#2)
different demographic##3##2##(2008-8#1)(2012-3#2)
different densities##2##2##(2008-10#1)(2008-11#1)
different density##2##2##(1995-8#1)(2013-8#1)
different detection modes##2##3##(2008-10#2)
different detection techniques##2##3##(1994-12#1)(2008-4#1)
different detection##6##2##(1994-12#1)(2008-10#4)(2008-4#1)
different developmental stages of Schistosoma mansoni##2##6##(1997-6#2)
different developmental stages of##3##4##(1997-6#2)(2011-2#1)
different developmental stages##9##3##(1993-3#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
different developmental##11##2##(1993-12#1)(1993-3#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
different devices##3##2##(1997-1#1)(2008-10#2)
different diagnostic##2##2##(1990-12#1)(2013-8#1)
different dicarboxylate ligands##2##3##(2008-10#2)
different dietary##4##2##(1993-11#1)(2008-10#2)(2008-3#1)
different digestion##2##2##(2008-10#2)
different directions##3##2##(2008-11#1)(2008-6#1)(2008-8#1)
different diseases by the same##5##5##(2013-8#5)
different diseases##14##2##(1996-9#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#7)
different distribution##2##2##(2008-10#2)
different distributions of##2##3##(2008-5#1)(2008-8#1)
different distributions##3##2##(2008-3#1)(2008-5#1)(2008-8#1)
different districts##2##2##(1994-2#1)(2008-10#1)
different doctors##2##2##(1994-6#1)(1996-6#1)
different domains##3##2##(2008-1#1)(2012-2#1)(2013-8#1)
different dosages of##2##3##(2010-8#1)(2012-12#1)
different dose##2##2##(2008-7#1)(2009-2#1)
different doses and##3##3##(1992-2#1)(2008-10#1)(2012-2#1)
different doses of##2##3##(2011-2#1)(2013-1#1)
different doses##7##2##(1992-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
different drug##4##2##(1992-2#1)(2008-10#2)(2012-2#1)
different dynamic##3##2##(1995-3#1)(2006-6#1)(2008-10#1)
different dynamics##4##2##(2008-8#1)(2011-2#1)(2012-3#2)
different ecological##2##2##(2008-10#1)(2012-2#1)
different ecotypes##2##2##(2008-10#2)
different effectors##3##2##(1990-3#2)(2012-2#1)
different effects of##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
different effects on the##3##4##(1997-7#1)(2008-10#2)
different effects on##5##3##(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#1)
different effects##10##2##(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#2)
different efficiency##2##2##(1992-2#1)(2008-11#1)
different electrode##2##2##(2008-10#1)(2008-9#1)
different electrodes##5##2##(2008-10#5)
different electron##2##2##(2008-10#1)(2008-12#1)
different elements##2##2##(1994-3#1)(2009-7#1)
different elevation levels##2##3##(2008-10#2)
different elevation##3##2##(2008-10#2)(2012-7#1)
different elevations##2##2##(2012-7#2)
different elution##3##2##(2008-10#3)
different emission##2##2##(2008-10#2)
different endpoints##2##2##(2008-10#1)(2008-5#1)
different environmental conditions##9##3##(2008-10#6)(2008-8#1)(2010-10#1)(2013-8#1)
different environmental##10##2##(2008-10#7)(2008-8#1)(2010-10#1)(2013-8#1)
different environments and##2##3##(2011-1#1)(2011-2#1)
different environments##14##2##(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#3)(2012-3#1)
different enzymatic##2##2##(2008-10#1)(2010-4#1)
different enzymes##3##2##(2008-10#2)(2008-5#1)
different epitopes##2##2##(1993-1#1)(2008-11#1)
different etiologies##2##2##(1991-8#1)(2012-3#1)
different events##2##2##(2008-10#1)(2008-9#1)
different evolutionary##3##2##(1997-2#1)(2008-10#2)
different experimental conditions##5##3##(2008-10#4)(2008-11#1)
different experimental designs##2##3##(2008-10#2)
different experimental models##2##3##(2008-7#1)(2009-7#1)
different experimental##18##2##(2007-8#1)(2008-10#11)(2008-11#2)(2008-7#2)(2009-7#1)(2012-3#1)
different experiments##2##2##(2008-10#2)
different expression##3##2##(1993-8#1)(2008-11#1)(2011-2#1)
different extent##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
different external##2##2##(2008-5#1)(2011-2#1)
different extraction conditions##2##3##(2008-10#2)
different extraction methods##3##3##(2008-10#3)
different extraction##6##2##(2008-10#6)
different facial##2##2##(2008-11#1)(2008-5#1)
different factors##14##2##(2008-10#6)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#1)
different families##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
different features##5##2##(2008-10#2)(2010-8#1)(2013-1#2)
different fiber##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
different fibre##2##2##(2009-7#1)(2011-2#1)
different field experiments##2##3##(2008-10#2)
different field##4##2##(2008-10#3)(2009-11#1)
different fields in the##2##4##(2008-10#2)
different fields in##4##3##(2008-10#3)(2008-12#1)
different fields##9##2##(2008-10#5)(2008-11#1)(2008-12#1)(2011-1#1)(2011-4#1)
different flow rates##2##3##(1996-2#1)(2008-10#1)
different flow##5##2##(1996-2#1)(2008-10#4)
different flux burdens##3##3##(2008-7#3)
different flux##4##2##(2008-7#4)
different food##3##2##(2008-10#3)
different foodstuffs##2##2##(2008-10#2)
different for different##4##3##(2008-10#2)(2012-2#2)
different for each##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
different for the two##2##4##(2008-10#1)(2008-7#1)
different for the##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
different for##17##2##(1992-12#1)(2008-10#8)(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#2)(2013-1#2)
different formats##5##2##(2008-10#2)(2008-4#1)(2010-10#2)
different forms of##13##3##(1994-11#1)(1994-8#1)(1996-1#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-12#3)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
different forms##20##2##(1990-12#3)(1990-5#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-1#1)(1997-2#1)(2006-6#1)(2008-10#3)(2008-12#3)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
different fractions of##5##3##(1997-1#1)(2008-10#3)(2012-3#1)
different fractions##7##2##(1997-1#1)(2008-10#4)(2008-11#1)(2012-3#1)
different fragments##3##2##(1997-1#1)(2008-10#1)(2010-6#1)
different frequencies##5##2##(1996-12#3)(1997-7#1)(2008-8#1)
different frequency##2##2##(2008-8#1)(2009-8#1)
different from controls##2##3##(1991-12#1)(1993-12#1)
different from each##3##3##(1993-3#1)(2008-10#2)
different from observed disease severity##2##5##(2008-10#2)
different from other##6##3##(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2010-10#1)
different from that in the##3##5##(1994-5#1)(1995-2#1)(2013-1#1)
different from that in##6##4##(1993-8#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
different from that of the##6##5##(2008-10#5)(2012-3#1)
different from that of##14##4##(1993-2#1)(1994-8#1)(1996-2#1)(2008-10#7)(2010-12#1)(2011-10#1)(2011-3#1)(2012-3#1)
different from that##32##3##(1990-8#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1996-2#1)(2008-10#12)(2008-11#3)(2008-7#1)(2008-8#1)(2010-12#1)(2011-10#1)(2011-3#1)(2012-3#1)(2013-1#1)
different from the ones##2##4##(2010-8#1)(2011-2#1)
different from the##34##3##(1991-1#1)(1992-11#1)(1993-1#1)(1993-8#3)(1995-10#1)(1995-3#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
different from those in##4##4##(1997-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
different from those of a##2##5##(2008-10#2)
different from those of the##3##5##(2008-10#2)(2008-9#1)
different from those of##10##4##(1992-1#1)(1993-8#1)(2008-10#4)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)
different from those##19##3##(1990-12#1)(1992-1#1)(1993-8#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-10#6)(2008-3#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
different from zero##4##3##(2008-10#4)
different from##155##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#5)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-10#63)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#6)(2009-7#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-8#3)(2011-10#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
different fruit##3##2##(2008-10#3)
different function##2##2##(2008-8#1)(2011-2#1)
different functional##5##2##(2008-10#2)(2008-8#1)(2008-9#2)
different functions for##2##3##(1995-12#1)(2010-10#1)
different functions##3##2##(1990-5#1)(1995-12#1)(2010-10#1)
different fungal species##2##3##(2009-8#1)(2012-2#1)
different fungal##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
different gas-liquid##2##2##(2008-10#2)
different genes##4##2##(1997-7#1)(2008-10#1)(2012-3#1)(2013-1#1)
different genetic backgrounds##3##3##(2008-10#1)(2012-3#2)
different genetic##7##2##(2008-10#4)(2012-3#2)(2013-1#1)
different genomes##3##2##(2008-10#1)(2008-8#1)(2010-7#1)
different genotypes at##2##3##(1997-7#1)(2008-12#1)
different genotypes were found##2##4##(2008-10#2)
different genotypes were##5##3##(2008-10#5)
different genotypes##14##2##(1997-7#1)(2008-10#11)(2008-12#1)(2013-8#1)
different geographic areas##2##3##(2008-10#1)(2011-2#1)
different geographic locations##3##3##(2008-10#2)(2008-9#1)
different geographic regions##2##3##(1993-12#1)(2008-10#1)
different geographic##8##2##(1993-12#1)(2008-10#4)(2008-6#1)(2008-9#1)(2011-2#1)
different geographical areas##2##3##(2008-10#1)(2013-1#1)
different geographical regions##3##3##(2008-10#3)
different geographical##9##2##(2008-10#6)(2008-12#1)(2011-2#1)(2013-1#1)
different glucose##2##2##(2008-5#1)(2010-10#1)
different groups of##6##3##(1993-8#1)(1997-2#1)(2008-10#2)(2008-6#1)(2008-7#1)
different groups##23##2##(1993-8#1)(1994-12#1)(1994-9#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#9)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
different growing areas was##2##4##(2008-10#2)
different growing media##3##3##(2008-12#3)
different growing##6##2##(2008-10#3)(2008-12#3)
different growth rates##2##3##(1993-12#1)(2010-12#1)
different growth regulator##2##3##(2008-12#1)(2013-1#1)
different growth##8##2##(1993-12#1)(2008-10#3)(2008-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
different habitats##3##2##(2008-8#2)(2013-8#1)
different hair##2##2##(2008-5#2)
different haplotypes##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
different health care##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
different health##4##2##(2008-11#2)(2008-4#1)(2011-2#1)
different hospitals##6##2##(1991-11#2)(1991-2#1)(1992-2#1)(1994-2#1)(2008-1#1)
different host plants##2##3##(2008-10#1)(2008-9#1)
different host species##2##3##(2008-9#2)
different host##11##2##(2008-10#8)(2008-9#3)
different hosts##13##2##(2008-10#12)(2012-2#1)
different humic##2##2##(2008-10#2)
different hybridization##2##2##(2008-10#2)
different hydrolysis##2##2##(2008-10#2)
different hydrophilic##2##2##(2008-10#2)
different imaging techniques##3##3##(2011-2#1)(2012-2#2)
different imaging##4##2##(2011-2#1)(2012-2#2)(2013-1#1)
different implements##2##2##(2008-10#2)
different in the two##2##4##(1992-3#1)(2008-10#1)
different in the##6##3##(1992-3#1)(2008-10#3)(2008-11#1)(2010-5#1)
different in vitro##5##3##(1992-2#1)(2008-5#4)
different in##30##2##(1990-8#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#4)(2009-7#2)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
different incubation temperatures##2##3##(2008-10#1)(2011-2#1)
different incubation##3##2##(2008-10#1)(2011-2#2)
different indicators of##2##3##(1995-12#1)(2010-11#1)
different individuals##8##2##(1993-12#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-7#1)
different industrial##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
different information##2##2##(1995-12#1)(2010-8#1)
different inhibitors##2##2##(1995-11#1)(2008-7#1)
different injection##2##2##(2008-10#1)(2010-4#1)
different inoculation##2##2##(2008-10#2)
different inoculum##3##2##(2008-10#3)
different inorganic##2##2##(2008-10#2)
different inspiratory##2##2##(1995-3#1)(2011-2#1)
different instrumental##2##2##(2008-10#1)(2008-5#1)
different intensities of heat##2##4##(1992-3#2)
different intensities of##4##3##(1992-3#3)(2008-8#1)
different intensities##6##2##(1992-3#3)(1996-2#1)(2008-8#1)(2008-9#1)
different interventions##2##2##(2008-10#2)
different intracellular##3##2##(1993-8#1)(2008-11#1)(2008-9#1)
different ionic##10##2##(1994-5#1)(1997-2#1)(2008-10#8)
different islands##2##2##(2008-10#1)(2008-8#1)
different isolates of##4##3##(2008-10#3)(2008-9#1)
different isolates##7##2##(2008-10#5)(2008-9#1)(2012-3#1)
different kind of samples##2##4##(2008-10#2)
different kind of##3##3##(2008-10#2)(2012-3#1)
different kinds of milk##2##4##(2008-10#2)
different kinds of water##2##4##(2008-11#2)
different kinds of##22##3##(1991-11#1)(1996-6#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-3#1)
different kinds##23##2##(1991-11#1)(1996-6#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-3#1)
different laboratories##7##2##(2008-10#5)(2008-5#1)(2011-2#1)
different leaf##4##2##(2008-10#2)(2008-12#1)(2010-3#1)
different length##2##2##(1996-6#1)(2008-10#1)
different lengths of##2##3##(1991-7#1)(2008-10#1)
different lengths##3##2##(1991-7#1)(2008-10#1)(2008-7#1)
different lesions##2##2##(2008-10#1)(2008-11#1)
different levels of resistance to Aphanomyces root rot and##2##9##(2008-10#2)
different levels of resistance##4##4##(2008-10#4)
different levels of the##2##4##(2008-7#1)(2009-7#1)
different levels of virulence##2##4##(2008-10#1)(2008-8#1)
different levels of##34##3##(1990-2#1)(1994-3#1)(1997-3#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#2)(2012-3#1)
different levels##43##2##(1990-2#1)(1991-6#1)(1994-3#1)(1997-3#1)(1997-7#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-7#2)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
different linear##2##2##(2008-10#2)
different local##2##2##(1993-1#1)(2010-8#1)
different locations in the##2##4##(2008-10#1)(2008-5#1)
different locations in##9##3##(2008-10#8)(2008-5#1)
different locations on the##2##4##(2008-10#1)(2009-7#1)
different locations##23##2##(1995-2#1)(1997-3#1)(2008-10#16)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#2)
different loci##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
different locking##2##2##(2008-3#1)(2008-8#1)
different magnitudes of##2##3##(2008-10#1)(2008-7#1)
different main##2##2##(2013-8#2)
different mammalian species##2##3##(1994-11#1)(1995-2#1)
different mammalian##4##2##(1993-9#1)(1994-11#1)(1995-2#1)(2008-7#1)
different manners##2##2##(2008-10#2)
different manufacture##2##2##(2008-10#2)
different manufacturers##2##2##(2008-10#2)
different materials##4##2##(2008-10#4)
different mathematical##2##2##(1994-5#1)(2013-8#1)
different mating types##2##3##(2008-10#2)
different mating##4##2##(2008-10#4)
different matrices such as##2##4##(2008-10#2)
different matrices##12##2##(2008-10#12)
different matrix##3##2##(1992-3#1)(2008-10#2)
different mats##2##2##(2011-2#2)
different measurement##2##2##(2008-10#2)
different measures of##2##3##(1991-11#1)(2010-7#1)
different measures##6##2##(1991-11#1)(2008-10#1)(2008-9#1)(2010-7#1)(2011-2#2)
different mechanism##5##2##(1991-5#1)(2008-10#3)(2008-8#1)
different mechanisms for##2##3##(1995-11#1)(2008-10#1)
different mechanisms of##5##3##(2006-6#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
different mechanisms##22##2##(1991-1#1)(1991-5#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-3#3)
different media and##2##3##(2008-10#1)(2008-11#1)
different media##4##2##(2008-10#2)(2008-11#2)
different medical##2##2##(1991-11#1)(2012-2#1)
different metabolic##2##2##(1995-12#1)(2011-1#1)
different metal ions##2##3##(2008-10#2)
different metal oxides##3##3##(2008-10#3)
different metal##5##2##(2008-10#5)
different metals##2##2##(2008-10#2)
different meteorological##2##2##(2008-2#2)
different methodologies##2##2##(2008-10#1)(2008-4#1)
different methods for the##4##4##(2008-10#2)(2008-4#1)(2009-8#1)
different methods for##7##3##(2008-10#3)(2008-4#2)(2008-8#1)(2009-8#1)
different methods have been##2##4##(2008-11#1)(2008-9#1)
different methods of##5##3##(1990-2#1)(1994-5#1)(2009-8#1)(2012-3#1)(2013-8#1)
different methods to##3##3##(2008-10#2)(2008-11#1)
different methods##34##2##(1990-2#1)(1990-5#1)(1991-3#2)(1994-5#1)(1996-5#1)(2008-10#12)(2008-11#4)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#3)(2012-12#1)(2012-3#1)(2013-8#1)
different microbes##2##2##(2011-2#1)(2012-2#1)
different microbial##2##2##(2008-10#1)(2011-2#1)
different milk##2##2##(2008-10#1)(2010-12#1)
different mixed##2##2##(2008-10#2)
different mixtures of##5##3##(2008-10#5)
different mixtures##6##2##(2008-10#6)
different mobility species##3##3##(1991-7#3)
different mode##2##2##(2008-3#1)(2010-11#1)
different model##2##2##(1997-2#1)(2008-10#1)
different models and##2##3##(1993-3#1)(2008-10#1)
different models of##4##3##(1992-3#1)(1996-1#1)(2009-1#1)(2010-12#1)
different models##11##2##(1992-3#1)(1993-12#1)(1993-3#1)(1996-1#1)(2008-10#4)(2008-8#1)(2009-1#1)(2010-12#1)
different modes of cytokinesis##2##4##(2009-10#2)
different modes of##4##3##(1995-2#1)(2009-10#2)(2010-11#1)
different modes##6##2##(1995-2#1)(2008-3#2)(2009-10#2)(2010-11#1)
different moisture##4##2##(2008-10#3)(2008-12#1)
different molar ratios of##3##4##(2008-10#2)(2008-8#1)
different molar ratios##5##3##(2008-10#4)(2008-8#1)
different molar##6##2##(2008-10#4)(2008-8#1)(2013-1#1)
different molecular descriptors##3##3##(2008-10#2)(2009-3#1)
different molecular weight##2##3##(2008-10#2)
different molecular weights##3##3##(2008-10#2)(2008-11#1)
different molecular##19##2##(1991-7#1)(1992-9#1)(1995-12#1)(2008-10#8)(2008-11#1)(2008-5#2)(2009-12#1)(2009-3#1)(2010-9#1)(2011-2#2)
different mouse models##2##3##(2008-11#1)(2011-2#1)
different mouse##3##2##(2008-11#2)(2011-2#1)
different natural##3##2##(2008-10#2)(2012-3#1)
different nebulizers##2##2##(1994-12#1)(1995-3#1)
different nerve##2##2##(1996-2#1)(2008-10#1)
different neural mechanisms##2##3##(1992-3#1)(2008-8#1)
different nominal##3##2##(1995-3#1)(2008-10#2)
different null models##2##3##(2008-8#2)
different number of##3##3##(1990-12#1)(2008-11#1)(2011-2#1)
different numbers of layers of##2##5##(2008-12#2)
different numbers of##7##3##(1990-12#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)
different objects##2##2##(1996-2#1)(2008-12#1)
different off-line methods##2##3##(2008-11#2)
different oils##2##2##(2008-5#1)(2013-1#1)
different open reading frames##2##4##(1997-7#1)(2008-10#1)
different operators##2##2##(2008-10#1)(2010-7#1)
different or##2##2##(2010-12#1)(2013-1#1)
different organic##5##2##(1995-11#1)(1997-2#1)(2008-10#2)(2008-3#1)
different organisms##6##2##(1993-2#2)(1993-6#1)(2008-4#1)(2008-8#2)
different organization##3##2##(1992-5#1)(2008-10#1)(2009-3#1)
different organs of##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
different organs##9##2##(1997-4#1)(2008-10#3)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
different orientations of##2##3##(2007-11#1)(2012-2#1)
different origins##10##2##(2008-10#9)(2008-3#1)
different oxidant##2##2##(2008-10#2)
different oxidation states with##2##4##(2008-10#2)
different oxidation states##6##3##(2008-10#6)
different oxygen##2##2##(1990-8#2)
different pH values##9##3##(1994-11#2)(2008-10#6)(2008-5#1)
different pH##21##2##(1994-11#2)(2008-10#15)(2008-5#2)(2010-12#1)(2012-6#1)
different pK(app)##2##2##(2008-10#2)
different packing##2##2##(2008-10#1)(2008-12#1)
different pairs of##2##3##(1991-6#1)(2008-10#1)
different parameters such as##3##4##(2008-10#2)(2011-3#1)
different parameters##13##2##(1990-9#1)(2008-10#10)(2011-2#1)(2011-3#1)
different parts of the plant##2##5##(2008-10#2)
different parts of the##11##4##(1990-12#1)(1993-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
different parts of##14##3##(1990-12#1)(1993-12#1)(1995-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
different pathogenic##2##2##(2008-10#2)
different pathogenicity##2##2##(2008-10#1)(2013-8#1)
different pathogens##5##2##(2006-5#1)(2008-10#4)
different pathotypes of##2##3##(2008-10#2)
different pathotypes##4##2##(2008-10#4)
different paths##3##2##(1996-1#1)(2008-3#1)(2009-8#1)
different pathways in liver cells##2##5##(1994-6#1)(1995-6#1)
different pathways##6##2##(1994-2#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
different patient populations##3##3##(1992-3#2)(2009-10#1)
different patient##4##2##(1992-3#2)(2009-10#1)(2010-10#1)
different pattern##2##2##(2008-11#2)
different patterns of##4##3##(1997-2#1)(2008-1#1)(2010-2#1)(2012-2#1)
different patterns##7##2##(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
different peptide##2##2##(1997-6#1)(2008-11#1)
different percentages of##4##3##(2008-10#4)
different perceptions##3##2##(2008-8#1)(2010-11#1)(2011-1#1)
different periods of##8##3##(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#2)
different periods##13##2##(1996-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2013-1#2)
different permanent modifiers##4##3##(2008-10#4)
different perspectives on##2##3##(1995-2#1)(2012-3#1)
different perspectives##5##2##(1995-2#1)(2008-11#2)(2008-12#1)(2012-3#1)
different pharmaceutical samples##2##3##(2008-10#2)
different pharmaceutical##3##2##(2008-10#3)
different phases are##2##3##(1990-5#1)(2008-3#1)
different phases of menstrual cycle##2##5##(2012-2#2)
different phases of##6##3##(2008-11#2)(2012-2#3)(2013-1#1)
different phases##11##2##(1990-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2012-2#3)(2013-1#1)
different phenolic##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
different phenotypes##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
different phenotypic##3##2##(2008-10#3)
different phylogenetic##4##2##(1995-12#1)(2008-10#2)(2008-8#1)
different physical##2##2##(1996-12#1)(2008-5#1)
different physiological stages##2##3##(1996-12#1)(2010-12#1)
different physiological##6##2##(1996-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)
different phytoplasmas##2##2##(2008-10#2)
different plant species was##2##4##(2008-10#2)
different plant species##4##3##(2008-10#3)(2008-8#1)
different plant##10##2##(2008-10#6)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)
different plants##2##2##(2008-9#1)(2011-2#1)
different plasticizers##2##2##(2008-10#2)
different points of the##4##4##(2008-10#3)(2009-3#1)
different points##5##2##(2008-10#3)(2009-3#1)(2010-2#1)
different polarity##5##2##(2008-10#5)
different polarization states##2##3##(2007-11#1)(2008-3#1)
different polarization##3##2##(2007-11#1)(2008-3#2)
different polyadenylation##3##2##(1990-2#2)(2008-8#1)
different polyamines##4##2##(2008-12#4)
different polymers##3##2##(2008-10#1)(2008-5#2)
different population##2##2##(2008-10#1)(2008-8#1)
different populations of##4##3##(1990-5#1)(1993-6#1)(1995-2#1)(2008-10#1)
different populations to##2##3##(1997-8#1)(2008-8#1)
different populations##10##2##(1990-5#1)(1993-6#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
different portions of the##2##4##(1995-2#1)(2008-5#1)
different portions of##3##3##(1995-2#1)(2008-10#1)(2008-5#1)
different positions in##2##3##(2008-10#2)
different potential##2##2##(2008-10#1)(2010-6#1)
different preparations##5##2##(2008-10#3)(2008-11#1)(2008-4#1)
different procedures##7##2##(2008-10#6)(2008-9#1)
different processes of##2##3##(2008-10#1)(2008-9#1)
different processes##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-7#1)
different processing##3##2##(1995-5#1)(2008-5#1)(2013-8#1)
different production##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
different products##3##2##(2008-10#2)(2008-5#1)
different profile##3##2##(1993-1#1)(2008-10#2)
different properties##6##2##(1993-6#1)(1996-2#2)(2009-5#1)(2010-8#1)(2012-2#1)
different proportions##4##2##(2008-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
different protein kinases and##2##4##(1990-8#1)(1997-2#1)
different protein kinases##3##3##(1990-8#2)(1997-2#1)
different protein##7##2##(1990-8#2)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
different proteins##4##2##(1994-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
different protocols##2##2##(2008-2#1)(2013-8#1)
different psychiatric##2##2##(2009-11#1)(2009-9#1)
different pulse##4##2##(1997-8#1)(2008-10#2)(2012-2#1)
different purification procedures##2##3##(2008-10#2)
different purposes##2##2##(2008-7#1)(2013-1#1)
different races of##2##3##(2008-10#2)
different races##3##2##(2008-10#3)
different random##2##2##(2008-3#1)(2008-5#1)
different ranges##2##2##(2008-10#1)(2008-3#1)
different raters##2##2##(2008-9#1)(2012-2#1)
different rates##4##2##(1996-2#1)(2008-10#2)(2008-7#1)
different ratios##7##2##(1991-5#1)(2008-10#4)(2008-5#1)(2012-2#1)
different reaction##6##2##(1996-5#1)(2008-10#3)(2010-10#2)
different reactions with##2##3##(1997-6#1)(2011-1#1)
different reasons##6##2##(1991-9#1)(1994-5#1)(2008-10#1)(2011-2#1)(2012-3#2)
different receptor##2##2##(2008-10#1)(2008-9#1)
different reference materials##3##3##(2008-10#3)
different reference##5##2##(2008-10#4)(2012-2#1)
different regimens##2##2##(1993-1#1)(2009-8#1)
different regional##2##2##(1994-12#1)(2008-1#1)
different regions of the##3##4##(2008-10#3)
different regions of##14##3##(1990-3#1)(1993-12#1)(2008-10#9)(2008-6#1)(2011-3#1)(2013-1#1)
different regions##19##2##(1990-3#1)(1993-12#1)(2008-10#13)(2008-6#1)(2011-1#1)(2011-3#1)(2013-1#1)
different regulation##2##2##(1991-5#1)(2008-7#1)
different regulatory##3##2##(1993-8#1)(2012-2#1)(2012-3#1)
different relative##3##2##(2008-10#2)(2011-2#1)
different requirements##2##2##(2010-12#1)(2010-8#1)
different residues##2##2##(1992-3#1)(2008-7#1)
different resistance genes##3##3##(2008-10#3)
different resistance##5##2##(2008-10#5)
different responses to##6##3##(1991-2#1)(2008-10#2)(2008-7#1)(2008-9#2)
different responses##13##2##(1991-2#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-6#1)(2013-1#1)
different restriction enzymes##2##3##(1996-2#1)(2008-10#1)
different restriction##4##2##(1996-2#1)(2008-10#3)
different results##2##2##(2008-10#2)
different retention times##3##3##(2008-10#1)(2008-11#2)
different retention##4##2##(2008-10#2)(2008-11#2)
different rice##4##2##(2008-10#2)(2008-9#2)
different risk##5##2##(2008-10#3)(2012-2#2)
different rivers##2##2##(2008-10#1)(2008-9#1)
different roles##4##2##(1995-11#1)(2008-11#2)(2012-2#1)
different rules##2##2##(1993-2#1)(2008-8#1)
different salt##2##2##(2008-10#1)(2010-4#1)
different sample extraction##2##3##(2008-10#2)
different sample##8##2##(2008-10#7)(2008-11#1)
different samples of##7##3##(2008-10#7)
different samples##17##2##(2008-10#16)(2011-3#1)
different sampling##5##2##(2008-10#4)(2008-11#1)
different scFv##2##2##(2008-10#2)
different scales and##2##3##(2008-10#1)(2008-8#1)
different scales##8##2##(2008-10#2)(2008-8#4)(2010-7#1)(2013-1#1)
different scores##2##2##(2008-9#1)(2012-2#1)
different seasons##6##2##(2008-10#2)(2008-8#2)(2012-2#2)
different sections of##2##3##(2008-10#1)(2009-12#1)
different sectors##3##2##(1991-3#1)(2010-12#1)(2012-3#1)
different selenium##2##2##(2008-10#2)
different sensitization##2##2##(2008-10#1)(2013-1#1)
different sequences##2##2##(1993-1#1)(2008-8#1)
different serogroups##2##2##(2008-10#1)(2008-5#1)
different serotypes##3##2##(1995-5#1)(1997-3#1)(2013-8#1)
different set of##5##3##(1992-2#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
different sets of##8##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-8#1)
different settings##5##2##(2008-11#1)(2009-10#1)(2009-12#1)(2012-12#1)(2012-3#1)
different shapes##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
different shoulder##2##2##(2010-7#1)(2011-2#1)
different signaling pathways##2##3##(2008-8#1)(2008-9#1)
different signaling##4##2##(2008-11#2)(2008-8#1)(2008-9#1)
different signals##2##2##(2008-10#1)(2010-10#1)
different significantly from that of##2##5##(2008-8#1)(2009-10#1)
different sites in##3##3##(2008-10#2)(2008-8#1)
different sites##7##2##(1990-5#1)(1991-12#1)(2008-10#3)(2008-5#1)(2008-8#1)
different situations##2##2##(1990-9#1)(2008-10#1)
different size##2##2##(2008-11#1)(2011-2#1)
different sized##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
different sizes and##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
different sizes##18##2##(1995-8#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#3)(2012-2#1)
different social##4##2##(2007-12#1)(2008-11#1)(2010-2#1)(2012-2#1)
different soil##5##2##(2008-10#5)
different soils##4##2##(2008-10#4)
different solid##2##2##(2008-10#2)
different solutions##3##2##(2008-10#2)(2013-1#1)
different solvent##2##2##(2008-10#2)
different solvents##7##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
different sorbents##2##2##(2008-10#2)
different sorption rates##2##3##(2008-10#2)
different sorption##3##2##(2008-10#3)
different source##2##2##(2008-10#2)
different sources##7##2##(1992-12#1)(2008-10#4)(2008-11#1)(2008-4#1)
different spatial scales##3##3##(2008-8#3)
different spatial##5##2##(1996-12#1)(2008-8#3)(2013-1#1)
different specialties##2##2##(1991-6#1)(2013-1#1)
different species and##2##3##(2008-10#2)
different species of##7##3##(1994-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-12#1)
different species with##2##3##(1990-5#1)(1997-3#1)
different species##36##2##(1990-5#1)(1993-6#1)(1994-11#1)(1997-3#1)(2008-10#21)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
different specific##3##2##(1994-11#1)(2008-11#1)(2008-7#1)
different spectral##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
different spectroscopic##2##2##(2008-10#2)
different stage of##2##3##(2008-10#1)(2008-9#1)
different stage##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
different stages of pregnancy##2##4##(1995-12#1)(2008-9#1)
different stages of the disease##2##5##(2008-5#1)(2008-8#1)
different stages of the##6##4##(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)
different stages of##28##3##(1990-5#1)(1993-1#1)(1993-9#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
different stages##37##2##(1990-5#1)(1993-1#1)(1993-9#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#3)(2009-6#1)(2009-8#1)(2010-5#2)(2010-6#1)(2011-2#4)(2012-2#1)
different standard##2##2##(1994-3#1)(2013-8#1)
different starting##2##2##(1994-5#1)(2008-10#1)
different states##5##2##(1990-11#1)(2008-10#2)(2008-8#1)(2013-8#1)
different steps of##2##3##(2008-10#1)(2011-2#1)
different steps##3##2##(2008-10#2)(2011-2#1)
different stimulus conditions##2##3##(1996-2#1)(2008-11#1)
different stimulus##5##2##(1994-3#3)(1996-2#1)(2008-11#1)
different strains of the##3##4##(2008-10#2)(2008-5#1)
different strains of##10##3##(2008-10#5)(2008-12#2)(2008-5#1)(2012-2#1)(2012-3#1)
different strains##18##2##(2008-10#8)(2008-12#2)(2008-5#2)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
different strategies for##3##3##(1994-12#1)(2008-10#2)
different strategies##9##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)
different stresses##3##2##(2008-7#1)(2009-8#1)(2011-2#1)
different structural##2##2##(2008-10#2)
different structures and##2##3##(2010-7#1)(2011-3#1)
different structures##4##2##(1997-8#1)(2008-10#1)(2010-7#1)(2011-3#1)
different studies##11##2##(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)
different subjects##2##2##(1991-12#1)(2010-8#1)
different subpopulations##3##2##(1995-12#1)(2008-10#2)
different subregions##2##2##(2008-8#2)
different subsets##2##2##(1994-3#1)(2008-6#1)
different substances##2##2##(2008-10#1)(2008-11#1)
different substrate##3##2##(2008-10#2)(2011-2#1)
different substrates##5##2##(1991-5#1)(2008-10#3)(2010-3#1)
different subtypes of##2##3##(2010-2#1)(2012-12#1)
different subunits in##2##3##(1991-10#1)(2008-9#1)
different subunits##4##2##(1991-10#2)(2008-4#1)(2008-9#1)
different sunscreen##2##2##(2008-5#2)
different synthetic##3##2##(2008-11#2)(2012-3#1)
different systems##5##2##(1993-2#1)(1993-3#1)(1995-1#1)(2008-10#2)
different target##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
different targets##2##2##(2008-10#1)(2010-7#1)
different tasks##3##2##(1996-3#1)(2008-11#1)(2013-8#1)
different taste substances##3##3##(2008-10#3)
different techniques and##2##3##(2008-10#2)
different techniques for##2##3##(1991-3#1)(2008-4#1)
different techniques of##2##3##(2008-10#1)(2010-7#1)
different techniques to##2##3##(2008-10#1)(2008-11#1)
different techniques##17##2##(1991-3#1)(2008-10#10)(2008-11#1)(2008-4#1)(2009-12#1)(2010-7#1)(2012-2#2)
different temperature##5##2##(2008-10#5)
different temperatures (ranging from 30 to##3##6##(2008-10#3)
different temperatures and##7##3##(1996-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
different temperatures were##2##3##(2008-10#2)
different temperatures##23##2##(1996-12#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-8#1)
different test##3##2##(2008-10#1)(2008-5#1)(2009-5#1)
different tests based on the same principle##3##7##(2008-10#3)
different than that##2##3##(1996-12#1)(2008-10#1)
different than the##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
different than##9##2##(1996-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#2)
different theoretical##2##2##(2008-10#1)(2009-12#1)
different therapeutic##2##2##(1993-11#1)(2009-4#1)
different tillage systems##3##3##(2008-10#3)
different tillage##4##2##(2008-10#4)
different time courses##2##3##(1991-2#1)(2008-11#1)
different time##11##2##(1991-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
different times after##3##3##(1994-5#1)(2008-10#2)
different times##13##2##(1994-5#1)(1994-8#1)(1997-3#1)(2008-10#6)(2008-8#2)(2008-9#1)(2011-2#1)
different tissue origins##2##3##(2008-8#1)(2009-9#1)
different tissue##4##2##(2008-8#2)(2009-9#1)(2011-2#1)
different tissues by##2##3##(1993-11#1)(2009-8#1)
different tissues##14##2##(1992-9#1)(1993-11#1)(1993-2#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-10#1)(2009-8#2)(2013-8#1)
different to that##4##3##(1994-8#1)(2008-10#3)
different to the##2##3##(1996-12#1)(2013-1#1)
different to##9##2##(1994-8#1)(1996-12#1)(2008-10#4)(2008-12#1)(2013-1#2)
different tomato cultivars##2##3##(2008-10#2)
different toxicity##5##2##(2008-10#4)(2008-5#1)
different traffic intensities##2##3##(2008-10#2)
different training##2##2##(1994-12#1)(2013-1#1)
different transcripts##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
different treatment modalities##2##3##(1993-8#1)(1995-5#1)
different treatment options##2##3##(2009-8#1)(2011-2#1)
different treatment##9##2##(1990-2#1)(1992-2#1)(1993-8#1)(1995-5#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
different treatments##7##2##(1992-9#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)
different tumor##2##2##(1993-11#1)(1997-7#1)
different type of##4##3##(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
different type##7##2##(2008-10#4)(2012-2#1)(2012-3#1)(2013-1#1)
different types and##2##3##(2010-7#2)
different types of commercial##2##4##(2008-10#2)
different types of data##2##4##(2008-4#1)(2011-2#1)
different types of exercise##3##4##(2013-1#3)
different types of sampling##2##4##(2008-10#2)
different types of tobacco##2##4##(2008-10#2)
different types of waters##2##4##(2008-10#2)
different types of##92##3##(1991-1#1)(1992-1#1)(1993-3#1)(1993-8#3)(1995-1#1)(1996-2#2)(1996-9#1)(1997-2#2)(2008-10#33)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#2)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#4)
different types##104##2##(1991-1#1)(1992-1#1)(1993-3#1)(1993-8#3)(1994-2#1)(1995-1#1)(1996-2#2)(1996-9#1)(1997-2#2)(2008-10#39)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#4)
different units##2##2##(1995-3#1)(2008-12#1)
different values obtained##2##3##(1992-3#1)(2008-10#1)
different values of##2##3##(2008-11#1)(2009-7#1)
different values##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2009-7#1)
different variables##9##2##(2008-10#9)
different varieties of##4##3##(2008-10#3)(2011-1#1)
different varieties##6##2##(2008-10#5)(2011-1#1)
different vehicles##2##2##(2008-5#2)
different versions of the##2##4##(2008-10#1)(2012-2#1)
different viral##3##2##(2008-10#2)(2013-8#1)
different virulence##2##2##(1995-2#1)(2008-10#1)
different viruses##2##2##(2008-10#1)(2008-11#1)
different voltammetric##2##2##(2008-10#2)
different volumes of##2##3##(2008-10#2)
different water samples##9##3##(2008-10#9)
different water##12##2##(2008-10#12)
different wavelengths##7##2##(1990-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
different ways of##2##3##(1991-2#1)(2008-10#1)
different ways to##2##3##(2008-10#1)(2012-2#1)
different ways##18##2##(1990-3#1)(1991-2#1)(1992-11#1)(1993-12#1)(1995-6#1)(2008-10#6)(2008-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
different wetness##2##2##(2008-10#2)
different wheat cultivars##2##3##(2008-10#2)
different when compared with##2##4##(2010-8#1)(2011-2#1)
different when compared##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
different when##5##2##(1996-3#1)(2008-11#1)(2009-8#1)(2010-8#1)(2011-2#1)
different wine##2##2##(2008-10#2)
different with respect to##2##4##(1991-6#1)(2008-10#1)
different years##6##2##(2008-10#5)(2008-12#1)
different##4130##1##(1990-11#6)(1990-12#18)(1990-2#8)(1990-3#6)(1990-5#19)(1990-6#2)(1990-8#9)(1990-9#8)(1991-1#5)(1991-10#2)(1991-11#9)(1991-12#9)(1991-2#8)(1991-3#8)(1991-5#10)(1991-6#8)(1991-7#6)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#12)(1992-2#9)(1992-3#18)(1992-5#1)(1992-6#3)(1992-9#6)(1993-1#9)(1993-11#9)(1993-12#23)(1993-2#8)(1993-3#9)(1993-5#1)(1993-6#11)(1993-8#22)(1993-9#3)(1994-1#1)(1994-11#13)(1994-12#17)(1994-2#7)(1994-3#13)(1994-5#18)(1994-6#7)(1994-8#8)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#8)(1995-12#26)(1995-2#18)(1995-3#7)(1995-5#9)(1995-6#8)(1995-8#8)(1995-9#1)(1996-1#6)(1996-11#2)(1996-12#22)(1996-2#19)(1996-3#6)(1996-5#5)(1996-6#7)(1996-9#2)(1997-1#7)(1997-2#18)(1997-3#16)(1997-4#3)(1997-5#1)(1997-6#11)(1997-7#16)(1997-8#20)(1997-9#3)(2006-5#1)(2006-6#6)(2007-11#3)(2007-12#12)(2007-8#5)(2008-1#12)(2008-10#1724)(2008-11#222)(2008-12#93)(2008-2#15)(2008-3#79)(2008-4#37)(2008-5#101)(2008-6#16)(2008-7#80)(2008-8#150)(2008-9#112)(2009-1#4)(2009-10#25)(2009-11#4)(2009-12#12)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#6)(2009-6#6)(2009-7#26)(2009-8#32)(2009-9#4)(2010-1#5)(2010-10#24)(2010-11#12)(2010-12#16)(2010-2#6)(2010-3#7)(2010-4#17)(2010-5#9)(2010-6#7)(2010-7#13)(2010-8#21)(2010-9#5)(2011-1#23)(2011-10#1)(2011-2#127)(2011-3#11)(2011-4#1)(2011-7#1)(2012-12#12)(2012-2#82)(2012-3#75)(2012-4#2)(2012-5#3)(2012-6#2)(2012-7#5)(2012-8#6)(2012-9#2)(2013-1#132)(2013-7#1)(2013-8#73)
different-ethnic##3##1##(2009-7#3)
different?##3##1##(1995-3#1)(2008-4#1)(2009-7#1)
differentiable##2##1##(2008-10#1)(2008-11#1)
differential absorption coefficient##3##3##(2008-2#3)
differential absorption lidar (DIAL) measurements##2##5##(2008-3#2)
differential absorption lidar (DIAL)##6##4##(2008-2#1)(2008-3#5)
differential absorption lidar system##3##4##(2008-3#3)
differential absorption lidar##17##3##(2007-12#1)(2008-2#2)(2008-3#14)
differential absorption##23##2##(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#16)
differential activation in##2##3##(2008-11#1)(2008-7#1)
differential and##2##2##(2008-11#1)(2008-3#1)
differential cell counts in##2##4##(1991-11#2)
differential cell##5##2##(1991-11#2)(1993-11#1)(2008-11#2)
differential clinical##2##2##(1991-8#1)(2009-4#1)
differential control##2##2##(1993-3#1)(2008-5#1)
differential cultivars##6##2##(2008-10#6)
differential determination of##3##3##(2008-10#3)
differential diagnoses are##2##3##(1990-9#1)(2011-2#1)
differential diagnoses##7##2##(1990-9#1)(1993-8#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-3#1)
differential diagnosis and##4##3##(1993-8#1)(1994-2#1)(2008-10#1)(2013-1#1)
differential diagnosis are discussed##2##4##(2008-11#1)(2012-3#1)
differential diagnosis are##3##3##(2008-11#1)(2012-3#2)
differential diagnosis between##2##3##(2012-3#1)(2013-1#1)
differential diagnosis for##6##3##(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
differential diagnosis has##2##3##(1993-2#2)
differential diagnosis in##5##3##(1990-12#1)(1991-2#1)(1996-11#1)(1997-4#1)(2010-6#1)
differential diagnosis includes##2##3##(2008-7#1)(2011-2#1)
differential diagnosis is##2##3##(1990-12#1)(1991-8#1)
differential diagnosis of dementia##2##4##(1996-11#2)
differential diagnosis of##45##3##(1990-2#1)(1990-6#2)(1990-9#2)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1996-11#3)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-12#2)(2008-5#4)(2009-1#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
differential diagnosis##93##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-5#2)(1993-2#4)(1993-8#1)(1994-12#1)(1994-2#1)(1996-11#4)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-12#5)(2008-2#1)(2008-5#4)(2008-7#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-6#1)(2010-7#1)(2011-2#9)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#4)
differential diagnostic##3##2##(1992-3#1)(1993-2#1)(1997-2#1)
differential display method##2##3##(1997-7#1)(2008-9#1)
differential display##14##2##(1997-7#1)(2008-2#3)(2008-8#4)(2008-9#4)(2010-12#2)
differential effect of##8##3##(1992-3#1)(1994-5#1)(2008-10#2)(2010-1#1)(2012-8#1)(2013-1#2)
differential effect##9##2##(1992-3#1)(1994-5#1)(2008-10#2)(2010-1#1)(2012-8#2)(2013-1#2)
differential effects on##4##3##(1996-12#1)(2007-12#1)(2009-10#1)(2012-3#1)
differential effects##7##2##(1995-12#1)(1996-12#1)(2007-12#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-3#1)
differential equation##6##2##(2008-2#2)(2008-6#1)(2008-8#1)(2013-8#2)
differential equations and##2##3##(1993-5#1)(2008-9#1)
differential equations for##2##3##(2008-10#1)(2013-8#1)
differential equations##15##2##(1993-5#1)(2008-10#2)(2008-6#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2013-8#5)
differential expression of the##3##4##(1993-11#1)(1993-12#1)(1997-7#1)
differential expression of##4##3##(1992-10#1)(1993-11#1)(1993-12#1)(1997-7#1)
differential expression patterns##2##3##(1992-6#1)(2010-12#1)
differential expression##14##2##(1992-10#1)(1992-6#1)(1993-11#1)(1993-12#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
differential global positioning##2##3##(2008-10#1)(2009-10#1)
differential hosts composing the scale##2##5##(2008-10#2)
differential hosts##8##2##(2008-10#8)
differential hybridization##2##2##(1991-9#1)(1993-6#1)
differential interactions##2##2##(2008-10#2)
differential interference contrast##2##3##(2008-4#2)
differential isolates of##3##3##(2008-10#3)
differential kinetic method##3##3##(2008-10#3)
differential kinetic##5##2##(2008-10#5)
differential method is##2##3##(2008-10#1)(2008-3#1)
differential method##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
differential optical absorption spectroscopy##4##4##(2008-3#4)
differential pathogenicity##3##2##(2008-10#3)
differential protein##2##2##(2010-12#2)
differential pulse (DPV) and square wave##2##6##(2008-10#2)
differential pulse adsorption cathodic stripping voltammetry##2##6##(2008-10#2)
differential pulse adsorption##3##3##(2008-10#3)
differential pulse adsorptive##4##3##(2008-10#4)
differential pulse and square wave voltammetric techniques##3##7##(2008-10#3)
differential pulse and square wave voltammetry using##2##7##(2008-10#2)
differential pulse and square wave voltammetry##3##6##(2008-10#3)
differential pulse and square wave##6##5##(2008-10#6)
differential pulse anodic stripping voltammetric##3##5##(2008-10#3)
differential pulse anodic stripping voltammetry (DPASV)##4##6##(2008-10#4)
differential pulse anodic stripping voltammetry##16##5##(2008-10#16)
differential pulse anodic stripping##19##4##(2008-10#19)
differential pulse cathodic stripping voltammetry (DPCSV)##2##6##(2008-10#2)
differential pulse cathodic stripping voltammetry##4##5##(2008-10#4)
differential pulse cathodic stripping##6##4##(2008-10#6)
differential pulse cathodic##7##3##(2008-10#7)
differential pulse polarographic method has been developed for the determination of trace amount of##3##14##(2008-10#3)
differential pulse polarographic method has been developed for the##4##9##(2008-10#4)
differential pulse polarographic##7##3##(2008-10#7)
differential pulse polarography (DPP)##6##4##(2008-10#6)
differential pulse polarography##20##3##(2008-10#20)
differential pulse stripping method##2##4##(2008-10#2)
differential pulse stripping##5##3##(2008-10#5)
differential pulse voltammetric (DPV)##2##4##(2008-10#2)
differential pulse voltammetric determination##2##4##(2008-10#2)
differential pulse voltammetric method##2##4##(2008-10#2)
differential pulse voltammetric##9##3##(2008-10#9)
differential pulse voltammetry (DPV) technique##2##5##(2008-10#2)
differential pulse voltammetry (DPV)##10##4##(2008-10#10)
differential pulse voltammetry##21##3##(2008-10#21)
differential pulse##112##2##(2008-10#112)
differential reaction to##2##3##(2008-10#2)
differential reactions##2##2##(2008-10#2)
differential regulation of##2##3##(1996-12#1)(2008-11#1)
differential regulation##3##2##(1996-12#1)(2008-11#2)
differential resistance##2##2##(2008-10#2)
differential scanning calorimetry (DSC)##7##4##(1992-10#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#1)
differential scanning calorimetry##13##3##(1991-5#1)(1992-10#1)(1993-8#3)(2008-10#2)(2008-11#1)(2008-5#3)(2009-3#1)(2011-2#1)
differential scanning potentiometry (DSP)##2##4##(2008-10#2)
differential scanning##16##2##(1991-5#1)(1992-10#1)(1993-8#3)(1995-8#1)(2008-10#4)(2008-11#1)(2008-5#3)(2009-3#1)(2011-2#1)
differential scattering##2##2##(1990-12#1)(2008-3#1)
differential selection at a##2##4##(2008-8#2)
differential series##3##2##(2008-10#3)
differential set##4##2##(2008-10#4)
differential staining##4##2##(1997-8#1)(2008-5#1)(2008-9#2)
differential susceptibility##3##2##(2011-2#3)
differential technique##2##2##(2008-10#2)
differential thermal##2##2##(2008-10#2)
differential varieties##2##2##(2008-10#2)
differential##560##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#3)(1991-10#1)(1991-11#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#6)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#7)(1994-12#1)(1994-2#2)(1994-5#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#5)(1996-12#3)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#7)(2008-10#232)(2008-11#14)(2008-12#9)(2008-2#12)(2008-3#32)(2008-4#3)(2008-5#9)(2008-6#8)(2008-7#9)(2008-8#18)(2008-9#10)(2009-1#1)(2009-10#3)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#10)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#4)(2011-2#19)(2012-12#6)(2012-2#3)(2012-3#8)(2012-8#2)(2013-1#12)(2013-8#13)
differential-absorption lidar##2##2##(2008-3#2)
differential-pulse polarography##2##2##(2008-10#2)
differential-pulse##3##1##(2008-10#3)
differentially affected##2##2##(2008-7#1)(2009-8#1)
differentially expressed between##2##3##(2008-9#1)(2012-3#1)
differentially expressed by##2##3##(1992-2#1)(2010-1#1)
differentially expressed genes were##2##4##(2008-9#2)
differentially expressed genes##6##3##(2008-11#1)(2008-8#2)(2008-9#2)(2009-8#1)
differentially expressed in the##3##4##(2008-11#1)(2008-5#1)(2009-10#1)
differentially expressed in##7##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-5#1)
differentially expressed miRNAs##2##3##(2013-8#2)
differentially expressed probesets##2##3##(2012-3#2)
differentially expressed protein##2##3##(2011-3#2)
differentially expressed proteins##8##3##(2010-12#4)(2011-3#4)
differentially expressed##42##2##(1992-2#1)(1992-6#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#8)(2010-5#1)(2011-3#6)(2012-3#3)(2013-8#2)
differentially mediate##3##2##(1993-6#1)(1994-2#2)
differentially methylated##2##2##(1991-6#1)(2008-10#1)
differentially processed##2##2##(1993-6#1)(2008-11#1)
differentially regulated##2##2##(1996-12#1)(2009-9#1)
differentially susceptible##2##2##(2008-10#2)
differentially up-regulated##2##2##(2011-2#1)(2013-1#1)
differentially with##2##2##(1996-2#1)(2007-12#1)
differentially##92##1##(1991-6#1)(1992-2#1)(1992-6#1)(1993-6#2)(1994-2#2)(1995-2#3)(1995-9#1)(1996-12#2)(1996-2#2)(1997-7#1)(2007-12#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#6)(2009-10#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#8)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#6)(2012-3#3)(2013-1#3)(2013-8#3)
differentials and##2##2##(2008-10#2)
differentials in##2##2##(1994-2#1)(2008-10#1)
differentials was##2##2##(2008-10#2)
differentials##32##1##(1993-9#1)(1994-2#1)(2008-10#27)(2008-8#2)(2009-6#1)
differentiate abnormally and##2##3##(2008-9#2)
differentiate among##5##2##(1994-1#1)(2008-10#4)
differentiate between the##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
differentiate between##17##2##(1994-9#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#2)
differentiate each##2##2##(2008-10#2)
differentiate into neurons##2##3##(1994-11#1)(2008-7#1)
differentiate into##20##2##(1994-11#1)(2008-11#10)(2008-4#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-11#1)(2012-4#1)
differentiate isolates##2##2##(2008-10#2)
differentiate the two##2##3##(2008-10#1)(2010-10#1)
differentiate the##11##2##(2008-10#5)(2008-12#2)(2009-10#1)(2010-10#1)(2012-5#1)(2013-1#1)
differentiate them from##2##3##(2008-10#1)(2008-2#1)
differentiate these cells##2##3##(2008-11#1)(2008-9#1)
differentiate these##5##2##(2008-10#2)(2008-11#2)(2008-9#1)
differentiate##114##1##(1990-5#2)(1991-12#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#34)(2008-11#17)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#3)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2011-2#4)(2012-2#1)(2012-3#2)(2012-4#1)(2012-5#2)(2013-1#3)
differentiated KU812F cells##2##3##(2008-11#2)
differentiated SNPs##3##2##(2013-1#3)
differentiated according to##3##3##(2008-10#3)
differentiated and##5##2##(1990-9#1)(1991-2#1)(1993-8#2)(2008-5#1)
differentiated at the##2##3##(2008-10#2)
differentiated by##8##2##(1996-2#1)(2008-10#5)(2011-3#1)(2012-3#1)
differentiated carcinomas##2##2##(1994-11#2)
differentiated cell##2##2##(2008-11#1)(2008-8#1)
differentiated cells##2##2##(2008-11#1)(2008-9#1)
differentiated from each##2##3##(2008-10#1)(2008-5#1)
differentiated from other##4##3##(2008-10#1)(2008-12#1)(2010-6#1)(2013-1#1)
differentiated from the##3##3##(2008-10#3)
differentiated from##16##2##(1995-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
differentiated hepatocytes##2##2##(2008-11#1)(2012-2#1)
differentiated human##2##2##(2008-11#2)
differentiated in terms of##2##4##(2008-10#1)(2012-2#1)
differentiated in##4##2##(2008-10#2)(2008-8#1)(2012-2#1)
differentiated into several##2##3##(2008-5#1)(2008-8#1)
differentiated into##9##2##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
differentiated macrophages##2##2##(1995-6#2)
differentiated phenotype##5##2##(1994-11#1)(1994-6#1)(1995-11#3)
differentiated progeny##2##2##(1995-11#1)(2008-10#1)
differentiated them from##2##3##(2008-10#2)
differentiated thyroid cancer##2##3##(2011-2#1)(2013-1#1)
differentiated thyroid carcinoma##2##3##(2012-3#1)(2013-1#1)
differentiated thyroid##5##2##(1994-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
differentiated tissues##2##2##(1994-11#1)(2008-11#1)
differentiated##164##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1993-8#4)(1994-11#7)(1994-6#1)(1995-11#4)(1995-2#1)(1995-3#1)(1995-6#5)(1995-8#1)(1996-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#48)(2008-11#20)(2008-12#3)(2008-5#6)(2008-7#5)(2008-8#9)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#3)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#9)(2013-8#1)
differentiates the##2##2##(2008-10#1)(2010-10#1)
differentiates##8##1##(2008-10#3)(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
differentiating and##2##2##(1990-5#1)(2012-2#1)
differentiating between##6##2##(1990-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#2)
differentiating cells of the##2##4##(2008-9#1)(2009-10#1)
differentiating cells##3##2##(2008-9#2)(2009-10#1)
differentiating into##4##2##(2008-11#1)(2008-9#2)(2012-2#1)
differentiating the##7##2##(2008-10#4)(2009-5#1)(2010-1#1)(2012-5#1)
differentiating##60##1##(1990-2#1)(1990-5#2)(1993-8#1)(1994-11#1)(1995-11#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#5)
differentiation (G(ST) = 0##3##4##(2008-10#3)
differentiation among isolates##2##3##(2008-10#2)
differentiation among provinces##2##3##(2008-10#2)
differentiation among##22##2##(1996-3#1)(2008-10#18)(2008-8#2)(2013-8#1)
differentiation and activation##4##3##(1990-9#1)(1995-6#2)(2011-2#1)
differentiation and apoptosis##2##3##(1993-3#2)
differentiation and growth of##2##4##(2009-10#1)(2011-2#1)
differentiation and growth##3##3##(2008-11#1)(2009-10#1)(2011-2#1)
differentiation and maturation##2##3##(2009-12#1)(2013-7#1)
differentiation and mitogenesis##3##3##(1997-7#3)
differentiation and the##2##3##(2008-4#1)(2011-2#1)
differentiation and##48##2##(1990-9#1)(1993-11#2)(1993-3#3)(1994-2#1)(1995-2#1)(1995-6#2)(1997-3#1)(1997-7#3)(2008-10#5)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-7#1)(2009-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
differentiation are##5##2##(2008-4#1)(2008-9#2)(2009-10#1)(2010-12#1)
differentiation as##3##2##(2008-11#2)(2008-9#1)
differentiation assays##2##2##(2008-11#1)(2008-4#1)
differentiation at the##4##3##(2009-8#2)(2012-3#2)
differentiation at##7##2##(2008-10#1)(2009-8#2)(2012-3#4)
differentiation between the##3##3##(2008-10#2)(2008-5#1)
differentiation between##21##2##(1991-3#1)(1995-2#1)(1996-3#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-9#2)(2012-3#1)
differentiation but##4##2##(1991-5#1)(1992-6#1)(1994-11#1)(2008-11#1)
differentiation by a##2##3##(1994-11#1)(2008-10#1)
differentiation by##9##2##(1990-5#1)(1994-11#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)
differentiation could be##2##3##(2008-10#2)
differentiation culture##2##2##(2008-11#1)(2008-4#1)
differentiation cultures##3##2##(2008-11#1)(2008-4#2)
differentiation during##2##2##(2010-9#1)(2011-2#1)
differentiation even##2##2##(2008-11#1)(2012-3#1)
differentiation from##5##2##(1991-6#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-12#1)
differentiation have been##2##3##(2008-11#1)(2010-5#1)
differentiation have##3##2##(2007-12#1)(2008-11#1)(2010-5#1)
differentiation in P19##2##3##(1994-11#2)
differentiation in SFME cells##2##4##(2008-11#2)
differentiation in a##2##3##(2008-10#1)(2008-11#1)
differentiation in the##6##3##(2008-10#1)(2008-11#3)(2008-5#2)
differentiation in vitro##5##3##(1993-8#1)(2008-11#2)(2008-9#1)(2009-10#1)
differentiation in##38##2##(1990-6#1)(1991-5#1)(1993-11#1)(1993-8#1)(1994-11#2)(1995-12#1)(1997-7#1)(2008-10#5)(2008-11#16)(2008-5#3)(2008-8#1)(2008-9#4)(2009-10#1)
differentiation induced by##2##3##(1994-11#1)(2008-11#1)
differentiation induced##3##2##(1994-11#1)(2008-11#2)
differentiation into an##2##3##(2008-11#1)(2009-8#1)
differentiation into astrocytes##2##3##(2008-11#2)
differentiation into multiple lineages##2##4##(2008-11#1)(2010-6#1)
differentiation into##11##2##(1995-12#1)(2008-11#6)(2008-9#1)(2009-8#1)(2010-6#1)(2013-1#1)
differentiation is accompanied by##2##4##(1993-8#1)(1994-11#1)
differentiation is##9##2##(1990-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1997-2#1)(2008-9#2)(2012-3#2)
differentiation markers##3##2##(1996-2#1)(1997-7#1)(2008-5#1)
differentiation observed##2##2##(2008-10#2)
differentiation occurred##2##2##(2008-10#1)(2008-6#1)
differentiation occurring##2##2##(1994-3#1)(2009-1#1)
differentiation of erythroid##2##3##(2008-11#1)(2008-9#1)
differentiation of human##6##3##(2008-11#3)(2008-7#1)(2009-10#2)
differentiation of limb mesenchymal cells##2##5##(1994-11#2)
differentiation of male and female##2##5##(2008-12#2)
differentiation of many cell types##2##5##(1993-6#1)(2008-11#1)
differentiation of many##3##3##(1993-6#2)(2008-11#1)
differentiation of the##23##3##(1990-11#1)(1991-6#1)(1991-7#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-10#10)(2008-11#1)(2009-8#1)(2011-2#1)
differentiation of these cells##2##4##(1993-3#1)(2008-11#1)
differentiation of this##2##3##(1990-5#1)(2008-7#1)
differentiation of various human myeloid leukemia cell lines##2##8##(1993-3#2)
differentiation of various##3##3##(1993-3#3)
differentiation of##122##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-6#2)(1991-7#1)(1993-3#4)(1993-6#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-8#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-6#1)(1997-7#3)(2008-10#29)(2008-11#19)(2008-12#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-7#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#2)
differentiation pathway##2##2##(2008-4#1)(2008-7#1)
differentiation potential of##2##3##(2008-11#2)
differentiation potential##4##2##(2008-11#4)
differentiation process of##2##3##(1991-11#1)(2008-7#1)
differentiation process##5##2##(1991-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
differentiation processes##2##2##(2008-11#1)(2012-3#1)
differentiation programs of##2##3##(1995-2#1)(1995-6#1)
differentiation regulator##2##2##(2008-8#1)(2010-7#1)
differentiation therapy##2##2##(1993-3#1)(2011-2#1)
differentiation to##5##2##(1994-12#1)(2007-12#1)(2008-11#1)(2009-6#1)(2012-4#1)
differentiation was detected##2##3##(2008-10#2)
differentiation was significantly##2##3##(2008-10#1)(2008-11#1)
differentiation was##15##2##(1994-11#1)(2008-10#6)(2008-11#6)(2008-5#1)(2012-3#1)
differentiation were##7##2##(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
differentiation within##2##2##(2008-10#1)(2008-11#1)
differentiation without##2##2##(1993-3#1)(2008-10#1)
differentiation##620##1##(1990-11#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#3)(1992-2#3)(1992-6#4)(1993-11#3)(1993-12#1)(1993-3#13)(1993-6#4)(1993-8#5)(1994-1#2)(1994-11#12)(1994-12#7)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-6#7)(1995-8#4)(1996-12#2)(1996-2#4)(1996-3#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#15)(2007-12#4)(2008-10#109)(2008-11#131)(2008-12#5)(2008-2#1)(2008-4#12)(2008-5#16)(2008-6#6)(2008-7#7)(2008-8#24)(2008-9#33)(2009-1#2)(2009-10#8)(2009-11#1)(2009-12#4)(2009-6#2)(2009-7#3)(2009-8#8)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#4)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#24)(2012-12#3)(2012-2#15)(2012-3#17)(2012-4#2)(2012-5#1)(2013-1#10)(2013-7#3)(2013-8#3)
differentiation-specific##2##1##(1993-6#1)(2008-5#1)
differentiations in the size of a group alone may have predisposed a group to either favorable or unfavorable comparisons to national standards##2##22##(1994-3#2)
differentiations##3##1##(1994-3#2)(2010-8#1)
differentiative##2##1##(2008-10#2)
differently and##2##2##(2008-10#1)(2008-11#1)
differently depending on##2##3##(1996-2#1)(2010-11#1)
differently from##5##2##(1990-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
differently in##3##2##(1991-1#1)(1995-2#1)(2008-10#1)
differently on the##2##3##(2008-9#1)(2011-2#1)
differently than##4##2##(1990-2#1)(2008-4#2)(2013-8#1)
differently to##2##2##(1995-8#1)(2008-10#1)
differently with the##2##3##(2008-8#1)(2009-12#1)
differently with##3##2##(1996-3#1)(2008-8#1)(2009-12#1)
differently##48##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#4)(2012-2#1)(2012-3#1)(2012-5#2)(2013-8#2)
differently?##2##1##(1994-1#1)(2009-10#1)
differing degrees##2##2##(1997-3#1)(2008-10#1)
differing from##3##2##(2008-10#2)(2008-8#1)
differing in susceptibility to##2##4##(2008-10#2)
differing in their##4##3##(2008-10#3)(2010-3#1)
differing in##22##2##(1994-3#1)(1995-12#2)(2008-10#9)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-6#1)(2013-1#1)
differing potencies##2##2##(1991-3#1)(2008-12#1)
differing##65##1##(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-12#4)(1995-2#1)(1996-12#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#5)(2008-3#3)(2008-7#1)(2008-8#5)(2008-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-6#1)(2013-1#2)
differs among##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
differs and##2##2##(2008-7#2)
differs between##3##2##(1993-3#1)(2008-11#1)(2008-8#1)
differs from other##4##3##(1996-12#1)(1997-3#1)(2008-3#1)(2011-2#1)
differs from that in##3##4##(1997-5#1)(2008-7#1)(2012-2#1)
differs from that of##3##4##(1995-2#1)(2007-12#1)(2008-11#1)
differs from that##8##3##(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
differs from the##13##3##(1991-9#1)(1993-6#1)(1994-5#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2012-2#1)
differs from##36##2##(1991-9#1)(1992-2#1)(1993-6#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
differs in##4##2##(2008-10#2)(2008-7#1)(2008-9#1)
differs significantly##4##2##(1994-5#1)(2008-10#1)(2008-6#1)(2008-9#1)
differs##62##1##(1991-9#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#2)(1995-2#1)(1996-12#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
difficile##7##1##(2010-11#1)(2011-2#4)(2013-1#2)
difficult and##16##2##(1990-12#1)(1990-5#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-3#1)(2013-1#1)
difficult as##4##2##(1992-9#1)(2008-10#1)(2008-12#2)
difficult because of the##3##4##(2008-10#1)(2009-7#1)(2010-12#1)
difficult because of##7##3##(2008-10#2)(2008-7#2)(2009-7#1)(2010-12#1)(2012-12#1)
difficult because the##2##3##(2008-10#1)(2008-3#1)
difficult because##16##2##(2008-10#5)(2008-3#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#2)
difficult cases##2##2##(2011-2#1)(2012-2#1)
difficult diagnosis##2##2##(1990-9#1)(1992-5#1)
difficult due to a##2##4##(2008-10#1)(2008-5#1)
difficult for##7##2##(1994-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2013-8#1)
difficult in##5##2##(1996-2#1)(1997-6#1)(2008-12#1)(2010-11#1)(2011-2#1)
difficult on##2##2##(1992-5#1)(2008-4#1)
difficult or impossible to##2##4##(1997-8#1)(2008-8#1)
difficult or##4##2##(1997-3#1)(1997-8#1)(2008-11#1)(2008-8#1)
difficult problem##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2010-6#1)
difficult task##6##2##(1990-9#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
difficult tasks##2##2##(2008-10#2)
difficult to achieve##7##3##(1992-3#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
difficult to apply##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
difficult to assess##3##3##(2008-11#2)(2012-3#1)
difficult to be##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
difficult to control##2##3##(2008-10#1)(2011-2#1)
difficult to define##2##3##(2010-10#1)(2013-8#1)
difficult to detect##8##3##(1994-11#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)
difficult to determine##5##3##(1993-2#1)(1995-12#1)(2008-10#2)(2008-2#1)
difficult to diagnose because##2##4##(2008-10#1)(2011-2#1)
difficult to diagnose##8##3##(1997-4#1)(2008-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
difficult to differentiate##3##3##(2008-12#2)(2012-2#1)
difficult to distinguish##3##3##(2008-10#1)(2012-9#1)(2013-8#1)
difficult to estimate##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
difficult to evaluate the##2##4##(1990-2#1)(2008-11#1)
difficult to evaluate##5##3##(1990-2#1)(2008-10#1)(2008-11#1)(2010-6#1)(2013-8#1)
difficult to identify##5##3##(2008-10#3)(2011-2#1)(2012-3#1)
difficult to implement##3##3##(2008-8#1)(2012-2#2)
difficult to make##3##3##(2008-7#1)(2009-8#1)(2013-8#1)
difficult to manage##3##3##(1996-2#1)(2008-10#1)(2012-3#1)
difficult to measure##2##3##(2012-2#1)(2013-1#1)
difficult to obtain by##2##4##(1991-2#1)(2008-10#1)
difficult to obtain in##2##4##(2008-10#1)(2008-9#1)
difficult to obtain##11##3##(1991-2#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#1)
difficult to perform##2##3##(2008-11#1)(2011-2#1)
difficult to preserve##2##3##(2008-5#1)(2012-2#1)
difficult to quantify##2##3##(1994-6#1)(2008-11#1)
difficult to reach##2##3##(1991-2#1)(1997-3#1)
difficult to resolve##2##3##(2008-11#1)(2010-12#1)
difficult to separate##2##3##(2008-10#1)(2008-7#1)
difficult to study because##2##4##(2008-10#1)(2008-9#1)
difficult to study##4##3##(2008-10#2)(2008-9#1)(2010-12#1)
difficult to treat##5##3##(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
difficult to understand##2##3##(1990-2#1)(2008-8#1)
difficult to##169##2##(1990-2#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#2)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-9#1)(2008-1#1)(2008-10#35)(2008-11#14)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#6)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#3)(2010-11#1)(2010-12#6)(2010-3#1)(2010-5#1)(2010-6#5)(2011-2#14)(2012-12#2)(2012-2#6)(2012-3#3)(2012-9#1)(2013-1#8)(2013-8#5)
difficult when##3##2##(1992-9#1)(2008-10#1)(2010-12#1)
difficult##350##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-6#2)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2008-1#3)(2008-10#61)(2008-11#24)(2008-12#13)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#11)(2008-8#9)(2008-9#15)(2009-1#3)(2009-12#2)(2009-5#1)(2009-7#2)(2009-8#5)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#9)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#7)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#23)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#11)(2012-3#9)(2012-9#1)(2013-1#16)(2013-8#11)
difficult-to-treat##2##1##(2008-12#1)(2009-11#1)
difficulties after the##2##3##(1994-3#1)(2008-12#1)
difficulties and their##2##3##(2010-1#1)(2012-3#1)
difficulties and##13##2##(2008-10#1)(2008-11#2)(2010-1#1)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
difficulties associated with##3##3##(1995-2#1)(2008-11#1)(2013-1#1)
difficulties associated##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
difficulties caused by##2##3##(2008-11#1)(2008-12#1)
difficulties due to##2##3##(2008-7#1)(2010-12#1)
difficulties encountered in##3##3##(1995-11#1)(1997-3#1)(2008-11#1)
difficulties encountered with##2##3##(1996-12#1)(2008-10#1)
difficulties encountered##6##2##(1995-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
difficulties faced by##3##3##(1992-3#1)(2008-11#1)(2011-2#1)
difficulties for##2##2##(2008-12#1)(2012-3#1)
difficulties have##2##2##(2008-10#1)(2008-11#1)
difficulties in interpreting##2##3##(1996-3#1)(2013-1#1)
difficulties in mobility##3##3##(2008-7#3)
difficulties in nursing practice##2##4##(2008-11#2)
difficulties in the##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
difficulties in walking##2##3##(2008-7#2)
difficulties in##30##2##(1992-3#1)(1992-5#1)(1993-12#1)(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#6)(2009-12#1)(2010-11#1)(2010-9#2)(2011-1#2)(2011-2#1)(2013-1#1)
difficulties of##11##2##(1991-6#1)(1992-5#1)(1995-12#1)(2008-10#1)(2008-11#3)(2009-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
difficulties that##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
difficulties they##2##2##(1996-1#1)(2008-12#1)
difficulties to##3##2##(2008-10#1)(2011-2#2)
difficulties with##4##2##(2008-11#1)(2008-12#2)(2013-1#1)
difficulties##136##1##(1990-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-5#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-8#1)(2008-10#11)(2008-11#27)(2008-12#8)(2008-2#1)(2008-5#2)(2008-7#9)(2008-9#2)(2009-10#4)(2009-12#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#5)(2011-1#5)(2011-2#10)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#3)
difficulty communicating##2##2##(2010-4#1)(2011-1#1)
difficulty in accessing##2##3##(2008-11#1)(2008-12#1)
difficulty in attracting##2##3##(1996-8#1)(2008-11#1)
difficulty in diagnosis##2##3##(2008-10#1)(2010-12#1)
difficulty in obtaining##2##3##(2008-10#1)(2008-9#1)
difficulty in##40##2##(1991-3#1)(1992-9#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-5#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#3)(2011-7#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
difficulty is##2##2##(2008-10#1)(2013-1#1)
difficulty of the##5##3##(1997-2#1)(2008-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
difficulty of##24##2##(1992-12#1)(1992-3#1)(1995-2#2)(1997-2#1)(2008-10#4)(2008-11#5)(2008-9#1)(2009-5#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
difficulty to##4##2##(1993-6#1)(2008-5#2)(2011-2#1)
difficulty with##6##2##(1994-11#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-3#2)
difficulty##103##1##(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-5#1)(2008-10#12)(2008-11#19)(2008-12#4)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#6)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#8)(2013-8#1)
diffract##3##1##(1992-11#1)(2008-8#2)
diffracted##3##1##(2007-11#1)(2008-3#2)
diffraction (XRD) analysis##2##3##(2009-7#1)(2010-4#1)
diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR)##2##8##(2008-10#2)
diffraction (XRD) and##6##3##(2008-10#6)
diffraction (XRD)##14##2##(2008-10#12)(2009-7#1)(2010-4#1)
diffraction analysis##6##2##(1992-11#1)(2008-10#2)(2010-4#1)(2010-8#1)(2011-2#1)
diffraction and##13##2##(1994-5#1)(1995-3#1)(2008-10#6)(2008-11#3)(2008-5#2)
diffraction data##3##2##(1991-5#1)(1992-9#1)(2008-8#1)
diffraction efficiency and##2##3##(2008-3#2)
diffraction efficiency as##2##3##(2008-3#2)
diffraction efficiency of##3##3##(2008-3#3)
diffraction efficiency##13##2##(2008-2#4)(2008-3#9)
diffraction from##2##2##(1992-11#1)(2008-3#1)
diffraction grating##4##2##(2007-12#2)(2008-2#2)
diffraction gratings##6##2##(2007-12#1)(2008-3#5)
diffraction integral##2##2##(2008-3#2)
diffraction losses##2##2##(2008-3#2)
diffraction method##2##2##(2008-3#1)(2013-8#1)
diffraction of the##2##3##(2009-5#1)(2010-4#1)
diffraction of##4##2##(1992-8#1)(2008-3#1)(2009-5#1)(2010-4#1)
diffraction orders##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
diffraction pattern##5##2##(2008-3#5)
diffraction patterns##3##2##(1992-9#1)(2008-10#2)
diffraction spectrometry##3##2##(2008-10#2)(2008-3#1)
diffraction theory##5##2##(2008-2#1)(2008-3#4)
diffraction##133##1##(1991-5#2)(1991-6#1)(1992-11#2)(1992-4#1)(1992-8#1)(1992-9#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-12#5)(2008-10#28)(2008-11#3)(2008-2#11)(2008-3#46)(2008-5#7)(2008-8#1)(2008-9#3)(2009-5#1)(2009-7#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-8#3)
diffraction-limited##2##1##(2007-11#1)(2008-2#1)
diffractive element##2##2##(2008-3#2)
diffractive elements##2##2##(2008-2#1)(2008-3#1)
diffractive optical element##5##3##(2008-3#5)
diffractive optical elements (DOEs)##2##4##(2008-3#2)
diffractive optical elements##6##3##(2008-3#6)
diffractive optical##12##2##(2008-3#12)
diffractive##24##1##(2008-2#2)(2008-3#22)
diffus aux deux##2##3##(2013-1#2)
diffuse PVNS##2##2##(2013-1#2)
diffuse atmospheric##2##2##(2008-11#2)
diffuse attenuation coefficient##3##3##(2008-2#1)(2008-3#2)
diffuse bronchoconstriction##2##2##(1996-3#2)
diffuse form##2##2##(2013-1#2)
diffuse into the##2##3##(1993-2#1)(2008-5#1)
diffuse into##3##2##(1993-2#1)(2008-10#1)(2008-5#1)
diffuse irradiance##3##2##(2008-2#2)(2008-3#1)
diffuse large B-cell lymphoma (DLBCL)##2##5##(2009-8#2)
diffuse large B-cell lymphoma##3##4##(2009-8#2)(2013-8#1)
diffuse large B-cell##6##3##(2009-8#5)(2013-8#1)
diffuse large##8##2##(2009-8#5)(2013-1#2)(2013-8#1)
diffuse media##3##2##(2008-3#3)
diffuse metastases##2##2##(1994-12#1)(1994-6#1)
diffuse pulmonary##2##2##(1991-12#1)(2011-2#1)
diffuse reflectance infrared Fourier transform spectroscopy##2##6##(2008-10#2)
diffuse reflectance infrared Fourier transform##3##5##(2008-10#3)
diffuse reflectance infrared Fourier##4##4##(2008-10#4)
diffuse reflectance infrared##5##3##(2008-10#5)
diffuse reflectance spectra and their first derivative spectra##2##8##(2008-10#2)
diffuse reflectance spectra##3##3##(2008-10#3)
diffuse reflectance spectroscopy##4##3##(2008-10#4)
diffuse reflectance##21##2##(2008-10#20)(2008-3#1)
diffuse reflection##3##2##(2008-2#2)(2013-8#1)
diffuse subarachnoid hemorrhage on##2##4##(2012-3#2)
diffuse subarachnoid hemorrhage##3##3##(2012-3#3)
diffuse traumatic brain injury##2##4##(2008-7#2)
diffuse##146##1##(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#10)(1991-8#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1996-3#2)(1997-1#2)(1997-8#2)(2007-12#1)(2008-10#29)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#16)(2008-5#3)(2008-7#6)(2008-8#1)(2009-1#1)(2009-8#6)(2009-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#12)(2013-8#3)
diffuse-reflectance##2##1##(2008-10#1)(2010-4#1)
diffused through the##2##3##(2008-10#2)
diffused through##3##2##(2008-10#3)
diffused##11##1##(1990-6#1)(1991-5#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)
diffusely distributed##2##2##(1994-2#1)(2007-12#1)
diffusely##10##1##(1994-2#1)(1997-1#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
diffuser##3##1##(2008-3#3)
diffusible##10##1##(1990-7#1)(1994-12#3)(2008-10#5)(2013-8#1)
diffusing into##2##2##(1991-5#1)(2008-10#1)
diffusing##11##1##(1991-5#1)(1997-6#1)(2007-12#4)(2008-10#3)(2008-3#1)(2009-6#1)
diffusion across the skin##2##4##(2008-11#2)
diffusion across the##5##3##(1991-5#2)(2008-10#1)(2008-11#2)
diffusion analysis##2##2##(2009-7#1)(2012-2#1)
diffusion and the##3##3##(1992-12#1)(2011-2#1)(2012-2#1)
diffusion and##13##2##(1990-6#1)(1992-12#2)(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#2)
diffusion cells##4##2##(2008-5#3)(2011-3#1)
diffusion coefficient and##3##3##(2008-10#1)(2008-9#1)(2009-11#1)
diffusion coefficient in##2##3##(2008-10#1)(2008-5#1)
diffusion coefficient of##2##3##(2008-10#1)(2008-7#1)
diffusion coefficient values of In(III) in potassium chloride and##2##9##(2008-10#2)
diffusion coefficient##23##2##(2008-10#13)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#2)(2010-12#2)
diffusion coefficients for##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
diffusion coefficients of##3##3##(2008-10#2)(2008-7#1)
diffusion coefficients were##3##3##(2008-10#2)(2008-7#1)
diffusion coefficients##16##2##(1991-5#1)(1997-6#1)(2008-10#8)(2008-5#1)(2008-7#3)(2010-4#1)(2012-2#1)
diffusion coefficients)##2##2##(2008-10#2)
diffusion controlled##6##2##(2008-10#4)(2008-9#1)(2012-2#1)
diffusion controlling##2##2##(2008-10#2)
diffusion deposition##2##2##(2008-11#2)
diffusion flame##2##2##(2008-3#2)
diffusion flames##2##2##(2008-3#2)
diffusion from skin##3##3##(2008-5#3)
diffusion from##5##2##(1997-1#1)(2008-10#1)(2008-5#3)
diffusion has been##2##3##(2008-10#1)(2010-10#1)
diffusion in the##2##3##(2008-10#2)
diffusion in##10##2##(1990-6#1)(1992-8#1)(2008-10#4)(2008-3#1)(2010-10#1)(2010-4#1)(2013-1#1)
diffusion is##6##2##(1993-12#1)(2008-1#1)(2008-3#1)(2008-8#2)(2013-8#1)
diffusion layer##4##2##(1990-12#1)(2008-10#3)
diffusion mechanism##2##2##(2008-10#1)(2008-11#1)
diffusion method##7##2##(2008-12#2)(2008-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
diffusion model##4##2##(2008-10#2)(2008-3#1)(2009-12#1)
diffusion of ions##2##3##(2008-10#1)(2008-8#1)
diffusion of the##8##3##(1990-9#1)(1994-5#1)(2007-12#1)(2008-10#5)
diffusion of##26##2##(1990-9#1)(1991-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
diffusion process##3##2##(1992-3#1)(2008-5#1)(2008-6#1)
diffusion properties##2##2##(2012-2#2)
diffusion rate##2##2##(2008-11#1)(2013-8#1)
diffusion rates##4##2##(2008-10#1)(2008-8#1)(2013-8#2)
diffusion reflectance spectroscopic detection was evaluated##2##6##(2008-10#2)
diffusion sequential injection system for##2##5##(2008-10#2)
diffusion technique##2##2##(1992-11#1)(2008-7#1)
diffusion theory##3##2##(2008-3#2)(2010-10#1)
diffusion through##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
diffusion to the##2##3##(2008-10#2)
diffusion to##4##2##(2008-10#4)
diffusion with##2##2##(2008-10#1)(2008-5#1)
diffusion within the##2##3##(1991-5#1)(2008-10#1)
diffusion##268##1##(1990-12#2)(1990-6#3)(1990-9#1)(1991-5#6)(1992-11#1)(1992-12#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-8#2)(1994-12#1)(1994-5#1)(1995-1#1)(1997-1#1)(1997-6#6)(2007-12#2)(2008-1#1)(2008-10#90)(2008-11#12)(2008-12#3)(2008-3#12)(2008-5#15)(2008-6#2)(2008-7#13)(2008-8#7)(2008-9#6)(2009-11#3)(2009-12#1)(2009-7#2)(2009-9#1)(2010-10#8)(2010-12#8)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#14)(2012-3#3)(2013-1#7)(2013-8#12)
diffusion-controlled process##2##2##(2008-10#2)
diffusion-controlled with limited adsorption properties##2##5##(2008-10#2)
diffusion-controlled##10##1##(2008-10#10)
diffusion-flow injection##5##2##(2008-10#5)
diffusion-weighted imaging##2##2##(2010-12#2)
diffusion-weighted##7##1##(2008-11#1)(2008-7#1)(2009-11#2)(2010-12#2)(2013-8#1)
diffusional limitations##2##2##(2008-11#1)(2008-7#1)
diffusional##4##1##(1997-6#1)(2008-11#1)(2008-7#2)
diffusive gradient in thin films##2##5##(2008-10#2)
diffusive samplers##2##2##(2008-10#2)
diffusive##16##1##(1991-9#1)(1992-9#1)(2008-10#10)(2008-2#3)(2008-8#1)
diffusivity##6##1##(2008-3#5)(2012-2#1)
difluoride (PVDF)##2##2##(2008-11#1)(2008-7#1)
difluoride##3##1##(2008-11#1)(2008-7#1)(2012-2#1)
digastric EMG##3##2##(1990-9#3)
digastric##6##1##(1990-9#6)
digenic epistatic interactions##2##3##(2008-10#2)
digenic##5##1##(2008-10#5)
digest of##5##2##(1990-8#1)(1992-12#1)(1993-9#1)(1997-2#1)(2008-8#1)
digest##14##1##(1990-8#1)(1992-12#1)(1992-6#1)(1993-9#1)(1997-2#2)(2008-10#6)(2008-11#1)(2008-8#1)
digested and the##2##3##(1990-12#1)(1992-6#1)
digested and##6##2##(1990-12#1)(1992-6#1)(2008-10#4)
digested by a suitably##2##4##(2008-10#2)
digested by a##3##3##(1995-8#1)(2008-10#2)
digested by##10##2##(1993-8#2)(1995-8#1)(2008-10#6)(2009-3#1)
digested in a##2##3##(2008-10#2)
digested in##4##2##(2008-10#4)
digested sample##5##2##(2008-10#5)
digested samples##7##2##(2008-10#7)
digested solutions##3##2##(2008-10#3)
digested with EcoRI##2##3##(1993-2#1)(2008-10#1)
digested with nitric acid##2##4##(2008-10#2)
digested with trypsin##2##3##(1990-2#1)(1997-2#1)
digested with##20##2##(1990-2#1)(1990-5#2)(1991-6#1)(1993-2#1)(1994-11#1)(1996-12#1)(1997-2#2)(2008-10#10)(2008-8#1)
digested##72##1##(1990-12#1)(1990-2#1)(1990-5#2)(1991-6#1)(1992-6#2)(1993-2#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-8#2)(1996-12#1)(1997-2#2)(2008-10#51)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)
digestibility of##3##2##(2008-10#2)(2013-1#1)
digestibility##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
digestible##5##1##(1990-5#1)(1993-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
digesting##3##1##(1995-8#1)(2008-10#1)(2012-3#1)
digestion and UV##2##3##(2008-10#2)
digestion and##21##2##(1990-5#2)(1992-6#1)(1993-12#1)(1993-8#1)(2008-10#14)(2012-2#1)(2012-3#1)
digestion by##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2010-11#1)
digestion conditions##2##2##(2008-10#2)
digestion for the##2##3##(2008-10#2)
digestion for##11##2##(2008-10#11)
digestion has been developed##2##4##(2008-10#1)(2011-2#1)
digestion in##3##2##(2008-10#3)
digestion is##3##2##(2008-10#2)(2012-3#1)
digestion method were##2##3##(2008-10#2)
digestion method##9##2##(2008-10#9)
digestion methods##11##2##(2008-10#11)
digestion of samples##6##3##(2008-10#6)
digestion of the samples in##3##5##(2008-10#3)
digestion of the samples##5##4##(2008-10#5)
digestion of the##18##3##(1990-2#1)(1990-5#1)(1991-5#1)(1994-11#1)(1996-12#1)(2008-10#12)(2008-2#1)
digestion of##49##2##(1990-2#1)(1990-5#2)(1991-5#2)(1992-12#2)(1992-4#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-12#2)(2008-10#27)(2008-2#1)(2008-4#3)(2008-9#1)(2010-8#1)
digestion patterns##2##2##(2008-10#2)
digestion procedure and##2##3##(2008-10#2)
digestion procedure by##2##3##(2008-10#2)
digestion procedure for##2##3##(2008-10#2)
digestion procedure was##2##3##(2008-10#2)
digestion procedure##15##2##(2008-10#15)
digestion procedures for##3##3##(2008-10#3)
digestion procedures were##2##3##(2008-10#2)
digestion procedures##9##2##(2008-10#9)
digestion showed##2##2##(2008-10#1)(2008-11#1)
digestion solution##3##2##(2008-10#2)(2008-11#1)
digestion system##6##2##(2008-10#6)
digestion the##3##2##(1995-6#1)(2008-10#2)
digestion time##3##2##(2008-10#3)
digestion to##2##2##(1994-8#1)(2008-10#1)
digestion under##2##2##(2008-10#2)
digestion using##4##2##(2008-10#4)
digestion vessel##2##2##(2008-10#2)
digestion was used to##2##4##(2008-10#1)(2008-8#1)
digestion was used##3##3##(2008-10#2)(2008-8#1)
digestion was##8##2##(2008-10#7)(2008-8#1)
digestion with AluI##2##3##(2008-10#2)
digestion with HNO(3)##2##3##(2008-10#2)
digestion with a##2##3##(2008-10#2)
digestion with four##2##3##(2008-10#2)
digestion with nitric acid##2##4##(2008-10#2)
digestion with##21##2##(1990-2#1)(1990-5#1)(1992-6#1)(2008-1#2)(2008-10#16)
digestion without##2##2##(2008-10#2)
digestion##272##1##(1990-12#3)(1990-2#3)(1990-5#5)(1991-5#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#3)(1993-12#1)(1993-8#6)(1994-11#1)(1994-5#2)(1994-8#3)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#2)(1996-2#1)(1997-1#1)(2008-1#2)(2008-10#201)(2008-11#6)(2008-2#1)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#4)
digestion-hydride##4##1##(2008-10#4)
digestions of##2##2##(1992-4#1)(2008-10#1)
digestions##9##1##(1992-4#1)(1995-11#1)(1995-6#1)(2008-10#4)(2008-8#2)
digestive disorders##2##2##(1995-2#1)(2008-10#1)
digestive endoscopy##2##2##(1992-9#1)(2013-1#1)
digestive gland##3##2##(2008-10#2)(2008-11#1)
digestive hemorrhage##4##2##(1991-11#2)(1992-5#2)
digestive system and##2##3##(2007-8#1)(2011-1#1)
digestive system##5##2##(2007-8#1)(2008-10#1)(2009-6#1)(2011-1#1)(2011-2#1)
digestive tract of##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
digestive tract##19##2##(1990-8#2)(2007-8#1)(2008-10#4)(2008-11#2)(2009-5#1)(2011-2#5)(2012-2#3)(2012-3#1)
digestive##60##1##(1990-8#2)(1991-11#2)(1991-3#1)(1992-5#2)(1992-9#1)(1993-11#1)(1995-2#1)(1997-7#1)(2007-12#4)(2007-8#2)(2008-10#13)(2008-11#5)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#2)
digests and##3##2##(2008-10#3)
digests of##11##2##(1990-8#2)(1992-8#1)(2008-10#8)
digests##24##1##(1990-8#2)(1992-8#1)(2008-10#20)(2008-7#1)
digging##2##1##(1993-3#1)(2007-12#1)
digit##7##1##(2008-9#3)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
digital Pacinian corpuscle hyperplasia##2##4##(2008-12#2)
digital abnormalities##2##2##(1997-3#2)
digital hologram##2##2##(2007-12#1)(2008-3#1)
digital holography##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
digital image analysis technique##2##4##(2008-10#2)
digital image analysis##6##3##(2008-10#5)(2012-2#1)
digital image##8##2##(2008-10#5)(2008-11#1)(2010-8#1)(2012-2#1)
digital images of the##2##4##(2008-5#1)(2008-6#1)
digital images##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-8#1)
digital imaging##4##2##(1992-6#1)(1996-2#1)(2008-1#1)(2008-11#1)
digital radio##2##2##(2009-3#2)
digital radiography##2##2##(1991-12#1)(2009-9#1)
digital rectal examination##2##3##(1991-7#1)(2008-7#1)
digital rectal examinations##3##3##(1991-7#2)(1994-12#1)
digital rectal##5##2##(1991-7#3)(1994-12#1)(2008-7#1)
digital revascularization##3##2##(2008-9#3)
digital subtraction angiography (DSA)##2##4##(1993-8#1)(2008-7#1)
digital subtraction angiography##7##3##(1993-8#2)(2008-7#3)(2011-2#2)
digital versatile##2##2##(2008-3#2)
digital##102##1##(1991-12#1)(1991-7#3)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-3#3)(1997-8#1)(2007-11#2)(2007-12#6)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#2)
digitalis##2##1##(1992-5#1)(1992-7#1)
digitatum were##3##2##(2008-10#3)
digitatum##15##1##(2008-10#15)
digitization##3##1##(2008-10#1)(2012-12#2)
digitized##4##1##(1991-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
digitorum longus##4##2##(2008-12#1)(2008-9#2)(2010-3#1)
digitorum##8##1##(2008-12#1)(2008-5#2)(2008-9#2)(2010-3#1)(2010-5#2)
digits##6##1##(1996-2#1)(2008-9#4)(2009-5#1)
dignity and##2##2##(1990-6#1)(2011-2#1)
dignity in##2##2##(2010-10#2)
dignity is presented in the main theme##2##7##(2010-10#2)
dignity##12##1##(1990-6#1)(1991-8#1)(1993-1#1)(2010-10#6)(2011-2#1)(2012-12#2)
digoxigenin##4##1##(2008-10#3)(2008-12#1)
digoxigenin-dUTP##2##1##(2008-10#2)
digoxigenin-labeled##4##1##(1996-12#1)(2008-10#3)
digoxin##3##1##(2008-7#1)(2009-10#2)
dihaloacetonitriles and halophenols##2##3##(2008-10#2)
dihedral angle##4##2##(1993-8#3)(2008-8#1)
dihedral##6##1##(1993-8#3)(2008-10#1)(2008-3#1)(2008-8#1)
diheptanoyl-PI##2##1##(1993-8#2)
dihydralazine##3##1##(2008-10#3)
dihydroberberine##3##1##(2008-11#3)
dihydrochloride##9##1##(1995-11#1)(1996-1#1)(1996-2#1)(2008-10#6)
dihydrodiol##2##1##(1990-11#2)
dihydroetorphine##6##1##(1995-11#6)
dihydrofolate reductase##7##2##(1990-8#1)(1992-8#1)(2008-11#4)(2011-1#1)
dihydrofolate##8##1##(1990-8#1)(1992-8#1)(2008-11#5)(2011-1#1)
dihydrogen phosphate##3##2##(2008-10#2)(2008-5#1)
dihydrogen##4##1##(2008-10#2)(2008-3#1)(2008-5#1)
dihydrokainic acid##2##2##(2008-7#1)(2008-8#1)
dihydrolipoamide dehydrogenase##4##2##(1995-6#4)
dihydroorotate dehydrogenase##2##2##(1993-2#2)
dihydropyridine##4##1##(1995-11#2)(1996-5#1)(2012-12#1)
dihydrotestosterone##5##1##(1990-11#4)(2008-5#1)
dihydroxyacetone##3##1##(1995-9#1)(2008-11#1)(2008-7#1)
dihydroxyacid##2##1##(1993-12#2)
dihydroxybenzene##2##1##(2008-10#2)
dihydroxybenzenes##2##1##(2008-10#2)
dihystera##2##1##(2008-10#2)
diimine##3##1##(2008-10#3)
diiodosalicylate (LIS)##2##2##(1996-12#1)(2008-8#1)
diiron site##5##2##(1991-12#5)
diiron##8##1##(1991-12#6)(1992-8#1)(2009-9#1)
diisopropyl ether##2##2##(2008-10#1)(2008-7#1)
diisopropylcarbodiimide in##2##2##(2008-9#2)
diisopropylcarbodiimide##6##1##(2008-9#6)
dilaceration in permanent##2##3##(2013-1#2)
dilaceration##3##1##(2013-1#3)
dilatation and curettage##3##3##(1992-12#1)(1993-12#1)(1995-3#1)
dilatation and##6##2##(1992-12#1)(1993-12#2)(1995-3#1)(2008-7#1)(2009-8#1)
dilatation of the##5##3##(1990-9#1)(2008-7#2)(2010-10#1)(2012-2#1)
dilatation of##9##2##(1990-9#1)(1992-9#1)(1994-9#1)(2008-7#2)(2010-10#1)(2011-3#1)(2012-2#2)
dilatation with##2##2##(1995-10#1)(2008-7#1)
dilatation##39##1##(1990-12#3)(1990-9#1)(1991-3#1)(1992-12#1)(1992-9#4)(1993-12#2)(1994-9#1)(1995-10#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#6)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#5)
dilated cardiomyopathy##12##2##(1993-2#3)(2008-10#2)(2009-10#1)(2011-2#2)(2012-2#3)(2012-3#1)
dilated##34##1##(1990-6#1)(1993-2#3)(1993-6#1)(1995-12#1)(1996-9#1)(1997-8#1)(2008-10#8)(2008-7#3)(2009-10#1)(2010-10#1)(2010-12#1)(2010-6#2)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#3)
dilation and##4##2##(1993-6#2)(2010-12#1)(2013-1#1)
dilation of the##3##3##(1997-8#1)(2010-10#2)
dilation of##4##2##(1997-8#1)(2010-10#2)(2012-3#1)
dilation##22##1##(1990-5#1)(1991-2#1)(1993-6#5)(1997-8#1)(2008-12#1)(2008-7#2)(2009-7#1)(2010-10#2)(2010-12#5)(2012-3#2)(2013-1#1)
dilatometry##2##1##(2008-10#2)
dilaurate##3##1##(1993-12#3)
dilauroylphosphatidylethanolamine##2##1##(1992-9#2)
dilazep and dipyridamole##2##3##(1995-8#2)
dilemma in##4##2##(1994-12#1)(1994-8#1)(2009-5#1)(2012-3#1)
dilemma of##9##2##(1991-8#1)(1992-1#1)(1992-3#1)(1996-2#1)(1996-8#1)(2008-11#1)(2009-11#1)(2013-1#2)
dilemma with##2##2##(2008-11#1)(2008-7#1)
dilemma##34##1##(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#2)(2009-5#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#6)
dilemmas and##4##2##(1991-1#1)(2008-11#1)(2012-12#1)(2013-1#1)
dilemmas are##3##2##(2009-6#1)(2009-8#1)(2010-4#1)
dilemmas in##4##2##(1993-2#1)(1995-3#1)(2008-12#1)(2012-3#1)
dilemmas of##2##2##(1991-9#1)(2010-10#1)
dilemmas that##2##2##(1997-3#1)(2013-8#1)
dilemmas##25##1##(1991-1#1)(1991-9#1)(1993-2#1)(1994-12#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#6)(2008-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
dill##6##1##(2008-10#6)
dilocus allozyme##2##2##(2008-10#2)
diltiazem in##2##2##(2008-7#2)
diltiazem##6##1##(2008-10#1)(2008-7#5)
diluent and##2##2##(2008-10#2)
diluent solution##2##2##(2008-10#2)
diluent with##3##2##(2008-10#3)
diluent##16##1##(2008-10#16)
diluents of low dielectric constants##2##5##(2008-10#2)
diluents of low dielectric##3##4##(2008-10#3)
diluents##13##1##(2008-10#13)
dilute acid##3##2##(2008-10#3)
dilute aqueous solutions##2##3##(2008-10#2)
dilute aqueous##7##2##(2008-10#7)
dilute hydrochloric acid##3##3##(2008-10#3)
dilute nitric acid##5##3##(2008-10#5)
dilute nitric##6##2##(2008-10#6)
dilute solution##3##2##(1995-6#1)(2008-10#2)
dilute solutions##3##2##(2008-10#2)(2009-5#1)
dilute sulfuric##2##2##(2008-10#1)(2013-1#1)
dilute##40##1##(1990-5#1)(1991-3#1)(1995-6#1)(2008-10#31)(2008-11#2)(2008-7#1)(2009-5#1)(2009-8#1)(2013-1#1)
diluted 1##2##2##(2010-4#1)(2011-2#1)
diluted H(2)SO(4)##2##2##(2008-10#2)
diluted by##2##2##(2008-10#2)
diluted five-fold with 0##3##4##(2008-10#3)
diluted in##3##2##(1992-6#1)(1994-9#1)(2008-10#1)
diluted samples##3##2##(2008-10#3)
diluted solution of the alcohol sample and quantitatively determined measuring the absorbance at##2##13##(2008-10#2)
diluted solutions##2##2##(2008-10#2)
diluted to##5##2##(2008-10#4)(2009-6#1)
diluted urine samples##3##3##(2008-10#3)
diluted urine##4##2##(2008-10#4)
diluted with##10##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2011-3#1)
diluted##79##1##(1990-12#1)(1991-12#1)(1992-3#1)(1992-6#1)(1994-9#2)(1996-2#1)(1997-3#1)(2008-10#60)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#2)(2011-3#1)
diluting the sample##2##3##(2008-10#1)(2009-6#1)
diluting##5##1##(2008-10#4)(2009-6#1)
dilution analysis##2##2##(2008-10#1)(2008-4#1)
dilution and##9##2##(2008-10#6)(2008-11#1)(2008-7#1)(2010-11#1)
dilution calibration##2##2##(2008-10#2)
dilution effect##3##2##(1995-3#1)(2008-10#2)
dilution for##3##2##(2008-10#3)
dilution in##5##2##(2008-10#5)
dilution method for##2##3##(2008-10#2)
dilution method##12##2##(2008-10#10)(2008-11#1)(2012-3#1)
dilution of a##2##3##(2008-10#2)
dilution of sample##2##3##(2008-10#2)
dilution of the sample##3##4##(2008-10#3)
dilution of the##13##3##(1992-8#1)(2008-10#10)(2008-5#2)
dilution of##28##2##(1992-3#2)(1992-8#1)(1995-11#1)(1995-3#1)(2008-10#20)(2008-5#3)
dilution on##2##2##(2008-10#1)(2008-11#1)
dilution plating##4##2##(2008-10#4)
dilution procedure##2##2##(2008-10#2)
dilution rate##5##2##(1997-2#1)(2008-11#1)(2008-7#3)
dilution rate)##2##2##(2008-11#2)
dilution rates##5##2##(2008-11#3)(2008-7#2)
dilution series##4##2##(2008-10#4)
dilution step##2##2##(2008-10#2)
dilution to##2##2##(2008-10#1)(2008-9#1)
dilution with##2##2##(2008-10#2)
dilution##155##1##(1990-11#2)(1991-5#1)(1992-3#2)(1992-8#1)(1993-8#1)(1995-11#1)(1995-3#3)(1997-2#1)(2008-10#111)(2008-11#13)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-9#2)(2010-11#1)(2012-3#2)
dilution)##3##1##(1990-12#1)(2008-10#2)
dilution-thermal ionisation mass spectrometry##2##4##(2008-10#2)
dilutions of##6##2##(1996-12#1)(2008-10#4)(2013-8#1)
dilutions##17##1##(1995-11#1)(1996-12#1)(2008-10#12)(2010-7#1)(2012-2#1)(2013-8#1)
dilysine-tagged##3##1##(1994-12#3)
dim##3##1##(2008-9#1)(2010-1#1)(2013-1#1)
dimedone##2##1##(2008-10#2)
dimenhydrinate##2##1##(2008-10#2)
dimension and##4##2##(2008-10#3)(2008-11#1)
dimension correlation##2##2##(2013-8#2)
dimension in##3##2##(1991-5#1)(2008-6#1)(2011-2#1)
dimension is##2##2##(2008-11#1)(2011-2#1)
dimension of pancreas##2##3##(2012-3#2)
dimension of the##3##3##(2008-10#1)(2008-7#2)
dimension of##22##2##(1991-2#1)(1995-2#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#2)(2009-1#1)(2009-11#2)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
dimension to the##2##3##(2008-11#1)(2011-2#1)
dimension to##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
dimension##73##1##(1991-2#2)(1991-5#1)(1995-2#1)(1996-2#2)(2007-11#1)(2008-10#15)(2008-11#10)(2008-12#3)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
dimensional changes##3##2##(2012-2#3)
dimensional stability##2##2##(1990-9#1)(2012-12#1)
dimensional##26##1##(1990-9#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-8#2)(2009-10#1)(2009-12#1)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-8#1)
dimensionality is##3##2##(2008-10#1)(2010-7#2)
dimensionality of##6##2##(1994-9#1)(2008-11#1)(2010-7#1)(2012-2#1)(2012-3#2)
dimensionality reduction##2##2##(2008-6#1)(2013-8#1)
dimensionality##16##1##(1993-12#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-10#1)(2010-7#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
dimensionless##2##1##(1995-2#2)
dimensions and function##2##3##(2008-12#2)
dimensions and##12##2##(1991-12#1)(1994-12#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
dimensions are##2##2##(2008-10#2)
dimensions as##2##2##(2008-9#1)(2011-2#1)
dimensions concerning##2##2##(2012-12#2)
dimensions in##2##2##(1992-3#1)(2010-12#1)
dimensions of mental health##2##4##(2013-1#2)
dimensions of the##8##3##(1992-2#2)(1996-2#1)(2008-10#3)(2009-11#1)(2010-4#1)
dimensions of##47##2##(1992-2#2)(1992-3#2)(1993-1#1)(1993-12#1)(1995-3#1)(1996-2#4)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
dimensions that##2##2##(2008-6#1)(2013-1#1)
dimensions to##2##2##(2008-1#1)(2008-11#1)
dimensions were##4##2##(2008-10#1)(2009-1#1)(2009-7#1)(2011-2#1)
dimensions with##2##2##(1991-3#1)(1997-6#1)
dimensions##134##1##(1991-12#1)(1991-3#2)(1992-2#3)(1992-3#3)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#2)(1996-2#8)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#10)(2008-12#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#2)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#8)(2013-8#7)
dimer assembly##2##2##(1995-8#2)
dimer containing##2##2##(1993-8#2)
dimer formation##4##2##(2008-10#4)
dimer is##2##2##(1993-3#1)(2008-10#1)
dimer of##3##2##(1991-12#1)(1991-7#1)(2008-10#1)
dimer or##2##2##(2008-8#1)(2008-9#1)
dimer species##2##2##(2008-10#1)(2010-10#1)
dimer##46##1##(1990-5#1)(1991-12#2)(1991-6#1)(1991-7#2)(1993-3#1)(1993-8#5)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-6#1)(1995-8#2)(2008-10#14)(2008-11#3)(2008-8#4)(2008-9#1)(2010-10#1)(2010-12#1)
dimeric aluminate species##2##3##(2008-10#2)
dimeric form##2##2##(2008-9#1)(2011-1#1)
dimeric forms##2##2##(2008-10#2)
dimeric protein##2##2##(1994-11#1)(2008-8#1)
dimeric##28##1##(1990-5#1)(1991-9#1)(1992-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-2#1)(2008-10#9)(2008-8#3)(2008-9#2)(2009-7#1)(2010-2#3)(2011-1#1)
dimerisation##2##1##(2010-10#2)
dimerization constant##2##2##(2008-10#2)
dimerization of##2##2##(1993-8#1)(2008-9#1)
dimerization or##2##2##(1996-5#1)(2008-10#1)
dimerization##19##1##(1993-8#4)(1996-5#1)(2008-10#10)(2008-9#1)(2009-7#1)(2011-1#1)(2013-8#1)
dimerize##2##1##(2008-10#2)
dimerizing domains##2##2##(1995-6#2)
dimerizing##3##1##(1995-6#3)
dimers in##3##2##(2008-10#1)(2010-7#2)
dimers##18##1##(1991-7#1)(1994-11#1)(1994-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-7#1)(2010-7#4)
dimethacrylate (EDMA)##2##2##(2008-10#2)
dimethacrylate##7##1##(2008-10#4)(2013-1#3)
dimethoate##2##1##(1990-9#1)(2008-10#1)
dimethomorph##2##1##(2008-10#2)
dimethyl PABA##3##2##(2008-5#3)
dimethyl carbonate##3##2##(2011-2#3)
dimethyl formamide (DMF)##2##3##(2008-10#2)
dimethyl formamide##3##2##(2008-10#2)(2008-5#1)
dimethyl sulfate##2##2##(1991-7#1)(2008-10#1)
dimethyl sulfide##3##2##(1996-5#3)
dimethyl sulfoxide (DMSO)##5##3##(1994-8#1)(2008-10#4)
dimethyl sulfoxide and##3##3##(1993-3#2)(2008-10#1)
dimethyl sulfoxide##12##2##(1993-3#2)(1994-8#1)(1996-12#1)(2008-10#7)(2010-1#1)
dimethyl trisulphide##2##2##(2008-10#2)
dimethyl##47##1##(1991-7#1)(1993-3#2)(1994-8#3)(1996-12#1)(1996-5#8)(2008-10#18)(2008-11#3)(2008-5#5)(2008-7#1)(2010-1#1)(2010-5#1)(2011-2#3)
dimethylamine##3##1##(2008-10#3)
dimethylarsinate##3##1##(2008-10#3)
dimethylarsinic acid (DMA) and##2##4##(2008-10#2)
dimethylarsinic acid (DMA)##6##3##(2008-10#6)
dimethylarsinic acid and##2##3##(2008-10#2)
dimethylarsinic acid##14##2##(2008-10#14)
dimethylarsinic##17##1##(2008-10#17)
dimethylated arsenic##2##2##(2008-10#2)
dimethylated##4##1##(1995-11#1)(2008-10#3)
dimethylation of arginine##2##3##(2009-7#2)
dimethyldioxirane##3##1##(1990-5#3)
dimethyldithiocarbamate##2##1##(2008-10#2)
dimethylformamide solution##3##2##(2008-10#3)
dimethylformamide##8##1##(2008-10#8)
dimethylglyoxime##6##1##(2008-10#6)
dimethylsuberimidate##2##1##(1993-8#1)(2008-10#1)
dimethylsulfoxide##10##1##(1993-8#1)(1994-11#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
dimethylsulphonazo(III)##2##1##(2008-10#2)
dimethylsulphoxide##2##1##(2008-10#1)(2008-5#1)
dimethyltin hydride##2##2##(2008-10#2)
dimethyltin##7##1##(2008-10#7)
diminish the##4##2##(1991-8#1)(2010-8#1)(2011-2#2)
diminish##16##1##(1990-11#1)(1991-8#1)(1994-3#1)(1995-3#1)(1996-11#2)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
diminished after##2##2##(1995-8#1)(2008-9#1)
diminished as##2##2##(1992-9#1)(2008-11#1)
diminished by##6##2##(1992-3#2)(1993-12#1)(1995-6#1)(1995-8#1)(2008-8#1)
diminished in the##2##3##(1994-3#1)(2008-10#1)
diminished in##8##2##(1993-12#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)
diminished or##2##2##(2008-10#1)(2008-11#1)
diminished the##3##2##(1994-8#1)(1996-3#1)(2008-10#1)
diminished their stimulatory actions##2##4##(2008-11#2)
diminished with##3##2##(1996-1#1)(2008-10#1)(2013-1#1)
diminished##71##1##(1991-12#1)(1991-2#1)(1992-3#3)(1992-4#1)(1992-9#1)(1993-12#2)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#8)(2008-11#8)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#2)
diminishes the##4##2##(1995-11#1)(2008-10#2)(2008-9#1)
diminishes##10##1##(1994-2#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-3#1)(2008-9#1)(2013-1#1)(2013-7#1)
diminishing the##2##2##(2008-10#2)
diminishing##9##1##(1996-1#2)(2008-10#4)(2008-8#1)(2012-2#1)(2013-1#1)
diminution in the##2##3##(1994-6#1)(2008-10#1)
diminution in##3##2##(1994-6#1)(2008-10#2)
diminution of the##2##3##(2008-5#1)(2013-7#1)
diminution of##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
diminution##7##1##(1994-6#1)(2008-10#4)(2008-5#1)(2013-7#1)
dimly fluorescent##2##2##(2008-9#2)
dimly##3##1##(2008-11#1)(2008-9#2)
dimmer##2##1##(2008-10#1)(2008-11#1)
dimorphic##11##1##(1992-3#4)(1993-8#1)(1996-6#1)(2008-5#1)(2008-8#3)(2008-9#1)
dimorphism in##4##2##(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)
dimorphism##11##1##(1996-6#1)(2007-12#1)(2008-8#4)(2008-9#1)(2010-6#1)(2012-3#3)
dimorphisms##4##1##(1994-2#1)(1997-3#2)(2008-9#1)
dinitrate##4##1##(1996-9#1)(2008-10#3)
dinucleotide (NADH)##3##2##(2008-10#2)(2013-1#1)
dinucleotide##22##1##(1991-5#1)(1991-6#1)(1992-12#3)(1997-6#6)(1997-7#1)(2008-10#5)(2008-4#1)(2011-2#3)(2013-1#1)
dinucleotides##4##1##(1991-6#1)(1993-2#2)(1996-2#1)
diocese##2##1##(1991-2#2)
dioctyl phthalate (DOP)##5##3##(2008-10#5)
dioctyl##7##1##(2008-10#7)
dioctylphthalate (DOP)##3##2##(2008-10#3)
dioctylphthalate##4##1##(2008-10#4)
diode (LED) as##2##3##(2008-10#2)
diode (LED)##7##2##(2008-10#6)(2008-11#1)
diode array detection##8##3##(2008-10#8)
diode array detector (DAD)##3##4##(2008-10#3)
diode array detector##8##3##(2008-10#8)
diode array spectrophotometer##4##3##(2008-10#4)
diode array##27##2##(1991-2#1)(2008-10#25)(2008-2#1)
diode emitting##2##2##(2008-10#1)(2008-3#1)
diode laser and##2##3##(2008-10#1)(2008-3#1)
diode laser at##2##3##(2008-2#1)(2008-3#1)
diode laser in the##2##4##(2008-2#1)(2013-1#1)
diode laser operating##2##3##(2008-3#2)
diode laser was##2##3##(2008-2#2)
diode laser with##2##3##(2008-2#1)(2008-3#1)
diode laser##37##2##(2007-12#1)(2008-10#5)(2008-2#11)(2008-3#19)(2013-1#1)
diode lasers##9##2##(2008-3#9)
diode pumping##2##2##(2008-3#2)
diode side-pumped Nd##2##3##(2008-2#2)
diode side-pumped solid-state##2##3##(2008-3#2)
diode side-pumped##4##2##(2008-2#2)(2008-3#2)
diode##131##1##(1991-2#1)(2007-12#4)(2008-10#50)(2008-11#1)(2008-2#20)(2008-3#52)(2008-7#1)(2013-1#2)
diode-array detection##2##2##(2008-10#1)(2010-11#1)
diode-array detector##2##2##(2008-10#2)
diode-array##5##1##(2008-10#4)(2010-11#1)
diode-end-pumped##5##1##(2008-2#5)
diode-laser absorption##4##2##(2008-2#1)(2008-3#3)
diode-laser light is##2##3##(2008-3#2)
diode-laser light##3##2##(2008-3#3)
diode-laser sensor##2##2##(2008-3#2)
diode-laser##14##1##(2008-2#1)(2008-3#13)
diode-laser-pumped##2##1##(2008-2#1)(2008-3#1)
diode-pumped Nd##8##2##(2008-3#8)
diode-pumped Yb##4##2##(2007-12#3)(2008-3#1)
diode-pumped##23##1##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#14)
diodes (LEDs)##3##2##(1995-3#1)(2008-10#2)
diodes have##2##2##(2007-12#1)(2008-3#1)
diodes##10##1##(1993-9#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)
dioica##6##1##(2008-10#1)(2008-12#5)
diol##6##1##(1991-5#1)(1997-2#2)(2008-11#1)(2008-4#1)(2008-5#1)
diolein##2##1##(1990-8#2)
dioleoyl PC##2##2##(1995-8#2)
diospyrin##4##1##(2008-10#4)
dioxane-water##2##1##(2008-10#2)
dioxide (SO(2)) in##2##3##(2008-10#2)
dioxide and##5##2##(2008-10#5)
dioxide in air##5##3##(2008-10#5)
dioxide in gaseous samples##3##4##(2008-10#3)
dioxide in the##3##3##(2008-10#3)
dioxide in water##4##3##(2008-10#4)
dioxide in##26##2##(1993-12#1)(2008-10#25)
dioxide laser in##2##3##(1992-1#1)(1992-3#1)
dioxide laser##7##2##(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-8#1)
dioxide using##3##2##(2008-10#3)
dioxide was##6##2##(2008-10#6)
dioxide were##4##2##(2008-10#4)
dioxide##165##1##(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#2)(1992-3#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1996-12#5)(2008-10#118)(2008-11#11)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-4#2)(2012-2#1)(2012-3#2)(2013-1#1)
dioxide)##3##1##(2008-10#2)(2008-7#1)
dioxin TEQ##2##2##(2008-10#2)
dioxin and##2##2##(2008-10#2)
dioxin contamination##2##2##(2008-10#1)(2008-11#1)
dioxin fraction##2##2##(2008-10#2)
dioxin levels in##2##3##(2008-10#2)
dioxin levels##4##2##(2008-10#4)
dioxin precursor##2##2##(2008-10#2)
dioxin##33##1##(2008-10#29)(2008-11#4)
dioxin-like PCBs##6##2##(2008-10#6)
dioxin-like compounds##5##2##(2008-10#5)
dioxin-like##17##1##(2008-10#17)
dioxin-responsive##3##1##(2008-11#3)
dioxins and dioxin-like##4##3##(2008-10#4)
dioxins and related##2##3##(2008-10#2)
dioxins and##9##2##(1994-3#1)(2008-10#8)
dioxins in feed##2##3##(2008-10#2)
dioxins in##9##2##(2008-10#9)
dioxins##27##1##(1994-3#1)(2008-10#22)(2008-11#4)
dioxygen by##2##2##(2008-10#2)
dioxygen to##2##2##(2008-10#2)
dioxygen##13##1##(1991-3#1)(2008-10#12)
dip in##2##2##(1990-6#1)(2008-3#1)
dip##17##1##(1990-6#5)(1992-2#1)(2008-10#8)(2008-3#3)
dip-coating##2##1##(2008-10#2)
dipalmitoyl PC##2##2##(1995-8#2)
dipalmitoyl##4##1##(1995-8#2)(2008-10#2)
dipeptide##7##1##(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)
dipeptides##8##1##(1994-8#2)(2008-10#4)(2008-11#1)(2009-8#1)
dipeptidyl##2##1##(1992-3#1)(1993-12#1)
diphenadione and chlorophacinone##2##3##(2008-10#2)
diphenhydramine hydrochloride##3##2##(2008-10#3)
diphenhydramine##11##1##(2008-10#10)(2010-9#1)
diphenyl ethers##7##2##(1993-12#1)(2008-10#6)
diphenyl##8##1##(1993-12#1)(2008-10#7)
diphenylamido##3##1##(2008-11#3)
diphenylamine (DPA)##2##2##(2008-10#2)
diphenylamine##6##1##(1996-5#1)(2008-10#5)
diphenylcarbazide##4##1##(2008-10#4)
diphenyleneiodonium##2##1##(1993-6#1)(1994-6#1)
diphosphate (ADP)##2##2##(2006-6#2)
diphosphate and##3##2##(1997-6#2)(2008-8#1)
diphosphate as##2##2##(2008-10#2)
diphosphate kinase##3##2##(1994-8#1)(1996-2#2)
diphosphate kinases##2##2##(1997-7#2)
diphosphate##19##1##(1993-6#1)(1993-9#1)(1994-8#1)(1995-8#2)(1996-2#2)(1997-6#2)(1997-7#2)(2006-6#2)(2008-10#3)(2008-5#1)(2008-8#2)
diphthamide##3##1##(1993-9#3)
diphtheria and tetanus toxoids and pertussis vaccine##2##7##(1995-3#1)(1995-5#1)
diphtheria##11##1##(1995-3#4)(1995-5#3)(1996-11#1)(1996-8#1)(2007-11#1)(2013-1#1)
diploid and##2##2##(2008-11#1)(2008-8#1)
diploid chromosome number##2##3##(2008-12#1)(2009-12#1)
diploid chromosome numbers##2##3##(2008-10#1)(2008-12#1)
diploid chromosome##4##2##(2008-10#1)(2008-12#2)(2009-12#1)
diploid clones##2##2##(2008-11#2)
diploid endosperm formation##2##3##(2009-12#2)
diploid fibroblasts##4##2##(1990-3#1)(1997-1#1)(2008-11#1)(2009-4#1)
diploid host##2##2##(1995-5#1)(2008-10#1)
diploid number of##2##3##(2008-12#2)
diploid number##3##2##(2008-12#3)
diploid##42##1##(1990-3#1)(1993-3#2)(1994-12#2)(1995-5#1)(1996-6#1)(1997-1#2)(2008-10#7)(2008-11#5)(2008-12#7)(2008-8#2)(2009-10#1)(2009-12#7)(2009-4#1)(2009-6#1)(2010-8#1)(2012-3#1)
diploidization##3##1##(1993-3#2)(2009-10#1)
diploids##5##1##(1995-9#3)(1997-4#1)(2008-11#1)
diploma in nursing##4##3##(2008-11#3)(2008-12#1)
diploma in##5##2##(2008-11#4)(2008-12#1)
diploma nursing##2##2##(2008-11#1)(2008-12#1)
diploma students##3##2##(2008-11#2)(2008-12#1)
diploma##16##1##(2008-1#1)(2008-11#8)(2008-12#7)
diplopia and##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
diplopia##12##1##(1996-9#1)(2008-7#7)(2011-2#3)(2012-3#1)
diplopods##3##1##(2007-12#2)(2008-11#1)
dipolar##4##1##(1993-8#2)(1994-5#1)(2008-10#1)
dipole moment##2##2##(2008-10#2)
dipole moments of##3##3##(1997-6#3)
dipole moments##6##2##(1997-6#6)
dipole source analysis##2##3##(2008-11#2)
dipole##19##1##(1992-12#2)(1997-6#8)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2010-8#1)
dipole-dipole interaction##2##2##(2008-10#2)
dipole-dipole##3##1##(2008-10#3)
dipoles##3##1##(1991-5#1)(1992-4#1)(2008-10#1)
dipped in##4##2##(1990-6#2)(2008-10#1)(2011-2#1)
dipped##6##1##(1990-6#2)(2008-10#3)(2011-2#1)
dipping animals in##2##3##(2010-1#2)
dipping##11##1##(1990-6#1)(2008-10#2)(2008-12#1)(2010-1#5)(2013-1#1)(2013-8#1)
diprotic acids##2##2##(2008-10#2)
dips##2##1##(2008-10#1)(2010-1#1)
dipsaci sensu stricto##2##3##(2008-10#2)
dipsaci##9##1##(2008-10#9)
dipteran##3##1##(1993-12#1)(2008-11#1)(2010-1#1)
dipterophagy##2##1##(2012-3#2)
dipyridamole##11##1##(1994-5#5)(1995-8#2)(2008-10#3)(2008-8#1)
dipyrone##5##1##(2008-10#5)
diquat and paraquat##2##3##(2008-10#2)
dire##3##1##(2008-11#1)(2008-5#1)(2012-2#1)
direct ELISA##2##2##(2008-10#1)(2008-11#1)
direct ETAAS##3##2##(2008-10#3)
direct UV##2##2##(2008-10#2)
direct access##2##2##(1996-5#1)(2013-1#1)
direct activation of##3##3##(1995-11#1)(2008-3#1)(2012-3#1)
direct adsorption of##2##3##(2008-10#2)
direct agglutination test (DAT)##2##4##(1996-12#1)(2012-2#1)
direct agglutination test##3##3##(1996-12#2)(2012-2#1)
direct analysis of solid##2##4##(2008-10#2)
direct analysis of the##3##4##(2008-10#2)(2008-9#1)
direct analysis of##11##3##(2008-10#10)(2008-9#1)
direct analysis##15##2##(2008-10#14)(2008-9#1)
direct and competitive##2##3##(2008-10#2)
direct and indirect PAD##2##4##(2008-10#2)
direct and indirect effects of##2##5##(1997-1#1)(2008-7#1)
direct and indirect effects##5##4##(1997-1#1)(2008-7#2)(2008-8#1)(2012-2#1)
direct and indirect health##3##4##(1991-6#1)(2010-1#1)(2013-8#1)
direct and indirect in situ##2##5##(2008-9#2)
direct and indirect organogenesis of Memordica charantia##2##7##(2008-12#2)
direct and indirect##26##3##(1990-12#1)(1991-12#1)(1991-6#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-1#1)(2010-7#1)(2012-2#1)(2013-8#1)
direct and simple##2##3##(1994-3#1)(2008-10#1)
direct and##49##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1994-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-1#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
direct application of the##3##4##(2008-10#2)(2008-3#1)
direct aspiration of the##2##4##(2008-10#2)
direct assay of##2##3##(1990-5#1)(2008-10#1)
direct assay##3##2##(1990-5#1)(2008-10#2)
direct binding of##4##3##(1994-11#1)(1995-11#1)(2008-4#1)(2008-9#1)
direct binding to##2##3##(1995-2#1)(2008-11#1)
direct binding##6##2##(1994-11#1)(1995-11#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-9#1)
direct bonding##2##2##(2008-10#1)(2008-3#1)
direct cDNA##2##2##(1996-2#1)(1997-8#1)
direct cell-cell contacts between the hepatic endoderm and##2##8##(2008-6#2)
direct cell-cell contacts##3##3##(2008-6#3)
direct chemiluminescence##4##2##(2008-10#4)
direct chemiluminescent##2##2##(2008-10#2)
direct colorimetric method##2##3##(2008-10#2)
direct communication between##2##3##(1993-9#1)(2008-7#1)
direct comparison##6##2##(1992-3#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
direct comparisons##3##2##(2008-10#2)(2008-5#1)
direct competition##2##2##(2008-11#1)(2009-10#1)
direct connection between##2##3##(2008-10#1)(2011-2#1)
direct consequence of##3##3##(1994-5#1)(2008-11#1)(2012-3#1)
direct consequence##4##2##(1994-5#1)(2008-10#1)(2008-11#1)(2012-3#1)
direct contact between##2##3##(1997-5#1)(2008-10#1)
direct contact with the##5##4##(2007-12#1)(2008-10#3)(2008-12#1)
direct contact with##8##3##(1995-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2011-2#1)
direct contact##11##2##(1995-11#1)(1997-5#1)(2007-12#1)(2008-10#6)(2008-12#1)(2011-2#1)
direct correlation between##4##3##(1994-11#1)(1994-5#1)(2008-11#1)(2011-1#1)
direct correlation##6##2##(1994-11#1)(1994-5#1)(2008-11#3)(2011-1#1)
direct costs##2##2##(2008-8#2)
direct current plasma##2##3##(2008-5#1)(2008-7#1)
direct current##10##2##(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#4)(2012-2#2)
direct detection and##3##3##(2008-10#2)(2008-2#1)
direct detection of##6##3##(2008-10#5)(2008-4#1)
direct detection optical##2##3##(2008-3#2)
direct detection##16##2##(2008-10#11)(2008-2#1)(2008-3#3)(2008-4#1)
direct determination of free##2##4##(2008-10#2)
direct determination of lead in##3##5##(2008-10#3)
direct determination of the##8##4##(2008-10#7)(2008-2#1)
direct determination of total##2##4##(2008-10#2)
direct determination of trace##5##4##(2008-10#5)
direct determination of##66##3##(1991-12#1)(2008-10#64)(2008-2#1)
direct determination##73##2##(1991-12#1)(2008-10#71)(2008-2#1)
direct determinations##3##2##(2008-10#3)
direct dissolution##2##2##(2008-10#1)(2010-5#1)
direct effect of##6##3##(1991-3#1)(2008-6#1)(2008-8#1)(2009-9#2)(2012-2#1)
direct effect on##4##3##(1992-6#1)(1994-2#1)(2008-5#1)(2008-8#1)
direct effect##11##2##(1991-3#1)(1992-6#1)(1994-2#1)(1995-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-9#2)(2012-2#1)
direct effects of##7##3##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
direct effects on the##2##4##(2007-11#1)(2008-10#1)
direct effects on##5##3##(2007-11#1)(2008-10#1)(2008-8#3)
direct effects##12##2##(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)
direct electrochemical##2##2##(2008-10#2)
direct electrochemistry##3##2##(2008-10#3)
direct electron transfer##2##3##(2008-10#2)
direct electronic##3##2##(1994-5#2)(2008-8#1)
direct emissions##2##2##(2008-11#2)
direct estimates of##2##3##(2008-10#1)(2008-9#1)
direct evidence for the##3##4##(2008-6#1)(2008-9#1)(2012-2#1)
direct evidence for##5##3##(1993-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
direct evidence that the##2##4##(2008-10#1)(2009-8#1)
direct evidence that##8##3##(1995-2#1)(1996-12#2)(2008-10#3)(2009-8#1)(2013-8#1)
direct evidence##18##2##(1993-12#1)(1995-2#1)(1996-12#2)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
direct examination##3##2##(2008-5#3)
direct experimental##2##2##(2008-10#1)(2012-3#1)
direct extraction##3##2##(2008-10#3)
direct fitness##3##2##(2008-8#3)
direct funding##2##2##(1991-2#1)(2009-4#1)
direct gene transfer##5##3##(1994-5#5)
direct government regulation##2##3##(1995-3#2)
direct immunoassay##3##2##(2008-10#2)(2008-4#1)
direct immunofluorescence##3##2##(2011-2#1)(2012-3#2)
direct infection##2##2##(2011-2#2)
direct inhibition of##4##3##(1994-8#1)(2008-4#1)(2008-5#1)(2012-2#1)
direct inhibition##5##2##(1994-6#1)(1994-8#1)(2008-4#1)(2008-5#1)(2012-2#1)
direct injection of##5##3##(2008-10#3)(2008-9#1)(2009-8#1)
direct injection##13##2##(2008-10#9)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)
direct interaction between##5##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
direct interaction of##3##3##(1995-5#1)(2010-11#1)(2011-2#1)
direct interaction with the##3##4##(1994-11#1)(1997-2#1)(2008-10#1)
direct interaction with##6##3##(1991-6#1)(1993-8#1)(1994-11#1)(1995-8#1)(1997-2#1)(2008-10#1)
direct interaction##15##2##(1991-6#1)(1993-8#2)(1994-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
direct interactions between##2##3##(1990-5#1)(2008-10#1)
direct interactions##3##2##(1990-5#1)(2008-10#2)
direct intramuscular injection of##2##4##(2008-8#2)
direct introduction into the##2##4##(1991-11#1)(2008-10#1)
direct introduction into##3##3##(1991-11#1)(2008-10#1)(2008-8#1)
direct introduction of##2##3##(2008-10#2)
direct introduction##5##2##(1991-11#1)(2008-10#3)(2008-8#1)
direct involvement of##6##3##(1992-6#1)(1995-8#1)(2008-11#2)(2008-12#1)(2013-1#1)
direct irradiance##4##2##(2008-2#3)(2008-3#1)
direct isolation##2##2##(2008-10#1)(2011-2#1)
direct link between##4##3##(1996-2#1)(2009-7#1)(2009-8#1)(2013-1#1)
direct liquid##2##2##(2008-10#2)
direct losses##2##2##(2008-10#1)(2011-2#1)
direct measure of the##3##4##(2008-10#2)(2008-3#1)
direct measure of##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
direct measurement by##2##3##(2008-10#2)
direct measurement of the##8##4##(2008-10#6)(2008-3#2)
direct measurement of##13##3##(1992-3#1)(1994-2#1)(2008-10#9)(2008-3#2)
direct measurement##18##2##(1992-3#1)(1994-2#1)(2008-10#12)(2008-3#2)(2008-9#1)(2012-2#1)
direct measurements of##2##3##(1992-12#1)(2008-10#1)
direct measurements##4##2##(1992-12#1)(2008-10#2)(2013-1#1)
direct measures of##3##3##(1994-3#1)(2012-2#1)(2013-8#1)
direct method for##3##3##(1990-5#1)(1995-12#1)(2008-10#1)
direct method##6##2##(1990-5#1)(1992-12#1)(1995-12#1)(2008-10#3)
direct methods##2##2##(2010-10#1)(2012-3#1)
direct numerical##2##2##(2008-3#1)(2008-9#1)
direct observation of##3##3##(1990-8#1)(2008-8#1)(2009-11#1)
direct observation##4##2##(1990-8#1)(2008-5#1)(2008-8#1)(2009-11#1)
direct one##2##2##(1994-8#1)(2008-10#1)
direct optical##2##2##(1997-7#1)(2009-5#1)
direct or indirect##3##3##(2008-9#1)(2009-3#1)(2009-9#1)
direct or##9##2##(1994-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)
direct osmotic stimulation of the##2##5##(1994-8#2)
direct patient##4##2##(2008-11#2)(2011-2#1)(2012-3#1)
direct penetration by##2##3##(2008-10#2)
direct penetration##4##2##(2008-10#3)(2011-10#1)
direct potentiometric determination of##2##4##(2008-10#2)
direct potentiometric method##3##3##(2008-10#3)
direct potentiometric##6##2##(2008-10#6)
direct proof##4##2##(1993-8#1)(2009-10#1)(2009-12#2)
direct reduction##2##2##(2008-10#1)(2009-9#1)
direct relationship between##6##3##(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
direct relationship with##2##3##(1990-6#1)(2008-9#1)
direct relationship##9##2##(1990-12#1)(1990-6#1)(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)
direct repeats##5##2##(1995-6#1)(1995-8#2)(2008-10#2)
direct sample##5##2##(2008-10#5)
direct sampling##2##2##(2008-10#2)
direct sequencing of the##2##4##(1996-2#1)(1996-8#1)
direct sequencing##5##2##(1996-2#1)(1996-8#1)(2008-4#2)(2011-2#1)
direct service volunteer##2##3##(1994-2#2)
direct service##3##2##(1994-2#2)(2012-2#1)
direct sinus packing##2##3##(2008-7#2)
direct solid##3##2##(2008-10#3)
direct speciation of##2##3##(2008-10#2)
direct spectrophotometric determination of##3##4##(2008-10#3)
direct spectrophotometric method##3##3##(2008-10#3)
direct spectrophotometric##8##2##(2008-10#8)
direct stimulation of##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
direct surgery##2##2##(2008-7#2)
direct switching##2##2##(2008-11#2)
direct the synthesis of##2##4##(1997-2#1)(2008-7#1)
direct the##10##2##(1994-8#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)
direct treatment of##3##3##(2008-7#1)(2009-6#1)(2010-6#1)
direct treatment##4##2##(2008-7#1)(2009-6#1)(2010-11#1)(2010-6#1)
direct view##2##2##(2008-4#1)(2011-2#1)
direct visual##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
direct visualization catheter##3##3##(2010-6#3)
direct visualization##5##2##(1996-1#1)(2009-10#1)(2010-6#3)
direct way to##2##3##(2009-6#1)(2013-1#1)
direct##887##1##(1990-11#4)(1990-12#3)(1990-2#1)(1990-5#5)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#5)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#4)(1994-11#4)(1994-12#1)(1994-2#7)(1994-3#4)(1994-5#10)(1994-6#1)(1994-8#8)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#10)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#6)(1996-1#1)(1996-12#9)(1996-2#6)(1996-5#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#1)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#357)(2008-11#42)(2008-12#11)(2008-2#6)(2008-3#24)(2008-4#14)(2008-5#22)(2008-6#7)(2008-7#24)(2008-8#28)(2008-9#27)(2009-10#6)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#4)(2010-7#8)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#25)(2011-3#1)(2012-12#2)(2012-2#16)(2012-3#15)(2013-1#15)(2013-8#6)
direct-binding##2##1##(2008-10#2)
direct-detection Doppler lidar systems##2##4##(2008-3#2)
direct-detection Doppler lidar##3##3##(2008-3#3)
direct-injection##2##1##(2008-10#1)(2008-2#1)
directed against the heavy chain of the cofactor##2##8##(1994-5#2)
directed against the##11##3##(1992-12#1)(1992-2#1)(1993-8#1)(1994-5#2)(1997-3#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
directed against##24##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-5#3)(1995-9#1)(1997-3#1)(1997-5#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#2)
directed at SSB consumption##2##4##(2012-2#2)
directed at the##4##3##(2008-10#1)(2008-12#1)(2009-12#1)(2012-2#1)
directed at##18##2##(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#4)(2009-4#1)(2010-12#1)(2012-2#4)(2013-8#1)
directed biopsy##5##2##(1991-2#1)(2008-11#4)
directed by a##2##3##(1990-11#1)(2009-8#1)
directed by the##3##3##(1990-11#1)(1992-12#1)(2008-9#1)
directed by##12##2##(1990-11#2)(1990-5#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-12#1)(1997-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)
directed evolution of##2##3##(2011-1#2)
directed evolution##6##2##(2008-9#2)(2010-4#1)(2011-1#3)
directed growth##2##2##(1997-3#2)
directed into##2##2##(2008-10#1)(2008-7#1)
directed to a##2##3##(2008-10#1)(2011-2#1)
directed to the GPIIIa##2##4##(2006-6#2)
directed to the##7##3##(1992-12#1)(2006-6#4)(2008-11#1)(2008-12#1)
directed to##22##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-12#1)(1995-11#1)(1995-12#1)(2006-6#5)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-9#1)(2010-5#1)(2011-2#1)
directed toward the##4##3##(1993-1#1)(1993-2#1)(1996-12#1)(2011-2#1)
directed toward##10##2##(1993-1#1)(1993-2#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)(2011-7#1)
directed towards the##3##3##(2008-6#2)(2011-2#1)
directed towards##8##2##(2008-10#2)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#2)
directed##147##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-8#1)(1991-2#2)(1991-6#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1997-3#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#5)(2008-1#1)(2008-10#15)(2008-11#18)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#9)(2009-12#5)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#11)(2011-7#1)(2012-2#4)(2013-1#2)(2013-8#2)
directing the##8##2##(1992-1#1)(1993-3#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
directing##15##1##(1992-1#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-1#1)
direction a##2##2##(1997-3#1)(2009-7#1)
direction and##8##2##(1992-2#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2012-3#1)
direction as##2##2##(2008-11#1)(2008-2#1)
direction changes##2##2##(1990-11#1)(2008-7#1)
direction could be##2##3##(2008-10#2)
direction for##3##2##(1994-2#1)(1994-3#1)(2009-6#1)
direction in the##2##3##(2008-3#1)(2008-9#1)
direction in##9##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-7#1)(2012-2#1)
direction of effect of gestational stress##2##6##(2008-11#2)
direction of effects##2##3##(2008-10#1)(2010-4#1)
direction of evolution##2##3##(2008-8#1)(2008-9#1)
direction of gaze##2##3##(2008-11#1)(2010-10#1)
direction of laterality##2##3##(1994-8#2)
direction of motion##2##3##(2008-10#1)(2008-8#1)
direction of selection##2##3##(2008-10#1)(2008-8#1)
direction of the##13##3##(1995-1#1)(1995-11#1)(2008-10#2)(2008-3#4)(2009-7#2)(2010-8#1)(2013-1#1)(2013-8#1)
direction of##57##2##(1990-9#1)(1991-2#2)(1991-3#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#7)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-7#2)(2010-10#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
direction or##2##2##(1993-12#1)(2008-10#1)
direction selectivity and##3##3##(2008-8#3)
direction selectivity##6##2##(2008-8#5)(2008-9#1)
direction to the##3##3##(1997-6#1)(2008-3#1)(2008-9#1)
direction to##5##2##(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
direction with##2##2##(2008-10#1)(2008-11#1)
direction##180##1##(1990-11#2)(1990-12#1)(1990-9#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#5)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-6#2)(2008-10#36)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#18)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#19)(2008-9#9)(2009-1#1)(2009-11#1)(2009-6#1)(2009-7#10)(2010-10#1)(2010-4#5)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#3)
direction)##2##1##(1991-5#1)(1992-12#1)
directional selection##3##2##(2008-10#1)(2008-8#2)
directional tuning of##2##3##(2008-8#2)
directional##26##1##(2008-10#3)(2008-11#1)(2008-3#9)(2008-6#1)(2008-8#9)(2010-7#1)(2012-2#1)(2013-1#1)
directionally selective cells##2##3##(2008-8#2)
directionally##4##1##(1996-12#1)(2008-8#3)
directions and##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2010-3#1)
directions are discussed##2##3##(2008-11#1)(2009-9#1)
directions are##6##2##(1994-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)
directions for future research are##2##5##(1995-2#1)(2008-12#1)
directions for future research##6##4##(1995-2#1)(1996-3#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-12#1)
directions for future##9##3##(1995-2#1)(1996-3#1)(1997-3#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#1)
directions for##23##2##(1991-2#2)(1994-12#1)(1994-2#2)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#2)(2009-7#2)(2010-12#1)(2010-9#1)(2011-2#3)(2013-1#1)
directions in##4##2##(1996-9#1)(2008-2#1)(2008-8#1)(2010-2#1)
directions of future##2##3##(2008-10#1)(2008-9#1)
directions of the##2##3##(1992-9#1)(2013-1#1)
directions of##13##2##(1990-5#1)(1992-9#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)
directions that##4##2##(1995-1#1)(2008-11#1)(2010-9#1)(2011-2#1)
directions with##2##2##(2008-3#1)(2008-9#1)
directions##113##1##(1990-10#1)(1990-5#1)(1991-2#3)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-2#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#3)(2008-1#1)(2008-10#15)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#7)(2009-11#2)(2009-3#1)(2009-7#3)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
directive##10##1##(1994-1#1)(1996-8#2)(1997-8#1)(2008-10#4)(2008-12#2)
directives##6##1##(1994-1#2)(1996-3#1)(2008-12#2)(2009-6#1)
directly about their##2##3##(1995-2#2)
directly address this##2##3##(1994-11#1)(2013-1#1)
directly address##3##2##(1994-11#1)(2013-1#2)
directly affect##2##2##(2008-10#1)(2008-11#1)
directly affected##2##2##(2008-3#1)(2012-2#1)
directly affects the##2##3##(1993-6#1)(1995-3#1)
directly after##6##2##(1990-11#1)(2008-10#3)(2008-12#1)(2010-8#1)
directly amplified##2##2##(1996-6#1)(2008-10#1)
directly and indirectly##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
directly and##12##2##(1993-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
directly applicable to##2##3##(2008-10#2)
directly applicable##4##2##(1994-9#1)(2008-10#2)(2008-11#1)
directly applied##4##2##(2008-10#4)
directly as##5##2##(1991-5#1)(1996-5#1)(2008-10#1)(2011-1#1)(2011-2#1)
directly assess##2##2##(1997-2#1)(2008-3#1)
directly associated with##2##3##(2008-10#1)(2012-2#1)
directly at the##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
directly at##5##2##(1991-2#1)(2008-11#1)(2008-9#1)(2011-2#1)(2011-3#1)
directly attributable to the##2##4##(2008-7#2)
directly attributable to##5##3##(2008-10#1)(2008-4#1)(2008-7#3)
directly be##2##2##(2008-10#2)
directly by use of##2##4##(2008-3#1)(2008-8#1)
directly by##24##2##(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
directly compare##2##2##(2008-10#1)(2008-8#1)
directly compared##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
directly correlate with the##2##4##(2008-7#1)(2008-9#1)
directly correlated with the##2##4##(1996-9#1)(2008-2#1)
directly correlated with##9##3##(1993-11#1)(1996-9#1)(2008-10#2)(2008-2#1)(2010-7#1)(2011-2#2)(2013-8#1)
directly correlates with##2##3##(2009-3#1)(2013-1#1)
directly coupled with fluorimetric detection in a##2##7##(2008-10#2)
directly coupled with##3##3##(2008-10#3)
directly coupled##4##2##(1994-6#1)(2008-10#3)
directly demonstrated##2##2##(2008-10#1)(2012-2#1)
directly dependent on the##2##4##(2008-10#1)(2008-8#1)
directly dependent on##3##3##(1990-8#1)(2008-10#1)(2008-8#1)
directly detected##2##2##(2008-10#2)
directly determined by the##2##4##(1993-6#1)(1995-11#1)
directly determined by##3##3##(1993-6#1)(1995-11#1)(2008-10#1)
directly determined##5##2##(1993-6#1)(1995-11#1)(2008-10#3)
directly exposed to##2##3##(2008-10#2)
directly from crude##2##3##(2008-10#1)(2008-4#1)
directly from the crude##2##4##(2008-11#2)
directly from the##17##3##(1993-12#1)(1994-12#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)
directly from##37##2##(1990-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
directly if##2##2##(1994-2#1)(2008-8#1)
directly impact on##2##3##(2013-8#2)
directly impact##4##2##(1992-1#1)(1994-3#1)(2013-8#2)
directly in soil##3##3##(2008-10#3)
directly in the##14##3##(1991-1#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2010-6#1)(2011-1#1)
directly in##22##2##(1991-1#1)(1995-12#1)(1997-7#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#1)(2010-6#1)(2011-1#1)
directly influence the##2##3##(1995-9#1)(2013-1#1)
directly influence##6##2##(1995-11#1)(1995-9#1)(1996-2#1)(2008-7#1)(2009-3#1)(2013-1#1)
directly influences the##2##3##(2008-10#2)
directly inhibit##2##2##(2008-5#1)(2008-9#1)
directly inhibits##2##2##(2008-11#1)(2011-2#1)
directly injected into##2##3##(2008-10#2)
directly injected##3##2##(2008-10#3)
directly inserted in the plasma for ICP-AES measurement##2##8##(2008-10#2)
directly inserted##3##2##(2008-10#3)
directly inside##2##2##(2008-11#1)(2008-8#1)
directly interact##2##2##(1995-2#1)(2008-11#1)
directly interfaced##2##2##(2008-1#1)(2008-10#1)
directly into a##4##3##(2008-10#3)(2008-11#1)
directly into the##15##3##(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-2#1)
directly into##25##2##(2008-10#16)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2011-2#2)(2013-2#1)
directly introduced into the flame##2##5##(2008-10#2)
directly introduced into the##5##4##(2008-10#5)
directly introduced into##6##3##(2008-10#6)
directly introduced##10##2##(1995-2#2)(2008-10#7)(2008-9#1)
directly involved in the##4##4##(1993-8#1)(1995-12#1)(1996-12#1)(2012-3#1)
directly involved in##6##3##(1993-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-11#1)(2012-3#1)
directly linked to##5##3##(1994-11#1)(2008-5#1)(2011-2#2)(2012-3#1)
directly linked##6##2##(1994-11#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-3#1)
directly measured##7##2##(1992-3#1)(1995-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-8#1)
directly measuring##3##2##(1991-3#1)(2007-12#1)(2008-10#1)
directly observed preventive therapy (DOPT)##2##5##(1996-3#1)(1997-2#1)
directly observed preventive therapy##3##4##(1996-3#1)(1997-2#2)
directly observed therapy (DOT)##5##4##(1996-11#1)(1996-3#4)
directly observed therapy in##2##4##(1996-3#2)
directly observed therapy##15##3##(1996-11#1)(1996-3#14)
directly observed##20##2##(1996-11#1)(1996-3#15)(1997-2#2)(2008-10#1)(2013-8#1)
directly on the##10##3##(1994-3#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#5)(2009-12#1)
directly on##23##2##(1993-9#1)(1994-3#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#10)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2012-3#1)(2013-1#1)
directly onto a##4##3##(2008-10#2)(2008-3#1)(2009-5#1)
directly onto##6##2##(2008-10#3)(2008-3#2)(2009-5#1)
directly or indirectly##8##3##(1992-9#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)
directly or##14##2##(1990-8#1)(1992-9#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)
directly performed##3##2##(2008-10#3)
directly proportional to the concentration of##4##6##(2008-10#4)
directly proportional to the##12##4##(2008-10#10)(2008-11#1)(2012-2#1)
directly proportional to##14##3##(2008-10#11)(2008-11#2)(2012-2#1)
directly related to the##10##4##(1990-5#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)
directly related to##26##3##(1990-5#2)(1993-11#1)(1994-12#1)(1994-2#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2012-3#1)(2013-1#1)(2013-8#1)
directly related with##2##3##(2008-10#1)(2011-2#1)
directly related##28##2##(1990-5#2)(1993-11#1)(1994-12#1)(1994-2#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
directly relevant to##2##3##(2008-8#1)(2013-8#1)
directly repeated##4##2##(1993-2#1)(1995-8#2)(1996-6#1)
directly stimulate##3##2##(1991-5#1)(2008-10#1)(2008-11#1)
directly the##4##2##(1995-1#1)(2008-10#2)(2008-2#1)
directly through the##4##3##(2008-10#4)
directly through##7##2##(2008-10#5)(2009-5#1)(2012-2#1)
directly to the nebulizer-burner system of the##2##7##(2008-10#2)
directly to the surface of##2##5##(1994-11#1)(2008-10#1)
directly to the##17##3##(1990-8#1)(1993-6#1)(1994-11#1)(1995-6#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-7#2)
directly to##33##2##(1990-8#1)(1990-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-1#1)(1997-1#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#2)
directly weighed##3##2##(2008-10#3)
directly with an##2##3##(1996-12#1)(2008-10#1)
directly with the##5##3##(1995-6#2)(1996-2#2)(2008-3#1)
directly with##16##2##(1993-12#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#2)(2008-10#6)(2008-3#1)
directly within the##2##3##(2008-11#2)
directly without the##3##3##(1995-8#1)(2008-10#1)(2008-12#1)
directly without##4##2##(1995-8#1)(2008-10#2)(2008-12#1)
directly##624##1##(1990-11#1)(1990-5#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-1#1)(1992-3#2)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#8)(1995-3#4)(1995-5#1)(1995-6#7)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#15)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#5)(1997-4#2)(1997-7#2)(2006-6#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#243)(2008-11#43)(2008-12#4)(2008-2#6)(2008-3#15)(2008-4#7)(2008-5#10)(2008-6#3)(2008-7#18)(2008-8#19)(2008-9#17)(2009-11#2)(2009-12#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#2)(2010-12#1)(2010-3#1)(2010-6#3)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#23)(2011-3#2)(2012-2#12)(2012-3#5)(2012-6#1)(2013-1#15)(2013-2#1)(2013-7#1)(2013-8#8)
director and##3##2##(1993-12#2)(1994-3#1)
director of the International AIDS Center##2##6##(1990-11#2)
director of the##4##3##(1990-11#2)(1992-8#1)(1997-6#1)
director of##6##2##(1990-11#2)(1992-8#1)(1993-12#1)(1995-1#1)(1997-6#1)
director##15##1##(1990-11#2)(1992-8#1)(1993-1#1)(1993-12#3)(1994-3#2)(1995-1#2)(1997-6#2)(2008-6#1)(2008-9#1)
director's##4##1##(1994-2#1)(1994-3#2)(1995-3#1)
directories##2##1##(1994-3#1)(2008-9#1)
directors and##6##2##(1992-12#1)(1994-1#2)(1994-12#1)(1995-12#1)(1995-3#1)
directors are##2##2##(1991-3#1)(1994-3#1)
directors in##2##2##(2007-12#1)(2009-8#1)
directors of##4##2##(1994-1#1)(1995-2#1)(1995-3#1)(1995-6#1)
directors##37##1##(1991-3#2)(1992-12#4)(1994-1#3)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-4#1)(2009-8#3)(2011-2#2)(2013-8#1)
directory##3##1##(1991-3#1)(1994-1#1)(1995-9#1)
directs the##5##2##(1994-2#1)(1994-5#1)(2008-7#1)(2010-5#1)(2011-1#1)
directs##13##1##(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#1)(1997-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-1#2)(2012-2#1)
dirhodum##2##1##(2008-10#2)
dirhodum)##2##1##(2008-10#2)
dirithromycin components##2##2##(2008-10#2)
dirithromycin##5##1##(2008-10#5)
dirty##5##1##(1991-3#1)(1993-1#1)(1996-2#1)(1997-5#1)(2013-7#1)
disabilities and##5##2##(1994-2#1)(1995-1#1)(1996-1#1)(2008-11#1)(2008-7#1)
disabilities as##2##2##(1995-12#1)(2008-7#1)
disabilities in##9##2##(1991-12#1)(1995-6#1)(1996-1#2)(1997-1#2)(1997-2#2)(2010-8#1)
disabilities of##2##2##(1995-2#1)(2008-9#1)
disabilities or##4##2##(1993-3#1)(2010-11#3)
disabilities were##2##2##(1995-1#1)(1996-1#1)
disabilities##80##1##(1991-12#1)(1993-1#1)(1993-3#5)(1993-9#1)(1994-1#2)(1994-2#1)(1995-1#4)(1995-12#5)(1995-2#1)(1995-6#3)(1996-1#10)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#3)(2008-11#4)(2008-12#3)(2008-7#2)(2008-9#2)(2009-6#7)(2010-10#2)(2010-11#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2012-2#2)(2012-3#2)(2013-1#1)
disability and##8##2##(1991-12#1)(1995-6#1)(1997-1#2)(2008-11#2)(2008-7#1)(2012-3#1)
disability as##3##2##(1995-1#1)(2008-7#1)(2012-12#1)
disability at##2##2##(2008-7#2)
disability in##5##2##(1993-3#1)(1995-2#1)(2011-7#1)(2013-1#2)
disability management program##2##3##(1997-2#2)
disability management##3##2##(1992-2#1)(1997-2#2)
disability pension##3##2##(1991-11#2)(1993-6#1)
disability policy##4##2##(1992-3#2)(1996-1#2)
disability were##2##2##(1995-12#1)(2008-7#1)
disability##115##1##(1990-6#1)(1991-1#1)(1991-11#5)(1991-12#2)(1991-3#1)(1992-12#2)(1992-2#3)(1992-3#3)(1993-3#2)(1993-6#4)(1994-1#2)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#4)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#5)(1997-2#2)(1997-8#1)(2008-11#11)(2008-12#6)(2008-4#2)(2008-7#12)(2008-8#2)(2009-11#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
disability-based distinctions##2##2##(1995-12#1)(1996-5#1)
disability-based##3##1##(1995-12#1)(1996-5#2)
disable##2##1##(2011-2#2)
disabled Medicare beneficiaries##3##3##(1991-1#1)(1991-2#1)(1991-3#1)
disabled Medicare enrollees##4##3##(1992-2#3)(1997-1#1)
disabled Medicare##9##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#3)(1995-12#2)(1997-1#1)
disabled and elderly subjects##2##4##(2008-7#2)
disabled and##6##2##(1991-12#1)(1994-2#1)(2008-7#4)
disabled in##3##2##(2008-7#2)(2009-1#1)
disabled patients##3##2##(1995-1#1)(1995-11#1)(2008-8#1)
disabled people##3##2##(1993-1#1)(1995-12#1)(2008-11#1)
disabled persons##2##2##(1992-3#1)(1995-3#1)
disabled population##2##2##(1997-2#2)
disabled state in##2##3##(1997-3#2)
disabled workers##3##2##(1994-1#1)(1995-2#2)
disabled##56##1##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#4)(1992-3#2)(1993-1#1)(1993-3#1)(1994-1#3)(1994-2#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#1)(2008-11#2)(2008-12#2)(2008-7#9)(2008-8#2)(2009-1#1)(2009-6#2)(2012-3#1)
disabling chronic conditions##2##3##(2011-2#2)
disabling conditions##4##2##(1994-1#1)(1997-2#3)
disabling tinnitus##2##2##(2010-7#2)
disabling##14##1##(1994-1#1)(1996-5#1)(1997-2#3)(1997-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#2)(2011-2#3)
disaccharidase activity##2##2##(2013-1#2)
disaccharide##10##1##(1990-2#1)(1992-12#4)(1992-6#1)(1994-8#1)(2009-6#1)(2010-11#2)
disaccharides and##2##2##(2008-10#1)(2008-7#1)
disaccharides##9##1##(1992-6#1)(1994-5#2)(2008-10#2)(2008-7#4)
disadvantage for##2##2##(2008-10#1)(2008-11#1)
disadvantage of##4##2##(1997-2#2)(2008-11#1)(2009-8#1)
disadvantage was##2##2##(2008-10#1)(2009-7#1)
disadvantage##22##1##(1990-2#1)(1992-3#1)(1997-2#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#5)(2009-8#1)(2010-9#1)(2013-1#1)
disadvantaged families##2##2##(2008-11#1)(2008-12#1)
disadvantaged##7##1##(1995-3#1)(2008-11#2)(2008-12#1)(2010-9#1)(2012-12#1)(2013-8#1)
disadvantageous##2##1##(2008-11#1)(2009-10#1)
disadvantages and##3##2##(1996-1#1)(1997-7#1)(2011-2#1)
disadvantages associated with##2##3##(2008-5#1)(2012-2#1)
disadvantages of the developed##2##4##(2008-10#1)(2010-8#1)
disadvantages of the##5##3##(1992-3#1)(2008-10#2)(2009-5#1)(2010-8#1)
disadvantages of##26##2##(1990-11#1)(1991-1#1)(1991-3#1)(1992-3#2)(1993-3#1)(1996-1#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-4#1)(2009-5#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
disadvantages to##2##2##(2010-4#1)(2012-2#1)
disadvantages with##2##2##(2008-7#1)(2010-11#1)
disadvantages##48##1##(1990-11#1)(1991-1#1)(1991-3#2)(1992-3#2)(1993-3#1)(1993-6#1)(1994-3#1)(1996-1#2)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
disaggregated##2##1##(1996-3#1)(2008-11#1)
disaggregation of##2##2##(2008-8#1)(2011-2#1)
disaggregation##3##1##(2008-8#1)(2008-9#1)(2011-2#1)
disagree##3##1##(1993-3#1)(2008-5#1)(2009-4#1)
disagreed with##2##2##(1995-6#1)(2008-10#1)
disagreed##4##1##(1995-6#1)(1996-5#2)(2008-10#1)
disagreement about the##2##3##(1997-7#1)(2011-10#1)
disagreement is##2##2##(2008-8#1)(2012-3#1)
disagreement with the##2##3##(1991-2#1)(2008-8#1)
disagreement with##3##2##(1991-2#1)(2008-8#1)(2010-10#1)
disagreement##15##1##(1990-12#1)(1991-2#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-2#1)(2010-10#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
disagreements##6##1##(1994-9#1)(2008-9#1)(2011-2#1)(2012-12#3)
disagrees with the##2##3##(1995-3#1)(2008-10#1)
disalicylic##2##1##(2008-10#2)
disappear##9##1##(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-7#2)(2010-11#1)
disappearance of the##7##3##(1993-8#1)(1996-3#2)(2008-10#2)(2008-3#1)(2009-9#1)
disappearance of##20##2##(1990-5#1)(1993-8#1)(1996-3#2)(1997-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2009-4#2)(2009-9#1)(2011-2#3)(2013-8#1)
disappearance##22##1##(1990-11#1)(1990-5#1)(1993-8#2)(1996-3#2)(1997-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2009-4#2)(2009-9#1)(2011-2#3)(2013-8#1)
disappeared after the##3##3##(1991-11#1)(1994-3#1)(2008-5#1)
disappeared after##7##2##(1991-11#1)(1994-3#1)(2008-11#2)(2008-5#2)(2008-7#1)
disappeared and##4##2##(1996-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
disappeared as##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
disappeared by##2##2##(1995-11#1)(1995-12#1)
disappeared completely##3##2##(1996-11#1)(2008-10#1)(2008-7#1)
disappeared from the##2##3##(2008-10#1)(2008-11#1)
disappeared from##4##2##(1996-2#1)(2008-10#2)(2008-11#1)
disappeared in the##3##3##(1992-6#1)(1997-8#1)(2008-7#1)
disappeared in##8##2##(1990-8#1)(1992-5#1)(1992-6#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
disappeared or##3##2##(1991-2#1)(1993-3#1)(2008-10#1)
disappeared when the##2##3##(1991-2#1)(2008-9#1)
disappeared when##3##2##(1991-2#1)(2008-9#1)(2011-2#1)
disappeared with##3##2##(2008-5#1)(2009-2#1)(2013-1#1)
disappeared##61##1##(1990-8#1)(1991-11#1)(1991-2#5)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-2#2)(1996-9#1)(1997-8#1)(2008-10#6)(2008-11#5)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#4)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#3)
disappearing##2##1##(1994-9#1)(2011-2#1)
disappears##6##1##(1992-6#1)(1993-8#1)(2008-10#1)(2008-11#2)(2012-3#1)
disappointing results##4##2##(1990-12#1)(1990-6#1)(1997-3#1)(2008-8#1)
disappointing##13##1##(1990-12#1)(1990-6#1)(1994-2#1)(1996-11#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-3#1)
disassemble##3##1##(2008-10#1)(2008-9#1)(2011-2#1)
disassembly of the nuclear##2##4##(2011-2#2)
disassembly of the##3##3##(2011-2#3)
disassembly of##5##2##(1994-12#1)(2011-2#4)
disassembly##7##1##(1994-12#1)(2008-11#1)(2011-2#5)
disaster management##2##2##(2008-11#1)(2009-12#1)
disaster nursing##3##2##(2008-11#3)
disaster strikes##2##2##(2010-8#1)(2012-3#1)
disaster##28##1##(1991-2#4)(1992-12#4)(1993-1#1)(1995-11#5)(2008-10#2)(2008-11#5)(2008-12#1)(2008-9#1)(2009-12#1)(2010-8#2)(2012-3#1)(2013-8#1)
disasters in##2##2##(1991-2#1)(2010-8#1)
disasters##9##1##(1991-2#3)(1993-1#1)(2008-11#1)(2010-8#3)(2012-3#1)
disastrous consequences##3##2##(2008-11#1)(2008-9#1)(2010-7#1)
disastrous##6##1##(2008-11#1)(2008-9#2)(2010-1#1)(2010-7#1)(2011-2#1)
disc and##4##2##(1994-11#1)(1996-6#1)(2008-10#1)(2008-12#1)
disc arthroplasty##5##2##(2011-2#3)(2012-12#2)
disc at##2##2##(2008-3#1)(2012-2#1)
disc degeneration##6##2##(2010-6#1)(2011-2#3)(2012-3#2)
disc diffusion method and##2##4##(2008-12#1)(2012-3#1)
disc diffusion method##5##3##(2008-12#2)(2012-2#1)(2012-3#2)
disc diffusion susceptibility##2##3##(2008-7#2)
disc diffusion##9##2##(2008-12#3)(2008-7#3)(2012-2#1)(2012-3#2)
disc disease##12##2##(2008-12#1)(2008-7#1)(2011-2#4)(2012-12#2)(2012-3#3)(2013-1#1)
disc electrode##8##2##(2008-10#8)
disc fragment##2##2##(2011-2#2)
disc harrow##3##2##(2008-10#3)
disc height##2##2##(2011-2#2)
disc herniation at##2##3##(2011-2#2)
disc herniation during pregnancy##2##4##(2008-12#2)
disc herniation##14##2##(1997-3#2)(2008-12#4)(2009-12#1)(2011-2#3)(2012-2#3)(2013-1#1)
disc implants##2##2##(2012-12#2)
disc protrusion##4##2##(2008-7#3)(2012-2#1)
disc replacement##13##2##(2012-12#13)
disc with a##2##3##(1994-11#1)(1995-12#1)
disc with##4##2##(1994-11#1)(1995-12#1)(2008-10#1)(2008-3#1)
disc##143##1##(1994-11#5)(1995-12#2)(1996-6#4)(1997-3#2)(2008-10#18)(2008-12#10)(2008-3#3)(2008-7#10)(2008-9#1)(2009-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#29)(2012-12#26)(2012-2#10)(2012-3#13)(2013-1#4)(2013-7#1)
disc-recordable##2##1##(2008-3#2)
discarded from##3##2##(2008-10#3)
discarded##12##1##(1996-9#1)(2008-10#8)(2008-11#3)
discarding##2##1##(2008-10#2)
discectomy##15##1##(1996-3#3)(2008-12#3)(2008-7#2)(2012-12#5)(2012-3#2)
discern##6##1##(2008-10#2)(2008-9#1)(2010-7#1)(2013-1#2)
discernable##5##1##(2008-10#1)(2008-11#2)(2008-9#1)(2010-3#1)
discerned##5##1##(1991-5#1)(1995-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
discernible##5##1##(1991-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)
discerning##2##1##(1997-1#1)(2008-11#1)
discharge and##7##2##(1990-11#1)(2008-10#3)(2008-11#1)(2010-7#1)(2011-2#1)
discharge for##2##2##(1991-2#1)(2013-1#1)
discharge from hospital##2##3##(1990-2#1)(1994-9#1)
discharge from the##6##3##(1992-3#1)(2008-11#1)(2008-8#1)(2010-10#1)(2012-12#1)(2013-8#1)
discharge from##14##2##(1990-2#1)(1992-3#1)(1994-9#1)(1995-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#2)(2010-10#1)(2012-12#1)(2013-8#1)
discharge of ascospores##4##3##(2008-10#4)
discharge of the##3##3##(1995-11#1)(2008-11#1)(2011-2#1)
discharge of##10##2##(1991-6#1)(1995-11#1)(2008-10#6)(2008-11#1)(2011-2#1)
discharge on the##2##3##(2012-12#1)(2013-1#1)
discharge or##2##2##(2008-11#1)(2012-12#1)
discharge planning and##2##3##(2008-11#1)(2010-11#1)
discharge planning##4##2##(2008-11#1)(2009-5#1)(2010-11#2)
discharge plans##3##2##(1991-3#1)(1995-1#1)(1997-3#1)
discharge rate##3##2##(1990-12#1)(1996-2#2)
discharge records##2##2##(1993-12#2)
discharge summary##2##2##(2008-11#1)(2012-12#1)
discharge the##2##2##(2008-1#1)(2008-10#1)
discharge were##2##2##(1990-11#1)(2008-11#1)
discharge##137##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-6#1)(1992-1#2)(1992-2#2)(1992-3#2)(1993-12#4)(1993-2#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#28)(2008-11#13)(2008-12#3)(2008-3#5)(2008-7#4)(2008-8#3)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#4)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#16)(2012-12#5)(2012-2#1)(2013-1#4)(2013-8#2)
discharged from the hospital##3##4##(1994-6#1)(2010-12#1)(2011-2#1)
discharged from##9##2##(1994-6#1)(1995-3#1)(2008-10#3)(2008-11#2)(2010-12#1)(2011-2#1)
discharged home with##2##3##(1995-3#1)(2010-7#1)
discharged home##4##2##(1995-3#2)(2008-12#1)(2010-7#1)
discharged into##2##2##(2008-10#1)(2008-5#1)
discharged on##5##2##(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#2)
discharged to##4##2##(1990-12#2)(1995-3#1)(2011-2#1)
discharged with home oxygen##2##4##(2012-12#2)
discharged with##3##2##(2008-10#1)(2012-12#2)
discharged##44##1##(1990-12#4)(1993-1#1)(1994-6#1)(1995-2#1)(1995-3#4)(1995-6#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#4)(2013-1#2)(2013-8#1)
discharges and##3##2##(1992-2#1)(2013-1#1)(2013-8#1)
discharges from##2##2##(1992-2#1)(1993-12#1)
discharges may##2##2##(2008-11#1)(2008-9#1)
discharges to home##2##3##(1991-2#2)
discharges to##3##2##(1991-2#3)
discharges##43##1##(1990-12#3)(1991-1#1)(1991-2#4)(1992-12#1)(1992-2#4)(1993-1#1)(1993-12#6)(1993-5#1)(1995-2#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#4)(2009-8#3)(2013-1#2)(2013-8#2)
discharging the##2##2##(2008-10#1)(2008-11#1)
discharging##5##1##(2008-10#3)(2008-11#1)(2012-2#1)
disciplinary##3##1##(1995-2#1)(2008-10#2)
discipline and##2##2##(2009-9#1)(2010-11#1)
discipline gap##2##2##(2008-12#2)
discipline in##2##2##(2010-11#1)(2013-1#1)
discipline of##3##2##(2008-12#1)(2008-4#1)(2010-1#1)
discipline strategies##2##2##(1995-2#1)(2010-11#1)
discipline with##2##2##(2008-11#1)(2008-12#1)
discipline##39##1##(1993-2#1)(1994-12#5)(1994-2#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#4)(2008-12#7)(2008-4#1)(2009-7#2)(2009-9#2)(2010-1#2)(2010-11#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
discipline)##2##1##(2009-9#1)(2010-11#1)
disciplines and##4##2##(1995-5#1)(2008-11#1)(2008-12#1)(2010-10#1)
disciplines are##3##2##(1991-2#1)(1996-12#1)(2011-2#1)
disciplines to##3##2##(1996-3#1)(2008-11#2)
disciplines##41##1##(1991-12#1)(1991-2#1)(1993-3#2)(1994-12#3)(1994-2#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-12#4)(2008-4#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
disclose the##4##2##(1990-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
disclose##8##1##(1990-12#1)(1991-12#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)
disclosed by##2##2##(1996-6#1)(2008-10#1)
disclosed that##6##2##(1990-12#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
disclosed to##3##2##(2009-4#3)
disclosed##20##1##(1990-12#1)(1990-3#1)(1991-3#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-3#2)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#3)(2012-3#1)
discloses##2##1##(1997-8#1)(2008-5#1)
disclosing the##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
disclosing##9##1##(1991-6#1)(1996-3#2)(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
disclosure in##2##2##(1995-3#1)(2009-4#1)
disclosure of##4##2##(1995-12#1)(2008-10#1)(2008-3#1)(2009-7#1)
disclosure##19##1##(1991-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-4#3)(2009-7#1)(2012-3#1)
discogenic##3##1##(2010-9#1)(2012-12#2)
discographies##2##1##(2012-12#2)
discography in patients with##3##4##(2012-12#3)
discography##12##1##(2012-12#12)
discoid lupus##2##2##(2008-8#1)(2011-2#1)
discoid##5##1##(2008-8#1)(2011-2#1)(2013-1#3)
discoideum##6##1##(1995-6#3)(1995-8#1)(2008-9#1)(2009-8#1)
discoloration of the skin##2##4##(1995-11#1)(2008-1#1)
discoloration of##4##2##(1995-11#1)(2008-1#1)(2008-10#1)(2013-1#1)
discoloration##17##1##(1995-11#1)(2008-1#1)(2008-10#14)(2013-1#1)
discolored##6##1##(1995-11#3)(2008-10#3)
discolouration##5##1##(2008-10#5)
discomfort and##4##2##(1991-2#1)(2008-7#1)(2011-2#2)
discomfort in##3##2##(1996-3#1)(2008-12#2)
discomfort##26##1##(1990-3#1)(1991-2#1)(1992-3#1)(1993-12#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-12#5)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-6#1)(2011-2#2)
disconnected##3##1##(1994-2#1)(1995-12#1)(2011-3#1)
disconnection of a central venous catheter##2##6##(2008-7#2)
disconnection##5##1##(2008-10#1)(2008-7#4)
disconnects##2##1##(2008-11#1)(2011-2#1)
discontinuation of the##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
discontinuation of##12##2##(1991-2#2)(1993-11#1)(2008-11#3)(2008-7#2)(2008-8#1)(2011-2#2)(2012-3#1)
discontinuation##18##1##(1991-2#2)(1993-11#1)(2008-11#7)(2008-7#2)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
discontinued because of##2##3##(2008-10#1)(2011-2#1)
discontinued##13##1##(1990-2#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
discontinuing##4##1##(2008-1#3)(2010-9#1)
discontinuities in##2##2##(1996-2#1)(2012-2#1)
discontinuities##5##1##(1996-2#1)(2007-12#1)(2008-3#2)(2012-2#1)
discontinuity##3##1##(1995-12#1)(2008-10#1)(2008-5#1)
discontinuous##18##1##(1995-2#2)(1996-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2010-4#1)(2012-2#1)
discordance in a pair of monozygotic twins##2##7##(2008-7#2)
discordant##3##1##(2008-11#1)(2010-12#1)(2011-2#1)
discount the##4##2##(2008-10#2)(2009-7#1)(2009-9#1)
discounting and collection policies for uninsured and underinsured patients##2##9##(2008-11#2)
discounting##3##1##(2008-11#2)(2009-4#1)
discourage##2##1##(2008-9#1)(2009-7#1)
discouraged##10##1##(1991-6#1)(1992-3#2)(1996-1#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-8#1)
discourse about##2##2##(2010-10#2)
discourse analysis##3##2##(2010-10#1)(2010-2#1)(2012-3#1)
discourse comprehension##3##2##(2011-1#1)(2012-3#2)
discourse of##2##2##(2010-10#1)(2013-8#1)
discourse##17##1##(2008-12#1)(2008-9#1)(2010-10#4)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-8#2)
discourses and##3##2##(2008-11#1)(2010-9#1)(2011-2#1)
discourses##10##1##(1994-1#1)(2008-11#2)(2010-10#3)(2010-9#3)(2011-2#1)
discover that##2##2##(2012-2#1)(2012-3#1)
discover##21##1##(1993-1#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#2)(2010-12#1)(2010-5#2)(2012-2#2)(2012-3#3)
discovered a##5##2##(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
discovered about##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
discovered and##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
discovered as a##4##3##(1991-11#1)(2008-10#1)(2009-4#1)(2011-2#1)
discovered by magnetic resonance imaging##2##5##(2008-7#1)(2009-5#1)
discovered by##8##2##(1990-5#1)(1993-8#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)
discovered during##4##2##(2008-5#2)(2009-8#1)(2011-2#1)
discovered in a##2##3##(1990-11#1)(2008-5#1)
discovered in the##7##3##(1991-7#1)(1996-11#1)(2008-7#1)(2008-9#2)(2010-7#1)(2012-3#1)
discovered in##19##2##(1990-11#2)(1991-7#1)(1996-11#1)(1996-3#1)(1996-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-7#2)(2011-3#1)(2012-3#1)(2013-1#1)
discovered that the##6##3##(1991-3#1)(2009-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
discovered that##18##2##(1991-3#1)(1996-1#1)(1997-1#1)(2008-10#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
discovered the##3##2##(1990-3#1)(1992-5#1)(1993-6#1)
discovered to##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
discovered##125##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#3)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(2007-11#1)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-4#2)(2010-6#1)(2010-7#4)(2011-2#12)(2011-3#1)(2012-2#4)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#3)
discoveries and##4##2##(1996-12#1)(2009-10#1)(2012-2#1)(2013-1#1)
discoveries in##2##2##(1997-1#1)(2012-2#1)
discoveries of##5##2##(1994-3#1)(2008-10#2)(2010-1#1)(2011-2#1)
discoveries to##2##2##(2010-1#1)(2010-10#1)
discoveries##27##1##(1994-3#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#4)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
discovering and##2##2##(2008-4#1)(2012-3#1)
discovering the##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
discovering##14##1##(1991-1#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
discovers##2##1##(2008-9#1)(2010-8#1)
discovery and biological##2##3##(2008-4#1)(2011-3#1)
discovery and characterization of novel##2##5##(2008-10#1)(2008-9#1)
discovery and characterization of##3##4##(1997-1#1)(2008-10#1)(2008-9#1)
discovery and development of DAPY derivatives as next-generation##2##8##(2011-3#2)
discovery and development of##3##4##(2010-8#1)(2011-3#2)
discovery and##18##2##(1997-1#1)(2008-10#3)(2008-4#3)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#5)(2012-3#1)(2013-8#1)
discovery in##5##2##(1994-9#1)(1995-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
discovery is##3##2##(2010-5#1)(2010-7#1)(2012-2#1)
discovery of a##4##3##(1990-12#1)(1992-6#1)(1993-3#1)(2010-7#1)
discovery of new##5##3##(2008-10#2)(2009-12#1)(2011-2#1)(2011-3#1)
discovery of novel##5##3##(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
discovery of potent and##2##4##(2008-11#1)(2008-5#1)
discovery of the##13##3##(1991-8#1)(2008-10#1)(2008-11#3)(2009-5#2)(2009-8#1)(2010-1#2)(2010-7#1)(2011-3#1)(2013-8#1)
discovery of##65##2##(1990-12#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-11#1)(1997-7#1)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#6)(2011-3#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
discovery that##3##2##(1997-2#1)(1997-3#1)(2012-2#1)
discovery to##3##2##(2008-9#1)(2012-2#1)(2013-8#1)
discovery##146##1##(1990-12#1)(1990-8#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-11#2)(1994-9#1)(1995-12#3)(1995-8#1)(1996-11#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#19)(2008-11#11)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#9)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#12)(2012-2#9)(2012-3#4)(2013-1#3)(2013-8#5)
discrepancies between##9##2##(1990-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)
discrepancies from##2##2##(2008-3#2)
discrepancies in##4##2##(2008-10#1)(2009-12#1)(2011-1#1)(2012-2#1)
discrepancies##19##1##(1990-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#4)(2008-9#2)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
discrepancy between the##3##3##(1991-12#1)(1997-4#1)(2008-11#1)
discrepancy between##7##2##(1991-12#1)(1995-1#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
discrepancy in##5##2##(1993-3#1)(1993-9#1)(2008-1#1)(2009-3#1)(2010-6#1)
discrepancy of##2##2##(2011-2#2)
discrepancy principle##2##2##(2008-2#2)
discrepancy##29##1##(1991-12#1)(1993-11#1)(1993-3#1)(1993-9#3)(1995-1#1)(1997-4#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#1)(2009-3#3)(2009-7#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
discrepant##3##1##(2011-2#2)(2012-12#1)
discrete Fourier transform##2##3##(2008-10#1)(2008-6#1)
discrete brain regions##2##3##(1995-2#1)(1996-12#1)
discrete clusters##2##2##(1996-12#1)(2008-10#1)
discrete density##2##2##(1995-3#1)(2008-3#1)
discrete mortality pockets##2##3##(2008-10#2)
discrete sample##2##2##(2008-10#2)
discrete scatterers##2##2##(2008-3#2)
discrete steps##2##2##(2008-11#1)(2008-5#1)
discrete##93##1##(1991-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#3)(2007-11#3)(2007-12#3)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#5)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
discrete-time##3##1##(2008-6#1)(2008-8#1)(2011-2#1)
discretionary##2##1##(1994-3#1)(2008-12#1)
discretization##2##1##(2008-3#1)(2013-8#1)
discriminant analyses in##2##3##(1991-12#2)
discriminant analyses##3##2##(1991-12#2)(2008-10#1)
discriminant analysis and artificial neural networks##3##6##(2008-10#3)
discriminant analysis and##7##3##(2008-10#5)(2008-5#2)
discriminant analysis identified##2##3##(1991-12#1)(2008-10#1)
discriminant analysis were##2##3##(2008-10#2)
discriminant analysis##40##2##(1991-12#1)(1991-2#1)(1992-1#1)(2008-10#31)(2008-11#1)(2008-5#3)(2008-7#1)(2010-8#1)
discriminant equation 'J##2##3##(2008-10#2)
discriminant equation##3##2##(2008-10#3)
discriminant factorial analysis##2##3##(2008-10#2)
discriminant function##2##2##(2008-10#1)(2008-5#1)
discriminant functions were##2##3##(2008-10#2)
discriminant functions##5##2##(2008-10#3)(2008-5#2)
discriminant partial least squares##2##4##(2008-10#2)
discriminant test##2##2##(1991-12#2)
discriminant##69##1##(1991-12#7)(1991-2#2)(1992-1#1)(2008-10#48)(2008-11#1)(2008-5#6)(2008-7#1)(2009-11#1)(2010-8#1)(2011-2#1)
discriminate against foreign songs recorded at##3##6##(2008-8#3)
discriminate against foreign songs##4##4##(2008-8#4)
discriminate against##7##2##(1990-2#1)(1994-2#1)(1994-3#1)(2008-8#4)
discriminate between tastants##3##3##(2008-11#3)
discriminate between##23##2##(1991-3#1)(1994-8#1)(1995-2#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#2)(2010-12#1)
discriminate different##2##2##(1991-5#1)(2008-10#1)
discriminate##65##1##(1990-2#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-2#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#8)(2008-9#4)(2009-12#1)(2010-10#2)(2010-12#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-2#2)
discriminated against##2##2##(1997-5#1)(2008-10#1)
discriminated between##3##2##(2008-10#1)(2008-6#1)(2011-10#1)
discriminated by##2##2##(1997-6#1)(2008-10#1)
discriminated##20##1##(1990-2#1)(1992-5#1)(1997-5#1)(1997-6#1)(2008-10#13)(2008-6#1)(2009-6#1)(2011-10#1)
discriminates##4##1##(1993-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
discriminating ability towards##6##3##(2008-10#6)
discriminating ability##7##2##(2008-10#7)
discriminating between##7##2##(1994-5#1)(2008-10#5)(2008-7#1)
discriminating power##2##2##(2008-10#1)(2011-2#1)
discriminating the##2##2##(2008-10#2)
discriminating##31##1##(1994-5#1)(1995-11#1)(1996-5#1)(2008-10#20)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#3)
discrimination ability##3##2##(2008-8#1)(2008-9#2)
discrimination against people with##2##4##(1995-12#1)(1995-6#1)
discrimination against##5##2##(1995-12#2)(1995-6#1)(2008-3#1)(2010-10#1)
discrimination and identification##3##3##(1996-2#1)(2008-9#2)
discrimination and##12##2##(1992-12#1)(1993-6#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2009-3#1)
discrimination are##2##2##(1996-3#1)(2008-3#1)
discrimination at the##2##3##(2011-2#2)
discrimination between different models##2##4##(2008-10#2)
discrimination between different##3##3##(2008-10#3)
discrimination between one component##2##4##(2008-10#2)
discrimination between##22##2##(1991-5#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)
discrimination can be##2##3##(2008-10#2)
discrimination from##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
discrimination in the##2##3##(1990-8#1)(2008-9#1)
discrimination in##9##2##(1990-8#1)(1991-1#1)(1996-2#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#2)
discrimination learning##3##2##(1992-12#3)
discrimination of coatings on##2##4##(2008-10#2)
discrimination of the##2##3##(2008-10#1)(2008-2#1)
discrimination of##27##2##(1993-6#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)
discrimination on##2##2##(1994-1#1)(2008-12#1)
discrimination power##10##2##(1995-11#1)(2008-10#2)(2008-12#1)(2011-2#4)(2013-1#2)
discrimination task##2##2##(1993-3#1)(2008-9#1)
discrimination test##3##2##(2008-9#3)
discrimination to##2##2##(2008-10#2)
discrimination using##4##2##(2008-12#1)(2008-4#2)(2008-9#1)
discrimination##155##1##(1990-2#2)(1990-8#1)(1991-1#1)(1991-2#2)(1991-5#1)(1992-12#5)(1993-3#1)(1993-6#2)(1994-1#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#1)(2007-12#1)(2008-10#49)(2008-11#3)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#16)(2009-10#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#7)(2012-2#1)(2013-1#2)(2013-8#1)
discriminative##3##1##(2010-4#1)(2010-8#1)(2012-12#1)
discriminator##5##1##(2008-10#4)(2008-11#1)
discriminatory power##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)
discriminatory##10##1##(1996-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2012-2#2)
discs of##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
discs taken from##3##3##(2008-10#3)
discs were##4##2##(2008-10#1)(2008-3#1)(2012-3#2)
discs with##5##2##(2008-3#1)(2008-9#1)(2009-7#1)(2012-12#2)
discs##44##1##(1993-2#1)(1994-11#1)(1996-6#1)(2007-8#5)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-7#2)(2012-12#4)(2012-3#7)(2013-8#1)
discuss a##12##2##(1990-9#1)(1997-2#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-6#1)(2011-2#2)(2013-1#1)(2013-8#2)
discuss about the##2##3##(2008-12#1)(2012-3#1)
discuss about##4##2##(1993-3#1)(2008-12#1)(2012-3#2)
discuss an##2##2##(2008-9#1)(2013-8#1)
discuss and##2##2##(2008-10#2)
discuss current##4##2##(2008-3#1)(2010-7#1)(2010-9#1)(2012-2#1)
discuss different aspects##2##3##(1997-3#1)(2008-11#1)
discuss different##3##2##(1991-11#1)(1997-3#1)(2008-11#1)
discuss here the##2##3##(2008-10#1)(2011-1#1)
discuss here##3##2##(2008-10#1)(2010-11#1)(2011-1#1)
discuss how the##2##3##(2012-2#1)(2013-8#1)
discuss how these##2##3##(2008-12#1)(2010-8#1)
discuss how to##2##3##(2008-9#1)(2011-2#1)
discuss how##12##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
discuss in##3##2##(2009-8#1)(2012-2#2)
discuss issues##2##2##(1992-12#1)(2011-2#1)
discuss its##4##2##(2008-11#3)(2010-7#1)
discuss many##2##2##(2011-2#1)(2012-2#1)
discuss new##4##2##(2008-7#1)(2011-2#1)(2012-2#2)
discuss our##7##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-6#1)(2012-3#1)
discuss possible explanations##2##3##(1991-11#1)(1993-11#1)
discuss possible##5##2##(1991-11#1)(1993-11#1)(2008-11#1)(2009-8#2)
discuss potential##2##2##(2008-9#1)(2011-2#1)
discuss recent advances in the##2##5##(2008-9#1)(2009-12#1)
discuss recent advances in##4##4##(1994-3#1)(2008-9#1)(2009-12#1)(2010-7#1)
discuss recent advances##5##3##(1994-3#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)
discuss recent studies##2##3##(2009-6#1)(2011-2#1)
discuss recent##9##2##(1994-3#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#2)
discuss several##7##2##(1994-2#1)(1995-9#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-2#1)
discuss some of the##5##4##(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)
discuss some##10##2##(1991-1#1)(2008-11#3)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)
discuss the advantages and limitations of##2##6##(2008-9#1)(2012-3#1)
discuss the advantages and##3##4##(2008-9#1)(2011-2#1)(2012-3#1)
discuss the application of##3##4##(2008-4#1)(2008-7#1)(2008-8#1)
discuss the benefits##2##3##(1993-1#1)(2008-9#1)
discuss the case of a##3##5##(1992-12#1)(2008-9#1)(2011-2#1)
discuss the case of##4##4##(1991-2#1)(1992-12#1)(2008-9#1)(2011-2#1)
discuss the case##5##3##(1991-2#1)(1992-12#1)(2008-9#1)(2011-2#2)
discuss the characteristics of##2##4##(2008-11#1)(2008-2#1)
discuss the current##3##3##(2008-11#2)(2012-3#1)
discuss the development of##3##4##(2008-10#1)(2008-11#2)
discuss the diagnosis##2##3##(1990-9#1)(2008-10#1)
discuss the diagnostic##2##3##(1990-9#1)(2013-1#1)
discuss the epidemiology##3##3##(2008-9#1)(2009-4#1)(2011-2#1)
discuss the findings of##2##4##(2008-12#1)(2013-1#1)
discuss the implications of##5##4##(1995-2#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
discuss the implications##6##3##(1995-2#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
discuss the importance of##4##4##(2008-11#2)(2011-2#2)
discuss the key##2##3##(1994-12#1)(2008-11#1)
discuss the methodological##2##3##(2008-10#1)(2008-8#1)
discuss the most##3##3##(2008-8#1)(2009-10#1)(2010-7#1)
discuss the possibility that##3##4##(1991-5#1)(2009-8#1)(2011-2#1)
discuss the possibility##4##3##(1991-5#1)(2009-5#1)(2009-8#1)(2011-2#1)
discuss the possible##6##3##(1992-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
discuss the potential##4##3##(2009-8#2)(2011-1#1)(2013-8#1)
discuss the problem of##2##4##(1997-4#1)(2008-10#1)
discuss the relationship between##2##4##(2008-5#1)(2011-2#1)
discuss the relationship##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
discuss the results of##2##4##(1995-2#1)(2013-8#1)
discuss the results##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
discuss the role of##8##4##(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#1)(2013-8#2)
discuss the roles of##2##4##(2008-7#1)(2009-3#1)
discuss the significance of##2##4##(2009-1#1)(2013-8#1)
discuss the use of##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
discuss the various##2##3##(2008-10#1)(2011-7#1)
discuss the##176##2##(1990-2#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#2)(1995-5#2)(1996-2#2)(1996-6#1)(1997-2#3)(1997-4#1)(2007-12#1)(2008-10#14)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#11)(2009-1#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#3)(2010-9#1)(2011-1#3)(2011-2#21)(2011-7#1)(2012-2#4)(2012-3#6)(2013-1#7)(2013-8#6)
discuss their##10##2##(1995-5#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
discuss these findings in##2##4##(2008-8#1)(2009-8#1)
discuss these issues and##2##4##(2009-9#1)(2010-11#1)
discuss these issues##3##3##(2008-10#1)(2009-9#1)(2010-11#1)
discuss these##8##2##(2008-10#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)
discuss this##6##2##(1990-9#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)
discuss two##4##2##(2008-11#2)(2008-8#1)(2009-10#1)
discuss various##3##2##(1991-11#1)(2008-11#1)(2008-12#1)
discuss ways of##2##3##(2008-11#1)(2008-3#1)
discuss ways##3##2##(1991-2#1)(2008-11#1)(2008-3#1)
discuss why##2##2##(2008-12#1)(2012-3#1)
discuss##385##1##(1990-2#2)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-9#1)(1996-11#1)(1996-2#5)(1996-6#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#29)(2008-11#37)(2008-12#10)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#14)(2008-8#19)(2008-9#21)(2009-1#1)(2009-10#5)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#7)(2009-7#1)(2009-8#19)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#7)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#39)(2011-7#1)(2012-12#1)(2012-2#14)(2012-3#13)(2013-1#12)(2013-7#1)(2013-8#13)
discussed along with##4##3##(1993-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
discussed and a##3##3##(1997-1#1)(2008-10#1)(2011-7#1)
discussed and compared with those##4##5##(1993-11#1)(2008-10#2)(2008-3#1)
discussed and compared with##7##4##(1993-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
discussed and compared##9##3##(1993-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)
discussed and illustrated with##2##4##(2008-10#1)(2012-2#1)
discussed and illustrated##3##3##(2008-10#1)(2012-2#2)
discussed and the##8##3##(1996-2#1)(2008-10#6)(2008-7#1)
discussed and##45##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
discussed are##6##2##(1992-12#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
discussed as a##4##3##(1995-3#1)(2008-10#1)(2009-6#1)(2013-8#1)
discussed as well##4##3##(1991-1#1)(2008-10#2)(2011-2#1)
discussed as##16##2##(1990-5#1)(1991-1#1)(1991-2#1)(1995-3#1)(2008-10#4)(2008-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
discussed based on the##2##4##(2008-10#2)
discussed both in##2##3##(1991-3#1)(1996-1#1)
discussed briefly##4##2##(1991-2#1)(2008-10#2)(2008-3#1)
discussed by##2##2##(2008-10#2)
discussed for##4##2##(2008-10#3)(2008-3#1)
discussed from the##2##3##(2008-10#1)(2008-3#1)
discussed from##3##2##(2008-10#1)(2008-3#1)(2010-11#1)
discussed here in##2##3##(1994-5#1)(1997-6#1)
discussed here##7##2##(1993-8#1)(1994-5#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-9#1)
discussed how##2##2##(2008-10#1)(2008-11#1)
discussed in connection with##2##4##(2008-10#1)(2008-11#1)
discussed in detail##22##3##(1990-2#1)(1994-2#1)(2008-10#16)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
discussed in details##2##3##(2008-10#2)
discussed in light of##7##4##(1994-2#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#1)
discussed in relation to other##2##5##(1993-11#1)(2008-10#1)
discussed in relation to the##13##5##(1992-12#1)(1994-2#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)
discussed in relation to##25##4##(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-9#1)(2012-2#1)
discussed in relation##26##3##(1990-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-9#1)(2012-2#1)
discussed in terms of the##11##5##(1990-7#1)(1993-6#1)(1995-11#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-6#1)(2009-12#1)
discussed in terms of##24##4##(1990-7#1)(1991-2#1)(1991-3#1)(1993-6#2)(1995-11#1)(1995-2#1)(1997-2#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2009-12#1)
discussed in the context of the##2##6##(2008-6#1)(2010-1#1)
discussed in the context of##11##5##(1993-11#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
discussed in the light of the##3##6##(1993-3#1)(1997-7#1)(2008-10#1)
discussed in the light of##7##5##(1993-3#1)(1997-7#1)(2008-10#4)(2012-3#1)
discussed in the literature##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
discussed in the present paper##2##5##(2008-10#2)
discussed in the##31##3##(1993-11#1)(1993-3#1)(1996-2#1)(1997-7#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
discussed in this article##9##4##(1997-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-7#2)(2013-1#1)
discussed in this paper##13##4##(1990-11#1)(1992-1#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#2)(2012-2#1)
discussed in this review##4##4##(2008-10#1)(2009-10#1)(2009-8#1)(2010-7#1)
discussed in this##34##3##(1990-11#1)(1992-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#4)(2010-12#1)(2010-2#1)(2010-7#3)(2012-12#1)(2012-2#1)(2013-1#1)
discussed in##160##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-11#2)(1993-3#1)(1993-6#3)(1994-2#3)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#59)(2008-11#10)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#5)(2010-1#1)(2010-12#1)(2010-2#2)(2010-7#4)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
discussed include##2##2##(2008-11#1)(2008-8#1)
discussed including##2##2##(2008-10#1)(2010-6#1)
discussed on the basis of the##3##6##(1994-6#1)(2008-10#1)(2009-6#1)
discussed on the basis of##4##5##(1994-6#1)(2008-10#2)(2009-6#1)
discussed regarding the##2##3##(2009-7#1)(2010-8#1)
discussed that##4##2##(1994-8#1)(1996-2#1)(2008-3#1)(2009-12#1)
discussed the##13##2##(1990-9#1)(1995-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#1)
discussed through##2##2##(2008-11#1)(2008-12#1)
discussed throughout##2##2##(1992-12#1)(1997-1#1)
discussed to##6##2##(1995-1#1)(2008-10#2)(2009-12#1)(2009-6#1)(2013-1#1)
discussed using##2##2##(1997-7#1)(2008-10#1)
discussed with a##2##3##(1995-11#1)(1995-12#1)
discussed with an emphasis on##2##5##(2008-11#1)(2010-3#1)
discussed with an##3##3##(1993-3#1)(2008-11#1)(2010-3#1)
discussed with reference to##2##4##(2008-12#1)(2011-1#1)
discussed with regard to##4##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
discussed with respect to##6##4##(1993-8#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)
discussed with respect##7##3##(1993-6#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)
discussed with##23##2##(1993-3#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-1#1)
discussed within the##2##3##(2008-11#1)(2013-1#1)
discussed##1117##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#8)(1991-1#4)(1991-11#3)(1991-12#5)(1991-2#8)(1991-3#6)(1991-5#2)(1991-6#2)(1991-8#5)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#5)(1993-6#8)(1993-8#7)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#3)(1995-11#5)(1995-12#5)(1995-2#5)(1995-3#7)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#4)(1996-2#9)(1996-3#6)(1996-5#1)(1996-6#2)(1997-1#10)(1997-2#6)(1997-3#8)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#4)(2007-11#1)(2007-12#6)(2008-1#6)(2008-10#371)(2008-11#68)(2008-12#33)(2008-2#14)(2008-3#43)(2008-4#23)(2008-5#19)(2008-6#10)(2008-7#28)(2008-8#26)(2008-9#22)(2009-1#1)(2009-10#3)(2009-11#7)(2009-12#11)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#8)(2009-8#11)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#7)(2010-2#7)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#6)(2010-9#6)(2011-1#4)(2011-2#25)(2011-3#6)(2011-7#5)(2012-12#3)(2012-2#16)(2012-3#5)(2012-4#1)(2013-1#31)(2013-7#1)(2013-8#11)
discusses a##5##2##(1994-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
discusses how the##4##3##(1993-12#1)(1993-2#1)(1995-12#1)(2008-4#1)
discusses how to##3##3##(1991-3#1)(2008-4#2)
discusses how##19##2##(1991-3#1)(1992-12#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-7#1)(2009-6#1)(2011-2#1)
discusses mass spectral##2##3##(2011-2#2)
discusses one##2##2##(2008-12#1)(2010-7#1)
discusses practical##2##2##(1991-11#1)(2008-10#1)
discusses recent advances in the field##2##6##(2008-9#1)(2010-12#1)
discusses recent##5##2##(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
discusses several##2##2##(2008-10#1)(2012-2#1)
discusses some of the##7##4##(1993-2#1)(1996-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-8#1)
discusses some##8##2##(1993-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-8#1)
discusses the application of##3##4##(1995-9#1)(2008-10#1)(2008-11#1)
discusses the aspects of##2##4##(2008-11#1)(2011-2#1)
discusses the current status of##2##5##(2008-10#1)(2008-11#1)
discusses the current##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)
discusses the development of##2##4##(2009-10#1)(2009-7#1)
discusses the development##3##3##(2008-10#1)(2009-10#1)(2009-7#1)
discusses the general##2##3##(2008-9#1)(2011-2#1)
discusses the history of##2##4##(2008-12#1)(2013-1#1)
discusses the importance of##6##4##(1994-2#1)(1997-2#1)(2008-11#3)(2011-2#1)
discusses the indications for##2##4##(1990-11#1)(1990-9#1)
discusses the literature##2##3##(2008-11#1)(2011-2#1)
discusses the medical##2##3##(1993-11#1)(2013-1#1)
discusses the need for##2##4##(1993-3#1)(1997-3#1)
discusses the potential##3##3##(1994-6#1)(1997-2#1)(2008-11#1)
discusses the principles##2##3##(2008-10#1)(2008-9#1)
discusses the process##2##3##(1996-2#1)(2008-7#1)
discusses the receptors##2##3##(2008-4#2)
discusses the role of##4##4##(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
discusses the use of##2##4##(1996-1#1)(2013-1#1)
discusses the##129##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#1)(1992-12#1)(1992-2#2)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1994-1#3)(1994-2#3)(1994-6#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#2)(2008-1#1)(2008-10#11)(2008-11#17)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#5)(2008-7#3)(2008-9#6)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#1)
discusses these##3##2##(2008-1#1)(2008-10#1)(2008-9#1)
discusses two##2##2##(2008-9#1)(2011-2#1)
discusses various##3##2##(1991-12#1)(1994-6#1)(2011-2#1)
discusses what##2##2##(1996-2#1)(2010-12#1)
discusses why##4##2##(1992-12#1)(1992-2#1)(1993-2#1)(1996-12#1)
discusses##251##1##(1990-11#1)(1990-6#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#3)(1992-2#3)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#5)(1993-3#6)(1993-6#1)(1994-1#4)(1994-12#2)(1994-2#4)(1994-3#3)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#2)(1997-6#2)(2008-1#3)(2008-10#17)(2008-11#22)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#22)(2008-5#3)(2008-6#6)(2008-7#6)(2008-9#19)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#11)(2013-8#3)
discussing how to##2##3##(1991-1#1)(1994-1#1)
discussing how##3##2##(1991-1#1)(1994-1#1)(2008-8#1)
discussing its##2##2##(2010-4#1)(2012-2#1)
discussing some##2##2##(1996-2#1)(2010-8#1)
discussing the results##2##3##(2008-10#1)(2008-3#1)
discussing the##15##2##(1990-9#1)(1993-2#1)(1995-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)
discussing##33##1##(1990-9#1)(1991-1#1)(1991-2#1)(1993-2#1)(1994-1#1)(1995-1#1)(1996-2#1)(1997-2#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
discussion about##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
discussion and##9##2##(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#1)
discussion between##2##2##(2008-11#1)(2013-8#1)
discussion concerning##3##2##(2010-1#1)(2010-11#2)
discussion focuses on##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
discussion groups in##2##3##(1996-11#1)(2008-11#1)
discussion groups##7##2##(1996-1#1)(1996-11#1)(2008-11#4)(2012-2#1)
discussion in the##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
discussion in##6##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2012-2#1)
discussion is based on##2##4##(2008-12#1)(2013-1#1)
discussion is##8##2##(1991-3#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-9#1)(2013-1#1)
discussion of future directions##2##4##(2008-9#1)(2013-8#1)
discussion of how##4##3##(2008-11#1)(2008-4#1)(2008-9#1)(2010-10#1)
discussion of its##2##3##(2009-7#1)(2013-1#1)
discussion of our##2##3##(2009-8#1)(2012-12#1)
discussion of possible##3##3##(1991-2#1)(1995-12#1)(2012-2#1)
discussion of some of the##4##5##(1993-2#1)(1996-2#1)(1997-3#1)(2008-4#1)
discussion of the##33##3##(1990-5#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#1)
discussion of their##4##3##(1997-3#1)(2008-10#2)(2012-3#1)
discussion of##95##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-9#1)(1993-2#2)(1994-3#2)(1994-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#4)(2007-12#2)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#4)(2008-3#3)(2008-4#8)(2008-7#2)(2008-8#1)(2008-9#13)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
discussion on how##2##3##(2008-10#1)(2012-2#1)
discussion on the##12##3##(1996-2#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
discussion on##23##2##(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
discussion paper##2##2##(2008-11#1)(2009-12#1)
discussion will explore##2##3##(2008-11#2)
discussion will##5##2##(2008-10#1)(2008-11#4)
discussion with the##2##3##(2008-11#1)(2012-3#1)
discussion with##5##2##(2008-11#2)(2008-12#1)(2008-8#1)(2012-3#1)
discussion##209##1##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-3#3)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#3)(1996-9#1)(1997-1#2)(1997-3#4)(2007-12#2)(2008-1#3)(2008-10#22)(2008-11#32)(2008-12#11)(2008-3#5)(2008-4#10)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#15)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#7)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#7)(2013-8#5)
discussions about the##3##3##(2008-10#1)(2008-5#1)(2009-5#1)
discussions about##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)
discussions among##2##2##(1994-6#1)(2013-1#1)
discussions of##7##2##(1996-2#1)(1996-9#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
discussions on the##3##3##(1992-12#1)(2008-12#1)(2008-9#1)
discussions on##4##2##(1992-12#1)(2008-12#1)(2008-9#1)(2009-3#1)
discussions with##4##2##(1993-2#1)(2008-11#2)(2009-5#1)
discussions##44##1##(1992-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-8#1)(1996-9#1)(2008-10#4)(2008-11#12)(2008-12#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
disease (AD)##21##2##(1991-1#1)(1992-12#1)(1995-12#1)(1995-8#1)(1996-2#2)(1997-2#1)(2008-5#2)(2008-6#2)(2008-7#6)(2009-10#1)(2011-2#2)(2012-3#1)
disease (ASD)##4##2##(2011-2#1)(2012-12#1)(2012-3#2)
disease (CD) is##2##3##(2011-2#1)(2013-8#1)
disease (CD)##9##2##(2008-10#2)(2009-12#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-8#1)
disease (COPD)##16##2##(1992-3#1)(1995-12#1)(1996-1#2)(2008-1#1)(2010-10#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-8#2)
disease (CVD)##9##2##(2008-6#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
disease (HD) gene##2##3##(1996-8#1)(2011-8#1)
disease (HD)##3##2##(1996-8#1)(2011-10#1)(2011-8#1)
disease (PAD)##2##2##(2008-8#1)(2012-2#1)
disease (PD) and##2##3##(2008-6#1)(2013-1#1)
disease (PD) is##9##3##(2008-12#1)(2008-7#5)(2008-8#1)(2010-8#1)(2013-8#1)
disease (PD)##40##2##(1990-2#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#23)(2008-8#1)(2010-12#2)(2010-8#1)(2012-2#1)(2013-1#3)(2013-8#2)
disease (n = 30)##2##4##(1990-8#1)(1993-1#1)
disease (n =##5##3##(1990-8#1)(1993-1#1)(2008-11#2)(2012-12#1)
disease -##3##2##(2007-12#1)(2010-12#1)(2012-12#1)
disease according to##2##3##(2008-6#1)(2012-3#1)
disease activity and flexibility##3##4##(2008-10#3)
disease activity##12##2##(1992-3#1)(1997-8#3)(2008-10#5)(2009-6#1)(2011-3#1)(2013-8#1)
disease affecting##7##2##(1991-11#1)(2008-10#6)
disease after##9##2##(1990-12#1)(1992-1#1)(1993-1#1)(1994-5#1)(1996-11#1)(1997-4#1)(2008-10#2)(2008-8#1)
disease also##2##2##(2008-10#1)(2013-1#1)
disease among##8##2##(1991-12#1)(1993-2#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#1)
disease and DON levels from##2##5##(2008-10#2)
disease and DON levels##3##4##(2008-10#3)
disease and a##3##3##(1994-9#1)(2008-8#1)(2010-11#1)
disease and associated##3##3##(2008-5#1)(2009-10#1)(2013-8#1)
disease and can##2##3##(2008-1#1)(2008-10#1)
disease and cancer##3##3##(1996-11#1)(2008-11#1)(2011-2#1)
disease and for##3##3##(1992-12#1)(1995-9#1)(2008-10#1)
disease and in##2##3##(1990-8#1)(2008-10#1)
disease and is##4##3##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
disease and it##2##3##(2008-7#1)(2010-7#1)
disease and its##6##3##(1991-2#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-12#1)(2013-7#1)
disease and of##2##3##(1990-3#1)(2012-3#1)
disease and that##3##3##(1992-12#1)(1997-8#1)(2008-10#1)
disease and the##18##3##(1992-3#1)(1992-9#1)(1993-6#1)(1995-2#1)(1997-8#1)(2007-8#1)(2008-10#8)(2008-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
disease and to##5##3##(1997-2#1)(1997-8#1)(2008-10#1)(2010-1#1)(2013-7#1)
disease and ulcerative##3##3##(1993-2#1)(2010-12#1)(2013-1#1)
disease and with##2##3##(2010-12#1)(2012-3#1)
disease and##207##2##(1990-11#1)(1990-3#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-12#3)(1992-3#1)(1992-6#2)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#6)(2006-5#1)(2007-12#1)(2007-8#3)(2008-1#5)(2008-10#47)(2008-11#3)(2008-12#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#6)(2012-4#1)(2013-1#9)(2013-7#2)(2013-8#5)
disease and/or##2##2##(1990-2#1)(2012-3#1)
disease appears to be##3##4##(1997-2#1)(2008-10#2)
disease appears to##4##3##(1992-3#1)(1997-2#1)(2008-10#2)
disease are at##2##3##(2008-11#1)(2013-1#1)
disease are discussed##3##3##(1993-8#1)(2008-10#1)(2013-8#1)
disease are not##4##3##(1990-12#1)(1996-11#1)(2008-7#1)(2013-1#1)
disease are reviewed##2##3##(2009-10#1)(2010-9#1)
disease are##29##2##(1990-12#1)(1993-8#1)(1996-11#1)(1997-8#2)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#2)(2009-10#2)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
disease as effectively as##2##4##(2008-10#2)
disease as well as##3##4##(1991-8#1)(2009-8#1)(2012-2#1)
disease as##13##2##(1991-8#1)(1993-11#1)(1993-3#2)(1997-1#1)(2008-10#2)(2008-11#3)(2009-8#1)(2012-2#1)(2012-3#1)
disease assessment and##2##3##(2008-10#2)
disease assessment##5##2##(2008-10#3)(2008-6#1)(2010-4#1)
disease associated with##8##3##(1991-11#1)(1995-12#1)(2008-1#1)(2008-7#2)(2010-1#1)(2011-2#2)
disease associated##9##2##(1991-11#1)(1995-12#1)(2008-1#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-2#2)
disease associations##2##2##(2008-10#2)
disease at all##2##3##(2008-10#2)
disease at the##4##3##(1991-3#1)(1995-3#1)(1997-3#1)(1997-4#1)
disease at##15##2##(1990-12#1)(1991-12#1)(1991-3#1)(1993-11#2)(1995-3#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-7#1)(2009-1#1)(2009-3#1)(2011-2#1)
disease be##2##2##(1994-8#1)(1997-8#1)
disease because##2##2##(1995-2#1)(2008-10#1)
disease burden##2##2##(2008-1#2)
disease but the##2##3##(1996-12#1)(2008-7#1)
disease but##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
disease by the##3##3##(1993-11#1)(1994-9#1)(2008-10#1)
disease by##16##2##(1992-8#1)(1993-11#1)(1994-9#1)(1997-3#1)(2008-10#9)(2011-2#1)(2012-3#1)(2013-1#1)
disease can be##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
disease category in##2##3##(2008-11#2)
disease caused by a##2##4##(2008-10#2)
disease caused by mutations in the##2##6##(1997-1#1)(2013-8#1)
disease caused by the##6##4##(2008-10#5)(2012-3#1)
disease caused by##28##3##(1997-1#1)(2008-10#18)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
disease caused##29##2##(1997-1#1)(2008-10#18)(2008-9#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
disease characterized by##3##3##(2008-11#1)(2012-12#1)(2013-8#1)
disease compared with the##2##4##(1997-8#1)(2008-10#1)
disease complex of banana##2##4##(2008-10#2)
disease complex##6##2##(2008-10#6)
disease conditions##2##2##(2011-2#2)
disease confined to##2##3##(1990-3#1)(2013-8#1)
disease control in the##2##4##(2008-10#2)
disease control in##4##3##(1997-7#1)(2008-10#2)(2008-7#1)
disease control measures##2##3##(1997-7#1)(2008-10#1)
disease control strategies##3##3##(2008-10#3)
disease control##55##2##(1990-12#1)(1991-8#1)(1997-7#4)(2008-10#46)(2008-7#1)(2008-9#1)(2012-3#1)
disease could be##2##3##(1994-12#1)(2008-10#1)
disease currently##3##2##(1994-9#1)(2008-10#2)
disease data##4##2##(2007-12#1)(2008-10#3)
disease detection##2##2##(2008-10#1)(2009-6#1)
disease developed##4##2##(2008-10#4)
disease development and##3##3##(2008-10#3)
disease development in the##2##4##(2008-10#2)
disease development in##6##3##(2008-10#6)
disease development on##3##3##(2008-10#3)
disease development was##4##3##(2008-10#4)
disease development##50##2##(2008-10#50)
disease develops##3##2##(2009-10#1)(2010-6#1)(2010-7#1)
disease diagnosed##2##2##(2010-8#1)(2013-1#1)
disease diagnosis##4##2##(2010-12#1)(2010-4#1)(2010-7#2)
disease did##2##2##(2008-10#1)(2008-7#1)
disease diversity##2##2##(2008-10#2)
disease due to##2##3##(2008-10#1)(2008-11#1)
disease duration##3##2##(1995-2#1)(2010-12#1)(2013-1#1)
disease during##6##2##(1991-6#1)(1992-9#1)(1994-8#1)(2008-10#1)(2011-2#2)
disease entities##3##2##(1991-2#1)(2009-7#1)(2011-2#1)
disease entity##3##2##(1991-2#1)(2008-7#2)
disease epidemics##8##2##(2008-10#8)
disease epidemiology##4##2##(2008-10#4)
disease estimated##2##2##(2008-10#1)(2012-12#1)
disease events##3##2##(2008-10#1)(2008-12#2)
disease expression##5##2##(2008-10#4)(2009-8#1)
disease extension##3##2##(1992-9#1)(2008-1#2)
disease foci##3##2##(2008-10#3)
disease for men##2##3##(2008-10#2)
disease for##11##2##(1992-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-7#1)(2010-11#1)(2013-8#1)
disease forecasting##3##2##(2008-10#3)
disease free at##4##3##(1990-6#1)(1991-8#1)(1992-5#1)(2011-2#1)
disease free##5##2##(1990-6#1)(1991-8#1)(1992-5#1)(2008-10#1)(2011-2#1)
disease frequently##2##2##(1994-11#1)(2008-7#1)
disease from the##2##3##(2008-8#1)(2011-2#1)
disease from##7##2##(2008-10#3)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
disease gene##5##2##(1992-3#1)(1993-1#1)(1995-5#1)(1997-8#2)
disease genes##5##2##(1994-9#1)(1997-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
disease gradients##2##2##(2008-10#2)
disease greater than 15 mm in diameter##2##7##(1995-12#2)
disease group##2##2##(1993-3#1)(2011-2#1)
disease had##2##2##(1994-9#1)(2008-7#1)
disease has a##2##3##(1991-2#1)(2008-10#1)
disease has been##8##3##(1990-3#1)(1995-5#1)(1997-8#1)(2008-10#4)(2013-1#1)
disease has not##2##3##(2008-10#1)(2008-4#1)
disease has##23##2##(1990-3#1)(1991-2#1)(1995-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2013-1#2)(2013-8#1)
disease have been##2##3##(1997-8#1)(2008-5#1)
disease have##8##2##(1995-1#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-5#1)(2013-1#1)(2013-8#1)
disease if##2##2##(1993-1#1)(2010-12#1)
disease in 2##2##3##(1990-6#1)(1991-8#1)
disease in 3##2##3##(1990-3#1)(1992-12#1)
disease in British##2##3##(1990-6#1)(2007-12#1)
disease in Europe##2##3##(2008-10#1)(2011-2#1)
disease in North America##3##4##(2008-10#2)(2008-11#1)
disease in Washington state##2##4##(2008-10#2)
disease in a##9##3##(1990-11#1)(1992-12#1)(1997-4#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)
disease in an##8##3##(1997-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#3)(2012-3#1)
disease in cases##2##3##(2012-3#1)(2013-1#1)
disease in childhood##3##3##(1991-8#1)(2008-12#1)(2012-2#1)
disease in children##3##3##(2012-12#1)(2012-2#2)
disease in elderly##2##3##(2007-12#1)(2008-7#1)
disease in grapevine##2##3##(2008-10#2)
disease in humans##2##3##(2008-10#1)(2012-12#1)
disease in north##2##3##(2008-10#1)(2008-12#1)
disease in northern##2##3##(1993-12#1)(2011-2#1)
disease in older##3##3##(2007-12#1)(2008-7#1)(2012-12#1)
disease in our##2##3##(1996-8#1)(1997-8#1)
disease in patients with##2##4##(2012-12#2)
disease in primary##2##3##(1996-3#1)(1996-8#1)
disease in sugar##2##3##(2008-10#1)(2012-3#1)
disease in the United##2##4##(2008-1#1)(2008-10#1)
disease in the field##4##4##(2008-10#4)
disease in the##33##3##(1990-9#1)(1991-12#1)(1992-9#2)(1993-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#2)(2010-1#1)(2010-12#1)(2013-8#1)
disease in this##2##3##(1997-3#1)(2008-10#1)
disease in tomato##2##3##(2008-10#2)
disease in two##2##3##(2008-10#2)
disease in which##3##3##(1997-8#1)(2011-2#1)(2013-1#1)
disease in women##2##3##(1996-8#1)(2011-2#1)
disease in##214##2##(1990-11#1)(1990-3#2)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#5)(1991-3#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-12#5)(1992-2#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#1)(1994-6#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-3#1)(1996-8#5)(1997-1#1)(1997-3#3)(1997-4#2)(1997-8#3)(2007-12#4)(2008-1#2)(2008-10#61)(2008-11#5)(2008-12#11)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#2)(2009-12#3)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#14)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#4)
disease incidence among sampling units##2##5##(2008-10#2)
disease incidence among##4##3##(2008-10#4)
disease incidence and disease severity##2##5##(1994-9#1)(2008-10#1)
disease incidence and severity##9##4##(2008-10#9)
disease incidence and##18##3##(1994-9#1)(2008-10#17)
disease incidence at the##2##4##(2008-10#2)
disease incidence at##6##3##(2008-10#6)
disease incidence between##3##3##(2008-10#3)
disease incidence from##3##3##(2008-10#3)
disease incidence in a spatial hierarchy##2##6##(2008-10#2)
disease incidence in a##4##4##(2008-10#4)
disease incidence in the greenhouse##2##5##(2008-10#2)
disease incidence in the##5##4##(1997-3#1)(2008-10#4)
disease incidence in##11##3##(1994-9#1)(1997-3#1)(2008-10#9)
disease incidence of##2##3##(2008-10#2)
disease incidence was not##2##4##(2008-10#2)
disease incidence was##12##3##(2008-10#12)
disease incidence were##2##3##(2008-10#2)
disease incidence##130##2##(1990-3#1)(1994-9#2)(1997-3#2)(2008-10#125)
disease incidence)##3##2##(2008-10#2)(2010-3#1)
disease incidences##4##2##(2008-10#3)(2011-2#1)
disease incited by##3##3##(2008-10#3)
disease including##4##2##(2009-8#1)(2011-2#3)
disease increased##2##2##(2008-10#2)
disease induced by##2##3##(1996-11#1)(2008-4#1)
disease induction is##2##3##(1991-12#1)(2008-10#1)
disease initiation and##2##3##(2008-10#2)
disease intensity index (DII)##2##4##(2008-10#2)
disease intensity##13##2##(2008-10#13)
disease involving##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
disease is a leading cause of##2##6##(1993-3#1)(2008-10#1)
disease is a multisystem disorder##2##5##(2008-9#1)(2012-3#1)
disease is a rare##2##4##(2010-12#1)(2013-1#1)
disease is a##16##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
disease is an##7##3##(1991-1#1)(1994-6#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-9#1)(2013-1#1)
disease is caused by##4##4##(2008-10#3)(2011-2#1)
disease is caused##5##3##(2008-10#4)(2011-2#1)
disease is characterised by##2##4##(1996-6#1)(2007-8#1)
disease is characterized by##4##4##(1991-11#1)(2008-10#1)(2010-6#1)(2011-1#1)
disease is difficult to##2##4##(1991-2#1)(2011-2#1)
disease is discussed##4##3##(1996-1#1)(2008-10#2)(2013-8#1)
disease is due##2##3##(2007-12#1)(2008-4#1)
disease is not associated with##2##5##(1996-12#1)(2008-10#1)
disease is not##5##3##(1996-12#1)(2008-10#3)(2010-1#1)
disease is one of the##2##5##(1997-3#1)(2012-12#1)
disease is one of##3##4##(1997-3#1)(2008-11#1)(2012-12#1)
disease is rare##3##3##(1995-9#1)(2010-8#1)(2012-3#1)
disease is rarely##2##3##(2011-2#1)(2012-12#1)
disease is responsible for##2##4##(1997-2#1)(2012-2#1)
disease is still a##2##4##(2008-10#1)(2010-12#1)
disease is the most common##2##5##(1993-1#1)(2008-10#1)
disease is the most##4##4##(1993-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
disease is the##10##3##(1993-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
disease is unknown##2##3##(1991-11#1)(2008-10#1)
disease is usually##4##3##(1990-12#1)(1991-4#1)(2008-12#1)(2011-2#1)
disease is##123##2##(1990-12#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#3)(2007-12#3)(2007-8#1)(2008-10#22)(2008-11#2)(2008-12#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#2)(2010-1#1)(2010-11#1)(2010-12#6)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#2)
disease known##2##2##(1996-3#1)(2008-11#1)
disease lesions##2##2##(2008-10#2)
disease level##6##2##(2008-10#6)
disease levels##6##2##(2008-10#5)(2008-4#1)
disease management decisions##2##3##(2008-10#2)
disease management in##2##3##(2008-10#1)(2010-12#1)
disease management program##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
disease management programs##3##3##(2008-10#1)(2008-11#2)
disease management strategies##3##3##(2008-10#3)
disease management strategy for##2##4##(2008-10#1)(2013-1#1)
disease management strategy##5##3##(2008-10#4)(2013-1#1)
disease management tools##2##3##(2008-10#2)
disease management was##2##3##(2008-10#2)
disease management##44##2##(1995-3#1)(1997-8#1)(2008-10#34)(2008-11#3)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
disease may be##4##3##(2010-6#1)(2011-2#1)(2013-8#2)
disease may##11##2##(1990-12#1)(1991-4#1)(1991-7#1)(1993-11#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#2)
disease might be##3##3##(1995-2#1)(1997-8#1)(2008-10#1)
disease might##5##2##(1991-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2010-12#1)
disease model##4##2##(2008-10#2)(2010-1#1)(2010-8#1)
disease monitoring##4##2##(2009-6#1)(2010-11#1)(2011-3#1)(2013-8#1)
disease morbidity and mortality##3##4##(1993-12#2)(1997-1#1)
disease more##2##2##(1994-9#1)(2008-7#1)
disease mortality of##2##3##(2010-2#2)
disease mortality##10##2##(1991-6#1)(1992-6#1)(1997-2#2)(2010-2#5)(2013-8#1)
disease nurseries##2##2##(2008-10#2)
disease occurred##2##2##(2008-10#2)
disease occurrence##2##2##(2008-10#1)(2011-2#1)
disease of apple##2##3##(2008-10#2)
disease of banana##2##3##(2008-10#2)
disease of barley in many##4##5##(2008-10#4)
disease of barley##5##3##(2008-10#5)
disease of cherry##2##3##(2008-10#2)
disease of citrus in##2##4##(2008-10#2)
disease of citrus##3##3##(2008-10#3)
disease of lettuce##2##3##(2008-10#2)
disease of maize##2##3##(2008-10#2)
disease of pear and apple##2##5##(2008-10#2)
disease of perennial ryegrass (Lolium##2##5##(2008-10#2)
disease of perennial ryegrass##3##4##(2008-10#3)
disease of pines##2##3##(2008-10#2)
disease of rice worldwide##2##4##(2008-10#2)
disease of rice##3##3##(2008-10#2)(2012-2#1)
disease of several##2##3##(2008-10#2)
disease of small##3##3##(1995-12#1)(2008-10#1)(2010-1#1)
disease of the cervical spine##2##5##(2012-12#2)
disease of the fetus##2##4##(2010-11#2)
disease of the##24##3##(1990-12#2)(1991-12#1)(1991-3#1)(1992-9#1)(1995-2#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#1)
disease of tomato under##2##4##(2008-10#2)
disease of tomato##3##3##(2008-10#3)
disease of unknown etiology##5##4##(1991-2#1)(1995-6#1)(2008-10#2)(2012-3#1)
disease of unknown##6##3##(1991-2#1)(1995-6#1)(1996-3#1)(2008-10#2)(2012-3#1)
disease of wheat##6##3##(2008-10#6)
disease of##137##2##(1990-12#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#4)(2008-10#85)(2008-11#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-4#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
disease often##2##2##(1992-3#1)(2008-10#1)
disease on St##2##3##(2008-10#2)
disease on lettuce##2##3##(2008-10#2)
disease on the##5##3##(2008-10#3)(2008-11#1)(2010-6#1)
disease on tomato and##2##4##(2008-10#2)
disease on##40##2##(2007-12#1)(2008-10#35)(2008-11#1)(2008-8#1)(2010-6#1)(2012-2#1)
disease only##5##2##(1991-12#1)(2008-10#3)(2011-3#1)
disease onset and##4##3##(2008-10#4)
disease onset but##2##3##(2008-10#1)(2012-3#1)
disease onset was##2##3##(2008-10#1)(2012-12#1)
disease onset##15##2##(1993-6#1)(2008-10#11)(2012-12#1)(2012-3#1)(2013-8#1)
disease or##19##2##(1990-3#1)(1991-8#1)(1994-12#1)(1994-9#1)(1997-2#1)(1997-7#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
disease outbreak##3##2##(1990-3#1)(1996-2#1)(2008-12#1)
disease outbreaks##7##2##(1996-12#1)(2007-12#1)(2008-10#2)(2010-2#1)(2010-5#1)(2011-2#1)
disease outcome##2##2##(2011-2#1)(2012-12#1)
disease outcomes##2##2##(2013-1#2)
disease over the##2##3##(2008-12#1)(2010-8#1)
disease over##4##2##(1994-11#1)(2008-10#1)(2008-12#1)(2010-8#1)
disease pathogenesis and##2##3##(2008-4#1)(2013-8#1)
disease pathogenesis##5##2##(1992-12#1)(1997-5#1)(2008-4#1)(2008-7#1)(2013-8#1)
disease patient##2##2##(2008-12#1)(2013-8#1)
disease patients with##2##3##(2008-7#1)(2009-8#1)
disease patients##13##2##(2008-1#1)(2008-10#1)(2008-7#3)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)
disease patterns##3##2##(1997-3#1)(2008-10#2)
disease phenotypes##3##2##(2008-10#2)(2008-9#1)
disease potential##2##2##(1991-12#1)(2008-10#1)
disease prediction model##2##3##(2008-10#2)
disease prediction##3##2##(2008-10#3)
disease presenting with##2##3##(2012-12#1)(2012-3#1)
disease presenting##4##2##(1991-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
disease pressure##11##2##(2008-10#11)
disease prevalence and##2##3##(2011-2#1)(2012-2#1)
disease prevalence in##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
disease prevalence##10##2##(1991-12#1)(2008-10#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
disease prevention and##2##3##(1997-1#1)(2009-6#1)
disease prevention##10##2##(1995-12#2)(1997-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-1#1)(2013-8#1)
disease problems in##2##3##(1997-7#1)(2008-11#1)
disease problems##5##2##(1997-7#1)(2008-10#3)(2008-11#1)
disease process##10##2##(1995-9#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
disease processes##5##2##(2008-2#1)(2008-7#1)(2010-12#2)(2010-2#1)
disease progress curve##23##3##(2008-10#23)
disease progress curves##2##3##(2008-10#2)
disease progress on##2##3##(2008-10#2)
disease progress were##2##3##(2008-10#2)
disease progress##39##2##(2008-10#39)
disease progressed##2##2##(1997-3#1)(2008-10#1)
disease progression and complications##2##4##(2009-8#1)(2013-1#1)
disease progression and##5##3##(2008-10#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
disease progression in##6##3##(2008-10#2)(2008-2#1)(2010-11#1)(2010-5#1)(2012-2#1)
disease progression or##2##3##(1994-8#1)(2008-10#1)
disease progression##32##2##(1994-8#1)(1997-5#1)(2008-10#10)(2008-2#2)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
disease protection##2##2##(2008-10#2)
disease ranged##2##2##(2008-10#2)
disease rates##2##2##(1991-8#1)(1996-3#1)
disease rating##6##2##(2008-10#5)(2008-7#1)
disease ratings in##2##3##(2008-10#2)
disease ratings were##2##3##(2008-10#2)
disease ratings##10##2##(2008-10#10)
disease reaction##5##2##(2008-10#5)
disease reactions##3##2##(2008-10#3)
disease receiving##2##2##(2013-1#2)
disease recurrence at##2##3##(2012-2#1)(2012-3#1)
disease recurrence##7##2##(2012-2#2)(2012-3#2)(2013-1#3)
disease reduction##6##2##(2008-10#6)
disease remains##2##2##(2012-3#1)(2013-7#1)
disease resistance QTLs##2##3##(2009-10#2)
disease resistance and##4##3##(2008-10#3)(2009-8#1)
disease resistance genes##2##3##(2008-10#2)
disease resistance in plants##2##4##(2008-10#2)
disease resistance in rice##2##4##(2008-9#1)(2009-10#1)
disease resistance in##8##3##(1992-9#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-10#1)
disease resistance is##2##3##(2008-10#2)
disease resistance to bacterial pathogens##2##5##(2008-10#2)
disease resistance##45##2##(1992-9#1)(2008-10#31)(2008-8#4)(2008-9#3)(2009-10#4)(2009-8#1)(2010-10#1)
disease response##3##2##(2008-10#3)
disease resulting from##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
disease results##2##2##(1995-2#1)(2011-2#1)
disease risk and##2##3##(2008-10#1)(2008-11#1)
disease risk factors##8##3##(1991-6#2)(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#3)
disease risk in##2##3##(2008-10#1)(2008-11#1)
disease risk##22##2##(1991-6#4)(1993-3#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-7#3)(2010-12#1)(2012-2#1)
disease seen##2##2##(2008-5#1)(2011-2#1)
disease severities##2##2##(2008-10#2)
disease severity and pathogen population##2##5##(2008-10#2)
disease severity and pathogen##3##4##(2008-10#3)
disease severity and##11##3##(2008-10#10)(2008-7#1)
disease severity at##4##3##(2008-10#4)
disease severity between##2##3##(2008-10#2)
disease severity by##3##3##(2008-10#3)
disease severity compared with##2##4##(2008-10#2)
disease severity in PEI##2##4##(2008-10#2)
disease severity in##11##3##(2008-10#11)
disease severity of##3##3##(2008-10#3)
disease severity on##5##3##(2008-10#5)
disease severity than##2##3##(2008-10#2)
disease severity values##2##3##(2008-10#2)
disease severity was##8##3##(2008-10#8)
disease severity were##3##3##(2008-10#3)
disease severity##127##2##(1994-9#1)(2008-10#115)(2008-11#1)(2008-7#4)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
disease severity)##4##2##(2008-10#4)
disease should be##10##3##(1991-8#1)(1997-8#2)(2008-10#3)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
disease should##14##2##(1991-8#1)(1997-7#1)(1997-8#2)(2008-10#3)(2008-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
disease shows that##2##3##(1993-2#1)(2008-8#1)
disease since##2##2##(2008-7#1)(2008-9#1)
disease sites##3##2##(2008-10#2)(2012-2#1)
disease spread##11##2##(1990-8#1)(2008-10#8)(2010-1#1)(2011-2#1)
disease stage and##3##3##(1990-12#1)(1992-6#1)(2013-1#1)
disease stage##7##2##(1990-12#1)(1991-8#1)(1992-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
disease stages##3##2##(1995-9#1)(2009-8#1)(2010-7#1)
disease state management##2##3##(2008-1#2)
disease states##12##2##(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#2)
disease status of##8##3##(1992-3#2)(2008-10#5)(2008-9#1)
disease status##10##2##(1992-3#2)(2008-10#6)(2008-9#1)(2011-2#1)
disease subjects##2##2##(1994-11#1)(2008-7#1)
disease such as##5##3##(1990-2#1)(1992-12#1)(2007-8#1)(2011-2#1)(2011-3#1)
disease suppression by the##2##4##(2008-10#2)
disease suppression by##7##3##(2008-10#7)
disease suppression in##2##3##(2008-10#2)
disease suppression was##4##3##(2008-10#4)
disease suppression with##2##3##(2008-10#2)
disease suppression##39##2##(2008-10#39)
disease suppressive##2##2##(2008-10#2)
disease suppressiveness of soils##3##4##(2008-10#3)
disease suppressiveness of##4##3##(2008-10#4)
disease suppressiveness##9##2##(2008-10#9)
disease surveillance system##3##3##(1994-9#1)(1997-3#2)
disease surveillance##13##2##(1994-9#1)(1995-12#1)(1996-6#1)(1997-3#6)(2008-1#1)(2009-6#1)(2010-4#1)(2011-2#1)
disease symptom##4##2##(2008-10#2)(2008-7#2)
disease symptoms and##3##3##(2008-10#1)(2008-7#2)
disease symptoms in##2##3##(2008-10#2)
disease symptoms on##4##3##(2008-10#4)
disease symptoms were##2##3##(2008-10#2)
disease symptoms##29##2##(2007-11#1)(2008-10#25)(2008-7#2)(2013-8#1)
disease syndromes##3##2##(2007-12#1)(2008-10#1)(2009-10#1)
disease than in those##2##4##(1992-12#1)(2012-3#1)
disease than##11##2##(1992-12#1)(2008-10#7)(2008-9#1)(2012-3#1)(2013-8#1)
disease that affects##3##3##(2008-10#2)(2009-9#1)
disease that can##3##3##(1996-11#1)(2009-1#1)(2011-2#1)
disease that is a##2##4##(2008-10#1)(2011-2#1)
disease that is##7##3##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
disease that originated##2##3##(2008-10#2)
disease that##29##2##(1994-12#1)(1994-9#1)(1996-11#1)(1997-3#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-9#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
disease the##3##2##(1990-11#1)(2008-11#1)(2011-2#1)
disease there##2##2##(2013-1#1)(2013-8#1)
disease through##2##2##(2006-6#1)(2008-10#1)
disease to be##3##3##(1990-9#1)(1997-3#1)(2008-11#1)
disease to the##6##3##(1990-12#1)(1991-8#1)(2008-1#2)(2008-10#1)(2011-2#1)
disease to##19##2##(1990-12#1)(1990-9#1)(1991-8#1)(1994-11#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-6#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
disease tolerance##2##2##(2008-10#2)
disease transmission##6##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#2)
disease treated##4##2##(1993-2#1)(2011-2#3)
disease type##4##2##(1995-8#1)(1997-2#2)(1997-3#1)
disease using measurements of dysphonia##2##5##(2010-8#2)
disease using##6##2##(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#2)(2010-9#1)
disease vaccine##2##2##(2007-12#1)(2011-2#1)
disease virus (NDV)##2##3##(2008-11#1)(2013-8#1)
disease virus##15##2##(1994-6#1)(2008-11#4)(2008-5#7)(2011-2#2)(2013-8#1)
disease warning system##2##3##(2008-10#2)
disease was detected##2##3##(1996-6#1)(2008-10#1)
disease was first##3##3##(2008-10#3)
disease was found to be##2##5##(2008-1#1)(2008-10#1)
disease was found to##3##4##(2008-1#1)(2008-10#1)(2008-7#1)
disease was investigated##2##3##(2008-10#2)
disease was less##2##3##(2012-12#1)(2013-1#1)
disease was made##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
disease was most##2##3##(2008-10#2)
disease was not##2##3##(1991-8#1)(2008-10#1)
disease was observed##7##3##(1991-8#1)(2008-10#3)(2008-7#1)(2010-11#2)
disease was present in##2##4##(1990-3#1)(2008-10#1)
disease was##63##2##(1990-3#1)(1991-3#1)(1991-8#3)(1992-12#1)(1993-1#1)(1994-9#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#39)(2008-5#1)(2008-7#2)(2010-11#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
disease were##21##2##(1992-2#1)(1994-2#1)(1997-3#1)(1997-8#3)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
disease when used alone##2##4##(2008-10#2)
disease when used##3##3##(2008-10#3)
disease when##4##2##(1993-2#1)(2008-10#3)
disease which is##2##3##(1992-9#1)(1993-6#1)
disease which##9##2##(1992-9#1)(1993-6#1)(1997-8#3)(2008-1#2)(2011-3#1)(2012-2#1)
disease while##2##2##(2011-2#1)(2013-8#1)
disease who was##3##3##(1997-5#1)(2008-1#1)(2010-12#1)
disease who were##2##3##(2008-12#1)(2010-12#1)
disease who##12##2##(1997-5#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-12#2)(2011-2#1)(2013-8#1)
disease will be##3##3##(1990-6#1)(1997-8#1)(2012-2#1)
disease will##6##2##(1990-6#1)(1997-8#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
disease with a poor prognosis##2##5##(1997-5#1)(2008-11#1)
disease with a##9##3##(1993-2#1)(1996-3#1)(1997-5#1)(2008-11#1)(2008-12#1)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
disease with##36##2##(1990-3#2)(1991-11#1)(1991-4#2)(1992-2#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-5#1)(1996-3#1)(1997-5#1)(1997-8#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
disease within##2##2##(2008-5#1)(2010-12#1)
disease without##3##2##(1992-3#1)(2008-1#1)(2009-11#1)
disease##3950##1##(1990-11#6)(1990-12#14)(1990-2#10)(1990-3#18)(1990-5#4)(1990-6#12)(1990-8#6)(1990-9#6)(1991-1#3)(1991-10#2)(1991-11#14)(1991-12#28)(1991-2#13)(1991-3#9)(1991-4#7)(1991-5#4)(1991-6#13)(1991-7#3)(1991-8#23)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#25)(1992-2#8)(1992-3#14)(1992-5#6)(1992-6#7)(1992-8#3)(1992-9#20)(1993-1#11)(1993-11#13)(1993-12#15)(1993-2#17)(1993-3#13)(1993-6#9)(1993-8#2)(1993-9#4)(1994-11#14)(1994-12#11)(1994-2#4)(1994-3#4)(1994-5#7)(1994-6#11)(1994-8#6)(1994-9#29)(1995-1#4)(1995-10#1)(1995-12#26)(1995-2#12)(1995-3#8)(1995-5#10)(1995-6#4)(1995-8#7)(1995-9#4)(1996-1#3)(1996-11#9)(1996-12#15)(1996-2#16)(1996-3#8)(1996-6#9)(1996-8#13)(1996-9#2)(1997-1#14)(1997-2#14)(1997-3#32)(1997-4#9)(1997-5#11)(1997-6#3)(1997-7#16)(1997-8#64)(2006-5#3)(2006-6#4)(2007-11#3)(2007-12#19)(2007-8#11)(2008-1#43)(2008-10#1453)(2008-11#89)(2008-12#53)(2008-2#6)(2008-3#6)(2008-4#18)(2008-5#62)(2008-6#20)(2008-7#191)(2008-8#48)(2008-9#33)(2009-1#10)(2009-10#28)(2009-11#5)(2009-12#13)(2009-3#4)(2009-4#4)(2009-5#7)(2009-6#16)(2009-7#6)(2009-8#23)(2009-9#4)(2010-1#23)(2010-10#22)(2010-11#25)(2010-12#102)(2010-2#10)(2010-3#5)(2010-4#13)(2010-5#15)(2010-6#24)(2010-7#14)(2010-8#14)(2010-9#9)(2011-1#10)(2011-10#2)(2011-2#222)(2011-3#13)(2011-7#4)(2011-8#1)(2012-12#59)(2012-2#90)(2012-3#82)(2012-4#1)(2013-1#140)(2013-3#1)(2013-7#14)(2013-8#86)
disease&quot##4##1##(1995-5#1)(2008-10#1)(2013-1#2)
disease's##3##1##(1992-2#1)(2009-1#1)(2012-12#1)
disease) and##2##2##(2013-8#2)
disease) is##2##2##(1990-5#1)(2008-10#1)
disease)##21##1##(1990-5#1)(1991-3#1)(1996-3#1)(1996-8#2)(1997-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#1)(2012-3#3)(2013-8#2)
disease- and##2##2##(1997-8#1)(2008-10#1)
disease-##3##1##(1997-8#1)(2008-10#2)
disease-associated##7##1##(1996-12#1)(1997-8#1)(2008-10#3)(2010-5#1)(2012-3#1)
disease-causing##2##1##(2008-10#1)(2012-3#1)
disease-free interval##5##2##(1993-11#1)(2010-3#3)(2011-2#1)
disease-free intervals##2##2##(1994-2#1)(2010-7#1)
disease-free survival rate was##3##4##(1997-7#2)(2011-2#1)
disease-free survival rate##5##3##(1997-7#4)(2011-2#1)
disease-free survival##15##2##(1991-8#2)(1992-12#1)(1994-12#1)(1994-6#1)(1997-7#4)(2008-10#3)(2011-2#3)
disease-free##31##1##(1990-12#1)(1991-8#3)(1992-12#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-7#5)(2008-10#5)(2010-3#4)(2010-7#1)(2011-2#6)(2013-8#1)
disease-induced root growth##2##3##(2008-10#2)
disease-induced root production##2##3##(2008-10#2)
disease-induced root##4##2##(2008-10#4)
disease-induced##5##1##(2008-10#5)
disease-related##7##1##(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
disease-resistant##4##1##(2008-10#3)(2011-10#1)
disease-specific survival##3##2##(2011-2#2)(2013-1#1)
disease-specific##5##1##(2009-12#1)(2011-2#3)(2013-1#1)
disease-suppressive mechanisms##2##2##(2008-10#2)
disease-suppressive soils##2##2##(2008-10#2)
disease-suppressive##6##1##(2008-10#6)
disease?##7##1##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
disease]##35##1##(1990-2#1)(1990-3#1)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#1)(1993-9#1)(1994-9#1)(1996-11#2)(1996-8#1)(1997-3#1)(1997-5#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#6)
diseased and##6##2##(1994-1#1)(2008-10#5)
diseased area##2##2##(2008-10#2)
diseased bean leaves##2##3##(2008-10#2)
diseased bean##3##2##(2008-10#3)
diseased cucumber##2##2##(2008-10#2)
diseased cultivar##2##2##(2008-10#2)
diseased from##2##2##(2008-10#1)(2011-2#1)
diseased fruit##2##2##(2008-10#2)
diseased individuals at##2##3##(2008-10#2)
diseased individuals##3##2##(2008-10#3)
diseased leaves was significantly higher##2##5##(2008-10#2)
diseased leaves##8##2##(2008-10#8)
diseased lettuce##4##2##(2008-10#4)
diseased orchards##2##2##(2008-10#2)
diseased plant units##2##3##(2008-10#2)
diseased plant##3##2##(2008-10#3)
diseased plants and##2##3##(2008-10#2)
diseased plants is##2##3##(2008-10#2)
diseased plants##15##2##(2008-10#15)
diseased plants)##2##2##(2008-10#2)
diseased roots##4##2##(2008-10#4)
diseased seedlings##4##2##(2008-10#4)
diseased than##3##2##(2008-10#3)
diseased tissue##4##2##(2008-10#4)
diseased tissues##2##2##(2008-10#1)(2010-8#1)
diseased trees##4##2##(2008-10#4)
diseased##134##1##(1992-3#2)(1992-6#1)(1993-2#1)(1994-1#1)(1994-11#1)(2008-10#118)(2008-4#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
diseased)##2##1##(2008-10#2)
diseases among##5##2##(1993-11#1)(1994-6#1)(1996-6#1)(2008-10#1)(2012-12#1)
diseases and in##2##3##(1990-3#1)(2008-11#1)
diseases and the##5##3##(1991-6#1)(2008-10#2)(2012-3#1)(2013-8#1)
diseases and to the development of##2##6##(1993-2#1)(2010-5#1)
diseases and total##2##3##(2008-10#1)(2013-8#1)
diseases and##58##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-6#4)(1993-2#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-8#2)(2009-10#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#4)
diseases and/or pathology##2##3##(2010-1#2)
diseases are not##2##3##(2008-10#1)(2012-2#1)
diseases are reviewed##2##3##(2008-7#1)(2010-9#1)
diseases are##22##2##(1991-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-8#1)
diseases as##6##2##(1994-6#1)(1997-7#1)(2008-11#1)(2009-7#1)(2010-8#1)(2012-3#1)
diseases associated with##7##3##(1992-6#1)(1995-9#1)(2008-10#1)(2009-12#1)(2010-10#1)(2012-2#1)(2012-3#1)
diseases at the##2##3##(1995-5#1)(2008-10#1)
diseases at##3##2##(1995-5#1)(2008-10#2)
diseases by##6##2##(2013-8#6)
diseases can be##3##3##(1996-9#1)(2008-10#2)
diseases can##4##2##(1992-6#1)(1996-9#1)(2008-10#2)
diseases caused by soilborne##2##4##(2008-10#2)
diseases caused by##11##3##(1995-2#1)(2008-10#6)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
diseases causing##2##2##(2010-12#2)
diseases characterised by##2##3##(2012-2#2)
diseases characterized by##2##3##(2009-8#1)(2011-2#1)
diseases during##3##2##(2008-10#2)(2012-12#1)
diseases for which##2##3##(2008-10#1)(2010-10#1)
diseases for##4##2##(2008-10#3)(2010-10#1)
diseases from##2##2##(2008-10#2)
diseases has##2##2##(2008-11#1)(2013-1#1)
diseases have been associated with##2##5##(2011-2#1)(2012-2#1)
diseases have been##7##3##(1991-2#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
diseases have##10##2##(1991-12#1)(1991-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#2)
diseases in North##2##3##(2008-10#1)(2010-1#1)
diseases in South Africa##2##4##(2010-1#2)
diseases in humans##5##3##(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
diseases in order to##2##4##(2011-2#1)(2011-7#1)
diseases in the elderly##3##4##(1991-3#1)(1994-5#1)(1997-8#1)
diseases in the##16##3##(1991-3#1)(1992-2#1)(1993-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-8#1)(2006-5#2)(2008-10#4)(2008-11#1)(2013-8#1)
diseases in which##2##3##(1997-8#1)(2006-6#1)
diseases in##64##2##(1990-3#2)(1990-8#1)(1991-3#1)(1991-6#2)(1992-2#1)(1993-3#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1997-3#2)(1997-8#5)(2006-5#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-7#1)(2009-10#1)(2010-1#3)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
diseases include##2##2##(2008-11#1)(2011-7#1)
diseases including##12##2##(2008-10#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-8#1)
diseases is##7##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#2)
diseases like##5##2##(1993-2#1)(1994-9#1)(2008-10#1)(2010-1#1)(2013-1#1)
diseases linked to##2##3##(2008-10#1)(2009-8#1)
diseases of barley in the##3##5##(2008-10#3)
diseases of childhood##3##3##(1991-2#1)(1997-8#1)(2008-10#1)
diseases of strawberry##2##3##(2008-10#2)
diseases of the brain##2##4##(2010-12#1)(2012-2#1)
diseases of the##16##3##(1990-5#1)(1992-9#1)(1994-1#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#3)(2012-2#1)(2013-1#1)
diseases of tropical##2##3##(2008-10#2)
diseases of wheat##6##3##(2008-10#5)(2011-10#1)
diseases of##60##2##(1990-5#1)(1991-2#1)(1992-9#1)(1994-1#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-8#1)(2011-10#1)(2012-2#3)(2012-3#2)(2013-1#2)
diseases often##3##2##(1990-11#1)(2008-8#1)(2008-9#1)
diseases on##5##2##(2008-10#3)(2013-1#2)
diseases or##7##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)
diseases related to##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
diseases such as atherosclerosis##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
diseases such as multiple sclerosis##2##5##(2011-2#1)(2012-3#1)
diseases such as##19##3##(1993-11#1)(1994-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-6#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
diseases suggest that##2##3##(2010-12#1)(2011-1#1)
diseases that are##2##3##(1997-3#1)(2008-4#1)
diseases that##10##2##(1997-3#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#2)(2012-3#1)
diseases they cause##2##3##(2008-10#2)
diseases through##2##2##(2011-2#1)(2013-1#1)
diseases to##4##2##(1993-1#1)(1995-12#1)(1996-1#1)(2008-10#1)
diseases treated##2##2##(2011-2#1)(2012-12#1)
diseases was##7##2##(2008-10#5)(2008-7#1)(2013-8#1)
diseases were excluded##2##3##(2011-2#1)(2013-8#1)
diseases were##11##2##(1991-3#1)(1992-2#1)(1993-11#1)(2008-10#2)(2008-7#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-8#1)
diseases when##2##2##(1996-9#1)(2008-10#1)
diseases which are##2##3##(1995-2#1)(2008-11#1)
diseases which##5##2##(1995-2#1)(2008-11#1)(2008-7#1)(2013-1#2)
diseases will##3##2##(1992-9#1)(1994-2#1)(2009-9#1)
diseases with similar##2##3##(1993-8#1)(2013-8#1)
diseases with##9##2##(1992-6#1)(1993-8#1)(1997-5#1)(2008-10#5)(2013-8#1)
diseases##852##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#4)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#8)(1991-3#4)(1991-6#9)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#7)(1992-3#1)(1992-5#1)(1992-6#5)(1992-9#4)(1993-1#1)(1993-11#4)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#8)(1994-9#4)(1995-10#1)(1995-12#4)(1995-2#8)(1995-3#1)(1995-5#5)(1995-9#2)(1996-1#2)(1996-11#4)(1996-12#5)(1996-2#2)(1996-3#4)(1996-6#6)(1996-9#3)(1997-1#5)(1997-2#1)(1997-3#12)(1997-4#1)(1997-5#5)(1997-6#3)(1997-7#7)(1997-8#12)(2006-5#2)(2006-6#1)(2007-12#2)(2008-1#11)(2008-10#201)(2008-11#28)(2008-12#3)(2008-3#1)(2008-4#9)(2008-5#10)(2008-6#1)(2008-7#17)(2008-8#10)(2008-9#10)(2009-1#4)(2009-10#4)(2009-12#7)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#11)(2010-10#6)(2010-11#2)(2010-12#17)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#8)(2011-10#3)(2011-2#66)(2011-3#7)(2011-7#6)(2011-9#1)(2012-12#16)(2012-2#42)(2012-3#26)(2013-1#45)(2013-7#5)(2013-8#30)
diseases) and##2##2##(1990-9#1)(2008-10#1)
diseases)##7##1##(1990-9#1)(1993-2#1)(1995-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
diseases]##17##1##(1990-3#1)(1991-2#1)(1993-11#3)(1993-2#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#1)(2013-1#1)
disengaged##2##1##(1992-4#1)(2011-2#1)
disengagement and re-engagement##3##3##(2010-2#3)
disengagement and##5##2##(2010-2#5)
disengagement##8##1##(2008-11#1)(2008-9#1)(2010-2#6)
disentangle the##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
disentangle##5##1##(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
disequilibria between##2##2##(2008-10#2)
disequilibrium between##3##2##(2008-10#2)(2008-9#1)
disequilibrium of##2##2##(1997-8#1)(2008-9#1)
disequilibrium was##2##2##(2008-10#1)(2012-3#1)
disequilibrium##30##1##(1995-6#1)(1997-8#1)(2008-10#17)(2008-12#1)(2008-9#2)(2010-12#1)(2010-5#1)(2012-2#2)(2012-3#3)(2012-5#1)
disfavor##2##1##(1991-5#1)(1995-6#1)
disfiguring##3##1##(1991-11#1)(1997-8#2)
disgust in##2##2##(2012-2#2)
disgust##21##1##(2008-11#4)(2009-8#3)(2012-2#11)(2013-8#3)
dish after##2##2##(2008-11#2)
dish that had a##2##4##(2008-11#2)
dish##25##1##(2008-10#4)(2008-11#20)(2009-8#1)
dishabituation##4##1##(1994-3#1)(2008-6#3)
dishes and##3##2##(1995-8#1)(2008-11#2)
dishes in##2##2##(2008-11#2)
dishes were##2##2##(1993-3#1)(2008-11#1)
dishes with a##2##3##(1995-8#1)(2008-11#1)
dishes with##4##2##(1995-8#1)(2008-10#1)(2008-11#2)
dishes##36##1##(1993-3#2)(1995-11#1)(1995-8#2)(1997-3#1)(2008-10#5)(2008-11#24)(2011-2#1)
dishonesty##4##1##(2008-12#4)
disilicate##2##1##(2009-7#2)
disinfectant##3##1##(1992-2#1)(2008-10#1)(2012-2#1)
disinfected##2##1##(2008-10#1)(2008-12#1)
disinfection by-products##4##2##(2008-10#1)(2008-9#3)
disinfection rates##3##2##(2013-1#3)
disinfection##18##1##(1992-2#1)(2008-10#4)(2008-7#1)(2008-9#5)(2013-1#7)
disinfested##3##1##(2008-10#3)
disinhibition##6##1##(1997-2#1)(2010-3#3)(2012-12#1)(2013-8#1)
disintegrants alone##2##2##(2012-2#2)
disintegrated##4##1##(2007-12#1)(2008-10#2)(2008-7#1)
disintegration of the##2##3##(2008-7#2)
disintegration of##4##2##(2008-10#1)(2008-7#2)(2011-2#1)
disintegration##9##1##(1997-3#3)(2008-10#3)(2008-7#2)(2011-2#1)
disjunct##2##1##(1996-2#1)(2008-10#1)
disk and##3##2##(2008-10#2)(2008-12#1)
disk assays##2##2##(2008-10#2)
disk by##2##2##(2008-10#2)
disk drive##2##2##(2008-3#2)
disk electrode with##2##3##(1990-12#1)(2008-10#1)
disk electrode##12##2##(1990-12#1)(2008-10#11)
disk hernias##2##2##(1990-9#2)
disk is##2##2##(2008-10#1)(2008-3#1)
disk microelectrode##3##2##(2008-10#3)
disk to##3##2##(2008-10#3)
disk with##3##2##(2008-10#2)(2008-2#1)
disk##75##1##(1990-12#2)(1990-9#2)(1996-3#2)(1997-3#1)(2008-10#46)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-8#1)(2009-3#5)(2013-8#1)
disk]##2##1##(1990-9#1)(1996-8#1)
disks and##3##2##(2008-10#2)(2008-3#1)
disks have been##2##3##(2008-10#2)
disks in##3##2##(2008-10#3)
disks of##3##2##(2008-10#2)(2008-11#1)
disks to##2##2##(2008-10#1)(2008-8#1)
disks was##2##2##(2008-10#2)
disks were##4##2##(2008-10#4)
disks##58##1##(2008-10#50)(2008-11#2)(2008-3#5)(2008-8#1)
disks)##2##1##(2009-3#2)
dislike##2##1##(1991-6#1)(1995-12#1)
dislocated##2##1##(2008-8#1)(2009-3#1)
dislocation loops##2##2##(2012-2#2)
dislocation of the##12##3##(2008-10#1)(2008-12#1)(2009-1#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)
dislocation of##14##2##(2008-10#1)(2008-12#1)(2009-1#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#1)
dislocation##36##1##(2008-10#1)(2008-12#8)(2008-8#2)(2009-1#1)(2009-3#1)(2010-3#3)(2011-2#9)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#1)
dislocations##5##1##(2008-12#2)(2009-7#1)(2011-2#1)(2012-2#1)
dislodged##3##1##(1997-6#1)(2008-8#1)(2011-2#1)
dismal##2##1##(1993-11#1)(2010-12#1)
dismiss##4##1##(1995-12#2)(1995-6#1)(1996-5#1)
dismissal of##2##2##(1995-12#1)(1995-6#1)
dismissal##3##1##(1991-2#1)(1995-12#1)(1995-6#1)
dismissed##7##1##(1993-5#1)(1993-9#2)(1995-12#1)(1995-6#1)(1996-5#1)(2008-12#1)
dismutase (SOD)##11##2##(1997-8#1)(2008-10#6)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
dismutase activity##3##2##(1990-3#1)(1991-5#1)(1992-12#1)
dismutase in##2##2##(1992-11#1)(2008-10#1)
dismutase##45##1##(1990-3#3)(1991-5#1)(1992-11#2)(1992-12#2)(1992-7#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-6#4)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-8#2)(2007-11#1)(2008-10#9)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
disodium 1-nitroso-2-naphthol-3##2##2##(2008-10#2)
disodium##7##1##(2008-10#7)
disomic substitution line##2##3##(2008-10#1)(2008-8#1)
disomic substitution##3##2##(2008-10#2)(2008-8#1)
disomic##7##1##(2008-10#4)(2008-8#2)(2012-2#1)
disorder (ADHD) is a##2##4##(1996-6#1)(2008-2#1)
disorder (ADHD)##5##2##(1996-6#1)(2008-2#1)(2008-9#1)(2009-9#1)(2011-2#1)
disorder among##2##2##(1995-5#1)(2013-8#1)
disorder and control##2##3##(2011-2#1)(2013-8#1)
disorder and the##4##3##(1991-2#1)(2008-7#2)(2010-12#1)
disorder and##28##2##(1990-11#1)(1991-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#5)
disorder are##6##2##(1997-2#1)(1997-8#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-3#1)
disorder associated with##4##3##(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)
disorder cases as compared##2##4##(2012-2#2)
disorder caused by a deficiency##2##5##(1996-8#1)(2011-2#1)
disorder caused by the##2##4##(2011-2#1)(2013-8#1)
disorder caused by##7##3##(1990-5#1)(1996-8#1)(2008-4#1)(2011-2#2)(2012-3#1)(2013-8#1)
disorder characterized by##10##3##(2008-1#1)(2008-4#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
disorder diagnoses##2##2##(1993-12#2)
disorder due to##2##3##(2008-10#1)(2013-1#1)
disorder has been##2##3##(2009-10#1)(2010-6#1)
disorder has##6##2##(2008-11#1)(2008-8#1)(2009-10#2)(2010-6#1)(2010-7#1)
disorder in adults##2##3##(1997-8#2)
disorder in children and adolescents##3##5##(2008-11#1)(2008-8#2)
disorder in the##2##3##(2008-8#1)(2009-9#1)
disorder in which##4##3##(1990-8#1)(1994-5#1)(2008-9#1)(2010-7#1)
disorder in##26##2##(1990-8#1)(1990-9#1)(1992-1#1)(1994-5#1)(1995-2#1)(1997-8#3)(2008-11#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
disorder is still##2##3##(1992-5#1)(2008-8#1)
disorder is##13##2##(1992-5#1)(1994-5#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-1#1)(2010-12#2)(2011-2#2)(2012-3#1)
disorder linked to##2##3##(1997-3#1)(2011-1#1)
disorder may be##2##3##(2010-6#1)(2011-1#1)
disorder not##2##2##(2008-12#1)(2011-2#1)
disorder of the##7##3##(1991-8#1)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
disorder of##16##2##(1991-11#1)(1991-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-6#2)(2011-2#2)(2012-3#2)(2013-1#1)
disorder resulting##2##2##(2006-6#1)(2008-10#1)
disorder such as##2##3##(2009-1#1)(2010-8#1)
disorder that affects##2##3##(2008-2#1)(2011-2#1)
disorder that is characterized by##2##5##(2008-12#1)(2008-4#1)
disorder that is##3##3##(2008-12#1)(2008-4#2)
disorder that##11##2##(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#2)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
disorder was##3##2##(2008-4#2)(2008-7#1)
disorder were##3##2##(2011-2#3)
disorder whose##2##2##(2009-6#1)(2013-8#1)
disorder with a high##3##4##(1991-6#1)(2008-4#1)(2012-3#1)
disorder with a##5##3##(1991-6#1)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)
disorder with##12##2##(1991-6#1)(1993-12#1)(2008-11#1)(2008-4#2)(2010-1#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
disorder##391##1##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-12#5)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-7#2)(1997-8#7)(2006-6#1)(2008-1#2)(2008-10#13)(2008-11#21)(2008-12#6)(2008-2#3)(2008-4#20)(2008-5#8)(2008-6#2)(2008-7#20)(2008-8#11)(2008-9#11)(2009-1#1)(2009-10#9)(2009-11#8)(2009-12#3)(2009-3#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#6)(2010-1#9)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#10)(2010-7#8)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#39)(2011-3#1)(2012-12#9)(2012-2#25)(2012-3#22)(2013-1#18)(2013-7#1)(2013-8#20)
disorder&quot##3##1##(2011-2#2)(2012-2#1)
disorder)##3##1##(2008-4#1)(2010-4#1)(2013-8#1)
disorder]##4##1##(1996-11#1)(2009-10#2)(2012-3#1)
disordered eating##8##2##(2010-1#2)(2011-2#1)(2012-2#5)
disordered##20##1##(1990-12#1)(1991-12#1)(1993-1#1)(1993-5#1)(1994-1#2)(1994-5#1)(1996-9#1)(2008-10#1)(2008-12#1)(2010-1#2)(2010-8#1)(2011-2#1)(2012-2#6)
disordering effect on the##2##4##(2008-10#1)(2008-11#1)
disordering effect##3##2##(2008-10#2)(2008-11#1)
disordering##5##1##(2008-10#3)(2008-11#1)(2012-2#1)
disorders (e##2##2##(2010-4#2)
disorders among##6##2##(2008-11#4)(2013-1#2)
disorders and may##2##3##(1994-11#1)(2013-8#1)
disorders and other##2##3##(2009-8#1)(2012-3#1)
disorders and the##5##3##(2008-11#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
disorders and##41##2##(1990-10#1)(1992-1#1)(1994-11#1)(1995-1#1)(1996-11#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-4#3)(2010-5#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
disorders are discussed##2##3##(2008-11#1)(2013-1#1)
disorders are##16##2##(1993-2#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-6#1)(2012-3#4)(2013-1#3)
disorders as a result of##2##5##(2008-11#1)(2012-3#1)
disorders as well as##2##4##(2012-2#1)(2013-8#1)
disorders as##7##2##(1990-10#1)(1992-9#1)(2008-11#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
disorders associated with##3##3##(2008-4#1)(2011-2#1)(2013-7#1)
disorders by##2##2##(1990-2#1)(2008-11#1)
disorders caused by##2##3##(1997-6#1)(2008-9#1)
disorders caused##3##2##(1993-3#1)(1997-6#1)(2008-9#1)
disorders characterized by##4##3##(1991-11#1)(2008-7#1)(2010-10#1)(2012-2#1)
disorders encountered##2##2##(1992-1#1)(2013-8#1)
disorders for##2##2##(2008-11#2)
disorders from##2##2##(1997-3#1)(2008-10#1)
disorders had##3##2##(1993-12#1)(2013-1#2)
disorders has been##2##3##(2010-6#1)(2013-8#1)
disorders has##6##2##(1992-1#1)(2008-10#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-8#1)
disorders have been##2##3##(2008-8#1)(2013-8#1)
disorders have##4##2##(2008-11#1)(2008-6#1)(2008-8#1)(2013-8#1)
disorders in cancer patients##4##4##(1991-3#1)(2013-1#3)
disorders in cerebral##2##3##(1997-3#2)
disorders in childhood##2##3##(2008-11#1)(2011-2#1)
disorders in children##3##3##(2009-6#1)(2013-8#2)
disorders in humans##3##3##(2008-11#1)(2012-3#2)
disorders in patients with##2##4##(2008-7#1)(2013-1#1)
disorders in the##6##3##(1997-3#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
disorders in which##2##3##(2008-1#1)(2012-2#1)
disorders in##46##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-6#1)(1993-2#1)(1994-12#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#2)(2008-1#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#2)(2011-2#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#3)
disorders including##8##2##(2008-10#1)(2008-7#3)(2011-1#1)(2012-3#3)
disorders is discussed##2##3##(1991-11#1)(1995-9#1)
disorders is##8##2##(1991-11#1)(1991-3#1)(1995-9#1)(1997-8#1)(2008-12#2)(2008-4#1)(2012-3#1)
disorders like##3##2##(2008-11#1)(2009-12#1)(2011-2#1)
disorders mapped to the##2##4##(1997-2#2)
disorders mapped##3##2##(1997-2#3)
disorders may be##2##3##(1991-3#1)(2008-7#1)
disorders may##3##2##(1991-3#1)(2008-7#1)(2011-2#1)
disorders of propionyl-CoA metabolism##2##4##(1991-12#2)
disorders of the CNS##2##4##(2008-7#1)(2010-12#1)
disorders of the##9##3##(1992-9#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#1)
disorders of##31##2##(1991-12#2)(1991-2#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-11#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#4)(2011-7#1)(2012-3#2)(2013-1#1)(2013-8#5)
disorders or##5##2##(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
disorders such as##13##3##(1991-2#1)(1995-1#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
disorders that are##3##3##(2009-8#1)(2011-2#1)(2012-3#1)
disorders that##6##2##(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
disorders to##2##2##(1990-2#1)(2012-2#1)
disorders were##2##2##(2008-12#1)(2013-1#1)
disorders with##2##2##(2008-6#1)(2012-2#1)
disorders##509##1##(1990-10#3)(1990-11#2)(1990-2#3)(1990-3#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-11#4)(1991-12#2)(1991-2#6)(1991-3#5)(1991-8#1)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-11#3)(1994-12#2)(1994-3#3)(1994-9#1)(1995-1#8)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#4)(1996-3#2)(1996-6#2)(1996-8#2)(1997-2#4)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#9)(2008-1#1)(2008-10#18)(2008-11#41)(2008-12#14)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#11)(2008-6#8)(2008-7#22)(2008-8#11)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#9)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#6)(2010-6#4)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#33)(2011-3#3)(2011-7#1)(2012-12#5)(2012-2#32)(2012-3#43)(2013-1#29)(2013-7#3)(2013-8#30)
disorders)##3##1##(2008-6#1)(2010-4#1)(2011-3#1)
disorders]##3##1##(1991-3#1)(1996-11#1)(2010-6#1)
disorganization and##3##2##(2008-10#3)
disorganization of the##5##3##(2008-10#3)(2008-7#1)(2009-10#1)
disorganization of##7##2##(1992-9#1)(2008-10#4)(2008-7#1)(2009-10#1)
disorganization##15##1##(1992-9#1)(2008-10#10)(2008-7#1)(2009-10#1)(2010-6#2)
disorganized##4##1##(2008-10#1)(2009-10#1)(2012-2#1)(2013-1#1)
disorientation##2##1##(2008-7#1)(2009-10#1)
dispar##4##1##(2008-12#4)
disparate##15##1##(1992-6#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
disparities between##2##2##(2008-1#1)(2008-10#1)
disparities in health##2##3##(2008-11#2)
disparities in the##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
disparities in##14##2##(1992-12#1)(1993-12#1)(2008-1#1)(2008-11#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
disparities##26##1##(1992-12#1)(1993-12#1)(1994-12#1)(2008-1#2)(2008-10#2)(2008-11#5)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#1)
disparity detector##4##2##(1990-8#4)
disparity in##2##2##(1997-1#1)(2008-8#1)
disparity##15##1##(1990-8#5)(1991-6#1)(1997-1#1)(2008-8#3)(2008-9#2)(2011-1#2)(2012-3#1)
dispel##3##1##(1993-3#1)(2008-7#1)(2010-4#1)
dispensable for##5##2##(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(2011-2#1)
dispensable##6##1##(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2011-2#1)
dispense with the need for##2##5##(1997-7#1)(2008-3#1)
dispense##7##1##(1995-1#2)(1995-2#2)(1996-1#1)(1997-7#1)(2008-3#1)
dispensed into##2##2##(2008-10#2)
dispensed over##2##2##(2008-10#1)(2013-8#1)
dispensed prescribing##2##2##(2008-11#2)
dispensed to##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
dispensed with##2##2##(2008-10#2)
dispensed##16##1##(1995-11#1)(2008-10#8)(2008-11#5)(2010-10#1)(2013-8#1)
dispensing costs##4##2##(1995-1#4)
dispensing##11##1##(1995-1#5)(2008-11#2)(2008-6#1)(2010-3#2)(2013-8#1)
dispensing-based##2##1##(2010-9#2)
dispersal ability##7##2##(2008-6#1)(2008-8#1)(2008-9#5)
dispersal and the##3##3##(2008-10#2)(2008-9#1)
dispersal and##18##2##(2008-10#4)(2008-8#9)(2008-9#3)(2009-6#1)(2013-1#1)
dispersal as##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
dispersal between##2##2##(2008-9#1)(2013-1#1)
dispersal can##2##2##(2008-8#1)(2008-9#1)
dispersal corridors##2##2##(2008-9#2)
dispersal distance##3##2##(2008-10#2)(2008-8#1)
dispersal distances##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
dispersal gradient##8##2##(2008-10#8)
dispersal gradients##3##2##(2008-10#3)
dispersal in marine species##2##4##(2013-1#2)
dispersal in##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
dispersal is##7##2##(2008-10#2)(2008-8#3)(2008-9#1)(2013-1#1)
dispersal of ascospores##2##3##(2008-10#2)
dispersal of spores##3##3##(2008-10#3)
dispersal of##23##2##(2008-10#20)(2010-3#1)(2011-2#1)(2012-3#1)
dispersal or##3##2##(2008-8#2)(2010-4#1)
dispersal rates can##2##3##(2008-8#2)
dispersal rates in##2##3##(2008-8#2)
dispersal rates##9##2##(2008-8#9)
dispersal strategies##2##2##(2008-8#2)
dispersal was##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
dispersal were##4##2##(2008-10#4)
dispersal with##2##2##(2008-10#2)
dispersal within##2##2##(2008-10#2)
dispersal##183##1##(2008-10#72)(2008-12#1)(2008-6#1)(2008-8#62)(2008-9#23)(2009-6#1)(2009-8#2)(2010-3#1)(2010-4#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#13)
disperse in the##2##3##(2008-10#1)(2008-7#1)
disperse in##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
disperse##11##1##(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#3)(2009-12#1)
dispersed by##6##2##(2008-10#2)(2008-8#1)(2008-9#2)(2013-1#1)
dispersed chicken kidney cells##2##4##(1991-3#2)
dispersed chicken##3##2##(1991-3#3)
dispersed in a##2##3##(2008-10#2)
dispersed into##3##2##(2008-10#2)(2008-6#1)
dispersed on##2##2##(2008-10#2)
dispersed organic silicon sol##2##4##(2008-10#2)
dispersed over##2##2##(2008-10#1)(2008-7#1)
dispersed phase##3##2##(2008-10#1)(2008-7#2)
dispersed throughout the##2##3##(1992-9#1)(2008-12#1)
dispersed to##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
dispersed within a##2##3##(2008-3#1)(2010-4#1)
dispersed##73##1##(1991-3#4)(1992-9#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#2)(2007-11#2)(2008-10#35)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2010-4#2)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
disperser##4##1##(2008-5#3)(2008-8#1)
dispersers##5##1##(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)
dispersible##2##1##(2008-10#1)(2008-5#1)
dispersing##6##1##(1991-12#1)(2008-10#1)(2008-3#1)(2008-8#3)
dispersion and##5##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
dispersion at##3##2##(2008-10#3)
dispersion caused by##2##3##(2008-3#1)(2008-8#1)
dispersion in##6##2##(1992-4#1)(2007-11#1)(2007-12#1)(2008-10#3)
dispersion is##5##2##(1991-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2012-2#1)
dispersion of the##9##3##(2008-10#5)(2008-2#1)(2008-3#2)(2010-4#1)
dispersion of##19##2##(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#4)(2010-4#1)
dispersion on the##2##3##(2008-3#2)
dispersion on##3##2##(2008-10#1)(2008-3#2)
dispersion than##2##2##(2008-5#2)
dispersion was##4##2##(2008-10#1)(2008-8#2)(2011-2#1)
dispersion##114##1##(1991-12#1)(1992-4#1)(1997-2#7)(2007-11#5)(2007-12#9)(2008-10#47)(2008-11#7)(2008-2#4)(2008-3#16)(2008-5#4)(2008-8#5)(2009-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#4)
dispersion-decreasing fiber##2##2##(2007-11#2)
dispersion-managed solitons##2##2##(2007-12#2)
dispersion-managed##4##1##(2007-11#2)(2007-12#2)
dispersions at pH##2##3##(2008-10#1)(2008-5#1)
dispersions containing##2##2##(1994-5#1)(2008-10#1)
dispersions of##3##2##(1994-5#1)(2012-2#2)
dispersions were evaluated##2##3##(2012-2#2)
dispersions were##3##2##(2008-5#1)(2012-2#2)
dispersions##20##1##(1994-5#4)(2008-10#7)(2008-5#3)(2012-2#6)
dispersive X-ray fluorescence spectroscopy##3##4##(2008-10#3)
dispersive X-ray fluorescence##9##3##(2008-10#9)
dispersive X-ray spectrometry##2##3##(2008-10#2)
dispersive X-ray##15##2##(2008-10#13)(2008-5#1)(2008-9#1)
dispersive spectroscopy##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
dispersive##27##1##(2007-11#3)(2007-12#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
disphosphonates##2##1##(2008-7#2)
displace the##2##2##(1992-3#1)(2008-8#1)
displace##7##1##(1992-3#1)(1994-12#1)(2008-8#4)(2009-8#1)
displaced by##7##2##(1990-8#1)(1993-1#1)(1994-2#1)(1994-3#1)(2008-10#1)(2010-10#1)(2011-2#1)
displaced femoral##2##2##(1991-9#1)(2008-12#1)
displaced fractures##3##2##(1991-9#1)(2013-1#2)
displaced persons##3##2##(1994-9#3)
displaced women##3##2##(2013-1#3)
displaced##41##1##(1990-8#1)(1991-9#2)(1993-1#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#4)(1995-3#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#11)
displacement and##2##2##(2009-3#1)(2013-1#1)
displacement by##3##2##(1990-11#1)(2008-5#1)(2008-8#1)
displacement chromatography##6##2##(2008-11#4)(2008-7#2)
displacement equilibrium##3##2##(2008-10#3)
displacement from##2##2##(2008-10#2)
displacement in##5##2##(2008-10#1)(2008-7#1)(2008-8#2)(2013-1#1)
displacement is##2##2##(2008-6#1)(2008-9#1)
displacement of the##14##3##(1991-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
displacement of##33##2##(1991-8#1)(1991-9#1)(1994-2#1)(1997-1#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#2)(2009-3#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#5)
displacement process##3##2##(1997-2#1)(2008-7#2)
displacement##107##1##(1990-11#3)(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-1#2)(1994-11#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#21)(2008-11#5)(2008-2#5)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#2)(2009-9#2)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#3)(2013-1#13)
displacements of##3##2##(2013-1#3)
displacements##10##1##(1990-11#2)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#5)
displacer##4##1##(2008-7#4)
displacers##2##1##(2008-7#2)
displaces the##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
displaces##4##1##(2008-11#2)(2008-7#1)(2010-7#1)
displacing##2##1##(1993-1#1)(2008-10#1)
display a##8##2##(1992-6#1)(1993-2#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-11#2)(2012-2#1)
display an##3##2##(1995-6#1)(2008-10#1)(2011-2#1)
display and##4##2##(1993-8#1)(2008-10#1)(2008-3#1)(2009-2#1)
display applications##2##2##(2008-3#2)
display devices##2##2##(2008-3#2)
display dramatic##2##2##(1995-11#1)(2008-11#1)
display enhanced##4##2##(1993-3#1)(2008-10#3)
display in##3##2##(1993-9#1)(1995-11#1)(2008-4#1)
display libraries##8##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-9#1)
display method##4##2##(1997-7#1)(2008-11#2)(2008-9#1)
display methods##2##2##(2008-10#1)(2010-12#1)
display of the##4##3##(1995-11#1)(2008-1#1)(2008-3#1)(2008-4#1)
display of##9##2##(1995-11#1)(1995-2#1)(2008-1#1)(2008-3#2)(2008-4#2)(2008-9#1)(2013-1#1)
display resolution##2##2##(2008-3#2)
display system##2##2##(2008-10#1)(2008-3#1)
display that##5##2##(2008-2#3)(2008-3#2)
display the ability to##2##4##(2008-10#1)(2008-11#1)
display the##11##2##(1994-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
display to##3##2##(2008-8#2)(2008-9#1)
display##186##1##(1990-11#1)(1990-12#2)(1990-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-5#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#5)(1995-2#5)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#31)(2008-11#12)(2008-2#4)(2008-3#28)(2008-4#12)(2008-5#1)(2008-8#13)(2008-9#14)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-2#6)(2011-3#1)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#3)
displayed a broad##2##3##(1994-8#1)(2008-10#1)
displayed a greater##2##3##(1991-5#1)(2009-10#1)
displayed a high##2##3##(2008-11#1)(2011-3#1)
displayed a##34##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-3#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#2)(2011-3#1)(2012-3#1)(2013-1#3)
displayed an##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
displayed at##2##2##(1994-3#1)(2012-2#1)
displayed both##2##2##(1995-12#1)(2008-7#1)
displayed by the##3##3##(2008-10#3)
displayed by##10##2##(1993-3#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2012-2#1)
displayed good##4##2##(1993-12#1)(2008-10#2)(2008-6#1)
displayed higher##2##2##(1995-2#1)(2011-2#1)
displayed improved##2##2##(2008-10#1)(2010-7#1)
displayed more##2##2##(2008-11#2)
displayed much##2##2##(2008-10#1)(2008-5#1)
displayed no##2##2##(1993-8#1)(2008-10#1)
displayed normal##2##2##(1993-6#1)(1995-9#1)
displayed on a##2##3##(1996-2#1)(2010-9#1)
displayed on the surface of##2##5##(2008-8#2)
displayed on##10##2##(1995-5#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-8#3)(2008-9#1)(2010-9#1)(2013-8#1)
displayed only a##2##3##(1995-2#1)(2008-9#1)
displayed only##4##2##(1995-2#1)(1997-3#1)(2008-7#1)(2008-9#1)
displayed reduced##3##2##(1990-6#1)(2008-10#1)(2008-5#1)
displayed remarkable##2##2##(1996-2#1)(2008-10#1)
displayed significant##4##2##(1993-1#1)(2008-10#2)(2012-3#1)
displayed significantly##4##2##(1994-2#1)(2008-9#1)(2013-1#1)(2013-8#1)
displayed similar##4##2##(1994-5#1)(2008-8#2)(2009-12#1)
displayed strong##2##2##(2008-10#2)
displayed that the##2##3##(2008-10#1)(2008-9#1)
displayed that##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
displayed the maximum##2##3##(2008-10#1)(2008-6#1)
displayed the same##2##3##(1994-3#1)(2008-10#1)
displayed the##15##2##(1992-8#1)(1994-11#1)(1994-3#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2010-6#1)
displayed##183##1##(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#3)(1997-3#4)(1997-8#1)(2008-10#60)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#4)(2009-12#1)(2009-7#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#3)
displaying a##6##2##(1990-2#1)(1994-11#1)(2008-10#2)(2008-11#1)(2013-1#1)
displaying significantly##2##2##(1994-3#1)(2008-10#1)
displaying the##2##2##(2008-10#2)
displaying##37##1##(1990-2#1)(1994-11#2)(1994-3#1)(1995-8#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
displays a high degree of##2##5##(1995-12#1)(2008-10#1)
displays a high##3##3##(1995-12#1)(2008-10#1)(2008-12#1)
displays a remarkable##2##3##(1995-6#1)(2008-10#1)
displays a##15##2##(1991-5#1)(1992-3#1)(1995-12#2)(1995-6#1)(1996-5#1)(2008-10#6)(2008-12#1)(2010-7#1)(2011-2#1)
displays an##2##2##(1990-12#1)(2011-2#1)
displays considerable##2##2##(1993-2#1)(1995-11#1)
displays gender-specific##2##2##(2008-11#2)
displays many##2##2##(2008-10#1)(2008-6#1)
displays the##2##2##(2008-3#2)
displays##58##1##(1990-12#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#2)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
disposable nebulizer##2##2##(1994-12#1)(1995-12#1)
disposable screen-printed##3##2##(2008-10#3)
disposable sensing##2##2##(2008-10#2)
disposable sensors##2##2##(2008-10#2)
disposable##33##1##(1992-12#1)(1994-12#2)(1994-2#1)(1995-12#1)(2008-1#2)(2008-10#21)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
disposal and##2##2##(2008-3#1)(2008-9#1)
disposal##19##1##(1992-6#1)(1993-3#1)(1994-3#1)(1994-9#1)(1997-5#2)(2008-10#5)(2008-12#3)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
dispose##2##1##(2008-10#1)(2008-11#1)
disposed of##2##2##(2008-4#1)(2008-5#1)
disposed##3##1##(2007-12#1)(2008-4#1)(2008-5#1)
disposition in##2##2##(1994-5#1)(2013-1#1)
disposition of##4##2##(1996-3#1)(2008-10#1)(2010-10#2)
disposition##12##1##(1991-2#2)(1994-5#2)(1996-1#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-8#1)(2010-10#2)(2013-1#1)
dispositions##3##1##(2008-11#3)
disproportional to surgical trauma##2##4##(2012-12#2)
disproportionate share##3##2##(1997-2#1)(2008-11#1)(2008-8#1)
disproportionate##5##1##(1991-12#1)(1997-2#1)(2008-11#1)(2008-8#2)
disproportionate-share##2##1##(1991-1#1)(1992-12#1)
disproportionately more##2##2##(2008-9#1)(2010-8#1)
disproportionately represented in##2##3##(2008-1#1)(2010-11#1)
disproportionately represented##3##2##(2008-1#2)(2010-11#1)
disproportionately##14##1##(1995-6#1)(2008-1#3)(2008-11#1)(2008-9#3)(2010-11#3)(2010-8#1)(2012-12#2)
dispute##2##1##(1990-3#1)(1997-3#1)
disputed##4##1##(1992-8#1)(2010-1#1)(2011-2#2)
disputes##3##1##(1990-6#1)(1991-12#1)(2008-11#1)
disregard##3##1##(1990-6#1)(1996-5#1)(2010-5#1)
disrupt the##9##2##(1990-7#1)(1991-3#1)(1994-11#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
disrupt##20##1##(1990-7#1)(1991-2#1)(1991-3#1)(1993-3#2)(1994-11#1)(1994-9#1)(1995-2#1)(1997-7#2)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
disrupted and##2##2##(1997-4#1)(2008-10#1)
disrupted by the##2##3##(1994-12#1)(2008-10#1)
disrupted by##7##2##(1993-2#1)(1994-11#1)(1994-12#1)(1996-5#1)(2008-10#1)(2009-10#1)(2012-3#1)
disrupted in##7##2##(1993-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-9#1)
disrupted##43##1##(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#3)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#13)(2008-12#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-3#1)(2010-10#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-3#1)
disrupting the##4##2##(2008-10#2)(2008-7#1)(2010-5#1)
disrupting##12##1##(1992-3#1)(1995-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
disruption and##4##2##(2008-4#2)(2008-7#1)(2008-8#1)
disruption by##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
disruption did not##2##3##(2008-10#1)(2008-5#1)
disruption even##2##2##(1995-2#1)(2009-10#1)
disruption in the##2##3##(1995-3#1)(1995-8#1)
disruption in##3##2##(1995-3#1)(1995-8#1)(2010-11#1)
disruption may be a##2##4##(1997-3#1)(2008-7#1)
disruption of the##16##3##(1994-11#2)(1994-12#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#4)(2008-7#1)(2011-2#1)(2013-8#1)
disruption of##37##2##(1991-2#1)(1993-3#1)(1994-11#3)(1994-12#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-5#1)(2010-7#1)(2011-2#3)(2013-8#1)
disruption to the##2##3##(2008-10#1)(2008-11#1)
disruption##91##1##(1991-2#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#2)(1995-2#3)(1995-3#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#4)(2008-10#18)(2008-11#4)(2008-12#2)(2008-4#6)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
disruptions in##4##2##(1993-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
disruptions##16##1##(1992-1#1)(1993-8#1)(1993-9#1)(1997-3#4)(2008-10#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
disruptive behavior##2##2##(1992-3#1)(2008-12#1)
disruptive behaviour##2##2##(2012-2#1)(2013-1#1)
disruptive selection##2##2##(2008-8#2)
disruptive##15##1##(1992-3#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#3)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
disruptive/violent##2##1##(1991-12#2)
disruptor##2##1##(2008-10#2)
disruptors##8##1##(2008-10#2)(2008-11#3)(2010-5#2)(2012-2#1)
disrupts the##6##2##(1993-9#1)(2010-4#2)(2012-3#1)(2013-1#2)
disrupts##12##1##(1990-5#1)(1993-9#1)(1996-12#1)(2009-10#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
dissatisfaction and disordered eating##3##4##(2012-2#3)
dissatisfaction with##3##2##(1994-12#1)(1996-3#1)(2008-11#1)
dissatisfaction##11##1##(1994-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-2#4)(2013-1#1)
dissect the##3##2##(2009-8#2)(2011-2#1)
dissect##4##1##(1997-9#1)(2009-8#2)(2011-2#1)
dissected from the##2##3##(2008-10#1)(2008-12#1)
dissected from##6##2##(2008-10#4)(2008-12#1)(2008-7#1)
dissected##18##1##(1994-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
dissecting aneurysm of the##2##4##(2008-7#2)
dissecting aneurysm##6##2##(1997-5#1)(2008-7#5)
dissecting the##4##2##(2008-10#2)(2008-12#1)(2009-12#1)
dissecting##16##1##(1994-3#1)(1997-5#1)(2008-10#4)(2008-12#1)(2008-7#5)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
dissection and the##2##3##(2011-2#1)(2013-1#1)
dissection and##5##2##(1991-8#2)(1994-2#1)(2011-2#1)(2013-1#1)
dissection are##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
dissection in a##2##3##(2013-1#2)
dissection in##5##2##(2013-1#5)
dissection intimal##2##2##(2011-2#2)
dissection is##6##2##(1991-8#1)(1994-12#1)(2008-7#1)(2010-10#1)(2011-2#2)
dissection may##2##2##(2010-10#2)
dissection of complex traits##2##4##(1994-9#2)
dissection of complex##3##3##(1994-9#3)
dissection of the nidus##2##4##(2008-7#2)
dissection of the superior mesenteric artery##3##6##(2013-1#3)
dissection of the##15##3##(1992-10#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#1)(2010-10#2)(2011-2#1)(2013-1#3)
dissection of##32##2##(1992-10#1)(1993-12#1)(1994-9#3)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#5)(2008-9#2)(2010-10#2)(2011-2#4)(2012-3#2)(2013-1#4)
dissection ofthe right##2##3##(2013-8#2)
dissection was##2##2##(2008-7#1)(2013-1#1)
dissection with##4##2##(2008-11#2)(2013-1#2)
dissection##103##1##(1991-2#1)(1991-8#4)(1992-10#1)(1993-12#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-9#3)(1995-2#1)(1995-6#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-4#1)(2008-7#11)(2008-9#3)(2009-6#1)(2009-9#1)(2010-10#7)(2011-2#13)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#18)(2013-8#4)
dissections##4##1##(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
disseminate the results##2##3##(1991-1#1)(1993-12#1)
disseminate##7##1##(1991-1#1)(1993-12#1)(1997-3#2)(2008-11#1)(2010-8#1)(2013-1#1)
disseminated by##4##2##(2008-10#2)(2010-1#1)(2013-8#1)
disseminated for##2##2##(2008-11#2)
disseminated intravascular coagulation##3##3##(2010-3#2)(2011-2#1)
disseminated pulmonary##2##2##(2008-10#2)
disseminated to##4##2##(1996-1#1)(1996-2#1)(2008-10#2)
disseminated##36##1##(1990-8#2)(1992-12#1)(1993-12#1)(1993-9#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-1#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
disseminates##3##1##(1994-3#1)(2012-2#1)(2013-8#1)
disseminating research##2##2##(2008-12#1)(2010-4#1)
disseminating structures##3##2##(2007-12#3)
disseminating##16##1##(1993-12#1)(1997-2#1)(1997-3#2)(2007-12#4)(2008-10#2)(2008-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
dissemination and##3##2##(1993-12#1)(1996-12#1)(2013-1#1)
dissemination in##4##2##(1997-5#1)(2008-10#2)(2010-10#1)
dissemination of conidia from##2##4##(2008-10#2)
dissemination of conidia##3##3##(2008-10#3)
dissemination of information##2##3##(1992-9#1)(1996-11#1)
dissemination of the##2##3##(2008-9#1)(2013-1#1)
dissemination of##19##2##(1992-9#1)(1993-6#1)(1996-11#1)(2008-10#8)(2008-11#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
dissemination to##2##2##(2008-10#1)(2013-8#1)
dissemination##57##1##(1990-6#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-12#5)(1993-6#1)(1996-11#1)(1996-12#1)(1997-5#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#5)(2008-9#3)(2009-1#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
dissertation##5##1##(2008-11#5)
dissimilar##19##1##(1990-11#1)(1990-4#1)(1990-5#1)(1993-2#2)(1994-2#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2012-2#1)
dissimilarities##2##1##(2008-10#1)(2010-6#1)
dissimilarity data##2##2##(1995-5#1)(2008-10#1)
dissimilarity##8##1##(1990-4#1)(1995-5#2)(2008-10#4)(2010-6#1)
dissipate##5##1##(1994-12#1)(1994-6#1)(2008-10#1)(2009-12#1)(2010-7#1)
dissipated##2##1##(2008-4#1)(2008-5#1)
dissipation in##2##2##(2008-7#1)(2012-2#1)
dissipation of##4##2##(1990-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
dissipation##25##1##(1990-2#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#12)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-6#1)
dissipative structures##2##2##(2012-2#2)
dissipative##6##1##(1992-8#1)(2008-3#1)(2009-5#1)(2010-7#1)(2012-2#2)
dissociable##3##1##(1996-2#1)(2008-11#2)
dissociate from##2##2##(1992-3#1)(1995-8#1)
dissociate##7##1##(1992-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-8#1)
dissociated cultures##2##2##(1996-2#1)(2009-9#1)
dissociated from the##2##3##(1995-6#1)(2008-8#1)
dissociated from##5##2##(1993-8#1)(1995-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
dissociated into##5##2##(1990-5#1)(1993-6#1)(2008-10#1)(2008-11#1)(2010-7#1)
dissociated##38##1##(1990-5#1)(1990-8#1)(1991-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(2008-10#11)(2008-11#2)(2008-8#5)(2009-9#3)(2010-12#1)(2010-7#1)(2013-8#1)
dissociates into##2##2##(1990-11#1)(2008-9#1)
dissociates##3##1##(1990-11#1)(1993-9#1)(2008-9#1)
dissociation (CID)##2##2##(2008-10#2)
dissociation and##4##2##(1993-8#1)(2008-10#3)
dissociation between the##3##3##(1993-6#1)(2010-8#1)(2013-8#1)
dissociation between##4##2##(1993-6#1)(1996-2#1)(2010-8#1)(2013-8#1)
dissociation constant at##2##3##(1993-3#1)(1993-8#1)
dissociation constant of the##3##4##(1993-8#1)(1996-3#1)(2008-11#1)
dissociation constant of##7##3##(1990-8#1)(1993-8#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
dissociation constant##26##2##(1990-11#1)(1990-5#1)(1990-8#1)(1993-3#2)(1993-8#4)(1996-3#1)(2008-10#14)(2008-11#1)(2008-9#1)
dissociation constants and##2##3##(2008-10#2)
dissociation constants for##2##3##(1995-6#1)(2008-10#1)
dissociation constants of##14##3##(1993-8#1)(1995-11#1)(2008-10#12)
dissociation constants were##3##3##(1991-5#1)(2008-10#2)
dissociation constants##39##2##(1990-8#1)(1991-5#1)(1992-3#1)(1993-8#2)(1994-5#1)(1995-11#1)(1995-6#1)(2008-10#31)
dissociation equilibria##2##2##(2008-10#2)
dissociation equilibrium##2##2##(2008-10#2)
dissociation from##2##2##(1995-11#1)(1995-2#1)
dissociation of the##2##3##(1995-11#1)(2012-3#1)
dissociation of##16##2##(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2012-3#1)
dissociation rate##4##2##(1991-5#1)(1992-6#1)(1993-8#1)(2008-10#1)
dissociation reactions of##3##3##(2008-10#3)
dissociation was##2##2##(1992-6#1)(2008-10#1)
dissociation##134##1##(1990-11#2)(1990-5#1)(1990-8#3)(1991-5#3)(1992-3#1)(1992-6#2)(1993-1#1)(1993-3#3)(1993-6#2)(1993-8#10)(1994-2#1)(1994-5#2)(1994-8#2)(1995-11#4)(1995-2#2)(1995-6#2)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#74)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
dissociations##3##1##(1990-11#1)(2008-10#1)(2008-11#1)
dissociative##8##1##(1992-8#1)(2008-9#1)(2009-10#2)(2013-1#4)
dissolution and##7##2##(2008-10#4)(2008-7#1)(2009-7#2)
dissolution in a##2##3##(2008-10#2)
dissolution in##6##2##(2008-10#6)
dissolution mixtures##2##2##(2008-10#2)
dissolution of a##3##3##(2008-10#2)(2010-5#1)
dissolution of the sample in##3##5##(2008-10#3)
dissolution of the##14##3##(1995-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2009-7#1)
dissolution of##37##2##(1995-8#1)(2008-1#1)(2008-10#31)(2008-11#1)(2008-12#1)(2009-7#1)(2010-5#1)
dissolution procedure##2##2##(2008-10#2)
dissolution profiles of isoniazid##3##4##(2008-10#3)
dissolution profiles of##4##3##(2008-10#4)
dissolution profiles##6##2##(2008-10#5)(2012-2#1)
dissolution rate and dissolution efficiency##2##5##(2012-2#2)
dissolution rate of##4##3##(2008-10#1)(2012-2#3)
dissolution rate##7##2##(2008-10#2)(2012-2#5)
dissolution rates##2##2##(2009-7#2)
dissolution studies of##2##3##(2008-10#2)
dissolution studies##4##2##(2008-10#4)
dissolution system##2##2##(2008-10#2)
dissolution testing is described##2##4##(2008-10#2)
dissolution testing##4##2##(2008-10#4)
dissolution tests##3##2##(2008-10#3)
dissolution than##2##2##(2008-10#1)(2012-2#1)
dissolution with##2##2##(2008-10#2)
dissolution##130##1##(1991-3#2)(1995-8#1)(2008-1#1)(2008-10#104)(2008-11#1)(2008-12#1)(2008-7#3)(2009-7#5)(2010-5#1)(2012-2#11)
dissolution-reaction##2##1##(2008-7#2)
dissolve##4##1##(1994-8#1)(2008-5#2)(2008-9#1)
dissolved Cr(III) and Cr(VI)##2##4##(2008-10#2)
dissolved O(2) level##2##3##(2011-2#2)
dissolved O(2) levels##3##3##(2011-2#3)
dissolved O(2)##6##2##(2011-2#6)
dissolved and##3##2##(2008-10#3)
dissolved by##2##2##(2008-10#2)
dissolved fractions##2##2##(2008-10#2)
dissolved humic##3##2##(2008-10#3)
dissolved in 0##2##3##(2008-10#2)
dissolved in 1 ml of##2##5##(2008-10#2)
dissolved in 90% ethanol##2##4##(2008-10#2)
dissolved in a##9##3##(2008-10#8)(2009-3#1)
dissolved in kerosene##2##3##(2008-10#2)
dissolved in the##4##3##(1990-5#1)(1991-5#1)(2008-10#1)(2008-5#1)
dissolved in water and##2##4##(2008-10#2)
dissolved in##58##2##(1990-5#1)(1991-5#1)(2008-10#51)(2008-11#3)(2008-5#1)(2009-3#1)
dissolved iron##3##2##(2008-10#3)
dissolved metal##4##2##(2008-10#4)
dissolved organic matter (DOM)##3##4##(2008-10#3)
dissolved organic matter##9##3##(2008-10#7)(2008-2#1)(2008-3#1)
dissolved organic##14##2##(2008-10#12)(2008-2#1)(2008-3#1)
dissolved oxygen (DO) probe##2##4##(2008-10#2)
dissolved oxygen (DO)##8##3##(2008-10#5)(2008-11#3)
dissolved oxygen and##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
dissolved oxygen concentration##2##3##(2008-10#1)(2008-7#1)
dissolved oxygen probe##4##3##(2008-10#4)
dissolved oxygen##38##2##(2008-10#26)(2008-11#7)(2008-7#3)(2010-8#1)(2011-2#1)
dissolved silica##2##2##(2008-10#2)
dissolved silicon##2##2##(2008-10#2)
dissolved substances in river water##2##5##(2008-10#2)
dissolved with 5 ml of dimethylformamide (DMF) and the metal determined by##2##12##(2008-10#2)
dissolved with 5 ml of dimethylformamide (DMF) and the metal##3##10##(2008-10#3)
dissolved with 5 ml of##4##5##(2008-10#4)
dissolved with water##2##3##(2008-10#2)
dissolved with##13##2##(2008-10#13)
dissolved##204##1##(1990-5#1)(1991-5#1)(2008-10#169)(2008-11#15)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#7)(2013-8#1)
dissolves##4##1##(2008-10#2)(2008-5#2)
dissolving agent for the##3##4##(2008-10#3)
dissolving the##4##2##(2008-10#4)
dissolving them in##2##3##(2008-10#2)
dissolving##21##1##(2008-10#15)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-2#2)
dissotocum##2##1##(2008-10#2)
distal and proximal##2##3##(1991-9#1)(2010-4#1)
distal clearance##2##2##(1991-12#2)
distal cues##2##2##(1993-6#1)(1994-8#1)
distal end##11##2##(1992-12#1)(1997-5#1)(1997-6#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
distal femoral##2##2##(1993-8#1)(2013-1#1)
distal femur##3##2##(2012-3#2)(2013-1#1)
distal half##2##2##(2007-12#1)(2008-7#1)
distal hypospadias repair##2##3##(2008-10#2)
distal limb##2##2##(1997-3#2)
distal metaphyseal##3##2##(2011-2#1)(2013-1#2)
distal pancreatectomy##3##2##(2010-1#1)(2011-2#1)(2013-1#1)
distal part of the##8##4##(1997-8#1)(2007-12#1)(2008-11#1)(2008-7#2)(2009-4#1)(2013-1#2)
distal parts of the##2##4##(1996-3#1)(2008-9#1)
distal portion##7##2##(1991-5#1)(1996-8#1)(2007-12#2)(2008-7#1)(2011-2#2)
distal radius fractures##2##3##(2008-9#1)(2011-2#1)
distal radius##8##2##(2008-9#5)(2011-2#2)(2013-1#1)
distal region##2##2##(1997-8#1)(2012-3#1)
distal renal tubular acidosis##2##4##(2008-1#2)
distal third##2##2##(2010-11#1)(2013-8#1)
distal tip of the##2##4##(2007-12#1)(2008-10#1)
distal tip##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
distal to the##12##3##(1991-8#1)(1993-3#1)(1994-11#1)(1994-6#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-1#1)(2013-1#1)
distal to##15##2##(1990-12#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-1#1)(2013-1#1)
distal tubal##3##2##(1991-12#1)(1993-1#2)
distal ureteric##2##2##(2008-10#1)(2009-5#1)
distal urethral##2##2##(2008-10#2)
distal##199##1##(1990-12#1)(1990-9#1)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-1#6)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#3)(1995-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#5)(1997-5#1)(1997-6#3)(1997-8#7)(2007-12#14)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#4)(2008-12#5)(2008-2#3)(2008-7#14)(2008-8#2)(2008-9#17)(2009-1#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#13)(2012-12#6)(2012-2#1)(2012-3#6)(2013-1#14)(2013-3#1)(2013-8#3)
distally located##2##2##(1996-5#1)(1997-3#1)
distally##8##1##(1996-5#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)
distance alone##2##2##(2008-8#1)(2009-8#1)
distance among##3##2##(2008-10#3)
distance and the##3##3##(2007-12#1)(2008-10#1)(2010-4#1)
distance and##11##2##(1990-3#1)(2007-12#1)(2008-10#4)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
distance at##2##2##(2008-10#2)
distance between populations##2##3##(2008-10#1)(2012-3#1)
distance between the two##2##4##(2008-10#1)(2008-3#1)
distance between the##17##3##(1993-12#1)(1994-5#2)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#4)(2008-6#1)(2011-2#1)
distance between two##2##3##(2008-10#1)(2008-11#1)
distance between##36##2##(1992-4#1)(1993-12#1)(1993-8#2)(1994-5#2)(1997-7#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
distance constraints##3##2##(1994-5#2)(2008-8#1)
distance education##4##2##(2012-3#4)
distance for##2##2##(1993-3#1)(2008-10#1)
distance from plants##2##3##(2008-10#2)
distance from the source##3##4##(2008-10#3)
distance from the##17##3##(1996-6#2)(2008-10#8)(2008-12#1)(2008-3#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
distance from##23##2##(1996-6#2)(2008-10#13)(2008-12#2)(2008-3#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
distance in##3##2##(2008-3#1)(2008-9#1)(2010-4#1)
distance learning approaches##2##3##(2008-11#2)
distance learning##8##2##(2008-11#6)(2010-10#2)
distance limitations##3##2##(2009-8#3)
distance measurements##2##2##(2008-10#1)(2008-3#1)
distance methods##2##2##(2008-4#1)(2008-8#1)
distance of 0##2##3##(2008-10#2)
distance of 2##3##3##(2008-10#2)(2008-9#1)
distance of 4##2##3##(2008-10#1)(2011-2#1)
distance of approximately##3##3##(2008-10#2)(2008-2#1)
distance of the##2##3##(2007-12#1)(2008-9#1)
distance of##37##2##(1992-1#1)(1993-8#1)(1995-2#1)(1996-6#1)(2007-12#1)(2008-10#19)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#3)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
distance on##2##2##(1997-3#1)(2008-10#1)
distance or##3##2##(1995-2#1)(2008-8#1)(2011-2#1)
distance to the##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
distance to##6##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)
distance was 0##2##3##(2008-10#1)(2013-1#1)
distance was found##3##3##(2008-10#3)
distance was##10##2##(1996-6#1)(2008-10#6)(2008-3#1)(2011-2#1)(2013-1#1)
distance were##2##2##(2008-8#1)(2012-3#1)
distance with##2##2##(2011-2#1)(2012-2#1)
distance##251##1##(1990-3#1)(1992-1#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-2#2)(1994-5#5)(1995-2#2)(1995-6#1)(1996-2#1)(1996-6#5)(1997-3#1)(1997-7#1)(2007-12#4)(2008-1#1)(2008-10#101)(2008-11#13)(2008-12#6)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#12)(2008-9#9)(2009-7#2)(2009-8#4)(2010-10#5)(2010-12#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#9)(2013-8#3)
distance)##3##1##(2008-10#3)
distances among##5##2##(2008-10#3)(2008-8#1)(2013-1#1)
distances are##2##2##(1993-8#1)(2008-10#1)
distances based on##2##3##(2008-10#1)(2010-7#1)
distances between the##2##3##(2008-5#1)(2008-9#1)
distances between##10##2##(1994-5#1)(1996-2#1)(2008-10#5)(2008-5#1)(2008-9#1)(2011-2#1)
distances by##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
distances from the##5##3##(1991-5#1)(1997-2#1)(2008-10#2)(2009-11#1)
distances from##8##2##(1991-5#1)(1995-12#1)(1997-2#1)(2008-10#3)(2009-11#1)(2011-2#1)
distances in##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
distances of spread##2##3##(2008-10#2)
distances of##8##2##(1995-2#1)(2007-12#1)(2008-10#5)(2010-10#1)
distances on##3##2##(2008-10#1)(2008-12#2)
distances over which##2##3##(1990-8#1)(2009-8#1)
distances were not##2##3##(2008-10#1)(2011-2#1)
distances were##10##2##(2008-10#5)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-1#1)
distances##105##1##(1990-8#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#43)(2008-11#2)(2008-12#7)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#7)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-7#3)(2011-2#6)(2013-1#5)(2013-8#2)
distant from the##4##3##(1994-5#1)(2008-10#1)(2008-6#1)(2008-8#1)
distant from##9##2##(1994-5#1)(2008-10#6)(2008-6#1)(2008-8#1)
distant metastases##13##2##(1990-6#1)(1991-8#1)(1992-12#1)(1993-1#2)(1996-10#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#1)
distant metastasis##6##2##(1994-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2010-3#2)
distant organ##2##2##(2009-10#1)(2011-2#1)
distant sites##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
distant##70##1##(1990-12#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-1#4)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-10#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#4)(2011-2#6)(2012-2#2)(2012-3#4)(2013-1#2)
distantly related to##5##3##(2008-10#5)
distantly related##11##2##(1991-5#1)(1995-6#1)(2008-10#9)
distasonis and B##3##3##(1997-2#3)
distasonis##4##1##(1997-2#4)
distended##3##1##(1993-6#1)(2013-1#2)
distensibility##5##1##(2013-3#5)
distension and##4##2##(2008-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
distension of##2##2##(2008-1#1)(2013-1#1)
distension##11##1##(2008-1#1)(2008-11#1)(2008-12#1)(2010-12#3)(2012-3#2)(2013-1#3)
distention##2##1##(1992-9#1)(1997-1#1)
distillation in##3##2##(2008-10#3)
distillation##12##1##(2008-10#11)(2008-12#1)
distilled drinks##3##2##(2008-10#3)
distilled water (DW)##2##3##(2008-10#1)(2013-1#1)
distilled water and##5##3##(2008-10#3)(2008-12#1)(2012-3#1)
distilled water as##2##3##(2008-10#1)(2012-2#1)
distilled water containing##2##3##(2008-10#1)(2008-5#1)
distilled water##26##2##(1996-12#1)(2008-10#14)(2008-12#1)(2008-5#4)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#3)
distilled water)##2##2##(1994-9#1)(2012-3#1)
distilled##40##1##(1994-2#1)(1994-9#1)(1996-12#1)(2008-10#23)(2008-12#3)(2008-5#4)(2009-6#1)(2012-2#1)(2012-3#2)(2013-1#3)
distilling##2##1##(2008-10#1)(2009-3#1)
distinct North##2##2##(2008-10#1)(2010-10#1)
distinct advantages over the##2##4##(1993-3#1)(1994-1#1)
distinct advantages##5##2##(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(2008-3#1)
distinct anatomical##2##2##(2012-2#2)
distinct and##9##2##(1991-1#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#2)
distinct areas##3##2##(1994-3#1)(2007-12#1)(2010-6#1)
distinct bands##4##2##(1995-12#2)(2008-10#1)(2008-9#1)
distinct biological##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
distinct changes##2##2##(2008-9#1)(2009-12#1)
distinct characteristics##2##2##(2008-11#1)(2008-8#1)
distinct clades##5##2##(2008-10#3)(2009-8#1)(2010-4#1)
distinct clinical##2##2##(2008-7#1)(2009-12#1)
distinct cluster##2##2##(2008-10#2)
distinct clusters of isolates were##2##5##(2008-10#2)
distinct clusters of isolates##3##4##(2008-10#3)
distinct clusters of##4##3##(2008-10#4)
distinct clusters##10##2##(2008-10#10)
distinct components##2##2##(1994-5#1)(2008-8#1)
distinct constructs##2##2##(2008-11#1)(2010-7#1)
distinct contributions##2##2##(2008-10#1)(2008-5#1)
distinct domains of##2##3##(1996-2#2)
distinct domains##3##2##(1996-2#2)(2011-2#1)
distinct effects##3##2##(1994-2#1)(1996-12#1)(2008-9#1)
distinct expression##3##2##(1993-8#1)(2010-1#1)(2011-2#1)
distinct features##2##2##(2008-7#1)(2009-8#1)
distinct for##2##2##(2008-10#2)
distinct forms of##2##3##(1990-5#1)(1995-6#1)
distinct forms##3##2##(1990-5#1)(1995-6#1)(2008-10#1)
distinct from a##3##3##(2008-10#2)(2012-2#1)
distinct from all##5##3##(2008-10#5)
distinct from other##11##3##(1990-8#1)(1995-2#1)(2008-10#8)(2008-11#1)
distinct from that of the##2##5##(1992-6#1)(2008-10#1)
distinct from that of##7##4##(1992-10#1)(1992-6#1)(1995-2#1)(2008-10#2)(2008-6#1)(2009-10#1)
distinct from that##10##3##(1992-10#1)(1992-6#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)
distinct from the other##2##4##(2008-10#2)
distinct from the##12##3##(1990-8#1)(1993-11#1)(1997-7#1)(2008-10#5)(2008-11#1)(2010-1#1)(2010-3#1)(2013-8#1)
distinct from these##2##3##(2008-10#2)
distinct from those of##2##4##(2008-10#1)(2008-11#1)
distinct from those##6##3##(2006-6#1)(2008-10#3)(2008-11#1)(2012-2#1)
distinct from##87##2##(1990-8#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#4)(1996-5#1)(1997-5#1)(1997-7#1)(2006-6#1)(2008-10#45)(2008-11#7)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
distinct function##2##2##(1995-5#1)(2008-11#1)
distinct functions##2##2##(1993-3#1)(2009-10#1)
distinct genetic##3##2##(2010-10#1)(2011-2#2)
distinct genotypes##4##2##(2008-10#4)
distinct geographic##3##2##(2008-10#3)
distinct groups corresponding to##2##4##(2008-10#1)(2008-9#1)
distinct groups in##2##3##(2008-10#2)
distinct groups of##6##3##(1991-2#1)(1996-2#1)(2008-10#2)(2008-9#1)(2009-4#1)
distinct groups that##2##3##(2008-10#2)
distinct groups##21##2##(1991-2#1)(1996-2#1)(2008-10#13)(2008-6#1)(2008-9#2)(2009-4#1)(2011-2#1)(2013-1#1)
distinct growth##2##2##(2008-10#1)(2011-2#1)
distinct haplotypes##2##2##(2008-10#2)
distinct host##2##2##(2008-10#1)(2008-5#1)
distinct in##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
distinct mechanisms##5##2##(1995-2#1)(1996-2#2)(2008-10#2)
distinct monophyletic groups in a phylogenetic tree##2##7##(2008-10#2)
distinct neural circuits##2##3##(1990-5#2)
distinct optical##2##2##(1990-8#1)(2008-10#1)
distinct pathotypes##2##2##(2008-10#2)
distinct patterns of##4##3##(1990-5#1)(2008-5#1)(2009-10#1)(2013-8#1)
distinct patterns##5##2##(1990-5#1)(1990-8#1)(2008-5#1)(2009-10#1)(2013-8#1)
distinct phases##3##2##(1996-3#1)(2008-5#1)(2008-7#1)
distinct populations##4##2##(1991-8#1)(2008-10#3)
distinct preferences for##2##3##(2008-8#1)(2013-1#1)
distinct properties##2##2##(1995-12#1)(2008-11#1)
distinct races were##2##3##(2008-10#2)
distinct races##4##2##(2008-10#4)
distinct regions of##3##3##(2008-10#2)(2008-11#1)
distinct regions##4##2##(2007-12#1)(2008-10#2)(2008-11#1)
distinct replicons##2##2##(2011-2#2)
distinct roles in##3##3##(1995-2#1)(1997-2#1)(2013-8#1)
distinct sets of##2##3##(1991-3#1)(2010-11#1)
distinct spatial##2##2##(2008-10#1)(2008-5#1)
distinct species of##2##3##(2008-10#2)
distinct species##11##2##(2008-10#10)(2008-5#1)
distinct stages of##2##3##(1994-12#1)(1997-6#1)
distinct stages##3##2##(1994-12#1)(1997-6#1)(2008-11#1)
distinct strain##2##2##(2008-10#2)
distinct subgroup##3##2##(2007-12#1)(2008-10#2)
distinct subgroups##3##2##(2008-10#3)
distinct taxa##2##2##(2008-10#2)
distinct types of##3##3##(1997-2#1)(2008-10#1)(2010-1#1)
distinct types##4##2##(1997-2#1)(2008-10#2)(2010-1#1)
distinct viruses##2##2##(2008-10#2)
distinct##557##1##(1990-12#1)(1990-5#6)(1990-8#7)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#4)(1993-8#3)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#10)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#7)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#3)(2006-6#1)(2007-12#5)(2008-1#4)(2008-10#244)(2008-11#29)(2008-12#5)(2008-3#3)(2008-4#4)(2008-5#15)(2008-6#4)(2008-7#6)(2008-8#11)(2008-9#14)(2009-10#5)(2009-12#6)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#26)(2012-2#13)(2012-3#5)(2012-5#1)(2013-1#11)(2013-8#9)
distinction between the##4##3##(2007-12#1)(2008-10#2)(2010-5#1)
distinction between##24##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1995-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-5#1)(2012-3#1)(2013-8#3)
distinction by##2##2##(2008-10#1)(2008-11#1)
distinction in##2##2##(2008-10#1)(2011-2#1)
distinction is##4##2##(1991-1#1)(1992-9#1)(2008-11#1)(2009-3#1)
distinction was##3##2##(2008-10#2)(2010-1#1)
distinction##42##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#3)(1991-3#1)(1992-9#1)(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#3)
distinctions between##5##2##(1990-8#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#1)
distinctions in##2##2##(1995-12#1)(2008-9#1)
distinctions##16##1##(1990-8#3)(1991-2#3)(1991-3#1)(1995-12#1)(1996-5#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-4#1)(2011-2#1)
distinctive feature of##2##3##(1995-2#1)(2008-10#1)
distinctive features##2##2##(2007-12#1)(2011-2#1)
distinctive##37##1##(1991-12#1)(1991-7#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#5)(2013-1#1)(2013-8#1)
distinctiveness##3##1##(2008-6#2)(2010-10#1)
distinctly different from those##2##4##(2008-10#1)(2008-9#1)
distinctly different##7##2##(2008-10#3)(2008-6#1)(2008-9#1)(2009-7#1)(2012-2#1)
distinctly##15##1##(1993-12#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-6#1)(2012-2#1)
distinguish among these##2##3##(2008-11#1)(2008-8#1)
distinguish among##7##2##(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-2#1)
distinguish between the##5##3##(2008-10#3)(2009-12#1)(2010-11#1)
distinguish between##32##2##(1993-2#1)(1994-3#1)(1994-9#1)(2008-10#17)(2008-11#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-8#1)
distinguish cells that##2##3##(1994-3#1)(2009-5#1)
distinguish normal and##2##3##(2008-4#1)(2010-12#1)
distinguish the two##4##3##(2008-10#3)(2008-11#1)
distinguish the##16##2##(1997-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)
distinguish them from##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
distinguish them##4##2##(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
distinguish these##2##2##(2008-10#1)(2008-4#1)
distinguish##129##1##(1991-6#2)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#2)(1994-9#1)(1996-3#1)(1997-3#2)(2008-10#50)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#6)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#1)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2012-9#1)(2013-1#2)(2013-8#5)
distinguishable by##2##2##(2008-10#2)
distinguishable from the##2##3##(2008-10#1)(2008-5#1)
distinguishable from##5##2##(2008-10#4)(2008-5#1)
distinguishable##20##1##(1995-11#1)(2008-10#9)(2008-11#3)(2008-5#4)(2008-7#1)(2010-10#1)(2012-3#1)
distinguished as##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
distinguished based on##2##3##(2008-10#2)
distinguished by##9##2##(1993-8#1)(1993-9#1)(2008-10#4)(2008-11#1)(2011-2#2)
distinguished experts from##3##3##(2010-12#3)
distinguished from each other by##3##5##(2008-10#2)(2008-4#1)
distinguished from each other##6##4##(2008-10#4)(2008-4#1)(2009-5#1)
distinguished from the##3##3##(1990-10#1)(1995-12#1)(2008-10#1)
distinguished from##25##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-9#1)(1995-12#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-4#1)(2009-5#1)(2012-2#1)(2013-1#1)
distinguished in##3##2##(2008-10#2)(2008-12#1)
distinguished into##2##2##(2008-10#1)(2010-12#1)
distinguished the##6##2##(1997-8#2)(2008-10#3)(2008-6#1)
distinguished##102##1##(1990-10#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-9#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#42)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)
distinguishes between##2##2##(1993-12#1)(1994-12#1)
distinguishes##6##1##(1993-12#1)(1994-12#1)(2008-10#2)(2008-12#1)(2010-5#1)
distinguishing between##5##2##(2008-4#2)(2008-9#2)(2011-2#1)
distinguishing isolates of##2##3##(2008-10#2)
distinguishing isolates##3##2##(2008-10#3)
distinguishing##37##1##(1991-1#1)(1991-12#1)(1992-5#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-6#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#2)(2008-9#4)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)
distonic##2##1##(2008-10#2)
distort the##2##2##(2008-10#1)(2010-5#1)
distorted and##4##2##(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
distorted##16##1##(1993-8#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-2#2)
distorters##2##1##(2012-3#2)
distorting##3##1##(2010-11#1)(2010-3#1)(2011-2#1)
distortion in lettuce##2##3##(2008-10#2)
distortion of the##5##3##(1997-7#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)
distortion of##8##2##(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#2)(2009-12#1)(2010-10#1)
distortion or##2##2##(1992-12#1)(2008-10#1)
distortion##31##1##(1990-9#1)(1992-12#2)(1997-7#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#4)(2009-10#2)(2009-12#2)(2009-9#1)(2010-10#1)(2013-8#2)
distortions and##2##2##(1994-1#1)(2007-12#1)
distortions can##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
distortions in glomerulonephritis##2##3##(1993-2#2)
distortions in the##2##3##(2008-10#2)
distortions in##6##2##(1993-2#2)(1994-8#1)(2008-10#2)(2008-3#1)
distortions##23##1##(1993-2#3)(1994-1#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#6)(2012-2#2)(2013-8#1)
distorts the##4##2##(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
distraction on##2##2##(2008-12#1)(2009-11#1)
distraction##20##1##(1993-12#1)(2008-12#1)(2009-11#4)(2009-3#2)(2010-10#2)(2010-3#1)(2011-1#1)(2011-2#7)(2012-2#1)
distress among##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
distress and parenting##2##3##(1995-2#1)(2009-12#1)
distress and##9##2##(1990-12#1)(1990-3#1)(1995-2#1)(2009-12#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
distress during##4##2##(1992-2#1)(1995-1#1)(1995-2#2)
distress in##5##2##(2008-7#1)(2008-9#1)(2010-2#1)(2013-1#1)(2013-8#1)
distress than##2##2##(1995-1#1)(2008-9#1)
distress that##2##2##(1995-9#1)(2008-11#1)
distress tolerance##4##2##(2013-8#4)
distress##98##1##(1990-11#2)(1990-12#2)(1990-3#1)(1991-1#1)(1991-12#1)(1992-2#4)(1992-3#3)(1993-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#5)(1995-9#1)(1996-5#1)(1997-1#2)(2008-11#5)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#12)(2013-1#1)(2013-7#1)(2013-8#11)
distressed couples##2##2##(2012-2#2)
distressed##3##1##(1995-12#1)(2012-2#2)
distressing##5##1##(1991-6#1)(2008-11#1)(2008-7#2)(2010-11#1)
distribute the##2##2##(2007-11#1)(2008-10#1)
distribute##6##1##(2007-11#1)(2008-10#3)(2008-11#2)
distributed across the##2##3##(2008-10#1)(2008-9#1)
distributed across##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
distributed along the##3##3##(1990-5#1)(1997-4#1)(2008-9#1)
distributed among the##2##3##(2008-10#1)(2008-12#1)
distributed among##15##2##(2008-10#9)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
distributed amongst##2##2##(2007-12#1)(2012-12#1)
distributed and##2##2##(1992-11#1)(2010-8#1)
distributed as##2##2##(1992-6#1)(2008-12#1)
distributed beacons##2##2##(2008-3#2)
distributed between the##2##3##(2008-10#2)
distributed between##5##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-2#1)
distributed data management##2##3##(2010-5#2)
distributed data##7##2##(1994-2#1)(2008-10#1)(2008-3#1)(2010-5#2)(2010-8#1)(2013-1#1)
distributed environments##3##2##(2010-8#3)
distributed feedback##6##2##(2008-3#6)
distributed forces##2##2##(2012-2#2)
distributed in a##2##3##(2008-10#1)(2011-2#1)
distributed in the cell##2##4##(1990-5#1)(2007-12#1)
distributed in the##15##3##(1990-5#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-9#2)(2009-12#1)(2010-6#1)(2013-8#1)
distributed in##29##2##(1990-5#1)(1993-11#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#15)(2008-12#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-6#1)(2011-2#1)(2013-8#2)
distributed information##2##2##(2008-11#1)(2010-8#1)
distributed into##2##2##(1994-9#1)(2008-12#1)
distributed on all##2##3##(2008-9#1)(2009-10#1)
distributed on the##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
distributed on##7##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)
distributed over a##2##3##(1993-12#1)(2008-9#1)
distributed over all##3##3##(2008-10#3)
distributed over##7##2##(1992-3#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-9#1)
distributed species##2##2##(2008-12#1)(2012-3#1)
distributed throughout the##8##3##(1996-1#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-5#1)(2010-8#1)
distributed throughout##10##2##(1996-1#1)(2008-10#5)(2008-11#1)(2009-8#1)(2010-5#1)(2010-8#1)
distributed to##5##2##(1990-2#3)(1997-2#1)(2010-8#1)
distributed uniformly##3##2##(1994-8#1)(2008-10#2)
distributed with##3##2##(2008-10#1)(2008-8#2)
distributed within a##2##3##(2008-10#2)
distributed within the##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
distributed within##11##2##(2008-10#9)(2008-7#1)(2008-9#1)
distributed##217##1##(1990-2#3)(1990-5#2)(1990-6#1)(1990-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-11#1)(2007-12#6)(2008-10#68)(2008-11#8)(2008-12#6)(2008-2#1)(2008-3#12)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#11)(2008-9#10)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-5#3)(2010-6#1)(2010-8#14)(2011-1#1)(2011-2#3)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#4)
distributed-feedback diode laser##3##3##(2008-2#2)(2008-3#1)
distributed-feedback laser##4##2##(2007-12#1)(2008-3#3)
distributed-feedback##9##1##(2007-12#1)(2008-2#2)(2008-3#6)
distributes##2##1##(1997-4#1)(2011-3#1)
distributing##2##1##(1991-1#1)(2010-5#1)
distribution along the##2##3##(2007-11#1)(2009-7#1)
distribution among##3##2##(1992-12#1)(1997-2#1)(2008-8#1)
distribution analysis##4##2##(2008-10#4)
distribution and a##2##3##(2010-3#1)(2012-3#1)
distribution and frequency of##2##4##(2008-10#2)
distribution and molecular##2##3##(2008-10#1)(2008-12#1)
distribution and particle size##2##4##(1993-2#1)(2008-3#1)
distribution and temporal development of##2##5##(2008-10#2)
distribution and the##9##3##(1992-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)
distribution and##66##2##(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#4)(2008-8#3)(2009-10#1)(2010-3#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
distribution are##2##2##(1996-12#1)(2008-6#1)
distribution as a function of##2##5##(2007-12#1)(2008-7#1)
distribution as a##3##3##(2007-12#1)(2008-7#2)
distribution as##6##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)
distribution at##5##2##(1995-3#1)(1997-4#1)(2008-10#1)(2008-6#1)(2012-2#1)
distribution between the##2##3##(1992-9#1)(2012-2#1)
distribution between##6##2##(1992-9#1)(1997-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
distribution by##5##2##(1992-9#1)(2008-10#1)(2008-3#3)
distribution can be##5##3##(1991-5#1)(2008-11#2)(2008-3#1)(2008-9#1)
distribution characteristics of##2##3##(2008-10#1)(2013-8#1)
distribution coefficient and##2##3##(2008-10#2)
distribution coefficient of##2##3##(2008-10#2)
distribution coefficient##10##2##(2008-10#10)
distribution coefficients for##2##3##(2008-10#2)
distribution coefficients##5##2##(2008-10#5)
distribution constant of##2##3##(2008-10#2)
distribution constant##5##2##(2008-10#5)
distribution constants of##7##3##(2008-10#7)
distribution constants##10##2##(2008-10#10)
distribution curves##3##2##(2008-10#2)(2013-8#1)
distribution data##3##2##(2008-10#3)
distribution diagrams of##2##3##(2008-10#2)
distribution diagrams##4##2##(2008-10#4)
distribution during##2##2##(1990-5#1)(2013-1#1)
distribution equilibria of##2##3##(2008-10#2)
distribution equilibrium##2##2##(2008-10#2)
distribution for the##4##3##(2008-10#3)(2008-3#1)
distribution for##12##2##(1992-9#1)(2008-10#7)(2008-3#1)(2009-2#1)(2012-3#1)(2013-1#1)
distribution function of##2##3##(2008-3#2)
distribution function##12##2##(2008-3#9)(2012-2#2)(2013-8#1)
distribution functions##5##2##(1992-9#2)(2008-10#1)(2008-3#1)(2010-8#1)
distribution has##2##2##(1996-2#1)(2008-2#1)
distribution in a##5##3##(1995-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
distribution in brain##2##3##(1997-2#1)(2009-7#1)
distribution in the##11##3##(1995-9#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
distribution in##45##2##(1994-5#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
distribution into##3##2##(1992-8#1)(1996-2#1)(2013-1#1)
distribution is not##2##3##(2008-10#1)(2008-9#1)
distribution is##20##2##(1992-9#1)(1993-8#1)(1994-5#1)(1995-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2013-1#2)(2013-8#1)
distribution may##2##2##(1997-2#1)(2012-2#1)
distribution model##2##2##(2008-10#2)
distribution of CaM##2##3##(2008-8#2)
distribution of P##2##3##(2008-10#2)
distribution of TiO _ 2##2##5##(2008-5#2)
distribution of a##7##3##(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)
distribution of aerosol##2##3##(1996-3#2)
distribution of airborne##2##3##(2008-10#1)(2008-11#1)
distribution of an##3##3##(1996-3#1)(2008-10#1)(2010-1#1)
distribution of blood##2##3##(1997-1#1)(2010-7#1)
distribution of calmodulin##2##3##(2008-8#2)
distribution of cases##2##3##(1992-12#1)(2008-10#1)
distribution of cells##2##3##(1997-1#1)(2008-11#1)
distribution of diseased##2##3##(2008-10#2)
distribution of doxorubicin##2##3##(2008-11#2)
distribution of fluorescent##2##3##(2010-4#1)(2012-3#1)
distribution of food##2##3##(2008-10#1)(2008-8#1)
distribution of four##2##3##(2008-10#2)
distribution of histopathologic types##2##4##(2011-2#2)
distribution of internal##2##3##(2009-10#1)(2012-3#1)
distribution of its##2##3##(1991-5#1)(2008-11#1)
distribution of mating types##2##4##(2008-10#2)
distribution of mating##3##3##(2008-10#3)
distribution of skin##2##3##(1994-12#1)(2010-6#1)
distribution of the final equilibria##2##5##(2008-10#2)
distribution of the incidence of seed infection##2##7##(2008-10#2)
distribution of the pathogen##2##4##(2008-10#2)
distribution of the population##2##4##(1994-6#1)(2008-10#1)
distribution of the primary##2##4##(1991-6#1)(2008-3#1)
distribution of the two##4##4##(1992-6#1)(1995-12#1)(2008-10#2)
distribution of the##77##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-3#2)(1991-6#2)(1992-2#3)(1992-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#30)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
distribution of their##3##3##(2008-3#1)(2008-4#1)(2009-8#1)
distribution of these##3##3##(2008-10#2)(2011-2#1)
distribution of this##2##3##(1997-8#1)(2008-10#1)
distribution of time to##2##4##(1995-9#1)(2012-3#1)
distribution of two##2##3##(1994-11#1)(2008-10#1)
distribution of vanadium##2##3##(1990-5#1)(2008-10#1)
distribution of various##2##3##(2008-3#1)(2009-10#1)
distribution of virus##2##3##(2008-10#2)
distribution of##398##2##(1990-11#1)(1990-12#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1992-12#3)(1992-2#6)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#4)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2007-12#3)(2008-10#130)(2008-11#23)(2008-12#5)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#12)(2008-8#28)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-2#9)(2011-7#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#8)(2013-8#7)
distribution on the##5##3##(1991-2#1)(1995-9#1)(2008-10#1)(2008-8#1)(2009-7#1)
distribution on##7##2##(1991-2#1)(1995-9#1)(2008-10#1)(2008-8#2)(2009-7#1)(2010-7#1)
distribution over##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
distribution pattern of the##3##4##(1996-12#1)(2008-5#1)(2012-3#1)
distribution pattern of##10##3##(1996-12#1)(2007-12#2)(2008-10#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
distribution pattern##18##2##(1992-3#1)(1996-12#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
distribution patterns of##5##3##(1992-3#1)(1997-2#1)(2008-10#3)
distribution patterns##10##2##(1992-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-6#2)(2008-9#1)(2010-1#1)
distribution profile##2##2##(1997-1#1)(2010-5#1)
distribution profiles of pseudosclerotia##2##4##(2008-10#2)
distribution profiles##3##2##(2008-10#3)
distribution ratio of##2##3##(2008-10#2)
distribution ratio##7##2##(2008-10#7)
distribution ratios##2##2##(2008-10#2)
distribution shows##2##2##(2008-10#1)(2008-3#1)
distribution system##2##2##(1992-3#1)(1996-12#1)
distribution that can##2##3##(2008-10#1)(2012-2#1)
distribution that##5##2##(2007-12#1)(2008-10#2)(2009-10#1)(2012-2#1)
distribution throughout the##3##3##(2008-10#2)(2009-8#1)
distribution to the##2##3##(2008-10#1)(2013-1#1)
distribution to##5##2##(2008-10#3)(2008-8#1)(2013-1#1)
distribution under##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
distribution was not##2##3##(2008-10#1)(2013-8#1)
distribution was##13##2##(2008-10#7)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
distribution were assessed##2##3##(1992-2#1)(1995-1#1)
distribution were##7##2##(1992-2#1)(1993-12#1)(1995-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
distribution width##3##2##(2008-10#3)
distribution with a##3##3##(1996-3#1)(2008-10#1)(2008-2#1)
distribution with##11##2##(1995-9#1)(1996-12#1)(1996-3#1)(2008-10#6)(2008-2#1)(2009-7#1)
distribution within the##4##3##(1993-11#1)(1994-1#1)(2008-10#1)(2008-3#1)
distribution within##7##2##(1993-11#1)(1994-1#1)(2008-10#2)(2008-3#2)(2010-7#1)
distribution##972##1##(1990-11#1)(1990-12#2)(1990-5#6)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#4)(1991-6#3)(1991-9#1)(1992-12#6)(1992-2#7)(1992-3#6)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#10)(1993-11#2)(1993-12#1)(1993-2#5)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#11)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#8)(1995-2#1)(1995-3#3)(1995-6#6)(1995-8#1)(1995-9#6)(1996-1#1)(1996-12#12)(1996-2#7)(1996-3#7)(1996-8#1)(1997-1#5)(1997-2#10)(1997-3#6)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#10)(2008-10#342)(2008-11#43)(2008-12#10)(2008-2#15)(2008-3#67)(2008-4#3)(2008-5#19)(2008-6#5)(2008-7#39)(2008-8#48)(2008-9#24)(2009-10#5)(2009-11#4)(2009-12#2)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#9)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#6)(2010-7#4)(2010-8#7)(2010-9#1)(2011-2#23)(2011-7#1)(2012-12#4)(2012-2#14)(2012-3#12)(2012-5#1)(2013-1#24)(2013-8#17)
distribution)##2##1##(2008-10#1)(2008-7#1)
distributional##3##1##(1994-2#2)(1996-3#1)
distributions (Brethaire##2##2##(1992-2#2)
distributions across##2##2##(2009-7#2)
distributions and thermal deformations of mirror substrates in laser resonators##2##10##(2008-3#2)
distributions and thermal deformations##3##4##(2008-3#3)
distributions and##10##2##(1992-2#1)(1996-2#1)(2008-11#2)(2008-3#4)(2008-9#2)
distributions are##9##2##(1994-12#1)(1995-12#1)(2008-10#2)(2008-2#2)(2008-8#1)(2012-2#1)(2013-1#1)
distributions at the##2##3##(2008-3#1)(2012-12#1)
distributions at##3##2##(2008-3#1)(2009-7#1)(2012-12#1)
distributions can##3##2##(2008-3#2)(2008-8#1)
distributions for the different##2##4##(2008-10#1)(2013-1#1)
distributions for the##4##3##(1994-9#1)(2008-10#2)(2013-1#1)
distributions for##14##2##(1994-9#1)(2008-10#4)(2008-3#4)(2008-7#1)(2009-2#2)(2011-2#1)(2013-1#1)
distributions from##2##2##(1992-2#1)(2008-3#1)
distributions in biochemical networks using##2##5##(2008-7#2)
distributions in the##2##3##(2008-3#1)(2013-1#1)
distributions in##15##2##(1994-2#1)(2008-3#5)(2008-7#3)(2008-9#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
distributions is##2##2##(2008-10#1)(2008-2#1)
distributions obtained from##2##3##(2008-10#1)(2012-12#1)
distributions of the##5##3##(2008-10#4)(2008-3#1)
distributions of##38##2##(1991-10#1)(1992-2#1)(1992-3#1)(1993-8#2)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2013-8#1)
distributions on##2##2##(2008-10#1)(2009-4#1)
distributions that##2##2##(2008-3#1)(2012-2#1)
distributions to##4##2##(1990-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
distributions were##6##2##(1992-2#2)(2008-10#2)(2011-2#2)
distributions with##2##2##(2008-10#1)(2010-12#1)
distributions within##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
distributions##179##1##(1990-12#1)(1991-10#1)(1992-1#1)(1992-2#7)(1992-3#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#29)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#33)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#16)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-4#1)(2009-7#3)(2009-8#1)(2010-11#3)(2010-12#1)(2010-7#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
district general##2##2##(1990-3#1)(1997-5#1)
district in##2##2##(2008-12#1)(2013-8#1)
district of##3##2##(1993-3#1)(1996-6#1)(2008-12#1)
district##37##1##(1990-3#3)(1991-12#1)(1993-11#3)(1993-3#2)(1994-6#1)(1996-6#1)(1997-5#2)(1997-6#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#5)(2013-8#4)
district]##2##1##(1997-3#1)(1997-5#1)
districts and##2##2##(1997-5#1)(2008-11#1)
districts of Bangladesh##2##3##(2008-10#2)
districts of Uganda##2##3##(2008-10#2)
districts of##9##2##(1991-2#1)(1994-6#1)(2008-10#6)(2011-2#1)
districts##21##1##(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1997-5#1)(2008-10#10)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
disturb the##6##2##(1994-8#1)(2008-10#3)(2008-5#1)(2012-3#1)
disturb##9##1##(1994-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
disturbance in##4##2##(1992-6#1)(1995-8#1)(2008-11#1)(2008-9#1)
disturbance of the##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
disturbance of##10##2##(1991-11#1)(1992-6#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)
disturbance##55##1##(1991-11#3)(1992-6#2)(1995-8#3)(1996-2#1)(1996-3#1)(1997-8#2)(2006-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#5)(2008-8#11)(2008-9#13)(2009-10#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
disturbances and##5##2##(2008-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
disturbances are##2##2##(2009-10#1)(2012-3#1)
disturbances have##2##2##(2008-7#1)(2011-2#1)
disturbances in Parkinson's disease##2##4##(2008-7#2)
disturbances in##17##2##(1991-2#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2011-1#3)(2012-2#1)
disturbances of##6##2##(1991-2#1)(2008-10#1)(2008-12#2)(2011-2#2)
disturbances on##3##2##(2008-10#2)(2008-9#1)
disturbances were##2##2##(1997-8#1)(2011-2#1)
disturbances##72##1##(1990-11#1)(1990-3#1)(1991-2#2)(1992-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#6)(2008-9#1)(2009-10#2)(2009-12#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#4)(2011-2#9)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#2)
disturbed by##2##2##(2008-11#1)(2011-1#1)
disturbed##21##1##(1991-12#1)(1992-3#1)(1994-8#2)(1997-4#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-12#1)(2011-1#1)(2011-10#1)(2013-1#1)
disturbing##9##1##(1991-1#1)(1995-12#1)(2008-10#5)(2008-3#1)(2008-4#1)
disulfide bond##3##2##(1993-6#1)(1993-8#1)(2008-9#1)
disulfide bonds and the glycosylation site in a lectin of the acorn barnacle Megabalanus rosa##2##15##(1990-5#2)
disulfide bonds are##2##3##(1990-5#1)(1994-11#1)
disulfide bonds in##2##3##(2008-10#1)(2008-4#1)
disulfide bonds were##2##3##(1990-5#2)
disulfide bonds##14##2##(1990-5#7)(1993-8#3)(1994-11#1)(2008-10#1)(2008-4#2)
disulfide exchange##2##2##(1990-2#2)
disulfide isomerase##9##2##(1993-6#6)(1995-3#1)(2013-1#2)
disulfide##57##1##(1990-2#2)(1990-5#7)(1990-8#1)(1991-12#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-6#7)(1993-8#5)(1994-11#7)(1994-5#1)(1995-3#1)(2008-10#9)(2008-11#2)(2008-4#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#2)(2012-2#1)(2013-1#2)
disulfides##7##1##(2008-10#3)(2008-9#4)
disulfiram##3##1##(1994-5#2)(2011-2#1)
disulfoton##2##1##(2008-10#2)
disulphide bond##2##2##(1993-9#2)
disulphide compounds##3##2##(2008-10#3)
disulphide##12##1##(1993-2#1)(1993-9#3)(2008-10#8)
disulphine blue##2##2##(2008-10#2)
disuse and misuse##3##3##(2013-1#3)
disuse##5##1##(2008-7#2)(2013-1#3)
diterpenoid##2##1##(2008-10#2)
dithering##2##1##(2007-12#2)
dithiane##2##1##(2010-7#2)
dithioacetal derivatives##2##2##(2008-10#2)
dithioacetal##3##1##(2008-10#3)
dithiocarbamate (APDC) was##2##3##(2008-10#2)
dithiocarbamate (APDC)##10##2##(2008-10#10)
dithiocarbamate and##2##2##(2008-10#2)
dithiocarbamate fungicides##2##2##(2008-10#2)
dithiocarbamate##24##1##(1994-5#1)(2008-10#23)
dithiocarbamates##4##1##(2008-10#4)
dithiocarbamoyl moieties##2##2##(2008-10#2)
dithiocarbamoyl##5##1##(2008-10#5)
dithiocarboxylate as a##2##3##(2008-10#2)
dithiols##2##1##(2008-11#2)
dithiophosphoric acid##2##2##(2008-10#2)
dithiothreitol (DTT)##2##2##(1995-8#1)(2012-2#1)
dithiothreitol##7##1##(1992-3#2)(1993-6#1)(1995-11#1)(1995-8#1)(2008-5#1)(2012-2#1)
dithizonate##5##1##(2008-10#5)
dithizone and##4##2##(2008-10#4)
dithizone sorbent##2##2##(2008-10#2)
dithizone##17##1##(2008-10#17)
dithizone-anchored microbeads##2##2##(2008-10#2)
dithizone-anchored poly (EGDMA-HEMA) microbeads##2##4##(2008-10#2)
dithizone-anchored##4##1##(2008-10#4)
dityrosine##4##1##(2009-8#4)
diuresis##2##1##(1990-9#1)(2011-2#1)
diuretic activity##2##2##(2012-2#2)
diuretic##10##1##(1992-11#1)(1992-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-1#1)(2012-2#2)
diuretics and beta-blockers##2##3##(1993-2#1)(1994-12#1)
diuretics and##5##2##(1992-11#1)(1993-2#1)(1994-12#1)(2010-10#2)
diuretics in##4##2##(2008-10#4)
diuretics##24##1##(1992-11#4)(1993-2#2)(1994-12#2)(1994-8#4)(2008-1#1)(2008-10#7)(2010-10#3)(2013-1#1)
diurnal foragers##2##2##(2007-12#2)
diurnal pattern of##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
diurnal pattern##4##2##(1997-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
diurnal rhythm##2##2##(2008-10#1)(2012-2#1)
diurnal rhythms##2##2##(1990-3#1)(2008-10#1)
diurnal variation in##2##3##(1992-3#1)(2008-5#1)
diurnal variation##3##2##(1990-3#1)(1992-3#1)(2008-5#1)
diurnal##28##1##(1990-3#2)(1992-3#1)(1997-8#2)(2007-12#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#5)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)
diuron##9##1##(2008-10#9)
divalent and##2##2##(2008-10#2)
divalent cation##7##2##(1990-2#4)(1997-3#1)(2008-10#1)(2008-6#1)
divalent cations##13##2##(1990-5#2)(1993-6#2)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(2008-10#4)
divalent ions##7##2##(2008-10#6)(2011-2#1)
divalent metal cations##3##3##(2008-10#3)
divalent metal ions##3##3##(1991-5#1)(2008-10#2)
divalent metal##6##2##(1991-5#1)(2008-10#5)
divalent##53##1##(1990-2#4)(1990-5#4)(1991-5#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-3#1)(2006-6#1)(2008-10#30)(2008-12#1)(2008-6#1)(2010-11#1)(2011-2#2)
divaricata##4##1##(2008-10#4)
diverge from the##2##3##(2008-8#1)(2010-12#1)
diverge##6##1##(1993-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
diverged from the ancestor of##2##5##(2008-9#1)(2009-10#1)
diverged from##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
diverged##13##1##(1991-5#2)(1991-6#1)(2008-10#3)(2008-5#1)(2008-9#2)(2009-10#1)(2009-8#2)(2012-3#1)
divergence among##3##2##(2008-10#2)(2010-10#1)
divergence and##6##2##(1997-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-1#1)
divergence angle##2##2##(2008-3#1)(2009-8#1)
divergence between populations##3##3##(2008-8#2)(2012-3#1)
divergence between##6##2##(1993-12#1)(2008-10#1)(2008-8#3)(2012-3#1)
divergence from##2##2##(1997-1#1)(2012-3#1)
divergence in potential##5##3##(2008-10#5)
divergence in potentials##5##3##(2008-10#5)
divergence in##17##2##(2008-10#13)(2008-8#2)(2012-2#1)(2012-3#1)
divergence is##4##2##(2008-3#2)(2008-8#1)(2012-3#1)
divergence of the##4##3##(1993-2#1)(1993-6#1)(1997-6#1)(2008-2#1)
divergence of##9##2##(1993-2#1)(1993-6#1)(1994-11#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-3#1)
divergence that is##2##3##(2008-10#1)(2008-3#1)
divergence to##2##2##(2008-10#2)
divergence##85##1##(1991-5#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-2#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#28)(2008-11#1)(2008-2#2)(2008-3#11)(2008-6#2)(2008-8#9)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#14)(2013-1#1)
divergences##3##1##(2008-10#2)(2009-10#1)
divergent 5'##2##2##(1990-8#1)(2008-10#1)
divergent from##2##2##(2008-11#1)(2009-8#1)
divergent natural selection##2##3##(2008-8#1)(2012-3#1)
divergent responses##2##2##(1994-6#2)
divergent##42##1##(1990-8#1)(1992-12#1)(1992-5#1)(1993-12#2)(1993-2#1)(1994-6#2)(1995-12#1)(1995-2#3)(1995-6#1)(1997-3#1)(1997-7#1)(1997-9#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-8#2)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#2)
diverging##2##1##(2008-10#1)(2012-3#1)
divers with primary affection of the##2##6##(1991-6#2)
divers##6##1##(1991-6#6)
diverse and##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#2)
diverse biological##2##2##(2009-7#1)(2011-1#1)
diverse cell types##2##3##(1995-12#1)(2008-9#1)
diverse cell##4##2##(1995-12#1)(2008-9#1)(2009-8#1)(2013-1#1)
diverse cellular##2##2##(1995-2#1)(2013-8#1)
diverse collection of##2##3##(1990-8#1)(2008-10#1)
diverse communities##2##2##(2009-6#1)(2010-8#1)
diverse community##2##2##(2008-12#1)(2012-2#1)
diverse conditions##2##2##(2008-10#1)(2008-7#1)
diverse cultures##3##2##(2010-1#1)(2010-8#1)(2013-8#1)
diverse environments##2##2##(2008-9#1)(2011-2#1)
diverse functions##4##2##(2008-10#2)(2009-10#2)
diverse geographic##3##2##(2008-10#3)
diverse geographical regions##2##3##(2008-10#1)(2012-3#1)
diverse group of##7##3##(2008-10#2)(2008-4#1)(2011-2#3)(2012-12#1)
diverse group##8##2##(2008-10#3)(2008-4#1)(2011-2#3)(2012-12#1)
diverse in##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
diverse ions on the##5##4##(2008-10#5)
diverse ions##7##2##(2008-10#7)
diverse locations##2##2##(2008-10#2)
diverse organisms##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
diverse physiological##2##2##(2009-6#1)(2013-8#1)
diverse population##6##2##(2008-10#3)(2011-1#1)(2011-2#1)(2013-8#1)
diverse populations of##3##3##(2008-10#2)(2008-11#1)
diverse populations##8##2##(2008-10#2)(2008-11#1)(2008-6#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-2#1)
diverse range of##12##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
diverse repertoire of##2##3##(2008-10#1)(2008-11#1)
diverse roles of##3##3##(1996-12#1)(2010-10#1)(2011-2#1)
diverse sample of##5##3##(2008-10#1)(2009-7#2)(2010-1#2)
diverse set of##5##3##(1991-3#1)(2008-10#1)(2008-9#1)(2012-4#1)(2013-1#1)
diverse species##5##2##(2008-10#3)(2008-11#1)(2009-10#1)
diverse symptoms##2##2##(2008-11#1)(2013-8#1)
diverse than previously##2##3##(2008-11#1)(2012-2#1)
diverse than##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
diverse work force##2##3##(1997-2#2)
diverse##278##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-3#1)(1991-5#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-7#1)(2008-1#3)(2008-10#86)(2008-11#18)(2008-12#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#8)(2009-10#6)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#6)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#14)(2011-3#2)(2011-9#1)(2012-12#1)(2012-2#17)(2012-3#9)(2012-4#2)(2013-1#13)(2013-8#8)
diversicaudatum##2##1##(2008-10#2)
diversicaudatum)##2##1##(2008-10#2)
diversification and##3##2##(2008-11#2)(2012-3#1)
diversification in##2##2##(2008-10#1)(2012-3#1)
diversification of##5##2##(1993-3#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)
diversification##22##1##(1991-3#2)(1993-3#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-8#3)(2009-8#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-3#4)
diversified##7##1##(1990-8#1)(1995-3#1)(2008-10#2)(2011-2#2)(2012-3#1)
diversifolia##3##1##(2008-10#3)
diversify##5##1##(2008-11#3)(2008-8#1)(2012-2#1)
diversifying##2##1##(2008-8#1)(2008-9#1)
diversion of##2##2##(1992-1#1)(2008-9#1)
diversion##11##1##(1992-1#1)(1993-3#1)(2008-10#4)(2008-12#1)(2008-7#3)(2008-9#1)
diversities##6##1##(2008-10#5)(2008-8#1)
diversity across##3##2##(2008-10#2)(2012-3#1)
diversity among X##4##3##(2008-10#4)
diversity among isolates from the##2##5##(2008-10#2)
diversity among isolates##4##3##(2008-10#4)
diversity among strains of##2##4##(2008-10#2)
diversity among strains##3##3##(2008-10#3)
diversity among##22##2##(2008-10#20)(2008-6#1)(2008-8#1)
diversity analyses##2##2##(2008-10#2)
diversity analysis##3##2##(2008-10#3)
diversity and pathogenic##2##3##(2008-10#2)
diversity and population differentiation at the innate##2##7##(2012-3#2)
diversity and population##3##3##(2012-3#2)(2013-8#1)
diversity and the##2##3##(2008-10#2)
diversity and##39##2##(2008-10#18)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#4)(2013-8#1)
diversity are discussed##2##3##(2008-10#1)(2008-8#1)
diversity are##3##2##(2008-10#2)(2008-8#1)
diversity as well as##2##4##(2008-9#1)(2012-3#1)
diversity as##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
diversity at the##3##3##(2008-10#3)
diversity at##6##2##(2008-10#4)(2008-8#2)
diversity because##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
diversity between populations##2##3##(2008-10#2)
diversity between##5##2##(1995-2#1)(2008-10#3)(2008-7#1)
diversity can##4##2##(1994-12#1)(2008-10#1)(2009-8#1)(2012-3#1)
diversity data##2##2##(2008-10#2)
diversity during##2##2##(1997-9#1)(2011-2#1)
diversity for aggressiveness##3##3##(2008-10#3)
diversity for the##2##3##(2008-10#1)(2008-8#1)
diversity for##11##2##(1996-1#1)(2008-10#8)(2008-8#1)(2012-3#1)
diversity found in the##2##4##(2008-10#2)
diversity in the##13##3##(1993-2#1)(1997-7#1)(2008-10#5)(2008-11#3)(2009-6#1)(2012-3#2)
diversity in this##8##3##(2008-10#7)(2012-3#1)
diversity in##52##2##(1990-8#1)(1992-8#1)(1993-2#1)(1994-12#1)(1996-1#1)(1997-7#1)(1997-8#2)(1997-9#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-7#1)(2008-8#4)(2009-6#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#4)
diversity indicated##2##2##(2008-10#2)
diversity indices##7##2##(2008-10#4)(2008-8#3)
diversity is##3##2##(2008-10#3)
diversity management##3##2##(1994-12#3)
diversity may be##2##3##(2008-10#2)
diversity may##5##2##(2008-10#4)(2012-3#1)
diversity of plant pathogens##2##4##(2008-10#2)
diversity of plant##3##3##(2008-10#3)
diversity of the isolates##2##4##(2008-10#2)
diversity of the population##2##4##(2008-10#1)(2008-6#1)
diversity of the##27##3##(1992-6#1)(1997-5#1)(1997-9#2)(2008-10#13)(2008-5#1)(2008-6#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-8#2)
diversity of this##3##3##(1992-3#1)(2008-10#2)
diversity of##102##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-9#2)(2008-10#50)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#4)
diversity on##5##2##(2008-10#5)
diversity revealed by##2##3##(2008-10#2)
diversity revealed##3##2##(2008-10#3)
diversity should be##2##3##(2008-8#1)(2008-9#1)
diversity that exists##3##3##(2008-10#1)(2008-12#2)
diversity that##4##2##(2008-10#2)(2008-12#2)
diversity to##2##2##(1996-1#1)(2008-9#1)
diversity was assessed using##2##4##(2008-10#2)
diversity was found within##2##4##(2008-10#2)
diversity was found##3##3##(2008-10#2)(2012-2#1)
diversity was greatest##2##3##(2008-10#2)
diversity was high##4##3##(2008-10#4)
diversity was##37##2##(2008-10#32)(2008-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
diversity were##2##2##(2008-10#1)(2012-5#1)
diversity within a field##2##4##(2008-10#2)
diversity within a##5##3##(2008-10#4)(2011-2#1)
diversity within and between##2##4##(2008-10#2)
diversity within populations##5##3##(2008-10#5)
diversity within the##9##3##(1997-2#1)(2008-10#7)(2008-8#1)
diversity within##31##2##(1997-2#1)(2008-10#26)(2008-8#2)(2008-9#1)(2011-2#1)
diversity##492##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#8)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-2#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(1997-9#5)(2008-1#1)(2008-10#289)(2008-11#8)(2008-12#8)(2008-2#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#44)(2008-9#12)(2009-10#3)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#4)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#5)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#21)(2012-5#2)(2013-1#4)(2013-8#10)
divert##2##1##(1991-1#1)(2008-11#1)
diverted to##3##2##(1990-2#1)(1990-5#1)(2008-9#1)
diverted##5##1##(1990-2#1)(1990-5#1)(2008-10#1)(2008-9#2)
diverticula##6##1##(1990-12#1)(1992-1#1)(2007-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
diverticulatis##2##1##(2009-1#2)
diverticulitis##6##1##(1993-2#1)(2009-8#3)(2012-2#2)
diverticulum in a female child##2##5##(2008-10#2)
diverticulum in a female##3##4##(2008-10#3)
diverticulum in a##5##3##(2008-10#3)(2011-2#2)
diverticulum in##6##2##(2008-10#3)(2009-8#1)(2011-2#2)
diverticulum##16##1##(1992-1#1)(1996-3#1)(2008-10#6)(2009-8#4)(2010-7#1)(2011-2#3)
divide the##2##2##(1996-2#1)(2008-2#1)
divide##7##1##(1995-11#1)(1996-2#1)(2008-11#2)(2008-2#1)(2009-10#1)(2010-10#1)
divided by the slope of the calibration##2##7##(2008-10#2)
divided by the##8##3##(1992-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
divided by##13##2##(1992-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)
divided in three##2##3##(2011-1#1)(2012-9#1)
divided in two##2##3##(1996-12#1)(2013-1#1)
divided in##8##2##(1996-12#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-1#2)
divided into 3 groups##3##4##(2008-10#1)(2012-4#1)(2013-1#1)
divided into 4##4##3##(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
divided into 6##2##3##(2008-10#1)(2013-1#1)
divided into a##3##3##(1995-5#1)(2008-11#1)(2011-2#1)
divided into either##2##3##(2008-10#1)(2008-3#1)
divided into five groups##6##4##(1990-12#1)(2008-10#1)(2010-1#1)(2010-7#1)(2011-2#1)(2011-3#1)
divided into five##12##3##(1990-12#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-1#1)(2010-7#1)(2011-2#1)(2011-3#1)
divided into four groups##10##4##(1991-2#1)(1992-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-7#1)(2011-2#2)(2013-1#1)
divided into four subgroups##2##4##(2008-10#1)(2009-8#1)
divided into four##17##3##(1991-2#1)(1992-1#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-7#1)(2011-2#3)(2013-1#1)
divided into groups##2##3##(1993-2#1)(2013-8#1)
divided into the primordial##2##4##(2007-12#2)
divided into the##7##3##(1990-5#1)(2007-12#2)(2008-10#3)(2010-6#1)
divided into three different##2##4##(1997-8#1)(2008-10#1)
divided into three groups##5##4##(1996-9#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
divided into three phases##2##4##(2008-10#1)(2010-8#1)
divided into three##15##3##(1996-9#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
divided into two groups and##2##5##(1993-2#1)(2012-3#1)
divided into two groups of##4##5##(1991-3#1)(2008-7#2)(2010-7#1)
divided into two groups##23##4##(1991-3#1)(1992-11#1)(1993-2#1)(1995-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#2)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
divided into two subgroups##3##4##(2008-9#1)(2011-2#1)(2013-1#1)
divided into two##43##3##(1991-3#1)(1992-11#1)(1993-2#1)(1995-3#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#5)
divided into##149##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1993-2#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-9#1)(1997-8#2)(2007-12#4)(2007-8#1)(2008-10#38)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#5)(2009-12#1)(2009-8#2)(2010-1#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#3)(2012-3#2)(2012-4#1)(2013-1#13)(2013-8#2)
divided the##4##2##(2008-10#1)(2008-12#1)(2010-1#1)(2011-2#1)
divided##190##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-2#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#2)(2007-12#5)(2007-8#1)(2008-10#53)(2008-11#11)(2008-12#8)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#7)(2009-12#2)(2009-8#2)(2010-1#2)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#12)(2011-3#3)(2012-3#2)(2012-4#1)(2012-9#1)(2013-1#15)(2013-8#2)
dividends##3##1##(1993-2#1)(1994-2#1)(1997-2#1)
divides the##2##2##(2007-12#1)(2012-2#1)
divides##4##1##(1990-3#1)(2007-12#1)(2012-2#2)
dividing cells##7##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#3)(2009-8#1)
dividing spermatogonia##2##2##(2012-2#2)
dividing the##2##2##(2008-10#1)(2008-9#1)
dividing##22##1##(1992-6#1)(1992-9#1)(1993-6#1)(1994-3#2)(1995-2#1)(2008-10#3)(2008-11#2)(2008-8#3)(2008-9#5)(2009-8#1)(2012-2#2)
divine##3##1##(1992-5#1)(2013-1#2)
diving is##2##2##(1991-6#1)(2010-3#1)
diving##10##1##(1991-6#5)(1996-2#2)(1997-1#1)(2010-3#2)
divinorum##3##1##(2008-12#3)
divinyl benzene##3##2##(2008-10#3)
divinylbenzene##2##1##(2008-10#1)(2008-11#1)
divinylbenzene/carboxen/polydimethylsiloxane (DVB/CAR/PDMS)##2##2##(2008-10#2)
divinylsulphone##4##1##(2008-10#4)
divisible space##4##2##(2008-8#4)
division and##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
division between##2##2##(2009-6#1)(2010-4#1)
division by##2##2##(1994-11#1)(2008-9#1)
division cycle##2##2##(1994-3#1)(1997-6#1)
division in##5##2##(1993-8#1)(1996-12#1)(2008-11#2)(2011-2#1)
division meeting##42##2##(2008-11#42)
division of labor in honeybee colonies##2##6##(2008-8#2)
division of labor in##3##4##(2008-8#3)
division of labor##7##3##(1996-1#1)(2008-8#6)
division of the##4##3##(1993-6#1)(2007-12#1)(2008-11#1)(2008-5#1)
division of##26##2##(1991-2#1)(1992-8#1)(1993-6#1)(1996-1#1)(1996-3#3)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#2)(2009-12#1)(2012-2#1)(2013-8#1)
division##136##1##(1990-6#1)(1991-2#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-6#2)(2007-12#3)(2008-10#8)(2008-11#51)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#7)(2008-9#6)(2009-10#5)(2009-12#5)(2009-5#4)(2009-6#2)(2009-8#2)(2010-4#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
divisions are##2##2##(2008-10#1)(2008-7#1)
divisions in##2##2##(2009-8#1)(2012-2#1)
divisions meeting##3##2##(2008-11#3)
divisions of##3##2##(2008-11#1)(2009-12#1)(2010-1#1)
divisions that##2##2##(2012-2#2)
divisions##25##1##(1994-1#1)(1994-12#1)(1996-3#1)(1997-8#2)(2007-12#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2012-2#5)
divisor-ratio spectra derivative##4##3##(2008-10#4)
divisum##2##1##(1991-9#2)
divorce in##2##2##(2008-12#1)(2011-2#1)
divorce##14##1##(2008-11#1)(2008-12#2)(2011-2#11)
divorced##3##1##(1994-6#2)(2008-9#1)
divulge##2##1##(1996-3#1)(2008-6#1)
dizocilpine maleate##4##2##(1996-12#4)
dizygotic twins##2##2##(2008-11#1)(2010-8#1)
dizygotic##4##1##(2008-11#2)(2010-8#1)(2013-1#1)
dizziness and##4##2##(1991-2#1)(2008-11#1)(2008-8#1)(2013-1#1)
dizziness##6##1##(1991-2#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
dl(-1)##2##1##(2008-10#2)
dl-dithiothreitol##3##1##(2008-10#3)
dlt operon is##2##3##(1995-6#2)
dlt operon##5##2##(1995-6#5)
dlt##6##1##(1995-6#6)
dltB and dltD##2##3##(1995-6#2)
dm(-3) with##5##2##(2008-10#5)
dm(-3)##67##1##(2008-10#67)
dm(-3))##11##1##(2008-10#11)
dm(3) mol(-1) cm(-1)##2##3##(2008-10#2)
dm(3) mol(-1)##4##2##(2008-10#4)
dm(3)##10##1##(2008-10#9)(2008-8#1)
dnaA##4##1##(1996-12#4)
dnaCts gene##2##2##(1991-12#2)
dnl4 mutants are##2##3##(1997-7#2)
do African American men##2##4##(2009-5#2)
do I##2##2##(1991-6#1)(1997-2#1)
do a##3##2##(1994-3#1)(2008-8#1)(2013-8#1)
do and do not##2##4##(1993-3#1)(2009-5#1)
do and##5##2##(1992-12#1)(1993-3#1)(1996-2#1)(2009-5#1)(2009-9#1)
do better##2##2##(2008-8#2)
do exist##3##2##(2008-7#1)(2010-10#1)(2011-2#1)
do for##2##2##(1997-1#1)(2012-12#1)
do have the##2##3##(1995-2#1)(1997-3#1)
do have##5##2##(1995-2#1)(1997-3#1)(2008-5#1)(2008-9#2)
do is##2##2##(1991-1#1)(1992-2#1)
do it##10##2##(1993-1#1)(1994-1#1)(1995-12#1)(2008-6#1)(2008-9#5)(2009-8#1)
do know##3##2##(1990-9#1)(1991-2#1)(1994-2#1)
do large##2##2##(2008-8#1)(2008-9#1)
do medical##2##2##(1993-6#1)(1995-3#1)
do more##3##2##(1992-8#1)(1993-3#1)(2008-11#1)
do no##3##2##(1996-10#1)(2008-10#1)(2008-11#1)
do not account for##3##4##(1994-6#1)(2008-10#1)(2008-3#1)
do not adequately describe the##2##5##(2008-9#1)(2013-1#1)
do not adequately##5##3##(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
do not affect the##4##4##(2008-10#3)(2008-5#1)
do not affect##7##3##(2007-11#1)(2008-10#4)(2008-5#1)(2009-8#1)
do not agree##2##3##(2008-8#1)(2013-1#1)
do not allow##2##3##(2012-2#2)
do not always##6##3##(1991-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
do not appear to be involved in##2##7##(2008-10#2)
do not appear to be irreversibly altered by chronic exposure to##2##11##(1991-4#2)
do not appear to be##9##5##(1991-2#1)(1991-4#2)(1995-1#1)(1995-3#1)(2008-10#2)(2008-7#1)(2008-8#1)
do not appear to##12##4##(1991-2#1)(1991-4#2)(1995-1#1)(1995-3#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
do not appear##13##3##(1991-2#1)(1991-4#2)(1995-1#1)(1995-3#1)(1996-3#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)
do not carry the##2##4##(1991-3#1)(2008-7#1)
do not cause##2##3##(2008-10#2)
do not change##3##3##(1994-8#1)(2008-5#2)
do not consider##2##3##(2008-10#1)(2008-8#1)
do not constitute##2##3##(2008-10#1)(2011-2#1)
do not contain any##2##4##(1993-12#1)(2008-11#1)
do not contain##5##3##(1992-10#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#1)
do not contribute to##3##4##(1994-12#1)(1995-11#1)(2008-3#1)
do not contribute##4##3##(1994-12#1)(1995-11#1)(2008-11#1)(2008-3#1)
do not cover##2##3##(1994-8#1)(2008-10#1)
do not differ between##3##4##(1991-11#1)(1992-1#1)(2008-8#1)
do not differ##6##3##(1991-11#1)(1992-1#1)(2008-10#1)(2008-8#2)(2013-1#1)
do not distinguish between##2##4##(2008-11#1)(2011-2#1)
do not engage##2##3##(2008-11#1)(2013-8#1)
do not exceed##2##3##(2008-10#1)(2012-2#1)
do not exhibit##4##3##(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#1)
do not exist in##4##4##(1992-2#1)(1994-2#1)(1997-3#1)(2008-10#1)
do not exist##7##3##(1992-2#1)(1994-2#1)(1997-3#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
do not explain the##2##4##(1996-12#1)(2009-7#1)
do not fit##2##3##(1993-6#1)(2008-10#1)
do not follow##3##3##(1994-9#1)(2009-11#1)(2009-4#1)
do not form complexes##2##4##(2008-10#2)
do not form##6##3##(1995-8#1)(2008-10#4)(2008-9#1)
do not fully##4##3##(1991-5#1)(2008-10#1)(2010-9#1)(2011-3#1)
do not get##2##3##(2008-12#1)(2013-1#1)
do not give##4##3##(2007-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
do not have a##7##4##(1993-8#1)(2008-11#1)(2008-7#2)(2010-10#1)(2010-12#1)(2012-2#1)
do not have an##2##4##(2008-7#1)(2012-3#1)
do not have the##4##4##(1992-12#1)(2008-9#1)(2010-11#1)(2011-1#1)
do not have to##2##4##(2008-10#1)(2008-5#1)
do not have##27##3##(1991-12#1)(1992-12#1)(1993-12#1)(1993-8#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
do not hold##2##3##(1990-8#1)(2008-11#1)
do not include##2##3##(1995-1#1)(2010-10#1)
do not increase##2##3##(1991-12#1)(2008-10#1)
do not influence##2##3##(2008-10#2)
do not interact##4##3##(1994-11#1)(1994-5#1)(1996-2#1)(2010-12#1)
do not interfere in the determination##2##6##(2008-10#2)
do not interfere in the proposed##3##6##(2008-10#3)
do not interfere in the##7##5##(2008-10#7)
do not interfere in##8##4##(2008-10#8)
do not interfere the##2##4##(2008-10#2)
do not interfere with the determination of##2##7##(2008-10#2)
do not interfere with the determination##5##6##(2008-10#5)
do not interfere with the##6##5##(2008-10#6)
do not interfere with##10##4##(1996-6#1)(2008-10#8)(2008-11#1)
do not interfere##26##3##(1996-6#1)(2008-10#24)(2008-11#1)
do not involve##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
do not know if##2##4##(1991-3#1)(2008-10#1)
do not know##8##3##(1991-3#2)(1993-3#1)(1994-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
do not make full use of the##2##7##(2008-8#1)(2013-8#1)
do not make##3##3##(1996-5#1)(2008-8#1)(2013-8#1)
do not necessarily##5##3##(1996-2#1)(2008-10#1)(2008-4#1)(2009-12#1)(2013-8#1)
do not need to be##3##5##(2008-10#2)(2008-11#1)
do not need to##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
do not need##5##3##(2008-10#3)(2008-11#1)(2008-7#1)
do not normally##2##3##(2008-11#1)(2008-9#1)
do not place##2##3##(2008-11#1)(2009-7#1)
do not produce##4##3##(1990-12#1)(1995-2#2)(2008-10#1)
do not provide##5##3##(1992-3#1)(1995-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
do not recommend##2##3##(1996-6#1)(2012-3#1)
do not reduce##2##3##(1991-12#1)(2008-10#1)
do not reflect##2##3##(1996-6#1)(2008-7#1)
do not relate to##2##4##(1992-9#1)(2008-7#1)
do not release##2##3##(1990-11#2)
do not represent a##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
do not represent##8##3##(1992-5#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-11#1)
do not require any separation step##2##6##(2008-10#2)
do not require any##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
do not require the##2##4##(2012-3#1)(2013-1#1)
do not require##14##3##(1991-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#1)
do not respond to##7##4##(1996-5#1)(1997-8#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)
do not result##2##3##(1996-5#1)(2008-10#1)
do not rule out##2##4##(2008-10#1)(2011-2#1)
do not see##2##3##(1990-6#1)(2008-12#1)
do not seem to be##4##5##(1991-6#1)(1995-2#1)(2011-2#1)(2012-3#1)
do not seem to have##2##5##(2008-10#1)(2009-6#1)
do not seem to##9##4##(1991-6#1)(1995-2#1)(2008-10#2)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
do not share##2##3##(2013-1#1)(2013-8#1)
do not show any##3##4##(1990-6#1)(2008-10#2)
do not show significant##2##4##(2008-10#2)
do not show##9##3##(1990-6#1)(1996-6#1)(2008-10#5)(2008-8#1)(2008-9#1)
do not support an association##2##5##(2008-11#1)(2011-2#1)
do not support an##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
do not support the hypothesis##2##5##(1991-12#1)(2008-7#1)
do not support the##8##4##(1990-2#1)(1991-12#1)(2008-7#2)(2008-8#2)(2009-7#1)(2013-8#1)
do not support##15##3##(1990-2#1)(1991-12#1)(1991-6#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#2)(2009-7#1)(2011-2#1)(2013-8#1)
do not take##2##3##(2008-10#1)(2009-4#1)
do not use##3##3##(1992-9#1)(1996-1#1)(2008-11#1)
do not usually##3##3##(1992-9#1)(1993-1#1)(2008-9#1)
do not vary with##3##4##(1995-2#1)(2008-11#1)(2008-9#1)
do not vary##5##3##(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
do not want to##2##4##(1996-8#1)(2012-3#1)
do not yet exist##2##4##(1995-2#1)(2008-11#1)
do not yield the##2##4##(2008-10#2)
do not##435##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#3)(1993-1#1)(1993-12#3)(1993-3#3)(1993-6#4)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#1)(1995-2#9)(1995-3#1)(1995-8#1)(1996-1#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#5)(1996-6#4)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#108)(2008-11#19)(2008-12#7)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#7)(2008-7#19)(2008-8#17)(2008-9#16)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#4)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#1)(2012-2#11)(2012-3#9)(2013-1#9)(2013-8#7)
do occur##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
do our beneficiaries##2##3##(1997-3#2)
do people##3##2##(1991-9#1)(1993-2#1)(2008-8#1)
do show##2##2##(2008-11#1)(2008-12#1)
do so by##2##3##(1991-7#1)(2008-11#1)
do so##20##2##(1991-7#1)(1992-12#1)(1993-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#4)(2008-8#2)(2008-9#2)(2012-2#1)(2012-6#1)
do that##2##2##(1991-1#1)(1994-3#1)
do the##12##2##(1990-2#1)(1991-12#1)(1991-2#1)(1993-12#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
do these##3##2##(1991-12#1)(1997-2#1)(2012-12#1)
do they work?##2##3##(1994-3#1)(1997-3#1)
do they##9##2##(1994-12#1)(1994-3#3)(1997-3#1)(2008-12#1)(2008-8#1)(2009-6#1)(2009-9#1)
do this##6##2##(1992-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)
do to##6##2##(1990-11#1)(2008-11#1)(2008-12#2)(2008-6#1)(2012-12#1)
do we go from here?##2##5##(2008-11#1)(2008-8#1)
do we have##2##3##(1993-2#1)(2008-10#1)
do we know##2##3##(2008-12#1)(2013-1#1)
do we##12##2##(1991-6#1)(1992-3#1)(1993-2#1)(1994-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-1#1)
do well##2##2##(1996-1#1)(2008-8#1)
do with##10##2##(1991-1#1)(1994-3#1)(1997-5#1)(1997-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-12#1)
do you want to be?##2##5##(1994-3#1)(2012-3#1)
do you##8##2##(1994-2#1)(1994-3#2)(1995-2#1)(2008-9#1)(2012-3#1)(2013-1#2)
do##690##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#4)(1991-11#2)(1991-12#12)(1991-2#4)(1991-3#6)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#5)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#6)(1993-6#5)(1993-8#3)(1994-1#3)(1994-11#2)(1994-12#5)(1994-2#5)(1994-3#14)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#7)(1995-12#2)(1995-2#12)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#5)(1996-10#1)(1996-12#7)(1996-2#5)(1996-3#5)(1996-5#5)(1996-6#4)(1996-8#1)(1997-1#3)(1997-2#6)(1997-3#6)(1997-4#1)(1997-5#4)(1997-6#3)(1997-7#2)(1997-8#4)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#124)(2008-11#40)(2008-12#15)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#22)(2008-8#38)(2008-9#32)(2009-10#3)(2009-11#1)(2009-12#3)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#8)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#23)(2011-3#1)(2012-12#5)(2012-2#16)(2012-3#12)(2012-6#1)(2013-1#16)(2013-7#1)(2013-8#9)
do?##2##1##(1997-6#1)(2011-2#1)
dobutamine##6##1##(1996-2#4)(2008-11#1)(2009-10#1)
docetaxel and cisplatin with##2##4##(2008-10#2)
docetaxel and cisplatin##4##3##(2008-10#4)
docetaxel##9##1##(2008-10#8)(2012-2#1)
docked##8##1##(1992-9#2)(1997-7#5)(2012-2#1)
docking and fusion##2##3##(1997-1#1)(2008-11#1)
docking and##4##2##(1997-1#1)(1997-7#1)(2008-11#1)(2012-2#1)
docking sites for##2##3##(1995-6#1)(1996-2#1)
docking sites##3##2##(1995-6#1)(1996-2#1)(1997-7#1)
docking##24##1##(1990-3#1)(1991-6#1)(1992-9#1)(1995-2#3)(1995-6#1)(1996-2#1)(1997-1#1)(1997-7#5)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#5)(2013-1#1)(2013-8#1)
docosahexaenoic acid (DHA)##2##3##(2008-3#1)(2010-1#1)
docosahexaenoic acid##3##2##(2008-3#1)(2010-1#1)(2013-1#1)
docosahexaenoic##4##1##(2008-3#1)(2010-1#1)(2011-2#1)(2013-1#1)
docs##3##1##(1992-8#1)(1997-3#2)
doctor and##5##2##(1992-5#1)(1993-11#1)(1993-12#1)(1997-8#1)(2013-1#1)
doctor has##2##2##(2008-10#1)(2010-12#1)
doctor in the##3##3##(1990-6#1)(2009-3#2)
doctor in##4##2##(1990-6#1)(1997-4#1)(2009-3#2)
doctor##31##1##(1990-3#1)(1990-6#1)(1991-6#1)(1992-5#2)(1993-11#2)(1993-12#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-12#1)(1996-6#2)(1996-8#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2009-3#2)(2009-5#2)(2010-12#2)(2010-9#3)(2012-12#1)(2013-1#1)
doctor's office##2##2##(1996-11#1)(2009-5#1)
doctor's##4##1##(1993-12#1)(1995-6#1)(1996-11#1)(2009-5#1)
doctors and patients##4##3##(1996-11#1)(2008-8#2)(2013-1#1)
doctors and##8##2##(1995-6#1)(1996-11#1)(1997-4#1)(1997-8#1)(2008-12#1)(2008-8#2)(2013-1#1)
doctors are##4##2##(1995-6#2)(1997-5#1)(2010-12#1)
doctors for##3##2##(1990-12#1)(1990-6#1)(1995-6#1)
doctors from##2##2##(1992-5#1)(1994-12#1)
doctors had##4##2##(1991-8#1)(1993-11#1)(1994-12#1)(1996-6#1)
doctors in the##4##3##(1991-8#2)(1997-8#1)(2008-5#1)
doctors in##12##2##(1991-8#5)(1993-3#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
doctors of##2##2##(1990-3#1)(1991-2#1)
doctors on##3##2##(1995-2#1)(1996-3#1)(2008-11#1)
doctors to##4##2##(1993-6#1)(1997-6#1)(1997-8#1)(2012-2#1)
doctors towards##2##2##(1990-6#1)(1996-6#1)
doctors were##2##2##(1990-9#1)(2008-10#1)
doctors who were##2##3##(2008-10#1)(2011-2#1)
doctors who##6##2##(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
doctors##112##1##(1990-12#1)(1990-3#3)(1990-6#3)(1990-9#4)(1991-2#5)(1991-6#3)(1991-8#8)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#3)(1994-12#3)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#7)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-8#5)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-12#1)(2010-12#1)(2011-2#8)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
doctors'##10##1##(1990-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-6#1)(1997-8#2)(2011-2#2)
doctrine of double effect##3##4##(2012-2#3)
doctrine of##4##2##(1994-3#1)(2012-2#3)
doctrine##7##1##(1993-1#1)(1994-3#3)(2012-2#3)
document is##2##2##(2008-10#2)
document that##3##2##(2008-10#2)(2008-11#1)
document the##10##2##(1995-6#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-6#1)(2011-2#1)(2011-3#1)
document was##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
document##43##1##(1992-12#1)(1993-11#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-9#2)(2010-1#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
documentation and##4##2##(1992-12#1)(1997-2#1)(2008-11#1)(2013-1#1)
documentation of an##2##3##(1997-3#1)(1997-4#1)
documentation of the##2##3##(1997-3#1)(2008-3#1)
documentation of##14##2##(1990-8#1)(1994-12#1)(1994-2#1)(1997-3#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
documentation on##2##2##(1993-6#1)(2008-3#1)
documentation##45##1##(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-8#1)(2008-10#1)(2008-11#5)(2008-12#4)(2008-3#4)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#5)
documented and##6##2##(1994-12#1)(2008-10#1)(2008-11#3)(2009-12#1)
documented as##4##2##(2008-11#1)(2008-12#2)(2011-7#1)
documented by a##2##3##(1996-11#1)(2008-7#1)
documented by##11##2##(1993-2#1)(1995-3#1)(1996-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2012-2#1)(2013-1#2)
documented cases of##2##3##(1996-5#1)(2008-5#1)
documented cases##4##2##(1996-5#2)(2008-5#1)(2013-1#1)
documented for##2##2##(2010-11#1)(2013-1#1)
documented in the##3##3##(1994-8#1)(1997-8#1)(2008-12#1)
documented in this##4##3##(1994-1#2)(1997-4#1)(2012-2#1)
documented in##27##2##(1991-7#1)(1992-3#1)(1994-1#2)(1994-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-2#1)(2012-2#4)(2013-1#3)
documented that##5##2##(1990-12#1)(1995-12#1)(2008-11#1)(2008-8#1)(2012-2#1)
documented the##4##2##(2008-10#1)(2008-11#1)(2010-9#1)(2013-1#1)
documented##147##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-2#3)(1994-1#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#3)(1997-4#3)(1997-8#2)(2007-12#2)(2008-10#13)(2008-11#18)(2008-12#11)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-2#9)(2012-3#2)(2013-1#12)(2013-8#3)
documenting##11##1##(1994-2#1)(1995-2#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
documents and##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
documents that##3##2##(1994-3#2)(2009-8#1)
documents the##3##2##(1994-2#1)(2008-11#1)(2012-3#1)
documents##33##1##(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#4)(1995-1#1)(1997-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-3#2)(2013-1#3)
dodecamer##2##1##(2008-7#2)
dodecane##4##1##(1997-2#1)(2008-10#3)
dodecapeptide##3##1##(1992-12#1)(2008-10#1)(2008-9#1)
dodecaurelia##4##1##(2008-12#4)
dodecyl benzene sulfonate##3##3##(2008-10#3)
dodecyl sulfate (SDS)##18##3##(1990-11#1)(2008-10#15)(2008-4#1)(2012-2#1)
dodecyl sulfate##40##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-3#1)(1996-12#1)(1996-5#1)(2008-10#28)(2008-11#1)(2008-4#2)(2010-11#1)(2012-2#2)
dodecyl sulfate-polyacrylamide gel electrophoresis analysis##3##5##(2008-10#3)
dodecyl sulfate-polyacrylamide gel electrophoresis of##5##5##(2008-10#5)
dodecyl sulfate-polyacrylamide gel electrophoresis##17##4##(1990-10#1)(1992-12#1)(2008-10#14)(2008-11#1)
dodecyl sulfate-polyacrylamide gel##18##3##(1990-10#1)(1991-2#1)(1992-12#1)(2008-10#14)(2008-11#1)
dodecyl sulphate (SDS)##4##3##(2008-10#3)(2008-5#1)
dodecyl sulphate##9##2##(1993-3#1)(2008-10#6)(2008-5#2)
dodecyl##81##1##(1990-10#2)(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1996-12#1)(1996-5#1)(2008-10#58)(2008-11#3)(2008-4#2)(2008-5#3)(2010-11#1)(2011-2#1)(2012-2#2)
dodecylamine-N##2##1##(2008-10#2)
dodecylbenzenesulfonate##2##1##(2008-10#2)
dodecylbenzenesulfonic acid##2##2##(2008-10#2)
dodecylpyridinium chloride##2##2##(2008-10#2)
dodecylpyridinium##3##1##(2008-10#3)
dodecylsulfate and##2##2##(1991-12#1)(2008-10#1)
dodecylsulfate##15##1##(1991-12#1)(2008-10#14)
dodecylsulphate##2##1##(2008-10#2)
dodecyltrimethylammonium##2##1##(2008-10#2)
dodine##4##1##(2008-10#4)
does appear to be##2##4##(1995-6#1)(2012-3#1)
does contain##2##2##(1993-6#1)(2008-9#1)
does exist##2##2##(2008-6#1)(2008-9#1)
does in##3##2##(1990-5#1)(1991-2#1)(2010-10#1)
does indeed##2##2##(2008-9#1)(2012-3#1)
does it change##2##3##(2008-11#1)(2011-2#1)
does it##13##2##(1991-3#1)(1992-12#1)(1994-5#1)(1997-7#1)(2008-10#2)(2008-11#4)(2010-3#1)(2011-2#1)(2012-12#1)
does not act as##2##4##(1993-8#1)(1995-6#1)
does not adversely affect##2##4##(1991-1#1)(2010-11#1)
does not affect the##13##4##(1992-3#1)(1993-11#1)(1994-5#2)(1995-8#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
does not affect##18##3##(1992-3#1)(1993-11#1)(1994-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
does not allow for##4##4##(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
does not allow##7##3##(1995-2#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-5#1)
does not alter the##3##4##(1994-2#1)(2010-9#1)(2011-2#1)
does not alter##4##3##(1992-3#1)(1994-2#1)(2010-9#1)(2011-2#1)
does not always##8##3##(1990-11#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-8#1)
does not appear to affect##2##5##(1994-3#1)(2008-7#1)
does not appear to be##11##5##(1991-6#1)(1994-3#1)(1996-12#2)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2013-1#2)
does not appear to preferentially##2##5##(1997-1#1)(2013-1#1)
does not appear to##19##4##(1991-6#1)(1992-9#1)(1994-3#2)(1996-12#2)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-2#1)(2013-1#3)
does not appear##20##3##(1991-6#1)(1992-9#1)(1994-3#2)(1996-12#2)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#3)
does not apply to##2##4##(1995-12#2)
does not apply##4##3##(1994-12#1)(1995-12#2)(2008-3#1)
does not block##2##3##(1994-2#1)(1996-2#1)
does not cause symptoms##2##4##(2008-10#2)
does not cause##7##3##(1991-5#1)(1994-5#1)(2008-10#4)(2008-12#1)
does not change the##5##4##(1993-11#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-8#1)
does not change with##2##4##(2008-10#1)(2008-8#1)
does not change##9##3##(1993-11#1)(1994-3#1)(1994-8#1)(1996-3#1)(2008-10#3)(2008-8#2)
does not completely##2##3##(1994-2#1)(2012-3#1)
does not confer##2##3##(1994-9#1)(2009-6#1)
does not conform to##2##4##(1995-8#1)(2008-10#1)
does not contain any##2##4##(1992-6#1)(2011-1#1)
does not contain##6##3##(1991-6#1)(1992-10#1)(1992-6#1)(1996-12#1)(2008-4#1)(2011-1#1)
does not depend on##6##4##(1995-2#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
does not depend##7##3##(1991-12#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
does not differ##3##3##(2008-10#2)(2011-2#1)
does not diminish##2##3##(1994-3#1)(2008-8#1)
does not enhance##2##3##(1990-6#1)(1993-8#1)
does not equal##2##3##(2007-11#1)(2008-8#1)
does not exceed##5##3##(1996-3#1)(2008-10#3)(2008-5#1)
does not exist##2##3##(2008-12#1)(2013-1#1)
does not explain the##2##4##(1990-6#1)(1997-8#1)
does not form##2##3##(1990-5#1)(2008-5#1)
does not give a##2##4##(1995-12#1)(2008-10#1)
does not give##3##3##(1994-6#1)(1995-12#1)(2008-10#1)
does not grow##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
does not happen##2##3##(1997-2#1)(2008-9#1)
does not have a##4##4##(1992-2#1)(1992-5#1)(1996-5#1)(2008-10#1)
does not have the##2##4##(1996-5#1)(2008-3#1)
does not have##10##3##(1990-2#1)(1992-2#1)(1992-5#1)(1996-5#2)(2008-10#1)(2008-3#2)(2008-8#1)(2011-3#1)
does not impair##2##3##(1993-1#1)(1997-7#1)
does not impede##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
does not imply##2##3##(1990-11#1)(2009-6#1)
does not improve##3##3##(2008-10#2)(2008-3#1)
does not include##2##3##(2008-9#1)(2010-10#1)
does not increase##2##3##(2008-10#1)(2011-2#1)
does not induce##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
does not interact with##2##4##(1994-5#1)(1995-2#1)
does not interfere with##4##4##(1995-2#1)(2008-10#1)(2008-4#2)
does not interfere##6##3##(1995-2#1)(2008-10#3)(2008-4#2)
does not involve##6##3##(1995-8#2)(1997-1#1)(1997-4#1)(2008-10#1)(2008-12#1)
does not lead to##4##4##(1992-6#1)(2008-10#2)(2008-8#1)
does not make##2##3##(1996-5#1)(2008-8#1)
does not match##3##3##(1997-7#1)(2007-11#1)(2012-2#1)
does not matter##2##3##(2011-2#1)(2013-1#1)
does not mediate##2##3##(1993-9#1)(1995-8#1)
does not necessarily follow##2##4##(1992-1#1)(2008-4#1)
does not necessarily imply##3##4##(1991-2#2)(2008-10#1)
does not necessarily##13##3##(1991-11#1)(1991-2#2)(1992-1#1)(1995-11#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2013-1#1)
does not need any##2##4##(2008-10#1)(2008-3#1)
does not need##5##3##(1996-3#1)(2008-10#3)(2008-3#1)
does not occur in##4##4##(1995-6#1)(2008-10#1)(2008-11#1)(2010-10#1)
does not occur##10##3##(1990-12#1)(1994-5#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-10#1)
does not offer##2##3##(1996-12#1)(2008-9#1)
does not permit##2##3##(2008-10#1)(2008-9#1)
does not play a role in##2##6##(2008-11#1)(2008-7#1)
does not play a##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
does not play##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)
does not present a##2##4##(2008-10#1)(2008-5#1)
does not present any##2##4##(2008-10#2)
does not present##4##3##(2008-10#3)(2008-5#1)
does not prevent##4##3##(1992-9#1)(1993-3#1)(2008-11#1)(2012-3#1)
does not produce##11##3##(1997-1#1)(2008-10#7)(2008-8#2)(2013-1#1)
does not prove##2##3##(1991-3#1)(1995-5#1)
does not provide##4##3##(1991-12#1)(1991-2#1)(1993-8#1)(1996-3#1)
does not recognize##3##3##(1995-6#1)(2008-4#1)(2008-8#1)
does not reduce##2##3##(1993-6#1)(1997-1#1)
does not represent##2##3##(2008-5#1)(2010-9#1)
does not require a##5##4##(1992-3#1)(2008-10#3)(2011-2#1)
does not require any sample pre-treatment##2##6##(2008-10#2)
does not require any sample##3##5##(2008-10#3)
does not require any##7##4##(2008-10#6)(2013-8#1)
does not require heating##2##4##(2008-10#2)
does not require the##6##4##(1992-6#1)(1995-6#1)(1996-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
does not require##44##3##(1991-2#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
does not result in a##3##5##(1997-3#1)(2008-5#1)(2008-6#1)
does not result in##4##4##(1995-6#1)(1997-3#1)(2008-5#1)(2008-6#1)
does not reveal##2##3##(1992-1#1)(2008-10#1)
does not seem to be##2##5##(1992-12#1)(2010-1#1)
does not seem to##7##4##(1990-8#1)(1991-2#1)(1992-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-1#1)
does not seem##9##3##(1990-8#1)(1991-2#1)(1992-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-1#1)
does not show a##2##4##(2008-11#1)(2008-7#1)
does not show the##2##4##(1992-9#1)(1996-2#1)
does not show##4##3##(1992-9#1)(1996-2#1)(2008-11#1)(2008-7#1)
does not significantly##3##3##(1995-1#1)(1995-2#1)(2008-2#1)
does not support the##3##4##(1993-3#1)(2008-8#1)(2008-9#1)
does not support##8##3##(1991-8#1)(1993-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-3#1)
does not undergo##3##3##(1993-6#1)(1995-6#1)(2008-11#1)
does not use##2##3##(2008-10#1)(2011-2#1)
does not vary##4##3##(1991-2#1)(2008-11#1)(2008-3#1)(2009-7#1)
does not work##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
does not##473##2##(1990-11#4)(1990-12#4)(1990-2#1)(1990-5#3)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#4)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#4)(1993-6#5)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#7)(1994-5#6)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#9)(1995-5#2)(1995-6#10)(1995-8#5)(1996-11#1)(1996-12#6)(1996-2#6)(1996-3#7)(1996-5#4)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#2)(1997-7#3)(1997-8#1)(2007-11#4)(2008-1#1)(2008-10#108)(2008-11#22)(2008-12#7)(2008-2#1)(2008-3#15)(2008-4#10)(2008-5#13)(2008-6#1)(2008-7#6)(2008-8#22)(2008-9#11)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#1)(2010-4#2)(2010-9#2)(2011-1#3)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#9)(2013-8#5)
does occur in##2##3##(2008-7#1)(2012-2#1)
does occur##5##2##(1991-6#1)(1992-2#1)(2008-7#1)(2009-9#1)(2012-2#1)
does restriction of privileges without due process violate medical staff##2##10##(1993-1#1)(1993-3#1)
does so##2##2##(1994-6#1)(2012-2#1)
does the##16##2##(1991-12#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
does this##2##2##(1991-6#1)(2008-9#1)
does##580##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-5#4)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#7)(1991-3#2)(1991-5#2)(1991-6#5)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#4)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#7)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#7)(1994-5#8)(1994-6#5)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#7)(1995-2#9)(1995-3#1)(1995-5#2)(1995-6#11)(1995-8#5)(1996-11#1)(1996-12#7)(1996-2#6)(1996-3#7)(1996-5#4)(1997-1#6)(1997-2#4)(1997-3#6)(1997-4#3)(1997-7#5)(1997-8#1)(2007-11#4)(2008-1#1)(2008-10#115)(2008-11#32)(2008-12#9)(2008-2#1)(2008-3#16)(2008-4#11)(2008-5#14)(2008-6#2)(2008-7#9)(2008-8#26)(2008-9#19)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#2)(2010-9#2)(2011-1#3)(2011-2#20)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#10)(2012-5#1)(2013-1#12)(2013-8#6)
doesn't necessarily##2##2##(1992-11#1)(2010-9#1)
doesn't##10##1##(1992-11#3)(1993-2#1)(1994-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(2010-9#1)(2013-1#1)
dog and rat liver microsomes##2##5##(2011-3#2)
dog and##4##2##(1990-6#1)(2011-3#3)
dog bite##3##2##(2008-12#3)
dog bites##5##2##(2013-8#5)
dog kidney##4##2##(1993-3#2)(1995-11#2)
dog liver##3##2##(1995-11#2)(2008-9#1)
dog owner/dog walkers##2##3##(2013-1#2)
dog owners##2##2##(2013-1#2)
dog was##2##2##(2008-5#1)(2013-8#1)
dog##58##1##(1990-6#1)(1991-3#1)(1991-6#3)(1992-10#1)(1993-3#2)(1995-11#5)(1995-2#2)(1995-9#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-5#3)(2008-9#3)(2010-6#1)(2011-3#3)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#8)
dogfish liver##2##2##(2008-10#2)
dogfish muscle##2##2##(2008-10#2)
dogfish##6##1##(2008-10#5)(2008-11#1)
dogma##6##1##(2008-11#1)(2008-12#3)(2010-5#1)(2012-2#1)
dogs (6##2##2##(1996-12#2)
dogs (class##2##2##(1992-3#2)
dogs and##5##2##(1994-8#1)(1996-12#1)(1996-6#1)(2008-12#1)(2012-3#1)
dogs are##2##2##(2008-12#1)(2011-2#1)
dogs demonstrated##2##2##(1994-2#1)(2008-5#1)
dogs exposed##2##2##(1996-1#1)(2008-10#1)
dogs in##4##2##(1996-12#1)(2008-12#1)(2008-5#2)
dogs than in##2##3##(2012-3#2)
dogs treated with surgery##2##4##(2012-3#2)
dogs were##6##2##(1996-6#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
dogs with##4##2##(1991-3#1)(1997-8#1)(2012-3#1)(2013-1#1)
dogs##112##1##(1990-6#1)(1991-3#2)(1992-12#1)(1992-3#2)(1992-5#7)(1992-6#2)(1994-11#1)(1994-2#1)(1994-8#4)(1995-2#1)(1996-1#1)(1996-11#2)(1996-12#11)(1996-6#4)(1997-1#1)(1997-5#2)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#11)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#3)(2011-2#10)(2012-3#17)(2013-1#4)(2013-8#2)
dogs)##2##1##(1996-12#2)
dogwood in the##2##3##(2008-10#2)
dogwood##4##1##(2008-10#4)
doi##17##1##(2008-11#6)(2009-12#5)(2012-3#1)(2013-8#5)
doing in##2##2##(1996-2#2)
doing so##12##2##(1992-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-8#1)(2011-1#1)(2013-1#2)
doing the##2##2##(1994-1#1)(2008-2#1)
doing this##2##2##(2008-11#2)
doing well##5##2##(2008-11#1)(2008-8#1)(2010-1#1)(2013-1#1)(2013-7#1)
doing##50##1##(1990-2#1)(1991-2#1)(1991-3#2)(1992-5#1)(1993-1#1)(1994-1#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-2#3)(2007-11#1)(2008-10#3)(2008-11#8)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#3)(2013-7#1)
doing?##2##1##(2008-11#1)(2011-2#1)
dolichol concentration##2##2##(1991-12#2)
dolichol##5##1##(1991-12#4)(1996-6#1)
dolichyl phosphoryl mannose synthase##3##4##(1996-6#3)
dollar spot disease##2##3##(2008-10#2)
dollar spot resistance in creeping bentgrass##2##6##(2008-10#2)
dollar spot resistance in##3##4##(2008-10#3)
dollar spot resistance##4##3##(2008-10#4)
dollar spot##8##2##(2008-10#8)
dollar##16##1##(1991-1#1)(1993-3#1)(1994-1#4)(1995-12#1)(2008-10#8)(2012-3#1)
dollars are##3##2##(1991-2#1)(1993-12#1)(1996-2#1)
dollars##15##1##(1991-2#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
dollars)##3##1##(1991-2#1)(1992-12#1)(1994-2#1)
domain (CTD)##2##2##(2009-7#1)(2012-2#1)
domain (ECD) of##2##3##(1995-12#1)(2008-11#1)
domain 2##3##2##(1995-6#1)(2008-7#1)(2008-8#1)
domain and a##2##3##(1993-2#1)(2009-3#1)
domain and the##2##3##(1993-6#1)(2008-10#1)
domain and##16##2##(1992-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1995-2#1)(1995-8#1)(1997-7#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-8#3)(2009-12#1)(2009-3#1)
domain are##4##2##(1995-2#1)(1995-6#1)(2008-11#1)(2008-3#1)
domain at its##2##3##(2007-12#1)(2011-2#1)
domain at their##2##3##(1994-11#2)
domain at##6##2##(1994-11#2)(1997-8#2)(2007-12#1)(2011-2#1)
domain binding##2##2##(2008-4#1)(2012-2#1)
domain bound##2##2##(1995-8#1)(2010-5#1)
domain but lack the##2##4##(2008-8#1)(2009-10#1)
domain by##6##2##(1991-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)
domain can##2##2##(2008-5#2)
domain composed##2##2##(1995-6#2)
domain containing##7##2##(1991-7#1)(1995-6#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
domain evolution##3##2##(2011-2#3)
domain for##6##2##(1996-3#1)(2008-7#1)(2010-8#3)(2011-2#1)
domain from the human JARID1C##2##5##(2009-7#2)
domain from the human##3##4##(1995-2#1)(2009-7#2)
domain from the##4##3##(1995-2#1)(1996-2#1)(2009-7#2)
domain from##6##2##(1995-11#1)(1995-2#1)(1996-2#1)(2009-7#2)(2013-1#1)
domain has##4##2##(1990-7#1)(1996-2#1)(2008-3#1)(2009-6#1)
domain in the##4##3##(2007-12#2)(2008-12#1)(2010-6#1)
domain in##11##2##(1993-1#1)(1994-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2009-7#2)(2010-6#1)(2011-2#1)(2012-2#1)
domain inversion##2##2##(2008-3#2)
domain is##11##2##(1990-7#2)(1993-2#1)(1993-3#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#1)
domain may##5##2##(1992-4#1)(1995-2#2)(2009-10#1)(2010-5#1)
domain of AC2##2##3##(2008-9#2)
domain of NF-L##2##3##(2008-8#2)
domain of Shc##2##3##(1997-7#1)(2012-2#1)
domain of cTR##2##3##(1991-6#2)
domain of human PTPN7##2##4##(2009-7#2)
domain of human##6##3##(2008-11#1)(2008-8#1)(2009-7#3)(2011-2#1)
domain of the human glucocorticoid receptor##2##6##(1990-11#1)(1995-2#1)
domain of the human##5##4##(1990-11#1)(1991-5#1)(1993-3#1)(1995-2#1)(2006-6#1)
domain of the##35##3##(1990-11#1)(1990-7#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-5#1)(1995-2#2)(1995-6#3)(1997-4#1)(2006-6#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-7#2)(2012-2#1)
domain of##107##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#5)(1994-11#3)(1994-5#2)(1995-11#1)(1995-2#3)(1995-6#9)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-6#4)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#9)(2009-3#1)(2009-7#14)(2009-8#2)(2011-1#1)(2011-2#3)(2012-2#2)
domain or##2##2##(1994-11#1)(2008-8#1)
domain organization##2##2##(1991-6#1)(2008-11#1)
domain protein##2##2##(2008-9#1)(2012-2#1)
domain proteins##2##2##(2008-9#2)
domain structure and##2##3##(1995-6#1)(2009-10#1)
domain structure##4##2##(1995-2#1)(1995-6#2)(2009-10#1)
domain that##3##2##(2008-10#1)(2009-10#1)(2013-1#1)
domain to the##3##3##(1991-10#1)(1995-6#1)(2009-6#1)
domain to##4##2##(1991-10#1)(1995-6#1)(2008-11#1)(2009-6#1)
domain was##5##2##(1995-6#2)(1997-2#1)(1997-7#1)(2008-8#1)
domain were##6##2##(1990-11#1)(1996-1#1)(2008-10#2)(2011-2#1)(2011-3#1)
domain which was##2##3##(2008-11#1)(2008-9#1)
domain which##7##2##(1993-6#1)(1993-9#1)(2008-11#3)(2008-7#1)(2008-9#1)
domain with##2##2##(2008-4#1)(2008-9#1)
domain within##2##2##(1993-8#1)(2013-1#1)
domain##467##1##(1990-11#3)(1990-5#2)(1990-7#4)(1990-8#2)(1991-1#1)(1991-10#2)(1991-12#4)(1991-3#2)(1991-5#2)(1991-6#4)(1991-7#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-3#4)(1992-4#3)(1992-9#1)(1993-1#2)(1993-12#8)(1993-2#4)(1993-3#2)(1993-6#10)(1993-8#19)(1993-9#2)(1994-11#9)(1994-5#2)(1995-11#3)(1995-12#1)(1995-2#15)(1995-6#31)(1995-8#5)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#8)(1997-8#6)(1997-9#1)(2006-6#4)(2007-12#6)(2008-10#32)(2008-11#17)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#34)(2008-9#27)(2009-10#9)(2009-12#3)(2009-3#3)(2009-5#1)(2009-6#9)(2009-7#26)(2009-8#10)(2010-10#1)(2010-12#2)(2010-5#4)(2010-6#1)(2010-8#6)(2011-1#3)(2011-2#18)(2011-3#1)(2012-2#13)(2012-3#1)(2013-1#9)(2013-8#4)
domain&quot##2##1##(2008-11#1)(2011-1#1)
domain-containing##3##1##(2008-10#1)(2009-6#1)(2009-7#1)
domains along the##2##3##(1992-4#1)(2008-3#1)
domains and is##2##3##(1997-7#1)(2008-10#1)
domains and##8##2##(1992-6#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2013-1#1)
domains are##7##2##(1993-6#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-2#1)
domains as well as##2##4##(2008-10#1)(2011-1#1)
domains as##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
domains for##2##2##(2011-2#1)(2012-2#1)
domains from##2##2##(1992-6#1)(2012-3#1)
domains in a##2##3##(1995-12#1)(2012-2#1)
domains in the##2##3##(1994-5#1)(2008-7#1)
domains in##9##2##(1993-5#1)(1993-8#1)(1994-5#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
domains including##2##2##(2008-10#1)(2011-3#1)
domains is##4##2##(1992-4#1)(2008-5#1)(2008-8#1)(2010-4#1)
domains may##2##2##(2008-10#1)(2009-12#1)
domains of NF-L##2##3##(2008-8#2)
domains of a##2##3##(1995-6#1)(1996-12#1)
domains of the##17##3##(1991-5#1)(1991-6#1)(1992-4#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
domains of##64##2##(1990-10#1)(1991-5#1)(1991-6#2)(1992-3#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#8)(1996-12#3)(1996-2#4)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-11#5)(2008-4#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
domains on the##3##3##(1993-3#2)(2011-2#1)
domains that##5##2##(1997-3#1)(2008-1#1)(2009-7#1)(2011-1#1)(2013-1#1)
domains to##3##2##(1993-6#1)(2009-8#1)(2009-9#1)
domains was##2##2##(1990-7#1)(2008-10#1)
domains were##2##2##(1993-12#1)(1993-8#1)
domains with lower##2##3##(1996-2#2)
domains with##6##2##(1996-2#4)(2008-11#1)(2008-2#1)
domains##227##1##(1990-10#1)(1990-5#1)(1990-7#3)(1991-5#1)(1991-6#2)(1992-3#2)(1992-4#7)(1992-6#2)(1992-7#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#5)(1993-8#6)(1994-12#2)(1994-5#3)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-6#12)(1995-8#3)(1996-12#5)(1996-2#11)(1997-2#1)(1997-3#5)(1997-4#1)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#14)(2008-11#14)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#13)(2008-9#6)(2009-1#3)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#7)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#12)(2011-3#1)(2011-8#1)(2012-2#8)(2012-3#2)(2013-1#3)(2013-8#2)
dome chondral and osteochondral lesions##2##5##(2011-2#2)
dome points##2##2##(2009-2#2)
dome##13##1##(1991-6#1)(1995-10#2)(2007-12#1)(2008-10#2)(2009-2#2)(2009-7#2)(2010-5#1)(2011-2#2)
domestic and foreign##2##3##(2009-8#1)(2012-3#1)
domestic and international##2##3##(2008-10#1)(2010-8#1)
domestic and##7##2##(2008-10#2)(2008-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
domestic animals and##2##3##(1996-12#1)(2008-12#1)
domestic animals in##3##3##(1990-3#1)(2007-12#1)(2008-12#1)
domestic animals##8##2##(1990-3#1)(1994-9#1)(1996-12#1)(2007-12#1)(2008-12#3)(2010-4#1)
domestic homicide cases##4##3##(2011-2#4)
domestic homicide##8##2##(2011-2#8)
domestic rabbits##2##2##(1996-3#2)
domestic violence##9##2##(1993-12#1)(1995-12#1)(2009-11#1)(2009-4#1)(2012-12#3)(2012-3#1)(2013-1#1)
domestic wastes##2##2##(2008-10#2)
domestic##77##1##(1990-3#1)(1991-2#1)(1992-12#1)(1993-12#2)(1993-3#2)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#4)(1996-2#1)(1996-3#2)(1997-3#1)(2007-12#3)(2008-10#14)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#12)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#3)
domestica##14##1##(1996-9#1)(2008-10#4)(2008-12#2)(2008-8#1)(2008-9#2)(2013-1#4)
domestica)##5##1##(2008-10#4)(2009-8#1)
domesticated##8##1##(1996-3#1)(2008-10#2)(2008-6#1)(2010-1#1)(2010-4#2)(2012-3#1)
domestication##3##1##(2009-10#1)(2010-4#2)
domesticus)##5##1##(2008-12#2)(2008-5#3)
dominance and##2##2##(1995-6#1)(2008-8#1)
dominance columns##5##2##(2008-11#5)
dominance for##2##2##(1996-2#1)(2008-10#1)
dominance hierarchies##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
dominance in##6##2##(2008-10#1)(2008-8#3)(2011-2#2)
dominance is##5##2##(2008-8#4)(2011-2#1)
dominance of the##2##3##(1991-12#1)(2008-3#1)
dominance of##10##2##(1991-12#1)(2008-10#3)(2008-3#1)(2008-8#2)(2009-7#1)(2012-2#1)(2013-1#1)
dominance was##2##2##(2008-10#1)(2008-8#1)
dominance##66##1##(1991-12#1)(1995-11#3)(1995-6#1)(1996-2#1)(2008-10#12)(2008-11#9)(2008-3#1)(2008-8#20)(2008-9#3)(2009-7#1)(2010-1#1)(2010-3#1)(2011-2#5)(2012-2#6)(2013-1#1)
dominant allele##3##2##(2008-10#3)
dominant and subordinate O##2##4##(2010-8#2)
dominant and subordinate##4##3##(2008-8#1)(2010-8#3)
dominant and##10##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-8#3)(2012-3#1)
dominant disorder##6##2##(1992-3#1)(1997-3#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
dominant factor##4##2##(1993-1#1)(2008-10#2)(2009-11#1)
dominant for avirulence##3##3##(2008-10#3)
dominant for##6##2##(1997-7#1)(2008-10#3)(2008-11#2)
dominant form of##2##3##(1997-2#1)(2012-12#1)
dominant gene action##2##3##(2008-10#2)
dominant gene and##2##3##(2008-10#2)
dominant gene for resistance to##3##5##(2008-10#3)
dominant gene for##5##3##(2008-10#5)
dominant gene was##2##3##(2008-10#2)
dominant gene##33##2##(2008-10#31)(2008-4#1)(2013-8#1)
dominant genes##2##2##(2008-10#2)
dominant in the##7##3##(1992-3#3)(2008-10#3)(2009-12#1)
dominant in##11##2##(1992-3#3)(2008-10#7)(2009-12#1)
dominant inheritance##2##2##(2008-7#2)
dominant loci##2##2##(2008-10#2)
dominant masculinity##2##2##(2008-11#2)
dominant model##2##2##(2008-8#1)(2010-5#1)
dominant multisystem disorder##2##3##(1993-12#1)(2012-3#1)
dominant negative##7##2##(1991-5#1)(1991-9#1)(1993-11#1)(1995-8#2)(2011-2#1)(2013-1#1)
dominant or symptomatic cavernoma##2##4##(1996-6#2)
dominant or##5##2##(1992-1#1)(1996-6#2)(2008-10#1)(2008-11#1)
dominant over##2##2##(2008-10#1)(2008-8#1)
dominant resistance gene##2##3##(2008-10#2)
dominant resistance##3##2##(2008-10#3)
dominant role in the##2##4##(1992-1#1)(2011-3#1)
dominant role in##3##3##(1992-1#1)(2010-11#1)(2011-3#1)
dominant role##4##2##(1992-1#1)(2008-2#1)(2010-11#1)(2011-3#1)
dominant species##6##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#2)
dominant trait##2##2##(2008-10#1)(2010-6#1)
dominant##261##1##(1990-11#1)(1990-5#2)(1991-5#1)(1991-9#2)(1992-1#2)(1992-3#5)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-2#2)(1996-3#1)(1996-6#3)(1997-1#3)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#4)(2008-10#104)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#13)(2013-1#5)(2013-8#3)
dominant-negative##3##1##(2008-6#2)(2012-12#1)
dominantly dual##2##2##(2009-8#2)
dominantly inherited##4##2##(1990-12#1)(1995-12#1)(1996-2#1)(2008-6#1)
dominantly##8##1##(1990-12#1)(1995-12#1)(1996-2#1)(2008-6#1)(2009-8#2)(2011-2#1)(2012-2#1)
dominants##9##1##(1992-1#4)(2008-8#4)(2010-8#1)
dominate the##5##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)
dominate##13##1##(1990-6#1)(1996-1#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-7#1)
dominated by a single##2##4##(1990-8#1)(2008-10#1)
dominated by a##3##3##(1990-8#1)(1997-6#1)(2008-10#1)
dominated by either##2##3##(2008-5#1)(2008-9#1)
dominated by the##8##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-10#1)
dominated by##35##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-9#1)(1997-6#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#1)(2010-4#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#1)
dominated the population##2##3##(2008-10#2)
dominated the##6##2##(2008-10#5)(2009-7#1)
dominated##55##1##(1990-5#1)(1990-8#1)(1992-12#1)(1992-9#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-4#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#1)
dominates in##2##2##(2008-11#2)
dominates the##4##2##(2008-10#1)(2008-3#2)(2009-7#1)
dominates##8##1##(2008-10#2)(2008-11#2)(2008-3#2)(2008-8#1)(2009-7#1)
dominating##8##1##(1996-6#2)(2008-10#5)(2008-8#1)
domination by##2##2##(1991-3#1)(2008-8#1)
domination of the community by##2##5##(2008-8#2)
domination of the##3##3##(2008-1#1)(2008-8#2)
domination of##4##2##(2008-1#1)(2008-11#1)(2008-8#2)
domination##6##1##(1991-3#1)(2008-1#1)(2008-11#1)(2008-8#3)
domino accidents##3##2##(2009-10#3)
domino##7##1##(2009-10#7)
domperidone cover##2##2##(2008-7#2)
domperidone##8##1##(2008-10#4)(2008-7#4)
don't have a##2##3##(1994-12#1)(2008-4#1)
don't know##2##2##(1991-2#1)(1994-2#1)
don't##22##1##(1990-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-4#3)(2011-2#2)(2013-8#3)
donated blood##2##2##(1996-9#2)
donated##11##1##(1992-1#1)(1992-3#1)(1995-12#1)(1996-9#3)(2008-10#4)(2008-11#1)
donation##17##1##(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-5#1)(1996-9#5)(2008-10#1)(2009-3#1)(2010-12#1)(2012-2#2)
donations##5##1##(1991-12#1)(1991-2#1)(1993-12#1)(1993-2#1)(1995-3#1)
done and##4##2##(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
done at the##2##3##(1990-3#2)
done at##13##2##(1990-3#2)(1992-3#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-12#1)(2008-10#3)(2008-11#1)(2010-7#2)
done because##2##2##(1995-2#1)(2008-10#1)
done before and after##2##4##(2008-10#1)(2012-2#1)
done before and##3##3##(2008-10#2)(2012-2#1)
done before##4##2##(1996-11#1)(2008-10#2)(2012-2#1)
done by a##3##3##(2010-1#1)(2013-1#2)
done by means of##2##4##(1991-2#1)(2008-10#1)
done by the##2##3##(1990-3#1)(2008-10#1)
done by using##5##3##(2008-10#4)(2008-11#1)
done by##35##2##(1990-3#1)(1991-2#1)(1993-11#1)(1995-1#1)(1997-3#1)(2008-10#23)(2008-11#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
done during##3##2##(1994-8#1)(2008-9#1)(2010-6#1)
done for a##2##3##(2008-10#1)(2011-2#1)
done for the##2##3##(2012-2#1)(2013-1#1)
done for##6##2##(1995-1#1)(2008-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
done in a##5##3##(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
done in our##2##3##(1995-1#1)(2008-11#1)
done in the##6##3##(1997-7#1)(2008-10#4)(2008-8#1)
done in##40##2##(1991-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#3)(2013-1#3)
done laparoscopically##2##2##(2011-2#2)
done on the##4##3##(1991-3#1)(1995-3#1)(2008-10#1)(2010-7#1)
done on##11##2##(1990-6#1)(1991-3#1)(1993-6#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)(2012-2#2)
done over##2##2##(1990-12#1)(2011-2#1)
done through the##5##3##(2008-10#2)(2012-12#2)(2012-2#1)
done through##7##2##(1994-1#1)(1994-3#1)(2008-10#2)(2012-12#2)(2012-2#1)
done to compare the##4##4##(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
done to determine the##2##4##(2008-10#1)(2008-11#1)
done to determine##3##3##(1993-2#1)(2008-10#1)(2008-11#1)
done to##33##2##(1990-5#1)(1991-1#1)(1992-11#1)(1992-8#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
done under##2##2##(1992-12#1)(2008-4#1)
done using the##2##3##(1997-8#2)
done using##10##2##(1997-8#2)(2008-10#5)(2008-11#1)(2008-5#1)(2012-2#1)
done with the##5##3##(2008-10#3)(2008-7#1)(2012-12#1)
done with two##2##3##(2008-10#1)(2008-11#1)
done with##18##2##(1990-12#1)(1992-6#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
done within 72 hours##3##4##(2013-1#3)
done within##4##2##(2012-3#1)(2013-1#3)
done without##3##2##(2008-10#2)(2010-10#1)
done##263##1##(1990-12#2)(1990-3#3)(1990-5#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#4)(1994-12#4)(1994-3#4)(1994-6#1)(1994-8#2)(1995-1#4)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#2)(1997-8#3)(2008-1#1)(2008-10#74)(2008-11#15)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-11#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#8)(2012-2#10)(2012-3#3)(2013-1#21)(2013-8#5)
done?##2##1##(1991-3#1)(2008-6#1)
donkey leukocyte##3##2##(2008-9#3)
donkey meat from##2##3##(2010-4#2)
donkey##10##1##(1990-3#2)(2008-9#3)(2010-4#5)
donnan##2##1##(2008-10#1)(2011-2#1)
données##4##1##(2013-1#4)
donor ability##2##2##(2008-10#2)
donor and acceptor##5##3##(2008-10#4)(2011-2#1)
donor and##9##2##(2008-10#7)(2011-2#1)(2012-2#1)
donor cells were transferred and##2##5##(2008-9#2)
donor cells##10##2##(2008-11#1)(2008-9#9)
donor ester##2##2##(1997-2#1)(2008-7#1)
donor for##2##2##(2008-10#1)(2008-9#1)
donor groups##2##2##(2008-10#2)
donor heart##2##2##(2010-12#2)
donor in##2##2##(1994-5#1)(2008-10#1)
donor is##5##2##(2008-4#1)(2008-8#3)(2010-7#1)
donor nephrectomy is##2##3##(2009-3#1)(2011-2#1)
donor nephrectomy##3##2##(2009-3#1)(2011-2#2)
donor of##3##2##(2008-10#2)(2012-2#1)
donor scars##2##2##(2008-9#2)
donor selection##2##2##(2011-2#1)(2011-3#1)
donor shortage##2##2##(2010-10#2)
donor site morbidity and##2##4##(2011-2#2)
donor site morbidity##6##3##(2009-10#1)(2011-2#3)(2012-3#2)
donor site##14##2##(2008-7#2)(2009-10#1)(2011-2#7)(2012-3#2)(2013-1#2)
donor solution##2##2##(2008-10#2)
donor stream##5##2##(2008-10#5)
donor to##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
donor##148##1##(1990-10#1)(1991-1#1)(1991-3#1)(1992-10#2)(1992-12#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-6#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-6#1)(2008-10#34)(2008-11#13)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#6)(2008-9#21)(2009-10#2)(2009-3#1)(2010-10#4)(2010-12#3)(2010-7#2)(2011-2#17)(2011-3#4)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#2)
donor-acceptor##4##1##(2008-10#1)(2009-3#3)
donors and##12##2##(1990-6#1)(1994-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2010-7#2)(2011-2#2)
donors as##2##2##(2008-5#1)(2012-2#1)
donors for##4##2##(1990-12#1)(2011-2#1)(2012-12#2)
donors in##7##2##(1992-12#1)(2008-10#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
donors of age##2##3##(2011-2#2)
donors of##3##2##(2010-12#1)(2011-2#2)
donors recruitment##2##2##(2008-10#2)
donors showed##3##2##(1990-6#1)(2008-11#1)(2008-7#1)
donors were##6##2##(2008-11#3)(2010-12#1)(2011-2#1)(2012-2#1)
donors##100##1##(1990-12#2)(1990-6#3)(1992-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-8#1)(2008-10#18)(2008-11#15)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#5)(2009-9#1)(2010-12#4)(2010-7#2)(2010-8#1)(2011-2#18)(2011-3#2)(2012-12#4)(2012-2#4)(2013-1#2)
dont la##2##2##(2013-1#2)
dont##5##1##(2013-1#5)
door##7##1##(1993-1#1)(1994-2#1)(1996-5#1)(2008-9#1)(2011-2#1)(2012-12#2)
doors##3##1##(2007-11#1)(2008-7#1)(2012-2#1)
dopamine (DA) and##2##3##(1994-2#1)(2008-10#1)
dopamine (DA)##15##2##(1993-6#1)(1994-2#1)(1996-12#2)(1997-2#1)(2008-10#9)(2009-7#1)
dopamine D(2) receptor##2##3##(2008-10#2)
dopamine D1 receptor##2##3##(1996-2#2)
dopamine D2 receptors##3##3##(1992-12#1)(1993-9#1)(1995-11#1)
dopamine D2##6##2##(1992-12#1)(1993-9#2)(1995-11#3)
dopamine D4##2##2##(1993-9#2)
dopamine agonist##4##2##(2008-7#3)(2008-8#1)
dopamine agonists##3##2##(2008-7#3)
dopamine and norepinephrine##2##3##(1995-11#1)(2012-3#1)
dopamine and serotonin##2##3##(1993-1#1)(1996-12#1)
dopamine and##20##2##(1990-8#1)(1991-1#1)(1993-1#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#8)(2008-7#2)(2012-3#1)
dopamine beta-hydroxylase (DBH)##2##3##(1995-12#1)(1997-3#1)
dopamine beta-hydroxylase##3##2##(1995-12#2)(1997-3#1)
dopamine biosynthesis in PC12 cells##2##5##(2008-11#2)
dopamine biosynthesis##3##2##(2008-11#3)
dopamine cell firing rate##2##4##(1994-2#2)
dopamine cell##3##2##(1994-2#2)(1995-2#1)
dopamine has been developed##2##4##(2008-10#2)
dopamine hydrochloride##4##2##(2008-10#4)
dopamine in the presence of ascorbic acid and uric acid##2##10##(2008-10#2)
dopamine in the presence of ascorbic acid##4##7##(2008-10#4)
dopamine in the##10##3##(1993-6#3)(2008-10#7)
dopamine in##19##2##(1993-6#4)(2008-10#15)
dopamine level##2##2##(2008-10#2)
dopamine levels in the##2##4##(1994-2#1)(2009-8#1)
dopamine levels##3##2##(1994-2#1)(2008-5#1)(2009-8#1)
dopamine ligand binding##2##3##(1996-12#2)
dopamine membrane transporter##2##3##(1996-12#2)
dopamine neuron##2##2##(1995-2#2)
dopamine neurons##6##2##(1995-2#1)(1996-2#2)(2008-7#3)
dopamine receptor antagonist##3##3##(1995-2#1)(1996-2#2)
dopamine receptor binding##3##3##(1996-12#3)
dopamine receptor stimulation##2##3##(1995-2#1)(2010-12#1)
dopamine receptor##12##2##(1992-12#1)(1993-5#1)(1995-2#3)(1996-12#3)(1996-2#2)(2008-7#1)(2010-12#1)
dopamine receptors in the substantia nigra##2##6##(1995-2#2)
dopamine receptors in the##3##4##(1994-2#1)(1995-2#2)
dopamine receptors##8##2##(1994-2#2)(1995-2#5)(2013-8#1)
dopamine release##4##2##(1993-6#2)(1997-2#1)(2013-8#1)
dopamine sensing##5##2##(2008-10#5)
dopamine transporter##6##2##(1995-11#1)(1996-2#5)
dopamine uptake system##4##3##(1995-11#4)
dopamine##225##1##(1990-7#1)(1990-8#3)(1991-1#2)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#2)(1993-11#1)(1993-5#1)(1993-6#8)(1993-9#5)(1994-2#7)(1994-8#2)(1995-11#11)(1995-12#2)(1995-2#15)(1995-8#4)(1996-12#13)(1996-2#17)(1997-2#3)(1997-3#5)(1997-4#1)(2008-10#79)(2008-11#6)(2008-5#1)(2008-7#17)(2008-8#1)(2009-12#1)(2009-7#2)(2009-8#3)(2010-12#2)(2011-1#1)(2012-3#2)(2013-8#3)
dopamine- and##2##2##(1991-10#1)(1995-11#1)
dopamine-##4##1##(1991-10#1)(1995-11#3)
dopamine-mediated##2##1##(1994-2#1)(1996-2#1)
dopamine-producing##2##1##(1995-8#1)(2010-12#1)
dopaminergic (DA)##2##2##(1996-2#1)(1996-5#1)
dopaminergic activity##2##2##(1992-12#1)(2008-7#1)
dopaminergic and##4##2##(1993-1#1)(2008-5#1)(2008-7#2)
dopaminergic cell##2##2##(1996-12#1)(2008-7#1)
dopaminergic cells of##2##3##(1996-12#2)
dopaminergic drug withdrawal##3##3##(2009-11#3)
dopaminergic drugs##2##2##(2008-7#1)(2009-11#1)
dopaminergic function in##4##3##(2008-7#4)
dopaminergic medication##2##2##(2010-12#1)(2013-8#1)
dopaminergic nerve##2##2##(1996-12#1)(1997-2#1)
dopaminergic neurons from##2##3##(1990-7#1)(1997-3#1)
dopaminergic neurons in the##4##4##(1996-12#1)(1997-3#2)(2008-7#1)
dopaminergic neurons in##7##3##(1996-12#2)(1997-3#2)(2008-7#3)
dopaminergic neurons of the substantia nigra##2##6##(1996-12#2)
dopaminergic neurons of the##4##4##(1996-12#2)(2008-7#2)
dopaminergic neurons##32##2##(1990-7#4)(1995-11#1)(1995-2#1)(1996-12#6)(1997-2#1)(1997-3#4)(2008-7#15)
dopaminergic neurotransmission##3##2##(1996-2#1)(2013-8#2)
dopaminergic system##3##2##(1996-2#2)(1997-3#1)
dopaminergic therapy##2##2##(2008-7#1)(2010-12#1)
dopaminergic transmission##2##2##(1994-2#1)(1995-2#1)
dopaminergic##91##1##(1990-7#7)(1990-8#1)(1990-9#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-2#2)(1995-11#2)(1995-2#2)(1996-12#14)(1996-2#5)(1996-5#1)(1997-2#3)(1997-3#5)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#26)(2009-11#4)(2009-7#1)(2009-8#1)(2010-12#3)(2012-12#2)(2013-7#2)(2013-8#3)
dopant##3##1##(2008-10#1)(2008-3#1)(2010-11#1)
dope##2##1##(1990-11#1)(2008-7#1)
doped compounds##2##2##(2008-10#2)
doped samples##3##2##(2008-10#3)
doped with Ru(bpy)(3)(2+)##2##3##(2008-10#2)
doped with a##2##3##(2008-10#2)
doped with##22##2##(2007-12#1)(2008-10#17)(2008-11#1)(2008-3#3)
doped##45##1##(1991-9#1)(2007-12#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-3#4)
doping behaviors in##2##3##(2009-11#2)
doping behaviors##3##2##(2009-11#3)
doping control##4##2##(2008-10#1)(2010-11#3)
doping in##2##2##(1990-12#1)(2008-10#1)
doping the##2##2##(2008-10#2)
doping##30##1##(1990-12#1)(1990-8#1)(2008-10#14)(2008-12#1)(2008-3#2)(2009-11#5)(2010-11#4)(2010-7#1)(2012-2#1)
dormancy progression in##3##3##(2012-8#3)
dormancy release in##3##3##(2012-8#3)
dormancy##18##1##(2008-10#3)(2008-8#4)(2009-10#1)(2012-8#10)
dormant D##2##2##(2008-8#2)
dormant buds##2##2##(2008-10#2)
dormant cell types##2##3##(2008-10#1)(2011-2#1)
dormant spores##2##2##(2011-2#2)
dormant##18##1##(2008-10#9)(2008-11#1)(2008-6#1)(2008-8#2)(2011-2#4)(2012-8#1)
dorsal and ventral##4##3##(1996-12#2)(2008-11#1)(2011-2#1)
dorsal and##7##2##(1991-12#1)(1996-12#3)(2008-11#1)(2008-7#1)(2011-2#1)
dorsal caudate-putamen injections of##2##4##(1993-6#2)
dorsal caudate-putamen##5##2##(1993-6#5)
dorsal hippocampus##5##2##(1991-2#2)(2008-11#2)(2013-8#1)
dorsal horn following##2##3##(1992-6#1)(1997-3#1)
dorsal horn that##2##3##(1994-2#1)(1997-3#1)
dorsal horn##16##2##(1992-6#1)(1994-2#3)(1995-12#3)(1996-12#1)(1997-3#8)
dorsal lips##5##2##(2011-2#5)
dorsal noradrenergic bundle##2##3##(1993-3#2)
dorsal or##2##2##(1996-2#1)(2008-9#1)
dorsal radiolar##2##2##(2011-2#2)
dorsal raphe of##2##3##(1994-2#2)
dorsal raphe##6##2##(1993-3#2)(1994-2#3)(1996-12#1)
dorsal rim area##2##3##(2007-12#2)
dorsal root ganglia (DRG)##2##4##(2008-7#1)(2008-9#1)
dorsal root ganglia##7##3##(1992-12#1)(1997-3#1)(2008-7#2)(2008-9#3)
dorsal root ganglion neurons##2##4##(2008-5#1)(2013-8#1)
dorsal root ganglion##10##3##(1991-7#1)(1995-12#1)(1997-2#2)(2008-5#1)(2008-8#3)(2011-2#1)(2013-8#1)
dorsal root##17##2##(1991-7#1)(1992-12#1)(1995-12#1)(1997-2#2)(1997-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2011-2#1)(2013-8#1)
dorsal skin layers##5##3##(2008-11#5)
dorsal skin##6##2##(1996-6#1)(2008-11#5)
dorsal striatum##4##2##(1993-6#1)(1996-2#1)(2013-8#2)
dorsal##146##1##(1990-2#1)(1990-9#2)(1991-12#2)(1991-2#4)(1991-7#2)(1992-12#1)(1992-6#1)(1993-3#6)(1993-6#6)(1994-12#1)(1994-2#7)(1994-8#2)(1995-12#5)(1996-12#5)(1996-2#3)(1996-6#1)(1997-2#2)(1997-3#14)(2007-12#8)(2007-8#1)(2008-10#2)(2008-11#10)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#16)(2010-7#1)(2010-8#2)(2011-2#13)(2012-3#3)(2013-1#1)(2013-8#7)
dorsal-ventral##2##1##(1994-12#1)(1997-3#1)
dorsalis##8##1##(1991-11#2)(2008-12#1)(2008-6#2)(2010-7#2)(2013-8#1)
dorsally##2##1##(1994-12#1)(2013-1#1)
dorsi muscle##2##2##(2008-7#1)(2013-1#1)
dorsi myocutaneous flap##2##3##(1990-9#1)(1993-11#1)
dorsi myocutaneous##3##2##(1990-9#1)(1993-11#1)(1994-12#1)
dorsi##14##1##(1990-9#2)(1992-9#1)(1993-11#1)(1994-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#3)
dorsiflexion##3##1##(2009-11#1)(2011-2#2)
dorso-lateral##2##1##(2008-7#1)(2011-2#1)
dorsolateral AVM##2##2##(2008-7#2)
dorsolateral prefrontal cortex##3##3##(1996-2#1)(2010-7#2)
dorsolateral prefrontal##4##2##(1996-2#1)(2010-7#2)(2011-2#1)
dorsolateral##12##1##(1994-8#1)(1996-2#1)(2007-12#3)(2008-12#1)(2008-7#3)(2010-7#2)(2011-2#1)
dorsoventral patterning##2##2##(1994-12#1)(1994-9#1)
dorsoventral##7##1##(1990-3#1)(1994-12#1)(1994-9#1)(1997-3#3)(2010-4#1)
dorsum of##4##2##(1997-4#1)(2008-5#1)(2010-3#1)(2012-3#1)
dorée phytoplasma##3##2##(2008-10#3)
dosage adjustments##2##2##(2008-1#2)
dosage and##9##2##(1992-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#3)
dosage calculations##2##2##(2008-11#2)
dosage form and##2##3##(2008-10#2)
dosage form##13##2##(2008-10#10)(2012-2#3)
dosage forms and biological fluids##5##5##(2008-10#5)
dosage forms and##6##3##(2008-10#6)
dosage forms by##2##3##(2008-10#2)
dosage forms##33##2##(2008-10#32)(2012-2#1)
dosage is##2##2##(2008-1#1)(2008-11#1)
dosage of 75##2##3##(1991-2#1)(1994-2#1)
dosage of##17##2##(1990-9#1)(1991-2#1)(1994-2#1)(1994-8#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#2)
dosage regimens##2##2##(2008-11#1)(2011-2#1)
dosage to##2##2##(1993-9#1)(2013-1#1)
dosage was##6##2##(1997-6#1)(2007-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
dosage##120##1##(1990-5#1)(1990-9#2)(1991-2#2)(1992-5#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#3)(1996-3#2)(1997-6#1)(2007-11#3)(2007-8#1)(2008-1#3)(2008-10#48)(2008-11#8)(2008-12#3)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#8)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
dosage-dependent##2##1##(1993-9#1)(2008-10#1)
dosages in##2##2##(1995-11#1)(2013-1#1)
dosages of##4##2##(1992-12#1)(2008-10#1)(2010-8#1)(2012-12#1)
dosages##16##1##(1992-12#1)(1993-12#1)(1994-12#4)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-8#2)(2012-12#1)(2013-1#1)
dose (ED(50))##3##2##(2008-10#3)
dose DAC##2##2##(2013-8#2)
dose and duration##2##3##(2008-11#1)(2011-2#1)
dose and##16##2##(1995-12#1)(1997-8#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
dose applied##2##2##(2008-10#2)
dose as##4##2##(1994-8#1)(1996-2#1)(2008-10#1)(2008-7#1)
dose at##2##2##(2008-10#2)
dose below##2##2##(2008-10#1)(2012-12#1)
dose but##2##2##(2008-11#1)(2008-7#1)
dose calculation##2##2##(2009-11#2)
dose concentration##2##2##(2008-7#2)
dose delivered##3##2##(1995-3#1)(1997-2#1)(2013-8#1)
dose dependency##2##2##(1994-3#1)(2008-5#1)
dose dependent##9##2##(1991-5#1)(1992-5#1)(1994-11#2)(1994-3#1)(1995-5#1)(2008-12#1)(2008-5#2)
dose dependently##3##2##(1994-2#1)(2012-2#1)(2012-3#1)
dose distribution##2##2##(2009-2#2)
dose distributions##5##2##(2009-2#5)
dose effect##3##2##(1993-6#1)(2008-6#1)(2008-7#1)
dose escalation##2##2##(2008-10#1)(2008-7#1)
dose for##8##2##(1990-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-11#2)(2009-2#1)(2009-6#1)
dose group##2##2##(2010-1#2)
dose groups##3##2##(2008-9#1)(2010-5#1)(2012-2#1)
dose has been##2##3##(2011-2#1)(2013-1#1)
dose in##7##2##(1993-6#1)(1994-12#1)(1997-2#1)(2008-7#2)(2010-6#1)(2011-2#1)
dose inhalers (MDI)##3##3##(1992-3#2)(1996-1#1)
dose inhalers##18##2##(1992-2#3)(1992-3#6)(1996-1#8)(1997-1#1)
dose intensity##7##2##(1991-6#1)(1992-2#1)(1993-11#1)(1994-12#1)(2008-5#1)(2008-7#2)
dose is##8##2##(1996-12#1)(2008-10#3)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
dose level##3##2##(1994-5#2)(2008-8#1)
dose levels##5##2##(1991-3#1)(1992-6#1)(1994-5#2)(2010-1#1)
dose may be##2##3##(1997-1#1)(2008-11#1)
dose may##3##2##(1993-9#1)(1997-1#1)(2008-11#1)
dose model##2##2##(1996-12#1)(1996-3#1)
dose of 0##7##3##(1990-9#1)(1995-11#1)(2008-12#1)(2008-7#1)(2011-1#2)(2013-1#1)
dose of 1##2##3##(1997-8#1)(2013-1#1)
dose of 10(9)##2##3##(1997-1#1)(2008-9#1)
dose of 100##2##3##(2012-2#2)
dose of 15##2##3##(2008-11#1)(2008-7#1)
dose of 2##7##3##(1992-12#1)(1996-2#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
dose of 20 mg##2##4##(1990-2#1)(1991-8#1)
dose of 20##3##3##(1990-2#1)(1991-8#1)(1994-8#1)
dose of 4##4##3##(1990-9#1)(2012-3#3)
dose of 40##3##3##(1991-2#1)(2008-8#1)(2009-11#1)
dose of 50 mg##2##4##(1990-11#1)(1994-8#1)
dose of 500 mg kg(-1) bw##2##6##(2008-10#2)
dose of 6 Gy##2##4##(2009-2#2)
dose of AdsiRNA-survivin##2##3##(2010-1#2)
dose of IFN##2##3##(2009-8#2)
dose of PMA##2##3##(1994-8#2)
dose of TBTO##2##3##(2008-10#2)
dose of a##2##3##(1992-3#1)(1994-9#1)
dose of anesthetic##2##3##(2012-3#2)
dose of aspirin##2##3##(1993-2#1)(2011-2#1)
dose of methotrexate##2##3##(1995-8#2)
dose of misoprostol##2##3##(1995-8#2)
dose of morphine##2##3##(2008-12#2)
dose of radiation##3##3##(2008-7#1)(2009-11#1)(2013-1#1)
dose of the##6##3##(1990-11#1)(1990-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2010-11#1)
dose of##173##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-6#2)(1990-9#3)(1991-11#1)(1991-2#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-6#1)(1994-8#9)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-8#4)(1996-12#4)(1996-2#3)(1997-1#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#6)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#14)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#3)(2009-2#2)(2009-8#2)(2010-1#4)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#8)(2012-3#12)(2013-1#7)(2013-8#1)
dose on##2##2##(2008-10#1)(2008-5#1)
dose optimization points##3##3##(2009-2#3)
dose optimization##4##2##(2009-2#4)
dose or##2##2##(2008-10#1)(2008-11#1)
dose oral##5##2##(2007-11#1)(2008-11#3)(2013-1#1)
dose per##3##2##(1993-9#1)(2012-2#1)(2013-1#1)
dose protected##2##2##(2008-7#2)
dose radiation (LDR)##2##3##(2008-7#1)(2013-1#1)
dose radiation##7##2##(2008-7#5)(2013-1#2)
dose range of##7##3##(1992-6#1)(1994-5#1)(1994-8#3)(2008-7#1)(2008-9#1)
dose range##9##2##(1992-6#1)(1993-6#1)(1994-5#1)(1994-8#3)(2008-5#1)(2008-7#1)(2008-9#1)
dose ranged##2##2##(1991-8#1)(2008-7#1)
dose rate##5##2##(1990-6#1)(2008-7#1)(2009-11#3)
dose rates of##2##3##(2008-12#1)(2008-7#1)
dose rates##4##2##(1996-12#1)(2008-12#1)(2008-7#1)(2009-7#1)
dose received##2##2##(2009-11#2)
dose reduction##4##2##(1990-9#1)(1991-8#1)(1997-8#1)(2009-11#1)
dose related##5##2##(1991-11#1)(1993-8#1)(1994-11#1)(2008-10#1)(2013-1#1)
dose response curves##3##3##(2008-11#1)(2008-7#2)
dose response##12##2##(1992-10#1)(1992-9#1)(1994-11#1)(2008-11#1)(2008-5#1)(2008-7#6)(2008-9#1)
dose selection##2##2##(2011-2#2)
dose studies which##2##3##(2008-7#2)
dose studies##4##2##(2008-7#4)
dose that##2##2##(1996-12#1)(2008-10#1)
dose to the##4##3##(1997-8#1)(2008-2#1)(2009-2#2)
dose to##11##2##(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-2#1)(2009-2#4)
dose was##11##2##(1990-12#1)(1991-2#2)(1993-11#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
dose with##2##2##(1993-9#1)(2008-10#1)
dose would##2##2##(2008-10#1)(2008-7#1)
dose##613##1##(1990-11#4)(1990-12#4)(1990-2#2)(1990-6#4)(1990-8#1)(1990-9#4)(1991-10#1)(1991-11#6)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#5)(1992-3#11)(1992-5#1)(1992-6#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-6#4)(1993-8#4)(1993-9#12)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#6)(1994-6#1)(1994-8#13)(1994-9#1)(1995-11#4)(1995-12#7)(1995-2#2)(1995-3#4)(1995-5#1)(1995-8#6)(1996-1#9)(1996-12#10)(1996-2#8)(1996-3#1)(1996-8#1)(1997-1#9)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#1)(1997-8#8)(2006-6#2)(2007-11#6)(2007-12#1)(2008-1#4)(2008-10#78)(2008-11#24)(2008-12#17)(2008-2#2)(2008-3#2)(2008-5#13)(2008-6#6)(2008-7#75)(2008-8#5)(2008-9#5)(2009-1#1)(2009-11#14)(2009-2#18)(2009-6#5)(2009-7#1)(2009-8#3)(2010-1#7)(2010-11#4)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#20)(2011-3#1)(2012-12#10)(2012-2#19)(2012-3#16)(2013-1#22)(2013-8#6)
dose)##3##1##(1992-11#1)(2008-10#1)(2008-6#1)
dose- and time-dependent##6##3##(1996-2#1)(2008-11#2)(2011-2#3)
dose- and##8##2##(1996-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#3)
dose-##9##1##(1996-2#1)(2008-11#2)(2008-12#1)(2008-5#2)(2011-2#3)
dose-dependant##2##1##(2008-10#1)(2011-1#1)
dose-dependent and##2##2##(2008-5#1)(2008-9#1)
dose-dependent fashion in##2##3##(1992-12#1)(1992-8#1)
dose-dependent fashion##7##2##(1992-12#3)(1992-8#1)(1994-6#1)(1995-2#1)(2008-11#1)
dose-dependent in##2##2##(1996-12#1)(2008-11#1)
dose-dependent increase in##11##3##(1993-3#1)(1994-11#2)(1996-12#1)(2006-6#1)(2008-10#3)(2008-5#2)(2012-2#1)
dose-dependent inhibition of##2##3##(1993-8#1)(2008-10#1)
dose-dependent manner and##2##3##(1994-8#1)(2008-11#1)
dose-dependent manner in##4##3##(1991-10#2)(1995-8#1)(2008-11#1)
dose-dependent manner##48##2##(1991-10#2)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-8#5)(1996-2#1)(1997-1#2)(1997-3#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-5#2)(2009-12#1)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
dose-dependent##108##1##(1990-5#1)(1990-6#1)(1991-10#2)(1991-5#1)(1992-12#5)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#5)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#3)(1995-12#5)(1995-2#2)(1995-6#1)(1995-8#5)(1996-12#2)(1996-2#3)(1997-1#4)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#8)(2008-11#12)(2008-12#2)(2008-5#6)(2008-7#1)(2008-9#3)(2009-12#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
dose-dependently inhibited##4##2##(1993-6#1)(1994-3#1)(2008-11#2)
dose-dependently suppressed##2##2##(1991-9#1)(2011-2#1)
dose-dependently##15##1##(1991-1#1)(1991-9#1)(1993-6#2)(1994-3#2)(2008-11#5)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
dose-limiting toxicity##3##2##(1994-8#1)(2008-5#1)(2008-7#1)
dose-limiting##5##1##(1994-8#1)(2008-5#2)(2008-7#2)
dose-rate##3##1##(1994-8#2)(2013-1#1)
dose-rates##2##1##(2013-1#2)
dose-related decreases in##2##3##(1994-2#2)
dose-related effects##2##2##(1991-1#1)(2011-2#1)
dose-related increase##2##2##(2008-10#1)(2008-9#1)
dose-related##21##1##(1991-1#1)(1992-6#1)(1994-2#3)(1994-8#1)(1995-11#1)(1996-1#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#2)(2008-9#2)(2011-2#1)(2013-1#1)
dose-response curve for##2##3##(1995-8#1)(1996-2#1)
dose-response curve##9##2##(1994-11#2)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#3)
dose-response curves##4##2##(1994-11#1)(1997-7#1)(2008-7#2)
dose-response model##2##2##(2008-10#1)(2008-7#1)
dose-response relationship and##2##3##(2008-7#1)(2011-2#1)
dose-response relationship##10##2##(1990-8#1)(1992-9#1)(1993-9#1)(1994-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
dose-response relationships for##2##3##(1995-8#1)(2008-7#1)
dose-response relationships in##2##3##(2008-10#1)(2008-7#1)
dose-response relationships##10##2##(1991-12#1)(1995-8#1)(2008-10#4)(2008-7#3)(2013-8#1)
dose-response study##4##2##(1994-8#2)(2008-5#1)(2012-2#1)
dose-response##51##1##(1990-8#1)(1991-12#1)(1992-9#1)(1993-9#1)(1994-11#3)(1994-8#4)(1995-8#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#11)(2008-11#4)(2008-5#2)(2008-7#9)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
dosed groups##4##2##(2008-9#4)
dosed with F3TdR##2##3##(1994-8#2)
dosed##17##1##(1994-8#2)(1995-11#1)(2008-10#2)(2008-9#8)(2011-3#1)(2013-1#3)
doses and concentrations##2##3##(2008-10#2)
doses and the##2##3##(1994-9#1)(2009-11#1)
doses and##12##2##(1992-2#1)(1994-9#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-7#3)(2009-11#1)(2012-2#1)(2013-1#1)
doses are##6##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-9#1)(1994-9#1)(2012-2#1)
doses as##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
doses at the gonads##2##4##(2009-11#2)
doses at##4##2##(2008-10#1)(2009-11#2)(2013-7#1)
doses by##4##2##(1995-12#2)(2008-8#2)
doses for##7##2##(1993-9#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
doses from##2##2##(1995-12#2)
doses have##2##2##(2008-12#1)(2009-11#1)
doses in##6##2##(1990-11#1)(1992-2#1)(1997-2#1)(2008-12#1)(2008-7#1)(2009-11#1)
doses may##2##2##(2008-10#1)(2013-1#1)
doses of 0##4##3##(1995-11#2)(2010-11#1)(2013-8#1)
doses of 250##2##3##(2008-10#1)(2008-7#1)
doses of 5##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
doses of DNA damaging agents##3##5##(2008-7#3)
doses of EP-IPV##2##3##(1995-5#2)
doses of antigen##5##3##(1995-5#1)(2008-11#4)
doses of drug##2##3##(1996-2#2)
doses of inhaled corticosteroids##2##4##(2007-11#2)
doses of medication##2##3##(1992-3#1)(1997-4#1)
doses of oral##2##3##(1994-9#1)(1995-3#1)
doses of radiation can##2##4##(2008-7#2)
doses of radiation##8##3##(1993-9#2)(2008-7#6)
doses of the##3##3##(1993-1#1)(2008-7#1)(2011-2#1)
doses of these##2##3##(2008-11#1)(2009-7#1)
doses of##145##2##(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-6#1)(1993-9#3)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-11#3)(2007-8#1)(2008-10#19)(2008-11#11)(2008-12#1)(2008-5#3)(2008-7#25)(2008-8#1)(2008-9#4)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
doses tested##3##2##(1993-6#1)(1994-11#1)(2010-1#1)
doses that##5##2##(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
doses to the##2##3##(2008-7#1)(2009-2#1)
doses to##6##2##(1997-8#2)(2008-10#1)(2008-7#2)(2009-2#1)
doses were##7##2##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2009-11#1)
doses when##2##2##(2008-12#1)(2009-11#1)
doses which##2##2##(1996-2#1)(2008-7#1)
doses with##3##2##(1994-8#1)(2008-10#1)(2009-11#1)
doses without##2##2##(1991-11#1)(2009-11#1)
doses##323##1##(1990-11#1)(1990-5#3)(1990-6#2)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#7)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#4)(1993-6#2)(1993-9#10)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#4)(1995-11#2)(1995-12#8)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#5)(2007-8#1)(2008-10#40)(2008-11#22)(2008-12#7)(2008-5#8)(2008-6#1)(2008-7#43)(2008-8#7)(2008-9#8)(2009-11#10)(2009-12#1)(2009-2#2)(2009-7#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#6)(2011-3#2)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#4)
dosimeter##4##1##(1993-1#3)(2009-11#1)
dosimeters##4##1##(1993-1#2)(1993-11#1)(1993-9#1)
dosimetric##2##1##(1995-12#1)(2009-11#1)
dosimetry and##2##2##(2008-7#1)(2009-12#1)
dosimetry of##2##2##(1993-1#1)(2008-10#1)
dosimetry##13##1##(1992-3#1)(1993-1#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-7#4)(2009-12#2)(2009-2#1)(2013-8#1)
dosing and##3##2##(2008-10#1)(2008-11#1)(2011-10#1)
dosing characteristics##2##2##(1995-12#1)(1997-2#1)
dosing for##2##2##(2008-7#1)(2013-1#1)
dosing in##3##2##(1991-8#1)(2008-9#1)(2010-5#1)
dosing of##2##2##(2008-11#1)(2012-2#1)
dosing regimen##2##2##(1994-2#1)(2008-5#1)
dosing schedule##2##2##(1996-3#1)(2008-5#1)
dosing##43##1##(1991-8#2)(1992-3#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#6)(1997-2#1)(2008-1#4)(2008-10#2)(2008-11#5)(2008-5#3)(2008-7#4)(2008-9#1)(2010-11#1)(2010-5#1)(2011-10#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-1#4)
dot blot hybridization##4##3##(1994-1#2)(2008-10#2)
dot blot##13##2##(1993-12#1)(1994-1#2)(2008-10#9)(2008-9#1)
dot##30##1##(1990-5#2)(1992-11#1)(1993-12#1)(1994-1#2)(1995-2#2)(2008-10#14)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-12#1)
dot-blot##2##1##(1990-8#1)(2008-10#1)
dothidea conidia##3##2##(2008-10#3)
dothidea from##4##2##(2008-10#4)
dothidea hyphae##2##2##(2008-10#2)
dothidea isolates##2##2##(2008-10#2)
dothidea##25##1##(2008-10#25)
dots are##2##2##(2008-10#1)(2009-11#1)
dots in##2##2##(2008-10#1)(2008-8#1)
dots to##2##2##(2008-10#1)(2008-7#1)
dots with##2##2##(2008-10#1)(2009-11#1)
dots##43##1##(1995-3#3)(1996-8#1)(2008-10#24)(2008-3#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#7)(2010-12#1)
dotted##2##1##(2008-9#1)(2009-8#1)
double and##3##2##(1991-9#1)(1995-6#1)(2008-10#1)
double antibody##2##2##(1990-12#1)(2008-10#1)
double beam UV-vis spectrophotometer##2##4##(2008-10#2)
double blind randomized##2##3##(2008-1#1)(2008-10#1)
double blind trial##2##3##(1997-1#1)(2008-10#1)
double blind##8##2##(1997-1#1)(2008-1#1)(2008-10#2)(2009-8#1)(2010-7#1)(2011-2#2)
double bond in##2##3##(1992-3#1)(1996-5#1)
double bond##7##2##(1992-3#1)(1995-8#1)(1996-5#2)(2008-10#2)(2009-8#1)
double bonds of##2##3##(1991-5#1)(1996-5#1)
double bonds##4##2##(1991-5#1)(1996-5#1)(2009-7#2)
double cell quartz crystal##2##4##(2008-10#2)
double centering##2##2##(2008-10#2)
double chamber bulk acoustic wave##2##5##(2008-10#2)
double divisor-ratio spectra derivative and ratio spectra-zero crossing methods##2##9##(2008-10#2)
double divisor-ratio spectra derivative##3##4##(2008-10#3)
double fertilization##3##2##(2009-12#2)(2009-8#1)
double helical##2##2##(2008-10#2)
double helix DNA##3##3##(2008-10#3)
double helix##9##2##(1995-8#2)(2008-10#6)(2008-11#1)
double knockout##6##2##(2008-8#5)(2009-10#1)
double layer##4##2##(2008-10#2)(2008-5#2)
double lumen##2##2##(1997-6#1)(2010-7#1)
double membrane phase separator##2##4##(2008-10#2)
double membrane##3##2##(2008-10#2)(2008-9#1)
double mutant##7##2##(1993-9#1)(1995-6#4)(1997-1#1)(2008-7#1)
double mutants##4##2##(1994-11#1)(2008-9#1)(2009-10#1)(2009-8#1)
double negative##4##2##(2008-10#1)(2008-12#1)(2008-5#2)
double or triple##2##3##(2008-10#1)(2012-3#1)
double positive##2##2##(1997-7#1)(2008-10#1)
double product##2##2##(2008-7#2)
double resistance to##2##3##(1993-8#1)(2008-10#1)
double resistance##3##2##(1993-8#1)(2008-10#2)
double strand##4##2##(1996-2#2)(2008-9#1)(2012-3#1)
double stranded (ds)##2##3##(2008-10#2)
double stranded DNA (dsDNA)##2##4##(2008-10#2)
double stranded DNA##4##3##(1990-12#1)(2008-10#2)(2013-8#1)
double stranded##13##2##(1990-12#1)(1990-5#1)(1994-8#1)(2008-10#8)(2008-11#1)(2013-8#1)
double that##2##2##(2008-10#2)
double the##2##2##(1991-3#1)(2008-11#1)
double vision##4##2##(1996-9#1)(2011-2#3)
double##209##1##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#4)(1992-12#2)(1992-2#3)(1992-3#1)(1993-12#1)(1993-5#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-6#6)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#65)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#8)(2009-10#4)(2009-12#2)(2009-7#3)(2009-8#5)(2010-11#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#4)
double- and##2##2##(1991-5#1)(1992-6#1)
double-antibody sandwich enzyme-linked immunosorbent assay##4##5##(2008-10#4)
double-antibody sandwich##6##2##(2008-10#5)(2010-12#1)
double-antibody##7##1##(2008-10#6)(2010-12#1)
double-balloon endoscopy##2##2##(2010-12#2)
double-balloon##3##1##(2010-12#2)(2013-1#1)
double-blind randomized##5##2##(1991-3#1)(1994-6#1)(2008-5#2)(2012-12#1)
double-blind studies##2##2##(1992-5#1)(2008-12#1)
double-blind study on##2##3##(1996-1#1)(2008-5#1)
double-blind study##7##2##(1991-2#1)(1996-1#2)(2008-5#3)(2008-7#1)
double-blind trial to evaluate##2##4##(2008-5#1)(2008-7#1)
double-blind trial##4##2##(2008-5#2)(2008-7#1)(2011-2#1)
double-blind##34##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-5#1)(1994-12#1)(1994-6#1)(1996-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#11)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
double-charged ions##2##2##(2008-10#2)
double-charged##3##1##(2008-10#3)
double-chirped mirrors##2##2##(2007-11#2)
double-clad thulium-doped fiber laser##2##4##(2008-3#2)
double-contrast##2##1##(1997-8#2)
double-difference pair##2##2##(2008-3#2)
double-edged##2##1##(2009-8#1)(2011-2#1)
double-focusing sector field ICP-MS##4##4##(2008-10#4)
double-focusing##7##1##(2008-10#7)
double-labeling##3##1##(1997-2#1)(2008-7#1)(2008-9#1)
double-layer##3##1##(2008-7#1)(2009-10#2)
double-random##2##1##(2008-3#2)
double-site mutation of the##2##4##(2008-8#2)
double-strand breaks##7##2##(1995-8#1)(1997-7#1)(2008-9#3)(2011-2#1)(2013-1#1)
double-strand##13##1##(1995-8#1)(1997-7#3)(2008-7#1)(2008-9#4)(2011-2#1)(2012-3#1)(2013-1#2)
double-stranded (ds)##2##2##(2008-10#2)
double-stranded DNA (dsDNA)##2##3##(1995-2#1)(2008-10#1)
double-stranded DNA breaks##2##3##(2008-11#1)(2008-7#1)
double-stranded DNA in the##2##4##(2008-10#2)
double-stranded DNA in##4##3##(2008-10#4)
double-stranded DNA##18##2##(1992-3#1)(1995-2#1)(2008-10#11)(2008-11#1)(2008-7#1)(2008-9#2)(2012-2#1)
double-stranded DNAs##2##2##(2008-10#2)
double-stranded RNA (dsRNA)##10##3##(2008-10#8)(2008-9#1)(2013-1#1)
double-stranded RNA##21##2##(1993-12#1)(2008-10#12)(2008-8#1)(2008-9#4)(2010-4#1)(2011-2#1)(2013-1#1)
double-stranded structure##2##2##(2008-10#1)(2011-2#1)
double-stranded##59##1##(1990-5#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#33)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#7)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
double-walled wall-pore sensilla##2##3##(2008-7#2)
double-walled##3##1##(2008-7#3)
doubled haploid (DH) population##3##4##(2008-10#2)(2008-9#1)
doubled haploid line##2##3##(2008-10#2)
doubled haploid population##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
doubled haploid##10##2##(2008-10#7)(2008-8#1)(2008-9#1)(2012-3#1)
doubled in##4##2##(1991-9#1)(2008-10#1)(2008-12#1)(2008-2#1)
doubled##26##1##(1990-8#1)(1991-3#1)(1991-9#1)(1992-1#1)(2007-11#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)
doubled-haploid##2##1##(2008-10#2)
doubles##2##1##(2012-2#1)(2013-1#1)
doublesex##4##1##(2007-12#4)
doublet is not##2##3##(1995-12#2)
doublet##3##1##(1995-12#3)
doubling crystal##3##2##(2008-3#3)
doubling of##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
doubling time of##5##3##(2008-11#5)
doubling time##11##2##(1994-6#1)(1996-12#1)(2008-11#8)(2008-9#1)
doubling##35##1##(1990-5#1)(1991-6#1)(1993-5#1)(1994-6#1)(1996-12#3)(2007-11#1)(2008-10#1)(2008-11#13)(2008-2#3)(2008-3#5)(2008-9#1)(2011-1#2)(2011-2#2)
doubly covalently bound##2##3##(1991-3#2)
doubly distilled water##2##3##(2008-10#2)
doubly infected with##2##3##(2008-10#2)
doubly infected##3##2##(2008-10#3)
doubly resonant##3##2##(2007-12#2)(2008-3#1)
doubly##15##1##(1991-3#3)(1992-3#1)(2007-12#2)(2008-10#7)(2008-3#1)(2010-11#1)
doubt on the##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
doubt on##5##2##(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
doubt##18##1##(1992-1#1)(1992-2#1)(1995-5#1)(1997-4#1)(2008-11#4)(2008-8#1)(2008-9#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
doubtful##8##1##(1994-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2009-5#1)(2012-2#1)
doubts##3##1##(1991-6#1)(2008-8#1)(2013-8#1)
dough stage##5##2##(2008-10#5)
dough##10##1##(2008-10#7)(2010-7#2)(2011-1#1)
douglasii##3##1##(1993-2#3)
douleur##2##1##(2013-1#2)
doves or##2##2##(2008-5#2)
doves##10##1##(2008-5#10)
down and##4##2##(1997-3#1)(2008-5#1)(2009-5#1)(2013-1#1)
down at##2##2##(2008-10#1)(2008-11#1)
down by##5##2##(1990-8#1)(1997-8#1)(2012-2#3)
down from##2##2##(1994-9#1)(2008-10#1)
down in##6##2##(1991-11#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-1#1)
down into the##2##3##(1995-5#1)(2010-9#1)
down into##3##2##(1995-5#1)(2010-9#1)(2011-2#1)
down its##2##2##(2009-9#1)(2011-2#1)
down of##2##2##(2008-7#1)(2012-2#1)
down on the##3##3##(1997-2#1)(2008-10#2)
down on##4##2##(1995-12#1)(1997-2#1)(2008-10#2)
down regulated##6##2##(1995-2#1)(2008-8#1)(2008-9#1)(2009-9#1)(2013-1#2)
down regulation of the##2##4##(1994-8#1)(2013-1#1)
down regulation of##3##3##(1994-8#1)(2008-11#1)(2013-1#1)
down regulation##4##2##(1994-8#1)(1995-2#1)(2008-11#1)(2013-1#1)
down state##2##2##(2008-11#2)
down the root##2##3##(2008-10#2)
down the##26##2##(1995-3#1)(1996-11#1)(1996-6#1)(1997-2#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-2#3)
down their##2##2##(2008-11#1)(2008-8#1)
down to 0##8##3##(2008-10#7)(2008-11#1)
down to 1##3##3##(2008-10#2)(2008-11#1)
down to 2##2##3##(2008-10#1)(2008-11#1)
down to 5##2##3##(1990-12#1)(2008-10#1)
down to a##4##3##(2008-10#2)(2008-8#1)(2009-10#1)
down to ca##2##3##(2008-10#1)(2008-11#1)
down to the##10##3##(1990-11#1)(1994-3#1)(2008-10#3)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#1)
down to##52##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-4#1)(2008-10#28)(2008-11#4)(2008-3#1)(2008-8#3)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
down##162##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#2)(1992-9#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#46)(2008-11#17)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#7)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-7#3)(2010-9#2)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#5)(2013-1#6)(2013-8#3)
down-regulate##3##1##(1995-2#1)(2008-7#1)(2010-5#1)
down-regulated and##2##2##(2008-8#1)(2013-8#1)
down-regulated by##3##2##(2008-8#1)(2009-10#1)(2011-2#1)
down-regulated cells##2##2##(1991-5#2)
down-regulated in response to##2##4##(1995-12#1)(2010-4#1)
down-regulated in##4##2##(1995-11#1)(1995-12#1)(2008-1#1)(2010-4#1)
down-regulated##19##1##(1991-5#2)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#3)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
down-regulates##4##1##(1992-1#1)(1995-12#1)(2008-11#2)
down-regulating##5##1##(1993-9#1)(1995-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
down-regulation in##2##2##(1994-2#1)(1996-12#1)
down-regulation of AR##2##3##(1995-12#2)
down-regulation of the##4##3##(1993-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
down-regulation of##29##2##(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#2)(1995-6#1)(1995-8#4)(1996-2#1)(1997-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-4#1)(2011-2#4)(2012-2#1)(2012-6#1)(2012-7#1)(2013-1#3)
down-regulation##39##1##(1992-6#1)(1993-6#1)(1993-8#2)(1994-2#1)(1995-12#5)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-9#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-6#1)(2012-7#1)(2013-1#4)
downhill##2##1##(2008-3#1)(2013-1#1)
download##2##1##(2008-4#1)(2008-9#1)
downloadable##2##1##(2008-5#1)(2012-3#1)
downloaded from##2##2##(2008-12#1)(2013-1#1)
downloaded##5##1##(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
downregulate the##2##2##(2008-10#1)(2008-9#1)
downregulate##5##1##(1993-12#1)(1994-11#1)(2008-10#1)(2008-9#1)(2009-8#1)
downregulated in##6##2##(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#1)
downregulated##15##1##(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2011-2#3)(2013-1#3)
downregulates##2##1##(1995-9#1)(2009-8#1)
downregulating##5##1##(2008-8#1)(2009-8#1)(2012-12#2)(2013-1#1)
downregulation of##10##2##(1997-1#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
downregulation##16##1##(1992-12#1)(1997-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
downs##2##1##(1995-3#1)(2013-7#1)
downsized flow set up##2##4##(2008-10#2)
downsized##3##1##(2008-10#3)
downstaging##2##1##(1993-11#1)(2010-12#1)
downstream DNA##2##2##(1995-6#1)(1997-7#1)
downstream component of oriLyt##3##4##(1997-3#3)
downstream component of##4##3##(1997-3#4)
downstream component##8##2##(1997-3#8)
downstream effector of##3##3##(1997-2#1)(2008-11#1)(2010-5#1)
downstream effector##4##2##(1997-2#1)(2008-11#1)(2010-5#1)(2013-1#1)
downstream from the##5##3##(1993-12#2)(1993-9#1)(2008-10#1)(2008-11#1)
downstream from##9##2##(1990-8#1)(1993-12#2)(1993-2#2)(1993-9#1)(1997-8#1)(2008-10#1)(2008-11#1)
downstream genes##3##2##(2009-8#2)(2011-2#1)
downstream occlusion##2##2##(2011-2#2)
downstream of the alcohol dehydrogenase##2##5##(1994-6#1)(1997-8#1)
downstream of the promoter##3##4##(2008-11#1)(2008-8#2)
downstream of the##14##3##(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-8#3)(2013-1#1)
downstream of this##2##3##(1992-3#1)(2008-3#1)
downstream of##30##2##(1992-3#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#2)(1996-6#2)(1997-1#1)(1997-8#1)(1997-9#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-8#6)(2009-6#1)(2012-2#1)(2013-1#2)
downstream pressure##2##2##(1991-3#1)(1997-1#1)
downstream processing##2##2##(2008-11#1)(2008-4#1)
downstream region of##2##3##(1991-9#1)(2008-9#1)
downstream sequence +1-+125nt##2##3##(2008-9#2)
downstream sequence##3##2##(2008-9#3)
downstream signaling pathways##3##3##(2008-11#1)(2009-10#1)(2013-7#1)
downstream target##2##2##(2011-2#1)(2012-2#1)
downstream targets##2##2##(2011-2#1)(2012-2#1)
downstream to##3##2##(2008-10#2)(2012-2#1)
downstream##122##1##(1990-11#1)(1990-8#1)(1991-3#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-12#4)(1993-2#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-6#1)(1995-2#3)(1995-6#1)(1996-12#2)(1996-6#3)(1997-1#2)(1997-2#1)(1997-3#9)(1997-7#4)(1997-8#2)(1997-9#1)(2008-10#12)(2008-11#8)(2008-3#4)(2008-4#2)(2008-6#1)(2008-8#8)(2008-9#7)(2009-10#4)(2009-3#1)(2009-6#2)(2009-8#2)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#7)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)
downward trend in##2##3##(1996-11#1)(2008-11#1)
downward trend##3##2##(1996-11#1)(2008-11#1)(2012-12#1)
downward##19##1##(1990-5#1)(1996-11#1)(2008-10#7)(2008-11#2)(2008-3#3)(2009-12#1)(2009-5#2)(2012-12#2)
downwardly##2##1##(2008-11#2)
downwards##2##1##(2009-12#1)(2011-2#1)
downy mildew (Pseudoperonospora cubensis)##2##4##(2008-10#2)
downy mildew development##4##3##(2008-10#4)
downy mildew incidence##3##3##(2008-10#3)
downy mildew of##3##3##(2008-10#3)
downy mildew resistance locus Pp523##2##5##(2012-3#2)
downy mildew##39##2##(2008-10#37)(2012-3#2)
doxazosin##3##1##(1993-2#3)
doxepin##4##1##(2008-10#4)
doxorubicin and##4##2##(2008-11#3)(2013-1#1)
doxorubicin##31##1##(1990-2#2)(1991-6#2)(1997-7#1)(2008-10#4)(2008-11#11)(2008-12#1)(2008-8#1)(2011-2#7)(2013-1#1)(2013-8#1)
doxorubicin-induced mutagenicity##2##2##(2011-2#2)
doxorubicin-induced##3##1##(2011-2#3)
doxorubicin-loaded##3##1##(2008-10#3)
doxycycline hydrochloride and chlortetracycline hydrochloride##3##5##(2008-10#3)
doxycycline hydrochloride and##4##3##(2008-10#4)
doxycycline hydrochloride##6##2##(2008-10#6)
doxycycline were##2##2##(2008-10#2)
doxycycline##18##1##(2008-10#16)(2011-2#2)
dozen##8##1##(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
dozens of##3##2##(1996-3#1)(2008-10#1)(2009-8#1)
dph##3##1##(2010-5#1)(2010-8#2)
dpi when##2##2##(2008-10#2)
dpi##11##1##(2008-10#11)
dpi)##2##1##(2008-10#2)
dpo##2##1##(2008-7#2)
dppm##2##1##(2009-9#2)
draft genome sequence of##2##4##(2008-9#1)(2011-2#1)
draft##5##1##(1991-9#1)(2008-9#2)(2011-1#1)(2011-2#1)
drag##2##1##(1997-1#1)(2010-8#1)
dragline silk##2##2##(2008-7#2)
dragon##2##1##(2008-10#1)(2008-3#1)
dragonfly##2##1##(2008-8#2)
drain##11##1##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#2)(2010-3#1)(2011-2#1)(2013-1#1)
drainage after##2##2##(2008-10#1)(2012-12#1)
drainage and##7##2##(1991-2#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
drainage for##2##2##(2011-2#1)(2013-1#1)
drainage in the##2##3##(1992-3#1)(2008-7#1)
drainage is##2##2##(1996-9#1)(2008-10#1)
drainage of the bile##2##4##(1991-3#2)
drainage of the##9##3##(1991-3#2)(1991-9#1)(1996-9#2)(2008-12#1)(2011-2#2)(2012-12#1)
drainage of##13##2##(1991-3#2)(1991-9#1)(1996-9#2)(2008-12#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
drainage procedure##2##2##(2009-9#2)
drainage was##4##2##(1991-3#1)(1995-2#1)(2008-7#1)(2013-8#1)
drainage##65##1##(1990-11#1)(1990-2#1)(1990-8#2)(1991-2#2)(1991-3#5)(1991-8#1)(1991-9#1)(1992-3#1)(1995-2#1)(1996-9#5)(1997-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#4)(2009-12#1)(2009-6#2)(2009-9#3)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#10)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
drainages##5##1##(1991-3#5)
drained directly into the##2##4##(2011-2#1)(2013-2#1)
drained into the##2##3##(1990-5#1)(1996-9#1)
drained into##3##2##(1990-5#1)(1996-9#1)(2008-10#1)
drained the##2##2##(2011-2#1)(2012-3#1)
drained##13##1##(1990-11#1)(1990-5#1)(1996-9#2)(1997-8#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-2#1)
drainer clipping##2##2##(1996-9#2)
drainer##3##1##(1996-9#3)
draining into the##2##3##(2011-2#1)(2013-2#1)
draining vein##2##2##(2008-7#2)
draining veins of##2##3##(2008-7#1)(2012-3#1)
draining veins##5##2##(1997-3#1)(2008-7#3)(2012-3#1)
draining##13##1##(1990-3#1)(1997-3#1)(2008-10#2)(2008-7#5)(2011-2#2)(2012-3#1)(2013-2#1)
drains into the##2##3##(1996-9#1)(1997-1#1)
drains##5##1##(1991-3#1)(1996-9#1)(1997-1#2)(2007-12#1)
dramatic changes in##2##3##(2008-7#1)(2008-8#1)
dramatic changes##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)
dramatic decrease##9##2##(1990-3#1)(1991-2#1)(1992-1#1)(2007-12#1)(2008-10#3)(2008-8#1)(2012-3#1)
dramatic differences in##2##3##(1995-11#1)(2008-10#1)
dramatic differences##4##2##(1992-12#1)(1995-11#1)(1996-12#1)(2008-10#1)
dramatic effect##2##2##(1991-3#1)(2008-10#1)
dramatic enhancement in##2##3##(2008-10#2)
dramatic growth##2##2##(1996-3#1)(2009-8#1)
dramatic improvement in the quality of care##2##7##(1997-1#1)(2008-7#1)
dramatic improvement in##5##3##(1991-4#1)(1993-2#1)(1997-1#1)(2008-10#1)(2008-7#1)
dramatic improvement##7##2##(1991-4#1)(1993-2#1)(1997-1#1)(2008-10#1)(2008-12#2)(2008-7#1)
dramatic improvements in##2##3##(1993-12#1)(2012-3#1)
dramatic increase in##9##3##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2011-2#1)
dramatic increase of##4##3##(1990-12#1)(1996-11#1)(2008-10#1)(2011-3#1)
dramatic increase##14##2##(1990-12#1)(1994-12#1)(1996-11#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2011-2#2)(2011-3#1)
dramatic symptoms##2##2##(1995-5#1)(2008-10#1)
dramatic##81##1##(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-10#19)(2008-11#5)(2008-12#4)(2008-7#3)(2008-8#6)(2008-9#2)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#5)
dramatically and##2##2##(1992-9#1)(2008-8#1)
dramatically change##2##2##(1997-3#1)(2011-2#1)
dramatically different##3##2##(2008-9#2)(2012-3#1)
dramatically improve the##2##3##(1992-12#1)(2008-9#1)
dramatically improved##3##2##(2010-12#1)(2010-7#1)(2011-2#1)
dramatically in the##2##3##(1996-3#1)(2009-7#1)
dramatically in##4##2##(1996-3#1)(2008-11#2)(2009-7#1)
dramatically increased in##2##3##(1993-3#1)(2008-6#1)
dramatically increased##6##2##(1993-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-6#1)
dramatically lower##2##2##(1995-3#1)(2008-11#1)
dramatically reduced##4##2##(1994-2#1)(2008-10#2)(2011-2#1)
dramatically with##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
dramatically##87##1##(1990-6#1)(1991-3#2)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#3)(1994-6#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#13)(2008-11#9)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-12#1)(2009-7#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
drank kava##5##2##(2008-1#5)
drank more##2##2##(1993-11#1)(2008-1#1)
drank##8##1##(1993-11#1)(2008-1#6)(2013-8#1)
drastic change in the##2##4##(2008-10#2)
drastic increase##2##2##(2008-10#1)(2011-1#1)
drastic reduction of##2##3##(2008-10#1)(2012-3#1)
drastic reduction##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
drastic##19##1##(1990-5#1)(1993-2#1)(1994-12#1)(1995-12#1)(1997-5#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
drastically change##2##2##(2008-11#1)(2013-1#1)
drastically improve the##2##3##(1994-1#1)(2010-4#1)
drastically reduced##10##2##(1991-3#1)(1995-2#1)(2008-10#6)(2008-11#1)(2013-1#1)
drastically reducing##2##2##(2008-10#1)(2008-3#1)
drastically the##4##2##(1990-5#1)(2008-10#3)
drastically##34##1##(1990-5#1)(1991-3#1)(1993-8#1)(1994-1#1)(1994-3#1)(1995-2#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-1#2)
draught##2##1##(2008-11#1)(2011-2#1)
draw attention to##4##3##(1990-9#1)(2008-9#1)(2011-1#1)(2011-2#1)
draw conclusions##4##2##(1990-3#1)(1991-1#1)(2010-12#1)(2010-3#1)
draw on##5##2##(1996-3#1)(1997-8#1)(2008-11#1)(2008-12#1)(2010-8#1)
draw upon our##2##3##(1997-1#1)(2011-2#1)
draw upon##3##2##(1994-2#1)(1997-1#1)(2011-2#1)
draw##31##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-11#1)(1994-12#1)(1994-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2013-8#1)
drawback of##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
drawback##8##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2013-1#1)
drawbacks are##3##2##(2008-10#2)(2009-12#1)
drawbacks in##2##2##(1996-3#1)(2012-3#1)
drawbacks of the##5##3##(2008-10#3)(2011-2#1)(2013-1#1)
drawbacks of using##2##3##(1995-3#1)(2008-3#1)
drawbacks of##13##2##(1995-3#1)(2008-10#6)(2008-3#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
drawbacks##31##1##(1990-2#1)(1992-9#1)(1995-3#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
drawing and discharging##3##3##(2008-10#3)
drawing and transportation##2##3##(2013-1#2)
drawing and##5##2##(2008-10#3)(2013-1#2)
drawing attention to the##2##4##(1996-2#1)(2009-8#1)
drawing from##2##2##(2008-1#1)(2008-12#1)
drawing on##5##2##(2008-1#1)(2008-12#1)(2009-10#1)(2010-4#1)(2010-8#1)
drawing##25##1##(1991-12#2)(1992-12#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-5#1)(2009-10#1)(2009-8#2)(2010-4#1)(2010-8#2)(2012-12#1)(2013-1#3)
drawings##6##1##(1996-2#2)(2007-12#1)(2008-11#1)(2008-6#2)
drawn between##2##2##(1991-1#1)(2008-10#1)
drawn from a##5##3##(1995-11#1)(2009-5#1)(2011-2#2)(2012-2#1)
drawn from clinical##2##3##(2008-12#1)(2013-8#1)
drawn from the##12##3##(1991-12#1)(1993-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2012-3#1)
drawn from##38##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
drawn into the##4##3##(1994-3#1)(2008-10#3)
drawn up##3##2##(1996-6#1)(2008-11#2)
drawn##80##1##(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-3#2)(1993-1#2)(1993-12#1)(1994-3#4)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#5)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#2)(2009-12#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-7#3)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
draws attention to the##2##4##(1997-8#1)(2008-10#1)
draws attention to##3##3##(1993-1#1)(1997-8#1)(2008-10#1)
draws on the##2##3##(2008-12#1)(2012-12#1)
draws on##8##2##(1993-12#1)(1994-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
draws##20##1##(1993-1#1)(1993-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2009-12#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
dread##3##1##(2008-11#2)(2009-10#1)
dreaded complication##2##2##(1994-8#1)(2009-9#1)
dreaded##6##1##(1990-11#1)(1993-2#1)(1994-8#1)(2008-11#1)(2008-5#1)(2009-9#1)
dream##7##1##(1994-9#1)(2008-12#1)(2008-8#1)(2010-10#1)(2012-3#2)(2013-8#1)
dreaming and##2##2##(2013-8#2)
dreaming##6##1##(2013-8#6)
dreams in##2##2##(2008-12#2)
dreams##7##1##(2008-12#4)(2009-10#1)(2013-1#1)(2013-8#1)
dreamy states##4##2##(2008-7#4)
dreamy##5##1##(2008-7#5)
drebrin E and Arp3##2##4##(2012-2#2)
drebrin E and##3##3##(2012-2#3)
drebrin E is##3##3##(2012-2#3)
drebrin E may be acting as a##2##7##(2012-2#2)
drebrin E was found to##2##5##(2012-2#2)
drebrin E was##3##3##(2012-2#3)
drebrin E##16##2##(2012-2#16)
drench##4##1##(2008-10#4)
dressed##4##1##(1997-5#2)(2008-11#1)(2011-1#1)
dressing percentage##2##2##(2008-12#2)
dressing##13##1##(1997-5#1)(2008-10#1)(2008-12#3)(2008-9#1)(2011-2#5)(2013-1#1)(2013-7#1)
dressings and##2##2##(2008-10#1)(2008-11#1)
drew attention to##2##3##(1993-12#1)(2008-12#1)
drew##6##1##(1993-12#1)(1996-5#1)(2008-12#1)(2008-5#1)(2010-8#1)(2013-1#1)
dried and##4##2##(2008-10#3)(2008-5#1)
dried blood spots##4##3##(1991-2#2)(1992-12#1)(2010-11#1)
dried blood##5##2##(1991-2#2)(1992-12#1)(2010-11#1)(2013-1#1)
dried chloroform##2##2##(2008-10#2)
dried leaves##2##2##(2008-10#1)(2012-2#1)
dried products##2##2##(2008-10#2)
dried with##2##2##(2008-7#1)(2013-1#1)
dried##41##1##(1991-2#2)(1992-12#1)(1994-6#1)(2008-10#29)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
drier##7##1##(2008-10#3)(2008-5#1)(2012-7#1)(2012-9#2)
drift from##2##2##(2008-11#1)(2008-5#1)
drift in the##3##3##(2008-10#3)
drift in##7##2##(2008-10#5)(2013-8#2)
drift is##3##2##(2008-10#3)
drift of the##3##3##(2008-10#2)(2008-3#1)
drift of##8##2##(1990-12#1)(2008-10#4)(2008-3#2)(2010-4#1)
drift on##2##2##(2008-3#1)(2013-8#1)
drift tube##2##2##(2008-10#2)
drift was##2##2##(2008-10#1)(2008-8#1)
drift##54##1##(1990-12#1)(1995-5#1)(2008-10#37)(2008-11#2)(2008-3#3)(2008-5#1)(2008-8#2)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#4)
drifted##3##1##(2008-2#1)(2008-3#1)(2010-4#1)
drifting##3##1##(2008-10#3)
drill##8##1##(1992-11#1)(1993-12#2)(1995-3#1)(2007-12#1)(2008-7#2)(2011-2#1)
drilling of the##2##3##(2009-1#1)(2009-4#1)
drilling of##4##2##(2008-3#1)(2008-9#1)(2009-1#1)(2009-4#1)
drilling units in the North Sea##2##6##(2009-10#2)
drilling units##4##2##(2009-10#4)
drilling##16##1##(1996-9#1)(2008-10#1)(2008-3#2)(2008-9#2)(2009-1#1)(2009-10#4)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
drink and##2##2##(2008-10#1)(2009-7#1)
drink kava##2##2##(2008-1#2)
drink sizes##5##2##(2009-7#5)
drink##28##1##(2008-1#2)(2008-10#12)(2008-11#1)(2008-5#1)(2009-7#10)(2011-2#2)
drinkers and##3##2##(1993-11#1)(2008-1#1)(2008-10#1)
drinkers##9##1##(1993-11#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#2)(2013-8#1)
drinking alcohol##2##2##(1991-9#1)(2008-10#1)
drinking and##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2010-5#1)(2010-9#1)(2011-2#1)
drinking behaviors##2##2##(2010-7#2)
drinking behaviour##5##2##(1990-2#1)(2008-10#1)(2009-7#2)(2011-2#1)
drinking contexts##3##2##(2008-12#3)
drinking habits##3##2##(1990-2#1)(2008-11#1)(2009-7#1)
drinking in##2##2##(2008-1#1)(2008-12#1)
drinking is##2##2##(2008-1#1)(2010-7#1)
drinking levels##2##2##(2008-11#1)(2009-7#1)
drinking of##2##2##(1991-11#1)(2008-11#1)
drinking or##2##2##(2010-7#1)(2010-9#1)
drinking patterns and drinking contexts##2##5##(2008-12#2)
drinking patterns##3##2##(2008-12#2)(2010-7#1)
drinking tap water##2##3##(2008-10#2)
drinking water and##12##3##(1990-6#1)(2008-10#9)(2008-9#2)
drinking water as##3##3##(2008-10#2)(2008-9#1)
drinking water by##7##3##(2008-10#7)
drinking water containing 0##8##4##(2008-10#2)(2008-9#6)
drinking water containing##9##3##(2008-10#3)(2008-9#6)
drinking water for 4##2##4##(2008-10#1)(2008-5#1)
drinking water for##11##3##(2008-10#3)(2008-5#1)(2008-9#6)(2013-1#1)
drinking water is##9##3##(2008-10#8)(2008-11#1)
drinking water samples##9##3##(2008-10#9)
drinking water studies##4##3##(2008-9#4)
drinking water supplies##2##3##(2008-10#1)(2008-9#1)
drinking water treatment##2##3##(1992-5#1)(2008-10#1)
drinking water##124##2##(1990-2#1)(1990-3#1)(1990-6#1)(1992-2#1)(1992-5#2)(1993-8#1)(1994-3#1)(2007-12#2)(2008-10#78)(2008-11#2)(2008-5#1)(2008-9#30)(2009-7#1)(2013-1#1)(2013-7#1)
drinking##206##1##(1990-2#3)(1990-3#1)(1990-6#1)(1991-11#1)(1991-6#1)(1991-9#2)(1992-2#2)(1992-5#2)(1993-6#2)(1993-8#1)(1994-2#2)(1994-3#1)(1995-11#3)(1995-9#1)(1996-2#1)(1997-6#1)(2007-12#2)(2008-1#2)(2008-10#96)(2008-11#8)(2008-12#11)(2008-5#1)(2008-9#30)(2009-5#3)(2009-7#7)(2010-5#1)(2010-7#12)(2010-9#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
drinking-water##3##1##(2008-10#3)
drinks and##5##2##(2008-10#4)(2009-7#1)
drinks is##2##2##(2008-10#2)
drinks##39##1##(1997-5#3)(2008-10#28)(2009-7#6)(2010-8#2)
drip irrigation and associated##2##4##(2008-10#2)
drip irrigation and##3##3##(2008-10#3)
drip irrigation was##2##3##(2008-10#2)
drip irrigation##18##2##(2008-10#18)
drip##25##1##(2008-10#23)(2011-2#1)(2013-1#1)
drippy bud##2##2##(2008-10#2)
drippy nut##2##2##(2008-10#2)
drippy##4##1##(2008-10#4)
drive control system##2##3##(2013-8#2)
drive differentiation##2##2##(2008-11#1)(2008-9#1)
drive in##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
drive the evolution of##2##4##(2008-9#1)(2010-5#1)
drive the##14##2##(2008-10#2)(2008-11#3)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
drive##59##1##(1991-5#1)(1992-12#1)(1995-6#1)(1996-2#1)(1997-1#2)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#10)(2008-12#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
driven by a##7##3##(1994-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
driven by an##3##3##(2008-11#2)(2008-8#1)
driven by the fact that##2##5##(2008-10#1)(2011-1#1)
driven by the##19##3##(1991-9#1)(1993-9#2)(1994-11#1)(1994-5#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
driven by##63##2##(1991-9#1)(1992-1#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1996-3#1)(2008-10#7)(2008-11#10)(2008-12#2)(2008-5#1)(2008-8#6)(2008-9#8)(2009-10#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
driven to the quartz flow cell and measured with##2##9##(2008-10#2)
driven to the##3##3##(2008-10#3)
driven to##6##2##(1993-8#1)(2008-10#5)
driven##95##1##(1990-12#1)(1991-9#2)(1992-1#1)(1992-3#2)(1993-12#1)(1993-5#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1996-3#2)(1997-3#1)(2008-10#15)(2008-11#12)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#10)(2009-10#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
driver##8##1##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
drivers and##2##2##(2010-8#1)(2011-2#1)
drivers for##2##2##(2008-12#1)(2013-1#1)
drivers of hybridization##2##3##(2012-3#2)
drivers of##3##2##(2008-11#1)(2012-3#2)
drivers##12##1##(2008-11#2)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#3)
drives the evolution of##2##4##(2008-8#1)(2010-7#1)
drives the##9##2##(1991-5#1)(1995-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
drives##21##1##(1991-5#1)(1993-12#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#2)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
driving force for the##2##4##(2008-10#2)
driving force for##5##3##(2008-10#3)(2009-7#1)(2010-1#1)
driving force in the##2##4##(1994-5#1)(2008-9#1)
driving force##12##2##(1991-12#1)(1994-5#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-7#1)(2010-1#1)
driving the##8##2##(1991-3#1)(1993-12#1)(1995-1#1)(1996-1#1)(2008-11#2)(2008-8#1)(2010-10#1)
driving##42##1##(1991-1#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-8#3)(2012-3#4)
drop and the##2##3##(2008-10#1)(2008-3#1)
drop and##4##2##(2008-10#2)(2008-3#1)(2009-11#1)
drop detachment##2##2##(2008-10#2)
drop formation##2##2##(2008-10#2)
drop growth##3##2##(2008-10#3)
drop in the##3##3##(1994-11#1)(1996-2#1)(2008-11#1)
drop in##11##2##(1990-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1996-2#1)(2008-10#4)(2008-11#1)(2010-6#1)
drop incidence was##3##3##(2008-10#3)
drop incidence##7##2##(2008-10#7)
drop interface##2##2##(2008-10#2)
drop into##2##2##(1991-5#1)(2008-10#1)
drop is##2##2##(1991-5#1)(2009-11#1)
drop of a##2##3##(2008-10#1)(2008-3#1)
drop of the##5##3##(1991-3#1)(2008-10#3)(2009-10#1)
drop of##17##2##(1991-3#1)(1993-3#2)(2008-10#8)(2008-3#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
drop or##2##2##(2008-10#1)(2008-2#1)
drop pressure##2##2##(2008-10#2)
drop radius##2##2##(2008-10#2)
drop shape##2##2##(2008-10#2)
drop size##2##2##(2008-10#1)(2008-5#1)
drop to##2##2##(2008-9#1)(2011-2#1)
drop volume##4##2##(2008-10#4)
drop was##2##2##(2008-10#2)
drop##173##1##(1990-11#1)(1991-3#1)(1991-5#4)(1993-2#1)(1993-3#3)(1994-11#1)(1994-2#2)(1996-2#1)(2008-10#126)(2008-11#5)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#3)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)
drop-based##4##1##(2008-10#4)
drop-out##4##1##(1990-2#1)(1993-1#1)(2008-7#1)(2013-1#1)
droperidol and fentanyl##2##3##(1996-6#2)
droperidol##4##1##(1996-6#2)(2008-10#2)
droplet and##5##2##(1995-3#1)(2008-10#2)(2008-12#2)
droplet deformation##2##2##(2008-3#2)
droplet generation and##2##3##(1995-3#2)
droplet manipulation##2##2##(2009-5#2)
droplet size distribution##2##3##(1996-3#1)(2008-7#1)
droplet size##10##2##(1994-12#1)(1995-3#1)(1996-3#2)(2008-3#1)(2008-5#3)(2008-7#2)
droplet sizes##3##2##(1994-12#1)(1995-3#1)(2008-5#1)
droplet##50##1##(1992-3#1)(1994-12#2)(1995-3#7)(1996-3#2)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#11)(2008-5#4)(2008-7#2)(2009-5#3)(2010-4#1)(2012-2#2)
droplets and droplets with inclusions##3##5##(2008-3#3)
droplets and vapor distributions in a##3##6##(2008-3#3)
droplets and##12##2##(1995-3#1)(2008-10#1)(2008-3#8)(2008-5#1)(2008-9#1)
droplets are##2##2##(2008-2#1)(2008-3#1)
droplets in the##2##3##(2008-10#1)(2008-3#1)
droplets in##3##2##(2008-10#1)(2008-3#2)
droplets is##2##2##(2008-3#1)(2008-5#1)
droplets of##2##2##(2008-10#2)
droplets were##3##2##(1994-12#1)(1995-3#1)(2008-10#1)
droplets with a##2##3##(1995-3#1)(2008-3#1)
droplets with inclusions##4##3##(2008-3#4)
droplets with##7##2##(1994-12#1)(1995-3#1)(2008-3#5)
droplets##67##1##(1994-12#2)(1995-2#1)(1995-3#9)(1996-3#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#24)(2008-5#5)(2008-7#1)(2008-9#2)(2009-5#1)(2011-3#1)
dropout##2##1##(2008-12#1)(2012-3#1)
dropped below the##2##3##(2008-10#1)(2012-2#1)
dropped below##3##2##(2008-10#2)(2012-2#1)
dropped from##2##2##(1994-9#1)(2008-2#1)
dropped fruit##4##2##(2008-10#4)
dropped on##2##2##(2008-10#1)(2008-12#1)
dropped out##3##2##(2010-11#1)(2013-1#2)
dropped to##8##2##(1990-11#1)(1990-6#1)(1993-6#1)(1994-8#1)(2008-10#2)(2008-8#1)(2012-3#1)
dropped##36##1##(1990-11#1)(1990-6#1)(1992-2#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
dropping mercury electrode##6##3##(2008-10#6)
dropping##11##1##(1991-12#1)(2008-10#10)
droppings##5##1##(1990-3#1)(1994-8#1)(1995-9#3)
drops in##2##2##(2008-10#2)
drops that##2##2##(2008-10#2)
drops were##2##2##(2008-10#2)
drops##28##1##(1990-11#1)(1993-9#1)(2008-10#19)(2008-7#1)(2010-10#1)(2011-2#2)(2011-3#2)(2012-3#1)
drought and air warming##3##4##(2012-6#3)
drought and air##4##3##(2012-6#3)(2012-9#1)
drought and elevated##2##3##(2012-6#1)(2012-7#1)
drought and##14##2##(2008-11#1)(2008-12#1)(2012-5#2)(2012-6#5)(2012-7#2)(2012-8#1)(2012-9#2)
drought and/or air warming##2##4##(2012-5#1)(2012-9#1)
drought resistant##3##2##(2008-12#2)(2012-6#1)
drought stress##6##2##(2008-12#5)(2012-6#1)
drought tolerance##3##2##(2008-8#1)(2012-5#1)(2012-9#1)
drought treatment##2##2##(2008-8#1)(2012-7#1)
drought##62##1##(2008-10#2)(2008-11#1)(2008-12#10)(2008-8#3)(2009-8#1)(2012-5#7)(2012-6#14)(2012-7#8)(2012-8#6)(2012-9#10)
drought- and##2##2##(2012-6#1)(2012-7#1)
drought-induced##2##1##(2012-7#2)
drought-mediated changes in##2##3##(2012-8#2)
drought-mediated##3##1##(2012-8#3)
drovers##2##1##(2011-2#2)
drowsiness and##2##2##(2008-10#1)(2008-12#1)
drowsiness##4##1##(2008-10#2)(2008-12#1)(2008-7#1)
drug abuse treatment programs##2##4##(2008-6#2)
drug abuse treatment##7##3##(1991-1#1)(2008-6#6)
drug abuse##25##2##(1990-2#1)(1991-1#2)(1992-2#1)(1992-3#2)(1993-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#7)(2009-6#1)(2009-7#3)(2011-1#1)
drug abuser##2##2##(1991-1#1)(2008-12#1)
drug abusers and##2##3##(2008-12#1)(2008-6#1)
drug abusers##7##2##(1991-1#4)(2008-12#1)(2008-6#2)
drug accumulation and##4##3##(2008-10#2)(2008-11#2)
drug accumulation##7##2##(2008-10#2)(2008-11#5)
drug activity##2##2##(1992-2#1)(2008-5#1)
drug addiction##6##2##(1996-11#1)(2008-5#1)(2009-7#3)(2012-3#1)
drug addicts in##2##3##(1993-2#1)(1996-11#1)
drug addicts##3##2##(1993-2#1)(1993-3#1)(1996-11#1)
drug administration##8##2##(1992-6#1)(1994-9#1)(1996-2#1)(2008-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
drug alone##2##2##(1993-8#1)(2011-10#1)
drug amantadine##2##2##(1992-3#2)
drug analysis and##2##3##(2008-10#1)(2010-7#1)
drug analysis##6##2##(2008-10#5)(2010-7#1)
drug and alcohol abuse##2##4##(1996-6#1)(2013-1#1)
drug and alcohol##5##3##(1993-3#1)(1996-6#1)(2008-12#1)(2009-8#1)(2013-1#1)
drug and its##4##3##(1995-11#1)(2008-10#3)
drug and the##4##3##(1994-5#1)(2008-10#2)(2011-3#1)
drug and##35##2##(1990-9#1)(1991-1#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-3#1)(1996-6#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
drug are##2##2##(2008-10#2)
drug as##2##2##(2008-10#1)(2008-11#1)
drug at the##2##3##(2008-10#1)(2008-11#1)
drug at##6##2##(1991-10#1)(1992-3#1)(2008-10#3)(2008-11#1)
drug benefit##6##2##(1995-1#4)(2008-11#1)(2008-4#1)
drug binding##3##2##(2008-10#1)(2008-9#1)(2009-9#1)
drug by##5##2##(1990-2#1)(2008-10#2)(2008-7#1)(2010-8#1)
drug calculation skills##2##3##(2008-11#2)
drug calculation##3##2##(2008-11#2)(2008-12#1)
drug calculations##3##2##(2008-11#2)(2008-12#1)
drug candidate##3##2##(2008-10#2)(2011-3#1)
drug candidates##3##2##(2009-12#1)(2011-3#2)
drug carriers##2##2##(1997-1#2)
drug concentration in##2##3##(1993-12#1)(1996-3#1)
drug concentration##7##2##(1990-2#1)(1993-12#1)(1994-8#1)(1996-3#3)(2008-10#1)
drug concentrations in##2##3##(2008-10#1)(2011-3#1)
drug concentrations##6##2##(1994-8#1)(2008-10#1)(2010-11#1)(2011-3#2)(2013-1#1)
drug coverage##4##2##(1992-1#1)(1995-1#1)(2009-3#2)
drug cross resistance##2##3##(2008-11#2)
drug delivered##2##2##(1992-3#1)(1996-3#1)
drug delivery and##2##3##(1996-2#1)(2013-1#1)
drug delivery devices##2##3##(2010-6#1)(2012-2#1)
drug delivery in##2##3##(1995-10#1)(1997-1#1)
drug delivery system##4##3##(1991-12#1)(1997-1#1)(2008-11#2)
drug delivery systems using##2##4##(1996-2#1)(2012-2#1)
drug delivery systems##6##3##(1992-3#1)(1996-2#1)(2008-7#2)(2009-12#1)(2012-2#1)
drug delivery##30##2##(1991-12#1)(1992-3#2)(1995-10#1)(1996-2#5)(1997-1#4)(2008-10#1)(2008-11#3)(2008-7#2)(2009-12#2)(2010-4#1)(2010-6#2)(2012-2#4)(2013-1#2)
drug design##5##2##(1992-9#1)(2008-5#1)(2011-3#3)
drug development for##2##3##(1991-3#1)(2011-1#1)
drug development##19##2##(1991-3#2)(1995-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-1#1)
drug did not##2##3##(2008-9#1)(2012-3#1)
drug discovery and##3##3##(2008-4#1)(2011-3#2)
drug discovery bioanalysis##3##3##(2008-10#3)
drug discovery##22##2##(1997-1#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#2)(2010-7#1)(2011-3#5)(2012-2#1)
drug disorder##3##2##(1993-12#3)
drug dissolution testing##2##3##(2008-10#2)
drug dosage##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
drug doses##2##2##(1994-6#1)(2008-11#1)
drug during the##2##3##(2008-11#1)(2012-12#1)
drug effects##3##2##(1993-1#1)(1995-2#1)(2009-12#1)
drug efficacy and##2##3##(2008-11#1)(2009-12#1)
drug efficacy##3##2##(1990-3#1)(2008-11#1)(2009-12#1)
drug efflux##2##2##(2008-11#2)
drug epidemics##3##2##(2013-8#3)
drug existed##2##2##(2008-10#1)(2010-1#1)
drug exposure##7##2##(1994-8#1)(1996-12#2)(2008-7#2)(2012-2#1)(2013-8#1)
drug for the##3##3##(1990-2#1)(2012-3#2)
drug for##15##2##(1990-2#1)(1990-9#1)(1995-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#2)
drug forms##2##2##(2008-10#1)(2011-3#1)
drug formulation using##2##3##(2008-10#2)
drug formulation##4##2##(2008-10#3)(2008-11#1)
drug formulations##8##2##(2008-10#8)
drug from##4##2##(1996-1#1)(2008-10#3)
drug has been##3##3##(1990-3#1)(1994-6#1)(2008-10#1)
drug has##4##2##(1990-3#1)(1994-6#1)(2008-10#2)
drug have been##2##3##(2008-5#1)(2010-11#1)
drug hypersensitivity##2##2##(2008-10#1)(2008-8#1)
drug in human##4##3##(2008-10#4)
drug in patients##2##3##(1990-12#1)(2008-10#1)
drug in pharmaceutical preparations##3##4##(2008-10#3)
drug in pharmaceutical##4##3##(2008-10#4)
drug in tablets##2##3##(2008-10#2)
drug in the##7##3##(1990-11#1)(1991-12#1)(1996-2#1)(2008-10#4)
drug in##34##2##(1990-11#1)(1990-12#1)(1991-12#1)(1996-2#1)(2008-10#25)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#1)
drug induced##4##2##(1991-8#1)(2008-11#2)(2008-8#1)
drug information##3##2##(2008-11#2)(2011-1#1)
drug injection##4##2##(1994-2#1)(2008-3#1)(2012-3#1)(2013-8#1)
drug insurance##3##2##(2010-5#3)
drug interactions##7##2##(1991-8#1)(1994-5#2)(1997-2#1)(2008-11#2)(2011-3#1)
drug is##8##2##(1992-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-2#1)
drug levels##4##2##(1992-3#1)(1994-2#1)(2008-7#1)(2010-6#1)
drug lords##2##2##(2013-8#2)
drug metabolic functions##3##3##(2008-11#3)
drug metabolising enzymes##2##3##(2008-11#2)
drug metabolism##5##2##(1993-12#1)(1994-5#1)(2011-2#3)
drug misuse##4##2##(1992-5#1)(2013-8#3)
drug monitoring of##2##3##(2008-6#1)(2010-11#1)
drug monitoring##8##2##(1991-3#1)(2008-6#1)(2010-11#5)(2010-7#1)
drug of choice for##2##4##(1991-10#1)(2010-2#1)
drug of choice##3##3##(1991-10#1)(2010-2#1)(2011-2#1)
drug of##6##2##(1991-10#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#2)
drug on##5##2##(1994-8#1)(1996-1#1)(1996-3#1)(2008-8#1)(2008-9#1)
drug onto##2##2##(2008-10#2)
drug or alcohol abuse##2##4##(2009-7#1)(2011-2#1)
drug or alcohol##3##3##(1992-12#1)(2009-7#1)(2011-2#1)
drug or gene##2##3##(2008-11#1)(2010-12#1)
drug or##8##2##(1992-12#1)(1992-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-2#1)
drug particles##2##2##(1992-2#1)(1996-2#1)
drug plan##3##2##(1995-6#2)(2008-8#1)
drug policies##3##2##(1991-1#1)(1995-1#2)
drug price##2##2##(1993-1#1)(1993-3#1)
drug problem##2##2##(1992-12#1)(2008-6#1)
drug properties##2##2##(1992-3#1)(2012-3#1)
drug racemates##3##2##(2008-10#3)
drug reactions##26##2##(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-8#1)(2011-2#13)(2013-8#5)
drug regimens##4##2##(1995-1#1)(2008-1#1)(2008-11#2)
drug release##6##2##(2012-2#6)
drug research##2##2##(1991-3#1)(2009-12#1)
drug resistance and##4##3##(1992-2#1)(2008-11#2)(2009-8#1)
drug resistance in##5##3##(1993-8#1)(2008-11#2)(2011-2#1)(2012-3#1)
drug resistance mutations##2##3##(2013-1#2)
drug resistance will##2##3##(1997-7#1)(2008-11#1)
drug resistance##45##2##(1990-2#1)(1991-2#1)(1992-2#2)(1993-8#1)(1996-11#2)(1997-7#4)(2008-10#1)(2008-11#20)(2009-8#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)
drug resistant cells##2##3##(2008-11#2)
drug resistant strain##2##3##(2011-2#2)
drug resistant##10##2##(2008-10#1)(2008-11#4)(2010-7#1)(2011-2#3)(2012-2#1)
drug response##3##2##(1990-2#1)(1992-2#1)(2008-8#1)
drug safety during##2##3##(2010-12#2)
drug safety##10##2##(2008-10#1)(2008-11#3)(2008-8#1)(2010-11#2)(2010-12#2)(2013-1#1)
drug samples##8##2##(2008-10#8)
drug screening##2##2##(1992-1#1)(2011-3#1)
drug seizures and##2##3##(2008-1#1)(2008-10#1)
drug seizures##4##2##(2008-1#1)(2008-10#3)
drug selection##2##2##(2011-10#1)(2013-1#1)
drug self-administration##2##2##(1993-6#1)(2012-3#1)
drug sensitive cells##2##3##(1990-2#2)
drug sensitivity##6##2##(1992-2#4)(1994-5#1)(1997-7#1)
drug showed##2##2##(1991-1#2)
drug solubilization##2##2##(2012-2#2)
drug solution##3##2##(2008-10#3)
drug solutions##2##2##(1995-3#1)(2008-10#1)
drug spending##4##2##(1994-2#1)(1995-1#2)(2008-11#1)
drug substance##8##2##(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2010-2#1)(2011-2#1)
drug substances##2##2##(2008-10#2)
drug susceptibility##2##2##(2011-2#1)(2013-1#1)
drug target for the treatment of##2##6##(2012-2#2)
drug target for##5##3##(2008-1#1)(2009-12#1)(2012-2#3)
drug target##7##2##(1995-6#1)(2008-1#1)(2008-11#1)(2009-12#1)(2012-2#3)
drug targeting##3##2##(1992-3#1)(2009-12#2)
drug targets##2##2##(2008-7#1)(2010-5#1)
drug that is##2##3##(1997-2#1)(2010-11#1)
drug therapies and##2##3##(2008-10#1)(2008-11#1)
drug therapies##6##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)
drug therapy in##2##3##(1997-1#1)(1997-8#1)
drug therapy is##2##3##(2010-12#1)(2011-2#1)
drug therapy to##2##3##(2010-11#1)(2010-12#1)
drug therapy##21##2##(1995-12#1)(1997-1#2)(1997-8#1)(2008-1#1)(2008-11#3)(2008-7#2)(2009-10#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-6#1)(2011-2#2)
drug to##8##2##(1996-1#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#1)
drug tolerance to intrathecal baclofen##3##5##(2011-2#3)
drug toxicity##5##2##(1991-1#1)(2008-10#1)(2008-7#3)
drug transport in##2##3##(1990-2#1)(2008-11#1)
drug transport##3##2##(1990-2#1)(2008-11#2)
drug transporter##2##2##(2008-11#2)
drug treatment##19##2##(1990-11#1)(1991-1#1)(1992-12#1)(1993-6#1)(1995-11#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-11#1)(2009-12#1)(2009-5#1)(2011-10#2)(2011-2#1)(2013-8#1)
drug treatments##3##2##(2008-5#1)(2009-10#1)(2012-2#1)
drug trials##4##2##(1991-3#1)(1994-2#2)(2008-6#1)
drug trimethoprim##2##2##(2008-10#2)
drug uptake##2##2##(1997-1#1)(2008-11#1)
drug use among##3##3##(1992-1#1)(1996-6#1)(2013-8#1)
drug use and##7##3##(1995-1#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-5#1)(2013-8#1)
drug use behaviors of##2##4##(1996-1#2)
drug use behaviors##4##3##(1996-1#4)
drug use in the##2##4##(2009-12#1)(2009-3#1)
drug use in##5##3##(1996-2#1)(2008-11#1)(2009-12#1)(2009-3#1)(2011-2#1)
drug use##52##2##(1992-1#1)(1992-12#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#4)(1996-11#1)(1996-2#2)(1996-6#2)(1997-6#1)(2008-1#5)(2008-11#4)(2008-6#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#8)(2013-8#7)
drug use)##2##2##(2010-1#1)(2010-9#1)
drug used##5##2##(1995-11#1)(1996-3#1)(2008-10#1)(2010-2#1)(2011-2#1)
drug user##3##2##(2008-1#1)(2009-6#2)
drug users and##2##3##(1992-9#1)(1997-6#1)
drug users##17##2##(1991-1#2)(1992-9#3)(1996-11#3)(1996-3#1)(1997-6#4)(2008-10#1)(2013-8#3)
drug using##2##2##(1996-2#1)(2008-10#1)
drug utilization is##2##3##(2008-11#2)
drug utilization studies##2##3##(1997-2#1)(2008-11#1)
drug utilization##6##2##(1992-1#1)(1997-2#1)(2008-11#4)
drug was evaluated in##2##4##(1991-3#1)(2008-5#1)
drug was##24##2##(1991-3#1)(1993-6#1)(1994-5#1)(1994-8#2)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#1)(2010-12#1)(2011-3#1)(2012-2#1)(2012-3#1)
drug were##9##2##(1990-9#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2013-8#1)
drug when##3##2##(2008-10#1)(2010-11#1)(2011-10#1)
drug which is##2##3##(1994-2#1)(2010-8#1)
drug with significantly different R(f) values##2##6##(2008-10#2)
drug with##13##2##(1995-2#1)(2008-10#6)(2008-11#1)(2008-8#2)(2010-6#1)(2010-8#1)(2012-12#1)
drug withdrawal##5##2##(1991-1#1)(2008-7#1)(2009-11#3)
drug within##2##2##(1992-2#1)(2008-10#1)
drug##1185##1##(1990-11#5)(1990-12#1)(1990-2#16)(1990-3#2)(1990-6#1)(1990-9#4)(1991-1#19)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#12)(1991-6#1)(1991-8#2)(1992-1#5)(1992-11#1)(1992-12#6)(1992-2#15)(1992-3#18)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#6)(1993-1#2)(1993-11#3)(1993-12#8)(1993-2#2)(1993-3#7)(1993-6#7)(1993-8#7)(1993-9#1)(1994-11#1)(1994-2#10)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#10)(1994-9#3)(1995-1#23)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#3)(1995-6#5)(1996-1#9)(1996-11#10)(1996-12#2)(1996-2#15)(1996-3#9)(1996-5#5)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#16)(1997-2#13)(1997-3#3)(1997-4#5)(1997-6#6)(1997-7#6)(1997-8#1)(2008-1#17)(2008-10#227)(2008-11#138)(2008-12#11)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#21)(2008-6#17)(2008-7#27)(2008-8#21)(2008-9#6)(2009-10#6)(2009-11#5)(2009-12#14)(2009-3#4)(2009-5#2)(2009-6#3)(2009-7#7)(2009-8#6)(2009-9#6)(2010-1#2)(2010-10#1)(2010-11#22)(2010-12#10)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#5)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#5)(2011-10#9)(2011-2#54)(2011-3#31)(2012-12#3)(2012-2#38)(2012-3#18)(2013-1#33)(2013-8#38)
drug's##4##1##(1994-8#1)(2011-2#1)(2013-8#2)
drug) and##2##2##(2008-10#2)
drug)##5##1##(1990-10#1)(2008-10#3)(2011-2#1)
drug- and##3##2##(2008-11#2)(2012-2#1)
drug-##4##1##(2008-11#2)(2012-2#2)
drug-dependent##2##1##(1991-9#1)(1996-12#1)
drug-drug interactions##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
drug-eluting stents in##3##3##(2008-11#2)(2008-12#1)
drug-eluting stents##12##2##(2008-11#7)(2008-12#3)(2011-2#1)(2013-8#1)
drug-eluting##15##1##(2008-11#10)(2008-12#3)(2011-2#1)(2013-8#1)
drug-free##3##1##(1996-3#1)(1997-2#2)
drug-induced liver##2##2##(1996-11#2)
drug-induced##25##1##(1990-11#1)(1991-1#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-11#2)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#2)
drug-like##2##1##(2009-4#1)(2012-2#1)
drug-naive##2##1##(1994-2#1)(1996-2#1)
drug-related##8##1##(2008-1#1)(2008-5#1)(2008-9#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
drug-resistant TB##4##2##(2008-10#2)(2010-5#2)
drug-resistant##16##1##(1992-2#2)(2008-10#3)(2010-5#3)(2011-2#1)(2011-3#3)(2012-2#3)(2013-1#1)
drug-taking behavior##2##2##(2012-3#2)
drug-taking##3##1##(2012-3#2)(2013-8#1)
drug-treated##2##1##(2008-10#1)(2008-11#1)
drug-treating##2##1##(2008-10#1)(2008-8#1)
drugs (NSAIDs)##5##2##(1993-2#1)(2008-11#1)(2008-12#1)(2010-1#1)(2012-2#1)
drugs against##4##2##(1993-8#1)(1995-11#1)(2009-12#1)(2010-5#1)
drugs and alcohol##3##3##(1992-12#1)(2008-11#1)(2009-12#1)
drugs and the##8##3##(1990-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
drugs and##61##2##(1990-3#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-6#1)(1994-2#1)(1994-9#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#4)(2011-3#3)(2013-1#3)(2013-8#2)
drugs approved##2##2##(2011-3#2)
drugs are now##2##3##(1993-2#1)(2011-2#1)
drugs are well##2##3##(1997-1#1)(2013-8#1)
drugs are##27##2##(1990-2#2)(1990-6#1)(1991-6#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#3)(2013-1#1)(2013-8#2)
drugs as well as##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
drugs as##9##2##(1992-11#1)(1995-1#1)(2008-10#3)(2008-11#2)(2009-12#1)(2010-12#1)
drugs at##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
drugs because##2##2##(2008-7#1)(2010-5#1)
drugs by capillary##2##3##(2008-10#2)
drugs by##9##2##(1991-1#1)(1992-3#1)(1996-3#1)(2008-10#4)(2008-11#1)(2012-2#1)
drugs can be##4##3##(1997-1#1)(2008-11#2)(2013-1#1)
drugs can##7##2##(1995-1#1)(1997-1#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
drugs come##2##2##(1995-1#1)(2012-12#1)
drugs commonly used##2##3##(1992-3#1)(1994-12#1)
drugs compared##2##2##(1997-7#1)(2013-1#1)
drugs could be##2##3##(1995-2#1)(2008-10#1)
drugs could##3##2##(1994-5#1)(1995-2#1)(2008-10#1)
drugs directed##2##2##(2009-12#1)(2011-2#1)
drugs do not##2##3##(1995-1#1)(2008-10#1)
drugs due to##3##3##(2008-9#1)(2011-2#1)(2011-3#1)
drugs during##4##2##(2008-11#2)(2012-12#1)(2012-2#1)
drugs either##3##2##(1996-11#1)(2008-10#1)(2008-7#1)
drugs employed##2##2##(1991-2#1)(2008-10#1)
drugs for the treatment of##3##5##(1997-1#1)(2008-10#1)(2009-12#1)
drugs for treating##3##3##(1994-12#1)(1997-6#1)(2011-2#1)
drugs for treatment##2##3##(2008-10#1)(2008-6#1)
drugs for##26##2##(1990-9#1)(1994-12#1)(1994-5#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-3#2)
drugs from spiked##2##3##(2008-10#2)
drugs from##4##2##(2008-10#4)
drugs had##2##2##(1990-8#1)(2008-11#1)
drugs has been##4##3##(1992-9#1)(1994-8#1)(2008-10#1)(2010-10#1)
drugs has##5##2##(1990-5#1)(1992-9#1)(1994-8#1)(2008-10#1)(2010-10#1)
drugs have been##4##3##(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)
drugs have##13##2##(1993-12#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
drugs in a##4##3##(1994-9#1)(1996-3#1)(2008-10#2)
drugs in patients with##2##4##(1991-3#1)(2008-3#1)
drugs in pharmaceutical##2##3##(2008-10#2)
drugs in the treatment of##2##5##(2007-11#1)(2011-2#1)
drugs in the##9##3##(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2011-2#2)(2012-2#1)
drugs in urine##3##3##(2008-10#3)
drugs in##52##2##(1991-12#1)(1991-3#1)(1991-8#1)(1993-2#1)(1994-9#1)(1996-3#1)(1996-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#22)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#1)
drugs into##3##2##(1997-1#1)(2008-1#1)(2011-2#1)
drugs is##5##2##(1991-8#1)(1995-3#1)(2008-10#2)(2010-5#1)
drugs like##2##2##(1990-11#1)(2008-11#1)
drugs may induce##3##3##(2008-10#2)(2009-12#1)
drugs may##9##2##(1990-11#1)(1993-2#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-12#1)
drugs namely##2##2##(2008-1#2)
drugs of abuse##10##3##(1991-1#2)(2008-10#5)(2009-7#1)(2013-8#2)
drugs of##16##2##(1991-1#3)(1994-2#1)(2008-10#8)(2009-7#1)(2013-1#1)(2013-8#2)
drugs on the##4##3##(1992-11#1)(2008-10#2)(2010-7#1)
drugs on##16##2##(1990-2#2)(1991-8#1)(1992-11#1)(1992-9#1)(2008-10#5)(2008-4#1)(2008-9#1)(2010-2#2)(2010-7#1)(2013-1#1)
drugs or##7##2##(1990-2#1)(1991-8#1)(1996-11#1)(1997-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
drugs prescribed##2##2##(1991-2#1)(2008-11#1)
drugs produced##2##2##(2008-10#1)(2008-7#1)
drugs should##4##2##(1990-11#1)(1992-5#1)(1996-6#1)(2012-3#1)
drugs showed##4##2##(1991-1#3)(2008-10#1)
drugs such as##10##3##(1990-11#1)(1992-3#1)(1994-8#2)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
drugs targeting TSPO##2##3##(2012-2#2)
drugs targeting##3##2##(2008-9#1)(2012-2#2)
drugs than among##2##3##(1995-1#2)
drugs than##4##2##(1995-1#2)(1996-6#1)(2013-1#1)
drugs that target##2##3##(2009-4#1)(2009-7#1)
drugs that##10##2##(1991-8#1)(1995-2#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-7#1)(2011-1#1)(2013-8#2)
drugs the##3##2##(1991-1#2)(2008-8#1)
drugs to the##2##3##(1995-12#1)(1997-1#1)
drugs to##8##2##(1995-12#1)(1997-1#1)(2008-10#2)(2008-9#1)(2009-12#2)(2009-9#1)
drugs use were##2##3##(2008-5#1)(2013-1#1)
drugs use##3##2##(1996-6#1)(2008-5#1)(2013-1#1)
drugs used in the##2##4##(1993-3#1)(1997-1#1)
drugs used in##3##3##(1993-3#1)(1997-1#1)(2008-5#1)
drugs used to treat##2##4##(2008-8#1)(2011-1#1)
drugs used to##3##3##(1996-3#1)(2008-8#1)(2011-1#1)
drugs used##10##2##(1993-3#2)(1996-1#1)(1996-3#1)(1997-1#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-3#1)
drugs using##2##2##(2008-10#2)
drugs was##7##2##(1991-8#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
drugs were used##2##3##(1994-12#1)(2008-1#1)
drugs were##10##2##(1994-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-9#1)(2011-3#1)
drugs which##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2009-12#2)
drugs with a##4##3##(1990-9#1)(1994-9#1)(2008-11#1)(2009-7#1)
drugs with different##2##3##(2008-11#2)
drugs with##22##2##(1990-9#1)(1994-9#1)(1997-5#1)(2008-10#4)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
drugs##753##1##(1990-11#6)(1990-2#13)(1990-3#2)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#7)(1991-1#13)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#11)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#2)(1992-9#4)(1993-1#4)(1993-11#7)(1993-12#1)(1993-2#4)(1993-3#3)(1993-6#1)(1993-8#4)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#7)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#10)(1995-11#2)(1995-12#3)(1995-2#8)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#5)(1996-3#5)(1996-6#8)(1996-9#1)(1997-1#16)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#6)(1997-8#2)(2006-6#1)(2007-11#3)(2007-7#1)(2008-1#9)(2008-10#159)(2008-11#77)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#26)(2008-8#13)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#15)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#9)(2010-2#4)(2010-4#2)(2010-5#7)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#6)(2011-1#3)(2011-10#1)(2011-2#45)(2011-3#18)(2012-12#5)(2012-2#14)(2012-3#11)(2013-1#29)(2013-8#13)
drugs)##2##1##(1997-2#1)(2008-11#1)
drugs]##7##1##(1990-2#1)(1991-8#1)(1992-2#1)(1995-11#1)(1997-3#1)(2008-10#1)(2011-3#1)
drum##2##1##(2008-11#1)(2008-9#1)
drunk##2##1##(1990-5#1)(1996-1#1)
dry acetonitrile##2##2##(2008-10#2)
dry air##3##2##(2008-10#1)(2012-3#2)
dry and wet##2##3##(2008-10#1)(2008-3#1)
dry and##8##2##(1997-5#1)(2008-10#3)(2008-3#1)(2008-5#3)
dry ashing method##2##3##(2008-10#2)
dry ashing procedure##2##3##(2008-10#2)
dry ashing##8##2##(2008-10#8)
dry bean##5##2##(2008-10#5)
dry biomass##2##2##(2008-12#1)(2008-7#1)
dry conditions##3##2##(2008-10#3)
dry cured ham volatile compounds##2##5##(2008-10#2)
dry heat##4##2##(2008-10#4)
dry heating##3##2##(2008-10#3)
dry mass##7##2##(2008-10#3)(2008-12#2)(2008-7#1)(2010-8#1)
dry matter accumulation##2##3##(2008-10#1)(2008-9#1)
dry matter production##3##3##(2008-9#3)
dry matter##14##2##(2008-10#7)(2008-11#2)(2008-9#4)(2009-6#1)
dry period##4##2##(2008-10#3)(2008-5#1)
dry periods##4##2##(2008-10#4)
dry powder budesonide 200##2##4##(2007-11#2)
dry powder inhaler (DPI)##2##4##(1997-2#2)
dry powder##8##2##(1992-3#1)(1997-1#1)(1997-2#2)(2007-11#4)
dry residues##2##2##(2008-10#1)(2008-11#1)
dry rot##3##2##(2008-10#3)
dry sediment##3##2##(2008-10#3)
dry skin conditions##2##3##(2008-5#2)
dry skin improvement potential##2##4##(2008-5#2)
dry skin improvement##3##3##(2008-5#3)
dry skin##19##2##(2008-5#19)
dry sodium chloride aerosol##2##4##(1996-3#2)
dry soil##4##2##(2008-10#2)(2008-11#2)
dry tissue##2##2##(1991-12#1)(2008-10#1)
dry weight##25##2##(1991-11#3)(1996-6#1)(2008-10#9)(2008-11#1)(2008-12#6)(2008-7#4)(2012-5#1)
dry weights##6##2##(2008-10#6)
dry wines##3##2##(2008-10#3)
dry##224##1##(1990-5#1)(1990-8#1)(1991-11#4)(1991-12#1)(1992-3#1)(1993-6#1)(1995-3#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-5#1)(2007-11#4)(2008-10#122)(2008-11#10)(2008-12#12)(2008-2#1)(2008-3#2)(2008-5#29)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-3#3)(2012-5#2)(2012-6#1)(2013-1#1)
drying and oxidation##2##3##(2008-10#2)
drying and##5##2##(2008-10#5)
drying experiments were conducted##2##4##(2011-2#2)
drying models##2##2##(2011-2#2)
drying of##6##2##(1990-12#1)(2008-10#5)
drying oils##5##2##(2008-10#5)
drying process##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
drying surface layers##2##3##(2012-2#2)
drying temperature##4##2##(2008-10#1)(2011-2#3)
drying##64##1##(1990-12#1)(1997-1#1)(2008-10#41)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2010-4#1)(2010-7#1)(2011-2#9)(2012-2#3)(2012-7#1)
dryness in##2##2##(2007-11#1)(2008-10#1)
dryness##20##1##(1994-3#1)(2007-11#2)(2008-10#13)(2008-5#4)
dsDNA could be##2##3##(1995-2#1)(2008-10#1)
dsDNA immobilized##2##2##(2008-10#2)
dsDNA in##2##2##(2008-10#1)(2008-8#1)
dsDNA##20##1##(1995-2#3)(2008-10#13)(2008-4#2)(2008-8#2)
dsRNA and##4##2##(2008-10#4)
dsRNA in##2##2##(2008-10#2)
dsRNA isolated from a plant infected with##2##7##(2008-10#2)
dsRNA isolated from##5##3##(2008-10#5)
dsRNA pattern##2##2##(2008-10#2)
dsRNA segments##2##2##(2008-10#2)
dsRNA targeting##2##2##(2008-9#2)
dsRNA virus##2##2##(2008-10#2)
dsRNA was##3##2##(2008-10#3)
dsRNA##54##1##(2008-10#46)(2008-9#6)(2013-1#2)
dsRNA-free##2##1##(2008-10#2)
dsRNAs from##4##2##(2008-10#4)
dsRNAs hybridized to##3##3##(2008-10#3)
dsRNAs of##2##2##(2008-10#2)
dsRNAs were##5##2##(2008-10#5)
dsRNAs##27##1##(2008-10#27)
du Tramadol seul##2##3##(2013-1#2)
du Tramadol##3##2##(2013-1#3)
du##30##1##(2008-11#3)(2008-5#1)(2010-1#1)(2011-2#8)(2013-1#16)(2013-8#1)
dual HBV/HCV##2##2##(2009-8#2)
dual action reagents##2##3##(2012-2#2)
dual action##4##2##(2008-10#1)(2012-2#3)
dual blood supply##3##3##(2010-12#1)(2011-2#2)
dual column system##3##3##(2008-10#3)
dual culture##2##2##(2008-10#2)
dual detector##2##2##(2008-10#2)
dual effect on##2##3##(1993-8#1)(1995-6#1)
dual effect##3##2##(1990-2#1)(1993-8#1)(1995-6#1)
dual electrochemical detector##2##3##(2008-10#2)
dual enzyme electrode##3##3##(2008-10#3)
dual integrin alpha(v)beta(3) and GRPR##2##5##(2010-6#2)
dual integrin##3##2##(2010-6#3)
dual length plane-wave-based QM/MM method to study both the associative and dissociative mechanisms of ATP hydrolysis##2##16##(2013-1#2)
dual length scale method for combined plane-wave and Eular exponential spline-based QM/MM simulations##2##13##(2013-1#2)
dual length##4##2##(2013-1#4)
dual luminophors##2##2##(2008-10#2)
dual mechanism bifunctional##2##3##(2008-10#2)
dual mechanism##3##2##(2008-10#2)(2012-2#1)
dual staining##3##2##(2008-11#3)
dual task##4##2##(2012-2#3)(2013-1#1)
dual therapy##2##2##(2013-8#2)
dual viral infection##2##3##(2009-8#2)
dual wavelength modulation##3##3##(2008-10#3)
dual##115##1##(1990-2#2)(1991-11#2)(1991-6#1)(1992-5#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-6#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-8#2)(2008-1#1)(2008-10#35)(2008-11#5)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#8)(2013-1#10)(2013-8#7)
dual-antibiotic-resistant colonies##2##2##(2008-10#2)
dual-band electrochemical cell##3##3##(2008-10#3)
dual-beam detector is##2##3##(2008-3#2)
dual-beam detector##3##2##(2008-3#3)
dual-beam##4##1##(2008-10#1)(2008-3#3)
dual-chamber##2##1##(2008-12#1)(2010-4#1)
dual-channel imaging##2##2##(2010-5#2)
dual-channel##4##1##(2008-3#1)(2010-5#3)
dual-color##2##1##(1997-6#1)(2008-9#1)
dual-emitting luminescent##2##2##(2008-10#2)
dual-energy X-ray absorptiometry (DXA)##2##4##(2008-10#1)(2008-7#1)
dual-energy X-ray absorptiometry##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
dual-energy##5##1##(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
dual-frequency beat signal##2##3##(2007-11#2)
dual-labeled##2##1##(2008-10#1)(2012-2#1)
dual-phase gas-permeation##2##2##(2008-10#2)
dual-process theory##2##2##(2008-6#1)(2013-1#1)
dual-process##4##1##(2008-6#2)(2013-1#2)
dual-pump coherent##2##2##(2008-2#2)
dual-vector##2##1##(2011-3#2)
dual-wavelength resonance light scattering##2##4##(2008-10#2)
dual-wavelength resonance##3##2##(2008-10#3)
dual-wavelength##9##1##(2007-12#1)(2008-10#5)(2008-3#2)(2009-12#1)
duality of##3##2##(2008-5#1)(2009-8#1)(2013-8#1)
dually infected chicks##3##3##(2008-5#3)
dually##5##1##(2008-10#1)(2008-5#3)(2012-2#1)
dubbed##3##1##(2008-10#1)(2008-9#1)(2012-3#1)
dubia##3##1##(2008-11#3)
dubious##2##1##(1990-6#1)(1992-2#1)
dubliniensis##9##1##(2008-5#9)
duck pineal gland##2##3##(1995-12#2)
duck pineal##3##2##(1995-12#3)
duck##7##1##(1995-12#3)(1996-8#1)(2008-5#2)(2011-2#1)
duckling##6##1##(1997-1#3)(2008-10#3)
ducklings##7##1##(2008-10#1)(2008-5#2)(2008-9#4)
ducks##5##1##(1992-2#1)(2008-5#3)(2008-9#1)
duckweed##3##1##(2008-10#3)
duct and##4##2##(2007-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
duct carcinoma arising from##2##4##(2008-10#2)
duct cysts##3##2##(2008-10#2)(2013-1#1)
duct in the##3##3##(1996-11#1)(2007-12#2)
duct in##4##2##(1996-11#1)(2007-12#2)(2008-12#1)
duct involvement##2##2##(2008-2#1)(2010-1#1)
duct ligation##2##2##(1995-11#1)(2013-8#1)
duct obstruction##2##2##(1997-8#1)(2010-11#1)
duct of##2##2##(1991-9#1)(2007-12#1)
duct syndrome##2##2##(1992-9#1)(2008-10#1)
duct##97##1##(1990-12#1)(1990-5#3)(1990-8#2)(1990-9#4)(1991-3#4)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#5)(1993-12#1)(1994-11#2)(1995-11#1)(1995-9#1)(1996-11#1)(1997-8#4)(2007-12#15)(2007-8#1)(2008-10#10)(2008-12#4)(2008-2#1)(2008-3#3)(2008-7#5)(2009-7#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#6)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
ductal carcinoma##2##2##(1990-12#1)(1994-12#1)
ductal structures##2##2##(1990-6#2)
ductal##14##1##(1990-12#1)(1990-6#2)(1994-12#2)(1995-11#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
ductility##3##1##(2009-11#1)(2009-7#2)
ducts and##4##2##(1997-8#1)(2008-11#1)(2008-8#1)(2013-8#1)
ducts were##2##2##(1990-6#1)(1994-9#1)
ducts with##2##2##(1994-9#1)(2013-1#1)
ducts##31##1##(1990-6#2)(1994-11#2)(1994-9#2)(1997-8#5)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-7#3)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
ductules##2##1##(2007-12#1)(2008-11#1)
ductus arteriosus##9##2##(1994-3#1)(1996-3#1)(1997-8#1)(2008-11#3)(2010-10#2)(2013-1#1)
ductus arteriosus]##2##2##(1994-9#1)(1997-8#1)
ductus##11##1##(1994-3#1)(1994-9#1)(1996-3#1)(1997-8#2)(2008-11#3)(2010-10#2)(2013-1#1)
due consideration in##2##3##(1991-12#1)(2012-12#1)
due consideration##3##2##(1991-12#1)(2008-9#1)(2012-12#1)
due diligence##4##2##(2008-11#4)
due either to##2##3##(1997-6#1)(2008-11#1)
due in part to the##6##5##(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
due in part to##9##4##(1995-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2010-1#1)
due in##12##2##(1993-11#1)(1995-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)
due mainly to##6##3##(1993-2#1)(1994-8#1)(1996-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
due only to##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
due primarily to##3##3##(1990-12#1)(2008-10#1)(2008-8#1)
due process##6##2##(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-9#1)(1997-7#1)
due solely to##2##3##(2007-12#1)(2008-7#1)
due to C##2##3##(2007-12#1)(2008-5#1)
due to CC##2##3##(2008-11#2)
due to DCM##2##3##(2011-2#2)
due to Fusobacterium necrophorum##2##4##(1990-3#2)
due to Musca domestica##2##4##(2013-1#2)
due to a combination of##5##5##(1991-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)
due to a decrease in##3##5##(1993-8#1)(1994-3#1)(2012-2#1)
due to a defective##2##4##(2008-10#1)(2008-7#1)
due to a direct##3##4##(1990-5#1)(1991-3#1)(1991-6#1)
due to a high##4##4##(2008-10#2)(2008-7#1)(2010-11#1)
due to a higher##2##4##(1993-8#1)(2008-10#1)
due to a lack of##6##5##(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
due to a number of##2##5##(2008-10#1)(2008-11#1)
due to a possible##2##4##(1990-8#1)(2010-3#1)
due to a reduction in##2##5##(1991-7#1)(2008-11#1)
due to a single##2##4##(2008-10#1)(2008-8#1)
due to a small##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
due to a##106##3##(1990-5#3)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-8#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-6#1)(2008-10#25)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-11#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#3)
due to activation of##2##4##(1992-12#1)(1994-11#1)
due to acute##2##3##(1996-8#1)(2011-2#1)
due to alterations in##2##4##(1997-2#1)(2008-7#1)
due to altered##3##3##(1990-5#1)(2012-7#1)(2013-8#1)
due to an increase in##3##5##(1997-1#1)(1997-7#1)(2008-10#1)
due to an increased##3##4##(1996-2#1)(1997-3#1)(2008-7#1)
due to an##29##3##(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#7)(2008-4#1)(2008-7#2)(2009-12#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
due to anatomical##2##3##(2009-9#1)(2011-2#1)
due to asbestos used in##2##5##(1991-12#2)
due to asymmetric##2##3##(2008-5#1)(2008-8#1)
due to attenuated##2##3##(2008-11#1)(2008-7#1)
due to better##4##3##(2008-10#1)(2008-11#1)(2012-7#1)(2013-1#1)
due to binding##2##3##(1990-12#1)(2012-2#1)
due to both##5##3##(1990-6#1)(1992-3#1)(1994-12#1)(1994-6#1)(2008-9#1)
due to brain##2##3##(1991-11#1)(2011-2#1)
due to cancer##2##3##(1990-9#1)(1992-2#1)
due to cardiac##2##3##(1992-3#1)(2011-2#1)
due to cell##3##3##(2008-11#2)(2008-7#1)
due to cervical##2##3##(2008-11#1)(2008-7#1)
due to changes in##4##4##(1993-6#1)(1994-11#1)(1997-2#1)(2008-10#1)
due to chemical##2##3##(2008-10#1)(2008-11#1)
due to complications##3##3##(2008-7#1)(2012-2#2)
due to compression of the##2##5##(1992-9#1)(2008-7#1)
due to compression##3##3##(1992-9#1)(2008-5#1)(2008-7#1)
due to contamination##2##3##(2008-10#1)(2012-2#1)
due to decreased##3##3##(1997-7#1)(2009-6#1)(2013-1#1)
due to deletions##2##3##(2008-10#1)(2012-3#1)
due to differences in##9##4##(1994-2#1)(1997-2#1)(2008-10#4)(2008-12#1)(2009-12#1)(2012-3#1)
due to differences##10##3##(1994-2#1)(1997-2#1)(2008-10#4)(2008-12#1)(2009-12#1)(2012-3#2)
due to different reasons##3##4##(2008-10#1)(2012-3#2)
due to different##7##3##(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#4)
due to direct##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
due to either##3##3##(1993-12#1)(1997-3#1)(2008-7#1)
due to emotional##2##3##(2011-2#1)(2012-12#1)
due to exposure to##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
due to foreign body##2##4##(1990-3#1)(2013-1#1)
due to gastric##2##3##(1993-5#1)(2007-11#1)
due to genetic##3##3##(2008-10#2)(2012-3#1)
due to growth##2##3##(2009-7#1)(2013-1#1)
due to hepatic##2##3##(2011-1#1)(2012-3#1)
due to high##6##3##(2008-10#2)(2008-11#1)(2009-3#1)(2009-9#1)(2010-12#1)
due to higher absorption##2##4##(2008-10#1)(2008-12#1)
due to higher##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-8#1)
due to host##2##3##(2008-10#2)
due to human##2##3##(2008-8#1)(2012-12#1)
due to iatrogenic##2##3##(1990-3#1)(1995-8#1)
due to impaired##2##3##(2008-10#1)(2008-3#1)
due to improved##3##3##(1991-12#1)(1994-5#1)(2013-1#1)
due to inadequate##6##3##(1993-11#1)(1993-9#1)(2008-10#3)(2012-3#1)
due to incomplete##4##3##(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#1)
due to inconsistent findings##3##4##(2009-10#1)(2012-12#2)
due to increased##10##3##(1990-11#1)(1990-5#1)(1992-9#1)(1994-3#1)(2008-10#3)(2009-5#1)(2012-2#1)(2012-3#1)
due to infection##3##3##(2008-10#2)(2008-9#1)
due to inherent##2##3##(2008-10#2)
due to insufficient##5##3##(1990-5#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
due to interactions##2##3##(2008-10#1)(2012-2#1)
due to internal##2##3##(1993-9#1)(1995-8#1)
due to involvement of##2##4##(2012-3#2)
due to its ability to##2##5##(1993-3#1)(2011-2#1)
due to its high##2##4##(1993-3#1)(2008-10#1)
due to its wide##2##4##(2008-10#1)(2009-1#1)
due to its##54##3##(1991-6#1)(1992-9#1)(1993-3#2)(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-5#4)(2008-8#1)(2009-1#1)(2009-10#1)(2010-12#2)(2011-10#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
due to lack of##10##4##(1993-12#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-8#2)(2012-12#1)(2013-1#2)
due to less##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
due to limitation of##2##4##(2008-10#2)
due to limited##2##3##(2008-10#1)(2013-8#1)
due to local##2##3##(2008-8#1)(2009-11#1)
due to longstanding AS##2##4##(2012-3#2)
due to loss of##2##4##(1991-12#1)(2009-8#1)
due to lower##2##3##(2011-1#1)(2012-2#1)
due to macular##2##3##(2011-2#1)(2013-1#1)
due to metoclopramide##2##3##(2012-12#2)
due to multiple##5##3##(2008-10#2)(2008-3#2)(2011-2#1)
due to mutations in##4##4##(2008-11#2)(2009-8#1)(2013-1#1)
due to natural##2##3##(2008-10#2)
due to obstruction##2##3##(2008-1#1)(2008-10#1)
due to oxygen##2##3##(1995-11#1)(2010-7#1)
due to pancreatic hypoplasia##2##4##(2011-1#2)
due to poor##5##3##(2008-10#1)(2008-11#1)(2009-4#1)(2009-7#1)(2012-3#1)
due to posttranscriptional##2##3##(1995-2#1)(1996-12#1)
due to reduced##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
due to respiratory failure##2##4##(2008-7#1)(2013-1#1)
due to respiratory##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
due to retinol per se##2##5##(2008-5#2)
due to right##2##3##(1996-2#1)(2012-2#1)
due to sample##6##3##(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
due to selection by##2##4##(2008-10#2)
due to several##2##3##(2008-7#1)(2012-3#1)
due to severe##2##3##(2008-10#1)(2013-8#1)
due to significant##2##3##(2008-10#2)
due to some##3##3##(1990-2#1)(1996-6#1)(2012-3#1)
due to spatial##2##3##(2008-8#2)
due to spectral interferences##2##4##(2008-10#2)
due to steric hindrance##2##4##(2008-10#2)
due to steric##3##3##(2008-10#3)
due to stimulation of##3##4##(1995-11#1)(2008-11#2)
due to strong##2##3##(2008-10#2)
due to systemic##2##3##(1990-8#1)(2008-10#1)
due to technical##2##3##(1991-12#1)(2012-2#1)
due to the ability of##2##5##(2008-10#1)(2008-11#1)
due to the absence of##5##5##(1991-6#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
due to the action of##2##5##(2008-10#1)(2011-2#1)
due to the changes##2##4##(2008-10#1)(2011-1#1)
due to the close similarity of their chemical properties##2##9##(2008-10#2)
due to the complex##2##4##(2010-1#1)(2010-12#1)
due to the complexation##2##4##(2008-10#2)
due to the complexity of the##2##6##(1997-3#1)(2011-2#1)
due to the complexity##3##4##(1997-3#1)(2011-2#2)
due to the cost##2##4##(2008-10#1)(2013-1#1)
due to the development of##2##5##(2009-7#1)(2011-3#1)
due to the different##2##4##(2008-10#2)
due to the emergence of##2##5##(2011-3#1)(2013-8#1)
due to the fact that##6##5##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
due to the fact##7##4##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
due to the formation of a##2##6##(2008-10#1)(2008-11#1)
due to the formation of##11##5##(2008-10#9)(2008-11#2)
due to the formation##12##4##(2008-10#9)(2008-11#2)(2008-3#1)
due to the high frequency##2##5##(2008-10#1)(2012-3#1)
due to the high##12##4##(2008-10#7)(2009-9#1)(2010-5#1)(2012-3#2)(2013-8#1)
due to the highly##2##4##(2008-11#1)(2013-1#1)
due to the improved##3##4##(2008-10#1)(2008-11#2)
due to the inability##2##4##(2008-1#1)(2012-3#1)
due to the increase##2##4##(2008-10#2)
due to the increased number of##2##6##(1991-12#1)(1991-3#1)
due to the increased##5##4##(1991-12#1)(1991-3#1)(1997-6#1)(2012-3#1)(2013-8#1)
due to the increasing##2##4##(2008-10#1)(2008-5#1)
due to the inhibition of the##2##6##(1992-9#1)(1993-8#1)
due to the inhibition of##5##5##(1990-5#1)(1992-9#1)(1993-8#1)(1994-8#1)(2008-11#1)
due to the insertion of##2##5##(2008-11#1)(2008-9#1)
due to the interaction of##2##5##(2008-10#2)
due to the interference of##2##5##(2008-10#1)(2008-5#1)
due to the lack of##13##5##(1991-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)
due to the larger##2##4##(2008-9#1)(2012-5#1)
due to the limited number##2##5##(2012-12#1)(2012-2#1)
due to the long##2##4##(1991-3#1)(2008-9#1)
due to the low##5##4##(2008-10#4)(2008-8#1)
due to the matrix##2##4##(2008-10#2)
due to the poor##2##4##(2008-10#2)
due to the presence of a##3##6##(1997-6#1)(2012-12#1)(2012-2#1)
due to the presence of##21##5##(1992-3#1)(1994-8#1)(1997-6#1)(1997-7#1)(2008-10#12)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
due to the production of##2##5##(2008-10#1)(2008-4#1)
due to the rapid##2##4##(2008-10#2)
due to the rarity of##2##5##(2011-2#1)(2013-1#1)
due to the reduction of##2##5##(2008-10#2)
due to the reduction##3##4##(1992-9#1)(2008-10#2)
due to the same##2##4##(2008-10#1)(2012-3#1)
due to the severe##2##4##(2008-10#1)(2013-1#1)
due to the small size##2##5##(2008-10#1)(2008-12#1)
due to the small##6##4##(2008-10#4)(2008-12#1)(2011-2#1)
due to the strong##2##4##(1996-5#1)(2009-5#1)
due to the use of##5##5##(1990-2#1)(1997-8#1)(2008-10#2)(2008-11#1)
due to the##361##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-6#3)(1997-7#2)(1997-8#4)(2007-12#1)(2008-1#2)(2008-10#147)(2008-11#30)(2008-12#8)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#3)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#3)(2010-8#2)(2011-1#3)(2011-2#9)(2011-3#3)(2012-12#6)(2012-2#11)(2012-3#9)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#4)
due to their ability to##2##5##(2008-10#1)(2008-11#1)
due to their copper##2##4##(2008-10#1)(2012-2#1)
due to their high##2##4##(2008-10#2)
due to their##34##3##(1991-2#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#5)(2008-7#2)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-5#1)(2013-1#1)
due to this##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
due to thrombosis##2##3##(2008-7#1)(2011-3#1)
due to trauma##3##3##(2012-3#1)(2013-1#2)
due to two##2##3##(2008-4#1)(2010-4#1)
due to type##2##3##(1991-3#1)(2011-1#1)
due to unsafe abortions##2##4##(2008-11#2)
due to variation in##2##4##(2008-9#1)(2011-2#1)
due to virus##2##3##(1997-1#1)(2008-11#1)
due to##1414##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#9)(1990-5#10)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-10#1)(1991-11#4)(1991-12#12)(1991-2#5)(1991-3#9)(1991-5#2)(1991-6#6)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#2)(1992-12#4)(1992-2#4)(1992-3#8)(1992-6#7)(1992-8#4)(1992-9#7)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#8)(1993-8#4)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#7)(1994-3#6)(1994-5#8)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#9)(1995-12#6)(1995-2#5)(1995-5#1)(1995-6#2)(1995-8#8)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#7)(1996-3#9)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#9)(1997-2#7)(1997-3#11)(1997-5#6)(1997-6#6)(1997-7#8)(1997-8#5)(2006-6#1)(2007-11#4)(2007-12#6)(2007-8#1)(2008-1#6)(2008-10#391)(2008-11#86)(2008-12#27)(2008-2#7)(2008-3#26)(2008-4#11)(2008-5#36)(2008-6#5)(2008-7#49)(2008-8#25)(2008-9#17)(2009-1#2)(2009-10#8)(2009-11#4)(2009-12#7)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#10)(2009-8#6)(2009-9#4)(2010-1#7)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#14)(2011-10#1)(2011-2#67)(2011-3#6)(2012-12#23)(2012-2#42)(2012-3#53)(2012-5#3)(2012-6#2)(2012-7#2)(2012-8#1)(2013-1#73)(2013-7#4)(2013-8#24)
due##1472##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#9)(1990-5#10)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-10#1)(1991-11#4)(1991-12#13)(1991-2#6)(1991-3#9)(1991-5#2)(1991-6#6)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#2)(1992-12#4)(1992-2#4)(1992-3#8)(1992-6#7)(1992-8#4)(1992-9#7)(1993-1#3)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#6)(1993-5#1)(1993-6#8)(1993-8#4)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#7)(1994-3#7)(1994-5#8)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#9)(1995-12#6)(1995-2#6)(1995-5#1)(1995-6#2)(1995-8#8)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#7)(1996-3#9)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#9)(1997-3#12)(1997-5#6)(1997-6#7)(1997-7#10)(1997-8#5)(2006-6#1)(2007-11#4)(2007-12#8)(2007-8#1)(2008-1#6)(2008-10#402)(2008-11#92)(2008-12#27)(2008-2#9)(2008-3#26)(2008-4#12)(2008-5#36)(2008-6#6)(2008-7#51)(2008-8#26)(2008-9#20)(2009-1#3)(2009-10#9)(2009-11#4)(2009-12#7)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#10)(2009-8#6)(2009-9#4)(2010-1#8)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#14)(2011-10#1)(2011-2#67)(2011-3#6)(2012-12#26)(2012-2#42)(2012-3#54)(2012-5#3)(2012-6#2)(2012-7#2)(2012-8#1)(2013-1#73)(2013-7#4)(2013-8#24)
duels and##2##2##(2012-3#2)
duels##3##1##(2012-3#3)
dueto##2##1##(2008-11#2)
duloxetine##7##1##(2008-10#2)(2008-4#1)(2008-9#2)(2011-2#1)(2013-1#1)
dumbbell##2##1##(1997-8#2)
dumping##5##1##(1993-2#1)(1994-3#1)(1997-1#1)(2008-10#1)(2008-12#1)
dune##2##1##(2008-3#1)(2011-2#1)
duodenal and gastric ulcer and##2##5##(1992-11#2)
duodenal and gastric ulcer##3##4##(1992-11#2)(2008-12#1)
duodenal and gastric##4##3##(1992-11#3)(2008-12#1)
duodenal and jejunal##2##3##(2008-5#1)(2013-1#1)
duodenal and##6##2##(1992-11#3)(2008-12#1)(2008-5#1)(2013-1#1)
duodenal atresia##2##2##(1997-3#2)
duodenal perforation##2##2##(2008-12#2)
duodenal ulcer after laparoscopic cholecystectomy##2##5##(2008-12#2)
duodenal ulcer disease##2##3##(1997-1#1)(2009-8#1)
duodenal ulcer patients##2##3##(1997-1#2)
duodenal ulcer##9##2##(1992-11#1)(1997-1#3)(2008-12#4)(2009-8#1)
duodenal ulcers##3##2##(1995-2#1)(1997-1#1)(2008-12#1)
duodenal##32##1##(1991-6#1)(1992-11#4)(1992-5#2)(1992-6#1)(1992-9#1)(1993-6#1)(1995-2#1)(1997-1#5)(1997-3#2)(2008-10#1)(2008-12#8)(2008-5#1)(2009-12#1)(2009-8#1)(2013-1#2)
duodenoscope##2##1##(2013-1#2)
duodenum and##2##2##(1997-8#1)(2013-1#1)
duodenum##14##1##(1994-11#1)(1995-11#2)(1996-11#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-12#3)(2011-2#1)(2013-1#2)
duplex DNA fragments##2##3##(2008-9#2)
duplex DNA##5##2##(1991-3#1)(1994-12#1)(2008-11#1)(2008-9#2)
duplex Doppler ultrasound##3##3##(2008-12#3)
duplex Doppler##4##2##(2008-12#3)(2011-5#1)
duplex fluorescent quantitative one-step RT-PCR assay##3##6##(2013-8#3)
duplex fluorescent quantitative one-step RT-PCR##4##5##(2013-8#4)
duplex oligomers containing a##2##4##(2008-11#2)
duplex oligomers containing##4##3##(2008-11#4)
duplex oligonucleotides##2##2##(1991-3#1)(1993-8#1)
duplex##38##1##(1990-12#1)(1990-5#2)(1991-3#2)(1993-8#4)(1994-12#1)(1995-12#2)(1996-3#2)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-12#3)(2008-4#1)(2008-9#2)(2011-5#1)(2013-1#1)(2013-8#4)
duplexes##4##1##(2008-10#2)(2008-4#2)
duplicate anterior inferior cerebellar artery feeding an associated dural arteriovenous malformation##2##11##(2008-7#2)
duplicate##18##1##(2008-10#4)(2008-11#7)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2012-3#1)
duplicated region##2##2##(2008-11#1)(2009-10#1)
duplicated##15##1##(1993-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2009-10#5)(2010-5#1)(2012-3#1)
duplication and##5##2##(2007-12#1)(2008-10#1)(2009-6#1)(2010-4#1)(2012-3#1)
duplication in the##2##3##(2008-10#1)(2009-10#1)
duplication in##3##2##(1996-3#1)(2008-10#1)(2009-10#1)
duplication is##2##2##(1997-3#1)(2009-10#1)
duplication of a##3##3##(1997-3#1)(2009-10#1)(2011-2#1)
duplication of the##3##3##(1996-6#1)(2008-10#1)(2008-7#1)
duplication of##17##2##(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#6)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-3#2)
duplication or##2##2##(1997-3#1)(2008-10#1)
duplication with##5##2##(2008-10#3)(2012-3#1)(2013-1#1)
duplication##54##1##(1993-3#1)(1994-3#1)(1996-1#1)(1996-3#2)(1996-6#1)(1997-3#5)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#9)(2008-11#6)(2008-12#2)(2008-7#1)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#10)(2013-1#1)
duplications and##3##2##(1997-3#2)(1997-7#1)
duplications in the##2##3##(2008-4#1)(2008-9#1)
duplications in##3##2##(2008-4#1)(2008-9#1)(2009-10#1)
duplications##18##1##(1993-12#2)(1993-6#1)(1997-3#4)(1997-7#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#5)(2011-2#1)(2011-3#1)
duplicative##3##1##(1995-2#1)(1995-3#1)(2010-8#1)
duplicitous##2##1##(2009-10#1)(2013-8#1)
dura around the##3##3##(1996-9#1)(2011-2#2)
dura mater##3##2##(2007-11#1)(2009-8#1)(2013-1#1)
dura##16##1##(1996-9#1)(2007-11#1)(2008-7#4)(2008-9#2)(2009-8#3)(2011-2#4)(2013-1#1)
durability and##2##2##(2010-6#1)(2012-2#1)
durability of resistance against##2##4##(2008-10#2)
durability of resistance##7##3##(2008-10#7)
durability of##18##2##(2007-11#2)(2008-10#14)(2012-12#1)(2013-1#1)
durability##30##1##(2007-11#2)(2008-10#20)(2010-6#2)(2012-12#3)(2012-2#1)(2013-1#2)
durable disease resistance##2##3##(2008-10#1)(2009-10#1)
durable resistance to stripe rust##2##5##(2008-10#2)
durable resistance to##7##3##(2008-10#6)(2008-8#1)
durable resistance##12##2##(2008-10#11)(2008-8#1)
durable##30##1##(1992-1#1)(2008-10#21)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
dural AVF##4##2##(1996-9#4)
dural and##2##2##(2008-7#1)(2011-2#1)
dural arteriovenous fistula##2##3##(2008-7#2)
dural arteriovenous fistulae (AVF)##2##4##(1996-9#2)
dural arteriovenous fistulae##3##3##(1996-9#3)
dural arteriovenous malformation##3##3##(2008-7#3)
dural arteriovenous malformations##4##3##(2008-7#4)
dural arteriovenous shunts##3##3##(1996-9#3)
dural arteriovenous##17##2##(1996-9#7)(2008-7#10)
dural closure##6##2##(2012-3#5)(2013-8#1)
dural defect##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
dural sealing techniques##4##3##(2012-3#4)
dural sealing##5##2##(2012-3#5)
dural sinus thrombosis##3##3##(2008-7#3)
dural sinus##4##2##(1996-9#1)(2008-7#3)
dural sinuses##3##2##(2008-7#3)
dural venous sinus##2##3##(1996-9#2)
dural venous##3##2##(1996-9#3)
dural##67##1##(1996-9#16)(1997-3#2)(2008-12#1)(2008-7#23)(2008-9#1)(2009-8#1)(2011-2#4)(2012-12#1)(2012-3#14)(2013-8#4)
durant##2##1##(2013-1#2)
duration (h) that temperature was between 15 and 30 degrees C##2##11##(2008-10#2)
duration (h)##3##2##(2008-10#3)
duration (p##2##2##(2008-7#1)(2011-2#1)
duration and temperature##2##3##(2008-10#2)
duration and the##3##3##(1992-12#1)(1993-1#1)(2008-7#1)
duration and timing of##2##4##(2008-11#1)(2012-3#1)
duration and##36##2##(1992-12#1)(1992-6#2)(1993-1#1)(1994-12#1)(1997-8#1)(2008-10#9)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
duration as##3##2##(2008-10#2)(2013-8#1)
duration at##4##2##(2008-10#4)
duration in##8##2##(1992-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)(2012-3#1)
duration increased##2##2##(2008-10#1)(2011-2#1)
duration is##4##2##(1991-2#1)(2008-3#2)(2012-2#1)
duration of 30##2##3##(1993-1#1)(2011-2#1)
duration of 4##2##3##(2008-1#1)(2008-10#1)
duration of a##2##3##(1993-1#1)(2008-7#1)
duration of action in##2##4##(1992-12#1)(1996-2#1)
duration of action##7##3##(1991-5#1)(1992-12#1)(1996-2#1)(2008-11#2)(2010-7#1)(2012-2#1)
duration of analysis##2##3##(2008-10#2)
duration of diabetes and##2##4##(1994-6#1)(2012-5#1)
duration of diabetes##7##3##(1994-12#1)(1994-6#2)(2012-2#2)(2012-5#2)
duration of disease##2##3##(2008-7#1)(2013-1#1)
duration of exponential##2##3##(2008-11#2)
duration of exposure##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
duration of follow-up##2##3##(2009-10#1)(2011-2#1)
duration of general anesthesia##2##4##(1990-11#2)
duration of high relative humidity##2##5##(2008-10#2)
duration of hospitalization##3##3##(1992-3#1)(2011-2#2)
duration of individual calls##2##4##(1994-8#2)
duration of infection and precancerous lesions##2##6##(2011-3#2)
duration of leaf wetness##5##4##(2008-10#5)
duration of pregnancy##3##3##(1991-9#1)(1993-3#1)(2012-3#1)
duration of response was##3##4##(1991-6#1)(1992-2#1)(1994-8#1)
duration of surgery##5##3##(2009-5#1)(2012-3#3)(2013-1#1)
duration of survival##3##3##(1993-1#1)(2008-10#2)
duration of symptoms##5##3##(2008-1#1)(2008-5#1)(2013-1#3)
duration of the IAI##2##4##(2008-12#2)
duration of the disease##5##4##(1994-12#1)(1997-8#2)(2011-2#1)(2013-1#1)
duration of the inhibition period and##2##6##(1991-12#2)
duration of the inhibition##3##4##(1991-12#2)(1996-2#1)
duration of the##49##3##(1990-12#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-6#1)(1994-12#1)(1996-2#3)(1997-2#4)(1997-4#1)(1997-8#3)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#2)
duration of treatment##4##3##(1995-2#1)(2008-7#2)(2013-8#1)
duration of wetness##3##3##(2008-10#3)
duration of##204##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#2)(1994-6#2)(1994-8#4)(1995-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-8#3)(2007-11#1)(2008-1#5)(2008-10#35)(2008-11#15)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#19)(2008-8#3)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#10)(2011-3#2)(2012-2#8)(2012-3#6)(2012-5#2)(2013-1#8)(2013-8#4)
duration on the##2##3##(2008-10#1)(2011-3#1)
duration on##6##2##(1991-2#1)(2008-1#1)(2008-10#3)(2011-3#1)
duration recorded##2##2##(2008-10#1)(2012-3#1)
duration than##2##2##(2008-11#1)(2009-8#1)
duration that##3##2##(1993-1#1)(2008-7#1)(2013-1#1)
duration time##2##2##(1994-2#1)(2008-7#1)
duration to##2##2##(1994-2#1)(2013-8#1)
duration was##11##2##(1991-2#1)(1994-2#1)(1996-11#1)(2008-10#5)(2008-7#2)(2011-2#1)
duration were##2##2##(2009-8#1)(2011-2#1)
duration##404##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#5)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#8)(1992-2#3)(1992-3#4)(1992-6#3)(1992-9#2)(1993-1#6)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#6)(1994-2#6)(1994-6#2)(1994-8#8)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#3)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#7)(1997-4#1)(1997-8#4)(2007-11#1)(2007-12#1)(2008-1#6)(2008-10#87)(2008-11#25)(2008-12#5)(2008-2#3)(2008-3#5)(2008-5#7)(2008-7#30)(2008-8#5)(2008-9#6)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#5)(2010-6#3)(2010-7#2)(2010-8#4)(2011-2#27)(2011-3#3)(2012-12#1)(2012-2#12)(2012-3#12)(2012-5#2)(2013-1#18)(2013-8#8)
duration)##4##1##(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
duration-were used##2##2##(2008-10#2)
durations of##6##2##(2008-10#2)(2008-3#2)(2010-6#1)(2012-3#1)
durations were##2##2##(2008-10#2)
durations##19##1##(1996-11#1)(2008-10#11)(2008-3#2)(2008-8#1)(2010-6#2)(2012-3#1)(2013-1#1)
during 0600 to 1000##2##4##(2008-10#2)
during 1 month##2##3##(2008-10#2)
during 1 week##2##3##(2008-10#1)(2008-7#1)
during 1##4##2##(2008-10#3)(2008-7#1)
during 10##4##2##(1992-12#1)(2008-10#3)
during 12 months##2##3##(2011-1#1)(2013-1#1)
during 12##4##2##(1994-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
during 1986##2##2##(1990-12#1)(1990-2#1)
during 1987 to##2##3##(2008-10#2)
during 1992##3##2##(1995-12#1)(1995-2#1)(2008-10#1)
during 1993 to##4##3##(2008-10#4)
during 1993##6##2##(1995-12#1)(2008-10#5)
during 1994 through 1996##2##4##(2008-10#2)
during 1994##7##2##(1995-3#1)(2008-10#6)
during 1996 and 1997##2##4##(1996-1#1)(2008-11#1)
during 1996##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
during 1997##4##2##(2008-10#3)(2008-11#1)
during 1998 to##2##3##(2008-10#2)
during 1999##3##2##(2008-10#3)
during 2 weeks##2##3##(1996-12#1)(2010-7#1)
during 2##5##2##(1993-1#1)(1996-12#1)(2009-10#1)(2010-7#1)(2012-3#1)
during 20##2##2##(2008-7#1)(2013-8#1)
during 2000##3##2##(2008-10#3)
during 2003-2004##2##2##(2008-10#2)
during 2005##2##2##(2009-6#1)(2013-1#1)
during 2008##2##2##(2011-2#2)
during 2011##3##2##(2013-1#1)(2013-8#2)
during 2011]##2##2##(2013-8#2)
during 24 h##2##3##(2008-10#2)
during 3##2##2##(2008-10#1)(2011-2#1)
during 4h##3##2##(2008-10#3)
during 5##4##2##(1990-12#1)(1991-2#1)(2008-10#1)(2011-2#1)
during 7 days##2##3##(2008-10#2)
during 7##4##2##(1990-12#1)(2008-10#2)(2008-7#1)
during AMI##2##2##(2010-12#2)
during ANP infusion##3##3##(2008-5#3)
during August##2##2##(2008-10#1)(2008-12#1)
during CoQ10 treatment (P = 0##2##6##(2013-1#2)
during CoQ10 treatment##5##3##(2013-1#5)
during DNA##2##2##(2009-7#1)(2011-2#1)
during EO versus EC##2##4##(2013-8#2)
during EO##3##2##(2013-8#3)
during G1 phase##2##3##(1993-8#1)(2008-8#1)
during G1##3##2##(1992-10#1)(1993-8#1)(2008-8#1)
during HIV infection##3##3##(2013-8#3)
during HK##2##2##(2011-2#2)
during IVM##2##2##(2013-1#2)
during July##3##2##(2008-10#2)(2008-3#1)
during June and July##2##4##(2010-10#1)(2011-2#1)
during June and##3##3##(2010-10#1)(2011-2#2)
during June##4##2##(2008-10#1)(2010-10#1)(2011-2#2)
during MRI##2##2##(1992-3#2)
during May##2##2##(2008-10#1)(2012-2#1)
during November##2##2##(1995-3#2)
during PPS##2##2##(1992-12#1)(1992-2#1)
during REM sleep##2##3##(1994-8#1)(2008-11#1)
during SDS-PAGE##2##2##(1992-10#2)
during WW I##2##3##(2008-11#2)
during a 1-year period##2##4##(2008-11#2)
during a 12-month period##2##4##(1994-9#1)(2010-4#1)
during a child's cancer treatment##3##5##(2009-9#3)
during a course##2##3##(2008-12#1)(2011-2#1)
during a growing season##2##4##(2008-10#2)
during a medical##2##3##(1992-2#1)(2011-2#1)
during a period of##4##4##(1991-2#2)(1997-5#1)(2008-10#1)
during a period##5##3##(1991-2#2)(1997-5#1)(2008-10#1)(2011-2#1)
during a re-exacerbation phase##2##4##(2011-2#2)
during a recent##2##3##(2008-1#1)(2008-10#1)
during a routine##2##3##(1993-2#1)(1995-2#1)
during a second##2##3##(1991-3#1)(2008-11#1)
during a single##3##3##(2008-10#2)(2013-1#1)
during a##131##2##(1990-8#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-8#1)(2008-1#1)(2008-10#30)(2008-11#13)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#2)(2013-1#8)(2013-8#3)
during acarbose##2##2##(1994-12#2)
during acid##2##2##(2008-10#1)(2011-1#1)
during acquisition##2##2##(2008-11#1)(2008-5#1)
during active##2##2##(2008-7#1)(2012-3#1)
during actual##2##2##(1992-12#1)(1992-3#1)
during acute hospitalization##2##3##(2011-2#2)
during acute illness in children with classic##2##7##(2010-2#2)
during acute##9##2##(1991-1#1)(1994-11#2)(1994-8#1)(2010-2#2)(2010-5#1)(2011-2#2)
during administration##2##2##(1993-1#2)
during adolescence##15##2##(2008-11#7)(2009-7#3)(2010-10#2)(2010-6#1)(2011-2#1)(2013-8#1)
during adulthood##3##2##(1995-12#1)(2009-7#1)(2010-3#1)
during ageing##3##2##(1990-5#2)(2008-10#1)
during aggressive interactions##2##3##(2008-8#2)
during aggressive##3##2##(1993-3#1)(2008-8#2)
during aging and##2##3##(1995-6#1)(2010-12#1)
during aging##10##2##(1990-3#1)(1995-6#1)(1997-2#1)(2008-7#3)(2010-12#1)(2011-2#2)(2013-7#1)
during air travel##2##3##(2010-5#2)
during air##3##2##(2008-10#1)(2010-5#2)
during all the##2##3##(2008-10#1)(2011-2#1)
during all##9##2##(1993-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
during an 8-month period##2##4##(1991-9#2)
during an extraction##2##3##(1990-5#2)
during an outbreak##2##3##(1991-11#1)(2008-10#1)
during an##30##2##(1990-5#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-9#2)(1992-3#2)(1993-6#1)(1994-3#1)(1995-6#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
during anal sex##2##3##(2010-7#2)
during analysis##2##2##(2008-10#2)
during and after the##2##4##(1991-2#1)(2008-10#1)
during and after##13##3##(1991-2#1)(1992-12#1)(1996-1#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-2#1)
during and following##2##3##(1994-2#1)(2012-2#1)
during and##20##2##(1991-2#1)(1992-12#1)(1994-2#2)(1996-1#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-2#2)(2013-8#2)
during anoscopy##5##2##(2013-1#5)
during antiviral##2##2##(2009-7#1)(2009-8#1)
during any##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
during aortocoronary bypass surgery on beating##2##6##(2012-3#2)
during application of##2##3##(1992-3#1)(2008-10#1)
during asexual reproduction##3##3##(2008-10#3)
during assessment##2##2##(1992-9#1)(2008-12#1)
during at least##2##3##(2008-10#2)
during autopsy##2##2##(2009-1#1)(2009-8#1)
during autumn##2##2##(2008-10#1)(2010-8#1)
during batch culture##2##3##(2008-11#2)
during batch growth##2##3##(2008-7#2)
during batch##7##2##(2008-11#4)(2008-7#2)(2011-2#1)
during bloom##8##2##(2008-10#8)
during both seasons##2##3##(2008-10#2)
during both the##2##3##(2008-10#1)(2012-12#1)
during both##9##2##(1996-12#1)(1996-3#1)(2008-10#4)(2008-12#1)(2012-12#1)(2013-8#1)
during brain development##2##3##(1995-2#1)(2008-1#1)
during brain##4##2##(1993-3#1)(1994-3#1)(1995-2#1)(2008-1#1)
during breastfeeding##2##2##(2010-12#2)
during cancer##6##2##(1991-12#1)(1995-2#1)(2011-2#2)(2012-2#2)
during cardiac surgery##2##3##(1991-3#1)(2012-3#1)
during cardiac##3##2##(1990-9#1)(1991-3#1)(2012-3#1)
during carotid##2##2##(2011-2#2)
during catalysis##2##2##(1995-6#1)(2008-8#1)
during cell growth##3##3##(2008-11#2)(2008-7#1)
during cell##11##2##(1993-12#1)(1994-2#1)(1995-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)
during cellular aging##2##3##(1990-3#2)
during cellular##3##2##(1990-3#2)(1991-2#1)
during certain decisions##2##3##(2008-11#2)
during certain##4##2##(2008-11#2)(2008-8#1)(2009-12#1)
during chemical##3##2##(2008-10#2)(2010-7#1)
during childhood##4##2##(1990-5#1)(2008-12#1)(2011-2#1)(2013-1#1)
during chronic infection##2##3##(2008-7#1)(2013-1#1)
during chronic##4##2##(1992-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
during clinical magnetic resonance diagnostic procedures##2##6##(1992-3#2)
during clinical placement##4##3##(2008-11#1)(2008-12#3)
during clinical##10##2##(1992-3#2)(1995-9#1)(2008-11#1)(2008-12#4)(2010-1#1)(2010-9#1)
during colonization##2##2##(2008-10#1)(2009-8#1)
during continuous##4##2##(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)
during control##2##2##(1997-1#2)
during conversion##2##2##(2008-6#1)(2010-10#1)
during cooling##2##2##(1995-3#2)
during coronary##4##2##(2008-12#1)(2009-12#1)(2011-2#1)(2012-3#1)
during critical##3##2##(2008-6#1)(2009-7#1)(2010-7#1)
during cultivation##4##2##(2008-11#3)(2008-7#1)
during cycle-exercise##2##2##(2008-10#2)
during cytokinesis##4##2##(2009-10#2)(2009-12#1)(2009-8#1)
during darkness##4##2##(2008-10#3)(2008-11#1)
during day##2##2##(1995-1#1)(2008-12#1)
during daytime##2##2##(2008-3#1)(2010-8#1)
during depolarization##2##2##(1994-2#2)
during deposition##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
during development and ageing##2##4##(1990-3#2)
during development and in##3##4##(1994-2#1)(2008-7#1)(2009-8#1)
during development and stress##2##4##(2009-10#2)
during development and##11##3##(1990-3#2)(1994-2#1)(1995-2#1)(2008-7#2)(2009-10#2)(2009-8#2)(2012-2#1)
during development from##2##3##(2008-10#1)(2011-2#1)
during development of the##2##4##(1994-11#1)(2008-5#1)
during development of##4##3##(1994-11#1)(1997-8#1)(2008-10#1)(2008-5#1)
during development##38##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-2#1)(1991-5#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#1)(2009-8#3)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#3)
during dialysis##2##2##(1990-5#1)(2008-10#1)
during different seasons##2##3##(2008-10#1)(2012-2#1)
during different stages of##2##4##(1993-1#1)(2008-9#1)
during different##7##2##(1993-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
during differentiation##4##2##(1995-6#1)(2008-11#2)(2012-2#1)
during dry##2##2##(2008-10#2)
during each##7##2##(1991-2#1)(1997-3#1)(2008-10#3)(2008-12#1)(2012-2#1)
during early childhood##2##3##(1997-7#1)(2008-11#1)
during early development##5##3##(1995-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2013-1#1)
during early life##2##3##(2012-12#1)(2012-2#1)
during early stages of##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
during early##27##2##(1993-12#1)(1993-6#1)(1995-12#1)(1995-8#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-9#1)(2009-8#3)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
during egg fertilization and##2##4##(1994-11#1)(2008-8#1)
during egg##3##2##(1994-11#1)(2007-12#1)(2008-8#1)
during either##3##2##(1993-1#1)(1993-2#1)(2008-10#1)
during electrophoresis##2##2##(2008-10#2)
during elution##3##2##(2008-10#3)
during embryogenesis##6##2##(1993-6#2)(1995-8#1)(2008-11#1)(2009-7#1)(2009-8#1)
during embryonic development##3##3##(1993-12#1)(2007-12#1)(2012-2#1)
during embryonic##5##2##(1993-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2012-2#1)
during endoscopic##2##2##(2008-9#1)(2013-1#1)
during ensiling##2##2##(2013-1#2)
during epidemics##2##2##(2008-10#2)
during episodes of##2##3##(2008-10#1)(2008-5#1)
during evaporation##2##2##(2008-5#2)
during evening hours##2##3##(2008-10#2)
during evolution##5##2##(1995-9#1)(1997-2#1)(2010-1#1)(2011-2#1)(2012-3#1)
during exercise##10##2##(1991-2#1)(1996-6#1)(2013-1#1)(2013-8#7)
during exhaustive##2##2##(2009-1#1)(2011-2#1)
during exponential growth phase##2##4##(2008-11#2)
during exponential growth##3##3##(2008-11#2)(2008-7#1)
during exposure to##2##3##(1990-5#1)(1994-2#1)
during exposure##4##2##(1990-5#1)(1994-2#1)(2007-12#1)(2012-2#1)
during extraction##3##2##(1991-3#1)(2008-10#2)
during fall##2##2##(2008-10#2)
during fermentation##6##2##(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#3)
during fertilization##4##2##(2008-11#3)(2008-9#1)
during fetal lung development##2##4##(1995-8#2)
during fetal##5##2##(1994-2#1)(1995-8#2)(2008-10#2)
during first##2##2##(2009-7#1)(2012-2#1)
during flight##2##2##(1996-12#1)(2008-9#1)
during fluid reasoning##2##3##(2008-11#2)
during follow-up##6##2##(1991-4#1)(2008-12#1)(2009-11#1)(2011-2#1)(2013-1#2)
during forensic##2##2##(2008-10#1)(2008-12#1)
during formation of the##2##4##(1995-12#1)(2008-12#1)
during four##2##2##(2008-10#1)(2010-12#1)
during fruit development##2##3##(2008-10#1)(2008-9#1)
during fruit ripening##2##3##(2011-2#2)
during fruit##5##2##(2008-10#2)(2008-9#1)(2011-2#2)
during functional##2##2##(2008-11#1)(2008-3#1)
during fungal infection##2##3##(2008-10#1)(2011-10#1)
during fungal##3##2##(2008-10#2)(2011-10#1)
during gait##2##2##(2008-12#1)(2008-7#1)
during general anesthesia##4##3##(1993-1#4)
during general##5##2##(1993-1#4)(2008-7#1)
during germination and##2##3##(2008-10#1)(2009-8#1)
during germination##5##2##(2008-10#2)(2009-8#3)
during gestation##10##2##(1990-5#3)(1990-9#1)(1994-8#1)(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#2)
during global##2##2##(2010-1#1)(2012-6#1)
during growth and##2##3##(1994-3#1)(2008-7#1)
during growth of cells on##3##5##(1995-9#2)(2008-10#1)
during growth of##5##3##(1992-4#1)(1995-9#2)(2008-10#1)(2008-7#1)
during growth on##2##3##(2008-7#2)
during growth##16##2##(1992-4#1)(1994-3#1)(1995-9#3)(2008-10#4)(2008-12#1)(2008-7#5)(2011-2#1)
during hardening##2##2##(2008-10#2)
during heat##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
during hospital admission##2##3##(2011-2#2)
during human##3##2##(1990-11#1)(2008-12#1)(2012-12#1)
during humidity detection##2##3##(2009-5#2)
during imbibition##2##2##(2008-10#2)
during in vitro aging of##2##5##(1990-3#2)
during in vitro culture##2##4##(2006-6#1)(2009-6#1)
during in vitro differentiation of##2##5##(1995-6#1)(2008-11#1)
during in vitro##8##3##(1990-3#3)(1995-6#1)(2006-6#1)(2008-11#2)(2009-6#1)
during in##9##2##(1990-3#3)(1995-6#1)(2006-6#1)(2008-11#2)(2009-6#1)(2010-1#1)
during incubation##5##2##(2006-6#1)(2008-10#4)
during individual sample periods##2##4##(2008-10#2)
during induced##2##2##(2008-10#1)(2008-8#1)
during induction##4##2##(2008-10#3)(2011-2#1)
during infection of susceptible crops such as maize (Zea##2##9##(2008-10#2)
during infection of susceptible crops such as maize##3##8##(2008-10#3)
during infection##13##2##(1994-5#1)(2008-10#7)(2008-5#1)(2008-9#1)(2013-1#3)
during inflammation##2##2##(1992-6#1)(2013-8#1)
during influenza seasons##2##3##(2012-12#2)
during influenza##3##2##(2012-12#3)
during initial##3##2##(1993-3#1)(2007-12#1)(2008-6#1)
during insertion##2##2##(2008-9#1)(2013-1#1)
during intermittent exercise##2##3##(2013-8#2)
during intervention##2##2##(2011-1#1)(2012-2#1)
during invasive##2##2##(1990-3#1)(1995-2#1)
during isometric##2##2##(2010-9#1)(2013-1#1)
during its evolution##2##3##(1991-8#1)(1992-9#1)
during its growth##2##3##(2008-10#2)
during its reaction with##3##4##(2008-10#3)
during its##15##2##(1991-8#1)(1992-9#1)(1997-2#1)(2008-10#7)(2008-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-2#1)
during labor##2##2##(1994-3#1)(2008-8#1)
during labour##2##2##(1994-3#2)
during landing##4##2##(2011-2#4)
during laparoscopic##3##2##(2008-12#2)(2012-12#1)
during late##4##2##(2008-10#2)(2009-10#1)(2012-3#1)
during lateral bending##3##3##(2013-1#3)
during life##6##2##(1990-6#1)(2008-12#1)(2008-7#4)
during liver resection##2##3##(2011-2#2)
during liver transplantation##2##3##(1992-3#1)(2013-1#1)
during liver##7##2##(1992-3#1)(1994-6#1)(2011-2#2)(2012-3#2)(2013-1#1)
during loaded isometric shoulder flexion##2##5##(2010-9#2)
during loaded shoulder flexion##2##4##(2010-9#2)
during loaded##4##2##(2010-9#4)
during long##3##2##(2008-10#2)(2008-11#1)
during long-term culture##2##3##(2008-11#2)
during long-term follow-up##2##3##(2013-1#2)
during long-term maintenance of##2##4##(2008-11#2)
during long-term##12##2##(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#6)(2013-1#2)
during luteal##3##2##(2008-9#1)(2012-2#2)
during maize##3##2##(2008-10#2)(2009-8#1)
during mandible occlusion without clenching##2##5##(2010-6#2)
during maturation and##2##3##(1991-7#1)(2008-7#1)
during maturation of##2##3##(2013-1#2)
during maturation##5##2##(1991-7#1)(2008-5#1)(2008-7#1)(2013-1#2)
during maximal occlusion##2##3##(2013-1#2)
during maximal##4##2##(2008-7#1)(2012-2#1)(2013-1#2)
during mechanical##2##2##(1994-2#1)(2013-1#1)
during meiosis##5##2##(2008-10#1)(2008-7#1)(2009-12#1)(2012-2#1)(2012-3#1)
during meiotic maturation##4##3##(2013-1#4)
during meiotic prophase I##3##4##(2011-2#3)
during meiotic##7##2##(2011-2#3)(2013-1#4)
during mitosis##2##2##(2009-5#1)(2011-2#1)
during mixed##2##2##(2008-10#2)
during moderate and severe grades of##2##6##(2011-2#2)
during moderate and severe##3##4##(2011-2#3)
during molecular##2##2##(2008-10#1)(2012-3#1)
during more than##2##3##(2008-10#2)
during most of the year##2##5##(2008-3#2)
during most of the##4##4##(2008-3#2)(2008-9#1)(2009-8#1)
during most##5##2##(2008-3#2)(2008-9#2)(2009-8#1)
during mouth opening##2##3##(1991-2#2)
during movement##3##2##(1991-5#2)(2013-8#1)
during murine##2##2##(1992-9#1)(2008-11#1)
during natural##2##2##(2008-9#1)(2012-3#1)
during neonatal##2##2##(2010-8#1)(2012-3#1)
during neuronal##3##2##(1995-3#1)(2010-1#1)(2011-2#1)
during normal aging##2##3##(2008-7#1)(2010-11#1)
during normal pregnancy##2##3##(1993-2#1)(1996-11#1)
during normal##10##2##(1991-3#1)(1993-2#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-9#1)
during one season##2##3##(2008-10#2)
during one year##2##3##(2007-12#1)(2013-8#1)
during one##6##2##(1991-11#1)(2007-12#1)(2008-10#3)(2013-8#1)
during ongoing##2##2##(2008-7#1)(2009-8#1)
during oocyte##2##2##(2010-3#1)(2010-5#1)
during oogenesis##4##2##(1994-12#1)(2007-12#1)(2008-9#1)(2010-5#1)
during operation##4##2##(1991-6#1)(1994-12#1)(2008-11#1)(2008-12#1)
during or after##3##3##(1995-6#1)(2010-8#1)(2012-12#1)
during or before##2##3##(2008-10#1)(2008-11#1)
during or##6##2##(1993-1#1)(1995-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)
during oral corticosteroid##2##3##(2008-11#2)
during oral##4##2##(1993-1#1)(2008-11#3)
during oviposition##2##2##(2010-8#2)
during passage##3##2##(2008-10#3)
during passive##2##2##(1990-8#1)(1991-5#1)
during pathogen##3##2##(2008-10#3)
during peak##2##2##(1992-8#1)(2008-10#1)
during pediatric hospitalization##2##3##(1992-2#2)
during periods of##6##3##(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
during physical activities##2##3##(2010-8#2)
during physical##5##2##(2009-1#1)(2010-10#1)(2010-2#1)(2010-8#2)
during placebo treatment##3##3##(2013-1#3)
during platelet##3##2##(1992-6#2)(2006-6#1)
during pollen##3##2##(2008-8#2)(2009-10#1)
during posterior##2##2##(2008-9#1)(2012-3#1)
during practice##2##2##(2008-11#2)
during pre-ecdysis##2##2##(2008-7#2)
during precipitation events##2##3##(2008-10#2)
during pregnancy and lactation##3##4##(2008-4#3)
during pregnancy and postpartum##2##4##(2008-9#2)
during pregnancy and##14##3##(1991-3#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(2008-4#3)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2012-2#1)
during pregnancy can##2##3##(1992-5#1)(2009-1#1)
during pregnancy in a##3##4##(1992-12#1)(2010-6#1)(2013-8#1)
during pregnancy in##5##3##(1992-12#1)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
during pregnancy is##2##3##(2008-12#1)(2011-1#1)
during pregnancy or##2##3##(2010-12#2)
during pregnancy##70##2##(1990-9#2)(1991-11#3)(1991-3#2)(1992-12#1)(1992-5#1)(1993-3#1)(1994-3#1)(1994-6#2)(1994-8#4)(1995-12#5)(1995-6#1)(2008-11#4)(2008-12#3)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#3)(2009-12#1)(2010-11#1)(2010-12#3)(2010-6#4)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#1)
during pregnancy?##2##2##(2008-11#1)(2013-1#1)
during pregnancy]##3##2##(1991-11#1)(1997-8#1)(2013-1#1)
during primary##4##2##(1990-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
during processing of##2##3##(1995-2#1)(2008-11#1)
during processing##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
during product development##2##3##(2008-5#2)
during prolonged##3##2##(1997-2#1)(2008-10#1)(2009-1#1)
during purification##2##2##(1990-5#1)(2008-11#1)
during radiation##2##2##(1991-2#1)(1993-2#1)
during radiotherapy##2##2##(1990-8#1)(1992-12#1)
during rapid##2##2##(2008-7#2)
during reading##2##2##(2008-9#1)(2013-8#1)
during recent##2##2##(1996-1#1)(2008-3#1)
during recovery from##6##3##(1990-5#1)(1996-2#1)(2008-11#1)(2011-2#1)(2013-8#2)
during regeneration##3##2##(2012-2#3)
during rehabilitation##2##2##(2008-7#1)(2010-4#1)
during removal of##2##3##(1991-2#1)(2011-2#1)
during repeated exposure to##2##4##(2012-2#2)
during repeated exposure##3##3##(2012-2#3)
during repeated##6##2##(2008-5#1)(2008-7#2)(2012-2#3)
during rest##3##2##(1994-8#2)(2009-3#1)
during resting##2##2##(2008-7#1)(2013-8#1)
during reversed flow##2##3##(1991-3#2)
during routine analysis##2##3##(2008-10#2)
during routine clinical practice##2##4##(2010-4#1)(2011-2#1)
during routine##12##2##(1991-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#4)(2012-3#1)(2013-1#1)
during secondary metabolism##2##3##(1990-12#1)(2008-7#1)
during secondary##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
during sepsis##3##2##(1997-1#1)(2013-8#2)
during sequential finger##2##3##(1996-2#2)
during sequential##3##2##(1996-2#2)(2011-2#1)
during several##2##2##(2008-10#1)(2008-3#1)
during sinus rhythm##2##3##(1990-3#1)(2009-10#1)
during sleep##6##2##(1997-4#1)(2009-8#2)(2012-3#2)(2013-8#1)
during spermatogenesis##4##2##(2009-10#1)(2012-2#3)
during spermiogenesis##3##2##(2008-7#1)(2012-2#2)
during spring and##2##3##(2008-10#1)(2012-3#1)
during stair##2##2##(2013-1#2)
during standing##2##2##(2010-3#1)(2010-9#1)
during steady-state growth at 23 degrees C##2##7##(1993-9#2)
during steady-state growth##3##3##(1993-9#2)(2008-7#1)
during storage of##2##3##(2008-10#1)(2011-2#1)
during storage##10##2##(2008-10#8)(2011-2#2)
during stress##3##2##(1997-4#2)(2008-10#1)
during studies##2##2##(2008-10#2)
during subcellular fractionation##2##3##(1990-5#2)
during such##2##2##(2008-12#1)(2012-2#1)
during summer##2##2##(1991-8#1)(2008-10#1)
during supramaximal exercise##3##3##(2013-8#3)
during surgery for##2##3##(2008-10#1)(2009-1#1)
during surgery##6##2##(1990-5#1)(1993-1#1)(2008-10#1)(2009-1#1)(2011-2#1)(2012-12#1)
during surgical procedures##2##3##(1993-1#1)(2009-12#1)
during surgical treatment##2##3##(1990-5#1)(2008-1#1)
during surgical##8##2##(1990-5#1)(1992-11#1)(1993-1#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)
during synthesis##2##2##(1993-8#1)(2011-2#1)
during systemic##2##2##(1990-6#1)(2008-10#1)
during terminal differentiation##2##3##(1994-3#1)(2008-9#1)
during testing##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
during the 1940s##2##3##(1993-6#1)(2011-2#1)
during the 1970s##3##3##(1993-12#1)(1996-1#1)(1997-4#1)
during the 1980s##2##3##(1994-9#1)(1997-4#1)
during the 1990s##2##3##(1992-6#1)(2008-10#1)
during the 1999##2##3##(2008-10#2)
during the 2002##2##3##(2008-10#2)
during the 20th century##2##4##(2008-4#1)(2008-8#1)
during the 4-year##2##3##(2008-10#2)
during the 48-h inoculation period##2##5##(2008-10#2)
during the 4th week##2##4##(1990-12#1)(2008-10#1)
during the active study##2##4##(2010-11#2)
during the active##3##3##(2008-7#1)(2010-11#2)
during the acute phase of##4##5##(2008-12#1)(2008-7#1)(2013-1#2)
during the acute phase##6##4##(1994-6#1)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#2)
during the acute##10##3##(1994-6#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#2)(2013-1#3)
during the administration of##2##4##(1991-12#1)(2009-8#1)
during the aging process##4##4##(1997-2#2)(2008-10#2)
during the biological##2##3##(2010-7#2)
during the cell cycle##3##4##(2011-2#2)(2012-2#1)
during the cell##4##3##(1997-6#1)(2011-2#2)(2012-2#1)
during the concentration##2##3##(2011-2#2)
during the course of an##2##5##(2008-10#1)(2008-11#1)
during the course of natural##2##5##(2008-11#1)(2013-8#1)
during the course of the disease##4##6##(1990-6#1)(1993-12#1)(2008-7#1)(2011-1#1)
during the course of the##9##5##(1990-6#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#1)(2013-1#1)
during the course of treatment##3##5##(1991-12#1)(1996-9#1)(2013-8#1)
during the course of##38##4##(1990-6#1)(1991-12#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-9#1)(1996-9#1)(1997-9#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
during the critical period##2##4##(2012-2#2)
during the cropping##2##3##(2008-10#2)
during the cultivation##2##3##(2008-11#2)
during the current##2##3##(2010-10#1)(2012-3#1)
during the dark period##2##4##(1995-11#1)(2008-11#1)
during the dark##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
during the day##3##3##(1996-3#1)(2008-10#1)(2011-2#1)
during the deposition##2##3##(2008-10#2)
during the development of the##3##5##(1992-6#1)(1995-3#1)(2008-10#1)
during the development of##8##4##(1992-6#1)(1993-12#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
during the developmental##2##3##(1992-12#1)(1994-9#1)
during the different##2##3##(2008-5#1)(2011-2#1)
during the early phase of##2##5##(1993-9#1)(1996-2#1)
during the early postnatal period##2##5##(2008-11#1)(2010-1#1)
during the early stages of##6##5##(1993-3#1)(1996-12#1)(2008-10#1)(2008-12#1)(2011-10#1)(2011-2#1)
during the early years##2##4##(1993-12#1)(2008-11#1)
during the early##23##3##(1990-11#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2010-1#1)(2011-10#1)(2011-2#1)(2012-3#1)
during the entire experiment##2##4##(2008-10#2)
during the entire##5##3##(1993-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
during the enzymatic reaction of##2##5##(2008-10#2)
during the enzymatic reaction##3##4##(2008-10#3)
during the enzymatic##5##3##(2008-10#5)
during the epidemics##2##3##(2012-3#2)
during the epithelial cycle##2##4##(2009-10#1)(2012-2#1)
during the evaluation##2##3##(2008-10#2)
during the evening and morning hours##2##6##(2012-5#2)
during the evolution##2##3##(2008-6#1)(2013-1#1)
during the experimental periods##2##4##(2008-10#1)(2013-1#1)
during the experimental##4##3##(2008-10#1)(2012-5#2)(2013-1#1)
during the experiments##2##3##(2008-10#2)
during the exponential growth phase##2##5##(2008-11#1)(2008-7#1)
during the exponential phase##3##4##(2008-11#3)
during the exponential##5##3##(2008-11#4)(2008-7#1)
during the extraction##3##3##(1990-5#1)(2008-10#2)
during the fabrication process##2##4##(2008-10#1)(2008-3#1)
during the fall##2##3##(2008-10#2)
during the field##2##3##(2008-10#1)(2008-12#1)
during the first 10##2##4##(1991-12#1)(2008-10#1)
during the first 2##3##4##(1995-1#1)(2008-10#1)(2008-9#1)
during the first 3 days##2##5##(1995-3#1)(2008-11#1)
during the first 3 months##2##5##(2008-10#1)(2013-1#1)
during the first 3 weeks of##2##6##(2008-11#1)(2008-5#1)
during the first 3##8##4##(1992-12#1)(1993-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
during the first 4##2##4##(1994-8#1)(1995-11#1)
during the first 5 years##2##5##(1994-12#1)(2008-9#1)
during the first 5##3##4##(1994-12#1)(2008-5#1)(2008-9#1)
during the first 6 h##2##5##(2008-10#1)(2008-11#1)
during the first 6##3##4##(2008-10#2)(2008-11#1)
during the first month##2##4##(1993-2#2)
during the first step of##2##5##(1992-8#1)(2008-10#1)
during the first trimester##3##4##(1990-9#1)(2013-1#2)
during the first week##3##4##(1991-2#1)(1996-3#1)(2012-3#1)
during the first year of life##3##6##(1995-8#1)(1996-11#1)(2008-12#1)
during the first year of##7##5##(1995-1#1)(1995-3#1)(1995-8#1)(1996-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
during the first year##10##4##(1995-1#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
during the first years of##2##5##(2008-11#1)(2008-5#1)
during the first years##3##4##(2008-11#1)(2008-5#1)(2011-2#1)
during the first##70##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-3#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-8#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#6)
during the folding process##2##4##(1991-6#2)
during the folding##3##3##(1991-6#3)
during the follow up##3##4##(2008-10#1)(2010-3#1)(2013-1#1)
during the follow-up period##3##4##(1997-8#1)(2011-1#1)(2011-2#1)
during the follow-up##5##3##(1990-9#1)(1997-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
during the following##3##3##(1991-6#1)(2008-10#2)
during the fourth##6##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
during the fruit development##4##4##(2008-9#4)
during the growing season##8##4##(2008-10#7)(2010-8#1)
during the growing##9##3##(2008-10#7)(2010-8#1)(2012-5#1)
during the host-free period##2##4##(2008-10#2)
during the hot##2##3##(2008-10#2)
during the hydrolysis process##2##4##(2008-10#2)
during the incubation period##2##4##(1991-12#1)(2008-10#1)
during the induction of##2##4##(2008-9#1)(2009-8#1)
during the induction##3##3##(2008-1#1)(2008-9#1)(2009-8#1)
during the infection##2##3##(2008-10#2)
during the initial phase##2##4##(2008-11#1)(2013-8#1)
during the initial stage of##2##5##(2008-10#1)(2008-7#1)
during the initial##10##3##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
during the initiation##2##3##(2008-8#1)(2013-1#1)
during the inoculation period##2##4##(2008-10#2)
during the interaction of##2##4##(1993-8#1)(2008-10#1)
during the interaction##4##3##(1993-8#1)(2008-10#3)
during the intraoperative period##2##4##(2010-5#1)(2011-3#1)
during the larval##3##3##(1990-3#1)(2008-7#1)(2008-8#1)
during the last 12 years##2##5##(1997-3#1)(2008-10#1)
during the last 15 years##2##5##(1991-9#1)(1993-11#1)
during the last 50 years##3##5##(1995-2#1)(2008-10#2)
during the last decade##3##4##(1996-11#1)(2008-10#1)(2012-2#1)
during the last decades##4##4##(2008-11#1)(2009-12#1)(2009-4#1)(2011-2#1)
during the last three##2##4##(2011-2#2)
during the last two##2##4##(2010-2#1)(2012-12#1)
during the last years##2##4##(2008-10#1)(2011-2#1)
during the last##32##3##(1990-3#1)(1991-9#1)(1993-11#1)(1994-12#3)(1994-6#1)(1995-2#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
during the late 1980s##2##4##(1995-12#1)(2008-10#1)
during the late nineteenth and early twentieth centuries##2##8##(2010-1#2)
during the late##8##3##(1995-12#1)(2008-10#4)(2008-5#1)(2010-1#2)
during the later stages of##2##5##(1990-5#1)(2009-5#1)
during the later stages##3##4##(1990-5#1)(2008-5#1)(2009-5#1)
during the latter##4##3##(1991-12#1)(1994-2#1)(2008-10#1)(2011-2#1)
during the light period of##2##5##(1994-8#1)(1995-11#1)
during the light##3##3##(1991-9#1)(1994-8#1)(1995-11#1)
during the luteal##2##3##(2012-2#2)
during the measurement##2##3##(2008-10#2)
during the molt cycle##2##4##(2008-6#2)
during the molt##3##3##(2008-6#2)(2008-7#1)
during the morning##2##3##(2008-3#1)(2010-5#1)
during the next##4##3##(1990-2#1)(1993-1#1)(1994-12#1)(1996-2#1)
during the night##3##3##(2008-10#2)(2010-8#1)
during the observation period##3##4##(1997-4#1)(2008-11#1)(2011-1#1)
during the observation##4##3##(1997-4#1)(2008-11#2)(2011-1#1)
during the oxidation##2##3##(2008-10#2)
during the past 3##2##4##(2008-10#1)(2010-7#1)
during the past century##2##4##(2008-10#1)(2011-2#1)
during the past decade##4##4##(2008-10#2)(2009-5#1)(2010-5#1)
during the past few years##3##5##(2008-10#1)(2008-9#2)
during the past several years##2##5##(1992-3#2)
during the past##25##3##(1991-3#1)(1992-3#2)(1992-9#1)(1994-1#1)(1994-3#1)(1997-1#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-9#2)(2009-5#1)(2010-5#2)(2010-7#1)(2011-2#2)
during the performance of##2##4##(1995-2#1)(2013-1#1)
during the period from##4##4##(1992-1#1)(1994-12#1)(2008-11#1)(2008-5#1)
during the period of##10##4##(1997-4#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
during the period##43##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-9#1)(1993-1#1)(1994-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1997-4#2)(1997-8#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#1)
during the perioperative period##2##4##(1992-3#1)(2011-1#1)
during the postpandemic##2##3##(2013-1#2)
during the preceding##2##3##(2008-10#1)(2013-1#1)
during the pregnancy##2##3##(2011-2#1)(2012-3#1)
during the primary##2##3##(2008-8#1)(2012-12#1)
during the prior##2##3##(2013-1#2)
during the procedure and##2##4##(1992-12#1)(2012-2#1)
during the procedure in three cases##2##6##(1997-3#2)
during the procedure##9##3##(1991-2#1)(1992-12#2)(1997-3#2)(2011-3#1)(2012-2#2)(2013-1#1)
during the process of##3##4##(2008-10#1)(2008-11#2)
during the process##4##3##(2008-10#2)(2008-11#2)
during the processing##2##3##(2010-8#1)(2013-8#1)
during the production of##2##4##(2008-11#2)
during the production##6##3##(2008-10#1)(2008-11#4)(2012-2#1)
during the programme##3##3##(2008-11#1)(2008-12#2)
during the progress of##2##4##(2008-10#1)(2008-11#1)
during the pupal stage##2##4##(2007-12#2)
during the purification##2##3##(1990-5#1)(2008-10#1)
during the rainy season##2##4##(1994-9#1)(2008-10#1)
during the reaction##6##3##(1995-6#1)(2008-10#5)
during the recovery phase from acute##2##6##(1996-2#2)
during the reproductive##2##3##(2012-2#1)(2013-1#1)
during the role plays##2##4##(2009-11#2)
during the same period of time##4##6##(1991-8#1)(2008-10#1)(2010-12#1)(2012-2#1)
during the same period##6##4##(1990-6#1)(1991-8#1)(1995-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
during the same##9##3##(1990-6#1)(1991-8#1)(1995-1#2)(1997-3#1)(2007-12#1)(2008-10#1)(2010-12#1)(2012-2#1)
during the sampling##3##3##(2008-10#2)(2011-3#1)
during the school##2##3##(2008-11#1)(2008-12#1)
during the season##5##3##(2008-10#4)(2008-8#1)
during the second infestation##2##4##(1996-12#2)
during the second##8##3##(1996-12#2)(2008-10#5)(2013-1#1)
during the seminiferous epithelial cycle of spermatogenesis##3##7##(2012-2#3)
during the separation##2##3##(2008-10#2)
during the spawning##2##3##(2010-8#2)
during the spring and fall seasons##2##6##(2008-10#2)
during the spring and##3##4##(2008-10#2)(2012-3#1)
during the spring##6##3##(2008-10#4)(2012-3#2)
during the stationary phase##2##4##(2008-11#1)(2008-7#1)
during the stress##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
during the study period##7##4##(1994-12#1)(2008-10#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
during the study##9##3##(1994-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#2)(2012-2#1)(2013-1#1)
during the subsequent##2##3##(2008-12#1)(2011-2#1)
during the summer months##2##4##(2008-11#1)(2011-1#1)
during the summer of##2##4##(1990-9#1)(2010-1#1)
during the summer##6##3##(1990-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2011-1#1)
during the test##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
during the thawing process##2##4##(2008-10#2)
during the therapeutic##2##3##(1991-12#1)(2008-5#1)
during the third##2##3##(1990-6#1)(2012-5#1)
during the titration##2##3##(2008-10#2)
during the total##2##3##(2008-10#1)(2013-1#1)
during the transition from hospital to##2##6##(2011-2#1)(2012-12#1)
during the transition from##4##4##(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
during the transition##5##3##(2008-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
during the treatment of##2##4##(1991-8#1)(2009-5#1)
during the treatment##5##3##(1991-8#1)(1992-12#1)(2008-10#1)(2008-7#1)(2009-5#1)
during the washing##2##3##(1997-2#1)(2008-7#1)
during the week of##2##4##(1995-6#1)(1996-5#1)
during the week##3##3##(1995-6#1)(1996-5#1)(2013-8#1)
during the whole process of##2##5##(1995-12#1)(2008-11#1)
during the whole##9##3##(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-8#1)(2012-2#1)
during the winter months and##2##5##(1991-8#1)(2011-1#1)
during the winter months##4##4##(1991-8#1)(2008-10#1)(2009-11#1)(2011-1#1)
during the winter##8##3##(1991-8#1)(1997-3#1)(2008-10#2)(2008-5#2)(2009-11#1)(2011-1#1)
during the winter/spring of 2008##2##5##(2011-2#2)
during the workday and##2##4##(2012-12#2)
during the workday##4##3##(2012-12#4)
during the year##3##3##(1996-1#1)(2013-8#2)
during the years##3##3##(1996-11#1)(2008-10#1)(2008-11#1)
during the##978##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#5)(1990-5#4)(1990-6#4)(1990-8#1)(1990-9#7)(1991-1#1)(1991-11#2)(1991-12#9)(1991-2#4)(1991-3#3)(1991-5#1)(1991-6#10)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#10)(1992-2#2)(1992-3#6)(1992-6#4)(1992-8#1)(1992-9#3)(1993-1#5)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#7)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#10)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#5)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#6)(1995-8#3)(1996-1#3)(1996-11#4)(1996-12#8)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#5)(1996-9#2)(1997-1#1)(1997-2#11)(1997-3#8)(1997-4#5)(1997-6#3)(1997-7#1)(1997-8#3)(1997-9#1)(2007-12#3)(2007-8#1)(2008-1#5)(2008-10#257)(2008-11#71)(2008-12#15)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#21)(2008-6#10)(2008-7#37)(2008-8#20)(2008-9#26)(2009-10#4)(2009-11#6)(2009-12#1)(2009-4#1)(2009-5#3)(2009-8#6)(2010-1#6)(2010-10#4)(2010-11#7)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#6)(2010-7#4)(2010-8#13)(2011-1#9)(2011-10#1)(2011-2#45)(2011-3#4)(2012-12#13)(2012-2#24)(2012-3#20)(2012-5#7)(2012-7#1)(2012-8#1)(2013-1#39)(2013-8#19)
during their first##4##3##(2008-11#3)(2011-1#1)
during their stay##2##3##(2013-1#2)
during their##36##2##(1990-12#1)(1990-6#1)(1991-9#1)(1992-12#1)(1993-2#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)
during therapy##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
during thermal##3##2##(2008-10#2)(2011-2#1)
during these##8##2##(1993-1#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
during this emergency##3##3##(2013-1#3)
during this period##12##3##(1990-5#1)(1992-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#5)
during this study##4##3##(2008-11#2)(2011-2#1)(2012-2#1)
during this##34##2##(1990-5#1)(1992-12#2)(1994-12#1)(1994-6#1)(1995-3#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#8)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#3)
during thoracic##2##2##(2008-12#1)(2011-2#1)
during three##4##2##(2008-10#2)(2008-4#1)(2009-3#1)
during tissue##2##2##(2010-9#2)
during titrations##2##2##(1991-5#1)(2008-10#1)
during total knee arthroplasty##2##4##(2008-8#2)
during total##4##2##(1992-9#1)(1996-2#1)(2008-8#2)
during training##2##2##(1993-3#1)(2011-2#1)
during transport##3##2##(2007-9#1)(2008-10#1)(2013-1#1)
during treatment with##5##3##(1994-8#1)(1996-6#1)(2009-12#1)(2009-8#1)(2012-3#1)
during treatment##18##2##(1991-6#1)(1994-8#1)(1996-6#1)(1997-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#2)(2009-8#1)(2011-2#3)(2012-3#4)(2013-1#1)
during two consecutive##3##3##(1996-12#1)(2008-5#1)(2012-12#1)
during two seasons##2##3##(2008-10#1)(2012-8#1)
during two years##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
during two##13##2##(1996-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#2)(2011-2#1)(2012-12#1)(2012-8#1)(2013-8#1)
during ultrafast##2##2##(2008-3#2)
during unilateral practice##2##3##(2013-8#2)
during use##2##2##(2008-11#1)(2008-5#1)
during vaginal##2##2##(2010-7#2)
during various stages of##3##4##(1991-7#1)(2008-10#1)(2008-8#1)
during various##6##2##(1991-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
during viral##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
during visual##2##2##(2008-10#1)(2013-8#1)
during waking##3##2##(2008-11#1)(2013-8#2)
during walking##4##2##(1997-2#2)(2008-12#1)(2013-1#1)
during which all##2##3##(2008-5#1)(2010-1#1)
during which the##5##3##(1994-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-9#1)
during which they##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
during which time##2##3##(1997-1#1)(2008-6#1)
during which##29##2##(1990-11#1)(1991-11#1)(1992-1#1)(1994-1#1)(1994-2#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2010-1#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
during winter##4##2##(1991-8#1)(2008-10#2)(2008-3#1)
during word processing##2##3##(2008-11#2)
during word##3##2##(1996-2#1)(2008-11#2)
during wound##2##2##(2008-10#1)(2008-5#1)
during##3208##1##(1990-11#5)(1990-12#10)(1990-2#4)(1990-3#19)(1990-5#31)(1990-6#8)(1990-8#5)(1990-9#17)(1991-1#3)(1991-11#12)(1991-12#18)(1991-2#23)(1991-3#13)(1991-4#1)(1991-5#12)(1991-6#15)(1991-7#2)(1991-8#9)(1991-9#10)(1992-1#2)(1992-10#4)(1992-11#2)(1992-12#27)(1992-2#7)(1992-3#23)(1992-4#1)(1992-5#2)(1992-6#14)(1992-8#3)(1992-9#9)(1993-1#22)(1993-11#3)(1993-12#12)(1993-2#10)(1993-3#17)(1993-6#5)(1993-8#10)(1993-9#6)(1994-1#3)(1994-11#12)(1994-12#19)(1994-2#23)(1994-3#21)(1994-5#5)(1994-6#10)(1994-8#16)(1994-9#9)(1995-1#8)(1995-11#6)(1995-12#18)(1995-2#19)(1995-3#13)(1995-5#5)(1995-6#17)(1995-8#8)(1995-9#8)(1996-1#8)(1996-11#6)(1996-12#15)(1996-2#21)(1996-3#7)(1996-5#5)(1996-6#12)(1996-9#4)(1997-1#5)(1997-2#20)(1997-3#17)(1997-4#9)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#9)(1997-9#3)(2006-6#3)(2007-12#15)(2007-8#2)(2007-9#1)(2008-1#12)(2008-10#694)(2008-11#247)(2008-12#59)(2008-2#6)(2008-3#31)(2008-4#17)(2008-5#62)(2008-6#23)(2008-7#129)(2008-8#57)(2008-9#69)(2009-1#10)(2009-10#20)(2009-11#9)(2009-12#12)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#9)(2009-6#7)(2009-7#13)(2009-8#41)(2009-9#4)(2010-1#19)(2010-10#15)(2010-11#17)(2010-12#14)(2010-2#10)(2010-3#7)(2010-4#12)(2010-5#17)(2010-6#9)(2010-7#17)(2010-8#35)(2010-9#13)(2011-1#23)(2011-10#2)(2011-2#194)(2011-3#6)(2011-7#1)(2012-12#35)(2012-2#91)(2012-3#75)(2012-4#1)(2012-5#7)(2012-6#1)(2012-7#1)(2012-8#2)(2013-1#155)(2013-7#3)(2013-8#96)
duringthe##2##1##(2009-8#1)(2013-8#1)
duroplasty##2##1##(2013-8#2)
durum cv##2##2##(2008-10#2)
durum wheat (T##2##3##(2008-10#1)(2012-3#1)
durum wheat in##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
durum wheat##27##2##(1991-12#1)(2008-10#21)(2008-8#1)(2012-3#1)(2013-8#3)
durum##37##1##(1991-12#1)(2008-10#31)(2008-8#1)(2012-3#1)(2013-8#3)
durum)##2##1##(2008-10#1)(2012-3#1)
dust and rock samples##2##4##(2008-10#2)
dust and##8##2##(2008-10#3)(2010-5#5)
dust control devices##4##3##(2009-12#4)
dust emissions##2##2##(2008-11#2)
dust samples##7##2##(1991-12#2)(2008-10#3)(2010-5#2)
dust##47##1##(1990-6#1)(1991-12#4)(1992-12#1)(1994-9#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2009-12#5)(2010-5#8)(2011-2#2)(2012-12#1)
dust)##2##1##(2008-10#2)
dusts##8##1##(1991-12#3)(2008-10#3)(2008-11#2)
duties##8##1##(1991-12#1)(1992-1#2)(2008-11#2)(2010-11#1)(2010-5#1)(2012-3#1)
duty cycle ratio##3##3##(2008-3#3)
duty cycle##9##2##(1992-3#1)(2008-2#1)(2008-3#7)
duty of##2##2##(1995-6#1)(2013-8#1)
duty to protect##2##3##(1991-12#1)(2008-11#1)
duty to##5##2##(1991-12#2)(1994-2#1)(1994-3#1)(2008-11#1)
duty##21##1##(1990-2#1)(1991-12#2)(1991-6#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-3#7)(2013-8#3)
dwarf disease##4##2##(2008-10#4)
dwarf luteovirus##2##2##(2008-10#2)
dwarf mistletoe on##2##3##(2008-10#2)
dwarf mistletoe##6##2##(2008-10#6)
dwarf rat##2##2##(1995-12#2)
dwarf rats##3##2##(1995-12#3)
dwarf virus in##3##3##(2008-10#3)
dwarf virus##29##2##(2008-10#26)(2008-8#3)
dwarf##70##1##(1995-12#6)(2008-10#55)(2008-8#3)(2008-9#4)(2010-8#1)(2013-1#1)
dwarfed##2##1##(1994-2#1)(2008-10#1)
dwarfing and##3##2##(2008-10#3)
dwarfing##6##1##(2008-10#4)(2009-8#2)
dwarfism##2##1##(1995-8#1)(1997-8#1)
dwell time##3##2##(2008-10#2)(2009-7#1)
dwell##4##1##(2008-10#2)(2009-2#1)(2009-7#1)
dwelling##6##1##(2008-1#1)(2008-12#3)(2010-7#1)(2011-2#1)
dyad##4##1##(1990-11#1)(1995-2#1)(2010-4#2)
dyadic##3##1##(2008-8#1)(2010-8#1)(2012-2#1)
dyads##8##1##(2008-8#1)(2008-9#1)(2009-11#2)(2010-4#4)
dye (Cy##2##2##(2008-10#2)
dye acridine orange##2##3##(1991-11#1)(2008-9#1)
dye affinity##2##2##(1997-2#2)
dye and##3##2##(2008-10#2)(2008-5#1)
dye by a##2##3##(2008-10#1)(2008-9#1)
dye by##4##2##(2008-10#3)(2008-9#1)
dye concentration##5##2##(2008-10#2)(2008-3#3)
dye concentrations##3##2##(2008-10#1)(2008-3#2)
dye content##3##2##(2008-10#2)(2010-4#1)
dye exclusion test##2##3##(2008-11#1)(2008-8#1)
dye exclusion##5##2##(2008-11#3)(2008-8#1)(2008-9#1)
dye for##2##2##(2008-10#1)(2008-5#1)
dye has been##2##3##(2008-10#2)
dye in the##2##3##(2008-10#2)
dye in##3##2##(2008-10#3)
dye injection##2##2##(2007-12#1)(2011-2#1)
dye into the##2##3##(2008-10#2)
dye into##3##2##(2008-10#2)(2010-4#1)
dye is##8##2##(1991-5#1)(2008-10#5)(2008-11#1)(2008-4#1)
dye laser with##2##3##(1996-11#1)(2008-2#1)
dye laser##10##2##(1996-11#1)(2008-10#1)(2008-2#4)(2008-3#3)(2009-4#1)
dye lasers##2##2##(2008-3#2)
dye loading##2##2##(2010-4#2)
dye molecules##3##2##(1991-5#1)(2010-4#2)
dye released##3##2##(1990-12#1)(2008-10#2)
dye to##2##2##(2008-10#1)(2008-9#1)
dye uptake##3##2##(2008-11#3)
dye was##4##2##(2008-10#4)
dye were##3##2##(2008-10#2)(2012-2#1)
dye with##4##2##(2008-10#2)(2008-4#1)(2010-5#1)
dye##216##1##(1990-12#2)(1990-2#1)(1990-5#2)(1991-11#1)(1991-5#5)(1992-6#1)(1994-12#1)(1994-2#1)(1996-11#2)(1997-2#2)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#117)(2008-11#12)(2008-2#5)(2008-3#11)(2008-4#5)(2008-5#4)(2008-8#2)(2008-9#13)(2009-12#1)(2009-4#1)(2010-4#9)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
dye-doped solgel silica##2##3##(2008-3#2)
dye-doped##3##1##(2008-10#1)(2008-3#2)
dye-exclusion test##2##2##(2008-11#2)
dye-exclusion##4##1##(2008-11#3)(2008-9#1)
dye/drug##2##1##(2012-3#2)
dyeing##5##1##(2008-5#1)(2011-1#4)
dyes and##14##2##(1990-6#4)(2008-10#7)(2008-11#1)(2008-9#2)
dyes are too##2##3##(2008-10#1)(2008-9#1)
dyes are##5##2##(2008-10#4)(2008-9#1)
dyes by##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
dyes from##2##2##(2008-10#2)
dyes have##2##2##(2008-10#2)
dyes in soft drinks##2##4##(2008-10#2)
dyes in##16##2##(2008-10#13)(2008-11#1)(2008-3#1)(2008-8#1)
dyes of##2##2##(2008-9#2)
dyes that##3##2##(2008-10#2)(2008-9#1)
dyes was##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
dyes were##5##2##(2008-10#3)(2008-3#2)
dyes##109##1##(1990-6#4)(2006-6#1)(2008-10#71)(2008-11#3)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#10)(2009-10#2)(2010-4#1)(2011-1#1)(2012-3#1)
dyestuff##2##1##(2008-10#2)
dyestuffs##2##1##(2008-10#2)
dying cells##2##2##(2008-4#1)(2008-9#1)
dying in##4##2##(1990-6#1)(1992-2#1)(2010-10#2)
dying or##2##2##(1993-12#1)(2012-12#1)
dying person##2##2##(1993-6#1)(2010-10#1)
dying with dignity##2##3##(2012-12#2)
dying##39##1##(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-2#1)(1993-12#2)(1993-6#2)(1994-9#1)(1997-6#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#5)(2010-8#3)(2011-2#3)(2012-12#3)(2013-1#1)
dynactin complex##3##2##(1995-2#3)
dynactin##5##1##(1995-2#4)(2010-5#1)
dynamic analysis##4##2##(2008-10#2)(2013-1#2)
dynamic and complex##2##3##(2008-10#1)(2008-11#1)
dynamic and static lung volumes##2##5##(1992-6#2)
dynamic and static measurements##2##4##(2012-2#2)
dynamic and static##4##3##(1992-6#2)(2012-2#2)
dynamic and##17##2##(1992-6#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2010-11#2)(2010-4#1)(2011-2#1)(2011-9#1)(2012-2#2)(2013-8#2)
dynamic changes in##4##3##(2008-11#1)(2008-12#1)(2013-8#2)
dynamic changes of##3##3##(2008-11#2)(2008-8#1)
dynamic changes##10##2##(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#2)
dynamic coating##4##2##(2008-10#4)
dynamic concentration range##2##3##(2008-10#2)
dynamic concentration##3##2##(2008-10#3)
dynamic conditions##4##2##(2006-6#1)(2008-10#1)(2008-7#1)(2012-4#1)
dynamic contrast-enhanced##5##2##(1997-8#1)(2010-12#2)(2013-1#1)(2013-8#1)
dynamic disorder and molecular memory in##2##6##(2012-2#2)
dynamic disorder##4##2##(2012-2#4)
dynamic equilibrium##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
dynamic event tree##2##3##(2009-10#2)
dynamic event##3##2##(2009-10#2)(2009-11#1)
dynamic expression##2##2##(2013-8#2)
dynamic extraction##4##2##(2008-10#4)
dynamic game##3##2##(2008-8#1)(2008-9#2)
dynamic in##2##2##(2008-1#1)(2009-7#1)
dynamic instability##2##2##(2008-9#2)
dynamic interactions##2##2##(2012-2#2)
dynamic leaching##2##2##(2008-10#2)
dynamic linear range##2##3##(2008-10#2)
dynamic measurements of##2##3##(1990-8#1)(2008-10#1)
dynamic measurements##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
dynamic measures of perceptions (p &lt##2##6##(2013-1#2)
dynamic mode##3##2##(2008-10#3)
dynamic model for##2##3##(2008-10#1)(2008-3#1)
dynamic model of##2##3##(2008-8#1)(2011-3#1)
dynamic model##7##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2011-3#1)
dynamic models to##2##3##(2008-8#1)(2011-2#1)
dynamic modification protocol##2##3##(2008-10#2)
dynamic organisation of##2##3##(2009-7#2)
dynamic pH junction##4##3##(2008-10#4)
dynamic pH##5##2##(2008-10#5)
dynamic patterns##2##2##(2007-12#1)(2008-8#1)
dynamic pelvic MRI##2##3##(2011-2#2)
dynamic phase##3##2##(2008-10#1)(2008-3#2)
dynamic process##3##2##(1995-3#1)(2008-10#1)(2009-8#1)
dynamic processes##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
dynamic programming##2##2##(2008-8#1)(2011-3#1)
dynamic properties##3##2##(1993-8#1)(1995-6#1)(2011-2#1)
dynamic quenching of##2##3##(2008-10#1)(2008-8#1)
dynamic quenching##4##2##(2008-10#3)(2008-8#1)
dynamic range and##3##3##(2008-10#2)(2008-3#1)
dynamic range between 0##2##4##(2008-10#2)
dynamic range between 10##2##4##(2008-10#2)
dynamic range between##6##3##(2008-10#6)
dynamic range for the##3##4##(2008-10#2)(2008-3#1)
dynamic range for##5##3##(2008-10#4)(2008-3#1)
dynamic range from 0##4##4##(2008-10#4)
dynamic range from##12##3##(2008-10#12)
dynamic range of 0##2##4##(2008-10#2)
dynamic range of 2##2##4##(2008-10#2)
dynamic range of the##7##4##(2007-11#1)(2008-10#4)(2008-3#1)(2013-8#1)
dynamic range of##29##3##(2007-11#1)(2008-10#20)(2008-3#6)(2009-8#1)(2013-8#1)
dynamic range was##7##3##(2008-10#7)
dynamic range##88##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#72)(2008-3#10)(2009-8#1)(2013-8#2)
dynamic ranges are##2##3##(2008-10#2)
dynamic ranges were##2##3##(2008-10#2)
dynamic ranges##13##2##(2008-10#13)
dynamic response##4##2##(2008-10#3)(2010-7#1)
dynamic signal##2##2##(2008-10#1)(2011-3#1)
dynamic simulation##3##2##(1992-4#1)(2008-11#1)(2008-3#1)
dynamic stabilization of##2##3##(1994-8#2)
dynamic stage migration with##2##4##(2011-2#2)
dynamic surface tension detector (DSTD)##3##5##(2008-10#3)
dynamic surface tension detector##4##4##(2008-10#4)
dynamic surface tension##10##3##(2008-10#10)
dynamic system##2##2##(2008-10#1)(2008-11#1)
dynamic vertebral segment##2##3##(2011-2#2)
dynamic##423##1##(1990-8#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#3)(1995-3#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#185)(2008-11#23)(2008-12#4)(2008-2#1)(2008-3#29)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#15)(2008-9#13)(2009-10#6)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#5)(2009-8#3)(2010-10#4)(2010-11#2)(2010-12#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#18)(2011-3#3)(2011-9#1)(2012-2#18)(2012-3#2)(2012-4#1)(2013-1#14)(2013-7#1)(2013-8#14)
dynamical structure of##2##3##(1990-5#1)(2008-11#1)
dynamical structure##3##2##(1990-5#2)(2008-11#1)
dynamical system##2##2##(2010-10#2)
dynamical systems##4##2##(2009-8#3)(2010-10#1)
dynamical##21##1##(1990-5#3)(2008-11#3)(2008-8#1)(2008-9#1)(2009-8#6)(2010-10#4)(2010-7#1)(2010-8#2)
dynamically changing##2##2##(2008-10#1)(2012-3#1)
dynamically to##2##2##(1990-8#1)(2010-11#1)
dynamically updated##2##2##(2008-6#2)
dynamically##28##1##(1990-8#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
dynamics and function##4##3##(2008-10#1)(2008-4#2)(2013-8#1)
dynamics and patterns of##2##4##(2008-10#2)
dynamics and regulation of biological populations##2##6##(2008-8#2)
dynamics and the##6##3##(1991-9#1)(2008-2#1)(2008-8#2)(2010-11#1)(2012-3#1)
dynamics and##37##2##(1991-9#1)(1994-8#1)(1995-5#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#9)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-3#3)(2013-8#3)
dynamics appear to##2##3##(1994-9#1)(2008-8#1)
dynamics are##7##2##(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)
dynamics as the##3##3##(2008-11#1)(2008-8#1)(2011-3#1)
dynamics as##5##2##(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-3#1)
dynamics at##2##2##(1990-8#1)(2013-8#1)
dynamics between##2##2##(2008-10#1)(2013-8#1)
dynamics by##2##2##(2008-8#1)(2012-2#1)
dynamics can##2##2##(2008-9#1)(2013-8#1)
dynamics during##4##2##(2008-11#1)(2011-2#1)(2012-2#2)
dynamics for##2##2##(2008-11#1)(2008-8#1)
dynamics found##2##2##(2007-12#1)(2008-8#1)
dynamics in a recurrent neural network model##2##7##(2008-11#2)
dynamics in a##3##3##(2008-11#2)(2008-9#1)
dynamics in the##11##3##(1990-8#1)(1991-3#1)(1992-8#1)(2008-10#1)(2008-11#3)(2009-11#1)(2009-8#1)(2010-8#1)(2012-3#1)
dynamics in##33##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-8#2)(1995-5#1)(2008-10#4)(2008-11#8)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
dynamics is##6##2##(2008-11#3)(2008-8#1)(2011-2#1)(2013-8#1)
dynamics may##2##2##(2008-11#1)(2008-9#1)
dynamics of HIV-1 in Italy##2##5##(1992-9#2)
dynamics of HIV-1##3##3##(1992-9#3)
dynamics of a population##2##4##(2008-11#1)(2008-8#1)
dynamics of a##8##3##(1993-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-7#1)(2010-8#1)
dynamics of cortical##2##3##(1994-3#1)(2008-11#1)
dynamics of each##3##3##(1995-5#1)(2008-10#2)
dynamics of evolution##2##3##(1997-6#1)(2008-8#1)
dynamics of measles##2##3##(1995-5#2)
dynamics of plant##3##3##(2008-10#3)
dynamics of the disease##2##4##(2008-10#2)
dynamics of the inoculum##2##4##(2008-10#2)
dynamics of the observed HIV-positive population size##2##7##(2008-1#2)
dynamics of the pathogen##2##4##(2008-10#2)
dynamics of the##40##3##(1990-8#1)(1992-6#1)(1992-9#2)(1993-2#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-8#1)(2010-10#1)(2012-3#1)
dynamics of two##3##3##(2008-8#3)
dynamics of word processing##3##4##(2008-11#3)
dynamics of##180##2##(1990-8#2)(1992-3#1)(1992-6#1)(1992-9#5)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-3#1)(1995-5#3)(1995-9#2)(1996-1#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-6#2)(2007-12#2)(2008-1#2)(2008-10#60)(2008-11#12)(2008-12#2)(2008-3#3)(2008-5#2)(2008-8#26)(2008-9#11)(2009-6#3)(2009-8#4)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#8)
dynamics on##3##2##(2008-3#1)(2008-8#1)(2009-8#1)
dynamics or##2##2##(2008-4#1)(2008-9#1)
dynamics simulations of##5##3##(1993-5#1)(2012-2#1)(2013-1#3)
dynamics simulations##7##2##(1993-5#1)(2008-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
dynamics through##2##2##(2008-10#1)(2011-2#1)
dynamics to##3##2##(1995-5#1)(2008-11#1)(2008-8#1)
dynamics was##3##2##(1993-1#1)(2009-6#1)(2011-2#1)
dynamics were##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
dynamics when##2##2##(2008-9#1)(2013-8#1)
dynamics with##5##2##(2008-8#2)(2009-10#1)(2011-2#1)(2013-8#1)
dynamics within##2##2##(1993-12#1)(2008-8#1)
dynamics##479##1##(1990-8#5)(1991-2#1)(1991-3#2)(1991-9#2)(1992-3#1)(1992-6#1)(1992-8#4)(1992-9#6)(1993-1#1)(1993-12#4)(1993-2#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#6)(1995-9#2)(1996-1#1)(1996-3#2)(1996-6#2)(1997-1#2)(1997-4#1)(1997-6#4)(2007-12#5)(2008-1#3)(2008-10#87)(2008-11#48)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#94)(2008-9#40)(2009-10#3)(2009-11#3)(2009-5#1)(2009-6#6)(2009-8#12)(2010-10#3)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-2#12)(2012-3#8)(2013-1#11)(2013-8#33)
dynamics?##2##1##(2008-8#1)(2013-8#1)
dynamin 1##3##2##(2013-8#3)
dynamometer##3##1##(2008-12#2)(2009-3#1)
dyne/cm##2##1##(2008-10#2)
dynein##6##1##(1995-2#1)(2010-5#1)(2012-2#4)
dysautonomia##4##1##(2008-10#4)
dyscrasia##3##1##(1992-12#1)(2011-2#1)(2013-8#1)
dysfunction and##15##2##(1991-7#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-10#2)(2011-2#4)(2012-12#2)
dysfunction as assessed##2##3##(2009-11#1)(2012-2#1)
dysfunction as##5##2##(2008-5#1)(2009-11#1)(2010-1#2)(2012-2#1)
dysfunction associated with##2##3##(1995-8#1)(2008-3#1)
dysfunction due to##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
dysfunction following##2##2##(1991-6#1)(1992-12#1)
dysfunction had##2##2##(2008-12#1)(2012-3#1)
dysfunction in a##2##3##(2011-2#1)(2013-8#1)
dysfunction in patients with##2##4##(2009-10#1)(2010-7#1)
dysfunction in patients##3##3##(2009-10#1)(2010-7#1)(2011-2#1)
dysfunction in the##3##3##(2008-10#1)(2010-4#1)(2010-9#1)
dysfunction in##24##2##(1992-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-10#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
dysfunction is a##3##3##(2010-5#1)(2011-2#1)(2012-2#1)
dysfunction is not##2##3##(2008-7#1)(2008-8#1)
dysfunction is##8##2##(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
dysfunction may##2##2##(1997-8#1)(2013-1#1)
dysfunction of the##6##3##(1991-2#1)(1995-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-9#1)
dysfunction of##12##2##(1991-2#2)(1995-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-9#1)(2013-1#1)
dysfunction plays a##3##3##(1991-7#1)(2008-11#1)(2012-3#1)
dysfunction plays##4##2##(1991-7#1)(2008-1#1)(2008-11#1)(2012-3#1)
dysfunction was associated with##2##4##(1991-8#1)(2009-10#1)
dysfunction was##5##2##(1991-8#1)(2008-7#2)(2009-10#1)(2011-1#1)
dysfunction with##4##2##(2008-12#1)(2012-3#1)(2013-1#2)
dysfunction##186##1##(1990-8#1)(1991-2#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#9)(2008-11#10)(2008-12#14)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#4)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#10)(2010-10#6)(2010-11#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#13)(2013-1#16)(2013-8#7)
dysfunctional postural and movement strategies##2##5##(2008-12#2)
dysfunctional uterine bleeding##2##3##(1994-12#1)(2008-10#1)
dysfunctional##15##1##(1990-12#2)(1991-12#1)(1993-1#1)(1994-12#2)(2008-10#3)(2008-12#2)(2008-6#1)(2009-9#1)(2011-2#1)(2012-2#1)
dysfunctions can##2##2##(1993-2#1)(2009-10#1)
dysfunctions of##2##2##(2008-10#1)(2009-12#1)
dysfunctions##11##1##(1990-2#1)(1993-2#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-12#1)(2010-5#1)(2010-9#1)(2011-3#1)
dysgalactiae##2##1##(1996-8#2)
dyskaryosis##2##1##(1990-6#1)(1994-2#1)
dyskerin##2##1##(2008-11#2)
dyskinesia##8##1##(1996-2#1)(2008-7#6)(2013-1#1)
dyslexia and##3##2##(2008-11#1)(2008-12#1)(2011-1#1)
dyslexia is##2##2##(1996-2#1)(2008-12#1)
dyslexia##23##1##(1996-2#2)(2008-11#4)(2008-12#11)(2011-1#1)(2012-2#4)(2013-8#1)
dyslexic##3##1##(2008-11#1)(2008-12#2)
dyslexics##3##1##(2008-11#2)(2008-12#1)
dyslipidaemia in##2##2##(2008-6#1)(2012-3#1)
dyslipidaemia##5##1##(2008-6#3)(2012-2#1)(2012-3#1)
dyslipidemia and##4##2##(2008-1#1)(2008-8#1)(2010-4#1)(2013-8#1)
dyslipidemia##15##1##(1996-11#1)(2008-1#1)(2008-3#4)(2008-7#1)(2008-8#2)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
dyslipidemias##3##1##(1991-11#1)(2008-11#2)
dyslipidemic drugs on##2##3##(2010-2#2)
dyslipidemic drugs##4##2##(2010-2#4)
dyslipidemic##6##1##(2008-10#1)(2010-2#4)(2012-3#1)
dysmenorrhea and##2##2##(1994-3#2)
dysmenorrhea##5##1##(1991-2#1)(1994-12#1)(1994-3#3)
dysmorphic features##2##2##(1990-9#1)(2013-1#1)
dysmorphic##3##1##(1990-9#1)(2012-12#1)(2013-1#1)
dysmotility##2##1##(2008-9#1)(2013-8#1)
dyspepsia in##2##2##(1995-10#1)(2011-2#1)
dyspepsia##7##1##(1995-10#5)(1997-1#1)(2011-2#1)
dyspeptic symptoms in SX patients##2##5##(2008-12#2)
dyspeptic symptoms in##3##3##(2008-12#3)
dyspeptic##5##1##(2008-12#4)(2013-1#1)
dysphagia and##4##2##(1990-12#1)(1997-8#1)(2008-1#1)(2013-1#1)
dysphagia symptoms##2##2##(2011-2#2)
dysphagia##21##1##(1990-12#1)(1990-9#1)(1992-6#1)(1992-9#2)(1993-6#4)(1997-8#1)(2008-1#3)(2008-12#2)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#1)
dysphasia##3##1##(1991-6#1)(1996-6#1)(2008-1#1)
dysphonia##4##1##(2008-12#1)(2010-8#3)
dysphoric##4##1##(2008-11#1)(2009-10#2)(2010-10#1)
dysplasia (BPD)##2##2##(2009-9#1)(2010-5#1)
dysplasia and carcinoma##2##3##(1993-8#2)
dysplasia and##6##2##(1993-8#2)(2008-11#1)(2012-2#1)(2013-1#2)
dysplasia associated with##2##3##(1993-8#1)(2008-9#1)
dysplasia in##3##2##(1992-12#1)(1992-9#1)(1996-3#1)
dysplasia is a##3##3##(1997-1#1)(1997-3#1)(2013-1#1)
dysplasia is##5##2##(1997-1#1)(1997-3#1)(2011-1#1)(2013-1#2)
dysplasia of##5##2##(2013-1#3)(2013-7#2)
dysplasia was##3##2##(1990-11#1)(2011-1#2)
dysplasia with##4##2##(2008-9#1)(2012-2#1)(2013-1#2)
dysplasia##65##1##(1990-11#1)(1990-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-8#7)(1996-3#3)(1997-1#2)(1997-3#4)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-1#8)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#11)(2013-7#2)
dysplastic lesions##6##2##(1993-8#5)(2013-1#1)
dysplastic##15##1##(1993-8#6)(2008-10#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
dyspnea and##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-1#1)(2013-8#2)
dyspnea##35##1##(1990-12#2)(1991-11#1)(1993-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-7#2)(2009-1#1)(2010-1#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#5)
dyspnoea on##2##2##(2013-7#1)(2013-8#1)
dyspnoea with##2##2##(2010-12#1)(2010-7#1)
dyspnoea##13##1##(1990-6#1)(2009-4#1)(2010-10#5)(2010-12#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#2)
dysprosium IIP particles and##2##4##(2008-10#2)
dysprosium IIP particles##3##3##(2008-10#3)
dysprosium##11##1##(1994-3#1)(2008-10#9)(2012-2#1)
dysraphism and##2##2##(2008-7#1)(2012-2#1)
dysraphism##3##1##(2008-7#1)(2012-2#1)(2013-1#1)
dysregulated in tumors##2##3##(2008-9#1)(2009-4#1)
dysregulated in##4##2##(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
dysregulated##12##1##(1992-12#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#3)
dysregulation and##2##2##(2010-3#1)(2010-5#1)
dysregulation of the##2##3##(2008-7#1)(2013-1#1)
dysregulation of##6##2##(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
dysregulation##8##1##(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
dysthymic disorder##4##2##(2011-2#4)
dysthymic##8##1##(2011-2#8)
dystocia##2##1##(1995-12#1)(1997-1#1)
dystonia following electric injury##2##4##(2008-7#2)
dystonia##27##1##(2008-7#18)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#4)
dystonic##2##1##(2012-12#2)
dystrophic epidermolysis##4##2##(1995-10#1)(2012-3#3)
dystrophic##8##1##(1992-12#1)(1995-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-3#3)
dystrophin##9##1##(1993-3#4)(1995-12#1)(1997-3#3)(2011-2#1)
dystrophinopathy##2##1##(1997-3#2)
dystrophy##22##1##(1993-3#1)(1995-12#1)(1996-8#1)(1997-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-1#5)
dysuria and hematuria##2##3##(2008-10#2)
dysuria and##3##2##(2008-10#3)
dysuria##6##1##(2008-10#6)
début de##2##2##(2013-1#2)
décès##3##1##(2009-10#1)(2013-1#2)
e antigen##3##2##(1995-2#2)(2013-1#1)
e was##3##2##(1992-6#1)(2008-10#2)
e##753##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#3)(1990-6#2)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#8)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#3)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#2)(1995-11#5)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-11#5)(1996-12#2)(1996-2#4)(1996-8#1)(1997-1#2)(1997-2#8)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#268)(2008-11#70)(2008-12#11)(2008-2#2)(2008-3#18)(2008-4#9)(2008-5#23)(2008-6#3)(2008-7#18)(2008-8#24)(2008-9#24)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#4)(2010-1#5)(2010-10#4)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#8)(2010-8#7)(2011-1#3)(2011-10#1)(2011-2#22)(2012-12#6)(2012-2#15)(2012-3#4)(2012-7#1)(2012-9#2)(2013-1#16)(2013-7#2)(2013-8#10)
e-learning##2##1##(2008-12#2)
e-mail##2##1##(1996-2#1)(2012-12#1)
e-portfolio##3##1##(2008-12#3)
e-tongue for the determination of##2##5##(2008-10#2)
e-training##2##1##(2008-11#2)
e14##2##1##(1996-6#1)(2013-1#1)
eFDPs##2##1##(2011-2#2)
eGFR measures##2##2##(2013-1#2)
eGfp content##2##2##(2008-11#2)
eGfp##4##1##(2008-11#4)
eIF-5A##4##1##(1994-3#2)(1997-1#2)
eIF2##2##1##(2012-2#2)
eIF2α##4##1##(2012-2#4)
eIF4E in##6##2##(1997-7#6)
eIF4E##8##1##(1997-7#8)
eNOS and##2##2##(1996-12#1)(2009-10#1)
eNOS##6##1##(1996-12#2)(2008-12#1)(2009-10#1)(2010-4#1)(2012-3#1)
ePTFE prosthesis##2##2##(2011-3#2)
ePTFE##3##1##(2011-3#3)
eQTL hotspot##2##2##(2012-3#2)
eQTL##3##1##(2012-3#3)
eSR and NRT##2##3##(2008-9#2)
eSR##4##1##(2008-9#4)
eSRT programmes##2##2##(2008-9#2)
eSRT##7##1##(2008-9#7)
eV##3##1##(1996-9#1)(2008-10#2)
each 'omic field##2##3##(2012-12#2)
each abdominal##2##2##(1994-2#1)(2011-2#1)
each aerosol component##3##3##(2008-3#3)
each allele##2##2##(2008-10#2)
each alpha polypeptide##2##3##(1994-5#2)
each aminoacid##2##2##(1992-9#2)
each and##2##2##(1997-8#1)(2008-10#1)
each animal##2##2##(1994-2#1)(2008-10#1)
each approach##6##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
each area##7##2##(1995-1#1)(2008-10#4)(2008-5#1)(2011-2#1)
each assay##4##2##(1990-12#1)(2008-10#2)(2011-2#1)
each assessment##2##2##(2008-10#2)
each associated with##2##3##(2007-12#1)(2008-10#1)
each at##2##2##(2008-3#1)(2008-5#1)
each bacterium##2##2##(2008-10#1)(2008-8#1)
each batch##2##2##(2008-11#2)
each beta polypeptide##2##3##(1994-5#2)
each case##17##2##(1990-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-8#1)(2011-2#2)(2013-1#1)
each caused##2##2##(1994-11#1)(2013-1#1)
each cell line##2##3##(2008-11#1)(2008-7#1)
each cell type##2##3##(1995-12#1)(1997-3#1)
each cell##10##2##(1995-12#2)(1997-3#1)(2008-10#1)(2008-11#3)(2008-7#1)(2012-3#1)(2013-8#1)
each chemical##4##2##(2008-10#4)
each child##3##2##(1991-2#1)(2008-11#1)(2008-9#1)
each class of##2##3##(2008-11#1)(2008-12#1)
each classification##2##2##(2011-2#2)
each cluster##3##2##(1991-5#1)(2008-10#1)(2010-11#1)
each collection##3##2##(2008-10#3)
each comparison was set to p&lt##2##6##(2010-6#1)(2010-9#1)
each comparison)##3##2##(1994-12#2)(1994-3#1)
each compartment##3##2##(1992-10#1)(2008-12#1)(2010-11#1)
each component##8##2##(2008-10#4)(2008-3#1)(2008-5#2)(2013-1#1)
each compound##13##2##(1993-12#1)(2008-10#12)
each consisting of##2##3##(2007-12#1)(2008-11#1)
each construct##2##2##(1995-8#1)(2008-10#1)
each contact##2##2##(1994-6#2)
each contain##2##2##(1993-12#1)(1995-2#1)
each containing a marker(s) specifically mapped on chromosome 5##2##9##(1997-6#1)(1997-8#1)
each containing a single##2##4##(2008-10#2)
each containing a##6##3##(1997-6#1)(1997-8#1)(2008-10#4)
each containing##10##2##(1994-12#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-8#1)
each country is##2##3##(1994-1#1)(1995-1#1)
each country##5##2##(1994-1#1)(1995-1#1)(2008-10#1)(2011-2#2)
each cross##2##2##(2008-10#2)
each cultivar##7##2##(2008-10#5)(2011-10#1)(2011-2#1)
each cycle##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#2)
each day for##3##3##(1990-2#1)(2008-7#1)(2013-1#1)
each day##13##2##(1990-2#4)(1991-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#3)(2013-1#1)
each different##2##2##(2008-10#2)
each dimension of##2##3##(1995-2#1)(2008-12#1)
each dimension##4##2##(1995-2#1)(2008-11#1)(2008-12#1)(2010-10#1)
each disease##2##2##(2008-10#2)
each domain of##2##3##(1993-12#1)(2008-7#1)
each domain##4##2##(1993-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
each drug##6##2##(1993-8#2)(2008-10#3)(2008-11#1)
each element##9##2##(2008-10#7)(2008-2#1)(2013-8#1)
each enantiomer##3##2##(2008-10#2)(2008-11#1)
each end##2##2##(2008-10#1)(2010-10#1)
each enzyme##4##2##(2008-10#4)
each experiment##13##2##(1994-3#2)(2008-10#10)(2008-11#1)
each experimental##2##2##(2008-10#1)(2008-12#1)
each extract##2##2##(2008-10#2)
each factor##3##2##(1995-2#1)(2008-11#1)(2008-5#1)
each field##9##2##(2008-10#8)(2009-12#1)
each food group##2##3##(2011-2#2)
each fraction##5##2##(1991-12#1)(2008-10#3)(2008-5#1)
each frame##2##2##(2008-3#1)(2008-6#1)
each from##10##2##(2008-10#6)(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
each fungal species##2##3##(2008-10#2)
each fungal##3##2##(2008-10#3)
each gene and##2##3##(2009-6#1)(2012-3#1)
each gene##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2012-3#1)
each generation##5##2##(2008-10#3)(2008-11#1)(2009-12#1)
each genotype##3##2##(1995-5#1)(2008-10#2)
each group and##2##3##(2008-10#2)
each group was##2##3##(2008-12#1)(2008-6#1)
each group were##4##3##(2006-6#1)(2008-11#1)(2008-7#1)(2011-2#1)
each group##35##2##(1991-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-1#1)(2006-6#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)
each group)##4##2##(1994-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
each had##3##2##(1993-3#1)(1995-12#1)(2008-10#1)
each having##2##2##(1997-7#1)(2013-1#1)
each hospital##2##2##(1993-12#1)(1995-2#1)
each host were##3##3##(2008-10#2)(2012-2#1)
each host##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
each hybrid##2##2##(2008-10#1)(2008-9#1)
each implement##2##2##(2008-10#1)(2008-12#1)
each in##3##2##(1994-5#1)(2008-10#2)
each individual patient##3##3##(1990-9#1)(2010-8#1)(2012-12#1)
each individual##21##2##(1990-5#1)(1990-9#1)(1994-9#1)(1995-9#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-9#1)(2010-8#1)(2012-12#1)(2013-8#2)
each inoculated##3##2##(2008-10#3)
each inoculation##4##2##(2008-10#4)
each inoculum##2##2##(2008-10#2)
each ion##3##2##(2008-10#3)
each is##3##2##(1990-8#1)(1995-11#1)(2010-5#1)
each isolate in##3##3##(2008-10#3)
each isolate##13##2##(2008-10#12)(2011-2#1)
each item##3##2##(1990-11#1)(2011-2#1)(2012-3#1)
each laboratory##2##2##(2008-10#2)
each layer##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
each lesion##2##2##(2008-10#2)
each level of##2##3##(1996-3#1)(2008-11#1)
each level##6##2##(1994-12#2)(1996-3#1)(2008-11#1)(2008-8#1)(2010-8#1)
each library##3##2##(1992-1#1)(1997-6#1)(2008-9#1)
each location##5##2##(2008-10#4)(2008-2#1)
each male##3##2##(2008-8#3)
each measurement##11##2##(2008-10#8)(2008-3#1)(2013-1#2)
each mechanism##2##2##(2008-10#1)(2008-8#1)
each metal in##2##3##(2008-10#2)
each metal ion##4##3##(2008-10#4)
each metal was##2##3##(2008-10#2)
each metal##11##2##(2008-10#11)
each method##5##2##(1995-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
each miRNA can##2##3##(2008-11#1)(2011-2#1)
each microplot##2##2##(2008-10#2)
each mode##2##2##(2008-3#1)(2011-1#1)
each model##4##2##(2008-10#2)(2008-4#1)(2011-2#1)
each molt##2##2##(2007-12#2)
each month from##2##3##(2008-10#2)
each month##7##2##(2008-10#6)(2010-6#1)
each morning##2##2##(1996-5#1)(2010-8#1)
each mutant##5##2##(1994-5#2)(1995-8#1)(2008-10#2)
each network's##2##2##(2010-10#2)
each neuron##2##2##(2008-11#1)(2009-10#1)
each nucleotide residue of double-stranded DNA##2##6##(2008-10#2)
each nucleotide residue##3##3##(2008-10#3)
each occasion##2##2##(1996-12#1)(2008-10#1)
each of 10##2##3##(1996-3#1)(2008-10#1)
each of 2 years##3##4##(2008-10#3)
each of 3 years##2##4##(2008-10#2)
each of N##3##3##(2008-10#3)
each of five##2##3##(1993-1#1)(2008-10#1)
each of four##2##3##(2008-10#2)
each of seven##2##3##(1995-3#1)(2008-5#1)
each of several##3##3##(1994-9#1)(1996-3#1)(2008-10#1)
each of the 12##3##4##(2008-10#2)(2008-5#1)
each of the clinical##2##4##(1992-1#1)(1995-12#1)
each of the components of##2##5##(1995-5#1)(2008-10#1)
each of the components##3##4##(1992-9#1)(1995-5#1)(2008-10#1)
each of the compounds##2##4##(1991-3#1)(2008-10#1)
each of the eight##3##4##(2008-10#2)(2008-7#1)
each of the following four##3##5##(1991-2#1)(1992-2#1)(2008-10#1)
each of the following##4##4##(1991-2#1)(1992-2#1)(2008-10#1)(2008-9#1)
each of the four##8##4##(1994-2#1)(1994-5#1)(1995-12#1)(2008-10#5)
each of the individual##2##4##(1995-2#1)(1997-9#1)
each of the new##2##4##(1991-12#1)(2008-10#1)
each of the three main##3##5##(2008-10#1)(2012-2#1)(2012-3#1)
each of the three##15##4##(1991-2#1)(1995-11#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
each of the two groups##2##5##(1995-12#1)(2008-10#1)
each of the two##8##4##(1994-5#1)(1995-12#1)(1996-2#1)(2008-10#5)
each of the##117##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#4)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-9#1)(2008-1#1)(2008-10#57)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
each of them##5##3##(2008-10#2)(2010-10#1)(2012-3#1)(2013-1#1)
each of these factors##2##4##(2008-11#1)(2011-2#1)
each of these groups##2##4##(2008-10#1)(2008-11#1)
each of these pathways##2##4##(1995-12#1)(2008-4#1)
each of these processes##2##4##(2008-8#2)
each of these specific##2##4##(1994-2#1)(2008-11#1)
each of these syndromes##2##4##(2009-12#2)
each of these##50##3##(1991-1#1)(1991-5#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
each of three##13##3##(1991-2#1)(1992-2#1)(1992-3#1)(1995-8#1)(2008-10#7)(2012-2#1)(2013-1#1)
each of two##10##3##(1994-5#1)(1996-2#1)(2008-10#6)(2008-8#2)
each of which##10##3##(1992-12#1)(1994-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)
each of##255##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-12#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-9#1)(2008-1#3)(2008-10#113)(2008-11#13)(2008-12#2)(2008-3#6)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#2)
each oil##2##2##(2008-10#2)
each one and##2##3##(2008-10#2)
each one of the##3##4##(2008-10#2)(2008-5#1)
each one##11##2##(2008-10#8)(2008-5#1)(2011-2#1)(2013-1#1)
each orchard##4##2##(2008-10#4)
each other and also##2##4##(1993-3#1)(2008-10#1)
each other and##27##3##(1993-3#1)(1996-2#1)(1996-3#1)(2006-6#1)(2008-10#14)(2008-11#3)(2008-5#1)(2008-8#1)(2010-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
each other as well as with##2##6##(1993-8#1)(2008-10#1)
each other in the##4##4##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
each other in##12##3##(1992-12#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-7#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-5#1)
each other or##2##3##(2008-11#1)(2008-6#1)
each other than##5##3##(1993-6#1)(2008-10#3)(2008-8#1)
each other to##4##3##(1995-2#1)(1997-3#1)(2008-8#1)(2013-8#1)
each other##136##2##(1991-10#1)(1991-12#2)(1992-12#1)(1992-6#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-8#3)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#46)(2008-11#11)(2008-12#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#8)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
each other's##3##2##(2008-11#1)(2009-6#1)(2010-11#1)
each other?##2##2##(2008-8#1)(2011-2#1)
each parental species and##2##4##(2008-10#1)(2012-3#1)
each parental##4##2##(1997-7#1)(2008-10#1)(2008-4#1)(2012-3#1)
each participant##3##2##(2008-11#1)(2009-1#1)(2013-1#1)
each particular##2##2##(2008-10#1)(2008-11#1)
each party##2##2##(1996-2#2)
each passage##2##2##(2013-1#1)(2013-8#1)
each pathogen##3##2##(2008-10#2)(2013-8#1)
each patient and##3##3##(2008-10#1)(2009-6#1)(2011-3#1)
each patient will##2##3##(2011-2#1)(2013-8#1)
each patient##30##2##(1991-3#1)(1991-5#1)(1992-9#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
each patient's##5##2##(1991-2#1)(1992-9#1)(2008-6#1)(2012-3#1)(2013-1#1)
each perturbation##2##2##(2008-10#2)
each phase of##2##3##(1991-2#1)(1991-3#1)
each phase##3##2##(1991-2#1)(1991-3#1)(2008-10#1)
each pixel is##2##3##(2008-10#1)(2008-3#1)
each pixel##3##2##(2008-10#1)(2008-3#2)
each plant##5##2##(2008-10#2)(2008-8#1)(2010-11#1)(2011-2#1)
each plot##6##2##(2008-10#6)
each point##3##2##(2008-10#2)(2012-2#1)
each population##6##2##(2008-10#5)(2009-8#1)
each position##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
each probe was##2##3##(2008-10#2)
each probe##4##2##(2008-10#3)(2008-8#1)
each procedure##3##2##(1993-12#1)(2008-10#2)
each protein was##2##3##(2008-10#1)(2008-8#1)
each protein##6##2##(1995-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
each pure##2##2##(2008-10#2)
each putative##2##2##(2008-10#2)
each quadrat##5##2##(2008-10#5)
each race##3##2##(2008-10#2)(2013-8#1)
each rat##2##2##(1997-2#1)(2008-11#1)
each reagent##3##2##(2008-10#3)
each receptor##2##2##(1995-11#1)(1997-2#1)
each region to##2##3##(2008-10#2)
each region##7##2##(1995-3#1)(2008-10#4)(2008-11#1)(2012-3#1)
each representing##2##2##(2008-10#1)(2010-4#1)
each research##2##2##(2008-11#1)(2013-1#1)
each sample injection##2##3##(2008-10#2)
each sample was##3##3##(2008-10#3)
each sample##26##2##(1991-3#1)(2008-10#22)(2008-4#1)(2008-9#1)(2009-11#1)
each sampling date##2##3##(2008-10#1)(2012-8#1)
each sampling##6##2##(2008-10#4)(2008-12#1)(2012-8#1)
each scan##2##2##(1992-3#1)(2011-2#1)
each scattering component##2##3##(2008-3#2)
each scenario##3##2##(1996-1#1)(2008-11#1)(2013-8#1)
each season##6##2##(2008-10#6)
each sector's##2##2##(1991-12#1)(1991-6#1)
each selected##2##2##(2008-10#1)(2013-1#1)
each sensillum type##2##3##(2007-12#2)
each sensor##2##2##(2008-10#2)
each sequence##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
each session##2##2##(2010-12#1)(2011-2#1)
each set of##2##3##(2008-10#1)(2009-1#1)
each set##3##2##(2008-10#1)(2008-5#1)(2009-1#1)
each sex##4##2##(2008-8#3)(2008-9#1)
each signal##2##2##(1997-7#1)(2010-8#1)
each single offspring##2##3##(2008-8#2)
each single##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
each site##3##2##(2008-10#3)
each solution##2##2##(2008-10#1)(2008-12#1)
each specialized for##2##3##(2007-12#1)(2008-11#1)
each species has##2##3##(2010-4#1)(2010-7#1)
each species were##2##3##(2008-10#1)(2008-8#1)
each species##25##2##(2008-10#9)(2008-12#1)(2008-7#1)(2008-8#3)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2012-5#1)
each specific##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
each stage of the##3##4##(1995-9#1)(2008-12#1)(2013-8#1)
each stage of##6##3##(1995-9#1)(2008-12#1)(2008-4#1)(2010-12#1)(2013-8#2)
each stage##12##2##(1993-12#1)(1995-1#1)(1995-9#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#2)
each state##4##2##(1992-2#1)(1996-2#1)(2008-10#2)
each step of##2##3##(1992-5#1)(2009-3#1)
each step##5##2##(1992-5#1)(1994-1#1)(2008-10#1)(2008-11#1)(2009-3#1)
each strain and##3##3##(2008-10#2)(2012-3#1)
each strain was##2##3##(2008-10#2)
each strain##10##2##(1993-9#1)(2008-10#6)(2008-9#1)(2012-3#2)
each strategy##2##2##(2008-12#1)(2008-8#1)
each structural##2##2##(1990-9#1)(2008-10#1)
each study##5##2##(2008-10#2)(2008-6#2)(2012-3#1)
each subgroup##2##2##(2008-10#2)
each subject##4##2##(2008-11#1)(2008-5#2)(2010-8#1)
each subunit##5##2##(1990-5#2)(1992-6#1)(1994-5#1)(2008-9#1)
each symptom dimension##2##3##(2011-2#2)
each symptom##3##2##(2008-7#1)(2011-2#2)
each technique##6##2##(2008-10#4)(2010-7#1)(2012-3#1)
each test sample##2##3##(2008-10#1)(2008-4#1)
each test##3##2##(2008-10#2)(2008-4#1)
each time##7##2##(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-10#1)(2011-2#1)(2012-2#1)
each tissue##3##2##(1990-2#1)(2008-11#1)(2012-2#1)
each treatment group##5##3##(1992-6#1)(1994-9#2)(2012-3#1)(2013-1#1)
each treatment##13##2##(1992-6#1)(1994-12#1)(1994-9#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
each tree##5##2##(2008-10#5)
each trial##8##2##(1994-3#1)(2008-5#3)(2009-10#2)(2010-5#1)(2013-8#1)
each triangle is##2##3##(2008-6#2)
each type of##8##3##(1990-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)
each type##9##2##(1990-5#1)(2008-10#5)(2008-3#1)(2008-5#1)(2011-2#1)
each variable##3##2##(1992-1#1)(2008-10#1)(2013-1#1)
each virus##6##2##(2008-10#5)(2008-5#1)
each vitamin##5##2##(2008-10#2)(2008-5#3)
each was##5##2##(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
each wavelength##2##2##(2008-2#1)(2008-3#1)
each week from##2##3##(2008-10#2)
each week##7##2##(2008-10#2)(2008-12#1)(2011-2#3)(2012-12#1)
each were##6##2##(1993-8#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-5#1)(2010-7#1)
each whey##2##2##(2008-10#2)
each wine##2##2##(2008-10#2)
each with a different##2##4##(2008-7#1)(2010-10#1)
each with a##4##3##(2007-9#1)(2008-7#1)(2010-10#1)(2011-2#1)
each with strong bootstrap support##2##5##(2008-10#2)
each with##14##2##(1995-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
each yard##2##2##(2008-10#2)
each year and##2##3##(1990-6#1)(2013-8#1)
each year from##2##3##(1992-12#1)(2008-10#1)
each year in##2##3##(2008-10#1)(2008-11#1)
each year level##2##3##(1993-12#2)
each year of##2##3##(2008-10#1)(2011-1#1)
each year##32##2##(1990-2#1)(1990-6#1)(1991-1#1)(1992-12#1)(1993-12#2)(1994-9#2)(2008-10#14)(2008-11#2)(2008-12#1)(2010-10#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2013-8#1)
each##1917##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#7)(1990-3#1)(1990-5#4)(1990-6#2)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#10)(1991-2#10)(1991-3#4)(1991-5#6)(1991-6#6)(1991-7#1)(1992-1#3)(1992-10#1)(1992-12#6)(1992-2#7)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#5)(1992-9#8)(1993-1#3)(1993-12#13)(1993-2#3)(1993-3#5)(1993-6#4)(1993-8#7)(1993-9#3)(1994-1#5)(1994-11#1)(1994-12#12)(1994-2#8)(1994-3#8)(1994-5#14)(1994-6#2)(1994-8#2)(1994-9#10)(1995-1#4)(1995-11#7)(1995-12#13)(1995-2#16)(1995-3#6)(1995-5#5)(1995-6#3)(1995-8#5)(1995-9#3)(1996-1#7)(1996-11#2)(1996-12#16)(1996-2#16)(1996-3#8)(1996-5#4)(1996-6#2)(1997-1#4)(1997-2#11)(1997-3#11)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#8)(1997-9#2)(2006-6#2)(2007-11#1)(2007-12#15)(2007-9#1)(2008-1#7)(2008-10#761)(2008-11#108)(2008-12#32)(2008-2#6)(2008-3#37)(2008-4#20)(2008-5#49)(2008-6#13)(2008-7#35)(2008-8#57)(2008-9#36)(2009-1#2)(2009-10#10)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#5)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#9)(2010-11#10)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#7)(2010-5#4)(2010-6#3)(2010-7#9)(2010-8#13)(2010-9#5)(2011-1#7)(2011-10#2)(2011-2#77)(2011-3#4)(2012-12#7)(2012-2#38)(2012-3#26)(2012-5#2)(2012-8#1)(2012-9#1)(2013-1#56)(2013-7#2)(2013-8#24)
each) and##2##2##(2008-10#1)(2008-11#1)
each) were##2##2##(2008-11#1)(2008-12#1)
each)##9##1##(1994-11#1)(1994-5#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2012-3#1)
ear and kernel rot of corn##2##6##(2008-10#2)
ear and kernel rot##4##4##(2008-10#4)
ear and nose##2##3##(2008-7#2)
ear and##8##2##(2008-10#5)(2008-7#2)(2013-1#1)
ear circumference##2##2##(2008-7#2)
ear height and GLS##2##4##(2008-10#2)
ear height##4##2##(2008-10#4)
ear or##2##2##(1994-9#1)(2008-9#1)
ear rot and aflatoxin production in##2##6##(2008-10#2)
ear rot and aflatoxin production##6##5##(2008-10#6)
ear rot and aflatoxin##7##4##(2008-10#7)
ear rot and##11##3##(2008-10#11)
ear rot severity##3##3##(2008-10#3)
ear rot##21##2##(2008-10#21)
ear rots and##3##3##(2008-10#3)
ear rots##6##2##(2008-10#6)
ear was##2##2##(1990-12#1)(2009-1#1)
ear##104##1##(1990-12#1)(1991-3#4)(1993-2#2)(1994-2#1)(1994-9#3)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#51)(2008-11#1)(2008-5#1)(2008-7#7)(2008-9#9)(2009-1#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#6)(2012-3#6)(2013-1#1)(2013-7#1)
earlier and##9##2##(1992-3#1)(1996-12#1)(2008-10#3)(2008-7#2)(2011-2#1)(2013-8#1)
earlier as a##2##3##(1991-11#1)(2008-7#1)
earlier data##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
earlier detection and##2##3##(2008-7#1)(2010-12#1)
earlier detection##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2011-7#1)
earlier development##2##2##(1993-6#1)(2011-2#1)
earlier diagnosis##2##2##(2011-2#1)(2012-2#1)
earlier finding that##2##3##(1997-2#1)(2008-10#1)
earlier findings that##2##3##(1991-6#1)(1994-11#1)
earlier findings##3##2##(1991-6#1)(1992-12#1)(1994-11#1)
earlier from##2##2##(2008-10#1)(2012-3#1)
earlier in the##4##3##(1995-12#1)(2008-10#2)(2008-7#1)
earlier in this##2##3##(2008-9#1)(2011-2#1)
earlier in##12##2##(1995-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
earlier models##3##2##(2008-8#1)(2010-10#1)(2012-2#1)
earlier onset##2##2##(2008-11#1)(2013-1#1)
earlier reported##2##2##(1990-2#1)(2012-2#1)
earlier reports of##2##3##(1993-6#1)(2008-10#1)
earlier reports##6##2##(1991-12#1)(1993-6#1)(1996-6#1)(2008-10#2)(2008-2#1)
earlier stage of##3##3##(1992-5#1)(1997-7#1)(2010-1#1)
earlier stage##5##2##(1992-3#1)(1992-5#1)(1997-7#1)(2010-1#1)(2011-2#1)
earlier stages and##2##3##(1997-7#1)(2011-2#1)
earlier studies we have##2##4##(2008-10#1)(2008-7#1)
earlier studies##15##2##(1990-11#1)(1990-8#1)(1991-6#1)(1993-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-3#1)
earlier than in##2##3##(1991-3#1)(2009-6#1)
earlier than the##4##3##(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
earlier than##14##2##(1991-3#1)(1994-8#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-9#1)(2009-6#2)(2010-6#1)(2011-2#2)(2013-1#1)
earlier that##2##2##(2008-11#1)(2009-12#1)
earlier use of##2##3##(1995-12#1)(2010-8#1)
earlier was##3##2##(2008-10#1)(2009-8#2)
earlier work##7##2##(1991-12#1)(2008-10#5)(2008-11#1)
earlier##233##1##(1990-11#1)(1990-2#3)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-6#3)(1992-12#1)(1992-3#3)(1992-5#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#52)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#5)(2008-7#8)(2008-8#11)(2008-9#3)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#20)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#3)(2012-4#1)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#4)
earliest stage##2##2##(1995-1#1)(2008-4#1)
earliest stages##5##2##(2008-10#2)(2008-9#1)(2010-10#1)(2012-7#1)
earliest##28##1##(1990-2#1)(1991-5#1)(1992-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-3#1)(2012-7#1)
early 1980s##6##2##(1994-2#1)(1995-6#1)(1996-11#1)(1996-5#2)(2008-5#1)
early 1990s in##2##3##(2008-10#2)
early 1990s##11##2##(1993-3#1)(2008-10#7)(2008-12#1)(2008-6#1)(2010-12#1)
early 2006##2##2##(2008-12#1)(2009-5#1)
early April##3##2##(1992-6#2)(2010-8#1)
early CT##2##2##(1990-3#2)
early ERCP##3##2##(2013-1#3)
early July##2##2##(2008-10#1)(2010-8#1)
early June##2##2##(2008-10#2)
early PD##2##2##(2008-7#1)(2010-12#1)
early Parkinson's disease##2##3##(2008-7#1)(2010-12#1)
early abortion##2##2##(2008-10#1)(2008-8#1)
early activation of##2##3##(2009-6#2)
early activation##4##2##(1992-3#1)(2008-9#1)(2009-6#2)
early adolescence##5##2##(1990-6#1)(2009-7#2)(2010-1#2)
early adolescents##5##2##(2008-12#3)(2009-7#2)
early adolescents'##2##2##(2009-7#1)(2010-1#1)
early after the##2##3##(2011-2#2)
early age##5##2##(2008-10#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
early alterations##2##2##(1992-12#1)(2012-2#1)
early and advanced##2##3##(1991-3#2)
early and late phase##2##4##(2008-11#1)(2010-8#1)
early and late replicating##2##4##(2008-12#2)
early and late##17##3##(1995-8#1)(1996-11#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2010-8#1)(2013-1#1)
early and##31##2##(1991-3#2)(1992-5#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#2)(2009-8#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-7#1)(2013-1#1)(2013-8#2)
early appearance of##2##3##(2008-4#1)(2013-1#1)
early appearance##3##2##(2008-4#1)(2009-4#1)(2013-1#1)
early as##27##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-12#1)(1997-3#2)(2008-10#8)(2008-12#2)(2008-7#3)(2009-7#1)(2010-4#1)(2011-4#1)(2012-3#1)(2013-1#2)
early assessment of##3##3##(2008-10#2)(2013-8#1)
early blight##2##2##(1992-8#1)(2008-10#1)
early breast cancer##9##3##(1992-2#1)(1993-11#1)(1993-9#1)(1994-12#2)(2011-2#4)
early brown rot infections##2##4##(2008-10#2)
early by##3##2##(2008-10#2)(2008-8#1)
early care##2##2##(1991-6#1)(2008-11#1)
early child development##3##3##(2008-11#2)(2013-8#1)
early child##4##2##(2008-11#3)(2013-8#1)
early childhood##17##2##(1997-7#1)(2007-8#1)(2008-11#5)(2008-4#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
early clinical##5##2##(1997-3#1)(2008-11#1)(2008-7#1)(2010-11#1)(2013-1#1)
early complications##3##2##(1991-9#1)(1994-12#1)(1996-3#1)
early control##4##2##(2008-12#1)(2013-1#3)
early coronary##3##2##(1992-9#1)(2008-11#2)
early cv##2##2##(2008-10#2)
early days##3##2##(2008-11#1)(2009-10#1)(2012-2#1)
early decades of the##2##4##(2008-10#1)(2010-1#1)
early dendritic injury##2##3##(2008-7#2)
early detection and intervention##2##4##(2008-11#1)(2012-2#1)
early detection and treatment##2##4##(1995-12#1)(2010-5#1)
early detection and##6##3##(1995-12#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
early detection of contralateral##2##4##(1990-8#2)
early detection of the##3##4##(2008-10#2)(2009-12#1)
early detection of##20##3##(1990-2#1)(1990-8#2)(1993-11#1)(1993-3#1)(1994-12#2)(1995-9#1)(2008-10#3)(2008-12#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-7#1)
early detection##38##2##(1990-2#1)(1990-8#2)(1991-3#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-12#1)(1995-9#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#2)(2009-12#1)(2009-4#2)(2009-5#1)(2010-12#3)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
early development and##2##3##(1995-12#1)(2008-11#1)
early development instrument##2##3##(2008-11#2)
early development of the reconstructed egg##2##6##(2008-9#2)
early development of the##3##4##(1993-3#1)(2008-9#2)
early development of##6##3##(1993-12#1)(1993-3#1)(2008-4#1)(2008-9#2)(2010-12#1)
early development##15##2##(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(2008-11#4)(2008-4#2)(2008-9#2)(2009-8#1)(2010-12#1)(2013-1#1)
early developmental##2##2##(2008-10#1)(2009-8#1)
early diagnosis and prompt treatment##2##5##(2008-12#1)(2013-1#1)
early diagnosis and prompt##3##4##(2008-12#1)(2010-5#1)(2013-1#1)
early diagnosis and treatment##4##4##(1990-6#1)(2011-2#1)(2013-1#2)
early diagnosis and##19##3##(1990-6#1)(1992-3#1)(1992-9#1)(1993-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#2)(2010-5#1)(2011-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
early diagnosis of prostatic carcinoma##2##5##(1991-2#2)
early diagnosis of##9##3##(1990-6#1)(1990-9#1)(1991-2#2)(1992-5#1)(1993-2#1)(1993-3#1)(2010-3#1)(2011-2#1)
early diagnosis##39##2##(1990-3#1)(1990-6#2)(1990-9#2)(1991-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(2008-11#2)(2008-12#2)(2008-5#1)(2009-1#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-1#7)(2013-7#1)(2013-8#1)
early discrimination of##2##3##(2008-10#2)
early disease##3##2##(1996-2#1)(2008-10#2)
early drinking##2##2##(2008-12#2)
early embryo##6##2##(2007-12#2)(2008-10#1)(2008-9#1)(2009-8#1)(2012-3#1)
early embryogenesis##3##2##(1997-8#1)(2008-11#1)(2008-6#1)
early embryonic development##2##3##(1995-2#1)(2012-2#1)
early embryonic mitoses##2##3##(2012-3#2)
early embryonic ventricular##2##3##(2008-11#2)
early embryonic##10##2##(1995-2#1)(2007-12#2)(2008-11#2)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#2)
early embryos##4##2##(1993-3#1)(1993-6#1)(2012-3#2)
early enough##3##2##(2011-3#2)(2012-2#1)
early event##4##2##(1990-7#1)(1991-1#1)(2009-12#2)
early events in##2##3##(1995-2#1)(2012-2#1)
early events##4##2##(1995-2#1)(2008-10#1)(2012-2#2)
early evolution of##2##3##(2008-9#1)(2009-6#1)
early experience##4##2##(1992-2#1)(1997-6#1)(2011-2#1)(2012-12#1)
early experiences of##2##3##(2008-11#1)(2009-12#1)
early family formation##2##3##(2011-2#2)
early flowering##3##2##(1997-8#1)(2008-10#2)
early forms of ARM##2##4##(2011-2#2)
early gastric cancer##3##3##(1990-9#2)(2008-12#1)
early gastric##6##2##(1990-9#3)(1992-9#1)(2008-12#1)(2009-8#1)
early gene##4##2##(1991-5#1)(1993-9#1)(1994-11#1)(2009-12#1)
early harvest##2##2##(2008-10#2)
early human##2##2##(1995-8#2)
early identification and##4##3##(1991-6#1)(2009-6#1)(2011-1#1)(2013-1#1)
early identification of patients at risk of##2##7##(1992-12#1)(2008-8#1)
early identification of patients at##3##5##(1992-12#2)(2008-8#1)
early identification of patients with##2##5##(1990-3#1)(2010-10#1)
early identification of patients##5##4##(1990-3#1)(1992-12#2)(2008-8#1)(2010-10#1)
early identification of this##2##4##(2010-12#1)(2012-12#1)
early identification of##9##3##(1990-3#1)(1992-12#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-12#1)
early identification##14##2##(1990-3#1)(1991-6#1)(1992-12#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
early implantation##2##2##(2008-9#2)
early in a##2##3##(2008-10#1)(2008-11#1)
early in adolescence##2##3##(2009-7#1)(2013-1#1)
early in development and##2##4##(2008-10#1)(2008-7#1)
early in evolution##2##3##(1993-6#1)(1994-3#1)
early in life##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
early in the course of##5##5##(1996-11#1)(2008-2#1)(2011-2#2)(2013-7#1)
early in the first##2##4##(2008-10#1)(2009-7#1)
early in the growing season##2##5##(2008-10#2)
early in the process##2##4##(2008-10#1)(2008-8#1)
early in the season##3##4##(2008-10#2)(2008-8#1)
early in the##24##3##(1995-12#1)(1996-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#4)(2009-7#1)(2011-2#2)(2013-7#1)
early in##46##2##(1990-9#1)(1992-10#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
early induction phase of drug-induced##2##5##(2008-10#2)
early induction##4##2##(1996-12#1)(1997-8#1)(2008-10#2)
early infancy##5##2##(1996-9#1)(2008-11#1)(2010-11#1)(2010-6#1)(2013-1#1)
early infection##3##2##(1997-5#1)(2008-10#1)(2008-11#1)
early initiation of##2##3##(1991-1#1)(2011-2#1)
early intervention services##3##3##(1994-1#3)
early intervention##18##2##(1991-12#1)(1992-12#1)(1994-1#3)(1995-1#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-9#2)(2010-10#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
early interventions##2##2##(1991-12#1)(1997-1#1)
early introduction of##2##3##(2008-10#1)(2011-2#1)
early invaders of the##2##4##(2008-11#2)
early leaf spot epidemics##2##4##(2008-10#2)
early leaf spot##4##3##(2008-10#4)
early learning##2##2##(2008-11#2)
early life stages of##2##4##(2010-8#2)
early life stages##3##3##(2010-8#2)(2012-12#1)
early life##10##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#2)
early literacy##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
early management##2##2##(2011-2#1)(2013-8#1)
early middle##2##2##(1990-8#1)(2011-2#1)
early mobilization##2##2##(2010-5#1)(2011-2#1)
early modern##3##2##(2008-11#3)
early morning##5##2##(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-7#1)
early mortality##3##2##(1992-1#1)(1992-9#1)(2008-1#1)
early mouse##2##2##(1997-7#1)(2008-11#1)
early neonatal##3##2##(1996-11#1)(2011-1#1)(2012-2#1)
early nonresponse criterion or response criterion##2##6##(2012-3#2)
early obliteration##3##2##(2012-3#3)
early on in the##3##4##(1994-1#1)(2008-10#1)(2011-2#1)
early on##4##2##(1994-1#1)(2008-10#2)(2011-2#1)
early onset and##2##3##(1997-3#1)(2011-1#1)
early onset##10##2##(1996-2#2)(1997-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)
early or late##3##3##(2011-2#1)(2011-3#1)(2013-1#1)
early or##4##2##(2011-2#1)(2011-3#1)(2013-1#2)
early part of##3##3##(1991-8#1)(2008-9#1)(2012-2#1)
early participants##2##2##(2012-2#2)
early passage##2##2##(2008-10#1)(2008-5#1)
early phase clinical##2##3##(2011-2#1)(2013-1#1)
early phase of##6##3##(1993-9#1)(1994-11#1)(1996-2#1)(2008-9#1)(2010-1#1)(2012-2#1)
early phase##12##2##(1993-9#1)(1994-11#1)(1996-2#1)(2008-12#1)(2008-9#1)(2010-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
early phases of##5##3##(1995-3#1)(2008-11#1)(2012-12#1)(2012-2#2)
early phases##6##2##(1991-8#1)(1995-3#1)(2008-11#1)(2012-12#1)(2012-2#2)
early planned operation##4##3##(1997-8#4)
early planned##5##2##(1997-8#5)
early plant growth##2##3##(2009-8#2)
early plant##3##2##(2008-10#1)(2009-8#2)
early post-operative##2##2##(2012-2#1)(2013-1#1)
early post-traumatic##2##2##(2008-8#1)(2011-2#1)
early postnatal life##2##3##(1994-2#1)(2008-11#1)
early postnatal period##3##3##(1990-5#1)(2008-11#1)(2010-1#1)
early postnatal##6##2##(1990-5#2)(1994-2#1)(2008-11#2)(2010-1#1)
early postoperative mortality##2##3##(2011-2#1)(2011-3#1)
early postoperative period##7##3##(1991-2#1)(1994-3#1)(2007-11#1)(2011-2#1)(2012-3#3)
early postoperative##16##2##(1991-2#1)(1992-5#1)(1994-3#1)(2007-11#1)(2008-9#1)(2011-2#6)(2011-3#1)(2012-3#4)
early pre-ecdysis##2##2##(2008-7#2)
early pregnancy##12##2##(1990-11#2)(1991-6#1)(1993-12#3)(1995-8#3)(2012-2#1)(2012-3#2)
early promoter##6##2##(1995-6#1)(1997-8#1)(2008-11#3)(2008-8#1)
early promoters##2##2##(1995-2#1)(1997-8#1)
early psychosis&quot##3##2##(2013-8#3)
early reading##2##2##(2008-11#1)(2008-12#1)
early recognition and##2##3##(2010-6#1)(2013-1#1)
early recognition of##2##3##(2008-11#1)(2012-12#1)
early recognition##7##2##(2008-11#1)(2010-6#1)(2012-12#2)(2012-3#2)(2013-1#1)
early recovery##2##2##(2010-4#1)(2010-7#1)
early referral##2##2##(2008-1#2)
early repolarization syndrome##3##3##(2012-3#3)
early repolarization##5##2##(2010-1#1)(2012-3#4)
early response##2##2##(1992-7#1)(2010-12#1)
early results are##2##3##(1995-11#1)(2011-2#1)
early results##6##2##(1995-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
early risk##3##2##(1991-12#1)(2008-10#1)(2012-3#1)
early season##2##2##(2008-10#2)
early secretory##2##2##(2008-10#1)(2008-7#1)
early sexual activity##4##3##(2013-8#4)
early sexual##7##2##(2009-12#1)(2013-8#6)
early signaling events##4##3##(1991-3#1)(2008-10#3)
early signaling##5##2##(1991-3#1)(2008-10#4)
early spermatids##2##2##(2008-7#2)
early spermatogenic cyst##3##3##(2012-2#3)
early spring infections##2##3##(2008-10#2)
early spring##9##2##(2008-10#8)(2011-2#1)
early stage of the##4##4##(1991-12#1)(2008-10#2)(2008-9#1)
early stage of##28##3##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1995-12#1)(1997-8#1)(2007-9#1)(2008-10#7)(2008-5#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
early stage##44##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1997-7#1)(1997-8#2)(2007-12#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
early stages of development##3##4##(2008-6#1)(2011-2#1)(2013-1#1)
early stages of embryonic development##2##5##(2007-12#1)(2008-11#1)
early stages of the disease##2##5##(2008-10#1)(2008-11#1)
early stages of##37##3##(1993-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#3)(2011-10#1)(2011-2#2)(2013-1#5)(2013-8#1)
early stages##48##2##(1993-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-6#1)(2010-7#1)(2010-8#5)(2011-10#1)(2011-2#5)(2013-1#5)(2013-8#1)
early step##3##2##(1994-12#1)(1994-3#1)(2008-10#1)
early steps of##2##3##(2008-4#1)(2011-2#1)
early steps##3##2##(2008-4#1)(2009-8#1)(2011-2#1)
early studies##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
early summer##2##2##(1993-6#1)(2008-10#1)
early surgical intervention##2##3##(1994-6#1)(2012-2#1)
early surgical##5##2##(1990-9#1)(1994-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
early symptoms of##2##3##(1992-9#1)(2008-10#1)
early therapeutic##2##2##(2011-2#1)(2013-1#1)
early time##2##2##(2008-11#1)(2012-4#1)
early to##11##2##(1991-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#2)(2011-3#2)
early treatment of##2##3##(2008-6#1)(2008-9#1)
early treatment##6##2##(1990-12#1)(1996-11#1)(2008-6#1)(2008-9#2)(2010-11#1)
early twentieth century##4##3##(2008-10#1)(2008-12#1)(2010-1#1)(2012-12#1)
early twentieth##6##2##(2008-10#1)(2008-12#1)(2010-1#3)(2012-12#1)
early twentieth-century##2##2##(2010-1#2)
early vascular and neurological complications of supracondylar humerus fractures in##2##10##(2013-1#2)
early warning##4##2##(1992-12#1)(2008-10#3)
early work##2##2##(2010-7#1)(2012-2#1)
early years of##4##3##(1992-2#1)(1993-12#1)(2008-10#1)(2010-1#1)
early years##7##2##(1992-2#1)(1993-12#1)(2008-10#1)(2008-11#3)(2010-1#1)
early##1178##1##(1990-11#6)(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#7)(1990-9#10)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#7)(1991-5#4)(1991-6#5)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#8)(1992-2#4)(1992-3#2)(1992-5#4)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#7)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#4)(1993-3#9)(1993-6#3)(1993-8#3)(1993-9#4)(1994-1#5)(1994-11#2)(1994-12#8)(1994-2#3)(1994-3#11)(1994-6#3)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#1)(1995-6#3)(1995-8#6)(1995-9#2)(1996-11#8)(1996-12#6)(1996-2#5)(1996-3#5)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#12)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#17)(2007-11#2)(2007-12#14)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#170)(2008-11#89)(2008-12#34)(2008-2#1)(2008-3#4)(2008-4#11)(2008-5#20)(2008-6#9)(2008-7#27)(2008-8#24)(2008-9#32)(2009-1#4)(2009-10#2)(2009-11#1)(2009-12#9)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#5)(2009-7#14)(2009-8#19)(2009-9#2)(2010-1#16)(2010-10#3)(2010-11#12)(2010-12#15)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#6)(2010-6#10)(2010-7#6)(2010-8#15)(2010-9#3)(2011-1#8)(2011-10#1)(2011-2#85)(2011-3#10)(2011-4#1)(2011-8#3)(2012-12#11)(2012-2#30)(2012-3#40)(2012-4#1)(2012-7#1)(2013-1#70)(2013-7#5)(2013-8#24)
early&quot##3##1##(1991-12#1)(2008-8#1)(2011-2#1)
early- and##2##2##(2008-10#1)(2010-12#1)
early-##4##1##(2008-10#2)(2010-12#1)(2011-2#1)
early-life##3##1##(2008-10#1)(2009-5#2)
early-onset##8##1##(1991-2#1)(1995-8#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-3#3)
early-phase##3##1##(1994-12#1)(2010-5#2)
early-season##2##1##(2008-10#2)
early-stage##7##1##(1995-9#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-12#2)(2013-8#1)
earmarked##2##1##(1994-9#1)(2008-10#1)
earn a##2##2##(1992-12#1)(2008-12#1)
earn##4##1##(1991-3#1)(1992-12#1)(1997-5#1)(2008-12#1)
earning##3##1##(1994-12#2)(2008-11#1)
earnings and##2##2##(1995-2#1)(2008-10#1)
earnings in##4##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-12#1)
earnings##14##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#2)(1993-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)
ears and tassels##2##3##(2008-8#2)
ears and##3##2##(2008-7#1)(2008-8#2)
ears was##2##2##(2008-10#1)(2008-8#1)
ears were##2##2##(2008-10#2)
ears##29##1##(1991-3#1)(2008-10#9)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#8)(2011-2#2)(2012-3#3)
earth and##8##2##(2008-10#7)(2010-11#1)
earth ions##2##2##(2008-10#2)
earth metal ions##6##3##(2008-10#6)
earth metal##17##2##(2008-10#17)
earth metals##9##2##(2008-10#9)
earth##101##1##(2008-10#95)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
earthquake and the##2##3##(1990-11#1)(2013-1#1)
earthquake and##3##2##(1990-11#1)(1992-12#1)(2013-1#1)
earthquake##16##1##(1990-11#5)(1992-12#1)(2013-1#7)(2013-8#3)
earthquakes##5##1##(1990-11#4)(2010-8#1)
earths##19##1##(2008-10#19)
earthworm gut metagenome##2##3##(2011-1#2)
earthworm##8##1##(2008-5#3)(2008-7#1)(2008-9#1)(2011-1#2)(2012-3#1)
earthworms##6##1##(2008-10#4)(2008-12#2)
ease and##3##2##(2008-10#1)(2009-5#1)(2012-3#1)
ease in##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#2)
ease of discovery##2##3##(2012-2#2)
ease of gastric tube placement##2##5##(2010-7#2)
ease of handling##2##3##(2008-10#1)(2008-9#1)
ease of insertion##2##3##(2010-7#2)
ease of operation##3##3##(2008-10#1)(2008-11#2)
ease of use##3##3##(1997-2#1)(2012-3#1)(2013-1#1)
ease of##40##2##(1994-12#1)(1997-2#1)(2008-10#14)(2008-11#3)(2008-6#1)(2008-9#2)(2009-12#1)(2010-7#4)(2010-9#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
ease the##3##2##(1992-1#1)(1996-1#1)(2008-11#1)
ease their##2##2##(1992-1#1)(2009-9#1)
ease##55##1##(1992-1#2)(1994-12#1)(1996-1#1)(1997-2#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-9#1)(2010-7#4)(2010-9#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
easier and safer##2##3##(1996-1#1)(1996-9#1)
easier and##6##2##(1991-3#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-9#1)
easier than##4##2##(2008-10#2)(2010-6#1)(2012-2#1)
easier to perform##2##3##(2008-10#1)(2008-4#1)
easier to##25##2##(1990-12#1)(1992-12#1)(1992-3#1)(1992-8#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-7#3)(2009-1#1)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
easier##54##1##(1990-11#1)(1990-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-3#1)(1996-1#2)(1996-9#1)(1997-7#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-4#2)(2008-7#3)(2008-9#2)(2009-1#1)(2009-12#1)(2010-6#2)(2010-7#2)(2011-2#4)(2012-2#2)(2013-1#2)
easiest##3##1##(1990-3#1)(2008-8#1)(2011-2#1)
easily accessible to##2##3##(2008-10#1)(2008-11#1)
easily accessible##4##2##(2008-10#2)(2008-11#1)(2010-7#1)
easily accomplished##2##2##(1995-8#1)(2008-10#1)
easily achieved##6##2##(2008-10#5)(2008-9#1)
easily adapted to##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
easily adapted##5##2##(2008-10#3)(2008-12#1)(2008-9#1)
easily and quickly##4##3##(1992-12#1)(2008-10#2)(2008-11#1)
easily and rapidly##2##3##(2008-10#1)(2008-11#1)
easily and##11##2##(1992-12#1)(2008-10#5)(2008-11#2)(2011-2#1)(2012-3#1)(2013-7#1)
easily available##9##2##(1990-6#1)(1996-5#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-12#1)
easily be##20##2##(1990-2#1)(1990-9#1)(1994-3#1)(1996-5#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2010-1#1)(2012-3#2)
easily by##2##2##(2008-10#1)(2008-7#1)
easily conjugated##2##2##(2008-10#2)
easily controlled##3##2##(1994-1#1)(2008-10#2)
easily converted##2##2##(2008-10#2)
easily detected in##2##3##(2008-10#2)
easily detected##9##2##(2006-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-6#1)
easily determined##4##2##(1993-1#1)(2008-10#2)(2008-8#1)
easily differentiated##2##2##(2008-10#1)(2008-5#1)
easily distinguish the##2##3##(2008-10#2)
easily eliminated by##4##3##(2008-10#4)
easily explained##2##2##(2008-10#2)
easily identified##3##2##(1992-2#1)(1996-12#1)(2008-10#1)
easily modified##2##2##(2008-10#1)(2008-5#1)
easily monitored by##2##3##(2008-10#1)(2008-11#1)
easily monitored##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
easily observed##2##2##(2007-11#1)(2008-8#1)
easily obtainable##2##2##(2008-10#2)
easily obtained##4##2##(1993-12#1)(1996-5#1)(2009-3#1)(2011-2#1)
easily on the##2##3##(1992-12#1)(2013-1#1)
easily oxidizable##2##2##(2008-10#2)
easily performed with a##2##4##(2008-10#1)(2011-2#1)
easily performed##7##2##(1990-12#1)(2008-10#3)(2010-11#2)(2011-2#1)
easily prepared##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
easily recognized##3##2##(2008-10#2)(2008-7#1)
easily regenerated by##2##3##(2008-10#2)
easily regenerated##5##2##(2008-10#5)
easily renewable by##4##3##(2008-10#4)
easily separated from##2##3##(2008-10#2)
easily separated##4##2##(2008-10#4)
easily than##4##2##(1997-3#1)(2008-12#1)(2008-8#1)(2012-2#1)
easily with##2##2##(2008-10#2)
easily##271##1##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#4)(1996-9#1)(1997-3#2)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#126)(2008-11#19)(2008-12#6)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#6)(2008-9#5)(2009-12#3)(2009-3#2)(2009-4#1)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
easiness##3##1##(2008-10#1)(2008-5#1)(2008-8#1)
easing##2##1##(2008-10#1)(2013-8#1)
east and##4##2##(2008-10#3)(2008-6#1)
east of##6##2##(1996-11#1)(2008-10#2)(2008-12#2)(2008-8#1)
east##17##1##(1996-11#1)(2008-10#10)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
east-west##3##1##(2008-10#3)
eastern Asia##3##2##(2008-8#2)(2008-9#1)
eastern Australia##2##2##(2008-10#2)
eastern Canada##3##2##(2008-10#1)(2009-6#1)(2010-8#1)
eastern Canadian##2##2##(2008-10#2)
eastern Europe##2##2##(2010-3#1)(2012-5#1)
eastern North America##8##3##(2008-10#6)(2008-8#2)
eastern North##9##2##(2008-10#7)(2008-8#2)
eastern and Western Australia##2##4##(2008-10#2)
eastern and western Germany##2##4##(2009-10#2)
eastern and western##10##3##(2008-10#8)(2009-10#2)
eastern and##13##2##(2008-10#11)(2009-10#2)
eastern filbert blight##4##3##(2008-10#4)
eastern populations##4##2##(2008-10#4)
eastern##82##1##(1996-6#1)(2008-10#54)(2008-11#1)(2008-5#1)(2008-8#6)(2008-9#3)(2009-10#3)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#3)(2011-2#1)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#2)
easy access to the##2##4##(1997-6#1)(2012-2#1)
easy access##4##2##(1997-6#1)(1997-8#1)(2008-4#1)(2012-2#1)
easy and##12##2##(1996-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-9#1)(2010-3#1)
easy construction##3##2##(1990-5#1)(2008-10#1)(2013-8#1)
easy for##3##2##(2008-10#1)(2008-5#1)(2010-9#1)
easy from##2##2##(2008-10#1)(2013-1#1)
easy identification##2##2##(1993-9#1)(2008-10#1)
easy quantification of##2##3##(2008-11#1)(2012-2#1)
easy to access##2##3##(2008-10#1)(2008-12#1)
easy to administer##3##3##(2008-7#1)(2010-7#1)(2010-8#1)
easy to adopt##2##3##(2011-2#1)(2012-12#1)
easy to apply##2##3##(2008-10#2)
easy to carry##3##3##(2008-10#3)
easy to handle and##2##4##(2008-10#1)(2008-11#1)
easy to implement##2##3##(2008-10#2)
easy to operate and##3##4##(2008-10#2)(2008-11#1)
easy to operate##4##3##(2008-10#3)(2008-11#1)
easy to perform##6##3##(1993-2#1)(2008-10#2)(2008-9#1)(2009-5#1)(2012-2#1)
easy to prepare##2##3##(2008-10#2)
easy to see how##2##4##(2008-11#1)(2011-2#1)
easy to see##3##3##(1994-12#1)(2008-11#1)(2011-2#1)
easy to use##12##3##(1991-11#1)(1991-9#1)(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
easy to##62##2##(1991-11#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-1#2)(1994-12#1)(1996-12#1)(1997-3#2)(2008-10#22)(2008-11#9)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#3)(2009-5#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-8#1)
easy way##4##2##(1997-2#1)(2008-10#2)(2013-8#1)
easy##153##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#3)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#3)(1996-3#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#58)(2008-11#16)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#6)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#5)
easy-to-implement##2##1##(2008-12#2)
easy-to-use##3##1##(2008-10#1)(2008-5#1)(2008-9#1)
eat##13##1##(1992-9#1)(1993-6#3)(1997-1#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)
eating and activity##2##3##(2009-6#1)(2013-1#1)
eating and physical activity##2##4##(2010-8#1)(2013-1#1)
eating and the##2##3##(2012-2#1)(2012-3#1)
eating and##7##2##(2009-6#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
eating disorder##4##2##(2008-11#1)(2010-11#1)(2012-2#2)
eating disorders and##2##3##(2010-11#1)(2012-2#1)
eating disorders##14##2##(1997-3#1)(2008-11#3)(2008-8#1)(2010-11#5)(2012-12#1)(2012-2#3)
eating disturbances##2##2##(2012-2#2)
eating habits and##2##3##(2010-7#1)(2012-2#1)
eating habits##5##2##(2010-1#3)(2010-7#1)(2012-2#1)
eating or##2##2##(1993-6#2)
eating times##2##2##(1993-6#2)
eating##63##1##(1993-6#6)(1994-3#1)(1997-3#1)(2008-10#2)(2008-11#7)(2008-4#1)(2008-8#1)(2009-6#1)(2010-1#6)(2010-11#7)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#15)(2012-3#1)(2013-1#4)
ebelactone B##5##2##(1995-6#1)(2010-10#4)
ebelactone##6##1##(1995-6#2)(2010-10#4)
eberconazole 1% cream##2##3##(2008-5#2)
eberconazole##5##1##(2008-5#5)
ecastophyllum##2##1##(2008-10#2)
eccentric##4##1##(2008-3#1)(2010-3#1)(2013-1#2)
eccrine sweat##7##2##(2008-5#7)
ecdysial##3##1##(2008-7#3)
ecdysone##4##1##(1995-8#3)(2008-6#1)
ecdysteroid secretion by##3##3##(1995-11#3)
ecdysteroid secretion is##2##3##(1995-11#2)
ecdysteroid secretion##9##2##(1995-11#9)
ecdysteroid titer##2##2##(1995-11#2)
ecdysteroid##14##1##(1995-11#12)(2008-6#1)(2008-9#1)
ecdysteroidogenesis##2##1##(1995-11#2)
ecdysteroids##6##1##(1995-11#1)(2008-9#3)(2012-2#2)
echinocandin##4##1##(2008-10#1)(2011-2#3)
echinocandins##3##1##(2008-10#1)(2011-2#2)
echinococcal cysts##2##2##(1995-12#1)(2008-7#1)
echinococcosis##7##1##(1993-6#4)(2008-12#1)(2012-2#2)
echinococcus##2##1##(2008-12#1)(2013-1#1)
echinomycin##5##1##(2008-10#5)
echo planar imaging##2##3##(1992-3#2)
echo signals##2##2##(2010-8#1)(2012-3#1)
echo was##3##2##(2009-5#1)(2012-3#2)
echo##14##1##(1992-3#2)(1993-2#1)(1996-1#1)(2008-1#2)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)
echo-poor or inhomogeneous##2##3##(1990-9#2)
echocardiogram##3##1##(2011-2#1)(2013-1#2)
echocardiograms##2##1##(2010-4#1)(2013-1#1)
echocardiographic findings##2##2##(2008-11#1)(2013-1#1)
echocardiographic recognition##2##2##(2008-11#2)
echocardiographic signs of ACP##2##4##(1991-11#2)
echocardiographic##13##1##(1990-8#1)(1991-11#3)(1997-5#2)(2008-10#1)(2008-11#3)(2011-2#1)(2012-3#1)(2013-1#1)
echocardiography and##4##2##(2008-11#2)(2008-7#1)(2011-2#1)
echocardiography are##2##2##(2010-10#1)(2012-2#1)
echocardiography has##2##2##(2011-2#2)
echocardiography revealed##2##2##(1997-4#1)(2013-1#1)
echocardiography was##3##2##(1991-11#1)(2011-2#2)
echocardiography##44##1##(1991-11#3)(1996-3#1)(1997-4#1)(1997-8#3)(2008-10#2)(2008-11#7)(2008-12#1)(2008-7#2)(2009-1#2)(2009-10#2)(2010-10#2)(2010-5#1)(2011-2#11)(2012-2#2)(2012-3#2)(2013-1#2)
echoes in##2##2##(1993-5#1)(2011-2#1)
echoes##5##1##(1993-5#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
echography##3##1##(1990-3#1)(1993-3#1)(2008-5#1)
echolocating##3##1##(2009-8#3)
eclampsia##2##1##(2013-1#2)
eclosion##3##1##(1995-11#1)(2008-10#1)(2008-6#1)
eco-friendly##5##1##(2008-10#4)(2011-2#1)
ecological adaptation##2##2##(2007-12#1)(2011-2#1)
ecological and epidemiological##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
ecological and social##2##3##(2008-8#1)(2008-9#1)
ecological and##11##2##(1997-7#1)(2008-10#1)(2008-8#5)(2008-9#2)(2010-12#1)(2012-5#1)
ecological approach##2##2##(2008-10#1)(2010-11#1)
ecological communities##8##2##(2008-8#4)(2008-9#3)(2013-1#1)
ecological conditions##4##2##(2008-11#1)(2008-8#1)(2012-2#2)
ecological constraints##12##2##(2008-10#1)(2008-8#11)
ecological factors##6##2##(1992-11#1)(2008-6#1)(2008-8#3)(2012-3#1)
ecological impacts of##2##3##(2008-11#2)
ecological interactions##3##2##(2008-9#2)(2009-8#1)
ecological isolating barrier##2##3##(2008-10#2)
ecological literature##2##2##(2008-11#1)(2008-9#1)
ecological model##3##2##(2008-1#1)(2010-11#2)
ecological niche##4##2##(1997-7#1)(2009-6#1)(2009-8#1)(2012-2#1)
ecological niches on citrus and##2##5##(2008-10#2)
ecological niches##5##2##(2008-10#4)(2011-2#1)
ecological or##3##2##(2008-10#1)(2008-8#1)(2010-12#1)
ecological populations##2##2##(2008-10#1)(2008-8#1)
ecological processes##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
ecological recovery##2##2##(2008-11#2)
ecological relevance##2##2##(1994-3#1)(2008-10#1)
ecological risk of##2##3##(2008-11#1)(2008-8#1)
ecological risk##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
ecological role##2##2##(2008-8#1)(2012-2#1)
ecological separation##2##2##(2008-8#1)(2012-2#1)
ecological studies##3##2##(1994-2#1)(2008-10#1)(2008-8#1)
ecological variation##2##2##(2012-2#1)(2012-3#1)
ecological##161##1##(1992-11#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-7#2)(2007-12#1)(2008-1#2)(2008-10#20)(2008-11#11)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#50)(2008-9#19)(2009-6#1)(2009-7#2)(2009-8#6)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#9)(2012-3#7)(2012-5#2)(2013-1#1)(2013-8#1)
ecologically relevant##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
ecologically##13##1##(2008-10#4)(2008-11#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2012-3#1)
ecologies##2##1##(2008-9#2)
ecologists##7##1##(2008-8#3)(2008-9#4)
ecology and##11##2##(2008-10#1)(2008-11#1)(2008-8#5)(2008-9#2)(2009-8#1)(2012-3#1)
ecology has##2##2##(2008-8#1)(2008-9#1)
ecology of the##4##3##(2008-10#1)(2008-5#1)(2009-10#1)(2010-8#1)
ecology of##16##2##(2007-12#1)(2008-10#8)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2013-1#1)
ecology##59##1##(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#14)(2008-9#11)(2009-10#1)(2009-8#2)(2010-1#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#2)
economic activity##3##2##(2010-7#1)(2011-2#2)
economic alternative##2##2##(2008-10#1)(2008-3#1)
economic analyses##2##2##(1993-12#2)
economic analysis##3##2##(1997-2#2)(2008-6#1)
economic and cultural##2##3##(1995-5#1)(2009-10#1)
economic and demographic##2##3##(1993-2#1)(2008-3#1)
economic and political##2##3##(2008-1#1)(2013-1#1)
economic and social##3##3##(1992-1#2)(2008-11#1)
economic and##17##2##(1992-1#2)(1993-2#1)(1995-5#1)(1996-1#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-6#1)(2013-1#1)
economic approach##2##2##(2008-10#2)
economic aspects of##3##3##(1993-12#2)(2011-2#1)
economic behavior##2##2##(1994-12#1)(2011-2#1)
economic benefit##2##2##(1994-2#1)(1996-3#1)
economic benefits of##2##3##(1996-1#1)(2008-10#1)
economic benefits##6##2##(1996-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
economic burden of##5##3##(1995-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-3#1)
economic burden to##2##3##(1995-11#1)(2009-8#1)
economic burden##7##2##(1995-11#2)(2007-12#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)
economic climate##2##2##(1992-12#1)(2008-11#1)
economic conditions##2##2##(1993-12#1)(1995-5#1)
economic cost##6##2##(1993-2#1)(2008-11#2)(2011-2#1)(2012-12#1)(2013-8#1)
economic costs##3##2##(2008-10#1)(2008-11#2)
economic crisis##2##2##(2012-2#1)(2013-8#1)
economic determinants of##2##3##(2009-10#2)
economic development##2##2##(1994-9#1)(2008-11#1)
economic evaluation##2##2##(2011-2#2)
economic factors##2##2##(1997-1#1)(2011-2#1)
economic gains from##2##3##(1994-3#2)
economic gains##3##2##(1994-3#3)
economic growth##5##2##(1994-2#3)(2008-11#2)
economic impact of the##2##4##(1997-2#1)(2008-10#1)
economic impact##7##2##(1992-6#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-7#2)
economic importance##8##2##(2008-10#4)(2008-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
economic issues##3##2##(1991-12#1)(2008-10#1)(2008-6#1)
economic levers##2##2##(1995-2#2)
economic losses in##2##3##(2008-10#2)
economic losses##6##2##(2007-12#1)(2008-10#4)(2011-2#1)
economic pressures##2##2##(1993-1#1)(1993-12#1)
economic problem##2##2##(2008-10#2)
economic return##2##2##(2008-10#2)
economic savings##2##2##(1994-6#1)(1995-1#1)
economic threat to##2##3##(2008-10#2)
economic value##2##2##(2008-10#1)(2013-8#1)
economic##213##1##(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#7)(1993-2#2)(1994-1#1)(1994-12#3)(1994-2#7)(1994-3#3)(1994-6#1)(1994-9#1)(1995-1#4)(1995-11#3)(1995-2#4)(1995-5#5)(1996-1#3)(1996-2#2)(1996-3#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#5)(2008-10#40)(2008-11#14)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#5)(2008-7#6)(2008-8#3)(2009-10#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#20)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#5)
economical and environmentally##2##3##(2008-10#2)
economical and##10##2##(1994-8#1)(2008-10#5)(2008-11#2)(2008-4#1)(2009-10#1)
economical##40##1##(1991-12#1)(1994-1#2)(1994-5#1)(1994-8#1)(1996-1#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#1)
economically feasible##2##2##(2008-10#1)(2011-2#1)
economically important diseases##2##3##(2008-10#2)
economically important pathogen##2##3##(2008-10#2)
economically important##12##2##(2008-10#11)(2008-12#1)
economically significant##2##2##(2008-10#2)
economically viable##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
economically##33##1##(1993-3#1)(1995-3#1)(1996-3#1)(1997-4#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-7#1)(2010-3#1)(2011-2#3)(2013-8#2)
economics and finance##2##3##(1993-3#1)(1997-3#1)
economics and##4##2##(1993-3#1)(1997-3#1)(2008-6#1)(2008-7#1)
economics of##9##2##(1991-2#1)(1994-3#3)(1997-8#1)(2008-11#2)(2009-8#1)(2010-4#1)
economics##20##1##(1991-2#1)(1993-2#1)(1993-3#1)(1994-3#3)(1994-8#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-7#1)
economies of scale##5##3##(1992-2#1)(1996-1#1)(1997-1#1)(2010-5#1)(2012-2#1)
economies of scope##2##3##(1997-1#2)
economies of##7##2##(1992-2#1)(1996-1#1)(1997-1#3)(2010-5#1)(2012-2#1)
economies##11##1##(1992-2#1)(1994-3#1)(1996-1#1)(1997-1#3)(2009-8#1)(2010-5#1)(2011-2#2)(2012-2#1)
economists##2##1##(1995-11#1)(1997-2#1)
economy and##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
economy during##2##2##(2008-11#1)(2011-2#1)
economy is##2##2##(1991-1#1)(2011-2#1)
economy of##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
economy to##2##2##(2008-1#1)(2008-11#1)
economy##37##1##(1991-1#2)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#1)(1994-2#2)(1994-5#1)(1995-3#1)(1996-3#2)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-9#3)(2010-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
economywide##3##1##(1991-12#1)(1992-1#1)(1992-2#1)
ecosystem dynamics##2##2##(1990-8#1)(2008-9#1)
ecosystem of##2##2##(2008-12#1)(2008-9#1)
ecosystem services of##3##3##(2008-9#3)
ecosystem services##4##2##(2008-9#4)
ecosystem##33##1##(1990-8#1)(1991-3#1)(1997-7#4)(2008-10#4)(2008-11#2)(2008-12#3)(2008-8#2)(2008-9#11)(2009-8#1)(2010-8#1)(2011-2#1)(2012-5#1)(2012-9#1)
ecosystems##28##1##(1995-3#1)(2008-10#9)(2008-11#2)(2008-8#6)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#4)(2012-6#1)(2012-9#1)
ecotoxicity##2##1##(2008-11#2)
ecotoxicological risk##2##2##(2008-11#1)(2008-9#1)
ecotoxicological##11##1##(2008-10#3)(2008-11#7)(2008-9#1)
ecotype##10##1##(2008-10#10)
ecotypes of Arabidopsis thaliana##2##4##(2008-10#2)
ecotypes of Arabidopsis##3##3##(2008-10#3)
ecotypes of##4##2##(2008-10#4)
ecotypes##9##1##(2008-10#7)(2012-3#2)
ectasia##2##1##(1997-8#1)(2008-11#1)
ectocervix##3##1##(1994-12#1)(2012-3#2)
ectoderm and##4##2##(1994-12#2)(2008-11#1)(2008-7#1)
ectoderm##7##1##(1994-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
ectodermal##3##1##(1993-12#1)(2012-12#1)(2013-1#1)
ectodermic##2##1##(2008-7#1)(2012-3#1)
ectodomain of##2##2##(1997-1#2)
ectodomain##4##1##(1997-1#3)(2008-5#1)
ectomesenchymal##2##1##(2013-1#2)
ectomycorrhizal##3##1##(2012-6#3)
ectoparasite##4##1##(1997-7#1)(2008-10#1)(2013-1#2)
ectoparasites##2##1##(1997-7#2)
ectoparasitic nematode damage##3##3##(2008-10#3)
ectoparasitic nematodes##2##2##(2008-10#2)
ectoparasitic##5##1##(2008-10#5)
ectophosphatase activities##2##2##(2008-10#2)
ectopia##2##1##(2008-10#1)(2011-2#1)
ectopic bone formation##2##3##(2011-2#1)(2012-12#1)
ectopic bone##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
ectopic discharges##3##2##(2008-9#3)
ectopic expression in##2##3##(1993-12#1)(2009-8#1)
ectopic expression of##2##3##(2008-11#2)
ectopic expression##4##2##(1993-12#1)(2008-11#2)(2009-8#1)
ectopic phallus##2##2##(2008-10#2)
ectopic pregnancies##3##2##(1993-12#1)(1995-8#1)(2011-1#1)
ectopic pregnancy is a##2##4##(2009-6#1)(2013-1#1)
ectopic pregnancy##10##2##(1991-12#1)(1992-5#1)(1993-3#1)(1994-3#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
ectopic third molar in the##2##5##(2013-1#2)
ectopic##59##1##(1990-9#1)(1991-12#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#2)(1995-12#1)(1995-8#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#2)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#4)(2011-1#2)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#9)
ectopically expressed##2##2##(1994-12#1)(2008-4#1)
ectopically##6##1##(1994-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
ectoplasmic specialization##5##2##(2009-10#1)(2012-2#4)
ectoplasmic##6##1##(2009-10#2)(2012-2#4)
ectopy##2##1##(1996-3#1)(2010-4#1)
ectothermic##2##1##(2008-12#1)(2008-6#1)
ectotherms to##2##2##(2008-8#2)
ectotherms##4##1##(2008-8#4)
eczema and atopy##2##3##(2010-6#2)
eczema and##3##2##(1991-2#1)(2010-6#2)
eczema##15##1##(1991-2#1)(1994-6#1)(2010-6#3)(2012-2#1)(2013-1#9)
ed##12##1##(1995-3#1)(2008-11#4)(2008-12#4)(2008-7#1)(2012-2#1)(2013-8#1)
edaphic##3##1##(2008-10#2)(2008-11#1)
eddy-correlation measurements##3##2##(2008-3#3)
edema and##8##2##(2008-7#2)(2009-1#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#2)
edema formation in##3##3##(1992-6#1)(1994-8#1)(2010-10#1)
edema formation##6##2##(1992-6#2)(1994-8#2)(2008-10#1)(2010-10#1)
edema in a##2##3##(2008-10#1)(2011-2#1)
edema in##10##2##(1992-6#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
edema were##2##2##(2008-11#1)(2010-2#1)
edema with##2##2##(2010-2#1)(2013-1#1)
edema##61##1##(1992-6#3)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-8#1)(2009-9#1)(2010-1#6)(2010-10#1)(2010-2#6)(2010-5#1)(2011-2#9)(2011-7#3)(2012-2#1)(2013-1#6)
edematous##2##1##(1990-3#1)(1995-11#1)
edentulism##3##1##(2011-7#1)(2012-2#1)(2013-1#1)
edentulous maxilla##3##2##(2011-7#1)(2013-1#2)
edentulous patient with##3##3##(2013-1#3)
edentulous patient##4##2##(2013-1#4)
edentulous patients##4##2##(2010-12#1)(2010-5#1)(2011-7#1)(2013-1#1)
edentulous##21##1##(1991-2#1)(1996-3#1)(2008-1#1)(2010-12#1)(2010-5#1)(2011-7#4)(2012-12#2)(2013-1#10)
edge and##2##2##(2009-11#1)(2010-11#1)
edge in##2##2##(1995-2#1)(2011-2#1)
edge of a##4##3##(2008-3#2)(2008-9#1)(2011-2#1)
edge of the hemilamina##2##4##(2011-2#2)
edge of the object##2##4##(2011-2#2)
edge of the##15##3##(1994-5#2)(1995-6#1)(2007-12#1)(2008-10#5)(2011-2#5)(2012-3#1)
edge of##25##2##(1994-1#1)(1994-5#3)(1995-6#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-6#1)(2008-9#1)(2011-2#7)(2012-3#1)
edge##52##1##(1991-2#1)(1992-8#1)(1993-11#1)(1994-1#1)(1994-5#3)(1995-2#2)(1995-6#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-3#4)(2008-6#3)(2008-9#5)(2009-11#1)(2009-7#1)(2010-11#1)(2011-2#10)(2012-2#1)(2012-3#1)
edges and##2##2##(2008-3#1)(2013-1#1)
edges are##3##2##(2008-3#1)(2008-9#2)
edges in##2##2##(2011-2#1)(2013-1#1)
edges of the##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
edges of##9##2##(1997-3#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-3#1)(2010-7#1)(2011-2#1)
edges provides##2##2##(2008-8#1)(2008-9#1)
edges##38##1##(1992-3#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-3#8)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#7)(2009-3#2)(2010-7#1)(2010-8#1)(2011-2#6)(2013-1#2)(2013-8#1)
edible films and coatings##2##4##(2010-7#2)
edible films and##3##3##(2010-7#3)
edible frogs and goldfish##2##4##(2008-12#2)
edible mushroom##3##2##(2008-10#2)(2008-11#1)
edible oil mixtures##2##3##(2008-10#2)
edible oils##8##2##(2008-10#7)(2011-2#1)
edible seaweed##4##2##(2008-10#4)
edible##36##1##(2008-10#21)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#4)(2011-2#1)
edited##5##1##(1993-12#1)(2008-11#1)(2008-3#1)(2010-1#1)(2012-2#1)
editing of##5##2##(1993-12#1)(1997-2#3)(2011-3#1)
editing##18##1##(1993-12#4)(1994-8#1)(1997-2#4)(2008-4#2)(2010-4#1)(2011-1#1)(2011-3#1)(2012-2#4)
edition of the##3##3##(1997-1#1)(1997-3#1)(2008-10#1)
edition of##5##2##(1993-12#1)(1997-1#1)(1997-3#1)(2008-10#2)
edition##11##1##(1993-12#1)(1993-3#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-12#1)(2010-5#2)(2013-8#1)
editions##3##1##(2008-10#3)
editor##24##1##(1996-9#1)(1997-3#1)(2008-11#5)(2008-12#8)(2008-7#1)(2008-9#2)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#3)
editorial board##4##2##(2010-12#3)(2013-1#1)
editorial##14##1##(1993-12#1)(1993-9#2)(2008-10#1)(2009-4#1)(2010-12#6)(2010-5#1)(2010-8#1)(2013-1#1)
editors##6##1##(1993-12#1)(1994-1#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
edodes by##2##2##(2008-11#2)
edodes##8##1##(2008-10#1)(2008-11#7)
educate and##3##2##(1995-12#1)(1997-6#1)(2008-10#1)
educate both##2##2##(1994-1#1)(2008-12#1)
educate##23##1##(1991-3#1)(1993-12#2)(1994-1#3)(1995-12#3)(1995-2#1)(1997-3#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-8#1)(2010-4#1)(2010-5#1)
educated about##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
educated in##2##2##(1994-1#1)(2008-12#1)
educated on##3##2##(2008-10#2)(2010-1#1)
educated##26##1##(1991-11#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2013-1#1)(2013-8#1)
educating the##2##2##(1991-2#1)(1992-3#1)
educating##9##1##(1990-9#1)(1991-2#1)(1992-1#1)(1992-3#1)(1996-1#2)(2008-10#1)(2008-12#1)(2013-7#1)
education (IPE)##2##2##(2008-11#1)(2008-12#1)
education (health)##2##2##(1997-6#2)
education about quality##2##3##(1993-3#2)
education about the##2##3##(1994-12#1)(2008-3#1)
education about##6##2##(1991-12#1)(1993-3#2)(1994-12#1)(2008-3#1)(2010-10#1)
education activities##2##2##(2008-9#2)
education and clinical practice##2##4##(2008-11#2)
education and clinical##3##3##(2008-11#3)
education and practice links##2##4##(2008-11#2)
education and practice##9##3##(2008-11#8)(2008-12#1)
education and the##7##3##(1991-2#1)(1993-3#1)(1994-3#1)(2008-11#1)(2011-2#2)(2013-1#1)
education and training needs##2##4##(1996-1#1)(2008-11#1)
education and training of##3##4##(2008-11#1)(2008-12#1)(2012-2#1)
education and training programme##3##4##(2008-12#3)
education and training programs##2##4##(1992-1#1)(2008-11#1)
education and training##17##3##(1991-1#1)(1992-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-11#4)(2008-12#4)(2008-6#1)(2010-8#1)(2012-2#1)
education and##85##2##(1990-2#1)(1991-1#1)(1991-2#2)(1992-1#2)(1992-2#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-1#3)(1996-2#1)(1996-3#2)(1997-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#24)(2008-12#14)(2008-6#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#4)(2013-1#6)(2013-8#1)
education are##8##2##(1993-6#2)(2008-1#1)(2008-11#2)(2008-12#1)(2009-9#1)(2012-3#1)
education as##3##2##(1991-2#1)(2008-11#1)(2009-10#1)
education at##4##2##(1991-2#1)(2008-1#1)(2008-11#2)
education can##2##2##(1993-11#1)(2008-11#1)
education department##3##2##(1991-2#1)(2008-12#1)(2008-9#1)
education during##2##2##(1994-12#1)(2010-10#1)
education for nurses##5##3##(2008-11#1)(2008-12#3)(2008-9#1)
education for the##2##3##(1991-2#1)(1992-3#1)
education for##25##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1996-3#1)(2008-11#4)(2008-12#6)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#3)(2013-1#1)
education has##11##2##(1991-1#1)(1991-8#1)(1997-3#1)(2008-1#1)(2008-11#4)(2008-12#1)(2012-2#1)(2012-3#1)
education in a##3##3##(1992-12#1)(1997-1#1)(2012-3#1)
education in all##2##3##(1994-12#1)(2009-6#1)
education in health care quality is##2##6##(1993-3#2)
education in health care quality##3##5##(1993-3#3)
education in health##5##3##(1991-1#1)(1993-3#3)(2008-12#1)
education in managed care##4##4##(1997-3#3)(2008-12#1)
education in quality##2##3##(1993-3#2)
education in schools##2##3##(1996-3#1)(2011-2#1)
education in the United States##4##5##(1991-8#2)(1994-12#2)
education in the United##5##4##(1991-8#2)(1994-12#2)(2008-11#1)
education in the pre-registration##2##4##(2008-11#2)
education in the##16##3##(1991-1#1)(1991-8#2)(1993-11#1)(1994-12#2)(2008-11#5)(2008-12#4)(2010-10#1)
education in##67##2##(1991-1#2)(1991-8#2)(1992-12#1)(1993-11#1)(1993-3#6)(1994-12#6)(1994-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#4)(1997-5#1)(2008-11#12)(2008-12#9)(2008-5#1)(2008-8#1)(2009-10#2)(2009-6#1)(2010-10#2)(2010-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
education is not##3##3##(1994-12#1)(2008-11#1)(2008-12#1)
education is the##2##3##(2012-3#1)(2013-8#1)
education is##19##2##(1994-12#3)(1997-4#1)(2008-11#6)(2008-12#5)(2011-2#1)(2012-3#1)(2013-8#2)
education level##2##2##(1991-2#1)(1994-12#1)
education may##4##2##(2008-11#1)(2008-12#1)(2013-8#2)
education needs to##2##3##(2010-3#1)(2012-2#1)
education needs##6##2##(1992-1#1)(1992-3#1)(1997-3#1)(1997-4#1)(2010-3#1)(2012-2#1)
education of clinical laboratory##2##4##(1994-12#2)
education of clinical##3##3##(1994-12#3)
education of health care administrators##2##5##(1992-2#1)(1993-3#1)
education of health care##3##4##(1992-2#1)(1993-3#1)(2008-12#1)
education of health professionals##3##4##(2008-11#3)
education of health##7##3##(1992-2#1)(1993-2#1)(1993-3#1)(2008-11#3)(2008-12#1)
education of the##4##3##(1993-5#1)(1994-8#1)(1995-2#1)(2008-10#1)
education of their##2##3##(1994-1#1)(2013-8#1)
education of##30##2##(1990-2#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#4)(1994-8#1)(1995-2#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-11#7)(2008-12#2)(2011-2#2)(2012-3#1)(2013-8#2)
education often##2##2##(1990-11#1)(2009-12#1)
education on the##2##3##(1990-3#1)(2013-1#1)
education on##8##2##(1990-3#1)(1991-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
education or##2##2##(2008-11#2)
education policy##2##2##(1994-2#1)(2012-3#1)
education program and##5##3##(1997-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
education program that##2##3##(1997-3#1)(2010-8#1)
education program##15##2##(1991-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-12#2)(2010-7#1)(2010-8#1)(2013-1#1)
education programme##7##2##(1991-6#1)(2008-11#2)(2010-10#2)(2012-2#1)(2013-8#1)
education programmes##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
education programs have##2##3##(1996-3#1)(2008-12#1)
education programs##19##2##(1991-2#1)(1992-2#1)(1993-2#2)(1994-12#1)(1995-1#2)(1995-12#1)(1995-9#1)(1996-1#2)(1996-3#1)(1997-6#1)(2008-1#1)(2008-11#3)(2008-12#1)(2012-2#1)
education providers##2##2##(2008-11#2)
education regarding the##3##3##(2008-12#1)(2010-1#1)(2010-2#1)
education regarding##6##2##(1997-3#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-1#1)(2010-2#1)
education services##3##2##(1993-3#1)(1995-1#1)(1995-12#1)
education system##4##2##(1992-8#1)(2008-10#1)(2008-11#2)
education through##3##2##(1990-2#1)(1994-2#1)(2008-12#1)
education to##7##2##(1992-1#1)(1992-8#1)(1996-1#1)(2008-12#4)
education today##2##2##(2008-11#1)(2011-2#1)
education was##6##2##(2008-12#3)(2008-7#1)(2009-11#1)(2010-1#1)
education with##2##2##(2011-2#1)(2012-3#1)
education within##2##2##(1992-2#1)(2008-11#1)
education##724##1##(1990-11#2)(1990-12#1)(1990-2#6)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#11)(1991-11#1)(1991-12#2)(1991-2#13)(1991-3#1)(1991-6#1)(1991-8#6)(1992-1#7)(1992-12#3)(1992-2#11)(1992-3#7)(1992-8#2)(1993-1#5)(1993-11#5)(1993-12#2)(1993-2#6)(1993-3#15)(1993-5#1)(1993-6#3)(1994-1#3)(1994-12#30)(1994-2#4)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#6)(1995-2#6)(1995-3#3)(1995-5#1)(1995-9#2)(1996-1#10)(1996-12#2)(1996-2#2)(1996-3#7)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#6)(1997-2#3)(1997-3#12)(1997-4#2)(1997-5#1)(1997-6#5)(1997-8#2)(2007-12#1)(2008-1#9)(2008-10#10)(2008-11#166)(2008-12#113)(2008-3#2)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#8)(2008-9#7)(2009-10#6)(2009-11#2)(2009-12#6)(2009-5#4)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#11)(2010-11#6)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#9)(2011-2#26)(2011-3#1)(2012-12#2)(2012-2#19)(2012-3#14)(2013-1#18)(2013-8#15)
education?##4##1##(2008-11#1)(2008-12#2)(2008-9#1)
education]##6##1##(1990-11#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-7#1)(2012-3#1)
educational and occupational level##2##4##(2010-11#2)
educational and##13##2##(1996-2#1)(2008-11#4)(2008-12#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#2)(2013-1#1)(2013-8#1)
educational approach##2##2##(1994-2#1)(1996-11#1)
educational attainment##4##2##(1994-3#1)(2008-11#1)(2009-10#1)(2010-7#1)
educational background##4##2##(1990-12#1)(1990-2#1)(1991-12#1)(2010-12#1)
educational backgrounds##2##2##(1994-2#1)(2008-9#1)
educational benefits##2##2##(2008-12#2)
educational campaigns##2##2##(1990-3#1)(2013-8#1)
educational context##2##2##(2008-12#1)(2011-2#1)
educational efforts##2##2##(1996-3#1)(1997-1#1)
educational evaluators##2##2##(2008-12#2)
educational expectations##3##2##(2009-7#3)
educational experience##2##2##(2008-12#1)(2011-2#1)
educational experiences##2##2##(2008-11#2)
educational institutions##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
educational intervention##7##2##(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#1)
educational interventions##4##2##(2008-11#1)(2012-2#3)
educational level and mother-infant interaction in##2##6##(1990-12#2)
educational level and mother-infant interaction##3##5##(1990-12#3)
educational level and##5##3##(1990-12#3)(1991-3#1)(1992-2#1)
educational level##9##2##(1990-12#3)(1990-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(2013-1#1)(2013-8#1)
educational levels##2##2##(2012-3#2)
educational materials##4##2##(1991-1#1)(2010-9#3)
educational methods##2##2##(2008-11#1)(2012-2#1)
educational needs of##4##3##(1992-12#2)(1992-3#1)(2008-11#1)
educational needs##5##2##(1992-12#2)(1992-3#1)(1993-3#1)(2008-11#1)
educational outcomes for##2##3##(2008-11#1)(2008-12#1)
educational outcomes##4##2##(1991-1#1)(2008-11#2)(2008-12#1)
educational preparation and##2##3##(2008-11#1)(2008-9#1)
educational preparation##4##2##(2008-11#3)(2008-9#1)
educational processes##4##2##(1992-2#1)(2008-12#3)
educational program##10##2##(1990-6#1)(1991-2#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-11#1)(2008-8#1)(2010-10#1)(2012-2#1)
educational programmes##5##2##(2008-11#4)(2008-12#1)
educational programs in##2##3##(1992-1#1)(2008-1#1)
educational programs##11##2##(1990-2#1)(1992-1#3)(1994-1#1)(1994-2#1)(1996-1#1)(2008-1#1)(2008-12#2)(2012-2#1)
educational providers##3##2##(2008-11#2)(2008-12#1)
educational requirements##2##2##(1992-1#1)(1995-12#1)
educational session##2##2##(2011-1#2)
educational standards##2##2##(2008-11#1)(2011-2#1)
educational strategies##3##2##(1995-2#1)(2008-11#1)(2008-8#1)
educational system##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
educational##215##1##(1990-12#4)(1990-2#4)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#7)(1992-12#2)(1992-2#3)(1992-3#2)(1993-1#1)(1993-3#3)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#2)(1995-12#4)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#56)(2008-12#31)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#6)(2011-1#2)(2011-2#6)(2012-2#7)(2012-3#3)(2013-1#5)(2013-8#3)
educationalists are##2##2##(2008-11#2)
educationalists##11##1##(2008-11#10)(2008-9#1)
educationally)##2##1##(2008-11#2)
educator and##2##2##(2008-11#1)(2012-3#1)
educator in##3##2##(1996-3#1)(2008-11#2)
educator##12##1##(1993-12#1)(1996-3#1)(1997-2#2)(2008-11#4)(2008-12#3)(2012-3#1)
educator's##3##1##(1992-2#1)(2008-11#1)(2008-12#1)
educators and students##2##3##(2008-11#1)(2010-10#1)
educators and##6##2##(2008-11#1)(2008-12#3)(2010-10#1)(2011-2#1)
educators are##5##2##(1996-2#1)(2008-11#1)(2008-12#3)
educators can##3##2##(2008-12#3)
educators in##3##2##(2008-11#2)(2013-8#1)
educators may##2##2##(1996-3#1)(2008-12#1)
educators need to##4##3##(1996-3#1)(2008-12#2)(2008-9#1)
educators of##2##2##(1995-5#1)(2008-12#1)
educators scored highest in the##2##5##(2008-11#2)
educators to##7##2##(2008-11#2)(2008-12#3)(2009-10#1)(2010-9#1)
educators who wish to##2##4##(2008-12#2)
educators who##3##2##(2008-11#1)(2008-12#2)
educators##76##1##(1993-1#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-2#2)(1996-3#2)(2008-11#27)(2008-12#29)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-10#2)(2010-9#1)(2011-2#1)(2013-8#2)
educators' critical thinking##2##3##(2008-11#2)
educators'##3##1##(2008-11#3)
edulis##2##1##(2008-11#2)
edwardsonii var##2##2##(2008-10#2)
edwardsonii##4##1##(2008-10#4)
ee##2##1##(1996-5#1)(2008-10#1)
eel##5##1##(2008-10#2)(2008-5#2)(2009-8#1)
eels##5##1##(2008-5#5)
efe gene##7##2##(2008-10#7)
efe homolog##2##2##(2008-10#2)
efe mutant##2##2##(2008-10#2)
efe mutants##2##2##(2008-10#2)
efe##16##1##(2008-10#16)
effect against the##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
effect against##8##2##(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#1)(2009-8#1)
effect also##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
effect and the##6##3##(1994-11#1)(2008-3#1)(2010-6#1)(2011-3#1)(2012-3#1)(2013-8#1)
effect and to##2##3##(2008-10#1)(2008-11#1)
effect and##40##2##(1991-6#2)(1992-11#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-6#3)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-6#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-8#1)
effect appeared##2##2##(2008-5#1)(2011-2#1)
effect are##5##2##(2008-10#5)
effect as a function of##2##5##(2008-10#1)(2008-5#1)
effect as##7##2##(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)
effect associated with##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
effect at the##3##3##(1996-5#1)(2008-6#1)(2009-8#1)
effect at##11##2##(1990-3#1)(1992-1#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-8#1)
effect based on##2##3##(2008-10#1)(2010-11#1)
effect being##4##2##(1990-5#1)(1991-2#1)(2008-10#1)(2008-11#1)
effect between##3##2##(1993-3#1)(2008-10#1)(2013-8#1)
effect but##2##2##(1993-3#1)(2013-1#1)
effect by##10##2##(1994-5#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
effect can be##4##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
effect can cause##2##3##(2008-8#1)(2011-2#1)
effect can##6##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-2#1)
effect caused by the##3##4##(2008-10#3)
effect caused by##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
effect compared with the##2##4##(1993-8#1)(2011-2#1)
effect could be##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
effect could##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-8#1)(2013-8#1)
effect depends on the##2##4##(1993-2#1)(2012-5#1)
effect did not##4##3##(1994-8#1)(1997-1#1)(2008-10#1)(2010-8#1)
effect disappeared##2##2##(1995-11#1)(2008-9#1)
effect does not involve##2##4##(1995-8#1)(1997-4#1)
effect does##3##2##(1995-8#1)(1997-4#1)(2008-11#1)
effect due to the##2##4##(1994-8#1)(2012-5#1)
effect due to##6##3##(1994-8#1)(2008-10#2)(2008-8#1)(2010-1#1)(2012-5#1)
effect during the##4##3##(2010-11#2)(2011-2#2)
effect during##5##2##(2010-11#2)(2011-2#3)
effect for the##4##3##(1993-3#1)(1996-3#1)(2008-10#1)(2008-12#1)
effect for##25##2##(1991-8#1)(1991-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-10#7)(2008-12#1)(2010-1#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
effect from##5##2##(2008-10#3)(2008-3#1)(2013-1#1)
effect has been##3##3##(1991-2#1)(2008-10#2)
effect has##4##2##(1991-2#1)(1995-8#1)(2008-10#2)
effect if the respondent##2##4##(2013-1#2)
effect if##4##2##(2008-7#1)(2009-7#1)(2013-1#2)
effect in a##2##3##(2008-9#1)(2013-8#1)
effect in patients##2##3##(2008-11#1)(2011-2#1)
effect in the##11##3##(2008-10#3)(2008-11#2)(2008-3#3)(2010-11#1)(2011-2#1)(2012-9#1)
effect in vivo##2##3##(1991-5#1)(1995-3#1)
effect in##67##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-5#1)(1991-7#1)(1991-8#4)(1993-3#1)(1993-6#1)(1995-11#3)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#2)(2010-11#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-9#1)(2013-8#3)
effect induced by##2##3##(1990-2#1)(2008-3#1)
effect is dependent on##3##4##(1992-8#1)(1997-2#1)(2011-2#1)
effect is due to##2##4##(1991-9#1)(2008-5#1)
effect is mediated by##2##4##(1993-3#1)(2008-11#1)
effect is mediated##3##3##(1993-3#1)(2008-11#1)(2008-8#1)
effect is observed##5##3##(2008-10#3)(2008-12#1)(2012-12#1)
effect is##59##2##(1990-5#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
effect may##5##2##(1992-4#1)(1996-2#1)(2008-5#1)(2008-8#1)(2010-11#1)
effect might be due to##2##5##(1991-2#1)(1995-11#1)
effect might be##3##3##(1991-2#1)(1995-11#1)(2008-5#1)
effect might##6##2##(1990-11#1)(1991-2#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
effect must be##2##3##(1994-6#1)(2011-2#1)
effect observed in the##3##4##(1993-8#1)(2008-10#2)
effect observed##5##2##(1993-8#1)(2008-10#3)(2010-12#1)
effect occurred##2##2##(2008-10#2)
effect of 1##2##3##(1992-1#1)(2012-12#1)
effect of 2##2##3##(1993-6#1)(1996-2#1)
effect of AMDL##2##3##(1995-8#2)
effect of Ad-HGF on##2##4##(2008-9#2)
effect of CC-516##3##3##(2008-5#3)
effect of CD-ROM##2##3##(1991-3#2)
effect of CGRP##4##3##(1997-4#4)
effect of Ca(2+)##2##3##(2008-8#2)
effect of Cl(-)##2##3##(2008-10#1)(2009-8#1)
effect of DA-9601##2##3##(2008-11#2)
effect of ET-1 on neutrophil migration##2##6##(1994-8#2)
effect of ET-1##4##3##(1994-8#4)
effect of HER-2/neu##2##3##(1997-7#2)
effect of HNO(3)##2##3##(2008-10#2)
effect of LDH##2##3##(2008-11#2)
effect of NOM##2##3##(2008-11#2)
effect of Primatone RL##2##4##(2008-7#2)
effect of RA and##2##4##(2008-11#2)
effect of RC-160##3##3##(1995-2#3)
effect of Safoof Mohazzil##3##4##(2013-1#3)
effect of Se(IV) on the##2##5##(2008-10#2)
effect of TI on##2##4##(2008-10#2)
effect of UV##2##3##(2008-2#1)(2011-2#1)
effect of a single##3##4##(1993-3#1)(1994-8#1)(2008-10#1)
effect of a##41##3##(1991-2#2)(1991-6#2)(1992-12#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-3#3)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
effect of acupuncture##2##3##(1995-12#1)(2013-1#1)
effect of adding##3##3##(2008-10#2)(2010-4#1)
effect of age at##2##4##(2008-9#1)(2009-5#1)
effect of age##5##3##(2008-7#3)(2008-9#1)(2009-5#1)
effect of amino acids##2##4##(1992-12#1)(2008-10#1)
effect of amino##3##3##(1992-12#1)(2008-10#1)(2008-11#1)
effect of an##8##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-6#1)(2011-1#1)(2013-1#2)
effect of aromatherapy##2##3##(2008-10#2)
effect of ascorbic##2##3##(2008-10#1)(2008-11#1)
effect of bcl-2##2##3##(2008-11#1)(2008-7#1)
effect of both##3##3##(1997-1#1)(2006-6#1)(2008-10#1)
effect of breastfeeding on##2##4##(1991-8#1)(2010-6#1)
effect of calcium##2##3##(1991-8#1)(2012-12#1)
effect of captopril on##4##4##(2008-10#2)(2008-7#2)
effect of carbachol##3##3##(1996-12#3)
effect of castration##2##3##(1994-2#2)
effect of cationic lipid-mediated##2##4##(1996-12#2)
effect of chemical##2##3##(1992-6#1)(2008-10#1)
effect of chloride on the##2##5##(1994-5#2)
effect of chronic##4##3##(1994-2#2)(2008-10#1)(2013-1#1)
effect of common##2##3##(2008-10#1)(2010-4#1)
effect of copper##3##3##(1990-8#1)(2008-10#2)
effect of copper(II)##2##3##(2008-10#2)
effect of counselling on the academic performance of college students##2##10##(2013-8#2)
effect of curcumin on the##2##5##(2008-11#2)
effect of curcumin##3##3##(2008-11#2)(2011-2#1)
effect of dexamethasone##2##3##(1994-3#2)
effect of dietary##3##3##(1990-3#1)(1997-8#1)(2013-1#1)
effect of different##26##3##(1995-12#1)(2008-10#14)(2008-12#4)(2008-5#1)(2011-1#1)(2012-3#1)(2012-8#2)(2013-1#2)
effect of direct##2##3##(1997-2#1)(2008-5#1)
effect of elevated##2##3##(2008-10#1)(2013-1#1)
effect of endothelin-1 on cardiac##2##5##(1992-3#2)
effect of endothelin-1 on##3##4##(1992-3#3)
effect of exercise##3##3##(2008-8#1)(2009-10#1)(2013-1#1)
effect of exogenous##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
effect of experimental parameters##3##4##(2008-10#3)
effect of exposure##3##3##(1991-12#1)(2008-10#1)(2009-12#1)
effect of extract##2##3##(2008-12#1)(2011-3#1)
effect of family routines##2##4##(2010-9#2)
effect of family##4##3##(2010-9#2)(2011-2#1)(2013-1#1)
effect of fluoride##2##3##(2008-10#1)(2013-1#1)
effect of foreign ions##4##4##(2008-10#4)
effect of gastrin on##2##4##(1994-8#2)
effect of gastrin##3##3##(1994-8#2)(1997-1#1)
effect of gender##2##3##(2010-1#1)(2012-2#1)
effect of glucose##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
effect of glutamate##2##3##(1994-11#1)(2008-11#1)
effect of green##2##3##(2008-11#1)(2009-8#1)
effect of habitat##2##3##(2008-8#1)(2008-9#1)
effect of halide##2##3##(1994-5#1)(2008-10#1)
effect of high##3##3##(2008-10#2)(2008-11#1)
effect of histamine on##2##4##(1995-12#1)(2008-12#1)
effect of histamine##3##3##(1995-12#2)(2008-12#1)
effect of host##2##3##(2008-10#1)(2008-8#1)
effect of human##2##3##(1997-3#1)(2008-11#1)
effect of hydroalcoholic extract of##2##5##(2008-12#1)(2012-12#1)
effect of hydroalcoholic##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
effect of hydrogen##3##3##(2008-10#3)
effect of hypericin on the conformation and catalytic activity of##2##10##(2009-3#2)
effect of increased##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
effect of increasing##3##3##(1991-2#1)(2008-10#1)(2012-8#1)
effect of incubation temperature##2##4##(2011-2#2)
effect of insulin resistance##2##4##(2008-6#1)(2011-1#1)
effect of insulin##3##3##(1996-11#1)(2008-6#1)(2011-1#1)
effect of interferences from##2##4##(2008-10#2)
effect of interferences##6##3##(2008-10#6)
effect of interfering ions##4##4##(2008-10#4)
effect of interferon##2##3##(1991-8#1)(1997-5#1)
effect of iron##2##3##(2009-8#2)
effect of jogging##2##3##(1991-8#2)
effect of light##4##3##(2008-10#4)
effect of low##9##3##(1992-5#1)(1992-7#1)(1993-1#1)(1996-12#1)(2008-11#1)(2008-7#1)(2010-12#2)(2010-9#1)
effect of magnetic field on the##2##6##(2008-10#1)(2008-8#1)
effect of manganese##3##3##(2008-10#3)
effect of massage on##2##4##(2008-12#1)(2009-3#1)
effect of massage##3##3##(2008-12#2)(2009-3#1)
effect of mechanical loading on the##2##6##(1994-6#1)(2009-8#1)
effect of melatonin on##2##4##(1990-5#1)(2010-12#1)
effect of melatonin##4##3##(1990-5#1)(2010-12#1)(2013-7#2)
effect of melittin on DPPC##2##5##(2008-10#2)
effect of membrane##3##3##(1990-8#1)(2008-10#1)(2009-9#1)
effect of metal ion##2##4##(2008-10#2)
effect of methylphenidate##2##3##(2008-9#1)(2012-2#1)
effect of morphine in##3##4##(1991-1#2)(1996-2#1)
effect of morphine##11##3##(1991-1#2)(1992-3#1)(1996-2#8)
effect of nicotine on##3##4##(1996-2#2)(2010-8#1)
effect of nicotine##5##3##(1996-2#4)(2010-8#1)
effect of nutrient##3##3##(2008-10#2)(2008-11#1)
effect of other ions in##2##5##(2008-10#2)
effect of other ions##4##4##(2008-10#4)
effect of other##9##3##(1996-2#1)(2008-10#6)(2008-9#1)(2009-12#1)
effect of oxidized##2##3##(1996-2#1)(2010-12#1)
effect of pH and##4##4##(2008-10#3)(2008-7#1)
effect of pH on the##3##5##(2008-10#3)
effect of pH on##5##4##(1991-5#1)(2008-10#4)
effect of pH##22##3##(1991-5#1)(2008-10#19)(2008-5#1)(2008-7#1)
effect of particle##2##3##(2008-10#2)
effect of physical parameters##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
effect of physical##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
effect of plant##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
effect of policies##2##3##(2012-2#2)
effect of postoperative##3##3##(2009-3#2)(2010-4#1)
effect of pressure##2##3##(2008-10#2)
effect of pyruvate in the##2##5##(2008-10#2)
effect of radiation##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
effect of reaction##2##3##(2008-5#1)(2011-2#1)
effect of remifentanil##2##3##(2011-2#2)
effect of repeated##2##3##(2008-10#1)(2013-1#1)
effect of resource aggregation##2##4##(2008-8#2)
effect of retinol##3##3##(1994-8#1)(2008-5#2)
effect of selected##2##3##(2008-7#1)(2011-2#1)
effect of sensory##2##3##(1992-6#1)(2008-11#1)
effect of several##5##3##(1995-6#1)(2008-10#4)
effect of silica##2##3##(2008-10#2)
effect of similar##2##3##(1996-2#1)(1997-4#1)
effect of simulated microgravity##2##4##(2008-9#2)
effect of simultaneous##2##3##(2008-10#1)(2008-6#1)
effect of solar##3##3##(2008-10#2)(2010-1#1)
effect of solution pH##2##4##(2008-10#1)(2008-5#1)
effect of solvent##2##3##(2008-10#2)
effect of some##7##3##(1996-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#1)
effect of specific##2##3##(1995-12#1)(2008-10#1)
effect of staged embolisation on seizure recurrence was##2##8##(1997-3#2)
effect of stress##2##3##(1997-4#1)(2009-7#1)
effect of such a##2##4##(2008-11#1)(2008-5#1)
effect of such##7##3##(1993-1#1)(2008-11#2)(2008-5#1)(2009-12#1)(2009-6#1)(2013-8#1)
effect of surgical##4##3##(1995-3#2)(2008-10#1)(2008-7#1)
effect of temperature and##2##4##(1996-12#1)(2008-10#1)
effect of temperature on##5##4##(2008-10#4)(2009-8#1)
effect of temperature##11##3##(1996-12#1)(2008-10#7)(2008-11#1)(2009-8#1)(2010-4#1)
effect of testosterone##2##3##(2008-9#2)
effect of tetramethylpyrazine on the##2##5##(1991-6#2)
effect of the chemical##2##4##(1995-11#1)(2008-10#1)
effect of the drug on##2##5##(1996-3#1)(2008-8#1)
effect of the drug##5##4##(1991-3#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-8#1)
effect of the high##3##4##(2008-10#2)(2008-3#1)
effect of the intervention##2##4##(2008-12#1)(2010-10#1)
effect of the ion exchanger##2##5##(2008-10#2)
effect of the ionic##2##4##(1997-2#1)(2008-10#1)
effect of the nature of the##2##6##(2008-10#2)
effect of the presence of##4##5##(2008-10#4)
effect of the thermal lens##2##5##(2008-3#2)
effect of the timing of##2##5##(2008-10#2)
effect of the two##2##4##(2008-10#1)(2013-8#1)
effect of the##152##3##(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#65)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#8)(2008-5#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#3)
effect of their##2##3##(1994-5#1)(2011-1#1)
effect of therapy##2##3##(2013-1#1)(2013-8#1)
effect of these##10##3##(1991-12#2)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
effect of this##8##3##(1990-12#1)(1993-11#1)(1994-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
effect of two##6##3##(1996-1#1)(2008-11#2)(2010-4#1)(2011-2#1)(2013-1#1)
effect of vaccination##2##3##(1996-3#2)
effect of vanadium##2##3##(2008-10#1)(2011-2#1)
effect of variables##2##3##(2008-10#1)(2008-8#1)
effect of various##12##3##(1993-2#1)(2008-10#7)(2008-11#2)(2013-1#2)
effect of very low##2##4##(2008-7#2)
effect of vesicles formed from monoglycerides on human skin##2##9##(2008-5#2)
effect of vitamin##8##3##(2008-10#2)(2008-11#2)(2010-1#1)(2010-12#1)(2011-1#2)
effect of water##5##3##(2008-10#3)(2008-7#2)
effect of weather##2##3##(2008-10#2)
effect of##1544##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#6)(1990-6#1)(1990-8#4)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#11)(1991-2#12)(1991-3#7)(1991-5#4)(1991-6#5)(1991-8#5)(1992-1#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#7)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#4)(1993-6#5)(1993-8#7)(1993-9#2)(1994-11#11)(1994-12#1)(1994-2#8)(1994-3#7)(1994-5#9)(1994-6#4)(1994-8#17)(1995-1#2)(1995-11#11)(1995-12#14)(1995-2#7)(1995-3#4)(1995-5#1)(1995-6#7)(1995-8#11)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#14)(1996-2#27)(1996-3#8)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#10)(1997-2#13)(1997-3#5)(1997-4#12)(1997-5#4)(1997-7#3)(1997-8#4)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#472)(2008-11#112)(2008-12#42)(2008-2#2)(2008-3#34)(2008-4#1)(2008-5#41)(2008-6#10)(2008-7#53)(2008-8#52)(2008-9#33)(2009-1#1)(2009-10#2)(2009-12#10)(2009-2#1)(2009-3#9)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#6)(2009-8#15)(2009-9#4)(2010-1#8)(2010-10#5)(2010-11#5)(2010-12#11)(2010-2#5)(2010-3#2)(2010-4#10)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#7)(2010-9#4)(2011-1#12)(2011-10#1)(2011-2#47)(2011-3#9)(2012-12#12)(2012-2#26)(2012-3#22)(2012-7#1)(2012-8#4)(2013-1#41)(2013-7#2)(2013-8#27)
effect on AD duration or seizure intensity##2##7##(1992-12#2)
effect on DNA##4##3##(1993-8#1)(1997-7#1)(2008-8#1)(2008-9#1)
effect on HIV##2##3##(1995-2#1)(2008-1#1)
effect on P##2##3##(2008-10#2)
effect on a##3##3##(2008-10#2)(2008-11#1)
effect on access to care##2##5##(1995-12#2)
effect on access##3##3##(1995-12#2)(1997-2#1)
effect on adult##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
effect on bacterial##2##3##(2008-10#1)(2008-5#1)
effect on basal##2##3##(1992-7#1)(1994-3#1)
effect on blood pressure and##2##5##(1997-8#1)(2008-7#1)
effect on blood pressure##5##4##(1991-6#1)(1993-2#1)(1997-8#1)(2008-7#1)(2010-4#1)
effect on both the##2##4##(1997-2#1)(2008-10#1)
effect on both##9##3##(1991-2#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)
effect on cell growth##2##4##(2008-11#2)
effect on cell##3##3##(2008-11#2)(2008-5#1)
effect on chlorophyll##2##3##(2008-9#2)
effect on distribution##3##3##(2008-10#3)
effect on early spermatogenic cyst survival in vitro##2##8##(2012-2#2)
effect on fibroblast##3##3##(2010-3#2)(2013-1#1)
effect on gene expression##2##4##(1996-12#1)(2008-10#1)
effect on gene transcription##2##4##(1993-6#2)
effect on gene##4##3##(1993-6#2)(1996-12#1)(2008-10#1)
effect on growth##3##3##(1994-8#1)(1995-2#1)(2008-10#1)
effect on hepatic##4##3##(1993-8#1)(1994-11#1)(2013-1#2)
effect on hospitals##2##3##(1993-1#1)(2008-11#1)
effect on human body##2##4##(2008-7#1)(2011-3#1)
effect on human##3##3##(2008-11#1)(2008-7#1)(2011-3#1)
effect on mycelial##2##3##(2008-10#2)
effect on other##2##3##(2008-11#1)(2008-9#1)
effect on retrieved##2##3##(2008-3#2)
effect on stress-induced##2##3##(1997-4#1)(2008-11#1)
effect on temperature##3##3##(1996-2#3)
effect on the activity of##2##5##(1994-5#1)(2008-10#1)
effect on the activity##3##4##(1994-5#1)(2008-10#1)(2008-11#1)
effect on the binding of##3##5##(1994-11#1)(1995-11#2)
effect on the cell##2##4##(2008-11#2)
effect on the degree##2##4##(1991-3#1)(2008-9#1)
effect on the determination of##4##5##(2008-10#4)
effect on the determination##5##4##(2008-10#5)
effect on the development of##3##5##(1993-12#1)(2008-10#1)(2008-12#1)
effect on the disease##2##4##(2008-10#2)
effect on the expression of##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
effect on the expression##4##4##(2008-10#2)(2012-2#1)(2013-1#1)
effect on the fluorescence##2##4##(1996-2#1)(2008-10#1)
effect on the growth of##3##5##(1996-12#1)(2008-10#1)(2012-2#1)
effect on the normal##2##4##(1993-11#1)(2008-9#1)
effect on the number of##2##5##(1993-1#1)(1994-2#1)
effect on the optical##2##4##(2008-3#2)
effect on the oxidation of carminic acid##4##7##(2008-10#4)
effect on the oxidation of##12##5##(2008-10#12)
effect on the oxidation reaction of##3##6##(2008-10#3)
effect on the oxidation##15##4##(2008-10#15)
effect on the plasma##3##4##(1992-9#1)(1994-3#1)(2013-8#1)
effect on the population##2##4##(2008-10#2)
effect on the proliferation of##3##5##(2008-11#1)(2008-8#1)(2011-2#1)
effect on the proliferation##4##4##(1995-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
effect on the quality of##2##5##(1991-11#1)(2008-10#1)
effect on the rate of##4##5##(1992-2#1)(1995-3#2)(2008-10#1)
effect on the recovery of##3##5##(2008-10#3)
effect on the redox reaction between bromate and hydrochloric acid##2##10##(2008-10#2)
effect on the redox reaction between##3##6##(2008-10#3)
effect on the release of##4##5##(1990-12#1)(1995-11#2)(2006-6#1)
effect on the release##5##4##(1990-12#1)(1995-11#2)(2006-6#1)(2008-10#1)
effect on the responses of##2##5##(1997-2#1)(2008-10#1)
effect on the stripping##2##4##(2008-10#2)
effect on the##237##3##(1990-12#1)(1990-5#3)(1991-11#2)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#4)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#3)(1994-8#1)(1995-11#6)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-6#1)(2008-10#103)(2008-11#15)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#3)
effect on their##2##3##(1995-12#1)(2008-10#1)
effect on these##2##3##(1990-2#1)(2012-3#1)
effect on this##2##3##(2008-10#1)(2008-7#1)
effect on tree##2##3##(2008-10#1)(2009-8#1)
effect on young##2##3##(1993-12#2)
effect on##639##2##(1990-12#3)(1990-2#2)(1990-5#6)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#4)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#4)(1993-6#7)(1993-8#6)(1993-9#1)(1994-11#4)(1994-2#8)(1994-3#5)(1994-5#7)(1994-6#3)(1994-8#9)(1995-11#8)(1995-12#7)(1995-2#9)(1995-3#6)(1995-6#6)(1995-8#7)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#11)(1996-3#4)(1996-5#2)(1996-6#2)(1997-1#4)(1997-2#5)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#4)(2006-6#2)(2007-11#1)(2008-1#1)(2008-10#182)(2008-11#43)(2008-12#14)(2008-2#2)(2008-3#11)(2008-4#6)(2008-5#14)(2008-7#18)(2008-8#24)(2008-9#13)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-7#1)(2009-8#5)(2010-1#2)(2010-10#2)(2010-3#2)(2010-4#6)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#3)(2012-2#9)(2012-3#12)(2012-4#1)(2012-5#1)(2013-1#20)(2013-7#2)(2013-8#5)
effect only##3##2##(2008-11#1)(2008-7#1)(2009-8#1)
effect or##2##2##(2008-7#1)(2011-2#1)
effect persisted##3##2##(1994-3#1)(2008-8#2)
effect profile##4##2##(1996-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
effect relative to##2##3##(1992-12#1)(2008-10#1)
effect remains##2##2##(1992-9#1)(1995-8#1)
effect should be##2##3##(1991-12#1)(2008-8#1)
effect should##3##2##(1991-12#1)(2008-10#1)(2008-8#1)
effect similar to that of##3##5##(1997-3#1)(2008-11#2)
effect size and##2##3##(2008-9#1)(2010-4#1)
effect size was##2##3##(2008-10#2)
effect size##10##2##(2008-10#2)(2008-6#1)(2008-9#3)(2009-9#1)(2010-4#2)(2010-5#1)
effect sizes for##2##3##(2008-10#1)(2013-1#1)
effect sizes were##2##3##(2008-10#1)(2011-2#1)
effect sizes##12##2##(1996-6#1)(2008-10#3)(2008-4#1)(2011-2#4)(2013-1#3)
effect such that##2##3##(1994-8#1)(2008-11#1)
effect than##6##2##(1993-11#1)(1994-11#1)(2008-10#2)(2008-5#1)(2009-10#1)
effect that is##3##3##(1993-3#1)(1994-6#1)(2010-7#1)
effect that##16##2##(1990-5#2)(1993-3#1)(1994-6#1)(2008-10#3)(2008-11#2)(2008-8#2)(2008-9#2)(2010-7#1)(2010-8#1)(2011-2#1)
effect the##3##2##(1996-1#1)(2008-10#2)
effect to the##2##3##(2008-10#2)
effect to##13##2##(1993-8#1)(1994-3#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
effect under##4##2##(2008-10#2)(2008-11#1)(2009-10#1)
effect up to##2##3##(2008-11#2)
effect upon the##2##3##(1994-5#1)(2008-5#1)
effect upon##4##2##(1993-6#1)(1994-5#1)(2008-10#1)(2008-5#1)
effect using the##2##3##(2008-10#1)(2012-2#1)
effect using##4##2##(2008-10#2)(2010-2#1)(2012-2#1)
effect varied##2##2##(1996-5#1)(2009-7#1)
effect was attributed to the##2##5##(2008-10#1)(2008-7#1)
effect was due to##2##4##(1995-12#1)(2008-9#1)
effect was employed##2##3##(1995-9#1)(2008-10#1)
effect was found in##2##4##(1991-6#1)(2008-11#1)
effect was found##5##3##(1990-2#1)(1991-6#1)(1993-6#1)(2008-11#1)(2008-8#1)
effect was greater##3##3##(2008-10#1)(2008-9#2)
effect was less##2##3##(2008-11#1)(2008-9#1)
effect was mediated by##2##4##(1996-12#1)(2008-10#1)
effect was more pronounced##2##4##(1997-1#1)(2008-10#1)
effect was more##3##3##(1997-1#1)(2008-10#1)(2011-2#1)
effect was most pronounced##2##4##(1993-8#1)(2013-8#1)
effect was most##3##3##(1993-8#1)(2008-11#1)(2013-8#1)
effect was not##11##3##(1991-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2012-2#2)
effect was observed for##3##4##(2008-10#1)(2008-11#1)(2010-1#1)
effect was observed in the##3##5##(1996-12#1)(2008-10#1)(2008-5#1)
effect was observed in##4##4##(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
effect was observed on the##2##5##(1995-2#1)(2008-10#1)
effect was observed on##3##4##(1995-2#1)(2008-10#2)
effect was observed##17##3##(1990-11#1)(1994-3#1)(1995-2#3)(1996-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2010-1#1)
effect was significant##2##3##(2008-10#2)
effect was stronger##2##3##(2008-10#1)(2008-9#1)
effect was studied##2##3##(1990-5#1)(2008-10#1)
effect was the##2##3##(2008-10#1)(2009-7#1)
effect was verified##2##3##(1990-6#1)(2008-10#1)
effect was##111##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-6#1)(1993-6#2)(1993-8#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#1)(1997-1#1)(2008-10#38)(2008-11#10)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#8)(2009-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
effect were##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
effect when the##5##3##(1992-12#1)(1993-8#1)(1996-2#1)(2008-10#1)(2008-3#1)
effect when##10##2##(1991-6#1)(1992-12#1)(1993-2#1)(1993-8#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-6#1)
effect which##4##2##(1994-2#1)(2008-5#1)(2012-3#1)(2013-1#1)
effect with##7##2##(1996-6#1)(2008-10#4)(2008-9#1)(2013-8#1)
effect##3163##1##(1990-10#1)(1990-11#8)(1990-12#8)(1990-2#5)(1990-3#3)(1990-5#23)(1990-6#7)(1990-8#6)(1990-9#2)(1991-1#6)(1991-10#1)(1991-11#2)(1991-12#13)(1991-2#18)(1991-3#17)(1991-5#6)(1991-6#15)(1991-7#2)(1991-8#11)(1991-9#2)(1992-1#3)(1992-11#4)(1992-12#17)(1992-2#4)(1992-3#13)(1992-4#4)(1992-5#3)(1992-6#10)(1992-7#2)(1992-8#6)(1992-9#6)(1993-1#13)(1993-11#6)(1993-12#11)(1993-2#12)(1993-3#14)(1993-6#20)(1993-8#20)(1993-9#3)(1994-1#2)(1994-11#25)(1994-12#4)(1994-2#20)(1994-3#17)(1994-5#23)(1994-6#14)(1994-8#35)(1994-9#1)(1995-1#3)(1995-11#27)(1995-12#25)(1995-2#28)(1995-3#13)(1995-5#2)(1995-6#17)(1995-8#26)(1995-9#3)(1996-1#5)(1996-11#4)(1996-12#28)(1996-2#50)(1996-3#19)(1996-5#7)(1996-6#11)(1996-8#2)(1996-9#1)(1997-1#17)(1997-2#21)(1997-3#11)(1997-4#19)(1997-5#6)(1997-6#2)(1997-7#8)(1997-8#9)(2006-6#4)(2007-11#3)(2007-12#4)(2007-8#2)(2008-1#5)(2008-10#926)(2008-11#222)(2008-12#69)(2008-2#12)(2008-3#74)(2008-4#11)(2008-5#86)(2008-6#18)(2008-7#93)(2008-8#119)(2008-9#77)(2009-1#3)(2009-10#6)(2009-11#2)(2009-12#14)(2009-2#2)(2009-3#11)(2009-4#3)(2009-5#5)(2009-6#5)(2009-7#12)(2009-8#29)(2009-9#6)(2010-1#17)(2010-10#8)(2010-11#14)(2010-12#15)(2010-2#6)(2010-3#5)(2010-4#20)(2010-5#4)(2010-6#6)(2010-7#9)(2010-8#13)(2010-9#5)(2011-1#15)(2011-10#3)(2011-2#100)(2011-3#15)(2011-7#1)(2012-12#18)(2012-2#51)(2012-3#43)(2012-4#1)(2012-5#3)(2012-7#1)(2012-8#5)(2012-9#1)(2013-1#77)(2013-7#4)(2013-8#48)
effect'##2##1##(2008-10#1)(2012-2#1)
effect) in##2##2##(2008-8#1)(2011-2#1)
effect)##10##1##(1990-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-8#2)
effect]##2##1##(1997-6#1)(2013-8#1)
effected by##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
effected##13##1##(1990-3#1)(1991-3#1)(1991-6#1)(1992-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
effecting##3##1##(1996-3#1)(2008-4#1)(2008-7#1)
effective (p&lt##2##2##(2013-1#2)
effective adhesion of##2##3##(2006-6#2)
effective against P##2##3##(2008-10#2)
effective against all##3##3##(2008-10#2)(2008-11#1)
effective against##20##2##(1997-4#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
effective agent##3##2##(1990-5#1)(1991-3#1)(2009-8#1)
effective alternative to##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
effective alternative##7##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
effective and economical##2##3##(1991-12#1)(2008-10#1)
effective and efficient##7##3##(1995-2#1)(1997-2#2)(2008-10#3)(2008-11#1)
effective and reliable##3##3##(1997-7#1)(2008-10#2)
effective and safe in##3##4##(1995-5#1)(2008-1#1)(2010-12#1)
effective and safe##6##3##(1994-3#1)(1995-5#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-5#1)
effective and well tolerated##5##4##(1990-12#1)(1991-11#1)(1996-2#1)(2008-11#2)
effective and well-tolerated##2##3##(1994-8#1)(2008-11#1)
effective and##42##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-7#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
effective approach to##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
effective approach##5##2##(2008-10#2)(2010-12#1)(2013-1#1)(2013-8#1)
effective approaches to##2##3##(1996-2#1)(2008-11#1)
effective approaches##3##2##(1996-2#1)(2008-11#1)(2013-1#1)
effective as a##3##3##(1995-9#1)(2008-11#1)(2012-2#1)
effective as an##2##3##(1990-2#1)(2008-11#1)
effective as##22##2##(1990-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-9#1)(1996-1#1)(2008-10#6)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
effective at reducing##2##3##(2008-10#2)
effective at the##3##3##(1990-5#1)(1994-11#1)(2008-10#1)
effective at##21##2##(1990-5#2)(1993-12#1)(1994-11#1)(1995-2#1)(2008-10#11)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
effective biocontrol agents##2##3##(2008-10#2)
effective biocontrol##4##2##(2008-10#4)
effective biological##2##2##(2008-10#1)(2008-8#1)
effective blood##2##2##(2008-11#1)(2008-12#1)
effective cancer##2##2##(2011-2#1)(2012-2#1)
effective care##3##2##(1993-2#1)(1994-2#1)(1995-2#1)
effective carrier##2##2##(1991-5#1)(2010-7#1)
effective clinical placement##2##3##(2008-12#2)
effective clinical##5##2##(1995-5#1)(2008-12#2)(2011-2#1)(2013-1#1)
effective closure##2##2##(1992-2#1)(1996-9#1)
effective collaboration##3##2##(2008-11#1)(2008-12#2)
effective collection of##2##3##(2008-10#1)(2012-12#1)
effective combination##2##2##(1996-11#1)(2008-11#1)
effective communication##2##2##(2008-11#1)(2013-8#1)
effective communications##2##2##(1993-2#1)(2010-5#1)
effective compounds against##2##3##(2008-10#1)(2011-3#1)
effective concentration (EC(50))##2##3##(2008-10#2)
effective concentration of##3##3##(1997-4#1)(2008-10#1)(2008-9#1)
effective concentration values##2##3##(2008-10#2)
effective concentration##11##2##(1997-4#1)(2008-10#9)(2008-9#1)
effective control of##3##3##(1991-8#1)(2011-2#2)
effective control##6##2##(1991-8#1)(2008-10#3)(2011-2#2)
effective delivery##3##2##(1995-3#1)(1997-1#1)(2012-3#1)
effective diffusion##2##2##(2008-10#1)(2008-7#1)
effective disease control##3##3##(2008-10#3)
effective disease management##2##3##(2008-10#2)
effective disease##5##2##(2008-10#5)
effective dose (ED(50))##2##3##(2008-10#2)
effective dose of##3##3##(1995-2#1)(1997-8#1)(2012-2#1)
effective dose to##2##3##(1997-8#1)(2008-10#1)
effective dose##23##2##(1995-12#1)(1995-2#1)(1996-12#3)(1997-8#4)(2008-10#9)(2008-12#3)(2012-2#2)
effective drug##2##2##(2008-1#1)(2008-7#1)
effective drugs##5##2##(1991-12#1)(1995-2#1)(2008-7#2)(2011-3#1)
effective enough to##2##3##(2008-11#1)(2012-2#1)
effective even##2##2##(1997-2#1)(2008-10#1)
effective for augmenting##2##3##(2012-2#1)(2013-1#1)
effective for control of##2##4##(2008-10#1)(2012-12#1)
effective for the##9##3##(1997-6#1)(2008-10#4)(2008-11#3)(2008-8#1)
effective for##38##2##(1991-3#1)(1993-2#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-10#13)(2008-11#5)(2008-4#2)(2008-8#2)(2010-4#2)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
effective form##2##2##(2008-11#1)(2008-7#1)
effective if##4##2##(2008-10#2)(2008-4#1)(2010-1#1)
effective implementation##2##2##(2008-10#1)(2013-1#1)
effective in achieving the##2##4##(2008-12#1)(2009-12#1)
effective in both##2##3##(2008-10#2)
effective in controlling the##2##4##(2008-7#1)(2013-1#1)
effective in controlling##5##3##(2008-10#3)(2008-7#1)(2013-1#1)
effective in detecting the##2##4##(2008-10#1)(2008-5#1)
effective in enhancing##2##3##(1997-8#1)(2009-1#1)
effective in helping##2##3##(2008-11#1)(2008-12#1)
effective in improving##4##3##(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
effective in increasing##3##3##(1990-5#1)(2008-11#1)(2013-1#1)
effective in inducing##3##3##(1990-12#1)(1995-5#1)(2011-2#1)
effective in inhibiting the##2##4##(2008-10#1)(2008-7#1)
effective in inhibiting##3##3##(2008-10#2)(2008-7#1)
effective in many##2##3##(1993-6#1)(2011-2#1)
effective in preventing##7##3##(1990-6#1)(1992-3#1)(1995-3#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)
effective in producing##2##3##(1992-12#1)(1996-1#1)
effective in promoting##2##3##(2008-11#1)(2010-10#1)
effective in protecting##2##3##(2008-10#2)
effective in reducing the severity of##2##6##(2008-10#2)
effective in reducing the##6##4##(1990-5#1)(2008-10#4)(2008-5#1)
effective in reducing##16##3##(1990-5#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
effective in removing##3##3##(1994-5#1)(2008-10#2)
effective in suppressing##5##3##(1994-8#1)(2008-10#2)(2008-11#1)(2011-3#1)
effective in terms of##2##4##(1992-12#1)(2008-11#1)
effective in the treatment of##2##5##(2009-3#1)(2011-2#1)
effective in the##10##3##(1995-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
effective in their##2##3##(2008-11#1)(2008-9#1)
effective in this##3##3##(2008-11#3)
effective in##132##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1997-1#1)(1997-8#2)(2006-6#1)(2008-10#36)(2008-11#14)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#5)(2008-9#1)(2009-1#1)(2009-12#4)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#11)(2013-8#2)
effective inhibitor##3##2##(1992-9#1)(1994-8#1)(2008-11#1)
effective intervention for##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
effective intervention##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
effective interventions##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
effective leadership##2##2##(1994-3#1)(1997-2#1)
effective learning##3##2##(2008-11#2)(2008-12#1)
effective length##2##2##(2008-10#2)
effective management of##3##3##(2008-10#2)(2008-12#1)
effective management##9##2##(1990-12#1)(1996-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2010-1#1)
effective means by which##2##4##(2008-10#2)
effective means for the##2##4##(2008-10#1)(2008-11#1)
effective means for##4##3##(2008-10#3)(2008-11#1)
effective means of##6##3##(1990-8#1)(1993-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
effective means##14##2##(1990-8#1)(1993-11#1)(2008-10#9)(2008-11#1)(2008-5#1)(2012-2#1)
effective measures to##3##3##(2008-8#1)(2012-2#1)(2013-1#1)
effective measures##4##2##(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
effective medium##2##2##(2008-10#2)
effective method for##8##3##(1991-2#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-6#1)(2010-3#1)(2011-2#1)
effective method of##6##3##(1991-7#1)(1993-1#1)(1993-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
effective method to reduce##2##4##(2008-5#1)(2013-1#1)
effective method to##6##3##(1990-12#1)(2008-10#2)(2008-5#1)(2011-3#1)(2013-1#1)
effective method##23##2##(1990-12#1)(1991-2#1)(1991-7#1)(1993-1#1)(1993-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-3#1)(2011-2#2)(2011-3#1)(2013-1#1)
effective methods for##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
effective methods of##2##3##(2008-11#1)(2013-1#1)
effective methods##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
effective migration rate##5##3##(2008-10#2)(2008-8#3)
effective models are##2##3##(1993-12#1)(2008-10#1)
effective nitrogen fixing microsymbiont of a diverse range of annual##2##10##(2011-2#2)
effective on##4##2##(1993-12#1)(1993-8#1)(2008-10#1)(2008-5#1)
effective only##2##2##(2008-10#1)(2008-4#1)
effective or##3##2##(1997-1#1)(2008-10#1)(2010-6#1)
effective partnership##2##2##(1994-1#1)(2008-11#1)
effective policies##2##2##(1995-6#1)(1997-3#1)
effective population size of##3##4##(2008-10#2)(2012-5#1)
effective production##2##2##(2008-10#1)(2008-3#1)
effective protection against##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
effective protection##5##2##(2008-10#2)(2008-5#1)(2009-6#1)(2010-7#1)
effective psychosocial##2##2##(2008-4#2)
effective public health##2##3##(1997-1#1)(1997-3#1)
effective public##3##2##(1997-1#1)(1997-3#1)(2009-4#1)
effective quality improvement##2##3##(1993-12#1)(2013-1#1)
effective quality##5##2##(1993-12#2)(2010-7#1)(2012-2#1)(2013-1#1)
effective recombination rate is##3##4##(2008-8#3)
effective refractive index of spherical plastic pigments in a##2##9##(2008-3#2)
effective refractive index of##3##4##(2008-3#3)
effective refractory period of##3##4##(1992-6#1)(2008-11#2)
effective removal of##2##3##(2008-10#2)
effective resistance##2##2##(2008-10#2)
effective sample size##5##3##(2008-10#5)
effective screening##2##2##(2008-10#1)(2008-8#1)
effective second##2##2##(1990-2#1)(1993-3#1)
effective separation##2##2##(2008-10#2)
effective size of a##3##4##(2007-12#1)(2008-8#2)
effective size of##5##3##(2007-12#1)(2008-10#1)(2008-8#3)
effective size##6##2##(2007-12#1)(2008-10#1)(2008-8#4)
effective solutions##2##2##(2008-7#1)(2013-1#1)
effective strategies in##2##3##(1996-3#1)(2008-10#1)
effective strategies to##2##3##(1993-12#1)(2008-11#1)
effective strategies##5##2##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#2)
effective strategy for the prevention and##2##6##(2011-2#1)(2013-1#1)
effective strategy for the##3##4##(2011-2#1)(2013-1#2)
effective strategy for##7##3##(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#3)
effective strategy##8##2##(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
effective surgical##2##2##(2008-10#1)(2013-8#1)
effective technique to##2##3##(2008-10#2)
effective technique##6##2##(2008-10#3)(2008-3#1)(2009-8#1)(2011-2#1)
effective technology##2##2##(1992-9#1)(2008-9#1)
effective than T(382)##2##3##(2008-10#2)
effective than the##6##3##(1995-9#1)(1996-5#1)(2008-10#3)(2008-7#1)
effective than##39##2##(1990-8#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#2)(1995-9#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
effective the##2##2##(1993-6#1)(2008-3#1)
effective therapeutic strategies##2##3##(2008-5#1)(2011-2#1)
effective therapeutic##7##2##(1994-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)
effective therapies##2##2##(2010-11#1)(2013-1#1)
effective therapy for##2##3##(1991-4#1)(1997-5#1)
effective therapy##8##2##(1991-4#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-10#2)(2012-12#1)(2013-1#1)
effective thickness##2##2##(2013-8#2)
effective time##2##2##(1992-2#1)(2008-10#1)
effective to correct##2##3##(2008-2#1)(2012-2#1)
effective to##12##2##(1993-6#1)(1994-1#2)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
effective tool for##4##3##(1993-12#1)(2008-10#1)(2008-11#2)
effective tool##11##2##(1993-12#1)(1994-3#1)(1996-3#1)(2008-10#3)(2008-11#2)(2010-10#1)(2013-7#1)(2013-8#1)
effective training##2##2##(1996-12#1)(2013-8#1)
effective transverse##2##2##(1996-5#1)(2012-2#1)
effective treatment for symptomatic##2##4##(1993-3#1)(2012-3#1)
effective treatment for this##2##4##(2012-2#1)(2013-1#1)
effective treatment for##10##3##(1993-3#1)(1994-3#1)(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
effective treatment with##2##3##(1996-6#1)(1997-6#1)
effective treatment##26##2##(1993-12#1)(1993-3#1)(1994-3#1)(1996-11#1)(1996-6#1)(1997-6#1)(2008-12#2)(2008-4#1)(2008-7#3)(2009-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)
effective treatments are available##2##4##(2008-11#1)(2010-10#1)
effective treatments for##2##3##(2008-6#1)(2012-3#1)
effective treatments##8##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-8#1)
effective use in##2##3##(1991-2#1)(1993-12#1)
effective use of##6##3##(1992-9#1)(1993-12#1)(1995-2#1)(2008-10#3)
effective use##9##2##(1991-2#1)(1992-2#1)(1992-9#1)(1993-12#2)(1995-2#1)(2008-10#3)
effective vaccine against##2##3##(1995-2#1)(2011-2#1)
effective vaccine##3##2##(1995-2#1)(1995-5#1)(2011-2#1)
effective way to##8##3##(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
effective way##10##2##(1991-2#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
effective when##7##2##(1992-12#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
effective with##5##2##(1993-12#1)(1994-12#1)(2008-10#2)(2008-9#1)
effective##1116##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#6)(1990-6#1)(1990-8#3)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#4)(1992-12#9)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#5)(1993-1#3)(1993-11#2)(1993-12#14)(1993-2#5)(1993-3#5)(1993-6#3)(1993-8#3)(1994-1#6)(1994-11#3)(1994-12#3)(1994-2#7)(1994-3#7)(1994-5#2)(1994-8#6)(1995-1#2)(1995-11#5)(1995-12#3)(1995-2#14)(1995-3#6)(1995-5#8)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#5)(1996-11#4)(1996-12#5)(1996-2#5)(1996-3#5)(1996-5#2)(1996-6#4)(1996-8#2)(1996-9#3)(1997-1#9)(1997-2#11)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#7)(2006-6#3)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#319)(2008-11#102)(2008-12#25)(2008-2#1)(2008-3#17)(2008-4#11)(2008-5#24)(2008-6#5)(2008-7#32)(2008-8#26)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#7)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#4)(2009-8#3)(2010-1#5)(2010-10#7)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#10)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#49)(2011-3#7)(2012-12#10)(2012-2#33)(2012-3#13)(2012-4#1)(2012-5#1)(2013-1#50)(2013-7#1)(2013-8#18)
effectively and efficiently##2##3##(1993-12#1)(2010-8#1)
effectively and##7##2##(1993-12#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)
effectively be##2##2##(1991-1#1)(2009-8#1)
effectively blocked##2##2##(1995-8#1)(2008-11#1)
effectively bound##2##2##(1995-6#1)(2008-11#1)
effectively communicate##3##2##(1992-2#1)(1994-2#1)(2013-1#1)
effectively control##2##2##(2007-11#1)(2010-10#1)
effectively controlled##2##2##(2008-10#1)(2008-8#1)
effectively cured##2##2##(1996-9#1)(2011-2#1)
effectively eliminated##2##2##(2008-10#2)
effectively form##2##2##(2008-6#1)(2010-10#1)
effectively from##3##2##(2008-10#2)(2013-1#1)
effectively implement##2##2##(1994-1#1)(2008-3#1)
effectively improved by a bimodal distribution##2##6##(2009-7#2)
effectively in a##2##3##(2008-10#1)(2008-9#1)
effectively in the##3##3##(1996-5#1)(2008-11#1)(2011-2#1)
effectively in##11##2##(1991-1#1)(1996-5#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
effectively increase##3##2##(2008-3#1)(2010-11#1)(2012-3#1)
effectively inhibit the##3##3##(1992-6#1)(2008-11#1)(2013-1#1)
effectively inhibit##4##2##(1992-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
effectively inhibited##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
effectively manage##3##2##(1996-2#1)(2007-11#1)(2010-7#1)
effectively prevent##2##2##(2011-2#1)(2013-1#1)
effectively produce##3##2##(2008-10#1)(2008-11#2)
effectively quenched##2##2##(2008-10#2)
effectively reduce##3##2##(2008-10#2)(2008-11#1)
effectively reduced the##2##3##(1995-6#1)(2008-11#1)
effectively reduced##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
effectively remove##2##2##(2008-10#2)
effectively removed##2##2##(2012-12#1)(2013-1#1)
effectively separated from##3##3##(2008-10#2)(2012-2#1)
effectively suppressed##4##2##(2008-10#3)(2008-8#1)
effectively the##3##2##(1995-5#1)(2008-10#1)(2008-8#1)
effectively to##4##2##(1994-8#1)(1997-1#1)(2010-10#1)(2013-8#1)
effectively with##8##2##(1992-2#1)(1993-3#1)(1995-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-9#1)
effectively##234##1##(1990-5#1)(1991-1#2)(1991-12#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#4)(1997-2#4)(1997-5#1)(1997-7#1)(2007-11#2)(2008-10#58)(2008-11#31)(2008-12#2)(2008-3#3)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#10)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#5)
effectiveness against##2##2##(2008-10#2)
effectiveness and safety of##3##4##(1997-3#1)(2013-1#1)(2013-8#1)
effectiveness and##12##2##(1991-2#1)(1994-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#3)(2013-8#1)
effectiveness are##2##2##(1993-3#1)(2011-2#1)
effectiveness as##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
effectiveness at##2##2##(2008-5#1)(2011-2#1)
effectiveness in a##2##3##(2008-10#1)(2008-11#1)
effectiveness in the##2##3##(2012-3#1)(2013-1#1)
effectiveness in##11##2##(1992-2#1)(1993-1#1)(2008-10#2)(2008-11#3)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
effectiveness is also##2##3##(2008-10#1)(2012-3#1)
effectiveness is##6##2##(1991-1#2)(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
effectiveness of a##10##3##(1990-6#1)(1992-2#1)(1995-3#1)(1996-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)
effectiveness of adjunctive##2##3##(2008-4#1)(2013-1#1)
effectiveness of antimicrobial##2##3##(2011-2#1)(2013-1#1)
effectiveness of global##2##3##(1994-1#1)(2013-1#1)
effectiveness of our##3##3##(1992-1#1)(2008-7#1)(2010-9#1)
effectiveness of such##2##3##(2008-8#1)(2010-12#1)
effectiveness of telemedicine##3##3##(1996-3#3)
effectiveness of the##36##3##(1991-3#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-3#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
effectiveness of these##5##3##(1993-8#1)(1996-1#1)(2011-2#1)(2012-2#2)
effectiveness of this##13##3##(1990-8#1)(1995-1#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#2)
effectiveness of treatment##3##3##(2008-7#2)(2012-2#1)
effectiveness of using##2##3##(2008-11#1)(2012-12#1)
effectiveness of##220##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#6)(1992-5#2)(1992-9#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#1)(1997-1#2)(1997-3#3)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#32)(2008-11#14)(2008-12#5)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#12)(2008-8#4)(2008-9#4)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#10)(2011-3#2)(2012-12#6)(2012-2#15)(2012-3#1)(2013-1#22)(2013-8#1)
effectiveness or##2##2##(2010-1#1)(2010-11#1)
effectiveness research##2##2##(1992-1#1)(1993-12#1)
effectiveness study##2##2##(2012-2#2)
effectiveness through##2##2##(1995-3#1)(1997-7#1)
effectiveness was##3##2##(1991-1#1)(1991-3#1)(2008-10#1)
effectiveness will##2##2##(1993-12#1)(1995-1#1)
effectiveness##324##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#6)(1991-2#3)(1991-3#3)(1991-7#1)(1992-1#4)(1992-12#3)(1992-2#10)(1992-5#2)(1992-9#2)(1993-1#1)(1993-12#8)(1993-2#5)(1993-3#3)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#5)(1995-2#1)(1995-3#5)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#4)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#43)(2008-11#20)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#6)(2008-7#13)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#2)(2012-12#8)(2012-2#20)(2012-3#4)(2013-1#30)(2013-8#4)
effecton##2##1##(2008-11#2)
effector and target cells##3##4##(1990-12#3)
effector and##4##2##(1990-12#4)
effector cells##8##2##(1990-12#2)(1995-2#1)(1995-5#1)(2008-4#1)(2008-8#2)(2011-2#1)
effector function in##2##3##(2010-5#1)(2012-2#1)
effector function##4##2##(1995-5#1)(2010-5#1)(2012-2#2)
effector functions##3##2##(1997-8#1)(2008-11#1)(2008-4#1)
effector mechanisms##7##2##(1994-2#1)(2008-10#5)(2011-2#1)
effector of##7##2##(1994-5#1)(1997-2#1)(2008-11#3)(2008-5#1)(2010-5#1)
effector protein##4##2##(2009-8#1)(2011-2#3)
effector##65##1##(1990-10#1)(1990-12#7)(1992-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#4)(2008-4#2)(2008-5#2)(2008-8#3)(2009-8#3)(2010-5#2)(2011-1#3)(2011-2#7)(2012-2#4)(2013-1#1)(2013-8#4)
effectors in the##2##3##(1990-10#1)(1990-3#1)
effectors of the##2##3##(2008-11#1)(2008-9#1)
effectors of##5##2##(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-9#1)
effectors##28##1##(1990-10#3)(1990-3#3)(1990-5#1)(1996-2#2)(1997-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#5)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
effects across##3##2##(1995-8#1)(2012-3#1)(2013-1#1)
effects after##5##2##(1997-5#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-11#1)
effects against##7##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
effects also##2##2##(2008-10#1)(2013-1#1)
effects analysis##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
effects and also##2##3##(2008-10#2)
effects and can##2##3##(1994-8#1)(1995-5#1)
effects and is##2##3##(1992-4#1)(2012-12#1)
effects and mechanism of##2##4##(2011-2#1)(2011-3#1)
effects and safety##2##3##(1995-2#1)(2011-2#1)
effects and the##9##3##(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#3)(2012-3#1)(2013-1#1)
effects and##75##2##(1991-1#1)(1992-3#1)(1992-4#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2010-1#3)(2010-11#1)(2010-8#3)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#5)
effects and/or##4##2##(1993-2#2)(2008-7#1)(2011-2#1)
effects appear to be##2##4##(2008-7#1)(2009-7#1)
effects appear##3##2##(2008-7#1)(2009-7#2)
effects are caused##2##3##(2011-2#2)
effects are discussed##4##3##(2008-10#3)(2008-4#1)
effects are due to##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
effects are mediated through##2##4##(1990-11#1)(2013-8#1)
effects are mediated##3##3##(1990-11#1)(2008-5#1)(2013-8#1)
effects are not##5##3##(1994-3#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-7#1)
effects are observed##2##3##(1994-5#1)(1995-11#1)
effects are the##2##3##(2008-10#2)
effects are##55##2##(1990-11#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1997-1#2)(1997-4#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#2)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
effects as well as##2##4##(1995-5#1)(2008-6#1)
effects as##8##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-6#1)(2008-7#1)(2012-2#1)
effects associated with##9##3##(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)
effects at the##3##3##(2008-11#1)(2009-6#1)(2012-2#1)
effects at##7##2##(2008-11#1)(2008-7#2)(2008-9#1)(2009-6#1)(2012-2#1)(2013-1#1)
effects become more##2##3##(2008-10#1)(2008-9#1)
effects become##6##2##(2008-10#3)(2008-3#1)(2008-9#1)(2009-5#1)
effects between##6##2##(1994-8#1)(2008-10#2)(2008-9#1)(2010-10#1)(2012-3#1)
effects by##11##2##(1993-3#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-1#1)(2012-2#1)(2012-6#1)
effects can be##6##3##(1992-11#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-7#1)
effects can##11##2##(1992-11#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-8#4)(2010-8#1)(2012-12#1)(2012-7#1)
effects cause##2##2##(1996-12#1)(2008-9#1)
effects caused by##4##3##(1995-12#1)(2008-10#3)
effects could be##2##3##(1990-6#1)(2008-10#1)
effects differed##2##2##(2008-10#1)(2012-6#1)
effects disappeared##2##2##(1991-2#1)(2008-10#1)
effects due to the##2##4##(2008-10#2)
effects due to##5##3##(1994-3#1)(2007-12#1)(2008-10#2)(2009-7#1)
effects during##4##2##(1993-1#1)(2007-12#1)(2008-8#1)(2012-12#1)
effects for all##2##3##(2008-10#1)(2013-8#1)
effects for the##4##3##(1991-6#1)(2008-5#1)(2008-8#1)(2010-7#1)
effects for##17##2##(1991-6#1)(2008-10#9)(2008-5#1)(2008-8#2)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
effects from the##4##3##(2008-2#1)(2009-5#1)(2009-8#1)(2011-2#1)
effects from##9##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#2)
effects has been##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
effects has##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
effects have also been##3##4##(1996-9#1)(2007-11#1)(2008-10#1)
effects have been reported##2##4##(1993-11#1)(2012-2#1)
effects have been##7##3##(1993-11#1)(1997-1#1)(2008-10#2)(2008-9#2)(2012-2#1)
effects have demonstrated##2##3##(1994-5#1)(1995-5#1)
effects have##14##2##(1993-11#1)(1994-5#1)(1995-5#1)(1996-9#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
effects in a##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
effects in both##4##3##(1990-2#1)(2008-10#1)(2008-11#1)(2010-12#1)
effects in different##2##3##(2008-10#1)(2012-12#1)
effects in humans##3##3##(1991-1#1)(2008-10#1)(2011-2#1)
effects in patients with##2##4##(2009-10#1)(2009-8#1)
effects in patients##4##3##(2008-10#2)(2009-10#1)(2009-8#1)
effects in the elevated plus-maze##2##5##(1993-3#2)
effects in the##15##3##(1993-3#3)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2009-7#1)(2010-7#1)
effects in vivo##3##3##(1995-11#1)(2008-11#1)(2009-12#1)
effects in##92##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#2)(1992-11#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-3#3)(1993-5#1)(1993-8#2)(1994-1#1)(1994-5#2)(1994-8#3)(1995-11#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
effects indicate that##2##3##(1991-5#1)(2008-10#1)
effects induced by##4##3##(1996-2#1)(1997-6#1)(2008-10#2)
effects is##9##2##(1991-12#1)(1994-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)
effects limit##2##2##(2008-9#1)(2009-12#1)
effects may be##4##3##(2008-10#1)(2008-9#2)(2013-8#1)
effects may##6##2##(2008-10#1)(2008-9#2)(2010-11#1)(2010-4#1)(2013-8#1)
effects meta-analysis##2##2##(1996-3#1)(2008-10#1)
effects might##2##2##(2008-11#1)(2008-9#1)
effects model##4##2##(1993-11#1)(2008-10#1)(2008-11#2)
effects observed with the##2##4##(1993-1#1)(2008-10#1)
effects observed##7##2##(1990-5#1)(1991-5#1)(1993-1#1)(2008-10#2)(2008-5#1)(2012-3#1)
effects occur in##2##3##(2008-8#1)(2009-7#1)
effects occur##3##2##(2008-8#1)(2009-7#1)(2012-3#1)
effects occurred##4##2##(1990-12#1)(2008-10#2)(2008-8#1)
effects of 2##2##3##(1993-12#1)(1994-5#1)
effects of 5-HT##2##3##(1990-5#2)
effects of CGRP##4##3##(1992-6#4)
effects of HG##2##3##(2008-7#2)
effects of HGF and EGF on##2##6##(1991-12#2)
effects of HIV-1 infection on the##2##6##(2008-11#1)(2008-2#1)
effects of HIV-1##3##3##(2008-11#2)(2008-2#1)
effects of ISIS 2302##3##4##(2008-10#3)
effects of MDM2##2##3##(2013-1#2)
effects of NSAIDs##2##3##(2008-10#2)
effects of RA##2##3##(1990-6#1)(2008-5#1)
effects of Rhizopus head rot##2##5##(2008-10#2)
effects of TCDD on DC##2##5##(2008-10#2)
effects of TCDD on##3##4##(2008-10#3)
effects of TNF##2##3##(1997-2#1)(2008-9#1)
effects of TNP-470 on##2##4##(1994-12#2)
effects of Vpr and Vpx##2##5##(1997-3#2)
effects of a##36##3##(1991-5#1)(1992-4#1)(1993-12#1)(1993-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
effects of acute##4##3##(1991-1#1)(1991-9#1)(2008-10#2)
effects of added##2##3##(2008-10#2)
effects of age##3##3##(1994-8#1)(1994-9#1)(2008-8#1)
effects of air pollution on##2##5##(1997-1#1)(2008-11#1)
effects of aluminium##2##3##(2008-10#2)
effects of amphetamine and##2##4##(1993-6#1)(1994-2#1)
effects of amphetamine##3##3##(1993-6#2)(1994-2#1)
effects of amphetamines##2##3##(2008-10#2)
effects of an integrated phonological awareness##2##6##(2011-1#2)
effects of an##7##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#2)(2011-2#1)
effects of and##2##3##(1995-2#1)(2008-5#1)
effects of bFGF##2##3##(1995-12#1)(2008-11#1)
effects of beam##2##3##(2008-3#2)
effects of both##5##3##(2008-10#4)(2008-11#1)
effects of broccoli residue##2##4##(2008-10#2)
effects of cadmium##2##3##(1990-5#1)(1994-6#1)
effects of caffeine on##3##4##(1995-11#3)
effects of calcium##4##3##(2008-10#2)(2009-8#1)(2012-2#1)
effects of caloric restriction and##2##5##(2008-7#2)
effects of caloric restriction##3##4##(2008-10#1)(2008-7#2)
effects of capsaicin##3##3##(1992-6#2)(1993-11#1)
effects of cell##3##3##(1995-3#1)(2008-11#2)
effects of chemical##3##3##(2008-10#2)(2008-12#1)
effects of chemicals##2##3##(2008-10#1)(2008-11#1)
effects of chemotherapy##3##3##(1994-2#1)(2008-7#2)
effects of chronic stress##2##4##(1991-1#1)(2008-11#1)
effects of chronic##7##3##(1991-1#2)(1991-4#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-6#1)
effects of cigarette smoke on the human skin##2##8##(2008-5#2)
effects of cocaethylene on##2##4##(1996-12#2)
effects of cocaine##3##3##(1991-1#2)(2010-11#1)
effects of colony size on##2##5##(2008-9#2)
effects of decreased##2##3##(1995-2#1)(2011-2#1)
effects of deep breathing##2##4##(2012-2#2)
effects of dexamethasone and##2##4##(1993-3#1)(1994-3#1)
effects of dexamethasone##3##3##(1993-3#1)(1994-3#1)(2010-12#1)
effects of dexrazoxane##2##3##(2008-11#2)
effects of dietary##5##3##(1994-3#1)(2008-10#1)(2008-7#2)(2009-8#1)
effects of different types of##3##5##(2008-10#1)(2008-8#1)(2011-1#1)
effects of different##13##3##(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
effects of disease##2##3##(2008-10#1)(2009-10#1)
effects of disturbance##2##3##(2008-8#1)(2008-9#1)
effects of drugs and##2##4##(1996-6#1)(1997-3#1)
effects of drugs##8##3##(1994-2#1)(1995-12#1)(1996-6#2)(1997-3#1)(2006-6#1)(2008-8#1)(2009-12#1)
effects of each##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#1)
effects of easily##2##3##(2008-10#2)
effects of electrical stimulation##2##4##(2008-9#1)(2009-10#1)
effects of environmental##5##3##(1991-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
effects of esomeprazole on the antiplatelet activity of clopidogrel in healthy individuals and patients after coronary stent implantation##2##18##(2011-2#2)
effects of estrogen on the proliferation of##2##7##(2008-11#1)(2008-6#1)
effects of estrogen on##5##4##(2008-11#2)(2008-6#1)(2008-7#2)
effects of estrogen##6##3##(2008-11#2)(2008-6#1)(2008-7#3)
effects of ethanol##2##3##(1996-2#1)(2009-7#1)
effects of exercise##2##3##(2010-1#1)(2013-1#1)
effects of experimental##4##3##(2008-10#4)
effects of extracellular##2##3##(2008-11#1)(2008-8#1)
effects of factors##2##3##(1995-8#1)(1995-9#1)
effects of five different variables##2##5##(2008-10#2)
effects of five##3##3##(1993-12#1)(2008-10#2)
effects of flow##2##3##(2008-10#1)(2010-4#1)
effects of fluoride##2##3##(2008-10#1)(2013-1#1)
effects of foliar##2##3##(2008-10#2)
effects of food##5##3##(1994-2#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-8#1)
effects of fornix##2##3##(1993-3#2)
effects of frequent##3##3##(2009-7#2)(2009-8#1)
effects of gene##2##3##(2008-11#1)(2008-9#1)
effects of genes##4##3##(1997-7#2)(2008-8#1)(2012-3#1)
effects of glyphosate##2##3##(2010-1#2)
effects of grade retention##2##4##(2008-12#2)
effects of heat##2##3##(2008-10#1)(2013-8#1)
effects of herbivory on##3##4##(2008-8#1)(2008-9#2)
effects of herbivory##4##3##(2008-8#1)(2008-9#3)
effects of host genotype##2##4##(2008-10#2)
effects of host##5##3##(2008-10#5)
effects of hypergravity##2##3##(2008-7#2)
effects of ibandronic acid on hormone- and drug-refractory prostate##2##9##(2011-2#2)
effects of imipramine and desipramine##2##5##(1990-5#2)
effects of imipramine##3##3##(1990-5#2)(1994-2#1)
effects of inaperisone##2##3##(1992-3#2)
effects of incident beam type on##2##6##(2008-2#2)
effects of inhibition of##2##4##(1994-3#1)(2008-9#1)
effects of insulin##2##3##(1996-3#1)(2010-10#1)
effects of ionizing##2##3##(2008-11#1)(2008-7#1)
effects of iron##2##3##(2008-10#2)
effects of its##2##3##(1995-11#1)(2008-9#1)
effects of light##3##3##(2008-10#2)(2008-3#1)
effects of long##2##3##(1991-2#1)(2008-5#1)
effects of long-term##3##3##(1990-3#1)(2008-5#1)(2012-2#1)
effects of low##6##3##(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
effects of maternal##3##3##(1992-12#1)(2008-8#1)(2009-7#1)
effects of mobile phase##2##4##(2008-10#2)
effects of morphine on##2##4##(1994-2#1)(2008-12#1)
effects of morphine##5##3##(1992-3#1)(1994-2#1)(2008-12#3)
effects of multiple##3##3##(1995-12#1)(2008-3#1)(2008-8#1)
effects of muscle##2##3##(1995-2#1)(2011-2#1)
effects of music on##2##4##(1991-12#2)
effects of natural##4##3##(2008-10#2)(2008-5#1)(2012-3#1)
effects of noscapine##2##3##(2008-11#2)
effects of okadaic acid on##2##5##(1992-8#1)(1993-8#1)
effects of other##3##3##(2008-10#2)(2011-2#1)
effects of pH and##3##4##(2008-10#3)
effects of pH on##2##4##(1991-5#1)(2008-5#1)
effects of pH##16##3##(1991-5#1)(2008-10#14)(2008-5#1)
effects of parameters##2##3##(2008-10#2)
effects of partial##2##3##(1990-5#1)(2008-10#1)
effects of phenytoin##2##3##(1994-2#1)(2008-11#1)
effects of phorbol esters##2##4##(1992-12#1)(2010-12#1)
effects of physical activity##2##4##(2012-12#2)
effects of physical##3##3##(2008-9#1)(2012-12#2)
effects of pile driving and other anthropogenic##2##7##(2010-8#2)
effects of plant age##2##4##(2008-10#2)
effects of plant##3##3##(2008-10#2)(2008-8#1)
effects of poverty##2##3##(2008-11#2)
effects of predation on##2##4##(2008-8#2)
effects of predation##5##3##(2008-8#4)(2008-9#1)
effects of prescription drug##2##4##(1995-1#2)
effects of pressure##3##3##(2008-10#3)
effects of prior##2##3##(2008-10#1)(2008-9#1)
effects of propranolol and dipyridamole on##2##6##(1994-5#2)
effects of protein##3##3##(1995-11#2)(2013-8#1)
effects of recombinant##2##3##(2008-11#2)
effects of red wine##2##4##(2008-10#1)(2008-7#1)
effects of redox-cycling##2##3##(2009-9#2)
effects of regional##2##3##(2008-9#2)
effects of sample volume##2##4##(2008-10#2)
effects of sample##3##3##(2008-10#2)(2009-10#1)
effects of saturation on the##2##5##(2008-3#2)
effects of several variables##2##4##(2008-10#2)
effects of several##10##3##(2008-10#7)(2008-11#2)(2012-5#1)
effects of simulated##2##3##(2008-9#1)(2012-5#1)
effects of skin##2##3##(2008-11#1)(2008-5#1)
effects of soil##2##3##(2008-10#2)
effects of solar##2##3##(2011-2#2)
effects of solvent##3##3##(2008-10#3)
effects of some##10##3##(2008-10#8)(2008-11#1)(2009-1#1)
effects of sowing date##2##4##(2008-10#2)
effects of specific##2##3##(2008-4#1)(2008-6#1)
effects of stress on##2##4##(2008-6#1)(2012-3#1)
effects of subcutaneous##3##3##(1991-6#3)
effects of such##2##3##(1991-12#1)(2010-11#1)
effects of sunlight##2##3##(2008-5#1)(2011-2#1)
effects of surface##2##3##(1994-5#1)(2009-7#1)
effects of synthetic##3##3##(1990-9#1)(1995-12#1)(1997-1#1)
effects of systemic##2##3##(1994-2#2)
effects of temperature and duration of wetness##2##7##(2008-10#2)
effects of temperature and##6##4##(2008-10#5)(2008-9#1)
effects of temperature##18##3##(1991-11#1)(1991-5#1)(2008-10#13)(2008-11#1)(2008-9#1)(2010-4#1)
effects of the consumption of##2##5##(2008-10#1)(2012-12#1)
effects of the different##2##4##(2008-10#1)(2008-11#1)
effects of the drug were observed##2##6##(1990-9#1)(2008-11#1)
effects of the drugs on##2##5##(2008-10#2)
effects of the drugs##3##4##(2008-10#2)(2011-2#1)
effects of the fungicide##2##4##(2008-10#2)
effects of the lectins##3##4##(1995-11#3)
effects of the mutation##3##4##(1993-8#2)(1993-9#1)
effects of the sun##2##4##(1991-6#1)(2011-2#1)
effects of the treatment##2##4##(2008-10#1)(2012-2#1)
effects of the##121##3##(1990-12#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#4)(1995-2#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-11#1)(2008-10#37)(2008-11#12)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)(2013-7#1)
effects of theanine##2##3##(2008-11#2)
effects of these agents##2##4##(1995-11#1)(2012-2#1)
effects of these drugs##3##4##(1991-1#1)(1996-11#1)(2013-1#1)
effects of these##28##3##(1990-11#1)(1990-5#1)(1991-1#1)(1993-3#2)(1995-11#2)(1996-11#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-4#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
effects of this##9##3##(1991-2#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#1)
effects of three##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
effects of toxins##2##3##(2008-7#1)(2009-11#1)
effects of traditional##3##3##(2009-11#1)(2010-12#2)
effects of treatment##3##3##(2008-12#1)(2008-5#1)(2008-6#1)
effects of treatments were##2##4##(2008-5#1)(2008-8#1)
effects of trophic cascades on##2##5##(2008-8#2)
effects of two different##2##4##(1993-1#1)(2009-1#1)
effects of two##11##3##(1993-1#1)(1994-5#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-1#1)
effects of using##3##3##(2012-3#1)(2013-1#2)
effects of various cationic interferences on percent recovery of##2##9##(2008-10#2)
effects of various cationic interferences on##5##6##(2008-10#5)
effects of various cationic##6##4##(2008-10#6)
effects of various##20##3##(1992-1#1)(1993-12#1)(1994-2#1)(1994-5#1)(2008-10#11)(2008-12#1)(2008-4#1)(2009-2#1)(2012-3#1)(2013-8#1)
effects of varying##9##3##(1991-1#1)(1991-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)(2012-4#1)(2013-8#1)
effects of vitamin D##2##4##(2008-1#1)(2012-2#1)
effects of vitamin##3##3##(1993-12#1)(2008-1#1)(2012-2#1)
effects of##1429##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#15)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#16)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#8)(1991-6#8)(1991-8#3)(1991-9#1)(1992-1#5)(1992-12#3)(1992-2#3)(1992-3#9)(1992-4#3)(1992-5#2)(1992-6#12)(1992-8#2)(1992-9#4)(1993-1#6)(1993-11#2)(1993-12#10)(1993-3#13)(1993-6#8)(1993-8#7)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#23)(1994-3#5)(1994-5#13)(1994-6#4)(1994-8#15)(1994-9#2)(1995-1#2)(1995-11#20)(1995-12#11)(1995-2#10)(1995-3#2)(1995-5#3)(1995-8#4)(1995-9#3)(1996-11#1)(1996-12#13)(1996-2#25)(1996-3#4)(1996-6#3)(1997-1#9)(1997-2#10)(1997-3#6)(1997-4#5)(1997-6#2)(1997-7#4)(1997-8#4)(2006-6#4)(2007-11#4)(2007-12#2)(2008-1#5)(2008-10#329)(2008-11#110)(2008-12#29)(2008-2#12)(2008-3#22)(2008-4#14)(2008-5#47)(2008-6#12)(2008-7#39)(2008-8#51)(2008-9#39)(2009-1#3)(2009-10#5)(2009-11#7)(2009-12#8)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#15)(2009-8#7)(2009-9#5)(2010-1#14)(2010-10#2)(2010-11#7)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#9)(2010-5#5)(2010-6#4)(2010-7#7)(2010-8#7)(2010-9#4)(2011-1#6)(2011-10#2)(2011-2#34)(2011-3#4)(2011-7#1)(2012-12#9)(2012-2#28)(2012-3#28)(2012-4#1)(2012-5#3)(2013-1#50)(2013-7#2)(2013-8#24)
effects often##2##2##(2008-11#1)(2010-12#1)
effects on DNA replication##2##4##(1994-5#1)(1997-3#1)
effects on DNA##3##3##(1993-8#1)(1994-5#1)(1997-3#1)
effects on S##2##3##(2008-10#2)
effects on a##2##3##(2008-10#1)(2011-2#1)
effects on blood##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
effects on both##2##3##(1996-1#1)(2009-5#1)
effects on cell growth##2##4##(1996-2#1)(2008-11#1)
effects on cell##4##3##(1996-2#1)(2008-11#2)(2008-5#1)
effects on cellular proliferation##2##4##(2013-7#2)
effects on cellular##4##3##(1997-1#1)(2008-9#1)(2013-7#2)
effects on disease##3##3##(2008-10#3)
effects on experimental##2##3##(2008-8#1)(2013-1#1)
effects on fitness##2##3##(2008-10#1)(2012-3#1)
effects on gene expression##2##4##(2008-10#1)(2011-1#1)
effects on glucose##3##3##(1994-12#1)(1994-3#1)(2008-3#1)
effects on growth##5##3##(1994-3#1)(2007-11#2)(2008-10#1)(2008-11#1)
effects on hair##2##3##(2008-5#2)
effects on host##2##3##(2008-8#1)(2008-9#1)
effects on how##2##3##(2008-8#1)(2009-10#1)
effects on human health##3##4##(2008-10#3)
effects on human##4##3##(2008-10#3)(2013-1#1)
effects on insect abundances##2##4##(2008-8#2)
effects on insect##4##3##(2008-8#4)
effects on neuroendocrine##2##3##(1996-12#1)(2008-2#1)
effects on other##4##3##(1993-8#1)(2008-12#1)(2008-3#1)(2008-8#1)
effects on plant growth and##2##5##(2008-10#2)
effects on plant growth##4##4##(2008-10#4)
effects on plant##6##3##(2008-10#4)(2008-8#2)
effects on pregnancy##2##3##(1991-3#1)(2013-1#1)
effects on radiation##2##3##(1997-8#1)(2008-9#1)
effects on resolution in ion mobility spectrometry##2##7##(2008-10#2)
effects on skin##3##3##(2008-5#2)(2008-9#1)
effects on soil resource heterogeneity##2##5##(2008-9#2)
effects on some##2##3##(1994-2#1)(2008-9#1)
effects on survival##2##3##(2008-10#1)(2009-10#1)
effects on target##2##3##(1996-12#1)(2008-12#1)
effects on the environment##2##4##(1991-6#1)(2008-10#1)
effects on the expression of##2##5##(2008-10#1)(2013-8#1)
effects on the expression##3##4##(2008-10#1)(2010-5#1)(2013-8#1)
effects on the growth of##5##5##(1990-11#1)(1991-5#1)(2008-10#2)(2010-8#1)
effects on the growth##6##4##(1990-11#1)(1991-5#1)(2008-10#2)(2008-11#1)(2010-8#1)
effects on the immune system##4##5##(1990-11#1)(1995-12#1)(2008-10#2)
effects on the release of##2##5##(1996-2#1)(1997-4#1)
effects on the skin##3##4##(2008-5#3)
effects on the##112##3##(1990-11#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#35)(2008-11#9)(2008-12#3)(2008-3#3)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#2)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
effects on this##3##3##(1990-12#1)(1995-2#1)(2011-2#1)
effects on yield##2##3##(2008-10#1)(2009-7#1)
effects on##422##2##(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#4)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#5)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#3)(1996-12#6)(1996-2#6)(1996-3#3)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#2)(2007-11#6)(2007-12#2)(2008-10#104)(2008-11#27)(2008-12#10)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#11)(2008-8#31)(2008-9#17)(2009-10#7)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#4)(2009-8#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#11)(2011-3#3)(2012-12#1)(2012-2#7)(2012-3#11)(2012-4#2)(2012-5#1)(2012-7#1)(2013-1#13)(2013-7#3)(2013-8#3)
effects or##9##2##(1990-6#1)(1995-8#1)(2008-10#2)(2008-7#2)(2008-8#1)(2012-3#1)(2013-1#1)
effects play##2##2##(2007-12#1)(2008-2#1)
effects produced by##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
effects rather than to##2##4##(1992-12#1)(2008-10#1)
effects related to##2##3##(2011-2#1)(2013-1#1)
effects related##3##2##(1994-3#1)(2011-2#1)(2013-1#1)
effects remain to be##2##4##(2010-7#1)(2011-2#1)
effects reported##2##2##(2008-10#1)(2008-5#1)
effects result from##3##3##(1997-7#1)(2008-6#1)(2008-9#1)
effects resulting from##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
effects seem to be##2##4##(1997-4#1)(2008-10#1)
effects seen with##2##3##(2008-8#1)(2011-2#1)
effects seen##3##2##(1991-12#1)(2008-8#1)(2011-2#1)
effects should be##2##3##(1991-12#1)(2008-9#1)
effects similar to##2##3##(1994-8#1)(2008-10#1)
effects such as##3##3##(2008-7#1)(2009-7#1)(2012-2#1)
effects than those##2##3##(2008-5#1)(2009-7#1)
effects than##4##2##(2008-11#1)(2008-5#1)(2009-7#1)(2010-12#1)
effects that are##4##3##(2008-3#1)(2010-6#1)(2012-2#2)
effects that have been##2##4##(2008-11#1)(2008-8#1)
effects that were##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
effects that##23##2##(1991-2#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-5#1)(2010-11#1)(2010-4#1)(2010-6#1)(2012-2#3)(2013-1#2)
effects the##2##2##(1993-2#1)(1993-6#1)
effects through##4##2##(1994-11#1)(1994-6#1)(2008-10#2)
effects to##9##2##(1991-9#1)(1993-12#1)(1994-8#1)(1997-7#1)(2008-10#3)(2008-8#2)
effects under##2##2##(2008-10#1)(2008-11#1)
effects upon##2##2##(2008-11#1)(2013-1#1)
effects via the##2##3##(2008-8#1)(2013-7#1)
effects was##12##2##(1990-7#1)(1993-2#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-4#1)
effects were achieved##2##3##(1997-8#1)(2008-3#1)
effects were also##2##3##(2008-10#2)
effects were considered##2##3##(2008-10#2)
effects were detected##3##3##(2008-10#3)
effects were evaluated by##2##4##(2008-11#1)(2008-5#1)
effects were evaluated##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
effects were found##3##3##(1993-2#1)(2008-10#1)(2013-1#1)
effects were minimal##3##3##(1990-6#1)(1991-8#1)(1997-7#1)
effects were minimized by##2##4##(1997-2#1)(2008-10#1)
effects were more pronounced##2##4##(2008-8#1)(2011-2#1)
effects were negligible##2##3##(1991-8#1)(2008-10#1)
effects were not##6##3##(1991-1#1)(1994-2#1)(2008-10#3)(2008-11#1)
effects were observed at##2##4##(1994-2#1)(1996-3#1)
effects were observed in##4##4##(1997-4#1)(2008-10#2)(2010-4#1)
effects were observed##12##3##(1990-11#1)(1991-3#1)(1994-2#2)(1996-3#1)(1997-4#1)(2008-10#5)(2010-4#1)
effects were seen##5##3##(1995-12#2)(1996-11#1)(2008-11#1)(2008-9#1)
effects were##89##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-2#3)(1995-11#1)(1995-12#2)(1996-11#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#35)(2008-11#7)(2008-3#1)(2008-5#5)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#3)
effects which are##2##3##(1997-4#1)(2013-7#1)
effects which##7##2##(1992-3#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-7#1)
effects will be##2##3##(1992-3#1)(1997-4#1)
effects will##4##2##(1992-3#1)(1997-4#1)(2007-11#1)(2008-11#1)
effects with##9##2##(1991-2#1)(1991-6#1)(2008-10#2)(2008-7#2)(2008-9#1)(2013-1#2)
effects##2911##1##(1990-10#1)(1990-11#9)(1990-12#4)(1990-2#5)(1990-3#1)(1990-5#18)(1990-6#9)(1990-7#2)(1990-8#3)(1990-9#6)(1991-1#24)(1991-10#2)(1991-11#2)(1991-12#15)(1991-2#13)(1991-3#14)(1991-4#1)(1991-5#16)(1991-6#14)(1991-8#6)(1991-9#4)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#20)(1992-4#4)(1992-5#3)(1992-6#14)(1992-8#4)(1992-9#6)(1993-1#13)(1993-11#8)(1993-12#13)(1993-2#7)(1993-3#21)(1993-5#1)(1993-6#16)(1993-8#13)(1993-9#1)(1994-1#3)(1994-11#7)(1994-12#4)(1994-2#31)(1994-3#12)(1994-5#23)(1994-6#6)(1994-8#28)(1994-9#4)(1995-1#3)(1995-11#26)(1995-12#20)(1995-2#22)(1995-3#3)(1995-5#7)(1995-6#5)(1995-8#8)(1995-9#3)(1996-1#4)(1996-11#3)(1996-12#23)(1996-2#38)(1996-3#17)(1996-5#1)(1996-6#5)(1996-8#3)(1996-9#2)(1997-1#23)(1997-2#19)(1997-3#9)(1997-4#14)(1997-5#1)(1997-6#5)(1997-7#13)(1997-8#8)(2006-6#6)(2007-11#17)(2007-12#10)(2008-1#7)(2008-10#668)(2008-11#216)(2008-12#47)(2008-2#22)(2008-3#59)(2008-4#21)(2008-5#92)(2008-6#21)(2008-7#92)(2008-8#143)(2008-9#94)(2009-1#4)(2009-10#15)(2009-11#9)(2009-12#18)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#34)(2009-8#18)(2009-9#9)(2010-1#23)(2010-10#10)(2010-11#14)(2010-12#13)(2010-2#3)(2010-3#2)(2010-4#15)(2010-5#6)(2010-6#5)(2010-7#14)(2010-8#15)(2010-9#6)(2011-1#10)(2011-10#2)(2011-2#81)(2011-3#9)(2011-7#1)(2012-12#19)(2012-2#64)(2012-3#62)(2012-4#3)(2012-5#4)(2012-6#3)(2012-7#2)(2013-1#103)(2013-7#11)(2013-8#36)
effects&quot##4##1##(1991-8#1)(2008-11#1)(2008-9#1)(2011-2#1)
effects)##4##1##(1990-9#1)(1994-8#1)(2008-10#1)(2008-12#1)
effects]##5##1##(1990-6#1)(1991-3#1)(1993-3#1)(1993-6#1)(1995-5#1)
efferent connections of the striatum and the nucleus accumbens##2##9##(1997-3#2)
efferent connections##3##2##(1997-3#3)
efferent fibers##2##2##(1996-12#1)(1997-3#1)
efferent projections##2##2##(1996-5#1)(2009-10#1)
efferent##13##1##(1992-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#5)(2008-7#2)(2009-10#1)
efficacies##4##1##(2008-10#1)(2008-5#2)(2012-2#1)
efficacious and safe##2##3##(1997-4#1)(2008-11#1)
efficacious and##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
efficacious for the##2##3##(1995-11#1)(2008-7#1)
efficacious in##6##2##(1991-3#1)(1992-1#1)(2008-10#2)(2008-11#1)(2008-8#1)
efficacious##34##1##(1990-3#1)(1990-5#1)(1991-3#1)(1992-1#1)(1993-1#1)(1994-8#1)(1995-11#3)(1996-1#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
efficacy achieved by##2##3##(2008-10#2)
efficacy after##2##2##(1993-11#1)(2008-10#1)
efficacy against##7##2##(2008-10#2)(2008-5#2)(2010-11#1)(2013-1#2)
efficacy among##2##2##(1995-2#1)(2008-5#1)
efficacy and perceptual##2##3##(2008-5#2)
efficacy and safety of a##2##5##(2008-8#1)(2013-1#1)
efficacy and safety of this##3##5##(1992-2#1)(1997-3#1)(2008-11#1)
efficacy and safety of##14##4##(1990-9#1)(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#3)
efficacy and safety##25##3##(1990-9#2)(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#4)(2013-1#4)
efficacy and side effects##2##4##(1993-1#1)(1993-6#1)
efficacy and side##3##3##(1993-1#1)(1993-6#1)(2011-10#1)
efficacy and stability##2##3##(2008-11#1)(2008-5#1)
efficacy and tolerability of##4##4##(1990-3#1)(1994-12#1)(2012-3#2)
efficacy and tolerability##6##3##(1990-3#1)(1994-12#1)(2007-11#1)(2008-5#1)(2012-3#2)
efficacy and toxicity##4##3##(1990-2#1)(1991-8#1)(2012-3#1)(2013-8#1)
efficacy and##80##2##(1990-2#1)(1990-3#2)(1990-9#2)(1991-11#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#7)(2013-8#2)
efficacy as##2##2##(1990-5#1)(2013-1#1)
efficacy assessment##2##2##(1993-12#1)(2008-5#1)
efficacy at the##2##3##(2008-10#1)(2012-2#1)
efficacy at##4##2##(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
efficacy by##2##2##(2008-10#1)(2008-5#1)
efficacy evaluations##2##2##(2008-5#2)
efficacy expectations##2##2##(2010-9#2)
efficacy for##9##2##(1995-5#1)(1995-8#1)(1996-2#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#1)
efficacy in patients with##2##4##(2009-10#1)(2011-2#1)
efficacy in the##2##3##(2008-5#1)(2008-9#1)
efficacy in##21##2##(1990-6#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-7#1)
efficacy is not##2##3##(1995-12#1)(2009-8#1)
efficacy is##10##2##(1994-8#2)(1995-12#1)(1995-5#1)(2008-5#2)(2008-6#1)(2009-8#1)(2012-3#2)
efficacy measure##3##2##(1994-9#2)(2012-2#1)
efficacy of a new##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
efficacy of a##16##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2009-2#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#1)
efficacy of an##5##3##(1993-5#1)(2008-10#2)(2011-2#1)(2012-12#1)
efficacy of biocontrol##2##3##(2008-10#2)
efficacy of biological control##2##4##(2008-10#2)
efficacy of different##2##3##(2008-10#2)
efficacy of entomopathogenic nematodes for##2##5##(2008-8#2)
efficacy of ethanolic extract of Lemon verbena##2##7##(2008-12#2)
efficacy of the approach##2##4##(2008-10#2)
efficacy of the##27##3##(1991-11#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-12#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-3#1)
efficacy of therapeutic##2##3##(2007-12#1)(2008-11#1)
efficacy of these drugs##3##4##(1991-8#1)(2008-11#1)(2010-5#1)
efficacy of these##5##3##(1991-8#1)(2008-11#2)(2010-5#1)(2010-6#1)
efficacy of this##4##3##(1994-5#1)(2008-10#2)(2008-11#1)
efficacy of using##2##3##(2008-9#1)(2011-2#1)
efficacy of##226##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#4)(1996-3#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#50)(2008-11#14)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#19)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#6)(2009-2#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#3)(2010-12#3)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#17)(2012-12#3)(2012-2#6)(2012-3#9)(2013-1#13)(2013-8#3)
efficacy on the##2##3##(2008-10#1)(2013-1#1)
efficacy on##3##2##(2008-10#2)(2013-1#1)
efficacy or##2##2##(2008-10#1)(2008-5#1)
efficacy studies##2##2##(1995-5#2)
efficacy testing##5##2##(1990-3#1)(1996-2#1)(2008-5#3)
efficacy than the##2##3##(2008-10#1)(2008-5#1)
efficacy than##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
efficacy to that##2##3##(2008-10#1)(2010-11#1)
efficacy to##6##2##(1995-5#1)(2008-10#2)(2008-5#1)(2010-11#1)(2013-1#1)
efficacy trial of##2##3##(1995-5#1)(2008-12#1)
efficacy trials##2##2##(1995-5#1)(2012-2#1)
efficacy under##2##2##(2008-10#2)
efficacy was found##2##3##(2008-11#1)(2008-5#1)
efficacy was highly variable##2##4##(2008-10#2)
efficacy was##9##2##(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
efficacy will be##2##3##(1992-3#1)(2008-5#1)
efficacy with##4##2##(1991-8#1)(1996-1#1)(2008-4#1)(2010-10#1)
efficacy##533##1##(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-3#2)(1991-6#1)(1991-8#3)(1992-1#1)(1992-2#1)(1992-3#3)(1992-9#4)(1993-1#6)(1993-11#3)(1993-12#5)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#4)(1994-9#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#14)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#96)(2008-11#27)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#66)(2008-6#9)(2008-7#10)(2008-8#11)(2008-9#7)(2009-1#1)(2009-10#4)(2009-12#7)(2009-2#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#1)(2010-3#1)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#4)(2011-1#3)(2011-10#1)(2011-2#35)(2011-3#2)(2012-12#10)(2012-2#12)(2012-3#17)(2013-1#30)(2013-7#1)(2013-8#8)
efficiencies and##3##2##(1997-1#1)(2008-10#1)(2008-5#1)
efficiencies are##2##2##(1991-12#1)(2011-3#1)
efficiencies for the##4##3##(2008-10#1)(2008-3#1)(2009-8#1)(2010-5#1)
efficiencies for##9##2##(2008-10#4)(2008-3#3)(2009-8#1)(2010-5#1)
efficiencies in##2##2##(2008-11#1)(2008-3#1)
efficiencies of##15##2##(1994-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-8#1)(2011-2#1)
efficiencies over##2##2##(2008-10#1)(2008-3#1)
efficiencies were##6##2##(2008-10#5)(2011-2#1)
efficiencies##61##1##(1991-12#2)(1994-8#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-10#30)(2008-11#6)(2008-2#1)(2008-3#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-5#1)(2011-2#3)(2011-3#1)
efficiency (CE) and##2##3##(2008-10#1)(2008-9#1)
efficiency 0##2##2##(2008-10#2)
efficiency allows##2##2##(2008-3#1)(2013-8#1)
efficiency and a##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
efficiency and effectiveness##2##3##(1993-3#1)(1995-3#1)
efficiency and expression##2##3##(2008-11#1)(2008-9#1)
efficiency and safety##4##3##(2008-11#1)(2008-8#1)(2012-3#2)
efficiency and selectivity of##2##4##(2008-10#2)
efficiency and selectivity##5##3##(2008-10#5)
efficiency and specificity of##2##4##(1997-2#1)(2010-5#1)
efficiency and stability##2##3##(2008-10#1)(2008-3#1)
efficiency and the influence of##3##5##(2008-10#3)
efficiency and the##7##3##(1997-8#1)(2008-10#3)(2008-11#2)(2008-3#1)
efficiency and##69##2##(1990-5#1)(1992-3#1)(1993-3#2)(1995-12#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#23)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#3)(2008-8#3)(2008-9#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)
efficiency as a function of##2##5##(2008-10#1)(2008-3#1)
efficiency as high as##2##4##(2008-10#1)(2008-3#1)
efficiency as well as##2##4##(2008-3#1)(2012-2#1)
efficiency as##12##2##(1990-5#1)(2008-10#6)(2008-12#1)(2008-3#3)(2012-2#1)
efficiency at##2##2##(1993-2#1)(2008-2#1)
efficiency between##2##2##(2008-10#1)(2008-8#1)
efficiency both in##2##3##(2008-11#1)(2008-8#1)
efficiency by##3##2##(2008-10#3)
efficiency can##3##2##(1997-3#1)(2008-2#1)(2008-8#1)
efficiency could be##2##3##(2008-10#2)
efficiency depending##2##2##(2008-10#1)(2008-6#1)
efficiency depends on the##2##4##(2008-10#1)(2008-2#1)
efficiency did not##2##3##(2008-10#2)
efficiency during##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
efficiency for a##2##3##(1994-5#1)(2008-10#1)
efficiency for##18##2##(1994-2#1)(1994-5#1)(2008-10#11)(2008-3#1)(2008-5#1)(2011-2#1)(2012-8#1)(2013-1#1)
efficiency from##2##2##(1997-1#1)(2008-10#1)
efficiency higher than##2##3##(2008-3#1)(2010-1#1)
efficiency in the##5##3##(1993-8#1)(2008-10#2)(2008-9#1)(2011-2#1)
efficiency in two##2##3##(2008-10#1)(2008-11#1)
efficiency in##24##2##(1990-5#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#2)
efficiency increased##4##2##(2008-10#2)(2008-2#1)(2013-1#1)
efficiency is##11##2##(2007-12#2)(2008-10#2)(2008-3#3)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
efficiency of 2##2##3##(2007-12#1)(2008-10#1)
efficiency of a##9##3##(1992-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)
efficiency of analyte##2##3##(2008-10#2)
efficiency of approximately##2##3##(2008-2#1)(2008-3#1)
efficiency of current##2##3##(2008-10#2)
efficiency of extraction##3##3##(2008-10#3)
efficiency of individual##2##3##(1992-2#1)(2012-3#1)
efficiency of ion##2##3##(2008-10#2)
efficiency of more than##2##4##(2008-11#1)(2008-2#1)
efficiency of oxalate absorption##2##4##(2012-2#2)
efficiency of ribosomal frameshifting##2##4##(1995-9#2)
efficiency of spinal anesthesia was##2##5##(2012-3#2)
efficiency of the extraction##2##4##(2008-10#2)
efficiency of the##45##3##(1990-5#1)(1992-2#1)(1992-9#2)(1997-2#1)(1997-8#1)(2008-10#27)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#2)(2012-2#1)(2013-8#1)
efficiency of these##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
efficiency of this##5##3##(1993-12#1)(2008-10#3)(2009-10#1)
efficiency of##213##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#3)(1992-9#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#2)(2007-12#6)(2008-10#89)(2008-11#17)(2008-12#4)(2008-2#12)(2008-3#12)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#3)
efficiency on##2##2##(1990-9#1)(2008-10#1)
efficiency over##3##2##(2008-10#2)(2008-3#1)
efficiency simultaneously##2##2##(2008-10#1)(2008-3#1)
efficiency than##4##2##(1992-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
efficiency that##3##2##(2008-10#1)(2009-5#1)(2012-2#1)
efficiency using##2##2##(2008-10#1)(2013-1#1)
efficiency was 12##2##3##(2008-10#1)(2008-3#1)
efficiency was found to be##2##5##(2008-10#1)(2008-5#1)
efficiency was not##2##3##(2008-11#2)
efficiency was##18##2##(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
efficiency were studied##2##3##(2008-10#2)
efficiency were##8##2##(1992-2#1)(2008-10#5)(2008-11#1)(2008-7#1)
efficiency with##4##2##(1992-2#1)(1996-1#1)(2008-10#1)(2008-2#1)
efficiency##614##1##(1990-12#1)(1990-5#5)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#10)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#5)(1995-1#1)(1995-12#2)(1995-3#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-6#1)(1997-8#3)(2007-11#1)(2007-12#8)(2008-10#245)(2008-11#51)(2008-12#12)(2008-2#28)(2008-3#44)(2008-5#12)(2008-6#6)(2008-7#3)(2008-8#17)(2008-9#15)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#10)(2011-2#13)(2011-3#4)(2011-7#1)(2012-12#1)(2012-2#20)(2012-3#14)(2012-6#1)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#9)
efficient algorithm##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
efficient amplification of##2##3##(2008-2#2)
efficient and accurate##2##3##(2009-8#1)(2012-2#1)
efficient and effective##3##3##(1994-2#1)(2008-12#1)(2012-3#1)
efficient and highly##2##3##(2008-10#1)(2008-11#1)
efficient and robust##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
efficient and##31##2##(1991-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1997-2#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
efficient approach##5##2##(1991-12#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-3#1)
efficient as##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
efficient at##4##2##(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
efficient because##2##2##(2008-11#1)(2012-3#1)
efficient catalytic##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
efficient compared to##2##3##(2008-10#1)(2008-12#1)
efficient delivery of DNA##2##4##(1994-5#1)(2008-11#1)
efficient delivery of##4##3##(1994-5#1)(1996-3#1)(2008-11#1)(2011-1#1)
efficient detection##3##2##(2008-10#1)(2012-2#2)
efficient device##2##2##(1996-12#1)(2008-11#1)
efficient digestion##2##2##(2008-10#1)(2012-2#1)
efficient elimination of##2##3##(2008-10#2)
efficient expression##2##2##(1991-5#1)(2008-11#1)
efficient extraction of##3##3##(2008-10#2)(2008-7#1)
efficient extraction##4##2##(2008-10#3)(2008-7#1)
efficient for the##2##3##(2008-10#1)(2008-5#1)
efficient for##8##2##(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)
efficient gene transfer##2##3##(2008-11#1)(2008-9#1)
efficient gene##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
efficient in the##3##3##(2008-10#2)(2012-2#1)
efficient in vitro##2##3##(2008-11#1)(2013-1#1)
efficient in##15##2##(1991-11#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
efficient infection##2##2##(2008-10#1)(2008-11#1)
efficient isolation##2##2##(1994-5#1)(2008-9#1)
efficient magnetic##2##2##(2008-10#2)
efficient management of##2##3##(1992-2#1)(1995-2#1)
efficient management##3##2##(1992-2#1)(1995-2#1)(2008-12#1)
efficient means##5##2##(1997-2#1)(2008-10#4)
efficient method for##6##3##(2008-10#4)(2008-11#1)(2008-9#1)
efficient method##15##2##(1990-2#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
efficient methods##3##2##(2008-10#1)(2008-4#1)(2011-7#1)
efficient operation##3##2##(2008-10#1)(2008-2#1)(2010-10#1)
efficient procedure for the##2##4##(2008-11#1)(2008-3#1)
efficient procedure for##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
efficient procedure##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
efficient production of##3##3##(1994-2#1)(2008-10#1)(2011-3#1)
efficient production system##3##3##(2008-7#1)(2008-9#2)
efficient production##7##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-3#1)
efficient protein##2##2##(2008-11#2)
efficient protocol for##2##3##(2008-10#1)(2008-9#1)
efficient pumping##2##2##(2008-2#1)(2008-3#1)
efficient radiative##2##2##(2008-2#2)
efficient removal of##3##3##(2008-10#2)(2011-1#1)
efficient sampling##3##2##(2008-10#3)
efficient separation##4##2##(2008-10#4)
efficient strategies##2##2##(2009-4#1)(2010-11#1)
efficient synthesis of##2##3##(1996-5#1)(2008-11#1)
efficient system for the##2##4##(1990-5#1)(2008-11#1)
efficient system for##3##3##(1990-5#1)(1993-8#1)(2008-11#1)
efficient system##4##2##(1990-5#1)(1993-8#1)(1995-2#1)(2008-11#1)
efficient technique for the##3##4##(2008-10#2)(2008-11#1)
efficient technique for##4##3##(2008-10#3)(2008-11#1)
efficient technique##5##2##(2008-10#4)(2008-11#1)
efficient than the##5##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-9#1)
efficient than##16##2##(1990-5#1)(1995-2#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
efficient to##2##2##(1997-2#1)(2012-3#1)
efficient tool##4##2##(2008-10#3)(2008-2#1)
efficient transduction##2##2##(1993-6#1)(1994-5#1)
efficient treatment##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
efficient use of##7##3##(1992-2#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-11#1)
efficient vectors of##3##3##(2008-10#3)
efficient vectors##4##2##(2008-10#4)
efficient viral##2##2##(1997-8#1)(2013-1#1)
efficient way to##6##3##(2008-10#4)(2008-3#1)(2008-8#1)
efficient way##7##2##(2008-10#4)(2008-3#1)(2008-8#1)(2010-11#1)
efficient when##2##2##(2008-10#2)
efficient##435##1##(1990-11#2)(1990-2#1)(1990-5#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#4)(1994-5#4)(1994-8#1)(1995-11#1)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#3)(1997-1#1)(1997-2#6)(1997-3#2)(1997-7#1)(1997-8#3)(2007-12#3)(2008-10#128)(2008-11#48)(2008-12#6)(2008-2#14)(2008-3#20)(2008-4#8)(2008-5#8)(2008-6#5)(2008-7#7)(2008-8#10)(2008-9#10)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#16)(2011-3#2)(2011-7#1)(2012-2#13)(2012-3#12)(2012-5#1)(2013-1#7)(2013-8#6)
efficiently and effectively##2##3##(1997-1#1)(2008-7#1)
efficiently and produce##2##3##(2008-10#1)(2009-8#1)
efficiently and##11##2##(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2011-2#1)
efficiently as##2##2##(2008-11#2)
efficiently by the##3##3##(1996-1#1)(2008-10#2)
efficiently by##4##2##(1996-1#1)(2008-10#2)(2008-2#1)
efficiently electrocatalytic oxidation for##2##4##(2008-10#2)
efficiently expressed##2##2##(2008-8#1)(2009-10#1)
efficiently extracted##3##2##(2008-10#3)
efficiently for##2##2##(1995-2#1)(2008-3#1)
efficiently in##3##2##(2008-10#1)(2011-3#1)(2013-1#1)
efficiently inhibited##2##2##(2010-1#1)(2013-1#1)
efficiently produced##2##2##(2008-11#1)(2008-8#1)
efficiently secreted##5##2##(1991-6#1)(1992-8#1)(2008-8#3)
efficiently separated##2##2##(2008-10#2)
efficiently to##4##2##(1994-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
efficiently transmitted##4##2##(2008-10#4)
efficiently vectored by##2##3##(2008-10#2)
efficiently with the##3##3##(1991-7#1)(1994-5#1)(2008-10#1)
efficiently with##6##2##(1991-7#1)(1993-2#1)(1994-5#1)(2008-1#1)(2008-10#1)(2011-2#1)
efficiently##140##1##(1990-12#1)(1990-5#1)(1991-10#1)(1991-6#1)(1991-7#2)(1992-8#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-5#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#2)(2008-1#2)(2008-10#42)(2008-11#14)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#9)(2008-9#5)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#4)(2011-2#4)(2011-3#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
effluent and##3##2##(2008-10#3)
effluent concentration##2##2##(2008-10#1)(2008-12#1)
effluent for##2##2##(2008-10#1)(2008-12#1)
effluent from the##2##3##(2008-10#2)
effluent from##4##2##(2008-10#4)
effluent of a##2##3##(2008-10#2)
effluent of##4##2##(2008-10#4)
effluent range and##2##3##(2008-10#2)
effluent samples##3##2##(2008-10#3)
effluent was mixed with the flow of##2##7##(2008-10#2)
effluent water##2##2##(2008-10#2)
effluent##57##1##(2008-10#42)(2008-11#3)(2008-12#7)(2008-7#2)(2011-2#3)
effluents in##2##2##(2008-10#2)
effluents of##3##2##(2008-10#2)(2008-11#1)
effluents##22##1##(2008-10#21)(2008-11#1)
effluvium##9##1##(2008-5#5)(2008-8#3)(2012-3#1)
efflux and##3##2##(1990-2#1)(1992-12#1)(2008-11#1)
efflux from##4##2##(1990-2#1)(1991-3#1)(1992-12#1)(1994-11#1)
efflux in##5##2##(1994-11#1)(1994-3#3)(1994-8#1)
efflux of##3##2##(1994-8#2)(2008-9#1)
efflux stimulating##2##2##(1992-12#2)
efflux was##4##2##(1994-11#1)(1994-3#3)
efflux with##2##2##(1994-3#1)(1994-8#1)
efflux##44##1##(1990-2#5)(1991-3#2)(1992-12#5)(1994-11#3)(1994-3#12)(1994-8#6)(2008-10#2)(2008-11#5)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
effort and##6##2##(2008-12#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
effort by the##4##3##(1992-1#1)(1995-12#2)(1997-3#1)
effort by##7##2##(1992-1#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-3#1)(2008-11#1)
effort for##2##2##(2008-10#1)(2008-8#1)
effort had##2##2##(1993-12#1)(1997-7#1)
effort has been directed##2##4##(2008-1#1)(2011-2#1)
effort has been made to##2##5##(1995-2#1)(2009-8#1)
effort has been made##3##4##(1995-2#1)(1997-6#1)(2009-8#1)
effort has been##10##3##(1992-9#1)(1995-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#1)
effort has##11##2##(1992-9#1)(1995-2#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#1)
effort in##6##2##(1991-2#1)(2008-8#2)(2009-10#2)(2010-9#1)
effort is needed to##2##4##(1994-12#1)(2008-1#1)
effort is##7##2##(1991-3#1)(1994-12#1)(1994-2#2)(2008-1#1)(2008-10#1)(2008-8#1)
effort of##3##2##(1991-2#1)(1991-3#1)(2013-8#1)
effort required##2##2##(1995-1#1)(1997-3#1)
effort that##3##2##(1994-12#1)(2008-8#1)(2011-2#1)
effort to identify##5##3##(1993-2#1)(1995-11#2)(1997-1#1)(2008-11#1)
effort to improve##3##3##(1993-12#1)(2010-10#1)(2012-3#1)
effort to increase##3##3##(1997-3#1)(2008-8#1)(2013-1#1)
effort to investigate##2##3##(2012-3#2)
effort to understand##3##3##(2008-3#1)(2008-5#1)(2009-9#1)
effort to##61##2##(1990-11#1)(1990-6#1)(1991-1#2)(1991-2#1)(1992-1#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-9#2)(2011-2#2)(2012-12#1)(2012-3#7)(2013-1#1)(2013-8#1)
effort toward##2##2##(1994-3#1)(1997-3#1)
effort towards##2##2##(2009-10#1)(2012-2#1)
effort was##5##2##(1990-6#1)(1991-6#1)(1993-12#1)(2008-8#2)
effort will##3##2##(1994-9#1)(1996-2#1)(2008-8#1)
effort##180##1##(1990-11#1)(1990-12#1)(1990-6#2)(1991-1#2)(1991-2#3)(1991-3#2)(1991-6#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#5)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#1)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-6#1)(1997-7#1)(2008-1#4)(2008-10#13)(2008-11#7)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#18)(2008-9#3)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-5#1)(2010-8#2)(2010-9#7)(2011-2#7)(2011-9#2)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#2)(2013-8#5)
effortful control abilities##3##3##(2011-2#3)
effortful control##4##2##(2011-2#4)
effortful##5##1##(2011-2#4)(2012-3#1)
efforts and##11##2##(1991-6#2)(1994-3#3)(1995-9#1)(1996-3#1)(1997-3#1)(2008-10#1)(2009-9#1)(2012-2#1)
efforts are needed##3##3##(1997-1#1)(1997-7#1)(2008-1#1)
efforts are underway##2##3##(1997-3#1)(2012-2#1)
efforts are##15##2##(1994-1#1)(1996-1#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-5#2)(2009-12#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
efforts as##2##2##(1994-1#1)(2010-8#1)
efforts by##3##2##(1991-6#1)(1993-12#1)(2008-10#1)
efforts for##5##2##(1996-12#1)(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
efforts from the##2##3##(2008-11#1)(2009-6#1)
efforts from##3##2##(2008-11#1)(2009-6#1)(2011-2#1)
efforts have been directed##2##4##(2008-10#1)(2009-12#1)
efforts have been focused##2##4##(2008-10#1)(2011-2#1)
efforts have been made to##2##5##(2008-10#1)(2008-11#1)
efforts have been##6##3##(2008-10#3)(2008-11#1)(2009-12#1)(2011-2#1)
efforts have##8##2##(2008-10#3)(2008-11#2)(2009-12#1)(2010-12#1)(2011-2#1)
efforts in the##6##3##(1993-2#1)(1994-9#1)(2009-10#1)(2011-3#1)(2012-2#1)(2013-8#1)
efforts in this##2##3##(1995-1#1)(2008-11#1)
efforts in##15##2##(1992-12#1)(1993-2#2)(1994-9#1)(1995-1#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-10#1)(2011-3#1)(2012-2#2)(2013-8#1)
efforts must be##2##3##(1992-9#1)(1994-5#1)
efforts of the##5##3##(1992-1#1)(1994-9#1)(1995-3#1)(1996-1#1)(2008-10#1)
efforts of##16##2##(1992-1#2)(1993-3#1)(1994-12#1)(1994-9#2)(1995-3#2)(1995-5#1)(1996-1#2)(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
efforts on behalf of##2##4##(1992-1#1)(2013-7#1)
efforts on##3##2##(1992-1#1)(2008-7#1)(2013-7#1)
efforts related to##2##3##(1995-12#1)(2008-10#1)
efforts should be##3##3##(1996-1#1)(2013-1#2)
efforts to combat##2##3##(1990-11#1)(1996-11#1)
efforts to control##2##3##(1995-1#1)(1997-1#1)
efforts to develop a##3##4##(1996-3#1)(2008-11#1)(2009-6#1)
efforts to develop##7##3##(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-6#1)(2011-2#1)
efforts to implement##2##3##(1994-1#1)(1995-2#1)
efforts to improve##5##3##(1993-3#1)(1994-2#1)(1995-3#1)(2008-11#1)(2013-1#1)
efforts to increase##2##3##(2008-10#1)(2008-11#1)
efforts to prevent##2##3##(1996-11#1)(2008-11#1)
efforts to quit##2##3##(2010-2#2)
efforts to transfer##2##3##(1997-7#1)(2008-12#1)
efforts to##76##2##(1990-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#3)(1994-2#3)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#4)(1997-1#1)(1997-3#1)(1997-7#2)(1997-9#1)(2008-10#8)(2008-11#11)(2008-12#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
efforts were##4##2##(2008-10#1)(2008-11#1)(2012-2#2)
efforts##237##1##(1990-11#2)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#2)(1992-1#3)(1992-12#2)(1992-3#3)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#2)(1994-1#7)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#2)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#7)(1996-6#1)(1996-9#1)(1997-1#7)(1997-2#3)(1997-3#4)(1997-7#3)(1997-9#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#23)(2008-11#21)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#5)(2011-10#1)(2011-2#9)(2011-3#2)(2012-2#14)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#1)
efforts?##2##1##(1994-9#1)(2013-1#1)
effusion and##4##2##(2008-10#2)(2010-5#1)(2012-3#1)
effusion in##4##2##(2008-5#2)(2010-12#1)(2011-2#1)
effusion is a##2##3##(1991-6#1)(2011-2#1)
effusion##25##1##(1991-12#4)(1991-6#1)(1992-2#1)(1997-4#3)(1997-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
effusions of##2##2##(1992-2#1)(1994-8#1)
effusions##9##1##(1990-2#1)(1991-6#2)(1992-2#3)(1994-8#1)(2008-9#1)(2011-2#1)
effusive##2##1##(1992-8#1)(2013-1#1)
efp##2##1##(2008-10#2)
eg##3##1##(2008-5#1)(2008-6#1)(2009-12#1)
egalitarian##2##1##(2009-7#1)(2013-8#1)
egg and##5##2##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#2)
egg can##2##2##(2008-9#1)(2011-2#1)
egg capsule##5##2##(2008-12#5)
egg cell##9##2##(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)
egg counts##4##2##(1996-12#3)(2008-10#1)
egg extract##2##2##(1993-2#1)(2008-8#1)
egg fertilization and##3##3##(1994-11#1)(2008-8#2)
egg in##2##2##(1997-6#1)(2008-8#1)
egg is##2##2##(2007-12#1)(2008-12#1)
egg laying##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
egg masses##7##2##(2008-10#4)(2010-8#3)
egg population##2##2##(2008-10#2)
egg product##2##2##(2011-2#2)
egg production for##2##3##(2008-12#1)(2008-8#1)
egg production##9##2##(2008-11#1)(2008-12#5)(2008-5#1)(2008-8#2)
egg recovery##3##2##(1996-12#3)
egg samples##2##2##(2008-10#2)
egg shedding##2##2##(1996-12#2)
egg size in##4##3##(1991-5#2)(2008-8#2)
egg size##10##2##(1991-5#5)(2008-8#3)(2010-8#2)
egg white and##2##3##(2008-10#2)
egg white##7##2##(1997-2#1)(2008-10#5)(2010-4#1)
egg yolk##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
egg##159##1##(1990-3#1)(1991-11#1)(1991-5#5)(1991-9#1)(1993-2#2)(1993-6#2)(1994-11#2)(1994-12#1)(1994-5#2)(1994-9#1)(1995-6#1)(1996-12#8)(1997-2#1)(1997-6#2)(2007-12#4)(2008-10#33)(2008-11#9)(2008-12#23)(2008-5#1)(2008-6#1)(2008-8#22)(2008-9#13)(2010-4#1)(2010-8#13)(2011-2#7)(2013-1#2)
eggerthii##3##1##(1997-2#3)
eggfish##6##1##(2010-8#6)
eggplant##8##1##(2008-10#8)
eggs a##2##2##(1991-4#1)(2008-8#1)
eggs and second-stage juveniles##2##4##(2008-10#2)
eggs and##17##2##(1993-6#2)(1996-12#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-8#1)
eggs at##2##2##(2008-6#1)(2010-8#1)
eggs from##3##2##(2008-10#2)(2008-6#1)
eggs in the##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
eggs in##10##2##(1996-12#2)(2007-12#1)(2008-10#3)(2008-8#2)(2013-1#2)
eggs is##2##2##(1993-6#1)(2008-6#1)
eggs of H##6##3##(2008-10#6)
eggs of##10##2##(2008-10#6)(2008-11#1)(2008-12#2)(2010-5#1)
eggs or##3##2##(1991-5#1)(2008-9#1)(2010-8#1)
eggs that##2##2##(1991-5#1)(2008-10#1)
eggs to##2##2##(1991-5#1)(2008-10#1)
eggs using##2##2##(1996-12#1)(2008-10#1)
eggs were##3##2##(1996-12#2)(2008-10#1)
eggs which##2##2##(1996-12#1)(2008-12#1)
eggs##136##1##(1991-4#1)(1991-5#5)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#5)(1994-11#1)(1995-2#1)(1996-12#10)(1997-7#1)(2007-12#3)(2008-10#38)(2008-11#7)(2008-12#7)(2008-5#3)(2008-6#4)(2008-8#21)(2008-9#7)(2010-5#2)(2010-8#8)(2011-2#2)(2012-2#1)(2013-1#5)(2013-8#1)
eggs)##2##1##(2008-8#2)
eggs/female##2##1##(2008-12#2)
eggshell membrane##4##2##(2008-10#4)
egl1##5##1##(2008-10#5)
egocentric##4##1##(1994-8#1)(2013-1#3)
egress##4##1##(2008-10#1)(2009-6#1)(2013-1#2)
egression##3##1##(2008-10#3)
ehrlichia chaffeensis&quot##2##2##(2013-1#2)
eicosanoid release##2##2##(1991-5#2)
eicosanoid synthesis##3##2##(1992-12#1)(1995-11#2)
eicosanoid##7##1##(1991-5#4)(1992-12#1)(1995-11#2)
eicosapentaenoic acid (EPA) and##2##4##(2008-11#1)(2010-1#1)
eicosapentaenoic acid##4##2##(2008-11#2)(2008-3#1)(2010-1#1)
eicosapentaenoic##5##1##(2008-11#2)(2008-3#1)(2010-1#1)(2011-2#1)
eigenmodes##5##1##(1992-8#1)(2008-2#2)(2008-3#2)
eight (9%)##2##2##(1996-9#1)(1997-3#1)
eight Ac elements##2##3##(2012-3#2)
eight Ac##3##2##(2012-3#3)
eight P##2##2##(2008-10#2)
eight amino##2##2##(1994-5#1)(1997-9#1)
eight animals##4##2##(1995-5#3)(1996-12#1)
eight cases of##2##3##(2008-5#1)(2011-2#1)
eight cases##5##2##(2008-5#1)(2008-7#2)(2009-4#1)(2011-2#1)
eight cell##2##2##(2008-10#1)(2008-11#1)
eight clades##2##2##(2008-10#2)
eight clones##2##2##(2008-10#2)
eight components##2##2##(1997-3#1)(2008-10#1)
eight compounds##2##2##(2008-10#1)(2011-3#1)
eight different##11##2##(1993-12#1)(2008-10#7)(2008-6#1)(2008-8#1)(2012-2#1)
eight domains##2##2##(2010-10#1)(2013-1#1)
eight exons##2##2##(1993-12#1)(1997-7#1)
eight families##2##2##(1992-7#1)(2008-12#1)
eight identified##2##2##(2008-10#1)(2010-12#1)
eight isolates##4##2##(2008-10#4)
eight of the##3##3##(1993-12#1)(1996-2#1)(2008-7#1)
eight of them##2##3##(2008-5#1)(2008-7#1)
eight of##9##2##(1993-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#4)
eight organic##2##2##(1992-3#1)(2008-10#1)
eight other isolates##2##3##(2008-10#2)
eight other##5##2##(1993-2#1)(2008-10#4)
eight patients with chronic##2##4##(1992-11#1)(2008-5#1)
eight patients with spontaneous##2##4##(2011-2#2)
eight patients with##7##3##(1992-11#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#2)
eight patients##17##2##(1990-11#1)(1991-6#1)(1992-11#1)(1993-1#1)(1994-9#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#2)(2011-2#5)
eight phthalates##2##2##(2008-10#2)
eight potential##2##2##(2008-5#1)(2008-8#1)
eight previously##2##2##(2008-10#1)(2013-8#1)
eight primer pairs##2##3##(2008-10#2)
eight primer##3##2##(2008-10#3)
eight race clusters##2##3##(2008-10#2)
eight replicate##5##2##(2008-10#5)
eight restriction enzymes##2##3##(2008-10#2)
eight samples##2##2##(1996-12#1)(2008-10#1)
eight silt loams##2##3##(2008-10#2)
eight species##2##2##(2008-10#1)(2008-12#1)
eight strains using##2##3##(2008-10#2)
eight strains##3##2##(2008-10#3)
eight times##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
eight to##3##2##(1992-1#1)(1997-5#1)(2012-3#1)
eight trees##2##2##(2008-10#2)
eight variables##3##2##(2008-10#3)
eight weeks##6##2##(1990-11#1)(1992-5#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#1)
eight women##2##2##(2008-10#1)(2011-2#1)
eight years of##2##3##(2012-3#1)(2013-1#1)
eight years##6##2##(1994-12#1)(1997-2#2)(2012-3#1)(2013-1#2)
eight##335##1##(1990-11#3)(1990-3#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-5#3)(1992-7#1)(1993-1#3)(1993-12#4)(1993-2#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-1#2)(1995-2#1)(1995-5#3)(1995-6#2)(1996-12#7)(1996-2#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-5#2)(1997-7#1)(1997-8#4)(1997-9#1)(2007-12#1)(2008-1#4)(2008-10#148)(2008-11#9)(2008-12#8)(2008-3#4)(2008-5#9)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#9)(2009-10#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#10)(2013-1#5)(2013-8#1)
eighteen##9##1##(1993-3#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#3)
eighteenth##4##1##(2008-10#1)(2010-1#1)(2010-5#1)(2011-2#1)
eightfold##7##1##(1995-2#1)(1997-7#1)(2008-10#3)(2011-1#1)(2011-2#1)
eighth##13##1##(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-9#1)(2011-2#4)(2013-1#1)
eighties##4##1##(1993-3#1)(1994-11#1)(2008-10#1)(2012-12#1)
eighty##2##1##(2008-11#1)(2011-1#1)
ein2-1 and##2##2##(2008-10#1)(2009-8#1)
ein2-1 plants##2##2##(2008-10#2)
ein2-1##8##1##(2008-10#7)(2009-8#1)
either 0##2##2##(1993-1#1)(2008-10#1)
either 1 or##2##3##(1992-10#1)(2008-10#1)
either 1%##2##2##(2008-5#2)
either 10##2##2##(1995-6#1)(2009-7#1)
either ACh or (1S##3##4##(1996-5#3)
either B##2##2##(1992-8#1)(2008-10#1)
either P##4##2##(2008-10#4)
either RNA or DNA##2##4##(1992-3#1)(2008-4#1)
either a##40##2##(1991-12#1)(1992-1#1)(1992-5#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(2008-1#1)(2008-10#16)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
either absent##2##2##(2008-10#1)(2008-7#1)
either after##3##2##(1991-8#1)(1994-9#1)(2013-1#1)
either all##3##2##(2008-10#1)(2013-8#2)
either alone or in combination##2##5##(2008-8#1)(2011-2#1)
either alone or in##4##4##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
either alone or##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
either alone##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
either an##12##2##(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2013-8#1)
either as a##5##3##(1990-11#1)(1996-11#1)(2008-10#2)(2008-9#1)
either as##14##2##(1990-11#1)(1994-8#1)(1996-11#1)(2008-10#6)(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#2)
either assay##2##2##(2008-10#2)
either assembly##2##2##(1997-3#1)(2011-2#1)
either at##8##2##(1993-6#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-8#1)
either before or after##2##4##(2008-10#1)(2008-9#1)
either before or##3##3##(1993-8#1)(2008-10#1)(2008-9#1)
either between##2##2##(1991-3#1)(2008-10#1)
either by an##2##3##(2008-10#1)(2011-2#1)
either by chemical##2##3##(1990-5#1)(1993-3#1)
either by the##2##3##(2007-12#1)(2008-5#1)
either by using##3##3##(2008-10#2)(2008-7#1)
either by##44##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1993-3#2)(1993-9#1)(1994-1#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#2)
either case##5##2##(2008-10#3)(2009-4#1)(2011-1#1)
either decreased or##2##3##(1993-1#1)(2008-10#1)
either diagnostic or##2##3##(1990-2#1)(2008-11#1)
either did not##2##3##(2008-10#1)(2008-9#1)
either direct or indirect##2##4##(2008-9#1)(2009-9#1)
either direct or##3##3##(2008-1#1)(2008-9#1)(2009-9#1)
either direct##5##2##(2008-1#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)
either directly or indirectly##2##4##(1996-2#1)(2008-10#1)
either directly or##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
either directly##10##2##(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-8#2)(2010-6#1)(2012-2#1)
either drug##2##2##(2008-7#1)(2011-10#1)
either due##2##2##(1996-9#1)(2013-1#1)
either during##2##2##(1993-1#1)(2013-1#1)
either end of the##3##4##(1995-2#1)(2008-3#1)(2008-8#1)
either end##4##2##(1995-2#1)(2008-11#1)(2008-3#1)(2008-8#1)
either enhance or##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
either enhance##5##2##(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)(2011-2#1)
either enzyme##3##2##(1990-11#1)(1993-9#1)(2008-7#1)
either for##4##2##(1990-6#1)(1994-8#1)(2008-4#1)(2010-7#1)
either from the##4##3##(1991-3#1)(2008-11#1)(2008-5#1)(2008-9#1)
either from##6##2##(1991-3#1)(1994-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
either fungus##3##2##(2008-10#3)
either group##5##2##(1994-12#1)(1997-2#1)(2008-10#1)(2010-7#1)(2011-1#1)
either had##2##2##(2008-10#2)
either having##2##2##(2008-10#1)(2008-7#1)
either hemisphere##2##2##(2008-11#1)(2011-2#1)
either high or low##2##4##(2008-8#1)(2008-9#1)
either high##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
either homophilic or heterophilic interactions of the CArG box binding factors##2##11##(1993-8#2)
either host##2##2##(2008-10#2)
either human##3##2##(2008-4#1)(2008-7#1)(2013-1#1)
either in a##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
either in pure form or in pharmaceutical formulations##2##8##(2008-10#2)
either in the##8##3##(1991-12#1)(1992-5#1)(2008-10#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
either in##31##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-6#1)(1996-2#2)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
either increased or decreased##2##4##(1991-9#1)(2008-10#1)
either increased or##4##3##(1991-9#1)(1997-1#1)(2008-10#2)
either increased##5##2##(1991-9#1)(1997-1#1)(2008-10#2)(2008-8#1)
either intact##2##2##(1993-8#1)(2008-11#1)
either internal##2##2##(1992-12#1)(2008-7#1)
either large##2##2##(1994-2#1)(2008-8#1)
either local##2##2##(1990-11#1)(1997-5#1)
either maize##2##2##(2008-10#2)
either method##2##2##(2010-7#2)
either more##4##2##(1994-12#1)(2008-10#1)(2010-11#1)(2012-6#1)
either no or##2##3##(2008-8#1)(2010-1#1)
either no##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-4#1)
either of the other##2##4##(1993-11#1)(2008-8#1)
either of the two##5##4##(1991-12#1)(1995-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
either of the##19##3##(1990-11#1)(1991-12#2)(1991-2#1)(1993-11#1)(1994-2#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)
either of these##5##3##(1991-9#1)(1994-8#1)(1996-2#1)(2008-10#1)(2011-10#1)
either of two##2##3##(2008-10#2)
either of##32##2##(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-9#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-10#1)(2011-2#1)(2012-2#1)
either on##10##2##(1991-8#1)(1994-1#1)(1997-3#1)(2008-10#4)(2008-8#1)(2008-9#1)(2011-1#1)
either one of two##3##4##(1990-12#2)(1997-3#1)
either one of##5##3##(1990-12#2)(1997-3#1)(2008-5#1)(2008-7#1)
either one or##2##3##(1991-5#1)(1993-8#1)
either one##11##2##(1990-12#2)(1991-5#1)(1993-6#1)(1993-8#1)(1995-6#1)(1997-3#1)(2008-5#2)(2008-7#1)(2011-2#1)
either parent##4##2##(2008-10#4)
either partially##2##2##(1993-8#1)(2012-3#1)
either positive##3##2##(1994-1#1)(1997-3#1)(2008-8#1)
either positively or negatively##2##4##(2008-10#1)(2008-4#1)
either positively##3##2##(2008-10#2)(2008-4#1)
either procedure##2##2##(2008-10#1)(2008-4#1)
either program##2##2##(1996-1#1)(1997-2#1)
either recombinant##2##2##(1995-6#2)
either reduced##2##2##(1996-12#1)(2008-11#1)
either resistance##2##2##(2008-10#2)
either risk##2##2##(2008-11#1)(2013-8#1)
either sex##4##2##(1994-2#1)(2008-8#1)(2010-4#1)(2010-7#1)
either side of##6##3##(1991-5#1)(1996-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
either side##7##2##(1991-5#1)(1996-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#1)
either sodium##2##2##(2008-10#2)
either specific##2##2##(2008-10#1)(2008-12#1)
either spontaneously or##2##3##(1997-2#1)(2009-8#1)
either strain##4##2##(1996-12#1)(2008-10#2)(2008-9#1)
either subconjunctivally or##2##3##(2008-12#2)
either that##3##2##(2008-10#2)(2008-9#1)
either the European or##2##4##(2008-10#2)
either the active##2##3##(1997-6#1)(2008-11#1)
either the posterior cutaneous##2##4##(1997-3#2)
either the presence##2##3##(1995-9#1)(2008-7#1)
either the same##2##3##(1994-8#1)(2008-4#1)
either the skin##2##3##(2008-10#1)(2008-5#1)
either the##81##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-5#3)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#22)(2008-11#9)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
either through the##2##3##(2008-3#1)(2008-7#1)
either through##6##2##(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#1)
either to the##3##3##(1991-8#1)(2008-10#1)(2008-7#1)
either to##12##2##(1991-8#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
either total##2##2##(1990-7#1)(2013-1#1)
either treated##2##2##(1991-11#1)(1995-8#1)
either treatment##4##2##(2008-10#2)(2008-3#1)(2009-8#1)
either upstream or downstream##2##4##(1992-3#1)(2012-2#1)
either very##2##2##(2008-10#1)(2013-8#1)
either virulent##3##2##(2008-10#2)(2008-5#1)
either visual##2##2##(2008-10#1)(2011-2#1)
either wild type##2##3##(1995-11#1)(2008-11#1)
either wild-type##2##2##(1997-7#1)(2008-11#1)
either with or without##4##4##(2006-5#1)(2008-10#1)(2008-5#2)
either with##16##2##(1991-12#1)(1991-5#1)(1994-12#1)(2006-5#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)
either##1086##1##(1990-11#7)(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#7)(1991-2#5)(1991-3#6)(1991-5#6)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#3)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#8)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#7)(1993-8#7)(1993-9#4)(1994-1#3)(1994-11#4)(1994-12#5)(1994-2#6)(1994-3#4)(1994-5#6)(1994-8#8)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#4)(1995-2#11)(1995-3#1)(1995-5#8)(1995-6#11)(1995-8#4)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#13)(1996-2#8)(1996-3#6)(1996-5#9)(1996-6#2)(1996-9#1)(1997-1#7)(1997-2#8)(1997-3#12)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#2)(2006-5#1)(2006-6#2)(2007-12#5)(2007-9#1)(2008-1#3)(2008-10#323)(2008-11#60)(2008-12#15)(2008-2#5)(2008-3#15)(2008-4#24)(2008-5#32)(2008-6#7)(2008-7#34)(2008-8#30)(2008-9#38)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#5)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#3)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#7)(2010-8#4)(2011-1#8)(2011-10#2)(2011-2#33)(2012-12#4)(2012-2#17)(2012-3#11)(2012-5#1)(2012-6#1)(2012-9#1)(2013-1#25)(2013-8#15)
ejaculate##3##1##(1997-8#3)
ejaculation##8##1##(1992-12#3)(1994-2#1)(1994-8#1)(1997-6#1)(2008-10#1)(2010-11#1)
ejaculatory duct##8##2##(2007-12#2)(2008-7#5)(2010-11#1)
ejaculatory##11##1##(1997-8#3)(2007-12#2)(2008-7#5)(2010-11#1)
ejected##3##1##(2008-10#2)(2008-8#1)
ejection fraction and fractional fiber shortening##2##6##(2012-2#2)
ejection fraction and##6##3##(1993-2#2)(2009-5#1)(2012-2#2)(2013-1#1)
ejection fraction was##3##3##(1997-5#1)(2008-12#1)(2011-2#1)
ejection fraction##21##2##(1990-9#1)(1993-2#2)(1997-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-6#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#2)
ejection##28##1##(1990-9#2)(1993-2#2)(1996-5#1)(1997-5#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-6#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#2)
elaborate##12##1##(1995-9#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-10#1)(2010-1#2)(2010-5#1)(2012-2#1)
elaborated and##2##2##(2008-9#1)(2011-2#1)
elaborated as##2##2##(2008-10#1)(2008-5#1)
elaborated for##3##2##(2008-10#3)
elaborated from##2##2##(2008-10#1)(2010-8#1)
elaborated on##2##2##(2008-12#1)(2010-5#1)
elaborated upon##3##2##(1990-2#1)(2010-12#1)(2012-2#1)
elaborated with##3##2##(2008-10#2)(2008-2#1)
elaborated##32##1##(1990-2#2)(1992-11#1)(1992-12#1)(1994-2#1)(1996-12#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
elaborates on##2##2##(1991-6#1)(1994-12#1)
elaborates##3##1##(1991-6#1)(1994-12#1)(1994-3#1)
elaborating##3##1##(1994-5#1)(2008-10#2)
elaboration and##2##2##(2008-10#1)(2008-9#1)
elaboration of##12##2##(1994-3#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-8#1)(2009-6#1)(2012-3#1)
elaboration procedure##2##2##(2008-2#2)
elaboration##24##1##(1991-3#1)(1994-3#1)(1996-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-6#1)(2012-3#2)
elafin##3##1##(1992-6#3)
elapsed between the##2##3##(1993-3#1)(2008-11#1)
elapsed between##3##2##(1993-3#1)(1996-3#1)(2008-11#1)
elapsed from the##2##3##(2008-10#1)(2008-11#1)
elapsed from##3##2##(1996-9#1)(2008-10#1)(2008-11#1)
elapsed##8##1##(1993-3#1)(1993-6#1)(1996-3#1)(1996-9#1)(2008-10#2)(2008-11#2)
elasmobranchs##2##1##(1995-12#1)(2008-11#1)
elastase (PPE)##4##2##(1991-3#1)(1991-9#1)(2008-5#2)
elastase activity##5##2##(2008-5#2)(2008-7#3)
elastase and cathepsin G##2##4##(2008-6#1)(2008-7#1)
elastase and##4##2##(1994-5#1)(2008-5#1)(2008-6#1)(2008-7#1)
elastase##36##1##(1990-2#3)(1991-3#2)(1991-9#1)(1992-12#4)(1993-3#1)(1993-8#2)(1994-5#4)(1995-6#1)(2008-5#12)(2008-6#1)(2008-7#4)(2008-8#1)
elastic and##2##2##(2008-3#1)(2008-5#1)
elastic distortions##2##2##(2012-2#2)
elastic fiber##2##2##(2008-5#1)(2010-4#1)
elastic fibers##3##2##(1992-12#1)(2010-4#1)(2012-2#1)
elastic light scattering##3##3##(2008-3#3)
elastic modulus K##2##3##(2008-9#2)
elastic modulus of the##2##4##(2009-7#1)(2010-4#1)
elastic modulus of##4##3##(2009-7#1)(2010-4#2)(2010-8#1)
elastic modulus##13##2##(2008-9#2)(2009-7#3)(2010-10#2)(2010-4#4)(2010-8#1)(2011-3#1)
elastic properties of##4##3##(2008-10#1)(2009-7#1)(2010-4#1)(2010-8#1)
elastic properties##6##2##(2008-10#1)(2009-7#2)(2010-4#1)(2010-8#1)(2013-8#1)
elastic recoil##3##2##(1992-9#1)(2009-7#1)(2013-1#1)
elastic scattering##2##2##(2008-3#2)
elastic##58##1##(1990-3#1)(1992-12#1)(1992-9#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-3#7)(2008-5#7)(2008-9#2)(2009-7#9)(2009-9#2)(2010-10#2)(2010-3#1)(2010-4#7)(2010-8#3)(2011-2#2)(2011-3#1)(2012-2#4)(2013-1#2)(2013-8#1)
elasticity and##6##2##(1992-5#1)(2008-10#1)(2008-5#2)(2009-7#1)(2011-2#1)
elasticity is##2##2##(2008-5#1)(2013-8#1)
elasticity of the##2##3##(1992-11#1)(2008-9#1)
elasticity of##4##2##(1992-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
elasticity##40##1##(1992-11#1)(1992-5#1)(1993-3#1)(2008-10#6)(2008-5#13)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-8#10)
elastin and collagen##2##3##(2008-5#1)(2009-7#1)
elastin and##3##2##(1992-12#1)(2008-5#1)(2009-7#1)
elastin degradation (E##2##3##(2009-7#2)
elastin degradation##3##2##(2009-7#3)
elastin peptides##2##2##(2008-7#2)
elastin##21##1##(1990-8#3)(1991-9#2)(1992-12#1)(2008-5#5)(2008-7#4)(2009-7#6)
elastins##2##1##(1991-9#2)
elastofibroma##4##1##(1991-6#2)(2009-4#2)
elastographic imaging##3##2##(2010-8#3)
elastography##4##1##(2009-9#1)(2010-8#3)
elastolytic##4##1##(1991-9#1)(1993-8#1)(2008-7#1)(2010-9#1)
elastomeric seals##2##2##(1996-1#1)(1996-2#1)
elastomeric##3##1##(1996-1#1)(1996-2#1)(2009-5#1)
elastosis##2##1##(2011-2#2)
elatius##7##1##(2008-10#7)
elbow and##2##2##(1997-6#1)(2008-12#1)
elbow ankylosis##2##2##(2011-2#2)
elbow##18##1##(1997-6#1)(2008-12#3)(2008-9#3)(2010-11#1)(2011-2#7)(2013-1#3)
elder abuse##5##2##(1991-1#3)(1991-2#2)
elder##7##1##(1991-1#3)(1991-2#2)(1994-2#1)(1997-3#1)
elderly Australian veterans##2##3##(2011-2#2)
elderly Chinese##2##2##(1992-3#1)(2008-7#1)
elderly Medicare##2##2##(1991-1#1)(1997-2#1)
elderly adults who were enrolled in##2##6##(2012-12#2)
elderly adults##6##2##(2011-2#2)(2012-12#4)
elderly and the##2##3##(1992-1#1)(2008-11#1)
elderly and##14##2##(1991-3#1)(1992-1#1)(1992-3#1)(1995-3#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-3#1)(2013-1#1)
elderly atherosclerotic patients##2##3##(2008-7#2)
elderly clients##3##2##(1991-12#1)(1994-1#2)
elderly control subjects##2##3##(2008-7#2)
elderly in##6##2##(1991-2#1)(1995-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
elderly individuals##3##2##(1997-3#1)(2007-12#1)(2010-6#1)
elderly institutionalised##3##2##(2008-7#1)(2011-2#2)
elderly institutionalized##2##2##(1997-8#1)(2008-7#1)
elderly men##3##2##(1992-9#1)(2011-2#2)
elderly participants##2##2##(1995-2#1)(2013-1#1)
elderly patient##6##2##(1990-11#1)(1992-3#1)(1993-11#1)(1996-3#1)(2008-7#1)(2013-1#1)
elderly patients with##9##3##(1990-2#1)(1991-8#1)(1994-12#1)(2008-7#5)(2008-8#1)
elderly patients##44##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#2)(1996-11#1)(1996-2#2)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#15)(2008-8#2)(2009-8#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-8#1)
elderly people##8##2##(1991-11#1)(1992-1#1)(1994-9#1)(1995-3#1)(2010-8#1)(2011-2#2)(2012-3#1)
elderly person##3##2##(2008-11#1)(2012-3#2)
elderly persons##7##2##(1990-3#1)(1994-1#2)(1994-6#1)(1995-8#1)(1996-3#1)(1997-4#1)
elderly population##18##2##(1991-3#1)(1993-3#2)(1995-12#1)(2008-10#1)(2008-12#2)(2008-7#4)(2008-8#1)(2010-10#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-3#1)
elderly residents##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)
elderly subjects##12##2##(1993-1#1)(2008-10#1)(2008-12#2)(2008-7#8)
elderly who are##2##3##(1992-2#1)(2012-2#1)
elderly with##4##2##(1991-2#1)(1991-6#1)(1997-2#1)(2012-3#1)
elderly women##6##2##(1991-8#1)(1994-12#1)(2008-7#1)(2011-2#3)
elderly##322##1##(1990-11#2)(1990-2#2)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#6)(1991-6#1)(1991-8#3)(1992-1#4)(1992-2#3)(1992-3#5)(1992-9#2)(1993-1#8)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#5)(1993-9#2)(1994-1#12)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#5)(2007-12#2)(2008-1#5)(2008-10#6)(2008-11#11)(2008-12#8)(2008-5#6)(2008-6#1)(2008-7#66)(2008-8#9)(2008-9#1)(2009-1#3)(2009-10#1)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#33)(2011-7#1)(2012-12#8)(2012-2#1)(2012-3#12)(2013-1#7)(2013-8#2)
elders in the##2##3##(2010-4#2)
elders in##4##2##(2010-4#4)
elders##13##1##(1992-2#1)(1993-12#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#5)(2012-2#1)
eldest##2##1##(2008-10#2)
elected euthanasia##2##2##(2013-8#2)
elected officials##2##2##(1995-6#2)
elected##12##1##(1991-1#1)(1991-3#1)(1995-6#2)(2008-10#5)(2012-3#1)(2013-8#2)
election##5##1##(1990-3#1)(1992-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
elective cesarean section##2##3##(1997-8#1)(2013-1#1)
elective hip##2##2##(1990-6#1)(2013-1#1)
elective operations##4##2##(1992-5#1)(1997-8#3)
elective surgery##7##2##(1990-11#2)(1992-5#1)(1995-1#1)(1996-3#1)(2010-7#2)
elective##41##1##(1990-11#3)(1990-12#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-6#2)(1992-5#3)(1993-3#1)(1995-1#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#5)
electivity##2##1##(2010-8#2)
electocatalytic##2##1##(2008-10#2)
electric activity##2##2##(2008-11#1)(2010-6#1)
electric changes##2##2##(1993-8#2)
electric charge##3##2##(2008-4#1)(2008-5#2)
electric current##2##2##(2008-10#2)
electric dipole##2##2##(1997-6#1)(2007-12#1)
electric eel##3##2##(2008-10#2)(2009-8#1)
electric field distribution##2##3##(2008-3#2)
electric field of##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
electric field strength of##2##4##(2008-10#2)
electric field strength##4##3##(2008-10#4)
electric field##32##2##(1990-8#1)(1995-12#1)(1997-6#1)(2007-11#1)(2008-10#11)(2008-11#4)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-4#1)
electric fields in##3##3##(1997-6#2)(2008-3#1)
electric fields##8##2##(1997-6#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)
electric fish##4##2##(2009-8#2)(2010-8#2)
electric injury##3##2##(2008-7#3)
electric organ discharge##2##3##(2009-8#1)(2010-8#1)
electric organ##3##2##(2009-8#2)(2010-8#1)
electric parameters##3##2##(1997-6#3)
electric##84##1##(1990-8#1)(1993-8#2)(1995-12#1)(1996-2#1)(1997-6#10)(2007-11#1)(2007-12#1)(2008-10#21)(2008-11#7)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#6)(2009-12#2)(2009-8#5)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#3)
electric-field##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
electrical activity of##4##3##(1994-2#1)(1996-2#1)(2009-8#1)(2010-8#1)
electrical activity was##2##3##(1991-12#1)(1996-2#1)
electrical activity##16##2##(1991-12#1)(1994-2#1)(1994-3#1)(1996-2#4)(2008-1#2)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#3)(2013-8#1)
electrical and mechanical##5##3##(1994-3#1)(2008-10#3)(2010-8#1)
electrical and##6##2##(1994-3#1)(2008-10#3)(2009-9#1)(2010-8#1)
electrical breakdown##2##2##(1991-5#2)
electrical charge##3##2##(2008-10#2)(2009-8#1)
electrical conductivity and##2##3##(2008-10#1)(2008-11#1)
electrical conductivity##6##2##(2008-10#4)(2008-11#2)
electrical coupling##3##2##(2008-11#1)(2008-3#1)(2010-11#1)
electrical detection of##2##3##(2008-10#2)
electrical devices##2##2##(1992-3#1)(2008-7#1)
electrical discharge##2##2##(2008-10#2)
electrical enrichment##2##2##(2008-10#2)
electrical field##3##2##(1997-4#1)(2009-8#1)(2012-2#1)
electrical impedance tomography##2##3##(2011-2#2)
electrical isolation##3##2##(2008-11#1)(2008-3#1)(2010-6#1)
electrical measurements##2##2##(2007-12#1)(2010-12#1)
electrical memory##2##2##(2009-8#2)
electrical potential##3##2##(2008-10#2)(2008-12#1)
electrical potentials##2##2##(1995-2#2)
electrical properties of the##2##4##(2008-10#1)(2008-5#1)
electrical properties of##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
electrical properties##4##2##(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
electrical pulse##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
electrical recordings##2##2##(1997-7#1)(2013-1#1)
electrical requirements##2##2##(2010-9#2)
electrical resistance in##2##3##(2008-11#1)(2008-9#1)
electrical resistance##11##2##(2008-10#3)(2008-11#3)(2008-12#2)(2008-9#1)(2011-2#2)
electrical resistivity##2##2##(2008-3#1)(2011-2#1)
electrical signals##2##2##(2012-3#1)(2013-1#1)
electrical stimulation of the auditory##3##5##(2008-9#1)(2010-7#2)
electrical stimulation of the##8##4##(1990-5#1)(1990-9#1)(1994-2#1)(1996-2#2)(2008-9#1)(2010-7#2)
electrical stimulation of##12##3##(1990-5#1)(1990-9#1)(1993-3#1)(1994-2#1)(1996-2#3)(2008-5#1)(2008-9#1)(2009-9#1)(2010-7#2)
electrical stimulation was##2##3##(1990-5#1)(1994-2#1)
electrical stimulation##29##2##(1990-5#4)(1990-9#1)(1993-3#1)(1994-2#3)(1996-2#4)(1996-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-7#2)(2011-2#2)(2012-2#1)
electrical stimuli##2##2##(2008-9#1)(2009-8#1)
electrical stunning##3##2##(1990-9#3)
electrical##166##1##(1990-5#4)(1990-9#4)(1991-12#1)(1991-5#2)(1992-3#2)(1992-6#1)(1993-3#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#2)(1995-2#3)(1996-2#8)(1996-6#1)(1997-4#2)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#27)(2008-11#9)(2008-12#6)(2008-3#5)(2008-5#3)(2008-7#4)(2008-9#8)(2009-10#2)(2009-3#2)(2009-5#2)(2009-8#11)(2009-9#3)(2010-1#3)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#3)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#4)(2013-8#1)
electrically charged##2##2##(2008-10#2)
electrically evoked stapedius reflex##3##4##(2008-9#3)
electrically evoked##5##2##(1996-12#1)(2008-9#4)
electrically neutral##2##2##(1995-2#1)(2010-7#1)
electrically stimulated##8##2##(1990-5#2)(1992-3#1)(1995-3#1)(1997-2#1)(2009-9#1)(2010-4#1)(2013-1#1)
electrically##31##1##(1990-5#2)(1992-3#1)(1992-8#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-3#3)(2008-9#5)(2009-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-7#2)(2010-9#1)(2013-1#1)
electrically-induced##2##1##(1990-5#1)(1991-5#1)
electricity##5##1##(1996-5#1)(2008-10#1)(2008-11#2)(2008-7#1)
electro##3##1##(2008-10#2)(2012-2#1)
electro-optic crystal##3##2##(2008-3#3)
electro-optic modulation technique##2##3##(2008-3#1)(2013-8#1)
electro-optic modulation##4##2##(2008-3#1)(2013-8#3)
electro-optic modulator##2##2##(2008-3#2)
electro-optic probe tip##2##3##(2008-3#2)
electro-optic sampling##3##2##(2008-2#2)(2008-3#1)
electro-optic##16##1##(2007-11#1)(2008-2#2)(2008-3#10)(2013-8#3)
electro-optically##3##1##(2008-2#1)(2008-3#2)
electro-osmotic flow##2##2##(2008-10#2)
electro-oxidation##2##1##(2008-10#2)
electro-sensitive##2##1##(2008-10#2)
electro-transformation##3##1##(1993-9#3)
electroactive and##2##2##(2008-10#2)
electroactive interferences##2##2##(2008-10#2)
electroactive material##6##2##(2008-10#6)
electroactive polymer##2##2##(2008-10#1)(2010-4#1)
electroactive species##3##2##(2008-10#3)
electroactive substance##2##2##(2008-10#2)
electroactive substances##2##2##(2008-10#2)
electroactive##40##1##(2008-10#37)(2008-4#1)(2010-4#2)
electroactivity##2##1##(2008-10#2)
electroacupuncture (EA)##2##2##(1995-12#1)(1996-12#1)
electroacupuncture at##2##2##(2010-7#2)
electroacupuncture##10##1##(1995-12#2)(1996-12#4)(2010-7#2)(2013-1#1)(2013-8#1)
electroanalysis##3##1##(2008-10#3)
electroanalytical applications##3##2##(2008-10#3)
electroanalytical behaviour of##2##3##(2008-10#2)
electroanalytical chemistry##2##2##(2008-10#1)(2010-7#1)
electroanalytical determination of##3##3##(2008-10#3)
electroanalytical determination##4##2##(2008-10#4)
electroanalytical method for the determination of##2##6##(2008-10#2)
electroanalytical method for##3##3##(2008-10#3)
electroanalytical method##5##2##(2008-10#5)
electroanalytical procedure##2##2##(2008-10#2)
electroanalytical techniques##3##2##(2008-10#3)
electroanalytical##27##1##(2008-10#26)(2010-7#1)
electroantennographic detector##3##2##(2008-10#3)
electroantennographic##4##1##(2008-10#4)
electrocardiogram (ECG)##5##2##(2008-12#1)(2008-3#1)(2010-1#1)(2010-8#1)(2012-12#1)
electrocardiogram in##2##2##(2008-11#1)(2008-12#1)
electrocardiogram was normal##2##3##(1993-1#1)(2008-12#1)
electrocardiogram##14##1##(1993-1#1)(2008-11#1)(2008-12#3)(2008-3#3)(2009-11#1)(2010-1#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
electrocardiographic##9##1##(1991-12#1)(1991-3#2)(2008-12#2)(2008-7#1)(2010-1#1)(2012-3#1)(2013-8#1)
electrocardiography##4##1##(1993-1#1)(2008-7#1)(2010-1#1)(2010-8#1)
electrocatalysis of##5##2##(2008-10#5)
electrocatalysis##8##1##(2008-10#7)(2013-1#1)
electrocatalyst##2##1##(2008-10#2)
electrocatalytic activity for the oxidation of##2##6##(2008-10#2)
electrocatalytic activity toward NADH oxidation##3##5##(2008-10#3)
electrocatalytic activity toward##5##3##(2008-10#5)
electrocatalytic activity towards the oxidation of##2##6##(2008-10#2)
electrocatalytic activity towards the oxidation##3##5##(2008-10#3)
electrocatalytic activity##11##2##(2008-10#11)
electrocatalytic current##2##2##(2008-10#2)
electrocatalytic detection of the##2##4##(1990-12#1)(2008-10#1)
electrocatalytic detection of##3##3##(1990-12#1)(2008-10#2)
electrocatalytic detection##4##2##(1990-12#2)(2008-10#2)
electrocatalytic effect##2##2##(2008-10#2)
electrocatalytic oxidation for##3##3##(2008-10#3)
electrocatalytic oxidation of##8##3##(2008-10#8)
electrocatalytic oxidation##11##2##(2008-10#11)
electrocatalytic reduction of##3##3##(2008-10#2)(2010-6#1)
electrocatalytic reduction peak current##2##4##(2008-10#2)
electrocatalytic reduction##7##2##(2008-10#6)(2010-6#1)
electrocatalytic##53##1##(1990-12#2)(2008-10#49)(2010-6#2)
electrocatalytically##2##1##(2008-10#2)
electrocautery##4##1##(1991-3#1)(1994-12#2)(2012-3#1)
electrochemical (EC)##3##2##(2008-10#2)(2008-5#1)
electrochemical DNA##6##2##(2008-10#6)
electrochemical activity of##2##3##(2008-12#2)
electrochemical activity##4##2##(2008-10#2)(2008-12#2)
electrochemical analysis of##3##3##(2008-10#3)
electrochemical and##6##2##(2008-10#6)
electrochemical behavior of the##4##4##(2008-10#4)
electrochemical behavior of##18##3##(2008-10#17)(2010-6#1)
electrochemical behavior##21##2##(2008-10#20)(2010-6#1)
electrochemical behaviors of these##2##4##(2008-10#2)
electrochemical behaviors of##4##3##(2008-10#4)
electrochemical behaviour of##2##3##(2008-10#2)
electrochemical behaviour##4##2##(2008-10#4)
electrochemical biosensor for the##2##4##(2008-10#2)
electrochemical biosensor##3##2##(2008-10#3)
electrochemical cell for##2##3##(2008-10#2)
electrochemical cell##10##2##(2008-10#10)
electrochemical characteristics of##4##3##(2008-10#4)
electrochemical characteristics##5##2##(2008-10#5)
electrochemical characterization##2##2##(2008-10#2)
electrochemical current##2##2##(2008-12#2)
electrochemical deposition##5##2##(2008-10#5)
electrochemical detection of the##2##4##(2008-10#2)
electrochemical detection of##8##3##(2008-10#6)(2008-12#2)
electrochemical detection##29##2##(1993-1#1)(2008-10#24)(2008-12#2)(2009-8#1)(2010-11#1)
electrochemical detector for##4##3##(2008-10#4)
electrochemical detector##14##2##(2008-10#13)(2008-6#1)
electrochemical detectors##2##2##(2008-10#2)
electrochemical determination of##9##3##(2008-10#9)
electrochemical flow##3##2##(2008-10#3)
electrochemical gradient##2##2##(2008-7#1)(2008-8#1)
electrochemical hydride generation and##3##4##(2008-10#3)
electrochemical hydride generation##10##3##(2008-10#10)
electrochemical hydride generator##4##3##(2008-10#4)
electrochemical hydride##14##2##(2008-10#14)
electrochemical immunoassay##3##2##(2008-10#3)
electrochemical immunosensor##2##2##(2008-10#2)
electrochemical impedance spectroscopy (EIS)##4##4##(2008-10#4)
electrochemical impedance spectroscopy and##2##4##(2008-10#2)
electrochemical impedance spectroscopy##11##3##(2008-10#11)
electrochemical impedance##12##2##(2008-10#12)
electrochemical method for the##2##4##(2008-10#2)
electrochemical method for##3##3##(2008-10#3)
electrochemical method was##2##3##(2008-10#2)
electrochemical method##16##2##(2008-10#15)(2009-3#1)
electrochemical methods##12##2##(2008-10#11)(2010-7#1)
electrochemical oxidation of##13##3##(2008-10#13)
electrochemical oxidation##14##2##(2008-10#14)
electrochemical potential##7##2##(1997-8#7)
electrochemical preconcentration##3##2##(2008-10#3)
electrochemical pretreatment##3##2##(2008-10#3)
electrochemical probe##3##2##(2008-10#3)
electrochemical process##3##2##(2008-10#2)(2013-1#1)
electrochemical properties of the##2##4##(1996-5#1)(2008-10#1)
electrochemical properties of##9##3##(1996-5#1)(2008-10#5)(2008-8#3)
electrochemical properties##12##2##(1994-3#1)(1996-5#1)(2008-10#7)(2008-8#3)
electrochemical quantification##2##2##(2008-10#2)
electrochemical quartz crystal microbalance##3##4##(2008-10#3)
electrochemical reaction##7##2##(1990-12#1)(2008-10#6)
electrochemical reactions of##2##3##(2008-10#2)
electrochemical reactions##4##2##(2008-10#3)(2009-12#1)
electrochemical reactivity##2##2##(2008-10#1)(2013-1#1)
electrochemical redox potentials##3##3##(2008-10#3)
electrochemical redox##5##2##(2008-10#5)
electrochemical reduction back to hydroquinone##2##5##(2008-10#2)
electrochemical reduction back to##3##4##(2008-10#3)
electrochemical reduction back##4##3##(2008-10#4)
electrochemical reduction of##9##3##(2008-10#9)
electrochemical reduction##18##2##(2008-10#18)
electrochemical response of##4##3##(2008-10#4)
electrochemical response##11##2##(2008-10#11)
electrochemical responses##2##2##(2008-10#2)
electrochemical sensing##3##2##(2008-10#1)(2010-11#1)(2013-1#1)
electrochemical sensor##13##2##(2008-10#13)
electrochemical sensors##7##2##(2008-10#5)(2010-7#1)(2013-1#1)
electrochemical signals##3##2##(2008-10#3)
electrochemical technique##2##2##(2008-10#1)(2009-10#1)
electrochemical techniques##8##2##(2008-10#7)(2008-4#1)
electrochemical##388##1##(1990-12#1)(1993-1#1)(1994-3#1)(1996-5#1)(1997-8#7)(2008-10#339)(2008-12#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-11#3)(2010-6#1)(2010-7#3)(2012-12#2)(2012-2#4)(2013-1#5)
electrochemically deposited on a##2##4##(2008-10#2)
electrochemically deposited on##3##3##(2008-10#3)
electrochemically deposited##6##2##(2008-10#6)
electrochemically generated##7##2##(2008-10#5)(2008-4#1)(2010-7#1)
electrochemically inactive##2##2##(2008-10#2)
electrochemically initiated reaction##2##3##(2008-10#2)
electrochemically non-active complex##2##3##(2008-10#2)
electrochemically non-active##3##2##(2008-10#3)
electrochemically on##2##2##(2008-10#2)
electrochemically with##2##2##(2008-10#2)
electrochemically##52##1##(2008-10#48)(2008-4#1)(2009-12#2)(2010-7#1)
electrochemiluminescence (ECL)##3##2##(2008-10#2)(2010-7#1)
electrochemiluminescence detection##4##2##(2008-10#4)
electrochemiluminescence of##4##2##(2008-10#4)
electrochemiluminescence##14##1##(2008-10#13)(2010-7#1)
electrochemiluminescent (ECL)##3##2##(2008-10#3)
electrochemiluminescent##8##1##(2008-10#8)
electrochemistry and##4##2##(2008-10#4)
electrochemistry of dopamine##3##3##(2008-10#3)
electrochemistry of##10##2##(2008-10#10)
electrochemistry##22##1##(2008-10#21)(2009-9#1)
electrochromatography##15##1##(1997-2#2)(2008-10#13)
electroconvulsive therapy##3##2##(2008-7#1)(2012-12#2)
electroconvulsive treatment##3##2##(1993-11#3)
electroconvulsive##8##1##(1993-11#3)(1996-12#2)(2008-7#1)(2012-12#2)
electrode (Ag/AgCl)##2##2##(2008-10#2)
electrode (BiFE)##4##2##(2008-10#4)
electrode (GCE)##16##2##(2008-10#16)
electrode (ISE)##14##2##(2008-10#14)
electrode (SCE)##2##2##(2008-10#2)
electrode E2##3##2##(2008-10#3)
electrode after##2##2##(2008-10#2)
electrode against##2##2##(2008-10#2)
electrode also##2##2##(2008-10#2)
electrode and a##7##3##(2008-10#7)
electrode and its application in##2##5##(2008-10#2)
electrode and its application to##2##5##(2008-10#2)
electrode and its application##7##4##(2008-10#7)
electrode and its##13##3##(2008-10#13)
electrode and the detection##2##4##(2008-10#2)
electrode and the##12##3##(2008-10#11)(2008-9#1)
electrode and##62##2##(1990-5#1)(2008-10#59)(2008-12#1)(2008-9#1)
electrode applied##2##2##(2008-10#2)
electrode are##5##2##(2008-10#5)
electrode area##2##2##(2008-10#2)
electrode array##6##2##(2008-10#3)(2008-9#2)(2009-9#1)
electrode arrays##5##2##(2008-10#3)(2008-9#2)
electrode as a sensor##2##4##(2008-10#2)
electrode as a##9##3##(2008-10#8)(2008-9#1)
electrode as the##3##3##(2008-10#3)
electrode as##19##2##(2008-10#18)(2008-9#1)
electrode at##8##2##(1990-5#1)(2008-10#7)
electrode based on a##8##4##(2008-10#8)
electrode based on maltodextrin##2##4##(2008-10#2)
electrode based on the##2##4##(2008-10#2)
electrode based on##45##3##(2008-10#45)
electrode by the##2##3##(1995-6#1)(2008-10#1)
electrode by##19##2##(1995-6#1)(2008-10#18)
electrode can be used as a##3##6##(2008-10#3)
electrode can be used for the determination of##2##8##(2008-10#2)
electrode can be used for##4##5##(2008-10#4)
electrode can be used##13##4##(2008-10#13)
electrode can be##17##3##(2008-10#17)
electrode can##22##2##(2008-10#21)(2008-7#1)
electrode caused by##2##3##(2008-10#2)
electrode caused##3##2##(2008-10#3)
electrode characteristics##2##2##(2008-10#2)
electrode consisted of##2##3##(2008-10#2)
electrode containing##3##2##(2008-10#3)
electrode could be used for##3##5##(2008-10#3)
electrode could be used##5##4##(2008-10#5)
electrode could be##7##3##(2008-10#7)
electrode could##8##2##(2008-10#8)
electrode coupled to##2##3##(2008-10#2)
electrode covered with a##2##4##(2008-10#2)
electrode covered with##3##3##(2008-10#3)
electrode covered##4##2##(2008-10#4)
electrode detector##11##2##(2008-10#11)
electrode doped with##2##3##(2008-10#2)
electrode exhibited a##6##3##(2008-10#6)
electrode exhibited##18##2##(2008-10#18)
electrode exhibits a Nernstian response##4##5##(2008-10#4)
electrode exhibits a Nernstian##7##4##(2008-10#7)
electrode exhibits a##14##3##(2008-10#14)
electrode exhibits good##2##3##(2008-10#2)
electrode exhibits high##2##3##(2008-10#2)
electrode exhibits##22##2##(2008-10#22)
electrode followed by##2##3##(2008-10#2)
electrode for bismuth(III)##2##3##(2008-10#2)
electrode for determination of##4##4##(2008-10#4)
electrode for glucose determination##2##4##(2008-10#2)
electrode for potentiometric titration of##2##5##(2008-10#2)
electrode for potentiometric##3##3##(2008-10#3)
electrode for salicylate##2##3##(2008-10#2)
electrode for the determination of Pb(2+)##2##6##(2008-10#2)
electrode for the determination of trace##2##6##(2008-10#2)
electrode for the determination of##17##5##(2008-10#17)
electrode for the oxidation of NADH is determined by cyclic voltammetry##2##11##(2008-10#2)
electrode for the##29##3##(2008-10#28)(2009-5#1)
electrode for##60##2##(2008-10#59)(2009-5#1)
electrode fouling and##2##3##(2008-10#2)
electrode fouling##5##2##(2008-10#5)
electrode from##2##2##(2008-10#2)
electrode gave comparable results to##2##5##(2008-10#2)
electrode gave##3##2##(2008-10#3)
electrode gives##2##2##(2008-10#2)
electrode had a##2##3##(2008-10#2)
electrode had##3##2##(2008-10#3)
electrode has a##7##3##(2008-10#7)
electrode has been applied for##2##5##(2008-10#2)
electrode has been applied##3##4##(2008-10#3)
electrode has been developed##5##4##(2008-10#5)
electrode has been investigated in##3##5##(2008-10#2)(2009-10#1)
electrode has been utilized as an end point indicator electrode for the determination of##2##14##(2008-10#2)
electrode has been utilized as an end point indicator electrode##3##10##(2008-10#3)
electrode has been##24##3##(2008-10#23)(2009-10#1)
electrode has shown##2##3##(2008-10#2)
electrode has##36##2##(2008-10#35)(2009-10#1)
electrode have been studied##2##4##(2008-10#2)
electrode have been##3##3##(2008-10#3)
electrode in 0##3##3##(2008-10#3)
electrode in a##8##3##(2008-10#8)
electrode in alkaline##3##3##(2008-10#3)
electrode in both##2##3##(2008-10#2)
electrode in pH##2##3##(2008-10#2)
electrode in the presence of surfactants##2##6##(2008-10#2)
electrode in the presence of##7##5##(2008-10#7)
electrode in the presence##8##4##(2008-10#8)
electrode in the##21##3##(2008-10#20)(2012-3#1)
electrode in which##2##3##(2008-10#2)
electrode in##70##2##(2008-10#66)(2008-7#1)(2008-9#1)(2009-10#1)(2012-3#1)
electrode increased##3##2##(2008-10#3)
electrode insertion##4##2##(2008-9#2)(2010-12#1)(2011-2#1)
electrode into the##2##3##(2008-10#2)
electrode into##3##2##(2008-10#3)
electrode is a##2##3##(2008-10#2)
electrode is described##4##3##(1990-12#1)(2008-10#3)
electrode is proposed##2##3##(2008-10#2)
electrode is reported##4##3##(2008-10#4)
electrode is##48##2##(1990-12#1)(2008-10#45)(2008-12#1)(2013-1#1)
electrode kinetics##2##2##(2008-10#2)
electrode material to##2##3##(2008-10#2)
electrode material##5##2##(2008-10#5)
electrode materials for##2##3##(2008-10#1)(2013-1#1)
electrode materials##6##2##(2008-10#5)(2013-1#1)
electrode membrane##4##2##(2008-10#4)
electrode method and##2##3##(2008-10#2)
electrode modified by a##2##4##(2008-10#2)
electrode modified by##6##3##(2008-10#6)
electrode modified with a##6##4##(2008-10#6)
electrode modified with trinuclear ruthenium ammine complex##2##7##(2008-10#2)
electrode modified with##36##3##(2008-10#36)
electrode modified##44##2##(2008-10#44)
electrode obtained from##2##3##(2008-10#2)
electrode obtained##3##2##(2008-10#3)
electrode of##5##2##(2008-10#5)
electrode on##2##2##(2008-10#1)(2008-9#1)
electrode optoelectronic tweezers##2##3##(2009-5#2)
electrode performance##5##2##(2008-10#5)
electrode placement in the##2##4##(2010-7#2)
electrode placement in##3##3##(2010-12#1)(2010-7#2)
electrode placement##5##2##(2010-12#1)(2010-7#4)
electrode polarized at 0##2##4##(2008-10#2)
electrode positioned opposite the outlet of##3##6##(2008-10#3)
electrode potential and##3##3##(2008-10#3)
electrode potential##10##2##(1993-8#1)(2008-10#9)
electrode potentiometry##2##2##(2008-10#2)
electrode preparation##2##2##(2008-10#2)
electrode prepared in the##2##4##(2008-10#2)
electrode prepared with##3##3##(2008-10#3)
electrode prepared##10##2##(2008-10#10)
electrode presented##2##2##(2008-10#2)
electrode process##5##2##(2008-10#5)
electrode provided a linear##2##4##(2008-10#2)
electrode provided well-resolved##2##3##(2008-10#2)
electrode provided##5##2##(2008-10#5)
electrode provides##3##2##(2008-10#3)
electrode reaction rate constant##2##4##(2008-10#1)(2008-8#1)
electrode reaction##6##2##(2008-10#5)(2008-8#1)
electrode reduction##3##2##(2008-10#3)
electrode responds to##3##3##(2008-10#3)
electrode response is##3##3##(2008-10#3)
electrode response was##7##3##(2008-10#7)
electrode response##21##2##(2008-10#21)
electrode responses##3##2##(2008-10#3)
electrode revealed##9##2##(2008-10#9)
electrode selective##2##2##(2008-10#2)
electrode sensitive to##4##3##(2008-10#4)
electrode should be##2##3##(2008-10#2)
electrode should##3##2##(2008-10#3)
electrode showed a##5##3##(2008-10#5)
electrode showed an##3##3##(2008-10#3)
electrode showed high sensitivity##2##4##(2008-10#2)
electrode showed high##3##3##(2008-10#3)
electrode showed##17##2##(2008-10#17)
electrode shows a good selectivity for##2##6##(2008-10#2)
electrode shows a linear response##2##5##(2008-10#2)
electrode shows a linear##4##4##(2008-10#4)
electrode shows a##11##3##(2008-10#11)
electrode shows an##2##3##(2008-10#1)(2012-2#1)
electrode shows electrocatalytic activity##2##4##(2008-10#2)
electrode shows excellent##2##3##(2008-10#2)
electrode shows good##2##3##(2008-10#2)
electrode shows##26##2##(2008-10#24)(2009-10#1)(2012-2#1)
electrode site##2##2##(2008-7#1)(2010-8#1)
electrode studied##2##2##(2008-10#2)
electrode such as##2##3##(2008-10#2)
electrode surface and the##2##4##(2008-10#2)
electrode surface and##7##3##(2008-10#7)
electrode surface at##4##3##(2008-10#4)
electrode surface by##6##3##(2008-10#6)
electrode surface in##4##3##(2008-10#4)
electrode surface is##2##3##(2008-10#2)
electrode surface to##2##3##(2008-10#2)
electrode surface under##2##3##(2008-10#2)
electrode surface was##3##3##(2008-10#3)
electrode surface##92##2##(2008-10#90)(2008-9#1)(2009-12#1)
electrode surfaces##7##2##(2008-10#7)
electrode system##3##2##(2008-10#3)
electrode that##2##2##(2008-10#2)
electrode the##2##2##(2008-10#2)
electrode through##2##2##(2008-10#2)
electrode to assess##2##3##(2008-10#2)
electrode to##12##2##(2008-10#12)
electrode type##2##2##(2008-10#2)
electrode used as a##2##4##(2008-10#2)
electrode using cyclic voltammetry##2##4##(2008-10#2)
electrode using cyclic##3##3##(2008-10#3)
electrode using##12##2##(2008-10#11)(2008-9#1)
electrode voltammetric##2##2##(2008-10#2)
electrode was 7##2##3##(2008-10#2)
electrode was also##2##3##(2008-10#2)
electrode was applied##3##3##(2008-10#3)
electrode was constructed##3##3##(2008-10#3)
electrode was developed##5##3##(2008-10#5)
electrode was employed##2##3##(2008-10#2)
electrode was found to##2##4##(2008-10#2)
electrode was found##3##3##(2008-10#2)(2008-12#1)
electrode was investigated##4##3##(2008-10#4)
electrode was prepared and used##2##5##(2008-10#2)
electrode was prepared by the##2##5##(2008-10#2)
electrode was prepared##5##3##(2008-10#5)
electrode was studied in##2##4##(2008-10#2)
electrode was studied##4##3##(2008-10#4)
electrode was successfully applied##4##4##(2008-10#4)
electrode was successfully##6##3##(2008-10#6)
electrode was used as a##2##5##(2008-10#2)
electrode was used as an amperometric detector for##2##8##(2008-10#2)
electrode was used as an##4##5##(2008-10#4)
electrode was used as##8##4##(2008-10#8)
electrode was used for the determination of##2##7##(2008-10#2)
electrode was used for the potentiometric##2##6##(2008-10#2)
electrode was used for the##5##5##(2008-10#4)(2009-10#1)
electrode was used to##3##4##(2008-10#3)
electrode was used##20##3##(2008-10#19)(2009-10#1)
electrode was##111##2##(2008-10#107)(2008-12#2)(2008-9#1)(2009-10#1)
electrode were examined##2##3##(2008-10#2)
electrode were investigated##3##3##(2008-10#3)
electrode were studied by cyclic voltammetry (CV)##2##7##(2008-10#2)
electrode were studied##3##3##(2008-10#3)
electrode were##21##2##(2008-10#21)
electrode which##3##2##(2008-10#3)
electrode with 3##2##3##(2008-10#2)
electrode with LaF(3)-membrane and##2##4##(2008-10#2)
electrode with a##5##3##(2008-10#4)(2012-2#1)
electrode with the##3##3##(2008-10#3)
electrode with##29##2##(1990-12#1)(1991-7#1)(2008-10#25)(2012-2#2)
electrode without##2##2##(2008-10#2)
electrode##1683##1##(1990-12#2)(1990-5#4)(1990-8#1)(1991-7#1)(1993-8#1)(1995-3#2)(1995-6#1)(1996-2#1)(2008-10#1596)(2008-11#2)(2008-12#8)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#29)(2009-10#4)(2009-12#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-12#3)(2010-7#5)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
electrode's##2##1##(2008-10#1)(2008-9#1)
electrode)##17##1##(2008-10#17)
electrodeposited imprinted sol-gel film##2##4##(2008-10#2)
electrodeposited on the##2##3##(2008-10#2)
electrodeposited on##3##2##(2008-10#3)
electrodeposited##14##1##(2008-10#14)
electrodeposition of##10##2##(2008-10#9)(2010-4#1)
electrodeposition##19##1##(2008-10#18)(2010-4#1)
electrodes (ISEs)##11##2##(2008-10#11)
electrodes (p = ##2##2##(2012-2#2)
electrodes and the##3##3##(2008-10#2)(2008-11#1)
electrodes and their application to the##2##6##(2008-10#2)
electrodes and their##3##3##(2008-10#3)
electrodes and##24##2##(1992-12#1)(2008-10#18)(2008-11#1)(2008-3#1)(2012-2#3)
electrodes are found##2##3##(2008-10#2)
electrodes are suitable for##2##4##(2008-10#2)
electrodes are##18##2##(2008-10#18)
electrodes as##5##2##(2008-10#5)
electrodes based on 1##2##4##(2008-10#2)
electrodes based on anilino-(1##2##4##(2008-10#2)
electrodes based on the##2##4##(2008-10#2)
electrodes based on##29##3##(2008-10#29)
electrodes based##30##2##(2008-10#30)
electrodes by##5##2##(2008-10#5)
electrodes can be##2##3##(2008-10#2)
electrodes can##4##2##(2008-10#4)
electrodes coated with##3##3##(2008-10#3)
electrodes constructed##2##2##(2008-10#2)
electrodes display##2##2##(2008-10#2)
electrodes essentially##2##2##(2008-10#2)
electrodes exhibit a##2##3##(2008-10#2)
electrodes exhibit##5##2##(2008-10#5)
electrodes exhibited##3##2##(2008-10#3)
electrodes for the detection of trace metals##2##7##(2008-10#2)
electrodes for the determination of##7##5##(2008-10#7)
electrodes for the measurement of##2##5##(2008-10#1)(2009-7#1)
electrodes for the##17##3##(2008-10#15)(2009-7#1)(2012-2#1)
electrodes for##36##2##(2008-10#31)(2009-7#1)(2010-6#1)(2012-2#2)(2013-1#1)
electrodes from##3##2##(2008-10#1)(2008-9#2)
electrodes has been##3##3##(2008-10#3)
electrodes have been##10##3##(2008-10#10)
electrodes have##13##2##(2008-10#13)
electrodes in a##3##3##(2008-10#3)
electrodes in series##2##3##(2008-10#2)
electrodes in the presence of##2##5##(2008-10#2)
electrodes in the##6##3##(2008-10#5)(2008-11#1)
electrodes in##22##2##(2008-10#21)(2008-11#1)
electrodes is presented##2##3##(2008-10#2)
electrodes is reported##2##3##(2008-10#2)
electrodes is##14##2##(2008-10#13)(2010-7#1)
electrodes made of##2##3##(2008-10#2)
electrodes made##3##2##(2008-10#3)
electrodes modified with##7##3##(2008-10#7)
electrodes of##2##2##(2008-10#2)
electrodes or amperometric##2##3##(2008-10#2)
electrodes or##3##2##(2008-10#3)
electrodes possess##3##2##(2008-10#3)
electrodes prepared with##2##3##(2008-10#2)
electrodes prepared##6##2##(2008-10#5)(2008-12#1)
electrodes reported in literature##2##4##(2008-10#2)
electrodes revealed##2##2##(2008-10#2)
electrodes show##2##2##(2008-10#2)
electrodes showed##2##2##(2008-10#2)
electrodes tested##2##2##(2008-10#2)
electrodes that##2##2##(2007-11#1)(2008-10#1)
electrodes the##2##2##(2008-10#2)
electrodes to##9##2##(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)
electrodes used as##2##3##(2008-10#2)
electrodes used##4##2##(2008-10#4)
electrodes using##5##2##(2008-10#5)
electrodes via##2##2##(2008-10#2)
electrodes was investigated##2##3##(2008-10#2)
electrodes was tested##2##3##(2008-10#2)
electrodes was##14##2##(2008-10#14)
electrodes were characterized##2##3##(2008-10#2)
electrodes were developed##2##3##(2008-10#2)
electrodes were fabricated##2##3##(2008-10#2)
electrodes were found to be##2##5##(2008-10#2)
electrodes were used##3##3##(2008-10#3)
electrodes were##48##2##(2008-10#46)(2008-9#2)
electrodes with hydrogel and##2##4##(2008-10#2)
electrodes with##16##2##(2008-10#16)
electrodes##594##1##(1992-12#2)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#545)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#10)(2009-7#1)(2009-8#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-2#11)(2013-1#3)
electrodes)##2##1##(2008-10#2)
electrodiagnosis##2##1##(2012-3#2)
electrodiagnostic studies##2##2##(2012-3#2)
electrodiagnostic##4##1##(2008-9#2)(2012-3#2)
electrodialysis##3##1##(2008-10#2)(2013-1#1)
electrodynamics##2##1##(2008-3#1)(2012-2#1)
electroencephalogram (EEG)##3##2##(2009-8#2)(2010-7#1)
electroencephalogram##5##1##(2009-8#2)(2010-12#1)(2010-7#1)(2011-2#1)
electroencephalograms (EEG)##2##2##(1993-6#1)(2008-11#1)
electroencephalographic (EEG)##3##2##(2008-7#1)(2009-8#1)(2010-8#1)
electroencephalography (EEG)##5##2##(2008-4#2)(2008-7#3)
electroencephalography##9##1##(2008-11#2)(2008-4#3)(2008-7#4)
electrogenerated chemiluminescence##5##2##(2008-10#4)(2010-7#1)
electrogenerated polymer##3##2##(2008-10#3)
electrogenerated##23##1##(2008-10#22)(2010-7#1)
electroinactive##4##1##(2008-10#4)
electroinjection##4##1##(2008-10#4)
electrokinetic capillary chromatography (MEKC) with##3##5##(2008-10#3)
electrokinetic capillary chromatography##10##3##(2008-10#10)
electrokinetic chromatography (MEKC)##7##3##(2008-10#6)(2010-7#1)
electrokinetic chromatography##19##2##(2008-10#17)(2010-7#2)
electrokinetic flow analysis system##3##4##(2008-10#3)
electrokinetic flow analysis##4##3##(2008-10#4)
electrokinetic##37##1##(2008-10#35)(2010-7#2)
electroless##3##1##(2008-10#3)
electrolysis of##2##2##(2008-11#2)
electrolysis time##5##2##(2008-10#5)
electrolysis##18##1##(2008-10#14)(2008-11#3)(2009-12#1)
electrolyte and##10##2##(1997-2#1)(2008-10#9)
electrolyte at##3##2##(2008-10#3)
electrolyte balance##3##2##(1991-2#1)(2010-7#2)
electrolyte concentration##4##2##(2008-10#4)
electrolyte containing##3##2##(2008-10#3)
electrolyte in##3##2##(2008-10#3)
electrolyte leakage and##2##3##(2008-10#2)
electrolyte leakage##15##2##(2008-10#12)(2008-12#3)
electrolyte of##2##2##(2008-10#2)
electrolyte on the##4##3##(2008-10#4)
electrolyte solution##9##2##(2008-10#9)
electrolyte solutions##5##2##(2008-10#5)
electrolyte used##2##2##(2008-10#2)
electrolyte using##3##2##(2008-10#3)
electrolyte was##4##2##(2008-10#4)
electrolyte##130##1##(1991-11#1)(1991-2#1)(1997-2#1)(2008-10#121)(2008-12#4)(2010-7#2)
electrolytes in##3##2##(2008-10#3)
electrolytes of##2##2##(2008-10#2)
electrolytes was##2##2##(2008-10#2)
electrolytes were##2##2##(2008-10#2)
electrolytes when##2##2##(2008-10#1)(2012-2#1)
electrolytes##49##1##(1991-6#1)(1996-6#1)(2008-10#42)(2008-12#1)(2011-2#1)(2012-2#3)
electrolytic cell##5##2##(2008-10#5)
electrolytic deposition of##2##3##(2008-10#2)
electrolytic deposition##3##2##(2008-10#3)
electrolytic lesions of the##2##4##(1993-3#1)(2009-10#1)
electrolytic lesions##3##2##(1993-3#1)(2009-10#1)(2013-7#1)
electrolytic potentiometric titration method for the determination of ciprofloxacin##2##9##(2008-10#2)
electrolytic##25##1##(1993-3#1)(2008-10#22)(2009-10#1)(2013-7#1)
electrolytically enriched##2##2##(2008-10#2)
electrolytically##5##1##(2008-10#5)
electrolyzed##3##1##(2008-10#2)(2008-11#1)
electromagnetic field##5##2##(1992-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
electromagnetic fields and##2##3##(1992-3#1)(2008-12#1)
electromagnetic fields##11##2##(1992-3#2)(2008-12#3)(2008-2#3)(2008-3#2)(2011-2#1)
electromagnetic scattering##2##2##(2008-3#2)
electromagnetic theory##5##2##(2008-2#1)(2008-3#4)
electromagnetic vector-field##2##2##(2008-2#2)
electromagnetic waves##5##2##(2008-3#1)(2010-7#1)(2012-3#3)
electromagnetic##46##1##(1992-3#4)(1992-4#1)(2007-12#1)(2008-12#3)(2008-2#9)(2008-3#15)(2009-10#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
electromagnetic-wave##2##1##(2007-12#1)(2008-3#1)
electromechanical##3##1##(1991-3#1)(2008-10#1)(2008-7#1)
electrometric##2##1##(2008-10#2)
electromobility shift##2##2##(2008-10#1)(2012-2#1)
electromotive force of galvanic##2##4##(2008-10#2)
electromotive force##4##2##(2008-10#4)
electromotive##5##1##(2008-10#5)
electromyogram##2##1##(2009-8#1)(2013-8#1)
electromyographic (EMG)##2##2##(1990-9#1)(2013-1#1)
electromyographic activity of the##5##4##(1995-2#1)(2010-6#2)(2010-9#2)
electromyographic activity##6##2##(1995-2#1)(2010-6#2)(2010-9#2)(2012-2#1)
electromyographic recordings##2##2##(1990-11#1)(1995-8#1)
electromyographic signal##3##2##(2010-6#1)(2010-9#2)
electromyographic##17##1##(1990-11#2)(1990-9#1)(1991-6#1)(1995-2#1)(1995-8#1)(1996-5#1)(2010-6#4)(2010-9#4)(2012-2#1)(2013-1#1)
electromyography (EMG)##3##2##(2010-8#1)(2010-9#1)(2012-12#1)
electromyography##14##1##(1996-5#1)(2010-6#4)(2010-8#2)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
electron acceptor in##2##3##(1995-2#1)(2008-10#1)
electron acceptor##5##2##(1995-2#1)(2008-10#2)(2008-11#1)(2009-8#1)
electron acceptors##2##2##(1994-5#1)(2009-9#1)
electron and##3##2##(2008-10#1)(2009-10#1)(2010-7#1)
electron attachment rate##2##3##(2008-10#2)
electron beam evaporation##4##3##(2008-10#4)
electron beam irradiated##2##3##(2009-7#2)
electron beam irradiation##6##3##(1991-6#1)(1992-12#1)(1994-11#2)(2008-11#1)(2009-7#1)
electron beam##17##2##(1991-6#1)(1992-12#1)(1994-11#2)(2008-10#4)(2008-11#1)(2009-11#2)(2009-7#5)(2011-2#1)
electron beams##3##2##(2009-11#3)
electron capture detection (ECD)##2##4##(2008-10#2)
electron capture detection##5##3##(2008-10#5)
electron capture detector (ECD)##2##4##(2008-10#2)
electron capture detector##6##3##(2008-10#6)
electron capture##12##2##(2008-10#12)
electron dense granules##2##3##(2007-12#1)(2008-5#1)
electron dense material##2##3##(2008-5#1)(2008-7#1)
electron dense##11##2##(1992-3#1)(2007-12#2)(2008-10#1)(2008-5#3)(2008-7#4)
electron density##12##2##(1991-3#1)(1992-9#2)(1993-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-9#2)
electron donor##6##2##(1993-8#1)(2008-8#4)(2011-2#1)
electron donors and##2##3##(1994-5#1)(2008-10#1)
electron donors##3##2##(1994-5#1)(2008-10#1)(2009-9#1)
electron flow##4##2##(2008-4#1)(2009-10#3)
electron impact mass spectrometric##3##4##(2008-10#3)
electron impact##5##2##(2008-10#5)
electron ionization##2##2##(2008-10#2)
electron lucent granules##2##3##(2008-5#1)(2008-7#1)
electron lucent##4##2##(2008-5#2)(2008-7#2)
electron mediator##3##2##(2008-10#3)
electron mediators##2##2##(2008-10#2)
electron micrographs of##2##3##(1991-5#1)(2008-5#1)
electron micrographs##5##2##(1991-5#1)(2008-10#3)(2008-5#1)
electron microprobe##3##2##(1990-5#1)(2008-10#2)
electron microscope and##2##3##(1991-12#1)(1991-9#1)
electron microscope investigations##3##3##(2008-10#2)(2008-6#1)
electron microscope##33##2##(1991-12#1)(1991-9#1)(1997-3#1)(2007-12#1)(2008-10#11)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-3#1)(2009-7#1)(2012-2#1)(2012-3#1)
electron microscopes##2##2##(2008-12#1)(2008-7#1)
electron microscopic examination##2##3##(1996-6#1)(2008-7#1)
electron microscopic level##3##3##(1995-3#1)(2008-7#2)
electron microscopic observations showed that##2##5##(1994-2#1)(2008-10#1)
electron microscopic##15##2##(1990-8#1)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2011-2#1)
electron microscopical study##2##3##(2007-12#2)
electron microscopical##5##2##(2007-12#3)(2008-7#2)
electron microscopy (EM)##2##3##(2008-10#1)(2012-2#1)
electron microscopy (SEM)##26##3##(1992-2#1)(1996-3#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#3)(2010-4#1)(2013-1#2)(2013-8#1)
electron microscopy (TEM)##10##3##(2008-10#5)(2008-11#1)(2008-5#1)(2009-7#2)(2011-2#1)
electron microscopy and##16##3##(1994-11#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-7#1)
electron microscopy in order to##3##5##(2007-12#1)(2008-10#1)(2008-7#1)
electron microscopy in##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
electron microscopy observations##2##3##(2008-10#2)
electron microscopy of vascular corrosion casts and correlative light microscopy##2##10##(2011-2#2)
electron microscopy of##10##3##(1992-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#2)
electron microscopy revealed that##4##4##(1997-3#1)(2008-10#2)(2008-8#1)
electron microscopy revealed##7##3##(1997-3#1)(2008-10#5)(2008-8#1)
electron microscopy showed that##5##4##(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
electron microscopy showed##8##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
electron microscopy studies##2##3##(2008-10#1)(2008-7#1)
electron microscopy to determine the##2##5##(2008-10#1)(2009-7#1)
electron microscopy to determine##3##4##(2008-10#1)(2008-5#1)(2009-7#1)
electron microscopy to##8##3##(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-7#1)
electron microscopy using##2##3##(2008-10#2)
electron microscopy was used##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
electron microscopy was##6##3##(2007-12#1)(2008-10#2)(2008-5#2)(2010-6#1)
electron microscopy were used##2##4##(2008-10#1)(2008-7#1)
electron microscopy were##3##3##(2008-10#2)(2008-7#1)
electron microscopy##193##2##(1990-2#1)(1991-5#1)(1992-2#3)(1992-9#1)(1994-11#1)(1996-3#1)(1997-3#4)(1997-7#1)(2006-6#1)(2007-12#12)(2008-10#86)(2008-11#7)(2008-12#2)(2008-2#1)(2008-5#14)(2008-7#14)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#2)(2009-5#1)(2009-7#8)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
electron microscopy-energy dispersive##2##3##(2008-10#1)(2011-2#1)
electron paramagnetic resonance (EPR) spectroscopy##2##5##(2008-10#1)(2008-5#1)
electron paramagnetic resonance (EPR)##5##4##(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)
electron paramagnetic resonance spectroscopy##2##4##(1997-1#1)(2008-10#1)
electron paramagnetic resonance##8##3##(1997-1#2)(2008-10#3)(2008-5#1)(2008-8#1)(2009-5#1)
electron pulse irradiation##2##3##(2008-8#1)(2008-9#1)
electron spin resonance (ESR)##4##4##(2008-10#3)(2008-9#1)
electron spin resonance##9##3##(2008-10#7)(2008-8#1)(2008-9#1)
electron temperature was##2##3##(2008-3#2)
electron temperature##3##2##(2008-3#3)
electron transfer (PET)##3##3##(2008-10#3)
electron transfer between##7##3##(2008-10#6)(2008-8#1)
electron transfer component##2##3##(1996-3#1)(2009-9#1)
electron transfer from##3##3##(1994-5#1)(1997-7#1)(2008-10#1)
electron transfer in##2##3##(1991-5#1)(1995-3#1)
electron transfer is##2##3##(2008-10#1)(2009-3#1)
electron transfer processes##2##3##(2008-10#2)
electron transfer rate between##2##4##(2008-10#1)(2008-8#1)
electron transfer rate constant##4##4##(2008-10#4)
electron transfer rate##8##3##(2008-10#7)(2008-8#1)
electron transfer was##3##3##(1995-2#1)(2008-10#2)
electron transfer##57##2##(1990-5#2)(1990-8#1)(1991-5#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-3#1)(1996-3#1)(1997-7#1)(2008-10#32)(2008-12#1)(2008-5#1)(2008-8#4)(2009-3#2)(2009-9#4)(2012-2#1)
electron transport rate##2##3##(2008-8#1)(2008-9#1)
electron transport system##2##3##(1991-5#1)(2013-1#1)
electron transport##21##2##(1990-5#1)(1991-5#2)(1994-3#3)(1995-3#1)(2008-8#4)(2008-9#1)(2009-9#6)(2010-12#1)(2011-2#1)(2013-1#1)
electron##513##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#4)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#6)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1992-9#3)(1993-8#4)(1993-9#2)(1994-11#3)(1994-2#3)(1994-3#4)(1994-5#4)(1995-2#3)(1995-3#4)(1995-6#2)(1995-8#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-3#5)(1997-7#2)(2006-6#1)(2007-12#18)(2008-10#209)(2008-11#17)(2008-12#6)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#26)(2008-6#1)(2008-7#29)(2008-8#24)(2008-9#12)(2009-10#5)(2009-11#11)(2009-3#3)(2009-5#2)(2009-7#15)(2009-8#1)(2009-9#13)(2010-12#2)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-2#12)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#7)(2013-8#2)
electron-beam##3##1##(2008-2#1)(2008-3#2)
electron-dense##15##1##(1992-2#1)(2007-12#2)(2008-10#10)(2008-7#2)
electron-lucent##4##1##(2008-7#4)
electron-microscopic##3##1##(1997-2#2)(2008-10#1)
electron-opaque material##4##2##(2008-10#4)
electron-opaque##5##1##(2008-10#5)
electron-transfer reactions##2##2##(2008-10#1)(2010-7#1)
electron-transfer##12##1##(1990-5#1)(1994-5#3)(2008-10#6)(2008-8#1)(2010-7#1)
electron-withdrawing##2##1##(1996-5#1)(2008-10#1)
electronic absorption##3##2##(1993-8#1)(2008-10#2)
electronic and steric##2##3##(1994-5#1)(2012-12#1)
electronic and##3##2##(1994-5#1)(2008-10#1)(2012-12#1)
electronic communication between##2##3##(2008-10#1)(2009-9#1)
electronic communication##3##2##(2008-10#1)(2009-9#1)(2010-8#1)
electronic conductivity##2##2##(2008-10#2)
electronic control devices##2##3##(2010-1#2)
electronic control##4##2##(2008-3#1)(2010-1#2)(2010-8#1)
electronic coupling##3##2##(2008-10#1)(2009-11#2)
electronic data##5##2##(1991-8#1)(1993-3#1)(2011-2#3)
electronic databases and##2##3##(2010-2#1)(2013-8#1)
electronic databases##7##2##(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
electronic devices##3##2##(2008-7#3)
electronic health record##7##3##(2010-8#2)(2013-1#5)
electronic health records##5##3##(2010-4#2)(2010-8#1)(2012-2#1)(2012-3#1)
electronic health##13##2##(2010-4#2)(2010-8#4)(2012-2#1)(2012-3#1)(2013-1#5)
electronic information##2##2##(1996-3#1)(1997-2#1)
electronic mail##3##2##(1995-2#1)(1996-1#1)(1997-2#1)
electronic media##2##2##(1993-12#1)(1997-2#1)
electronic medical databases##3##3##(2010-8#3)
electronic medical records##4##3##(2012-3#4)
electronic medical##9##2##(2009-10#1)(2010-8#4)(2012-3#4)
electronic microscopy##6##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)
electronic nerve stimulators##2##3##(2008-10#2)
electronic nose##10##2##(2008-10#8)(2008-11#2)
electronic patient record##3##3##(1997-1#2)(2010-4#1)
electronic properties##2##2##(1992-8#1)(2008-10#1)
electronic records##3##2##(2008-10#2)(2011-2#1)
electronic search##2##2##(2012-2#1)(2013-1#1)
electronic sensor##2##2##(2008-10#2)
electronic spectra##2##2##(2008-10#2)
electronic structure of##2##3##(1993-5#1)(2010-7#1)
electronic structure##6##2##(1993-5#1)(1994-5#2)(2008-10#1)(2008-7#1)(2010-7#1)
electronic tongue (ET)##2##3##(2008-10#2)
electronic tongue based on##2##4##(2008-10#2)
electronic tongue for##2##3##(2008-10#2)
electronic tongue was##2##3##(2008-10#2)
electronic tongue##11##2##(2008-10#11)
electronic tongue&quot##2##2##(2008-10#2)
electronic type##2##2##(2008-7#2)
electronic version##2##2##(2008-3#1)(2008-9#1)
electronic##175##1##(1991-5#1)(1991-8#1)(1992-10#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-5#6)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#5)(1997-1#2)(1997-2#3)(1997-5#1)(2008-10#55)(2008-11#8)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#3)(2010-7#2)(2010-8#11)(2011-2#7)(2011-9#2)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#12)(2013-8#2)
electronical##2##1##(2008-11#2)
electronically##3##1##(1993-5#1)(2008-10#1)(2010-7#1)
electronics##10##1##(2008-10#4)(2008-3#1)(2008-7#3)(2010-7#1)(2012-2#1)
electrons##17##1##(1990-12#1)(1991-5#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2009-11#1)(2011-2#1)
electroosmosis pump##3##2##(2008-10#3)
electroosmosis##4##1##(2008-10#4)
electroosmotic flow (EOF)##4##3##(1997-2#1)(2008-10#3)
electroosmotic flow##8##2##(1997-2#1)(2008-10#7)
electroosmotic mobility##3##2##(2008-10#3)
electroosmotic pump flow injection system##2##5##(2008-10#2)
electroosmotic pump##4##2##(2008-10#4)
electroosmotic##17##1##(1997-2#1)(2008-10#16)
electrooxidation##4##1##(2008-10#4)
electropherogram##3##1##(2008-10#3)
electropherograms were##2##2##(2008-10#2)
electropherograms##4##1##(2008-10#4)
electrophilic##6##1##(1993-8#1)(1994-5#1)(1996-5#2)(2008-11#1)(2008-4#1)
electrophoresed##5##1##(1992-8#1)(1993-6#1)(2008-4#3)
electrophoresis (CE) has##3##3##(2008-10#2)(2008-5#1)
electrophoresis (CE) with##4##3##(2008-10#4)
electrophoresis (CE)##32##2##(1997-2#1)(2008-10#28)(2008-4#1)(2008-5#1)(2010-7#1)
electrophoresis and detected##2##3##(2008-10#2)
electrophoresis and##22##2##(1991-12#1)(1991-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#4)(2008-4#3)(2008-8#1)(2012-3#1)(2013-8#1)
electrophoresis at##2##2##(2008-10#2)
electrophoresis coupled##2##2##(2008-10#2)
electrophoresis for the separation of##2##5##(2008-10#1)(2008-4#1)
electrophoresis for the##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
electrophoresis for##8##2##(2008-10#5)(2008-4#2)(2008-5#1)
electrophoresis in##5##2##(2008-10#3)(2008-12#1)(2008-9#1)
electrophoresis is##5##2##(2008-10#4)(2008-4#1)
electrophoresis method for the determination of##3##6##(2008-10#3)
electrophoresis method for the##7##4##(1997-2#2)(2008-10#5)
electrophoresis method for##8##3##(1997-2#2)(2008-10#6)
electrophoresis method##14##2##(1997-2#2)(2008-10#11)(2009-8#1)
electrophoresis mobility##2##2##(2008-11#1)(2008-9#1)
electrophoresis of##16##2##(1993-6#1)(1994-8#1)(2008-10#12)(2008-4#2)
electrophoresis on##2##2##(1991-12#1)(1995-2#1)
electrophoresis or##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
electrophoresis separation##3##2##(2008-10#3)
electrophoresis showed##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
electrophoresis tandem mass spectrometry (mPC-CE-MS/MS)##2##5##(2008-10#2)
electrophoresis to##11##2##(1991-5#1)(1997-3#1)(2008-10#8)(2010-12#1)
electrophoresis using##8##2##(2008-10#8)
electrophoresis was##3##2##(2008-5#2)(2008-8#1)
electrophoresis were##2##2##(2008-10#2)
electrophoresis with amperometric detection##6##4##(2008-10#6)
electrophoresis with electrochemical detection (CE-ED) was##2##6##(2008-10#2)
electrophoresis with electrochemical detection##5##4##(2008-10#5)
electrophoresis with electrochemical##7##3##(2008-10#7)
electrophoresis with##34##2##(1991-12#1)(1997-2#1)(2008-10#31)(2008-8#1)
electrophoresis##390##1##(1990-10#2)(1990-11#3)(1990-5#2)(1991-12#4)(1991-2#1)(1991-5#4)(1991-9#2)(1992-12#3)(1992-6#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#3)(1994-11#1)(1994-8#2)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#10)(1997-3#1)(2008-10#265)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#17)(2008-5#9)(2008-7#1)(2008-8#5)(2008-9#4)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
electrophoresis)##3##1##(1990-2#1)(2008-10#1)(2008-4#1)
electrophoresis-tandem mass spectrometry##4##3##(1997-2#4)
electrophoretic analysis of##3##3##(1991-12#1)(1994-6#1)(2008-2#1)
electrophoretic analysis##4##2##(1990-11#1)(1991-12#1)(1994-6#1)(2008-2#1)
electrophoretic buffer##2##2##(1997-2#1)(2008-10#1)
electrophoretic determination of##2##3##(2008-10#2)
electrophoretic method was##3##3##(2008-10#3)
electrophoretic method##5##2##(2008-10#5)
electrophoretic microchip##2##2##(2008-10#2)
electrophoretic migration##2##2##(1990-5#1)(2008-10#1)
electrophoretic mobilities of##3##3##(2008-10#3)
electrophoretic mobility of##4##3##(1992-8#1)(1994-11#1)(2008-10#2)
electrophoretic mobility shift assay##4##4##(2008-11#2)(2008-4#1)(2011-2#1)
electrophoretic mobility shift##6##3##(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#1)
electrophoretic mobility##21##2##(1992-6#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-4#2)(2008-8#1)(2008-9#2)(2011-2#1)
electrophoretic paint##2##2##(2008-10#2)
electrophoretic separation of proteins##2##4##(2010-11#1)(2012-2#1)
electrophoretic separation of##3##3##(1997-2#1)(2010-11#1)(2012-2#1)
electrophoretic separation##5##2##(1997-2#1)(2008-10#2)(2010-11#1)(2012-2#1)
electrophoretic system incorporating an##2##4##(2008-10#2)
electrophoretic##73##1##(1990-11#1)(1990-5#1)(1991-12#1)(1992-6#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#3)(2008-10#41)(2008-11#4)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)
electrophoretically##5##1##(1994-5#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
electrophysiologic studies##2##2##(1990-3#2)
electrophysiologic study##2##2##(2008-12#2)
electrophysiologic##11##1##(1990-3#3)(2008-10#1)(2008-12#2)(2010-7#2)(2010-8#1)(2012-3#1)(2013-1#1)
electrophysiological and psychophysical##2##3##(2008-9#2)
electrophysiological and##3##2##(2008-11#1)(2008-9#2)
electrophysiological evidence##2##2##(1997-2#1)(1997-3#1)
electrophysiological##29##1##(1990-9#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
electrophysiologically##7##1##(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
electrophysiology of##2##2##(2008-7#1)(2012-2#1)
electrophysiology study##2##2##(2008-11#2)
electrophysiology##15##1##(1990-5#1)(1992-3#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-7#2)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
electroplating baths##3##2##(2008-10#3)
electroplating plant##3##2##(2008-10#3)
electroplating##10##1##(2008-10#10)
electropolymerization and##2##2##(2008-10#2)
electropolymerization of pyrrole##3##3##(2008-10#3)
electropolymerization of##12##2##(2008-10#12)
electropolymerization##21##1##(2008-10#21)
electropolymerized films of metal tetraaminophthalocyanines##2##5##(2008-10#2)
electropolymerized films of##3##3##(2008-10#3)
electropolymerized o-phenylenediamine film doped with##2##5##(2008-10#2)
electropolymerized o-phenylenediamine film##3##3##(2008-10#3)
electropolymerized onto##3##2##(2008-10#3)
electropolymerized##19##1##(1995-3#1)(2008-10#18)
electroporated##4##1##(1994-8#2)(2008-10#1)(2008-9#1)
electroporation for##2##2##(2008-11#2)
electroporation of##5##2##(2008-10#1)(2008-11#2)(2008-9#2)
electroporation##20##1##(1997-8#1)(2008-10#2)(2008-11#13)(2008-9#4)
electroreduction##2##1##(2008-10#2)
electroresection##2##1##(1991-9#2)
electrospinning and mineralization##2##3##(2009-7#2)
electrospinning##4##1##(2009-12#1)(2009-7#3)
electrospray ionization (ESI)##2##3##(2008-10#2)
electrospray ionization MS##2##3##(2008-10#1)(2009-6#1)
electrospray ionization mass spectrometry##5##4##(1990-12#1)(2008-10#3)(2010-6#1)
electrospray ionization mass##8##3##(1990-12#1)(2008-10#6)(2010-6#1)
electrospray ionization##18##2##(1990-12#1)(2008-10#11)(2009-6#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-3#1)
electrospray ionization-ion mobility spectrometry##2##4##(2008-10#2)
electrospray ionization-ion##3##2##(2008-10#3)
electrospray ionization-mass spectrometry (ESI-MS)##2##4##(2008-5#1)(2011-1#1)
electrospray mass spectrometry (ESI-MS)##2##4##(2008-10#2)
electrospray mass spectrometry detection##4##4##(2008-10#4)
electrospray mass spectrometry was used##2##5##(2008-10#2)
electrospray mass spectrometry##11##3##(1996-12#1)(2008-10#10)
electrospray##44##1##(1990-12#1)(1996-12#1)(1997-2#2)(2008-10#32)(2008-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-3#1)
electrospray-mass spectrometry##2##2##(2008-10#2)
electrospun scaffolds##2##2##(2009-7#2)
electrospun##6##1##(2009-12#1)(2009-7#5)
electrostatic adsorption##2##2##(2008-10#2)
electrostatic binding##3##2##(1990-2#1)(1997-2#2)
electrostatic effect##2##2##(1997-2#1)(2008-10#1)
electrostatic effects##2##2##(1994-8#1)(2008-7#1)
electrostatic field##2##2##(2008-10#2)
electrostatic force##4##2##(2008-10#4)
electrostatic free energy##2##3##(2008-4#2)
electrostatic interaction between##2##3##(2008-10#1)(2013-1#1)
electrostatic interaction is##2##3##(2008-10#2)
electrostatic interaction of##3##3##(2008-10#3)
electrostatic interaction##11##2##(1996-5#1)(2008-10#9)(2013-1#1)
electrostatic interactions and##2##3##(2008-10#2)
electrostatic interactions##15##2##(1994-5#1)(1996-5#1)(2008-10#8)(2008-4#4)(2013-1#1)
electrostatic potential##2##2##(2008-4#1)(2008-8#1)
electrostatic repulsion between##2##3##(2008-10#2)
electrostatic repulsion##3##2##(2008-10#2)(2008-8#1)
electrostatic surface##2##2##(1994-5#2)
electrostatic##81##1##(1990-12#1)(1990-2#1)(1994-12#1)(1994-5#4)(1994-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#3)(2008-10#41)(2008-11#1)(2008-4#13)(2008-7#6)(2008-8#2)(2010-12#1)(2013-1#2)
electrostatically##7##1##(2008-10#5)(2008-4#1)(2009-12#1)
electrostatics and##2##2##(2008-10#1)(2008-4#1)
electrostatics##5##1##(2008-10#1)(2008-4#3)(2013-1#1)
electrostriction##2##1##(2008-10#1)(2008-2#1)
electrosurgery and##2##2##(1996-1#2)
electrosurgery vs##2##2##(1996-1#2)
electrosurgery##4##1##(1996-1#4)
electrosurgical coagulation waveform##2##3##(1992-12#2)
electrosurgical loop conization##3##3##(1994-12#3)
electrosurgical loop##4##2##(1994-12#4)
electrosurgical##9##1##(1992-12#4)(1992-2#1)(1994-12#4)
electrosynthesis of##2##2##(2008-10#2)
electrosynthesized##2##1##(2008-10#2)
electrothermal AAS##2##2##(2008-10#2)
electrothermal atomic absorption spectrometric (ETAAS)##2##5##(2008-10#2)
electrothermal atomic absorption spectrometric determination of cadmium and lead##2##9##(2008-10#2)
electrothermal atomic absorption spectrometric determination of##4##6##(2008-10#4)
electrothermal atomic absorption spectrometric determination##5##5##(2008-10#5)
electrothermal atomic absorption spectrometric##8##4##(2008-10#8)
electrothermal atomic absorption spectrometry (ET AAS)##3##6##(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS) determination of##2##7##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) is described##2##7##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) is##3##6##(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS) using##2##6##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) with##3##6##(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS)##28##5##(2008-10#28)
electrothermal atomic absorption spectrometry in##4##5##(2008-10#4)
electrothermal atomic absorption spectrometry with a##2##6##(2008-10#2)
electrothermal atomic absorption spectrometry with##8##5##(2008-10#8)
electrothermal atomic absorption spectrometry##103##4##(2008-10#103)
electrothermal atomic absorption##118##3##(2008-10#118)
electrothermal atomization atomic absorption spectrometry##2##5##(2008-10#2)
electrothermal atomization##5##2##(2008-10#5)
electrothermal vaporisation##3##2##(2008-10#3)
electrothermal vaporization (ETV)##2##3##(2008-10#2)
electrothermal vaporization inductively coupled plasma mass spectrometry##4##7##(2008-10#4)
electrothermal vaporization inductively coupled plasma##5##5##(2008-10#5)
electrothermal vaporization##15##2##(2008-10#15)
electrothermal vaporization-inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
electrothermal vaporizer for sample introduction##2##5##(2008-10#2)
electrothermal##151##1##(2008-10#151)
electroweak##2##1##(1992-8#2)
electroxidation of##2##2##(2008-10#2)
elegans and##4##2##(1995-6#1)(2008-6#1)(2008-9#1)(2012-3#1)
elegans##39##1##(1990-5#2)(1993-12#2)(1994-11#2)(1994-12#2)(1995-3#1)(1995-6#3)(1995-9#1)(1996-6#2)(1997-7#2)(2008-10#10)(2008-6#1)(2008-7#2)(2008-9#4)(2012-3#5)
elegant approach##2##2##(2008-11#1)(2013-1#1)
elegant##7##1##(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-7#1)(2013-1#1)
element (CRE)##4##2##(1994-11#1)(1997-2#2)(2013-1#1)
element (TRE)##2##2##(1993-3#1)(1993-8#1)
element analyses##2##2##(2008-10#2)
element analysis of##2##3##(2008-10#1)(2013-1#1)
element analysis##5##2##(2008-10#3)(2009-7#1)(2013-1#1)
element and##5##2##(1995-6#1)(2008-10#2)(2008-9#1)(2012-3#1)
element at##2##2##(2008-10#2)
element by##2##2##(2008-10#2)
element concentration##3##2##(1993-2#1)(2008-10#2)
element concentrations (Cu##2##3##(1993-2#2)
element concentrations in##2##3##(2008-10#2)
element concentrations##5##2##(1993-2#2)(2008-10#3)
element content of##2##3##(2008-10#1)(2011-2#1)
element determinations##2##2##(2008-10#2)
element for##4##2##(1995-6#1)(1996-6#1)(2008-10#2)
element from##2##2##(1991-6#1)(1993-12#1)
element in strain##2##3##(2008-10#2)
element in the##12##3##(1992-6#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2013-1#1)
element in##29##2##(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#2)(1995-6#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-3#2)(2013-1#1)
element is##5##2##(2008-10#3)(2008-3#1)(2012-3#1)
element of##13##2##(1991-3#1)(1992-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2013-1#1)
element on the##2##3##(2008-10#1)(2008-2#1)
element on##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
element or##3##2##(2008-10#3)
element that##5##2##(1995-2#1)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)
element was##6##2##(1991-7#1)(1995-6#1)(2008-10#4)
element whose##2##2##(2008-3#1)(2012-2#1)
element zinc in##2##3##(2008-10#1)(2012-2#1)
element##256##1##(1990-11#1)(1990-3#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-6#4)(1992-8#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#6)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#8)(1995-6#7)(1995-9#1)(1996-12#2)(1996-6#2)(1997-2#2)(1997-3#2)(1997-7#3)(2008-10#97)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#16)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#3)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#9)(2013-1#5)(2013-8#5)
element)##2##1##(1995-6#1)(2008-10#1)
element-based##3##1##(2008-10#2)(2008-3#1)
element-dependent##3##1##(2008-10#3)
element-specific##2##1##(2008-10#2)
elemental Hg##2##2##(2008-10#2)
elemental analyses##4##2##(2008-10#3)(2008-11#1)
elemental analysis and X-ray fluorescence techniques##2##6##(2008-10#2)
elemental analysis and##6##3##(2008-10#6)
elemental analysis in##2##3##(2008-10#2)
elemental analysis of glass##2##4##(2008-10#2)
elemental analysis of##8##3##(2008-10#8)
elemental analysis##35##2##(2008-10#34)(2008-11#1)
elemental analyzer with thermal conductivity detector##2##6##(2008-10#2)
elemental and harmful transition##2##4##(2008-10#2)
elemental and thermogravimetric##2##3##(2008-10#2)
elemental and##5##2##(2008-10#5)
elemental association##3##2##(2008-10#3)
elemental carbon##4##2##(2008-10#3)(2010-11#1)
elemental composition of##5##3##(2008-10#5)
elemental composition##11##2##(2008-10#9)(2008-5#1)(2011-2#1)
elemental concentrations in the##2##4##(2008-10#2)
elemental concentrations##6##2##(2008-10#3)(2008-5#3)
elemental determination##2##2##(2008-10#2)
elemental determinations##2##2##(2008-10#2)
elemental images##2##2##(2008-3#2)
elemental sulfur and polysulfides##2##4##(2008-10#2)
elemental sulfur##3##2##(2008-10#3)
elemental##103##1##(2008-10#87)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#4)(2010-11#2)(2011-2#1)(2013-8#2)
elementary and middle##2##3##(2012-2#2)
elementary bodies##2##2##(1993-9#1)(1996-12#1)
elementary events underlying force generation in neuronal lamellipodia##2##8##(2012-2#2)
elementary events underlying force generation##3##5##(2012-2#3)
elementary events##4##2##(2012-2#4)
elementary school##4##2##(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
elementary schools##2##2##(2008-12#1)(2012-2#1)
elementary##18##1##(1993-9#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#3)(2012-2#8)(2012-3#1)
elements (Al##2##2##(2008-10#2)
elements (As##5##2##(2008-10#5)
elements (CRE)##2##2##(1993-3#1)(1996-2#1)
elements (Pb##2##2##(2008-10#2)
elements (RE)##2##2##(2008-10#2)
elements (REEs)##4##2##(2008-10#3)(2008-9#1)
elements (e##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
elements and the##4##3##(1990-2#1)(2008-10#2)(2013-1#1)
elements and##28##2##(1990-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-6#2)(2011-1#1)(2011-2#1)(2013-1#2)
elements are also##2##3##(1995-8#1)(2008-10#1)
elements are in##2##3##(2008-10#1)(2012-3#1)
elements are##23##2##(1993-12#1)(1993-8#1)(1993-9#1)(1995-8#2)(2008-10#8)(2008-11#1)(2008-3#3)(2009-7#1)(2010-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
elements as##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
elements associated with##2##3##(2008-10#1)(2008-2#1)
elements at the##3##3##(2008-3#2)(2008-9#1)
elements at##6##2##(1997-2#1)(2008-10#2)(2008-3#2)(2008-9#1)
elements bound##2##2##(1993-8#1)(2008-11#1)
elements by inductively coupled plasma mass spectrometry##2##7##(2008-10#2)
elements by inductively coupled plasma##3##5##(2008-10#3)
elements by##8##2##(2008-10#6)(2008-7#1)(2009-7#1)
elements can be##2##3##(1995-2#1)(2008-10#1)
elements can##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
elements could##2##2##(1993-6#1)(2008-10#1)
elements derived from##3##3##(2008-11#1)(2012-3#2)
elements for the determination of##2##5##(2008-10#2)
elements for the##4##3##(2008-10#2)(2010-7#1)(2013-1#1)
elements for##12##2##(1993-8#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
elements from the##2##3##(2008-3#1)(2012-3#1)
elements from##7##2##(2008-10#5)(2008-3#1)(2012-3#1)
elements has been##2##3##(2008-10#2)
elements have been##2##3##(2011-2#1)(2012-3#1)
elements have##3##2##(1993-6#1)(2011-2#1)(2012-3#1)
elements in biological##2##3##(2008-10#1)(2008-11#1)
elements in coal by##2##4##(2008-10#2)
elements in coal##3##3##(2008-10#3)
elements in geological samples by##2##5##(2008-10#2)
elements in honey##2##3##(2008-10#2)
elements in its##2##3##(1993-6#1)(1994-3#1)
elements in seawater##2##3##(2008-10#2)
elements in several##2##3##(2008-10#1)(2008-7#1)
elements in solid samples##2##4##(2008-10#2)
elements in solid##3##3##(2008-10#3)
elements in some##2##3##(2008-10#2)
elements in the same##2##4##(2008-10#1)(2009-7#1)
elements in the sample##2##4##(2008-10#2)
elements in the##16##3##(1993-12#1)(2008-10#12)(2009-10#1)(2009-7#1)(2009-9#1)
elements in their promoter##2##4##(1994-11#1)(1995-2#1)
elements in##96##2##(1993-12#4)(1993-6#1)(1994-11#2)(1994-3#3)(1995-2#1)(2008-10#66)(2008-11#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#3)
elements investigated##3##2##(2008-10#3)
elements involved in##4##3##(1993-12#2)(2008-10#1)(2013-1#1)
elements is##10##2##(2008-10#6)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)
elements may be##3##3##(2008-11#1)(2008-3#1)(2012-3#1)
elements of a##5##3##(2008-11#3)(2008-3#1)(2008-4#1)
elements of care##2##3##(1994-3#2)
elements of the##26##3##(1991-6#1)(1994-1#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#3)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
elements of this##3##3##(1993-6#1)(1994-12#1)(2010-8#1)
elements of##78##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-3#3)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(2007-12#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-3#7)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#7)(2010-1#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
elements on the##3##3##(2008-10#3)
elements on##7##2##(2008-10#6)(2012-3#1)
elements or##2##2##(1993-2#1)(2008-10#1)
elements present in##2##3##(2008-10#2)
elements present##3##2##(2008-10#3)
elements recoveries##2##2##(2008-10#2)
elements studied##3##2##(2008-10#3)
elements such as Ba##2##4##(2008-10#2)
elements such as##10##3##(2008-10#8)(2008-3#1)(2009-7#1)
elements tested##3##2##(1991-6#1)(2008-10#2)
elements that are##2##3##(2008-11#1)(2009-12#1)
elements that may be##2##4##(2008-12#1)(2008-6#1)
elements that##11##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2012-3#3)(2013-1#1)
elements the##2##2##(2008-10#2)
elements to##8##2##(1993-12#1)(2008-10#3)(2009-10#1)(2010-8#2)(2013-8#1)
elements using a##2##3##(2008-10#1)(2008-9#1)
elements was##6##2##(2008-10#5)(2008-8#1)
elements were considered as chemical descriptors##2##6##(2008-10#2)
elements were determined by##2##4##(2008-10#2)
elements were determined##5##3##(2008-10#5)
elements were found to be##2##5##(1993-12#1)(2008-10#1)
elements were found to##3##4##(1993-12#1)(2008-10#2)
elements were found##4##3##(1993-12#1)(2008-10#3)
elements were identified in the##2##5##(1991-6#1)(1991-7#1)
elements were identified in##3##4##(1991-6#1)(1991-7#1)(2008-10#1)
elements were identified##4##3##(1991-6#1)(1991-7#1)(1995-8#1)(2008-10#1)
elements were investigated in##2##4##(2008-10#2)
elements were investigated##3##3##(2008-10#3)
elements were present##2##3##(1991-6#1)(2012-3#1)
elements were##41##2##(1991-6#2)(1991-7#1)(1993-12#2)(1994-3#1)(1995-8#1)(2008-10#31)(2008-3#1)(2008-7#1)(2012-3#1)
elements when##2##2##(2008-10#2)
elements which##8##2##(1996-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-3#1)
elements with the##4##3##(1995-2#1)(2008-10#2)(2009-3#1)
elements with##11##2##(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-1#1)(2009-3#1)(2010-6#1)(2012-2#1)
elements within the##7##3##(2008-10#5)(2008-4#1)(2009-7#1)
elements##729##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#8)(1991-7#2)(1992-1#1)(1992-4#1)(1993-12#15)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#12)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#7)(1994-5#1)(1995-12#4)(1995-2#4)(1995-6#2)(1995-8#14)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#369)(2008-11#35)(2008-12#3)(2008-2#3)(2008-3#36)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#17)(2009-1#1)(2009-10#9)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#6)(2009-7#6)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#5)(2010-8#4)(2011-1#3)(2011-2#15)(2012-12#2)(2012-2#12)(2012-3#23)(2013-1#15)(2013-8#6)
elements)##6##1##(2008-10#4)(2008-11#1)(2010-7#1)
elevate the##4##2##(1993-12#1)(1995-8#1)(2008-10#1)(2008-6#1)
elevate##12##1##(1992-8#2)(1993-12#1)(1993-6#1)(1994-11#1)(1995-8#2)(2008-10#3)(2008-5#1)(2008-6#1)
elevated CO(2) concentration##3##3##(2008-10#3)
elevated CO(2)##7##2##(2008-10#7)
elevated IgE values##2##3##(2008-10#2)
elevated K+ suppressed##2##3##(1997-1#2)
elevated K+##5##2##(1996-2#1)(1997-1#4)
elevated TSH##4##2##(1995-8#1)(2008-4#1)(2012-12#2)
elevated and##3##2##(1996-6#1)(2008-5#1)(2009-1#1)
elevated as##3##2##(1990-6#1)(2008-10#1)(2008-5#1)
elevated at the##4##3##(2008-10#1)(2008-5#1)(2011-2#2)
elevated at##6##2##(1990-5#1)(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#1)
elevated blood pressure in the acute phase of##3##8##(1997-5#3)
elevated blood pressure in##4##4##(1997-5#3)(2008-5#1)
elevated blood pressure readings##2##4##(2008-5#2)
elevated blood pressure##10##3##(1997-2#1)(1997-5#5)(2008-5#3)(2008-7#1)
elevated blood##13##2##(1992-5#1)(1994-5#1)(1997-2#1)(1997-5#5)(2008-5#3)(2008-7#2)
elevated by##8##2##(1993-8#1)(1994-8#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
elevated circulating##2##2##(1991-12#1)(2013-1#1)
elevated concentrations of the##2##4##(2008-10#1)(2008-7#1)
elevated concentrations of##8##3##(1991-6#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
elevated creatine kinase##2##3##(2009-11#1)(2011-2#1)
elevated cytosolic##2##2##(2008-11#1)(2009-9#1)
elevated daytime temperature##3##3##(2012-7#3)
elevated during the##2##3##(1993-1#1)(2008-10#1)
elevated during##4##2##(1993-1#1)(1994-2#1)(2008-10#1)(2013-8#1)
elevated expression of##2##3##(1990-5#1)(2009-8#1)
elevated glucose##2##2##(1992-8#2)
elevated glutamate##2##2##(2008-11#2)
elevated immune##2##2##(2008-9#1)(2010-12#1)
elevated in patients##2##3##(1992-6#1)(2008-12#1)
elevated in schizophrenia##2##3##(1993-9#2)
elevated in the##6##3##(1993-9#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#2)
elevated in two##2##3##(1990-9#1)(2008-7#1)
elevated in##28##2##(1990-9#1)(1991-7#1)(1992-6#2)(1993-6#1)(1993-9#4)(1994-2#1)(1994-3#2)(1994-5#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-6#1)(2013-1#2)
elevated intracranial pressure##2##3##(2011-2#2)
elevated level##3##2##(1991-7#1)(1996-12#1)(1997-8#1)
elevated levels of extracellular##2##4##(1993-6#1)(1994-2#1)
elevated levels of persistent##2##4##(2008-11#2)
elevated levels of root##2##4##(2008-10#2)
elevated levels of##30##3##(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#2)(1993-6#1)(1994-2#2)(1995-2#2)(1996-12#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-5#3)(2008-7#1)(2009-10#1)(2011-2#3)(2013-1#2)
elevated levels##32##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#2)(1993-6#1)(1994-2#2)(1995-2#2)(1996-12#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-5#3)(2008-7#1)(2009-10#1)(2011-2#3)(2013-1#2)
elevated plasma insulin##2##3##(1994-8#1)(1996-12#1)
elevated plasma##9##2##(1994-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
elevated pressures##2##2##(2008-3#1)(2010-4#1)
elevated rates of##2##3##(2012-2#1)(2013-8#1)
elevated rates##3##2##(2008-1#1)(2012-2#1)(2013-8#1)
elevated resistance to##2##3##(2008-11#2)
elevated risk of##2##3##(1994-9#1)(2009-10#1)
elevated risk##4##2##(1994-9#1)(1996-11#1)(2009-10#1)(2013-1#1)
elevated serum##6##2##(1991-8#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-5#1)
elevated simultaneously##2##2##(2008-9#1)(2009-6#1)
elevated temperature##8##2##(2008-10#3)(2008-5#1)(2012-6#1)(2012-7#3)
elevated temperatures and##2##3##(2008-3#1)(2010-4#1)
elevated temperatures##9##2##(1990-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)
elevated the levels of##2##4##(2008-10#1)(2011-2#1)
elevated the##5##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
elevated throughout the##3##3##(1992-3#1)(1994-2#1)(2008-12#1)
elevated##303##1##(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#2)(1991-12#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#4)(1993-6#2)(1993-8#4)(1993-9#4)(1994-2#5)(1994-3#2)(1994-5#4)(1994-8#6)(1994-9#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#6)(1996-2#2)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-5#5)(1997-7#4)(1997-8#5)(2006-6#1)(2008-1#1)(2008-10#46)(2008-11#19)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#12)(2008-6#2)(2008-7#13)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#2)(2009-6#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#21)(2012-12#3)(2012-2#2)(2012-3#5)(2012-5#1)(2012-6#2)(2012-7#6)(2013-1#16)(2013-8#7)
elevates##7##1##(1990-2#1)(1994-2#1)(1994-6#1)(1997-1#1)(2010-12#2)(2013-1#1)
elevating##6##1##(1990-2#1)(1992-8#1)(1996-2#1)(1997-1#1)(2008-10#2)
elevation acute##2##2##(2008-3#1)(2012-3#1)
elevation in circulating##2##3##(2008-10#1)(2012-2#1)
elevation in##13##2##(1990-6#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
elevation is##3##2##(1990-5#1)(1990-8#1)(1994-6#1)
elevation myocardial infarction##5##3##(2008-11#1)(2008-3#3)(2013-8#1)
elevation of IOP##2##3##(2011-2#2)
elevation of [Ca2+]c##2##3##(1991-12#1)(1995-8#1)
elevation of [Ca2+]i##2##3##(2011-3#2)
elevation of intracellular##3##3##(1990-2#1)(1990-8#1)(2008-11#1)
elevation of the##8##3##(1994-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-5#1)(2011-2#1)
elevation of##41##2##(1990-2#2)(1990-8#1)(1991-12#2)(1991-5#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-6#1)(1995-8#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-5#1)(2011-2#3)(2011-3#2)
elevation populations of##2##3##(2012-7#2)
elevation populations##3##2##(2012-7#3)
elevation##92##1##(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-2#2)(1994-6#2)(1995-6#1)(1995-8#2)(1997-1#1)(1997-3#2)(2006-6#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#3)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-11#1)(2010-5#1)(2011-2#3)(2011-3#2)(2012-2#2)(2012-3#3)(2012-7#3)(2013-1#1)(2013-8#1)
elevations and##2##2##(2008-10#1)(2008-8#1)
elevations in##4##2##(1992-12#1)(1992-6#1)(1995-8#1)(2008-3#1)
elevations with a central pore##2##5##(2007-12#2)
elevations##22##1##(1992-12#1)(1992-3#1)(1992-6#1)(1994-6#1)(1995-8#1)(2007-12#2)(2008-10#7)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2012-6#1)(2012-7#2)
eleven of##3##2##(2008-10#1)(2013-1#1)(2013-7#1)
eleven subjects##2##2##(2008-5#1)(2010-6#1)
eleven##22##1##(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#3)(2010-6#1)(2012-3#3)(2013-1#2)(2013-7#1)
eleventh##2##1##(1995-5#1)(2012-12#1)
elicit AF##2##2##(2011-2#2)
elicit a##6##2##(1991-5#1)(1993-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-8#1)
elicit an##2##2##(2008-10#1)(2008-12#1)
elicit significant##2##2##(2008-10#1)(2008-9#1)
elicit the##5##2##(1991-2#1)(2008-11#2)(2009-5#1)(2013-8#1)
elicit their##2##2##(1994-11#1)(2009-12#1)
elicit##59##1##(1990-5#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-12#1)(1994-11#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#3)(1996-12#2)(1996-2#1)(2008-10#8)(2008-11#12)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
elicitation of the##3##3##(2008-10#2)(2008-4#1)
elicitation of##5##2##(2008-10#3)(2008-4#2)
elicitation phase##2##2##(2008-10#2)
elicitation##11##1##(2008-10#8)(2008-4#2)(2011-10#1)
elicited a##10##2##(1991-2#1)(1991-9#1)(1994-11#1)(2008-10#3)(2010-1#2)(2013-8#2)
elicited by Pseudomonas##2##3##(2008-10#2)
elicited by both##2##3##(2008-10#2)
elicited by in vitro immunization##2##5##(2008-11#2)
elicited by noradrenaline##2##3##(1997-4#2)
elicited by the##9##3##(1995-5#1)(1997-2#1)(2008-10#4)(2008-11#2)(2009-8#1)
elicited by##44##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2008-10#15)(2008-11#5)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#2)(2010-9#1)(2013-8#3)
elicited in##3##2##(1993-8#1)(1994-8#1)(1996-2#1)
elicited only##2##2##(1993-8#1)(1994-3#1)
elicited systemic##2##2##(2008-10#2)
elicited the##3##2##(1994-3#1)(1995-12#1)(2008-10#1)
elicited##88##1##(1990-2#1)(1990-5#1)(1991-2#3)(1991-9#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-8#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#3)(1997-4#3)(1997-7#1)(1997-8#1)(2008-10#24)(2008-11#9)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-10#1)(2012-12#1)(2013-8#6)
elicitin production##3##2##(2008-10#3)
elicitin##10##1##(2008-10#10)
eliciting a##3##2##(1996-12#1)(2008-12#1)(2013-8#1)
eliciting the##2##2##(2008-10#2)
eliciting##17##1##(1992-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#2)
elicitins##6##1##(2008-10#6)
elicitor in##2##2##(2008-10#2)
elicitor properties##3##2##(2008-10#3)
elicitor##23##1##(2008-10#23)
elicitors of##2##2##(2008-10#2)
elicitors##8##1##(2008-10#8)
elicits a##2##2##(1994-8#1)(2013-8#1)
elicits##12##1##(1992-9#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-8#1)(2013-8#1)
eligibility criteria##3##2##(2010-10#1)(2013-1#2)
eligibility on##2##2##(1992-2#1)(1996-1#1)
eligibility##19##1##(1992-2#5)(1993-6#1)(1994-2#3)(1995-12#2)(1995-2#1)(1996-1#1)(1997-2#2)(2008-12#1)(2010-10#1)(2013-1#2)
eligible for##15##2##(1990-6#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-1#1)(1997-7#3)(2007-12#1)(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#2)
eligible patients were##2##3##(1997-7#1)(2012-2#1)
eligible patients##7##2##(1991-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-2#1)(2013-1#1)
eligible physicians and##2##3##(1992-3#1)(2008-11#1)
eligible##36##1##(1990-6#2)(1991-2#1)(1992-3#1)(1994-2#1)(1995-12#4)(1995-2#2)(1996-1#1)(1996-2#1)(1997-2#4)(1997-7#4)(2007-12#1)(2008-10#2)(2008-11#2)(2010-10#2)(2012-2#1)(2012-3#1)(2013-1#6)
eligibles##2##1##(1995-12#2)
eliminate any##3##2##(1994-3#2)(2008-10#1)
eliminate much of the##2##4##(1996-2#1)(2010-11#1)
eliminate the##26##2##(1992-2#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-3#2)(2008-8#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-8#1)
eliminate this##2##2##(1995-6#1)(1996-1#1)
eliminate##64##1##(1992-2#1)(1992-9#2)(1994-12#1)(1994-3#3)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#2)(2007-12#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#2)(2009-4#1)(2010-11#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
eliminated by a##4##3##(1991-12#1)(2008-10#2)(2008-11#1)
eliminated by the##8##3##(2008-10#7)(2008-7#1)
eliminated by##39##2##(1991-12#1)(1991-5#1)(1994-11#1)(1996-1#1)(2008-10#24)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
eliminated due to##2##3##(1991-6#1)(2013-8#1)
eliminated from the##2##3##(2008-10#1)(2008-7#1)
eliminated from##3##2##(1992-1#1)(2008-10#1)(2008-7#1)
eliminated in##4##2##(1991-12#1)(1994-9#1)(1995-12#1)(2008-10#1)
eliminated the need for##3##4##(1996-1#1)(2008-11#2)
eliminated the need to##2##4##(2008-10#1)(2008-11#1)
eliminated the need##5##3##(1996-1#1)(2008-10#1)(2008-11#3)
eliminated the##10##2##(1990-3#1)(1996-1#1)(2008-10#4)(2008-11#4)
eliminated using##2##2##(2008-10#1)(2008-11#1)
eliminated with the##2##3##(2008-10#2)
eliminated with##6##2##(2007-12#1)(2008-10#5)
eliminated##116##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-9#1)(1997-8#1)(2007-12#1)(2008-10#63)(2008-11#11)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#4)
eliminates the need for a##2##5##(1992-1#1)(2012-3#1)
eliminates the need for##6##4##(1992-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2012-3#1)
eliminates the need##7##3##(1992-1#1)(2007-11#1)(2008-10#3)(2008-4#1)(2012-3#1)
eliminates the##13##2##(1992-1#1)(1995-1#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
eliminates##24##1##(1992-1#1)(1994-2#1)(1995-1#1)(1996-3#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
eliminating the interference##2##3##(2008-10#2)
eliminating the need for##2##4##(2008-10#2)
eliminating the##14##2##(1996-2#2)(2008-10#9)(2008-3#1)(2010-1#1)(2011-2#1)
eliminating##31##1##(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
elimination at##2##2##(1997-2#1)(2012-3#1)
elimination by##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
elimination from the##2##3##(1996-12#1)(2008-10#1)
elimination from##5##2##(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
elimination in the##2##3##(2008-1#1)(2008-11#1)
elimination in##5##2##(2007-11#1)(2008-1#2)(2008-11#1)(2008-12#1)
elimination of interferences##4##3##(2008-10#4)
elimination of methanol##2##3##(1996-5#2)
elimination of some##2##3##(1997-7#1)(2008-10#1)
elimination of the##7##3##(1991-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
elimination of##60##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#4)(1997-7#1)(2007-12#1)(2008-10#20)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#4)(2013-1#1)
elimination process##2##2##(1994-2#1)(2008-11#1)
elimination programmes##2##2##(2008-1#2)
elimination rate##3##2##(1994-5#1)(2008-11#1)(2008-5#1)
elimination voltammetry##4##2##(2008-10#4)
elimination##124##1##(1990-11#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1994-2#2)(1994-5#2)(1994-9#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#4)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#7)(2008-10#42)(2008-11#13)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#8)(2012-3#3)(2013-1#1)
elite L##2##2##(2008-10#2)
elite and high-performance##2##3##(2011-2#2)
elite and##3##2##(2011-2#3)
elite athletes##2##2##(2010-1#1)(2013-1#1)
elite inbreds##2##2##(2008-10#1)(2008-9#1)
elite junior##2##2##(2011-2#2)
elite winter wheat##2##3##(2008-10#2)
elite##34##1##(1990-6#1)(1993-2#1)(1993-6#1)(1996-6#1)(1996-8#1)(2008-10#11)(2008-12#2)(2008-9#1)(2009-1#2)(2009-7#3)(2010-1#1)(2011-2#8)(2013-1#1)
ellipse##3##1##(2007-11#1)(2008-10#2)
ellipsoidal##3##1##(2008-10#2)(2008-7#1)
ellipsometry##9##1##(2008-10#4)(2008-3#5)
ellipsospora##2##1##(2008-10#2)
elliptic##6##1##(2007-11#1)(2008-2#2)(2008-3#2)(2010-8#1)
elliptical##11##1##(2007-11#1)(2008-10#3)(2008-3#6)(2008-7#1)
elliptical-core fibers##2##2##(2008-3#2)
elliptical-core##4##1##(2008-3#4)
elliptically polarized light##2##3##(2007-11#1)(2007-12#1)
elliptically polarized##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
ellipticity##6##1##(2007-11#1)(2008-10#1)(2008-3#4)
elm##7##1##(2008-10#7)
elongate##7##1##(2007-12#1)(2008-6#2)(2008-7#2)(2012-2#2)
elongated fragments##3##2##(1991-12#1)(1994-8#2)
elongated##27##1##(1990-6#1)(1991-12#3)(1994-5#1)(1994-8#5)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#2)(2013-8#1)
elongating##7##1##(2008-10#2)(2009-10#1)(2011-2#1)(2012-2#3)
elongation and##9##2##(1994-11#1)(1996-5#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-1#1)
elongation factor##12##2##(1996-2#2)(2008-10#7)(2008-11#1)(2008-8#1)(2012-12#1)
elongation of##5##2##(1994-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
elongation rate##2##2##(2008-10#1)(2008-7#1)
elongation##62##1##(1990-5#2)(1991-12#2)(1993-5#1)(1994-11#1)(1994-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(2008-1#1)(2008-10#21)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#1)
eloquent areas##4##2##(1996-3#1)(2008-7#2)(2012-3#1)
eloquent cortex##2##2##(2008-7#1)(2009-9#1)
eloquent##8##1##(1996-3#1)(2008-7#3)(2009-9#1)(2011-2#1)(2012-3#2)
else##8##1##(1994-3#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-11#1)(2012-12#1)
elsevier##6##1##(2008-10#3)(2008-11#3)
elsewhere in the body##2##4##(2010-6#1)(2011-2#1)
elsewhere in the series##3##4##(2008-4#3)
elsewhere in the##10##3##(2008-10#4)(2008-4#4)(2010-6#1)(2011-2#1)
elsewhere in##15##2##(1996-1#1)(2008-10#6)(2008-11#2)(2008-4#4)(2010-6#1)(2011-2#1)
elsewhere##43##1##(1990-6#1)(1991-2#1)(1992-2#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-4#5)(2008-8#1)(2010-10#1)(2010-6#1)(2011-2#5)
eluant##5##1##(2008-10#5)
eluate is##2##2##(2008-10#1)(2008-5#1)
eluate was##6##2##(1993-2#1)(2008-10#5)
eluate##17##1##(1990-2#1)(1993-2#1)(2008-10#14)(2008-5#1)
eluates##8##1##(2008-10#8)
elucidate a potential##2##3##(2008-10#1)(2009-6#1)
elucidate genetic mechanisms of##2##4##(2008-10#2)
elucidate the effect of##2##4##(2008-10#1)(2008-8#1)
elucidate the mechanisms of##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
elucidate the mechanisms##6##3##(1995-8#1)(1997-3#1)(2008-10#2)(2012-12#1)(2012-2#1)
elucidate the molecular mechanism of##2##5##(2008-10#1)(2008-9#1)
elucidate the molecular mechanism##3##4##(2008-10#1)(2008-9#1)(2009-8#1)
elucidate the molecular##5##3##(1997-7#1)(2008-10#2)(2008-9#1)(2009-8#1)
elucidate the role of the##3##5##(1992-3#1)(1992-6#1)(2008-5#1)
elucidate the role of##10##4##(1990-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1995-2#1)(2008-10#2)(2008-5#1)(2009-8#1)(2013-7#1)
elucidate the##74##2##(1990-2#1)(1991-5#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#22)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-6#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-6#1)(2013-7#1)(2013-8#1)
elucidate##104##1##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#38)(2008-11#7)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-6#1)(2013-7#1)(2013-8#1)
elucidated and##3##2##(1991-6#1)(1995-9#1)(2008-10#1)
elucidated by##6##2##(2008-10#2)(2008-11#1)(2008-2#1)(2010-6#1)(2011-3#1)
elucidated from the##2##3##(2008-10#1)(2010-10#1)
elucidated in detail##2##3##(1996-5#1)(2008-10#1)
elucidated in##3##2##(1996-5#1)(2008-10#2)
elucidated the##2##2##(1996-2#1)(2008-12#1)
elucidated with##2##2##(2011-2#2)
elucidated##61##1##(1990-2#1)(1991-6#2)(1993-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#3)(2013-1#2)
elucidating the mechanisms of##2##4##(2008-10#1)(2008-8#1)
elucidating the##10##2##(1990-12#1)(1992-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-5#1)
elucidating##13##1##(1990-12#1)(1992-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-5#1)
elucidation of an extraction equilibrium##2##5##(2008-10#2)
elucidation of small molecules using mass spectrometry##2##7##(2011-2#2)
elucidation of small molecules##3##4##(2011-2#3)
elucidation of the##7##3##(2008-10#1)(2009-12#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
elucidation of##21##2##(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-2#4)(2012-2#1)(2013-1#1)
elucidation##23##1##(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#4)(2012-2#1)(2013-1#1)
eluent and##9##2##(2008-10#9)
eluent concentration##5##2##(2008-10#5)
eluent containing##4##2##(2008-10#4)
eluent flow##3##2##(2008-10#3)
eluent is##3##2##(2008-10#3)
eluent on##2##2##(2008-10#2)
eluent solution##2##2##(2008-10#2)
eluent type and##2##3##(2008-10#2)
eluent type##4##2##(2008-10#4)
eluent volume##4##2##(2008-10#4)
eluent was##3##2##(2008-10#3)
eluent##89##1##(2008-10#89)
eluents##6##1##(2008-10#6)
elusive##28##1##(1992-9#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
eluted and##2##2##(2008-10#2)
eluted as##2##2##(1997-2#1)(2008-10#1)
eluted at the##2##3##(2008-11#2)
eluted by 2M nitric acid and##2##6##(2008-10#2)
eluted by##8##2##(2008-10#8)
eluted directly##2##2##(2008-10#2)
eluted from a##2##3##(2008-10#2)
eluted from the column with##2##5##(1990-12#1)(2008-10#1)
eluted from the column##7##4##(1990-12#1)(2008-10#6)
eluted from the resin##2##4##(2008-10#2)
eluted from the##13##3##(1990-12#1)(2008-10#11)(2008-4#1)
eluted from##21##2##(1990-12#1)(1992-6#1)(2008-10#17)(2008-4#1)(2012-2#1)
eluted in the##4##3##(1993-6#1)(2008-10#3)
eluted in##6##2##(1993-6#1)(2008-10#5)
eluted metals##3##2##(2008-10#3)
eluted quantitatively##2##2##(1990-12#1)(2008-10#1)
eluted with 0##5##3##(2008-10#5)
eluted with 1##4##3##(2008-10#4)
eluted with 2 mol l(-1)##2##5##(2008-10#2)
eluted with 2##3##3##(2008-10#3)
eluted with a small volume of##2##6##(2008-10#2)
eluted with a##7##3##(2008-10#6)(2008-4#1)
eluted with an##2##3##(1992-6#1)(2008-10#1)
eluted with ethanol##3##3##(2008-10#3)
eluted with isobutyl methyl ketone (IBMK) and introduced##2##8##(2008-10#2)
eluted with##46##2##(1992-6#1)(2008-10#42)(2008-4#1)(2008-5#2)
eluted##116##1##(1990-12#2)(1992-6#2)(1993-2#1)(1993-6#1)(1996-2#1)(1997-2#1)(2008-10#101)(2008-11#2)(2008-4#2)(2008-5#2)(2012-2#1)
elutes##3##1##(2008-10#3)
eluting agent##2##2##(2008-10#2)
eluting from a##2##3##(2008-10#2)
eluting from##4##2##(1990-5#1)(2008-10#3)
eluting with##2##2##(2008-10#2)
eluting##24##1##(1990-5#1)(2008-10#22)(2008-11#1)
elution and##3##2##(2008-10#3)
elution by##3##2##(2008-10#3)
elution conditions were##2##3##(2008-10#2)
elution conditions##5##2##(2008-10#5)
elution flow rate##2##3##(2008-10#2)
elution flow##4##2##(2008-10#4)
elution for##2##2##(2008-10#2)
elution in##2##2##(2008-10#2)
elution is##3##2##(2008-10#3)
elution of Au##2##3##(2008-10#2)
elution of the##6##3##(2008-10#6)
elution of##25##2##(2008-10#25)
elution order of the enantiomers##2##5##(2008-10#2)
elution order of the##3##4##(2008-10#3)
elution order of##6##3##(2008-10#6)
elution order##7##2##(2008-10#7)
elution profile from##2##3##(1990-11#1)(2008-10#1)
elution profiles##2##2##(1990-12#1)(1994-8#1)
elution solution and interfering ions on the recovery of the##2##10##(2008-10#2)
elution solution and##3##3##(2008-10#3)
elution solution##5##2##(2008-10#5)
elution solvents##3##2##(2008-10#2)(2008-11#1)
elution using##2##2##(2008-10#1)(2009-8#1)
elution volume##3##2##(2008-10#3)
elution was##7##2##(2008-10#7)
elution were##2##2##(2008-10#2)
elution with 0##5##3##(2008-10#5)
elution with acetonitrile-water##2##3##(2008-10#2)
elution with##25##2##(1995-11#1)(2008-10#24)
elution##166##1##(1990-11#1)(1990-12#1)(1990-5#1)(1992-6#1)(1993-12#2)(1994-8#2)(1995-11#1)(1997-2#3)(2008-10#150)(2008-11#1)(2009-4#1)(2009-8#1)(2010-6#1)
elutriation##2##1##(2008-10#1)(2008-11#1)
em##2##1##(2008-5#2)
emaciation##2##1##(2008-5#1)(2011-2#1)
email##4##1##(1996-8#1)(2008-1#2)(2008-12#1)
emanate##2##1##(1995-8#1)(2008-11#1)
emanating from##7##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-12#1)
emanating##8##1##(1991-3#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-8#1)(2010-12#1)
embark on##3##2##(1994-2#1)(2008-12#1)(2010-12#1)
embarked on a##3##3##(1991-2#1)(1995-12#1)(1996-2#1)
embarked on##4##2##(1991-2#1)(1991-3#1)(1995-12#1)(1996-2#1)
embarrassment##4##1##(1996-5#1)(2008-12#1)(2013-8#2)
embed##2##1##(2008-11#1)(2008-12#1)
embedded and##3##2##(1991-2#1)(2009-12#1)(2011-2#1)
embedded in a##5##3##(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)
embedded in the##8##3##(1990-5#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)
embedded in##30##2##(1990-5#1)(1992-12#1)(1992-2#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)
embedded into##2##2##(1991-5#1)(2008-9#1)
embedded tissue##2##2##(1991-2#2)
embedded with##2##2##(2008-10#1)(2011-2#1)
embedded within the##2##3##(2009-7#1)(2012-2#1)
embedded within##5##2##(1997-7#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
embedded##65##1##(1990-5#1)(1991-2#3)(1991-5#1)(1992-12#1)(1992-2#1)(1993-9#1)(1995-3#1)(1996-12#1)(1997-7#2)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#3)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
embedding interprofessional##2##2##(2012-2#2)
embedding the vision##2##3##(2008-12#2)
embedding##13##1##(2008-10#3)(2008-12#4)(2008-6#1)(2008-7#3)(2012-2#2)
embeddings##2##1##(2008-6#2)
embelin content##2##2##(2012-2#2)
embelin##4##1##(2012-2#4)
embodied in the##2##3##(2009-10#1)(2010-10#1)
embodied in##3##2##(2009-10#1)(2010-10#1)(2010-7#1)
embodied##10##1##(1994-9#1)(2008-11#3)(2008-12#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-7#1)(2012-2#1)
embodies##4##1##(2009-10#2)(2012-2#2)
embodiment##2##1##(1996-6#1)(2009-10#1)
emboli##12##1##(1996-8#1)(1997-3#1)(2008-7#1)(2011-2#8)(2013-8#1)
embolic agents##2##2##(1996-9#2)
embolic stroke##2##2##(2008-10#1)(2008-7#1)
embolic##10##1##(1996-9#3)(2008-10#1)(2008-11#1)(2008-7#4)(2011-2#1)
embolisation in a vein of##2##5##(1996-6#2)
embolisation in##3##2##(1996-6#2)(1997-6#1)
embolisation of the##2##3##(1996-3#1)(1997-6#1)
embolisation of##7##2##(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#3)(2008-7#1)
embolisation was##3##2##(1996-3#1)(1996-6#1)(1997-3#1)
embolisation without##2##2##(1997-6#2)
embolisation##38##1##(1991-6#1)(1995-11#2)(1996-3#5)(1996-6#5)(1996-9#5)(1997-3#10)(1997-6#9)(2008-7#1)
embolisations##2##1##(1996-9#2)
embolised with acrylic glue##2##4##(1997-3#1)(1997-6#1)
embolised##8##1##(1996-3#1)(1997-3#2)(1997-6#5)
embolism and##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
embolism in##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
embolism through a patent foramen ovale##2##6##(2008-7#2)
embolism##44##1##(1991-11#7)(1991-3#1)(1992-5#1)(1993-9#1)(2008-10#2)(2008-12#1)(2008-7#12)(2009-10#1)(2010-1#1)(2010-10#2)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
embolization alone##2##2##(2008-7#1)(2012-3#1)
embolization and##3##2##(2008-7#3)
embolization in the##2##3##(2008-7#1)(2010-11#1)
embolization in##5##2##(1997-8#1)(2008-7#2)(2009-10#1)(2010-11#1)
embolization is##2##2##(2008-7#1)(2012-3#1)
embolization of cerebral arteriovenous##2##4##(2008-7#2)
embolization of cerebral##3##3##(2008-7#3)
embolization of##13##2##(1997-8#1)(2008-7#7)(2009-9#2)(2012-3#2)(2013-8#1)
embolization therapy##2##2##(2008-7#2)
embolization to##3##2##(1991-2#1)(2008-7#1)(2013-1#1)
embolization with##3##2##(1991-2#1)(2008-7#1)(2012-3#1)
embolization##64##1##(1991-2#2)(1997-8#4)(2008-11#2)(2008-12#2)(2008-7#33)(2009-10#1)(2009-9#3)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#10)(2013-1#2)(2013-8#1)
embolized##3##1##(1991-2#1)(2008-7#2)
embossed##2##1##(2008-3#2)
embossing##2##1##(2008-3#2)
embrace the##2##2##(2008-11#1)(2010-8#1)
embrace##5##1##(1994-1#1)(2008-11#1)(2008-8#1)(2010-7#1)(2010-8#1)
embraced##2##1##(2008-7#1)(2013-1#1)
embracement##4##1##(2011-2#3)(2012-3#1)
embracing the##2##2##(1992-12#1)(1997-1#1)
embracing##3##1##(1992-12#1)(1997-1#1)(2008-11#1)
embryo calvaria cell cultures##2##4##(1990-11#2)
embryo concentration##2##2##(2008-9#2)
embryo development##8##2##(2008-5#1)(2008-9#2)(2009-8#3)(2011-2#2)
embryo fibroblasts and##3##3##(1991-5#1)(1993-6#1)(1993-8#1)
embryo fibroblasts##13##2##(1991-5#2)(1991-6#1)(1993-6#3)(1993-8#2)(1995-11#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-11#1)
embryo formation##3##2##(2009-8#1)(2011-2#2)
embryo from##2##2##(2008-10#2)
embryo implantation and##2##3##(2008-9#1)(2013-1#1)
embryo implantation##4##2##(1994-8#1)(2008-9#2)(2013-1#1)
embryo or female PGCs to##2##5##(2008-11#2)
embryo proteins from##2##3##(2008-10#2)
embryo proteins##3##2##(2008-10#3)
embryo sac and##2##3##(2009-12#2)
embryo sac##10##2##(2008-11#4)(2009-12#3)(2009-8#3)
embryo sacs of##3##3##(2008-11#2)(2008-9#1)
embryo sacs##6##2##(2008-10#1)(2008-11#4)(2008-9#1)
embryo to##3##2##(2007-12#1)(2008-11#1)(2012-3#1)
embryo transfer##5##2##(1994-8#1)(1996-8#1)(1996-9#1)(2008-11#1)(2012-3#1)
embryo##124##1##(1990-11#2)(1990-3#1)(1990-8#1)(1991-5#2)(1991-6#1)(1992-5#1)(1993-12#4)(1993-2#1)(1993-6#3)(1993-8#2)(1994-12#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-7#1)(2007-12#7)(2008-10#15)(2008-11#20)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-9#15)(2009-12#3)(2009-8#9)(2010-1#1)(2010-11#2)(2011-1#2)(2011-2#5)(2012-3#5)(2013-1#2)(2013-8#1)
embryo)##2##1##(2008-11#2)
embryo-fetal##3##1##(2011-2#3)
embryogenesis abundant##3##2##(2008-10#2)(2008-9#1)
embryogenesis in##2##2##(2008-11#1)(2009-8#1)
embryogenesis of##2##2##(2008-10#1)(2009-7#1)
embryogenesis##32##1##(1993-6#2)(1995-2#1)(1995-8#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#3)(2009-7#2)(2009-8#5)(2011-2#1)(2013-1#1)
embryogenic##3##1##(2008-12#1)(2008-9#2)
embryoid bodies (EBs)##5##3##(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)
embryoid##7##1##(2008-10#1)(2008-11#3)(2008-9#2)(2011-2#1)
embryological limb development##2##3##(2009-3#2)
embryological##7##1##(2008-10#2)(2009-3#2)(2009-8#1)(2013-1#2)
embryology and##2##2##(2008-12#1)(2011-3#1)
embryology laboratory##2##2##(2008-11#2)
embryology##9##1##(1990-6#1)(2008-11#4)(2008-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
embryonal carcinoma cells##2##3##(1995-2#1)(2013-1#1)
embryonal carcinoma##3##2##(1995-2#1)(2013-1#2)
embryonal histology##2##2##(2013-1#2)
embryonal##13##1##(1994-11#1)(1995-2#1)(2008-11#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#5)
embryonated eggs##3##2##(2008-5#3)
embryonic and##6##2##(2008-11#3)(2009-3#1)(2012-5#1)(2013-1#1)
embryonic brain of the grasshopper Schistocerca gregaria##4##7##(2007-12#4)
embryonic brain##6##2##(2007-12#4)(2008-8#1)(2008-9#1)
embryonic chick##3##2##(1996-2#1)(2008-11#1)(2008-9#1)
embryonic day 12##2##3##(2008-10#1)(2008-7#1)
embryonic day 15##3##3##(1993-3#1)(1994-2#1)(1996-12#1)
embryonic day##10##2##(1993-3#2)(1994-2#1)(1996-12#2)(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)
embryonic days##2##2##(1994-3#1)(1996-12#1)
embryonic development and##2##3##(1993-12#1)(2009-3#1)
embryonic development##16##2##(1993-12#1)(1994-11#1)(1995-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-5#2)(2012-2#3)
embryonic fibroblasts##8##2##(1997-1#2)(2008-11#1)(2008-2#2)(2008-4#1)(2013-1#2)
embryonic lethal##2##2##(1995-2#1)(2008-8#1)
embryonic liver##3##2##(2013-1#3)
embryonic reproductive##2##2##(2008-11#2)
embryonic stages##4##2##(1993-6#1)(1995-12#1)(1996-2#2)
embryonic stem (ES) cell##2##4##(2008-11#2)
embryonic stem (ES) cells##4##4##(1997-8#1)(2008-11#2)(2009-12#1)
embryonic stem (ES)##6##3##(1997-8#1)(2008-11#4)(2009-12#1)
embryonic stem cell research##2##4##(2008-11#1)(2008-9#1)
embryonic stem cell##11##3##(2008-11#4)(2008-8#3)(2008-9#2)(2010-7#1)(2011-2#1)
embryonic stem cells (ESCs)##2##4##(2008-9#2)
embryonic stem cells (hESCs)##2##4##(2008-9#1)(2012-5#1)
embryonic stem cells are##2##4##(2008-11#1)(2008-8#1)
embryonic stem cells in##3##4##(2008-11#2)(2012-3#1)
embryonic stem cells##33##3##(1995-2#3)(1997-8#1)(2008-10#1)(2008-11#16)(2008-4#1)(2008-8#1)(2008-9#6)(2009-3#1)(2010-10#1)(2012-3#1)(2012-5#1)
embryonic stem##51##2##(1995-2#3)(1997-8#2)(2008-10#1)(2008-11#24)(2008-4#1)(2008-8#5)(2008-9#8)(2009-12#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2012-5#1)
embryonic##172##1##(1990-5#2)(1990-8#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#7)(1996-12#6)(1996-2#3)(1997-1#3)(1997-8#2)(2007-12#7)(2008-10#4)(2008-11#48)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#10)(2008-9#17)(2009-1#1)(2009-12#1)(2009-3#4)(2010-10#1)(2010-5#2)(2010-7#4)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#7)(2012-5#3)(2013-1#8)
embryos and fry##2##3##(2008-6#2)
embryos and##10##2##(2008-10#3)(2008-6#2)(2008-9#1)(2009-12#3)(2009-8#1)
embryos are##4##2##(2008-10#1)(2008-11#1)(2009-5#2)
embryos at##3##2##(1997-9#1)(2009-12#1)(2011-2#1)
embryos by##5##2##(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
embryos correlates with##2##3##(2008-5#1)(2009-8#1)
embryos derived from##4##3##(2008-11#1)(2008-9#3)
embryos developing##2##2##(2008-11#1)(2009-12#1)
embryos for##2##2##(2008-11#2)
embryos from##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
embryos in the##3##3##(2007-12#2)(2008-8#1)
embryos in##6##2##(1992-3#2)(2007-12#2)(2008-8#1)(2008-9#1)
embryos of##7##2##(1993-3#1)(1997-7#1)(2008-10#3)(2008-8#1)(2009-7#1)
embryos on each explant##2##4##(2008-12#2)
embryos that##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
embryos treated with##2##3##(1993-12#1)(2008-11#1)
embryos were##15##2##(1993-12#2)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#3)(2009-12#1)
embryos##163##1##(1990-5#1)(1991-3#1)(1991-5#1)(1992-3#2)(1993-12#7)(1993-2#1)(1993-3#4)(1993-6#2)(1994-11#2)(1994-3#1)(1995-2#3)(1995-8#1)(1996-8#6)(1997-7#6)(1997-8#1)(1997-9#1)(2007-12#4)(2008-10#14)(2008-11#23)(2008-12#7)(2008-2#2)(2008-4#3)(2008-5#11)(2008-6#5)(2008-8#10)(2008-9#20)(2009-12#7)(2009-5#2)(2009-7#2)(2009-8#4)(2011-2#4)(2012-3#4)(2013-1#1)
emerge as##2##2##(1995-3#1)(2008-11#1)
emerge by##2##2##(2008-11#1)(2008-9#1)
emerge from this##2##3##(2008-11#1)(2008-8#1)
emerge from##8##2##(2008-11#3)(2008-2#1)(2008-8#1)(2009-6#1)(2010-11#1)(2012-2#1)
emerge in##4##2##(1995-1#1)(1996-2#1)(1996-5#1)(2009-10#1)
emerge when##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
emerge##40##1##(1990-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-6#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
emerged as a major##3##4##(1993-3#1)(2008-9#1)(2013-1#1)
emerged as a promising##2##4##(2008-9#1)(2010-8#1)
emerged as a##17##3##(1993-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
emerged as an important##4##4##(2008-11#1)(2008-5#1)(2010-7#1)(2013-3#1)
emerged as an##10##3##(1995-11#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-2#1)(2013-3#1)
emerged as the##5##3##(1992-12#1)(1997-1#1)(2008-9#1)(2009-3#1)(2011-7#1)
emerged as##41##2##(1992-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-3#1)(2013-8#3)
emerged at##2##2##(2008-10#1)(2009-6#1)
emerged between##2##2##(1997-8#1)(2008-10#1)
emerged for the##2##3##(2010-7#1)(2012-2#1)
emerged for##6##2##(2008-12#2)(2009-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
emerged from a##2##3##(2008-10#1)(2008-11#1)
emerged from the analysis##2##4##(2008-11#1)(2013-1#1)
emerged from the data##2##4##(2008-11#1)(2010-12#1)
emerged from the fiber##2##4##(2008-10#1)(2008-3#1)
emerged from the##13##3##(1994-12#1)(1996-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2010-12#1)(2010-7#1)(2013-1#2)
emerged from##23##2##(1991-12#1)(1994-12#1)(1996-8#1)(2008-10#8)(2008-11#7)(2008-3#1)(2010-12#1)(2010-7#1)(2013-1#2)
emerged in the##5##3##(1990-6#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-10#1)
emerged in##16##2##(1990-6#1)(1990-8#2)(1991-3#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-1#2)(2010-10#1)(2010-6#1)(2012-12#1)(2012-2#1)
emerged over the##2##3##(2008-10#1)(2013-8#1)
emerged that##2##2##(1996-1#1)(2008-10#1)
emerged which##3##2##(1994-12#1)(2008-11#1)(2010-10#1)
emerged with##2##2##(1990-12#1)(2008-10#1)
emerged##152##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-12#4)(1995-11#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#28)(2008-11#22)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#9)(2013-3#1)(2013-8#5)
emergence and##4##2##(2008-10#3)(2013-1#1)
emergence by##6##2##(2008-10#5)(2008-8#1)
emergence from##2##2##(2008-10#2)
emergence inhibitors##3##2##(2008-10#3)
emergence of a new##4##4##(1994-1#1)(1994-12#1)(2008-10#2)
emergence of a##8##3##(1991-3#1)(1994-1#1)(1994-12#1)(2008-10#2)(2008-11#2)(2011-2#1)
emergence of extensively##2##3##(2008-10#1)(2010-5#1)
emergence of new##2##3##(1994-1#1)(2008-10#1)
emergence of resistance to##2##4##(2008-11#1)(2010-11#1)
emergence of resistance##3##3##(2008-11#2)(2010-11#1)
emergence of sociality##2##3##(2008-8#2)
emergence of these##2##3##(2008-10#1)(2010-5#1)
emergence of this##3##3##(2008-10#2)(2012-2#1)
emergence of viral##2##3##(1996-1#1)(2013-1#1)
emergence of##62##2##(1991-3#2)(1994-1#2)(1994-12#1)(1994-3#2)(1996-1#1)(2008-10#12)(2008-11#13)(2008-8#5)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#4)(2011-3#1)(2011-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
emergence to##2##2##(2008-10#2)
emergence##106##1##(1991-3#2)(1994-1#2)(1994-12#1)(1994-3#2)(1996-1#1)(2008-10#50)(2008-11#13)(2008-12#2)(2008-8#6)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#4)(2011-3#1)(2011-9#1)(2012-2#1)(2013-1#5)(2013-8#1)
emergencies in##13##2##(1995-12#1)(2008-1#2)(2008-10#1)(2008-11#4)(2009-4#1)(2009-9#1)(2011-2#2)(2012-12#1)
emergencies were##2##2##(2008-1#1)(2011-2#1)
emergencies##32##1##(1991-6#1)(1992-5#1)(1994-12#3)(1995-12#1)(1997-8#1)(2008-1#5)(2008-10#1)(2008-11#4)(2009-4#1)(2009-9#1)(2010-9#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2013-1#2)
emergency and##2##2##(1990-3#1)(1995-5#1)
emergency caesarean##2##2##(1994-3#1)(2011-2#1)
emergency care##6##2##(1991-6#1)(1995-2#2)(2008-11#1)(2008-4#1)(2009-6#1)
emergency contraception##2##2##(2008-11#1)(2011-2#1)
emergency cover##2##2##(1990-3#1)(2011-2#1)
emergency department (ED)##6##3##(2008-11#1)(2009-6#2)(2010-8#1)(2011-9#1)(2012-2#1)
emergency department##50##2##(1991-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-12#2)(2006-5#2)(2008-10#2)(2008-11#8)(2008-3#9)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-9#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-2#2)(2012-3#1)(2013-1#3)
emergency departments (EDs)##2##3##(2008-11#1)(2008-7#1)
emergency departments##8##2##(1991-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-9#1)(2012-3#1)(2013-8#1)
emergency drugs and equipment##2##4##(2008-1#2)
emergency medical care##3##3##(1997-8#1)(2010-8#2)
emergency medical##7##2##(1996-3#2)(1997-8#1)(2007-9#1)(2010-8#3)
emergency medicine in##2##3##(2008-11#1)(2009-4#1)
emergency medicine##9##2##(2008-11#3)(2009-4#1)(2009-6#4)(2011-2#1)
emergency nurses##7##2##(2008-11#5)(2013-1#2)
emergency nursing##7##2##(2008-11#3)(2013-1#4)
emergency obstetric##2##2##(1994-1#1)(2010-11#1)
emergency operation##2##2##(1997-8#1)(2011-2#1)
emergency postpartum hysterectomy##2##3##(1995-12#2)
emergency procedure##2##2##(1992-5#1)(2008-7#1)
emergency response##3##2##(1991-3#1)(1992-12#1)(2008-7#1)
emergency room##16##2##(1992-2#1)(1992-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
emergency service##2##2##(1994-5#1)(2012-3#1)
emergency services##6##2##(1993-11#1)(1993-12#3)(2008-11#1)(2012-3#1)
emergency surgery##7##2##(1991-3#2)(1992-9#2)(2008-11#1)(2008-7#2)
emergency treatment##4##2##(1996-1#1)(2007-9#1)(2010-8#1)(2013-1#1)
emergency##223##1##(1990-3#2)(1991-12#1)(1991-2#1)(1991-3#5)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-5#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-5#3)(1997-8#2)(2006-5#4)(2007-12#3)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#28)(2008-12#1)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#11)(2008-8#3)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#5)(2009-6#9)(2009-9#4)(2010-1#1)(2010-11#3)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#8)(2011-1#3)(2011-2#13)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#24)(2013-8#2)
emergent literacy skills##2##3##(2011-2#2)
emergent literacy##6##2##(2009-9#1)(2011-2#5)
emergent##20##1##(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-1#1)(2009-9#1)(2010-1#2)(2010-4#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-8#1)
emerges as a##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
emerges for##2##2##(1992-9#1)(2012-2#1)
emerges from a##2##3##(2008-11#1)(2013-1#1)
emerges from##6##2##(1990-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
emerges that##2##2##(1990-9#1)(2011-2#1)
emerges##20##1##(1990-8#1)(1990-9#1)(1992-9#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
emerging and##7##2##(2008-10#2)(2008-11#1)(2010-10#2)(2012-2#1)(2013-1#1)
emerging as important##2##3##(2008-12#1)(2013-1#1)
emerging as##10##2##(1992-1#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
emerging clinical##3##2##(2009-11#1)(2011-2#1)(2013-1#1)
emerging disease##3##2##(2008-8#1)(2009-8#1)(2012-12#1)
emerging diseases##3##2##(2008-8#1)(2010-8#1)(2011-2#1)
emerging evidence of##2##3##(2008-4#1)(2010-8#1)
emerging evidence##6##2##(1994-5#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-8#1)(2012-12#1)
emerging field##3##2##(2009-12#1)(2009-7#1)(2013-8#1)
emerging from the##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
emerging from##9##2##(1994-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2010-6#1)(2013-1#1)
emerging health##3##2##(1997-3#1)(2008-7#1)(2012-2#1)
emerging imaging##2##2##(2012-2#2)
emerging in the##2##3##(2008-5#1)(2012-3#1)
emerging in##4##2##(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
emerging lateral roots##2##3##(2008-10#1)(2008-8#1)
emerging leaves##2##2##(2008-10#2)
emerging novel##2##2##(2009-12#1)(2013-1#1)
emerging pathogen##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
emerging pathogens##2##2##(1996-1#1)(2013-8#1)
emerging patient##2##2##(2009-5#1)(2010-8#1)
emerging role of##2##3##(2010-7#1)(2012-2#1)
emerging role##3##2##(2010-7#1)(2012-2#2)
emerging trends##4##2##(1994-2#1)(1997-2#1)(1997-3#1)(2008-12#1)
emerging viruses of##2##3##(2013-8#2)
emerging##167##1##(1990-8#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#1)(1996-1#3)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#5)(2008-10#21)(2008-11#9)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#10)(2011-1#1)(2011-2#11)(2012-12#2)(2012-2#12)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#7)
emery paper&gt##2##2##(2008-10#2)
emery##3##1##(2008-10#3)
emesis induced##2##2##(1994-12#1)(2010-12#1)
emesis was##3##2##(2008-8#1)(2010-12#2)
emesis##10##1##(1990-12#1)(1991-2#1)(1994-12#1)(2008-7#2)(2008-8#2)(2010-12#3)
emesis)##2##1##(2008-7#2)
emetic##5##1##(2011-2#5)
emetogenic##3##1##(2008-7#1)(2010-12#2)
emigrants##3##1##(2008-8#1)(2013-1#2)
emigrating##3##1##(2008-10#2)(2010-8#1)
emigration##3##1##(2008-8#3)
eminence##4##1##(1995-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
eminent##2##1##(1994-9#1)(2011-2#1)
emission and excitation spectra##2##4##(2008-10#2)
emission and solar absorption##2##4##(2008-3#2)
emission and##7##2##(2008-10#5)(2008-3#2)
emission at##8##2##(1991-5#1)(2008-10#4)(2008-2#2)(2008-3#1)
emission band##3##2##(2008-10#2)(2008-2#1)
emission based##2##2##(2008-10#2)
emission caused by##2##3##(2008-10#2)
emission characteristics##2##2##(2008-10#2)
emission computed tomography##8##3##(1994-1#2)(1995-5#1)(1996-12#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#1)
emission filter##2##2##(2008-10#1)(2008-9#1)
emission from the##4##3##(2008-10#3)(2008-9#1)
emission from##12##2##(1992-8#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-9#1)(2009-11#1)
emission generated##2##2##(2008-10#2)
emission in##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
emission intensities of the##2##4##(2008-10#2)
emission intensities##3##2##(2008-10#3)
emission intensity of##2##3##(2008-10#2)
emission intensity##11##2##(2008-10#11)
emission is##6##2##(2007-12#1)(2008-10#4)(2008-2#1)
emission line##2##2##(2008-10#1)(2008-3#1)
emission lines of##2##3##(2008-10#2)
emission lines##6##2##(2008-10#5)(2008-3#1)
emission maxima##7##2##(2008-10#7)
emission maximum at##4##3##(2008-10#1)(2008-3#1)(2008-8#2)
emission maximum##5##2##(2008-10#2)(2008-3#1)(2008-8#2)
emission monochromators##2##2##(2008-10#2)
emission of these##3##3##(2008-10#3)
emission of##38##2##(1990-9#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2011-3#1)(2012-2#1)
emission peak of##2##3##(2008-10#2)
emission peak##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
emission produced by##2##3##(2008-10#1)(2010-7#1)
emission radiation##2##2##(2008-10#1)(2008-7#1)
emission rate##3##2##(2008-11#1)(2011-10#2)
emission rates##4##2##(2008-11#1)(2011-10#3)
emission source##2##2##(2008-10#2)
emission sources##6##2##(2008-10#4)(2008-11#2)
emission spectra for##2##3##(2008-10#2)
emission spectra of##6##3##(1990-5#1)(2008-10#2)(2008-9#2)(2009-10#1)
emission spectra##14##2##(1990-5#1)(2008-10#8)(2008-3#2)(2008-9#2)(2009-10#1)
emission spectrometer##5##2##(2008-10#5)
emission spectrometric##4##2##(2008-10#4)
emission spectrometry (ICP OES) and##2##5##(2008-10#2)
emission spectrometry (ICP OES)##3##4##(2008-10#3)
emission spectrometry (ICP##4##3##(2008-10#4)
emission spectrometry (ICP-AES) with##2##4##(2008-10#2)
emission spectrometry (ICP-AES)##19##3##(2008-10#19)
emission spectrometry (ICP-OES) after##2##4##(2008-10#2)
emission spectrometry (ICP-OES)##13##3##(2008-10#13)
emission spectrometry coupled with##2##4##(2008-10#2)
emission spectrometry were##2##3##(2008-10#2)
emission spectrometry##109##2##(1992-3#1)(2008-10#108)
emission spectrophotometry##4##2##(2008-10#4)
emission spectroscopic##3##2##(2008-10#2)(2008-3#1)
emission spectroscopy (ICP-OES)##2##3##(2008-10#1)(2011-2#1)
emission spectroscopy in##2##3##(2008-10#2)
emission spectroscopy##21##2##(2008-10#15)(2008-5#1)(2010-11#3)(2011-2#2)
emission spectrum##2##2##(2008-10#2)
emission tomography in##3##3##(1996-2#1)(2008-12#1)(2008-7#1)
emission tomography##23##2##(1990-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#3)(2009-11#1)(2009-5#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
emission was monitored##3##3##(2008-10#3)
emission was observed##2##3##(2008-10#1)(2008-5#1)
emission was##9##2##(2008-10#8)(2008-5#1)
emission wavelength at##4##3##(2008-10#4)
emission wavelength of##8##3##(1997-2#1)(2008-10#7)
emission wavelength##22##2##(1991-3#1)(1997-2#1)(2008-10#19)(2008-3#1)
emission wavelengths in##2##3##(2008-10#1)(2009-12#1)
emission wavelengths of##2##3##(2008-10#2)
emission wavelengths were##4##3##(2008-10#3)(2008-3#1)
emission wavelengths##18##2##(2008-10#16)(2008-3#1)(2009-12#1)
emission were##5##2##(2008-10#4)(2011-10#1)
emission##515##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#3)(1992-11#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-3#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#4)(1997-2#1)(2007-12#4)(2008-1#2)(2008-10#366)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#36)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-5#1)(2010-1#1)(2010-11#4)(2010-12#3)(2010-7#2)(2011-1#1)(2011-10#7)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
emission)##2##1##(2007-12#1)(2008-10#1)
emissions and the##2##3##(2008-11#2)
emissions and working areas##6##4##(2008-10#6)
emissions and##9##2##(2008-10#7)(2008-11#2)
emissions are##2##2##(2007-12#1)(2008-10#1)
emissions by##3##2##(2008-11#2)(2008-3#1)
emissions for##3##2##(1991-6#1)(1996-3#1)(2008-10#1)
emissions from##10##2##(2007-12#2)(2008-11#2)(2008-3#3)(2011-10#1)(2011-2#2)
emissions in##2##2##(2008-11#1)(2013-8#1)
emissions of##7##2##(1991-6#2)(2008-10#1)(2008-11#2)(2011-10#2)
emissions##65##1##(1991-6#3)(1996-3#1)(2007-12#3)(2008-10#19)(2008-11#17)(2008-2#2)(2008-3#6)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2011-10#6)(2011-2#2)(2013-8#1)
emissions)##2##1##(2008-10#2)
emissive##2##1##(2008-3#1)(2009-5#1)
emissivity of the liquid##2##4##(2008-3#2)
emissivity##3##1##(2008-3#3)
emit fluorescence##2##2##(2008-10#1)(2008-8#1)
emit##8##1##(2008-10#3)(2008-11#3)(2008-4#1)(2008-8#1)
emits light##2##2##(2008-10#1)(2010-7#1)
emits##8##1##(1991-5#1)(2007-11#1)(2008-10#2)(2008-3#2)(2010-7#1)(2013-1#1)
emitted by a molecular fluorine##2##5##(2008-3#2)
emitted by a##3##3##(1992-1#1)(2008-3#2)
emitted by cars equipped with catalytic converters##2##7##(2008-11#2)
emitted by the##2##3##(2008-10#1)(2008-11#1)
emitted by##14##2##(1992-1#2)(2008-10#4)(2008-11#3)(2008-3#2)(2009-8#1)(2011-10#2)
emitted fluorescence##4##2##(2008-10#3)(2008-3#1)
emitted from the##3##3##(2008-10#2)(2008-11#1)
emitted from##5##2##(2008-10#4)(2008-11#1)
emitted light##2##2##(2008-10#2)
emitted##40##1##(1992-1#2)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#18)(2008-11#6)(2008-3#4)(2008-7#1)(2009-6#1)(2009-8#1)(2011-10#3)(2013-1#1)
emitter##11##1##(2007-12#5)(2008-10#3)(2008-3#3)
emitters##3##1##(2007-12#1)(2008-10#1)(2008-3#1)
emitting at##4##2##(2007-12#1)(2008-10#3)
emitting diode##14##2##(1991-2#1)(2008-10#11)(2008-11#1)(2008-7#1)
emitting##32##1##(1991-2#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#18)(2008-11#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-6#1)(2013-1#1)
emodin and physcion##2##3##(2008-10#2)
emodin##3##1##(2008-10#3)
emollient efficiency and activity##2##4##(2008-5#2)
emollient##5##1##(2008-5#5)
emotion and##4##2##(1996-2#1)(2008-4#1)(2009-1#1)(2011-2#1)
emotion expectancies##6##2##(2013-8#6)
emotion##35##1##(1990-11#1)(1996-2#1)(2008-11#13)(2008-4#1)(2009-1#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#7)
emotion-focused##4##1##(1991-1#3)(2008-1#1)
emotional and behavioral responses##2##4##(2010-1#2)
emotional and##9##2##(1991-2#1)(1992-3#1)(1995-1#1)(2008-11#2)(2010-1#2)(2012-2#1)(2013-8#1)
emotional assessment##2##2##(2008-5#2)
emotional behaviour##2##2##(2009-10#2)
emotional burnout##2##2##(2008-10#1)(2008-11#1)
emotional climate##2##2##(1990-11#1)(2010-10#1)
emotional distress during##2##3##(1992-2#1)(1995-1#1)
emotional distress##13##2##(1991-12#1)(1992-2#1)(1992-3#3)(1995-1#2)(1995-9#1)(1996-5#1)(2008-6#1)(2009-6#1)(2009-9#1)(2013-8#1)
emotional exhaustion##4##2##(1996-2#1)(2008-11#2)(2010-7#1)
emotional expression##3##2##(2010-10#1)(2013-8#2)
emotional expressions##5##2##(2008-11#5)
emotional face##2##2##(2008-11#1)(2009-4#1)
emotional factors##3##2##(1990-11#1)(2009-12#1)(2012-12#1)
emotional intelligence##2##2##(2008-11#1)(2013-1#1)
emotional labour##2##2##(2008-11#2)
emotional perspective##2##2##(2008-11#2)
emotional problems##3##2##(2009-11#1)(2011-2#1)(2013-8#1)
emotional processing##2##2##(2008-11#1)(2013-1#1)
emotional reactions##2##2##(1993-11#1)(2008-11#1)
emotional response##3##2##(1992-2#1)(2008-12#1)(2008-4#1)
emotional responses##3##2##(2008-11#1)(2009-10#1)(2010-9#1)
emotional stability##2##2##(1995-8#1)(2008-11#1)
emotional state##5##2##(2008-11#1)(2010-4#3)(2013-1#1)
emotional states##2##2##(2009-12#1)(2010-10#1)
emotional status##2##2##(2008-12#1)(2012-2#1)
emotional support from##2##3##(1994-1#1)(2009-7#1)
emotional support##4##2##(1994-1#1)(2008-12#1)(2009-7#1)(2013-1#1)
emotional well-being##4##2##(2008-7#1)(2012-12#1)(2013-1#2)
emotional##138##1##(1990-11#4)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#2)(1992-3#4)(1993-11#1)(1994-1#1)(1994-5#1)(1995-1#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#36)(2008-12#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#4)(2009-10#5)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-2#2)(2010-4#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#9)
emotionality and##2##2##(1994-2#1)(2010-10#1)
emotionality##5##1##(1993-3#1)(1994-2#2)(2010-10#2)
emotionally challenging situations##4##3##(2008-11#4)
emotionally challenging##6##2##(2008-11#5)(2008-7#1)
emotionally related events##2##3##(1991-2#2)
emotionally##16##1##(1991-2#2)(1991-8#1)(1995-1#1)(1995-12#1)(1997-1#1)(2008-11#7)(2008-12#1)(2008-7#1)(2013-8#1)
emotions and##6##2##(1994-2#1)(2008-11#3)(2011-2#1)(2013-1#1)
emotions as##2##2##(1997-3#1)(2009-10#1)
emotions in##3##2##(1997-2#1)(2013-8#2)
emotions of##2##2##(1990-11#1)(2013-8#1)
emotions##33##1##(1990-11#1)(1994-2#1)(1997-2#1)(1997-3#1)(2008-11#9)(2008-12#1)(2009-10#3)(2009-9#1)(2010-1#3)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#8)
empathic##2##1##(1995-5#1)(2011-2#1)
empathy##5##1##(1993-12#1)(1995-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
emphases on##2##2##(1992-1#2)
emphasis and##2##2##(1994-12#1)(2008-11#1)
emphasis has been on##2##4##(1993-2#1)(1996-6#1)
emphasis has been placed on##2##5##(2008-12#1)(2013-8#1)
emphasis has been##5##3##(1993-2#1)(1995-12#1)(1996-6#1)(2008-12#1)(2013-8#1)
emphasis has##6##2##(1993-2#2)(1995-12#1)(1996-6#1)(2008-12#1)(2013-8#1)
emphasis is needed##2##3##(1993-1#1)(2008-1#1)
emphasis is on##6##3##(1991-2#1)(1997-8#1)(2008-10#1)(2008-4#2)(2012-2#1)
emphasis is placed on##10##4##(1992-1#1)(1993-3#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)
emphasis is##23##2##(1991-2#1)(1992-1#1)(1993-1#1)(1993-3#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2012-2#1)
emphasis of##4##2##(1996-6#1)(2008-10#1)(2008-12#1)(2013-8#1)
emphasis on basic##2##3##(1991-12#1)(2009-3#1)
emphasis on primary##2##3##(1993-11#1)(1996-12#1)
emphasis on the importance of##2##5##(1991-3#1)(2010-10#1)
emphasis on the##32##3##(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-5#1)(1995-9#2)(1996-3#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
emphasis on##96##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#2)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-5#1)(2008-10#15)(2008-11#14)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
emphasis placed on the##2##4##(2008-11#1)(2012-2#1)
emphasis placed on##5##3##(1997-3#1)(2008-10#1)(2008-11#2)(2012-2#1)
emphasis should be placed on##3##5##(1997-3#1)(2008-10#1)(2008-11#1)
emphasis should be##5##3##(1997-3#1)(2008-10#2)(2008-11#2)
emphasis upon##2##2##(1992-1#1)(2013-8#1)
emphasis##156##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-9#2)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#24)(2008-11#23)(2008-12#5)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#5)
emphasise the importance of##3##4##(1991-6#1)(2008-11#2)
emphasise the##6##2##(1991-6#1)(2008-11#2)(2008-12#2)(2012-2#1)
emphasise##7##1##(1991-6#1)(1996-6#1)(2008-11#2)(2008-12#2)(2012-2#1)
emphasised in nursing education##2##4##(2008-11#2)
emphasised the##2##2##(2008-11#1)(2009-1#1)
emphasised##18##1##(1996-6#3)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#7)(2008-7#1)(2009-1#1)(2010-2#1)(2012-12#2)
emphasises##2##1##(2010-10#1)(2012-6#1)
emphasising##2##1##(2008-11#2)
emphasize that the##2##3##(1997-1#1)(2010-10#1)
emphasize that##9##2##(1990-9#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-2#1)
emphasize the importance of the##2##5##(1991-12#1)(2009-10#1)
emphasize the importance of##14##4##(1991-12#1)(1991-8#1)(1991-9#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)
emphasize the need for##4##4##(1993-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
emphasize the need##5##3##(1990-5#1)(1993-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
emphasize the role##2##3##(1993-6#1)(2008-11#1)
emphasize the##41##2##(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-6#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
emphasize##67##1##(1990-5#2)(1990-9#2)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-6#2)(1994-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)
emphasized by the##2##3##(1997-3#1)(2008-10#1)
emphasized for##2##2##(2008-10#1)(2009-3#1)
emphasized on##2##2##(2008-10#1)(2008-12#1)
emphasized that the##3##3##(1990-2#1)(1993-12#1)(1996-12#1)
emphasized that##7##2##(1990-2#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)
emphasized the importance of a##2##5##(2008-10#1)(2008-11#1)
emphasized the importance of##5##4##(2008-10#2)(2008-11#2)(2008-9#1)
emphasized the importance##6##3##(2008-10#2)(2008-11#2)(2008-9#1)(2010-4#1)
emphasized the need##2##3##(1990-3#1)(2008-11#1)
emphasized the##12##2##(1990-3#1)(1991-6#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-9#2)(2010-4#1)
emphasized##50##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-3#1)(1993-12#2)(1994-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-2#2)(2013-1#1)
emphasizes identification of##2##3##(1995-2#1)(2008-4#1)
emphasizes that##2##2##(1992-1#1)(2009-8#1)
emphasizes the importance of##5##4##(1991-6#1)(1996-3#1)(2009-11#1)(2009-7#2)
emphasizes the need for##4##4##(1991-2#2)(2008-10#1)(2008-12#1)
emphasizes the role of##3##4##(2010-8#1)(2012-3#1)(2013-1#1)
emphasizes the##27##2##(1990-5#1)(1991-2#4)(1991-6#1)(1992-1#1)(1993-1#1)(1995-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
emphasizes##44##1##(1990-5#1)(1991-2#4)(1991-6#1)(1992-1#3)(1993-1#1)(1994-2#1)(1994-6#1)(1995-2#2)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-3#1)(2012-3#5)(2013-1#3)(2013-8#1)
emphasizing that##2##2##(2008-11#1)(2012-3#1)
emphasizing the need##2##3##(1992-2#1)(1993-2#1)
emphasizing the##10##2##(1992-2#1)(1993-12#1)(1993-2#1)(2008-10#3)(2008-11#1)(2010-1#1)(2011-2#1)(2012-2#1)
emphasizing##20##1##(1991-6#1)(1992-2#1)(1993-12#2)(1993-2#1)(1994-12#1)(1997-2#1)(2008-10#4)(2008-11#2)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)
emphysema in##2##2##(1994-3#1)(2008-7#1)
emphysema##10##1##(1992-12#1)(1993-1#2)(1994-3#2)(2008-7#3)(2009-5#1)(2011-3#1)
emphysematous cystitis##3##2##(2012-3#3)
empiric therapy for##2##3##(2011-2#1)(2013-1#1)
empiric##6##1##(2007-11#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
empirical analysis of##2##3##(1992-2#1)(1996-2#1)
empirical analysis##3##2##(1992-2#1)(1994-1#1)(1996-2#1)
empirical approach##2##2##(2008-10#1)(2010-5#1)
empirical data that##2##3##(2008-8#1)(2008-9#1)
empirical data##8##2##(1992-12#1)(1996-3#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#1)(2011-3#1)
empirical evidence exists##3##3##(2008-11#1)(2008-8#2)
empirical evidence for##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)
empirical evidence to support the##2##5##(2008-11#1)(2008-7#1)
empirical evidence to support##3##4##(2008-11#1)(2008-7#1)(2013-8#1)
empirical evidence##14##2##(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#1)(2013-8#2)
empirical findings##4##2##(1992-1#1)(1992-9#1)(2008-11#1)(2013-8#1)
empirical model##2##2##(2008-2#1)(2008-3#1)
empirical or##2##2##(1993-12#1)(2010-10#1)
empirical perspective##2##2##(1991-12#1)(2010-4#1)
empirical relationship between##2##3##(2008-10#2)
empirical relationships##2##2##(2008-8#2)
empirical research that##3##3##(1996-3#1)(2008-12#1)(2010-10#1)
empirical research##7##2##(1993-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2012-2#1)
empirical results##5##2##(2008-10#1)(2008-8#3)(2013-1#1)
empirical studies in##3##3##(1996-1#1)(2008-11#1)(2013-1#1)
empirical studies##13##2##(1995-11#1)(1996-1#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-9#1)(2011-3#1)(2013-1#2)
empirical study##5##2##(1992-2#1)(1992-3#1)(2008-11#1)(2009-8#1)(2010-10#1)
empirical support##2##2##(2008-11#1)(2008-4#1)
empirical test of##2##3##(2008-12#1)(2008-9#1)
empirical test##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
empirical testing##3##2##(2007-9#1)(2008-12#2)
empirical tests##3##2##(1993-3#1)(2008-8#2)
empirical treatment##3##2##(1996-11#1)(2008-11#1)(2008-6#1)
empirical work##3##2##(2008-11#1)(2008-8#2)
empirical##138##1##(1990-11#1)(1991-12#1)(1992-1#1)(1992-12#6)(1992-2#2)(1992-3#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1994-1#1)(1995-1#1)(1995-11#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(2007-9#1)(2008-10#16)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#20)(2008-9#7)(2009-4#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#4)(2010-12#3)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
empirically and##2##2##(2008-10#1)(2011-3#1)
empirically derived##2##2##(2008-6#1)(2008-8#1)
empirically testable##2##2##(2008-2#1)(2010-1#1)
empirically##28##1##(1991-2#1)(1994-2#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-10#5)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-1#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
employ a##7##2##(1991-3#1)(2008-10#2)(2008-8#1)(2009-8#2)(2013-1#1)
employ different##3##2##(1994-6#1)(2010-10#1)(2013-1#1)
employ health##2##2##(1990-9#1)(1993-12#1)
employ the##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
employ##46##1##(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-6#1)(2007-11#2)(2008-10#7)(2008-11#6)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#3)(2010-10#1)(2010-11#1)(2011-10#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
employed a##8##2##(1991-2#1)(2006-6#1)(2008-10#3)(2008-9#1)(2009-12#1)(2013-8#1)
employed and the##2##3##(2008-10#1)(2008-11#1)
employed and##6##2##(1991-12#1)(1996-9#1)(2008-10#3)(2008-11#1)
employed as a##6##3##(1990-2#1)(2008-10#5)
employed as the##6##3##(2008-10#4)(2008-2#1)(2008-3#1)
employed as##25##2##(1990-2#2)(1995-1#1)(2008-1#1)(2008-10#18)(2008-2#1)(2008-3#1)(2008-5#1)
employed at a##2##3##(2008-10#1)(2008-9#1)
employed at##3##2##(1990-2#1)(2008-10#1)(2008-9#1)
employed by hospital##2##3##(1993-3#1)(2008-11#1)
employed by the##4##3##(1991-12#1)(1992-12#1)(2008-10#1)(2013-1#1)
employed by##15##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-3#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2009-8#1)(2013-1#1)
employed clinically##2##2##(2009-12#1)(2013-1#1)
employed epidemiologists##3##2##(2008-11#3)
employed for a##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
employed for an##2##3##(2008-10#1)(2008-3#1)
employed for quantitative measurement##2##4##(2008-10#1)(2008-3#1)
employed for quantitative##5##3##(2008-10#4)(2008-3#1)
employed for the analysis of##2##5##(2008-10#2)
employed for the assay of##2##5##(2008-10#2)
employed for the determination of##10##5##(2008-10#10)
employed for the preconcentration of##2##5##(2008-10#2)
employed for the treatment of##2##5##(2008-10#2)
employed for the##29##3##(2008-10#24)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-2#1)
employed for##77##2##(1990-12#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-2#1)(2008-10#56)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)
employed here##2##2##(2008-10#2)
employed in a##2##3##(2008-10#1)(2013-1#1)
employed in addition to the##2##5##(1997-2#1)(1997-6#1)
employed in order to##4##4##(1997-7#1)(2008-10#1)(2008-11#1)(2009-7#1)
employed in the##22##3##(1990-12#2)(1991-12#1)(1994-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#3)
employed in this study##2##4##(2008-10#2)
employed in this##7##3##(2008-10#2)(2010-11#1)(2010-8#4)
employed in##63##2##(1990-12#3)(1991-12#1)(1991-2#1)(1993-1#1)(1994-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#5)(2012-2#1)(2013-1#4)
employed only##2##2##(2008-10#1)(2008-4#1)
employed the##8##2##(1992-2#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2013-1#1)
employed to analyze##4##3##(2008-10#3)(2008-11#1)
employed to calculate##2##3##(2008-10#1)(2008-3#1)
employed to characterize##4##3##(2008-10#2)(2008-3#1)(2010-8#1)
employed to demonstrate the##2##4##(2008-10#2)
employed to detect##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
employed to determine the##3##4##(1993-8#1)(2008-10#1)(2008-11#1)
employed to determine##8##3##(1993-8#1)(2008-10#5)(2008-11#2)
employed to develop##2##3##(1994-3#1)(2011-2#1)
employed to elucidate the##2##4##(2008-10#1)(2008-6#1)
employed to gather data from##2##5##(2008-11#2)
employed to generate##2##3##(2008-2#1)(2008-3#1)
employed to identify##2##3##(2008-11#1)(2008-8#1)
employed to investigate the##3##4##(2008-10#1)(2008-11#1)(2009-7#1)
employed to investigate##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2009-7#1)
employed to measure the##4##4##(1991-2#1)(2008-10#2)(2010-7#1)
employed to monitor##3##3##(2008-10#3)
employed to obtain the##2##4##(1993-8#1)(2008-10#1)
employed to obtain##3##3##(1993-8#1)(2008-10#1)(2008-9#1)
employed to predict the##2##4##(1990-8#1)(2009-7#1)
employed to predict##3##3##(1990-8#1)(2008-9#1)(2009-7#1)
employed to produce##2##3##(2008-10#2)
employed to study the##3##4##(2008-10#2)(2013-8#1)
employed to the##3##3##(2008-10#2)(2008-11#1)
employed to##101##2##(1990-6#1)(1990-8#2)(1991-2#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(2008-10#49)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-5#1)(2009-7#3)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#3)
employed was##3##2##(2008-10#3)
employed were##2##2##(2008-10#1)(2008-12#1)
employed with##6##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)
employed within the##2##3##(2008-11#1)(2008-2#1)
employed within##3##2##(1994-12#1)(2008-11#1)(2008-2#1)
employed##468##1##(1990-12#7)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#5)(1991-12#5)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2008-1#3)(2008-10#229)(2008-11#38)(2008-12#8)(2008-2#6)(2008-3#14)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#11)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#7)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#6)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#9)(2013-8#6)
employee and organization##2##3##(1991-2#2)
employee and##4##2##(1991-2#2)(1996-5#1)(2008-11#1)
employee had##3##2##(1994-2#1)(1995-6#2)
employee health##2##2##(1993-3#1)(1997-1#1)
employee##47##1##(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#2)(1992-12#1)(1992-2#1)(1993-1#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#6)(1995-1#2)(1995-2#1)(1995-6#6)(1996-5#8)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#3)(2012-12#1)(2012-3#1)
employees a##2##2##(1993-12#1)(2008-10#1)
employees and##5##2##(1991-1#1)(1991-2#1)(1993-3#1)(1996-2#1)(2008-11#1)
employees are##2##2##(1992-5#1)(2008-9#1)
employees in##4##2##(1993-12#1)(1993-3#1)(2008-11#1)(2010-8#1)
employees is##2##2##(1994-1#1)(2008-11#1)
employees of a##2##3##(1991-12#1)(2012-2#1)
employees of##4##2##(1991-12#1)(1993-3#1)(2012-2#1)(2012-3#1)
employees to become##2##3##(1994-1#1)(2009-3#1)
employees to##4##2##(1993-1#1)(1994-1#1)(1994-12#1)(2009-3#1)
employees who##3##2##(1993-3#1)(1994-2#1)(1996-1#1)
employees with##2##2##(1991-12#1)(2012-3#1)
employees working##3##2##(1991-3#1)(2009-10#1)(2012-3#1)
employees##78##1##(1990-2#1)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#2)(1992-1#1)(1992-12#2)(1992-3#3)(1992-5#2)(1993-1#7)(1993-12#2)(1993-3#6)(1994-1#3)(1994-12#4)(1994-2#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#11)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2010-6#1)(2010-8#1)(2012-2#2)(2012-3#5)
employees' health##3##2##(1996-2#1)(1997-1#1)(2009-10#1)
employees'##7##1##(1993-1#1)(1996-2#1)(1997-1#1)(2009-10#3)(2012-3#1)
employer refused##2##2##(1995-6#2)
employer##12##1##(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-6#3)(1997-2#1)(2012-3#1)
employer's##6##1##(1994-12#1)(1994-2#1)(1995-12#2)(1995-6#1)(2008-6#1)
employer-sponsored##6##1##(1993-3#1)(1996-3#1)(1997-2#2)(2008-11#2)
employers to##2##2##(1991-2#1)(1996-5#1)
employers##17##1##(1991-1#2)(1991-2#2)(1991-3#1)(1992-11#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-6#1)(2010-10#1)
employing a set of##2##4##(2008-10#1)(2008-5#1)
employing a##31##2##(1990-12#1)(1990-5#1)(1992-2#2)(2008-10#22)(2008-11#1)(2008-4#1)(2008-5#2)(2010-10#1)
employing an##5##2##(1995-8#1)(2008-10#4)
employing both##4##2##(2008-10#3)(2008-11#1)
employing different##2##2##(2008-10#2)
employing differential pulse##2##3##(2008-10#2)
employing flow injection##2##3##(2008-10#2)
employing methanol##2##2##(2008-10#1)(2012-2#1)
employing only##3##2##(2008-10#3)
employing reference##2##2##(2008-10#2)
employing the##13##2##(2008-10#8)(2008-8#1)(2009-10#1)(2010-10#1)(2010-7#1)(2010-8#1)
employing these##2##2##(1992-2#1)(2008-9#1)
employing three##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
employing##145##1##(1990-12#2)(1990-5#1)(1991-10#2)(1991-2#1)(1992-12#1)(1992-2#3)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#87)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2010-10#2)(2010-4#1)(2010-7#2)(2010-8#4)(2011-2#2)(2012-12#1)(2012-2#2)
employment and to##2##3##(1995-1#1)(2008-11#1)
employment and##3##2##(1991-9#1)(1995-1#1)(2008-11#1)
employment as##3##2##(1991-12#1)(1995-1#1)(2008-10#1)
employment contracts##2##2##(2008-11#1)(2008-9#1)
employment in##4##2##(1991-1#1)(1991-12#1)(1994-2#1)(2008-11#1)
employment of the##2##3##(1992-9#1)(2008-10#1)
employment of##8##2##(1990-3#1)(1992-9#1)(2008-10#5)(2008-12#1)
employment opportunities##3##2##(1996-2#2)(2008-9#1)
employment status##2##2##(2008-11#1)(2011-3#1)
employment##66##1##(1990-3#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#6)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#3)(1995-12#2)(1995-6#1)(1995-9#1)(1996-2#5)(1996-3#1)(1997-2#2)(1997-3#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-9#3)(2010-6#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-8#1)
employs a##7##2##(1996-3#1)(2008-10#5)(2008-9#1)
employs an##3##2##(2008-10#3)
employs the##6##2##(2008-10#3)(2008-2#1)(2008-4#1)(2009-5#1)
employs two##3##2##(2008-10#1)(2008-3#2)
employs##37##1##(1996-3#1)(1997-2#1)(2008-10#20)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-8#1)
empop##3##1##(2008-12#3)
empower##4##1##(1992-2#1)(1993-1#1)(2008-11#1)(2010-7#1)
empowered by##2##2##(1993-12#1)(1995-12#1)
empowered##3##1##(1993-12#1)(1995-12#1)(2010-10#1)
empowering##7##1##(1993-1#1)(1994-3#1)(1996-1#1)(2008-11#3)(2010-10#1)
empowerment and##3##2##(1994-1#1)(1997-3#2)
empowerment approach##2##2##(1993-1#1)(1996-3#1)
empowerment of##2##2##(1993-1#1)(2008-11#1)
empowerment through##2##2##(1993-3#1)(1996-1#1)
empowerment##16##1##(1991-2#1)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-3#3)(2008-11#1)(2009-8#1)
empty sella##2##2##(1991-11#1)(2013-1#1)
empty##17##1##(1991-11#1)(1993-6#1)(1994-11#1)(2008-10#6)(2008-12#1)(2008-8#4)(2010-12#1)(2011-2#1)(2013-1#1)
emptying of##2##2##(1997-4#2)
emptying rate of##4##3##(1997-4#4)
emptying the##2##2##(2008-7#1)(2013-1#1)
emptying##16##1##(1990-12#1)(1997-4#9)(2008-7#2)(2012-2#3)(2013-1#1)
empyema##6##1##(1990-3#1)(2010-1#4)(2010-12#1)
emsp14##3##1##(2010-10#3)
emulate##5##1##(1991-12#1)(2008-3#4)
emulgel##3##1##(1990-9#3)
emulsifiable concentrate formulations##3##3##(2008-10#3)
emulsification time##2##2##(2008-7#2)
emulsified in##4##2##(1995-5#1)(2008-10#2)(2008-4#1)
emulsified##10##1##(1995-5#1)(2008-10#8)(2008-4#1)
emulsifier concentration##2##2##(2008-5#1)(2008-7#1)
emulsifier##13##1##(2008-10#2)(2008-5#10)(2008-7#1)
emulsifier-free##2##1##(2008-5#2)
emulsifying agent##2##2##(2008-10#2)
emulsifying##9##1##(2008-10#2)(2008-5#2)(2010-4#5)
emulsion and##7##2##(2008-10#3)(2008-5#4)
emulsion containing##3##2##(2008-5#3)
emulsion formed##2##2##(2008-10#2)
emulsion in the##2##3##(2008-5#2)
emulsion or suspension##2##3##(2008-10#1)(2008-11#1)
emulsion samples##2##2##(2008-10#1)(2008-5#1)
emulsion stability##5##2##(2008-5#5)
emulsion was##4##2##(2008-10#3)(2008-5#1)
emulsion were##2##2##(2008-11#1)(2008-5#1)
emulsion with##2##2##(2008-5#2)
emulsion##78##1##(2008-10#21)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#40)(2010-4#2)(2010-6#1)(2011-3#1)(2012-2#1)
emulsions and##2##2##(2008-5#2)
emulsions of##2##2##(2008-10#1)(2008-5#1)
emulsions with low concentrations of##2##5##(2008-5#2)
emulsions with low concentrations##3##4##(2008-5#3)
emulsions with##9##2##(2008-5#7)(2010-4#2)
emulsions##46##1##(2008-10#6)(2008-11#3)(2008-3#3)(2008-5#30)(2010-4#3)(2011-2#1)
en bloc##5##2##(1996-3#1)(2008-4#1)(2008-7#2)(2011-2#1)
en consultation##2##2##(2013-1#2)
en the##2##2##(2010-1#1)(2012-12#1)
en##45##1##(1991-6#1)(1993-2#1)(1994-8#1)(1996-3#1)(1997-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-1#1)(2011-2#10)(2012-12#1)(2013-1#18)
enable a more##2##3##(2008-10#1)(2008-11#1)
enable a##7##2##(1997-3#1)(2008-10#3)(2008-11#2)(2013-1#1)
enable an##2##2##(1993-1#1)(2008-11#1)
enable educators##2##2##(2008-11#1)(2008-12#1)
enable health professionals to##2##4##(2008-11#2)
enable identification of##3##3##(2008-10#2)(2009-5#1)
enable students to##2##3##(2008-11#2)
enable students##3##2##(2008-11#2)(2008-12#1)
enable the detection of##4##4##(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
enable the study of##2##4##(1994-11#1)(2011-2#1)
enable the study##3##3##(1994-11#1)(2011-2#1)(2012-3#1)
enable the##36##2##(1993-6#1)(1994-11#1)(1994-3#1)(1996-9#1)(1997-6#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2010-9#1)(2011-2#7)(2012-2#2)(2012-3#1)
enable them to##2##3##(1994-9#1)(2008-11#1)
enable these##2##2##(1993-2#1)(2008-9#1)
enable us to##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
enable##123##1##(1991-11#1)(1992-12#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(2008-10#30)(2008-11#17)(2008-12#4)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#4)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#13)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
enabled a##6##2##(2008-10#4)(2008-11#1)(2008-5#1)
enabled simultaneous##3##2##(2008-10#3)
enabled the selection of##2##4##(1991-11#1)(1993-1#1)
enabled the##30##2##(1991-11#1)(1991-6#1)(1993-1#1)(1997-2#1)(1997-4#1)(2008-10#11)(2008-11#3)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#2)(2013-1#2)(2013-8#1)
enabled to##2##2##(2008-10#1)(2008-11#1)
enabled us to##8##3##(1992-2#1)(1996-2#1)(2008-10#5)(2008-3#1)
enabled##84##1##(1990-2#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-1#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#35)(2008-11#12)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
enables a##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
enables an##2##2##(2008-10#1)(2012-2#1)
enables identification of##2##3##(1993-2#1)(2008-10#1)
enables one to##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
enables one##4##2##(2008-10#2)(2008-2#1)(2008-4#1)
enables optimization##2##2##(2008-11#1)(2008-7#1)
enables precise##2##2##(2008-10#1)(2008-2#1)
enables quantitative##2##2##(2008-10#2)
enables the design##2##3##(2008-10#1)(2008-3#1)
enables the detection##2##3##(2008-10#2)
enables the determination of##2##4##(2008-10#2)
enables the determination##3##3##(2008-10#3)
enables the direct determination of##2##5##(2008-10#2)
enables the direct##3##3##(2008-10#2)(2010-5#1)
enables the rapid##2##3##(2008-10#1)(2008-8#1)
enables the use of##2##4##(2008-10#1)(2012-2#1)
enables the##42##2##(1991-2#1)(2008-10#23)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
enables them to##2##3##(2008-10#1)(2008-11#1)
enables to decrease the##2##4##(2008-10#1)(2012-3#1)
enables to##6##2##(2008-10#1)(2008-11#2)(2008-5#2)(2012-3#1)
enables us to##15##3##(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-8#1)
enables us##16##2##(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-8#1)
enables##146##1##(1990-3#1)(1991-11#1)(1991-2#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#3)(1996-3#2)(1997-8#1)(2007-12#1)(2008-10#48)(2008-11#16)(2008-2#2)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#2)
enabling both##2##2##(1991-11#1)(2008-10#1)
enabling rapid##2##2##(2008-10#1)(2008-5#1)
enabling students to##2##3##(2008-11#2)
enabling the##15##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2013-1#1)
enabling##52##1##(1991-11#1)(1993-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#15)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-2#2)(2013-1#4)(2013-8#2)
enabling&quot##2##1##(1993-12#1)(1995-3#1)
enact##5##1##(1991-2#1)(1993-5#1)(1995-12#1)(2008-11#1)(2010-11#1)
enacted##11##1##(1991-2#3)(1993-3#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#1)(2012-2#1)(2012-3#1)
enactment##2##1##(1991-2#1)(1996-3#1)
enamel and dentin##4##3##(1991-2#1)(2008-7#1)(2012-12#2)
enamel and##5##2##(1991-2#2)(2008-7#1)(2012-12#2)
enamel were##2##2##(1995-9#1)(2011-2#1)
enamel with cavity##2##3##(2013-1#2)
enamel without cavity##2##3##(2013-1#2)
enamel##27##1##(1991-2#2)(1995-9#1)(2008-5#2)(2008-7#1)(2009-7#5)(2010-10#2)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#9)
enantiomer in human##2##3##(2008-10#2)
enantiomer was##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
enantiomer##10##1##(1992-12#2)(2008-10#6)(2008-11#1)(2008-4#1)
enantiomeric composition of samples by##2##5##(2008-10#2)
enantiomeric composition of##5##3##(2008-10#5)
enantiomeric composition##6##2##(2008-10#6)
enantiomeric excess##2##2##(2008-10#2)
enantiomeric fractions##2##2##(2008-10#2)
enantiomeric mixtures##3##2##(2008-10#3)
enantiomeric separation of##3##3##(2008-10#3)
enantiomeric separation##4##2##(2008-10#4)
enantiomeric##20##1##(1996-5#1)(1997-2#1)(2008-10#18)
enantiomerically pure##4##2##(1995-3#2)(1996-5#1)(2008-7#1)
enantiomers and##2##2##(2008-10#2)
enantiomers by##2##2##(2008-10#2)
enantiomers can be##2##3##(2008-10#2)
enantiomers in human##2##3##(2008-10#1)(2008-11#1)
enantiomers in##7##2##(1991-12#1)(2008-10#5)(2008-11#1)
enantiomers of the##2##3##(1992-11#1)(2008-10#1)
enantiomers of##13##2##(1992-11#1)(1992-12#1)(2008-10#9)(2008-11#1)(2011-1#1)
enantiomers on##3##2##(2008-10#3)
enantiomers were##4##2##(1991-12#1)(1994-8#2)(2008-10#1)
enantiomers##43##1##(1991-12#2)(1992-11#1)(1992-12#1)(1994-8#2)(1997-2#1)(2008-10#33)(2008-11#2)(2011-1#1)
enantiopurity##6##1##(2008-10#6)
enantioselective and##2##2##(2011-1#2)
enantioselective gas##2##2##(2008-10#2)
enantioselective membrane electrode based on##2##5##(2008-10#2)
enantioselective membrane electrode##3##3##(2008-10#3)
enantioselective membrane##6##2##(2008-10#6)
enantioselective separation of##3##3##(2008-10#3)
enantioselective separation##4##2##(2008-10#4)
enantioselective##26##1##(2008-10#23)(2011-1#3)
enantioselectivity was##4##2##(2008-10#4)
enantioselectivity##13##1##(2008-10#12)(2011-1#1)
enantioseparation of clenbuterol##2##3##(2008-10#2)
enantioseparation##6##1##(2008-10#6)
encapsulant##2##1##(2008-10#1)(2008-7#1)
encapsulate##2##1##(2013-1#1)(2013-8#1)
encapsulated bacteria##2##2##(1990-9#1)(1994-9#1)
encapsulated by##5##2##(2008-10#3)(2008-12#1)(2011-3#1)
encapsulated form##2##2##(2008-5#2)
encapsulated in a##2##3##(2008-10#1)(2008-5#1)
encapsulated in##6##2##(1996-5#1)(2008-10#2)(2008-11#2)(2008-5#1)
encapsulated retinol##2##2##(2008-5#2)
encapsulated silica##2##2##(2008-10#2)
encapsulated##36##1##(1990-9#1)(1994-9#2)(1996-5#2)(2007-12#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-5#8)(2011-3#1)(2013-1#1)
encapsulating##5##1##(2008-10#1)(2011-2#3)(2012-2#1)
encapsulation efficiency##2##2##(2008-10#1)(2010-6#1)
encapsulation in##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
encapsulation of the##2##3##(2008-10#1)(2008-5#1)
encapsulation of##5##2##(2008-10#3)(2008-5#1)(2010-6#1)
encapsulation on the##3##3##(1996-5#1)(2008-11#1)(2008-5#1)
encapsulation##19##1##(1996-5#1)(2008-10#6)(2008-11#3)(2008-5#3)(2008-7#2)(2009-12#1)(2010-6#2)(2013-1#1)
encased in a##2##3##(2008-10#2)
encasement##2##1##(2008-10#2)
encephalitis##17##1##(1995-12#2)(1996-11#1)(2007-12#1)(2008-12#2)(2008-7#3)(2009-10#1)(2010-8#1)(2011-2#6)
encephalocele##4##1##(2011-2#1)(2012-3#3)
encephalomyelitis (EAE)##4##2##(1994-6#1)(1995-12#1)(2010-12#1)(2012-2#1)
encephalomyelitis##9##1##(1994-6#1)(1995-12#2)(2010-12#2)(2011-2#1)(2012-2#2)(2013-7#1)
encephalomyocarditis virus##2##2##(1997-8#2)
encephalomyocarditis##3##1##(1997-8#2)(2010-7#1)
encephalopathies##3##1##(1991-3#1)(2008-11#1)(2008-4#1)
encephalopathy##23##1##(1992-5#1)(1994-3#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-11#3)(2008-4#2)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#1)
enchondroma in##2##2##(2010-3#2)
enchondroma##3##1##(2008-9#1)(2010-3#2)
enchytraeid##2##1##(2008-11#1)(2010-8#1)
enchytraeids##3##1##(2008-10#3)
encircles the follicle##2##3##(2011-2#2)
encircles##3##1##(1994-12#1)(2011-2#2)
encircling lymphovasculogenesis##3##2##(2011-2#3)
encircling##4##1##(2008-10#1)(2011-2#3)
enclosed in##2##2##(2008-10#1)(2008-3#1)
enclosed##9##1##(1995-11#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2010-7#1)(2013-1#1)
encloses##2##1##(2007-12#1)(2008-11#1)
enclosing##2##1##(2007-12#1)(2008-10#1)
enclosure##4##1##(2008-9#1)(2012-2#2)(2013-8#1)
encode a##20##2##(1990-11#1)(1990-8#1)(1992-10#1)(1992-4#1)(1993-12#3)(1993-2#3)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-8#1)
encode an##2##2##(1992-10#1)(2008-10#1)
encode novel##2##2##(1996-8#1)(2013-8#1)
encode proteins involved in##2##4##(1996-3#1)(2011-2#1)
encode proteins##5##2##(1993-12#1)(1994-9#1)(1996-3#1)(2011-2#1)(2012-3#1)
encode the##8##2##(1990-11#1)(1991-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(2008-4#1)(2011-2#1)(2013-8#1)
encode transcription##2##2##(1993-6#1)(2008-9#1)
encode##72##1##(1990-11#2)(1990-8#2)(1991-6#1)(1992-10#2)(1992-4#2)(1993-12#5)(1993-2#4)(1993-6#3)(1993-9#2)(1994-11#3)(1994-12#1)(1994-9#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#2)(1997-8#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-8#3)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
encoded a protein of##3##4##(1992-3#1)(2008-9#1)(2010-5#1)
encoded a##9##2##(1991-12#1)(1992-3#1)(1993-8#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-5#1)
encoded by a gene##2##4##(1996-3#1)(2008-8#1)
encoded by a##6##3##(1993-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-4#1)(2008-8#1)
encoded by exons##2##3##(1997-8#1)(2010-5#1)
encoded by the genes##2##4##(1993-9#1)(2009-10#1)
encoded by the small RNA of TSWV##2##7##(2008-10#2)
encoded by the small RNA##3##5##(2008-10#3)
encoded by the##30##3##(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2011-1#1)(2011-2#1)(2013-8#1)
encoded by two##4##3##(1992-6#1)(1993-6#1)(1993-9#1)(1997-7#1)
encoded by##71##2##(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-7#3)(1997-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#2)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-2#1)(2013-8#3)
encoded in the##2##3##(2011-2#1)(2012-2#1)
encoded in this##2##3##(1997-3#1)(2008-10#1)
encoded in##9##2##(1995-6#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#1)
encoded on##3##2##(1993-9#1)(1995-8#1)(2008-7#1)
encoded protein##3##2##(1992-8#1)(2008-11#2)
encoded the##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
encoded##129##1##(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#3)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2008-10#19)(2008-11#10)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#10)(2009-10#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#6)(2012-2#2)(2012-3#1)(2013-8#4)
encodes a novel##7##3##(1990-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1996-2#1)
encodes a polypeptide##3##3##(1990-11#1)(1996-6#1)(2008-10#1)
encodes a protein of##17##4##(1991-7#1)(1992-9#2)(1993-6#1)(1994-11#2)(1996-12#1)(1996-6#3)(1997-7#2)(2008-10#3)(2008-6#1)(2008-9#1)
encodes a protein with##6##4##(2008-10#2)(2008-8#3)(2009-10#1)
encodes a protein##25##3##(1991-7#1)(1992-9#2)(1993-6#1)(1994-11#2)(1996-12#1)(1996-6#4)(1997-7#2)(2008-10#5)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)
encodes a putative protein##2##4##(2008-10#1)(2010-5#1)
encodes a putative##3##3##(2008-10#2)(2010-5#1)
encodes a small##4##3##(1993-8#1)(1996-6#1)(1996-8#1)(1997-3#1)
encodes a##76##2##(1990-11#4)(1990-12#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-12#3)(1993-2#1)(1993-6#4)(1993-8#2)(1994-11#4)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#7)(1996-8#1)(1997-3#1)(1997-7#3)(1997-9#1)(2008-10#10)(2008-6#2)(2008-8#5)(2008-9#6)(2009-10#1)(2009-8#1)(2010-5#1)(2012-3#1)
encodes an enzyme##3##3##(2008-10#2)(2009-8#1)
encodes an##9##2##(1990-11#1)(1991-7#1)(1994-12#1)(1994-8#1)(2008-10#4)(2009-8#1)
encodes for a##2##3##(1994-11#1)(1996-12#1)
encodes the##16##2##(1992-9#1)(1993-2#2)(1993-3#2)(1995-12#1)(1995-2#1)(1995-6#2)(1997-4#1)(2008-11#1)(2008-4#1)(2008-9#3)(2011-2#1)
encodes two##3##2##(1990-8#1)(2008-10#1)(2011-10#1)
encodes##128##1##(1990-11#5)(1990-12#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-10#1)(1991-7#3)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#4)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#7)(1993-8#2)(1994-11#5)(1994-12#1)(1994-8#2)(1995-12#3)(1995-2#4)(1995-6#3)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#8)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(1997-9#1)(2008-10#18)(2008-11#3)(2008-4#1)(2008-6#3)(2008-8#5)(2008-9#9)(2009-10#2)(2009-3#1)(2009-8#2)(2010-5#1)(2011-10#1)(2011-2#1)(2012-3#1)
encoding 6##2##2##(2008-8#1)(2011-2#1)
encoding a beta-thyroid hormone receptor##2##5##(1997-1#2)
encoding a killer toxin##2##4##(1993-12#2)
encoding a liver UDP-glucuronosyltransferase (UDPGT)##2##5##(2008-11#2)
encoding a polypeptide of##3##4##(1990-5#1)(1995-2#1)(2008-8#1)
encoding a polypeptide##4##3##(1990-5#1)(1995-2#1)(1995-9#1)(2008-8#1)
encoding a protein of##3##4##(1991-9#1)(1993-2#1)(2008-10#1)
encoding a protein with##2##4##(1994-6#1)(1997-7#1)
encoding a protein##8##3##(1991-9#1)(1993-2#2)(1994-6#1)(1997-7#1)(2008-10#1)(2008-9#2)
encoding a putative##3##3##(1992-3#1)(1995-9#1)(1997-8#1)
encoding a##57##2##(1990-5#2)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#4)(1993-2#2)(1993-9#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#2)(1996-12#2)(1997-1#2)(1997-7#6)(1997-8#1)(2008-10#3)(2008-11#2)(2008-8#6)(2008-9#6)(2013-8#1)
encoding alpha##2##2##(1993-6#1)(2008-8#1)
encoding an exo-beta-1##2##3##(2008-10#2)
encoding an##7##2##(1992-12#1)(1993-2#1)(1995-2#1)(2008-10#3)(2008-6#1)
encoding and##3##2##(2008-11#1)(2008-3#1)(2009-10#1)
encoding apolipoprotein AI##2##3##(1993-12#2)
encoding beta-galactosidase##2##2##(1996-3#1)(2008-8#1)
encoding chicken##2##2##(1993-12#1)(1993-2#1)
encoding different##2##2##(1991-6#1)(1996-12#1)
encoding for the##5##3##(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
encoding for##12##2##(1996-12#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#1)
encoding gene##4##2##(1990-5#1)(2008-10#1)(2008-5#1)(2009-6#1)
encoding genes##5##2##(2008-10#1)(2009-10#1)(2011-2#2)(2012-3#1)
encoding human##12##2##(1990-8#1)(1991-5#1)(1994-11#2)(1995-6#1)(1997-7#1)(2008-11#1)(2008-8#4)(2008-9#1)
encoding its##2##2##(1993-2#1)(1993-8#1)
encoding key##2##2##(2008-8#1)(2012-3#1)
encoding mSTI1##2##2##(1997-7#2)
encoding mask##2##2##(2013-8#2)
encoding of the##3##3##(1996-2#1)(2008-11#2)
encoding of##7##2##(1996-2#1)(2008-11#3)(2013-8#3)
encoding phytoene synthase and##2##4##(1995-2#1)(2010-10#1)
encoding phytoene##3##2##(1995-2#2)(2010-10#1)
encoding proteins with##2##3##(2008-10#1)(2008-4#1)
encoding proteins##5##2##(2008-10#2)(2008-4#1)(2009-6#1)(2012-3#1)
encoding rat aldosterone synthase##2##4##(1990-5#2)
encoding strength##2##2##(2008-6#2)
encoding tRNA(TGASer)##2##2##(1991-6#2)
encoding the 7-ku protein##2##4##(2008-9#2)
encoding the alpha##3##3##(1993-2#2)(1995-2#1)
encoding the alpha-toxin##2##3##(2010-6#2)
encoding the human##3##3##(1993-12#1)(1993-8#1)(2008-5#1)
encoding the major##2##3##(2008-10#1)(2008-5#1)
encoding the receptor##2##3##(1994-11#1)(1995-6#1)
encoding the replication##2##3##(1993-9#1)(2008-10#1)
encoding the small##2##3##(1993-12#1)(1993-6#1)
encoding the soluble##2##3##(1992-6#1)(1996-8#1)
encoding the##94##2##(1990-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#2)(1993-12#4)(1993-2#5)(1993-3#4)(1993-6#5)(1993-8#5)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#5)(1995-6#4)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#2)(2008-10#14)(2008-11#2)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2010-6#3)(2010-7#1)(2011-2#1)(2013-1#2)
encoding this##5##2##(1993-2#1)(1994-12#1)(1995-6#1)(2008-10#2)
encoding transcription##2##2##(1992-12#1)(2011-1#1)
encoding vitellogenin##2##2##(2008-6#2)
encoding##377##1##(1990-11#1)(1990-5#7)(1990-8#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#10)(1991-7#2)(1991-9#4)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#3)(1992-6#4)(1992-9#3)(1993-12#18)(1993-2#19)(1993-3#4)(1993-6#10)(1993-8#6)(1993-9#5)(1994-11#7)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-2#10)(1995-6#11)(1995-8#1)(1995-9#3)(1996-12#12)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#5)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#16)(1997-8#1)(1997-9#1)(2008-10#45)(2008-11#20)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#2)(2008-8#24)(2008-9#15)(2009-10#3)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-5#2)(2010-6#3)(2010-7#2)(2011-1#5)(2011-2#9)(2012-2#3)(2012-3#6)(2013-1#3)(2013-8#7)
encompass the##3##2##(1997-2#1)(2008-12#1)(2012-3#1)
encompass##8##1##(1994-8#1)(1995-6#1)(1997-2#1)(2008-12#1)(2008-5#1)(2012-3#2)(2013-1#1)
encompassed by##3##2##(1993-3#1)(1994-3#1)(2007-12#1)
encompassed##4##1##(1993-3#1)(1994-3#1)(2007-12#1)(2009-9#1)
encompasses all##2##2##(1997-8#1)(2010-6#1)
encompasses the##4##2##(1995-6#1)(2008-2#1)(2010-8#1)(2011-3#1)
encompasses##14##1##(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2010-6#2)(2010-8#1)(2011-3#1)(2012-12#1)
encompassing the##9##2##(1990-8#1)(1991-5#1)(1991-8#1)(1994-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
encompassing##23##1##(1990-2#1)(1990-8#1)(1991-5#1)(1991-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-8#2)(2008-10#6)(2008-5#1)(2008-8#3)(2011-2#1)(2013-1#1)
encounter and##2##2##(2008-11#1)(2010-7#1)
encounter between##2##2##(1994-1#1)(2008-8#1)
encounter data##3##2##(1997-2#3)
encounter in##4##2##(2010-10#1)(2010-9#1)(2012-3#2)
encounter patients##3##2##(2009-7#1)(2010-8#1)(2013-1#1)
encounter when##3##2##(1996-1#1)(2008-4#1)(2008-7#1)
encounter with##3##2##(1995-5#1)(2008-11#1)(2008-8#1)
encounter##42##1##(1991-12#1)(1992-12#1)(1994-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-2#5)(2008-10#2)(2008-11#6)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#3)
encountered and their##2##3##(1990-9#1)(2013-8#1)
encountered and##5##2##(1990-9#1)(2008-10#1)(2009-10#1)(2010-4#1)(2013-8#1)
encountered as##3##2##(1991-11#1)(2010-10#1)(2012-2#1)
encountered at##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
encountered by the##3##3##(1992-1#1)(2013-1#2)
encountered by##10##2##(1992-1#1)(1993-12#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
encountered during the##3##3##(2008-10#1)(2008-11#2)
encountered during##5##2##(2008-10#1)(2008-11#2)(2010-11#1)(2012-2#1)
encountered in a##2##3##(2008-10#2)
encountered in clinical practice##5##4##(2007-8#1)(2008-12#2)(2011-2#2)
encountered in clinical##6##3##(2007-8#1)(2008-12#2)(2011-2#3)
encountered in our##2##3##(2008-8#1)(2010-12#1)
encountered in the##11##3##(1992-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-1#1)(2011-2#1)
encountered in two##2##3##(2008-7#1)(2008-9#1)
encountered in##49##2##(1992-3#1)(1992-4#1)(1993-8#1)(1995-11#1)(1995-9#1)(1997-3#2)(1997-8#1)(2006-6#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#8)(2012-2#3)(2013-1#1)
encountered when##3##2##(1996-9#1)(2008-10#2)
encountered with##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
encountered##127##1##(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#2)(1995-5#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-9#3)(1997-3#2)(1997-8#2)(2006-6#1)(2007-8#1)(2008-10#23)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-8#4)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#5)(2011-2#12)(2011-3#1)(2012-2#9)(2012-3#1)(2013-1#4)(2013-8#2)
encountering##7##1##(1993-12#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-10#1)
encounters and##2##2##(1991-6#1)(1991-9#1)
encounters in##3##2##(1991-6#1)(2008-10#1)(2010-10#1)
encounters with older##2##3##(2010-10#2)
encounters with##4##2##(2008-11#1)(2008-8#1)(2010-10#2)
encounters##31##1##(1991-3#1)(1991-6#5)(1991-9#2)(1993-3#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-8#6)(2008-9#1)(2010-10#7)(2010-8#1)(2011-2#1)(2013-1#1)
encourage a##3##2##(2009-8#1)(2012-12#1)(2013-1#1)
encourage authors to##3##3##(2013-1#3)
encourage further##2##2##(2008-10#1)(2008-7#1)
encourage more##2##2##(2009-9#1)(2013-8#1)
encourage other##2##2##(1991-1#1)(2008-12#1)
encourage the development and##2##4##(2008-10#1)(2008-5#1)
encourage the use of##3##4##(1996-6#1)(1996-9#1)(2008-11#1)
encourage the##9##2##(1995-5#1)(1996-6#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)
encourage them to##2##3##(1995-11#1)(2010-3#1)
encourage##58##1##(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#2)(1994-1#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-6#1)(2008-10#3)(2008-11#6)(2008-12#4)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
encouraged a##2##2##(1996-1#1)(2008-11#1)
encouraged the##5##2##(1993-12#1)(2008-12#1)(2010-11#1)(2010-5#1)(2011-2#1)
encouraged to do##2##3##(1993-1#1)(1993-3#1)
encouraged to participate in##2##4##(2008-11#1)(2009-6#1)
encouraged to utilize##2##3##(1991-3#1)(1996-12#1)
encouraged to##13##2##(1991-3#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-12#1)(2008-11#3)(2009-6#1)(2010-11#1)(2012-3#1)
encouraged when##2##2##(2008-11#1)(2011-2#1)
encouraged##38##1##(1991-3#2)(1991-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#8)(2008-12#1)(2009-3#1)(2009-6#1)(2010-11#3)(2010-5#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
encouragement##6##1##(2008-1#1)(2008-11#1)(2008-3#1)(2010-1#1)(2010-10#1)(2013-1#1)
encourages##6##1##(1992-12#1)(1993-3#1)(1994-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
encouraging and##2##2##(2008-5#1)(2012-3#1)
encouraging early##2##2##(2010-6#1)(2012-2#1)
encouraging in##2##2##(1994-2#1)(2010-12#1)
encouraging results##6##2##(1992-9#1)(1997-8#1)(2008-10#2)(2010-2#1)(2010-8#1)
encouraging students to##2##3##(2008-11#2)
encouraging the##4##2##(1993-11#1)(1994-1#1)(1994-12#1)(2008-11#1)
encouraging##46##1##(1991-9#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-2#2)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
encroachment of##2##2##(2008-12#1)(2010-12#1)
encroachment##3##1##(1990-2#1)(2008-12#1)(2010-12#1)
encrypted##4##1##(2008-10#1)(2008-3#3)
encryption technique##2##2##(2008-3#2)
encryption##3##1##(2008-3#3)
encumbered##3##1##(1997-8#2)(2008-11#1)
encysted zoospores##2##2##(2008-10#2)
encystment of zoospores##2##3##(2008-10#2)
encystment##4##1##(2008-10#4)
end and a##2##3##(2008-10#1)(2013-8#1)
end and##8##2##(2008-10#3)(2008-3#1)(2008-8#2)(2008-9#1)(2013-8#1)
end diastolic##2##2##(1996-3#1)(2013-8#1)
end groups##3##2##(1992-12#1)(2008-10#2)
end in##8##2##(1990-3#1)(1990-5#1)(1996-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
end joining##4##2##(1993-2#2)(1997-7#2)
end labeling##6##2##(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)
end matches the previously described gene##2##6##(1996-6#2)
end of a##17##3##(1992-12#1)(1994-2#1)(1997-1#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-8#2)(2013-1#1)
end of its##2##3##(1997-7#1)(2008-12#1)
end of life decisions##3##4##(2012-12#3)
end of life##7##3##(2008-12#1)(2010-10#1)(2011-2#1)(2012-12#4)
end of one##2##3##(1995-8#1)(2008-4#1)
end of shelf life##2##4##(2011-2#2)
end of the cell##2##4##(2008-11#1)(2009-10#1)
end of the coding region of##2##6##(2008-4#1)(2008-8#1)
end of the molecule##2##4##(1993-8#1)(2008-8#1)
end of the##149##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#5)(1992-3#3)(1992-6#1)(1992-8#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#3)(1994-9#4)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#3)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#1)(2007-12#3)(2008-10#34)(2008-11#15)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#7)(2009-10#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-7#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#2)
end of##264##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#6)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#4)(1994-3#1)(1994-9#4)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#4)(2007-12#3)(2008-10#58)(2008-11#17)(2008-12#10)(2008-3#3)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#12)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#2)(2010-1#2)(2010-10#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#10)(2011-3#2)(2012-12#5)(2012-2#4)(2012-7#1)(2012-9#1)(2013-1#15)(2013-7#1)(2013-8#3)
end on##3##2##(1995-2#1)(1997-7#2)
end point in##2##3##(2008-10#1)(2009-11#1)
end point##16##2##(2008-10#10)(2008-11#1)(2008-5#1)(2009-11#1)(2009-8#2)(2012-12#1)
end points of##2##3##(2008-10#1)(2012-3#1)
end points##12##2##(1990-12#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-2#2)(2012-3#1)(2013-1#2)
end product##3##2##(2008-10#2)(2008-11#1)
end products##6##2##(1995-2#1)(2008-1#1)(2008-7#3)(2010-10#1)
end pumping##2##2##(2007-11#2)
end sequences##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
end stage renal disease (ESRD) patients##2##6##(1991-3#1)(1995-12#1)
end stage renal disease (ESRD)##7##5##(1991-3#1)(1995-1#1)(1995-12#2)(1996-2#1)(2008-1#1)(2012-2#1)
end stage renal disease##10##4##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(2008-1#1)(2010-7#1)(2012-2#1)(2013-1#1)
end stage renal failure##2##4##(1997-8#2)
end stage renal##12##3##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-8#2)(2008-1#1)(2010-7#1)(2012-2#1)(2013-1#1)
end stage##15##2##(1991-11#1)(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-8#2)(2008-1#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
end to the##2##3##(1992-6#1)(2008-3#1)
end to##7##2##(1991-3#1)(1992-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
end users##8##2##(1991-12#2)(1992-1#1)(1992-12#4)(2009-6#1)
end were##2##2##(1996-12#1)(2008-10#1)
end with##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-8#2)
end##496##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#11)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-2#5)(1994-3#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#5)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#3)(1996-5#1)(1996-6#4)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#8)(1997-8#3)(2007-11#3)(2007-12#3)(2008-1#4)(2008-10#102)(2008-11#29)(2008-12#17)(2008-2#6)(2008-3#13)(2008-4#8)(2008-5#8)(2008-6#6)(2008-7#14)(2008-8#27)(2008-9#15)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#4)(2010-10#4)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#3)(2011-1#4)(2011-2#15)(2011-3#2)(2012-12#9)(2012-2#5)(2012-3#7)(2012-7#1)(2012-9#1)(2013-1#22)(2013-7#1)(2013-8#9)
end-capped##2##1##(2008-10#2)
end-channel##5##1##(2008-10#5)
end-column##4##1##(2008-10#4)
end-joining##3##1##(2013-1#3)
end-labeled##4##1##(1993-8#1)(2008-10#3)
end-of-life care##4##2##(2010-10#1)(2010-4#1)(2012-12#2)
end-of-life##11##1##(1994-12#1)(2009-11#1)(2010-10#1)(2010-4#4)(2012-12#4)
end-organ##2##1##(2010-6#1)(2011-1#1)
end-point detection##6##2##(2008-10#6)
end-point indication##3##2##(2008-10#3)
end-point of##4##2##(2008-10#3)(2011-2#1)
end-point was detected##2##3##(2008-10#2)
end-point##32##1##(1993-2#1)(2008-10#27)(2008-11#1)(2008-7#2)(2011-2#1)
end-points##3##1##(1993-6#1)(1995-12#1)(2008-10#1)
end-pumping configuration##2##2##(2008-2#1)(2008-3#1)
end-stage heart failure##2##3##(2010-6#2)
end-stage liver disease##3##3##(2008-12#1)(2011-2#2)
end-stage lung diseases##2##3##(2011-3#2)
end-stage lung##3##2##(2011-3#3)
end-stage pulmonary disease##2##3##(1994-3#2)
end-stage pulmonary##3##2##(1994-3#2)(2011-3#1)
end-stage renal disease##9##3##(1994-12#1)(1994-5#1)(1996-2#1)(2008-1#2)(2008-10#1)(2010-10#1)(2013-1#2)
end-stage renal failure##2##3##(2013-1#2)
end-stage renal##12##2##(1994-12#1)(1994-5#1)(1996-2#1)(2008-1#3)(2008-10#1)(2010-10#1)(2013-1#4)
end-stage##32##1##(1990-12#1)(1994-12#1)(1994-3#2)(1994-5#1)(1996-2#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-12#1)(2010-10#2)(2010-12#1)(2010-6#2)(2011-2#3)(2011-3#6)(2013-1#6)
end-tidal##2##1##(2012-3#2)
end-to-end##3##1##(2008-11#2)(2008-7#1)
end-to-side##3##1##(1993-3#2)(2008-9#1)
end-user##6##1##(1991-3#3)(1992-1#3)
endangered##10##1##(1991-5#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#2)
endarterectomy for##3##2##(2008-7#1)(2008-8#1)(2010-9#1)
endarterectomy in##2##2##(1993-1#1)(2013-1#1)
endarterectomy##14##1##(1993-1#1)(2008-11#2)(2008-7#2)(2008-8#3)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2013-1#2)
endcap##6##1##(2008-4#6)
endcapped oligonucleotides##2##2##(2008-4#2)
endcapped##4##1##(2008-10#2)(2008-4#2)
endcaps##2##1##(2008-4#2)
endeavor##4##1##(1995-2#1)(1997-2#1)(1997-4#1)(2008-4#1)
endeavour at the##2##3##(2008-5#1)(2009-6#1)
endeavour##4##1##(2008-11#1)(2008-5#1)(2009-10#1)(2009-6#1)
endeavours to##2##2##(2008-12#2)
endeavours##4##1##(1992-3#1)(2008-12#2)(2010-11#1)
ended in the##3##3##(1997-3#1)(2008-12#1)(2013-1#1)
ended in##4##2##(1997-3#1)(2008-12#1)(2008-9#1)(2013-1#1)
ended with##2##2##(2008-10#1)(2013-1#1)
ended##12##1##(1994-9#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2013-1#3)(2013-8#1)
endemic area for##4##3##(1996-11#1)(2008-5#2)(2012-2#1)
endemic area is known in the##2##6##(1996-11#2)
endemic area##12##2##(1995-12#1)(1996-11#5)(2008-5#3)(2012-2#1)(2013-8#2)
endemic areas in##3##3##(1996-11#3)
endemic areas of##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
endemic areas##10##2##(1996-11#6)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
endemic circulation of##2##3##(2012-12#2)
endemic focus of##2##3##(2008-5#2)
endemic for##3##2##(2008-5#1)(2009-8#2)
endemic fungal infections##2##3##(2011-2#2)
endemic in##6##2##(1991-11#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
endemic region##4##2##(2008-10#1)(2011-2#2)(2012-3#1)
endemic regions##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
endemic to the##2##3##(2010-1#1)(2010-8#1)
endemic to##6##2##(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)(2012-3#1)
endemic##70##1##(1991-11#1)(1995-12#1)(1996-11#12)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#8)(2008-8#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#3)
endemicity##3##1##(1994-9#1)(2008-11#1)(2010-1#1)
ending with##4##2##(1994-3#2)(2008-11#1)(2012-2#1)
ending##11##1##(1994-3#2)(1996-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#2)(2012-2#1)
endings were##2##2##(2008-6#1)(2009-7#1)
endings##10##1##(1992-6#3)(1997-2#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-7#1)
endlessly single-mode##2##2##(2007-11#2)
endo##12##1##(1991-3#2)(1993-6#1)(1996-5#7)(2008-10#1)(2008-5#1)
endo-##2##1##(2009-3#1)(2009-6#1)
endo-1##2##1##(2008-10#2)
endo-2-cineolylol##2##1##(2008-5#2)
endo-PG##6##1##(2008-10#6)
endo-beta-1##3##1##(2008-10#3)
endoPG-disrupted mutant##2##2##(2008-10#2)
endoblasts##4##1##(2007-12#4)
endobronchial##6##1##(1994-9#5)(2010-2#1)
endocannabinoid system is##2##3##(2009-8#2)
endocarditis (IE)##3##2##(2006-6#1)(2011-2#2)
endocarditis is##4##2##(1996-11#1)(2011-2#3)
endocarditis of##2##2##(2009-5#2)
endocarditis to##2##2##(1996-11#1)(2011-2#1)
endocarditis##31##1##(1993-2#1)(1996-11#5)(1997-5#1)(1997-8#1)(2006-6#3)(2009-5#3)(2011-2#17)
endocarditis]##3##1##(1996-11#1)(1997-2#1)(1997-8#1)
endocervical button##2##2##(1991-2#2)
endocervical##13##1##(1990-2#3)(1991-2#3)(1992-1#2)(1992-2#1)(1994-12#1)(2009-6#2)(2011-2#1)
endochitinase activity##4##2##(2008-10#4)
endochitinase##11##1##(2008-10#11)
endocrine and##4##2##(2008-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
endocrine cells##5##2##(1993-12#2)(1995-12#1)(1997-7#2)
endocrine disruptors have been##2##4##(2008-11#1)(2010-5#1)
endocrine disruptors##7##2##(2008-10#2)(2008-11#2)(2010-5#2)(2012-2#1)
endocrine dysfunction##2##2##(2008-7#1)(2012-3#1)
endocrine pancreas##4##2##(1991-7#1)(1994-12#2)(1994-8#1)
endocrine pancreatic##4##2##(1994-11#3)(2010-11#1)
endocrine system##4##2##(2007-12#1)(2008-11#2)(2013-1#1)
endocrine systems##4##2##(1990-3#1)(2008-2#1)(2008-5#1)(2010-5#1)
endocrine therapy##4##2##(2013-8#4)
endocrine treatment of breast cancer##2##5##(1990-11#2)
endocrine treatment of breast##3##4##(1990-11#2)(1997-7#1)
endocrine##86##1##(1990-11#3)(1990-2#1)(1990-3#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#3)(1994-12#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#3)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-7#2)(2010-11#3)(2010-5#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#5)
endocrine-disrupting##2##1##(2008-10#1)(2010-9#1)
endocrine-immune interactions##2##2##(2008-8#1)(2008-9#1)
endocrine-immune##3##1##(2008-8#1)(2008-9#1)(2012-3#1)
endocrinologic##4##1##(2008-10#1)(2008-11#2)(2013-1#1)
endocrinological##3##1##(2008-4#1)(2012-2#1)(2013-7#1)
endocrinologists##6##1##(1997-2#1)(2011-2#4)(2013-1#1)
endocrinology##6##1##(2008-4#1)(2011-2#3)(2013-1#2)
endocrinopathies##2##1##(1997-3#1)(2013-1#1)
endocrinopathy##2##1##(2008-10#2)
endocytic pathway##2##2##(1995-6#1)(2008-11#1)
endocytic pathways##2##2##(1996-2#1)(2012-2#1)
endocytic uptake##2##2##(1997-7#1)(2010-4#1)
endocytic##10##1##(1995-6#2)(1996-2#1)(1997-7#1)(2008-11#1)(2009-8#1)(2010-4#1)(2012-2#3)
endocytosed##2##1##(1993-8#1)(1995-6#1)
endocytosis and##3##2##(1993-9#1)(2008-7#1)(2013-1#1)
endocytosis##30##1##(1991-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#2)(1997-7#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#3)
endoderm and the##2##3##(2008-6#2)
endoderm and##3##2##(2008-6#3)
endoderm in##2##2##(2008-6#1)(2008-9#1)
endoderm##12##1##(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#5)(2008-7#2)(2008-9#2)
endodermal cells##3##2##(2008-10#1)(2010-11#2)
endodermal##4##1##(2008-10#1)(2008-7#1)(2010-11#2)
endodontic therapy##2##2##(2012-3#2)
endodontic##8##1##(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
endodontically treated##3##2##(2013-1#3)
endogenous ADP##2##2##(2008-7#2)
endogenous Furin##2##2##(2008-11#2)
endogenous IFNalpha is##2##3##(2007-11#2)
endogenous PtdInsP2 and PtdInsP##2##4##(1993-6#2)
endogenous TSPO ligands##2##3##(2012-2#2)
endogenous ammonia##2##2##(1995-3#1)(2008-10#1)
endogenous and exogenous##4##3##(1992-5#1)(2008-1#1)(2008-10#1)(2012-12#1)
endogenous anti-oxidants##2##2##(2012-2#2)
endogenous cannabinoids##2##2##(1997-8#2)
endogenous cations##2##2##(2008-10#2)
endogenous components##2##2##(2008-8#1)(2010-11#1)
endogenous compounds##3##2##(2008-11#2)(2011-2#1)
endogenous cytokines##5##2##(1996-12#5)
endogenous gene expression##2##3##(1995-2#1)(2008-9#1)
endogenous gene##3##2##(1990-5#1)(1995-2#1)(2008-9#1)
endogenous genes##3##2##(1995-6#1)(2008-9#2)
endogenous levels of##3##3##(2012-7#2)(2013-1#1)
endogenous levels##4##2##(2008-10#1)(2012-7#2)(2013-1#1)
endogenous ligands##4##2##(1990-5#1)(2009-7#2)(2012-2#1)
endogenous lipid##2##2##(1994-12#1)(1996-2#1)
endogenous opiates##3##2##(1994-8#1)(1995-12#2)
endogenous opioid##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
endogenous peptidases##2##2##(1996-2#2)
endogenous protease##2##2##(1991-10#1)(2008-11#1)
endogenous regulatory mechanisms##2##3##(2008-11#2)
endogenous retrovirus##2##2##(2008-11#1)(2010-10#1)
endogenous sphingosine##2##2##(1994-3#2)
endogenous substances##3##2##(2008-10#2)(2008-11#1)
endogenous substrate##3##2##(1992-9#1)(1993-6#1)(1995-8#1)
endogenous substrates##2##2##(1993-3#1)(2008-5#1)
endogenous##202##1##(1990-2#1)(1990-5#7)(1991-10#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-6#6)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-12#5)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#11)(1996-2#5)(1996-6#1)(1997-1#2)(1997-4#1)(1997-7#2)(1997-8#5)(2007-11#2)(2008-1#3)(2008-10#22)(2008-11#32)(2008-4#2)(2008-5#3)(2008-7#11)(2008-8#7)(2008-9#5)(2009-7#3)(2009-8#8)(2010-10#1)(2010-11#5)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#3)(2012-7#2)(2013-1#2)(2013-7#3)
endogenously released##2##2##(1992-6#1)(1997-1#1)
endogenously##9##1##(1992-6#1)(1993-1#1)(1994-3#1)(1995-8#1)(1997-1#1)(2008-5#1)(2009-10#1)(2013-1#1)(2013-8#1)
endoglucanase##5##1##(1990-5#1)(2008-10#3)(2008-9#1)
endoglycosidase##2##1##(1992-3#1)(1995-11#1)
endoleak type Ib##2##3##(2011-3#2)
endoleak type##3##2##(2011-3#3)
endoleak##4##1##(2011-3#4)
endolymph##4##1##(2009-8#2)(2012-2#2)
endometrial ablation##3##2##(1993-1#2)(1996-1#1)
endometrial adenocarcinoma##4##2##(1995-3#1)(2011-2#3)
endometrial cancer cell##2##3##(1995-12#1)(2008-4#1)
endometrial cancer##13##2##(1992-12#2)(1995-12#1)(2008-10#5)(2008-4#1)(2009-2#1)(2011-2#3)
endometrial carcinoma##9##2##(1991-3#1)(1995-3#3)(2008-11#1)(2011-2#4)
endometrial carcinomas and##2##3##(2011-2#2)
endometrial carcinomas##9##2##(2011-2#9)
endometrial cells##2##2##(1990-5#1)(2008-9#1)
endometrial cyst##2##2##(1992-3#2)
endometrial glands##2##2##(2009-8#1)(2011-2#1)
endometrial laser##2##2##(1994-12#2)
endometrial line##2##2##(1995-3#2)
endometrial receptivity##3##2##(2008-9#2)(2012-3#1)
endometrial samples##2##2##(1995-12#2)
endometrial thickness##2##2##(1995-3#2)
endometrial tissue##3##2##(1995-3#3)
endometrial##84##1##(1990-5#1)(1991-3#1)(1992-12#6)(1992-3#2)(1993-1#2)(1994-12#2)(1995-12#6)(1995-3#15)(1996-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#3)(2009-2#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#27)(2012-3#4)(2013-1#2)
endometrioid adenocarcinoma##2##2##(2011-2#2)
endometrioid##5##1##(1994-8#1)(2011-2#4)
endometriomas##5##1##(1992-3#2)(1996-1#3)
endometriosis and##2##2##(1995-12#1)(2013-1#1)
endometriosis cells##3##2##(1995-12#3)
endometriosis in##4##2##(1991-3#1)(2010-12#3)
endometriosis of the##2##3##(1991-3#1)(2010-12#1)
endometriosis should be##2##3##(2009-8#1)(2013-1#1)
endometriosis##46##1##(1991-3#5)(1992-1#2)(1992-2#3)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#7)(1995-2#4)(1996-8#1)(2009-8#4)(2010-12#8)(2012-3#1)(2013-1#8)
endometrioticimplants##2##1##(2009-8#2)
endometritis##3##1##(2011-2#2)(2012-3#1)
endometrium and##5##2##(1990-5#1)(1991-3#2)(2012-3#2)
endometrium in##3##2##(1995-11#2)(2008-9#1)
endometrium##32##1##(1990-5#1)(1991-3#2)(1993-9#1)(1995-11#3)(1995-12#1)(1995-3#3)(2008-4#1)(2008-9#2)(2011-2#12)(2012-3#6)
endomyocardial biopsy##2##2##(2008-10#2)
endomyocardial##3##1##(2008-10#3)
endomysium##2##1##(2013-1#2)
endonasal surgery##2##2##(2013-1#2)
endonasal##4##1##(2011-2#1)(2013-1#3)
endonuclease VII##2##2##(1995-12#2)
endonuclease and##2##2##(1991-7#1)(2008-10#1)
endonuclease##18##1##(1991-7#2)(1991-9#1)(1992-12#1)(1993-12#2)(1993-9#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-6#2)(1996-12#1)(2008-10#2)(2008-8#1)
endonucleases##2##1##(2008-10#1)(2012-2#1)
endoparasites##2##1##(1997-7#1)(2008-10#1)
endoparasitoid##2##1##(2009-8#1)(2010-4#1)
endopeptidase 24##4##2##(1990-5#1)(1992-6#3)
endopeptidase activity##2##2##(1990-5#1)(2008-11#1)
endopeptidase domain##2##2##(2009-6#2)
endopeptidase##17##1##(1990-5#6)(1992-3#1)(1992-6#3)(1995-6#1)(2008-11#3)(2008-5#1)(2009-6#2)
endopeptidases##2##1##(2008-4#2)
endophenotypes##4##1##(2010-1#4)
endophthalmitis##2##1##(2011-2#2)
endophyte##8##1##(2008-10#7)(2008-8#1)
endophytes##9##1##(2008-8#8)(2009-6#1)
endophytic##12##1##(2008-10#11)(2011-2#1)
endoplasmic reticulum (ER)##11##3##(1991-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(2008-11#1)(2009-10#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
endoplasmic reticulum and Golgi##2##4##(1994-11#1)(2008-5#1)
endoplasmic reticulum and##10##3##(1994-11#1)(1995-5#1)(2007-12#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)
endoplasmic reticulum##63##2##(1991-10#1)(1991-2#2)(1992-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-3#3)(1997-1#1)(1997-7#1)(2007-12#4)(2008-10#2)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#8)(2008-8#3)(2009-10#1)(2009-7#1)(2009-8#4)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)
endoplasmic reticulum-Golgi system##2##3##(1994-11#2)
endoplasmic reticulum-Golgi##3##2##(1993-8#1)(1994-11#2)
endoplasmic##68##1##(1991-10#1)(1991-2#2)(1992-12#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-3#3)(1997-1#1)(1997-7#1)(2007-12#4)(2008-10#2)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#4)(2009-9#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)
endopolygalacturonase gene##3##2##(2008-10#3)
endopolygalacturonase##8##1##(2008-10#8)
endoprotease##4##1##(1995-8#1)(1997-1#1)(2008-11#1)(2008-7#1)
endorectal MRI##2##2##(1997-8#2)
endorectal##4##1##(1997-8#2)(2013-1#2)
endorsed by##3##2##(1991-1#1)(2008-1#1)(2013-1#1)
endorsed##11##1##(1991-1#1)(1992-2#1)(1993-3#1)(1995-1#1)(1997-7#1)(2008-1#2)(2008-12#1)(2013-1#2)(2013-8#1)
endorsement of##3##2##(1991-2#1)(1994-12#1)(2013-1#1)
endorsement##4##1##(1991-2#1)(1994-12#1)(2008-10#1)(2013-1#1)
endorsing##3##1##(1993-11#1)(2009-11#1)(2013-1#1)
endos##4##1##(2012-3#4)
endos(00003) and##2##2##(2012-3#2)
endos(00003)##3##1##(2012-3#3)
endoscope##7##1##(1990-11#1)(1991-12#1)(2007-12#1)(2008-7#2)(2009-8#1)(2013-1#1)
endoscopic adrenalectomy##2##2##(2012-12#2)
endoscopic and histological findings##2##4##(2008-10#1)(2013-1#1)
endoscopic and histopathological##2##3##(1991-3#1)(2011-2#1)
endoscopic and##6##2##(1991-3#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
endoscopic approach##3##2##(1996-3#1)(2011-2#2)
endoscopic balloon dilation##3##3##(2010-12#3)
endoscopic biopsies##2##2##(2009-8#2)
endoscopic discectomy##2##2##(2008-12#2)
endoscopic examination##5##2##(1997-8#1)(2008-11#1)(2008-12#1)(2009-1#1)(2013-1#1)
endoscopic findings in##2##3##(2011-2#1)(2012-2#1)
endoscopic findings##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
endoscopic injection##2##2##(2008-10#2)
endoscopic instruments##3##2##(1991-3#1)(1992-12#1)(1995-2#1)
endoscopic laser##3##2##(1992-2#2)(2010-9#1)
endoscopic or##2##2##(2011-2#1)(2013-8#1)
endoscopic papillotomy##4##2##(1991-3#2)(1997-8#2)
endoscopic procedure##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
endoscopic procedures##2##2##(1993-2#1)(2012-12#1)
endoscopic skull base surgery##2##4##(2011-2#2)
endoscopic sphincterotomy##4##2##(1990-2#1)(2007-8#3)
endoscopic submucosal dissection##2##3##(2013-1#2)
endoscopic surgery##4##2##(1991-3#1)(1993-3#1)(2011-2#1)(2013-1#1)
endoscopic surgical##2##2##(1994-3#2)
endoscopic system##3##2##(2011-2#3)
endoscopic transpapillary##3##2##(1990-3#2)(2013-1#1)
endoscopic transsphenoidal approach##5##3##(2011-2#5)
endoscopic treatment of##2##3##(1991-11#1)(1993-6#1)
endoscopic treatment##10##2##(1991-11#1)(1993-2#1)(1993-6#2)(2008-10#3)(2013-1#3)
endoscopic ultrasonography##3##2##(1992-7#1)(1992-9#1)(2013-1#1)
endoscopic ultrasound (EUS)##2##3##(2008-2#1)(2010-12#1)
endoscopic ultrasound##4##2##(2008-2#1)(2009-8#1)(2010-12#1)(2013-1#1)
endoscopic##137##1##(1990-2#1)(1990-3#2)(1991-11#1)(1991-12#1)(1991-3#8)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1994-3#2)(1995-10#1)(1995-2#1)(1996-3#1)(1997-1#2)(1997-8#4)(2007-8#4)(2008-10#11)(2008-11#2)(2008-12#5)(2008-2#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#2)(2009-7#1)(2009-8#6)(2010-12#9)(2010-9#1)(2011-2#22)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#21)(2013-8#3)
endoscopically##12##1##(1990-3#1)(1990-8#1)(1992-11#1)(1996-6#1)(2008-10#1)(2010-12#4)(2011-2#2)(2013-1#1)
endoscopy and##2##2##(2008-1#1)(2011-2#1)
endoscopy in the##2##3##(1997-8#1)(2011-2#1)
endoscopy in##6##2##(1992-9#1)(1997-8#1)(2009-8#1)(2010-12#1)(2011-2#2)
endoscopy is##2##2##(1995-10#1)(2011-2#1)
endoscopy showed##2##2##(1992-5#1)(2011-2#1)
endoscopy time##2##2##(1990-11#2)
endoscopy##49##1##(1990-11#3)(1990-2#1)(1990-9#1)(1991-11#2)(1992-11#1)(1992-5#2)(1992-9#1)(1993-2#1)(1994-12#1)(1995-10#3)(1996-3#1)(1997-8#3)(2008-1#1)(2008-11#1)(2008-12#2)(2009-8#3)(2010-12#6)(2011-2#12)(2012-2#2)(2013-1#2)
endosepsis in##3##2##(2008-10#3)
endosepsis##7##1##(2008-10#7)
endoskeletal structures##3##2##(2007-12#3)
endoskeletal##4##1##(2007-12#4)
endosomal membranes##2##2##(1995-6#1)(2009-8#1)
endosomal##6##1##(1995-6#3)(2009-8#1)(2012-2#1)(2013-8#1)
endosome##5##1##(1994-5#1)(1995-2#1)(2008-11#1)(2009-8#2)
endosomes by##2##2##(1995-6#2)
endosomes##9##1##(1995-5#1)(1995-6#6)(2008-4#2)
endosonography##4##1##(1994-3#3)(1995-3#1)
endosperm cell wall##2##3##(1995-6#2)
endosperm formation in Tulipa spp##2##5##(2009-12#2)
endosperm formation in##3##3##(2009-12#3)
endosperm formation##5##2##(2009-12#5)
endosperm proteins##2##2##(1995-3#1)(2008-10#1)
endosperm tissue##2##2##(1995-6#1)(2008-10#1)
endosperm##26##1##(1995-3#1)(1995-6#3)(2008-10#6)(2008-9#8)(2009-10#1)(2009-12#7)
endosperms##5##1##(2008-10#1)(2009-12#4)
endospore formation##3##2##(2008-10#2)(2011-2#1)
endospore##4##1##(1990-12#1)(2008-10#2)(2011-2#1)
endospore-forming bacteria##7##2##(2008-10#7)
endospore-forming##8##1##(2008-10#7)(2011-2#1)
endospores##2##1##(2011-2#2)
endosulfan sulfate##2##2##(2008-10#2)
endosulfan##6##1##(2008-10#3)(2008-12#3)
endosymbiont##6##1##(1996-12#3)(2009-6#1)(2012-3#2)
endosymbionts##7##1##(1996-12#2)(2007-12#1)(2009-6#1)(2009-8#2)(2012-3#1)
endosymbiosis##2##1##(2009-8#1)(2012-2#1)
endosymbiotic##3##1##(2009-6#1)(2009-8#2)
endothel cells##2##2##(1992-5#2)
endothelial NO synthase##3##3##(1995-11#2)(2010-4#1)
endothelial activation##2##2##(2008-1#1)(2010-12#1)
endothelial and##4##2##(1996-2#1)(2006-6#1)(2008-11#1)(2010-11#1)
endothelial cell count##2##3##(2011-2#2)
endothelial cell density##2##3##(2011-2#2)
endothelial cell loss##3##3##(2011-2#3)
endothelial cell surfaces##2##3##(1995-2#2)
endothelial cell##30##2##(1991-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#4)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#3)(2009-11#1)(2010-11#1)(2011-2#7)(2012-4#1)(2013-1#2)(2013-8#1)
endothelial cells (HUVEC)##8##3##(1994-8#1)(1997-1#1)(2008-8#2)(2008-9#2)(2010-3#1)(2012-2#1)
endothelial cells and##5##3##(1991-5#1)(1996-12#1)(2008-8#2)(2010-1#1)
endothelial cells are##3##3##(1991-5#1)(2011-2#2)
endothelial cells by##5##3##(1993-8#1)(1994-8#1)(2008-8#1)(2008-9#1)(2010-1#1)
endothelial cells can be##3##4##(2008-9#3)
endothelial cells can##5##3##(1993-3#1)(2008-9#4)
endothelial cells for##2##3##(1996-12#1)(2008-11#1)
endothelial cells from##2##3##(1993-6#1)(1994-6#1)
endothelial cells in##5##3##(1996-12#1)(1997-1#1)(2008-11#1)(2010-11#1)(2010-6#1)
endothelial cells is##2##3##(1994-6#2)
endothelial cells secrete##2##3##(1994-11#1)(2013-8#1)
endothelial cells were##4##3##(1991-5#1)(1993-8#1)(2008-11#1)(2008-8#1)
endothelial cells with##2##3##(1994-11#1)(1994-8#1)
endothelial cells##121##2##(1990-12#2)(1991-5#9)(1992-10#2)(1992-6#1)(1992-9#1)(1993-3#5)(1993-6#2)(1993-8#2)(1994-11#5)(1994-5#2)(1994-6#5)(1994-8#3)(1996-12#5)(1997-1#6)(1997-7#1)(2008-10#1)(2008-11#16)(2008-5#3)(2008-8#7)(2008-9#10)(2009-10#1)(2009-3#3)(2009-7#1)(2010-1#7)(2010-11#2)(2010-3#1)(2010-6#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
endothelial dysfunction and##2##3##(2008-11#1)(2010-10#1)
endothelial dysfunction in##3##3##(2010-10#1)(2013-8#2)
endothelial dysfunction plays a key role in the##2##8##(2008-11#1)(2012-3#1)
endothelial dysfunction plays##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
endothelial dysfunction##13##2##(2008-1#1)(2008-11#4)(2009-10#1)(2010-10#4)(2012-3#1)(2013-8#2)
endothelial function##7##2##(2008-8#1)(2012-12#1)(2012-3#3)(2013-8#2)
endothelial growth factor (VEGF)##13##4##(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
endothelial growth factor##22##3##(1994-11#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#4)(2008-9#4)(2009-3#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
endothelial growth factor/vascular permeability factor##2##5##(1994-3#2)
endothelial growth##25##2##(1994-11#1)(1994-3#2)(1997-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#4)(2008-9#4)(2009-3#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
endothelial nitric oxide synthase gene##2##5##(2008-12#1)(2008-7#1)
endothelial nitric oxide synthase##3##4##(1997-3#1)(2008-12#1)(2008-7#1)
endothelial permeability##2##2##(1997-8#1)(2010-12#1)
endothelial progenitor cells##4##3##(2010-1#2)(2010-6#2)
endothelial##242##1##(1990-12#2)(1991-5#10)(1992-10#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#7)(1993-6#3)(1993-8#3)(1994-11#6)(1994-3#2)(1994-5#3)(1994-6#5)(1994-8#3)(1995-11#4)(1995-2#7)(1996-12#7)(1996-2#1)(1997-1#8)(1997-3#1)(1997-7#4)(1997-8#2)(2006-6#1)(2008-1#4)(2008-10#6)(2008-11#29)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#12)(2008-9#14)(2009-10#3)(2009-11#1)(2009-3#4)(2009-7#1)(2009-8#1)(2010-1#10)(2010-10#5)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#4)(2010-7#1)(2011-2#19)(2011-3#1)(2012-12#4)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#4)(2013-8#8)
endothelin 1##4##2##(1993-3#4)
endothelin antagonist##2##2##(1992-4#2)
endothelin receptors##2##2##(1994-11#1)(1997-4#1)
endothelin##12##1##(1992-3#1)(1992-4#2)(1993-3#5)(1994-11#1)(1994-9#1)(1997-4#1)(2008-11#1)
endothelin-1 (ET-1)##3##2##(1991-5#1)(1993-8#1)(1994-8#1)
endothelin-1##12##1##(1991-5#1)(1992-3#7)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)
endothelin-3##3##1##(1994-12#2)(1994-3#1)
endothelin-B receptor gene##3##3##(1994-12#3)
endothelin-B receptor is essential##2##4##(1994-12#2)
endothelin-B receptor##7##2##(1994-12#7)
endothelin-B##8##1##(1994-12#8)
endothelin-receptor antagonist##2##2##(2009-10#1)(2010-10#1)
endothelium and##8##2##(1993-8#1)(1995-2#2)(1997-7#1)(2008-10#1)(2008-3#1)(2012-3#2)
endothelium in##2##2##(2008-9#1)(2011-2#1)
endothelium of##3##2##(2012-3#3)
endothelium##34##1##(1991-5#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-8#2)(1994-8#2)(1994-9#1)(1995-2#6)(1997-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-3#5)
endothelium-dependent##5##1##(2010-10#4)(2013-8#1)
endothelium-derived##3##1##(1991-6#1)(1994-11#1)(2010-11#1)
endothelium-intact##2##1##(1993-8#2)
endothiapepsin##2##1##(1995-6#2)
endotoxin##17##1##(1990-12#3)(1996-12#9)(2008-10#1)(2008-12#1)(2008-4#1)(2009-6#1)(2012-12#1)
endotoxin-induced##3##1##(1994-8#1)(1996-12#2)
endotoxins##2##1##(2008-11#2)
endotracheal tube##3##2##(1996-3#1)(2010-7#1)(2012-12#1)
endotracheal##6##1##(1995-12#1)(1996-3#1)(2010-10#2)(2010-7#1)(2012-12#1)
endovaginal ultrasound in the##2##4##(2009-6#2)
endovaginal ultrasound##3##2##(2009-6#3)
endovascular and##3##2##(2008-7#1)(2011-3#1)(2012-3#1)
endovascular embolization##3##2##(2008-12#1)(2008-7#2)
endovascular management of##2##3##(2009-9#1)(2010-12#1)
endovascular procedure##4##2##(1996-6#1)(2008-7#2)(2013-8#1)
endovascular procedures on the external carotid arteries##2##7##(1996-9#2)
endovascular procedures##5##2##(1996-6#1)(1996-9#3)(1997-6#1)
endovascular surgery##4##2##(1995-11#1)(1996-9#1)(2008-7#1)(2012-3#1)
endovascular techniques##2##2##(1995-11#1)(2011-3#1)
endovascular treatment of##4##3##(1996-9#1)(1997-3#1)(2008-10#1)(2011-3#1)
endovascular treatment##12##2##(1995-11#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#2)(1997-6#1)(2008-10#1)(2011-3#1)(2013-1#1)
endovascular##60##1##(1995-11#7)(1996-3#2)(1996-6#4)(1996-9#6)(1997-3#3)(1997-4#1)(1997-6#4)(2008-10#2)(2008-12#2)(2008-7#8)(2009-9#1)(2010-12#4)(2011-2#2)(2011-3#5)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
endowed with a##2##3##(1997-1#1)(2008-11#1)
endowed with##3##2##(1997-1#1)(2008-11#1)(2008-9#1)
endplate##2##1##(1995-12#1)(1997-5#1)
endpoint is##2##2##(1992-9#2)
endpoint of##2##2##(2008-10#1)(2010-4#1)
endpoint was to##2##3##(2008-10#2)
endpoint was##4##2##(2008-10#3)(2010-12#1)
endpoint##18##1##(1992-12#1)(1992-9#5)(2008-10#6)(2008-7#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)
endpoints and##2##2##(1992-9#1)(2008-7#1)
endpoints are##2##2##(1996-2#1)(2008-10#1)
endpoints for##3##2##(2008-11#2)(2011-2#1)
endpoints in##2##2##(1994-9#1)(2008-11#1)
endpoints were##2##2##(2008-10#1)(2010-4#1)
endpoints##32##1##(1992-10#1)(1992-9#1)(1994-2#1)(1994-9#1)(1996-2#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-5#3)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#3)(2011-7#1)(2013-1#3)
ends and##5##2##(1995-6#1)(2008-10#3)(2008-11#1)
ends at##2##2##(2007-12#1)(2008-6#1)
ends in the##2##3##(1992-9#1)(1996-3#1)
ends in##3##2##(1992-9#1)(1996-3#1)(2008-7#1)
ends of the##5##3##(1993-12#1)(1993-3#1)(2008-1#1)(2008-5#1)(2008-8#1)
ends of##22##2##(1993-12#2)(1993-3#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#3)(2012-2#1)(2013-1#1)
ends to##3##2##(2008-4#2)(2008-9#1)
ends with##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2009-12#1)
ends##78##1##(1991-3#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#4)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-7#5)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#6)(2008-2#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#4)(2009-12#2)(2009-5#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
endurance exercise##2##2##(2013-1#2)
endurance training (n = 30)##2##5##(2013-8#2)
endurance training##3##2##(2010-12#1)(2013-8#2)
endurance##17##1##(1991-8#2)(2007-8#2)(2008-12#2)(2010-1#3)(2010-12#1)(2011-2#1)(2013-1#3)(2013-8#3)
endured##3##1##(2008-12#1)(2010-2#1)(2012-3#1)
enduring##11##1##(1992-2#1)(1994-1#1)(1995-5#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
enediolate##2##1##(2008-10#2)
enediyne antitumor##2##2##(2008-9#2)
enema##8##1##(1997-5#1)(1997-8#1)(2010-12#3)(2011-2#1)(2012-12#2)
enemy##4##1##(1997-4#1)(2008-8#2)(2013-8#1)
energetic costs of##2##3##(2008-9#2)
energetic costs##4##2##(2008-9#3)(2010-8#1)
energetic level##3##2##(2008-8#3)
energetic materials##3##2##(2008-10#1)(2008-3#2)
energetic requirements##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
energetic##38##1##(1990-8#1)(1993-8#1)(1994-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#9)(2008-9#11)(2010-8#1)
energetically##5##1##(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)
energies and##2##2##(1991-6#1)(1996-5#1)
energies are##2##2##(2008-10#1)(2008-3#1)
energies of the##2##3##(2009-9#1)(2010-7#1)
energies of##7##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-7#1)
energies that##2##2##(1995-6#1)(2010-7#1)
energies##33##1##(1991-5#1)(1991-6#1)(1992-8#1)(1995-6#2)(1996-5#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#10)(2008-5#1)(2008-9#2)(2009-9#2)(2010-7#3)(2011-1#1)(2013-8#1)
energy allocation##3##2##(2008-8#3)
energy and chemical reactivity##2##4##(2008-8#2)
energy and##19##2##(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
energy are##2##2##(1990-2#1)(2008-2#1)
energy at##5##2##(1993-5#1)(2008-10#2)(2008-3#1)(2012-2#1)
energy availability##2##2##(2008-8#1)(2010-1#1)
energy balance and##2##3##(2008-4#2)
energy balance##5##2##(2008-11#1)(2008-3#1)(2008-4#2)(2013-8#1)
energy barriers##2##2##(2008-4#1)(2011-1#1)
energy between##2##2##(2009-5#1)(2013-1#1)
energy budget##2##2##(2008-9#2)
energy by##2##2##(2008-11#1)(2010-7#1)
energy can##2##2##(2008-4#1)(2009-7#1)
energy change##2##2##(2008-10#1)(2010-7#1)
energy charge##2##2##(1996-6#1)(2008-11#1)
energy coding##4##2##(2008-11#4)
energy conformations##2##2##(1995-11#1)(2008-10#1)
energy contribution##5##2##(2008-4#1)(2013-1#2)(2013-8#2)
energy conversion##2##2##(1994-3#1)(2007-12#1)
energy delivered##5##2##(2008-10#1)(2008-9#1)(2013-1#3)
energy demand##2##2##(1992-9#1)(2008-11#1)
energy density##4##2##(2008-10#3)(2008-3#1)
energy difference##2##2##(2008-3#1)(2010-7#1)
energy dispersive X-ray fluorescence (EDXRF)##2##5##(2008-10#2)
energy dispersive X-ray fluorescence spectrometry##3##5##(2008-10#3)
energy dispersive X-ray fluorescence##7##4##(2008-10#7)
energy dispersive X-ray##12##3##(2008-10#10)(2008-5#1)(2008-9#1)
energy dispersive##15##2##(2008-10#13)(2008-5#1)(2008-9#1)
energy dissipation##17##2##(2008-7#12)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-6#1)
energy distribution##2##2##(2008-10#2)
energy efficiency##2##2##(1993-2#1)(2012-2#1)
energy electronic state becomes favorable##2##5##(2008-10#2)
energy electronic state##3##3##(2008-10#3)
energy electronic states of##3##4##(2008-10#3)
energy electronic##6##2##(2008-10#6)
energy expenditure##9##2##(1994-8#1)(2008-10#2)(2012-2#2)(2013-1#2)(2013-8#2)
energy for the##4##3##(1996-11#1)(2008-10#2)(2008-11#1)
energy for##10##2##(1992-3#1)(1996-11#1)(2008-10#5)(2008-11#1)(2012-2#1)(2013-1#1)
energy formation from glutamine##2##4##(2008-11#2)
energy from##5##2##(1995-11#1)(2008-3#3)(2012-2#1)
energy function##2##2##(1995-3#1)(2008-3#1)
energy generation##2##2##(1991-3#1)(2008-11#1)
energy homeostasis##6##2##(1994-2#1)(2008-10#1)(2008-4#2)(2013-1#2)
energy imparted##2##2##(1997-8#2)
energy in the##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
energy in##5##2##(2008-10#2)(2008-3#1)(2010-8#1)(2013-1#1)
energy intake can##2##3##(2008-11#2)
energy intake##16##2##(1997-8#2)(2008-11#4)(2008-4#1)(2008-5#2)(2012-2#3)(2013-8#4)
energy is##2##2##(2008-10#1)(2008-3#1)
energy levels##3##2##(1995-2#1)(2008-8#1)(2011-2#1)
energy malnutrition##2##2##(1991-8#1)(2012-2#1)
energy metabolism and##2##3##(1993-11#1)(2008-1#1)
energy metabolism in##2##3##(2008-11#1)(2008-7#1)
energy metabolism of the##2##4##(2008-11#1)(2008-7#1)
energy metabolism of##4##3##(2008-11#1)(2008-7#1)(2008-8#2)
energy metabolism##11##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#2)(2013-1#1)
energy minimization##3##2##(1991-5#1)(1992-4#1)(2008-10#1)
energy needs##2##2##(1994-2#1)(2008-7#1)
energy obtained##2##2##(2008-3#1)(2008-9#1)
energy of the##6##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
energy of##23##2##(1990-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-8#1)(1996-6#1)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2009-11#1)(2009-7#1)(2012-2#1)
energy on the##2##3##(1997-6#1)(2008-10#1)
energy on##4##2##(1997-2#1)(1997-6#1)(2008-10#1)(2008-12#1)
energy or##2##2##(2008-10#1)(2008-8#1)
energy production##2##2##(1994-2#1)(2008-11#1)
energy ratio##2##2##(2008-10#1)(2008-5#1)
energy requirements##3##2##(2008-7#2)(2013-8#1)
energy reserves##3##2##(2008-8#2)(2013-1#1)
energy source for##2##3##(2008-7#1)(2011-2#1)
energy source##5##2##(2008-3#1)(2008-7#2)(2011-2#2)
energy sources##3##2##(1991-8#1)(2008-11#1)(2013-8#1)
energy status and##2##3##(2010-8#1)(2013-1#1)
energy status##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
energy storage##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
energy supply##3##2##(1994-2#1)(1994-8#1)(2009-8#1)
energy than##5##2##(1996-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
energy to accelerate the##2##4##(2008-10#2)
energy to##7##2##(2008-10#4)(2008-3#1)(2008-9#1)(2010-6#1)
energy transfer and##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
energy transfer between##4##3##(2008-10#3)(2008-7#1)
energy transfer from##3##3##(2008-10#2)(2013-1#1)
energy transfer in##2##3##(1996-2#1)(2008-10#1)
energy transfer occurred##2##3##(2008-10#1)(2008-3#1)
energy transfer processes##2##3##(2008-8#2)
energy transfer##47##2##(1992-11#1)(1994-5#2)(1996-2#1)(2008-10#25)(2008-3#3)(2008-4#3)(2008-7#2)(2008-8#4)(2008-9#1)(2010-12#2)(2011-3#1)(2013-1#1)(2013-8#1)
energy transfers##2##2##(1996-2#1)(2008-10#1)
energy transport##2##2##(2009-8#2)
energy value##2##2##(2008-10#1)(2010-4#1)
energy was##9##2##(1992-3#1)(2008-10#4)(2008-2#1)(2008-8#1)(2009-7#1)(2010-8#1)
energy were##2##2##(2008-10#1)(2012-2#1)
energy##513##1##(1990-11#1)(1990-2#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#3)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#2)(1995-11#3)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#2)(1997-2#2)(1997-6#2)(1997-8#6)(2007-12#3)(2008-1#3)(2008-10#125)(2008-11#28)(2008-12#2)(2008-2#8)(2008-3#32)(2008-4#19)(2008-5#7)(2008-7#32)(2008-8#29)(2008-9#18)(2009-10#4)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#5)(2009-8#6)(2010-1#3)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#4)(2010-8#7)(2011-1#3)(2011-2#10)(2011-3#2)(2012-12#2)(2012-2#20)(2012-6#1)(2013-1#37)(2013-8#21)
energy-##2##1##(1990-2#1)(1992-3#1)
energy-dependent##3##1##(1992-3#2)(2008-11#1)
energy-dispersive X-ray##5##2##(2008-10#4)(2013-1#1)
energy-matched continuous exercise and##2##4##(2013-8#2)
energy-matched continuous exercise##3##3##(2013-8#3)
energy-transfer##7##1##(1996-2#2)(2008-10#1)(2008-2#2)(2008-3#1)(2009-9#1)
enfants##4##1##(2008-11#4)
enforce##6##1##(1992-1#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
enforced by means of a##2##5##(2008-11#1)(2008-3#1)
enforced by the##3##3##(1991-12#1)(2011-2#2)
enforced by##6##2##(1991-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#2)
enforced##14##1##(1991-12#1)(1992-12#1)(1993-12#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#3)
enforcement cloning##2##2##(1993-12#2)
enforcement of##4##2##(1997-6#1)(1997-7#1)(2008-11#1)(2011-2#1)
enforcement##15##1##(1993-12#2)(1994-3#1)(1996-1#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-8#3)
enforces##3##1##(2008-11#2)(2012-12#1)
enforcing##4##1##(2008-12#1)(2011-2#1)(2013-1#2)
engage in the same##2##4##(2008-11#1)(2012-12#1)
engage in the##3##3##(2008-11#1)(2010-7#1)(2012-12#1)
engage in##30##2##(1990-2#1)(1997-3#1)(2008-1#1)(2008-11#7)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
engage students##2##2##(2008-12#2)
engage the##2##2##(2008-11#2)
engage with##2##2##(1993-3#1)(2013-1#1)
engage##47##1##(1990-2#1)(1993-3#1)(1994-11#1)(1997-3#1)(2008-1#1)(2008-11#9)(2008-12#7)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#8)(2013-8#3)
engaged in a##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
engaged in risky##2##3##(2013-8#2)
engaged in the##4##3##(1995-11#1)(2008-11#1)(2008-5#1)(2013-1#1)
engaged in this##2##3##(2010-10#1)(2013-8#1)
engaged in##39##2##(1992-12#1)(1993-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-5#1)(2008-9#2)(2009-3#2)(2010-10#2)(2011-2#1)(2012-2#5)(2013-1#6)(2013-7#1)(2013-8#3)
engaged##47##1##(1992-12#1)(1993-1#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(2008-10#2)(2008-11#6)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#2)(2010-10#2)(2011-2#1)(2012-2#5)(2013-1#6)(2013-7#1)(2013-8#3)
engagement among##2##2##(2009-7#2)
engagement and##4##2##(2008-11#1)(2008-12#1)(2008-6#1)(2013-1#1)
engagement in preventive##2##3##(2009-5#2)
engagement in school##3##3##(2009-7#3)
engagement in the##2##3##(1997-3#1)(2013-1#1)
engagement in##12##2##(1997-3#1)(2009-5#2)(2009-7#4)(2010-8#1)(2012-2#1)(2013-1#3)
engagement of##4##2##(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
engagement strategies##3##2##(2012-2#3)
engagement trajectories##3##2##(2008-12#3)
engagement with##5##2##(2008-11#1)(2010-3#1)(2011-2#2)(2012-2#1)
engagement##63##1##(1994-3#1)(1997-3#1)(2008-11#2)(2008-12#13)(2008-4#1)(2008-6#1)(2009-5#2)(2009-7#11)(2010-3#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#8)(2013-1#12)(2013-8#1)
engages##3##1##(1995-12#1)(2008-10#1)(2008-11#1)
engaging and##3##2##(2008-12#2)(2010-9#1)
engaging in##12##2##(1991-12#1)(2008-11#2)(2008-12#3)(2009-11#1)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
engaging the public##2##3##(2013-1#2)
engaging##21##1##(1991-12#1)(2008-11#3)(2008-12#5)(2009-11#1)(2009-5#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
engendered##2##1##(2008-11#1)(2013-1#1)
engendering##2##1##(2008-11#1)(2012-3#1)
engenders##2##1##(1994-1#1)(1995-3#1)
engine oil##2##2##(2008-10#2)
engine##9##1##(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#2)
engineer or select for##2##4##(2011-1#2)
engineer##10##1##(2008-10#1)(2008-11#5)(2008-7#1)(2011-1#2)(2011-2#1)
engineered CHO cells##3##3##(2008-11#3)
engineered antibodies##2##2##(2008-10#2)
engineered for##3##2##(2008-10#2)(2012-2#1)
engineered to contain##2##3##(2008-10#2)
engineered to express##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
engineered to produce##2##3##(2008-10#1)(2008-11#1)
engineered to secrete human##2##4##(2008-11#1)(2008-5#1)
engineered to##12##2##(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)
engineered##57##1##(1994-11#1)(1995-2#4)(1997-2#1)(1997-3#1)(2008-10#11)(2008-11#13)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-7#2)(2010-11#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
engineering and regenerative medicine##4##4##(2008-11#1)(2009-7#1)(2012-5#2)
engineering and##15##2##(2008-10#1)(2008-11#4)(2008-7#1)(2009-3#1)(2009-7#1)(2011-3#2)(2012-2#1)(2012-5#2)(2013-1#2)
engineering approaches##2##2##(1994-8#1)(2013-1#1)
engineering are##2##2##(1994-8#1)(2008-11#1)
engineering has##2##2##(2008-11#1)(2011-2#1)
engineering in##3##2##(2008-11#2)(2009-7#1)
engineering of##9##2##(1995-3#1)(1997-2#1)(2008-11#2)(2008-7#2)(2010-10#1)(2011-1#1)(2012-2#1)
engineering or##2##2##(2009-7#1)(2012-3#1)
engineering strategies are##2##3##(2008-11#2)
engineering strategies##4##2##(2008-11#4)
engineering to##3##2##(2008-11#2)(2008-8#1)
engineering##119##1##(1990-11#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#2)(1992-11#2)(1994-5#1)(1994-8#4)(1995-12#1)(1995-3#2)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#35)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#3)(2009-3#1)(2009-7#10)(2010-10#3)(2010-7#1)(2010-9#3)(2011-1#2)(2011-2#8)(2011-3#2)(2012-2#7)(2012-3#2)(2012-5#3)(2013-1#5)
engineering)##2##1##(2008-10#1)(2008-11#1)
engineers to##2##2##(2008-11#1)(2008-8#1)
engineers##9##1##(1990-11#1)(1993-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2012-3#1)
engines##6##1##(2008-10#2)(2008-11#1)(2008-2#2)(2010-1#1)
engrafted##3##1##(1992-1#1)(2010-11#1)(2013-1#1)
engraftment in##4##2##(2010-11#2)(2011-2#1)(2013-1#1)
engraftment of the##2##3##(2010-11#2)
engraftment of##5##2##(2008-11#1)(2010-11#4)
engraftment was##2##2##(2011-2#2)
engraftment##16##1##(2008-11#1)(2010-11#7)(2011-2#5)(2013-1#3)
engrailed protein##3##2##(2007-12#3)
engrailed##9##1##(1993-2#1)(2007-12#8)
engraved##2##1##(2007-12#1)(2008-10#1)
enhance a##3##2##(1994-3#1)(1996-11#1)(1997-8#1)
enhance biological##2##2##(2008-10#2)
enhance cell##5##2##(1997-1#1)(2008-11#2)(2009-6#1)(2012-3#1)
enhance communication##3##2##(2008-11#1)(2010-4#1)(2011-2#1)
enhance disease resistance##2##3##(2008-10#2)
enhance disease##3##2##(2008-10#3)
enhance female##2##2##(2008-5#2)
enhance food availability for guppies##2##5##(2008-8#2)
enhance frequency##2##2##(1996-2#1)(2008-3#1)
enhance growth##2##2##(2008-10#1)(2011-2#1)
enhance immune##2##2##(2008-2#1)(2008-7#1)
enhance its##3##2##(2008-10#2)(2008-3#1)
enhance local diversity##2##3##(2008-8#2)
enhance or##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
enhance our understanding of##4##4##(1991-3#1)(1993-12#1)(2008-7#1)(2013-1#1)
enhance our understanding##5##3##(1991-3#1)(1993-12#1)(2008-7#1)(2009-9#1)(2013-1#1)
enhance our##8##2##(1991-3#1)(1993-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
enhance patient care##4##3##(1992-2#1)(1995-12#1)(2008-10#1)(2008-11#1)
enhance patient##5##2##(1992-2#1)(1995-12#1)(2008-10#1)(2008-11#2)
enhance performance and##2##3##(2008-10#1)(2008-8#1)
enhance plant##2##2##(2008-10#2)
enhance professional##2##2##(2008-12#1)(2009-6#1)
enhance quality##2##2##(1995-12#1)(1996-2#1)
enhance resistance##2##2##(2008-10#2)
enhance student learning##4##3##(2008-11#2)(2008-12#2)
enhance student##5##2##(2008-11#3)(2008-12#2)
enhance the CL##4##3##(2008-10#4)
enhance the ECL of Ru(bpy)(3)(2+) in##2##6##(2008-10#2)
enhance the ECL##3##3##(2008-10#3)
enhance the accuracy##3##3##(2008-10#2)(2008-6#1)
enhance the acetylcholinesterase##3##3##(2008-11#3)
enhance the cell surface##2##4##(2008-11#2)
enhance the cell##3##3##(1993-8#1)(2008-11#2)
enhance the chemiluminescence##2##3##(2008-10#2)
enhance the differentiation##2##3##(2008-5#1)(2012-12#1)
enhance the educational##2##3##(1993-3#1)(2008-12#1)
enhance the effect of##2##4##(1997-5#1)(2013-1#1)
enhance the production of##2##4##(2008-11#1)(2012-3#1)
enhance the productivity##2##3##(2008-11#2)
enhance the replication##2##3##(2013-1#2)
enhance the response##2##3##(1995-11#1)(2008-10#1)
enhance the secretion of##3##4##(2008-11#3)
enhance the sensitivity of##5##4##(2008-10#3)(2008-3#1)(2009-4#1)
enhance the sensitivity##7##3##(2008-10#5)(2008-3#1)(2009-4#1)
enhance the sorption##2##3##(2008-10#2)
enhance the understanding of##3##4##(2011-2#1)(2011-7#1)(2012-2#1)
enhance the##136##2##(1990-2#1)(1990-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-3#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#22)(2008-12#5)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-5#1)(2011-1#2)(2011-2#5)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)
enhance their##8##2##(2008-10#1)(2008-12#2)(2008-6#1)(2008-8#2)(2010-1#1)(2012-3#1)
enhance##314##1##(1990-2#3)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#4)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1997-1#4)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#3)(2008-10#82)(2008-11#44)(2008-12#12)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#10)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#13)(2011-3#1)(2011-7#1)(2011-9#1)(2012-12#2)(2012-2#8)(2012-3#5)(2012-4#1)(2013-1#12)(2013-8#4)
enhanced CT##2##2##(2008-7#1)(2013-8#1)
enhanced DNA##2##2##(1993-3#1)(2008-4#1)
enhanced ECL##5##2##(2008-10#5)
enhanced RLS intensity##5##3##(2008-10#5)
enhanced RLS signals##3##3##(2008-10#3)
enhanced RLS##10##2##(2008-10#10)
enhanced T cell##2##3##(1993-12#1)(2008-11#1)
enhanced a##2##2##(2008-10#2)
enhanced after##6##2##(1990-11#1)(1992-6#1)(2008-10#2)(2008-6#1)(2013-1#1)
enhanced and##5##2##(1997-4#1)(2008-10#2)(2008-12#1)(2008-9#1)
enhanced antibody production##2##3##(1995-5#1)(2008-11#1)
enhanced apple##2##2##(2008-10#2)
enhanced as##2##2##(1994-8#1)(2008-11#1)
enhanced at##3##2##(2007-12#1)(2008-10#2)
enhanced both##2##2##(1994-6#1)(2008-11#1)
enhanced by a##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
enhanced by increased##2##3##(1996-12#1)(1996-2#1)
enhanced by the addition of##8##5##(2007-11#1)(2008-10#5)(2008-11#2)
enhanced by the presence of##4##5##(2008-10#4)
enhanced by the##21##3##(1992-9#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#3)(2009-8#1)
enhanced by##89##2##(1990-2#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#3)(2007-11#1)(2007-12#1)(2008-10#38)(2008-11#10)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)
enhanced cell##4##2##(2008-11#4)
enhanced cellular productivity##2##3##(2008-11#2)
enhanced cellular##3##2##(2008-10#1)(2008-11#2)
enhanced chemiluminescence##4##2##(2008-10#3)(2012-2#1)
enhanced cytotoxicity##3##2##(1990-5#1)(1993-3#1)(1994-8#1)
enhanced depth imaging optical coherence tomography (EDI-OCT)##2##7##(2011-7#1)(2013-1#1)
enhanced disease##4##2##(2008-10#4)
enhanced due to the##2##4##(2008-10#2)
enhanced during##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
enhanced endothelial##2##2##(1997-8#1)(2013-1#1)
enhanced expression and##2##3##(2008-9#1)(2012-2#1)
enhanced expression of##7##3##(1990-2#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-11#1)(2012-2#1)
enhanced expression##10##2##(1990-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-2#2)
enhanced fluorescence##4##2##(1991-9#1)(2008-10#3)
enhanced formation of##3##3##(1993-3#1)(2008-11#1)(2013-1#1)
enhanced friendship networks and##2##4##(2008-4#2)
enhanced greatly##3##2##(2008-10#2)(2008-8#1)
enhanced green fluorescent protein##3##4##(2008-11#3)
enhanced green##4##2##(2008-11#3)(2013-8#1)
enhanced growth of apple and##2##5##(2008-10#2)
enhanced growth of apple in##2##5##(2008-10#2)
enhanced growth of apple##5##4##(2008-10#5)
enhanced growth of##6##3##(2008-10#5)(2013-7#1)
enhanced growth##11##2##(1992-8#1)(2008-10#7)(2008-11#1)(2009-10#1)(2013-7#1)
enhanced host resistance to blast##2##5##(2008-10#2)
enhanced in the##6##3##(2008-10#5)(2009-8#1)
enhanced in##21##2##(2008-10#15)(2008-11#2)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
enhanced intensity##3##2##(2008-10#3)
enhanced its##2##2##(1991-2#1)(2008-10#1)
enhanced levels of##5##3##(1994-1#2)(2008-10#1)(2008-5#1)(2011-2#1)
enhanced lipid peroxidation##2##3##(2009-8#2)
enhanced markedly##2##2##(1994-8#2)
enhanced mass##2##2##(2008-12#1)(2010-7#1)
enhanced metabolic##2##2##(1991-10#1)(2013-1#1)
enhanced more than##2##3##(2008-10#1)(2008-11#1)
enhanced nonlinear##2##2##(2007-12#1)(2008-10#1)
enhanced oospore##2##2##(2008-10#2)
enhanced pathogen##3##2##(2008-10#3)
enhanced peroxidase##2##2##(2009-3#2)
enhanced photobleaching##2##2##(2008-10#2)
enhanced populations of##3##3##(2008-10#3)
enhanced potency##3##2##(1990-12#1)(1991-3#1)(1995-5#1)
enhanced potentiometric selectivity toward##2##4##(2008-10#2)
enhanced potentiometric##3##2##(2008-10#3)
enhanced production of interferon-beta on the##2##6##(2008-11#2)
enhanced production##3##2##(2008-11#3)
enhanced q (Ab)##2##3##(2008-11#2)
enhanced ray-optics##2##2##(2008-3#2)
enhanced replication of##2##3##(1995-12#1)(2010-11#1)
enhanced resistance to Sclerotium rolfsii##3##5##(2008-10#3)
enhanced resistance to##5##3##(2008-10#5)
enhanced resistance##8##2##(2008-10#7)(2011-1#1)
enhanced resolution##2##2##(2007-12#1)(2008-10#1)
enhanced resonance light scattering##4##4##(2008-10#4)
enhanced resonance##8##2##(2008-10#8)
enhanced responding selectively##2##3##(1993-6#2)
enhanced secretion of##2##3##(2008-11#1)(2008-7#1)
enhanced sensitivity of##2##3##(1996-12#1)(2008-10#1)
enhanced sensitivity##7##2##(1996-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-1#1)
enhanced susceptibility##2##2##(2008-10#2)
enhanced the cell##2##3##(2008-11#2)
enhanced the contractile##2##3##(1990-5#2)
enhanced the damage##2##3##(2008-10#1)(2008-9#1)
enhanced the expression of##2##4##(2008-10#1)(2008-8#1)
enhanced the sensitivity of the method##2##6##(2008-10#2)
enhanced the sensitivity##4##3##(2008-10#4)
enhanced the##60##2##(1990-5#4)(1992-3#1)(1992-6#1)(1993-8#3)(1994-11#2)(1994-5#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#16)(2008-11#9)(2008-12#2)(2008-7#2)(2008-8#4)(2008-9#4)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
enhanced to##2##2##(2008-10#1)(2008-11#1)
enhanced transcription##2##2##(1993-6#1)(1993-9#1)
enhanced ultrafiltration##2##2##(2008-10#2)
enhanced when##7##2##(1994-1#1)(1995-6#1)(1996-12#1)(2008-10#4)
enhanced with##6##2##(1997-3#1)(2008-10#3)(2008-4#1)(2010-4#1)
enhanced##628##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#8)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#5)(1993-8#5)(1993-9#1)(1994-1#3)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#8)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-5#4)(1995-6#2)(1996-1#1)(1996-12#7)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2006-6#3)(2007-11#2)(2007-12#7)(2008-10#253)(2008-11#73)(2008-12#7)(2008-3#5)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#12)(2008-8#9)(2008-9#15)(2009-10#3)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#10)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#18)(2013-7#2)(2013-8#7)
enhancement and suppression##2##3##(1995-6#1)(1997-2#1)
enhancement and##5##2##(1995-6#2)(1997-2#1)(2008-10#2)
enhancement by##3##2##(1994-5#1)(2008-3#1)(2008-4#1)
enhancement can be##2##3##(1993-3#1)(2008-10#1)
enhancement due to##2##3##(1992-8#1)(2008-10#1)
enhancement effect##9##2##(2008-10#8)(2009-12#1)
enhancement factor of##4##3##(2008-10#4)
enhancement factor was##5##3##(2008-10#5)
enhancement factor##9##2##(2008-10#9)
enhancement for##4##2##(2008-10#2)(2010-8#1)(2012-2#1)
enhancement in CL##3##3##(2008-10#3)
enhancement in selectivity coefficients##2##4##(2008-10#2)
enhancement in the##6##3##(2008-10#3)(2008-11#1)(2013-1#2)
enhancement in##28##2##(1995-3#1)(1997-8#2)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#2)(2013-1#2)
enhancement is not##2##3##(1993-9#1)(2008-11#1)
enhancement is##8##2##(1993-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
enhancement of a##4##3##(1996-2#1)(2008-10#2)(2010-5#1)
enhancement of electrical activity##3##4##(1996-2#3)
enhancement of growth and##2##4##(2008-10#1)(2008-11#1)
enhancement of the emission##2##4##(2008-10#2)
enhancement of the fluorescence##2##4##(2008-10#2)
enhancement of the mass##2##4##(2008-10#1)(2013-8#1)
enhancement of the mutation frequency##2##5##(1997-3#2)
enhancement of the##43##3##(1993-3#1)(1995-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#23)(2008-11#5)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
enhancement of##122##2##(1990-12#1)(1990-6#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-6#3)(1996-12#1)(1996-2#4)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#3)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#55)(2008-11#14)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
enhancement on##4##2##(1991-9#1)(1997-8#2)(2008-12#1)
enhancement or##4##2##(1995-5#1)(2008-10#1)(2008-9#1)(2009-9#1)
enhancement than iodine##2##3##(1997-8#2)
enhancement than##3##2##(1997-8#3)
enhancement to##2##2##(1995-6#1)(2013-1#1)
enhancement was found##2##3##(1991-3#1)(2008-10#1)
enhancement was##12##2##(1991-12#1)(1991-3#1)(1994-6#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-8#1)(2012-12#1)
enhancement with##3##2##(2008-10#2)(2008-3#1)
enhancement##273##1##(1990-12#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-3#3)(1991-9#2)(1992-6#2)(1992-8#2)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#6)(1996-12#1)(1996-2#4)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#12)(2006-6#2)(2007-11#1)(2007-12#2)(2008-10#117)(2008-11#25)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#11)(2013-1#6)(2013-8#1)
enhancements in the##2##3##(2008-10#1)(2013-8#1)
enhancements in##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
enhancements of##3##2##(1994-8#1)(1995-11#1)(2010-8#1)
enhancements##10##1##(1994-8#2)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#2)(2013-8#1)
enhancer activity##3##2##(1993-8#1)(1994-11#1)(1995-2#1)
enhancer of##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
enhancer region of the XBP1 gene##2##6##(2011-2#2)
enhancer region##3##2##(1994-6#1)(2011-2#2)
enhancer##33##1##(1991-5#3)(1992-10#1)(1993-2#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1995-2#2)(1995-8#2)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#3)(2011-2#3)(2012-3#4)
enhancers in the##2##3##(1995-6#1)(2008-8#1)
enhancers of##3##2##(2008-8#1)(2012-3#2)
enhancers##12##1##(1994-12#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#3)(2011-2#1)(2012-3#2)
enhances a##2##2##(2008-12#1)(2013-1#1)
enhances binding of agonists to the##2##6##(1994-5#2)
enhances both the##2##3##(2008-10#1)(2008-8#1)
enhances both##3##2##(2008-10#1)(2008-8#1)(2010-11#1)
enhances recombinant protein##2##3##(2008-11#1)(2008-7#1)
enhances the extraction efficiency##2##4##(2008-10#2)
enhances the##29##2##(1993-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
enhances##85##1##(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#3)(1997-2#2)(1997-7#1)(2008-10#15)(2008-11#8)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
enhancing acute performance##2##3##(2009-1#2)
enhancing and##2##2##(2009-4#1)(2010-10#1)
enhancing effect of vitamin A acetate##2##6##(2008-11#2)
enhancing effect of##4##3##(2008-10#2)(2008-11#2)
enhancing effect on##6##3##(2008-10#5)(2009-8#1)
enhancing effect##12##2##(2008-10#8)(2008-11#3)(2009-8#1)
enhancing effects of##2##3##(1994-5#1)(2008-8#1)
enhancing effects##4##2##(1994-5#1)(2008-5#1)(2008-8#2)
enhancing factor##2##2##(1994-11#1)(2008-10#1)
enhancing patient##2##2##(2008-11#1)(2008-3#1)
enhancing protein production##2##3##(2008-11#1)(2008-7#1)
enhancing the capacity of##2##4##(1997-1#1)(1997-3#1)
enhancing the efficacy of##2##4##(2007-12#1)(2009-12#1)
enhancing the production of##3##4##(2008-11#2)(2011-1#1)
enhancing the sensitivity##2##3##(2008-10#2)
enhancing the##27##2##(1993-9#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#5)(2008-12#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
enhancing their##4##2##(1997-1#1)(2008-11#1)(2008-12#1)(2008-6#1)
enhancing##114##1##(1991-2#1)(1991-3#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#26)(2008-11#18)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2009-1#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#5)(2013-8#5)
enigma##4##1##(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
enigmatic##9##1##(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2012-2#2)
enjoy enhanced levels of staff development and motivation and improve long-term financial performance##2##13##(1994-1#2)
enjoy more##2##2##(1991-12#1)(2008-11#1)
enjoy music##2##2##(2008-11#1)(2008-9#1)
enjoy the##2##2##(1996-3#1)(2008-11#1)
enjoy##13##1##(1990-2#1)(1991-12#2)(1992-2#1)(1994-1#2)(1996-3#1)(1996-5#1)(1997-1#1)(2008-11#3)(2008-9#1)
enjoyable and##2##2##(2008-11#1)(2008-8#1)
enjoyed##8##1##(1994-1#1)(1995-1#1)(1996-5#1)(1996-6#1)(2008-11#2)(2008-12#1)(2012-2#1)
enjoying##2##1##(2008-7#1)(2008-9#1)
enjoys##2##1##(2013-1#2)
enkephalin##2##1##(1996-12#1)(2008-10#1)
enkephalins##2##1##(1991-3#1)(2009-7#1)
enlarge the##3##2##(2008-10#3)
enlarge##7##1##(2008-10#4)(2008-7#1)(2012-2#1)(2012-3#1)
enlarged and##2##2##(1993-12#1)(2008-7#1)
enlarged canopy##2##2##(2008-10#2)
enlarged in##3##2##(2008-10#2)(2008-11#1)
enlarged over##2##2##(2008-10#1)(2008-7#1)
enlarged##42##1##(1993-12#1)(1995-2#1)(1996-6#3)(1997-7#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
enlargement is##2##2##(2008-7#1)(2012-12#1)
enlargement of the##8##3##(1997-5#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
enlargement of##11##2##(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#3)(2012-3#1)
enlargement##20##1##(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-9#1)(2011-2#3)(2012-12#6)(2012-3#1)(2013-8#1)
enlargements of the##2##3##(2008-7#1)(2013-1#1)
enlarging##9##1##(1990-2#1)(1994-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
enlighten##3##1##(1993-3#1)(2008-8#1)(2013-1#1)
enlightened##2##1##(1995-3#1)(2008-12#1)
enlightening##4##1##(1995-9#1)(2008-11#2)(2012-3#1)
enlightenment##3##1##(1994-1#1)(1995-5#1)(2011-2#1)
enlisted##3##1##(1991-3#1)(1991-8#1)(1994-12#1)
enolase (NSE) in##4##3##(1990-2#1)(1990-6#1)(1992-11#1)(2011-2#1)
enolase (NSE)##5##2##(1990-2#1)(1990-6#1)(1992-11#1)(2011-2#2)
enolase##15##1##(1990-2#3)(1990-6#1)(1991-8#1)(1992-11#2)(1992-2#1)(2009-6#1)(2011-2#5)(2013-8#1)
enolate##3##1##(1996-5#3)
enological##2##1##(2008-10#2)
enone##2##1##(1996-5#1)(2010-7#1)
enormous impact on##2##3##(2008-10#2)
enormous##29##1##(1992-3#1)(1995-12#1)(1997-5#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
enormously##2##1##(1994-1#1)(2013-1#1)
enough for field##2##3##(2011-1#2)
enough for the##3##3##(1994-1#1)(2008-10#1)(2010-6#1)
enough for##9##2##(1994-1#1)(1995-3#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-1#2)(2012-12#1)(2013-1#1)
enough in the##2##3##(2008-11#1)(2012-2#1)
enough in##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
enough to allow##3##3##(1997-6#1)(2008-10#2)
enough to be##5##3##(1991-3#1)(2008-10#2)(2008-4#1)(2013-8#1)
enough to cause##2##3##(2008-3#2)
enough to interfere with##2##4##(2008-7#2)
enough to perform##2##3##(2008-1#1)(2008-10#1)
enough to produce##2##3##(2008-10#1)(2008-11#1)
enough to##55##2##(1991-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-9#1)(1997-6#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-1#1)(2011-2#2)(2011-3#1)(2012-2#3)(2013-8#1)
enough##99##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-1#2)(2008-10#25)(2008-11#11)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-8#1)(2010-1#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#3)
enoxacin (ENO)##3##2##(2008-10#3)
enoxacin##4##1##(2008-10#4)
enoxaparin##2##1##(2008-10#2)
enquiry based learning##4##3##(2008-11#3)(2008-12#1)
enquiry was##2##2##(2008-10#2)
enquiry##11##1##(2008-10#5)(2008-11#4)(2008-12#2)
enquiry-based learning##3##2##(2008-12#3)
enrich the##2##2##(2008-11#1)(2010-10#1)
enrich##9##1##(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-4#1)(2012-2#1)
enriched (137)Ba##4##2##(2010-8#4)
enriched at##3##2##(2008-10#2)(2012-3#1)
enriched by the##3##3##(2008-10#3)
enriched by##5##2##(2008-10#4)(2009-6#1)
enriched environment##3##2##(1991-2#2)(2008-7#1)
enriched for the##2##3##(2008-10#1)(2009-8#1)
enriched for##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
enriched in the##6##3##(1994-11#1)(1994-5#1)(1995-2#1)(2008-10#3)
enriched in transcriptionally active DNA##2##5##(1990-7#2)
enriched in##24##2##(1990-12#1)(1990-7#3)(1994-11#1)(1994-5#1)(1995-2#2)(1995-6#1)(2008-1#1)(2008-10#8)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
enriched solution##4##2##(2008-10#2)(2010-7#2)
enriched with the##2##3##(2008-10#2)
enriched with##10##2##(1996-2#1)(2008-10#5)(2008-11#2)(2011-1#1)(2013-1#1)
enriched##88##1##(1990-12#1)(1990-6#1)(1990-7#3)(1991-12#1)(1991-2#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(2008-1#1)(2008-10#33)(2008-11#9)(2008-4#1)(2008-7#3)(2008-9#2)(2009-6#1)(2009-8#2)(2010-2#1)(2010-7#2)(2010-8#7)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
enriches the##2##2##(2008-11#1)(2008-8#1)
enriching##4##1##(2008-10#1)(2008-9#1)(2012-2#1)(2012-4#1)
enrichment and determination of silver##2##5##(2008-10#2)
enrichment and determination of##5##4##(2008-10#5)
enrichment and##10##2##(2008-10#9)(2009-8#1)
enrichment by##2##2##(1997-3#1)(2008-10#1)
enrichment culture was##3##3##(2008-6#2)(2008-7#1)
enrichment efficiency##2##2##(2008-10#2)
enrichment factor (EF)##4##3##(2008-10#4)
enrichment factor for##3##3##(2008-10#3)
enrichment factor of##23##3##(2008-10#23)
enrichment factor was##3##3##(2008-10#3)
enrichment factor##41##2##(2008-10#41)
enrichment factors of##6##3##(2008-10#6)
enrichment factors##14##2##(2008-10#14)
enrichment from##2##2##(2008-10#1)(2011-2#1)
enrichment has been##2##3##(2008-10#1)(2008-11#1)
enrichment in##3##2##(2008-7#2)(2009-8#1)
enrichment method##2##2##(2008-10#2)
enrichment of metal ions in aquatic environments##2##7##(2008-10#2)
enrichment of metal ions##6##4##(2008-10#6)
enrichment of the##6##3##(1995-12#1)(1996-11#1)(2008-10#4)
enrichment of##45##2##(1992-9#1)(1995-12#2)(1995-6#1)(1996-11#1)(2008-10#33)(2008-11#3)(2008-4#1)(2010-7#1)(2011-2#1)(2012-4#1)
enrichment on##2##2##(2008-10#1)(2008-8#1)
enrichment should##2##2##(2008-10#1)(2008-11#1)
enrichment system##3##2##(2008-10#2)(2011-2#1)
enrichment technique in minimal medium##2##5##(2012-2#2)
enrichment technique##4##2##(2008-10#2)(2012-2#2)
enrichment time##3##2##(2008-10#3)
enrichment##187##1##(1991-12#1)(1992-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#1)(1997-3#2)(2008-10#136)(2008-11#6)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-8#4)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#2)(2012-4#1)
enrichments##2##1##(2008-7#2)
enrofloxacin##5##1##(2008-10#1)(2008-5#4)
enroll##4##1##(1994-3#1)(1995-12#1)(1997-1#1)(1997-2#1)
enrolled and##2##2##(1995-12#1)(2007-12#1)
enrolled at##2##2##(1991-12#1)(2010-6#1)
enrolled in a##8##3##(1993-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-2#1)(2012-3#1)(2013-1#1)
enrolled in the study##5##4##(1995-8#1)(2008-11#2)(2010-12#1)(2011-1#1)
enrolled in the##12##3##(1992-2#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)
enrolled in this study##4##4##(1994-12#1)(2012-3#1)(2013-1#2)
enrolled in this##6##3##(1994-12#1)(2008-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
enrolled in##45##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-8#1)(1996-1#3)(1996-3#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#4)(2013-8#1)
enrolled##74##1##(1991-1#1)(1991-12#2)(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#3)(1996-2#2)(1996-3#2)(2007-12#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#6)(2012-5#1)(2013-1#6)(2013-8#1)
enrollee##3##1##(1993-3#2)(1997-3#1)
enrollee)##2##1##(1991-2#1)(1996-3#1)
enrollees are##3##2##(1994-2#2)(1997-3#1)
enrollees in prepaid##2##3##(1991-2#1)(1994-2#1)
enrollees in##4##2##(1991-2#1)(1994-2#1)(1996-2#1)(1997-2#1)
enrollees##38##1##(1991-1#1)(1991-2#1)(1991-3#2)(1992-2#4)(1993-1#1)(1993-12#1)(1993-3#2)(1994-2#6)(1994-3#2)(1995-1#3)(1995-3#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#3)
enrollees'##4##1##(1991-1#1)(1997-2#1)(1997-3#2)
enrolling and##2##2##(1994-3#1)(1996-3#1)
enrolling##6##1##(1991-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-3#1)(2010-11#1)
enrollment and##3##2##(1991-12#1)(1991-3#1)(1994-3#1)
enrollment in health##2##3##(1991-3#1)(1995-1#1)
enrollment in##5##2##(1991-12#1)(1991-3#1)(1994-3#1)(1995-1#1)(1997-3#1)
enrollment to##3##2##(1991-2#2)(2010-11#1)
enrollment##35##1##(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#4)(1992-2#2)(1993-3#1)(1994-2#1)(1994-3#5)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#2)(1997-3#2)(2010-10#1)(2010-11#1)(2012-5#2)(2013-1#3)
enrollments##2##1##(1992-1#1)(1994-12#1)
enrolment##4##1##(1997-3#1)(2007-12#1)(2008-11#1)(2009-3#1)
ensemble of##4##2##(1994-5#2)(1997-6#1)(2010-3#1)
ensemble##9##1##(1994-5#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#1)(2010-3#1)
ensembles of GC neurons##2##4##(2008-11#2)
ensembles of##4##2##(2008-11#2)(2009-8#2)
ensembles##10##1##(2008-10#2)(2008-11#4)(2009-8#2)(2013-8#2)
ensheath##2##1##(2008-7#2)
ensheathing cells (OECs)##2##3##(2008-7#2)
ensheathing cells##5##2##(2008-7#5)
ensiling in##2##2##(2008-10#1)(2013-1#1)
ensiling##6##1##(2008-10#3)(2013-1#3)
ensued##2##1##(1997-1#1)(2008-10#1)
ensues##2##1##(2009-1#1)(2011-2#1)
ensuing##14##1##(1996-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-3#2)(2013-1#1)
ensure a balanced##2##3##(1993-12#1)(2011-2#1)
ensure a##7##2##(1993-12#1)(1996-3#1)(2008-6#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
ensure adequate##2##2##(1996-1#1)(2008-11#1)
ensure complete##4##2##(2008-10#2)(2008-11#2)
ensure quality##2##2##(2008-11#1)(2008-12#1)
ensure that the##7##3##(1994-3#1)(1996-9#1)(1997-8#1)(2008-11#2)(2008-5#1)(2012-3#1)
ensure that##40##2##(1991-8#1)(1993-1#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#9)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-3#3)(2013-1#4)
ensure the most##2##3##(1992-2#1)(2008-10#1)
ensure the security##2##3##(1993-2#1)(1994-3#1)
ensure the##27##2##(1991-1#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#1)
ensure they are##3##3##(1995-12#1)(1996-12#1)(2013-1#1)
ensure they##4##2##(1994-2#1)(1995-12#1)(1996-12#1)(2013-1#1)
ensure##146##1##(1991-1#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-9#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-8#1)(2008-10#20)(2008-11#25)(2008-12#8)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#7)(2012-9#1)(2013-1#8)
ensured by##3##2##(2008-10#2)(2010-7#1)
ensured the##3##2##(2008-10#2)(2008-6#1)
ensured##15##1##(1991-5#1)(2008-10#8)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#2)(2013-8#1)
ensures a##4##2##(1991-11#1)(1997-3#1)(2008-10#1)(2008-3#1)
ensures an##2##2##(2008-10#1)(2008-3#1)
ensures that##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
ensures##16##1##(1991-11#1)(1991-2#1)(1995-5#2)(1997-3#1)(2008-10#6)(2008-3#3)(2008-6#1)(2009-5#1)
ensuring adequate##2##2##(2008-12#1)(2012-12#1)
ensuring that students have##2##4##(2008-11#1)(2012-12#1)
ensuring that##8##2##(1997-2#1)(1997-5#1)(2008-11#3)(2008-4#1)(2012-12#1)(2012-2#1)
ensuring the##6##2##(1992-1#1)(2008-11#1)(2008-9#1)(2010-6#1)(2010-8#1)(2013-1#1)
ensuring##42##1##(1991-3#1)(1992-1#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
entA##4##1##(2008-10#4)
entactin##7##1##(1995-6#7)
entail a##2##2##(1993-6#1)(2011-2#1)
entail##4##1##(1993-6#1)(2008-11#1)(2011-2#1)(2013-8#1)
entailed##5##1##(1996-3#1)(2008-10#1)(2010-1#1)(2013-1#2)
entails a##2##2##(2011-2#1)(2012-3#1)
entails the##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
entails##15##1##(1991-2#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-3#1)
entangled##2##1##(2008-10#1)(2011-2#1)
entanglement##3##1##(2012-2#3)
entecavir and##2##2##(2009-8#1)(2013-1#1)
entecavir##4##1##(2009-8#2)(2013-1#2)
enter a##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
enter hair cells##3##3##(2009-8#1)(2012-2#2)
enter into the##2##3##(1991-2#1)(2008-8#1)
enter into##4##2##(1991-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
enter the cell##3##3##(2008-10#1)(2008-11#1)(2011-3#1)
enter the##17##2##(1991-2#1)(1991-5#1)(1994-8#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)(2010-1#1)(2011-2#2)(2011-3#1)
enter##41##1##(1990-12#1)(1991-2#2)(1991-5#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#2)(2010-1#1)(2011-2#6)(2011-3#1)(2012-2#3)
enteral nutrition##2##2##(1993-12#1)(2011-2#1)
enteral##3##1##(1993-12#1)(2011-2#1)(2012-12#1)
entered a##2##2##(1990-6#1)(2008-6#1)
entered in##2##2##(1993-11#1)(2008-7#1)
entered into a##3##3##(1993-1#1)(2008-1#1)(2008-10#1)
entered into the##2##3##(2008-12#1)(2011-1#1)
entered into##7##2##(1993-1#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2011-1#1)
entered the internal##2##3##(2008-10#1)(2011-2#1)
entered the study##4##3##(1991-2#1)(1995-1#1)(2008-10#1)(2011-2#1)
entered the##11##2##(1991-2#1)(1995-1#1)(1997-6#1)(1997-8#1)(2008-10#3)(2011-2#3)(2012-2#1)
entered##40##1##(1990-6#2)(1991-2#2)(1993-1#1)(1993-11#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
enteric fever##2##2##(2012-3#2)
enteric nervous system##4##3##(1992-6#2)(2008-8#2)
enteric pathogen##3##2##(2011-1#2)(2011-2#1)
enteric##19##1##(1992-6#2)(1994-12#2)(1995-5#1)(1996-12#1)(2008-10#2)(2008-8#2)(2011-1#3)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
enterica serovar Typhimurium##4##3##(2008-10#2)(2008-11#2)
enterica serovar##6##2##(2008-10#2)(2008-11#2)(2012-3#2)
entering a##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
entering clinical trials##2##3##(1996-6#1)(2008-10#1)
entering into##2##2##(2008-12#1)(2008-8#1)
entering the##13##2##(1991-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-1#1)
entering##31##1##(1991-12#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#4)(2010-2#1)(2010-9#1)(2012-3#1)(2013-1#1)
enteritidis infection##2##2##(1995-9#2)
enteritidis##15##1##(1990-12#1)(1991-11#2)(1993-2#1)(1995-9#9)(1997-3#1)(2008-10#1)
enteritis in##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
enteritis##13##1##(1991-3#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-12#3)(2011-2#3)(2012-2#2)
enterobacterial repetitive intergenic consensus (ERIC)##2##5##(2008-10#2)
enterobacterial repetitive intergenic consensus##3##4##(2008-10#3)
enterobacterial repetitive##4##2##(2008-10#4)
enterobacterial##6##1##(1995-2#1)(2008-10#5)
enterococci##2##1##(2007-12#1)(2008-10#1)
enterocolitica and##2##2##(2013-8#2)
enterocolitica##7##1##(1996-12#2)(2008-11#2)(2013-8#3)
enterocolitis in##2##2##(2011-2#1)(2012-2#1)
enterocolitis##3##1##(2011-2#1)(2012-2#2)
enterocolitis]##2##1##(2010-6#1)(2011-2#1)
enterocyte effacement##2##2##(1995-2#1)(2011-1#1)
enterocyte##4##1##(1991-12#2)(1995-2#1)(2011-1#1)
enterohemolysin##2##1##(1993-9#2)
enterohemorrhagic##2##1##(1995-2#1)(2008-9#1)
enteroliths##2##1##(2010-12#2)
enteroparesis##2##1##(2012-3#2)
enteropathogenic Escherichia coli##2##3##(2011-1#1)(2011-2#1)
enteropathogenic##3##1##(2011-1#1)(2011-2#2)
enteropathy##2##1##(1997-5#1)(2011-2#1)
enteroscopy##2##1##(2009-8#1)(2013-1#1)
enterotoxigenic Escherichia coli##2##3##(2008-8#2)
enterotoxin production##3##2##(2011-2#3)
enterotoxin##9##1##(1990-12#2)(1993-3#1)(1995-2#1)(2008-10#1)(2011-2#4)
enterovirus 71 strain##2##3##(2013-8#2)
enterovirus 71##5##2##(2008-12#2)(2013-8#3)
enterovirus##8##1##(2008-12#2)(2011-3#2)(2012-3#1)(2013-8#3)
enteroviruses##3##1##(2008-8#1)(2012-2#1)(2013-8#1)
enterprise##7##1##(1994-12#2)(1996-1#1)(1996-3#1)(1997-3#2)(1997-5#1)
enterprise-wide Electronic Health Record##2##4##(2008-7#2)
enterprises##2##1##(1995-6#1)(2013-8#1)
enters the##10##2##(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
enters##12##1##(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
entertainment##4##1##(2008-1#1)(2008-11#3)
enthalpically##3##1##(1993-8#1)(2008-10#2)
enthalpies##4##1##(1992-10#1)(1997-2#1)(2008-10#2)
enthalpimetric measurements##2##2##(2008-10#2)
enthalpimetric##3##1##(2008-10#3)
enthalpy and entropy of##3##4##(2008-10#2)(2008-4#1)
enthalpy and entropy##5##3##(1997-2#1)(2008-10#3)(2008-4#1)
enthalpy and free energy##2##4##(2008-10#2)
enthalpy and volume changes##2##4##(1990-8#2)
enthalpy and##9##2##(1990-8#2)(1997-2#1)(2008-10#5)(2008-4#1)
enthalpy change##4##2##(1993-8#1)(2008-10#2)(2008-11#1)
enthalpy in Tris##2##3##(1992-10#2)
enthalpy of##5##2##(1992-10#2)(1994-5#1)(2008-10#1)(2008-2#1)
enthalpy##30##1##(1990-8#2)(1992-10#4)(1993-8#3)(1994-5#1)(1997-2#3)(2008-10#13)(2008-11#1)(2008-2#2)(2008-4#1)
enthalpy-entropy compensation study revealed that##2##5##(2008-10#2)
enthalpy-entropy##3##1##(2008-10#3)
enthusiasm and##2##2##(1995-12#1)(2008-11#1)
enthusiasm##4##1##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
entire genomes##3##2##(2008-4#2)(2009-10#1)
entire genomic sequence##2##3##(1996-12#1)(2008-10#1)
entire growing season##2##3##(2008-10#1)(2012-7#1)
entire length##4##2##(1996-6#1)(1997-4#1)(2008-2#1)(2009-7#1)
entire lifetime##2##2##(2008-10#1)(2011-2#1)
entire method##2##2##(1997-3#1)(2008-10#1)
entire mtDNA control region sequences were generated and analyzed in a population sample from##2##14##(2008-12#2)
entire mtDNA##3##2##(2008-12#3)
entire open reading frame##3##4##(1993-6#1)(2008-8#1)(2013-8#1)
entire procedure##6##2##(1993-1#1)(1994-8#1)(2008-10#3)(2008-9#1)
entire region##3##2##(1995-6#1)(1996-6#1)(2009-7#1)
entire sequence of##4##3##(1991-3#1)(1996-8#1)(2008-5#1)(2013-8#1)
entire sequence##9##2##(1991-3#1)(1992-3#1)(1993-8#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-5#1)(2013-8#1)
entire##200##1##(1990-2#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-12#2)(1995-6#2)(1995-9#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#7)(1996-8#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#47)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#4)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#10)(2012-2#7)(2012-3#2)(2012-7#1)(2012-9#1)(2013-1#2)(2013-3#1)(2013-8#2)
entirely by the##2##3##(2008-12#1)(2012-2#1)
entirely different##2##2##(1994-11#1)(2012-3#1)
entirely eliminated##2##2##(1990-11#1)(2008-10#1)
entirely independent##2##2##(2008-10#1)(2008-9#1)
entirely new##3##2##(1990-12#1)(1993-2#1)(2008-3#1)
entirely of##2##2##(2008-10#1)(2011-2#1)
entirely##47##1##(1990-11#2)(1990-12#1)(1991-12#1)(1991-2#1)(1993-12#3)(1993-2#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
entirety of##2##2##(1997-3#1)(2012-3#1)
entities from##2##2##(2008-10#1)(2009-2#1)
entities in the##2##3##(2008-10#1)(2010-7#1)
entities in##5##2##(1991-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2010-7#1)
entities such as##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
entities that##4##2##(1991-3#1)(1993-3#1)(2009-8#1)(2013-1#1)
entities which##2##2##(1991-8#1)(2012-12#1)
entities with##2##2##(1991-8#1)(2008-11#1)
entities##43##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#3)(1993-1#1)(1993-2#1)(1993-3#2)(1995-12#1)(1995-5#2)(1996-3#2)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)
entitled &quot##3##2##(1994-12#1)(1997-3#1)(2013-1#1)
entitled the##2##2##(1996-2#1)(2011-2#1)
entitled to##5##2##(1992-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(1997-1#1)
entitled##14##1##(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
entitlement##4##1##(1992-2#1)(1992-8#1)(1993-2#1)(2011-2#1)
entity and##2##2##(1993-12#1)(2013-1#1)
entity for##2##2##(2009-12#1)(2009-6#1)
entity in##4##2##(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
entity of##3##2##(1997-2#1)(2008-10#1)(2009-4#1)
entity that is##2##3##(1993-8#1)(2011-2#1)
entity that##4##2##(1993-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
entity whose##2##2##(1991-6#1)(2012-2#1)
entity##66##1##(1991-12#1)(1991-2#1)(1991-6#2)(1992-2#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-7#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#2)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#2)
entomological knowledge##2##2##(2010-1#2)
entomological##10##1##(2010-1#6)(2012-12#4)
entomologist##3##1##(2010-1#3)
entomologists##5##1##(2010-1#5)
entomology and parasitology##2##3##(2010-1#2)
entomology and##4##2##(2010-1#4)
entomology in Brazil##2##3##(2010-1#2)
entomology in##6##2##(2010-1#6)
entomology##23##1##(2010-1#23)
entopeduncular##2##1##(1996-12#1)(1997-3#1)
entorhinal cortex pars medialis##2##4##(1994-8#2)
entorhinal cortex##12##2##(1992-1#1)(1994-2#1)(1994-8#2)(1996-12#1)(1997-3#1)(2008-11#6)
entorhinal-hippocampal loop##3##2##(2008-11#3)
entrained##3##1##(1995-11#1)(1995-3#1)(2008-5#1)
entrainer##2##1##(1990-5#1)(2013-1#1)
entrainment of##3##2##(1990-5#2)(2008-5#1)
entrainment##5##1##(1990-5#2)(1994-2#1)(2008-5#2)
entrance into##2##2##(2008-10#1)(2009-7#1)
entrance of##2##2##(1997-2#1)(2008-10#1)
entrance##12##1##(1994-12#1)(1995-11#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-11#1)(2011-2#1)
entrants##2##1##(1991-12#1)(1997-2#1)
entrapment and##2##2##(2008-11#1)(2008-7#1)
entrapment by estoppel##3##3##(1994-3#3)
entrapment by##4##2##(1994-3#3)(2012-3#1)
entrapment in##4##2##(2008-10#4)
entrapment of##4##2##(2008-10#3)(2008-11#1)
entrapment##27##1##(1992-2#1)(1994-3#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-7#4)(2008-8#1)(2011-2#3)(2012-3#1)
entrapped hepatocytes##2##2##(2008-11#2)
entrapped in a##3##3##(2008-10#3)
entrapped in the##4##3##(2008-10#4)
entrapped in##10##2##(2008-10#9)(2013-1#1)
entrapped peroxidase##2##2##(2008-10#2)
entrapped within##2##2##(2008-10#1)(2008-8#1)
entrapped##23##1##(1995-3#1)(2008-10#14)(2008-11#5)(2008-8#1)(2011-2#1)(2013-1#1)
entrapping##4##1##(2008-10#3)(2011-2#1)
entraps##2##1##(1997-1#1)(2008-11#1)
entre##3##1##(2009-10#2)(2011-2#1)
entrepreneurs##3##1##(1996-2#3)
entries into##3##2##(1993-6#1)(1993-8#1)(2008-11#1)
entries that used##2##3##(2008-10#2)
entries that##3##2##(2008-10#3)
entries were##2##2##(1993-6#1)(2008-10#1)
entries##16##1##(1993-6#3)(1993-8#1)(2008-10#10)(2008-11#1)(2011-2#1)
entropically driven##3##2##(1993-8#3)
entropically##6##1##(1993-8#3)(2008-10#3)
entropy analysis##2##2##(2007-12#2)
entropy and##2##2##(1993-12#1)(2008-10#1)
entropy of the##2##3##(1993-12#1)(2008-10#1)
entropy of##4##2##(1993-12#1)(2008-10#2)(2008-4#1)
entropy##20##1##(1993-12#4)(1993-3#1)(1997-2#1)(2007-12#2)(2008-10#8)(2008-4#1)(2008-5#1)(2009-8#1)(2010-7#1)
entry and##7##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
entry in the##2##3##(1995-2#1)(2008-5#1)
entry in##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
entry inhibitors##7##2##(2011-2#6)(2011-3#1)
entry into S phase##2##4##(1992-10#2)
entry into S##3##3##(1992-10#2)(1994-3#1)
entry into the##7##3##(1990-8#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
entry into##15##2##(1990-5#1)(1990-8#1)(1992-10#2)(1994-3#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-5#1)(2012-2#2)
entry of##6##2##(1994-8#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)
entry point##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
entry site##4##2##(1993-6#1)(1997-8#1)(2008-10#1)(2011-2#1)
entry sites##2##2##(2008-11#1)(2009-8#1)
entry to##6##2##(1994-12#1)(2008-10#1)(2008-11#2)(2012-2#1)(2012-3#1)
entry via##3##2##(2008-10#1)(2008-11#2)
entry was##2##2##(1993-9#1)(2008-11#1)
entry##94##1##(1990-5#1)(1990-8#1)(1991-3#1)(1992-10#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#2)(1995-2#5)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#15)(2008-11#16)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#9)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
enucleated##6##1##(2008-9#6)
enumerate##3##1##(2008-4#2)(2010-8#1)
enumerated##4##1##(2008-10#3)(2008-11#1)
enumerating##7##1##(2008-10#2)(2008-9#3)(2010-10#1)(2012-2#1)
enumeration and##4##2##(2008-10#2)(2008-9#2)
enumeration of these cells##2##4##(2008-9#1)(2010-1#1)
enumeration of##10##2##(1996-3#1)(2008-10#1)(2008-9#7)(2010-1#1)
enumeration task##3##2##(2013-8#3)
enumeration##22##1##(1996-3#1)(2008-10#3)(2008-9#14)(2010-1#1)(2013-8#3)
enuresis##3##1##(1994-8#1)(2008-10#2)
env##7##1##(1994-12#1)(2008-11#2)(2008-9#3)(2013-8#1)
envelope (CE)##2##2##(2008-5#2)
envelope and##7##2##(1993-12#1)(2008-12#2)(2008-9#1)(2011-2#3)
envelope glycoprotein##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
envelope glycoproteins##2##2##(1990-2#1)(2011-2#1)
envelope is##2##2##(1994-5#1)(2008-12#1)
envelope of the##2##3##(2007-12#1)(2009-8#1)
envelope of##3##2##(2007-12#1)(2009-8#1)(2013-1#1)
envelope protein or##2##3##(1993-12#1)(1995-5#1)
envelope protein##3##2##(1993-12#1)(1995-5#1)(2008-8#1)
envelope proteins##3##2##(1995-2#1)(2009-8#1)(2011-2#1)
envelope##65##1##(1990-2#1)(1993-12#3)(1994-11#4)(1994-3#1)(1994-5#3)(1995-2#4)(1995-5#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-12#6)(2008-4#2)(2008-5#8)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#2)(2011-2#16)(2012-3#1)(2013-1#3)(2013-8#1)
enveloped by##2##2##(2008-1#1)(2008-7#1)
enveloped##7##1##(1995-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
envelopes##8##1##(1994-11#3)(1994-5#1)(2007-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
enveloping##2##1##(2008-5#1)(2008-7#1)
envelopment##6##1##(1992-2#5)(2008-7#1)
environment allows##2##2##(1995-2#1)(2011-7#1)
environment and operators##2##3##(2012-2#2)
environment and social##2##3##(1996-2#1)(2008-12#1)
environment and the##4##3##(1993-11#1)(2008-10#1)(2008-8#1)(2012-12#1)
environment and##61##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-3#2)(2008-10#3)(2008-11#7)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#7)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#1)
environment as##4##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)
environment at trace levels##2##4##(2008-10#2)
environment at trace##3##3##(2008-10#3)
environment at##5##2##(2008-10#4)(2012-2#1)
environment based on##2##3##(2008-7#1)(2009-3#1)
environment became less controlled##2##4##(2008-10#2)
environment but##2##2##(2008-8#1)(2009-7#1)
environment by##2##2##(1996-2#1)(2008-10#1)
environment can##2##2##(2008-10#1)(2008-8#1)
environment during##2##2##(2008-10#2)
environment experiments##3##2##(2008-10#3)
environment for##15##2##(1992-2#2)(1992-3#2)(1993-2#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-9#1)
environment has##6##2##(1991-2#1)(1993-12#1)(2008-10#3)(2012-7#1)
environment in the##4##3##(1990-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
environment in which##4##3##(1991-2#1)(1995-6#1)(2008-8#1)(2010-8#1)
environment in##16##2##(1990-3#1)(1991-2#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
environment is##15##2##(1994-3#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
environment may##4##2##(1997-7#1)(2008-10#2)(2013-8#1)
environment of the region to##2##5##(2008-11#1)(2013-1#1)
environment of the##9##3##(1991-6#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-6#1)(2010-4#1)(2013-1#1)
environment of##21##2##(1990-5#1)(1991-6#1)(1994-5#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
environment on the##3##3##(2008-10#2)(2008-3#1)
environment on##7##2##(2008-10#3)(2008-12#1)(2008-3#2)(2010-1#1)
environment or##4##2##(1991-1#1)(1996-12#1)(2008-5#1)(2008-8#1)
environment that##4##2##(1992-2#1)(1996-2#1)(2008-10#1)(2010-11#1)
environment through##2##2##(2008-8#1)(2010-7#1)
environment to##11##2##(1995-2#1)(1996-3#1)(1997-7#2)(2008-10#3)(2008-12#2)(2008-7#1)(2011-2#1)
environment was##7##2##(1993-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
environment were##2##2##(2008-10#1)(2008-7#1)
environment where##5##2##(1991-12#1)(2008-10#1)(2008-11#2)(2008-8#1)
environment while##2##2##(2008-11#1)(2008-4#1)
environment with##3##2##(2008-10#2)(2013-8#1)
environment##570##1##(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#8)(1991-11#1)(1991-12#5)(1991-2#5)(1991-3#5)(1991-5#1)(1991-6#1)(1992-1#3)(1992-11#1)(1992-2#8)(1992-3#4)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#3)(1993-6#4)(1993-8#1)(1994-1#1)(1994-12#6)(1994-2#1)(1994-3#11)(1994-5#2)(1994-8#3)(1995-12#1)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#6)(1996-2#5)(1996-3#11)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-7#6)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#135)(2008-11#62)(2008-12#21)(2008-2#3)(2008-3#10)(2008-4#8)(2008-5#11)(2008-6#1)(2008-7#13)(2008-8#32)(2008-9#17)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#17)(2011-7#1)(2012-12#4)(2012-2#10)(2012-3#8)(2012-4#4)(2012-7#1)(2013-1#7)(2013-8#9)
environment&quot##2##1##(2008-10#1)(2008-8#1)
environment)##3##1##(2008-11#1)(2008-3#1)(2008-8#1)
environment-friendly##2##1##(2008-9#1)(2009-10#1)
environment]##2##1##(1991-6#1)(2010-12#1)
environmental accounting##2##2##(2008-11#2)
environmental agent##2##2##(1991-12#2)
environmental analysis##9##2##(2008-10#6)(2008-11#1)(2008-3#2)
environmental and biological samples##14##4##(2008-10#14)
environmental and biological##17##3##(2008-10#17)
environmental and clinical##2##3##(2008-11#1)(2011-2#1)
environmental and commodity samples##2##4##(2008-10#2)
environmental and developmental##2##3##(2008-7#1)(2009-8#1)
environmental and food##4##3##(2008-10#2)(2010-11#1)(2010-5#1)
environmental and genetic factors##4##4##(2008-7#1)(2008-9#1)(2009-8#2)
environmental and genetic##5##3##(2008-7#1)(2008-9#1)(2009-8#2)(2010-4#1)
environmental and industrial##3##3##(2008-10#3)
environmental and occupational##2##3##(2009-12#1)(2013-1#1)
environmental and pharmaceutical samples##2##4##(2008-10#2)
environmental and social##2##3##(2008-7#1)(2011-2#1)
environmental and waste##2##3##(2008-10#2)
environmental and##66##2##(1990-9#1)(1993-12#1)(2008-10#38)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#2)
environmental and/or##2##2##(2008-10#1)(2008-4#1)
environmental applications##2##2##(2008-10#2)
environmental areas##2##2##(2008-10#2)
environmental assessment##2##2##(2008-10#1)(2009-8#1)
environmental atmosphere##2##2##(2008-10#2)
environmental chamber##6##2##(2008-10#6)
environmental change##7##2##(2008-8#1)(2011-2#5)(2012-3#1)
environmental changes and##2##3##(2011-2#1)(2012-3#1)
environmental changes##9##2##(2008-11#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#2)(2013-8#1)
environmental chemicals##4##2##(1994-3#2)(2008-10#1)(2009-9#1)
environmental chemistry##4##2##(2008-10#4)
environmental compartments##2##2##(2008-10#1)(2008-11#1)
environmental compounds##2##2##(2008-10#1)(2009-6#1)
environmental conditions and##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
environmental conditions are##5##3##(2008-10#3)(2008-9#1)(2009-9#1)
environmental conditions for##2##3##(2008-10#1)(2008-11#1)
environmental conditions such as##2##4##(2008-10#1)(2008-4#1)
environmental conditions that##2##3##(2008-10#2)
environmental conditions were##2##3##(2008-10#2)
environmental conditions##70##2##(1992-12#1)(1993-2#1)(1995-9#1)(1996-12#1)(1997-6#1)(2008-10#38)(2008-11#6)(2008-4#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#2)
environmental constraints##3##2##(2010-6#2)(2011-2#1)
environmental contaminants##2##2##(1994-3#2)
environmental contamination##2##2##(2008-10#1)(2008-11#1)
environmental data##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
environmental design##2##2##(1991-1#2)
environmental differences##3##2##(2008-8#1)(2012-3#2)
environmental effects##3##2##(2008-11#1)(2009-8#1)(2010-8#1)
environmental estrogenic mimics##2##3##(2010-5#2)
environmental exposure##3##2##(1996-3#1)(2008-12#1)(2010-1#1)
environmental exposures##6##2##(1991-12#3)(2008-10#2)(2013-1#1)
environmental factor in##2##3##(2008-12#1)(2013-8#1)
environmental factor##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
environmental factors (e##2##3##(2008-4#1)(2008-7#1)
environmental factors affect##2##3##(2008-10#1)(2010-6#1)
environmental factors and##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
environmental factors are##5##3##(2008-10#1)(2008-7#2)(2012-5#1)(2013-7#1)
environmental factors influence##2##3##(2008-10#1)(2008-7#1)
environmental factors on##2##3##(2008-10#1)(2012-2#1)
environmental factors such as##5##4##(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#1)
environmental factors that##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
environmental factors##54##2##(1993-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
environmental fate##3##2##(1995-11#3)
environmental feedback##2##2##(2008-8#2)
environmental fields##2##2##(2008-10#1)(2008-11#1)
environmental fluctuations##3##2##(2008-8#3)
environmental gradients##2##2##(2008-8#2)
environmental health services##3##3##(1997-2#3)
environmental health##11##2##(1991-12#1)(1997-2#4)(2008-1#4)(2008-11#2)
environmental heterogeneity##3##2##(2008-8#3)
environmental impact##6##2##(1996-1#1)(2008-10#3)(2008-11#2)
environmental impacts of the##2##4##(2008-11#2)
environmental impacts of##3##3##(2008-11#3)
environmental impacts##5##2##(2008-11#4)(2008-12#1)
environmental influences##5##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
environmental intervention##2##2##(2012-2#1)(2013-1#1)
environmental issues##2##2##(1996-1#1)(2008-10#1)
environmental levels##2##2##(2008-10#1)(2008-11#1)
environmental management##2##2##(2008-11#1)(2008-8#1)
environmental matrices##10##2##(2008-10#8)(2008-11#2)
environmental monitoring and##3##3##(2008-10#2)(2010-8#1)
environmental monitoring of##5##3##(2008-10#4)(2012-2#1)
environmental monitoring##20##2##(2008-10#15)(2008-4#1)(2010-8#1)(2012-2#3)
environmental noise##12##2##(2008-8#7)(2008-9#2)(2011-1#1)(2011-2#2)
environmental or##5##2##(1991-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-11#1)
environmental organic pollutants##2##3##(2008-10#2)
environmental oxygen##2##2##(2008-10#1)(2011-2#1)
environmental parameters##2##2##(2008-10#1)(2012-3#1)
environmental policy##2##2##(2008-11#2)
environmental pollutant##4##2##(2008-10#3)(2009-3#1)
environmental pollutants##7##2##(1994-3#1)(2008-10#6)
environmental pollution##4##2##(2008-10#2)(2009-12#1)(2010-7#1)
environmental problems##3##2##(2008-10#1)(2008-11#1)(2009-3#1)
environmental protection##2##2##(2008-10#1)(2008-11#1)
environmental quality##2##2##(2008-10#1)(2008-11#1)
environmental research##4##2##(2008-10#3)(2008-11#1)
environmental risk assessment##6##3##(2008-10#2)(2008-11#2)(2008-9#1)(2010-5#1)
environmental risk factors##3##3##(1992-12#2)(2008-11#1)
environmental risk##11##2##(1992-12#2)(2008-10#3)(2008-11#4)(2008-9#1)(2010-5#1)
environmental safety##2##2##(2008-10#1)(2008-11#1)
environmental sample##2##2##(2008-10#2)
environmental samples and##2##3##(2008-10#2)
environmental samples are##3##3##(2008-10#3)
environmental samples by##6##3##(2008-10#6)
environmental samples has##2##3##(2008-10#1)(2011-2#1)
environmental samples was##2##3##(2008-10#2)
environmental samples with satisfactory results##2##5##(2008-10#2)
environmental samples with##3##3##(2008-10#3)
environmental samples##87##2##(2008-10#81)(2008-11#3)(2011-2#2)(2012-12#1)
environmental scanning electron microscopy##3##4##(2008-10#1)(2008-9#2)
environmental science##2##2##(2008-10#1)(2008-11#1)
environmental signals##3##2##(2008-10#1)(2009-8#1)(2011-1#1)
environmental significance##3##2##(2008-10#2)(2010-7#1)
environmental sources##4##2##(2008-10#3)(2008-8#1)
environmental stimuli##4##2##(2008-11#1)(2008-4#1)(2008-5#2)
environmental stochasticity##3##2##(2008-8#1)(2008-9#2)
environmental stress##11##2##(2008-10#3)(2009-8#1)(2010-4#4)(2011-1#1)(2012-2#1)(2012-3#1)
environmental stresses##3##2##(2008-11#1)(2011-2#2)
environmental stressors##4##2##(2008-7#1)(2009-8#1)(2010-4#2)
environmental studies##3##2##(2008-10#3)
environmental systems##2##2##(2008-10#1)(2010-11#1)
environmental variability##4##2##(2008-8#3)(2010-8#1)
environmental variable##2##2##(2008-10#1)(2008-8#1)
environmental variables##8##2##(2008-10#6)(2008-11#1)(2008-5#1)
environmental variance##3##2##(2008-8#2)(2008-9#1)
environmental water samples by##2##4##(2008-10#2)
environmental water samples has been developed##2##6##(2008-10#2)
environmental water samples##10##3##(2008-10#10)
environmental water##12##2##(2008-10#12)
environmental waters (potable and polluted)##2##5##(2008-10#2)
environmental waters by##2##3##(2008-10#2)
environmental waters##10##2##(2008-10#10)
environmental##770##1##(1990-6#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#9)(1991-6#1)(1992-12#3)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#6)(1995-11#4)(1995-2#1)(1995-9#1)(1996-1#5)(1996-12#1)(1996-3#4)(1997-2#4)(1997-3#4)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#4)(2008-10#378)(2008-11#60)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#9)(2008-7#16)(2008-8#59)(2008-9#16)(2009-11#1)(2009-12#6)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#15)(2009-9#3)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-4#9)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#7)(2011-2#28)(2011-3#1)(2012-12#2)(2012-2#12)(2012-3#13)(2012-5#1)(2012-9#3)(2013-1#9)(2013-7#1)(2013-8#7)
environmentally benign##3##2##(2008-10#2)(2012-2#1)
environmentally determined##2##2##(2008-8#2)
environmentally driven variability in##2##4##(2008-8#2)
environmentally friendly method##2##3##(2008-10#2)
environmentally friendly##7##2##(1992-3#1)(2008-10#6)
environmentally important##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)
environmentally induced bias in phenotypic estimates of##2##7##(2008-8#2)
environmentally induced bias##3##3##(2008-8#3)
environmentally induced##4##2##(2008-8#4)
environmentally relevant##3##2##(2008-10#3)
environmentally##40##1##(1992-3#1)(2008-10#20)(2008-11#3)(2008-3#2)(2008-8#10)(2011-1#1)(2012-2#3)
environments and##17##2##(1990-11#1)(2008-10#5)(2008-8#3)(2008-9#3)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
environments are##2##2##(2008-1#1)(2008-10#1)
environments by##4##2##(1997-7#1)(2008-10#1)(2008-2#1)(2008-9#1)
environments can##3##2##(2008-8#1)(2008-9#2)
environments due to##2##3##(2008-10#1)(2010-5#1)
environments for##3##2##(1996-12#1)(2008-11#2)
environments has##3##2##(2008-10#1)(2012-2#2)
environments if##2##2##(1997-7#1)(2008-8#1)
environments in##2##2##(1991-3#1)(2008-10#1)
environments including##2##2##(2011-2#2)
environments is##2##2##(2008-10#2)
environments of the##2##3##(2008-9#2)
environments of##4##2##(2008-10#1)(2008-12#1)(2008-9#2)
environments such as##2##3##(2008-10#1)(2011-2#1)
environments that##4##2##(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#1)
environments to##4##2##(2008-11#1)(2010-4#1)(2010-5#1)(2012-2#1)
environments via##2##2##(2008-5#1)(2010-4#1)
environments were##2##2##(2008-10#2)
environments where##2##2##(2008-11#1)(2008-8#1)
environments with a##2##3##(2008-10#1)(2008-12#1)
environments with##5##2##(2008-10#2)(2008-12#1)(2008-9#1)(2010-1#1)
environments##234##1##(1990-11#1)(1991-1#2)(1991-3#1)(1991-5#1)(1993-2#4)(1994-2#2)(1994-3#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-7#5)(2008-1#1)(2008-10#64)(2008-11#15)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#37)(2008-9#18)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#5)(2010-7#2)(2010-8#5)(2011-1#3)(2011-2#10)(2012-2#11)(2012-3#7)(2012-5#2)(2013-1#3)(2013-8#3)
environments)##4##1##(2008-8#3)(2012-12#1)
envisage##6##1##(1991-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
envisaged in##2##2##(1991-11#1)(2008-10#1)
envisaged##10##1##(1991-11#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-3#1)(2012-3#1)
envision the##2##2##(1993-2#1)(1994-12#1)
envision##5##1##(1993-2#2)(1993-5#1)(1994-12#1)(1997-1#1)
envisioned##4##1##(2008-10#2)(2008-9#1)(2009-12#1)
enzootic##3##1##(2008-10#1)(2011-2#2)
enzymatic activities of##3##3##(1993-12#1)(2008-10#2)
enzymatic activities##13##2##(1993-12#1)(1993-2#3)(2008-10#5)(2008-5#1)(2008-7#2)(2010-12#1)
enzymatic activity and##4##3##(2008-11#1)(2008-7#1)(2010-12#2)
enzymatic activity in##2##3##(1994-11#1)(2008-10#1)
enzymatic activity of##9##3##(1993-3#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-6#1)
enzymatic activity was##4##3##(1992-6#1)(2008-10#3)
enzymatic activity##42##2##(1992-6#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-2#2)(1995-6#2)(2008-10#14)(2008-11#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2010-12#3)(2011-1#1)
enzymatic analysis of##2##3##(1997-2#1)(2008-10#1)
enzymatic and non-enzymatic##2##3##(2008-5#2)
enzymatic and##4##2##(1990-8#1)(1994-11#1)(2008-5#2)
enzymatic assay and##2##3##(2008-10#2)
enzymatic assay for##2##3##(1990-2#1)(1997-8#1)
enzymatic assay of##3##3##(2008-10#3)
enzymatic assay##8##2##(1990-2#2)(1997-8#1)(2008-10#5)
enzymatic assays for the##2##4##(1990-2#1)(2011-2#1)
enzymatic assays##6##2##(1990-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
enzymatic biosensors##2##2##(2008-10#2)
enzymatic catalysis##2##2##(1990-12#1)(2008-10#1)
enzymatic cofactor##2##2##(1990-9#1)(2012-2#1)
enzymatic complex##3##2##(1990-11#1)(1997-2#1)(1997-7#1)
enzymatic degradation of##3##3##(2008-10#3)
enzymatic degradation##8##2##(1993-2#1)(1994-11#1)(1997-2#1)(2008-10#4)(2011-1#1)
enzymatic digestion of##2##3##(1990-5#1)(1991-5#1)
enzymatic digestion##3##2##(1990-5#2)(1991-5#1)
enzymatic extracts were##2##3##(2008-10#2)
enzymatic hydrolysis of urea##2##4##(2008-10#2)
enzymatic hydrolysis of##8##3##(2008-10#6)(2008-5#2)
enzymatic hydrolysis##20##2##(1991-9#1)(2008-10#14)(2008-5#3)(2009-8#1)(2013-1#1)
enzymatic kinetics##2##2##(1996-2#1)(2008-9#1)
enzymatic label##2##2##(2008-10#2)
enzymatic method##2##2##(2008-10#2)
enzymatic oxidation of##3##3##(2008-10#3)
enzymatic oxidation##5##2##(2008-10#5)
enzymatic pretreatment##3##2##(2008-6#3)
enzymatic probe##4##2##(2008-10#2)(2008-9#2)
enzymatic properties of##3##3##(1995-6#1)(2008-10#1)(2009-8#1)
enzymatic purification of PCR products for direct sequencing##2##8##(2008-4#2)
enzymatic purification of##3##3##(2008-4#2)(2008-5#1)
enzymatic reaction and##4##3##(2008-10#3)(2011-2#1)
enzymatic reaction of##5##3##(1991-5#1)(2008-10#4)
enzymatic reaction##27##2##(1991-5#1)(2008-10#22)(2008-7#2)(2009-5#1)(2011-2#1)
enzymatic reactions using##2##3##(2008-4#1)(2009-6#1)
enzymatic reactions##9##2##(1990-5#2)(1994-3#1)(2008-10#1)(2008-4#2)(2009-6#1)(2010-10#2)
enzymatic reactor was##2##3##(2008-10#2)
enzymatic reactor##3##2##(2008-10#3)
enzymatic reactors and their applications in proteome##2##7##(2008-12#2)
enzymatic reactors##6##2##(2008-12#6)
enzymatic reduction##2##2##(2008-10#2)
enzymatic system##4##2##(2008-10#3)(2011-1#1)
enzymatic systems##3##2##(1991-8#1)(2008-10#1)(2013-1#1)
enzymatic treatment##2##2##(2008-6#1)(2008-9#1)
enzymatic##269##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#4)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#3)(1993-12#2)(1993-2#5)(1993-3#2)(1993-8#3)(1993-9#1)(1994-11#3)(1994-3#1)(1995-2#2)(1995-6#3)(1995-9#1)(1996-2#1)(1997-2#4)(1997-7#1)(1997-8#1)(2008-10#129)(2008-11#8)(2008-12#7)(2008-4#8)(2008-5#12)(2008-6#6)(2008-7#12)(2008-9#6)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#5)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#4)(2012-2#2)(2012-6#1)(2013-1#3)(2013-8#1)
enzymatically active##6##2##(1992-12#1)(1994-11#1)(1994-6#1)(1995-6#1)(2008-4#2)
enzymatically converted to##2##3##(2008-10#2)
enzymatically dissociated##2##2##(1994-11#1)(2008-11#1)
enzymatically produced hydrogen peroxide##2##4##(2008-10#2)
enzymatically produced##3##2##(2008-10#3)
enzymatically##26##1##(1992-12#1)(1994-11#2)(1994-6#1)(1995-2#1)(1995-6#1)(2008-10#12)(2008-11#2)(2008-4#4)(2008-5#1)(2008-9#1)
enzyme (ACE) inhibitor##2##3##(2008-1#1)(2008-7#1)
enzyme (ACE)##5##2##(1993-12#1)(2008-1#1)(2008-6#1)(2008-7#2)
enzyme active against##2##3##(2010-3#2)
enzyme active##5##2##(1995-6#3)(2010-3#2)
enzyme activities in both##2##4##(1994-11#1)(2008-9#1)
enzyme activities in##5##3##(1994-11#2)(2008-12#1)(2008-5#1)(2008-9#1)
enzyme activities involved in##2##4##(2008-10#2)
enzyme activities were##4##3##(1994-11#1)(1995-2#1)(2008-10#2)
enzyme activities##20##2##(1993-8#1)(1994-11#5)(1995-2#1)(2008-10#4)(2008-12#2)(2008-5#2)(2008-7#2)(2008-9#1)(2011-10#1)(2012-6#1)
enzyme activity and##2##3##(1990-6#1)(1997-6#1)
enzyme activity by##4##3##(1990-5#1)(1994-8#2)(2011-1#1)
enzyme activity in the liver##2##5##(1995-2#1)(2008-6#1)
enzyme activity in the##5##4##(1991-5#1)(1993-1#1)(1995-2#1)(2008-10#1)(2008-6#1)
enzyme activity in##11##3##(1991-5#1)(1992-10#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-6#2)(2008-7#1)
enzyme activity is##2##3##(1996-3#1)(2008-8#1)
enzyme activity measurement##2##3##(2008-10#1)(2008-5#1)
enzyme activity of##4##3##(1993-3#1)(2008-10#1)(2011-2#1)(2012-6#1)
enzyme activity was##10##3##(1990-5#1)(1994-11#2)(2008-10#5)(2008-11#1)(2008-6#1)
enzyme activity were##2##3##(1990-5#1)(2013-1#1)
enzyme activity##80##2##(1990-5#3)(1990-6#1)(1991-5#2)(1992-10#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#4)(1993-8#1)(1993-9#1)(1994-11#4)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#2)(1996-3#1)(1997-6#3)(2008-10#16)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-6#1)(2013-1#2)
enzyme and a##2##3##(1995-2#1)(2008-10#1)
enzyme and the##5##3##(1997-9#1)(2008-10#4)
enzyme and##28##2##(1990-5#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#2)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#3)(1997-9#1)(2008-10#9)(2008-11#2)(2008-6#1)
enzyme apparently##2##2##(1992-3#1)(1995-6#1)
enzyme are##2##2##(1991-3#1)(1992-1#1)
enzyme as##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
enzyme assay##8##2##(1990-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#2)
enzyme assays##2##2##(2008-10#1)(2008-6#1)
enzyme binds##2##2##(1994-5#1)(1997-7#1)
enzyme biosensor based on pH-ISFETs##2##5##(2008-10#2)
enzyme biosensor for##2##3##(2008-10#2)
enzyme biosensor##5##2##(2008-10#5)
enzyme bound##4##2##(1991-5#1)(1994-5#1)(1995-6#1)(2009-8#1)
enzyme by##11##2##(1991-10#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
enzyme can be##2##3##(1992-12#1)(2008-10#1)
enzyme can##4##2##(1992-12#1)(2008-10#3)
enzyme carboxypeptidase##2##2##(1990-5#1)(1995-8#1)
enzyme catalyzing the synthesis##2##4##(1992-6#1)(1994-11#1)
enzyme catalyzing the##3##3##(1992-6#1)(1994-11#1)(2008-7#1)
enzyme complex and##2##3##(2008-11#1)(2012-2#1)
enzyme complex##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
enzyme component##3##2##(1992-9#1)(2008-9#2)
enzyme concentration##2##2##(2008-10#1)(2008-11#1)
enzyme conjugate as signal generator##2##5##(2008-7#2)
enzyme conjugate##3##2##(2008-7#3)
enzyme contained##3##2##(1990-5#1)(1994-11#1)(1995-6#1)
enzyme could be##2##3##(1997-7#1)(2008-10#1)
enzyme could##3##2##(1997-7#1)(2008-10#2)
enzyme digestion##5##2##(1993-12#1)(2008-10#2)(2008-11#2)
enzyme digests of##2##3##(2008-10#2)
enzyme during##3##2##(2008-10#2)(2008-7#1)
enzyme electrode and##2##3##(2008-10#2)
enzyme electrode based on##2##4##(2008-10#2)
enzyme electrode for##3##3##(2008-10#3)
enzyme electrode has been##2##4##(2008-10#2)
enzyme electrode has##3##3##(2008-10#3)
enzyme electrode##22##2##(2008-10#22)
enzyme electrodes were##2##3##(2008-10#2)
enzyme electrodes##8##2##(2008-10#8)
enzyme exhibited a##2##3##(1994-11#1)(2008-6#1)
enzyme exhibited##3##2##(1994-11#1)(2008-6#1)(2012-2#1)
enzyme for##14##2##(1990-5#1)(1993-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-3#1)
enzyme form##2##2##(1990-11#1)(1991-9#1)
enzyme from##17##2##(1990-5#1)(1992-3#1)(1992-6#3)(1993-2#1)(1994-11#3)(1995-8#1)(1996-2#3)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
enzyme function##4##2##(1991-3#1)(1991-9#1)(2011-1#1)(2012-2#1)
enzyme gene##2##2##(2008-12#1)(2012-5#1)
enzyme had a##2##3##(2008-10#1)(2008-11#1)
enzyme had##5##2##(1990-10#1)(1991-5#1)(1995-8#1)(2008-10#1)(2008-11#1)
enzyme has a##2##3##(1990-11#1)(2008-8#1)
enzyme has been##4##3##(1990-5#1)(1997-7#1)(2008-10#1)(2009-3#1)
enzyme has##12##2##(1990-11#2)(1990-5#1)(1994-11#2)(1995-2#1)(1997-7#1)(2008-10#2)(2008-8#1)(2009-3#1)(2011-1#1)
enzyme immobilization##4##2##(2008-10#3)(2008-12#1)
enzyme immunoassay (EIA)##2##3##(1990-12#1)(2008-10#1)
enzyme immunoassay for clenbuterol##2##4##(2008-10#2)
enzyme immunoassay for##6##3##(1996-12#1)(2008-10#5)
enzyme immunoassay##18##2##(1990-12#1)(1990-2#1)(1992-3#1)(1993-2#1)(1996-12#3)(1997-2#1)(2008-10#9)(2008-6#1)
enzyme immunoassays##5##2##(1990-11#1)(1993-11#1)(1993-2#1)(2008-10#1)(2010-11#1)
enzyme immunosensing system##2##3##(2008-10#2)
enzyme in a body lotion##2##5##(2008-10#2)
enzyme in a##4##3##(1995-6#1)(2008-10#3)
enzyme in human##3##3##(1992-12#1)(2006-6#1)(2011-3#1)
enzyme in the presence of##2##5##(2008-10#1)(2008-4#1)
enzyme in the##15##3##(1990-5#1)(1991-9#1)(1993-12#1)(1995-2#1)(2008-10#7)(2008-4#1)(2008-9#1)(2009-3#1)(2009-7#1)
enzyme in##42##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#2)(2006-6#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-3#1)(2012-2#1)
enzyme inactivation##4##2##(1993-8#1)(1994-5#1)(2011-2#2)
enzyme inhibition##6##2##(2008-10#6)
enzyme inhibitors##8##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)(2013-1#1)
enzyme involved in the##3##4##(1992-3#1)(2008-11#1)(2008-9#1)
enzyme involved in##6##3##(1992-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
enzyme is a##3##3##(1993-8#1)(1997-7#1)(2008-9#1)
enzyme is##22##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-8#4)(1994-8#1)(1995-6#2)(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)(2012-6#1)
enzyme kinetic parameters##2##3##(2008-10#2)
enzyme kinetic##3##2##(2008-10#2)(2011-1#1)
enzyme kinetics##3##2##(1992-3#1)(1997-6#1)(2011-3#1)
enzyme labels##2##2##(2008-10#2)
enzyme layer##5##2##(2008-10#5)
enzyme levels were##2##3##(2008-1#1)(2008-5#1)
enzyme levels##5##2##(2008-1#1)(2008-10#1)(2008-5#3)
enzyme linked immunosorbent assay (ELISA)##3##5##(1990-2#1)(2008-1#1)(2011-3#1)
enzyme linked immunosorbent assay##4##4##(1990-2#1)(2008-1#1)(2008-10#1)(2011-3#1)
enzyme linked immunosorbent##5##3##(1990-2#1)(2008-1#1)(2008-10#2)(2011-3#1)
enzyme loading##6##2##(2008-10#4)(2011-2#2)
enzyme mediated##2##2##(1992-9#1)(2008-10#1)
enzyme molecule##2##2##(1993-8#1)(2012-2#1)
enzyme molecules##5##2##(2008-10#3)(2011-2#1)(2012-2#1)
enzyme nor##2##2##(2008-10#1)(2008-9#1)
enzyme of the##4##3##(1994-11#1)(1994-8#1)(2010-12#1)(2011-1#1)
enzyme of##15##2##(1992-1#1)(1992-8#1)(1993-6#1)(1994-11#3)(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-8#1)(2010-12#2)(2011-1#1)
enzyme on##4##2##(1995-6#1)(2008-10#3)
enzyme or##2##2##(1995-6#1)(2008-11#1)
enzyme preparation##3##2##(1991-12#1)(1994-8#1)(2008-11#1)
enzyme preparations##3##2##(1997-7#1)(2008-7#2)
enzyme production##7##2##(2008-10#1)(2008-6#1)(2008-7#3)(2011-2#1)(2012-2#1)
enzyme protein##2##2##(1992-10#1)(1993-8#1)
enzyme purified from##3##3##(1993-8#2)(1994-6#1)
enzyme reaction##7##2##(2008-10#7)
enzyme reactions##3##2##(1990-2#1)(1992-9#1)(2011-2#1)
enzyme reactor##4##2##(2008-10#4)
enzyme reactors##5##2##(2008-10#5)
enzyme remains##2##2##(1995-2#1)(2008-10#1)
enzyme replacement therapy##4##3##(2008-10#2)(2012-12#2)
enzyme responsible##3##2##(1990-8#1)(2008-11#2)
enzyme secretion##2##2##(1994-8#1)(2008-10#1)
enzyme sensor##2##2##(2008-10#2)
enzyme sensors##2##2##(2008-10#2)
enzyme sequences##2##2##(2008-10#2)
enzyme shows##3##2##(1992-1#1)(1995-2#1)(2008-8#1)
enzyme solutions##2##2##(2008-10#1)(2011-2#1)
enzyme source##2##2##(2008-10#1)(2008-5#1)
enzyme stability##2##2##(2008-7#2)
enzyme subunit##3##2##(1990-10#1)(1994-5#2)
enzyme system in##2##3##(2008-11#1)(2009-9#1)
enzyme system##8##2##(1993-8#1)(2008-10#3)(2008-11#1)(2009-9#3)
enzyme systems in##2##3##(1990-11#1)(2009-9#1)
enzyme systems##6##2##(1990-11#2)(2008-10#2)(2008-8#1)(2009-9#1)
enzyme that hydrolyzes valaciclovir##2##4##(1995-6#2)
enzyme that is required for##2##5##(2008-9#1)(2009-8#1)
enzyme that is##4##3##(2008-7#1)(2008-9#1)(2009-8#2)
enzyme that##17##2##(1990-5#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-6#2)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
enzyme the##2##2##(1994-8#1)(2009-5#1)
enzyme through the##3##3##(2008-10#2)(2008-11#1)
enzyme to be##2##3##(2008-10#1)(2009-8#1)
enzyme to the##3##3##(1992-12#1)(1995-6#1)(1995-8#1)
enzyme to##15##2##(1990-2#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-6#2)(1995-8#1)(2008-10#6)(2009-8#1)
enzyme was also##2##3##(2008-11#2)
enzyme was immobilized on##2##4##(2008-10#2)
enzyme was immobilized##3##3##(2008-10#3)
enzyme was purified to##2##4##(1990-10#1)(1993-8#1)
enzyme was purified##6##3##(1990-10#1)(1993-8#1)(1994-6#1)(1994-8#2)(1997-2#1)
enzyme was stable##2##3##(1997-2#1)(2008-6#1)
enzyme was##50##2##(1990-10#3)(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#3)(1995-6#4)(1995-8#1)(1997-2#2)(1997-6#1)(2008-10#13)(2008-11#2)(2008-6#2)(2008-7#4)(2008-9#2)(2011-2#2)
enzyme were##6##2##(2006-6#1)(2008-10#3)(2009-6#1)(2010-3#1)
enzyme which catalyzes the##2##4##(1993-8#1)(2008-11#1)
enzyme which is##2##3##(1990-2#1)(1990-8#1)
enzyme which##7##2##(1990-2#1)(1990-8#1)(1993-8#1)(1995-12#1)(2008-11#2)(2008-5#1)
enzyme with a##3##3##(1993-6#1)(1994-5#1)(1995-8#1)
enzyme with an##2##3##(1995-6#1)(2008-10#1)
enzyme with##9##2##(1993-6#1)(1994-5#1)(1995-6#3)(1995-8#1)(2008-10#2)(2011-1#1)
enzyme##1067##1##(1990-10#11)(1990-11#12)(1990-12#2)(1990-2#7)(1990-5#23)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#2)(1991-10#1)(1991-12#8)(1991-3#4)(1991-5#14)(1991-7#2)(1991-9#7)(1992-1#4)(1992-10#8)(1992-12#7)(1992-3#13)(1992-4#1)(1992-6#12)(1992-7#1)(1992-8#4)(1992-9#11)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#6)(1993-6#13)(1993-8#31)(1993-9#4)(1994-11#30)(1994-2#1)(1994-3#2)(1994-5#19)(1994-6#3)(1994-8#27)(1995-11#5)(1995-12#4)(1995-2#11)(1995-3#6)(1995-6#53)(1995-8#8)(1996-12#7)(1996-2#10)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#6)(1997-2#7)(1997-6#8)(1997-7#12)(1997-8#3)(1997-9#1)(2006-6#3)(2007-12#3)(2008-1#4)(2008-10#316)(2008-11#43)(2008-12#6)(2008-3#1)(2008-4#3)(2008-5#20)(2008-6#15)(2008-7#40)(2008-8#10)(2008-9#24)(2009-10#2)(2009-12#1)(2009-3#3)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#9)(2009-9#4)(2010-11#1)(2010-12#3)(2010-3#4)(2010-8#2)(2011-1#14)(2011-10#1)(2011-2#28)(2011-3#4)(2012-12#2)(2012-2#16)(2012-3#1)(2012-5#1)(2012-6#4)(2013-1#8)(2013-8#3)
enzyme's##7##1##(1993-8#1)(1994-5#1)(1995-6#1)(1997-6#1)(2008-10#2)(2011-1#1)
enzyme(s)##2##1##(1994-5#1)(1994-8#1)
enzyme)##3##1##(1994-8#1)(1995-6#1)(2008-10#1)
enzyme-bound amide hydrate##2##3##(1991-9#2)
enzyme-bound##3##1##(1991-9#2)(1992-3#1)
enzyme-catalyzed reaction and##3##3##(2008-10#3)
enzyme-catalyzed reaction##8##2##(1990-5#1)(2008-10#7)
enzyme-catalyzed reactions##2##2##(2008-7#2)
enzyme-catalyzed##12##1##(1990-5#1)(1993-8#1)(2008-10#7)(2008-7#2)(2008-9#1)
enzyme-digested fucoidan extracts##2##3##(2008-11#2)
enzyme-digested fucoidan##3##2##(2008-11#3)
enzyme-gold##2##1##(2008-10#2)
enzyme-immobilized eggshell membrane##2##3##(2008-10#2)
enzyme-immobilized##3##1##(2008-10#3)
enzyme-inhibitor complex##3##2##(1991-3#1)(1992-9#1)(1993-8#1)
enzyme-inhibitor##5##1##(1991-3#1)(1992-9#1)(1993-8#1)(1994-8#1)(2008-10#1)
enzyme-labeled##5##1##(2008-10#1)(2008-9#1)(2010-11#1)(2012-2#2)
enzyme-less##3##1##(2008-10#3)
enzyme-linked immunoassay##5##2##(2008-10#4)(2008-11#1)
enzyme-linked immunosorbent assay (ELISA) absorbance values##2##6##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) analysis##2##5##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) and##3##5##(2008-10#3)
enzyme-linked immunosorbent assay (ELISA) for the determination of##2##8##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) for##6##5##(1994-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
enzyme-linked immunosorbent assay (ELISA) method##3##5##(2008-10#3)
enzyme-linked immunosorbent assay (ELISA)##29##4##(1994-3#2)(1995-11#1)(1996-9#1)(2008-10#20)(2008-11#2)(2008-4#2)(2011-2#1)
enzyme-linked immunosorbent assay and##2##4##(2008-10#2)
enzyme-linked immunosorbent assay for determination of##2##6##(2008-10#2)
enzyme-linked immunosorbent assay for##4##4##(1995-11#1)(2008-10#2)(2011-2#1)
enzyme-linked immunosorbent assay in##2##4##(2008-10#2)
enzyme-linked immunosorbent assay of##2##4##(2008-10#2)
enzyme-linked immunosorbent assay or##2##4##(2008-10#2)
enzyme-linked immunosorbent assay tests##2##4##(2008-10#2)
enzyme-linked immunosorbent assay using##4##4##(2008-10#3)(2010-4#1)
enzyme-linked immunosorbent assay##77##3##(1990-12#1)(1990-5#1)(1991-9#2)(1994-3#2)(1995-11#2)(1996-9#1)(2008-10#57)(2008-11#2)(2008-4#2)(2010-4#1)(2011-2#5)(2012-3#1)
enzyme-linked immunosorbent assays (ELISA)##2##4##(2008-10#1)(2011-2#1)
enzyme-linked immunosorbent assays##5##3##(2008-10#4)(2011-2#1)
enzyme-linked immunosorbent##84##2##(1990-12#1)(1990-5#1)(1991-9#2)(1994-3#2)(1995-11#2)(1996-9#1)(2008-10#63)(2008-11#2)(2008-4#2)(2010-4#1)(2011-2#6)(2012-3#1)
enzyme-linked##97##1##(1990-12#1)(1990-5#1)(1991-9#3)(1994-3#2)(1995-11#3)(1996-9#1)(2008-10#72)(2008-11#3)(2008-4#2)(2010-4#1)(2011-2#7)(2012-3#1)
enzyme-mediated##7##1##(2008-10#4)(2009-9#2)(2010-10#1)
enzyme-substrate complexes##2##2##(1994-5#2)
enzyme-substrate##9##1##(1990-9#1)(1994-5#4)(2008-10#3)(2008-5#1)
enzymelinked immunosorbent assay##3##3##(2008-10#3)
enzymes (Sma I##2##3##(1992-6#2)
enzymes -##2##2##(2008-10#1)(2011-1#1)
enzymes and lipid##2##3##(1994-11#1)(2008-6#1)
enzymes and the##4##3##(1997-6#1)(2008-10#2)(2008-2#1)
enzymes and##21##2##(1993-9#1)(1994-11#1)(1997-6#2)(2006-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-3#2)
enzymes are##7##2##(1994-5#1)(1996-3#1)(2008-10#2)(2008-9#2)(2012-2#1)
enzymes by##7##2##(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-5#2)
enzymes for##5##2##(1996-12#2)(2008-5#1)(2008-9#1)(2011-2#1)
enzymes from the##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
enzymes from##4##2##(1991-8#1)(2008-10#1)(2008-5#1)(2010-7#1)
enzymes has been##2##3##(2008-10#1)(2008-4#1)
enzymes have been##2##3##(1993-12#1)(1994-5#1)
enzymes have##3##2##(1993-12#1)(1994-5#1)(2008-9#1)
enzymes in a##3##3##(1993-8#1)(1996-3#1)(2008-9#1)
enzymes in both##2##3##(1994-8#1)(2008-9#1)
enzymes in the##10##3##(1995-9#1)(1997-3#1)(2006-6#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#2)
enzymes in this##2##3##(2009-9#1)(2011-1#1)
enzymes in##29##2##(1990-11#1)(1990-3#1)(1993-8#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
enzymes including##2##2##(2011-1#1)(2013-8#1)
enzymes induced by##2##3##(1991-2#1)(2008-5#1)
enzymes into##2##2##(2008-10#1)(2008-6#1)
enzymes involved in the##6##4##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2012-5#1)
enzymes involved in these##2##4##(2008-4#1)(2011-1#1)
enzymes involved in##14##3##(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)
enzymes involved##15##2##(1992-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)
enzymes is##5##2##(1990-11#1)(1994-5#1)(2008-10#3)
enzymes isolated from##2##3##(2011-1#1)(2011-3#1)
enzymes may##4##2##(2008-11#1)(2008-4#1)(2008-8#1)(2009-9#1)
enzymes of Aspergillus##2##3##(1997-2#2)
enzymes of the##4##3##(1993-3#1)(1997-1#1)(2008-10#1)(2013-8#1)
enzymes of##12##2##(1992-8#1)(1993-3#1)(1997-1#1)(1997-2#2)(2008-10#1)(2008-8#1)(2010-7#2)(2012-2#1)(2013-8#2)
enzymes on the##2##3##(2008-10#2)
enzymes on##5##2##(1990-2#1)(1995-8#1)(2008-10#3)
enzymes or##2##2##(1994-8#1)(2008-7#1)
enzymes participating##2##2##(2013-1#2)
enzymes produced by##2##3##(2008-10#1)(2011-1#1)
enzymes revealed##3##2##(1990-5#1)(2008-10#2)
enzymes showed##2##2##(1994-8#1)(2008-12#1)
enzymes studied##3##2##(1995-12#1)(2008-5#2)
enzymes such as##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
enzymes suggests##2##2##(1993-8#1)(2012-6#1)
enzymes that##7##2##(1992-3#1)(2008-1#1)(2008-4#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
enzymes to be determined##2##4##(2010-3#2)
enzymes to##4##2##(1995-3#1)(2010-3#2)(2012-2#1)
enzymes viz##3##2##(2013-1#3)
enzymes was##2##2##(1995-6#1)(2008-5#1)
enzymes were found to be##2##5##(2008-10#1)(2011-1#1)
enzymes were##18##2##(1992-6#1)(1993-2#1)(1994-11#1)(1994-5#1)(1997-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
enzymes with##2##2##(2011-1#1)(2013-8#1)
enzymes##374##1##(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#4)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1992-11#1)(1992-3#2)(1992-4#2)(1992-6#4)(1992-7#2)(1992-8#4)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-5#5)(1994-6#1)(1994-8#13)(1995-12#1)(1995-3#3)(1995-6#5)(1995-8#4)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-6#4)(1997-7#4)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#86)(2008-11#13)(2008-12#8)(2008-2#2)(2008-4#7)(2008-5#19)(2008-6#3)(2008-7#14)(2008-8#7)(2008-9#17)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#5)(2010-5#1)(2010-7#4)(2011-1#12)(2011-2#16)(2011-3#3)(2012-12#1)(2012-2#7)(2012-3#4)(2012-5#1)(2012-6#1)(2013-1#10)(2013-8#4)
enzymic##4##1##(1990-9#1)(1992-12#1)(1992-3#1)(2008-10#1)
enzymogenes strain C3##3##3##(2008-10#3)
enzymogenes##6##1##(2008-10#6)
enzymology##2##1##(1995-3#1)(2009-9#1)
eosin and##2##2##(2008-10#1)(2011-2#1)
eosin##8##1##(2008-10#3)(2008-12#1)(2011-2#2)(2013-1#2)
eosinophil accumulation##2##2##(1994-11#2)
eosinophil chemoattractant##2##2##(1994-11#2)
eosinophil chemotactic##2##2##(1992-6#2)
eosinophil##12##1##(1992-3#2)(1992-6#2)(1994-11#4)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
eosinophilia and##2##2##(1990-9#1)(2008-10#1)
eosinophilia##19##1##(1990-3#1)(1990-9#1)(1991-12#2)(1993-6#1)(1995-1#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2010-6#2)(2011-2#1)(2012-3#1)
eosinophilic cytoplasm##2##2##(1994-6#1)(2010-6#1)
eosinophilic differentiation in KU812 cells##4##5##(2008-11#4)
eosinophilic differentiation in##5##3##(2008-11#5)
eosinophilic enteritis##3##2##(2010-12#3)
eosinophilic granular##2##2##(2008-5#2)
eosinophilic material##2##2##(2010-6#2)
eosinophilic pneumonia and eosinophilic pleural effusion##2##6##(1991-12#2)
eosinophilic pneumonia##3##2##(1991-12#3)
eosinophilic variant of Wegener's granulomatosis##2##5##(2010-11#2)
eosinophilic##25##1##(1991-12#5)(1992-3#1)(1994-6#1)(2008-11#5)(2008-5#2)(2008-7#1)(2010-11#2)(2010-12#3)(2010-6#3)(2011-2#1)(2013-1#1)
eosinophils from##2##2##(1992-3#2)
eosinophils into##2##2##(2008-10#2)
eosinophils##18##1##(1991-12#1)(1992-12#2)(1992-3#4)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2010-6#2)(2013-8#1)
eotaxin##2##1##(1994-11#2)
epact##2##1##(2010-12#2)
ependymal##3##1##(1991-7#1)(2008-12#2)
ependymomas##2##1##(1991-8#1)(1993-9#1)
eperisone-HCl was##2##2##(1996-2#2)
eperisone-HCl##3##1##(1996-2#3)
ephedra callus##3##2##(2008-10#3)
ephedra##4##1##(2008-10#4)
ephedrine derivatives in##3##3##(2008-10#3)
ephedrine derivatives##4##2##(2008-10#4)
ephedrine##9##1##(2008-10#9)
ephemeral fever##2##2##(2008-10#2)
ephemeral##4##1##(2008-10#2)(2008-8#2)
ephrin##2##1##(2008-7#2)
epi-fluorescence microscopy##2##2##(2008-10#2)
epi-fluorescence##4##1##(2008-10#4)
epi-inositol##3##1##(2008-11#3)
epi-spiro##3##1##(1996-5#3)
epicatechin and##2##2##(2008-10#1)(2008-11#1)
epicatechin##14##1##(1993-8#2)(2008-10#10)(2008-11#2)
epichlorohydrin##4##1##(2008-10#3)(2008-7#1)
epicondylalgia##4##1##(2008-12#4)
epicotyl segments##2##2##(2008-11#2)
epicotyls##3##1##(2008-10#1)(2008-11#1)(2008-8#1)
epicuticular hydrocarbon##3##2##(2008-8#3)
epicuticular waxes##3##2##(2008-10#3)
epicuticular##8##1##(2008-10#3)(2008-7#1)(2008-8#4)
epidemic and##5##2##(1990-12#3)(1995-5#1)(2008-10#1)
epidemic curve##3##2##(1994-9#2)(2008-10#1)
epidemic data##2##2##(2008-10#2)
epidemic development##5##2##(2008-10#5)
epidemic during the growing season##2##5##(2008-10#2)
epidemic for##3##2##(1992-2#1)(2008-10#2)
epidemic growth rate##2##3##(2008-10#2)
epidemic in Latin##2##3##(1992-5#2)
epidemic in the##3##3##(1995-1#1)(1996-6#1)(2011-2#1)
epidemic in##19##2##(1990-12#2)(1990-3#1)(1992-5#2)(1995-1#1)(1995-6#1)(1996-11#2)(1996-3#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2011-2#1)
epidemic is##2##2##(2008-10#1)(2010-5#1)
epidemic model##3##2##(1995-5#2)(2008-10#1)
epidemic occurred##3##2##(2008-10#2)(2011-2#1)
epidemic of##11##2##(1992-5#1)(1993-12#1)(1996-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)
epidemic onset##10##2##(2008-10#10)
epidemic progress##2##2##(2008-10#2)
epidemic proportions##8##2##(2008-1#1)(2008-10#2)(2009-9#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
epidemic that has##2##3##(2010-12#1)(2011-2#1)
epidemic was##4##2##(2008-10#4)
epidemic##178##1##(1990-11#1)(1990-12#9)(1990-3#3)(1992-2#2)(1992-5#3)(1992-9#4)(1993-12#2)(1994-9#2)(1995-1#3)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-11#6)(1996-3#2)(1996-5#3)(1996-6#1)(1997-6#1)(2008-1#4)(2008-10#89)(2008-11#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#3)
epidemic's##3##1##(1997-6#1)(2008-8#2)
epidemics and##4##2##(2008-10#4)
epidemics are##2##2##(2008-10#2)
epidemics at##2##2##(2008-10#1)(2008-9#1)
epidemics caused by##4##3##(2008-10#3)(2012-3#1)
epidemics developing##2##2##(2008-10#2)
epidemics have been reported##2##4##(2008-10#2)
epidemics have##3##2##(2008-10#3)
epidemics in a##2##3##(2008-10#2)
epidemics in southern##2##3##(2008-10#1)(2011-2#1)
epidemics in sugar beet##2##4##(2008-10#2)
epidemics in##26##2##(1995-5#2)(2008-10#20)(2011-2#3)(2012-2#1)
epidemics occurred in##2##3##(2008-10#2)
epidemics of Fusarium##2##3##(2008-10#2)
epidemics of the disease##2##4##(2008-10#2)
epidemics of the past##2##4##(2008-10#2)
epidemics of the##5##3##(2008-10#5)
epidemics of##24##2##(1994-9#1)(2008-10#21)(2008-5#1)(2008-8#1)
epidemics on##4##2##(2008-10#4)
epidemics to##3##2##(2008-10#3)
epidemics was##4##2##(2008-10#3)(2011-2#1)
epidemics were##5##2##(2008-10#5)
epidemics with##2##2##(2008-10#2)
epidemics##156##1##(1994-9#1)(1995-5#4)(2008-10#131)(2008-5#1)(2008-8#3)(2008-9#3)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
epidemiologic data##4##2##(1995-5#1)(2011-2#2)(2013-8#1)
epidemiologic investigations##2##2##(1991-12#1)(1995-9#1)
epidemiologic studies##8##2##(1991-12#1)(1994-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(2010-5#1)(2011-1#1)(2013-8#1)
epidemiologic study##2##2##(1992-12#1)(2011-2#1)
epidemiologic##27##1##(1990-6#1)(1990-9#1)(1991-12#3)(1992-12#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-7#2)(2010-5#2)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#2)
epidemiological and clinical##2##3##(2008-10#1)(2013-1#1)
epidemiological and##9##2##(1995-5#1)(1997-8#1)(2008-10#4)(2008-5#1)(2011-2#1)(2013-1#1)
epidemiological aspects##2##2##(2008-10#1)(2008-5#1)
epidemiological components##3##2##(2008-10#3)
epidemiological data (a##2##3##(1992-12#1)(2013-1#1)
epidemiological data##9##2##(1992-12#1)(2008-10#2)(2008-7#3)(2009-12#1)(2013-1#2)
epidemiological evidence##7##2##(2008-10#1)(2008-11#3)(2008-8#1)(2010-6#1)(2013-1#1)
epidemiological features##2##2##(1997-4#1)(2013-1#1)
epidemiological investigation##2##2##(1992-9#1)(2013-8#1)
epidemiological investigations##2##2##(1991-8#1)(2008-10#1)
epidemiological model##4##2##(2008-10#3)(2008-8#1)
epidemiological parameters##2##2##(2008-10#2)
epidemiological perspective##2##2##(2008-11#2)
epidemiological research##4##2##(2008-11#1)(2011-2#3)
epidemiological situation in##3##3##(1992-5#1)(1994-6#1)(1996-6#1)
epidemiological situation##4##2##(1990-6#1)(1992-5#1)(1994-6#1)(1996-6#1)
epidemiological studies and##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
epidemiological studies have##4##3##(1994-2#1)(2008-10#2)(2008-5#1)
epidemiological studies of##4##3##(2008-10#2)(2009-7#1)(2010-9#1)
epidemiological studies##22##2##(1991-12#1)(1994-2#1)(1994-6#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-9#1)(2011-2#1)
epidemiological study##7##2##(1991-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-12#1)
epidemiological surveillance##3##2##(2012-12#2)(2013-8#1)
epidemiological unit##2##2##(2008-10#2)
epidemiological##132##1##(1990-3#1)(1990-6#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-6#3)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#48)(2008-11#11)(2008-12#1)(2008-5#5)(2008-7#7)(2008-8#5)(2009-12#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-2#13)(2011-3#1)(2012-12#3)(2013-1#8)(2013-8#3)
epidemiologically important##2##2##(2008-10#2)
epidemiologically##8##1##(1992-9#1)(1995-12#1)(2007-12#1)(2008-10#2)(2011-2#2)(2012-3#1)
epidemiologists##14##1##(1991-12#1)(1993-3#1)(2008-10#1)(2008-11#11)
epidemiology and##20##2##(1991-2#1)(1994-3#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#2)(2011-3#1)(2012-3#3)
epidemiology department##2##2##(2008-11#2)
epidemiology has##2##2##(2008-10#2)
epidemiology in##3##2##(2008-11#2)(2013-8#1)
epidemiology of##39##2##(1991-6#2)(1992-12#1)(1993-3#1)(1994-6#1)(1995-9#1)(2008-10#15)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-4#1)(2011-2#6)(2011-3#1)(2013-1#1)(2013-8#1)
epidemiology services##2##2##(2008-11#2)
epidemiology was##2##2##(2008-10#2)
epidemiology##124##1##(1990-9#1)(1991-2#1)(1991-6#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#3)(2008-1#1)(2008-10#39)(2008-11#13)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#17)(2011-3#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#3)
epidermal and cortical cells##2##4##(2008-10#1)(2008-9#1)
epidermal and cortical##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
epidermal and##8##2##(2008-10#5)(2008-12#1)(2008-5#1)(2008-9#1)
epidermal cell wall##2##3##(2008-10#2)
epidermal cell walls##5##3##(2008-10#5)
epidermal cell##11##2##(1993-12#1)(2008-10#8)(2008-5#1)(2008-7#1)
epidermal cells by##2##3##(2008-10#2)
epidermal cells of##3##3##(2008-10#3)
epidermal cells##25##2##(1993-12#1)(2008-10#19)(2008-12#1)(2008-7#2)(2012-2#2)
epidermal growth factor (EGF) and##3##5##(1990-12#1)(1995-11#1)(2008-8#1)
epidermal growth factor (EGF)##9##4##(1990-12#1)(1991-12#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-8#1)(2008-11#1)(2008-8#1)(2011-2#1)
epidermal growth factor receptor##9##4##(1993-8#1)(1995-11#1)(1995-6#2)(2008-11#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)
epidermal growth factor##28##3##(1990-12#1)(1991-12#1)(1991-7#2)(1993-1#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#3)(1995-6#3)(1995-8#2)(2008-11#3)(2008-8#2)(2009-4#1)(2011-2#3)(2012-3#1)
epidermal growth##31##2##(1990-12#2)(1991-12#1)(1991-7#2)(1992-7#1)(1993-1#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-8#1)(1995-11#3)(1995-6#3)(1995-8#2)(2008-11#3)(2008-8#2)(2009-4#1)(2011-2#3)(2012-3#1)
epidermal hyperkeratosis and hyperplasia##2##4##(2008-9#2)
epidermal hyperkeratosis##3##2##(2008-9#3)
epidermal hyperplasia##2##2##(2008-9#2)
epidermal melanocytes##2##2##(1994-12#2)
epidermal ornithine decarboxylase##2##3##(1992-8#2)
epidermal##118##1##(1990-12#2)(1991-12#1)(1991-7#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#3)(1995-6#3)(1995-8#2)(2007-12#4)(2007-8#1)(2008-10#39)(2008-11#4)(2008-12#2)(2008-5#13)(2008-7#3)(2008-8#2)(2008-9#9)(2009-10#2)(2009-4#1)(2011-2#4)(2012-2#2)(2012-3#1)
epidermidis##9##1##(1991-3#4)(1993-9#1)(2008-7#2)(2012-2#2)
epidermis and dermis##4##3##(1996-12#1)(2008-5#3)
epidermis and outer##5##3##(2008-10#5)
epidermis and##18##2##(1996-12#1)(2008-10#10)(2008-11#1)(2008-5#5)(2008-7#1)
epidermis can##2##2##(2008-5#2)
epidermis is##3##2##(2008-12#1)(2008-5#1)(2010-7#1)
epidermis of the##2##3##(2008-10#1)(2008-12#1)
epidermis of##5##2##(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#1)
epidermis##87##1##(1993-8#2)(1994-5#1)(1995-11#1)(1996-12#5)(1996-2#1)(1996-6#1)(2008-10#18)(2008-11#2)(2008-12#3)(2008-5#43)(2008-7#2)(2010-6#4)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
epidermitis##2##1##(2013-8#2)
epidermoid cancer of cervix##5##4##(2013-1#5)
epidermoid##11##1##(2007-8#1)(2008-7#3)(2010-3#2)(2013-1#5)
epidermolysis bullosa##8##2##(1992-3#2)(2012-3#6)
epidermolysis##9##1##(1992-3#2)(1995-10#1)(2012-3#6)
epididymal sperm##3##2##(2008-12#3)
epididymal##6##1##(1993-6#1)(1996-9#1)(1997-8#1)(2008-12#3)
epididymides##2##1##(2008-12#2)
epididymis and##3##2##(1997-6#1)(2008-12#1)(2008-9#1)
epididymis##7##1##(1997-6#1)(2008-10#1)(2008-12#4)(2008-9#1)
epididymitis and orchitis##2##3##(1997-8#2)
epididymitis and##3##2##(1997-8#2)(2008-12#1)
epidural abscess##7##2##(1991-3#1)(2011-2#2)(2012-3#4)
epidural anaesthesia for##2##3##(2007-8#2)
epidural anaesthesia##3##2##(2007-8#3)
epidural anesthesia with##2##3##(2012-3#2)
epidural anesthesia##12##2##(2012-3#11)(2013-8#1)
epidural catheter##3##2##(2011-2#3)
epidural disc herniation##2##3##(2011-2#2)
epidural disc##3##2##(2011-2#3)
epidural hematoma##3##2##(2008-7#3)
epidural space##5##2##(2008-12#1)(2009-3#1)(2010-7#1)(2011-2#2)
epidural##52##1##(1991-3#1)(1992-12#2)(1996-3#1)(2007-8#4)(2008-12#1)(2008-7#8)(2009-3#1)(2009-5#1)(2010-7#4)(2011-2#11)(2012-2#1)(2012-3#16)(2013-8#1)
epifluorescence microscopy##4##2##(2008-10#4)
epifluorescence##6##1##(1994-5#1)(2008-10#5)
epigallocatechin##3##1##(2008-10#1)(2008-11#2)
epigastralgia##2##1##(1992-9#1)(2013-1#1)
epigastric pain##2##2##(2013-1#2)
epigastric##5##1##(2013-1#5)
epigenetic alterations##3##2##(2009-4#2)(2009-6#1)
epigenetic changes in##2##3##(2009-4#2)
epigenetic changes##5##2##(2009-4#4)(2011-2#1)
epigenetic events##2##2##(2009-4#1)(2013-8#1)
epigenetic factors##3##2##(2008-11#1)(2008-12#1)(2011-9#1)
epigenetic influence of##3##3##(2009-3#3)
epigenetic influence##4##2##(2009-3#4)
epigenetic marks##2##2##(2009-12#2)
epigenetic mechanisms##4##2##(2009-4#1)(2011-2#1)(2011-9#1)(2012-3#1)
epigenetic phenomenon##2##2##(2011-2#2)
epigenetic regulation of##2##3##(2011-2#1)(2012-12#1)
epigenetic regulation##4##2##(2009-10#1)(2011-2#2)(2012-12#1)
epigenetic##43##1##(2008-11#2)(2008-12#1)(2009-10#2)(2009-12#2)(2009-3#4)(2009-4#9)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#7)(2011-9#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#4)
epigenetically##3##1##(2008-10#1)(2009-4#1)(2012-3#1)
epigenetics and epigenomics##2##3##(2009-4#2)
epigenetics##6##1##(2009-4#5)(2011-2#1)
epigenomics##3##1##(2009-4#3)
epilepsy and##4##2##(1996-12#1)(1997-8#1)(2008-11#1)(2011-1#1)
epilepsy health promotion##2##3##(2008-12#2)
epilepsy is##2##2##(1994-2#1)(2009-9#1)
epilepsy patients##5##2##(2009-8#1)(2009-9#1)(2010-8#3)
epilepsy service##3##2##(1997-8#3)
epilepsy##58##1##(1990-3#1)(1990-9#2)(1992-9#1)(1994-2#2)(1995-12#2)(1995-2#1)(1996-12#1)(1996-6#1)(1997-8#10)(2008-10#1)(2008-11#7)(2008-12#3)(2008-4#7)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-8#6)(2011-1#2)(2011-2#2)(2013-8#1)
epileptic attacks##2##2##(1995-12#1)(2008-11#1)
epileptic patients##2##2##(2008-11#1)(2008-7#1)
epileptic seizures##5##2##(1994-2#1)(2008-5#1)(2008-7#2)(2010-8#1)
epileptic##24##1##(1994-2#1)(1995-12#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#6)(2009-8#2)(2010-4#1)(2010-8#6)
epileptogenesis in##3##2##(2009-8#2)(2013-8#1)
epileptogenesis##5##1##(1996-12#1)(2009-8#3)(2013-8#1)
epimer##2##1##(1996-5#1)(2008-10#1)
epimerization##2##1##(2010-7#1)(2011-1#1)
epimorphin##3##1##(1993-3#3)
epimysium and deep fasciae##3##4##(2013-1#3)
epinephrine (E) and##2##3##(2008-10#2)
epinephrine (E)##4##2##(2008-10#3)(2008-7#1)
epinephrine (EP)##2##2##(2008-10#2)
epinephrine and l-dopa##4##3##(2008-10#4)
epinephrine and##8##2##(1990-5#1)(1997-6#1)(2008-10#4)(2010-1#1)(2010-2#1)
epinephrine was##2##2##(1990-5#1)(1997-6#1)
epinephrine##39##1##(1990-5#5)(1993-1#5)(1997-6#2)(2008-10#20)(2008-7#1)(2010-1#2)(2010-2#2)(2013-1#2)
epinephrine-containing local anesthetic##2##3##(1993-1#2)
epinephrine-containing local##3##2##(1993-1#3)
epinephrine-free and epinephrine-containing local##2##4##(1993-1#2)
epinephrine-free##3##1##(1993-1#3)
epinuclear##2##1##(2008-7#2)
epiphyseal cartilage##4##2##(1990-11#4)
epiphyseal plate##2##2##(2011-2#2)
epiphyseal plates##2##2##(1996-11#1)(2011-2#1)
epiphyseal##11##1##(1990-11#4)(1996-11#1)(2007-11#1)(2009-7#1)(2011-2#4)
epiphysis##5##1##(2008-8#4)(2013-7#1)
epiphytes##4##1##(2008-10#4)
epiphytic growth##2##2##(2008-10#2)
epiphytic populations of##2##3##(2008-10#2)
epiphytic##7##1##(2008-10#7)
epiphytotics##4##1##(2008-10#4)
epiretinal##3##1##(2011-2#2)(2013-1#1)
epirubicin and VP-16##2##3##(1992-12#2)
epirubicin##10##1##(1990-12#1)(1991-2#2)(1991-6#3)(1992-12#2)(1993-2#1)(1995-10#1)
episiotomy##2##1##(2010-11#1)(2011-2#1)
episode of AP##2##3##(2013-1#2)
episode of acute##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
episode of##28##2##(1991-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
episode was##2##2##(1994-2#1)(2008-9#1)
episode##43##1##(1991-3#3)(1991-8#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#2)
episode-of-care analysis##2##2##(1994-12#2)
episodes and##2##2##(2008-11#1)(2010-10#1)
episodes in the##2##3##(2008-1#1)(2008-10#1)
episodes in##5##2##(1994-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-6#1)
episodes of brain##2##3##(2012-3#2)
episodes of care##2##3##(1994-2#1)(1996-3#1)
episodes of desaturation##2##3##(1993-1#2)
episodes of recurrent##2##3##(2010-6#1)(2012-3#1)
episodes of##52##2##(1990-6#1)(1991-3#1)(1993-1#4)(1993-12#1)(1993-3#1)(1994-2#3)(1994-6#3)(1995-5#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#4)(2008-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#7)(2013-1#4)(2013-7#1)
episodes were##3##2##(2008-10#1)(2012-3#2)
episodes##86##1##(1990-12#3)(1990-6#1)(1991-3#1)(1993-1#5)(1993-12#3)(1993-3#1)(1994-2#3)(1994-5#1)(1994-6#3)(1994-9#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#2)(2010-8#3)(2011-2#1)(2012-12#3)(2012-3#9)(2012-4#1)(2013-1#4)(2013-7#1)
episodes)##2##1##(2008-10#1)(2008-8#1)
episodes/patient-year (p = 0##2##4##(2011-2#2)
episodes/patient-year##3##1##(2011-2#3)
episodic hypoglycemia##2##2##(2011-1#2)
episodic selection##2##2##(2008-10#2)
episodic##15##1##(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#2)(2011-1#2)(2012-3#3)
episodically in##2##2##(1990-11#1)(2008-10#1)
episomal telomere sequence##2##3##(2008-11#2)
episomal##5##1##(1993-12#1)(1993-9#1)(1995-2#1)(2008-11#2)
epispadias##2##1##(2008-10#2)
epistasis through##2##2##(2008-8#2)
epistasis##9##1##(1995-9#1)(2008-10#5)(2008-8#3)
epistatic effects were##2##3##(2008-10#2)
epistatic interaction##2##2##(2008-10#1)(2012-3#1)
epistatic interactions between##2##3##(2008-9#1)(2012-3#1)
epistatic interactions##5##2##(2008-10#2)(2008-9#1)(2012-3#2)
epistatic##11##1##(1997-7#1)(2008-10#5)(2008-9#1)(2010-5#1)(2012-3#3)
epistaxis##6##1##(1994-3#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
epistemological##3##1##(1994-12#1)(2008-11#1)(2010-1#1)
epistemology of##2##2##(2009-11#1)(2013-1#1)
epistemology##4##1##(1996-1#1)(2008-12#1)(2009-11#1)(2013-1#1)
epistome##2##1##(2011-2#2)
epitaxial##4##1##(1990-12#1)(1991-9#1)(1992-11#1)(2008-3#1)
epitaxy##6##1##(1994-9#1)(1995-3#1)(2007-12#1)(2009-11#3)
epithelia##11##1##(2007-12#1)(2008-10#4)(2008-11#4)(2008-7#1)(2009-10#1)
epithelial and stromal cells##4##4##(2008-11#1)(2011-2#3)
epithelial and vascular smooth muscle##2##5##(2008-11#2)
epithelial and vascular##4##3##(1991-5#2)(2008-11#2)
epithelial and##13##2##(1991-5#2)(2008-10#1)(2008-11#4)(2011-2#4)(2012-3#1)(2013-8#1)
epithelial buccal cells##2##3##(2008-5#2)
epithelial cancer##2##2##(2009-4#1)(2013-1#1)
epithelial carcinoma##2##2##(1995-12#1)(2008-11#1)
epithelial cell line##2##3##(2008-8#2)
epithelial cell proliferation##3##3##(1994-3#1)(1995-9#1)(2012-3#1)
epithelial cell##21##2##(1991-2#1)(1991-5#1)(1993-11#1)(1994-11#2)(1994-3#1)(1995-6#1)(1995-9#1)(1997-1#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#3)(2012-3#1)
epithelial cells and##11##3##(1990-12#1)(1992-3#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-9#3)(2010-5#1)(2012-2#1)
epithelial cells but##2##3##(1993-11#1)(2013-1#1)
epithelial cells from##2##3##(1990-11#1)(2011-2#1)
epithelial cells in primary culture##2##5##(1993-3#1)(2008-6#1)
epithelial cells in##5##3##(1993-3#1)(1993-8#1)(2008-11#1)(2008-6#1)(2013-1#1)
epithelial cells is##3##3##(2008-5#1)(2008-6#2)
epithelial cells isolated from##2##4##(1990-11#1)(1991-5#1)
epithelial cells of the##2##4##(1994-2#1)(1997-5#1)
epithelial cells of##12##3##(1994-2#2)(1994-5#1)(1997-5#1)(2008-10#3)(2012-12#4)(2013-1#1)
epithelial cells throughout the##2##4##(1997-1#1)(2008-7#1)
epithelial cells were##2##3##(1993-3#1)(2008-6#1)
epithelial cells with##5##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
epithelial cells##116##2##(1990-11#2)(1990-12#1)(1990-2#4)(1991-11#3)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-8#2)(1993-11#5)(1993-3#3)(1993-8#1)(1994-11#4)(1994-2#3)(1994-3#3)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#2)(1997-1#4)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#12)(2008-12#4)(2008-5#2)(2008-6#12)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2010-1#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
epithelial cycle##11##2##(2009-10#5)(2012-2#6)
epithelial hyperplasia##3##2##(1990-12#2)(1994-12#1)
epithelial lining of the##2##4##(1992-1#1)(2007-12#1)
epithelial lining##4##2##(1992-1#1)(2007-12#1)(2008-7#1)(2010-5#1)
epithelial membrane antigen##7##3##(1991-12#1)(1992-2#1)(1994-8#3)(2008-7#1)(2011-2#1)
epithelial origin##3##2##(1994-5#1)(1995-6#1)(2013-1#1)
epithelial ovarian cancer##2##3##(1994-12#1)(2010-8#1)
epithelial ovarian##4##2##(1994-12#1)(2009-5#1)(2010-8#1)(2011-1#1)
epithelial permeability##2##2##(1993-2#1)(1997-1#1)
epithelial tumours##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
epithelial##249##1##(1990-11#2)(1990-12#3)(1990-2#4)(1991-11#3)(1991-12#3)(1991-2#1)(1991-5#4)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#3)(1993-1#5)(1993-11#8)(1993-12#1)(1993-2#1)(1993-3#5)(1993-8#3)(1994-11#7)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#2)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#1)(1995-9#3)(1997-1#6)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#6)(2008-10#8)(2008-11#31)(2008-12#5)(2008-5#5)(2008-6#12)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#5)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#19)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#10)(2013-8#2)
epithelioid##3##1##(1997-7#1)(2009-9#1)(2011-2#1)
epithelium and##13##2##(1991-5#1)(2007-12#1)(2008-7#2)(2009-10#1)(2011-2#2)(2012-3#2)(2013-1#4)
epithelium are##4##2##(1990-2#1)(2008-7#1)(2009-10#1)(2011-7#1)
epithelium as##2##2##(1992-2#1)(2007-12#1)
epithelium at##2##2##(1994-5#1)(2011-2#1)
epithelium during spermiogenesis and spermiation##2##5##(2012-2#2)
epithelium during##4##2##(2008-7#1)(2012-2#3)
epithelium in##2##2##(2009-10#1)(2013-1#1)
epithelium is##4##2##(2007-12#2)(2008-7#1)(2009-10#1)
epithelium lining##2##2##(1993-1#1)(2007-12#1)
epithelium may be##2##3##(1991-2#1)(2010-1#1)
epithelium of the##7##3##(1995-6#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-2#1)
epithelium of##10##2##(1995-6#1)(2007-12#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#2)
epithelium that##2##2##(1992-9#1)(2007-12#1)
epithelium to##2##2##(2008-11#1)(2011-2#1)
epithelium was##5##2##(1991-5#1)(1995-8#1)(2008-7#1)(2008-9#1)(2012-3#1)
epithelium were##2##2##(1994-5#1)(1997-1#1)
epithelium##133##1##(1990-2#1)(1990-6#2)(1991-2#2)(1991-5#2)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-5#2)(1995-11#4)(1995-12#1)(1995-6#1)(1995-8#5)(1995-9#1)(1997-1#5)(1997-2#2)(2007-12#8)(2008-10#2)(2008-11#3)(2008-12#6)(2008-5#4)(2008-6#1)(2008-7#12)(2008-9#4)(2009-10#16)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#7)(2011-7#3)(2012-12#1)(2012-2#11)(2012-3#4)(2013-1#7)
epithelium-derived factor (PEDF)##2##3##(2012-5#2)
epithelium-derived factor##4##2##(2008-7#2)(2012-5#2)
epithelization##2##1##(2008-11#1)(2011-2#1)
epitope in##2##2##(1997-1#1)(2008-8#1)
epitope mapping##3##2##(1996-12#1)(2008-11#1)(2013-1#1)
epitope minigenes##2##2##(2008-8#2)
epitope of##4##2##(1993-9#1)(1995-2#1)(1996-12#2)
epitope on##2##2##(1996-12#1)(2009-8#1)
epitope peptides##2##2##(2008-8#1)(2011-2#1)
epitope recognized by the##2##4##(2008-11#1)(2008-8#1)
epitope regions##4##2##(2008-11#4)
epitope##60##1##(1990-5#1)(1992-2#1)(1993-1#2)(1993-12#1)(1993-9#2)(1995-12#2)(1995-2#10)(1996-12#4)(1997-1#1)(1997-8#1)(2006-6#1)(2008-10#7)(2008-11#9)(2008-8#10)(2009-8#1)(2011-2#2)(2012-2#4)(2013-1#1)
epitope-tagged phosphatase 2A##2##3##(1992-9#2)
epitope-tagged##4##1##(1992-9#2)(1995-2#1)(2008-11#1)
epitopes and##3##2##(1993-1#1)(1994-8#1)(2011-2#1)
epitopes are##3##2##(2006-6#1)(2008-10#2)
epitopes as##2##2##(1990-5#1)(2008-11#1)
epitopes at##2##2##(1995-5#1)(2008-8#1)
epitopes common to##2##3##(1995-12#1)(1996-12#1)
epitopes from the##2##3##(1991-12#1)(2008-10#1)
epitopes have##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
epitopes identified by##2##3##(1996-12#1)(2008-10#1)
epitopes in##4##2##(1995-12#1)(1995-5#1)(1996-12#1)(2006-6#1)
epitopes of the##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
epitopes of##7##2##(2008-10#2)(2008-11#2)(2008-4#1)(2011-2#1)(2012-2#1)
epitopes on the##3##3##(1993-1#1)(2008-5#1)(2008-8#1)
epitopes on##4##2##(1993-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
epitopes that##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
epitopes were##3##2##(1995-2#1)(2008-8#1)(2011-2#1)
epitopes with##3##2##(2008-10#2)(2008-5#1)
epitopes##72##1##(1990-5#1)(1991-1#1)(1991-12#1)(1993-1#2)(1994-8#1)(1995-12#3)(1995-2#6)(1995-5#4)(1996-12#4)(2006-6#2)(2008-10#16)(2008-11#5)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#11)(2011-2#4)(2012-2#2)
epitopic##2##1##(1993-1#1)(2008-11#1)
epoch##2##1##(2008-10#2)
epochs##3##1##(2008-10#2)(2010-8#1)
epoxidation of##4##2##(1996-5#1)(2008-8#1)(2011-2#2)
epoxidation##7##1##(1996-5#2)(2008-8#1)(2011-2#4)
epoxide##2##1##(1994-5#1)(1996-8#1)
epoxides##5##1##(1996-5#4)(2008-8#1)
epoxy coatings##2##2##(2010-4#2)
epoxy group##2##2##(1996-5#1)(2008-10#1)
epoxy matrix##2##2##(2008-10#2)
epoxy resin##6##2##(2008-10#4)(2010-4#1)(2010-9#1)
epoxy##18##1##(1996-5#2)(2008-10#11)(2009-7#1)(2010-4#3)(2010-9#1)
epristeride##3##1##(2008-5#3)
epsilon +##2##2##(1996-12#2)
epsilon 2##4##2##(1991-3#2)(1995-12#2)
epsilon 4 allele frequency##3##4##(1995-12#3)
epsilon 4 allele##4##3##(1995-12#4)
epsilon 4##6##2##(1995-12#6)
epsilon and beta##3##3##(1991-5#1)(2008-8#2)
epsilon and##4##2##(1991-5#1)(2008-8#3)
epsilon is##2##2##(1995-2#1)(2009-6#1)
epsilon##41##1##(1990-8#1)(1991-3#2)(1991-5#1)(1994-5#1)(1995-12#9)(1995-2#10)(1996-12#3)(2008-10#2)(2008-3#1)(2008-8#9)(2009-6#2)
epsilon(C)##2##1##(2008-10#2)
epsilon)##2##1##(1990-8#1)(1994-8#1)
epsilon-viniferin##3##1##(2008-10#3)
epsps##5##1##(2008-9#5)
eq##2##1##(2008-10#2)
equal amounts of##3##3##(2008-10#3)
equal amounts##7##2##(2008-10#4)(2008-11#2)(2010-12#1)
equal and##2##2##(2008-6#1)(2008-8#1)
equal for##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
equal frequencies##3##2##(2008-10#3)
equal frequency##2##2##(1997-3#1)(2008-10#1)
equal in##3##2##(1994-11#1)(2008-10#1)(2012-3#1)
equal male and female##2##4##(2008-8#2)
equal mixture of the##2##4##(2008-10#2)
equal mixture of##3##3##(1990-3#1)(2008-10#2)
equal numbers of##2##3##(2008-11#1)(2008-9#1)
equal numbers##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
equal or greater##2##3##(2008-10#1)(2008-8#1)
equal or higher than##2##4##(2008-10#2)
equal or lower than##2##4##(2008-10#1)(2011-2#1)
equal or##9##2##(1992-1#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-8#1)(2011-2#1)
equal proportions##2##2##(1995-12#1)(2008-10#1)
equal to 0##7##3##(1991-5#1)(1994-5#1)(1996-3#1)(2008-10#4)
equal to 1##9##3##(1990-12#1)(1993-12#1)(2008-10#4)(2011-2#1)(2012-2#1)(2012-3#1)
equal to 100##2##3##(1992-12#1)(2008-10#1)
equal to 3##2##3##(1990-12#1)(2013-1#1)
equal to 5##3##3##(1992-5#1)(2008-10#1)(2012-3#1)
equal to 7##2##3##(1990-3#1)(2008-10#1)
equal to a##2##3##(2008-10#1)(2013-1#1)
equal to or greater than##2##5##(1990-12#1)(1991-2#1)
equal to or larger than##2##5##(1995-9#1)(2007-11#1)
equal to or slightly##2##4##(1997-8#1)(2008-10#1)
equal to or##10##3##(1990-12#1)(1991-2#1)(1995-9#1)(1997-8#1)(2007-11#1)(2008-10#4)(2013-1#1)
equal to that of the##2##5##(2008-12#1)(2013-8#1)
equal to that of##4##4##(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
equal to that##6##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
equal to the number of##2##5##(2008-10#1)(2008-9#1)
equal to the##19##3##(1992-12#1)(1995-3#2)(2008-10#8)(2008-3#4)(2008-9#2)(2009-12#1)(2013-1#1)
equal to##113##2##(1990-11#2)(1990-12#5)(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#4)(1992-1#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-3#4)(1995-9#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#39)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#4)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
equal volume of##4##3##(1992-6#1)(1997-2#1)(2011-2#1)(2012-2#1)
equal volume##6##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
equal weight to the##2##4##(1993-1#1)(2010-10#1)
equal##234##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#4)(1992-1#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-5#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#3)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#78)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#15)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-10#1)(2011-2#7)(2012-2#4)(2012-3#6)(2013-1#9)(2013-8#2)
equaled or##2##2##(1994-12#1)(2008-10#1)
equaled##3##1##(1994-12#1)(2008-10#1)(2008-11#1)
equality of##2##2##(1996-3#2)
equality##3##1##(1996-3#2)(2009-7#1)
equally as##3##2##(1995-1#1)(2008-11#1)(2008-5#1)
equally effective against##3##3##(2008-10#2)(2012-2#1)
equally effective##13##2##(1992-12#1)(1993-6#1)(1995-2#1)(1996-11#1)(1996-2#1)(2008-10#3)(2008-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
equally important##5##2##(1993-11#1)(1993-2#1)(2008-12#1)(2010-10#1)(2010-2#1)
equally in##9##2##(1995-12#1)(1996-12#1)(2008-10#5)(2011-2#1)(2012-3#1)
equally potent in inhibiting the##2##5##(1992-3#2)
equally susceptible to##3##3##(1994-2#1)(1995-11#1)(2008-10#1)
equally susceptible##5##2##(1994-2#1)(1995-11#1)(2008-10#3)
equally to##2##2##(2008-11#1)(2008-7#1)
equally well for##2##3##(2008-12#1)(2011-2#1)
equally well##6##2##(1992-4#1)(2008-11#2)(2008-12#1)(2008-3#1)(2011-2#1)
equally##87##1##(1992-12#3)(1992-3#2)(1992-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-9#1)(2008-10#17)(2008-11#9)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
equals 1##2##2##(2008-3#1)(2008-8#1)
equals a##2##2##(2008-10#1)(2008-7#1)
equals the##2##2##(2008-8#1)(2013-1#1)
equals##12##1##(1991-12#1)(1994-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#4)(2013-1#1)
equated##3##1##(2008-12#1)(2008-5#2)
equation and##6##2##(2008-10#4)(2008-3#1)(2012-2#1)
equation are compared##2##3##(2008-2#1)(2008-3#1)
equation are##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
equation can##2##2##(1993-3#1)(2008-10#1)
equation for a##2##3##(2008-10#1)(2008-3#1)
equation for the##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2009-8#1)
equation for##18##2##(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2009-10#1)(2009-8#1)(2013-8#1)
equation has been##2##3##(2008-10#1)(2009-8#1)
equation has##4##2##(2008-10#2)(2009-8#1)(2011-3#1)
equation in##2##2##(2008-10#1)(2008-2#1)
equation is solved##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
equation is##13##2##(2008-10#4)(2008-2#3)(2008-3#4)(2009-10#1)(2013-1#1)
equation model##4##2##(2008-10#1)(2008-8#1)(2013-8#2)
equation modeling##10##2##(2008-11#1)(2008-12#1)(2009-11#1)(2010-10#1)(2010-2#2)(2010-6#1)(2012-3#1)(2013-8#2)
equation of the##10##3##(2008-10#7)(2008-2#1)(2008-8#1)(2009-10#1)
equation of##15##2##(2008-1#1)(2008-10#8)(2008-2#2)(2008-8#2)(2009-10#1)(2009-8#1)
equation that is##2##3##(2008-11#1)(2008-2#1)
equation that##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
equation to##5##2##(1997-2#1)(2008-1#1)(2008-3#3)
equation was##7##2##(2008-10#6)(2008-3#1)
equation where the##2##3##(2008-10#2)
equation with##6##2##(1990-8#1)(2008-10#3)(2008-8#1)(2009-3#1)
equation##191##1##(1990-5#1)(1990-8#2)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#2)(1997-2#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#81)(2008-11#3)(2008-12#2)(2008-2#12)(2008-3#30)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-10#4)(2009-11#1)(2009-3#1)(2009-8#5)(2010-10#2)(2010-2#2)(2010-6#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#7)
equations and the##2##3##(2008-10#1)(2008-9#1)
equations and##10##2##(1993-5#1)(1995-8#1)(2008-10#4)(2008-3#1)(2008-9#2)(2012-3#1)
equations are used##2##3##(2008-11#1)(2008-3#1)
equations are##6##2##(2007-12#1)(2008-11#1)(2008-3#3)(2010-10#1)
equations could be##2##3##(2008-10#1)(2008-11#1)
equations could##3##2##(2008-10#2)(2008-11#1)
equations for K(m)##2##3##(2008-10#2)
equations for the##9##3##(1990-8#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-3#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
equations for##21##2##(1990-8#1)(1993-5#1)(1995-5#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#2)(2013-8#2)
equations in##2##2##(2007-11#1)(2012-3#1)
equations of##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
equations over##2##2##(2008-10#1)(2008-3#1)
equations relating the##2##3##(2008-10#1)(2008-8#1)
equations relating##3##2##(2008-10#2)(2008-8#1)
equations that##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
equations to##4##2##(2008-10#1)(2008-7#1)(2013-8#2)
equations were used to##2##4##(2008-10#2)
equations were##7##2##(1996-12#1)(2008-10#5)(2008-11#1)
equations##139##1##(1990-8#1)(1991-9#1)(1993-5#2)(1994-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#51)(2008-11#11)(2008-2#4)(2008-3#11)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#5)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#10)
equatorial##4##1##(1995-11#1)(1996-5#1)(2008-3#1)(2012-12#1)
equilibrated at a(w) = 0##2##5##(2008-7#2)
equilibrated at##5##2##(2008-10#3)(2008-7#2)
equilibrated for##2##2##(2008-10#1)(2008-11#1)
equilibrated with##3##2##(2008-10#3)
equilibrated##15##1##(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)
equilibrating##3##1##(2008-10#3)
equilibration temperature##2##2##(2008-10#2)
equilibration time##7##2##(2008-10#7)
equilibration times##2##2##(2008-10#2)
equilibration##18##1##(1994-5#1)(1996-5#1)(2008-10#15)(2011-2#1)
equilibrative nucleoside##2##2##(1994-8#1)(1995-8#1)
equilibrative uridine transport##2##3##(1995-8#2)
equilibrative##5##1##(1994-8#2)(1995-8#3)
equilibria and##5##2##(2008-10#4)(2013-8#1)
equilibria are##3##2##(2008-10#2)(2008-8#1)
equilibria at the##2##3##(2008-10#2)
equilibria at##4##2##(1993-8#1)(2008-10#2)(2008-8#1)
equilibria between the##2##3##(2008-10#2)
equilibria between##3##2##(2008-10#3)
equilibria for##2##2##(2008-10#2)
equilibria in ethanol-aqueous solution of##2##5##(2008-10#2)
equilibria in the##2##3##(2008-10#2)
equilibria in##9##2##(2008-10#7)(2008-8#1)(2008-9#1)
equilibria of magnesium(II) with purpurin##2##5##(2008-10#2)
equilibria of metal##2##3##(2008-10#2)
equilibria of some##3##3##(2008-10#3)
equilibria of the##2##3##(2008-10#2)
equilibria of##27##2##(2008-10#26)(2008-7#1)
equilibria were##3##2##(2008-10#2)(2008-8#1)
equilibria##89##1##(1993-8#1)(1995-3#1)(2008-10#77)(2008-7#1)(2008-8#6)(2008-9#2)(2013-8#1)
equilibrium and##5##2##(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-8#1)
equilibrium between the##8##3##(1992-11#1)(1995-3#1)(2008-10#6)
equilibrium between##11##2##(1992-11#1)(1995-3#1)(2008-10#9)
equilibrium binding##5##2##(1993-8#1)(1995-11#1)(1995-8#1)(1997-2#2)
equilibrium by##2##2##(2008-10#2)
equilibrium concentration##4##2##(2008-10#4)
equilibrium concentrations of##3##3##(1993-6#1)(2008-10#2)
equilibrium concentrations##4##2##(1993-6#1)(2008-10#3)
equilibrium conditions##2##2##(1997-2#1)(2008-10#1)
equilibrium constant for##3##3##(1997-2#1)(2008-10#2)
equilibrium constant of##2##3##(1995-6#1)(2008-10#1)
equilibrium constant##12##2##(1995-6#1)(1997-2#1)(2008-10#10)
equilibrium constants and##3##3##(2008-10#3)
equilibrium constants for##3##3##(2008-10#2)(2008-4#1)
equilibrium constants is##2##3##(2008-10#2)
equilibrium constants of##8##3##(2008-10#7)(2008-7#1)
equilibrium constants were##3##3##(2008-10#3)
equilibrium constants##40##2##(1990-8#1)(2008-10#37)(2008-4#1)(2008-7#1)
equilibrium data##3##2##(2008-10#2)(2008-12#1)
equilibrium dissociation constant##2##3##(1993-3#2)
equilibrium distribution of the low (alpha-) and high (beta-) energy##2##10##(2008-10#2)
equilibrium distribution of the##3##4##(2008-10#3)
equilibrium exchange##2##2##(1991-5#2)
equilibrium for##4##2##(1993-3#1)(2008-10#2)(2010-7#1)
equilibrium in##5##2##(2008-10#4)(2008-12#1)
equilibrium is reached##2##3##(2008-10#2)
equilibrium is##7##2##(1992-3#1)(2008-10#4)(2008-5#1)(2008-9#1)
equilibrium model##2##2##(2008-10#1)(2008-4#1)
equilibrium of an asymmetric##2##4##(2008-10#2)
equilibrium of the##4##3##(2008-10#3)(2008-8#1)
equilibrium of##18##2##(1993-8#1)(2008-10#14)(2008-8#1)(2010-1#1)(2012-2#1)
equilibrium or##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
equilibrium partitioning##2##2##(2008-10#1)(2008-11#1)
equilibrium point##3##2##(2008-9#1)(2013-8#2)
equilibrium population size##4##3##(2008-8#3)(2008-9#1)
equilibrium population sizes##2##3##(2008-8#1)(2008-9#1)
equilibrium population##7##2##(2008-8#5)(2008-9#2)
equilibrium potential##3##2##(1997-2#1)(2008-10#2)
equilibrium properties of##3##3##(1993-8#3)
equilibrium solutions##2##2##(2013-8#2)
equilibrium stability##2##2##(2008-10#1)(2013-8#1)
equilibrium system##3##2##(2008-10#2)(2008-9#1)
equilibrium systems##2##2##(2008-10#2)
equilibrium was##3##2##(2008-10#3)
equilibrium when##2##2##(2013-8#2)
equilibrium with##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
equilibrium##289##1##(1990-8#2)(1991-2#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-3#3)(1993-6#1)(1993-8#6)(1994-9#1)(1995-11#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-5#3)(1997-2#5)(2008-10#160)(2008-11#5)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#22)(2008-9#14)(2009-5#4)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#11)(2012-2#2)(2012-3#3)(2013-8#8)
equimolar amounts of##3##3##(1994-3#1)(2008-10#1)(2008-5#1)
equimolar proportions##2##2##(1991-10#2)
equimolar##22##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#2)(1991-12#1)(1993-12#1)(1994-3#1)(1994-5#2)(1997-2#1)(2008-10#8)(2008-5#2)(2008-7#1)
equine##10##1##(1997-4#1)(2008-10#3)(2008-9#2)(2009-10#1)(2009-7#2)(2013-1#1)
equipment and##11##2##(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
equipment for##3##2##(1991-2#1)(2008-10#1)(2012-3#1)
equipment in the##2##3##(1991-1#1)(2010-12#1)
equipment in##5##2##(1990-9#1)(1991-1#1)(2010-12#1)(2010-8#1)(2011-1#1)
equipment inventory##2##2##(2011-2#2)
equipment is##4##2##(1994-6#1)(1996-12#1)(2008-10#2)
equipment needed##2##2##(2008-11#1)(2008-4#1)
equipment or##2##2##(2008-10#1)(2009-6#1)
equipment purchases##3##2##(1991-1#1)(1994-1#1)(1994-3#1)
equipment request forms##2##3##(1994-12#2)
equipment to##2##2##(2008-10#1)(2008-11#1)
equipment was##2##2##(1997-3#1)(2008-3#1)
equipment were##2##2##(2008-1#1)(2008-10#1)
equipment##110##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#3)(1992-6#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#6)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#2)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#19)(2008-11#9)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#2)
equipment]##2##1##(1992-5#1)(2012-3#1)
equipments##4##1##(2008-12#1)(2011-2#2)(2012-3#1)
equipotent##2##1##(1996-2#1)(2008-10#1)
equipped to deal with##2##4##(1995-9#1)(1996-1#1)
equipped to##7##2##(1993-2#1)(1995-9#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#1)
equipped with a chemiluminescence##3##4##(2008-10#3)
equipped with a transversely heated graphite##2##6##(2008-10#2)
equipped with a##21##3##(2008-10#17)(2008-11#2)(2008-7#1)(2008-9#1)
equipped with an##7##3##(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2010-1#1)
equipped with the##5##3##(2008-10#3)(2008-11#1)(2011-2#1)
equipped with two##2##3##(2008-3#1)(2013-1#1)
equipped with##53##2##(1990-12#1)(1997-3#1)(2007-12#2)(2008-10#25)(2008-11#9)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#3)(2010-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
equipped##63##1##(1990-12#1)(1993-12#1)(1993-2#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#25)(2008-11#10)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-3#1)(2010-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
equitable##6##1##(1991-1#1)(1995-12#1)(2008-11#1)(2008-8#1)(2010-10#1)(2013-1#1)
equity in the##3##3##(1992-12#1)(1995-1#1)(1996-1#1)
equity in##4##2##(1992-12#1)(1992-2#1)(1995-1#1)(1996-1#1)
equity of access##2##3##(1997-4#1)(2012-2#1)
equity of##3##2##(1997-4#1)(2008-11#1)(2012-2#1)
equity##15##1##(1991-12#1)(1992-12#2)(1992-2#1)(1993-1#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-3#1)(1997-4#1)(2008-11#2)(2010-4#1)(2012-2#1)
equivalence between##4##2##(2008-10#3)(2008-11#1)
equivalence of##2##2##(1995-9#1)(2008-10#1)
equivalence point was##3##3##(2008-10#3)
equivalence point##10##2##(2008-10#10)
equivalence ratio##2##2##(1996-12#1)(2008-3#1)
equivalence ratios##3##2##(2008-2#1)(2008-3#2)
equivalence with##3##2##(2008-10#2)(2008-11#1)
equivalence##43##1##(1994-9#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#2)(2009-11#3)
equivalence&quot##2##1##(1995-5#1)(2009-10#1)
equivalency##3##1##(1991-12#1)(2008-10#1)(2008-9#1)
equivalent amount of##2##3##(2008-10#2)
equivalent at##2##2##(2008-7#1)(2012-12#1)
equivalent circuit##2##2##(2008-10#1)(2013-8#1)
equivalent concentrations##2##2##(2008-10#2)
equivalent dose##2##2##(2008-10#1)(2008-12#1)
equivalent effects##2##2##(1992-12#1)(1997-7#1)
equivalent efficacy with##2##3##(1991-8#1)(1996-1#1)
equivalent efficacy##3##2##(1991-8#1)(1996-1#1)(2010-11#1)
equivalent factor##2##2##(2008-10#2)
equivalent for##2##2##(1994-5#1)(2008-10#1)
equivalent in##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
equivalent isotropic scattering##2##3##(2008-3#2)
equivalent isotropic##4##2##(2008-3#4)
equivalent levels##4##2##(1993-6#1)(1995-11#1)(2008-11#1)(2013-1#1)
equivalent model##8##2##(2008-5#8)
equivalent of a##2##3##(2010-11#1)(2010-5#1)
equivalent of##8##2##(2008-10#4)(2009-12#1)(2010-11#1)(2010-5#1)(2012-2#1)
equivalent particle##2##2##(2008-10#1)(2008-8#1)
equivalent protection against bronchial provocation##2##5##(1996-1#1)(1996-2#1)
equivalent to a##6##3##(2008-10#5)(2012-3#1)
equivalent to holo human transferrin in##2##6##(2008-11#2)
equivalent to that of##5##4##(1997-4#1)(2008-10#2)(2008-11#1)(2008-6#1)
equivalent to that##6##3##(1997-4#1)(2008-10#2)(2008-11#2)(2008-6#1)
equivalent to the##8##3##(1991-3#1)(1993-8#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
equivalent to those achieved##2##4##(2008-10#2)
equivalent to those##4##3##(2008-10#3)(2008-11#1)
equivalent to wild-type Rev##2##4##(1993-8#2)
equivalent to##53##2##(1990-5#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-9#3)(1993-8#3)(1995-5#1)(1997-4#1)(2008-10#24)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
equivalent with##2##2##(2008-10#1)(2010-9#1)
equivalent##186##1##(1990-5#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-9#3)(1993-12#1)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#2)(1996-1#4)(1996-2#3)(1997-4#1)(1997-6#3)(1997-7#1)(2008-10#62)(2008-11#17)(2008-12#2)(2008-2#2)(2008-3#11)(2008-5#15)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
equivalently##3##1##(2008-10#1)(2008-3#1)(2008-6#1)
equivalents of##4##2##(2008-10#2)(2008-11#1)(2010-5#1)
equivalents##18##1##(1990-5#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-9#2)(2010-5#1)
equivocal lesions##2##2##(1994-1#2)
equivocal##11##1##(1991-3#1)(1994-1#3)(1997-8#3)(2008-1#1)(2008-9#2)(2009-10#1)
equol##3##1##(2010-1#3)
er##2##1##(2008-3#2)
era has##2##2##(2008-10#1)(2012-12#1)
era of health care reform##4##5##(1993-12#1)(1997-3#1)(2010-5#1)(2010-8#1)
era of health reform##3##4##(1996-1#1)(1996-3#2)
era of health##7##3##(1993-12#1)(1996-1#1)(1996-3#2)(1997-3#1)(2010-5#1)(2010-8#1)
era of##27##2##(1993-1#3)(1993-12#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-3#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)
era##60##1##(1991-2#1)(1991-8#1)(1993-1#3)(1993-12#2)(1995-2#1)(1995-8#1)(1996-1#2)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#6)(2011-7#1)(2012-12#2)(2012-3#3)(2013-1#2)
eradicate the disease##4##3##(1994-9#2)(2011-2#2)
eradicate##10##1##(1994-9#5)(1997-5#1)(1997-7#1)(2011-2#2)(2013-1#1)
eradicated from##3##2##(1990-3#2)(1994-9#1)
eradicated##6##1##(1990-3#2)(1994-9#2)(1996-6#1)(2008-11#1)
eradicating##8##1##(1996-11#1)(1996-12#1)(2008-10#1)(2008-8#1)(2011-2#3)(2012-2#1)
eradication of BE##2##3##(2010-12#2)
eradication of the##4##3##(1992-6#1)(1997-1#1)(2008-5#1)(2011-2#1)
eradication of##18##2##(1992-6#1)(1995-5#1)(1997-1#3)(2007-12#1)(2008-11#2)(2008-5#1)(2010-1#1)(2010-12#3)(2010-6#1)(2011-2#4)
eradication protocol##2##2##(2008-10#2)
eradication rate##3##2##(1996-11#1)(2010-12#1)(2011-2#1)
eradication therapy##5##2##(1996-11#2)(2010-12#2)(2013-1#1)
eradication##52##1##(1992-6#1)(1994-9#2)(1995-5#1)(1996-11#3)(1997-1#5)(2007-12#1)(2008-10#6)(2008-11#3)(2008-5#1)(2010-1#2)(2010-11#1)(2010-12#10)(2010-6#1)(2011-2#7)(2011-3#2)(2012-12#4)(2012-2#1)(2013-1#1)
erbium##6##1##(2008-10#5)(2008-7#1)
erbium-doped fiber amplifier##3##3##(2008-2#1)(2008-3#2)
erbium-doped fiber##4##2##(2008-2#2)(2008-3#2)
erect##3##1##(2009-10#1)(2011-2#2)
erectile dysfunction (ED)##2##3##(2010-10#1)(2011-2#1)
erectile dysfunction##6##2##(2008-3#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
erectile##7##1##(2008-3#1)(2010-10#1)(2011-2#3)(2012-12#1)(2013-8#1)
erection##2##1##(2008-10#2)
ergometer##4##1##(2008-9#3)(2009-1#1)
ergonomic##3##1##(2008-11#2)(2013-1#1)
ergonomics##2##1##(1996-1#1)(2008-10#1)
ergosterol content##3##2##(2008-10#3)
ergosterol##11##1##(1997-2#4)(2008-10#7)
ergot in the Texas##2##4##(2008-10#2)
ergot##14##1##(1996-2#1)(2008-10#11)(2008-8#1)(2010-7#1)
ergot-favorable##2##1##(2008-10#2)
erinacea##2##1##(2010-8#2)
eriocalyx##4##1##(2008-12#4)
eriochrome##2##1##(2008-10#2)
eriophyid mite##2##2##(2008-10#2)
eriophyid mite-transmitted##3##2##(2008-10#3)
eriophyid##6##1##(2008-10#6)
erlotinib##4##1##(2009-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
eroded##2##1##(1996-6#1)(2010-11#1)
eroding##2##1##(1995-12#1)(2012-3#1)
erosion and##3##2##(2008-12#2)(2010-6#1)
erosion of the##6##3##(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#2)
erosion of##9##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#2)
erosion##23##1##(2008-10#5)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)
erosions and##2##2##(2011-2#1)(2013-1#1)
erosions in##3##2##(2011-2#2)(2013-1#1)
erosions##6##1##(1990-3#1)(2011-2#3)(2013-1#2)
erosive OLP##4##2##(2013-1#4)
erosive challenge##4##2##(2013-1#4)
erosive##13##1##(1997-8#1)(2009-8#1)(2011-2#1)(2013-1#10)
errata##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
erratic##11##1##(1996-3#3)(2008-10#5)(2008-5#1)(2010-2#1)(2013-1#1)
erroneous position data from##2##4##(2009-10#2)
erroneous##7##1##(1996-11#1)(2009-10#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
erroneously##6##1##(1997-4#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-10#1)
error analysis of##3##3##(2008-10#2)(2008-3#1)
error analysis##6##2##(2008-10#2)(2008-3#3)(2008-6#1)
error and##11##2##(1992-12#1)(1992-9#3)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2013-1#1)
error associated with##2##3##(2008-3#1)(2008-6#1)
error by##2##2##(1994-9#1)(2008-3#1)
error can be##2##3##(2008-6#2)
error correction##3##2##(2007-12#1)(2008-3#2)
error covariance matrix##2##3##(2008-2#2)
error depends on##2##3##(2008-3#2)
error due to##2##3##(2008-10#2)
error for the##5##3##(2008-10#2)(2008-12#1)(2013-1#2)
error for##12##2##(2008-10#5)(2008-12#2)(2008-3#1)(2008-9#1)(2010-5#1)(2013-1#2)
error function##2##2##(2008-11#2)
error functions were calculated for deducing the number of factors##2##10##(2008-10#2)
error functions##3##2##(2008-10#2)(2008-11#1)
error in the##13##3##(1992-12#1)(1992-4#1)(2008-10#4)(2008-3#5)(2012-2#2)
error in##25##2##(1992-12#1)(1992-4#1)(1993-9#1)(2008-10#11)(2008-11#1)(2008-3#7)(2008-9#1)(2012-2#2)
error inherent in the##2##4##(2008-10#2)
error is##3##2##(1995-3#1)(2008-3#1)(2008-8#1)
error less than##2##3##(2008-10#2)
error of 0##3##3##(2008-10#3)
error of 3##2##3##(2008-10#2)
error of prediction (RSEP)##2##4##(2008-10#2)
error of prediction##11##3##(2008-10#11)
error of the##7##3##(2008-10#3)(2008-3#3)(2008-6#1)
error of##54##2##(1995-3#1)(2008-10#42)(2008-12#1)(2008-3#6)(2008-6#1)(2009-10#1)(2010-12#1)(2013-1#1)
error on the##3##3##(1993-9#1)(2007-11#1)(2008-3#1)
error pattern##2##2##(2010-1#2)
error prevention and##4##3##(2011-1#4)
error prevention##5##2##(2011-1#5)
error propagation##3##2##(2008-10#3)
error rate of##2##3##(2008-10#1)(2012-2#1)
error rate that##2##3##(2013-1#2)
error rate##9##2##(2008-10#1)(2012-2#6)(2013-1#2)
error rates##2##2##(2011-2#1)(2012-2#1)
error signals##2##2##(2008-11#1)(2013-8#1)
error sum of squares (PRESS)##2##5##(2008-10#2)
error that is due to##2##5##(2008-3#2)
error that is##3##3##(2008-3#3)
error that##5##2##(2008-3#5)
error type##2##2##(2009-8#2)
error variances##2##2##(2012-3#2)
error was calculated##2##3##(2008-10#1)(2008-12#1)
error was##10##2##(1991-11#1)(2008-10#5)(2008-12#2)(2008-3#1)(2013-8#1)
error##294##1##(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#3)(1992-4#1)(1992-9#5)(1993-9#2)(1994-9#1)(1995-2#1)(1995-3#2)(2007-11#3)(2007-12#2)(2008-10#141)(2008-11#9)(2008-12#6)(2008-2#4)(2008-3#49)(2008-6#8)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-8#3)(2010-1#4)(2010-12#1)(2010-5#1)(2011-1#5)(2011-2#3)(2012-2#10)(2012-3#2)(2013-1#8)(2013-8#3)
error)##6##1##(2008-10#6)
error-perception##2##1##(2008-11#2)
error-prone##3##1##(2008-8#1)(2011-1#2)
errorless trials##3##2##(1992-12#3)
errors and##12##2##(1990-11#1)(2008-10#3)(2008-11#3)(2008-3#2)(2011-1#3)
errors are present##2##3##(2008-11#1)(2008-3#1)
errors are##5##2##(1990-11#1)(1992-9#1)(2008-11#2)(2008-3#1)
errors associated with##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
errors at##2##2##(2008-12#1)(2008-3#1)
errors can be##2##3##(2008-10#1)(2008-3#1)
errors caused by##3##3##(2008-2#1)(2008-3#2)
errors could##2##2##(2008-10#1)(2011-2#1)
errors due to##4##3##(1995-5#1)(2008-10#3)
errors for##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
errors in the##8##3##(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)
errors in##29##2##(1995-9#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)(2011-2#2)(2012-2#2)
errors is##2##2##(2008-10#1)(2008-3#1)
errors made##2##2##(2008-10#1)(2012-12#1)
errors of prediction##4##3##(2008-10#4)
errors of the##4##3##(2007-11#1)(2008-10#3)
errors of##23##2##(2007-11#1)(2007-12#1)(2008-10#19)(2011-2#1)(2012-2#1)
errors on##3##2##(2008-2#2)(2008-3#1)
errors that are##2##3##(2008-3#2)
errors that##3##2##(2008-10#1)(2008-3#2)
errors were##7##2##(1994-3#1)(2008-10#3)(2008-11#1)(2011-1#2)
errors with##3##2##(1996-11#1)(2008-6#2)
errors##163##1##(1990-11#3)(1992-9#1)(1994-3#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-2#2)(2007-11#1)(2007-12#2)(2008-10#65)(2008-11#10)(2008-12#2)(2008-2#6)(2008-3#28)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-3#2)(2011-1#7)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
erupt##2##1##(2008-10#1)(2013-1#1)
erupted##2##1##(2008-10#1)(2013-1#1)
eruption and##2##2##(2008-8#1)(2010-6#1)
eruption of##2##2##(2008-10#1)(2008-3#1)
eruption##12##1##(1994-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#4)(2012-3#1)(2013-1#1)
eruptive##2##1##(2010-6#1)(2012-3#1)
erysimi##2##1##(2009-8#2)
erythema and##5##2##(1991-6#1)(2008-5#2)(2011-2#1)(2013-1#1)
erythema in##2##2##(1994-12#1)(2008-5#1)
erythema nodosum##4##2##(1993-8#2)(1997-8#1)(2008-8#1)
erythema##22##1##(1991-11#1)(1991-6#2)(1993-8#2)(1994-12#1)(1996-11#1)(1997-8#2)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#1)
erythemal##4##1##(2008-5#4)
erythematous macules##4##2##(2010-6#4)
erythematous##11##1##(1990-2#1)(2010-6#5)(2011-2#1)(2012-3#3)(2013-1#1)
erythroblasts##5##1##(1993-8#1)(2008-11#1)(2008-9#2)(2010-8#1)
erythrocyte acetylcholinesterase##2##2##(1992-8#1)(1994-8#1)
erythrocyte and platelet magnesium levels in##2##6##(2008-7#2)
erythrocyte and##3##2##(2008-5#1)(2008-7#2)
erythrocyte count##2##2##(2008-9#2)
erythrocyte creatine##2##2##(1990-2#2)
erythrocyte ghosts##2##2##(2008-10#1)(2009-8#1)
erythrocyte membrane##7##2##(1990-12#1)(1992-11#1)(1993-6#1)(1995-8#1)(2008-11#3)
erythrocyte membranes##9##2##(1991-5#2)(1992-9#1)(1994-8#1)(2008-11#1)(2008-8#2)(2009-8#2)
erythrocyte sedimentation rate are##2##4##(1993-2#1)(1997-8#1)
erythrocyte sedimentation rate##4##3##(1990-9#1)(1993-2#1)(1997-8#2)
erythrocyte sodium##2##2##(1992-12#1)(1995-8#1)
erythrocyte water##4##2##(1993-2#4)
erythrocyte##68##1##(1990-12#5)(1990-2#5)(1990-9#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-2#5)(1993-6#2)(1994-8#4)(1995-6#1)(1995-8#5)(1997-8#2)(2008-10#5)(2008-11#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-8#3)(2012-12#1)(2013-8#4)
erythrocytes and lymphocytes##2##3##(1991-2#1)(2009-12#1)
erythrocytes and##12##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-6#1)(1993-2#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-12#1)
erythrocytes by##2##2##(1991-5#1)(2008-10#1)
erythrocytes of##5##2##(1990-12#1)(1991-12#1)(1996-12#1)(2008-11#1)(2008-9#1)
erythrocytes was##2##2##(2008-10#1)(2008-9#1)
erythrocytes were observed##2##3##(1990-2#1)(2008-9#1)
erythrocytes##79##1##(1990-11#1)(1990-12#3)(1990-2#3)(1991-12#2)(1991-2#2)(1991-5#6)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#3)(1994-3#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-6#3)(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#7)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#18)(2009-12#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
erythrocytic##2##1##(1994-8#1)(2012-12#1)
erythrodysesthesia##2##1##(2008-7#2)
erythroid and basophilic##2##3##(1990-5#2)
erythroid and##3##2##(1990-5#2)(2008-11#1)
erythroid cells##6##2##(1991-5#1)(2008-4#2)(2008-8#1)(2008-9#2)
erythroid differentiation related gene##2##4##(2008-8#2)
erythroid differentiation related##3##3##(2008-8#2)(2008-9#1)
erythroid differentiation##8##2##(1991-5#1)(1993-8#2)(2008-8#2)(2008-9#3)
erythroid##30##1##(1990-5#2)(1991-2#1)(1991-5#3)(1992-12#1)(1993-8#2)(2008-11#3)(2008-4#3)(2008-8#5)(2008-9#9)(2011-2#1)
erythroleukemia cell line##4##3##(1990-2#2)(2008-9#2)
erythroleukemia cells##2##2##(1993-8#2)
erythroleukemia##7##1##(1990-2#2)(1993-8#2)(2008-9#2)(2009-9#1)
erythromycin##4##1##(1993-12#1)(2008-7#2)(2012-3#1)
erythrophagocytosis assay##2##2##(1990-12#2)
erythropoiesis##5##1##(1993-12#1)(1994-5#1)(2008-4#1)(2008-9#1)(2012-2#1)
erythropoietin (EPO)##5##2##(2008-1#1)(2008-11#2)(2008-12#1)(2008-8#1)
erythropoietin (Epo) and##3##3##(2008-11#3)
erythropoietin produced by##5##3##(2008-11#5)
erythropoietin##35##1##(1990-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#2)(2008-1#6)(2008-10#1)(2008-11#16)(2008-12#1)(2008-4#1)(2008-8#2)(2010-7#1)(2011-2#1)
erythropoietin-associated##2##1##(2008-10#2)
erythroseptica##2##1##(2008-10#2)
erythrosine B##2##2##(2008-10#2)
erythrospilus##3##1##(2010-8#3)
erythroxyli is##2##2##(2008-10#2)
erythroxyli##11##1##(2008-10#11)
es##2##1##(2008-10#1)(2008-11#1)
esca symptoms##3##2##(2008-10#3)
esca##8##1##(2008-10#8)
escalated##2##1##(1990-12#1)(2008-8#1)
escalating costs##2##2##(2008-11#1)(2012-12#1)
escalating##6##1##(1990-11#1)(1993-9#1)(1995-2#1)(1996-5#1)(2008-11#1)(2012-12#1)
escalation events##3##2##(2009-10#3)
escalation vectors##2##2##(2009-10#2)
escalation##11##1##(1992-6#1)(2008-10#1)(2008-7#1)(2009-10#8)
escapable stress##2##2##(2008-11#2)
escape from the protein##2##4##(1990-8#2)
escape from the##5##3##(1990-8#2)(1996-12#1)(2008-12#1)(2008-8#1)
escape of##4##2##(1995-3#2)(1996-12#1)(2008-10#1)
escape the##3##2##(1992-12#1)(2008-10#1)(2013-1#1)
escape##26##1##(1990-8#2)(1992-12#1)(1995-3#2)(1996-12#6)(2007-12#2)(2008-10#5)(2008-12#1)(2008-8#2)(2008-9#3)(2010-7#1)(2013-1#1)
escaped##3##1##(1995-12#1)(1995-3#1)(2011-2#1)
escapes##4##1##(1995-5#1)(2008-10#1)(2008-9#1)(2010-5#1)
escaping##4##1##(1996-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
escitalopram##7##1##(2012-3#7)
esculenta)##3##1##(2008-10#3)
esculentum##13##1##(1993-12#1)(2008-10#12)
esomeprazole##6##1##(2011-2#6)
esophageal adenocarcinoma##4##2##(2008-12#2)(2010-6#2)
esophageal atresia##2##2##(2008-8#1)(2012-3#1)
esophageal cancer and##2##3##(2008-8#1)(2010-12#1)
esophageal cancer##9##2##(1992-9#1)(2008-8#1)(2010-12#3)(2010-6#3)(2013-1#1)
esophageal candidiasis##2##2##(1990-3#1)(2008-5#1)
esophageal carcinoma cell lines##3##4##(1992-8#3)
esophageal carcinoma##4##2##(1992-8#3)(1993-8#1)
esophageal carcinomas##3##2##(1992-8#3)
esophageal diseases##4##2##(2013-1#4)
esophageal hiatal##2##2##(2008-12#1)(2011-2#1)
esophageal pH-metry##3##2##(1996-3#3)
esophageal squamous cell carcinoma##2##4##(2008-12#1)(2010-6#1)
esophageal squamous##3##2##(2008-12#1)(2010-12#1)(2010-6#1)
esophageal varices##4##2##(2009-8#1)(2013-1#3)
esophageal varices]##2##2##(1992-2#1)(2013-1#1)
esophageal##69##1##(1990-12#1)(1990-3#1)(1990-8#1)(1992-2#1)(1992-6#3)(1992-8#7)(1992-9#4)(1993-8#1)(1996-3#3)(1997-8#1)(2008-12#4)(2008-5#2)(2008-8#2)(2009-11#1)(2009-8#1)(2010-12#5)(2010-6#7)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#15)(2013-8#1)
esophagitis in##2##2##(1992-5#1)(2013-1#1)
esophagitis##11##1##(1992-3#1)(1992-5#1)(2008-10#3)(2008-12#2)(2011-2#2)(2013-1#2)
esophagogastric##2##1##(1991-11#1)(1992-9#1)
esophagoscopy##2##1##(1992-9#1)(2012-3#1)
esophagus and stomach##3##3##(2011-2#1)(2012-3#2)
esophagus and##5##2##(2008-11#1)(2011-2#1)(2012-3#3)
esophagus##27##1##(1990-8#2)(1992-6#1)(1992-9#1)(1993-8#2)(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#3)(2010-12#2)(2011-2#6)(2012-3#4)(2013-1#2)
especially Streptococcus pneumoniae##2##3##(1994-9#2)
especially after##6##2##(1990-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#2)
especially alpha-amylase##2##2##(1990-3#2)
especially among children and##2##4##(1991-6#1)(2010-7#1)
especially among##5##2##(1991-6#1)(2008-11#1)(2010-7#1)(2012-12#1)(2012-3#1)
especially as the##2##3##(1994-9#1)(2008-8#1)
especially as they##2##3##(2008-3#1)(2010-7#1)
especially as##9##2##(1993-8#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)
especially at high##2##3##(1996-2#1)(2008-10#1)
especially at low##4##3##(2008-10#3)(2008-11#1)
especially at night##2##3##(1997-4#2)
especially at the##5##3##(1994-12#1)(2008-7#3)(2010-1#1)
especially at##19##2##(1994-12#1)(1996-2#1)(1996-9#1)(1997-4#2)(2008-10#6)(2008-11#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#1)
especially because##3##2##(1996-11#1)(2009-1#1)(2013-1#1)
especially before##2##2##(1997-3#1)(2010-11#1)
especially by##2##2##(2008-5#1)(2008-8#1)
especially clinical##2##2##(1994-9#1)(2010-7#1)
especially concerning##3##2##(2008-10#2)(2011-2#1)
especially designed for##2##3##(1993-2#1)(2008-10#1)
especially designed##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
especially difficult##4##2##(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
especially during the##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
especially during##7##2##(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#3)(2011-2#1)
especially fatigue##2##2##(2008-7#1)(2009-5#1)
especially for patients who##2##4##(1993-12#1)(2011-2#1)
especially for patients with##2##4##(2010-10#1)(2010-5#1)
especially for patients##4##3##(1993-12#1)(2010-10#1)(2010-5#1)(2011-2#1)
especially for the##9##3##(1991-12#1)(1991-3#1)(2008-10#3)(2008-3#1)(2009-11#1)(2010-8#1)(2012-2#1)
especially for those##2##3##(2008-7#1)(2011-2#1)
especially for##48##2##(1990-9#1)(1991-12#2)(1991-3#1)(1993-12#1)(1994-9#1)(1996-1#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)
especially from large amounts of nitrate##2##6##(2008-10#2)
especially from##8##2##(1994-3#1)(2008-10#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
especially given##2##2##(1991-1#1)(2008-10#1)
especially high##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
especially if##3##2##(1997-4#1)(2008-8#1)(2012-3#1)
especially important for##2##3##(1994-3#1)(2011-2#1)
especially important##7##2##(1992-5#1)(1994-3#1)(2008-11#1)(2008-9#1)(2010-1#1)(2011-2#2)
especially in case of##2##4##(2010-8#1)(2011-2#1)
especially in food##2##3##(2008-10#1)(2008-9#1)
especially in males##2##3##(2010-12#1)(2011-2#1)
especially in patients with##4##4##(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
especially in patients##5##3##(1993-1#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
especially in plants##2##3##(2009-6#1)(2009-8#1)
especially in the case of##5##5##(1991-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
especially in the case##6##4##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
especially in the presence of##3##5##(2008-10#1)(2011-2#1)(2012-12#1)
especially in the##35##3##(1991-6#1)(1993-12#1)(1994-12#1)(1996-11#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#2)(2009-10#1)(2010-7#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#2)
especially in their##2##3##(1993-8#1)(2008-5#1)
especially in women##2##3##(1991-8#1)(2008-7#1)
especially in##116##2##(1990-12#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#18)(2008-11#6)(2008-12#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#18)(2011-7#1)(2012-12#5)(2012-2#3)(2012-3#6)(2012-8#1)(2013-1#6)(2013-8#1)
especially interesting##2##2##(2008-10#1)(2010-7#1)
especially of the##2##3##(2008-10#1)(2008-11#1)
especially of##6##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
especially on the##2##3##(1992-12#1)(2008-10#1)
especially regarding the##2##3##(2008-11#1)(2010-8#1)
especially since the##3##3##(1997-3#1)(2008-10#1)(2011-1#1)
especially since##5##2##(1997-3#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-1#1)
especially that of##2##3##(2009-10#1)(2011-3#1)
especially that##3##2##(2008-11#1)(2009-10#1)(2011-3#1)
especially the most##2##3##(1996-1#1)(2008-10#1)
especially the spatial pattern of the initial inocula##2##8##(2008-10#2)
especially the##34##2##(1991-3#1)(1991-8#1)(1992-2#1)(1994-5#1)(1996-1#1)(1996-12#1)(2008-10#6)(2008-12#2)(2008-5#4)(2008-7#1)(2008-9#4)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#3)(2012-3#1)
especially those involving##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
especially those of the##3##4##(1996-2#1)(2011-2#1)(2012-2#1)
especially those of##5##3##(1996-2#1)(1997-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
especially those that##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
especially those with##4##3##(1994-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
especially those##24##2##(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#8)(2008-11#3)(2008-7#1)(2009-11#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
especially to the##2##3##(1995-11#1)(2008-9#1)
especially to##5##2##(1995-11#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#1)
especially true in##2##3##(2008-8#1)(2010-11#1)
especially true##6##2##(1990-12#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-3#1)
especially useful for##3##3##(2008-10#2)(2008-5#1)
especially useful in##4##3##(1995-11#1)(2007-11#1)(2008-4#1)(2012-2#1)
especially useful##9##2##(1991-12#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)
especially valuable##2##2##(2011-2#1)(2013-1#1)
especially vulnerable to##2##3##(1994-6#1)(2008-7#1)
especially when surgical##2##3##(2011-2#1)(2012-2#1)
especially when the##2##3##(1992-3#1)(2008-10#1)
especially when they are##2##4##(2008-8#1)(2013-1#1)
especially when##26##2##(1990-12#1)(1992-3#1)(1996-11#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
especially where##2##2##(2008-10#1)(2008-8#1)
especially with a##2##3##(2008-1#1)(2012-3#1)
especially with respect to##3##4##(2008-10#2)(2008-8#1)
especially with the##4##3##(1992-3#1)(1993-12#1)(2008-11#1)(2010-12#1)
especially with##11##2##(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
especially##525##1##(1990-12#4)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#4)(1991-3#4)(1991-5#1)(1991-6#4)(1991-8#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#2)(2007-8#4)(2008-1#6)(2008-10#105)(2008-11#25)(2008-12#17)(2008-3#4)(2008-4#2)(2008-5#14)(2008-6#4)(2008-7#12)(2008-8#12)(2008-9#20)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#7)(2010-1#6)(2010-10#2)(2010-11#4)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#11)(2010-8#8)(2011-1#3)(2011-2#47)(2011-3#6)(2011-7#1)(2012-12#8)(2012-2#14)(2012-3#16)(2012-8#1)(2013-1#18)(2013-8#7)
essay is to##5##3##(1997-8#1)(2006-6#1)(2012-2#3)
essay provides##2##2##(2009-6#1)(2012-2#1)
essay will##4##2##(2008-1#1)(2008-12#3)
essay##25##1##(1997-8#2)(2006-6#1)(2008-1#1)(2008-12#6)(2009-10#1)(2009-6#1)(2010-1#2)(2012-2#10)(2013-1#1)
essence of the##3##3##(1996-3#1)(2008-8#1)(2009-7#1)
essence of##8##2##(1992-3#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)
essence##15##1##(1992-3#1)(1993-11#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2013-1#1)
essential amino acid##5##3##(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)
essential amino acids##3##3##(2010-4#2)(2012-2#1)
essential amino##8##2##(2008-11#2)(2008-5#1)(2010-4#2)(2011-2#1)(2012-2#2)
essential and##5##2##(1990-12#1)(2008-10#2)(2008-11#1)(2012-3#1)
essential as##2##2##(1996-3#1)(2010-5#1)
essential aspect of##2##3##(2008-9#1)(2009-10#1)
essential but##2##2##(2008-7#1)(2008-8#1)
essential component for the##2##4##(1996-12#1)(2012-2#1)
essential component##18##2##(1990-5#1)(1991-6#1)(1992-1#1)(1994-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-1#1)(2012-2#2)(2013-8#3)
essential dyspepsia##2##2##(1995-10#2)
essential elements of##2##3##(1991-2#1)(2008-4#1)
essential elements##3##2##(1991-2#1)(2008-10#1)(2008-4#1)
essential factors##2##2##(2008-10#2)
essential fatty acids##2##3##(2010-4#1)(2013-1#1)
essential feature##2##2##(1995-2#1)(2008-3#1)
essential for a##2##3##(2008-5#1)(2011-2#1)
essential for cellular##2##3##(2008-10#1)(2009-9#1)
essential for development##2##3##(1994-12#1)(2012-3#1)
essential for function##2##3##(1994-5#1)(2008-8#1)
essential for growth and##2##4##(1995-2#1)(2008-11#1)
essential for intracellular processing##2##4##(1993-8#2)
essential for its##5##3##(1992-12#1)(2008-8#2)(2009-7#1)(2011-3#1)
essential for n-alkane assimilation##2##4##(1991-9#1)(1993-12#1)
essential for successful##5##3##(1992-6#1)(2008-11#1)(2010-11#1)(2011-2#2)
essential for the development of cell-free assays that reconstitute complicated cellular processes##2##12##(2008-4#2)
essential for the development of##5##5##(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#2)
essential for the function of##3##5##(1993-12#1)(1995-6#1)(2008-11#1)
essential for the##43##3##(1990-11#1)(1990-5#1)(1991-5#1)(1992-5#1)(1993-12#2)(1995-6#2)(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#4)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2009-8#4)(2011-1#3)(2011-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
essential for their##2##3##(2011-2#2)
essential for viability##2##3##(1993-9#1)(1997-7#1)
essential for viral##2##3##(1997-3#1)(2008-10#1)
essential for##175##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#2)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#1)(1995-11#2)(1995-2#2)(1995-6#4)(1995-8#3)(1995-9#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#10)(2008-12#2)(2008-4#2)(2008-5#7)(2008-7#5)(2008-8#10)(2008-9#6)(2009-10#5)(2009-7#1)(2009-8#8)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#19)(2011-3#2)(2012-2#8)(2012-3#4)(2013-1#5)(2013-7#1)
essential genes##2##2##(2008-7#1)(2008-9#1)
essential hypertension in##5##3##(1993-2#1)(2008-9#2)(2010-4#1)(2013-7#1)
essential hypertension##21##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-1#2)(2010-4#4)(2011-2#2)(2012-2#3)(2013-7#1)
essential hypertensive##2##2##(2010-4#1)(2013-8#1)
essential if##3##2##(1993-12#1)(2013-1#1)(2013-8#1)
essential in the##6##3##(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)
essential in##18##2##(1992-3#1)(1993-3#1)(1994-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2013-7#1)
essential nursing##2##2##(2008-11#1)(2008-12#1)
essential oil of Elephantopus scaber##2##5##(2008-11#2)
essential oil of the fruits##6##5##(2008-11#5)(2008-12#1)
essential oil of the##7##4##(2008-11#6)(2008-12#1)
essential oil of##11##3##(2008-11#10)(2008-12#1)
essential oil##21##2##(2008-10#3)(2008-11#10)(2008-12#5)(2012-2#2)(2012-3#1)
essential oils and their components##2##5##(2008-10#2)
essential oils and their##3##4##(2008-10#3)
essential oils from##2##3##(2008-10#1)(2008-12#1)
essential oils of Thymus persicus and Thymus eriocalyx##2##8##(2008-12#2)
essential oils of##5##3##(2008-10#1)(2008-11#2)(2008-12#2)
essential oils were##2##3##(2008-10#1)(2008-12#1)
essential oils##22##2##(2008-10#9)(2008-11#3)(2008-12#4)(2008-5#5)(2013-1#1)
essential requirement for##2##3##(2008-10#1)(2008-8#1)
essential role in##16##3##(1992-11#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
essential role##27##2##(1992-11#1)(1992-3#1)(1993-8#1)(1994-12#2)(1995-12#2)(1995-2#2)(1995-6#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
essential roles##4##2##(2008-11#1)(2008-2#1)(2013-8#2)
essential sequences##2##2##(1990-5#1)(1991-5#1)
essential skill##2##2##(2008-11#1)(2010-4#1)
essential skills in##2##3##(1995-1#2)
essential step in##2##3##(2008-11#1)(2011-2#1)
essential step##6##2##(1990-12#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
essential to identify##2##3##(2008-10#1)(2011-2#1)
essential to the development##2##4##(2008-12#2)
essential to the##9##3##(1993-3#1)(1995-5#1)(1997-3#1)(2008-12#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
essential to##52##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#2)(1993-3#2)(1994-9#1)(1995-5#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-12#5)(2008-5#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)
essential trace element##3##3##(2008-10#1)(2012-2#2)
essential trace##4##2##(1990-2#1)(2008-10#1)(2012-2#2)
essential tremor##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
essential use exemptions##2##3##(1996-1#2)
essential viral##2##2##(2013-1#2)
essential when##2##2##(2008-10#1)(2012-2#1)
essential##594##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#4)(1990-9#1)(1991-12#1)(1991-2#4)(1991-5#6)(1991-6#3)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#2)(1992-3#5)(1992-5#1)(1992-6#4)(1992-9#1)(1993-11#2)(1993-12#6)(1993-2#4)(1993-3#4)(1993-6#2)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#7)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#12)(1997-5#1)(1997-7#5)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#76)(2008-11#52)(2008-12#20)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#22)(2008-6#3)(2008-7#18)(2008-8#20)(2008-9#19)(2009-1#2)(2009-10#7)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#3)(2010-4#10)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#37)(2011-3#4)(2012-12#2)(2012-2#30)(2012-3#13)(2013-1#25)(2013-7#4)(2013-8#15)
essentially a##3##2##(1992-2#1)(2008-4#1)(2010-5#1)
essentially an##2##2##(2008-10#1)(2008-5#1)
essentially different##2##2##(1992-9#1)(2008-7#1)
essentially identical to the##2##4##(2008-10#1)(2008-8#1)
essentially identical to##4##3##(1992-8#1)(1997-8#1)(2008-10#1)(2008-8#1)
essentially identical##8##2##(1992-8#2)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
essentially normal##2##2##(2008-10#1)(2008-12#1)
essentially quantitative##2##2##(1996-5#1)(2008-10#1)
essentially similar##2##2##(2008-7#1)(2009-8#1)
essentially the same as##2##4##(1995-6#1)(2008-10#1)
essentially the same in##2##4##(1991-2#1)(2008-10#1)
essentially the same##8##3##(1991-2#1)(1994-1#1)(1995-6#1)(2008-10#4)(2008-12#1)
essentially the##10##2##(1991-2#1)(1994-1#1)(1995-6#1)(2008-10#5)(2008-12#1)(2011-2#1)
essentially unaltered##2##2##(1994-11#1)(2008-10#1)
essentially unchanged##3##2##(1992-6#1)(1993-8#1)(2008-10#1)
essentially##83##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-3#1)(1993-8#3)(1994-1#2)(1994-11#2)(1995-12#1)(1995-6#1)(1996-1#1)(1996-5#2)(1997-8#2)(2008-10#27)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-12#2)(2010-5#2)(2011-2#3)(2013-8#1)
est fait##2##2##(2011-2#1)(2013-1#1)
est un##2##2##(2013-1#2)
est une##3##2##(2011-2#1)(2013-1#2)
est##23##1##(2011-2#6)(2013-1#17)
establish a new##2##3##(1990-12#1)(2013-8#1)
establish a##40##2##(1990-12#1)(1991-1#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
establish an##5##2##(1992-5#1)(2008-10#2)(2008-11#1)(2008-12#1)
establish and maintain##2##3##(2008-7#1)(2012-2#1)
establish and##5##2##(1991-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
establish its##3##2##(1990-2#1)(2008-10#1)(2008-7#1)
establish suitable##3##2##(1992-2#1)(2008-10#1)(2011-2#1)
establish that a##2##3##(1995-9#1)(2008-11#1)
establish that the##2##3##(1994-11#1)(2008-3#1)
establish that##11##2##(1992-10#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
establish the existence of##2##4##(1991-12#1)(1995-2#1)
establish the##52##2##(1991-12#1)(1991-6#1)(1992-1#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
establish##205##1##(1990-12#1)(1990-2#2)(1991-1#3)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#22)(2008-12#4)(2008-2#2)(2008-3#5)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#5)
established ELISA##2##2##(2008-10#1)(2008-11#1)
established a new##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
established a novel##2##3##(2008-10#1)(2008-7#1)
established a real-time quantitative##2##4##(2008-10#1)(2008-11#1)
established a##31##2##(1991-12#1)(1993-1#1)(1994-12#1)(1997-1#2)(2008-10#8)(2008-11#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
established after##6##2##(2008-10#4)(2012-12#1)(2013-1#1)
established an in vitro immunization##2##5##(2008-11#2)
established an##4##2##(1996-2#1)(2008-11#3)
established and the##3##3##(2010-11#1)(2011-3#1)(2012-2#1)
established and##21##2##(2008-10#7)(2008-11#2)(2008-12#1)(2008-9#3)(2010-11#1)(2010-12#3)(2010-6#1)(2011-3#1)(2012-2#1)(2013-1#1)
established as a##7##3##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#2)
established as the##4##3##(1995-5#1)(2008-10#2)(2011-2#1)
established as##23##2##(1994-8#1)(1995-5#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-12#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
established at##5##2##(1994-9#1)(2008-1#2)(2008-10#2)
established based on##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
established between a##2##3##(1990-9#1)(2008-9#1)
established between the##6##3##(2008-10#5)(2008-5#1)
established between##19##2##(1990-9#1)(2008-10#14)(2008-5#2)(2008-9#1)(2013-1#1)
established by a##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
established by flow##2##3##(1993-11#1)(2008-10#1)
established by means of##2##4##(2008-10#1)(2008-11#1)
established by parallel##2##3##(2008-10#2)
established by the##12##3##(1991-2#1)(1993-3#1)(1995-12#1)(1996-1#1)(2008-10#3)(2008-11#4)(2008-3#1)
established by##51##2##(1990-5#1)(1991-11#1)(1991-2#1)(1993-11#1)(1993-3#1)(1995-12#2)(1996-1#1)(2008-10#24)(2008-11#12)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
established coronary artery disease##2##4##(2008-11#1)(2009-12#1)
established enrollees##2##2##(1995-1#2)
established for a##2##3##(1995-8#1)(2008-10#1)
established for the##9##3##(1990-11#1)(2008-10#7)(2011-2#1)
established for##28##2##(1990-11#1)(1992-3#1)(1995-8#2)(2008-10#17)(2008-11#2)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
established from embryonic##2##3##(2008-11#2)
established from##15##2##(1992-8#1)(1994-11#1)(2008-10#3)(2008-11#7)(2008-12#1)(2012-2#1)(2013-1#1)
established in 1978##2##3##(1991-12#1)(1994-12#1)
established in a##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
established in the##16##3##(1995-2#1)(2008-10#8)(2008-9#1)(2009-1#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
established in this##2##3##(2008-10#1)(2008-9#1)
established in which##3##3##(2008-7#1)(2008-8#2)
established in##48##2##(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#1)
established mechanism##2##2##(1992-3#1)(2009-10#1)
established method is##2##3##(2008-10#2)
established method##6##2##(2008-10#5)(2011-2#1)
established methods##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
established on a##2##3##(1993-6#1)(2008-10#1)
established on the basis of##3##5##(1990-9#1)(1994-5#1)(2012-2#1)
established on##7##2##(1990-9#1)(1993-6#1)(1994-5#1)(2007-8#1)(2008-10#2)(2012-2#1)
established or##2##2##(1997-3#1)(1997-4#1)
established over the last##2##4##(2008-2#1)(2009-4#1)
established over the##3##3##(2008-10#1)(2008-2#1)(2009-4#1)
established over##4##2##(2008-10#2)(2008-2#1)(2009-4#1)
established procedure##2##2##(2008-10#1)(2008-9#1)
established rat##3##2##(2008-11#2)(2008-7#1)
established risk##2##2##(2008-3#1)(2011-2#1)
established spectrophotometrically##2##2##(2008-10#2)
established technique##2##2##(1991-1#1)(2012-12#1)
established that all##2##3##(2008-10#1)(2013-1#1)
established that the##13##3##(1990-8#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
established that this##3##3##(1997-7#1)(2008-10#1)(2011-2#1)
established that##47##2##(1990-2#1)(1990-8#1)(1992-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#2)(1997-1#2)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
established the##12##2##(1994-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-10#5)(2009-10#1)(2009-5#1)(2010-1#1)
established through##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
established to be##2##3##(2008-10#2)
established to determine##3##3##(2008-10#2)(2008-11#1)
established to produce##2##3##(2008-11#1)(2008-5#1)
established to##20##2##(1992-6#1)(1995-11#1)(1996-1#1)(1997-2#1)(2008-10#11)(2008-11#3)(2008-5#1)(2011-2#1)
established two##4##2##(1994-8#1)(2008-10#1)(2008-5#2)
established under the##2##3##(1993-12#1)(1995-3#1)
established under##3##2##(1993-12#1)(1995-3#1)(2008-9#1)
established using a##2##3##(2008-10#1)(2008-11#1)
established using##6##2##(1997-9#1)(2008-10#4)(2008-11#1)
established were##2##2##(2008-10#1)(2008-11#1)
established with the regression equation##2##5##(2008-10#2)
established with the##5##3##(2008-10#3)(2011-2#1)(2012-2#1)
established with##15##2##(1991-2#1)(1992-3#1)(2008-10#8)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)
established within##2##2##(1990-6#1)(2008-12#1)
established##704##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#6)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#3)(1997-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#273)(2008-11#85)(2008-12#10)(2008-2#1)(2008-3#5)(2008-5#21)(2008-6#1)(2008-7#12)(2008-8#6)(2008-9#23)(2009-1#2)(2009-10#5)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#8)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#35)(2011-3#6)(2011-4#1)(2012-12#7)(2012-2#11)(2012-3#9)(2012-8#1)(2013-1#23)(2013-7#2)(2013-8#11)
establishes a new##2##3##(2008-11#1)(2013-1#1)
establishes a##6##2##(1995-1#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
establishes an##2##2##(1994-11#1)(2012-3#1)
establishes the relationship between##2##4##(2008-5#1)(2012-2#1)
establishes the##9##2##(1992-9#1)(1993-12#1)(1994-6#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
establishes##25##1##(1991-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#2)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
establishing a new##2##3##(1995-2#1)(2008-11#1)
establishing a##20##2##(1990-2#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-1#1)(2008-10#5)(2008-11#3)(2010-1#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
establishing criteria for##2##3##(1994-3#1)(1996-2#1)
establishing in##2##2##(2008-10#1)(2008-9#1)
establishing the diagnosis##2##3##(1991-2#1)(2013-1#1)
establishing the relationship##2##3##(1993-12#1)(2008-10#1)
establishing the##17##2##(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#2)(2013-1#1)
establishing##86##1##(1990-2#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-6#2)(1994-12#2)(1994-3#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-1#2)(1997-3#4)(2007-12#1)(2008-10#16)(2008-11#10)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#3)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
establishment and maintenance of##2##4##(2012-3#1)(2013-1#1)
establishment and maintenance##4##3##(2009-8#2)(2012-3#1)(2013-1#1)
establishment and##9##2##(2008-10#2)(2008-8#2)(2009-8#2)(2012-3#1)(2013-1#2)
establishment in the##3##3##(2008-10#2)(2008-11#1)
establishment in##4##2##(2008-10#2)(2008-11#1)(2010-3#1)
establishment of a##15##3##(1991-12#1)(1991-2#1)(1993-2#1)(2006-6#1)(2008-10#6)(2008-11#2)(2011-2#1)(2013-1#2)
establishment of an##3##3##(2008-10#2)(2012-3#1)
establishment of new##2##3##(2008-10#1)(2008-11#1)
establishment of recombinant protein##2##4##(2008-11#2)
establishment of social##2##3##(2008-11#2)
establishment of the##17##3##(1991-6#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)(2013-8#1)
establishment of this##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
establishment of##88##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#22)(2008-11#15)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
establishment was##2##2##(2008-8#1)(2012-2#1)
establishment##116##1##(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#31)(2008-11#17)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#2)(2009-8#4)(2010-12#1)(2010-3#2)(2010-6#2)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2012-9#1)(2013-1#5)(2013-8#1)
establishments##2##1##(2007-12#1)(2008-10#1)
ester (BTH)##3##2##(2008-10#3)
ester and methyl##2##3##(2008-10#2)
ester and##11##2##(1992-12#1)(1994-11#3)(2008-10#6)(2008-5#1)
ester content##4##2##(1995-6#1)(2008-10#2)(2009-8#1)
ester formation##3##2##(1990-8#1)(1991-5#1)(2011-1#1)
ester fraction##2##2##(1995-2#2)
ester groups##3##2##(2008-10#3)
ester is##2##2##(1995-2#1)(1997-1#1)
ester of##3##2##(1993-6#1)(1995-2#1)(1995-6#1)
ester on##2##2##(1995-6#1)(2008-10#1)
ester or##2##2##(1990-12#1)(2008-10#1)
ester prodrug of##2##3##(1995-6#1)(2008-5#1)
ester synthesis##7##2##(1990-8#1)(2011-1#6)
ester to##2##2##(1990-5#1)(1997-2#1)
ester treatment##3##2##(1993-8#1)(1995-6#1)(1997-1#1)
ester was used##2##3##(1996-5#1)(2008-10#1)
ester was##3##2##(1996-5#1)(2008-10#1)(2008-7#1)
ester##164##1##(1990-12#2)(1990-5#1)(1990-8#3)(1991-5#2)(1992-10#1)(1992-12#2)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#2)(1994-11#8)(1994-6#2)(1994-8#1)(1995-11#3)(1995-2#6)(1995-3#1)(1995-6#6)(1995-8#2)(1996-2#2)(1996-5#5)(1997-1#3)(1997-2#2)(2008-10#47)(2008-11#11)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#10)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#4)(2010-4#1)(2011-1#10)(2011-10#1)(2011-2#2)(2012-3#1)
ester) and##2##2##(1997-2#1)(2008-10#1)
ester)##9##1##(1995-11#2)(1997-2#1)(2008-10#6)
ester-type polyurethane membrane##2##3##(2008-10#2)
ester-type##3##1##(2008-10#3)
esterase and##2##2##(2008-9#1)(2011-1#1)
esterase##23##1##(1992-3#1)(1992-6#1)(1995-6#1)(1997-5#2)(2008-10#5)(2008-11#2)(2008-9#2)(2011-1#9)
esterases and##2##2##(2011-1#2)
esterases from##2##2##(2011-1#1)(2013-1#1)
esterases##9##1##(2008-8#1)(2011-1#6)(2013-1#2)
esterification in murine macrophages##2##4##(1990-8#2)
esterification in##5##2##(1990-8#3)(1994-8#2)
esterification of##4##2##(1992-6#1)(1993-6#1)(1995-6#1)(2008-7#1)
esterification reaction##3##2##(2008-10#2)(2008-7#1)
esterification##19##1##(1990-8#3)(1992-12#1)(1992-6#1)(1993-6#1)(1994-8#3)(1995-6#1)(2008-10#5)(2008-7#3)(2012-12#1)
esterified##8##1##(1994-11#2)(1995-2#1)(2008-10#4)(2012-2#1)
esters and the##2##3##(2008-5#1)(2011-1#1)
esters and##4##2##(1992-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
esters are##6##2##(1994-11#1)(1995-2#1)(2008-11#2)(2009-8#1)(2011-1#1)
esters in the##3##3##(1994-8#1)(1995-2#1)(2008-11#1)
esters in##8##2##(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)
esters of##12##2##(1992-12#2)(1993-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-1#1)
esters on##4##2##(2008-10#3)(2010-12#1)
esters was##2##2##(1995-2#1)(2010-12#1)
esters were##2##2##(2008-10#1)(2009-8#1)
esters##99##1##(1991-12#1)(1991-5#2)(1992-12#3)(1993-8#5)(1994-11#3)(1994-3#1)(1994-8#5)(1995-2#7)(1995-6#4)(1996-2#3)(1996-5#4)(2008-10#25)(2008-11#6)(2008-12#1)(2008-5#5)(2008-7#6)(2009-8#6)(2010-12#2)(2010-4#1)(2011-1#8)(2013-1#1)
esters)##2##1##(1993-8#1)(2008-10#1)
esthetic outcomes of##2##3##(2013-1#2)
esthetic##12##1##(1990-9#2)(1992-9#1)(1993-11#1)(2008-5#1)(2008-7#4)(2013-1#3)
esthetics##4##1##(1990-5#1)(2013-1#3)
estimate a##4##2##(1992-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
estimate and##3##2##(1996-3#1)(2008-9#1)(2009-12#1)
estimate dispersal##2##2##(2013-1#2)
estimate for the##2##3##(1990-5#1)(2013-1#1)
estimate for##3##2##(1990-5#1)(1992-2#1)(2013-1#1)
estimate long-term##2##2##(2008-8#1)(2009-8#1)
estimate of a##2##3##(2008-10#1)(2008-8#1)
estimate of its##2##3##(1990-3#1)(2008-12#1)
estimate of the##20##3##(1991-12#1)(1994-9#1)(1995-9#1)(1996-3#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-7#1)(2012-2#2)
estimate of##43##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1994-9#1)(1995-9#1)(1996-3#1)(2007-12#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#2)
estimate that the##3##3##(1996-11#1)(2008-10#1)(2008-11#1)
estimate that##10##2##(1993-12#1)(1994-9#1)(1996-11#2)(2008-10#3)(2008-11#2)(2008-5#1)
estimate the effect##2##3##(2008-11#1)(2010-4#1)
estimate the effective##2##3##(2008-10#1)(2008-3#1)
estimate the risk##2##3##(2008-7#1)(2010-5#1)
estimate the##110##2##(1991-3#1)(1992-12#2)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-9#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-10#37)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#9)(2008-8#2)(2008-9#1)(2009-8#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#4)(2012-12#2)(2013-1#2)(2013-8#1)
estimate these##2##2##(2010-3#1)(2013-1#1)
estimate with##2##2##(2008-3#1)(2012-12#1)
estimate##262##1##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#5)(1992-2#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#6)(1995-1#1)(1995-10#1)(1995-12#2)(1995-9#2)(1996-11#2)(1996-3#2)(1997-1#1)(1997-2#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#81)(2008-11#18)(2008-12#3)(2008-2#4)(2008-3#19)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#9)(2008-8#14)(2008-9#4)(2009-12#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#3)(2012-8#1)(2013-1#12)(2013-8#2)
estimated a##3##2##(1993-6#1)(2008-10#1)(2013-1#1)
estimated and the##2##3##(2008-10#1)(2010-8#1)
estimated and##7##2##(2008-10#6)(2010-8#1)
estimated as 0##5##3##(2008-10#5)
estimated as##26##2##(1990-11#1)(1993-8#1)(1995-1#1)(1995-12#1)(2008-10#20)(2008-11#2)
estimated at 0##3##3##(2008-10#3)
estimated at the##2##3##(2008-10#1)(2009-11#1)
estimated at##19##2##(1991-1#1)(1992-12#1)(1992-2#1)(2008-10#11)(2008-9#1)(2009-11#1)(2010-3#1)(2012-12#1)(2012-2#1)
estimated average##3##2##(1997-2#1)(2008-10#1)(2013-8#1)
estimated blood loss##2##3##(2008-10#1)(2013-1#1)
estimated both##2##2##(1993-8#1)(2008-10#1)
estimated by a##4##3##(1993-3#1)(2008-10#3)
estimated by an##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
estimated by analysis of##3##4##(2008-10#3)
estimated by fitting##2##3##(2008-10#1)(2008-7#1)
estimated by measuring the##2##4##(2008-10#2)
estimated by measuring##3##3##(2008-10#2)(2009-8#1)
estimated by non-linear regression of {pK(a)##2##6##(2008-10#2)
estimated by the##6##3##(1994-3#1)(1997-2#1)(2008-10#3)(2008-9#1)
estimated by using a linear##2##5##(2008-10#2)
estimated by using a##3##4##(2008-10#2)(2010-6#1)
estimated by using##6##3##(1994-5#1)(2008-10#4)(2010-6#1)
estimated by##61##2##(1992-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-9#1)(1997-2#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
estimated convexity is##3##3##(2008-6#3)
estimated costs##3##2##(1995-1#2)(2012-12#1)
estimated detection limit##2##3##(2008-10#2)
estimated disease##2##2##(2008-10#2)
estimated for each cultivar##2##4##(2008-10#2)
estimated for each##3##3##(2008-10#2)(2011-2#1)
estimated for the##3##3##(1991-12#1)(1991-2#1)(2008-10#1)
estimated for##14##2##(1991-12#1)(1991-2#1)(2008-10#10)(2008-2#1)(2011-2#1)
estimated from literature##2##3##(2008-10#1)(2008-7#1)
estimated from the##16##3##(1991-3#1)(1996-3#1)(1996-5#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-8#1)
estimated from##36##2##(1991-3#1)(1992-10#1)(1996-3#1)(1996-5#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#3)(2011-2#2)(2012-12#1)(2013-1#1)
estimated in the##5##3##(1991-6#1)(1997-7#1)(2008-10#1)(2010-3#1)(2013-8#1)
estimated in##12##2##(1991-6#1)(1996-8#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-6#1)(2010-3#1)(2012-2#1)(2013-8#1)
estimated molecular mass##2##3##(1995-2#1)(2008-11#1)
estimated molecular weight##3##3##(2008-10#1)(2009-9#1)(2012-2#1)
estimated molecular##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2012-2#1)
estimated pathophysiological concentrations##3##3##(1996-12#2)(1996-2#1)
estimated prevalence of##2##3##(2008-11#1)(2011-2#1)
estimated relative##2##2##(2008-10#2)
estimated standard deviation##2##3##(2008-3#2)
estimated that in##2##3##(2008-11#1)(2009-4#1)
estimated that the##2##3##(1991-6#1)(1992-2#1)
estimated that##20##2##(1990-2#1)(1991-6#1)(1992-2#1)(1992-9#1)(1994-2#1)(2008-10#2)(2008-11#4)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
estimated the expression##2##3##(2008-11#1)(2013-7#1)
estimated the##20##2##(1990-2#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-10#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
estimated theta parameter of the beta-binomial##2##6##(2008-10#2)
estimated to affect##2##3##(2008-5#1)(2012-12#1)
estimated to be 0##5##4##(2008-10#4)(2013-1#1)
estimated to be 1##3##4##(1995-11#1)(2008-10#2)
estimated to be 2##3##4##(2008-10#3)
estimated to be 6##2##4##(2008-10#1)(2008-11#1)
estimated to be approximately##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
estimated to be less than##4##5##(2008-10#2)(2008-3#2)
estimated to be##48##3##(1990-12#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-11#2)(1996-3#1)(1997-6#1)(2008-10#24)(2008-11#1)(2008-3#7)(2008-5#1)(2008-8#1)(2010-8#2)(2011-2#2)(2013-1#2)
estimated to have##4##3##(1990-5#1)(1991-5#1)(1997-6#1)(2011-2#1)
estimated to range from 1##2##5##(2008-10#1)(2013-1#1)
estimated to range from##4##4##(1995-5#1)(2008-10#1)(2012-2#1)(2013-1#1)
estimated to range##5##3##(1995-5#1)(2008-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
estimated to##68##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-3#1)(1997-6#2)(2008-10#26)(2008-11#1)(2008-3#8)(2008-5#3)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#3)
estimated total##2##2##(2008-10#1)(2008-11#1)
estimated under##3##2##(1995-11#1)(2008-10#1)(2009-11#1)
estimated using a##2##3##(2008-10#1)(2008-8#1)
estimated using the##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
estimated using##12##2##(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#1)(2009-11#1)(2013-1#1)
estimated with##10##2##(1996-6#1)(2008-10#5)(2008-3#2)(2008-6#1)(2011-2#1)
estimated##507##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#4)(1993-1#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#4)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#229)(2008-11#19)(2008-12#6)(2008-2#3)(2008-3#22)(2008-5#9)(2008-6#5)(2008-7#13)(2008-8#15)(2008-9#7)(2009-11#4)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#3)(2011-2#19)(2012-12#6)(2012-2#9)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#4)
estimates are##9##2##(1991-3#1)(1991-6#1)(1997-3#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-10#1)(2012-2#1)
estimates based on##2##3##(2008-10#1)(2008-8#1)
estimates between##3##2##(2008-10#2)(2010-8#1)
estimates for the##3##3##(1991-5#1)(2008-7#1)(2010-11#1)
estimates for##14##2##(1991-5#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
estimates from##6##2##(2008-10#2)(2008-3#1)(2008-9#1)(2010-11#1)(2013-1#1)
estimates is##2##2##(1991-2#1)(1992-9#1)
estimates obtained##2##2##(1993-3#1)(2008-10#1)
estimates of disease##2##3##(1992-9#1)(2008-10#1)
estimates of health##2##3##(1991-2#1)(1992-12#1)
estimates of inoculum##2##3##(2008-10#2)
estimates of insulin secretory function##2##5##(2010-10#2)
estimates of linear##2##3##(2008-12#1)(2008-8#1)
estimates of selection and##2##4##(2008-8#2)
estimates of selection##5##3##(2008-8#4)(2010-4#1)
estimates of the probability of##2##5##(1992-9#1)(2012-3#1)
estimates of the strength of selection##2##6##(2008-8#1)(2010-4#1)
estimates of the##26##3##(1990-11#1)(1992-9#1)(1994-9#1)(1996-1#1)(1996-8#1)(1997-2#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#3)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
estimates of##95##2##(1990-11#1)(1991-2#4)(1991-3#1)(1992-12#2)(1992-3#2)(1992-9#4)(1993-3#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-2#3)(1996-1#1)(1996-8#1)(1997-2#1)(1997-3#2)(2008-10#27)(2008-11#1)(2008-12#2)(2008-3#3)(2008-6#1)(2008-8#12)(2008-9#6)(2010-10#2)(2010-3#2)(2010-4#2)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-3#1)
estimates on##2##2##(1991-2#1)(1995-12#1)
estimates reported##2##2##(2010-10#1)(2011-3#1)
estimates show##2##2##(2008-3#1)(2008-8#1)
estimates that##7##2##(1990-2#1)(1992-9#1)(1993-12#1)(1994-9#2)(1996-3#1)(2008-10#1)
estimates the##3##2##(1997-2#1)(2010-1#1)(2013-8#1)
estimates using##2##2##(2008-10#1)(2010-8#1)
estimates were comparable to those##2##5##(2008-10#1)(2008-8#1)
estimates were made##2##3##(1991-3#1)(2010-10#1)
estimates were used to##3##4##(1990-9#1)(2008-10#2)
estimates were##16##2##(1990-9#1)(1991-3#1)(1991-6#1)(1993-1#1)(2008-10#8)(2008-8#3)(2010-10#1)
estimates with##2##2##(1995-12#1)(2008-10#1)
estimates##225##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#6)(1991-3#3)(1991-5#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#7)(1993-1#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#2)(1994-9#8)(1995-1#1)(1995-12#3)(1995-2#3)(1996-1#1)(1996-12#2)(1996-3#3)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#3)(2008-10#64)(2008-11#5)(2008-12#3)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#22)(2008-9#11)(2010-1#1)(2010-10#6)(2010-11#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#4)(2011-2#12)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-3#1)(2013-8#1)
estimating a##2##2##(1994-2#1)(1995-9#1)
estimating equation##3##2##(1995-2#1)(1995-9#1)(2012-12#1)
estimating recruitment##2##2##(2010-8#2)
estimating the quantity##2##3##(1992-3#1)(2008-10#1)
estimating the##31##2##(1991-11#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-9#1)(2008-10#10)(2008-11#1)(2008-3#6)(2008-6#1)(2010-1#1)(2011-2#2)(2013-1#1)
estimating##74##1##(1991-11#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-9#4)(1996-6#1)(2008-10#15)(2008-11#3)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-1#2)(2010-11#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2013-1#5)(2013-3#1)(2013-8#2)
estimation and##8##2##(1994-9#1)(1997-3#1)(2008-10#2)(2008-3#1)(2013-8#3)
estimation are##2##2##(1995-9#1)(2008-10#1)
estimation as well as##2##4##(2008-10#1)(2008-7#1)
estimation for##2##2##(2008-7#1)(2009-10#1)
estimation in##3##2##(2008-10#2)(2008-9#1)
estimation of acetaminophen##3##3##(2008-10#3)
estimation of binding parameters##3##4##(2008-10#3)
estimation of catechol##2##3##(2008-10#2)
estimation of central location##2##4##(2008-10#2)
estimation of conditional##2##3##(2008-10#2)
estimation of the activity coefficients of the##2##7##(2008-10#2)
estimation of the activity coefficients##3##5##(2008-10#3)
estimation of the impurity profile of##2##6##(2008-10#2)
estimation of the measurement uncertainty of##2##6##(2008-10#2)
estimation of the##42##3##(1992-12#2)(1995-12#1)(1995-9#2)(2008-10#24)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#2)(2010-5#1)(2012-2#2)(2012-3#1)
estimation of##113##2##(1992-12#2)(1992-9#1)(1994-3#2)(1995-12#2)(1995-2#1)(1995-9#2)(2008-10#69)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)
estimation procedure##3##2##(2010-1#1)(2010-11#1)(2013-1#1)
estimation trial for counterbalance order I (p &lt##2##8##(2013-8#2)
estimation trial##3##2##(2013-8#3)
estimation was##2##2##(2008-10#1)(2013-1#1)
estimation##173##1##(1990-3#1)(1992-12#2)(1992-6#2)(1992-9#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-9#3)(1997-3#1)(2008-10#89)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#13)(2008-4#2)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#7)
estimations are##2##2##(2008-10#1)(2008-3#1)
estimations in the##2##3##(2008-12#1)(2013-1#1)
estimations of##5##2##(1990-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
estimations show##2##2##(2008-10#1)(2011-2#1)
estimations##16##1##(1990-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
estimator and##3##2##(1997-3#1)(2008-10#2)
estimator of the##2##3##(1996-3#1)(2012-12#1)
estimator of##4##2##(1996-3#1)(1997-3#1)(2012-12#1)(2012-3#1)
estimator##12##1##(1992-9#1)(1995-12#1)(1996-3#1)(1997-3#2)(2008-10#2)(2009-10#3)(2012-12#1)(2012-3#1)
estimators are##2##2##(2008-6#1)(2010-11#1)
estimators of the##2##3##(1995-9#1)(2008-10#1)
estimators of##3##2##(1995-9#1)(1996-8#1)(2008-10#1)
estimators##10##1##(1995-9#2)(1996-8#1)(2008-10#4)(2008-6#1)(2009-10#1)(2010-11#1)
estradiol (E2)##4##2##(1993-1#1)(1995-12#1)(2008-10#1)(2010-5#1)
estradiol addition##2##2##(2008-11#2)
estradiol and progesterone##2##3##(2008-12#2)
estradiol and##9##2##(1990-11#1)(1991-12#1)(1992-3#2)(1992-4#1)(2008-10#1)(2008-12#2)(2012-3#1)
estradiol is##2##2##(1994-3#1)(2008-11#1)
estradiol levels##2##2##(2008-11#1)(2008-4#1)
estradiol receptor bindings##2##3##(1992-3#2)
estradiol receptor##3##2##(1992-3#3)
estradiol##42##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-3#8)(1992-4#1)(1993-1#1)(1994-3#1)(1995-12#1)(2008-10#6)(2008-11#11)(2008-12#3)(2008-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
estradiol-17 beta##6##2##(1990-11#1)(1992-9#1)(1994-3#2)(1995-12#1)(1996-2#1)
estriol in##2##2##(2008-10#2)
estriol##9##1##(2008-10#6)(2008-11#3)
estrogen and progesterone##4##3##(1994-2#1)(1995-11#1)(2008-7#1)(2013-8#1)
estrogen and##7##2##(1994-2#1)(1995-11#1)(2008-11#1)(2008-12#1)(2008-7#2)(2013-8#1)
estrogen could##2##2##(2010-5#2)
estrogen directly##2##2##(2008-11#2)
estrogen in##7##2##(1995-9#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-6#1)
estrogen levels##2##2##(2008-10#1)(2008-11#1)
estrogen receptive neurons##2##3##(1992-3#2)
estrogen receptor (ER) and##2##4##(2008-11#1)(2011-2#1)
estrogen receptor (ER)##11##3##(1990-11#1)(1990-12#1)(1992-6#1)(1993-1#2)(1994-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)
estrogen receptor alpha##4##3##(2008-11#1)(2008-12#2)(2011-2#1)
estrogen receptor content##3##3##(1993-1#1)(2008-11#2)
estrogen receptor contents##3##3##(2008-11#3)
estrogen receptor##55##2##(1990-11#2)(1990-12#1)(1990-5#2)(1992-3#3)(1992-6#2)(1993-1#3)(1993-11#1)(1993-6#2)(1994-12#1)(1995-11#2)(2008-10#3)(2008-11#23)(2008-12#2)(2008-6#1)(2010-5#2)(2011-1#2)(2011-2#3)
estrogen receptor-negative##2##2##(1997-7#1)(2011-1#1)
estrogen receptor-positive##4##2##(1992-4#1)(1997-7#1)(2008-11#1)(2011-1#1)
estrogen receptors (ER)##2##3##(2012-2#1)(2013-8#1)
estrogen receptors##7##2##(1997-7#1)(2008-11#4)(2012-2#1)(2013-8#1)
estrogen responsive##3##2##(2008-10#2)(2011-2#1)
estrogen stimulated##3##2##(2008-11#3)
estrogen treatment##3##2##(1992-9#1)(1993-6#1)(1994-3#1)
estrogen##155##1##(1990-11#2)(1990-12#1)(1990-5#6)(1992-3#6)(1992-4#1)(1992-6#4)(1992-9#2)(1993-1#5)(1993-11#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#4)(1995-12#1)(1995-9#1)(1997-7#4)(2008-10#16)(2008-11#57)(2008-12#3)(2008-6#7)(2008-7#8)(2010-5#4)(2010-6#1)(2011-1#4)(2011-2#6)(2012-2#1)(2013-1#1)(2013-8#2)
estrogen-modulated##2##1##(1990-8#1)(1992-9#1)
estrogen-regulated##2##1##(1992-6#1)(2011-2#1)
estrogen-responsive##2##1##(1993-6#1)(2008-11#1)
estrogenic activity##2##2##(2008-11#1)(2008-6#1)
estrogenic effect##2##2##(1991-3#1)(2012-3#1)
estrogenic potency of dietary##3##4##(2008-10#3)
estrogenic potency##5##2##(2008-10#5)
estrogenic##26##1##(1991-3#1)(2008-10#11)(2008-11#5)(2008-6#1)(2010-5#5)(2011-1#1)(2012-2#1)(2012-3#1)
estrogenicity##7##1##(2008-10#7)
estrogens and androgens##2##3##(2008-11#1)(2012-3#1)
estrogens and##3##2##(2008-11#2)(2012-3#1)
estrogens in##8##2##(1990-5#2)(1995-12#1)(2008-10#2)(2008-12#2)(2012-2#1)
estrogens##28##1##(1990-5#2)(1995-12#1)(1996-11#1)(2008-10#7)(2008-11#6)(2008-12#2)(2010-5#1)(2011-1#2)(2012-2#4)(2012-3#2)
estrone##10##1##(1990-11#1)(1995-8#2)(2008-10#7)
estrous cycle##3##2##(1993-11#2)(2008-8#1)
estrus##9##1##(1993-11#2)(2008-8#1)(2013-1#6)
estuaries and##2##2##(2008-10#1)(2012-5#1)
estuaries##6##1##(2008-10#2)(2010-8#3)(2012-5#1)
estuarine and seawater##3##3##(2008-10#3)
estuarine and##5##2##(2008-10#5)
estuarine sediments##3##2##(2008-10#3)
estuarine##15##1##(2008-10#15)
estuary##3##1##(2008-10#2)(2010-8#1)
et Mor##2##2##(2008-8#2)
et al##226##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#9)(1993-3#2)(1993-6#2)(1993-8#6)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#5)(1995-8#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#18)(2008-11#33)(2008-12#7)(2008-3#2)(2008-5#10)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#29)(2012-12#1)(2012-3#5)(2013-1#8)(2013-8#3)
et aux##2##2##(2008-11#1)(2013-1#1)
et de la##4##3##(2011-2#1)(2013-1#3)
et de son##2##3##(2013-1#2)
et de##13##2##(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#3)(2013-1#7)
et des##2##2##(2008-11#2)
et grossesse est rare##2##4##(2011-2#1)(2013-1#1)
et grossesse est##3##3##(2011-2#1)(2013-1#2)
et la mise en place d'un timbre##2##7##(2013-1#2)
et la##6##2##(2011-2#2)(2013-1#4)
et le##5##2##(2008-11#1)(2013-1#4)
et les##4##2##(1990-6#1)(2011-2#1)(2013-1#2)
et par##2##2##(2008-5#1)(2013-1#1)
et thérapeutique##2##2##(2013-1#2)
et une##4##2##(2008-11#1)(2013-1#3)
et##313##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#9)(1993-3#2)(1993-6#2)(1993-8#6)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#5)(1995-8#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#20)(2008-11#40)(2008-12#7)(2008-3#2)(2008-5#18)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#7)(2009-10#6)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#44)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#53)(2013-8#3)
eta##3##1##(1992-8#1)(2008-10#2)
etalon##6##1##(2008-2#4)(2008-3#2)
etanercept##3##1##(2008-8#3)
etc##123##1##(1990-2#1)(1990-4#1)(1990-9#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-5#3)(1996-1#1)(1996-6#1)(2007-8#1)(2008-10#51)(2008-11#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#3)
etc)##4##1##(2008-10#1)(2008-4#1)(2011-2#2)
etch##2##1##(2008-10#2)
etched capillaries##2##2##(1997-2#2)
etched##12##1##(1997-2#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2013-1#1)
etching and##2##2##(2009-7#1)(2013-1#1)
etching depth##2##2##(2008-2#1)(2008-3#1)
etching of silicon##2##3##(2008-10#2)
etching of##5##2##(2008-10#5)
etching process##3##2##(1997-2#1)(2008-10#2)
etching solution##4##2##(2008-10#4)
etching the##2##2##(1997-2#1)(2008-3#1)
etching time##2##2##(2013-1#2)
etching##35##1##(1997-2#2)(2007-11#1)(2008-10#15)(2008-2#1)(2008-3#10)(2009-7#2)(2013-1#4)
ethacrynic acid##2##2##(1994-8#2)
ethambutol##2##1##(2008-1#1)(2008-10#1)
ethane##3##1##(2008-10#2)(2008-11#1)
ethanethiol##2##1##(2008-10#2)
ethanol and acetone##2##3##(2008-10#2)
ethanol and aqueous##2##3##(2012-2#2)
ethanol and this##2##3##(2008-10#2)
ethanol and##28##2##(1991-1#1)(1992-7#1)(2008-10#19)(2008-11#1)(2008-5#1)(2009-12#2)(2012-2#2)(2013-1#1)
ethanol as##2##2##(1991-1#1)(2008-10#1)
ethanol at##3##2##(1992-7#1)(2008-10#2)
ethanol by##3##2##(2008-10#2)(2008-6#1)
ethanol concentration##7##2##(1997-2#1)(2008-10#4)(2008-7#1)(2011-2#1)
ethanol concentrations in##2##3##(1991-1#1)(2008-11#1)
ethanol concentrations##4##2##(1991-1#1)(2008-11#3)
ethanol consumption##3##2##(1992-1#1)(1996-2#2)
ethanol content##3##2##(2008-10#3)
ethanol extract of##4##3##(2008-10#1)(2008-11#1)(2011-3#1)(2012-2#1)
ethanol extract##5##2##(2008-10#2)(2008-11#1)(2011-3#1)(2012-2#1)
ethanol extracts##2##2##(2008-11#1)(2012-2#1)
ethanol fixation##2##2##(2008-11#1)(2008-9#1)
ethanol for##2##2##(1996-2#1)(2008-9#1)
ethanol from##3##2##(2008-10#1)(2011-2#2)
ethanol fuel##3##2##(2008-10#3)
ethanol in all types of alcoholic beverages##2##7##(2008-10#2)
ethanol in different##2##3##(2008-10#2)
ethanol in the##4##3##(1997-2#1)(2008-10#3)
ethanol in##18##2##(1990-5#1)(1993-8#1)(1997-2#1)(2008-10#13)(2008-2#1)(2008-7#1)
ethanol induced cell death##2##4##(2009-12#2)
ethanol is##3##2##(2008-10#3)
ethanol levels in##2##3##(2008-11#2)
ethanol levels##3##2##(2008-11#3)
ethanol metabolism is##2##3##(1992-6#2)
ethanol metabolism##4##2##(1992-6#3)(2008-11#1)
ethanol mixture##2##2##(2008-10#2)
ethanol on##4##2##(1992-6#1)(1992-7#1)(2008-10#1)(2009-7#1)
ethanol or##5##2##(1991-5#1)(1994-8#1)(2008-10#3)
ethanol orally##2##2##(2008-11#2)
ethanol precipitation##4##2##(1990-2#1)(2008-11#3)
ethanol reinforcement mechanisms##2##3##(2009-7#2)
ethanol reinforcement##3##2##(2009-7#3)
ethanol response##2##2##(2012-3#2)
ethanol solution##2##2##(2008-10#2)
ethanol than##2##2##(1992-7#1)(2009-12#1)
ethanol to##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
ethanol using##2##2##(2008-6#1)(2013-1#1)
ethanol was##4##2##(1990-2#1)(1991-5#1)(2008-10#1)(2008-7#1)
ethanol##266##1##(1990-2#2)(1990-5#1)(1991-1#6)(1991-5#2)(1992-1#1)(1992-6#5)(1992-7#8)(1993-8#5)(1994-5#2)(1994-8#1)(1996-2#5)(1997-1#2)(1997-2#3)(1997-8#2)(2008-10#133)(2008-11#23)(2008-12#2)(2008-2#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-12#8)(2009-7#5)(2009-8#4)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#5)(2013-1#8)
ethanol's motor impairment##3##3##(1997-2#3)
ethanol's##5##1##(1997-2#4)(2009-7#1)
ethanol)##4##1##(2008-10#4)
ethanol-induced motor incoordination##7##3##(1997-2#7)
ethanol-induced motor##11##2##(1997-2#11)
ethanol-induced##20##1##(1992-6#1)(1994-5#1)(1997-2#11)(2009-7#1)(2009-8#3)(2012-3#3)
ethanol-precipitated##3##1##(2008-10#2)(2013-1#1)
ethanol-water solution##2##2##(2008-10#2)
ethanol-water##9##1##(2008-10#4)(2011-2#3)(2013-1#2)
ethanol/water##3##1##(2008-10#2)(2008-9#1)
ethanolamine##3##1##(2008-10#2)(2008-7#1)
ethanolic extract of Lemon verbena##5##5##(2008-12#5)
ethanolic extract of defatted C##2##5##(2008-10#2)
ethanolic extract of##11##3##(2008-10#3)(2008-12#5)(2011-2#1)(2013-1#2)
ethanolic extract was##2##3##(2008-10#2)
ethanolic extract##13##2##(2008-10#5)(2008-12#5)(2011-2#1)(2013-1#2)
ethanolic##25##1##(2008-10#12)(2008-12#5)(2008-5#3)(2011-2#1)(2013-1#4)
ethanolysis##4##1##(2008-10#4)
ethene##3##1##(2008-3#3)
ethenolysis##2##1##(2009-8#2)
ether (18C6)##2##2##(2008-10#2)
ether (NPOE)##5##2##(2008-10#5)
ether (o-NPOE)##6##2##(2008-10#6)
ether analogue##2##2##(1994-8#2)
ether and##5##2##(1993-12#1)(2008-10#4)
ether as##4##2##(2008-10#4)
ether complex##2##2##(2008-10#2)
ether compounds##2##2##(2008-10#2)
ether extraction and##2##3##(2008-10#1)(2008-11#1)
ether or##4##2##(1997-2#1)(2008-10#1)(2008-5#2)
ether to##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
ether was##2##2##(2008-10#2)
ether##109##1##(1993-12#2)(1994-2#1)(1994-8#3)(1995-8#1)(1996-5#4)(1997-2#1)(2008-10#79)(2008-11#3)(2008-12#4)(2008-5#8)(2008-7#1)(2009-8#1)(2013-8#1)
ether)##5##1##(2008-10#2)(2008-11#1)(2009-8#2)
ether-type polyurethane membrane##3##3##(2008-10#3)
ether-type##4##1##(2008-10#4)
ethers and##2##2##(1996-5#1)(2008-10#1)
ethers for which the##2##4##(2008-10#2)
ethers for##3##2##(2008-10#3)
ethers using##2##2##(2008-10#2)
ethers with##2##2##(2008-10#1)(2009-8#1)
ethers##43##1##(1992-12#2)(1993-12#2)(1996-5#1)(2008-10#36)(2008-7#1)(2009-8#1)
ethic##4##1##(1992-2#1)(1994-2#1)(2012-2#2)
ethical and legal##3##3##(1997-2#1)(2008-11#1)(2008-12#1)
ethical and##7##2##(1997-2#1)(2008-11#3)(2008-12#1)(2011-2#1)(2013-8#1)
ethical aspects of##3##3##(1991-3#1)(2008-11#1)(2010-11#1)
ethical aspects##4##2##(1991-3#1)(2008-11#1)(2010-11#1)(2012-12#1)
ethical concerns##2##2##(2008-11#1)(2008-12#1)
ethical considerations##3##2##(1996-2#1)(1996-6#1)(2008-11#1)
ethical dilemma##2##2##(2009-11#2)
ethical dilemmas##3##2##(2009-8#1)(2013-8#2)
ethical guidelines##2##2##(1992-2#1)(2008-12#1)
ethical implications of##2##3##(1995-9#1)(2008-11#1)
ethical implications##3##2##(1995-9#1)(2008-11#1)(2008-12#1)
ethical issues and proposals for management##4##6##(2008-11#4)
ethical issues in##3##3##(1992-3#1)(2009-4#2)
ethical issues##10##2##(1992-3#1)(2008-11#5)(2009-4#2)(2012-2#1)(2013-1#1)
ethical principle of##3##3##(1995-9#3)
ethical problem##2##2##(2008-7#1)(2010-11#1)
ethical problems##2##2##(1991-11#1)(1991-3#1)
ethical reasons##3##2##(2008-10#1)(2008-11#2)
ethical##91##1##(1991-11#1)(1991-2#3)(1991-3#3)(1992-2#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-1#2)(1994-9#2)(1995-6#1)(1995-9#4)(1996-2#5)(1996-6#1)(1996-9#1)(1997-2#2)(2008-10#1)(2008-11#22)(2008-12#11)(2008-7#1)(2008-9#2)(2009-11#2)(2009-4#4)(2009-8#1)(2010-11#4)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
ethical-social and legal aspects##2##4##(2011-2#2)
ethical/value##2##1##(1996-2#2)
ethically##5##1##(1991-3#1)(2008-9#1)(2009-6#1)(2010-11#2)
ethics and##4##2##(1991-1#1)(1992-2#1)(2011-2#1)(2013-1#1)
ethics education##2##2##(2013-8#2)
ethics in##3##2##(1991-3#1)(1997-8#1)(2011-3#1)
ethics of##6##2##(1991-3#1)(1993-9#1)(1995-5#1)(1996-8#1)(2010-3#1)(2013-8#1)
ethics was not a major part of the curriculum##2##9##(1994-1#2)
ethics##44##1##(1991-1#1)(1991-3#2)(1992-12#1)(1992-2#1)(1993-9#1)(1994-1#4)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-11#6)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#8)
ethidium bromide##8##2##(1990-2#2)(1993-12#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#2)
ethidium##9##1##(1990-2#2)(1993-12#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-6#1)
ethinylestradiol##7##1##(2008-10#2)(2011-3#5)
ethion and dichlorovos##2##3##(2008-10#2)
ethion and##3##2##(2008-10#3)
ethion##4##1##(2008-10#4)
ethiopathogenesis##2##1##(1997-8#1)(2008-10#1)
ethirimol##7##1##(2008-10#7)
ethmoid##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
ethnic belonging##2##2##(2009-7#2)
ethnic composition of school class##2##5##(2010-1#2)
ethnic composition of school##3##4##(2010-1#3)
ethnic composition of##4##3##(2010-1#4)
ethnic differences in##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
ethnic differences##4##2##(2008-5#1)(2010-10#1)(2013-1#1)(2013-8#1)
ethnic exploration and##2##3##(2009-7#2)
ethnic exploration##3##2##(2009-7#3)
ethnic group##6##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-10#1)
ethnic groups in##3##3##(2008-1#1)(2008-9#2)
ethnic groups##19##2##(1992-2#1)(1995-2#1)(1997-1#1)(2008-1#5)(2008-12#2)(2008-5#1)(2008-9#4)(2009-10#1)(2011-2#1)(2012-2#2)
ethnic identity##3##2##(2009-7#3)
ethnic minorities##2##2##(1990-6#1)(2008-10#1)
ethnic minority adolescents##2##3##(2010-1#2)
ethnic specific##3##2##(2008-1#3)
ethnic##63##1##(1990-6#1)(1991-11#1)(1992-2#1)(1994-12#2)(1995-2#1)(1997-1#1)(1997-8#2)(2008-1#10)(2008-10#2)(2008-12#4)(2008-5#3)(2008-8#1)(2008-9#5)(2009-10#2)(2009-7#8)(2010-1#8)(2010-10#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#3)
ethnically diverse sample of##4##4##(2009-7#2)(2010-1#2)
ethnically diverse##7##2##(2008-12#1)(2009-7#2)(2009-9#1)(2010-1#3)
ethnically##10##1##(2008-1#1)(2008-12#1)(2009-7#2)(2009-9#1)(2010-1#5)
ethnically-diverse##2##1##(2008-12#1)(2009-4#1)
ethnicity and##4##2##(2008-12#1)(2009-9#1)(2010-1#1)(2010-5#1)
ethnicity##17##1##(2008-12#1)(2008-9#1)(2009-11#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)
ethno-epidemiological##2##1##(2008-1#2)
ethnocultural communities##3##2##(1995-1#3)
ethnocultural##5##1##(1995-1#5)
ethnographic research##2##2##(2011-2#2)
ethnographic##8##1##(1993-1#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-9#1)(2011-2#3)
ethnography##4##1##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
ethoxyresorufin and##2##2##(1994-8#2)
ethoxyresorufin##6##1##(1993-12#1)(1994-8#4)(2008-11#1)
ethyl acetate and ethanol##2##4##(2008-10#2)
ethyl acetate and water fractions##2##5##(2008-10#2)
ethyl acetate and##6##3##(2008-10#6)
ethyl acetate as the##3##4##(2008-10#3)
ethyl acetate##31##2##(2008-10#25)(2008-11#1)(2008-12#2)(2011-3#1)(2012-2#1)(2013-1#1)
ethyl acetoacetate##2##2##(2008-11#1)(2012-3#1)
ethyl alcohol##5##2##(1990-5#1)(2008-10#3)(2008-11#1)
ethyl benzene and xylenes##2##4##(2008-10#2)
ethyl benzene##5##2##(2008-10#5)
ethyl beta-carboline-3-carboxylate##2##2##(1996-2#2)
ethyl bromoacetate##3##2##(1996-5#1)(2008-10#2)
ethyl cellulose##3##2##(2008-10#3)
ethyl ester derivative##2##3##(2008-7#2)
ethyl ester##20##2##(1992-6#4)(1995-3#1)(2008-10#2)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#2)
ethyl esters##6##2##(2008-10#3)(2008-11#1)(2011-1#2)
ethyl xanthate##4##2##(2008-10#4)
ethyl##115##1##(1990-5#2)(1991-6#1)(1992-6#4)(1993-1#2)(1995-11#1)(1995-3#1)(1996-2#2)(1996-5#5)(2008-10#67)(2008-11#6)(2008-12#2)(2008-3#6)(2008-5#2)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
ethylacetate##2##1##(2008-10#2)
ethylacetoacetate##3##1##(2008-10#2)(2008-11#1)
ethylarsine dichloride##3##2##(2008-11#3)
ethylation (Eth)##2##2##(2008-10#2)
ethylation##3##1##(2008-10#3)
ethylbenzene##3##1##(2008-10#3)
ethylene and##2##2##(2008-10#2)
ethylene biosynthesis##2##2##(2008-10#2)
ethylene biosynthetic##2##2##(1995-2#1)(2008-10#1)
ethylene dimethacrylate##2##2##(2008-10#2)
ethylene glycol and##2##3##(2008-10#2)
ethylene glycol dimethacrylate##2##3##(2008-10#2)
ethylene glycol##12##2##(1997-5#1)(2008-10#9)(2008-3#2)
ethylene glycol-functionalized##2##2##(2008-10#2)
ethylene production##7##2##(2008-10#5)(2011-2#2)
ethylene treatments##2##2##(1993-12#2)
ethylene##68##1##(1992-3#1)(1993-12#4)(1995-2#1)(1997-5#1)(2008-10#49)(2008-2#1)(2008-3#5)(2009-8#4)(2011-2#2)
ethylene-forming enzyme##2##2##(2008-10#2)
ethylene-insensitive##6##1##(2008-10#6)
ethylenediamine##8##1##(2008-10#8)
ethylenediamine-N##5##1##(2008-10#4)(2008-5#1)
ethylenediaminetetraacetate (EDTA)##3##2##(1994-5#1)(2008-10#2)
ethylenediaminetetraacetate##4##1##(1994-5#1)(2008-10#3)
ethylenediaminetetraacetic acid (EDTA)##8##3##(2008-10#5)(2008-11#1)(2010-3#1)(2013-1#1)
ethylenediaminetetraacetic acid##12##2##(2008-10#8)(2008-11#1)(2010-3#1)(2013-1#2)
ethyleneglycol##2##1##(2008-10#1)(2008-5#1)
ethylhexylphosphates##2##1##(2008-10#2)
ethylmercury and phenylmercury##3##3##(2008-10#3)
ethylmercury and##4##2##(2008-10#4)
ethylmercury##5##1##(2008-10#5)
etidronate##8##1##(1991-11#2)(2008-11#6)
etiologic agent of##3##3##(1997-5#1)(2008-4#1)(2008-5#1)
etiologic agent##6##2##(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)
etiologic agents##2##2##(2008-11#1)(2011-2#1)
etiologic and##3##2##(1991-3#1)(1991-6#1)(2012-3#1)
etiologic factors##2##2##(2009-10#1)(2010-8#1)
etiologic##18##1##(1991-12#1)(1991-3#1)(1991-6#1)(1995-5#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-8#1)(2011-2#3)(2012-3#2)
etiological agent of##3##3##(1992-3#1)(2008-9#2)
etiological agent##5##2##(1992-3#1)(2008-5#2)(2008-9#2)
etiological##15##1##(1992-3#1)(1992-5#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#2)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
etiologies of##3##2##(2008-8#1)(2010-1#1)(2010-7#1)
etiologies##13##1##(1991-8#1)(2008-7#1)(2008-8#1)(2010-1#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)
etiology and management of##4##4##(1991-3#1)(2009-10#3)
etiology and treatment of##2##4##(2012-2#1)(2013-8#1)
etiology and treatment##3##3##(1991-2#1)(2012-2#1)(2013-8#1)
etiology and##15##2##(1990-11#1)(1991-2#1)(1991-3#1)(1992-3#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
etiology for the##2##3##(2008-1#1)(2011-2#1)
etiology for##4##2##(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
etiology has##3##2##(2008-10#2)(2012-3#1)
etiology is##4##2##(2009-3#1)(2011-2#2)(2013-1#1)
etiology of PD##2##3##(2008-7#2)
etiology of disease##2##3##(2008-10#2)
etiology of the disease##2##4##(1991-11#1)(2008-10#1)
etiology of the diseases##2##4##(2008-10#2)
etiology of the##9##3##(1991-11#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
etiology of this condition##2##4##(2011-2#1)(2013-1#1)
etiology of this##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
etiology of##63##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#2)(1994-6#1)(1995-2#2)(1996-11#1)(1997-2#1)(2007-11#1)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#8)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
etiology remains##2##2##(1991-2#1)(2008-5#1)
etiology was##3##2##(1991-8#1)(2007-8#1)(2013-7#1)
etiology##142##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#4)(1991-3#3)(1991-6#1)(1991-8#2)(1992-3#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-11#2)(1997-2#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-1#7)(2008-10#22)(2008-11#5)(2008-12#4)(2008-4#3)(2008-5#5)(2008-7#10)(2008-8#2)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-6#4)(2010-7#3)(2011-2#13)(2011-3#2)(2012-2#2)(2012-3#9)(2013-1#8)(2013-7#1)(2013-8#2)
etiopathogenesis##5##1##(1990-2#1)(1991-2#1)(2010-1#1)(2011-2#1)(2013-7#1)
etiopathogenetic##3##1##(1990-8#1)(1990-9#1)(1991-6#1)
etodolac##5##1##(2008-10#5)
etomidate##2##1##(1995-8#1)(2009-6#1)
etonogestrel and ethinylestradiol in plasma by LC-MS/MS##2##7##(2011-3#2)
etonogestrel and ethinylestradiol##3##3##(2011-3#3)
etonogestrel and##5##2##(2011-3#5)
etonogestrel##8##1##(2011-2#2)(2011-3#6)
etoposide in##2##2##(1993-8#1)(1996-10#1)
etoposide##12##1##(1993-8#5)(1994-12#2)(1996-10#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
etoposide-induced##2##1##(2013-1#2)
etr1-1##2##1##(2008-10#2)
etretinate##4##1##(1991-11#3)(1992-2#1)
et al##3##1##(2011-2#3)
eubacteria##2##1##(2008-8#2)
eubacterial##4##1##(1991-6#1)(1992-3#1)(1992-8#1)(2008-10#1)
eucalypt species##2##2##(2008-10#1)(2010-3#1)
eucalypt##3##1##(2008-10#1)(2010-3#2)
eucalypts##2##1##(2008-10#1)(2010-3#1)
eucalyptus##6##1##(2007-12#1)(2008-10#2)(2008-6#1)(2009-3#2)
euchromatic regions##3##2##(2009-10#2)(2013-1#1)
euchromatic##5##1##(2008-5#1)(2009-10#3)(2013-1#1)
eudermata##2##1##(2008-10#2)
eudicots##2##1##(2008-10#1)(2010-5#1)
eukaryote##3##1##(1995-2#1)(2008-8#1)(2008-9#1)
eukaryotes and is##2##3##(2010-8#1)(2012-2#1)
eukaryotes and##5##2##(1992-8#1)(2008-8#1)(2010-8#1)(2012-2#2)
eukaryotes to##2##2##(2008-11#1)(2008-7#1)
eukaryotes##44##1##(1992-12#1)(1992-8#1)(1993-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#3)(2008-11#5)(2008-7#3)(2008-8#3)(2009-10#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#6)(2012-3#2)
eukaryotic DNA polymerase##2##3##(1994-12#2)
eukaryotic DNA##4##2##(1994-12#2)(1995-6#1)(2008-4#1)
eukaryotic GeneMark##2##2##(2008-4#2)
eukaryotic and prokaryotic##3##3##(1994-12#1)(1997-4#1)(2011-2#1)
eukaryotic and##4##2##(1994-12#1)(1995-2#1)(1997-4#1)(2011-2#1)
eukaryotic cell##7##2##(1993-9#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2012-2#1)(2012-3#1)
eukaryotic cells and##3##3##(1995-2#1)(1995-9#1)(2011-3#1)
eukaryotic cells as##2##3##(2008-11#1)(2009-6#1)
eukaryotic cells is##2##3##(2008-11#1)(2008-4#1)
eukaryotic cells##23##2##(1990-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-9#1)(1997-7#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#2)(2011-3#1)(2013-8#1)
eukaryotic expression plasmid containing teloRZ##2##5##(2008-9#2)
eukaryotic expression vector##3##3##(1992-8#1)(2008-8#2)
eukaryotic expression##7##2##(1992-8#1)(2008-8#2)(2008-9#2)(2009-9#1)(2011-3#1)
eukaryotic gene##2##2##(2008-9#2)
eukaryotic genes##3##2##(1996-2#1)(1996-3#1)(2008-9#1)
eukaryotic genomes##6##2##(1996-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#2)
eukaryotic initiation##2##2##(2010-4#1)(2012-2#1)
eukaryotic nucleus##4##2##(2008-8#4)
eukaryotic organisms##2##2##(1990-7#1)(2011-2#1)
eukaryotic protein##2##2##(1994-5#1)(2009-6#1)
eukaryotic sources##2##2##(1997-7#1)(2008-7#1)
eukaryotic translation initiation factor##2##4##(1997-1#1)(2010-12#1)
eukaryotic##113##1##(1990-5#2)(1990-7#1)(1992-8#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#1)(1995-2#5)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-4#2)(1997-7#3)(2008-1#1)(2008-10#4)(2008-11#7)(2008-2#1)(2008-4#8)(2008-5#2)(2008-7#3)(2008-8#9)(2008-9#9)(2009-10#1)(2009-12#2)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#7)(2011-3#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
eumetazoan##4##1##(2010-4#4)
eumusae##5##1##(2008-10#5)
eumusae)##2##1##(2008-10#2)
euphoria##2##1##(1991-1#1)(2009-7#1)
euphratica##2##1##(2008-11#2)
euro##2##1##(2009-4#2)
europaeum##3##1##(2008-10#3)
europium (III) are##2##3##(2008-10#2)
europium (III) is##2##3##(2008-10#2)
europium (III)##8##2##(2008-10#8)
europium and ytterbium##2##3##(2008-10#2)
europium and##3##2##(2008-10#3)
europium in##2##2##(2008-10#2)
europium##22##1##(2008-10#21)(2012-2#1)
europium(III)##4##1##(2008-10#4)
europium-substituted heteropolytungstate##2##2##(2008-10#2)
eurosids II##2##2##(2008-10#2)
euryarchaeon##4##1##(2012-2#4)
eusocial##5##1##(2008-8#4)(2010-4#1)
eutectic formation##4##2##(2013-1#4)
eutectic##7##1##(1993-1#1)(1993-8#2)(2013-1#4)
euteiches and A##2##3##(2008-10#2)
euteiches and##3##2##(2008-10#3)
euteiches from##3##2##(2008-10#3)
euteiches in##3##2##(2008-10#3)
euteiches was##2##2##(2008-10#2)
euteiches##35##1##(2008-10#35)
euthanasia or assisted suicide was##2##5##(1991-8#2)
euthanasia or assisted suicide##6##4##(1991-8#6)
euthanasia program##2##2##(2008-12#2)
euthanasia##23##1##(1990-6#2)(1991-2#1)(1991-8#6)(1991-9#1)(1994-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-7#1)(2011-2#2)(2012-12#2)(2013-7#1)(2013-8#2)
euthanized##2##1##(2008-10#1)(2008-9#1)
euthermar##2##1##(2008-8#2)
euthyroid##7##1##(1990-6#1)(1990-9#1)(1995-12#1)(2008-11#1)(2008-7#1)(2011-1#2)
euthyroidism##3##1##(2011-1#3)
eutopic##3##1##(1995-12#3)
eutrophic remodeling##2##2##(2009-1#2)
eutrophic##3##1##(2009-1#3)
eutrophication##2##1##(2012-3#2)
evacuation of a##2##3##(1991-11#1)(1991-2#1)
evacuation of the##3##3##(1997-6#1)(2008-7#1)(2012-12#1)
evacuation of##8##2##(1991-11#1)(1991-2#1)(1997-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
evacuation##19##1##(1991-11#1)(1991-2#2)(1994-12#1)(1996-6#1)(1997-6#1)(2008-7#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#4)
evacuees##4##1##(2008-7#1)(2011-2#3)
evade##5##1##(2008-10#3)(2013-1#2)
evagination##4##1##(2008-10#3)(2008-9#1)
evaluable for##2##2##(1990-6#1)(1991-6#1)
evaluable patients##3##2##(1990-12#1)(1991-8#1)(1996-1#1)
evaluable##10##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-6#2)(1991-8#2)(1992-12#1)(1996-1#1)(1997-2#1)
evaluate a new##2##3##(1991-1#1)(2008-6#1)
evaluate a##20##2##(1991-1#1)(1996-1#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
evaluate an##4##2##(1997-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
evaluate and##7##2##(1993-1#1)(1996-2#1)(2008-10#1)(2010-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
evaluate four##2##2##(1991-3#1)(2008-10#1)
evaluate how well##2##3##(2008-9#1)(2009-12#1)
evaluate how##6##2##(1993-2#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-8#1)
evaluate if##3##2##(2008-4#1)(2013-1#2)
evaluate its##9##2##(1990-2#1)(1992-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-11#1)(2010-12#1)
evaluate job satisfaction##2##3##(2008-11#2)
evaluate possible##4##2##(1997-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
evaluate quality of##2##3##(2008-7#1)(2013-1#1)
evaluate the clinical##2##3##(2011-2#1)(2013-1#1)
evaluate the diagnostic##2##3##(2011-2#1)(2012-12#1)
evaluate the effect of##23##4##(1997-4#1)(2008-1#2)(2008-10#5)(2008-12#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
evaluate the effect##24##3##(1997-4#1)(2008-1#2)(2008-10#5)(2008-12#3)(2008-5#1)(2008-7#2)(2008-9#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
evaluate the effectiveness of an##2##5##(1997-1#1)(2008-8#1)
evaluate the effectiveness of the##4##5##(1997-3#1)(2008-10#2)(2011-1#1)
evaluate the effectiveness of##17##4##(1991-2#1)(1994-6#1)(1996-11#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
evaluate the effects of##18##4##(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-5#2)(2009-11#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluate the effects##19##3##(1996-2#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-5#2)(2009-11#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluate the efficacy and##2##4##(2008-10#2)
evaluate the efficacy of##12##4##(1993-1#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
evaluate the efficacy##16##3##(1993-1#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
evaluate the feasibility of##4##4##(1992-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
evaluate the impact of a##2##5##(2008-11#1)(2012-3#1)
evaluate the impact of##9##4##(1991-1#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2012-3#1)(2013-1#2)
evaluate the incidence of##4##4##(1990-3#1)(2010-2#1)(2012-3#1)(2013-1#1)
evaluate the incidence##5##3##(1990-3#1)(2008-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
evaluate the influence of##7##4##(1990-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
evaluate the long-term##4##3##(2010-3#1)(2011-2#1)(2011-7#1)(2012-3#1)
evaluate the new##2##3##(2008-10#1)(2010-8#1)
evaluate the performance of a##2##5##(2008-3#2)
evaluate the performance of##6##4##(2008-10#1)(2008-11#1)(2008-3#4)
evaluate the possibility##4##3##(1992-2#1)(1994-5#1)(2008-11#2)
evaluate the predictive##2##3##(2012-3#2)
evaluate the prevalence of##5##4##(2007-8#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
evaluate the quality of##5##4##(1991-3#1)(2008-10#2)(2008-11#1)(2012-3#1)
evaluate the reliability##2##3##(2010-10#1)(2013-8#1)
evaluate the reproducibility of##3##4##(2008-10#3)
evaluate the reproducibility##4##3##(2008-10#3)(2009-11#1)
evaluate the robustness of##2##4##(2008-10#2)
evaluate the role of the##2##5##(2011-2#1)(2012-2#1)
evaluate the role of##8##4##(2008-10#2)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
evaluate the survival##2##3##(1994-12#2)
evaluate the total##3##3##(1994-3#1)(2008-10#1)(2011-3#1)
evaluate the treatment##2##3##(2011-2#2)
evaluate the use of##3##4##(1990-11#1)(2008-11#1)(2013-1#1)
evaluate the voltammetric behavior of##2##5##(2008-10#2)
evaluate the##367##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-9#2)(1991-1#2)(1991-2#2)(1991-3#2)(1992-12#2)(1992-2#2)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#4)(1994-3#2)(1994-5#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#6)(2007-8#2)(2008-1#5)(2008-10#96)(2008-11#22)(2008-12#12)(2008-3#12)(2008-4#1)(2008-5#17)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#9)(2009-11#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#26)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#11)(2012-3#15)(2012-8#1)(2013-1#31)(2013-8#6)
evaluate their##11##2##(1990-2#1)(1994-3#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-7#1)(2013-8#1)
evaluate these##2##2##(1991-3#1)(2008-12#1)
evaluate this potential##2##3##(2009-12#1)(2013-1#1)
evaluate this##8##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
evaluate total##2##2##(1991-6#1)(2011-2#1)
evaluate whether##16##2##(1993-8#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
evaluate##606##1##(1990-11#2)(1990-12#1)(1990-2#7)(1990-3#1)(1990-5#1)(1990-9#3)(1991-1#3)(1991-11#1)(1991-2#2)(1991-3#6)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#4)(1992-2#4)(1992-3#1)(1992-5#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#2)(1994-12#7)(1994-3#5)(1994-5#2)(1994-6#1)(1995-5#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-2#4)(1996-3#3)(1996-6#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#8)(2007-8#2)(2008-1#7)(2008-10#144)(2008-11#39)(2008-12#22)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#23)(2008-6#3)(2008-7#15)(2008-8#8)(2008-9#18)(2009-1#1)(2009-11#3)(2009-12#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#5)(2010-7#4)(2010-8#7)(2011-1#11)(2011-2#41)(2011-3#3)(2011-7#1)(2012-12#2)(2012-2#16)(2012-3#20)(2012-8#1)(2012-9#1)(2013-1#47)(2013-8#11)
evaluated a##3##2##(2008-9#1)(2009-6#1)(2010-3#1)
evaluated according to the##5##4##(2008-10#2)(2011-1#1)(2012-3#1)(2013-1#1)
evaluated according to##7##3##(2008-10#3)(2011-1#1)(2012-3#1)(2013-1#2)
evaluated across##2##2##(2010-7#1)(2013-1#1)
evaluated after##3##2##(2008-10#2)(2013-1#1)
evaluated against the##2##3##(2008-1#1)(2008-5#1)
evaluated against##8##2##(2008-1#1)(2008-10#3)(2008-5#1)(2012-2#3)
evaluated and compared in##2##4##(2008-10#2)
evaluated and compared with the##2##5##(2008-10#2)
evaluated and compared with##5##4##(2008-10#5)
evaluated and compared##8##3##(2008-10#8)
evaluated and discussed##2##3##(2008-10#2)
evaluated and it##2##3##(2008-10#1)(2008-11#1)
evaluated and optimized##2##3##(2008-10#2)
evaluated and the calibration curve is linear over a range of 0##2##12##(2008-10#2)
evaluated and the possible detection mechanism##2##6##(2008-10#2)
evaluated and the##10##3##(1991-5#1)(2008-10#9)
evaluated and##43##2##(1991-5#1)(1992-3#1)(2008-10#35)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#2)
evaluated are##2##2##(1992-2#1)(2008-10#1)
evaluated as a function of the##2##6##(2008-10#1)(2009-8#1)
evaluated as a function of##6##5##(2008-10#4)(2008-11#1)(2009-8#1)
evaluated as the relative standard deviation##2##6##(2008-10#2)
evaluated as the##4##3##(2008-10#4)
evaluated as##27##2##(1990-8#1)(1993-1#1)(1993-2#1)(1997-2#1)(2008-10#18)(2008-11#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
evaluated at different##2##3##(2008-10#1)(2013-1#1)
evaluated at the standard state of the##2##7##(2008-10#2)
evaluated at the##4##3##(2008-10#4)
evaluated at three##4##3##(1993-2#1)(2008-10#2)(2008-11#1)
evaluated at##18##2##(1993-2#1)(1996-3#1)(2008-10#10)(2008-11#2)(2008-5#2)(2013-1#2)
evaluated based on##2##3##(2008-10#2)
evaluated before##4##2##(1994-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
evaluated between##2##2##(1992-1#1)(2008-10#1)
evaluated both##4##2##(2008-10#1)(2009-10#1)(2010-7#1)(2012-3#1)
evaluated by a##5##3##(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
evaluated by analysis of##3##4##(2008-10#3)
evaluated by analyzing a##2##4##(2008-10#2)
evaluated by analyzing their##2##4##(1997-3#1)(2008-10#1)
evaluated by analyzing##8##3##(1997-3#1)(2008-10#7)
evaluated by assaying##2##3##(2008-10#2)
evaluated by calculating the##2##4##(2008-11#1)(2008-5#1)
evaluated by calculating##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
evaluated by carrying out##2##4##(2008-10#2)
evaluated by comparing the##3##4##(2008-10#3)
evaluated by comparing with##2##4##(2008-10#1)(2008-5#1)
evaluated by comparing##7##3##(2008-10#5)(2008-11#1)(2008-5#1)
evaluated by comparison##4##3##(2008-10#4)
evaluated by determining##3##3##(2008-10#3)
evaluated by five##2##3##(1997-2#1)(2008-10#1)
evaluated by injecting##2##3##(2008-10#2)
evaluated by investigating##2##3##(2008-10#2)
evaluated by means of a##2##5##(1991-12#1)(2008-10#1)
evaluated by means of the##4##5##(1991-12#1)(2008-10#2)(2008-11#1)
evaluated by means of##11##4##(1991-12#2)(1997-3#1)(1997-4#1)(2008-10#4)(2008-11#1)(2009-7#1)(2011-2#1)
evaluated by measuring##2##3##(1994-8#1)(2008-10#1)
evaluated by replicate analyses of##3##5##(2008-10#3)
evaluated by replicate##4##3##(2008-10#4)
evaluated by testing##3##3##(2008-10#2)(2013-8#1)
evaluated by the analysis of##4##5##(2008-10#4)
evaluated by the##24##3##(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(2008-10#15)(2008-11#1)(2009-7#1)(2011-7#1)(2013-1#1)
evaluated by using##7##3##(2008-10#5)(2008-8#1)(2012-12#1)
evaluated by##162##2##(1991-11#1)(1991-12#2)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(1997-9#1)(2007-8#1)(2008-10#95)(2008-11#9)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#2)(2011-2#6)(2011-3#2)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#3)
evaluated concentrations##2##2##(2013-1#2)
evaluated during##2##2##(1995-2#1)(2013-8#1)
evaluated every##3##2##(1993-6#1)(2013-8#2)
evaluated for disease##2##3##(2008-10#2)
evaluated for four##2##3##(2008-10#2)
evaluated for its capacity to##2##5##(2008-10#2)
evaluated for its##8##3##(2008-10#7)(2009-2#1)
evaluated for monitoring##2##3##(2008-10#1)(2008-5#1)
evaluated for resistance to southern leaf blight (SLB)##2##8##(2008-10#2)
evaluated for resistance to##6##4##(2008-10#6)
evaluated for sensitivity##2##3##(2008-10#2)
evaluated for suppression of##2##4##(2008-10#2)
evaluated for the determination of##5##5##(2008-10#5)
evaluated for the first time##2##5##(2008-10#1)(2013-1#1)
evaluated for the##28##3##(1991-5#1)(1992-2#1)(1997-1#1)(1997-2#1)(2008-10#20)(2008-11#2)(2011-3#1)(2013-1#1)
evaluated for their##20##3##(1991-5#1)(1992-9#1)(1997-6#1)(2008-10#9)(2008-11#3)(2008-12#2)(2009-3#1)(2011-1#1)(2011-2#1)
evaluated for virulence##2##3##(2008-10#2)
evaluated for##137##2##(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#90)(2008-11#6)(2008-12#3)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluated four times##2##3##(2008-10#2)
evaluated from a##2##3##(2008-10#1)(2008-12#1)
evaluated from the##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
evaluated from##13##2##(1992-12#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)
evaluated here##2##2##(2008-10#2)
evaluated histopathologically##2##2##(2008-7#1)(2013-1#1)
evaluated in a##11##3##(1996-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
evaluated in an##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
evaluated in comparison##2##3##(2008-11#1)(2012-2#1)
evaluated in field##2##3##(2008-10#2)
evaluated in greenhouse##5##3##(2008-10#5)
evaluated in human##2##3##(2008-11#2)
evaluated in order to##2##4##(1994-8#1)(2008-10#1)
evaluated in term of relative standard deviation (R##2##8##(2008-10#2)
evaluated in term of relative standard deviation##3##7##(2008-10#3)
evaluated in terms of the##4##5##(2008-10#3)(2008-9#1)
evaluated in terms of##11##4##(2008-10#7)(2008-9#2)(2009-7#1)(2013-1#1)
evaluated in the context of##2##5##(2008-6#1)(2008-7#1)
evaluated in the field##2##4##(2008-10#2)
evaluated in the greenhouse##4##4##(2008-10#4)
evaluated in the presence of##3##5##(2008-10#2)(2008-12#1)
evaluated in the presence##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
evaluated in the##22##3##(1991-3#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
evaluated in this##4##3##(1992-2#1)(1997-3#1)(2008-11#1)(2010-11#1)
evaluated in vitro and##2##4##(2008-10#2)
evaluated in vitro##3##3##(1994-8#1)(2008-10#2)
evaluated in##126##2##(1990-3#3)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#2)(1993-2#1)(1994-8#2)(1995-12#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#61)(2008-11#12)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#3)(2009-1#1)(2009-7#2)(2010-1#2)(2010-11#2)(2010-3#1)(2011-2#3)(2011-3#1)(2012-2#5)(2013-1#5)(2013-8#1)
evaluated on the basis of##5##5##(1991-1#1)(1991-3#1)(2008-5#2)(2008-7#1)
evaluated on the##7##3##(1991-1#1)(1991-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-8#1)
evaluated on##22##2##(1991-1#1)(1991-3#1)(1993-3#1)(1996-12#1)(2008-10#8)(2008-12#1)(2008-5#3)(2008-7#1)(2009-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
evaluated over##5##2##(2008-10#3)(2011-1#1)(2012-3#1)
evaluated patients##2##2##(1990-12#1)(2011-2#1)
evaluated the ability of##2##4##(1995-11#1)(2008-10#1)
evaluated the clinical##3##3##(2010-6#1)(2013-1#2)
evaluated the effect of the##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
evaluated the effect of##6##4##(1993-6#1)(1995-6#1)(2008-10#2)(2008-11#1)(2011-1#1)
evaluated the effectiveness of the##2##5##(2008-5#1)(2012-2#1)
evaluated the effectiveness of##3##4##(2008-5#1)(2012-2#2)
evaluated the effects of##4##4##(1995-12#1)(2008-11#2)(2013-1#1)
evaluated the frequency##2##3##(1997-3#1)(2008-7#1)
evaluated the impact of##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
evaluated the in##2##3##(1991-2#1)(1995-12#1)
evaluated the influence of##2##4##(2008-10#1)(2011-2#1)
evaluated the potential##2##3##(1992-12#1)(2008-10#1)
evaluated the role of##5##4##(1994-1#1)(1995-8#1)(1997-2#1)(2009-8#1)(2013-1#1)
evaluated the safety of##2##4##(2012-3#1)(2013-1#1)
evaluated the use of##2##4##(1996-12#1)(2008-10#1)
evaluated the use##3##3##(1996-12#1)(2008-10#1)(2013-1#1)
evaluated the##82##2##(1990-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#12)(2008-11#9)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#9)
evaluated through the##3##3##(2008-10#3)
evaluated through##7##2##(1991-1#1)(2008-10#6)
evaluated to assess##2##3##(1997-3#1)(2008-10#1)
evaluated to be 0##2##4##(2008-10#2)
evaluated to be##5##3##(2008-10#4)(2008-9#1)
evaluated to date##2##3##(1990-6#1)(1997-7#1)
evaluated to determine the##3##4##(1992-9#1)(2008-10#2)
evaluated to determine##6##3##(1992-9#1)(2008-10#4)(2008-9#1)
evaluated to ensure that##2##4##(2008-10#1)(2013-1#1)
evaluated to measure##2##3##(2008-10#1)(2008-9#1)
evaluated to##30##2##(1990-6#1)(1992-9#1)(1997-3#1)(1997-7#1)(2008-10#18)(2008-11#1)(2008-5#1)(2008-9#3)(2011-2#1)(2013-1#1)(2013-7#1)
evaluated under##6##2##(2008-10#5)(2012-2#1)
evaluated using a##8##3##(2008-10#5)(2008-7#1)(2010-12#1)(2012-12#1)
evaluated using an##2##3##(2008-10#1)(2011-2#1)
evaluated using data##2##3##(1990-12#1)(2008-10#1)
evaluated using the##8##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
evaluated using three##2##3##(2008-10#1)(2010-8#1)
evaluated using##52##2##(1990-11#1)(1990-12#1)(1992-12#1)(1994-5#1)(1994-8#1)(1996-3#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)
evaluated via##4##2##(1997-2#1)(2008-10#2)(2012-2#1)
evaluated was##4##2##(2008-10#4)
evaluated were##7##2##(2008-1#1)(2008-10#6)
evaluated whether the##2##3##(2013-1#2)
evaluated whether##5##2##(1997-3#1)(2008-7#1)(2009-11#1)(2013-1#2)
evaluated with a##5##3##(2006-5#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
evaluated with an##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
evaluated with respect to the##4##5##(2008-10#3)(2012-2#1)
evaluated with respect to##8##4##(1993-1#1)(2008-10#6)(2012-2#1)
evaluated with respect##9##3##(1993-1#1)(2008-10#7)(2012-2#1)
evaluated with the##6##3##(1990-5#1)(1996-11#1)(2008-10#3)(2013-1#1)
evaluated with##42##2##(1990-5#1)(1993-1#1)(1995-2#1)(1995-3#2)(1996-11#1)(1997-8#2)(2006-5#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-3#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
evaluated within##3##2##(2008-10#1)(2008-11#2)
evaluated##1189##1##(1990-11#1)(1990-12#3)(1990-3#5)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#3)(1991-6#2)(1991-8#2)(1992-1#2)(1992-12#7)(1992-2#5)(1992-3#5)(1992-8#2)(1992-9#3)(1993-1#6)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#1)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#5)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#8)(1997-3#8)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#5)(1997-9#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#6)(2008-10#618)(2008-11#67)(2008-12#21)(2008-3#13)(2008-4#1)(2008-5#29)(2008-6#6)(2008-7#22)(2008-8#9)(2008-9#15)(2009-1#3)(2009-10#3)(2009-11#2)(2009-2#3)(2009-3#4)(2009-6#1)(2009-7#5)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#3)(2010-6#1)(2010-7#4)(2010-8#2)(2011-1#9)(2011-2#44)(2011-3#7)(2011-7#1)(2012-12#8)(2012-2#23)(2012-3#16)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#53)(2013-7#1)(2013-8#13)
evaluates a##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
evaluates the effect of##3##4##(2008-7#1)(2009-9#1)(2013-8#1)
evaluates the impact of##2##4##(1995-12#1)(2010-11#1)
evaluates the##16##2##(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-9#1)(2010-11#1)(2010-2#1)(2013-8#1)
evaluates##34##1##(1992-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#3)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
evaluating a##5##2##(1991-12#1)(1995-3#1)(1996-3#1)(2009-10#2)
evaluating access and quality##2##4##(1995-12#2)
evaluating an##2##2##(2011-2#1)(2013-1#1)
evaluating and monitoring##2##3##(2007-11#1)(2011-2#1)
evaluating and##9##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)(2010-1#1)(2011-2#1)
evaluating disease##4##2##(2008-10#4)
evaluating public health surveillance systems##2##5##(2008-7#2)
evaluating the clinical##3##3##(1993-12#1)(1997-2#1)(2011-2#1)
evaluating the effect of##2##4##(2008-10#2)
evaluating the effects##2##3##(1996-2#1)(2011-2#1)
evaluating the efficacy of##4##4##(2008-1#1)(2008-6#1)(2012-12#1)(2013-1#1)
evaluating the impact of the##2##5##(1992-1#1)(2008-11#1)
evaluating the impact of##3##4##(1992-1#1)(2008-11#1)(2013-1#1)
evaluating the performance of##2##4##(2008-10#2)
evaluating the quality of##2##4##(2008-10#1)(2008-12#1)
evaluating the##73##2##(1990-2#1)(1991-1#2)(1992-1#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-6#1)(1996-2#1)(1996-6#1)(1997-2#3)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
evaluating their##3##2##(2008-11#1)(2010-4#1)(2012-3#1)
evaluating this##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
evaluating##172##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#2)(1992-1#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#3)(1994-6#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-2#3)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#14)(2008-12#6)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#3)(2010-1#2)(2010-11#1)(2010-12#3)(2010-4#1)(2011-2#13)(2012-12#6)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#9)(2013-8#2)
evaluation and comparison##3##3##(2008-10#2)(2008-5#1)
evaluation and management##2##3##(1992-6#1)(2006-5#1)
evaluation and prediction##4##3##(2008-10#2)(2010-12#2)
evaluation and treatment of##3##4##(2009-1#1)(2009-3#1)(2010-12#1)
evaluation and treatment##8##3##(1993-1#1)(1997-2#2)(2008-9#1)(2009-1#1)(2009-3#1)(2010-1#1)(2010-12#1)
evaluation and##53##2##(1992-1#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1995-5#1)(1997-2#3)(1997-3#2)(2006-5#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-12#3)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#3)
evaluation are##3##2##(1993-2#1)(2008-11#1)(2012-3#1)
evaluation as well as##2##4##(1996-2#1)(1997-2#1)
evaluation as##4##2##(1996-2#1)(1997-2#2)(2008-4#1)
evaluation based on##2##3##(2008-10#1)(2011-2#1)
evaluation by##6##2##(1993-1#1)(1996-9#1)(2008-10#2)(2009-10#1)(2013-1#1)
evaluation data##2##2##(2008-11#1)(2013-1#1)
evaluation due to##2##3##(2008-11#1)(2011-2#1)
evaluation factors##2##2##(2011-2#2)
evaluation for a##2##3##(1997-3#1)(2008-7#1)
evaluation for##10##2##(1993-1#1)(1997-3#1)(2008-10#2)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-3#1)
evaluation form##3##2##(2012-2#2)(2013-1#1)
evaluation forms##2##2##(2008-12#1)(2012-2#1)
evaluation has##4##2##(1992-12#1)(2008-10#1)(2008-12#2)
evaluation in patients##2##3##(1990-2#1)(2011-2#1)
evaluation in the treatment of##2##5##(1990-12#1)(1992-12#1)
evaluation in the##5##3##(1990-12#1)(1992-12#1)(2008-12#1)(2011-2#1)(2012-2#1)
evaluation in##23##2##(1990-12#1)(1990-2#1)(1992-12#1)(2006-6#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#3)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluation included##2##2##(2011-2#2)
evaluation is##7##2##(1994-2#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-12#1)(2013-8#1)
evaluation methods##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
evaluation of a child##2##4##(2008-11#1)(2010-7#1)
evaluation of a personal##2##4##(1993-6#2)
evaluation of a program##2##4##(1993-11#1)(2008-12#1)
evaluation of a##35##3##(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-1#1)(1995-1#1)(1995-12#1)(1996-2#2)(1997-2#2)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#4)(2008-3#1)(2008-5#2)(2010-7#1)(2011-2#1)(2012-2#2)
evaluation of acute##2##3##(2008-12#1)(2011-2#1)
evaluation of all##2##3##(2011-2#1)(2013-1#1)
evaluation of an analytical##2##4##(2008-10#2)
evaluation of an innovative##2##4##(2008-12#2)
evaluation of an##16##3##(1992-12#1)(1994-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
evaluation of chronic wrist pain##2##5##(2008-9#2)
evaluation of clinical##4##3##(2008-12#1)(2011-3#1)(2013-8#2)
evaluation of different##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
evaluation of functional##2##3##(2008-10#1)(2008-7#1)
evaluation of health##2##3##(1993-11#1)(2010-10#1)
evaluation of medical##2##3##(1992-1#1)(1994-2#1)
evaluation of natural##2##3##(1993-9#1)(2008-10#1)
evaluation of new##4##3##(2008-11#1)(2008-9#1)(2012-3#2)
evaluation of pain##3##3##(1991-11#1)(2013-1#2)
evaluation of patients with##11##4##(1990-9#1)(1992-12#1)(1996-3#1)(1997-8#1)(2008-7#2)(2008-9#2)(2009-9#1)(2012-2#1)(2013-1#1)
evaluation of patients##15##3##(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#1)(1994-6#1)(1996-3#1)(1997-8#1)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
evaluation of peroxide##2##3##(2008-10#2)
evaluation of platelets##2##3##(2008-9#2)
evaluation of possible##3##3##(2008-11#1)(2009-6#1)(2011-2#1)
evaluation of potential immunotoxicity##2##4##(2008-10#2)
evaluation of potential##3##3##(2008-10#3)
evaluation of prognostic##2##3##(1994-12#1)(2013-8#1)
evaluation of recovery##2##3##(2008-10#2)
evaluation of results##2##3##(1990-2#1)(1990-9#1)
evaluation of some##3##3##(2008-10#2)(2012-2#1)
evaluation of student##2##3##(2008-11#1)(2008-12#1)
evaluation of students'##2##3##(1993-1#1)(2012-3#1)
evaluation of the clinical##2##4##(1990-3#1)(2011-2#1)
evaluation of the correlation##3##4##(2008-10#3)
evaluation of the data##2##4##(2008-10#1)(2011-3#1)
evaluation of the effects of##4##5##(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
evaluation of the error##2##4##(2008-3#1)(2012-2#1)
evaluation of the functional status of the##2##7##(1997-8#1)(2008-9#1)
evaluation of the hydropathy##2##4##(1990-5#2)
evaluation of the in##2##4##(2008-5#1)(2008-7#1)
evaluation of the method##2##4##(2008-10#2)
evaluation of the model##2##4##(2008-7#2)
evaluation of the specific##2##4##(2007-11#1)(2008-7#1)
evaluation of the toxicity##2##4##(1996-12#1)(2008-7#1)
evaluation of the##116##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-9#2)(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#3)(2007-11#1)(2008-10#34)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#8)(2008-9#5)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
evaluation of their own##2##4##(1995-2#1)(2009-4#1)
evaluation of their##8##3##(1990-6#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2011-7#1)
evaluation of these##4##3##(1993-2#1)(2008-10#1)(2012-2#1)(2013-8#1)
evaluation of this##6##3##(1991-12#1)(2008-11#2)(2008-5#1)(2013-1#2)
evaluation of transcript##2##3##(2008-10#2)
evaluation of treatment##2##3##(2009-8#1)(2010-12#1)
evaluation of two##2##3##(2008-10#2)
evaluation of various##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
evaluation of##485##2##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#6)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#2)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#4)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#4)(1996-1#3)(1996-12#3)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#1)(1997-8#4)(2007-11#2)(2008-1#3)(2008-10#114)(2008-11#36)(2008-12#20)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#22)(2008-6#1)(2008-7#18)(2008-8#3)(2008-9#23)(2009-1#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#23)(2011-3#3)(2011-7#2)(2012-12#3)(2012-2#18)(2012-3#13)(2013-1#24)(2013-8#9)
evaluation presented##2##2##(1992-2#1)(2008-12#1)
evaluation procedure##2##2##(2008-11#2)
evaluation procedures##2##2##(2008-3#1)(2010-7#1)
evaluation process##6##2##(1993-3#1)(2008-10#1)(2008-11#3)(2008-12#1)
evaluation project##2##2##(1995-3#1)(2008-12#1)
evaluation research design for##2##4##(2013-1#2)
evaluation revealed##3##2##(1996-3#1)(2008-8#1)(2011-1#1)
evaluation scales##2##2##(1993-2#1)(2013-1#1)
evaluation showed##2##2##(2012-3#1)(2013-8#1)
evaluation shows that##2##3##(1993-3#1)(1994-3#1)
evaluation study##4##2##(1994-1#2)(2008-10#1)(2008-11#1)
evaluation suggests##2##2##(2008-11#2)
evaluation system for##2##3##(2008-11#1)(2011-2#1)
evaluation system##8##2##(2008-10#1)(2008-11#4)(2008-3#1)(2011-2#2)
evaluation team##2##2##(2013-1#2)
evaluation techniques##3##2##(2008-3#1)(2008-7#1)(2010-5#1)
evaluation to be##2##3##(2008-10#1)(2013-1#1)
evaluation to##5##2##(1990-6#1)(2008-10#1)(2009-9#1)(2013-1#2)
evaluation units##3##2##(1994-12#3)
evaluation using##2##2##(2008-10#1)(2008-11#1)
evaluation was performed##5##3##(1990-12#1)(2008-12#2)(2009-3#1)(2011-2#1)
evaluation was##15##2##(1990-12#1)(1993-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-9#1)(2009-3#1)(2011-2#2)(2013-8#1)
evaluation were##2##2##(1996-9#1)(2008-12#1)
evaluation with##2##2##(2008-11#2)
evaluation##852##1##(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#5)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#7)(1991-1#2)(1991-11#3)(1991-12#6)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#7)(1992-12#4)(1992-2#3)(1992-3#2)(1992-6#1)(1993-1#6)(1993-11#5)(1993-12#3)(1993-2#6)(1993-3#5)(1993-5#1)(1993-6#4)(1993-9#1)(1994-1#5)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#3)(1995-1#4)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#6)(1996-1#4)(1996-11#1)(1996-12#4)(1996-2#7)(1996-3#3)(1996-9#2)(1997-1#4)(1997-2#14)(1997-3#7)(1997-4#1)(1997-7#2)(1997-8#5)(2006-5#2)(2006-6#1)(2007-11#3)(2007-9#1)(2008-1#3)(2008-10#161)(2008-11#75)(2008-12#41)(2008-2#6)(2008-3#13)(2008-4#8)(2008-5#37)(2008-6#2)(2008-7#25)(2008-8#7)(2008-9#33)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#12)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#52)(2011-3#6)(2011-7#3)(2012-12#7)(2012-2#27)(2012-3#24)(2013-1#48)(2013-8#18)
evaluation]##2##1##(1993-3#1)(1994-9#1)
evaluations and comparisons##2##3##(1995-2#2)
evaluations and##4##2##(1995-2#2)(1996-8#1)(2008-11#1)
evaluations are##3##2##(2008-2#2)(2010-1#1)
evaluations of the##2##3##(1991-3#1)(1996-2#1)
evaluations of their##2##3##(1992-3#1)(2012-2#1)
evaluations of##14##2##(1991-1#1)(1991-3#2)(1992-3#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
evaluations on##2##2##(1994-12#1)(2008-10#1)
evaluations##61##1##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-2#3)(1996-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#7)(2008-12#3)(2008-2#3)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
evaluative study##2##2##(2008-11#2)
evaluative##6##1##(1992-3#1)(1993-1#1)(2008-11#3)(2012-3#1)
evanescent wave##4##2##(2008-10#3)(2008-3#1)
evanescent##6##1##(2008-10#4)(2008-3#2)
evanescent-wave fluorescence##2##2##(1997-7#1)(2008-3#1)
evanescent-wave##7##1##(1997-7#1)(2008-2#2)(2008-3#2)(2010-7#2)
evansi and LATEX/T##2##3##(2011-2#2)
evansi##5##1##(2011-2#5)
evaporate##2##1##(2008-11#1)(2010-4#1)
evaporated in##2##2##(2008-10#1)(2008-5#1)
evaporated to dryness and##2##4##(2008-10#2)
evaporated to dryness##7##3##(2008-10#7)
evaporated under reduced pressure##2##4##(2008-11#2)
evaporated##21##1##(2007-12#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#4)(2009-12#1)
evaporation and absorption##2##3##(2008-5#2)
evaporation and##6##2##(2008-10#4)(2008-5#2)
evaporation from##3##2##(2008-5#3)
evaporation in##2##2##(2008-10#1)(2008-11#1)
evaporation manifold##2##2##(2008-11#2)
evaporation of sweat##2##3##(1992-3#1)(2008-5#1)
evaporation of water##2##3##(2008-10#1)(2008-11#1)
evaporation of##9##2##(1992-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)
evaporation rate##2##2##(2008-5#2)
evaporation to dryness##3##3##(2008-10#3)
evaporation##51##1##(1992-3#2)(1995-3#2)(2008-10#25)(2008-11#5)(2008-3#1)(2008-5#14)(2009-11#1)(2012-2#1)
evaporative##4##1##(2008-10#3)(2012-5#1)
evaporator##6##1##(2008-10#6)
evapotranspiration##2##1##(2008-10#1)(2008-8#1)
evasion##3##1##(2009-8#1)(2013-1#2)
even 4##2##2##(1997-4#1)(2008-10#1)
even a single##2##3##(2010-5#1)(2012-12#1)
even a##8##2##(1990-11#1)(1994-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#1)
even after a##2##3##(2008-10#1)(2008-5#1)
even after controlling for##5##4##(1994-2#1)(2008-11#1)(2009-10#1)(2012-12#1)(2012-3#1)
even after four##2##3##(2008-11#2)
even after several##2##3##(2008-9#1)(2009-12#1)
even after the##5##3##(1996-3#1)(1997-3#1)(2008-3#1)(2008-6#1)(2012-3#1)
even after##47##2##(1990-12#2)(1991-12#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-3#1)(1997-3#1)(2008-10#9)(2008-11#7)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#3)(2013-1#1)
even among##4##2##(1991-12#1)(2008-12#1)(2008-8#2)
even an##2##2##(2008-10#1)(2008-12#1)
even as##3##2##(1991-12#1)(1994-8#1)(2011-2#1)
even at a time when these##2##6##(2008-10#2)
even at a time when##3##5##(2008-10#3)
even at a##7##3##(2008-10#6)(2008-11#1)
even at concentrations as high as##3##6##(2008-10#1)(2008-11#2)
even at the##3##3##(2008-10#2)(2008-9#1)
even at very low##2##4##(1992-12#1)(1993-8#1)
even at very##3##3##(1992-12#1)(1993-8#1)(2012-3#1)
even at##28##2##(1992-12#1)(1992-3#1)(1993-8#1)(1996-3#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
even be##3##2##(2008-10#1)(2008-12#1)(2010-10#1)
even before the##2##3##(1994-3#1)(1996-11#1)
even before##6##2##(1994-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)
even better##5##2##(2008-1#1)(2008-10#2)(2013-1#1)(2013-7#1)
even between##2##2##(1996-1#1)(1996-6#1)
even by##2##2##(1993-3#1)(2008-10#1)
even cause##3##2##(2008-8#2)(2011-2#1)
even death##5##2##(2007-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
even distribution of##5##3##(1990-11#1)(2008-10#2)(2008-5#1)(2013-1#1)
even distribution##6##2##(1990-11#1)(1996-2#1)(2008-10#2)(2008-5#1)(2013-1#1)
even fatal##2##2##(1994-6#1)(2011-2#1)
even for a##2##3##(2012-2#1)(2013-8#1)
even for low##2##3##(2008-10#2)
even for##22##2##(1991-6#1)(1991-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
even from a##2##3##(2008-11#1)(2009-10#1)
even from##4##2##(2008-10#1)(2008-11#2)(2009-10#1)
even further##2##2##(2008-2#1)(2008-7#1)
even greater##6##2##(1993-3#1)(1994-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
even harder##2##2##(1996-6#1)(2008-9#1)
even higher##8##2##(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)
even if all##2##3##(2008-8#1)(2011-2#1)
even if it##2##3##(2008-11#1)(2008-3#1)
even if the##14##3##(1992-5#1)(1996-9#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
even if they are##3##4##(1996-8#1)(2008-10#1)(2008-11#1)
even if they##6##3##(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-3#1)
even if##40##2##(1990-5#1)(1992-5#1)(1994-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
even improved##2##2##(2008-10#1)(2008-11#1)
even in a##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
even in cases with##2##4##(1990-12#1)(2011-2#1)
even in cases##4##3##(1990-12#1)(1990-2#1)(2008-10#1)(2011-2#1)
even in the absence of ecological constraints##2##7##(2008-8#2)
even in the absence of##12##5##(1994-3#1)(2008-8#5)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
even in the case of a##2##6##(1993-6#1)(2008-3#1)
even in the case of##4##5##(1993-6#1)(2008-10#1)(2008-3#2)
even in the presence of a##4##6##(1994-5#1)(2008-10#3)
even in the presence of large##2##6##(2008-10#2)
even in the presence of##19##5##(1990-12#1)(1991-12#1)(1991-5#1)(1993-3#1)(1994-5#1)(2008-10#8)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#2)
even in the presence##20##4##(1990-12#1)(1991-12#1)(1991-5#1)(1993-3#1)(1994-5#1)(2008-10#8)(2008-11#3)(2008-9#1)(2011-2#1)(2013-1#2)
even in the##45##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#10)(2008-11#5)(2008-3#2)(2008-5#1)(2008-8#5)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
even in very##2##3##(2008-10#1)(2008-11#1)
even in##91##2##(1990-12#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#23)(2008-11#14)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#8)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
even increase##2##2##(2008-10#1)(2008-8#1)
even larger##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
even lead to##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
even less is known about##2##5##(1994-3#1)(2009-8#1)
even less##6##2##(1994-3#1)(2007-12#1)(2008-10#2)(2009-8#1)(2013-8#1)
even lower##4##2##(1994-5#1)(2008-10#1)(2008-8#1)(2010-12#1)
even more pronounced##2##3##(2007-12#1)(2008-10#1)
even more##26##2##(1990-9#1)(1992-6#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-5#3)(2009-8#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
even on a##2##3##(1995-2#1)(2008-11#1)
even on##4##2##(1995-2#1)(2008-11#2)(2008-9#1)
even only##2##2##(2008-11#1)(2010-3#1)
even severe##2##2##(1991-3#1)(2008-7#1)
even some##2##2##(2008-10#1)(2010-8#1)
even stronger##2##2##(1993-12#1)(1995-11#1)
even subtle##2##2##(1994-12#1)(2011-2#1)
even that##2##2##(2008-10#2)
even the expert##2##3##(1992-1#1)(1994-1#1)
even the most common##2##4##(1994-6#1)(2011-2#1)
even the most##4##3##(1994-6#1)(1995-3#1)(1997-1#1)(2011-2#1)
even the##19##2##(1992-1#1)(1994-1#1)(1994-6#1)(1995-3#1)(1997-1#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)
even those##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
even though it is##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
even though it##7##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
even though the##15##3##(1990-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-7#1)(2011-2#2)
even though their##2##3##(2008-10#1)(2009-10#1)
even though they##3##3##(1993-2#1)(2008-10#1)(2010-10#1)
even though this##3##3##(1993-3#1)(1997-3#1)(2008-10#1)
even though##60##2##(1990-12#1)(1990-5#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1995-11#2)(1995-6#2)(1996-12#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#22)(2008-11#4)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#2)(2011-2#5)(2012-2#1)(2013-8#1)
even to##7##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
even today##2##2##(1995-5#1)(2011-2#1)
even under##4##2##(1993-3#1)(2008-10#2)(2008-11#1)
even upon##2##2##(1995-2#1)(2008-10#1)
even using##2##2##(1990-12#1)(2008-10#1)
even when a##2##3##(2008-10#2)
even when all##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
even when challenged with##2##4##(2008-10#2)
even when it is##2##4##(2008-9#1)(2012-2#1)
even when only a##2##4##(1995-12#1)(2008-3#1)
even when the##21##3##(1990-9#1)(1993-1#1)(1996-11#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
even when there is a##2##5##(1993-8#1)(2013-1#1)
even when there is##4##4##(1993-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
even when they are##2##4##(1990-12#1)(1995-2#1)
even when they##6##3##(1990-12#1)(1993-12#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-8#1)
even when##80##2##(1990-12#1)(1990-9#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#6)(2009-4#1)(2010-1#2)(2010-12#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#3)
even where##3##2##(2008-10#2)(2013-8#1)
even with a##5##3##(2008-10#2)(2008-7#2)(2009-8#1)
even with an##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
even with the##4##3##(1992-5#1)(1992-9#1)(2008-11#1)(2011-2#1)
even with these##2##3##(2008-8#1)(2013-8#1)
even with##26##2##(1990-8#1)(1992-11#1)(1992-5#1)(1992-9#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-7#6)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#3)(2013-8#1)
even within##2##2##(1997-3#1)(2008-10#1)
even without Sm##2##3##(1993-12#2)
even without##9##2##(1993-12#2)(1994-9#1)(2008-10#5)(2008-11#1)
even years##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
even##752##1##(1990-11#3)(1990-12#8)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#8)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#8)(1993-2#5)(1993-3#7)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#8)(1994-5#5)(1994-6#4)(1994-8#2)(1994-9#2)(1995-11#6)(1995-12#2)(1995-2#10)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#6)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#3)(2007-12#8)(2008-1#5)(2008-10#173)(2008-11#69)(2008-12#7)(2008-2#1)(2008-3#18)(2008-4#2)(2008-5#23)(2008-6#4)(2008-7#27)(2008-8#41)(2008-9#23)(2009-10#7)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#10)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#9)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#8)(2011-2#44)(2011-3#1)(2012-12#5)(2012-2#9)(2012-3#16)(2013-1#21)(2013-7#3)(2013-8#14)
evening##8##1##(2007-12#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-5#2)
evenly distributed in the##2##4##(2008-10#1)(2008-9#1)
evenly distributed on##2##3##(2007-12#1)(2008-8#1)
evenly distributed##8##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
evenly spaced sampling units##2##4##(2008-10#2)
evenly##14##1##(1994-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-8#1)
evenness##6##1##(2008-10#4)(2008-8#2)
event after##2##2##(2008-11#1)(2013-8#1)
event among##2##2##(2008-1#1)(2008-11#1)
event and the##2##3##(2008-10#1)(2008-11#1)
event and##10##2##(1992-8#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-11#1)(2011-2#1)(2013-8#1)
event but##2##2##(1991-12#1)(1994-8#1)
event data##2##2##(1995-9#1)(1997-3#1)
event for##3##2##(1997-1#1)(2008-7#1)(2012-2#1)
event has##2##2##(2008-10#1)(2011-1#1)
event in a##2##3##(1995-1#1)(2008-8#1)
event in the pathogenesis of##2##5##(2008-10#1)(2011-1#1)
event in the##7##3##(1990-7#1)(1995-9#1)(2008-10#1)(2008-8#1)(2011-1#2)(2011-2#1)
event in##16##2##(1990-7#1)(1991-12#1)(1993-12#1)(1995-1#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
event is##6##2##(1991-2#1)(1993-11#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-3#1)
event occurred in the##2##4##(2008-10#1)(2011-2#1)
event occurred##3##2##(2008-10#2)(2011-2#1)
event of a##3##3##(1990-9#1)(2008-7#1)(2011-2#1)
event of##14##2##(1990-3#1)(1990-9#1)(1991-6#1)(1997-2#1)(2008-7#1)(2009-12#2)(2010-1#1)(2010-12#1)(2011-2#5)
event probabilities##3##2##(1992-9#2)(2011-2#1)
event rates##2##2##(2008-11#1)(2013-1#1)
event reporting##2##2##(2008-11#2)
event reports##2##2##(2008-11#1)(2012-3#1)
event that##4##2##(1997-8#1)(2009-8#1)(2012-3#2)
event with##2##2##(2008-10#2)
event##191##1##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#4)(1996-2#5)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-7#2)(1997-8#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#30)(2008-11#20)(2008-12#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#7)(2009-11#3)(2009-12#3)(2009-3#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#16)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#6)(2013-8#7)
event-related brain potential##2##3##(1995-12#1)(2008-11#1)
event-related brain##3##2##(1995-12#1)(2008-11#2)
event-related potentials##3##2##(2008-11#3)
event-related##11##1##(1995-12#1)(1995-2#1)(2008-11#7)(2013-8#2)
eventration##2##1##(2010-5#2)
events after##2##2##(1991-3#1)(1992-9#1)
events and in##2##3##(2008-7#1)(2008-8#1)
events and the##3##3##(1991-6#1)(2008-11#1)(2009-10#1)
events and their##2##3##(2008-10#1)(2011-2#1)
events and##27##2##(1991-6#1)(1993-2#1)(1994-8#1)(1996-2#2)(2006-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
events are not##3##3##(1992-8#1)(1996-2#1)(2008-7#1)
events are rare##2##3##(2008-10#1)(2008-9#1)
events are##18##2##(1992-8#1)(1994-11#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
events as##4##2##(2008-11#1)(2010-12#2)(2013-1#1)
events associated with##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
events at##5##2##(2008-12#3)(2011-2#1)(2012-2#1)
events between##3##2##(2008-10#2)(2013-8#1)
events both##2##2##(1994-5#1)(2008-1#1)
events by##2##2##(2008-10#1)(2008-8#1)
events can##2##2##(2008-3#1)(2008-9#1)
events could##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
events during##9##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#1)(2012-3#1)(2013-1#1)
events experienced##2##2##(1992-1#1)(2009-4#1)
events following##2##2##(1996-12#1)(2013-7#1)
events for##7##2##(1992-9#1)(1993-8#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-1#1)(2013-1#1)
events from##5##2##(1993-8#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-3#1)
events has been##2##3##(2008-11#1)(2010-12#1)
events has##4##2##(2008-11#1)(2008-7#1)(2010-1#1)(2010-12#1)
events have##3##2##(1997-1#1)(2007-11#1)(2008-9#1)
events in alendronate users##2##4##(2008-11#2)
events in living cells##2##4##(2008-1#1)(2009-7#1)
events in patients##2##3##(1993-2#1)(2009-12#1)
events in pediatric##2##3##(2012-3#2)
events in the##14##3##(1991-3#1)(1992-10#1)(1992-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-8#1)(2012-2#1)
events in##46##2##(1991-3#1)(1992-10#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
events including##2##2##(2008-10#1)(2009-6#1)
events involving##3##2##(1993-12#1)(2011-2#1)(2013-1#1)
events is##2##2##(2008-3#1)(2010-1#1)
events leading to the establishment of##2##6##(1996-9#1)(2008-11#1)
events leading to the##4##4##(1991-5#1)(1996-9#1)(2008-10#1)(2008-11#1)
events leading to##9##3##(1991-5#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#1)(2012-3#1)
events leading##10##2##(1990-9#1)(1991-5#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#1)(2012-3#1)
events occur##2##2##(1995-12#1)(2008-10#1)
events occurring##4##2##(1994-5#1)(1995-2#1)(1995-6#1)(2012-6#1)
events of apoptosis##2##3##(2008-11#1)(2008-8#1)
events of the##2##3##(2008-10#2)
events of##13##2##(1995-2#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2009-10#1)(2011-2#2)
events on##4##2##(2008-10#1)(2008-7#1)(2012-2#1)(2012-6#1)
events or##2##2##(2008-10#1)(2010-1#1)
events related to##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
events require##2##2##(2008-10#1)(2012-3#1)
events similar to those observed##2##5##(2008-10#2)
events such as the##2##4##(2009-5#1)(2012-12#1)
events such as##12##3##(1992-8#1)(1995-11#1)(1996-12#1)(2008-10#2)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
events suggests##2##2##(1996-11#1)(2008-8#1)
events that are##4##3##(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#1)
events that have##2##3##(2008-9#1)(2011-2#1)
events that lead to the formation##2##6##(2008-12#1)(2012-2#1)
events that lead to##3##4##(2008-11#1)(2008-12#1)(2012-2#1)
events that occur##2##3##(1997-7#1)(2008-4#1)
events that regulate##2##3##(2008-1#1)(2012-2#1)
events that##24##2##(1991-2#1)(1993-6#1)(1994-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#2)
events triggered by fire##2##4##(2009-10#2)
events underlying##5##2##(2008-10#1)(2009-10#1)(2012-2#3)
events was##8##2##(1995-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2013-8#1)
events were the##2##3##(1991-2#1)(2008-10#1)
events were##19##2##(1991-2#1)(1995-6#2)(1996-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)(2013-8#1)
events which##3##2##(1993-2#1)(2008-5#1)(2011-2#1)
events with##3##2##(1997-3#1)(2008-9#1)(2012-3#1)
events within the##2##3##(2008-11#1)(2009-10#1)
events##489##1##(1990-9#2)(1991-12#2)(1991-2#6)(1991-3#3)(1991-5#2)(1991-6#1)(1992-1#3)(1992-10#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#5)(1993-3#2)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#9)(1995-6#8)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-9#1)(1997-1#1)(1997-3#4)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#77)(2008-11#56)(2008-12#15)(2008-2#1)(2008-3#4)(2008-4#11)(2008-5#7)(2008-7#13)(2008-8#19)(2008-9#18)(2009-1#1)(2009-10#11)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#8)(2010-10#1)(2010-12#15)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#26)(2011-3#1)(2012-12#2)(2012-2#20)(2012-3#8)(2012-6#2)(2013-1#15)(2013-7#3)(2013-8#15)
events)##2##1##(2008-1#1)(2008-9#1)
eventual aim##2##2##(1995-2#1)(2008-11#1)
eventual##26##1##(1990-5#2)(1992-12#1)(1994-12#1)(1995-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
eventually develop##3##2##(1991-1#1)(2008-1#1)(2008-7#1)
eventually lead##2##2##(2008-10#2)
eventually to##2##2##(1996-3#1)(2008-10#1)
eventually##58##1##(1990-7#1)(1991-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
ever been##2##2##(2008-12#1)(2012-3#1)
ever more sophisticated##2##3##(2008-11#1)(2008-7#1)
ever more##9##2##(1993-11#1)(1993-6#1)(1994-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
ever since##2##2##(2008-11#1)(2013-8#1)
ever to##2##2##(1992-1#1)(2008-4#1)
ever##49##1##(1991-2#1)(1991-3#1)(1992-1#2)(1992-9#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
ever-increasing##4##1##(1997-2#1)(2008-11#1)(2008-12#1)(2008-8#1)
evergreen##3##1##(2011-10#3)
eversmanni##2##1##(2008-6#2)
every 12##2##2##(1995-12#1)(2008-10#1)
every 15 days##2##3##(2013-1#1)(2013-8#1)
every 2 days##3##3##(2008-10#2)(2010-12#1)
every 2 h for##2##4##(1994-2#1)(2008-7#1)
every 2 weeks##3##3##(2008-10#1)(2013-1#2)
every 2##12##2##(1994-2#1)(1994-9#1)(2007-9#1)(2008-10#3)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
every 21 days##2##3##(1991-6#1)(2008-10#1)
every 3 months##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
every 3 weeks##4##3##(1991-2#1)(1991-6#1)(2008-10#2)
every 3##9##2##(1991-2#1)(1991-6#1)(1992-12#1)(2008-10#3)(2010-12#1)(2011-2#1)(2013-1#1)
every 3-4##2##2##(2008-11#1)(2008-9#1)
every 4 weeks##2##3##(1990-12#1)(1991-6#1)
every 4##5##2##(1990-12#1)(1991-6#1)(1992-12#1)(1995-11#1)(2008-10#1)
every 5 min##3##3##(1993-6#1)(2012-3#1)(2013-8#1)
every case of##2##3##(1992-9#1)(2008-11#1)
every case##5##2##(1992-5#1)(1992-9#1)(1993-12#1)(1996-3#1)(2008-11#1)
every day in##2##3##(2009-10#1)(2010-6#1)
every day##12##2##(1991-9#1)(1994-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-12#3)(2010-6#2)
every detector sees some fluorescence from every fluorochrome##2##8##(2008-9#2)
every five##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
every group##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
every isolate##3##2##(2008-10#3)
every month##2##2##(2008-6#1)(2013-1#1)
every new##2##2##(1995-2#1)(2008-10#1)
every other day for 27 days##2##6##(2008-10#2)
every other day for##3##4##(1994-12#1)(2008-10#2)
every other##7##2##(1994-12#1)(1996-11#1)(2008-10#2)(2010-11#1)(2010-6#1)(2011-2#1)
every patient##6##2##(1990-3#1)(1993-12#1)(1996-6#1)(2008-7#2)(2009-4#1)
every plan##2##2##(1994-2#1)(1995-2#1)
every sample##2##2##(2008-10#1)(2008-9#1)
every second##4##2##(2008-10#2)(2008-12#1)(2008-8#1)
every single##3##2##(1995-5#1)(2008-10#1)(2010-11#1)
every sixth month##2##3##(1997-8#2)
every stage##2##2##(2008-10#1)(2011-2#1)
every step##2##2##(1993-12#1)(2008-9#1)
every three##2##2##(1993-6#1)(2012-12#1)
every time##2##2##(2008-10#1)(2008-9#1)
every type of##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
every week##3##2##(1991-9#1)(1992-2#1)(2008-10#1)
every year and##2##3##(2008-12#1)(2008-7#1)
every year##21##2##(1990-6#1)(1991-6#1)(1996-6#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
every##229##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#5)(1991-9#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#3)(1997-2#2)(1997-6#1)(1997-8#4)(2007-9#1)(2008-10#55)(2008-11#16)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#9)(2009-10#3)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#3)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#15)(2013-8#2)
everybody##2##1##(1991-3#1)(1997-4#1)
everyday academic resilience##2##3##(2008-12#2)
everyday life##4##2##(2008-11#2)(2008-12#1)(2010-10#1)
everyday practice##2##2##(2008-11#1)(2010-1#1)
everyday reality##2##2##(2009-10#2)
everyday##34##1##(1994-6#1)(1995-1#1)(2008-1#1)(2008-11#5)(2008-12#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)
everyone##7##1##(1993-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(2008-11#1)(2010-10#1)
everything in##2##2##(1995-6#1)(2010-9#1)
everything##5##1##(1994-3#1)(1995-6#1)(2008-10#1)(2010-9#1)(2011-2#1)
everywhere##6##1##(2008-10#1)(2008-4#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
evidence about the##4##3##(2008-10#1)(2012-12#1)(2013-8#2)
evidence about##6##2##(1996-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#2)
evidence against the##2##3##(1995-12#1)(2008-7#1)
evidence against##3##2##(1995-12#1)(2008-12#1)(2008-7#1)
evidence also##2##2##(2010-10#1)(2011-2#1)
evidence and practice##2##3##(1993-12#2)
evidence and the##3##3##(1993-12#1)(2008-11#1)(2013-1#1)
evidence and##19##2##(1993-12#4)(1996-3#1)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
evidence argues##2##2##(1992-3#1)(2008-10#1)
evidence at##2##2##(1993-12#1)(1996-3#1)
evidence base for##4##3##(2008-2#1)(2012-12#1)(2013-1#2)
evidence base in##2##3##(2010-12#1)(2010-5#1)
evidence base of##2##3##(2008-11#1)(2008-12#1)
evidence base##13##2##(2008-11#1)(2008-12#2)(2008-2#1)(2009-6#1)(2010-12#1)(2010-5#2)(2011-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
evidence based practice - a##2##5##(2008-11#2)
evidence based practice##7##3##(2008-11#7)
evidence based##11##2##(2008-10#1)(2008-11#7)(2010-1#1)(2012-3#1)(2013-1#1)
evidence behind the##2##3##(2011-2#1)(2013-8#1)
evidence can##2##2##(1993-12#1)(2008-11#1)
evidence concerning##3##2##(1990-6#1)(1991-2#1)(1993-12#1)
evidence confirms that##2##3##(2008-11#1)(2012-2#1)
evidence continues to emerge##2##4##(1996-5#1)(2011-1#1)
evidence demonstrates##3##2##(2008-11#1)(2011-2#1)(2013-7#1)
evidence demonstrating that##2##3##(2008-11#1)(2010-9#1)
evidence demonstrating the##2##3##(2008-3#1)(2011-2#1)
evidence demonstrating##4##2##(2008-11#1)(2008-3#1)(2010-9#1)(2011-2#1)
evidence exists that##3##3##(2009-8#1)(2011-2#2)
evidence exists to support##2##4##(2008-11#2)
evidence exists to##3##3##(2008-11#2)(2008-8#1)
evidence exists##8##2##(2008-11#2)(2008-8#2)(2009-8#1)(2010-10#1)(2011-2#2)
evidence for a direct##2##4##(1994-5#1)(1997-2#1)
evidence for a role of##2##5##(1993-8#1)(2008-10#1)
evidence for a role##3##4##(1990-5#1)(1993-8#1)(2008-10#1)
evidence for a significant##3##4##(1991-12#1)(1993-12#1)(2012-3#1)
evidence for a##30##3##(1990-12#2)(1990-5#2)(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
evidence for an##7##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
evidence for and against##2##4##(2008-6#1)(2011-2#1)
evidence for both##3##3##(1994-6#1)(2008-7#1)(2008-8#1)
evidence for functional##2##3##(1996-2#1)(2008-10#1)
evidence for inbreeding avoidance##2##4##(2008-9#2)
evidence for recombination##2##3##(2008-10#1)(2008-12#1)
evidence for strong##2##3##(2008-3#1)(2008-8#1)
evidence for the effectiveness of##2##5##(2012-2#1)(2013-1#1)
evidence for the existence of a##2##6##(1990-5#1)(1994-12#1)
evidence for the existence of##5##5##(1990-5#1)(1994-12#1)(1997-6#1)(2008-7#1)(2008-9#1)
evidence for the hypothesis that##2##5##(2008-12#1)(2011-2#1)
evidence for the occurrence of##2##5##(1992-6#1)(2008-10#1)
evidence for the presence of##2##5##(2008-5#1)(2008-7#1)
evidence for the restoration of##2##5##(2011-2#1)(2013-1#1)
evidence for the role of##4##5##(1997-2#1)(2008-10#1)(2010-4#1)(2011-2#1)
evidence for the##49##3##(1990-5#1)(1991-6#1)(1992-10#1)(1992-3#2)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#1)
evidence for their##2##3##(2008-10#1)(2008-12#1)
evidence for this##3##3##(2008-9#1)(2011-2#1)(2012-3#1)
evidence for two##4##3##(1996-12#1)(1996-2#2)(2008-3#1)
evidence for##188##2##(1990-11#1)(1990-12#2)(1990-5#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#4)(1996-5#2)(1997-1#1)(1997-2#3)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#31)(2008-11#8)(2008-12#5)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-4#2)(2010-6#1)(2011-2#10)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#9)(2013-8#4)
evidence from functional##2##3##(2012-2#1)(2013-8#1)
evidence from the##4##3##(1994-3#1)(2008-11#1)(2010-12#2)
evidence from##33##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#2)(1994-3#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-11#1)(2009-5#1)(2009-7#2)(2010-12#2)(2010-5#1)(2011-2#2)(2012-2#2)(2013-8#1)
evidence has been##3##3##(2008-1#1)(2008-10#1)(2010-11#1)
evidence has shown that##2##4##(2011-2#1)(2013-1#1)
evidence has##13##2##(1992-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
evidence in favour of##2##4##(1993-3#1)(2013-1#1)
evidence in support of##2##4##(2008-11#1)(2011-2#1)
evidence in the literature##2##4##(2010-1#1)(2010-12#1)
evidence in the##4##3##(1990-9#1)(1993-12#1)(2010-1#1)(2010-12#1)
evidence in their##2##3##(2008-11#2)
evidence in this##2##3##(1995-5#1)(2008-12#1)
evidence in##21##2##(1990-9#1)(1991-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-5#1)(1995-5#1)(1996-6#1)(2008-11#5)(2008-12#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
evidence indicate##7##2##(1994-9#1)(1996-6#1)(2008-10#1)(2008-7#2)(2009-7#1)(2011-2#1)
evidence indicated that##3##3##(2008-10#3)
evidence indicates that the##5##4##(1993-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)
evidence indicates that##15##3##(1993-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-7#1)
evidence indicates##16##2##(1990-9#1)(1993-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-7#1)
evidence indicating##2##2##(1991-12#1)(2011-2#1)
evidence into##2##2##(1996-6#1)(2008-7#1)
evidence is assessed as##2##4##(2013-8#2)
evidence is available##4##3##(1992-5#1)(2012-12#3)
evidence is lacking##2##3##(1993-12#1)(2010-12#1)
evidence is limited##2##3##(1993-12#1)(2008-12#1)
evidence is presented that##2##4##(2008-10#2)
evidence is presented##3##3##(2008-10#2)(2013-1#1)
evidence is sparse##2##3##(1993-12#1)(2013-1#1)
evidence is##37##2##(1990-6#1)(1992-2#1)(1992-5#1)(1993-12#3)(1993-3#3)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#4)(2013-1#6)(2013-8#2)
evidence of DNA##2##3##(1996-12#1)(2008-10#1)
evidence of a##18##3##(1990-12#1)(1990-6#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
evidence of active##2##3##(1992-5#1)(2008-10#1)
evidence of an##7##3##(1991-12#1)(1992-2#1)(1996-5#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-12#1)
evidence of any##3##3##(1995-3#1)(1996-3#1)(2010-12#1)
evidence of biphasic dose-response relationships##2##5##(2008-7#2)
evidence of disease recurrence##3##4##(2012-2#1)(2013-1#2)
evidence of disease##5##3##(1990-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
evidence of host##2##3##(2008-10#2)
evidence of its##2##3##(2011-2#1)(2012-2#1)
evidence of liver##2##3##(1993-12#1)(2009-8#1)
evidence of local##3##3##(2010-3#1)(2012-7#1)(2013-1#1)
evidence of malignancy##3##3##(1992-2#1)(1994-12#1)(2008-10#1)
evidence of necrosis##2##3##(1991-3#1)(1994-6#1)
evidence of new##2##3##(1997-5#1)(2008-10#1)
evidence of old##2##3##(1995-3#1)(2008-7#1)
evidence of previous##3##3##(1997-3#1)(2008-12#1)(2009-8#1)
evidence of reduced##2##3##(1992-9#1)(2012-12#1)
evidence of sexual##2##3##(2008-10#1)(2010-8#1)
evidence of systemic##2##3##(2008-7#1)(2009-8#1)
evidence of the existence of the##2##6##(2008-3#1)(2010-5#1)
evidence of the existence of##3##5##(1995-8#1)(2008-3#1)(2010-5#1)
evidence of the##20##3##(1990-11#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#3)(2008-8#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#2)
evidence of their##2##3##(2008-10#2)
evidence of two##2##3##(2008-10#2)
evidence of##245##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-3#3)(1997-5#2)(1997-6#2)(1997-8#1)(2006-5#1)(2007-12#3)(2008-10#45)(2008-11#8)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#6)(2009-8#5)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#15)(2012-12#4)(2012-2#7)(2012-3#10)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#1)
evidence on the effectiveness of##2##5##(2012-2#2)
evidence on the effects of##2##5##(2012-2#1)(2013-1#1)
evidence on the link between##2##5##(2008-11#2)
evidence on the##11##3##(1991-3#1)(1994-6#1)(1995-5#1)(2008-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
evidence on which to##2##4##(2008-11#2)
evidence on which##3##3##(2008-11#2)(2008-12#1)
evidence on##23##2##(1991-3#1)(1994-6#1)(1995-5#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
evidence pointing to##2##3##(1995-12#1)(1997-2#1)
evidence points to##2##3##(2009-8#1)(2013-7#1)
evidence presented##2##2##(2008-12#1)(2008-7#1)
evidence regarding##5##2##(1995-11#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
evidence show##2##2##(2008-4#1)(2012-3#1)
evidence shows that##2##3##(2008-12#1)(2008-9#1)
evidence suggest##3##2##(2008-2#1)(2011-2#2)
evidence suggested that##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
evidence suggesting that##7##3##(1992-12#1)(2008-10#4)(2008-12#1)(2008-8#1)
evidence suggests a##2##3##(1994-3#1)(2008-10#1)
evidence suggests that the##2##4##(2008-5#1)(2009-8#1)
evidence suggests that these##2##4##(1990-12#1)(2009-7#1)
evidence suggests that this##2##4##(2009-8#1)(2013-1#1)
evidence suggests that##34##3##(1990-12#1)(1991-12#1)(1993-3#1)(1994-9#1)(1995-6#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
evidence suggests##38##2##(1990-12#1)(1991-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-6#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
evidence supporting the hypothesis that##3##5##(2008-10#1)(2009-10#1)(2009-3#1)
evidence supporting the##10##3##(1992-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2011-2#2)
evidence supporting this##2##3##(2008-2#1)(2011-2#1)
evidence supporting##18##2##(1992-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2011-2#3)
evidence supports the##2##3##(2008-10#1)(2008-7#1)
evidence supports##4##2##(2008-10#1)(2008-7#1)(2010-4#1)(2013-1#1)
evidence that R##2##3##(2008-10#2)
evidence that a##8##3##(1991-5#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-6#1)
evidence that chronic##2##3##(1993-8#1)(2011-2#1)
evidence that excessive##2##3##(2008-5#1)(2012-3#1)
evidence that higher##2##3##(2008-10#1)(2008-9#1)
evidence that it##2##3##(2008-11#1)(2013-1#1)
evidence that most##2##3##(2008-8#1)(2008-9#1)
evidence that platelets##2##3##(2006-6#2)
evidence that the##36##3##(1991-5#1)(1991-6#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1996-3#1)(1996-8#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-11#1)(2013-8#1)
evidence that these##3##3##(1995-11#1)(2009-10#1)(2010-11#1)
evidence that they##2##3##(1997-3#1)(2011-2#1)
evidence that this##2##3##(1991-5#1)(2008-1#1)
evidence that two##5##3##(1993-8#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-9#1)
evidence that##200##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-12#1)(1991-5#3)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-3#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-8#1)(1996-12#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2006-6#2)(2007-12#2)(2008-1#1)(2008-10#32)(2008-11#14)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#11)(2009-10#3)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#4)(2010-11#2)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#11)(2012-12#1)(2012-3#5)(2012-4#1)(2013-1#4)(2013-8#4)
evidence the##4##2##(2008-10#2)(2011-2#2)
evidence to date##3##3##(2008-11#1)(2010-1#1)(2011-2#1)
evidence to indicate that##3##4##(2008-5#1)(2010-11#1)(2013-1#1)
evidence to practice##2##3##(1993-12#1)(2008-11#1)
evidence to recommend the##2##4##(2008-10#1)(2011-2#1)
evidence to suggest that the##3##5##(2008-10#1)(2008-7#1)(2008-9#1)
evidence to suggest that##6##4##(1994-9#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
evidence to suggest##7##3##(1994-9#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-9#2)(2011-2#1)
evidence to support the use of##2##6##(2013-1#2)
evidence to support the##8##4##(2008-11#3)(2008-2#1)(2008-7#1)(2013-1#3)
evidence to support this##4##4##(2008-10#2)(2008-8#2)
evidence to support##16##3##(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
evidence to the##2##3##(1995-2#1)(2008-11#1)
evidence to##46##2##(1993-12#3)(1993-3#1)(1994-9#1)(1995-2#2)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2010-1#1)(2010-11#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
evidence was found that##2##4##(2008-10#1)(2009-1#1)
evidence was found##8##3##(1990-12#1)(1993-12#1)(1994-8#1)(2008-10#4)(2009-1#1)
evidence was obtained##2##3##(1996-8#1)(2010-11#1)
evidence was##15##2##(1990-12#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-12#1)(1996-5#2)(1996-8#1)(2008-10#4)(2009-1#1)(2010-11#1)(2013-8#1)
evidence##1167##1##(1990-11#3)(1990-12#6)(1990-2#5)(1990-3#1)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-12#11)(1991-2#3)(1991-3#3)(1991-5#5)(1991-6#3)(1991-8#1)(1992-1#2)(1992-10#2)(1992-12#5)(1992-2#6)(1992-3#10)(1992-5#5)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#6)(1993-1#1)(1993-12#34)(1993-2#1)(1993-3#12)(1993-6#4)(1993-8#6)(1993-9#3)(1994-1#1)(1994-11#9)(1994-12#5)(1994-2#1)(1994-3#5)(1994-5#7)(1994-6#3)(1994-8#4)(1994-9#4)(1995-11#8)(1995-12#9)(1995-2#8)(1995-3#2)(1995-5#4)(1995-6#5)(1995-8#5)(1996-1#1)(1996-12#10)(1996-2#4)(1996-3#5)(1996-5#7)(1996-6#7)(1996-8#2)(1997-1#4)(1997-2#5)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#4)(1997-8#2)(2006-5#1)(2006-6#2)(2007-12#8)(2008-1#4)(2008-10#168)(2008-11#89)(2008-12#30)(2008-2#6)(2008-3#9)(2008-4#8)(2008-5#19)(2008-6#11)(2008-7#50)(2008-8#34)(2008-9#40)(2009-1#2)(2009-10#14)(2009-11#3)(2009-12#2)(2009-3#5)(2009-5#2)(2009-6#5)(2009-7#14)(2009-8#18)(2009-9#1)(2010-1#8)(2010-10#8)(2010-11#10)(2010-12#15)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#11)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#2)(2011-10#2)(2011-2#79)(2012-12#24)(2012-2#31)(2012-3#31)(2012-4#1)(2012-7#1)(2013-1#53)(2013-7#5)(2013-8#22)
evidence)##3##1##(2011-2#1)(2012-3#2)
evidence-based clinical##2##2##(2010-6#1)(2010-9#1)
evidence-based educational##2##2##(2008-11#1)(2008-8#1)
evidence-based guideline##2##2##(2008-8#1)(2012-12#1)
evidence-based guidelines##2##2##(2008-3#1)(2010-12#1)
evidence-based literature##2##2##(2008-7#1)(2013-8#1)
evidence-based medicine##4##2##(2008-11#3)(2008-8#1)
evidence-based nursing##3##2##(2008-11#2)(2008-12#1)
evidence-based postoperative pain assessment practices##6##5##(2010-11#6)
evidence-based practice (EBP)##3##3##(2008-11#1)(2013-1#2)
evidence-based practice in##3##3##(2008-11#2)(2008-8#1)
evidence-based practice##14##2##(2008-11#5)(2008-12#3)(2008-8#1)(2010-9#1)(2013-1#4)
evidence-based practices##3##2##(2010-10#2)(2010-7#1)
evidence-based strategies for##2##3##(2013-1#2)
evidence-based##83##1##(1993-12#2)(2008-10#1)(2008-11#17)(2008-12#5)(2008-3#1)(2008-7#1)(2008-8#7)(2009-12#1)(2009-3#2)(2010-10#3)(2010-11#7)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#7)(2013-1#12)(2013-8#2)
evidenced a##2##2##(1991-12#1)(2013-1#1)
evidenced by a##4##3##(1993-3#1)(1997-3#1)(2008-10#1)(2008-7#1)
evidenced by the fact that##3##5##(1991-3#1)(2008-10#1)(2008-11#1)
evidenced by the##11##3##(1991-3#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)
evidenced by##31##2##(1991-3#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-3#2)(2008-10#11)(2008-11#3)(2008-5#2)(2008-7#3)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
evidenced in the##5##3##(1994-2#1)(1996-1#1)(2008-10#2)(2012-5#1)
evidenced in##9##2##(1994-2#1)(1994-3#1)(1996-1#1)(2008-1#1)(2008-10#3)(2012-3#1)(2012-5#1)
evidenced that the##3##3##(2008-10#2)(2009-10#1)
evidenced the##4##2##(2008-10#3)(2011-2#1)
evidenced##63##1##(1990-8#1)(1991-12#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-3#2)(1997-4#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-5#3)(2008-7#4)(2009-10#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-3#4)(2012-5#1)(2013-1#1)(2013-8#1)
evidences for##4##2##(2008-10#2)(2010-3#1)(2012-2#1)
evidences indicate that##2##3##(2008-11#1)(2011-2#1)
evidences##15##1##(1997-5#1)(2008-10#6)(2008-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
evidencing the##2##2##(2008-10#2)
evidencing##6##1##(2008-1#1)(2008-10#2)(2008-12#1)(2009-6#1)(2013-1#1)
evident after##5##2##(1991-6#1)(1994-8#1)(1995-2#1)(2008-10#1)(2012-3#1)
evident and##4##2##(1990-5#1)(2008-3#1)(2008-9#1)(2009-10#1)
evident at days 14 and 21 p##2##7##(2008-5#2)
evident at##6##2##(1994-3#1)(2008-12#1)(2008-5#2)(2011-2#1)(2013-1#1)
evident bleeding source was detected in only##2##7##(2011-2#2)
evident by##2##2##(1997-3#2)
evident for the##2##3##(1990-12#1)(2008-10#1)
evident for##7##2##(1990-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
evident from the##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
evident from##6##2##(1994-11#1)(2008-10#3)(2008-11#1)(2013-1#1)
evident improvement in PS##2##4##(1990-2#2)
evident in practice##2##3##(2008-11#2)
evident in the##11##3##(1996-12#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
evident in##31##2##(1992-12#1)(1996-12#1)(1996-3#1)(1997-3#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-8#2)(2009-10#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#1)
evident on##2##2##(1996-6#1)(2008-10#1)
evident that the##6##3##(1993-1#1)(1997-8#1)(2008-10#2)(2008-9#1)(2011-3#1)
evident that##22##2##(1992-1#1)(1993-1#1)(1993-12#1)(1994-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
evident the##2##2##(2008-10#1)(2008-11#1)
evident when##2##2##(1992-2#1)(2011-1#1)
evident with##2##2##(1991-12#1)(2008-10#1)
evident##152##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#5)(1997-8#1)(2008-1#1)(2008-10#37)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#9)(2013-8#2)
evidential##2##1##(2008-12#1)(2013-8#1)
evidently##6##1##(2008-10#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
evil spirit or##2##3##(2009-10#1)(2012-3#1)
evil##4##1##(2009-10#3)(2012-3#1)
evisceration##2##1##(1990-2#1)(2008-12#1)
evo-devo##2##1##(2010-7#1)(2012-12#1)
evocation##2##1##(2012-2#1)(2012-3#1)
evoke the##3##2##(1994-11#1)(2009-12#1)(2009-8#1)
evoke##11##1##(1992-6#2)(1993-12#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-12#2)(2009-8#1)(2013-8#1)
evoked a##3##2##(1990-5#1)(1993-3#2)
evoked and##2##2##(1997-7#1)(2008-4#1)
evoked by electrical stimulation##2##4##(1996-2#1)(2011-2#1)
evoked by low##2##3##(1992-3#1)(1995-11#1)
evoked by##14##2##(1990-9#1)(1992-3#3)(1994-5#1)(1995-11#2)(1996-2#1)(1997-4#1)(2008-11#2)(2008-7#1)(2010-9#1)(2011-2#1)
evoked potentials were##2##3##(1990-9#1)(1996-6#1)
evoked potentials##9##2##(1990-9#1)(1996-2#1)(1996-6#3)(1997-6#1)(2008-12#1)(2008-9#1)(2011-2#1)
evoked response##3##2##(1990-5#1)(1991-1#2)
evoked the##4##2##(1994-11#1)(1994-2#1)(1995-11#1)(2008-9#1)
evoked##64##1##(1990-5#4)(1990-9#2)(1991-1#2)(1992-12#1)(1992-3#3)(1993-3#3)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#6)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#3)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#7)(2009-6#1)(2010-11#1)(2010-9#1)(2011-2#6)
evokes a##2##2##(2009-4#1)(2013-8#1)
evokes##8##1##(1990-5#1)(2008-10#1)(2008-9#1)(2009-10#2)(2009-4#1)(2012-2#1)(2013-8#1)
evoking impulses on##2##3##(2008-8#2)
evoking##5##1##(1990-11#1)(1994-5#1)(2008-8#3)
evolution and function of##2##4##(1996-2#1)(2008-9#1)
evolution and the##7##3##(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-3#1)
evolution and##26##2##(1990-3#1)(1991-12#1)(1993-12#1)(1993-6#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-3#2)
evolution are##2##2##(2008-10#1)(2010-5#1)
evolution as a##2##3##(2008-8#1)(2010-5#1)
evolution at the##2##3##(1990-6#1)(1992-6#1)
evolution at##4##2##(1990-6#1)(1992-6#1)(2008-8#1)(2010-3#1)
evolution by##3##2##(1997-4#1)(2010-4#1)(2012-3#1)
evolution can##2##2##(1997-6#1)(2008-10#1)
evolution experiments##4##2##(1997-6#4)
evolution for##2##2##(2008-3#1)(2008-8#1)
evolution from##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
evolution has been##2##3##(2008-9#1)(2012-3#1)
evolution has##5##2##(2008-9#1)(2010-4#1)(2010-5#1)(2012-3#2)
evolution in a##5##3##(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#1)
evolution in metapopulations##2##3##(2008-8#1)(2008-9#1)
evolution in the##6##3##(1992-11#1)(1996-3#1)(2008-10#1)(2008-8#1)(2012-3#2)
evolution in##33##2##(1992-11#1)(1996-3#1)(1997-5#1)(1997-6#1)(2008-10#6)(2008-2#1)(2008-8#8)(2008-9#5)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-3#3)
evolution is the##3##3##(1997-6#1)(2011-10#1)(2011-2#1)
evolution is##13##2##(1993-3#1)(1997-6#2)(2008-8#2)(2009-11#1)(2011-10#1)(2011-2#3)(2012-3#3)
evolution may##2##2##(2008-8#1)(2011-2#1)
evolution occurs##2##2##(2008-8#1)(2012-3#1)
evolution of a##4##3##(2008-10#1)(2008-9#1)(2010-8#1)(2013-1#1)
evolution of altruism##3##3##(2008-8#2)(2008-9#1)
evolution of an##2##3##(1997-6#1)(2008-10#1)
evolution of behavior##2##3##(2008-8#2)
evolution of coloniality##2##3##(2008-9#2)
evolution of conspecific##2##3##(2008-8#2)
evolution of cooperation##5##3##(2008-8#4)(2010-4#1)
evolution of cuticular hydrocarbons##2##4##(2012-3#2)
evolution of desmoid tumors##2##4##(1997-8#2)
evolution of dispersal##4##3##(2008-8#3)(2008-9#1)
evolution of egg size##2##4##(1991-5#2)
evolution of eukaryotic##2##3##(1990-7#1)(2008-8#1)
evolution of exploitation##2##3##(1995-5#2)
evolution of fitter influenza strains##2##5##(2012-2#2)
evolution of generalized reciprocity##2##4##(2012-3#2)
evolution of honest##2##3##(1995-5#1)(2008-9#1)
evolution of interacting phenotypes##2##4##(2008-8#2)
evolution of its##3##3##(1992-1#1)(2008-10#1)(2008-4#1)
evolution of life##3##3##(2008-8#1)(2008-9#2)
evolution of male##3##3##(2008-8#2)(2008-9#1)
evolution of parasite virulence##4##4##(2008-8#4)
evolution of parasite##5##3##(2008-8#5)
evolution of plant##3##3##(2008-10#2)(2008-8#1)
evolution of races##2##3##(2008-10#2)
evolution of resistance##4##3##(1995-6#2)(2008-8#1)(2008-9#1)
evolution of sexually##2##3##(2008-8#1)(2008-9#1)
evolution of sociality##2##3##(2008-8#2)
evolution of the coprinoid mushroom genus Parasola##2##7##(2010-3#2)
evolution of the disease##2##4##(1993-11#1)(2008-11#1)
evolution of the skin-color##2##4##(2008-6#2)
evolution of the##52##3##(1990-6#1)(1990-7#1)(1991-11#1)(1992-11#1)(1993-11#1)(1993-2#2)(1996-1#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#3)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-7#4)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#2)
evolution of these##3##3##(1995-3#1)(2008-8#1)(2010-8#1)
evolution of this##2##3##(2010-6#1)(2011-2#1)
evolution of traits##2##3##(2008-8#2)
evolution of##331##2##(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-5#2)(1992-1#1)(1992-11#1)(1993-11#1)(1993-2#5)(1993-3#1)(1995-3#1)(1995-5#3)(1995-6#4)(1996-1#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#3)(1997-8#3)(1997-9#1)(2007-12#2)(2008-10#39)(2008-11#11)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#94)(2008-9#37)(2009-10#3)(2009-11#1)(2009-5#1)(2009-6#5)(2009-8#7)(2010-12#2)(2010-3#2)(2010-4#7)(2010-5#6)(2010-6#1)(2010-7#7)(2010-8#2)(2011-1#4)(2011-2#6)(2012-2#3)(2012-3#14)(2013-1#5)(2013-8#8)
evolution on##2##2##(1997-8#1)(2008-10#1)
evolution over the##2##3##(1994-3#1)(1996-3#1)
evolution over time##2##3##(2008-5#1)(2013-1#1)
evolution over##5##2##(1992-3#1)(1994-3#1)(1996-3#1)(2008-5#1)(2013-1#1)
evolution rate##2##2##(1991-6#1)(2008-11#1)
evolution that##2##2##(2008-8#1)(2011-2#1)
evolution to##5##2##(1997-6#1)(2008-8#2)(2011-1#2)
evolution toward##3##2##(2008-10#1)(2008-9#1)(2009-4#1)
evolution was##5##2##(1991-3#1)(1997-8#1)(2008-10#1)(2013-1#2)
evolution with##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
evolution within the##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
evolution##599##1##(1990-3#1)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#2)(1993-6#3)(1994-11#1)(1994-12#1)(1994-3#3)(1995-3#1)(1995-5#4)(1995-6#4)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#25)(1997-8#5)(1997-9#2)(2007-12#3)(2008-10#65)(2008-11#15)(2008-12#6)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#126)(2008-9#54)(2009-1#1)(2009-10#6)(2009-11#2)(2009-4#2)(2009-5#1)(2009-6#10)(2009-7#1)(2009-8#10)(2010-1#3)(2010-12#3)(2010-3#5)(2010-4#17)(2010-5#14)(2010-6#2)(2010-7#7)(2010-8#3)(2011-1#9)(2011-10#1)(2011-2#26)(2012-12#1)(2012-2#10)(2012-3#38)(2013-1#12)(2013-8#11)
evolutionarily conserved and##2##3##(1995-6#1)(1997-7#1)
evolutionarily conserved protein##2##3##(1997-1#1)(1997-7#1)
evolutionarily conserved##10##2##(1994-6#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-7#2)(2009-3#1)(2009-8#1)(2011-2#1)
evolutionarily significant##2##2##(1995-2#1)(2008-8#1)
evolutionarily stable and##2##3##(2008-8#2)
evolutionarily stable strategy (ESS)##5##4##(2008-8#2)(2008-9#3)
evolutionarily stable strategy##7##3##(2008-8#2)(2008-9#5)
evolutionarily stable##23##2##(2008-8#11)(2008-9#12)
evolutionarily##49##1##(1993-12#1)(1994-11#2)(1994-6#1)(1995-2#2)(1995-6#2)(1997-1#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-8#15)(2008-9#12)(2009-3#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-3#2)
evolutionary adaptation##2##2##(2008-8#1)(2012-3#1)
evolutionary and##4##2##(2008-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
evolutionary behavioral##2##2##(2008-8#2)
evolutionary biologists##2##2##(2008-8#1)(2008-9#1)
evolutionary biology and##2##3##(1997-7#1)(2009-6#1)
evolutionary biology##6##2##(1997-7#1)(2007-12#1)(2008-8#1)(2009-6#1)(2009-7#1)(2012-3#1)
evolutionary biotechnology##2##2##(1997-6#2)
evolutionary change##7##2##(2008-8#2)(2010-4#4)(2012-3#1)
evolutionary changes in##2##3##(2008-11#1)(2008-8#1)
evolutionary changes##4##2##(2007-12#1)(2008-11#1)(2008-8#1)(2010-4#1)
evolutionary consequences of##3##3##(2008-8#3)
evolutionary consequences##4##2##(2008-8#3)(2009-6#1)
evolutionary conservation##2##2##(1993-2#1)(2013-8#1)
evolutionary distance##2##2##(1995-2#1)(2010-7#1)
evolutionary distances##2##2##(2008-4#1)(2010-7#1)
evolutionary divergence##2##2##(2008-10#1)(2011-2#1)
evolutionary dynamics of##3##3##(2008-8#2)(2010-8#1)
evolutionary dynamics##6##2##(2008-8#4)(2008-9#1)(2010-8#1)
evolutionary event##2##2##(2008-10#1)(2008-9#1)
evolutionary force##2##2##(2008-9#1)(2012-3#1)
evolutionary forces##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#1)
evolutionary function##2##2##(2008-9#1)(2012-3#1)
evolutionary genetic##2##2##(2008-8#2)
evolutionary histories##2##2##(2008-10#1)(2012-3#1)
evolutionary history of##3##3##(2008-10#2)(2008-8#1)
evolutionary history##6##2##(2008-10#2)(2008-8#1)(2010-3#1)(2010-5#2)
evolutionary lineage##2##2##(2011-2#2)
evolutionary lineages##2##2##(2008-10#1)(2011-2#1)
evolutionary mechanisms##3##2##(2008-8#1)(2009-6#1)(2010-4#1)
evolutionary model##2##2##(2008-8#2)
evolutionary optimization##2##2##(1997-6#2)
evolutionary origin of##3##3##(2007-12#1)(2008-7#1)(2010-1#1)
evolutionary origin##8##2##(1990-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-3#1)
evolutionary origins of##3##3##(2008-11#1)(2009-6#1)(2013-8#1)
evolutionary origins##7##2##(2008-10#3)(2008-11#1)(2008-7#1)(2009-6#1)(2013-8#1)
evolutionary perspective##4##2##(2008-8#2)(2009-8#1)(2012-3#1)
evolutionary potential of##2##3##(2008-10#2)
evolutionary potential##4##2##(2008-10#3)(2008-8#1)
evolutionary process##4##2##(2007-12#1)(2010-4#1)(2010-5#1)(2012-3#1)
evolutionary processes##8##2##(1995-5#1)(2008-10#2)(2008-8#1)(2010-3#2)(2010-4#1)(2012-12#1)
evolutionary relationships of##2##3##(1994-11#1)(2008-10#1)
evolutionary relationships##7##2##(1994-11#2)(2008-10#1)(2008-4#1)(2011-2#2)(2013-8#1)
evolutionary response##3##2##(2008-8#2)(2012-3#1)
evolutionary significance##3##2##(2007-12#1)(2012-2#1)(2012-3#1)
evolutionary strategies can##2##3##(1997-6#2)
evolutionary strategies##3##2##(1997-6#3)
evolutionary trees##2##2##(2008-4#2)
evolutionary##223##1##(1990-5#1)(1991-6#2)(1993-2#1)(1994-11#2)(1994-2#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-6#8)(1997-7#1)(1997-9#2)(2007-12#5)(2008-10#26)(2008-11#6)(2008-12#2)(2008-4#4)(2008-7#3)(2008-8#54)(2008-9#16)(2009-10#1)(2009-12#2)(2009-6#9)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#4)(2010-4#9)(2010-5#7)(2010-7#5)(2010-8#1)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#20)(2013-8#8)
evolutions##2##1##(1994-2#1)(2008-10#1)
evolvability##2##1##(2010-10#2)
evolvable##2##1##(1997-6#1)(2010-10#1)
evolve and##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
evolve as a result of##2##5##(2008-11#1)(2008-8#1)
evolve as a##3##3##(2008-11#1)(2008-8#2)
evolve as##5##2##(2008-10#1)(2008-11#1)(2008-8#2)(2012-3#1)
evolve in close##2##3##(1994-12#1)(2008-8#1)
evolve in##7##2##(1990-6#1)(1993-1#1)(1994-12#1)(2008-8#3)(2011-2#1)
evolve into##3##2##(1992-12#1)(2009-12#1)(2011-2#1)
evolve more##2##2##(1991-6#1)(2008-9#1)
evolve to##4##2##(1995-5#1)(1997-3#1)(2008-11#1)(2011-2#1)
evolve under##4##2##(1994-12#1)(2008-8#3)
evolve when##4##2##(2008-8#3)(2010-10#1)
evolve##64##1##(1990-6#1)(1991-6#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-5#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-6#2)(2008-8#21)(2008-9#7)(2009-12#1)(2010-10#5)(2011-2#5)(2012-3#1)(2013-1#3)
evolved a##2##2##(1990-8#1)(2010-1#1)
evolved as the scientific community##2##5##(2012-2#2)
evolved as##3##2##(2009-8#1)(2012-2#2)
evolved before the##2##3##(2008-8#1)(2008-9#1)
evolved during the##2##3##(2008-11#1)(2013-8#1)
evolved during##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
evolved from the##3##3##(1995-6#1)(2008-9#1)(2012-12#1)
evolved from##12##2##(1993-1#1)(1995-6#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-12#1)(2013-8#1)
evolved gas##5##2##(2008-10#5)
evolved in response to the##2##5##(2008-9#1)(2010-5#1)
evolved in response to##4##4##(1993-12#1)(2008-8#1)(2008-9#1)(2010-5#1)
evolved in the##3##3##(2008-10#2)(2010-4#1)
evolved in##9##2##(1993-12#1)(1994-3#1)(2008-10#2)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#1)
evolved independently##2##2##(2008-10#1)(2013-8#1)
evolved into##5##2##(2008-10#2)(2008-9#1)(2012-12#1)(2013-1#1)
evolved lines##2##2##(2008-8#2)
evolved over##3##2##(1997-1#1)(2010-6#1)(2012-2#1)
evolved the##2##2##(2008-11#1)(2011-2#1)
evolved to be##2##3##(2008-10#1)(2008-11#1)
evolved to##8##2##(2008-10#1)(2008-11#3)(2008-8#1)(2009-9#1)(2010-4#1)(2013-1#1)
evolved under##3##2##(1997-9#1)(2009-6#1)(2011-2#1)
evolved via##2##2##(2011-1#1)(2012-3#1)
evolved with##2##2##(1997-3#1)(2008-8#1)
evolved##114##1##(1990-8#1)(1992-1#1)(1993-1#1)(1993-12#2)(1994-3#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-9#2)(2008-10#28)(2008-11#8)(2008-12#1)(2008-7#1)(2008-8#10)(2008-9#6)(2009-1#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#5)
evolves in a##2##3##(2007-11#1)(2012-3#1)
evolves in##3##2##(2007-11#1)(2008-11#1)(2012-3#1)
evolves to##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
evolves##16##1##(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#3)(2008-9#3)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#2)
evolving and##2##2##(1996-3#1)(2010-12#1)
evolving in##4##2##(1991-2#1)(1994-2#1)(2012-3#2)
evolving latent projections (HELP)##2##4##(2008-10#2)
evolving over time##2##3##(2008-10#1)(2013-1#1)
evolving role of##5##3##(1993-12#1)(1994-2#1)(1996-9#1)(1997-3#1)(2009-2#1)
evolving role##6##2##(1993-12#1)(1994-2#1)(1996-9#1)(1997-3#1)(2009-2#1)(2012-3#1)
evolving systems##2##2##(1997-6#1)(2008-8#1)
evolving the##3##2##(1994-2#2)(2010-7#1)
evolving##56##1##(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#4)(1995-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-7#2)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
ewe##2##1##(1994-3#1)(2008-8#1)
ewes aged##2##2##(2008-9#2)
ewes with##3##2##(1996-12#1)(2010-12#2)
ewes##17##1##(1991-8#2)(1994-3#1)(1996-12#2)(2008-9#8)(2010-12#4)
ex MbSA)##3##2##(2011-2#3)
ex Planch##2##2##(2008-12#2)
ex Steud##2##2##(2008-8#2)
ex situ##3##2##(2008-10#1)(2008-3#2)
ex vivo and in vivo##2##5##(2008-3#1)(2008-5#1)
ex vivo and##4##3##(2008-11#1)(2008-3#1)(2008-5#2)
ex vivo assay##2##3##(2008-11#1)(2008-5#1)
ex vivo expansion##2##3##(2008-11#2)
ex vivo stimulation##2##3##(2008-4#1)(2009-6#1)
ex vivo##47##2##(2006-6#4)(2008-10#1)(2008-11#12)(2008-3#1)(2008-4#2)(2008-5#11)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#7)
ex##66##1##(1994-5#2)(1994-8#1)(1997-1#1)(2006-6#4)(2008-10#3)(2008-11#12)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#11)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-9#2)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#7)
ex-smokers##3##1##(1994-6#1)(1996-3#1)(2008-11#1)
ex-type strain V##3##3##(2008-10#3)
ex-type strain##4##2##(2008-10#4)
ex-type##5##1##(2008-10#5)
ex-vivo##2##1##(2008-11#1)(2008-5#1)
exacerbate the##2##2##(2008-10#1)(2008-12#1)
exacerbate##9##1##(1992-6#1)(2008-10#4)(2008-12#1)(2008-7#2)(2013-7#1)
exacerbated by##4##2##(2008-10#1)(2008-7#1)(2010-1#1)(2011-10#1)
exacerbated##9##1##(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-10#1)(2011-2#1)(2012-7#1)(2013-1#1)
exacerbates##3##1##(2008-5#1)(2008-7#1)(2013-1#1)
exacerbating##3##1##(2010-12#1)(2012-12#2)
exacerbation of##6##2##(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-9#1)
exacerbation##12##1##(1996-8#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)
exacerbations and the presence of##2##5##(2008-7#1)(2012-12#1)
exacerbations and##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
exacerbations in##3##2##(2008-5#1)(2010-8#2)
exacerbations of##7##2##(1996-11#1)(2007-12#1)(2008-7#2)(2011-2#1)(2012-12#2)
exacerbations##23##1##(1996-11#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-7#5)(2010-5#1)(2010-8#2)(2011-2#7)(2012-12#3)
exact cause##2##2##(1993-1#1)(2013-8#1)
exact determination of##2##3##(2008-10#1)(2008-5#1)
exact diagnosis##2##2##(1990-12#1)(2011-2#1)
exact etiology##2##2##(1991-3#1)(2013-1#1)
exact in##2##2##(2008-3#1)(2012-12#1)
exact mechanism of##3##3##(2008-6#1)(2008-7#1)(2009-7#1)
exact mechanism##6##2##(2008-11#1)(2008-6#1)(2008-7#2)(2009-7#1)(2013-1#1)
exact method##2##2##(1994-9#1)(2008-3#1)
exact solution##2##2##(2008-3#1)(2008-6#1)
exact solutions##2##2##(1993-5#1)(2008-6#1)
exact test##2##2##(2008-12#1)(2013-1#1)
exact tests##2##2##(1996-3#1)(2012-2#1)
exact##87##1##(1990-12#2)(1990-8#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-3#4)(1996-6#1)(2007-11#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-3#11)(2008-5#2)(2008-6#5)(2008-7#4)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
exactly at##2##2##(2008-8#2)
exactly known##2##2##(2008-10#2)
exactly mimic##2##2##(2008-1#1)(2009-7#1)
exactly the same##2##3##(1995-12#1)(2008-10#1)
exactly the##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
exactly to##2##2##(2008-10#1)(2008-9#1)
exactly##28##1##(1991-11#1)(1993-1#1)(1995-12#1)(1995-9#1)(1997-3#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-5#1)
exaggerate##2##1##(2008-7#1)(2011-1#1)
exaggerated application##2##2##(2008-5#2)
exaggerated##16##1##(1996-11#2)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-8#1)(2011-2#1)
exaggeration##2##1##(1990-11#1)(2008-5#1)
exam and##3##2##(2011-2#3)
exam##22##1##(1991-3#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-2#5)(2013-1#1)
examination after##2##2##(1990-11#1)(2008-7#1)
examination and a##2##3##(1990-6#1)(1995-2#1)
examination and laboratory##2##3##(1991-3#1)(2008-11#1)
examination and the##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
examination and##31##2##(1990-3#1)(1990-6#1)(1991-3#2)(1992-5#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
examination are##6##2##(2006-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
examination at 1##2##3##(2011-2#2)
examination can be##2##3##(1992-12#1)(1997-8#1)
examination confirmed##2##2##(2007-8#1)(2013-1#1)
examination demonstrated##5##2##(1996-11#1)(2008-5#1)(2009-6#1)(2012-2#1)(2012-3#1)
examination did not show any##2##5##(2008-10#1)(2013-8#1)
examination disclosed##2##2##(2008-10#1)(2008-7#1)
examination for##3##2##(1996-12#1)(2011-2#1)(2012-3#1)
examination in the##2##3##(1990-6#1)(1997-4#1)
examination in##12##2##(1990-6#1)(1990-9#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-4#2)(2008-1#2)(2008-11#1)(2008-7#2)
examination indicated that##2##3##(2008-10#1)(2008-6#1)
examination indicated##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
examination is##6##2##(1991-3#1)(1994-12#1)(1995-11#1)(2008-11#1)(2010-4#1)(2011-2#1)
examination of Fasciola##2##3##(1996-12#2)
examination of a##4##3##(2008-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
examination of infected##2##3##(2008-10#1)(2008-9#1)
examination of the brain##2##4##(2008-7#1)(2013-1#1)
examination of the literature##2##4##(1991-12#1)(1993-11#1)
examination of the##47##3##(1990-11#1)(1990-6#1)(1991-12#1)(1992-10#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-7#2)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
examination of these##5##3##(1993-12#1)(2008-10#2)(2008-7#1)(2010-6#1)
examination of##117##2##(1990-11#2)(1990-6#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-3#1)(1995-11#3)(1995-12#1)(1995-9#2)(1996-12#3)(1996-3#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-4#1)(2009-8#2)(2010-1#3)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#1)
examination or##2##2##(1994-12#1)(2008-5#1)
examination proved##2##2##(1991-6#1)(2012-12#1)
examination revealed a##9##3##(1992-9#1)(2008-11#1)(2010-6#2)(2011-2#2)(2012-12#2)(2012-3#1)
examination revealed increased##2##3##(2011-1#1)(2011-2#1)
examination revealed that the##2##4##(2008-10#1)(2013-1#1)
examination revealed that##5##3##(1994-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
examination revealed the##3##3##(2008-11#1)(2009-1#1)(2013-8#1)
examination revealed##29##2##(1992-9#1)(1993-12#2)(1994-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2010-6#2)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
examination showed a##2##3##(2007-8#1)(2011-1#1)
examination showed that the##2##4##(1995-2#1)(2011-2#1)
examination showed##11##2##(1995-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
examination techniques##3##2##(1997-4#2)(1997-8#1)
examination that##2##2##(1993-2#1)(2011-2#1)
examination the##2##2##(1992-2#1)(2011-2#1)
examination through a##2##3##(2012-12#2)
examination to##5##2##(1994-6#1)(2008-10#1)(2010-7#1)(2011-2#2)
examination under##3##2##(1992-12#2)(1994-2#1)
examination using##3##2##(1992-5#1)(2008-11#1)(2011-2#1)
examination was carried out##2##4##(1991-6#1)(2008-1#1)
examination was normal##2##3##(2007-12#1)(2010-7#1)
examination was performed##2##3##(1996-6#1)(1997-4#1)
examination was##15##2##(1991-6#1)(1993-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
examination were##2##2##(2009-7#1)(2013-1#1)
examination with##4##2##(1990-9#1)(2008-1#1)(2008-7#1)(2011-2#1)
examination##453##1##(1990-11#3)(1990-3#3)(1990-6#4)(1990-8#2)(1990-9#4)(1991-12#6)(1991-3#5)(1991-6#6)(1991-7#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#4)(1994-12#6)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#3)(1996-11#4)(1996-12#5)(1996-2#1)(1996-3#3)(1996-6#5)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#6)(1997-5#3)(1997-7#1)(1997-8#12)(2006-5#2)(2007-11#1)(2007-12#5)(2007-8#2)(2007-9#3)(2008-1#7)(2008-10#33)(2008-11#23)(2008-12#14)(2008-3#2)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#27)(2008-8#6)(2008-9#7)(2009-1#2)(2009-10#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#6)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#9)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#36)(2011-3#1)(2011-7#1)(2012-12#15)(2012-2#15)(2012-3#14)(2012-7#1)(2013-1#20)(2013-8#14)
examination)##3##1##(2008-7#1)(2008-8#1)(2012-3#1)
examinations after##2##2##(1990-6#1)(1996-11#1)
examinations and##6##2##(1990-8#1)(1997-7#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
examinations are##4##2##(1990-12#1)(1997-8#1)(2008-11#1)(2010-1#1)
examinations at the nearest hospital##2##5##(1997-4#2)
examinations at the##3##3##(1997-4#3)
examinations for##3##2##(1990-3#1)(1991-7#1)(2010-6#1)
examinations including##2##2##(2008-12#1)(2013-1#1)
examinations is##2##2##(1997-8#1)(2013-1#1)
examinations of the##4##3##(1994-12#1)(1997-8#1)(2008-5#1)(2008-9#1)
examinations of##8##2##(1991-11#1)(1994-12#1)(1996-6#1)(1997-8#3)(2008-5#1)(2008-9#1)
examinations on##2##2##(2011-2#2)
examinations that##2##2##(2008-11#1)(2010-6#1)
examinations under##2##2##(1995-5#1)(2011-7#1)
examinations were performed in##2##4##(2011-2#1)(2012-12#1)
examinations were##8##2##(1990-8#1)(1993-12#1)(1997-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
examinations##101##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#3)(1990-9#1)(1991-11#1)(1991-6#3)(1991-7#5)(1992-5#2)(1993-12#1)(1994-12#3)(1994-6#1)(1995-5#3)(1996-11#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#11)(2008-10#2)(2008-11#6)(2008-12#5)(2008-3#1)(2008-5#3)(2008-7#5)(2008-9#2)(2009-12#1)(2010-1#1)(2010-3#1)(2010-6#3)(2011-2#7)(2011-3#2)(2011-7#2)(2012-12#2)(2012-2#4)(2013-1#4)
examine a##6##2##(1995-3#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)
examine and##3##2##(1993-12#1)(1994-1#1)(2010-9#1)
examine factors that##2##3##(2008-10#1)(2008-7#1)
examine how the##3##3##(2008-8#1)(2010-10#1)(2010-7#1)
examine how##10##2##(1993-2#1)(1995-6#1)(2008-8#4)(2010-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
examine if##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)
examine its##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
examine possible mechanisms##2##3##(1991-5#1)(2008-11#1)
examine possible##3##2##(1991-5#1)(2008-11#1)(2010-7#1)
examine some of the##2##4##(2008-12#1)(2008-8#1)
examine some##3##2##(2008-12#1)(2008-8#1)(2013-8#1)
examine that##2##2##(2011-2#1)(2012-2#1)
examine the association between##5##4##(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
examine the association##6##3##(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
examine the conditions##2##3##(2008-8#2)
examine the consequences of##4##4##(1995-2#1)(1995-6#1)(2008-11#1)(2008-8#1)
examine the effects of##12##4##(1991-12#1)(1993-3#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
examine the evidence for##2##4##(2008-6#1)(2011-2#1)
examine the evolution of##2##4##(2007-12#1)(2009-8#1)
examine the expression of##3##4##(1993-8#1)(1994-6#1)(1995-2#1)
examine the expression##4##3##(1991-5#1)(1993-8#1)(1994-6#1)(1995-2#1)
examine the extent to which##3##5##(1991-12#1)(2008-8#1)(2012-2#1)
examine the general##2##3##(2008-2#1)(2009-10#1)
examine the influence of##2##4##(2008-11#2)
examine the mechanisms by which##2##5##(2008-7#2)
examine the potential##2##3##(2008-11#1)(2008-7#1)
examine the relationship between##11##4##(1992-2#1)(1994-5#1)(1997-1#1)(2008-10#2)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
examine the relationship of##2##4##(2011-2#1)(2012-2#1)
examine the relationship##13##3##(1992-2#1)(1994-5#1)(1997-1#1)(2008-10#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
examine the role of the##2##5##(1991-2#1)(1995-2#1)
examine the role of##7##4##(1991-2#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-9#1)
examine the student##2##3##(1993-1#1)(2008-11#1)
examine the temporal##2##3##(2008-10#1)(2008-3#1)
examine the##208##2##(1990-5#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#4)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#24)(2008-11#25)(2008-12#9)(2008-2#2)(2008-3#9)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#13)(2008-9#9)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#3)(2009-8#2)(2010-11#2)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#5)(2013-8#6)
examine their##5##2##(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2013-1#1)
examine these##3##2##(1993-12#1)(2008-6#1)(2012-2#1)
examine this##3##2##(1993-1#1)(2008-11#1)(2009-10#1)
examine whether a##3##3##(1997-6#1)(2008-10#1)(2010-5#1)
examine whether the##6##3##(1993-12#1)(2008-11#1)(2008-5#1)(2008-6#2)(2011-1#1)
examine whether##22##2##(1993-12#1)(1993-8#1)(1994-8#1)(1995-9#1)(1997-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
examine##364##1##(1990-5#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1992-12#2)(1992-2#6)(1992-6#3)(1992-8#1)(1993-1#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#37)(2008-11#47)(2008-12#15)(2008-2#2)(2008-3#11)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#13)(2008-8#21)(2008-9#17)(2009-10#6)(2009-12#3)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#13)(2012-3#5)(2012-5#1)(2013-1#11)(2013-8#8)
examined 34##2##2##(1991-6#1)(2013-1#1)
examined a##3##2##(1990-8#1)(2008-10#1)(2010-11#1)
examined after##6##2##(1993-8#2)(1994-5#1)(1997-3#1)(1997-5#1)(2008-10#1)
examined again##2##2##(1990-2#1)(1991-11#1)
examined among##4##2##(1992-2#1)(2008-10#1)(2009-5#1)(2012-2#1)
examined and compared##3##3##(2008-10#2)(2011-2#1)
examined and it##2##3##(1990-3#1)(2008-10#1)
examined and optimized##3##3##(2008-10#2)(2008-8#1)
examined and the##9##3##(1991-3#1)(1992-6#1)(2008-10#5)(2008-8#1)(2008-9#1)
examined and##37##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-6#1)(1994-1#1)(1994-11#1)(1995-8#1)(1996-6#1)(2008-10#20)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#3)(2013-1#1)
examined are##2##2##(2011-2#2)
examined as a##11##3##(1990-12#1)(1991-3#1)(1994-5#1)(2008-10#5)(2009-8#1)(2010-1#1)(2012-2#1)
examined as an##3##3##(2008-10#3)
examined as well##2##3##(2008-10#1)(2008-5#1)
examined as##22##2##(1990-12#1)(1991-3#1)(1994-5#1)(2008-10#14)(2008-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
examined associations between##2##3##(2011-2#1)(2013-1#1)
examined at different##3##3##(2008-8#1)(2011-2#1)(2012-2#1)
examined at the##5##3##(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2011-2#1)
examined at##15##2##(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#2)
examined both##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
examined by a##2##3##(1991-2#1)(2008-2#1)
examined by comparing the##2##4##(2008-10#1)(2008-8#1)
examined by comparing##3##3##(2008-10#1)(2008-8#2)
examined by differential pulse##2##4##(2008-10#2)
examined by direct##2##3##(2008-3#1)(2012-3#1)
examined by electron microscopy##3##4##(2008-10#1)(2008-7#2)
examined by electron##4##3##(2008-10#1)(2008-7#3)
examined by light##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
examined by means of##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
examined by scanning electron microscopy##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
examined by the##5##3##(1993-11#1)(2008-10#2)(2008-5#2)
examined by transmission electron microscopy##2##5##(2008-10#1)(2008-5#1)
examined by using##6##3##(2008-10#3)(2008-7#1)(2008-8#1)(2009-12#1)
examined by##82##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-10#29)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
examined cases##2##2##(1997-8#1)(2009-4#1)
examined competition##2##2##(2008-8#1)(2008-9#1)
examined during##3##2##(2008-10#1)(2008-5#1)(2012-8#1)
examined for a##2##3##(2008-11#1)(2013-1#1)
examined for all##2##3##(1991-1#1)(2008-10#1)
examined for its##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
examined for the presence of##4##5##(2008-10#4)
examined for the##18##3##(1992-3#1)(1997-8#1)(2008-10#13)(2008-3#2)(2009-12#1)
examined for their ability to##5##5##(2008-10#3)(2008-11#1)(2009-4#1)
examined for their##10##3##(1993-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2009-4#1)
examined for##71##2##(1991-1#1)(1991-12#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-11#2)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#35)(2008-11#5)(2008-12#3)(2008-3#4)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
examined from the##3##3##(1992-3#1)(2010-1#1)(2013-1#1)
examined from##5##2##(1992-3#1)(1993-3#1)(2009-6#1)(2010-1#1)(2013-1#1)
examined genetically##2##2##(2008-10#1)(2008-8#1)
examined here##2##2##(1995-5#1)(2008-10#1)
examined how the##2##3##(2008-12#1)(2008-8#1)
examined how##9##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-8#1)
examined in a greenhouse##2##4##(2008-10#2)
examined in a sample of##3##5##(2008-11#1)(2008-9#1)(2011-2#1)
examined in a##13##3##(1991-8#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#2)(2013-1#1)
examined in cultured##2##3##(1990-8#1)(2008-11#1)
examined in detail##5##3##(2008-10#4)(2008-11#1)
examined in field##2##3##(2008-10#2)
examined in greater##2##3##(1992-5#1)(2013-1#1)
examined in membranes from##2##4##(1993-1#1)(1993-6#1)
examined in one##2##3##(1992-3#1)(2012-3#1)
examined in order to##4##4##(1996-12#1)(2008-10#3)
examined in our##2##3##(1997-4#1)(2008-10#1)
examined in relation to the##4##5##(1990-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
examined in relation to##6##4##(1990-3#2)(1994-8#1)(2008-10#1)(2008-5#1)(2009-8#1)
examined in terms of##2##4##(1991-3#1)(2008-11#1)
examined in the context of##2##5##(2008-11#2)
examined in the presence of##2##5##(2008-10#1)(2008-11#1)
examined in the##22##3##(1990-5#1)(1993-1#1)(1993-3#2)(1995-5#1)(1996-3#1)(1997-8#1)(2008-10#5)(2008-11#4)(2008-6#1)(2008-7#2)(2010-8#1)(2012-3#1)(2013-1#1)
examined in this study##7##4##(1991-4#1)(1992-9#1)(2008-10#5)
examined in this##10##3##(1991-3#1)(1991-4#1)(1992-9#1)(1995-12#1)(2008-10#5)(2008-5#1)
examined in vitro and##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
examined in vitro##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
examined in##125##2##(1990-12#1)(1990-3#3)(1990-5#1)(1990-8#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#3)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#3)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-5#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#35)(2008-11#10)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-6#1)(2010-8#3)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)
examined intrinsic##2##2##(1991-2#1)(1992-6#1)
examined on##11##2##(1991-7#1)(1993-12#1)(1995-12#1)(1995-3#1)(1997-5#1)(2007-8#1)(2008-10#3)(2010-7#1)(2010-8#1)
examined over a##3##3##(1991-3#1)(1991-9#1)(2008-8#1)
examined over##4##2##(1991-3#1)(1991-9#1)(1996-3#1)(2008-8#1)
examined protein##3##2##(1992-8#1)(2008-10#1)(2008-11#1)
examined samples##2##2##(2008-10#2)
examined that##2##2##(2011-2#1)(2012-3#1)
examined the ability of##3##4##(1995-8#1)(2008-10#2)
examined the association between##2##4##(2011-2#1)(2012-12#1)
examined the effect of##20##4##(1991-2#2)(1992-8#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#6)(2010-4#1)(2010-9#1)(2011-2#2)(2013-1#1)
examined the effects of##29##4##(1990-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-12#3)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)
examined the effects##30##3##(1990-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-12#3)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2013-1#1)
examined the efficacy of##2##4##(2009-1#1)(2012-3#1)
examined the functional##2##3##(1995-8#1)(2008-7#1)
examined the genetic##2##3##(2008-10#1)(2011-2#1)
examined the influence of##3##4##(1990-2#1)(1994-3#1)(1994-8#1)
examined the interaction of##2##4##(1995-6#1)(2008-11#1)
examined the relationship between the##2##5##(2008-11#1)(2011-2#1)
examined the relationship between##10##4##(1995-2#1)(2008-10#2)(2008-11#1)(2009-11#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
examined the relationships between##2##4##(2010-1#1)(2012-3#1)
examined the relationships##3##3##(2008-11#1)(2010-1#1)(2012-3#1)
examined the response of##2##4##(2008-10#1)(2013-1#1)
examined the role of the##2##5##(1993-6#1)(1997-7#1)
examined the role of##8##4##(1991-12#1)(1993-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)
examined the temporal##2##3##(2008-11#1)(2013-8#1)
examined the##169##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#6)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#20)(2008-11#28)(2008-12#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#4)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#4)
examined their##2##2##(1995-6#1)(2008-11#1)
examined these##3##2##(1994-9#1)(2008-3#1)(2009-5#1)
examined this##3##2##(1990-5#1)(2009-6#1)(2012-2#1)
examined tissues##3##2##(2008-8#1)(2009-8#2)
examined to determine if##2##4##(1994-2#1)(2009-7#1)
examined to determine the##2##4##(1993-3#1)(2008-10#1)
examined to determine##9##3##(1992-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(2008-10#4)(2009-7#1)
examined to evaluate the##2##4##(2008-11#1)(2013-1#1)
examined to##23##2##(1992-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-6#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#2)(2010-8#2)(2013-1#2)
examined two##3##2##(2008-5#1)(2009-9#1)(2011-2#1)
examined using a##7##3##(1992-6#1)(1994-5#1)(1997-2#1)(2008-10#4)
examined using an##3##3##(1992-3#1)(1994-11#1)(2008-11#1)
examined using data##2##3##(2008-10#2)
examined using the##4##3##(1992-6#1)(2008-10#1)(2008-7#1)(2010-12#1)
examined using##43##2##(1990-7#1)(1990-9#1)(1992-3#2)(1992-4#1)(1992-6#3)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
examined was##2##2##(2008-10#2)
examined were##10##2##(1991-1#1)(1991-10#1)(1995-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)
examined whether the##3##3##(1996-5#1)(2008-11#1)(2008-6#1)
examined whether##24##2##(1996-12#1)(1996-5#1)(1997-3#1)(2008-11#3)(2008-12#2)(2008-6#2)(2008-8#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
examined with a##3##3##(1996-2#1)(2008-10#2)
examined with the##4##3##(1997-3#1)(2008-10#2)(2009-10#1)
examined with##17##2##(1991-10#1)(1993-1#1)(1996-2#1)(1997-3#1)(2008-10#8)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2012-2#1)
examined##1175##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#5)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#6)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#10)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#9)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#3)(1992-9#1)(1993-1#6)(1993-11#2)(1993-12#8)(1993-2#7)(1993-3#12)(1993-6#4)(1993-8#11)(1993-9#1)(1994-1#2)(1994-11#7)(1994-12#2)(1994-2#10)(1994-3#3)(1994-5#12)(1994-8#6)(1994-9#1)(1995-1#3)(1995-11#7)(1995-12#10)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#8)(1996-1#1)(1996-11#1)(1996-12#13)(1996-2#6)(1996-3#2)(1996-5#2)(1996-6#5)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#10)(2007-12#9)(2007-8#1)(2008-1#3)(2008-10#359)(2008-11#90)(2008-12#24)(2008-2#3)(2008-3#20)(2008-4#2)(2008-5#40)(2008-6#6)(2008-7#33)(2008-8#22)(2008-9#16)(2009-1#2)(2009-10#5)(2009-11#5)(2009-12#3)(2009-3#4)(2009-4#3)(2009-5#6)(2009-6#4)(2009-7#6)(2009-8#11)(2009-9#2)(2010-1#9)(2010-10#7)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#3)(2010-7#7)(2010-8#7)(2010-9#4)(2011-1#4)(2011-2#45)(2011-3#1)(2012-12#1)(2012-2#21)(2012-3#18)(2012-7#1)(2012-8#1)(2013-1#31)(2013-7#1)(2013-8#14)
examinee##2##1##(2008-12#1)(2011-2#1)
examiner##5##1##(1993-12#2)(2008-1#1)(2008-12#1)(2011-2#1)
examiners##4##1##(2008-10#1)(2008-12#2)(2013-1#1)
examines Medicare##2##2##(1994-3#1)(1995-12#1)
examines a##3##2##(1992-2#1)(2008-10#1)(2012-2#1)
examines and##2##2##(2008-11#1)(2012-3#1)
examines both##2##2##(2010-8#1)(2013-1#1)
examines how##7##2##(1994-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-1#1)(2011-2#1)
examines some of the##2##4##(1992-12#1)(2008-5#1)
examines the effects of##2##4##(2008-10#1)(2010-11#1)
examines the impact of##4##4##(1994-12#1)(1994-2#1)(1995-12#1)(2008-11#1)
examines the influence##3##3##(1995-2#2)(2012-3#1)
examines the relationship between##5##4##(1995-12#1)(1997-3#1)(2008-6#1)(2009-5#1)(2013-1#1)
examines the relationship##6##3##(1995-12#1)(1997-3#1)(2008-11#1)(2008-6#1)(2009-5#1)(2013-1#1)
examines the role of##2##4##(1992-12#1)(2008-11#1)
examines the##70##2##(1991-1#1)(1991-2#1)(1992-1#2)(1992-12#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#3)(1996-1#1)(1996-2#2)(1996-3#2)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#9)(2008-12#2)(2008-5#2)(2008-6#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#3)
examines whether##6##2##(1993-3#1)(1994-12#1)(2008-11#2)(2010-2#1)(2010-7#1)
examines##135##1##(1991-1#1)(1991-2#1)(1992-1#3)(1992-12#4)(1992-2#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#3)(1994-1#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#1)(1995-1#3)(1995-12#4)(1995-2#3)(1995-3#3)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#5)(1997-3#1)(2007-12#1)(2008-1#4)(2008-10#8)(2008-11#16)(2008-12#4)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2010-1#1)(2010-11#2)(2010-2#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#1)
examining how##2##2##(2008-11#1)(2008-9#1)
examining its##2##2##(1996-3#1)(2013-8#1)
examining the##31##2##(1991-2#1)(1994-11#1)(1995-11#1)(1995-2#2)(1996-9#1)(1997-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
examining their##2##2##(2008-10#1)(2008-7#1)
examining whether##3##2##(1993-3#1)(1995-12#1)(2009-7#1)
examining##97##1##(1990-11#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#5)(2010-1#1)(2010-10#5)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
example and##2##2##(2008-12#1)(2009-4#1)
example data##2##2##(2008-4#1)(2009-11#1)
example for the##2##3##(2008-10#1)(2013-8#1)
example for##3##2##(2008-10#1)(2013-8#2)
example from the##2##3##(1995-9#1)(2013-8#1)
example from##4##2##(1995-9#1)(1996-6#1)(2013-8#2)
example in##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)
example is given to##2##4##(1997-3#1)(2012-2#1)
example is given##4##3##(1997-3#1)(2008-11#1)(2008-3#1)(2012-2#1)
example is##12##2##(1995-9#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
example of a##16##3##(1991-2#1)(1992-8#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-3#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
example of process##2##3##(2008-12#1)(2013-8#1)
example of the##12##3##(1993-3#1)(1993-9#1)(1997-1#1)(2008-10#5)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#1)
example of this is##2##4##(2008-3#1)(2009-8#1)
example of this##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
example of##78##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-9#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-9#1)(2008-10#21)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-6#2)(2009-8#2)(2010-12#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#1)
example that##4##2##(1995-12#1)(2010-11#1)(2013-1#2)
example to illustrate##2##3##(2008-10#1)(2008-9#1)
example to##8##2##(1994-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#1)
example##318##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-9#3)(1996-11#1)(1996-3#3)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#71)(2008-11#29)(2008-12#9)(2008-2#1)(2008-3#11)(2008-4#11)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#17)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#10)(2012-3#8)(2013-1#4)(2013-8#10)
examples are given of##2##4##(2008-11#1)(2008-4#1)
examples are given to##2##4##(1995-5#1)(2009-12#1)
examples are given##5##3##(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)
examples are presented##2##3##(2007-12#1)(2008-10#1)
examples are##15##2##(1990-2#1)(1992-11#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2012-2#2)
examples for##2##2##(2008-1#1)(2009-10#1)
examples from the literature##2##4##(2008-10#1)(2010-10#1)
examples from the##7##3##(1992-1#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-7#1)
examples from##15##2##(1992-1#1)(1992-9#1)(1993-12#2)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)
examples in the##2##3##(1993-3#1)(2008-10#1)
examples in##4##2##(1993-3#1)(2008-10#2)(2011-2#1)
examples include##4##2##(1994-12#1)(2009-6#1)(2010-12#1)(2010-7#1)
examples of a##3##3##(1992-12#1)(1997-3#1)(2009-8#1)
examples of analytical##2##3##(2008-10#1)(2008-11#1)
examples of convergent evolution##2##4##(2011-2#2)
examples of how##2##3##(1994-3#1)(1997-3#1)
examples of some of the##2##5##(1997-2#1)(2011-2#1)
examples of such##3##3##(2012-2#1)(2013-1#1)(2013-8#1)
examples of the application of##2##5##(2008-10#1)(2008-9#1)
examples of the##8##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)
examples of these##2##3##(1997-3#1)(2008-11#1)
examples of this##2##3##(1996-5#1)(2008-11#1)
examples of##67##2##(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(2008-10#14)(2008-11#4)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
examples to##2##2##(2008-11#1)(2010-4#1)
examples were##2##2##(2008-10#2)
examples where the##2##3##(2008-10#1)(2012-2#1)
examples will be##2##3##(2008-10#1)(2013-8#1)
examples##162##1##(1990-2#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#3)(1993-12#3)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#33)(2008-11#12)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#2)(2009-11#5)(2009-12#4)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#4)(2011-2#7)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#7)
exams##6##1##(1991-3#2)(1995-1#1)(2008-7#1)(2012-2#2)
excavation##3##1##(1990-5#1)(2008-10#1)(2008-5#1)
excavations##2##1##(2008-10#1)(2008-5#1)
exceed a critical##2##3##(2008-8#1)(2008-9#1)
exceed a##6##2##(2008-10#3)(2008-8#2)(2008-9#1)
exceed the##9##2##(1994-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-8#1)
exceed those##4##2##(1990-11#1)(1994-12#1)(1996-12#1)(2008-9#1)
exceed three##2##2##(1997-5#1)(2008-9#1)
exceed##44##1##(1990-11#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
exceeded 0##3##2##(2008-10#2)(2008-9#1)
exceeded 20##2##2##(1990-5#1)(2008-10#1)
exceeded 90%##2##2##(1997-2#1)(2008-10#1)
exceeded that of##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
exceeded the##5##2##(1996-12#1)(1997-6#1)(2008-10#1)(2013-1#2)
exceeded##47##1##(1990-5#1)(1993-2#1)(1994-11#1)(1994-12#2)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
exceeding 1##2##2##(2008-10#1)(2008-9#1)
exceeding 2##2##2##(2008-10#1)(2008-3#1)
exceeding 20##3##2##(2008-10#3)
exceeding 50%##2##2##(2008-11#1)(2010-4#1)
exceeding a##2##2##(2008-10#1)(2008-7#1)
exceeding increases##2##2##(1991-12#1)(1991-2#1)
exceeding##26##1##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#10)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2013-8#1)
exceedingly rare##8##2##(2008-11#1)(2009-1#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
exceedingly##9##1##(2008-11#2)(2009-1#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
exceeds a threshold##2##3##(2008-10#1)(2008-8#1)
exceeds that of##3##3##(1991-11#1)(1997-3#1)(2008-10#1)
exceeds that##4##2##(1991-11#1)(1997-3#1)(2008-10#1)(2008-8#1)
exceeds the number of##3##4##(1993-9#1)(1995-12#1)(2008-9#1)
exceeds the##10##2##(1993-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
exceeds##28##1##(1991-11#1)(1993-9#1)(1995-12#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2011-2#2)(2011-3#1)(2013-1#1)
excellence in##4##2##(1992-3#1)(1996-8#1)(2012-12#1)(2012-2#1)
excellence##14##1##(1992-1#1)(1992-3#2)(1993-1#1)(1994-1#2)(1996-8#1)(2008-11#2)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
excellent affinity##2##2##(2008-10#2)
excellent agreement between##2##3##(2008-3#1)(2008-7#1)
excellent agreement with the##7##4##(1990-8#1)(1995-2#1)(2008-10#5)
excellent agreement with those##2##4##(2008-10#1)(2008-3#1)
excellent agreement with##12##3##(1990-8#1)(1995-2#1)(2007-11#1)(2008-10#7)(2008-3#2)
excellent agreement##21##2##(1990-8#1)(1995-2#1)(2007-11#1)(2008-10#10)(2008-3#7)(2008-7#1)
excellent agreements##2##2##(2008-10#2)
excellent analytical##2##2##(2008-10#2)
excellent and##4##2##(1993-12#1)(2006-6#1)(2008-10#1)(2008-5#1)
excellent catalytic activity##6##3##(2008-10#6)
excellent catalytic##7##2##(2008-10#7)
excellent correlation between the##3##4##(1992-2#1)(2008-10#2)
excellent correlation between##5##3##(1992-2#1)(2008-10#3)(2008-5#1)
excellent correlation to the##2##4##(1990-12#2)
excellent correlation##10##2##(1990-12#2)(1992-2#1)(2008-10#6)(2008-5#1)
excellent correspondence with##2##3##(2008-10#2)
excellent cosmetic and functional results##2##5##(1991-9#1)(2008-9#1)
excellent cosmetic##3##2##(1991-9#1)(2008-10#1)(2008-9#1)
excellent derivative yields##2##3##(2008-10#2)
excellent discriminating ability##2##3##(2008-10#2)
excellent electrocatalytic activity##4##3##(2008-10#4)
excellent electrocatalytic##6##2##(2008-10#6)
excellent enrichment factor##2##3##(2008-10#2)
excellent enrichment##3##2##(2008-10#3)
excellent fit##2##2##(2008-11#1)(2013-1#1)
excellent for##3##2##(1995-2#1)(2008-10#2)
excellent functional##2##2##(2008-12#1)(2013-1#1)
excellent in##5##2##(1992-2#1)(1996-9#2)(2008-10#1)(2011-2#1)
excellent linear dynamic relationship in the range of##2##8##(2008-10#2)
excellent linear##3##2##(2008-10#3)
excellent long-term##3##2##(2008-10#1)(2009-12#1)(2012-3#1)
excellent opportunities to##2##3##(2012-2#2)
excellent or good##2##3##(1991-8#1)(1997-6#1)
excellent outcome##2##2##(2008-10#1)(2013-1#1)
excellent outcomes##3##2##(1994-12#1)(2008-11#1)(2008-9#1)
excellent performance##5##2##(2008-10#5)
excellent precision##3##2##(1990-2#1)(2008-10#2)
excellent prognosis##2##2##(1997-1#1)(2008-10#1)
excellent properties##2##2##(2008-10#2)
excellent recoveries and##2##3##(2008-10#2)
excellent recovery##2##2##(2008-7#1)(2012-3#1)
excellent repeatability##2##2##(2008-10#2)
excellent reproducibility##4##2##(2008-10#4)
excellent response##2##2##(2008-10#2)
excellent results were obtained##2##4##(2008-10#2)
excellent results##9##2##(1991-2#1)(1996-3#1)(2008-10#5)(2008-8#1)(2011-3#1)
excellent safety##2##2##(2008-10#1)(2011-2#1)
excellent selectivity for##6##3##(2008-10#6)
excellent selectivity##7##2##(2008-10#7)
excellent sensitivity and specificity##2##4##(2011-2#2)
excellent sensitivity##8##2##(2008-10#3)(2008-9#1)(2011-2#3)(2012-2#1)
excellent skin compatibility##2##3##(2008-5#2)
excellent skin##3##2##(2008-5#3)
excellent stability for##3##3##(2008-10#2)(2008-11#1)
excellent stability##5##2##(2008-10#4)(2008-11#1)
excellent throughput##2##2##(2008-10#2)
excellent visualization##3##2##(1993-12#1)(1994-3#1)(2011-7#1)
excellent with##4##2##(1996-11#1)(1996-9#1)(2008-10#2)
excellent yields##2##2##(2008-5#1)(2010-8#1)
excellent##317##1##(1990-12#3)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#4)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-8#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#151)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#10)(2008-7#7)(2008-8#1)(2008-9#13)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#2)(2011-7#1)(2012-2#9)(2012-3#6)(2013-1#9)
excellently##2##1##(1992-5#1)(2008-7#1)
except 2##2##2##(1991-8#1)(2012-2#1)
except CE-UV##2##2##(2008-10#2)
except at the highest##2##4##(1993-6#1)(2008-10#1)
except at the##3##3##(1993-6#1)(2008-10#2)
except at##5##2##(1993-6#1)(2008-10#4)
except exon##2##2##(1994-12#1)(1997-8#1)
except for Ca(II) and Ba(II)##3##5##(2008-10#3)
except for Fe and##2##4##(2008-10#2)
except for a##5##3##(1993-1#1)(1993-12#1)(2008-10#1)(2008-8#1)(2011-1#1)
except for isolates##2##3##(2008-10#2)
except for one##5##3##(1991-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
except for the##22##3##(1990-5#1)(1991-6#1)(1993-12#1)(1994-12#1)(1994-5#1)(1996-5#1)(2008-10#7)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#2)
except for two##4##3##(1991-1#1)(2008-10#2)(2008-11#1)
except for##90##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#1)(1993-1#1)(1993-12#2)(1994-12#1)(1994-5#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#2)(2007-12#1)(2008-10#43)(2008-11#6)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
except in cases of life endangerment##2##6##(1996-5#2)
except in one##2##3##(2008-10#2)
except in the case of##4##5##(2008-10#3)(2008-11#1)
except in the##7##3##(1995-1#1)(1995-11#1)(1997-4#1)(2008-10#3)(2008-11#1)
except in##21##2##(1991-12#1)(1992-3#1)(1995-1#1)(1995-11#1)(1996-5#2)(1997-4#1)(2008-10#9)(2008-11#2)(2010-6#1)(2011-2#1)(2012-3#1)
except one##10##2##(1995-2#1)(1997-8#2)(2008-1#1)(2008-10#3)(2008-5#2)(2013-1#1)
except that one##2##3##(1992-2#1)(2008-9#1)
except that the##5##3##(1995-8#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
except that##18##2##(1990-11#1)(1992-2#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
except the##12##2##(1993-8#1)(1996-12#1)(1996-3#1)(2008-10#6)(2008-12#1)(2010-6#1)(2011-2#1)
except those from Jk(a-b-)##2##4##(1995-6#2)
except those##6##2##(1995-11#1)(1995-6#2)(2008-10#2)(2008-3#1)
except two##2##2##(2008-10#1)(2008-7#1)
except when the##3##3##(1992-3#1)(2008-8#1)(2009-8#1)
except when##7##2##(1992-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-8#1)
except##240##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#2)(1994-8#3)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#4)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#4)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#100)(2008-11#16)(2008-12#5)(2008-3#4)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#2)
excepted##2##1##(2008-5#1)(2010-7#1)
excepting##3##1##(2008-10#2)(2008-5#1)
exception of##69##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#2)(1993-8#2)(1994-3#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#25)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
exception to the##3##3##(1993-1#1)(1995-12#1)(2008-10#1)
exception to##5##2##(1993-1#1)(1995-12#1)(2008-10#2)(2012-3#1)
exception was the##2##3##(1995-6#1)(2013-1#1)
exception was##5##2##(1995-6#1)(2008-10#3)(2013-1#1)
exception##98##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-8#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#39)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
exceptional##20##1##(1995-2#2)(1995-6#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-1#4)
exceptionally##17##1##(1991-3#1)(1995-11#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2013-8#1)
exceptions the##2##2##(2008-10#1)(2008-8#1)
exceptions were##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
exceptions##24##1##(1990-11#1)(1990-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-12#2)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
excerpts##2##1##(1994-1#1)(2008-9#1)
excess I(-) to##2##3##(2008-10#2)
excess adiposity##2##2##(2012-2#2)
excess and##3##2##(1991-12#2)(2008-7#1)
excess cancer mortality##2##3##(1991-12#2)
excess cancer##4##2##(1991-12#3)(1991-3#1)
excess demand##6##2##(1995-2#5)(2008-11#1)
excess for##3##2##(1991-6#2)(2008-10#1)
excess mortality##2##2##(1993-1#1)(1993-12#1)
excess of ascorbic acid##2##4##(2008-10#2)
excess of cationic##2##3##(1995-2#2)
excess of hydrocarbons##2##3##(2008-10#2)
excess of mastocytes##2##3##(1991-11#2)
excess of sodium##3##3##(2008-10#3)
excess of the##6##3##(1993-1#1)(1994-11#1)(2008-10#3)(2012-2#1)
excess of unlabeled##2##3##(1991-12#2)
excess of##84##2##(1990-11#1)(1990-12#1)(1991-11#2)(1991-12#4)(1991-6#2)(1992-6#2)(1993-1#1)(1993-8#1)(1994-11#1)(1994-5#3)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#47)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2012-2#1)
excess over##3##2##(1991-5#2)(2008-10#1)
excess reagent##3##2##(2008-10#3)
excess risk##4##2##(1991-12#1)(1996-2#1)(1996-3#1)(2011-2#1)
excess thymidine##2##2##(2008-11#2)
excess was##3##2##(2008-10#2)(2013-1#1)
excess##202##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#12)(1991-3#1)(1991-5#2)(1991-6#4)(1991-9#1)(1992-2#1)(1992-6#4)(1993-1#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#3)(1995-11#1)(1995-12#1)(1995-2#7)(1995-8#3)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#90)(2008-11#11)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#2)(2009-3#2)(2009-7#1)(2009-8#1)(2011-2#3)(2012-2#6)(2013-1#4)
excesses of##2##2##(2008-10#2)
excessive amounts of##2##3##(2008-10#2)
excessive grooming##2##2##(1994-8#2)
excessive irrigation##2##2##(2008-10#2)
excessive neuronal processing##2##3##(2008-11#2)
excessive production of##2##3##(1992-5#1)(2008-11#1)
excessive production##3##2##(1992-5#1)(2008-11#1)(2013-1#1)
excessive use of##2##3##(2008-10#1)(2011-1#1)
excessive weight##2##2##(2008-10#1)(2013-1#1)
excessive##66##1##(1991-11#2)(1992-11#1)(1992-3#2)(1992-5#1)(1993-6#1)(1994-8#2)(1995-1#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-4#1)(2008-5#5)(2008-7#5)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-4#1)(2013-1#4)
excessively##6##1##(2008-10#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-8#1)
exchange and gel##2##3##(2008-10#2)
exchange and##19##2##(1991-5#1)(1992-8#1)(1993-9#1)(1997-4#1)(2008-10#11)(2008-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
exchange approach##2##2##(2008-11#1)(2008-12#1)
exchange as well as##2##4##(1997-3#1)(2008-10#1)
exchange as##4##2##(1995-12#1)(1996-1#1)(1997-3#1)(2008-10#1)
exchange between##4##2##(1990-9#1)(1994-1#1)(2008-10#2)
exchange capacities##2##2##(2008-10#2)
exchange capacity (CEC)##2##3##(2008-10#2)
exchange capacity of the##2##4##(2008-10#2)
exchange capacity##6##2##(2008-10#6)
exchange chromatographic##3##2##(2008-10#3)
exchange chromatography and##2##3##(1994-6#1)(1994-8#1)
exchange chromatography##14##2##(1990-2#1)(1994-6#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-3#2)(2009-9#1)(2011-2#1)
exchange column for##2##3##(2008-10#2)
exchange column was##2##3##(2008-10#1)(2008-11#1)
exchange column##17##2##(1992-12#1)(2008-10#14)(2008-11#2)
exchange columns##6##2##(1991-5#1)(2008-10#5)
exchange efficiency##3##2##(2011-2#3)
exchange experiments##2##2##(1991-5#1)(1994-5#1)
exchange factor##3##2##(1995-2#1)(2013-8#2)
exchange for##5##2##(1993-12#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-12#1)
exchange ideas with##2##3##(1995-3#1)(2008-10#1)
exchange in the##3##3##(1997-1#1)(2008-7#1)(2010-5#1)
exchange in##10##2##(1990-8#1)(1992-4#1)(1997-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-5#1)
exchange is##5##2##(1995-8#1)(1996-2#1)(1997-1#2)(2007-12#1)
exchange kinetics##4##2##(1992-4#1)(1995-6#1)(2008-10#2)
exchange membrane##4##2##(2008-10#4)
exchange membranes##4##2##(2008-10#3)(2013-1#1)
exchange model##2##2##(2008-10#2)
exchange of DNA##2##3##(2008-10#2)
exchange of genetic##2##3##(2008-10#2)
exchange of information##5##3##(1991-2#3)(1996-12#1)(2011-2#1)
exchange of the##2##3##(1991-9#1)(2008-11#1)
exchange of##37##2##(1991-2#3)(1991-9#2)(1992-4#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-7#2)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#2)
exchange on##3##2##(1995-2#1)(1996-2#1)(1997-2#1)
exchange or##2##2##(1994-3#1)(2008-10#1)
exchange primarily in the##2##4##(1997-1#2)
exchange rate##5##2##(2008-10#2)(2008-7#2)(2012-2#1)
exchange reaction of##2##3##(2008-10#2)
exchange reaction##5##2##(2008-10#5)
exchange resin Amberlite##2##3##(2008-10#2)
exchange resin Dowex##2##3##(2008-10#2)
exchange resin##21##2##(2008-10#21)
exchange resins##7##2##(2008-10#7)
exchange systems##4##2##(2008-10#2)(2008-7#2)
exchange techniques##2##2##(2008-10#2)
exchange the##3##2##(1997-1#1)(2008-10#2)
exchange to##2##2##(2008-10#2)
exchange was##4##2##(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
exchange with the##3##3##(1990-2#1)(1995-6#1)(2008-10#1)
exchange with##8##2##(1990-2#1)(1995-6#1)(2008-10#3)(2011-2#3)
exchange##355##1##(1990-2#3)(1990-6#2)(1990-8#1)(1990-9#4)(1991-1#1)(1991-2#3)(1991-5#5)(1991-6#1)(1991-9#3)(1992-10#3)(1992-12#2)(1992-2#2)(1992-4#5)(1992-8#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#7)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#12)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#3)(2008-10#172)(2008-11#16)(2008-12#5)(2008-4#1)(2008-7#11)(2008-8#4)(2008-9#3)(2009-3#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#6)(2010-5#2)(2010-8#5)(2011-2#16)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#6)
exchange)##4##1##(2008-10#2)(2008-9#1)(2011-2#1)
exchangeable##5##1##(1992-4#1)(2008-10#3)(2010-8#1)
exchanged with##2##2##(2008-10#1)(2008-11#1)
exchanged##8##1##(1994-5#1)(2008-10#4)(2008-11#1)(2009-5#1)(2013-1#1)
exchanger Dowex##2##2##(2008-10#2)
exchanger and##4##2##(1993-3#2)(2008-10#2)
exchanger by##2##2##(2008-10#2)
exchanger in high performance liquid chromatography##2##6##(2008-10#2)
exchanger in##5##2##(2008-10#5)
exchanger was used##2##3##(2008-10#2)
exchanger##59##1##(1990-5#1)(1992-1#1)(1993-3#4)(2008-10#52)(2013-7#1)
exchangers has been##2##3##(2008-10#2)
exchangers##13##1##(1990-5#1)(1992-2#2)(1997-2#1)(2008-10#7)(2008-11#2)
exchanges and##2##2##(1992-2#1)(1993-12#1)
exchanges in##3##2##(1992-4#1)(2008-11#2)
exchanges##22##1##(1992-2#1)(1992-4#1)(1992-6#1)(1993-12#2)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
exchanging with##2##2##(1994-2#1)(2008-10#1)
exchanging##9##1##(1994-11#1)(1994-2#1)(1997-2#1)(2008-10#4)(2010-10#1)(2010-8#1)
excimer laser##3##2##(1991-3#1)(2008-3#2)
excimer lasers##2##2##(2008-3#2)
excimer##5##1##(1991-3#1)(2008-3#4)
excipient##13##1##(2008-10#3)(2008-5#4)(2011-2#1)(2012-2#5)
excipients and##5##2##(1992-11#1)(2008-10#4)
excipients are being used in early phases of clinical trials to support novel therapeutic entities##2##15##(2012-2#2)
excipients are##6##2##(2012-2#6)
excipients rendering the method suitable for##2##6##(2008-10#2)
excipients used as additives in pharmaceuticals do not interfere##2##9##(2008-10#2)
excipients used as additives##3##4##(2008-10#3)
excipients used##5##2##(2008-10#3)(2012-2#2)
excipients##40##1##(1992-11#1)(2008-10#25)(2008-5#1)(2011-2#1)(2012-2#12)
excise##4##1##(1994-3#1)(1994-8#1)(2008-1#1)(2008-10#1)
excised and##6##2##(1992-1#1)(2008-10#1)(2009-1#1)(2011-2#2)(2012-12#1)
excised antenna##2##2##(2008-10#2)
excised broccoli head##2##3##(2008-10#2)
excised from the##2##3##(1995-11#1)(2008-10#1)
excised from##5##2##(1993-12#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-8#1)
excised human SC##2##3##(2008-5#2)
excised human epidermis##3##3##(2008-5#3)
excised human##5##2##(2008-5#5)
excised leaf tissues##5##3##(2008-10#5)
excised leaf##8##2##(2008-10#8)
excised leaves##4##2##(2008-10#4)
excised roots##3##2##(2008-10#2)(2008-12#1)
excised##67##1##(1991-2#1)(1991-5#2)(1992-1#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-11#1)(1996-3#1)(1997-8#2)(2008-10#27)(2008-12#3)(2008-4#2)(2008-5#7)(2008-8#1)(2008-9#2)(2009-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#5)
excising##2##1##(1991-6#1)(1994-3#1)
excision and##8##2##(1996-1#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
excision followed by##2##3##(1990-2#1)(2008-7#1)
excision in##5##2##(1990-3#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
excision is##3##2##(2008-9#1)(2009-4#1)(2010-3#1)
excision of a##2##3##(1994-12#1)(2013-1#1)
excision of an##2##3##(2008-10#1)(2013-1#1)
excision of benign##2##3##(1991-2#1)(2011-2#1)
excision of the tumor##2##4##(1992-9#1)(2013-8#1)
excision of the##23##3##(1990-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-2#2)(2008-10#2)(2008-12#1)(2009-1#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#1)
excision of##42##2##(1990-3#1)(1990-6#1)(1991-2#2)(1992-2#2)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#4)(2008-10#6)(2008-12#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#6)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#1)
excision repair and##2##3##(1994-9#1)(2008-11#1)
excision repair##11##2##(1993-3#1)(1994-9#2)(1995-9#2)(2008-11#6)
excision was##4##2##(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
excision##101##1##(1990-2#1)(1990-3#2)(1990-6#1)(1991-2#2)(1992-2#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-9#2)(1995-5#1)(1995-9#2)(1996-1#1)(1997-7#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-2#11)(2012-12#3)(2012-3#9)(2013-1#10)(2013-8#1)
excisional biopsy of the##2##4##(2010-11#1)(2011-2#1)
excisional biopsy revealed##2##3##(2010-11#1)(2013-1#1)
excisional biopsy##7##2##(2010-11#2)(2011-2#2)(2013-1#3)
excisional cone##2##2##(1991-1#1)(1992-2#1)
excisional conization##3##2##(1991-1#3)
excisional##15##1##(1991-1#5)(1992-2#2)(1994-12#1)(2010-11#2)(2011-2#2)(2013-1#3)
excisions##5##1##(1994-6#1)(2008-7#3)(2008-9#1)
excitability and##3##2##(2008-7#1)(2010-7#1)(2012-2#1)
excitability of##2##2##(2010-7#2)
excitability##15##1##(1991-2#1)(1994-12#1)(2008-5#1)(2008-7#2)(2010-7#3)(2011-2#2)(2012-2#2)(2013-8#3)
excitation and emission maxima at##3##5##(2008-10#3)
excitation and emission maxima##4##4##(2008-10#4)
excitation and emission wavelength##2##4##(2008-10#2)
excitation and emission wavelengths are##3##5##(2008-10#3)
excitation and emission wavelengths were##3##5##(2008-10#3)
excitation and emission wavelengths##13##4##(2008-10#13)
excitation and emission##29##3##(2008-10#28)(2008-9#1)
excitation and reference##2##3##(2008-10#2)
excitation and##35##2##(2008-10#31)(2008-3#2)(2008-9#1)(2011-2#1)
excitation at##11##2##(1995-3#1)(2008-10#8)(2008-3#2)
excitation by##2##2##(1992-3#1)(2008-3#1)
excitation emission##5##2##(2008-10#5)
excitation laser light##3##3##(2008-10#1)(2008-3#2)
excitation light##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
excitation of##10##2##(1992-8#1)(1994-2#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-3#1)
excitation on##2##2##(1991-5#1)(2008-3#1)
excitation scheme##2##2##(2008-3#2)
excitation signal##3##2##(2008-10#3)
excitation source and a##2##4##(2008-10#2)
excitation source##8##2##(2008-10#7)(2008-7#1)
excitation spectra of##2##3##(2008-10#2)
excitation spectra##4##2##(2008-10#3)(2008-3#1)
excitation temperature##2##2##(2008-10#2)
excitation using an##2##3##(2008-10#2)
excitation was##2##2##(1994-2#1)(2008-10#1)
excitation wavelength and##2##3##(2008-10#1)(2008-3#1)
excitation wavelength of##8##3##(1997-2#1)(2008-10#7)
excitation wavelength##17##2##(1994-5#1)(1997-2#1)(2008-10#12)(2008-3#1)(2008-9#1)(2010-1#1)
excitation wavelengths##3##2##(2008-10#3)
excitation with##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
excitation##159##1##(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-2#2)(1994-5#2)(1995-3#1)(1996-2#1)(1997-2#1)(2007-12#3)(2008-10#99)(2008-11#3)(2008-2#2)(2008-3#24)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#3)
excitation-emission matrix##3##2##(2008-10#3)
excitation-emission##8##1##(2008-10#8)
excitations in##2##2##(1992-11#1)(1993-5#1)
excitations##5##1##(1992-11#1)(1993-5#2)(1994-8#1)(1996-5#1)
excitatory amino acid##4##3##(1990-7#1)(1994-11#1)(2008-7#2)
excitatory and inhibitory recurrent connections##2##5##(2008-11#2)
excitatory and inhibitory##5##3##(1996-12#1)(2008-11#3)(2009-8#1)
excitatory input##2##2##(1996-12#1)(1997-3#1)
excitatory neurons##2##2##(1997-3#1)(2008-11#1)
excitatory neurotransmission##2##2##(1995-6#1)(1997-4#1)
excitatory or inhibitory##2##3##(1996-2#1)(1997-3#1)
excitatory synapses##4##2##(1996-2#1)(1997-2#1)(2008-11#1)(2012-2#1)
excitatory synaptic transmission##2##3##(1995-6#1)(1996-2#1)
excitatory synaptic##3##2##(1995-6#1)(1996-2#1)(2009-9#1)
excitatory transmission##2##2##(1997-4#2)
excitatory##42##1##(1990-7#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-6#2)(1996-12#2)(1996-2#3)(1996-5#2)(1997-2#4)(1997-3#4)(1997-4#5)(2008-11#9)(2008-7#3)(2009-8#1)(2009-9#1)(2012-2#1)(2013-8#1)
excite##4##1##(1991-3#1)(2008-3#1)(2008-9#1)(2009-8#1)
excited at##4##2##(2008-10#4)
excited by a##2##3##(2008-10#1)(2013-8#1)
excited by the##4##3##(1992-12#1)(2008-3#2)(2008-9#1)
excited by##8##2##(1992-12#1)(1997-3#2)(2008-10#1)(2008-3#2)(2008-9#1)(2013-8#1)
excited delirium##3##2##(2010-1#3)
excited singlet state##3##3##(1995-6#1)(2008-10#2)
excited singlet##4##2##(1995-6#1)(2008-10#3)
excited state##7##2##(1995-11#1)(2008-10#3)(2008-3#1)(2009-12#1)(2010-7#1)
excited states of##3##3##(2008-10#2)(2010-7#1)
excited states##5##2##(2008-10#3)(2008-2#1)(2010-7#1)
excited wave##2##2##(2008-3#1)(2009-8#1)
excited with##4##2##(2008-10#3)(2008-3#1)
excited##56##1##(1992-12#1)(1992-5#1)(1995-11#1)(1995-6#1)(1997-3#2)(2008-10#24)(2008-2#2)(2008-3#10)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#5)(2010-7#2)(2012-12#1)(2012-3#1)(2013-8#1)
excited-state absorption cross##2##3##(2008-3#2)
excited-state absorption##8##2##(2008-10#2)(2008-3#6)
excited-state##10##1##(1991-5#1)(2008-10#2)(2008-3#7)
excitement##5##1##(1990-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
exciting at 277nm##2##3##(2008-10#2)
exciting field of##2##3##(2008-7#1)(2011-1#1)
exciting field##3##2##(1992-9#1)(2008-7#1)(2011-1#1)
exciting new##3##2##(1995-3#1)(2008-4#1)(2008-9#1)
exciting##33##1##(1992-12#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
exciton chirality##2##2##(2008-10#2)
exciton splitting on the##2##4##(1994-5#2)
exciton splitting##4##2##(1994-5#4)
exciton##8##1##(1994-5#6)(2008-10#2)
excitotoxic lesions of the##2##4##(1993-6#2)
excitotoxic process##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
excitotoxic##6##1##(1993-6#2)(1995-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
excitotoxicity##4##1##(1995-12#3)(2008-7#1)
exclude a##6##2##(1991-11#1)(1991-12#2)(2008-1#1)(2008-12#1)(2008-8#1)
exclude the##5##2##(1991-12#1)(2008-1#1)(2008-10#2)(2011-2#1)
exclude##30##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#2)(1991-12#3)(1994-5#1)(1995-12#1)(1997-3#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#3)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#2)
excluded and##5##2##(1991-11#1)(1994-12#1)(1997-8#1)(2008-12#1)(2013-1#1)
excluded as##2##2##(1997-4#1)(2009-3#1)
excluded by##4##2##(1990-9#1)(1991-6#1)(1995-2#1)(1996-3#1)
excluded from the##13##3##(1991-1#1)(1993-12#1)(1995-2#1)(1996-11#1)(2008-10#3)(2008-2#1)(2010-1#1)(2011-2#3)(2013-1#1)
excluded from##17##2##(1991-1#1)(1992-12#1)(1993-12#1)(1995-2#1)(1996-11#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2011-2#3)(2013-1#1)
excluded in##3##2##(1993-9#1)(2008-1#1)(2011-1#1)
excluded the##2##2##(1996-3#1)(2008-10#1)
excluded##67##1##(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-2#2)(1996-11#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#3)(2011-8#1)(2012-12#5)(2013-1#7)(2013-8#2)
excluder##6##1##(2008-10#6)
excludes##3##1##(1991-2#1)(2009-11#1)(2013-1#1)
excluding a poly(A) tail##2##4##(2008-10#2)
excluding the 3'-poly (A) tail##2##5##(2008-9#2)
excluding the possibility##2##3##(1995-5#1)(2009-10#1)
excluding the##6##2##(1993-8#1)(1995-5#1)(2008-1#1)(2008-9#2)(2009-10#1)
excluding##19##1##(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-9#2)(2009-10#1)(2011-1#1)(2012-12#1)
exclusion and##2##2##(1997-1#1)(2011-2#1)
exclusion criteria were##2##3##(2012-2#1)(2013-1#1)
exclusion criteria##5##2##(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
exclusion of the##3##3##(1992-9#1)(2008-8#2)
exclusion of women##2##3##(1991-3#1)(2009-10#1)
exclusion of##33##2##(1990-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-9#1)(1994-2#1)(1995-11#1)(1997-3#1)(2008-10#9)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)
exclusion or##2##2##(2008-10#1)(2012-2#1)
exclusion##78##1##(1990-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-6#1)(1992-9#1)(1994-2#1)(1995-11#1)(1995-9#1)(1997-1#1)(1997-3#1)(2008-10#23)(2008-11#6)(2008-7#1)(2008-8#8)(2008-9#8)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#2)
exclusionary##2##1##(1991-1#1)(1997-2#1)
exclusive and##3##2##(2010-12#1)(2010-6#1)(2011-2#1)
exclusive breastfeeding##2##2##(2010-6#1)(2012-2#1)
exclusive home ranges##4##3##(2008-8#2)(2008-9#2)
exclusive of##2##2##(1992-3#1)(1994-11#1)
exclusive regioselective fragmentation of##2##4##(1996-5#2)
exclusive##39##1##(1990-2#1)(1991-1#1)(1991-3#2)(1992-12#1)(1992-3#1)(1994-11#1)(1995-9#1)(1996-5#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
exclusively 5 min after##2##4##(2008-12#2)
exclusively at##2##2##(1993-8#1)(1995-2#1)
exclusively by##3##2##(1994-5#1)(2008-10#2)
exclusively derived from##2##3##(2008-10#1)(2008-4#1)
exclusively for##2##2##(2008-10#1)(2008-12#1)
exclusively from##2##2##(2008-10#1)(2008-12#1)
exclusively gave the##2##3##(1996-5#2)
exclusively in the##5##3##(1990-5#1)(2008-10#3)(2012-3#1)
exclusively in##13##2##(1990-5#2)(2008-10#6)(2008-7#1)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)
exclusively of##2##2##(1995-12#1)(2008-10#1)
exclusively on the##3##3##(1997-6#1)(2008-11#1)(2008-5#1)
exclusively on##11##2##(1993-3#1)(1997-6#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
exclusively targeted##2##2##(2012-2#2)
exclusively to the##3##3##(1991-12#1)(2008-5#1)(2012-2#1)
exclusively to##6##2##(1991-12#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
exclusively with##4##2##(1997-4#1)(2008-10#1)(2008-9#2)
exclusively##91##1##(1990-5#3)(1991-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#8)(2012-3#2)(2013-8#2)
excreted by##3##2##(2008-10#3)
excreted in the urine##2##4##(2012-2#1)(2013-8#1)
excreted in the##3##3##(2008-5#1)(2012-2#1)(2013-8#1)
excreted in urine##2##3##(1994-12#1)(2008-10#1)
excreted in##8##2##(1994-12#1)(1997-2#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-8#1)
excreted##26##1##(1991-11#1)(1991-12#1)(1993-6#1)(1994-12#1)(1995-9#1)(1996-12#1)(1997-2#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-8#1)
excreting##3##1##(1991-11#1)(1995-9#1)(2008-11#1)
excretion (p less than 0##2##5##(1990-2#2)
excretion and##3##2##(1993-12#1)(1995-11#1)(2008-10#1)
excretion in##5##2##(1994-8#1)(2008-10#1)(2013-1#2)(2013-8#1)
excretion is##2##2##(2013-1#1)(2013-8#1)
excretion of arsenic##5##3##(1995-11#5)
excretion of gold##2##3##(1994-5#2)
excretion of the##2##3##(1994-5#1)(2008-10#1)
excretion of two##2##3##(1991-12#2)
excretion of##32##2##(1990-5#1)(1991-12#5)(1991-3#1)(1993-12#1)(1994-5#6)(1995-11#9)(1997-8#1)(2008-10#3)(2008-11#2)(2012-2#3)
excretion or##2##2##(1994-5#1)(2008-6#1)
excretion rates of##2##3##(1991-12#1)(1997-8#1)
excretion was##2##2##(1992-9#1)(1996-6#1)
excretion with##2##2##(1992-3#1)(2008-7#1)
excretion##85##1##(1990-2#2)(1990-5#2)(1991-11#1)(1991-12#8)(1991-3#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#5)(1994-5#9)(1994-8#1)(1995-11#11)(1996-6#6)(1997-8#4)(2008-10#7)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#1)(2011-2#3)(2011-3#3)(2012-2#4)(2013-1#5)(2013-8#2)
excretory duct in the silk gland of the sugarcane borer Diatraea saccharalis##2##12##(2007-12#2)
excretory duct##4##2##(2007-12#4)
excretory pore##2##2##(2008-10#2)
excretory##7##1##(2007-12#4)(2008-10#2)(2011-2#1)
excurrents##3##1##(2008-9#3)
excursion##7##1##(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#3)(2012-2#1)
excursions##2##1##(2012-3#1)(2012-5#1)
executed by a##2##3##(1993-12#1)(2009-10#1)
executed##9##1##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
executing a##2##2##(2009-1#1)(2009-11#1)
executing##4##1##(2008-7#1)(2009-1#1)(2009-11#1)(2013-1#1)
execution and withholding of##2##4##(2013-8#2)
execution of a##2##3##(1992-3#1)(2013-8#1)
execution of##12##2##(1992-3#1)(2008-10#1)(2008-11#3)(2009-8#2)(2013-1#2)(2013-8#3)
execution##22##1##(1991-3#2)(1991-6#2)(1992-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-8#3)(2011-2#1)(2013-1#3)(2013-8#5)
executive compensation##3##2##(2008-11#3)
executive directors##3##2##(1994-12#1)(1995-3#1)(1997-3#1)
executive function tasks##3##3##(2013-8#3)
executive function##10##2##(2009-10#5)(2012-2#1)(2013-8#4)
executive functions##3##2##(2008-2#1)(2009-10#2)
executive information systems##2##3##(1993-2#2)
executive information##3##2##(1993-2#3)
executive leadership##2##2##(1996-1#1)(1996-3#1)
executive management in##2##3##(1996-1#1)(2008-11#1)
executive##44##1##(1992-8#1)(1993-12#1)(1993-2#3)(1994-12#1)(1995-12#1)(1995-3#2)(1996-1#2)(1996-2#4)(1996-3#1)(1996-5#1)(1997-3#1)(2008-11#5)(2008-2#1)(2008-8#1)(2009-10#9)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#7)
executives and##2##2##(1994-12#2)
executives are##3##2##(1996-2#1)(1996-3#1)(2008-11#1)
executives who##2##2##(1991-12#1)(1996-2#1)
executives##25##1##(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-3#1)(1995-12#1)(1996-2#6)(1996-3#3)(2008-11#3)
exemplar##4##1##(2008-10#1)(2008-11#2)(2008-8#1)
exemplars##2##1##(2010-11#1)(2012-2#1)
exemplary##3##1##(2008-11#1)(2008-12#1)(2011-2#1)
exemplified by the##7##3##(2008-10#4)(2008-5#1)(2008-8#1)(2013-8#1)
exemplified by##16##2##(1990-5#1)(1993-2#1)(1997-1#1)(2008-10#4)(2008-5#1)(2008-8#2)(2011-2#3)(2012-2#2)(2013-8#1)
exemplified with petrochemical##2##3##(2008-10#2)
exemplified##20##1##(1990-5#1)(1993-2#1)(1997-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#3)(2011-2#3)(2012-2#2)(2013-8#1)
exemplifies the##2##2##(2008-11#1)(2011-1#1)
exemplifies##4##1##(2008-11#1)(2009-10#1)(2011-1#1)(2012-3#1)
exemplify how##2##2##(1991-1#1)(2008-9#1)
exemplify the##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
exemplify##7##1##(1991-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#1)
exemplifying results of##2##3##(2008-3#2)
exemplifying##3##1##(2008-3#2)(2008-8#1)
exempt##2##1##(2008-10#1)(2009-10#1)
exemption and##3##2##(1991-2#1)(2008-11#2)
exemption by##2##2##(1995-2#1)(1996-2#1)
exemption for##2##2##(1996-1#2)
exemption is##2##2##(1996-2#1)(2008-11#1)
exemption##17##1##(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-5#1)(1995-2#1)(1996-1#2)(1996-2#4)(2008-11#5)
exemptions##4##1##(1996-1#3)(1996-2#1)
exendin 9-39##2##2##(1996-2#2)
exendin receptors##4##2##(1994-8#4)
exendin##7##1##(1994-8#4)(1996-2#2)(2011-2#1)
exendin-4##7##1##(1994-8#6)(2011-2#1)
exercise (SSE)##2##2##(2013-1#1)(2013-8#1)
exercise and##22##2##(1990-3#1)(1992-12#1)(1996-11#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-8#5)
exercise are##2##2##(2012-2#1)(2013-1#1)
exercise as a##2##3##(2013-1#1)(2013-8#1)
exercise as##3##2##(2010-1#1)(2013-1#1)(2013-8#1)
exercise bout##3##2##(2013-1#1)(2013-8#2)
exercise capacity##6##2##(2009-10#1)(2010-10#5)
exercise for##7##2##(2008-10#1)(2008-11#1)(2010-4#1)(2012-2#2)(2013-1#2)
exercise in##11##2##(1992-12#1)(2008-12#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#5)
exercise induced##3##2##(1996-6#1)(2011-2#1)(2012-3#1)
exercise intensity##3##2##(2010-1#1)(2011-2#1)(2013-8#1)
exercise intervention##2##2##(2010-4#1)(2013-1#1)
exercise is##4##2##(2008-11#1)(2008-7#1)(2013-8#2)
exercise of##5##2##(1991-12#1)(2008-11#2)(2008-12#1)(2012-3#1)
exercise on a##2##3##(2008-12#1)(2013-1#1)
exercise on physical fitness##2##4##(2010-4#2)
exercise on the##3##3##(2008-7#1)(2010-4#1)(2013-8#1)
exercise on##13##2##(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2010-4#3)(2012-2#1)(2013-1#1)(2013-8#1)
exercise or##2##2##(2013-8#2)
exercise program##4##2##(2008-11#1)(2013-1#3)
exercise programs for OA##3##4##(2013-1#3)
exercise programs for##5##3##(2013-1#5)
exercise programs##9##2##(2012-2#1)(2013-1#8)
exercise protocol##2##2##(2013-8#2)
exercise stress##6##2##(1993-1#1)(2008-10#3)(2008-7#2)
exercise test##5##2##(1990-3#1)(1996-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
exercise testing and##2##3##(1996-3#1)(1996-6#1)
exercise testing##5##2##(1993-2#1)(1996-3#1)(1996-6#1)(2008-12#1)(2008-7#1)
exercise that##2##2##(2008-11#1)(2009-4#1)
exercise therapy##3##2##(2008-11#1)(2008-12#1)(2010-9#1)
exercise to##5##2##(1991-2#1)(1995-11#1)(1996-3#1)(2008-12#2)
exercise tolerance and##2##3##(2008-1#1)(2013-8#1)
exercise tolerance in##2##3##(2013-8#2)
exercise tolerance##5##2##(2008-1#1)(2010-4#1)(2013-8#3)
exercise training##6##2##(2009-10#1)(2013-1#5)
exercise under##3##2##(2010-12#1)(2013-8#2)
exercise was##7##2##(1992-12#1)(2008-10#3)(2008-12#2)(2010-4#1)
exercise with##3##2##(2009-1#2)(2010-4#1)
exercise##292##1##(1990-3#2)(1991-12#5)(1991-2#2)(1991-6#1)(1991-8#2)(1992-12#9)(1993-1#1)(1993-2#3)(1993-6#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-11#3)(1996-3#2)(1996-6#4)(2008-1#5)(2008-10#18)(2008-11#20)(2008-12#21)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#1)(2009-1#4)(2009-10#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#6)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#8)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#7)(2011-3#1)(2012-2#11)(2012-3#5)(2013-1#56)(2013-8#51)
exercise)##2##1##(2013-8#2)
exercise-induced anaphylaxis##6##2##(2010-1#3)(2010-6#3)
exercise-induced bronchoconstriction##2##2##(2010-1#2)
exercise-induced##21##1##(1992-9#1)(1996-6#1)(1997-1#1)(2008-5#2)(2010-1#6)(2010-6#4)(2011-2#1)(2013-1#2)(2013-8#3)
exercise-intensity domains##2##2##(2009-1#2)
exercised##9##1##(1993-6#1)(2008-10#4)(2008-11#1)(2009-3#1)(2013-8#2)
exercises and##3##2##(2010-6#2)(2012-2#1)
exercises at##2##2##(2010-9#1)(2013-8#1)
exercises in##2##2##(2008-12#1)(2010-9#1)
exercises on##3##2##(2008-10#1)(2009-1#1)(2012-3#1)
exercises were##2##2##(2008-10#1)(2010-9#1)
exercises##37##1##(1992-12#1)(1994-3#1)(1994-6#2)(1995-8#1)(1997-7#1)(2008-10#3)(2008-12#4)(2008-6#1)(2009-1#3)(2010-1#1)(2010-6#4)(2010-9#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
exercising##3##1##(2008-10#1)(2010-7#1)(2011-2#1)
exeresis##6##1##(1990-3#3)(1991-11#1)(1994-6#2)
exergonic##2##1##(2010-7#2)
exert a##11##2##(1990-12#1)(1992-6#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)
exert its##5##2##(1990-12#1)(1994-11#1)(2011-1#1)(2012-2#2)
exert similar##2##2##(1995-11#1)(2008-10#1)
exert strong##2##2##(2008-11#2)
exert the##2##2##(2008-10#1)(2008-9#1)
exert their##6##2##(1993-3#1)(1993-8#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)
exert##49##1##(1990-12#2)(1990-8#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#2)(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
exerted a##8##2##(1993-12#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-4#1)
exerted by the##3##3##(1997-2#1)(2008-10#1)(2009-8#1)
exerted by##8##2##(1993-8#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-5#1)(2009-8#1)
exerted direct##2##2##(1992-6#1)(1995-11#1)
exerted no##3##2##(1992-6#1)(2008-11#1)(2008-7#1)
exerted on the##2##3##(2008-10#2)
exerted on##4##2##(2008-10#3)(2008-3#1)
exerted the##2##2##(2008-10#1)(2008-5#1)
exerted##37##1##(1990-12#1)(1992-6#2)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-4#1)
exerting##8##1##(1994-5#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
exertion##11##1##(2008-12#1)(2010-10#2)(2013-1#1)(2013-7#1)(2013-8#6)
exertional##2##1##(1992-2#1)(2012-12#1)
exerts a strong##3##3##(1994-3#2)(2009-8#1)
exerts a##6##2##(1994-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)
exerts an##5##2##(1990-3#1)(1992-5#1)(1997-1#1)(2008-3#1)(2012-3#1)
exerts differential##2##2##(1993-3#1)(1996-2#1)
exerts its effect##2##3##(1993-3#1)(2011-3#1)
exerts its effects##2##3##(2008-8#1)(2009-6#1)
exerts its##10##2##(1992-6#1)(1993-3#1)(1995-12#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-3#1)(2013-1#1)
exerts potent##2##2##(1993-1#1)(2009-8#1)
exerts##31##1##(1990-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-3#2)(1994-3#2)(1995-12#1)(1996-2#2)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
exfoliated##5##1##(1991-2#1)(1992-9#1)(2008-10#2)(2010-4#1)
exfoliation##2##1##(2011-2#2)
exgA##5##1##(2008-10#5)
exhalation##3##1##(1993-3#1)(1996-1#1)(1996-2#1)
exhaled air##3##2##(2008-10#2)(2011-2#1)
exhaled breath condensate##2##3##(2010-5#2)
exhaled breath##3##2##(2008-10#1)(2010-5#2)
exhaled nitric oxide##2##3##(2010-5#2)
exhaled##13##1##(1995-3#1)(1996-6#3)(1997-1#1)(2008-10#3)(2010-5#4)(2011-2#1)
exhaust and##2##2##(2008-10#1)(2008-3#1)
exhaust gas##2##2##(2008-10#2)
exhaust##15##1##(2008-10#6)(2008-11#2)(2008-3#7)
exhausted by##2##2##(2008-2#1)(2010-8#1)
exhausted##10##1##(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-9#1)(2010-8#1)(2011-2#1)(2011-3#1)
exhaustion of##2##2##(2008-10#1)(2010-11#1)
exhaustion was##2##2##(2008-11#1)(2013-8#1)
exhaustion##25##1##(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#8)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#3)(2013-8#7)
exhaustive exercise##2##2##(2011-2#1)(2013-1#1)
exhaustive##15##1##(1991-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-1#1)(2010-10#1)(2011-2#1)(2013-1#3)
exhibit a good##2##3##(2008-10#2)
exhibit a high##3##3##(1990-6#1)(2008-10#1)(2008-3#1)
exhibit a maximum##2##3##(2008-10#2)
exhibit a##41##2##(1990-6#1)(1991-12#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#21)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
exhibit an##10##2##(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-5#1)(2009-12#1)(2013-8#2)
exhibit any##5##2##(1996-3#1)(1997-3#1)(1997-6#1)(2008-12#1)(2011-2#1)
exhibit differences in##2##3##(2008-10#1)(2011-2#1)
exhibit different##5##2##(1995-2#1)(2008-10#2)(2008-7#1)(2012-2#1)
exhibit elevated##2##2##(2008-11#1)(2011-2#1)
exhibit enhanced##2##2##(1991-3#1)(1995-2#1)
exhibit fast##2##2##(2008-10#2)
exhibit good##3##2##(2008-10#2)(2009-5#1)
exhibit high##3##2##(2008-10#2)(2008-12#1)
exhibit increased##3##2##(1992-6#1)(1992-8#1)(2008-11#1)
exhibit independent##2##2##(1993-8#1)(2008-8#1)
exhibit large##2##2##(2008-11#1)(2010-10#1)
exhibit larger##2##2##(2008-9#1)(2013-8#1)
exhibit low##2##2##(2008-9#1)(2012-5#1)
exhibit lower##2##2##(1993-9#1)(2008-9#1)
exhibit many##2##2##(2008-11#1)(2013-8#1)
exhibit moderate##2##2##(1996-12#1)(2008-10#1)
exhibit negligible##2##2##(1996-12#1)(2008-10#1)
exhibit no##2##2##(1996-2#1)(2008-5#1)
exhibit potent##3##2##(1991-5#1)(2008-5#2)
exhibit reduced##2##2##(2008-9#2)
exhibit several##2##2##(2009-3#1)(2013-1#1)
exhibit significant##7##2##(1996-8#1)(1997-2#1)(1997-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2012-2#1)
exhibit significantly##2##2##(1995-5#1)(2008-10#1)
exhibit similar##2##2##(1996-12#1)(2008-8#1)
exhibit strong##3##2##(2008-10#3)
exhibit the same##2##3##(1993-8#1)(2008-5#1)
exhibit the##13##2##(1991-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)
exhibit two##2##2##(2008-3#1)(2009-11#1)
exhibit unique##2##2##(2008-10#1)(2009-11#1)
exhibit various##2##2##(2008-10#1)(2011-1#1)
exhibit##229##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#67)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#6)(2008-7#7)(2008-8#11)(2008-9#12)(2009-10#2)(2009-11#3)(2009-12#5)(2009-3#2)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#6)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#3)(2013-8#7)
exhibited 93%##2##2##(1990-8#1)(1995-8#1)
exhibited a Nernstian response for##2##5##(2008-10#2)
exhibited a clear##2##3##(2008-8#1)(2009-6#1)
exhibited a distinct##2##3##(2008-10#2)
exhibited a good##3##3##(2008-10#3)
exhibited a greater##2##3##(2008-10#1)(2011-2#1)
exhibited a high##7##3##(1990-5#1)(1992-12#1)(1994-11#1)(2008-10#3)(2010-11#1)
exhibited a linear response##3##4##(2008-10#3)
exhibited a linear##4##3##(2008-10#4)
exhibited a period of maximum susceptibility from midbloom until##2##9##(2008-10#2)
exhibited a remarkable##2##3##(2012-2#1)(2013-1#1)
exhibited a significant##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2010-5#1)
exhibited a single##3##3##(1994-5#1)(1995-11#1)(2008-10#1)
exhibited a very##2##3##(1994-12#1)(2008-10#1)
exhibited a##79##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(2008-10#34)(2008-11#9)(2008-6#1)(2008-8#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)
exhibited aggregated cytoplasm and##2##4##(2008-10#2)
exhibited an excellent##3##3##(2008-10#3)
exhibited an increase in##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
exhibited an##13##2##(1997-7#1)(2008-10#9)(2008-11#1)(2010-7#1)(2010-8#1)
exhibited better##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
exhibited both##2##2##(1990-5#1)(1997-2#1)
exhibited by a##3##3##(1993-12#1)(1996-2#1)(2008-3#1)
exhibited by the##6##3##(1993-1#1)(1993-8#1)(1995-3#1)(2008-10#2)(2009-8#1)
exhibited by these##3##3##(1996-2#1)(2008-10#1)(2011-3#1)
exhibited by##23##2##(1993-1#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-2#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
exhibited characteristic##2##2##(2008-10#1)(2011-2#1)
exhibited complete##2##2##(1997-7#1)(2008-10#1)
exhibited components of partial resistance in greenhouse tests##2##8##(2008-10#2)
exhibited considerable##2##2##(2008-10#2)
exhibited different levels of##2##4##(2008-10#2)
exhibited different##5##2##(2008-10#4)(2010-11#1)
exhibited elevated##2##2##(2008-10#1)(2012-3#1)
exhibited enhanced##4##2##(2008-10#2)(2009-6#1)(2013-1#1)
exhibited equivalent##2##2##(1993-6#2)
exhibited excellent##7##2##(2008-10#5)(2008-3#1)(2011-2#1)
exhibited extensive chlorosis to##2##4##(2008-10#2)
exhibited extensive##3##2##(2008-10#3)
exhibited fast##2##2##(2008-10#2)
exhibited good##11##2##(2008-10#10)(2010-4#1)
exhibited greater##5##2##(2008-10#1)(2011-2#2)(2012-3#2)
exhibited high selectivity##4##3##(2008-10#3)(2013-1#1)
exhibited high sensitivity##2##3##(2008-10#2)
exhibited high##15##2##(2008-10#12)(2008-6#1)(2011-2#1)(2013-1#1)
exhibited higher##4##2##(2008-10#1)(2013-1#2)(2013-8#1)
exhibited in##5##2##(1991-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
exhibited increased##2##2##(1994-5#1)(2008-12#1)
exhibited little##3##2##(1991-1#1)(2008-10#2)
exhibited low##4##2##(1996-12#1)(2008-10#2)(2009-3#1)
exhibited maximum##2##2##(2009-6#1)(2012-2#1)
exhibited more than##3##3##(2008-5#2)(2011-2#1)
exhibited more##8##2##(1997-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#1)
exhibited nearly##3##2##(1995-11#1)(2008-10#1)(2009-5#1)
exhibited no##10##2##(1995-6#1)(2008-10#6)(2008-11#2)(2011-2#1)
exhibited one well-defined##2##3##(2008-10#2)
exhibited one##3##2##(2008-10#3)
exhibited only##2##2##(1997-6#1)(2011-1#1)
exhibited reduced##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
exhibited resistance to##2##3##(2008-10#1)(2008-11#1)
exhibited resistance##4##2##(2008-10#2)(2008-11#2)
exhibited severe##2##2##(2008-10#2)
exhibited significant##13##2##(1994-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#2)(2013-8#1)
exhibited similar##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
exhibited slightly##3##2##(1994-8#1)(2008-10#2)
exhibited strong##7##2##(1992-12#1)(2008-10#5)(2008-11#1)
exhibited stronger##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
exhibited substantial##2##2##(1992-9#1)(2008-12#1)
exhibited the best##4##3##(2008-10#3)(2008-5#1)
exhibited the highest##4##3##(2008-10#4)
exhibited the same##2##3##(2008-10#2)
exhibited the strongest##2##3##(2008-10#1)(2009-7#1)
exhibited the##20##2##(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#13)(2008-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
exhibited very##3##2##(2008-10#3)
exhibited when##2##2##(2008-10#1)(2008-7#1)
exhibited wide##3##2##(2008-10#2)(2008-7#1)
exhibited##447##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#2)(1990-8#2)(1991-1#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-6#3)(1993-8#4)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#5)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#4)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#1)(2007-12#1)(2008-10#215)(2008-11#28)(2008-12#6)(2008-3#4)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#10)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#15)(2011-3#1)(2012-2#11)(2012-3#6)(2013-1#14)(2013-8#5)
exhibiting a##7##2##(1993-12#1)(2008-10#3)(2008-8#1)(2009-3#1)(2013-1#1)
exhibiting an##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
exhibiting high##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
exhibiting higher##2##2##(2008-10#1)(2011-2#1)
exhibiting low##2##2##(1996-12#1)(2008-10#1)
exhibiting the highest##2##3##(2010-8#1)(2013-8#1)
exhibiting the##6##2##(2008-10#4)(2010-8#1)(2013-8#1)
exhibiting varying##2##2##(2008-10#2)
exhibiting##59##1##(1993-12#1)(1993-3#1)(1994-5#1)(1995-8#1)(1996-12#2)(1996-6#1)(2007-11#1)(2008-10#25)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
exhibits a Nernstian response for##5##5##(2008-10#5)
exhibits a Nernstian response##6##4##(2008-10#6)
exhibits a Nernstian##9##3##(2008-10#9)
exhibits a fast response time##2##5##(2008-10#2)
exhibits a fast##3##3##(2008-10#3)
exhibits a good##2##3##(2008-10#2)
exhibits a high##3##3##(2008-10#2)(2008-11#1)
exhibits a higher##2##3##(2008-10#1)(2008-5#1)
exhibits a linear response over##2##5##(2008-10#2)
exhibits a linear response##5##4##(2008-10#5)
exhibits a linear##7##3##(2008-10#7)
exhibits a strong##2##3##(2008-10#2)
exhibits a very good##2##4##(2008-10#2)
exhibits a##55##2##(1991-3#1)(1991-6#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(2008-10#40)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
exhibits an excellent##2##3##(2008-10#2)
exhibits an##8##2##(1990-8#1)(1995-8#1)(2008-10#6)
exhibits excellent##4##2##(2008-10#3)(2012-2#1)
exhibits good##6##2##(2008-10#6)
exhibits high selectivity for##2##4##(2008-10#2)
exhibits high selectivity##3##3##(2008-10#3)
exhibits high virulence on##2##4##(2008-10#2)
exhibits high##11##2##(1990-5#1)(1995-11#1)(2008-10#7)(2008-11#1)(2009-8#1)
exhibits low##3##2##(2008-10#3)
exhibits no##3##2##(2008-10#3)
exhibits strong##3##2##(2008-10#3)
exhibits the##12##2##(1990-8#1)(1991-3#1)(1994-8#2)(1995-6#1)(2008-10#6)(2008-8#1)
exhibits very##2##2##(2008-10#2)
exhibits##175##1##(1990-5#2)(1990-8#2)(1991-3#3)(1991-6#1)(1992-12#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-5#3)(1994-8#3)(1995-11#2)(1995-2#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-9#1)(2007-12#2)(2008-10#100)(2008-11#5)(2008-12#2)(2008-3#6)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
exine##4##1##(2011-2#4)
exist among##2##2##(1996-1#1)(2008-10#1)
exist and##7##2##(1993-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
exist as##5##2##(2008-10#3)(2008-9#1)(2011-3#1)
exist at##2##2##(1991-9#1)(1995-8#1)
exist between the##4##3##(1994-5#1)(2008-11#1)(2008-9#1)(2009-5#1)
exist between##12##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
exist but##2##2##(1997-3#1)(2008-10#1)
exist even when##2##3##(1994-5#1)(2008-10#1)
exist for##9##2##(1994-12#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)(2011-2#1)
exist in a##4##3##(1994-2#1)(1995-3#1)(2008-7#2)
exist in all##2##3##(1995-11#1)(1996-3#1)
exist in some##2##3##(2008-10#1)(2008-9#1)
exist in the##19##3##(1994-5#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-9#5)(2009-7#1)(2012-3#1)
exist in##47##2##(1992-2#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#7)(2009-6#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
exist on##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2009-8#1)
exist regarding##2##2##(2009-5#1)(2012-3#1)
exist to support##2##3##(1995-2#1)(2008-7#1)
exist to##9##2##(1995-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
exist##166##1##(1990-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#3)(1996-1#1)(1996-12#3)(1996-3#2)(1997-3#3)(1997-7#1)(2007-12#1)(2008-10#29)(2008-11#13)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#15)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#6)(2010-1#1)(2010-10#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#5)(2013-1#8)(2013-8#2)
exist?##2##1##(1994-8#1)(2008-8#1)
exist?]##3##1##(1992-2#1)(1994-3#1)(1997-5#1)
existed among##8##2##(1992-3#1)(2008-10#4)(2010-11#1)(2012-2#2)
existed between the##5##3##(1992-3#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
existed between##9##2##(1992-2#1)(1992-3#1)(1993-2#1)(2008-10#2)(2008-12#2)(2012-3#1)(2013-1#1)
existed in South America##2##4##(2008-10#2)
existed in the genome of##2##5##(2008-9#2)
existed in the##9##3##(1990-5#1)(1992-1#1)(1993-8#1)(2008-10#2)(2008-9#2)(2011-2#1)(2013-1#1)
existed in##25##2##(1990-5#1)(1992-1#1)(1993-8#1)(1994-11#1)(1995-8#1)(2008-10#10)(2008-11#1)(2008-8#3)(2008-9#2)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
existed##55##1##(1990-5#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-8#1)(1997-8#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-8#3)(2008-9#3)(2009-3#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
existence and uniqueness of##2##4##(2009-10#1)(2013-8#1)
existence and##12##2##(1990-5#1)(1991-12#1)(1997-8#1)(2007-12#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
existence of a##30##3##(1990-5#1)(1990-8#2)(1992-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#3)(1995-8#1)(1997-9#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-10#1)(2013-1#1)
existence of bidirectional##2##3##(2008-2#1)(2008-5#1)
existence of distinct##3##3##(1990-8#1)(1995-8#1)(2008-10#1)
existence of rate isomorphy##2##4##(2008-8#2)
existence of subsets##2##3##(1997-8#1)(2008-9#1)
existence of the##10##3##(1991-3#1)(1994-11#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-5#1)
existence of two##4##3##(2008-10#2)(2008-11#2)
existence of##162##2##(1990-12#1)(1990-5#2)(1990-8#3)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#4)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#4)(1997-8#1)(1997-9#1)(2007-12#3)(2008-10#37)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#9)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#4)
existence##187##1##(1990-12#1)(1990-5#3)(1990-8#3)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#4)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#2)(1997-9#1)(2007-12#4)(2007-8#1)(2008-10#38)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#9)(2008-8#12)(2008-9#5)(2009-1#1)(2009-10#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#7)
existential##5##1##(1991-2#1)(1993-6#1)(1994-6#1)(2012-3#2)
existing analytical##2##2##(2008-10#1)(2008-2#1)
existing and future##2##3##(2008-10#1)(2012-2#1)
existing and##3##2##(2008-10#2)(2012-2#1)
existing as##3##2##(1993-8#1)(2008-10#2)
existing between the##2##3##(2008-10#2)
existing between##5##2##(1994-8#1)(2008-10#3)(2008-11#1)
existing chemical##4##2##(2008-10#3)(2011-1#1)
existing clinical##3##2##(2010-10#1)(2010-8#1)(2011-8#1)
existing data##6##2##(1994-1#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-1#1)
existing evidence##3##2##(2008-7#1)(2013-1#2)
existing governance and information technology efforts were leveraged to minimize additional bioprocess resources required##2##14##(2012-2#2)
existing in a##2##3##(1993-8#1)(2013-1#1)
existing in the##8##3##(1994-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-7#1)(2013-7#1)
existing in##14##2##(1993-8#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2013-1#1)(2013-7#1)
existing information##3##2##(1995-1#1)(2008-11#1)(2010-10#1)
existing literature has##2##3##(2008-12#1)(2013-1#1)
existing literature on##3##3##(1992-12#1)(1993-12#1)(1996-11#1)
existing literature##10##2##(1992-12#1)(1993-12#1)(1996-11#1)(1996-2#1)(2008-11#2)(2008-12#2)(2008-7#1)(2013-1#1)
existing methods for##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
existing methods##11##2##(1990-2#1)(2008-10#7)(2008-5#1)(2010-6#1)(2013-1#1)
existing models##4##2##(2008-8#2)(2009-7#1)(2009-9#1)
existing national##2##2##(2008-11#1)(2012-3#1)
existing problems##3##2##(2010-12#1)(2011-3#1)(2012-3#1)
existing programs##2##2##(1996-3#1)(2008-11#1)
existing research by##2##3##(2010-3#1)(2013-1#1)
existing research##3##2##(2008-6#1)(2010-3#1)(2013-1#1)
existing statutory##2##2##(1995-6#1)(2008-11#1)
existing theory##2##2##(2008-8#1)(2008-9#1)
existing##237##1##(1990-2#2)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-3#2)(1993-12#3)(1993-2#1)(1993-8#2)(1994-1#2)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#55)(2008-11#26)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#4)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2011-8#1)(2011-9#1)(2012-12#2)(2012-2#10)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#5)
exists a##9##2##(1990-5#2)(1992-9#1)(1994-12#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
exists among##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
exists and##2##2##(1990-6#1)(2008-8#1)
exists as a##4##3##(1992-6#1)(1993-9#1)(1994-12#1)(2008-10#1)
exists as to the##2##4##(2010-10#1)(2013-1#1)
exists as##8##2##(1992-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(2008-10#1)(2010-10#1)(2013-1#1)(2013-8#1)
exists at##3##2##(1991-9#1)(1993-12#1)(1993-3#1)
exists between the##3##3##(2008-10#2)(2009-8#1)
exists between##11##2##(1993-8#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#3)(2009-8#1)(2013-7#1)
exists for the##2##3##(1993-12#1)(2008-10#1)
exists for##8##2##(1993-12#1)(1994-2#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#2)(2009-3#1)
exists in a##3##3##(1993-8#1)(2012-3#1)(2013-1#1)
exists in an##2##3##(1995-6#1)(2008-9#1)
exists in common bean##2##4##(2008-10#1)(2013-8#1)
exists in multiple##2##3##(1990-6#1)(2013-8#1)
exists in the##15##3##(1992-6#1)(1993-3#1)(1994-12#1)(1995-5#1)(1996-12#1)(2008-10#6)(2008-12#2)(2008-5#1)(2013-1#1)
exists in these##3##3##(1990-3#1)(1997-6#1)(2008-10#1)
exists in two forms##2##4##(1993-8#1)(2008-10#1)
exists in two##4##3##(1991-3#1)(1993-8#1)(2008-10#1)(2008-5#1)
exists in##51##2##(1990-3#1)(1990-6#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-5#2)(2008-8#3)(2008-9#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
exists on the##2##3##(2008-8#1)(2013-1#1)
exists on##4##2##(1995-12#1)(2008-8#1)(2013-1#1)(2013-8#1)
exists only in##2##3##(2009-8#1)(2010-5#1)
exists over##2##2##(1995-3#1)(2008-9#1)
exists regarding the##2##3##(2008-10#1)(2011-2#1)
exists regarding##3##2##(2008-10#1)(2011-2#1)(2012-5#1)
exists that##6##2##(1990-12#1)(1996-9#1)(2008-10#1)(2009-8#1)(2011-2#2)
exists to support the##2##4##(2008-11#1)(2008-9#1)
exists to support##3##3##(2008-11#2)(2008-9#1)
exists to##5##2##(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)
exists with##2##2##(2008-10#1)(2008-9#1)
exists within##2##2##(2008-10#1)(2008-12#1)
exists##167##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1991-12#2)(1991-3#1)(1991-9#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2008-1#1)(2008-10#27)(2008-11#11)(2008-12#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#14)(2008-9#10)(2009-3#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#7)
exit from the##2##3##(1994-3#1)(2009-6#1)
exit from##4##2##(1994-3#1)(2009-6#1)(2011-2#2)
exit pupil##4##2##(2008-3#4)
exit site##4##2##(2008-5#1)(2011-2#3)
exit voltage##2##2##(2008-10#2)
exit##27##1##(1990-3#1)(1991-3#1)(1993-9#1)(1994-3#1)(1995-2#1)(1997-1#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2009-6#1)(2011-2#5)(2013-1#1)
exit-pupil##3##1##(2008-3#3)
exit-site infection##2##2##(2011-2#2)
exiting##3##1##(1996-5#1)(2011-2#1)(2012-12#1)
exits from##2##2##(2008-10#2)
exits##3##1##(2008-10#2)(2011-2#1)
exo##2##1##(1991-3#1)(1996-5#1)
exo-anomeric##2##1##(1990-5#1)(1992-12#1)
exo-antigen was##2##2##(2008-5#2)
exo-antigen##5##1##(2008-5#5)
exo-beta-1##13##1##(1992-11#2)(2008-10#11)
exoantigen##2##1##(2008-5#2)
exocarp##5##1##(2008-10#5)
exocellular##2##1##(1990-5#1)(1996-3#1)
exochitinase##4##1##(2008-10#4)
exocortis disease##2##2##(2008-10#2)
exocortis##7##1##(2008-10#7)
exocortis-like##3##1##(2008-10#3)
exocrine and endocrine##2##3##(2009-7#2)
exocrine##5##1##(1992-11#1)(1993-3#1)(2009-7#2)(2013-8#1)
exocytosis of##3##2##(1995-11#1)(1995-2#1)(1997-7#1)
exocytosis without##2##2##(1995-11#2)
exocytosis##23##1##(1992-6#3)(1995-11#5)(1995-2#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
exocytotic##3##1##(1994-8#1)(2008-12#1)(2008-4#1)
exoenzyme##6##1##(1992-3#5)(2012-6#1)
exogastric##2##1##(1992-5#2)
exogenous ADP##3##2##(2008-7#3)
exogenous MLT was##2##3##(2013-7#2)
exogenous MLT##3##2##(2013-7#3)
exogenous VEGF(165)##2##2##(2008-9#2)
exogenous [3H]PtdIns##3##2##(1993-6#3)
exogenous addition of##2##3##(2008-10#2)
exogenous agonist##2##2##(1995-12#1)(2008-9#1)
exogenous alkylresorcinols##2##2##(2008-11#2)
exogenous application of##4##3##(1990-5#1)(2008-10#2)(2010-3#1)
exogenous factors##6##2##(1990-8#1)(1991-2#1)(2008-10#2)(2008-12#1)(2012-3#1)
exogenous gene##6##2##(2008-8#3)(2008-9#3)
exogenous glucose##2##2##(1992-9#1)(2011-1#1)
exogenous hTERT##2##2##(2008-11#2)
exogenous hormones##3##2##(2008-7#1)(2008-8#2)
exogenous insulin therapy##2##3##(2010-12#2)
exogenous insulin##4##2##(2010-11#1)(2010-12#2)(2012-2#1)
exogenous plant##2##2##(2008-10#1)(2008-9#1)
exogenous signals##2##2##(2008-11#1)(2010-10#1)
exogenous substances##3##2##(1990-11#1)(2008-11#1)(2008-5#1)
exogenous substrate##2##2##(1990-10#1)(2008-5#1)
exogenous surfactant will##2##3##(1997-1#2)
exogenous surfactant##3##2##(1997-1#3)
exogenous wt-p53##2##2##(1997-7#2)
exogenous##124##1##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-12#3)(1997-1#4)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#15)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#12)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-7#3)(2013-8#1)
exogenously added##3##2##(1993-6#1)(2008-11#2)
exogenously supplied##3##2##(2008-10#1)(2008-11#2)
exogenously##11##1##(1993-12#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-10#1)(2008-11#5)(2011-10#1)
exoglc1##4##1##(2008-10#4)
exoglucanase##3##1##(1997-1#3)
exon 1##3##2##(1992-3#1)(1994-12#1)(2010-4#1)
exon 3##3##2##(1992-8#1)(1995-6#1)(1997-7#1)
exon 4##3##2##(1994-12#1)(1997-8#1)(2008-10#1)
exon 5##4##2##(1997-7#1)(1997-8#2)(2011-1#1)
exon 6##3##2##(1991-12#1)(1993-8#1)(2008-10#1)
exon 7##4##2##(1993-8#2)(2008-7#1)(2009-8#1)
exon 8##3##2##(1993-8#2)(1994-12#1)
exon 9##2##2##(2008-12#2)
exon VIII##3##2##(1993-6#3)
exon and##5##2##(1990-8#1)(1991-5#2)(1993-2#1)(1993-6#1)
exon boundaries##2##2##(1997-7#1)(2008-9#1)
exon of##2##2##(1997-8#1)(2012-3#1)
exon trapping##2##2##(1996-2#1)(1997-2#1)
exon##67##1##(1990-8#3)(1991-12#1)(1991-5#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#5)(1993-8#9)(1994-12#3)(1995-12#1)(1995-6#2)(1996-2#1)(1997-2#3)(1997-3#1)(1997-7#6)(1997-8#4)(1997-9#1)(2008-10#3)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-4#1)(2011-1#1)(2012-3#4)(2013-1#1)
exon-intron structure##2##2##(1993-3#2)
exon-intron##3##1##(1993-3#2)(1994-11#1)
exon/intron##2##1##(1996-8#1)(1997-8#1)
exonic##5##1##(1993-12#2)(1993-2#1)(1996-12#1)(1997-7#1)
exons 2##2##2##(1994-12#1)(1997-7#1)
exons and three introns##2##4##(1994-11#1)(2010-5#1)
exons and##10##2##(1991-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-8#1)(2008-4#2)(2008-9#1)(2010-5#1)
exons in##2##2##(1990-8#1)(2008-4#1)
exons of the##2##3##(1992-10#1)(2010-12#1)
exons of##6##2##(1992-10#1)(1994-11#1)(1996-6#1)(2008-8#2)(2010-12#1)
exons spanning##3##2##(1996-8#1)(1997-7#1)(2008-7#1)
exons were##3##2##(1996-2#1)(1997-2#1)(2008-8#1)
exons which##3##2##(1993-2#1)(1997-6#1)(1997-8#1)
exons##67##1##(1990-8#3)(1991-5#2)(1991-6#2)(1991-9#1)(1992-10#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#3)(1994-12#3)(1995-8#4)(1996-2#2)(1996-6#1)(1996-8#1)(1997-2#8)(1997-6#1)(1997-7#3)(1997-8#3)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#6)(2010-12#1)(2010-5#2)(2011-2#1)(2012-3#1)
exonuclease activity##3##2##(1995-2#2)(1997-8#1)
exonuclease##8##1##(1995-2#2)(1997-8#4)(2008-10#1)(2008-8#1)
exophytic mass##2##2##(2012-12#1)(2012-3#1)
exophytic##5##1##(1991-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
exoskeleton and##2##2##(2007-12#1)(2008-7#1)
exoskeleton##5##1##(1993-12#1)(2007-12#2)(2008-12#1)(2008-7#1)
exoskeletons##2##1##(2007-12#1)(2009-7#1)
exothermic and spontaneous nature of sorption##2##6##(2008-10#2)
exothermic##5##1##(2008-10#4)(2011-1#1)
exotic##12##1##(2007-12#1)(2008-10#4)(2008-8#1)(2010-3#4)(2012-2#2)
exotoxin##4##1##(1990-8#1)(2008-10#2)(2008-5#1)
expand the use of##2##4##(1994-2#1)(1996-12#1)
expand the##12##2##(1994-2#2)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2012-2#1)
expand their##3##2##(2008-11#1)(2008-8#1)(2009-5#1)
expand this##2##2##(1994-3#1)(1995-12#1)
expand to##2##2##(1990-8#1)(2008-1#1)
expand##38##1##(1990-8#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-5#1)(1994-2#2)(1994-3#1)(1995-12#3)(1996-12#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-3#1)(2008-5#1)(2008-8#3)(2009-5#1)(2012-2#2)(2013-1#2)(2013-8#1)
expandable##2##1##(1992-9#1)(2009-3#1)
expanded and##3##2##(2008-11#1)(2008-9#2)
expanded by##2##2##(2008-11#1)(2008-8#1)
expanded during the past##2##4##(1992-3#1)(2008-9#1)
expanded in##4##2##(1990-8#1)(2008-9#1)(2009-6#1)(2011-2#1)
expanded its##3##2##(1991-2#1)(2008-10#1)(2011-7#1)
expanded measuring range##2##3##(2008-10#2)
expanded their##2##2##(2010-4#2)
expanded to include##4##3##(1991-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
expanded to the##2##3##(2008-10#1)(2008-11#1)
expanded to##15##2##(1991-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2010-12#1)(2011-9#1)(2012-2#1)(2013-1#1)
expanded uncertainties##2##2##(2008-10#2)
expanded uncertainty##5##2##(2008-10#5)
expanded##97##1##(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#26)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#7)(2009-10#1)(2009-6#1)(2010-10#2)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2011-7#1)(2011-9#1)(2012-2#3)(2012-3#1)(2013-1#4)
expander##3##1##(1992-5#1)(1993-11#1)(2008-3#1)
expanders##3##1##(1992-9#1)(2008-3#1)(2011-2#1)
expanding access to##4##3##(1996-3#1)(2012-3#1)(2013-1#2)
expanding and##2##2##(2010-12#1)(2013-1#1)
expanding areas of##2##3##(1996-3#1)(2010-7#1)
expanding culture is washed##2##4##(2008-8#2)
expanding drop##2##2##(2008-10#2)
expanding the##10##2##(1993-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)
expanding##52##1##(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#2)(1993-12#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#3)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#4)
expands our##2##2##(2008-11#1)(2012-2#1)
expands the##4##2##(1991-5#1)(2008-10#2)(2011-1#1)
expands##13##1##(1991-3#1)(1991-5#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-8#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
expansa##5##1##(2008-10#5)
expansile##2##1##(2013-1#2)
expansion and##13##2##(1995-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-8#3)(2011-2#1)
expansion at##2##2##(1997-3#1)(2008-8#1)
expansion during##3##2##(2009-10#2)(2010-11#1)
expansion into##2##2##(2008-10#1)(2008-8#1)
expansion is##2##2##(1992-5#1)(2008-10#1)
expansion method##2##2##(2008-11#1)(2012-2#1)
expansion of antigen-specific##2##3##(2008-11#1)(2012-12#1)
expansion of hematopoietic cells##2##4##(2008-11#2)
expansion of hematopoietic##4##3##(2008-11#4)
expansion of human hematopoietic##2##4##(2008-11#2)
expansion of human##3##3##(2008-11#2)(2008-8#1)
expansion of the##23##3##(1993-1#1)(1995-1#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-10#8)(2008-11#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#2)
expansion of##68##2##(1991-3#2)(1992-12#1)(1993-1#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(2007-12#2)(2008-10#11)(2008-11#18)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
expansion to the##2##3##(2008-10#1)(2009-1#1)
expansion to##3##2##(2008-10#1)(2009-1#1)(2009-6#1)
expansion##145##1##(1991-3#4)(1992-12#1)(1992-5#2)(1993-1#1)(1995-1#1)(1995-2#2)(1996-12#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#34)(2008-11#24)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-1#3)(2009-10#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#7)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#5)(2011-8#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#4)(2013-8#2)
expansion-survival trade-off##2##2##(2008-8#2)
expansions of##2##2##(2008-8#1)(2010-1#1)
expansions##11##1##(1992-11#1)(1995-12#2)(1996-2#1)(2008-11#1)(2008-8#1)(2009-1#2)(2010-1#2)(2010-7#1)
expansive growth##2##2##(2013-1#2)
expansive##5##1##(2007-12#1)(2008-7#1)(2013-1#3)
expansum and##3##2##(2008-10#3)
expansum conidia##2##2##(2008-10#2)
expansum on##2##2##(2008-10#2)
expansum##25##1##(2008-10#25)
expect in the##2##3##(1996-2#1)(2013-7#1)
expect that##5##2##(2008-3#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#1)
expect the##2##2##(2011-2#1)(2012-12#1)
expect to see##2##3##(1995-12#1)(2008-8#1)
expect to##9##2##(1994-12#1)(1995-12#1)(2008-10#1)(2008-8#2)(2011-2#2)(2013-7#1)(2013-8#1)
expect##36##1##(1994-12#2)(1994-3#1)(1995-12#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-8#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
expect?##2##1##(1993-2#2)
expectancies for##4##2##(2008-11#1)(2011-2#2)(2013-8#1)
expectancies were##2##2##(2008-11#1)(2013-8#1)
expectancies##12##1##(2008-11#3)(2008-8#1)(2011-2#2)(2013-8#6)
expectancy and##3##2##(2008-11#1)(2008-4#1)(2012-12#1)
expectancy in##3##2##(1993-1#1)(1997-6#1)(2008-7#1)
expectancy is##3##2##(1997-6#1)(2008-11#1)(2008-7#1)
expectancy##30##1##(1991-3#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-6#3)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#3)(2009-9#1)(2010-10#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)
expectant mothers##3##2##(1991-12#1)(1992-12#1)(2009-4#1)
expectant##4##1##(1991-12#1)(1992-12#1)(2008-10#1)(2009-4#1)
expectation for##2##2##(1991-1#1)(2012-3#1)
expectation in##2##2##(1991-8#1)(2008-10#1)
expectation of##3##2##(1994-3#1)(2008-11#1)(2008-12#1)
expectation that##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
expectation##23##1##(1991-1#1)(1991-8#2)(1992-9#1)(1993-2#1)(1994-3#1)(1997-6#2)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-3#1)
expectations and the##2##3##(2008-9#2)
expectations and youth's##2##3##(2009-7#2)
expectations and##10##2##(1993-2#1)(1995-1#1)(2008-12#1)(2008-9#3)(2009-11#1)(2009-7#2)(2013-1#1)
expectations are##2##2##(1995-1#1)(2009-7#1)
expectations for a##2##3##(2008-10#1)(2008-9#1)
expectations for##6##2##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
expectations from##3##2##(1997-2#1)(2008-10#1)(2008-12#1)
expectations of a##3##3##(2008-9#1)(2010-10#1)(2013-1#1)
expectations of the multidisciplinary pain rehabilitation programme##2##7##(2013-1#2)
expectations of the rehabilitation##2##4##(2013-1#2)
expectations of the##6##3##(1995-1#1)(2013-1#5)
expectations of##24##2##(1994-2#1)(1995-1#1)(1995-2#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-9#3)(2010-10#1)(2010-9#1)(2011-1#1)(2013-1#9)
expectations on##2##2##(2009-7#2)
expectations over time##2##3##(2008-9#2)
expectations regarding the##2##3##(1993-6#1)(2008-7#1)
expectations regarding##3##2##(1993-6#1)(2008-7#1)(2011-2#1)
expectations that##2##2##(1995-3#1)(1997-1#1)
expectations to##3##2##(2008-12#1)(2010-9#1)(2011-2#1)
expectations when##2##2##(2011-2#2)
expectations##97##1##(1991-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#1)(2008-10#7)(2008-11#5)(2008-12#10)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#13)(2009-11#1)(2009-7#7)(2010-10#2)(2010-11#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#14)
expected and observed##4##3##(2008-10#1)(2008-9#2)(2013-8#1)
expected and##7##2##(1993-3#1)(1994-9#1)(2008-10#2)(2008-9#2)(2013-8#1)
expected based on##3##3##(1991-2#1)(1995-1#1)(2008-10#1)
expected based##5##2##(1991-2#1)(1992-6#1)(1995-1#1)(2008-10#1)(2008-11#1)
expected by##5##2##(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)
expected changes in##2##3##(1991-1#1)(1997-2#1)
expected for a##2##3##(2008-10#1)(2008-11#1)
expected for the##3##3##(1992-3#2)(2008-3#1)
expected for##15##2##(1992-3#3)(1994-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2011-2#1)
expected frequency##2##2##(1995-2#1)(1997-2#1)
expected from the##4##3##(1992-12#1)(2008-10#2)(2008-8#1)
expected from##13##2##(1992-12#1)(1993-2#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)
expected future##2##2##(2008-8#2)
expected genetic##2##2##(2008-10#1)(2010-5#1)
expected high##2##2##(2008-3#1)(2009-3#1)
expected in a##2##3##(2008-10#1)(2012-3#1)
expected in the general population##2##5##(2008-7#2)
expected in the##7##3##(1996-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-7#2)
expected in##21##2##(1992-2#2)(1993-1#1)(1993-5#1)(1994-8#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#2)(2012-3#1)(2013-8#1)
expected not##2##2##(2009-7#1)(2010-11#1)
expected number of##2##3##(2008-10#2)
expected numbers##2##2##(2008-10#2)
expected outcomes##2##2##(1993-3#1)(2010-6#1)
expected results##2##2##(2008-4#1)(2008-9#1)
expected size##2##2##(1992-8#1)(1995-9#1)
expected sizes##3##2##(1991-5#1)(1995-12#1)(2008-10#1)
expected that this##2##3##(2008-10#1)(2008-11#1)
expected that##14##2##(1991-1#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-3#1)
expected the##2##2##(2008-10#1)(2008-5#1)
expected time to extinction##3##4##(2008-9#3)
expected time to##4##3##(2008-5#1)(2008-9#3)
expected time##6##2##(2008-10#1)(2008-5#2)(2008-9#3)
expected to arise##2##3##(2010-5#1)(2012-3#1)
expected to be useful##2##4##(2008-10#2)
expected to be##20##3##(1992-12#1)(1995-8#1)(1996-1#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-5#3)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#3)
expected to form##3##3##(2008-3#1)(2008-6#2)
expected to increase##6##3##(1991-12#1)(1996-11#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
expected to remain##2##3##(1996-5#1)(2010-5#1)
expected to replace##2##3##(1995-1#1)(2012-3#1)
expected to##98##2##(1990-12#1)(1991-1#2)(1991-12#1)(1991-3#1)(1992-12#2)(1993-1#1)(1993-11#1)(1994-5#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#3)(1997-6#1)(1997-8#1)(2008-10#10)(2008-11#12)(2008-12#3)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#3)(2009-12#1)(2010-10#1)(2010-5#2)(2010-6#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#8)
expected under##3##2##(2008-10#3)
expected values of##2##3##(1990-6#1)(2012-3#1)
expected values##4##2##(1990-6#1)(2008-10#2)(2012-3#1)
expected with##2##2##(2008-10#1)(2008-9#1)
expected##392##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#4)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#4)(1996-5#4)(1996-9#1)(1997-2#6)(1997-3#1)(1997-6#4)(1997-8#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#86)(2008-11#34)(2008-12#3)(2008-2#2)(2008-3#21)(2008-4#1)(2008-5#16)(2008-6#3)(2008-7#7)(2008-8#15)(2008-9#23)(2009-10#5)(2009-12#2)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#3)(2010-6#3)(2011-1#2)(2011-2#10)(2012-12#2)(2012-2#4)(2012-3#10)(2012-7#1)(2013-1#12)(2013-8#7)
expecting an##2##2##(1997-4#1)(1997-8#1)
expecting##3##1##(1997-4#1)(1997-8#1)(2010-10#1)
expectorant##2##1##(1996-1#2)
expectoration##4##1##(1991-11#1)(2008-1#1)(2008-5#1)(2008-7#1)
expects to##2##2##(2008-5#2)
expects##5##1##(1993-1#1)(2008-5#3)(2010-12#1)
expedite the##3##2##(1996-1#1)(2008-10#1)(2008-12#1)
expedite##5##1##(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
expedited##2##1##(1997-2#1)(2008-10#1)
expeditious##2##1##(2008-10#1)(2008-8#1)
expended##2##1##(1992-9#1)(2011-2#1)
expenditure and##2##2##(1991-2#1)(2012-2#1)
expenditure estimates##2##2##(1995-12#1)(1996-3#1)
expenditure for##2##2##(1991-2#1)(2012-2#1)
expenditure on##4##2##(1993-6#1)(2008-11#1)(2008-2#1)(2008-5#1)
expenditure to##2##2##(1995-12#1)(2012-2#1)
expenditure was##2##2##(2008-9#1)(2013-8#1)
expenditure##51##1##(1991-1#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#6)(2012-2#4)(2013-1#2)(2013-8#3)
expenditures and##10##2##(1992-1#1)(1992-12#2)(1992-2#1)(1995-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
expenditures associated with thyroid disorders##2##5##(2013-1#2)
expenditures by##2##2##(1995-2#1)(1997-3#1)
expenditures for##15##2##(1991-12#1)(1991-2#2)(1992-1#1)(1992-3#3)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-3#1)(1997-3#1)(2008-11#1)
expenditures from##2##2##(1994-3#1)(1995-2#1)
expenditures grow##2##2##(1993-3#1)(1996-2#1)
expenditures have##2##2##(1992-2#1)(1997-2#1)
expenditures in the United States##2##5##(1993-3#1)(1995-1#1)
expenditures in##6##2##(1991-12#1)(1991-2#1)(1992-1#1)(1993-3#1)(1994-2#1)(1995-1#1)
expenditures of##3##2##(1992-12#1)(1994-1#1)(1994-2#1)
expenditures on##4##2##(1990-11#1)(1994-2#2)(2009-3#1)
expenditures per##2##2##(1993-12#1)(1995-1#1)
expenditures than##2##2##(1991-12#2)
expenditures through##2##2##(1993-3#1)(1996-2#1)
expenditures to##2##2##(1992-12#1)(2013-1#1)
expenditures was##2##2##(2013-1#2)
expenditures were##4##2##(1991-12#1)(1992-3#1)(1993-1#1)(1994-2#1)
expenditures##114##1##(1990-11#1)(1990-2#2)(1991-12#5)(1991-2#5)(1991-3#3)(1992-1#3)(1992-12#7)(1992-2#3)(1992-3#5)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#9)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#9)(1994-3#2)(1995-1#4)(1995-12#3)(1995-2#6)(1995-3#5)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#5)(2008-11#4)(2009-3#1)(2012-2#1)(2012-3#2)(2013-1#14)(2013-8#1)
expense##22##1##(1990-11#1)(1990-9#1)(1992-1#1)(1993-12#1)(1994-1#4)(1995-12#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-1#1)(2012-3#1)(2012-9#1)(2013-1#1)
expenses and##2##2##(2008-11#2)
expenses##21##1##(1990-12#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-11#4)(2009-8#1)(2011-2#1)(2013-8#1)
expensive alternatives##2##2##(1992-1#1)(1993-11#1)
expensive and##12##2##(1991-2#1)(1991-3#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
expensive cases##2##2##(1992-12#2)
expensive commercial##2##2##(2008-10#2)
expensive drugs##2##2##(1997-6#1)(2010-5#1)
expensive equipment##2##2##(2009-5#1)(2009-6#1)
expensive in##3##2##(1993-3#1)(1994-12#1)(2008-10#1)
expensive than##5##2##(1994-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
expensive##79##1##(1990-3#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-8#1)(1995-12#1)(1996-1#2)(1996-11#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#2)(2008-1#1)(2008-10#15)(2008-11#9)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)
experience a##5##2##(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
experience about the##3##3##(1992-5#1)(1996-2#1)(2012-2#1)
experience about##4##2##(1990-5#1)(1992-5#1)(1996-2#1)(2012-2#1)
experience and the##4##3##(2008-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
experience and training##2##3##(1994-12#1)(2008-9#1)
experience and##35##2##(1992-2#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-1#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-11#3)(2008-12#5)(2008-6#1)(2008-9#2)(2009-8#1)(2010-10#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
experience are##3##2##(1992-2#1)(2008-11#1)(2008-12#1)
experience as a##4##3##(1994-12#1)(1994-2#1)(1995-3#1)(2008-11#1)
experience as##6##2##(1994-12#1)(1994-2#1)(1995-3#1)(2008-11#2)(2009-5#1)
experience at a##2##3##(2010-11#1)(2013-8#1)
experience at the##4##3##(1991-2#1)(1992-2#1)(2008-11#1)(2009-9#1)
experience at##11##2##(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
experience by##3##2##(1995-11#1)(1995-8#1)(2008-11#1)
experience caring for##2##3##(2008-11#2)
experience demonstrates that##2##3##(1991-6#1)(2008-10#1)
experience difficulties##2##2##(2008-12#1)(2010-10#1)
experience during##3##2##(1995-1#1)(2008-11#1)(2009-9#1)
experience for the##4##3##(1992-12#1)(1994-1#2)(2008-12#1)
experience for##7##2##(1992-12#1)(1993-1#1)(1994-1#2)(2008-11#1)(2008-12#2)
experience from the##2##3##(1990-11#1)(2008-10#1)
experience from##9##2##(1990-11#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-3#1)(2012-2#2)(2013-8#1)
experience gained##4##2##(1994-12#1)(1995-2#1)(2008-10#1)(2012-2#1)
experience has been##2##3##(2008-11#2)
experience has shown that##2##4##(1997-2#1)(2008-10#1)
experience has##5##2##(1997-2#1)(2008-10#1)(2008-11#3)
experience higher##2##2##(2008-8#1)(2008-9#1)
experience in a##2##3##(1997-3#1)(2008-11#1)
experience in the##10##3##(1990-3#2)(1990-5#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2011-2#2)
experience in##42##2##(1990-3#2)(1990-5#2)(1990-9#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-3#1)(2008-10#4)(2008-11#4)(2008-8#1)(2008-9#2)(2009-5#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#6)
experience indicates##2##2##(2008-7#1)(2011-2#1)
experience into##2##2##(2008-11#2)
experience is##10##2##(1991-3#1)(1991-6#1)(1992-11#1)(2008-1#1)(2008-11#3)(2008-7#1)(2011-2#1)(2013-1#1)
experience may##2##2##(2008-11#2)
experience more##5##2##(1997-2#1)(2008-7#2)(2008-8#1)(2013-1#1)
experience of HIV/AIDS##2##3##(2008-1#2)
experience of SIP##2##3##(1993-6#2)
experience of a##9##3##(1990-3#1)(1991-9#1)(1995-1#1)(1996-3#1)(1997-3#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#1)
experience of family##2##3##(1991-12#1)(2008-11#1)
experience of social support after the death of a child##2##10##(2009-5#2)
experience of social##3##3##(1996-11#1)(2009-5#2)
experience of the##21##3##(1990-3#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
experience of undertaking##2##3##(2008-11#2)
experience of##104##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-5#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#1)(1994-12#1)(1995-1#3)(1995-10#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#1)(2008-1#4)(2008-10#5)(2008-11#13)(2008-12#11)(2008-3#1)(2008-7#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#6)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
experience on##5##2##(1990-3#2)(1990-9#1)(2008-8#2)
experience or##3##2##(2011-3#2)(2012-2#1)
experience reported##3##2##(1991-2#1)(1994-9#1)(1995-1#1)
experience should##2##2##(1996-1#1)(2008-7#1)
experience suggests that##2##3##(2012-2#1)(2013-8#1)
experience symptoms of##2##3##(2012-12#1)(2013-1#1)
experience the##6##2##(1991-3#1)(1992-5#1)(1996-9#1)(2008-9#1)(2009-7#1)(2010-9#1)
experience to be##2##3##(2008-12#2)
experience to##7##2##(1996-2#1)(2008-11#3)(2008-12#3)
experience using##4##2##(1991-3#1)(2010-6#2)(2011-2#1)
experience was a##2##3##(2008-12#2)
experience were##2##2##(2008-11#1)(2008-12#1)
experience will##2##2##(1994-3#1)(2008-10#1)
experience with a##2##3##(1994-12#1)(2012-2#1)
experience with an##2##3##(2008-11#1)(2008-7#1)
experience with the use of##2##5##(2008-12#1)(2012-3#1)
experience with the##8##3##(1995-3#1)(1996-8#1)(1997-4#1)(2008-12#2)(2008-9#1)(2011-3#1)(2012-3#1)
experience with this##5##3##(1993-3#1)(1996-1#1)(2008-11#1)(2008-9#1)(2012-2#1)
experience with##66##2##(1990-9#1)(1991-3#1)(1992-5#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#3)(1995-5#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-11#1)(2010-11#2)(2010-6#2)(2010-8#2)(2011-2#6)(2011-3#2)(2011-7#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
experience##639##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#10)(1990-5#4)(1990-9#5)(1991-12#5)(1991-2#6)(1991-3#5)(1991-6#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#8)(1992-3#4)(1992-5#5)(1993-1#4)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#3)(1993-6#3)(1993-9#2)(1994-1#5)(1994-12#9)(1994-2#5)(1994-3#7)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#12)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#7)(1995-5#3)(1995-8#1)(1996-1#11)(1996-11#2)(1996-12#2)(1996-2#8)(1996-3#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#9)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#14)(2008-10#25)(2008-11#80)(2008-12#42)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#16)(2008-8#13)(2008-9#23)(2009-1#1)(2009-10#1)(2009-11#6)(2009-12#4)(2009-2#1)(2009-4#4)(2009-5#10)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#1)(2011-2#44)(2011-3#8)(2011-7#1)(2012-12#11)(2012-2#21)(2012-3#11)(2013-1#20)(2013-8#15)
experience)##6##1##(1995-3#3)(1997-2#1)(2008-11#1)(2011-2#1)
experience-based##2##1##(1997-1#1)(2008-8#1)
experience-dependent##2##1##(2010-7#1)(2012-2#1)
experience]##17##1##(1990-3#2)(1990-5#1)(1990-9#1)(1991-3#2)(1992-3#3)(1992-5#1)(1992-9#1)(1993-3#1)(1995-5#1)(2008-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
experienced a greater impact on##2##5##(2013-1#2)
experienced a significant##3##3##(1994-1#1)(1996-3#1)(2008-8#1)
experienced a transition##2##3##(1996-3#1)(2012-12#1)
experienced a##16##2##(1994-1#1)(1995-12#1)(1996-3#2)(2007-8#1)(2008-12#1)(2008-8#2)(2009-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
experienced an##4##2##(1991-6#1)(2008-11#1)(2012-3#1)(2013-1#1)
experienced as##2##2##(1995-1#1)(2008-11#1)
experienced at least one severe (grade##2##6##(2008-10#2)
experienced at least one##3##4##(1994-6#1)(2008-10#2)
experienced at##5##2##(1994-6#1)(2008-10#2)(2010-11#1)(2011-2#1)
experienced by a##2##3##(2009-8#1)(2012-2#1)
experienced by parents##2##3##(1992-2#1)(1993-3#1)
experienced by the##4##3##(1991-12#1)(2008-7#1)(2009-8#1)(2010-7#1)
experienced by##22##2##(1991-12#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-3#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-10#3)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
experienced during##4##2##(2008-8#1)(2010-4#1)(2011-2#2)
experienced greater##2##2##(2008-12#1)(2013-1#1)
experienced in the##4##3##(1994-3#1)(1996-6#1)(2008-12#1)(2011-2#1)
experienced in##14##2##(1994-12#1)(1994-3#1)(1996-6#1)(1997-6#1)(2008-11#2)(2008-12#1)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-3#1)
experienced individuals##2##2##(2011-2#2)
experienced less##2##2##(1993-2#1)(2008-9#1)
experienced more##2##2##(1994-6#1)(2008-9#1)
experienced nausea##2##2##(2008-7#2)
experienced no further##2##3##(2008-10#1)(2013-1#1)
experienced physicians##2##2##(1991-6#1)(1993-3#1)
experienced practitioner##2##2##(2008-11#2)
experienced serious##2##2##(1994-6#1)(2012-6#1)
experienced sexual##2##2##(1992-1#1)(2012-2#1)
experienced significant##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
experienced the##3##2##(2008-10#1)(2008-12#1)(2010-8#1)
experienced transient##3##2##(1990-10#1)(2010-3#1)(2012-3#1)
experienced was##2##2##(2008-12#1)(2009-4#1)
experienced##209##1##(1990-10#1)(1990-6#2)(1991-11#1)(1991-12#3)(1991-3#3)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#9)(1992-12#1)(1992-2#3)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#3)(1995-1#3)(1995-10#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#3)(2007-12#2)(2007-8#2)(2008-10#7)(2008-11#18)(2008-12#10)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#12)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-10#3)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#16)(2012-12#2)(2012-2#6)(2012-3#8)(2012-6#1)(2013-1#10)(2013-8#3)
experiences a##2##2##(1991-2#1)(2008-8#1)
experiences among##2##2##(2009-11#1)(2012-2#1)
experiences and perceptions of##2##4##(2008-11#1)(2010-10#1)
experiences and perceptions##3##3##(2008-11#2)(2010-10#1)
experiences and##22##2##(1993-3#1)(2008-11#5)(2008-12#3)(2009-10#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
experiences as##2##2##(1996-1#1)(2013-8#1)
experiences during##2##2##(2009-9#1)(2013-8#1)
experiences for##4##2##(1996-1#1)(2008-11#2)(2008-12#1)
experiences from##3##2##(1991-3#1)(2008-10#1)(2013-1#1)
experiences in caring for patients##3##5##(2010-7#2)(2010-8#1)
experiences in caring for##4##4##(2010-7#2)(2010-8#1)(2011-2#1)
experiences in the##4##3##(2008-10#1)(2008-11#1)(2009-10#1)(2009-12#1)
experiences in this##2##3##(2008-11#2)
experiences in##20##2##(1991-2#1)(2008-10#1)(2008-11#5)(2008-12#3)(2009-10#1)(2009-12#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
experiences of a##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-8#1)
experiences of general student nurses on their first clinical placement##2##10##(2008-12#2)
experiences of general student nurses on their first clinical##3##9##(2008-12#3)
experiences of healthcare##2##3##(2008-12#2)
experiences of living##2##3##(1993-1#1)(2008-12#1)
experiences of one##2##3##(1992-3#1)(2008-11#1)
experiences of psilocybin users and non-users##3##6##(2013-8#3)
experiences of psilocybin users##4##4##(2013-8#4)
experiences of students##2##3##(2008-11#2)
experiences of the##8##3##(1994-1#1)(1995-12#1)(2008-11#2)(2008-12#1)(2010-10#2)(2013-1#1)
experiences of what##2##3##(2010-10#2)
experiences of##77##2##(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#19)(2008-12#17)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-5#1)(2010-10#5)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#7)
experiences that##2##2##(2008-11#1)(2008-12#1)
experiences through##2##2##(2010-10#1)(2010-7#1)
experiences were##4##2##(1992-2#1)(2008-10#2)(2010-2#1)
experiences will##2##2##(2008-11#2)
experiences with nursing##2##3##(2008-12#2)
experiences with the##3##3##(1997-3#1)(2008-11#1)(2013-7#1)
experiences with##19##2##(1993-3#1)(1994-1#1)(1995-12#1)(1996-1#1)(1997-3#3)(2008-10#2)(2008-11#2)(2008-12#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-7#1)
experiences within##2##2##(2010-4#1)(2013-8#1)
experiences##244##1##(1990-6#2)(1991-2#3)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#4)(1994-2#1)(1995-1#2)(1995-12#2)(1995-3#1)(1996-1#4)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#11)(2008-11#48)(2008-12#36)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#10)(2010-11#3)(2010-12#1)(2010-2#5)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#6)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#17)
experiences]##2##1##(1991-2#1)(2009-10#1)
experiencing an##4##2##(2008-11#3)(2008-12#1)
experiencing dramatic##2##2##(2008-12#2)
experiencing it##2##2##(2010-3#1)(2010-6#1)
experiencing the##4##2##(2011-2#2)(2012-3#1)(2013-8#1)
experiencing##37##1##(1991-2#2)(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#8)(2008-12#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-3#3)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
experiential activities##2##2##(2008-11#2)
experiential knowledge##2##2##(2008-11#2)
experiential learning##8##2##(2008-11#7)(2009-8#1)
experiential##24##1##(1996-1#2)(2008-1#2)(2008-11#15)(2009-8#2)(2010-10#2)(2013-8#1)
experiment 1##6##2##(2008-10#5)(2010-8#1)
experiment 2##5##2##(2008-10#5)
experiment and the##2##3##(1991-3#1)(1997-3#1)
experiment and##12##2##(1991-3#1)(1994-3#1)(1997-3#1)(2008-10#6)(2008-5#1)(2008-8#2)
experiment at##2##2##(2008-10#2)
experiment cockle##2##2##(1996-12#2)
experiment design##3##2##(2008-10#2)(2008-11#1)
experiment for##2##2##(1996-12#1)(2008-5#1)
experiment has##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
experiment in the##3##3##(2008-10#2)(2008-8#1)
experiment in which##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
experiment in##16##2##(1994-6#1)(1995-3#1)(1996-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-3#1)
experiment is to##2##3##(2008-10#1)(2008-3#1)
experiment is##7##2##(1992-4#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2012-2#1)
experiment of the##2##3##(2008-11#1)(2008-12#1)
experiment of##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)
experiment on##4##2##(1992-2#1)(2008-3#1)(2009-8#1)(2011-3#1)
experiment show that##2##3##(2008-10#1)(2008-9#1)
experiment showed that##6##3##(1995-3#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)
experiment showed##7##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)
experiment that tested##2##3##(1997-3#1)(2008-9#1)
experiment to##11##2##(1994-11#1)(2008-10#3)(2008-3#4)(2008-6#1)(2010-8#2)
experiment using##4##2##(2008-10#1)(2008-12#1)(2008-3#2)
experiment was a##2##3##(2008-10#2)
experiment was carried out in##2##5##(2008-10#1)(2008-11#1)
experiment was conducted at the##2##5##(2008-12#1)(2011-1#1)
experiment was conducted in##3##4##(2008-10#1)(2008-12#1)(2012-7#1)
experiment was conducted to determine the##2##6##(2008-10#2)
experiment was conducted to determine##3##5##(1992-3#1)(2008-10#2)
experiment was conducted to##6##4##(1992-2#1)(1992-3#1)(2008-10#3)(2008-12#1)
experiment was conducted##13##3##(1992-2#1)(1992-3#1)(2008-10#4)(2008-12#3)(2008-5#1)(2011-1#1)(2012-6#1)(2012-7#1)
experiment was designed to test the##2##6##(1997-8#1)(2008-10#1)
experiment was designed to##4##4##(1997-8#1)(2008-10#2)(2008-11#1)
experiment was##35##2##(1992-2#1)(1992-3#1)(1994-8#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-12#7)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-6#1)(2012-7#1)
experiment we##3##2##(2009-10#1)(2010-8#1)(2013-8#1)
experiment with##8##2##(1991-3#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)
experiment##336##1##(1990-11#1)(1990-5#1)(1991-1#1)(1991-3#2)(1992-1#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#2)(1995-6#1)(1996-12#5)(1996-2#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#132)(2008-11#17)(2008-12#14)(2008-2#3)(2008-3#35)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#19)(2008-9#17)(2009-10#2)(2009-8#3)(2010-1#1)(2010-3#1)(2010-5#2)(2010-8#6)(2011-1#2)(2011-3#1)(2012-2#3)(2012-3#2)(2012-6#2)(2012-7#1)(2012-9#1)(2013-1#2)(2013-8#4)
experiment]##2##1##(1990-9#1)(2012-3#1)
experimental As(III)##2##2##(2008-10#2)
experimental allergic encephalomyelitis##2##3##(1994-6#1)(2011-2#1)
experimental allergic##3##2##(1994-6#2)(2011-2#1)
experimental analysis of##2##3##(2008-7#1)(2008-9#1)
experimental analysis##4##2##(2008-2#1)(2008-7#1)(2008-9#1)(2012-3#1)
experimental and calculated##3##3##(2008-10#2)(2008-3#1)
experimental and clinical studies##4##4##(1996-9#1)(2008-11#1)(2009-7#1)(2012-5#1)
experimental and clinical##12##3##(1996-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-7#1)(2011-2#1)(2012-5#1)
experimental and control##3##3##(1991-12#1)(2011-2#2)
experimental and modeling##2##3##(2008-7#2)
experimental and numerical results##3##4##(2008-3#3)
experimental and numerical##4##3##(2008-3#3)(2009-7#1)
experimental and observational##2##3##(2008-9#1)(2012-12#1)
experimental and theoretical##5##3##(1992-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
experimental and##45##2##(1991-12#1)(1992-3#1)(1996-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-7#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
experimental animal models##5##3##(1992-6#1)(1993-11#1)(1995-5#1)(2008-11#1)(2009-10#1)
experimental animal studies##2##3##(1991-12#1)(2008-12#1)
experimental animal##11##2##(1991-12#1)(1992-6#1)(1993-11#1)(1995-5#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
experimental animals##9##2##(1990-12#1)(1995-5#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
experimental approach to the##2##4##(1991-6#1)(2008-10#1)
experimental approach to##4##3##(1991-6#1)(2008-10#2)(2008-11#1)
experimental approach used##2##3##(1994-8#1)(2008-10#1)
experimental approach##11##2##(1990-2#1)(1991-6#1)(1994-8#1)(1997-7#1)(2008-10#4)(2008-11#2)(2009-7#1)
experimental approaches to##2##3##(2008-7#1)(2008-8#1)
experimental approaches##4##2##(1995-6#1)(2008-7#2)(2008-8#1)
experimental atherosclerosis##2##2##(1997-8#1)(2013-1#1)
experimental autoimmune encephalomyelitis (EAE)##2##4##(2010-12#1)(2012-2#1)
experimental autoimmune encephalomyelitis##5##3##(1995-12#1)(2010-12#2)(2012-2#1)(2013-7#1)
experimental autoimmune##6##2##(1995-12#2)(2010-12#2)(2012-2#1)(2013-7#1)
experimental calibration matrix##3##3##(2008-10#3)
experimental calibration##5##2##(2008-10#5)
experimental characterization of##2##3##(2007-12#1)(2010-8#1)
experimental colitis##2##2##(1992-6#1)(2011-3#1)
experimental comparison##2##2##(2008-10#1)(2010-4#1)
experimental condition##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
experimental conditions and##5##3##(2008-10#4)(2009-12#1)
experimental conditions for the##2##4##(2008-10#2)
experimental conditions for##7##3##(2008-10#6)(2008-9#1)
experimental conditions is##2##3##(2008-10#2)
experimental conditions of##3##3##(1992-4#1)(2008-10#2)
experimental conditions such as##2##4##(2008-10#2)
experimental conditions used##2##3##(1997-3#1)(2008-10#1)
experimental conditions was##3##3##(2008-10#3)
experimental conditions were investigated##3##4##(2008-10#3)
experimental conditions were##12##3##(2008-10#12)
experimental conditions##123##2##(1990-2#1)(1991-6#1)(1992-4#1)(1993-3#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#2)(1997-3#1)(2008-10#96)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-12#2)(2009-8#1)(2010-10#1)
experimental data and##4##3##(2008-2#1)(2008-7#2)(2010-10#1)
experimental data are##5##3##(1990-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)
experimental data available##2##3##(2008-7#1)(2009-10#1)
experimental data by##2##3##(2008-10#2)
experimental data for##3##3##(1997-2#1)(2008-7#1)(2011-2#1)
experimental data from##5##3##(2008-2#1)(2008-3#2)(2008-9#1)(2013-1#1)
experimental data is##2##3##(2008-10#2)
experimental data obtained##4##3##(1995-3#1)(2008-10#3)
experimental data on the##3##4##(2009-3#1)(2010-10#1)(2013-8#1)
experimental data on##5##3##(2008-7#1)(2009-3#1)(2010-10#1)(2013-1#1)(2013-8#1)
experimental data points##2##3##(2008-10#2)
experimental data sets##2##3##(2008-10#1)(2008-7#1)
experimental data was##2##3##(2008-10#2)
experimental data were##2##3##(2008-10#1)(2008-3#1)
experimental data with##2##3##(2007-12#1)(2008-3#1)
experimental data##93##2##(1990-5#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#34)(2008-11#7)(2008-2#3)(2008-3#8)(2008-4#1)(2008-7#11)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#3)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#4)
experimental demonstration##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
experimental demonstrations of##2##3##(2008-9#1)(2012-3#1)
experimental design and##5##3##(2008-10#4)(2008-8#1)
experimental design approach##4##3##(2008-10#4)
experimental design was used##3##4##(2008-10#2)(2008-11#1)
experimental design was##4##3##(2008-10#3)(2008-11#1)
experimental design with##2##3##(2008-10#1)(2012-2#1)
experimental design##48##2##(1994-12#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2012-2#2)
experimental design-neural##2##2##(2008-10#2)
experimental designs##13##2##(1992-9#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
experimental domain##2##2##(2008-10#2)
experimental ecosystems##2##2##(2008-8#2)
experimental effort##2##2##(2008-10#1)(2008-3#1)
experimental enrichment factor##2##3##(2008-10#2)
experimental error##5##2##(1991-5#1)(2008-10#4)
experimental estimation of the##2##4##(2008-10#1)(2008-2#1)
experimental evidence for##4##3##(1992-9#1)(2008-11#1)(2008-3#1)(2008-8#1)
experimental evidence has##2##3##(2011-2#2)
experimental evidence that##3##3##(2008-8#2)(2008-9#1)
experimental evidence to support this##2##5##(2008-10#1)(2008-8#1)
experimental evidence##19##2##(1990-8#1)(1992-9#1)(1993-9#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#4)(2008-9#3)(2011-2#2)(2012-2#1)
experimental evolution##2##2##(2008-10#1)(2012-3#1)
experimental factors on##2##3##(2008-10#2)
experimental factors##5##2##(1993-6#1)(2008-10#3)(2011-2#1)
experimental field study of##2##4##(2008-9#1)(2010-1#1)
experimental field##4##2##(2008-10#2)(2008-9#1)(2010-1#1)
experimental findings##4##2##(1995-9#1)(2008-11#3)
experimental fungicide##2##2##(2008-10#2)
experimental group had##2##3##(2008-11#1)(2010-4#1)
experimental group of##2##3##(1991-12#1)(2008-11#1)
experimental group was##2##3##(2007-8#1)(2010-6#1)
experimental group##28##2##(1991-12#2)(1992-9#1)(1993-6#1)(1995-1#1)(2007-8#2)(2008-11#7)(2008-12#8)(2010-4#2)(2010-6#3)(2012-3#1)
experimental groups of##2##3##(2007-8#1)(2008-12#1)
experimental groups##11##2##(1991-2#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-12#3)(2011-2#1)(2013-1#3)
experimental host range##6##3##(2008-10#6)
experimental implementation##2##2##(2008-11#1)(2008-3#1)
experimental inoculation##2##2##(1993-8#1)(2008-10#1)
experimental investigation of the##3##4##(2008-3#3)
experimental investigation of##4##3##(2008-10#1)(2008-3#3)
experimental investigation##7##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-6#1)
experimental investigations##3##2##(2008-10#1)(2008-6#1)(2010-5#1)
experimental levels##2##2##(2008-7#2)
experimental manipulation##2##2##(2008-8#2)
experimental manipulations##2##2##(2008-8#1)(2012-2#1)
experimental measurement of the##2##4##(2008-2#1)(2008-3#1)
experimental measurement##3##2##(2008-2#1)(2008-3#2)
experimental measurements##5##2##(2008-3#3)(2009-7#1)(2010-10#1)
experimental method for##2##3##(2008-10#1)(2008-3#1)
experimental method is##2##3##(1992-9#1)(2008-3#1)
experimental method##7##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-3#3)
experimental methods##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
experimental model for##3##3##(1993-1#1)(1994-3#1)(2008-10#1)
experimental model of##3##3##(1994-2#1)(2008-12#1)(2008-5#1)
experimental model systems##2##3##(1997-6#1)(2008-10#1)
experimental model##15##2##(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)
experimental models of##5##3##(1994-12#1)(1996-6#1)(2008-11#1)(2008-4#1)(2009-6#1)
experimental models##12##2##(1994-12#1)(1996-6#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2012-12#1)(2012-3#1)
experimental murine##2##2##(2008-4#1)(2012-2#1)
experimental observations##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2013-8#1)
experimental or##2##2##(2008-11#1)(2013-1#1)
experimental parameters for##2##3##(2008-10#2)
experimental parameters have been##2##4##(2008-10#2)
experimental parameters on the##2##4##(1997-2#1)(2008-10#1)
experimental parameters such as##2##4##(2008-10#2)
experimental parameters were##5##3##(2008-10#5)
experimental parameters##33##2##(1994-2#1)(1997-2#1)(2008-10#30)(2010-4#1)
experimental period##5##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-5#2)
experimental plant##2##2##(2008-8#2)
experimental plots##5##2##(2008-10#5)
experimental pneumothorax##2##2##(1990-5#2)
experimental populations##4##2##(1997-7#1)(2008-8#2)(2011-1#1)
experimental procedure##3##2##(2008-5#1)(2008-8#1)(2010-3#1)
experimental procedures##2##2##(2008-4#1)(2008-9#1)
experimental program##2##2##(1996-2#1)(2011-7#1)
experimental rats##4##2##(2011-2#2)(2012-2#1)(2013-1#1)
experimental repetitions##2##2##(2008-10#2)
experimental research##2##2##(2008-11#1)(2008-4#1)
experimental result##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
experimental results and a##2##4##(2007-12#1)(2008-3#1)
experimental results and##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
experimental results are##9##3##(2008-10#2)(2008-11#1)(2008-3#6)
experimental results demonstrate that##3##4##(1997-2#1)(2008-10#1)(2008-7#1)
experimental results for##6##3##(1996-5#1)(2008-10#2)(2008-2#2)(2008-7#1)
experimental results from##3##3##(2008-11#1)(2008-3#2)
experimental results indicate that the##5##5##(1990-12#1)(2008-10#3)(2012-3#1)
experimental results indicated that##4##4##(2008-10#2)(2008-9#2)
experimental results obtained##3##3##(2008-10#2)(2008-3#1)
experimental results of the##2##4##(2008-10#1)(2008-3#1)
experimental results of##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
experimental results show that the##3##5##(2008-10#2)(2013-8#1)
experimental results show that##7##4##(2008-10#3)(2008-3#1)(2008-8#1)(2013-8#2)
experimental results show##9##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#2)
experimental results support the##2##4##(2008-10#1)(2010-12#1)
experimental results was##2##3##(2008-10#1)(2008-7#1)
experimental results were##6##3##(2008-10#3)(2010-4#1)(2011-2#2)
experimental results##98##2##(1990-12#1)(1991-12#1)(1995-3#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#2)(2008-10#33)(2008-11#4)(2008-2#5)(2008-3#20)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
experimental selective COX-2##2##3##(2008-10#2)
experimental set-up##3##2##(2008-10#3)
experimental settings##2##2##(2008-11#2)
experimental setup and##2##3##(2010-12#1)(2010-4#1)
experimental setup##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2010-10#1)(2010-12#1)(2010-4#1)
experimental site##3##2##(2008-10#1)(2008-12#2)
experimental spectra##5##2##(2008-10#1)(2008-3#4)
experimental steps are##3##3##(2008-10#3)
experimental studies have shown##2##4##(2009-7#1)(2011-2#1)
experimental studies have##5##3##(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
experimental studies in##2##3##(2008-8#1)(2009-8#1)
experimental studies##19##2##(1996-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
experimental study of##5##3##(2008-12#1)(2008-2#1)(2008-3#3)
experimental study was##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
experimental study##18##2##(1990-9#1)(1992-9#1)(1993-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-9#1)(2010-7#1)(2010-8#1)(2012-3#2)
experimental support for##2##3##(2008-10#1)(2008-8#1)
experimental system for##3##3##(1993-2#1)(1996-2#1)(2008-9#1)
experimental system##13##2##(1993-2#1)(1996-2#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2012-3#1)
experimental systems##4##2##(1994-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
experimental techniques##2##2##(2008-10#1)(2008-7#1)
experimental test##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
experimental tests and##2##3##(2011-2#2)
experimental tests##3##2##(2008-8#1)(2011-2#2)
experimental tools##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
experimental treatment##3##2##(1990-12#1)(2008-10#1)(2010-9#1)
experimental unit##2##2##(2008-10#2)
experimental vaccines##2##2##(2008-11#1)(2008-4#1)
experimental value of##2##3##(2008-10#2)
experimental value##3##2##(2008-10#3)
experimental values of##2##3##(2008-10#1)(2008-11#1)
experimental values##6##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-2#1)
experimental variables affecting the fluorescence intensity##2##6##(2008-10#2)
experimental variables affecting the##3##4##(2008-10#3)
experimental variables such as##3##4##(2008-10#3)
experimental variables##17##2##(2008-10#17)
experimental verification##2##2##(1995-3#1)(2011-2#1)
experimental work##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
experimental works##2##2##(1997-7#1)(2008-10#1)
experimental##1075##1##(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#4)(1990-8#1)(1990-9#2)(1991-12#7)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#5)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#7)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#1)(1996-5#3)(1996-6#3)(1996-9#2)(1997-2#9)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#2)(2006-6#1)(2007-11#3)(2007-12#6)(2007-8#3)(2008-10#418)(2008-11#68)(2008-12#27)(2008-2#19)(2008-3#78)(2008-4#13)(2008-5#23)(2008-6#4)(2008-7#46)(2008-8#40)(2008-9#25)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#2)(2009-6#3)(2009-7#8)(2009-8#6)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#31)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#13)(2012-3#16)(2012-5#3)(2012-9#1)(2013-1#22)(2013-7#1)(2013-8#15)
experimentally and theoretically##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
experimentally and##8##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2011-3#1)
experimentally by##4##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
experimentally demonstrated by use of##2##5##(2008-3#2)
experimentally demonstrated##5##2##(1997-6#1)(2008-2#1)(2008-3#2)(2011-2#1)
experimentally derived##2##2##(2008-10#1)(2008-8#1)
experimentally determined##8##2##(1994-3#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)
experimentally examined##2##2##(2008-10#1)(2008-3#1)
experimentally filled##3##2##(2009-7#3)
experimentally for the##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
experimentally for##4##2##(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
experimentally in##5##2##(2008-10#2)(2008-3#3)
experimentally induced##7##2##(1992-6#1)(1995-11#1)(1995-12#1)(2008-12#1)(2009-11#1)(2010-8#1)(2012-3#1)
experimentally infected with##2##3##(2008-12#1)(2008-5#1)
experimentally infected##5##2##(1996-12#1)(2008-12#1)(2008-5#2)(2010-1#1)
experimentally investigated##2##2##(1997-2#1)(2008-3#1)
experimentally measured responses##2##3##(2008-10#1)(2008-11#1)
experimentally measured##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
experimentally observed##4##2##(2007-12#1)(2008-7#2)(2012-2#1)
experimentally obtained##5##2##(2007-11#1)(2008-3#3)(2008-7#1)
experimentally recorded##2##2##(2008-3#1)(2009-8#1)
experimentally relevant##2##2##(2009-5#1)(2009-7#1)
experimentally studied##2##2##(2008-3#2)
experimentally tested##3##2##(2008-3#1)(2008-8#1)(2012-9#1)
experimentally the##2##2##(2008-3#1)(2011-2#1)
experimentally through##2##2##(2008-10#1)(2008-5#1)
experimentally verified by##2##3##(2008-10#1)(2008-3#1)
experimentally verified##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
experimentally with##2##2##(1995-9#1)(1996-3#1)
experimentally##159##1##(1991-5#2)(1992-6#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-6#6)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#31)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#36)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#2)(2009-5#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#3)(2013-8#1)
experimentally-induced MD cutaneous lymphoma lesions##2##5##(2008-5#2)
experimentation in##2##2##(1997-7#1)(2008-10#1)
experimentation is##2##2##(1991-12#1)(2013-1#1)
experimentation with##2##2##(2009-12#1)(2013-8#1)
experimentation##19##1##(1991-12#1)(1991-9#1)(1993-2#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
experimented with##2##2##(2008-11#1)(2011-2#1)
experimenter##2##1##(2008-11#2)
experiments 1 and 2##2##4##(2008-10#1)(2008-11#1)
experiments and genetic##2##3##(2008-11#1)(2008-8#1)
experiments and in##2##3##(1991-12#1)(1995-9#1)
experiments and the##3##3##(2008-10#2)(2008-3#1)
experiments and##23##2##(1991-12#1)(1995-8#1)(1995-9#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
experiments are described##2##3##(2008-11#1)(2008-4#1)
experiments are part of a larger study designed to investigate the influence of husbandry parameters on the life history of the##2##21##(2008-11#2)
experiments are##15##2##(1991-12#1)(1991-6#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#1)(2009-12#1)(2011-3#1)
experiments as well as##2##4##(1995-12#1)(2008-10#1)
experiments as well##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
experiments as##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
experiments at##4##2##(2008-10#3)(2010-10#1)
experiments between##2##2##(2008-10#1)(2008-5#1)
experiments can##2##2##(2009-10#1)(2011-3#1)
experiments carried out on##2##4##(2008-10#1)(2008-5#1)
experiments carried out##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
experiments compared with the##2##4##(2008-10#2)
experiments conducted at two locations##2##5##(2008-10#2)
experiments conducted at##4##3##(2008-10#2)(2008-3#1)(2009-7#1)
experiments conducted in##4##3##(2008-10#3)(2010-8#1)
experiments conducted##12##2##(1995-12#1)(2008-10#8)(2008-3#1)(2009-7#1)(2010-8#1)
experiments confirmed that##2##3##(2008-10#1)(2008-11#1)
experiments confirmed##4##2##(2008-10#3)(2008-11#1)
experiments could##2##2##(2008-11#1)(2009-8#1)
experiments demonstrate that##2##3##(2008-10#1)(2008-11#1)
experiments demonstrate the##3##3##(1995-2#1)(2008-3#2)
experiments demonstrate##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#2)
experiments demonstrated that both##2##4##(1994-5#1)(2008-11#1)
experiments demonstrated that the##2##4##(2008-10#1)(2008-6#1)
experiments demonstrated that##9##3##(1994-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)
experiments do not##2##3##(2008-10#1)(2008-3#1)
experiments examine##2##2##(2008-9#1)(2010-4#1)
experiments for the##2##3##(2008-10#1)(2008-3#1)
experiments for##6##2##(2008-10#4)(2008-11#1)(2008-3#1)
experiments from##5##2##(2008-10#4)(2009-10#1)
experiments further established that##2##4##(2008-10#2)
experiments have been carried out##2##5##(2008-10#1)(2008-5#1)
experiments have been performed##2##4##(1995-11#1)(2008-3#1)
experiments have been##4##3##(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
experiments have identified##2##3##(2008-10#1)(2008-11#1)
experiments have provided##3##3##(1991-2#1)(2009-12#1)(2010-4#1)
experiments have shown that##4##4##(2006-6#1)(2008-10#1)(2008-7#1)(2010-4#1)
experiments have##21##2##(1990-2#1)(1991-2#1)(1995-11#1)(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#2)(2012-3#1)(2013-1#1)
experiments in a##2##3##(2008-11#1)(2008-8#1)
experiments in contact##2##3##(2008-10#2)
experiments in mice##2##3##(2008-10#1)(2009-6#1)
experiments in the##5##3##(1993-8#1)(2008-10#3)(2008-2#1)
experiments in which the##3##4##(2008-7#2)(2011-2#1)
experiments in which##9##3##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)
experiments in##53##2##(1993-8#1)(1994-8#1)(1996-12#1)(1997-6#2)(2008-10#27)(2008-11#7)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#2)(2010-1#1)(2011-2#1)(2012-3#1)
experiments included##2##2##(2008-10#2)
experiments indicate that the##2##4##(1993-6#1)(2008-7#1)
experiments indicate that##10##3##(1993-6#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
experiments indicated that the##2##4##(2008-10#2)
experiments indicated that##9##3##(2008-10#8)(2013-1#1)
experiments indicated the##2##3##(1997-3#1)(2010-2#1)
experiments indicated##13##2##(1995-11#1)(1997-3#1)(2008-10#8)(2010-2#1)(2011-1#1)(2013-1#1)
experiments involving##4##2##(1995-8#1)(2008-10#1)(2008-6#1)(2013-8#1)
experiments led to the##2##4##(2008-7#1)(2010-7#1)
experiments of##8##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
experiments on the##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
experiments on##14##2##(1994-5#2)(1995-3#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#2)(2010-1#1)(2010-4#1)
experiments over two##2##3##(2008-10#1)(2013-8#1)
experiments performed with the##3##4##(2008-10#2)(2009-8#1)
experiments performed with##4##3##(2008-10#3)(2009-8#1)
experiments performed##8##2##(1990-2#1)(2008-10#5)(2009-8#1)(2011-2#1)
experiments proved that##2##3##(2009-3#1)(2012-3#1)
experiments provide##2##2##(2008-11#1)(2013-8#1)
experiments reported here##4##3##(1990-5#1)(1993-6#1)(2008-7#2)
experiments reported##5##2##(1990-5#1)(1993-6#1)(2008-7#2)(2012-2#1)
experiments revealed that the##2##4##(1993-8#1)(2008-10#1)
experiments revealed that##13##3##(1993-8#1)(1994-2#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#1)
experiments revealed##15##2##(1993-8#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#1)
experiments show that the##5##4##(1990-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
experiments show that##11##3##(1990-11#1)(1990-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-3#1)
experiments show##13##2##(1990-11#1)(1990-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-3#1)
experiments showed that the##6##4##(1991-7#1)(2008-10#5)
experiments showed that##18##3##(1991-7#1)(1992-2#1)(1996-3#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-6#1)(2008-9#2)
experiments showed the##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
experiments showed##23##2##(1991-7#1)(1992-2#1)(1996-3#1)(1997-2#1)(2008-10#11)(2008-11#4)(2008-6#1)(2008-9#3)
experiments showing##2##2##(2008-11#1)(2013-8#1)
experiments suggest that##6##3##(1990-5#1)(1994-8#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-8#1)
experiments suggest##7##2##(1990-5#1)(1992-10#1)(1994-8#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-8#1)
experiments support##2##2##(2008-10#1)(2008-6#1)
experiments that can##2##3##(2008-11#1)(2010-10#1)
experiments that##11##2##(1993-2#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-4#1)
experiments the##2##2##(2008-11#2)
experiments to##10##2##(1993-2#1)(1993-3#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-8#2)(2009-6#1)(2009-8#1)(2012-2#1)
experiments under##3##2##(2008-10#3)
experiments using a##2##3##(2009-10#1)(2010-1#1)
experiments using different##2##3##(2008-10#1)(2008-5#1)
experiments using the##2##3##(1993-8#1)(2008-7#1)
experiments using##18##2##(1993-8#1)(1995-8#1)(2008-10#4)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-1#1)(2011-2#1)
experiments utilizing##2##2##(2008-10#1)(2008-4#1)
experiments was##5##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
experiments were carried out at##2##5##(2008-10#2)
experiments were carried out in##2##5##(2008-10#1)(2008-11#1)
experiments were carried out to##4##5##(2008-10#2)(2008-6#1)(2013-1#1)
experiments were carried out##13##4##(2008-10#9)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
experiments were conducted in a##2##5##(2008-10#1)(2011-2#1)
experiments were conducted in##6##4##(2008-10#5)(2011-2#1)
experiments were conducted to determine the##2##6##(2008-10#1)(2010-11#1)
experiments were conducted to determine##3##5##(2008-10#1)(2010-11#1)(2011-2#1)
experiments were conducted to investigate the##2##6##(2008-10#1)(2008-6#1)
experiments were conducted to study the effects of##2##8##(2008-10#2)
experiments were conducted to study the##4##6##(2008-10#4)
experiments were conducted to test##2##5##(2008-10#1)(2008-11#1)
experiments were conducted to##14##4##(1996-2#1)(2008-10#8)(2008-11#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-3#1)
experiments were conducted with##5##4##(2008-10#3)(2010-2#1)(2010-8#1)
experiments were conducted##29##3##(1996-2#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-6#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-3#1)
experiments were performed in order to##2##6##(2008-10#2)
experiments were performed in##6##4##(1993-12#1)(2008-10#4)(2008-11#1)
experiments were performed to##6##4##(1995-11#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
experiments were performed using##2##4##(2008-10#2)
experiments were performed##23##3##(1990-12#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(2006-6#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-5#1)(2011-2#1)
experiments were used to##3##4##(2008-10#2)(2008-8#1)
experiments were used##4##3##(2008-10#3)(2008-8#1)
experiments were##82##2##(1990-12#1)(1990-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(2006-6#1)(2007-12#1)(2008-10#44)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)
experiments where##4##2##(2008-10#3)(2008-9#1)
experiments with a##3##3##(2008-10#3)
experiments with an##2##3##(2008-10#1)(2008-5#1)
experiments with rats##3##3##(2008-5#3)
experiments with the##3##3##(2008-10#1)(2008-2#1)(2009-7#1)
experiments with##57##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1995-12#1)(1996-2#1)(1996-5#2)(2008-10#18)(2008-11#6)(2008-2#1)(2008-5#6)(2008-6#1)(2009-7#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
experiments##884##1##(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#8)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#8)(1993-6#5)(1993-8#9)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#8)(1994-3#2)(1994-5#7)(1994-8#4)(1994-9#1)(1995-11#4)(1995-12#6)(1995-2#6)(1995-3#3)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#5)(1996-3#2)(1996-5#3)(1996-6#2)(1996-8#1)(1997-2#4)(1997-3#6)(1997-4#1)(1997-6#9)(1997-7#1)(1997-8#1)(2006-6#3)(2007-11#1)(2007-12#8)(2008-10#364)(2008-11#78)(2008-12#4)(2008-2#4)(2008-3#22)(2008-4#8)(2008-5#32)(2008-6#15)(2008-7#28)(2008-8#30)(2008-9#23)(2009-10#7)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#2)(2011-2#13)(2011-3#4)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#9)
experiments)##5##1##(1992-6#1)(2008-10#2)(2008-8#1)(2013-1#1)
expert group##6##2##(1990-11#1)(2008-10#1)(2008-11#2)(2010-12#1)(2012-3#1)
expert in the##3##3##(1993-12#1)(1995-11#1)(2011-2#1)
expert in##6##2##(1993-12#1)(1994-12#1)(1995-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
expert opinion when##2##3##(1993-12#2)
expert opinion##8##2##(1993-12#2)(1996-2#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
expert panel - EPACT II##2##5##(2010-12#2)
expert panel##5##2##(2010-12#5)
expert practice in##2##3##(2008-11#2)
expert system##7##2##(2008-10#6)(2011-2#1)
expert systems##2##2##(1996-2#1)(2011-2#1)
expert witness##2##2##(1994-3#1)(2012-2#1)
expert##88##1##(1990-11#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#4)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-6#1)(1997-8#1)(2008-10#12)(2008-11#8)(2008-5#5)(2008-7#1)(2009-6#1)(2010-10#3)(2010-12#9)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-10#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
expertise and resources##3##3##(1990-12#1)(2008-12#1)(2013-1#1)
expertise and##10##2##(1990-11#1)(1990-12#1)(1994-1#2)(1995-3#1)(2008-10#1)(2008-12#1)(2009-8#2)(2013-1#1)
expertise for##2##2##(1996-2#1)(2013-1#1)
expertise in##2##2##(2008-10#1)(2013-1#1)
expertise is##3##2##(1995-11#1)(1996-2#1)(2008-12#1)
expertise of the##3##3##(1992-1#1)(1997-8#1)(2011-1#1)
expertise of##6##2##(1992-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-8#1)(2011-1#1)
expertise##49##1##(1990-11#1)(1990-12#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-1#6)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#3)(1997-8#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2011-9#2)(2012-2#1)(2013-1#3)(2013-8#1)
experts and##5##2##(1990-6#1)(1996-1#1)(2008-11#1)(2010-10#1)(2011-2#1)
experts are##2##2##(1992-8#1)(2013-1#1)
experts from the region##2##4##(2008-8#1)(2009-8#1)
experts from the##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
experts from##9##2##(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#3)(2011-10#1)(2011-8#1)(2013-1#1)
experts in the##2##3##(2008-10#1)(2013-1#1)
experts in##5##2##(2008-10#1)(2008-5#2)(2011-10#1)(2013-1#1)
experts on##2##2##(1996-2#1)(2008-10#1)
experts to##2##2##(1995-12#1)(2011-10#1)
experts who##2##2##(2010-10#2)
experts##62##1##(1990-6#1)(1991-12#2)(1991-3#2)(1992-8#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-5#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#8)(2010-5#1)(2011-10#5)(2011-2#5)(2011-8#1)(2012-2#1)(2013-1#3)(2013-8#1)
expiration##3##1##(1990-11#1)(2008-7#2)
expiratory flow##6##2##(1996-1#1)(2008-1#3)(2008-7#1)(2009-1#1)
expiratory pressure##3##2##(1991-2#1)(1997-3#2)
expiratory volume in##2##3##(2011-2#1)(2012-3#1)
expiratory volume##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
expiratory##21##1##(1991-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-1#4)(2008-11#1)(2008-7#4)(2008-8#1)(2009-1#1)(2011-2#1)(2012-3#1)
explain a##5##2##(1994-5#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
explain all##2##2##(1991-11#1)(2008-10#1)
explain differences in the##2##4##(1992-12#1)(2008-10#1)
explain how the##2##3##(2008-3#1)(2008-8#1)
explain how##7##2##(1993-2#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-11#1)
explain in##2##2##(1997-8#1)(2012-2#1)
explain its##3##2##(1993-8#1)(2008-11#1)(2009-6#1)
explain most##2##2##(2008-10#1)(2008-9#1)
explain phenotypic##2##2##(2011-2#1)(2013-8#1)
explain some of the observed##2##5##(2008-10#1)(2008-8#1)
explain some##4##2##(1992-9#1)(2008-10#2)(2008-8#1)
explain the coexistence of##2##4##(2008-8#1)(2008-9#1)
explain the differences##2##3##(1991-11#1)(1992-2#1)
explain the effect of##3##4##(1990-12#1)(1994-5#1)(2008-7#1)
explain the effect##4##3##(1990-12#1)(1994-5#1)(2008-3#1)(2008-7#1)
explain the evolution of##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
explain the high##2##3##(2008-10#2)
explain the observed##7##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-7#1)
explain the occurrence of##2##4##(2008-8#1)(2012-3#1)
explain the rationale for##2##4##(1992-2#1)(2009-6#1)
explain the##119##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-2#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#26)(2008-11#9)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#10)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#2)(2013-8#1)
explain their##7##2##(1995-12#1)(2008-10#2)(2008-7#1)(2011-10#1)(2011-2#2)
explain these##5##2##(1993-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-2#1)
explain this behavior##2##3##(2008-9#1)(2012-2#1)
explain this phenomenon##2##3##(2008-4#1)(2009-8#1)
explain this##9##2##(1996-5#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-2#1)
explain why##12##2##(1994-8#1)(2008-10#2)(2008-12#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
explain##231##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-3#2)(1997-7#2)(1997-8#3)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#52)(2008-11#12)(2008-12#4)(2008-3#5)(2008-4#3)(2008-5#4)(2008-7#12)(2008-8#21)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#4)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#2)(2011-10#1)(2011-2#6)(2011-7#1)(2012-12#3)(2012-2#9)(2012-3#5)(2012-4#1)(2013-1#2)(2013-8#4)
explainable by##3##2##(1995-12#2)(2008-9#1)
explainable##5##1##(1995-12#2)(1997-7#1)(2008-9#1)(2012-2#1)
explained a##2##2##(2008-10#2)
explained about##2##2##(2008-10#1)(2012-3#1)
explained as a##2##3##(2008-10#1)(2008-8#1)
explained as##4##2##(2008-10#2)(2008-8#1)(2009-6#1)
explained between##2##2##(2008-10#2)
explained by a##13##3##(1990-11#1)(1993-1#1)(1993-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-8#2)(2008-9#1)
explained by assuming the##4##4##(2008-10#3)(2013-1#1)
explained by assuming##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
explained by differences##3##3##(2008-10#1)(2008-8#1)(2009-7#1)
explained by its##3##3##(1992-8#1)(1995-11#1)(2008-10#1)
explained by the fact that the##2##6##(1992-1#1)(2008-11#1)
explained by the presence of##2##5##(2008-10#1)(2008-3#1)
explained by the underlying##2##4##(2008-11#2)
explained by the##36##3##(1990-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-5#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#3)(2013-8#1)
explained by##106##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-1#2)(2008-10#33)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#6)(2008-9#4)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
explained from an##2##3##(2008-10#1)(2012-3#1)
explained from##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
explained how##2##2##(1993-12#1)(2013-1#1)
explained in detail##2##3##(2008-10#2)
explained in terms of a##2##5##(1993-8#2)
explained in terms of the##3##5##(2008-10#2)(2008-12#1)
explained in terms of##9##4##(1990-8#1)(1991-3#1)(1993-8#2)(1997-2#1)(2008-10#3)(2008-12#1)
explained in##14##2##(1990-8#2)(1991-3#1)(1993-8#2)(1997-2#1)(2008-10#5)(2008-12#1)(2008-4#1)(2013-1#1)
explained more than##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
explained most variance##2##3##(2008-9#2)
explained most##3##2##(2008-10#1)(2008-9#2)
explained on the basis of##2##5##(1990-5#1)(2008-10#1)
explained on##3##2##(1990-5#1)(1996-2#1)(2008-10#1)
explained only##2##2##(2008-7#1)(2008-9#1)
explained that##2##2##(2008-7#1)(2013-8#1)
explained the##3##2##(2008-10#2)(2008-9#1)
explained through the##2##3##(2008-10#2)
explained through##3##2##(2008-1#1)(2008-10#2)
explained up to##5##3##(2008-10#5)
explained using a##2##3##(2008-5#1)(2008-7#1)
explained using the##2##3##(2008-10#2)
explained using##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
explained with##3##2##(1996-3#1)(2008-10#1)(2008-3#1)
explained##242##1##(1990-11#1)(1990-12#1)(1990-5#3)(1990-8#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-8#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#101)(2008-11#12)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#10)(2008-9#9)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#10)(2013-8#3)
explaining between##2##2##(2008-10#2)
explaining over##2##2##(2008-10#2)
explaining the##6##2##(2008-10#3)(2008-12#1)(2008-8#1)(2010-7#1)
explaining##40##1##(1991-2#1)(1992-12#1)(1995-2#2)(1997-8#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-7#2)(2008-8#7)(2008-9#1)(2009-9#1)(2010-2#1)(2010-7#1)(2013-8#1)
explains how the##3##3##(1991-1#1)(1995-1#1)(2010-5#1)
explains how to##2##3##(1993-3#1)(2008-12#1)
explains how##9##2##(1991-1#1)(1991-2#1)(1992-12#1)(1993-3#1)(1994-2#1)(1995-1#1)(2008-12#1)(2009-10#1)(2010-5#1)
explains the##19##2##(1992-1#1)(1993-3#1)(1994-12#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
explains why##7##2##(1991-1#1)(1992-10#1)(1992-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
explains##42##1##(1991-1#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
explanation based on##2##3##(2008-9#1)(2013-1#1)
explanation for how##2##3##(2010-1#1)(2010-3#1)
explanation for the lack of##4##5##(1997-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
explanation for the previously##2##4##(1992-3#1)(2011-1#1)
explanation for the##27##3##(1991-12#1)(1992-3#1)(1992-5#1)(1994-8#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
explanation for these##4##3##(1997-2#1)(2008-9#1)(2010-1#1)(2010-12#1)
explanation for this##5##3##(2007-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
explanation for##47##2##(1991-12#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-2#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#8)(2010-1#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
explanation is that##2##3##(1993-8#1)(2009-7#1)
explanation is##5##2##(1993-8#1)(2008-3#1)(2009-10#1)(2009-7#1)(2011-2#1)
explanation of the phenomenon##2##4##(2008-11#1)(2008-3#1)
explanation of the##11##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-3#1)(2013-8#1)
explanation of this##4##3##(1990-12#1)(1991-6#1)(1997-1#1)(2008-10#1)
explanation of##23##2##(1990-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2010-3#1)(2013-8#1)
explanation why##2##2##(1997-1#1)(2012-2#1)
explanation##93##1##(1990-12#1)(1991-12#3)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#3)(1997-1#3)(1997-2#2)(1997-4#1)(2007-11#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
explanations for the##5##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
explanations for this##5##3##(1991-2#1)(1992-12#1)(1993-11#1)(2008-8#1)(2011-2#1)
explanations for##14##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#4)(2008-9#1)(2011-1#1)(2011-2#1)
explanations of the##3##3##(1991-11#1)(2008-5#1)(2010-1#1)
explanations of##5##2##(1991-11#1)(1991-3#1)(2008-10#1)(2008-5#1)(2010-1#1)
explanations to the##2##3##(2008-10#1)(2008-8#1)
explanations##29##1##(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#3)(2009-10#1)(2010-1#1)(2011-1#1)(2011-2#2)
explanatory power##6##2##(1993-3#1)(1997-1#1)(2008-10#3)(2010-4#1)
explanatory value##2##2##(1995-11#1)(2008-11#1)
explanatory variables on##2##3##(2008-10#1)(2008-4#1)
explanatory variables##6##2##(1995-12#1)(2008-10#2)(2008-4#1)(2010-1#1)(2013-8#1)
explanatory##21##1##(1992-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2010-1#1)(2010-4#1)(2013-8#2)
explant cultures##2##2##(1994-3#1)(1995-9#1)
explant for##3##2##(2008-12#1)(2013-1#2)
explant outgrowth##2##2##(2008-11#2)
explant##17##1##(1994-3#1)(1995-9#2)(2008-10#1)(2008-11#5)(2008-12#4)(2008-7#1)(2011-3#1)(2013-1#2)
explantation of##2##2##(2008-9#2)
explantation##4##1##(2008-9#4)
explanted retina##2##2##(2010-1#2)
explanted##11##1##(2008-10#1)(2008-11#1)(2008-9#2)(2010-1#2)(2012-12#3)(2012-3#1)(2013-1#1)
explants indicate##2##2##(1993-11#1)(2013-1#1)
explants of##2##2##(2008-12#2)
explants##25##1##(1993-11#1)(1994-5#1)(2008-12#13)(2008-8#2)(2010-1#4)(2013-1#4)
explicable##2##1##(2008-4#1)(2008-5#1)
explicate##3##1##(2008-12#1)(2010-10#1)(2012-2#1)
explicit and##2##2##(2008-12#1)(2009-9#1)
explicit attitudes##5##2##(2009-9#5)
explicit expressions of##2##3##(2008-10#2)
explicit goal to##2##3##(2008-11#2)
explicit goal##3##2##(2008-11#3)
explicit or##3##2##(2013-1#3)
explicit representation of the##2##4##(2008-4#1)(2008-8#1)
explicit simulation model##2##3##(2008-8#1)(2008-9#1)
explicit solvent##2##2##(2008-4#1)(2009-7#1)
explicit##58##1##(1993-3#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#13)(2008-9#4)(2009-10#1)(2009-7#1)(2009-9#6)(2010-12#2)(2010-5#1)(2012-3#3)(2013-1#5)(2013-8#1)
explicitly considered##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
explicitly include##2##2##(2008-10#1)(2009-8#1)
explicitly##33##1##(1990-11#1)(1991-6#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)
explode##2##1##(1991-1#1)(2008-5#1)
exploit the##8##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-8#1)
exploit##17##1##(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#1)(2009-8#1)(2012-2#1)
exploitation and##2##2##(1995-5#1)(2008-8#1)
exploitation by##2##2##(2012-3#1)(2013-1#1)
exploitation of the Ni(III)/Ni(II)##2##4##(2008-10#2)
exploitation of the##3##3##(2007-11#1)(2008-10#2)
exploitation of##11##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#2)
exploitation strategies##5##2##(2008-8#5)
exploitation##39##1##(1995-3#1)(1995-5#7)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#13)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#2)
exploitative##3##1##(1995-5#1)(2008-8#1)(2008-9#1)
exploited as##4##2##(2008-10#3)(2013-1#1)
exploited by##2##2##(1993-2#1)(2008-8#1)
exploited for the##2##3##(2009-3#1)(2011-2#1)
exploited for##9##2##(1995-5#1)(2008-10#4)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
exploited in order to##2##4##(2008-10#2)
exploited in##9##2##(1996-11#1)(2008-10#7)(2008-11#1)
exploited the##2##2##(1992-4#1)(2008-10#1)
exploited to determine##2##3##(2008-10#1)(2008-8#1)
exploited to develop##3##3##(2008-10#2)(2009-6#1)
exploited to##15##2##(2008-10#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-7#1)
exploited##55##1##(1990-8#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-11#1)(2008-10#26)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
exploiting multicommutation and##2##3##(2008-10#2)
exploiting multicommutation##3##2##(2008-10#3)
exploiting the##9##2##(1990-8#1)(2008-10#5)(2008-11#2)(2008-3#1)
exploiting##29##1##(1990-8#1)(1993-12#1)(1997-7#1)(2008-10#19)(2008-11#2)(2008-3#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-3#1)
exploits the##5##2##(2008-10#3)(2008-3#1)(2012-2#1)
exploits##11##1##(1995-6#1)(2008-10#3)(2008-3#3)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
exploration and##6##2##(1992-2#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-7#1)
exploration for##2##2##(1991-6#1)(2008-10#1)
exploration of the##18##3##(1990-2#1)(1991-6#1)(1993-12#1)(1994-1#1)(2008-10#3)(2008-12#4)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-8#1)
exploration of this##2##3##(2009-5#1)(2012-5#1)
exploration of##39##2##(1990-2#1)(1991-3#1)(1991-6#1)(1993-11#1)(1993-12#1)(1994-1#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-12#5)(2008-5#1)(2009-12#2)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#3)
exploration##76##1##(1990-2#1)(1991-3#2)(1991-6#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1996-2#1)(1997-3#1)(2008-10#10)(2008-11#3)(2008-12#6)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#3)(2009-5#2)(2009-7#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#6)(2013-8#3)
explorations of##2##2##(2009-4#1)(2010-11#1)
explorations##3##1##(2009-4#1)(2010-11#1)(2012-3#1)
explorative##6##1##(1991-3#1)(1992-5#1)(2009-12#1)(2011-2#1)(2013-1#2)
exploratory analysis##3##2##(1995-5#1)(2011-2#1)(2012-12#1)
exploratory and##2##2##(2008-11#1)(2012-3#1)
exploratory behavior##3##2##(1993-6#2)(1996-2#1)
exploratory data analysis##3##3##(2008-10#2)(2011-2#1)
exploratory factor##3##2##(2009-11#1)(2009-12#1)(2010-11#1)
exploratory investigation of reactions##2##4##(2008-10#2)
exploratory laparotomy##3##2##(1990-2#1)(1993-6#1)(2011-2#1)
exploratory study of##2##3##(2009-5#1)(2010-10#1)
exploratory study was undertaken##2##4##(2008-11#2)
exploratory study was##3##3##(2008-11#2)(2011-2#1)
exploratory study##18##2##(2008-10#1)(2008-11#4)(2009-5#3)(2010-10#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
exploratory##59##1##(1990-2#1)(1991-8#2)(1992-1#1)(1993-2#2)(1993-3#1)(1993-6#3)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#1)(2009-11#1)(2009-12#1)(2009-5#3)(2010-10#3)(2010-11#2)(2010-6#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
explore a##6##2##(1991-12#1)(1994-12#1)(1995-8#1)(2008-11#2)(2008-9#1)
explore how##5##2##(1997-3#1)(2008-11#1)(2008-8#2)(2012-12#1)
explore nursing##2##2##(2008-12#1)(2010-10#1)
explore possible##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
explore relationships##2##2##(2013-1#2)
explore the consequences of##3##4##(2008-8#1)(2009-8#1)(2010-10#1)
explore the effects of##3##4##(1995-9#1)(2008-8#1)(2008-9#1)
explore the evolution of##2##4##(2008-8#2)
explore the factors##2##3##(2008-8#1)(2011-2#1)
explore the mechanisms underlying##2##4##(2008-9#2)
explore the possibility of##4##4##(1993-12#1)(1993-3#1)(2008-11#1)(2012-3#1)
explore the potential for##2##4##(2008-10#1)(2008-11#1)
explore the potential##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
explore the reasons why##2##4##(1991-2#1)(2013-1#1)
explore the relationship##3##3##(2008-7#1)(2010-11#1)(2013-8#1)
explore the relationships##3##3##(2008-9#1)(2010-8#1)(2012-2#1)
explore the##79##2##(1991-12#1)(1991-2#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-9#1)(1996-1#1)(1996-2#2)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#4)(2008-4#1)(2008-7#1)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#3)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
explore their##4##2##(1994-6#1)(2008-11#1)(2010-8#1)(2011-2#1)
explore this possibility##4##3##(2008-8#1)(2008-9#1)(2010-10#1)(2013-8#1)
explore this##7##2##(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2013-8#2)
explore various##2##2##(2008-5#1)(2012-3#1)
explore ways##2##2##(1994-1#1)(1997-1#1)
explore whether##4##2##(2008-10#2)(2008-11#1)(2009-4#1)
explore##170##1##(1991-12#2)(1991-2#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#3)(1994-12#2)(1994-3#2)(1994-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#4)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#14)(2008-11#21)(2008-12#10)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#13)(2008-9#7)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#9)(2010-11#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#9)(2013-8#5)
explored and##7##2##(1992-2#1)(1994-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)(2013-8#1)
explored as##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2010-4#1)
explored at##3##2##(1995-2#1)(2008-10#2)
explored by##5##2##(1993-12#1)(1995-8#1)(2008-10#2)(2008-11#1)
explored for##10##2##(2008-10#5)(2008-7#1)(2009-12#2)(2012-2#1)(2012-5#1)
explored how##3##2##(2008-11#1)(2008-12#1)(2012-3#1)
explored in a##3##3##(1990-12#1)(2008-10#1)(2010-1#1)
explored in this##2##3##(1994-2#1)(2008-12#1)
explored in##13##2##(1990-12#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2009-10#1)(2010-1#1)(2010-6#1)(2013-1#1)
explored the analytical##2##3##(2008-10#2)
explored the idea##2##3##(2008-10#1)(2008-8#1)
explored the perceptions of##2##4##(2008-11#1)(2010-9#1)
explored the perceptions##3##3##(2008-11#1)(2010-11#1)(2010-9#1)
explored the##36##2##(1992-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-4#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)
explored to##4##2##(2008-10#3)(2008-8#1)
explored using##2##2##(1993-1#1)(2013-1#1)
explored##171##1##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-8#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#38)(2008-11#22)(2008-12#10)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#5)(2008-9#7)(2009-10#5)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
explorers##2##1##(1994-3#1)(2012-2#1)
explores access to##2##3##(2008-11#1)(2008-12#1)
explores how##6##2##(2008-11#2)(2008-12#1)(2009-6#1)(2010-9#1)(2013-8#1)
explores recent##2##2##(1996-3#1)(2008-11#1)
explores several##2##2##(1994-2#1)(2008-12#1)
explores the impact of##2##4##(1997-1#1)(2008-11#1)
explores the relationship between##2##4##(1996-2#1)(2011-2#1)
explores the relationship##3##3##(1996-2#2)(2011-2#1)
explores the##34##2##(1992-9#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-1#2)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
explores whether##2##2##(2008-11#1)(2012-3#1)
explores##75##1##(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#4)(1996-3#2)(1997-1#4)(1997-3#1)(2008-1#2)(2008-10#3)(2008-11#14)(2008-12#8)(2008-5#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
exploring the changes in##2##4##(2008-11#1)(2013-8#1)
exploring the effect of##3##4##(2008-11#1)(2010-2#1)(2013-1#1)
exploring the impact of##2##4##(2008-11#1)(2009-4#1)
exploring the##26##2##(1995-8#1)(2008-10#2)(2008-11#10)(2008-12#1)(2008-3#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
exploring their##2##2##(2008-11#1)(2008-7#1)
exploring##44##1##(1994-8#1)(1995-8#1)(2008-10#3)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-1#3)(2013-8#2)
explosion due to##2##3##(2009-10#2)
explosion of##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
explosion##7##1##(2008-11#2)(2008-12#1)(2009-10#3)(2013-1#1)
explosions##2##1##(2008-10#1)(2009-10#1)
explosive compounds and##2##3##(2008-10#2)
explosive compounds##3##2##(2008-10#3)
explosive odor##2##2##(2008-10#2)
explosive substances##2##2##(2009-10#2)
explosive##32##1##(2008-10#27)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#2)
explosives and##5##2##(2008-10#5)
explosives detection##5##2##(2008-10#5)
explosives in soil##2##3##(2008-10#2)
explosives in##5##2##(2008-10#5)
explosives is##2##2##(2008-10#2)
explosives were##2##2##(2008-10#2)
explosives##54##1##(2008-10#49)(2008-11#4)(2009-10#1)
exponent of##3##2##(2008-3#1)(2008-7#2)
exponent##7##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-8#1)
exponential cell growth##2##3##(2008-11#2)
exponential decay##2##2##(2008-2#1)(2012-2#1)
exponential decrease##2##2##(2008-11#2)
exponential growth in##2##3##(2008-11#1)(2011-2#1)
exponential growth phase and##2##4##(2008-11#2)
exponential growth phase##9##3##(2008-11#6)(2008-7#2)(2011-2#1)
exponential growth##19##2##(1995-8#1)(1995-9#1)(2008-11#7)(2008-7#6)(2009-12#1)(2011-2#2)(2013-8#1)
exponential increase of##2##3##(1995-9#1)(2008-10#1)
exponential increase##4##2##(1995-3#1)(1995-9#1)(2008-10#1)(2012-2#1)
exponential model##4##2##(1995-9#1)(2008-10#2)(2013-8#1)
exponential phase##13##2##(1993-8#1)(1994-8#1)(2008-11#9)(2008-7#1)(2011-2#1)
exponential##72##1##(1992-9#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-8#1)(1995-9#3)(1996-1#1)(2008-10#17)(2008-11#20)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2009-12#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#3)
exponential-growth phase##2##2##(2008-11#2)
exponentially distributed##3##2##(1995-6#1)(2008-8#2)
exponentially with increasing##3##3##(2008-10#3)
exponentially with##10##2##(2008-10#8)(2008-11#1)(2009-11#1)
exponentially##24##1##(1995-6#1)(1996-12#1)(2008-10#10)(2008-11#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
exponents for##2##2##(1990-12#1)(2008-8#1)
exponents##3##1##(1990-12#1)(1993-5#1)(2008-8#1)
export in##2##2##(2008-10#1)(2008-7#1)
export of##5##2##(2008-10#1)(2008-8#1)(2009-9#1)(2011-2#1)(2011-3#1)
export with##2##2##(2008-8#2)
export##30##1##(1991-6#1)(1994-3#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#4)(2009-9#1)(2011-2#4)(2011-3#5)(2012-2#1)
exported##4##1##(1991-6#1)(1995-6#1)(2008-11#1)(2008-9#1)
expose the##5##2##(1992-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
expose##11##1##(1992-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
exposed PS##2##2##(2008-11#2)
exposed and##7##2##(1990-5#1)(1990-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-3#1)
exposed by##2##2##(2008-10#1)(2008-9#1)
exposed diaphragma sellae##2##3##(2011-2#2)
exposed during##2##2##(2008-10#2)
exposed for##7##2##(1991-12#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-9#3)
exposed groups was similar to that of##3##7##(2008-9#3)
exposed groups##5##2##(2008-9#5)
exposed hydrophobic##2##2##(1993-9#1)(2008-10#1)
exposed in##6##2##(2006-6#1)(2008-10#1)(2008-11#2)(2012-3#1)(2012-7#1)
exposed individuals##3##2##(1991-12#3)
exposed loop##2##2##(1993-12#1)(1995-8#1)
exposed on the soil surface##2##5##(2008-10#1)(2008-11#1)
exposed on the##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
exposed on##4##2##(1991-2#1)(1995-6#1)(2008-10#1)(2008-11#1)
exposed only##3##2##(1997-8#1)(2008-9#2)
exposed population##2##2##(1991-12#1)(2009-10#1)
exposed populations##4##2##(1991-12#1)(2008-10#1)(2008-9#2)
exposed the##5##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
exposed to 1##4##3##(2008-11#1)(2008-9#3)
exposed to 100##2##3##(2008-10#2)
exposed to 2##3##3##(1992-12#1)(2008-10#1)(2008-8#1)
exposed to H(2)S##2##3##(2008-10#2)
exposed to IOFB##3##3##(2009-12#3)
exposed to LPS##2##3##(1995-12#1)(2008-11#1)
exposed to NaCl##2##3##(2008-10#2)
exposed to UV light##2##4##(2008-10#2)
exposed to a single pulsed electric field##2##7##(2008-9#2)
exposed to a single##3##4##(2008-10#1)(2008-9#2)
exposed to a##22##3##(1990-2#1)(1995-5#1)(2008-10#4)(2008-11#5)(2008-7#3)(2008-9#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
exposed to air warming##2##4##(2012-5#1)(2012-6#1)
exposed to air##3##3##(2008-10#1)(2012-5#1)(2012-6#1)
exposed to ambient##3##3##(2008-10#1)(2009-9#1)(2012-7#1)
exposed to bFGF##2##3##(2008-11#2)
exposed to cadmium##2##3##(1993-12#1)(2008-10#1)
exposed to constant temperatures of##2##5##(2008-10#2)
exposed to constant##4##3##(2008-10#3)(2012-4#1)
exposed to dichloroacetic acid for 26 or##2##7##(2008-9#2)
exposed to dichloroacetic acid in the drinking water##4##8##(2008-9#4)
exposed to dichloroacetic acid in##5##5##(2008-9#5)
exposed to dichloroacetic acid##8##4##(2008-9#8)
exposed to different##4##3##(2008-10#4)
exposed to environmental##2##3##(2010-4#2)
exposed to high##2##3##(1991-5#1)(1992-6#1)
exposed to light##3##3##(2008-10#1)(2009-4#1)(2009-9#1)
exposed to mealybugs##3##3##(2008-10#3)
exposed to natural##2##3##(2008-10#1)(2013-8#1)
exposed to negative nonparental adult##2##5##(2009-7#2)
exposed to periods of##2##4##(2008-10#2)
exposed to radiation##2##3##(1997-3#1)(2008-7#1)
exposed to selection##2##3##(2008-10#1)(2008-9#1)
exposed to sodium bromate##3##4##(2008-9#3)
exposed to soil##2##3##(2008-10#1)(2012-6#1)
exposed to temperatures ranging from##2##5##(2008-10#2)
exposed to the environment##2##4##(2008-11#1)(2008-5#1)
exposed to the##25##3##(1990-2#1)(1990-6#1)(1991-5#1)(1994-5#1)(1995-12#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
exposed to##276##2##(1990-11#2)(1990-2#3)(1990-5#2)(1990-6#1)(1990-8#2)(1991-12#3)(1991-2#2)(1991-5#4)(1992-12#2)(1992-3#3)(1992-6#2)(1993-12#2)(1993-8#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#5)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#80)(2008-11#23)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#29)(2009-12#6)(2009-3#1)(2009-4#1)(2009-7#3)(2009-9#2)(2010-11#2)(2010-4#2)(2010-5#4)(2010-8#5)(2011-1#2)(2011-2#13)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2012-5#1)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#10)(2013-8#6)
exposed workers##5##2##(2008-10#1)(2009-12#3)(2011-2#1)
exposed##394##1##(1990-11#2)(1990-2#4)(1990-5#3)(1990-6#1)(1990-8#4)(1990-9#1)(1991-12#11)(1991-2#3)(1991-5#4)(1992-12#2)(1992-3#6)(1992-6#2)(1993-12#4)(1993-8#3)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#6)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#102)(2008-11#32)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#54)(2009-1#1)(2009-10#1)(2009-12#10)(2009-3#1)(2009-4#1)(2009-7#3)(2009-9#2)(2010-11#2)(2010-4#2)(2010-5#4)(2010-8#5)(2011-1#2)(2011-2#18)(2012-12#3)(2012-2#3)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#2)(2012-7#2)(2012-8#1)(2013-1#13)(2013-8#8)
exposes##3##1##(2008-6#1)(2008-7#2)
exposing##13##1##(1990-5#1)(2008-10#5)(2008-11#2)(2010-8#1)(2011-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
exposition of the##2##3##(1996-2#1)(2008-10#1)
exposition to fluoroscopy##2##3##(2013-1#2)
exposition##9##1##(1996-2#1)(2008-10#3)(2009-9#1)(2011-2#2)(2013-1#2)
exposure among infants##2##3##(1992-12#1)(2011-2#1)
exposure among##3##2##(1991-12#1)(1992-12#1)(2011-2#1)
exposure and subsequent##2##3##(1990-5#1)(2008-7#1)
exposure and that##2##3##(1995-8#1)(2010-11#1)
exposure and the##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
exposure and was##2##3##(1990-5#1)(2008-5#1)
exposure and##34##2##(1990-5#3)(1990-8#1)(1991-12#3)(1992-3#1)(1994-3#1)(1995-2#1)(1995-8#1)(2006-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#4)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#1)
exposure are necessary##2##3##(2008-10#1)(2009-11#1)
exposure are##6##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-11#1)(2013-1#1)
exposure as##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
exposure assessment and##2##3##(2008-5#1)(2011-2#1)
exposure at a##2##3##(2008-10#1)(2010-11#1)
exposure at the##2##3##(1995-2#1)(2008-5#1)
exposure at##7##2##(1995-2#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-11#1)
exposure can be##2##3##(2011-1#1)(2012-3#1)
exposure can impair the##2##4##(2008-10#2)
exposure can##5##2##(2008-10#2)(2011-1#1)(2011-2#1)(2012-3#1)
exposure causes##2##2##(2008-10#1)(2011-2#1)
exposure concentration##2##2##(1990-5#1)(1996-12#1)
exposure concentrations##2##2##(1990-5#1)(1993-8#1)
exposure did not##2##3##(2008-10#1)(2010-8#1)
exposure during##4##2##(1992-3#1)(1993-1#2)(1995-12#1)
exposure for##11##2##(1992-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2013-8#1)
exposure from##2##2##(1991-12#1)(1992-3#1)
exposure has been##2##3##(2008-10#1)(2008-5#1)
exposure in a##2##3##(2008-11#1)(2008-7#1)
exposure in human##2##3##(2008-12#1)(2013-8#1)
exposure in the##3##3##(1991-12#1)(2009-12#1)(2011-2#1)
exposure in unison##2##3##(2009-12#2)
exposure in##22##2##(1991-12#3)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-12#3)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
exposure is associated with##2##4##(2008-10#2)
exposure is##10##2##(1996-2#1)(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
exposure level##2##2##(1993-3#1)(2008-10#1)
exposure levels##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
exposure limits##2##2##(2008-12#2)
exposure may##6##2##(1994-11#1)(1994-5#1)(1995-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
exposure of humans to##2##4##(1994-5#1)(2011-2#1)
exposure of mycelium of P##2##5##(2008-10#2)
exposure of skin##2##3##(2008-5#2)
exposure of the cells to a##2##6##(1990-5#1)(2008-11#1)
exposure of the cells to##3##5##(1990-5#1)(1992-8#1)(2008-11#1)
exposure of the whole body##2##5##(1992-3#1)(2008-7#1)
exposure of the##28##3##(1990-5#1)(1990-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-5#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#2)(2011-2#3)(2013-1#1)(2013-8#1)
exposure of##77##2##(1990-5#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#6)(1994-11#3)(1994-3#2)(1994-5#2)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-1#2)(2009-8#2)(2010-11#1)(2011-2#8)(2012-2#2)(2013-1#5)(2013-8#2)
exposure on##9##2##(1992-4#1)(2008-10#3)(2008-7#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-4#1)
exposure period##3##2##(2008-10#2)(2008-11#1)
exposure periods##3##2##(2008-10#3)
exposure resulted in##2##3##(1992-12#1)(2008-9#1)
exposure study##2##2##(2008-10#2)
exposure than##2##2##(2008-10#1)(2012-2#1)
exposure time and##2##3##(2008-10#1)(2008-3#1)
exposure time in##2##3##(2008-10#2)
exposure time were##2##3##(2008-10#2)
exposure time##22##2##(1996-12#2)(2008-10#10)(2008-11#3)(2008-3#5)(2008-7#1)(2011-2#1)
exposure times##7##2##(2008-10#5)(2008-11#1)(2012-2#1)
exposure to 2##2##3##(2008-10#1)(2013-1#1)
exposure to 50##2##3##(2008-10#2)
exposure to 85% relative humidity at 85 degrees C for##2##10##(2008-2#2)
exposure to Al##3##3##(2013-8#3)
exposure to HG##2##3##(2008-7#2)
exposure to OP pesticides##2##4##(2010-5#2)
exposure to UV##3##3##(1997-3#1)(2008-5#1)(2011-2#1)
exposure to UVB##2##3##(2008-5#2)
exposure to VCZ at the##2##5##(2008-10#2)
exposure to VCZ##4##3##(2008-10#4)
exposure to a drug##2##4##(2008-8#1)(2010-11#1)
exposure to a##22##3##(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-11#2)(2012-12#5)
exposure to asbestos in place##2##5##(1991-12#2)
exposure to asbestos in##3##4##(1991-12#2)(1997-5#1)
exposure to asbestos is well established##2##6##(1991-12#1)(1995-2#1)
exposure to asbestos used in railroads##2##6##(1991-12#2)
exposure to asbestos##9##3##(1991-12#7)(1995-2#1)(1997-5#1)
exposure to benzene##3##3##(2008-10#1)(2008-11#2)
exposure to biological##2##3##(2012-3#2)
exposure to both CO concentrations##2##5##(1990-5#2)
exposure to both##5##3##(1990-5#2)(2008-10#1)(2010-5#2)
exposure to cigarette smoke##2##4##(1993-8#1)(2008-5#1)
exposure to delta##2##3##(1991-4#2)
exposure to different##4##3##(1996-12#1)(2006-5#1)(2011-2#1)(2013-1#1)
exposure to extremely##2##3##(2008-12#2)
exposure to heavy metals##5##4##(2008-10#3)(2013-1#2)
exposure to low##3##3##(2008-10#1)(2008-11#2)
exposure to nitrous oxide##3##4##(1993-1#1)(2008-7#2)
exposure to organic solvents##2##4##(1990-8#2)
exposure to organic##3##3##(1990-8#2)(2009-8#1)
exposure to parasites##2##3##(2008-8#1)(2008-9#1)
exposure to pollutants##2##3##(2008-10#1)(2012-3#1)
exposure to predators##2##3##(2008-8#1)(2008-9#1)
exposure to repeated##2##3##(2010-12#1)(2012-3#1)
exposure to sodium##3##3##(1995-8#1)(2008-12#1)(2008-9#1)
exposure to soil##3##3##(2008-10#2)(2012-5#1)
exposure to solvents##3##3##(1990-2#1)(1990-8#1)(2008-7#1)
exposure to sunlight##4##3##(2011-2#4)
exposure to supraconducive##2##3##(2008-10#2)
exposure to the fungicides##2##4##(2008-10#2)
exposure to the##17##3##(1992-1#1)(1993-6#1)(1994-2#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#2)(2013-1#1)
exposure to these##5##3##(1994-3#1)(2008-10#2)(2011-2#1)(2012-3#1)
exposure to threat-relevant stimuli##2##4##(2012-2#2)
exposure to tobacco##2##3##(1991-11#1)(2013-1#1)
exposure to##299##2##(1990-11#3)(1990-2#3)(1990-5#6)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#10)(1991-4#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#3)(1993-1#3)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#1)(1995-12#3)(1995-2#2)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#66)(2008-11#22)(2008-12#8)(2008-2#2)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#9)(2008-8#9)(2008-9#10)(2009-12#4)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#5)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#15)(2012-12#6)(2012-2#4)(2012-3#10)(2012-5#1)(2013-1#14)(2013-8#5)
exposure using##2##2##(2008-11#1)(2012-3#1)
exposure was observed##2##3##(1992-6#1)(2008-11#1)
exposure was##12##2##(1991-12#1)(1992-6#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
exposure were also##2##3##(2008-12#1)(2012-2#1)
exposure were##7##2##(1991-12#1)(1995-12#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-12#1)(2012-2#1)
exposure with##6##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
exposure##786##1##(1990-11#3)(1990-2#3)(1990-5#15)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#30)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#1)(1992-1#3)(1992-12#4)(1992-2#1)(1992-3#8)(1992-4#1)(1992-6#6)(1992-8#1)(1993-1#6)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#12)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#10)(1995-2#4)(1995-3#4)(1995-6#1)(1995-8#3)(1996-1#4)(1996-12#12)(1996-2#5)(1996-3#7)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-5#1)(2006-6#4)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#179)(2008-11#57)(2008-12#21)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#23)(2008-6#4)(2008-7#29)(2008-8#16)(2008-9#18)(2009-1#3)(2009-11#1)(2009-12#14)(2009-4#2)(2009-6#1)(2009-7#6)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#9)(2010-12#3)(2010-5#8)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#49)(2012-12#8)(2012-2#18)(2012-3#24)(2012-4#2)(2012-5#1)(2013-1#30)(2013-8#15)
exposure)##5##1##(1992-9#1)(2008-10#3)(2008-11#1)
exposure-response relations in##2##3##(2008-7#2)
exposure-response relations##3##2##(2008-7#3)
exposure-response##4##1##(1991-12#1)(2008-7#3)
exposures and##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
exposures are##2##2##(2008-7#2)
exposures for##2##2##(2008-10#1)(2009-7#1)
exposures from##2##2##(2008-11#1)(2013-1#1)
exposures have##2##2##(2008-10#1)(2008-7#1)
exposures in##2##2##(2008-10#2)
exposures to the##2##3##(1994-3#1)(2008-10#1)
exposures to##15##2##(1994-3#2)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2010-1#1)(2010-11#1)(2012-2#1)(2013-1#1)
exposures##65##1##(1991-12#6)(1994-3#2)(1996-12#4)(2007-12#1)(2008-10#13)(2008-11#4)(2008-5#1)(2008-7#11)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#2)(2010-1#1)(2010-11#3)(2010-4#2)(2011-2#1)(2012-2#2)(2013-1#6)(2013-8#2)
exposures)##2##1##(1992-3#2)
expounded##2##1##(2008-12#1)(2008-8#1)
express a##6##2##(1993-12#1)(1994-2#1)(2007-12#1)(2008-11#2)(2013-1#1)
express an##3##2##(1991-12#1)(2008-4#1)(2008-7#1)
express and purify##2##3##(2011-2#1)(2012-2#1)
express and##4##2##(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
express both##4##2##(1995-11#1)(1995-12#1)(2008-11#1)(2008-5#1)
express full-length##2##2##(1996-12#1)(2008-11#1)
express high levels of##3##4##(2008-11#1)(2008-8#2)
express human##2##2##(2008-8#2)
express low levels of##2##4##(1993-3#1)(2011-2#1)
express low##3##2##(1993-3#1)(2010-6#1)(2011-2#1)
express recombinant##4##2##(2008-11#3)(2008-7#1)
express the##19##2##(1991-2#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2011-1#1)(2012-2#1)
express##140##1##(1991-12#2)(1991-2#1)(1992-10#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#4)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#1)(1995-11#2)(1995-12#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#9)(1996-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#21)(2008-4#4)(2008-5#4)(2008-7#4)(2008-8#8)(2008-9#13)(2009-10#1)(2009-6#1)(2009-8#3)(2010-11#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#3)
expressed CD25##3##2##(2008-11#3)
expressed a##7##2##(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-3#1)
expressed after##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
expressed alone##3##2##(1995-2#2)(2009-8#1)
expressed and purified##2##3##(2009-3#1)(2009-6#1)
expressed and##8##2##(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)(2012-2#1)(2013-8#1)
expressed as R##3##3##(2008-10#3)
expressed as RSD##2##3##(2008-10#2)
expressed as a function of##2##5##(2008-10#2)
expressed as a##19##3##(1992-6#1)(1992-9#1)(1993-2#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)
expressed as an##2##3##(2008-10#2)
expressed as cumulative##2##3##(2008-11#1)(2008-5#1)
expressed as relative standard deviation (R##3##6##(2008-10#3)
expressed as relative standard deviation (s(r))##3##6##(2008-10#3)
expressed as relative standard deviation of##4##6##(2008-10#4)
expressed as relative standard deviation##21##5##(2008-10#20)(2009-8#1)
expressed as relative standard##22##4##(2008-10#21)(2009-8#1)
expressed as relative##23##3##(2008-10#22)(2009-8#1)
expressed as the number of##2##5##(2008-10#1)(2008-12#1)
expressed as the##9##3##(1996-1#1)(2006-6#1)(2008-10#5)(2008-12#2)
expressed as##96##2##(1991-12#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-1#1)(1996-6#1)(2006-6#1)(2007-12#2)(2008-10#62)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
expressed at high levels in the##3##6##(1995-2#1)(1996-2#1)(2008-1#1)
expressed at high levels in##4##5##(1995-2#2)(1996-2#1)(2008-1#1)
expressed at high levels##5##4##(1995-2#2)(1996-12#1)(1996-2#1)(2008-1#1)
expressed at high##6##3##(1990-5#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-1#1)
expressed at low##2##3##(1993-2#1)(2008-8#1)
expressed at the##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
expressed at##21##2##(1990-5#1)(1991-6#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-12#3)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)
expressed both##3##2##(2008-6#1)(2008-8#2)
expressed by a##8##3##(1992-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2013-1#1)
expressed by alpha2##2##3##(2008-11#2)
expressed by cells in##2##4##(2010-8#1)(2011-2#1)
expressed by cutting##2##3##(2008-9#2)
expressed by the##7##3##(1990-2#1)(1993-3#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)
expressed by##58##2##(1990-12#1)(1990-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#3)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-1#2)(2008-10#12)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
expressed cDNA##4##2##(1991-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
expressed concern on##2##3##(1990-2#1)(1996-1#1)
expressed concern##3##2##(1990-2#1)(1996-1#1)(2008-9#1)
expressed constitutively##2##2##(1993-12#1)(1995-6#1)
expressed differentially##2##2##(1997-7#1)(2008-9#1)
expressed during the##3##3##(2008-10#2)(2008-11#1)
expressed during##9##2##(1992-6#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
expressed either##2##2##(1991-2#1)(1997-7#1)
expressed enzyme##3##2##(1991-5#1)(1993-8#2)
expressed from a##2##3##(2010-10#1)(2012-3#1)
expressed from the##2##3##(1994-11#1)(2008-11#1)
expressed from##6##2##(1994-11#1)(2008-11#1)(2010-10#1)(2011-1#1)(2012-3#2)
expressed gene##4##2##(1995-8#1)(1995-9#1)(1997-8#1)(2012-2#1)
expressed genes from##3##3##(2008-2#1)(2008-8#1)(2010-1#1)
expressed genes##12##2##(1996-12#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2012-3#1)
expressed grade 3-4)##2##3##(2008-10#2)
expressed high level of##2##4##(2008-8#2)
expressed human##2##2##(1995-11#1)(2008-7#1)
expressed in Bacillus subtilis##2##4##(1990-11#1)(2009-3#1)
expressed in CHO##3##3##(1992-10#1)(2008-11#1)(2011-2#1)
expressed in COS 1 cells##3##5##(2008-11#3)
expressed in COS cells##2##4##(1992-3#1)(2008-8#1)
expressed in COS##6##3##(1992-3#1)(2008-11#4)(2008-8#1)
expressed in COS-1 cells##3##4##(1992-10#1)(1992-6#1)(1993-3#1)
expressed in E##4##3##(1990-11#1)(1991-5#1)(2008-4#1)(2008-9#1)
expressed in Escherichia coli and##2##5##(1995-2#1)(2008-10#1)
expressed in Escherichia coli using##2##5##(1991-3#1)(1993-8#1)
expressed in Escherichia coli##15##4##(1990-11#1)(1991-3#1)(1991-5#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-3#1)
expressed in Xenopus laevis oocytes##2##5##(1992-3#1)(1994-8#1)
expressed in Xenopus oocytes##3##4##(1995-11#3)
expressed in Xenopus##5##3##(1992-3#1)(1994-8#1)(1995-11#3)
expressed in a cell- or tissue-specific manner##2##7##(1995-8#1)(1996-2#1)
expressed in a developmentally##2##4##(1993-3#1)(2008-11#1)
expressed in a tissue-##2##4##(1994-5#1)(2008-5#1)
expressed in a##15##3##(1990-8#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)
expressed in adult##2##3##(1995-6#1)(2011-2#1)
expressed in all##7##3##(1990-12#1)(1993-6#1)(1995-6#1)(1996-12#1)(2008-4#1)(2010-5#1)(2011-2#1)
expressed in bacteria##2##3##(1994-11#1)(2008-4#1)
expressed in both the##2##4##(2008-6#1)(2008-8#1)
expressed in both##5##3##(1994-12#1)(1995-11#1)(2008-6#1)(2008-8#1)(2012-3#1)
expressed in different##3##3##(1995-11#1)(2008-8#1)(2010-12#1)
expressed in embryonic stem##2##4##(1997-8#1)(2008-4#1)
expressed in embryonic##4##3##(1996-12#1)(1997-8#1)(2008-11#1)(2008-4#1)
expressed in human##3##3##(1994-11#1)(2008-8#1)(2008-9#1)
expressed in insect cells##2##4##(1993-6#1)(2008-7#1)
expressed in mammalian cells##2##4##(1995-6#1)(2008-8#1)
expressed in mammalian##3##3##(1995-2#1)(1995-6#1)(2008-8#1)
expressed in many##3##3##(1992-3#1)(1997-7#1)(2010-5#1)
expressed in normal##4##3##(1990-5#1)(2008-5#1)(2008-9#1)(2013-1#1)
expressed in rat##2##3##(1996-2#1)(2008-11#1)
expressed in terms of##5##4##(1996-12#1)(2008-10#3)(2008-7#1)
expressed in testis##3##3##(1995-6#1)(1995-8#1)(2008-8#1)
expressed in the adult##2##4##(1997-7#1)(2013-1#1)
expressed in the brain##2##4##(1997-2#2)
expressed in the central nervous system##2##6##(1995-8#1)(1996-12#1)
expressed in the form of##2##5##(2008-10#1)(2009-3#1)
expressed in the liver##2##4##(1995-2#1)(1995-8#1)
expressed in the pituitary##2##4##(1992-10#1)(2008-4#1)
expressed in the presence of##2##5##(2008-11#2)
expressed in the##58##3##(1990-5#1)(1992-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#1)(1997-2#4)(1997-7#2)(2007-12#1)(2008-10#5)(2008-11#7)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#4)
expressed in these cells##2##4##(2008-11#1)(2008-6#1)
expressed in these##3##3##(1995-2#1)(2008-11#1)(2008-6#1)
expressed in transgenic##2##3##(2008-10#1)(2008-8#1)
expressed in various##3##3##(1993-3#1)(1997-8#1)(2011-2#1)
expressed in vitro##3##3##(1995-8#1)(1996-2#1)(2008-10#1)
expressed in yeast##5##3##(1993-8#1)(1994-11#1)(1997-7#1)(2008-10#1)(2008-9#1)
expressed in##298##2##(1990-11#3)(1990-12#1)(1990-5#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-10#4)(1992-3#5)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#5)(1993-6#4)(1993-8#6)(1993-9#1)(1994-11#7)(1994-12#2)(1994-5#1)(1994-8#3)(1995-11#7)(1995-12#3)(1995-2#5)(1995-5#1)(1995-6#8)(1995-8#10)(1996-12#10)(1996-2#5)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#7)(1997-8#3)(2007-12#1)(2008-10#29)(2008-11#29)(2008-12#2)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#19)(2008-9#14)(2009-10#4)(2009-12#1)(2009-3#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-12#4)(2010-5#4)(2010-7#2)(2011-1#2)(2011-2#13)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#4)
expressed inE##4##2##(2008-8#2)(2008-9#2)
expressed markers##2##2##(1994-3#1)(2010-12#1)
expressed miRNAs##3##2##(2013-8#3)
expressed more##3##2##(1995-3#1)(2008-11#1)(2013-8#1)
expressed on##14##2##(1991-5#1)(1993-12#1)(1995-11#1)(1995-2#1)(1995-6#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-5#1)(2013-1#1)
expressed only in the##2##4##(2008-11#1)(2008-5#1)
expressed only in##3##3##(1994-11#1)(2008-11#1)(2008-5#1)
expressed only##7##2##(1992-4#1)(1994-11#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#1)(2012-2#1)
expressed predominantly in the brain##2##5##(1995-12#1)(2008-6#1)
expressed predominantly##3##2##(1995-12#1)(1995-8#1)(2008-6#1)
expressed preferentially##2##2##(1995-2#1)(2008-8#1)
expressed protein was##2##3##(2008-8#1)(2010-6#1)
expressed protein##12##2##(1993-6#2)(1994-11#2)(1995-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-3#2)(2013-1#1)
expressed proteins##14##2##(1993-8#1)(1994-5#1)(1995-11#1)(2008-4#2)(2010-12#4)(2011-3#4)(2012-3#1)
expressed relative to##2##3##(1994-11#1)(2008-5#1)
expressed sequence tag (EST)##2##4##(1997-6#1)(2008-11#1)
expressed sequence tags (EST) and##2##5##(1995-9#1)(1997-2#1)
expressed sequence tags (ESTs)##6##4##(1995-8#1)(1997-6#1)(2009-10#1)(2010-10#1)(2010-4#1)(2013-8#1)
expressed sequence tags from##2##4##(2008-8#1)(2010-4#1)
expressed sequence tags##11##3##(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#2)(2013-8#1)
expressed sequence##13##2##(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-6#2)(2008-11#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#2)(2013-8#1)
expressed several##2##2##(1991-11#1)(1993-9#1)
expressed slightly higher##2##3##(1993-2#1)(2008-11#1)
expressed specifically in the##3##4##(1993-12#2)(1995-2#1)
expressed specifically in##7##3##(1993-12#2)(1993-8#1)(1995-2#1)(2008-10#2)(2008-8#1)
expressed the##15##2##(1993-6#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#4)(2009-10#2)(2010-4#1)(2010-6#1)
expressed them##2##2##(1997-7#1)(2008-11#1)
expressed through##2##2##(2008-12#1)(2012-12#1)
expressed throughout the##2##3##(1991-5#1)(2012-7#1)
expressed throughout##4##2##(1991-5#1)(1993-2#1)(2011-2#1)(2012-7#1)
expressed ubiquitously##3##2##(1995-6#1)(1997-7#1)(2010-7#1)
expressed under the control of##2##5##(2008-10#1)(2008-8#1)
expressed under the##3##3##(2008-10#1)(2008-8#2)
expressed under##4##2##(2008-10#1)(2008-11#1)(2008-8#2)
expressed via##2##2##(2008-10#1)(2012-3#1)
expressed was secreted##2##3##(1990-8#1)(2008-8#1)
expressed##850##1##(1990-11#5)(1990-12#3)(1990-2#2)(1990-5#5)(1990-8#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#9)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#5)(1992-11#1)(1992-2#1)(1992-3#8)(1992-4#2)(1992-6#7)(1992-9#3)(1993-11#1)(1993-12#11)(1993-2#6)(1993-3#10)(1993-6#7)(1993-8#13)(1993-9#3)(1994-11#17)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#7)(1995-11#16)(1995-12#8)(1995-2#14)(1995-3#1)(1995-5#1)(1995-6#17)(1995-8#15)(1995-9#3)(1996-1#3)(1996-12#20)(1996-2#8)(1996-3#2)(1996-5#1)(1996-6#3)(1997-1#3)(1997-2#5)(1997-3#2)(1997-6#4)(1997-7#17)(1997-8#6)(1997-9#1)(2006-6#1)(2007-12#4)(2008-1#4)(2008-10#143)(2008-11#81)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#11)(2008-5#10)(2008-6#9)(2008-7#13)(2008-8#56)(2008-9#34)(2009-10#14)(2009-12#2)(2009-3#5)(2009-6#5)(2009-8#10)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#12)(2010-4#5)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#2)(2011-1#6)(2011-2#20)(2011-3#7)(2012-12#1)(2012-2#12)(2012-3#17)(2012-5#1)(2012-7#1)(2013-1#14)(2013-7#1)(2013-8#11)
expresses a##3##2##(1993-3#1)(2008-10#1)(2010-5#1)
expresses the##5##2##(2008-10#3)(2008-2#1)(2008-8#1)
expresses##25##1##(1990-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
expressing IL-1ra in brain##2##4##(2008-8#2)
expressing a humanized##2##3##(2008-11#1)(2008-7#1)
expressing a##20##2##(1990-5#2)(1995-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
expressing both##2##2##(2008-10#1)(2008-11#1)
expressing breast cancer cells##2##4##(2010-6#2)
expressing cells##6##2##(1993-3#1)(1995-12#1)(2008-11#3)(2008-9#1)
expressing either##3##2##(2008-10#1)(2008-7#1)(2011-10#1)
expressing enhanced green fluorescent protein##2##5##(2008-11#2)
expressing enhanced green##3##3##(2008-11#2)(2013-8#1)
expressing human##4##2##(1993-6#1)(1995-11#1)(1995-2#1)(2008-11#1)
expressing its##2##2##(2008-11#1)(2013-1#1)
expressing only##2##2##(1996-12#1)(2008-10#1)
expressing recombinant proteins##2##3##(1993-9#1)(2008-4#1)
expressing recombinant##4##2##(1993-9#1)(2008-11#2)(2008-4#1)
expressing the human##3##3##(2008-11#3)
expressing the##37##2##(1992-2#1)(1993-6#1)(1993-8#1)(1995-11#4)(1995-2#3)(1995-6#2)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#6)(2008-7#1)(2008-8#2)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
expressing this##2##2##(1994-5#1)(1994-8#1)
expressing##183##1##(1990-5#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#6)(1995-12#1)(1995-2#9)(1995-5#3)(1995-6#4)(1996-12#4)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#36)(2008-11#39)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#11)(2008-9#6)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-6#2)(2011-10#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#2)
expression activity of##2##3##(2008-11#1)(2008-9#1)
expression after##5##2##(1994-3#1)(1996-2#1)(2008-10#1)(2008-9#2)
expression also##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
expression alterations##2##2##(2008-10#1)(2012-3#1)
expression among##3##2##(1992-10#1)(2009-6#1)(2012-3#1)
expression analyses##5##2##(1994-11#1)(1996-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
expression analysis and##2##3##(2008-8#1)(2010-5#1)
expression analysis of a##2##4##(2008-2#1)(2010-5#1)
expression analysis of##7##3##(2008-2#1)(2008-8#1)(2009-10#2)(2010-12#1)(2010-5#2)
expression analysis##17##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#4)(2008-9#1)(2009-10#2)(2010-12#1)(2010-5#3)(2011-2#1)(2012-3#1)
expression and activation##2##3##(2010-12#1)(2012-2#1)
expression and characterization of##2##4##(2008-9#1)(2009-9#1)
expression and characterization##4##3##(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)
expression and differentiation##2##3##(1993-11#1)(2008-10#1)
expression and enzyme activity##2##4##(1994-11#1)(2011-2#1)
expression and function of##4##4##(1994-8#1)(2007-12#1)(2008-6#1)(2012-2#1)
expression and function##5##3##(1994-8#1)(2007-12#1)(2008-6#1)(2012-2#2)
expression and functional##2##3##(2008-11#1)(2009-10#1)
expression and gene##2##3##(2008-11#1)(2008-4#1)
expression and localization##2##3##(2012-2#1)(2013-1#1)
expression and presentation of##2##4##(1996-12#1)(2008-8#1)
expression and proliferation##2##3##(1996-12#2)
expression and purification of the##2##5##(1994-6#1)(2009-9#1)
expression and purification of##6##4##(1994-6#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-9#1)
expression and regulation##2##3##(1995-11#1)(2008-9#1)
expression and secretion of##3##4##(1996-2#1)(2008-11#1)(2008-5#1)
expression and secretion##5##3##(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
expression and subcellular##3##3##(1996-6#1)(2008-9#2)
expression and the##7##3##(1991-9#1)(1995-6#1)(1997-8#1)(2008-8#1)(2008-9#2)(2010-8#1)
expression and viral##2##3##(2008-10#1)(2011-3#1)
expression and##147##2##(1990-2#2)(1990-5#1)(1991-10#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-11#3)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-6#3)(1996-12#5)(1996-2#1)(1996-6#1)(1997-8#2)(2007-12#2)(2008-10#13)(2008-11#11)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#11)(2008-9#11)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#2)(2011-2#9)(2011-3#2)(2012-2#6)(2012-3#5)(2013-1#8)(2013-8#3)
expression are##10##2##(1992-3#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2013-8#1)
expression as well as##5##4##(1990-12#1)(1993-6#1)(1994-8#1)(2008-8#1)(2011-2#1)
expression as##7##2##(1990-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-12#1)(2008-8#1)(2011-2#1)
expression assay##4##2##(1993-8#1)(1995-6#1)(2008-11#2)
expression assays##3##2##(1993-8#2)(1995-6#1)
expression at the##9##3##(1991-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#2)(2012-2#2)
expression at##15##2##(1991-5#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
expression becomes restricted to the presumptive##2##6##(1994-12#2)
expression becomes##3##2##(1994-12#2)(2011-2#1)
expression between##3##2##(1994-12#1)(2008-8#1)(2010-12#1)
expression but also##2##3##(2008-7#1)(2012-3#1)
expression but##4##2##(1990-5#1)(1991-3#1)(2008-7#1)(2012-3#1)
expression by RNA interference##2##4##(2009-9#1)(2011-2#1)
expression by##35##2##(1991-5#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-1#1)(2011-2#4)(2012-3#1)
expression can be##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)
expression can##6##2##(1992-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)
expression cassette##5##2##(1993-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
expression cassettes##3##2##(2008-11#3)
expression categories##2##2##(2008-11#2)
expression caused##2##2##(1997-7#1)(2008-10#1)
expression characterization of##3##3##(2008-8#1)(2008-9#2)
expression construct##4##2##(2008-11#3)(2008-4#1)
expression correlates with##3##3##(2009-8#1)(2012-2#1)(2013-1#1)
expression could be detected in##2##5##(1995-6#1)(2012-2#1)
expression could be##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
expression could##4##2##(1990-12#1)(1995-6#1)(2008-11#1)(2012-2#1)
expression data##17##2##(1993-12#1)(2008-4#5)(2008-7#1)(2009-10#2)(2009-4#1)(2010-1#1)(2010-10#3)(2011-3#1)(2012-3#1)(2013-1#1)
expression differences##2##2##(2008-4#1)(2012-3#1)
expression during##12##2##(1992-6#1)(1994-8#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-3#1)
expression efficiency of##2##3##(1997-8#1)(2008-11#1)
expression efficiency##4##2##(1997-8#1)(2008-11#3)
expression factor gene##2##3##(1997-3#2)
expression factor##3##2##(1997-3#3)
expression following##2##2##(1995-11#1)(2010-12#1)
expression for the##10##3##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#4)(2011-1#1)
expression for three##2##3##(1996-2#1)(2010-1#1)
expression for##20##2##(1991-3#1)(1994-11#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#4)(2009-4#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-8#1)
expression from##3##2##(1995-6#1)(2008-10#1)(2011-1#1)
expression had##2##2##(2010-3#1)(2011-2#1)
expression have not been##2##4##(1995-6#1)(2008-11#1)
expression in COS cells##2##4##(1992-9#1)(1997-9#1)
expression in Escherichia coli##2##4##(1993-8#1)(2008-10#1)
expression in Saccharomyces cerevisiae##3##4##(1993-9#1)(1996-3#1)(2008-8#1)
expression in St##2##3##(2008-10#2)
expression in Xenopus##2##3##(1995-11#1)(2008-11#1)
expression in a##13##3##(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1997-3#1)(2008-8#2)(2009-8#2)(2011-2#1)(2012-12#1)
expression in bone marrow##2##4##(2010-12#1)(2010-8#1)
expression in both##2##3##(1997-7#1)(2011-2#1)
expression in bovine##2##3##(1990-8#1)(1992-10#1)
expression in cancer##2##3##(2008-11#1)(2009-3#1)
expression in cells##2##3##(2008-11#1)(2009-7#1)
expression in cultured##2##3##(1995-12#1)(2008-11#1)
expression in human##12##3##(1990-5#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-9#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
expression in mammalian cells##7##4##(1992-9#1)(1993-6#2)(2008-11#3)(2008-8#1)
expression in multiple##2##3##(1997-7#1)(2008-4#1)
expression in music##2##3##(2013-8#2)
expression in normal##3##3##(1992-3#1)(1993-12#1)(2012-12#1)
expression in plaques##2##3##(1991-10#2)
expression in prostate##2##3##(2011-2#2)
expression in rat##6##3##(1993-11#1)(1993-3#1)(1995-12#1)(2008-8#1)(2008-9#2)
expression in response to##6##4##(1995-2#1)(1996-3#1)(2008-10#1)(2009-8#1)(2010-10#1)(2010-6#1)
expression in the brain##2##4##(1995-12#1)(2008-11#1)
expression in the central##2##4##(1996-12#2)
expression in the kidney##2##4##(2008-11#1)(2009-6#1)
expression in the pancreas##2##4##(2013-7#2)
expression in the rat brain##3##5##(1996-12#3)
expression in the rat##4##4##(1995-11#1)(1996-12#3)
expression in the##59##3##(1993-12#1)(1994-2#2)(1994-3#2)(1995-11#2)(1995-12#1)(1995-2#2)(1996-12#16)(1997-1#2)(1997-2#3)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#9)(2008-6#1)(2008-8#1)(2009-6#3)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
expression in these##3##3##(1994-3#1)(1995-6#1)(2010-7#1)
expression in transfected##2##3##(1995-12#1)(2008-11#1)
expression in transient##2##3##(1993-6#1)(2008-11#1)
expression in tumor##3##3##(1992-2#1)(2009-3#1)(2010-7#1)
expression in various##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
expression in vivo is##2##4##(1994-11#1)(2008-10#1)
expression in##283##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-5#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#3)(1993-9#2)(1994-11#8)(1994-12#1)(1994-2#4)(1994-3#5)(1995-11#4)(1995-12#13)(1995-2#5)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#21)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#4)(1997-9#2)(2007-12#1)(2008-10#20)(2008-11#33)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#13)(2008-9#11)(2009-10#2)(2009-12#1)(2009-3#2)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#1)(2011-1#2)(2011-10#3)(2011-2#16)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#8)(2013-7#3)(2013-8#3)
expression indicated that the##2##4##(1995-8#1)(2012-2#1)
expression is also##3##3##(1990-2#1)(2008-9#1)(2013-1#1)
expression is derived##2##3##(2007-11#1)(2008-3#1)
expression is detected in##3##4##(1996-12#1)(2013-1#2)
expression is in##2##3##(1996-12#1)(2011-3#1)
expression is not##3##3##(2007-12#1)(2008-6#1)(2012-3#1)
expression is one##2##3##(1996-12#1)(2008-1#1)
expression is regulated by##2##4##(1996-2#1)(2008-9#1)
expression is regulated in##2##4##(1994-11#1)(2011-1#1)
expression is regulated##5##3##(1992-3#1)(1994-11#1)(1996-2#1)(2008-9#1)(2011-1#1)
expression is stimulated by##2##4##(1990-5#1)(1992-12#1)
expression is##57##2##(1990-2#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#5)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#5)
expression lasted##2##2##(2008-8#2)
expression level in##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#1)
expression level of the##4##4##(1997-8#1)(2008-10#1)(2008-9#2)
expression level of##20##3##(1997-8#2)(2008-10#2)(2008-11#5)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2010-12#1)(2010-5#1)(2013-8#1)
expression level was##2##3##(2008-10#1)(2009-3#1)
expression level##35##2##(1996-6#1)(1997-8#2)(2008-10#5)(2008-11#6)(2008-7#2)(2008-8#4)(2008-9#4)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-5#2)(2012-5#1)(2013-1#2)(2013-8#1)
expression levels and##8##3##(1995-12#1)(2008-10#2)(2011-1#1)(2012-2#2)(2012-3#2)
expression levels are##2##3##(2008-11#2)
expression levels in the##2##4##(2008-11#1)(2013-1#1)
expression levels in##8##3##(2008-11#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#2)(2013-1#2)
expression levels of PFLP in root tissue##2##7##(2008-10#2)
expression levels of SEAP##2##4##(2008-11#2)
expression levels of the##2##4##(2008-11#1)(2012-3#1)
expression levels of##26##3##(1991-5#1)(1995-12#1)(1997-7#1)(2008-10#4)(2008-11#10)(2008-7#1)(2008-9#2)(2009-8#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
expression levels were##9##3##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#3)(2012-2#1)
expression levels##72##2##(1991-5#1)(1993-6#1)(1995-12#3)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#9)(2008-11#19)(2008-7#5)(2008-8#1)(2008-9#7)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#3)
expression library##5##2##(1993-9#1)(2008-8#2)(2008-9#2)
expression may be##4##3##(1993-8#1)(1995-2#1)(1996-12#1)(2010-4#1)
expression may##6##2##(1993-8#1)(1995-12#1)(1995-2#1)(1996-12#2)(2010-4#1)
expression occurred##2##2##(1994-6#1)(2008-11#1)
expression of A20##2##3##(1992-7#2)
expression of BDNF##2##3##(1997-2#2)
expression of BMP-2/4##2##3##(2011-2#2)
expression of BMP-7##2##3##(2011-2#2)
expression of Bcl-2##3##3##(2008-9#2)(2010-12#1)
expression of CD in##2##4##(1994-5#1)(2008-7#1)
expression of CD##3##3##(1994-5#2)(2008-7#1)
expression of CD38##2##3##(1994-11#1)(2008-9#1)
expression of CYP1A1 mRNA##2##4##(2008-11#2)
expression of CYP1A1##3##3##(1995-11#1)(2008-11#2)
expression of ERalpha##2##3##(2008-12#2)
expression of FIX protein##2##4##(1995-2#2)
expression of Fos-LI##2##3##(1994-2#2)
expression of GPNMB##2##3##(2009-4#2)
expression of HBD-2##2##3##(2011-3#2)
expression of HCMV genes##2##4##(1997-3#2)
expression of HGF##2##3##(2008-9#1)(2011-2#1)
expression of HLA class I heavy chains##2##7##(1997-9#2)
expression of HLA class I##3##5##(1994-5#1)(1997-9#2)
expression of HLA##4##3##(1994-5#1)(1997-9#3)
expression of HO-1##2##3##(2011-2#2)
expression of ICAM-1 mRNA and infiltration of PMNLs and##2##9##(2010-1#2)
expression of ICAM-1 mRNA##3##4##(2010-1#3)
expression of IGF-I##4##3##(1996-2#2)(2008-11#2)
expression of IGF-IR##2##3##(2008-8#2)
expression of LTP##2##3##(1995-2#1)(1997-2#1)
expression of MHC class##2##4##(2008-1#1)(2008-8#1)
expression of SSTR2##3##3##(2011-2#3)
expression of TH and##2##4##(1996-12#1)(2013-1#1)
expression of TH##3##3##(1996-12#2)(2013-1#1)
expression of TPO##2##3##(2008-8#2)
expression of TRPV2##2##3##(2011-2#2)
expression of a gene##2##4##(2008-10#1)(2009-8#1)
expression of a reporter gene##2##5##(2008-8#1)(2010-10#1)
expression of a reporter##3##4##(2008-11#1)(2008-8#1)(2010-10#1)
expression of a##35##3##(1991-6#1)(1991-9#1)(1992-6#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-10#2)(2013-1#1)(2013-8#1)
expression of active##2##3##(1992-3#1)(2008-11#1)
expression of adenosine##2##3##(1993-6#2)
expression of aggrecan mRNA compared with##2##6##(2008-11#2)
expression of aggrecan##3##3##(1992-1#1)(2008-11#2)
expression of aminopeptidase N##2##4##(1995-8#2)
expression of antioxidant##2##3##(1990-3#1)(2011-2#1)
expression of auxin##2##3##(2008-8#1)(2008-9#1)
expression of beta-galactosidase##3##3##(1993-12#1)(1997-8#1)(2008-8#1)
expression of both##5##3##(1990-12#1)(1993-12#1)(1993-6#1)(2008-10#1)(2009-12#1)
expression of c-Met receptor##3##4##(2011-2#3)
expression of c-fos##2##3##(1997-2#1)(2008-9#1)
expression of c-myc##4##3##(1993-2#1)(2008-11#1)(2008-8#2)
expression of cell surface##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
expression of cell##4##3##(2008-10#1)(2008-11#2)(2008-4#1)
expression of cellular##3##3##(2008-11#1)(2010-1#1)(2011-2#1)
expression of chemokines##2##3##(2008-10#1)(2013-1#1)
expression of cloned genes##2##4##(1990-5#1)(1993-9#1)
expression of constitutive##2##3##(1994-11#1)(1994-8#1)
expression of cyclin##2##3##(1997-8#1)(2008-9#1)
expression of cytokine##2##3##(1996-12#1)(2013-1#1)
expression of each##3##3##(1995-11#1)(1996-12#1)(2008-10#1)
expression of exogenous gene in transgenic plant##2##7##(2008-9#2)
expression of exogenous gene##3##4##(2008-9#3)
expression of extracellular matrix##2##4##(1990-5#1)(1994-12#1)
expression of five##2##3##(2008-10#1)(2010-10#1)
expression of foreign genes##3##4##(1995-5#1)(1997-8#1)(2008-11#1)
expression of foreign##4##3##(1995-5#2)(1997-8#1)(2008-11#1)
expression of functional##2##3##(1994-12#1)(2008-7#1)
expression of genes encoding##2##4##(1996-3#1)(2012-2#1)
expression of genes##10##3##(1993-9#2)(1996-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
expression of green fluorescent protein##2##5##(2008-7#2)
expression of group I metabotropic glutamate receptors##2##7##(1996-12#2)
expression of growth##2##3##(2008-11#1)(2008-9#1)
expression of hFIX##2##3##(2008-8#1)(2008-9#1)
expression of harpin protein gene in transgenic##2##7##(2008-8#2)
expression of hepatitis B virus##2##5##(1994-8#1)(2008-8#1)
expression of human##9##3##(1993-9#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)
expression of induced resistance##2##4##(2008-10#2)
expression of inducible nitric oxide synthase##2##6##(1996-12#2)
expression of inducible##3##3##(1996-12#3)
expression of inflammation-responsive##2##3##(2013-1#2)
expression of its##2##3##(2008-8#1)(2013-1#1)
expression of key##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
expression of lambdaN gene##3##4##(2008-8#2)(2008-9#1)
expression of listeriolysin O by##2##5##(1996-12#2)
expression of liver##2##3##(2008-11#1)(2009-8#1)
expression of mRNAs for##2##4##(1995-2#1)(1996-12#1)
expression of mRNAs##4##3##(1995-2#1)(1996-12#2)(2008-11#1)
expression of major histocompatibility complex class##2##6##(2008-10#1)(2013-1#1)
expression of many##2##3##(2010-4#1)(2010-7#1)
expression of matrix##3##3##(2008-9#2)(2012-3#1)
expression of metalloproteinase##2##3##(1992-6#2)
expression of mouse##2##3##(1997-7#1)(2008-11#1)
expression of neurotrophins##2##3##(1996-12#1)(2008-7#1)
expression of one##2##3##(1992-9#1)(2011-2#1)
expression of p16INK4A##2##3##(1997-7#2)
expression of pathogenesis-related (PR)##2##4##(2008-10#2)
expression of pathogenesis-related##3##3##(2008-10#2)(2011-10#1)
expression of rat##3##3##(1993-3#2)(2008-8#1)
expression of receptor##2##3##(1995-8#1)(2007-11#1)
expression of recombinant human##3##4##(2008-11#2)(2008-8#1)
expression of recombinant protein##2##4##(2008-11#2)
expression of recombinant proteins##4##4##(2008-11#4)
expression of recombinant##13##3##(1992-9#1)(2008-11#10)(2008-8#2)
expression of resistance##3##3##(2008-10#3)
expression of several##5##3##(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)
expression of sodium channel##2##4##(1996-12#2)
expression of specific##4##3##(1994-3#1)(2008-4#1)(2008-9#1)(2012-2#1)
expression of stress##2##3##(2008-10#1)(2008-11#1)
expression of survivin in##2##4##(2010-1#1)(2011-2#1)
expression of tga1a##2##3##(2008-9#2)
expression of the GIP gene##2##5##(1995-11#2)
expression of the angiogenic phenotype##2##5##(2013-1#2)
expression of the chicken##2##4##(1991-5#1)(1993-12#1)
expression of the corresponding gene##2##5##(1995-8#1)(2011-1#1)
expression of the corresponding##3##4##(1995-8#1)(2009-8#1)(2011-1#1)
expression of the first##2##4##(1995-2#1)(2009-9#1)
expression of the gene##6##4##(1993-1#1)(1993-12#1)(1993-8#1)(1994-5#1)(2008-10#1)(2009-10#1)
expression of the genes for##2##5##(1997-2#1)(2010-11#1)
expression of the genes##6##4##(1993-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2010-11#1)
expression of the homeobox-containing gene Msx1##2##6##(1994-11#2)
expression of the indicator trait##2##5##(2008-9#2)
expression of the inhibitory##2##4##(1997-1#1)(2012-12#1)
expression of the inserted##2##4##(1997-8#2)
expression of the mouse##2##4##(1996-12#1)(2008-11#1)
expression of the receptor##2##4##(1991-5#1)(1994-12#1)
expression of the reporter gene##4##5##(2008-11#2)(2008-9#1)(2011-1#1)
expression of the somatostatin gene##2##5##(1995-8#2)
expression of the two##2##4##(2008-11#1)(2008-9#1)
expression of the viral##2##4##(1993-6#1)(1995-2#1)
expression of the##164##3##(1990-12#1)(1990-2#1)(1990-5#3)(1991-3#1)(1991-5#2)(1991-7#1)(1992-1#2)(1992-10#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#5)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#5)(1996-12#4)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#6)(1997-8#7)(2007-12#1)(2008-10#15)(2008-11#21)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
expression of their##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
expression of these genes in##3##5##(1995-12#1)(1996-12#1)(2008-11#1)
expression of these genes##5##4##(1995-12#2)(1996-12#1)(1997-8#1)(2008-11#1)
expression of these two genes##2##5##(1991-9#1)(1994-11#1)
expression of these##17##3##(1991-9#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-8#2)(2008-11#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
expression of this protein##3##4##(1993-1#1)(2008-10#2)
expression of this receptor gene was##2##6##(1991-5#2)
expression of this##11##3##(1991-5#2)(1993-1#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#3)(2009-9#1)
expression of those##2##3##(1995-2#1)(2013-8#1)
expression of three##2##3##(2008-10#2)
expression of topoisomerase II##2##4##(1993-8#2)
expression of topoisomerase##3##3##(1993-8#3)
expression of two##3##3##(1995-2#1)(2008-9#1)(2010-1#1)
expression of wcmmVtg##2##3##(2010-5#2)
expression of yellow gene##2##4##(2008-8#2)
expression of##904##2##(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#9)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#3)(1992-10#3)(1992-12#1)(1992-3#8)(1992-4#1)(1992-6#7)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#4)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#9)(1993-6#10)(1993-8#9)(1993-9#8)(1994-11#15)(1994-12#10)(1994-2#5)(1994-3#2)(1994-5#7)(1994-6#3)(1994-8#7)(1995-11#8)(1995-12#10)(1995-2#15)(1995-5#2)(1995-6#5)(1995-8#13)(1995-9#3)(1996-11#1)(1996-12#39)(1996-2#7)(1996-3#3)(1996-6#1)(1997-1#3)(1997-2#10)(1997-3#7)(1997-6#1)(1997-7#17)(1997-8#19)(1997-9#3)(2006-6#2)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#75)(2008-11#114)(2008-12#4)(2008-2#1)(2008-4#9)(2008-5#12)(2008-6#4)(2008-7#15)(2008-8#60)(2008-9#59)(2009-10#4)(2009-12#4)(2009-3#3)(2009-4#4)(2009-6#1)(2009-7#1)(2009-8#14)(2009-9#7)(2010-1#9)(2010-10#3)(2010-11#6)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#6)(2010-7#3)(2011-1#4)(2011-10#3)(2011-2#51)(2011-3#9)(2012-12#4)(2012-2#18)(2012-3#14)(2013-1#22)(2013-7#2)(2013-8#12)
expression ofthe##2##2##(2008-11#2)
expression on cell##2##3##(2008-11#1)(2008-7#1)
expression on day 12 and##2##5##(1995-12#2)
expression on day##3##3##(1995-12#3)
expression on the breast epithelial mucin##2##6##(1993-1#2)
expression on the##6##3##(1993-1#2)(1995-2#1)(1997-1#1)(2008-11#1)(2008-8#1)
expression on##20##2##(1992-10#1)(1993-1#2)(1993-12#1)(1995-10#1)(1995-12#3)(1995-2#2)(1997-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
expression or##5##2##(2008-11#1)(2008-6#1)(2009-8#1)(2010-11#1)(2013-1#1)
expression pattern during##2##3##(2008-10#1)(2008-11#1)
expression pattern in##2##3##(2008-8#2)
expression pattern is##2##3##(2008-11#1)(2012-2#1)
expression pattern of human##2##4##(1997-7#1)(2008-5#1)
expression pattern of the##4##4##(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#1)
expression pattern of##19##3##(1993-2#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-8#1)(2011-2#1)(2012-3#1)
expression pattern was##2##3##(2010-12#2)
expression pattern##34##2##(1993-2#1)(1993-8#1)(1995-2#2)(1995-6#1)(1996-12#2)(1997-7#2)(2007-12#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-2#1)(2012-3#1)
expression patterns during##2##3##(2008-10#1)(2009-10#1)
expression patterns in##5##3##(1997-7#1)(2008-10#3)(2008-4#1)
expression patterns of##9##3##(1991-5#1)(1993-12#1)(1996-12#1)(2008-10#2)(2008-7#1)(2010-1#1)(2010-7#1)(2012-3#1)
expression patterns##31##2##(1991-5#1)(1992-6#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-12#2)(1997-7#1)(2008-10#6)(2008-11#1)(2008-4#3)(2008-7#1)(2009-10#2)(2010-1#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#2)
expression plasmid containing##3##3##(1993-8#1)(2008-9#2)
expression plasmid##11##2##(1990-8#1)(1993-8#1)(1994-8#1)(1995-6#1)(2008-11#3)(2008-9#4)
expression plasmids##12##2##(1993-12#1)(1993-6#2)(1997-8#2)(2008-5#1)(2008-8#4)(2008-9#2)
expression product##3##2##(2008-9#3)
expression profile in##3##3##(1997-6#1)(2010-12#1)(2013-8#1)
expression profile of the##2##4##(2010-6#1)(2012-2#1)
expression profile of##7##3##(1996-2#2)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#1)
expression profile with##2##3##(1996-2#1)(2009-6#1)
expression profile##15##2##(1996-2#3)(1997-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
expression profiles of##7##3##(1996-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
expression profiles##22##2##(1993-8#1)(1996-2#1)(1996-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#5)(2012-2#2)(2012-3#1)
expression profiling in##2##3##(2008-10#1)(2013-1#1)
expression profiling of##9##3##(2008-10#3)(2008-11#1)(2008-6#2)(2008-8#1)(2010-11#1)(2012-3#1)
expression profiling##17##2##(2008-10#5)(2008-11#2)(2008-6#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
expression ratios were##2##3##(2008-10#1)(2011-2#1)
expression ratios##3##2##(2008-10#2)(2011-2#1)
expression reached##2##2##(2008-8#1)(2008-9#1)
expression regulation##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
expression sequence##2##2##(1997-2#1)(2008-9#1)
expression serves as a##2##4##(1997-9#1)(2008-4#1)
expression showed that##2##3##(1997-7#1)(2008-10#1)
expression showed##4##2##(1995-12#1)(1997-7#1)(2008-10#1)(2011-2#1)
expression signal##2##2##(1996-12#1)(2008-8#1)
expression signatures##4##2##(2009-6#3)(2013-1#1)
expression studies in##3##3##(1996-6#2)(2008-4#1)
expression studies of##3##3##(1993-3#1)(2008-5#1)(2008-8#1)
expression studies##9##2##(1993-3#1)(1996-6#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
expression system and##3##3##(1994-5#1)(2008-11#2)
expression system in which##2##4##(1991-9#1)(1992-10#1)
expression system in##3##3##(1991-9#1)(1992-10#1)(1993-9#1)
expression system to##2##3##(1997-3#1)(2008-11#1)
expression system##30##2##(1991-9#1)(1992-10#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-11#7)(2008-7#1)(2008-8#2)(2011-2#3)(2012-2#1)
expression systems and##2##3##(1996-12#1)(2008-11#1)
expression systems are##2##3##(2008-4#1)(2009-9#1)
expression systems##11##2##(1995-11#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-9#1)(2011-1#1)
expression technology##5##2##(2008-11#4)(2011-2#1)
expression than##2##2##(1996-12#1)(2008-11#1)
expression that##4##2##(1995-2#1)(1997-3#1)(2008-4#1)(2008-8#1)
expression through##3##2##(2008-9#1)(2010-3#1)(2011-2#1)
expression to##8##2##(1993-12#1)(1996-12#1)(1997-1#1)(2008-11#2)(2008-3#1)(2010-1#1)(2010-10#1)
expression under##4##2##(2008-10#2)(2008-9#1)(2011-1#1)
expression unit##2##2##(2008-11#1)(2008-7#1)
expression used##2##2##(1995-2#1)(2012-3#1)
expression using##2##2##(2008-10#1)(2008-11#1)
expression vector and##2##3##(1992-8#1)(2008-8#1)
expression vector containing the##2##4##(1990-5#1)(2008-11#1)
expression vector containing##3##3##(1990-5#1)(2008-11#1)(2008-8#1)
expression vector of human tumor necrosis factor alpha (hTNF-alpha) gene and its expression in a cyanobacterium##2##16##(2008-8#2)
expression vector of##3##3##(2008-8#3)
expression vector was##3##3##(1993-8#1)(1995-8#1)(2008-9#1)
expression vector##54##2##(1990-5#5)(1992-8#1)(1993-6#2)(1993-8#2)(1994-5#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-8#3)(2008-10#3)(2008-11#10)(2008-4#1)(2008-7#4)(2008-8#12)(2008-9#4)(2010-5#1)
expression vectors and##3##3##(1993-3#1)(2008-11#1)(2008-8#1)
expression vectors for HIV-1 Tat and Rev##2##7##(1993-2#2)
expression vectors for##3##3##(1990-5#1)(1993-2#2)
expression vectors in##3##3##(1991-6#1)(2008-11#1)(2008-8#1)
expression vectors which##2##3##(1993-6#1)(1996-6#1)
expression vectors with the##2##4##(2008-11#2)
expression vectors##34##2##(1990-5#1)(1991-6#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1994-6#1)(1995-5#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#10)(2008-8#4)(2008-9#3)(2011-3#1)
expression was also##4##3##(2008-10#1)(2008-8#2)(2011-2#1)
expression was detected in##2##4##(2008-11#1)(2008-9#1)
expression was detected##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
expression was either##2##3##(2008-9#1)(2012-2#1)
expression was elevated##2##3##(1993-6#1)(1997-3#1)
expression was enhanced##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
expression was examined##2##3##(1992-3#1)(2008-9#1)
expression was increased##3##3##(1994-11#1)(2008-8#2)
expression was investigated using##2##4##(1993-6#1)(2010-5#1)
expression was investigated##3##3##(1993-6#1)(2008-10#1)(2010-5#1)
expression was observed in leaf##2##5##(2008-10#2)
expression was observed in the##3##5##(1992-8#1)(1993-2#1)(2011-2#1)
expression was observed in##9##4##(1992-8#1)(1993-12#1)(1993-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2011-2#1)
expression was restricted to the##2##5##(2008-11#1)(2008-8#1)
expression was restricted to##3##4##(1997-8#1)(2008-11#1)(2008-8#1)
expression was retained and apoptosis was prevented##2##7##(1995-2#2)
expression was significantly higher##2##4##(2008-10#1)(2012-3#1)
expression was significantly less##2##4##(1995-12#1)(2008-10#1)
expression was significantly##7##3##(1995-12#1)(2008-10#4)(2008-11#1)(2012-3#1)
expression was##85##2##(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#3)(1994-11#2)(1995-12#2)(1995-2#3)(1996-12#2)(1997-3#1)(1997-7#1)(1997-8#3)(2008-10#13)(2008-11#11)(2008-3#1)(2008-6#1)(2008-8#10)(2008-9#8)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-2#3)(2012-3#3)(2013-1#4)
expression were detected##3##3##(1995-11#1)(2012-2#2)
expression were found##2##3##(2008-7#1)(2011-10#1)
expression were##13##2##(1995-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#2)(2011-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
expression which##3##2##(1992-1#1)(1996-12#1)(2008-5#1)
expression with a##2##3##(1997-8#1)(2008-9#1)
expression with the##3##3##(1993-9#1)(1997-7#1)(2008-11#1)
expression with##10##2##(1993-9#1)(1994-8#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)
expression within the##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
expression within##6##2##(2007-12#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-3#1)
expression##2681##1##(1990-12#7)(1990-2#5)(1990-3#2)(1990-5#22)(1990-6#1)(1990-8#3)(1991-10#3)(1991-2#2)(1991-3#4)(1991-5#14)(1991-6#5)(1991-7#1)(1991-9#7)(1992-1#6)(1992-10#11)(1992-12#3)(1992-2#2)(1992-3#16)(1992-4#1)(1992-6#13)(1992-7#3)(1992-8#5)(1992-9#6)(1993-1#6)(1993-11#6)(1993-12#30)(1993-2#9)(1993-3#17)(1993-6#34)(1993-8#28)(1993-9#17)(1994-11#45)(1994-12#15)(1994-2#11)(1994-3#9)(1994-5#13)(1994-6#12)(1994-8#17)(1995-10#1)(1995-11#21)(1995-12#45)(1995-2#57)(1995-5#4)(1995-6#24)(1995-8#22)(1995-9#5)(1996-11#1)(1996-12#107)(1996-2#24)(1996-3#5)(1996-6#7)(1996-8#2)(1997-1#10)(1997-2#18)(1997-3#20)(1997-5#1)(1997-6#3)(1997-7#32)(1997-8#39)(1997-9#12)(2006-6#2)(2007-11#4)(2007-12#12)(2008-1#5)(2008-10#229)(2008-11#361)(2008-12#5)(2008-2#5)(2008-3#9)(2008-4#50)(2008-5#20)(2008-6#16)(2008-7#63)(2008-8#185)(2008-9#165)(2009-10#29)(2009-12#6)(2009-3#12)(2009-4#7)(2009-6#12)(2009-7#3)(2009-8#42)(2009-9#14)(2010-1#24)(2010-10#13)(2010-11#13)(2010-12#27)(2010-3#4)(2010-4#5)(2010-5#25)(2010-6#6)(2010-7#13)(2010-8#5)(2011-1#18)(2011-10#7)(2011-2#143)(2011-3#15)(2012-12#11)(2012-2#61)(2012-3#58)(2012-5#2)(2013-1#68)(2013-7#6)(2013-8#30)
expression)##5##1##(1992-3#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-8#1)
expressionefficiency##2##1##(2008-11#2)
expressions and##4##2##(2008-11#1)(2008-3#1)(2013-1#2)
expressions are##3##2##(2008-12#1)(2008-7#1)(2012-3#1)
expressions for the##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
expressions for##9##2##(1995-9#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2010-7#2)
expressions in##4##2##(2008-11#2)(2008-9#1)(2012-3#1)
expressions of emotion##3##3##(2008-11#3)
expressions of the##2##3##(1995-12#1)(2008-10#1)
expressions of##18##2##(1990-2#1)(1995-12#1)(2008-10#2)(2008-11#4)(2008-9#3)(2009-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-8#1)
expressions were##7##2##(2008-11#1)(2008-8#1)(2012-3#4)(2013-8#1)
expressions when##2##2##(2008-11#2)
expressions##83##1##(1990-2#1)(1995-12#3)(1995-9#2)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#25)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-4#3)(2009-8#4)(2010-10#1)(2010-7#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#10)(2013-1#3)(2013-8#3)
expressionvector system##2##2##(2008-11#2)
expressive morpho-syntactic##2##2##(2011-1#2)
expressive vocabulary##2##2##(2008-12#2)
expressive##17##1##(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#2)(2009-8#2)(2010-10#1)(2010-6#1)(2011-1#3)(2012-2#1)(2012-3#1)
expressly##2##1##(1990-11#1)(2008-9#1)
expulsion of##2##2##(2009-5#1)(2013-8#1)
expulsion##4##1##(1993-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
exquisite sensitivity##2##2##(2012-2#2)
exquisite##4##1##(2008-8#1)(2011-2#1)(2012-2#2)
exquisitely##4##1##(1990-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
exstrophy in##2##2##(2008-10#2)
exstrophy##24##1##(2008-10#24)
exstrophy-epispadias complex##2##2##(2008-10#2)
extant##12##1##(1994-11#1)(2007-12#2)(2008-10#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#2)
extend a##2##2##(1996-2#1)(2011-3#1)
extend beyond##3##2##(1997-1#1)(2008-10#1)(2013-1#1)
extend its applicability##2##3##(2008-10#2)
extend its##4##2##(2008-10#3)(2008-12#1)
extend our##2##2##(1994-12#1)(1996-3#1)
extend previous research##2##3##(2009-4#1)(2013-8#1)
extend previous studies##2##3##(1994-12#1)(2008-3#1)
extend previous##5##2##(1994-12#1)(1994-8#1)(2008-3#1)(2009-4#1)(2013-8#1)
extend the indications##2##3##(2008-10#1)(2011-7#1)
extend the utility of##2##4##(2008-11#1)(2013-1#1)
extend the##34##2##(1991-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
extend this##4##2##(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
extend to##10##2##(1991-3#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-8#1)(2013-8#1)
extend##85##1##(1991-2#1)(1991-3#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-7#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
extended X-ray absorption fine structure##2##5##(2008-9#1)(2010-11#1)
extended biliverdins##3##2##(1990-8#3)
extended by##7##2##(2008-10#3)(2008-11#1)(2008-4#2)(2013-8#1)
extended colostrum##3##2##(2012-2#3)
extended extinction##4##2##(2008-5#4)
extended for the##2##3##(2008-10#1)(2008-3#1)
extended for use##2##3##(2008-10#1)(2008-3#1)
extended for##9##2##(1990-8#1)(2008-10#6)(2008-3#2)
extended from the##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
extended from##10##2##(2008-10#5)(2008-11#3)(2008-7#1)(2011-2#1)
extended into##5##2##(1990-5#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
extended linear##2##2##(2008-10#2)
extended multiple processes##2##3##(1997-3#2)
extended periods of time##2##4##(2008-10#1)(2008-11#1)
extended periods of##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
extended periods##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)
extended position##2##2##(2008-12#1)(2008-9#1)
extended primers##2##2##(2008-10#1)(2008-9#1)
extended spectrum##2##2##(2008-11#1)(2012-2#1)
extended studies##3##2##(1992-5#1)(1994-12#1)(2009-12#1)
extended the##10##2##(1990-5#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
extended these studies##2##3##(2008-10#1)(2008-11#1)
extended these##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
extended time##2##2##(2008-10#1)(2008-7#1)
extended to a##3##3##(2008-10#2)(2008-5#1)
extended to all##2##3##(1990-6#1)(1992-2#1)
extended to deal##2##3##(2008-3#1)(2008-6#1)
extended to many##2##3##(1997-6#1)(2010-1#1)
extended to other##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
extended to the##8##3##(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)
extended to##40##2##(1990-6#1)(1992-12#1)(1992-2#1)(1995-11#1)(1995-5#1)(1997-6#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-3#1)
extended two##2##2##(1997-3#1)(2008-10#1)
extended up to##3##3##(2008-10#3)
extended with a##2##3##(2008-11#1)(2009-12#1)
extended with##4##2##(1997-8#1)(2008-11#1)(2008-3#1)(2009-12#1)
extended##228##1##(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#5)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-3#7)(1997-6#1)(1997-8#5)(2007-11#1)(2008-1#1)(2008-10#63)(2008-11#17)(2008-12#4)(2008-2#2)(2008-3#15)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#6)(2009-12#2)(2009-4#1)(2009-7#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#1)(2013-8#2)
extended-MDR##4##1##(2008-11#4)
extended-cavity diode laser##2##3##(2008-3#2)
extended-release carvedilol##4##2##(2010-4#4)
extended-release metoprolol in##2##3##(2010-4#2)
extended-release metoprolol##5##2##(2010-4#5)
extended-release##14##1##(2010-12#1)(2010-4#9)(2012-3#1)(2013-1#3)
extending from the##3##3##(2008-10#1)(2009-8#1)(2009-9#1)
extending from##7##2##(2008-10#2)(2008-2#2)(2009-8#1)(2009-9#1)(2013-1#1)
extending into the frontal sinus##2##5##(2011-2#2)
extending into the##7##3##(1997-8#1)(2007-12#1)(2010-12#1)(2011-2#3)(2013-1#1)
extending into##9##2##(1992-6#1)(1997-8#1)(2007-12#2)(2010-12#1)(2011-2#3)(2013-1#1)
extending the duration of##2##4##(2008-11#2)
extending the##9##2##(2008-10#2)(2008-11#2)(2008-8#1)(2009-10#1)(2011-2#2)(2012-3#1)
extending to the##5##3##(1991-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
extending to##8##2##(1991-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)
extending##51##1##(1991-8#1)(1992-6#1)(1992-9#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#2)
extends from##3##2##(2008-10#1)(2008-11#2)
extends in##2##2##(1993-12#1)(2008-8#1)
extends life##2##2##(1995-6#1)(2008-4#1)
extends out##2##2##(2007-12#1)(2012-2#1)
extends over##3##2##(1991-6#1)(1997-4#1)(2008-10#1)
extends previous findings##2##3##(2008-7#1)(2010-2#1)
extends previous##5##2##(1994-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-8#1)
extends the##11##2##(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)(2011-3#2)(2012-3#2)
extends to the##3##3##(1997-3#1)(1997-6#1)(2008-10#1)
extends to##7##2##(1996-1#1)(1997-3#1)(1997-6#1)(2008-10#3)(2013-1#1)
extends##49##1##(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-12#2)(2008-10#9)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
extensibility##3##1##(2008-5#1)(2009-12#1)(2012-3#1)
extension AROM##4##2##(2008-12#4)
extension analysis of##2##3##(1993-2#1)(1997-8#1)
extension analysis##4##2##(1992-10#1)(1993-2#1)(1997-7#1)(1997-8#1)
extension and the##4##3##(1991-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
extension and##14##2##(1991-9#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
extension at##2##2##(1995-6#1)(2008-11#1)
extension by##2##2##(1992-9#1)(2008-7#1)
extension into the##6##3##(2008-7#2)(2009-3#1)(2009-8#1)(2013-1#2)
extension moment compared to Group 1##2##6##(2011-2#2)
extension of a##2##3##(1996-6#1)(2008-10#1)
extension of our##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
extension of survival##2##3##(1991-12#1)(1995-12#1)
extension of the##29##3##(1992-3#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
extension of this##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
extension of##61##2##(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-6#2)(1997-2#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
extension peptide##3##2##(1990-5#3)
extension phase##4##2##(1997-2#4)
extension to a##2##3##(1995-9#1)(2008-12#1)
extension to##3##2##(1995-9#1)(2008-12#1)(2013-8#1)
extension was##2##2##(2008-10#2)
extension##177##1##(1990-11#1)(1990-5#3)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-8#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#2)(1996-6#2)(1997-2#8)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#5)(2008-10#29)(2008-11#8)(2008-12#11)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#2)(2010-11#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#8)(2012-2#1)(2012-3#5)(2013-1#7)(2013-8#4)
extensions of##3##2##(1994-11#2)(2008-8#1)
extensions##14##1##(1994-11#3)(1997-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
extensive analysis##2##2##(2008-10#1)(2008-7#1)
extensive and##5##2##(1996-12#1)(2008-10#3)(2008-9#1)
extensive bone##2##2##(2008-12#2)
extensive cell##2##2##(2008-11#1)(2008-6#1)
extensive changes##2##2##(1994-1#1)(2010-11#1)
extensive chlorosis to conidial inoculations##2##5##(2008-10#2)
extensive chlorosis to##3##3##(2008-10#3)
extensive chlorosis##5##2##(2008-10#5)
extensive commentary##2##2##(2008-9#2)
extensive damage##2##2##(2008-10#1)(2008-9#1)
extensive data##2##2##(1991-2#1)(2009-3#1)
extensive digital postprocessing##2##3##(2008-3#2)
extensive diversity in##2##3##(2008-10#2)
extensive downstream##2##2##(2008-4#1)(2009-10#1)
extensive exposure##2##2##(2008-7#1)(2011-2#1)
extensive homology##3##2##(1990-11#1)(1993-12#1)(1995-6#1)
extensive in##2##2##(2008-5#1)(2009-3#1)
extensive investigation##2##2##(2008-7#2)
extensive junction restructuring##2##3##(2009-10#2)
extensive knowledge of##2##3##(2008-8#1)(2009-8#1)
extensive knowledge##3##2##(1993-2#1)(2008-8#1)(2009-8#1)
extensive literature search was##2##4##(1996-12#1)(2011-2#1)
extensive literature##4##2##(1996-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
extensive necrosis##2##2##(1991-12#1)(1994-5#1)
extensive preclinical##2##2##(2010-6#2)
extensive range of##2##3##(1990-8#1)(2008-10#1)
extensive research##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
extensive review of the literature##3##5##(1995-1#1)(1996-12#1)(1997-5#1)
extensive review of##4##3##(1995-1#1)(1996-12#1)(1997-5#1)(2008-11#1)
extensive sample##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
extensive sequence##2##2##(1997-8#1)(2009-10#1)
extensive similarity to##2##3##(1994-6#2)
extensive similarity##4##2##(1994-6#3)(1995-6#1)
extensive tissue##2##2##(2008-12#1)(2011-2#1)
extensive toxicological##2##2##(1996-1#1)(1996-2#1)
extensive use of##4##3##(1990-9#1)(1991-6#1)(1997-1#1)(2012-2#1)
extensive use##5##2##(1990-9#1)(1991-6#1)(1997-1#1)(2012-2#1)(2013-1#1)
extensive##237##1##(1990-11#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-5#1)(1997-8#1)(2007-12#3)(2008-10#51)(2008-11#11)(2008-12#5)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#10)(2009-10#4)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#4)(2010-8#1)(2011-1#1)(2011-2#10)(2012-2#5)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#1)
extensively and##2##2##(2010-5#1)(2010-7#1)
extensively as##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
extensively colonized##2##2##(2008-10#2)
extensively drug-resistant TB##3##3##(2008-10#1)(2010-5#2)
extensively drug-resistant##4##2##(2008-10#2)(2010-5#2)
extensively evaluated##2##2##(2008-10#2)
extensively for##2##2##(1990-8#1)(2008-6#1)
extensively in the##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
extensively in##7##2##(1995-12#1)(1997-3#1)(2008-10#2)(2008-6#1)(2011-2#1)(2013-8#1)
extensively metabolized##2##2##(1990-11#1)(2010-11#1)
extensively studied in##3##3##(2008-10#1)(2008-8#1)(2009-11#1)
extensively studied##7##2##(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-11#1)(2011-2#1)
extensively used in##2##3##(2008-10#2)
extensively used##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
extensively washed membrane fractions##2##4##(1996-2#2)
extensively washed##3##2##(1995-11#1)(1996-2#2)
extensively##83##1##(1990-11#2)(1990-8#2)(1991-5#1)(1992-1#1)(1992-4#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-5#5)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#2)
extensor carpi##3##2##(1996-6#1)(2008-12#1)(2008-9#1)
extensor digitorum longus##3##3##(2008-9#2)(2010-3#1)
extensor muscle afferents on the timing of locomotor##2##8##(1997-2#2)
extensor muscle afferents##3##3##(1997-2#3)
extensor muscle##4##2##(1997-2#4)
extensor##17##1##(1993-3#1)(1996-6#1)(1997-2#6)(2008-12#1)(2008-5#1)(2008-9#4)(2010-3#1)(2010-6#1)(2012-2#1)
extent and kinetics##2##3##(1995-11#1)(2012-2#1)
extent and the##2##3##(1995-6#1)(2008-3#1)
extent and##13##2##(1993-8#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#2)
extent as##7##2##(1993-6#1)(2008-10#3)(2008-3#1)(2012-12#1)(2013-8#1)
extent at##2##2##(1995-11#1)(2013-1#1)
extent by##3##2##(1994-8#1)(1996-6#1)(2008-3#1)
extent for##2##2##(2008-10#1)(2012-12#1)
extent from the##2##3##(2008-10#1)(2008-11#1)
extent in the##4##3##(1990-12#1)(1997-2#1)(1997-9#1)(2008-10#1)
extent in##11##2##(1990-12#2)(1990-3#1)(1997-2#1)(1997-9#1)(2008-10#3)(2008-11#1)(2012-3#1)(2013-8#1)
extent of P##2##3##(2008-10#1)(2012-2#1)
extent of infection##3##3##(2008-10#3)
extent of involvement##2##3##(1990-12#1)(1997-8#1)
extent of subclinical atherosclerosis##2##4##(2008-11#2)
extent of surgical resection##3##4##(1990-9#1)(2008-7#2)
extent of surgical##4##3##(1990-9#1)(2008-7#3)
extent of the disease##3##4##(1994-9#1)(2010-8#1)(2012-3#1)
extent of the##20##3##(1990-12#1)(1991-6#1)(1993-6#2)(1993-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(2008-10#6)(2008-11#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)
extent of##141##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-5#1)(1996-2#2)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#3)(2008-10#45)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#4)
extent on##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
extent than by##2##3##(1995-11#1)(2012-2#1)
extent than the##2##3##(2008-10#1)(2009-8#1)
extent than##11##2##(1990-9#1)(1991-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-10#1)(2009-8#2)(2009-9#1)(2011-2#1)(2012-2#1)
extent that##4##2##(1990-11#1)(1994-6#1)(2008-10#2)
extent the##7##2##(1997-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-2#1)
extent to which the##6##4##(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)
extent to which##43##3##(1991-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(2008-10#4)(2008-11#9)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#3)(2012-3#2)
extent to##49##2##(1990-11#1)(1991-12#1)(1991-8#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#4)(2008-11#9)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
extent##345##1##(1990-11#2)(1990-12#6)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-12#4)(1991-3#1)(1991-6#3)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#3)(1993-8#6)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#4)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#4)(1997-9#2)(2007-12#1)(2008-10#86)(2008-11#31)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#7)(2008-7#9)(2008-8#10)(2008-9#5)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#4)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#4)(2012-6#1)(2013-1#6)(2013-8#3)
extents##7##1##(1992-11#1)(1995-6#1)(2008-10#3)(2008-7#1)(2010-6#1)
exterior environments##2##2##(1993-2#2)
exterior##5##1##(1993-2#4)(1995-2#1)
external Ca2+##2##2##(1990-5#1)(1995-11#1)
external agents##2##2##(1992-9#1)(2008-5#1)
external and internal colonization of##2##5##(2008-10#2)
external and internal##7##3##(1993-12#1)(1996-2#1)(2008-10#2)(2008-4#1)(2010-4#1)(2010-8#1)
external and skeletal anomalies##2##4##(1993-12#2)
external and##11##2##(1993-12#3)(1996-2#1)(2008-10#2)(2008-4#2)(2010-4#1)(2010-8#1)(2013-1#1)
external auditory##2##2##(1994-2#1)(2013-7#1)
external beam##8##2##(1993-11#1)(2008-10#2)(2008-2#2)(2008-7#2)(2009-2#1)
external calibration (EC)##2##3##(2008-10#2)
external calibration with##2##3##(2008-10#2)
external calibration##12##2##(2008-10#12)
external carotid arteries##3##3##(1996-9#2)(2011-2#1)
external carotid artery##7##3##(1997-3#2)(1997-6#5)
external carotid##14##2##(1996-9#5)(1997-3#2)(1997-6#5)(2011-2#1)(2013-1#1)
external cavity diode laser##2##4##(2008-2#1)(2008-3#1)
external cavity##7##2##(2008-2#2)(2008-3#5)
external conditions##2##2##(2011-2#2)
external contamination##2##2##(2008-10#2)
external cues##3##2##(2008-11#2)(2009-8#1)
external devices##2##2##(2008-3#1)(2008-8#1)
external electric field##2##3##(2008-10#1)(2008-9#1)
external evidence##2##2##(1996-6#2)
external factors##5##2##(1991-2#1)(1991-6#1)(1996-8#1)(2009-10#1)(2010-1#1)
external fixation of##3##3##(2009-4#2)(2012-2#1)
external fixation##10##2##(2008-12#2)(2008-8#2)(2009-4#3)(2010-12#1)(2012-2#2)
external fixators##2##2##(2008-8#2)
external forces##2##2##(2009-12#1)(2012-3#1)
external iliac artery##2##3##(2011-2#1)(2013-1#1)
external iliac##3##2##(2011-2#2)(2013-1#1)
external imagery##6##2##(1992-12#6)
external information##2##2##(1992-9#1)(2012-2#1)
external input##2##2##(2008-11#2)
external inputs##2##2##(2008-11#1)(2009-6#1)
external medium##2##2##(1991-5#1)(2008-7#1)
external mirror##3##2##(2008-3#3)
external morphology##3##2##(2007-12#3)
external or internal##2##3##(2013-8#2)
external osmolarity##3##2##(1991-11#3)
external otitis##3##2##(2008-5#3)
external power##2##2##(2011-2#2)
external radiotherapy##2##2##(1990-6#1)(2008-7#1)
external rotation##2##2##(2013-1#2)
external solution##2##2##(1996-2#1)(2008-8#1)
external standards##2##2##(2008-10#1)(2012-2#1)
external stimuli##5##2##(2008-10#1)(2008-11#1)(2009-6#1)(2010-1#1)(2010-10#1)
external substrate##2##2##(2008-7#2)
external to the##2##3##(1993-12#1)(2008-10#1)
external validation##7##2##(2008-10#7)
external validity##2##2##(2010-10#1)(2013-1#1)
external vertebral venous plexus##3##4##(2011-2#3)
external##304##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#2)(1991-11#3)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-12#6)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#6)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(1996-1#4)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#5)(1996-8#1)(1996-9#5)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#5)(1997-7#1)(2007-12#7)(2007-8#1)(2008-10#65)(2008-11#19)(2008-12#6)(2008-2#9)(2008-3#16)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#15)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#4)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#3)(2009-8#3)(2010-1#2)(2010-10#4)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#15)(2012-2#7)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#4)
external-cavity semiconductor lasers##2##3##(2007-12#2)
external-cavity semiconductor##3##2##(2007-12#2)(2008-3#1)
external-cavity##7##1##(2007-12#2)(2008-2#1)(2008-3#4)
externalizing behavior##3##2##(2008-12#3)
externalizing problems##2##2##(2008-9#1)(2013-1#1)
externalizing##10##1##(1995-2#1)(2008-12#4)(2008-9#1)(2009-7#2)(2013-1#2)
externally##13##1##(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2011-2#2)
extinct##7##1##(2008-8#5)(2008-9#1)(2009-8#1)
extinction and##9##2##(2008-2#1)(2008-3#6)(2008-9#1)(2013-8#1)
extinction boundary##2##2##(2008-8#2)
extinction by##3##2##(2008-3#2)(2008-6#1)
extinction coefficient of##2##3##(2008-10#2)
extinction coefficient##7##2##(2008-10#4)(2008-3#3)
extinction coefficients and##2##3##(2008-10#2)
extinction coefficients at##2##3##(2008-2#1)(2008-3#1)
extinction coefficients of##2##3##(2008-10#2)
extinction coefficients##10##2##(2008-10#5)(2008-2#3)(2008-3#2)
extinction data##3##2##(2008-3#3)
extinction error##3##2##(2008-3#3)
extinction has##2##2##(2008-3#1)(2008-9#1)
extinction in##7##2##(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#3)
extinction measurements##2##2##(2008-3#2)
extinction of a##2##3##(2008-5#1)(2008-8#1)
extinction of the##4##3##(2008-5#1)(2008-8#1)(2008-9#2)
extinction of this population##2##4##(2008-9#2)
extinction of##13##2##(2008-5#2)(2008-8#5)(2008-9#5)(2009-8#1)
extinction or##3##2##(1993-6#1)(2008-3#1)(2013-8#1)
extinction probabilities and colonization probabilities##2##5##(2008-8#2)
extinction probabilities and##3##3##(2008-8#3)
extinction probabilities are (almost) equal should one##2##7##(2008-8#2)
extinction probabilities##7##2##(2008-8#7)
extinction profiles##2##2##(2008-3#2)
extinction rate##4##2##(2008-8#2)(2008-9#2)
extinction rates##3##2##(2008-8#3)
extinction ratio##2##2##(2008-3#1)(2010-4#1)
extinction risk in##2##3##(2008-8#1)(2008-9#1)
extinction risk##6##2##(2008-8#3)(2008-9#3)
extinction threshold##2##2##(2008-8#2)
extinction times##2##2##(2008-8#2)
extinction trials##7##2##(2008-5#7)
extinction were##2##2##(2008-5#2)
extinction##162##1##(1991-5#1)(1992-12#3)(1993-6#1)(2008-10#9)(2008-2#9)(2008-3#39)(2008-5#17)(2008-6#1)(2008-8#54)(2008-9#20)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#2)
extinction-colonization dynamics##2##2##(2008-8#1)(2008-9#1)
extinctions##7##1##(2008-3#2)(2008-8#4)(2008-9#1)
extinguished##10##1##(2008-10#1)(2008-5#9)
extirpation of the##2##3##(1994-5#1)(2008-7#1)
extirpation##4##1##(1994-5#1)(2008-7#3)
extra methylene group##2##3##(2008-10#2)
extra survival##3##2##(1995-12#3)
extra##33##1##(1992-3#1)(1992-6#1)(1994-8#1)(1995-12#3)(1995-6#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
extra- and intracellular##4##3##(2008-11#2)(2012-2#1)(2013-8#1)
extra- and##7##2##(2008-10#2)(2008-11#3)(2012-2#1)(2013-8#1)
extra-##8##1##(2008-10#2)(2008-11#3)(2008-7#1)(2012-2#1)(2013-8#1)
extra-adrenal##2##1##(2012-2#2)
extra-articular##4##1##(2007-8#1)(2009-1#1)(2012-2#1)(2013-1#1)
extra-axial hemorrhagic##2##2##(2012-3#2)
extra-axial##5##1##(2011-2#1)(2012-3#4)
extra-cellular domain##2##2##(1995-12#1)(2008-5#1)
extra-cellular##5##1##(1995-12#1)(2008-1#1)(2008-5#3)
extra-heavy crude oil##2##3##(2008-10#2)
extra-hepatic metastasis##2##2##(2008-10#2)
extra-hepatic##7##1##(1992-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2013-1#1)
extra-intestinal manifestations##2##2##(2010-12#2)
extra-laboratory##2##1##(2013-1#2)
extra-pancreatic##4##1##(1994-8#3)(2008-2#1)
extracapsular cataract##2##2##(1991-9#1)(2011-2#1)
extracapsular##4##1##(1990-9#1)(1991-9#1)(2011-2#2)
extracellular Ca2+##7##2##(1990-2#1)(1991-5#1)(1991-6#1)(1993-8#2)(1994-6#1)(1996-12#1)
extracellular CaM##3##2##(2008-8#3)
extracellular alpha-amylase##2##2##(2008-10#2)
extracellular and##5##2##(1993-6#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)
extracellular calcium and##2##3##(1990-5#1)(1994-2#1)
extracellular calcium##10##2##(1990-5#1)(1991-12#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(2008-11#1)(2008-8#1)
extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens##2##9##(1994-8#2)
extracellular concentrations of acetylcholine in neostriatum##3##6##(1994-8#3)
extracellular domain of the##2##4##(1991-5#1)(1995-2#1)
extracellular domain of##8##3##(1991-5#1)(1991-6#1)(1992-12#2)(1994-11#1)(1995-11#1)(1995-2#1)(2008-11#1)
extracellular domain##19##2##(1991-5#1)(1991-6#2)(1992-12#2)(1993-6#2)(1993-8#2)(1994-11#1)(1995-11#3)(1995-2#2)(2008-11#2)(2008-8#1)(2009-8#1)
extracellular domains of the##2##4##(1991-6#1)(2008-4#1)
extracellular domains of##3##3##(1991-6#2)(2008-4#1)
extracellular domains##5##2##(1991-6#2)(1993-8#1)(1995-11#1)(2008-4#1)
extracellular dopamine##2##2##(1993-6#1)(1994-2#1)
extracellular electron##2##2##(2008-7#1)(2009-9#1)
extracellular environment##2##2##(2008-11#1)(2013-8#1)
extracellular enzymatic activities##2##3##(2008-10#1)(2008-5#1)
extracellular enzyme##2##2##(2008-10#1)(2012-6#1)
extracellular exo-beta-1##2##2##(2008-10#2)
extracellular fatty acid binding protein##2##5##(2008-8#2)
extracellular field##2##2##(1995-12#1)(2008-7#1)
extracellular fluid##2##2##(2008-7#1)(2012-2#1)
extracellular free Ca2+##2##3##(1990-2#1)(1994-2#1)
extracellular glutamate##2##2##(2008-7#2)
extracellular matrices##3##2##(2008-11#2)(2008-7#1)
extracellular matrix (ECM)##7##3##(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
extracellular matrix components##2##3##(2008-7#1)(2011-1#1)
extracellular matrix genes##3##3##(1990-5#1)(1991-5#1)(1992-8#1)
extracellular matrix in##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
extracellular matrix proteins##5##3##(1994-12#1)(2008-11#2)(2008-5#1)(2009-12#1)
extracellular matrix##49##2##(1990-5#3)(1991-5#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-11#4)(2008-5#6)(2008-7#2)(2008-9#3)(2009-10#2)(2009-12#3)(2009-3#1)(2009-7#2)(2009-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
extracellular matrix-rich##3##2##(2010-12#1)(2010-4#2)
extracellular mediators##2##2##(2008-5#1)(2009-3#1)
extracellular neuronal activity in##2##4##(2008-4#2)
extracellular neuronal activity##3##3##(2008-11#1)(2008-4#2)
extracellular oxidative enzymes##2##3##(2008-10#2)
extracellular polysaccharide##2##2##(2008-10#2)
extracellular protease produced by##2##4##(2008-10#2)
extracellular protease##5##2##(2008-10#5)
extracellular protein##2##2##(2008-10#2)
extracellular proteins of M##2##4##(1995-2#2)
extracellular proteins of##4##3##(1995-2#4)
extracellular purines##3##2##(2013-8#3)
extracellular recording##2##2##(1991-2#1)(2009-10#1)
extracellular signal-regulated kinase (ERK)##3##4##(2009-8#1)(2011-2#1)(2013-1#1)
extracellular signal-regulated kinase 1/2##2##4##(2010-12#1)(2011-2#1)
extracellular signal-regulated kinase##6##3##(2009-8#1)(2010-12#1)(2011-2#3)(2013-1#1)
extracellular signal-regulated##7##2##(1995-6#1)(2009-8#1)(2010-12#1)(2011-2#3)(2013-1#1)
extracellular signaling##2##2##(2010-1#1)(2013-8#1)
extracellular stimuli##4##2##(1994-11#1)(1996-2#2)(2011-2#1)
extracellular structures##2##2##(2008-8#2)
extracellular vesicles##5##2##(2013-8#5)
extracellular##268##1##(1990-2#2)(1990-5#5)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#5)(1992-11#1)(1992-12#4)(1992-8#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#7)(1993-8#5)(1994-11#5)(1994-12#1)(1994-2#5)(1994-3#4)(1994-6#1)(1994-8#7)(1995-11#5)(1995-12#1)(1995-2#9)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-9#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#33)(2008-11#19)(2008-4#4)(2008-5#12)(2008-6#4)(2008-7#12)(2008-8#10)(2008-9#5)(2009-10#3)(2009-12#3)(2009-3#5)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#1)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#3)(2013-8#15)
extracellular-superoxide dismutase##2##2##(1992-11#2)
extracellularly and##2##2##(1992-12#1)(2008-6#1)
extracellularly in##2##2##(1995-6#1)(2008-8#1)
extracellularly##8##1##(1992-12#1)(1992-8#1)(1993-6#1)(1995-6#1)(2008-6#1)(2008-8#1)(2011-2#2)
extracerebral##3##1##(2008-7#2)(2012-2#1)
extrachromosomal DNA##2##2##(2007-12#1)(2008-10#1)
extrachromosomal##4##1##(2007-12#2)(2008-10#2)
extracolonic##3##1##(2008-1#1)(2009-12#2)
extraconal##2##1##(2011-2#2)
extracorporeal circuit##2##2##(1992-1#2)
extracorporeal circulation##4##2##(1996-11#1)(2012-3#3)
extracorporeal liver support##2##3##(2008-11#2)
extracorporeal shock wave lithotripsy##3##4##(2011-2#1)(2012-12#1)(2013-1#1)
extracorporeal shock wave therapy##2##4##(1997-6#2)
extracorporeal shock wave##5##3##(1997-6#2)(2011-2#1)(2012-12#1)(2013-1#1)
extracorporeal shockwave lithotripsy##3##3##(2013-1#3)
extracorporeal##28##1##(1991-11#1)(1991-3#1)(1992-1#4)(1995-1#2)(1996-11#1)(1997-6#2)(2008-11#3)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#4)
extracranial carotid##2##2##(1992-5#2)
extracranial orbital decompression##3##3##(2008-7#3)
extracranial##12##1##(1992-5#2)(1997-4#1)(2008-7#6)(2011-2#1)(2012-3#2)
extract (0##2##2##(2008-10#1)(2012-2#1)
extract (CC-516)##2##2##(2008-5#2)
extract a##2##2##(2009-8#1)(2010-5#1)
extract against##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
extract and to##2##3##(2008-10#2)
extract and##19##2##(2008-10#11)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
extract are##2##2##(2008-10#1)(2008-5#1)
extract as a##2##3##(2008-10#1)(2008-5#1)
extract as##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
extract by##2##2##(2008-11#1)(2008-5#1)
extract containing##3##2##(1992-9#1)(2008-10#2)
extract for##5##2##(1993-2#1)(2011-2#2)(2013-1#2)
extract from a##3##3##(2008-11#3)
extract from##17##2##(1991-5#1)(1993-2#1)(1996-12#2)(2008-10#9)(2008-11#3)(2008-5#1)
extract has been##2##3##(1990-2#1)(2008-11#1)
extract in a dose-dependent manner##2##5##(2008-12#1)(2012-3#1)
extract in an##2##3##(2008-10#1)(2008-5#1)
extract in##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2012-3#1)(2013-8#1)
extract inhibited##2##2##(2008-11#1)(2012-2#1)
extract is##10##2##(2008-10#6)(2008-5#3)(2008-8#1)
extract of Garcinia cambogia##2##4##(2012-2#2)
extract of P##2##3##(2008-10#1)(2013-1#1)
extract of leaves of##2##4##(2008-10#1)(2011-3#1)
extract of leaves##3##3##(2008-10#2)(2011-3#1)
extract of the##10##3##(1992-3#1)(2008-10#2)(2008-11#5)(2010-6#1)(2012-2#1)
extract of##67##2##(1990-2#1)(1990-5#1)(1992-3#1)(1993-6#1)(2008-10#15)(2008-11#8)(2008-12#12)(2008-5#2)(2008-8#1)(2010-2#1)(2010-6#1)(2011-2#2)(2011-3#3)(2012-12#1)(2012-2#11)(2012-3#1)(2013-1#4)(2013-8#1)
extract on##10##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2010-1#1)(2013-1#2)
extract or##4##2##(1997-3#1)(2008-10#3)
extract reduces##2##2##(1993-2#1)(2008-11#1)
extract showed##3##2##(2008-12#1)(2008-5#1)(2009-6#1)
extract significantly##2##2##(2008-12#2)
extract the##15##2##(2008-10#9)(2008-3#2)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
extract thermodynamic##2##2##(1997-2#1)(2008-3#1)
extract to##2##2##(2008-10#1)(2008-5#1)
extract was determined##2##3##(2008-10#1)(2008-5#1)
extract was##20##2##(2008-10#12)(2008-11#3)(2008-12#2)(2008-5#3)
extract were##8##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)
extract whereas##2##2##(1993-2#1)(2008-10#1)
extract##371##1##(1990-12#1)(1990-2#3)(1990-5#3)(1991-5#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#6)(1993-6#1)(1994-5#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#143)(2008-11#59)(2008-12#27)(2008-3#5)(2008-4#1)(2008-5#39)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#9)(2011-3#3)(2012-12#1)(2012-2#14)(2012-3#2)(2013-1#10)(2013-8#4)
extract)##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
extractability and selectivity of univalent metal picrates##2##7##(2008-10#2)
extractability and selectivity##3##3##(2008-10#3)
extractability is##2##2##(2008-10#2)
extractability of##13##2##(1994-8#1)(2008-10#11)(2008-7#1)
extractability##28##1##(1994-8#2)(2008-10#25)(2008-7#1)
extractable contents##2##2##(2008-10#2)
extractable from##2##2##(2008-10#2)
extractable in##2##2##(2008-10#2)
extractable to##2##2##(2008-10#2)
extractable with##3##2##(2008-10#2)(2008-11#1)
extractable##33##1##(1994-8#1)(2008-10#29)(2008-11#3)
extractant and chemical modifier##2##4##(2008-10#2)
extractant and##6##2##(2008-10#6)
extractant composition##3##2##(2008-10#3)
extractant concentration##3##2##(2008-10#3)
extractant for##5##2##(2008-10#5)
extractant has been developed for##2##5##(2008-10#2)
extractant has been##3##3##(2008-10#3)
extractant is##2##2##(2008-10#2)
extractant of##2##2##(2008-10#2)
extractant##53##1##(2008-10#53)
extractants and##2##2##(2008-10#2)
extractants for##2##2##(2008-10#2)
extractants used##2##2##(2008-10#2)
extractants was##2##2##(2008-10#2)
extractants##25##1##(2008-10#25)
extracted DNA##3##2##(2008-10#2)(2008-12#1)
extracted and determined##2##3##(2008-10#2)
extracted and##18##2##(1995-11#1)(1996-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
extracted arsenic##3##2##(2008-10#3)
extracted as##5##2##(2008-10#5)
extracted at##5##2##(1996-12#1)(2008-10#4)
extracted by the##2##3##(2008-10#1)(2008-11#1)
extracted by using##4##3##(2008-10#3)(2008-11#1)
extracted by##26##2##(1991-7#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-8#1)
extracted compounds##2##2##(2008-10#2)
extracted for##3##2##(2008-10#3)
extracted from a##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
extracted from cultured##3##3##(2008-11#1)(2009-6#1)(2012-2#1)
extracted from different##2##3##(2008-10#1)(2012-2#1)
extracted from human##2##3##(2008-10#1)(2008-5#1)
extracted from rats##2##3##(1990-5#1)(2010-6#1)
extracted from samples##2##3##(2008-10#1)(2008-12#1)
extracted from soil samples##2##4##(2008-10#2)
extracted from soil##6##3##(2008-10#6)
extracted from the samples##2##4##(2008-10#2)
extracted from the##27##3##(1993-3#1)(1996-8#1)(1997-6#1)(2008-10#16)(2008-11#2)(2008-5#3)(2008-7#1)(2010-8#1)(2013-1#1)
extracted from##115##2##(1990-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-6#1)(2008-10#74)(2008-11#4)(2008-12#4)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
extracted in chloroform##5##3##(2008-10#5)
extracted in the##2##3##(2008-10#2)
extracted in##14##2##(2008-10#13)(2008-5#1)
extracted into 1##2##3##(2008-10#2)
extracted into chloroform##6##3##(2008-10#6)
extracted into dichloromethane##2##3##(2008-10#2)
extracted into the acetonitrile layer with high yield##2##8##(2008-10#2)
extracted into the organic phase##3##5##(2008-10#3)
extracted into the organic##4##4##(2008-10#4)
extracted into the surfactant-rich phase##2##5##(2008-10#1)(2008-7#1)
extracted into the upper phase in the pH##2##8##(2008-10#2)
extracted into the upper phase##3##5##(2008-10#3)
extracted into the##17##3##(2008-10#16)(2008-7#1)
extracted into##34##2##(2008-10#33)(2008-7#1)
extracted metal##2##2##(2008-10#2)
extracted more##2##2##(2008-10#2)
extracted quantitatively with##3##3##(2008-10#3)
extracted quantitatively##4##2##(2008-10#4)
extracted simultaneously##2##2##(2008-10#2)
extracted species is##3##3##(2008-10#3)
extracted species##10##2##(2008-10#10)
extracted to the##3##3##(2008-10#3)
extracted to##6##2##(2008-10#4)(2008-3#1)(2009-6#1)
extracted under the optimum##2##4##(2008-10#2)
extracted under the##3##3##(2008-10#3)
extracted using##3##2##(2008-10#2)(2011-2#1)
extracted with a##4##3##(2008-10#4)
extracted with diethyl ether to obtain extract##2##7##(2008-11#2)
extracted with the##2##3##(1997-2#1)(2008-10#1)
extracted with##39##2##(1993-8#1)(1997-2#2)(2008-10#31)(2008-11#3)(2008-5#1)(2012-2#1)
extracted##383##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-6#2)(2007-12#1)(2008-10#284)(2008-11#12)(2008-12#9)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#5)(2009-3#1)(2009-6#2)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#1)
extracting solutions##2##2##(2008-10#2)
extracting solvent was##2##3##(2008-10#2)
extracting solvent##6##2##(2008-10#6)
extracting the##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
extracting##43##1##(1996-12#1)(2008-10#33)(2008-3#3)(2008-9#3)(2010-7#1)(2012-2#1)(2012-3#1)
extraction (CPE)##3##2##(2008-10#3)
extraction (K(ex))##2##2##(2008-10#2)
extraction (MAE) for the##2##4##(2008-10#2)
extraction (MAE)##4##2##(2008-10#4)
extraction (SFE) and##2##3##(2008-10#2)
extraction (SFE)##11##2##(2008-10#11)
extraction (SPE) and##4##3##(2008-10#3)(2008-11#1)
extraction (SPE) method##3##3##(2008-10#3)
extraction (SPE) of the##2##4##(2008-10#2)
extraction (SPE) on##2##3##(2008-10#2)
extraction (SPE) using##3##3##(2008-10#3)
extraction (SPE)##42##2##(1997-2#1)(2008-10#40)(2008-11#1)
extraction ability and selectivity##3##4##(2008-10#3)
extraction ability of##2##3##(2008-10#2)
extraction ability##6##2##(2008-10#6)
extraction and HPLC determination of##2##5##(2008-10#2)
extraction and a##2##3##(2008-10#2)
extraction and clean-up##5##3##(2008-10#5)
extraction and derivatization##2##3##(2008-10#1)(2008-11#1)
extraction and desorption##3##3##(2008-10#3)
extraction and determination of bismuth in##3##6##(2008-10#3)
extraction and determination of trace##2##5##(2008-10#2)
extraction and determination of##13##4##(2008-10#13)
extraction and gas chromatography##2##4##(2008-10#2)
extraction and gas chromatography-mass spectrometry##3##5##(2008-10#3)
extraction and gas chromatography-mass##4##4##(2008-10#4)
extraction and gas##6##3##(2008-10#6)
extraction and graphite furnace atomic absorption##3##6##(2008-10#3)
extraction and in##2##3##(2008-10#2)
extraction and on-line##2##3##(2008-10#2)
extraction and potentiometry##2##3##(2008-10#2)
extraction and preconcentration##4##3##(2008-10#4)
extraction and purification##4##3##(2008-10#3)(2008-8#1)
extraction and quantification of##2##4##(1992-3#1)(2008-10#1)
extraction and selective##2##3##(2008-10#2)
extraction and separation##2##3##(2008-10#1)(2008-11#1)
extraction and simultaneous spectrophotometric determination of##2##6##(2008-10#2)
extraction and solvent##2##3##(2008-10#2)
extraction and spectrophotometric determination of##2##5##(2008-10#2)
extraction and spectrophotometric determination##3##4##(2008-10#3)
extraction and spectrophotometric##4##3##(2008-10#4)
extraction and standard addition##2##4##(2008-10#2)
extraction and stripping##3##3##(2008-10#3)
extraction and the##8##3##(2008-10#6)(2008-11#1)(2011-2#1)
extraction and##133##2##(1992-11#1)(1992-3#1)(1997-2#2)(2008-10#118)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
extraction and/or##2##2##(2008-10#2)
extraction approach##2##2##(2008-10#2)
extraction are found to be##2##5##(2008-10#2)
extraction are##9##2##(2008-10#8)(2008-11#1)
extraction as well as##2##4##(2008-10#2)
extraction as##5##2##(2008-10#5)
extraction at##6##2##(2008-10#5)(2013-1#1)
extraction behavior of divalent##2##4##(2008-10#2)
extraction behavior of the##2##4##(2008-10#2)
extraction behavior of##5##3##(2008-10#5)
extraction behavior##6##2##(2008-10#6)
extraction behaviour of##5##3##(2008-10#5)
extraction by using##2##3##(2008-10#2)
extraction by##13##2##(2008-10#10)(2008-8#1)(2011-2#2)
extraction cartridge##2##2##(1997-2#1)(2008-10#1)
extraction chromatographic resin##4##3##(2008-10#4)
extraction chromatographic separation of##2##4##(2008-10#2)
extraction chromatographic separation##4##3##(2008-10#4)
extraction chromatographic##13##2##(2008-10#13)
extraction chromatography material##2##3##(2008-10#2)
extraction chromatography##11##2##(2008-10#11)
extraction coil##3##2##(2008-10#3)
extraction column##2##2##(2008-10#1)(2009-8#1)
extraction condition##2##2##(2008-10#2)
extraction conditions were##4##3##(2008-10#4)
extraction conditions##13##2##(2008-10#13)
extraction constant of##4##3##(2008-10#4)
extraction constant##14##2##(2008-10#14)
extraction constants##5##2##(2008-10#5)
extraction data##3##2##(2008-10#3)
extraction device##4##2##(1997-2#2)(2008-10#2)
extraction disks##2##2##(2008-10#2)
extraction does not##2##3##(2008-10#2)
extraction efficiencies for the##2##4##(2009-8#1)(2010-5#1)
extraction efficiencies for##3##3##(2008-10#1)(2009-8#1)(2010-5#1)
extraction efficiencies##7##2##(2008-10#5)(2009-8#1)(2010-5#1)
extraction efficiency and selectivity##4##4##(2008-10#4)
extraction efficiency and##8##3##(2008-10#8)
extraction efficiency as##2##3##(2008-10#2)
extraction efficiency for##3##3##(2008-10#3)
extraction efficiency of the##5##4##(2008-10#5)
extraction efficiency of##12##3##(2008-10#12)
extraction efficiency was##3##3##(2008-10#2)(2012-2#1)
extraction efficiency were##2##3##(2008-10#2)
extraction efficiency##47##2##(2008-10#45)(2008-12#1)(2012-2#1)
extraction equilibria of##3##3##(2008-10#3)
extraction equilibria##4##2##(2008-10#4)
extraction equilibrium constants##4##3##(2008-10#4)
extraction equilibrium of##2##3##(2008-10#2)
extraction equilibrium##10##2##(2008-10#10)
extraction followed by##11##3##(2008-10#11)
extraction for the determination of##2##5##(2008-10#2)
extraction for##11##2##(2008-10#10)(2008-5#1)
extraction from soil##2##3##(2008-10#2)
extraction from the##2##3##(2008-10#2)
extraction from##20##2##(2008-10#19)(2011-2#1)
extraction gas##2##2##(2008-10#2)
extraction gave##2##2##(1993-8#1)(2008-10#1)
extraction has been developed##3##4##(2008-10#3)
extraction has been##4##3##(2008-10#4)
extraction has##5##2##(1990-5#1)(2008-10#4)
extraction in a##3##3##(2008-10#3)
extraction in an ultrasonic bath##2##5##(2008-10#2)
extraction in the presence of##2##5##(2008-10#2)
extraction in the##4##3##(2008-10#3)(2009-8#1)
extraction in##14##2##(2008-10#12)(2008-7#1)(2009-8#1)
extraction into chloroform##2##3##(2008-10#2)
extraction into##10##2##(2008-10#10)
extraction is##14##2##(2008-10#13)(2008-7#1)
extraction kinetics##2##2##(2008-10#2)
extraction mechanism was##2##3##(2008-10#2)
extraction mechanism##6##2##(2008-10#6)
extraction medium##5##2##(2008-10#5)
extraction membrane and##2##3##(2008-10#2)
extraction membrane##4##2##(2008-10#4)
extraction method and the##2##4##(2008-10#2)
extraction method and##3##3##(2008-10#3)
extraction method for the##4##4##(2008-10#4)
extraction method for##5##3##(2008-10#5)
extraction method is##2##3##(2008-10#2)
extraction method of##2##3##(2008-10#2)
extraction method using##3##3##(2008-10#3)
extraction method was also##2##4##(2008-10#2)
extraction method was##3##3##(2008-10#3)
extraction method##31##2##(2008-10#30)(2009-8#1)
extraction methodology##3##2##(2008-10#3)
extraction methods##10##2##(2008-10#10)
extraction of Cd(2+)##2##3##(2008-10#2)
extraction of Co##2##3##(2008-10#2)
extraction of Co(II) and Zn(II) by##2##6##(2008-10#2)
extraction of Co(II) and Zn(II)##3##5##(2008-10#3)
extraction of Cr(VI)##2##3##(2008-10#2)
extraction of Cu(II)##2##3##(2008-10#2)
extraction of DNA##2##3##(2008-10#1)(2008-12#1)
extraction of PAHs##2##3##(2008-10#2)
extraction of U/Pu##2##3##(2008-10#2)
extraction of a##6##3##(2008-10#6)
extraction of acids from##3##4##(2008-10#3)
extraction of alkali metal picrates with##2##6##(2008-10#2)
extraction of an##2##3##(2008-10#1)(2011-2#1)
extraction of analyte from water##2##5##(2008-10#2)
extraction of astaxanthin from crustaceans##2##5##(2008-10#2)
extraction of b(5)##3##3##(2008-7#3)
extraction of both metals##2##4##(2008-10#2)
extraction of both##4##3##(2008-10#4)
extraction of chromium(VI)##3##3##(2008-10#3)
extraction of copper##3##3##(2008-10#3)
extraction of copper(II) ions##2##4##(2008-10#2)
extraction of copper(II)##3##3##(2008-10#3)
extraction of free##2##3##(2008-10#2)
extraction of gallium##2##3##(2008-10#2)
extraction of genistein##3##3##(2012-2#3)
extraction of iron(III) and titanium(IV)##2##5##(2008-10#2)
extraction of lanthanoids(III) with##2##4##(2008-10#2)
extraction of magnesium##2##3##(2008-10#2)
extraction of membrane proteins##2##4##(2008-7#2)
extraction of mercury from##2##4##(2008-10#2)
extraction of mercury species##2##4##(2008-10#2)
extraction of mercury##4##3##(2008-10#4)
extraction of mercury(II) from##2##4##(2008-10#2)
extraction of mercury(II)##3##3##(2008-10#3)
extraction of metal ions by##2##5##(2008-10#2)
extraction of metal ions##5##4##(2008-10#5)
extraction of metal##6##3##(2008-10#6)
extraction of metals from##3##4##(2008-10#3)
extraction of metals##6##3##(2008-10#6)
extraction of platinum(II) with##2##4##(2008-10#2)
extraction of polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
extraction of rhodium(III)##2##3##(2008-10#2)
extraction of soil##2##3##(2008-10#2)
extraction of some##2##3##(2008-10#2)
extraction of tanshinones from Salvia miltiorrhiza bunge##2##7##(2008-10#2)
extraction of the##26##3##(1992-3#1)(2008-10#20)(2008-5#1)(2008-7#2)(2010-12#1)(2013-8#1)
extraction of these##3##3##(2008-10#3)
extraction of thorium(IV) and uranium(VI)##2##5##(2008-10#2)
extraction of tin(IV)##2##3##(2008-10#2)
extraction of trivalent##2##3##(2008-10#2)
extraction of uranium##3##3##(2008-10#3)
extraction of vanillin and##2##4##(2008-10#2)
extraction of volatile organic compounds##2##5##(2008-10#2)
extraction of volatile##3##3##(2008-10#3)
extraction of##259##2##(1991-3#1)(1992-3#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-2#2)(2008-10#229)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#8)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
extraction or separation##2##3##(2008-10#2)
extraction or##8##2##(1992-11#1)(2008-10#6)(2008-3#1)
extraction parameters##6##2##(2008-10#6)
extraction period##2##2##(2008-10#2)
extraction phase##2##2##(2008-10#2)
extraction preconcentration##5##2##(2008-10#5)
extraction procedure and##3##3##(2008-10#3)
extraction procedure for the##4##4##(2008-10#4)
extraction procedure for##14##3##(2008-10#14)
extraction procedure of##2##3##(2008-10#2)
extraction procedure was optimized##2##4##(2008-10#2)
extraction procedure was##7##3##(2008-10#7)
extraction procedure with##2##3##(2008-10#2)
extraction procedure##54##2##(1990-5#1)(2008-10#53)
extraction procedures were##3##3##(2008-10#3)
extraction procedures##19##2##(1997-1#1)(2008-10#18)
extraction process for##2##3##(2008-10#1)(2012-3#1)
extraction process was##6##3##(2008-10#6)
extraction process##30##2##(2008-10#26)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
extraction processes of##2##3##(2008-10#1)(2012-2#1)
extraction processes##3##2##(2008-10#2)(2012-2#1)
extraction protocol##4##2##(2008-10#3)(2011-2#1)
extraction provided##2##2##(2008-10#2)
extraction rate and##2##3##(2011-2#2)
extraction rate data##3##3##(2008-10#3)
extraction rate is##3##3##(2008-10#1)(2008-8#2)
extraction rate of platinum(II) was##2##5##(2008-10#2)
extraction rate of platinum(II)##3##4##(2008-10#3)
extraction rate##14##2##(2008-10#8)(2008-8#2)(2011-2#4)
extraction recoveries##2##2##(2008-10#2)
extraction recovery##2##2##(2008-10#2)
extraction reservoir (H)##2##3##(2008-10#2)
extraction reservoir##3##2##(2008-10#3)
extraction resin was##2##3##(2008-10#2)
extraction resin##8##2##(2008-10#8)
extraction scheme##3##2##(2008-10#3)
extraction schemes##4##2##(2008-10#4)
extraction selectivity for##4##3##(2008-10#4)
extraction selectivity of##3##3##(2008-10#3)
extraction selectivity##9##2##(2008-10#9)
extraction separation of##3##3##(2008-10#3)
extraction separation##7##2##(2008-10#7)
extraction solution##5##2##(2008-10#5)
extraction solvent##8##2##(2008-10#8)
extraction solvents##6##2##(2008-10#6)
extraction species##2##2##(2008-10#2)
extraction spectrophotometric determination of##3##4##(2008-10#3)
extraction step was##2##3##(2008-10#1)(2008-7#1)
extraction step##12##2##(2008-10#10)(2008-7#2)
extraction study of##3##3##(2008-10#3)
extraction support##3##2##(2008-10#3)
extraction system and##3##3##(2008-10#3)
extraction system for##3##3##(2008-10#3)
extraction system on##2##3##(2008-10#2)
extraction system using##2##3##(2008-10#2)
extraction system##26##2##(2008-10#26)
extraction systems##7##2##(2008-10#7)
extraction technique for##3##3##(2008-10#3)
extraction technique was##2##3##(2008-10#1)(2013-8#1)
extraction technique##10##2##(1991-12#1)(1992-11#1)(1996-12#1)(2008-10#6)(2013-8#1)
extraction techniques have been##2##4##(2008-10#2)
extraction techniques##7##2##(2008-10#7)
extraction temperature##7##2##(2008-10#7)
extraction through##2##2##(2008-10#2)
extraction time and total analyte pulse width##2##7##(2008-10#2)
extraction time and total##3##4##(2008-10#3)
extraction time and##12##3##(2008-10#12)
extraction time##48##2##(2008-10#47)(2009-8#1)
extraction time)##3##2##(2008-10#3)
extraction times##2##2##(2008-10#2)
extraction to##3##2##(2008-10#2)(2008-9#1)
extraction under##2##2##(2008-10#2)
extraction using a##2##3##(2008-10#2)
extraction using the##2##3##(2008-10#2)
extraction using##19##2##(1997-2#1)(2008-10#17)(2012-2#1)
extraction vessel (H)##2##3##(2008-10#2)
extraction vessel##7##2##(2008-10#7)
extraction vial##2##2##(2008-10#2)
extraction was applied##2##3##(2008-10#2)
extraction was carried out##2##4##(2008-10#2)
extraction was developed##2##3##(2008-10#2)
extraction was performed##2##3##(2008-10#2)
extraction was used to extract##2##5##(2008-10#2)
extraction was used to##4##4##(2008-10#4)
extraction was##26##2##(2008-10#25)(2008-11#1)
extraction were##5##2##(2008-10#5)
extraction with a mixture of##2##5##(2008-10#2)
extraction with a##4##3##(2008-10#4)
extraction with acidic##2##3##(2008-10#1)(2008-8#1)
extraction with chloroform##2##3##(2008-10#2)
extraction with the##3##3##(2008-10#2)(2008-12#1)
extraction with##39##2##(1991-7#1)(2008-10#35)(2008-12#1)(2008-8#1)(2011-3#1)
extraction yield of##3##3##(2008-10#2)(2008-7#1)
extraction yield##5##2##(2008-10#4)(2008-7#1)
extraction yields##3##2##(2008-10#3)
extraction##1515##1##(1990-5#4)(1991-12#1)(1991-3#3)(1991-7#1)(1991-9#1)(1992-11#4)(1992-3#2)(1992-8#1)(1993-8#1)(1994-6#1)(1995-2#2)(1996-12#2)(1997-1#1)(1997-2#11)(2008-10#1387)(2008-11#9)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#15)(2008-8#5)(2008-9#3)(2009-11#1)(2009-8#5)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#6)
extraction)##5##1##(2008-10#5)
extraction-ability and -selectivity of##2##4##(2008-10#2)
extraction-ability and -selectivity##3##3##(2008-10#3)
extraction-selectivity##3##1##(2008-10#3)
extraction-spectrophotometric determination of##5##3##(2008-10#5)
extraction-spectrophotometric method for the determination of##2##6##(2008-10#2)
extraction-spectrophotometric##8##1##(2008-10#8)
extractions of##2##2##(2008-10#2)
extractions were##7##2##(2008-10#6)(2011-2#1)
extractions with##2##2##(2008-10#2)
extractions##27##1##(1991-9#1)(1993-1#1)(1994-12#1)(1997-2#1)(2008-10#21)(2011-2#1)(2013-1#1)
extractions)##2##1##(2008-10#1)(2008-12#1)
extractive fermentation##3##2##(2011-2#3)
extractive flow injection analysis##2##4##(2008-10#2)
extractive preconcentration and separation of##2##5##(2008-10#2)
extractive preconcentration##6##2##(2008-10#6)
extractive separation of##3##3##(2008-10#3)
extractive##24##1##(2008-10#21)(2011-2#3)
extractograms##2##1##(2008-10#2)
extractor##20##1##(2008-10#18)(2008-11#1)(2008-3#1)
extractors##3##1##(2008-10#3)
extracts after##3##2##(2008-10#2)(2008-11#1)
extracts and in##2##3##(2008-10#2)
extracts and##16##2##(2008-10#12)(2008-5#2)(2012-2#1)(2013-8#1)
extracts but##2##2##(1990-11#1)(1997-7#1)
extracts by##10##2##(1992-6#1)(2008-10#7)(2008-4#1)(2010-12#1)
extracts can be##2##3##(2008-10#2)
extracts contained only##2##3##(2008-10#2)
extracts containing##5##2##(1990-5#1)(1994-5#1)(2008-10#3)
extracts derived from##2##3##(2008-10#2)
extracts exhibited##2##2##(2011-1#1)(2013-8#1)
extracts for##5##2##(1991-7#1)(1993-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
extracts from Glycyrrhiza uralensis Fisch##2##5##(2008-11#2)
extracts from a##2##3##(1996-12#1)(2008-10#1)
extracts from the##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
extracts from##46##2##(1990-12#1)(1991-12#2)(1993-6#2)(1993-8#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#22)(2008-11#6)(2008-8#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
extracts had##2##2##(1990-5#1)(1991-12#1)
extracts has##2##2##(2008-10#1)(2010-7#1)
extracts have been##2##3##(2008-10#2)
extracts have##3##2##(2008-10#2)(2012-2#1)
extracts in##5##2##(1990-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
extracts indicates that##2##3##(1996-2#1)(1997-7#1)
extracts is described##2##3##(2008-10#2)
extracts is##4##2##(2008-10#3)(2008-11#1)
extracts obtained##4##2##(2008-10#4)
extracts of Inula##2##3##(2008-10#2)
extracts of human##2##3##(1994-8#1)(2008-10#1)
extracts of infected potato leaves##2##5##(2008-10#2)
extracts of infected potato##3##4##(2008-10#3)
extracts of infected##4##3##(2008-10#4)
extracts of soil##2##3##(2008-10#1)(2008-11#1)
extracts of the##5##3##(2008-10#5)
extracts of##57##2##(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#30)(2008-11#10)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#4)
extracts on##6##2##(2008-10#1)(2008-11#3)(2008-5#1)(2010-3#1)
extracts prepared##2##2##(1993-6#1)(2008-11#1)
extracts produced##2##2##(2008-10#1)(2008-12#1)
extracts reduce the##2##3##(2008-10#1)(2010-2#1)
extracts revealed##3##2##(2008-10#3)
extracts showed##2##2##(1990-5#1)(2011-1#1)
extracts significantly##2##2##(2008-10#1)(2008-11#1)
extracts that##4##2##(1993-6#1)(2008-10#1)(2008-4#1)(2013-8#1)
extracts the##2##2##(2008-10#2)
extracts to##4##2##(2008-10#1)(2008-11#1)(2010-2#1)(2013-1#1)
extracts using##5##2##(2008-10#4)(2008-4#1)
extracts was##13##2##(1990-5#1)(2008-10#10)(2008-5#1)(2013-1#1)
extracts were analysed by gas chromatography##2##6##(2008-10#2)
extracts were analyzed##2##3##(2008-10#2)
extracts were carried out by##2##5##(2008-10#2)
extracts were determined using the##2##5##(2008-10#2)
extracts were determined##4##3##(2008-10#2)(2008-6#1)(2011-1#1)
extracts were fractionated by##2##4##(2008-10#1)(2008-5#1)
extracts were fractionated##3##3##(2008-10#2)(2008-5#1)
extracts were obtained##2##3##(2008-10#2)
extracts were tested##2##3##(1993-6#1)(2008-11#1)
extracts were##38##2##(1990-10#1)(1990-12#1)(1990-5#1)(1992-9#1)(1993-6#2)(1995-2#1)(2008-10#27)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)
extracts with##5##2##(2008-10#4)(2013-8#1)
extracts##383##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-5#6)(1990-8#1)(1991-12#3)(1991-7#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#10)(1993-8#2)(1994-5#1)(1994-8#3)(1995-11#2)(1995-2#5)(1995-6#1)(1996-12#3)(1996-2#2)(1997-3#1)(1997-7#2)(2008-10#217)(2008-11#38)(2008-12#3)(2008-3#1)(2008-4#5)(2008-5#11)(2008-6#2)(2008-8#3)(2008-9#4)(2009-6#1)(2010-12#2)(2010-2#4)(2010-3#3)(2010-7#1)(2011-1#5)(2011-2#2)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#15)
extracts)##2##1##(1990-5#1)(2008-5#1)
extracurricular activities##6##2##(2009-7#6)
extracurricular##7##1##(2009-7#7)
extradural anterior clinoidectomy via the trans-SOF approach##3##7##(2011-2#3)
extradural##11##1##(2008-12#2)(2008-7#4)(2011-2#3)(2012-3#2)
extraembryonic coelomic fluid##3##3##(1995-8#3)
extragenic##6##1##(1990-11#1)(1990-5#1)(2008-10#4)
extrahepatic##5##1##(1991-8#1)(1994-8#1)(1995-6#1)(2008-2#1)(2013-1#1)
extraintestinal##4##1##(1997-3#2)(1997-5#1)(2013-1#1)
extramammary Paget's disease##2##3##(1993-1#1)(2012-12#1)
extramedullary masses may##2##3##(2011-2#2)
extramedullary masses##5##2##(2011-2#5)
extramedullary plasmacytoma of the thyroid##2##5##(2009-3#2)
extramedullary plasmacytoma##4##2##(2009-3#3)(2012-12#1)
extramedullary spinal##2##2##(2008-7#1)(2012-3#1)
extramedullary##19##1##(1993-2#1)(2008-10#1)(2008-7#3)(2009-3#3)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#1)
extramucosal##2##1##(1992-9#1)(2009-8#1)
extramural##4##1##(1991-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
extraneous##7##1##(1991-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#1)
extranodal##5##1##(2008-5#2)(2009-8#2)(2013-1#1)
extraocular muscles##7##2##(1997-3#6)(2008-7#1)
extraocular##8##1##(1997-3#7)(2008-7#1)
extraoral##2##1##(2011-2#2)
extraordinarily##12##1##(1990-8#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(2008-10#3)(2008-11#1)(2010-5#1)
extraordinary polarization##2##2##(2008-3#2)
extraordinary##5##1##(1993-6#1)(2008-10#1)(2008-2#1)(2008-3#2)
extrapelvic endometriosis##2##2##(2009-8#1)(2013-1#1)
extrapelvic##3##1##(2009-8#1)(2013-1#2)
extrapolate##4##1##(2008-11#2)(2008-2#1)(2010-8#1)
extrapolated from##2##2##(2008-11#1)(2009-5#1)
extrapolated##4##1##(2008-10#1)(2008-11#1)(2009-5#1)(2009-8#1)
extrapolating##3##1##(1995-8#1)(2008-10#1)(2008-8#1)
extrapolation of##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
extrapolation##9##1##(1991-8#1)(1992-6#1)(2008-10#5)(2008-5#1)(2013-1#1)
extrapolations##2##1##(2008-7#1)(2010-6#1)
extrapulmonary hydatid##2##2##(2013-1#2)
extrapulmonary sites##2##2##(1991-12#1)(2013-1#1)
extrapulmonary tuberculosis##2##2##(1996-11#2)
extrapulmonary##10##1##(1991-12#1)(1996-11#3)(1997-1#1)(2011-3#1)(2013-1#4)
extrapyramidal##6##1##(1990-6#1)(1992-12#1)(1995-2#1)(2008-7#2)(2008-8#1)
extraradical##3##1##(2008-11#3)
extraskeletal##2##1##(2012-2#1)(2012-3#1)
extrastriate##4##1##(1990-8#3)(2008-11#1)
extrasystole##3##1##(1996-3#2)(1996-6#1)
extrasystoles##6##1##(1996-3#2)(1996-6#4)
extrathoracic##4##1##(1994-12#1)(2008-11#2)(2008-7#1)
extrathyroidal##2##1##(2012-3#1)(2013-1#1)
extrauterine##2##1##(1994-12#2)
extravasation##2##1##(2009-10#2)
extravascular lung water##4##3##(1994-8#4)
extreme case##2##2##(2008-10#1)(2010-3#1)
extreme cases##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
extreme conditions##2##2##(2008-10#2)
extreme flexion and##2##3##(2008-8#2)
extreme hardness and insolubility##2##4##(2008-10#2)
extreme heat##2##2##(2011-1#1)(2011-2#1)
extreme of##2##2##(1997-3#1)(2012-3#1)
extreme outgroups that elicit disgust##2##5##(2008-11#2)
extreme outgroups##3##2##(2008-11#3)
extreme penoscrotal transposition##2##3##(2008-10#2)
extreme phenotypes##3##2##(2008-8#3)
extreme phenotypic##2##2##(2008-9#1)(2009-6#1)
extreme scale-down##2##2##(2013-1#2)
extreme sensitivity##2##2##(2009-6#1)(2010-11#1)
extreme##93##1##(1990-6#1)(1990-8#1)(1991-2#2)(1991-6#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#21)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#11)(2008-9#4)(2009-6#2)(2010-1#3)(2010-11#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#2)(2013-1#3)
extreme-ultraviolet##2##1##(2008-3#2)
extremely challenging##2##2##(2010-11#1)(2012-3#1)
extremely complex##5##2##(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
extremely difficult##6##2##(1994-12#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-11#1)
extremely efficient##2##2##(2008-10#2)
extremely high concentrations of##2##4##(1997-4#1)(2008-10#1)
extremely high##15##2##(1991-5#1)(1993-3#1)(1994-8#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-3#1)
extremely important##6##2##(1995-9#2)(2007-12#1)(2008-8#2)(2008-9#1)
extremely long##2##2##(1992-12#1)(1997-3#1)
extremely low birth weight##4##4##(1991-6#1)(2008-11#3)
extremely low frequency electromagnetic fields##2##5##(2008-12#1)(2011-2#1)
extremely low frequency##3##3##(2008-12#1)(2008-5#1)(2011-2#1)
extremely low##24##2##(1990-11#1)(1991-12#1)(1991-6#1)(1993-8#1)(1997-3#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#3)
extremely rare and##6##3##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#2)(2013-7#1)
extremely rare case of##2##4##(1990-5#1)(2013-1#1)
extremely rare in##4##3##(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
extremely rare##39##2##(1990-5#1)(1994-9#1)(1995-5#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#6)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#8)(2013-7#1)
extremely robust##2##2##(2008-10#2)
extremely sensitive to##5##3##(1995-5#1)(1996-2#1)(1997-6#1)(2008-10#1)(2009-5#1)
extremely sensitive##10##2##(1994-8#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)
extremely small##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
extremely stable##2##2##(2008-10#2)
extremely strong##2##2##(2008-10#1)(2008-11#1)
extremely thermophilic##2##2##(2008-8#2)
extremely useful for##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
extremely useful##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)
extremely variable##5##2##(1991-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
extremely well##4##2##(1990-11#1)(1990-12#1)(2008-8#1)(2011-1#1)
extremely##203##1##(1990-11#3)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#2)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#42)(2008-11#17)(2008-12#10)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#8)(2008-7#6)(2008-8#9)(2008-9#6)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#11)(2011-3#3)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#1)
extremes of the##3##3##(2008-10#1)(2008-8#2)
extremes##10##1##(1996-2#1)(2008-10#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)
extremities and##3##2##(1993-6#1)(2007-12#1)(2010-6#1)
extremities is##2##2##(2008-7#1)(2010-11#1)
extremities of##2##2##(1997-8#1)(2010-6#1)
extremities##31##1##(1993-6#1)(1995-8#1)(1997-4#2)(1997-8#4)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#3)(2010-11#1)(2010-3#1)(2010-6#4)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
extremity and##3##2##(1993-9#1)(2012-2#1)(2013-1#1)
extremity function##2##2##(2008-8#1)(2013-1#1)
extremity of the##2##3##(1991-11#1)(2008-7#1)
extremity of##3##2##(1991-11#1)(2008-3#1)(2008-7#1)
extremity weakness##4##2##(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
extremity##48##1##(1991-11#1)(1991-12#1)(1993-9#1)(1995-8#1)(2008-12#7)(2008-3#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-1#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#6)(2012-3#3)(2013-1#9)
extrinsic apoptotic pathway##2##3##(2009-9#1)(2011-2#1)
extrinsic apoptotic##3##2##(2009-9#1)(2010-3#1)(2011-2#1)
extrinsic factors##6##2##(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#2)
extrinsic skin##2##2##(2008-5#1)(2011-2#1)
extrinsic surface##2##2##(2008-6#1)(2009-11#1)
extrinsic work values##4##3##(2010-10#4)
extrinsic work##5##2##(1996-1#1)(2010-10#4)
extrinsic##45##1##(1990-5#1)(1994-3#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-9#1)(2010-1#1)(2010-10#9)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#8)(2013-1#2)
extruded##4##1##(2008-10#1)(2008-9#1)(2012-2#2)
extrudes##2##1##(2008-5#2)
extrusion and heat treatment##2##4##(2012-2#2)
extrusion of##3##2##(1996-5#1)(2008-9#1)(2011-2#1)
extrusion processes##3##2##(2008-10#3)
extrusion##18##1##(1996-5#1)(2008-10#5)(2008-5#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)
extubation##3##1##(1993-1#1)(2010-7#1)(2012-3#1)
exuberant##2##1##(2008-12#1)(2011-2#1)
exudate##2##1##(1992-5#1)(2008-10#1)
exudates from##8##2##(2008-10#8)
exudates on##3##2##(2008-10#3)
exudates were##2##2##(2008-10#1)(2012-8#1)
exudates##22##1##(1994-12#1)(2008-10#20)(2012-8#1)
exudation##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
exudative##8##1##(2008-11#1)(2010-9#1)(2011-2#3)(2013-1#1)(2013-8#2)
exuded##2##1##(2009-8#2)
eye and##8##2##(1994-3#1)(2008-10#1)(2010-10#1)(2011-2#3)(2013-1#1)(2013-7#1)
eye bank##2##2##(2010-10#1)(2011-2#1)
eye care products##2##3##(1992-11#2)
eye care##5##2##(1992-11#2)(2011-2#1)(2011-7#2)
eye centers##2##2##(2008-11#2)
eye contact##4##2##(2008-11#2)(2008-6#2)
eye disease##5##2##(2008-7#4)(2011-7#1)
eye drops##6##2##(1990-11#1)(2008-10#1)(2010-10#1)(2011-2#1)(2011-3#2)
eye for##2##2##(2013-7#1)(2013-8#1)
eye gaze##5##2##(2008-11#4)(2008-6#1)
eye in##3##2##(2007-12#2)(2011-2#1)
eye is##3##2##(2007-12#2)(2008-11#1)
eye make-up##3##2##(2008-5#3)
eye movement##4##2##(1991-9#1)(2008-11#1)(2008-7#1)(2013-8#1)
eye movements and##2##3##(2010-5#1)(2013-8#1)
eye region##2##2##(2007-12#1)(2010-1#1)
eye view##3##2##(1993-9#1)(2013-1#2)
eye were##2##2##(2008-11#1)(2009-5#1)
eye with##2##2##(2010-10#1)(2011-2#1)
eye##162##1##(1990-11#1)(1990-12#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-2#4)(1994-3#1)(1997-3#1)(2007-12#11)(2008-10#9)(2008-11#17)(2008-12#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#10)(2008-9#4)(2009-5#1)(2010-1#9)(2010-10#7)(2010-5#3)(2010-8#1)(2010-9#1)(2011-2#23)(2011-3#2)(2011-7#7)(2012-2#3)(2012-3#1)(2013-1#11)(2013-7#4)(2013-8#6)
eye-gaze##2##1##(2008-6#1)(2009-10#1)
eyeball##2##1##(2008-6#1)(2010-11#1)
eyebrow##2##1##(2012-12#2)
eyelid##2##1##(1992-12#1)(2011-2#1)
eyes and##5##2##(1992-6#1)(2008-5#1)(2009-10#1)(2013-1#2)
eyes are##2##2##(2008-5#1)(2010-8#1)
eyes in##2##2##(1993-3#1)(2008-7#1)
eyes of the##2##3##(2008-1#1)(2013-1#1)
eyes of##15##2##(1994-3#1)(1995-9#1)(2007-12#2)(2008-1#1)(2008-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#5)(2013-8#1)
eyes suffering from##2##3##(2013-1#2)
eyes were##2##2##(1993-3#1)(2013-1#1)
eyes with##2##2##(1991-2#1)(2013-1#1)
eyes##78##1##(1990-11#1)(1990-12#2)(1991-2#1)(1992-6#1)(1993-3#3)(1994-3#1)(1995-9#2)(1996-1#1)(2007-12#4)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#2)(2010-8#3)(2010-9#2)(2011-2#11)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#3)
eyes)##6##1##(1990-12#2)(2011-2#2)(2013-1#2)
eyes-closed##3##1##(1995-5#1)(2013-8#2)
eyes-open##2##1##(2013-8#2)
eyespot of##2##2##(2008-10#1)(2012-3#1)
eyespot resistance##2##2##(2008-10#2)
eyespot that##2##2##(2009-10#1)(2012-3#1)
eyespot##19##1##(2008-10#10)(2008-9#1)(2009-10#2)(2012-3#6)
eyespots##8##1##(2008-9#7)(2012-3#1)
eyestalk##3##1##(1994-11#2)(2008-5#1)
f##309##1##(1993-2#1)(1994-5#1)(2008-10#298)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
f(C)##3##1##(2008-11#3)
f(s)##2##1##(2008-3#2)
fLumo##3##1##(2013-1#3)
fMLP##6##1##(1994-11#1)(1995-6#1)(1996-2#3)(2008-10#1)
fMLP-induced##3##1##(1995-6#2)(1996-2#1)
fMRI and##2##2##(2008-5#1)(2009-9#1)
fMRI data##4##2##(2008-11#4)
fMRI investigation##2##2##(2008-11#1)(2013-8#1)
fMRI study##3##2##(2011-2#1)(2013-8#2)
fMRI##33##1##(1996-2#2)(2008-11#14)(2008-5#2)(2009-8#1)(2009-9#7)(2011-2#1)(2013-8#6)
fabA##4##1##(1992-8#4)
faba bean (Vicia faba)##3##4##(2008-10#2)(2009-8#1)
faba bean##12##2##(2008-10#11)(2009-8#1)
faba##26##1##(2008-10#16)(2008-8#6)(2009-8#4)
fabae##10##1##(2008-10#6)(2009-8#4)
fabella##4##1##(2011-2#4)
fabric##7##1##(2008-1#1)(2008-10#5)(2008-11#1)
fabricate the##2##2##(2008-10#1)(2008-12#1)
fabricate##13##1##(2008-10#6)(2008-12#1)(2008-3#2)(2008-7#2)(2009-11#1)(2013-1#1)
fabricated a##2##2##(2008-2#1)(2012-2#1)
fabricated and##7##2##(2008-10#5)(2008-3#1)(2009-7#1)
fabricated as##2##2##(2008-10#2)
fabricated at the end of##2##5##(2008-10#2)
fabricated by a##2##3##(2008-10#2)
fabricated by layer-by-layer##2##3##(2008-10#2)
fabricated by use of##2##4##(2008-3#2)
fabricated by using##2##3##(2008-10#1)(2013-8#1)
fabricated by##22##2##(1994-2#1)(2008-10#15)(2008-2#1)(2008-3#2)(2009-5#1)(2009-7#1)(2013-8#1)
fabricated for##3##2##(2009-11#1)(2010-12#1)(2013-1#1)
fabricated from Gwent##2##3##(2008-10#2)
fabricated from a##2##3##(2008-10#1)(2010-4#1)
fabricated from fluorinated polyimides##3##4##(2008-2#3)
fabricated from glass##2##3##(2009-7#2)
fabricated from##13##2##(2008-10#6)(2008-2#3)(2008-7#1)(2009-7#2)(2010-4#1)
fabricated in##3##2##(2008-2#1)(2008-3#2)
fabricated on a##2##3##(2008-10#2)
fabricated on##3##2##(2008-10#3)
fabricated to##4##2##(2008-10#2)(2008-3#1)(2009-12#1)
fabricated using##4##2##(2008-10#3)(2008-12#1)
fabricated with##3##2##(2007-12#1)(2008-3#1)(2010-4#1)
fabricated##95##1##(1994-2#1)(2007-12#1)(2008-10#52)(2008-12#2)(2008-2#7)(2008-3#15)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#4)(2010-12#2)(2010-4#3)(2012-2#1)(2013-1#1)(2013-8#1)
fabricating a##2##2##(2008-3#1)(2013-1#1)
fabricating##11##1##(2008-10#7)(2008-3#2)(2009-11#1)(2013-1#1)
fabrication and characterization of##2##4##(2008-12#1)(2009-9#1)
fabrication and characterization##3##3##(2008-10#1)(2008-12#1)(2009-9#1)
fabrication and##9##2##(2008-10#3)(2008-12#1)(2008-4#2)(2009-12#1)(2009-9#1)(2012-2#1)
fabrication by##2##2##(2008-10#1)(2010-9#1)
fabrication errors##4##2##(2008-2#1)(2008-3#3)
fabrication method##2##2##(2008-10#1)(2008-7#1)
fabrication methods##2##2##(2008-10#2)
fabrication of a##5##3##(2008-10#3)(2009-9#1)(2013-1#1)
fabrication of continuous##2##3##(2007-11#2)
fabrication of films##2##3##(2008-12#2)
fabrication of the##3##3##(2008-10#1)(2008-3#2)
fabrication of thin-film##2##3##(2008-10#1)(2008-3#1)
fabrication of##34##2##(2007-11#2)(2008-10#14)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-9#1)(2013-1#1)
fabrication process##3##2##(2008-10#1)(2008-3#1)(2010-9#1)
fabrication techniques##2##2##(2009-9#1)(2010-9#1)
fabrication##88##1##(2007-11#2)(2008-10#35)(2008-12#6)(2008-2#3)(2008-3#19)(2008-4#3)(2008-7#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-9#3)(2010-7#1)(2010-9#6)(2012-2#1)(2013-1#1)
fabrics##5##1##(2008-10#2)(2008-5#1)(2010-4#1)(2012-3#1)
fac-Re(CO)(3)(dpknph)Cl in##4##2##(2008-10#4)
fac-Re(CO)(3)(dpknph)Cl##17##1##(2008-10#17)
facades##4##1##(2008-2#2)(2008-3#2)
face SC##2##2##(2008-5#2)
face a dilemma##2##3##(1994-1#1)(2008-11#1)
face a##3##2##(1994-1#1)(2008-11#1)(2013-1#1)
face and##10##2##(1996-11#1)(1996-3#1)(2008-5#2)(2009-10#1)(2010-1#1)(2010-6#2)(2011-1#1)(2011-2#1)
face challenges in##2##3##(1995-3#1)(1997-3#1)
face expression##3##2##(2009-10#3)
face in##3##2##(1994-2#1)(2008-11#1)(2008-5#1)
face is##2##2##(2008-5#1)(2010-1#1)
face it##2##2##(1994-12#1)(1995-5#1)
face membrane##2##2##(1990-2#2)
face of the##5##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
face of##22##2##(1990-11#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-5#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#2)(2009-7#1)(2010-7#1)(2011-2#2)(2013-1#1)
face or##2##2##(2009-10#1)(2013-8#1)
face perception##2##2##(2008-11#2)
face the##10##2##(1990-6#1)(1994-1#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-11#1)(2013-1#1)
face validity##3##2##(1996-2#1)(2008-7#2)
face when attempting to##3##4##(2008-4#3)
face when##4##2##(2008-4#3)(2013-1#1)
face with##4##2##(2008-10#1)(2008-6#1)(2010-1#1)(2012-3#1)
face##164##1##(1990-11#1)(1990-2#2)(1990-6#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#2)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#3)(1994-5#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#2)(1996-3#2)(1997-1#4)(1997-2#1)(1997-3#4)(2008-10#4)(2008-11#17)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#14)(2008-6#6)(2008-7#6)(2008-8#1)(2009-10#9)(2009-11#1)(2009-12#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#6)(2010-10#1)(2010-12#1)(2010-6#5)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-2#1)(2012-3#6)(2013-1#17)(2013-8#4)
face)##3##1##(2008-11#2)(2012-3#1)
face-selective neurons##2##2##(2009-10#2)
face-specific hypothesis##2##2##(2008-11#2)
face-specific##3##1##(2008-11#3)
face-to-face interviews##2##2##(2009-5#1)(2010-10#1)
face-to-face##12##1##(1991-1#1)(1996-5#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
faced by the National##2##4##(1997-3#1)(2008-11#1)
faced by the##4##3##(1997-3#1)(2008-11#2)(2013-1#1)
faced by##16##2##(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-3#1)(1996-2#1)(1997-3#1)(2008-11#3)(2008-12#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
faced during##2##2##(2008-10#1)(2012-2#1)
faced in##3##2##(2008-11#1)(2010-1#1)(2013-1#1)
faced with a##4##3##(1990-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
faced with an##2##3##(2008-11#1)(2012-2#1)
faced with the##5##3##(1992-3#1)(1995-5#1)(1996-1#1)(2008-11#1)(2008-12#1)
faced with##19##2##(1990-11#1)(1992-3#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
faced##45##1##(1990-11#1)(1991-12#1)(1991-2#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#8)(2008-12#2)(2009-11#1)(2010-1#2)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
faces in the##3##3##(1991-12#1)(2009-4#1)(2011-2#1)
faces of##4##2##(1992-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
faces that consistently looked##2##4##(2010-10#2)
faces that##4##2##(2008-11#1)(2010-10#3)
faces with##3##2##(2008-11#1)(2008-5#2)
faces##45##1##(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#9)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2009-10#3)(2009-4#3)(2009-8#1)(2010-10#6)(2010-11#1)(2011-2#1)(2013-8#1)
facet joint##4##2##(1996-9#1)(2011-2#2)(2012-3#1)
facet joints##5##2##(1996-9#2)(2011-2#1)(2013-8#2)
facet modal reflectivity##3##3##(2008-3#3)
facet of##2##2##(1992-9#1)(2008-3#1)
facet reflectivity##2##2##(2008-3#2)
facet##22##1##(1992-9#1)(1996-9#4)(2008-3#10)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
facets of the##2##3##(1991-2#1)(2008-4#1)
facets of##8##2##(1991-2#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-3#1)
facets##13##1##(1991-2#1)(1994-12#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2011-2#2)(2012-3#1)
facial aging##2##2##(2008-7#2)
facial and hand abnormalities##2##4##(1997-3#2)
facial and##4##2##(1997-3#4)
facial appearance##2##2##(1996-3#1)(2008-5#1)
facial attributes##4##2##(2008-5#4)
facial bones##2##2##(2009-1#1)(2011-2#1)
facial expression##8##2##(2008-11#7)(2013-8#1)
facial expressions of emotion##2##4##(2008-11#2)
facial expressions##19##2##(2008-11#13)(2009-4#3)(2009-8#2)(2013-8#1)
facial feature##2##2##(2012-12#2)
facial injuries##3##2##(2010-1#3)
facial nerve branches##2##3##(2011-2#2)
facial nerve palsy##3##3##(2011-2#3)
facial nerve paralysis##2##3##(2008-9#1)(2011-2#1)
facial nerve stimulation##3##3##(2008-9#3)
facial nerve##23##2##(2008-12#2)(2008-7#3)(2008-9#7)(2011-2#10)(2012-3#1)
facial nerves##3##2##(2011-2#2)(2012-3#1)
facial pain patients##4##3##(1993-1#4)
facial pain##8##2##(1993-1#6)(2011-2#2)
facial paralysis##2##2##(1991-6#1)(2011-2#1)
facial rejuvenation##2##2##(2008-7#2)
facial selectivity##2##2##(1996-5#2)
facial skeleton##3##2##(1992-4#1)(2012-3#2)
facial skin##6##2##(1997-2#1)(2008-5#5)
facial##147##1##(1991-6#2)(1992-4#1)(1993-1#6)(1995-6#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#6)(1997-5#1)(1997-8#1)(2008-11#22)(2008-12#5)(2008-5#20)(2008-6#1)(2008-7#10)(2008-9#11)(2009-1#1)(2009-4#3)(2009-8#3)(2010-1#5)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#21)(2012-12#2)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#3)
facile##13##1##(1990-5#1)(1991-12#1)(1996-5#1)(2008-10#5)(2008-12#1)(2008-3#1)(2009-11#1)(2011-2#1)(2012-3#1)
facilitate a##4##2##(2008-11#1)(2008-9#1)(2010-1#1)(2011-2#1)
facilitate an##2##2##(1993-2#1)(2011-1#1)
facilitate and##4##2##(1995-3#1)(2008-12#1)(2010-4#1)(2010-8#1)
facilitate effective##2##2##(2008-11#2)
facilitate further##2##2##(2008-9#1)(2009-5#1)
facilitate identification of##2##3##(2008-10#1)(2008-6#1)
facilitate maximum##2##2##(1994-12#1)(2013-1#1)
facilitate molecular##2##2##(2008-10#1)(2008-9#1)
facilitate or##2##2##(2009-5#1)(2013-8#1)
facilitate studies##2##2##(2008-10#1)(2012-3#1)
facilitate the creation of##2##4##(1993-6#1)(2008-10#1)
facilitate the design##2##3##(1995-6#1)(2011-2#1)
facilitate the development of##9##4##(1992-1#1)(1997-2#1)(2008-11#3)(2008-12#2)(2009-4#1)(2011-2#1)
facilitate the dispersal of##2##4##(2008-10#1)(2012-3#1)
facilitate the identification of##2##4##(2008-10#1)(2009-6#1)
facilitate the implementation##2##3##(1994-12#1)(1996-1#1)
facilitate the induction of long-term potentiation##2##6##(1995-12#2)
facilitate the induction of##3##4##(1995-12#3)
facilitate the maintenance of##2##4##(1996-8#1)(2009-8#1)
facilitate the study of##4##4##(1993-12#1)(2008-9#1)(2009-10#1)(2012-3#1)
facilitate the##80##2##(1991-5#1)(1992-1#1)(1992-10#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-12#3)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#15)(2008-11#10)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-3#2)(2013-1#2)
facilitate their##3##2##(2008-10#1)(2010-5#1)(2012-3#1)
facilitate this##3##2##(1994-8#1)(2012-3#1)(2013-1#1)
facilitate timely##2##2##(2008-10#1)(2008-11#1)
facilitate transmission##2##2##(2013-1#2)
facilitate understanding##2##2##(2008-10#1)(2008-3#1)
facilitate##237##1##(1991-10#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#2)(1995-12#3)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#2)(1996-3#3)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#38)(2008-11#25)(2008-12#16)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#12)(2009-10#8)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-2#2)(2012-3#5)(2013-1#13)(2013-8#3)
facilitated and##3##2##(1996-6#1)(2008-11#1)(2008-4#1)
facilitated by a new##2##4##(1995-12#1)(2012-3#1)
facilitated by the##6##3##(1995-1#1)(1995-12#1)(2008-10#2)(2010-5#1)(2013-8#1)
facilitated by##20##2##(1990-2#1)(1991-7#1)(1992-12#1)(1995-1#1)(1995-12#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
facilitated diffusion##2##2##(1992-3#1)(2008-10#1)
facilitated in##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
facilitated the analysis of##2##4##(2008-10#2)
facilitated the##19##2##(1993-6#1)(1994-8#1)(1996-1#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
facilitated through##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
facilitated transport through the nuclear pore complex##2##7##(1994-11#2)
facilitated transport##3##2##(1994-11#3)
facilitated##91##1##(1990-2#1)(1990-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#3)(1993-9#1)(1994-11#4)(1994-8#2)(1995-1#1)(1995-12#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#17)(2008-11#16)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
facilitates detection##2##2##(1996-12#1)(2008-3#1)
facilitates the detection of##2##4##(2008-3#1)(2008-6#1)
facilitates the##16##2##(1990-5#2)(1994-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-6#1)(2009-7#1)(2011-2#3)(2013-1#1)
facilitates##50##1##(1990-5#2)(1991-2#1)(1992-1#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#2)
facilitating learning##2##2##(2008-11#1)(2013-8#1)
facilitating the transport of##2##4##(1993-11#1)(1994-3#1)
facilitating the##16##2##(1991-9#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-3#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-5#1)(2011-2#1)(2013-7#1)
facilitating their##2##2##(2008-10#1)(2008-12#1)
facilitating##53##1##(1991-1#3)(1991-9#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#13)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
facilitation between##3##2##(2008-10#1)(2008-8#2)
facilitation in patient care##3##4##(2010-8#3)
facilitation in##4##2##(2008-12#1)(2010-8#3)
facilitation of##10##2##(2008-10#1)(2008-11#3)(2008-7#2)(2010-10#1)(2012-2#1)(2012-3#2)
facilitation##23##1##(1993-12#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2010-10#2)(2010-8#3)(2012-2#1)(2012-3#3)
facilitative##7##1##(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)
facilitator##9##1##(1991-2#1)(1993-12#2)(2008-11#2)(2008-12#3)(2008-7#1)
facilitators of##3##2##(2010-10#1)(2012-3#1)(2013-1#1)
facilitators##10##1##(1993-12#1)(1995-1#1)(2008-12#2)(2010-10#2)(2011-2#1)(2012-3#1)(2013-1#2)
facilitators'##2##1##(2010-10#2)
facilitatory##4##1##(1990-5#1)(1991-2#2)(2008-7#1)
facilities and##12##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-6#1)(2009-11#1)(2013-1#1)
facilities are##4##2##(1991-2#1)(1993-3#1)(1997-2#1)(2009-12#1)
facilities can##3##2##(1991-12#1)(1993-12#1)(1997-3#1)
facilities have##4##2##(1991-3#1)(1993-12#1)(1996-3#1)(1997-1#1)
facilities in the##3##3##(1991-3#1)(1997-2#1)(2008-11#1)
facilities in##9##2##(1991-3#1)(1992-2#1)(1994-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
facilities of##2##2##(1992-2#1)(1995-6#1)
facilities or##2##2##(1991-2#1)(1995-6#1)
facilities to##5##2##(1993-12#1)(1996-1#1)(2007-12#1)(2008-10#2)
facilities were##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
facilities with##3##2##(1992-2#1)(1995-12#2)
facilities##135##1##(1990-2#1)(1991-1#2)(1991-12#7)(1991-2#4)(1991-3#6)(1992-1#1)(1992-12#5)(1992-2#6)(1992-8#2)(1993-12#5)(1993-2#2)(1993-3#5)(1994-1#1)(1994-12#6)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#8)(1995-2#1)(1995-3#1)(1995-6#3)(1996-1#3)(1996-11#1)(1996-3#2)(1996-5#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-5#2)(1997-8#4)(2007-12#3)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-8#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
facility for##4##2##(1992-11#1)(1994-12#1)(1997-6#1)(2010-8#1)
facility in response to##2##4##(1992-2#1)(1993-12#1)
facility is##3##2##(1991-12#1)(1993-12#1)(2011-2#1)
facility level##2##2##(1991-1#1)(1994-12#1)
facility management##3##2##(1992-2#3)
facility master plan##3##3##(1992-2#3)
facility of##2##2##(2008-9#1)(2012-3#1)
facility residents##2##2##(1995-2#1)(2008-12#1)
facility should##3##2##(1994-12#2)(2011-1#1)
facility to##7##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1994-3#1)(2008-3#1)
facility##107##1##(1991-1#7)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#4)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#14)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#8)(1994-2#2)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#5)
facility's##2##1##(1992-2#1)(2011-2#1)
facility-related problems##2##2##(1994-12#2)
facing health care##2##3##(1991-2#1)(1996-3#1)
facing increasing##2##2##(1991-9#1)(1993-3#1)
facing the##13##2##(1991-1#1)(1991-10#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-5#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
facing##48##1##(1991-1#2)(1991-10#1)(1991-2#2)(1991-3#2)(1991-9#2)(1992-2#1)(1993-3#2)(1994-12#2)(1996-1#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-7#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
fact is that##2##3##(1996-3#1)(2008-10#1)
fact is##6##2##(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#2)(2013-1#1)
fact of##3##2##(2008-10#1)(2008-6#1)(2009-10#1)
fact that the study was##2##5##(1993-3#1)(2008-11#1)
fact that the##45##3##(1990-2#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-1#1)(1992-3#3)(1992-5#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-6#1)(2008-10#10)(2008-11#9)(2008-7#1)(2008-9#2)(2009-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-1#1)
fact that there##3##3##(2008-10#2)(2008-11#1)
fact that this##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2009-3#1)
fact that##148##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#42)(2008-11#18)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
fact##240##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(2007-11#2)(2007-8#2)(2008-10#61)(2008-11#24)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#10)(2009-10#4)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#10)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#1)
factitious disorder##2##2##(2010-12#2)
factitious##3##1##(1997-2#1)(2010-12#2)
factor (CRF)##4##2##(1990-12#1)(1996-12#1)(1997-4#1)(2008-4#1)
factor (GM-CSF)##3##2##(1992-3#1)(1995-6#1)(2008-4#1)
factor (LIF)##5##2##(1991-12#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-4#1)
factor 0##2##2##(2008-10#2)
factor 1##13##2##(1995-8#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#3)(2009-3#1)(2010-10#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-8#1)
factor 1)##2##2##(1995-2#2)
factor 1-alpha##3##2##(2008-10#2)(2013-1#1)
factor 100##2##2##(2008-10#2)
factor 1alpha##5##2##(2008-10#4)(2009-8#1)
factor 2##9##2##(1990-8#1)(1995-2#4)(2008-11#1)(2010-4#1)(2010-6#1)(2011-2#1)
factor 3##4##2##(1990-8#1)(1996-2#2)(2010-12#1)
factor 4##2##2##(1990-8#1)(1994-12#1)
factor B##2##2##(2009-8#1)(2013-1#1)
factor H##9##2##(1997-9#1)(2009-6#8)
factor I##6##2##(1993-2#1)(2008-11#3)(2008-8#1)(2012-12#1)
factor IX deficiency mouse##2##4##(2008-8#2)
factor IX mutant protein##2##4##(2008-9#2)
factor IX mutant##3##3##(2008-9#3)
factor IX promoter##2##3##(1990-5#2)
factor IX##24##2##(1990-5#5)(1995-2#3)(2008-8#6)(2008-9#10)
factor IgG##2##2##(1996-2#2)
factor TFIIB and##2##3##(1995-2#1)(2008-9#1)
factor VIII##3##2##(2008-5#1)(2011-2#2)
factor VIIa##2##2##(2008-8#1)(2011-2#1)
factor Va##7##2##(1994-5#7)
factor X##2##2##(1990-5#1)(2008-11#1)
factor XI is activated##2##4##(1991-9#2)
factor XI##7##2##(1991-9#7)
factor XIII in protein-free##2##4##(2008-11#2)
factor XIII in##3##3##(2008-11#3)
factor XIII production##2##3##(2008-11#2)
factor XIII##9##2##(2008-11#9)
factor XIIa##2##2##(1991-9#2)
factor Xa##6##2##(1991-3#2)(1994-5#4)
factor activity##5##2##(1990-12#1)(1991-12#2)(1991-6#1)(2008-1#1)
factor affecting##4##2##(1994-3#1)(2008-11#2)(2013-1#1)
factor against##4##2##(1995-12#1)(2009-11#2)(2009-8#1)
factor alpha##12##2##(1990-5#1)(1992-7#1)(1994-11#1)(1994-8#1)(1995-2#2)(1997-1#1)(2008-11#2)(2008-8#2)(2011-2#1)
factor analyses##4##2##(2009-11#1)(2010-11#2)(2012-2#1)
factor analysis and##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
factor analysis is##2##3##(2008-10#2)
factor analysis of##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
factor analysis was applied to##2##5##(2008-10#2)
factor analysis was##4##3##(2008-10#2)(2010-6#1)(2011-2#1)
factor analysis##37##2##(2008-10#26)(2008-11#2)(2008-12#1)(2009-12#1)(2010-1#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-1#1)
factor and a##2##3##(2008-10#1)(2009-11#1)
factor and its##3##3##(1991-7#1)(2008-9#1)(2012-2#1)
factor and regression line between##2##5##(2008-10#2)
factor and the##6##3##(1991-11#1)(1996-2#1)(2008-10#4)
factor and##33##2##(1990-12#1)(1991-11#1)(1991-7#2)(1993-8#1)(1994-11#1)(1995-3#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-9#3)(2009-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-8#1)
factor as an##2##3##(2008-5#1)(2009-8#1)
factor as##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
factor b##4##2##(1993-12#4)
factor between##2##2##(2008-10#2)
factor binding sites##4##3##(1990-12#1)(1994-11#1)(1997-8#1)(2012-3#1)
factor binding to##2##3##(1993-3#1)(1995-12#1)
factor binding##11##2##(1990-12#2)(1992-4#1)(1993-3#2)(1994-11#1)(1995-12#1)(1997-8#1)(2008-9#1)(2012-3#2)
factor bound##2##2##(1993-3#1)(1996-2#1)
factor by##3##2##(1991-5#1)(2008-10#1)(2008-11#1)
factor can##4##2##(1993-12#1)(2008-3#1)(2010-10#2)
factor contributing to##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)
factor could be##2##3##(1997-5#1)(2008-10#1)
factor determining population structure##2##4##(2008-10#2)
factor determining the##4##3##(1993-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
factor determining##7##2##(1993-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)
factor explaining##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
factor expression in##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
factor expression##5##2##(1997-1#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
factor for a##2##3##(2008-10#1)(2012-2#1)
factor for cutaneous##2##3##(2008-9#1)(2012-2#1)
factor for developing##3##3##(2008-6#1)(2008-8#1)(2012-5#1)
factor for successful##4##3##(2008-11#1)(2008-9#1)(2009-10#1)(2013-1#1)
factor for the development of##3##5##(2008-11#1)(2012-12#1)(2012-3#1)
factor for the##10##3##(1992-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
factor for this##2##3##(2008-10#1)(2009-7#1)
factor for##90##2##(1990-8#1)(1992-10#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#2)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#8)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
factor from##3##2##(1991-12#1)(1995-2#1)(2008-8#1)
factor gene##4##2##(1997-3#2)(2008-11#1)(2010-12#1)
factor genes##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2013-7#1)
factor has been##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
factor has##4##2##(1995-6#1)(2008-10#1)(2008-8#2)
factor in determining the##3##4##(1993-3#1)(2008-10#1)(2008-5#1)
factor in determining##4##3##(1993-3#1)(2008-10#2)(2008-5#1)
factor in developing##2##3##(1996-12#1)(1996-3#1)
factor in establishing##2##3##(1997-3#1)(2008-10#1)
factor in the development of##3##5##(1997-2#1)(2008-12#1)(2011-2#1)
factor in the etiology of##2##5##(2008-1#1)(2008-5#1)
factor in the pathogenesis of##3##5##(1991-3#1)(2012-2#1)(2013-1#1)
factor in the##32##3##(1991-11#2)(1991-3#1)(1992-1#1)(1992-6#1)(1993-8#1)(1995-6#1)(1997-2#2)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
factor in##100##2##(1990-5#1)(1990-9#1)(1991-11#2)(1991-3#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#2)(1993-3#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-8#1)(2007-8#3)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#3)(2008-9#4)(2009-10#2)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#4)
factor induced##2##2##(1994-12#1)(1995-12#1)
factor infertility##2##2##(1996-9#1)(2011-2#1)
factor influencing##3##2##(1993-12#1)(1996-2#1)(2011-2#1)
factor inhibitor##2##2##(2012-3#2)
factor involved in##3##3##(1995-2#1)(2008-9#1)(2011-2#1)
factor is likely to be##2##5##(1990-2#1)(2008-10#1)
factor is##25##2##(1990-2#2)(1992-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#1)(2011-3#1)(2011-4#1)(2013-8#1)
factor levels in##2##3##(1991-6#1)(2013-1#1)
factor levels##3##2##(1991-6#2)(2013-1#1)
factor limiting##2##2##(1997-3#1)(2008-8#1)
factor mRNA##2##2##(1997-2#1)(2008-9#1)
factor may##2##2##(1994-12#1)(2013-1#1)
factor modulated##2##2##(1994-5#1)(2008-10#1)
factor more##2##2##(2008-10#1)(2008-5#1)
factor obtained##3##2##(2008-10#3)
factor of 0##3##3##(2008-10#3)
factor of 10##7##3##(1992-3#3)(2008-10#3)(2008-5#1)
factor of 100 was##2##4##(2008-10#2)
factor of 100##4##3##(2008-10#4)
factor of 17##2##3##(1991-3#1)(2011-1#1)
factor of 20##4##3##(2008-10#3)(2008-8#1)
factor of 23##2##3##(2008-10#2)
factor of 25##3##3##(2008-10#3)
factor of 30##3##3##(1993-9#1)(1995-3#1)(2008-10#1)
factor of 33##2##3##(2008-10#2)
factor of 40##3##3##(2008-10#3)
factor of 5##2##3##(2008-10#1)(2008-3#1)
factor of about##2##3##(2008-10#2)
factor of approximately##2##3##(2008-10#1)(2008-3#1)
factor of the##10##3##(1993-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2010-8#1)
factor of this##2##3##(2008-10#2)
factor of##133##2##(1990-11#1)(1991-3#1)(1992-12#1)(1992-3#3)(1992-6#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#83)(2008-11#3)(2008-2#1)(2008-3#8)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#2)(2009-7#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
factor on the##2##3##(1994-8#1)(2008-5#1)
factor on##5##2##(1990-2#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-5#1)
factor or##6##2##(1991-7#1)(1991-9#1)(1993-6#1)(2008-9#1)(2010-11#1)(2011-2#1)
factor pathway inhibitor##2##3##(1992-10#2)
factor reached##2##2##(2007-8#2)
factor regulating##2##2##(1991-5#1)(1994-11#1)
factor related##2##2##(1997-7#1)(2012-2#1)
factor required by##2##3##(1994-12#1)(2009-8#1)
factor required##3##2##(1994-12#1)(1995-6#1)(2009-8#1)
factor responsible for##3##3##(1994-5#1)(2008-11#1)(2009-8#1)
factor screening##2##2##(1991-6#1)(2008-11#1)
factor specific to##2##3##(2007-12#1)(2011-2#1)
factor structure##4##2##(2008-1#1)(2008-11#1)(2010-1#1)(2013-8#1)
factor studied##2##2##(1993-12#1)(2008-11#1)
factor that##19##2##(1991-2#1)(1994-11#1)(1996-12#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
factor to the##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
factor to##12##2##(1991-3#1)(1993-11#1)(1993-12#1)(1995-2#1)(2008-10#2)(2008-11#3)(2010-5#1)(2011-2#1)(2012-12#1)
factor used in this work was##2##6##(2008-10#2)
factor was 0##3##3##(2008-8#1)(2008-9#2)
factor was introduced##2##3##(2008-11#1)(2008-9#1)
factor was##33##2##(1990-6#1)(1993-11#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-8#2)(2008-9#3)(2010-1#1)(2012-12#1)(2013-8#1)
factor were##4##2##(1991-12#1)(1996-2#1)(2007-8#2)
factor which##8##2##(1991-11#1)(1993-12#1)(1994-11#1)(1995-6#1)(1996-2#1)(2008-11#2)(2008-5#1)
factor with##4##2##(1991-5#1)(1995-2#1)(1996-2#1)(2008-10#1)
factor##1381##1##(1990-11#1)(1990-12#11)(1990-2#4)(1990-5#14)(1990-6#2)(1990-7#2)(1990-8#9)(1990-9#2)(1991-11#6)(1991-12#11)(1991-2#2)(1991-3#10)(1991-5#5)(1991-6#5)(1991-7#6)(1991-8#1)(1991-9#13)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#8)(1992-4#1)(1992-6#4)(1992-7#4)(1992-8#1)(1992-9#1)(1993-1#6)(1993-11#4)(1993-12#15)(1993-2#4)(1993-3#11)(1993-6#5)(1993-8#7)(1993-9#4)(1994-11#17)(1994-12#12)(1994-2#3)(1994-3#7)(1994-5#16)(1994-6#3)(1994-8#7)(1995-11#11)(1995-12#16)(1995-2#34)(1995-3#2)(1995-6#22)(1995-8#11)(1995-9#2)(1996-1#2)(1996-12#11)(1996-2#22)(1996-3#4)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#7)(1997-2#9)(1997-3#8)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#9)(1997-8#4)(1997-9#1)(2007-11#2)(2007-12#4)(2007-8#11)(2008-1#12)(2008-10#295)(2008-11#112)(2008-12#9)(2008-2#6)(2008-3#23)(2008-4#14)(2008-5#21)(2008-6#7)(2008-7#12)(2008-8#48)(2008-9#50)(2009-10#5)(2009-11#7)(2009-12#4)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#8)(2009-7#8)(2009-8#20)(2009-9#1)(2010-1#5)(2010-10#7)(2010-11#7)(2010-12#4)(2010-3#3)(2010-4#5)(2010-5#3)(2010-6#6)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#69)(2011-3#2)(2011-4#1)(2012-12#10)(2012-2#29)(2012-3#29)(2012-5#4)(2013-1#31)(2013-7#3)(2013-8#17)
factor&quot##2##1##(1997-8#1)(2008-8#1)
factor(s) which##2##2##(1992-12#2)
factor(s)##8##1##(1992-12#5)(1993-3#1)(2008-10#1)(2008-12#1)
factor)##9##1##(1994-12#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2011-2#1)
factor-##3##1##(1991-5#1)(1995-6#1)(2010-10#1)
factor-1 and##2##2##(1993-11#1)(2013-1#1)
factor-1##12##1##(1990-12#1)(1990-5#1)(1991-6#1)(1993-11#1)(1994-11#1)(1995-12#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
factor-2##6##1##(1995-12#2)(1997-2#2)(2008-11#1)(2012-2#1)
factor-induced##4##1##(1992-10#1)(1997-1#1)(2010-8#1)(2011-2#1)
factor-producing##2##1##(1995-6#1)(2011-2#1)
factored##2##1##(1996-12#1)(2013-8#1)
factorial analysis##4##2##(2008-10#4)
factorial and##4##2##(2008-10#4)
factorial design and Doehlert##2##4##(2008-10#2)
factorial design and a##2##4##(2008-10#2)
factorial design and##5##3##(2008-10#5)
factorial design is##2##3##(2008-10#2)
factorial design was used for optimization of##2##7##(2008-10#2)
factorial design was used to##3##5##(2008-10#3)
factorial design was used##6##4##(2008-10#5)(2013-8#1)
factorial design was##10##3##(2008-10#9)(2013-8#1)
factorial design with##2##3##(2008-10#1)(2010-4#1)
factorial design##52##2##(1994-3#1)(2008-10#43)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
factorial designs##5##2##(2008-10#5)
factorial experiment##2##2##(2008-10#1)(2009-10#1)
factorial experiments##2##2##(2008-10#1)(2008-5#1)
factorial##82##1##(1994-3#1)(2008-10#69)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
factories##2##1##(2008-10#1)(2008-11#1)
factors (TFs)##2##2##(2010-7#1)(2012-2#1)
factors (e##6##2##(2006-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
factors (eg##2##2##(2010-1#1)(2011-2#1)
factors (i##6##2##(1993-3#1)(2008-10#1)(2008-11#3)(2008-7#1)
factors -##2##2##(2011-2#1)(2013-1#1)
factors VIII and IX##2##4##(2011-2#2)
factors accounted for##2##3##(2010-5#1)(2013-8#1)
factors across##2##2##(1993-2#1)(2011-2#1)
factors affect the ability##2##4##(2008-10#1)(2008-9#1)
factors affect the##4##3##(1996-3#1)(2008-10#2)(2008-9#1)
factors affect##6##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)
factors affecting the determination##2##4##(2008-10#2)
factors affecting the hydride generation##3##5##(2008-10#3)
factors affecting the##26##3##(1992-1#1)(1997-8#1)(2008-1#1)(2008-10#16)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#1)
factors affecting##46##2##(1990-12#1)(1990-6#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
factors also##4##2##(2008-10#1)(2008-6#1)(2009-10#1)(2013-1#1)
factors among##4##2##(1996-2#1)(2008-10#2)(2008-8#1)
factors and by##3##3##(2008-11#2)(2013-1#1)
factors and interaction##2##3##(1997-1#1)(2008-10#1)
factors and the##7##3##(1997-8#1)(2008-10#3)(2010-6#1)(2011-2#1)(2013-1#1)
factors and their##7##3##(1991-12#1)(2008-10#3)(2008-11#1)(2010-8#1)(2011-2#1)
factors and##101##2##(1990-6#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#2)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#2)(2009-12#3)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#4)
factors are associated with##4##4##(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
factors are considered##4##3##(1991-6#1)(2008-10#2)(2013-1#1)
factors are discussed##2##3##(1990-9#1)(1995-3#1)
factors are involved in##2##4##(2008-10#1)(2008-7#1)
factors are involved##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
factors are not##3##3##(2008-11#1)(2010-11#1)(2011-1#1)
factors are of##2##3##(2008-10#1)(2010-12#1)
factors are presented##2##3##(1993-1#1)(1993-3#1)
factors are required##2##3##(2008-9#1)(2010-1#1)
factors are responsible for the##2##5##(2010-11#1)(2011-2#1)
factors are the##2##3##(2008-10#2)
factors are##74##2##(1990-9#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-8#1)(2008-1#3)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-1#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#1)
factors as well##2##3##(1990-3#1)(2008-10#1)
factors as##12##2##(1990-2#1)(1990-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
factors associated with anemia among##2##5##(2011-2#2)
factors associated with delirium among##2##5##(2010-10#2)
factors associated with early sexual##2##5##(2013-8#2)
factors associated with failure##2##4##(2010-12#1)(2010-6#1)
factors associated with severe periodontitis##2##5##(2008-10#2)
factors associated with the##7##4##(1994-12#1)(2008-5#1)(2009-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
factors associated with##44##3##(1993-11#1)(1994-12#2)(1995-3#1)(1996-3#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#5)
factors associated##45##2##(1993-11#1)(1994-12#2)(1995-3#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#5)
factors at##2##2##(2008-10#1)(2013-1#1)
factors before##2##2##(1994-3#1)(2009-7#1)
factors between##3##2##(2008-10#2)(2009-8#1)
factors binding##5##2##(1990-5#1)(2008-10#1)(2008-7#1)(2008-9#2)
factors by##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)
factors can affect##2##3##(2008-10#1)(2012-2#1)
factors can be##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
factors can have##2##3##(2008-10#1)(2009-8#1)
factors can influence the##2##4##(2008-5#1)(2013-1#1)
factors can influence##5##3##(2008-5#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
factors can##17##2##(1994-3#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
factors causing##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
factors considered##2##2##(2008-10#1)(2008-9#1)
factors contain##2##2##(1996-2#1)(2008-9#1)
factors contribute to the##2##4##(2008-11#1)(2008-7#1)
factors contribute to##3##3##(1991-12#1)(2008-11#1)(2008-7#1)
factors contributing to the##2##4##(2008-10#1)(2008-11#1)
factors contributing to##7##3##(1994-12#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2012-3#1)
factors contributing##8##2##(1994-12#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2012-3#1)
factors could be##4##3##(2008-10#2)(2011-2#1)(2013-8#1)
factors could##6##2##(1996-12#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
factors derived from##2##3##(1990-7#1)(2012-3#1)
factors determining the##4##3##(1996-11#1)(2008-10#2)(2011-2#1)
factors determining##6##2##(1996-11#1)(2008-10#2)(2008-9#1)(2011-2#2)
factors do not##4##3##(1992-9#1)(1996-12#1)(2008-10#1)(2010-9#1)
factors during the##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
factors during##6##2##(1992-12#1)(2008-11#3)(2010-1#1)(2013-8#1)
factors encoded##2##2##(2010-4#1)(2011-1#1)
factors explaining the##2##3##(2008-10#2)
factors explaining##3##2##(2008-10#3)
factors for falls##2##3##(2008-7#2)
factors for survival##2##3##(2009-1#1)(2012-3#1)
factors for the##13##3##(1997-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
factors for uterine cervical neoplasms##2##5##(2012-12#2)
factors for##115##2##(1991-9#1)(1992-12#1)(1993-2#2)(1993-3#3)(1994-2#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-5#2)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#9)(2008-12#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#2)(2009-1#1)(2009-5#1)(2009-8#1)(2010-10#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#4)
factors found in##2##3##(2008-10#2)
factors found##3##2##(2008-10#3)
factors from##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
factors had##3##2##(2008-10#2)(2012-3#1)
factors have been identified##3##4##(2008-11#1)(2008-6#1)(2010-11#1)
factors have been##7##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-11#1)
factors have not##2##3##(2008-10#1)(2008-12#1)
factors have##19##2##(1991-6#1)(1993-3#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#3)
factors identified by##2##3##(1992-1#1)(2008-10#1)
factors identified##3##2##(1992-1#1)(2008-10#1)(2008-11#1)
factors implicated in the##2##4##(1991-8#1)(2009-5#1)
factors in a##6##3##(2010-4#2)(2010-6#1)(2012-2#1)(2013-8#2)
factors in combination##3##3##(1992-12#1)(1994-11#1)(2008-8#1)
factors in determining##5##3##(1994-12#1)(2008-10#2)(2008-11#1)(2010-10#1)
factors in the etiology##2##4##(2008-1#1)(2008-8#1)
factors in the study##2##4##(2008-10#1)(2010-1#1)
factors in the##33##3##(1991-5#1)(1993-11#1)(1993-2#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
factors in##111##2##(1990-12#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(1997-9#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#3)(2010-8#1)(2011-1#3)(2011-2#7)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#5)
factors include##7##2##(1992-12#1)(1993-1#1)(1993-3#1)(1995-2#1)(2007-11#1)(2008-5#1)(2008-7#1)
factors included in the##2##4##(2008-10#2)
factors included##5##2##(2008-10#3)(2008-9#1)(2013-1#1)
factors including the##3##3##(2008-11#1)(2009-11#1)(2011-2#1)
factors including##10##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
factors inducing##2##2##(2008-10#1)(2013-1#1)
factors influence the##4##3##(1996-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
factors influence##10##2##(1992-11#1)(1996-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
factors influenced##2##2##(2008-12#1)(2008-7#1)
factors influencing the determination of##2##5##(2008-10#2)
factors influencing the##12##3##(1993-1#1)(1993-9#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-10#1)(2010-12#1)(2012-3#1)
factors influencing##26##2##(1993-1#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-5#2)(2010-10#1)(2010-12#1)(2012-3#1)
factors interact in##2##3##(2008-11#1)(2008-8#1)
factors interact##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
factors involved in the##4##4##(1997-8#2)(2008-11#1)(2009-6#1)
factors involved in##9##3##(1993-12#1)(1997-5#1)(1997-8#2)(2008-1#1)(2008-11#2)(2009-6#1)(2013-1#1)
factors involved##15##2##(1993-12#1)(1994-6#1)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#2)(2009-8#1)(2013-1#2)
factors is necessary##2##3##(1995-6#1)(2008-11#1)
factors is the##2##3##(2009-10#1)(2010-7#1)
factors is##17##2##(1991-12#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
factors known to##3##3##(1995-8#1)(2007-12#1)(2008-1#1)
factors leading to##5##3##(2008-1#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-1#1)
factors like##2##2##(2008-11#2)
factors limiting the##2##3##(2008-3#1)(2008-7#1)
factors linked to##2##3##(2007-12#1)(2013-1#1)
factors may be more##2##4##(2013-1#2)
factors may be##4##3##(2008-5#1)(2012-2#1)(2013-1#2)
factors may contribute to the##2##5##(2011-2#1)(2012-3#1)
factors may##16##2##(1995-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
factors must be considered##2##4##(2009-10#1)(2013-8#1)
factors must be##3##3##(1993-2#1)(2009-10#1)(2013-8#1)
factors namely##2##2##(2008-10#2)
factors not##2##2##(2008-11#1)(2011-1#1)
factors obtained##3##2##(2008-10#2)(2008-11#1)
factors of 0##2##3##(2008-10#1)(2008-9#1)
factors of ADRs##2##3##(2011-2#2)
factors of anemia##2##3##(2011-2#1)(2012-12#1)
factors of cardiovascular diseases in##2##5##(1991-6#1)(2009-10#1)
factors of cardiovascular diseases##3##4##(1991-6#1)(2008-11#1)(2009-10#1)
factors of job strain in##2##5##(2008-10#2)
factors of the##7##3##(1996-3#1)(2008-10#3)(2010-8#1)(2013-1#1)(2013-8#1)
factors of##72##2##(1991-11#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-12#2)(1994-8#1)(1996-3#2)(1996-6#1)(2008-1#3)(2008-10#21)(2008-11#4)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#2)(2010-10#2)(2010-2#1)(2010-7#3)(2010-8#2)(2011-2#8)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
factors on the##8##3##(1993-12#1)(1994-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
factors on##31##2##(1990-6#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-6#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-6#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
factors or##5##2##(1990-5#1)(1991-8#1)(2008-12#1)(2010-3#1)(2011-2#1)
factors other than##5##3##(1990-2#1)(1991-2#1)(2008-10#1)(2010-1#1)(2011-2#1)
factors play##4##2##(1993-12#1)(2008-12#1)(2010-5#1)(2011-2#1)
factors present##2##2##(2008-11#1)(2010-10#1)
factors probably##3##2##(1992-10#1)(2008-6#1)(2008-7#1)
factors regulating the##2##3##(1997-7#1)(2011-1#1)
factors related to the##5##4##(1991-12#1)(1992-3#1)(2010-1#1)(2011-1#1)(2012-12#1)
factors related to##11##3##(1990-8#1)(1991-12#1)(1992-3#2)(2008-10#1)(2008-11#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#2)
factors related##12##2##(1990-8#1)(1991-12#1)(1992-3#2)(2008-10#2)(2008-11#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#2)
factors released##2##2##(2012-4#1)(2013-1#1)
factors remains##2##2##(2008-10#1)(2011-2#1)
factors required for##4##3##(1990-5#1)(2008-10#1)(2008-9#1)(2011-1#1)
factors required##5##2##(1990-5#1)(2008-10#2)(2008-9#1)(2011-1#1)
factors responsible for the##2##4##(1997-7#1)(2008-12#1)
factors responsible for##8##3##(1995-12#1)(1997-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
factors should be considered##2##4##(1993-1#1)(2008-7#1)
factors should be##3##3##(1993-1#1)(2008-11#1)(2008-7#1)
factors such as age and##2##5##(1994-3#1)(2012-12#1)
factors such as age##3##4##(1994-3#1)(2008-10#1)(2012-12#1)
factors such as pH##2##4##(2008-10#2)
factors such as the##6##4##(1997-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
factors such as##51##3##(1991-2#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-1#2)(2008-1#1)(2008-10#14)(2008-11#7)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-6#2)(2009-8#3)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
factors than the##2##3##(2008-11#1)(2009-7#1)
factors than##3##2##(1996-12#1)(2008-11#1)(2009-7#1)
factors that affect the##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
factors that affect##9##3##(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)
factors that are associated with##2##5##(1994-12#1)(2008-7#1)
factors that are important##2##4##(2008-8#1)(2010-2#1)
factors that are involved in##4##5##(1993-12#1)(2006-6#1)(2008-11#1)(2008-7#1)
factors that are##11##3##(1991-5#1)(1993-12#1)(1994-12#1)(2006-6#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2013-1#1)
factors that contribute to the##3##5##(2008-10#2)(2008-11#1)
factors that contribute to##7##4##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
factors that could##4##3##(2008-9#1)(2009-4#1)(2013-1#1)(2013-8#1)
factors that determine##3##3##(1993-6#1)(2008-10#1)(2008-9#1)
factors that facilitate##2##3##(2008-11#1)(2008-12#1)
factors that have been##3##4##(1995-2#1)(1997-1#1)(2008-10#1)
factors that have##5##3##(1995-2#1)(1997-1#1)(2008-10#1)(2012-2#1)(2013-8#1)
factors that impact##3##3##(2008-10#1)(2008-12#1)(2009-12#1)
factors that influence the##14##4##(1991-11#1)(1993-11#1)(1995-2#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-9#2)(2010-10#1)(2011-1#1)(2013-8#1)
factors that influence##20##3##(1991-11#1)(1993-11#1)(1994-12#1)(1995-2#1)(1995-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#3)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
factors that influenced the##3##4##(1991-2#1)(2008-10#1)(2008-11#1)
factors that influenced##4##3##(1991-2#1)(1996-2#1)(2008-10#1)(2008-11#1)
factors that led to##2##4##(2008-3#1)(2008-8#1)
factors that limit##2##3##(2008-2#1)(2008-7#1)
factors that may be##3##4##(2008-10#1)(2010-1#1)(2010-4#1)
factors that may##8##3##(1993-1#1)(1995-6#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-4#1)(2012-2#1)
factors that might influence##2##4##(1993-1#1)(2010-2#1)
factors that might##5##3##(1993-1#1)(1993-12#1)(2008-10#1)(2008-8#1)(2010-2#1)
factors that predict##3##3##(1995-3#1)(1995-9#1)(2013-8#1)
factors that regulate##3##3##(1995-8#1)(1996-12#1)(2011-2#1)
factors that were##2##3##(2008-12#1)(2012-3#1)
factors that will##2##3##(1995-2#1)(1997-1#1)
factors that##140##2##(1991-11#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-2#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-5#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-2#2)(1997-1#2)(2006-6#2)(2007-8#1)(2008-10#25)(2008-11#11)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#4)
factors themselves##2##2##(1995-6#1)(2008-10#1)
factors through##2##2##(1994-8#1)(2010-10#1)
factors to consider in##2##4##(1993-1#1)(2009-12#1)
factors to consider##3##3##(1991-12#1)(1993-1#1)(2009-12#1)
factors to regulate##2##3##(1994-5#1)(2008-9#1)
factors to the##3##3##(2008-11#1)(2009-4#1)(2012-2#1)
factors to##21##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-3#1)(1994-5#1)(1996-12#2)(2008-10#1)(2008-11#4)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
factors used in##2##3##(1992-12#1)(2008-10#1)
factors was##6##2##(1991-12#1)(1991-6#1)(1996-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
factors were associated with##4##4##(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
factors were considered##2##3##(2008-3#1)(2008-7#1)
factors were found##2##3##(2011-2#1)(2012-2#1)
factors were identified##2##3##(2008-10#1)(2009-3#1)
factors were investigated##5##3##(2008-10#5)
factors were##45##2##(1991-2#1)(1991-6#1)(1994-6#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-7#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
factors when##3##2##(1994-1#2)(2012-3#1)
factors which affect the##3##4##(2008-10#1)(2008-8#1)(2010-8#1)
factors which affect##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)
factors which can##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
factors which could##2##3##(2007-11#1)(2008-10#1)
factors which influence the##2##4##(2008-11#1)(2013-8#1)
factors which influence##4##3##(2008-11#1)(2010-9#1)(2013-8#2)
factors which may##2##3##(1996-3#1)(2008-12#1)
factors which might##2##3##(1991-6#1)(2008-5#1)
factors which were##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
factors which##40##2##(1990-11#1)(1990-6#1)(1991-6#1)(1992-1#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-11#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2010-9#2)(2011-2#1)(2013-1#1)(2013-8#2)
factors will##3##2##(2008-9#1)(2010-8#1)(2013-1#1)
factors with##5##2##(1994-2#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
factors##1815##1##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#5)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#16)(1991-2#8)(1991-3#7)(1991-5#5)(1991-6#9)(1991-8#2)(1991-9#1)(1992-1#5)(1992-10#3)(1992-11#2)(1992-12#14)(1992-2#5)(1992-3#3)(1992-6#2)(1992-9#3)(1993-1#11)(1993-11#4)(1993-12#15)(1993-2#13)(1993-3#16)(1993-6#6)(1993-8#3)(1993-9#3)(1994-1#4)(1994-11#6)(1994-12#15)(1994-2#5)(1994-3#12)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#10)(1995-2#7)(1995-3#6)(1995-6#10)(1995-8#7)(1995-9#3)(1996-1#4)(1996-11#5)(1996-12#18)(1996-2#12)(1996-3#12)(1996-6#2)(1996-8#3)(1997-1#9)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#4)(1997-7#4)(1997-8#9)(1997-9#1)(2006-6#4)(2007-11#4)(2007-12#4)(2007-8#5)(2008-1#27)(2008-10#351)(2008-11#146)(2008-12#32)(2008-2#8)(2008-3#8)(2008-4#12)(2008-5#35)(2008-6#12)(2008-7#78)(2008-8#34)(2008-9#51)(2009-1#5)(2009-10#11)(2009-11#2)(2009-12#12)(2009-3#2)(2009-4#10)(2009-5#8)(2009-6#8)(2009-7#9)(2009-8#28)(2010-1#13)(2010-10#23)(2010-11#13)(2010-12#7)(2010-2#4)(2010-3#3)(2010-4#7)(2010-5#6)(2010-6#16)(2010-7#11)(2010-8#13)(2010-9#7)(2011-1#20)(2011-2#104)(2011-3#2)(2011-9#1)(2012-12#23)(2012-2#55)(2012-3#51)(2012-4#1)(2012-5#2)(2013-1#93)(2013-3#2)(2013-7#9)(2013-8#46)
factors) and##2##2##(2011-2#1)(2012-3#1)
factors)##4##1##(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
factors]##6##1##(1995-5#1)(1996-3#1)(1997-3#1)(1997-5#1)(2013-8#2)
factory workers##6##2##(1991-12#3)(2008-11#3)
factory##14##1##(1991-12#3)(2008-10#3)(2008-11#4)(2008-5#1)(2009-12#2)(2010-8#1)
facts about##3##2##(1994-9#1)(1997-1#1)(2008-10#1)
facts and##2##2##(1991-2#1)(2008-10#1)
facts that##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
facts##25##1##(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-8#1)(1997-1#2)(2008-10#6)(2008-11#3)(2008-8#1)(2008-9#2)(2010-7#1)
factual##3##1##(1992-12#1)(1995-11#1)(2008-10#1)
facultative##2##1##(2008-12#1)(2011-2#1)
faculties##4##1##(1991-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
faculty and##4##2##(1993-2#1)(1996-1#1)(2008-11#1)(2013-1#1)
faculty as##3##2##(2008-12#2)(2013-1#1)
faculty development and curriculum renewal##2##5##(1993-2#2)
faculty development for##2##3##(2009-12#2)
faculty development##6##2##(1993-2#2)(2009-12#2)(2013-1#2)
faculty from##3##2##(1992-1#1)(2008-12#1)(2009-4#1)
faculty in##3##2##(1993-1#1)(2008-11#1)(2009-4#1)
faculty member##2##2##(1993-2#1)(1996-1#1)
faculty members##13##2##(1992-1#2)(1996-2#1)(1996-3#3)(2008-11#2)(2008-12#3)(2013-1#1)(2013-8#1)
faculty of##3##2##(2008-11#1)(2008-12#1)(2009-10#1)
faculty practice##5##2##(2008-11#3)(2008-12#2)
faculty regarding##3##2##(2008-11#2)(2008-12#1)
faculty research##2##2##(1996-1#1)(2008-12#1)
faculty that##2##2##(2008-11#1)(2008-12#1)
faculty to##2##2##(1993-1#1)(2008-11#1)
faculty##89##1##(1992-1#3)(1993-1#3)(1993-2#7)(1995-1#1)(1996-1#9)(1996-2#1)(1996-3#3)(1997-2#2)(2008-1#1)(2008-11#20)(2008-12#19)(2008-8#1)(2009-10#1)(2009-12#2)(2009-4#7)(2013-1#8)(2013-8#1)
fad##2##1##(1991-3#1)(1996-1#1)
fading##5##1##(1991-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
faecal egg counts##3##3##(1996-12#3)
faecal excretion##4##2##(1991-11#1)(1995-11#3)
faecal samples from##3##3##(1996-12#2)(2011-2#1)
faecal samples##8##2##(1996-12#7)(2011-2#1)
faecal##23##1##(1991-11#1)(1995-11#4)(1996-12#13)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
faecalis##5##1##(2007-11#1)(2008-11#1)(2013-1#3)
faecaluria##2##1##(2009-1#1)(2012-12#1)
faeces by##3##2##(2008-10#3)
faeces of##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
faeces##16##1##(1991-11#1)(1996-12#3)(1997-3#1)(2008-10#4)(2008-11#2)(2008-5#3)(2011-2#1)(2012-2#1)
fail to capture##2##3##(1995-5#1)(2008-1#1)
fail to correlate with##2##4##(2011-2#2)
fail to describe##2##3##(2008-6#1)(2012-3#1)
fail to detect##2##3##(1991-12#1)(2011-2#1)
fail to discriminate against foreign songs recorded at 18##2##9##(2008-8#2)
fail to exhibit##3##3##(1994-11#2)(1996-3#1)
fail to facilitate##2##3##(1995-1#1)(2008-10#1)
fail to match##2##3##(2008-10#1)(2013-8#1)
fail to provide##2##3##(1995-11#1)(2008-12#1)
fail to use##2##3##(2009-10#1)(2011-3#1)
fail to##52##2##(1990-8#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-11#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
fail##63##1##(1990-8#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#2)(2009-11#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
failed and##2##2##(1990-6#1)(2013-1#1)
failed ankle prosthesis##2##3##(2010-5#2)
failed ankle##3##2##(2010-5#3)
failed attempts to##2##3##(1996-5#1)(2012-2#1)
failed because##2##2##(1991-1#1)(2013-1#1)
failed conservative##2##2##(2008-9#1)(2011-2#1)
failed for##2##2##(2008-10#1)(2012-12#1)
failed in##5##2##(1991-2#1)(1997-3#1)(2008-10#2)(2010-8#1)
failed to alter the##2##4##(1994-5#1)(2008-5#1)
failed to alter##3##3##(1992-6#1)(1994-5#1)(2008-5#1)
failed to attenuate##2##3##(1992-8#1)(1997-1#1)
failed to benefit##2##3##(2008-10#1)(2012-2#1)
failed to bind##2##3##(1990-12#1)(1995-2#1)
failed to complement the##2##4##(1994-12#1)(2008-8#1)
failed to complement##3##3##(1994-12#1)(1997-4#1)(2008-8#1)
failed to demonstrate##4##3##(1995-5#1)(1996-5#1)(2008-5#1)(2011-1#1)
failed to detect any##2##4##(1993-2#1)(2008-10#1)
failed to detect the##2##4##(2008-10#1)(2008-5#1)
failed to detect##9##3##(1993-2#1)(1997-3#1)(2008-10#4)(2008-5#2)(2009-8#1)
failed to do so##2##4##(1995-8#1)(1997-1#1)
failed to enhance##4##3##(1991-6#1)(1994-5#1)(2008-10#1)(2008-11#1)
failed to form##3##3##(2008-8#2)(2013-1#1)
failed to germinate##2##3##(2008-10#2)
failed to give##2##3##(2008-12#1)(2012-12#1)
failed to identify##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
failed to improve##3##3##(1991-4#1)(1993-3#1)(2008-10#1)
failed to induce##3##3##(1992-12#1)(1997-7#1)(2008-10#1)
failed to inhibit the##2##4##(1991-5#1)(1997-1#1)
failed to inhibit##3##3##(1990-8#1)(1991-5#1)(1997-1#1)
failed to meet##3##3##(1995-12#1)(2008-11#2)
failed to predict##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
failed to prevent##2##3##(1994-2#1)(1995-8#1)
failed to produce##5##3##(1993-9#1)(2008-10#4)
failed to provide adequate##2##4##(2011-2#1)(2012-2#1)
failed to provide##3##3##(2011-2#1)(2012-2#2)
failed to reduce the##2##4##(2008-10#1)(2011-2#1)
failed to respond to##6##4##(1990-2#2)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#1)
failed to reveal any##3##4##(2008-7#1)(2009-10#1)(2009-6#1)
failed to reveal##6##3##(2008-7#2)(2009-10#1)(2009-6#1)(2009-9#2)
failed to show a##3##4##(1994-2#1)(1994-3#1)(2008-10#1)
failed to show##7##3##(1994-2#1)(1994-3#1)(2008-10#2)(2008-5#2)(2011-2#1)
failed to significantly##2##3##(1997-2#1)(2008-11#1)
failed to support sporulation##2##4##(2008-10#2)
failed to support##5##3##(2008-10#4)(2012-5#1)
failed to##147##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#1)(1995-8#4)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#37)(2008-11#8)(2008-12#1)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#3)
failed##210##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#1)(1995-8#4)(1996-12#1)(1996-3#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#48)(2008-11#13)(2008-12#1)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-12#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#11)
failing to##4##2##(2008-10#1)(2013-1#3)
failing##12##1##(1995-9#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
fails to produce##2##3##(1991-1#1)(1994-2#1)
fails to protect##2##3##(1991-6#1)(2009-6#1)
fails to##22##2##(1991-1#2)(1991-3#1)(1991-4#1)(1991-6#1)(1994-2#1)(1995-2#3)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-10#1)(2011-2#1)(2012-3#1)
fails##26##1##(1991-1#2)(1991-3#1)(1991-4#1)(1991-6#1)(1994-2#1)(1995-2#3)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-6#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
failure (MOF)##3##2##(1992-5#1)(1997-1#1)(2009-7#1)
failure after##2##2##(1994-3#1)(2012-3#1)
failure and a##2##3##(2008-1#1)(2009-4#1)
failure and default##2##3##(2013-8#2)
failure and##29##2##(1990-9#1)(1993-11#1)(1993-3#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#3)
failure are##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
failure as##2##2##(2009-10#1)(2009-7#1)
failure associated with##2##3##(2008-11#1)(2013-1#1)
failure by##3##2##(1994-8#1)(2008-11#1)(2013-8#1)
failure can##2##2##(2008-8#1)(2012-12#1)
failure cases##3##2##(1996-3#3)
failure did not##2##3##(1997-8#1)(2010-6#1)
failure due to##7##3##(1996-3#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)
failure in the##5##3##(1991-8#1)(1994-6#1)(2009-10#1)(2011-1#1)(2011-2#1)
failure in##21##2##(1991-8#1)(1994-6#1)(1995-5#1)(1997-2#1)(2008-1#3)(2008-11#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)
failure is##6##2##(1994-5#1)(1996-3#1)(2008-1#2)(2008-8#1)(2010-8#1)
failure may##2##2##(1992-5#1)(1996-6#1)
failure mode and effects analysis##2##5##(2008-10#1)(2012-2#1)
failure mode of##2##3##(2008-10#1)(2013-1#1)
failure mode##6##2##(2008-10#2)(2008-9#1)(2012-2#1)(2013-1#2)
failure modes##2##2##(2009-10#1)(2013-1#1)
failure of Vim DBS##2##4##(2012-3#2)
failure of conservative##2##3##(2011-2#1)(2013-1#1)
failure of endoscopic therapy##2##4##(2010-12#2)
failure of the procedure##2##4##(2008-7#1)(2011-2#1)
failure of the##10##3##(1992-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#1)
failure of##47##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-3#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#1)
failure on##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
failure or##9##2##(1992-6#1)(1997-5#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-3#2)
failure patients##3##2##(2008-10#1)(2012-2#2)
failure probability##3##2##(1990-11#1)(2009-10#1)(2009-7#1)
failure properties##2##2##(2009-7#2)
failure rate##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
failure rates##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
failure syndrome##2##2##(2008-11#1)(2011-2#1)
failure time##4##2##(2008-10#2)(2012-3#2)
failure to achieve##2##3##(1994-12#1)(2013-1#1)
failure to complete##2##3##(2008-10#1)(2010-6#1)
failure to diagnose##3##3##(1995-6#3)
failure to respond to##2##4##(1994-12#1)(2008-5#1)
failure to thrive##4##3##(1994-3#1)(2010-6#2)(2011-1#1)
failure to##38##2##(1990-6#1)(1991-3#1)(1993-12#2)(1994-12#2)(1994-3#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
failure types##2##2##(1995-9#1)(2009-7#1)
failure was##2##2##(1991-2#1)(2008-10#1)
failure who are##2##3##(1993-2#1)(2010-6#1)
failure who##3##2##(1993-2#1)(2010-6#1)(2013-1#1)
failure with##7##2##(1991-11#1)(1997-8#1)(2008-10#1)(2013-1#4)
failure##413##1##(1990-11#1)(1990-6#1)(1990-9#5)(1991-11#2)(1991-2#3)(1991-3#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-9#1)(1996-12#1)(1996-3#10)(1996-5#1)(1996-6#4)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-8#5)(2006-6#1)(2007-12#2)(2008-1#14)(2008-10#36)(2008-11#34)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#21)(2008-8#8)(2008-9#4)(2009-10#19)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#17)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#1)(2010-5#2)(2010-6#12)(2010-8#2)(2011-1#2)(2011-2#29)(2011-3#4)(2012-12#13)(2012-2#11)(2012-3#16)(2013-1#34)(2013-8#10)
failure&quot##2##1##(1992-5#1)(2009-10#1)
failure)##2##1##(2013-1#2)
failure?]##2##1##(1993-2#1)(1996-11#1)
failure]##4##1##(1997-2#1)(2008-10#1)(2010-12#1)(2013-8#1)
failures and##7##2##(1990-11#1)(1991-2#1)(1993-1#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
failures are##2##2##(1990-11#1)(2012-3#1)
failures of##4##2##(1990-11#1)(2010-3#1)(2012-3#1)(2012-5#1)
failures that##2##2##(2011-2#1)(2012-12#1)
failures to##2##2##(1994-12#1)(2008-9#1)
failures were##4##2##(2011-2#1)(2012-12#1)(2013-1#2)
failures with##3##2##(2010-10#1)(2010-12#1)(2013-1#1)
failures##52##1##(1990-11#3)(1991-2#2)(1991-8#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-11#3)(1996-3#2)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#1)
faint##7##1##(1995-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-6#1)
fainting##2##1##(2008-1#1)(2008-10#1)
fair and##2##2##(1991-2#1)(2009-3#1)
fair to substantial##2##3##(1997-8#2)
fair to##4##2##(1997-8#3)(2010-6#1)
fair##28##1##(1991-2#3)(1992-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-8#3)(2007-12#1)(2008-10#6)(2008-11#4)(2008-12#1)(2009-10#1)(2009-3#1)(2010-6#1)(2012-2#1)(2013-1#1)
fairly close##2##2##(2008-10#1)(2008-5#1)
fairly constant##3##2##(1996-12#1)(2008-10#2)
fairly good##6##2##(1996-6#1)(2008-10#4)(2008-7#1)
fairly large amounts##2##3##(2008-11#1)(2008-3#1)
fairly large##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
fairly low##3##2##(2008-10#1)(2012-12#2)
fairly rapid##3##2##(2008-10#3)
fairly selective##2##2##(2008-10#2)
fairly well with data obtained using atomic absorption spectrometry##2##9##(2008-10#2)
fairly well with data obtained using##3##6##(2008-10#3)
fairly well with data obtained##4##5##(2008-10#4)
fairly well##6##2##(2008-10#4)(2008-11#1)(2011-2#1)
fairly##57##1##(1990-2#1)(1992-12#1)(1994-1#1)(1994-3#1)(1996-12#1)(1996-6#2)(2008-10#29)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#3)(2012-12#2)(2013-1#2)
fairy##2##1##(2008-11#1)(2008-8#1)
fait##3##1##(2011-2#1)(2013-1#2)
faite de##2##2##(2013-1#2)
faite##3##1##(2011-2#1)(2013-1#2)
faith and##4##2##(1991-2#1)(1997-5#1)(2008-12#1)(2009-11#1)
faith development##4##2##(2008-12#2)(2011-1#2)
faith in##2##2##(1990-9#1)(2012-2#1)
faith##17##1##(1990-9#1)(1991-2#1)(1993-12#2)(1994-3#1)(1997-5#1)(2008-12#6)(2009-11#1)(2011-1#2)(2012-2#1)(2013-1#1)
faithful##2##1##(1991-2#1)(1993-12#1)
faithfully##3##1##(1996-2#1)(2008-11#1)(2008-12#1)
falciparum and##2##2##(1992-6#1)(2012-12#1)
falciparum malaria##5##2##(1997-4#1)(2011-2#3)(2012-3#1)
falciparum parasites in infants##2##4##(1995-12#2)
falciparum plasmepsin##2##2##(2008-4#2)
falciparum##34##1##(1990-12#2)(1991-4#1)(1991-8#1)(1992-6#2)(1993-2#3)(1995-12#2)(1997-4#1)(2008-4#2)(2008-8#3)(2008-9#1)(2011-2#3)(2012-12#6)(2012-2#4)(2012-3#2)(2013-8#1)
fall 1999##2##2##(2008-10#2)
fall and spring##2##3##(2008-10#1)(2008-12#1)
fall and##6##2##(2008-10#3)(2008-12#1)(2008-8#1)(2010-11#1)
fall below the##2##3##(2008-10#1)(2009-8#1)
fall crops##2##2##(2008-10#2)
fall in the##3##3##(1995-2#1)(2008-10#1)(2010-8#1)
fall in##15##2##(1990-5#1)(1991-12#1)(1991-3#1)(1995-2#1)(1997-1#3)(2008-10#2)(2008-5#1)(2008-7#2)(2010-7#2)(2010-8#1)
fall into##5##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)
fall of 1997##2##3##(2008-3#1)(2008-7#1)
fall of##12##2##(1991-2#1)(1996-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2011-9#1)
fall short of##2##3##(1995-2#1)(2008-11#1)
fall to##2##2##(2008-12#1)(2008-5#1)
fall under the##2##3##(2008-2#1)(2011-2#1)
fall under##3##2##(2008-2#1)(2009-11#1)(2011-2#1)
fall within a##2##3##(1993-12#1)(2008-8#1)
fall within the##2##3##(1990-2#1)(2008-11#1)
fall within##6##2##(1990-2#1)(1991-6#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
fall##107##1##(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#4)(1996-1#1)(1997-1#3)(2008-1#1)(2008-10#43)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-7#2)(2010-8#1)(2011-2#2)(2011-9#1)(2013-1#3)
fall-planted##2##1##(2008-10#2)
fallax and##2##2##(2008-10#2)
fallax from M##2##3##(2008-10#2)
fallax in##2##2##(2008-10#2)
fallax isolates##2##2##(2008-10#2)
fallax was##2##2##(2008-10#2)
fallax##25##1##(2008-10#25)
fallen##7##1##(1993-6#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)
falling in##3##2##(1994-9#1)(2008-10#1)(2008-9#1)
falling into##2##2##(1991-1#1)(1994-2#1)
falling short##2##2##(1991-3#1)(1994-3#1)
falling to##2##2##(2008-11#2)
falling within##2##2##(2008-10#1)(2012-2#1)
falling##21##1##(1990-2#1)(1991-1#1)(1991-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-11#2)(2012-2#1)(2012-3#1)
fallopian tube##11##2##(1991-3#1)(1992-1#3)(1992-12#2)(1993-1#1)(1993-2#1)(2012-3#2)(2013-1#1)
fallopian##13##1##(1991-12#1)(1991-3#1)(1992-1#3)(1992-12#2)(1993-1#1)(1993-2#1)(2008-7#1)(2012-3#2)(2013-1#1)
fallow##3##1##(2008-10#2)(2008-12#1)
falls among##3##2##(2008-7#3)
falls and##4##2##(1990-9#1)(2008-7#2)(2010-11#1)
falls in the##2##3##(2008-10#1)(2011-2#1)
falls in##5##2##(1994-12#1)(1994-6#2)(2008-10#1)(2011-2#1)
falls into the##2##3##(1991-3#1)(2009-7#1)
falls##36##1##(1990-9#1)(1991-3#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#7)(2009-3#1)(2009-7#1)(2010-10#3)(2010-11#4)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)
false lumen##4##2##(1991-2#1)(2008-11#3)
false negative results##6##3##(1990-6#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#2)
false negative##11##2##(1990-6#1)(1992-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#2)
false negatives##3##2##(1996-9#1)(1997-8#1)(2008-10#1)
false positive and##2##3##(2008-1#1)(2011-2#1)
false positive results##2##3##(1997-2#1)(2008-10#1)
false positive##11##2##(1990-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-3#1)(2011-2#1)(2012-2#1)
false positives##5##2##(1997-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
false##49##1##(1990-2#1)(1990-6#1)(1991-2#1)(1992-3#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-4#3)(1997-8#2)(2008-1#2)(2008-10#9)(2008-11#10)(2008-2#1)(2008-6#1)(2009-3#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
false-alarm##2##1##(2008-10#1)(2008-3#1)
false-negative results##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
false-negative##6##1##(1994-1#1)(1996-9#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
false-negatives##6##1##(2010-10#1)(2012-12#5)
false-positive results##4##2##(2008-11#1)(2011-2#2)(2012-12#1)
false-positive##9##1##(1996-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#2)(2012-12#2)(2012-2#1)
falsely##3##1##(1996-6#1)(2008-5#1)(2012-12#1)
familial Mediterranean fever##2##3##(1992-9#1)(1997-5#1)
familial adenomatous polyposis (FAP)##2##4##(2009-12#2)
familial adenomatous polyposis##7##3##(2009-12#5)(2011-2#1)(2012-3#1)
familial cardiac amyloidosis##2##3##(1992-8#2)
familial caregivers of ventilator-assisted children##2##5##(2010-7#2)
familial episodic ataxias##2##3##(2012-3#2)
familial hypercholesterolemia##4##2##(1990-2#1)(1991-11#3)
familial incidence##2##2##(2008-7#2)
familial multiple sclerosis##2##3##(2011-2#2)
familial occurrence##2##2##(1990-9#1)(2010-6#1)
familial susceptibility##2##2##(2012-12#1)(2013-8#1)
familial tendency##2##2##(2011-2#1)(2012-12#1)
familial##76##1##(1990-12#1)(1990-2#1)(1990-9#2)(1991-1#1)(1991-11#3)(1991-2#2)(1991-3#1)(1992-12#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-6#1)(1994-11#1)(1995-8#2)(1996-11#1)(1996-5#1)(1997-5#1)(1997-8#2)(2008-10#4)(2008-12#1)(2008-4#2)(2008-7#10)(2009-10#1)(2009-12#6)(2009-8#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-7#2)(2011-2#6)(2012-12#2)(2012-3#7)(2013-1#1)(2013-8#1)
familiar and##2##2##(1994-8#1)(2011-2#1)
familiar melodies##2##2##(2008-9#2)
familiar to##2##2##(1990-6#1)(2008-11#1)
familiar with its clinical##2##4##(2008-11#1)(2013-8#1)
familiar with its##3##3##(2008-11#1)(2008-8#1)(2013-8#1)
familiar with the##4##3##(1997-8#1)(2008-11#1)(2008-2#1)(2012-2#1)
familiar with##12##2##(1990-8#1)(1994-5#1)(1997-8#1)(2008-11#3)(2008-2#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
familiar##37##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1993-6#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-1#1)(1997-8#1)(2008-11#5)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
familiarity with the##6##3##(1991-2#1)(2008-10#1)(2008-4#1)(2009-12#1)(2012-2#1)(2013-1#1)
familiarity with##10##2##(1991-2#1)(1993-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
familiarity##16##1##(1991-2#1)(1993-1#2)(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-1#1)
familiarize##3##1##(1992-12#1)(2008-8#1)(2011-2#1)
families and children##2##3##(1995-1#1)(2012-3#1)
families and##19##2##(1990-6#1)(1991-12#1)(1994-2#1)(1995-1#2)(1995-3#1)(1995-5#1)(1996-11#1)(1997-7#1)(1997-9#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
families are##9##2##(2008-11#3)(2008-6#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#2)
families for##4##2##(1991-12#1)(1994-1#1)(2008-11#1)(2008-8#1)
families from the##2##3##(2008-10#2)
families from##4##2##(1995-1#1)(2008-10#3)
families had##2##2##(1995-1#1)(2008-10#1)
families has been##2##3##(1992-7#1)(2012-2#1)
families have been##3##3##(1993-3#1)(2010-12#1)(2011-1#1)
families have##8##2##(1991-12#1)(1993-3#1)(1997-6#1)(2008-1#1)(2010-12#2)(2011-1#1)(2013-1#1)
families in the##2##3##(2008-10#1)(2011-2#1)
families in##13##2##(1992-3#1)(1997-1#2)(2008-10#1)(2008-12#2)(2010-9#6)(2011-2#1)
families indicated that##2##3##(2008-10#1)(2010-8#1)
families indicated##3##2##(2008-10#2)(2010-8#1)
families manage##2##2##(2008-6#1)(2010-7#1)
families might##2##2##(1991-12#1)(2008-9#1)
families of children with##3##4##(1995-1#2)(2012-2#1)
families of children##4##3##(1995-1#3)(2012-2#1)
families of older people##2##4##(2010-10#2)
families of proteins##2##3##(1994-5#1)(2008-9#1)
families of the##2##3##(2008-10#1)(2008-8#1)
families of##34##2##(1993-12#1)(1994-5#1)(1995-1#3)(2007-12#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-8#2)(2011-10#1)(2012-2#1)(2012-3#2)(2013-8#2)
families regarding##2##2##(2008-11#1)(2010-4#1)
families that##4##2##(1994-9#1)(2008-12#1)(2008-9#1)(2013-1#1)
families to the##2##3##(1997-9#1)(2009-6#1)
families to##3##2##(1997-9#1)(2009-6#1)(2009-9#1)
families using##2##2##(2008-9#1)(2009-9#1)
families were##8##2##(2008-10#5)(2008-12#2)(2012-3#1)
families who##3##2##(1993-2#1)(2010-9#1)(2013-8#1)
families with children##2##3##(1995-5#1)(1997-2#1)
families with##21##2##(1990-12#2)(1993-1#2)(1994-6#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
families would##2##2##(2008-10#2)
families##320##1##(1990-12#5)(1990-2#1)(1990-6#2)(1991-12#5)(1991-2#2)(1992-2#3)(1992-3#3)(1992-7#3)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#3)(1995-1#7)(1995-2#1)(1995-3#4)(1995-5#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#3)(1997-7#4)(1997-9#4)(2006-6#2)(2007-12#2)(2008-1#3)(2008-10#45)(2008-11#36)(2008-12#10)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#15)(2009-10#4)(2009-11#3)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#10)(2010-1#1)(2010-10#6)(2010-12#3)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#5)(2010-9#11)(2011-1#7)(2011-10#3)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#13)(2013-1#9)(2013-8#8)
families' lived experience##2##3##(2009-9#2)
families' lived##3##2##(2009-9#3)
families'##7##1##(1995-1#2)(2009-9#3)(2010-7#1)(2013-8#1)
families) and##2##2##(2008-11#1)(2010-8#1)
families) was##2##2##(2008-10#1)(2008-11#1)
families)##7##1##(2008-10#3)(2008-11#2)(2008-9#1)(2010-8#1)
familistic values##2##2##(2010-1#2)
family 'Chitinophagaceae'##2##2##(2011-2#2)
family (solute carriers##2##3##(2008-7#2)
family 2##2##2##(1994-11#2)
family Coriobacteriaceae##2##2##(2011-2#2)
family Deferribacteraceae##2##2##(2011-2#2)
family Geminiviridae##3##2##(2008-10#3)
family Geminiviridae)##3##2##(2008-10#3)
family Halobacteriaceae##2##2##(2011-2#2)
family Potyviridae)##3##2##(2008-10#3)
family Segniliparaceae##2##2##(2011-2#2)
family and are##2##3##(1996-12#1)(1997-8#1)
family and community##3##3##(1993-3#1)(1993-5#1)(2010-8#1)
family and peer connections and prosocial norms##2##7##(2013-1#2)
family and peer connections##3##4##(2013-1#3)
family and the##5##3##(1990-12#2)(1997-9#1)(2008-10#1)(2013-8#1)
family and##44##2##(1990-12#2)(1993-12#1)(1993-3#1)(1993-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#2)(1997-7#1)(1997-8#2)(1997-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#6)(2013-8#3)
family are##10##2##(1993-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
family as a##2##3##(1990-12#1)(2008-5#1)
family can be##2##3##(1990-5#1)(2012-3#1)
family care##2##2##(2009-5#1)(2010-10#1)
family caregivers of##2##3##(2008-6#1)(2011-2#1)
family caregivers##7##2##(1991-1#1)(2008-6#1)(2010-4#3)(2011-2#1)(2013-1#1)
family characteristics##3##2##(2008-11#1)(2011-2#2)
family conflict##2##2##(2009-9#2)
family connectedness and body satisfaction##3##5##(2010-10#3)
family connectedness##5##2##(2010-10#5)
family consists of a##2##4##(1996-2#1)(2008-9#1)
family consists of##3##3##(1996-2#1)(2008-7#1)(2008-9#1)
family dinners##7##2##(2010-8#1)(2013-1#6)
family doctors in North Holland (n =##3##7##(1991-8#3)
family doctors in##5##3##(1991-8#5)
family doctors##9##2##(1991-8#7)(1996-11#1)(2008-11#1)
family dynamics##4##2##(2008-11#2)(2009-11#2)
family environment##4##2##(2008-7#3)(2012-3#1)
family factors##3##2##(2010-4#1)(2013-8#2)
family formation and##2##3##(2009-10#1)(2011-2#1)
family formation##10##2##(2008-8#1)(2009-10#5)(2011-2#4)
family from##2##2##(1997-7#1)(2008-10#1)
family functioning and##3##3##(2008-9#1)(2013-1#2)
family functioning was##3##3##(2013-1#3)
family functioning##15##2##(2008-6#1)(2008-7#3)(2008-9#1)(2013-1#10)
family gene##2##2##(1996-12#1)(2008-11#1)
family has been##3##3##(1991-6#1)(1993-12#1)(1997-6#1)
family have been##2##3##(1991-6#1)(2008-7#1)
family have##5##2##(1991-6#1)(1992-7#1)(2008-7#1)(2011-1#1)(2011-2#1)
family health##4##2##(2008-11#1)(2008-12#1)(2012-3#2)
family history and##2##3##(2008-4#1)(2012-3#1)
family history of##11##3##(1993-1#1)(1997-6#1)(2008-6#2)(2008-7#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
family history##29##2##(1993-1#1)(1994-12#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#2)(2010-6#2)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
family in##9##2##(1991-2#1)(1993-12#2)(1995-2#1)(1995-5#1)(1997-7#1)(2008-9#1)(2009-10#1)(2013-8#1)
family includes##2##2##(1993-12#1)(2010-1#1)
family involvement##2##2##(2011-1#1)(2012-2#1)
family is##6##2##(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#1)(2009-9#1)(2011-2#1)
family life##4##2##(2009-9#1)(2010-4#1)(2011-2#2)
family meals##4##2##(2013-1#4)
family means##2##2##(2008-10#2)
family member##11##2##(1992-2#1)(1992-3#2)(1993-2#3)(1995-8#1)(1996-12#1)(1996-2#1)(2011-2#1)(2012-2#1)
family members and##2##3##(2008-10#1)(2011-2#1)
family members are##5##3##(1996-9#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#1)
family members in##4##3##(1990-5#1)(1992-2#1)(2010-4#1)(2012-3#1)
family members of##3##3##(2008-11#2)(2009-11#1)
family members##40##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-2#1)(1992-2#1)(1992-7#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-11#9)(2008-6#3)(2008-7#1)(2009-11#1)(2009-12#2)(2009-6#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)
family model##2##2##(1996-3#2)
family of cysteine proteases##4##4##(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
family of enzymes##2##3##(2008-4#2)
family of intracellular##2##3##(2008-4#1)(2008-5#1)
family of long##2##3##(1995-12#1)(1996-6#1)
family of operators in##2##4##(2011-2#2)
family of peptides##2##3##(1992-6#1)(1995-12#1)
family of protein tyrosine kinases##2##5##(1996-2#2)
family of protein##3##3##(1996-2#2)(2008-10#1)
family of proteins##11##3##(1990-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#2)(2009-7#1)(2013-8#2)
family of transcription factors##2##4##(2009-8#2)
family of transmembrane proteins##2##4##(2009-8#2)
family of transmembrane##3##3##(1993-12#1)(2009-8#2)
family of##109##2##(1990-5#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#4)(1995-6#4)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#5)(1996-5#1)(1996-6#1)(1997-7#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#6)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
family physician##5##2##(1993-3#1)(1994-12#1)(1995-11#1)(1997-4#2)
family physicians in##2##3##(1995-9#1)(1996-11#1)
family physicians##7##2##(1995-9#1)(1996-11#1)(2008-10#2)(2008-11#2)(2010-4#1)
family planning and##2##3##(2008-11#1)(2010-7#1)
family planning programs##2##3##(1997-2#2)
family planning services and##2##4##(1994-8#2)
family planning services##4##3##(1994-8#4)
family planning##25##2##(1991-1#5)(1991-3#1)(1994-3#1)(1994-8#7)(1994-9#2)(1997-2#4)(1997-5#1)(2008-11#2)(2010-1#1)(2010-7#1)
family plays an##2##3##(1993-3#1)(2012-12#1)
family policy##2##2##(2010-4#2)
family practice##3##2##(1992-1#1)(1996-11#1)(1996-8#1)
family problems##4##2##(1992-1#3)(2009-9#1)
family proteins##4##2##(2008-11#1)(2010-12#1)(2011-2#2)
family psychopathology and##2##3##(2008-11#2)
family relationship##2##2##(2011-2#1)(2012-12#1)
family satisfaction##3##2##(1997-1#1)(2010-2#1)(2012-2#1)
family size intentions are##2##4##(2009-12#2)
family size intentions##5##3##(2009-12#5)
family size##9##2##(1990-6#1)(2008-12#2)(2009-12#5)(2011-2#1)
family support systems##2##3##(2009-7#2)
family support##8##2##(1995-1#1)(2008-7#3)(2009-7#3)(2012-12#1)
family therapy##3##2##(1990-12#1)(1996-6#1)(2008-11#1)
family was##3##2##(1994-11#1)(1997-8#1)(2009-9#1)
family well being##2##3##(1995-1#2)
family were##2##2##(1993-9#1)(2008-11#1)
family which##6##2##(1995-5#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-8#1)
family with a##2##3##(2008-7#1)(2009-10#1)
family with##9##2##(1993-12#1)(1993-2#1)(1997-8#2)(2008-7#2)(2009-10#1)(2010-10#1)(2012-3#1)
family##892##1##(1990-11#3)(1990-12#10)(1990-3#2)(1990-5#5)(1990-6#1)(1991-1#7)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#7)(1991-6#3)(1991-8#7)(1991-9#1)(1992-1#4)(1992-12#1)(1992-2#4)(1992-3#6)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#14)(1993-2#8)(1993-3#6)(1993-5#1)(1993-6#6)(1993-9#4)(1994-1#4)(1994-11#7)(1994-12#6)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#4)(1995-1#6)(1995-11#4)(1995-12#4)(1995-2#10)(1995-3#1)(1995-5#6)(1995-6#11)(1995-8#6)(1995-9#2)(1996-11#4)(1996-12#10)(1996-2#12)(1996-3#3)(1996-5#1)(1996-6#5)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#6)(1997-4#9)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#10)(1997-9#3)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#95)(2008-11#48)(2008-12#18)(2008-2#1)(2008-3#4)(2008-4#8)(2008-5#10)(2008-6#19)(2008-7#33)(2008-8#23)(2008-9#15)(2009-10#13)(2009-11#7)(2009-12#10)(2009-5#3)(2009-6#4)(2009-7#8)(2009-8#11)(2009-9#18)(2010-1#8)(2010-10#9)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#12)(2010-5#1)(2010-6#5)(2010-7#6)(2010-8#6)(2010-9#5)(2011-1#7)(2011-2#83)(2011-3#1)(2012-12#10)(2012-2#12)(2012-3#23)(2013-1#39)(2013-8#19)
family's##6##1##(1994-5#1)(1995-1#2)(1996-1#1)(2010-11#1)(2011-2#1)
family)##2##1##(2008-10#1)(2011-2#1)
family-based therapy##2##2##(2008-6#2)
family-based##4##1##(2008-6#3)(2009-12#1)
family-centered care##2##2##(1992-3#1)(1994-3#1)
family-centered##7##1##(1992-3#1)(1993-3#1)(1994-3#2)(1995-3#1)(2010-9#2)
family-school##2##1##(2012-12#2)
family/friends##2##1##(2010-2#2)
family]##2##1##(1990-12#1)(1997-8#1)
famine##2##1##(2008-10#2)
famotidine in##3##2##(2008-10#3)
famotidine##7##1##(2008-10#6)(2010-9#1)
famous##4##1##(2008-11#1)(2008-9#2)(2013-7#1)
fan-beam DT##4##2##(2008-3#4)
fan-beam##7##1##(2008-3#7)
fanning behavior##2##2##(2013-8#2)
fanning##11##1##(2008-2#2)(2008-3#6)(2013-8#3)
fantail and##4##2##(2010-8#4)
fantail##6##1##(2010-8#6)
fantasy##5##1##(1995-8#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
far and##4##2##(1991-12#1)(2008-11#1)(2008-9#1)(2011-2#1)
far as 1##2##3##(1997-6#1)(2008-10#1)
far as the##9##3##(1991-1#1)(1997-1#1)(2008-10#2)(2008-5#1)(2010-1#1)(2011-2#2)(2012-12#1)
far as##24##2##(1990-9#1)(1991-1#1)(1991-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
far away from ore body rock##3##6##(2013-8#3)
far away from ore body##4##5##(2013-8#4)
far away from##5##3##(1995-10#1)(2013-8#4)
far below the##5##3##(1990-5#1)(1997-4#1)(2008-10#2)(2011-2#1)
far below##7##2##(1990-5#1)(1991-3#1)(1997-4#1)(2008-10#3)(2011-2#1)
far beyond the##2##3##(1992-12#1)(2008-10#1)
far beyond##6##2##(1992-12#1)(1995-6#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-8#1)
far exceeds the##2##3##(2011-2#1)(2013-1#1)
far fewer##3##2##(2008-10#2)(2008-11#1)
far from being##2##3##(1996-2#1)(2009-5#1)
far from the##4##3##(1993-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
far from##21##2##(1992-4#1)(1992-9#1)(1993-8#1)(1994-12#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
far higher than##2##3##(2008-7#1)(2011-2#1)
far in the##6##3##(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
far in##9##2##(1995-12#1)(2008-10#3)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
far less##4##2##(1993-2#1)(2008-11#1)(2008-3#1)(2011-1#1)
far lower##3##2##(2008-11#1)(2009-7#1)(2011-2#1)
far more##10##2##(1992-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
far only##2##2##(2008-10#1)(2008-7#1)
far the##7##2##(1990-5#1)(1993-1#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
far western##5##2##(2008-4#4)(2011-2#1)
far##241##1##(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#3)(2007-12#1)(2008-10#42)(2008-11#15)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#7)(2009-10#2)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#5)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#15)(2012-12#5)(2012-2#3)(2013-1#11)(2013-7#1)(2013-8#9)
far-field intensity##2##2##(2008-2#1)(2008-3#1)
far-field scattering##3##2##(2008-2#2)(2008-3#1)
far-field##19##1##(2008-2#6)(2008-3#13)
far-reaching##2##1##(1992-3#1)(2008-12#1)
fare##3##1##(1995-12#1)(1996-11#1)(2009-12#1)
fared##2##1##(1990-8#1)(2011-2#1)
faring##3##1##(2009-7#1)(2012-3#1)(2013-1#1)
farm and##2##2##(2011-2#2)
farm animal##2##2##(1990-6#1)(2011-2#1)
farm in the Himalayan state of Jammu and Kashmir##2##9##(2011-2#2)
farm##25##1##(1990-3#1)(1990-6#1)(1990-9#1)(1994-3#1)(1996-12#2)(1997-5#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#6)
farmed##2##1##(1991-8#1)(2013-1#1)
farmer##4##1##(1997-7#1)(2008-12#2)(2013-1#1)
farmer-managed##3##1##(2008-12#3)
farmers in##2##2##(2010-1#2)
farmers##9##1##(1996-12#1)(1996-8#1)(1997-7#2)(2008-10#1)(2008-8#1)(2010-1#3)
farmers'##4##1##(2008-10#2)(2010-1#1)(2011-2#1)
farming communities##3##2##(2008-11#1)(2009-8#2)
farming##14##1##(1991-8#1)(1997-7#1)(2008-10#4)(2008-11#1)(2009-8#4)(2010-1#1)(2010-6#1)(2011-2#1)
farms around Charlottetown##2##3##(2012-3#2)
farms in the##2##3##(1991-8#1)(2011-2#1)
farms in##6##2##(1991-8#1)(2008-10#3)(2011-2#1)(2011-3#1)
farms were##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
farms with a history of##2##5##(1996-12#2)
farms with##3##2##(1996-12#2)(2008-10#1)
farms##31##1##(1991-8#1)(1996-12#5)(1997-5#2)(2008-10#11)(2008-5#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#3)
farnesyl cysteine##2##2##(2008-10#2)
farnesyl diphosphate##2##2##(1993-9#1)(2008-8#1)
farnesyl pyrophosphate##2##2##(1990-12#2)
farnesyl##7##1##(1990-12#2)(1993-9#1)(1997-7#1)(2008-10#2)(2008-8#1)
farnesylated##4##1##(1997-7#2)(2008-10#2)
farnesylation##2##1##(1993-9#1)(2008-5#1)
farnesyltransferase##5##1##(1993-9#2)(1995-2#2)(2008-5#1)
farrowing##2##1##(1996-12#2)
farther##2##1##(2008-1#1)(2008-10#1)
fascia is##3##2##(2009-1#3)
fascia oriented##2##2##(2013-1#2)
fascia##27##1##(1991-2#3)(1992-5#1)(2008-9#1)(2009-1#8)(2009-3#1)(2009-9#8)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#2)
fasciae##6##1##(2009-3#3)(2013-1#3)
fascial closure##6##2##(1991-1#2)(1991-2#2)(1992-1#1)(1992-2#1)
fascial dehiscence##2##2##(1991-2#2)
fascial incisions##2##2##(1992-1#1)(1992-2#1)
fascial##28##1##(1991-1#2)(1991-2#5)(1992-1#3)(1992-2#3)(2008-9#3)(2009-1#4)(2009-9#5)(2013-1#3)
fascicles##2##1##(2009-5#1)(2010-12#1)
fascicularis##2##1##(1994-2#1)(2011-2#1)
fasciculata##2##1##(1990-5#1)(2011-2#1)
fasciculation##2##1##(1996-12#1)(1997-3#1)
fascifrons##2##1##(2008-10#2)
fascinating##8##1##(2008-10#1)(2008-11#2)(2008-12#1)(2009-10#1)(2009-7#1)(2010-8#1)(2012-12#1)
fasciolosis##5##1##(2008-12#4)(2009-8#1)
fashion and##3##2##(1992-12#1)(2008-10#2)
fashion by##2##2##(1990-2#1)(2008-10#1)
fashion for##2##2##(2008-10#1)(2008-9#1)
fashion in the##2##3##(1997-2#1)(2008-9#1)
fashion in##10##2##(1992-12#1)(1992-8#1)(1993-8#1)(1995-2#2)(1997-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
fashion to##5##2##(1994-5#1)(1995-11#1)(2006-6#1)(2008-11#1)(2008-7#1)
fashion with a##2##3##(1993-8#1)(2008-11#1)
fashion with##6##2##(1991-9#1)(1993-8#1)(1994-5#1)(1995-6#1)(2008-11#1)(2011-2#1)
fashion##100##1##(1990-2#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#4)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(2006-6#1)(2008-10#16)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-12#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-2#6)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#5)
fashions##2##1##(1991-5#1)(1993-3#1)
fast (&lt##2##2##(2008-10#1)(2009-3#1)
fast Fourier transformation##2##3##(2008-10#1)(2013-1#1)
fast Fourier##4##2##(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
fast analysis of##2##3##(2008-10#2)
fast analysis##6##2##(2008-10#5)(2010-9#1)
fast and easy##2##3##(1996-12#1)(2008-10#1)
fast and effective##2##3##(2008-10#1)(2013-1#1)
fast and reliable##8##3##(2008-10#6)(2009-12#1)(2013-1#1)
fast and reproducible##3##3##(2008-10#3)
fast and robust##2##3##(2008-10#2)
fast and sensitive method##2##4##(2008-10#2)
fast and sensitive##10##3##(2008-10#8)(2008-11#1)(2008-9#1)
fast and simple method##2##4##(1995-3#1)(2008-10#1)
fast and simple##5##3##(1995-3#1)(2008-10#4)
fast and slow##3##3##(2008-10#1)(2008-9#2)
fast and stable##3##3##(2008-10#3)
fast and##67##2##(1995-3#1)(1996-12#1)(2008-10#47)(2008-11#3)(2008-7#2)(2008-9#6)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
fast as##2##2##(2008-10#1)(2008-3#1)
fast chemiluminescence (CL) flow-injection##2##4##(2008-10#2)
fast chemiluminescence##3##2##(2008-10#3)
fast convergence##2##2##(2008-10#2)
fast determination of##3##3##(2008-10#3)
fast extraction##2##2##(2008-10#2)
fast food##4##2##(2008-7#1)(2009-5#1)(2011-2#2)
fast growing##2##2##(2008-11#1)(2011-2#1)
fast method for##8##3##(2008-10#7)(2008-11#1)
fast method has been developed##3##5##(2008-10#3)
fast method##13##2##(2008-10#12)(2008-11#1)
fast nuclear-magnetic-resonance##2##2##(2008-11#2)
fast rate##4##2##(2008-10#1)(2008-9#3)
fast response and##5##3##(2008-10#5)
fast response time (&lt##3##4##(2008-10#3)
fast response time (within 10-30s)##2##5##(2008-10#2)
fast response time and##4##4##(2008-10#4)
fast response time of ca##2##5##(2008-10#2)
fast response time of##16##4##(2008-10#16)
fast response time##32##3##(2007-11#1)(2008-10#31)
fast response##47##2##(2007-11#1)(2008-10#45)(2009-10#1)
fast separation##3##2##(2008-10#3)
fast time##2##2##(1990-2#2)
fast wave##2##2##(1994-8#2)
fast waves##3##2##(1994-8#3)
fast when##2##2##(2008-9#1)(2013-8#1)
fast##349##1##(1990-2#2)(1991-12#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#5)(1995-3#3)(1995-8#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#4)(2008-1#3)(2008-10#236)(2008-11#8)(2008-12#1)(2008-3#9)(2008-5#4)(2008-6#2)(2008-7#7)(2008-9#10)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#7)(2011-7#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#4)
fast-food consumption##3##2##(2009-5#2)(2013-1#1)
fast-food##4##1##(1994-6#1)(2009-5#2)(2013-1#1)
fast-growing##4##1##(2008-10#2)(2008-8#1)(2012-2#1)
fast-start performance##2##2##(2010-8#2)
fast-start##3##1##(2010-8#3)
fasted and fed##2##3##(2008-11#1)(2008-7#1)
fasted animals##3##2##(1992-12#1)(1994-8#2)
fasted for##2##2##(1994-8#1)(2008-7#1)
fasted human VLDL##2##3##(1995-6#2)
fasted overnight##2##2##(1995-11#1)(2011-2#1)
fasted rats##5##2##(1993-8#2)(1994-8#2)(2008-11#1)
fasted##27##1##(1991-3#2)(1992-12#1)(1993-8#3)(1994-8#8)(1995-11#1)(1995-6#4)(2008-11#2)(2008-7#5)(2011-2#1)
faster and easier##3##3##(2008-10#1)(2008-4#1)(2010-6#1)
faster and less##2##3##(2008-10#1)(2008-11#1)
faster and more##7##3##(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)
faster and##17##2##(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-7#1)(2010-6#1)(2012-3#1)
faster at##2##2##(2008-11#1)(2008-5#1)
faster because##2##2##(1992-2#1)(2008-10#1)
faster for##2##2##(2007-12#1)(2008-10#1)
faster in response to##2##4##(2008-11#1)(2008-9#1)
faster in the presence of##2##5##(1996-5#1)(2008-11#1)
faster in the##3##3##(1996-5#1)(2008-11#1)(2008-8#1)
faster in##10##2##(1991-2#1)(1996-5#2)(2008-11#2)(2008-8#3)(2008-9#2)
faster on##2##2##(2008-10#2)
faster rate than##2##3##(1991-3#1)(1992-12#1)
faster rate##3##2##(1991-3#1)(1992-12#1)(2008-10#1)
faster recovery and##2##3##(1991-3#1)(1993-2#1)
faster recovery##3##2##(1991-3#1)(1993-2#1)(1996-3#1)
faster response##2##2##(1996-2#1)(2010-2#1)
faster than any other##5##4##(1994-3#2)(2008-10#1)(2008-6#1)(2012-3#1)
faster than in##4##3##(2008-10#3)(2008-11#1)
faster than men##2##3##(2013-8#2)
faster than that of##2##4##(1993-8#1)(2008-10#1)
faster than that##4##3##(1993-8#1)(2008-10#3)
faster than the##10##3##(1991-5#1)(1993-1#1)(1993-6#1)(1995-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)
faster than##40##2##(1990-9#1)(1991-5#2)(1993-1#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-3#2)(1994-8#1)(1995-3#1)(1996-2#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-8#2)
faster the##2##2##(2008-10#2)
faster to##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
faster with##4##2##(1995-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
faster##153##1##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1992-12#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#2)(1995-3#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-3#1)(2007-12#2)(2007-8#2)(2008-10#54)(2008-11#16)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#2)(2013-8#3)
fastest##14##1##(1994-3#2)(2008-10#9)(2008-11#1)(2011-2#1)(2013-8#1)
fastidiosa can##2##2##(2008-10#2)
fastidiosa cell number##2##3##(2008-10#2)
fastidiosa in##5##2##(2008-10#5)
fastidiosa isolated from##2##3##(2008-10#2)
fastidiosa strains from##2##3##(2008-10#2)
fastidiosa strains were##2##3##(2008-10#2)
fastidiosa strains##9##2##(2008-10#9)
fastidiosa subsp##4##2##(2008-10#4)
fastidiosa to##2##2##(2008-10#2)
fastidiosa was##3##2##(2008-10#3)
fastidiosa##63##1##(2008-10#63)
fastidious bacterium##2##2##(2008-10#2)
fastidious##5##1##(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)
fasting and postprandial##4##3##(2011-1#3)(2012-3#1)
fasting and##10##2##(1994-12#2)(1994-8#1)(2008-11#1)(2008-7#2)(2011-1#3)(2012-3#1)
fasting blood glucose##3##3##(1993-2#1)(2008-10#1)(2010-4#1)
fasting blood sugar##3##3##(2008-12#2)(2010-10#1)
fasting blood##7##2##(1993-2#1)(2008-10#1)(2008-12#2)(2010-10#1)(2010-4#1)(2012-3#1)
fasting glucose##3##2##(1991-7#1)(2008-10#1)(2013-1#1)
fasting hyperglycemia##3##2##(1991-7#3)
fasting plasma glucose##2##3##(1994-12#1)(2010-10#1)
fasting plasma##4##2##(1994-11#1)(1994-12#1)(2008-7#1)(2010-10#1)
fasting##43##1##(1991-3#1)(1991-7#4)(1992-9#2)(1993-2#1)(1994-11#1)(1994-12#5)(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#6)(2010-10#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-3#4)(2013-1#1)
fastness##2##1##(2008-10#2)
fat accumulation##2##2##(1994-5#1)(2008-8#1)
fat and cholesterol##2##3##(1990-8#1)(1995-2#1)
fat and##17##2##(1990-8#1)(1994-2#1)(1995-2#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2012-2#1)(2013-1#1)
fat attenuation##2##2##(2011-2#1)(2013-1#1)
fat cell##2##2##(1994-11#1)(1994-12#1)
fat cells and##2##3##(1997-1#1)(2012-2#1)
fat cells##3##2##(1997-1#1)(2012-2#2)
fat content##2##2##(2008-4#1)(2010-4#1)
fat distribution##6##2##(2008-11#1)(2010-6#5)
fat emulsion##3##2##(2008-10#2)(2008-5#1)
fat from##2##2##(1995-2#2)
fat graft##3##2##(2011-2#3)
fat grafting##5##2##(2013-1#5)
fat in the##2##3##(2008-10#1)(2008-6#1)
fat injection##5##2##(2011-2#3)(2013-1#2)
fat intake##4##2##(1994-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
fat is##3##2##(1991-2#1)(2008-11#2)
fat milk##4##2##(1993-11#1)(2008-10#3)
fat necrosis of the newborn##2##5##(2012-2#2)
fat necrosis##7##2##(2012-2#3)(2013-1#4)
fat necrosis/oil cysts##2##3##(2013-1#2)
fat pad adipose precursor cells##2##5##(1990-11#2)
fat pad##4##2##(1990-11#2)(1993-6#1)(2008-11#1)
fat pads##3##2##(2008-11#3)
fat percentage##2##2##(2008-8#1)(2009-7#1)
fat products##2##2##(2008-10#2)
fat restriction##4##2##(2008-4#4)
fat showed##2##2##(2008-7#1)(2010-4#1)
fat tissue##2##2##(1994-5#1)(2012-3#1)
fat transplant##2##2##(1997-3#2)
fat transplantation##4##2##(1997-3#4)
fat with##2##2##(1994-2#1)(2012-2#1)
fat##189##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-2#1)(1993-11#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#2)(1995-2#8)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#6)(1997-8#3)(2008-1#2)(2008-10#28)(2008-11#14)(2008-12#2)(2008-3#4)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2009-7#2)(2010-12#1)(2010-4#14)(2010-6#8)(2011-2#11)(2012-12#2)(2012-2#15)(2012-3#1)(2012-4#2)(2013-1#20)(2013-7#1)(2013-8#1)
fat)##2##1##(1996-12#1)(2008-6#1)
fatal accidents##2##2##(1996-12#1)(1996-2#1)
fatal acute##2##2##(1991-8#1)(2013-1#1)
fatal cases##3##2##(1995-5#1)(2008-11#1)(2013-8#1)
fatal complication##2##2##(2011-2#1)(2012-3#1)
fatal disease##5##2##(1993-2#1)(1993-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
fatal neurodegenerative##2##2##(1997-3#1)(2010-12#1)
fatal outcome##4##2##(2008-12#1)(2009-1#1)(2013-8#2)
fatal paediatric case of##2##4##(2008-11#2)
fatal##57##1##(1990-9#1)(1991-8#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#8)(2012-12#2)(2012-3#3)(2013-1#4)(2013-8#3)
fatalities##6##1##(1993-12#1)(1995-11#1)(2008-12#1)(2010-11#2)(2011-2#1)
fatality rates##5##2##(1990-2#1)(2011-2#3)(2013-8#1)
fatality##8##1##(1990-2#1)(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#3)(2013-8#1)
fate and##4##2##(1995-11#1)(1996-11#1)(2010-6#1)(2011-1#1)
fate decisions are##2##3##(2009-12#2)
fate decisions##6##2##(2008-11#2)(2009-12#3)(2009-8#1)
fate during##2##2##(1993-6#1)(2013-8#1)
fate in##2##2##(2008-11#1)(2009-12#1)
fate of the##8##3##(2008-1#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-11#1)(2013-1#1)
fate of##25##2##(1994-3#2)(1995-2#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-11#4)(2009-10#1)(2009-6#1)(2009-8#2)(2010-11#2)(2013-1#1)
fate##57##1##(1993-6#1)(1994-12#2)(1994-3#2)(1995-11#3)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(2008-1#1)(2008-10#9)(2008-11#11)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#4)(2009-6#1)(2009-8#4)(2010-11#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
fates##5##1##(1994-12#1)(2007-12#1)(2009-12#2)(2009-8#1)
father##10##1##(1990-12#1)(1994-12#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#1)
fathers and##2##2##(2008-12#1)(2009-5#1)
fathers of##4##2##(1992-2#1)(1997-3#1)(2008-10#1)(2010-11#1)
fathers##13##1##(1992-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#5)(2010-11#2)(2010-7#1)
fathers' social##2##2##(2009-5#2)
fathers'##5##1##(1990-2#1)(2009-5#4)
fatigue analyses##2##2##(2009-7#2)
fatigue and##10##2##(2008-12#1)(2008-7#1)(2009-1#1)(2009-11#1)(2009-7#2)(2010-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
fatigue effects in##2##3##(2009-8#1)(2013-8#1)
fatigue protocols##4##2##(2013-8#4)
fatigue syndrome (CFS)##2##3##(2009-10#1)(2010-1#1)
fatigue syndrome##6##2##(1993-2#1)(1995-5#1)(2008-12#1)(2009-10#1)(2010-1#2)
fatigue was##2##2##(2011-2#1)(2013-8#1)
fatigue##72##1##(1991-6#2)(1992-2#1)(1993-2#1)(1995-5#1)(1996-8#1)(1997-4#1)(2008-10#6)(2008-12#2)(2008-7#5)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-5#2)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#4)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#8)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#11)
fatigued##2##1##(2008-10#1)(2010-8#1)
fatness##3##1##(2008-10#2)(2012-2#1)
fats and##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
fats##8##1##(1990-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)
fattening##2##1##(2008-10#1)(2013-1#1)
fatty acid analysis##2##3##(1992-3#1)(2008-10#1)
fatty acid and##4##3##(1990-8#1)(1995-6#1)(2008-5#1)(2010-11#1)
fatty acid binding protein##5##4##(1994-8#2)(2008-8#2)(2009-8#1)
fatty acid biosynthesis##2##3##(1995-6#1)(1996-6#1)
fatty acid biosynthetic##3##3##(1992-4#3)
fatty acid chain##3##3##(1993-8#3)
fatty acid chains##2##3##(1993-8#1)(1997-2#1)
fatty acid composition of##5##4##(1991-12#2)(1992-12#1)(2008-11#1)(2011-1#1)
fatty acid composition##12##3##(1991-12#3)(1992-12#2)(1994-8#1)(2008-10#1)(2008-11#2)(2011-1#3)
fatty acid compositions##2##3##(2008-11#1)(2012-2#1)
fatty acid concentrations##2##3##(1994-12#1)(2008-12#1)
fatty acid content##3##3##(1990-5#1)(2008-5#2)
fatty acid desaturase gene##2##4##(1996-6#1)(2010-4#1)
fatty acid desaturase##4##3##(1996-6#2)(2010-4#1)(2013-1#1)
fatty acid esters##2##3##(2008-11#1)(2008-7#1)
fatty acid ethyl ester synthase##2##5##(1992-6#2)
fatty acid ethyl ester synthase-III in##2##6##(1992-6#2)
fatty acid ethyl ester##4##4##(1992-6#4)
fatty acid ethyl##5##3##(1992-6#4)(2008-11#1)
fatty acid metabolism##2##3##(1995-2#1)(2012-2#1)
fatty acid methyl ester (FAME)##2##5##(2008-10#2)
fatty acid methyl ester analysis##2##5##(2008-10#2)
fatty acid methyl ester##5##4##(2008-10#5)
fatty acid methyl esters (FAMEs)##2##5##(2008-10#2)
fatty acid methyl esters##5##4##(2008-10#4)(2009-8#1)
fatty acid methyl##11##3##(1997-2#1)(2008-10#9)(2009-8#1)
fatty acid oxidation##4##3##(1993-3#1)(1995-2#1)(2008-1#2)
fatty acid profiles##10##3##(1991-12#1)(2008-10#6)(2010-11#1)(2010-4#1)(2011-2#1)
fatty acid release##3##3##(1991-12#3)
fatty acid synthesis##5##3##(1992-4#1)(1992-8#1)(1995-6#2)(2012-2#1)
fatty acid##127##2##(1990-5#1)(1990-8#2)(1991-12#9)(1992-12#3)(1992-3#2)(1992-4#4)(1992-6#4)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#8)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-11#2)(1995-2#2)(1995-6#4)(1996-12#1)(1996-3#3)(1996-6#3)(1997-2#2)(2008-1#2)(2008-10#25)(2008-11#8)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#2)(2010-1#1)(2010-11#3)(2010-4#2)(2011-1#5)(2011-2#1)(2012-2#4)(2013-1#2)
fatty acid-binding protein##2##3##(1994-8#2)
fatty acids and fatty##2##4##(1994-8#1)(1995-3#1)
fatty acids and##12##3##(1990-8#1)(1991-12#2)(1994-8#1)(1995-3#1)(2008-10#3)(2008-5#2)(2010-4#1)(2013-1#1)
fatty acids are##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
fatty acids as##2##3##(2008-10#1)(2012-2#1)
fatty acids from grape seed##2##5##(2008-10#2)
fatty acids from##9##3##(1991-12#1)(1994-8#2)(2008-10#4)(2008-6#1)(2009-8#1)
fatty acids in both##2##4##(2008-11#1)(2010-4#1)
fatty acids in the##7##4##(1990-5#1)(1990-6#1)(1991-12#1)(2008-11#1)(2010-4#2)(2012-2#1)
fatty acids in##15##3##(1990-5#1)(1990-6#1)(1991-12#4)(1991-6#1)(2008-11#3)(2010-4#3)(2012-2#1)(2012-3#1)
fatty acids released##2##3##(1991-12#1)(2008-10#1)
fatty acids via##2##3##(1992-6#1)(1993-9#1)
fatty acids were found as high as##2##7##(2008-11#2)
fatty acids were##7##3##(1994-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-8#1)
fatty acids which##3##3##(2011-1#2)(2013-1#1)
fatty acids with##2##3##(1994-8#1)(2012-2#1)
fatty acids##133##2##(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#9)(1991-6#2)(1992-6#1)(1992-8#2)(1993-3#1)(1993-9#2)(1994-12#1)(1994-8#5)(1995-11#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-3#5)(1997-2#1)(2008-10#34)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#4)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-6#2)(2011-1#5)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
fatty acyl##3##2##(1994-5#1)(1997-2#1)(2012-12#1)
fatty infiltration of##2##3##(2011-2#2)
fatty liver disease##3##3##(2008-5#1)(2010-10#1)(2011-2#1)
fatty liver##6##2##(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-8#1)
fatty tissue##4##2##(1993-3#1)(1997-4#1)(2008-1#1)(2008-5#1)
fatty##288##1##(1990-5#4)(1990-6#1)(1990-8#3)(1991-12#18)(1991-6#2)(1992-12#3)(1992-3#2)(1992-4#4)(1992-6#5)(1992-8#3)(1992-9#1)(1993-3#3)(1993-8#8)(1993-9#3)(1994-12#2)(1994-5#2)(1994-8#11)(1995-11#3)(1995-2#4)(1995-3#2)(1995-6#4)(1995-9#1)(1996-12#1)(1996-3#8)(1996-6#3)(1997-2#5)(1997-4#1)(2008-1#3)(2008-10#60)(2008-11#18)(2008-12#2)(2008-4#3)(2008-5#16)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-8#6)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-4#7)(2010-6#2)(2011-1#10)(2011-2#7)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#8)(2013-8#5)
fatty-acid fingerprints##2##2##(2008-10#2)
fatty-acid##6##1##(1994-3#1)(2008-10#5)
faujasite##3##1##(2008-10#3)
fault##4##1##(1990-11#2)(1991-12#1)(2008-12#1)
faulty##2##1##(1993-3#1)(2012-2#1)
faun tail##3##2##(2010-6#3)
fauna of##2##2##(2012-2#1)(2013-1#1)
fauna##5##1##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
favor one##2##2##(1995-6#1)(2008-9#1)
favor the evolution of##2##4##(2008-8#2)
favor the##7##2##(1996-3#1)(2008-10#1)(2008-8#4)(2011-2#1)
favor##47##1##(1991-1#2)(1991-2#1)(1993-2#1)(1995-6#1)(1996-3#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#8)(2008-9#6)(2009-10#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
favorability##3##1##(2008-10#3)
favorable conditions for##2##3##(2008-10#1)(2008-11#1)
favorable conditions##5##2##(2008-10#4)(2008-11#1)
favorable environmental conditions##2##3##(2008-10#2)
favorable environmental##3##2##(2008-10#2)(2013-8#1)
favorable for the##2##3##(2008-10#2)
favorable for##8##2##(2008-10#7)(2009-6#1)
favorable in##2##2##(1997-8#1)(2009-4#1)
favorable outcomes##2##2##(2012-2#1)(2012-3#1)
favorable prognosis##3##2##(2012-3#1)(2013-1#2)
favorable to##5##2##(2008-10#5)
favorable##93##1##(1990-6#1)(1990-8#2)(1991-1#1)(1991-3#2)(1992-11#1)(1993-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-8#1)(2008-10#46)(2008-11#3)(2008-4#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
favorably cardiac function##2##3##(2011-2#2)
favorably compared with those##2##4##(2008-10#2)
favorably compared with##3##3##(2008-10#2)(2008-3#1)
favorably compared##4##2##(2008-10#3)(2008-3#1)
favorably to##9##2##(1992-2#1)(1993-12#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#1)
favorably with those##5##3##(2008-10#5)
favorably with##14##2##(1994-1#1)(2008-10#9)(2008-3#3)(2008-9#1)
favorably##38##1##(1991-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1996-9#1)(2008-10#18)(2008-11#2)(2008-3#4)(2008-7#1)(2008-9#2)(2009-9#1)(2011-2#3)
favored a##4##2##(1996-1#2)(2008-10#1)(2012-3#1)
favored budding##2##2##(2008-10#2)
favored by low##2##3##(2008-10#2)
favored by selection##2##3##(2008-9#1)(2013-8#1)
favored by##11##2##(1992-8#1)(2008-10#5)(2008-8#2)(2008-9#2)(2013-8#1)
favored the##3##2##(1995-11#1)(2008-10#2)
favored when##2##2##(2008-8#1)(2008-9#1)
favored##45##1##(1990-8#1)(1992-8#1)(1994-5#1)(1995-11#1)(1996-1#3)(2008-10#14)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#10)(2008-9#6)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
favoring the##3##2##(1990-6#1)(2008-6#1)(2013-1#1)
favoring##20##1##(1990-6#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-5#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
favorite##3##1##(2008-10#1)(2008-4#1)(2013-1#1)
favors the##5##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
favors##23##1##(1990-12#1)(1995-2#2)(1996-5#1)(2008-10#3)(2008-11#1)(2008-8#10)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
favour the##4##2##(1997-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
favour##30##1##(1990-5#1)(1991-2#1)(1991-5#2)(1993-3#1)(1994-6#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)
favourable clinical##2##2##(1991-6#1)(2008-5#1)
favourable effect##2##2##(1996-6#1)(2008-10#1)
favourable for##3##2##(1990-9#1)(2008-5#1)(2010-8#1)
favourable in##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
favourable physical##2##2##(2008-1#1)(2008-5#1)
favourable with##3##2##(1991-8#1)(2008-5#1)(2010-12#1)
favourable##48##1##(1990-9#1)(1991-6#3)(1991-8#1)(1993-2#2)(1995-1#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-5#2)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#5)(2008-7#3)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
favourably to##2##2##(1992-5#1)(2008-10#1)
favourably with the##3##3##(2008-10#3)
favourably with those##2##3##(2008-10#2)
favourably with##8##2##(1991-9#1)(2008-10#6)(2008-7#1)
favourably##14##1##(1991-9#1)(1992-5#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-7#1)
favoured by##2##2##(2010-10#1)(2012-3#1)
favoured in##2##2##(2008-10#1)(2010-12#1)
favoured when##2##2##(2008-10#1)(2008-11#1)
favoured##15##1##(1991-6#1)(1997-7#1)(2008-10#3)(2008-11#2)(2010-10#1)(2010-12#2)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#1)
favourite##2##1##(2010-5#1)(2011-2#1)
favours##4##1##(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#1)
fbn-1 gene##2##2##(1997-8#2)
fc##2##1##(2008-10#2)
fcu-7AL##2##1##(2008-10#2)
fear and disgust levels##2##4##(2012-2#2)
fear and disgust##7##3##(2009-8#2)(2012-2#3)(2013-8#2)
fear and##8##2##(2009-8#2)(2012-2#3)(2013-1#1)(2013-8#2)
fear conditioning##10##2##(1997-7#4)(2008-11#6)
fear in##5##2##(1993-1#1)(2008-11#2)(2010-9#2)
fear learning##2##2##(2008-11#2)
fear levels##3##2##(2012-2#3)
fear of cancer being detected##2##5##(1991-6#1)(1992-2#1)
fear of death##2##3##(1996-6#2)
fear of the unknown##2##4##(2011-2#2)
fear of##26##2##(1990-6#1)(1991-6#1)(1992-2#1)(1996-5#1)(1996-6#5)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#8)(2013-1#1)(2013-8#1)
fear reactions##2##2##(1994-2#2)
fear to##2##2##(1997-7#1)(2011-2#1)
fear##86##1##(1990-11#3)(1990-6#1)(1991-1#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#6)(1994-2#2)(1996-5#1)(1996-6#5)(1997-3#1)(1997-7#6)(2008-10#1)(2008-11#19)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#3)(2010-11#1)(2010-2#1)(2010-9#3)(2011-2#10)(2012-2#7)(2013-1#3)(2013-8#4)
fear-potentiation##2##1##(2008-11#2)
feared HIV##2##2##(1995-12#2)
feared##5##1##(1995-12#2)(1996-6#1)(2008-11#1)(2011-3#1)
fearful facial expressions##2##3##(2008-11#2)
fearful##6##1##(2008-11#4)(2009-9#2)
fears about##2##2##(2008-11#1)(2010-2#1)
fears and anxieties##4##3##(2011-2#4)
fears and##6##2##(1995-2#1)(2008-3#1)(2011-2#4)
fears that##2##2##(2008-10#2)
fears##26##1##(1992-8#1)(1993-1#1)(1995-1#1)(1995-2#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#7)
feasibility and safety of##5##4##(2008-10#2)(2012-12#1)(2013-1#1)(2013-8#1)
feasibility and##14##2##(1992-2#2)(1994-2#1)(2008-10#3)(2008-11#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
feasibility for a##2##3##(2010-10#1)(2011-2#1)
feasibility for##5##2##(2008-10#2)(2008-5#1)(2010-10#1)(2011-2#1)
feasibility of a##6##3##(1990-5#1)(1996-2#1)(2008-10#2)(2008-2#1)(2010-10#1)
feasibility of developing##4##3##(1994-3#1)(2008-10#1)(2009-7#2)
feasibility of employing##2##3##(2008-10#2)
feasibility of selective##2##3##(1995-11#1)(2011-2#1)
feasibility of the SI-MSFA##2##4##(2008-10#2)
feasibility of the##22##3##(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
feasibility of this method##3##4##(2007-11#1)(2008-10#2)
feasibility of this##5##3##(2007-11#1)(2008-10#4)
feasibility of using##12##3##(1994-11#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#1)
feasibility of##96##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-2#2)(1996-3#2)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#39)(2008-11#6)(2008-2#2)(2008-3#6)(2008-5#3)(2008-8#4)(2008-9#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#2)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
feasibility study and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
feasibility study of##3##3##(1990-12#1)(1994-6#1)(2013-1#1)
feasibility study on the##2##4##(2010-7#1)(2013-1#1)
feasibility study on##3##3##(2009-12#1)(2010-7#1)(2013-1#1)
feasibility study##12##2##(1990-12#1)(1994-6#1)(2008-10#2)(2009-12#1)(2010-10#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#2)
feasibility to##4##2##(2008-10#3)(2008-11#1)
feasibility##144##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-2#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#54)(2008-11#8)(2008-2#2)(2008-3#6)(2008-5#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#2)(2010-10#4)(2010-11#1)(2010-4#1)(2010-7#4)(2011-2#12)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
feasible and effective##3##3##(2008-11#1)(2013-1#1)(2013-8#1)
feasible and##13##2##(1992-2#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
feasible at##2##2##(1996-2#1)(2008-9#1)
feasible but##2##2##(1995-5#1)(2008-8#1)
feasible for##3##2##(1992-2#1)(1995-2#1)(2013-1#1)
feasible in##5##2##(1991-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)
feasible option##2##2##(2008-10#1)(2012-3#1)
feasible to##5##2##(1994-6#1)(2008-10#2)(2008-11#1)(2011-1#1)
feasible with##6##2##(1997-6#1)(2008-10#2)(2008-11#1)(2010-4#1)(2012-3#1)
feasible##94##1##(1991-2#2)(1991-8#1)(1992-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#9)(2008-12#2)(2008-3#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#4)
feasible?##2##1##(2008-10#1)(2011-2#1)
feather disease in##2##3##(2008-5#2)
feather disease##6##2##(1992-2#1)(2008-5#5)
feather quality##3##2##(2008-9#3)
feather##14##1##(1992-2#1)(2008-5#7)(2008-9#6)
feathers##3##1##(2008-5#2)(2008-9#1)
feathery mottle virus##4##3##(2008-10#4)
feathery mottle##7##2##(2008-10#7)
feature a##2##2##(2008-3#1)(2009-7#1)
feature and##2##2##(1996-1#1)(2008-12#1)
feature at##2##2##(1994-11#1)(2008-3#1)
feature can##2##2##(1991-12#1)(2008-11#1)
feature characteristic##2##2##(1995-12#1)(1997-8#1)
feature dimensions##2##2##(2008-10#1)(2009-5#1)
feature extraction##3##2##(2008-10#2)(2008-3#1)
feature in the##2##3##(1992-3#1)(2009-9#1)
feature in##9##2##(1991-5#1)(1992-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-9#2)(2010-1#1)
feature is##3##2##(2008-3#1)(2008-6#1)(2011-2#1)
feature not##2##2##(1994-3#1)(2008-8#1)
feature of cell##2##3##(2008-10#1)(2009-5#1)
feature of chronic##2##3##(2011-2#1)(2013-8#1)
feature of diabetes##2##3##(2008-10#1)(2011-2#1)
feature of the method is##2##5##(2008-10#2)
feature of the proposed##2##4##(2008-10#1)(2008-3#1)
feature of the##28##3##(1990-9#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
feature of these##6##3##(1991-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
feature of this##4##3##(2008-10#3)(2010-6#1)
feature of##94##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2008-10#18)(2008-11#9)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#6)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#4)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
feature on the##3##3##(1991-5#1)(1996-6#1)(2008-12#1)
feature results##2##2##(2008-10#1)(2009-6#1)
feature selection##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
feature sizes##2##2##(2008-10#1)(2008-7#1)
feature that##3##2##(2008-1#1)(2008-12#1)(2008-7#1)
feature was##2##2##(1996-6#1)(2008-10#1)
feature##190##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#3)(2008-1#1)(2008-10#33)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#9)(2008-7#7)(2008-8#5)(2008-9#7)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#4)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#4)
featured in##2##2##(1995-3#1)(2009-3#1)
featured##9##1##(1992-12#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-7#1)(2011-2#1)
features a##5##2##(2008-10#1)(2008-9#2)(2011-2#1)(2013-8#1)
features and functions##2##3##(2011-2#1)(2012-2#1)
features and management of##3##4##(2008-11#1)(2010-5#1)(2012-3#1)
features and the##6##3##(1991-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
features and tumor-associated lymphoid proliferation in##2##6##(2008-11#2)
features and##46##2##(1990-9#1)(1991-2#1)(1992-12#1)(1993-3#1)(1994-5#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
features are important##2##3##(1997-8#1)(2013-1#1)
features are presented##2##3##(2012-3#1)(2013-1#1)
features are similar to those##2##5##(1992-2#1)(2008-5#1)
features are##29##2##(1990-12#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-6#1)(1995-11#1)(1997-4#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
features as a##2##3##(2008-11#1)(2010-6#1)
features as##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
features associated with the##2##4##(2008-10#1)(2013-1#1)
features associated with##4##3##(2007-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
features by##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
features characteristic of##2##3##(1990-10#1)(2008-7#1)
features combined##2##2##(1996-12#1)(2008-10#1)
features described above##2##3##(1996-2#1)(2008-7#1)
features described##3##2##(1996-2#1)(2008-7#2)
features due to##2##3##(2008-10#1)(2009-11#1)
features for the##3##3##(2010-12#1)(2012-5#1)(2012-8#1)
features for##10##2##(1993-12#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-5#1)(2012-8#1)
features from##5##2##(1996-9#1)(2008-10#2)(2011-2#1)(2012-7#1)
features has been##2##3##(2008-4#1)(2010-10#1)
features have##6##2##(1990-6#1)(1997-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-5#1)
features in cancer##2##3##(2010-8#1)(2011-2#1)
features in the##8##3##(1991-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
features in##18##2##(1991-2#1)(1995-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
features include##4##2##(1991-1#1)(2008-1#1)(2008-10#1)(2009-12#1)
features is reported##2##3##(1990-6#1)(2008-12#1)
features made##2##2##(2008-10#1)(2012-3#1)
features not only##2##3##(1997-3#1)(2009-8#1)
features not##3##2##(1997-3#1)(2008-11#1)(2009-8#1)
features observed in##3##3##(2008-10#1)(2009-3#1)(2013-8#1)
features of Burkitt's lymphoma##2##4##(2008-1#2)
features of PfTrx-2##2##3##(2012-2#2)
features of a##10##3##(1990-11#1)(1991-6#1)(1993-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
features of acute##2##3##(2010-5#1)(2013-1#1)
features of each##2##3##(1996-12#1)(2012-2#1)
features of food##2##3##(1993-6#2)
features of human##3##3##(2010-9#1)(2012-2#1)(2013-8#1)
features of learned##2##3##(2008-8#2)
features of our##2##3##(1993-8#1)(2012-2#1)
features of patients##2##3##(2007-8#1)(2013-8#1)
features of primary##2##3##(2008-7#1)(2009-3#1)
features of the flow-through##2##4##(2008-10#2)
features of the most##2##4##(2008-5#1)(2012-2#1)
features of the##75##3##(1990-11#1)(1990-3#1)(1991-12#3)(1991-3#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#2)(1995-6#1)(1997-6#2)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2011-2#7)(2012-2#4)(2013-1#2)
features of their##2##3##(2009-5#1)(2009-8#1)
features of this organism##14##4##(2011-2#14)
features of this##25##3##(1991-6#1)(1993-1#1)(1994-2#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#15)(2013-8#1)
features of##274##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-3#2)(1991-6#2)(1991-8#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#2)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-11#2)(1995-6#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-8#4)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#8)(2008-10#35)(2008-11#11)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#35)(2012-2#19)(2012-3#9)(2012-9#1)(2013-1#13)(2013-8#4)
features on the##5##3##(1991-5#1)(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
features on##8##2##(1991-5#1)(2008-3#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
features or##2##2##(2008-8#1)(2012-3#1)
features resembling##2##2##(1994-12#1)(2008-5#1)
features responsible for##2##3##(1995-8#1)(2010-12#1)
features revealed##2##2##(1997-8#1)(2008-10#1)
features similar to##2##3##(2008-12#1)(2008-5#1)
features such as##15##3##(1992-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-3#1)
features suggest that##2##3##(1993-9#1)(2008-5#1)
features suggest##3##2##(1993-9#1)(2008-10#1)(2008-5#1)
features surrounding the translation initiation sites##2##6##(1996-8#2)
features surrounding the##3##3##(1996-8#2)(1997-2#1)
features that are##5##3##(1992-9#1)(1994-5#1)(2008-2#1)(2008-5#1)(2012-3#1)
features that distinguish##2##3##(2009-4#1)(2013-8#1)
features that make it##2##4##(1997-2#1)(2008-9#1)
features that make##4##3##(1996-11#1)(1997-2#1)(2008-9#1)(2011-2#1)
features that should be##2##4##(2010-8#1)(2011-2#1)
features that##28##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-9#1)(1993-2#1)(1994-5#1)(1996-11#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
features to##4##2##(1991-12#1)(2008-11#1)(2008-3#1)(2012-3#1)
features were##10##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2009-12#1)
features which##4##2##(1994-12#1)(1997-2#1)(2008-3#1)(2012-3#1)
features with a##2##3##(2008-10#1)(2009-10#1)
features with##10##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
features within##3##2##(1994-3#1)(2008-11#1)(2009-10#1)
features##709##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#6)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#3)(1992-4#2)(1992-9#4)(1993-1#2)(1993-12#2)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#3)(1995-11#4)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#2)(1997-8#9)(2007-11#1)(2007-12#8)(2007-8#2)(2008-1#13)(2008-10#98)(2008-11#41)(2008-12#16)(2008-2#6)(2008-3#26)(2008-4#7)(2008-5#20)(2008-6#14)(2008-7#27)(2008-8#14)(2008-9#13)(2009-1#2)(2009-10#10)(2009-11#4)(2009-12#7)(2009-3#4)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#5)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#14)(2010-9#3)(2011-1#7)(2011-10#1)(2011-2#69)(2012-12#4)(2012-2#28)(2012-3#25)(2012-5#3)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#28)(2013-8#12)
features)##2##1##(2010-8#1)(2011-2#1)
featuring##4##1##(1992-3#1)(2008-10#2)(2009-8#1)
febrile illness##2##2##(1997-8#1)(2012-3#1)
febrile infections##2##2##(2008-10#2)
febrile morbidity##5##2##(1994-2#1)(1995-1#1)(1995-12#2)(1996-1#1)
febrile neutropenia##2##2##(2008-7#2)
febrile urinary infections##2##3##(2008-10#2)
febrile##22##1##(1993-8#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-12#1)(1997-8#1)(2006-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2010-8#1)(2012-3#1)(2013-1#2)
fecal coliforms##2##2##(2008-10#2)
fecal excretion of##2##3##(1994-5#1)(2008-10#1)
fecal occult blood testing##2##4##(2009-12#1)(2010-8#1)
fecal occult blood##4##3##(1991-3#1)(1994-2#1)(2009-12#1)(2010-8#1)
fecal samples##3##2##(2012-12#2)(2012-3#1)
fecal##26##1##(1991-3#2)(1993-3#2)(1994-2#1)(1994-5#1)(1995-5#1)(1996-12#1)(2008-10#6)(2009-12#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#1)
feces and##3##2##(1996-12#1)(2008-10#1)(2013-1#1)
feces by##2##2##(1993-2#1)(2008-10#1)
feces in##3##2##(1991-3#1)(2008-12#2)
feces##23##1##(1990-6#1)(1991-3#2)(1993-2#4)(1996-12#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
feces]##2##1##(1993-6#1)(1995-12#1)
fecundity and##6##2##(2008-11#1)(2008-8#1)(2008-9#2)(2010-8#2)
fecundity of##3##2##(2010-8#2)(2012-3#1)
fecundity on##2##2##(2008-8#2)
fecundity or##2##2##(2008-11#1)(2008-8#1)
fecundity ranged from##2##3##(2008-12#2)
fecundity##34##1##(1991-3#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-8#9)(2008-9#9)(2010-8#7)(2012-3#2)
fed 0##2##2##(2008-10#1)(2008-7#1)
fed 7 days prior to##2##5##(1996-12#2)
fed a diet##4##3##(1991-12#1)(1995-11#1)(1995-2#1)(2013-1#1)
fed a high##2##3##(1997-5#1)(2011-2#1)
fed a##14##2##(1991-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-5#1)(2008-11#3)(2011-2#1)(2013-1#4)
fed ad##2##2##(2008-9#1)(2013-1#1)
fed and##4##2##(1990-6#1)(1994-8#2)(2008-7#1)
fed by##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
fed diet and carcinogens like Gr##2##6##(2008-10#2)
fed diet##3##2##(2008-10#3)
fed diets containing##2##3##(1995-8#1)(2008-5#1)
fed ethanol##3##2##(2008-11#3)
fed into the##2##3##(2008-10#1)(2008-11#1)
fed normal low protein##2##4##(2008-10#2)
fed on##11##2##(1997-8#2)(2008-10#7)(2008-7#1)(2013-1#1)
fed rats##9##2##(1992-12#1)(1993-8#2)(1994-8#3)(1997-2#1)(2008-11#1)(2013-1#1)
fed the##5##2##(1993-11#1)(1993-12#1)(2008-11#1)(2008-7#2)
fed to##3##2##(2008-11#1)(2008-12#1)(2008-6#1)
fed upon by##2##3##(1990-11#1)(2008-10#1)
fed with##11##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#6)(2012-2#1)
fed##128##1##(1990-11#1)(1990-3#1)(1990-6#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-8#2)(1994-11#2)(1994-5#3)(1994-8#8)(1995-11#1)(1995-2#1)(1995-8#2)(1996-12#4)(1997-2#1)(1997-5#2)(1997-8#2)(2008-10#22)(2008-11#18)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#12)(2008-8#4)(2008-9#2)(2010-4#1)(2011-2#8)(2012-2#2)(2013-1#11)
fed)##3##1##(2008-10#2)(2008-7#1)
fed-batch addition of fresh substrate##2##5##(2011-2#2)
fed-batch bioreactors##2##2##(2008-11#1)(2008-7#1)
fed-batch culture of##3##3##(2008-11#3)
fed-batch culture##10##2##(2008-11#8)(2008-7#2)
fed-batch cultures of a##2##4##(2008-11#2)
fed-batch cultures##7##2##(2008-11#7)
fed-batch mode##3##2##(2008-11#2)(2008-7#1)
fed-batch process##3##2##(2008-11#2)(2011-1#1)
fed-batch##44##1##(2008-11#25)(2008-7#11)(2011-1#1)(2011-2#5)(2013-1#2)
fedbatch fermentation##5##2##(2008-7#5)
fedbatch##6##1##(2008-7#6)
federal and state agencies##2##4##(1997-3#1)(2008-10#1)
federal and state##9##3##(1991-2#1)(1996-1#2)(1996-3#1)(1997-3#1)(2008-10#3)(2013-1#1)
federal government##9##2##(1991-1#1)(1992-1#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)
federal health care##2##3##(1991-2#1)(1993-12#1)
federal health policy##2##3##(1996-12#1)(1996-3#1)
federal health##6##2##(1991-2#1)(1993-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2009-5#1)
federal or state##2##3##(1995-2#1)(2013-1#1)
federal or##3##2##(1995-2#1)(2012-2#1)(2013-1#1)
federal regulations##4##2##(1995-2#2)(1996-3#1)(2008-10#1)
federal regulatory##2##2##(1996-1#1)(2010-9#1)
federal requirements##2##2##(1993-3#1)(1995-2#1)
federal##64##1##(1991-1#1)(1991-2#2)(1992-1#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-6#3)(1996-1#5)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#3)(2008-10#6)(2008-11#3)(2009-11#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-9#2)(2011-9#2)(2012-2#2)(2012-3#1)(2013-1#2)
federally funded research##2##3##(1995-2#2)
federally funded##5##2##(1995-2#3)(2008-6#1)(2013-1#1)
federally##7##1##(1995-2#4)(2008-12#1)(2008-6#1)(2013-1#1)
federally-funded##2##1##(1995-12#1)(1996-12#1)
fee for service system##2##4##(1997-5#1)(2013-8#1)
fee for service##3##3##(1993-3#1)(1997-5#1)(2013-8#1)
fee for##4##2##(1990-9#1)(1993-3#1)(1997-5#1)(2013-8#1)
fee reductions##4##2##(1994-1#1)(1994-12#3)
fee schedule##14##2##(1991-12#1)(1993-3#1)(1994-1#9)(1994-12#1)(1996-3#1)(2012-3#1)
fee schedules##3##2##(1993-3#3)
fee setting and rationing--it will outline a values clarification plan and finally will conclude by providing a framework for making moral decisions##2##22##(1994-1#2)
fee##34##1##(1990-9#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-3#5)(1994-1#13)(1994-12#4)(1995-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
fee-for-service (FFS) patients##2##3##(1995-3#1)(1996-2#1)
fee-for-service (FFS)##9##2##(1993-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-2#5)
fee-for-service sector##3##2##(1993-1#1)(1993-3#1)(1997-2#1)
fee-for-service##18##1##(1991-1#1)(1991-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-2#7)
feed additives##7##2##(2008-10#7)
feed and##9##2##(2008-10#8)(2011-2#1)
feed back##2##2##(2008-11#1)(2008-12#1)
feed concentration##3##2##(2008-7#3)
feed conversion ratio##2##3##(2008-12#1)(2008-5#1)
feed conversion##4##2##(2008-12#1)(2008-5#3)
feed cost##2##2##(2008-12#2)
feed flow##2##2##(2008-10#2)
feed for##3##2##(2008-7#1)(2010-11#2)
feed forward neural##2##3##(2008-10#1)(2010-8#1)
feed forward##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
feed intake##2##2##(2008-12#1)(2008-5#1)
feed on the##2##3##(2008-9#1)(2009-6#1)
feed on##5##2##(2008-10#2)(2008-9#1)(2009-6#1)(2011-2#1)
feed or##2##2##(2008-10#1)(2008-5#1)
feed rate##4##2##(1997-2#1)(2008-11#2)(2008-7#1)
feed rates##2##2##(2008-11#2)
feed samples##3##2##(2008-10#3)
feed solution##5##2##(2008-10#5)
feed to##2##2##(1995-11#1)(2008-10#1)
feed were##2##2##(2008-10#1)(2008-12#1)
feed##105##1##(1993-12#1)(1995-11#1)(1997-2#1)(2008-10#54)(2008-11#9)(2008-12#12)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#2)(2010-6#1)(2010-8#2)(2011-2#2)(2013-1#1)
feed)##2##1##(2008-10#2)
feed-forward##7##1##(2008-10#4)(2008-11#3)
feedback about##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
feedback after each trial##2##4##(2009-10#2)
feedback and the##2##3##(1991-12#1)(2008-12#1)
feedback and##8##2##(1991-12#1)(2008-11#3)(2008-12#1)(2008-2#1)(2009-10#1)(2010-10#1)
feedback between reduced plant cover and increased##2##7##(2008-8#2)
feedback between##3##2##(2008-7#1)(2008-8#2)
feedback control of##4##3##(2008-3#1)(2013-1#3)
feedback control##5##2##(2008-3#2)(2013-1#3)
feedback following##2##2##(2009-10#2)
feedback from the##4##3##(2008-11#1)(2008-6#1)(2013-1#2)
feedback from##11##2##(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#1)(2013-1#4)
feedback in##4##2##(1996-2#1)(2008-3#1)(2009-10#1)(2009-8#1)
feedback is##3##2##(1994-12#1)(2010-10#1)(2012-2#1)
feedback loop##7##2##(1991-5#2)(1991-7#1)(2009-8#3)(2012-2#1)
feedback loops##3##2##(2008-12#1)(2010-10#2)
feedback mechanism##7##2##(1994-12#1)(2008-10#1)(2010-10#4)(2011-2#1)
feedback mechanisms##2##2##(1996-2#1)(2008-2#1)
feedback of##3##2##(1996-12#1)(2012-2#2)
feedback on##6##2##(1995-1#1)(2008-11#1)(2008-2#1)(2009-7#1)(2009-8#1)(2013-1#1)
feedback regarding##3##2##(1996-1#1)(2007-12#1)(2012-12#1)
feedback regulation##3##2##(1990-8#1)(2010-7#1)(2012-2#1)
feedback system##3##2##(1996-12#1)(2008-10#2)
feedback to the##3##3##(2009-12#1)(2012-2#1)(2013-1#1)
feedback to##10##2##(1994-12#1)(1996-1#2)(2008-11#1)(2008-3#1)(2009-12#1)(2009-3#1)(2012-2#2)(2013-1#1)
feedback##147##1##(1990-3#1)(1990-8#1)(1991-12#2)(1991-5#2)(1991-7#1)(1991-9#1)(1994-12#3)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#3)(1996-12#3)(1996-2#3)(2007-12#1)(2008-10#6)(2008-11#15)(2008-12#3)(2008-2#4)(2008-3#17)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#10)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#8)(2010-10#11)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#11)(2013-1#14)(2013-8#3)
feedback-based flow##3##2##(2008-10#3)
feedback-based##6##1##(2008-10#6)
feedbacks##3##1##(2008-8#1)(2008-9#1)(2010-10#1)
feeder cells##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
feeder to##2##2##(1997-3#1)(1997-6#1)
feeder##16##1##(1992-12#2)(1993-3#1)(1997-3#3)(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-10#1)
feeder-free culture##2##2##(2008-11#1)(2012-5#1)
feeders and##2##2##(2008-7#2)
feeders in##3##2##(1992-12#2)(2008-7#1)
feeders##11##1##(1992-12#3)(1997-3#1)(1997-6#1)(2008-7#6)
feedforward loops##2##2##(2008-11#2)
feedforward neural networks trained by back-propagation##2##6##(2008-10#2)
feedforward##6##1##(2008-10#2)(2008-11#3)(2012-2#1)
feeding and the##2##3##(1991-12#1)(2008-8#1)
feeding and##11##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-8#1)(1996-2#1)(2008-12#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)
feeding aphids##2##2##(2009-8#2)
feeding apparatus##5##2##(2010-8#5)
feeding at##2##2##(2009-8#1)(2012-12#1)
feeding behavior##4##2##(1993-6#1)(1994-2#1)(2008-4#1)(2013-8#1)
feeding difficulties##4##2##(2010-9#4)
feeding frequency##3##2##(2008-11#3)
feeding habits##2##2##(2008-10#1)(2008-8#1)
feeding in the##5##3##(2008-10#1)(2010-8#1)(2012-2#3)
feeding in##10##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-2#5)
feeding is##4##2##(1991-6#1)(2008-11#1)(2010-6#1)(2012-2#1)
feeding itself and##2##3##(2008-9#2)
feeding may##2##2##(2012-12#2)
feeding medium##4##2##(2008-10#3)(2008-7#1)
feeding of the##2##3##(2009-8#1)(2011-2#1)
feeding of##10##2##(1992-9#1)(2008-10#1)(2008-11#4)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#1)
feeding on infected##2##3##(2008-10#2)
feeding on the##3##3##(2008-10#2)(2012-2#1)
feeding on##19##2##(1994-8#2)(2008-10#10)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#2)
feeding pedicles##2##2##(1996-9#1)(1997-3#1)
feeding periods##2##2##(2008-10#1)(2013-1#1)
feeding practices and behaviours##3##4##(2010-6#3)
feeding practices and##4##3##(2010-6#4)
feeding preferences##2##2##(2008-10#1)(2011-2#1)
feeding rates##3##2##(2008-9#3)
feeding regimes##2##2##(1996-12#1)(2008-10#1)
feeding sites of##2##3##(2008-10#2)
feeding sites##8##2##(2007-12#1)(2008-10#7)
feeding situation##4##2##(1990-12#4)
feeding strategy can##2##3##(2008-7#2)
feeding strategy##7##2##(2008-11#2)(2008-7#5)
feeding systems##2##2##(2010-4#2)
feeding tube##2##2##(1994-12#2)
feeding vessels##2##2##(1996-6#1)(2008-7#1)
feeding was##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
feeding with##2##2##(2010-5#1)(2011-2#1)
feeding##226##1##(1990-12#5)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-12#2)(1993-6#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1996-12#1)(1996-2#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#40)(2008-11#28)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#19)(2008-8#6)(2008-9#12)(2009-10#1)(2009-8#15)(2010-4#4)(2010-5#5)(2010-6#8)(2010-8#11)(2010-9#6)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#11)(2013-1#2)(2013-8#1)
feeding)##2##1##(2008-10#1)(2009-8#1)
feedlot##2##1##(2013-1#2)
feeds and##2##2##(2008-10#1)(2011-2#1)
feeds without prior sample treatment or destruction through direct application of the fibre-optic probe on the sample##2##17##(2008-10#2)
feeds##20##1##(2008-10#12)(2008-12#2)(2008-6#1)(2009-8#1)(2010-7#2)(2011-2#2)
feedstock for biodiesel production##2##4##(2009-3#2)
feedstock##4##1##(2009-3#3)(2011-1#1)
feedstocks##3##1##(2008-10#2)(2013-1#1)
feel more##2##2##(1993-11#1)(2010-8#1)
feel of the hair##2##4##(2008-5#2)
feel that##3##2##(1992-3#1)(2008-10#1)(2009-6#1)
feel the##2##2##(1992-3#1)(2012-3#1)
feel##22##1##(1992-1#1)(1992-3#4)(1993-11#1)(1996-1#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#4)(2009-6#1)(2010-8#1)(2012-3#1)(2013-8#1)
feeling in##2##2##(2008-11#2)
feeling of##5##2##(1990-11#1)(1994-1#1)(2008-1#1)(2008-11#1)(2013-8#1)
feeling##21##1##(1990-11#1)(1994-1#1)(1994-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#2)(2012-2#2)(2013-8#1)
feelings about physical activity##3##4##(2009-6#3)
feelings about##5##2##(1992-3#1)(1996-3#1)(2009-6#3)
feelings and##5##2##(2008-9#1)(2009-9#1)(2010-6#1)(2012-3#1)(2013-1#1)
feelings of anxiety##2##3##(1995-1#1)(2012-3#1)
feelings of loneliness##2##3##(2009-12#1)(2011-2#1)
feelings of##12##2##(1995-1#1)(2008-11#1)(2009-12#1)(2010-10#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
feelings##36##1##(1992-2#1)(1992-3#1)(1995-1#1)(1996-3#1)(1997-2#1)(2008-11#4)(2008-9#1)(2009-12#1)(2009-6#4)(2009-9#2)(2010-10#2)(2010-11#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
feels##4##1##(1991-6#1)(1996-5#1)(2008-5#1)(2013-1#1)
fees are##5##2##(1993-3#1)(1994-1#4)
fees for##5##2##(1993-3#1)(1994-1#1)(1996-3#1)(2008-11#2)
fees in##2##2##(1994-1#1)(1996-3#1)
fees to##2##2##(1994-1#2)
fees under##2##2##(1994-12#1)(1996-3#1)
fees##43##1##(1990-9#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#3)(1994-1#20)(1994-12#1)(1994-2#1)(1995-12#2)(1996-12#1)(1996-3#7)(2008-11#2)
feet at##2##2##(2010-3#2)
feet in##3##2##(2009-10#1)(2010-11#1)(2012-3#1)
feet##30##1##(1994-12#1)(1994-8#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-11#3)(2010-3#2)(2010-9#5)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#5)
feet)##5##1##(2009-5#1)(2010-3#1)(2011-2#3)
feline immunodeficiency virus##3##3##(1997-3#2)(2012-3#1)
feline leukemia virus##2##3##(2008-11#1)(2012-3#1)
feline model##2##2##(2008-4#2)
feline##12##1##(1997-3#2)(2008-11#4)(2008-4#2)(2012-3#2)(2013-8#2)
felis and##2##2##(2013-8#2)
fell below##2##2##(2007-12#1)(2011-2#1)
fell into one##2##3##(2008-10#1)(2008-5#1)
fell into the##2##3##(1996-3#1)(2013-8#1)
fell into two##2##3##(2008-5#1)(2008-8#1)
fell into##7##2##(1991-1#1)(1996-3#1)(2008-10#1)(2008-5#2)(2008-8#1)(2013-8#1)
fell on##2##2##(1996-9#1)(2013-8#1)
fell onto a##2##3##(2011-2#1)(2013-1#1)
fell onto##3##2##(2011-2#1)(2013-1#2)
fell to##4##2##(1990-9#1)(1993-3#1)(2008-10#1)(2008-11#1)
fell within the##3##3##(2008-10#3)
fell within##4##2##(1996-2#1)(2008-10#3)
fell##35##1##(1990-9#1)(1991-1#1)(1991-5#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#3)(2009-12#1)(2011-2#3)(2013-1#2)(2013-8#2)
felled##2##1##(2008-10#2)
fellow##7##1##(1991-2#1)(1996-1#1)(1996-8#1)(2008-4#1)(2011-2#2)(2013-7#1)
fellows##7##1##(1996-1#1)(1997-2#1)(1997-7#1)(2009-4#1)(2011-2#2)(2013-8#1)
fellowship##11##1##(1993-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(2008-10#1)(2010-5#1)(2011-2#3)(2012-12#1)
fellowships in##2##2##(1994-12#1)(2008-10#1)
fellowships##6##1##(1993-2#3)(1994-12#1)(1994-3#1)(2008-10#1)
felodipine##2##1##(2008-10#1)(2012-3#1)
felon##3##1##(2008-9#3)
felt by##2##2##(1992-3#1)(2008-11#1)
felt in##2##2##(2008-5#1)(2010-1#1)
felt more confident##2##3##(2008-11#1)(2013-7#1)
felt more##3##2##(2008-11#1)(2008-12#1)(2013-7#1)
felt that the##4##3##(1993-1#2)(1997-8#1)(2008-9#1)
felt that##14##2##(1991-3#1)(1993-1#2)(1993-2#1)(1994-3#1)(1997-1#1)(1997-8#1)(2008-9#2)(2009-4#2)(2010-11#1)(2013-1#2)
felt they had##2##3##(1995-1#1)(2008-1#1)
felt they##3##2##(1995-1#1)(2008-1#1)(2008-8#1)
felt to be##4##3##(1991-1#1)(2009-1#1)(2009-5#1)(2012-2#1)
felt to##5##2##(1991-1#1)(2008-7#1)(2009-1#1)(2009-5#1)(2012-2#1)
felt##48##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#2)(1993-2#1)(1994-3#2)(1995-1#1)(1997-1#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#1)
female CD rats##2##3##(2008-10#2)
female CHCs were##2##3##(2012-3#2)
female PGCs##3##2##(2008-11#3)
female Tg##19##2##(2008-9#19)
female Wistar rats##2##3##(1994-2#1)(2013-1#1)
female adolescents##2##2##(2008-11#1)(2012-2#1)
female and male cells##2##4##(1990-3#2)
female and male rats##3##4##(1990-11#1)(1992-8#1)(1994-2#1)
female and male##13##3##(1990-11#1)(1990-3#2)(1992-3#1)(1992-8#3)(1994-2#2)(2008-12#1)(2010-4#1)(2010-8#2)
female and##21##2##(1990-11#1)(1990-3#3)(1992-3#1)(1992-8#3)(1993-12#1)(1994-2#2)(1997-8#2)(2008-12#1)(2010-4#1)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
female biased##2##2##(1997-3#1)(2010-8#1)
female breast cancer##5##3##(1990-12#2)(1992-2#1)(1997-7#1)(2009-5#1)
female breast##10##2##(1990-11#1)(1990-12#3)(1991-2#1)(1992-2#1)(1992-3#1)(1997-7#1)(2008-3#1)(2009-5#1)
female buffalo meat##3##3##(2010-4#3)
female carriers##2##2##(2011-2#2)
female cells##3##2##(2008-12#1)(2008-4#2)
female child##4##2##(2008-10#2)(2010-1#1)(2010-3#1)
female choice##3##2##(2008-8#3)
female college students##2##3##(1992-12#1)(2008-12#1)
female diagnosed with##2##3##(2011-2#1)(2013-1#1)
female excess##2##2##(1991-6#1)(2008-7#1)
female fecundity##4##2##(2008-8#2)(2008-9#2)
female fitness##6##2##(2008-8#3)(2008-9#3)
female gender##2##2##(2011-2#1)(2013-1#1)
female genital tract##5##3##(1990-2#1)(1990-8#1)(1994-1#1)(2009-2#1)(2011-2#1)
female genital##8##2##(1990-2#1)(1990-5#1)(1990-8#1)(1994-1#1)(2007-12#1)(2009-2#1)(2011-2#1)(2012-3#1)
female group##2##2##(1990-11#1)(2011-1#1)
female hormone##2##2##(1991-6#1)(2008-10#1)
female imago of C##2##4##(2013-8#2)
female in the##3##3##(1993-2#1)(2008-7#1)(2011-2#1)
female in##4##2##(1993-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
female infant##2##2##(2008-10#1)(2012-3#1)
female is##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
female lower genital tract##2##4##(1992-3#1)(2011-2#1)
female managers##4##2##(2012-3#4)
female mate##2##2##(2008-8#1)(2008-9#1)
female mating decisions##2##3##(2008-8#2)
female meiotic##2##2##(2008-9#1)(2012-3#1)
female mice and##2##3##(2008-12#1)(2008-6#1)
female mice##6##2##(1995-11#1)(1995-12#1)(2008-12#1)(2008-6#1)(2008-9#2)
female migration##4##2##(2011-2#4)
female multiple mating can##2##4##(2008-8#2)
female multiple mating##5##3##(2008-8#5)
female of##2##2##(2008-10#1)(2008-12#1)
female offspring##2##2##(2008-10#2)
female p53 haploinsufficient mice were exposed to drinking water containing 0##3##11##(2008-9#3)
female p53 haploinsufficient mice were exposed to##4##7##(2008-9#4)
female p53 haploinsufficient mice were##5##5##(2008-9#5)
female p53 haploinsufficient mice##9##4##(2008-9#9)
female p53##10##2##(2008-9#10)
female parent##4##2##(2008-10#4)
female participants were##2##3##(2008-10#1)(2008-5#1)
female participants##3##2##(2008-10#1)(2008-5#1)(2009-4#1)
female patient was admitted to##2##5##(1993-6#2)
female patient was admitted##3##4##(1993-6#2)(2013-1#1)
female patient was##4##3##(1993-6#2)(2010-5#1)(2013-1#1)
female patient who had##2##4##(2008-12#1)(2013-8#1)
female patient who presented with##3##5##(2010-5#1)(2012-3#1)(2013-7#1)
female patient who##5##3##(2008-12#1)(2010-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
female patient with a##4##4##(2008-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
female patient with##16##3##(1991-8#1)(1992-12#1)(2008-1#1)(2008-11#1)(2008-12#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#4)
female patient##40##2##(1991-8#1)(1992-12#2)(1993-6#2)(1995-12#1)(1996-3#1)(2008-1#1)(2008-11#2)(2008-12#4)(2008-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
female patients with##3##3##(1996-8#1)(1997-8#1)(2008-11#1)
female patients##9##2##(1996-11#1)(1996-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-3#1)
female physicians who##2##3##(2011-2#2)
female physicians##5##2##(1993-6#1)(2011-2#4)
female plants##2##2##(2008-10#2)
female preference##3##2##(2008-8#3)
female preferences##2##2##(2008-8#2)
female presented with a##2##4##(1990-2#1)(2012-3#1)
female presented with##3##3##(1990-2#1)(2011-2#1)(2012-3#1)
female presented##4##2##(1990-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
female prostitute##2##2##(1996-5#1)(2008-5#1)
female rat##2##2##(1990-11#2)
female rats and##2##3##(1995-11#1)(1995-2#1)
female rats but only##2##4##(1994-2#2)
female rats were##2##3##(1995-12#1)(2008-11#1)
female rats##22##2##(1990-11#2)(1994-2#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#3)(2008-10#1)(2008-11#3)(2008-8#1)(2010-1#1)(2013-1#3)
female reproductive system##2##3##(2007-12#1)(2010-8#1)
female reproductive tracts##2##3##(2008-5#1)(2011-2#1)
female reproductive##7##2##(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
female sex##8##2##(1990-8#1)(1997-7#1)(2008-10#1)(2008-7#4)(2012-3#1)
female sexuals##4##2##(2008-8#4)
female sperm storage##2##3##(2007-12#1)(2008-6#1)
female students##2##2##(1990-2#1)(2012-2#1)
female subjects were##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
female subjects##6##2##(1994-12#1)(2008-10#1)(2008-5#2)(2012-3#1)(2013-1#1)
female three-spined sticklebacks##2##3##(2008-9#1)(2010-8#1)
female to male##2##3##(1997-7#1)(2012-3#1)
female to##3##2##(1997-7#1)(2008-8#1)(2012-3#1)
female volunteers##3##2##(2008-10#2)(2008-5#1)
female white New Zealand rabbits were anesthetized##2##7##(1992-3#2)
female white##3##2##(1992-3#2)(2010-5#1)
female who had##2##3##(1994-12#1)(2008-7#1)
female who presented with##5##4##(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#2)
female who##9##2##(1994-12#1)(2008-12#2)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#3)
female whole-body##3##2##(2013-8#3)
female with a##5##3##(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
female with##16##2##(1990-6#1)(1992-12#1)(1993-12#1)(1994-3#1)(1997-6#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
female##586##1##(1990-11#9)(1990-12#3)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#11)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-6#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#9)(1994-3#3)(1995-11#3)(1995-12#7)(1995-2#1)(1995-8#5)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-7#4)(1997-8#3)(2007-12#8)(2008-1#1)(2008-10#34)(2008-11#21)(2008-12#26)(2008-3#1)(2008-4#5)(2008-5#21)(2008-6#5)(2008-7#19)(2008-8#56)(2008-9#58)(2009-1#1)(2009-10#7)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#2)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#2)(2011-2#41)(2012-12#8)(2012-2#8)(2012-3#37)(2013-1#36)(2013-7#2)(2013-8#12)
female) were##2##2##(2008-12#1)(2010-1#1)
female)##12##1##(1997-8#1)(2008-10#1)(2008-12#2)(2008-8#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#3)
female- and##2##2##(1990-8#1)(2008-10#1)
female-biased##4##1##(1994-8#2)(2008-8#1)(2008-9#1)
female-search##5##1##(2008-6#5)
female/male##2##1##(2008-7#1)(2013-8#1)
females (5##2##2##(2008-7#1)(2012-2#1)
females (mean##2##2##(2007-12#1)(2008-1#1)
females after##2##2##(1993-8#1)(2008-10#1)
females aged##3##2##(1994-6#1)(1997-4#1)(2008-5#1)
females and I##2##3##(2012-3#2)
females and males in##2##4##(2008-5#1)(2013-8#1)
females and males##4##3##(2008-5#1)(2011-2#2)(2013-8#1)
females and##32##2##(1991-8#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-2#2)(1995-10#1)(1996-9#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#7)(2009-10#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
females are more##2##3##(2008-10#1)(2008-9#1)
females are##10##2##(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#3)(2010-7#1)(2012-3#2)
females at 26 weeks##3##4##(2008-9#3)
females at 27 weeks and in##2##6##(2008-9#2)
females at 27 weeks##4##4##(2008-9#4)
females at 43 weeks##4##4##(2008-9#4)
females at##14##2##(2008-9#13)(2010-7#1)
females but##2##2##(1994-2#1)(2008-8#1)
females by##2##2##(2009-8#1)(2012-3#1)
females can gain##3##3##(2008-8#3)
females can##5##2##(2008-8#3)(2008-9#1)(2012-2#1)
females carrying##2##2##(1993-6#1)(2008-9#1)
females during##3##2##(2008-8#1)(2012-2#2)
females exposed to dichloroacetic acid in the drinking water for##2##10##(2008-9#2)
females exposed to dichloroacetic acid##3##5##(2008-9#3)
females exposed to##5##3##(2008-9#5)
females exposed##7##2##(2008-9#7)
females for##2##2##(1991-6#1)(2008-8#1)
females from the##2##3##(2012-12#1)(2012-3#1)
females from##4##2##(1991-2#1)(2012-12#2)(2012-3#1)
females gain##2##2##(2008-8#2)
females had##4##2##(1991-12#1)(2008-9#2)(2013-1#1)
females having##3##2##(1997-7#1)(2011-2#2)
females in both studies##7##4##(2008-9#7)
females in both##8##3##(2008-9#7)(2013-8#1)
females in the##5##3##(2008-8#1)(2008-9#3)(2009-10#1)
females in##23##2##(1997-4#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#12)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
females may##4##2##(2008-8#4)
females of##6##2##(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
females reported##2##2##(2008-4#1)(2008-5#1)
females than in##3##3##(1994-2#1)(2008-11#1)(2010-4#1)
females than males##2##3##(2008-8#1)(2010-4#1)
females than##6##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#2)
females to##6##2##(2008-7#1)(2008-8#3)(2008-9#1)(2012-3#1)
females use##2##2##(2008-8#2)
females was##8##2##(1994-6#1)(1997-7#1)(2007-12#1)(2008-9#4)(2009-8#1)
females were less than those of the control groups##2##9##(2008-9#2)
females were less than those of the##4##7##(2008-9#4)
females were##21##2##(1991-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#8)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
females when##2##2##(2008-10#1)(2008-9#1)
females who##4##2##(1995-2#2)(1997-8#1)(2009-5#1)
females with a##3##3##(1995-10#1)(2008-11#1)(2012-2#1)
females with##10##2##(1991-5#1)(1995-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
females##410##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#8)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#4)(1994-3#1)(1994-6#9)(1995-10#2)(1995-2#3)(1995-6#2)(1995-8#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#3)(1997-8#2)(2007-12#8)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#12)(2008-12#8)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#16)(2008-8#64)(2008-9#95)(2009-1#1)(2009-10#5)(2009-5#1)(2009-6#1)(2009-8#4)(2010-11#1)(2010-3#1)(2010-4#5)(2010-7#4)(2010-8#4)(2011-2#17)(2012-12#6)(2012-2#8)(2012-3#23)(2013-1#8)(2013-7#1)(2013-8#7)
females) were##2##2##(1993-6#1)(2011-1#1)
females)##19##1##(1990-3#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#3)(2008-11#2)(2008-7#1)(2008-9#2)(2010-10#1)(2011-1#2)(2011-2#1)(2012-3#1)
feminine##7##1##(2008-9#1)(2009-10#3)(2012-3#2)(2013-1#1)
feminist##4##1##(1996-1#1)(2008-10#1)(2009-10#1)(2009-11#1)
feminization##4##1##(2008-8#3)(2008-9#1)
femme##5##1##(2008-12#2)(2013-1#3)
femoral access##3##2##(2011-2#3)
femoral approach##3##2##(1996-3#1)(2011-2#2)
femoral artery##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
femoral condylar##2##2##(1992-3#1)(2013-1#1)
femoral condyle##2##2##(2011-2#1)(2013-1#1)
femoral epiphysis##2##2##(2008-8#1)(2013-7#1)
femoral fracture##6##2##(2008-12#2)(2009-4#1)(2013-1#3)
femoral fractures##2##2##(2010-11#1)(2013-1#1)
femoral head##2##2##(1992-6#2)
femoral metaphyseal##2##2##(2013-1#2)
femoral metaphysis##2##2##(1991-11#1)(1993-8#1)
femoral nail##2##2##(2010-11#1)(2013-1#1)
femoral neck BMD##4##3##(2010-1#1)(2010-3#1)(2011-2#2)
femoral neck and##2##3##(2010-3#1)(2013-1#1)
femoral neck fractures##5##3##(1991-9#4)(2009-3#1)
femoral neck##18##2##(1991-11#1)(1991-9#4)(2009-3#4)(2010-1#1)(2010-3#3)(2011-2#4)(2013-1#1)
femoral shortening osteotomy fixed with interlocking intramedullary nail##2##8##(2013-1#2)
femoral shortening osteotomy fixed with interlocking##3##6##(2013-1#3)
femoral shortening osteotomy fixed with##4##5##(2013-1#4)
femoral vein##4##2##(2011-3#3)(2013-1#1)
femoral##86##1##(1991-11#2)(1991-9#4)(1992-3#1)(1992-6#2)(1993-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#4)(2009-4#4)(2010-1#1)(2010-11#2)(2010-3#3)(2011-2#18)(2011-3#3)(2012-3#2)(2013-1#28)(2013-7#1)
femoral-tibial contact##2##2##(2013-1#2)
femoris##13##1##(2008-12#5)(2010-4#5)(2011-2#3)
femtogram##3##1##(2008-10#3)
femtomolar##3##1##(2008-10#2)(2010-1#1)
femtomole##2##1##(2008-10#1)(2010-7#1)
femtosecond Ti##2##2##(2008-2#1)(2008-3#1)
femtosecond laser pulses##2##3##(2008-2#1)(2008-3#1)
femtosecond laser##7##2##(2007-11#2)(2008-2#1)(2008-3#3)(2010-1#1)
femtosecond optical parametric generator##2##4##(2007-12#1)(2008-2#1)
femtosecond optical parametric##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
femtosecond optical##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
femtosecond pulses##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
femtosecond##24##1##(2007-11#6)(2007-12#2)(2008-2#7)(2008-3#8)(2010-1#1)
femur and##2##2##(2008-12#1)(2008-7#1)
femur##19##1##(1991-11#3)(2008-12#2)(2008-7#1)(2009-3#1)(2009-4#1)(2011-2#3)(2012-3#2)(2013-1#6)
femurs of female##2##3##(2013-1#2)
femurs of##3##2##(2013-1#3)
femurs##4##1##(2013-1#4)
fenarimol##4##1##(2008-10#4)
fenbendazole##3##1##(2008-10#3)
fenbuconazole##4##1##(2008-10#4)
fence lizards##2##2##(2008-8#2)
fence##4##1##(2008-3#2)(2008-8#2)
fenestra ( approximately 1##2##4##(2008-9#2)
fenestrated A1 segment##3##3##(2013-8#3)
fenestrated A1##4##2##(2013-8#4)
fenestrated proximal##3##2##(2013-8#3)
fenestrated##12##1##(2008-5#1)(2010-12#2)(2013-8#9)
fenitrothion##2##1##(2008-10#1)(2012-12#1)
fens##2##1##(2008-8#2)
fentanyl##13##1##(1991-1#1)(1993-1#5)(1996-6#2)(2007-8#1)(2010-7#1)(2011-2#2)(2013-1#1)
feral##4##1##(2008-10#1)(2008-5#1)(2012-3#2)
ferbam in##4##2##(2008-10#4)
ferbam##10##1##(2008-10#10)
ferment##3##1##(1992-11#1)(2012-3#2)
fermentans##3##1##(2011-2#3)
fermentation broth##3##2##(2008-7#1)(2009-6#1)(2012-2#1)
fermentation by##3##2##(1990-5#1)(2008-7#1)(2012-2#1)
fermentation can be##2##3##(2008-11#1)(2008-7#1)
fermentation in a##2##3##(2008-7#1)(2012-3#1)
fermentation in##3##2##(2008-7#1)(2012-3#2)
fermentation inhibitors##2##2##(2011-1#2)
fermentation media##2##2##(2008-10#2)
fermentation of##7##2##(2008-7#3)(2008-8#1)(2011-2#3)
fermentation process##15##2##(2008-10#8)(2008-11#3)(2010-4#1)(2011-2#2)(2012-3#1)
fermentation processes##3##2##(2008-10#2)(2011-2#1)
fermentation rate##2##2##(2012-3#2)
fermentation samples##2##2##(2008-10#2)
fermentation traits##4##2##(2012-3#4)
fermentation using##4##2##(2008-6#1)(2008-7#2)(2011-2#1)
fermentation was##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
fermentation with##3##2##(2008-10#1)(2011-2#2)
fermentation##118##1##(1990-5#1)(2008-10#27)(2008-11#8)(2008-6#1)(2008-7#33)(2008-8#2)(2009-6#1)(2010-4#1)(2011-1#5)(2011-2#13)(2012-2#4)(2012-3#19)(2013-1#3)
fermentations with##3##2##(2008-10#1)(2008-7#2)
fermentations##14##1##(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#4)(2012-3#1)(2013-1#1)
fermentative quality##2##2##(2013-1#2)
fermentative##8##1##(2008-11#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#2)
fermented milk##5##2##(1991-3#1)(2008-11#3)(2013-1#1)
fermented products##2##2##(2009-11#2)
fermented sausages of Basilicata region##2##5##(2010-4#2)
fermented sausages##3##2##(2010-4#3)
fermented with Lactobacillus delbrueckii ssp##2##5##(2008-11#2)
fermented##16##1##(1991-3#1)(1997-1#1)(2008-11#5)(2008-8#1)(2009-11#3)(2010-4#3)(2011-1#1)(2013-1#1)
fermenters##4##1##(2008-10#1)(2008-11#1)(2008-7#2)
fermenting##6##1##(2008-10#3)(2012-3#3)
fermentor##4##1##(2008-10#1)(2008-9#2)(2012-2#1)
fermentors##2##1##(2008-11#1)(2011-2#1)
fermion##2##1##(1990-12#1)(1991-9#1)
fern##4##1##(1994-9#1)(2008-10#2)(2008-8#1)
ferredoxin reductase-like protein##2##3##(1997-7#2)
ferredoxin##8##1##(1991-5#2)(1994-5#3)(1997-7#2)(2008-11#1)
ferredoxins##3##1##(1994-5#3)
ferret##6##1##(2008-6#5)(2010-4#1)
ferric anguibactin transport##3##3##(2011-2#3)
ferric anguibactin##4##2##(2011-2#4)
ferric reducing ability##2##3##(2008-11#2)
ferric##20##1##(1993-8#2)(1997-7#1)(2008-10#7)(2008-11#3)(2008-5#1)(2011-2#6)
ferricyanide and##3##2##(2008-10#3)
ferricyanide as##2##2##(2008-10#2)
ferricyanide by##2##2##(1994-3#1)(2008-10#1)
ferricyanide was##2##2##(2008-10#2)
ferricyanide##25##1##(1994-3#1)(2008-10#23)(2009-9#1)
ferriprotoporphyrin IX##3##2##(1993-8#3)
ferriprotoporphyrin##4##1##(1993-8#3)(1994-8#1)
ferritin H mRNA##2##3##(1990-5#1)(1994-11#1)
ferritin H##6##2##(1990-5#4)(1994-11#2)
ferritin aggregation##3##2##(2013-8#3)
ferritin and haptoglobin##2##3##(1996-12#2)
ferritin and##4##2##(1996-12#2)(2008-1#2)
ferritin in human serum##2##4##(2008-10#2)
ferritin in the##2##3##(1993-11#1)(2008-7#1)
ferritin in##5##2##(1993-11#1)(2008-10#3)(2008-7#1)
ferritin levels##2##2##(1993-11#1)(2009-8#1)
ferritin##40##1##(1990-5#7)(1993-11#4)(1994-11#3)(1996-12#2)(1996-2#3)(2008-1#2)(2008-10#6)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#9)
ferrocene##5##1##(2008-10#4)(2012-12#1)
ferrocenyl##2##1##(2008-10#1)(2009-9#1)
ferrocyanide##9##1##(2008-10#9)
ferrocytochrome c##4##2##(1994-5#4)
ferroelectric domains##2##2##(2008-2#2)
ferroelectric##3##1##(2008-2#2)(2008-3#1)
ferromagnetic##3##1##(1992-11#1)(1992-3#1)(2012-2#1)
ferrooxidans##3##1##(2008-8#3)
ferrous sulfate##2##2##(2008-11#2)
ferrous##14##1##(1990-8#1)(1992-8#2)(1993-8#1)(2008-10#6)(2008-11#3)(2008-5#1)
ferrozine##6##1##(2008-10#6)
fertile women##3##2##(1990-2#1)(2011-1#2)
fertile##22##1##(1990-2#2)(2008-10#6)(2008-12#4)(2008-5#2)(2008-8#3)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
fertilisation##4##1##(1990-6#1)(1991-3#1)(1996-8#1)(2011-10#1)
fertilisers##3##1##(2008-10#3)
fertility amendments##2##2##(2008-10#2)
fertility and##4##2##(1994-3#2)(1997-1#1)(2008-9#1)
fertility decisions##2##2##(2011-2#2)
fertility disorders##2##2##(1991-11#2)
fertility in the##2##3##(1997-1#1)(2012-2#1)
fertility in##8##2##(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-2#1)
fertility rate in##2##3##(2009-10#1)(2012-3#1)
fertility rate##3##2##(2008-8#1)(2009-10#1)(2012-3#1)
fertility##78##1##(1990-2#1)(1991-11#2)(1991-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-1#3)(1997-6#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-8#6)(2008-9#10)(2009-10#13)(2009-12#3)(2010-7#1)(2011-2#5)(2012-2#5)(2012-3#5)(2013-1#1)
fertilization and##4##2##(1994-11#1)(1996-9#1)(2008-8#2)
fertilization in##2##2##(1994-9#1)(2008-10#1)
fertilization is##2##2##(2008-10#1)(2009-12#1)
fertilization of##2##2##(1995-6#1)(2013-1#1)
fertilization success##3##2##(2008-8#3)
fertilization with##2##2##(2008-11#1)(2012-3#1)
fertilization##64##1##(1993-1#1)(1994-11#2)(1994-5#2)(1994-9#2)(1995-6#1)(1996-9#4)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#6)(2008-6#1)(2008-8#12)(2008-9#5)(2009-12#4)(2009-8#1)(2010-8#2)(2012-3#2)(2013-1#6)
fertilize##3##1##(2008-8#2)(2010-7#1)
fertilized eggs of##2##3##(2008-11#1)(2010-5#1)
fertilized eggs##6##2##(1993-3#1)(2008-11#2)(2010-5#2)(2010-8#1)
fertilized##10##1##(1993-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-5#2)(2010-8#1)
fertilizer application##2##2##(1996-12#1)(2008-12#1)
fertilizer in##2##2##(2008-10#1)(2008-12#1)
fertilizer samples##2##2##(2008-10#2)
fertilizer to##2##2##(2008-10#1)(2008-12#1)
fertilizer##26##1##(1996-12#2)(2008-10#16)(2008-12#7)(2013-8#1)
fertilizers and##2##2##(2008-10#1)(2009-8#1)
fertilizers##8##1##(2008-10#6)(2008-12#1)(2009-8#1)
fertilizes##2##1##(1995-2#1)(2008-9#1)
ferulic acid and##5##3##(1994-5#1)(2008-10#1)(2011-1#2)(2013-8#1)
ferulic acid##27##2##(1994-5#9)(2008-10#12)(2008-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
ferulic##29##1##(1994-5#10)(2008-10#13)(2008-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
feruloyl##2##1##(2011-1#1)(2013-1#1)
fervor##2##1##(1992-11#2)
fescue and##3##2##(2008-10#2)(2008-8#1)
fescue##19##1##(2008-10#17)(2008-8#2)
festival##5##1##(2008-11#1)(2009-10#4)
festucae##2##1##(2008-8#2)
fetal alcohol spectrum disorders##2##4##(2008-11#2)
fetal alcohol##4##2##(2008-11#4)
fetal and neonatal##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
fetal and##6##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
fetal anomalies##4##2##(2008-11#4)
fetal astrocytes##2##2##(1992-6#2)
fetal bladder outflow obstruction##2##4##(2008-10#2)
fetal blood sampling and##2##4##(1996-3#2)
fetal blood sampling##5##3##(1990-9#1)(1996-3#3)(2008-4#1)
fetal bovine serum (FBS)##6##4##(1995-3#1)(2008-11#5)
fetal bovine serum##11##3##(1990-6#1)(1995-12#1)(1995-3#1)(2008-11#8)
fetal brain##5##2##(1995-6#1)(1996-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
fetal calf serum##7##3##(1992-6#2)(1995-2#1)(2008-11#3)(2008-7#1)
fetal calf##8##2##(1992-6#2)(1992-8#1)(1995-2#1)(2008-11#3)(2008-7#1)
fetal care##2##2##(2008-11#2)
fetal cell##2##2##(2012-3#2)
fetal cells##5##2##(2008-4#1)(2012-3#4)
fetal death##4##2##(1992-5#1)(2008-7#1)(2013-1#2)
fetal demise##4##2##(2008-11#1)(2009-1#1)(2010-8#1)(2012-3#1)
fetal development##2##2##(2008-10#1)(2008-9#1)
fetal growth and##3##3##(1993-3#1)(1995-12#1)(2008-11#1)
fetal growth##6##2##(1993-3#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#1)
fetal heart rate##2##3##(1994-3#2)
fetal kidney##2##2##(1994-11#1)(2008-10#1)
fetal life##4##2##(1993-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
fetal liver and##2##3##(2008-9#1)(2013-1#1)
fetal liver##10##2##(1990-5#1)(1997-7#2)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2013-1#1)
fetal lung##5##2##(1993-3#1)(1995-12#1)(1995-8#3)
fetal membranes##2##2##(1995-2#1)(2012-3#1)
fetal mice##2##2##(2008-10#1)(2008-7#1)
fetal neural##2##2##(1994-8#1)(2009-10#1)
fetal or##2##2##(1994-2#1)(1995-11#1)
fetal rat##2##2##(1994-11#1)(1995-8#1)
fetal##176##1##(1990-11#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-6#2)(1992-12#1)(1992-5#2)(1992-6#5)(1992-8#1)(1993-12#1)(1993-3#3)(1994-11#2)(1994-2#1)(1994-3#9)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#4)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2008-1#1)(2008-10#16)(2008-11#34)(2008-4#3)(2008-7#7)(2008-8#3)(2008-9#5)(2009-1#2)(2009-10#3)(2010-11#5)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#13)(2013-1#14)
fetoprotein##5##1##(1990-9#1)(1991-8#2)(2008-10#1)(2013-7#1)
fetus and##3##2##(1995-11#1)(2008-7#1)(2010-11#1)
fetus in##2##2##(2010-8#1)(2013-1#1)
fetus##24##1##(1990-5#1)(1990-9#2)(1993-12#1)(1995-11#1)(1996-11#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-7#2)(2010-11#4)(2010-8#2)(2012-2#1)(2012-3#3)(2013-1#3)
fetuses were##2##2##(1993-12#1)(1996-3#1)
fetuses with##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
fetuses##21##1##(1991-6#1)(1993-12#7)(1995-11#2)(1996-3#1)(2008-11#3)(2008-7#2)(2010-11#1)(2011-2#1)(2012-3#3)
fever and##9##2##(1992-2#1)(1996-11#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
fever for##2##2##(2009-4#1)(2011-2#1)
fever group##2##2##(1995-12#2)
fever in children##2##3##(2008-10#1)(2008-11#1)
fever in##9##2##(1994-12#1)(1994-3#3)(1996-12#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
fever of##2##2##(2008-1#1)(2011-2#1)
fever with##4##2##(1992-9#1)(2006-5#1)(2008-7#1)(2010-12#1)
fever##106##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-9#2)(1993-2#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-9#2)(1995-10#1)(1995-12#3)(1995-9#1)(1996-11#2)(1996-12#6)(1997-4#1)(1997-5#1)(2006-5#4)(2007-12#6)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#3)(2009-11#4)(2009-4#1)(2009-6#1)(2010-1#4)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#2)(2013-8#6)
fever)##2##1##(1996-8#1)(2013-1#1)
fever-like##2##1##(1994-2#2)
fever]##2##1##(1994-3#1)(1997-4#1)
feverfew extracts##4##2##(2008-10#4)
feverfew##9##1##(2008-10#9)
feverish##2##1##(1990-9#1)(2008-5#1)
fevers##6##1##(1990-10#1)(1990-2#1)(1996-3#1)(2007-12#1)(2009-10#1)(2013-8#1)
few additional##2##2##(2008-10#2)
few and##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
few are##2##2##(1996-1#1)(2008-10#1)
few as##6##2##(2008-10#3)(2008-9#1)(2012-12#1)(2013-8#1)
few cases have been reported in##3##6##(1997-8#2)(2013-1#1)
few cases have been reported##6##5##(1991-8#1)(1997-8#2)(2012-12#1)(2013-1#2)
few cases have been##7##4##(1991-8#1)(1997-8#2)(2012-12#1)(2013-1#3)
few cases of##6##3##(1994-3#1)(1996-11#1)(2008-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
few cases##24##2##(1991-11#1)(1991-8#1)(1994-3#1)(1996-11#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#5)
few cells##5##2##(1991-10#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
few changes##2##2##(2008-10#1)(2009-10#1)
few complications##3##2##(1990-11#1)(2009-3#1)(2010-7#1)
few data on##2##3##(1992-3#1)(1996-2#1)
few data##4##2##(1992-3#1)(1996-2#1)(2010-12#1)(2012-3#1)
few days after##2##3##(1997-5#1)(2011-2#1)
few days##10##2##(1991-4#1)(1995-2#1)(1996-6#1)(1997-5#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
few decades##15##2##(1995-1#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
few differences in the##2##4##(2008-10#1)(2008-8#1)
few differences in##3##3##(2008-10#2)(2008-8#1)
few documented cases##2##3##(1996-5#1)(2013-1#1)
few eggs##3##2##(1991-5#1)(2008-9#2)
few examples of##5##3##(2008-10#2)(2008-9#2)(2011-2#1)
few examples##6##2##(2008-10#3)(2008-9#2)(2011-2#1)
few exceptions##6##2##(2008-10#3)(2008-7#1)(2011-1#1)(2012-3#1)
few genes##2##2##(2008-10#1)(2009-10#1)
few have been##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
few have##5##2##(2008-10#1)(2008-12#2)(2008-9#1)(2012-3#1)
few hours after the##2##4##(1990-9#1)(2008-6#1)
few hours after##6##3##(1990-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-12#1)
few hours to##2##3##(2008-10#1)(2008-12#1)
few hours##15##2##(1990-9#1)(1994-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
few hundred##3##2##(2008-11#2)(2008-3#1)
few if any##2##3##(2008-10#1)(2011-3#1)
few in the period##2##4##(1990-6#2)
few individuals##2##2##(1997-2#1)(2008-10#1)
few infants##2##2##(1994-6#1)(2012-2#1)
few isolates##2##2##(2008-10#1)(2010-4#1)
few key##2##2##(1993-12#2)
few large##3##2##(1994-3#1)(2008-5#1)(2008-8#1)
few methods exist for##2##4##(2008-9#1)(2010-6#1)
few methods##4##2##(2008-4#1)(2008-9#1)(2010-6#1)(2012-3#1)
few microliters##2##2##(2008-10#2)
few minutes##7##2##(1996-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-7#1)
few models##2##2##(2008-11#1)(2008-8#1)
few months##3##2##(1996-9#1)(2009-9#1)(2012-2#1)
few number of##2##3##(2008-10#1)(2008-12#1)
few of the##2##3##(1991-12#1)(1995-3#1)
few of them##2##3##(1997-8#1)(2011-2#1)
few of these##4##3##(1990-2#1)(1993-12#1)(1995-6#1)(2008-8#1)
few of##11##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-12#1)(1995-3#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-8#2)(2011-2#1)
few or no##3##3##(2008-10#1)(2008-9#1)(2010-5#1)
few or##5##2##(2008-10#1)(2008-11#1)(2008-9#2)(2010-5#1)
few papers##2##2##(1997-8#1)(2008-11#1)
few patients with##2##3##(1997-3#1)(2008-7#1)
few patients##6##2##(1992-3#1)(1994-1#1)(1997-3#1)(1997-5#1)(2008-7#1)(2013-1#1)
few physicians##2##2##(1990-2#1)(2008-12#1)
few published##2##2##(1991-5#1)(2008-11#1)
few recent studies##2##3##(2008-10#2)
few recent##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
few reports about##2##3##(2008-10#1)(2011-2#1)
few reports have##2##3##(2008-10#1)(2011-2#1)
few reports in the literature##2##5##(2008-9#1)(2009-3#1)
few reports of##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
few reports##14##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#3)(2012-12#1)(2012-3#1)
few side effects##2##3##(2011-3#1)(2012-12#1)
few spores##2##2##(2008-10#2)
few studies have examined the##2##5##(2008-7#1)(2013-8#1)
few studies have examined##3##4##(2008-7#1)(2008-9#1)(2013-8#1)
few studies have##10##3##(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
few studies that##3##3##(2008-11#1)(2009-6#1)(2011-2#1)
few studies##22##2##(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#4)(2013-1#4)(2013-8#1)
few such##3##2##(2008-8#1)(2010-6#2)
few symptoms##2##2##(2008-10#1)(2013-1#1)
few weeks##6##2##(1996-11#1)(1996-5#1)(2008-10#3)(2009-7#1)
few years of life##2##4##(1996-9#1)(2008-12#1)
few years of##3##3##(1996-9#1)(2008-12#1)(2008-9#1)
few years##47##2##(1990-11#2)(1991-3#2)(1991-6#1)(1992-9#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-9#3)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)
few##538##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#2)(1992-9#2)(1993-12#3)(1993-2#2)(1993-6#3)(1994-1#3)(1994-12#4)(1994-2#1)(1994-3#3)(1994-6#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#5)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#135)(2008-11#33)(2008-12#13)(2008-2#1)(2008-3#9)(2008-4#7)(2008-5#13)(2008-6#2)(2008-7#16)(2008-8#14)(2008-9#21)(2009-10#5)(2009-12#2)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#5)(2010-12#3)(2010-4#3)(2010-5#2)(2010-6#8)(2010-7#7)(2010-8#4)(2011-1#1)(2011-2#27)(2011-3#2)(2012-12#10)(2012-2#12)(2012-3#9)(2012-4#1)(2012-5#1)(2013-1#26)(2013-8#5)
few&quot##2##1##(1994-1#1)(2013-8#1)
few-mode fibers##2##2##(2007-11#2)
few-tillering##4##1##(2008-9#4)
fewer admissions##2##2##(1991-3#1)(2011-1#1)
fewer and##2##2##(2008-10#1)(2009-8#1)
fewer categories and##2##3##(1993-12#1)(2008-7#1)
fewer complications##5##2##(1990-11#1)(1995-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
fewer in number##2##3##(1991-12#1)(2008-10#1)
fewer in##3##2##(1991-12#1)(2008-10#1)(2008-6#1)
fewer lesions##2##2##(2008-10#2)
fewer problems##2##2##(1990-12#1)(2009-11#1)
fewer resources##4##2##(1991-12#1)(1997-2#1)(2008-11#2)
fewer side effects##4##3##(2008-9#1)(2009-12#2)(2011-2#1)
fewer side##5##2##(1996-5#1)(2008-9#1)(2009-12#2)(2011-2#1)
fewer studies##2##2##(2011-2#1)(2012-3#1)
fewer symptom-days##2##2##(2013-1#2)
fewer than 100##2##3##(2008-10#1)(2008-11#1)
fewer than##9##2##(1992-9#1)(1993-9#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)(2011-2#1)
fewer treatment##2##2##(1991-3#1)(1996-11#1)
fewer##140##1##(1990-11#1)(1990-12#1)(1991-12#2)(1991-3#4)(1992-2#2)(1992-3#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#3)(1995-3#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-5#1)(2008-1#2)(2008-10#39)(2008-11#9)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#5)(2009-11#3)(2009-12#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
fg cell(-1) for##2##3##(2008-10#2)
fg of##8##2##(2008-10#8)
fg##17##1##(2008-10#17)
fiber (100##2##2##(2008-10#2)
fiber Bragg grating as##2##4##(2008-2#1)(2008-3#1)
fiber Bragg grating##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
fiber Bragg gratings##3##3##(2008-3#2)(2013-8#1)
fiber Bragg##9##2##(2007-12#1)(2008-2#1)(2008-3#6)(2013-8#1)
fiber Raman amplifiers##3##3##(2007-11#3)
fiber amplifier (EDFA)##2##3##(2008-10#1)(2008-2#1)
fiber amplifier##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
fiber amplifiers##3##2##(2008-2#1)(2008-3#2)
fiber and an##2##3##(2008-3#2)
fiber and##12##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#3)(2009-6#1)(2011-2#2)
fiber are##4##2##(1994-2#1)(2008-3#3)
fiber as##2##2##(2008-10#1)(2008-3#1)
fiber at##2##2##(1995-2#1)(2008-10#1)
fiber bragg gratings##2##3##(2008-3#2)
fiber bundle##4##2##(1991-2#1)(2008-3#1)(2008-7#2)
fiber cells##5##2##(2008-10#4)(2008-9#1)
fiber coated with##2##3##(2008-2#1)(2009-8#1)
fiber coatings##5##2##(2008-10#5)
fiber content##2##2##(1991-12#2)
fiber coupled light emitting diode##2##5##(2008-10#2)
fiber coupling##3##2##(2008-2#1)(2008-3#2)
fiber cylindrical microelectrode-based detector##2##4##(2008-10#2)
fiber development##2##2##(2008-8#1)(2008-9#1)
fiber diameter##2##2##(2007-12#2)
fiber end##3##2##(2008-2#1)(2008-3#2)
fiber filters##5##2##(2008-10#4)(2008-11#1)
fiber for##5##2##(1995-2#1)(2008-10#4)
fiber grating##4##2##(2007-12#2)(2008-3#2)
fiber gratings##5##2##(2007-12#3)(2008-3#1)(2013-8#1)
fiber has been##2##3##(2008-10#2)
fiber in##2##2##(2008-10#2)
fiber initiation and##2##3##(2008-8#2)
fiber into##2##2##(2008-10#1)(2008-3#1)
fiber is##5##2##(2007-12#1)(2008-10#3)(2008-2#1)
fiber laser cavity##2##3##(2008-3#2)
fiber laser had a##2##4##(2008-2#2)
fiber laser with a##2##4##(2008-3#2)
fiber laser with##3##3##(2008-2#1)(2008-3#2)
fiber laser##17##2##(1997-6#1)(2008-2#5)(2008-3#11)
fiber loading##2##2##(2009-7#2)
fiber optic probe##2##3##(2008-10#2)
fiber optic sensor##10##3##(2008-10#10)
fiber optic sensors##2##3##(2008-10#2)
fiber optic surface plasmon resonance##2##5##(2008-10#2)
fiber optic system##2##3##(2008-10#2)
fiber optic##26##2##(2008-10#25)(2010-6#1)
fiber plexus##3##2##(1992-3#3)
fiber probe##2##2##(2007-12#2)
fiber ring##5##2##(2008-2#2)(2008-3#3)
fiber systems##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
fiber technology##2##2##(2008-10#1)(2008-11#1)
fiber tip##4##2##(1992-1#1)(1995-2#1)(2008-3#2)
fiber was placed##2##3##(2008-10#1)(2008-3#1)
fiber was used to##2##4##(2008-10#2)
fiber was used##3##3##(1992-1#1)(2008-10#2)
fiber was##14##2##(1992-1#2)(2008-10#11)(2008-3#1)
fiber were##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
fiber with##4##2##(2008-10#1)(2008-3#2)(2013-1#1)
fiber##389##1##(1991-1#1)(1991-10#1)(1991-12#7)(1991-2#1)(1992-1#4)(1992-12#1)(1992-3#3)(1993-11#6)(1994-2#2)(1995-2#3)(1996-12#2)(1997-6#1)(2007-11#13)(2007-12#17)(2008-10#147)(2008-11#18)(2008-2#23)(2008-3#83)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#4)(2010-10#1)(2010-4#5)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#7)(2012-3#6)(2012-5#1)(2013-1#3)(2013-8#2)
fiber) and##2##2##(2008-10#2)
fiber)##3##1##(2008-10#3)
fiber-based##3##1##(2008-10#2)(2008-3#1)
fiber-ceramic matrix composite material model##2##5##(2009-7#2)
fiber-coupled##6##1##(2007-12#1)(2008-3#5)
fiber-in-tube liquid phase microextraction##2##4##(2008-10#2)
fiber-optic DNA biosensor##3##3##(2008-9#3)
fiber-optic DNA biosensors##2##3##(2008-9#2)
fiber-optic DNA##5##2##(2008-9#5)
fiber-optic beam delivery##2##3##(2008-3#2)
fiber-optic immunosensor##2##2##(2008-10#2)
fiber-optic probe##2##2##(2008-10#2)
fiber-optic sensor##2##2##(2007-11#1)(2008-10#1)
fiber-optic##24##1##(2007-11#2)(2007-12#2)(2008-10#10)(2008-2#1)(2008-3#4)(2008-9#5)
fiber-optic-based surface plasmon resonance##2##4##(2008-10#2)
fiber-to-fiber##2##1##(2008-10#2)
fiberoptic##6##1##(1991-2#2)(1991-3#2)(1993-12#1)(1994-12#1)
fibers and##12##2##(1991-12#1)(1992-3#1)(2008-10#3)(2008-3#3)(2008-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
fibers are presented##2##3##(2008-10#1)(2008-3#1)
fibers are##12##2##(1991-1#1)(1991-12#1)(1992-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
fibers at##2##2##(2008-5#1)(2013-8#1)
fibers by using##3##3##(2008-2#1)(2008-3#2)
fibers by##6##2##(1991-2#2)(2008-2#1)(2008-3#3)
fibers can be observed##2##4##(1990-5#1)(2007-12#1)
fibers can be##4##3##(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
fibers for##6##2##(1991-1#1)(2008-10#3)(2008-2#1)(2008-3#1)
fibers from the##2##3##(1991-12#1)(1996-12#1)
fibers from##6##2##(1991-12#3)(1995-2#1)(1996-12#1)(2008-10#1)
fibers in the##7##3##(1990-3#1)(1990-5#1)(1992-12#1)(1992-6#1)(1996-12#1)(1997-4#1)(2012-2#1)
fibers in##11##2##(1990-3#1)(1990-5#1)(1991-12#3)(1992-12#1)(1992-6#1)(1996-12#2)(1997-4#1)(2012-2#1)
fibers is##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
fibers of the##2##3##(1990-5#1)(1997-3#1)
fibers of##6##2##(1990-5#2)(1996-12#1)(1997-3#1)(2007-11#1)(2008-9#1)
fibers on##3##2##(1991-12#1)(2008-2#1)(2008-3#1)
fibers that##3##2##(1991-1#1)(2008-3#1)(2008-9#1)
fibers to##5##2##(1995-12#1)(1997-4#1)(2007-11#1)(2008-3#2)
fibers was##3##2##(1992-3#1)(2008-2#1)(2008-5#1)
fibers were seen in##3##4##(1991-12#3)
fibers were##22##2##(1990-5#2)(1991-12#5)(1992-12#1)(1994-11#1)(1997-3#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#2)
fibers with##11##2##(1990-3#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#3)(2008-5#1)(2011-2#1)
fibers##237##1##(1990-3#2)(1990-5#7)(1991-1#3)(1991-12#25)(1991-2#3)(1991-3#1)(1991-9#1)(1992-12#7)(1992-3#5)(1992-6#5)(1994-11#2)(1995-12#2)(1995-2#6)(1995-6#1)(1996-12#7)(1997-3#6)(1997-4#2)(2007-11#8)(2007-12#9)(2008-10#34)(2008-11#3)(2008-2#8)(2008-3#33)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#7)(2009-7#13)(2009-8#1)(2010-1#5)(2010-12#2)(2010-4#2)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#2)
fibers&quot##2##1##(1991-12#2)
fibre diameter and##3##3##(2009-7#2)(2010-4#1)
fibre optic##3##2##(2008-10#3)
fibre orientation##2##2##(2009-7#2)
fibre type##5##2##(2008-10#1)(2011-2#4)
fibre types##4##2##(2008-10#1)(2011-2#3)
fibre##67##1##(1992-6#1)(1995-12#1)(2008-10#32)(2008-11#2)(2008-3#1)(2008-5#5)(2008-7#1)(2009-7#10)(2009-9#1)(2010-4#2)(2010-6#1)(2011-2#8)(2013-1#2)
fibre-optic probe for the##2##4##(2008-10#2)
fibre-optic probe##6##2##(2008-10#6)
fibre-optic##7##1##(2008-10#7)
fibreboard##3##1##(2008-10#3)
fibres and##2##2##(2008-5#1)(2012-3#1)
fibres are##2##2##(2008-10#1)(2008-7#1)
fibres in##2##2##(1996-2#2)
fibres of##2##2##(1991-3#1)(2009-7#1)
fibres was##2##2##(1996-2#1)(1997-3#1)
fibres were affected most##2##4##(2011-2#2)
fibres were##6##2##(1997-3#1)(1997-4#1)(2008-10#1)(2011-2#3)
fibres##42##1##(1991-3#1)(1994-9#1)(1996-2#4)(1997-3#6)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#5)(2009-7#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
fibril##3##1##(1994-5#1)(2011-2#1)(2012-2#1)
fibrillar layer##2##2##(2008-5#2)
fibrillar material##2##2##(2008-10#2)
fibrillar##13##1##(1997-7#1)(2007-12#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#2)(2010-4#2)
fibrillary##7##1##(1990-7#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-7#2)(2009-1#1)
fibrillation (AF)##3##2##(2010-12#1)(2012-12#1)(2012-3#1)
fibrillation and##4##2##(2007-7#1)(2008-12#1)(2010-6#1)(2012-12#1)
fibrillation in##3##2##(1993-3#1)(2012-3#1)(2013-8#1)
fibrillation induced by##2##3##(1996-3#1)(2011-2#1)
fibrillation##39##1##(1992-6#1)(1993-3#1)(1994-8#1)(1996-3#3)(1997-7#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-3#2)(2008-7#3)(2009-10#1)(2009-12#2)(2009-9#1)(2010-1#2)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
fibrillin-1 gene##2##2##(1997-8#2)
fibrillin-1##3##1##(1997-8#2)(2012-2#1)
fibrillogenesis##2##1##(1996-2#2)
fibrils of the##2##3##(2008-5#2)
fibrils of##3##2##(2008-11#1)(2008-5#2)
fibrils##23##1##(1992-6#4)(1994-5#1)(2008-1#1)(2008-11#1)(2008-5#6)(2008-7#8)(2011-2#1)(2012-2#1)
fibrin clot##2##2##(1994-5#1)(1995-6#1)
fibrin deposition##2##2##(1994-3#2)
fibrin glue##2##2##(1992-3#1)(1992-5#1)
fibrin plate##2##2##(1994-5#1)(2010-3#1)
fibrin sealant##2##2##(1992-3#1)(2009-6#1)
fibrin##23##1##(1992-3#2)(1992-5#1)(1994-3#2)(1994-5#5)(1995-3#1)(1995-6#2)(2008-11#4)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
fibrinogen and##3##2##(2006-6#1)(2008-10#1)(2008-5#1)
fibrinogen binding##3##2##(1995-2#1)(2006-6#2)
fibrinogen concentration##2##2##(2008-10#2)
fibrinogen measurement is##2##3##(2008-10#2)
fibrinogen measurement##6##2##(2008-10#6)
fibrinogen receptor##9##2##(1993-8#5)(2006-6#4)
fibrinogen standard and##2##3##(2008-10#2)
fibrinogen standard##4##2##(2008-10#4)
fibrinogen##61##1##(1990-2#1)(1993-3#1)(1993-8#5)(1994-5#2)(1995-2#7)(2006-6#14)(2008-10#27)(2008-5#1)(2008-7#2)(2011-2#1)
fibrinogen-based collagen fleece##2##3##(2013-8#2)
fibrinogen-based collagen##3##2##(2013-8#3)
fibrinolysis##11##1##(1994-5#1)(1995-8#1)(1996-6#2)(1997-6#1)(2008-4#1)(2008-7#2)(2010-3#2)(2013-1#1)
fibrinolytic activity was##2##3##(2010-3#2)
fibrinolytic activity##7##2##(1994-5#3)(2010-3#4)
fibrinolytic enzyme component A##2##4##(2008-9#2)
fibrinolytic enzyme##3##2##(2008-9#3)
fibrinolytic##22##1##(1993-2#1)(1994-3#1)(1994-5#7)(1997-1#3)(2008-9#3)(2010-3#4)(2013-1#1)(2013-8#2)
fibro-osseous##2##1##(2011-2#1)(2013-1#1)
fibroadenoma##2##1##(1992-2#1)(2008-10#1)
fibroadenomas##4##1##(1992-9#1)(1994-12#2)(1995-11#1)
fibroblast and keratinocyte cells##2##4##(2012-3#2)
fibroblast and##5##2##(1995-3#2)(2008-5#1)(2012-3#2)
fibroblast cell line##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
fibroblast cell lines##2##3##(2008-12#1)(2011-2#1)
fibroblast cell##10##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
fibroblast cells on##2##3##(2008-11#2)
fibroblast cells were##2##3##(2008-9#1)(2013-1#1)
fibroblast cells##9##2##(1995-11#1)(2008-11#5)(2008-12#1)(2008-9#1)(2013-1#1)
fibroblast growth factor (aFGF)##2##4##(1990-8#1)(1997-7#1)
fibroblast growth factor (bFGF)##5##4##(1992-3#1)(1994-11#1)(1995-12#2)(2008-11#1)
fibroblast growth factor##31##3##(1990-8#2)(1991-12#1)(1992-3#2)(1993-6#2)(1994-11#2)(1994-12#1)(1995-11#2)(1995-12#7)(1997-7#2)(2008-11#7)(2009-8#1)(2010-6#1)(2013-8#1)
fibroblast growth##36##2##(1990-8#2)(1991-12#1)(1992-3#2)(1993-6#2)(1994-11#2)(1994-12#1)(1995-11#2)(1995-12#8)(1995-3#1)(1997-1#1)(1997-7#2)(2008-11#8)(2009-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
fibroblast proliferation##4##2##(1995-3#1)(2008-5#1)(2010-3#2)
fibroblast##81##1##(1990-5#1)(1990-8#3)(1991-12#1)(1992-3#2)(1993-3#1)(1993-6#3)(1994-11#2)(1994-12#1)(1995-11#4)(1995-12#8)(1995-3#4)(1995-6#1)(1996-12#1)(1997-1#2)(1997-7#2)(2008-10#1)(2008-11#14)(2008-12#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#4)(2009-8#1)(2010-3#3)(2010-6#1)(2011-2#1)(2012-3#3)(2013-1#7)(2013-8#1)
fibroblast-like cells##3##2##(2008-11#2)(2008-9#1)
fibroblast-like##10##1##(2008-11#6)(2008-9#2)(2013-8#2)
fibroblastic##3##1##(2008-5#1)(2012-2#1)(2013-1#1)
fibroblasts (MEFs)##2##2##(2008-2#1)(2011-2#1)
fibroblasts (line FLK)##2##3##(1995-8#1)(2008-11#1)
fibroblasts and the##4##3##(1992-8#1)(2008-5#3)
fibroblasts and##19##2##(1991-12#1)(1991-5#1)(1992-8#2)(1993-6#1)(1993-8#2)(1995-12#1)(1995-3#1)(2008-11#1)(2008-5#5)(2008-8#1)(2011-2#1)(2013-1#2)
fibroblasts are##3##2##(1990-3#1)(1992-8#1)(2009-4#1)
fibroblasts as##3##2##(1995-2#1)(1995-8#1)(1997-7#1)
fibroblasts by##7##2##(1990-8#1)(1992-9#1)(1994-12#1)(1995-12#1)(2008-11#2)(2008-12#1)
fibroblasts constitutively##2##2##(1995-6#2)
fibroblasts exposed to##2##3##(2012-2#1)(2013-1#1)
fibroblasts from##9##2##(1990-2#1)(1990-8#1)(1991-7#1)(1993-3#1)(1994-11#2)(1995-11#1)(1995-8#1)(1997-7#1)
fibroblasts in##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
fibroblasts is##2##2##(1991-6#1)(1995-8#1)
fibroblasts to##3##2##(1995-8#1)(2012-2#1)(2012-3#1)
fibroblasts treated with##3##3##(2008-10#1)(2008-9#2)
fibroblasts were treated with##2##4##(2008-5#1)(2012-2#1)
fibroblasts were##8##2##(1995-8#1)(2008-5#3)(2008-7#1)(2012-2#1)(2013-1#2)
fibroblasts with##6##2##(1990-5#1)(1994-5#1)(1995-3#1)(1995-6#1)(2008-11#1)(2013-1#1)
fibroblasts without##2##2##(1990-2#1)(1997-7#1)
fibroblasts##195##1##(1990-2#5)(1990-3#3)(1990-5#6)(1990-6#2)(1990-8#2)(1991-12#2)(1991-5#3)(1991-6#2)(1991-7#1)(1992-8#9)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#4)(1994-11#7)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#6)(1995-3#4)(1995-6#5)(1995-8#10)(1996-12#1)(1997-1#4)(1997-3#1)(1997-7#9)(2007-11#2)(2008-10#2)(2008-11#12)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#22)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#5)(2013-1#16)(2013-8#3)
fibrocartilage##3##1##(2008-9#1)(2009-7#2)
fibroid##3##1##(2011-1#1)(2013-8#2)
fibroids##7##1##(1993-12#3)(1994-2#3)(2011-1#1)
fibroin##4##1##(2008-11#2)(2008-9#1)(2012-2#1)
fibroma##11##1##(1994-2#1)(2007-12#2)(2009-1#2)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
fibromas##3##1##(1997-3#1)(2010-12#1)(2011-2#1)
fibromatosis##8##1##(1994-5#2)(1997-7#3)(2011-2#3)
fibromuscular##2##1##(1991-8#1)(2008-7#1)
fibromyalgia syndrome##3##2##(1997-8#1)(2009-11#1)(2010-12#1)
fibromyalgia##11##1##(1994-1#1)(1997-8#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-1#1)
fibronectin (FN)##4##2##(1990-8#1)(1994-11#1)(2012-2#1)(2012-5#1)
fibronectin and##4##2##(2008-11#3)(2008-7#1)
fibronectin in##3##2##(2008-7#2)(2012-2#1)
fibronectin or matrigel##2##3##(2008-11#2)
fibronectin or##4##2##(2008-11#4)
fibronectin protein##2##2##(2011-2#2)
fibronectin values and##2##3##(2008-7#2)
fibronectin was##2##2##(2008-7#1)(2010-1#1)
fibronectin##42##1##(1990-5#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-8#3)(1994-11#1)(1995-2#1)(2008-11#15)(2008-7#7)(2010-1#1)(2011-2#5)(2012-2#2)(2012-5#1)
fibronectin-##2##1##(2008-11#2)
fibronectin-coated dishes was about##2##4##(2008-11#2)
fibronectin-coated dishes##3##2##(2008-11#3)
fibronectin-degrading##2##1##(1994-5#2)
fibrosarcoma cell line##2##3##(1994-11#1)(2008-11#1)
fibrosarcoma##8##1##(1991-8#1)(1994-11#1)(2008-11#3)(2011-2#1)(2012-2#1)(2012-3#1)
fibrosis (CF)##4##2##(1997-1#2)(2011-3#2)
fibrosis (n =##2##3##(1994-3#2)
fibrosis and##17##2##(1991-12#2)(1993-11#1)(1994-5#1)(2008-10#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
fibrosis as##2##2##(2013-1#2)
fibrosis from##2##2##(2012-2#1)(2013-1#1)
fibrosis in##6##2##(1997-8#1)(2008-5#1)(2010-12#1)(2013-1#2)(2013-8#1)
fibrosis is##4##2##(1991-12#2)(2010-5#1)(2013-8#1)
fibrosis of the##3##3##(2008-5#1)(2008-9#1)(2009-7#1)
fibrosis##100##1##(1990-4#1)(1991-12#9)(1991-2#4)(1991-8#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1997-1#3)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-12#2)(2010-5#3)(2011-2#9)(2011-3#7)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#11)
fibrositis##2##1##(1991-6#1)(1993-11#1)
fibrostenotic Crohn's disease##4##3##(2010-12#4)
fibrostenotic##6##1##(2010-12#6)
fibrosus##4##1##(2009-1#1)(2009-3#1)(2012-2#2)
fibrotic##4##1##(2008-1#1)(2008-5#1)(2011-2#1)(2012-12#1)
fibrous and##2##2##(2008-12#1)(2011-2#1)
fibrous bands##2##2##(2008-8#1)(2011-2#1)
fibrous dysplasia with aneurysmal bone cyst##2##6##(2013-1#2)
fibrous dysplasia##5##2##(2010-12#1)(2013-1#4)
fibrous histiocytoma##2##2##(2008-11#1)(2010-12#1)
fibrous matrix##7##2##(2008-11#7)
fibrous network##2##2##(2008-7#2)
fibrous roots##2##2##(2008-10#2)
fibrous stroma##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
fibrous tissue##4##2##(1997-5#1)(2008-10#1)(2008-9#1)(2010-5#1)
fibrous tremolite##3##2##(1991-12#3)
fibrous##55##1##(1991-12#3)(1997-5#1)(2008-10#4)(2008-11#14)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#4)(2010-5#1)(2011-2#6)(2012-12#1)(2013-1#8)
fibula##2##1##(2009-1#1)(2012-2#1)
fibular (peroneal) nerve##2##3##(2012-3#2)
fibular nerve##3##2##(1997-8#1)(2012-3#2)
fibular##7##1##(1997-8#1)(2009-1#1)(2010-6#1)(2012-3#4)
fiction##3##1##(1990-2#1)(2009-11#1)(2010-5#1)
fictitious##2##1##(1991-1#1)(1996-5#1)
fideistic##3##1##(2013-1#3)
fidelity during##2##2##(2012-2#1)(2013-1#1)
fidelity of##5##2##(2008-10#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
fidelity##17##1##(1995-6#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-1#1)(2010-4#2)(2010-7#2)(2012-2#1)(2012-3#1)(2013-1#3)
field (0##2##2##(2009-11#2)
field after##3##2##(2008-10#2)(2008-11#1)
field analysis##5##2##(2008-10#1)(2009-3#2)(2010-12#1)(2011-2#1)
field and greenhouse experiments##2##4##(2008-10#1)(2008-8#1)
field and greenhouse##6##3##(2008-10#5)(2008-8#1)
field and growth-chamber##2##3##(2008-10#2)
field and the##4##3##(1994-1#1)(2008-5#1)(2012-12#1)(2013-1#1)
field and##40##2##(1992-9#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#20)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#1)
field applied##2##2##(1990-8#1)(2008-3#1)
field are##5##2##(1992-3#1)(1996-2#1)(2008-11#1)(2011-1#1)(2013-1#1)
field as a##3##3##(1996-2#1)(2008-10#1)(2009-10#1)
field as well as##2##4##(2008-10#1)(2008-11#1)
field as##7##2##(1996-2#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-7#1)
field at##3##2##(2008-10#3)
field by##4##2##(1995-12#1)(2008-10#1)(2008-3#2)
field conditions and##2##3##(2008-10#1)(2008-5#1)
field conditions at##4##3##(2008-10#4)
field conditions in##3##3##(2008-10#3)
field conditions##37##2##(2008-10#32)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#2)
field data##9##2##(2008-10#6)(2008-8#2)(2008-9#1)
field distribution##6##2##(2007-12#2)(2008-3#4)
field distributions##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
field effect on##2##3##(2008-10#2)
field effect transistor (ISFET)##2##4##(2008-10#2)
field effect transistor##7##3##(2008-10#7)
field effect##10##2##(2008-10#10)
field effects##2##2##(2008-10#2)
field emission scanning##2##3##(2008-7#1)(2011-2#1)
field environment##4##2##(2008-10#3)(2008-3#1)
field environments##2##2##(2008-10#2)
field experience##2##2##(1996-1#1)(2008-1#1)
field experiences##2##2##(1996-1#2)
field experiment##22##2##(2008-10#16)(2008-12#1)(2008-3#1)(2008-8#4)
field experiments conducted in##2##4##(2008-10#2)
field experiments conducted##5##3##(2008-10#5)
field experiments from##3##3##(2008-10#3)
field experiments in##3##3##(2008-10#2)(2008-9#1)
field experiments that##2##3##(2008-9#2)
field experiments were conducted in##2##5##(2008-10#2)
field experiments were conducted to study the##3##7##(2008-10#3)
field experiments were conducted to##4##5##(2008-10#4)
field experiments were conducted##7##4##(2008-10#6)(2008-12#1)
field experiments##50##2##(2008-10#38)(2008-12#3)(2008-3#1)(2008-8#4)(2008-9#4)
field exposure##2##2##(1992-3#1)(1992-4#1)
field flow preconcentration system##2##4##(2008-10#2)
field for##11##2##(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#2)
field formulation##2##2##(2008-2#2)
field from##3##2##(2008-10#2)(2008-8#1)
field galls##2##2##(2008-10#2)
field gel electrophoresis (PFGE)##2##4##(1992-6#1)(2008-10#1)
field gel electrophoresis##6##3##(1992-6#1)(1995-8#1)(2008-10#3)(2012-3#1)
field have##3##2##(2008-11#1)(2009-10#1)(2011-2#1)
field in a##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
field in the##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
field in##21##2##(2007-12#2)(2008-10#11)(2008-3#3)(2008-8#2)(2011-2#2)(2012-2#1)
field induced##2##2##(1997-6#1)(2008-8#1)
field is critical##2##3##(2008-10#2)
field is presented##3##3##(1997-7#1)(2008-11#1)(2008-8#1)
field is##19##2##(1990-11#1)(1992-9#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)
field isolate##3##2##(2008-10#3)
field isolates of##3##3##(2008-10#2)(2008-12#1)
field isolates were##2##3##(2008-10#2)
field isolates##14##2##(1996-12#1)(2008-10#12)(2008-12#1)
field level##2##2##(2008-10#1)(2011-10#1)
field locations##6##2##(2008-10#5)(2008-11#1)
field measurements##3##2##(2008-10#2)(2008-2#1)
field method for##2##3##(2008-10#2)
field method##5##2##(2008-10#4)(2013-1#1)
field monitoring##3##2##(2008-10#3)
field observations##4##2##(2008-10#2)(2008-8#2)
field of biocatalysis##2##3##(2008-7#1)(2011-1#1)
field of flow##2##3##(2008-10#2)
field of research##3##3##(1994-9#1)(2008-5#1)(2008-7#1)
field of science##3##3##(2008-11#1)(2009-3#1)(2011-2#1)
field of selenium##2##3##(2008-10#1)(2010-11#1)
field of social##2##3##(2008-11#1)(2010-10#1)
field of study##4##3##(1997-2#1)(1997-7#1)(2008-11#1)(2010-10#1)
field of the##7##3##(1997-3#2)(2008-10#1)(2008-3#2)(2009-5#1)(2013-8#1)
field of view and##2##4##(2007-12#1)(2008-3#1)
field of view##11##3##(2007-12#1)(2008-2#2)(2008-3#4)(2008-6#3)(2010-12#1)
field of##164##2##(1990-3#1)(1991-1#2)(1991-6#1)(1991-8#1)(1992-1#3)(1992-3#2)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-9#3)(1995-1#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#25)(2008-11#9)(2008-12#7)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-10#3)(2010-11#2)(2010-12#5)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#6)(2013-1#1)(2013-8#9)
field on the##3##3##(2008-10#2)(2008-8#1)
field on##7##2##(2008-10#5)(2008-8#2)
field or plot-level disease##2##4##(2008-10#2)
field or##6##2##(2008-10#5)(2008-5#1)
field performance of##2##3##(2008-10#2)
field performance##3##2##(2008-10#3)
field plants##2##2##(2008-10#2)
field plot in##2##3##(2008-10#2)
field plot##5##2##(2008-10#5)
field plots in##5##3##(2008-10#5)
field plots were inoculated with##2##5##(2008-10#2)
field plots##19##2##(2008-10#19)
field population##4##2##(2008-10#4)
field populations of the##2##4##(2008-10#1)(2008-9#1)
field populations of##9##3##(2008-10#8)(2008-9#1)
field populations was##2##3##(2008-10#2)
field populations were##2##3##(2008-10#2)
field populations##22##2##(2008-10#20)(2008-8#1)(2008-9#1)
field portable##3##2##(2008-10#3)
field potential##2##2##(1990-5#1)(1995-12#1)
field potentials##4##2##(2008-11#2)(2008-7#2)
field resistance in##4##3##(2008-10#4)
field resistance to##2##3##(2008-10#2)
field resistance##14##2##(2008-10#14)
field resistant isolates##2##3##(2008-10#2)
field resistant##3##2##(2008-10#3)
field results##4##2##(2008-10#4)
field samples by##2##3##(2008-10#1)(2012-12#1)
field samples##11##2##(2008-10#10)(2012-12#1)
field season##2##2##(2008-10#2)
field seasons##2##2##(2008-10#2)
field setting##2##2##(2008-10#1)(2011-2#1)
field sites in##2##3##(2008-10#2)
field sites##9##2##(2008-10#8)(2013-8#1)
field soil samples##2##3##(2008-10#2)
field soil that was##2##4##(2008-10#2)
field soil was##2##3##(2008-10#2)
field soil with##2##3##(2008-10#2)
field soil##20##2##(2008-10#20)
field soils##4##2##(2008-10#4)
field speciation of##2##3##(2008-10#2)
field stimulation##2##2##(1990-5#1)(1997-4#1)
field strength of##3##3##(2008-10#3)
field strength##8##2##(1992-3#1)(2008-10#6)(2010-9#1)
field stress##2##2##(2008-3#2)
field structures##2##2##(2008-3#1)(2012-2#1)
field studies##13##2##(2008-10#12)(2013-8#1)
field study##12##2##(2008-10#8)(2008-12#1)(2008-9#1)(2009-9#1)(2010-1#1)
field surrounding##2##2##(2008-3#1)(2009-7#1)
field surveys##2##2##(1992-11#1)(2008-10#1)
field technique##2##2##(2008-10#1)(2009-2#1)
field test##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
field testing##3##2##(1993-3#1)(2008-10#2)
field tests##4##2##(2008-10#3)(2011-8#1)
field that is##2##3##(2008-2#1)(2008-3#1)
field that##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
field the##2##2##(2008-10#1)(2008-2#1)
field through##2##2##(1997-7#1)(2008-10#1)
field to##12##2##(1995-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
field trial##8##2##(1990-6#1)(1996-12#1)(2008-10#5)(2010-10#1)
field trials conducted in##3##4##(2008-10#3)
field trials in##4##3##(1993-3#1)(2008-10#3)
field trials planted##2##3##(2008-10#2)
field trials##31##2##(1993-3#1)(2008-10#28)(2008-12#1)(2010-10#1)
field use##2##2##(1997-7#1)(2013-1#1)
field using##2##2##(1995-8#1)(2010-6#1)
field was##10##2##(2007-12#1)(2008-10#5)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)
field were##8##2##(1994-12#1)(2008-10#5)(2008-5#1)(2013-1#1)
field when##2##2##(2008-10#1)(2009-10#1)
field which##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
field with a##2##3##(1995-12#1)(2008-10#1)
field with##10##2##(1995-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)
field work##2##2##(1994-3#1)(2008-11#1)
field##1249##1##(1990-11#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#4)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#2)(1994-1#3)(1994-12#5)(1994-2#3)(1994-3#6)(1994-9#3)(1995-1#3)(1995-12#5)(1995-3#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-12#3)(1996-2#13)(1996-6#2)(1997-2#3)(1997-3#6)(1997-4#2)(1997-6#4)(1997-7#4)(1997-8#2)(2007-11#2)(2007-12#13)(2008-1#1)(2008-10#660)(2008-11#35)(2008-12#22)(2008-2#16)(2008-3#52)(2008-4#4)(2008-5#16)(2008-6#7)(2008-7#16)(2008-8#42)(2008-9#36)(2009-10#8)(2009-11#5)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#9)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#10)(2010-8#6)(2010-9#3)(2011-1#6)(2011-10#2)(2011-2#40)(2011-3#1)(2011-7#2)(2011-8#1)(2012-12#8)(2012-2#19)(2012-3#5)(2012-8#2)(2013-1#11)(2013-8#16)
field)##3##1##(1996-12#1)(2008-10#1)(2008-12#1)
field-based##4##1##(2008-1#1)(2008-10#2)(2010-8#1)
field-collected##5##1##(2008-10#5)
field-effect transistor##3##2##(1995-8#1)(2008-10#1)(2009-5#1)
field-effect transistors (ISFETs)##2##3##(2008-10#2)
field-effect transistors##7##2##(2008-10#7)
field-effect##11##1##(1995-8#1)(2008-10#8)(2009-5#2)
field-emission scanning electron microscopy##2##4##(2008-10#2)
field-flow fractionation##9##2##(2008-10#7)(2011-2#2)
field-grown potato crops##2##3##(2008-10#2)
field-grown##10##1##(2008-10#10)
field-test kits##2##2##(2008-10#2)
field-test##3##1##(1995-2#1)(2008-10#2)
field-tested##4##1##(1992-3#1)(1993-1#1)(2008-10#1)(2012-3#1)
fields and a##3##3##(1991-12#1)(2007-12#1)(2008-12#1)
fields and was##2##3##(2008-10#2)
fields and##19##2##(1991-12#1)(1992-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-3#1)(2010-8#1)(2011-2#2)
fields are##10##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#1)
fields as##6##2##(2008-10#3)(2008-11#1)(2011-3#1)(2012-2#1)
fields at##4##2##(2008-10#4)
fields between##2##2##(2008-10#1)(2008-2#1)
fields but##2##2##(2008-10#2)
fields by##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
fields cropped##2##2##(2008-10#2)
fields during##3##2##(1992-3#1)(2008-10#2)
fields for##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
fields from##3##2##(2008-10#3)
fields have been##2##3##(2008-10#1)(2008-7#1)
fields in California##2##3##(2008-10#2)
fields in Illinois##3##3##(2008-10#3)
fields in Iowa##2##3##(2008-10#2)
fields in Minnesota##3##3##(2008-10#3)
fields in New York##2##4##(2008-10#2)
fields in North##3##3##(2008-10#3)
fields in Ohio##3##3##(2008-10#3)
fields in all states##3##4##(2008-10#3)
fields in different##4##3##(2008-10#3)(2008-12#1)
fields in four##2##3##(2008-10#2)
fields in the##8##3##(1993-9#1)(2008-10#5)(2008-3#1)(2011-10#1)
fields in##63##2##(1993-3#1)(1993-9#1)(1996-2#1)(1997-6#2)(2007-12#1)(2008-10#48)(2008-12#2)(2008-3#3)(2008-8#1)(2011-10#1)(2013-1#1)(2013-8#1)
fields located in the##2##4##(1996-2#1)(2008-10#1)
fields located in##3##3##(1996-2#1)(2008-10#2)
fields located##5##2##(1996-2#1)(2008-10#4)
fields of a##4##3##(1995-6#1)(2008-10#1)(2008-3#1)(2012-2#1)
fields of research##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
fields of##34##2##(1990-9#1)(1991-6#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#4)(2009-8#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
fields on##2##2##(2008-10#1)(2008-8#1)
fields planted to##2##3##(2008-10#2)
fields planted##3##2##(2008-10#3)
fields such as##4##3##(1993-2#1)(2008-12#1)(2008-3#1)(2011-2#1)
fields surveyed##2##2##(2008-10#2)
fields that are##2##3##(2008-11#1)(2009-9#1)
fields that##8##2##(2008-10#2)(2008-11#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
fields to##5##2##(1992-3#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
fields was##4##2##(1990-5#1)(2008-10#2)(2008-2#1)
fields were randomly selected##2##4##(2008-10#2)
fields were##8##2##(1993-9#1)(2008-10#7)
fields will##2##2##(1992-3#1)(2008-11#1)
fields with a##2##3##(2008-10#2)
fields with##6##2##(2008-10#5)(2008-6#1)
fields##375##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#3)(1992-3#16)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#4)(1994-2#1)(1994-9#1)(1995-6#3)(1996-1#1)(1996-2#5)(1996-3#1)(1996-5#1)(1997-6#3)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#203)(2008-11#16)(2008-12#12)(2008-2#5)(2008-3#14)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#7)(2011-3#2)(2011-4#1)(2011-8#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#4)
fields)##2##1##(2008-12#1)(2012-3#1)
fieldwork and##2##2##(2009-5#1)(2013-1#1)
fieldwork in##2##2##(2008-12#1)(2009-10#1)
fieldwork##4##1##(2008-12#1)(2009-10#1)(2009-5#1)(2013-1#1)
fifteen minutes##2##2##(2008-1#1)(2008-11#1)
fifteen patients##2##2##(1994-2#1)(2008-1#1)
fifteen##17##1##(1992-3#2)(1994-2#1)(1997-1#1)(2008-1#2)(2008-10#4)(2008-11#2)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
fifteenth##2##1##(2012-3#1)(2013-8#1)
fifth and sixth##2##3##(2010-1#1)(2013-7#1)
fifth and##3##2##(2008-10#1)(2010-1#1)(2013-7#1)
fifth instar larvae##2##3##(1995-11#1)(1997-8#1)
fifth instar##3##2##(1995-11#1)(1997-8#1)(2008-7#1)
fifth metatarsal##5##2##(2010-11#2)(2012-12#1)(2012-2#2)
fifth of the##3##3##(1990-9#1)(2011-2#1)(2012-12#1)
fifth of those##2##3##(1990-11#1)(2008-7#1)
fifth of##8##2##(1990-11#1)(1990-9#1)(1996-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
fifth##62##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-3#3)(1997-8#2)(2008-10#12)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-11#2)(2010-3#3)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
fifth-harmonic##2##1##(2008-3#2)
fifty patients##2##2##(1992-12#1)(2008-5#1)
fifty years ago##2##3##(2009-8#1)(2010-8#1)
fifty years of##2##3##(2010-1#1)(2012-3#1)
fifty years##6##2##(2009-8#1)(2010-1#1)(2010-8#1)(2012-3#3)
fifty##16##1##(1991-12#1)(1992-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-3#5)
fifty-five##2##1##(1990-3#1)(1992-1#1)
fifty-six##2##1##(1995-2#1)(2012-2#1)
fig orchards##2##2##(2008-10#2)
fig pollinator trees##2##3##(2008-10#2)
fig##9##1##(2008-10#9)
fight against##8##2##(1993-12#2)(1993-6#1)(1995-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
fight for##2##2##(2008-11#1)(2012-12#1)
fight in##2##2##(1993-2#1)(1996-5#1)
fight##26##1##(1990-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-6#1)(1995-1#2)(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
fighting##9##1##(1990-11#1)(1991-12#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-8#2)
fights and##2##2##(2008-9#2)
fights in##2##2##(2008-9#2)
fights on##2##2##(1995-6#1)(2008-9#1)
fights##12##1##(1995-6#1)(2008-10#1)(2008-9#10)
figs##4##1##(2008-10#4)
figure for##2##2##(1996-8#1)(2008-10#1)
figure in##2##2##(1990-6#1)(2008-9#1)
figure of merit##2##3##(2008-10#1)(2008-3#1)
figure of##5##2##(2008-10#2)(2008-3#1)(2009-10#1)(2011-2#1)
figure##15##1##(1990-6#2)(1992-1#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
figure-of-8##5##1##(2009-3#5)
figured##2##1##(2008-12#1)(2011-3#1)
figures are##3##2##(1996-1#1)(1997-6#1)(2008-9#1)
figures in##2##2##(1994-1#1)(2008-12#1)
figures of merit and interferences are also discussed##2##8##(2008-10#2)
figures of merit are##2##4##(2008-10#2)
figures of merit for##2##4##(2008-10#1)(2011-2#1)
figures of merit of the##7##5##(2008-10#7)
figures of merit were##3##4##(2008-10#3)
figures of merit##23##3##(2008-10#22)(2011-2#1)
figures of##28##2##(1996-12#1)(2007-11#1)(2008-10#24)(2011-2#1)(2012-2#1)
figures were##5##2##(1992-2#1)(1997-5#1)(2008-10#2)(2008-11#1)
figures##56##1##(1990-6#1)(1991-2#2)(1991-3#1)(1992-2#1)(1994-1#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-2#2)
fijiensis##7##1##(2008-10#7)
filaggrin##3##1##(2008-5#3)
filament bundles at the##3##4##(2012-2#3)
filament bundles at##4##3##(2012-2#4)
filament bundles##5##2##(2012-2#5)
filament networks##2##2##(2009-9#1)(2011-2#1)
filament structure##2##2##(2008-11#2)
filament##39##1##(1991-1#1)(1991-12#1)(1991-5#1)(1992-3#2)(1993-8#1)(1993-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#2)(2011-2#3)(2012-2#6)
filamentous actin (F-actin)##2##3##(1994-6#1)(2008-11#1)
filamentous actin##5##2##(1994-6#2)(2008-11#1)(2008-9#1)(2011-2#1)
filamentous actinomycetes##2##2##(2008-10#2)
filamentous ascomycete##2##2##(1995-6#1)(2012-3#1)
filamentous bacteriophages##2##2##(2008-4#1)(2008-8#1)
filamentous fungi that##2##3##(1994-5#1)(2010-7#1)
filamentous fungi##15##2##(1994-5#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
filamentous fungus##3##2##(1993-2#1)(2008-11#1)(2010-10#1)
filamentous material in the##2##4##(2008-10#2)
filamentous material##5##2##(2008-10#4)(2008-7#1)
filamentous phage and##2##3##(1993-8#1)(2008-11#1)
filamentous##58##1##(1993-2#1)(1993-8#1)(1994-5#1)(1994-6#2)(1995-6#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#1)
filaments and##7##2##(1992-9#1)(1993-8#3)(2008-8#1)(2009-10#1)(2011-2#1)
filaments are##2##2##(2009-10#2)
filaments in##7##2##(2008-10#1)(2008-8#3)(2009-10#2)(2009-12#1)
filaments is##3##2##(2008-7#2)(2008-8#1)
filaments of the##2##3##(1993-12#1)(2008-11#1)
filaments of##4##2##(1993-12#1)(1995-6#1)(2008-11#1)(2008-8#1)
filaments were##5##2##(1997-3#1)(2008-7#1)(2008-8#2)(2010-5#1)
filaments##72##1##(1991-5#1)(1992-6#2)(1992-9#3)(1993-12#2)(1993-6#2)(1993-8#3)(1993-9#1)(1995-2#2)(1995-6#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-7#12)(2008-8#14)(2008-9#4)(2009-10#7)(2009-12#1)(2009-8#1)(2009-9#4)(2010-5#1)(2011-2#1)(2012-2#1)
filamentsin vitro##2##2##(2008-8#2)
filarial parasite##2##2##(1991-5#2)
filarial##3##1##(1991-5#3)
filariasis elimination in##2##3##(2008-1#2)
filariasis elimination##5##2##(2008-1#5)
filariasis##8##1##(2008-1#6)(2010-1#1)(2012-2#1)
file and##2##2##(2008-10#1)(2008-9#1)
file format##2##2##(2008-4#1)(2011-1#1)
file which##2##2##(1991-3#1)(2013-1#1)
file##29##1##(1990-2#2)(1991-12#1)(1991-2#2)(1991-3#3)(1993-12#1)(1994-3#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-4#2)(2008-9#6)(2011-1#1)(2013-1#2)
filed a complaint##2##3##(1995-12#1)(1996-5#1)
filed a##3##2##(1995-12#1)(1995-6#1)(1996-5#1)
filed an##3##2##(1995-12#1)(1995-6#1)(2008-5#1)
filed by##6##2##(1995-12#3)(1995-6#2)(1996-5#1)
filed##16##1##(1995-12#5)(1995-6#6)(1996-5#2)(2008-10#1)(2008-5#2)
files and the##2##3##(1992-2#1)(1994-2#1)
files and##7##2##(1991-1#1)(1992-2#1)(1994-2#1)(1996-1#1)(2008-12#1)(2008-9#1)(2011-2#1)
files in##2##2##(1991-2#1)(2011-3#1)
files of##5##2##(1990-2#1)(1995-12#1)(1997-2#1)(2009-6#1)(2012-2#1)
files##40##1##(1990-2#1)(1991-1#1)(1991-2#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-9#2)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1996-1#1)(1997-2#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#6)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
filiform apparatus##2##2##(2008-11#1)(2009-8#1)
filiform##6##1##(1992-2#1)(2008-11#1)(2008-7#3)(2009-8#1)
filings and##2##2##(2008-10#1)(2008-11#1)
filings##6##1##(2008-10#2)(2008-11#4)
fill factor##2##2##(2008-3#2)
fill in##3##2##(1995-6#1)(2008-10#1)(2010-11#1)
fill its##2##2##(1991-2#1)(1995-6#1)
fill the##7##2##(1993-3#1)(2008-1#1)(2008-10#4)(2013-1#1)
fill##23##1##(1991-2#1)(1992-8#1)(1993-3#1)(1995-3#1)(1995-6#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2009-12#1)(2010-11#1)(2010-6#1)(2010-9#1)(2012-2#1)(2013-1#1)
filled by##2##2##(2008-10#1)(2009-3#1)
filled in a syringe prior to their determination by##2##9##(2008-10#2)
filled in a syringe##3##4##(2008-10#3)
filled in a##5##3##(1994-9#1)(2008-10#4)
filled in##6##2##(1994-9#1)(2008-10#4)(2008-5#1)
filled out##2##2##(2008-11#1)(2010-2#1)
filled recycled##2##2##(2009-3#2)
filled resins##3##2##(2009-7#3)
filled up##2##2##(2013-1#2)
filled with a##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)
filled with glass##2##3##(2008-10#2)
filled with mycelium##2##3##(2008-10#2)
filled with the##4##3##(2008-10#3)(2009-7#1)
filled with##56##2##(1993-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-12#3)(2008-10#28)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#2)
filled##83##1##(1992-8#1)(1993-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-12#3)(2008-1#1)(2008-10#35)(2008-11#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-3#4)(2009-7#6)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#5)
filler##6##1##(2009-7#1)(2010-4#1)(2011-2#3)(2013-1#1)
fillers##8##1##(2009-7#6)(2010-4#1)(2012-2#1)
filling and dilatation of the##2##5##(2008-7#2)
filling and##4##2##(2008-10#1)(2008-4#1)(2008-7#2)
filling in##6##2##(1991-6#1)(2008-3#4)(2013-1#1)
filling material##2##2##(2008-12#1)(2013-1#1)
filling of the##2##3##(2008-7#1)(2012-2#1)
filling of##4##2##(1993-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
filling or##2##2##(1991-2#1)(2008-2#1)
filling the##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)
filling##47##1##(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-11#1)(1994-2#1)(1995-11#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-6#2)(2008-7#4)(2008-9#4)(2009-7#1)(2011-2#1)(2012-2#3)(2013-1#6)
fills##4##1##(2007-12#1)(2011-2#1)(2013-1#2)
film and the##8##3##(2007-12#1)(2008-10#6)(2009-5#1)
film and##18##2##(2007-12#1)(2008-10#13)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)
film are##2##2##(2008-10#2)
film as a##3##3##(2008-10#2)(2008-3#1)
film as the##3##3##(2008-10#3)
film as##8##2##(2008-10#7)(2008-3#1)
film at the##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
film at##5##2##(1997-2#1)(2008-10#3)(2008-11#1)
film based##2##2##(2008-10#2)
film bearing 2##2##3##(2008-10#2)
film by##5##2##(1997-2#1)(2008-10#3)(2009-10#1)
film can be##4##3##(2008-10#4)
film causes##2##2##(2008-10#2)
film coated glassy carbon electrode (GCE)##2##6##(2008-10#2)
film coated glassy carbon electrode##5##5##(2008-10#5)
film coated glassy carbon##6##4##(2008-10#6)
film coated on a glassy carbon electrode##2##7##(2008-10#2)
film coated on##3##3##(2008-10#3)
film coated##12##2##(2008-10#12)
film composed of##2##3##(2008-10#2)
film considerably##2##2##(2008-10#2)
film consisting of##2##3##(2008-10#2)
film containing##4##2##(2008-10#4)
film deposited##2##2##(2008-10#1)(2008-2#1)
film doped with##4##3##(2008-10#4)
film electrode (BiFE)##3##3##(2008-10#3)
film electrode##29##2##(2008-10#28)(2008-12#1)
film electrodes for the##3##4##(2008-10#3)
film electrodes for##4##3##(2008-10#4)
film electrodes##25##2##(2008-10#23)(2008-12#2)
film exhibited high selectivity toward##2##5##(2008-10#1)(2013-1#1)
film exhibited##3##2##(2008-10#2)(2013-1#1)
film for the##2##3##(2008-10#1)(2009-10#1)
film for##5##2##(2008-10#3)(2008-3#1)(2009-10#1)
film formation##3##2##(2008-10#2)(2008-5#1)
film formed##2##2##(2008-10#2)
film has been##2##3##(2008-10#1)(2008-3#1)
film has##4##2##(2008-10#2)(2008-3#1)(2009-5#1)
film in the##2##3##(2008-10#1)(2008-5#1)
film in##4##2##(2008-10#3)(2008-5#1)
film is also##2##3##(2008-10#1)(2008-11#1)
film is##16##2##(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
film modified electrode##7##3##(2008-10#7)
film modified electrodes##2##3##(2008-10#2)
film modified##14##2##(2008-10#14)
film of water##2##3##(2008-10#1)(2011-2#1)
film of##22##2##(2008-10#19)(2008-2#1)(2008-8#1)(2011-2#1)
film on a glassy carbon electrode##3##6##(2008-10#3)
film on a glassy carbon##4##5##(2008-10#4)
film on a##7##3##(2008-10#7)
film on the##3##3##(2008-10#3)
film on##16##2##(2008-10#15)(2012-3#1)
film or##2##2##(2008-10#2)
film over the##2##3##(2008-10#2)
film over##3##2##(2008-10#3)
film prepared##2##2##(2008-10#2)
film surface##3##2##(2008-10#1)(2008-5#2)
film that##2##2##(2008-10#2)
film thickness and##2##3##(2008-10#2)
film thickness on the##2##4##(2008-10#2)
film thickness##14##2##(2008-10#14)
film to##6##2##(2008-10#6)
film using stable ground-state complex##2##5##(2008-10#2)
film using##3##2##(2008-10#2)(2009-10#1)
film was characterized by##3##4##(2008-10#3)
film was characterized##4##3##(2008-10#3)(2009-10#1)
film was found to be##2##5##(2008-10#2)
film was investigated##3##3##(2008-10#3)
film was obtained##2##3##(2008-10#2)
film was prepared by##2##4##(2008-10#2)
film was##29##2##(2008-10#25)(2008-11#1)(2008-3#1)(2009-10#1)(2010-4#1)
film were##5##2##(2008-10#5)
film with##8##2##(2008-10#7)(2008-11#1)
film##478##1##(1991-12#2)(1993-6#1)(1994-11#1)(1994-5#1)(1996-1#1)(1997-2#6)(1997-8#3)(2007-12#4)(2008-10#386)(2008-11#11)(2008-12#6)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#16)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#4)(2009-5#5)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
film's##2##1##(2008-10#1)(2008-5#1)
film)##2##1##(2008-10#1)(2008-8#1)
film-based treatment planning##2##3##(2009-11#2)
film-based##3##1##(2008-10#1)(2009-11#2)
film-modified electrode was##2##3##(2008-10#2)
film-modified electrode##3##2##(2008-10#3)
film-modified##4##1##(2008-10#4)
film-plated carbon paste electrode##2##4##(2008-10#2)
films and the##3##3##(2008-10#2)(2008-2#1)
films and##14##2##(2008-10#8)(2008-2#1)(2008-5#1)(2010-7#4)
films are prepared##2##3##(2008-10#2)
films are##8##2##(2008-10#7)(2008-3#1)
films as##4##2##(2008-10#4)
films at 193 nm##2##4##(2008-3#2)
films at##5##2##(2008-10#3)(2008-3#2)
films by the##2##3##(2008-10#1)(2008-2#1)
films by##4##2##(2008-10#3)(2008-2#1)
films cast##2##2##(2008-10#2)
films coated##2##2##(2008-10#2)
films composed of##2##3##(2008-10#1)(2008-12#1)
films containing##8##2##(2008-10#6)(2010-4#1)(2013-1#1)
films deposited##2##2##(2008-10#2)
films fabricated##2##2##(2008-12#2)
films for##7##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2009-5#1)
films from##2##2##(2008-10#2)
films have been##2##3##(2008-10#1)(2011-2#1)
films have##4##2##(2008-10#2)(2010-4#1)(2011-2#1)
films having##2##2##(2008-12#2)
films in the##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
films in##6##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
films is discussed in##2##4##(2008-10#1)(2008-5#1)
films is reported##2##3##(2008-10#1)(2009-12#1)
films is##12##2##(2008-10#7)(2008-3#1)(2008-5#1)(2009-11#1)(2009-12#2)
films made of##2##3##(2008-11#2)
films made##3##2##(2008-10#1)(2008-11#2)
films modified##2##2##(2008-10#2)
films obtained from##2##3##(2008-10#1)(2009-11#1)
films obtained##3##2##(2008-10#2)(2009-11#1)
films of tin oxide##2##4##(2008-10#2)
films of##14##2##(2008-10#14)
films on a##2##3##(2008-10#2)
films on glassy carbon##2##4##(2008-10#2)
films on##12##2##(2008-10#10)(2008-12#1)(2008-5#1)
films prepared by the##3##4##(2008-11#3)
films prepared by##4##3##(2008-10#1)(2008-11#3)
films prepared##7##2##(2008-10#3)(2008-11#4)
films self-assembled##2##2##(2008-10#2)
films showed a##2##3##(1995-6#1)(2008-10#1)
films showed##3##2##(1995-6#1)(2008-10#2)
films that##3##2##(2008-12#1)(2012-3#2)
films to##2##2##(2008-10#1)(2009-5#1)
films using##2##2##(2008-10#1)(2009-11#1)
films was##10##2##(2008-10#6)(2008-11#1)(2008-3#1)(2009-11#1)(2009-12#1)
films were characterized##3##3##(2008-10#3)
films were studied##3##3##(2008-10#3)
films were##24##2##(2008-10#21)(2008-11#1)(2009-12#2)
films with a##2##3##(2008-10#1)(2008-2#1)
films with##5##2##(2008-10#2)(2008-2#2)(2012-2#1)
films##296##1##(1990-12#1)(1990-8#2)(1991-12#3)(1992-8#2)(1993-5#1)(1995-6#2)(1997-8#1)(2006-6#1)(2008-10#180)(2008-11#20)(2008-12#12)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#11)(2008-9#1)(2009-11#7)(2009-12#5)(2009-5#5)(2010-4#6)(2010-5#1)(2010-7#6)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
films)##2##1##(2008-10#2)
filopodia##2##1##(2008-6#1)(2008-7#1)
filter and a##3##3##(2008-3#2)(2008-5#1)
filter and##11##2##(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#1)(2013-8#1)
filter as##2##2##(2008-10#1)(2008-11#1)
filter binding##2##2##(1993-8#2)
filter effect##5##2##(2008-10#3)(2008-11#2)
filter for the##2##3##(2008-10#1)(2008-2#1)
filter for##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
filter hybridization##2##2##(2010-10#1)(2012-3#1)
filter in the##2##3##(1997-8#1)(2008-5#1)
filter in##4##2##(1997-8#1)(2008-5#3)
filter is##7##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
filter medium##2##2##(2008-10#2)
filter on##2##2##(2008-3#1)(2010-8#1)
filter paper and##2##3##(2008-10#2)
filter paper cylinder (C)##3##4##(2008-10#3)
filter paper##28##2##(2008-10#27)(2012-2#1)
filter samples##4##2##(2008-10#3)(2008-11#1)
filter testing##2##2##(1993-3#2)
filter that##2##2##(2008-3#2)
filter to##5##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
filter was##5##2##(1992-6#2)(2008-10#2)(2008-5#1)
filter were##3##2##(2008-10#3)
filter with a##2##3##(2008-2#2)
filter##189##1##(1992-12#1)(1992-6#3)(1993-3#4)(1993-8#2)(1995-3#1)(1996-6#1)(1997-8#2)(2007-12#5)(2008-1#1)(2008-10#85)(2008-11#12)(2008-2#15)(2008-3#29)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-10#1)(2010-8#4)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
filter-based##3##1##(2008-10#1)(2008-3#2)
filterable##3##1##(2008-10#3)
filtered and##3##2##(2008-10#3)
filtered supernatant##2##2##(2008-12#2)
filtered##21##1##(1996-3#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#2)(2009-7#1)(2011-2#1)(2013-1#1)
filtering is##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
filtering method##2##2##(2010-8#2)
filtering the##2##2##(2008-6#1)(2009-8#1)
filtering##29##1##(1992-12#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#10)(2008-6#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-8#4)
filters and##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)(2011-2#1)
filters are##2##2##(2008-10#1)(2008-2#1)
filters by##2##2##(2008-10#2)
filters collected##2##2##(2008-10#2)
filters for##2##2##(2008-10#1)(2008-3#1)
filters have been##2##3##(2008-10#1)(2008-2#1)
filters in##6##2##(1990-12#1)(1992-12#1)(1993-3#1)(2008-3#2)(2011-2#1)
filters is##4##2##(2008-10#1)(2008-2#1)(2008-6#2)
filters that##3##2##(2007-12#1)(2008-3#1)(2008-6#1)
filters used in##2##3##(1993-3#1)(1997-1#1)
filters were analyzed by##2##4##(2008-5#2)
filters were##7##2##(2008-10#3)(2008-11#1)(2008-5#3)
filters with##4##2##(2007-11#2)(2008-6#1)(2008-9#1)
filters##88##1##(1990-12#1)(1992-12#1)(1992-5#1)(1993-3#3)(1996-3#1)(1997-1#1)(2007-11#2)(2007-12#3)(2008-10#29)(2008-11#5)(2008-2#4)(2008-3#10)(2008-5#12)(2008-6#7)(2008-9#4)(2009-7#1)(2011-2#3)
filters)##2##1##(2008-10#2)
filtrate and##4##2##(2008-10#4)
filtrate of##6##2##(2008-10#6)
filtrate was##4##2##(2008-10#4)
filtrate##33##1##(1990-2#1)(2008-10#27)(2008-7#4)(2008-8#1)
filtrates of##8##2##(2008-10#7)(2008-11#1)
filtrates was##2##2##(2008-10#2)
filtrates##21##1##(2008-10#20)(2008-11#1)
filtration and a##2##3##(2008-10#2)
filtration and##15##2##(1992-12#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#2)(2013-1#1)
filtration chromatography and##5##3##(1990-2#1)(1994-8#1)(2008-10#3)
filtration chromatography##13##2##(1990-2#1)(1991-3#1)(1991-9#1)(1994-5#1)(1994-8#1)(2008-10#6)(2008-11#1)(2009-3#1)
filtration for##2##2##(1995-11#1)(2008-10#1)
filtration is##2##2##(2008-10#2)
filtration of##3##2##(1992-11#1)(1993-6#1)(2008-10#1)
filtration rate##11##2##(1996-6#4)(2008-9#1)(2010-4#1)(2011-2#4)(2013-8#1)
filtration was used to##2##4##(1995-11#1)(2008-7#1)
filtration was##3##2##(1995-11#1)(1997-8#1)(2008-7#1)
filtration##107##1##(1990-2#2)(1991-12#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#4)(1995-11#3)(1996-6#4)(1997-1#1)(1997-8#3)(2008-10#42)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
fimA and fimF##4##3##(2008-10#4)
fimA##5##1##(2008-10#5)
fimF genes##3##2##(2008-10#3)
fimF##5##1##(2008-10#5)
fimbria##2##1##(1996-12#1)(2012-12#1)
fimbria-fornix lesioned rats##2##3##(1994-8#2)
fimbria-fornix lesions##2##2##(1994-8#2)
fimbria-fornix##4##1##(1994-8#4)
fimbriae##10##1##(1995-5#1)(1996-12#4)(2008-10#1)(2008-8#3)(2011-1#1)
fimbrial##13##1##(1996-6#1)(2008-10#6)(2012-12#6)
fimbriata complex##2##2##(2008-10#2)
fimbriata on the##2##3##(2008-10#2)
fimbriata##11##1##(2008-10#11)
fin##6##1##(1993-12#1)(2008-11#1)(2008-8#1)(2010-8#3)
fin)##3##1##(2010-8#3)
fin-to-limb##2##1##(2012-12#2)
final DII##2##2##(2008-10#2)
final IgA concentration##2##3##(2008-11#2)
final MAb##3##2##(2008-11#2)(2008-7#1)
final R factor of##2##4##(1991-3#1)(2008-8#1)
final R factor##3##3##(1991-3#1)(2008-8#2)
final R##5##2##(1991-3#1)(1993-8#1)(1996-5#1)(2008-8#2)
final amount of disease##2##4##(2008-10#2)
final analysis of##2##3##(2009-3#1)(2012-2#1)
final analysis##5##2##(1992-3#1)(1996-3#1)(2009-3#1)(2012-2#2)
final antibody titer##2##3##(2008-11#2)
final antibody##3##2##(2008-11#3)
final assessment##2##2##(2008-7#2)
final cell density##3##3##(2008-11#3)
final cell##5##2##(2008-11#4)(2011-2#1)
final data##2##2##(2008-10#1)(2010-5#1)
final decision##4##2##(1992-5#1)(1994-3#1)(1995-11#1)(2012-3#1)
final decline##2##2##(2008-10#2)
final determination##3##2##(2008-10#3)
final diagnosis and##2##3##(1994-6#1)(2012-12#1)
final diagnosis of##4##3##(2008-12#1)(2008-5#1)(2010-6#1)(2012-3#1)
final diagnosis was##2##3##(2010-11#1)(2013-8#1)
final diagnosis##11##2##(1991-6#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-3#2)(2013-8#1)
final disease incidence##2##3##(2008-10#2)
final disease intensity##3##3##(2008-10#3)
final disease severity##3##3##(2008-10#3)
final disease##10##2##(2008-10#10)
final evaluation##2##2##(2008-10#1)(2008-12#1)
final extract##2##2##(2008-10#1)(2008-5#1)
final height##3##2##(2007-11#2)(2008-4#1)
final incidence##3##2##(2008-10#3)
final measurements are##2##3##(2008-8#2)
final model is##2##3##(2008-10#2)
final model##9##2##(1992-4#1)(2008-10#5)(2008-9#1)(2009-7#2)
final models were##2##3##(2008-10#1)(2011-2#1)
final number of##2##3##(2008-10#2)
final number##3##2##(2008-10#3)
final outcome##5##2##(1991-8#1)(2007-11#1)(2008-7#2)(2012-12#1)
final outcomes##3##2##(1997-7#1)(2008-9#1)(2013-1#1)
final ozonides##4##2##(1996-5#4)
final part##5##2##(1993-12#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-2#1)
final product of the##2##4##(2008-10#2)
final product##18##2##(1992-3#1)(1994-6#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-5#2)(2010-10#2)(2010-4#1)(2012-2#2)
final products##5##2##(1996-5#1)(2008-10#2)(2008-4#1)(2011-2#1)
final protein##2##2##(2008-11#1)(2008-5#1)
final report##2##2##(1993-3#1)(1993-9#1)
final residue##2##2##(2008-10#2)
final result##2##2##(2010-7#1)(2013-1#1)
final results and the different##2##5##(2008-10#2)
final results##5##2##(2008-10#4)(2013-1#1)
final sample##2##2##(2013-1#2)
final section##2##2##(2008-10#1)(2008-4#1)
final solution##5##2##(2008-10#5)
final stage of##2##3##(2008-7#2)
final stages##5##2##(1990-5#1)(1997-8#1)(2007-12#1)(2008-5#1)(2011-2#1)
final steps of##3##3##(1992-12#1)(1997-7#1)(2008-4#1)
final steps##4##2##(1991-6#1)(1992-12#1)(1997-7#1)(2008-4#1)
final volume##4##2##(2008-10#4)
final year of##3##3##(2008-11#2)(2008-12#1)
final##330##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-3#2)(1996-5#12)(1996-9#1)(1997-3#1)(1997-7#3)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#101)(2008-11#32)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#10)(2008-5#11)(2008-6#2)(2008-7#16)(2008-8#6)(2008-9#6)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#4)(2009-8#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#17)(2011-7#1)(2012-12#3)(2012-2#9)(2012-3#3)(2012-9#1)(2013-1#10)(2013-8#2)
finalistic##2##1##(2012-3#2)
finally applied to the##2##4##(2008-10#2)
finally applied##3##2##(2008-10#3)
finally confirmed##2##2##(1996-6#1)(2011-2#1)
finally resulted in##2##3##(2008-10#1)(2012-2#1)
finally to##2##2##(2008-8#1)(2009-6#1)
finally##110##1##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-2#1)(1993-2#1)(1993-8#1)(1994-1#2)(1994-3#3)(1994-6#1)(1995-2#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(2008-10#35)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#8)(2012-2#3)(2012-3#4)(2013-1#8)
finance and##2##2##(2008-11#1)(2008-12#1)
finance##18##1##(1991-2#2)(1992-2#1)(1993-3#2)(1994-2#1)(1994-3#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-11#2)(2008-12#1)(2010-5#2)(2013-8#1)
financed by the##4##3##(1994-1#1)(1995-2#1)(1996-1#1)(1996-2#1)
financed by##5##2##(1994-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)
financed competition##3##2##(1992-2#3)
financed##13##1##(1992-2#3)(1994-1#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)
finances##2##1##(1994-1#1)(1996-3#1)
financial and operational##3##3##(1992-2#1)(1997-3#1)(2010-8#1)
financial and##11##2##(1992-2#1)(1994-1#2)(1995-12#1)(1996-1#2)(1997-3#2)(2008-11#1)(2010-8#2)
financial attitudes##2##2##(2010-10#2)
financial behavior##2##2##(2010-10#2)
financial benefits##3##2##(1993-1#1)(1993-2#1)(2009-12#1)
financial burden##2##2##(2007-12#1)(2012-12#1)
financial commitment##2##2##(1994-1#1)(1994-9#1)
financial gains##2##2##(1991-2#1)(1993-12#1)
financial impact##3##2##(1991-2#1)(2008-11#1)(2008-9#1)
financial incentives in##2##3##(1994-1#1)(1996-12#1)
financial incentives##7##2##(1991-12#1)(1994-1#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-11#1)
financial indicators##3##2##(2008-11#3)
financial learning##3##2##(2010-10#3)
financial losses##2##2##(1992-1#1)(1997-5#1)
financial management##6##2##(1992-12#1)(1994-3#1)(1996-3#1)(2008-11#3)
financial performance under##2##3##(1993-1#1)(1993-3#1)
financial performance##10##2##(1991-3#1)(1993-1#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(2008-11#2)(2008-6#1)
financial planning##3##2##(1991-12#1)(1994-2#1)(1996-2#1)
financial pressures##2##2##(2008-11#1)(2013-1#1)
financial resources##4##2##(1993-11#1)(1997-7#1)(2009-6#1)(2011-2#1)
financial risk##2##2##(1992-12#1)(1995-2#1)
financial socialization##3##2##(2010-10#3)
financial status##3##2##(1993-12#1)(2008-11#2)
financial strain##2##2##(2013-1#2)
financial support##2##2##(2008-11#1)(2010-10#1)
financial systems##3##2##(1994-3#1)(1996-1#1)(1997-3#1)
financial##131##1##(1991-1#1)(1991-12#4)(1991-2#4)(1991-3#1)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1994-1#8)(1994-12#2)(1994-2#5)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#2)(1997-7#1)(2007-12#1)(2008-11#22)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#14)(2010-5#3)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
financially##5##1##(1991-1#1)(1993-3#1)(1994-1#1)(1996-3#2)
financing and##6##2##(1993-2#1)(1994-1#1)(1995-12#1)(1995-2#1)(1997-5#1)(2008-11#1)
financing health care##3##3##(1993-3#1)(1996-3#1)(2008-1#1)
financing health##4##2##(1993-3#1)(1995-2#1)(1996-3#1)(2008-1#1)
financing in##2##2##(1991-3#1)(1993-2#1)
financing of the health##2##4##(1992-12#1)(2013-8#1)
financing of the##3##3##(1992-1#1)(1992-12#1)(2013-8#1)
financing of##11##2##(1992-1#3)(1992-12#1)(1992-3#1)(1993-2#2)(1997-3#1)(2008-10#1)(2013-8#2)
financing options##2##2##(2008-1#2)
financing##60##1##(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#4)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#10)(1993-3#3)(1994-1#1)(1994-2#6)(1994-3#1)(1995-12#1)(1995-2#6)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2008-1#5)(2008-10#1)(2008-11#4)(2013-8#3)
finasteride##5##1##(2008-5#4)(2012-3#1)
finch##4##1##(2008-8#4)
finches##9##1##(2008-8#8)(2008-9#1)
find a weak##2##3##(2008-10#2)
find a##28##2##(1990-3#1)(1991-12#1)(1996-2#1)(1997-6#2)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2011-2#3)(2012-3#1)(2013-8#1)
find an association between##2##4##(2012-12#1)(2012-3#1)
find an##5##2##(2008-10#1)(2009-10#1)(2009-6#1)(2012-12#1)(2012-3#1)
find and##3##2##(1994-1#1)(1996-8#1)(2008-11#1)
find any significant##2##3##(2007-8#1)(2012-3#1)
find any##4##2##(2007-8#1)(2008-12#1)(2010-6#1)(2012-3#1)
find applications in the##2##4##(2008-10#1)(2010-7#1)
find at least##2##3##(1997-6#1)(2008-9#1)
find better##2##2##(2011-3#1)(2012-2#1)
find differences##2##2##(2008-5#1)(2010-5#1)
find evidence for##2##3##(2008-8#1)(2012-3#1)
find evidence##4##2##(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
find good##2##2##(2008-3#1)(2008-6#1)
find it difficult to##2##4##(2008-11#1)(2010-10#1)
find it##4##2##(1992-8#1)(2008-11#1)(2010-10#1)(2012-2#1)
find many##3##2##(2008-3#1)(2008-8#1)(2009-12#1)
find new##2##2##(1991-1#1)(1997-2#1)
find no##3##2##(2008-11#1)(2009-10#2)
find out how##2##3##(2008-5#1)(2011-2#1)
find out the##4##3##(1990-2#1)(2010-12#1)(2013-1#2)
find out##18##2##(1990-2#2)(1990-6#1)(1991-11#1)(1991-6#1)(1993-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
find that in##3##3##(2010-3#1)(2013-1#2)
find that the presence of##2##5##(1995-11#1)(2008-10#1)
find that the##20##3##(1992-3#1)(1993-6#1)(1994-12#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-8#1)(2011-2#1)(2012-12#1)
find that there are two##2##5##(2008-3#1)(2008-9#1)
find that there are##3##4##(1993-12#1)(2008-3#1)(2008-9#1)
find that there##5##3##(1991-3#1)(1993-12#1)(1994-3#1)(2008-3#1)(2008-9#1)
find that while##2##3##(2013-1#2)
find that##74##2##(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#3)(1995-11#2)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-8#12)(2008-9#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
find the relationship##3##3##(2011-3#1)(2013-8#2)
find the##35##2##(1990-12#1)(1992-12#1)(1993-11#1)(1994-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-7#1)(2010-4#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#2)
find themselves##4##2##(1994-1#2)(2008-10#1)(2008-11#1)
find ways to##3##3##(1992-12#1)(1995-9#1)(1996-5#1)
find wide##3##2##(2008-10#2)(2012-3#1)
find##278##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#3)(1994-3#4)(1994-9#1)(1995-11#3)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#17)(2008-12#4)(2008-2#1)(2008-3#17)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#23)(2008-9#13)(2009-10#6)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#14)(2011-3#3)(2012-12#4)(2012-2#9)(2012-3#9)(2013-1#9)(2013-8#4)
finding a##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)(2012-3#1)
finding an##3##2##(1996-1#1)(2008-11#1)(2008-6#1)
finding and##6##2##(1991-8#1)(1993-6#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-12#1)
finding at##2##2##(2011-2#2)
finding by##2##2##(2008-10#1)(2010-4#1)
finding demonstrates that##2##3##(1996-12#1)(2008-7#1)
finding during##3##2##(1992-9#1)(2008-12#1)(2010-12#1)
finding in a##2##3##(2008-12#1)(2009-6#1)
finding in this##2##3##(2011-1#2)
finding in##21##2##(1995-11#1)(1995-2#1)(1996-6#1)(1997-2#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-9#3)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
finding is consistent with##3##4##(1993-8#1)(2008-11#1)(2008-6#1)
finding is that##4##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
finding is the##2##3##(1994-11#1)(2008-10#1)
finding is##11##2##(1992-3#1)(1992-5#1)(1993-8#1)(1994-11#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
finding may##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
finding more##2##2##(1991-1#1)(1994-3#1)
finding of a##6##3##(1996-12#2)(2008-7#2)(2011-2#1)(2013-1#1)
finding of this study##2##4##(1997-8#1)(2009-7#1)
finding of##28##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-8#2)(2008-11#1)(2008-7#3)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
finding on##4##2##(2010-11#1)(2011-2#1)(2013-1#2)
finding represents##2##2##(2008-10#1)(2012-3#1)
finding suggests that the##2##4##(1993-6#2)
finding suggests that##8##3##(1992-2#1)(1993-6#2)(2008-10#2)(2008-12#1)(2010-10#1)(2010-12#1)
finding suggests##10##2##(1992-2#1)(1992-6#1)(1993-6#2)(2008-10#2)(2008-12#1)(2009-8#1)(2010-10#1)(2010-12#1)
finding supports the##3##3##(1990-11#2)(1996-3#1)
finding supports##5##2##(1990-11#2)(1996-3#1)(2008-10#1)(2008-12#1)
finding that the##9##3##(1994-8#1)(1995-11#1)(1995-6#2)(1997-2#1)(2008-10#3)(2008-5#1)
finding that##36##2##(1992-6#1)(1993-6#1)(1994-2#1)(1994-8#3)(1995-11#1)(1995-6#3)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#3)(2010-10#2)(2010-7#1)(2013-1#2)(2013-8#1)
finding the optimal##3##3##(2008-11#1)(2008-6#1)(2013-8#1)
finding the##8##2##(1992-12#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#1)
finding was a##2##3##(1990-8#1)(2008-11#1)
finding was that the##2##4##(2008-10#1)(2010-5#1)
finding was that##5##3##(1992-12#1)(2008-10#2)(2008-7#1)(2010-5#1)
finding was the##3##3##(2008-12#2)(2009-8#1)
finding was##13##2##(1990-8#1)(1992-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#1)(2009-8#1)(2010-5#1)(2013-1#1)
finding##257##1##(1990-11#2)(1990-12#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#19)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#12)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#6)(2010-10#4)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#1)(2011-1#5)(2011-2#10)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#12)(2013-8#6)
findings about the##2##3##(1992-3#1)(2009-5#1)
findings about##3##2##(1992-3#1)(2009-5#1)(2012-12#1)
findings also suggest that##3##4##(1995-2#1)(2009-7#1)(2010-8#1)
findings also##8##2##(1994-12#1)(1995-2#1)(2008-11#2)(2009-7#1)(2010-2#1)(2010-8#1)(2012-2#1)
findings among##2##2##(2010-2#1)(2011-2#1)
findings and clinical##2##3##(1993-11#1)(2012-12#1)
findings and implications##2##3##(1996-2#2)
findings and policy implications##2##4##(1991-12#2)
findings and the##5##3##(1995-5#1)(1997-8#1)(2008-11#1)(2013-1#2)
findings and##43##2##(1990-3#1)(1991-12#2)(1993-11#1)(1994-2#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-4#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#7)
findings appear##2##2##(1991-5#1)(2008-10#1)
findings are considered##2##3##(1993-3#1)(2010-1#1)
findings are consistent with the##2##5##(2011-2#1)(2013-8#1)
findings are consistent with##5##4##(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
findings are described##2##3##(1991-3#1)(1995-3#1)
findings are discussed and recommendations for##2##6##(2008-12#1)(2009-7#1)
findings are discussed in relation to the##3##7##(2008-12#1)(2008-7#1)(2012-2#1)
findings are discussed in relation to##5##6##(1993-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-2#1)
findings are discussed in relation##6##5##(1990-8#1)(1993-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-2#1)
findings are discussed in terms of##3##6##(1991-2#1)(2008-10#1)(2009-12#1)
findings are discussed in##11##4##(1990-8#1)(1991-2#1)(1993-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-7#1)(2010-9#1)(2012-2#2)
findings are discussed##20##3##(1990-8#1)(1991-2#2)(1993-11#1)(1993-8#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-7#1)(2010-9#1)(2012-2#2)
findings are more##2##3##(1993-12#1)(1997-3#1)
findings are of##2##3##(1994-8#1)(2008-10#1)
findings are presented##2##3##(1993-2#1)(2011-2#1)
findings are reported##2##3##(2008-6#1)(2009-7#1)
findings are supported##2##3##(2008-5#1)(2012-2#1)
findings are##69##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-3#1)(1997-3#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#2)(2009-5#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#2)
findings as##3##2##(1995-5#1)(1997-8#1)(2009-3#1)
findings between##3##2##(2009-10#1)(2012-12#2)
findings by##4##2##(1990-2#1)(1995-8#1)(1996-2#1)(2011-2#1)
findings can be##5##3##(1995-11#1)(2008-11#2)(2008-6#1)(2012-2#1)
findings can##6##2##(1995-11#1)(2008-11#2)(2008-6#1)(2009-9#1)(2012-2#1)
findings cannot##2##2##(2008-11#1)(2010-12#1)
findings concerning the##3##3##(1991-2#1)(2008-11#1)(2009-7#1)
findings concerning##6##2##(1991-2#1)(2008-11#3)(2009-7#1)(2011-2#1)
findings confirmed that##2##3##(2010-1#1)(2011-2#1)
findings confirmed the##2##3##(2008-12#1)(2008-5#1)
findings confirmed##5##2##(1994-8#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)
findings consistent with##2##3##(2008-10#2)
findings could##4##2##(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
findings demonstrate that##7##3##(1997-4#2)(2008-5#2)(2009-7#1)(2011-2#1)(2013-8#1)
findings demonstrate the importance of##2##5##(1993-3#1)(2010-7#1)
findings demonstrate the##4##3##(1993-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
findings demonstrate##12##2##(1993-3#1)(1997-4#2)(2008-5#2)(2009-7#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#2)
findings demonstrated that##2##3##(1994-1#1)(2008-11#1)
findings do not support the##2##5##(2009-7#1)(2013-8#1)
findings do not support##3##4##(1991-6#1)(2009-7#1)(2013-8#1)
findings do not##4##3##(1991-12#1)(1991-6#1)(2009-7#1)(2013-8#1)
findings during##3##2##(2008-3#1)(2009-8#1)(2011-2#1)
findings emphasize the##2##3##(1993-6#1)(2008-10#1)
findings for the##4##3##(1991-5#1)(1994-8#1)(2008-10#1)(2009-11#1)
findings for##15##2##(1991-5#1)(1992-12#1)(1993-1#1)(1994-8#1)(1995-1#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-11#1)(2009-4#1)(2009-7#1)(2012-2#1)
findings from a##8##3##(1990-8#1)(1992-11#1)(1993-12#1)(2008-11#3)(2012-2#2)
findings from the survey##2##4##(1994-3#1)(1996-1#1)
findings from the##11##3##(1992-9#1)(1994-3#1)(1996-1#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#2)
findings from##35##2##(1990-8#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#6)(2008-6#1)(2009-1#1)(2009-3#1)(2010-10#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
findings have been##2##3##(1990-6#1)(2008-12#1)
findings have implications for##3##4##(1992-2#1)(2010-10#1)(2012-2#1)
findings have important implications##2##4##(2008-10#1)(2009-8#1)
findings have important##3##3##(1994-12#1)(2008-10#1)(2009-8#1)
findings have shown##3##3##(2008-4#1)(2010-1#1)(2012-2#1)
findings have##20##2##(1990-6#1)(1992-2#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#3)
findings help##2##2##(2008-5#1)(2013-8#1)
findings highlight that##2##3##(2011-2#1)(2013-1#1)
findings highlight the##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
findings highlight##6##2##(1995-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
findings identify##2##2##(2008-1#1)(2013-1#1)
findings illustrate that##2##3##(2008-9#1)(2012-2#1)
findings illustrate the##2##3##(2008-10#1)(2008-8#1)
findings illustrate##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#2)
findings imply that##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
findings in a##3##3##(2008-7#1)(2011-2#2)
findings in children with##2##4##(2011-2#2)
findings in different##2##3##(2011-2#1)(2013-1#1)
findings in our##2##3##(2010-10#1)(2011-2#1)
findings in patients with##4##4##(1990-12#1)(1997-8#1)(2008-7#1)(2012-12#1)
findings in patients##5##3##(1990-12#1)(1997-8#1)(2008-7#1)(2008-9#1)(2012-12#1)
findings in relation to the##2##5##(2008-8#1)(2008-9#1)
findings in the field##2##4##(2009-10#1)(2012-2#1)
findings in the##9##3##(1990-11#1)(1990-9#1)(1993-3#1)(1995-1#1)(2008-10#1)(2009-10#2)(2009-8#1)(2012-2#1)
findings in this##4##3##(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
findings in##67##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-12#2)(1996-11#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#12)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#2)
findings include the##2##3##(1993-3#1)(2011-2#1)
findings include##6##2##(1993-1#1)(1993-3#1)(1996-3#1)(1997-3#1)(2008-9#1)(2011-2#1)
findings included a##3##3##(1991-12#1)(2008-9#1)(2010-5#1)
findings included##4##2##(1991-12#1)(2008-5#1)(2008-9#1)(2010-5#1)
findings indicate a##5##3##(1994-11#1)(1996-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
findings indicate that ET-1##2##4##(1991-5#1)(1993-3#1)
findings indicate that the##6##4##(1993-6#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-5#1)(2010-11#1)
findings indicate that##44##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#3)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
findings indicate the##2##3##(2008-12#1)(2008-7#1)
findings indicate##57##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#2)
findings indicated that##9##3##(1994-11#1)(1994-8#1)(2008-11#3)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)
findings into##2##2##(2008-11#1)(2012-2#1)
findings is##3##2##(2009-10#1)(2009-5#1)(2009-7#1)
findings may be##3##3##(1990-8#1)(1991-2#1)(2008-11#1)
findings may have##2##3##(2008-4#1)(2013-1#1)
findings may provide##2##3##(1993-1#1)(2008-10#1)
findings may##11##2##(1990-12#1)(1990-8#1)(1991-2#1)(1993-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#2)
findings must##2##2##(1991-11#1)(2013-1#1)
findings obtained from##2##3##(1991-2#1)(2009-8#1)
findings obtained##6##2##(1990-8#1)(1991-2#1)(1995-9#1)(2008-10#1)(2008-5#1)(2009-8#1)
findings of a##17##3##(1991-8#1)(1995-1#1)(1996-3#1)(1997-8#2)(2008-1#1)(2008-11#4)(2008-12#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-8#1)
findings of an##3##3##(1992-3#1)(1994-2#1)(2008-12#1)
findings of other investigators##2##4##(1990-3#1)(1994-8#1)
findings of patients with##2##4##(1996-11#1)(1997-8#1)
findings of sexual abuse##2##4##(2009-9#2)
findings of the##14##3##(1995-11#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
findings of this study are##3##5##(2008-11#1)(2008-7#1)(2011-1#1)
findings of this study##14##4##(1994-2#1)(1994-8#1)(1995-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-1#1)(2013-1#1)
findings of this##19##3##(1994-2#1)(1994-8#1)(1995-9#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-7#2)(2009-5#2)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
findings of##110##2##(1990-3#1)(1991-8#1)(1992-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#2)(1997-3#1)(1997-8#7)(2008-1#2)(2008-10#9)(2008-11#12)(2008-12#5)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#2)
findings offer##2##2##(2011-1#1)(2012-2#1)
findings on MR##2##3##(1997-8#2)
findings on the##10##3##(1991-1#1)(1991-12#1)(1994-1#1)(1994-8#1)(2008-11#2)(2008-12#1)(2008-8#2)(2008-9#1)
findings on##24##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-1#1)(1994-8#1)(1997-3#2)(1997-8#3)(2008-11#4)(2008-12#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
findings point to the need for##2##6##(1994-2#1)(2008-10#1)
findings point to##5##3##(1991-2#1)(1994-2#1)(2008-10#1)(2008-12#1)(2011-3#1)
findings present##3##2##(2008-12#1)(2008-9#1)(2010-12#1)
findings presented##2##2##(2008-11#1)(2010-8#1)
findings provide evidence that##2##4##(1995-2#1)(1997-3#1)
findings provide##11##2##(1995-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
findings regarding the##5##3##(1992-12#1)(1993-3#1)(2008-11#1)(2012-2#1)(2013-8#1)
findings regarding##6##2##(1992-12#1)(1993-3#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
findings related to##3##3##(2011-1#1)(2012-2#1)(2013-8#1)
findings reported in##3##3##(2008-12#1)(2011-3#1)(2012-3#1)
findings reported##4##2##(1993-8#1)(2008-12#1)(2011-3#1)(2012-3#1)
findings represent a##2##3##(1997-3#1)(2008-10#1)
findings represent##3##2##(1997-3#1)(2008-10#1)(2009-10#1)
findings require##2##2##(2008-11#1)(2011-2#1)
findings reveal an##2##3##(1995-2#1)(2010-8#1)
findings reveal##5##2##(1995-2#1)(1996-12#1)(2009-5#1)(2010-8#1)(2012-2#1)
findings revealed that##2##3##(2008-10#1)(2008-12#1)
findings revealed##7##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2012-3#1)
findings seem to suggest that##2##5##(2009-7#1)(2012-12#1)
findings seem to##3##3##(2009-6#1)(2009-7#1)(2012-12#1)
findings seem##4##2##(2008-7#1)(2009-6#1)(2009-7#1)(2012-12#1)
findings should be##3##3##(2008-11#1)(2009-11#1)(2013-1#1)
findings should##4##2##(2008-11#1)(2009-11#1)(2012-2#1)(2013-1#1)
findings show that##7##3##(1996-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-7#1)(2013-1#1)
findings show##12##2##(1990-8#1)(1991-2#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#2)
findings showed a##2##3##(1991-11#1)(2009-1#1)
findings showed that##4##3##(2008-10#1)(2008-12#1)(2010-2#1)(2011-2#1)
findings showed##11##2##(1991-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2009-1#1)(2010-2#1)(2010-6#3)(2011-2#1)(2013-8#1)
findings showing##3##2##(2008-7#2)(2013-7#1)
findings strongly support the##2##4##(1997-7#1)(2008-5#1)
findings strongly##4##2##(1995-12#1)(1997-7#1)(2008-5#1)(2012-3#1)
findings such as##2##3##(1997-8#1)(2010-12#1)
findings suggest a role for##2##5##(1992-6#1)(1994-11#1)
findings suggest a##9##3##(1990-5#1)(1992-6#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2010-4#1)(2010-5#1)
findings suggest an##3##3##(1992-2#1)(1996-3#1)(1997-8#1)
findings suggest its##2##3##(2008-5#1)(2013-1#1)
findings suggest that the barrier##2##5##(2008-10#1)(2008-7#1)
findings suggest that the##21##4##(1990-11#1)(1990-6#1)(1991-2#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-11#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
findings suggest that there are##3##5##(1992-3#1)(1993-2#1)(2008-7#1)
findings suggest that##93##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#2)(1992-1#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#4)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#3)(2008-10#12)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
findings suggest the##8##3##(1992-2#1)(1992-6#1)(1993-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-4#1)
findings suggest##122##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#2)(1994-11#5)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#3)(1997-7#1)(1997-8#1)(2008-10#14)(2008-11#11)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#6)
findings suggested that##9##3##(1991-12#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
findings suggested##11##2##(1991-12#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
findings support the##5##3##(1991-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2013-8#1)
findings support##8##2##(1990-8#1)(1991-7#1)(1995-1#1)(2009-8#1)(2009-9#1)(2010-1#1)(2012-2#1)(2013-8#1)
findings that have##2##3##(2008-10#1)(2008-11#1)
findings that the##3##3##(1992-12#1)(1994-8#1)(2008-10#1)
findings that##21##2##(1991-6#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)
findings to##9##2##(1990-6#1)(1994-2#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-7#1)(2010-2#1)
findings underscore the##2##3##(1991-2#1)(2008-5#1)
findings was that##2##3##(1991-6#1)(2011-2#1)
findings was##5##2##(1991-3#1)(1991-6#1)(2008-11#1)(2011-2#2)
findings were compatible with##3##4##(1991-8#2)(2011-2#1)
findings were confirmed by##2##4##(2008-10#1)(2010-11#1)
findings were confirmed##5##3##(2008-10#1)(2008-11#2)(2010-11#1)(2011-2#1)
findings were consistent with##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
findings were discussed##2##3##(2009-8#1)(2010-1#1)
findings were##33##2##(1990-9#1)(1991-3#1)(1991-8#2)(1993-2#1)(1995-11#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-7#2)(2009-1#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#5)(2013-1#3)(2013-8#1)
findings which##2##2##(1995-11#1)(2008-11#1)
findings will help##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
findings will##6##2##(1993-2#1)(2008-11#2)(2010-5#1)(2012-2#1)(2013-1#1)
findings with respect to##2##4##(1994-3#1)(2008-1#1)
findings with the##2##3##(1991-2#1)(2010-7#1)
findings with##13##2##(1990-3#1)(1991-2#1)(1994-3#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
findings##1150##1##(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#4)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#12)(1991-2#14)(1991-3#6)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#6)(1993-11#2)(1993-12#7)(1993-2#7)(1993-3#11)(1993-6#2)(1993-8#4)(1993-9#1)(1994-1#4)(1994-11#9)(1994-12#7)(1994-2#8)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#10)(1994-9#2)(1995-1#8)(1995-11#10)(1995-12#5)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#5)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#6)(1996-12#8)(1996-2#5)(1996-3#6)(1996-5#1)(1996-6#2)(1997-1#4)(1997-2#4)(1997-3#16)(1997-4#3)(1997-7#3)(1997-8#23)(2006-6#3)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#7)(2008-10#89)(2008-11#95)(2008-12#31)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#23)(2008-6#7)(2008-7#30)(2008-8#19)(2008-9#29)(2009-1#5)(2009-10#12)(2009-11#3)(2009-12#10)(2009-3#6)(2009-4#4)(2009-5#8)(2009-6#5)(2009-7#13)(2009-8#14)(2009-9#12)(2010-1#9)(2010-10#6)(2010-11#6)(2010-12#13)(2010-2#8)(2010-3#1)(2010-4#6)(2010-5#5)(2010-6#11)(2010-7#7)(2010-8#6)(2010-9#5)(2011-1#13)(2011-10#1)(2011-2#79)(2011-3#4)(2011-7#2)(2012-12#22)(2012-2#64)(2012-3#17)(2012-7#1)(2013-1#52)(2013-7#2)(2013-8#37)
finds a##3##2##(2008-11#1)(2008-5#1)(2009-8#1)
finds that##5##2##(1992-2#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-1#1)
finds the##3##2##(1991-3#1)(1996-1#1)(1997-6#1)
finds##20##1##(1991-3#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-2#2)(1995-9#1)(1996-1#2)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)(2009-8#1)(2010-4#1)(2013-1#1)
fine and coarse##4##3##(2008-10#1)(2008-3#3)
fine chlorotic streaks##2##3##(2008-10#2)
fine mapping##3##2##(2008-11#2)(2009-10#1)
fine needle aspiration biopsy##2##4##(1991-6#1)(1997-2#1)
fine needle aspiration cytology##4##4##(1990-6#2)(2010-11#1)(2010-8#1)
fine needle aspiration##10##3##(1990-6#2)(1991-3#1)(1991-6#2)(1997-2#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-8#1)
fine needle##13##2##(1990-6#2)(1991-3#2)(1991-6#2)(1997-2#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-8#1)
fine particle mass##3##3##(1996-2#2)(1997-2#1)
fine particles##2##2##(2008-12#2)
fine structure and##2##3##(1990-12#1)(2007-12#1)
fine structure is##2##3##(2008-10#1)(2008-2#1)
fine structure of the##4##4##(1992-1#1)(2007-12#1)(2008-7#1)(2008-8#1)
fine structure of##7##3##(1992-1#1)(2007-12#3)(2008-7#2)(2008-8#1)
fine structure##18##2##(1990-12#1)(1992-1#1)(2007-12#5)(2008-10#3)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)
fine##88##1##(1990-12#1)(1990-6#2)(1991-3#2)(1991-6#2)(1992-1#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-2#2)(1997-2#4)(1997-3#1)(1997-5#1)(2007-12#6)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#1)
fine-needle aspirate biopsies##2##3##(2008-9#2)
fine-needle aspiration biopsy (FNAB)##2##4##(2011-1#1)(2011-2#1)
fine-needle aspiration biopsy##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
fine-needle aspiration##7##2##(1994-6#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
fine-needle##10##1##(1994-6#1)(2008-10#1)(2008-2#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
fine-structure##2##1##(2008-10#2)
fine-tuned##2##1##(2008-10#1)(2012-2#1)
fine-tuning of##3##2##(1995-9#1)(2008-10#1)(2013-8#1)
fine-tuning##6##1##(1995-9#2)(2008-10#2)(2011-2#1)(2013-8#1)
finely##9##1##(1994-11#1)(1995-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)
fines##2##1##(1993-3#1)(1995-12#1)
finesse##2##1##(2008-3#2)
finger and##2##2##(1996-2#1)(2013-1#1)
finger counting##2##2##(2013-8#2)
finger family##2##2##(1997-3#1)(1997-9#1)
finger marks##2##2##(2012-2#2)
finger movements##2##2##(1996-2#1)(2008-11#1)
finger protein##7##2##(1992-7#2)(1996-6#1)(1997-3#3)(2013-1#1)
finger that##2##2##(2008-12#1)(2008-9#1)
finger##48##1##(1990-5#1)(1991-10#1)(1992-7#2)(1996-2#5)(1996-6#2)(1997-3#4)(1997-9#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#7)(2009-3#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#8)
finger-like##2##1##(2007-12#1)(2009-7#1)
fingerprint and##3##2##(1996-12#1)(2008-10#2)
fingerprint data##2##2##(2008-10#2)
fingerprint of##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
fingerprint patterns##7##2##(2008-10#7)
fingerprint probe##4##2##(2008-10#4)
fingerprint profiles were##2##3##(2008-10#2)
fingerprint profiles##3##2##(2008-10#3)
fingerprint to##2##2##(2008-10#2)
fingerprint with##2##2##(2008-10#2)
fingerprint##52##1##(1993-8#2)(1996-12#1)(2008-10#44)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#2)
fingerprinted by##2##2##(2008-10#1)(2011-2#1)
fingerprinted##3##1##(2008-10#2)(2011-2#1)
fingerprinting and##3##2##(2008-10#3)
fingerprinting of##4##2##(1996-12#1)(2008-10#3)
fingerprinting using##2##2##(2008-10#1)(2008-11#1)
fingerprinting was used to##2##4##(2008-10#1)(2008-5#1)
fingerprinting##40##1##(1993-8#1)(1995-6#1)(1996-12#2)(2008-10#31)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)
fingerprints and##6##2##(2008-10#4)(2011-3#2)
fingerprints for##4##2##(2008-10#3)(2013-1#1)
fingerprints from##2##2##(2008-10#2)
fingerprints of the##2##3##(2008-10#2)
fingerprints of##12##2##(2008-10#10)(2008-5#1)(2011-3#1)
fingerprints showed##2##2##(2008-10#2)
fingerprints using##2##2##(2008-10#2)
fingerprints were identified from the##2##5##(2008-10#2)
fingerprints were##8##2##(2008-10#8)
fingerprints##54##1##(2008-10#44)(2008-12#1)(2008-5#2)(2010-7#1)(2011-1#1)(2011-3#4)(2013-1#1)
fingers and##2##2##(1997-7#1)(2013-8#1)
fingers at##2##2##(2008-1#1)(2010-10#1)
fingers in##3##2##(2013-8#3)
fingers of the##2##3##(2008-10#1)(2008-5#1)
fingers of##3##2##(2008-10#2)(2008-5#1)
fingers##26##1##(1991-12#1)(1993-2#1)(1996-2#1)(1996-8#1)(1997-3#3)(1997-7#4)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-8#4)
fingertip reconstruction##2##2##(2008-9#2)
fingertip##4##1##(2008-9#3)(2011-2#1)
finish##2##1##(2010-4#1)(2011-2#1)
finished product##2##2##(2008-10#1)(2008-5#1)
finished products##2##2##(2008-5#2)
finished within##2##2##(1995-3#1)(2008-10#1)
finished##23##1##(1992-2#1)(1995-3#1)(1996-8#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-5#4)(2010-4#2)(2010-5#1)(2012-2#1)(2012-3#2)
finishes##2##1##(1995-6#1)(2012-12#1)
finishing##7##1##(1990-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-7#1)
finite element analysis##2##3##(2009-7#1)(2013-1#1)
finite element method##2##3##(2009-7#1)(2013-8#1)
finite element model##2##3##(2011-2#2)
finite element##7##2##(2009-7#2)(2011-2#2)(2013-1#2)(2013-8#1)
finite life##2##2##(2008-11#1)(2008-9#1)
finite##32##1##(1990-5#1)(1997-7#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-3#9)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#2)(2010-11#1)(2011-2#3)(2013-1#5)(2013-8#1)
finite-difference time-domain##3##2##(2008-2#1)(2008-3#2)
finite-element##3##1##(1994-5#1)(2008-3#2)
fins and limbs##2##3##(2012-12#2)
fins of##2##2##(2009-7#2)
fins##8##1##(2009-7#2)(2010-8#1)(2012-12#5)
fir (Abies##2##2##(2008-10#2)
fir trees##3##2##(2008-10#3)
fir##11##1##(2008-10#11)
fir-woods##2##1##(2011-2#2)
fire assays##2##2##(2008-10#2)
fire blight and##2##3##(2008-10#2)
fire blight warning systems in Israel##2##6##(2008-10#2)
fire blight##32##2##(2008-10#31)(2008-8#1)
fire environment##2##2##(1996-12#2)
fire in##2##2##(1993-12#1)(2008-11#1)
fire##79##1##(1990-8#3)(1991-12#1)(1991-3#1)(1993-12#1)(1994-12#2)(1995-6#1)(1996-12#11)(2007-12#3)(2008-10#37)(2008-11#4)(2008-8#3)(2009-10#7)(2009-8#1)(2012-2#2)(2012-3#2)
firearm##2##1##(2008-10#2)
fired##3##1##(1991-3#1)(1995-12#1)(1995-6#1)
firefly luciferase gene##2##3##(1997-1#1)(2008-11#1)
firefly luciferase##7##2##(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#2)
fireplace##2##1##(2008-10#2)
fires is##2##2##(1996-12#2)
fires##9##1##(1996-12#6)(2008-12#1)(2011-1#1)(2011-2#1)
firewood##3##1##(2008-10#1)(2011-2#2)
firework##3##1##(2012-2#3)
firing in##3##2##(1995-12#1)(1996-2#1)(2008-11#1)
firing of##5##2##(1996-2#1)(2008-11#3)(2009-10#1)
firing pattern##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
firing patterns##2##2##(2008-11#2)
firing process##3##2##(2008-10#3)
firing rate##13##2##(1994-2#2)(1996-2#4)(2008-11#5)(2008-7#1)(2009-10#1)
firing rates and##2##3##(2008-11#2)
firing rates##5##2##(2008-11#5)
firing stages##2##2##(2008-10#2)
firing##53##1##(1994-2#2)(1995-12#2)(1996-2#12)(2008-10#5)(2008-11#23)(2008-2#1)(2008-7#2)(2008-8#2)(2009-10#3)(2013-8#1)
firings##3##1##(2008-10#2)(2012-2#1)
firm##30##1##(1990-12#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-3#3)(1993-5#1)(1994-2#1)(1994-5#1)(1995-12#2)(1997-1#3)(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
firm's##2##1##(1991-9#1)(1993-3#1)
firmly established##4##2##(1995-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
firmly##9##1##(1990-12#1)(1993-1#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
firmness##5##1##(2008-10#1)(2008-5#3)(2011-2#1)
firms##14##1##(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-2#2)(1994-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(2012-2#1)
first 100##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
first 2 years of##3##4##(1995-1#1)(2008-10#1)(2008-8#1)
first 2 years##4##3##(1995-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
first 2##14##2##(1995-1#1)(2008-10#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
first 22##2##2##(1990-11#1)(2013-1#1)
first Stokes##2##2##(2007-12#2)
first a##3##2##(1992-1#1)(2008-11#1)(2008-5#1)
first admission##2##2##(1991-11#1)(2011-2#1)
first aid##3##2##(2008-1#1)(2010-8#2)
first and last##3##3##(1997-3#1)(2008-10#1)(2012-2#1)
first and second dissociation constants##2##5##(2008-10#2)
first and second dissociation##3##4##(2008-10#3)
first and second##26##3##(1990-8#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#10)(2008-6#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#3)(2013-8#1)
first and the last##2##4##(2008-10#1)(2008-7#1)
first and the##7##3##(2008-10#5)(2008-11#1)(2008-7#1)
first and then##3##3##(1995-6#1)(2008-10#2)
first and##45##2##(1990-12#1)(1990-8#1)(1994-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#20)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-8#1)
first antibody##2##2##(1994-11#1)(2008-11#1)
first appear##2##2##(1991-2#1)(2008-11#1)
first appearance of##2##3##(1995-12#2)
first appearance##3##2##(1990-9#1)(1995-12#2)
first appeared in##2##3##(2008-5#1)(2012-2#1)
first applied to the##2##4##(2008-10#1)(2008-8#1)
first applied to##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
first applied##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
first approach to##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
first approach##7##2##(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)
first article##2##2##(1990-3#1)(1991-2#1)
first assay##3##2##(2008-10#2)(2008-5#1)
first assessment##2##2##(2008-7#1)(2009-4#1)
first attempt in##3##3##(2010-2#1)(2010-7#2)
first attempt to##6##3##(1997-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
first attempt##12##2##(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-2#1)(2010-7#3)(2011-2#1)(2012-2#1)(2013-1#1)
first basic protocol##2##3##(2008-4#2)
first basic##3##2##(1992-2#1)(2008-4#2)
first being##3##2##(1994-6#1)(2008-11#1)(2008-9#1)
first biochemical##2##2##(1994-11#1)(2011-1#1)
first birth##4##2##(2009-10#1)(2009-5#3)
first by##5##2##(1990-6#1)(2008-10#2)(2008-11#1)(2009-12#1)
first campaign##2##2##(1997-6#1)(2010-1#1)
first cancer##3##2##(1990-8#2)(1991-8#1)
first carpometacarpal##2##2##(2008-9#2)
first case of a##5##4##(1997-8#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
first case of##18##3##(1995-12#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)
first case##35##2##(1991-2#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-12#3)(2008-5#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#4)
first choice for##4##3##(1991-6#1)(1997-4#1)(2008-7#1)(2011-2#1)
first choice of##2##3##(1992-9#1)(2011-10#1)
first choice##13##2##(1990-3#1)(1991-6#1)(1992-9#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-10#2)(2011-2#1)(2013-1#1)
first clinical##5##2##(1990-12#1)(2008-12#3)(2008-5#1)
first column##2##2##(2008-10#2)
first component##2##2##(1990-11#1)(2009-8#1)
first comprehensive##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
first confirmed##2##2##(2008-10#1)(2010-3#1)
first contact##2##2##(1994-3#1)(1995-1#1)
first course##2##2##(1990-6#2)
first data set##2##3##(1995-9#1)(2008-10#1)
first data##3##2##(1995-9#1)(2008-10#1)(2008-11#1)
first day after##2##3##(1990-12#1)(2012-3#1)
first day##10##2##(1990-12#3)(1991-6#1)(1992-5#1)(1993-12#2)(2008-5#1)(2011-2#1)(2012-3#1)
first demonstrated##2##2##(2008-2#1)(2008-7#1)
first demonstration##12##2##(1993-9#1)(1994-5#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-8#1)(2009-8#1)
first derivative UV-spectrophotometry##2##3##(2008-10#2)
first derivative at##2##3##(2008-10#2)
first derivative spectra of##2##4##(2008-10#2)
first derivative spectra##6##3##(2008-10#6)
first derivative spectrophotometry##2##3##(2008-10#2)
first derivative##23##2##(2008-10#23)
first describe how##2##3##(2008-10#1)(2012-2#1)
first describe the##3##3##(2008-10#2)(2013-8#1)
first describe##6##2##(2008-10#3)(2012-2#1)(2012-3#1)(2013-8#1)
first described by##4##3##(2008-11#1)(2010-5#1)(2011-1#1)(2011-2#1)
first described in##8##3##(1995-8#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-2#1)
first described##22##2##(1992-2#1)(1994-3#1)(1995-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)
first description of##8##3##(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-7#1)(2013-1#1)
first description##10##2##(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-7#1)(2011-2#2)(2013-1#1)
first design##3##2##(2008-2#2)(2012-2#1)
first detected at##3##3##(2008-10#1)(2009-6#1)(2012-2#1)
first detected in the##4##4##(1995-11#1)(2008-10#3)
first detected in##5##3##(1995-11#1)(2008-10#3)(2012-2#1)
first detected##11##2##(1993-3#1)(1995-11#1)(2008-10#5)(2009-6#1)(2012-2#3)
first detection##2##2##(2008-10#2)
first developed##5##2##(2008-10#3)(2008-11#1)(2010-6#1)
first diagnosed##2##2##(2008-10#1)(2012-3#1)
first direct evidence that##4##4##(1996-12#2)(2008-10#2)
first direct##6##2##(1993-3#1)(1996-12#2)(2008-10#2)(2011-1#1)
first discuss the##2##3##(1996-2#1)(2008-9#1)
first dorsal web space##3##4##(2008-9#3)
first egg##3##2##(2008-12#3)
first encounter##3##2##(2008-11#2)(2010-7#1)
first episode of psychosis##2##4##(2011-1#2)
first episode of##3##3##(2011-1#2)(2011-2#1)
first established in##2##3##(1994-12#1)(2008-11#1)
first evaluated##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
first event##2##2##(1990-2#1)(2008-10#1)
first evidence for##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
first evidence##10##2##(1992-2#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2012-3#1)(2013-8#1)
first examination##4##2##(1996-6#1)(2008-5#1)(2008-7#1)(2010-1#1)
first examined##2##2##(2008-11#1)(2008-12#1)
first exon##5##2##(1991-5#1)(1993-2#1)(1993-6#1)(1993-8#1)(1997-7#1)
first exons and promoters##2##4##(2008-4#2)
first exons##4##2##(1995-8#1)(2008-4#3)
first experiment##9##2##(1996-12#1)(2008-10#7)(2013-8#1)
first for##3##2##(1994-2#1)(1996-5#1)(2008-5#1)
first from##2##2##(2008-10#1)(2008-9#1)
first generation##4##2##(1991-12#1)(1991-6#1)(2010-6#1)(2010-7#1)
first glance##3##2##(1995-12#1)(2008-11#1)(2013-8#1)
first grade##6##2##(2008-10#1)(2008-11#1)(2008-12#4)
first group of##5##3##(2007-8#1)(2011-2#1)(2012-3#3)
first group was##2##3##(1990-2#1)(2008-11#1)
first group##22##2##(1990-2#3)(1991-5#1)(1994-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2011-2#3)(2012-3#6)(2013-1#3)
first hospital##2##2##(1992-12#1)(2008-10#1)
first hot##2##2##(2008-3#1)(2013-8#1)
first identified##7##2##(1993-6#1)(1995-2#1)(2008-10#2)(2008-9#1)(2009-9#1)(2013-7#1)
first in the##2##3##(2008-10#1)(2008-8#1)
first in##7##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)
first increases##2##2##(2008-10#1)(2008-9#1)
first instance##4##2##(2008-11#1)(2008-12#1)(2010-12#1)(2013-1#1)
first instar##3##2##(2007-12#1)(2008-10#1)(2010-10#1)
first international##3##2##(2008-12#1)(2013-8#2)
first interview##2##2##(2008-11#1)(2009-12#1)
first introduced##4##2##(1991-3#1)(2008-10#1)(2008-11#2)
first investigated##2##2##(2008-12#1)(2008-5#1)
first investigation of##2##3##(2008-11#1)(2009-10#1)
first investigation##5##2##(1996-3#1)(2008-11#1)(2008-6#1)(2009-10#1)(2013-8#1)
first is a##4##3##(1992-11#1)(2007-12#1)(2008-10#1)(2009-4#1)
first is##15##2##(1992-11#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-4#1)(2012-2#1)(2012-3#1)
first issue of the Journal of Pediatric Urology##2##8##(2008-10#2)
first issue of##5##3##(2008-10#2)(2010-12#3)
first issue##6##2##(2008-1#1)(2008-10#2)(2010-12#3)
first kind##3##2##(2008-10#2)(2008-2#1)
first lactation##2##2##(1996-8#1)(2008-12#1)
first language##3##2##(1995-1#1)(2010-1#1)(2013-8#1)
first line##9##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-1#1)
first linker repeat##2##3##(2008-6#2)
first linker##3##2##(2008-6#3)
first manifestation of##3##3##(1991-3#1)(1996-11#1)(2011-2#1)
first manifestation##5##2##(1991-3#1)(1996-11#1)(1997-8#1)(2011-2#2)
first measurement##2##2##(2008-12#1)(2008-3#1)
first medical##2##2##(1990-12#1)(1991-8#1)
first metatarsal##6##2##(2008-12#4)(2012-2#2)
first method##8##2##(2008-10#5)(2008-3#2)(2012-2#1)
first molars##3##2##(2012-12#1)(2013-1#2)
first observed at##2##3##(2008-10#2)
first observed in the##2##4##(2008-10#1)(2008-7#1)
first observed in##5##3##(2008-10#4)(2008-7#1)
first observed##11##2##(2008-10#10)(2008-7#1)
first of the##2##3##(1994-5#1)(2008-3#1)
first of these##3##3##(2008-10#2)(2013-1#1)
first of##12##2##(1990-9#1)(1993-2#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
first on##5##2##(2008-10#5)
first one is##3##3##(2008-11#1)(2008-3#1)(2009-10#1)
first one##9##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
first operation##3##2##(1991-3#1)(1992-9#1)(2008-7#1)
first or second##2##3##(2008-7#1)(2013-1#1)
first or##6##2##(1990-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#1)
first order kinetics##3##3##(1990-2#1)(2008-10#1)(2008-11#1)
first order reaction##2##3##(2008-10#2)
first order##15##2##(1990-2#1)(1995-6#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-3#1)(2012-2#1)
first oxidation##2##2##(1996-5#1)(2009-9#1)
first part of the##3##4##(1993-6#1)(1997-4#1)(2009-6#1)
first part of this##5##4##(1992-1#1)(2008-10#2)(2010-12#1)(2012-2#1)
first part of##10##3##(1992-1#1)(1993-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
first part##16##2##(1992-1#1)(1993-6#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#2)(2013-8#2)
first passage##3##2##(2008-10#2)(2008-11#1)
first patient##5##2##(1995-11#1)(2008-1#1)(2009-1#1)(2011-2#1)(2013-1#1)
first patients##2##2##(1997-3#1)(2012-3#1)
first peak##5##2##(1996-12#2)(2008-10#2)(2008-11#1)
first performed##4##2##(1994-2#1)(2008-10#1)(2008-6#1)(2013-8#1)
first permanent##2##2##(2013-1#2)
first phase##8##2##(1991-12#1)(1993-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2009-7#1)(2011-3#1)
first population##3##2##(2008-10#3)
first postnatal day##2##3##(1991-2#1)(1993-3#1)
first postoperative##2##2##(2010-4#1)(2011-2#1)
first practice##5##2##(1992-8#1)(2008-11#3)(2008-9#1)
first presented##3##2##(2010-11#1)(2012-2#1)(2012-3#1)
first principal component##2##3##(2008-10#1)(2013-1#1)
first principles##2##2##(1992-3#1)(1995-3#1)
first priority##3##2##(1992-12#1)(1997-4#1)(2010-8#1)
first proposed by##2##3##(2008-3#1)(2008-5#1)
first proposed##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
first prototype##2##2##(2008-10#1)(2008-3#1)
first published in##2##3##(1997-8#1)(2012-12#1)
first published##5##2##(1997-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-12#1)
first quarter##2##2##(1997-3#1)(2008-5#1)
first recognition##2##2##(2008-1#1)(2008-11#1)
first recognized##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
first record in##2##3##(2008-10#2)
first record##3##2##(2008-10#3)
first recorded in##2##3##(2008-10#2)
first recorded##3##2##(2008-10#2)(2008-5#1)
first report##88##2##(1990-5#1)(1990-6#1)(1991-4#1)(1992-10#1)(1992-3#2)(1994-12#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#39)(2008-11#9)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
first reported case of##13##4##(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
first reported use of##2##4##(2008-10#2)
first reported##25##2##(1992-8#1)(2008-10#9)(2008-11#1)(2008-7#2)(2008-9#2)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
first results##4##2##(1994-8#1)(1997-2#1)(2008-10#1)(2008-3#1)
first round of##2##3##(1995-12#1)(2011-1#1)
first round##4##2##(1991-6#2)(1995-12#1)(2011-1#1)
first sample##3##2##(2008-10#2)(2011-2#1)
first section##8##2##(1991-3#1)(1992-6#1)(2008-10#2)(2008-4#4)
first series##2##2##(2008-10#1)(2008-5#1)
first settlement of##3##3##(2008-10#2)(2008-8#1)
first show##2##2##(1996-5#1)(2008-10#1)
first sign of##3##3##(1993-2#1)(2011-2#2)
first sonication##3##2##(2008-10#3)
first species##2##2##(2008-10#1)(2008-12#1)
first stage of the##2##4##(2008-10#1)(2010-8#1)
first stage of##4##3##(2008-10#2)(2010-8#1)(2011-2#1)
first stage##11##2##(1990-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
first step for##5##3##(1993-6#1)(1993-8#1)(1996-3#1)(2008-10#1)(2013-1#1)
first step in the##6##4##(1995-2#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
first step in##18##3##(1990-7#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
first step of the##3##4##(1992-8#1)(2008-10#1)(2013-8#1)
first step of##14##3##(1992-8#1)(1994-8#1)(1996-2#1)(2008-10#6)(2008-9#2)(2012-3#1)(2013-8#2)
first step to##6##3##(1992-12#1)(1993-2#1)(2007-12#1)(2008-10#1)(2010-10#1)(2011-2#1)
first step toward the##2##4##(2009-1#1)(2009-7#1)
first step toward##8##3##(1995-6#1)(1997-7#1)(2008-10#1)(2008-6#1)(2009-1#1)(2009-7#1)(2010-12#1)(2012-3#1)
first step##70##2##(1990-7#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#4)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-12#1)(2008-10#19)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
first steps##2##2##(1996-3#1)(2012-2#1)
first study##11##2##(1994-3#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#1)
first subgroup##2##2##(2008-10#1)(2009-7#1)
first suggested##2##2##(1992-9#1)(2008-10#1)
first survey of##2##3##(1997-8#1)(2012-2#1)
first symptom##3##2##(1990-12#2)(2008-12#1)
first system##3##2##(2008-10#2)(2008-11#1)
first task##2##2##(1991-2#1)(1991-3#1)
first tested##2##2##(1995-5#1)(2008-10#1)
first the##2##2##(2008-11#1)(2008-8#1)
first therapeutic##2##2##(2007-11#1)(2013-8#1)
first three months of##2##4##(1991-8#1)(2009-7#1)
first three##12##2##(1991-8#1)(1992-10#1)(1992-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#2)(2011-2#1)(2012-2#1)
first time in##14##3##(1990-9#1)(1991-11#1)(1993-2#1)(1994-12#1)(2007-12#2)(2008-10#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)
first time##218##2##(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#3)(2007-12#4)(2008-10#95)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#8)(2009-1#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#3)(2012-2#9)(2012-3#2)(2012-8#1)(2013-1#9)(2013-8#2)
first to the##2##3##(1991-6#1)(1994-8#1)
first to##22##2##(1990-2#1)(1991-6#1)(1993-1#1)(1994-8#1)(1995-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-3#1)
first treated with##2##3##(2008-10#1)(2008-9#1)
first trimester##10##2##(1990-6#1)(1990-9#1)(1993-3#2)(2007-12#1)(2008-11#1)(2011-1#1)(2013-1#3)
first two experiments were##2##4##(1994-2#1)(2008-6#1)
first two##29##2##(1990-8#1)(1991-2#1)(1993-12#1)(1993-8#2)(1994-2#1)(1997-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
first type of##3##3##(1997-3#1)(2008-10#1)(2008-3#1)
first type##7##2##(1997-3#1)(2008-10#4)(2008-3#1)(2011-2#1)
first use##2##2##(2008-10#1)(2009-7#1)
first used##5##2##(2008-10#1)(2008-11#3)(2011-10#1)
first visit##3##2##(1994-2#1)(2008-1#1)(2008-10#1)
first was##4##2##(2008-10#2)(2010-6#1)(2010-8#1)
first wave##3##2##(2008-11#2)(2010-5#1)
first were##2##2##(1993-8#1)(2008-10#1)
first with the##3##3##(2008-10#1)(2013-1#2)
first with##8##2##(2008-10#3)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#2)
first year of##24##3##(1990-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-3#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-11#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2011-1#2)(2013-1#2)
first year students##2##3##(2008-12#1)(2013-1#1)
first year##44##2##(1990-11#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-1#3)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#3)(1997-1#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#5)(2008-7#2)(2008-9#1)(2009-10#1)(2011-1#3)(2011-2#1)(2013-1#5)
first##2144##1##(1990-10#1)(1990-11#5)(1990-12#11)(1990-2#10)(1990-3#5)(1990-5#7)(1990-6#7)(1990-7#1)(1990-8#9)(1990-9#10)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#11)(1991-3#9)(1991-4#1)(1991-5#6)(1991-6#14)(1991-8#4)(1991-9#2)(1992-1#8)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#5)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#4)(1992-8#5)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#12)(1993-2#15)(1993-3#12)(1993-5#1)(1993-6#15)(1993-8#11)(1993-9#1)(1994-1#5)(1994-11#10)(1994-12#10)(1994-2#5)(1994-3#12)(1994-5#4)(1994-6#3)(1994-8#6)(1994-9#3)(1995-1#7)(1995-11#7)(1995-12#10)(1995-2#8)(1995-3#5)(1995-5#5)(1995-6#16)(1995-8#6)(1995-9#2)(1996-1#2)(1996-11#4)(1996-12#17)(1996-2#3)(1996-3#12)(1996-5#8)(1996-6#7)(1996-8#5)(1996-9#3)(1997-1#5)(1997-2#11)(1997-3#13)(1997-4#5)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#9)(2007-11#5)(2007-12#15)(2007-8#4)(2007-9#2)(2008-1#9)(2008-10#590)(2008-11#128)(2008-12#53)(2008-2#10)(2008-3#43)(2008-4#29)(2008-5#37)(2008-6#25)(2008-7#42)(2008-8#51)(2008-9#64)(2009-1#4)(2009-10#13)(2009-11#6)(2009-12#6)(2009-3#1)(2009-4#3)(2009-5#7)(2009-6#6)(2009-7#13)(2009-8#10)(2009-9#5)(2010-1#12)(2010-10#7)(2010-11#7)(2010-12#11)(2010-2#3)(2010-3#6)(2010-4#4)(2010-5#13)(2010-6#8)(2010-7#9)(2010-8#18)(2010-9#3)(2011-1#18)(2011-10#4)(2011-2#109)(2011-3#8)(2011-4#1)(2011-8#1)(2012-12#15)(2012-2#55)(2012-3#41)(2012-8#1)(2013-1#81)(2013-3#1)(2013-7#1)(2013-8#35)
first- and second-order##3##3##(2007-11#1)(2008-5#2)
first- and##4##2##(2007-11#1)(2008-10#1)(2008-5#2)
first-degree relatives##3##2##(1995-9#1)(2008-7#1)(2012-12#1)
first-derivative spectrophotometric##2##2##(2008-10#2)
first-derivative spectrophotometry##2##2##(2008-10#2)
first-derivative##15##1##(2008-10#15)
first-ever clinical##2##2##(2009-10#2)
first-ever##3##1##(2009-10#3)
first-generation process##2##2##(2008-11#2)
first-generation##4##1##(1994-2#1)(2008-11#2)(2011-2#1)
first-grade##2##1##(2008-12#1)(2011-2#1)
first-line agents##3##2##(1996-11#1)(2008-9#1)(2012-2#1)
first-line nurse managers##2##3##(1997-2#2)
first-line therapy for##3##3##(1994-12#1)(2008-8#1)(2010-12#1)
first-line therapy with sunitinib##2##4##(2013-1#2)
first-line therapy##8##2##(1994-12#1)(2008-8#1)(2010-11#1)(2010-12#2)(2013-1#2)(2013-8#1)
first-line treatment for##2##3##(2008-10#1)(2010-12#1)
first-line treatment of##3##3##(2011-2#2)(2013-8#1)
first-line treatment##7##2##(2008-10#1)(2010-12#2)(2011-2#3)(2013-8#1)
first-line##36##1##(1994-12#1)(1994-8#1)(1996-11#1)(1997-2#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#8)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
first-order derivative##3##2##(2008-10#3)
first-order processes##3##2##(2008-10#2)(2008-5#1)
first-order rate##3##2##(1995-6#1)(2008-10#2)
first-order reaction##2##2##(2008-10#2)
first-order##30##1##(1992-3#1)(1995-3#2)(1995-6#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-3#6)(2008-5#2)
first-person##3##1##(2013-8#3)
first-round##3##1##(2008-10#3)
first-time##2##1##(2012-3#1)(2013-1#1)
first-world##2##1##(2009-8#2)
first-year college students##2##3##(2010-10#2)
first-year##5##1##(1994-12#1)(2008-3#1)(2010-10#2)(2010-3#1)
firstly developed##4##2##(2008-10#4)
firstly to##2##2##(2008-10#1)(2010-8#1)
firstly##32##1##(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
fiscal 1995##2##2##(1995-6#2)
fiscal and##4##2##(1993-1#1)(1994-2#1)(1995-3#1)(1996-3#1)
fiscal impacts##2##2##(1991-1#1)(2008-1#1)
fiscal restraint##2##2##(1995-3#1)(1997-2#1)
fiscal year (FY)##2##3##(1992-12#1)(1993-12#1)
fiscal year 1991##2##3##(1992-1#1)(1997-1#1)
fiscal year##8##2##(1991-1#1)(1992-1#1)(1992-12#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-2#1)
fiscal years##2##2##(1992-12#1)(1993-1#1)
fiscal##31##1##(1991-1#2)(1991-12#1)(1992-1#2)(1992-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#3)(1995-6#4)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#3)(2008-1#1)(2008-6#1)(2009-3#1)
fischeri##9##1##(2008-10#8)(2013-8#1)
fish (p = 0##4##4##(2011-2#4)
fish and##13##2##(1993-12#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)
fish bone##2##2##(2011-2#2)
fish by##2##2##(2009-7#1)(2010-5#1)
fish cells##6##2##(1992-6#2)(2008-11#4)
fish exposed to##3##3##(2010-5#1)(2010-8#2)
fish freshness##6##2##(2008-10#6)
fish from##2##2##(2008-11#2)
fish have not##2##3##(2012-3#2)
fish in##3##2##(2008-2#2)(2011-2#1)
fish larvae##2##2##(2008-8#1)(2010-8#1)
fish muscle was##2##3##(2008-10#2)
fish muscle##4##2##(2008-10#4)
fish oil supplementation##2##3##(2010-1#2)
fish oil##4##2##(2008-10#1)(2010-1#3)
fish oils##2##2##(2008-6#1)(2010-1#1)
fish opened##2##2##(2008-5#2)
fish otolith##2##2##(2008-10#1)(2008-7#1)
fish otoliths by electrothermal vaporization inductively coupled plasma mass spectrometry##2##10##(2008-10#2)
fish pathogen##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
fish pathogens##2##2##(2008-9#1)(2009-6#1)
fish products##3##2##(2008-10#1)(2011-2#2)
fish samples##9##2##(2008-10#8)(2012-2#1)
fish species##15##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-5#1)(2010-8#8)
fish sperm DNA (fsDNA)##4##4##(2008-10#4)
fish sperm DNA##12##3##(2008-10#12)
fish tissue##2##2##(2008-10#2)
fish tissues and urine##2##4##(2008-10#2)
fish tissues##4##2##(2008-10#3)(2012-12#1)
fish to##6##2##(2008-11#1)(2008-4#1)(2009-6#2)(2012-2#1)(2012-3#1)
fish were##7##2##(2008-11#1)(2008-12#1)(2010-8#5)
fish##274##1##(1990-8#4)(1991-2#1)(1991-8#1)(1992-6#3)(1993-12#2)(1993-3#1)(1994-11#3)(1995-11#1)(1995-12#2)(1995-2#1)(1997-9#1)(2008-10#73)(2008-11#24)(2008-12#11)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#15)(2008-9#5)(2009-6#6)(2009-7#2)(2009-8#3)(2010-1#8)(2010-4#1)(2010-5#20)(2010-8#32)(2010-9#1)(2011-2#17)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#4)
fisheries management##2##2##(2010-8#2)
fisheries##4##1##(2010-8#4)
fisherman##2##1##(1991-6#2)
fishermen##4##1##(1993-11#4)
fishes and##4##2##(1995-12#1)(2008-7#1)(2008-8#1)(2010-8#1)
fishes can##2##2##(2010-8#2)
fishes of##2##2##(2008-7#1)(2011-2#1)
fishes with##3##2##(2010-8#3)
fishes##43##1##(1995-12#1)(2008-10#2)(2008-12#1)(2008-7#5)(2008-8#8)(2008-9#2)(2010-8#20)(2011-2#1)(2012-2#3)
fishing and farming communities##2##4##(2009-8#2)
fishing and##3##2##(2009-8#3)
fishing##8##1##(2008-12#1)(2009-8#4)(2010-8#1)(2011-1#1)(2012-2#1)
fission of##3##2##(1992-8#1)(2009-10#2)
fission products##5##2##(2008-10#5)
fission yeast Schizosaccharomyces pombe##5##4##(1995-2#1)(1995-9#1)(1997-3#1)(2008-9#1)(2012-3#1)
fission yeast##10##2##(1993-9#1)(1995-2#3)(1995-9#1)(1997-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
fission##25##1##(1992-8#1)(1993-9#1)(1995-2#3)(1995-6#1)(1995-9#1)(1997-3#1)(2008-10#7)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)
fissure##5##1##(1990-3#1)(1996-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
fissures##2##1##(1997-3#1)(2008-10#1)
fistula and stenosis##2##3##(1992-9#1)(2010-12#1)
fistula and##4##2##(1992-9#1)(2008-11#1)(2008-7#1)(2010-12#1)
fistula animals##3##2##(2008-7#3)
fistula between the##2##3##(2012-12#2)
fistula developed##2##2##(1991-3#1)(1996-3#1)
fistula formation##2##2##(2008-7#1)(2013-1#1)
fistula in a##2##3##(1990-9#1)(2008-10#1)
fistula in##4##2##(1990-9#1)(1993-6#1)(2008-10#1)(2008-11#1)
fistula is##3##2##(1997-3#1)(2009-1#1)(2012-12#1)
fistula of the##2##3##(1993-2#1)(1996-9#1)
fistula was found##2##3##(2008-7#1)(2013-1#1)
fistula was##8##2##(1996-9#3)(1997-3#1)(2008-7#1)(2013-1#3)
fistula##82##1##(1990-9#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-9#1)(1993-2#3)(1993-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#10)(1997-3#8)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#3)(2008-7#8)(2008-8#1)(2009-1#5)(2010-12#1)(2011-2#2)(2011-3#2)(2012-12#8)(2012-3#3)(2013-1#10)
fistulae##18##1##(1991-6#1)(1996-9#9)(2007-8#1)(2008-11#2)(2008-7#3)(2012-2#1)(2013-1#1)
fistulas and##2##2##(1997-8#1)(2008-7#1)
fistulas##20##1##(1993-2#1)(1996-3#3)(1996-6#1)(1997-8#4)(2008-7#6)(2010-12#3)(2012-12#1)(2013-1#1)
fistulizing and fibrostenotic Crohn's disease##2##5##(2010-12#2)
fistulizing##4##1##(2008-10#1)(2010-12#3)
fistulous##2##1##(2008-11#1)(2008-7#1)
fit a##5##2##(1991-5#1)(2008-10#3)(2008-9#1)
fit and##4##2##(1993-12#1)(1997-2#1)(2012-2#1)(2013-1#1)
fit best##2##2##(2008-10#2)
fit between their##2##3##(1993-1#1)(2009-10#1)
fit between##5##2##(1993-1#1)(2008-11#1)(2009-10#1)(2009-7#1)(2012-3#1)
fit constellations##2##2##(2009-10#2)
fit for practice##3##3##(2008-11#2)(2008-12#1)
fit for##9##2##(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)
fit in the##2##3##(1994-2#1)(2008-10#1)
fit in##4##2##(1994-2#1)(2008-10#3)
fit indices##4##2##(2012-2#3)(2013-1#1)
fit into the##2##3##(2009-6#1)(2013-1#1)
fit into##9##2##(1991-12#1)(1992-12#1)(1994-12#1)(1997-4#1)(2008-10#2)(2009-6#1)(2010-11#1)(2013-1#1)
fit of the##7##3##(2008-10#5)(2008-2#1)(2011-2#1)
fit of##13##2##(1996-3#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
fit parameters##2##2##(2008-10#1)(2008-8#1)
fit than##3##2##(2008-10#2)(2013-8#1)
fit the Rasch##2##3##(2012-2#2)
fit the data##3##3##(2008-3#3)
fit the##19##2##(2008-10#6)(2008-12#1)(2008-3#4)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
fit to a##3##3##(2008-10#3)
fit to the full molecular line shape in conjunction with in situ##2##12##(2008-3#2)
fit to the observed data##2##5##(2008-10#1)(2008-8#1)
fit to the observed##4##4##(2008-10#2)(2008-8#1)(2010-10#1)
fit to the##11##3##(1996-12#1)(2008-10#5)(2008-3#3)(2008-8#1)(2010-10#1)
fit to##19##2##(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#10)(2008-3#3)(2008-8#1)(2010-10#1)(2013-1#1)
fit was##2##2##(1995-9#1)(2008-10#1)
fit well with the##2##4##(2008-1#1)(2011-2#1)
fit well with##3##3##(1993-6#1)(2008-1#1)(2011-2#1)
fit well##5##2##(1993-6#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
fit with##3##2##(2008-10#1)(2009-4#1)(2013-1#1)
fit##149##1##(1991-12#1)(1991-5#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(2008-1#1)(2008-10#52)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#11)(2008-8#6)(2008-9#3)(2009-10#8)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#4)(2012-2#12)(2012-3#3)(2013-1#6)(2013-8#4)
fitness (number of seeds##2##4##(2008-9#2)
fitness and its##2##3##(2008-9#1)(2012-2#1)
fitness and that##2##3##(2008-10#1)(2008-8#1)
fitness and##15##2##(1997-7#1)(2008-10#3)(2008-8#2)(2008-9#3)(2012-2#4)(2012-3#1)(2013-1#1)
fitness are##2##2##(2008-10#1)(2008-9#1)
fitness at##2##2##(2008-8#2)
fitness benefit##2##2##(2008-10#1)(2008-8#1)
fitness benefits##4##2##(2008-10#1)(2008-8#1)(2012-3#2)
fitness by##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
fitness components##9##2##(2008-10#1)(2008-8#5)(2008-9#2)(2013-1#1)
fitness consequences of##3##3##(2008-8#3)
fitness consequences##4##2##(2008-8#4)
fitness cost##5##2##(2008-10#1)(2008-8#4)
fitness costs##3##2##(2008-8#1)(2008-9#2)
fitness for##2##2##(2008-10#1)(2008-11#1)
fitness function##3##2##(2008-10#1)(2008-9#1)(2010-10#1)
fitness gain functions##3##3##(2008-9#3)
fitness have been##2##3##(2008-8#1)(2008-9#1)
fitness in the##3##3##(2008-10#1)(2008-9#2)
fitness in##16##2##(1997-7#2)(2008-10#4)(2008-11#1)(2008-8#4)(2008-9#5)
fitness is a##2##3##(2008-8#2)
fitness is##7##2##(2008-7#1)(2008-8#5)(2008-9#1)
fitness level##4##2##(2013-1#1)(2013-8#3)
fitness measures##2##2##(2008-8#2)
fitness of females##2##3##(2008-9#2)
fitness of the##5##3##(2008-10#4)(2008-8#1)
fitness of##18##2##(2008-10#10)(2008-8#5)(2008-9#3)
fitness payoffs##2##2##(2008-8#2)
fitness through increased##2##3##(2008-8#1)(2008-9#1)
fitness was##2##2##(2008-10#2)
fitness##215##1##(1991-3#1)(1991-8#1)(1995-2#1)(1996-2#1)(1997-7#3)(2008-10#43)(2008-11#2)(2008-7#2)(2008-8#78)(2008-9#41)(2009-5#1)(2009-8#1)(2010-1#4)(2010-10#2)(2010-4#4)(2011-2#1)(2012-2#9)(2012-3#10)(2013-1#5)(2013-8#5)
fitness)##3##1##(2008-8#1)(2010-10#2)
fits into##2##2##(2008-11#1)(2010-5#1)
fits with##3##2##(1994-3#1)(2008-8#1)(2010-8#1)
fits##17##1##(1994-3#1)(1996-1#2)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-6#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
fitted into a##2##3##(2008-5#1)(2008-9#1)
fitted model##3##2##(2008-10#2)(2008-8#1)
fitted the##6##2##(1991-12#1)(2008-10#5)
fitted to experimental##2##3##(2008-3#1)(2008-7#1)
fitted to the##7##3##(1996-2#1)(2008-10#6)
fitted to##23##2##(1996-2#1)(2008-10#12)(2008-11#1)(2008-3#3)(2008-7#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
fitted values##2##2##(1995-9#1)(2008-10#1)
fitted well##2##2##(2008-10#1)(2008-5#1)
fitted with a##7##3##(1994-8#1)(1997-2#1)(2008-10#2)(2008-9#2)(2009-12#1)
fitted with##13##2##(1992-12#1)(1994-8#1)(1997-2#2)(2008-10#4)(2008-11#1)(2008-9#2)(2009-12#1)(2011-2#1)
fitted##61##1##(1991-12#1)(1992-12#1)(1994-8#1)(1995-9#1)(1996-2#1)(1997-2#2)(2008-10#30)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-7#1)(2011-2#4)(2011-3#1)(2012-3#3)(2013-1#1)
fitter##3##1##(2012-2#3)
fitting a##3##2##(2008-10#3)
fitting of##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
fitting procedure##3##2##(2008-10#3)
fitting the data##4##3##(1990-8#1)(2008-10#1)(2008-7#1)(2010-4#1)
fitting the experimental data##2##4##(2008-10#1)(2008-2#1)
fitting the##14##2##(1990-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)
fitting them to##2##3##(2008-10#1)(2010-1#1)
fitting to##2##2##(2008-3#1)(2008-8#1)
fitting##61##1##(1990-8#1)(1992-3#1)(1996-1#1)(2008-10#22)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#9)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
five Candida##2##2##(2008-5#2)
five adult##2##2##(1996-6#2)
five amino##2##2##(1992-9#1)(1994-5#1)
five analytes##2##2##(2008-10#2)
five and six##2##3##(1990-3#1)(2008-10#1)
five and##7##2##(1990-3#1)(1995-1#1)(1996-8#1)(2008-10#2)(2008-12#1)(2008-5#1)
five areas##3##2##(1993-1#2)(2010-10#1)
five cases of##4##3##(2009-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
five cases##13##2##(1991-6#1)(1991-8#1)(1996-11#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-7#1)(2009-12#2)(2011-2#1)(2012-12#1)(2013-8#1)
five categories##4##2##(1997-1#1)(2008-11#1)(2008-9#1)(2009-6#1)
five cell lines##2##3##(2012-2#2)
five cell##4##2##(2008-11#1)(2008-6#1)(2012-2#2)
five certified##2##2##(2008-10#1)(2008-11#1)
five children##3##2##(1995-5#1)(1996-11#1)(2008-9#1)
five clusters##3##2##(2008-10#3)
five commercial##3##2##(2008-10#3)
five commercially##2##2##(2008-10#2)
five complete open reading frames##2##5##(1995-9#2)
five complete##3##2##(1990-3#1)(1995-9#2)
five compounds##3##2##(2008-10#3)
five consecutive##2##2##(1995-8#1)(2008-5#1)
five continents##3##2##(2008-10#2)(2012-3#1)
five cultivars of##2##3##(2008-10#2)
five cultivars##5##2##(2008-10#4)(2009-8#1)
five cysteine##2##2##(1993-8#1)(1994-11#1)
five days##8##2##(1991-3#1)(1992-5#1)(1995-12#1)(1997-4#1)(2008-11#1)(2008-5#2)(2012-2#1)
five decades##2##2##(1996-3#1)(2012-3#1)
five determinations##3##2##(2008-10#3)
five different groups##2##3##(2008-10#2)
five different##32##2##(1991-1#1)(1992-12#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-5#1)(2013-1#1)
five differentials##3##2##(2008-10#3)
five distinct##2##2##(2008-10#1)(2012-3#1)
five endometriosis##2##2##(1995-12#2)
five experimental##2##2##(2008-10#2)
five experiments##2##2##(2008-10#1)(2012-3#1)
five families##2##2##(1992-7#1)(2008-10#1)
five fractions of##2##3##(2008-10#2)
five fractions##3##2##(2008-10#3)
five genes##4##2##(1995-6#1)(1996-8#1)(2008-10#2)
five genetic##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
five geographic##2##2##(1993-1#1)(2008-10#1)
five groups##10##2##(1990-12#1)(1991-6#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)
five had##2##2##(1992-5#1)(2009-10#1)
five heavy##2##2##(2008-10#2)
five important##2##2##(2008-10#1)(2008-11#1)
five independent##2##2##(2008-10#2)
five individual##2##2##(2008-10#2)
five isolates of##3##3##(1996-12#1)(2008-10#2)
five isolates##7##2##(1996-12#1)(2008-10#6)
five known##2##2##(1997-8#1)(2008-11#1)
five locations throughout##2##3##(2008-10#2)
five locations##4##2##(2008-10#3)(2008-4#1)
five loci##2##2##(2008-12#2)
five main##2##2##(2008-11#2)
five major##2##2##(2008-10#1)(2011-2#1)
five measurements##6##2##(2008-10#6)
five members of the##2##4##(1991-2#1)(1993-12#1)
five minutes##2##2##(2008-10#1)(2008-8#1)
five months##5##2##(1990-9#2)(1993-11#1)(1995-9#1)(2009-6#1)
five naturally##2##2##(2008-10#2)
five of the seven##3##4##(1996-6#1)(2008-10#1)(2008-8#1)
five of the##7##3##(1990-12#1)(1994-12#1)(1996-6#1)(2008-10#2)(2008-8#1)(2008-9#1)
five of these##6##3##(2006-6#1)(2008-10#3)(2008-9#1)(2013-1#1)
five of which##2##3##(2008-10#1)(2010-3#1)
five of##20##2##(1990-12#1)(1991-6#1)(1992-5#1)(1994-12#1)(1996-12#1)(1996-6#1)(2006-6#1)(2008-10#8)(2008-8#1)(2008-9#2)(2010-3#1)(2013-1#1)
five or##4##2##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
five orders##2##2##(2008-10#1)(2011-2#1)
five other##6##2##(2008-10#2)(2008-11#2)(2008-3#1)(2009-6#1)
five others##2##2##(1995-12#1)(2011-3#1)
five out of seven##2##4##(2008-10#1)(2008-9#1)
five out of##4##3##(1996-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
five pCP plants##2##3##(2008-10#2)
five patients with a##2##4##(2013-1#2)
five patients with##7##3##(1990-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)
five patients##15##2##(1990-9#1)(1991-9#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#2)(2012-3#1)(2013-1#4)
five pea lines##2##3##(2008-10#2)
five points along##2##3##(2011-2#2)
five points##4##2##(1991-2#1)(2008-10#1)(2011-2#2)
five populations##2##2##(2008-10#2)
five previously##2##2##(2008-10#1)(2011-2#1)
five protein bands##2##3##(2008-10#2)
five regions##2##2##(2008-10#2)
five repeated##2##2##(2008-10#1)(2011-1#1)
five replant soils##2##3##(2008-10#2)
five replicate analysis of##2##4##(2008-10#2)
five replicate determinations##2##3##(2008-10#2)
five replicate##6##2##(2008-10#6)
five replicates##2##2##(2008-10#2)
five resistant##2##2##(2008-10#2)
five sample injections##2##3##(2008-10#2)
five servings of fruits or vegetables##2##6##(1994-2#1)(2010-8#1)
five soils##2##2##(2008-10#2)
five species in##2##3##(2008-10#1)(2008-9#1)
five species of the genus##2##5##(2010-8#2)
five species of##6##3##(2007-12#1)(2008-10#2)(2010-8#2)(2013-1#1)
five species##14##2##(2007-12#1)(2008-10#6)(2008-11#1)(2008-9#3)(2010-8#2)(2013-1#1)
five states##2##2##(2008-10#2)
five steps##2##2##(2008-10#2)
five strains or four strains without GUT9##2##7##(2008-10#2)
five strains##4##2##(2008-10#4)
five successive##2##2##(2008-10#2)
five susceptible genotypes##2##3##(2008-10#2)
five teacher actions to encourage##3##5##(2008-4#3)
five teacher actions##5##3##(2008-4#5)
five teacher##6##2##(2008-4#6)
five times greater than##2##4##(1993-1#1)(2008-10#1)
five times longer##2##3##(2008-10#2)
five times the##2##3##(2008-10#2)
five times##16##2##(1993-1#1)(1997-8#1)(2008-10#12)(2011-2#2)
five to seven##2##3##(1991-6#1)(2008-11#1)
five to##3##2##(1991-6#1)(1992-5#1)(2008-11#1)
five variables##4##2##(2008-10#4)
five viruses##2##2##(2008-10#2)
five volunteers##2##2##(1992-3#1)(2008-11#1)
five weeks##2##2##(2012-2#2)
five were##4##2##(1991-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
five year##2##2##(1997-2#1)(2013-1#1)
five years after the##2##4##(1991-9#1)(1994-9#1)
five years after##4##3##(1991-9#1)(1993-11#1)(1994-9#1)(2008-9#1)
five years ago##2##3##(1997-3#1)(2010-9#1)
five years in##2##3##(1997-5#1)(2008-1#1)
five years later##3##3##(2012-2#3)
five years of age##2##4##(2011-2#1)(2012-3#1)
five years of##4##3##(1991-8#1)(1992-2#1)(2011-2#1)(2012-3#1)
five years post-implant##3##3##(2008-9#3)
five years##30##2##(1991-8#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-2#1)(1996-11#2)(1997-3#1)(1997-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#5)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
five years' experience##2##3##(1990-3#1)(2012-12#1)
five##728##1##(1990-12#4)(1990-3#4)(1990-5#1)(1990-9#5)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#5)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#5)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#3)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#3)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#3)(1996-6#3)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#4)(1997-7#2)(1997-8#8)(2006-6#2)(2007-12#2)(2008-1#6)(2008-10#308)(2008-11#38)(2008-12#12)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#18)(2008-6#3)(2008-7#10)(2008-8#12)(2008-9#20)(2009-10#1)(2009-12#5)(2009-3#2)(2009-6#5)(2009-8#3)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#3)(2011-2#27)(2011-3#2)(2012-12#5)(2012-2#16)(2012-3#12)(2012-5#1)(2012-9#2)(2013-1#19)(2013-8#10)
five)##2##1##(2008-10#1)(2008-7#1)
five-##2##1##(1993-6#1)(2008-10#1)
five-carbon##2##1##(2012-3#2)
five-component##2##1##(2008-10#2)
five-fold##6##1##(1994-5#1)(2008-10#5)
five-step##2##1##(1996-5#1)(2008-11#1)
five-wave longitudinal study##2##3##(2009-7#2)
five-year follow-up##2##2##(2008-7#1)(2008-8#1)
five-year longitudinal##2##2##(2012-2#2)
five-year period##7##2##(1991-12#1)(1991-6#1)(1991-9#2)(1992-1#1)(2008-10#1)(2008-12#1)
five-year survival##2##2##(2008-7#1)(2011-2#1)
five-year##16##1##(1991-12#1)(1991-6#1)(1991-9#2)(1992-1#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
five-year-old##2##1##(2008-11#1)(2013-1#1)
fivefold increase in##2##3##(2008-10#1)(2008-7#1)
fivefold##7##1##(1993-2#1)(1997-7#1)(2008-10#4)(2008-7#1)
fix the##2##2##(2008-10#1)(2010-9#1)
fix##8##1##(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-9#1)(2011-2#1)
fixated with##3##2##(1991-9#1)(2009-3#2)
fixated##5##1##(1991-9#1)(2008-11#1)(2008-2#1)(2009-3#2)
fixation and##9##2##(2007-11#1)(2008-10#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
fixation device##4##2##(2008-11#1)(2012-2#1)(2013-1#2)
fixation devices##2##2##(2008-11#1)(2013-1#1)
fixation for##5##2##(2011-2#2)(2012-12#1)(2013-1#2)
fixation group##4##2##(2009-3#4)
fixation has##3##2##(2008-8#1)(2010-5#1)(2011-2#1)
fixation in the##5##3##(2008-11#1)(2008-7#1)(2009-3#1)(2009-7#1)(2013-1#1)
fixation in##14##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#4)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
fixation is##5##2##(1991-9#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-3#1)
fixation method##2##2##(2008-11#1)(2008-8#1)
fixation of an OCD loose body##2##6##(2013-1#2)
fixation of the##6##3##(2008-10#3)(2008-7#1)(2009-4#1)(2013-1#1)
fixation of##18##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#4)
fixation protocol##2##2##(2008-9#1)(2009-8#1)
fixation should be##2##3##(2009-4#1)(2012-12#1)
fixation techniques for##2##3##(2008-12#1)(2012-3#1)
fixation techniques##3##2##(2008-12#1)(2010-12#1)(2012-3#1)
fixation test##2##2##(1992-5#1)(2013-1#1)
fixation to the##2##3##(2008-10#1)(2008-8#1)
fixation to##3##2##(2008-10#1)(2008-8#1)(2010-12#1)
fixation was used in##3##4##(2008-7#1)(2009-3#2)
fixation was used##4##3##(2008-7#1)(2009-3#3)
fixation was##8##2##(2008-12#1)(2008-7#1)(2009-3#3)(2011-2#1)(2013-1#2)
fixation with##3##2##(1995-2#1)(2008-12#1)(2011-2#1)
fixation##154##1##(1990-12#1)(1990-6#1)(1991-9#1)(1992-5#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#8)(2008-12#6)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#3)(2009-3#14)(2009-4#4)(2009-7#2)(2009-8#3)(2010-12#5)(2010-5#2)(2010-9#1)(2011-2#12)(2012-12#7)(2012-2#4)(2012-3#5)(2012-8#1)(2013-1#27)
fixation)##2##1##(2008-11#1)(2008-12#1)
fixation-free rehalogenating bleaching##2##3##(2008-3#2)
fixation-free rehalogenating##3##2##(2008-3#3)
fixations##3##1##(1990-6#1)(2008-11#1)(2013-1#1)
fixative solution##2##2##(2008-9#1)(2010-9#1)
fixative##7##1##(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-9#1)
fixatives##2##1##(2008-5#1)(2008-9#1)
fixator##3##1##(2007-8#1)(2008-8#2)
fixators##3##1##(2007-11#1)(2008-8#2)
fixed a##2##2##(2008-10#1)(2009-7#1)
fixed and##9##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
fixed at##5##2##(2008-10#3)(2008-2#1)(2008-5#1)
fixed by##2##2##(2008-10#1)(2008-12#1)
fixed cell##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
fixed cells##5##2##(1990-12#1)(2008-10#1)(2008-9#3)
fixed combination##3##2##(1991-6#1)(2013-1#2)
fixed in the##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
fixed in##9##2##(1996-5#1)(2008-10#6)(2008-11#1)(2008-5#1)
fixed interference method (FIM) indicate##2##5##(2008-10#2)
fixed interference method (FIM)##3##4##(2008-10#3)
fixed interference method##5##3##(2008-10#5)
fixed interference##6##2##(2008-10#6)
fixed muscle weakness##2##3##(1991-12#2)
fixed nitrogen##3##2##(2008-9#2)(2011-2#1)
fixed on Sephadex##2##3##(2008-10#2)
fixed on a##5##3##(2008-10#5)
fixed on the##3##3##(2008-10#2)(2010-8#1)
fixed on##12##2##(2008-10#11)(2010-8#1)
fixed or##2##2##(2008-4#1)(2013-1#1)
fixed parameter controller##2##3##(1997-2#2)
fixed parameter##3##2##(1997-2#2)(2008-9#1)
fixed samples##2##2##(2008-7#1)(2008-9#1)
fixed time and initial rate##2##5##(2008-10#2)
fixed time and##3##3##(2008-10#3)
fixed time##8##2##(2008-10#7)(2012-2#1)
fixed to##3##2##(1995-3#1)(1995-9#1)(2008-10#1)
fixed triangular waves##2##3##(2008-10#2)
fixed weight##2##2##(1993-3#1)(1996-2#1)
fixed with a##4##3##(2008-10#1)(2008-9#1)(2010-3#1)(2013-1#1)
fixed with##10##2##(1990-12#1)(1996-12#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-1#5)
fixed##210##1##(1990-12#3)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1997-2#2)(2008-10#74)(2008-11#11)(2008-12#7)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#11)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#7)(2011-7#2)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#3)
fixed)##2##1##(2008-10#1)(2008-9#1)
fixed-bed bioreactor##2##2##(2008-11#2)
fixed-bed column##2##2##(2008-12#2)
fixed-bed reactor##3##2##(2008-11#2)(2008-7#1)
fixed-bed##8##1##(2008-11#5)(2008-12#2)(2008-7#1)
fixed-removable prosthesis##2##2##(2013-1#2)
fixed-time (45##2##2##(2008-5#2)
fixed-time method##2##2##(2008-10#2)
fixed-time##6##1##(2008-10#3)(2008-5#3)
fixing the##3##2##(1991-11#1)(2008-10#2)
fixing##10##1##(1991-11#1)(2008-10#3)(2008-8#2)(2008-9#1)(2011-2#3)
flaccid paralysis##4##2##(2010-8#4)
flaccid##5##1##(2010-8#5)
flaccidifolious##2##1##(2013-1#2)
flag leaf##7##2##(2008-10#6)(2008-9#1)
flag leaves and##3##3##(2008-9#3)
flag leaves of##2##3##(2008-10#2)
flag leaves##12##2##(2008-10#7)(2008-9#5)
flag shoot subpopulation of E##2##5##(2008-10#2)
flag shoot subpopulation##4##3##(2008-10#4)
flag shoot##5##2##(2008-10#5)
flag shoots for##2##3##(2008-10#2)
flag shoots##5##2##(2008-10#5)
flag##35##1##(2008-10#24)(2008-12#5)(2008-9#6)
flagella##11##1##(2007-12#7)(2008-10#1)(2011-1#1)(2011-2#2)
flagellar##4##1##(1993-12#2)(2007-12#1)(2008-10#1)
flagellate zoospores##2##2##(2008-10#2)
flagellomeres##3##1##(2007-12#3)
flagellum and##3##2##(2007-12#2)(2008-7#1)
flagellum##16##1##(2007-12#5)(2008-10#1)(2008-7#9)(2009-8#1)
flags##6##1##(2008-10#1)(2008-12#5)
flakes##2##1##(2008-5#2)
flame AAS after##2##3##(2008-10#2)
flame AAS method##2##3##(2008-10#2)
flame AAS was used##2##4##(2008-10#2)
flame AAS##14##2##(2008-10#14)
flame absorption##2##2##(2008-10#2)
flame and##4##2##(2008-10#4)
flame atomic absorption spectrometer (FAAS)##2##5##(2008-10#2)
flame atomic absorption spectrometer##11##4##(2008-10#11)
flame atomic absorption spectrometric determination of##3##6##(2008-10#3)
flame atomic absorption spectrometric determination##4##5##(2008-10#4)
flame atomic absorption spectrometric##11##4##(2008-10#11)
flame atomic absorption spectrometry (AAS)##2##5##(2008-10#2)
flame atomic absorption spectrometry (FAAS) and##6##6##(2008-10#6)
flame atomic absorption spectrometry (FAAS) determination of##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) for##2##6##(2008-10#2)
flame atomic absorption spectrometry (FAAS) is proposed##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) is##5##6##(2008-10#5)
flame atomic absorption spectrometry (FAAS) was developed##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) was##4##6##(2008-10#4)
flame atomic absorption spectrometry (FAAS)##48##5##(2008-10#48)
flame atomic absorption spectrometry and UV-visible spectrophotometric methods##2##8##(2008-10#2)
flame atomic absorption spectrometry and##3##5##(2008-10#3)
flame atomic absorption spectrometry for##3##5##(2008-10#3)
flame atomic absorption spectrometry in##2##5##(2008-10#2)
flame atomic absorption spectrometry is##4##5##(2008-10#4)
flame atomic absorption spectrometry was used##2##6##(2008-10#2)
flame atomic absorption spectrometry with##2##5##(2008-10#2)
flame atomic absorption spectrometry##121##4##(2008-10#121)
flame atomic absorption spectrophotometry (FAAS)##4##5##(2008-10#4)
flame atomic absorption spectrophotometry##10##4##(2008-10#10)
flame atomic absorption##162##3##(2008-10#162)
flame atomic emission##2##3##(2008-10#2)
flame atomic##166##2##(2008-10#166)
flame emission##2##2##(2008-10#2)
flame ionisation##3##2##(2008-10#3)
flame ionization detector##5##3##(2008-10#4)(2008-11#1)
flame ionization##6##2##(2008-10#5)(2008-11#1)
flame is##2##2##(2008-10#1)(2008-2#1)
flame photometric detector##3##3##(2008-10#3)
flame photometric##6##2##(2008-10#6)
flame that##2##2##(2008-3#2)
flame was##3##2##(2008-10#1)(2008-3#2)
flame##261##1##(1997-3#1)(2008-10#238)(2008-11#2)(2008-2#3)(2008-3#17)
flame-AAS##2##1##(2008-10#2)
flame-synthesized##2##1##(2008-3#2)
flames were##2##2##(2008-3#2)
flames##21##1##(1994-12#1)(2008-2#1)(2008-3#19)
flank##10##1##(1993-8#1)(1995-6#1)(1997-7#1)(2008-12#3)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#1)
flanked by a##2##3##(1993-8#1)(2012-3#1)
flanked by##5##2##(1993-8#1)(2008-10#2)(2008-8#1)(2012-3#1)
flanking DNA of##3##3##(2008-11#2)(2008-8#1)
flanking DNA##4##2##(1991-6#1)(2008-11#2)(2008-8#1)
flanking genomic##2##2##(1995-2#1)(1997-7#1)
flanking region of the human##2##5##(1993-12#2)
flanking region of##4##3##(1991-5#1)(1993-12#3)
flanking region##10##2##(1991-5#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-6#2)(1994-11#1)(2008-12#1)
flanking regions and##2##3##(1994-11#1)(1995-5#1)
flanking regions were##2##3##(1993-8#1)(2008-8#1)
flanking regions##10##2##(1990-11#1)(1990-8#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-5#1)(2008-8#1)
flanking sequences##6##2##(1994-11#1)(1995-6#1)(1997-7#1)(2008-10#2)(2011-10#1)
flanking the##13##2##(1991-10#1)(1991-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#4)(2008-11#1)(2010-4#1)(2010-8#1)(2012-3#1)
flanking##61##1##(1990-11#1)(1990-8#2)(1991-10#1)(1991-5#1)(1991-6#2)(1992-3#2)(1993-12#6)(1993-2#1)(1993-6#5)(1993-8#2)(1994-11#3)(1994-5#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1997-7#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-8#4)(2008-9#1)(2010-4#1)(2010-8#1)(2011-10#1)(2012-3#1)
flap after##2##2##(1994-12#1)(2013-1#1)
flap and##4##2##(2008-7#1)(2008-9#2)(2013-1#1)
flap for##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)
flap in breast reconstruction##2##4##(1990-9#2)
flap in##4##2##(1990-9#2)(2008-9#1)(2011-2#1)
flap is##3##2##(2008-9#1)(2012-12#2)
flap of the##2##3##(2011-2#2)
flap of##3##2##(1993-3#1)(2011-2#2)
flap perfusion##2##2##(2013-1#2)
flap reconstruction##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
flap reconstructions##2##2##(2012-2#2)
flap to##2##2##(2008-9#2)
flap was##6##2##(1992-9#1)(2008-9#2)(2009-1#1)(2013-1#2)
flap##67##1##(1990-9#4)(1992-9#1)(1993-11#2)(1993-3#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-7#7)(2008-9#15)(2009-1#5)(2010-11#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#12)
flaps##18##1##(2008-12#3)(2008-9#6)(2010-6#2)(2011-2#1)(2012-12#2)(2013-1#4)
flare##2##1##(1992-5#1)(2008-5#1)
flares##2##1##(1992-5#1)(2008-7#1)
flash of ions due to the ionisation of##2##8##(2008-10#2)
flash##8##1##(1997-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-5#2)
flash-lamp-pumped dye laser##3##3##(2008-2#2)(2008-3#1)
flash-lamp-pumped##5##1##(2008-2#3)(2008-3#2)
flashes in##2##2##(2008-7#1)(2009-5#1)
flashes##8##1##(1995-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-5#2)
flask by##2##2##(2008-10#1)(2008-11#1)
flask in##2##2##(2008-10#1)(2008-11#1)
flask##19##1##(2008-10#4)(2008-11#13)(2008-12#1)(2008-4#1)
flasks and##3##2##(2008-11#3)
flasks using##2##2##(2008-11#1)(2011-2#1)
flasks##20##1##(1995-11#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#6)
flat cell##2##2##(2008-10#2)
flat end##2##2##(2008-10#2)
flat or##2##2##(2008-8#2)
flat surfaces##4##2##(2008-3#3)(2010-7#1)
flat top beam profile was used in single point mode sampling##2##11##(2008-10#2)
flat##46##1##(1991-2#4)(1993-8#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-3#8)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
flat-flame burner##3##2##(2008-3#3)
flatness##2##1##(2007-12#1)(2008-11#1)
flattened cells##2##2##(1990-6#1)(2013-1#1)
flattened##11##1##(1990-6#1)(1993-12#1)(1994-12#1)(1997-2#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-9#1)(2013-1#1)
flattening of the##2##3##(1990-3#1)(2008-5#1)
flattening of##3##2##(1990-3#1)(1995-1#1)(2008-5#1)
flattening##5##1##(1990-3#1)(1995-1#1)(2008-5#1)(2008-7#1)(2009-9#1)
flattop##3##1##(2008-2#1)(2008-3#2)
flavanols##2##1##(2008-10#1)(2012-12#1)
flavescens##2##1##(2008-11#2)
flavida##3##1##(2011-2#3)
flavilium cation##3##2##(2008-10#3)
flavin##6##1##(1992-1#2)(1992-12#1)(2008-11#1)(2008-8#1)(2009-3#1)
flavodoxin and##4##2##(1994-5#4)
flavodoxin gene##3##2##(1997-7#3)
flavodoxin##12##1##(1994-5#8)(1997-7#4)
flavone##2##1##(2008-10#2)
flavone-C-glycoside##2##1##(2008-10#2)
flavone-C-glycosides##3##1##(2008-10#3)
flavones##6##1##(2008-10#1)(2008-11#1)(2011-3#2)(2012-3#1)(2013-8#1)
flavonoid aglycones##3##2##(2008-11#3)
flavonoid derivatives##2##2##(1993-8#2)
flavonoid structure##2##2##(2008-10#1)(2008-11#1)
flavonoid##22##1##(1993-8#2)(2008-10#8)(2008-11#5)(2008-5#1)(2008-9#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#1)
flavonoids and##3##2##(2008-10#2)(2009-8#1)
flavonoids from##2##2##(2012-12#2)
flavonoids in H##2##3##(2008-10#2)
flavonoids in the##3##3##(2008-10#1)(2008-11#2)
flavonoids in##12##2##(2008-10#9)(2008-11#2)(2011-2#1)
flavonoids of##3##2##(2008-10#2)(2013-8#1)
flavonoids##56##1##(1992-5#1)(1993-8#1)(2008-10#31)(2008-11#11)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#4)(2011-3#1)(2012-12#3)(2013-8#1)
flavonols##3##1##(2008-10#2)(2008-11#1)
flavopiridol##4##1##(2008-5#4)
flavor compounds##3##2##(2008-10#1)(2012-2#2)
flavor##13##1##(2008-10#3)(2008-5#4)(2010-7#2)(2011-2#1)(2012-2#3)
flavors##7##1##(1991-3#2)(2008-10#4)(2009-9#1)
flavour##7##1##(2008-10#4)(2008-5#1)(2010-4#1)(2012-3#1)
flavoviridis##2##1##(2008-6#2)
flavus and F##2##3##(2008-10#2)
flavus and##13##2##(2008-10#13)
flavus by##2##2##(2008-10#2)
flavus can be divided into the S and L strains##2##10##(2008-10#2)
flavus in##3##2##(2008-10#3)
flavus infection and aflatoxin accumulation##2##5##(2008-10#2)
flavus infection and##3##3##(2008-10#3)
flavus infection##6##2##(2008-10#6)
flavus infection)##2##2##(2008-10#2)
flavus is##3##2##(2008-10#3)
flavus isolates##2##2##(2008-10#2)
flavus was grown##2##3##(2008-10#2)
flavus was##6##2##(2008-10#6)
flavus were##2##2##(2008-10#2)
flavus##81##1##(2008-10#79)(2009-5#1)(2013-1#1)
flavus-inoculated rows##2##2##(2008-10#2)
flaw##2##1##(2009-7#1)(2013-1#1)
flawed##4##1##(1991-3#1)(1995-12#1)(1996-8#1)(2012-3#1)
flaws##10##1##(2008-12#6)(2009-7#2)(2010-7#1)(2011-2#1)
flax roots##3##2##(2008-10#3)
flax##12##1##(1992-8#2)(2008-10#9)(2008-12#1)
flaxseed flour##10##2##(2010-4#10)
fldA gene##5##2##(1997-7#5)
fldA##7##1##(1997-7#7)
flea beetle populations##2##3##(2008-10#2)
flea##11##1##(2008-10#9)(2012-3#2)
fled##3##1##(1994-9#2)(2008-11#1)
fleece score##3##2##(1997-5#3)
fleece##10##1##(1997-5#8)(2013-8#2)
fleeing##2##1##(1996-2#1)(1997-2#1)
fleet##3##1##(1996-12#1)(2008-11#2)
fleeting##2##1##(1992-5#1)(2009-8#1)
flesh##5##1##(1990-5#1)(2008-10#2)(2008-12#1)(2008-9#1)
fleshy fruits##4##2##(2008-8#1)(2008-9#3)
fleshy##8##1##(1992-1#1)(2008-8#2)(2008-9#5)
fleur de peau'##2##3##(2008-5#2)
fleur de##3##2##(2008-5#3)
flexed and##2##2##(2008-12#2)
flexed##11##1##(1997-8#6)(2007-12#1)(2008-12#3)(2013-1#1)
flexibility and friction##2##3##(1997-3#2)
flexibility and##12##2##(1992-1#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2013-1#1)(2013-8#1)
flexibility by##2##2##(1997-2#1)(2008-9#1)
flexibility in patients with##2##4##(2008-10#1)(2010-12#1)
flexibility in the##3##3##(1994-11#1)(2010-1#1)(2011-1#1)
flexibility in##15##2##(1991-1#1)(1994-11#2)(1994-6#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
flexibility of the##5##3##(1995-11#1)(2008-10#2)(2008-6#1)(2008-8#1)
flexibility of##14##2##(1995-11#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-9#1)
flexibility to##4##2##(1995-8#1)(1997-3#1)(2008-10#1)(2012-2#1)
flexibility##72##1##(1990-12#1)(1990-4#2)(1991-1#1)(1992-1#2)(1994-11#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-11#1)(2008-10#13)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2011-1#2)(2011-2#1)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
flexible and##11##2##(1992-2#1)(1994-12#1)(1995-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)
flexible behavioral##2##2##(2008-9#2)
flexible enough to##2##3##(2008-10#1)(2009-8#1)
flexible enough##3##2##(2008-10#1)(2009-8#1)(2011-1#1)
flexible hysteroscopy##2##2##(1993-12#2)
flexible mirror##2##2##(2008-3#2)
flexible polyimide##2##2##(2008-10#2)
flexible response##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
flexible to##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
flexible way##2##2##(2008-10#1)(2008-3#1)
flexible##96##1##(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#2)(1994-12#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-6#2)(2007-12#4)(2007-9#1)(2008-10#19)(2008-11#10)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#5)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
flexibly##3##1##(2008-10#1)(2008-7#1)(2009-6#1)
flexicurity##5##1##(2012-2#5)
flexing##2##1##(2008-12#2)
flexion and extension##2##3##(1991-6#1)(1996-6#1)
flexion and##5##2##(1991-6#1)(1996-6#1)(2008-8#2)(2011-2#1)
flexion angle##5##2##(2011-2#1)(2013-1#4)
flexion at##2##2##(2009-11#1)(2013-8#1)
flexion by##2##2##(2008-9#2)
flexion excursion##2##2##(2011-2#2)
flexion in the##2##3##(2008-9#1)(2010-9#1)
flexion in##5##2##(2008-12#2)(2008-9#1)(2009-3#1)(2010-9#1)
flexion of the##4##3##(2008-9#3)(2009-1#1)
flexion of##6##2##(2008-9#4)(2009-1#1)(2013-1#1)
flexion phase##3##2##(1997-2#3)
flexion with the##2##3##(1993-3#1)(2010-9#1)
flexion with##3##2##(1993-3#1)(2010-9#2)
flexion##51##1##(1991-6#1)(1993-3#1)(1996-6#1)(1997-2#3)(2007-8#1)(2008-12#5)(2008-8#3)(2008-9#11)(2009-1#2)(2009-11#1)(2009-3#2)(2010-9#6)(2011-2#6)(2012-3#1)(2013-1#6)(2013-8#1)
flexneri 2a strain##2##3##(2008-9#2)
flexneri injectisomes##2##2##(2013-8#2)
flexneri##7##1##(1993-12#2)(2008-10#1)(2008-9#2)(2013-8#2)
flexor digitorum brevis##2##3##(2010-5#2)
flexor digitorum##5##2##(2008-12#1)(2008-5#2)(2010-5#2)
flexor spasms due to a##2##5##(2009-11#2)
flexor spasms##4##2##(2009-11#4)
flexor tendons and the##2##4##(2008-9#2)
flexor##22##1##(2007-12#2)(2008-12#1)(2008-5#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#4)(2010-5#2)(2010-7#2)(2011-2#2)(2012-3#1)
flexuous filamentous##2##2##(2008-10#2)
flexuous particles##2##2##(2008-10#2)
flexuous rod-shaped##2##2##(2008-10#2)
flexuous##6##1##(2008-10#6)
flexural modulus##2##2##(2009-7#2)
flexural resonance frequency shift of a piezoelectric microcantilever sensor##2##9##(2009-5#2)
flexural resonance frequency shift of##3##5##(2009-5#3)
flexural resonance frequency shift##4##4##(2009-5#4)
flexural strength##8##2##(2009-7#8)
flexural##17##1##(2008-5#2)(2009-5#4)(2009-7#10)(2013-1#1)
flexure##7##1##(1990-3#1)(2008-12#4)(2009-7#1)(2012-12#1)
flies (Raphidioptera)##2##2##(2008-12#2)
flies and##5##2##(2008-10#1)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#1)
flies are##3##2##(2008-12#2)(2008-9#1)
flies in##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
flies to##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
flies was##3##2##(2008-12#1)(2013-8#2)
flies##66##1##(1990-3#1)(1993-9#1)(1995-2#1)(1995-6#10)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#9)(2008-8#7)(2008-9#11)(2010-1#2)(2010-10#1)(2010-4#3)(2012-3#2)(2013-1#4)(2013-8#6)
flies/trap/week)##2##1##(2013-8#2)
flight behavior##2##2##(2008-10#1)(2008-9#1)
flight muscles##3##2##(2008-9#3)
flight season##3##2##(2008-5#1)(2012-3#2)
flight tests##2##2##(1996-12#1)(2008-3#1)
flight##38##1##(1991-2#1)(1996-12#6)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#3)(2008-8#4)(2008-9#8)(2009-8#1)(2012-3#2)
flight-capable##3##1##(2008-9#3)
flightless G##2##2##(2008-9#2)
flightless individuals##2##2##(2008-9#2)
flightless##7##1##(2008-8#1)(2008-9#6)
flights are##2##2##(2008-3#2)
flights##7##1##(1990-6#1)(2008-11#2)(2008-3#2)(2008-9#1)(2010-3#1)
flint##4##1##(2008-10#4)
flip-flop of##2##2##(1994-5#2)
flip-flop##12##1##(1994-5#12)
float##4##1##(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
floater##4##1##(2008-8#2)(2008-9#2)
floaters##11##1##(2008-10#1)(2008-8#9)(2008-9#1)
floating AH109A cells##3##3##(2008-11#3)
floating##12##1##(2008-11#6)(2008-9#3)(2009-5#1)(2011-2#1)(2012-3#1)
floc size##2##2##(2008-7#2)
floc strength##2##2##(2008-7#2)
floc##6##1##(2008-10#2)(2008-7#4)
flocculated##2##1##(2008-11#2)
flocculation during##2##2##(2008-7#2)
flocculation##13##1##(2008-10#2)(2008-11#1)(2008-7#10)
flocculosa as##2##2##(2008-10#2)
flocculosa from other##2##3##(2008-10#2)
flocculosa##9##1##(2008-10#9)
flock##2##1##(2008-5#2)
flocks and##2##2##(2008-5#2)
flocks was##2##2##(2008-5#1)(2011-2#1)
flocks##9##1##(2008-5#6)(2011-2#3)
flocs and##2##2##(2008-7#2)
flocs##3##1##(2008-7#3)
flood depth##2##2##(2008-10#2)
flood in##2##2##(1996-6#1)(2013-8#1)
flood water##4##2##(1996-6#1)(2008-10#3)
flood##14##1##(1991-2#1)(1996-6#2)(2007-11#1)(2008-10#6)(2008-3#1)(2009-3#1)(2013-8#2)
flooded##3##1##(2008-10#2)(2013-8#1)
flooding##10##1##(1991-2#1)(2008-10#1)(2012-5#7)(2013-8#1)
floods in##2##2##(1996-6#1)(2008-10#1)
floods##9##1##(1992-12#1)(1996-6#3)(2008-10#1)(2013-8#4)
floor and##6##2##(1996-12#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
floor of##5##2##(1996-5#1)(1997-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
floor plate##6##2##(1993-12#2)(1994-12#4)
floor##43##1##(1993-12#2)(1994-12#5)(1995-6#3)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)
floors##3##1##(1996-12#2)(2008-3#1)
flora and##2##2##(2008-5#1)(2011-2#1)
flora in##2##2##(2011-2#1)(2013-1#1)
flora##14##1##(1990-6#1)(1993-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-1#1)(2011-2#5)(2012-2#1)(2013-1#1)
floral and##3##2##(2008-10#2)(2011-2#1)
floral homeotic##2##2##(2008-8#2)
floral integration has##2##3##(2009-8#2)
floral integration##7##2##(2009-8#7)
floral organ identity##2##3##(1997-8#1)(2008-8#1)
floral organs##7##2##(2008-10#3)(2008-8#4)
floral traits##5##2##(2008-8#1)(2009-8#4)
floral##42##1##(1997-8#1)(2008-10#13)(2008-8#10)(2009-6#3)(2009-8#13)(2011-10#1)(2011-2#1)
floras of##3##2##(2008-8#3)
floras##4##1##(2008-8#4)
floret mouth##2##2##(2008-10#2)
floret##7##1##(2008-10#7)
florets##11##1##(2008-10#9)(2008-8#1)(2012-3#1)
floribunda 821##4##2##(2008-10#4)
floribunda##5##1##(2008-10#5)
florid##2##1##(1990-3#1)(2011-2#1)
florisil cartridges##2##2##(2008-10#2)
florisil column##2##2##(2008-10#1)(2008-11#1)
florisil##4##1##(2008-10#3)(2008-11#1)
floristic relationships##2##2##(2008-8#2)
floristic similarity between EAS##2##4##(2008-8#2)
floristic similarity between##3##3##(2008-8#3)
floristic##5##1##(2008-8#5)
flos##2##1##(2013-8#2)
flotation and##2##2##(2008-10#2)
flotation##15##1##(2008-10#14)(2008-4#1)
flotation-extraction##2##1##(2008-10#2)
flounder##5##1##(1994-11#1)(2008-6#2)(2010-8#2)
flour and##3##2##(1990-3#1)(2008-10#2)
flour beetle##2##2##(2008-12#1)(2008-9#1)
flour was##3##2##(2008-10#2)(2010-4#1)
flour##45##1##(1990-3#6)(1991-6#1)(1997-2#1)(2008-10#24)(2008-12#1)(2008-9#1)(2010-4#11)
flour)##4##1##(2008-10#4)
flourish##2##1##(1992-3#1)(2009-5#1)
flow (EOF)##5##2##(1997-2#1)(2008-10#4)
flow allows##2##2##(2008-11#1)(2008-9#1)
flow analysis (MSFA)##3##3##(2008-10#3)
flow analysis (SI-MSFA)##2##3##(2008-10#2)
flow analysis database##2##3##(2008-10#2)
flow analysis in##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
flow analysis method##2##3##(2008-10#2)
flow analysis of##4##3##(2008-10#4)
flow analysis system##10##3##(2008-10#10)
flow analysis systems##3##3##(2008-10#3)
flow analysis##57##2##(2007-8#2)(2008-10#53)(2008-9#2)
flow analyzer##2##2##(2008-10#2)
flow and image cytometry##2##4##(2008-9#2)
flow and the##5##3##(1996-2#1)(2008-10#3)(2008-11#1)
flow and##34##2##(1991-3#1)(1991-9#1)(1994-2#1)(1996-2#1)(1996-9#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
flow apparatus##2##2##(2008-10#2)
flow approach##2##2##(2008-10#2)
flow as##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
flow assembly##2##2##(2008-10#2)
flow at the##2##3##(2008-10#1)(2008-12#1)
flow at##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)
flow behavior##2##2##(2011-2#2)
flow by##3##2##(2008-7#1)(2013-8#2)
flow can be##2##3##(2008-9#2)
flow cell and##6##3##(2008-10#6)
flow cell for##4##3##(2008-10#4)
flow cell in the##2##4##(2008-10#2)
flow cell is##2##3##(2008-10#2)
flow cell made##2##3##(2008-10#2)
flow cell to##3##3##(2008-10#3)
flow cell was##2##3##(2008-10#2)
flow cell were##3##3##(2008-10#3)
flow cell with a##3##4##(2008-10#3)
flow cell with##4##3##(2008-10#4)
flow cell##74##2##(2008-10#74)
flow cells combined with##2##4##(2008-10#2)
flow cells were##2##3##(2008-10#2)
flow cells##14##2##(2008-10#14)
flow chamber##3##2##(2008-10#1)(2008-11#2)
flow channel##2##2##(2008-10#1)(2013-1#1)
flow channels##2##2##(2008-10#1)(2011-2#1)
flow chart##2##2##(1995-2#1)(2008-4#1)
flow conditions##15##2##(1991-3#1)(1997-1#1)(2006-6#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#2)(2009-10#1)
flow configuration##2##2##(2008-10#2)
flow control##2##2##(2008-7#2)
flow cytometer to##2##3##(2008-9#2)
flow cytometer##16##2##(2006-6#1)(2008-11#1)(2008-4#1)(2008-9#13)
flow cytometers##5##2##(2008-4#1)(2008-9#4)
flow cytometric DNA##2##3##(1993-1#1)(1994-12#1)
flow cytometric analysis confirmed##2##4##(2009-12#2)
flow cytometric analysis of##8##4##(1994-3#1)(2008-11#1)(2008-4#1)(2008-9#4)(2012-3#1)
flow cytometric analysis##19##3##(1993-2#1)(1994-3#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#8)(2009-12#2)(2012-3#1)
flow cytometric approach##3##3##(1995-9#1)(2006-6#1)(2008-11#1)
flow cytometric detection##2##3##(2008-10#1)(2008-9#1)
flow cytometric determination of##2##4##(2008-9#2)
flow cytometric platelet##2##3##(2011-2#2)
flow cytometric procedure##2##3##(2006-6#1)(2008-9#1)
flow cytometric studies##2##3##(1993-8#1)(2008-9#1)
flow cytometric study##2##3##(1993-8#1)(2008-7#1)
flow cytometric##53##2##(1990-12#4)(1993-1#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-9#2)(2006-6#2)(2008-10#2)(2008-11#6)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#21)(2009-12#2)(2010-1#1)(2011-2#2)(2012-3#1)
flow cytometry analysis##4##3##(1995-8#1)(1997-2#1)(1997-7#1)(2008-9#1)
flow cytometry and is##2##4##(2008-4#1)(2008-9#1)
flow cytometry and microscopy##2##4##(2008-9#2)
flow cytometry and##10##3##(2008-11#2)(2008-4#1)(2008-9#5)(2010-7#1)(2011-2#1)
flow cytometry approaches##2##3##(2008-9#2)
flow cytometry for the##2##4##(2008-11#1)(2008-7#1)
flow cytometry for##6##3##(2008-11#2)(2008-7#1)(2008-9#3)
flow cytometry has##5##3##(2008-9#5)
flow cytometry in##6##3##(2008-11#1)(2008-7#1)(2008-9#4)
flow cytometry measurements##2##3##(1995-8#1)(2008-9#1)
flow cytometry methods##2##3##(2008-4#1)(2008-8#1)
flow cytometry of##3##3##(2008-9#3)
flow cytometry on##2##3##(1993-11#1)(2008-11#1)
flow cytometry to##3##3##(2006-6#1)(2008-11#1)(2008-9#1)
flow cytometry##141##2##(1990-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#2)(1995-8#2)(1996-6#1)(1997-2#1)(1997-7#2)(2006-6#3)(2008-10#4)(2008-11#14)(2008-4#10)(2008-7#6)(2008-8#2)(2008-9#80)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
flow diagram##2##2##(2008-10#2)
flow electroporation##3##2##(2008-11#3)
flow field of##2##3##(2008-3#1)(2008-8#1)
flow field##7##2##(2008-11#2)(2008-3#4)(2008-8#1)
flow field-flow fractionation channel##2##4##(2008-10#2)
flow field-flow fractionation##5##3##(2008-10#3)(2011-2#2)
flow fields##2##2##(2008-11#1)(2008-2#1)
flow filtration##6##2##(2008-10#2)(2008-7#4)
flow for##3##2##(2008-7#1)(2010-1#1)(2013-1#1)
flow from##5##2##(1996-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)
flow hydride generation##3##3##(2008-10#3)
flow in a##2##3##(1996-9#1)(2008-7#1)
flow in the subarachnoid space##2##5##(2008-7#2)
flow in the##9##3##(1992-1#1)(1993-3#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-7#2)(2008-8#1)(2012-3#1)
flow in##26##2##(1992-1#1)(1992-6#1)(1993-3#2)(1995-5#3)(1996-12#1)(1996-6#2)(1996-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
flow increase##2##2##(1996-2#1)(2008-10#1)
flow indices##3##2##(1995-3#3)
flow induced##2##2##(1992-6#1)(2012-2#1)
flow initially without analyte##2##4##(2008-10#2)
flow initially##4##2##(2008-10#4)
flow injection (FI) analysis##4##4##(2008-10#4)
flow injection (FI) manifold##2##4##(2008-10#2)
flow injection (FI) method for##3##5##(2008-10#3)
flow injection (FI) method##6##4##(2008-10#6)
flow injection (FI) on-line##4##4##(2008-10#4)
flow injection (FI) system for the##2##6##(2008-10#2)
flow injection (FI) system for##3##5##(2008-10#3)
flow injection (FI) system was##2##5##(2008-10#2)
flow injection (FI) system##13##4##(2008-10#13)
flow injection (FI) with##2##4##(2008-10#2)
flow injection (FI)##53##3##(2008-10#53)
flow injection ICP-MS##2##3##(2008-10#2)
flow injection amperometric##2##3##(2008-10#2)
flow injection analyser##2##3##(2008-10#2)
flow injection analysis (FIA) for the##3##6##(2008-10#3)
flow injection analysis (FIA) is##3##5##(2008-10#3)
flow injection analysis (FIA) of##2##5##(2008-10#2)
flow injection analysis (FIA) system coupled##2##6##(2008-10#2)
flow injection analysis (FIA) system with##2##6##(2008-10#2)
flow injection analysis (FIA) system##9##5##(2008-10#8)(2008-11#1)
flow injection analysis (FIA) technique for##2##6##(2008-10#2)
flow injection analysis (FIA) with##3##5##(2008-10#3)
flow injection analysis (FIA)##37##4##(2008-10#36)(2008-11#1)
flow injection analysis and##6##4##(2008-10#6)
flow injection analysis by##2##4##(2008-10#2)
flow injection analysis for##3##4##(2008-10#3)
flow injection analysis manifold##2##4##(2008-10#2)
flow injection analysis method##2##4##(2008-10#2)
flow injection analysis of##14##4##(2008-10#14)
flow injection analysis stopped-flow##2##4##(2008-10#2)
flow injection analysis system for##2##5##(2008-10#2)
flow injection analysis system##6##4##(2008-10#6)
flow injection analysis systems##2##4##(2008-10#2)
flow injection analysis using##2##4##(2008-10#2)
flow injection analysis with amperometric detection##2##6##(2008-10#2)
flow injection analysis with##14##4##(2008-10#14)
flow injection analysis##134##3##(2008-10#132)(2008-11#1)(2008-9#1)
flow injection and sequential injection##2##5##(2008-10#2)
flow injection and##4##3##(2008-10#4)
flow injection approach##4##3##(2008-10#4)
flow injection catalytic spectrophotometric method is proposed for the##2##9##(2008-10#2)
flow injection catalytic##3##3##(2008-10#3)
flow injection chemiluminescence (CL) method is##2##6##(2008-10#2)
flow injection chemiluminescence (CL) method##3##5##(2008-10#3)
flow injection chemiluminescence method is##2##5##(2008-10#2)
flow injection chemiluminescence##7##3##(2008-10#7)
flow injection conditions##2##3##(2008-10#2)
flow injection configuration##2##3##(2008-10#2)
flow injection determination of amylase activity##2##6##(2008-10#2)
flow injection determination of calcium and fluoride in natural and borehole water with conventional##2##14##(2008-10#2)
flow injection determination of##12##4##(2008-10#12)
flow injection determination##14##3##(2008-10#14)
flow injection electrochemiluminescent inhibition method##2##5##(2008-10#2)
flow injection hydride generation atomic absorption##2##6##(2008-10#2)
flow injection hydride generation atomic##3##5##(2008-10#3)
flow injection hydride generation##5##4##(2008-10#5)
flow injection inductively coupled plasma atomic emission##2##7##(2008-10#2)
flow injection inductively coupled plasma##3##5##(2008-10#3)
flow injection manifold##6##3##(2008-10#6)
flow injection method for the##6##5##(2008-10#6)
flow injection method for##8##4##(2008-10#8)
flow injection method is described for the##2##7##(2008-10#2)
flow injection method is##5##4##(2008-10#5)
flow injection method##26##3##(2008-10#26)
flow injection mode##4##3##(2008-10#4)
flow injection on-line preconcentration with##2##5##(2008-10#2)
flow injection on-line preconcentration##3##4##(2008-10#3)
flow injection on-line##9##3##(2008-10#9)
flow injection photometric method##3##4##(2008-10#3)
flow injection photometric##4##3##(2008-10#4)
flow injection potentiometric##2##3##(2008-10#2)
flow injection potentiometry##4##3##(2008-10#4)
flow injection preconcentration##2##3##(2008-10#2)
flow injection procedure for##3##4##(2008-10#3)
flow injection procedure##4##3##(2008-10#4)
flow injection sorption##2##3##(2008-10#2)
flow injection spectrophotometric determination of##4##5##(2008-10#4)
flow injection spectrophotometric method for the determination of##2##8##(2008-10#2)
flow injection spectrophotometric method for##3##5##(2008-10#3)
flow injection spectrophotometric method##4##4##(2008-10#4)
flow injection spectrophotometric##9##3##(2008-10#9)
flow injection spectrophotometry##2##3##(2008-10#2)
flow injection system and##8##4##(2008-10#8)
flow injection system coupled with##2##5##(2008-10#2)
flow injection system coupled##4##4##(2008-10#4)
flow injection system for the determination of dissolved silver at##2##10##(2008-10#2)
flow injection system for the determination of##4##7##(2008-10#4)
flow injection system for the##6##5##(2008-10#6)
flow injection system for##12##4##(2008-10#12)
flow injection system has been developed##2##6##(2008-10#2)
flow injection system is described##3##5##(2008-10#3)
flow injection system is proposed##2##5##(2008-10#2)
flow injection system is##8##4##(2008-10#8)
flow injection system was##2##4##(2008-10#2)
flow injection system with spectrophotometric##2##5##(2008-10#2)
flow injection system with##12##4##(2008-10#12)
flow injection system##68##3##(2008-10#68)
flow injection systems##3##3##(2008-10#3)
flow injection technique for##3##4##(2008-10#3)
flow injection technique##9##3##(2008-10#9)
flow injection time-based method##2##4##(2008-10#2)
flow injection with amperometric detection##3##5##(2008-10#3)
flow injection with##7##3##(2008-10#7)
flow injection##465##2##(2008-10#463)(2008-11#1)(2008-9#1)
flow injection-hydride##5##2##(2008-10#5)
flow injection-inductively coupled plasma##3##4##(2008-10#3)
flow injection-pervaporation##2##2##(2008-10#2)
flow injection/stopped-flow detection technique##2##4##(2008-10#2)
flow into the##2##3##(2008-10#1)(2008-7#1)
flow is##5##2##(1991-3#1)(1996-12#1)(2008-10#2)(2011-2#1)
flow levels##2##2##(2008-7#2)
flow manifold##10##2##(2008-10#10)
flow measurements##5##2##(1995-8#1)(1996-6#3)(2008-11#1)
flow method##5##2##(2008-10#4)(2010-8#1)
flow methodologies##2##2##(2008-10#2)
flow methods applied to the##2##5##(2008-10#2)
flow methods##4##2##(2008-10#4)
flow mode##3##2##(2008-10#3)
flow model##2##2##(2008-7#2)
flow network##3##2##(2008-10#3)
flow of a##2##3##(2008-10#1)(2008-11#1)
flow of nitrogen##3##3##(2008-10#3)
flow of the sample##3##4##(2008-10#3)
flow of the##10##3##(2008-10#9)(2008-5#1)
flow of##45##2##(1991-12#1)(1991-3#2)(1994-2#1)(1996-3#1)(1996-6#1)(2008-10#30)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
flow on a regional level##2##5##(2008-10#2)
flow on the##2##3##(2008-11#1)(2010-6#1)
flow on##4##2##(2008-10#2)(2008-11#1)(2010-6#1)
flow path##2##2##(2008-10#1)(2008-7#1)
flow paths##2##2##(2008-10#1)(2008-6#1)
flow preconcentration system##4##3##(2008-10#4)
flow preconcentration##5##2##(2008-10#5)
flow procedure based on multicommutation##2##5##(2008-10#2)
flow procedure##4##2##(2008-10#4)
flow program##3##2##(2008-10#3)
flow programming##2##2##(2008-10#2)
flow programs##2##2##(2008-10#2)
flow properties##4##2##(2008-2#3)(2012-2#1)
flow provides##2##2##(2008-12#1)(2012-3#1)
flow range##3##2##(2008-10#3)
flow rate (Ql/Qa)##2##3##(1995-3#2)
flow rate 0##3##3##(2008-10#3)
flow rate F(B)##2##3##(2008-10#2)
flow rate and concentration of##2##5##(2008-10#2)
flow rate and interfering ions on the recovery of the##2##10##(2008-10#2)
flow rate and sample volume##2##5##(2008-10#2)
flow rate and temperature##2##4##(2008-10#1)(2010-4#1)
flow rate and volume##2##4##(2008-10#2)
flow rate and##32##3##(1996-3#1)(2008-10#28)(2008-12#1)(2008-7#1)(2010-4#1)
flow rate during##2##3##(2008-10#2)
flow rate for the##2##4##(2008-10#2)
flow rate for##3##3##(2008-10#3)
flow rate have been##2##4##(2008-10#2)
flow rate in the##2##4##(2008-10#2)
flow rate is##4##3##(1994-2#1)(2008-10#3)
flow rate of 0##7##4##(2008-10#6)(2008-5#1)
flow rate of 1##18##4##(2008-10#18)
flow rate of 2##6##4##(2008-10#6)
flow rate of 3##4##4##(2008-10#3)(2008-4#1)
flow rate of 4##4##4##(2008-10#4)
flow rate of 5##2##4##(2008-10#2)
flow rate of 6##4##4##(2008-10#4)
flow rate of 6mlmin(-1)##2##4##(2008-10#2)
flow rate of carrier gas##2##5##(2008-10#2)
flow rate of carrier##3##4##(2008-10#3)
flow rate of metal##2##4##(2008-10#2)
flow rate of sample solution##2##5##(2008-10#2)
flow rate of sample##3##4##(2008-10#3)
flow rate of the mobile phase##2##6##(2008-10#2)
flow rate of the sample solution##2##6##(2008-10#2)
flow rate of the titrant solution##2##6##(2008-10#2)
flow rate of the##10##4##(1996-3#1)(2008-10#9)
flow rate of##83##3##(1996-12#1)(1996-3#1)(2008-10#79)(2008-4#1)(2008-5#1)
flow rate on the##4##4##(1997-2#2)(2008-10#2)
flow rate on##5##3##(1997-2#2)(2008-10#3)
flow rate or##2##3##(2008-10#1)(2008-8#1)
flow rate was##7##3##(1995-3#1)(2008-10#6)
flow rate were##5##3##(2008-10#5)
flow rate##245##2##(1994-2#2)(1995-3#4)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#5)(2008-10#208)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2010-4#2)(2010-9#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
flow rate) were##5##3##(2008-10#5)
flow rate)##6##2##(2008-10#6)
flow rates and##6##3##(2008-10#6)
flow rates between##2##3##(1996-2#1)(2008-10#1)
flow rates of sample and eluent##2##6##(2008-10#2)
flow rates of sample solution and eluent##2##7##(2008-10#2)
flow rates of sample##4##4##(2008-10#4)
flow rates of##15##3##(1996-2#1)(2008-10#14)
flow rates##61##2##(1991-3#1)(1995-3#1)(1996-1#1)(1996-2#3)(1997-2#1)(2008-10#44)(2008-11#2)(2008-7#1)(2008-8#2)(2010-4#5)
flow rates)##2##2##(2008-10#2)
flow ratiometry##4##2##(2008-10#4)
flow reactor##2##2##(2008-2#1)(2008-7#1)
flow resistance##2##2##(2008-7#2)
flow reversals##3##2##(2008-10#3)
flow sensor on a chip for the determination of terbutaline in human serum##2##13##(2008-10#2)
flow sensor##3##2##(2008-10#3)
flow sorters##2##2##(2008-9#2)
flow stress##2##2##(2009-7#2)
flow system allowed##2##3##(2008-10#2)
flow system and##3##3##(2008-10#2)(2008-9#1)
flow system comprised##2##3##(2008-10#2)
flow system for simultaneous determination of iron and chromium in steel alloys##2##12##(2008-10#2)
flow system for the determination of##8##6##(2008-10#8)
flow system for the##12##4##(2008-10#12)
flow system for##20##3##(2008-10#20)
flow system is proposed for##2##5##(2008-10#2)
flow system is proposed##3##4##(2008-10#3)
flow system is##5##3##(2008-10#5)
flow system to##2##3##(2008-10#2)
flow system was assembled##2##4##(2008-10#2)
flow system was##12##3##(2008-10#12)
flow system with a##3##4##(2008-10#3)
flow system with##6##3##(2008-10#6)
flow system##100##2##(2008-10#99)(2008-9#1)
flow systems and##2##3##(2008-10#2)
flow systems is##2##3##(2008-10#2)
flow systems##20##2##(2008-10#18)(2008-11#2)
flow techniques for##2##3##(2008-10#2)
flow techniques##7##2##(2008-10#7)
flow through cell##3##3##(2008-10#3)
flow through the##6##3##(1997-1#1)(2008-12#4)(2008-3#1)
flow through##12##2##(1993-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)
flow titration of iron(II)##2##4##(2008-10#2)
flow titration of##3##3##(2008-10#3)
flow titration##8##2##(2008-10#8)
flow titrations##2##2##(2008-10#2)
flow to the##3##3##(1993-3#1)(2008-12#1)(2011-2#1)
flow to##6##2##(1993-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2011-2#2)
flow type quartz crystal microbalance##2##5##(2008-10#2)
flow type##4##2##(2008-10#4)
flow velocities in the##3##4##(1996-2#1)(1996-6#1)(2008-11#1)
flow velocities##4##2##(1996-2#1)(1996-6#1)(2008-11#2)
flow velocity and##2##3##(2007-11#1)(2008-11#1)
flow velocity of the##3##4##(1996-3#1)(2008-3#1)(2011-2#1)
flow velocity of##5##3##(1996-3#1)(2008-3#1)(2011-2#3)
flow velocity##18##2##(1996-2#1)(1996-3#2)(1996-6#1)(2007-11#3)(2008-11#2)(2008-3#1)(2011-2#6)(2013-1#2)
flow was##5##2##(1995-5#1)(1996-2#1)(2008-10#1)(2008-5#1)(2012-3#1)
flow were##7##2##(2008-10#3)(2008-12#1)(2011-2#1)(2013-3#1)(2013-8#1)
flow with##2##2##(2008-10#2)
flow##1950##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#8)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#3)(1992-6#5)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#5)(1993-8#4)(1994-1#1)(1994-12#1)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#4)(1995-3#14)(1995-5#9)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#12)(1996-3#6)(1996-6#12)(1996-9#5)(1997-1#8)(1997-2#8)(1997-3#1)(1997-4#1)(1997-7#2)(2006-6#8)(2007-11#3)(2007-8#3)(2008-1#3)(2008-10#1316)(2008-11#66)(2008-12#14)(2008-2#6)(2008-3#12)(2008-4#16)(2008-5#12)(2008-6#3)(2008-7#48)(2008-8#15)(2008-9#144)(2009-1#1)(2009-10#4)(2009-12#3)(2009-6#2)(2009-7#3)(2009-8#3)(2010-1#3)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#7)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#27)(2011-3#2)(2012-2#13)(2012-3#12)(2012-4#1)(2013-1#21)(2013-3#1)(2013-7#1)(2013-8#10)
flow)##4##1##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
flow-assisted##2##1##(2008-10#2)
flow-based analytical##2##2##(2008-10#2)
flow-based procedures##2##2##(2008-10#2)
flow-based##13##1##(2008-10#11)(2008-9#2)
flow-cell##4##1##(2008-10#4)
flow-dependent##2##1##(1992-9#1)(2008-9#1)
flow-injection (FI) method##2##3##(2008-10#2)
flow-injection (FI)##8##2##(2008-10#8)
flow-injection analysis (FIA) system##4##4##(2008-10#4)
flow-injection analysis (FIA)##14##3##(2008-10#14)
flow-injection analysis system##3##3##(2008-10#3)
flow-injection analysis with##2##3##(2008-10#2)
flow-injection analysis##39##2##(2008-10#39)
flow-injection atomic absorption##2##3##(2008-10#2)
flow-injection biosensor##2##2##(1995-3#1)(2008-10#1)
flow-injection chemiluminescence (CL) method for##2##5##(2008-10#2)
flow-injection chemiluminescence (CL) system##2##4##(2008-10#2)
flow-injection chemiluminescence (CL)##4##3##(2008-10#4)
flow-injection chemiluminescence##6##2##(2008-10#6)
flow-injection determination of##8##3##(2008-10#8)
flow-injection fluorimetric##2##2##(2008-10#2)
flow-injection ion spray ionization tandem mass spectrometry##2##7##(2008-10#2)
flow-injection liposome immunoanalysis (FILIA)##2##4##(2008-10#2)
flow-injection manifold for##2##3##(2008-10#2)
flow-injection manifold##6##2##(2008-10#6)
flow-injection method for the determination of##3##6##(2008-10#3)
flow-injection method for the##4##4##(2008-10#4)
flow-injection method for##5##3##(2008-10#5)
flow-injection method is proposed for the determination of##3##8##(2008-10#3)
flow-injection method is proposed for the##4##6##(2008-10#4)
flow-injection method is##5##3##(2008-10#5)
flow-injection method##12##2##(2008-10#12)
flow-injection multisensor system##2##3##(2008-10#2)
flow-injection procedure for##3##3##(2008-10#3)
flow-injection procedure##5##2##(2008-10#5)
flow-injection spectrophotometric method has been developed for the##2##8##(2008-10#2)
flow-injection spectrophotometric method##3##3##(2008-10#3)
flow-injection spectrophotometric procedure is proposed for##2##6##(2008-10#2)
flow-injection spectrophotometric##6##2##(2008-10#6)
flow-injection system coupled##2##3##(2008-10#2)
flow-injection system for the spectrophotometric determination of##2##7##(2008-10#2)
flow-injection system for the##5##4##(2008-10#5)
flow-injection system for##6##3##(2008-10#6)
flow-injection system made up by a 16-way switching valve##2##9##(2008-10#2)
flow-injection system with a##2##4##(2008-10#2)
flow-injection system with##4##3##(2008-10#4)
flow-injection system##22##2##(1995-3#1)(2008-10#21)
flow-injection variables##2##2##(2008-10#2)
flow-injection with##2##2##(2008-10#2)
flow-injection##162##1##(1995-3#2)(2008-10#160)
flow-rate and##3##2##(2008-10#3)
flow-rate of 0##3##3##(2008-10#3)
flow-rate of 1##4##3##(2008-10#3)(2008-5#1)
flow-rate of##12##2##(2008-10#11)(2008-5#1)
flow-rate##24##1##(1997-2#2)(2008-10#20)(2008-5#1)(2008-9#1)
flow-rates##2##1##(2008-10#2)
flow-through cell and##2##3##(2008-10#2)
flow-through cell for##4##3##(2008-10#4)
flow-through cell##11##2##(2008-10#10)(2013-1#1)
flow-through electrode##4##2##(2008-10#4)
flow-through ion-selective electrodes##2##3##(2008-10#2)
flow-through multisensor##2##2##(2008-10#2)
flow-through optical##3##2##(2008-10#3)
flow-through sensor array##2##3##(2008-10#2)
flow-through sensor for ofloxacin##2##4##(2008-10#2)
flow-through sensor is##2##3##(2008-10#2)
flow-through sensor##8##2##(2008-10#8)
flow-through solid phase##2##3##(2008-10#2)
flow-through##71##1##(2008-10#69)(2013-1#2)
flow-type##3##1##(2008-10#3)
flow-volume##2##1##(1996-3#1)(1997-2#1)
flowable composite##2##2##(2013-1#2)
flowable##3##1##(2008-4#1)(2013-1#2)
flowcharts##2##1##(1996-2#1)(2008-4#1)
flowed##6##1##(2008-10#6)
flower age at inoculation##3##4##(2008-10#3)
flower age##4##2##(2008-10#4)
flower and fruit##2##3##(2008-10#2)
flower and##6##2##(2008-10#4)(2008-12#1)(2009-5#1)
flower break virus##2##3##(2008-10#2)
flower break##3##2##(2008-10#3)
flower buds##3##2##(2008-10#2)(2008-8#1)
flower development##3##2##(1997-8#2)(2008-8#1)
flower extracts##4##2##(2008-10#4)
flower infection##5##2##(2008-10#5)
flower production##2##2##(2008-8#1)(2009-5#1)
flower stigmas##2##2##(2008-10#2)
flower thrips##6##2##(2008-10#5)(2009-8#1)
flower##74##1##(1993-2#1)(1997-8#4)(2008-10#46)(2008-12#4)(2008-8#8)(2008-9#1)(2009-5#3)(2009-6#3)(2009-8#2)(2010-4#1)(2011-10#1)
flowering and fruiting##2##3##(2008-12#1)(2012-4#1)
flowering and##5##2##(1997-8#1)(2008-12#1)(2008-8#1)(2012-4#1)(2012-6#1)
flowering by a##2##3##(2008-8#2)
flowering in cereals##2##3##(2009-8#2)
flowering in##3##2##(2008-8#1)(2009-8#2)
flowering of##2##2##(2008-10#1)(2008-6#1)
flowering plants##7##2##(2008-8#1)(2008-9#1)(2009-8#2)(2010-5#3)
flowering time##9##2##(1997-8#2)(2008-8#1)(2009-8#2)(2012-3#3)(2012-7#1)
flowering types##2##2##(2008-10#2)
flowering##64##1##(1997-8#3)(2008-10#25)(2008-12#2)(2008-6#1)(2008-8#9)(2008-9#1)(2009-8#8)(2010-5#3)(2011-2#1)(2012-3#5)(2012-4#1)(2012-6#1)(2012-7#1)(2013-8#3)
flowers and##7##2##(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)
flowers are##2##2##(2008-10#1)(2012-3#1)
flowers in##4##2##(2008-10#3)(2009-5#1)
flowers inoculated on the day of anthesis##2##7##(2008-10#2)
flowers of##5##2##(2008-10#4)(2009-6#1)
flowers on healthy##2##3##(2008-10#2)
flowers on##3##2##(2008-10#3)
flowers that opened##3##3##(2008-10#3)
flowers that##5##2##(2008-10#5)
flowers to##2##2##(2008-10#1)(2013-8#1)
flowers was not##2##3##(2008-10#2)
flowers was##3##2##(2008-10#3)
flowers were##8##2##(2008-10#8)
flowers##71##1##(2008-10#48)(2008-12#4)(2008-5#1)(2008-8#6)(2008-9#2)(2009-5#3)(2009-6#1)(2009-8#2)(2011-10#1)(2012-3#2)(2013-8#1)
flowing aqueous##2##2##(2008-10#2)
flowing fluid##2##2##(2008-9#1)(2011-2#1)
flowing solutions##2##2##(2008-10#2)
flowing stream of##3##3##(2008-10#3)
flowing stream techniques##4##3##(2008-10#4)
flowing stream##8##2##(2008-10#8)
flowing streams##5##2##(2008-10#5)
flowing system##3##2##(2008-10#3)
flowing the##2##2##(2008-10#2)
flowing through the##2##3##(2008-10#2)
flowing##48##1##(1993-12#1)(2008-10#42)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)
flowing-stream##2##1##(2008-10#2)
flowmetry##2##1##(2008-5#1)(2013-1#1)
flows and##3##2##(1994-2#1)(2008-11#1)(2008-3#1)
flows has been##2##3##(2008-10#2)
flows in a##2##3##(2008-10#1)(2008-8#1)
flows in##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
flows through##2##2##(1991-3#1)(2008-10#1)
flows##39##1##(1991-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-3#2)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#8)(2008-8#1)(2008-9#5)(2013-1#4)
flu-like symptoms##2##2##(2008-7#1)(2008-8#1)
flu-like##4##1##(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
fluazinam##2##1##(2008-10#2)
fluconazole and##5##2##(2008-11#1)(2008-5#4)
fluconazole##14##1##(2008-10#1)(2008-11#1)(2008-5#12)
fluctuant##2##1##(2008-10#1)(2010-3#1)
fluctuate##2##1##(2008-10#1)(2008-8#1)
fluctuated##4##1##(2008-10#3)(2008-12#1)
fluctuates##3##1##(2008-8#2)(2011-3#1)
fluctuating asymmetry and##2##3##(2008-9#2)
fluctuating asymmetry##4##2##(2008-8#2)(2008-9#2)
fluctuating conditions##4##2##(2008-10#2)(2008-9#2)
fluctuating environments##2##2##(2008-8#1)(2010-4#1)
fluctuating selection##2##2##(2008-8#1)(2012-3#1)
fluctuating temperature##2##2##(2008-10#2)
fluctuating##28##1##(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#4)(2010-4#1)(2010-7#1)(2012-3#2)
fluctuation of##3##2##(1996-12#1)(2008-10#1)(2011-3#1)
fluctuation##10##1##(1996-12#1)(1996-3#2)(2008-10#2)(2008-3#3)(2010-8#1)(2011-3#1)
fluctuations and##2##2##(2008-10#1)(2008-8#1)
fluctuations can##5##2##(2008-8#5)
fluctuations in species'##2##3##(2008-9#2)
fluctuations in the##9##3##(1994-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)
fluctuations in##20##2##(1991-1#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#2)(2010-10#1)(2010-8#1)(2012-5#1)
fluctuations of##7##2##(1991-12#1)(1996-12#2)(2008-10#2)(2008-9#1)(2012-2#1)
fluctuations were##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
fluctuations##68##1##(1991-1#1)(1991-12#1)(1994-11#1)(1996-12#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#11)(2008-5#1)(2008-7#5)(2008-8#18)(2008-9#5)(2010-10#2)(2010-7#1)(2010-8#1)(2012-2#2)(2012-5#2)(2013-8#1)
fludarabine##4##1##(2009-12#4)
flue dust##2##2##(2008-10#2)
flue dusts##2##2##(2008-10#2)
flue gas##3##2##(2008-10#3)
flue##7##1##(2008-10#7)
fluence profiles and water depth##2##5##(2009-11#2)
fluence rates##3##2##(2008-7#3)
fluence##10##1##(2008-3#5)(2008-7#3)(2009-11#2)
fluence-limiting defects##3##2##(2008-3#3)
fluence-limiting##4##1##(2008-3#4)
fluency and##2##2##(1996-2#1)(2010-6#1)
fluency in##2##2##(2008-12#1)(2011-2#1)
fluency##15##1##(1996-2#2)(2008-12#7)(2008-2#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#2)
fluent##5##1##(2008-2#5)
flufenamic##4##1##(2008-10#4)
fluid (CSF)##23##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#2)(1994-8#1)(1996-12#1)(2008-12#1)(2008-7#4)(2009-11#1)(2011-2#5)(2012-3#2)(2013-1#1)
fluid (median##2##2##(1995-8#2)
fluid analysis##2##2##(2011-2#1)(2012-3#1)
fluid and a##3##3##(1991-3#1)(1992-2#1)(2008-10#1)
fluid and the##2##3##(2008-10#1)(2008-9#1)
fluid and##15##2##(1991-2#1)(1991-3#1)(1992-2#1)(1995-8#2)(2007-11#1)(2008-10#7)(2008-9#2)
fluid at##3##2##(1990-11#1)(2008-7#1)(2012-2#1)
fluid balance##4##2##(1991-6#1)(2011-2#3)
fluid bed granulation##2##3##(2008-11#2)
fluid by##5##2##(1993-6#1)(2008-10#2)(2008-5#2)
fluid chromatography (SFC)##4##3##(2008-10#4)
fluid chromatography##10##2##(2008-10#10)
fluid collections##3##2##(2009-9#2)(2010-6#1)
fluid contains##2##2##(1990-11#1)(2008-8#1)
fluid dynamic analysis##2##3##(2013-1#2)
fluid dynamic##6##2##(2008-11#1)(2008-3#1)(2008-7#2)(2013-1#2)
fluid dynamics##4##2##(2008-10#1)(2008-11#2)(2008-8#1)
fluid examination##2##2##(2008-1#1)(2013-8#1)
fluid extraction (SFE)##10##3##(2008-10#10)
fluid extraction of##8##3##(2008-10#7)(2012-3#1)
fluid extraction was used to##2##5##(2008-10#2)
fluid extraction##26##2##(2008-10#23)(2008-11#1)(2012-2#1)(2012-3#1)
fluid flow and##2##3##(2011-2#1)(2012-2#1)
fluid flow##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
fluid from patients with##3##4##(1990-2#3)
fluid from the##2##3##(2008-10#2)
fluid from##9##2##(1990-2#4)(2008-10#5)
fluid in the##3##3##(1992-5#1)(1994-8#1)(2008-12#1)
fluid in##9##2##(1990-9#1)(1991-2#1)(1992-5#1)(1993-2#1)(1994-8#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
fluid injections##2##2##(1994-8#2)
fluid intake##2##2##(2010-1#1)(2013-8#1)
fluid lactase activity##2##3##(1991-12#2)
fluid lactase##3##2##(1991-12#3)
fluid lamellar signal##3##3##(1994-5#3)
fluid leakage##2##2##(2008-7#1)(2012-3#1)
fluid leaks##4##2##(2011-2#4)
fluid obtained##2##2##(1994-11#1)(1996-6#1)
fluid of##8##2##(1990-5#2)(1993-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
fluid overload##2##2##(2011-2#2)
fluid protein##2##2##(1997-3#1)(2007-8#1)
fluid reasoning##4##2##(2008-11#4)
fluid resuscitation##2##2##(2011-2#2)
fluid room temperature phosphorescence##2##4##(2008-10#2)
fluid samples from##4##3##(1993-12#1)(2008-5#2)(2012-3#1)
fluid samples##7##2##(1990-9#1)(1991-2#1)(1993-12#1)(2008-5#2)(2012-2#1)(2012-3#1)
fluid shear##4##2##(2008-11#1)(2008-7#2)(2012-2#1)
fluid shifts and##2##3##(2010-1#1)(2010-7#1)
fluid shifts##3##2##(2010-1#2)(2010-7#1)
fluid taken##2##2##(1991-2#1)(2008-10#1)
fluid technology##3##2##(2012-2#3)
fluid therapy##4##2##(2011-2#3)(2012-3#1)
fluid transport systems##3##3##(1990-8#3)
fluid transport##4##2##(1990-8#4)
fluid was##5##2##(1992-12#1)(2008-10#1)(2008-7#2)(2010-12#1)
fluid were##4##2##(1991-12#1)(1995-8#1)(2008-10#2)
fluid##351##1##(1990-11#2)(1990-2#8)(1990-5#3)(1990-6#1)(1990-8#4)(1990-9#3)(1991-12#7)(1991-2#5)(1991-3#1)(1991-6#2)(1991-7#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#4)(1994-8#9)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#9)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-8#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#92)(2008-11#15)(2008-12#10)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#25)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#2)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#1)(2010-12#6)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#34)(2011-7#2)(2012-2#10)(2012-3#9)(2013-1#5)(2013-7#2)(2013-8#4)
fluid-fluid level##4##2##(2011-2#4)
fluidic circuit##2##2##(2009-5#2)
fluidic##6##1##(2008-10#2)(2009-5#3)(2009-9#1)
fluidity and##4##2##(1995-11#2)(2008-8#1)(2008-9#1)
fluidity in##2##2##(1991-5#1)(1995-8#1)
fluidity of the##2##3##(2008-7#1)(2008-9#1)
fluidity of##7##2##(1991-5#2)(1995-8#1)(2008-7#1)(2008-9#3)
fluidity##21##1##(1991-5#7)(1995-11#2)(1995-8#3)(1996-12#1)(1997-1#1)(2008-7#1)(2008-8#1)(2008-9#4)(2011-2#1)
fluidized bed bioreactor##4##3##(2008-11#4)
fluidized bed##7##2##(2008-11#4)(2008-7#3)
fluidized##8##1##(2008-11#5)(2008-7#3)
fluidizing##3##1##(1991-5#1)(1995-11#2)
fluids (plasma##2##2##(2008-10#2)
fluids and tissues##2##3##(2008-10#2)
fluids and##13##2##(1990-2#2)(1993-1#1)(1993-2#1)(2008-10#5)(2009-8#1)(2012-2#2)(2013-1#1)
fluids by##6##2##(1992-1#1)(2008-10#5)
fluids from patients with##2##4##(1990-2#2)
fluids from##5##2##(1990-2#4)(2008-7#1)
fluids in##4##2##(1991-1#1)(1996-3#1)(2008-10#2)
fluids of##4##2##(1990-11#1)(2008-10#2)(2011-2#1)
fluids such as##2##3##(2008-10#1)(2008-11#1)
fluids was##2##2##(1990-2#1)(2008-10#1)
fluids were##3##2##(1995-11#1)(2008-10#2)
fluids with##3##2##(1993-1#1)(2008-10#2)
fluids##112##1##(1990-11#1)(1990-2#7)(1991-1#1)(1992-1#1)(1992-12#1)(1993-1#3)(1993-2#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(2008-10#67)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
fluke##4##1##(1996-12#1)(2008-12#3)
flumethrin and##3##2##(2008-10#3)
flumethrin##6##1##(1996-12#3)(2008-10#3)
flumioxazin##2##1##(2008-10#2)
flumorph##6##1##(2008-10#6)
fluo-3##6##1##(1990-2#2)(1991-5#2)(2006-6#1)(2008-9#1)
fluoranthene##5##1##(2008-10#5)
fluorene##5##1##(2008-10#5)
fluorescamine##3##1##(2008-10#3)
fluorescein isothiocyanate (FITC)-labeled##2##3##(2008-10#2)
fluorescein isothiocyanate##4##2##(2008-10#3)(2008-4#1)
fluorescein##35##1##(1990-5#2)(1996-12#1)(2008-10#20)(2008-12#6)(2008-3#1)(2008-4#2)(2008-9#2)(2011-2#1)
fluorescein-conjugated##2##1##(1990-12#1)(2008-9#1)
fluorescein-hydrazide##2##1##(2008-10#2)
fluorescein-labeled##2##1##(2008-10#1)(2008-11#1)
fluorescence (FL)##2##2##(2008-10#2)
fluorescence (LIF)##9##2##(2008-10#5)(2008-2#1)(2008-3#3)
fluorescence (SyF)##2##2##(2008-10#2)
fluorescence (TPF)##2##2##(2008-10#1)(2008-3#1)
fluorescence activated cell sorting##2##4##(2008-11#1)(2011-2#1)
fluorescence after##4##2##(2008-10#3)(2008-8#1)
fluorescence analysis##2##2##(2008-2#1)(2008-5#1)
fluorescence and UV-vis##2##3##(2008-10#2)
fluorescence and flow##2##3##(2008-10#1)(2008-9#1)
fluorescence and reflectance##2##3##(2008-3#2)
fluorescence and the##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
fluorescence and##26##2##(1993-11#1)(2008-10#12)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#4)(2010-12#1)(2010-4#1)(2012-2#1)
fluorescence anisotropy##3##2##(2008-10#3)
fluorescence as the##2##3##(1994-5#1)(2008-10#1)
fluorescence as##3##2##(1994-5#1)(1996-2#1)(2008-10#1)
fluorescence at##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
fluorescence but##2##2##(2008-10#2)
fluorescence by##5##2##(1991-5#1)(1994-5#1)(2008-10#2)(2008-9#1)
fluorescence can##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
fluorescence change was##2##3##(1995-6#2)
fluorescence changes observed##2##3##(1994-5#2)
fluorescence changes##6##2##(1994-5#4)(1995-6#1)(2008-10#1)
fluorescence characteristics of##2##3##(2008-10#2)
fluorescence correlation spectroscopy and##2##4##(1997-6#1)(2007-12#1)
fluorescence correlation spectroscopy##5##3##(1997-6#3)(2007-12#1)(2008-10#1)
fluorescence data##3##2##(2008-10#3)
fluorescence decays##5##2##(2008-10#3)(2008-2#2)
fluorescence derivatization##3##2##(2008-10#3)
fluorescence detection for##3##3##(2008-10#3)
fluorescence detection has##2##3##(1997-6#1)(2008-10#1)
fluorescence detection of##3##3##(2008-10#3)
fluorescence detection with##2##3##(2007-12#1)(2008-10#1)
fluorescence detection##47##2##(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#40)(2008-11#1)(2008-2#1)(2010-7#1)(2012-2#1)
fluorescence detector for capillary electrophoresis##3##5##(2008-10#3)
fluorescence detector##14##2##(2008-10#14)
fluorescence determination of##5##3##(2008-10#5)
fluorescence dyes##2##2##(2008-4#1)(2008-9#1)
fluorescence emission band##2##3##(2008-10#2)
fluorescence emission intensity##2##3##(2008-10#2)
fluorescence emission maximum##3##3##(2008-10#1)(2008-8#2)
fluorescence emission of these compounds in##2##6##(2008-10#2)
fluorescence emission of##4##3##(2008-10#4)
fluorescence emission spectra##2##3##(2008-10#1)(2008-3#1)
fluorescence emission##32##2##(2008-10#24)(2008-3#3)(2008-8#3)(2008-9#1)(2009-12#1)
fluorescence energy transfer##6##3##(2008-10#6)
fluorescence enhancement of Au nanoparticles##2##5##(2008-10#2)
fluorescence enhancement of the##2##4##(2008-10#2)
fluorescence enhancement of##10##3##(1992-6#2)(2008-10#8)
fluorescence enhancement##16##2##(1991-3#2)(1992-6#2)(2008-10#12)
fluorescence excitation and emission spectra##2##5##(2008-10#1)(2008-9#1)
fluorescence excitation and emission##3##4##(2008-10#2)(2008-9#1)
fluorescence excitation emission matrices##2##4##(2008-10#2)
fluorescence excitation##9##2##(2008-10#7)(2008-3#1)(2008-9#1)
fluorescence excitation-emission matrices##2##3##(2008-10#2)
fluorescence excitation-emission##3##2##(2008-10#3)
fluorescence for##2##2##(2008-10#1)(2008-3#1)
fluorescence from a##2##3##(2008-3#1)(2008-8#1)
fluorescence from##10##2##(2008-10#3)(2008-3#4)(2008-8#1)(2008-9#2)
fluorescence has##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
fluorescence imaging of##2##3##(2008-3#1)(2009-8#1)
fluorescence imaging##5##2##(2008-11#1)(2008-3#1)(2009-8#1)(2011-3#1)(2012-2#1)
fluorescence in situ hybridization (FISH)##5##5##(1993-12#1)(1997-2#1)(2008-11#1)(2008-9#2)
fluorescence in situ hybridization##14##4##(1993-12#1)(1997-2#1)(1997-8#1)(2008-11#3)(2008-9#5)(2010-1#2)(2011-2#1)
fluorescence in situ##16##3##(1993-12#1)(1997-2#1)(1997-8#1)(2008-11#3)(2008-12#2)(2008-9#5)(2010-1#2)(2011-2#1)
fluorescence in the cytoplasm##2##4##(2008-9#2)
fluorescence in the##5##3##(2008-10#3)(2008-9#2)
fluorescence in##28##2##(1993-12#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#2)(2008-9#7)(2010-1#2)(2011-2#1)
fluorescence increase##3##2##(2008-10#3)
fluorescence intensities of the##2##4##(2008-10#2)
fluorescence intensities##10##2##(2008-10#7)(2008-11#1)(2008-9#2)
fluorescence intensity and the##5##4##(2008-10#5)
fluorescence intensity and##8##3##(2008-10#8)
fluorescence intensity at##2##3##(2008-10#2)
fluorescence intensity distributions within##2##4##(2008-3#2)
fluorescence intensity distributions##3##3##(2008-3#2)(2010-12#1)
fluorescence intensity from the##2##4##(2008-10#1)(2008-3#1)
fluorescence intensity is proportional to the concentration of##2##8##(2008-10#1)(2008-12#1)
fluorescence intensity is##4##3##(2008-10#3)(2008-12#1)
fluorescence intensity of salicylic acid##2##5##(2008-10#2)
fluorescence intensity of scopoletin##2##4##(2008-10#2)
fluorescence intensity of the system##2##5##(2008-10#2)
fluorescence intensity of the##11##4##(1990-12#1)(1995-11#1)(1995-6#1)(2008-10#8)
fluorescence intensity of##21##3##(1990-12#1)(1995-11#1)(1995-6#1)(2008-10#18)
fluorescence intensity that##2##3##(2008-10#1)(2008-9#1)
fluorescence intensity was linear over a##2##6##(2008-10#2)
fluorescence intensity was##9##3##(2008-10#9)
fluorescence intensity##75##2##(1990-12#1)(1995-11#1)(1995-6#1)(2008-10#60)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#2)(2010-12#1)
fluorescence is##15##2##(1990-12#2)(2008-10#11)(2008-11#1)(2008-3#1)
fluorescence labeling##4##2##(1993-2#2)(2008-4#1)(2008-9#1)
fluorescence lidar##2##2##(2008-2#1)(2008-3#1)
fluorescence lifetime and##2##3##(1991-5#1)(2008-3#1)
fluorescence lifetime of##2##3##(1994-5#1)(2008-10#1)
fluorescence lifetime##5##2##(1991-5#1)(1994-5#1)(2008-10#1)(2008-3#2)
fluorescence maxima##2##2##(2008-10#2)
fluorescence measurement##3##2##(2008-10#2)(2013-8#1)
fluorescence measurements##8##2##(1991-3#1)(1992-10#1)(2008-10#6)
fluorescence method for##2##3##(2008-10#2)
fluorescence method##3##2##(2008-10#3)
fluorescence microscope##4##2##(2008-1#1)(2008-10#2)(2008-4#1)
fluorescence microscopy and##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
fluorescence microscopy in##2##3##(1996-6#1)(2012-2#1)
fluorescence microscopy##29##2##(1991-5#1)(1994-5#2)(1996-6#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-5#1)(2008-9#5)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#3)
fluorescence of GFP##2##3##(2008-4#1)(2008-9#1)
fluorescence of native enzyme##2##4##(1995-6#2)
fluorescence of the##17##3##(1990-2#1)(1990-5#1)(2006-6#1)(2008-10#12)(2008-8#1)(2008-9#1)
fluorescence of these##2##3##(2008-10#2)
fluorescence of##60##2##(1990-2#1)(1990-5#3)(1991-5#1)(1992-6#1)(1995-6#2)(2006-6#1)(2008-1#1)(2008-10#38)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#4)(2009-5#1)
fluorescence on the##2##3##(2008-10#1)(2008-3#1)
fluorescence on##4##2##(2008-10#1)(2008-3#3)
fluorescence optosensing##2##2##(2008-10#2)
fluorescence or##2##2##(2008-10#2)
fluorescence polarization##8##2##(1991-3#1)(1991-5#1)(1995-8#1)(2008-10#3)(2008-8#1)(2008-9#1)
fluorescence postlabeling##4##2##(1991-5#4)
fluorescence probe for##3##3##(2008-10#1)(2008-12#2)
fluorescence probe##7##2##(2008-10#5)(2008-12#2)
fluorescence properties of##2##3##(2008-10#1)(2008-8#1)
fluorescence properties##4##2##(1994-5#1)(2008-10#1)(2008-8#1)(2010-4#1)
fluorescence quantum yield##2##3##(2008-10#2)
fluorescence quantum##3##2##(2008-10#3)
fluorescence quenching agent for alternant##2##5##(2008-10#2)
fluorescence quenching agent for##4##4##(2008-10#4)
fluorescence quenching agent##5##3##(2008-10#5)
fluorescence quenching data##2##3##(1995-6#1)(2008-10#1)
fluorescence quenching method##4##3##(2008-10#4)
fluorescence quenching of CdSe nanocrystals##3##5##(2008-10#3)
fluorescence quenching of a##3##4##(2008-10#3)
fluorescence quenching of##14##3##(2008-10#14)
fluorescence quenching reaction##3##3##(2008-10#3)
fluorescence quenching##41##2##(1993-8#1)(1995-6#1)(1997-8#1)(2008-10#37)(2008-8#1)
fluorescence reactions##2##2##(2008-10#2)
fluorescence recovery##5##2##(2008-10#4)(2008-7#1)
fluorescence resonance energy transfer (FRET) from a##2##7##(2008-10#2)
fluorescence resonance energy transfer (FRET)##5##5##(2008-10#3)(2008-4#2)
fluorescence resonance energy transfer##6##4##(1994-5#1)(2008-10#3)(2008-4#2)
fluorescence resonance energy##7##3##(1994-5#1)(2008-10#3)(2008-4#2)(2008-9#1)
fluorescence scan##2##2##(2008-10#2)
fluorescence signal on##2##3##(2008-10#1)(2008-9#1)
fluorescence signal##14##2##(2008-10#10)(2008-11#1)(2008-4#1)(2008-9#2)
fluorescence signals##8##2##(1994-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)
fluorescence spectra of##5##3##(2008-10#4)(2008-9#1)
fluorescence spectra were##3##3##(2008-10#3)
fluorescence spectra##20##2##(2008-10#16)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
fluorescence spectral##2##2##(2008-10#2)
fluorescence spectrometer##3##2##(2008-10#3)
fluorescence spectrometric detection##3##3##(2008-10#3)
fluorescence spectrometric##7##2##(2008-10#7)
fluorescence spectrometry (HG-AFS)##4##3##(2008-10#4)
fluorescence spectrometry (HGAFS)##3##3##(2008-10#3)
fluorescence spectrometry after##3##3##(2008-10#3)
fluorescence spectrometry for##3##3##(2008-10#3)
fluorescence spectrometry using##2##3##(2008-10#2)
fluorescence spectrometry was used##2##4##(2008-10#2)
fluorescence spectrometry was##4##3##(2008-10#4)
fluorescence spectrometry##56##2##(2008-10#56)
fluorescence spectroscopic##2##2##(1995-6#1)(2008-10#1)
fluorescence spectroscopy and##5##3##(2008-10#4)(2008-3#1)
fluorescence spectroscopy##25##2##(1991-3#1)(1994-5#1)(2008-10#18)(2008-11#1)(2008-3#3)(2013-8#1)
fluorescence spectrum of##3##3##(2008-10#2)(2008-9#1)
fluorescence spectrum##7##2##(2008-10#5)(2008-3#1)(2008-9#1)
fluorescence study##3##2##(1994-5#1)(1995-3#1)(2008-10#1)
fluorescence system##3##2##(2008-10#3)
fluorescence technique##6##2##(1994-5#1)(2008-10#4)(2008-4#1)
fluorescence that##2##2##(2008-10#2)
fluorescence to##3##2##(1996-2#1)(2008-10#1)(2008-3#1)
fluorescence upon binding##2##3##(1995-6#1)(2008-10#1)
fluorescence using partial##2##3##(2008-10#2)
fluorescence was monitored##2##3##(1996-2#1)(2008-10#1)
fluorescence was observed in##2##4##(2008-10#1)(2008-11#1)
fluorescence was observed##6##3##(1992-6#1)(2008-10#4)(2008-11#1)
fluorescence was visualized##2##3##(2008-9#2)
fluorescence was##17##2##(1992-6#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-9#4)(2013-8#1)
fluorescence when##2##2##(2008-10#1)(2009-5#1)
fluorescence with##3##2##(2008-10#3)
fluorescence yield##4##2##(2008-10#1)(2008-11#1)(2012-2#2)
fluorescence##982##1##(1990-12#3)(1990-2#1)(1990-5#3)(1991-3#5)(1991-5#12)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-5#16)(1995-11#2)(1995-3#1)(1995-6#9)(1995-8#2)(1996-12#1)(1996-2#5)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#4)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#653)(2008-11#26)(2008-12#6)(2008-2#9)(2008-3#59)(2008-4#15)(2008-5#5)(2008-7#3)(2008-8#16)(2008-9#51)(2009-10#1)(2009-12#3)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#6)(2010-3#1)(2010-4#2)(2010-7#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#1)(2013-8#7)
fluorescence-activated cell sorting##2##3##(1992-6#1)(2008-4#1)
fluorescence-based##6##1##(2008-10#4)(2008-9#1)(2009-12#1)
fluorescence-detected circular dichroism##2##3##(2008-10#2)
fluorescence-detected##3##1##(1994-5#1)(2008-10#2)
fluorescens 5064##5##2##(2008-10#5)
fluorescens A506##7##2##(2008-10#7)
fluorescens Pf-5 is##2##3##(2008-10#2)
fluorescens Pf-5##3##2##(2008-10#3)
fluorescens Q8r1-96##3##2##(2008-10#3)
fluorescens RG 26##2##3##(2008-10#2)
fluorescens WCS374r##2##2##(2008-10#2)
fluorescens and##3##2##(2008-10#3)
fluorescens m6418##3##2##(2008-10#3)
fluorescens strain A506##6##3##(2008-10#6)
fluorescens strain##11##2##(2008-10#11)
fluorescens##76##1##(2008-10#75)(2008-8#1)
fluorescent Pseudomonas spp##7##3##(2008-10#7)
fluorescent Pseudomonas##8##2##(2008-10#8)
fluorescent amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
fluorescent amplified fragment length polymorphism##3##5##(2008-10#3)
fluorescent antibody##2##2##(2008-5#1)(2011-2#1)
fluorescent beads##2##2##(2008-10#1)(2008-4#1)
fluorescent calcium##2##2##(1990-2#1)(1991-5#1)
fluorescent cells##2##2##(2008-11#2)
fluorescent chelate##2##2##(2008-10#2)
fluorescent compound##4##2##(2008-10#3)(2008-11#1)
fluorescent derivatization##3##2##(2008-10#3)
fluorescent detection of##3##3##(2008-10#2)(2008-9#1)
fluorescent detection##6##2##(2008-10#5)(2008-9#1)
fluorescent dye##10##2##(1991-11#1)(1992-6#1)(1997-7#1)(2008-10#5)(2008-4#1)(2009-12#1)
fluorescent dyes##11##2##(2006-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
fluorescent in situ hybridization##2##4##(2012-3#1)(2013-1#1)
fluorescent in##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
fluorescent indicators##2##2##(1990-8#1)(2008-9#1)
fluorescent intensity was##2##3##(2008-10#2)
fluorescent intensity##5##2##(2008-10#5)
fluorescent labeling of##2##3##(2008-10#1)(2013-7#1)
fluorescent labeling##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2013-7#1)
fluorescent lifetime##2##2##(2009-10#2)
fluorescent light##4##2##(1994-12#1)(2008-1#1)(2008-10#2)
fluorescent marker for##2##3##(1996-6#1)(2008-11#1)
fluorescent markers##2##2##(2008-10#1)(2009-9#1)
fluorescent metabolites with##2##3##(1993-8#2)
fluorescent microscope##2##2##(1992-6#1)(2008-9#1)
fluorescent microscopy##3##2##(1990-5#1)(1997-2#1)(2008-9#1)
fluorescent nanoparticles##3##2##(1997-1#1)(2008-11#1)(2010-4#1)
fluorescent optode membrane for sodium ion##2##6##(2008-10#2)
fluorescent pH indicator##2##3##(2008-10#2)
fluorescent probe##9##2##(2008-10#8)(2008-8#1)
fluorescent probes and##2##3##(2008-9#2)
fluorescent probes##11##2##(2008-10#2)(2008-9#6)(2009-7#1)(2010-12#2)
fluorescent probing##2##2##(2008-10#2)
fluorescent product##3##2##(1994-11#1)(2008-10#2)
fluorescent protein (GFP)##17##3##(1996-6#1)(2008-10#5)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#2)(2011-3#1)(2013-8#1)
fluorescent protein as a##2##4##(1996-6#1)(2008-11#1)
fluorescent protein in##4##3##(2008-11#3)(2008-7#1)
fluorescent protein##50##2##(1996-6#2)(1997-8#1)(2008-10#11)(2008-11#15)(2008-7#6)(2008-8#4)(2008-9#5)(2009-8#1)(2009-9#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
fluorescent pseudomonad##6##2##(2008-10#6)
fluorescent pseudomonads##6##2##(2008-10#6)
fluorescent quantitative##5##2##(2008-10#1)(2013-8#4)
fluorescent reagent##8##2##(2008-10#8)
fluorescent sensor for##2##3##(2008-10#2)
fluorescent sensor##4##2##(2008-10#4)
fluorescent signals##2##2##(2008-10#1)(2008-4#1)
fluorescent species##2##2##(2008-10#2)
fluorescent spectrum of##2##3##(2008-10#1)(2008-8#1)
fluorescent staining##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
fluorescent substrate##2##2##(2008-10#2)
fluorescent triazole##2##2##(2008-10#2)
fluorescent##328##1##(1990-2#2)(1990-5#2)(1990-8#1)(1991-11#1)(1991-5#2)(1992-6#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#2)(1995-11#1)(1995-6#1)(1996-6#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#177)(2008-11#31)(2008-12#3)(2008-3#2)(2008-4#9)(2008-5#1)(2008-7#9)(2008-8#7)(2008-9#23)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#4)(2010-4#5)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
fluorescently labeled##8##2##(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#2)
fluorescently##11##1##(2008-10#3)(2008-11#3)(2008-4#1)(2008-9#4)
fluorescing##7##1##(2007-12#1)(2008-10#4)(2008-3#2)
fluoride and carbonate##3##3##(2008-10#3)
fluoride and##10##2##(2008-10#8)(2008-12#1)(2011-2#1)
fluoride at##2##2##(2008-5#1)(2013-1#1)
fluoride concentration in##3##3##(2008-10#3)
fluoride concentration##4##2##(2008-10#4)
fluoride determination##2##2##(2008-10#2)
fluoride in##16##2##(1992-12#1)(2008-10#12)(2008-12#2)(2013-1#1)
fluoride ion in##3##3##(2008-10#3)
fluoride ion is##2##3##(2008-10#2)
fluoride ion selective electrode##2##4##(2008-10#1)(2008-5#1)
fluoride ion##14##2##(2008-10#12)(2008-5#2)
fluoride ion-selective electrode##7##3##(2008-10#7)
fluoride is##3##2##(2008-10#2)(2009-5#1)
fluoride levels##2##2##(2008-12#1)(2012-2#1)
fluoride load##2##2##(2008-12#2)
fluoride present##2##2##(2008-10#2)
fluoride##144##1##(1991-11#3)(1991-5#1)(1991-6#1)(1992-12#1)(1994-5#2)(1994-8#2)(1996-12#1)(2008-10#96)(2008-11#2)(2008-12#9)(2008-5#4)(2009-5#3)(2011-2#7)(2012-2#1)(2013-1#11)
fluoride) and##2##2##(1992-12#1)(2008-10#1)
fluoride)##4##1##(1992-12#2)(2008-10#2)
fluoride-selective electrode##3##2##(2008-10#3)
fluoride-selective membrane##2##2##(2008-10#2)
fluoride-selective##5##1##(2008-10#5)
fluorides in##2##2##(2008-10#1)(2008-12#1)
fluorides##6##1##(2008-10#5)(2008-12#1)
fluorimeter##3##1##(2008-10#2)(2009-10#1)
fluorimetric analysis of##4##3##(2008-10#4)
fluorimetric assay##3##2##(2008-10#3)
fluorimetric data##2##2##(2008-10#2)
fluorimetric detection##19##2##(1997-2#1)(2008-10#18)
fluorimetric detector##3##2##(2008-10#3)
fluorimetric determination of##13##3##(2008-10#13)
fluorimetric determination##16##2##(2008-10#16)
fluorimetric method for the determination of##6##6##(2008-10#6)
fluorimetric method for##7##3##(2008-10#7)
fluorimetric method has been##2##4##(2008-10#2)
fluorimetric method##18##2##(2008-10#18)
fluorimetric methods reported##2##3##(2008-10#2)
fluorimetric methods##6##2##(2008-10#6)
fluorimetric study of##2##3##(2008-10#2)
fluorimetric##86##1##(1997-2#1)(2008-10#85)
fluorimetrically##6##1##(2008-10#6)
fluorimetry for##4##2##(2008-10#4)
fluorimetry##16##1##(1994-3#1)(2008-10#15)
fluorinated##10##1##(1991-12#1)(1992-12#1)(2008-1#1)(2008-10#2)(2008-2#4)(2013-1#1)
fluorination assisted electrothermal vaporization (FETV)-inductively coupled plasma optical emission spectrometry (ICP-OES)##2##11##(2008-10#2)
fluorine determination##2##2##(2008-10#2)
fluorine in blood##2##3##(2008-10#2)
fluorine in the air##2##4##(2008-10#2)
fluorine in the##3##3##(2008-10#3)
fluorine in##9##2##(2008-10#9)
fluorine laser##2##2##(2008-3#2)
fluorine##21##1##(1991-6#1)(2008-10#16)(2008-3#3)(2012-3#1)
fluoro-substituted##2##1##(2012-3#2)
fluoroacetate##2##1##(2011-1#2)
fluorochrome##11##1##(1990-12#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-9#3)
fluorochromes##14##1##(1990-12#1)(2008-11#1)(2008-12#2)(2008-9#10)
fluorodeoxyglucose##2##1##(1993-9#1)(2008-1#1)
fluorogenic probe##2##2##(2008-10#2)
fluorogenic reagent##4##2##(2008-10#4)
fluorogenic substrates##2##2##(2008-10#1)(2008-9#1)
fluorogenic##15##1##(2008-10#14)(2008-9#1)
fluorography and##2##2##(1990-12#1)(2008-4#1)
fluoroimmunosensor for##2##2##(2008-10#2)
fluoroimmunosensor##4##1##(2008-10#4)
fluoroionophores##4##1##(2008-10#4)
fluorometer##2##1##(2008-10#2)
fluorometric detection##4##2##(1995-11#1)(2008-10#3)
fluorometric determination of##5##3##(2008-10#5)
fluorometric enzyme immunoassay for 17beta-estradiol##2##5##(2008-10#2)
fluorometric enzyme##3##2##(2008-10#3)
fluorometric method##3##2##(2008-10#3)
fluorometric##28##1##(1991-9#1)(1992-11#1)(1993-3#1)(1995-11#1)(2008-10#23)(2011-2#1)
fluorometrically at##2##2##(2008-10#2)
fluorometrically##5##1##(1993-3#1)(2008-10#4)
fluorophore is##2##2##(2008-10#2)
fluorophore##20##1##(1997-2#3)(2008-10#13)(2008-12#1)(2008-3#1)(2008-9#1)(2010-5#1)
fluorophore-assisted##2##1##(2008-11#1)(2008-5#1)
fluorophores that##2##2##(2008-10#1)(2009-5#1)
fluorophores to##3##2##(2008-1#1)(2008-4#2)
fluorophores##23##1##(1990-8#1)(2008-1#1)(2008-10#8)(2008-3#2)(2008-4#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-5#2)
fluorophosphate##2##1##(2008-10#2)
fluorophotometer at##2##2##(1993-2#1)(2008-10#1)
fluoroquinolone derivatives##2##2##(2008-10#2)
fluoroquinolone##7##1##(1991-3#1)(2008-10#4)(2011-2#1)(2012-3#1)
fluoroquinolones and##3##2##(2007-12#1)(2008-10#1)(2010-6#1)
fluoroquinolones in##3##2##(2007-12#1)(2008-10#2)
fluoroquinolones was##2##2##(2008-10#1)(2008-7#1)
fluoroquinolones##21##1##(2007-12#2)(2008-10#11)(2008-7#4)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
fluoroscopic##4##1##(2008-8#1)(2011-2#2)(2013-1#1)
fluoroscopically guided##2##2##(1993-1#1)(2009-3#1)
fluoroscopy##10##1##(1994-9#1)(2008-10#1)(2008-9#1)(2010-7#2)(2012-3#1)(2013-1#4)
fluorosis##3##1##(1990-6#1)(1991-11#2)
fluorouracil##5##1##(1990-2#4)(1995-10#1)
fluorozirconate##2##1##(1991-1#1)(2008-3#1)
fluoxetine was##2##2##(2008-10#1)(2008-7#1)
fluoxetine##20##1##(2008-10#9)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#3)(2012-3#1)(2013-1#3)
fluphenazine##5##1##(2008-10#5)
flurbiprofen as##2##2##(2011-2#2)
flurbiprofen sodium eye drops##2##4##(2011-3#2)
flurbiprofen##14##1##(2008-10#4)(2011-2#4)(2011-3#6)
flushed##5##1##(1995-3#1)(2008-11#1)(2008-3#1)(2013-1#2)
flushing reaction##4##2##(1994-5#4)
flushing##9##1##(1994-5#4)(2008-10#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-3#1)
flusilazole##3##1##(2008-10#3)
fluticasone propionate (FP)##3##3##(1996-1#1)(1996-2#2)
fluticasone propionate##4##2##(1996-1#1)(1996-2#2)(2007-11#1)
flutter##4##1##(2010-11#3)(2011-2#1)
fluviatilis##3##1##(1993-3#1)(1997-3#2)
flux analysis##3##2##(2008-7#3)
flux and storage##2##3##(2008-8#2)
flux and##5##2##(2008-10#1)(2008-7#1)(2008-8#2)(2010-10#1)
flux density of##4##3##(2008-10#4)
flux density##10##2##(1995-6#2)(2008-10#7)(2010-10#1)
flux in the##2##3##(2008-10#1)(2008-7#1)
flux in##5##2##(1991-1#1)(1991-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
flux measurements##3##2##(1995-3#1)(2008-11#1)(2008-3#1)
flux of##12##2##(2008-10#5)(2008-11#2)(2008-6#2)(2008-7#2)(2012-2#1)
flux rate##2##2##(1991-5#1)(2008-7#1)
flux through the pyruvate-dehydrogenase complex##2##5##(1991-3#2)
flux through the##7##3##(1991-3#2)(1994-8#1)(1997-2#1)(2008-11#2)(2008-3#1)
flux through##10##2##(1991-3#3)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)
flux was##3##2##(1991-5#2)(1993-3#1)
flux##110##1##(1990-5#1)(1991-1#1)(1991-3#4)(1991-5#5)(1993-2#1)(1993-3#1)(1994-8#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#2)(1997-2#1)(2008-10#26)(2008-11#11)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#26)(2008-8#2)(2008-9#1)(2010-10#5)(2011-1#1)(2012-2#6)(2013-1#2)
flux)##5##1##(1991-3#2)(2008-7#2)(2012-2#1)
flux-grown BBO##2##2##(2008-2#2)
fluxes across##2##2##(2008-10#1)(2008-9#1)
fluxes and##4##2##(1995-11#2)(2008-10#1)(2008-7#1)
fluxes for##2##2##(2008-7#2)
fluxes of##4##2##(2008-10#1)(2008-11#3)
fluxes##41##1##(1990-5#1)(1991-5#1)(1992-6#1)(1993-3#1)(1995-11#2)(2008-10#5)(2008-11#14)(2008-3#1)(2008-6#1)(2008-7#10)(2008-9#1)(2010-7#1)(2011-1#2)
fly ash and sediment##2##4##(2008-10#2)
fly ash and##6##3##(2008-10#6)
fly ash precipitates##4##3##(2008-10#4)
fly ash samples##5##3##(2008-10#5)
fly ash##23##2##(2008-10#23)
fly ash)##3##2##(2008-10#3)
fly research##2##2##(2008-12#1)(2013-1#1)
fly##64##1##(1990-5#1)(1991-11#1)(1993-12#1)(1993-5#1)(1994-3#1)(1997-7#1)(2007-12#3)(2008-10#27)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-9#6)(2009-8#1)(2010-1#3)(2010-10#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
flying##8##1##(1992-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)
fmol and##2##2##(1997-2#2)
fmol for##5##2##(2008-10#5)
fmol l(-1) to##2##3##(2008-10#2)
fmol##17##1##(1994-8#1)(1997-2#4)(2008-10#11)(2008-6#1)
fmol/mg protein##3##2##(1990-8#1)(1992-12#1)(1993-3#1)
fmol/mg protein)##2##2##(1990-11#1)(1994-8#1)
fmol/mg##5##1##(1990-11#1)(1990-8#1)(1992-12#1)(1993-3#1)(1994-8#1)
fmol/ml in##2##2##(1991-5#2)
foam and C(18)##2##3##(2008-10#2)
foam and##5##2##(2008-10#5)
foam packed##2##2##(2008-10#2)
foam##62##1##(1990-8#1)(1996-3#1)(2008-10#44)(2008-11#5)(2008-5#1)(2008-7#3)(2009-7#3)(2012-2#3)(2012-3#1)
foaming properties##2##2##(2010-4#2)
foaming##5##1##(2008-10#2)(2010-4#2)(2011-2#1)
foams##11##1##(2008-10#3)(2008-11#2)(2008-5#1)(2009-7#5)
foamy macrophages##2##2##(2010-3#1)(2012-2#1)
focal adhesion kinase##2##3##(1996-12#1)(2012-2#1)
focal adhesion-like process underlies##2##4##(2008-7#2)
focal adhesion-like process##3##3##(2008-7#3)
focal adhesions##2##2##(2008-7#2)
focal and general##2##3##(2008-10#2)
focal and##5##2##(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
focal brain##2##2##(1996-6#1)(2008-11#1)
focal cerebral ischemia##4##3##(1996-12#1)(1997-2#1)(2011-2#1)(2013-1#1)
focal cerebral##8##2##(1996-11#1)(1996-12#3)(1997-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
focal epidemics##3##2##(2008-10#3)
focal hepatic lesion##3##3##(1997-8#3)
focal hepatic##4##2##(1997-8#4)
focal initiation##2##2##(1997-3#2)
focal ischaemia-reperfusion##2##2##(2008-7#2)
focal length##3##2##(2008-2#1)(2008-3#2)
focal lesions##2##2##(2008-7#1)(2012-2#1)
focal liver lesions (FLLs)##2##4##(2010-12#2)
focal liver lesions in##3##4##(2010-12#3)
focal liver lesions##13##3##(2010-12#12)(2012-2#1)
focal liver##14##2##(2008-1#1)(2010-12#12)(2012-2#1)
focal motor##2##2##(2010-1#2)
focal neural lesions##2##3##(2011-2#2)
focal neural##3##2##(2011-2#3)
focal neurological##2##2##(1992-6#1)(1996-9#1)
focal point of the##3##4##(1996-5#1)(1997-6#1)(2008-10#1)
focal point of##4##3##(1992-3#1)(1996-5#1)(1997-6#1)(2008-10#1)
focal point##6##2##(1992-3#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
focal trees##2##2##(2008-10#2)
focal##117##1##(1990-6#1)(1990-9#2)(1992-3#2)(1992-6#1)(1993-11#1)(1996-11#1)(1996-12#5)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#5)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#3)(2009-8#2)(2010-1#3)(2010-12#12)(2010-7#1)(2011-2#13)(2012-2#7)(2012-3#5)(2013-1#5)(2013-8#2)
focalized##4##1##(2008-10#4)
focally##7##1##(1990-2#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
foci by##2##2##(2008-10#1)(2008-11#1)
foci enlarged##2##2##(2008-10#2)
foci in heated##2##3##(2011-2#2)
foci in the##4##3##(2008-10#1)(2008-9#1)(2009-8#1)(2012-12#1)
foci in##7##2##(2008-10#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)
foci of infection##2##3##(2008-10#1)(2011-2#1)
foci of the##2##3##(2008-10#1)(2008-9#1)
foci of##14##2##(1993-3#1)(2008-10#4)(2008-11#2)(2008-9#2)(2011-2#3)(2013-1#2)
foci were##4##2##(1990-6#1)(2008-10#3)
foci##58##1##(1990-6#1)(1993-3#1)(2008-10#28)(2008-11#3)(2008-3#2)(2008-6#1)(2008-9#6)(2009-8#1)(2010-11#2)(2011-2#7)(2012-12#1)(2013-1#5)
focus and##7##2##(1993-12#2)(1997-3#1)(2008-10#2)(2008-7#1)(2013-1#1)
focus at the##2##3##(2010-10#1)(2013-8#1)
focus for the##2##3##(2008-12#1)(2009-7#1)
focus for##6##2##(2008-11#1)(2008-12#2)(2009-7#1)(2011-2#1)(2012-2#1)
focus group discussions (N =##2##5##(2010-2#1)(2012-2#1)
focus group discussions##5##3##(2008-11#2)(2009-3#1)(2010-2#1)(2012-2#1)
focus group interview##3##3##(1992-2#1)(2008-11#2)
focus group interviews with##2##4##(2010-10#1)(2011-2#1)
focus group interviews##7##3##(2008-11#3)(2008-12#2)(2010-10#1)(2011-2#1)
focus group study##3##3##(2008-9#1)(2010-2#1)(2011-1#1)
focus group transcripts##2##3##(1997-3#1)(2011-1#1)
focus group##25##2##(1992-2#1)(1997-3#1)(2008-11#9)(2008-12#2)(2008-9#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-2#2)(2011-1#3)(2011-2#1)(2012-2#1)
focus groups and##3##3##(2010-10#1)(2012-3#2)
focus groups to##3##3##(1994-12#1)(1997-3#1)(2008-10#1)
focus groups were##3##3##(2009-5#1)(2012-12#1)(2013-1#1)
focus groups##28##2##(1994-12#2)(1997-2#1)(1997-3#4)(2008-10#1)(2008-11#6)(2008-12#2)(2009-3#1)(2009-5#2)(2010-10#2)(2012-12#1)(2012-3#5)(2013-1#1)
focus has been on##2##4##(1996-2#1)(2013-1#1)
focus has been##6##3##(1996-2#1)(1996-3#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-1#1)
focus has##7##2##(1996-2#1)(1996-3#1)(2007-11#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-1#1)
focus in the##4##3##(1997-4#1)(2008-11#1)(2009-1#1)(2011-2#1)
focus in##7##2##(1992-2#1)(1997-4#1)(2008-11#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
focus is on the##3##4##(2008-11#2)(2011-2#1)
focus is on##6##3##(1994-9#1)(2008-10#1)(2008-11#2)(2010-5#1)(2011-2#1)
focus is to##2##3##(1997-3#1)(2009-3#1)
focus is##10##2##(1994-9#1)(1997-3#1)(2008-10#1)(2008-11#3)(2009-3#1)(2010-5#1)(2011-2#2)
focus more##4##2##(1997-1#1)(2008-11#2)(2012-2#1)
focus of attention##5##3##(2008-12#1)(2008-9#1)(2010-7#1)(2013-1#2)
focus of intense##3##3##(2008-9#1)(2009-3#1)(2010-7#1)
focus of the##9##3##(1991-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-9#1)
focus of this article is on##2##6##(2008-10#1)(2010-2#1)
focus of this article is##4##5##(2008-10#1)(2008-11#1)(2010-2#1)(2012-2#1)
focus of this review is on##2##6##(2008-10#1)(2011-1#1)
focus of this review is##4##5##(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#1)
focus of this review##9##4##(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
focus of this##21##3##(1992-2#1)(1995-12#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
focus of##62##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-3#3)(1995-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#9)(2008-12#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#5)(2009-10#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#1)
focus on a specific##2##4##(1994-12#1)(2008-9#1)
focus on a##7##3##(1994-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-8#1)
focus on current##2##3##(2008-7#1)(2013-8#1)
focus on health promotion##2##4##(2008-1#1)(2008-12#1)
focus on health##3##3##(2008-1#2)(2008-12#1)
focus on how##3##3##(2009-10#1)(2009-5#1)(2009-6#1)
focus on improving##2##3##(1991-6#1)(2010-7#1)
focus on some##2##3##(1997-3#1)(2009-4#1)
focus on the contribution of##2##5##(2008-11#1)(2008-7#1)
focus on the dynamics##2##4##(2008-10#1)(2013-8#1)
focus on the effects of##3##5##(1994-2#1)(2008-11#2)
focus on the effects##4##4##(1994-2#1)(2008-10#1)(2008-11#2)
focus on the link between##2##5##(2010-1#2)
focus on the recent##2##4##(1994-12#1)(2011-2#1)
focus on the role of##2##5##(2011-2#1)(2013-1#1)
focus on the role##4##4##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
focus on the use of##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
focus on the##63##3##(1993-12#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#2)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
focus on these issues##2##4##(1993-3#1)(2009-12#1)
focus on##180##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#3)(1994-12#4)(1994-2#1)(1994-3#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#2)(1996-11#1)(1996-2#2)(1997-2#4)(1997-3#2)(1997-8#1)(2008-1#3)(2008-10#14)(2008-11#17)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#6)(2010-11#4)(2010-12#2)(2010-5#2)(2010-7#3)(2010-8#3)(2011-10#1)(2011-2#13)(2011-3#1)(2012-2#6)(2012-3#2)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#9)
focus than##2##2##(2008-10#1)(2008-3#1)
focus the##2##2##(2008-7#1)(2011-1#1)
focus their attention##2##3##(1993-6#1)(2008-12#1)
focus their##3##2##(1993-6#1)(2008-10#1)(2008-12#1)
focus to##2##2##(1997-1#1)(2009-9#1)
focus was a##2##3##(1990-3#1)(2008-11#1)
focus was##6##2##(1990-3#1)(2008-11#2)(2010-11#1)(2011-2#1)(2012-12#1)
focus which##2##2##(1994-2#1)(1997-1#1)
focus within##2##2##(1997-2#1)(2008-11#1)
focus##409##1##(1990-11#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#4)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#6)(1994-2#4)(1994-3#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-3#3)(1997-1#5)(1997-2#9)(1997-3#10)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#32)(2008-11#57)(2008-12#21)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#12)(2009-1#1)(2009-10#3)(2009-12#2)(2009-3#5)(2009-4#2)(2009-5#7)(2009-6#7)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#11)(2010-11#5)(2010-12#2)(2010-2#3)(2010-5#3)(2010-6#2)(2010-7#6)(2010-8#3)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#27)(2011-3#1)(2012-12#2)(2012-2#14)(2012-3#8)(2012-6#1)(2013-1#18)(2013-7#1)(2013-8#12)
focused almost exclusively on##2##4##(1993-3#1)(2013-8#1)
focused approach##2##2##(1992-3#1)(2008-7#1)
focused attention##2##2##(1992-12#1)(1994-2#1)
focused by##2##2##(2008-2#2)
focused care##10##2##(1993-1#1)(1993-2#4)(1993-3#2)(1994-12#1)(1994-2#1)(1996-2#1)
focused into a##2##3##(2007-12#1)(2008-10#1)
focused ion beam##2##3##(2008-10#2)
focused laser beam##4##3##(2008-2#1)(2008-3#1)(2009-5#2)
focused laser##5##2##(2008-2#1)(2008-3#2)(2009-5#2)
focused microwave##10##2##(2008-10#10)
focused microwave-assisted##4##2##(2008-10#4)
focused on a##2##3##(2009-8#1)(2013-1#1)
focused on how##3##3##(1996-6#1)(2008-10#1)(2008-8#1)
focused on improving##2##3##(2010-8#1)(2010-9#1)
focused on other traffic-related actors##2##5##(2011-2#2)
focused on the role of##3##5##(1997-8#1)(2008-10#1)(2012-2#1)
focused on the use of##2##5##(2011-7#1)(2013-1#1)
focused on the##49##3##(1991-12#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-5#1)(1995-1#1)(1996-3#1)(1997-1#2)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-2#3)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#6)
focused on these##3##3##(1996-3#1)(2008-11#1)(2012-2#1)
focused on##146##2##(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-6#1)(1994-1#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#4)(1997-3#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#24)(2008-11#11)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#10)(2011-7#1)(2011-9#1)(2012-2#8)(2012-3#5)(2013-1#13)(2013-8#3)
focused their##2##2##(2008-10#1)(2009-1#1)
focused ultrasound (TFU)##2##3##(2008-10#2)
focused ultrasound##7##2##(2008-10#7)
focused upon##2##2##(1991-6#1)(1997-1#1)
focused##248##1##(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#3)(1993-12#4)(1993-2#5)(1993-3#4)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#3)(1996-3#4)(1996-6#1)(1997-1#6)(1997-3#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#58)(2008-11#15)(2008-12#3)(2008-2#4)(2008-3#12)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#11)(2011-7#1)(2011-9#1)(2012-2#10)(2012-3#6)(2013-1#13)(2013-8#4)
focused-ion-beam milling##3##2##(2008-3#3)
focused-microwave##2##1##(2008-10#2)
focuses on issues##2##3##(1996-2#1)(2009-11#1)
focuses on some##2##3##(1992-12#1)(2011-2#1)
focuses on the application of##2##5##(2008-10#1)(2011-2#1)
focuses on the development of##2##5##(2008-10#1)(2008-11#1)
focuses on the importance of##2##5##(1992-12#1)(2010-12#1)
focuses on the issue of##2##5##(2009-10#2)
focuses on the key##2##4##(1991-7#1)(2010-12#1)
focuses on the practical##2##4##(2008-11#1)(2008-4#1)
focuses on the role of##2##5##(2008-10#1)(2012-2#1)
focuses on the safety##2##4##(1992-2#1)(1993-12#1)
focuses on the strengths##2##4##(2008-10#1)(2012-2#1)
focuses on the use of##2##5##(2008-11#1)(2013-1#1)
focuses on the##62##3##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-2#1)(1995-9#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#2)(2008-4#3)(2008-5#4)(2008-9#1)(2009-10#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#1)
focuses on those##2##3##(2008-12#1)(2008-8#1)
focuses on two##2##3##(2008-11#1)(2008-4#1)
focuses on##118##2##(1990-11#2)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#3)(1997-6#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#11)(2008-12#5)(2008-3#1)(2008-4#6)(2008-5#4)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#1)(2013-8#1)
focuses primarily on##2##3##(1996-1#1)(2008-10#1)
focuses upon##5##2##(1991-2#1)(1997-2#2)(2008-11#1)(2008-7#1)
focuses##136##1##(1990-11#2)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#4)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#3)(1997-2#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#2)(2013-8#2)
focusing (IEF)##2##2##(2008-11#2)
focusing and##4##2##(1991-1#1)(2008-11#1)(2008-3#1)(2008-4#1)
focusing of##5##2##(1991-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
focusing on studies##2##3##(2008-11#1)(2012-12#1)
focusing on the development of##3##5##(1992-2#1)(2008-10#1)(2008-9#1)
focusing on the##14##3##(1992-2#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-1#2)
focusing on##42##2##(1992-2#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#4)
focusing was##3##2##(2008-10#2)(2008-3#1)
focusing##82##1##(1991-1#1)(1991-12#2)(1992-2#1)(1992-3#1)(1995-2#1)(1996-6#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-10#2)(2010-11#2)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
focussed microwave system##2##3##(2008-10#2)
focussed on how##2##3##(2009-8#1)(2010-9#1)
focussed on the##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
focussed on##10##2##(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-9#3)(2013-8#1)
focussed##19##1##(1997-6#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-7#1)(2009-8#1)(2010-9#3)(2013-8#1)
focussing on##3##2##(2007-12#1)(2008-11#1)(2008-12#1)
focussing##4##1##(2007-12#1)(2008-11#1)(2008-12#1)(2010-11#1)
foe?##2##1##(1996-3#1)(2013-8#1)
foetal MRI##3##2##(2012-2#3)
foetal bovine##2##2##(1993-3#1)(2008-11#1)
foetal liver##4##2##(1990-5#1)(2008-10#3)
foetal morbidity##2##2##(1991-9#1)(2008-7#1)
foetal##27##1##(1990-5#3)(1991-9#2)(1993-3#1)(1994-6#1)(1996-11#3)(1996-3#1)(2008-10#4)(2008-11#3)(2008-7#1)(2009-3#2)(2011-2#1)(2012-2#4)(2013-1#1)
foeto-maternal##2##1##(2009-1#1)(2009-3#1)
foetus##10##1##(1990-5#1)(1991-9#2)(1992-5#2)(1996-11#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-2#1)
foetuses##4##1##(1990-5#1)(2008-11#3)
fog##4##1##(1997-1#1)(2008-10#3)
fogs##2##1##(2008-3#2)
foil##2##1##(2008-10#2)
foils##3##1##(1997-6#1)(2008-10#2)
folate deficiency##3##2##(1992-9#3)
folate levels in##3##3##(1992-9#3)
folate levels##4##2##(1992-9#4)
folate on##2##2##(1992-10#1)(1992-9#1)
folate supplementation##2##2##(1992-9#2)
folate synthesis##3##2##(2011-2#3)
folate transporter##3##2##(1994-6#3)
folate turnover##2##2##(1992-9#1)(2011-2#1)
folate##33##1##(1992-10#1)(1992-9#14)(1994-6#8)(2009-12#1)(2009-8#3)(2011-2#6)
folate-conjugated and##2##2##(2012-12#2)
folate-mediated##2##1##(1992-10#2)
folate-receptor-overexpressing##2##1##(2012-12#2)
folates##3##1##(1990-2#1)(2011-2#2)
fold after##2##2##(1994-11#1)(2008-11#1)
fold and##6##2##(2008-10#1)(2008-5#5)
fold compared to that##2##4##(2008-11#2)
fold compared to##3##3##(2008-11#3)
fold higher concentrations##2##3##(2008-11#2)
fold higher than the##2##4##(1993-8#1)(2011-2#1)
fold higher than##3##3##(1993-8#2)(2011-2#1)
fold higher##7##2##(1993-8#2)(1994-11#1)(2008-11#3)(2011-2#1)
fold in##3##2##(1993-12#1)(1993-9#1)(1996-12#1)
fold increase in the dissolution rate of mefenamic acid##2##9##(2012-2#2)
fold increase in the##4##4##(1990-2#1)(2008-10#1)(2012-2#2)
fold increase in##7##3##(1990-2#1)(1992-7#1)(1993-8#1)(2008-10#1)(2008-11#1)(2012-2#2)
fold increase##10##2##(1990-2#1)(1992-7#1)(1993-8#1)(2008-10#1)(2008-11#2)(2011-2#2)(2012-2#2)
fold of##2##2##(1994-5#1)(1995-8#1)
fold##74##1##(1990-2#2)(1991-5#2)(1992-7#2)(1992-8#1)(1993-12#1)(1993-8#4)(1993-9#1)(1994-11#3)(1994-5#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#16)(2008-5#6)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#4)(2011-2#3)(2011-3#1)(2012-2#8)(2013-1#2)
foldable##2##1##(2011-2#1)(2013-1#1)
folded and 8 M urea-denatured state of SUMO from Drosophila melanogaster##2##11##(2009-7#2)
folded into##2##2##(2008-10#1)(2008-7#1)
folded##18##1##(1991-6#1)(1992-6#1)(1993-9#1)(1995-2#2)(2008-10#1)(2008-3#4)(2008-4#2)(2008-7#2)(2009-7#3)(2009-9#1)
folders##2##1##(2008-11#1)(2008-12#1)
folding and maturation of##3##4##(2009-6#2)(2010-4#1)
folding and##12##2##(1991-6#2)(1994-12#2)(2008-4#3)(2008-8#1)(2009-5#1)(2009-6#2)(2010-4#1)
folding behavior##3##2##(2008-9#3)
folding intermediates##3##2##(1997-4#2)(2008-4#1)
folding leaf##2##2##(2008-8#2)
folding leaves##2##2##(2008-8#2)
folding of the##2##3##(1992-6#1)(2008-7#1)
folding of this##2##3##(1993-2#1)(1997-6#1)
folding of##7##2##(1992-6#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-6#1)(2008-7#1)(2010-4#1)
folding or assembly##2##3##(1994-12#2)
folding reactions##2##2##(1992-6#2)
folding stage##2##2##(2008-8#2)
folding units##2##2##(1993-8#1)(1997-6#1)
folding##67##1##(1990-5#1)(1991-6#6)(1991-7#1)(1992-10#1)(1992-6#4)(1993-2#1)(1993-8#2)(1993-9#1)(1994-12#6)(1994-5#2)(1995-12#1)(1995-6#1)(1997-4#2)(1997-6#2)(2008-3#1)(2008-4#5)(2008-7#2)(2008-8#9)(2008-9#5)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-4#7)(2011-2#2)
folds and the##2##3##(2008-10#1)(2008-11#1)
folds and##4##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
folds into##2##2##(1995-2#1)(2008-9#1)
folds##22##1##(1993-3#2)(1995-2#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
foliage and##3##2##(2008-10#3)
foliage infection##2##2##(2008-10#2)
foliage mass##2##2##(2012-9#2)
foliage may##2##2##(2008-10#2)
foliage of##4##2##(2008-10#4)
foliage was##2##2##(2008-10#2)
foliage were##2##2##(2008-10#2)
foliage##40##1##(2008-10#38)(2012-9#2)
foliage-inoculated plants##2##2##(2008-10#2)
foliar SDS severity##3##3##(2008-10#3)
foliar SDS symptoms##2##3##(2008-10#2)
foliar SDS##5##2##(2008-10#5)
foliar and##5##2##(2008-10#5)
foliar blight##2##2##(2008-10#2)
foliar disease in##2##3##(2008-10#1)(2012-3#1)
foliar disease of##2##3##(2008-10#2)
foliar disease##7##2##(2008-10#6)(2012-3#1)
foliar diseases of barley in the##2##6##(2008-10#2)
foliar diseases of##5##3##(2008-10#5)
foliar diseases##8##2##(2008-10#8)
foliar epidemics##2##2##(2008-10#2)
foliar pathogens##2##2##(2008-10#1)(2013-8#1)
foliar spray##3##2##(2008-10#3)
foliar symptoms##6##2##(2008-10#6)
foliar terpene##2##2##(2011-10#2)
foliar##64##1##(2008-10#56)(2008-8#2)(2011-10#3)(2012-3#1)(2013-8#2)
foliar-drench##2##1##(2008-10#2)
folic acid in##2##3##(1992-9#1)(2009-8#1)
folic acid##12##2##(1992-9#4)(1997-8#1)(2008-10#2)(2008-11#1)(2009-8#2)(2010-1#2)
folic##13##1##(1992-9#4)(1997-8#1)(2008-10#2)(2008-11#1)(2009-8#2)(2010-1#3)
folimycin##3##1##(1993-6#3)
folinic acid##4##2##(1992-2#2)(2008-10#2)
folk medicinal##2##2##(2008-12#1)(2008-9#1)
folk##9##1##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#4)
folklore##3##1##(2009-10#3)
follicle cells in##4##3##(2008-6#2)(2008-7#2)
follicle cells of##4##3##(2008-6#2)(2008-7#2)
follicle cells##12##2##(2008-6#6)(2008-7#5)(2012-2#1)
follicle in the##2##3##(2008-12#1)(2012-3#1)
follicle in##3##2##(2008-12#1)(2008-5#1)(2012-3#1)
follicle is##2##2##(1990-8#1)(2011-2#1)
follicle stimulating hormone (FSH) in##2##5##(1993-11#2)
follicle stimulating hormone##3##3##(1993-11#2)(2007-7#1)
follicle without##2##2##(2008-5#1)(2012-3#1)
follicle##39##1##(1990-8#1)(1993-11#2)(1995-12#1)(2007-7#1)(2008-12#4)(2008-5#8)(2008-6#6)(2008-7#6)(2008-8#2)(2011-2#4)(2012-2#2)(2012-3#2)
follicle-stimulating hormone (FSH)##3##3##(2010-5#2)(2011-1#1)
follicle-stimulating hormone##8##2##(1990-2#1)(1990-4#1)(1991-3#2)(2010-5#2)(2011-1#1)(2013-1#1)
follicles and##6##2##(2008-12#5)(2008-9#1)
follicles in##4##2##(2008-12#3)(2012-3#1)
follicles with##3##2##(2012-3#3)
follicles##64##1##(1995-12#6)(1997-1#1)(2007-12#1)(2008-11#5)(2008-12#23)(2008-5#1)(2008-8#11)(2008-9#6)(2009-8#1)(2010-8#1)(2012-3#7)(2013-7#1)
follicular atresia in##2##3##(2008-7#1)(2008-8#1)
follicular atresia was##2##3##(2008-7#1)(2008-8#1)
follicular atresia##8##2##(2008-7#5)(2008-8#3)
follicular cell hypertrophy##3##3##(2008-9#3)
follicular cell##4##2##(2008-12#1)(2008-9#3)
follicular cells##2##2##(2008-7#2)
follicular development and atresia##2##4##(2008-8#1)(2010-3#1)
follicular development##3##2##(2008-8#2)(2010-3#1)
follicular growth##3##2##(2008-12#2)(2010-11#1)
follicular layer##2##2##(2008-12#1)(2008-6#1)
follicular lymphoma##2##2##(2010-11#2)
follicular neoplasia&quot##2##2##(1997-2#2)
follicular secretory depletion##2##3##(2008-9#2)
follicular unit-like wigs##5##3##(2012-3#5)
follicular##51##1##(1990-8#1)(1994-12#2)(1995-12#2)(1997-2#2)(1997-5#1)(2008-11#2)(2008-12#5)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#5)(2010-11#4)(2010-3#1)(2010-8#1)(2012-3#8)
follistatin##3##1##(1992-6#2)(1994-11#1)
follow a##11##2##(1994-8#1)(1997-2#1)(2008-10#2)(2008-8#1)(2009-11#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
follow one of two##2##4##(2008-12#1)(2009-8#1)
follow the kinetics of the##2##5##(1995-9#1)(2008-10#1)
follow the kinetics of##3##4##(1995-9#1)(2008-10#2)
follow the trend##2##3##(1990-11#1)(2008-10#1)
follow the##34##2##(1990-11#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1995-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
follow their##2##2##(2008-11#1)(2010-10#1)
follow to##2##2##(2008-11#1)(2011-2#1)
follow up and##2##3##(2010-8#1)(2011-2#1)
follow up in##2##3##(2009-6#1)(2011-2#1)
follow up is##2##3##(2010-11#1)(2013-8#1)
follow up of 5##2##4##(1992-6#1)(2007-8#1)
follow up of##6##3##(1992-6#1)(1996-3#1)(2007-8#1)(2008-4#1)(2013-1#1)(2013-8#1)
follow up period was##2##4##(2011-2#1)(2013-1#1)
follow up period##3##3##(2010-2#1)(2011-2#1)(2013-1#1)
follow up was##3##3##(2009-11#1)(2010-3#1)(2011-2#1)
follow up##57##2##(1990-9#1)(1991-3#1)(1992-6#1)(1993-12#1)(1996-3#3)(1996-6#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#2)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#5)
follow##145##1##(1990-11#2)(1990-9#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#6)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#2)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#2)(2011-2#11)(2012-2#2)(2012-3#4)(2013-1#17)(2013-7#1)(2013-8#5)
follow-on study##2##2##(2008-6#2)
follow-on##3##1##(2008-10#1)(2008-6#2)
follow-up (mean##3##2##(1992-9#1)(1995-5#1)(2011-3#1)
follow-up MR##5##2##(1996-6#4)(2012-2#1)
follow-up MRI##2##2##(2012-2#1)(2013-8#1)
follow-up after##7##2##(1990-3#1)(1992-1#1)(1993-1#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
follow-up and##9##2##(1992-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
follow-up angiography##2##2##(1997-3#1)(2008-7#1)
follow-up appointment##4##2##(1994-3#1)(2008-4#1)(2013-1#2)
follow-up are##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
follow-up assessment##2##2##(2008-11#1)(2008-7#1)
follow-up at##3##2##(1991-2#1)(2012-3#1)(2013-1#1)
follow-up data##2##2##(2008-10#1)(2011-1#1)
follow-up evaluation##2##2##(2008-10#1)(2008-9#1)
follow-up examination of##2##3##(1990-11#1)(1992-2#1)
follow-up examination##6##2##(1990-11#2)(1992-2#1)(1997-3#1)(2008-7#2)
follow-up examinations##3##2##(1996-11#1)(1997-3#1)(2008-7#1)
follow-up for##6##2##(1990-12#1)(1990-6#1)(1993-11#1)(1994-12#1)(2011-1#1)(2012-12#1)
follow-up imaging##2##2##(2008-2#1)(2008-7#1)
follow-up in a##2##3##(2008-10#1)(2012-3#1)
follow-up in##9##2##(1994-3#1)(2008-10#1)(2008-11#2)(2011-2#3)(2012-3#1)(2013-1#1)
follow-up information##2##2##(2008-7#1)(2012-2#1)
follow-up interval##2##2##(2008-7#2)
follow-up interview##2##2##(2013-8#2)
follow-up is necessary##3##3##(1992-5#1)(1997-8#1)(2012-12#1)
follow-up is##10##2##(1990-6#1)(1992-5#1)(1994-9#1)(1996-3#1)(1997-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
follow-up may##2##2##(1993-11#1)(2008-11#1)
follow-up of 1##3##3##(1990-6#1)(1996-6#1)(2013-1#1)
follow-up of 15##2##3##(2010-12#1)(2012-3#1)
follow-up of 25##2##3##(1990-12#1)(1991-6#1)
follow-up of 30##2##3##(2008-7#1)(2009-3#1)
follow-up of 46##2##3##(1994-2#1)(1996-9#1)
follow-up of 48 months##2##4##(1992-12#1)(2008-8#1)
follow-up of 8##2##3##(2009-3#1)(2012-12#1)
follow-up of a##2##3##(2013-1#2)
follow-up of patients with##7##4##(1990-6#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-9#1)(2012-2#2)
follow-up of patients##9##3##(1990-6#1)(1990-9#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-9#1)(2012-2#2)
follow-up of the##5##3##(1993-6#1)(1997-4#1)(2008-10#1)(2010-8#1)(2011-2#1)
follow-up of this##3##3##(1997-8#1)(2009-8#1)(2011-1#1)
follow-up of treated##3##3##(1991-2#1)(2008-6#1)(2011-2#1)
follow-up of##73##2##(1990-12#2)(1990-6#5)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-6#2)(1996-9#1)(1997-4#3)(1997-8#5)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#3)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)
follow-up period and##2##3##(2008-7#2)
follow-up period of##3##3##(1990-8#1)(2008-7#2)
follow-up period was##3##3##(1997-8#1)(2012-5#1)(2013-1#1)
follow-up period##23##2##(1990-8#1)(1994-3#1)(1996-3#1)(1997-8#2)(2008-3#1)(2008-7#8)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#6)
follow-up periods of##3##3##(2012-12#2)(2013-1#1)
follow-up periods##4##2##(2012-12#3)(2013-1#1)
follow-up programs is##2##3##(2008-11#2)
follow-up programs##9##2##(2008-11#9)
follow-up questionnaire##2##2##(2008-11#2)
follow-up report##2##2##(1991-12#1)(2013-1#1)
follow-up results are##2##3##(1990-9#1)(1994-2#1)
follow-up results##4##2##(1990-9#1)(1994-2#1)(2012-12#2)
follow-up revealed##3##2##(1991-8#1)(1994-3#1)(2010-9#1)
follow-up showed##3##2##(1991-2#1)(2013-1#2)
follow-up studies in##2##3##(2008-11#1)(2009-8#1)
follow-up studies##5##2##(1992-9#1)(2008-11#2)(2009-8#1)(2011-2#1)
follow-up study in##2##3##(1997-8#2)
follow-up study of four##2##4##(2008-7#2)
follow-up study of##5##3##(1991-2#1)(1994-3#1)(1995-1#1)(2008-7#2)
follow-up study was##2##3##(1994-3#1)(2008-11#1)
follow-up study##11##2##(1991-2#1)(1991-3#2)(1994-3#2)(1995-1#1)(1997-8#2)(2008-11#1)(2008-7#2)
follow-up study]##2##2##(1990-3#1)(1996-6#1)
follow-up survey##3##2##(1997-1#1)(2008-9#1)(2010-12#1)
follow-up test##2##2##(2012-2#2)
follow-up time was##2##3##(1993-1#1)(2011-2#1)
follow-up time##3##2##(1993-1#1)(2008-8#1)(2011-2#1)
follow-up to##2##2##(1996-8#1)(2013-1#1)
follow-up until##2##2##(1993-12#1)(2010-1#1)
follow-up visit##3##2##(2010-10#1)(2012-3#1)(2013-1#1)
follow-up was##17##2##(1993-11#1)(1993-3#1)(2008-7#2)(2008-9#2)(2009-3#4)(2010-1#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#2)
follow-up were##3##2##(2008-7#1)(2012-12#1)(2012-5#1)
follow-up with##7##2##(1993-3#1)(2008-10#2)(2008-12#1)(2011-2#2)(2013-8#1)
follow-up##432##1##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#3)(1990-6#8)(1990-8#1)(1990-9#4)(1991-1#2)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#3)(1992-9#4)(1993-1#4)(1993-11#6)(1993-12#1)(1993-3#5)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#6)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-11#2)(1996-12#1)(1996-3#4)(1996-6#7)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#13)(2008-10#16)(2008-11#36)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#34)(2008-8#11)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#3)(2009-3#8)(2009-4#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#35)(2011-3#3)(2012-12#20)(2012-2#11)(2012-3#10)(2012-5#3)(2013-1#36)(2013-8#8)
follow-up)##2##1##(1997-3#1)(2008-10#1)
follow-up]##3##1##(1990-9#1)(1991-11#1)(2011-1#1)
follow-ups are needed to##2##4##(2013-1#2)
follow-ups of##3##2##(2012-12#3)
follow-ups##8##1##(2008-8#1)(2012-12#3)(2013-1#4)
followed 10##2##2##(2008-7#1)(2013-8#1)
followed a pattern similar to##2##5##(2008-10#2)
followed a##11##2##(1990-8#1)(2008-10#7)(2008-7#1)(2009-8#1)(2012-2#1)
followed at the##2##3##(2011-2#1)(2012-2#1)
followed at##9##2##(1992-2#1)(1993-1#1)(1994-5#1)(1995-2#1)(2008-10#3)(2011-2#1)(2012-2#1)
followed both##2##2##(2008-10#1)(2008-5#1)
followed by 1##2##3##(2008-10#1)(2011-2#1)
followed by GC-MS analysis##2##4##(2008-10#1)(2008-5#1)
followed by GC-MS##3##3##(2008-10#2)(2008-5#1)
followed by ICP-MS##2##3##(2008-10#2)
followed by SDS-PAGE##2##3##(1990-11#1)(1994-8#1)
followed by TEGDMA##2##3##(2013-1#2)
followed by a &quot##2##4##(1992-12#1)(2008-10#1)
followed by a computational##2##4##(2008-10#2)
followed by a decline to##2##5##(1990-7#1)(1991-2#1)
followed by a decline##3##4##(1990-3#1)(1990-7#1)(1991-2#1)
followed by a decrease##2##4##(2008-11#1)(2010-5#1)
followed by a discussion of the##3##6##(1997-3#1)(2008-12#1)(2009-12#1)
followed by a discussion of##6##5##(1996-3#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#1)
followed by a discussion##7##4##(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#1)
followed by a production phase##2##5##(2008-11#2)
followed by a second##2##4##(1990-5#1)(2008-10#1)
followed by a sharp##2##4##(2008-10#1)(2008-11#1)
followed by a slow##2##4##(1994-6#1)(1997-1#1)
followed by a##88##3##(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#10)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#2)
followed by addition of##2##4##(1996-5#1)(2008-10#1)
followed by adjuvant##4##3##(1990-9#1)(2008-10#1)(2008-11#1)(2012-3#1)
followed by alkaline##2##3##(2008-6#1)(2009-9#1)
followed by all##2##3##(1997-3#1)(2008-9#1)
followed by amikacin##2##3##(1991-3#2)
followed by an accumulation period##2##5##(2008-10#2)
followed by an evaluation of matrix spiking and recovery analyses##3##10##(2008-10#3)
followed by an##16##3##(1992-12#1)(1996-5#1)(2008-10#8)(2008-11#2)(2008-8#1)(2009-8#1)(2011-1#1)(2013-8#1)
followed by atomic absorption##2##4##(2008-10#2)
followed by both##2##3##(2008-10#1)(2011-2#1)
followed by cell##2##3##(1995-11#1)(2008-11#1)
followed by chemical##2##3##(2008-10#2)
followed by chemotherapy##3##3##(2007-8#2)(2013-8#1)
followed by continuous##2##3##(2008-10#2)
followed by corn##2##3##(2008-10#2)
followed by deprotection##3##3##(1996-5#3)
followed by differential pulse##2##4##(2008-10#2)
followed by direct##2##3##(2008-10#2)
followed by either##2##3##(2008-10#1)(2013-8#1)
followed by elution with##3##4##(2008-10#3)
followed by extraction into##2##4##(2008-10#2)
followed by extraction##5##3##(2008-10#5)
followed by flame atomic absorption spectrometry##2##6##(2008-10#2)
followed by further##2##3##(2008-10#2)
followed by gas chromatography##2##4##(2008-10#2)
followed by gas##3##3##(2008-10#3)
followed by gel##2##3##(1994-8#1)(2008-10#1)
followed by high performance liquid chromatography with##2##7##(2008-10#2)
followed by high-performance liquid chromatography with fluorescence detection##2##8##(2008-10#2)
followed by high-performance liquid chromatography##3##5##(2008-10#3)
followed by hybridization##2##3##(2008-10#1)(2012-2#1)
followed by inductively coupled##2##4##(2008-10#2)
followed by ion##2##3##(2008-10#2)
followed by liquid##4##3##(2008-10#4)
followed by locomotion##2##3##(1993-3#1)(1997-2#1)
followed by on-line elution##2##4##(2008-10#2)
followed by on-line##4##3##(2008-10#4)
followed by physical##2##3##(1997-2#1)(2010-6#1)
followed by potentiometric##2##3##(2008-10#2)
followed by progressive##2##3##(1992-12#1)(2012-3#1)
followed by races##2##3##(2008-10#2)
followed by radiation##2##3##(2008-7#1)(2013-1#1)
followed by radiotherapy##3##3##(1990-6#1)(1991-9#1)(2010-11#1)
followed by reduction with##4##4##(1996-5#4)
followed by reduction##6##3##(1996-5#4)(2008-10#2)
followed by removal of##3##4##(1991-5#1)(2008-10#1)(2010-10#1)
followed by reversed-phase##2##3##(1996-12#1)(2008-10#1)
followed by secondary##3##3##(2008-10#2)(2008-11#1)
followed by selective##2##3##(2008-10#2)
followed by simple##2##3##(2008-10#1)(2008-4#1)
followed by single-flap##2##3##(2008-7#2)
followed by slow##2##3##(1992-8#1)(2010-7#1)
followed by spectrophotometric##2##3##(2008-10#2)
followed by superinfection with##2##4##(1993-8#1)(2008-8#1)
followed by surgical##2##3##(2008-12#1)(2013-1#1)
followed by the demonstration of##2##5##(1995-12#2)
followed by the provision of##2##5##(2008-7#1)(2012-12#1)
followed by the superior##2##4##(2008-11#1)(2010-9#1)
followed by the##37##3##(1992-5#1)(1994-11#1)(1995-11#1)(1995-12#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
followed by their##2##3##(1997-8#1)(2013-1#1)
followed by treatment with##3##4##(1996-5#2)(2008-11#1)
followed by two##4##3##(1995-12#1)(1995-2#1)(2011-2#1)(2012-2#1)
followed by##611##2##(1990-11#5)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#5)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#2)(1993-3#4)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#3)(1995-12#5)(1995-2#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#19)(1996-6#5)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#3)(2007-8#3)(2008-1#5)(2008-10#241)(2008-11#40)(2008-12#13)(2008-3#3)(2008-4#6)(2008-5#14)(2008-6#1)(2008-7#15)(2008-8#9)(2008-9#10)(2009-1#1)(2009-11#1)(2009-12#4)(2009-4#1)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#19)(2011-3#1)(2012-12#7)(2012-2#7)(2012-3#11)(2013-1#23)(2013-7#1)(2013-8#14)
followed during the##3##3##(2008-10#2)(2008-11#1)
followed during##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
followed for 4 years##2##4##(2011-2#2)
followed for 4##3##3##(2011-2#2)(2013-1#1)
followed for an average of##2##5##(2008-10#1)(2009-10#1)
followed for at least##2##4##(1996-1#1)(2011-1#1)
followed for##14##2##(1996-1#1)(1996-3#1)(2008-10#2)(2008-7#2)(2009-10#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
followed in the##4##3##(1992-5#1)(2008-10#2)(2009-11#1)
followed in##11##2##(1992-5#1)(1996-2#1)(2008-10#5)(2008-5#1)(2009-11#1)(2010-5#1)(2011-2#1)
followed over a period of##2##5##(2008-10#2)
followed over##4##2##(2008-10#3)(2012-7#1)
followed the Poisson##2##3##(1995-6#1)(2008-10#1)
followed the##21##2##(1994-11#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2012-12#1)(2013-1#1)
followed through##2##2##(1991-1#1)(2008-11#1)
followed to##7##2##(1993-12#1)(1994-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)
followed up after##2##3##(1997-2#1)(2013-1#1)
followed up at##5##3##(1995-3#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)
followed up for##11##3##(1991-9#1)(1996-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
followed up##32##2##(1990-3#1)(1991-11#1)(1991-9#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-8#2)(2008-10#4)(2008-11#2)(2008-7#3)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
followed using##3##2##(2008-10#3)
followed with##6##2##(1997-2#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
followed##800##1##(1990-11#5)(1990-12#2)(1990-2#4)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-8#3)(1994-11#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#4)(1995-12#9)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#19)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#6)(2007-12#4)(2007-8#3)(2008-1#6)(2008-10#295)(2008-11#51)(2008-12#17)(2008-3#4)(2008-4#6)(2008-5#17)(2008-6#2)(2008-7#30)(2008-8#13)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#5)(2009-4#2)(2009-6#1)(2009-7#7)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#11)(2011-2#29)(2011-3#1)(2012-12#10)(2012-2#11)(2012-3#14)(2012-7#1)(2013-1#33)(2013-7#1)(2013-8#18)
followed-up at the##2##3##(2008-1#1)(2011-2#1)
followed-up at##3##2##(1991-6#1)(2008-1#1)(2011-2#1)
followed-up##6##1##(1991-6#1)(2008-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
following 2##3##2##(2008-10#2)(2010-1#1)
following 4##2##2##(2008-5#2)
following C-ADR##5##2##(2012-12#5)
following LPS##2##2##(2008-10#2)
following TCA overdose##2##3##(2010-1#2)
following UV mutagenesis of the##2##5##(2008-10#2)
following a fall##2##3##(2013-1#2)
following a normal##2##3##(1994-5#1)(2013-1#1)
following a rise in body core temperature##2##7##(2008-5#2)
following a similar##2##3##(1993-11#1)(1995-2#1)
following a##58##2##(1990-3#1)(1991-11#1)(1991-2#1)(1992-12#1)(1993-11#1)(1994-1#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-5#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-6#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
following acute##5##2##(1990-12#1)(1990-6#1)(2008-11#1)(2009-10#2)
following addition of##2##3##(2008-10#2)
following administration of##3##3##(1996-8#1)(2008-10#1)(2012-12#1)
following administration##4##2##(1996-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
following amendment##2##2##(2008-10#2)
following an##15##2##(1994-2#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
following ankle##3##2##(2009-1#2)(2012-3#1)
following application of##3##3##(2008-10#3)
following aspects##3##2##(1994-12#1)(2008-10#1)(2008-4#1)
following brain##2##2##(2008-7#1)(2013-1#1)
following breeding##2##2##(2008-9#2)
following brief acquisition and various amounts of extinction##2##8##(2008-5#2)
following brief##3##2##(2008-5#2)(2009-6#1)
following cervical##2##2##(2008-12#1)(2012-12#1)
following challenge with##2##3##(2008-10#2)
following challenge##3##2##(2008-10#2)(2008-5#1)
following characteristics of##2##3##(2008-10#1)(2013-1#1)
following characteristics##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
following cochlear implantation in##2##4##(2008-9#2)
following cochlear implantation##8##3##(2008-9#8)
following complete##3##2##(1995-11#1)(2012-3#2)
following conclusions##6##2##(1992-3#1)(1993-12#1)(1994-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
following conditions##3##2##(2008-10#2)(2011-2#1)
following continuous##4##2##(1995-8#1)(2008-10#2)(2009-9#1)
following data##2##2##(1994-11#1)(2012-2#1)
following definitive##2##2##(2008-10#1)(2012-3#1)
following disease##2##2##(2008-10#1)(2012-3#1)
following each##2##2##(1992-3#1)(2013-8#1)
following either##2##2##(2008-6#1)(2011-2#1)
following endoscopic anterior skull base surgery##2##6##(2011-2#2)
following endotoxin##2##2##(1996-12#1)(2008-12#1)
following experimental##3##2##(1990-5#1)(2008-10#2)
following exposure to##8##3##(1990-5#1)(1992-6#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2012-3#2)
following exposure##9##2##(1990-5#1)(1992-6#1)(1993-11#1)(1997-7#1)(2008-10#2)(2008-5#1)(2012-3#2)
following extraction##2##2##(2008-10#2)
following feeding on source plants##2##5##(2008-10#2)
following feeding on the##2##4##(2008-10#2)
following feeding on##5##3##(2008-10#5)
following focal cerebral ischemia##2##4##(1996-12#1)(1997-2#1)
following groups##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
following harvest##2##2##(2008-10#2)
following heat shock##2##3##(1994-8#1)(1996-12#1)
following heat##4##2##(1994-8#1)(1996-12#1)(2008-10#1)(2009-3#1)
following hospitalization##3##2##(1991-2#2)(2009-10#1)
following immunization##2##2##(1995-5#1)(2008-9#1)
following implantation##4##2##(2008-12#1)(2008-9#2)(2010-5#1)
following in vitro##2##3##(2008-10#1)(2008-11#1)
following in##3##2##(2008-10#2)(2008-11#1)
following induction##2##2##(1995-11#1)(2008-10#1)
following infection of##2##3##(1996-12#1)(2008-5#1)
following infection##7##2##(1994-9#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-5#1)
following ingestion of##2##3##(2008-7#1)(2010-8#1)
following initial##2##2##(1997-7#1)(2008-4#1)
following initiation of##2##3##(2010-5#1)(2010-6#1)
following injection##4##2##(1996-2#1)(2010-6#3)
following injury##2##2##(2010-6#1)(2012-2#1)
following inoculation in##2##3##(2008-10#2)
following inoculation of leaves with##2##5##(2008-10#2)
following inoculation of##6##3##(2008-10#6)
following inoculation with##3##3##(2008-10#3)
following inoculation##22##2##(2008-10#22)
following intranasal##2##2##(2008-10#2)
following irradiation##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
following is##2##2##(2008-11#1)(2013-8#1)
following its##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#2)
following laparoscopic##3##2##(1996-8#1)(2010-8#1)(2013-1#1)
following liver injury##3##3##(2013-1#3)
following liver transplantation##2##3##(2008-5#1)(2009-6#1)
following liver##5##2##(2008-5#1)(2009-6#1)(2013-1#3)
following lung transplantation##2##3##(2011-2#1)(2011-3#1)
following mastectomy##2##2##(1990-9#1)(2013-1#1)
following mild##2##2##(1996-12#1)(2008-7#1)
following mitosis##2##2##(1995-2#2)
following musculoskeletal injury##3##3##(2013-1#3)
following nitric acid##2##3##(2008-10#2)
following optimization of##2##3##(2008-10#2)
following oral administration of##3##4##(2008-10#1)(2008-11#2)
following oral##4##2##(1995-11#1)(2008-10#1)(2008-11#2)
following paediatric cochlear implantation##2##4##(2008-9#2)
following paediatric##4##2##(2008-9#2)(2009-10#2)
following parameters were studied##2##4##(2008-10#2)
following parameters were##4##3##(2008-10#4)
following parameters##8##2##(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)
following percutaneous balloon compression##2##4##(2008-7#2)
following percutaneous transluminal coronary angioplasty (PTCA)##2##6##(2008-5#2)
following percutaneous##5##2##(2008-12#1)(2008-5#2)(2008-7#2)
following peripheral inflammation##2##3##(1997-2#2)
following peripheral nerve injury##2##4##(2008-9#2)
following peripheral##4##2##(1997-2#2)(2008-9#2)
following physical##2##2##(1990-6#1)(2013-1#1)
following points##2##2##(2008-8#1)(2010-1#1)
following primary##2##2##(2008-11#1)(2008-7#1)
following procedure##2##2##(2008-10#2)
following properties##2##2##(2008-10#2)
following prosthetic##2##2##(1994-8#1)(2008-10#1)
following radical##2##2##(1992-12#1)(1992-9#1)
following radiotherapy and##2##3##(1993-9#1)(2008-7#1)
following radiotherapy##3##2##(1993-9#1)(2008-7#2)
following recommendations##2##2##(2008-10#1)(2013-1#1)
following removal of##2##3##(2008-5#1)(2008-7#1)
following repeated partial ischemia##2##4##(1994-2#2)
following repeated##6##2##(1992-7#1)(1994-2#3)(2008-10#1)(2009-11#1)
following separation##2##2##(2008-10#2)
following severe##2##2##(2008-7#2)
following skin##3##2##(1992-6#1)(2008-5#2)
following stimulation of the##2##4##(1991-2#1)(2008-11#1)
following stimulation##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
following stroke##4##2##(1997-2#1)(2008-7#2)(2008-8#1)
following surgery for##2##3##(2008-7#2)
following surgery##13##2##(1991-1#2)(1994-3#3)(1995-2#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)(2013-1#1)
following systemic##2##2##(1992-3#1)(1993-6#1)
following the addition of HGF##3##5##(2008-11#3)
following the addition of##4##4##(2008-11#4)
following the administration of##2##4##(1993-1#1)(2008-12#1)
following the first##3##3##(1993-11#1)(1993-3#1)(1996-12#1)
following the intervention##2##3##(2008-4#1)(2013-1#1)
following the introduction of the##2##5##(2008-10#2)
following the methods recommended##2##4##(2012-12#2)
following the procedure##2##3##(2008-10#1)(2008-7#1)
following the removal of##3##4##(1993-1#1)(2008-11#1)(2008-7#1)
following the same##2##3##(2009-10#1)(2013-1#1)
following the use of##2##4##(1995-11#1)(2012-3#1)
following the##101##2##(1991-3#1)(1992-12#1)(1993-1#2)(1993-11#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-8#1)(1996-9#1)(2008-1#1)(2008-10#17)(2008-11#12)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-3#3)(2013-1#4)(2013-8#3)
following their##8##2##(1996-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-10#1)(2013-8#2)
following themes##2##2##(2008-11#1)(2008-12#1)
following therapy##2##2##(1990-6#1)(2008-10#1)
following thermal##2##2##(2008-9#1)(2009-3#1)
following these##3##2##(1996-12#1)(2008-1#1)(2008-10#1)
following this##3##2##(2008-11#1)(2009-7#1)(2010-3#1)
following three##5##2##(2008-8#2)(2008-9#1)(2009-6#1)(2013-1#1)
following tissue solubilization##2##3##(2008-10#2)
following total hip replacement##3##4##(2010-10#3)
following total hip##5##3##(1994-3#1)(2010-10#3)(2012-2#1)
following total##7##2##(1994-3#1)(2008-8#1)(2010-10#3)(2012-2#1)(2013-1#1)
following transarterial##2##2##(1996-9#1)(2013-7#1)
following transient expression##2##3##(1992-9#1)(1994-11#1)
following transient##3##2##(1992-9#1)(1994-11#1)(1996-12#1)
following transplantation##2##2##(2008-7#1)(2011-2#1)
following transsphenoidal surgery for##2##4##(2008-7#2)
following treatment of cells with##2##5##(2008-11#2)
following treatment of##5##3##(1992-1#1)(2008-11#2)(2012-2#1)(2012-3#1)
following treatment with##6##3##(1990-12#1)(1997-1#1)(2008-10#1)(2010-5#1)(2012-3#1)(2013-8#1)
following treatment##23##2##(1990-12#1)(1991-1#1)(1991-6#1)(1992-1#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-1#1)(2008-10#4)(2008-11#2)(2009-9#2)(2010-5#1)(2012-2#3)(2012-3#2)(2013-8#1)
following two different##2##3##(2008-10#2)
following two##8##2##(1990-11#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#1)
following vaccination##4##2##(1995-5#1)(2008-11#2)(2008-5#1)
following volcanic##2##2##(1990-6#1)(2008-9#1)
following weight loss##2##3##(2013-8#2)
following were##4##2##(1997-8#1)(2008-11#1)(2008-7#1)(2010-11#1)
following year##3##2##(2008-10#2)(2008-9#1)
following##1177##1##(1990-11#5)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#6)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#11)(1991-3#4)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#9)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#6)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#7)(1993-6#6)(1993-8#3)(1993-9#3)(1994-1#3)(1994-11#2)(1994-12#3)(1994-2#9)(1994-3#8)(1994-5#6)(1994-6#1)(1994-8#8)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#11)(1995-12#12)(1995-2#8)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#7)(1995-9#4)(1996-12#19)(1996-2#4)(1996-3#5)(1996-5#2)(1996-6#1)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#8)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#5)(2006-6#1)(2007-11#2)(2007-12#5)(2008-1#3)(2008-10#281)(2008-11#60)(2008-12#26)(2008-2#3)(2008-3#6)(2008-4#9)(2008-5#38)(2008-6#4)(2008-7#65)(2008-8#21)(2008-9#46)(2009-1#3)(2009-10#13)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#5)(2010-1#5)(2010-10#5)(2010-11#4)(2010-12#8)(2010-2#5)(2010-3#3)(2010-5#4)(2010-6#14)(2010-7#6)(2010-8#6)(2010-9#2)(2011-1#3)(2011-2#48)(2011-3#5)(2012-12#18)(2012-2#13)(2012-3#31)(2013-1#73)(2013-7#2)(2013-8#19)
follows a##11##2##(1994-5#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#2)(2009-12#1)
follows an##3##2##(2008-7#2)(2012-3#1)
follows from##2##2##(2008-3#1)(2013-8#1)
follows that##4##2##(1997-1#1)(2008-10#1)(2008-11#1)(2010-1#1)
follows the same pattern as##2##5##(1997-7#1)(2008-10#1)
follows the same pattern##3##4##(1994-9#1)(1997-7#1)(2008-10#1)
follows the##18##2##(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-7#1)(2012-7#1)(2013-8#1)
follows##113##1##(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#31)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#7)(2008-8#4)(2009-12#1)(2009-6#1)(2010-1#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-4#1)(2012-7#1)(2013-1#3)(2013-8#3)
followup##11##1##(1991-1#1)(1991-8#1)(1995-12#1)(1997-6#1)(2009-4#1)(2010-8#1)(2012-3#2)(2013-1#3)
fonction##2##1##(2007-8#1)(2011-2#1)
food abundance##2##2##(2010-8#2)
food additive##3##2##(1993-11#1)(1994-3#1)(2011-2#1)
food additives and##2##3##(2008-11#1)(2011-2#1)
food additives##6##2##(1994-3#1)(2008-11#2)(2010-9#2)(2011-2#1)
food analysis##8##2##(2008-10#8)
food and agriculture##2##3##(1997-2#1)(2010-7#1)
food and beverage##2##3##(2008-10#1)(2010-9#1)
food and environmental##2##3##(2008-10#2)
food and feed samples##2##4##(2008-10#2)
food and feed##9##3##(1993-12#1)(2008-10#8)
food and feeds##2##3##(2010-7#2)
food and nutrient intake##2##4##(2010-6#2)
food and water##4##3##(1991-2#2)(2008-10#1)(2013-1#1)
food and##37##2##(1991-2#2)(1993-12#2)(1993-6#1)(1997-2#1)(1997-6#1)(2008-10#20)(2010-5#2)(2010-6#2)(2010-7#3)(2010-9#1)(2011-2#1)(2013-1#1)
food as well as##2##4##(2008-10#2)
food as##4##2##(2008-10#2)(2009-4#1)(2012-2#1)
food at##2##2##(2008-10#1)(2008-11#1)
food availability for##3##3##(2008-8#3)
food availability##6##2##(2008-8#3)(2008-9#2)(2012-2#1)
food bolus##3##2##(2007-12#2)(2009-7#1)
food borne##2##2##(2011-2#2)
food carrying##2##2##(1993-6#2)
food chain##15##2##(1994-3#1)(2008-10#5)(2008-8#3)(2008-9#3)(2011-2#2)(2013-8#1)
food chains are##2##3##(2008-9#2)
food chains by##2##3##(2008-8#1)(2008-9#1)
food chains##10##2##(2008-8#4)(2008-9#6)
food choice##2##2##(1991-1#1)(2010-6#1)
food components##2##2##(2008-10#1)(2012-2#1)
food conditions##2##2##(2008-9#2)
food consumption##10##2##(1993-6#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-7#3)(2010-6#1)(2012-2#2)
food containing##2##2##(2008-10#2)
food control##3##2##(2008-10#2)(2011-2#1)
food crops##2##2##(2011-2#2)
food for##4##2##(1997-2#1)(1997-7#1)(2008-10#1)(2009-10#1)
food from##2##2##(1994-3#1)(2008-10#1)
food guide##4##2##(2011-2#4)
food guides##4##2##(2011-2#4)
food habits##3##2##(2008-11#1)(2012-2#2)
food handlers##2##2##(2007-12#1)(2013-1#1)
food handling##3##2##(1994-3#1)(2007-12#1)(2010-4#1)
food hoarding##2##2##(2008-9#2)
food ingredients##5##2##(1994-3#1)(2011-2#3)(2012-2#1)
food intake and##2##3##(1993-8#1)(2009-8#1)
food intake of the##2##4##(2008-7#1)(2012-3#1)
food intake of##4##3##(1996-2#1)(2008-7#1)(2010-6#1)(2012-3#1)
food intake was##2##3##(1993-8#1)(2010-8#1)
food intake##22##2##(1993-12#1)(1993-8#2)(1996-2#5)(2008-7#2)(2008-9#1)(2009-12#3)(2009-8#2)(2010-6#3)(2010-8#1)(2011-2#1)(2012-3#1)
food is##5##2##(1993-6#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
food items##4##2##(2007-12#1)(2008-10#1)(2008-12#2)
food manufacturing##3##2##(1994-3#3)
food on the##2##3##(2008-11#1)(2009-10#1)
food on##3##2##(1997-1#1)(2008-11#1)(2009-10#1)
food or##7##2##(1993-6#1)(1994-11#1)(1995-10#1)(2008-11#2)(2011-2#1)(2012-2#1)
food packaging##4##2##(1994-3#2)(2008-10#1)(2010-7#1)
food pairing##2##2##(2012-2#2)
food particles##3##2##(2008-6#1)(2008-7#2)
food poisoning##4##2##(2011-2#4)
food preservation##2##2##(2010-7#1)(2011-2#1)
food processing##2##2##(2008-9#1)(2011-2#1)
food products with##4##3##(2008-10#2)(2010-7#1)(2011-2#1)
food products##24##2##(2007-12#1)(2008-10#10)(2009-8#2)(2010-7#5)(2011-2#6)
food purchases##2##2##(2011-2#2)
food quality and safety##2##4##(2010-7#1)(2011-2#1)
food quality##4##2##(2008-10#1)(2008-9#1)(2010-7#1)(2011-2#1)
food quantity and##2##3##(2008-9#2)
food quantity##4##2##(2008-9#4)
food ration##4##2##(2010-8#4)
food rations##2##2##(2010-8#2)
food resources regulated the size of##2##6##(2008-8#2)
food resources##7##2##(2008-8#5)(2008-9#1)(2012-3#1)
food restriction on the##3##4##(1990-3#1)(1993-12#2)
food restriction##8##2##(1990-3#6)(1993-12#2)
food safety in the home##2##5##(2007-12#2)
food safety##10##2##(2007-12#5)(2008-10#1)(2008-11#2)(2011-2#2)
food samples after digestion##2##4##(2008-10#2)
food samples by##2##3##(2008-10#2)
food samples is##2##3##(2008-10#2)
food samples##33##2##(2008-10#32)(2008-11#1)
food scores##2##2##(1991-12#2)
food security##5##2##(1994-12#3)(1997-7#1)(2008-10#1)
food source##2##2##(2008-10#1)(2008-11#1)
food spoilage and##2##3##(2011-2#2)
food spoilage##6##2##(2011-2#6)
food substances##3##2##(2008-11#3)
food supply##4##2##(2007-12#1)(2008-10#1)(2009-3#1)(2010-6#1)
food to eat it##2##4##(1993-6#2)
food to##4##2##(1993-6#4)
food types##4##2##(2008-10#1)(2008-11#2)(2010-6#1)
food web##13##2##(2008-10#1)(2008-8#4)(2008-9#8)
food webs and##2##3##(2008-9#2)
food webs##14##2##(2008-8#4)(2008-9#7)(2012-12#2)(2012-2#1)
food with##2##2##(1994-3#1)(2008-10#1)
food##565##1##(1990-2#1)(1990-3#6)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-6#20)(1993-8#3)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#22)(1994-6#1)(1994-8#2)(1995-10#2)(1995-5#1)(1996-12#2)(1996-2#5)(1997-1#2)(1997-2#6)(1997-6#1)(1997-7#2)(2007-12#15)(2008-1#6)(2008-10#148)(2008-11#27)(2008-12#4)(2008-4#5)(2008-5#3)(2008-6#6)(2008-7#8)(2008-8#24)(2008-9#51)(2009-10#3)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#4)(2010-6#12)(2010-7#18)(2010-8#11)(2010-9#4)(2011-2#64)(2012-12#2)(2012-2#23)(2012-3#2)(2013-1#4)(2013-8#4)
food)##2##1##(2007-12#1)(2008-11#1)
food-borne##3##1##(2008-10#1)(2008-9#1)(2011-2#1)
food-deprived rats##2##2##(1993-6#1)(1997-2#1)
food-derived##2##1##(1992-6#1)(2012-2#1)
food-hoarding##2##1##(2008-9#2)
food-related##3##1##(1993-6#1)(2011-2#1)(2012-3#1)
foodborne botulism##2##2##(2007-12#1)(2011-2#1)
foodborne disease##8##2##(2007-12#8)
foodborne illness##4##2##(2007-12#2)(2011-2#2)
foodborne parasites##2##2##(2007-12#2)
foodborne pathogen##2##2##(2011-1#1)(2011-2#1)
foodborne pathogens##6##2##(2007-12#1)(2008-10#1)(2010-4#1)(2011-2#2)(2012-2#1)
foodborne##31##1##(2007-12#19)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#1)
foods and beverages##4##3##(2008-10#1)(2012-12#2)(2012-2#1)
foods and food##2##3##(2007-12#1)(2011-2#1)
foods and##13##2##(2007-12#1)(2008-10#3)(2008-11#2)(2010-1#2)(2011-2#1)(2012-12#2)(2012-2#2)
foods as##2##2##(2008-10#2)
foods by##3##2##(2008-10#3)
foods for##2##2##(1994-3#1)(1997-2#1)
foods has##2##2##(2008-10#1)(2010-7#1)
foods in##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
foods is##2##2##(1994-3#1)(2008-1#1)
foods of##3##2##(2008-1#1)(2012-2#2)
foods on##2##2##(2012-12#2)
foods or##2##2##(2008-4#1)(2011-2#1)
foods rich in##4##3##(1997-8#2)(2010-6#2)
foods that##3##2##(2008-11#2)(2012-12#1)
foods through##2##2##(2010-1#1)(2011-2#1)
foods were##3##2##(2008-4#1)(2010-6#2)
foods with##4##2##(2007-12#1)(2008-10#3)
foods##106##1##(1991-6#1)(1994-3#6)(1997-1#1)(1997-2#2)(1997-8#2)(2007-12#7)(2008-1#7)(2008-10#27)(2008-11#6)(2008-4#4)(2009-11#2)(2010-1#3)(2010-10#1)(2010-6#7)(2010-7#1)(2011-2#13)(2012-12#6)(2012-2#9)(2013-7#1)
foodservice##5##1##(1992-1#1)(1996-2#1)(1997-2#2)(1997-3#1)
foodstuff samples##2##2##(2008-10#2)
foodstuff##3##1##(2008-10#3)
foodstuffs##18##1##(2008-10#13)(2010-3#1)(2011-2#4)
foot and ankle##15##3##(2008-12#1)(2009-10#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#6)(2012-3#1)
foot and mouth disease in the##2##6##(2008-12#2)
foot and mouth disease in##4##5##(2008-12#4)
foot and mouth disease##8##4##(2008-12#5)(2011-2#1)(2013-8#2)
foot and mouth##9##3##(2008-12#5)(2011-2#2)(2013-8#2)
foot and##28##2##(2008-12#6)(2009-10#1)(2010-3#2)(2010-7#3)(2011-2#6)(2012-2#7)(2012-3#1)(2013-8#2)
foot care##2##2##(2013-1#2)
foot deformity##6##2##(2010-11#1)(2012-2#1)(2012-3#4)
foot during##2##2##(1996-11#1)(2008-7#1)
foot melanoma##4##2##(2012-3#4)
foot of##3##2##(1992-2#1)(2008-3#1)(2013-1#1)
foot pain##3##2##(2010-3#2)(2011-2#1)
foot ulcers##3##2##(2010-10#2)(2012-2#1)
foot with##2##2##(2008-12#1)(2010-3#1)
foot##112##1##(1991-2#1)(1992-2#1)(1994-8#1)(1995-6#2)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-12#10)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#2)(2010-10#3)(2010-11#3)(2010-3#18)(2010-5#1)(2010-7#3)(2010-9#2)(2011-2#10)(2012-12#2)(2012-2#17)(2012-3#12)(2013-1#11)(2013-8#4)
football##4##1##(2009-1#1)(2010-5#1)(2010-9#1)(2013-1#1)
foothold in##2##2##(2008-11#1)(2008-12#1)
footplate##2##1##(2008-9#2)
footprint of the##2##3##(2008-4#1)(2013-1#1)
footprint of##4##2##(2008-4#1)(2012-2#2)(2013-1#1)
footprint##6##1##(2008-4#1)(2008-8#1)(2009-11#1)(2012-2#2)(2013-1#1)
footprinting and##3##2##(1995-6#1)(1997-7#1)(2008-9#1)
footprinting##9##1##(1995-6#1)(1997-7#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)
footshock##2##1##(2008-11#2)
footwear##2##1##(1990-3#1)(2010-3#1)
for &gt##7##2##(1995-2#2)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
for &lt##2##2##(2011-2#2)
for &quot##15##2##(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-11#1)(2009-12#1)(2009-3#1)(2010-4#3)(2011-2#1)
for 'Oketsu'##2##2##(2008-10#2)
for 'Okrun'##2##2##(2008-10#2)
for 'Spanco'##3##2##(2008-10#3)
for 0##31##2##(1991-6#2)(1997-2#1)(2008-10#25)(2008-11#1)(2012-2#2)
for 1 h##13##3##(1990-12#1)(1992-12#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
for 1 hour##2##3##(1993-8#1)(2008-10#1)
for 1 min##2##3##(2008-10#2)
for 1 mug ml(-1)##2##4##(2008-10#2)
for 1 mug##3##3##(2008-10#3)
for 1 or##2##3##(2008-10#1)(2013-8#1)
for 1 to##4##3##(1993-8#1)(2008-10#1)(2008-6#1)(2013-8#1)
for 1 week##7##3##(2008-10#2)(2008-11#2)(2009-7#1)(2011-2#1)(2013-8#1)
for 1 x##2##3##(2008-10#2)
for 1 year##6##3##(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)
for 1##78##2##(1990-12#2)(1992-12#1)(1993-8#2)(1995-12#2)(2008-10#45)(2008-11#4)(2008-2#3)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-8#4)
for 1-3##2##2##(2008-10#1)(2008-5#1)
for 10 and##3##3##(1997-2#1)(2008-10#2)
for 10 consecutive##2##3##(2008-10#1)(2013-8#1)
for 10 days##3##3##(2008-11#1)(2011-2#2)
for 10 determinations of##2##4##(2008-10#2)
for 10 h##4##3##(2008-10#2)(2008-9#1)(2012-2#1)
for 10 min##8##3##(1990-11#1)(1990-12#1)(1993-3#1)(1994-8#1)(2008-10#4)
for 10 minutes##2##3##(2008-11#1)(2010-1#1)
for 10 mug##2##3##(2008-10#2)
for 10 replicate determinations of##2##5##(2008-10#2)
for 10 replicate determinations##6##4##(2008-10#6)
for 10 replicate##7##3##(2008-10#7)
for 10 successive##2##3##(2008-10#2)
for 10 years##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)
for 10##60##2##(1990-11#1)(1990-12#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#37)(2008-11#3)(2008-3#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
for 100##7##2##(2008-10#6)(2011-2#1)
for 105##2##2##(1994-6#1)(2009-12#1)
for 10min in an##2##4##(2008-10#2)
for 10min##6##2##(2008-10#6)
for 10 days##3##2##(2013-1#3)
for 11 replicate determinations of##2##5##(2008-10#2)
for 11 replicate##5##3##(2008-10#5)
for 11##12##2##(2008-10#9)(2008-3#1)(2012-2#1)(2013-1#1)
for 110##2##2##(2008-10#1)(2013-8#1)
for 12 h##8##3##(1991-9#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)
for 12 hours##2##3##(1993-6#1)(2010-2#1)
for 12 months##3##3##(1990-6#1)(2010-1#1)(2011-2#1)
for 12 to##2##3##(2008-10#2)
for 12 weeks##5##3##(2008-1#2)(2008-10#3)
for 12##28##2##(1990-6#1)(1991-6#1)(1991-9#1)(1993-6#1)(1996-2#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-3#1)
for 120##2##2##(2008-10#2)
for 120s##2##2##(2008-10#2)
for 13 days##2##3##(1990-11#1)(2008-7#1)
for 13##7##2##(1990-11#1)(1992-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
for 14 days##11##3##(1990-12#1)(1991-11#1)(2008-10#3)(2008-11#2)(2010-5#1)(2011-2#2)(2012-3#1)
for 14 weeks##2##3##(2008-10#1)(2013-1#1)
for 14##20##2##(1990-12#1)(1991-11#1)(2008-10#8)(2008-11#3)(2008-6#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
for 15 min##10##3##(1994-6#1)(1994-8#1)(1995-12#1)(1997-1#1)(2008-10#4)(2012-3#1)(2013-8#1)
for 15##26##2##(1993-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-7#1)(2010-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
for 15min##2##2##(2008-10#2)
for 16##9##2##(1990-6#1)(1991-11#1)(1994-1#1)(2008-10#3)(2008-12#1)(2013-1#2)
for 17##8##2##(1991-6#1)(1994-8#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-12#1)(2011-2#1)
for 18 h##3##3##(1996-2#1)(2008-11#1)(2009-6#1)
for 18 hours##2##3##(1993-8#1)(2010-6#1)
for 18##9##2##(1993-8#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-11#1)(2009-6#1)(2010-6#1)
for 180##3##2##(2008-10#2)(2008-2#1)
for 18C6##2##2##(2008-10#2)
for 19##5##2##(1995-9#1)(2008-10#3)(2008-12#1)
for 1984##2##2##(1992-2#1)(1993-3#1)
for 1988##2##2##(1990-12#1)(1991-3#1)
for 1994##3##2##(1994-1#1)(1995-3#2)
for 1996 and 1997##2##4##(2008-10#2)
for 1996##3##2##(2008-10#2)(2008-11#1)
for 1 week##2##2##(2013-1#2)
for 2 and##2##3##(2008-10#1)(2009-3#1)
for 2 h with##2##4##(1995-8#1)(2008-10#1)
for 2 h##11##3##(1990-2#1)(1994-3#1)(1995-11#1)(1995-8#3)(2008-10#4)(2008-6#1)
for 2 min##3##3##(1993-1#1)(2008-10#2)
for 2 months##4##3##(1990-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
for 2 or##2##3##(2008-10#1)(2008-11#1)
for 2 to##2##3##(1993-1#1)(2008-5#1)
for 2 week##2##3##(2008-11#2)
for 2 weeks##9##3##(1993-11#1)(1996-12#1)(2008-10#2)(2008-5#3)(2012-12#1)(2013-8#1)
for 2 x##2##3##(2008-10#2)
for 2 years##8##3##(1995-11#1)(1997-7#1)(2008-10#5)(2008-11#1)
for 2##89##2##(1990-2#3)(1992-6#1)(1993-1#3)(1993-11#1)(1994-3#1)(1995-11#2)(1995-8#3)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#48)(2008-11#12)(2008-5#5)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
for 2-[125I]iodomelatonin##2##2##(1995-12#2)
for 20 h##2##3##(2008-10#1)(2008-9#1)
for 20 min##9##3##(1992-3#1)(1997-1#1)(2008-10#5)(2008-11#2)
for 20 mul loop)##2##4##(2008-10#2)
for 20 mul##3##3##(2008-10#3)
for 20 or##2##3##(2008-7#1)(2008-9#1)
for 20 weeks##2##3##(2008-9#2)
for 20##30##2##(1992-3#1)(1996-12#1)(1997-1#1)(2008-10#17)(2008-11#2)(2008-7#3)(2008-9#4)(2013-1#1)
for 20s##4##2##(2008-10#4)
for 21##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
for 22##5##2##(1992-3#1)(1993-3#1)(2008-10#2)(2012-2#1)
for 23##3##2##(1991-3#1)(2008-10#1)(2008-7#1)
for 24 h in##3##4##(2008-10#2)(2008-8#1)
for 24 h##27##3##(1990-12#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2012-12#1)
for 24 hours##5##3##(1992-6#1)(1996-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
for 24##44##2##(1990-10#1)(1990-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
for 24-48##2##2##(1994-8#1)(1996-2#1)
for 24-h##2##2##(1995-11#2)
for 24h##4##2##(1990-11#1)(2008-10#2)(2012-3#1)
for 25##3##2##(1991-2#1)(2008-10#2)
for 250 ml sample##2##4##(2008-10#2)
for 26 or 39 weeks##4##5##(2008-9#4)
for 26 or 41 weeks##3##5##(2008-9#3)
for 26 or##7##3##(2008-9#7)
for 26 weeks with additional groups of 10 males and 10 females##3##12##(2008-9#3)
for 26 weeks##8##3##(2008-7#1)(2008-9#7)
for 26##15##2##(2008-7#1)(2008-9#14)
for 27 of##2##3##(1994-1#1)(2008-10#1)
for 27 or 43 weeks##4##5##(2008-9#4)
for 27 weeks##4##3##(2008-9#4)
for 27##12##2##(1994-1#1)(2008-10#3)(2008-9#8)
for 28 days##7##3##(2008-10#3)(2008-9#1)(2010-6#1)(2013-1#2)
for 28##8##2##(2008-10#4)(2008-9#1)(2010-6#1)(2013-1#2)
for 2min##2##2##(2008-10#2)
for 2x2##2##2##(2010-1#2)
for 3 days followed by##2##5##(1991-11#1)(2008-10#1)
for 3 days##13##3##(1990-2#1)(1991-11#1)(1993-6#1)(1995-12#1)(1996-2#1)(2008-10#5)(2008-7#1)(2009-4#1)(2012-2#1)
for 3 h at 37°C##2##5##(2013-1#2)
for 3 h at##3##4##(2013-1#3)
for 3 h##8##3##(1991-9#1)(1995-11#1)(2008-10#2)(2008-9#1)(2013-1#3)
for 3 min of preconcentration time##2##6##(2008-10#2)
for 3 min##10##3##(2008-10#4)(2008-11#1)(2013-1#5)
for 3 months at##2##4##(2008-10#1)(2008-5#1)
for 3 months##11##3##(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2013-8#2)
for 3 of##2##3##(2008-10#1)(2010-4#1)
for 3 weeks##4##3##(2008-11#1)(2008-8#2)(2013-1#1)
for 3 years##5##3##(1997-7#1)(2008-10#3)(2008-5#1)
for 3##70##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-9#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-4#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#10)(2013-8#2)
for 30 days##3##3##(1993-3#1)(2008-10#1)(2013-1#1)
for 30 min at##2##4##(2008-10#1)(2010-1#1)
for 30 min##13##3##(1990-12#1)(1991-5#1)(1994-3#1)(1997-2#1)(2008-10#6)(2008-7#1)(2010-1#2)
for 30 s##6##3##(2008-10#3)(2008-9#1)(2011-2#1)(2013-1#1)
for 30 successive##2##3##(2008-10#2)
for 30 years##4##3##(1996-3#1)(1996-8#1)(2011-2#1)(2012-2#1)
for 30##34##2##(1990-12#1)(1990-8#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-3#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#15)(2008-7#1)(2008-9#1)(2010-1#2)(2011-2#2)(2012-2#1)(2013-1#2)
for 30min##4##2##(2008-10#4)
for 30s##3##2##(2008-10#3)
for 32##2##2##(2008-10#1)(2013-1#1)
for 34##2##2##(2008-10#1)(2011-2#1)
for 35##2##2##(2008-12#1)(2013-1#1)
for 36 h##3##3##(2008-10#3)
for 36##5##2##(1991-5#1)(2008-10#4)
for 38 days when stored at##2##6##(2008-10#2)
for 39 weeks##3##3##(2008-9#3)
for 39##4##2##(2008-10#1)(2008-9#3)
for 3D##5##2##(2008-3#1)(2009-1#1)(2009-12#1)(2009-3#1)(2011-7#1)
for 3min##2##2##(2008-10#2)
for 3 years##2##2##(2012-6#1)(2012-9#1)
for 4 and##3##3##(1990-5#1)(1992-12#1)(2008-10#1)
for 4 days##5##3##(1997-2#2)(2008-10#1)(2008-11#1)(2010-5#1)
for 4 h at##2##4##(1990-12#1)(2008-5#1)
for 4 h##5##3##(1990-12#1)(1991-5#1)(1991-9#1)(2008-10#1)(2008-5#1)
for 4 hr##2##3##(1995-2#1)(2008-11#1)
for 4 months##3##3##(1991-8#1)(2008-10#1)(2013-1#1)
for 4 or##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
for 4 weeks##7##3##(1996-12#2)(2008-10#4)(2008-12#1)
for 4 years##7##3##(2008-10#3)(2008-7#1)(2010-6#1)(2011-2#2)
for 4##50##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1994-1#1)(1995-12#1)(1995-2#1)(1996-12#3)(1997-2#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-5#1)(2010-6#1)(2011-2#3)(2013-1#1)
for 4% of##2##3##(1997-6#1)(2008-10#1)
for 4-NP determination##2##3##(2008-10#2)
for 4-aminophenol##2##2##(2008-10#2)
for 40 min##2##3##(2008-10#2)
for 40##6##2##(1994-11#1)(2008-10#3)(2008-7#1)(2011-2#1)
for 41 weeks##5##3##(2008-9#5)
for 41##6##2##(2008-10#1)(2008-9#5)
for 42##3##2##(2008-10#2)(2011-3#1)
for 43##4##2##(1993-11#1)(2008-9#3)
for 45##3##2##(1990-12#1)(2010-4#1)(2013-1#1)
for 45%##2##2##(1991-6#1)(2012-2#1)
for 48 h##16##3##(1990-11#1)(1993-8#1)(1994-5#1)(1995-12#1)(2008-10#4)(2008-11#4)(2008-8#1)(2013-1#1)(2013-8#2)
for 48 hr##2##3##(1994-8#1)(1995-2#1)
for 48##22##2##(1990-11#1)(1990-6#1)(1992-2#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#5)(2008-8#2)(2013-1#1)(2013-8#2)
for 5 days##9##3##(1990-11#1)(1990-2#1)(1993-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2011-2#1)
for 5 min##5##3##(2008-10#5)
for 5 months##2##3##(2008-10#2)
for 5 weeks##3##3##(2008-10#2)(2008-5#1)
for 5 years##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
for 5##48##2##(1990-11#2)(1990-2#1)(1991-2#1)(1993-1#1)(1993-3#1)(1997-2#1)(2007-11#1)(2007-8#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
for 5-10##2##2##(2008-10#1)(2010-3#1)
for 5-HT##2##2##(1996-12#1)(2008-10#1)
for 50 and##2##3##(2008-10#2)
for 50 s##2##3##(2008-10#2)
for 50##10##2##(2008-10#8)(2008-5#1)(2012-12#1)
for 50% of the maximum number of apothecia to##2##9##(2008-10#2)
for 50% of the##5##4##(2008-10#4)(2008-7#1)
for 50% of##6##3##(1991-2#1)(2008-10#4)(2008-7#1)
for 50%##11##2##(1991-2#1)(1992-12#1)(2008-10#6)(2008-11#2)(2008-7#1)
for 50-300##2##2##(2008-10#2)
for 5min##4##2##(2008-10#4)
for 6 days in##2##4##(1995-8#1)(2008-10#1)
for 6 days##5##3##(1995-11#1)(1995-8#3)(2008-10#1)
for 6 h##4##3##(1990-12#1)(1994-8#1)(2008-10#1)(2008-6#1)
for 6 min##3##3##(2008-10#3)
for 6 months in##2##4##(1996-3#1)(2008-10#1)
for 6 months##11##3##(1991-12#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-6#2)(2011-2#1)(2013-1#2)
for 6 weeks in##2##4##(2008-10#1)(2013-1#1)
for 6 weeks##13##3##(1990-12#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-1#1)(2010-3#1)(2010-6#1)(2013-1#2)
for 6 weeks)##2##3##(1992-3#1)(2008-8#1)
for 6 years##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
for 6##48##2##(1990-12#2)(1991-12#1)(1992-12#1)(1992-3#1)(1994-8#1)(1995-11#1)(1995-8#3)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-3#1)(2010-6#3)(2011-2#3)(2013-1#4)
for 60 min##6##3##(1994-8#1)(2008-10#5)
for 60 s##4##3##(1993-8#1)(2008-10#3)
for 60##10##2##(1993-8#1)(1994-8#1)(2008-10#8)
for 60% of all##2##4##(2008-5#1)(2011-2#1)
for 60s##4##2##(2008-10#4)
for 631##2##2##(2008-10#1)(2013-1#1)
for 64##2##2##(1997-6#1)(2008-5#1)
for 66##2##2##(2012-12#1)(2012-3#1)
for 7 consecutive days##2##4##(2008-11#1)(2011-2#1)
for 7 d)##2##3##(2008-10#2)
for 7 days and##2##4##(2010-1#1)(2011-2#1)
for 7 days or##2##4##(1994-3#1)(2008-10#1)
for 7 days prior to##2##5##(2008-10#2)
for 7 days##15##3##(1994-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#2)(2010-1#1)(2011-2#3)
for 7 days)##2##3##(1994-6#1)(2008-11#1)
for 7##30##2##(1994-3#1)(1994-6#1)(1995-2#1)(2008-10#10)(2008-11#3)(2008-12#4)(2008-7#3)(2010-1#1)(2010-8#1)(2011-2#4)(2012-12#1)
for 7-methyl-dGp and 7-ethyl-dGp##2##4##(2008-12#2)
for 7-methyl-dGp##3##2##(2008-12#3)
for 72 h to##2##4##(2008-10#2)
for 72 h##7##3##(1995-8#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#1)
for 72 hours##2##3##(1993-3#1)(2011-3#1)
for 72##11##2##(1993-3#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-8#1)(2011-3#1)
for 78##2##2##(2008-10#1)(2009-9#1)
for 8 days##4##3##(1995-2#1)(2008-10#1)(2008-11#2)
for 8 h##3##3##(2008-10#3)
for 8 months##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
for 8 weeks in##2##4##(2008-8#1)(2013-1#1)
for 8 weeks##5##3##(2008-8#1)(2009-3#1)(2010-1#1)(2011-3#1)(2013-1#1)
for 8 years##3##3##(2008-10#3)
for 8##27##2##(1995-2#1)(1996-1#1)(2008-10#13)(2008-11#3)(2008-5#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-3#1)(2013-1#3)
for 8-14##2##2##(1991-9#2)
for 80% of the variance in##2##6##(2008-10#1)(2012-3#1)
for 81##2##2##(1994-12#1)(2008-10#1)
for 84##4##2##(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
for 85##2##2##(1996-12#1)(2011-2#1)
for 85% of the##3##4##(1996-2#1)(2008-10#2)
for 85% of##4##3##(1990-8#1)(1996-2#1)(2008-10#2)
for 89##2##2##(1995-12#1)(2008-10#1)
for 8h##3##2##(2008-10#3)
for 9 months##2##3##(1996-2#1)(2008-10#1)
for 9##8##2##(1991-1#1)(1993-3#1)(1994-1#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
for 90 days##2##3##(1995-12#1)(2008-12#1)
for 90 min##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
for 90##9##2##(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
for 90% of the isolates##2##5##(2008-7#1)(2011-2#1)
for 90% of##4##3##(1991-3#1)(2008-12#1)(2008-7#1)(2011-2#1)
for 90%##6##2##(1991-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)
for 91##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
for 96 h##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
for 96##4##2##(2008-10#1)(2008-12#2)(2008-7#1)
for A and B procedures##2##5##(2008-10#2)
for A and##3##3##(1992-12#1)(2008-10#2)
for A vs##2##3##(2011-2#2)
for A##11##2##(1992-12#1)(1995-12#1)(2008-10#6)(2010-7#1)(2011-2#2)
for AA##4##2##(2008-10#4)
for ACR##2##2##(2008-10#2)
for ADP and##2##3##(2006-6#1)(2008-10#1)
for ADP in##2##3##(2006-6#1)(2008-7#1)
for ADP##5##2##(2006-6#2)(2008-10#1)(2008-7#2)
for AF##3##2##(2010-12#2)(2012-2#1)
for AG##2##2##(2008-10#2)
for AIDS##12##2##(1990-3#1)(1990-6#1)(1992-9#3)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-9#1)(2011-2#1)
for AIDS-related##2##2##(1995-12#1)(1995-2#1)
for AL##2##2##(2008-10#2)
for ALS##3##2##(1996-5#1)(2009-9#2)
for AM1##3##2##(2008-10#3)
for AP and##4##3##(1993-12#1)(2012-3#3)
for AP##5##2##(1993-12#1)(2012-3#3)(2013-1#1)
for APR to powdery mildew##2##5##(2008-10#2)
for AR##2##2##(2010-1#1)(2011-2#1)
for ARF-C isolates##2##3##(2008-10#2)
for ARF-L##2##2##(2008-10#2)
for ASA##2##2##(2008-10#2)
for AT##2##2##(1993-8#2)
for ATP in##2##3##(1993-6#1)(2008-7#1)
for ATP was observed##2##4##(1993-6#1)(1994-8#1)
for ATP##8##2##(1991-9#1)(1993-6#2)(1994-8#1)(2008-10#3)(2008-7#1)
for AVMs##3##2##(1997-3#1)(1997-6#1)(2008-7#1)
for Aboriginal##3##2##(2008-12#1)(2008-6#2)
for Acute Lung Injury##2##4##(2010-12#2)
for Acute##5##2##(2008-12#1)(2010-12#2)(2012-2#1)(2012-3#1)
for Adults##2##2##(1991-1#1)(1995-2#1)
for Advanced Medical Studies##2##4##(1994-12#2)
for Advanced##5##2##(1994-12#2)(1997-3#1)(1997-7#1)(2012-3#1)
for African Americans with CKD##2##5##(2010-4#2)
for African##3##2##(2010-4#2)(2011-1#1)
for Ag##5##2##(2008-10#5)
for Ag(+)##4##2##(2008-10#4)
for Ag(I)##2##2##(2008-10#2)
for Aging##2##2##(2010-5#1)(2012-3#1)
for Al##4##2##(2008-10#3)(2009-8#1)
for Al(III) and##3##3##(2008-10#3)
for Al(III)##4##2##(2008-10#4)
for Alzheimer's disease (AD)##3##4##(2008-6#1)(2008-7#1)(2011-2#1)
for Alzheimer's##4##2##(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)
for Animal Health##5##3##(2011-2#5)
for Animal##6##2##(2011-2#5)(2013-8#1)
for Antimicrobial Stewardship##2##3##(2013-1#2)
for Aroclor##2##2##(2008-10#2)
for As and Se##4##4##(2008-10#4)
for As and##8##3##(2008-10#8)
for As##24##2##(2008-10#23)(2013-1#1)
for As(III) and As(V)##3##4##(2008-10#3)
for As(III) and##4##3##(2008-10#4)
for As(III)##13##2##(2008-10#13)
for As(III+V)##3##2##(2008-10#3)
for As(V) and##4##3##(2008-10#4)
for As(V)##8##2##(2008-10#8)
for Assessment of##2##3##(2008-10#2)
for Au##2##2##(2008-10#2)
for Aujeszky's disease virus##2##4##(2008-11#1)(2011-2#1)
for Australian##2##2##(1992-1#1)(2008-11#1)
for B##12##2##(1991-3#1)(1992-12#1)(1995-12#1)(1995-5#1)(2008-10#6)(2008-4#1)(2011-2#1)
for B-cell epitope identification##2##4##(2008-10#2)
for B-cell malignancies##2##3##(2010-11#2)
for B-cell##5##2##(2008-10#2)(2008-7#1)(2010-11#2)
for B73 x Tex6##2##4##(2008-10#2)
for BDNF##3##2##(1996-12#2)(2013-8#1)
for BET inhibitor##2##3##(2012-12#2)
for BMI##2##2##(2008-10#1)(2012-2#1)
for BP##2##2##(2008-10#2)
for BSA and 0##2##4##(2008-10#2)
for BSA and##5##3##(2008-10#5)
for BSA##6##2##(2008-10#6)
for Ba##2##2##(2008-10#2)
for Batten disease##3##3##(1994-11#3)
for Bi##2##2##(2008-10#2)
for Biological Control of##4##4##(2008-10#4)
for Brassica##2##2##(2011-10#2)
for Breast Cancer##3##3##(1994-12#1)(1997-7#1)(2011-2#1)
for Breast##6##2##(1990-12#1)(1994-12#1)(1997-7#2)(2011-2#1)(2013-1#1)
for British##2##2##(1996-3#1)(2008-8#1)
for C points##3##3##(2007-11#3)
for C##15##2##(1993-8#1)(2007-11#3)(2008-10#6)(2008-5#3)(2008-8#1)(2009-8#1)
for C(18) and##2##3##(2008-10#2)
for C/EBP##2##2##(1993-12#1)(1997-8#1)
for CA##2##2##(2008-10#2)
for CAT##2##2##(1995-8#1)(2008-4#1)
for CBB resistance##2##3##(2008-10#2)
for CD##2##2##(2010-12#2)
for CD30##2##2##(2012-3#2)
for CD86##2##2##(2008-10#2)
for CDP##2##2##(1997-2#2)
for CEC##2##2##(2008-10#1)(2010-1#1)
for CF##3##2##(1997-1#1)(2008-10#1)(2011-3#1)
for CGRP##2##2##(1992-6#2)
for CH(3)Hg(+)##4##2##(2008-10#4)
for CHF##3##2##(1995-12#3)
for CLL##2##2##(1995-2#1)(2011-2#1)
for CLM##2##2##(2008-10#1)(2012-3#1)
for CMV##3##2##(2008-10#3)
for CNTF##2##2##(1990-5#1)(1996-2#1)
for CO(2)##4##2##(2008-2#1)(2008-3#3)
for COD##3##2##(2008-10#3)
for COPD##3##2##(1995-12#1)(2011-2#2)
for CP##6##2##(2008-10#4)(2011-2#2)
for CPM##2##2##(2008-7#2)
for CPS patients##2##3##(2008-4#2)
for CRT##3##2##(2008-10#3)
for CS##4##2##(2013-1#4)
for CYP2E1##2##2##(2008-8#2)
for Ca and##4##3##(1991-5#1)(2008-10#3)
for Ca##7##2##(1991-5#1)(2008-10#6)
for Ca(2+)##5##2##(1996-5#1)(2008-10#3)(2013-1#1)
for Ca2+##2##2##(1990-2#1)(1995-6#1)
for California##2##2##(1992-2#1)(1995-3#1)
for Canadian##3##2##(1991-1#1)(1995-12#1)(2008-11#1)
for Cancer Therapy##2##3##(2012-2#1)(2013-1#1)
for Cancer##6##2##(1994-12#1)(1994-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
for Cardiovascular Health##2##3##(2008-11#1)(2013-1#1)
for Cat-floc##2##2##(2008-10#2)
for Catholic healthcare##2##3##(1997-3#2)
for Catholic##3##2##(1997-3#3)
for Cd and Pb##3##4##(2008-10#3)
for Cd and##10##3##(2008-10#10)
for Cd determination##2##3##(2008-10#2)
for Cd in##2##3##(2008-10#2)
for Cd##34##2##(2008-10#34)
for Cd(2+) ions##2##3##(2008-10#2)
for Cd(2+)##5##2##(2008-10#5)
for Cd(II) and##3##3##(2008-10#3)
for Cd(II)##13##2##(2008-10#13)
for Child##2##2##(2008-11#2)
for Children and##2##3##(2009-7#1)(2010-12#1)
for Children with##2##3##(1994-3#1)(2012-2#1)
for Children##9##2##(1991-2#1)(1994-3#1)(1995-5#1)(1996-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2012-2#1)
for Chinese##2##2##(2008-12#1)(2012-2#1)
for Chromosome##2##2##(2008-11#1)(2012-3#1)
for Cl(-)##2##2##(2008-10#2)
for ClO(3)(-)##3##2##(2008-10#3)
for Clinical Laboratory##2##3##(1994-12#1)(2008-5#1)
for Clinical##3##2##(1994-12#2)(2008-5#1)
for Co and 0##2##4##(2008-10#2)
for Co and##4##3##(2008-10#4)
for Co##10##2##(2008-10#10)
for Co(2+)##3##2##(2008-10#3)
for Co(II) and##2##3##(2008-10#2)
for Co(II)##10##2##(2008-10#10)
for Colombia##3##2##(2012-12#2)(2013-1#1)
for Complex##2##2##(2011-2#1)(2012-2#1)
for Control of##2##3##(2008-10#2)
for Cr and##2##3##(2008-10#2)
for Cr in##2##3##(2008-10#2)
for Cr##13##2##(2008-10#13)
for Cr(III) and Cr(VI)##3##4##(2008-10#3)
for Cr(III) ions##2##3##(2008-10#2)
for Cr(III) over a wide variety of metal ions##2##9##(2008-10#2)
for Cr(III) over a wide##3##5##(2008-10#3)
for Cr(III)##13##2##(2008-10#13)
for Cr(VI) and Cr(III)##4##4##(2008-10#4)
for Cr(VI) and from##2##4##(2008-10#2)
for Cr(VI) and##9##3##(2008-10#9)
for Cr(VI)##17##2##(2008-10#17)
for Crohn's disease##3##3##(1995-8#1)(2010-12#1)(2013-1#1)
for Cs(+)##2##2##(2008-10#2)
for Cu and Mn##3##4##(2008-10#3)
for Cu and Zn##5##4##(2008-10#5)
for Cu and##12##3##(2008-10#11)(2013-8#1)
for Cu in##2##3##(2008-10#1)(2012-2#1)
for Cu##35##2##(2008-10#32)(2012-2#1)(2013-8#2)
for Cu(2+) ions over##2##4##(2008-10#2)
for Cu(2+) ions##3##3##(2008-10#3)
for Cu(2+) over##2##3##(2008-10#2)
for Cu(2+)##14##2##(2008-10#12)(2008-12#2)
for Cu(II) and##6##3##(2008-10#5)(2013-1#1)
for Cu(II) over a wide##2##5##(2008-10#2)
for Cu(II)##24##2##(2008-10#23)(2013-1#1)
for CuHCF##2##2##(2008-10#2)
for CyA and##3##3##(2008-10#3)
for CyA##5##2##(2008-10#5)
for Cypermethrin and##2##3##(2008-10#2)
for Cys##2##2##(2008-10#2)
for D##7##2##(2008-10#5)(2008-5#2)
for DA##2##2##(2008-10#2)
for DBP##2##2##(1993-12#1)(2008-10#1)
for DBS(-) ion over a wide##2##6##(2008-10#2)
for DBS(-)##3##2##(2008-10#3)
for DBT##2##2##(2008-11#2)
for DEET##2##2##(2008-5#2)
for DKA##2##2##(1994-12#2)
for DMA##3##2##(2008-10#3)
for DNA binding##4##3##(1991-5#1)(1992-6#1)(1995-6#1)(2008-8#1)
for DNA content##2##3##(2008-9#2)
for DNA damage##2##3##(1991-5#1)(1993-12#1)
for DNA delivery and##2##4##(2008-11#1)(2010-8#1)
for DNA detection##3##3##(2008-10#3)
for DNA electrochemical sensor##2##4##(2008-10#2)
for DNA synthesis##2##3##(1992-10#1)(1995-11#1)
for DNA##45##2##(1991-5#2)(1992-10#1)(1992-6#4)(1993-12#1)(1995-11#1)(1995-6#2)(1995-8#2)(1996-6#1)(1997-8#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#6)(2009-10#1)(2010-7#1)(2010-8#1)
for DON accumulation##2##3##(2008-10#2)
for DON##3##2##(2008-10#3)
for DPV##2##2##(2008-10#2)
for DRE function##2##3##(1995-6#2)
for Detecting##2##2##(2008-10#2)
for Detection of##2##3##(2008-10#1)(2012-3#1)
for Determining##2##2##(1996-5#1)(2008-10#1)
for Development of##2##3##(2012-2#1)(2013-1#1)
for Disease Control##21##3##(1992-2#1)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#1)(2008-11#1)
for Disease##23##2##(1992-2#1)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#2)(2008-11#1)(2011-9#1)
for Domestic Violence##2##3##(2012-12#2)
for Doppler##2##2##(2008-3#1)(2010-10#1)
for Drosophila##3##2##(1995-6#1)(2008-9#2)
for DuP##2##2##(1991-5#2)
for Dy and Eu by##2##5##(2008-10#2)
for Dy and Eu##3##4##(2008-10#3)
for Dy##4##2##(2008-10#4)
for E and##2##3##(2008-10#2)
for E##12##2##(2008-10#8)(2008-12#1)(2009-7#1)(2011-1#1)(2012-2#1)
for E1 and##2##3##(2008-10#2)
for E2##3##2##(2008-10#3)
for E3##2##2##(2008-10#2)
for ED##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
for EEG##2##2##(2008-4#1)(2010-7#1)
for EGF##6##2##(1991-12#1)(1991-7#1)(1992-7#1)(1993-3#1)(2008-8#1)(2010-5#1)
for ENO##3##2##(2008-10#3)
for ENX and##2##3##(2008-10#2)
for EPOF##3##2##(1993-12#3)
for ER##2##2##(2009-8#1)(2013-1#1)
for Early##4##2##(2008-11#1)(2008-12#1)(2012-2#2)
for Economic##5##2##(1993-2#1)(1993-3#2)(1994-1#1)(2008-11#1)
for Emergency##2##2##(1995-11#1)(2007-9#1)
for England and##3##3##(2008-11#1)(2012-12#2)
for England##4##2##(2008-11#1)(2008-12#1)(2012-12#2)
for Environmental##2##2##(2008-10#1)(2008-3#1)
for Eu##3##2##(2008-10#3)
for European##6##2##(2008-1#1)(2008-10#2)(2008-12#1)(2009-7#1)(2013-8#1)
for Evaluating the##2##3##(2008-10#2)
for Evaluating##4##2##(2008-10#3)(2008-7#1)
for F##9##2##(1995-2#1)(2008-10#8)
for F1-27##2##2##(2008-10#2)
for FBZ##2##2##(2008-10#2)
for FHB resistance##6##3##(2008-10#6)
for FHB##8##2##(2008-10#8)
for FIA##3##2##(2008-10#3)
for FM##2##2##(2009-11#1)(2010-12#1)
for FRET##2##2##(2008-4#1)(2008-9#1)
for FTIR determination of##2##4##(2008-10#2)
for Fe and##5##3##(2008-10#5)
for Fe##12##2##(2008-10#11)(2008-5#1)
for Fe(2+)##3##2##(2008-10#3)
for Fe(II)##2##2##(2008-10#2)
for Fe(III) and##2##3##(2008-10#2)
for Fe(III)##10##2##(2008-10#9)(2008-5#1)
for Fourier##2##2##(2008-10#2)
for France##3##2##(1990-8#2)(2008-10#1)
for Fusarium wilt##4##3##(2008-10#4)
for Fusarium##5##2##(2008-10#5)
for G1/S transition##2##3##(1993-8#1)(1997-1#1)
for GI##2##2##(2012-3#1)(2013-8#1)
for GPP##2##2##(2008-9#2)
for GSH##2##2##(1990-2#1)(2008-10#1)
for GTP##2##2##(1995-6#1)(1995-8#1)
for H##2##2##(2008-10#2)
for H(+)##3##2##(2008-10#3)
for H(2)O(2) and##2##3##(2008-10#1)(2013-1#1)
for H(2)O(2) in##3##3##(2008-10#3)
for H(2)O(2)##8##2##(2008-10#7)(2013-1#1)
for HA##4##2##(2008-10#3)(2011-2#1)
for HBV##3##2##(1990-8#1)(2009-5#1)(2013-1#1)
for HCB##2##2##(2008-10#2)
for HCC##3##2##(2010-12#1)(2011-2#1)(2013-8#1)
for HCV infection##2##3##(2011-2#2)
for HCl##2##2##(2008-10#2)
for HClO and ClO(2)(-)##2##4##(2008-10#2)
for HClO##3##2##(2008-10#3)
for HD##3##2##(2008-9#3)
for HER-2- and control-transfected##2##4##(1997-7#2)
for HHNK)##2##2##(1994-12#2)
for HIV among##2##3##(2011-2#1)(2013-1#1)
for HIV antibodies##5##3##(1995-12#1)(1996-5#4)
for HIV care##3##3##(2013-1#3)
for HIV infection##6##3##(1994-9#1)(1995-1#2)(1996-5#1)(2007-12#1)(2008-5#1)
for HIV##32##2##(1990-3#1)(1993-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-6#1)(1996-5#5)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#7)(2013-8#1)
for HIV-1##6##2##(1991-9#1)(1993-2#2)(1993-3#1)(1996-9#1)(2009-9#1)
for HIV-infected patients##2##3##(1995-6#1)(2011-3#1)
for HIV-infected##4##2##(1993-9#1)(1995-6#1)(2008-10#1)(2011-3#1)
for HIV-positive##2##2##(1994-1#1)(2008-12#1)
for HMOs##2##2##(1997-2#1)(1997-6#1)
for HMX##3##2##(2008-10#3)
for HORs##2##2##(2008-7#2)
for HPLC##6##2##(2008-10#6)
for HQ##2##2##(2008-10#2)
for HR##2##2##(1996-5#1)(2008-10#1)
for HRP##5##2##(2008-10#5)
for HSA and##2##3##(2008-10#2)
for HSA##6##2##(2008-10#6)
for HTLV-I##2##2##(2008-8#2)
for HbA(1c) testing has##2##4##(2008-6#2)
for HbA(1c) testing##3##3##(2008-6#3)
for Health##8##2##(1992-8#1)(1993-12#1)(1997-3#1)(2009-5#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
for Healthcare##4##2##(1991-12#1)(1992-12#1)(1993-3#1)(1996-9#1)
for Helicobacter##2##2##(1996-11#1)(2010-12#1)
for Herring testis DNA##2##4##(2008-10#2)
for Hg and##2##3##(2008-10#2)
for Hg##5##2##(2008-10#5)
for Hg(2+) and CH(3)Hg(+)##4##4##(2008-10#4)
for Hg(2+) and MeHg(+)##3##4##(2008-10#3)
for Hg(2+) and##10##3##(2008-10#10)
for Hg(2+)##14##2##(2008-10#14)
for Hg(II)##8##2##(2008-10#8)
for High##2##2##(2008-11#1)(2008-7#1)
for Hoechst dye uptake##2##4##(2008-11#2)
for Hoechst##3##2##(2008-11#3)
for Hospital##2##2##(1991-12#1)(1991-3#1)
for I##3##2##(2008-10#3)
for ICP-AES##3##2##(2008-10#3)
for ICP-MS##4##2##(2008-10#4)
for IGF-I##4##2##(1995-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
for IHD and##2##3##(1995-12#2)
for IL-1##6##2##(1990-12#3)(1995-2#2)(1996-12#1)
for IL-2 and IL-4##3##4##(2008-11#3)
for IL-2##4##2##(1994-5#1)(2008-11#3)
for IMP##2##2##(1995-6#1)(2008-10#1)
for IND##2##2##(2008-10#2)
for IPM##2##2##(2008-10#2)
for IPV##2##2##(2010-11#2)
for ISEs with##2##3##(2008-10#2)
for ITS region##2##3##(2008-10#2)
for IVH##2##2##(2008-7#2)
for IgG##2##2##(2008-10#1)(2008-11#1)
for In Planta Detection of##2##5##(2008-10#2)
for In##3##2##(2008-10#2)(2013-1#1)
for India##2##2##(1994-3#1)(1996-1#1)
for Integrated##2##2##(2008-10#2)
for International##2##2##(1996-11#1)(1997-2#1)
for Japanese encephalitis##2##3##(2011-2#2)
for Japanese native horses##2##4##(2013-1#2)
for Japanese nurses##2##3##(2008-11#2)
for Japanese##8##2##(1994-12#1)(2008-11#2)(2008-12#1)(2011-2#2)(2013-1#2)
for K##3##2##(2008-10#3)
for K(+) than for Na(+)##2##5##(2008-10#2)
for K(+)##6##2##(2008-10#5)(2012-2#1)
for L##5##2##(1995-6#1)(2008-10#1)(2010-4#1)(2011-1#1)(2013-8#1)
for L-dopa##2##2##(2008-10#2)
for LBP##2##2##(2010-9#2)
for LC##2##2##(2008-10#1)(2013-1#1)
for LCA##2##2##(2010-10#1)(2011-2#1)
for LDH##2##2##(2008-11#1)(2010-4#1)
for LTP##2##2##(1990-5#1)(1995-2#1)
for LV and MTX##3##4##(2008-10#3)
for LVH detection##2##3##(2009-1#2)
for LVH##3##2##(2009-1#3)
for La##2##2##(2008-10#2)
for La(3+)##3##2##(2008-10#3)
for La(III) ions##2##3##(2008-10#2)
for La(III)##7##2##(2008-10#7)
for Li(+)##2##2##(2008-10#2)
for Li/Na and K/Na mixed cation chloride sodalites##2##8##(2008-10#2)
for Liver##2##2##(2008-11#1)(2011-2#1)
for Lp(a)##3##2##(1993-2#2)(2008-6#1)
for Lr34/Yr18##3##2##(2008-10#3)
for Lyme borreliosis##2##3##(1994-6#1)(2008-10#1)
for Lyme disease##2##3##(1992-1#1)(2008-8#1)
for Lyme##4##2##(1992-1#1)(1994-6#1)(2008-10#1)(2008-8#1)
for M##13##2##(1997-3#1)(2008-10#10)(2010-12#1)(2012-2#1)
for MARYBLYT##2##2##(2008-10#2)
for MB3##2##2##(1992-3#2)
for MBT##2##2##(2008-11#2)
for MBr1##2##2##(1990-12#2)
for MBr8##2##2##(1990-12#2)
for MC##2##2##(2008-10#1)(2012-12#1)
for MCA and DCA##2##4##(2008-10#2)
for MDIs##2##2##(1996-1#2)
for MG##3##2##(2008-10#3)
for MMA and##2##3##(2008-10#2)
for MR##2##2##(1992-3#1)(2010-9#1)
for MRI##10##2##(1992-3#3)(1995-5#1)(2008-6#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)
for MS##3##2##(1995-12#1)(2011-2#2)
for MT##6##2##(1993-12#1)(2008-10#5)
for Magicicada##2##2##(2008-9#2)
for Maori##3##2##(2008-1#3)
for Mathematical##2##2##(2013-8#2)
for Medicaid managed care##3##4##(1996-2#1)(1997-2#2)
for Medicaid recipients##2##3##(1992-2#1)(1997-2#1)
for Medicaid##16##2##(1991-2#2)(1991-3#1)(1992-2#1)(1994-12#1)(1994-2#2)(1996-2#2)(1997-1#1)(1997-2#4)(2013-1#2)
for Medical##6##2##(1990-3#1)(1994-12#1)(2008-12#1)(2009-12#1)(2011-2#1)(2012-3#1)
for Medicare and Medicaid##4##4##(1991-3#1)(1996-2#2)(2008-11#1)
for Medicare beneficiaries##5##3##(1992-12#1)(1993-12#1)(1995-12#1)(1995-2#1)(1997-3#1)
for Medicare patients##3##3##(1993-12#2)(1995-3#1)
for Medicare##29##2##(1991-1#1)(1991-3#3)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#3)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-6#1)(2012-3#1)
for Mental Health##2##3##(2008-11#2)
for Mg##8##2##(2008-10#8)
for Mg(2+)##3##2##(2008-10#3)
for Mn##5##2##(2008-10#5)
for Mn(II)##4##2##(2008-10#4)
for Mo##2##2##(2008-10#2)
for Mo(VI)##2##2##(2008-10#2)
for Mycobacterium tuberculosis##3##3##(2011-2#2)(2013-1#1)
for Mycoplasma##3##2##(1992-5#1)(2007-12#1)(2012-3#1)
for Mäori##3##2##(2008-1#3)
for NA##2##2##(2008-10#1)(2008-11#1)
for NAD##3##2##(2008-10#3)
for NADH##4##2##(2008-10#3)(2008-11#1)
for NB1-RGB cells##2##3##(2008-11#2)
for NB1-RGB##3##2##(2008-11#3)
for NDELA##2##2##(2008-5#2)
for NE##3##2##(2008-10#3)
for NHS##2##2##(1996-8#1)(2008-11#1)
for NN127##2##2##(2008-10#2)
for NO##4##2##(1994-11#1)(2008-10#1)(2008-3#1)(2010-6#1)
for NO(2)##3##2##(2008-10#3)
for NO(3)(-)##2##2##(2008-10#2)
for NR##2##2##(2008-10#2)
for NS0##2##2##(2008-11#2)
for Na##6##2##(2008-10#6)
for Na(+) and K(+)##4##4##(2008-10#4)
for Na(+) over##2##3##(2008-10#2)
for Na(+)##9##2##(2008-10#9)
for National##2##2##(1995-6#1)(2012-12#1)
for Nepalese##2##2##(2008-10#1)(2012-3#1)
for Ni and##4##3##(2008-10#4)
for Ni##16##2##(2008-10#15)(2008-5#1)
for Ni(2+)##2##2##(2008-10#1)(2010-11#1)
for Ni(II) and##2##3##(2008-10#2)
for Ni(II)##13##2##(2008-10#13)
for Nicotine##2##2##(2011-2#1)(2013-1#1)
for Nursing and##3##3##(2008-11#2)(2008-12#1)
for Nursing##15##2##(2008-11#10)(2008-12#2)(2012-3#1)(2013-1#2)
for O(3)##2##2##(2008-10#1)(2008-3#1)
for OA##7##2##(2010-11#1)(2013-1#6)
for OP##2##2##(2010-5#1)(2011-2#1)
for OTC and SCP##2##4##(2008-10#2)
for OTC and##3##3##(2008-10#3)
for OTC in##2##3##(2008-10#2)
for OTC##5##2##(2008-10#5)
for P##36##2##(2008-10#34)(2008-8#1)(2009-6#1)
for P1##4##2##(1996-12#1)(2008-9#1)(2012-3#2)
for P450##2##2##(2008-4#1)(2009-9#1)
for PA##2##2##(2008-10#1)(2008-11#1)
for PAH##2##2##(2008-10#1)(2010-10#1)
for PAHs with##3##3##(2008-10#3)
for PAHs##8##2##(2008-10#8)
for PAV##2##2##(2008-10#2)
for PB##2##2##(2008-10#2)
for PC##2##2##(1991-5#1)(2008-10#1)
for PCP##2##2##(2008-10#2)
for PCR##4##2##(1994-8#1)(1996-8#1)(1997-7#1)(2008-5#1)
for PD##2##2##(2008-7#2)
for PE and/or DVT##2##4##(2012-2#2)
for PE##6##2##(2011-2#2)(2012-2#4)
for PET imaging of##2##4##(2010-6#2)
for PETN##2##2##(2008-10#2)
for PG##3##2##(2008-10#3)
for PGGT-I##2##2##(1995-2#2)
for PH##2##2##(2008-1#1)(2008-9#1)
for PI##2##2##(2008-10#2)
for PLS##2##2##(2008-10#2)
for PME##2##2##(1991-9#2)
for PP##2##2##(2008-11#1)(2008-5#1)
for PPH##2##2##(1997-5#2)
for PR##2##2##(2008-10#2)
for PSA promoter##2##3##(2008-9#2)
for Parkinson's disease##2##3##(2009-11#1)(2012-2#1)
for Parkinson's##4##2##(2008-11#1)(2008-7#1)(2009-11#1)(2012-2#1)
for Part B physicians' services##2##5##(1991-2#2)
for Partial##4##2##(1991-1#2)(2008-10#2)
for Pb and Cu##2##4##(2008-10#2)
for Pb and##8##3##(2008-10#8)
for Pb by using##2##4##(2008-10#2)
for Pb##24##2##(2008-10#24)
for Pb(2+) over a wide variety of##2##7##(2008-10#2)
for Pb(2+) over a wide##3##5##(2008-10#3)
for Pb(2+) over##4##3##(2008-10#4)
for Pb(2+)##7##2##(2008-10#7)
for Pb(II) and##3##3##(2008-10#3)
for Pb(II)##16##2##(2008-10#16)
for Phytophthora infestans##2##3##(2008-10#2)
for Phytophthora ramorum##2##3##(2008-10#2)
for Phytophthora##6##2##(2008-10#6)
for Pi7(t)##2##2##(2008-10#2)
for Plasmodium falciparum##2##3##(2008-8#1)(2012-3#1)
for Pr##4##2##(2008-10#3)(2008-3#1)
for Predicting##3##2##(2008-10#3)
for Prevention##3##2##(1997-3#2)(2012-3#1)
for Psychiatric##3##2##(2008-11#2)(2013-1#1)
for Pu##3##2##(2008-10#3)
for Public Health##6##3##(1995-12#2)(1996-1#3)(1997-3#1)
for Public##7##2##(1990-6#1)(1995-12#2)(1996-1#3)(1997-3#1)
for Pyoderma gangrenosum and ankylosing spondylitis##2##6##(2010-12#2)
for Pyoderma gangrenosum##4##3##(2010-12#4)
for Q##3##2##(2008-10#1)(2012-5#2)
for Quality##10##2##(1995-2#1)(2008-12#1)(2012-2#1)(2013-1#7)
for Quantitative##2##2##(2008-10#1)(2008-3#1)
for R##2##2##(2008-7#1)(2009-6#1)
for RAPD##4##2##(2008-10#4)
for RB##2##2##(2008-10#1)(2013-1#1)
for RDX##4##2##(2008-10#4)
for RE##2##2##(2008-10#2)
for REEs were##2##3##(2008-10#2)
for REEs##5##2##(2008-10#5)
for RFLP##2##2##(2008-10#1)(2008-8#1)
for RNA##2##2##(1992-3#1)(2011-1#1)
for RNs##2##2##(2010-10#2)
for Rapid##2##2##(2008-10#1)(2013-1#1)
for Research and Treatment of##2##5##(2010-11#1)(2011-2#1)
for Research##3##2##(2009-4#1)(2010-11#1)(2011-2#1)
for Resistance to##11##3##(2008-10#11)
for RsGshT##2##2##(1995-2#2)
for Ru(bpy)(3)(2+)/TPrA system##3##3##(2008-10#3)
for Ru(phen)(3)(2+)/TPrA##3##2##(2008-10#3)
for S##11##2##(2008-10#7)(2008-2#1)(2010-4#1)(2013-1#2)
for S-100##2##2##(2008-11#1)(2011-2#1)
for SC##3##2##(2008-10#1)(2008-5#2)
for SCMV resistance were##2##4##(2008-10#2)
for SCP in##2##3##(2008-10#2)
for SCP##3##2##(2008-10#3)
for SIDS##2##2##(1991-11#1)(2008-1#1)
for SIP##3##2##(1993-6#3)
for SIT with other##2##4##(2011-2#2)
for SLB resistance##2##3##(2008-10#2)
for SNP genotyping and mapping in##2##6##(2012-3#2)
for SNP genotyping##3##3##(2012-3#3)
for SNP##4##2##(2012-3#4)
for SO(2)##2##2##(2008-10#1)(2008-3#1)
for SPL##2##2##(2011-1#2)
for SPME##5##2##(2008-10#5)
for SPR##2##2##(2008-10#2)
for SS##2##2##(2009-11#1)(2013-8#1)
for SSLB resistance in##2##4##(2008-10#2)
for SSLB resistance##4##3##(2008-10#4)
for SSR variation##3##3##(2008-10#3)
for SSR##4##2##(2008-10#4)
for SSTR2##2##2##(1994-11#1)(1995-2#1)
for SY##2##2##(2008-10#2)
for Sb##2##2##(2008-10#2)
for Sb(III) and Sb(V)##4##4##(2008-10#4)
for Sb(III) and from##2##4##(2008-10#2)
for Sb(III) and##9##3##(2008-10#9)
for Sb(III)##11##2##(2008-10#11)
for Sb(V)##6##2##(2008-10#6)
for Sclerotinia##3##2##(2008-10#3)
for Se##3##2##(2008-10#3)
for Se(IV) and##2##3##(2008-10#2)
for Se(IV)##7##2##(2008-10#7)
for Se(VI)##4##2##(2008-10#4)
for Sensitive##2##2##(2008-10#2)
for Si##3##2##(2008-10#3)
for South##2##2##(2011-2#1)(2013-8#1)
for Southern hybridization##2##3##(1992-6#1)(2008-10#1)
for Standardization##2##2##(1997-2#1)(2008-10#1)
for Streptococcus##2##2##(1992-5#1)(2011-2#1)
for Stys's##2##2##(2013-8#2)
for T cells##2##3##(1995-2#1)(2013-8#1)
for T##10##2##(1995-2#1)(2008-10#4)(2008-12#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
for TAC##2##2##(2008-10#2)
for TB##2##2##(1996-3#1)(2010-5#1)
for TBT##2##2##(2008-11#2)
for TC##3##2##(2009-5#1)(2011-2#2)
for TE and TM polarizations##2##5##(2008-2#2)
for TE##3##2##(2008-2#2)(2008-3#1)
for TM polarization##2##3##(2007-12#1)(2008-3#1)
for TMA and ovalbumin##2##4##(2008-10#2)
for TMA##4##2##(2008-10#4)
for TMV##2##2##(2008-10#2)
for TNS##2##2##(2008-10#2)
for TNT##6##2##(2008-10#6)
for TQM in health care##2##5##(1994-2#2)
for TQM##3##2##(1994-2#3)
for TS##3##2##(2008-10#1)(2008-7#2)
for TYL##2##2##(2008-10#2)
for TYLCV##2##2##(2008-10#2)
for TYLCV-Is##2##2##(2008-10#2)
for Tartrazine##2##2##(2008-10#2)
for Ti##2##2##(2007-11#1)(2008-10#1)
for Tomato##2##2##(2008-10#2)
for Type 1 diabetes##2##4##(2010-10#2)
for Type##3##2##(2010-10#3)
for U##3##2##(2008-10#1)(2008-12#2)
for U(VI) and Th(IV)##3##4##(2008-10#3)
for U(VI) over##3##3##(2008-10#3)
for U(VI)##12##2##(2008-10#12)
for UK##2##2##(1991-3#1)(2008-11#1)
for UO(2)(2+)##3##2##(2008-10#3)
for UV##2##2##(2008-10#1)(2010-4#1)
for V##6##2##(2008-10#5)(2008-4#1)
for V(V) and##2##3##(2008-10#2)
for V(V)##3##2##(2008-10#3)
for VO(2+)##3##2##(2008-10#3)
for VOCs analysis##2##3##(2008-10#2)
for Verification of##2##3##(2008-10#1)(2012-2#1)
for Vero cells##2##3##(2008-11#2)
for Verticillium##2##2##(2008-10#2)
for Veterinary##2##2##(2008-11#1)(2011-2#1)
for Volunteer##4##2##(1994-3#2)(1995-12#2)
for Women##4##2##(1991-2#1)(1996-12#2)(2012-3#1)
for X##6##2##(2008-10#6)
for Zn and##3##3##(2008-10#2)(2011-2#1)
for Zn##17##2##(2008-10#14)(2010-11#1)(2011-2#1)(2013-8#1)
for Zn(2+)##3##2##(2008-10#3)
for Zn(II) and##4##3##(2008-10#4)
for Zn(II)##13##2##(2008-10#13)
for Zr##2##2##(2008-10#2)
for a &quot##2##3##(1993-12#1)(1994-2#1)
for a 0##4##3##(2008-10#3)(2008-3#1)
for a 1##4##3##(2008-10#4)
for a 10##2##3##(1996-3#1)(2008-10#1)
for a 2-min##2##3##(2008-10#2)
for a 20##2##3##(2008-10#2)
for a 25##2##3##(2008-10#2)
for a 5-min##2##3##(2008-10#1)(2008-2#1)
for a 5-ml sample was 0##2##6##(2008-10#2)
for a Medicare##2##3##(1992-2#2)
for a New##2##3##(2008-10#2)
for a better understanding of the##2##6##(1991-12#1)(2011-2#1)
for a better##7##3##(1990-12#1)(1991-12#1)(1991-2#2)(2008-11#1)(2011-2#1)(2011-7#1)
for a broad range of##2##5##(2007-11#1)(2011-2#1)
for a calibration##2##3##(2008-10#2)
for a cell##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
for a cervical##2##3##(2011-2#1)(2013-1#1)
for a challenging##2##3##(1996-3#1)(2008-12#1)
for a change in##2##4##(2011-2#1)(2012-2#1)
for a change##3##3##(1997-6#1)(2011-2#1)(2012-2#1)
for a children's##2##3##(1991-1#1)(1994-3#1)
for a clinical##4##3##(1997-2#1)(1997-4#1)(2008-12#1)(2011-2#1)
for a cohort##2##3##(2012-12#1)(2013-1#1)
for a common##3##3##(1993-8#1)(1994-5#1)(2012-3#1)
for a complete##3##3##(1991-1#1)(1997-8#1)(2008-10#1)
for a comprehensive##4##3##(1992-2#1)(1993-3#1)(1997-6#1)(2013-8#1)
for a concentration of##6##4##(2008-10#6)
for a concentration##8##3##(2008-10#7)(2009-8#1)
for a considerable##3##3##(1990-3#1)(2008-11#1)(2008-9#1)
for a constant analyte mass##2##5##(2008-10#2)
for a constant##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
for a continuous##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
for a correct##3##3##(1991-6#1)(1992-9#1)(2008-10#1)
for a detailed##2##3##(2008-10#1)(2008-3#1)
for a dietitian in an##2##5##(1993-12#2)
for a difference##2##3##(2008-11#1)(2010-11#1)
for a different##4##3##(1990-12#1)(1992-2#1)(2008-11#2)
for a direct interaction##2##4##(1995-2#1)(1997-2#1)
for a direct##5##3##(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#2)
for a dry##2##3##(2008-10#1)(2008-3#1)
for a duration of##2##4##(2008-10#1)(2013-8#1)
for a family of##2##4##(1993-6#1)(1995-2#1)
for a family##3##3##(1992-3#1)(1993-6#1)(1995-2#1)
for a few##8##3##(1996-3#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-8#2)(2012-2#1)
for a fixed period of time##2##6##(2008-10#1)(2008-12#1)
for a fully##2##3##(2008-3#1)(2010-10#1)
for a further##3##3##(1991-2#1)(2008-10#1)(2008-12#1)
for a general##4##3##(1992-2#1)(1997-1#1)(2008-1#1)(2008-10#1)
for a given value of##2##5##(2008-10#2)
for a given##23##3##(1990-5#1)(1992-2#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#3)(2008-8#3)(2008-9#3)(2011-3#1)(2013-1#1)
for a good##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
for a greater response and##2##5##(2013-1#2)
for a greater##3##3##(2011-3#1)(2013-1#2)
for a group of##3##4##(1993-2#1)(2008-11#1)(2009-3#1)
for a health##2##3##(1993-9#1)(1996-3#1)
for a hexagonal##2##3##(2008-3#2)
for a high level of##2##5##(2008-10#2)
for a high##4##3##(2008-10#3)(2010-7#1)
for a higher##3##3##(2008-11#1)(2008-4#1)(2009-12#1)
for a hospital##3##3##(1991-12#1)(1993-12#1)(2010-8#1)
for a job##3##3##(1990-2#1)(1991-3#1)(1993-1#1)
for a known##2##3##(1991-1#1)(1993-6#1)
for a large number of##3##5##(1991-8#1)(2008-10#1)(2010-12#1)
for a large proportion of##3##5##(1992-12#1)(1996-2#1)(2008-10#1)
for a large##15##3##(1991-8#1)(1992-12#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
for a large-scale##2##3##(1997-6#1)(2010-1#1)
for a larger##2##3##(1992-2#1)(1996-3#1)
for a limited##2##3##(1993-3#1)(2008-10#1)
for a long time##15##4##(1990-5#1)(1991-11#1)(1993-8#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-7#1)
for a long##20##3##(1990-5#1)(1991-11#1)(1993-8#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-7#1)
for a long-term##3##3##(1994-12#1)(2008-10#1)(2011-1#1)
for a longer period of time##2##6##(2008-1#1)(2010-12#1)
for a longer time##3##4##(1991-3#1)(2008-10#1)(2008-5#1)
for a longer##6##3##(1991-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
for a low##2##3##(1990-12#1)(2008-10#1)
for a major##2##3##(1991-5#1)(2008-10#1)
for a majority of##2##4##(1996-1#1)(2012-2#1)
for a maximum of##2##4##(1991-6#1)(2008-11#1)
for a maximum##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
for a mean of##2##4##(2009-4#1)(2012-2#1)
for a mean##4##3##(2008-1#2)(2009-4#1)(2012-2#1)
for a medical##2##3##(2009-11#1)(2011-2#1)
for a mild##2##3##(1997-3#1)(2011-2#1)
for a minimum##2##3##(1994-8#1)(2008-10#1)
for a mixed##2##3##(2008-10#1)(2008-11#1)
for a model##2##3##(2008-2#1)(2013-8#1)
for a molecular##2##3##(2008-4#1)(2008-5#1)
for a month##2##3##(2008-11#2)
for a more##11##3##(1991-6#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-11#3)(2012-3#2)(2013-1#1)
for a national##3##3##(1991-11#1)(1997-3#1)(2013-8#1)
for a near##2##3##(2008-10#2)
for a negative##2##3##(2010-7#1)(2013-1#1)
for a new sample##2##4##(2008-10#2)
for a new##18##3##(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-5#1)
for a novel##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
for a number of different##2##5##(2008-10#1)(2010-5#1)
for a number of patients##2##5##(2011-3#1)(2012-12#1)
for a number of reasons##2##5##(2008-12#1)(2008-3#1)
for a number of##21##4##(1992-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#1)
for a panel of##2##4##(2008-10#1)(2008-5#1)
for a particular##11##3##(1990-11#1)(1993-3#1)(1995-5#1)(1995-9#1)(1997-1#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2013-1#1)
for a patient with##3##4##(1997-4#1)(2008-11#1)(2008-12#1)
for a patient##4##3##(1997-4#1)(2008-11#1)(2008-12#1)(2008-9#1)
for a period of two months##2##6##(2008-10#1)(2009-11#1)
for a period of##15##4##(1990-12#1)(1990-9#1)(1993-12#1)(2008-10#7)(2008-11#3)(2009-11#1)(2010-11#1)
for a polypeptide##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
for a positive##3##3##(1992-1#1)(2012-2#1)(2013-1#1)
for a possible##2##3##(1992-9#1)(2008-10#1)
for a precise##2##3##(2008-10#1)(2012-3#1)
for a preconcentration time of 120 s##2##7##(2008-10#2)
for a preconcentration time of##4##5##(2008-10#4)
for a preliminary##2##3##(1995-11#1)(2009-10#1)
for a primary##4##3##(1996-3#1)(2008-8#1)(2009-11#1)(2012-2#1)
for a prolonged period##2##4##(2008-7#2)
for a prolonged##3##3##(2008-11#1)(2008-7#2)
for a prospective payment system##3##5##(1991-1#2)(1992-2#1)
for a protein of##3##4##(1994-11#1)(1995-2#1)(1995-8#1)
for a protein with##2##4##(1995-8#1)(2011-2#1)
for a protein##8##3##(1993-12#1)(1994-11#1)(1995-2#1)(1995-8#2)(2011-2#2)(2013-1#1)
for a putative##4##3##(1997-7#1)(1997-8#1)(2008-10#2)
for a quantitative##3##3##(1997-6#1)(2008-10#1)(2010-7#1)
for a quartz##2##3##(2008-10#2)
for a random##2##3##(2008-9#1)(2012-3#1)
for a range of##10##4##(1994-1#1)(2008-10#5)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
for a rapid##6##3##(2008-10#4)(2010-5#1)(2011-2#1)
for a regular##3##3##(2008-7#1)(2011-2#2)
for a relationship between##5##4##(2013-8#5)
for a relatively short time##2##5##(1995-11#1)(2008-10#1)
for a relatively##3##3##(1995-11#1)(2008-10#2)
for a reliable##3##3##(2008-10#3)
for a representative##4##3##(2008-10#1)(2009-5#1)(2011-2#2)
for a research##2##3##(2008-12#2)
for a sample containing##2##4##(2008-10#2)
for a sample injection volume of##2##6##(2008-10#2)
for a sample injection##3##4##(2008-10#3)
for a sample of##2##4##(1992-12#1)(1994-1#1)
for a sample volume of##3##5##(2008-10#3)
for a sample##12##3##(1992-12#1)(1994-1#1)(2008-10#10)
for a sampling volume of##2##5##(2008-10#2)
for a second##4##3##(1992-1#1)(2008-10#2)(2008-8#1)
for a selected group of##2##5##(1994-6#1)(2008-10#1)
for a selected##4##3##(1994-6#1)(2008-10#1)(2008-3#1)(2009-10#1)
for a selective##2##3##(2008-10#2)
for a sensitive##2##3##(2008-10#2)
for a separate##2##3##(1992-1#1)(2012-3#1)
for a series of##8##4##(1991-5#1)(2008-10#5)(2008-11#1)(2008-12#1)
for a set of##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
for a short period##2##4##(2008-5#1)(2011-2#1)
for a short time##2##4##(1991-3#1)(2008-11#1)
for a short##6##3##(1991-3#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
for a significant##8##3##(1991-12#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)
for a simple##3##3##(2008-11#2)(2008-9#1)
for a simultaneous determination of##2##5##(2008-10#2)
for a single point calibration of a GC/FID system##2##9##(2008-10#2)
for a single##14##3##(1993-1#1)(1994-12#1)(1994-3#1)(1995-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2010-12#1)(2013-8#1)
for a small##4##3##(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)
for a solution containing 5##2##5##(2008-10#2)
for a solution containing##6##4##(2008-10#6)
for a solution##7##3##(2008-10#7)
for a specific##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
for a specified##3##3##(1990-2#1)(1992-9#1)(2008-11#1)
for a subset of##2##4##(1995-8#1)(2008-10#1)
for a successful##4##3##(1991-9#1)(1993-2#1)(2008-10#1)(2008-12#1)
for a survey of##2##4##(1996-12#1)(2008-10#1)
for a sustainable##2##3##(2010-10#1)(2010-7#1)
for a system##2##3##(2008-10#1)(2008-9#1)
for a total of##7##4##(1990-11#1)(1990-12#1)(1994-2#1)(1994-5#1)(2008-10#1)(2011-2#2)
for a total##10##3##(1990-11#1)(1990-12#1)(1991-2#1)(1994-2#1)(1994-5#1)(2008-10#1)(2009-11#1)(2011-2#2)(2012-3#1)
for a trial##3##3##(1995-9#1)(2010-8#1)(2012-2#1)
for a typical##3##3##(1994-12#1)(2008-10#2)
for a unique##3##3##(1994-1#1)(2008-10#1)(2013-1#1)
for a variety of applications##2##5##(2009-10#1)(2009-12#1)
for a variety of biological##2##5##(2008-10#1)(2011-2#1)
for a variety of reasons##2##5##(1995-12#1)(2008-9#1)
for a variety of##30##4##(1991-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-9#3)(2009-10#3)(2009-12#1)(2010-4#1)(2011-2#2)(2012-2#2)
for a very##5##3##(1993-3#1)(2008-10#2)(2009-12#1)(2010-7#1)
for a wide range of conditions##2##6##(2008-10#1)(2009-7#1)
for a wide range of##13##5##(1995-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#1)(2013-8#1)
for a wide variety of##7##5##(1992-3#1)(1996-12#1)(1996-5#1)(2008-11#2)(2008-3#1)(2012-2#1)
for a wide##21##3##(1992-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#5)(2008-3#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
for a yield##2##3##(2008-10#2)
for a##1101##2##(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#5)(1991-11#4)(1991-12#6)(1991-2#6)(1991-3#5)(1991-5#2)(1991-6#5)(1991-8#1)(1991-9#2)(1992-1#5)(1992-11#1)(1992-12#4)(1992-2#9)(1992-3#6)(1992-6#1)(1992-9#4)(1993-1#4)(1993-11#3)(1993-12#14)(1993-2#4)(1993-3#7)(1993-6#4)(1993-8#5)(1993-9#4)(1994-1#5)(1994-11#4)(1994-12#8)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#5)(1995-12#5)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#5)(1995-9#5)(1996-1#5)(1996-12#5)(1996-2#3)(1996-3#10)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#7)(1997-4#3)(1997-6#7)(1997-7#3)(1997-8#6)(2006-6#1)(2007-11#3)(2007-12#7)(2008-1#8)(2008-10#303)(2008-11#72)(2008-12#26)(2008-2#11)(2008-3#77)(2008-4#13)(2008-5#13)(2008-6#4)(2008-7#17)(2008-8#27)(2008-9#29)(2009-1#2)(2009-10#9)(2009-11#5)(2009-12#6)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#7)(2010-11#3)(2010-12#7)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#5)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#43)(2011-3#4)(2011-7#1)(2012-12#8)(2012-2#23)(2012-3#14)(2013-1#25)(2013-8#21)
for abdominal##5##2##(1990-2#1)(1991-3#1)(1992-9#1)(2009-11#1)(2012-3#1)
for ability to##2##3##(1995-6#1)(2008-10#1)
for abortion##2##2##(1991-1#2)
for about 4##2##3##(2008-10#1)(2008-9#1)
for about##22##2##(1992-6#1)(1993-1#1)(1994-3#1)(1995-12#1)(1997-6#1)(2008-10#11)(2008-11#4)(2008-9#1)(2010-2#1)
for absolute cell##2##3##(2008-9#2)
for absolute##5##2##(2007-11#2)(2008-9#3)
for absorbance##5##2##(2008-10#5)
for absorption##2##2##(2008-10#2)
for abundant##2##2##(2008-11#1)(2008-9#1)
for academic##3##2##(1996-1#1)(2008-11#2)
for accelerating the##2##3##(2010-10#1)(2011-1#1)
for accelerating##5##2##(2010-10#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
for access to##2##3##(1993-12#1)(1993-2#1)
for access##3##2##(1993-12#1)(1993-2#1)(2010-8#1)
for accessing##5##2##(1997-2#1)(2008-4#1)(2009-10#2)(2012-3#1)
for acclimating to##2##3##(2008-8#2)
for accomplishing##3##2##(1991-3#1)(1995-2#1)(2008-10#1)
for accountability##3##2##(1993-1#1)(1995-3#1)(2012-2#1)
for accreditation##2##2##(1993-2#2)
for accumulation of##4##3##(2008-10#3)(2008-9#1)
for accumulation##5##2##(2008-10#4)(2008-9#1)
for accuracy##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-11#1)
for accurate and##2##3##(2008-11#1)(2008-9#1)
for accurate assessment of##2##4##(2008-10#2)
for accurate##17##2##(1990-3#1)(1994-2#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-7#1)(2012-2#1)
for acetaminophen##2##2##(2008-10#2)
for acetone##3##2##(2008-10#3)
for acetylcholine##3##2##(1996-12#2)(1996-2#1)
for achieving improvement in##2##4##(1993-12#1)(2008-11#1)
for achieving optimal##2##3##(1991-12#1)(2008-3#1)
for achieving##15##2##(1991-12#1)(1992-12#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-10#1)(2013-1#1)(2013-8#1)
for acid##4##2##(2008-10#4)
for acidic##2##2##(1994-5#1)(2011-2#1)
for acquired immunodeficiency syndrome##3##4##(1993-1#1)(1995-1#1)(2013-1#1)
for acquired##6##2##(1993-1#1)(1994-5#1)(1995-1#1)(2008-10#2)(2013-1#1)
for action##5##2##(1991-2#1)(1992-6#1)(1996-3#1)(2008-10#1)(2008-11#1)
for actionable##2##2##(1996-3#1)(1997-1#1)
for actions##2##2##(2008-11#1)(2013-8#1)
for activating##2##2##(1992-10#1)(2008-9#1)
for activation of the##2##4##(1995-6#1)(2008-11#1)
for activation of##5##3##(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-6#1)
for activation##8##2##(1990-2#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2009-6#1)(2013-8#1)
for active##12##2##(1991-12#1)(1994-8#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#2)(2011-2#1)
for activity of the##2##4##(1995-6#1)(2006-6#1)
for activity of##3##3##(1995-6#1)(2006-6#1)(2008-5#1)
for activity##11##2##(1994-3#1)(1994-5#1)(1995-6#1)(2006-6#1)(2008-10#3)(2008-5#1)(2011-1#1)(2011-2#2)
for actual##2##2##(2008-10#1)(2012-2#1)
for acute coronary syndrome##2##4##(2008-11#1)(2008-3#1)
for acute coronary syndromes##2##4##(2008-3#1)(2011-2#1)
for acute coronary##4##3##(2008-11#1)(2008-3#2)(2011-2#1)
for acute disease##3##3##(1997-8#3)
for acute lymphoblastic##2##3##(2008-7#1)(2010-6#1)
for acute myocardial infarction##3##4##(1995-12#1)(2008-5#1)(2013-1#1)
for acute myocardial##4##3##(1995-12#1)(2008-5#1)(2009-11#1)(2013-1#1)
for acute variceal##2##3##(1995-8#1)(2008-8#1)
for acute##37##2##(1992-2#1)(1992-9#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-3#2)(1997-8#4)(2008-10#2)(2008-11#5)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#5)(2013-1#1)(2013-8#1)
for adaptation to##2##3##(1990-2#1)(2008-8#1)
for adaptation##4##2##(1990-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
for adaptive evolution##2##3##(2008-8#2)
for adaptive##4##2##(2008-8#3)(2010-2#1)
for adding##2##2##(1991-12#1)(1994-12#1)
for addition##2##2##(2008-10#2)
for additional information##2##3##(2008-10#1)(2011-2#1)
for additional research##2##3##(2008-6#1)(2010-10#1)
for additional##11##2##(1994-3#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-5#1)(2010-10#1)(2011-2#2)
for addressing these##3##3##(1997-1#1)(2008-12#2)
for addressing##10##2##(1993-1#1)(1993-2#1)(1997-1#1)(2008-1#1)(2008-12#4)(2008-9#1)(2013-1#1)
for adenocarcinoma of the##2##4##(1990-9#1)(1993-2#1)
for adenocarcinoma##3##2##(1990-9#1)(1993-2#1)(2009-1#1)
for adenomas##2##2##(2008-1#2)
for adenovirus##2##2##(2008-11#2)
for adequacy##2##2##(1992-12#1)(2011-2#1)
for adequate##7##2##(1993-9#1)(1995-2#1)(1996-1#1)(2008-10#1)(2011-3#1)(2013-1#1)(2013-8#1)
for adherent##3##2##(1994-3#1)(2008-11#1)(2008-9#1)
for adhesion##4##2##(2006-6#1)(2008-11#1)(2008-7#1)(2013-7#1)
for adjusting the##2##3##(2008-10#1)(2012-2#1)
for adjusting##5##2##(1991-1#1)(1992-12#1)(1997-1#1)(2008-10#1)(2012-2#1)
for adjuvant therapy##2##3##(1993-11#1)(2008-10#1)
for adjuvant##3##2##(1993-11#1)(2008-10#1)(2012-3#1)
for administering##2##2##(2008-4#1)(2011-2#1)
for administration##2##2##(1992-1#1)(1997-1#1)
for administrative##2##2##(1991-9#1)(1995-2#1)
for administrators##2##2##(1993-1#1)(1996-3#1)
for admission to##2##3##(1995-5#1)(2011-2#1)
for admission##4##2##(1995-2#1)(1995-5#1)(2011-2#1)(2013-1#1)
for adnexal surgery##2##3##(1996-3#2)
for adnexal##3##2##(1996-3#3)
for adolescent girls##2##3##(2008-1#1)(2013-1#1)
for adolescent##6##2##(2008-1#1)(2009-7#1)(2012-2#1)(2013-1#3)
for adolescents with cancer##2##4##(1993-3#1)(2010-11#1)
for adolescents with##4##3##(1993-3#2)(2010-1#1)(2010-11#1)
for adolescents##10##2##(1993-2#1)(1993-3#2)(1995-12#2)(2008-11#1)(2009-7#2)(2010-1#1)(2010-11#1)
for adopting##3##2##(1990-2#2)(2010-2#1)
for adsorption##4##2##(2008-10#3)(2008-7#1)
for adsorptive##2##2##(2008-10#2)
for adult hepatocytes##2##3##(2008-11#2)
for adult##15##2##(1996-2#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
for adult-plant##3##2##(2008-10#3)
for adults in##2##3##(2008-8#1)(2013-1#1)
for adults##12##2##(1996-8#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-9#1)(2012-2#2)(2013-1#1)
for advanced lateral skull base##2##5##(2011-2#2)
for advanced##9##2##(1994-12#1)(1997-7#1)(2007-8#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
for advances in##3##3##(2008-10#2)(2008-11#1)
for advancing the##2##3##(1993-3#1)(2012-2#1)
for advancing##3##2##(1993-3#1)(2010-7#1)(2012-2#1)
for adverse##2##2##(2008-7#1)(2010-5#1)
for advice##2##2##(1990-3#1)(2008-11#1)
for aerosol##10##2##(1992-3#2)(1997-1#2)(2008-10#2)(2008-2#1)(2008-3#3)
for aflatoxin##3##2##(2008-10#3)
for age and gender##2##4##(2008-11#1)(2010-9#1)
for age and size at life-history transitions##2##7##(2008-8#2)
for age and size at##3##5##(2008-8#3)
for age and##10##3##(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#3)(2010-9#1)(2011-1#1)(2012-3#1)
for age##25##2##(1992-2#1)(1995-1#1)(1996-3#2)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
for aged and disabled Medicare##2##5##(1991-2#1)(1997-1#1)
for aged##3##2##(1991-2#1)(1994-12#1)(1997-1#1)
for agents##2##2##(2008-10#1)(2011-2#1)
for aggregate##2##2##(2008-10#1)(2012-12#1)
for aggregation##3##2##(1994-5#1)(2006-6#1)(2008-10#1)
for aggressiveness##4##2##(2008-10#4)
for aging##2##2##(2012-2#1)(2012-3#1)
for aiding##2##2##(2008-9#1)(2010-5#1)
for air##3##2##(2008-10#1)(2008-11#1)(2009-11#1)
for airborne##2##2##(2008-10#2)
for alanine##2##2##(1993-8#1)(2008-10#1)
for alcohol abuse##2##3##(1990-2#2)
for alcohol determination in##2##4##(2008-10#2)
for alcohol determination##3##3##(2008-10#3)
for alcohol problems##2##3##(2008-11#2)
for alcohol use##2##3##(2008-11#1)(2009-7#1)
for alcohol##13##2##(1990-2#2)(1992-3#1)(1993-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2009-7#1)(2009-8#1)
for alcohol-abusing##2##2##(1990-2#1)(1992-5#1)
for alcoholism##2##2##(1991-1#1)(2008-10#1)
for alendronate##2##2##(2008-10#1)(2008-11#1)
for alkali and alkaline earth metal##2##6##(2008-10#2)
for alkali metal##2##3##(2008-10#2)
for alkali##6##2##(2008-10#6)
for alkaline##2##2##(2008-10#2)
for all Medicaid##2##3##(1991-1#1)(1991-9#1)
for all Se##2##3##(2008-10#2)
for all analyses##2##3##(2008-10#1)(2008-11#1)
for all analytes##4##3##(2008-10#4)
for all analytical##2##3##(2008-10#2)
for all but one##2##4##(1990-12#2)
for all but##4##3##(1990-12#2)(2008-10#2)
for all cases##5##3##(1993-12#1)(2008-10#3)(2008-11#1)
for all children with##2##4##(1994-3#1)(2008-11#1)
for all children##3##3##(1994-3#1)(2008-11#1)(2012-2#1)
for all components##3##3##(2008-10#3)
for all compounds##5##3##(2008-10#5)
for all cultivars##2##3##(2008-10#1)(2009-8#1)
for all data sets##2##4##(2008-10#2)
for all data##3##3##(1993-8#1)(2008-10#2)
for all eight##2##3##(2008-10#1)(2012-3#1)
for all elements and##2##4##(2008-10#2)
for all elements##9##3##(2008-10#7)(2011-2#2)
for all entries##2##3##(2008-10#2)
for all experiments##2##3##(2008-10#1)(2008-7#1)
for all hospitals##2##3##(1992-12#1)(1995-1#1)
for all major##2##3##(2008-10#1)(2008-8#1)
for all medical##2##3##(1995-12#1)(2008-11#1)
for all members##2##3##(2006-6#1)(2008-11#1)
for all metal##2##3##(2008-10#2)
for all of the##5##4##(1992-2#1)(1995-11#1)(2008-10#3)
for all of them##2##4##(2008-10#1)(2008-9#1)
for all of##9##3##(1992-2#1)(1995-11#1)(2008-10#5)(2008-9#1)(2010-9#1)
for all patients with##2##4##(2009-8#1)(2011-2#1)
for all patients##10##3##(1991-12#1)(1991-6#1)(1992-3#1)(1997-4#1)(2008-3#2)(2009-8#1)(2011-2#2)(2013-1#1)
for all samples##6##3##(2008-10#5)(2012-2#1)
for all sites##2##3##(2008-10#2)
for all species investigated##2##4##(2008-11#1)(2012-5#1)
for all species##8##3##(2008-10#5)(2008-11#1)(2008-7#1)(2012-5#1)
for all steps of the##2##5##(2008-10#2)
for all steps##3##3##(2008-10#2)(2008-4#1)
for all strains##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
for all students##2##3##(2008-12#1)(2008-9#1)
for all the analytes##2##4##(2008-10#2)
for all the compounds##4##4##(2008-10#3)(2008-7#1)
for all the elements##4##4##(2008-10#4)
for all the metal ions##2##5##(2008-10#2)
for all the parameters##4##4##(1992-2#1)(1992-3#1)(2008-12#2)
for all the samples##3##4##(2008-10#3)
for all the three analytes##2##5##(2008-10#2)
for all the three pesticides##2##5##(2008-10#2)
for all the three##4##4##(2008-10#4)
for all the##48##3##(1990-6#2)(1991-12#1)(1992-2#1)(1992-3#1)(1995-8#1)(2008-10#32)(2008-12#2)(2008-3#4)(2008-7#2)(2011-2#1)(2013-1#1)
for all these##3##3##(1994-5#1)(1996-5#1)(2008-10#1)
for all three analytes##2##4##(2008-10#2)
for all three##8##3##(1995-12#1)(1997-1#1)(2008-10#5)(2008-4#1)
for all time periods##2##4##(2008-10#1)(2009-11#1)
for all time##3##3##(2008-10#1)(2009-11#1)(2013-8#1)
for all treatments##2##3##(2008-10#2)
for all##303##2##(1990-12#2)(1990-2#1)(1990-6#3)(1991-1#1)(1991-11#1)(1991-12#4)(1991-6#1)(1991-9#3)(1992-12#1)(1992-2#3)(1992-3#3)(1993-12#2)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#144)(2008-11#17)(2008-12#6)(2008-3#10)(2008-4#4)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#8)(2012-2#3)(2012-3#4)(2012-5#1)(2012-6#1)(2013-1#7)(2013-8#3)
for all-solid-state##2##2##(2008-10#2)
for allergic##3##2##(1990-3#1)(2008-5#1)(2013-1#1)
for alleviating##4##2##(2008-10#1)(2009-12#1)(2011-2#1)(2013-8#1)
for allowing##2##2##(2010-4#1)(2011-2#1)
for almost all##6##3##(2008-10#4)(2008-12#1)(2011-2#1)
for almost one##3##3##(1997-7#1)(2009-12#1)(2012-3#1)
for almost##14##2##(1993-3#1)(1996-11#1)(1997-5#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#2)(2012-3#1)
for altered##2##2##(1991-5#1)(1993-3#1)
for altering the##2##3##(2008-4#1)(2008-5#1)
for alternative model rural hospitals##2##5##(1993-12#2)
for alternative##6##2##(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(2013-1#1)
for altitudes##2##2##(2008-3#2)
for aluminium and manganese##2##4##(2008-10#2)
for aluminium and##4##3##(2008-10#4)
for aluminium##10##2##(1992-3#1)(2008-10#9)
for aluminum##3##2##(2008-10#3)
for alveolar##3##2##(1993-2#1)(1994-3#2)
for ambulatory care##5##3##(1991-3#1)(1994-3#2)(1997-3#2)
for ambulatory surgery##5##3##(1991-1#3)(1995-2#1)(1997-2#1)
for ambulatory therapy of acute##2##5##(1994-2#2)
for ambulatory##15##2##(1991-1#3)(1991-3#1)(1994-2#2)(1994-3#2)(1995-2#1)(1996-2#2)(1997-2#1)(1997-3#2)(2013-1#1)
for amino acid##2##3##(1992-3#1)(2008-10#1)
for ammonia##4##2##(1995-3#1)(2007-12#1)(2008-10#2)
for ammonium and##2##3##(2008-10#2)
for ammonium dihydrogenphosphate##2##3##(2008-10#2)
for ammonium##13##2##(2008-10#13)
for amniocentesis##2##2##(1990-9#1)(2012-3#1)
for amperometric detection of NADH##2##5##(2008-10#2)
for amperometric detection of##4##4##(2008-10#4)
for amperometric determination of ascorbic acid##2##6##(2008-10#2)
for amperometric determination of##4##4##(2008-10#4)
for amperometric##11##2##(2008-10#11)
for amplification and##2##3##(1993-12#1)(2011-2#1)
for amplification of##4##3##(2008-10#3)(2008-9#1)
for amplification##8##2##(1991-6#1)(1993-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
for amplified##2##2##(2007-12#1)(2008-10#1)
for amplifying##4##2##(1995-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
for an accumulation##2##3##(2008-10#2)
for an acute##2##3##(1991-6#1)(1997-3#1)
for an additional##6##3##(1996-2#2)(2008-10#3)(2010-5#1)
for an assessment##2##3##(2008-9#2)
for an average of##9##4##(1990-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-3#1)(2011-2#1)
for an early##2##3##(2008-8#1)(2013-1#1)
for an efficient##2##3##(2008-10#2)
for an extended period##2##4##(1997-2#1)(2008-11#1)
for an extended##4##3##(1992-8#1)(1997-2#1)(2008-11#2)
for an hour##2##3##(1992-12#1)(2008-10#1)
for an increase in##2##4##(2008-12#1)(2008-9#1)
for an increased risk of##2##5##(2008-11#1)(2013-1#1)
for an increased##3##3##(2008-11#2)(2013-1#1)
for an increasing share of total##2##6##(1991-2#1)(1996-2#1)
for an increasing##3##3##(1991-2#1)(1991-3#1)(1996-2#1)
for an infectious##2##3##(1997-3#1)(2009-1#1)
for an international##4##3##(2008-10#1)(2008-11#1)(2009-10#2)
for an inverse relationship between##3##5##(2013-8#3)
for an on-line##2##3##(2008-10#2)
for an optical##2##3##(2008-10#1)(2008-3#1)
for an optimal##2##3##(2008-5#1)(2008-7#1)
for an##172##2##(1990-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#37)(2008-11#12)(2008-12#4)(2008-2#4)(2008-3#16)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#6)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#4)
for anal cancer##2##3##(1991-6#2)
for analyses##2##2##(2008-10#1)(2013-1#1)
for analysing the##2##3##(2011-2#2)
for analysing##8##2##(1992-9#1)(1994-3#1)(1995-12#1)(2008-10#1)(2010-11#1)(2010-2#1)(2011-2#2)
for analysis and##5##3##(1992-2#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-1#1)
for analysis by##2##3##(2008-10#1)(2010-6#1)
for analysis in##2##3##(2008-10#1)(2008-12#1)
for analysis is##2##3##(2008-10#2)
for analysis of a##2##4##(2008-4#1)(2012-12#1)
for analysis of the##4##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
for analysis of these##3##4##(1995-9#1)(2008-10#2)
for analysis of##53##3##(1993-12#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#3)(2008-4#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2011-3#1)(2012-12#2)(2012-2#1)
for analysis##83##2##(1992-2#1)(1993-12#1)(1995-9#1)(1997-2#2)(2007-12#1)(2008-1#1)(2008-10#46)(2008-11#4)(2008-12#2)(2008-4#2)(2008-9#5)(2009-1#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)
for analyte ions##2##3##(2008-10#2)
for analyte##5##2##(2008-10#5)
for analytes##4##2##(2008-10#4)
for analytical SEC##2##3##(1997-2#2)
for analytical and##2##3##(2008-10#1)(2012-2#1)
for analytical chemists##2##3##(2008-10#2)
for analytical determination of paraquat##2##5##(2008-10#2)
for analytical methods##2##3##(2008-9#1)(2010-9#1)
for analytical preconcentration##2##3##(2008-10#2)
for analytical purposes##5##3##(2008-10#3)(2010-7#1)(2011-2#1)
for analytical##22##2##(1997-2#2)(2008-10#15)(2008-9#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
for analyzing the##8##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#4)(2013-1#1)
for analyzing##26##2##(1997-3#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#6)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-1#1)(2013-1#2)
for and against##3##3##(1997-4#1)(2008-6#1)(2011-2#1)
for and##16##2##(1991-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-1#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#2)
for angiotensin##4##2##(1993-8#2)(1994-2#1)(1995-11#1)
for angular##2##2##(2013-1#2)
for animal cell culture##3##4##(2008-11#2)(2008-7#1)
for animal cell##5##3##(2008-11#4)(2008-7#1)
for animal##12##2##(1997-7#1)(2008-10#2)(2008-11#5)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
for anionic surfactants##2##3##(2008-10#2)
for anionic##4##2##(2008-10#4)
for anions and##2##3##(2008-10#2)
for anions##4##2##(2008-10#4)
for ankle arthrosis with##2##4##(2008-12#2)
for ankle arthrosis##3##3##(2008-12#2)(2011-2#1)
for ankle##5##2##(2008-12#4)(2011-2#1)
for anodic stripping##2##3##(2008-10#2)
for another##8##2##(1993-2#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-3#3)(2011-2#1)
for anterior cruciate ligament##2##4##(2008-11#1)(2012-2#1)
for anterior##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
for anthracnose##3##2##(2008-10#3)
for anthropogenic##2##2##(2008-11#2)
for anti-HCV##2##2##(2008-1#1)(2013-8#1)
for anti-HIV##2##2##(1996-5#1)(2011-3#1)
for anti-aging properties##2##3##(2008-5#2)
for anti-cancer therapy##3##3##(1997-1#1)(2011-2#1)(2013-1#1)
for anti-cancer##5##2##(1997-1#1)(2008-9#1)(2011-2#2)(2013-1#1)
for antibiotic##2##2##(2010-6#1)(2012-3#1)
for antibodies to##3##3##(1990-12#1)(2008-10#1)(2012-3#1)
for antibodies##7##2##(1990-12#1)(1997-1#1)(2008-10#3)(2008-9#1)(2012-3#1)
for antibody##12##2##(1995-5#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
for antiestrogen##2##2##(2008-10#1)(2008-11#1)
for antifungal##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
for antimicrobial##5##2##(2011-2#2)(2012-2#2)(2013-1#1)
for antimony##2##2##(2008-10#2)
for antioxidant##3##2##(2008-10#2)(2010-7#1)
for antioxidants##3##2##(2008-10#3)
for anxiety##2##2##(2008-12#1)(2011-2#1)
for any combination of##2##4##(1995-9#1)(2008-3#1)
for any desired##2##3##(1994-8#1)(2011-2#1)
for any given##6##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-3#1)
for any of the##4##4##(2008-10#2)(2008-12#1)(2012-2#1)
for any of##5##3##(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#1)
for any one##2##3##(2009-12#1)(2012-2#1)
for any other##3##3##(1993-2#1)(1997-5#1)(2012-2#1)
for any##60##2##(1992-2#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#15)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#5)(2008-8#1)(2008-9#5)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
for apoptosis##6##2##(1995-2#4)(1996-12#1)(2008-8#1)
for apple##3##2##(1997-2#1)(2008-10#2)
for application as##2##3##(2008-10#2)
for application in the##4##4##(2008-10#4)
for application in##16##3##(2008-10#11)(2008-11#1)(2008-5#3)(2010-8#1)
for application of##5##3##(1990-5#1)(1994-11#1)(2008-10#2)(2008-3#1)
for application to the##2##4##(2008-3#1)(2008-9#1)
for application to##6##3##(2008-10#3)(2008-3#2)(2008-9#1)
for application##30##2##(1990-5#1)(1994-11#1)(2008-10#19)(2008-11#1)(2008-3#3)(2008-5#3)(2008-9#1)(2010-8#1)
for applications in##7##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
for applications of##2##3##(2008-10#1)(2008-11#1)
for applications such as##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
for applications##16##2##(2007-12#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
for applying the##5##3##(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)
for applying##9##2##(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#1)(2010-7#1)
for approaching##2##2##(2008-7#2)
for appropriate##11##2##(1997-3#1)(2008-10#2)(2008-11#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
for approximately 25% of##2##4##(2011-2#1)(2012-2#1)
for approximately 3##2##3##(2008-10#1)(2010-1#1)
for approximately##29##2##(1990-3#1)(1992-1#1)(1992-12#1)(1995-12#1)(1995-6#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
for aquatic##2##2##(2008-10#1)(2008-9#1)
for aqueous solutions##2##3##(2008-10#1)(2008-3#1)
for aqueous##8##2##(2008-10#7)(2008-3#1)
for arbitrary##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
for archaeological##2##2##(2008-10#2)
for area##2##2##(1996-2#1)(2008-10#1)
for aromatase##2##2##(1991-5#1)(1993-8#1)
for aromatic cations##2##3##(2008-10#2)
for aromatic##3##2##(2008-10#3)
for around 20##2##3##(2008-10#2)
for around##4##2##(2008-10#3)(2013-8#1)
for arrhythmia diagnostics##2##3##(2010-8#2)
for arrhythmia##3##2##(2007-8#1)(2010-8#2)
for arsenic and selenium##4##4##(2008-10#4)
for arsenic compounds##2##3##(2008-10#2)
for arsenic determination in##3##4##(2008-10#3)
for arsenic determination##7##3##(2008-10#7)
for arsenic speciation in environmental samples##2##6##(2008-10#2)
for arsenic speciation in environmental##3##5##(2008-10#3)
for arsenic speciation in##5##4##(2008-10#5)
for arsenic species##2##3##(2008-10#2)
for arsenic##25##2##(2008-10#25)
for arsenite##3##2##(2008-10#3)
for arteriovenous malformation##2##3##(2008-7#2)
for arteriovenous##3##2##(2008-7#3)
for articles##5##2##(2009-7#1)(2012-12#4)
for artificial##2##2##(2008-10#2)
for as long as##3##4##(1991-8#1)(1995-5#1)(2008-10#1)
for as##6##2##(1991-8#1)(1994-5#1)(1995-5#1)(2008-10#3)
for ascending##2##2##(1991-6#1)(2013-1#1)
for ascorbate##2##2##(1990-9#1)(2008-10#1)
for ascorbic acid and##3##4##(2008-10#3)
for ascorbic acid##11##3##(2008-10#11)
for ascospore##2##2##(2008-10#2)
for ascospores##3##2##(2008-10#3)
for aspartate and Mg2+ of##2##5##(1995-6#2)
for aspartate and##3##3##(1995-6#3)
for aspartate##5##2##(1995-6#4)(2008-4#1)
for aspartic##2##2##(1995-6#1)(2008-10#1)
for assaying##2##2##(2008-10#1)(2008-4#1)
for assays##2##2##(2008-10#1)(2008-4#1)
for assembling##2##2##(2008-11#1)(2008-9#1)
for assessing the effects of##3##5##(2008-5#1)(2009-12#1)(2010-5#1)
for assessing the##19##3##(1993-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2013-1#3)(2013-8#1)
for assessing toxic##2##3##(2008-10#1)(2008-11#1)
for assessing##45##2##(1992-3#1)(1993-12#1)(1994-12#1)(1997-4#1)(1997-5#1)(2008-10#10)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-8#1)(2012-2#1)(2012-5#1)(2013-1#5)(2013-8#1)
for assessment of the##3##4##(1997-8#1)(2009-5#1)(2009-8#1)
for assessment of##19##3##(1993-1#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-9#2)(2009-5#2)(2009-8#1)(2010-3#1)(2012-2#1)(2012-3#1)
for assessment##24##2##(1993-1#1)(1996-1#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#2)(2009-11#1)(2009-5#2)(2009-8#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
for assisted living##2##3##(2008-12#2)
for association of##2##3##(2008-10#1)(2008-9#1)
for association##4##2##(1991-12#1)(2008-10#2)(2008-9#1)
for associations of##2##3##(2008-10#2)
for assuring##2##2##(1997-1#1)(2012-2#1)
for asthma##10##2##(1995-12#1)(1996-2#1)(2008-11#3)(2008-5#2)(2010-5#1)(2010-9#1)(2012-12#1)
for astrocytes##2##2##(2008-11#1)(2009-6#1)
for asymptomatic##2##2##(2011-2#1)(2011-3#1)
for at least 2 months##4##5##(2008-10#4)
for at least 2 weeks##3##5##(2008-10#3)
for at least 2##8##4##(2008-10#8)
for at least 20##2##4##(1995-12#1)(2008-10#1)
for at least 24 h##2##5##(1995-12#1)(2008-10#1)
for at least 24##3##4##(1992-6#1)(1995-12#1)(2008-10#1)
for at least 3 months##9##5##(2008-10#9)
for at least 3##10##4##(2008-10#9)(2011-2#1)
for at least 30##2##4##(1991-6#1)(1995-2#1)
for at least 4 weeks##2##5##(2008-10#1)(2013-1#1)
for at least 5##4##4##(1990-5#1)(2008-10#2)(2013-1#1)
for at least 6 months at##2##6##(2008-10#1)(2008-8#1)
for at least 6 months##5##5##(1996-1#1)(2008-10#3)(2008-8#1)
for at least 6 weeks##2##5##(1990-9#1)(2008-10#1)
for at least 6##7##4##(1990-9#1)(1996-1#1)(2008-10#4)(2008-8#1)
for at least 8##2##4##(2008-10#1)(2009-10#1)
for at least 90##2##4##(1996-12#1)(2008-10#1)
for at least a##2##4##(2008-2#1)(2013-8#1)
for at least five##2##4##(1993-6#1)(2011-1#1)
for at least one year##3##5##(2008-11#2)(2011-1#1)
for at least one##6##4##(1993-8#1)(2008-10#2)(2008-11#2)(2011-1#1)
for at least some##2##4##(2008-10#1)(2012-3#1)
for at least two months##2##5##(2008-10#1)(2008-6#1)
for at least##69##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#42)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
for at##71##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#42)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
for atherosclerosis##2##2##(2008-10#1)(2008-6#1)
for atmospheric##10##2##(2008-2#2)(2008-3#8)
for atomic##2##2##(2008-10#2)
for atrazine and##2##3##(2008-10#2)
for atrazine determination##2##3##(2008-10#2)
for atrazine##7##2##(2008-10#7)
for atrial septal defect##2##4##(2008-11#2)
for atrial##5##2##(1996-11#1)(2008-11#2)(2008-3#2)
for attending##2##2##(1992-12#1)(2013-1#1)
for atypical pneumonia and hemorrhagic##2##5##(2010-6#2)
for atypical pneumonia##3##3##(2010-6#3)
for atypical##4##2##(2008-7#1)(2010-6#3)
for augmenting##3##2##(2010-11#1)(2012-2#1)(2013-1#1)
for authentication and##2##3##(2008-11#1)(2011-2#1)
for autism##2##2##(2008-11#1)(2013-8#1)
for autoantibodies##2##2##(1996-11#1)(2013-7#1)
for autoimmune##3##2##(1997-2#1)(2012-3#2)
for autologous stem cell##2##4##(2012-12#1)(2012-4#1)
for autologous##5##2##(1995-1#1)(1996-9#1)(2012-12#1)(2012-4#1)(2013-1#1)
for automated evolution experiments in vitro##2##6##(1997-6#2)
for automated sample##2##3##(2008-10#2)
for automated##15##2##(1997-6#2)(2008-10#12)(2008-11#1)
for automatic##7##2##(2008-10#6)(2008-11#1)
for automatically##2##2##(2008-11#1)(2011-3#1)
for automation to##2##3##(2008-10#2)
for automation##4##2##(2008-10#4)
for autoradiography##2##2##(2008-4#2)
for available##3##2##(2010-8#2)(2013-1#1)
for avoiding##4##2##(1992-3#1)(1994-5#1)(2008-10#1)(2013-8#1)
for bFGF and its receptor##2##5##(1995-12#2)
for bFGF##4##2##(1992-3#1)(1995-12#3)
for babies##2##2##(1997-1#1)(2008-11#1)
for backpropagation##2##2##(2008-10#2)
for bacoside A##2##3##(2012-2#2)
for bacterial blight resistance##3##4##(2008-10#3)
for bacterial blight##6##3##(2008-10#5)(2009-10#1)
for bacterial growth##2##3##(2008-4#1)(2012-2#1)
for bacterial##16##2##(2008-10#9)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2012-2#1)
for band intensity and band area measurements##2##7##(2008-10#2)
for band##3##2##(2008-10#2)(2008-3#1)
for basal##2##2##(2010-11#1)(2012-3#1)
for baseline##2##2##(2008-10#1)(2008-12#1)
for basic research##2##3##(1995-3#1)(2008-11#1)
for basic##11##2##(1994-3#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
for batch and##4##3##(2008-10#3)(2008-11#1)
for batch##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
for beam##2##2##(2008-3#2)
for behavioral##6##2##(2008-4#1)(2008-6#1)(2008-8#3)(2009-11#1)
for behaviors##2##2##(1993-6#1)(2008-8#1)
for being##3##2##(2008-11#1)(2010-10#1)(2013-1#1)
for benign esophageal diseases##2##4##(2013-1#2)
for benign esophageal##3##3##(2013-1#3)
for benign##10##2##(1990-6#3)(1991-2#1)(1992-9#1)(1993-12#1)(2012-3#1)(2013-1#3)
for benzene##4##2##(2008-10#4)
for bereaved parents##3##3##(2008-11#3)
for beryllium##3##2##(2008-10#3)
for beta##4##2##(1991-2#1)(1993-6#2)(1995-11#1)
for beta-galactosidase##4##2##(1993-9#1)(1995-12#1)(1997-8#1)(2008-11#1)
for better data on clinical##2##5##(1994-1#2)
for better understanding of##2##4##(2008-10#1)(2009-8#1)
for better understanding##4##3##(1997-8#1)(2008-10#1)(2009-8#1)(2011-2#1)
for better##20##2##(1991-2#1)(1994-1#2)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
for between##2##2##(1991-5#1)(2008-10#1)
for bilateral cochlear##3##3##(2012-2#3)
for bilateral##10##2##(2008-10#2)(2008-7#1)(2009-3#2)(2012-2#5)
for biliary##2##2##(1990-9#1)(2010-12#1)
for bilirubin##2##2##(2008-10#2)
for binary##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
for binding to the##2##4##(1991-3#1)(1995-5#1)
for binding to##12##3##(1991-3#1)(1993-1#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1995-5#1)(1997-8#2)(2006-6#1)
for binding##25##2##(1990-11#1)(1991-3#1)(1993-1#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-5#1)(1997-8#2)(2006-6#1)(2008-10#6)(2008-8#1)(2008-9#2)(2010-11#1)
for bioanalytical assays##2##3##(2008-10#1)(2010-11#1)
for biochemical##7##2##(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2013-1#2)
for biocontrol of##2##3##(2008-5#1)(2012-2#1)
for biocontrol##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
for biodiesel production##4##3##(2009-3#4)
for biological activity##2##3##(1993-8#1)(2008-11#1)
for biological and##2##3##(2008-10#2)
for biological control of plant##2##5##(2008-10#2)
for biological control of postharvest diseases##2##6##(2008-10#2)
for biological control of##10##4##(2008-10#10)
for biological control##17##3##(2008-10#15)(2008-11#1)(2008-8#1)
for biological removal of inhibitors from lignocellulosic##2##7##(2011-1#2)
for biological systems##2##3##(2008-10#1)(2008-5#1)
for biological##39##2##(1992-12#1)(1992-9#1)(1993-8#1)(2008-10#22)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)
for biologically##3##2##(1995-3#1)(2008-10#1)(2010-4#1)
for biologists##2##2##(2008-8#1)(2008-9#1)
for biomarker discovery##3##3##(2008-4#1)(2010-5#1)(2013-8#1)
for biomedical applications##3##3##(1994-11#1)(1994-3#1)(2009-7#1)
for biomedical##8##2##(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(2009-7#1)(2010-1#1)(2010-8#2)
for biopsy##3##2##(1990-2#1)(2011-2#1)(2012-3#1)
for bioreactor##2##2##(2008-11#1)(2011-2#1)
for bioremediation of##2##3##(2012-2#2)
for biosensing##2##2##(2008-10#2)
for biosensors##5##2##(1995-3#1)(2008-10#3)(2008-11#1)
for biosynthesis##3##2##(2008-10#2)(2008-7#1)
for biotechnological applications##2##3##(2011-1#1)(2011-2#1)
for biotechnology##2##2##(2008-11#2)
for biotin##2##2##(1995-2#1)(2008-9#1)
for birth incidence##2##3##(2008-11#2)
for bismuth##4##2##(2008-10#3)(2010-11#1)
for black##2##2##(2008-10#1)(2011-2#1)
for bladder##3##2##(1991-8#1)(1994-5#1)(2012-2#1)
for bleeding##4##2##(1990-2#1)(1995-11#1)(2011-2#1)(2013-1#1)
for blood pressure##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2013-8#1)
for blood##15##2##(1991-3#1)(2008-1#1)(2008-10#4)(2008-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-8#2)
for board##2##2##(1992-3#1)(2008-11#1)
for body##4##2##(2008-12#1)(2009-12#1)(2010-1#1)(2012-2#1)
for bond lengths and 1##2##5##(1992-4#1)(2008-8#1)
for bond lengths and##3##4##(1992-4#1)(2008-8#1)(2008-9#1)
for bond##6##2##(1992-4#2)(2008-8#2)(2008-9#2)
for bone tissue engineering##3##4##(2009-7#3)
for bone##10##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-7#4)(2011-2#1)(2013-1#1)
for both analytes and the##2##5##(2008-10#2)
for both analytes##8##3##(2008-10#8)
for both antioxidants##2##3##(2008-10#2)
for both cations##3##3##(2008-10#3)
for both classes of##2##4##(2008-11#1)(2008-7#1)
for both compounds##2##3##(2008-10#2)
for both coronary##3##3##(1993-12#2)(2009-7#1)
for both diagnosis and##3##4##(2008-12#2)(2008-9#1)
for both drugs##5##3##(1990-9#1)(2008-10#4)
for both elements##2##3##(2008-10#2)
for both enantiomers##2##3##(2008-10#2)
for both fungi##2##3##(2008-10#1)(2008-5#1)
for both groups##8##3##(1991-1#1)(1994-2#1)(2008-10#2)(2008-11#2)(2009-11#1)(2009-3#1)
for both inpatient and outpatient##2##5##(1995-2#1)(1996-3#1)
for both medical and##2##4##(1994-12#1)(1996-6#1)
for both metals##4##3##(2008-10#4)
for both methods##5##3##(1992-3#1)(2008-10#3)(2008-5#1)
for both normal##2##3##(2008-10#1)(2009-1#1)
for both of##3##3##(2008-10#2)(2009-10#1)
for both oils##3##3##(2008-10#2)(2008-11#1)
for both polarization states##2##4##(2008-3#2)
for both processes##2##3##(1993-8#1)(2008-10#1)
for both samples##2##3##(2008-10#2)
for both sexes in##3##4##(1991-6#1)(1997-4#1)(2008-10#1)
for both sexes##4##3##(1991-6#1)(1997-4#1)(2008-10#1)(2008-5#1)
for both species##6##3##(1993-8#1)(2008-10#3)(2008-8#1)(2010-8#1)
for both spore##2##3##(2008-10#2)
for both substrates##4##3##(1991-9#1)(1994-6#1)(2008-5#1)(2011-2#1)
for both systems##2##3##(2008-10#2)
for both techniques##2##3##(2008-10#2)
for both the patient and the##2##6##(1991-12#1)(2012-12#1)
for both the##33##3##(1991-12#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
for both types of##5##4##(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)
for both viruses##2##3##(2008-10#2)
for both water and##2##4##(2008-3#1)(2012-12#1)
for both##349##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#3)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#4)(1997-4#2)(1997-7#2)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#149)(2008-11#22)(2008-12#7)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#9)(2008-9#10)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#2)(2013-8#2)
for both)##4##2##(1990-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
for bovine serum albumin (BSA)##4##5##(2008-10#3)(2008-7#1)
for bovine serum albumin##5##4##(2008-10#4)(2008-7#1)
for bovine##8##2##(1993-8#1)(1995-11#1)(2008-10#5)(2008-7#1)
for boys and girls##3##4##(2008-11#1)(2009-7#2)
for boys##9##2##(1990-9#1)(2008-11#1)(2009-12#1)(2009-7#3)(2010-1#1)(2010-10#1)(2013-1#1)
for brain##9##2##(1990-3#1)(1995-5#1)(1996-2#2)(1996-3#1)(2008-11#2)(2010-12#1)(2012-2#1)
for breast and##3##3##(1990-6#1)(1990-8#1)(2008-10#1)
for breast cancer patients##2##4##(1993-1#1)(1995-2#1)
for breast cancer##23##3##(1990-12#1)(1990-2#1)(1992-7#1)(1993-1#2)(1993-11#1)(1995-2#1)(1995-9#2)(1996-10#1)(1997-3#1)(2008-7#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-2#2)(2013-8#2)
for breast cancers##2##3##(1990-11#1)(1993-11#1)
for breast reconstruction##3##3##(1992-5#2)(2013-1#1)
for breast##38##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-5#2)(1992-7#1)(1993-1#2)(1993-11#2)(1995-2#1)(1995-9#2)(1996-10#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#2)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#3)(2013-1#2)(2013-8#2)
for breeding for##2##3##(2008-10#2)
for breeding opportunities##2##3##(2008-8#1)(2008-9#1)
for breeding##8##2##(2008-10#4)(2008-8#1)(2008-9#3)
for broad-spectrum##2##2##(2008-10#1)(2009-10#1)
for bromide##3##2##(2008-10#3)
for brown##2##2##(2008-10#1)(2013-1#1)
for building a##2##3##(1994-3#1)(2010-8#1)
for building##9##2##(1994-2#1)(1994-3#1)(1995-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-8#1)
for burn##2##2##(2009-6#1)(2012-3#1)
for burnout##2##2##(2008-10#1)(2010-2#1)
for business##2##2##(1991-12#2)
for by a##2##3##(1990-5#1)(2008-10#1)
for by the##2##3##(1995-6#1)(2008-7#1)
for by##20##2##(1990-10#1)(1990-5#1)(1994-3#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#1)(2013-1#1)
for cadmium and##6##3##(2008-10#6)
for cadmium determination in seawater##2##5##(2008-10#2)
for cadmium determination in##4##4##(2008-10#4)
for cadmium determination##5##3##(2008-10#5)
for cadmium in##2##3##(2008-10#2)
for cadmium##28##2##(2008-10#27)(2008-11#1)
for caffeine##3##2##(2008-10#2)(2008-5#1)
for calcium and##2##3##(2008-10#2)
for calcium##7##2##(1990-2#1)(2008-10#5)(2008-9#1)
for calculating the##10##3##(2008-10#2)(2008-2#2)(2008-3#6)
for calculating##14##2##(1995-9#1)(2008-10#3)(2008-2#2)(2008-3#7)(2013-1#1)
for calculation of the##3##4##(1996-3#1)(2008-10#2)
for calculation of##5##3##(1996-3#1)(2008-10#4)
for calendar##2##2##(1991-2#1)(1995-12#1)
for calf thymus DNA (ctDNA)##2##5##(2008-10#2)
for calf thymus DNA and##2##5##(2008-10#2)
for calf thymus DNA##9##4##(2008-10#9)
for calibration and##2##3##(2008-10#2)
for calibration of##3##3##(1991-5#1)(2008-10#2)
for calibration##14##2##(1991-5#1)(2008-10#12)(2008-9#1)
for calmodulin##3##2##(1993-6#3)
for cancer cell##3##3##(2008-11#2)(2013-1#1)
for cancer control##2##3##(1997-1#2)
for cancer diagnosis##2##3##(2012-12#2)
for cancer gene therapy##4##4##(1994-5#2)(2008-8#1)(2011-2#1)
for cancer immunotherapy##4##3##(2008-11#4)
for cancer of the##3##4##(2007-8#2)(2009-11#1)
for cancer pain##3##3##(1997-5#1)(2008-7#2)
for cancer patients in##2##4##(1990-6#1)(2012-2#1)
for cancer patients##7##3##(1990-6#1)(1992-3#1)(1994-6#1)(1996-2#1)(1997-4#1)(2009-12#1)(2012-2#1)
for cancer prevention and##2##4##(1997-1#1)(2008-7#1)
for cancer prevention##3##3##(1997-1#1)(2008-7#1)(2009-3#1)
for cancer research##3##3##(2008-11#1)(2009-12#1)(2009-4#1)
for cancer therapy##5##3##(1994-5#1)(2008-11#1)(2011-2#2)(2012-2#1)
for cancer##59##2##(1990-6#1)(1990-8#1)(1990-9#1)(1992-3#1)(1994-5#4)(1994-6#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-1#3)(1997-4#1)(1997-5#1)(2007-8#2)(2008-1#1)(2008-11#10)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
for cancers##3##2##(1992-12#1)(1995-9#1)(1997-3#1)
for candidate##2##2##(1995-12#1)(2011-2#1)
for canine##3##2##(2008-10#1)(2012-3#2)
for capacity##2##2##(2010-11#1)(2010-8#1)
for capillary electrophoresis (CE)##2##4##(2008-10#2)
for capillary electrophoresis using##2##4##(2008-10#2)
for capillary electrophoresis##10##3##(2008-10#8)(2008-2#2)
for capillary##12##2##(2008-10#10)(2008-2#2)
for capital##2##2##(1994-3#2)
for capturing##4##2##(1992-3#1)(2008-11#1)(2011-2#1)(2013-8#1)
for carbendazim##2##2##(2008-10#2)
for carbohydrate##2##2##(2008-9#1)(2013-1#1)
for carbon dioxide##2##3##(2008-10#2)
for carbon monoxide##3##3##(1996-12#1)(2008-10#1)(2010-10#1)
for carbon##5##2##(1996-12#1)(2008-10#3)(2010-10#1)
for carbonate##2##2##(2008-10#2)
for carboxin resistance##2##3##(2008-10#2)
for carcinoma of the vulva##2##5##(1992-3#2)
for carcinoma of the##4##4##(1990-9#2)(1992-3#2)
for carcinoma##5##2##(1990-9#2)(1992-3#2)(1994-12#1)
for cardiac##8##2##(1993-12#1)(1997-8#1)(2008-12#2)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
for cardiovascular disease risk factors##2##5##(1991-6#2)
for cardiovascular disease##3##3##(1991-6#2)(2013-8#1)
for cardiovascular diseases##2##3##(2010-6#1)(2012-3#1)
for cardiovascular risk##2##3##(2009-1#1)(2011-2#1)
for cardiovascular##15##2##(1991-6#2)(1993-3#1)(2008-11#1)(2009-1#1)(2009-12#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
for care and##3##3##(2007-8#1)(2008-3#1)(2013-1#1)
for care##12##2##(1992-11#1)(1995-12#1)(2007-8#1)(2008-11#2)(2008-3#2)(2013-1#5)
for caregivers##2##2##(2008-6#1)(2013-1#1)
for carotid endarterectomy##2##3##(2010-3#1)(2010-7#1)
for carotid stenosis##2##3##(2008-11#1)(2011-2#1)
for carotid##7##2##(2008-11#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
for carpogenic germination of##2##4##(2008-10#2)
for carpogenic germination##4##3##(2008-10#4)
for carrier to carrier transfer##2##5##(2008-11#2)
for carrying out##5##3##(1993-3#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-5#1)
for cartilage##2##2##(1991-5#1)(2009-9#1)
for case mix##5##3##(1992-12#1)(1995-2#3)(2010-12#1)
for case##7##2##(1991-12#1)(1992-12#1)(1993-12#1)(1995-2#3)(2010-12#1)
for case-mix##2##2##(1991-2#1)(1994-2#1)
for cases in which##2##4##(2008-3#1)(2011-2#1)
for cases of##2##3##(1991-12#1)(2013-8#1)
for cases with##2##3##(2008-2#1)(2010-3#1)
for cases##9##2##(1991-12#1)(1995-1#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
for catalysis##2##2##(1994-11#1)(2011-2#1)
for catalytic activity##2##3##(1991-7#1)(1992-6#1)
for catalytic##6##2##(1991-7#1)(1992-6#1)(1996-12#1)(2008-10#2)(2008-11#1)
for catechol##5##2##(2008-10#5)
for cathepsin D##2##3##(1990-5#2)
for cathepsin##3##2##(1990-5#2)(2008-7#1)
for cations##2##2##(2008-10#2)
for causes##2##2##(1991-8#1)(1994-2#1)
for causing##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
for caution##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
for cell apoptosis##2##3##(2008-11#1)(2008-8#1)
for cell attachment##2##3##(2009-12#1)(2010-9#1)
for cell culture##9##3##(2008-11#9)
for cell cycle##2##3##(2008-11#1)(2008-9#1)
for cell growth and##2##4##(1995-9#1)(2008-7#1)
for cell growth in a##2##5##(2008-11#1)(2008-7#1)
for cell growth##10##3##(1990-5#1)(1993-11#1)(1995-6#1)(1995-9#1)(2008-11#4)(2008-7#2)
for cell lines##2##3##(2008-11#2)
for cell proliferation##2##3##(2008-11#1)(2012-2#1)
for cell##61##2##(1990-2#1)(1990-5#1)(1993-11#1)(1993-5#1)(1995-11#1)(1995-6#1)(1995-9#1)(2008-10#4)(2008-11#33)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#2)(2009-5#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
for cell-to-cell##2##2##(2008-10#1)(2011-2#1)
for cells grown in##2##4##(1991-11#1)(2008-11#1)
for cells grown##3##3##(1991-11#2)(2008-11#1)
for cells in suspension##2##4##(2008-11#2)
for cells in##5##3##(2008-11#2)(2009-10#1)(2010-1#1)(2013-8#1)
for cells with##3##3##(1990-8#2)(2008-11#1)
for cells##15##2##(1990-8#2)(1991-11#2)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#5)(2009-10#1)(2010-1#1)(2013-8#1)
for cellular##7##2##(1995-12#1)(1996-6#1)(2008-10#2)(2008-11#2)(2009-9#1)
for central##5##2##(1991-3#1)(1993-5#1)(1994-3#1)(1996-2#1)(2008-9#1)
for centuries##2##2##(1991-6#1)(2009-8#1)
for ceramic##2##2##(1991-3#1)(2008-10#1)
for cerebral arteriovenous malformations##2##4##(1996-3#1)(2008-7#1)
for cerebral##7##2##(1993-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#1)(2008-7#2)
for certain classes of##2##4##(2011-2#1)(2013-8#1)
for certain drugs##2##3##(1990-2#1)(2008-11#1)
for certain##13##2##(1990-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
for certified##2##2##(2008-10#2)
for cervical cancer##5##3##(1991-6#1)(1992-2#1)(1993-2#1)(1995-9#1)(2008-4#1)
for cervical intraepithelial neoplasia##2##4##(1991-2#1)(2013-1#1)
for cervical##14##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-2#1)(1995-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
for cesium ion over alkali##2##5##(2008-10#2)
for cesium ion over##4##4##(2008-10#4)
for cesium##9##2##(2008-10#9)
for change in the##2##4##(1994-1#1)(1995-1#1)
for change in##3##3##(1994-1#1)(1995-1#1)(1997-8#1)
for change##14##2##(1991-2#3)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-4#1)(1997-8#1)(2008-12#1)(2008-5#1)(2010-1#1)(2013-8#1)
for changes in##6##3##(1995-11#1)(2008-10#3)(2008-7#1)(2009-7#1)
for changing##4##2##(1994-6#1)(2008-10#2)(2011-2#1)
for characterisation of##2##3##(2008-1#1)(2008-10#1)
for characterising the##2##3##(2008-10#2)
for characterising##5##2##(2008-10#2)(2008-11#1)(2011-2#2)
for characterization of##10##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-12#1)(2010-7#2)(2013-8#1)
for characterizing the##7##3##(1992-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2012-3#1)
for characterizing##13##2##(1992-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)(2012-3#1)
for charge##2##2##(2008-10#1)(2013-1#1)
for checking##2##2##(1995-9#1)(2012-2#1)
for chemical analysis##5##3##(2008-10#3)(2010-7#2)
for chemical##11##2##(1990-8#1)(2008-10#7)(2008-4#1)(2010-7#2)
for chemicals##2##2##(2008-11#1)(2011-3#1)
for chemiluminescence##3##2##(2008-10#3)
for chemoprevention of##4##3##(1995-9#2)(2011-2#1)(2013-1#1)
for chemoprevention##5##2##(1995-9#2)(2011-2#2)(2013-1#1)
for chemotherapy##5##2##(1991-5#1)(1997-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
for chest pain##2##3##(2008-3#1)(2012-2#1)
for chickpea##2##2##(2008-10#2)
for child and adolescent##2##4##(1993-1#1)(2008-11#1)
for child##3##2##(1993-1#1)(2008-11#2)
for childhood immunizations##2##3##(1996-12#2)
for childhood##6##2##(1991-3#1)(1996-12#3)(2008-10#1)(2012-2#1)
for children aged##3##3##(1995-3#1)(2010-6#1)(2012-2#1)
for children and adolescents##3##4##(1991-2#1)(1992-1#1)(2008-11#1)
for children and pregnant women##3##5##(1995-2#2)(2013-8#1)
for children and##9##3##(1991-2#1)(1992-1#1)(1992-3#1)(1995-2#2)(1995-3#1)(2008-11#1)(2009-10#1)(2013-8#1)
for children in##3##3##(1995-5#2)(2013-1#1)
for children with special health care needs##2##7##(1995-12#2)
for children with special##3##4##(1995-12#2)(1997-2#1)
for children with##17##3##(1990-12#1)(1991-2#1)(1995-1#1)(1995-12#2)(1997-2#3)(2008-11#2)(2010-7#1)(2010-9#2)(2011-1#1)(2012-2#2)(2013-1#1)
for children##55##2##(1990-12#1)(1990-8#1)(1991-2#2)(1992-1#1)(1992-3#1)(1994-1#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#3)(1996-12#1)(1997-2#3)(1997-4#1)(1997-8#1)(2008-11#8)(2008-9#3)(2009-10#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2012-2#9)(2013-1#2)(2013-8#2)
for children's##2##2##(1994-3#1)(2010-12#1)
for chiral##2##2##(2008-10#2)
for chitosan##2##2##(2008-10#2)
for chloride determination##4##3##(2008-10#4)
for chloride##7##2##(2008-10#7)
for chloride)##2##2##(2008-10#2)
for chlorine dioxide##2##3##(2008-10#2)
for chloroform and dichloromethane##2##4##(2008-10#2)
for chloroform##3##2##(2008-10#3)
for chlorophyll a##2##3##(2008-10#1)(2008-3#1)
for chlorophyll##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
for chlorpyrifos##2##2##(2008-10#2)
for chlortetracycline##2##2##(2008-10#2)
for choice##2##2##(1997-2#1)(1997-3#1)
for cholera toxin##2##3##(1993-8#1)(2008-11#1)
for cholera##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
for cholesterol##5##2##(1996-11#1)(2008-10#4)
for cholinergic##2##2##(1997-2#1)(2013-8#1)
for choosing the##2##3##(2008-10#1)(2013-1#1)
for choosing##5##2##(2008-10#1)(2008-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
for chromatographic analysis##3##3##(2008-10#3)
for chromatographic determination of##2##4##(2008-10#2)
for chromatographic determination##3##3##(2008-10#3)
for chromatographic separation##4##3##(2008-10#3)(2008-4#1)
for chromatographic##12##2##(2008-10#11)(2008-4#1)
for chromium determination##2##3##(2008-10#2)
for chromium##9##2##(2008-10#9)
for chromium(VI)##3##2##(2008-10#3)
for chromosomal##4##2##(2008-11#1)(2008-7#1)(2012-3#2)
for chromosome##8##2##(1996-12#4)(2008-10#1)(2008-11#2)(2012-3#1)
for chronic Achilles tendinosis##2##4##(2009-10#1)(2010-3#1)
for chronic disease##3##3##(1993-3#2)(1997-8#1)
for chronic hemodialysis##2##3##(1991-6#1)(2008-1#1)
for chronic hepatitis##2##3##(2009-5#1)(2009-8#1)
for chronic lymphocytic leukemia##2##4##(2008-7#1)(2009-6#1)
for chronic obstructive pulmonary disease##2##5##(2011-2#2)
for chronic total occlusion##2##4##(2008-11#2)
for chronic total##3##3##(2008-11#3)
for chronic##36##2##(1991-12#1)(1991-6#1)(1992-3#1)(1993-3#2)(1994-5#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#4)(2012-3#1)(2013-1#3)
for ciprofloxacin##2##2##(2008-10#2)
for circulating##5##2##(2008-10#4)(2012-3#1)
for cited##2##2##(1993-3#1)(2008-10#1)
for citrate##2##2##(1997-8#1)(2011-2#1)
for class II MHC##2##4##(1993-3#2)
for class II##3##3##(1993-3#2)(2013-1#1)
for class##4##2##(1993-3#2)(2008-10#1)(2013-1#1)
for classical##2##2##(1994-5#1)(2008-10#1)
for classification##6##2##(2008-10#3)(2008-8#1)(2010-8#1)(2012-2#1)
for classifying##3##2##(1993-12#1)(2008-10#1)(2012-12#1)
for clean##2##2##(2008-10#1)(2011-2#1)
for cleaning##4##2##(2008-10#2)(2008-9#2)
for cleavage of##2##3##(2008-10#1)(2008-6#1)
for cleavage##3##2##(1990-5#1)(2008-10#1)(2008-6#1)
for clenbuterol##4##2##(2008-10#4)
for client care##2##3##(1992-3#1)(2008-11#1)
for client##4##2##(1992-3#1)(1996-12#1)(2008-11#1)(2013-8#1)
for clinic##2##2##(1992-8#1)(1995-12#1)
for clinical application of##2##4##(2008-8#1)(2010-11#1)
for clinical application##4##3##(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
for clinical characteristics##2##3##(2008-12#1)(2012-3#1)
for clinical education##2##3##(2008-12#1)(2013-8#1)
for clinical evaluation##3##3##(1992-12#1)(1995-5#1)(1997-3#1)
for clinical investigation##2##3##(2008-12#1)(2013-8#1)
for clinical management##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
for clinical nursing##2##3##(1990-2#1)(2008-12#1)
for clinical practice##6##3##(1993-2#1)(1994-3#1)(2008-11#1)(2008-7#1)(2010-10#1)(2012-2#1)
for clinical research##4##3##(1994-12#1)(2010-8#1)(2010-9#1)(2013-1#1)
for clinical testing##2##3##(2008-4#1)(2008-5#1)
for clinical trials##5##3##(1996-9#1)(2006-6#1)(2008-11#2)(2008-9#1)
for clinical use in the##2##5##(2007-11#1)(2009-12#1)
for clinical use in##6##4##(1991-9#1)(1994-12#1)(2007-11#1)(2009-12#1)(2011-2#1)(2011-3#1)
for clinical use##11##3##(1991-9#1)(1993-2#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-12#1)(2011-2#2)(2011-3#1)
for clinical##82##2##(1990-2#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#2)(1994-12#5)(1994-3#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-9#1)(1997-3#3)(2006-6#1)(2007-11#2)(2008-10#8)(2008-11#6)(2008-12#8)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
for clinically##2##2##(1994-2#1)(2008-11#1)
for clinicians to##4##3##(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
for clinicians##11##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
for cloacal##2##2##(1996-12#1)(2008-10#1)
for clomiphene-resistant polycystic##2##3##(2007-7#2)
for clones##3##2##(1993-12#1)(1993-6#1)(2008-4#1)
for cloning##2##2##(1996-2#1)(2008-4#1)
for closure##2##2##(2008-11#1)(2011-2#1)
for cloud##2##2##(2008-10#1)(2008-3#1)
for cluster##2##2##(2008-10#2)
for coated##2##2##(1997-1#1)(2008-10#1)
for cobalt determination in##2##4##(2008-10#2)
for cobalt##7##2##(2008-10#7)
for cocaine dependent##2##3##(2009-7#2)
for cocaine##8##2##(1991-1#3)(1993-6#1)(2009-7#4)
for cochlear implantation##5##3##(2008-9#5)
for cochlear##6##2##(2008-9#6)
for cognitive##3##2##(2008-11#1)(2008-12#1)(2010-7#1)
for collaboration and##2##3##(1993-12#1)(2008-11#1)
for collaboration##3##2##(1993-12#1)(1997-3#1)(2008-11#1)
for collaborative work##2##3##(1993-12#1)(2008-11#1)
for collagen##2##2##(2008-7#1)(2009-7#1)
for collecting and##2##3##(1992-1#1)(2008-9#1)
for collecting##8##2##(1992-1#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
for collection of##2##3##(2008-3#1)(2008-9#1)
for collection##6##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
for colonization##3##2##(2008-10#1)(2009-8#1)(2011-1#1)
for colony density##2##3##(2008-10#2)
for colony##6##2##(2008-10#3)(2008-2#1)(2008-9#1)(2012-5#1)
for color development##2##3##(1991-2#1)(2008-10#1)
for color##5##2##(1991-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
for colorectal cancer##8##3##(1990-6#1)(1991-6#2)(1993-3#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
for colorectal##11##2##(1990-6#1)(1991-6#2)(1992-5#1)(1993-3#1)(2008-10#1)(2009-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
for colorimetric##3##2##(2008-10#3)
for colour##2##2##(1992-5#1)(2008-10#1)
for colouring##2##2##(2008-5#2)
for colposcopy##3##2##(1992-3#1)(2008-11#2)
for column preconcentration##2##3##(2008-10#2)
for column##4##2##(2008-10#4)
for combination vaccines##3##3##(1995-5#3)
for combination##4##2##(1995-5#3)(2010-10#1)
for combined##7##2##(1995-5#2)(1997-3#1)(2008-9#1)(2012-3#1)(2013-1#2)
for combining##2##2##(2008-9#1)(2010-9#1)
for combustion##2##2##(1996-12#1)(2008-3#1)
for commercial samples were##2##4##(2008-10#1)(2008-5#1)
for commercial samples##3##3##(2008-10#2)(2008-5#1)
for commercial use##3##3##(2008-10#3)
for commercial##12##2##(1997-7#1)(2008-10#9)(2008-3#1)(2008-5#1)
for common##9##2##(1991-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
for communicating quality##2##3##(1997-3#2)
for communicating##5##2##(1997-3#3)(2010-4#1)(2013-1#1)
for communication##6##2##(1997-1#1)(2009-6#1)(2009-8#1)(2010-12#3)
for community mental health##2##4##(1996-1#1)(1997-3#1)
for community nurses##2##3##(1996-2#2)
for community##9##2##(1996-1#1)(1996-2#2)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-1#1)
for comparative studies##3##3##(2006-6#1)(2008-10#2)
for comparative##8##2##(2006-6#1)(2008-10#4)(2009-10#1)(2012-2#1)(2012-3#1)
for comparing the##4##3##(2008-10#1)(2008-5#2)(2012-3#1)
for comparing##11##2##(1992-9#1)(1994-6#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-9#1)(2012-12#1)(2012-3#1)
for comparison of##4##3##(2008-10#4)
for comparison##31##2##(1991-3#2)(1991-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-10#16)(2008-3#1)(2008-5#2)(2010-8#3)(2011-2#1)
for comparisons##2##2##(2008-10#1)(2010-11#1)
for compatibility type##2##3##(2008-10#2)
for complementary##3##2##(2008-10#1)(2010-6#2)
for complete##10##2##(1991-1#1)(1995-5#1)(1996-2#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-7#1)
for complex samples##2##3##(2008-10#2)
for complex##13##2##(1995-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-3#1)
for complexation of##2##3##(2008-10#2)
for complexation##3##2##(2008-10#3)
for complexes##2##2##(2008-10#2)
for complicated##2##2##(1997-3#1)(2012-12#1)
for complications##4##2##(1990-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
for compound-specific stable carbon isotope analysis##2##6##(2008-10#2)
for compounds containing##2##3##(2008-10#2)
for compounds##9##2##(1991-5#1)(2008-10#5)(2008-11#1)(2010-10#1)(2012-2#1)
for comprehensive analysis of##3##4##(1992-1#1)(1995-8#1)(1996-8#1)
for comprehensive##6##2##(1992-1#1)(1994-2#1)(1995-8#1)(1996-8#1)(2011-7#1)(2013-1#1)
for computational##2##2##(2008-6#1)(2009-12#1)
for computing the##10##3##(1990-2#1)(1992-9#1)(2008-3#5)(2008-6#1)(2009-3#1)(2012-3#1)
for computing##11##2##(1990-2#1)(1992-9#1)(2008-3#5)(2008-6#1)(2009-3#1)(2012-3#1)(2013-1#1)
for concentrated##2##2##(2008-10#2)
for concentration levels##2##3##(2008-10#2)
for concentration##8##2##(1997-2#1)(2008-10#4)(2008-11#1)(2010-11#1)(2010-4#1)
for concentrations of##3##3##(2008-10#2)(2008-11#1)
for concern##4##2##(1992-3#1)(1997-5#1)(2008-10#1)(2013-8#1)
for conditional##2##2##(2008-11#2)
for conditioning and germination##2##4##(2008-10#2)
for conditioning##4##2##(2008-10#2)(2008-5#2)
for conducting##9##2##(1992-1#1)(1995-5#1)(2008-10#2)(2009-4#2)(2011-2#1)(2012-2#2)
for conferring##2##2##(1996-2#1)(2008-10#1)
for confirmatory##2##2##(2009-3#1)(2012-2#1)
for confirming filariasis elimination##2##4##(2008-1#2)
for confirming##5##2##(2008-1#4)(2008-8#1)
for confounders##2##2##(2010-6#1)(2012-5#1)
for confounding factors##2##3##(2010-1#1)(2012-12#1)
for confounding##3##2##(1992-9#1)(2010-1#1)(2012-12#1)
for congenital heart disease##2##4##(2010-9#1)(2012-3#1)
for congenital##10##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#3)(2010-9#1)(2012-12#1)(2012-3#2)
for conidia##3##2##(2008-10#3)
for conidial germination##2##3##(2008-10#2)
for conservation##4##2##(2008-6#1)(2008-8#3)
for considerable##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
for consideration##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
for considering##2##2##(1997-6#1)(2010-10#1)
for consistent##3##2##(2008-10#2)(2008-9#1)
for constitutive##2##2##(2008-11#2)
for constructing a##3##3##(2008-4#1)(2010-8#1)(2012-3#1)
for constructing##13##2##(1993-2#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-11#1)(2010-8#1)(2012-3#1)
for construction of the##2##4##(2008-10#1)(2012-3#1)
for construction of##8##3##(1993-2#1)(1995-6#1)(2008-10#3)(2008-8#1)(2010-4#1)(2012-3#1)
for consultation##2##2##(2008-10#1)(2011-2#1)
for consumer##3##2##(1993-1#1)(2008-8#2)
for consumers##3##2##(1997-3#1)(2011-2#1)(2013-1#1)
for contact##2##2##(2008-10#1)(2009-7#1)
for contamination##5##2##(2008-10#2)(2008-11#2)(2012-2#1)
for contemporary##5##2##(2008-12#2)(2008-7#1)(2010-1#2)
for content##2##2##(2008-10#1)(2011-2#1)
for continued##6##2##(1995-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#1)
for continuing education##2##3##(1994-12#1)(2013-1#1)
for continuing##4##2##(1991-1#1)(1994-12#1)(2008-10#1)(2013-1#1)
for continuous flow##2##3##(2008-10#2)
for continuous long-term##2##3##(2008-11#2)
for continuous measurements##2##3##(2008-10#2)
for continuous monitoring of##2##4##(2008-10#2)
for continuous operation##2##3##(2008-10#1)(2013-1#1)
for continuous##23##2##(1991-11#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2009-10#1)(2011-2#3)(2013-1#2)(2013-8#1)
for contraceptives##2##2##(1996-6#1)(2011-3#1)
for control and##2##3##(1995-11#1)(2008-5#1)
for control of the##2##4##(2008-8#1)(2008-9#1)
for control of##14##3##(1994-11#1)(2008-10#7)(2008-8#1)(2008-9#1)(2011-10#1)(2012-12#1)(2012-2#2)
for control##32##2##(1990-6#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-10#1)(2012-12#1)(2012-2#2)(2013-1#1)
for controlling expenditures##2##3##(1992-2#1)(1994-3#1)
for controlling the##7##3##(1991-12#1)(2008-10#5)(2008-5#1)
for controlling##23##2##(1991-12#1)(1991-2#1)(1992-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-12#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#2)
for controls##3##2##(2008-7#1)(2013-1#2)
for conventional##3##2##(1992-8#1)(2008-11#1)(2009-10#1)
for converging research using##2##4##(2011-2#2)
for conversion of##3##3##(2008-10#2)(2008-7#1)
for conversion##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
for converting##2##2##(2008-8#1)(2010-10#1)
for cooperative##2##2##(1990-8#1)(1995-2#1)
for coordinating##2##2##(1997-2#1)(2008-10#1)
for coping with##2##3##(1991-2#1)(1996-9#1)
for copper and mercury ions##2##5##(2008-10#2)
for copper and zinc##3##4##(1992-3#1)(2008-10#2)
for copper and##12##3##(1992-3#1)(2008-10#11)
for copper concentrations##2##3##(2008-10#2)
for copper determination by##2##4##(2008-10#2)
for copper determination in##5##4##(2008-10#5)
for copper determination##10##3##(2008-10#10)
for copper in##2##3##(2008-10#2)
for copper resistance##2##3##(2008-10#2)
for copper##44##2##(1992-3#1)(2008-10#43)
for copper(II) and cadmium(II) was##2##5##(2008-10#2)
for copper(II)##8##2##(2008-10#7)(2008-12#1)
for coronary angiography##2##3##(2011-2#2)
for coronary artery bypass grafting##2##5##(1993-12#1)(2011-2#1)
for coronary artery disease##2##4##(1993-2#1)(1997-8#1)
for coronary artery##5##3##(1993-12#1)(1993-2#1)(1997-8#1)(2011-2#1)(2013-8#1)
for coronary disease##2##3##(1996-11#1)(2007-8#1)
for coronary heart disease##4##4##(2008-12#2)(2008-6#1)(2010-4#1)
for coronary procedures##2##3##(2011-2#2)
for coronary##17##2##(1993-12#1)(1993-2#1)(1996-11#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-10#1)(2010-4#1)(2011-2#5)(2013-8#1)
for correct##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
for correcting the wavelength misalignment in measured##2##7##(2008-3#2)
for correcting##3##2##(2008-3#3)
for correction##2##2##(2012-2#2)
for correlated##2##2##(1995-9#1)(2013-8#1)
for corresponding##2##2##(1991-5#1)(2008-11#1)
for cortical bone##2##3##(1996-3#1)(2009-7#1)
for cortical thickness of 4##2##5##(2013-1#2)
for cortical thickness##3##3##(2013-1#3)
for cortical##7##2##(1996-2#1)(1996-3#1)(1997-2#1)(2009-7#1)(2013-1#3)
for cosmetic##6##2##(2008-5#5)(2013-1#1)
for cosmetics##3##2##(2008-5#3)
for cost##3##2##(1994-2#1)(1995-2#1)(2012-3#1)
for costs##2##2##(1995-12#1)(1995-3#1)
for counterbalance order II (p &lt##2##6##(2013-8#2)
for counterbalance order##4##3##(2013-8#4)
for couple##2##2##(2008-10#1)(2012-2#1)
for coupling to the##2##4##(2008-10#1)(2008-3#1)
for coupling##6##2##(1992-3#1)(2008-10#3)(2008-3#1)(2008-4#1)
for covalent immobilization of a##2##5##(2008-10#2)
for coverage of##2##3##(2008-9#1)(2010-11#1)
for coverage##3##2##(1996-3#1)(2008-9#1)(2010-11#1)
for cows in##2##3##(2008-12#1)(2012-3#1)
for cranial##2##2##(2011-2#2)
for creating a##4##3##(2008-10#2)(2008-9#1)(2009-7#1)
for creating##9##2##(1993-6#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
for creatinine determination##2##3##(2008-10#2)
for creatinine##5##2##(1991-12#1)(2008-10#4)
for creative##3##2##(1995-1#2)(2008-11#1)
for criteria##2##2##(2008-11#1)(2012-3#1)
for critical##7##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
for cross##2##2##(2008-10#2)
for crown rust resistance##2##4##(2008-10#2)
for crown rust##3##3##(2008-10#3)
for crystal##2##2##(1994-5#1)(2013-1#1)
for cubital tunnel syndrome##4##4##(2008-12#1)(2008-9#3)
for cultivars##2##2##(2008-10#2)
for cultivation and##2##3##(2008-11#2)
for cultivation of##3##3##(2008-10#1)(2008-11#2)
for cultivation##5##2##(2008-10#1)(2008-11#4)
for culture##2##2##(2008-11#2)
for cultures##2##2##(2008-7#2)
for culturing##3##2##(2008-9#2)(2010-6#1)
for current##7##2##(2008-10#5)(2010-5#1)(2012-2#1)
for currently##3##2##(1997-1#1)(2008-10#1)(2013-1#1)
for cutaneous##3##2##(2008-5#1)(2008-9#1)(2012-2#1)
for cyanide##5##2##(1990-12#1)(2008-10#4)
for cyst and egg##3##4##(2008-10#3)
for cyst##6##2##(2008-10#6)
for cysteine and##2##3##(2008-10#2)
for cysteine##5##2##(2008-10#4)(2012-2#1)
for cystic fibrosis##2##3##(1991-2#1)(2011-3#1)
for cystic##3##2##(1991-2#1)(2010-11#1)(2011-3#1)
for cystine##2##2##(2008-10#1)(2008-11#1)
for cystocoele##2##2##(2011-2#2)
for cytidine##2##2##(2008-10#2)
for cytochrome c##2##3##(1993-6#1)(2008-10#1)
for cytochrome oxidase##2##3##(1993-2#1)(2008-6#1)
for cytochrome##6##2##(1993-2#1)(1993-6#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-6#1)
for cytogenetic##3##2##(1997-4#1)(2008-11#1)(2010-1#1)
for cytokeratin##6##2##(1991-12#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-7#1)
for cytokeratins##2##2##(1994-8#1)(2010-12#1)
for cytokines##3##2##(2008-9#1)(2011-2#2)
for cytokinesis##2##2##(2009-10#1)(2009-8#1)
for d-lactic acid analysis##3##4##(2008-10#3)
for daily##2##2##(2008-3#1)(2012-2#1)
for damping-off##2##2##(2008-10#2)
for data analysis and##2##4##(1991-12#1)(2008-10#1)
for data analysis##9##3##(1991-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-11#1)(2010-12#1)
for data collection##6##3##(1994-12#3)(1995-2#1)(2010-11#1)(2013-8#1)
for data obtained##2##3##(2008-2#1)(2008-3#1)
for data with##2##3##(1994-2#1)(2013-1#1)
for data##28##2##(1991-12#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-2#1)(1995-9#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#1)(2010-11#2)(2010-12#1)(2013-1#1)(2013-8#1)
for data-based##4##2##(1997-1#4)
for day surgery##3##3##(1995-1#2)(1995-2#1)
for days##5##2##(1990-12#2)(2008-10#1)(2008-11#1)(2008-5#1)
for deaf##2##2##(2011-2#2)
for dealing with##3##3##(2008-3#1)(2010-11#1)(2010-5#1)
for decades##15##2##(2008-10#6)(2008-12#1)(2008-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for decentralized##2##2##(1994-3#1)(2008-10#1)
for deciding##4##2##(1994-2#1)(2008-4#1)(2008-7#1)(2012-2#1)
for decision makers##2##3##(2008-10#1)(2012-12#1)
for decision making in crop loss assessment and pest management##2##10##(2008-10#2)
for decision making##4##3##(1994-3#1)(2008-10#3)
for decision##6##2##(1994-3#1)(2008-10#4)(2012-12#1)
for decision-making##2##2##(2010-2#1)(2011-7#1)
for decreased##2##2##(2008-11#1)(2011-2#1)
for decreasing of##2##3##(2008-12#1)(2012-3#1)
for decreasing##6##2##(2008-10#4)(2008-12#1)(2012-3#1)
for defects##2##2##(2008-10#1)(2011-2#1)
for defense against##2##3##(2008-10#2)
for defense##3##2##(2008-10#2)(2009-8#1)
for defiance##2##2##(2008-12#2)
for defining##10##2##(1992-3#1)(1994-2#1)(1995-6#1)(1997-7#1)(2008-10#3)(2010-11#1)(2011-1#1)(2011-2#1)
for definition##3##2##(1995-2#1)(2008-3#1)(2010-7#1)
for definitive diagnosis##2##3##(2008-5#1)(2008-7#1)
for definitive##5##2##(1990-12#1)(1991-6#1)(2008-5#1)(2008-7#1)(2011-2#1)
for degenerative disc disease##4##4##(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
for degradation of##3##3##(1994-5#1)(2008-11#2)
for degradation##4##2##(1994-5#1)(2008-11#2)(2013-1#1)
for degree of sensitivity to##2##5##(2008-10#2)
for degree of##3##3##(2008-10#2)(2008-9#1)
for delayed dispersal##2##3##(2008-8#2)
for delayed##4##2##(1996-12#1)(2008-8#2)(2012-3#1)
for delivering##7##2##(1992-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-5#1)(2008-6#1)(2013-8#1)
for delivery and##3##3##(1996-11#2)(2013-1#1)
for delivery of##5##3##(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-11#1)
for delivery##8##2##(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(2008-11#1)(2013-1#1)
for dementia##5##2##(2008-6#2)(2008-7#3)
for demographic##5##2##(2010-12#1)(2012-3#1)(2013-1#3)
for demonstrating##4##2##(1995-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
for denial##2##2##(2008-4#2)
for density##2##2##(2008-10#1)(2008-9#1)
for dental hygienists##2##3##(1993-1#2)
for dental##7##2##(1993-1#3)(1994-6#1)(2008-1#1)(2010-10#1)(2013-1#1)
for deployment##2##2##(2008-10#2)
for deposition##2##2##(2008-10#1)(2008-11#1)
for depressed##3##2##(1991-2#1)(1993-2#1)(2008-4#1)
for depression##8##2##(1991-10#1)(2010-10#1)(2011-10#1)(2011-3#1)(2012-2#2)(2013-8#2)
for depth##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
for derivatization of##3##3##(2008-10#3)
for dermal##2##2##(2008-5#2)
for describing##6##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)
for descriptive##2##2##(2008-10#1)(2011-2#1)
for design and##2##3##(1997-3#1)(2008-10#1)
for design of##2##3##(1995-12#1)(2008-2#1)
for design##6##2##(1992-9#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
for designing and##2##3##(1994-3#1)(2008-3#1)
for designing##19##2##(1993-11#1)(1993-8#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-8#2)
for desorption of the##2##4##(2008-10#2)
for desorption of##3##3##(2008-10#3)
for desorption##5##2##(2008-10#5)
for detailed analysis of##2##4##(1993-2#1)(2008-4#1)
for detailed##5##2##(1993-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#1)
for detecting DNA##2##3##(2008-10#2)
for detecting HPV DNA##2##4##(1994-1#2)
for detecting HPV##3##3##(1992-3#1)(1994-1#2)
for detecting a##2##3##(2008-10#2)
for detecting and##4##3##(2008-10#1)(2008-9#1)(2010-8#1)(2013-1#1)
for detecting explosives##2##3##(2008-10#2)
for detecting small##2##3##(2008-10#1)(2010-12#1)
for detecting the##3##3##(1995-12#1)(2008-10#2)
for detecting##68##2##(1990-12#1)(1992-3#1)(1994-1#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-8#1)(2008-1#1)(2008-10#36)(2008-12#1)(2008-3#2)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
for detection and characterization of##2##5##(2008-10#1)(2008-4#1)
for detection and quantification of##5##5##(2008-10#4)(2010-7#1)
for detection and quantification##6##4##(2008-10#5)(2010-7#1)
for detection and quantitation of##2##5##(2008-4#1)(2013-8#1)
for detection and##13##3##(2008-10#8)(2008-4#2)(2009-6#1)(2010-7#1)(2013-8#1)
for detection of paraoxon##2##4##(2008-10#2)
for detection of the##4##4##(2008-3#1)(2010-8#2)(2011-2#1)
for detection of##68##3##(1990-12#1)(1991-1#1)(1991-2#1)(1992-5#1)(1993-3#1)(1995-2#1)(1996-12#2)(2008-1#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#2)(2013-8#1)
for detection##92##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-5#1)(1993-3#1)(1995-2#1)(1996-12#2)(1997-8#1)(2008-1#1)(2008-10#53)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#2)(2013-8#2)
for determination by##2##3##(2008-10#2)
for determination of Ag(I)##2##4##(2008-10#2)
for determination of COD##2##4##(2008-10#2)
for determination of GSH##2##4##(2008-10#2)
for determination of acid##3##4##(2008-10#3)
for determination of aluminium##2##4##(2008-10#2)
for determination of ascorbic acid##4##5##(2008-10#4)
for determination of both##2##4##(2008-10#2)
for determination of cobalt##2##4##(2008-10#2)
for determination of copper and##2##5##(2008-10#2)
for determination of copper in##2##5##(2008-10#2)
for determination of copper##7##4##(2008-10#7)
for determination of copper(II)##2##4##(2008-10#2)
for determination of elemental##2##4##(2008-10#2)
for determination of glucose in##2##5##(2008-10#2)
for determination of glucose##4##4##(2008-10#4)
for determination of iodate##2##4##(2008-10#2)
for determination of iron##2##4##(2008-10#2)
for determination of lead##2##4##(2008-10#2)
for determination of low##2##4##(2008-10#2)
for determination of magnesium##2##4##(2008-10#2)
for determination of metoclopramide##2##4##(2008-10#2)
for determination of nickel in##2##5##(2008-10#2)
for determination of nickel##3##4##(2008-10#3)
for determination of nitrite##2##4##(2008-10#2)
for determination of sulfonamides in##2##5##(2008-10#2)
for determination of the##9##4##(2008-10#6)(2008-3#1)(2008-8#1)(2008-9#1)
for determination of tin in##2##5##(2008-10#2)
for determination of total##3##4##(2008-10#3)
for determination of trace amounts of##3##6##(2008-10#3)
for determination of trace elements##2##5##(2008-10#2)
for determination of trace##9##4##(2008-10#9)
for determination of ultra-trace##2##4##(2008-10#2)
for determination of##220##3##(1993-2#1)(2008-10#210)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#2)
for determination the optimum therapeutic parameters##2##6##(2010-8#2)
for determination##232##2##(1993-2#1)(2008-10#220)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#4)
for determinations##4##2##(2008-10#4)
for determining andrographolide##2##3##(2008-10#2)
for determining caffeine##2##3##(2008-10#2)
for determining cell##3##3##(1993-6#1)(2008-11#2)
for determining iron(III)##2##3##(2008-10#2)
for determining reducing sugars##2##4##(2008-10#2)
for determining the##28##3##(1990-2#1)(1994-12#1)(1995-12#1)(1996-5#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
for determining##98##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#2)(1995-12#1)(1996-5#1)(1997-2#1)(2008-10#59)(2008-11#5)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-8#1)
for developing a##4##3##(1995-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
for developing an##3##3##(1995-1#1)(1997-1#1)(2008-10#1)
for developing breast cancer##3##4##(1993-1#1)(2012-3#2)
for developing##62##2##(1991-2#1)(1992-2#2)(1993-1#1)(1993-3#1)(1995-1#2)(1995-5#1)(1996-3#1)(1997-1#2)(1997-3#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#7)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#1)(2013-8#1)
for development and##2##3##(2008-10#1)(2010-5#1)
for development of##23##3##(1993-3#1)(1994-12#1)(1995-5#1)(1996-2#1)(1997-3#2)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#2)(2011-2#3)(2013-1#1)
for development##31##2##(1993-3#1)(1994-12#1)(1995-5#1)(1996-2#1)(1997-3#2)(2008-10#7)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)
for developmental##6##2##(1992-12#2)(2010-1#1)(2010-4#1)(2011-2#1)(2013-7#1)
for device##3##2##(2008-11#1)(2012-12#2)
for devices##2##2##(2008-7#1)(2012-12#1)
for diabetes mellitus##2##3##(1993-2#1)(2010-11#1)
for diabetes##5##2##(1993-2#1)(2008-1#1)(2008-5#1)(2010-11#2)
for diabetic##5##2##(2008-1#1)(2008-10#3)(2010-10#1)
for diagnosing##11##2##(1991-6#1)(1993-2#1)(2008-10#2)(2010-1#1)(2011-2#4)(2012-2#2)
for diagnosis and management##2##4##(1997-3#1)(2011-2#1)
for diagnosis and therapy##2##4##(1990-9#1)(2011-2#1)
for diagnosis and treatment of##3##5##(1990-9#1)(2010-8#1)(2011-2#1)
for diagnosis and treatment##6##4##(1990-3#1)(1990-9#1)(2009-5#1)(2010-8#1)(2011-2#2)
for diagnosis and##14##3##(1990-3#1)(1990-9#2)(1991-6#1)(1995-1#1)(1997-3#1)(2008-10#1)(2009-5#1)(2010-8#1)(2011-2#4)(2012-2#1)
for diagnosis are##2##3##(1994-3#1)(1997-4#1)
for diagnosis of carpal tunnel syndrome##2##6##(2010-8#2)
for diagnosis of the##2##4##(2008-9#1)(2011-2#1)
for diagnosis of##18##3##(1995-1#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-8#2)(2011-2#4)(2012-12#1)(2013-8#1)
for diagnosis##43##2##(1990-3#1)(1990-9#2)(1991-3#1)(1991-6#1)(1992-12#1)(1994-3#1)(1995-1#2)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
for diagnostic and therapeutic##2##4##(2012-12#1)(2012-2#1)
for diagnostic and##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
for diagnostic##11##2##(1993-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
for diazepam and prazepam respectively##2##5##(2008-10#2)
for diazepam and##3##3##(2008-10#3)
for diazinon##2##2##(2008-10#2)
for dichlorvos##4##2##(2008-10#4)
for diclofenac##5##2##(2008-10#3)(2008-12#1)(2011-2#1)
for dielectric##3##2##(2007-12#1)(2008-3#2)
for dietary changes##3##3##(1990-6#3)
for dietary##4##2##(1990-6#3)(2010-6#1)
for differences in##10##3##(1991-3#1)(1994-1#2)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2012-2#1)
for differences##12##2##(1991-3#1)(1994-1#2)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#2)(2012-2#1)
for different applications##3##3##(2008-4#2)(2013-8#1)
for different concentration##2##3##(2008-10#2)
for different individuals##2##3##(2008-11#1)(2008-9#1)
for different people##2##3##(1994-12#1)(2010-2#1)
for different periods##5##3##(2008-10#5)
for different reasons##2##3##(1994-5#1)(2011-2#1)
for different types of##2##4##(2008-10#1)(2010-10#1)
for different types##3##3##(2008-10#1)(2010-10#1)(2010-7#1)
for different##85##2##(1990-2#1)(1990-8#2)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-12#1)(2008-10#38)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#5)(2012-4#1)(2013-1#2)(2013-8#4)
for differential diagnosis##5##3##(1993-2#1)(1994-12#1)(2008-5#1)(2012-3#1)(2013-8#1)
for differential pulse and square wave voltammetric techniques##2##8##(2008-10#2)
for differential##14##2##(1991-11#1)(1993-2#1)(1994-12#1)(1996-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-8#1)
for differentiating##5##2##(2008-10#5)
for differentiation between##2##3##(1995-2#1)(2008-10#1)
for differentiation of##4##3##(2008-10#3)(2008-5#1)
for differentiation##8##2##(1995-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-6#1)
for difficult##2##2##(2008-10#1)(2011-2#1)
for digestion##2##2##(2008-10#1)(2008-4#1)
for digital revascularization##2##3##(2008-9#2)
for digital##3##2##(2007-12#1)(2008-9#2)
for diospyrin determination in nanomolar concentrations##2##6##(2008-10#2)
for dioxin##3##2##(2008-10#3)
for dioxins and PCBs##2##4##(2008-10#2)
for dioxins and dioxin-like PCBs##2##5##(2008-10#2)
for dioxins and##4##3##(2008-10#4)
for dioxins##5##2##(2008-10#5)
for dioxygen##2##2##(1991-3#1)(2008-10#1)
for direct and indirect##2##4##(2008-4#1)(2008-9#1)
for direct and##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
for direct detection##2##3##(2008-10#2)
for direct determination of the##2##5##(2008-10#2)
for direct determination of##10##4##(2008-10#10)
for direct determination##11##3##(2008-10#11)
for direct measurement of##2##4##(2008-10#2)
for direct measurement##3##3##(2008-10#3)
for direct measurements##2##3##(2008-10#2)
for direct solid sampling##2##4##(2008-10#2)
for direct##45##2##(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#29)(2008-4#6)(2008-7#1)(2008-9#1)(2009-10#1)
for directing the##2##3##(1993-3#1)(2008-10#1)
for directing##3##2##(1993-3#1)(2008-10#1)(2009-4#1)
for direction of##2##3##(1994-8#2)
for direction##4##2##(1990-12#1)(1993-1#1)(1994-8#2)
for directly observed therapy##2##4##(1996-3#2)
for directly##3##2##(1996-3#2)(1997-7#1)
for disability##2##2##(1993-6#1)(1995-12#1)
for disabled##2##2##(1992-2#1)(2008-8#1)
for discharge##2##2##(2011-2#1)(2012-2#1)
for discovering##4##2##(1994-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
for discovery of##2##3##(2008-8#1)(2012-3#1)
for discrete##2##2##(2008-8#1)(2008-9#1)
for discriminating between alternant versus nonalternant polycyclic aromatic hydrocarbons##3##9##(2008-10#3)
for discriminating##5##2##(2008-10#3)(2009-6#1)(2011-2#1)
for discrimination between closely similar DNA sequences in situ##2##9##(2008-4#1)(2008-9#1)
for discrimination between##5##3##(1996-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
for discrimination##8##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)
for discussion##7##2##(1993-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-3#1)(2013-8#1)
for discussions##2##2##(2008-10#1)(2008-11#1)
for disease control##7##3##(1990-12#1)(2008-10#6)
for disease development##8##3##(2008-10#8)
for disease incidence##3##3##(2008-10#3)
for disease management##4##3##(2008-10#4)
for disease resistance##2##3##(2008-10#1)(2009-10#1)
for disease severity##3##3##(2008-10#3)
for disease suppression##4##3##(2008-10#4)
for disease##51##2##(1990-12#1)(1997-3#1)(2008-10#42)(2008-11#1)(2009-10#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
for diseases##3##2##(1991-2#1)(1997-3#1)(2012-2#1)
for dispersal##3##2##(2008-9#1)(2013-1#2)
for display##4##2##(2008-3#3)(2008-9#1)
for dissecting##2##2##(2009-12#1)(2011-2#1)
for dissolution of##2##3##(2008-10#2)
for dissolution##4##2##(2008-10#3)(2009-7#1)
for distal##3##2##(1997-3#1)(2008-10#1)(2008-9#1)
for distance##2##2##(2008-3#1)(2009-7#1)
for distinct##4##2##(1994-11#1)(2008-1#1)(2008-10#1)(2008-9#1)
for distinguishing between##2##3##(2008-4#1)(2008-9#1)
for distinguishing##9##2##(1996-6#1)(2008-10#3)(2008-4#1)(2008-9#2)(2010-5#1)(2012-12#1)
for distributed##3##2##(2008-11#1)(2010-8#2)
for disulphide##2##2##(1993-2#1)(1993-9#1)
for diuron and atrazine##2##4##(2008-10#2)
for diverse##5##2##(2008-12#1)(2008-9#1)(2009-6#1)(2010-1#1)(2013-1#1)
for diversity##2##2##(1996-1#1)(2008-10#1)
for diving##2##2##(1991-6#1)(1997-1#1)
for doctors##3##2##(1992-5#1)(1993-3#1)(2013-8#1)
for doing##2##2##(2008-10#1)(2008-11#1)
for dominant##3##2##(2010-4#1)(2012-3#2)
for dopamine and##2##3##(2008-10#2)
for dopamine##5##2##(2008-10#5)
for dormancy release in apricot##2##5##(2012-8#2)
for dose##3##2##(1992-9#1)(2009-2#1)(2011-2#1)
for double-focusing sector field ICP-MS##2##5##(2008-10#2)
for drug and##2##3##(1991-1#1)(2009-8#1)
for drug delivery##2##3##(2008-10#1)(2008-11#1)
for drug discovery and##2##4##(2008-4#1)(2011-3#1)
for drug discovery applications##2##4##(2008-11#2)
for drug discovery##8##3##(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-11#2)(2011-3#1)
for drug therapy##2##3##(2008-1#1)(2010-12#1)
for drug##34##2##(1990-11#1)(1990-3#1)(1991-1#1)(1992-5#1)(1993-2#1)(1993-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-4#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#4)(2010-12#1)(2011-1#1)(2011-10#1)(2011-3#2)
for drug-induced##2##2##(1996-11#1)(2008-10#1)
for drugs and##2##3##(2008-5#1)(2010-6#1)
for drugs##6##2##(1992-2#1)(2008-10#2)(2008-5#1)(2010-6#1)(2012-3#1)
for dry##2##2##(2008-10#1)(2008-11#1)
for dual##2##2##(2008-11#1)(2010-6#1)
for durable resistance##3##3##(2008-10#3)
for dyads by##2##3##(2009-11#2)
for dynamic##8##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#2)(2012-2#1)
for e##2##2##(2008-10#2)
for each analyte##3##3##(2008-10#3)
for each attribute##2##3##(2008-5#2)
for each cell##3##3##(1997-3#1)(2008-11#1)(2008-7#1)
for each chemical##2##3##(2008-10#2)
for each child##2##3##(2008-11#1)(2008-9#1)
for each compound and##2##4##(2008-10#2)
for each compound##8##3##(1993-12#1)(2008-10#7)
for each cultivar and experiment##2##5##(2008-10#2)
for each cultivar and##3##4##(2008-10#2)(2011-10#1)
for each cultivar##5##3##(2008-10#3)(2011-10#1)(2011-2#1)
for each drug##5##3##(1993-8#1)(2008-10#3)(2008-11#1)
for each element##3##3##(2008-10#3)
for each enantiomer##2##3##(2008-10#2)
for each experiment##3##3##(2008-10#3)
for each gene##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
for each genotype##2##3##(2008-10#2)
for each group##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
for each individual patient##2##4##(1990-9#1)(2012-12#1)
for each individual##6##3##(1990-9#1)(2008-10#3)(2012-12#1)(2013-8#1)
for each inoculation##2##3##(2008-10#2)
for each isolate##4##3##(2008-10#4)
for each measurement##3##3##(2008-10#3)
for each metal ion##3##4##(2008-10#3)
for each metal##6##3##(2008-10#6)
for each model##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
for each of the three##4##5##(1995-12#1)(2008-10#2)(2012-2#1)
for each of the##22##4##(1991-12#1)(1995-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-5#1)(2010-11#1)(2012-2#1)
for each of these##5##4##(1994-3#1)(2008-10#2)(2009-12#1)(2010-7#1)
for each of three##2##4##(1992-3#1)(2013-1#1)
for each of##33##3##(1991-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-3#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
for each one##2##3##(2008-10#2)
for each patient##10##3##(1992-9#1)(1996-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
for each procedure##2##3##(1993-12#1)(2008-10#1)
for each reagent##2##3##(2008-10#2)
for each sample##6##3##(2008-10#5)(2009-11#1)
for each sex##2##3##(2008-8#2)
for each species and##2##4##(2008-10#2)
for each species of bacterium##2##5##(2011-2#2)
for each species##12##3##(2008-10#3)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-5#1)
for each specific##2##3##(2008-10#1)(2011-2#1)
for each stage##2##3##(2009-3#1)(2010-12#1)
for each study##2##3##(2008-10#1)(2012-3#1)
for each subject##2##3##(2008-11#1)(2010-8#1)
for each system##2##3##(2008-10#2)
for each test##2##3##(2008-10#2)
for each treatment group##2##4##(1994-9#1)(2013-1#1)
for each treatment##6##3##(1994-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
for each type of##4##4##(1990-5#1)(2008-10#3)
for each virus##2##3##(2008-10#1)(2008-5#1)
for each vitamin##2##3##(2008-10#1)(2008-5#1)
for each year##3##3##(1992-12#1)(1993-12#1)(2008-10#1)
for each##321##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#3)(1991-2#2)(1992-12#1)(1992-3#3)(1992-9#3)(1993-1#1)(1993-12#5)(1993-3#1)(1993-8#2)(1994-1#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#160)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-10#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#6)(2012-5#2)(2013-1#13)(2013-8#2)
for ear rot##3##3##(2008-10#3)
for earlier##3##2##(2009-10#1)(2012-12#1)(2012-2#1)
for early breast cancer##2##4##(1994-12#1)(2011-2#1)
for early detection of##3##4##(1990-2#1)(2008-10#1)(2009-5#1)
for early detection##6##3##(1990-2#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)
for early diagnosis and##3##4##(1992-3#1)(2008-5#1)(2013-8#1)
for early diagnosis of##2##4##(1992-5#1)(2010-3#1)
for early diagnosis##7##3##(1992-3#1)(1992-5#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-3#1)(2013-8#1)
for early intervention services##2##4##(1994-1#2)
for early intervention##3##3##(1994-1#2)(2010-9#1)
for early screening##2##3##(2008-10#1)(2008-12#1)
for early syphilis##2##3##(1997-5#1)(1997-7#1)
for early##35##2##(1990-2#1)(1992-3#1)(1992-5#1)(1994-1#2)(1994-12#2)(1997-3#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
for easy and##2##3##(2008-10#1)(2008-2#1)
for easy##6##2##(1990-2#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-2#1)
for eating disorders##2##3##(2008-8#1)(2010-11#1)
for economic##2##2##(1994-2#1)(2009-10#1)
for ectopic##2##2##(1993-12#1)(2013-1#1)
for education in##2##3##(1993-3#2)
for education##7##2##(1993-3#4)(2008-1#1)(2008-11#1)(2012-2#1)
for educational##4##2##(1990-2#1)(1991-2#1)(1992-1#1)(2008-11#1)
for educators to##2##3##(2008-12#2)
for educators##8##2##(1996-2#1)(2008-12#5)(2009-12#1)(2013-8#1)
for effect##2##2##(1994-6#1)(2013-8#1)
for effective collaboration##2##3##(2008-12#2)
for effective urban air quality management##2##6##(2008-11#2)
for effective##27##2##(1992-1#1)(1993-12#2)(1994-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
for effectively##2##2##(2008-10#1)(2010-4#1)
for effectiveness##2##2##(1996-3#1)(2012-12#1)
for effects on##2##3##(1993-8#1)(2008-10#1)
for efficacy of##2##3##(2011-2#1)(2013-8#1)
for efficacy##6##2##(1991-3#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
for efficient production##2##3##(2008-11#1)(2011-3#1)
for efficient##28##2##(1990-5#1)(1994-5#1)(1995-6#1)(1997-2#2)(1997-7#1)(2008-10#2)(2008-11#10)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
for eight determinations of##2##4##(2008-10#2)
for eight replicate measurements##3##4##(2008-10#3)
for eight replicate##4##3##(2008-10#4)
for eight##19##2##(1996-12#1)(1996-2#1)(2008-10#12)(2008-3#2)(2012-12#1)(2013-1#2)
for either genus##2##3##(2008-10#2)
for either##24##2##(1991-2#1)(1991-3#1)(1992-3#1)(1994-3#1)(1996-12#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-10#1)(2011-1#1)(2013-8#2)
for elaidic acid##2##3##(2008-10#2)
for elderly institutionalised adults##2##4##(2011-2#2)
for elderly patients##2##3##(2008-8#1)(2012-12#1)
for elderly##10##2##(1994-1#1)(1995-3#1)(1997-8#1)(2008-8#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#1)
for elective surgery##3##3##(1995-1#1)(2010-7#2)
for elective##8##2##(1990-6#1)(1995-1#1)(1996-9#1)(2007-8#1)(2010-7#2)(2011-2#1)(2013-1#1)
for electrical##3##2##(2008-10#1)(2009-9#2)
for electroanalytical applications##2##3##(2008-10#2)
for electroanalytical##4##2##(2008-10#4)
for electrocatalytic oxidation of nitrite ion##2##6##(2008-10#2)
for electrochemical##8##2##(2008-10#4)(2010-11#1)(2012-2#1)(2013-1#2)
for electrode types [I] and [II]##2##6##(2008-10#2)
for electrode##5##2##(2008-10#4)(2008-9#1)
for electromagnetic##2##2##(2008-3#2)
for electron beams##2##3##(2009-11#2)
for electron##3##2##(1990-5#1)(2009-11#2)
for electronic##5##2##(1994-5#1)(2008-11#2)(2010-8#1)(2012-3#1)
for electrothermal atomic absorption spectrometric##2##5##(2008-10#2)
for electrothermal atomic absorption spectrometry##3##5##(2008-10#3)
for electrothermal atomic absorption##5##4##(2008-10#5)
for electrothermal##6##2##(2008-10#6)
for element-dependent signal##2##3##(2008-10#2)
for elemental analysis of##2##4##(2008-10#2)
for elemental analysis##3##3##(2008-10#3)
for elemental##5##2##(2008-10#5)
for elements of##2##3##(1993-6#1)(2008-9#1)
for elements##5##2##(1993-6#1)(2008-10#3)(2008-9#1)
for eleven##2##2##(2008-10#2)
for elicitation##2##2##(2008-10#1)(2008-4#1)
for eliciting##2##2##(1996-12#1)(2008-10#1)
for eliminating##3##2##(1996-3#1)(2008-10#2)
for elimination of##3##3##(2008-10#2)(2013-1#1)
for elimination##4##2##(2008-10#3)(2013-1#1)
for elucidating the##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
for elucidating##5##2##(2008-10#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-5#1)
for elution of##4##3##(2008-10#4)
for elution##6##2##(2008-10#6)
for embedding in##2##3##(2008-7#2)
for embryo##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
for emergency services##2##3##(2008-11#1)(2012-3#1)
for emergency##7##2##(1991-2#1)(1995-2#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-8#1)(2012-3#1)
for emotional##2##2##(1995-2#1)(2008-11#1)
for empirical##3##2##(1995-1#1)(2009-4#1)(2012-3#1)
for employment##2##2##(1996-2#1)(2008-11#1)
for encapsulation##2##2##(1996-5#1)(2008-11#1)
for encoding##2##2##(2008-10#1)(2008-11#1)
for end stage renal disease##2##5##(1995-12#1)(2010-7#1)
for end stage##3##3##(1995-12#1)(2010-7#1)(2011-2#1)
for end##4##2##(1991-3#1)(1995-12#1)(2010-7#1)(2011-2#1)
for end-point##2##2##(2008-10#1)(2008-11#1)
for end-stage renal disease##2##4##(1994-5#1)(1996-2#1)
for end-stage##4##2##(1994-5#1)(1996-2#1)(2011-2#1)(2011-3#1)
for endemic##2##2##(2012-12#1)(2012-2#1)
for endometrial##5##2##(1992-12#2)(2011-2#3)
for endoscopic##2##2##(1991-9#1)(2013-1#1)
for energy##2##2##(2009-8#1)(2013-1#1)
for engaging##2##2##(2008-11#1)(2012-2#1)
for engineering##2##2##(2009-7#1)(2010-7#1)
for enhanced##10##2##(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-3#1)(2013-8#1)
for enhancing the effectiveness of##2##5##(2009-6#1)(2012-2#1)
for enhancing the##9##3##(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2009-5#1)(2009-6#1)(2012-2#1)
for enhancing##20##2##(1991-3#1)(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-6#1)(2009-1#1)(2009-5#1)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#2)
for enrichment of##7##3##(2008-10#7)
for enrichment##8##2##(2008-10#8)
for enrolling##3##2##(1994-3#1)(1996-1#1)(2010-11#1)
for ensuring##4##2##(1996-3#1)(2008-12#1)(2008-5#1)(2011-3#1)
for entries that##2##3##(2008-10#2)
for entries##3##2##(2008-10#3)
for entry##2##2##(2008-10#1)(2012-2#1)
for environmental and biological samples##2##5##(2008-10#2)
for environmental and##3##3##(2008-10#3)
for environmental monitoring of##2##4##(2008-10#2)
for environmental monitoring purposes##2##4##(2008-10#2)
for environmental monitoring##7##3##(2008-10#7)
for environmental risk assessment##3##4##(2008-10#1)(2008-11#2)
for environmental##21##2##(2008-10#17)(2008-11#2)(2008-12#1)(2010-5#1)
for environmentally##2##2##(2008-3#1)(2008-8#1)
for enzymatic reaction##2##3##(2008-10#2)
for enzymatic##13##2##(1990-5#1)(1993-12#1)(1993-9#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
for enzyme##6##2##(1992-6#1)(1993-8#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-6#1)
for epidemics##2##2##(2008-10#2)
for epidemiological studies and##2##4##(2008-10#1)(2011-2#1)
for epidemiological##6##2##(2008-10#4)(2011-2#1)(2013-8#1)
for epilepsy##2##2##(2008-5#1)(2010-8#1)
for epinephrine##2##2##(2008-10#2)
for equilibrium constants in##2##4##(2008-10#2)
for equilibrium##4##2##(2008-10#3)(2008-9#1)
for equipment acquisition##2##3##(1994-3#1)(1996-1#1)
for equipment##3##2##(1994-3#1)(1996-1#1)(1996-12#1)
for equivalence##2##2##(1994-9#1)(2008-10#1)
for eradication of##2##3##(2010-12#1)(2011-2#1)
for error##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
for essential##2##2##(2012-2#1)(2012-3#1)
for establishing a##4##3##(1990-2#1)(1993-1#1)(1996-1#1)(2008-11#1)
for establishing the##3##3##(1991-2#1)(2008-11#1)(2009-8#1)
for establishing##15##2##(1990-2#1)(1991-1#1)(1991-2#1)(1993-1#1)(1996-1#1)(2008-11#4)(2008-4#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
for establishment##2##2##(2008-10#1)(2012-3#1)
for estimating maximum permissible load##2##5##(2013-1#2)
for estimating the motion of##2##5##(2008-3#2)
for estimating the##12##3##(1992-9#1)(1993-3#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-3#3)(2010-1#1)(2013-1#1)
for estimating##31##2##(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-9#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-5#2)(2008-7#3)(2010-1#1)(2010-11#1)(2010-8#1)(2013-1#5)(2013-3#1)
for estimation of blood##2##4##(2008-10#2)
for estimation of the##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
for estimation of##14##3##(2008-10#9)(2008-11#2)(2008-3#1)(2012-2#1)(2013-1#1)
for estimation##17##2##(2008-10#12)(2008-11#2)(2008-3#1)(2012-2#1)(2013-1#1)
for estradiol and##2##3##(2008-10#1)(2008-12#1)
for ethanol and##2##3##(2008-10#2)
for ethanol##6##2##(2008-10#6)
for ethical reasons##2##3##(2008-11#2)
for ethical##3##2##(1997-2#1)(2008-11#2)
for ethics##2##2##(2008-11#1)(2013-8#1)
for ethnic groups##2##3##(1995-2#1)(2008-5#1)
for ethnic##4##2##(1990-6#1)(1995-2#1)(2008-5#1)(2009-7#1)
for evacuation is##2##3##(2013-1#2)
for evaluating and##4##3##(2008-10#2)(2008-11#2)
for evaluating skin##2##3##(2008-5#2)
for evaluating the efficacy of##2##5##(2008-1#1)(2012-12#1)
for evaluating the measurement##2##4##(2008-10#1)(2008-9#1)
for evaluating the potential##2##4##(2008-10#2)
for evaluating the uncertainty##2##4##(2008-10#2)
for evaluating the##24##3##(1990-2#1)(1991-1#1)(1994-2#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#13)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
for evaluating##56##2##(1990-2#1)(1990-8#1)(1991-1#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-6#2)(1997-7#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#1)
for evaluation and treatment##2##4##(1993-1#1)(2010-12#1)
for evaluation and##5##3##(1993-1#1)(2008-10#1)(2008-6#1)(2010-12#1)(2012-2#1)
for evaluation of an##2##4##(1994-1#1)(2008-10#1)
for evaluation of different##2##4##(2008-11#1)(2008-9#1)
for evaluation of the##3##4##(1997-8#2)(2008-2#1)
for evaluation of##22##3##(1991-11#1)(1992-1#1)(1993-1#1)(1994-1#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#3)(2010-1#1)(2011-2#1)(2013-8#1)
for evaluation##43##2##(1991-11#1)(1991-12#1)(1992-1#1)(1993-1#2)(1994-1#1)(1994-2#1)(1995-12#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#2)(2006-5#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
for evanescent##2##2##(2008-10#1)(2008-3#1)
for even##2##2##(1991-12#1)(1992-1#1)
for every##22##2##(1991-2#1)(1993-12#1)(1995-5#1)(1996-6#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
for everyone##3##2##(1993-1#1)(1994-12#1)(1996-1#1)
for evidence of##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
for evidence##5##2##(2007-12#1)(2008-11#3)(2011-2#1)
for evidence-based##3##2##(2008-11#1)(2008-12#1)(2010-6#1)
for evolution##3##2##(1992-6#1)(2008-8#2)
for evolutionarily##2##2##(1995-2#1)(2008-8#1)
for evolutionary##3##2##(1997-6#1)(2008-8#2)
for ewes##2##2##(2008-9#2)
for exact##2##2##(1992-3#1)(2008-3#1)
for examination of##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2009-4#1)
for examination##5##2##(1991-12#1)(1995-12#1)(2008-10#1)(2008-3#1)(2009-4#1)
for examining the##8##3##(1995-11#1)(1995-2#2)(2008-1#1)(2008-11#1)(2008-4#2)(2012-2#1)
for examining##18##2##(1992-2#1)(1993-9#1)(1995-11#1)(1995-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-9#3)(2010-10#1)(2012-2#1)(2012-3#1)
for example by##2##3##(1995-5#1)(2008-10#1)
for example in##2##3##(2008-11#1)(2008-7#1)
for example the##5##3##(1993-2#1)(2008-10#2)(2010-7#1)(2011-2#1)
for example when##3##3##(1996-11#1)(2010-11#1)(2013-8#1)
for example##75##2##(1990-8#1)(1993-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-4#1)(1997-6#2)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#8)(2008-12#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#4)
for excellence in##3##3##(1992-3#1)(1996-8#1)(2012-12#1)
for exchanging##2##2##(2010-10#1)(2010-8#1)
for excision of##2##3##(2011-2#2)
for excision##3##2##(2008-10#1)(2011-2#2)
for excitation##3##2##(2008-10#1)(2008-3#2)
for executive##2##2##(1993-2#1)(1996-2#1)
for exercise##2##2##(1996-11#1)(2013-1#1)
for existence of##2##3##(2008-10#1)(2008-8#1)
for existing##2##2##(2008-8#1)(2012-2#1)
for exogenous##3##2##(2008-11#1)(2008-7#2)
for expanded##3##2##(1991-3#1)(1994-12#1)(1995-1#1)
for expanding the##2##3##(1993-12#1)(2008-4#1)
for expanding##5##2##(1992-2#2)(1993-12#1)(2008-4#1)(2012-3#1)
for expansion##2##2##(2008-11#2)
for experienced##2##2##(1992-1#1)(2008-11#1)
for experimental##9##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-7#1)(2013-1#1)
for experiments in##2##3##(2008-11#1)(2008-5#1)
for experiments##4##2##(1996-2#1)(2008-11#2)(2008-5#1)
for explaining##5##2##(1992-12#1)(1995-2#1)(2008-7#1)(2008-8#2)
for exploitation##2##2##(1995-5#1)(2008-10#1)
for exploration##2##2##(1992-2#1)(2009-5#1)
for exploratory##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
for exploring the##2##3##(2008-11#1)(2008-8#1)
for exploring##3##2##(2008-11#1)(2008-8#1)(2009-5#1)
for explosives detection##2##3##(2008-10#2)
for explosives##5##2##(2008-10#5)
for exposure to##2##3##(2008-9#1)(2012-3#1)
for exposure##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
for expressing the##2##3##(2008-10#1)(2011-2#1)
for expression and##2##3##(1996-12#1)(2008-4#1)
for expression of the##2##4##(1990-5#1)(1992-4#1)
for expression of##11##3##(1990-5#1)(1992-4#1)(1993-1#1)(1997-8#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)
for expression##16##2##(1990-5#1)(1992-4#1)(1993-1#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)
for extended periods##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
for extended##7##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)
for extension##2##2##(1990-5#1)(2008-10#1)
for extensive##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
for external##4##2##(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
for extracellular##2##2##(2008-10#1)(2008-8#1)
for extracorporeal##2##2##(1995-1#1)(1996-11#1)
for extracting the##3##3##(2008-10#2)(2008-3#1)
for extracting##12##2##(2008-10#7)(2008-3#2)(2008-9#2)(2010-7#1)
for extraction and##3##3##(2008-10#3)
for extraction of the##2##4##(2008-10#2)
for extraction of these##2##4##(2008-10#2)
for extraction of##9##3##(2008-10#7)(2008-7#1)(2012-2#1)
for extraction##24##2##(2008-10#21)(2008-11#1)(2008-7#1)(2012-2#1)
for extractive concentration of##2##4##(2008-10#2)
for extractive##3##2##(2008-10#3)
for extraneous##3##2##(1991-12#1)(2008-11#1)(2012-12#1)
for extreme ultraviolet lithography##2##4##(2008-2#2)
for extreme##4##2##(2008-2#2)(2008-8#1)(2008-9#1)
for extremely##2##2##(1992-12#1)(2008-11#1)
for fabricating##6##2##(2008-10#4)(2008-3#1)(2009-11#1)
for fabrication of##8##3##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-1#1)
for facial##3##2##(2008-7#1)(2010-4#1)(2012-3#1)
for facilitated##2##2##(1994-11#1)(2008-10#1)
for facilitating##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
for factor##2##2##(1991-9#1)(2008-11#1)
for factors##2##2##(2008-10#1)(2012-12#1)
for faculty development##2##3##(1993-2#1)(2013-1#1)
for faculty members##2##3##(1992-1#1)(1996-3#1)
for faculty##8##2##(1992-1#1)(1993-1#1)(1993-2#2)(1996-3#1)(2008-11#2)(2013-1#1)
for failure to##3##3##(1993-12#1)(1994-12#1)(2008-12#1)
for failure##7##2##(1993-12#1)(1994-12#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#2)
for falls among##2##3##(2008-7#2)
for falls##5##2##(2008-7#3)(2010-11#1)(2011-2#1)
for familial##2##2##(1992-12#1)(2011-2#1)
for families and##2##3##(1995-1#1)(2008-7#1)
for families##4##2##(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
for family##5##2##(1996-11#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
for fascial closure##5##3##(1991-1#2)(1991-2#2)(1992-1#1)
for fascial##6##2##(1991-1#2)(1991-2#2)(1992-1#1)(2013-1#1)
for fast response##2##3##(2008-10#2)
for fast##11##2##(2008-10#7)(2008-7#1)(2009-12#1)(2009-8#1)(2013-1#1)
for fatty acid##3##3##(1992-6#1)(1993-9#1)(1996-12#1)
for fatty##4##2##(1992-6#1)(1993-9#1)(1995-3#1)(1996-12#1)
for fear##2##2##(2008-8#1)(2013-8#1)
for feeding##2##2##(2008-10#1)(2012-2#1)
for feline##2##2##(2012-3#2)
for females##12##2##(1991-6#2)(1995-2#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2013-1#1)
for fenbendazole and mebendazole was 1##2##6##(2008-10#2)
for fermentation##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
for fertility##3##2##(1993-3#1)(1995-6#1)(2008-9#1)
for fetal anomalies##2##3##(2008-11#2)
for fetal##4##2##(1994-3#1)(2008-11#3)
for fiber##2##2##(1991-12#1)(2008-3#1)
for fibrinogen##2##2##(2006-6#1)(2008-10#1)
for field applications##2##3##(2008-10#2)
for field monitoring of##2##4##(2008-10#2)
for field resistance##2##3##(2008-10#2)
for field screening of##2##4##(2008-10#2)
for field##20##2##(2008-10#16)(2008-8#1)(2009-2#1)(2011-1#2)
for fields##2##2##(2009-2#1)(2011-2#1)
for filling##3##2##(2008-4#2)(2009-7#1)
for filtering noise##2##3##(2008-3#2)
for final##3##2##(2008-10#2)(2008-11#1)
for financing health care##2##4##(1993-3#1)(2008-1#1)
for financing##5##2##(1992-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(2008-1#1)
for finding##5##2##(2008-11#2)(2008-6#2)(2011-2#1)
for fine-tuning##2##2##(1995-9#1)(2011-2#1)
for fire blight##3##3##(2008-10#3)
for first and##2##3##(2008-10#2)
for first##5##2##(1996-8#1)(2008-10#3)(2008-12#1)
for fiscal year##4##3##(1992-1#1)(1993-12#1)(1995-6#1)(1997-2#1)
for fiscal##7##2##(1992-1#1)(1993-12#1)(1995-6#3)(1996-5#1)(1997-2#1)
for fish sperm DNA (fsDNA)##2##5##(2008-10#2)
for fish sperm DNA##8##4##(2008-10#8)
for fish##13##2##(2008-10#11)(2008-12#1)(2010-8#1)
for fitness##3##2##(1997-7#1)(2008-8#2)
for fitting##4##2##(2008-10#1)(2008-9#1)(2009-7#1)(2010-1#1)
for five 1##2##3##(2008-10#2)
for five determinations of##2##4##(2008-10#2)
for five different##3##3##(2008-10#3)
for five measurements##3##3##(2008-10#3)
for five replicate##3##3##(2008-10#3)
for five years##2##3##(2008-12#1)(2008-9#1)
for five##28##2##(1990-5#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2012-9#1)
for fixation of##2##3##(2008-10#1)(2008-7#1)
for fixation##5##2##(2008-10#2)(2008-7#1)(2009-3#1)(2012-12#1)
for fixed##2##2##(1994-3#1)(2012-2#1)
for flame atomic absorption##3##4##(2008-10#3)
for flat##2##2##(2008-3#2)
for flavonoids##2##2##(2008-10#1)(2012-12#1)
for flexible##2##2##(1993-1#1)(2009-4#1)
for flow analysis##3##3##(2008-10#3)
for flow cytometric analysis##3##4##(2008-4#1)(2008-9#2)
for flow cytometric##7##3##(2008-4#1)(2008-9#6)
for flow cytometry##6##3##(2008-4#1)(2008-9#5)
for flow injection analysis of##5##5##(2008-10#5)
for flow injection analysis##10##4##(2008-10#10)
for flow injection##14##3##(2008-10#14)
for flow rates##2##3##(2008-10#1)(2008-11#1)
for flow##35##2##(2008-10#19)(2008-11#1)(2008-4#2)(2008-9#12)(2012-2#1)
for fluconazole##3##2##(2008-5#3)
for fluorescein##2##2##(2008-10#2)
for fluorescence detection##2##3##(2008-10#2)
for fluorescence##7##2##(2008-10#3)(2008-4#1)(2008-9#2)(2011-2#1)
for fluoride and##2##3##(2008-10#2)
for fluoride##5##2##(2008-10#5)
for fluoxetine##3##2##(2012-2#3)
for focal##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
for foliar##2##2##(2008-10#2)
for follow-up##3##2##(1995-2#2)(2008-11#1)
for food##13##2##(1990-2#1)(1993-6#2)(2008-10#3)(2008-11#1)(2008-9#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-2#2)
for foraging##3##2##(2008-8#1)(2008-9#2)
for force##2##2##(2009-5#1)(2013-1#1)
for forensic identification##2##3##(2008-12#2)
for forensic investigations##2##3##(1995-11#1)(2012-3#1)
for forensic##6##2##(1995-11#1)(2008-10#1)(2008-12#3)(2012-3#1)
for forest##2##2##(2008-10#2)
for formaldehyde determination##2##3##(2008-10#2)
for formaldehyde##4##2##(2008-10#3)(2008-11#1)
for formation of##2##3##(2008-10#1)(2008-11#1)
for formation##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
for formic##3##2##(2008-10#3)
for forming##2##2##(2008-10#1)(2008-11#1)
for four days##3##3##(1993-2#1)(2008-10#1)(2013-1#1)
for four dimensions##2##3##(2008-6#1)(2011-2#1)
for four months##3##3##(1994-6#2)(2010-11#1)
for four##28##2##(1990-11#1)(1991-9#1)(1993-2#1)(1993-9#2)(1994-6#2)(1995-12#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-6#1)(2009-7#1)(2010-11#1)(2011-2#2)(2013-1#2)
for fractionation of##2##3##(2008-10#2)
for fragments##2##2##(1997-6#1)(2008-10#1)
for free##6##2##(1990-8#1)(1991-2#1)(2008-10#3)(2008-7#1)
for fresh water##2##3##(2008-10#2)
for fresh##3##2##(1996-12#1)(2008-10#2)
for freshly prepared##2##3##(2008-10#2)
for fruit infection##2##3##(2008-10#2)
for fruit juices and##2##4##(2008-10#2)
for fruit##8##2##(2008-10#8)
for fuels##2##2##(2008-10#2)
for full face##2##3##(2013-1#2)
for full##7##2##(1991-5#1)(1993-8#1)(2008-10#3)(2013-1#2)
for fumaric acid##3##3##(2008-10#3)
for functional##12##2##(1991-6#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#2)(2009-10#3)(2009-5#2)(2012-3#1)
for funding purposes##2##3##(1991-12#1)(1995-6#1)
for funding##5##2##(1991-12#2)(1993-12#1)(1995-6#1)(2012-2#1)
for fungal growth##2##3##(2008-10#2)
for fungal##10##2##(2008-10#10)
for further analyses##2##3##(2008-10#1)(2008-9#1)
for further analysis##9##3##(1991-12#1)(1994-12#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-9#1)
for further development of##2##4##(2010-7#1)(2012-2#1)
for further development##6##3##(2008-10#1)(2010-7#1)(2011-2#3)(2012-2#1)
for further developments##2##3##(2008-10#2)
for further evaluation##3##3##(1990-6#1)(1991-5#1)(2008-10#1)
for further investigation##2##3##(1997-8#1)(2008-12#1)
for further investigations##2##3##(1990-11#1)(2013-1#1)
for further research on##3##4##(2009-6#1)(2013-1#2)
for further research that##2##4##(2008-11#1)(2008-12#1)
for further research##10##3##(1997-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-5#1)(2013-1#2)
for further studies##6##3##(1993-1#1)(2008-10#2)(2008-9#1)(2010-10#1)(2011-1#1)
for further study on##2##4##(1994-5#1)(1995-8#1)
for further study##8##3##(1994-5#1)(1994-9#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-8#1)
for further use##2##3##(2008-11#1)(2010-1#1)
for further##90##2##(1990-11#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#23)(2008-11#7)(2008-12#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#2)(2013-1#6)(2013-8#1)
for future applications##2##3##(1994-8#1)(2008-11#1)
for future clinical##2##3##(2010-11#1)(2010-12#1)
for future development##4##3##(1991-1#1)(2008-12#1)(2008-2#1)(2012-2#1)
for future experiments##2##3##(1994-11#1)(2008-10#1)
for future functional##2##3##(2010-4#1)(2012-2#1)
for future investigation##2##3##(1992-3#1)(2008-10#1)
for future practice##2##3##(2008-11#2)
for future research and clinical##2##5##(2008-11#1)(2010-9#1)
for future research and##4##4##(1992-3#1)(2008-10#1)(2008-11#1)(2010-9#1)
for future research are##6##4##(1995-2#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-7#1)
for future research on##2##4##(1996-3#1)(2012-2#1)
for future research##26##3##(1992-3#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-2#2)
for future studies of##2##4##(1995-5#1)(2010-5#1)
for future studies##11##3##(1992-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
for future study##2##3##(2008-10#1)(2010-9#1)
for future work##2##3##(1997-3#1)(2008-10#1)
for future##100##2##(1991-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#3)(1997-3#1)(2007-11#1)(2008-10#11)(2008-11#13)(2008-12#8)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#3)(2011-2#3)(2012-2#6)(2012-3#4)(2012-4#1)(2012-9#1)(2013-1#3)
for gallbladder cancer##2##3##(2010-12#2)
for gallium and##2##3##(2008-10#2)
for gallium-APDC complex was##2##4##(2008-10#2)
for gallium-PCV complex was##2##4##(2008-10#2)
for gas##7##2##(2007-12#1)(2008-10#4)(2008-3#1)(2011-2#1)
for gas-phase##2##2##(2008-10#1)(2008-3#1)
for gaseous##3##2##(2008-10#3)
for gastric cancer##3##3##(1990-9#1)(1997-1#1)(2011-2#1)
for gastric##5##2##(1990-9#1)(1997-1#1)(2011-2#1)(2013-1#2)
for gastroesophageal##2##2##(2008-11#1)(2011-2#1)
for gastrointestinal##2##2##(1996-8#1)(2012-3#1)
for gastroschisis##2##2##(1997-3#1)(2008-11#1)
for gender##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)
for gene expression in mammalian cells##2##6##(1993-6#2)
for gene expression##6##3##(1993-6#2)(1996-6#1)(2008-4#1)(2008-9#1)(2011-2#1)
for gene therapy and##3##4##(2008-11#2)(2011-2#1)
for gene therapy of##2##4##(1997-1#1)(2008-8#1)
for gene therapy##13##3##(1997-1#2)(2008-11#9)(2008-8#1)(2011-2#1)
for gene##29##2##(1991-5#1)(1993-6#2)(1995-2#1)(1996-6#1)(1997-1#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#9)(2008-4#2)(2008-8#2)(2008-9#2)(2009-6#1)(2011-1#1)(2011-2#2)
for general practice##3##3##(1994-12#1)(1996-8#1)(2011-2#1)
for general##22##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-12#1)(1996-8#1)(1997-4#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
for generating the##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
for generating##28##2##(1990-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(2007-11#2)(2008-10#4)(2008-11#5)(2008-4#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-5#1)
for generation of##3##3##(1992-3#1)(2008-11#1)(2008-4#1)
for genes##6##2##(1994-11#1)(1996-2#1)(2008-10#4)
for genetic analyses##2##3##(2008-11#1)(2008-4#1)
for genetic analysis of##2##4##(2008-9#1)(2012-3#1)
for genetic counseling##2##3##(2008-7#1)(2013-1#1)
for genetic studies##3##3##(1997-7#1)(2008-10#1)(2013-8#1)
for genetic variation##2##3##(2008-10#2)
for genetic##25##2##(1993-12#1)(1995-12#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#4)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
for genetics##2##2##(1995-9#1)(1997-3#1)
for geniposidic##2##2##(2008-10#2)
for genome analysis##3##3##(1996-12#1)(2008-10#2)
for genome##4##2##(1991-11#1)(1996-12#1)(2008-10#2)
for genome-wide analysis of##2##4##(2007-12#2)
for genome-wide##4##2##(2007-12#2)(2008-9#1)(2012-3#1)
for genomic sequencing that##2##4##(2008-10#2)
for genomic sequencing##6##3##(2008-10#6)
for genomic##10##2##(1995-12#1)(2008-10#7)(2008-4#1)(2011-3#1)
for genotyping##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
for geographic##2##2##(1991-2#1)(1992-2#1)
for germ##2##2##(1992-12#1)(2009-7#1)
for germanium##2##2##(2008-10#2)
for germination##3##2##(2008-10#2)(2011-2#1)
for gestational##4##2##(1994-3#1)(2008-10#1)(2011-1#1)(2013-1#1)
for giant##3##2##(1993-1#1)(2007-12#1)(2008-7#1)
for girls##8##2##(1990-9#1)(2008-7#1)(2009-7#2)(2010-10#1)(2013-1#3)
for glass electrode##2##3##(2008-10#2)
for glass##4##2##(1995-3#1)(2008-10#3)
for glioblastoma multiforme##2##3##(1994-2#1)(2008-11#1)
for global##2##2##(2008-1#1)(2008-10#1)
for glucose and##6##3##(1991-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)
for glucose determination in##3##4##(2008-10#3)
for glucose determination##7##3##(2008-10#7)
for glucose in##2##3##(2008-10#2)
for glucose##25##2##(1991-5#1)(2008-10#18)(2008-11#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
for glutamate##2##2##(1997-3#1)(2008-7#1)
for glutamine##2##2##(1995-12#1)(2008-11#1)
for glutathione##3##2##(2008-10#3)
for glycerol##2##2##(2008-10#2)
for glycine##4##2##(1996-5#1)(1997-2#2)(2008-10#1)
for glycogen##3##2##(1990-2#1)(2008-10#1)(2009-7#1)
for good performance of the vertebrae and pedicle screw unit##2##10##(2007-11#2)
for good performance##3##3##(1996-12#1)(2007-11#2)
for good##11##2##(1990-11#1)(1995-1#1)(1996-12#1)(1996-8#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
for government##2##2##(1992-2#1)(1994-2#1)
for graduate##2##2##(1991-2#1)(1996-1#1)
for graduates##2##2##(1994-12#1)(1996-3#1)
for granted##2##2##(2008-11#2)
for graphite##2##2##(1991-5#1)(2008-10#1)
for gray leaf spot of maize##2##6##(2008-10#2)
for gray leaf spot##6##4##(2008-10#6)
for gray##7##2##(1996-3#1)(2008-10#6)
for greater##12##2##(1990-5#1)(1994-1#2)(1994-8#1)(1996-1#1)(1997-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#1)
for group practices##2##3##(1993-1#1)(1997-3#1)
for group##10##2##(1993-1#1)(1994-6#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-4#1)(2013-8#1)
for grouping##3##2##(2008-10#3)
for groups with##2##3##(1994-9#1)(2008-9#1)
for groups##4##2##(1994-9#1)(2008-10#2)(2008-9#1)
for growing##4##2##(1996-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
for growth and##4##3##(1995-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
for growth hormone-releasing hormone 1-44 NH2##2##6##(1992-9#2)
for growth in##3##3##(1996-8#1)(2008-10#2)
for growth of##3##3##(2008-10#3)
for growth under##3##3##(2008-7#1)(2011-2#2)
for growth##30##2##(1992-12#1)(1992-9#3)(1994-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1996-8#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#5)
for guanine##2##2##(2008-10#1)(2010-11#1)
for guaranteeing##2##2##(2008-10#1)(2008-11#1)
for guidance on##2##3##(1993-1#1)(2012-12#1)
for guiding the##2##3##(1993-1#1)(2011-2#1)
for guiding##3##2##(1993-1#1)(2010-6#1)(2011-2#1)
for hair##2##2##(2008-10#1)(2008-5#1)
for hand##2##2##(2011-1#1)(2013-1#1)
for handling##6##2##(1991-1#1)(1991-12#1)(2008-10#3)(2008-4#1)
for harsh##2##2##(2008-10#1)(2008-9#1)
for having##2##2##(1994-12#1)(2012-2#1)
for hazard identification##3##3##(2008-10#3)
for hazardous drinking##2##3##(2008-12#2)
for hazardous##4##2##(1993-3#1)(2008-12#2)(2009-10#1)
for head and neck##2##4##(2011-2#1)(2013-1#1)
for head movement##2##3##(1990-5#1)(1995-5#1)
for head##5##2##(1990-5#1)(1995-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
for headspace##2##2##(2008-10#2)
for health administration##3##3##(1992-2#1)(1992-3#1)(1993-1#1)
for health administrators##2##3##(1994-2#1)(2008-12#1)
for health and social care##2##5##(2008-11#2)
for health and##5##3##(1991-12#1)(1991-3#1)(2008-10#1)(2008-11#2)
for health care CQI##2##4##(1994-2#1)(1994-3#1)
for health care administrators##2##4##(1997-3#1)(2009-8#1)
for health care expenditures##2##4##(1993-2#1)(1993-3#1)
for health care is##3##4##(1991-3#1)(1993-3#1)(1997-8#1)
for health care organizations##3##4##(1992-3#1)(1994-12#1)(2011-2#1)
for health care providers to##3##5##(1991-2#1)(1996-3#1)(2009-5#1)
for health care providers##6##4##(1991-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2009-5#1)(2010-2#1)
for health care reform##3##4##(1994-12#1)(1995-2#1)(1996-3#1)
for health care##42##3##(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#1)(1995-2#4)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#3)(2009-1#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)
for health education##2##3##(1994-6#1)(1995-12#1)
for health information##2##3##(1996-6#1)(2010-8#1)
for health professionals##4##3##(2008-11#1)(2008-12#2)(2013-8#1)
for health sector##2##3##(1997-1#1)(2012-3#1)
for health service managers##2##4##(1992-1#2)
for health service##3##3##(1992-1#2)(1993-12#1)
for health services##10##3##(1991-2#1)(1991-3#1)(1992-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(2012-3#1)
for health##99##2##(1990-2#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-6#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#5)(1994-1#3)(1994-12#4)(1994-2#5)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#4)(1996-1#1)(1996-2#2)(1996-3#4)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#1)(2008-10#3)(2008-11#8)(2008-12#4)(2008-2#1)(2008-7#1)(2009-1#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
for healthcare##10##2##(1992-1#1)(1992-2#2)(1993-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-9#1)(2012-12#1)(2013-8#1)
for healthy##5##2##(1996-3#1)(2008-10#2)(2008-5#1)(2013-1#1)
for heart failure##2##3##(2008-11#1)(2012-2#1)
for heart##4##2##(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
for heat##2##2##(1990-11#1)(2009-8#1)
for heating and##2##3##(2008-10#2)
for heavy metal##2##3##(2008-10#1)(2013-1#1)
for heavy metals##4##3##(2008-10#3)(2011-2#1)
for heavy##8##2##(1997-9#1)(2008-10#4)(2008-9#1)(2011-2#1)(2013-1#1)
for height##2##2##(2008-12#1)(2008-8#1)
for help##2##2##(1992-1#1)(2010-11#1)
for hematopoietic progenitor##2##3##(2008-11#1)(2008-7#1)
for hematopoietic stem##2##3##(2008-7#1)(2008-9#1)
for hematopoietic##5##2##(1993-8#1)(2008-11#1)(2008-7#2)(2008-9#1)
for hemodialysis##6##2##(1991-6#1)(2008-10#4)(2011-3#1)
for hemoglobin (Hb)##2##3##(1990-8#1)(2008-10#1)
for hemoglobin##4##2##(1990-8#1)(2008-10#3)
for hemophilia B##3##3##(2008-8#1)(2008-9#2)
for hepatic##7##2##(1990-11#1)(1991-12#1)(1991-8#1)(1997-8#1)(2008-10#1)(2011-2#2)
for hepatitis B##2##3##(2008-10#1)(2008-12#1)
for hepatitis##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2009-8#1)
for hepatocellular carcinoma##4##3##(2008-1#1)(2010-12#1)(2013-7#1)(2013-8#1)
for hepatocyte##2##2##(1995-2#1)(2008-6#1)
for her##4##2##(1993-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
for hereditary##4##2##(1996-11#1)(1997-8#1)(2011-2#2)
for heterogeneity##2##2##(1997-3#1)(2008-10#1)
for heterologous##4##2##(1995-5#1)(2008-11#1)(2008-7#1)(2008-8#1)
for heterosexual##2##2##(1997-6#1)(2013-1#1)
for heterozygotes##2##2##(2008-10#2)
for hexagonal columns##2##3##(2008-3#2)
for hexagonal##3##2##(2008-3#3)
for high expression##2##3##(1997-8#1)(2008-11#1)
for high performance liquid chromatography (HPLC)##2##6##(2008-10#2)
for high pump##2##3##(2008-3#2)
for high##31##2##(1992-6#1)(1994-6#1)(1996-2#1)(1997-8#1)(2008-10#8)(2008-11#5)(2008-3#4)(2008-7#2)(2009-10#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-8#2)
for high-efficiency##2##2##(1991-6#1)(2008-10#1)
for high-frequency##2##2##(2009-5#1)(2010-12#1)
for high-level expression of##2##4##(1996-3#1)(2008-9#1)
for high-quality##3##2##(2008-11#1)(2013-1#2)
for high-resolution##2##2##(2008-3#1)(2012-2#1)
for high-risk patients##2##3##(1995-2#1)(2008-11#1)
for high-risk##5##2##(1995-2#1)(2008-11#1)(2011-2#2)(2012-12#1)
for high-throughput screening##2##3##(2008-10#2)
for high-throughput##9##2##(1994-3#1)(2008-10#4)(2008-4#1)(2010-11#1)(2010-7#1)(2011-1#1)
for higher##10##2##(1993-12#1)(2008-11#2)(2008-12#1)(2008-8#3)(2011-2#2)(2013-8#1)
for highly efficient##2##3##(2008-7#1)(2012-2#1)
for highly##12##2##(1995-11#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
for him##2##2##(1992-3#2)
for himself##2##2##(1990-11#1)(1993-11#1)
for hip##2##2##(2008-10#1)(2008-8#1)
for his or her##2##4##(1992-2#1)(1997-8#1)
for his##11##2##(1991-6#1)(1992-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2010-1#1)(2010-3#1)(2010-4#1)
for histamine##4##2##(2008-10#3)(2008-11#1)
for histidase##2##2##(1994-5#2)
for histidine##2##2##(1995-8#1)(2008-10#1)
for histological##2##2##(2008-11#1)(2011-2#1)
for holographic##2##2##(2008-3#2)
for home care##3##3##(1995-3#1)(2008-10#1)(2012-2#1)
for home##6##2##(1991-2#1)(1992-2#1)(1995-3#1)(1997-4#1)(2008-10#1)(2012-2#1)
for homeostasis##2##2##(2008-9#1)(2011-1#1)
for homocysteine##2##2##(2008-10#2)
for homogeneous##6##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
for honokiol and##2##3##(2008-10#2)
for horizontal##2##2##(1991-5#1)(2008-9#1)
for hospice##2##2##(1991-2#1)(1996-3#1)
for hospital care##6##3##(1992-1#1)(1993-2#1)(1994-12#2)(1994-2#1)(2010-10#1)
for hospital inpatient services##2##4##(1994-12#1)(2008-11#1)
for hospital security##3##3##(1994-12#1)(1994-2#1)(1995-12#1)
for hospital##19##2##(1991-12#1)(1991-3#1)(1992-1#2)(1993-2#1)(1993-5#1)(1994-12#5)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-11#1)(2010-10#1)
for hospitalization##3##2##(1993-2#1)(2013-1#2)
for hospitalized children##2##3##(2008-11#2)
for hospitalized##3##2##(2008-11#2)(2013-1#1)
for hospitals and##2##3##(1992-12#1)(1993-2#1)
for hospitals to##3##3##(1992-1#1)(2008-11#1)(2010-9#1)
for hospitals##16##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#2)(1993-2#1)(1994-12#1)(2008-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
for host##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
for hosts##2##2##(1997-7#1)(2008-8#1)
for hours##2##2##(1997-1#1)(2008-5#1)
for how##12##2##(1991-2#1)(2008-11#1)(2008-3#1)(2008-9#2)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
for human and animal##2##4##(2008-10#1)(2011-2#1)
for human consumption##2##3##(2008-11#1)(2008-3#1)
for human diseases##2##3##(1994-5#1)(2008-4#1)
for human gene##2##3##(2008-9#1)(2011-2#1)
for human health##3##3##(2008-11#1)(2012-3#1)(2013-7#1)
for human identification##2##3##(1993-2#1)(2008-12#1)
for human immunodeficiency virus (HIV)##2##5##(1990-6#1)(1997-3#1)
for human placenta DNA##2##4##(2008-10#2)
for human placenta##3##3##(1992-10#1)(2008-10#2)
for human serum albumin (HSA)##2##5##(2008-10#2)
for human serum##3##3##(2008-10#3)
for human use##2##3##(2010-6#1)(2011-2#1)
for human##80##2##(1990-2#4)(1990-6#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-2#2)(1994-11#2)(1994-5#2)(1995-11#1)(1995-5#1)(1996-2#3)(1996-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-7#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#8)(2012-2#1)(2012-3#1)(2012-5#1)(2013-7#1)(2013-8#2)
for humans and##2##3##(2008-10#1)(2013-8#1)
for humans##8##2##(1994-9#1)(1997-1#1)(2008-10#2)(2008-12#1)(2010-11#1)(2012-2#1)(2013-8#1)
for hybridization##3##2##(2008-10#3)
for hydrazine and phenylhydrazine##2##4##(2008-10#2)
for hydrazine and##3##3##(2008-10#3)
for hydrazine is##2##3##(2008-10#2)
for hydrazine##7##2##(2008-10#7)
for hydrodynamic##2##2##(2008-10#1)(2008-12#1)
for hydrogen peroxide##12##3##(2008-10#10)(2008-5#1)(2012-2#1)
for hydrogen sulfide determination##2##4##(2008-10#2)
for hydrogen sulfide##3##3##(2008-10#3)
for hydrogen##22##2##(1991-3#1)(1996-5#1)(2008-10#16)(2008-5#2)(2008-7#1)(2012-2#1)
for hydrophobic##4##2##(2008-10#4)
for hydroquinone##6##2##(2008-10#6)
for hydroxyl##2##2##(2008-10#1)(2008-4#1)
for hygroscopic##2##2##(1996-12#2)
for hypertension and##3##3##(1994-6#1)(2007-8#1)(2008-10#1)
for hypertension##5##2##(1994-6#2)(2007-8#1)(2008-10#1)(2010-5#1)
for hyphal##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
for hypothesis testing and##2##4##(2008-10#2)
for hysterectomy##3##2##(1991-1#1)(1994-2#1)(2010-3#1)
for i##2##2##(1993-8#1)(2008-1#1)
for ibuprofen##2##2##(2008-10#2)
for identical twin boys with childhood apraxia of speech (CAS)##2##10##(2011-1#2)
for identification and##7##3##(1995-12#1)(1997-7#1)(2008-10#4)(2013-8#1)
for identification of##17##3##(1995-12#1)(2008-10#8)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
for identification##28##2##(1995-12#2)(1997-7#2)(2008-1#1)(2008-10#13)(2008-4#1)(2008-7#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for identifying and##3##3##(2008-10#2)(2008-7#1)
for identifying novel##2##3##(2008-9#1)(2013-8#1)
for identifying potential##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
for identifying the##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)
for identifying##46##2##(1991-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#2)(2008-10#10)(2008-11#7)(2008-4#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
for idiopathic##4##2##(1997-3#1)(2008-7#2)(2012-3#1)
for illicit##2##2##(2008-10#2)
for illustrative purposes##2##3##(1992-2#1)(2010-7#1)
for image##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#1)
for imaging in##2##3##(1990-11#1)(2008-9#1)
for imaging of##3##3##(1990-11#1)(2010-12#1)(2011-7#1)
for imaging the anterior segment of the eye##2##8##(2011-7#2)
for imaging##22##2##(1990-11#2)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-7#3)(2012-2#2)
for immediate##8##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#2)(2011-7#1)(2012-2#1)
for immobilization##2##2##(2008-10#2)
for immobilizing##4##2##(2008-10#4)
for immune##3##2##(2008-1#1)(2008-10#2)
for immunization##3##2##(1997-8#1)(2008-10#2)
for immunoassay##2##2##(2008-10#1)(2008-11#1)
for immunoassays##5##2##(2008-10#5)
for immunoglobulin##2##2##(2008-7#1)(2009-8#1)
for immunolocalization of##2##3##(1994-2#1)(2008-9#1)
for immunolocalization##3##2##(1994-2#1)(2008-11#1)(2008-9#1)
for immunologic##2##2##(1990-12#1)(2011-2#1)
for immunotoxicology evaluation##2##3##(2008-10#2)
for impact##3##2##(2008-4#2)(2013-8#1)
for impaction and##2##3##(2008-11#1)(2013-8#1)
for impaired##3##2##(2008-11#2)(2008-5#1)
for implant##2##2##(2010-12#1)(2012-2#1)
for implantable##3##2##(2008-7#1)(2009-10#1)(2010-8#1)
for implantation##2##2##(1995-11#1)(2010-12#1)
for implementation of##4##3##(2008-11#3)(2008-7#1)
for implementation##8##2##(1993-12#1)(2008-11#4)(2008-7#2)(2010-8#1)
for implementing##10##2##(1991-2#1)(1994-1#2)(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-8#2)
for important##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
for improved##19##2##(1993-8#1)(1995-8#1)(2008-10#4)(2008-11#3)(2008-3#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-1#1)(2012-2#1)(2013-1#1)
for improvement in##3##3##(1996-2#1)(2008-11#1)(2012-12#1)
for improvement of the##2##4##(1996-8#1)(2008-10#1)
for improvement of##9##3##(1996-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
for improvement##23##2##(1991-1#1)(1994-12#2)(1994-2#2)(1996-2#2)(1996-8#1)(1997-4#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
for improvements in##2##3##(1994-1#1)(2008-5#1)
for improving both##2##3##(1991-3#1)(1997-2#1)
for improving pathogen##2##3##(2008-10#2)
for improving the##13##3##(1991-1#1)(1993-2#1)(1994-1#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-9#2)(2012-12#1)(2013-1#1)
for improving##55##2##(1991-1#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#3)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
for in a##4##3##(1996-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
for in planta##2##3##(2008-10#2)
for in situ gas sampling##2##5##(2012-2#2)
for in situ monitoring##2##4##(2008-10#2)
for in situ##18##3##(2008-10#11)(2008-3#3)(2008-7#1)(2008-8#1)(2012-2#2)
for in the##4##3##(1992-3#1)(1997-3#1)(2008-3#1)(2009-5#1)
for in vitro and in vivo##2##6##(1996-12#1)(2008-10#1)
for in vitro selection##4##4##(1997-6#1)(2008-4#3)
for in vitro studies##4##4##(1997-1#1)(2008-10#1)(2008-11#2)
for in vitro testing##2##4##(1994-2#1)(2008-5#1)
for in vitro##23##3##(1994-2#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-6#2)(2008-10#4)(2008-11#4)(2008-4#3)(2008-5#3)(2008-7#2)
for in vivo##9##3##(1992-6#1)(1993-8#1)(2008-10#1)(2008-4#2)(2009-3#1)(2010-6#2)(2011-7#1)
for in##64##2##(1991-6#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#2)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-6#3)(2011-2#1)(2011-7#1)(2012-2#2)
for in-depth##2##2##(2008-9#1)(2013-8#1)
for in-line##3##2##(2008-10#3)
for inbreeding avoidance##3##3##(2008-9#3)
for incapacitation##2##2##(1996-12#2)
for incidence of##2##3##(2008-10#2)
for incidence##4##2##(2008-10#4)
for incident##2##2##(1997-3#1)(2008-2#1)
for including##2##2##(1996-1#1)(2008-5#1)
for inclusion in##3##3##(1996-1#1)(2008-7#1)(2013-1#1)
for inclusion of##2##3##(1995-5#1)(2008-9#1)
for inclusion production##2##3##(2008-10#2)
for inclusion##13##2##(1995-5#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#4)
for incomplete##2##2##(1996-12#1)(2010-8#1)
for incorporating##6##2##(1994-12#1)(1995-12#1)(2008-10#2)(2008-12#1)(2013-1#1)
for incorporation of##2##3##(2008-10#1)(2008-4#1)
for incorporation##4##2##(1996-2#1)(2008-10#2)(2008-4#1)
for increase##2##2##(2008-12#1)(2008-3#1)
for increased##24##2##(1993-3#1)(1995-11#2)(2008-10#7)(2008-12#1)(2008-8#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
for increases in##2##3##(2008-9#1)(2009-5#1)
for increasing the##11##3##(1992-2#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#1)(2012-4#1)
for increasing##21##2##(1992-2#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-8#2)(2012-4#1)(2013-1#1)(2013-8#2)
for independent##2##2##(2008-10#2)
for indirect determination of##3##4##(2008-10#3)
for indirect monitoring of the##2##5##(2008-10#2)
for indirect##9##2##(1991-12#1)(2008-10#6)(2012-3#1)(2013-8#1)
for individual based##2##3##(1997-6#2)
for individual patients##2##3##(2013-1#2)
for individual services##2##3##(1995-12#1)(1997-3#1)
for individual##30##2##(1991-12#1)(1992-6#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-3#2)(1997-6#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
for individualized##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
for individuals who##2##3##(1997-3#1)(2012-3#1)
for individuals with##6##3##(1993-1#1)(1993-3#1)(1994-12#2)(2008-11#1)(2013-8#1)
for individuals##9##2##(1992-1#1)(1993-1#1)(1993-3#1)(1994-12#2)(1997-3#1)(2008-11#1)(2012-3#1)(2013-8#1)
for inducing##11##2##(1991-2#1)(1991-6#1)(1995-2#1)(2008-10#3)(2008-4#2)(2008-5#2)(2008-9#1)
for induction of##8##3##(1991-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
for induction##11##2##(1990-6#1)(1991-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
for industrial applications##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
for industrial##12##2##(1991-5#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
for indwelling electrodes##3##3##(2012-2#3)
for indwelling##4##2##(2012-2#4)
for inertial confinement fusion (ICF)##2##5##(2008-3#2)
for infant abduction prevention and response##2##6##(1996-12#2)
for infant##5##2##(1994-3#1)(1995-5#1)(1996-12#2)(2012-2#1)
for infants and##2##3##(1992-1#1)(2012-2#1)
for infants with##4##3##(1993-3#2)(2008-10#1)(2008-11#1)
for infants##12##2##(1992-1#1)(1993-12#1)(1993-3#2)(1994-9#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-6#2)(2012-2#1)
for infection and##3##3##(2008-10#3)
for infection by##5##3##(2008-10#4)(2008-12#1)
for infection efficiency##2##3##(2008-10#2)
for infection of##8##3##(2008-10#6)(2008-5#1)(2008-7#1)
for infection to occur##2##4##(2008-10#2)
for infection was##2##3##(2008-10#2)
for infection##35##2##(2008-10#29)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
for infectious diseases##3##3##(1997-3#2)(2010-6#1)
for infectious##4##2##(1997-3#2)(2008-4#1)(2010-6#1)
for inferring##3##2##(2008-4#2)(2010-10#1)
for infertility##3##2##(1991-3#1)(1993-3#1)(2008-12#1)
for inflammatory##5##2##(1994-6#1)(1996-2#1)(1997-8#1)(2008-7#1)(2012-2#1)
for influx and efflux##2##4##(1994-8#2)
for information on##2##3##(1991-3#1)(1994-6#1)
for information systems##2##3##(1995-1#2)
for information##14##2##(1991-3#1)(1994-6#1)(1995-1#2)(1996-6#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)
for inhalation##2##2##(1996-3#1)(1997-2#1)
for inherent##2##2##(1994-11#2)
for inhibiting##4##2##(1995-11#1)(2008-10#1)(2008-4#2)
for inhibition of##8##3##(1995-11#1)(1995-12#1)(1996-5#1)(2008-10#4)(2012-2#1)
for inhibition##10##2##(1993-3#1)(1995-11#1)(1995-12#1)(1996-5#1)(2008-10#5)(2012-2#1)
for inhibitors of##4##3##(2008-11#1)(2009-6#1)(2013-1#2)
for initial##11##2##(1991-2#1)(1992-4#1)(1992-6#1)(1994-5#1)(1995-3#1)(2008-10#3)(2010-9#1)(2011-2#1)(2012-12#1)
for initiating##2##2##(2008-5#1)(2008-8#1)
for injection##4##2##(2008-10#1)(2011-3#2)(2013-1#1)
for innovation##2##2##(2008-11#1)(2010-5#1)
for inoperable##2##2##(1993-6#1)(1996-3#1)
for inorganic and organic##2##4##(2008-10#2)
for inorganic and##3##3##(2008-10#3)
for inorganic arsenic##3##3##(2008-10#3)
for inorganic##10##2##(2008-10#10)
for inpatient care##3##3##(1991-1#1)(1991-3#1)(1993-3#1)
for inpatient##9##2##(1991-1#1)(1991-3#2)(1993-12#1)(1993-3#1)(1996-3#1)(2010-10#2)(2012-2#1)
for insect cell culture##2##4##(2008-11#2)
for insect##5##2##(1995-6#1)(2008-10#1)(2008-11#2)(2009-8#1)
for insecticide##2##2##(1996-12#1)(2008-10#1)
for insensitivity in the##2##4##(2008-10#2)
for insensitivity to##2##3##(2008-10#2)
for insensitivity##4##2##(2008-10#4)
for inserting##2##2##(1993-12#1)(2008-10#1)
for insertion of##3##3##(2008-11#1)(2008-8#1)(2010-7#1)
for insertional mutagenesis##2##3##(2008-10#2)
for insertional##3##2##(2008-10#2)(2010-3#1)
for insomnia##2##2##(2013-1#2)
for instance##11##2##(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-10#1)(2010-7#1)
for instrumental##2##2##(2008-10#1)(2008-4#1)
for insulin resistance##5##3##(1994-12#1)(2011-1#3)(2013-8#1)
for insulin##13##2##(1993-8#1)(1994-11#2)(1994-12#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-11#1)(2011-1#3)(2012-2#1)(2013-8#1)
for insulin-like growth factor##2##4##(2008-8#1)(2010-4#1)
for insulin-like growth##3##3##(2008-8#2)(2010-4#1)
for insurance##2##2##(1995-1#1)(1996-2#1)
for intact##2##2##(1995-6#1)(2013-8#1)
for integrated##8##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2012-12#1)
for integrating the##2##3##(2008-6#1)(2009-11#1)
for integrating##7##2##(1991-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-11#1)(2010-7#1)
for integration##5##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
for intensity and initial rate measurements##2##6##(2008-10#2)
for intensity##3##2##(2008-10#2)(2010-1#1)
for intensive##4##2##(1992-1#1)(1997-2#1)(2007-11#1)(2011-2#1)
for interacting##2##2##(2008-4#1)(2008-8#1)
for interaction##3##2##(1990-4#1)(2008-10#1)(2010-11#1)
for interactions##3##2##(1991-7#1)(2012-3#1)(2013-1#1)
for interactive##2##2##(2008-6#1)(2008-9#1)
for interdisciplinary##3##2##(1991-6#1)(1996-1#1)(1996-2#1)
for interference##5##2##(2008-10#3)(2008-2#1)(2012-2#1)
for interferences##2##2##(2008-10#2)
for intermediate##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
for internal##5##2##(1990-3#1)(1992-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
for international##5##2##(1993-2#1)(1996-8#1)(2008-10#1)(2008-11#2)
for interpretation of##2##3##(1991-12#1)(2009-8#1)
for interpretation##3##2##(1991-1#1)(1991-12#1)(2009-8#1)
for interpreting the##2##3##(1996-2#1)(2008-10#1)
for interpreting##6##2##(1996-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)
for interprofessional education##2##3##(2008-11#2)
for interprofessional##3##2##(2008-11#2)(2012-12#1)
for intervention research##2##3##(2008-2#1)(2011-2#1)
for intervention##11##2##(1991-2#1)(1992-12#1)(1994-6#1)(1995-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
for interventions##4##2##(2009-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
for intestinal##2##2##(1992-5#1)(2011-2#1)
for intimate##2##2##(2010-11#1)(2012-2#1)
for intracellular processing##3##3##(1993-8#3)
for intracellular##7##2##(1993-8#3)(2008-11#2)(2008-8#1)(2008-9#1)
for intracranial##2##2##(2008-7#2)
for intractable##3##2##(2008-7#1)(2010-12#1)(2010-7#1)
for intraoperative##2##2##(1992-2#1)(2013-1#1)
for intravenous##3##2##(1993-6#1)(2008-1#1)(2009-12#1)
for intrinsic##2##2##(2011-2#1)(2013-1#1)
for introducing##4##2##(1997-1#1)(2008-4#2)(2009-11#1)
for introduction##2##2##(2008-9#1)(2010-9#1)
for invasion##3##2##(2008-10#3)
for invasive procedures##3##3##(2012-2#2)(2013-1#1)
for invasive##7##2##(1991-2#1)(1994-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
for investigating the##5##3##(1993-8#1)(1997-2#1)(2008-10#1)(2008-6#1)(2010-6#1)
for investigating##13##2##(1993-8#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-3#1)(2012-2#1)
for investigation of the effect of##2##6##(2008-10#1)(2008-3#1)
for investigation of the##7##4##(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#1)
for investigation of##8##3##(1995-12#1)(2008-10#5)(2008-11#1)(2008-3#1)
for investigation##13##2##(1994-6#1)(1995-12#1)(1996-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)
for investigations of##2##3##(1993-1#1)(2008-10#1)
for investigations##3##2##(1993-1#1)(2008-10#2)
for investigators to##2##3##(2008-5#1)(2012-3#1)
for investigators##5##2##(2008-4#1)(2008-5#1)(2009-10#1)(2012-12#1)(2012-3#1)
for involvement of the##2##4##(1994-5#1)(2008-4#1)
for involvement##3##2##(1994-5#1)(2008-12#1)(2008-4#1)
for iodide ion##2##3##(2008-10#2)
for iodide##5##2##(2008-10#5)
for ion##4##2##(2008-10#3)(2012-7#1)
for ion-selective electrode##2##3##(2008-10#2)
for ion-selective##4##2##(2008-10#4)
for ionic conduction##2##3##(2010-7#2)
for ionic##5##2##(2008-10#1)(2008-11#1)(2010-7#3)
for iron and zinc##2##4##(2008-10#2)
for iron and##3##3##(2008-10#3)
for iron determination##2##3##(2008-10#2)
for iron##17##2##(2008-10#17)
for iron(III)##2##2##(2008-10#2)
for irradiation##3##2##(1994-11#1)(2008-10#2)
for irreversible##2##2##(1991-3#1)(2008-5#1)
for irrigation##2##2##(2008-10#2)
for ischemic stroke##3##3##(2008-9#1)(2012-12#2)
for ischemic##4##2##(2008-10#1)(2008-9#1)(2012-12#2)
for isocitrate##3##2##(2008-10#3)
for isofraxidin and##3##3##(2008-10#3)
for isolate##3##2##(2008-10#3)
for isolated##6##2##(1993-8#2)(1994-8#1)(2008-10#2)(2012-3#1)
for isolates CS-1##3##3##(2008-10#3)
for isolates collected from##4##4##(2008-10#4)
for isolates from##4##3##(2008-10#4)
for isolates##17##2##(2008-10#17)
for isolating##10##2##(1993-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#2)
for isolation of##12##3##(1994-6#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-9#3)(2011-2#1)
for isolation##14##2##(1994-6#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-9#4)(2011-2#1)
for isoniazid##4##2##(2008-10#4)
for isotopic analysis##2##3##(2008-10#2)
for isotopic##3##2##(2008-10#2)(2008-4#1)
for it to be##2##4##(1990-2#1)(2008-7#1)
for it to##3##3##(1990-2#1)(1995-5#1)(2008-7#1)
for it!##2##2##(1994-12#1)(2008-4#1)
for items with##2##3##(2010-2#1)(2012-2#1)
for items##4##2##(1993-1#1)(2010-2#1)(2012-2#2)
for its ability to##6##4##(2008-10#5)(2009-9#1)
for its ability##7##3##(2008-10#5)(2008-11#1)(2009-9#1)
for its assembly##2##3##(2008-11#1)(2008-8#1)
for its detection##3##3##(2008-10#3)
for its determination in##3##4##(2008-10#3)
for its determination##8##3##(1997-2#2)(2008-10#6)
for its patients##2##3##(1992-3#1)(1996-1#1)
for its potential to##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
for its role in##5##4##(1995-2#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
for its strong##2##3##(2008-9#1)(2010-11#1)
for its treatment##2##3##(2011-2#1)(2012-12#1)
for its use in the##4##5##(2008-1#1)(2008-10#2)(2011-2#1)
for its use in##8##4##(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)
for its use##10##3##(2008-1#1)(2008-10#4)(2008-7#2)(2010-12#1)(2010-6#1)(2011-2#1)
for its##150##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-12#3)(1995-2#3)(1995-6#2)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#52)(2008-11#7)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#4)(2009-2#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#15)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
for jfm binding##2##3##(1990-2#2)
for jobs##3##2##(1990-2#1)(1993-1#2)
for joint##2##2##(2012-3#1)(2013-1#1)
for judging##2##2##(2008-3#1)(2010-4#1)
for just##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
for juvenile myelomonocytic leukemia##2##4##(2013-1#2)
for juvenile##4##2##(2008-11#2)(2013-1#2)
for k##3##2##(1992-9#2)(1996-3#1)
for keeping##3##2##(2008-1#1)(2008-5#1)(2010-9#1)
for key##4##2##(1995-12#1)(2008-11#1)(2010-6#1)(2010-8#1)
for kidney##9##2##(1994-5#2)(1995-2#1)(1995-9#2)(2008-11#1)(2011-2#2)(2012-3#1)
for kinetic analysis of soluble Interleukin-1 receptor I##2##8##(2008-10#2)
for kinetic##4##2##(2008-10#4)
for knowledge##4##2##(1993-3#1)(1997-5#1)(2008-11#1)(2010-10#1)
for known##3##2##(1991-6#1)(2008-10#1)(2011-2#1)
for l-cysteine and glutathione##3##4##(2008-10#3)
for l-cysteine and##4##3##(2008-10#4)
for labeling##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
for labor##3##2##(2010-10#1)(2011-2#1)(2012-3#1)
for laboratories##2##2##(2008-11#1)(2013-1#1)
for laboratory##9##2##(1992-12#1)(1993-1#1)(1994-12#2)(1996-6#1)(2008-10#4)
for laboratory-scale##2##2##(2008-4#2)
for lack of##3##3##(1990-2#1)(2008-10#2)
for language##2##2##(1996-2#1)(2012-3#1)
for lanthanide##2##2##(2008-10#2)
for lanthanides##2##2##(2008-10#2)
for laparoscopic surgery##2##3##(2010-7#1)(2012-3#1)
for laparoscopic##8##2##(1993-12#1)(1994-3#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
for large and##2##3##(2008-7#1)(2011-2#1)
for large numbers of##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
for large scale##5##3##(2008-10#2)(2008-11#3)
for large##23##2##(1991-1#1)(1993-11#1)(1995-1#1)(1997-2#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#2)(2009-7#1)(2010-8#1)(2011-2#1)
for large-scale expansion of NSCs##2##5##(2008-11#2)
for large-scale production##2##3##(1992-11#1)(2011-2#1)
for large-scale##17##2##(1992-11#1)(1993-9#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#2)(2013-8#2)
for larger##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
for larval##2##2##(1996-12#1)(2008-8#1)
for laryngeal carcinoma##3##3##(2011-2#3)
for laryngopharyngitis##2##2##(2011-2#2)
for laser##5##2##(1996-1#1)(2008-3#3)(2008-9#1)
for late blight##2##3##(2008-10#2)
for late##4##2##(2008-10#3)(2008-11#1)
for latent infection##2##3##(2008-10#2)
for latent period##3##3##(2008-10#3)
for latent##6##2##(2008-10#5)(2012-2#1)
for later##10##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
for lateral##2##2##(2007-12#1)(2008-9#1)
for latex##2##2##(1990-12#1)(2008-10#1)
for leaching of##2##3##(2008-10#2)
for leaching##4##2##(2008-10#4)
for lead (II)##2##3##(2008-10#2)
for lead and##8##3##(2008-10#8)
for lead concentration of##2##4##(2008-10#2)
for lead determination by##3##4##(2008-10#3)
for lead determination in##2##4##(2008-10#2)
for lead determination using##2##4##(2008-10#2)
for lead determination##8##3##(2008-10#8)
for lead in##2##3##(2008-10#2)
for lead##40##2##(1990-8#1)(2008-10#38)(2009-5#1)
for lead(II)##2##2##(2008-10#2)
for leaf infection##2##3##(2008-10#2)
for leaf rust and stripe rust##3##6##(2008-10#3)
for leaf rust resistance##4##4##(2008-10#4)
for leaf rust##8##3##(2008-10#8)
for leaf##14##2##(2008-10#12)(2008-8#1)(2009-5#1)
for leaflets and leaves##2##4##(2008-10#2)
for learners##2##2##(2008-12#2)
for learning and memory in##2##5##(2008-10#1)(2009-8#1)
for learning and memory##3##4##(2008-10#1)(2009-8#1)(2012-2#1)
for learning and##4##3##(2008-10#1)(2009-8#1)(2012-2#2)
for learning##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-2#2)
for left ventricular##2##3##(1992-12#1)(2008-12#1)
for left##5##2##(1992-12#1)(2008-12#1)(2011-2#3)
for lesbian and##2##3##(1992-1#1)(2008-12#1)
for lesion##4##2##(1997-8#2)(2008-10#2)
for lesions##4##2##(1994-12#1)(2008-10#2)(2012-2#1)
for less than##8##3##(1990-6#1)(1991-2#1)(1993-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
for less##11##2##(1990-6#1)(1991-2#1)(1992-1#1)(1993-2#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2009-12#1)(2013-1#1)
for levels of##2##3##(2010-8#1)(2013-8#1)
for levodopa##2##2##(2008-10#1)(2010-12#1)
for lidar##4##2##(2008-3#4)
for lidocaine##3##2##(1993-1#1)(2008-10#2)
for life##6##2##(1991-12#1)(1996-5#1)(2008-10#1)(2008-7#1)(2011-3#2)
for life-prolonging##2##2##(2009-11#2)
for lifelong##2##2##(2008-8#1)(2012-12#1)
for ligand##3##2##(1994-8#1)(2008-10#2)
for ligands##3##2##(1990-8#1)(2008-10#2)
for light##11##2##(2006-6#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
for limited##4##2##(1995-2#1)(2008-10#1)(2010-12#1)(2011-2#1)
for limiting##3##2##(1992-2#1)(2008-12#1)(2008-8#1)
for linear##3##2##(1995-9#2)(2008-10#1)
for linearity##2##2##(1997-2#1)(2008-10#1)
for linkage##2##2##(2008-10#1)(2008-7#1)
for lipid lowering##2##3##(2009-12#1)(2009-6#1)
for lipid##7##2##(1990-5#3)(2008-10#1)(2008-11#1)(2009-12#1)(2009-6#1)
for liquid chromatographic##2##3##(2008-10#2)
for liquid chromatography##5##3##(2008-10#5)
for liquid##12##2##(1995-11#1)(2008-10#10)(2008-7#1)
for lithium determination in##2##4##(2008-10#2)
for lithium##3##2##(2008-10#3)
for liver cancer##3##3##(1990-8#1)(2010-12#1)(2013-1#1)
for liver imaging##2##3##(2010-12#2)
for liver##13##2##(1990-8#1)(1991-8#1)(1995-10#1)(2008-9#1)(2009-8#2)(2010-12#3)(2011-2#1)(2013-1#3)
for livestock production##2##3##(2011-2#2)
for livestock##3##2##(2010-1#1)(2011-2#2)
for local##11##2##(1992-12#1)(1994-2#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)
for localization##3##2##(1994-11#1)(1996-6#2)
for localized##2##2##(2008-7#1)(2008-9#1)
for locating the##2##3##(2007-12#1)(2008-10#1)
for locating##3##2##(1990-5#1)(2007-12#1)(2008-10#1)
for long term##4##3##(1993-3#1)(2008-11#1)(2008-8#1)(2011-3#1)
for long##10##2##(1993-3#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-3#1)
for long-range##2##2##(2008-3#1)(2008-4#1)
for long-term care##4##3##(1995-3#1)(1997-1#2)(2013-1#1)
for long-term maintenance of##2##4##(2008-11#1)(2008-7#1)
for long-term storage##2##3##(2008-10#1)(2008-9#1)
for long-term##31##2##(1990-6#1)(1992-2#1)(1995-2#2)(1995-3#1)(1997-1#3)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-7#3)(2008-9#4)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
for longer time##2##3##(2008-12#1)(2013-8#1)
for longer##5##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
for lopinavir##3##2##(2011-3#3)
for loss of##2##3##(1996-11#1)(2008-10#1)
for loved ones##2##3##(2009-5#1)(2013-8#1)
for low back pain##2##4##(1993-6#1)(2012-3#1)
for low concentrations of##2##4##(2008-10#2)
for low concentrations##3##3##(2008-10#3)
for low dose studies##2##4##(2008-7#2)
for low molecular##2##3##(2008-10#2)
for low##27##2##(1991-7#1)(1993-3#1)(1993-6#1)(1997-3#1)(2008-10#16)(2008-3#2)(2008-7#2)(2012-3#2)(2013-1#1)
for low-coherence interferometry##2##3##(2008-3#2)
for low-income##2##2##(1992-2#1)(1995-12#1)
for low-level##5##2##(2008-10#3)(2008-2#2)
for lower##7##2##(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#1)(2013-1#2)
for lumbar disc##2##3##(2012-12#1)(2013-1#1)
for lumbar##5##2##(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
for luminescence##3##2##(2008-10#3)
for luminol##2##2##(2008-10#2)
for lung cancer##7##3##(1990-12#1)(1990-8#1)(1996-3#1)(2008-11#2)(2011-2#1)(2013-1#1)
for lung##10##2##(1990-12#1)(1990-8#1)(1991-12#1)(1996-3#1)(2008-11#2)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
for lymph node metastasis##2##4##(1990-2#1)(2013-1#1)
for lymph##4##2##(1990-2#1)(1997-7#1)(2009-12#1)(2013-1#1)
for lymphocytes##2##2##(1990-3#1)(2008-11#1)
for lysozyme##2##2##(2008-10#2)
for m##3##2##(2008-10#1)(2013-1#2)
for m-nitroaniline##2##2##(2008-10#2)
for mAb##2##2##(1996-12#1)(2008-11#1)
for mRNA##2##2##(2010-11#1)(2012-2#1)
for magnesium##6##2##(2008-10#5)(2008-7#1)
for magnetic resonance imaging##2##4##(1992-3#1)(2011-2#1)
for magnetic resonance##3##3##(1992-3#1)(2011-2#2)
for magnolol##2##2##(2008-10#1)(2011-2#1)
for maintaining the##3##3##(2008-8#2)(2008-9#1)
for maintaining##15##2##(2008-11#7)(2008-7#1)(2008-8#3)(2008-9#2)(2011-2#2)
for maintenance of##8##3##(1991-7#1)(1995-2#1)(2008-11#2)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
for maintenance##12##2##(1991-7#1)(1995-2#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
for maize##3##2##(2008-10#2)(2008-12#1)
for major##10##2##(2008-10#3)(2008-8#1)(2011-2#4)(2012-2#1)(2012-3#1)
for making a##2##3##(1992-5#1)(1997-8#1)
for making##17##2##(1991-11#1)(1992-2#1)(1992-5#1)(1994-1#2)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-8#1)
for malaria##5##2##(1997-7#1)(2012-12#3)(2013-1#1)
for male fertility##2##3##(2008-9#1)(2012-2#1)
for male##6##2##(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)
for males and##6##3##(1991-6#2)(2008-10#1)(2008-7#2)(2013-1#1)
for males than##2##3##(2008-8#1)(2008-9#1)
for males##13##2##(1991-6#2)(1994-6#1)(2008-10#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2013-1#1)
for malformations##2##2##(2008-10#1)(2011-2#1)
for malignant transformation##2##3##(1990-5#1)(1990-8#1)
for malignant##8##2##(1990-10#1)(1990-5#1)(1990-8#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-11#1)(2013-1#1)
for malpractice##3##2##(1992-2#1)(1996-2#1)(1997-8#1)
for mammalian cell##3##3##(2008-11#2)(2008-9#1)
for mammalian cells##5##3##(1993-12#1)(2008-11#3)(2008-7#1)
for mammalian##12##2##(1993-12#1)(2008-11#7)(2008-7#1)(2008-9#2)(2012-2#1)
for managed care##6##3##(1994-12#1)(1994-2#1)(1995-1#2)(1996-3#1)(2008-6#1)
for management of##11##3##(1997-2#1)(2008-10#3)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
for management##25##2##(1992-1#1)(1992-2#1)(1994-1#1)(1997-2#1)(2008-10#7)(2008-11#6)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
for managers##3##2##(1991-1#1)(1993-1#1)(1994-2#1)
for managing##13##2##(1991-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-9#1)(2012-12#1)(2013-1#2)
for manganese and##3##3##(2008-10#3)
for manganese##8##2##(2008-10#8)
for manganese(II)##2##2##(2008-10#2)
for manipulating##2##2##(2008-6#1)(2009-5#1)
for manual##4##2##(2008-10#2)(2008-4#1)(2010-9#1)
for many different##2##3##(2008-7#1)(2008-9#1)
for many months##3##3##(1996-6#1)(2008-10#1)(2008-9#1)
for many of the##2##4##(2008-11#1)(2012-3#1)
for many of##4##3##(1994-2#1)(2008-11#1)(2008-9#1)(2012-3#1)
for many other applications##2##4##(1997-7#1)(2012-2#1)
for many other##4##3##(1997-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
for many patients##3##3##(1992-2#1)(2008-11#1)(2012-2#1)
for many people##2##3##(1997-4#1)(2008-12#1)
for many years##10##3##(1991-12#1)(1993-3#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-5#1)(2011-7#1)
for many##62##2##(1991-12#2)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)
for mapping##7##2##(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
for marine water##2##3##(2008-10#2)
for marine##4##2##(2008-10#3)(2008-2#1)
for marker-assisted selection of##2##4##(2008-10#2)
for marker-assisted selection##7##3##(2008-10#7)
for marker-assisted##8##2##(2008-10#8)
for marketing##3##2##(2008-5#1)(2012-2#2)
for mass production of##2##4##(2008-11#2)
for mass production##5##3##(2008-10#2)(2008-11#2)(2008-3#1)
for mass##14##2##(1990-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2010-7#1)(2010-8#1)(2011-2#1)
for massive##2##2##(2008-5#1)(2012-3#1)
for mast##2##2##(1995-11#1)(2008-8#1)
for mate##2##2##(1995-6#1)(2008-8#1)
for materials##3##2##(1996-12#3)
for maternal age##2##3##(2008-10#1)(2010-6#1)
for mating type and##2##4##(2008-10#2)
for mating type##6##3##(2008-10#6)
for mating##11##2##(1995-12#1)(2008-10#7)(2008-8#2)(2008-9#1)
for matrix##3##2##(2008-10#1)(2009-3#1)(2010-7#1)
for maxillofacial surgery##2##3##(1993-1#1)(2012-3#1)
for maximal##9##2##(1991-5#1)(1993-3#1)(1993-8#1)(1997-3#2)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)
for maximizing##3##2##(2008-11#1)(2008-6#1)(2012-2#1)
for maximum##15##2##(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#1)(2012-2#4)
for mean##2##2##(1991-11#1)(2008-10#1)
for measles##2##2##(2011-2#1)(2012-12#1)
for measurement of dissolved##2##4##(2008-10#2)
for measurement of oropharyngeal clearance in##2##6##(1996-2#2)
for measurement of the##4##4##(2008-3#3)(2011-2#1)
for measurement of##24##3##(1996-2#2)(2008-10#8)(2008-12#1)(2008-3#3)(2008-4#3)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
for measurement##30##2##(1996-2#2)(2008-10#13)(2008-12#1)(2008-3#3)(2008-4#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
for measurements of##6##3##(2008-10#3)(2008-3#2)(2010-11#1)
for measurements##9##2##(2008-10#4)(2008-3#3)(2009-9#1)(2010-11#1)
for measuring chlorine dioxide in##2##5##(2008-10#2)
for measuring phase##3##3##(2008-3#3)
for measuring prescribing volume##2##4##(2008-11#2)
for measuring the##24##3##(1990-11#1)(1991-5#1)(1994-8#1)(1996-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#6)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
for measuring##85##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-5#2)(1992-1#1)(1992-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-6#1)(2007-11#2)(2008-10#22)(2008-11#5)(2008-2#2)(2008-3#16)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#4)
for meat##2##2##(2011-2#1)(2013-1#1)
for mechanical ventilation##2##3##(1994-6#1)(2008-11#1)
for mechanical##5##2##(1994-6#1)(2008-10#1)(2008-11#1)(2010-6#1)(2013-8#1)
for medical and##3##3##(1993-12#1)(1994-12#1)(2008-10#1)
for medical appointments##2##3##(2013-8#2)
for medical care##4##3##(1991-12#1)(1993-12#1)(1995-2#1)(2008-3#1)
for medical group##3##3##(1993-1#1)(1994-1#2)
for medical manpower##3##3##(1990-6#3)
for medical personnel##2##3##(2008-10#1)(2013-1#1)
for medical practitioners##2##3##(2009-10#1)(2013-8#1)
for medical##47##2##(1990-6#3)(1991-12#3)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#3)(1993-6#1)(1994-1#2)(1994-12#2)(1995-2#1)(1996-2#1)(1996-9#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
for medically##4##2##(1993-1#2)(2008-10#2)
for medication##2##2##(2011-1#1)(2011-2#1)
for medicinal##2##2##(2008-10#1)(2012-3#1)
for medicine##2##2##(1992-3#1)(2011-2#1)
for medium optimization##2##3##(2008-11#2)
for medium##4##2##(2008-11#4)
for medulloblastoma##3##2##(1997-3#2)(2008-7#1)
for meeting##3##2##(1994-2#2)(2010-8#1)
for meiotic##2##2##(2008-9#1)(2012-3#1)
for melanoma##6##2##(1994-5#1)(1997-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
for members of the##4##4##(1996-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
for membrane##6##2##(1990-5#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-11#1)(2011-1#1)
for memory##3##2##(1995-5#1)(2008-10#1)(2008-8#1)
for men in Okinawa##2##4##(2008-10#2)
for men in##3##3##(1997-4#1)(2008-10#2)
for men##12##2##(1990-6#1)(1991-7#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#1)(2009-5#1)(2011-2#1)(2011-7#1)(2012-12#1)
for mental health nurses##2##4##(2008-11#1)(2008-12#1)
for mental health professionals to##2##5##(2009-9#2)
for mental health professionals##3##4##(2008-11#1)(2009-9#2)
for mental health##11##3##(1992-2#1)(2008-11#3)(2008-12#2)(2009-9#2)(2012-2#1)(2013-1#2)
for mental##13##2##(1992-2#1)(1997-4#1)(2008-11#3)(2008-12#2)(2009-9#2)(2012-2#1)(2012-3#1)(2013-1#2)
for mentally retarded##2##3##(1991-6#1)(1997-8#1)
for mequitazine##2##2##(2008-10#2)
for mercuric ion##2##3##(2008-10#2)
for mercury (II)##2##3##(2008-10#2)
for mercury ions were##2##4##(2008-10#2)
for mercury ions##3##3##(2008-10#3)
for mercury speciation##5##3##(2008-10#5)
for mercury##19##2##(2008-10#19)
for mercury(II) chloride##2##3##(2008-10#2)
for mercury(II)##6##2##(2008-10#6)
for mesothelioma##2##2##(1991-12#2)
for meta-analysis##2##2##(1995-12#1)(2008-10#1)
for metabolic##5##2##(1994-6#1)(2008-11#3)(2008-3#1)
for metal analysis##2##3##(2008-10#2)
for metal ion##4##3##(2008-10#4)
for metal ions##8##3##(2008-10#8)
for metal##24##2##(2008-10#23)(2008-8#1)
for metals##2##2##(2008-10#2)
for metastatic disease##2##3##(2007-11#1)(2013-1#1)
for metastatic renal cell carcinoma##2##5##(1991-8#2)
for metastatic##8##2##(1991-8#2)(1994-2#1)(2007-11#1)(2011-2#2)(2011-3#1)(2013-1#1)
for metered dose inhalers##2##4##(1996-1#2)
for methane##3##2##(2008-10#3)
for methanol and##2##3##(2008-10#2)
for methanol##4##2##(2008-10#4)
for methods A and B##3##5##(2008-10#3)
for methyl##4##2##(1992-12#1)(2008-10#2)(2008-11#1)
for methylene##2##2##(2008-10#2)
for micro amounts of nucleic acids##2##6##(2008-10#2)
for microbiological##2##2##(2008-5#1)(2012-2#1)
for microchip##3##2##(2008-10#3)
for microcystin-LR##2##2##(2008-10#2)
for microfluidic##2##2##(2008-10#2)
for microscale analytical systems##2##4##(2008-10#2)
for microscopic##2##2##(2008-4#1)(2013-8#1)
for microscopy##3##2##(2008-9#1)(2009-12#1)(2009-7#1)
for microtubule association##2##3##(1995-2#2)
for microwave##3##2##(2008-10#3)
for middle##2##2##(1995-2#1)(2008-11#1)
for migraine##3##2##(2008-6#1)(2008-9#2)
for migration time and##3##4##(2008-10#3)
for migration time##5##3##(2008-10#5)
for migration times##2##3##(2008-10#2)
for migration##11##2##(1994-8#1)(1995-8#3)(2008-10#7)
for mild##5##2##(1993-1#1)(1995-2#1)(2011-2#1)(2013-1#2)
for milk##3##2##(2008-10#1)(2013-1#2)
for mineral##2##2##(2008-10#2)
for mineralogical##2##2##(2008-10#2)
for minimally##2##2##(2008-10#1)(2009-12#1)
for minimising##2##2##(2008-7#1)(2012-2#1)
for minimizing##3##2##(2008-3#1)(2011-2#2)
for minor##2##2##(2008-10#1)(2008-7#1)
for minority##2##2##(1997-2#1)(2010-11#1)
for mission##2##2##(1992-2#2)
for mitochondrial DNA##2##3##(2008-10#2)
for mitochondrial##5##2##(1995-6#1)(2008-10#2)(2012-3#1)(2013-1#1)
for mitral cell##2##3##(2013-1#2)
for mitral valve repair##3##4##(2008-10#1)(2011-2#2)
for mitral valve##5##3##(2008-10#1)(2011-2#3)(2013-1#1)
for mitral##7##2##(2008-10#1)(2011-2#3)(2013-1#3)
for mixed##4##2##(1997-6#1)(2008-10#2)(2009-7#1)
for mixture##2##2##(2008-10#2)
for mixtures##2##2##(2008-10#2)
for mobile##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2011-2#1)
for mode##2##2##(2008-3#1)(2011-1#1)
for model##4##2##(2008-11#1)(2008-9#1)(2009-12#1)(2010-8#1)
for modeling the##6##3##(2008-10#3)(2008-3#2)(2013-1#1)
for modeling##15##2##(2008-10#6)(2008-11#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-4#1)(2013-1#2)(2013-8#1)
for modelling##3##2##(1993-9#1)(2011-3#2)
for models I and II##2##5##(2008-10#2)
for models##5##2##(1991-12#1)(2007-12#1)(2008-10#2)(2008-11#1)
for moderate or severe hypothermia##2##5##(2011-2#2)
for moderate to severe##2##4##(2008-6#1)(2013-1#1)
for moderate##8##2##(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
for modern##8##2##(1993-12#1)(1994-3#2)(1995-5#1)(1997-5#1)(2011-2#1)(2011-3#1)(2012-3#1)
for modification##3##2##(1993-3#1)(2008-4#1)(2009-10#1)
for modified##2##2##(1993-8#1)(2008-10#1)
for moisture##2##2##(2008-10#1)(2010-4#1)
for molecular analysis##2##3##(1994-8#1)(2010-9#1)
for molecular biology##2##3##(2008-8#1)(2008-9#1)
for molecular cytogenetics##2##3##(2008-9#2)
for molecular imaging##2##3##(2010-6#1)(2010-9#1)
for molecular spectroscopy##2##3##(2008-10#1)(2008-3#1)
for molecular##21##2##(1994-8#1)(1995-11#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#4)(2010-10#1)(2010-6#1)(2010-9#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
for molecules##3##2##(2008-10#1)(2008-11#2)
for molybdenum##3##2##(2008-10#3)
for monitoring and analysing##2##4##(1994-9#2)
for monitoring and##4##3##(1994-9#2)(2008-11#1)(2008-4#1)
for monitoring dedifferentiation##2##3##(2008-11#2)
for monitoring diseases##2##3##(2008-10#1)(2009-12#1)
for monitoring environmental##2##3##(2008-10#2)
for monitoring formaldehyde##3##3##(2008-10#3)
for monitoring metal##2##3##(1994-11#2)
for monitoring of##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
for monitoring the response##2##4##(2006-6#1)(2012-2#1)
for monitoring the service condition of diesel-engine lubricating oils##2##9##(2008-10#2)
for monitoring the##23##3##(1991-2#1)(2006-6#1)(2008-10#17)(2008-3#2)(2008-4#1)(2012-2#1)
for monitoring their##2##3##(1994-12#1)(2008-11#1)
for monitoring trace##3##3##(2008-10#3)
for monitoring##84##2##(1991-2#1)(1994-11#2)(1994-12#1)(1994-9#2)(1997-2#3)(2006-6#2)(2008-10#48)(2008-11#8)(2008-3#3)(2008-4#4)(2008-5#1)(2009-12#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
for mono- and##2##3##(1991-7#1)(2008-10#1)
for mono-##5##2##(1991-7#1)(2008-10#4)
for monolithic##2##2##(2008-10#2)
for monosaccharide##2##2##(1997-2#1)(2008-10#1)
for monovalent##2##2##(2008-10#2)
for more accurate##2##3##(1992-9#1)(2013-1#1)
for more aggressive isolates##2##4##(2008-10#2)
for more comprehensive##2##3##(1995-2#1)(2008-4#1)
for more detailed##2##3##(1995-12#2)
for more effective##4##3##(1990-12#1)(2008-10#2)(2008-4#1)
for more intensive##2##3##(2008-8#2)
for more patients##2##3##(1994-12#1)(2011-2#1)
for more than 1 year##2##5##(2008-10#1)(2008-7#1)
for more than 1##6##4##(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#2)
for more than 10##2##4##(2008-11#2)
for more than 12 days##2##5##(2008-11#2)
for more than 12##5##4##(1990-12#1)(1996-6#1)(2008-11#2)(2012-2#1)
for more than 15##2##4##(2008-10#1)(2008-9#1)
for more than 2 months##2##5##(2008-10#2)
for more than 2 weeks##2##5##(2008-10#1)(2011-2#1)
for more than 2##5##4##(2008-10#3)(2008-11#1)(2011-2#1)
for more than 20 years##3##5##(1993-3#1)(2011-2#2)
for more than 24##2##4##(2008-10#1)(2008-12#1)
for more than 3 months##3##5##(2008-10#3)
for more than 5##2##4##(1991-8#1)(2008-10#1)
for more than 50##3##4##(1996-3#1)(2008-10#2)
for more than 6 months##2##5##(1991-2#1)(2008-10#1)
for more than a century##5##5##(1992-5#1)(1994-3#2)(2008-8#1)(2013-8#1)
for more than a decade##2##5##(1994-12#1)(1996-5#1)
for more than a##8##4##(1992-5#1)(1994-12#1)(1994-3#2)(1996-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
for more than one week##2##5##(1992-1#1)(1994-12#1)
for more than one##4##4##(1992-1#1)(1994-12#1)(2008-10#1)(2011-2#1)
for more than six months##2##5##(2008-1#1)(2008-7#1)
for more than three months##4##5##(1990-12#2)(1996-3#1)(2012-3#1)
for more than three##6##4##(1990-12#2)(1996-3#1)(2006-6#1)(2012-3#2)
for more than two##3##4##(1990-6#1)(1991-9#1)(2008-10#1)
for more than##87##3##(1990-12#4)(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#2)(1993-3#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(2006-6#1)(2008-1#1)(2008-10#25)(2008-11#6)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#4)(2008-9#2)(2011-2#8)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
for more##130##2##(1990-12#5)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(2006-6#1)(2008-1#1)(2008-10#34)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-3#1)(2010-8#1)(2011-2#11)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#1)
for morphine##2##2##(2008-10#2)
for morphological index##2##3##(2008-8#2)
for morphological##5##2##(2008-10#1)(2008-11#1)(2008-8#3)
for mortality and morbidity##2##4##(1992-2#1)(2011-3#1)
for mortality in##2##3##(2008-2#1)(2011-2#1)
for mortality##4##2##(1992-2#1)(2008-2#1)(2011-2#1)(2011-3#1)
for most combinations of##2##4##(2008-10#1)(2008-8#1)
for most elements##3##3##(2008-10#3)
for most locations##2##3##(2008-10#1)(2008-5#1)
for most of the analytes##3##5##(2008-10#3)
for most of the elements##3##5##(2008-10#3)
for most of the##24##4##(1991-9#1)(1994-3#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
for most of these##3##4##(2008-10#3)
for most of##30##3##(1991-9#1)(1994-3#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
for most procedures##2##3##(1993-12#1)(2012-2#1)
for most##71##2##(1990-11#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-3#1)(1997-8#1)(2008-10#39)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
for mother and##2##3##(1992-5#1)(2008-7#1)
for mothers##4##2##(1991-1#1)(1992-2#1)(2008-10#1)(2013-1#1)
for motor##3##2##(2008-7#1)(2010-12#1)(2013-8#1)
for mouse##4##2##(1994-9#1)(1995-8#1)(2008-10#1)(2008-11#1)
for movement##3##2##(1991-5#1)(1993-9#1)(2008-10#1)
for moving##3##2##(1997-1#1)(2008-11#1)(2010-9#1)
for mtDNA##2##2##(2008-10#1)(2008-8#1)
for much of the##2##4##(2008-11#1)(2008-9#1)
for much of##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
for much##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)
for mucormycosis##3##2##(2011-2#3)
for multi-element analysis##2##3##(2008-10#2)
for multi-element##3##2##(2008-10#3)
for multianalyte detection##2##3##(2008-10#2)
for multicolor flow##2##3##(2008-9#2)
for multilevel##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
for multiple comparisons##2##3##(2008-11#2)
for multiple diseases##2##3##(2008-10#1)(2008-7#1)
for multiple generations##2##3##(2008-10#1)(2011-2#1)
for multiple passages##2##3##(2008-11#2)
for multiple scattering##3##3##(2008-3#3)
for multiple sclerosis (MS)##2##4##(1995-12#1)(2010-12#1)
for multiple sclerosis##3##3##(1995-12#1)(2010-12#2)
for multiple##33##2##(1990-9#1)(1991-12#1)(1991-6#1)(1993-2#1)(1995-12#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#5)(2008-7#1)(2010-12#2)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
for multiplex##2##2##(2008-10#2)
for multiplexed##2##2##(2008-9#2)
for multivariate##3##2##(2008-10#3)
for multivessel##2##2##(2008-10#1)(2008-11#1)
for murine##2##2##(1993-8#1)(2008-11#1)
for muscle##4##2##(1990-5#1)(2008-11#2)(2013-1#1)
for musculoskeletal##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
for music##2##2##(2008-9#2)
for mutant##2##2##(2008-8#1)(2008-9#1)
for mutations in##2##3##(1991-12#1)(1994-11#1)
for mutations##4##2##(1991-12#1)(1993-9#1)(1994-11#1)(2008-9#1)
for mycelial##2##2##(2008-10#2)
for myocardial infarction##3##3##(1991-6#1)(1992-12#1)(2008-10#1)
for myocardial regeneration##2##3##(2010-6#2)
for myocardial##8##2##(1991-3#1)(1991-6#1)(1992-12#1)(2008-10#1)(2010-6#2)(2012-2#1)(2013-8#1)
for naphazoline##2##2##(2008-10#2)
for naproxen##2##2##(2008-10#2)
for nasopharyngeal carcinoma##2##3##(1991-8#1)(2008-9#1)
for national##2##2##(1992-12#1)(2008-11#1)
for native##4##2##(1990-5#1)(1992-2#1)(2008-10#1)(2008-11#1)
for natural##7##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
for nearly##11##2##(1992-1#1)(1992-12#1)(1996-11#1)(1996-3#1)(1997-7#2)(2008-10#3)(2008-11#1)(2009-8#1)
for necropsy##2##2##(2008-5#1)(2010-7#1)
for necrotrophic##2##2##(2008-10#2)
for needle##2##2##(2008-8#1)(2009-12#1)
for negative##2##2##(2008-11#2)
for negligent##2##2##(1991-12#1)(1993-12#1)
for neonatal##4##2##(1991-11#1)(1991-2#2)(2008-11#1)
for neoplastic##2##2##(1992-5#1)(1994-5#1)
for nephrectomy in##2##3##(2008-10#2)
for nerve##3##2##(1993-1#1)(2008-10#1)(2012-2#1)
for nervous system##2##3##(2008-7#1)(2009-8#1)
for neuron-specific enolase##2##3##(1991-8#1)(1992-2#1)
for neuronal##3##2##(1995-12#1)(1995-8#1)(2008-7#1)
for neuropathic pain based on recent clinical trials##2##8##(2008-9#2)
for neuropathic pain##7##3##(1997-3#1)(2008-9#6)
for neuroscience##2##2##(2008-11#1)(2008-4#1)
for neurotrophins in##3##3##(1995-8#1)(1996-12#2)
for neutral##2##2##(1991-7#2)
for new applications##2##3##(1991-2#1)(2008-10#1)
for new parents##2##3##(1995-1#1)(2008-11#1)
for new therapeutic##2##3##(2008-5#1)(2013-1#1)
for new##38##2##(1991-2#1)(1991-3#1)(1992-1#2)(1993-1#1)(1993-11#1)(1994-3#2)(1995-1#1)(1996-2#1)(1997-7#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-5#3)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
for newborn##2##2##(1990-11#1)(2010-8#1)
for newborns##2##2##(1991-12#1)(1991-3#1)
for newly admitted patients##2##4##(1991-1#2)
for newly##3##2##(1991-1#2)(2008-9#1)
for nickel determination in food samples##2##6##(2008-10#2)
for nickel determination in##4##4##(2008-10#4)
for nickel determination##5##3##(2008-10#5)
for nickel in##2##3##(2008-10#2)
for nickel##15##2##(2008-10#15)
for nine replicate##2##3##(2008-10#2)
for nine##10##2##(1991-12#1)(1991-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-11#1)(2012-3#1)
for nitrate##7##2##(2008-10#7)
for nitric oxide (NO)##2##4##(1997-2#1)(2008-3#1)
for nitric oxide##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
for nitrite and nitrate##2##4##(2008-10#2)
for nitrite and##5##3##(2008-10#5)
for nitrite based on##2##4##(2008-10#2)
for nitrite determination in##2##4##(2008-10#2)
for nitrite determination##3##3##(2008-10#3)
for nitrite##17##2##(2008-10#17)
for nitrogen and phosphorus##2##4##(2008-10#2)
for nitrogen determination in##2##4##(2008-10#2)
for nitrogen dioxide##2##3##(2008-10#2)
for nitrogen##6##2##(2008-10#6)
for no obvious reason##2##4##(2008-11#1)(2010-12#1)
for no##4##2##(2008-11#2)(2008-5#1)(2010-12#1)
for non##3##2##(1995-11#2)(2008-3#1)
for non-linear##2##2##(2008-10#2)
for non-proteolytic C##2##3##(2011-2#2)
for nondisplaced scaphoid##2##3##(2008-9#2)
for nonlinear##6##2##(2008-10#3)(2008-2#1)(2008-3#2)
for nonprofit hospitals##3##3##(1993-1#2)(1996-2#1)
for nonprofit managers##2##3##(1994-12#2)
for nonprofit organizations##2##3##(1992-3#1)(1995-3#1)
for nonprofit##7##2##(1992-3#1)(1993-1#2)(1994-12#2)(1995-3#1)(1996-2#1)
for nonspecific##2##2##(2008-10#1)(2010-1#1)
for nonunion##2##2##(2008-8#1)(2011-2#1)
for noradrenaline##2##2##(2008-10#2)
for norfloxacin##2##2##(2008-10#2)
for normal FIA and reversed FIA respectively##2##7##(2008-10#2)
for normal embryo development##2##4##(2009-8#2)
for normal mouse##2##3##(1992-10#1)(1995-2#1)
for normal##17##2##(1992-10#1)(1992-3#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)
for normalizing##2##2##(2008-10#1)(2009-10#1)
for normally distributed data and##2##5##(1994-2#1)(2013-1#1)
for not only##2##3##(1992-2#1)(1995-5#1)
for not##9##2##(1992-2#1)(1993-1#1)(1994-12#1)(1995-5#1)(1996-2#1)(2008-1#1)(2011-2#2)(2013-7#1)
for novel##13##2##(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
for now##3##2##(2008-10#2)(2011-2#1)
for nuclear transport##3##3##(1991-2#2)(2011-2#1)
for nuclear##15##2##(1991-2#2)(1995-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#5)(2011-2#1)(2013-1#3)
for nucleic acids##3##3##(1991-6#1)(1997-6#1)(2008-10#1)
for nucleic##5##2##(1991-6#1)(1997-6#1)(2008-10#1)(2009-6#1)(2012-2#1)
for numerical##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
for numerous##3##2##(2008-10#2)(2012-2#1)
for nurse educators##2##3##(2008-11#2)
for nurse##5##2##(2008-11#4)(2010-4#1)
for nurses and##3##3##(2008-11#1)(2008-12#2)
for nurses in##4##3##(2008-11#2)(2008-12#1)(2010-10#1)
for nurses to##2##3##(2008-11#1)(2010-11#1)
for nurses working in##2##4##(2008-11#1)(2013-8#1)
for nurses##31##2##(1992-1#1)(1993-1#1)(1997-4#1)(2008-11#12)(2008-12#7)(2008-9#2)(2010-10#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-8#3)
for nursing and medical students##2##5##(2008-11#1)(2008-12#1)
for nursing education##3##3##(2008-11#1)(2008-12#2)
for nursing home care##2##4##(1993-3#1)(1996-3#1)
for nursing home##6##3##(1991-2#1)(1993-3#2)(1994-2#1)(1996-3#1)(1997-1#1)
for nursing practice##2##3##(2008-11#2)
for nursing students and##2##4##(2008-11#1)(2008-12#1)
for nursing students##3##3##(2008-11#2)(2008-12#1)
for nursing##26##2##(1990-12#1)(1991-2#2)(1993-3#2)(1994-2#1)(1996-3#2)(1997-1#1)(2008-11#8)(2008-12#5)(2013-1#4)
for nutrient##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
for nutrients##6##2##(2008-10#6)
for nutrition and##2##3##(1997-1#1)(2008-10#1)
for obesity##3##2##(2008-11#1)(2008-4#2)
for objects##4##2##(1996-2#1)(2008-3#3)
for observation##4##2##(1992-2#1)(2006-5#1)(2008-10#2)
for observed##2##2##(1996-5#1)(2013-1#1)
for observing##3##2##(2008-1#1)(2011-2#1)(2013-8#1)
for obstetrical##2##2##(1994-1#2)
for obtaining a##5##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
for obtaining accurate##2##3##(2008-10#1)(2013-1#1)
for obtaining an##2##3##(2008-10#1)(2012-5#1)
for obtaining the##2##3##(2008-10#1)(2008-3#1)
for obtaining##29##2##(1990-12#1)(1992-8#1)(1994-12#1)(1995-2#1)(1996-3#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-9#1)(2012-3#1)(2012-5#1)(2013-1#1)
for occult##2##2##(1993-3#1)(2008-5#1)
for octopole collision cell ICP-MS##2##5##(2008-10#2)
for odour##3##2##(1997-4#1)(2008-7#2)
for oesophageal cancer##2##3##(1990-9#2)
for ofloxacin##6##2##(2008-10#6)
for older adults##3##3##(1992-1#3)
for older people and their families##2##6##(1997-3#1)(2010-10#1)
for older people in##3##4##(1991-2#1)(2009-3#1)(2010-10#1)
for older people##13##3##(1991-2#1)(1997-3#1)(2009-3#2)(2010-10#9)
for older persons##2##3##(1994-2#1)(2011-2#1)
for older##21##2##(1991-2#1)(1992-1#3)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#1)(2009-3#2)(2010-10#9)(2011-2#1)(2012-12#1)
for oligosaccharide##2##2##(1993-8#1)(2009-8#1)
for olive oil authentication##2##4##(2008-10#2)
for on##3##2##(1994-12#1)(2008-11#1)(2010-6#1)
for on-line determination##2##3##(2008-10#2)
for on-line monitoring of##3##4##(2008-10#2)(2008-7#1)
for on-line preconcentration and determination of copper##2##7##(2008-10#2)
for on-line preconcentration and determination of##5##6##(2008-10#5)
for on-line preconcentration of##2##4##(2008-10#2)
for on-line preconcentration##7##3##(2008-10#7)
for on-line sample##2##3##(2008-10#2)
for on-line##33##2##(2008-10#32)(2008-7#1)
for on-site##3##2##(2008-10#3)
for one day##2##3##(1993-2#1)(2008-11#1)
for one field##2##3##(2008-10#2)
for one hour##2##3##(1992-6#1)(2008-12#1)
for one month##2##3##(2008-5#1)(2013-8#1)
for one of the##4##4##(1991-2#1)(2008-10#1)(2008-11#2)
for one of these##2##4##(1997-2#1)(2008-11#1)
for one of##8##3##(1991-2#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#3)
for one or##3##3##(1991-9#1)(2008-10#1)(2013-8#1)
for one sample##3##3##(2008-10#3)
for one to##2##3##(1992-11#1)(2008-2#1)
for one type of##2##4##(1992-6#1)(2008-10#1)
for one week##5##3##(2008-11#2)(2008-12#1)(2008-5#1)(2013-1#1)
for one year after##2##4##(1996-6#1)(1997-6#1)
for one year##11##3##(1992-3#1)(1993-2#1)(1994-3#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#2)(2012-12#1)(2012-3#1)(2013-1#1)
for one##72##2##(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-6#1)(2008-10#19)(2008-11#10)(2008-12#3)(2008-2#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
for ongoing##3##2##(2008-10#1)(2008-11#2)
for only 2% of##2##4##(2010-5#1)(2012-3#1)
for only a few##2##4##(1992-2#1)(2008-10#1)
for only a##3##3##(1992-2#1)(1995-5#1)(2008-10#1)
for only##13##2##(1992-2#1)(1992-5#1)(1995-5#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-3#1)
for open##5##2##(1992-2#1)(1996-1#1)(2008-10#1)(2008-3#1)(2010-9#1)
for operation##5##2##(2008-10#3)(2008-3#1)(2010-4#1)
for operative laparoscopy##3##3##(1995-2#3)
for operative##5##2##(1991-3#2)(1995-2#3)
for operators##2##2##(2008-11#1)(2008-9#1)
for ophthalmic##2##2##(2008-10#1)(2011-3#1)
for opioid##4##2##(1991-1#1)(1996-12#1)(2008-6#1)(2008-7#1)
for optic neuropathy in Graves' eye disease##2##7##(2008-7#2)
for optical switching##2##3##(1995-6#1)(2008-3#1)
for optical##16##2##(1995-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#8)(2008-6#1)(2013-8#1)
for optimal feature##2##3##(2008-6#2)
for optimal growth##2##3##(2008-11#1)(2008-9#1)
for optimal##22##2##(1994-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
for optimisation##2##2##(1997-6#1)(2008-10#1)
for optimization of the##2##4##(2008-10#1)(2008-2#1)
for optimization of##10##3##(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)
for optimization##14##2##(1995-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)
for optimizing the##7##3##(1996-6#1)(2008-10#3)(2008-11#1)(2008-3#2)
for optimizing##11##2##(1996-6#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#1)
for optimum##7##2##(2008-10#6)(2008-3#1)
for or against##2##3##(2008-9#1)(2012-3#1)
for or##5##2##(1992-2#2)(2008-9#1)(2011-2#1)(2012-3#1)
for oral and##2##3##(2008-11#1)(2011-2#1)
for oral health##2##3##(1991-6#1)(2013-1#1)
for oral squamous cell carcinoma##2##5##(2013-1#2)
for oral##13##2##(1991-6#1)(1992-5#1)(1993-1#1)(2008-10#1)(2008-11#3)(2011-2#1)(2011-7#1)(2013-1#4)
for ordering##2##2##(2008-7#1)(2013-1#1)
for organ##5##2##(1991-3#1)(1996-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
for organic##8##2##(1996-5#1)(2008-10#6)(2008-3#1)
for organizational##4##2##(1992-1#1)(1992-12#1)(1994-12#1)(2012-3#1)
for orientation and##2##3##(2009-8#1)(2010-10#1)
for orientation##3##2##(2008-11#1)(2009-8#1)(2010-10#1)
for orlistat##2##2##(2008-5#2)
for oropharyngeal##2##2##(2011-2#2)
for orthopaedic##2##2##(2008-12#1)(2012-4#1)
for orthopedic##2##2##(2009-6#1)(2012-3#1)
for orthophosphate##5##2##(2008-10#5)
for osmotic##2##2##(2008-11#1)(2008-12#1)
for other pathologies##2##3##(1993-3#1)(2007-8#1)
for other poorly##2##3##(2008-7#1)(2012-2#1)
for other species of##2##4##(2008-10#1)(2008-5#1)
for other species##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
for other types of##2##4##(2008-9#1)(2012-3#1)
for other##79##2##(1990-5#1)(1991-1#1)(1991-2#2)(1991-8#2)(1992-12#1)(1992-2#1)(1993-3#1)(1995-12#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#10)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#1)
for others to##2##3##(1995-1#1)(1995-12#1)
for others##8##2##(1994-3#2)(1995-1#1)(1995-12#1)(2008-11#1)(2008-12#2)(2008-9#1)
for our understanding of the##3##5##(2008-10#1)(2010-6#1)(2013-1#1)
for our understanding of##4##4##(2008-10#1)(2008-9#1)(2010-6#1)(2013-1#1)
for our##20##2##(1992-9#1)(1993-11#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
for outbreak##2##2##(1996-1#1)(2013-1#1)
for outcomes##4##2##(1993-12#1)(1997-1#1)(2008-4#1)(2012-12#1)
for outpatient services##3##3##(1994-2#1)(1996-1#1)(2010-6#1)
for outpatient##9##2##(1993-1#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-1#1)(2006-5#1)(2010-2#2)(2010-6#1)
for ovarian cancer##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
for ovarian##8##2##(1996-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
for over 1##2##3##(2008-10#1)(2008-11#1)
for over 300##2##3##(2008-11#1)(2012-2#1)
for over a##4##3##(2008-10#1)(2008-11#1)(2009-12#1)(2012-3#1)
for over three##2##3##(2008-10#1)(2010-12#1)
for over##28##2##(1993-1#1)(1994-2#1)(1994-3#1)(1997-2#1)(2008-10#8)(2008-11#5)(2008-2#2)(2008-9#1)(2009-12#1)(2010-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
for overall##7##2##(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-7#1)
for overcoming the##2##3##(2008-10#1)(2008-11#1)
for overcoming##7##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)
for overweight##3##2##(2008-1#1)(2011-2#2)
for overwintering##3##2##(2008-8#1)(2008-9#2)
for ovine##2##2##(1992-3#1)(2013-8#1)
for ox liver##2##3##(1994-8#2)
for oxidation of##3##3##(2008-10#3)
for oxybenzone##2##2##(2008-5#2)
for oxygen##13##2##(1990-5#1)(1991-6#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-9#3)
for ozone monitoring##2##3##(2008-10#2)
for ozone##6##2##(1991-5#1)(2008-10#4)(2008-3#1)
for p &lt##2##3##(2011-2#2)
for p = 0##3##4##(2011-2#3)
for p##6##2##(2008-11#1)(2011-2#5)
for p-aminobenzoate##2##2##(2008-10#2)
for pH##8##2##(2008-10#5)(2008-11#1)(2008-7#1)(2010-5#1)
for pK(a(1)) and 7##2##4##(2008-10#2)
for packaging##2##2##(1990-11#1)(1993-6#1)
for paediatric##5##2##(1997-8#1)(2008-11#4)
for pain are##2##3##(2008-11#2)
for pain assessment##2##3##(2008-11#1)(2012-2#1)
for pain treatment##2##3##(1997-3#1)(2007-8#1)
for pain##19##2##(1997-3#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
for palladium##6##2##(2008-10#6)
for palliation##2##2##(1991-12#1)(2008-1#1)
for pancreatic cancer##3##3##(1990-9#2)(2013-1#1)
for pancreatic##6##2##(1990-9#2)(2009-7#1)(2010-1#1)(2013-1#1)(2013-7#1)
for paracetamol##5##2##(1990-2#1)(2008-10#4)
for parallel##2##2##(2008-4#1)(2010-7#1)
for parameters##2##2##(2008-11#1)(2008-3#1)
for paraneoplasic neurological syndromes##2##4##(1996-11#2)
for parasite control##2##3##(1997-7#1)(2008-9#1)
for parasite##3##2##(1997-7#1)(2008-8#1)(2008-9#1)
for parental##5##2##(1995-1#1)(2008-9#3)(2010-6#1)
for parents and##2##3##(2008-10#1)(2008-6#1)
for parents in##2##3##(2010-5#1)(2011-2#1)
for parents to##2##3##(2008-9#1)(2012-12#1)
for parents##10##2##(1992-2#1)(1995-1#1)(1995-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)
for parking##2##2##(1992-12#1)(2008-10#1)
for partial field resistance in the United States##2##8##(2008-10#2)
for partial least squares##3##4##(2008-10#3)
for partial or##2##3##(1997-8#1)(2011-7#1)
for partial##14##2##(1991-1#1)(1992-1#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#1)(2011-7#1)
for participants to##2##3##(1992-1#1)(2010-11#1)
for participants##4##2##(1992-1#1)(2010-11#1)(2010-7#1)(2013-1#1)
for participation##3##2##(1997-1#1)(2008-1#1)(2013-1#1)
for particle##4##2##(2008-10#1)(2008-3#3)
for particles with##2##3##(2008-3#2)
for particles##4##2##(2008-11#2)(2008-3#2)
for particular##6##2##(1990-11#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)
for partitioning##2##2##(1990-5#1)(2009-8#1)
for passive##4##2##(2008-10#2)(2008-3#2)
for past##4##2##(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
for pathogen detection##2##3##(2008-10#1)(2011-2#1)
for pathogen##6##2##(2008-10#4)(2011-2#1)(2012-2#1)
for pathogenicity on##6##3##(2008-10#6)
for pathogenicity##11##2##(2008-10#10)(2011-2#1)
for pathological##3##2##(1995-5#1)(2008-9#1)(2010-1#1)
for pathway##2##2##(2009-6#1)(2012-3#1)
for patient care##4##3##(1990-3#1)(1997-8#1)(2008-11#1)(2008-9#1)
for patient focused##2##3##(1993-12#1)(1993-3#1)
for patient safety##3##3##(1992-3#1)(2008-10#1)(2010-11#1)
for patient##20##2##(1990-3#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-2#2)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
for patient-friendly##2##2##(2010-11#2)
for patients admitted to##2##4##(2008-3#2)
for patients admitted##3##3##(2008-3#3)
for patients and##6##3##(1996-1#1)(1997-2#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
for patients at the##2##4##(2011-2#1)(2012-12#1)
for patients at##5##3##(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
for patients having##2##3##(2007-8#1)(2008-10#1)
for patients in the##2##4##(1990-8#1)(1991-2#1)
for patients in##5##3##(1990-8#1)(1991-2#1)(2009-10#1)(2010-4#1)(2011-2#1)
for patients not##2##3##(2010-11#1)(2011-2#1)
for patients receiving##3##3##(1992-3#1)(2008-12#1)(2012-12#1)
for patients suffering from##2##4##(1991-11#1)(2011-2#1)
for patients treated with##2##4##(2013-1#2)
for patients undergoing##3##3##(1991-11#1)(1992-3#1)(2011-2#1)
for patients who had##3##4##(1997-7#1)(2008-11#1)(2012-3#1)
for patients who##9##3##(1993-1#1)(1993-12#1)(1997-7#1)(2008-11#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
for patients with a##6##4##(1990-12#1)(1994-12#1)(2008-11#2)(2010-5#1)(2011-2#1)
for patients with acute##4##4##(2009-11#1)(2010-11#1)(2010-12#1)(2012-12#1)
for patients with advanced##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
for patients with cancer##2##4##(2008-7#1)(2010-11#1)
for patients with chronic hepatitis B##2##6##(2009-8#1)(2011-2#1)
for patients with coexisting##2##4##(2008-10#1)(2013-1#1)
for patients with limited English proficiency##2##6##(2010-8#2)
for patients with low back pain##2##6##(2008-12#2)
for patients with lung##2##4##(2009-11#1)(2012-2#1)
for patients with severe disease and##2##6##(2011-2#1)(2013-1#1)
for patients with severe##4##4##(2011-2#2)(2012-12#1)(2013-1#1)
for patients with suspected##2##4##(2008-12#2)
for patients with##99##3##(1990-11#1)(1990-12#2)(1991-6#2)(1992-3#1)(1993-5#1)(1994-12#2)(1995-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#7)(2008-12#5)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#9)(2013-1#9)(2013-8#3)
for patients##169##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-11#2)(1991-2#1)(1991-6#2)(1992-3#4)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#2)(2007-8#1)(2008-10#7)(2008-11#10)(2008-12#8)(2008-3#6)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#7)(2012-2#5)(2012-3#12)(2013-1#13)(2013-8#6)
for patients'##5##2##(1994-1#2)(1994-3#1)(2008-11#1)(2010-8#1)
for patterns of##5##3##(2007-12#1)(2008-10#2)(2008-8#2)
for patterns##6##2##(2007-12#1)(2008-10#2)(2008-8#2)(2011-2#1)
for paying##2##2##(1992-12#1)(1992-2#1)
for payment##3##2##(1991-1#1)(1992-12#1)(1993-12#1)
for peak area and peak height##3##6##(2008-10#3)
for peak area##6##3##(2008-10#6)
for peak##11##2##(2008-10#11)
for peanut##2##2##(1994-8#1)(2008-10#1)
for pediatric nurse practitioners to understand##2##6##(2009-9#1)(2010-10#1)
for pediatric nurses##3##3##(2011-1#3)
for pediatric##10##2##(2008-10#1)(2009-12#1)(2009-9#2)(2010-10#1)(2011-1#4)(2011-2#1)
for peer##2##2##(1994-1#1)(2009-7#1)
for pelvi-ureteric junction obstruction in children##2##6##(2008-10#2)
for pelvic##2##2##(2008-1#1)(2012-2#1)
for pendimethalin##2##2##(2008-11#2)
for people in##2##3##(2008-1#1)(2008-11#1)
for people who##3##3##(1994-1#2)(2013-8#1)
for people with mental health problems##5##6##(1993-1#3)(2008-11#2)
for people with mental##7##4##(1993-1#3)(1997-8#1)(2008-11#2)(2011-1#1)
for people with severe##2##4##(1997-1#2)
for people with##21##3##(1991-1#1)(1993-1#3)(1993-3#1)(1995-12#2)(1996-1#1)(1997-1#3)(1997-8#1)(2008-11#2)(2008-7#1)(2010-10#2)(2011-1#2)(2012-3#1)(2013-8#1)
for people##28##2##(1991-1#1)(1992-3#1)(1993-1#3)(1993-3#1)(1994-1#2)(1995-12#2)(1996-1#1)(1997-1#3)(1997-8#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-3#1)(2010-10#2)(2011-1#2)(2012-3#1)(2013-8#2)
for perceived##3##2##(1991-12#1)(1996-3#1)(2008-11#1)
for percent##2##2##(2008-10#2)
for perchlorate determination in##2##4##(2008-10#2)
for perchlorate determination##3##3##(2008-10#3)
for perchlorate##4##2##(2008-10#4)
for percussion drilling##2##3##(2008-3#2)
for percutaneous coronary procedures##2##4##(2011-2#2)
for percutaneous coronary##3##3##(2011-2#3)
for percutaneous##7##2##(2008-11#1)(2010-12#1)(2011-2#5)
for perennial ryegrass##2##3##(2008-10#2)
for performance##4##2##(1992-1#1)(1996-2#1)(2008-9#1)(2010-7#1)
for performing##16##2##(1993-11#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
for perfusion##3##2##(2008-11#2)(2008-4#1)
for periodical cicadas##3##3##(2008-9#3)
for periods of##4##3##(1994-1#1)(2008-10#2)(2010-6#1)
for periods up to##2##4##(2008-10#2)
for periods##9##2##(1994-1#1)(1995-8#1)(2008-10#5)(2008-5#1)(2010-6#1)
for perioperative##2##2##(1990-11#1)(2010-12#1)
for peripheral##2##2##(2008-5#1)(2011-2#1)
for peritoneal##2##2##(2008-5#1)(2011-2#1)
for permanent modification##2##3##(2008-10#2)
for permanent##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
for peroxidase##2##2##(1996-12#1)(2008-10#1)
for peroxide##2##2##(2008-10#2)
for persistence##3##2##(2008-8#2)(2013-1#1)
for personal##5##2##(1991-1#1)(1992-3#1)(1995-12#1)(1997-1#1)(2008-11#1)
for persons who##2##3##(1991-6#1)(1995-2#1)
for persons with special health care needs##2##7##(1997-2#2)
for persons with##13##3##(1991-12#2)(1993-1#1)(1993-3#1)(1995-3#1)(1997-2#3)(1997-3#1)(2009-6#2)(2013-1#2)
for persons##17##2##(1991-12#2)(1991-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1995-2#1)(1995-3#1)(1997-2#3)(1997-3#1)(2008-11#1)(2009-6#2)(2013-1#2)
for pest##2##2##(1997-7#1)(2008-9#1)
for pesticide##4##2##(2008-10#4)
for pesticides##2##2##(2008-10#1)(2008-11#1)
for pharmaceutical analysis##2##3##(2008-10#2)
for pharmaceutical##7##2##(1992-3#1)(2008-10#3)(2008-6#1)(2012-12#1)(2012-2#1)
for pharmaceuticals##2##2##(1993-3#1)(1996-1#1)
for pharmacists##2##2##(2011-1#1)(2013-1#1)
for pharmacokinetic studies##2##3##(2008-10#2)
for phase control##2##3##(2008-3#2)
for phase##8##2##(2008-3#5)(2008-5#1)(2008-8#1)(2010-7#1)
for phenanthrene##2##2##(2008-10#2)
for phenol and intermediate products in##2##6##(2008-3#2)
for phenol and##3##3##(2008-10#1)(2008-3#2)
for phenol##10##2##(2008-10#7)(2008-3#2)(2008-8#1)
for phenolic##2##2##(2008-10#1)(2008-11#1)
for phenols determination##2##3##(2008-10#2)
for phenols##4##2##(2008-10#4)
for phenotypic##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
for phenylalanine##2##2##(1992-9#1)(2008-10#1)
for phi##4##2##(1991-5#1)(1996-12#3)
for phosphate##4##2##(2008-10#4)
for phosphorus##6##2##(2008-10#4)(2008-12#1)(2008-8#1)
for phosphorylation##3##2##(1995-12#1)(1995-6#2)
for photon##4##2##(1993-9#1)(2008-10#1)(2008-3#2)
for photosynthesis##3##2##(1995-6#1)(2008-8#1)(2009-6#1)
for phylogenetic analysis##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
for physical activity##5##3##(2008-4#3)(2013-1#2)
for physical##14##2##(1992-3#1)(1992-6#1)(1995-1#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#2)
for physician and supplier services##2##5##(1992-1#2)
for physician and##3##3##(1992-1#2)(2008-6#1)
for physician services##5##3##(1992-1#1)(1992-2#2)(1993-12#1)(1994-3#1)
for physician##13##2##(1992-1#3)(1992-2#2)(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-6#1)(2013-1#1)
for physicians and##3##3##(1991-2#2)(1997-1#1)
for physicians in##3##3##(1990-6#1)(1993-12#1)(1996-2#1)
for physicians to##2##3##(1996-1#1)(2012-2#1)
for physicians who##2##3##(1991-2#1)(2008-11#1)
for physicians##21##2##(1990-6#2)(1991-2#6)(1992-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1996-1#2)(1996-2#1)(1997-1#1)(2008-11#3)(2011-2#1)(2012-2#1)
for physicians'##2##2##(1991-12#1)(1991-2#1)
for physiological##3##2##(1993-9#1)(2008-11#1)(2013-7#1)
for pigment##3##2##(2008-10#2)(2008-7#1)
for placement of##2##3##(2008-10#1)(2010-12#1)
for planar##2##2##(2008-3#1)(2008-6#1)
for planning and##2##3##(1994-6#1)(1997-1#1)
for planning##8##2##(1991-9#1)(1993-2#1)(1993-3#1)(1994-6#1)(1996-1#1)(1997-1#1)(2011-2#1)(2012-3#1)
for plant disease##3##3##(2008-10#3)
for plant diseases##2##3##(2008-10#2)
for plant height##2##3##(2008-10#1)(2008-9#1)
for plant##24##2##(1994-11#1)(2008-10#14)(2008-11#1)(2008-9#5)(2011-2#1)(2012-5#1)(2013-1#1)
for plants##8##2##(2008-10#5)(2008-8#1)(2008-9#1)(2009-8#1)
for plasma fibrinogen measurement##2##4##(2008-10#2)
for plasma fibrinogen##3##3##(2008-10#3)
for plasma membrane##3##3##(1992-12#1)(1995-12#1)(2009-9#1)
for plasma##10##2##(1992-12#1)(1995-12#1)(2008-10#5)(2009-9#1)(2013-1#1)(2013-8#1)
for plasmid##4##2##(1994-8#2)(2008-10#1)(2010-8#1)
for plasminogen##2##2##(1990-11#1)(1994-11#1)
for platelet aggregation##2##3##(2006-6#1)(2007-12#1)
for platelet##4##2##(1992-6#1)(2006-6#2)(2007-12#1)
for platinum and##2##3##(2008-10#2)
for platinum determination##2##3##(2008-10#2)
for platinum##6##2##(2008-10#6)
for policy development##3##3##(1994-1#1)(1996-3#1)(2007-12#1)
for policy##6##2##(1992-12#1)(1994-1#1)(1996-3#1)(2007-12#1)(2010-10#1)(2013-1#1)
for pollen tube##2##3##(2008-10#1)(2009-8#1)
for pollen##5##2##(2008-10#1)(2009-10#2)(2009-8#1)(2013-1#1)
for poly-drug users##2##3##(2013-8#2)
for polymerase chain reaction (PCR)##5##5##(2008-10#5)
for polymerase chain reaction##6##4##(2008-10#6)
for polymeric membrane##2##3##(2008-10#2)
for polymorphisms##3##2##(2008-10#3)
for poor##4##2##(1995-12#1)(1996-12#1)(2008-12#1)(2013-1#1)
for population growth##2##3##(1994-2#1)(2008-10#1)
for population##9##2##(1994-2#1)(1995-5#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-12#1)
for population-based##2##2##(1997-8#1)(2012-12#1)
for populations of##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
for populations##9##2##(1995-12#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
for porcine pancreatic elastase (PPE) and##2##6##(2008-5#2)
for porcine##3##2##(1994-11#1)(2008-5#2)
for positional cloning of the##2##5##(2008-10#2)
for positional##4##2##(2008-10#3)(2012-3#1)
for positions##2##2##(1990-2#2)
for positive##7##2##(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)
for possible use##2##3##(2008-11#1)(2008-5#1)
for possible##13##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2011-2#2)(2012-2#1)(2013-8#1)
for post##4##2##(2010-10#1)(2011-2#2)(2013-1#1)
for post-acute##2##2##(1992-3#1)(1994-12#1)
for post-market##2##2##(2011-2#2)
for post-registration##2##2##(2008-11#2)
for posterior##4##2##(2008-10#1)(2010-9#1)(2012-3#1)(2013-1#1)
for postharvest##2##2##(2008-10#2)
for postoperative##6##2##(1990-9#1)(1991-3#1)(1993-1#2)(2008-7#1)(2012-3#1)
for postsynaptic##3##2##(1997-2#1)(1997-3#1)(2009-8#1)
for potential confounding factors##2##4##(2010-1#1)(2010-11#1)
for potential confounding##3##3##(2008-4#1)(2010-1#1)(2010-11#1)
for potential use in human##2##5##(1993-2#1)(2008-5#1)
for potential use in##3##4##(1993-2#1)(2008-10#1)(2008-5#1)
for potential##21##2##(1993-2#1)(1996-6#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#4)
for potentially##2##2##(1994-1#1)(1996-12#1)
for potentiometric determination of chloride##2##5##(2008-10#2)
for potentiometric determination of##3##4##(2008-10#3)
for potentiometric##10##2##(2008-10#10)
for powdery mildew resistance in##2##5##(2008-10#2)
for powdery mildew resistance##3##4##(2008-10#3)
for practical application##3##3##(2008-10#2)(2012-3#1)
for practical applications##2##3##(2008-10#1)(2008-7#1)
for practical##9##2##(2008-10#5)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
for practice and##2##3##(2008-11#1)(2012-2#1)
for practice expense##2##3##(1994-1#2)
for practice##18##2##(1994-1#2)(2008-1#1)(2008-11#9)(2008-12#1)(2010-10#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
for practice'##2##2##(2008-11#2)
for practitioners##2##2##(2008-1#1)(2008-11#1)
for prazosin)##2##2##(1991-6#2)
for pre- and##2##3##(2008-10#2)
for pre-clinical##2##2##(2008-10#1)(2008-11#1)
for pre-concentrating and##2##3##(2008-10#2)
for pre-registration nursing##2##3##(2008-11#2)
for pre-registration##3##2##(2008-11#3)
for precise##11##2##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2010-7#1)(2011-2#1)
for precision##4##2##(2008-10#4)
for preclinical##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
for preconcentrating##5##2##(2008-10#5)
for preconcentration and determination of copper##2##6##(2008-10#2)
for preconcentration and determination of lead##2##6##(2008-10#2)
for preconcentration and determination of##6##5##(2008-10#6)
for preconcentration and determination##7##4##(2008-10#7)
for preconcentration and separation of##2##5##(2008-10#2)
for preconcentration and##15##3##(2008-10#15)
for preconcentration of metal ions##2##5##(2008-10#2)
for preconcentration of trace##3##4##(2008-10#3)
for preconcentration of##20##3##(2008-10#20)
for preconcentration##40##2##(2008-10#40)
for predicting RNA##2##3##(2008-4#1)(2011-3#1)
for predicting linear##2##3##(2008-10#2)
for predicting the##11##3##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
for predicting##38##2##(1992-9#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)
for prediction of the##2##4##(1997-6#1)(2008-4#1)
for prediction of##10##3##(1995-5#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-5#2)(2012-2#1)(2013-1#1)
for prediction##12##2##(1995-5#1)(1997-6#1)(2008-10#4)(2008-4#1)(2008-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
for predictions of##2##3##(2008-10#1)(2008-9#1)
for predictive##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
for pregnancy termination##2##3##(2011-2#1)(2013-1#1)
for pregnancy##3##2##(2011-2#1)(2013-1#2)
for pregnant women##2##3##(1995-12#1)(2010-6#1)
for preliminary evaluation of the correlation time of local dynamics##2##10##(2008-10#2)
for preliminary##3##2##(2008-10#3)
for prelingually##2##2##(2008-9#2)
for premature##3##2##(1995-8#1)(2011-3#1)(2012-3#1)
for prenatal diagnosis##2##3##(2007-7#1)(2008-4#1)
for prenatal##6##2##(1993-12#1)(1994-3#1)(1996-2#1)(2007-7#1)(2008-4#1)(2012-3#1)
for preoperative##3##2##(2008-12#1)(2013-1#2)
for preparation of a##2##4##(2008-10#1)(2008-9#1)
for preparation of##16##3##(1992-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#3)(2008-9#5)(2011-2#1)
for preparation##18##2##(1992-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#3)(2008-9#6)(2011-2#1)(2012-12#1)
for preparative##2##2##(2008-10#1)(2011-1#1)
for preparing a##4##3##(2008-10#1)(2008-4#2)(2008-9#1)
for preparing the##3##3##(2008-10#2)(2008-4#1)
for preparing##19##2##(1994-11#1)(2008-1#1)(2008-10#6)(2008-4#5)(2008-5#1)(2008-9#4)(2012-2#1)
for prescription drugs##3##3##(1993-1#2)(1993-3#1)
for prescription##4##2##(1993-1#2)(1993-3#1)(2013-1#1)
for presence of##3##3##(2009-8#1)(2011-2#1)(2012-12#1)
for presence##5##2##(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#1)
for presentation of##2##3##(1990-5#1)(1995-12#1)
for presentation##4##2##(1990-5#1)(1995-12#1)(2008-12#1)(2012-2#1)
for preservation of##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
for preserving##2##2##(2008-11#1)(2008-3#1)
for pressures##2##2##(2008-3#2)
for preterm##2##2##(2008-11#1)(2010-5#1)
for preventing and##3##3##(2008-5#2)(2013-1#1)
for preventing the##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
for preventing##20##2##(1992-12#1)(1992-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)(2013-1#4)
for prevention and control##2##4##(2010-5#1)(2011-2#1)
for prevention and treatment##4##4##(1990-12#1)(2008-7#2)(2009-11#1)
for prevention and##9##3##(1990-12#1)(1995-3#1)(1997-3#1)(2008-7#2)(2009-11#1)(2009-7#1)(2010-5#1)(2011-2#1)
for prevention of heterotopic ossification##2##5##(1994-8#2)
for prevention of##11##3##(1994-8#2)(1995-3#1)(1997-3#1)(2007-12#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
for prevention##30##2##(1990-12#1)(1992-12#1)(1994-8#2)(1994-9#1)(1995-3#2)(1996-11#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-11#2)(2008-7#2)(2009-11#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
for preventive health##3##3##(1994-2#1)(1995-12#1)(2010-8#1)
for preventive##10##2##(1990-6#1)(1992-3#1)(1992-5#2)(1992-9#1)(1994-2#1)(1995-12#1)(1996-1#1)(2008-12#1)(2010-8#1)
for previously##3##2##(1990-6#1)(1997-3#1)(2007-12#1)
for primary care##2##3##(2008-12#1)(2008-6#1)
for primary hyperparathyroidism##2##3##(2008-10#2)
for primary##23##2##(1991-9#1)(1992-12#1)(1994-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
for primary-care##2##2##(1992-8#1)(1996-3#1)
for prime##2##2##(2010-4#1)(2013-8#1)
for proactive##2##2##(1994-2#1)(2008-11#1)
for probing##2##2##(1990-8#1)(2008-3#1)
for procaine##2##2##(2008-10#2)
for procedures##4##2##(1996-1#1)(1996-9#1)(2008-10#1)(2008-11#1)
for process##2##2##(2008-10#1)(2008-11#1)
for processing animate stimuli##2##4##(2008-11#2)
for processing the##2##3##(2008-5#1)(2008-6#1)
for processing##15##2##(1992-12#1)(1992-6#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-6#1)(2009-7#1)(2010-4#2)(2013-1#1)
for producing human##2##3##(2008-11#2)
for producing the##2##3##(2008-10#1)(2008-9#1)
for producing##15##2##(1993-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)
for product##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
for production of a##2##4##(1997-7#1)(2008-4#1)
for production of##18##3##(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)
for production##20##2##(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#8)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)
for products##2##2##(2008-5#1)(2008-7#1)
for professional##10##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(2008-11#2)(2012-3#1)(2013-1#2)
for professionals##6##2##(1991-2#1)(1993-1#1)(1994-12#1)(1995-3#1)(2008-11#1)(2010-2#1)
for prognosis##4##2##(2008-10#1)(2009-8#1)(2012-3#1)(2013-1#1)
for prognostic##2##2##(2010-11#1)(2011-2#1)
for program##5##2##(1992-1#1)(1994-2#1)(1996-1#1)(2008-1#1)(2008-11#1)
for programming##5##2##(1990-3#1)(2008-9#3)(2011-3#1)
for programs##3##2##(1992-3#1)(1996-3#1)(2012-2#1)
for progress##4##2##(2008-10#1)(2008-6#2)(2012-3#1)
for progression of##2##3##(1992-12#1)(2009-8#1)
for progression##3##2##(1992-12#1)(1993-8#1)(2009-8#1)
for prolonged periods of time##2##5##(2008-11#1)(2008-7#1)
for prolonged periods##6##3##(2008-11#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)
for prolonged##8##2##(1996-3#1)(1997-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)
for promoting##4##2##(1993-2#1)(1995-12#1)(2009-5#1)(2009-8#1)
for prompt##2##2##(2008-1#1)(2011-2#1)
for propagating mCMV##2##3##(2008-4#2)
for propagating##4##2##(2008-3#1)(2008-4#2)(2008-9#1)
for propagation in##2##3##(2008-3#2)
for propagation##3##2##(2008-12#1)(2008-3#2)
for proper##12##2##(1993-3#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
for prophylactic##2##2##(1990-2#1)(2011-2#1)
for prophylaxis after##2##3##(1990-2#1)(1990-9#1)
for prophylaxis##4##2##(1990-2#1)(1990-9#2)(2009-12#1)
for prospective##2##2##(1992-12#1)(2008-10#1)
for prostate cancer diagnosis##2##4##(2008-10#1)(2011-2#1)
for prostate cancer in##2##4##(2008-8#1)(2009-5#1)
for prostate cancer##14##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#3)(2011-2#2)(2012-3#1)(2013-8#2)
for prostate##17##2##(1991-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#3)(2011-2#2)(2012-3#1)(2013-8#2)
for prostatic cancer##3##3##(1991-7#2)(1993-8#1)
for prostatic##6##2##(1990-9#1)(1991-7#2)(1993-8#2)(2008-5#1)
for protecting##2##2##(1994-8#1)(2008-5#1)
for protection against##3##3##(2008-10#1)(2008-5#2)
for protection of##2##3##(2008-10#1)(2008-4#1)
for protection##10##2##(1995-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-8#1)
for protein expression##2##3##(2008-11#1)(2008-4#1)
for protein isoprenylation##2##3##(1994-11#2)
for protein kinase C##3##4##(1990-8#2)(1994-11#1)
for protein kinase##6##3##(1990-8#2)(1994-11#1)(1994-5#1)(1995-2#1)(2011-2#1)
for protein production##2##3##(2008-11#2)
for protein synthesis##3##3##(1990-12#1)(1993-12#1)(1996-2#1)
for protein##40##2##(1990-12#1)(1990-8#2)(1991-5#1)(1993-12#2)(1994-11#3)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-2#2)(2013-8#1)
for proteins##10##2##(2008-10#8)(2008-11#1)(2012-2#1)
for proteomic##2##2##(2008-4#1)(2013-8#1)
for provider##2##2##(1995-2#1)(2010-12#1)
for providers##2##2##(1994-1#1)(2010-10#1)
for providing the##3##3##(2008-2#1)(2010-7#1)(2012-12#1)
for providing##13##2##(1991-2#1)(1995-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
for provision of##3##3##(1992-12#1)(1997-5#1)(2008-5#1)
for proximal##2##2##(1990-9#1)(1997-3#1)
for psilocin##2##2##(2008-10#2)
for psoriasis##3##2##(1993-11#2)(2007-11#1)
for psychiatric##10##2##(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(2008-11#2)(2009-4#1)(2010-12#1)(2010-7#1)(2013-1#1)
for psychosocial##2##2##(2008-11#1)(2013-8#1)
for public and##2##3##(1993-1#1)(1994-12#1)
for public health agencies##2##4##(1995-12#2)
for public health practitioners##2##4##(1997-2#2)
for public health surveillance##5##4##(1997-3#5)
for public health##30##3##(1991-12#1)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#5)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#6)(2008-7#1)(2010-8#2)(2012-12#1)
for public##36##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#4)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#6)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#6)(2008-7#1)(2010-8#2)(2012-12#1)
for publication in##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
for publication##8##2##(1996-2#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-4#1)
for publications##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
for pulmonary##9##2##(1991-12#1)(1992-3#1)(2008-7#1)(2009-10#1)(2010-10#3)(2011-2#2)
for pulp##2##2##(1990-9#1)(2008-6#1)
for pulse##2##2##(2008-10#1)(2008-3#1)
for pure stands##2##3##(2008-10#2)
for pure water##2##3##(2008-2#1)(2010-4#1)
for pure##8##2##(2008-10#5)(2008-2#1)(2008-3#1)(2010-4#1)
for purification and##3##3##(2008-10#1)(2008-4#2)
for purification of##6##3##(1991-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#2)
for purification##11##2##(1991-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-8#1)
for purpose##2##2##(2008-10#1)(2008-11#1)
for purposes of##8##3##(1991-2#1)(1991-6#1)(1992-3#1)(1994-6#1)(1995-5#1)(1997-2#1)(2008-11#1)(2011-2#1)
for putrescine##2##2##(2008-10#2)
for pyrocatechol##2##2##(2008-10#2)
for pyrolysis and atomization##4##4##(2008-10#4)
for pyrolysis and##5##3##(2008-10#5)
for pyruvate##2##2##(2008-10#1)(2011-2#1)
for qualitative and quantitative analysis of##2##6##(2008-5#1)(2012-3#1)
for qualitative and quantitative analysis##3##5##(2008-10#1)(2008-5#1)(2012-3#1)
for qualitative##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
for quality aging##2##3##(2011-2#2)
for quality assessment and##2##4##(1993-3#1)(2008-10#1)
for quality assurance##5##3##(1993-9#1)(1994-6#1)(2008-12#2)(2008-3#1)
for quality control##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
for quality improvement##2##3##(1996-11#1)(2012-2#1)
for quality in##2##3##(1996-3#1)(2008-11#1)
for quality##38##2##(1991-2#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-3#2)(1997-5#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
for quantification of the##2##4##(2008-10#2)
for quantification of##12##3##(2008-10#11)(2008-11#1)
for quantification phenoxyl##2##3##(2008-10#2)
for quantification##18##2##(2008-10#16)(2008-11#2)
for quantifying the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
for quantifying##15##2##(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
for quantitating the##2##3##(1990-12#1)(2008-4#1)
for quantitating##7##2##(1990-12#1)(2008-10#3)(2008-4#2)(2012-2#1)
for quantitation of##3##3##(1992-12#1)(1993-3#1)(2008-10#1)
for quantitation##6##2##(1992-12#1)(1993-3#1)(2008-10#3)(2008-9#1)
for quantitative analysis of octahydro-1##2##5##(2008-10#2)
for quantitative analysis of##10##4##(2008-10#10)
for quantitative analysis##18##3##(2008-10#18)
for quantitative determination of the##2##5##(2008-10#2)
for quantitative determination of##10##4##(2008-10#10)
for quantitative determination##13##3##(2008-10#13)
for quantitative extraction##2##3##(2008-10#2)
for quantitative recovery is 5##2##5##(2008-10#2)
for quantitative recovery##3##3##(2008-10#3)
for quantitative resistance to Sclerotinia trifoliorum##4##6##(2008-10#4)
for quantitative resistance to##5##4##(2008-10#5)
for quantitative sorption##5##3##(2008-10#5)
for quantitative##67##2##(2008-10#58)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#2)(2010-7#1)(2011-2#1)(2013-1#1)
for quantitatively##2##2##(2008-9#1)(2010-5#1)
for quaternary##2##2##(2008-10#2)
for r##2##2##(2008-10#2)
for rAAV production##2##3##(2008-8#2)
for rAAV##4##2##(2008-8#3)(2008-9#1)
for rHBsAg##2##2##(2008-8#2)
for race##2##2##(2008-10#2)
for radial##6##2##(2008-2#1)(2008-9#1)(2011-2#4)
for radiation protection##2##3##(2008-7#1)(2013-1#1)
for radiation##9##2##(1994-3#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-11#1)(2013-1#2)
for radical##3##2##(1990-3#1)(1990-9#1)(2008-10#1)
for radiographers##3##2##(1991-2#1)(1996-1#1)(2008-10#1)
for radiology managers##3##3##(1991-1#1)(1993-3#1)(1994-1#1)
for radiology##6##2##(1991-1#1)(1993-3#2)(1994-1#1)(1996-2#2)
for rainwater##2##2##(2008-10#2)
for raising##4##2##(1991-9#1)(2008-11#1)(2008-5#1)(2008-6#1)
for random##2##2##(1990-9#1)(2012-3#1)
for ranitidine##2##2##(2008-10#1)(2008-11#1)
for rapid and accurate##2##4##(2008-10#2)
for rapid and direct##2##4##(2008-10#1)(2008-11#1)
for rapid and selective extraction##3##5##(2008-10#3)
for rapid and##17##3##(2008-10#11)(2008-11#2)(2008-9#1)(2011-2#2)(2013-1#1)
for rapid determination of##3##4##(2008-10#3)
for rapid diagnosis of##2##4##(2008-10#1)(2012-2#1)
for rapid growth##2##3##(2008-9#1)(2010-7#1)
for rapid identification of##4##4##(2008-10#2)(2010-4#2)
for rapid identification##5##3##(2008-10#2)(2008-12#1)(2010-4#2)
for rapid sample##2##3##(2008-10#2)
for rapid screening##2##3##(2008-10#1)(2008-4#1)
for rapid separation and##2##4##(1997-2#1)(2008-10#1)
for rapid##66##2##(1993-6#1)(1994-2#1)(1997-2#1)(2008-10#34)(2008-11#6)(2008-12#3)(2008-4#2)(2008-8#1)(2008-9#3)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)
for rat liver##2##3##(1994-8#1)(2008-4#1)
for rat pancreatic##2##3##(2008-11#2)
for rat##14##2##(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)
for rational##2##2##(1991-11#1)(2010-10#1)
for rats and##2##3##(1990-11#1)(1995-11#1)
for reaching##3##2##(1997-2#1)(2008-10#1)(2011-2#1)
for reaction to##2##3##(2008-10#2)
for reaction##5##2##(1996-5#1)(2008-10#4)
for readmissions##2##2##(1990-12#1)(2011-2#1)
for real samples##3##3##(2008-10#3)
for real time##2##3##(2008-10#2)
for real##12##2##(1996-2#1)(2008-10#11)
for real-time monitoring of##3##4##(2008-10#2)(2008-3#1)
for real-time##10##2##(2008-10#5)(2008-11#1)(2008-3#3)(2008-6#1)
for realistic##4##2##(2008-11#1)(2008-3#2)(2008-8#1)
for realization of##2##3##(1996-5#1)(2008-10#1)
for reasons##2##2##(2008-10#1)(2008-8#1)
for receptor##5##2##(1990-4#1)(1994-5#2)(2008-8#1)(2011-2#1)
for recognition of##2##3##(2008-10#1)(2008-8#1)
for recognition##6##2##(2008-10#2)(2008-6#2)(2008-8#1)(2012-2#1)
for recognizing##5##2##(2008-11#1)(2008-3#2)(2008-9#1)(2012-2#1)
for recombinant protein production##3##4##(2008-11#2)(2011-1#1)
for recombinant protein##4##3##(2008-11#2)(2008-4#1)(2011-1#1)
for recombinant##14##2##(1991-9#1)(2008-11#8)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
for reconstructing##2##2##(2008-3#1)(2008-9#1)
for reconstruction of##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
for reconstruction##6##2##(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
for recording##4##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
for recovery of##5##3##(2008-10#3)(2008-7#2)
for recovery##10##2##(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#3)(2012-3#1)
for recruitment##2##2##(1994-3#1)(2010-10#1)
for rectal cancer##4##3##(1990-9#1)(1997-7#3)
for rectal##5##2##(1990-9#1)(1997-7#3)(2012-12#1)
for recurrence##4##2##(1996-11#1)(2008-10#2)(2008-4#1)
for recurrent##6##2##(1994-1#1)(1997-4#1)(2007-7#1)(2008-11#1)(2009-12#1)(2013-1#1)
for red wines##4##3##(2008-10#4)
for red##7##2##(2008-10#6)(2008-12#1)
for reduced##8##2##(1990-5#1)(2008-10#6)(2013-1#1)
for reducing the##3##3##(2008-10#2)(2008-11#1)
for reducing##24##2##(1991-11#1)(1996-3#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
for reduction of##4##3##(1990-11#1)(2008-10#1)(2008-4#1)(2013-1#1)
for reduction##5##2##(1990-11#1)(2008-10#2)(2008-4#1)(2013-1#1)
for reductive##3##2##(2008-10#3)
for reference materials##2##3##(2008-10#2)
for reference##6##2##(2008-10#3)(2011-2#3)
for refining##6##2##(1992-2#1)(1992-3#1)(1993-12#2)(2010-3#1)(2010-7#1)
for reflection##2##2##(2008-11#1)(2008-8#1)
for reflective practice in##2##4##(2008-11#2)
for reflective##3##2##(2008-11#2)(2008-3#1)
for reform##6##2##(1991-12#1)(1993-5#1)(1994-12#1)(1995-1#1)(1997-3#1)(2008-10#1)
for reform?##2##2##(1995-2#1)(1997-2#1)
for reforming##2##2##(1994-3#1)(2008-11#1)
for refractive##2##2##(1991-9#1)(2008-10#1)
for refractory##4##2##(2008-7#2)(2008-8#1)(2011-2#1)
for regeneration of##2##3##(2008-11#1)(2008-12#1)
for regeneration##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
for regenerative medicine##2##3##(2008-9#1)(2009-12#1)
for regional##2##2##(1997-2#1)(2011-2#1)
for regions##3##2##(1990-4#1)(1993-2#1)(2008-10#1)
for registered nurses##3##3##(2008-11#2)(2008-12#1)
for registration of##2##3##(1991-11#1)(2008-10#1)
for registration##5##2##(1991-11#1)(2008-10#1)(2008-11#3)
for regression##4##2##(1996-8#1)(2008-10#1)(2008-8#1)(2010-12#1)
for regular##4##2##(1995-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
for regulated##3##2##(1993-9#1)(2008-4#1)(2012-2#1)
for regulating##7##2##(1995-8#1)(2008-11#4)(2008-9#1)(2011-2#1)
for regulation of##6##3##(1991-5#1)(1992-6#1)(2007-12#1)(2008-9#2)(2012-3#1)
for regulation##8##2##(1991-5#1)(1992-6#1)(1993-11#1)(2007-12#1)(2008-9#2)(2010-12#1)(2012-3#1)
for regulatory purposes##3##3##(1991-12#1)(2008-11#2)
for regulatory##8##2##(1991-12#1)(1991-5#1)(2008-10#1)(2008-11#4)(2009-6#1)
for rehabilitation##7##2##(1991-12#1)(1992-3#1)(1994-12#1)(2008-7#2)(2013-1#2)
for reimbursement##2##2##(1995-1#1)(2011-2#1)
for rejection of##2##3##(2008-10#1)(2008-2#1)
for related##2##2##(1995-11#1)(2013-8#1)
for relationships##2##2##(2010-4#1)(2013-8#1)
for relative##6##2##(1992-12#1)(1995-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-6#1)
for relatively##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
for releasing##2##2##(2008-10#1)(2009-8#1)
for relevant##5##2##(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
for reliability##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
for reliable and##2##3##(1995-1#1)(2008-10#1)
for reliable##14##2##(1993-2#1)(1995-1#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
for remote sensing##2##3##(2008-10#1)(2008-3#1)
for remote##10##2##(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)
for removal of##10##3##(1991-12#1)(2008-10#5)(2010-12#2)(2012-3#1)(2013-1#1)
for removal##11##2##(1991-12#1)(2008-10#6)(2010-12#2)(2012-3#1)(2013-1#1)
for removing##12##2##(1990-5#1)(1991-3#1)(2008-10#9)(2010-3#1)
for renal##4##2##(1991-12#1)(1993-12#1)(1997-5#1)(1997-8#1)
for renewing##2##2##(2008-11#1)(2008-8#1)
for repeatability##4##2##(2008-10#3)(2008-5#1)
for repeated use##2##3##(2008-10#2)
for repeated##11##2##(1992-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
for replacement##2##2##(2011-1#1)(2011-3#1)
for replacing##2##2##(1992-12#1)(2008-10#1)
for replicate##2##2##(2008-10#2)
for replication and##3##3##(2008-10#2)(2008-11#1)
for replication in##2##3##(1991-12#1)(1997-3#1)
for replication##6##2##(1991-12#1)(1997-3#1)(2008-10#3)(2008-11#1)
for reporting##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
for representing##2##2##(2008-10#1)(2010-12#1)
for reproducibility##3##2##(2008-10#3)
for reproduction##6##2##(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#2)
for reproductive##2##2##(1992-3#1)(2012-2#1)
for research and the##2##4##(1995-1#1)(2011-7#1)
for research and##5##3##(1995-1#1)(1997-7#1)(2008-11#2)(2011-7#1)
for research into##4##3##(1994-1#1)(1997-7#1)(2008-10#1)(2009-7#1)
for research on##3##3##(2008-10#2)(2010-3#1)
for research purposes##3##3##(1993-1#1)(2008-11#1)(2011-1#1)
for research##33##2##(1993-1#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-9#1)(1996-3#2)(1997-7#2)(2008-10#5)(2008-11#7)(2008-12#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-3#1)(2011-7#1)(2012-2#2)
for researchers in##2##3##(2008-9#1)(2010-7#1)
for researchers to##2##3##(1992-3#1)(2009-8#1)
for researchers##9##2##(1992-3#1)(2008-11#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2013-8#1)
for resection of##4##3##(2011-2#4)
for residents##2##2##(1993-3#1)(1995-2#1)
for residual chlorine##2##3##(2008-10#2)
for residual##3##2##(2008-10#2)(2010-12#1)
for residues##4##2##(2008-10#3)(2009-7#1)
for resin coated with##2##4##(2008-10#2)
for resistance against##2##3##(2008-10#1)(2009-6#1)
for resistance and##2##3##(2008-10#2)
for resistance genes##2##3##(2008-10#2)
for resistance in the##2##4##(2008-10#2)
for resistance in##13##3##(2008-10#13)
for resistance is##2##3##(2008-10#2)
for resistance to FHB##2##4##(2008-10#2)
for resistance to M##2##4##(2008-10#2)
for resistance to P##3##4##(2008-10#3)
for resistance to STB##3##4##(2008-10#3)
for resistance to aflatoxin production##2##5##(2008-10#2)
for resistance to bacterial blight##2##5##(2008-10#2)
for resistance to leaf rust and##2##6##(2008-10#2)
for resistance to leaf rust##3##5##(2008-10#3)
for resistance to southern leaf blight##3##6##(2008-10#3)
for resistance to these##2##4##(2008-10#2)
for resistance to white pine blister rust##5##7##(2008-10#5)
for resistance to white pine blister##6##6##(2008-10#6)
for resistance to##69##3##(2008-10#69)
for resistance was##3##3##(2008-10#3)
for resistance##112##2##(2008-10#109)(2008-8#2)(2009-6#1)
for resolution of##2##3##(2008-10#2)
for resolution##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
for resolving chemical##2##3##(2008-10#2)
for resolving ternary mixtures of##2##5##(2008-10#2)
for resolving##10##2##(2008-10#8)(2008-12#1)(2011-2#1)
for resorcinol and##3##3##(2008-10#3)
for resorcinol##4##2##(2008-10#4)
for resources and##2##3##(2008-10#1)(2008-11#1)
for resources##5##2##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
for response to##3##3##(2008-10#2)(2010-12#1)
for response##6##2##(1990-2#1)(1991-6#1)(2008-10#2)(2008-11#1)(2010-12#1)
for restoration of##5##3##(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#2)
for restriction fragment length polymorphisms##2##5##(1996-12#1)(2008-10#1)
for restriction fragment length##3##4##(1996-12#1)(2008-10#2)
for restriction fragment##4##3##(1996-12#1)(2008-10#3)
for restriction##5##2##(1994-8#1)(1996-12#1)(2008-10#3)
for restructuring##3##2##(1994-12#1)(1995-3#1)(1996-1#1)
for retention and##2##3##(1993-1#1)(2008-10#1)
for retention modeling in##2##4##(2008-10#2)
for retention of##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
for retention##10##2##(1993-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2012-2#1)
for retrieval of the##3##4##(1993-12#1)(2008-3#2)
for retrieval of##7##3##(1993-12#1)(1994-12#1)(2008-3#4)(2008-6#1)
for retrieving##2##2##(2008-3#1)(2008-6#1)
for retroviral##2##2##(2008-11#1)(2011-3#1)
for return##2##2##(2008-9#1)(2009-3#1)
for reverse##2##2##(2008-10#1)(2008-9#1)
for reversed##2##2##(2008-10#1)(2011-1#1)
for reviewing##2##2##(1995-12#1)(2013-1#1)
for revision surgery##2##3##(2012-2#1)(2013-1#1)
for revision##5##2##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#2)
for rhEPO##2##2##(2008-8#2)
for rheumatoid arthritis##4##3##(1997-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
for rhodium##2##2##(2008-10#2)
for rice##8##2##(2008-10#3)(2008-11#1)(2008-9#2)(2009-10#1)(2009-8#1)
for right##3##2##(2011-2#2)(2012-3#1)
for risk assessment##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#2)
for risk stratification##3##3##(2010-9#1)(2012-2#1)(2012-3#1)
for risk##17##2##(1990-11#1)(1992-9#2)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
for river water samples##2##4##(2008-10#2)
for river water##3##3##(2008-10#3)
for river##5##2##(2008-10#5)
for road##3##2##(2008-10#1)(2009-10#1)(2010-8#1)
for robot##2##2##(2008-6#2)
for robust and reliable##2##4##(2013-1#1)(2013-8#1)
for robust##3##2##(2010-7#1)(2013-1#1)(2013-8#1)
for root##6##2##(1991-3#1)(2008-10#4)(2013-1#1)
for rotational##2##2##(1997-6#1)(2008-11#1)
for routine analyses of##2##4##(2008-10#1)(2008-5#1)
for routine analyses##3##3##(2008-10#1)(2008-5#2)
for routine analysis of##6##4##(2008-10#6)
for routine analysis##10##3##(2008-10#10)
for routine clinical##2##3##(1997-7#1)(2008-10#1)
for routine determination of##2##4##(2008-10#2)
for routine monitoring##2##3##(2008-10#2)
for routine testing##3##3##(2012-2#3)
for routine use##5##3##(1991-6#1)(1995-5#1)(2008-10#1)(2008-9#2)
for routine##51##2##(1991-6#1)(1991-7#1)(1995-5#1)(1997-7#1)(2008-10#34)(2008-12#1)(2008-5#3)(2008-9#5)(2012-2#4)
for rural health##3##3##(1992-12#1)(1996-2#1)(1996-3#1)
for rural##8##2##(1992-12#1)(1994-1#2)(1994-2#1)(1996-2#1)(1996-3#2)(2013-1#1)
for rust##5##2##(2008-10#5)
for safe and##2##3##(1992-6#1)(1993-3#1)
for safe##4##2##(1992-6#1)(1993-3#1)(2008-8#1)(2009-5#1)
for safety and efficacy##2##4##(2008-5#1)(2011-2#1)
for safety and##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
for safety##5##2##(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-3#1)
for salbutamol##2##2##(2008-10#2)
for salicylate##6##2##(2008-10#6)
for salicylate-selective##2##2##(2008-10#2)
for salicylic acid##2##3##(2008-10#2)
for salivary##2##2##(2011-2#1)(2013-8#1)
for salt##2##2##(1997-8#1)(2012-2#1)
for sample and reagent##2##4##(2008-10#2)
for sample injection##2##3##(2008-10#2)
for sample preconcentration##2##3##(2008-10#2)
for sample preparation and##2##4##(2008-10#1)(2008-9#1)
for sample preparation##5##3##(2008-10#3)(2008-4#1)(2008-9#1)
for sample treatment##3##3##(2008-10#3)
for sample##34##2##(2008-10#30)(2008-4#2)(2008-9#1)(2013-1#1)
for samples from##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
for samples of##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
for samples spiked with single species##3##6##(2008-10#3)
for samples spiked with##4##4##(2008-10#4)
for samples##20##2##(1992-11#2)(1995-12#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
for sampling and##2##3##(2008-10#2)
for sampling##12##2##(2008-10#10)(2008-9#1)(2011-2#1)
for sanitation##3##2##(2008-10#3)
for satellite##2##2##(2008-2#1)(2008-3#1)
for saturation##2##2##(2008-10#1)(2008-3#1)
for scab resistance##2##3##(2008-10#2)
for scab##4##2##(2008-10#4)
for scale-up##2##2##(2008-11#2)
for scattering##2##2##(2008-3#2)
for schizophrenia##4##2##(1994-12#1)(2010-1#2)(2011-1#1)
for school##4##2##(1994-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
for scientific##2##2##(1993-12#1)(2010-3#1)
for scientists##2##2##(2008-11#1)(2010-8#1)
for scintillations##2##2##(2008-3#2)
for screening and##4##3##(2008-10#3)(2013-1#1)
for screening hepatitis B in blood donors##2##7##(2011-2#2)
for screening hepatitis B##3##4##(2011-2#3)
for screening large numbers of##3##5##(2008-10#2)(2008-9#1)
for screening of##4##3##(1992-11#1)(2008-10#1)(2008-12#1)(2012-2#1)
for screening polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
for screening potato##2##3##(2008-10#2)
for screening purposes##10##3##(1990-6#2)(1995-12#1)(1997-1#1)(2008-10#6)
for screening the##2##3##(2008-9#1)(2013-1#1)
for screening##63##2##(1990-6#3)(1992-11#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-8#1)(1997-1#2)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)
for searching##4##2##(1992-1#1)(1995-6#1)(2008-4#1)(2008-9#1)
for second-order##2##2##(1997-7#1)(2008-3#1)
for secondary##7##2##(1990-2#1)(1990-9#1)(2008-10#3)(2008-4#1)(2009-7#1)
for secretion##2##2##(1991-6#1)(2008-10#1)
for sectioning##2##2##(2008-4#1)(2008-9#1)
for securing##2##2##(1991-3#1)(2008-11#1)
for security##5##2##(1991-1#1)(1993-12#1)(1996-12#1)(2008-10#1)(2010-8#1)
for sediments##2##2##(2008-10#2)
for seed coat##3##3##(2013-8#3)
for seed transmission of##2##4##(2008-10#2)
for seed##9##2##(2008-10#3)(2008-9#2)(2009-10#1)(2013-8#3)
for segmentation and##2##3##(2011-7#2)
for segmentation##3##2##(2008-7#1)(2011-7#2)
for seizure generation##2##3##(1990-5#1)(2009-8#1)
for seizure##3##2##(1990-5#1)(2008-7#1)(2009-8#1)
for select##6##2##(1991-1#1)(1993-3#1)(2008-10#1)(2011-2#2)(2012-3#1)
for selected patients##3##3##(1992-6#1)(2008-9#1)(2010-10#1)
for selected##17##2##(1991-2#1)(1992-6#1)(1995-12#1)(1996-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-10#1)(2011-2#1)(2011-3#1)
for selecting a##3##3##(2008-9#1)(2010-7#1)(2012-5#1)
for selecting an appropriate##2##4##(2008-9#1)(2011-2#1)
for selecting the##5##3##(1990-5#1)(1995-12#1)(2008-10#2)(2008-3#1)
for selecting##19##2##(1990-5#1)(1994-2#1)(1995-12#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-9#2)(2009-4#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-5#1)
for selection based on disease progression##2##6##(2008-10#2)
for selection based on maximal disease##2##6##(2008-10#2)
for selection based on##4##4##(2008-10#4)
for selection of stable##2##4##(1993-12#1)(2008-11#1)
for selection of##9##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)
for selection on##4##3##(2008-8#4)
for selection##20##2##(1993-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#6)(2008-9#1)(2011-2#2)(2012-3#1)
for selective detection of##2##4##(2008-10#2)
for selective detection##3##3##(2008-10#3)
for selective determination of##3##4##(2008-10#3)
for selective extraction of mercury(II)##2##5##(2008-10#2)
for selective##21##2##(2008-10#13)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
for selectivity##2##2##(2008-10#1)(2011-2#1)
for selenium determination in##2##4##(2008-10#2)
for selenium in the##2##4##(2008-10#2)
for selenium##12##2##(2008-10#11)(2009-10#1)
for self-evaluation##2##2##(1990-2#1)(1994-6#1)
for self-help groups and##2##4##(1994-1#1)(2008-4#1)
for self-referenced oxygen sensing##2##4##(2008-10#2)
for senior##2##2##(1993-12#1)(2008-11#1)
for sensing is##2##3##(2008-10#1)(2012-2#1)
for sensing##8##2##(2008-10#6)(2008-3#1)(2012-2#1)
for sensitive and##3##3##(2008-10#2)(2008-9#1)
for sensitive detection##2##3##(2008-10#2)
for sensitive##8##2##(2008-10#5)(2008-3#2)(2008-9#1)
for sensitivity and##2##3##(2008-10#2)
for sensitivity to the##2##4##(2008-10#2)
for sensitivity to##5##3##(2008-10#4)(2008-7#1)
for sensitivity##13##2##(2008-10#10)(2008-7#1)(2008-8#1)(2008-9#1)
for sensitization in##2##3##(2008-10#2)
for sensor 1##2##3##(2008-10#2)
for sensor applications##3##3##(2008-10#3)
for sensor##7##2##(2008-10#7)
for sensory##3##2##(2008-7#1)(2009-8#1)(2013-8#1)
for sentinel lymph nodes mapping##2##5##(2012-12#2)
for separate##3##2##(1995-8#1)(2008-10#1)(2008-5#1)
for separating and##3##3##(2008-10#3)
for separating##8##2##(2008-10#6)(2008-11#1)(2008-9#1)
for separation and detection##2##4##(2008-10#2)
for separation and determination of##4##5##(2008-10#3)(2009-8#1)
for separation and preconcentration of nickel##2##6##(2008-10#2)
for separation and preconcentration of##5##5##(2008-10#5)
for separation and preconcentration##6##4##(2008-10#6)
for separation and##15##3##(2008-10#14)(2009-8#1)
for separation of##21##3##(1995-11#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#2)(2013-1#1)
for separation##47##2##(1995-11#1)(1997-2#1)(2008-10#34)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-11#2)(2009-8#1)(2010-7#1)(2013-1#1)
for sepsis##3##2##(2011-2#2)(2012-3#1)
for septic##2##2##(2007-8#1)(2008-10#1)
for sequence##3##2##(1993-6#1)(1996-2#1)(2008-10#1)
for sequences##3##2##(2008-10#1)(2008-9#2)
for sequencing##6##2##(1990-5#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-8#1)
for sequential determination of##3##4##(2008-10#3)
for sequential injection##3##3##(2008-10#3)
for sequential##12##2##(2008-10#12)
for serial##3##2##(2008-10#1)(2008-7#1)(2012-5#1)
for serine binding##2##3##(1994-5#2)
for serine##5##2##(1994-5#3)(1997-1#1)(2008-10#1)
for serious##3##2##(1996-6#1)(2011-2#2)
for seriously##2##2##(1996-8#1)(2012-12#1)
for serological##2##2##(2008-10#1)(2008-5#1)
for serum p53 Abs##2##4##(2011-2#2)
for serum samples##2##3##(2008-10#2)
for serum##10##2##(1990-2#1)(2008-10#4)(2008-11#1)(2011-2#2)(2013-1#2)
for serum-free##3##2##(2008-11#3)
for service##8##2##(1992-1#1)(1993-12#1)(1993-3#1)(1995-1#1)(1997-5#1)(2008-11#1)(2009-6#1)(2013-8#1)
for services##4##2##(1992-2#1)(1993-3#1)(1995-12#1)(1997-3#1)
for serving##2##2##(1997-6#1)(2008-10#1)
for setting up##2##3##(2008-4#1)(2008-9#1)
for setting##6##2##(1995-1#1)(2008-10#1)(2008-4#1)(2008-9#2)(2012-2#1)
for seven consecutive##2##3##(2008-10#2)
for seven days##2##3##(1994-5#1)(2008-8#1)
for seven of##2##3##(1991-2#1)(1994-9#1)
for seven replicate determinations##2##4##(2008-10#2)
for seven##17##2##(1991-2#1)(1994-5#1)(1994-9#1)(2008-10#10)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
for several days on##2##4##(2007-12#2)
for several days##6##3##(1991-3#1)(2007-12#2)(2008-10#2)(2008-7#1)
for several decades##3##3##(2008-10#2)(2012-2#1)
for several different##2##3##(2008-10#1)(2008-4#1)
for several months##6##3##(1996-12#1)(2008-10#2)(2008-9#1)(2009-12#2)
for several of##2##3##(1995-6#1)(2011-2#1)
for several reasons##2##3##(2008-10#1)(2009-6#1)
for several tissues##2##3##(2008-5#1)(2008-7#1)
for several weeks##3##3##(2008-10#2)(2008-11#1)
for several##64##2##(1991-3#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-12#3)(2008-10#25)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
for severe malaria##2##3##(2012-12#2)
for severe##19##2##(1990-3#2)(1990-8#1)(1991-11#1)(1992-7#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#3)
for severely##2##2##(1997-2#1)(2013-1#1)
for severity of##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
for severity##5##2##(2008-10#3)(2012-12#1)(2012-2#1)
for sex##4##2##(1991-8#1)(1997-3#1)(2008-10#1)(2010-5#1)
for sexual reproduction##2##3##(2008-10#2)
for sexual selection##5##3##(1995-2#1)(2008-8#4)
for sexual##13##2##(1991-6#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-8#4)(2009-9#1)(2012-3#2)
for sexually transmitted infections##2##4##(2008-11#1)(2011-2#1)
for sexually transmitted##3##3##(1996-6#1)(2008-11#1)(2011-2#1)
for sexually##4##2##(1995-12#1)(1996-6#1)(2008-11#1)(2011-2#1)
for shared##2##2##(2008-12#1)(2008-3#1)
for shiga toxin##2##3##(2008-8#2)
for short and##2##3##(2008-10#1)(2011-2#1)
for short##10##2##(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
for short- and##2##3##(1993-12#2)
for short-term##2##2##(2008-11#1)(2008-9#1)
for shorter##3##2##(2008-10#1)(2009-3#1)(2013-1#1)
for showing the##2##3##(1996-6#1)(2008-12#1)
for showing##3##2##(1993-2#1)(1996-6#1)(2008-12#1)
for sigma##2##2##(1992-12#1)(1996-3#1)
for signal transduction##2##3##(1997-3#1)(2009-8#1)
for signal##7##2##(1996-2#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#1)
for significance##2##2##(2008-10#1)(2012-2#1)
for significant##11##2##(1991-12#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
for signs##2##2##(1997-3#1)(2010-12#1)
for silicon and phosphorous##2##4##(2008-11#2)
for silver##5##2##(2008-10#4)(2008-4#1)
for similar conditions##2##3##(2008-10#1)(2010-12#1)
for similar##6##2##(1996-3#1)(2008-10#3)(2010-12#1)(2012-3#1)
for simple and complex##2##4##(2010-12#1)(2011-2#1)
for simple##12##2##(1990-12#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-2#1)
for simulating##3##2##(2011-2#1)(2013-1#2)
for simulation##3##2##(2008-10#1)(2008-11#2)
for simultaneous analysis of##5##4##(2008-10#4)(2008-9#1)
for simultaneous detection##2##3##(2008-10#1)(2008-9#1)
for simultaneous determination of Fe(II) and Fe(III)##2##7##(2008-10#2)
for simultaneous determination of Fe(II)##3##5##(2008-10#3)
for simultaneous determination of ammonium##2##5##(2008-10#2)
for simultaneous determination of some metals##2##6##(2008-10#2)
for simultaneous determination of some##3##5##(2008-10#3)
for simultaneous determination of uric acid##3##6##(2008-10#3)
for simultaneous determination of##43##4##(2008-10#41)(2011-3#1)(2012-2#1)
for simultaneous determination##44##3##(2008-10#42)(2011-3#1)(2012-2#1)
for simultaneous electrochemical determination of ascorbic acid##2##7##(2008-10#2)
for simultaneous measurements of##4##4##(2008-10#3)(2008-2#1)
for simultaneous quantification of##3##4##(2008-10#1)(2008-11#1)(2011-3#1)
for simultaneous separation of##2##4##(2008-10#2)
for simultaneous separation##3##3##(2008-10#3)
for simultaneous spectrophotometric determination of##3##5##(2008-10#3)
for simultaneous spectrophotometric##4##3##(2008-10#4)
for simultaneous##88##2##(2007-12#1)(2008-10#73)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2011-3#3)(2012-2#1)(2013-8#1)
for simultaneously##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
for single scattering##2##3##(2008-3#1)(2009-11#1)
for single##13##2##(1990-5#1)(1993-2#1)(1997-9#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-11#1)(2009-12#3)
for sinusitis##3##2##(1993-2#1)(1996-1#1)(1997-3#1)
for site##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
for sites##2##2##(2008-10#1)(2009-10#1)
for situations where##3##3##(1997-5#1)(2008-10#1)(2008-4#1)
for situations##5##2##(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
for six measurements##2##3##(2008-10#2)
for six months##3##3##(1993-2#1)(2008-1#1)(2008-12#1)
for six replicate##2##3##(2008-10#2)
for six replicates##2##3##(2008-10#2)
for six times##2##3##(2008-10#2)
for six##25##2##(1991-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-2#1)(1996-3#1)(2008-1#1)(2008-10#17)(2008-12#1)
for size based iron speciation of particles##2##7##(2008-10#2)
for size parameters##2##3##(2008-3#2)
for size##9##2##(2007-12#1)(2008-10#5)(2008-3#2)(2008-8#1)
for skin##11##2##(1995-1#1)(1997-2#1)(2008-5#6)(2008-8#1)(2011-2#1)(2013-1#1)
for skull base surgery##2##4##(2011-2#1)(2012-3#1)
for skull base##4##3##(2011-2#3)(2012-3#1)
for slurry##2##2##(2008-10#2)
for small bowel##2##3##(2010-12#2)
for small molecules##2##3##(2008-4#2)
for small##20##2##(1991-5#1)(1991-6#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#2)(2008-5#1)(2009-1#1)(2009-5#1)(2010-12#2)(2012-2#1)(2013-8#1)
for small-scale##2##2##(2007-12#1)(2008-11#1)
for smaller##4##2##(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
for smoking cessation##4##3##(2009-7#1)(2013-1#3)
for smooth##3##2##(1997-1#1)(2008-6#2)
for so##2##2##(1994-12#1)(2008-10#1)
for social phobia##3##3##(2008-4#3)
for social##11##2##(1996-8#1)(2008-11#4)(2008-4#3)(2008-7#1)(2008-8#1)(2012-3#1)
for sodium and potassium##3##4##(2008-10#3)
for sodium##11##2##(1996-12#1)(2008-10#10)
for soft##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
for soil##2##2##(2008-10#2)
for soilborne##3##2##(2008-10#3)
for soils##3##2##(2008-10#3)
for solar##2##2##(2008-10#1)(2008-3#1)
for solid phase##8##3##(1990-12#1)(1993-2#1)(2008-10#6)
for solid##17##2##(1990-12#1)(1992-3#1)(1993-2#1)(1995-3#1)(2008-10#11)(2013-1#2)
for solid-phase##3##2##(2008-10#2)(2008-4#1)
for soluble##2##2##(2008-10#1)(2008-11#1)
for solution of##3##3##(1994-9#1)(2008-10#1)(2008-3#1)
for solution##5##2##(1994-5#1)(1994-9#1)(2008-10#2)(2008-3#1)
for solutions containing##2##3##(2008-10#2)
for solutions##7##2##(1997-7#1)(2008-10#5)(2012-2#1)
for solvent extraction##2##3##(2008-10#2)
for solvent##4##2##(2008-10#4)
for solving##8##2##(1993-5#1)(2008-10#1)(2008-12#1)(2008-6#3)(2009-10#1)(2011-2#1)
for somatic##4##2##(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)
for some drugs##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
for some metal ions##3##4##(2008-10#3)
for some of the##8##4##(1990-9#1)(1992-4#1)(1994-5#1)(1995-12#1)(1996-6#1)(2008-3#1)(2008-8#1)(2009-1#1)
for some of these##3##4##(1994-6#1)(2008-10#1)(2008-4#1)
for some of this##2##4##(1991-12#1)(2013-1#1)
for some of##14##3##(1990-9#1)(1991-12#1)(1992-4#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2013-1#1)
for some species##2##3##(1995-3#2)
for some time in##2##4##(1992-3#1)(2010-1#1)
for some time to##2##4##(1995-12#1)(2009-6#1)
for some time##8##3##(1992-3#1)(1995-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2012-2#1)
for some##89##2##(1990-9#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
for sorbic acid##2##3##(2008-10#2)
for sorption##2##2##(2008-10#2)
for sorting##2##2##(2008-9#1)(2011-2#1)
for source##2##2##(2008-10#2)
for soybean rust##2##3##(2008-10#2)
for soybean##3##2##(2008-10#3)
for space##4##2##(1990-5#1)(2008-10#1)(2008-3#1)(2008-9#1)
for spatial pattern##2##3##(2008-10#1)(2008-8#1)
for spatial##8##2##(1993-3#2)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#2)
for spatially##2##2##(2008-2#1)(2008-8#1)
for spawning##2##2##(2010-8#2)
for special##6##2##(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
for speciation analysis##2##3##(2008-10#2)
for speciation of Al-citrate and other negatively charged Al complexes##2##10##(2008-10#2)
for speciation of chromium##2##4##(2008-10#2)
for speciation of##13##3##(2008-10#13)
for speciation##18##2##(2008-10#18)
for species identification##2##3##(2008-10#1)(2010-3#1)
for species##13##2##(1997-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-3#2)
for species-specific##2##2##(2008-10#1)(2012-3#1)
for specific determination of##2##4##(2008-10#2)
for specific##36##2##(1990-5#1)(1992-2#1)(1993-1#2)(1993-2#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
for specificity##7##2##(2008-1#1)(2008-10#5)(2008-9#1)
for spectral##7##2##(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#1)
for spectrophotometric and##2##3##(2008-10#2)
for spectrophotometric detection##2##3##(2008-10#2)
for spectrophotometric determination of boron in plants##2##7##(2008-10#2)
for spectrophotometric determination of boron##3##5##(2008-10#3)
for spectrophotometric determination of##16##4##(2008-10#16)
for spectrophotometric determination##17##3##(2008-10#17)
for spectrophotometric determinations of##2##4##(2008-10#2)
for spectrophotometric##26##2##(2008-10#26)
for spectroscopic##2##2##(2008-3#2)
for speech##4##2##(1995-1#1)(2008-9#2)(2011-1#1)
for sperm##6##2##(1994-5#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-8#1)(2013-1#1)
for spiked##4##2##(2008-10#4)
for spinal##4##2##(2012-2#1)(2012-3#2)(2013-1#1)
for spine##2##2##(2007-8#1)(2008-8#1)
for spiritual##2##2##(2009-11#1)(2010-11#1)
for spironolactone determination##2##3##(2008-10#2)
for splash dispersal##2##3##(2008-10#2)
for splitting##2##2##(2008-5#1)(2013-8#1)
for spore##5##2##(2008-10#5)
for spore-forming##2##2##(2011-2#2)
for sporulation##3##2##(1995-9#2)(2008-10#1)
for square-wave##3##2##(2008-10#2)(2008-3#1)
for stability##2##2##(1995-5#1)(2008-9#1)
for stabilizing##4##2##(2008-10#2)(2010-4#1)(2013-1#1)
for stable##6##2##(1995-5#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
for staff##2##2##(2008-11#2)
for stage III and##2##4##(1990-6#1)(1997-3#1)
for stage IIIA##2##3##(1992-12#1)(2008-10#1)
for stage##12##2##(1990-6#4)(1992-12#2)(1997-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
for staging##2##2##(2008-2#1)(2012-2#1)
for staining cell colonies##2##4##(2008-11#2)
for staining##4##2##(2008-11#3)(2008-4#1)
for standard setting##2##3##(2011-2#1)(2012-2#1)
for standard##10##2##(2008-10#3)(2008-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
for standardisation##2##2##(1990-3#1)(2008-10#1)
for standards and##2##3##(1992-11#2)
for standards##3##2##(1992-11#2)(1996-2#1)
for starting##2##2##(2008-10#1)(2008-4#1)
for state health agencies##2##4##(1995-12#1)(1997-1#1)
for state health##3##3##(1995-12#1)(1996-3#1)(1997-1#1)
for state##4##2##(1995-12#2)(1996-3#1)(1997-1#1)
for states##2##2##(1991-2#1)(1993-12#1)
for statistical analysis##4##3##(1996-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
for statistical##10##2##(1996-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#2)(2010-11#1)(2012-3#1)
for statistically##2##2##(2008-11#1)(2013-1#1)
for stem cell##4##3##(2008-10#1)(2008-11#2)(2009-8#1)
for stem##8##2##(2008-10#4)(2008-11#2)(2008-4#1)(2009-8#1)
for stenosis##2##2##(1993-8#1)(2010-12#1)
for stimulating the##2##3##(1992-10#1)(2008-11#1)
for stimulating##3##2##(1992-10#1)(2008-11#1)(2010-5#1)
for stimulation of##5##3##(1994-11#1)(1995-8#1)(1997-7#1)(2008-11#2)
for stoichiometry##2##2##(2008-10#1)(2010-5#1)
for stomach##2##2##(1990-8#1)(1996-12#1)
for storage##3##2##(1991-5#1)(1994-3#2)
for storing##2##2##(2008-4#1)(2010-10#1)
for strain##4##2##(2008-10#4)
for strains##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
for strategic##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
for strengthening##2##2##(2008-12#1)(2013-1#1)
for stress##4##2##(2008-3#1)(2010-7#1)(2011-2#2)
for stripe rust##2##3##(2008-10#2)
for stripping##2##2##(2008-10#2)
for stroke##5##2##(1993-12#1)(2007-9#1)(2008-8#2)(2011-2#1)
for strong##8##2##(1990-5#1)(1994-3#1)(2008-3#5)(2008-8#1)
for structural and functional##2##4##(1993-6#1)(1995-12#1)
for structural##5##2##(1993-6#1)(1995-12#1)(2008-4#2)(2012-2#1)
for student learning##2##3##(2008-11#1)(2008-12#1)
for student nurse learning##2##4##(2008-11#2)
for student nurses##6##3##(2008-11#5)(2008-12#1)
for student##12##2##(1991-1#1)(2008-11#8)(2008-12#3)
for students from##2##3##(2008-12#2)
for students in##2##3##(2008-11#1)(2011-1#1)
for students to##6##3##(1992-3#1)(1993-1#1)(1996-1#1)(2008-11#2)(2008-12#1)
for students with dyslexia##2##4##(2008-12#2)
for students##22##2##(1992-3#1)(1993-1#1)(1996-1#1)(1997-2#1)(2008-11#7)(2008-12#8)(2008-3#1)(2011-1#1)(2012-2#1)
for studies of##10##3##(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)
for studies on the##3##4##(1995-12#1)(2008-10#1)(2008-5#1)
for studies on##5##3##(1995-12#1)(1995-8#1)(2008-10#2)(2008-5#1)
for studies that##2##3##(2008-7#1)(2008-8#1)
for studies with##2##3##(2010-7#1)(2011-2#1)
for studies##26##2##(1994-3#1)(1995-12#2)(1995-8#1)(1996-12#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-7#1)(2011-2#1)
for study of##7##3##(1995-11#2)(2008-10#4)(2008-7#1)
for study question##2##3##(2012-12#2)
for study##17##2##(1991-3#1)(1995-11#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#4)(2010-11#1)(2012-12#2)
for studying mechanisms of##2##4##(2008-11#1)(2008-4#1)
for studying membrane transport of Fe(II)##2##6##(1996-2#2)
for studying the molecular##2##4##(2008-10#1)(2008-2#1)
for studying the##33##3##(1990-5#1)(1991-6#1)(1993-8#1)(1995-11#1)(1995-2#2)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-12#1)(2011-2#1)(2012-12#1)
for studying##84##2##(1990-5#3)(1991-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#5)(1996-12#1)(1996-2#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#20)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#8)(2008-9#5)(2009-12#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#5)(2013-1#2)
for subcutaneous##3##2##(1990-3#1)(1994-3#1)(2012-2#1)
for subjects##2##2##(2013-1#2)
for subpopulations##2##2##(2008-10#1)(2011-2#1)
for subsequent analysis##3##3##(2008-10#2)(2008-4#1)
for subsequent treatment##2##3##(1992-12#1)(2010-6#1)
for subsequent##28##2##(1992-10#1)(1992-12#1)(1992-2#1)(1993-3#1)(1995-8#1)(2008-10#12)(2008-11#3)(2008-4#2)(2008-9#4)(2010-6#1)(2011-1#1)
for substance abuse problems##2##4##(1993-2#1)(2008-4#1)
for substance abuse##6##3##(1993-2#1)(2008-4#2)(2008-6#2)(2009-9#1)
for substrate##2##2##(2008-11#1)(2011-1#1)
for substrates##3##2##(1990-10#1)(1995-8#1)(2008-10#1)
for subunit##2##2##(1991-6#1)(2008-9#1)
for success##6##2##(1992-3#1)(1993-3#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-7#1)
for successful management##2##3##(2008-7#1)(2011-2#1)
for successful treatment of##2##4##(2009-7#1)(2013-8#1)
for successful treatment##3##3##(2009-7#1)(2013-1#1)(2013-8#1)
for successful##31##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-6#1)(1997-5#1)(2008-10#4)(2008-11#6)(2008-4#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
for successfully##3##2##(2008-10#1)(2008-12#1)(2009-11#1)
for successive##4##2##(2008-10#2)(2011-2#2)
for such a##7##3##(1990-12#1)(1992-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
for such an##2##3##(1994-3#1)(2009-8#1)
for such analysis##2##3##(1995-5#1)(2011-3#1)
for such measurements##2##3##(2008-10#2)
for such patients##4##3##(2008-10#1)(2008-7#1)(2012-12#2)
for such##50##2##(1990-12#1)(1990-8#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-5#2)(2008-10#13)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
for sucrose##4##2##(1997-2#1)(2008-10#3)
for sugar##2##2##(2008-10#2)
for suicidal behavior##2##3##(2013-1#2)
for suicidal##3##2##(2008-11#1)(2013-1#2)
for suitable##2##2##(1995-11#1)(2008-10#1)
for sulfaguanidine and sulfamerazine and between##3##6##(2008-10#3)
for sulfaguanidine##4##2##(2008-10#4)
for sulfate##2##2##(2008-10#2)
for sulfide##5##2##(2008-10#5)
for sulfur dioxide in##2##4##(2008-10#2)
for sulfur dioxide##3##3##(2008-10#3)
for sulfur##5##2##(2008-10#4)(2008-11#1)
for sulisobenzone##2##2##(2008-5#2)
for sulphate determination in automotive fuel##2##6##(2008-10#2)
for sulphate##4##2##(2008-10#4)
for sulphide##2##2##(2008-10#2)
for summation##2##2##(2008-10#2)
for sunscreen##4##2##(2008-4#1)(2008-5#3)
for supercritical fluid extraction##2##4##(2008-10#2)
for superior##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
for supernatant##3##2##(2008-10#3)
for support##4##2##(1992-12#1)(1994-1#2)(1996-11#1)
for suppression of the##2##4##(1995-2#1)(2008-10#1)
for suppression of##10##3##(1995-2#1)(2007-12#1)(2008-10#7)(2008-9#1)
for surface and##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
for surface electrodes and##2##4##(2012-2#2)
for surface electrodes##3##3##(2012-2#3)
for surface mapping of phosphate in##2##6##(2008-10#2)
for surface reconstruction##2##3##(2008-6#2)
for surface##12##2##(2008-10#5)(2008-3#1)(2008-6#2)(2008-9#1)(2012-2#3)
for surgeons##2##2##(2011-2#1)(2013-1#1)
for surgery and##2##3##(1990-9#1)(1997-3#1)
for surgery##13##2##(1990-3#1)(1990-6#1)(1990-9#1)(1992-12#1)(1994-1#1)(1997-2#1)(1997-3#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
for surgical procedures##2##3##(1991-1#1)(1994-12#1)
for surgical treatment of##2##4##(1990-9#1)(1993-3#1)
for surgical treatment##3##3##(1990-6#1)(1990-9#1)(1993-3#1)
for surgical##16##2##(1990-6#1)(1990-9#1)(1991-1#3)(1993-12#1)(1993-3#1)(1994-12#2)(2008-4#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
for surveillance and##2##3##(2008-10#1)(2009-12#1)
for surveillance of##2##3##(2011-2#1)(2012-12#1)
for surveillance##5##2##(2008-10#1)(2009-12#1)(2011-2#1)(2011-9#1)(2012-12#1)
for survival and##2##3##(2008-4#1)(2010-11#1)
for survival##13##2##(1991-12#1)(1992-9#1)(1994-1#1)(1996-12#1)(2008-12#1)(2008-4#1)(2009-1#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#2)
for susceptibility##3##2##(2008-10#2)(2011-2#1)
for susceptible##2##2##(2008-10#1)(2011-10#1)
for suspected##2##2##(1991-11#1)(2011-2#1)
for sustainable##3##2##(2008-11#1)(2012-9#1)(2013-8#1)
for sustained##2##2##(1995-8#1)(2013-1#1)
for switching from##2##3##(2008-10#2)
for symptom##2##2##(2008-10#1)(2010-11#1)
for symptomatic##13##2##(1993-3#1)(2008-7#5)(2008-8#2)(2011-3#1)(2012-12#2)(2012-3#2)
for synaptic plasticity##2##3##(1997-7#1)(2008-11#1)
for synaptic##3##2##(1995-2#1)(1997-7#1)(2008-11#1)
for synergistic##2##2##(2008-10#1)(2013-8#1)
for synthesis of##5##3##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
for synthesis##7##2##(1992-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
for synthesizing high-molecular-weight##2##3##(1994-11#2)
for synthesizing##6##2##(1994-11#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-6#1)
for synthetic##3##2##(1996-5#1)(2008-10#1)(2011-1#1)
for syphilis##2##2##(1997-5#1)(2011-2#1)
for system##5##2##(1996-12#1)(1996-2#1)(2008-10#2)(2008-3#1)
for systematic##3##2##(1997-2#1)(2008-11#1)(2008-4#1)
for systemic infection##2##3##(2009-11#1)(2013-1#1)
for systemic##8##2##(1995-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2013-1#1)
for systems with##2##3##(2008-8#1)(2010-10#1)
for systems##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2010-10#1)
for tagging##4##2##(1995-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
for tailoring##2##2##(2009-5#1)(2010-2#1)
for tan spot##3##3##(2008-10#3)
for tandem##2##2##(2008-11#1)(2011-2#1)
for tap water##2##3##(2008-10#2)
for tap##3##2##(2008-10#3)
for target selective SPECT/CT imaging and##2##6##(2012-12#2)
for target selective##3##3##(2012-12#3)
for target##10##2##(1997-3#1)(2008-10#4)(2011-2#1)(2012-12#3)(2012-2#1)
for targeted##12##2##(1997-3#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-4#1)(2013-1#3)
for targeting##4##2##(1995-2#1)(2008-6#1)(2009-10#1)(2011-2#1)
for tartaric acid##2##3##(2008-10#2)
for taxonomic differentiation of##2##4##(2008-10#1)(2008-12#1)
for taxonomic differentiation##3##3##(2008-10#2)(2008-12#1)
for taxonomic##5##2##(2008-10#2)(2008-12#1)(2011-2#2)
for teaching and##3##3##(1992-12#1)(2008-11#1)(2008-12#1)
for teaching computer literacy##3##4##(1996-1#3)
for teaching##12##2##(1992-12#1)(1996-1#4)(1997-2#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#1)
for teenagers##2##2##(2008-9#1)(2013-1#1)
for telomere##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
for temperature and##4##3##(2008-10#4)
for temperature##7##2##(2008-10#6)(2008-3#1)
for ten determinations of 0##2##5##(2008-10#2)
for ten determinations of##4##4##(2008-10#4)
for ten different##2##3##(2008-10#1)(2010-7#1)
for ten independent analyses of 100 ng ml(-1)##2##8##(2008-10#2)
for ten independent##3##3##(2008-10#3)
for ten replicate##3##3##(2008-10#3)
for ten##23##2##(1990-5#1)(1991-12#1)(2008-10#17)(2008-11#1)(2010-7#1)(2012-2#2)
for terahertz##2##2##(2007-12#1)(2012-12#1)
for terminating##2##2##(1994-11#1)(1996-6#1)
for termination##2##2##(1996-6#1)(2013-8#1)
for terrestrial taxa##2##3##(2008-8#2)
for territories##3##2##(2008-8#3)
for testing and##2##3##(2008-10#1)(2012-3#1)
for testing multiple##2##3##(1994-12#1)(2010-1#1)
for testing of##2##3##(1995-11#1)(2008-5#1)
for testing the##4##3##(1996-3#1)(2008-10#2)(2008-4#1)
for testing this##2##3##(1991-2#1)(1993-9#1)
for testing##23##2##(1991-2#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#4)(2008-9#1)(2010-1#1)(2010-3#1)(2012-2#1)(2012-3#1)
for tetracycline and##2##3##(2008-10#1)(2008-12#1)
for tetracycline##5##2##(2008-10#4)(2008-12#1)
for thalassemia##2##2##(2008-10#2)
for thallium##2##2##(2008-10#2)
for that##8##2##(1991-12#1)(2008-10#4)(2008-12#1)(2008-8#1)(2012-2#1)
for the 1##4##3##(1997-2#1)(2008-10#2)(2008-3#1)
for the 12##2##3##(2012-3#1)(2013-8#1)
for the 1990s##5##3##(1991-2#2)(1992-1#1)(1993-12#1)(1997-3#1)
for the 2##3##3##(1992-3#1)(2008-10#1)(2009-1#1)
for the 21st century##7##4##(1994-1#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-12#1)
for the 21st century?##2##4##(1994-3#1)(2012-3#1)
for the 21st##10##3##(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-12#1)(1997-3#1)(2007-12#1)(2008-12#1)(2012-3#1)
for the 3##2##3##(1992-3#1)(2009-2#1)
for the 4##2##3##(1997-2#1)(2008-10#1)
for the 5'##2##3##(1997-8#1)(2008-10#1)
for the A##4##3##(1995-12#1)(1995-2#1)(2008-10#2)
for the ACE and CIS speech-processing strategies in the Nucleus 24 cochlear implant system##2##14##(2008-9#2)
for the AF4Q initiative##2##4##(2013-1#2)
for the AIDS##2##3##(1990-3#2)
for the ANN##2##3##(2008-10#2)
for the AR##2##3##(1990-11#1)(2010-1#1)
for the American##3##3##(2008-10#1)(2010-5#1)(2010-6#1)
for the BOD sensing film##2##5##(2008-10#2)
for the BOD##3##3##(2008-10#3)
for the CAF+FT group and##3##5##(1997-7#3)
for the CAF+FT+TAM group##2##4##(1997-7#2)
for the California##2##3##(2008-10#2)
for the Care of##3##4##(1992-3#1)(1994-3#1)(2012-12#1)
for the Cerro Negro##2##4##(2008-10#2)
for the Cr(VI)##2##3##(2008-10#2)
for the Detection##2##3##(2008-10#2)
for the Diagnosis of##2##4##(2008-10#1)(2011-2#1)
for the Donnan effect during##2##5##(2011-2#2)
for the Elderly (PACE)##3##4##(1992-1#1)(1994-2#1)(1995-1#1)
for the Elderly##5##3##(1992-1#1)(1994-2#1)(1995-1#1)(2008-4#1)(2013-1#1)
for the FIA##2##3##(2008-10#2)
for the HPLC determination of##2##5##(2008-10#2)
for the Health Care Financing Administration##2##6##(1992-1#1)(1997-2#1)
for the Health Care##3##4##(1992-1#1)(1997-2#1)(2008-11#1)
for the Health##4##3##(1991-12#1)(1992-1#1)(1997-2#1)(2008-11#1)
for the I and bc-1(2) alleles##2##6##(2008-10#2)
for the I##3##3##(2008-10#3)
for the Identification##2##3##(2008-10#2)
for the International##2##3##(1991-9#1)(2008-10#1)
for the MS##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
for the Management of##2##4##(2008-3#1)(2011-2#1)
for the Measurement of Atmospheric##2##5##(2008-3#2)
for the N-terminal##2##3##(2008-10#1)(2009-7#1)
for the NHS##7##3##(1997-5#5)(2008-11#1)(2008-12#1)
for the New York##2##4##(1996-3#1)(1996-5#1)
for the Organization for Economic Cooperation and Development##2##8##(1993-3#2)
for the Preparation of##3##4##(1996-5#2)(2008-11#1)
for the SPE##2##3##(2008-10#2)
for the Simultaneous##2##3##(2008-10#1)(2012-2#1)
for the Study of##4##4##(1992-2#1)(1995-11#1)(2008-5#1)(2013-1#1)
for the TPF##2##3##(2008-10#1)(2008-3#1)
for the Treatment of##4##4##(2008-10#1)(2009-9#1)(2012-2#1)(2012-3#1)
for the U##3##3##(1991-9#1)(1995-6#1)(2008-10#1)
for the United States##3##4##(1993-2#1)(1995-3#1)(1997-3#1)
for the ability to reduce##2##5##(2008-10#2)
for the ability to##7##4##(1997-3#1)(2008-10#6)
for the ability##8##3##(1992-10#1)(1997-3#1)(2008-10#6)
for the above##3##3##(1995-9#1)(2008-10#1)(2008-12#1)
for the absence of##6##4##(1997-3#1)(2008-10#3)(2008-8#1)(2011-2#1)
for the accumulation of##2##4##(1997-2#1)(2008-10#1)
for the accumulation##3##3##(1997-2#1)(2008-10#2)
for the accurate and##4##4##(2008-10#4)
for the accurate determination of##2##5##(2008-10#2)
for the accurate##7##3##(2008-10#6)(2008-2#1)
for the acquisition of##3##4##(1991-2#1)(2008-3#1)(2010-12#1)
for the acquisition##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
for the activated carbon and##3##5##(2008-10#3)
for the activated carbon##5##4##(2008-10#5)
for the activated##6##3##(2008-10#6)
for the activation of##6##4##(1995-2#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-3#1)
for the activation##8##3##(1995-2#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
for the active##3##3##(1994-5#1)(2008-10#2)
for the activity of##3##4##(1990-5#1)(2008-1#1)(2012-3#1)
for the activity##5##3##(1990-5#1)(1991-5#1)(1994-8#1)(2008-1#1)(2012-3#1)
for the addition of the##3##5##(1990-8#2)(2008-10#1)
for the addition of##5##4##(1990-8#2)(1992-10#1)(2008-10#1)(2009-8#1)
for the addition##6##3##(1990-8#2)(1992-10#1)(2008-10#1)(2008-2#1)(2009-8#1)
for the additional##2##3##(1991-3#1)(2011-2#1)
for the adequacy of##2##4##(2008-11#2)
for the administration##2##3##(1996-8#1)(2012-2#1)
for the adsorption of##5##4##(2008-10#5)
for the adsorption##8##3##(2008-10#8)
for the advancement of##2##4##(2008-11#1)(2011-2#1)
for the age of the##2##5##(1997-6#2)
for the alpha 7##2##4##(1996-12#1)(2010-8#1)
for the alpha##5##3##(1992-8#1)(1993-6#1)(1995-11#1)(1996-12#1)(2010-8#1)
for the altered##2##3##(1993-6#1)(2009-1#1)
for the ambulatory##2##3##(1991-1#1)(2013-1#1)
for the amino acid##2##4##(1995-12#1)(2008-10#1)
for the amount of##2##4##(2008-10#2)
for the amperometric detection of##6##5##(2008-10#6)
for the amperometric##7##3##(2008-10#7)
for the amplification of##6##4##(1993-2#1)(2008-10#4)(2008-11#1)
for the analyses of##3##4##(2008-10#3)
for the analyses##5##3##(1997-7#1)(2008-10#4)
for the analysis and##4##4##(2008-10#2)(2008-4#2)
for the analysis of different##2##5##(2008-10#2)
for the analysis of glass##3##5##(2008-10#3)
for the analysis of organophosphorus pesticides##3##6##(2008-10#3)
for the analysis of parabens##2##5##(2008-10#2)
for the analysis of polycyclic aromatic hydrocarbons (PAHs)##4##8##(2008-10#4)
for the analysis of polycyclic aromatic hydrocarbons in water samples##2##10##(2008-10#2)
for the analysis of polycyclic aromatic hydrocarbons in##3##8##(2008-10#3)
for the analysis of polycyclic aromatic hydrocarbons##8##7##(2008-10#8)
for the analysis of real##2##5##(2008-10#2)
for the analysis of selected##2##5##(2008-10#2)
for the analysis of sodium##2##5##(2008-10#2)
for the analysis of some##3##5##(2008-10#3)
for the analysis of synthetic##2##5##(2008-10#1)(2008-4#1)
for the analysis of the##12##5##(2008-10#10)(2008-11#1)(2008-9#1)
for the analysis of these##2##5##(2008-10#2)
for the analysis of this##3##5##(2008-10#3)
for the analysis of trace##4##5##(2008-10#4)
for the analysis of##142##4##(1990-12#1)(1996-3#1)(1997-2#1)(2008-10#123)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-7#1)(2008-9#2)(2010-6#1)(2011-2#1)
for the analysis##152##3##(1990-12#1)(1996-3#1)(1997-2#1)(2008-10#130)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#8)(2008-7#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-2#1)
for the analyte##6##3##(2008-10#6)
for the analytes are in the range of##2##8##(2008-10#2)
for the analytes##9##3##(2008-10#8)(2010-5#1)
for the analytical##4##3##(2008-10#3)(2008-3#1)
for the antigen##2##3##(1996-2#1)(2008-10#1)
for the antioxidant##2##3##(2008-10#1)(2009-6#1)
for the apparent##4##3##(2008-10#4)
for the appearance of##2##4##(2008-5#1)(2010-4#1)
for the application of##9##4##(1993-3#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
for the application##10##3##(1993-3#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
for the appropriate##2##3##(2008-7#1)(2009-12#1)
for the assay of D-Mtx##2##5##(2008-10#2)
for the assay of R-baclofen##2##5##(2008-10#2)
for the assay of l-carnitine##2##5##(2008-10#2)
for the assay of perphenazine in drug##2##7##(2008-10#2)
for the assay of perphenazine##4##5##(2008-10#4)
for the assay of the##2##5##(2008-10#1)(2008-4#1)
for the assay of three##2##5##(2008-10#2)
for the assay of##47##4##(1990-2#1)(2008-10#45)(2008-4#1)
for the assay##49##3##(1990-2#1)(2008-10#46)(2008-11#1)(2008-4#1)
for the assays of##2##4##(2008-10#2)
for the assays##3##3##(2008-10#3)
for the assembly of##2##4##(2008-10#1)(2008-8#1)
for the assessment of the##5##5##(2008-10#2)(2008-5#2)(2013-8#1)
for the assessment of unwanted immunogenicity##2##6##(2008-10#2)
for the assessment of##32##4##(1990-12#1)(1991-1#1)(1996-12#1)(1996-6#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
for the associated##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
for the association of##2##4##(1995-2#1)(2008-10#1)
for the association##4##3##(1995-2#1)(2008-10#2)(2012-3#1)
for the attachment of##3##4##(1994-12#1)(2008-10#1)(2008-4#1)
for the auditory evaluation of the hearing impaired##2##8##(2008-9#2)
for the automated##3##3##(2008-10#3)
for the automatic##2##3##(2008-10#1)(2008-11#1)
for the automation of analytical procedures##2##6##(2008-10#2)
for the automation of##3##4##(2008-10#3)
for the average##2##3##(1991-1#1)(1996-3#1)
for the backbone##2##3##(1994-5#1)(2009-7#1)
for the benefit of the virus##2##6##(2013-1#2)
for the benefit of##4##4##(1995-5#1)(2012-3#1)(2013-1#2)
for the best##9##3##(2008-10#6)(2008-9#1)(2012-3#1)(2013-1#1)
for the beta 3-adrenoceptor##2##4##(1995-11#2)
for the beta##3##3##(1992-9#1)(1995-11#2)
for the better health##2##4##(1994-3#1)(1997-2#1)
for the better##3##3##(1994-3#1)(1997-2#1)(2010-8#1)
for the bifurcated##2##3##(2008-10#2)
for the binary##2##3##(2008-10#2)
for the binding of##7##4##(1995-12#1)(1995-2#1)(1997-9#1)(2008-10#3)(2008-8#1)
for the binding##9##3##(1991-12#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-8#1)
for the biochemical##2##3##(2008-9#1)(2012-3#1)
for the biological activity##2##4##(2008-10#1)(2010-12#1)
for the biological control of##7##5##(2008-10#6)(2008-8#1)
for the biological##10##3##(2008-10#7)(2008-8#1)(2010-12#1)(2013-7#1)
for the biosynthesis of the##2##5##(2008-7#1)(2011-2#1)
for the biosynthesis of##4##4##(1993-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
for the biovolume##2##3##(2008-11#2)
for the bond##2##3##(2008-9#2)
for the bovine##2##3##(1994-8#2)
for the brain##3##3##(1994-12#1)(2008-9#1)(2010-12#1)
for the breast cancer##2##4##(1993-11#1)(2012-3#1)
for the calculation of##3##4##(1997-3#1)(2008-10#2)
for the calculations##3##3##(2008-10#3)
for the calibration of##3##4##(2008-10#3)
for the calibration##7##3##(2008-10#7)
for the carbohydrate##2##3##(1990-5#2)
for the care of##7##4##(1992-1#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
for the case of a##2##5##(2008-10#1)(2008-3#1)
for the case of##6##4##(2008-10#2)(2008-3#3)(2008-8#1)
for the case##7##3##(1995-2#1)(2008-10#2)(2008-3#3)(2008-8#1)
for the cases##2##3##(1997-3#1)(2013-1#1)
for the catalysis##3##3##(2008-10#2)(2008-11#1)
for the catalytic##3##3##(1992-3#1)(1992-6#1)(2008-10#1)
for the cationic##2##3##(2008-10#1)(2008-5#1)
for the cations##2##3##(2008-10#2)
for the cause of##3##4##(1996-8#1)(2008-11#1)(2010-3#1)
for the cell##3##3##(2008-4#2)(2011-2#1)
for the central##2##3##(1994-8#1)(2007-12#1)
for the change of##2##4##(2008-12#1)(2013-8#1)
for the change##3##3##(1995-11#1)(2008-12#1)(2013-8#1)
for the changes in##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
for the changes##4##3##(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
for the characterisation of##6##4##(2008-10#4)(2008-11#1)(2012-2#1)
for the characterisation##7##3##(2008-10#5)(2008-11#1)(2012-2#1)
for the characteristic##2##3##(1994-11#1)(2008-4#1)
for the characterization and##2##4##(2008-10#1)(2008-3#1)
for the characterization of##11##4##(1992-2#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#2)
for the characterization##13##3##(1992-2#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#2)
for the chemical analysis of##2##5##(2008-10#2)
for the chemical##6##3##(2008-10#6)
for the chemiluminescence##2##3##(2008-10#2)
for the chemiluminescent##3##3##(2008-10#3)
for the chemiluminometric determination of##2##5##(2008-10#2)
for the child##2##3##(2008-11#1)(2010-9#1)
for the children who##2##4##(1994-6#1)(2011-1#1)
for the children's##2##3##(1990-2#1)(2008-11#1)
for the chromatographic##3##3##(2008-10#3)
for the classical##2##3##(1990-12#1)(2012-12#1)
for the classification of##5##4##(2008-10#2)(2008-12#1)(2009-6#1)(2010-12#1)
for the classification##8##3##(2008-10#4)(2008-12#1)(2009-6#1)(2010-12#1)(2010-8#1)
for the clean-up of##2##4##(2008-10#1)(2008-11#1)
for the client##3##3##(1994-2#1)(2008-11#1)(2013-8#1)
for the clinical application##2##4##(1990-2#1)(2008-11#1)
for the clinical data specialist##3##5##(2007-12#3)
for the clinical##15##3##(1990-2#1)(1992-12#1)(2007-12#3)(2008-11#4)(2008-6#1)(2009-12#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-1#1)
for the clinician##3##3##(1990-9#1)(2008-12#1)(2012-2#1)
for the coated##2##3##(2008-10#1)(2008-2#1)
for the cohered structure##2##4##(1991-7#2)
for the collaborative##2##3##(2008-11#1)(2012-2#1)
for the collection of##2##4##(1997-3#1)(2008-10#1)
for the colony-stimulating##2##3##(1991-6#1)(1992-10#1)
for the colorimetric determination##2##4##(2008-10#2)
for the column##2##3##(1992-11#1)(2008-10#1)
for the combined##2##3##(1996-3#1)(2008-10#1)
for the common##5##3##(2008-10#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-2#1)
for the community##5##3##(1991-1#1)(1995-9#1)(2008-8#2)(2013-1#1)
for the comparison of##2##4##(1994-9#1)(2008-10#1)
for the comparison##3##3##(1994-9#1)(2008-10#1)(2009-12#1)
for the compensation##2##3##(1991-2#1)(2008-10#1)
for the complex##4##3##(1992-4#1)(1993-8#1)(2008-10#1)(2012-2#1)
for the complexation of the##2##5##(2008-10#2)
for the complexation##4##3##(2008-10#4)
for the complexes##2##3##(2008-10#2)
for the complexity of##3##4##(1993-2#1)(1997-6#1)(2010-7#1)
for the compounds were##3##4##(1993-1#1)(2008-10#2)
for the compounds##5##3##(1993-1#1)(1997-2#1)(2008-10#2)(2009-8#1)
for the computation of##2##4##(2008-10#2)
for the concentration of##2##4##(2008-10#1)(2008-12#1)
for the concentration##3##3##(2008-10#2)(2008-12#1)
for the concentrations of##2##4##(1990-8#1)(2008-10#1)
for the concept of a##2##5##(1991-1#1)(1995-12#1)
for the concept##3##3##(1991-1#1)(1995-12#1)(1995-2#1)
for the confirmation of##2##4##(2008-10#1)(2011-2#1)
for the conidial germination assays##2##5##(2008-10#2)
for the conidial germination##3##4##(2008-10#3)
for the consecutive##2##3##(2008-10#2)
for the construction of a##6##5##(1991-5#1)(2008-10#1)(2008-11#3)(2010-5#1)
for the construction of##14##4##(1991-5#1)(1993-2#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-9#1)(2010-5#1)
for the construction##15##3##(1991-5#1)(1993-2#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-9#1)(2010-5#1)
for the continuing##2##3##(1993-3#1)(1997-8#1)
for the continuous##12##3##(1993-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)
for the control and##2##4##(2008-7#2)
for the control group##3##4##(2008-12#1)(2009-1#1)(2011-2#1)
for the control of the##2##5##(1996-12#1)(2008-10#1)
for the control of##23##4##(1993-9#1)(1996-12#2)(2008-10#13)(2008-11#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
for the control##31##3##(1993-8#1)(1993-9#1)(1996-12#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-7#3)(2009-1#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)
for the controlled##2##3##(1995-3#1)(2008-10#1)
for the convenient##2##3##(2008-10#1)(2008-9#1)
for the conventional##2##3##(2008-10#1)(2008-11#1)
for the conversion of##3##4##(1995-3#1)(1996-2#1)(1997-7#1)
for the correct##4##3##(1993-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
for the correction of##3##4##(2008-10#1)(2009-10#1)(2013-1#1)
for the correlation between##3##4##(1991-9#1)(1996-3#1)(2012-3#1)
for the corresponding##5##3##(1990-5#1)(1997-7#1)(2008-10#2)(2008-11#1)
for the cosmetic industry##2##4##(2008-5#2)
for the coupling##2##3##(2008-4#1)(2009-5#1)
for the creation of##5##4##(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#2)
for the crystal##2##3##(1993-12#1)(1994-5#1)
for the cultivation of##4##4##(2008-11#3)(2008-9#1)
for the culture of##3##4##(2008-11#3)
for the current##5##3##(1995-12#1)(1996-6#1)(2007-12#1)(2012-2#1)(2013-8#1)
for the dRTA##2##3##(2008-1#2)
for the decision##2##3##(1997-4#1)(1997-8#1)
for the decomposition of##2##4##(2008-10#1)(2009-11#1)
for the decreased##2##3##(2011-1#1)(2013-1#1)
for the degradation of##6##4##(1994-8#1)(1995-6#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-4#1)
for the degree of##4##4##(1990-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
for the delivery of##7##4##(1994-5#1)(1995-12#1)(1995-3#2)(2008-5#2)(2011-2#1)
for the delivery##8##3##(1992-2#1)(1994-5#1)(1995-12#1)(1995-3#2)(2008-5#2)(2011-2#1)
for the departure##2##3##(2008-3#2)
for the deposition of##3##4##(1994-12#1)(2008-10#1)(2008-11#1)
for the derivation of##3##4##(2008-10#1)(2008-7#1)(2009-2#1)
for the derivation##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)
for the design and##2##4##(2008-3#1)(2010-4#1)
for the design of an##2##5##(2008-11#1)(2008-3#1)
for the design of new##2##5##(2011-2#1)(2011-3#1)
for the design of##13##4##(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-2#1)(2011-3#1)
for the design##18##3##(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#1)(2011-2#1)(2011-3#1)
for the detection and determination of##3##6##(2008-10#1)(2008-11#2)
for the detection and identification of##3##6##(2008-10#3)
for the detection and##15##4##(1990-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)
for the detection of DNA##4##5##(1995-12#1)(2008-10#3)
for the detection of Escherichia coli O157##2##7##(2008-10#2)
for the detection of IgM antibodies to either one of two##2##11##(1990-12#2)
for the detection of NO##4##5##(2008-10#1)(2008-3#2)(2010-7#1)
for the detection of P##2##5##(2008-10#2)
for the detection of Phytophthora ramorum##2##6##(2008-10#2)
for the detection of Salmonella##2##5##(1990-12#1)(2008-10#1)
for the detection of Schistosoma japonicum antibody##2##7##(2008-10#2)
for the detection of a##2##5##(2008-10#1)(2009-3#1)
for the detection of anti-West Nile virus IgG##2##8##(2008-10#2)
for the detection of antibodies to##4##6##(1990-12#2)(1991-3#2)
for the detection of antibodies##5##5##(1990-12#3)(1991-3#2)
for the detection of begomoviruses##2##5##(2008-10#2)
for the detection of cancer##2##5##(1990-6#1)(2008-11#1)
for the detection of hantavirus##2##5##(2008-10#2)
for the detection of hydrogen peroxide##2##6##(2008-10#2)
for the detection of hydrogen##3##5##(2008-10#3)
for the detection of mercury(II)##2##5##(2008-10#2)
for the detection of nitric oxide##2##6##(2008-10#2)
for the detection of peroxynitrite##2##5##(2008-10#2)
for the detection of pesticides in##2##6##(2008-10#2)
for the detection of plant viruses##2##6##(2008-10#2)
for the detection of retroviruses##2##5##(2008-11#2)
for the detection of several##2##5##(2008-10#1)(2009-3#1)
for the detection of the##8##5##(1990-12#1)(2008-10#6)(2008-9#1)
for the detection of toxicants in water##3##7##(2008-10#3)
for the detection of trace levels of##2##7##(2008-10#2)
for the detection of trace##6##5##(2008-10#6)
for the detection of##158##4##(1990-12#9)(1990-2#1)(1990-6#1)(1990-8#2)(1991-3#3)(1992-11#1)(1992-3#1)(1995-12#1)(1996-12#2)(1997-3#1)(2007-12#1)(2008-10#103)(2008-11#6)(2008-12#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-9#2)(2009-1#1)(2009-3#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#2)
for the detection##175##3##(1990-12#10)(1990-2#1)(1990-6#1)(1990-8#2)(1991-3#3)(1992-11#1)(1992-3#1)(1995-12#1)(1996-12#2)(1997-3#1)(2007-12#1)(2008-10#114)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-9#2)(2009-1#1)(2009-3#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#2)
for the determination and speciation of arsenic##2##7##(2008-10#2)
for the determination and speciation##3##5##(2008-10#3)
for the determination and##4##4##(2008-10#3)(2010-11#1)
for the determination of 0##2##5##(2008-10#2)
for the determination of 1##2##5##(2008-10#2)
for the determination of 2##2##5##(2008-10#2)
for the determination of 4-aminophenol##2##5##(2008-10#2)
for the determination of 50##3##5##(2008-10#3)
for the determination of 6-mercaptopurine##2##5##(2008-10#2)
for the determination of Aflatoxin B(1)##2##6##(2008-10#2)
for the determination of Ag##3##5##(2008-10#3)
for the determination of As and Sb##2##7##(2008-10#2)
for the determination of As##4##5##(2008-10#4)
for the determination of As(III)##4##5##(2008-10#4)
for the determination of Bi##2##5##(2008-10#2)
for the determination of Ca##2##5##(2008-10#2)
for the determination of Cd and Pb##2##7##(2008-10#2)
for the determination of Cd in acid-digested solutions of##2##9##(2008-10#2)
for the determination of Cd in##3##6##(2008-10#3)
for the determination of Cd##7##5##(2008-10#7)
for the determination of Co##2##5##(2008-10#2)
for the determination of Cu and##2##6##(2008-10#2)
for the determination of Cu##6##5##(2008-10#6)
for the determination of Cu(II) in##3##6##(2008-10#3)
for the determination of Cu(II)##5##5##(2008-10#5)
for the determination of DMA in##2##6##(2008-10#2)
for the determination of Hg(II)##3##5##(2008-10#3)
for the determination of Mg(2+)##2##5##(2008-10#2)
for the determination of Mo##2##5##(2008-10#2)
for the determination of NO##2##5##(2008-10#2)
for the determination of Ni(II) and Co(II)##2##7##(2008-10#2)
for the determination of PA##2##5##(2008-10#2)
for the determination of Pb(II) at trace##2##7##(2008-10#2)
for the determination of Sb(V) in##2##6##(2008-10#2)
for the determination of Se compounds in##2##7##(2008-10#2)
for the determination of Se in##2##6##(2008-10#2)
for the determination of Se##6##5##(2008-10#6)
for the determination of VB(2)##2##5##(2008-10#2)
for the determination of VHCs##2##5##(2009-8#2)
for the determination of Vitamin##2##5##(2008-10#2)
for the determination of Zn(2+)##2##5##(2008-10#2)
for the determination of a##3##5##(2008-10#3)
for the determination of acetylcholine##3##5##(2008-10#3)
for the determination of alendronate##2##5##(2008-10#2)
for the determination of aliphatic##2##5##(2008-10#2)
for the determination of aluminium##2##5##(2008-10#2)
for the determination of aminomethylbenzoic acid##2##6##(2008-10#2)
for the determination of ammonium##2##5##(2008-10#2)
for the determination of anionic surfactants in##2##7##(2008-10#2)
for the determination of anionic##3##5##(2008-10#3)
for the determination of antimony in pharmaceuticals##2##7##(2008-10#2)
for the determination of antimony##4##5##(2008-10#4)
for the determination of antithyroid drugs##2##6##(2008-10#2)
for the determination of arsenic in environmental samples##2##8##(2008-10#2)
for the determination of arsenic in##5##6##(2008-10#5)
for the determination of arsenic##8##5##(2008-10#8)
for the determination of ascorbic acid in##2##7##(2008-10#2)
for the determination of ascorbic acid##8##6##(2008-10#8)
for the determination of atmospheric##2##5##(2008-10#2)
for the determination of atropine and pethidine##2##7##(2008-10#2)
for the determination of benzo[a]pyrene in##2##6##(2008-10#2)
for the determination of benzoic acid in##2##7##(2008-10#2)
for the determination of boron##2##5##(2008-10#2)
for the determination of bromide##3##5##(2008-10#3)
for the determination of cadmium and##2##6##(2008-10#2)
for the determination of cadmium by graphite furnace atomic absorption spectrometry##2##11##(2008-10#2)
for the determination of cadmium in##4##6##(2008-10#4)
for the determination of cadmium##11##5##(2008-10#11)
for the determination of calcium##3##5##(2008-10#3)
for the determination of carbon dioxide##3##6##(2008-10#3)
for the determination of carbon##4##5##(2008-10#4)
for the determination of carbonyl compounds##2##6##(2008-10#2)
for the determination of cardiac troponin I##2##7##(2008-10#2)
for the determination of cationic##2##5##(2008-10#2)
for the determination of cetylpyridinium##2##5##(2008-10#2)
for the determination of chloride in##2##6##(2008-10#2)
for the determination of chloride ion in##2##7##(2008-10#2)
for the determination of chloride##5##5##(2008-10#5)
for the determination of chromium##6##5##(2008-10#6)
for the determination of ciprofloxacin in drug formulations##2##8##(2008-10#2)
for the determination of ciprofloxacin##3##5##(2008-10#3)
for the determination of cobalt in##3##6##(2008-10#3)
for the determination of cobalt##7##5##(2008-10#7)
for the determination of copper by##2##6##(2008-10#2)
for the determination of copper in##3##6##(2008-10#3)
for the determination of copper##10##5##(2008-10#10)
for the determination of copper(II) based on##2##7##(2008-10#2)
for the determination of copper(II)##4##5##(2008-10#4)
for the determination of cyanide##3##5##(2008-10#3)
for the determination of cysteine##6##5##(2008-10#6)
for the determination of d-serine in neural samples##2##8##(2008-10#2)
for the determination of dissolved oxygen##2##6##(2008-10#2)
for the determination of dissolved##7##5##(2008-10#7)
for the determination of dithiocarbamate##2##5##(2008-10#2)
for the determination of dopamine##3##5##(2008-10#3)
for the determination of drug in##2##6##(2008-10#2)
for the determination of drug##3##5##(2008-10#3)
for the determination of eight##2##5##(2008-10#2)
for the determination of ethanol in##4##6##(2008-10#4)
for the determination of ethanol##6##5##(2008-10#6)
for the determination of famotidine##2##5##(2008-10#2)
for the determination of fish freshness##4##6##(2008-10#4)
for the determination of fluoride ion in##2##7##(2008-10#2)
for the determination of fluoride ion##3##6##(2008-10#3)
for the determination of fluoride##4##5##(2008-10#4)
for the determination of gallium##2##5##(2008-10#2)
for the determination of glucose in animal blood serum##2##9##(2008-10#2)
for the determination of glucose in##4##6##(2008-10#4)
for the determination of glucose##5##5##(2008-10#5)
for the determination of glutathione##2##5##(2008-10#2)
for the determination of hemoglobin##2##5##(2008-10#2)
for the determination of hydrazine##3##5##(2008-10#3)
for the determination of hydrogen peroxide in rainwater##2##8##(2008-10#2)
for the determination of hydrogen peroxide in##4##7##(2008-10#4)
for the determination of hydrogen peroxide##9##6##(2008-10#9)
for the determination of hydrogen##10##5##(2008-10#10)
for the determination of hydroquinone in##2##6##(2008-10#2)
for the determination of inorganic##4##5##(2008-10#4)
for the determination of iodide##2##5##(2008-10#2)
for the determination of ion exchange equilibrium constants##2##8##(2008-10#2)
for the determination of iron (II)##2##6##(2008-10#2)
for the determination of iron in##3##6##(2008-10#3)
for the determination of iron##8##5##(2008-10#8)
for the determination of isoniazid##2##5##(2008-10#2)
for the determination of l- and d-enantiomers of methotrexate##2##9##(2008-10#2)
for the determination of lead and##2##6##(2008-10#2)
for the determination of lead in##6##6##(2008-10#6)
for the determination of lead##11##5##(2008-10#11)
for the determination of lead(II)##3##5##(2008-10#3)
for the determination of linezolid in the presence of its alkaline-induced degradation products##2##13##(2008-10#2)
for the determination of low##3##5##(2008-10#3)
for the determination of manganese##3##5##(2008-10#3)
for the determination of manganese(II)##3##5##(2008-10#3)
for the determination of mercury by##3##6##(2008-10#3)
for the determination of mercury##6##5##(2008-10#6)
for the determination of metal##2##5##(2008-10#1)(2010-11#1)
for the determination of metals in##5##6##(2008-10#5)
for the determination of metronidazole##3##5##(2008-10#3)
for the determination of molybdenum##4##5##(2008-10#4)
for the determination of morphine##2##5##(2008-10#2)
for the determination of nanogram##2##5##(2008-10#2)
for the determination of naproxen##2##5##(2008-10#2)
for the determination of nickel in##2##6##(2008-10#2)
for the determination of nitrite in##2##6##(2008-10#2)
for the determination of nitrite##9##5##(2008-10#9)
for the determination of nitrogen##2##5##(2008-10#2)
for the determination of organophosphorous pesticides##2##6##(2008-10#2)
for the determination of orthophosphate##2##5##(2008-10#2)
for the determination of ozone##2##5##(2008-10#2)
for the determination of panaxynol in##2##6##(2008-10#2)
for the determination of papaverine##2##5##(2008-10#2)
for the determination of paracetamol in##2##6##(2008-10#2)
for the determination of paraquat##3##5##(2008-10#3)
for the determination of pentoxyverine##2##5##(2008-10#2)
for the determination of perphenazine##2##5##(2008-10#2)
for the determination of phenolic##2##5##(2008-10#2)
for the determination of phenylephrine hydrochloride in pharmaceutical##2##8##(2008-10#2)
for the determination of phosphorus species in##2##7##(2008-10#2)
for the determination of phosphorus##6##5##(2008-10#6)
for the determination of piroxicam##2##5##(2008-10#2)
for the determination of platinum in##2##6##(2008-10#2)
for the determination of platinum##3##5##(2008-10#3)
for the determination of polycyclic aromatic hydrocarbons (PAHs) in##2##9##(2008-10#2)
for the determination of polycyclic aromatic hydrocarbons##3##7##(2008-10#3)
for the determination of potentiometric selectivity coefficients of##2##8##(2008-10#2)
for the determination of prenalterol##2##5##(2008-10#2)
for the determination of protein##3##5##(1990-12#1)(2008-10#2)
for the determination of proteins with##2##6##(2008-10#2)
for the determination of proteins##4##5##(2008-10#4)
for the determination of pyrimethamine##3##5##(2008-10#3)
for the determination of rare earth##2##6##(2008-10#2)
for the determination of reductive sulphur##2##6##(2008-10#2)
for the determination of retinyl acetate##2##6##(2008-10#2)
for the determination of rhodium##3##5##(2008-10#3)
for the determination of ruthenium##3##5##(2008-10#3)
for the determination of salsalate##2##5##(2008-10#2)
for the determination of selenium##2##5##(2008-10#2)
for the determination of several##2##5##(2008-10#2)
for the determination of silver##2##5##(2008-10#2)
for the determination of some##6##5##(2008-10#6)
for the determination of stability constants of##2##7##(2008-10#2)
for the determination of sulfate##2##5##(2008-10#2)
for the determination of sulfide##2##5##(2008-10#2)
for the determination of sulfite in##2##6##(2008-10#2)
for the determination of sulfite##4##5##(2008-10#4)
for the determination of sulphur##2##5##(2008-10#2)
for the determination of thallium##3##5##(1991-12#1)(2008-10#2)
for the determination of the above##2##6##(2008-10#2)
for the determination of the analyte##2##6##(2008-10#2)
for the determination of the concentration of##4##7##(2008-10#3)(2008-11#1)
for the determination of the drug in##2##7##(2008-10#2)
for the determination of the drug##3##6##(2008-10#3)
for the determination of the four##2##6##(2008-10#2)
for the determination of the herbicide##3##6##(2008-10#3)
for the determination of the stability##2##6##(2008-10#2)
for the determination of the studied drugs in their pharmaceutical##2##10##(2008-10#2)
for the determination of the total amount of##2##8##(2008-10#2)
for the determination of the widely used herbicide##2##8##(2008-10#2)
for the determination of the##66##5##(1990-12#2)(1991-7#1)(2008-10#60)(2008-11#1)(2008-12#2)
for the determination of these##5##5##(2008-10#5)
for the determination of this##3##5##(2008-10#3)
for the determination of three##3##5##(2008-10#3)
for the determination of tin##2##5##(2008-10#2)
for the determination of total arsenic##2##6##(2008-10#2)
for the determination of total mercury##3##6##(2008-10#3)
for the determination of total phosphorus in##2##7##(2008-10#2)
for the determination of total sulfur##2##6##(2008-10#2)
for the determination of total sulphur##3##6##(2008-10#3)
for the determination of total##21##5##(2008-10#21)
for the determination of trace amount of indium in##2##9##(2008-10#2)
for the determination of trace amount of##7##7##(2008-10#7)
for the determination of trace amounts of bromide##2##8##(2008-10#2)
for the determination of trace amounts of nitrite##2##8##(2008-10#2)
for the determination of trace amounts of##24##7##(2008-10#24)
for the determination of trace elements in##4##7##(2008-10#3)(2011-2#1)
for the determination of trace elements##6##6##(2008-10#5)(2011-2#1)
for the determination of trace levels of##5##7##(2008-10#5)
for the determination of trace metal##2##6##(2008-10#2)
for the determination of trace metals by##2##7##(2008-10#2)
for the determination of trace metals##4##6##(2008-10#4)
for the determination of trace silver(I)##2##6##(2008-10#2)
for the determination of trace##71##5##(2008-10#70)(2011-2#1)
for the determination of traces of##4##6##(2008-10#4)
for the determination of transparent exopolymer particles (TEP) in freshwater##2##10##(2008-10#2)
for the determination of tungsten in##2##6##(2008-10#2)
for the determination of tungsten##3##5##(2008-10#3)
for the determination of two##3##5##(2008-10#3)
for the determination of ultra trace##2##6##(2008-10#2)
for the determination of ultra-trace##2##5##(2008-10#2)
for the determination of uranium in##2##6##(2008-10#2)
for the determination of uranium##4##5##(2008-10#4)
for the determination of uric acid##3##6##(2008-10#3)
for the determination of vanadium in##2##6##(2008-10#2)
for the determination of vanadium##6##5##(2008-10#6)
for the determination of very low##2##6##(1990-12#1)(2008-10#1)
for the determination of volatile##3##5##(2008-10#3)
for the determination of zinc##4##5##(2008-10#4)
for the determination of##1037##4##(1990-12#5)(1990-2#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-12#1)(1995-3#1)(1996-3#1)(2008-10#1005)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#4)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
for the determination##1047##3##(1990-12#5)(1990-2#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-12#1)(1995-3#1)(1996-3#1)(2008-10#1014)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#4)(2010-11#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
for the determinations of##4##4##(2008-10#4)
for the developed##2##3##(2008-10#2)
for the development of a new##3##6##(2008-10#3)
for the development of a##12##5##(1994-2#1)(2008-10#7)(2008-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
for the development of an##2##5##(2008-10#1)(2008-3#1)
for the development of atherosclerosis##2##5##(1995-8#1)(2012-3#1)
for the development of mental health##2##6##(1994-1#1)(2009-6#1)
for the development of new##4##5##(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)
for the development of novel##4##5##(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
for the development of robust##2##5##(2008-10#1)(2008-7#1)
for the development of the##6##5##(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)
for the development of##84##4##(1990-12#1)(1990-2#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-8#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#21)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-6#2)(2009-7#2)(2010-12#2)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
for the development##88##3##(1990-12#1)(1990-2#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-8#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#21)(2008-11#12)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-6#2)(2009-7#2)(2010-12#2)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
for the diagnosis and the##2##5##(1993-6#1)(2010-12#1)
for the diagnosis and treatment of##2##6##(2009-4#1)(2013-1#1)
for the diagnosis and##7##4##(1993-6#1)(2008-4#1)(2009-4#1)(2010-12#2)(2012-2#1)(2013-1#1)
for the diagnosis of##22##4##(1991-12#1)(1991-3#1)(1994-6#1)(1996-11#2)(1997-2#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#2)
for the diagnosis##33##3##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-11#2)(1997-2#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#3)
for the difference in##2##4##(1993-12#1)(2008-10#1)
for the difference##3##3##(1993-12#1)(1996-12#1)(2008-10#1)
for the differences in##4##4##(1992-3#1)(1994-5#1)(2008-10#1)(2008-11#1)
for the differences##6##3##(1992-3#1)(1994-5#1)(1997-9#1)(2008-10#2)(2008-11#1)
for the different species##3##4##(2008-10#2)(2008-8#1)
for the different##20##3##(1995-12#1)(1997-2#1)(2008-10#12)(2008-8#1)(2008-9#2)(2010-4#1)(2012-8#1)(2013-1#1)
for the differential diagnosis of##3##5##(1990-2#1)(1991-10#1)(1996-11#1)
for the differential##5##3##(1990-2#1)(1991-10#1)(1996-11#1)(1997-7#1)(2008-10#1)
for the differentiation and##2##4##(1990-9#1)(2008-10#1)
for the differentiation of##3##4##(2008-10#2)(2008-9#1)
for the differentiation##5##3##(1990-9#1)(2008-10#3)(2008-9#1)
for the diffuse##2##3##(2008-2#2)
for the digestion of##3##4##(2008-10#2)(2010-8#1)
for the digestion##4##3##(2008-10#3)(2010-8#1)
for the dioxin##3##3##(2008-10#3)
for the direct analysis of##3##5##(2008-10#3)
for the direct and##2##4##(2008-10#2)
for the direct detection of##2##5##(2008-10#1)(2008-4#1)
for the direct detection##3##4##(2008-10#2)(2008-4#1)
for the direct determination of copper##2##6##(2008-10#2)
for the direct determination of##25##5##(2008-10#25)
for the direct##46##3##(1997-2#1)(2008-10#42)(2008-2#1)(2008-4#1)(2011-2#1)
for the disabled##3##3##(1992-12#1)(1992-3#1)(2009-6#1)
for the discovery of novel##2##5##(2008-9#1)(2011-2#1)
for the discovery of##4##4##(2008-10#1)(2008-9#2)(2011-2#1)
for the discovery##5##3##(1997-2#1)(2008-10#1)(2008-9#2)(2011-2#1)
for the discrimination of##4##4##(2008-10#3)(2008-12#1)
for the disease##12##3##(1991-5#1)(1994-9#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
for the dissolution of##3##4##(2008-10#3)
for the dissolution##4##3##(2008-10#4)
for the distribution of##2##4##(2008-12#1)(2011-2#1)
for the distribution##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
for the diversity##2##3##(1997-2#1)(1997-5#1)
for the downstream rivers##2##4##(2008-10#2)
for the drug accumulation and##2##5##(2008-10#2)
for the drug##10##3##(1993-12#1)(1997-6#1)(2008-10#4)(2008-11#1)(2010-9#1)(2011-2#1)(2012-2#1)
for the drugs##2##3##(2008-10#1)(2011-2#1)
for the duration of the experiment##2##6##(2008-10#2)
for the duration of the##6##5##(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)
for the duration##7##3##(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2010-1#1)
for the dynamics of##2##4##(1995-5#1)(2008-8#1)
for the dynamics##3##3##(1995-5#1)(2008-8#1)(2010-10#1)
for the ear##2##3##(2008-10#1)(2008-7#1)
for the early detection of##2##5##(2008-10#1)(2008-12#1)
for the early stages of##2##5##(2010-8#2)
for the early##8##3##(1991-2#1)(2008-10#2)(2008-12#1)(2010-8#2)(2011-2#1)(2012-12#1)
for the easy construction of##2##5##(1990-5#1)(2013-8#1)
for the effect of##3##4##(1996-3#1)(2011-3#1)(2012-2#1)
for the effect##4##3##(1996-3#1)(2008-11#1)(2011-3#1)(2012-2#1)
for the effective##8##3##(2006-6#1)(2008-10#4)(2008-3#2)(2008-8#1)
for the effectiveness of##3##4##(1992-2#1)(2012-2#1)(2013-1#1)
for the effects of##9##4##(1991-5#2)(2008-10#2)(2008-11#2)(2008-3#1)(2012-2#1)(2013-8#1)
for the efficacy and##2##4##(2008-10#1)(2013-1#1)
for the efficacy##4##3##(1997-4#1)(2008-10#1)(2010-8#1)(2013-1#1)
for the efficiency of##2##4##(2008-12#1)(2013-7#1)
for the efficient and##2##4##(2011-2#1)(2013-1#1)
for the efficient##5##3##(2008-11#2)(2011-1#1)(2011-2#1)(2013-1#1)
for the eight##3##3##(1993-6#1)(1997-3#1)(2009-10#1)
for the elaboration of##2##4##(2008-10#2)
for the elaboration##3##3##(2008-10#2)(2008-9#1)
for the elderly and##2##4##(1992-3#1)(2008-7#1)
for the elderly are##2##4##(1994-1#1)(1995-2#1)
for the elderly##14##3##(1990-6#1)(1991-2#2)(1991-3#2)(1992-2#1)(1992-3#2)(1993-2#1)(1994-1#1)(1995-2#1)(2008-11#1)(2008-7#2)
for the electrocatalytic##3##3##(2008-10#3)
for the electrochemical determination of sulphur-containing compounds##2##7##(2008-10#2)
for the electrochemical determination of##4##5##(2008-10#4)
for the electrochemical##6##3##(2008-10#6)
for the electrode##5##3##(2008-10#5)
for the electron##2##3##(2008-10#1)(2008-8#1)
for the electrothermal atomic absorption##2##5##(2008-10#2)
for the elemental analysis##2##4##(2008-10#2)
for the elemental##3##3##(2008-10#3)
for the elements##3##3##(2008-10#3)
for the elevation of##2##4##(1995-6#1)(2009-1#1)
for the elimination of distal periodontal pockets adjacent to edentulous areas##2##11##(2012-12#2)
for the elimination of##5##4##(2008-10#1)(2008-11#1)(2012-12#3)
for the elution of##2##4##(2008-10#2)
for the emergence of##4##4##(1994-1#1)(2008-8#1)(2009-6#1)(2010-5#1)
for the empirical##2##3##(2008-2#1)(2010-1#1)
for the enantiomers of##2##4##(2008-10#2)
for the enantioselective##3##3##(2008-10#3)
for the enhanced ECL##2##4##(2008-10#2)
for the enhanced##4##3##(1992-8#1)(2008-10#2)(2008-11#1)
for the enhancement of the##2##5##(2008-10#2)
for the enhancement of##4##4##(2008-10#3)(2008-9#1)
for the enhancement##6##3##(1990-6#1)(1995-5#1)(2008-10#3)(2008-9#1)
for the enrichment of##4##4##(2008-10#4)
for the enrichment##5##3##(2008-10#5)
for the entire##6##3##(2008-10#2)(2008-7#2)(2010-11#1)(2012-3#1)
for the environmental##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
for the enzymatic determination of##3##5##(2008-10#3)
for the enzymatic##4##3##(2008-10#3)(2008-7#1)
for the enzyme from##2##4##(1994-11#1)(1996-2#1)
for the enzyme##9##3##(1991-5#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-5#1)(1996-2#1)(2008-10#2)
for the enzyme-catalyzed##2##3##(1993-8#1)(2008-7#1)
for the epidemic in##2##4##(1992-5#1)(1996-11#1)
for the epidemiology##2##3##(2008-10#2)
for the establishment of the##2##5##(1992-6#1)(2009-8#1)
for the establishment of##4##4##(1992-6#1)(2008-10#1)(2009-8#1)(2013-1#1)
for the establishment##5##3##(1992-6#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
for the estimated##2##3##(2008-10#1)(2008-3#1)
for the estimation of binding parameters##2##6##(2008-10#2)
for the estimation of ritodrine hydrochloride##2##6##(2008-10#2)
for the estimation of the##5##5##(2008-10#4)(2009-10#1)
for the estimation of##21##4##(2008-10#18)(2008-11#1)(2008-4#1)(2009-10#1)
for the estrogen receptor##2##4##(2008-11#2)
for the evaluation and##3##4##(2008-9#1)(2011-2#1)(2011-3#1)
for the evaluation of public##2##5##(2008-7#1)(2010-5#1)
for the evaluation of the effects of##2##7##(2008-10#1)(2013-1#1)
for the evaluation of the##8##5##(2008-10#6)(2008-7#1)(2013-1#1)
for the evaluation of##38##4##(1990-11#2)(1996-12#2)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-5#3)(2008-7#3)(2009-1#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
for the evaluation##42##3##(1990-11#2)(1996-12#2)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)
for the evolution of sexual dimorphism##2##6##(2008-8#2)
for the evolution of the##2##5##(2010-7#2)
for the evolution of##17##4##(1995-5#1)(2008-10#2)(2008-8#8)(2008-9#2)(2010-7#3)(2013-8#1)
for the evolution##18##3##(1995-5#1)(2008-10#2)(2008-8#9)(2008-9#2)(2010-7#3)(2013-8#1)
for the exchange of##2##4##(2011-2#2)
for the exchange##3##3##(2010-8#1)(2011-2#2)
for the excitation##2##3##(2008-10#1)(2008-3#1)
for the exercise##3##3##(1991-8#1)(2008-10#2)
for the existence of a##5##5##(1990-5#1)(1992-11#1)(1993-8#1)(1994-12#1)(2008-7#1)
for the existence of##11##4##(1990-5#1)(1992-11#1)(1993-8#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-7#2)(2008-9#2)(2012-3#1)
for the exogenous##2##3##(2008-7#2)
for the expansion of##2##4##(2008-11#1)(2008-4#1)
for the experimental group##2##4##(1991-12#1)(2008-12#1)
for the experimental##4##3##(1991-12#1)(2008-10#2)(2008-12#1)
for the experiments##3##3##(2008-11#2)(2008-5#1)
for the exploration of##2##4##(2008-5#1)(2011-2#1)
for the exponential band model##2##5##(2008-3#2)
for the expression of both##2##5##(1993-12#1)(2008-10#1)
for the expression of recombinant##2##5##(2008-11#2)
for the expression of the##2##5##(1997-8#1)(2013-8#1)
for the expression of##18##4##(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#3)(2009-3#1)(2011-1#1)(2013-8#1)
for the expression##20##3##(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#3)(2009-3#1)(2011-1#1)(2013-8#1)
for the extinction##2##3##(2008-10#1)(2008-3#1)
for the extractable##2##3##(2008-10#2)
for the extraction and##6##4##(2008-10#6)
for the extraction of Hg##2##5##(2008-10#2)
for the extraction of a##2##5##(2008-10#2)
for the extraction of soluble##3##5##(2008-10#3)
for the extraction of the##2##5##(2008-10#2)
for the extraction of##27##4##(2008-10#26)(2008-12#1)
for the extraction##38##3##(2008-10#37)(2008-12#1)
for the extractive##4##3##(2008-10#3)(2011-2#1)
for the fabrication of the##2##5##(2008-10#1)(2008-3#1)
for the fabrication of##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
for the family##2##3##(1995-1#1)(2008-10#1)
for the fast##4##3##(2008-10#3)(2011-2#1)
for the fetus##2##3##(1996-11#1)(2013-1#1)
for the field##2##3##(2008-11#1)(2010-8#1)
for the final##4##3##(1992-5#1)(1996-5#1)(2008-10#1)(2012-3#1)
for the first and second##3##5##(1997-2#1)(2008-10#2)
for the first and the second##2##6##(2008-10#2)
for the first and##5##4##(1997-2#1)(2008-10#4)
for the first dose##3##4##(2012-12#3)
for the first time a##3##5##(2008-10#1)(2009-8#1)(2012-2#1)
for the first time and##2##5##(2008-10#1)(2008-11#1)
for the first time as##3##5##(2008-10#3)
for the first time by##5##5##(1996-5#1)(2008-10#3)(2009-11#1)
for the first time from##2##5##(1990-5#1)(2013-1#1)
for the first time in the##2##6##(2008-10#1)(2008-9#1)
for the first time in this##2##6##(2008-10#1)(2009-9#1)
for the first time in##10##5##(1993-2#1)(2007-12#2)(2008-10#3)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#1)
for the first time on##2##5##(1996-3#1)(2008-5#1)
for the first time that the##5##6##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
for the first time that##14##5##(1992-12#1)(1992-8#1)(2008-10#4)(2008-9#3)(2011-2#2)(2012-2#2)(2013-8#1)
for the first time the##9##5##(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
for the first time to our knowledge##10##7##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)
for the first time to the##2##6##(2007-11#1)(2008-10#1)
for the first time to##17##5##(1992-9#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#4)(2009-7#1)
for the first time used##2##5##(2008-10#2)
for the first time using##2##5##(2008-10#1)(2008-11#1)
for the first time with##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
for the first time##176##4##(1990-2#2)(1990-5#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#3)(2007-12#4)(2008-10#75)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-1#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#3)(2012-2#7)(2012-3#2)(2013-1#9)(2013-8#2)
for the first two##3##4##(1990-8#1)(1993-8#1)(2008-10#1)
for the first##207##3##(1990-2#2)(1990-5#2)(1990-8#1)(1991-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#84)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-1#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#3)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#10)(2013-8#3)
for the five##7##3##(2008-10#7)
for the flame atomic absorption spectrometric##2##6##(2008-10#2)
for the flame atomic absorption##3##5##(2008-10#3)
for the flow injection##4##4##(2008-10#4)
for the flow##6##3##(2008-10#6)
for the flow-injection determination of##2##5##(2008-10#2)
for the flow-injection##3##3##(2008-10#3)
for the fluorescence##3##3##(2008-10#3)
for the fluorimetric determination of##5##5##(2008-10#5)
for the fluorimetric##6##3##(2008-10#6)
for the fluorometric determination of##4##5##(2008-10#4)
for the fluoroquinolones##2##3##(2008-10#1)(2012-2#1)
for the follow-up of##2##4##(1997-4#1)(2011-2#1)
for the following##9##3##(1997-2#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-9#3)(2012-2#1)
for the forensic analysis of##2##5##(2008-10#2)
for the formation of a##2##5##(1991-5#1)(2008-10#1)
for the formation of the##7##5##(1993-2#1)(2008-10#4)(2008-5#2)
for the formation of##34##4##(1991-5#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#1)(2008-10#19)(2008-5#2)(2009-8#1)(2010-1#1)(2011-2#2)(2013-1#1)
for the formation##35##3##(1991-5#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#1)(2008-10#19)(2008-5#2)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2013-1#1)
for the former and##3##4##(1995-6#1)(2007-8#1)(2008-10#1)
for the former##5##3##(1995-6#1)(2007-8#1)(2008-10#3)
for the formulation of##4##4##(1993-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
for the formulation##5##3##(1993-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
for the four analytes##2##4##(2008-10#2)
for the four##10##3##(2008-10#7)(2008-3#1)(2008-8#1)(2013-1#1)
for the fractionation of##4##4##(2008-10#4)
for the frail elderly##3##4##(1993-1#1)(1993-3#1)(1994-2#1)
for the frequency##3##3##(2008-2#1)(2009-5#1)(2012-3#1)
for the fruit##2##3##(1993-3#1)(2008-10#1)
for the full##6##3##(2008-7#1)(2008-8#2)(2009-11#1)(2010-10#1)(2012-2#1)
for the function of##4##4##(1993-12#1)(1995-6#1)(2008-11#1)(2009-8#1)
for the functional##2##3##(2008-11#1)(2012-3#1)
for the fungal##2##3##(2008-10#1)(2009-8#1)
for the fungicide##2##3##(2008-10#2)
for the further development of##2##5##(2010-11#1)(2013-8#1)
for the further##6##3##(2008-10#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#2)
for the fusion##2##3##(2008-9#1)(2013-1#1)
for the future of##5##4##(1995-12#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
for the future##33##3##(1990-3#1)(1990-9#1)(1991-3#1)(1992-2#1)(1992-3#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#2)(1996-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-11#5)(2008-12#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
for the gas chromatographic (GC)##2##5##(2008-10#2)
for the gas chromatographic##3##4##(2008-10#3)
for the gene##6##3##(1995-11#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
for the gene-for-gene relationship in the##2##6##(2008-10#2)
for the general##5##3##(1994-3#1)(1996-11#1)(1997-8#1)(2008-9#1)(2009-7#1)
for the generation of the##2##5##(2008-11#1)(2012-3#1)
for the generation of##13##4##(1990-5#1)(1993-8#1)(1997-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2012-3#1)(2012-4#1)
for the genetic##3##3##(2008-7#1)(2008-9#2)
for the genus##2##3##(2008-10#1)(2013-8#1)
for the given##2##3##(1997-6#1)(2008-10#1)
for the global##3##3##(1991-6#1)(2007-12#1)(2010-8#1)
for the good##2##3##(1993-12#1)(2008-10#1)
for the great##2##3##(2008-10#1)(2013-8#1)
for the greater##2##3##(2008-10#2)
for the group with##2##4##(1992-2#1)(1995-2#1)
for the group##5##3##(1992-2#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-2#1)
for the growth and##2##4##(1991-6#1)(2008-11#1)
for the growth of##5##4##(1990-5#1)(2008-11#1)(2013-1#2)(2013-8#1)
for the growth##8##3##(1990-5#1)(1991-6#1)(1992-1#1)(2008-11#2)(2013-1#2)(2013-8#1)
for the health care industry##4##5##(1993-12#1)(1995-12#1)(1997-2#1)(1997-3#1)
for the health care##5##4##(1993-12#1)(1995-12#1)(1997-2#1)(1997-3#1)(2010-4#1)
for the health##9##3##(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2010-4#1)(2010-7#1)
for the helix##2##3##(2008-2#1)(2010-7#1)
for the high quality##2##4##(2008-10#1)(2011-2#1)
for the high##8##3##(1995-11#2)(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
for the high-affinity##2##3##(1994-3#1)(1994-5#1)
for the highest##3##3##(1990-8#1)(2008-10#1)(2013-8#1)
for the highly sensitive##2##4##(2008-10#2)
for the highly##7##3##(1997-3#1)(2008-10#5)(2012-2#1)
for the host##3##3##(2008-8#3)
for the human genome##2##4##(1995-8#1)(2008-4#1)
for the human##14##3##(1991-6#1)(1991-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-9#1)(2008-4#1)(2009-7#2)(2012-3#1)
for the hydride forming elements##2##5##(2008-10#2)
for the hydrolysis and##2##4##(2008-10#2)
for the hydrolysis of the##2##5##(1994-5#2)
for the hydrolysis of##8##4##(1993-8#1)(1994-5#4)(2008-10#1)(2008-7#1)(2011-2#1)
for the hydrolysis##10##3##(1993-8#1)(1994-5#4)(2008-10#3)(2008-7#1)(2011-2#1)
for the hypothesis that##3##4##(1994-8#1)(2008-12#1)(2011-2#1)
for the hypothesis##5##3##(1994-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
for the idea##2##3##(2008-11#1)(2011-2#1)
for the identification and determination of##2##6##(2008-10#2)
for the identification and quantification of##2##6##(2008-10#2)
for the identification and##12##4##(2008-1#1)(2008-10#8)(2008-9#1)(2011-2#2)
for the identification of novel##2##5##(2008-10#1)(2013-1#1)
for the identification of proteins##2##5##(1997-2#1)(2008-1#1)
for the identification of the##5##5##(2008-10#4)(2011-2#1)
for the identification of##27##4##(1990-3#1)(1997-2#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
for the identification##40##3##(1990-3#1)(1997-2#2)(2008-1#2)(2008-10#24)(2008-11#1)(2008-5#1)(2008-9#2)(2010-11#1)(2011-2#4)(2012-2#1)(2013-1#1)
for the imaging of##2##4##(2008-2#1)(2012-2#1)
for the immature and mature seed oils##2##7##(2008-11#2)
for the immobilisation##2##3##(2008-10#2)
for the immobilization of##7##4##(2008-10#6)(2008-11#1)
for the immobilized##2##3##(2008-7#1)(2009-10#1)
for the impact of##3##4##(1995-12#1)(2008-11#1)(2009-12#1)
for the implementation of##6##4##(1994-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)
for the improvement##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
for the in situ##3##4##(2008-10#2)(2008-11#1)
for the in vitro##5##4##(2008-1#1)(2008-10#1)(2008-11#3)
for the in vivo##3##4##(2008-10#1)(2008-5#2)
for the in##12##3##(2008-1#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#2)
for the in-line##2##3##(2008-10#2)
for the in-row rotary cultivator##2##5##(2008-10#2)
for the inactivation of##3##4##(1993-8#1)(2009-8#1)(2012-2#1)
for the incidence of##2##4##(2008-10#2)
for the incidence##3##3##(2008-10#2)(2008-11#1)
for the inclusion##2##3##(2008-10#1)(2008-5#1)
for the incoming##2##3##(2008-10#1)(2010-7#1)
for the increase##5##3##(1994-6#1)(2008-12#2)(2008-8#1)(2011-2#1)
for the increased##4##3##(1991-11#1)(2008-11#1)(2010-11#1)(2012-3#1)
for the increasing##2##3##(1997-2#1)(2010-12#1)
for the indirect determination of##3##5##(2008-10#3)
for the indirect##4##3##(2008-10#4)
for the individual##8##3##(1992-12#1)(1994-12#1)(1995-8#1)(2008-1#1)(2008-10#2)(2012-3#1)(2013-8#1)
for the induction of##11##4##(1991-12#1)(1991-9#1)(1992-10#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-6#1)(2011-2#1)
for the infant##2##3##(1994-3#1)(2012-2#1)
for the infection##2##3##(2008-10#1)(2013-1#1)
for the influence of##3##4##(1993-2#1)(2008-10#1)(2011-2#1)
for the inhibition of protein phosphatase##2##6##(1995-8#2)
for the inhibition of##10##4##(1992-3#1)(1995-11#1)(1995-8#3)(2008-10#1)(2008-5#2)(2010-4#1)(2012-3#1)
for the inhibition##11##3##(1992-3#1)(1993-8#1)(1995-11#1)(1995-8#3)(2008-10#1)(2008-5#2)(2010-4#1)(2012-3#1)
for the initial##7##3##(1992-12#1)(1993-11#1)(1995-3#1)(2008-10#2)(2008-11#2)
for the initiation of##5##4##(1990-5#1)(1994-11#1)(2008-10#1)(2008-7#1)(2009-8#1)
for the initiation##7##3##(1990-5#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
for the inorganic species##2##4##(2008-10#2)
for the inorganic##4##3##(2008-10#4)
for the integration of chemical and##2##6##(2008-10#2)
for the integration of##5##4##(1996-2#1)(2008-10#2)(2008-11#1)(2008-6#1)
for the integrity of##2##4##(2009-7#1)(2012-2#1)
for the intensity##4##3##(2008-10#1)(2008-3#2)(2010-11#1)
for the interaction of##6##4##(1993-8#1)(2008-10#5)
for the interaction##10##3##(1993-8#1)(2008-10#7)(2011-2#2)
for the interactions##2##3##(2008-10#1)(2013-8#1)
for the interpretation of##4##4##(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)
for the interpretation##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)
for the interventions##2##3##(2009-7#1)(2013-1#1)
for the introduction of##4##4##(1993-9#3)(2008-10#1)
for the introduction##5##3##(1990-3#1)(1993-9#3)(2008-10#1)
for the invasion and##2##4##(1990-11#1)(2008-10#1)
for the invasion##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
for the investigation of sex##2##5##(2008-10#2)
for the investigation of the##4##5##(2008-10#2)(2008-4#1)(2010-12#1)
for the investigation of##12##4##(1997-6#1)(2008-10#5)(2008-4#2)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)
for the investigation##15##3##(1991-3#1)(1997-6#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)
for the involvement of##4##4##(1992-3#1)(1992-6#1)(1993-3#1)(2008-11#1)
for the ion exchange resin##2##5##(2008-10#2)
for the ion##4##3##(2008-10#4)
for the isolated##3##3##(1992-6#1)(1993-8#1)(1996-2#1)
for the isolates##2##3##(2008-10#1)(2008-5#1)
for the isolation and##4##4##(2008-11#1)(2008-4#2)(2008-9#1)
for the isolation of##8##4##(2008-10#2)(2008-11#4)(2008-9#1)(2009-12#1)
for the isolation##13##3##(2008-10#3)(2008-11#5)(2008-4#2)(2008-9#2)(2009-12#1)
for the key##3##3##(2008-11#1)(2013-1#2)
for the kinetic determination of##2##5##(2008-10#2)
for the kinetic##3##3##(1991-9#1)(2008-10#2)
for the knowledge##3##3##(2008-10#2)(2012-3#1)
for the known##2##3##(1990-11#1)(2013-8#1)
for the laboratory##2##3##(1993-1#1)(2008-9#1)
for the lack of##6##4##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
for the large scale production##2##5##(2008-11#2)
for the large scale##3##4##(2008-11#3)
for the large##4##3##(2008-10#1)(2008-11#3)
for the large-scale##2##3##(1995-6#1)(2008-11#1)
for the largest##6##3##(1997-7#1)(2008-10#3)(2009-4#1)(2013-1#1)
for the last ten years##2##5##(1991-9#1)(1996-11#1)
for the last##11##3##(1990-8#1)(1991-11#1)(1991-9#1)(1994-1#1)(1996-1#1)(1996-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-1#1)(2010-3#1)
for the later##2##3##(2007-8#1)(2013-8#1)
for the latter##11##3##(1991-6#2)(1995-6#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)
for the lead##2##3##(1995-12#1)(2008-10#1)
for the less##3##3##(1997-2#1)(2008-11#2)
for the limited##3##3##(1995-12#1)(2008-10#2)
for the line strength##2##4##(2008-3#2)
for the liquid-liquid extraction##2##4##(2008-10#2)
for the local and##2##4##(2010-7#1)(2011-2#1)
for the local##5##3##(2008-12#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
for the localization of##3##4##(2008-10#1)(2008-7#1)(2010-7#1)
for the long-term##6##3##(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2010-2#1)
for the loss##2##3##(1994-8#1)(2008-3#1)
for the low##4##3##(1991-9#1)(1993-3#1)(1994-9#1)(1997-7#1)
for the lower##3##3##(2008-10#2)(2011-2#1)
for the lumbar##3##3##(2008-12#1)(2010-3#2)
for the lung##3##3##(1996-3#1)(2010-7#1)(2012-2#1)
for the maintenance of the##2##5##(1996-12#1)(2008-10#1)
for the maintenance of##9##4##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)
for the maintenance##11##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2013-1#1)
for the major part of the##2##6##(1997-8#1)(2013-1#1)
for the major##7##3##(1990-12#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
for the majority of##13##4##(1991-1#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)
for the majority##14##3##(1991-1#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)
for the management of ACS##2##5##(2008-3#2)
for the management of chronic##2##5##(2009-12#1)(2013-1#1)
for the management of patients with##2##6##(2008-12#1)(2008-3#1)
for the management of sorghum##2##5##(2008-10#2)
for the management of the##2##5##(2008-10#1)(2008-12#1)
for the management of this disease##2##6##(1991-2#1)(2011-2#1)
for the management of this##3##5##(1991-2#1)(2010-12#1)(2011-2#1)
for the management of##40##4##(1991-1#1)(1991-2#2)(1992-12#1)(1992-3#1)(1994-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#3)(2011-2#2)(2013-1#4)(2013-8#1)
for the management##41##3##(1991-1#1)(1991-2#2)(1992-12#1)(1992-3#1)(1994-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#3)(2011-2#2)(2013-1#5)(2013-8#1)
for the manganese##2##3##(2008-10#2)
for the manipulation of##3##4##(2008-11#2)(2009-8#1)
for the manipulation##4##3##(1995-5#1)(2008-11#2)(2009-8#1)
for the manufacturing of##2##4##(2008-11#2)
for the many##2##3##(2008-10#1)(2008-9#1)
for the mass##2##3##(2008-10#1)(2008-7#1)
for the mature##2##3##(1995-8#1)(2009-7#1)
for the maximum##7##3##(1997-3#1)(2008-10#5)(2008-7#1)
for the mean##5##3##(2008-10#1)(2008-12#1)(2008-8#2)(2009-8#1)
for the measurement of##32##4##(1990-11#1)(1990-2#1)(1992-11#1)(1992-12#1)(1993-1#1)(2008-10#19)(2008-11#3)(2008-4#1)(2008-5#2)(2009-7#1)(2010-11#1)
for the measurement##38##3##(1990-11#1)(1990-2#1)(1992-11#1)(1992-12#1)(1993-1#1)(2008-10#25)(2008-11#3)(2008-4#1)(2008-5#2)(2009-7#1)(2010-11#1)
for the measurements##2##3##(2008-3#2)
for the medical##3##3##(1995-8#1)(2009-11#1)(2012-2#1)
for the medium-scale distribution##2##4##(2008-10#2)
for the membrane##7##3##(1994-5#1)(1997-1#1)(2008-10#3)(2009-8#1)(2012-2#1)
for the mentally retarded##4##4##(1991-1#2)(1997-8#2)
for the mentally##5##3##(1991-1#2)(1992-1#1)(1997-8#2)
for the metabolic##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
for the metabolism##2##3##(2008-10#1)(2013-1#1)
for the metal ions##3##4##(2008-10#3)
for the metal##7##3##(2008-10#6)(2010-11#1)
for the metals##2##3##(2008-10#2)
for the methodology##2##3##(2008-10#2)
for the micro determination of##2##5##(2008-10#2)
for the microsatellites containing##2##4##(2008-10#2)
for the minimum number of##2##5##(1992-9#1)(2008-8#1)
for the mitochondrial##2##3##(1991-5#1)(1992-10#1)
for the model##4##3##(2008-7#2)(2011-2#1)(2012-12#1)
for the modification of##4##4##(2008-10#4)
for the modification##5##3##(2008-10#5)
for the molecular##4##3##(1995-2#1)(2008-10#1)(2012-2#2)
for the monitoring of##9##4##(2008-10#7)(2008-11#1)(2012-2#1)
for the monitoring##11##3##(2008-10#8)(2008-11#2)(2012-2#1)
for the more##3##3##(1991-3#1)(2008-5#1)(2010-8#1)
for the most part the##2##5##(1991-3#1)(2010-4#1)
for the most part##14##4##(1991-1#1)(1991-3#1)(1994-12#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#3)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)
for the most##21##3##(1991-1#1)(1991-3#1)(1994-12#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)
for the multi-element determination##2##4##(2008-10#2)
for the multi-element##3##3##(2008-10#3)
for the murine##4##3##(1990-5#1)(1994-11#1)(1995-2#1)(2008-9#1)
for the mutant##3##3##(1991-5#1)(1995-6#1)(1996-2#1)
for the mycelial growth assays and##2##6##(2008-10#2)
for the national##2##3##(1994-1#1)(2008-3#1)
for the native protein##2##4##(1994-11#1)(2008-10#1)
for the native##4##3##(1994-11#2)(2008-10#1)(2009-8#1)
for the nature of the##2##5##(1991-5#1)(1997-8#1)
for the nature##3##3##(1991-5#1)(1997-8#1)(2010-5#1)
for the nebulizers FISO Neb##2##5##(1993-2#2)
for the need##2##3##(2008-1#1)(2008-7#1)
for the new##7##3##(1991-9#1)(1992-2#1)(2008-10#4)(2011-2#1)
for the next generation of##3##5##(2008-11#1)(2012-2#1)(2013-1#1)
for the next generation##4##4##(1992-3#1)(2008-11#1)(2012-2#1)(2013-1#1)
for the next##15##3##(1991-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#2)(2010-5#1)(2012-2#1)(2013-1#1)
for the nitrate##2##3##(2008-10#2)
for the nitrite##3##3##(2008-10#3)
for the noninvasive##2##3##(2010-9#1)(2012-2#1)
for the normal allele##2##4##(1994-11#2)
for the normal##4##3##(1994-11#2)(2009-3#1)(2012-3#1)
for the novice##2##3##(1991-1#1)(2008-11#1)
for the nuclear##4##3##(1992-11#1)(1995-2#1)(2008-10#1)(2008-11#1)
for the number of##2##4##(2008-10#1)(2008-9#1)
for the objective##2##3##(2008-10#2)
for the observation of##2##4##(2008-10#1)(2008-3#1)
for the observed behavior##2##4##(2008-3#1)(2010-6#1)
for the observed##13##3##(1992-10#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2009-8#2)(2010-6#1)(2011-2#1)
for the occurrence of two##2##5##(1992-6#1)(2008-8#1)
for the occurrence of##9##4##(1992-6#1)(2008-10#4)(2008-11#1)(2008-8#2)(2011-2#1)
for the older##2##3##(2010-10#2)
for the oldest##3##3##(1996-2#1)(2012-3#2)
for the on##2##3##(2008-10#2)
for the on-line determination of palladium(II) and platinum(IV)##2##8##(2008-10#2)
for the on-line determination of##7##5##(2008-10#7)
for the on-line preconcentration of##2##5##(2008-10#2)
for the on-line##19##3##(2008-10#19)
for the onset of##3##4##(2008-11#1)(2010-6#1)(2010-7#1)
for the operative treatment of##3##5##(1992-2#2)(2013-1#1)
for the optical##2##3##(2008-3#1)(2010-7#1)
for the optimal##4##3##(1997-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
for the optimisation of##2##4##(2008-10#2)
for the optimization of##9##4##(2008-10#7)(2008-3#1)(2008-7#1)
for the optimum##3##3##(2008-10#2)(2008-7#1)
for the organism##2##3##(1991-6#1)(2008-7#1)
for the origin of##3##4##(2007-12#1)(2008-12#1)(2009-6#1)
for the original data##2##4##(2008-10#2)
for the other two##2##4##(2008-10#2)
for the other##26##3##(1990-6#1)(1993-8#1)(1997-3#1)(2008-10#17)(2008-12#1)(2011-2#2)(2012-5#1)(2013-1#2)
for the overall##6##3##(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
for the overexpression of##2##4##(2008-11#2)
for the overexpression##3##3##(2008-11#2)(2011-2#1)
for the oxidation of NADH##3##5##(2008-10#3)
for the oxidation of luminol with hydrogen peroxide catalyzed by microperoxidase 8##2##12##(2008-10#2)
for the oxidation of##16##4##(1993-9#1)(2008-10#14)(2008-11#1)
for the oxidation##17##3##(1993-9#1)(2008-10#15)(2008-11#1)
for the oxidative##2##3##(2008-10#2)
for the pH##2##3##(2011-2#2)
for the paediatric##2##3##(2008-10#1)(2008-11#1)
for the parameters##2##3##(1994-9#1)(2008-10#1)
for the parametric##2##3##(2009-10#1)(2010-5#1)
for the participants##2##3##(2008-10#1)(2009-10#1)
for the particular##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)
for the past##7##3##(1991-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
for the pathogen and##2##4##(2008-10#2)
for the pathogen##4##3##(2008-10#4)
for the pathogenesis of##2##4##(2008-6#1)(2013-8#1)
for the pathogenesis##3##3##(1990-11#1)(2008-6#1)(2013-8#1)
for the patient and##2##4##(1992-2#1)(1992-3#1)
for the patient in##2##4##(2008-11#1)(2008-12#1)
for the patient with##2##4##(2011-2#1)(2012-12#1)
for the patient##17##3##(1992-2#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
for the patient's##2##3##(1994-11#1)(2010-1#1)
for the patient?]##2##3##(1991-11#1)(1993-3#1)
for the patients in##2##4##(1993-11#1)(2008-10#1)
for the patients who##2##4##(1995-3#1)(1997-4#1)
for the patients with##2##4##(2008-11#1)(2011-3#1)
for the patients##12##3##(1991-2#1)(1993-11#1)(1995-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-1#1)(2011-2#1)(2011-3#1)
for the peak##3##3##(2008-10#3)
for the perchlorate system##2##4##(2008-10#2)
for the perchlorate##3##3##(2008-10#3)
for the performance of##4##4##(1992-1#1)(1996-2#1)(2008-10#2)
for the performance##5##3##(1992-1#1)(1994-12#1)(1996-2#1)(2008-10#2)
for the period between growth stages##2##6##(2008-10#2)
for the period##13##3##(1991-2#1)(1992-1#1)(1995-3#2)(1995-8#1)(1996-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2010-3#1)(2012-3#1)
for the persistence of##2##4##(2008-8#1)(2011-3#1)
for the pharmaceutical##2##3##(2008-10#1)(2012-2#1)
for the phase##2##3##(2010-12#2)
for the phenotypic##2##3##(2008-10#1)(2013-1#1)
for the physiological##2##3##(2008-11#1)(2011-1#1)
for the picrate##3##3##(2008-10#3)
for the placement of##2##4##(2008-2#1)(2012-12#1)
for the placement##3##3##(2008-12#1)(2008-2#1)(2012-12#1)
for the polymer##2##3##(2008-10#2)
for the polymeric##2##3##(2008-10#2)
for the pooled##3##3##(1995-8#1)(2008-10#1)(2012-3#1)
for the population##7##3##(1991-12#1)(1992-2#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-8#1)
for the positive##2##3##(2008-5#1)(2013-8#1)
for the possibility of##3##4##(1991-5#1)(2008-10#1)(2009-7#1)
for the possibility##4##3##(1991-5#1)(2008-10#1)(2008-8#1)(2009-7#1)
for the possible##6##3##(1992-3#1)(1992-9#1)(2008-10#2)(2008-8#1)(2009-12#1)
for the potential treatment of##3##5##(2008-5#3)
for the potential treatment##4##4##(2008-5#4)
for the potential use##2##4##(2008-5#2)
for the potential##9##3##(2008-10#2)(2008-5#6)(2012-3#1)
for the potentiometric determination of##3##5##(2008-10#3)
for the potentiometric selectivity of##2##5##(2008-10#2)
for the potentiometric titration of##3##5##(2008-10#3)
for the potentiometric##11##3##(2008-10#11)
for the practical##2##3##(1992-3#1)(2008-9#1)
for the practice##2##3##(1996-2#1)(2008-10#1)
for the pre-analysis sample stabilization##2##5##(2008-10#2)
for the pre-concentration of##2##4##(2008-10#2)
for the precise##2##3##(1993-2#1)(2009-8#1)
for the preclinical##2##3##(1991-9#1)(2008-9#1)
for the preconcentration and determination of##2##6##(2008-10#2)
for the preconcentration and separation of trace##2##7##(2008-10#2)
for the preconcentration and separation of##4##6##(2008-10#4)
for the preconcentration and speciation of##2##6##(2008-10#2)
for the preconcentration and##11##4##(2008-10#11)
for the preconcentration of trace metals##2##6##(2008-10#2)
for the preconcentration of trace##5##5##(2008-10#5)
for the preconcentration of##18##4##(2008-10#18)
for the preconcentration##32##3##(2008-10#32)
for the prediction of retention##2##5##(2008-10#2)
for the prediction of the##2##5##(2008-10#1)(2008-3#1)
for the prediction of##18##4##(1995-5#1)(1996-12#1)(1997-6#1)(2008-10#8)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-3#1)(2012-2#1)
for the prediction##20##3##(1995-5#1)(1996-12#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-3#1)(2012-2#1)
for the preparation of bifunctional##2##5##(2012-3#2)
for the preparation of polyacrylamide gradient gel-filled capillaries with low UV detection background##2##13##(2008-10#2)
for the preparation of##32##4##(1990-12#1)(1996-5#1)(1997-2#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2011-1#1)(2012-3#2)
for the preparation##34##3##(1990-12#1)(1996-5#1)(1997-2#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2011-1#1)(2012-3#2)
for the presence of oesophageal varices##2##6##(2009-8#2)
for the presence of the##3##5##(2008-10#3)
for the presence of##40##4##(1991-3#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-12#1)(1997-8#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-8#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
for the presence or absence of##3##6##(1995-6#1)(1997-8#1)(2008-10#1)
for the presence##45##3##(1991-3#1)(1992-6#1)(1992-9#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#2)(2008-10#19)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-8#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
for the present study##2##4##(1992-1#1)(2011-2#1)
for the present##7##3##(1992-1#1)(1992-3#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#1)(2011-2#1)
for the presentation of##2##4##(1993-12#1)(2008-11#1)
for the presentation##3##3##(1993-12#1)(1995-11#1)(2008-11#1)
for the pretreatment of##5##4##(2008-10#4)(2013-1#1)
for the prevention and control of##2##6##(2008-9#1)(2011-2#1)
for the prevention and treatment of##2##6##(2007-7#1)(2013-1#1)
for the prevention and##4##4##(2007-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
for the prevention of obesity in rats##2##7##(2011-2#2)
for the prevention of obesity##3##5##(2008-10#1)(2011-2#2)
for the prevention of##13##4##(1996-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#2)(2010-7#1)(2011-2#4)(2012-3#1)
for the prevention##18##3##(1995-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#2)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#1)
for the previously##7##3##(1992-3#1)(1993-6#1)(1995-11#1)(1996-2#1)(1997-8#1)(2008-7#1)(2011-1#1)
for the primary##7##3##(2008-11#2)(2008-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
for the principle of##2##4##(1996-3#1)(2008-11#1)
for the procedure##5##3##(2008-1#1)(2008-10#3)(2008-3#1)
for the procedures##3##3##(1997-2#1)(2008-9#1)(2010-6#1)
for the process of##3##4##(1995-6#1)(2008-8#1)(2012-3#1)
for the processing of##2##4##(1990-8#1)(2010-8#1)
for the product##2##3##(2012-2#2)
for the production of a##3##5##(2008-11#3)
for the production of antibodies##2##5##(2008-11#1)(2011-2#1)
for the production of biopharmaceuticals##2##5##(2008-11#1)(2011-2#1)
for the production of ethanol##2##5##(2008-7#1)(2008-8#1)
for the production of monoclonal##2##5##(2008-11#2)
for the production of recombinant proteins for##2##7##(2008-11#2)
for the production of recombinant proteins##6##6##(2008-11#6)
for the production of recombinant##9##5##(2008-11#9)
for the production of singlet oxygen (1O2)##2##7##(2008-5#2)
for the production of##50##4##(1990-8#1)(1992-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-10#4)(2008-11#27)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
for the production##52##3##(1990-8#1)(1992-11#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-10#4)(2008-11#28)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
for the prognostication of##2##4##(2011-2#2)
for the program##2##3##(1992-2#1)(2008-9#1)
for the progress##2##3##(2008-10#1)(2008-5#1)
for the project##2##3##(2008-11#2)
for the proper##6##3##(1993-2#1)(2008-10#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
for the proportion of##2##4##(2008-10#2)
for the proposed method is##2##5##(2008-10#2)
for the proposed method##4##4##(2008-10#4)
for the proposed##9##3##(2008-10#8)(2008-3#1)
for the protection of##2##4##(1992-3#1)(2008-11#1)
for the protein is##2##4##(1992-8#1)(2009-5#1)
for the protein##11##3##(1992-8#1)(1994-5#1)(1995-2#1)(2008-10#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-2#1)
for the provision of##3##4##(1994-1#1)(1995-3#1)(2013-1#1)
for the psychiatrically##2##3##(1993-3#1)(1995-8#1)
for the pure##3##3##(2008-10#3)
for the purification of the##4##5##(2008-10#1)(2008-11#2)(2008-4#1)
for the purification of##10##4##(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2009-12#1)(2012-2#1)
for the purification##11##3##(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#2)(2009-12#1)(2012-2#1)
for the purpose of developing##2##5##(1996-5#1)(2009-1#1)
for the purpose of enhancing##2##5##(2008-10#1)(2008-11#1)
for the purpose of this##2##5##(2008-10#1)(2010-12#1)
for the purpose of##28##4##(1991-2#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1996-5#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-2#3)(2012-3#1)
for the purpose##30##3##(1991-2#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1996-5#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-2#3)(2012-3#1)
for the purposes of##5##4##(1990-3#1)(1993-3#1)(2008-7#1)(2008-9#1)(2010-6#1)
for the putative##4##3##(1995-8#1)(1996-12#3)
for the pyralid##2##3##(2008-10#2)
for the qualitative and quantitative##2##5##(2008-10#1)(2008-2#1)
for the qualitative##4##3##(2008-10#2)(2008-2#1)(2010-9#1)
for the quality control analysis of##2##6##(2008-10#2)
for the quality control##3##4##(2008-10#3)
for the quality##7##3##(2008-10#5)(2008-11#1)(2013-8#1)
for the quantification of beta-cell function and insulin sensitivity##2##9##(1994-12#2)
for the quantification of the##3##5##(2008-10#2)(2011-1#1)
for the quantification of these##2##5##(2008-10#1)(2010-1#1)
for the quantification of##27##4##(1990-12#1)(1994-12#2)(2008-10#19)(2008-12#1)(2008-3#1)(2009-8#1)(2010-1#1)(2011-1#1)
for the quantitation of FB(1)##2##5##(2008-10#2)
for the quantitation of fumonisin B(1)##2##6##(2008-10#2)
for the quantitation of##11##4##(1997-2#2)(2008-10#8)(2008-4#1)
for the quantitative analysis of##6##5##(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-1#1)
for the quantitative determination of small amounts of pollutants##2##9##(2008-10#2)
for the quantitative determination of##21##5##(1997-2#1)(2008-10#19)(2008-12#1)
for the quantitative measurement of##2##5##(2008-10#1)(2010-11#1)
for the quantitative##35##3##(1997-2#1)(1997-6#1)(2008-10#28)(2008-12#2)(2008-3#1)(2010-1#1)(2010-11#1)
for the radiology manager##2##4##(1991-1#1)(1991-12#1)
for the range of##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
for the rapid analysis of##2##5##(2008-10#1)(2010-9#1)
for the rapid and sensitive determination of##3##7##(2008-10#3)
for the rapid and sensitive##4##5##(2008-10#4)
for the rapid and##9##4##(2008-10#8)(2008-9#1)
for the rapid detection of##3##5##(2008-10#1)(2008-11#1)(2009-6#1)
for the rapid determination of immunoglobulin A##2##7##(2008-10#2)
for the rapid determination of##6##5##(2008-10#6)
for the rapid determination##7##4##(2008-10#7)
for the rapid separation and purification of##2##7##(1997-2#1)(2008-10#1)
for the rapid separation and##4##5##(1997-2#1)(2008-10#3)
for the rapid##39##3##(1997-2#1)(2008-10#31)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-9#2)(2013-1#1)
for the rat##6##3##(1993-6#1)(1994-11#1)(1995-2#1)(1996-12#2)(2008-11#1)
for the rate##2##3##(2008-10#2)
for the raw materials##2##4##(2008-10#2)
for the reaction of prostaglandin H##2##6##(1994-5#2)
for the reaction of##5##4##(1994-5#2)(2008-10#3)
for the reaction was##2##4##(2008-10#2)
for the reaction##16##3##(1992-3#1)(1994-5#2)(2008-10#13)
for the reactions##2##3##(1994-5#1)(2009-8#1)
for the real##3##3##(1993-12#1)(2008-10#2)
for the real-time##2##3##(2008-10#1)(2009-12#1)
for the recognition and##2##4##(2008-10#1)(2008-4#1)
for the recognition##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
for the recommended procedure##2##4##(2008-10#2)
for the recommended##3##3##(2008-10#2)(2010-6#1)
for the reconstruction of##2##4##(1993-6#1)(2013-1#1)
for the recovery of##2##4##(2008-10#1)(2008-6#1)
for the recycling of##3##4##(1994-11#1)(2008-10#2)
for the reduced##5##3##(1991-11#1)(1996-12#1)(2008-10#2)(2008-5#1)
for the reduction of##8##4##(1993-3#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#1)
for the reduction##13##3##(1993-3#1)(1994-5#1)(2008-10#6)(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#2)
for the reductive##2##3##(1996-5#1)(2008-11#1)
for the reestablishment of##2##4##(1991-12#1)(1995-2#1)
for the reference##3##3##(2008-10#3)
for the referred##3##3##(1992-3#1)(2008-12#1)(2008-9#1)
for the regional##2##3##(2008-10#2)
for the regression##2##3##(2008-10#2)
for the regulation of##5##4##(1991-5#1)(1996-2#1)(2008-11#2)(2012-2#1)
for the relationship between##4##4##(1996-3#1)(2008-10#3)
for the relative##2##3##(2008-10#2)
for the relatively##2##3##(2008-10#1)(2013-1#1)
for the release of##2##4##(2008-10#1)(2008-11#1)
for the remaining##4##3##(1993-1#1)(1996-3#1)(2008-10#1)(2008-11#1)
for the removal of heavy metal##2##6##(2008-10#1)(2013-1#1)
for the removal of heavy##3##5##(2008-10#2)(2013-1#1)
for the removal of##10##4##(1996-1#1)(2008-10#5)(2008-11#1)(2008-7#1)(2013-1#2)
for the reproductive##2##3##(1991-1#1)(2012-3#1)
for the research of##2##4##(2008-11#1)(2010-12#1)
for the research##5##3##(2008-11#3)(2010-12#1)(2013-1#1)
for the resistance##5##3##(1990-8#1)(2008-10#4)
for the resistant A(549)/DDP cells##2##5##(2008-9#2)
for the resistant allele##2##4##(2008-10#2)
for the resistant##5##3##(2008-10#3)(2008-9#2)
for the resolution of mixtures of##2##6##(2008-10#2)
for the resolution of the##2##5##(2008-10#1)(2008-11#1)
for the resolution of##12##4##(2008-10#11)(2008-11#1)
for the respective cultivars##2##4##(2008-10#2)
for the respective##3##3##(1995-11#1)(2008-10#2)
for the rest of the##2##5##(2008-10#1)(2012-9#1)
for the rest of their lives##2##6##(1994-9#1)(1997-8#1)
for the rest of##5##4##(1994-9#1)(1995-2#1)(1997-8#1)(2008-10#1)(2012-9#1)
for the rest##8##3##(1994-9#1)(1995-2#1)(1997-4#1)(1997-8#1)(2008-10#2)(2012-12#1)(2012-9#1)
for the restoration of##5##4##(1990-12#1)(2008-11#1)(2011-2#1)(2013-1#2)
for the retention and##2##4##(2008-10#2)
for the retention of##3##4##(2008-10#2)(2009-6#1)
for the retention##6##3##(2008-10#5)(2009-6#1)
for the revelation of##2##4##(2008-5#1)(2012-2#1)
for the revised##2##3##(1992-1#1)(2012-2#1)
for the right##2##3##(1996-3#1)(2010-7#1)
for the risk assessment of##3##5##(1997-4#1)(2008-11#2)
for the risk of##2##4##(1997-8#1)(2008-8#1)
for the risk##5##3##(1997-4#1)(1997-8#1)(2008-11#2)(2008-8#1)
for the role of##8##4##(1997-2#1)(2008-10#1)(2008-12#1)(2009-11#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-7#1)
for the routine analysis of##3##5##(2008-10#3)
for the routine##9##3##(2008-10#8)(2010-4#1)
for the safe##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
for the safety##2##3##(1996-5#1)(2012-2#1)
for the sake of##3##4##(2008-10#2)(2008-12#1)
for the salicylate##2##3##(2008-10#2)
for the salivary##3##3##(2008-11#2)(2011-2#1)
for the same purpose##2##4##(2008-10#1)(2009-8#1)
for the same samples##5##4##(2008-10#4)(2008-3#1)
for the same##31##3##(1992-3#1)(1992-9#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
for the sample##11##3##(1995-9#1)(2008-10#8)(2009-11#1)(2012-2#1)
for the samples##3##3##(2008-10#3)
for the scattering properties of##2##5##(2008-3#2)
for the scattering##3##3##(2008-2#1)(2008-3#2)
for the screening of##7##4##(1990-12#1)(2008-10#4)(2008-11#1)(2008-5#1)
for the screening##10##3##(1990-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-8#1)
for the seasonal##2##3##(2008-10#2)
for the second##8##3##(1991-8#1)(1994-3#1)(2008-10#3)(2011-2#2)(2012-2#1)
for the selected##2##3##(2011-2#1)(2012-2#1)
for the selection of variables##2##5##(2008-10#2)
for the selection of##6##4##(1994-2#1)(2008-10#3)(2009-8#1)(2010-1#1)
for the selection##7##3##(1994-2#1)(2008-10#4)(2009-8#1)(2010-1#1)
for the selective and##2##4##(2008-10#2)
for the selective determination of##4##5##(2008-10#4)
for the selective extraction and##3##5##(2008-10#3)
for the selective extraction of U(VI)##2##6##(2008-10#2)
for the selective extraction of trace##2##6##(2008-10#2)
for the selective extraction of##4##5##(2008-10#4)
for the selective extraction##7##4##(2008-10#7)
for the selective separation and##3##5##(2008-10#3)
for the selective##23##3##(2008-10#22)(2008-7#1)
for the sensing##2##3##(2008-10#2)
for the sensitive and selective determination of##2##7##(2008-10#2)
for the sensitive detection of##2##5##(2008-10#1)(2010-12#1)
for the sensitive determination of##5##5##(2008-10#5)
for the sensitive##12##3##(2008-10#9)(2008-9#2)(2010-12#1)
for the sensitivity of##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
for the sensor##6##3##(2008-10#6)
for the separation and detection of##3##6##(2008-10#3)
for the separation and determination of##10##6##(2008-10#10)
for the separation and preconcentration of##7##6##(2008-10#7)
for the separation and##26##4##(2008-10#26)
for the separation of the##4##5##(2008-10#4)
for the separation of zinc##2##5##(2008-10#2)
for the separation of##43##4##(1991-12#1)(2008-10#39)(2008-11#1)(2008-4#1)(2010-7#1)
for the separation##74##3##(1991-12#1)(2008-10#68)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)
for the sequence##2##3##(2008-4#2)
for the sequential determination of##3##5##(2008-10#3)
for the sequential##7##3##(1994-8#1)(2008-10#6)
for the seven##2##3##(2008-10#2)
for the severity of##2##4##(2008-10#1)(2013-1#1)
for the severity##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
for the sexual##2##3##(1994-2#1)(1996-2#1)
for the simple##5##3##(1992-3#1)(2008-10#4)
for the simultaneous analysis of##4##5##(2008-10#4)
for the simultaneous detection of##7##5##(2008-10#4)(2008-2#1)(2008-9#1)(2010-11#1)
for the simultaneous determination of As##2##6##(2008-10#2)
for the simultaneous determination of ammonia##2##6##(1995-3#2)
for the simultaneous determination of caffeine##2##6##(2008-10#2)
for the simultaneous determination of four##2##6##(2008-10#2)
for the simultaneous determination of lead and##2##7##(2008-10#2)
for the simultaneous determination of nitrite and nitrate in##3##9##(2008-10#3)
for the simultaneous determination of nitrite and nitrate##5##8##(2008-10#5)
for the simultaneous determination of the three##2##7##(2008-10#2)
for the simultaneous determination of the##6##6##(2008-10#6)
for the simultaneous determination of trace##4##6##(2008-10#4)
for the simultaneous determination of##83##5##(1995-3#2)(2008-10#80)(2009-6#1)
for the simultaneous determination##84##4##(1995-3#2)(2008-10#81)(2009-6#1)
for the simultaneous estimation of##2##5##(2008-10#2)
for the simultaneous separation and pre-concentration of##2##7##(2008-10#2)
for the simultaneous separation##3##4##(2008-10#3)
for the simultaneous spectrophotometric determination of##7##6##(2008-10#7)
for the simultaneous##123##3##(1994-5#1)(1995-3#2)(2008-10#114)(2008-2#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-11#1)
for the single##5##3##(2008-10#4)(2012-3#1)
for the site##2##3##(2008-10#2)
for the six##3##3##(2008-10#3)
for the size fractionation##2##4##(2008-10#2)
for the size##3##3##(2008-10#3)
for the small-scale##2##3##(2008-10#2)
for the solid phase extraction##2##5##(2008-10#2)
for the solid##3##3##(2008-10#2)(2008-12#1)
for the solid-liquid##2##3##(2008-10#2)
for the solid-phase##2##3##(2008-10#2)
for the solvent##2##3##(2008-10#2)
for the sorption of##2##4##(2008-10#2)
for the spatial##2##3##(1996-6#1)(2008-3#1)
for the speciation analysis##2##4##(2008-10#2)
for the speciation and##2##4##(2008-10#2)
for the speciation of arsenic##2##5##(2008-10#2)
for the speciation of chromium in natural water##2##8##(2008-10#2)
for the speciation of chromium##3##5##(2008-10#3)
for the speciation of selenium##2##5##(2008-10#2)
for the speciation of##16##4##(2008-10#16)
for the speciation##22##3##(2008-10#22)
for the species##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2010-4#1)
for the specific##13##3##(1991-9#1)(1992-10#1)(1993-3#1)(1994-1#1)(2008-10#4)(2008-11#1)(2008-9#2)(2009-10#1)(2009-5#1)
for the spectral##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
for the spectrometer##2##3##(2008-10#2)
for the spectrophotometric determination of copper(II)##2##6##(2008-10#2)
for the spectrophotometric determination of lead in##3##7##(2008-10#3)
for the spectrophotometric determination of lead##4##6##(2008-10#4)
for the spectrophotometric determination of nickel##3##6##(2008-10#3)
for the spectrophotometric determination of##33##5##(2008-10#33)
for the spectrophotometric##34##3##(2008-10#34)
for the speed of sound and##2##6##(2008-3#2)
for the spiked##2##3##(2008-10#2)
for the spread of##2##4##(1997-6#1)(2008-10#1)
for the spread##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
for the stability of##2##4##(1993-3#1)(1994-2#1)
for the stability##3##3##(1993-3#1)(1994-2#1)(2008-10#1)
for the standard##3##3##(2008-10#3)
for the stem cell population##2##5##(2008-11#1)(2010-7#1)
for the stimulation of##2##4##(1991-6#1)(1996-2#1)
for the stimulatory##2##3##(1994-3#1)(2008-8#1)
for the stripping##2##3##(2008-10#2)
for the structural##2##3##(1997-2#1)(1997-8#1)
for the structure##2##3##(1995-6#1)(2008-11#1)
for the student##3##3##(2008-11#3)
for the students##3##3##(2008-11#3)
for the studied##5##3##(2008-10#5)
for the study of gene expression##2##6##(2008-4#2)
for the study of polymeric acids was used##2##8##(2008-10#2)
for the study of the##6##5##(1996-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#1)
for the study of##47##4##(1991-12#1)(1991-2#1)(1993-3#1)(1994-5#1)(1996-12#2)(2008-1#2)(2008-10#14)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-4#1)(2010-6#2)(2012-3#4)
for the study period##2##4##(2012-12#2)
for the study##63##3##(1990-3#1)(1991-12#1)(1991-2#1)(1993-3#1)(1994-5#1)(1995-1#1)(1996-12#2)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-4#1)(2010-6#3)(2010-7#1)(2011-2#3)(2012-12#3)(2012-3#5)(2013-8#1)
for the subsequent##5##3##(1991-12#1)(2008-10#3)(2008-8#1)
for the substrate##2##3##(1992-3#1)(1993-8#1)
for the success of the##2##5##(2012-2#2)
for the success of##6##4##(1992-3#1)(2008-10#2)(2010-8#1)(2012-2#2)
for the successful##7##3##(1991-3#1)(1994-3#1)(2008-10#2)(2008-11#2)(2010-11#1)
for the successive determination of##3##5##(2008-10#3)
for the sudden infant death syndrome##2##6##(1993-12#2)
for the sudden##3##3##(1993-12#2)(2008-10#1)
for the sunscreen##3##3##(2008-5#3)
for the suppression of##8##4##(1997-8#1)(2008-10#6)(2008-11#1)
for the surface##2##3##(2008-10#1)(2011-1#1)
for the surgeon##2##3##(2008-9#1)(2010-12#1)
for the surgical##4##3##(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
for the survival of##3##4##(1991-6#1)(2009-8#1)(2012-5#1)
for the survival##4##3##(1991-6#1)(2009-8#2)(2012-5#1)
for the susceptible##2##3##(2008-10#2)
for the symptoms##2##3##(2008-10#1)(2011-2#1)
for the synthesis and##3##4##(2008-11#1)(2008-4#1)(2011-1#1)
for the synthesis of##30##4##(1990-5#2)(1992-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#4)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
for the synthesis##34##3##(1990-5#2)(1992-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#3)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#4)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)
for the synthetic##2##3##(1990-10#1)(2008-10#1)
for the system##4##3##(1995-2#1)(2008-10#2)(2013-8#1)
for the systemic##2##3##(1990-11#1)(2008-10#1)
for the target##4##3##(1995-1#1)(1995-5#1)(1997-2#1)(2008-10#1)
for the teaching##2##3##(2008-11#1)(2008-12#1)
for the temporal profile##2##4##(2008-3#2)
for the temporal##3##3##(1992-3#1)(2008-3#2)
for the temporary##2##3##(2008-11#2)
for the termination of##2##4##(1995-8#1)(1996-12#1)
for the ternary complexes##2##4##(2008-10#2)
for the test##5##3##(2008-10#3)(2008-12#1)(2012-3#1)
for the testing of##2##4##(2008-11#1)(2008-5#1)
for the tetrapeptide##2##3##(1993-9#1)(1994-5#1)
for the theoretical##2##3##(2008-12#1)(2012-3#1)
for the therapeutic##2##3##(1991-8#1)(2013-1#1)
for the therapy of##3##4##(2008-9#1)(2009-8#1)(2010-2#1)
for the thermal##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
for the thermodynamic##2##3##(2008-10#1)(2008-3#1)
for the third dose of##2##5##(1995-3#2)
for the third##6##3##(1995-3#3)(2008-10#2)(2008-8#1)
for the three##28##3##(1990-2#1)(1995-12#1)(2008-10#20)(2008-11#1)(2008-7#2)(2008-8#1)(2010-12#1)(2013-1#1)
for the threshold##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
for the time##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
for the timely##2##3##(1997-7#1)(2011-2#1)
for the titration##3##3##(2008-10#3)
for the titrimetric determination of##2##5##(2008-10#2)
for the total removal of##2##5##(2008-7#2)
for the total##11##3##(1991-1#1)(1991-6#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-1#1)(2010-11#1)(2013-1#1)
for the trace determination of zinc##2##6##(2008-10#2)
for the trace determination of##3##5##(2008-10#3)
for the trace##11##3##(2008-10#11)
for the training##2##3##(1992-1#1)(2008-10#1)
for the trait##2##3##(2008-10#1)(2012-3#1)
for the transcription of the##2##5##(1997-8#2)
for the transcription##4##3##(1993-6#1)(1997-8#2)(2010-11#1)
for the transient##4##3##(1996-2#1)(2008-10#1)(2008-2#2)
for the translation of##2##4##(2008-11#1)(2008-8#1)
for the transport##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
for the treatment of Crohn's disease##2##6##(1994-6#1)(2013-1#1)
for the treatment of a##2##5##(2011-2#1)(2013-1#1)
for the treatment of asthma##2##5##(1996-1#1)(1996-2#1)
for the treatment of benign##2##5##(2008-5#1)(2011-2#1)
for the treatment of brain tumors##2##6##(1995-2#1)(2008-11#1)
for the treatment of cancer##5##5##(2008-10#1)(2008-5#2)(2009-11#1)(2009-12#1)
for the treatment of chronic##4##5##(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)
for the treatment of diabetic##2##5##(2008-1#1)(2013-1#1)
for the treatment of distal radial osteosarcoma##2##7##(2013-8#2)
for the treatment of inflammatory diseases##2##6##(2011-1#2)
for the treatment of localized##2##5##(1995-2#1)(2013-1#1)
for the treatment of neuropathic pain##2##6##(2008-9#2)
for the treatment of opioid##2##5##(2008-11#1)(2008-6#1)
for the treatment of osteoporosis##2##5##(2008-11#1)(2012-12#1)
for the treatment of several##3##5##(2008-11#2)(2009-1#1)
for the treatment of severe##2##5##(2008-8#1)(2013-1#1)
for the treatment of the##3##5##(1996-2#1)(2008-5#1)(2011-7#1)
for the treatment of this##2##5##(1993-6#1)(2013-1#1)
for the treatment of##142##4##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#2)(2007-11#1)(2008-1#4)(2008-10#8)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#4)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#3)(2011-1#4)(2011-10#1)(2011-2#10)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#14)(2013-8#4)
for the treatment##149##3##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#2)(2007-11#1)(2008-1#4)(2008-10#8)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#6)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#4)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#2)(2010-6#3)(2011-1#4)(2011-10#1)(2011-2#12)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#14)(2013-8#4)
for the two drugs##2##4##(2008-11#2)
for the two systems##2##4##(2008-10#1)(2008-7#1)
for the two##43##3##(1990-5#1)(1991-6#1)(1992-4#1)(1994-5#3)(1995-2#1)(1995-5#1)(1996-11#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-8#1)
for the type I alpha regulatory subunit##2##7##(1990-2#2)
for the type of##2##4##(1990-12#1)(1996-6#1)
for the type##5##3##(1990-12#1)(1990-2#2)(1994-11#1)(1996-6#1)
for the understanding##2##3##(1994-5#1)(2008-8#1)
for the unique##2##3##(2008-2#1)(2009-1#1)
for the unprotonated and protonated##2##5##(1991-9#2)
for the unretained##2##3##(2008-10#2)
for the upper and lower##2##5##(2008-12#1)(2008-7#1)
for the upper and##3##4##(2008-12#2)(2008-7#1)
for the upper##4##3##(2008-12#2)(2008-7#1)(2010-12#1)
for the uptake of##2##4##(2008-10#2)
for the use in##3##4##(2008-10#2)(2008-11#1)
for the use of a##2##5##(1992-1#1)(2008-10#1)
for the use of cortical allograft##3##6##(2011-2#3)
for the use of these##3##5##(1992-2#1)(2008-10#2)
for the use of this##3##5##(1990-9#1)(2008-10#1)(2008-11#1)
for the use of##37##4##(1990-9#3)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-6#1)(2008-10#8)(2008-11#5)(2008-4#2)(2008-5#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#1)
for the use##40##3##(1990-9#3)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-6#1)(2008-10#10)(2008-11#6)(2008-4#2)(2008-5#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#1)
for the utilization of##2##4##(2008-12#1)(2008-7#1)
for the value of##2##4##(2008-11#1)(2009-4#1)
for the vanadium determination##2##4##(2008-10#2)
for the vanadium##4##3##(2008-10#4)
for the variation in the##2##5##(1995-11#1)(2008-10#1)
for the various##6##3##(1991-11#1)(1991-6#1)(2008-10#3)(2008-7#1)
for the viability##2##3##(1995-12#1)(2008-11#1)
for the visual##2##3##(2008-10#1)(2008-8#1)
for the voltammetric detection of##3##5##(2008-10#3)
for the voltammetric determination of##2##5##(2008-10#2)
for the voltammetric##5##3##(2008-10#5)
for the volume##3##3##(1990-2#1)(2008-9#1)(2010-7#1)
for the water content determination of##2##6##(2008-10#2)
for the water##5##3##(2008-10#2)(2008-3#2)(2008-5#1)
for the way in which##2##5##(1993-8#1)(2008-8#1)
for the weak##2##3##(2008-10#1)(2008-5#1)
for the whole analytical##2##4##(2008-10#2)
for the whole sample##2##4##(2008-10#1)(2010-10#1)
for the whole##14##3##(1992-2#1)(1992-5#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2013-8#1)
for the wider##2##3##(2010-2#1)(2013-1#1)
for the wild-type enzyme##3##4##(1991-5#1)(1995-6#2)
for the wild-type##5##3##(1991-5#1)(1995-6#2)(2008-10#2)
for the work of##3##4##(1996-1#1)(2008-11#1)(2012-2#1)
for the work##4##3##(1996-1#1)(2008-11#2)(2012-2#1)
for the year##3##3##(1997-3#1)(2008-11#1)(2012-12#1)
for the years##4##3##(1991-3#1)(1996-1#1)(1997-7#1)(2013-1#1)
for the##7766##2##(1990-10#1)(1990-11#15)(1990-12#34)(1990-2#21)(1990-3#10)(1990-5#20)(1990-6#4)(1990-7#1)(1990-8#17)(1990-9#8)(1991-1#19)(1991-10#2)(1991-11#6)(1991-12#24)(1991-2#19)(1991-3#26)(1991-4#1)(1991-5#25)(1991-6#14)(1991-7#3)(1991-8#5)(1991-9#15)(1992-1#17)(1992-10#9)(1992-11#10)(1992-12#23)(1992-2#22)(1992-3#45)(1992-4#2)(1992-5#6)(1992-6#11)(1992-8#4)(1992-9#14)(1993-1#12)(1993-11#6)(1993-12#27)(1993-2#17)(1993-3#32)(1993-5#3)(1993-6#17)(1993-8#34)(1993-9#9)(1994-1#18)(1994-11#22)(1994-12#19)(1994-2#20)(1994-3#26)(1994-5#37)(1994-6#7)(1994-8#18)(1994-9#8)(1995-1#7)(1995-11#17)(1995-12#41)(1995-2#38)(1995-3#23)(1995-5#9)(1995-6#39)(1995-8#19)(1995-9#8)(1996-1#13)(1996-11#11)(1996-12#41)(1996-2#33)(1996-3#31)(1996-5#27)(1996-6#10)(1996-8#5)(1996-9#4)(1997-1#20)(1997-2#48)(1997-3#22)(1997-4#14)(1997-5#10)(1997-6#18)(1997-7#20)(1997-8#29)(1997-9#5)(2006-6#2)(2007-11#13)(2007-12#28)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#26)(2008-10#3797)(2008-11#439)(2008-12#110)(2008-2#46)(2008-3#168)(2008-4#79)(2008-5#122)(2008-6#22)(2008-7#124)(2008-8#111)(2008-9#135)(2009-1#16)(2009-10#24)(2009-11#17)(2009-12#24)(2009-2#4)(2009-3#14)(2009-4#9)(2009-5#10)(2009-6#20)(2009-7#30)(2009-8#52)(2009-9#7)(2010-1#24)(2010-10#16)(2010-11#32)(2010-12#33)(2010-2#3)(2010-3#11)(2010-4#17)(2010-5#22)(2010-6#22)(2010-7#31)(2010-8#29)(2010-9#13)(2011-1#29)(2011-10#2)(2011-2#198)(2011-3#15)(2011-7#3)(2011-9#1)(2012-12#41)(2012-2#106)(2012-3#87)(2012-4#1)(2012-5#3)(2012-8#1)(2012-9#1)(2013-1#146)(2013-7#7)(2013-8#71)
for their abilities to inhibit##2##5##(1993-8#1)(2008-10#1)
for their abilities to##4##4##(1993-8#1)(2008-10#2)(2009-12#1)
for their ability to act as##2##6##(1990-11#1)(2008-10#1)
for their ability to act##3##5##(1990-11#1)(2008-10#2)
for their ability to degrade##3##5##(2008-10#1)(2011-2#2)
for their ability to induce##4##5##(2008-10#3)(2008-4#1)
for their ability to inhibit the##2##6##(1995-11#1)(2008-11#1)
for their ability to inhibit##6##5##(1992-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
for their ability to produce##2##5##(1991-2#1)(2008-10#1)
for their ability to transmit##3##5##(2008-10#3)
for their ability to##42##4##(1990-11#1)(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#1)(1997-3#1)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)
for their adult##2##3##(2008-11#1)(2010-9#1)
for their age and##2##4##(2012-12#2)
for their atomic absorption##2##4##(2008-10#2)
for their binding##2##3##(1995-8#1)(2012-2#1)
for their biocontrol activity against##2##5##(2008-10#2)
for their biocontrol potential##2##4##(2008-10#2)
for their biocontrol##4##3##(2008-10#4)
for their child##2##3##(1995-1#1)(1995-12#1)
for their children##4##3##(1993-3#1)(1996-1#2)(2012-3#1)
for their determination in##2##4##(2008-10#2)
for their effect on##3##4##(2008-10#3)
for their effect##4##3##(2008-10#3)(2012-2#1)
for their effectiveness##2##3##(2008-11#1)(2008-12#1)
for their effects on##5##4##(1991-3#1)(2008-10#3)(2012-2#1)
for their efficacy in##2##4##(2008-10#1)(2009-7#1)
for their efficacy##3##3##(2008-10#1)(2009-7#1)(2013-1#1)
for their expression##2##3##(1997-2#1)(1997-7#1)
for their flame atomic absorption spectrometric##2##6##(2008-10#2)
for their growth##2##3##(2008-10#1)(2008-11#1)
for their identification##3##3##(2008-10#1)(2008-12#1)(2011-3#1)
for their implementation##2##3##(1994-2#1)(2008-3#1)
for their in vitro##2##4##(2008-10#1)(2011-2#1)
for their inhibitory activity##2##4##(2008-4#1)(2011-1#1)
for their offspring##2##3##(2008-8#2)
for their own##3##3##(1994-12#1)(1994-2#1)(2008-11#1)
for their parents##2##3##(1990-12#1)(2012-2#1)
for their pathogenicity on##2##4##(2008-10#2)
for their possible##2##3##(2008-12#1)(2008-7#1)
for their potential to##2##4##(1993-9#1)(1996-1#1)
for their potential##5##3##(1993-9#1)(1996-1#1)(1996-12#1)(2008-7#1)(2009-5#1)
for their primary##2##3##(1991-3#1)(2007-12#1)
for their research##2##3##(2008-11#1)(2008-12#1)
for their resistance##2##3##(2008-10#1)(2012-3#1)
for their role in##2##4##(2008-12#1)(2008-7#1)
for their role##4##3##(2008-12#2)(2008-7#1)(2008-9#1)
for their sensitivity to##3##4##(2008-10#3)
for their sensitivity##4##3##(2008-10#3)(2008-12#1)
for their separation##2##3##(2008-10#2)
for their simultaneous##2##3##(1993-8#1)(2008-10#1)
for their study##2##3##(2008-10#1)(2008-11#1)
for their survival##2##3##(2008-10#1)(2012-7#1)
for their tolerance##2##3##(2008-12#1)(2012-5#1)
for their virulence##2##3##(2008-10#2)
for their work##2##3##(1994-2#1)(1997-1#1)
for their##295##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#5)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#5)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-8#2)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#96)(2008-11#17)(2008-12#11)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#6)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#4)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#3)
for them to##4##3##(1995-1#1)(1997-2#1)(2008-11#1)(2008-9#1)
for them##14##2##(1992-3#1)(1993-3#1)(1995-1#1)(1997-1#2)(1997-2#2)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#2)(2013-8#1)
for themselves##7##2##(1990-6#1)(1992-1#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
for theophylline##2##2##(2008-10#2)
for theory##2##2##(2008-11#2)
for therapeutic intervention##2##3##(2008-11#1)(2009-4#1)
for therapeutic interventions##2##3##(2011-2#2)
for therapeutic##19##2##(1991-6#1)(2007-12#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
for therapy and##2##3##(1992-9#1)(2008-11#1)
for therapy##14##2##(1992-3#2)(1992-9#1)(1996-11#1)(1997-8#1)(2008-11#2)(2010-1#1)(2010-12#1)(2011-2#4)(2011-3#1)
for there to##2##3##(1992-9#1)(2008-10#1)
for thermal stabilization of##2##4##(2008-10#2)
for thermal##5##2##(1993-8#1)(1995-2#1)(2008-10#3)
for these activities##2##3##(1996-2#1)(1997-7#1)
for these adjustments##2##3##(1991-1#2)
for these analytes##2##3##(2008-10#2)
for these and other##2##4##(2008-11#1)(2008-8#1)
for these children##2##3##(2008-3#1)(2008-9#1)
for these compounds was##2##4##(2008-10#2)
for these compounds##6##3##(2008-10#5)(2008-11#1)
for these determinations##2##3##(2008-10#2)
for these differences##3##3##(1993-11#1)(1995-2#1)(2008-9#1)
for these enzymes##2##3##(1990-3#1)(2006-6#1)
for these estimates##2##3##(2008-12#1)(2008-9#1)
for these findings are##2##4##(2009-5#1)(2011-1#1)
for these four##2##3##(2008-10#2)
for these genes##2##3##(1993-6#1)(2008-9#1)
for these interactions##2##3##(1997-2#1)(2008-5#1)
for these ions##2##3##(2008-10#2)
for these lesions##2##3##(2008-7#1)(2011-2#1)
for these less##2##3##(2009-10#1)(2011-2#1)
for these metal ions##2##4##(2008-10#2)
for these new##2##3##(1997-2#1)(1997-9#1)
for these parameters##4##3##(1990-4#1)(2008-10#1)(2012-3#1)(2013-3#1)
for these patients##12##3##(1991-2#1)(1991-6#1)(1994-12#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
for these phenomena##2##3##(1993-6#1)(2008-11#1)
for these procedures##2##3##(2008-10#2)
for these proteins##4##3##(1991-12#1)(1997-6#1)(2009-8#1)(2012-3#1)
for these results##2##3##(1991-11#1)(2010-1#1)
for these samples##4##3##(2008-10#4)
for these services##2##3##(1992-3#1)(2012-2#1)
for these three##3##3##(2008-10#3)
for these two##4##3##(1996-3#1)(1997-7#1)(2008-10#1)(2012-2#1)
for these##198##2##(1990-11#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#5)(1997-3#2)(1997-6#2)(1997-7#3)(1997-8#1)(1997-9#1)(2006-6#1)(2008-1#1)(2008-10#53)(2008-11#16)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#10)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-2#4)(2012-3#5)(2013-1#4)(2013-3#1)(2013-8#1)
for thiabendazole##3##2##(2008-10#3)
for thin##3##2##(2008-3#2)(2008-9#1)
for thiocyanate##2##2##(2008-10#2)
for thiocyanate-selective##2##2##(2008-10#2)
for thiols##2##2##(2008-10#2)
for thiosulfate##2##2##(2008-10#2)
for thiram##2##2##(2008-10#2)
for third##2##2##(2008-11#1)(2008-12#1)
for this analysis##2##3##(2008-10#1)(2008-4#1)
for this and other##2##4##(2008-3#1)(2008-9#1)
for this application##2##3##(2008-10#2)
for this assay##2##3##(2008-11#2)
for this association##3##3##(2008-12#1)(2008-9#1)(2013-1#1)
for this cancer##2##3##(2008-5#1)(2011-2#1)
for this case##3##3##(1995-5#1)(2008-10#1)(2010-2#1)
for this class of##4##4##(1993-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
for this community##2##3##(2008-11#2)
for this complex##2##3##(1994-5#1)(2009-7#1)
for this compound##2##3##(1990-8#1)(1991-5#1)
for this condition##3##3##(2010-11#1)(2012-3#1)(2013-1#1)
for this determination##2##3##(2008-10#2)
for this devastating disease##2##4##(2008-11#1)(2008-7#1)
for this devastating##3##3##(2008-11#1)(2008-7#2)
for this disease##7##3##(2008-10#3)(2009-5#1)(2009-7#1)(2009-8#1)(2011-3#1)
for this disorder##4##3##(2008-4#2)(2008-7#2)
for this effect is##3##4##(2007-11#1)(2008-10#1)(2012-3#1)
for this effect##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-3#1)
for this enzyme in##3##4##(1994-8#1)(2008-5#1)(2011-3#1)
for this enzyme##5##3##(1990-8#1)(1991-12#1)(1994-8#1)(2008-5#1)(2011-3#1)
for this group of##2##4##(2008-9#1)(2009-12#1)
for this group##6##3##(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
for this important##2##3##(2008-6#1)(2008-9#1)
for this indication##3##3##(2008-5#1)(2008-9#2)
for this kind of##3##4##(1991-3#1)(1996-6#1)(2008-3#1)
for this method##6##3##(1990-2#1)(1995-8#1)(2008-10#4)
for this new member of the genus##2##7##(2008-10#2)
for this pathogen##5##3##(2008-10#5)
for this patient##2##3##(2011-2#1)(2012-3#1)
for this period##2##3##(1990-6#1)(1997-1#1)
for this phenomenon is##3##4##(1992-9#1)(2008-9#1)(2009-7#1)
for this phenomenon##7##3##(1990-2#1)(1992-9#1)(1997-6#1)(2008-7#2)(2008-9#1)(2009-7#1)
for this population##2##3##(1991-12#1)(2008-10#1)
for this process##2##3##(1991-3#1)(2008-5#1)
for this protein##4##3##(1990-5#1)(1990-7#1)(1993-1#1)(2008-10#1)
for this purpose and##2##4##(2008-4#1)(2012-2#1)
for this purpose are##3##4##(2008-10#2)(2008-11#1)
for this purpose##33##3##(1991-8#1)(1995-2#2)(1995-5#1)(2008-10#14)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#2)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
for this reason##2##3##(2008-10#1)(2008-3#1)
for this result##2##3##(1993-11#1)(2011-2#1)
for this species##2##3##(2007-12#1)(2010-3#1)
for this study##22##3##(1990-12#1)(1991-12#1)(1992-2#1)(1993-3#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2010-3#1)(2010-7#1)(2010-8#1)(2013-1#2)
for this system was##2##4##(2008-10#1)(2008-12#1)
for this system##3##3##(2008-10#2)(2008-12#1)
for this task##3##3##(2008-10#2)(2008-2#1)
for this tumor##2##3##(2008-10#2)
for this type of##5##4##(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
for this variation##2##3##(2008-10#2)
for this##317##2##(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#2)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#85)(2008-11#22)(2008-12#6)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#12)(2009-12#2)(2009-3#2)(2009-5#1)(2009-7#3)(2009-8#4)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#15)(2011-3#2)(2012-12#2)(2012-2#7)(2012-3#11)(2013-1#13)(2013-8#5)
for thoracic##3##2##(2012-12#3)
for thorough##3##2##(1991-2#1)(2008-4#1)(2008-5#1)
for those in##2##3##(1993-11#1)(2008-8#1)
for those interested in##2##4##(2008-11#1)(2008-9#1)
for those involved##2##3##(1996-8#1)(2008-10#1)
for those not##2##3##(1993-1#2)
for those patients##3##3##(2011-2#3)
for those that##3##3##(2008-10#2)(2011-2#1)
for those who##11##3##(1991-12#1)(1991-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-3#1)(2013-1#1)
for those wishing to##2##4##(2008-4#1)(2012-12#1)
for those with##6##3##(1994-8#1)(2008-10#1)(2010-10#1)(2011-2#3)
for those##63##2##(1991-12#1)(1991-3#2)(1993-1#3)(1993-11#1)(1993-12#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-8#2)(2008-10#12)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#2)(2010-1#1)(2010-10#2)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
for thousands of years##4##4##(1996-11#1)(2008-9#1)(2009-1#1)(2011-2#1)
for thousands of##5##3##(1996-11#1)(2008-10#1)(2008-9#1)(2009-1#1)(2011-2#1)
for three consecutive##4##3##(1991-3#1)(1996-1#1)(2008-10#2)
for three days##2##3##(1991-5#1)(2007-12#1)
for three different##5##3##(1992-3#1)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#1)
for three independent##2##3##(2008-10#1)(2008-9#1)
for three months##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
for three of the##4##4##(2008-10#3)(2008-3#1)
for three of##5##3##(1992-3#1)(2008-10#3)(2008-3#1)
for three weeks##2##3##(1991-6#1)(2011-2#1)
for three##51##2##(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-9#2)(2010-1#1)(2011-2#2)(2012-2#3)(2012-3#1)
for threonine##2##2##(1993-8#2)
for thrombocytopenia##2##2##(2008-8#2)
for thrombosis##3##2##(1994-6#1)(2008-5#2)
for thyroid carcinoma##2##3##(2008-7#1)(2012-3#1)
for thyroid##7##2##(1994-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#2)
for tibiocalcaneal fusion##2##3##(2009-3#2)
for tilted and offset planes##2##5##(2008-3#2)
for tilted##3##2##(2008-3#2)(2011-7#1)
for time##4##2##(2008-10#2)(2009-12#1)(2013-1#1)
for time-resolved##3##2##(2008-11#3)
for timely##2##2##(2010-9#1)(2012-3#1)
for tin##4##2##(2008-10#4)
for tissue engineering##6##3##(2008-11#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-5#1)
for tissue regeneration##4##3##(2009-12#1)(2012-3#1)(2013-1#2)
for tissue##13##2##(2008-10#1)(2008-11#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
for titanium##2##2##(2008-10#2)
for titration##2##2##(2008-10#1)(2008-11#1)
for to##3##2##(2008-10#2)(2011-1#1)
for tobacco dependence##2##3##(2010-11#1)(2013-7#1)
for today##2##2##(1996-3#1)(2008-12#1)
for today's##2##2##(1992-2#1)(2008-11#1)
for tolerance##4##2##(1991-3#1)(2008-10#2)(2011-3#1)
for tomato##2##2##(2008-10#2)
for topical##3##2##(1993-11#1)(2007-11#1)(2008-5#1)
for total As##2##3##(2008-10#2)
for total arsenic and##2##4##(2008-10#2)
for total chromium##2##3##(2008-10#2)
for total inorganic##5##3##(2008-10#5)
for total knee arthroplasty##3##4##(2013-1#3)
for total mercury##2##3##(2008-10#2)
for total removal##2##3##(2008-7#2)
for total thyroidectomy##3##3##(2011-2#3)
for total##54##2##(1990-12#1)(1991-2#1)(1994-9#1)(1996-1#2)(1996-12#1)(1996-3#2)(2008-10#31)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#4)(2013-1#5)
for toxic##2##2##(2008-10#2)
for toxicity testing##2##3##(1992-3#1)(2008-11#1)
for toxicity##6##2##(1992-3#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
for toxin reaction##2##3##(2008-10#2)
for toxin##5##2##(2008-10#5)
for toxoplasmosis##2##2##(1990-9#1)(1996-11#1)
for trace analysis of##2##4##(2008-10#2)
for trace analysis##4##3##(2008-10#4)
for trace determination of##3##4##(2008-10#3)
for trace element determination##3##4##(2008-10#3)
for trace enrichment of metal ions##3##6##(2008-10#3)
for trace gas analysis and##2##5##(2008-10#2)
for trace##31##2##(2008-10#29)(2008-3#1)(2013-8#1)
for traces of##3##3##(2008-10#3)
for traditional##8##2##(1992-1#1)(1993-12#2)(1996-2#1)(1997-2#2)(2008-10#1)(2011-2#1)
for training and##2##3##(2008-10#1)(2010-8#1)
for training in##2##3##(1993-12#1)(2008-11#1)
for training##14##2##(1991-2#1)(1993-12#1)(1994-3#1)(2008-10#3)(2008-11#3)(2010-1#2)(2010-8#2)(2012-3#1)
for traits##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
for tramadol##2##2##(2008-10#2)
for transcranial resection##2##3##(2011-2#2)
for transcranial##3##2##(2010-7#1)(2011-2#2)
for transcription factors##2##3##(1990-5#1)(1993-6#1)
for transcription##6##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(2012-2#1)
for transcriptional##3##2##(1993-3#1)(1993-8#1)(2008-6#1)
for transduction with##2##3##(1990-11#2)
for transfection##2##2##(1991-5#1)(2008-11#1)
for transfer to##2##3##(2008-9#1)(2010-5#1)
for transfer##3##2##(1993-8#1)(2008-9#1)(2010-5#1)
for transferrin##3##2##(2008-10#2)(2013-7#1)
for transferring##2##2##(2009-6#1)(2012-2#1)
for transformation##7##2##(1990-8#1)(1992-12#1)(1993-2#1)(2008-11#2)(2008-2#1)(2009-12#1)
for transfusion##3##2##(1990-11#1)(2008-10#1)(2011-2#1)
for transgene##3##2##(2008-11#1)(2009-10#1)(2011-1#1)
for transient expression##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
for transient##7##2##(1996-11#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)
for transition##2##2##(2008-10#2)
for translating##2##2##(1997-1#1)(2008-10#1)
for translation##2##2##(2009-10#1)(2010-4#1)
for transmission electron microscopy##2##4##(2008-10#1)(2008-5#1)
for transmission##6##2##(2008-10#3)(2008-3#1)(2008-5#2)
for transmissive##2##2##(2008-3#2)
for transmitting##3##2##(2008-10#1)(2008-2#1)(2010-1#1)
for transplantation of##2##3##(2008-10#1)(2011-2#1)
for transplantation##9##2##(1994-1#1)(2008-10#1)(2008-11#2)(2010-12#2)(2011-2#3)
for transport##6##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
for transposition##2##2##(1996-11#1)(1997-7#1)
for transradial##2##2##(2011-2#2)
for trapping##2##2##(2008-10#2)
for trauma##3##2##(1992-8#1)(2008-6#1)(2012-2#1)
for treated and##2##3##(1991-11#1)(2008-10#1)
for treated##3##2##(1991-11#1)(2008-10#2)
for treating a##2##3##(2011-2#1)(2012-2#1)
for treating cardiac arrhythmias##2##4##(2011-2#2)
for treating##38##2##(1990-9#1)(1991-2#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-1#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#7)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
for treatment and the##2##4##(1991-2#1)(1996-12#1)
for treatment and##9##3##(1991-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(2008-12#1)(2008-6#1)(2009-12#1)(2010-5#1)(2010-7#1)
for treatment in##3##3##(1991-11#1)(1992-12#1)(1994-12#1)
for treatment of depression##2##4##(2008-4#2)
for treatment of refractory##2##4##(2011-2#2)
for treatment of the##4##4##(1996-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
for treatment of##59##3##(1990-11#1)(1991-9#2)(1992-1#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-6#3)(2011-2#11)(2012-12#1)(2012-3#1)(2013-1#5)
for treatment##86##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#3)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#4)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-5#2)(2010-6#3)(2010-7#1)(2011-2#12)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
for trichlorfon##4##2##(2008-10#4)
for trichothecene##2##2##(2008-10#1)(2008-11#1)
for trigeminal neuralgia##4##3##(2008-7#1)(2011-2#2)(2013-1#1)
for triggering##3##2##(1990-5#1)(2008-8#2)
for triplex formation at low##2##5##(1993-8#2)
for triplex formation##4##3##(1993-8#4)
for tropospheric##4##2##(2008-11#1)(2008-2#2)(2008-3#1)
for trunk##2##2##(2008-12#2)
for trypsin-APC and##2##3##(1997-2#2)
for trypsin-APC##3##2##(1997-2#3)
for trypsin-SAPC##3##2##(1997-2#3)
for tubal##2##2##(1991-3#1)(1993-3#1)
for tuberculosis##6##2##(1990-6#2)(1995-5#1)(1996-3#3)
for tumor cell##2##3##(2008-9#1)(2011-2#1)
for tumor immunotherapy##2##3##(1994-5#1)(2011-2#1)
for tumor##14##2##(1991-12#1)(1993-11#2)(1994-5#1)(1994-8#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#4)(2013-8#2)
for tumors##4##2##(1993-11#1)(2010-7#1)(2011-2#2)
for tumour##2##2##(2008-10#1)(2011-2#1)
for twenty-first century##2##3##(1997-1#2)
for twins##2##2##(1997-7#1)(2008-12#1)
for two different##2##3##(1991-5#1)(2008-3#1)
for two groups##2##3##(1997-2#1)(2012-2#1)
for two months##2##3##(2008-10#1)(2012-2#1)
for two or more##2##4##(1994-9#1)(2008-9#1)
for two populations##2##3##(2008-10#1)(2013-8#1)
for two samples##2##3##(2008-10#2)
for two species##2##3##(2008-10#1)(2008-8#1)
for two to##2##3##(1992-5#1)(1997-5#1)
for two types of##2##4##(2008-3#1)(2010-3#1)
for two weeks##2##3##(1994-12#1)(2009-11#1)
for two years in Urbana##2##5##(2008-10#2)
for two years##10##3##(1997-8#2)(2008-10#4)(2008-5#1)(2010-11#1)(2011-2#2)
for two##88##2##(1991-1#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#2)(2008-10#27)(2008-11#5)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
for two-dimensional##2##2##(2007-12#1)(2008-3#1)
for type 2 diabetes##2##4##(2010-12#1)(2012-2#1)
for type I##3##3##(1996-2#1)(2008-8#1)(2009-7#1)
for type II##2##3##(1994-11#1)(2008-10#1)
for type##8##2##(1994-11#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-2#1)
for typical##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
for typing##2##2##(2008-9#1)(2012-2#1)
for tyrosinase immobilisation##2##3##(2008-10#2)
for tyrosinase##3##2##(2008-10#2)(2008-5#1)
for tyrosine##3##2##(1992-7#1)(1993-9#1)(2008-10#1)
for ultra##2##2##(1992-3#1)(2008-10#1)
for ultra-high##2##2##(2008-11#1)(2011-7#1)
for ultrabrief##2##2##(2012-12#2)
for ultrasensitive detection of##2##4##(2008-10#1)(2008-3#1)
for ultrasensitive##3##2##(2008-10#2)(2008-3#1)
for ultrasonic##2##2##(1991-1#1)(2009-5#1)
for ultrasound##2##2##(1993-1#1)(2010-12#1)
for ultrastructural studies##2##3##(2008-7#2)
for ultrastructural##5##2##(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)
for ultratrace##2##2##(2008-10#2)
for uncertainty##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
for uncovering##2##2##(1995-5#1)(2008-7#1)
for undergraduate nursing students##5##4##(2008-11#4)(2008-12#1)
for undergraduate##13##2##(1991-1#1)(2008-11#6)(2008-12#5)(2013-1#1)
for understanding and treating##2##4##(1995-2#1)(2012-12#1)
for understanding and##5##3##(1991-12#1)(1994-12#1)(1995-2#1)(1997-3#1)(2012-12#1)
for understanding of##2##3##(2008-10#1)(2012-3#1)
for understanding the evolution of##2##5##(2008-11#1)(2008-6#1)
for understanding the##21##3##(1992-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#1)
for understanding why##2##3##(2008-10#1)(2010-4#1)
for understanding##44##2##(1991-12#1)(1992-2#2)(1994-1#1)(1994-12#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
for undertaking##2##2##(2008-11#1)(2008-9#1)
for underwater##2##2##(2008-3#2)
for uniformity##2##2##(1995-3#1)(2008-10#1)
for union##2##2##(1996-3#1)(1997-6#1)
for unique##5##2##(2008-10#1)(2008-11#1)(2012-2#2)(2013-1#1)
for uniqueness##2##2##(2010-10#2)
for unit##2##2##(2008-3#2)
for universal##2##2##(1991-2#1)(2008-8#1)
for unknown##3##2##(1991-5#1)(2008-10#1)(2012-3#1)
for unresectable##2##2##(1993-9#1)(2013-1#1)
for unstable angina##2##3##(2008-5#2)
for untreated and NEM-treated cells##3##5##(1995-8#3)
for untreated populations##2##3##(2008-10#1)(2008-6#1)
for untreated##7##2##(1995-8#3)(2008-10#1)(2008-5#2)(2008-6#1)
for up to 15##3##4##(2008-10#2)(2008-8#1)
for up to 2 months##2##5##(1996-12#2)
for up to 2 weeks##2##5##(1990-12#1)(2008-10#1)
for up to 2 years##2##5##(2008-7#1)(2010-8#1)
for up to 2##7##4##(1990-12#1)(1993-8#1)(1996-12#2)(2008-10#1)(2008-7#1)(2010-8#1)
for up to 3##2##4##(2008-10#1)(2008-5#1)
for up to 30##3##4##(1991-5#1)(2008-10#2)
for up to 4 months##2##5##(2008-11#2)
for up to 6 days##2##5##(2008-11#2)
for up to 6 months##2##5##(2008-10#2)
for up to 6 weeks##2##5##(2008-10#2)
for up to 6##7##4##(2008-10#4)(2008-11#2)(2008-8#1)
for up to 9##2##4##(1995-11#1)(1995-2#1)
for up to##46##3##(1990-12#1)(1991-5#1)(1993-8#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-12#2)(1997-1#1)(2008-10#20)(2008-11#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2010-8#1)
for up##47##2##(1990-12#1)(1991-5#1)(1993-8#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-12#2)(1997-1#1)(2008-10#21)(2008-11#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2010-8#1)
for upper##7##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#2)
for uranium##3##2##(2008-10#3)
for uranium(VI) and thorium(IV) prior to##2##6##(2008-10#2)
for urban##5##2##(1994-1#1)(1994-2#1)(2008-12#1)(2010-9#2)
for uric acid and##2##4##(2008-10#2)
for uric acid detection##2##4##(2008-10#2)
for uric acid##6##3##(2008-10#6)
for urinary##2##2##(1993-2#1)(2008-10#1)
for urine##2##2##(1990-11#1)(2008-10#1)
for us to##5##3##(1992-1#1)(1995-1#1)(2008-3#1)(2010-6#1)(2010-7#1)
for us##6##2##(1992-1#1)(1995-1#1)(2008-10#1)(2008-3#1)(2010-6#1)(2010-7#1)
for use against##2##3##(1993-2#1)(2008-10#1)
for use as a##7##4##(1994-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
for use as an##3##4##(2008-10#2)(2008-11#1)
for use as##13##3##(1994-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#2)(2012-2#1)(2013-1#2)
for use at##2##3##(1990-12#2)
for use by##5##3##(1992-3#1)(1996-12#1)(2008-10#2)(2013-1#1)
for use during##2##3##(2008-12#1)(2010-8#1)
for use in a##5##4##(1990-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
for use in gene##2##4##(2008-10#1)(2010-1#1)
for use in immunoassays##3##4##(2008-10#3)
for use in nursing##2##4##(2008-11#1)(2010-11#1)
for use in the##9##4##(1995-5#1)(1996-1#1)(1997-1#1)(2008-10#3)(2008-12#2)(2013-1#1)
for use in##78##3##(1990-2#1)(1991-3#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#26)(2008-11#5)(2008-12#2)(2008-3#3)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
for use of the##2##4##(2008-7#1)(2009-11#1)
for use of##7##3##(1990-3#1)(1993-6#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
for use on##2##3##(1991-2#1)(2008-3#1)
for use with the##2##4##(2008-10#1)(2012-3#1)
for use with##14##3##(2008-10#5)(2008-4#3)(2008-6#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
for use##137##2##(1990-12#2)(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1997-1#1)(2008-10#41)(2008-11#9)(2008-12#3)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
for user facilities##2##3##(1993-3#2)
for users of##2##3##(1991-3#1)(2008-4#1)
for users##3##2##(1991-3#1)(2008-4#1)(2010-5#1)
for using the##2##3##(2008-4#1)(2012-2#1)
for using this##4##3##(1996-5#1)(2008-11#2)(2008-5#1)
for using##20##2##(1991-1#1)(1994-11#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-5#1)
for uterine##4##2##(2010-12#1)(2012-12#2)(2012-2#1)
for utilization##2##2##(1993-12#1)(2008-10#1)
for vaccination##3##2##(1996-1#2)(2007-11#1)
for vaccines##3##2##(1995-5#2)(2011-2#1)
for vaginal##7##2##(1991-3#1)(1992-1#1)(1993-1#1)(1993-12#1)(2009-2#2)(2010-7#1)
for validation of##2##3##(2008-10#1)(2008-7#1)
for validation studies##2##3##(2008-10#1)(2008-3#1)
for validation##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
for values in##2##3##(2008-10#2)
for vanadium##6##2##(2008-10#6)
for vanadium(IV) and##2##3##(2008-10#2)
for variable selection##3##3##(2008-10#2)(2010-1#1)
for variables##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
for variance##2##2##(1994-9#1)(2008-9#1)
for variation at 16 putative random amplified polymorphic DNA##2##9##(2008-10#2)
for variation at##3##3##(2008-10#3)
for variation in##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
for variation##8##2##(2008-10#5)(2008-11#1)(2008-9#1)(2012-3#1)
for various indications##2##3##(2008-11#2)
for various periods##2##3##(1996-2#1)(2008-10#1)
for various quadrat sizes suggested##2##5##(2008-10#2)
for various reasons##4##3##(1993-3#1)(1994-5#1)(1995-5#1)(2013-8#1)
for various types of##4##4##(1991-2#1)(1995-3#1)(1995-5#1)(1997-3#1)
for various##62##2##(1990-3#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(2008-10#17)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
for varying times##3##3##(1993-6#1)(1993-8#2)
for varying##9##2##(1991-12#1)(1993-6#1)(1993-8#2)(2008-10#2)(2008-3#1)(2008-8#1)(2010-11#1)
for vascular##8##2##(1994-3#1)(2008-11#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-1#1)(2012-12#1)(2012-2#1)
for vegetative compatibility groups (VCGs)##2##5##(2008-10#2)
for vegetative compatibility##5##3##(2008-10#5)
for verification of the##2##4##(2008-4#1)(2009-2#1)
for verification of##3##3##(2008-4#1)(2009-2#2)
for vertebrobasilar##2##2##(2008-12#1)(2008-7#1)
for very##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
for vesicles##2##2##(1994-5#1)(1997-6#1)
for veterinary##2##2##(1997-7#1)(2011-2#1)
for viability##5##2##(1993-9#1)(1997-7#1)(2008-10#3)
for viewing##2##2##(2008-4#1)(2010-7#1)
for vimentin and##2##3##(2008-11#1)(2010-12#1)
for violence##2##2##(1996-12#1)(2013-1#1)
for viral##13##2##(1994-11#1)(1995-9#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-8#1)(2011-3#1)(2013-1#1)
for virulence against Mi##2##4##(2008-10#2)
for virulence and##4##3##(2008-10#3)(2011-10#1)
for virulence on##4##3##(2008-10#4)
for virulence phenotypes on##2##4##(2008-10#2)
for virulence##22##2##(2008-10#20)(2008-8#1)(2011-10#1)
for virus resistance##4##3##(2008-10#4)
for virus##6##2##(2008-10#5)(2008-9#1)
for virus-resistant cultivars##2##3##(2008-10#2)
for viruses##2##2##(2008-10#2)
for visible##3##2##(2008-10#1)(2008-3#2)
for visual and quantitative analysis of different tastes using##2##9##(2008-10#2)
for visual##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
for visualisation of##3##3##(2008-10#2)(2011-3#1)
for visualisation##4##2##(2008-10#2)(2011-3#2)
for visualization of##2##3##(2008-1#1)(2008-3#1)
for visualizing and##2##3##(2008-4#1)(2012-2#1)
for visualizing##5##2##(2008-4#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)
for vitamin##4##2##(1991-8#1)(1994-3#1)(2008-10#2)
for vitellogenin##2##2##(2008-10#1)(2008-6#1)
for vocational##2##2##(2008-12#1)(2010-9#1)
for voltammetric determination of trace amount of##2##7##(2008-10#2)
for voltammetric##4##2##(2008-10#3)(2010-6#1)
for volume##11##2##(2008-10#10)(2008-3#1)
for volunteer programs##3##3##(1994-2#3)
for vortices##2##2##(2007-11#2)
for vulnerable populations##2##3##(1995-12#2)
for vulnerable##4##2##(1995-12#2)(2013-8#2)
for waiting##3##2##(1991-11#2)(2008-8#1)
for waiver##2##2##(1993-1#1)(2012-3#1)
for waste##3##2##(2008-10#1)(2008-12#2)
for wastewater quality monitoring##3##4##(2008-10#3)
for water disinfection##2##3##(2008-10#2)
for water in##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
for water samples##2##3##(2008-10#2)
for water##23##2##(2008-10#14)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2013-1#1)
for water-dissolved oxygen sensing##2##4##(2008-10#2)
for wavelength##4##2##(2008-10#4)
for wavelengths##2##2##(2008-2#1)(2008-3#1)
for ways in which##2##4##(2008-2#1)(2008-8#1)
for wear##2##2##(2008-8#1)(2013-1#1)
for weight loss##5##3##(2008-10#1)(2008-3#2)(2012-2#1)(2013-8#1)
for weight##6##2##(2008-10#1)(2008-3#2)(2012-2#2)(2013-8#1)
for well-being##2##2##(2008-12#1)(2010-10#1)
for what is##2##3##(2008-12#1)(2010-4#1)
for what it##2##3##(2012-3#2)
for what they##5##3##(1992-12#3)(1995-1#1)(2009-9#1)
for what##12##2##(1992-12#3)(1994-12#1)(1995-1#1)(2008-10#1)(2008-12#1)(2009-4#1)(2009-9#1)(2010-4#1)(2012-3#2)
for wheat powdery mildew resistance in##2##6##(2008-10#2)
for wheat##8##2##(1997-3#1)(2008-10#7)
for which a##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-7#1)
for which it##2##3##(2008-1#1)(2008-10#1)
for which no##3##3##(1997-2#1)(2008-10#2)
for which the name##7##4##(2008-10#7)
for which the##30##3##(1991-5#1)(2008-10#17)(2008-3#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2013-1#1)
for which there are no##2##5##(2008-10#2)
for which there are##3##4##(2008-10#2)(2008-3#1)
for which there is no##4##5##(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
for which there is##7##4##(1996-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
for which there##12##3##(1996-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
for which they are##3##4##(1993-1#1)(1996-12#1)(2008-10#1)
for which they##5##3##(1993-1#1)(1996-12#1)(2008-10#1)(2010-11#1)(2013-7#1)
for which this##3##3##(1990-6#1)(1996-12#1)(2008-10#1)
for which we##2##3##(2008-10#1)(2008-11#1)
for which##114##2##(1990-2#1)(1990-6#1)(1991-5#1)(1992-5#1)(1993-1#1)(1994-3#2)(1995-2#1)(1995-5#1)(1996-12#3)(1996-9#1)(1997-2#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#42)(2008-11#4)(2008-12#1)(2008-3#17)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#2)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#1)
for white crests##2##3##(2008-9#2)
for white wines and 0##2##5##(2008-10#2)
for white wines##4##3##(2008-10#4)
for white##7##2##(2008-10#5)(2008-9#2)
for whole milk##2##3##(2008-10#2)
for whole##7##2##(1993-2#1)(2008-1#1)(2008-10#4)(2008-4#1)
for whom it##2##3##(2012-3#2)
for whom##14##2##(1990-2#1)(1990-6#1)(1992-2#1)(1992-3#2)(1995-5#1)(1996-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-3#2)(2013-1#1)
for widespread##4##2##(2008-10#3)(2008-11#1)
for wild-type and##2##3##(2008-10#1)(2008-8#1)
for wild-type##3##2##(2008-10#2)(2008-8#1)
for with##2##2##(2008-10#1)(2008-9#1)
for within##3##2##(2010-11#1)(2010-12#2)
for within-run##2##2##(2008-10#2)
for women aged 50 to 69 years##2##7##(2012-12#2)
for women and##3##3##(1990-6#1)(1995-6#1)(1997-4#1)
for women in##2##3##(2008-11#1)(2013-1#1)
for women who are##2##4##(1995-9#1)(1997-1#1)
for women with breast cancer##3##5##(1994-3#1)(2008-4#1)(2011-2#1)
for women with##6##3##(1994-3#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
for women##27##2##(1990-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
for women's##2##2##(2008-10#1)(2011-2#1)
for working with##7##3##(2008-10#1)(2008-4#1)(2008-9#3)(2010-3#1)(2010-8#1)
for working##8##2##(2008-10#2)(2008-4#1)(2008-9#3)(2010-3#1)(2010-8#1)
for wound##5##2##(1992-1#1)(2008-9#1)(2012-3#3)
for years in##3##3##(1997-8#1)(2011-2#2)
for years##14##2##(1991-3#1)(1993-2#1)(1994-12#1)(1995-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#3)
for yeast RNA##6##3##(2008-10#6)
for yeast##13##2##(1992-3#1)(1993-6#1)(1993-8#1)(2008-10#6)(2008-7#1)(2010-11#1)(2011-1#1)(2012-3#1)
for you##2##2##(1994-3#2)
for young children##5##3##(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
for young women with breast cancer##2##6##(2013-1#2)
for young women with##3##4##(2008-9#1)(2013-1#2)
for young women##4##3##(2008-11#1)(2008-9#1)(2013-1#2)
for young##15##2##(1990-3#1)(1992-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#3)
for your organization##2##3##(1996-1#1)(1996-2#1)
for your##20##2##(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#2)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1996-1#1)(1996-2#1)(2008-11#1)(2010-9#1)(2011-2#3)(2013-8#1)
for youth who##2##3##(2009-6#1)(2010-1#1)
for youth##8##2##(2008-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2012-2#2)(2013-1#1)
for ytterbium##2##2##(2008-10#2)
for zinc and##2##3##(2008-10#2)
for zinc determination in##3##4##(2008-10#3)
for zinc determination##4##3##(2008-10#4)
for zinc is 0##2##4##(2008-10#2)
for zinc##14##2##(1992-3#1)(2008-10#13)
for##37058##1##(1990-10#5)(1990-11#72)(1990-12#123)(1990-2#101)(1990-3#46)(1990-4#4)(1990-5#96)(1990-6#62)(1990-7#2)(1990-8#76)(1990-9#55)(1991-1#102)(1991-10#6)(1991-11#47)(1991-12#150)(1991-2#170)(1991-3#121)(1991-4#2)(1991-5#95)(1991-6#96)(1991-7#20)(1991-8#33)(1991-9#65)(1992-1#98)(1992-10#23)(1992-11#29)(1992-12#148)(1992-2#133)(1992-3#197)(1992-4#12)(1992-5#40)(1992-6#67)(1992-7#6)(1992-8#25)(1992-9#72)(1993-1#125)(1993-11#46)(1993-12#181)(1993-2#125)(1993-3#173)(1993-5#13)(1993-6#89)(1993-8#136)(1993-9#47)(1994-1#113)(1994-11#98)(1994-12#177)(1994-2#128)(1994-3#143)(1994-5#146)(1994-6#60)(1994-8#100)(1994-9#48)(1995-1#81)(1995-10#3)(1995-11#88)(1995-12#250)(1995-2#242)(1995-3#86)(1995-5#90)(1995-6#152)(1995-8#89)(1995-9#58)(1996-1#115)(1996-10#1)(1996-11#52)(1996-12#212)(1996-2#209)(1996-3#177)(1996-5#91)(1996-6#59)(1996-8#37)(1996-9#32)(1997-1#142)(1997-2#247)(1997-3#190)(1997-4#52)(1997-5#44)(1997-6#86)(1997-7#122)(1997-8#134)(1997-9#13)(2006-5#3)(2006-6#24)(2007-11#62)(2007-12#124)(2007-7#9)(2007-8#28)(2007-9#4)(2008-1#175)(2008-10#13900)(2008-11#2340)(2008-12#618)(2008-2#211)(2008-3#957)(2008-4#518)(2008-5#569)(2008-6#198)(2008-7#672)(2008-8#688)(2008-9#998)(2009-1#45)(2009-10#143)(2009-11#78)(2009-12#123)(2009-2#28)(2009-3#80)(2009-4#44)(2009-5#75)(2009-6#92)(2009-7#144)(2009-8#182)(2009-9#54)(2010-1#122)(2010-10#147)(2010-11#177)(2010-12#210)(2010-2#31)(2010-3#63)(2010-4#109)(2010-5#112)(2010-6#125)(2010-7#191)(2010-8#181)(2010-9#79)(2011-1#149)(2011-10#16)(2011-2#1382)(2011-3#105)(2011-7#28)(2011-8#2)(2011-9#5)(2012-12#286)(2012-2#694)(2012-3#577)(2012-4#10)(2012-5#22)(2012-6#3)(2012-7#2)(2012-8#3)(2012-9#6)(2013-1#1043)(2013-3#4)(2013-7#24)(2013-8#463)
for-profit hospitals##2##2##(1992-12#1)(2008-11#1)
for-profit##11##1##(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#2)(2008-11#3)(2008-5#1)
forH##4##1##(2008-8#4)
forage legume##2##2##(2008-10#2)
forage yield##2##2##(2008-10#2)
forage##14##1##(2008-10#8)(2008-6#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-8#1)
forager distributions##2##2##(2008-9#2)
forager##4##1##(2008-9#4)
foragers in##2##2##(2008-9#2)
foragers##20##1##(2007-12#4)(2008-8#7)(2008-9#9)
foraging and##2##2##(2008-9#2)
foraging bees##2##2##(2007-12#2)
foraging behavior of##2##3##(2008-8#2)
foraging behavior##3##2##(2008-8#3)
foraging in the##2##3##(2008-8#1)(2009-6#1)
foraging in##4##2##(2008-8#2)(2008-9#1)(2009-6#1)
foraging performance##3##2##(2008-9#3)
foraging strategies##3##2##(2008-9#3)
foraging theory##2##2##(2008-9#2)
foraging##52##1##(1995-2#2)(2007-12#2)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#28)(2009-6#2)(2009-8#2)(2012-3#1)
foramen magnum##5##2##(1996-9#2)(2008-7#2)(2011-2#1)
foramen ovale and##2##3##(1996-3#1)(2008-7#1)
foramen ovale in##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
foramen ovale##10##2##(1996-3#1)(2008-11#1)(2008-7#3)(2009-10#1)(2011-2#3)(2012-2#1)
foramen##31##1##(1996-3#1)(1996-9#2)(1997-8#2)(2008-1#1)(2008-11#1)(2008-7#7)(2009-10#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
foraminal##3##1##(1997-8#2)(2011-2#1)
forbidden##5##1##(2007-12#2)(2008-10#1)(2008-11#1)(2011-2#1)
force and the##2##3##(2008-10#1)(2008-11#1)
force and##9##2##(1991-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
force at the##2##3##(2009-7#1)(2013-1#1)
force behind##2##2##(1995-3#1)(2011-2#1)
force between the##3##3##(2008-10#3)
force between##5##2##(2008-10#4)(2008-5#1)
force distribution##2##2##(2008-7#2)
force effects##3##2##(2008-10#1)(2008-3#2)
force field##4##2##(2008-10#1)(2008-4#1)(2012-2#2)
force for the##3##3##(2008-10#2)(2008-11#1)
force for##8##2##(1994-1#1)(2008-10#4)(2008-11#1)(2009-7#1)(2010-1#1)
force in the evolution of##2##5##(2008-10#1)(2008-9#1)
force in the##5##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-9#2)
force is##2##2##(1991-2#1)(1995-2#1)
force like expression##2##3##(2008-11#2)
force mapping of##2##3##(2009-5#2)
force measurements##3##2##(2008-10#1)(2008-5#2)
force microscope has##2##3##(1994-9#1)(2008-4#1)
force microscope##6##2##(1994-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
force microscopy (AFM)##16##3##(2008-10#12)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)
force microscopy and##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
force microscopy##34##2##(1994-9#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
force of 293 cells##2##4##(2008-11#2)
force of FF units##2##4##(2013-8#2)
force of##11##2##(1991-12#1)(1994-9#1)(2008-10#2)(2008-11#2)(2010-5#1)(2012-3#2)(2013-8#2)
force on##3##2##(1994-12#1)(1995-5#1)(2008-5#1)
force plate##2##2##(2010-12#1)(2010-9#1)
force to##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
force will##2##2##(1991-1#1)(2008-11#1)
force without##2##2##(2008-10#2)
force##195##1##(1990-2#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1996-5#3)(1997-2#8)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#47)(2008-11#14)(2008-3#4)(2008-4#3)(2008-5#12)(2008-7#7)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#5)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-2#9)(2012-3#3)(2013-1#11)(2013-8#4)
force&quot##2##1##(1991-3#1)(2008-8#1)
force)##2##1##(1994-8#1)(2008-10#1)
force-frequency##2##1##(2013-8#2)
force/torque measurements##2##2##(2013-1#2)
force/torque##3##1##(2013-1#3)
forced and##2##2##(1995-5#1)(2012-3#1)
forced expiratory volume##2##3##(2008-7#1)(2012-3#1)
forced expiratory##6##2##(1991-2#1)(2008-1#2)(2008-7#2)(2012-3#1)
forced expression of##3##3##(2008-11#1)(2010-11#1)(2011-2#1)
forced into a##2##3##(2008-2#1)(2008-7#1)
forced swim##4##2##(2008-11#4)
forced swimming##2##2##(1990-5#1)(2013-1#1)
forced to##11##2##(1992-1#1)(1994-2#1)(1995-1#1)(1996-5#3)(1996-6#1)(2008-10#2)(2008-7#1)(2008-9#1)
forced treatment of##2##3##(1990-2#1)(2008-11#1)
forced vital capacity (FVC)##3##4##(1997-3#1)(2008-1#1)(2012-2#1)
forced##44##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-5#4)(1996-6#1)(1997-2#1)(1997-3#1)(2008-1#3)(2008-10#3)(2008-11#6)(2008-2#1)(2008-7#4)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
forceful##3##1##(1992-9#1)(2010-1#1)(2013-1#1)
forceps##4##1##(1992-12#1)(2008-10#1)(2010-12#1)(2013-8#1)
forces acting on##3##3##(1997-2#1)(2012-3#1)(2013-1#1)
forces acting##4##2##(1997-2#1)(2007-12#1)(2012-3#1)(2013-1#1)
forces and##14##2##(1994-12#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
forces are##4##2##(1997-1#1)(2008-8#1)(2010-11#1)(2013-8#1)
forces at##3##2##(1997-3#1)(2008-9#1)(2009-6#1)
forces between##2##2##(1994-9#1)(2008-4#1)
forces in##2##2##(1993-2#1)(2011-2#1)
forces is##2##2##(2007-8#1)(2012-2#1)
forces of##4##2##(1992-9#1)(1997-2#1)(2009-8#1)(2012-2#1)
forces shaping the##2##3##(2008-8#1)(2009-6#1)
forces should##2##2##(2008-10#1)(2012-2#1)
forces that##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#2)(2010-4#1)(2013-8#1)
forces the##3##2##(2007-12#1)(2008-7#1)(2009-4#1)
forces##101##1##(1990-8#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-2#5)(1997-3#1)(2007-12#5)(2007-8#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-2#3)(2012-3#5)(2013-1#10)(2013-8#4)
forcing the##4##2##(1994-5#1)(1997-8#1)(2008-10#2)
forcing##12##1##(1990-2#1)(1992-1#2)(1993-2#1)(1994-5#1)(1997-8#1)(2008-10#3)(2008-8#3)
fore##2##1##(2008-11#1)(2008-12#1)
forearm muscles in##2##3##(2008-9#2)
forearm to cigarette smoke##2##4##(2008-5#2)
forearm##35##1##(1994-6#1)(2008-10#1)(2008-5#15)(2008-9#9)(2011-2#6)(2012-3#2)(2013-1#1)
forearms##5##1##(2008-10#1)(2008-5#2)(2008-7#1)(2010-6#1)
forebrain and##2##2##(1994-8#1)(2008-7#1)
forebrain bundle##4##2##(1991-2#2)(1992-12#1)(1996-2#1)
forebrain ischemia##5##2##(1990-5#2)(1996-12#3)
forebrain regions##2##2##(1993-8#2)
forebrain##24##1##(1990-5#2)(1991-12#2)(1991-2#2)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#2)(1994-8#2)(1995-11#1)(1996-12#3)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#3)
forecast models##2##2##(2008-10#1)(2008-3#1)
forecast##11##1##(1991-12#1)(1993-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2009-8#1)(2012-12#1)(2013-8#2)
forecasters##3##1##(2008-10#3)
forecasting and##2##2##(1993-3#1)(2008-10#1)
forecasting elemental contents in geological samples##2##6##(2013-8#2)
forecasting model for##2##3##(2008-10#2)
forecasting model##3##2##(2008-10#3)
forecasting system for##4##3##(2008-10#4)
forecasting system##6##2##(2008-10#6)
forecasting systems##2##2##(2008-10#2)
forecasting##26##1##(1993-3#1)(1994-12#3)(1994-9#1)(2008-10#15)(2008-11#3)(2008-9#1)(2013-8#2)
forecasts of##2##2##(2008-10#1)(2008-11#1)
forecasts the##3##2##(1993-1#1)(2008-11#1)(2009-10#1)
forecasts##9##1##(1993-1#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-10#1)
foregone##3##1##(1994-1#2)(2008-11#1)
foregut##8##1##(2007-12#4)(2008-10#2)(2011-2#2)
forehand##3##1##(2011-2#3)
forehead##11##1##(1992-2#1)(1993-2#1)(2008-5#6)(2010-1#1)(2010-6#1)(2012-3#1)
foreign DNA into##2##3##(2008-11#1)(2008-8#1)
foreign DNA##4##2##(2008-11#2)(2008-8#2)
foreign and##2##2##(1994-2#1)(2008-11#1)
foreign bodies##3##2##(2008-12#1)(2009-12#1)(2013-1#1)
foreign body##20##2##(1990-3#3)(1993-6#1)(2008-12#4)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#5)
foreign gene##8##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-8#1)
foreign ions are##2##3##(2008-10#2)
foreign ions have been##3##4##(2008-10#3)
foreign ions have##4##3##(2008-10#4)
foreign ions on the determination of##2##6##(2008-10#2)
foreign ions on the##4##4##(2008-10#4)
foreign ions on##6##3##(2008-10#6)
foreign ions was##2##3##(2008-10#2)
foreign ions were also##2##4##(2008-10#2)
foreign ions were##4##3##(2008-10#4)
foreign ions##35##2##(2008-10#35)
foreign material##3##2##(1991-6#1)(1992-12#1)(2008-11#1)
foreign parasites##2##2##(1997-7#2)
foreign protein##2##2##(2008-11#1)(2008-7#1)
foreign songs recorded at##4##4##(2008-8#4)
foreign songs##5##2##(2008-8#5)
foreign species##3##2##(2008-10#3)
foreign substances was##2##3##(2008-10#2)
foreign substances##5##2##(2008-10#5)
foreign##135##1##(1990-3#3)(1991-6#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-6#2)(1997-7#2)(1997-8#2)(2008-10#53)(2008-11#14)(2008-12#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#13)(2008-9#2)(2009-12#2)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
foreign-body response##2##2##(2011-2#2)
foreign-body##3##1##(2011-2#2)(2012-12#1)
foreign-born##6##1##(2011-2#6)
foreigners and##2##2##(1990-3#1)(2008-12#1)
foreigners##4##1##(1990-3#2)(1997-6#1)(2008-12#1)
forelimb lameness##3##2##(2012-3#1)(2013-8#2)
forelimb##9##1##(1992-12#3)(1994-8#1)(2012-2#1)(2012-3#1)(2013-8#3)
forelimbs##7##1##(1992-12#2)(1993-3#1)(1996-6#1)(2011-2#2)(2012-3#1)
foremost##4##1##(1990-11#1)(1995-11#1)(2008-8#1)(2013-8#1)
forensic DNA##3##2##(2008-12#3)
forensic STR profiling##2##3##(2008-12#2)
forensic analysis##4##2##(2008-10#3)(2008-12#1)
forensic and##2##2##(2008-12#1)(2013-1#1)
forensic applications in the##2##4##(2008-10#1)(2008-12#1)
forensic casework##2##2##(2008-10#1)(2008-12#1)
forensic chemistry##3##2##(2008-10#1)(2010-7#2)
forensic chemists##2##2##(2008-10#2)
forensic drug analysis##2##3##(2008-10#2)
forensic interview##2##2##(2011-2#2)
forensic investigations##5##2##(1995-11#1)(2008-10#1)(2008-12#1)(2012-3#2)
forensic psychiatry##6##2##(2011-2#6)
forensic samples##3##2##(2008-10#3)
forensic science##2##2##(2008-10#1)(2008-12#1)
forensic toxicology##2##2##(1997-2#1)(2008-10#1)
forensic trace evidence##2##3##(2008-10#2)
forensic##71##1##(1993-2#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#26)(2008-12#24)(2010-7#3)(2011-2#10)(2012-3#2)(2013-1#1)
forerunners of Colombian independence's thoughts##2##5##(2011-2#2)
forerunners of##3##2##(2011-2#3)
forerunners##4##1##(2011-2#4)
foresee##4##1##(1991-6#1)(2010-6#1)(2012-12#1)(2013-1#1)
foreseeability##2##1##(1991-1#2)
foreseeable##5##1##(1996-1#1)(2007-12#1)(2008-2#1)(2008-8#1)(2012-2#1)
foreseen##4##1##(2008-10#1)(2008-5#1)(2012-2#2)
foreshadowed##2##1##(2008-10#1)(2011-2#1)
foreskin##2##1##(2008-10#1)(2008-11#1)
forest and##2##2##(2008-9#1)(2011-2#1)
forest cover##4##2##(1995-3#2)(2009-8#2)
forest diseases##2##2##(2008-10#2)
forest ecosystem##10##2##(2008-10#1)(2008-11#1)(2008-9#7)(2012-5#1)
forest ecosystems##3##2##(2008-10#3)
forest fragmentation##2##2##(1995-3#2)
forest in##2##2##(2008-9#1)(2012-5#1)
forest pathologists##2##2##(2008-10#2)
forest pathology##7##2##(2008-10#7)
forest soil##3##2##(2008-11#1)(2011-2#1)(2012-9#1)
forest soils##4##2##(2008-11#1)(2008-9#2)(2012-6#1)
forest to##2##2##(2008-10#1)(2008-8#1)
forest trees##7##2##(2008-10#1)(2008-12#1)(2008-8#4)(2010-4#1)
forest##110##1##(1995-12#1)(1995-3#6)(2008-10#39)(2008-11#4)(2008-12#2)(2008-8#17)(2008-9#18)(2009-8#5)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#5)(2012-3#1)(2012-5#3)(2012-6#1)(2012-9#2)(2013-1#2)
forested##2##1##(2008-10#2)
forestry##2##1##(2008-10#1)(2008-11#1)
forests and##5##2##(2008-10#3)(2010-4#1)(2011-2#1)
forests in##4##2##(2008-10#3)(2012-9#1)
forests of##3##2##(1996-11#1)(2010-4#1)(2012-12#1)
forests##31##1##(1990-8#1)(1996-11#1)(2008-10#17)(2008-8#3)(2008-9#2)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-9#1)
forge##2##1##(1993-5#1)(2008-11#1)
forgery##2##1##(1996-5#1)(2008-10#1)
forget##3##1##(1991-2#1)(2012-12#1)(2013-8#1)
forgetting##3##1##(1997-4#1)(2009-10#2)
forging##2##1##(2008-12#2)
forgotten##10##1##(1991-12#1)(1992-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
fork##15##1##(1991-12#3)(1992-3#5)(2007-12#1)(2010-8#1)(2011-2#1)(2012-3#4)
forked##4##1##(1995-6#2)(2010-8#1)(2011-2#1)
form (P##2##2##(2008-10#2)
form A##2##2##(1997-1#2)
form I plasmid##2##3##(2008-9#2)
form I##5##2##(2008-8#3)(2008-9#2)
form II##3##2##(1992-3#1)(2008-8#2)
form a &quot##3##3##(2008-1#1)(2008-8#1)(2009-10#1)
form a colored complex with##2##5##(2008-10#2)
form a colored complex##4##4##(2008-10#4)
form a colored##9##3##(2008-10#9)
form a compact##2##3##(2008-10#2)
form a complex with##3##4##(1995-6#1)(2008-10#1)(2008-8#1)
form a complex##5##3##(1995-6#1)(2008-10#2)(2008-8#1)(2008-9#1)
form a fluorescent##2##3##(2008-10#2)
form a large##3##3##(2008-10#3)
form a long##2##3##(1994-12#1)(2008-5#1)
form a monophyletic##3##3##(2008-10#2)(2010-8#1)
form a much##2##3##(1994-3#1)(2008-10#1)
form a stable##3##3##(1997-7#1)(2008-10#1)(2008-4#1)
form a ternary complex with##2##5##(2008-10#2)
form a##138##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-5#2)(1992-9#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-2#3)(1995-6#2)(1997-7#1)(2007-12#5)(2008-1#1)(2008-10#78)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-8#3)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
form aggregates##2##2##(2008-11#1)(2011-2#1)
form an##15##2##(2008-10#9)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
form and function##3##3##(2008-9#1)(2009-8#1)(2010-6#1)
form and the##6##3##(2008-10#3)(2008-3#1)(2011-2#1)(2013-1#1)
form and##28##2##(1992-3#1)(1992-6#1)(1995-2#1)(1996-6#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#2)
form are##2##2##(2008-10#1)(2008-4#1)
form as well##2##3##(2008-10#1)(2008-7#1)
form as##4##2##(1990-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
form at##2##2##(1990-2#1)(2011-2#1)
form by the##2##3##(1992-8#1)(2008-9#1)
form by##7##2##(1992-8#1)(1995-8#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-2#1)
form complexes with##7##3##(2008-10#5)(2009-8#1)(2010-11#1)
form complexes##8##2##(2008-10#6)(2009-8#1)(2010-11#1)
form for each##2##3##(2008-12#1)(2008-5#1)
form for the##6##3##(1990-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-9#1)
form for##13##2##(1990-12#1)(1995-12#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-4#1)(2012-3#1)
form from##3##2##(1994-5#1)(2011-2#2)
form in the##6##3##(1990-11#1)(1990-2#1)(1992-6#1)(1997-3#1)(2008-10#2)
form in##15##2##(1990-11#2)(1990-2#1)(1992-6#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
form insoluble##2##2##(2008-10#2)
form into##4##2##(1995-11#1)(2008-5#1)(2009-8#1)(2012-2#1)
form is##6##2##(1990-5#1)(2008-10#1)(2008-11#2)(2009-5#1)(2011-2#1)
form large##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
form liposomes##2##2##(1990-2#2)
form more##2##2##(2008-10#1)(2008-12#1)
form of Al##2##3##(2008-10#2)
form of DNA##2##3##(1997-7#1)(2008-10#1)
form of RNA polymerase##2##4##(1994-3#1)(2008-9#1)
form of a##20##3##(1991-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
form of acute##3##3##(1994-9#2)(2009-6#1)
form of an##6##3##(1994-5#1)(2008-10#3)(2008-11#1)(2010-6#1)
form of angioedema of the##2##5##(2013-1#2)
form of angioedema##3##3##(2013-1#3)
form of cell death##4##4##(1994-11#1)(2008-11#1)(2008-7#1)(2009-3#1)
form of cooperative##2##3##(2008-7#1)(2008-9#1)
form of density dependence##2##4##(2008-8#2)
form of inorganic##2##3##(2008-10#2)
form of oxygen##2##3##(2012-3#1)(2013-1#1)
form of surgery##2##3##(1990-9#1)(1993-6#1)
form of synaptic homeostasis##2##4##(2009-9#2)
form of the binary power law with##2##7##(2008-10#2)
form of the enzyme##4##4##(1994-11#1)(1994-5#1)(1995-8#1)(2009-7#1)
form of the fungus##3##4##(2008-10#3)
form of the model##2##4##(2008-8#1)(2013-8#1)
form of the receptor##2##4##(1990-11#1)(1995-11#1)
form of the##58##3##(1990-10#1)(1990-11#2)(1991-5#1)(1994-11#3)(1994-2#1)(1994-5#2)(1995-11#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
form of therapy##2##3##(1992-11#1)(1993-12#1)
form of transforming growth factor-beta 1##2##6##(1990-2#2)
form of treatment for##2##4##(2008-7#1)(2013-1#1)
form of treatment is##2##4##(1993-6#1)(1997-2#1)
form of treatment##4##3##(1993-6#1)(1997-2#1)(2008-7#1)(2013-1#1)
form of vitamin##2##3##(2012-12#1)(2013-1#1)
form of##353##2##(1990-10#1)(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#5)(1992-6#1)(1993-12#2)(1993-2#1)(1993-6#4)(1993-8#3)(1994-1#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#3)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#7)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#101)(2008-11#24)(2008-12#4)(2008-3#3)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#13)(2008-8#12)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#4)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#3)(2010-10#2)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#5)(2012-2#7)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#4)
form on##2##2##(1996-11#1)(2010-10#1)
form or##5##2##(1996-1#1)(2008-10#3)(2009-8#1)
form particles that##2##3##(1994-12#2)
form particles##3##2##(1994-12#2)(1995-5#1)
form reported##2##2##(2008-9#1)(2010-6#1)
form small##2##2##(1994-5#1)(2009-8#1)
form spheroids##3##2##(2008-11#3)
form stable##8##2##(1993-6#1)(2008-10#5)(2008-8#1)(2010-11#1)
form synapses with##3##3##(2011-2#3)
form that is##2##3##(1992-8#1)(2008-12#1)
form that##5##2##(1991-5#1)(1992-8#1)(1996-12#1)(2008-12#1)(2010-6#1)
form the basis for the##2##5##(1995-2#1)(2012-3#1)
form the basis for##5##4##(1995-2#1)(1996-2#1)(2008-10#1)(2009-5#1)(2012-3#1)
form the basis of##3##4##(1996-2#1)(2008-10#1)(2011-2#1)
form the basis##8##3##(1995-2#1)(1996-2#2)(2008-10#2)(2009-5#1)(2011-2#1)(2012-3#1)
form the core of##2##4##(1991-2#1)(2012-2#1)
form the##51##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-2#2)(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#21)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)
form their##2##2##(1995-2#1)(2008-10#1)
form two##7##2##(1994-5#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2010-10#1)
form two-dimensional##2##2##(2008-3#1)(2008-8#1)
form volatile hydrides##2##3##(2008-10#2)
form volatile##3##2##(2008-10#3)
form was also##2##3##(2008-10#1)(2011-1#1)
form was##9##2##(1990-9#1)(1995-8#3)(2008-10#4)(2011-1#1)
form were##4##2##(1990-9#1)(1991-9#1)(2008-10#1)(2008-8#1)
form when##2##2##(2008-10#2)
form which##2##2##(1992-6#1)(2008-3#1)
form with E(m##2##3##(2008-10#2)
form with##11##2##(1991-5#1)(2008-10#6)(2008-9#1)(2009-5#1)(2013-1#2)
form within##2##2##(2008-11#1)(2010-7#1)
form##1075##1##(1990-10#1)(1990-11#8)(1990-12#2)(1990-2#10)(1990-3#2)(1990-5#10)(1990-8#4)(1990-9#5)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-5#9)(1991-6#2)(1991-7#1)(1991-9#8)(1992-1#2)(1992-10#4)(1992-11#2)(1992-12#5)(1992-3#3)(1992-6#9)(1992-8#3)(1992-9#2)(1993-1#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#6)(1994-1#2)(1994-11#8)(1994-12#7)(1994-2#1)(1994-3#3)(1994-5#11)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#8)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#10)(1996-1#1)(1996-11#2)(1996-12#5)(1996-2#6)(1996-3#3)(1996-5#3)(1996-6#2)(1996-8#2)(1997-1#7)(1997-2#8)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#4)(2007-11#1)(2007-12#14)(2008-1#2)(2008-10#384)(2008-11#54)(2008-12#17)(2008-2#3)(2008-3#12)(2008-4#15)(2008-5#25)(2008-6#10)(2008-7#25)(2008-8#38)(2008-9#33)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#12)(2009-9#5)(2010-10#6)(2010-11#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#6)(2010-6#5)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#28)(2011-3#1)(2012-12#9)(2012-2#29)(2012-3#10)(2013-1#28)(2013-7#2)(2013-8#6)
form)##5##1##(1991-3#1)(2008-10#3)(2012-12#1)
forma specialis##4##2##(2008-10#4)
formae speciales##9##2##(2008-10#9)
formal and informal##2##3##(1992-12#2)
formal and##4##2##(1992-12#2)(1997-1#1)(2010-4#1)
formal education##4##2##(1994-3#1)(2008-11#1)(2009-12#2)
formal educational##2##2##(2008-11#2)
formal evaluation##2##2##(1991-12#1)(2008-10#1)
formal genetic##2##2##(2008-12#1)(2008-8#1)
formal lectures##2##2##(1994-12#2)
formal potential of##5##3##(2008-10#5)
formal potential##13##2##(2008-10#13)
formal potentials##3##2##(2008-10#3)
formal training##4##2##(1994-12#1)(2008-11#1)(2008-6#1)(2010-11#1)
formal##79##1##(1990-12#1)(1991-1#2)(1991-12#1)(1992-12#2)(1992-3#1)(1994-1#1)(1994-12#8)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#5)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#23)(2008-11#8)(2008-12#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#4)(2009-5#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
formaldehyde and acetaldehyde##4##3##(2008-10#1)(2008-11#3)
formaldehyde and##10##2##(2008-10#7)(2008-11#3)
formaldehyde degradation##2##2##(2008-7#2)
formaldehyde in air##6##3##(2008-10#6)
formaldehyde in shiitake mushroom##3##4##(2008-10#3)
formaldehyde in the air##2##4##(2008-10#2)
formaldehyde in the##5##3##(2008-10#4)(2008-7#1)
formaldehyde in##26##2##(2008-10#23)(2008-7#3)
formaldehyde to##4##2##(2008-10#1)(2008-7#3)
formaldehyde was##3##2##(2008-10#2)(2008-7#1)
formaldehyde with##2##2##(2008-10#1)(2008-7#1)
formaldehyde##84##1##(1991-3#1)(1995-2#1)(2008-10#59)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#15)(2011-2#1)
formalin solution##2##2##(1996-12#2)
formalin##6##1##(1991-2#1)(1996-12#5)
formalin-fixed##4##1##(1991-7#1)(1997-3#1)(2008-11#1)(2009-8#1)
formalism for WM spectrometry##2##4##(2008-3#2)
formalism for##4##2##(1993-5#1)(2008-3#2)(2013-1#1)
formalism##21##1##(1993-5#1)(1997-2#2)(2008-10#3)(2008-2#1)(2008-3#10)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
formalize##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
formalized##4##1##(1994-12#1)(1994-2#1)(1996-3#2)
formally##15##1##(1992-2#1)(1994-12#1)(1996-6#2)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-4#1)(2010-7#1)(2013-1#2)
formamide##8##1##(1992-8#1)(2008-10#6)(2008-5#1)
format and the##2##3##(2008-10#1)(2008-9#1)
format and##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
format as well as##2##4##(2011-1#1)(2013-1#1)
format as##3##2##(2011-1#1)(2012-2#1)(2013-1#1)
format for##9##2##(2008-10#7)(2008-11#1)(2011-2#1)
format is##2##2##(2008-3#1)(2012-3#1)
format of##5##2##(1990-2#1)(1995-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
format that##4##2##(1994-2#1)(2008-10#2)(2010-10#1)
format using##3##2##(2008-10#1)(2008-9#1)(2010-6#1)
format##73##1##(1990-2#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-2#1)(2008-10#30)(2008-11#9)(2008-12#3)(2008-3#2)(2008-4#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#1)
format)##3##1##(2010-10#1)(2010-8#2)
formate and##2##2##(2008-10#1)(2011-1#1)
formate##10##1##(1992-10#2)(1996-5#1)(2008-10#5)(2011-1#2)
formation and functional##2##3##(2008-11#1)(2008-9#1)
formation and maturation##2##3##(2009-9#1)(2012-2#1)
formation and provides##2##3##(1995-6#1)(2008-9#1)
formation and stabilization of##3##4##(1994-5#1)(2008-10#1)(2009-8#1)
formation and stabilization##4##3##(1994-5#1)(2008-10#2)(2009-8#1)
formation and structure of the##2##5##(2008-10#1)(2008-7#1)
formation and subsequent##2##3##(2008-10#1)(2012-2#1)
formation and the##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
formation and to##3##3##(2008-10#2)(2008-7#1)
formation and##77##2##(1991-1#1)(1991-5#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(2008-10#24)(2008-11#5)(2008-3#3)(2008-5#1)(2008-7#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#3)(2009-9#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
formation and/or##2##2##(2008-5#1)(2008-7#1)
formation are##4##2##(1997-6#1)(2008-12#1)(2008-3#1)(2009-10#1)
formation as a##2##3##(2008-10#1)(2009-6#1)
formation as##5##2##(1994-5#1)(2008-10#2)(2008-12#1)(2009-6#1)
formation at an early stage##2##5##(2008-10#1)(2010-3#1)
formation at the##2##3##(2008-11#1)(2008-3#1)
formation at various##2##3##(2006-6#1)(2011-2#1)
formation at##13##2##(1993-8#2)(2006-6#2)(2008-10#3)(2008-11#1)(2008-3#1)(2009-12#1)(2010-3#1)(2011-2#2)
formation between the##2##3##(2008-10#1)(2008-8#1)
formation between##18##2##(1993-8#1)(2008-10#15)(2008-7#1)(2008-8#1)
formation but##2##2##(2010-6#1)(2011-2#1)
formation by the##3##3##(2008-10#3)
formation by##14##2##(1991-5#1)(1993-3#1)(1993-8#1)(1994-8#1)(1996-2#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-1#1)(2012-2#1)
formation can##2##2##(2009-8#1)(2011-2#1)
formation constant of##8##3##(2008-10#8)
formation constant values##2##3##(2008-10#2)
formation constant##16##2##(2008-10#16)
formation constants are##3##3##(2008-10#3)
formation constants of the resulting##3##5##(2008-10#3)
formation constants of the##7##4##(2008-10#7)
formation constants of##17##3##(2008-10#17)
formation constants were##2##3##(2008-10#2)
formation constants##33##2##(2008-10#33)
formation could be##2##3##(1992-9#1)(2013-1#1)
formation during##8##2##(2008-10#4)(2008-11#2)(2009-8#2)
formation enthalpies##2##2##(2008-10#2)
formation equilibria of some beta-amino-alcohols with lead(II) and cadmium(II)##2##9##(2008-10#2)
formation equilibria##6##2##(2008-10#6)
formation following##4##2##(1991-1#1)(2008-11#2)(2012-2#1)
formation for##7##2##(1997-1#1)(2008-10#4)(2008-11#1)(2013-1#1)
formation from##7##2##(1996-5#1)(2008-10#1)(2008-11#3)(2008-9#1)(2013-1#1)
formation has been##4##3##(1990-11#1)(1997-8#1)(2008-10#1)(2009-8#1)
formation has##5##2##(1990-11#1)(1997-8#1)(2008-10#2)(2009-8#1)
formation in both##2##3##(1992-2#1)(2008-11#1)
formation in human##3##3##(1993-8#1)(1994-8#1)(1995-10#1)
formation in isolated##2##3##(1991-3#1)(2008-11#1)
formation in response to##4##4##(1992-8#2)(1994-8#1)(2008-10#1)
formation in the##17##3##(1991-3#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2013-8#1)
formation in vivo##3##3##(1993-9#1)(1994-3#1)(2013-1#1)
formation in whole blood##4##4##(2006-6#3)(2013-1#1)
formation in winter and spring barley##2##6##(2008-10#2)
formation in##101##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-5#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-8#1)(1993-9#1)(1994-3#5)(1994-5#2)(1994-8#4)(1995-10#2)(1995-12#3)(1995-2#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-6#4)(2007-12#2)(2007-8#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-12#3)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-4#1)(2013-1#3)(2013-8#1)
formation independently of##2##3##(1994-3#1)(2006-6#1)
formation induced by##2##3##(1994-6#1)(2013-8#1)
formation into##2##2##(1991-12#1)(2008-10#1)
formation is a##2##3##(1993-8#1)(2013-8#1)
formation is also##2##3##(2008-10#1)(2011-2#1)
formation is##23##2##(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-8#1)(2006-6#1)(2008-10#6)(2008-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
formation of 1##3##3##(1994-3#1)(2008-10#2)
formation of DNA##2##3##(1993-8#1)(2008-11#1)
formation of Fe(III) and Fe(II) chelates with##2##7##(2008-10#2)
formation of GS and##3##4##(2008-10#3)
formation of a 1##4##4##(2008-10#4)
formation of a complex##4##4##(1995-2#1)(2008-10#2)(2008-4#1)
formation of a high-molecular##2##4##(2008-10#2)
formation of a single##2##4##(2008-10#1)(2011-2#1)
formation of a specified##2##4##(2008-3#2)
formation of a ternary complex##2##5##(1994-5#1)(2008-10#1)
formation of a##60##3##(1991-3#1)(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#1)(1995-2#2)(1995-6#1)(2007-12#1)(2008-10#34)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)
formation of actin waves during regeneration after axonal lesion##2##9##(2012-2#2)
formation of actin##3##3##(2008-9#1)(2012-2#2)
formation of all##2##3##(1993-11#1)(2008-7#1)
formation of an##12##3##(1992-9#1)(1993-8#1)(1994-5#1)(2007-12#1)(2008-10#7)(2009-8#1)
formation of both##5##3##(1991-3#1)(2006-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
formation of different##3##3##(2008-10#3)
formation of gellike##2##3##(2008-11#2)
formation of human##2##3##(1990-2#1)(1995-12#1)
formation of inositol##2##3##(1993-8#1)(1995-11#1)
formation of intracellular##2##3##(2008-11#1)(2008-7#1)
formation of ion pairs##2##4##(2008-10#2)
formation of ion##3##3##(2008-10#2)(2008-9#1)
formation of iron##2##3##(2008-10#2)
formation of mineralized##2##3##(2008-11#1)(2013-1#1)
formation of new##4##3##(1990-11#1)(2008-9#1)(2012-12#1)(2013-8#1)
formation of papillae##3##3##(2008-10#3)
formation of reactive oxygen species##4##5##(1992-12#1)(2009-8#1)(2010-1#1)(2010-10#1)
formation of reactive##7##3##(1992-12#1)(2008-11#3)(2009-8#1)(2010-1#1)(2010-10#1)
formation of sclerotia##2##3##(2008-10#2)
formation of secondary##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
formation of simple##2##3##(2008-3#1)(2010-9#1)
formation of superoxide anion##2##4##(1995-6#1)(2008-10#1)
formation of the catalytic##2##4##(1997-7#1)(2008-10#1)
formation of the corresponding##2##4##(1996-5#1)(2009-10#1)
formation of the ion association complex##3##6##(2008-10#3)
formation of the ion##4##4##(2008-10#4)
formation of the##75##3##(1990-5#1)(1991-3#2)(1991-5#1)(1992-10#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-5#4)(1997-7#2)(1997-8#1)(2006-6#1)(2008-10#37)(2008-12#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#2)(2009-8#1)(2010-7#1)(2011-2#3)(2012-5#1)
formation of these##6##3##(1991-5#2)(1995-2#1)(1996-5#1)(2008-10#2)
formation of thromboxane by##2##4##(1993-3#2)
formation of uniform##2##3##(2008-10#1)(2009-12#1)
formation of##507##2##(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-5#5)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#5)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#7)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#6)(1994-5#5)(1994-8#7)(1995-11#2)(1995-12#5)(1995-2#6)(1995-6#4)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#12)(1997-1#4)(1997-3#1)(1997-7#2)(1997-8#3)(2006-6#2)(2007-11#1)(2007-12#3)(2008-10#226)(2008-11#26)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#12)(2008-8#7)(2008-9#10)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#17)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#8)(2013-8#2)
formation on the##3##3##(2008-10#2)(2008-9#1)
formation on##13##2##(1990-11#1)(1990-9#1)(1991-9#1)(1993-12#1)(1994-11#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#2)
formation or##7##2##(1990-7#1)(1992-3#2)(1995-9#1)(2006-6#1)(2009-8#1)(2013-1#1)
formation patterns##2##2##(2008-7#1)(2009-10#1)
formation process##4##2##(1993-8#1)(2008-10#2)(2008-3#1)
formation reaction##6##2##(2008-10#6)
formation reactions of##2##3##(2008-10#2)
formation reactions##3##2##(2008-10#3)
formation required##2##2##(1995-2#1)(2008-10#1)
formation that##2##2##(2007-12#1)(2008-10#1)
formation to be##2##3##(2011-1#1)(2013-8#1)
formation to##4##2##(2009-6#1)(2009-8#1)(2011-1#1)(2013-8#1)
formation was inhibited by##2##4##(1993-8#1)(2008-10#1)
formation was inhibited##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
formation was observed##4##3##(1994-11#1)(2008-10#2)(2008-11#1)
formation was##35##2##(1991-3#1)(1991-5#2)(1993-1#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-2#1)(1995-8#1)(2006-6#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
formation were##7##2##(1994-8#1)(2008-10#5)(2008-7#1)
formation when the##2##3##(1995-8#1)(2008-10#1)
formation when##7##2##(1992-6#1)(1995-11#1)(1995-8#1)(2008-10#3)(2013-1#1)
formation which##2##2##(1994-3#1)(2009-8#1)
formation with the##2##3##(1992-9#1)(2008-11#1)
formation with##14##2##(1992-9#1)(1994-2#1)(1995-6#1)(1997-7#1)(2008-10#8)(2008-11#1)(2011-2#1)
formation##1268##1##(1990-11#5)(1990-12#3)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#5)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#11)(1991-5#16)(1991-6#1)(1991-9#3)(1992-1#4)(1992-10#1)(1992-12#6)(1992-2#1)(1992-3#11)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#2)(1992-9#6)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#3)(1993-8#19)(1993-9#2)(1994-1#1)(1994-11#6)(1994-12#4)(1994-2#4)(1994-3#14)(1994-5#10)(1994-6#3)(1994-8#18)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#10)(1995-2#9)(1995-3#2)(1995-6#10)(1995-8#5)(1995-9#3)(1996-12#6)(1996-2#3)(1996-3#2)(1996-5#14)(1997-1#6)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#6)(2006-6#23)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#506)(2008-11#67)(2008-12#12)(2008-3#15)(2008-4#1)(2008-5#21)(2008-6#7)(2008-7#36)(2008-8#13)(2008-9#24)(2009-10#11)(2009-11#1)(2009-12#9)(2009-3#1)(2009-4#1)(2009-6#8)(2009-7#8)(2009-8#31)(2009-9#3)(2010-1#5)(2010-10#4)(2010-11#4)(2010-12#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#51)(2011-3#3)(2012-12#3)(2012-2#21)(2012-3#6)(2012-4#1)(2012-5#1)(2013-1#31)(2013-7#1)(2013-8#13)
formation)##4##1##(2008-10#2)(2008-11#2)
formations of##2##2##(2008-10#1)(2011-2#1)
formations##5##1##(2008-10#1)(2008-11#1)(2011-2#3)
formative##5##1##(2008-11#1)(2009-6#1)(2010-6#1)(2013-1#2)
formats and##3##2##(1991-3#1)(2008-10#1)(2010-10#1)
formats that##2##2##(2008-11#1)(2013-1#1)
formats were##2##2##(2008-10#1)(2012-2#1)
formats##26##1##(1991-3#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#4)(2008-9#1)(2010-10#5)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
formatted##2##1##(2008-10#1)(2009-2#1)
formazan##3##1##(2008-10#1)(2008-11#2)
formed 1##2##2##(2008-10#2)
formed a basis for##2##4##(2008-10#2)
formed a strongly supported##2##4##(2008-10#1)(2008-9#1)
formed a well-supported##2##3##(2008-10#2)
formed a##34##2##(1995-12#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
formed after the##2##3##(2008-10#1)(2009-9#1)
formed after##6##2##(1991-3#1)(2008-10#3)(2008-11#1)(2009-9#1)
formed an##3##2##(2008-10#2)(2013-1#1)
formed and##9##2##(1993-1#1)(1997-7#1)(2008-10#6)(2008-12#1)
formed appressoria##2##2##(2008-10#2)
formed are##3##2##(2008-10#3)
formed as a result of##2##5##(2008-10#2)
formed as a##3##3##(2008-10#3)
formed as##6##2##(2008-10#5)(2011-2#1)
formed at pH##2##3##(2008-10#2)
formed at the##10##3##(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)
formed at##20##2##(1997-3#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-7#1)(2009-7#1)(2010-11#2)
formed between the##4##3##(2008-10#3)(2008-4#1)
formed between##28##2##(1994-5#3)(2008-10#23)(2008-4#1)(2009-8#1)
formed by a##6##3##(2007-12#2)(2008-10#2)(2011-2#1)(2013-1#1)
formed by addition of##2##4##(2008-10#2)
formed by coupling##2##3##(2008-10#2)
formed by rat hepatic microsomes##2##5##(2011-1#2)
formed by sodium##2##3##(2008-10#2)
formed by the##26##3##(1990-5#1)(1991-3#1)(1992-11#1)(1992-4#2)(1994-12#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#3)
formed by two##4##3##(2007-12#1)(2008-10#2)(2012-2#1)
formed by using##2##3##(2008-10#1)(2008-11#1)
formed by##108##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-4#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(2007-12#5)(2008-10#46)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-11#1)(2010-8#3)(2011-1#2)(2011-2#9)(2012-2#3)(2013-1#1)
formed colonies##2##2##(1993-12#1)(2008-10#1)
formed complex##2##2##(2008-10#2)
formed complexes were##2##3##(2008-10#2)
formed complexes##5##2##(1990-11#1)(2008-10#4)
formed conidia with##2##3##(2008-10#2)
formed due to##3##3##(1996-5#1)(2008-10#2)
formed during the##7##3##(1994-11#1)(2008-10#3)(2008-9#1)(2012-5#2)
formed during##11##2##(1992-4#1)(1994-11#1)(2008-10#3)(2008-9#1)(2009-7#1)(2011-2#1)(2012-5#2)(2013-8#1)
formed exhibits##2##2##(2008-10#2)
formed first##2##2##(1995-6#1)(2007-12#1)
formed from the##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
formed from##19##2##(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
formed immediately##2##2##(2008-10#2)
formed in a##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
formed in response to##2##4##(2008-10#1)(2008-9#1)
formed in solution##4##3##(2008-10#4)
formed in the formulations##2##4##(2008-10#2)
formed in the presence of the##3##6##(1992-3#1)(2008-10#2)
formed in the presence of##5##5##(1992-3#1)(1994-5#1)(2008-10#3)
formed in the reaction of##2##5##(2008-10#2)
formed in the sample##2##4##(2008-10#2)
formed in the##30##3##(1992-3#1)(1993-3#1)(1994-5#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#23)(2008-11#1)
formed in these##3##3##(2008-10#2)(2008-11#1)
formed in##70##2##(1992-3#1)(1993-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#47)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-5#2)(2009-7#1)(2010-11#1)
formed inside##3##2##(2007-12#1)(2008-10#2)
formed is a##2##3##(2008-10#1)(2008-7#1)
formed is extracted into##3##4##(2008-10#3)
formed is measured at##2##4##(2008-10#2)
formed is##15##2##(2008-10#14)(2008-7#1)
formed on a##3##3##(2008-10#3)
formed on an##2##3##(2008-10#2)
formed on the surface of##3##5##(2008-10#2)(2010-7#1)
formed on the surface##4##4##(2008-10#3)(2010-7#1)
formed on the##10##3##(2008-10#7)(2008-12#1)(2008-5#1)(2010-7#1)
formed on##24##2##(1990-11#1)(1995-6#1)(2008-10#19)(2008-12#1)(2008-5#1)(2010-7#1)
formed over the##2##3##(1994-12#1)(2008-10#1)
formed spheroids##3##2##(2008-11#3)
formed synapses with##2##3##(1997-3#1)(2011-2#1)
formed synapses##3##2##(1997-2#1)(1997-3#1)(2011-2#1)
formed the basis##2##3##(2008-11#1)(2008-12#1)
formed the##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
formed through##2##2##(2008-10#2)
formed to##5##2##(1997-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
formed two##3##2##(2008-10#2)(2011-2#1)
formed under##2##2##(1996-5#1)(2008-10#1)
formed upon the##2##3##(2008-5#1)(2013-1#1)
formed via##3##2##(1996-5#1)(2008-10#2)
formed was##4##2##(1997-1#1)(2008-10#2)(2013-8#1)
formed were##2##2##(2008-10#2)
formed when the##2##3##(1994-9#1)(2008-10#1)
formed with the##2##3##(1997-3#1)(2008-7#1)
formed with##16##2##(1994-5#1)(1995-11#1)(1995-6#1)(1997-3#2)(2008-10#9)(2008-6#1)(2008-7#1)
formed within##4##2##(1997-6#1)(2008-10#2)(2008-9#1)
formed##589##1##(1990-11#3)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-11#2)(1992-3#1)(1992-4#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#2)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-1#2)(1996-12#3)(1996-5#9)(1996-6#1)(1997-1#2)(1997-2#6)(1997-3#10)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#9)(2008-10#343)(2008-11#27)(2008-12#7)(2008-3#7)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#11)(2008-8#6)(2008-9#13)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-11#4)(2010-4#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#17)(2012-12#1)(2012-2#5)(2012-3#1)(2012-5#3)(2013-1#9)(2013-8#4)
former East##2##2##(1995-1#1)(2008-11#1)
former German Democratic##2##3##(1995-1#1)(2008-10#1)
former ammunition plant##3##3##(2008-11#3)
former and##5##2##(1995-6#1)(1997-8#1)(2007-8#1)(2008-10#2)
former are##2##2##(1997-8#1)(2009-8#1)
former group##2##2##(1996-2#1)(2008-7#1)
former had##2##2##(2008-9#1)(2012-3#1)
former is##4##2##(1990-12#1)(2008-10#1)(2008-8#2)
former smokers##2##2##(1996-3#1)(2008-10#1)
former were##2##2##(1990-8#1)(2008-8#1)
former##112##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#3)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#10)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#4)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
formerly known as##3##3##(2010-11#1)(2011-2#1)(2012-2#1)
formerly##11##1##(1995-12#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#3)(2012-2#1)
formers and##2##2##(1991-12#1)(1995-3#1)
formers##9##1##(1991-12#6)(1995-3#1)(2011-2#2)
formic acid##12##2##(1990-9#1)(2008-10#9)(2008-11#1)(2011-3#1)
formic##16##1##(1990-9#1)(2008-10#13)(2008-11#1)(2011-3#1)
formidable##5##1##(1991-2#1)(1996-3#1)(2008-12#1)(2008-8#1)(2010-6#1)
forming a complex##2##3##(2008-10#2)
forming a##17##2##(1990-5#1)(1991-5#1)(1992-6#1)(1994-5#1)(1995-8#1)(2008-10#10)(2008-8#1)(2009-10#1)
forming an##7##2##(1992-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-3#1)(2012-2#1)
forming and##2##2##(2008-10#1)(2011-2#1)
forming cell##2##2##(2008-10#2)
forming in##4##2##(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
forming of the##2##3##(2008-10#1)(2011-2#1)
forming of##4##2##(1991-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
forming reagent##2##2##(2008-10#2)
forming the##12##2##(1995-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2011-2#3)
forming units of##3##3##(2008-10#3)
forming units##7##2##(1996-12#1)(1997-3#1)(2008-10#4)(2008-5#1)
forming##140##1##(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-5#2)(1995-11#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-3#4)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#59)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#1)(2009-8#4)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#11)(2012-2#1)
forms a 1##2##3##(2008-10#2)
forms a complex with##2##4##(2008-10#2)
forms a complex##3##3##(2008-10#3)
forms a specialized infection structure##2##5##(2008-10#2)
forms a##37##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-6#1)(2008-10#23)(2008-11#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
forms an##5##2##(1992-11#1)(2007-12#1)(2008-10#2)(2008-5#1)
forms and##18##2##(1994-12#1)(1996-8#1)(2008-10#11)(2008-12#2)(2008-8#1)(2010-12#1)(2011-2#1)
forms are##9##2##(1990-5#1)(1994-8#1)(1995-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-12#1)
forms as well as in##3##5##(2008-10#2)(2008-11#1)
forms as well as##4##4##(1997-7#1)(2008-10#2)(2008-11#1)
forms as##6##2##(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)
forms by the##2##3##(2008-10#1)(2008-8#1)
forms by##5##2##(2008-10#4)(2008-8#1)
forms complexes with##2##3##(1993-8#1)(2010-11#1)
forms containing##2##2##(1996-12#1)(2008-10#1)
forms for##2##2##(1990-2#1)(2008-10#1)
forms from these##2##3##(2008-10#1)(2012-12#1)
forms in chromaffin cells##2##4##(1990-5#2)
forms in the##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)
forms in##14##2##(1990-5#2)(1992-9#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#2)(2011-2#1)
forms into##3##2##(2008-10#2)(2008-11#1)
forms more stable##3##3##(2008-10#3)
forms more##4##2##(2008-10#4)
forms of ARM##4##3##(2011-2#4)
forms of BCG##2##3##(2011-2#2)
forms of Cr##2##3##(2008-10#2)
forms of IGF-I##2##3##(2010-5#2)
forms of MS##4##3##(2010-12#2)(2012-3#2)
forms of cancer##3##3##(1997-2#1)(2010-7#1)(2011-2#1)
forms of cathepsin##2##3##(1995-6#2)
forms of chromium##2##3##(2008-10#2)
forms of congenital##2##3##(2008-10#1)(2008-4#1)
forms of dementia##2##3##(1990-11#1)(2008-7#1)
forms of gonadotropin-releasing##2##3##(1994-8#1)(1995-11#1)
forms of human##2##3##(1997-7#2)
forms of incomplete resistance##2##4##(2008-10#2)
forms of insurance contract##2##4##(1992-1#2)
forms of learning##2##3##(1997-7#1)(2008-11#1)
forms of presentation##2##3##(2010-3#1)(2011-2#1)
forms of stress##2##3##(2012-3#1)(2013-7#1)
forms of synaptic plasticity##2##4##(1993-12#1)(2009-9#1)
forms of synaptic##3##3##(1993-12#1)(2009-9#2)
forms of the disease are##2##5##(2008-11#1)(2008-5#1)
forms of the disease##3##4##(1993-2#1)(2008-11#1)(2008-5#1)
forms of the pathogen##2##4##(2008-10#2)
forms of the##16##3##(1991-5#1)(1993-2#1)(1994-11#1)(1995-5#1)(1995-6#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)
forms of this##4##3##(1991-12#1)(1991-7#1)(2006-6#1)(2013-1#1)
forms of training##2##3##(1994-12#1)(2009-1#1)
forms of treatment##2##3##(2012-3#1)(2013-1#1)
forms of##201##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#3)(1994-11#4)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#6)(1996-1#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(1997-9#1)(2006-6#2)(2008-10#37)(2008-11#7)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#7)(2010-3#1)(2010-5#6)(2010-7#1)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#1)
forms on##3##2##(2008-10#3)
forms or##4##2##(1991-2#1)(1995-5#1)(2008-10#2)
forms part of the##2##4##(2008-12#1)(2008-7#1)
forms part of##4##3##(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
forms the basis for##2##4##(2008-7#1)(2013-8#1)
forms the basis of##2##4##(2008-10#1)(2011-2#1)
forms the basis##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
forms the##11##2##(1992-6#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)(2013-8#1)
forms to##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
forms using packed column supercritical fluid chromatography##2##7##(2008-10#2)
forms using##4##2##(2008-10#4)
forms were##12##2##(1990-9#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#3)(2012-12#1)
forms with##4##2##(1990-11#1)(2008-10#3)
forms##501##1##(1990-11#2)(1990-12#6)(1990-2#3)(1990-3#1)(1990-5#11)(1990-8#2)(1990-9#3)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#6)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#5)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#5)(1993-9#1)(1994-11#6)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#9)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#9)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#2)(1997-9#2)(2006-6#2)(2007-12#6)(2008-1#1)(2008-10#157)(2008-11#18)(2008-12#12)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#14)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#3)(2009-4#5)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#12)(2010-3#1)(2010-5#7)(2010-7#1)(2010-8#2)(2011-2#29)(2011-3#2)(2012-12#6)(2012-2#5)(2012-3#8)(2012-6#1)(2013-1#10)(2013-7#1)(2013-8#2)
forms)##2##1##(1993-8#1)(2008-10#1)
formula and##2##2##(1991-12#1)(2010-10#1)
formula for the mean lifetime of metapopulations in heterogeneous landscapes##2##10##(2008-8#2)
formula for the transient##2##4##(2008-2#2)
formula for the##7##3##(1992-9#1)(1995-9#1)(2008-12#1)(2008-2#2)(2008-8#2)
formula for##13##2##(1992-9#2)(1993-3#1)(1995-9#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)
formula is##4##2##(1993-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
formula used##2##2##(1992-12#1)(1994-12#1)
formula with##2##2##(2008-3#1)(2008-5#1)
formula##60##1##(1991-12#3)(1992-12#2)(1992-9#3)(1993-3#4)(1994-1#1)(1994-12#1)(1994-6#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#11)(2008-8#7)(2010-10#1)(2012-3#1)(2013-8#1)
formulae##13##1##(2008-10#4)(2008-5#5)(2012-3#4)
formulas derived##2##2##(2008-1#1)(2008-3#1)
formulas for##4##2##(2008-3#2)(2008-8#1)(2013-1#1)
formulas that##2##2##(1991-12#1)(2008-3#1)
formulas##21##1##(1991-12#1)(1993-1#1)(1994-6#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-3#4)(2008-5#2)(2008-8#1)(2013-1#1)
formulate a##2##2##(2009-7#1)(2010-1#1)
formulate the##3##2##(2008-2#1)(2008-5#1)(2012-2#1)
formulate##20##1##(1993-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-3#1)(2009-7#1)(2010-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
formulated and the##2##3##(2008-5#1)(2013-8#1)
formulated and##6##2##(2008-11#2)(2008-5#3)(2013-8#1)
formulated as assimilative hyphae in##2##5##(2008-10#2)
formulated as##6##2##(1996-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
formulated by##6##2##(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#2)(2013-8#1)
formulated differently##2##2##(1995-3#1)(1996-1#1)
formulated for the##2##3##(2008-10#1)(2012-4#1)
formulated for##3##2##(2008-10#1)(2008-2#1)(2012-4#1)
formulated in the laboratory##2##4##(2008-5#2)
formulated in##6##2##(1994-12#1)(1995-12#1)(1996-12#1)(2008-3#1)(2008-5#2)
formulated product##3##2##(2008-10#1)(2008-5#2)
formulated to##3##2##(1992-1#1)(2008-7#1)(2012-2#1)
formulated with the##2##3##(2008-10#2)
formulated with##11##2##(1995-5#1)(1996-1#1)(2008-10#6)(2008-11#1)(2009-6#1)(2010-4#1)
formulated##59##1##(1992-1#1)(1994-12#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-8#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#2)(2011-2#3)(2012-2#1)(2012-4#1)(2013-8#2)
formulating a##3##2##(1995-8#1)(2008-10#1)(2008-7#1)
formulating the##2##2##(2008-12#1)(2008-3#1)
formulating##12##1##(1991-3#1)(1992-3#1)(1994-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
formulation and##12##2##(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-3#1)
formulation are##2##2##(2008-11#1)(2008-2#1)
formulation at##2##2##(2008-10#1)(2008-9#1)
formulation based on canola meal##2##5##(2008-10#2)
formulation based on##5##3##(2008-10#3)(2008-5#2)
formulation by##2##2##(2008-10#2)
formulation containing##2##2##(1995-5#1)(2008-5#1)
formulation development##2##2##(1992-3#1)(2008-5#1)
formulation for the##2##3##(1996-3#1)(2012-2#1)
formulation for##6##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2012-2#1)
formulation in##2##2##(1996-1#1)(2011-3#1)
formulation is##6##2##(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
formulation of a##6##3##(1992-9#1)(2008-11#1)(2008-5#2)(2010-12#1)(2011-2#1)
formulation of cosmetic products##2##4##(2008-5#2)
formulation of the##7##3##(2007-12#1)(2008-10#4)(2008-11#1)(2010-1#1)
formulation of##33##2##(1992-9#1)(1993-1#1)(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-5#7)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#5)(2011-3#1)(2012-2#1)
formulation or##2##2##(2007-11#1)(2008-10#1)
formulation that##2##2##(2008-10#1)(2012-2#1)
formulation to##2##2##(1996-1#1)(2008-10#1)
formulation was##7##2##(2008-10#3)(2008-5#2)(2011-2#1)(2013-1#1)
formulation with##2##2##(2008-11#1)(2008-5#1)
formulation##176##1##(1990-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#2)(1995-12#2)(1995-5#2)(1996-1#2)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#59)(2008-11#15)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#42)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#7)(2011-3#4)(2012-2#7)(2013-1#3)
formulations and biological samples##2##4##(2008-10#2)
formulations and biological##4##3##(2008-10#4)
formulations and##13##2##(2008-10#12)(2009-7#1)
formulations are##5##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#2)
formulations at##4##2##(1996-1#1)(2008-10#3)
formulations by applying##2##3##(2008-10#2)
formulations by means of the##2##5##(2008-10#1)(2008-5#1)
formulations by using##4##3##(2008-10#4)
formulations by##15##2##(2008-10#14)(2008-5#1)
formulations containing a combination of##2##5##(2008-10#2)
formulations containing##13##2##(2008-10#7)(2008-5#6)
formulations for the##2##3##(1997-1#1)(2008-11#1)
formulations from##2##2##(2008-10#1)(2008-11#1)
formulations in##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
formulations is##8##2##(2008-10#7)(2010-10#1)
formulations of amphotericin B##2##4##(2008-5#1)(2011-2#1)
formulations of amphotericin##3##3##(2008-5#1)(2011-2#2)
formulations of salbutamol##2##3##(1996-1#2)
formulations of##22##2##(1996-1#3)(2008-10#10)(2008-4#1)(2008-5#3)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)
formulations tested##2##2##(2008-10#2)
formulations that contained##2##3##(2008-10#1)(2008-5#1)
formulations that##5##2##(2008-10#1)(2008-5#3)(2012-2#1)
formulations used##2##2##(2008-10#1)(2008-5#1)
formulations using the##2##3##(2008-10#2)
formulations using##14##2##(2008-10#14)
formulations was developed##3##3##(2008-10#3)
formulations was tested##2##3##(2008-10#2)
formulations was##8##2##(2008-10#7)(2008-5#1)
formulations were##13##2##(2008-10#10)(2008-5#3)
formulations will##3##2##(2008-5#2)(2008-9#1)
formulations with##4##2##(2008-10#4)
formulations##306##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#1)(1994-5#1)(1995-5#3)(1996-1#6)(1996-2#1)(1997-1#1)(2008-10#195)(2008-11#11)(2008-2#1)(2008-4#2)(2008-5#64)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-2#4)(2012-2#2)(2013-1#2)
formulator##4##1##(2008-10#1)(2008-5#2)(2011-1#1)
formycin B##3##2##(1994-8#3)
formyl##2##1##(1990-9#1)(1993-6#1)
fornix and##2##2##(1993-3#1)(1993-6#1)
fornix lesions##3##2##(1993-3#2)(1993-6#1)
fornix##11##1##(1991-8#1)(1993-3#5)(1993-6#2)(1996-12#1)(2008-10#1)(2011-2#1)
forproducing##2##1##(2008-11#2)
forskolin (10##2##2##(1995-11#1)(1997-2#1)
forskolin and##2##2##(1994-11#1)(1995-12#1)
forskolin was##3##2##(1997-1#1)(1997-2#1)(2008-11#1)
forskolin##25##1##(1990-8#1)(1992-6#1)(1993-6#1)(1994-11#3)(1995-11#1)(1995-12#1)(1995-8#5)(1997-1#3)(1997-2#6)(2008-11#3)
forskolin-induced##2##1##(1995-6#1)(1996-12#1)
forskolin-stimulated adenylyl cyclase##3##3##(1995-11#1)(1997-1#2)
forsterite crystal##2##2##(2008-2#2)
forsterite laser##6##2##(2008-2#2)(2008-3#4)
forsterite regenerative amplifier##2##3##(2007-11#1)(2007-12#1)
forsterite##13##1##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#6)
forsythus##4##1##(2008-12#4)
forth a##2##2##(2008-11#1)(2012-2#1)
forth in##3##2##(1997-3#1)(1997-5#1)(2007-12#1)
forth##15##1##(1991-2#1)(1993-3#1)(1994-12#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-11#2)(2009-10#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
forthcoming##6##1##(1994-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
forthe##3##1##(2008-11#3)
forthis##2##1##(2008-11#2)
fortification levels##2##2##(2008-10#2)
fortification of##4##2##(1997-8#1)(2008-10#2)(2010-1#1)
fortification##12##1##(1997-8#1)(2008-10#6)(2008-11#2)(2010-1#3)
fortified at levels##2##3##(2008-10#2)
fortified at##3##2##(2008-10#3)
fortified medium##4##2##(2008-11#4)
fortified with##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
fortified##18##1##(2008-10#10)(2008-11#5)(2009-8#1)(2010-1#1)(2011-2#1)
fortifying##2##1##(2008-10#2)
fortuitous ORFs##3##2##(1996-3#3)
fortuitous##10##1##(1991-5#1)(1996-3#6)(2008-10#1)(2008-11#1)(2008-3#1)
fortuitum was##2##2##(2008-11#1)(2011-2#1)
fortuitum##6##1##(2008-11#2)(2011-2#4)
forty percent of##2##3##(1995-6#1)(2008-11#1)
forty years of##2##3##(1996-9#1)(2012-3#1)
forty##12##1##(1993-6#1)(1994-12#1)(1995-6#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-8#1)
forty-three##3##1##(1991-8#1)(2008-10#1)(2010-2#1)
forum for##3##2##(1995-3#1)(1996-1#1)(2008-5#1)
forum to##3##2##(2008-10#1)(2008-11#2)
forum##14##1##(1991-2#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
forums as##2##2##(2011-2#1)(2012-12#1)
forums##4##1##(2010-4#1)(2011-2#2)(2012-12#1)
forward SRS##2##2##(2008-3#2)
forward and backward anisotropic scattering##2##5##(2008-3#2)
forward and backward##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
forward and reverse##3##3##(1992-6#1)(2008-10#1)(2009-9#1)
forward and##10##2##(1992-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2009-9#1)(2012-2#1)
forward displacement of the##2##4##(2008-10#1)(2013-1#1)
forward genetics##2##2##(2007-12#1)(2012-3#1)
forward head posture##3##3##(2010-9#3)
forward in the##2##3##(2008-10#1)(2008-5#1)
forward in##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-11#1)(2010-9#1)
forward model##2##2##(1995-3#1)(2008-3#1)
forward neural networks##2##3##(2008-10#1)(2010-8#1)
forward neural##3##2##(2008-10#2)(2010-8#1)
forward the##2##2##(2009-7#1)(2012-2#1)
forward with##2##2##(2008-8#1)(2009-3#1)
forward##75##1##(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2010-9#4)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)
forward)##2##1##(2008-5#1)(2011-1#1)
forward-scattering##2##1##(2008-2#2)
forwards##2##1##(2008-10#1)(2008-9#1)
fos##3##1##(1994-6#1)(2008-11#2)
fosfestrol##3##1##(2008-10#3)
fosfomycin##6##1##(2008-10#4)(2008-7#1)(2011-2#1)
fosmid##2##1##(2008-11#2)
fossa abscess after pelvic floor##2##5##(2012-3#2)
fossa and##3##2##(1996-6#1)(2008-7#1)(2012-3#1)
fossa of the##2##3##(2011-2#2)
fossa ovalis atrial septal defect##2##5##(2008-11#2)
fossa ovalis atrial septal##3##4##(2008-11#3)
fossa##40##1##(1993-1#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-8#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#9)(2009-9#2)(2011-2#13)(2012-3#4)(2013-1#1)
fossil fuel##2##2##(2008-11#1)(2009-3#1)
fossil##16##1##(1994-3#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#2)(2009-3#2)(2010-4#1)(2012-9#3)
fossilized##3##1##(1990-11#1)(1995-3#2)
foster care##2##2##(1997-2#1)(2009-9#1)
foster children##3##2##(2008-12#3)
foster parents##2##2##(1995-5#2)
foster this##2##2##(2008-11#1)(2013-1#1)
foster##32##1##(1990-11#1)(1991-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-3#1)(1997-2#1)(2008-11#6)(2008-12#8)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-7#1)(2012-2#2)(2013-1#1)
fostered the##2##2##(1997-2#1)(2012-12#1)
fostered##10##1##(1997-2#1)(2008-10#1)(2008-11#4)(2009-8#1)(2012-12#1)(2012-2#1)(2012-5#1)
fostering deep learning##2##3##(2008-11#2)
fostering##13##1##(1990-12#6)(1996-3#1)(2008-11#3)(2008-12#1)(2008-9#1)(2011-3#1)
fought##2##1##(1991-3#1)(2013-1#1)
foul##4##1##(1990-6#1)(2009-10#1)(2013-1#2)
fouling and##3##2##(2008-10#3)
fouling processes##2##2##(2008-11#2)
fouling##23##1##(2008-10#10)(2008-11#4)(2008-7#5)(2010-8#2)(2013-1#2)
found 30##2##2##(2008-10#2)
found a significant decrease##2##4##(2008-11#1)(2008-5#1)
found a significant##6##3##(2008-11#2)(2008-5#1)(2013-1#2)(2013-8#1)
found a way##2##3##(1991-9#1)(2010-5#1)
found a##35##2##(1990-3#1)(1991-1#1)(1991-9#1)(1992-1#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-4#1)(2013-1#2)(2013-8#1)
found after##12##2##(1993-2#1)(1994-8#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)
found almost##2##2##(2008-10#2)
found along##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
found among children##2##3##(2012-3#1)(2013-1#1)
found among isolates##2##3##(2008-10#2)
found among the##12##3##(1993-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2012-2#1)(2012-5#1)
found among##33##2##(1993-2#1)(1995-1#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)
found an##12##2##(1993-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
found and##11##2##(1997-9#1)(2008-10#4)(2008-7#1)(2011-3#1)(2013-1#3)(2013-8#1)
found are##2##2##(2008-10#2)
found around the##2##3##(2008-10#1)(2008-9#1)
found around##3##2##(2008-10#2)(2008-9#1)
found as 0##3##3##(2008-10#3)
found as a##3##3##(1996-6#2)(2008-10#1)
found as the##2##3##(2008-10#1)(2008-11#1)
found as##19##2##(1996-6#2)(2008-10#11)(2008-11#3)(2008-12#1)(2011-1#1)(2012-12#1)
found associated with##6##3##(1990-5#1)(1994-12#1)(2008-10#3)(2008-11#1)
found at operation##2##3##(1991-6#1)(2008-10#1)
found at the sites##2##4##(2008-10#1)(2011-1#1)
found at the##16##3##(1991-5#1)(1991-6#1)(1992-5#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-8#1)(2010-9#1)(2011-1#1)
found at##36##2##(1990-5#1)(1991-5#1)(1991-6#2)(1992-5#1)(1994-11#1)(1996-12#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
found beneficial in##2##3##(2008-10#1)(2011-2#1)
found between disease##2##3##(2008-10#2)
found between groups in##2##4##(1996-1#1)(2008-12#1)
found between the child's and##2##5##(1993-2#2)
found between the peak##2##4##(2008-10#2)
found between the two##3##4##(1990-6#1)(2008-10#1)(2008-7#1)
found between the##52##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#2)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#2)(1995-12#1)(1996-11#1)(1997-3#1)(1997-6#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
found between##125##2##(1990-12#3)(1990-6#2)(1990-8#3)(1991-2#2)(1991-5#2)(1991-6#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#4)(1994-5#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#46)(2008-11#4)(2008-12#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-5#1)(2012-6#1)(2013-1#4)(2013-8#1)
found both##2##2##(2008-9#1)(2010-7#1)
found by an##2##3##(2008-10#2)
found by means of##2##4##(1990-6#1)(2008-3#1)
found by the##3##3##(1990-9#1)(2008-10#1)(2008-3#1)
found by##41##2##(1990-6#1)(1990-9#1)(1993-11#1)(1993-9#1)(1997-8#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)
found concerning the##2##3##(2008-10#1)(2013-1#1)
found concerning##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
found correlation between##2##3##(2011-2#2)
found correlation##3##2##(2008-10#1)(2011-2#2)
found during the##3##3##(1990-3#1)(1996-1#1)(2008-10#1)
found during##11##2##(1990-3#1)(1990-5#1)(1995-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-12#1)(2010-9#1)(2012-12#1)
found either##2##2##(1994-1#1)(2008-9#1)
found evidence for##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
found evidence of the##2##4##(2008-5#1)(2012-3#1)
found evidence of##4##3##(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
found evidence##10##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
found experimentally##2##2##(2008-10#1)(2008-3#1)
found for Cu##3##3##(2008-10#3)
found for a##3##3##(2008-10#1)(2008-3#2)
found for all##2##3##(1997-1#1)(2008-10#1)
found for both##2##3##(2008-10#1)(2008-2#1)
found for each##2##3##(2008-10#2)
found for the presence of##2##5##(2008-10#2)
found for the##25##3##(1994-5#1)(1995-6#1)(1996-6#1)(2008-10#15)(2008-12#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)
found for these##2##3##(1997-1#1)(2008-10#1)
found for##89##2##(1990-12#1)(1992-3#1)(1994-5#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#47)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)
found frequently in##2##3##(2008-10#1)(2011-2#1)
found from the slope##2##4##(2008-10#2)
found from the##6##3##(2008-10#6)
found from##10##2##(2008-10#8)(2008-8#1)(2012-12#1)
found high##3##2##(1991-3#1)(2011-1#1)(2011-2#1)
found in 13##2##3##(2008-10#1)(2013-1#1)
found in 3##2##3##(2007-11#1)(2008-9#1)
found in 9 of##2##4##(2011-2#1)(2013-1#1)
found in Europe##2##3##(2008-12#2)
found in P##2##3##(1995-2#1)(2008-12#1)
found in Spanish##2##3##(2008-10#1)(2008-11#1)
found in a number of##2##5##(1993-9#1)(2008-10#1)
found in a similar##2##4##(1991-10#1)(2008-11#1)
found in a##22##3##(1990-11#1)(1990-3#1)(1991-10#1)(1993-9#1)(1996-12#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#3)(2013-1#1)
found in all of the##2##5##(2008-11#1)(2008-5#1)
found in all populations##2##4##(2008-10#1)(2013-8#1)
found in all six##2##4##(2008-10#1)(2008-5#1)
found in all the##3##4##(1993-2#1)(2008-10#2)
found in all##24##3##(1993-2#1)(1994-11#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
found in an earlier study##2##5##(1995-8#1)(2008-10#1)
found in an##6##3##(1990-3#1)(1993-1#1)(1995-8#1)(2008-10#2)(2010-1#1)
found in another##2##3##(2008-10#1)(2009-8#1)
found in any##2##3##(2008-10#1)(2009-5#1)
found in association with##3##4##(1995-12#1)(2008-7#1)(2013-1#1)
found in both the##3##4##(1993-2#1)(2008-10#1)(2008-9#1)
found in both##8##3##(1993-2#1)(1994-2#1)(1997-6#1)(2008-10#3)(2008-7#1)(2008-9#1)
found in brain##2##3##(1992-12#1)(1996-2#1)
found in cell##2##3##(1990-5#1)(2008-7#1)
found in common##2##3##(1996-6#1)(2008-10#1)
found in different##4##3##(2008-10#2)(2008-7#1)(2010-3#1)
found in each##3##3##(1991-5#1)(2008-10#1)(2009-12#1)
found in either##2##3##(1991-9#1)(1995-12#1)
found in ground##2##3##(2008-10#2)
found in houses##2##3##(2011-2#2)
found in human##3##3##(1992-8#1)(2008-11#1)(2012-2#1)
found in large##2##3##(1991-5#1)(2008-10#1)
found in leaf##2##3##(2008-10#2)
found in many##5##3##(1990-5#1)(1993-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
found in members of the##2##5##(1991-12#1)(2009-6#1)
found in most##5##3##(1994-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2011-2#1)
found in natural waters##2##4##(2008-10#2)
found in naturally##2##3##(2008-10#1)(2008-9#1)
found in normal##5##3##(1994-11#1)(1995-8#1)(2008-11#2)(2008-9#1)
found in one##2##3##(2008-10#1)(2008-9#1)
found in only##2##3##(1991-11#1)(2011-2#1)
found in other##9##3##(1991-5#1)(1993-6#1)(1994-6#1)(1997-7#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
found in our##3##3##(1996-8#1)(2008-10#2)
found in patients with##2##4##(1990-12#1)(2011-2#1)
found in patients##4##3##(1990-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
found in plants##2##3##(1997-8#1)(2009-8#1)
found in purified##2##3##(1992-8#1)(1997-3#1)
found in rat##2##3##(1992-6#1)(1993-12#1)
found in regard to##2##4##(1994-5#1)(2008-7#1)
found in resistant##2##3##(2008-10#2)
found in rice##3##3##(2008-8#1)(2008-9#1)(2009-10#1)
found in samples##2##3##(2008-10#1)(2011-2#1)
found in several##3##3##(1994-11#1)(2011-2#2)
found in single##2##3##(2008-10#1)(2008-7#1)
found in six##2##3##(2008-10#2)
found in some##5##3##(1997-7#1)(2007-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
found in subjects##2##3##(1995-8#1)(2008-11#1)
found in the F##2##4##(2008-10#2)
found in the Japanese population##2##5##(1993-3#2)
found in the adult##2##4##(2008-1#1)(2013-7#1)
found in the analysis of##3##5##(2008-10#3)
found in the female##2##4##(2008-10#1)(2011-2#1)
found in the field##2##4##(2008-10#2)
found in the group##2##4##(1991-6#1)(2013-1#1)
found in the hEp genomic clones##2##6##(1993-12#1)(1993-6#1)
found in the literature##6##4##(1990-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
found in the present study##2##5##(1994-8#1)(2008-10#1)
found in the present##3##4##(1994-8#1)(2008-10#1)(2013-8#1)
found in the range##3##4##(2008-10#3)
found in the vascular##2##4##(2008-10#2)
found in the##197##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#3)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#4)(1993-3#2)(1993-6#3)(1993-8#3)(1994-11#3)(1994-2#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-6#2)(1996-2#1)(1996-6#1)(1997-3#2)(2007-12#2)(2008-1#2)(2008-10#60)(2008-11#14)(2008-12#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
found in these##5##3##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#2)
found in this study##3##4##(2008-10#2)(2012-2#1)
found in this##6##3##(1993-2#1)(1997-6#1)(2008-10#3)(2012-2#1)
found in two##7##3##(1990-5#1)(2007-12#1)(2008-10#4)(2008-5#1)
found in urine##2##3##(2008-10#1)(2009-9#1)
found in various##3##3##(1997-2#1)(2012-2#2)
found in women##2##3##(1990-2#1)(2008-4#1)
found in##672##2##(1990-11#4)(1990-12#2)(1990-2#6)(1990-3#4)(1990-5#5)(1990-6#5)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-5#6)(1991-6#3)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#4)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#7)(1993-2#5)(1993-3#2)(1993-6#5)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#7)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#4)(1995-2#6)(1995-3#1)(1995-6#2)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-5#1)(1996-6#3)(1996-8#2)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#5)(1997-7#3)(1997-8#4)(1997-9#1)(2007-11#2)(2007-12#6)(2007-8#4)(2008-1#6)(2008-10#204)(2008-11#45)(2008-12#14)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#14)(2008-6#2)(2008-7#26)(2008-8#14)(2008-9#24)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#7)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#5)(2011-1#2)(2011-10#1)(2011-2#31)(2011-3#1)(2012-12#5)(2012-2#17)(2012-3#10)(2013-1#18)(2013-7#2)(2013-8#7)
found incidentally##3##2##(2009-1#1)(2009-4#1)(2012-3#1)
found increased##2##2##(1996-3#1)(2011-2#1)
found insufficient evidence to##2##4##(2013-1#2)
found is##2##2##(2008-10#2)
found it to be##4##4##(1993-8#1)(1995-2#1)(1997-2#1)(2008-3#1)
found it##6##2##(1993-8#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-3#1)(2013-1#1)
found mainly in the##3##4##(1990-9#1)(2008-7#1)(2008-8#1)
found mainly in##6##3##(1990-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
found mainly##9##2##(1990-9#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-7#1)
found more stable##2##3##(2008-10#1)(2008-5#1)
found more##4##2##(1997-1#1)(2008-10#2)(2008-5#1)
found most##5##2##(1991-10#1)(1992-3#1)(2008-10#2)(2013-1#1)
found mostly in##2##3##(2008-10#1)(2011-2#1)
found multiple##2##2##(1994-11#1)(2012-3#1)
found neurons expressing##2##3##(1996-12#2)
found no difference##2##3##(2009-10#1)(2010-7#1)
found no differences between##2##4##(1995-2#1)(1995-5#1)
found no differences##4##3##(1995-2#1)(1995-5#1)(2008-8#1)(2013-1#1)
found no evidence of##2##4##(1995-11#1)(2008-6#1)
found no evidence##6##3##(1995-11#1)(1995-12#1)(2008-6#1)(2009-8#1)(2009-9#1)(2013-1#1)
found no relationship between##3##4##(2008-8#2)(2013-1#1)
found no##34##2##(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
found not only##2##3##(2008-10#1)(2008-8#1)
found not to##5##3##(1991-2#1)(2007-11#1)(2008-10#3)
found not##8##2##(1991-2#1)(1991-6#1)(2007-11#1)(2008-10#4)(2008-8#1)
found on different##2##3##(2008-10#2)
found on other##2##3##(2008-10#2)
found on the##12##3##(1991-2#1)(1995-11#1)(1995-2#1)(1996-5#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-9#1)(2011-2#1)
found on##43##2##(1991-2#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-6#1)(2007-12#2)(2008-1#1)(2008-10#23)(2008-12#1)(2008-5#2)(2008-9#1)(2011-1#3)(2011-2#2)(2012-2#2)
found only in the##4##4##(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
found only in##14##3##(1994-1#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
found only##19##2##(1994-1#1)(1996-5#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
found out that##3##3##(1996-9#1)(2008-11#1)(2013-1#1)
found out##6##2##(1996-9#1)(2008-11#1)(2012-3#3)(2013-1#1)
found previously in##2##3##(2007-12#1)(2008-10#1)
found previously##4##2##(1994-8#1)(2007-12#1)(2008-10#2)
found repeated##2##2##(1995-8#1)(1996-8#1)
found satisfactory##2##2##(2008-10#1)(2010-8#1)
found significant differences##2##3##(2011-3#1)(2012-2#1)
found significant##6##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
found significantly##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
found some##3##2##(1992-11#1)(2008-8#1)(2011-3#1)
found statistically significant##3##3##(1996-3#1)(2010-12#1)(2012-2#1)
found statistically##4##2##(1996-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
found such##2##2##(1994-8#1)(2008-11#1)
found suitable for the##2##4##(2008-10#1)(2008-11#1)
found suitable for##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
found suitable##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)
found that 5##2##3##(1991-11#1)(2012-2#1)
found that a##7##3##(1994-2#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2013-1#1)
found that alcuronium##2##3##(1995-11#2)
found that all##3##3##(2008-10#3)
found that an##2##3##(2008-11#1)(2013-8#1)
found that at least##2##4##(1990-5#1)(2008-10#1)
found that at##5##3##(1990-5#1)(1991-5#1)(1994-3#1)(2008-10#2)
found that both the##4##4##(2008-10#2)(2010-4#1)(2012-2#1)
found that both##8##3##(2008-10#2)(2008-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-2#1)
found that by##2##3##(2008-5#1)(2009-12#1)
found that estrogen##2##3##(2008-11#1)(2008-6#1)
found that expression of##2##4##(2008-11#1)(2012-2#1)
found that females##2##3##(2008-4#1)(2008-8#1)
found that for##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
found that human##2##3##(1993-3#1)(2010-8#1)
found that in the##7##4##(1993-8#2)(1994-8#1)(2008-10#4)
found that in##11##3##(1993-1#1)(1993-8#2)(1994-8#1)(1995-6#1)(2008-10#6)
found that it##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
found that many##3##3##(2008-10#1)(2009-8#1)(2012-3#1)
found that mean##2##3##(2008-8#1)(2013-1#1)
found that monoclonal##2##3##(2008-5#1)(2008-8#1)
found that most##3##3##(2008-6#1)(2011-2#1)(2012-3#1)
found that no##2##3##(2008-7#1)(2011-1#1)
found that participants##2##3##(2008-12#1)(2010-9#1)
found that patients##2##3##(1991-3#1)(2008-11#1)
found that selenium##2##3##(2008-6#2)
found that some##2##3##(2008-10#1)(2008-11#1)
found that sweating was influenced by##2##6##(2008-5#2)
found that the addition of 3##2##6##(2008-10#2)
found that the addition of##3##5##(2008-10#2)(2008-5#1)
found that the amounts of##2##5##(1994-11#1)(2008-10#1)
found that the complexation##2##4##(2008-10#2)
found that the first##2##4##(1997-4#1)(2008-10#1)
found that the major##2##4##(2008-10#1)(2008-12#1)
found that the model##2##4##(2008-10#1)(2011-2#1)
found that the most##2##4##(2009-8#1)(2012-3#1)
found that the neural##2##4##(2008-10#1)(2008-11#1)
found that the number of##2##5##(2008-9#2)
found that the overall##2##4##(2008-11#1)(2010-7#1)
found that the peak##2##4##(2008-10#2)
found that the relative##2##4##(2008-10#1)(2008-5#1)
found that the response##2##4##(2008-10#1)(2009-8#1)
found that the use of##3##5##(1993-2#1)(2008-10#1)(2011-2#1)
found that the##184##3##(1990-11#1)(1990-12#1)(1990-8#2)(1991-1#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-11#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-10#76)(2008-11#14)(2008-12#3)(2008-2#3)(2008-3#7)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#10)(2008-9#5)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
found that their##3##3##(2008-10#2)(2011-2#1)
found that there is an##2##5##(2008-11#1)(2008-3#1)
found that there is##3##4##(2008-11#1)(2008-3#1)(2012-3#1)
found that there was no##2##5##(2008-10#1)(2013-1#1)
found that there was##3##4##(1996-12#1)(2008-10#1)(2013-1#1)
found that there##10##3##(1993-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2012-3#1)(2013-1#1)
found that these##4##3##(1996-8#1)(2008-1#1)(2013-1#2)
found that they can##2##4##(2008-9#1)(2010-1#1)
found that they were##2##4##(1995-12#1)(2008-10#1)
found that they##6##3##(1995-12#1)(2008-10#2)(2008-9#1)(2010-1#1)(2012-3#1)
found that this##8##3##(1996-8#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)
found that treatment with##2##4##(1994-11#1)(2009-8#1)
found that treatment##3##3##(1994-11#1)(2009-8#1)(2010-1#1)
found that two##2##3##(2008-5#1)(2009-10#1)
found that while##3##3##(2008-5#1)(2009-11#1)(2013-8#1)
found that with##2##3##(2008-10#1)(2008-8#1)
found that##552##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#4)(1994-11#8)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#3)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#167)(2008-11#51)(2008-12#10)(2008-2#3)(2008-3#18)(2008-4#1)(2008-5#21)(2008-6#8)(2008-7#11)(2008-8#32)(2008-9#17)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-6#1)(2009-7#6)(2009-8#17)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#13)(2012-12#1)(2012-2#12)(2012-3#11)(2013-1#9)(2013-7#2)(2013-8#9)
found the following##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
found the##28##2##(1990-12#1)(1990-2#1)(1991-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
found this##2##2##(2008-11#1)(2008-9#1)
found through##4##2##(1993-12#1)(2008-10#2)(2008-7#1)
found till##2##2##(2011-3#1)(2013-1#1)
found to affect##4##3##(2008-10#2)(2008-7#1)(2010-3#1)
found to be &gt##3##4##(2008-10#3)
found to be &lt##2##4##(2008-10#2)
found to be 0##27##4##(1990-6#1)(2008-10#26)
found to be 1##21##4##(2008-10#19)(2008-12#1)(2013-1#1)
found to be 2##22##4##(1996-5#1)(2008-10#21)
found to be 3##7##4##(2008-10#5)(2008-3#1)(2012-2#1)
found to be 4##11##4##(1994-5#1)(1995-12#1)(2008-10#8)(2012-3#1)
found to be 5##4##4##(2008-10#4)
found to be 6##2##4##(2008-10#2)
found to be 60##2##4##(2008-10#2)
found to be 7##4##4##(1991-5#1)(2008-10#3)
found to be 9##2##4##(1991-5#1)(2008-10#1)
found to be a fairly##2##5##(1992-12#1)(2008-10#1)
found to be a more##3##5##(1994-11#1)(2008-10#2)
found to be a powerful##3##5##(1993-8#1)(2008-11#2)
found to be a suitable##2##5##(2008-10#1)(2008-11#1)
found to be a##35##4##(1990-11#1)(1990-9#1)(1991-5#2)(1992-12#1)(1993-8#1)(1994-11#1)(1996-3#1)(2007-12#1)(2008-10#14)(2008-11#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
found to be accurate##5##4##(2008-10#3)(2010-11#1)(2012-2#1)
found to be active##2##4##(2008-11#1)(2011-1#1)
found to be an##6##4##(1992-3#1)(1996-12#1)(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
found to be approximately##6##4##(2008-10#4)(2008-11#1)(2008-2#1)
found to be associated with a variety of##2##8##(2011-2#1)(2012-3#1)
found to be associated with##7##5##(1993-11#1)(1993-3#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
found to be associated##8##4##(1993-11#1)(1993-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
found to be better than##5##5##(2008-10#4)(2008-5#1)
found to be better##7##4##(2008-10#6)(2008-5#1)
found to be between##6##4##(2008-10#4)(2008-11#1)(2010-4#1)
found to be cell##2##4##(1993-8#1)(2008-11#1)
found to be close to##3##5##(2008-10#2)(2009-5#1)
found to be comparable to##4##5##(2008-10#3)(2008-7#1)
found to be comparable##8##4##(2008-10#7)(2008-7#1)
found to be consistent with##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
found to be consistent##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)
found to be contaminated##2##4##(1994-3#1)(2008-11#1)
found to be dependent on the##3##6##(1991-3#1)(2008-10#2)
found to be dependent on##6##5##(1991-3#1)(1993-8#1)(1995-3#1)(2008-10#2)(2008-11#1)
found to be dependent upon the##2##6##(2008-10#2)
found to be dependent##8##4##(1991-3#1)(1993-8#1)(1995-3#1)(2008-10#4)(2008-11#1)
found to be different##2##4##(1993-12#1)(2008-10#1)
found to be difficult##2##4##(2008-11#1)(2008-12#1)
found to be directly proportional to the##2##7##(2008-10#2)
found to be effective in preventing##2##6##(1992-3#1)(2010-7#1)
found to be effective in##3##5##(1992-3#1)(2008-11#1)(2010-7#1)
found to be effective##4##4##(1992-3#1)(2008-11#1)(2010-7#1)(2012-2#1)
found to be efficient##2##4##(2008-10#1)(2008-5#1)
found to be either##2##4##(1995-11#1)(1997-1#1)
found to be enriched##2##4##(1994-11#1)(2008-10#1)
found to be excellent##2##4##(1997-2#1)(2008-5#1)
found to be expressed##4##4##(1991-6#1)(1995-8#1)(2008-10#1)(2008-11#1)
found to be extracted##4##4##(2008-10#4)
found to be good##2##4##(2008-10#2)
found to be greater than##2##5##(1990-12#1)(2008-2#1)
found to be greater##3##4##(1990-12#1)(1993-6#1)(2008-2#1)
found to be growth##2##4##(2008-11#2)
found to be higher than##3##5##(2008-11#2)(2011-2#1)
found to be higher##5##4##(2008-11#4)(2011-2#1)
found to be highly phosphorylated in##2##6##(1995-6#1)(1995-8#1)
found to be highly##13##4##(1992-12#1)(1995-6#2)(1995-8#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
found to be homologous##2##4##(1996-12#1)(2008-8#1)
found to be identical to that##2##6##(1996-12#1)(2008-10#1)
found to be identical to##3##5##(1996-12#1)(2008-10#2)
found to be identical##5##4##(1990-8#1)(1996-12#1)(2008-10#2)(2008-11#1)
found to be impaired##3##4##(1990-11#1)(2008-7#2)
found to be important##4##4##(1993-12#1)(2008-10#1)(2009-12#1)(2009-7#1)
found to be in the range of 5##2##8##(2008-10#2)
found to be in the range of##6##7##(2008-10#6)
found to be in the range##7##6##(2008-10#7)
found to be in the##8##5##(2008-10#8)
found to be in##17##4##(2008-10#15)(2012-2#1)(2013-8#1)
found to be independent of the##2##6##(2008-10#2)
found to be independent of##3##5##(2008-10#2)(2012-2#1)
found to be independent##4##4##(1990-12#1)(2008-10#2)(2012-2#1)
found to be ineffective##2##4##(1994-2#1)(1996-2#1)
found to be infected##3##4##(2008-10#2)(2011-2#1)
found to be influenced by the##2##6##(1994-5#1)(2008-10#1)
found to be influenced by##3##5##(1994-5#1)(2008-10#1)(2008-11#1)
found to be less than##4##5##(2008-10#3)(2008-11#1)
found to be less##7##4##(2008-10#5)(2008-11#1)(2008-9#1)
found to be linear in the range of##3##8##(2008-10#3)
found to be linear over the##2##6##(2008-10#2)
found to be linear##9##4##(2008-10#7)(2008-11#1)(2012-2#1)
found to be linearly proportional##2##5##(1995-3#1)(2008-10#1)
found to be linearly##3##4##(1995-3#1)(2008-10#2)
found to be linked to##2##5##(2008-10#2)
found to be localized##2##4##(2008-5#1)(2009-10#1)
found to be located##3##4##(1997-6#1)(2008-11#1)(2008-8#1)
found to be mainly##2##4##(2008-5#2)
found to be mediated by##2##5##(2008-11#1)(2009-10#1)
found to be more effective##3##5##(1992-5#1)(2008-10#1)(2012-2#1)
found to be more##12##4##(1990-12#1)(1990-6#1)(1992-5#1)(1993-12#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#2)
found to be most##2##4##(2008-10#2)
found to be much##4##4##(2008-10#3)(2009-7#1)
found to be necessary to##2##5##(2008-10#2)
found to be necessary##5##4##(2008-10#3)(2009-1#1)(2011-2#1)
found to be positively##2##4##(2009-11#1)(2009-7#1)
found to be predominant##2##4##(1990-6#1)(2008-10#1)
found to be present in##5##5##(2008-1#1)(2008-10#2)(2008-12#2)
found to be present##6##4##(2008-1#1)(2008-10#3)(2008-12#2)
found to be quite##3##4##(2008-10#3)
found to be rapid and##2##5##(2008-10#2)
found to be related to##5##5##(1997-1#1)(2008-10#1)(2008-7#2)(2008-9#1)
found to be relatively##6##4##(2008-10#4)(2008-11#1)(2010-7#1)
found to be rich in neutral lipids##2##7##(2008-11#2)
found to be sensitive to##2##5##(1997-2#1)(2008-3#1)
found to be sensitive##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
found to be significant##3##4##(1997-2#1)(2008-10#1)(2008-9#1)
found to be significantly associated with##2##6##(2010-11#1)(2012-2#1)
found to be significantly correlated##2##5##(1992-12#1)(1994-3#1)
found to be significantly different##2##5##(2007-12#1)(2011-2#1)
found to be significantly higher##3##5##(1994-8#1)(1996-1#1)(2008-10#1)
found to be significantly increased in##2##6##(1997-3#1)(2008-11#1)
found to be significantly##18##4##(1992-12#1)(1994-3#1)(1994-8#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-7#1)
found to be similar to##3##5##(1990-2#1)(2008-10#2)
found to be similar##5##4##(1990-2#1)(2008-10#3)(2008-3#1)
found to be slightly more##2##5##(1990-12#1)(1993-12#1)
found to be slightly##3##4##(1990-12#1)(1993-12#1)(1993-2#1)
found to be statistically##5##4##(1990-2#2)(2008-10#1)(2010-8#1)(2011-2#1)
found to be suitable##7##4##(1991-9#1)(2008-10#6)
found to be superior##4##4##(1995-3#1)(1996-2#1)(2008-10#2)
found to be the best##7##5##(1990-9#1)(2008-10#3)(2008-7#1)(2009-7#1)(2011-2#1)
found to be the main##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
found to be the##34##4##(1990-9#1)(1992-1#1)(1994-3#1)(1996-5#1)(1996-9#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2011-2#2)(2012-2#1)
found to be useful for##2##5##(2008-10#1)(2008-11#1)
found to be useful##4##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
found to be variable##2##4##(1993-12#1)(2013-8#1)
found to be very##10##4##(1993-9#1)(1997-8#1)(2008-10#4)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#1)
found to be##764##3##(1990-11#3)(1990-12#5)(1990-2#6)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#4)(1994-11#2)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#5)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#3)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#6)(1996-2#4)(1996-3#1)(1996-5#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#405)(2008-11#48)(2008-12#12)(2008-2#5)(2008-3#9)(2008-5#11)(2008-7#19)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#4)(2009-5#1)(2009-7#5)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#1)(2011-1#2)(2011-2#15)(2012-2#14)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#3)
found to bind##4##3##(1990-11#1)(1995-6#1)(2008-10#1)(2012-2#1)
found to cause##4##3##(1993-2#1)(2008-10#1)(2009-12#1)(2012-3#1)
found to change dramatically##2##4##(1995-12#1)(2008-11#1)
found to consist of##3##4##(1991-10#1)(1993-6#1)(2008-10#1)
found to contain the##2##4##(1993-6#1)(2008-10#1)
found to contain##12##3##(1993-6#1)(1994-5#1)(1994-6#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-5#1)(2011-2#1)
found to correlate with##5##4##(1994-2#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-7#1)
found to correspond to known##2##5##(2008-10#1)(2008-11#1)
found to correspond to##4##4##(2008-10#3)(2008-11#1)
found to decrease the##5##4##(1990-5#1)(1997-2#1)(2008-10#1)(2010-4#1)(2012-2#1)
found to decrease with##3##4##(1996-3#1)(2008-10#2)
found to decrease##15##3##(1990-5#3)(1994-5#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
found to depend on the##2##5##(1991-1#1)(2008-10#1)
found to depend on##3##4##(1991-1#1)(2008-10#2)
found to depend##4##3##(1991-1#1)(2008-10#2)(2008-11#1)
found to display unique photophysical properties in the presence of##2##10##(2008-10#2)
found to display##3##3##(2008-10#2)(2012-2#1)
found to encode a##2##4##(1993-12#1)(1997-7#1)
found to encode##4##3##(1992-10#1)(1993-12#1)(1994-12#1)(1997-7#1)
found to enhance the acetylcholinesterase (AChE) activity of the rat neuronal cell line PC12 at##2##15##(2008-11#2)
found to enhance the##6##4##(2008-10#2)(2008-11#3)(2012-2#1)
found to enhance##7##3##(1991-2#1)(2008-10#2)(2008-11#3)(2012-2#1)
found to exhibit a##3##4##(2008-10#3)
found to exhibit##4##3##(2008-10#3)(2009-5#1)
found to exist##6##3##(1992-3#1)(1996-12#1)(2008-10#4)
found to express##2##3##(1996-12#1)(2008-5#1)
found to fall##2##3##(2008-10#2)
found to give the##3##4##(2008-10#2)(2008-11#1)
found to give##11##3##(2008-10#9)(2008-11#1)(2008-7#1)
found to have a significant##2##5##(2008-2#1)(2008-5#1)
found to have a##23##4##(1992-6#1)(1993-3#1)(1993-9#1)(1994-11#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
found to have an##6##4##(2008-10#3)(2008-11#1)(2008-7#2)
found to have approximately##2##4##(1992-6#1)(2009-3#1)
found to have significant##4##4##(1993-2#1)(2008-10#3)
found to have the greatest##2##5##(2008-10#1)(2012-3#1)
found to have the##3##4##(2008-10#1)(2011-3#1)(2012-3#1)
found to have##80##3##(1992-12#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#4)(2009-11#1)(2009-3#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
found to hold##2##3##(2008-9#1)(2011-2#1)
found to include##2##3##(1993-2#1)(2009-7#1)
found to increase##11##3##(1992-8#1)(1994-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)
found to induce##4##3##(1990-5#1)(1993-6#1)(1994-9#1)(2008-10#1)
found to influence##2##3##(2009-7#1)(2009-9#1)
found to inhibit the growth of##2##6##(2008-10#2)
found to inhibit the##3##4##(1994-5#1)(2008-10#2)
found to inhibit##9##3##(1994-5#2)(1994-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)
found to lie##2##3##(2008-10#2)
found to limit the##2##4##(2008-10#1)(2008-2#1)
found to mediate##2##3##(2008-6#1)(2009-10#1)
found to occur##4##3##(1990-11#2)(1996-12#1)(2008-10#1)
found to possess##2##3##(2008-10#1)(2008-11#1)
found to produce a##3##4##(2008-10#3)
found to produce##7##3##(2008-10#4)(2008-11#1)(2008-12#1)(2012-2#1)
found to provide the best##2##5##(2008-10#2)
found to provide##6##3##(2008-10#5)(2008-3#1)
found to range from##2##4##(2008-10#1)(2012-3#1)
found to react##2##3##(2008-10#2)
found to reduce##3##3##(1993-2#1)(2008-10#2)
found to relate##2##3##(2008-10#1)(2008-11#1)
found to release##2##3##(1997-1#1)(2008-5#1)
found to respond##2##3##(1990-12#1)(2008-11#1)
found to selectively##2##3##(1992-6#1)(2008-10#1)
found to share significant homology##2##5##(1993-12#1)(1995-2#1)
found to share##3##3##(1993-12#1)(1995-2#1)(1995-6#1)
found to show an##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
found to show##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
found to significantly##3##3##(1990-12#1)(1991-12#1)(2008-10#1)
found to stimulate##3##3##(1990-10#1)(1992-3#1)(1995-2#1)
found to strongly##3##3##(1995-6#1)(2008-10#2)
found to substantially##2##3##(2008-10#2)
found to vary##7##3##(1995-3#1)(1997-3#1)(2008-10#4)(2009-7#1)
found to##1155##2##(1990-10#1)(1990-11#6)(1990-12#7)(1990-2#7)(1990-5#7)(1990-6#4)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#6)(1991-6#3)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#10)(1993-2#5)(1993-3#3)(1993-6#6)(1993-8#4)(1993-9#5)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#6)(1994-5#9)(1994-6#3)(1994-8#7)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#7)(1995-3#4)(1995-6#9)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#9)(1996-2#6)(1996-3#4)(1996-5#8)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#6)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#3)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#547)(2008-11#87)(2008-12#21)(2008-2#8)(2008-3#14)(2008-5#20)(2008-6#2)(2008-7#29)(2008-8#14)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#6)(2009-3#6)(2009-5#2)(2009-6#1)(2009-7#11)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#8)(2011-2#21)(2011-3#3)(2012-12#1)(2012-2#25)(2012-3#10)(2013-1#18)(2013-7#2)(2013-8#6)
found two##4##2##(1995-2#1)(2008-10#2)(2008-3#1)
found upstream of##2##3##(1997-3#1)(2008-10#1)
found using##3##2##(2008-8#2)(2013-1#1)
found values##3##2##(2008-10#3)
found was##2##2##(1995-11#1)(2008-10#1)
found were##8##2##(2008-10#7)(2012-12#1)
found when a##2##3##(1997-8#1)(2009-10#1)
found when the##4##3##(1994-3#2)(2008-10#1)(2008-3#1)
found when##13##2##(1994-3#2)(1996-2#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-10#1)(2011-2#1)(2011-3#1)
found which##6##2##(1990-11#1)(1990-12#1)(2008-10#2)(2011-2#1)(2012-12#1)
found with high##2##3##(2008-10#1)(2008-7#1)
found with increasing##2##3##(2008-10#1)(2008-7#1)
found with the##6##3##(1990-9#1)(1992-2#1)(2008-10#4)
found with##38##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1993-6#2)(1994-5#2)(1996-2#1)(2008-10#12)(2008-3#1)(2008-7#5)(2009-5#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
found within a##4##3##(1992-9#1)(1996-6#1)(2008-10#2)
found within the##5##3##(1991-9#1)(1993-12#1)(1994-3#1)(2008-10#2)
found within##18##2##(1991-9#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-6#1)(2006-6#1)(2008-10#9)(2008-7#1)(2009-10#1)
found without##3##2##(1991-11#1)(1991-12#1)(2008-7#1)
found##3604##1##(1990-10#1)(1990-11#13)(1990-12#20)(1990-2#20)(1990-3#9)(1990-5#19)(1990-6#13)(1990-8#6)(1990-9#9)(1991-1#4)(1991-10#4)(1991-11#5)(1991-12#13)(1991-2#11)(1991-3#7)(1991-5#19)(1991-6#11)(1991-7#3)(1991-8#1)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#17)(1992-2#6)(1992-3#14)(1992-5#3)(1992-6#7)(1992-8#7)(1992-9#4)(1993-1#6)(1993-11#5)(1993-12#26)(1993-2#20)(1993-3#8)(1993-6#16)(1993-8#14)(1993-9#9)(1994-1#3)(1994-11#21)(1994-12#8)(1994-2#11)(1994-3#19)(1994-5#18)(1994-6#5)(1994-8#16)(1994-9#2)(1995-1#2)(1995-11#14)(1995-12#16)(1995-2#24)(1995-3#9)(1995-5#2)(1995-6#17)(1995-8#11)(1995-9#3)(1996-1#5)(1996-11#2)(1996-12#24)(1996-2#19)(1996-3#7)(1996-5#19)(1996-6#12)(1996-8#8)(1996-9#7)(1997-1#10)(1997-2#17)(1997-3#25)(1997-4#5)(1997-5#1)(1997-6#10)(1997-7#7)(1997-8#18)(1997-9#2)(2006-6#2)(2007-11#9)(2007-12#18)(2007-8#5)(2008-1#11)(2008-10#1348)(2008-11#232)(2008-12#75)(2008-2#14)(2008-3#52)(2008-4#6)(2008-5#77)(2008-6#16)(2008-7#110)(2008-8#94)(2008-9#84)(2009-1#5)(2009-10#19)(2009-11#9)(2009-12#14)(2009-3#9)(2009-4#5)(2009-5#6)(2009-6#5)(2009-7#24)(2009-8#34)(2009-9#6)(2010-1#11)(2010-10#5)(2010-11#7)(2010-12#12)(2010-2#4)(2010-3#7)(2010-4#9)(2010-5#12)(2010-6#3)(2010-7#14)(2010-8#10)(2010-9#5)(2011-1#27)(2011-10#1)(2011-2#132)(2011-3#11)(2011-4#1)(2012-12#22)(2012-2#71)(2012-3#53)(2012-4#1)(2012-5#3)(2012-6#1)(2013-1#86)(2013-7#8)(2013-8#37)
foundation and##4##2##(2008-10#2)(2010-1#1)(2013-1#1)
foundation for a##4##3##(1996-1#1)(2008-10#1)(2009-10#1)(2012-12#1)
foundation for further##2##3##(2008-10#1)(2013-8#1)
foundation for the development##2##4##(2008-10#1)(2013-8#1)
foundation for the##5##3##(1995-12#1)(2008-10#2)(2010-5#1)(2013-8#1)
foundation for##32##2##(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-1#2)(1996-2#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-9#1)(2012-12#1)(2013-8#2)
foundation in##2##2##(1993-11#1)(2008-12#1)
foundation with##2##2##(1993-12#1)(2008-5#1)
foundation##63##1##(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#2)
foundational##5##1##(2008-11#1)(2008-12#1)(2010-9#1)(2012-3#1)(2013-1#1)
foundations for##2##2##(1995-2#1)(2008-11#1)
foundations of##6##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2013-1#1)
foundations##16##1##(1991-1#1)(1992-12#1)(1993-12#2)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2010-4#2)(2012-2#1)(2013-1#1)
founded and##2##2##(2010-1#1)(2011-4#1)
founded by##2##2##(2008-10#1)(2008-6#1)
founded in##5##2##(1992-1#1)(1993-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
founded on the##2##3##(2008-2#1)(2013-1#1)
founded on##5##2##(1993-11#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
founded##20##1##(1992-1#1)(1993-11#1)(1993-12#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2010-1#1)(2010-10#1)(2011-2#1)(2011-4#2)(2012-3#1)(2013-1#1)
founder##8##1##(2008-10#6)(2008-8#1)(2009-6#1)
founding##3##1##(2008-10#1)(2008-9#1)(2013-8#1)
foundresses##2##1##(2008-8#2)
fountain##3##1##(2008-10#2)(2011-2#1)
four E##2##2##(1995-6#2)
four European##2##2##(2008-10#2)
four Fusarium spp##2##3##(2008-10#2)
four QTL##2##2##(2008-10#1)(2012-3#1)
four S compounds##3##3##(2008-10#3)
four Venezuelan##3##2##(2008-10#1)(2011-2#2)
four additional##3##2##(1995-6#1)(2008-10#2)
four amino acid##2##3##(2008-10#1)(2013-1#1)
four amino##4##2##(1992-9#1)(1994-8#1)(2008-10#1)(2013-1#1)
four analytes##3##2##(2008-10#3)
four and five##3##3##(2008-10#1)(2012-2#2)
four and##5##2##(1992-5#1)(2008-10#1)(2010-12#1)(2012-2#2)
four anions##2##2##(2008-10#2)
four aortic##2##2##(2013-3#2)
four apple cultivars##2##3##(2008-10#2)
four areas##3##2##(1993-12#1)(2008-12#1)(2008-5#1)
four articles describing##2##3##(1997-1#1)(2012-12#1)
four bands##3##2##(2008-10#2)(2008-9#1)
four cases of##8##3##(1991-12#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#3)(2009-6#1)
four cases##22##2##(1990-12#1)(1990-9#2)(1991-12#2)(1994-12#3)(1996-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)
four categories of##3##3##(1994-12#2)(2013-1#1)
four categories##6##2##(1994-12#2)(1997-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
four chemicals##2##2##(2008-5#2)
four classes of##2##3##(2008-10#1)(2011-2#1)
four classes##3##2##(1990-3#1)(2008-10#1)(2011-2#1)
four closely related##2##3##(2012-3#1)(2012-5#1)
four closely##3##2##(2008-12#1)(2012-3#1)(2012-5#1)
four clusters##5##2##(2008-10#5)
four combinations of##2##3##(2008-10#1)(2008-9#1)
four commercial##2##2##(2008-10#2)
four common##3##2##(2008-10#2)(2010-9#1)
four compounds##5##2##(1992-3#1)(2008-10#3)(2008-9#1)
four consecutive##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
four countries##3##2##(1990-11#1)(2009-3#2)
four cultivars were##2##3##(2008-10#1)(2011-10#1)
four cultivars##5##2##(2008-10#4)(2011-10#1)
four cycles of##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
four days before##2##3##(2008-10#1)(2008-11#1)
four days of##2##3##(2008-11#1)(2008-2#1)
four days##11##2##(1993-2#1)(2008-10#2)(2008-11#5)(2008-2#1)(2010-4#1)(2013-1#1)
four decades##4##2##(1994-3#1)(1997-1#1)(1997-7#1)(2008-10#1)
four different genotypes##2##3##(2008-10#2)
four different nursing homes in##2##5##(2010-10#2)
four different temperatures##2##3##(2008-10#2)
four different##51##2##(1990-2#1)(1991-3#1)(1993-11#1)(1995-12#1)(2008-10#36)(2008-11#2)(2008-2#1)(2008-5#3)(2008-8#1)(2010-10#2)(2013-1#1)(2013-8#1)
four dimensions of OCE##2##4##(2011-2#2)
four dimensions of##4##3##(2011-2#4)
four dimensions##8##2##(2008-6#1)(2009-1#1)(2011-2#4)(2012-3#2)
four directions##3##2##(2008-10#3)
four distinct##11##2##(1995-12#1)(1996-3#1)(1997-6#1)(2008-10#4)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
four eastern##2##2##(2008-10#2)
four elements##2##2##(2008-10#1)(2008-6#1)
four episodes##2##2##(2012-12#2)
four exons##4##2##(1993-2#1)(1993-6#1)(1994-11#2)
four experiments##3##2##(2008-6#1)(2011-1#1)(2013-8#1)
four factors##4##2##(2008-10#3)(2008-11#1)
four families##2##2##(1992-7#1)(2013-8#1)
four field experiments##3##3##(2008-10#3)
four field##5##2##(2008-10#5)
four flavonoids##3##2##(2008-10#3)
four fluorescence##2##2##(2008-4#1)(2008-9#1)
four fluoroquinolones##3##2##(2008-10#1)(2008-7#2)
four fractions##2##2##(2008-10#1)(2013-1#1)
four genes##10##2##(1993-12#1)(1993-6#1)(1995-12#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2012-3#1)
four genotypes##2##2##(2008-10#2)
four groups based on##3##4##(2008-9#1)(2010-8#1)(2011-2#1)
four groups of##3##3##(1991-7#1)(1992-2#1)(2013-1#1)
four groups were##3##3##(1993-3#1)(2008-10#1)(2008-12#1)
four groups##31##2##(1991-2#1)(1991-7#1)(1992-1#2)(1992-2#1)(1993-3#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-7#3)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#5)(2013-1#4)
four growing##2##2##(2008-10#1)(2013-1#1)
four had##2##2##(2008-5#1)(2008-9#1)
four highly##2##2##(1997-1#1)(2008-10#1)
four hormones##2##2##(1995-11#1)(2013-7#1)
four hospitals##2##2##(1992-5#1)(1994-3#1)
four hours after the##2##4##(2008-12#1)(2008-7#1)
four hours after##3##3##(2008-12#1)(2008-7#1)(2012-12#1)
four hours##4##2##(1990-2#1)(2008-12#1)(2008-7#1)(2012-12#1)
four impurities##3##2##(2008-10#3)
four in##3##2##(2008-10#3)
four isolates of BSV##2##4##(2008-10#2)
four isolates of##4##3##(2008-10#4)
four isolates##7##2##(2008-10#7)
four key##6##2##(1995-3#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-9#1)
four kinds of##6##3##(2008-10#5)(2008-5#1)
four leaves##2##2##(2008-10#1)(2008-12#1)
four levels of##3##3##(2008-10#2)(2013-3#1)
four levels##5##2##(2008-10#3)(2008-9#1)(2013-3#1)
four lineages##2##2##(2008-10#2)
four locations##6##2##(2008-10#5)(2010-12#1)
four main##4##2##(1990-5#1)(2009-5#1)(2011-2#1)(2012-3#1)
four major taxa##2##3##(2008-10#1)(2008-9#1)
four major##12##2##(1991-2#1)(1995-6#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
four mammalian##4##2##(1997-7#1)(2008-11#2)(2008-8#1)
four markers (Kmy1##2##3##(1997-8#2)
four markers##3##2##(1997-8#2)(2008-10#1)
four medical##2##2##(1991-6#1)(2012-3#1)
four metabolites##2##2##(2008-10#1)(2008-11#1)
four methods##4##2##(2008-10#4)
four microsatellite loci##2##3##(2008-10#2)
four microsatellite##3##2##(2008-10#3)
four mixtures##2##2##(2008-10#2)
four models##2##2##(2008-11#1)(2010-4#1)
four modifiable risk factors##2##4##(2008-1#2)
four months##12##2##(1990-9#1)(1993-2#1)(1993-8#2)(1994-6#2)(1997-5#1)(2008-10#2)(2010-11#1)(2010-12#1)(2011-2#1)
four multivariate methods##2##3##(2008-10#2)
four municipalities##2##2##(1994-6#2)
four new##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
four novel##3##2##(1991-5#2)(2008-10#1)
four of seven##3##3##(2008-10#3)
four of six##5##3##(1994-5#1)(2008-10#1)(2008-5#2)(2008-7#1)
four of the five##6##4##(1991-6#1)(1995-5#1)(1997-8#1)(2008-10#3)
four of the six##3##4##(1990-5#1)(2008-8#1)(2013-8#1)
four of the##14##3##(1990-5#1)(1991-6#1)(1994-6#1)(1995-5#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2013-8#2)
four of them##3##3##(1993-2#1)(1995-3#1)(2011-2#1)
four of these##4##3##(1995-9#1)(2008-10#1)(2008-11#1)(2009-8#1)
four of##39##2##(1990-5#1)(1991-6#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-8#2)
four oligopeptide substrates##2##3##(1991-9#2)
four open reading frames##5##4##(1997-3#1)(2008-10#3)(2008-8#1)
four or more##2##3##(1997-7#1)(2010-6#1)
four orders of magnitude##3##4##(2008-10#2)(2012-2#1)
four orders of##5##3##(2008-10#4)(2012-2#1)
four other cases##2##3##(2006-6#1)(2011-2#1)
four other##11##2##(2006-6#1)(2008-10#7)(2008-11#1)(2009-8#1)(2011-2#1)
four out of five##3##4##(1991-9#1)(1993-8#1)(2008-10#1)
four out of##5##3##(1991-9#1)(1993-8#1)(2008-10#2)(2008-5#1)
four outcomes##2##2##(2008-7#1)(2008-8#1)
four pH values##2##3##(2008-10#1)(2008-5#1)
four pairs of##4##3##(1996-5#1)(2008-10#1)(2008-12#1)(2008-6#1)
four patients with##8##3##(1993-2#1)(1994-12#1)(1996-9#1)(2008-12#2)(2008-7#1)(2009-8#1)(2013-8#1)
four patients##36##2##(1990-9#1)(1991-11#1)(1991-8#1)(1993-1#1)(1993-2#2)(1993-3#2)(1994-12#1)(1996-9#1)(1997-8#2)(2008-10#2)(2008-12#3)(2008-5#3)(2008-7#5)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
four peaks##4##2##(2008-10#1)(2008-8#3)
four pear##2##2##(2008-10#2)
four phenotypes##2##2##(2008-10#2)
four plants##2##2##(2008-10#2)
four points##4##2##(1995-1#1)(2008-12#1)(2009-2#1)(2010-5#1)
four populations collected from##2##4##(2008-10#2)
four populations##4##2##(2008-10#4)
four potential##2##2##(1993-8#1)(2010-4#1)
four predictors##2##2##(1992-3#1)(2011-2#1)
four previously##3##2##(2008-10#2)(2013-8#1)
four primary##5##2##(1990-12#2)(1994-2#1)(1995-12#1)(2012-12#1)
four principal##2##2##(1991-3#1)(2008-5#1)
four procedures##3##2##(1995-2#1)(2008-10#2)
four putative##2##2##(1995-9#1)(2008-10#1)
four quadrants of##2##3##(2009-7#2)
four randomized##2##2##(2010-12#1)(2012-3#1)
four regions of##2##3##(2008-11#1)(2013-8#1)
four regions##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
four replicate##2##2##(2008-10#1)(2008-8#1)
four replications##6##2##(2008-10#4)(2008-12#2)
four restriction enzymes##2##3##(2008-10#2)
four restriction##3##2##(2008-10#3)
four rounds of##2##3##(2008-10#2)
four samples of##2##3##(2008-3#1)(2010-10#1)
four samples##5##2##(2008-10#2)(2008-3#1)(2010-10#1)(2011-2#1)
four seasons##2##2##(2008-10#1)(2008-12#1)
four sections##3##2##(2008-10#1)(2010-6#1)(2012-2#1)
four selected##3##2##(2008-8#1)(2011-3#1)(2013-8#1)
four separate##3##2##(1994-2#1)(2008-10#2)
four serogroups##2##2##(2008-10#2)
four sets of##2##3##(2008-10#1)(2008-9#1)
four siblings##2##2##(2011-1#2)
four sites were##2##3##(1993-12#1)(2008-11#1)
four sites##6##2##(1991-3#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#2)
four smaller##2##2##(1991-5#1)(2008-10#1)
four social health maintenance##2##4##(1991-3#1)(1992-1#1)
four sociologists##2##2##(2008-12#2)
four solar radiometers##2##3##(2008-3#2)
four species of##3##3##(2008-8#1)(2009-8#1)(2010-8#1)
four species##11##2##(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-3#1)(2012-5#2)
four stages of##2##3##(2008-10#1)(2008-7#1)
four stages##5##2##(1991-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
four standard reference materials##2##4##(2008-10#2)
four standard##3##2##(2008-10#3)
four states##3##2##(2008-10#3)
four stationary phases##2##3##(2008-10#2)
four step##2##2##(1992-12#1)(2008-10#1)
four steps##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
four strains and##2##3##(2008-10#2)
four strains of X##3##4##(2008-10#3)
four strains of##5##3##(1990-5#1)(2008-10#3)(2013-1#1)
four strains##12##2##(1990-5#1)(2008-10#10)(2013-1#1)
four studies##4##2##(2008-11#2)(2008-5#1)(2011-2#1)
four subgroups##5##2##(1990-8#1)(2008-10#3)(2009-8#1)
four subpopulations##5##2##(2008-10#3)(2008-11#1)(2008-9#1)
four subtropical##2##2##(2008-8#2)
four successive##3##2##(2008-10#2)(2008-8#1)
four taxa##2##2##(2008-11#1)(2008-12#1)
four temperatures##2##2##(2008-10#1)(2010-4#1)
four times##13##2##(2007-12#1)(2008-10#6)(2008-11#1)(2009-1#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
four to five##3##3##(1993-1#1)(2008-10#2)
four to##7##2##(1993-1#1)(1997-3#1)(2008-10#4)(2008-11#1)
four treatments##4##2##(2008-10#1)(2008-12#1)(2012-6#1)(2012-9#1)
four types of##7##3##(1990-2#1)(1991-2#1)(2008-10#3)(2008-5#1)(2009-8#1)
four types##8##2##(1990-2#1)(1991-2#1)(2008-10#4)(2008-5#1)(2009-8#1)
four variables##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
four videos##2##2##(2008-11#1)(2008-9#1)
four weeks##4##2##(1991-6#1)(2013-1#2)(2013-8#1)
four were##5##2##(2008-10#2)(2009-3#1)(2010-1#1)(2012-3#1)
four who##2##2##(1990-11#1)(2008-1#1)
four year##2##2##(1997-8#1)(2008-11#1)
four years of##2##3##(2008-11#1)(2009-9#1)
four years##12##2##(1990-11#1)(1990-12#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-2#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2009-9#1)(2011-2#1)
four##1253##1##(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#4)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#4)(1991-5#3)(1991-6#7)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#5)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#8)(1992-4#4)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#10)(1993-3#7)(1993-6#7)(1993-8#7)(1993-9#3)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#3)(1994-6#6)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#8)(1995-8#1)(1995-9#6)(1996-1#2)(1996-12#7)(1996-2#3)(1996-3#7)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#12)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#13)(1997-9#2)(2006-6#1)(2007-11#4)(2007-12#4)(2008-1#9)(2008-10#507)(2008-11#55)(2008-12#37)(2008-2#2)(2008-3#9)(2008-4#7)(2008-5#40)(2008-6#7)(2008-7#29)(2008-8#29)(2008-9#24)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#7)(2010-3#4)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#9)(2010-9#2)(2011-1#5)(2011-10#2)(2011-2#49)(2011-3#2)(2012-12#9)(2012-2#10)(2012-3#21)(2012-5#3)(2012-6#1)(2012-7#1)(2012-9#2)(2013-1#30)(2013-3#3)(2013-7#1)(2013-8#16)
four)##2##1##(1995-12#1)(2008-10#1)
four- and##3##2##(2008-10#2)(2011-1#1)
four-##5##1##(2008-10#4)(2011-1#1)
four-channel##6##1##(1996-1#2)(2007-12#1)(2008-10#2)(2008-3#1)
four-color##5##1##(2008-4#1)(2008-9#4)
four-flux##3##1##(2008-2#1)(2008-3#2)
four-fold##2##1##(2008-10#1)(2008-11#1)
four-leaf##3##1##(2008-10#2)(2012-3#1)
four-level##2##1##(2008-3#1)(2010-10#1)
four-part##4##1##(2008-9#1)(2009-12#1)(2012-3#1)(2013-8#1)
four-point##2##1##(2008-2#1)(2011-2#1)
four-wave mixing in##3##3##(2007-11#3)
four-wave mixing##11##2##(1991-9#1)(2007-11#4)(2007-12#2)(2008-3#4)
four-way##2##1##(1995-8#1)(2009-9#1)
four-week##3##1##(1992-9#1)(2008-5#1)(2011-3#1)
fourfold##7##1##(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#2)
fourier transform##4##2##(2008-10#1)(2008-3#3)
fourier##9##1##(2008-10#2)(2008-3#7)
fourier-transform##2##1##(2008-3#2)
fourteen##9##1##(1992-1#1)(1995-12#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-3#2)
fourth and fifth##10##3##(1997-3#2)(2008-10#3)(2010-11#2)(2010-3#2)(2012-3#1)
fourth and##12##2##(1997-3#2)(2008-10#3)(2010-11#2)(2010-3#2)(2012-3#2)(2012-9#1)
fourth derivative spectrophotometry##2##3##(2008-10#2)
fourth derivative##3##2##(2008-10#3)
fourth ed##2##2##(2008-11#2)
fourth month##2##2##(1990-9#1)(2007-8#1)
fourth year##3##2##(1992-12#2)(2008-10#1)
fourth##81##1##(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-12#2)(1993-3#2)(1993-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2010-11#2)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#6)
fourth-order##4##1##(2008-2#1)(2008-3#1)(2008-6#2)
foveal##4##1##(2011-7#1)(2013-1#3)
fox##5##1##(1994-8#3)(1996-12#2)
foxes##3##1##(1996-12#2)(2008-12#1)
foxtail millet##4##2##(2008-10#4)
foxtail##7##1##(2008-10#7)
fr##3##1##(2008-10#2)(2008-11#1)
fractal design##2##2##(2008-10#2)
fractal dimension##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
fractal geometry##2##2##(2011-2#2)
fractal##13##1##(2008-10#4)(2008-3#2)(2008-8#4)(2011-2#3)
fractal-based##2##1##(2008-10#1)(2009-12#1)
fractal-like##2##1##(2008-10#1)(2012-2#1)
fraction 9##3##2##(1992-12#3)
fraction B##2##2##(1990-5#2)
fraction F1##4##2##(2008-11#4)
fraction and the##5##3##(1993-2#2)(2008-10#1)(2008-9#1)(2009-3#1)
fraction and##18##2##(1993-2#2)(1993-8#1)(1994-2#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2012-2#2)(2012-5#1)(2013-1#1)
fraction containing##3##2##(1990-7#1)(1993-6#1)(2008-10#1)
fraction for##3##2##(1992-6#1)(2008-10#2)
fraction from##5##2##(1990-2#1)(1994-11#1)(1996-2#2)(2012-2#1)
fraction in the##5##3##(1997-7#1)(2008-10#3)(2008-11#1)
fraction in##9##2##(1991-12#1)(1994-2#1)(1997-7#1)(2008-10#5)(2008-11#1)
fraction increased##2##2##(2008-10#1)(2011-2#1)
fraction of 0##2##3##(2008-10#2)
fraction of a##2##3##(1997-6#1)(2008-3#1)
fraction of arsenic##2##3##(2008-10#2)
fraction of both##2##3##(2008-10#2)
fraction of cells##3##3##(1997-1#1)(2008-11#1)(2008-9#1)
fraction of metals##3##3##(2008-10#3)
fraction of patients##2##3##(1995-2#1)(2008-3#1)
fraction of smoking mothers##2##4##(1991-11#2)
fraction of the##28##3##(1993-8#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
fraction of these##2##3##(2008-11#1)(2013-1#1)
fraction of total cells that##2##5##(2008-7#2)
fraction of total##4##3##(2008-10#2)(2008-7#2)
fraction of##126##2##(1990-5#1)(1990-8#1)(1991-11#5)(1991-12#1)(1991-5#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#3)(1997-1#3)(1997-6#2)(2008-10#45)(2008-11#10)(2008-12#1)(2008-3#4)(2008-5#3)(2008-7#14)(2008-8#4)(2008-9#1)(2011-2#3)(2011-3#2)(2012-2#1)(2013-1#3)(2013-8#2)
fraction to##2##2##(2008-10#1)(2008-4#1)
fraction was##18##2##(1990-5#3)(1991-5#1)(1995-2#1)(1997-5#1)(2008-10#7)(2008-11#1)(2008-12#2)(2011-2#1)(2013-8#1)
fraction were##5##2##(2008-10#2)(2008-11#3)
fraction with a##2##3##(1992-11#1)(2008-10#1)
fraction with##7##2##(1991-12#1)(1991-5#1)(1992-11#1)(1997-2#1)(2008-10#3)
fraction##349##1##(1990-11#2)(1990-2#3)(1990-5#10)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#5)(1991-12#5)(1991-5#5)(1992-11#1)(1992-12#4)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#7)(1994-12#1)(1994-2#5)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#7)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#6)(1996-3#1)(1997-1#3)(1997-2#5)(1997-5#2)(1997-6#2)(1997-7#1)(2008-10#121)(2008-11#34)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#19)(2008-8#6)(2008-9#4)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#9)(2011-3#2)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#7)
fraction)##5##1##(1991-2#1)(2008-10#3)(2008-11#1)
fractional derivative##2##2##(2008-3#2)
fractional distribution##2##2##(2008-10#2)
fractional factorial design##7##3##(2008-10#6)(2013-1#1)
fractional factorial##9##2##(2008-10#8)(2013-1#1)
fractional fiber shortening is##2##4##(2012-2#2)
fractional fiber shortening##4##3##(2012-2#4)
fractional interception##2##2##(2008-10#2)
fractional##35##1##(1992-3#1)(1993-5#1)(1994-5#1)(1995-3#1)(1996-12#2)(1997-8#1)(2008-10#13)(2008-11#1)(2008-3#5)(2008-7#3)(2012-2#4)(2012-3#1)(2013-1#1)
fractionate##6##1##(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)
fractionated by##6##2##(1991-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
fractionated into##2##2##(2008-10#2)
fractionated on##5##2##(1991-5#1)(1993-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
fractionated radiotherapy##2##2##(1997-4#1)(2008-10#1)
fractionated with##2##2##(2008-10#1)(2008-12#1)
fractionated##30##1##(1991-12#1)(1991-5#1)(1993-2#1)(1993-3#1)(1993-9#1)(1996-10#1)(1997-2#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#2)
fractionation and##5##2##(2008-10#2)(2008-4#1)(2011-2#1)(2012-2#1)
fractionation channel is##2##3##(2008-10#2)
fractionation channel##3##2##(2008-10#3)
fractionation data##2##2##(2008-10#2)
fractionation in##6##2##(1995-6#1)(2008-10#5)
fractionation is##3##2##(2008-10#2)(2008-4#1)
fractionation of arsenic in soils##2##5##(2008-10#2)
fractionation of arsenic in##3##4##(2008-10#3)
fractionation of arsenic##4##3##(2008-10#4)
fractionation of metals##2##3##(2008-10#2)
fractionation of the##2##3##(2008-11#1)(2008-5#1)
fractionation of tissue culture cells##3##5##(2008-4#3)
fractionation of trace##2##3##(2008-10#2)
fractionation of##32##2##(1993-12#1)(1993-8#1)(2008-10#21)(2008-11#4)(2008-4#4)(2008-5#1)
fractionation procedures##2##2##(2008-11#1)(2008-4#1)
fractionation process##2##2##(2008-7#2)
fractionation scheme##2##2##(2008-10#2)
fractionation studies##2##2##(1995-6#2)
fractionation techniques##4##2##(1995-6#1)(2008-4#3)
fractionation with##2##2##(2008-10#2)
fractionation##96##1##(1990-11#1)(1990-5#2)(1991-12#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#4)(1997-1#1)(2008-10#55)(2008-11#10)(2008-4#11)(2008-5#1)(2008-7#3)(2011-2#2)(2012-2#1)
fractionations##4##1##(1997-1#1)(2008-10#1)(2008-11#1)(2009-8#1)
fractions A and B##2##4##(1990-5#2)
fractions and##9##2##(1993-11#1)(1994-11#1)(2008-10#4)(2008-11#2)(2011-2#1)
fractions are##2##2##(2008-10#1)(2008-7#1)
fractions at##3##2##(2008-10#2)(2008-7#1)
fractions by##4##2##(2008-10#4)
fractions collected from##2##3##(2008-10#1)(2012-2#1)
fractions contained##2##2##(1996-2#1)(2008-10#1)
fractions containing##3##2##(1997-3#1)(2008-10#2)
fractions demonstrated##2##2##(1996-2#1)(2008-11#1)
fractions for##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
fractions from##5##2##(1996-2#1)(2008-10#3)(2008-11#1)
fractions had##2##2##(1996-2#1)(2008-11#1)
fractions in a##2##3##(1996-2#1)(2008-10#1)
fractions in##8##2##(1991-12#2)(1996-2#1)(2008-10#5)
fractions of high##2##3##(1990-5#1)(2008-10#1)
fractions of natural##2##3##(2008-10#1)(2011-2#1)
fractions of the##8##3##(1990-5#1)(1991-6#1)(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
fractions of these##2##3##(1992-6#1)(2008-10#1)
fractions of##45##2##(1990-11#2)(1990-5#2)(1991-6#1)(1992-6#1)(1993-8#1)(1994-11#2)(1995-12#1)(1997-1#2)(2008-10#22)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2011-2#1)(2012-3#1)
fractions showed that the##3##4##(1995-8#1)(2008-10#2)
fractions that##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
fractions was##7##2##(1991-12#1)(1997-2#1)(2008-10#5)
fractions were##13##2##(1995-8#1)(2008-10#8)(2008-11#3)(2008-5#1)
fractions with##5##2##(1993-8#1)(2008-10#2)(2008-2#1)(2009-11#1)
fractions##225##1##(1990-11#5)(1990-12#1)(1990-5#10)(1991-12#4)(1991-5#2)(1991-6#2)(1991-8#1)(1992-11#2)(1992-6#2)(1993-11#2)(1993-8#4)(1994-11#3)(1994-8#1)(1995-12#1)(1995-8#2)(1996-12#2)(1996-2#8)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(2008-10#114)(2008-11#27)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)
fractions)##2##1##(2008-10#2)
fractions/##2##1##(2008-10#2)
fracture and##9##2##(1991-11#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-1#1)(2011-2#1)(2013-1#2)
fracture are##2##2##(2007-8#1)(2008-5#1)
fracture as##2##2##(2009-1#1)(2013-1#1)
fracture at##2##2##(2008-11#1)(2013-1#1)
fracture cases##3##2##(2008-11#1)(2011-2#2)
fracture dislocation##4##2##(2012-2#4)
fracture fragments##2##2##(2008-12#2)
fracture gap##3##2##(2009-3#2)(2012-2#1)
fracture in the##2##3##(1991-11#1)(2008-8#1)
fracture in##4##2##(1991-11#1)(1991-8#1)(2008-8#1)(2013-1#1)
fracture is the most##2##4##(1996-6#1)(2013-1#1)
fracture is##4##2##(1996-6#1)(2011-2#1)(2013-1#2)
fracture line orientation##2##3##(2013-1#2)
fracture line##4##2##(2011-2#1)(2013-1#3)
fracture of human##2##3##(2008-5#1)(2013-8#1)
fracture of the##6##3##(2008-12#1)(2009-1#1)(2009-5#1)(2013-1#3)
fracture of##15##2##(1991-11#1)(2008-12#2)(2008-5#2)(2009-1#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#5)(2013-8#1)
fracture resistance##5##2##(2011-2#1)(2013-1#4)
fracture risk##4##2##(2008-8#1)(2010-10#1)(2011-2#2)
fracture site##3##2##(2008-9#2)(2011-2#1)
fracture strain##2##2##(2009-7#2)
fracture strength##2##2##(2012-2#2)
fracture threshold&quot##3##2##(1991-11#3)
fracture was##5##2##(2007-11#1)(2008-11#1)(2008-9#2)(2010-5#1)
fracture were##2##2##(2008-8#1)(2013-1#1)
fracture with##3##2##(2009-1#1)(2009-3#1)(2009-4#1)
fracture##186##1##(1991-11#11)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-8#4)(2008-10#1)(2008-11#8)(2008-12#12)(2008-5#5)(2008-7#1)(2008-8#9)(2008-9#8)(2009-1#8)(2009-11#1)(2009-3#5)(2009-4#2)(2009-5#1)(2009-7#13)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#4)(2011-2#25)(2012-12#1)(2012-2#11)(2012-3#2)(2013-1#36)(2013-8#3)
fracture)##3##1##(2010-12#1)(2011-2#1)(2013-1#1)
fractured##9##1##(1990-3#1)(1991-11#2)(2007-11#1)(2011-2#2)(2013-1#3)
fractures and##9##2##(1991-11#1)(2007-11#1)(2008-12#1)(2009-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
fractures are a##2##3##(2012-12#1)(2013-1#1)
fractures are common injuries##2##4##(2010-12#1)(2013-1#1)
fractures are##6##2##(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
fractures at##2##2##(2008-11#1)(2013-1#1)
fractures during the##2##3##(2010-3#1)(2013-1#1)
fractures during##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
fractures have##2##2##(2008-9#1)(2011-2#1)
fractures in children##5##3##(2009-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
fractures in the##6##3##(1991-11#1)(2008-11#1)(2008-8#2)(2013-1#2)
fractures in##18##2##(1991-11#1)(2008-11#2)(2008-8#2)(2009-3#4)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#4)
fractures is##2##2##(1991-9#1)(2013-1#1)
fractures of the femoral neck##2##5##(2009-3#2)
fractures of the##11##3##(1991-11#3)(1997-4#1)(2007-11#1)(2008-12#1)(2009-3#2)(2013-1#3)
fractures of##14##2##(1991-11#3)(1997-4#1)(2007-11#1)(2007-8#1)(2008-12#1)(2009-3#2)(2010-11#1)(2011-2#1)(2013-1#3)
fractures on##2##2##(2011-2#1)(2013-1#1)
fractures treated by##2##3##(2007-8#1)(2008-12#1)
fractures were treated##4##3##(2009-4#1)(2011-2#1)(2013-1#2)
fractures were##8##2##(1991-9#1)(2009-3#2)(2009-4#1)(2011-2#2)(2013-1#2)
fractures with##2##2##(2009-3#1)(2011-2#1)
fractures##138##1##(1990-6#1)(1991-11#12)(1991-8#1)(1991-9#8)(1993-11#1)(1996-6#1)(1996-8#2)(1997-4#1)(2007-11#2)(2007-8#6)(2008-11#9)(2008-12#7)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#2)(2009-3#15)(2009-4#2)(2009-7#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#1)(2010-9#1)(2011-2#15)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#28)
fragariae to##2##2##(2008-10#2)
fragariae was##3##2##(2008-10#3)
fragariae##16##1##(2008-10#16)
fragariae&quot##5##1##(2008-10#5)
fragariae)##2##1##(2008-10#2)
fragile X##2##2##(1991-2#1)(1997-8#1)
fragile and##2##2##(2008-10#1)(2008-5#1)
fragile site##2##2##(2011-2#2)
fragile sites in cancer##3##4##(2011-2#3)
fragile sites##8##2##(2011-2#8)
fragile##31##1##(1991-2#1)(1992-10#1)(1992-3#1)(1994-11#1)(1995-3#3)(1996-3#1)(1997-8#1)(2008-10#5)(2008-5#3)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#10)(2013-1#1)
fragilis##3##1##(1997-2#3)
fragility of the##3##3##(1991-11#1)(1995-3#1)(2007-9#1)
fragility of##4##2##(1991-11#1)(1992-6#1)(1995-3#1)(2007-9#1)
fragility##9##1##(1991-11#1)(1991-12#1)(1992-6#1)(1995-3#2)(2007-9#1)(2008-5#1)(2008-9#2)
fragment (scFv)##3##2##(2008-10#2)(2008-8#1)
fragment 13##3##2##(1997-6#3)
fragment 32##3##2##(1997-6#3)
fragment and##3##2##(1990-11#1)(1991-10#1)(1993-12#1)
fragment as a probe##2##4##(1993-12#1)(2008-8#1)
fragment as probe##2##3##(1991-5#1)(2008-8#1)
fragment as##5##2##(1991-10#1)(1991-5#1)(1993-12#1)(2008-8#2)
fragment by##3##2##(1991-5#1)(2008-3#1)(2008-8#1)
fragment carrying the##2##3##(2008-10#2)
fragment carrying##3##2##(1991-6#1)(2008-10#2)
fragment confirmed##2##2##(2008-9#1)(2011-2#1)
fragment contained##2##2##(1991-6#1)(1996-8#1)
fragment containing the##6##3##(1993-12#1)(1993-6#2)(1997-8#1)(2008-11#1)(2008-2#1)
fragment containing##9##2##(1993-12#1)(1993-6#2)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
fragment contains one complete open reading frame##2##7##(2008-8#2)
fragment contains one complete##3##4##(2008-8#2)(2008-9#1)
fragment contains##5##2##(1990-11#1)(2008-8#3)(2008-9#1)
fragment encoding the##2##3##(1994-8#1)(2008-10#1)
fragment encoding##4##2##(1994-8#1)(1997-7#2)(2008-10#1)
fragment from DNA of##2##4##(2008-10#2)
fragment from a##2##3##(1991-2#1)(2008-10#1)
fragment from the C-terminus of beta-amyloid##2##6##(1992-6#2)
fragment from the left arm of##2##6##(1995-9#1)(1996-3#1)
fragment from the##8##3##(1992-6#2)(1995-9#1)(1996-3#1)(1997-7#1)(2008-10#3)
fragment from##18##2##(1991-2#1)(1992-6#2)(1993-3#1)(1995-9#1)(1996-3#2)(1997-7#1)(2008-10#8)(2008-11#1)(2008-8#1)
fragment in##8##2##(2008-10#2)(2008-11#1)(2008-8#4)(2013-1#1)
fragment into##2##2##(1993-8#1)(1997-2#1)
fragment ions##4##2##(2008-10#4)
fragment length polymorphism (AFLP) marker##2##5##(2008-10#2)
fragment length polymorphism (AFLP) markers were##2##6##(2008-10#2)
fragment length polymorphism (AFLP) markers##9##5##(2008-10#9)
fragment length polymorphism (AFLP)##40##4##(2008-10#40)
fragment length polymorphism (PCR-RFLP)##4##4##(1997-8#1)(2008-10#3)
fragment length polymorphism (RFLP) analysis of##5##6##(1995-12#1)(2008-10#4)
fragment length polymorphism (RFLP) analysis##9##5##(1995-12#1)(2008-10#7)(2012-3#1)
fragment length polymorphism (RFLP) markers were##4##6##(2008-10#3)(2008-9#1)
fragment length polymorphism (RFLP) markers##10##5##(1995-6#1)(1996-12#1)(2008-10#7)(2008-9#1)
fragment length polymorphism (RFLP)##35##4##(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#30)(2008-9#1)(2012-3#1)
fragment length polymorphism among the##2##5##(2008-10#2)
fragment length polymorphism among##3##4##(1996-8#1)(2008-10#2)
fragment length polymorphism analyses of the##2##6##(2008-10#2)
fragment length polymorphism analyses##3##4##(2008-10#3)
fragment length polymorphism analysis of##8##5##(2008-10#8)
fragment length polymorphism analysis##16##4##(2008-10#15)(2008-11#1)
fragment length polymorphism and##5##4##(2008-10#5)
fragment length polymorphism linkage##2##4##(2008-10#2)
fragment length polymorphism loci##3##4##(2008-10#3)
fragment length polymorphism marker##6##4##(2008-10#6)
fragment length polymorphism markers##10##4##(2008-10#10)
fragment length polymorphism##167##3##(1995-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#153)(2008-11#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
fragment length polymorphisms (AFLPs)##3##4##(2008-10#3)
fragment length polymorphisms (RFLPs)##8##4##(2008-10#8)
fragment length polymorphisms with##2##4##(1996-12#1)(2008-10#1)
fragment length polymorphisms##25##3##(1996-12#2)(2008-10#23)
fragment length##195##2##(1995-12#1)(1995-6#1)(1996-12#3)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#177)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
fragment lengths##5##2##(2008-10#4)(2008-7#1)
fragment located##2##2##(1995-9#1)(2008-8#1)
fragment of E##2##3##(2008-10#1)(2008-4#1)
fragment of LIR was##2##4##(2008-9#2)
fragment of genomic DNA##2##4##(1992-3#1)(2008-10#1)
fragment of human parathyroid hormone##2##5##(1991-6#2)
fragment of the##7##3##(1991-6#1)(1994-11#1)(1996-6#1)(2008-10#3)(2008-12#1)
fragment of##35##2##(1990-5#2)(1991-6#3)(1992-12#1)(1992-3#1)(1994-11#2)(1994-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)(2013-8#1)
fragment signals##2##2##(2008-10#2)
fragment size##4##2##(2008-10#2)(2008-12#1)(2008-8#1)
fragment that##4##2##(1995-6#1)(1997-2#1)(2013-1#2)
fragment to##5##2##(1992-3#1)(2008-10#1)(2008-8#3)
fragment used##2##2##(1991-5#1)(2008-10#1)
fragment was amplified##2##3##(2008-10#2)
fragment was identified to be##2##5##(1993-8#2)
fragment was observed##2##3##(1994-11#1)(2011-2#1)
fragment was##24##2##(1990-11#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#3)(1994-11#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#6)(2010-1#1)(2010-6#1)(2011-2#2)
fragment were##2##2##(2008-10#2)
fragment which can##2##3##(2008-8#1)(2008-9#1)
fragment which##3##2##(1997-2#1)(2008-8#1)(2008-9#1)
fragment with##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
fragment within the##4##3##(2008-10#4)
fragment##458##1##(1990-11#3)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#8)(1991-9#2)(1992-12#1)(1992-3#6)(1992-4#1)(1992-6#4)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#5)(1993-8#7)(1994-11#5)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-6#3)(1995-8#2)(1995-9#3)(1996-12#5)(1996-3#4)(1996-6#4)(1996-8#4)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-6#6)(1997-7#4)(1997-8#3)(2008-10#245)(2008-11#6)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#39)(2008-9#13)(2009-6#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#9)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
fragmentary##4##1##(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
fragmentation and the##2##3##(1995-3#1)(2012-3#1)
fragmentation and##8##2##(1993-8#1)(1995-3#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#2)
fragmentation in##4##2##(1993-8#1)(1995-2#1)(1995-3#1)(2008-9#1)
fragmentation of care##2##3##(2012-3#2)
fragmentation of the primary ozonides##2##5##(1996-5#2)
fragmentation of the##5##3##(1995-2#1)(1996-5#2)(2008-10#2)
fragmentation of##23##2##(1991-3#1)(1992-2#1)(1995-2#1)(1996-12#1)(1996-5#3)(1997-8#5)(2008-10#4)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#4)
fragmentation to##2##2##(1995-8#1)(2008-10#1)
fragmentation##77##1##(1991-3#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-8#6)(1995-12#2)(1995-2#3)(1995-3#4)(1995-8#1)(1996-12#3)(1996-5#4)(1997-8#7)(2007-12#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#10)(2013-8#1)
fragmented and##5##2##(1997-3#1)(2008-10#1)(2008-8#2)(2013-1#1)
fragmented cancer care##2##3##(2012-3#2)
fragmented landscapes##7##2##(1995-3#1)(2008-8#4)(2008-9#2)
fragmented systems##3##2##(2008-9#3)
fragmented##29##1##(1995-3#2)(1996-12#1)(1997-3#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#6)(2008-9#7)(2012-3#4)(2013-1#1)
fragments after##2##2##(1993-6#1)(2008-10#1)
fragments amplified by##2##3##(2008-10#2)
fragments amplified##3##2##(2007-12#1)(2008-10#2)
fragments and##10##2##(1992-6#1)(1994-11#1)(1995-6#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
fragments are##4##2##(1993-3#1)(1995-8#3)
fragments associated with##2##3##(2008-10#2)
fragments but##2##2##(1997-1#1)(2008-8#1)
fragments by##7##2##(1992-12#1)(1993-6#1)(1994-5#1)(2008-10#3)(2008-2#1)
fragments containing the##3##3##(1991-7#1)(1992-3#1)(2008-10#1)
fragments containing##7##2##(1991-7#1)(1992-3#1)(2008-10#2)(2008-5#1)(2008-8#2)
fragments could##3##2##(1995-11#1)(1997-2#1)(2008-9#1)
fragments did not##2##3##(1990-5#1)(2008-8#1)
fragments for##2##2##(1992-7#1)(1993-6#1)
fragments from the##5##3##(1993-2#2)(1996-2#1)(2008-10#1)(2008-11#1)
fragments from##12##2##(1992-6#1)(1993-2#2)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-7#1)
fragments generated by##2##3##(1992-6#1)(2008-10#1)
fragments have been##2##3##(1995-12#1)(2008-8#1)
fragments in a##2##3##(2008-10#1)(2008-12#1)
fragments in the##4##3##(2008-10#4)
fragments in##16##2##(1992-6#1)(1993-8#1)(1994-11#1)(1997-4#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
fragments into##2##2##(1995-2#1)(1996-2#1)
fragments located##2##2##(2008-8#2)
fragments obtained##3##2##(1992-6#1)(2008-10#2)
fragments of the##8##3##(1992-6#2)(1993-6#1)(1996-6#1)(2008-1#1)(2008-10#3)
fragments of##47##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1992-10#1)(1992-4#1)(1992-6#3)(1993-6#2)(1994-11#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-2#3)(1996-6#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-8#4)
fragments on the##2##3##(1993-8#1)(2013-1#1)
fragments on##4##2##(1993-8#1)(1995-12#1)(1996-12#1)(2013-1#1)
fragments or##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
fragments originating from##2##3##(2008-10#2)
fragments showed##2##2##(1993-6#1)(2008-10#1)
fragments specific##2##2##(2008-10#2)
fragments that##2##2##(1992-12#1)(2008-10#1)
fragments to##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
fragments was##4##2##(1992-3#1)(1994-8#1)(2008-9#1)(2012-2#1)
fragments were amplified##2##3##(2008-8#2)
fragments were cloned and sequenced##2##5##(2008-10#1)(2008-8#1)
fragments were cloned and##3##4##(2008-10#2)(2008-8#1)
fragments were cloned##6##3##(2008-10#3)(2008-8#2)(2010-6#1)
fragments were fixed##2##3##(2008-7#2)
fragments were##27##2##(1991-5#1)(1993-6#1)(1993-8#2)(1995-6#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-8#9)(2008-9#2)(2010-6#1)
fragments with##10##2##(1991-12#1)(1993-8#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)
fragments within##2##2##(1992-12#1)(2011-2#1)
fragments##303##1##(1990-11#2)(1990-12#1)(1990-5#5)(1990-6#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-6#13)(1992-7#1)(1993-2#4)(1993-3#1)(1993-6#7)(1993-8#7)(1994-11#6)(1994-5#3)(1994-8#5)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#6)(1995-8#4)(1996-12#1)(1996-2#7)(1996-6#1)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#2)(2008-1#3)(2008-10#93)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#33)(2008-9#9)(2009-12#1)(2009-3#1)(2009-6#2)(2010-4#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#5)
fragrance components##2##2##(2008-5#2)
fragrance compounds in##2##3##(2008-5#2)
fragrance compounds##3##2##(2008-5#3)
fragrance evaporation##2##2##(2008-5#2)
fragrance materials##3##2##(2008-5#3)
fragrance molecules##2##2##(2008-5#2)
fragrance##22##1##(2008-5#22)
fragrances##3##1##(2008-5#3)
frail elderly##8##2##(1991-12#1)(1993-1#3)(1993-3#1)(1994-2#1)(1995-2#2)
frail##11##1##(1991-12#1)(1992-3#1)(1993-1#3)(1993-3#1)(1994-2#2)(1995-2#2)(2010-6#1)
frailty##4##1##(1995-2#1)(2008-7#1)(2010-10#2)
frame (ORF) encoding##4##3##(1993-12#1)(1993-6#1)(1997-7#1)(2010-5#1)
frame (ORF)##21##2##(1990-11#1)(1991-9#1)(1993-12#4)(1993-6#1)(1994-12#1)(1995-8#1)(1996-8#1)(1997-7#2)(2008-10#4)(2008-8#3)(2008-9#1)(2010-5#1)
frame and##3##2##(1992-3#1)(1996-3#1)(2012-3#1)
frame as##2##2##(2008-4#1)(2008-9#1)
frame by##2##2##(1993-3#1)(1995-9#1)
frame in the##2##3##(1994-11#1)(1995-8#1)
frame in##4##2##(1994-11#1)(1995-8#1)(1995-9#1)(2010-1#1)
frame is##2##2##(1993-6#1)(2008-6#1)
frame of reference to##2##4##(1992-2#1)(1996-1#1)
frame of reference##4##3##(1990-12#1)(1990-2#1)(1992-2#1)(1996-1#1)
frame of the##7##3##(1990-2#1)(1992-6#1)(1993-12#1)(2008-10#1)(2008-3#3)
frame of##35##2##(1990-12#1)(1990-2#2)(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#2)(1994-6#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-9#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#2)(2012-2#1)(2013-1#1)
frame on##2##2##(2008-10#1)(2008-11#1)
frame was##3##2##(1993-3#1)(2013-1#2)
frame##150##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#6)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-6#2)(1995-2#3)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-9#3)(2008-10#23)(2008-11#3)(2008-3#10)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#6)(2010-1#1)(2010-5#1)(2010-8#1)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#2)
frames in##4##2##(1996-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
frames of##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
frames##79##1##(1990-5#2)(1991-9#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#2)(1995-12#2)(1995-9#6)(1996-12#2)(1996-3#8)(1996-6#8)(1997-3#3)(1997-6#1)(1997-7#1)(1997-9#1)(2008-10#24)(2008-11#4)(2008-3#2)(2008-6#1)(2008-8#3)(2008-9#3)(2012-2#1)
frameshift mutations##2##2##(1993-8#1)(2012-3#1)
frameshift##5##1##(1993-8#1)(1993-9#1)(2008-9#1)(2010-4#1)(2012-3#1)
frameshifting in##2##2##(1995-9#2)
frameshifting##6##1##(1995-9#6)
framework and##4##2##(1993-2#1)(2008-12#1)(2013-1#2)
framework as##2##2##(2008-11#1)(2009-6#1)
framework can##3##2##(1997-2#1)(2008-8#1)(2013-8#1)
framework for a##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
framework for developing##2##3##(1997-1#1)(2008-12#1)
framework for studying the##2##4##(2008-11#1)(2008-8#1)
framework for studying##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
framework for the##8##3##(1993-3#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
framework for##74##2##(1991-12#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#13)(2008-12#4)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
framework in the##2##3##(1993-2#1)(2008-4#1)
framework in which##2##3##(1994-3#1)(2012-2#1)
framework in##6##2##(1993-2#1)(1994-3#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
framework is a##2##3##(2008-9#1)(2009-12#1)
framework is##9##2##(1992-12#1)(1996-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-5#1)(2013-1#1)
framework of the##11##3##(1990-6#1)(1994-6#1)(1995-5#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
framework of##30##2##(1990-12#1)(1990-6#1)(1991-3#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-5#2)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-2#2)(2013-1#1)
framework presented##2##2##(1996-2#1)(2008-7#1)
framework provides##2##2##(2008-7#1)(2013-1#1)
framework that can##2##3##(2008-12#1)(2008-8#1)
framework that##5##2##(1995-12#1)(1996-3#1)(2008-12#1)(2008-8#1)(2009-11#1)
framework to assist##2##3##(2008-10#1)(2008-12#1)
framework to guide the##3##4##(2008-11#3)
framework to##15##2##(1995-2#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-9#1)(2011-1#1)(2012-2#1)
framework was developed to##2##4##(1992-9#1)(2012-2#1)
framework was developed##3##3##(1992-9#1)(2008-10#1)(2012-2#1)
framework was##6##2##(1992-9#1)(2008-10#1)(2010-10#1)(2012-2#3)
framework with which to##2##4##(2008-5#1)(2013-8#1)
framework with which##3##3##(1992-2#1)(2008-5#1)(2013-8#1)
framework with##4##2##(1992-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
framework within which##2##3##(1993-2#1)(1994-2#1)
framework##237##1##(1990-12#1)(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-9#1)(1993-2#4)(1993-3#1)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#4)(1995-2#5)(1995-5#2)(1996-1#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#24)(2008-12#15)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#14)(2008-9#4)(2009-1#4)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#14)(2012-3#12)(2013-1#13)(2013-8#4)
frameworks for##3##2##(1996-2#1)(2008-9#1)(2009-7#1)
frameworks##18##1##(1992-11#1)(1996-2#2)(2008-11#2)(2008-12#2)(2008-9#2)(2009-7#2)(2010-12#3)(2010-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
framing of##4##2##(2008-1#1)(2008-11#1)(2008-4#2)
framing##7##1##(2008-1#1)(2008-11#1)(2008-4#4)(2010-2#1)
frankfurters##3##1##(2008-10#1)(2010-4#2)
françai##4##1##(2008-10#4)
frass##2##1##(2008-10#1)(2013-8#1)
fraud and abuse##8##3##(1991-1#3)(1992-3#1)(1993-1#2)(1993-12#1)(1994-2#1)
fraud and##9##2##(1991-1#3)(1991-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1994-2#1)
fraud prevention##2##2##(1994-2#2)
fraud##24##1##(1991-1#3)(1991-2#3)(1992-3#1)(1993-1#2)(1993-12#5)(1993-2#1)(1994-2#7)(1995-12#1)(1996-5#1)
fraught with##3##2##(2008-11#1)(2008-9#1)(2009-11#1)
fraxini##3##1##(2008-10#3)
free Ca(2+) concentration##2##3##(2008-11#1)(2008-9#1)
free Ca(2+)##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
free Ca2+ concentration##4##3##(1990-2#1)(1995-11#1)(1995-8#2)
free Ca2+##9##2##(1990-10#1)(1990-2#2)(1994-2#1)(1995-11#1)(1995-8#2)(1997-1#1)(2008-9#1)
free FA##2##2##(2009-3#2)
free NIR##2##2##(2012-2#2)
free T(4)##2##2##(2008-4#1)(2008-7#1)
free T3##3##2##(2008-7#1)(2011-1#1)(2012-3#1)
free T4##3##2##(2008-6#1)(2008-7#1)(2012-3#1)
free access to##2##3##(1992-12#1)(2008-11#1)
free air##2##2##(1993-3#1)(1993-6#1)
free amino acid content##2##4##(2008-12#1)(2008-5#1)
free amino acid##3##3##(1990-12#1)(2008-12#1)(2008-5#1)
free amino acids##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)
free amino##8##2##(1990-12#1)(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-6#1)
free and DOM-bound##2##3##(2008-11#2)
free and conjugated bile acids in serum##2##7##(1993-2#2)
free and conjugated##3##3##(1993-2#2)(2008-10#1)
free and protein-bound Gla##2##4##(1991-12#2)
free and total##8##3##(1991-2#1)(2008-10#3)(2008-5#1)(2008-7#3)
free and##36##2##(1990-12#1)(1991-12#2)(1991-2#1)(1992-6#1)(1993-2#2)(1994-3#1)(1997-3#1)(2008-10#14)(2008-11#4)(2008-5#2)(2008-7#6)(2009-7#1)
free available chlorine##3##3##(2008-10#3)
free available##6##2##(2008-10#6)
free caged activity##2##3##(2009-3#2)
free calcium concentration ([Ca2+]i)##2##4##(1992-6#2)
free calcium concentration in##2##4##(1992-6#1)(2008-10#1)
free calcium concentration##6##3##(1991-12#1)(1992-6#3)(2008-10#1)(2008-7#1)
free calcium##9##2##(1991-12#1)(1991-5#1)(1992-6#3)(1994-6#1)(1997-1#1)(2008-10#1)(2008-7#1)
free carboxyl##2##2##(2008-10#2)
free chlorine##5##2##(2008-10#5)
free cholesterol and##2##3##(1990-8#1)(1991-12#1)
free cholesterol##4##2##(1990-8#2)(1991-12#1)(2008-10#1)
free conditions##3##2##(1990-5#1)(2008-11#2)
free copper##2##2##(1997-8#1)(2008-10#1)
free cyanide##4##2##(2008-10#4)
free diffusion##2##2##(2008-11#1)(2008-8#1)
free disc##2##2##(2011-2#2)
free electron##2##2##(1993-8#1)(2010-8#1)
free energies of##2##3##(2008-10#1)(2009-9#1)
free energy (E) of##2##4##(2008-10#2)
free energy contribution##3##3##(2008-4#1)(2013-1#2)
free energy contributions##4##3##(2013-1#4)
free energy of##4##3##(1991-6#1)(1992-3#1)(1996-6#1)(2008-10#1)
free energy##31##2##(1991-6#1)(1992-3#1)(1995-2#1)(1996-6#1)(1997-2#1)(2008-10#12)(2008-4#3)(2008-5#1)(2010-7#3)(2012-2#1)(2013-1#6)
free enzyme##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
free fall##2##2##(2008-2#2)
free fat transplantation##2##3##(1997-3#2)
free fat##4##2##(1997-3#3)(2011-2#1)
free fatty acid##6##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)(2012-2#1)
free fatty acids##7##3##(1994-8#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-5#1)
free fatty##13##2##(1994-5#1)(1994-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2010-11#1)(2012-2#1)
free filamentous mycelia##2##3##(2008-7#2)
free flap##3##2##(2011-2#1)(2012-12#2)
free flap)##2##2##(1993-11#1)(2012-3#1)
free flaps##2##2##(2012-12#2)
free form##2##2##(2008-10#2)
free from any##2##3##(2008-10#1)(2008-11#1)
free from interference##4##3##(2008-10#4)
free from interferences##3##3##(2008-10#3)
free from the interference of##4##5##(2008-10#4)
free from the##5##3##(2008-10#4)(2010-11#1)
free from##34##2##(1990-6#1)(1991-12#1)(2008-10#26)(2008-11#2)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
free glucose was##2##3##(1995-6#1)(2008-10#1)
free glucose##4##2##(1995-6#1)(2008-10#2)(2008-11#1)
free hydroxy##2##2##(1996-5#1)(2008-10#1)
free in solution##2##3##(2008-10#2)
free in the##3##3##(1993-6#1)(1997-3#1)(2007-12#1)
free in##7##2##(1993-6#1)(1997-3#1)(2007-12#1)(2008-10#4)
free iodine##2##2##(2008-10#2)
free iron##3##2##(1996-2#1)(2008-10#2)
free ligand##3##2##(2008-10#3)
free magnesium concentration##4##3##(2008-7#4)
free magnesium##6##2##(2008-7#6)
free market##2##2##(1991-3#1)(1997-1#1)
free medium##9##2##(2008-11#8)(2009-6#1)
free metal ions##2##3##(2008-10#2)
free metal##5##2##(2008-10#5)
free moisture##3##2##(2008-10#3)
free of any##2##3##(2008-10#1)(2008-11#1)
free of disease at##3##4##(1993-11#2)(2009-1#1)
free of pain##2##3##(2011-2#2)
free of serum##2##3##(2008-11#1)(2008-7#1)
free of the disease##2##4##(2010-11#1)(2011-2#1)
free of the pathogen##2##4##(2008-10#2)
free of the##7##3##(1996-12#1)(2008-10#4)(2010-11#1)(2011-2#1)
free of##65##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-7#1)(1991-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#14)(2008-11#4)(2008-3#3)(2008-5#2)(2008-7#2)(2009-1#1)(2010-11#1)(2011-2#6)(2012-2#4)(2013-1#2)(2013-3#1)(2013-8#1)
free on##2##2##(2008-10#1)(2010-5#1)
free or##2##2##(1996-12#1)(2008-5#1)
free parameters##3##2##(1997-2#1)(2008-6#1)(2012-2#1)
free phosphate##2##2##(2008-10#2)
free radical generation##2##3##(2008-11#1)(2009-9#1)
free radical reaction and lipid peroxidation##2##6##(1996-2#2)
free radical reaction##4##3##(1996-2#4)
free radical scavenger##6##3##(1995-11#1)(1995-8#3)(2008-11#1)(2008-5#1)
free radical scavengers##4##3##(1996-2#1)(2008-11#1)(2011-2#2)
free radical scavenging activities##2##4##(2008-12#1)(2009-3#1)
free radical scavenging activity##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
free radical scavenging##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-3#1)(2013-1#1)
free radical##34##2##(1994-5#1)(1995-11#1)(1995-8#3)(1996-2#5)(1996-5#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-5#3)(2009-3#1)(2009-9#1)(2011-2#2)(2011-3#1)(2013-1#1)
free radicals and##5##3##(1995-8#2)(2008-10#2)(2008-5#1)
free radicals in##2##3##(2008-10#1)(2008-5#1)
free radicals##31##2##(1992-9#3)(1993-11#1)(1993-2#1)(1993-6#3)(1995-8#4)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#2)(2009-7#1)(2009-8#1)(2010-10#3)(2013-8#1)
free range##3##2##(2008-10#3)
free substrate##2##2##(1994-5#2)
free sugars##3##2##(2008-10#3)
free sulfhydryl##2##2##(2008-10#1)(2008-4#1)
free sulfide and##2##3##(2008-10#2)
free survival##6##2##(1993-2#1)(2008-10#4)(2012-2#1)
free suspension##2##2##(2008-11#2)
free trade##2##2##(2008-1#2)
free up##2##2##(1994-2#1)(1995-12#1)
free water##3##2##(2008-10#2)(2008-5#1)
free##635##1##(1990-10#1)(1990-12#3)(1990-2#3)(1990-5#4)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#7)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#6)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#2)(1993-2#4)(1993-3#1)(1993-6#5)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#4)(1995-11#3)(1995-12#2)(1995-2#3)(1995-6#1)(1995-8#9)(1996-12#2)(1996-2#8)(1996-3#2)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#5)(1997-5#1)(1997-7#1)(1997-8#3)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#226)(2008-11#48)(2008-12#8)(2008-2#2)(2008-3#10)(2008-4#5)(2008-5#19)(2008-6#3)(2008-7#31)(2008-8#4)(2008-9#5)(2009-1#1)(2009-3#5)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#4)(2010-11#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#23)(2011-3#1)(2012-12#8)(2012-2#13)(2012-3#7)(2013-1#15)(2013-3#1)(2013-7#3)(2013-8#6)
free-electron laser##2##2##(1993-5#1)(2008-3#1)
free-electron##3##1##(1991-9#1)(1993-5#1)(2008-3#1)
free-flight##2##1##(2008-9#2)
free-form##2##1##(2008-10#2)
free-living animals##5##2##(2008-9#5)
free-living##15##1##(1992-9#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#5)(2011-2#3)
free-radical scavengers##2##2##(2008-6#2)
free-radical##6##1##(1992-9#1)(1993-6#1)(1997-7#1)(2008-3#1)(2008-6#2)
free-ranging females##2##2##(2008-8#2)
free-ranging##3##1##(2008-8#3)
free-running##5##1##(1990-5#1)(2008-2#2)(2008-3#2)
free-space interference patterns##2##3##(2008-3#2)
free-space optical interconnection##2##3##(2008-3#2)
free-space optical##3##2##(2008-3#3)
free-space##9##1##(2008-3#7)(2009-5#1)(2013-8#1)
free-spawning##2##1##(2008-8#2)
free-stall##2##1##(2012-3#2)
free-standing##3##1##(1996-3#1)(2012-2#2)
freedom from##4##2##(1993-9#1)(1995-3#1)(2011-2#1)(2012-3#1)
freedom##20##1##(1990-8#1)(1991-5#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-3#2)(1997-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#1)
freeing##2##1##(2008-10#2)
freely available online##2##3##(2009-2#1)(2010-12#1)
freely available##3##2##(2009-2#1)(2010-12#1)(2011-3#1)
freely behaving##2##2##(1991-2#2)
freely moving rats##3##3##(1994-8#1)(1997-2#1)(1997-3#1)
freely soluble##2##2##(2008-10#2)
freely suspended##4##2##(2008-10#2)(2008-11#2)
freely##30##1##(1990-2#1)(1991-2#2)(1992-1#1)(1994-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-3#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-8#2)
freestanding diagnostic imaging centers##2##4##(1991-1#2)
freestanding facilities##2##2##(1995-2#1)(1996-3#1)
freestanding renal##2##2##(1995-12#2)
freestanding##9##1##(1991-1#4)(1995-12#2)(1995-2#1)(1996-3#1)(2008-11#1)
freeze fixation##2##2##(2008-7#2)
freeze or##2##2##(1993-3#1)(2008-8#1)
freeze tolerance##2##2##(2011-1#2)
freeze##10##1##(1993-3#1)(2008-10#1)(2008-7#3)(2008-8#2)(2011-1#3)
freeze-avoidance##2##1##(2008-8#2)
freeze-dried antigen for the##2##4##(1996-12#2)
freeze-dried apple##2##2##(2008-10#2)
freeze-dried powder for injection##2##4##(2011-3#2)
freeze-dried powder##3##2##(2011-2#1)(2011-3#2)
freeze-dried##11##1##(1996-12#2)(2008-10#5)(2011-2#1)(2011-3#2)(2012-12#1)
freeze-tolerance##2##1##(2008-8#2)
freezing and thawing##9##3##(1994-11#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)
freezing and##10##2##(1994-11#1)(1994-8#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)
freezing in##2##2##(1992-11#1)(2008-7#1)
freezing of##2##2##(1992-9#1)(1993-5#1)
freezing or##2##2##(2008-10#1)(2012-3#1)
freezing temperatures##3##2##(2008-10#2)(2010-7#1)
freezing tolerance##3##2##(2009-8#3)
freezing##38##1##(1992-11#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-8#1)(1996-3#1)(2008-10#10)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-8#3)(2010-7#1)(2011-1#1)(2012-3#3)
freezing-thawing##4##1##(2008-10#4)
frenatus##2##1##(2010-8#2)
frequencies and##8##2##(1991-12#1)(2008-10#3)(2008-12#1)(2011-2#3)
frequencies did not##2##3##(1996-12#1)(2008-10#1)
frequencies for##7##2##(1997-8#1)(2007-11#1)(2008-12#2)(2008-3#3)
frequencies from##3##2##(2008-10#1)(2008-12#2)
frequencies in the##3##3##(1994-11#1)(1994-2#1)(2012-2#1)
frequencies in##8##2##(1994-11#1)(1994-2#1)(1995-12#1)(2008-10#2)(2008-9#1)(2009-4#1)(2012-2#1)
frequencies indicate##2##2##(2008-10#1)(2008-5#1)
frequencies of 3##2##3##(2013-1#2)
frequencies of Cr2##2##3##(2008-10#2)
frequencies of the##6##3##(2008-10#2)(2008-12#2)(2011-2#2)
frequencies of##44##2##(1993-12#1)(1993-8#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#20)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2013-1#2)
frequencies ranging from##2##3##(2007-12#1)(2008-10#1)
frequencies reported##2##2##(1990-3#1)(2010-8#1)
frequencies to##2##2##(2008-3#2)
frequencies was##2##2##(2008-10#2)
frequencies were determined##2##3##(2008-10#1)(2008-7#1)
frequencies were significantly different##2##4##(2008-10#2)
frequencies were##12##2##(1993-8#1)(2008-10#9)(2008-5#1)(2008-7#1)
frequencies with##3##2##(1997-7#1)(2008-10#1)(2008-3#1)
frequencies within the##2##3##(2008-10#2)
frequencies within##3##2##(2008-10#2)(2012-3#1)
frequencies##160##1##(1990-3#1)(1991-12#1)(1993-12#1)(1993-8#5)(1994-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#4)(1996-2#2)(1997-6#1)(1997-7#1)(1997-8#4)(2007-11#2)(2007-12#1)(2008-10#68)(2008-11#3)(2008-12#10)(2008-3#8)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-4#1)(2009-8#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
frequency after a##2##3##(2008-10#1)(2008-8#1)
frequency after##3##2##(2008-10#2)(2008-8#1)
frequency among##2##2##(2008-10#1)(2008-8#1)
frequency analysis of##2##3##(2008-9#1)(2011-2#1)
frequency analysis##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
frequency and a##2##3##(2008-7#1)(2012-3#1)
frequency and amplitude##2##3##(2012-2#2)
frequency and levels##2##3##(2008-10#2)
frequency and severity of##3##4##(1991-12#1)(2012-2#1)(2012-3#1)
frequency and severity##5##3##(1991-12#1)(1995-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
frequency and the##9##3##(1992-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#1)
frequency and timing noise##2##4##(2007-11#2)
frequency and timing##3##3##(2007-11#3)
frequency and##55##2##(1990-3#1)(1991-12#1)(1992-3#1)(1995-5#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#3)(2008-10#9)(2008-11#5)(2008-3#5)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
frequency are##2##2##(2008-3#1)(2008-9#1)
frequency as a##2##3##(1991-2#1)(2008-7#1)
frequency as##3##2##(1991-2#1)(1995-12#1)(2008-7#1)
frequency at the##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
frequency at##4##2##(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
frequency but##3##2##(1993-8#1)(2007-12#1)(2008-3#1)
frequency changes##6##2##(2007-12#1)(2008-10#4)(2009-5#1)
frequency compared with##2##3##(2008-10#2)
frequency compared##3##2##(2008-10#2)(2009-8#1)
frequency conversion of##2##3##(2008-3#2)
frequency conversion##3##2##(2008-3#3)
frequency dependence and##2##3##(2008-2#1)(2008-8#1)
frequency dependence of##2##3##(2008-10#1)(2008-2#1)
frequency dependence##6##2##(2008-10#1)(2008-2#2)(2008-8#3)
frequency dependent##2##2##(1995-5#1)(2008-10#1)
frequency detection time##2##3##(2008-10#2)
frequency differences##2##2##(2008-10#1)(2008-12#1)
frequency distribution of##5##3##(2008-10#2)(2008-7#3)
frequency distribution was##3##3##(2008-10#2)(2008-7#1)
frequency distribution##10##2##(2008-10#5)(2008-7#5)
frequency distributions of##3##3##(2008-10#3)
frequency distributions##6##2##(2008-10#5)(2008-12#1)
frequency domain##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
frequency doubled##3##2##(1992-1#1)(2008-2#1)(2008-3#1)
frequency doubling of a##2##4##(2008-2#1)(2008-3#1)
frequency doubling##4##2##(2008-2#2)(2008-3#2)
frequency for##3##2##(1993-11#1)(2008-11#1)(2008-12#1)
frequency from##5##2##(1995-2#1)(2008-10#3)(2008-8#1)
frequency generation##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
frequency impulse activity##2##3##(2008-5#2)
frequency in this##2##3##(2008-10#1)(2011-2#1)
frequency in##6##2##(1993-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
frequency is##10##2##(1995-12#1)(2007-11#1)(2008-10#5)(2008-7#1)(2012-2#2)
frequency modulation##3##2##(2008-3#3)
frequency noise##2##2##(2008-3#1)(2010-8#1)
frequency of 1##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
frequency of 100##2##3##(2008-10#1)(2012-2#1)
frequency of 12h(-1)##2##3##(2008-10#2)
frequency of 20 samples per hour##2##6##(2008-10#2)
frequency of 20##4##3##(2008-10#3)(2008-9#1)
frequency of 24h(-1)##2##3##(2008-10#2)
frequency of 27##3##3##(2008-10#3)
frequency of 28##2##3##(2008-10#2)
frequency of 30 samples per##2##5##(2008-10#2)
frequency of 30##4##3##(2008-10#4)
frequency of 40##3##3##(2008-10#3)
frequency of 60 h(-1)##3##4##(2008-10#3)
frequency of 7##2##3##(2008-10#1)(2008-11#1)
frequency of 90 h(-1)##2##4##(2008-10#2)
frequency of 90##3##3##(2008-10#3)
frequency of P##5##3##(2008-10#5)
frequency of a##2##3##(2008-2#1)(2011-2#1)
frequency of antigen##2##3##(2008-10#1)(2008-11#1)
frequency of cankered trees in infected stands##2##7##(2008-10#2)
frequency of dermatoses in##2##4##(2011-2#2)
frequency of family dinners##4##4##(2013-1#4)
frequency of females is##2##4##(2008-9#2)
frequency of females##4##3##(1991-5#1)(2008-9#3)
frequency of finger use##2##4##(2013-8#2)
frequency of involvement of the##2##5##(1997-8#2)
frequency of isolation of##2##4##(2008-10#2)
frequency of micronucleated erythrocytes##2##4##(2008-9#2)
frequency of multiple##2##3##(2008-5#1)(2008-9#1)
frequency of occurrence among##2##4##(2008-10#1)(2008-5#1)
frequency of occurrence##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
frequency of positive##2##3##(2011-2#2)
frequency of reported##2##3##(1993-2#1)(2008-11#1)
frequency of resistance##2##3##(1993-8#1)(2008-10#1)
frequency of restenosis##2##3##(1994-9#2)
frequency of sex##3##3##(2008-10#1)(2012-3#2)
frequency of sexual reproduction##2##4##(2008-10#1)(2012-3#1)
frequency of sexual##3##3##(2008-10#1)(2012-3#2)
frequency of side effects##2##4##(1993-2#1)(1997-1#1)
frequency of the AA genotype##3##5##(2011-2#3)
frequency of the##38##3##(1990-8#1)(1993-11#1)(1995-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#3)(2008-9#2)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#1)
frequency of these##2##3##(2008-11#1)(2012-3#1)
frequency of twin births##2##4##(1990-6#2)
frequency of two##2##3##(2008-10#1)(2009-8#1)
frequency of use of##2##4##(1990-8#1)(2013-1#1)
frequency of use##4##3##(1990-8#1)(2012-2#2)(2013-1#1)
frequency of virulence##2##3##(2008-10#2)
frequency of which##2##3##(1997-7#1)(2008-7#1)
frequency of##332##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#3)(1990-9#2)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-2#6)(1993-3#2)(1993-8#3)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#7)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#6)(1997-9#1)(2006-6#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#122)(2008-11#15)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#9)(2008-9#13)(2009-10#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#27)(2012-12#1)(2012-2#4)(2012-3#14)(2012-5#1)(2013-1#10)(2013-8#4)
frequency on##5##2##(1990-8#1)(2008-10#3)(2008-11#1)
frequency or##2##2##(2008-11#1)(2009-3#1)
frequency range of##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)
frequency range##7##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-8#3)
frequency response of##3##3##(2008-3#2)(2009-5#1)
frequency response##6##2##(2008-10#2)(2008-3#2)(2009-5#2)
frequency shift curves##2##3##(2008-10#2)
frequency shift was##2##3##(2008-10#1)(2009-5#1)
frequency shift##12##2##(2007-12#1)(2008-10#5)(2008-2#1)(2009-5#4)(2012-2#1)
frequency stability of##2##3##(2008-3#2)
frequency sweep##2##2##(2008-3#2)
frequency than##2##2##(1993-2#1)(1995-8#1)
frequency to##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
frequency tuning##2##2##(1996-2#1)(2008-11#1)
frequency was 70##2##3##(2008-10#2)
frequency was not##2##3##(1994-6#1)(1995-12#1)
frequency was##29##2##(1994-6#1)(1995-12#1)(2008-10#18)(2008-11#2)(2008-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
frequency were##5##2##(1990-8#1)(2008-10#4)
frequency with##8##2##(1995-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)
frequency##789##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-6#3)(1990-8#5)(1990-9#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#7)(1993-3#2)(1993-6#1)(1993-8#6)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#9)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#8)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1997-1#4)(1997-2#2)(1997-3#14)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#7)(1997-9#1)(2006-6#2)(2007-11#7)(2007-12#13)(2007-8#1)(2008-1#2)(2008-10#248)(2008-11#41)(2008-12#13)(2008-2#19)(2008-3#59)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#23)(2008-8#28)(2008-9#26)(2009-10#3)(2009-11#1)(2009-3#1)(2009-5#9)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#36)(2012-12#3)(2012-2#16)(2012-3#21)(2012-5#1)(2013-1#17)(2013-8#10)
frequency-chirped response of##2##3##(2008-3#2)
frequency-dependent selection##2##2##(2008-10#1)(2008-8#1)
frequency-dependent##4##1##(2008-10#2)(2008-8#1)(2008-9#1)
frequency-domain##3##1##(2007-12#1)(2008-3#1)(2010-7#1)
frequency-doubled Nd##2##2##(1992-1#1)(2008-3#1)
frequency-doubled femtosecond##2##2##(2008-2#1)(2008-3#1)
frequency-doubled output##2##2##(2008-2#2)
frequency-doubled##12##1##(1992-1#1)(2008-2#3)(2008-3#8)
frequency-doubling##2##1##(2007-11#1)(2008-3#1)
frequency-modulated lasers##2##2##(2008-3#2)
frequency-modulated##4##1##(2008-3#4)
frequency-resolved##2##1##(2007-11#1)(2008-3#1)
frequency-shifted##2##1##(2008-2#1)(2008-3#1)
frequency-stabilized##2##1##(2008-2#1)(2008-3#1)
frequeney##2##1##(2013-8#2)
frequent 100 percent juice##2##4##(2012-2#2)
frequent among##4##2##(1995-12#1)(2009-5#1)(2010-11#1)(2012-6#1)
frequent and##4##2##(1993-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
frequent as##3##2##(1990-12#1)(1990-8#1)(1997-3#1)
frequent cause of##8##3##(1990-9#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
frequent causes of##3##3##(1992-5#1)(1993-6#1)(2011-2#1)
frequent changes in##3##3##(1992-3#1)(2008-9#1)(2009-8#1)
frequent complication in##3##3##(2008-5#1)(2010-5#1)(2012-3#1)
frequent complication of##4##3##(2008-1#1)(2009-9#1)(2011-2#1)(2013-1#1)
frequent complication##7##2##(2008-1#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
frequent daily spiritual experience##2##4##(2009-11#2)
frequent daily##3##2##(2009-11#3)
frequent disease##2##2##(2007-8#1)(2012-3#1)
frequent exposure to##2##3##(2009-7#1)(2013-1#1)
frequent in patients with##2##4##(2011-2#1)(2013-8#1)
frequent in the##2##3##(1991-3#1)(2013-1#1)
frequent in women##2##3##(1990-8#1)(2009-8#1)
frequent in##20##2##(1990-8#1)(1991-3#1)(1991-6#1)(1994-6#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#4)(2013-1#5)(2013-8#1)
frequent mixed infections##2##3##(2013-1#2)
frequent occurrence of##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
frequent recombination##2##2##(2008-10#2)
frequent than##10##2##(1994-3#1)(1996-11#1)(1996-3#1)(1997-3#2)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#2)
frequent travel##2##2##(2007-12#1)(2011-2#1)
frequent##218##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#3)(1990-9#3)(1991-12#1)(1991-3#2)(1991-6#2)(1991-8#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-11#2)(1996-3#4)(1996-6#1)(1996-8#1)(1997-3#4)(1997-6#1)(1997-8#1)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#20)(2008-11#9)(2008-12#2)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#24)(2011-3#4)(2012-12#3)(2012-2#9)(2012-3#6)(2012-6#1)(2013-1#22)(2013-8#6)
frequently and##5##2##(1990-12#1)(1992-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
frequently are##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
frequently as##4##2##(1996-6#1)(2008-11#1)(2008-12#1)(2013-1#1)
frequently associated with##11##3##(1990-6#1)(1994-11#1)(2008-10#1)(2008-7#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#3)
frequently at##2##2##(2008-10#1)(2008-8#1)
frequently been##4##2##(1992-9#1)(2010-1#1)(2011-2#1)(2012-12#1)
frequently caused by##2##3##(1994-3#1)(2011-2#1)
frequently caused##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
frequently cited as##2##3##(2008-11#1)(2008-12#1)
frequently detected in##4##3##(1996-12#1)(2008-10#1)(2009-8#1)(2010-5#1)
frequently detected##11##2##(1996-12#1)(2008-10#6)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
frequently during##3##2##(1996-6#1)(2008-10#1)(2012-3#1)
frequently employed##2##2##(2008-1#1)(2008-10#1)
frequently encountered in##3##3##(1997-8#1)(2011-2#2)
frequently encountered##7##2##(1993-12#1)(1997-8#1)(2008-5#1)(2011-2#2)(2011-3#1)(2012-2#1)
frequently formed##2##2##(2008-10#2)
frequently found in##3##3##(2008-10#2)(2011-2#1)
frequently found##8##2##(1994-3#1)(1996-8#2)(2008-10#4)(2011-2#1)
frequently from##3##2##(2008-10#2)(2008-5#1)
frequently have##2##2##(1993-2#1)(2011-2#1)
frequently in the##9##3##(1991-10#1)(1993-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#2)(2013-8#1)
frequently in##19##2##(1991-10#1)(1993-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#4)(2013-1#1)(2013-8#1)
frequently involved##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
frequently isolated from##2##3##(2008-10#1)(2011-2#1)
frequently isolated##3##2##(2008-10#2)(2011-2#1)
frequently leads to##2##3##(2008-7#1)(2011-1#1)
frequently noted##2##2##(2008-1#1)(2008-7#1)
frequently observed in##7##3##(1994-12#1)(1996-8#1)(2007-12#1)(2008-10#2)(2013-1#2)
frequently observed##15##2##(1994-12#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-5#2)(2009-7#1)(2010-1#2)(2011-2#1)(2013-1#2)
frequently occurring##4##2##(1995-2#1)(2008-12#1)(2011-2#1)(2012-12#1)
frequently overlooked##2##2##(2008-10#1)(2008-9#1)
frequently performed##5##2##(1990-9#1)(1992-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
frequently present in##2##3##(2009-10#1)(2012-12#1)
frequently present##4##2##(1994-12#1)(2009-10#1)(2009-9#1)(2012-12#1)
frequently reported in association with##2##5##(2008-7#1)(2011-2#1)
frequently reported in##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
frequently reported##4##2##(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
frequently required##2##2##(1994-12#1)(2013-1#1)
frequently results##2##2##(2008-9#1)(2013-1#1)
frequently screened##2##2##(1990-12#2)
frequently seen in##3##3##(1994-11#1)(2008-11#1)(2011-2#1)
frequently seen##5##2##(1993-8#1)(1994-11#1)(1996-6#1)(2008-11#1)(2011-2#1)
frequently studied##2##2##(2009-3#1)(2012-7#1)
frequently than##8##2##(1993-11#1)(1994-5#1)(1996-11#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-2#1)(2013-1#1)
frequently the##4##2##(1997-2#1)(1997-8#1)(2008-5#1)(2010-12#1)
frequently to##2##2##(2008-10#1)(2011-2#1)
frequently used and##2##3##(2008-10#1)(2010-8#1)
frequently used in the##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
frequently used in##8##3##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
frequently used methods##2##3##(2008-4#1)(2011-2#1)
frequently used to##2##3##(2010-5#1)(2013-8#1)
frequently used##27##2##(1996-3#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
frequently were##2##2##(2008-10#2)
frequently##356##1##(1990-12#5)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-3#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#1)(1995-1#1)(1995-2#2)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#5)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#3)(2007-12#4)(2008-1#2)(2008-10#70)(2008-11#25)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#16)(2008-6#2)(2008-7#14)(2008-8#4)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#34)(2011-3#2)(2012-12#7)(2012-2#14)(2012-3#6)(2012-7#1)(2013-1#17)(2013-8#5)
fresh AMI##2##2##(1995-2#2)
fresh CAPD fluids##2##3##(2008-10#2)
fresh air##2##2##(1993-2#1)(1996-12#1)
fresh and immortalised##2##3##(2008-11#2)
fresh and marine##3##3##(2008-10#2)(2008-9#1)
fresh and saline water##2##4##(2008-10#1)(2012-5#1)
fresh and##12##2##(2008-10#6)(2008-11#3)(2008-9#1)(2010-8#1)(2012-5#1)
fresh axilla secretions##2##3##(2008-5#2)
fresh broccoli##2##2##(2008-10#2)
fresh fish (p = 0##2##5##(2011-2#2)
fresh frozen##3##2##(1990-2#1)(1993-6#1)(2008-9#1)
fresh ginseng##3##2##(2008-11#1)(2012-3#2)
fresh leaf juice##3##3##(2008-10#3)
fresh medium##7##2##(2008-11#7)
fresh or##3##2##(1990-12#1)(2008-10#1)(2012-5#1)
fresh osteochondral allograft##2##3##(2012-3#2)
fresh osteochondral allografts##2##3##(2012-3#2)
fresh osteochondral##4##2##(2012-3#4)
fresh root##2##2##(2008-10#2)
fresh surface ready##2##3##(2008-10#2)
fresh tissue##2##2##(2008-10#2)
fresh vegetable##2##2##(2008-10#2)
fresh water samples##2##3##(2008-10#2)
fresh water##13##2##(2008-10#10)(2010-8#1)(2011-2#1)(2012-5#1)
fresh waters##5##2##(2008-10#5)
fresh weight##13##2##(2008-10#8)(2008-12#2)(2009-6#3)
fresh##143##1##(1990-12#2)(1990-2#1)(1991-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-6#2)(1995-2#2)(1996-12#3)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#67)(2008-11#15)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-6#4)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#8)(2012-5#3)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
fresh-keeping##2##1##(2010-7#2)
freshly added##2##2##(2008-11#1)(2011-2#1)
freshly isolated cells##2##3##(1995-11#2)
freshly isolated rat renal proximal tubules##2##6##(1997-1#2)
freshly isolated##9##2##(1992-6#1)(1995-11#2)(1995-8#1)(1997-1#2)(2008-11#1)(2008-4#1)(2011-2#1)
freshly prepared##4##2##(2008-10#3)(2008-7#1)
freshly##27##1##(1992-6#1)(1992-8#1)(1993-3#1)(1995-11#2)(1995-8#2)(1997-1#2)(2008-10#10)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#2)
freshmen##2##1##(2013-8#2)
freshness was##2##2##(2008-10#2)
freshness##13##1##(2008-10#13)
freshwater fish##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
freshwater fishes with enriched stable isotopes##2##6##(2010-8#2)
freshwater fishes##4##2##(2008-8#2)(2010-8#2)
freshwater samples##5##2##(2008-10#5)
freshwater snails##2##2##(2008-12#1)(2011-2#1)
freshwater systems##3##2##(2008-11#1)(2012-12#1)(2012-5#1)
freshwater##51##1##(2007-12#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#3)(2010-6#1)(2010-8#8)(2011-2#7)(2012-12#2)(2012-2#2)(2012-5#1)
freshwaters##2##1##(2008-10#1)(2008-11#1)
freundii##3##1##(2010-6#2)(2011-2#1)
friction and##3##2##(1997-3#1)(2008-10#1)(2009-9#1)
friction behavior##3##2##(2010-10#3)
friction between##6##2##(1990-6#2)(1994-9#1)(1997-3#1)(2008-5#1)(2010-10#1)
friction coefficient##3##2##(2008-5#2)(2010-4#1)
friction images##2##2##(1994-9#2)
friction##30##1##(1990-6#2)(1994-9#4)(1997-3#4)(2008-10#2)(2008-3#1)(2008-5#4)(2008-7#2)(2009-9#3)(2010-10#4)(2010-4#2)(2012-2#2)
frictional##8##1##(2008-10#1)(2008-5#1)(2010-10#2)(2010-4#2)(2011-2#1)(2012-2#1)
friend##12##1##(1996-12#1)(1996-3#1)(2008-7#1)(2009-7#3)(2010-1#1)(2013-1#4)(2013-8#1)
friendly method##3##2##(2008-10#3)
friendly##15##1##(1992-2#1)(1992-3#1)(2008-10#9)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
friends (who##2##2##(2009-7#2)
friends and family##3##3##(1994-1#1)(2008-6#1)(2010-8#1)
friends and the##2##3##(2009-7#1)(2011-2#1)
friends and##9##2##(1994-1#1)(1995-1#1)(2008-6#1)(2009-7#3)(2010-8#2)(2011-2#1)
friends in##2##2##(2009-7#2)
friends or relatives##2##3##(2008-12#1)(2008-7#1)
friends showed##2##2##(2009-7#2)
friends##40##1##(1994-1#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-7#27)(2010-8#2)(2011-2#3)(2013-1#1)
friends'##2##1##(2009-7#2)
friendship##6##1##(2008-4#2)(2009-7#2)(2013-1#2)
friendships##4##1##(2009-11#1)(2009-7#3)
fringe modulation##2##2##(2008-3#2)
fringe patterns##2##2##(2008-3#2)
fringe##12##1##(1996-3#1)(2007-11#1)(2008-2#1)(2008-3#8)(2013-8#1)
fringes in##3##2##(2008-3#3)
fringes##7##1##(2008-3#6)(2013-8#1)
fritillary##3##1##(2008-8#2)(2012-3#1)
frizzled naked neck and##2##4##(2008-5#2)
frizzled naked neck##3##3##(2008-5#3)
frm2##3##1##(1996-3#3)
frog (Rana catesbeiana) brain and intestine##2##6##(1991-5#2)
frog (Rana##3##2##(1991-5#2)(2012-3#1)
frog Physalaemus biligonigerus##2##3##(2008-7#2)
frog##26##1##(1990-5#1)(1991-5#2)(1993-3#4)(1993-8#1)(1994-11#2)(1994-5#2)(1996-2#2)(1996-6#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-3#2)
frogs (Rana##2##2##(2008-8#1)(2008-9#1)
frogs and##3##2##(2008-12#3)
frogs##11##1##(1991-1#1)(1996-6#2)(2008-12#3)(2008-8#3)(2008-9#2)
from &lt##7##2##(1995-6#1)(2008-10#5)(2008-7#1)
from &quot##6##2##(1991-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
from (0##2##2##(2008-10#1)(2008-6#1)
from +0##3##2##(2008-10#3)
from -0##6##2##(2008-10#6)
from -1##3##2##(2008-10#3)
from -5##2##2##(2008-10#2)
from 0 to 0##4##4##(2008-10#2)(2008-11#1)(2010-4#1)
from 0 to 1##4##4##(2008-10#4)
from 0 to 100##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
from 0 to 100% of##2##5##(1993-8#1)(2008-9#1)
from 0 to 100%##3##4##(1993-8#1)(2008-9#2)
from 0 to 3##2##4##(2008-10#1)(2008-8#1)
from 0 to 5##2##4##(2008-10#2)
from 0 to##53##3##(1991-2#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#28)(2008-11#2)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2010-4#1)(2011-2#1)(2012-8#1)(2013-1#2)(2013-8#1)
from 0##307##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#212)(2008-11#9)(2008-12#2)(2008-3#7)(2008-5#4)(2008-7#4)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#2)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#2)(2010-4#2)(2011-2#7)(2012-2#2)(2012-8#1)(2013-1#10)(2013-8#5)
from 0% in##3##3##(1995-1#1)(2008-10#1)(2013-8#1)
from 0% to##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
from 0%##6##2##(1995-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
from 1 to &gt##2##4##(1997-3#1)(2008-10#1)
from 1 to 10##3##4##(2008-10#1)(2008-7#1)(2010-8#1)
from 1 to 100##2##4##(2008-10#1)(2008-11#1)
from 1 to 13##2##4##(2008-10#2)
from 1 to 4##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
from 1 to 5##2##4##(2008-10#1)(2008-3#1)
from 1 to 6##3##4##(2008-10#2)(2013-1#1)
from 1 to##34##3##(1993-11#1)(1997-3#2)(2008-10#22)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
from 1##134##2##(1990-2#1)(1990-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-3#2)(2008-10#86)(2008-11#6)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
from 1% to##3##3##(1993-8#1)(1994-12#1)(2012-12#1)
from 10 ml of##2##4##(2008-10#2)
from 10 to 30##3##4##(1994-11#1)(2008-10#1)(2009-7#1)
from 10 to 60##2##4##(2008-10#2)
from 10 to##24##3##(1994-11#1)(1994-3#1)(2008-10#18)(2008-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
from 10##55##2##(1991-7#1)(1993-1#1)(1994-11#1)(1994-3#2)(2008-10#37)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
from 10(-1) to##3##3##(2008-10#3)
from 10(-3) to##3##3##(2008-10#3)
from 10(-5)##2##2##(2008-10#2)
from 10(3) to##2##3##(2008-10#2)
from 100 000##2##3##(2008-10#2)
from 100 to##8##3##(2008-10#6)(2008-7#1)(2011-1#1)
from 100##16##2##(1993-12#1)(2008-10#12)(2008-7#1)(2011-1#1)(2011-2#1)
from 101 to 103%##2##4##(2008-10#2)
from 101 to##3##3##(2008-10#3)
from 103##3##2##(2008-10#2)(2011-2#1)
from 104##2##2##(1991-6#1)(2008-10#1)
from 11 to##5##3##(1996-12#1)(2008-10#2)(2008-9#1)(2009-9#1)
from 11##15##2##(1996-12#1)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#1)(2009-9#1)(2012-3#2)(2013-1#1)
from 110##2##2##(1997-2#1)(2008-10#1)
from 115##2##2##(1996-11#1)(2008-10#1)
from 117##3##2##(2008-10#2)(2010-1#1)
from 12 to 24##2##4##(2008-10#2)
from 12 to 32 degrees C##2##6##(2008-10#2)
from 12 to##14##3##(1997-5#1)(1997-8#1)(2008-10#10)(2008-11#1)(2009-7#1)
from 12##29##2##(1992-12#1)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-3#1)(2012-5#1)(2013-8#1)
from 12%##2##2##(2008-10#1)(2008-5#1)
from 120##2##2##(2008-10#2)
from 129##2##2##(1994-9#1)(2008-5#1)
from 13##3##2##(1991-12#1)(2008-2#1)(2012-3#1)
from 14 to##3##3##(1993-12#1)(2008-10#2)
from 14##6##2##(1993-12#1)(2008-10#4)(2011-2#1)
from 149##3##2##(1993-8#1)(1997-8#1)(2009-5#1)
from 15 to 30##2##4##(2008-10#2)
from 15 to##3##3##(2008-10#3)
from 15##21##2##(1991-12#1)(1997-1#1)(2007-12#1)(2008-10#10)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
from 152##2##2##(2008-10#1)(2012-2#1)
from 159##2##2##(1993-12#1)(2008-8#1)
from 16##6##2##(2008-10#2)(2008-12#1)(2010-5#1)(2010-8#1)(2013-8#1)
from 17##7##2##(2008-10#6)(2008-11#1)
from 170 to##3##3##(1991-2#1)(2008-10#2)
from 170##4##2##(1991-2#1)(2008-10#3)
from 18 to##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
from 18##11##2##(1992-11#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-5#1)(2012-3#1)
from 18-month-old residues that were##2##5##(2008-10#2)
from 180##2##2##(1991-6#1)(2008-10#1)
from 19 patients##2##3##(1993-2#1)(2008-5#1)
from 19 to##2##3##(2008-10#1)(2008-11#1)
from 19##7##2##(1993-2#1)(1993-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
from 1950##2##2##(1991-3#1)(1993-6#1)
from 1960 to##4##3##(1995-2#1)(1995-3#1)(1997-3#1)(2008-10#1)
from 1970 through##3##3##(1990-6#1)(1991-2#1)(1992-1#1)
from 1970 to##2##3##(1991-2#1)(2008-12#1)
from 1970##5##2##(1990-6#1)(1991-2#2)(1992-1#1)(2008-12#1)
from 1974##2##2##(1990-5#1)(2008-10#1)
from 1975 to##3##3##(1991-9#2)(2012-2#1)
from 1979 through##2##3##(1993-12#1)(2008-9#1)
from 1979 to 2008##2##4##(2012-12#2)
from 1979##4##2##(1993-12#1)(2008-9#1)(2012-12#2)
from 1980 through##2##3##(1991-3#1)(2008-7#1)
from 1980 to##2##3##(1990-3#1)(2008-10#1)
from 1980##4##2##(1990-3#1)(1991-3#1)(2008-10#1)(2008-7#1)
from 1981 to##2##3##(1990-12#1)(2008-10#1)
from 1983 to##2##3##(1991-9#1)(1994-2#1)
from 1983 until##2##3##(1996-11#1)(2008-10#1)
from 1983##7##2##(1990-11#1)(1991-12#1)(1991-9#1)(1994-2#2)(1996-11#1)(2008-10#1)
from 1984 to##3##3##(1994-2#1)(1994-3#1)(2008-10#1)
from 1984##4##2##(1994-2#1)(1994-3#1)(2008-10#1)(2008-8#1)
from 1985 through 1987##2##4##(1991-12#1)(1993-12#1)
from 1985 through##3##3##(1991-12#1)(1992-12#1)(1993-12#1)
from 1985 to##3##3##(1993-3#1)(1996-3#1)(2012-3#1)
from 1985##6##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1996-3#1)(2012-3#1)
from 1986 to##3##3##(1990-12#1)(1994-3#1)(2008-10#1)
from 1986##4##2##(1990-12#1)(1993-11#1)(1994-3#1)(2008-10#1)
from 1988 to 1998##2##4##(2008-9#2)
from 1988 to##3##3##(2008-10#1)(2008-9#2)
from 1988##4##2##(1994-6#1)(2008-10#1)(2008-9#2)
from 1989 to##2##3##(2008-1#1)(2008-9#1)
from 1989##4##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-9#1)
from 1990 to 1993##2##4##(1996-3#1)(1996-6#1)
from 1990 to 1998##2##4##(2007-12#1)(2011-2#1)
from 1990 to##10##3##(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#5)(2011-2#1)(2012-12#1)
from 1990##11##2##(1994-6#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#5)(2011-2#1)(2012-12#1)
from 1991 to 1993##2##4##(1995-12#1)(1995-3#1)
from 1992 to 1996##2##4##(1996-9#1)(2008-10#1)
from 1992 to##5##3##(1996-9#1)(2008-10#3)(2010-8#1)
from 1992##7##2##(1996-9#1)(2008-10#4)(2010-4#1)(2010-8#1)
from 1993 to 1998##2##4##(2008-1#1)(2008-10#1)
from 1993 to##5##3##(2008-1#1)(2008-10#4)
from 1993##6##2##(2008-1#1)(2008-10#5)
from 1994 to 1996##3##4##(1997-6#1)(2008-10#2)
from 1994 to 1997##2##4##(2008-10#2)
from 1994 to##8##3##(1997-6#1)(2008-10#4)(2008-9#1)(2011-2#2)
from 1994##10##2##(1997-3#1)(1997-6#1)(2008-10#5)(2008-9#1)(2011-2#2)
from 1995 to 1997##3##4##(2008-10#3)
from 1995 to 1998##2##4##(2008-10#1)(2008-11#1)
from 1995 to##9##3##(2008-10#5)(2008-11#1)(2008-12#1)(2010-12#1)(2012-12#1)
from 1996 to 1998##2##4##(2008-10#2)
from 1996 to##3##3##(2008-10#2)(2013-1#1)
from 1996##5##2##(2008-10#4)(2013-1#1)
from 1997 to##2##3##(2008-10#2)
from 1998 to 2000##2##4##(2008-10#2)
from 1998 to##3##3##(2008-10#3)
from 1998##5##2##(2008-10#5)
from 1999 to##3##3##(2008-11#1)(2010-8#1)(2013-8#1)
from 1999##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2013-8#1)
from 1x10(-3) to##2##3##(2008-10#2)
from 1x10(-7) to##2##3##(2008-10#2)
from 2 days to##2##4##(2013-1#2)
from 2 to 10##3##4##(2008-10#2)(2008-11#1)
from 2 to 4##2##4##(2008-10#1)(2012-2#1)
from 2 to##20##3##(1991-2#1)(1992-12#1)(1997-8#1)(2008-10#13)(2008-11#1)(2010-5#1)(2012-2#2)
from 2##85##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#46)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-5#2)(2011-2#2)(2012-2#2)(2013-1#6)
from 2% to##2##3##(2008-10#1)(2012-12#1)
from 2-adamantanone##2##2##(2008-5#2)
from 20 to 30 degrees C##2##6##(2008-10#2)
from 20 to 300##2##4##(2008-10#2)
from 20 to 70##2##4##(2008-10#2)
from 20 to##20##3##(1996-12#1)(2008-10#16)(2008-12#1)(2011-2#1)(2013-8#1)
from 20##32##2##(1991-2#1)(1994-5#1)(1994-8#1)(1996-12#2)(2008-10#20)(2008-12#4)(2011-2#2)(2013-8#1)
from 20%##2##2##(2008-7#2)
from 20-##2##2##(2008-10#1)(2008-8#1)
from 200 to##2##3##(2008-10#2)
from 200##4##2##(2008-10#3)(2011-2#1)
from 2000 to 2005##3##4##(2008-10#1)(2008-11#2)
from 2000 to##5##3##(2008-10#1)(2008-11#2)(2010-12#1)(2012-12#1)
from 2000##6##2##(2008-10#1)(2008-11#2)(2010-12#1)(2012-12#1)(2012-3#1)
from 2001 to 2005##2##4##(2008-12#1)(2010-8#1)
from 2001 to##4##3##(2008-11#1)(2008-12#1)(2010-8#1)(2013-8#1)
from 2001##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2010-8#1)(2013-8#1)
from 2002 to 2004##2##4##(2008-10#2)
from 2002 to##5##3##(2008-10#2)(2010-8#1)(2011-2#1)(2012-3#1)
from 2003 to##3##3##(2009-12#1)(2010-8#1)(2011-2#1)
from 2003##5##2##(2008-10#2)(2009-12#1)(2010-8#1)(2011-2#1)
from 2004##5##2##(2008-1#1)(2008-10#3)(2012-3#1)
from 2005 to##2##3##(2013-1#1)(2013-8#1)
from 21 to##2##3##(1990-11#1)(2008-10#1)
from 21##6##2##(1990-11#1)(1992-3#1)(1997-8#1)(2008-10#3)
from 22##6##2##(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2010-11#1)
from 23 to##2##3##(1995-3#1)(2009-3#1)
from 23##6##2##(1992-12#1)(1995-3#1)(1997-3#1)(2008-10#2)(2009-3#1)
from 23%##2##2##(2008-10#1)(2010-5#1)
from 24 to##2##3##(1993-12#1)(2008-10#1)
from 24##8##2##(1993-12#1)(2008-10#4)(2008-5#1)(2010-11#1)(2012-3#1)
from 240 to##2##3##(2008-10#2)
from 25 patients##2##3##(1992-3#1)(2008-7#1)
from 25 primary health care centers##2##6##(2011-2#2)
from 25 to 50 degrees C##2##6##(2008-10#1)(2008-3#1)
from 25 to##12##3##(1995-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
from 25##23##2##(1991-2#1)(1992-3#1)(1995-8#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-2#2)
from 250 to##4##3##(2008-10#3)(2008-2#1)
from 250##5##2##(2008-10#4)(2008-2#1)
from 253##2##2##(2008-10#1)(2013-1#1)
from 257##2##2##(2008-7#1)(2011-2#1)
from 26##4##2##(1991-3#1)(2008-11#2)(2008-9#1)
from 27##7##2##(1991-7#1)(2008-10#4)(2008-7#1)(2010-4#1)
from 28##6##2##(1990-12#1)(1991-11#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
from 28% in##2##3##(2008-10#1)(2013-8#1)
from 28%##4##2##(1995-3#1)(2008-10#2)(2013-8#1)
from 29 to##3##3##(1990-8#1)(2006-5#1)(2008-10#1)
from 29##6##2##(1990-8#1)(2006-5#1)(2008-10#3)(2008-12#1)
from 290##2##2##(2008-10#1)(2008-3#1)
from 3 to 5##2##4##(2008-12#1)(2011-2#1)
from 3 to 8##2##4##(2010-11#1)(2011-2#1)
from 3 to##16##3##(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
from 3##56##2##(1990-12#1)(1993-9#1)(1994-3#2)(1995-8#1)(1996-5#1)(1997-2#1)(1997-9#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#2)
from 3%##2##2##(1994-12#1)(2008-10#1)
from 30 to 15##2##4##(2008-10#1)(2010-8#1)
from 30 to 60##2##4##(1993-1#1)(2008-10#1)
from 30 to##17##3##(1993-1#1)(1996-12#1)(1997-8#1)(2008-10#10)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#1)
from 30##21##2##(1991-9#1)(1993-1#1)(1994-11#1)(1996-12#1)(1997-8#1)(2008-10#11)(2008-5#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)
from 300 mOsmol kg-1 to##3##5##(2008-11#3)
from 300 to##2##3##(2008-10#1)(2008-3#1)
from 300##8##2##(2008-10#2)(2008-11#5)(2008-3#1)
from 31 to##3##3##(2007-12#1)(2008-10#2)
from 31##5##2##(2007-12#1)(2008-10#3)(2008-5#1)
from 32##5##2##(2008-10#3)(2008-11#1)(2010-1#1)
from 33##4##2##(1990-2#1)(2008-10#3)
from 34##4##2##(2008-10#2)(2008-12#1)(2009-10#1)
from 35##8##2##(1991-2#1)(2008-10#3)(2008-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
from 350 to##2##3##(2008-10#1)(2008-3#1)
from 36 to##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
from 36##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
from 37 to##4##3##(1992-9#1)(1997-7#1)(2008-11#2)
from 37##9##2##(1992-9#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-12#1)
from 38##4##2##(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)
from 39##2##2##(2008-10#2)
from 3x10(-9) to##2##3##(2008-10#2)
from 4 months to##2##4##(1997-3#1)(2008-9#1)
from 4 to 10##2##4##(2008-10#1)(2008-11#1)
from 4 to 11##2##4##(2008-10#2)
from 4 to##13##3##(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2013-8#1)
from 4##46##2##(1990-11#1)(1991-5#1)(1995-3#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#23)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#3)(2010-10#1)(2013-8#2)
from 4%##2##2##(1997-3#1)(2008-10#1)
from 4-week-old plants##2##3##(2008-10#2)
from 40 to 400##2##4##(2008-10#2)
from 40 to##7##3##(1993-8#1)(2008-10#4)(2008-11#1)(2008-5#1)
from 40##10##2##(1993-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
from 400 to##7##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
from 400##8##2##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
from 42##2##2##(2008-10#2)
from 43##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
from 45 to 65##2##4##(2010-7#1)(2013-8#1)
from 45 to##5##3##(2008-10#2)(2009-3#1)(2010-7#1)(2013-8#1)
from 45##10##2##(1993-3#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2013-8#1)
from 450 to##2##3##(2008-10#2)
from 46##4##2##(1990-2#1)(1997-3#1)(2008-10#2)
from 47 to##2##3##(2008-10#1)(2013-1#1)
from 48 to##2##3##(2008-10#1)(2008-8#1)
from 48##5##2##(1993-8#1)(2008-10#2)(2008-12#1)(2008-8#1)
from 495##2##2##(2008-12#1)(2012-2#1)
from 5 to 15##3##4##(2008-10#3)
from 5 to 200muM and##2##5##(2008-10#2)
from 5 to 25 degrees C##3##6##(2008-10#3)
from 5 to##31##3##(1990-6#1)(1991-2#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-10#19)(2008-11#1)(2008-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
from 5 x##2##3##(2008-10#2)
from 5##81##2##(1990-6#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#50)(2008-11#2)(2008-3#3)(2008-5#2)(2008-9#3)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
from 5% in##2##3##(1994-3#1)(2008-10#1)
from 5% to 10%##2##4##(2008-3#1)(2008-9#1)
from 5% to##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
from 5%##7##2##(1994-3#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#1)
from 5-day-old##2##2##(2011-2#2)
from 50 to##8##3##(1992-12#1)(2008-10#7)
from 50##15##2##(1992-12#1)(1993-1#1)(1996-2#1)(1997-4#1)(2008-10#10)(2011-2#1)
from 50% of##2##3##(2008-10#1)(2008-11#1)
from 50%##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
from 51##2##2##(2008-12#1)(2011-2#1)
from 52##5##2##(1990-2#1)(1993-2#1)(1995-3#1)(2008-10#1)(2008-9#1)
from 53##3##2##(2008-10#1)(2011-2#1)(2012-5#1)
from 54 to##3##3##(1995-3#1)(2008-10#2)
from 540##2##2##(2008-10#1)(2008-8#1)
from 58##3##2##(2008-10#2)(2010-11#1)
from 59##2##2##(1993-3#1)(2008-1#1)
from 5x10(-10) to##2##3##(2008-10#2)
from 5x10(-4) to##2##3##(2008-10#2)
from 6 to 0##2##4##(2008-10#2)
from 6 to##11##3##(1995-3#1)(2008-10#8)(2008-12#1)(2010-4#1)
from 6##32##2##(1992-12#2)(1992-3#1)(1992-9#1)(1993-8#1)(1995-3#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
from 60 to##4##3##(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#1)
from 60##6##2##(1994-12#1)(1994-2#1)(1994-9#1)(1996-12#1)(2008-10#1)(2012-12#1)
from 600 to##2##3##(1991-5#1)(2008-10#1)
from 600##3##2##(1990-12#1)(1991-5#1)(2008-10#1)
from 61##4##2##(1995-11#1)(2008-10#1)(2008-12#1)(2009-3#1)
from 62 to##2##3##(2008-10#2)
from 62##3##2##(2008-10#3)
from 64##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
from 65##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)
from 66 to##2##3##(2008-10#1)(2009-8#1)
from 66##3##2##(2008-10#2)(2009-8#1)
from 68 to##3##3##(1995-6#1)(2008-10#2)
from 68##5##2##(1995-6#1)(2008-10#3)(2012-3#1)
from 7 to##7##3##(2008-10#7)
from 7##16##2##(1991-2#1)(1993-8#1)(2008-10#12)(2008-7#2)
from 70##6##2##(1992-2#1)(2008-10#3)(2008-11#1)(2013-1#1)
from 72##2##2##(2008-10#2)
from 75 to##2##3##(2008-10#1)(2008-11#1)
from 75##3##2##(2008-10#2)(2008-11#1)
from 77##2##2##(2008-10#2)
from 78 to##2##3##(2008-10#1)(2010-9#1)
from 78##3##2##(2008-10#2)(2010-9#1)
from 79##3##2##(1991-6#1)(2008-10#1)(2011-2#1)
from 8 to##3##3##(2008-10#3)
from 8##17##2##(1990-8#1)(1993-9#1)(2008-10#11)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
from 80 to 104%##2##4##(2008-10#2)
from 80 to##6##3##(2008-10#6)
from 80##9##2##(1992-3#1)(2008-10#7)(2010-8#1)
from 81 to##3##3##(1993-6#1)(2008-10#2)
from 81##5##2##(1993-6#1)(1996-12#1)(2008-10#3)
from 82 to##2##3##(2008-10#2)
from 83##2##2##(1997-2#1)(2008-10#1)
from 86 to##3##3##(2008-10#3)
from 86##4##2##(2008-10#4)
from 88 to##4##3##(2008-10#3)(2008-8#1)
from 88##5##2##(2008-10#4)(2008-8#1)
from 9 to##6##3##(2008-10#4)(2008-7#1)(2012-2#1)
from 9##13##2##(1995-6#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
from 90 to##5##3##(2008-10#5)
from 90##8##2##(2008-10#5)(2009-3#1)(2013-1#2)
from 91 to##6##3##(2008-10#6)
from 91##8##2##(2008-10#7)(2009-4#1)
from 92 to##3##3##(2008-10#3)
from 92##6##2##(2008-10#6)
from 93 to##2##3##(2008-10#2)
from 93##5##2##(2008-10#5)
from 94 to##2##3##(2008-10#2)
from 94##3##2##(2008-10#3)
from 95 to##2##3##(2008-10#2)
from 95##13##2##(1990-3#1)(2008-10#12)
from 96 to 104%##2##4##(2008-10#2)
from 96 to##6##3##(2008-10#6)
from 96##10##2##(1991-8#1)(2008-10#7)(2010-4#1)(2013-8#1)
from 97 to##3##3##(2008-10#3)
from 97##12##2##(1992-11#1)(2008-10#8)(2008-12#3)
from 98 to##2##3##(2008-10#2)
from 98##6##2##(1992-11#1)(2008-10#5)
from 99##11##2##(1990-11#1)(1992-11#1)(2008-10#9)
from A##12##2##(1996-2#1)(2008-10#8)(2008-5#2)(2008-9#1)
from AG-1-IA##2##2##(2008-10#2)
from AIDS##5##2##(1995-2#1)(1996-11#3)(1997-6#1)
from Africa and the##2##4##(1994-3#1)(2008-10#1)
from Africa and##3##3##(1994-3#1)(2008-10#2)
from Africa##7##2##(1993-11#1)(1994-3#1)(2008-10#5)
from African cultivated rice##2##4##(2009-10#2)
from African##4##2##(2008-10#1)(2008-12#1)(2009-10#2)
from Agricultural##2##2##(1995-3#1)(2008-10#1)
from Agrobacterium radiobacter##2##3##(2008-10#2)
from Andean##2##2##(2008-10#2)
from April to##2##3##(2008-10#2)
from April##7##2##(1994-6#1)(2008-10#5)(2012-3#1)
from Arabidopsis thaliana##3##3##(1993-2#1)(2008-10#1)(2012-3#1)
from Arabidopsis##4##2##(1993-2#1)(2008-10#1)(2009-10#1)(2012-3#1)
from Areca catechu##2##3##(2008-5#2)
from Arkansas##2##2##(2008-10#2)
from Aspergillus nidulans##2##3##(1997-4#2)
from Aspergillus niger##4##3##(1991-9#1)(1997-2#2)(2008-10#1)
from Aspergillus##9##2##(1991-9#1)(1993-2#1)(1996-6#1)(1997-2#2)(1997-4#2)(2008-10#2)
from August##2##2##(2008-10#1)(2012-2#1)
from Australia##6##2##(2008-10#6)
from Australian##2##2##(2008-10#1)(2010-10#1)
from B##13##2##(1992-3#3)(2008-10#7)(2008-11#1)(2008-7#1)(2012-2#1)
from B1##2##2##(1990-2#1)(2008-11#1)
from BALB/c mice##4##3##(1996-12#2)(2008-11#1)(2012-3#1)
from BALB/c##5##2##(1996-12#2)(2008-11#1)(2008-8#1)(2012-3#1)
from Bacillus amyloliquefaciens##3##3##(1990-11#2)(1991-6#1)
from Bacillus cereus##3##3##(2010-12#2)(2011-1#1)
from Bacillus subtilis##4##3##(1991-6#2)(2011-1#2)
from Bacillus thuringiensis##2##3##(1993-12#1)(1993-8#1)
from Bacillus##14##2##(1990-11#2)(1991-6#3)(1993-12#1)(1993-8#1)(2010-12#2)(2011-1#4)(2011-2#1)
from Baja California##2##3##(2008-8#1)(2008-9#1)
from Bangalore##2##2##(2008-10#2)
from Barcelona harbour##2##3##(2008-10#2)
from Bombyx mori##3##3##(1997-7#1)(2008-11#2)
from Bos taurus##4##3##(1993-12#1)(1993-2#3)
from Brassica##2##2##(2008-10#2)
from Brazil##6##2##(2008-10#5)(2008-11#1)
from Burkina Faso##2##3##(2008-12#2)
from C##13##2##(1992-3#1)(1993-9#1)(1996-3#1)(2008-10#7)(2008-5#2)(2013-1#1)
from C57BL/6##2##2##(1995-2#1)(2012-3#1)
from CBCT##2##2##(2012-3#1)(2013-1#1)
from CC##2##2##(2008-10#2)
from California and##2##3##(2008-10#1)(2008-8#1)
from California##12##2##(2008-10#11)(2008-8#1)
from Cameroon##2##2##(2013-1#2)
from Canada##3##2##(1994-1#1)(2008-10#2)
from Canadian##4##2##(2008-10#3)(2013-1#1)
from Candida parapsilosis##3##3##(1997-2#3)
from Candida tropicalis##2##3##(1990-5#1)(1991-9#1)
from Candida##9##2##(1990-5#1)(1991-9#1)(1995-3#1)(1996-3#2)(1997-2#4)
from Central Asia and the Caucasus were##2##7##(2008-10#2)
from Central##3##2##(1997-3#1)(2008-10#2)
from Chenopodium##2##2##(2008-10#1)(2008-11#1)
from Chiapas##2##2##(2008-10#2)
from China##4##2##(2008-10#3)(2008-9#1)
from Chinese herbs##4##3##(2008-5#3)(2011-3#1)
from Chinese##6##2##(2008-5#3)(2008-7#1)(2008-8#1)(2011-3#1)
from Citrus tristeza virus##2##4##(2008-10#2)
from Citrus##4##2##(2008-10#4)
from Cochliobolus##2##2##(2008-10#2)
from Colorado##3##2##(1997-1#1)(2008-10#2)
from Cr(III)##5##2##(2008-10#5)
from Crikvenica##3##2##(2011-2#3)
from Cultivated##2##2##(2008-10#2)
from D##3##2##(1993-12#1)(2008-10#2)
from D-R isotherm##2##3##(2008-10#2)
from DNA and##2##3##(2008-11#1)(2009-5#1)
from DNA microarray experiments##2##4##(2008-4#1)(2013-8#1)
from DNA of##3##3##(1993-8#1)(2008-10#2)
from DNA sequence##2##3##(1994-8#1)(2008-10#1)
from DNA sequences of##2##4##(1997-2#1)(2008-10#1)
from DNA sequences##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
from DNA##14##2##(1993-8#1)(1994-8#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2013-8#1)
from DPP##2##2##(2008-10#2)
from December##4##2##(1991-8#1)(1997-8#1)(2012-12#1)(2013-7#1)
from Descemet's membrane##2##3##(1990-8#2)
from Diseased##2##2##(2008-10#2)
from Drosophila melanogaster##4##3##(2008-11#1)(2009-7#2)(2012-3#1)
from Drosophila##5##2##(2008-11#1)(2009-7#2)(2009-8#1)(2012-3#1)
from E##16##2##(1991-3#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#1)(2009-7#1)(2010-3#1)
from ECV to ECII##2##4##(2008-11#2)
from ES cells##2##3##(2008-11#1)(2009-12#1)
from ES##3##2##(2008-11#2)(2009-12#1)
from East##4##2##(2008-10#3)(2010-8#1)
from Ecuador##3##2##(2008-10#3)
from Egypt##3##2##(2008-10#3)
from Eisenia fetida##2##3##(2008-9#2)
from Erwinia##2##2##(1990-5#1)(2008-10#1)
from Escherichia coli##10##3##(1991-5#1)(1992-6#1)(1993-8#2)(1994-5#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)
from Ethiopia##5##2##(2008-10#5)
from Europe and North America##3##5##(2008-10#1)(2011-2#2)
from Europe and##6##3##(2008-10#4)(2011-2#2)
from Europe were##2##3##(2008-10#2)
from Europe##15##2##(2008-10#12)(2011-2#2)(2013-8#1)
from F##5##2##(2008-10#5)
from Fe(III)##2##2##(2008-10#2)
from February##4##2##(1997-7#1)(2008-11#2)(2008-7#1)
from Florida##4##2##(2008-10#4)
from France##3##2##(2008-10#3)
from Fusarium oxysporum##3##3##(2008-10#3)
from Fusarium solani##2##3##(1995-3#1)(2008-10#1)
from Fusarium verticillioides##2##3##(2008-10#2)
from Fusarium##8##2##(1995-3#1)(2008-10#7)
from G in the codon for##2##6##(2008-10#2)
from G##3##2##(2008-10#2)(2013-1#1)
from G1 to##2##3##(1994-5#1)(2008-11#1)
from G1##3##2##(1994-5#1)(1996-3#1)(2008-11#1)
from GC##2##2##(2008-10#2)
from GSR##2##2##(2012-2#2)
from Galicia##2##2##(2008-10#2)
from GenBank##2##2##(2008-12#1)(2013-1#1)
from Germany##2##2##(1992-12#1)(2011-2#1)
from Guatemala##2##2##(2008-10#2)
from H##7##2##(2008-10#6)(2009-3#1)
from H(2)SO(4)-HF##2##2##(2008-10#2)
from HC##2##2##(2008-10#1)(2008-11#1)
from HIV##3##2##(1990-2#1)(1995-1#1)(2008-5#1)
from HIV-1 infected##2##3##(1997-3#1)(2011-3#1)
from HIV-1##3##2##(1992-6#1)(1997-3#1)(2011-3#1)
from HIV-infected patients##2##3##(2008-5#2)
from HIV-infected##3##2##(2008-5#3)
from HPLC##2##2##(2008-10#2)
from HeLa cells##2##3##(1993-8#1)(1994-11#1)
from Helicobacter pylori##2##3##(1996-12#2)
from I##3##2##(2008-10#3)
from IECs##4##2##(2008-11#4)
from Ilyobacter tartaricus##2##3##(1993-12#2)
from India and##2##3##(2008-10#2)
from India##8##2##(1994-9#1)(1996-9#1)(2008-10#4)(2011-2#1)(2013-8#1)
from Indian##3##2##(1996-8#1)(2008-10#1)(2010-10#1)
from Indiana##2##2##(2008-10#2)
from Indonesia##2##2##(2008-10#2)
from Indonesian women##3##3##(2008-11#3)
from Iran##3##2##(2008-10#2)(2012-2#1)
from Israel and##2##3##(2008-10#2)
from Israel##9##2##(2008-10#9)
from Italy and##3##3##(2008-10#3)
from Italy##9##2##(2008-10#7)(2008-12#1)(2008-8#1)
from January 1997##2##3##(2008-10#1)(2013-1#1)
from January 2001##2##3##(2007-11#1)(2007-8#1)
from January 2003##2##3##(2010-6#1)(2013-1#1)
from January 2006 to December##2##5##(2011-2#1)(2013-1#1)
from January 2008 to##2##4##(2011-2#2)
from January to##2##3##(1993-12#1)(2009-8#1)
from January##18##2##(1990-9#1)(1993-12#1)(1994-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#2)(2010-6#1)(2011-2#5)(2013-1#3)
from Japan and##3##3##(2008-10#3)
from Japan##12##2##(2008-10#11)(2008-11#1)
from Jordan##2##2##(2008-10#1)(2012-2#1)
from July##6##2##(1990-2#1)(1991-2#1)(1995-12#1)(2008-10#1)(2010-9#1)(2013-7#1)
from June##2##2##(1991-8#1)(2008-10#1)
from Jurkat cells##2##3##(1992-6#1)(1994-6#1)
from K##2##2##(1993-5#1)(2012-2#1)
from KG-1 leukemic cells##2##4##(1993-12#2)
from KG-1##3##2##(1993-12#3)
from Kentucky##4##2##(2008-10#4)
from Kjeldahl and 0##2##4##(2008-10#2)
from Klebsiella pneumoniae##3##3##(1997-7#2)(2008-9#1)
from Klebsiella##4##2##(1993-12#1)(1997-7#2)(2008-9#1)
from Kostrena##4##2##(2011-2#4)
from L##2##2##(2008-10#2)
from L-arginine##2##2##(1992-12#1)(2008-5#1)
from La##2##2##(2008-10#2)
from Latin America##4##3##(2008-10#2)(2008-12#1)(2013-1#1)
from Latin##5##2##(1990-6#1)(2008-10#2)(2008-12#1)(2013-1#1)
from Lettuce##2##2##(2008-10#2)
from Lycopersicon hirsutum##3##3##(2008-10#3)
from M##8##2##(2008-10#6)(2008-6#1)(2011-10#1)
from MRL(+/+) mice##2##3##(2008-10#2)
from Macedonia##2##2##(2008-12#2)
from Malus##3##2##(2008-10#3)
from March to July##2##4##(2012-6#2)
from March##6##2##(1991-12#1)(1994-9#1)(2008-7#1)(2009-6#1)(2012-6#2)
from May to November##2##4##(1996-12#1)(2011-2#1)
from May to October##2##4##(2008-10#1)(2013-8#1)
from May to##5##3##(1996-12#2)(2008-10#1)(2011-2#1)(2013-8#1)
from May##8##2##(1991-2#1)(1996-12#2)(2008-10#1)(2008-11#1)(2011-2#2)(2013-8#1)
from Medicaid##2##2##(1992-2#1)(2009-6#1)
from Medicare##2##2##(1993-12#1)(1995-2#1)
from Mexico City##4##3##(2008-12#4)
from Mexico and##3##3##(1996-12#1)(2008-5#1)(2009-8#1)
from Mexico##11##2##(1996-12#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-5#1)(2009-8#1)
from Michigan##3##2##(2008-10#3)
from Mississippi)##2##2##(2008-10#2)
from Monte Carlo simulations##2##4##(2008-3#1)(2013-1#1)
from Monte Carlo##3##3##(2008-3#2)(2013-1#1)
from Mycobacterium tuberculosis##3##3##(2008-9#1)(2009-7#2)
from Mycobacterium##5##2##(2007-12#1)(2008-9#1)(2009-7#2)(2012-2#1)
from N##3##2##(1991-3#1)(2008-10#2)
from NIST##2##2##(2008-10#2)
from Na(+)##2##2##(2008-10#2)
from Natronobacterium pharaonis##2##3##(1994-5#2)
from Nd##2##2##(2007-12#1)(2008-2#1)
from Nebraska##3##2##(2008-10#1)(2008-8#2)
from Nepal##2##2##(2011-2#2)
from Neurospora crassa##4##3##(1995-2#3)(2008-10#1)
from Neurospora##5##2##(1995-2#3)(2008-10#1)(2013-1#1)
from New World##2##3##(2008-10#1)(2012-2#1)
from New York##2##3##(1993-1#1)(2008-10#1)
from New Zealand and##2##4##(2008-10#2)
from New Zealand##3##3##(2008-10#3)
from New##10##2##(1993-1#1)(2008-10#7)(2008-8#1)(2012-2#1)
from Ni(II)##2##2##(2008-10#2)
from Nigeria##2##2##(1990-3#1)(2008-10#1)
from North America##7##3##(2008-10#5)(2011-10#1)(2012-3#1)
from North##10##2##(1992-2#1)(2008-10#7)(2011-10#1)(2012-3#1)
from Norwegian##2##2##(1991-2#1)(2011-2#1)
from November##5##2##(1996-1#1)(2008-10#2)(2011-2#2)
from O##2##2##(1991-3#1)(2008-10#1)
from ODN-chain##2##2##(2008-10#2)
from October##4##2##(1995-3#1)(1995-5#1)(2008-10#1)(2011-3#1)
from Other##2##2##(2008-10#2)
from P##18##2##(1990-12#1)(1993-2#1)(1993-9#1)(1995-5#1)(2008-10#13)(2011-2#1)
from PAP##2##2##(1995-11#1)(2010-7#1)
from PC12 cells##2##3##(1990-8#1)(1997-2#1)
from PC12##3##2##(1990-8#1)(1997-2#1)(2008-11#1)
from PCR amplified real samples##2##5##(2008-10#2)
from PD##4##2##(2008-10#3)(2008-7#1)
from PSV##2##2##(2008-10#2)
from PVC##2##2##(2008-10#2)
from Pakistan##2##2##(2012-2#2)
from Palinurus versicolor##2##3##(2008-9#2)
from Panax ginseng##2##3##(1995-8#2)
from Paracoccus denitrificans##2##3##(1992-3#2)
from Part I##3##3##(2009-2#3)
from Pennsylvania##2##2##(2008-10#2)
from Phanerochaete chrysosporium##3##3##(1990-12#1)(2008-6#2)
from Phytophthora##2##2##(2008-10#2)
from Pistachio and Other##2##4##(2008-10#2)
from Pm##3##2##(2011-1#3)
from Portugal##2##2##(2008-10#2)
from Potato##3##2##(2008-10#3)
from Pseudomonas##6##2##(1994-5#2)(2008-10#2)(2008-7#2)
from Puerto Rico##4##3##(2008-10#3)(2008-11#1)
from Pyrenophora tritici-repentis##2##3##(2008-10#2)
from Pyrenophora##3##2##(2008-10#3)
from R##7##2##(1995-12#2)(2008-10#5)
from RFLP marker##2##3##(2008-10#2)
from RFLP##3##2##(2008-10#3)
from RNA##5##2##(1997-2#1)(1997-6#1)(2008-10#2)(2008-9#1)
from Rayleigh##2##2##(2008-3#2)
from Rio##2##2##(2008-10#1)(2012-3#1)
from Roma##2##2##(2008-10#1)(2011-3#1)
from Roman##2##2##(2008-10#2)
from S##11##2##(1990-2#1)(1990-5#1)(1993-12#2)(1994-12#1)(2008-10#3)(2008-11#1)(2008-9#2)
from Saccharomyces cerevisiae was##2##4##(1996-3#1)(1997-8#1)
from Saccharomyces cerevisiae##16##3##(1993-12#1)(1993-9#2)(1995-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-7#3)(1997-8#1)(2008-4#2)(2009-7#2)(2013-1#1)
from Salvia miltiorrhiza##3##3##(2008-10#3)
from Sclerotinia##2##2##(2008-10#2)
from September##4##2##(1990-12#1)(2008-10#2)(2011-2#1)
from Sf9 cells##2##3##(1992-3#1)(2008-1#1)
from Sf9##3##2##(1992-3#1)(1993-8#1)(2008-1#1)
from Si##2##2##(1994-2#1)(2008-10#1)
from Sm10T##2##2##(2008-10#2)
from Small##2##2##(2008-10#2)
from South Africa##5##3##(2008-10#1)(2008-12#2)(2010-1#2)
from South America and##4##4##(2008-10#4)
from South America##7##3##(2008-10#7)
from South##12##2##(2008-10#8)(2008-12#2)(2010-1#2)
from Soybean##2##2##(2008-10#2)
from Spain and Israel##2##4##(2008-10#2)
from Spain and##4##3##(2008-10#3)(2013-8#1)
from Spain##6##2##(2008-10#5)(2013-8#1)
from Spanish##4##2##(2008-10#4)
from Ss275##2##2##(2008-10#2)
from Staphylococcus aureus##3##3##(1990-12#1)(1994-3#1)(1996-12#1)
from Strawberry##2##2##(2008-10#2)
from Streptomyces cattleya##2##3##(2008-8#2)
from Streptomyces coelicolor##2##3##(2008-8#1)(2011-2#1)
from Streptomyces##8##2##(1994-3#1)(2008-10#1)(2008-8#4)(2009-6#1)(2011-2#1)
from Sulfolobus##2##2##(1990-2#1)(2008-9#1)
from Synechococcus PCC7002##2##3##(1997-4#2)
from T cell##2##3##(2008-11#2)
from T cells##2##3##(2008-4#1)(2008-7#1)
from T##11##2##(1996-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#1)
from T3##2##2##(2008-10#2)
from T50 to##2##3##(2013-8#2)
from TA 870##2##3##(2008-10#2)
from Tagetes mendocina##2##3##(2008-11#2)
from Taiwan##2##2##(2008-10#2)
from Tanzania##2##2##(2008-11#2)
from Tex6##2##2##(2008-10#2)
from Texas##3##2##(1996-12#1)(2008-10#2)
from Th##2##2##(2008-9#2)
from Thinopyrum##2##2##(2008-10#1)(2008-8#1)
from Tomato and Potato in##2##5##(2008-10#2)
from Tomato##5##2##(2008-10#5)
from Trichoderma reesei##2##3##(2008-9#2)
from Trichoderma##4##2##(2008-10#2)(2008-9#2)
from U##3##2##(1996-12#1)(2008-10#1)(2013-8#1)
from UV##2##2##(2008-10#1)(2008-5#1)
from V##3##2##(1997-8#1)(2008-10#2)
from Varian (Australia)##2##3##(2008-10#2)
from Venezuela##3##2##(2008-10#3)
from Verticillium##2##2##(2008-10#2)
from Vicia faba##3##3##(2008-10#2)(2008-8#1)
from Victoria Harbor##2##3##(2010-5#2)
from WHO##2##2##(2008-3#1)(2010-5#1)
from West##2##2##(2008-1#1)(2009-10#1)
from Western##3##2##(1990-6#1)(1994-8#1)(2008-12#1)
from Wheat##4##2##(2008-10#4)
from X##3##2##(2008-10#3)
from Xenopus laevis##4##3##(1993-12#1)(1993-2#1)(1993-6#1)(2008-11#1)
from Xenopus##6##2##(1993-12#1)(1993-2#1)(1993-6#1)(1996-2#1)(2008-11#1)(2008-5#1)
from Yunnan##3##2##(2008-8#1)(2013-8#2)
from a 0##2##3##(2008-10#1)(2012-2#1)
from a Dutch##2##3##(2009-12#1)(2011-2#1)
from a Nd##3##3##(2008-2#3)
from a broad##2##3##(2008-10#2)
from a cDNA library##2##4##(1995-8#1)(2011-2#1)
from a cDNA##3##3##(1995-8#1)(1997-7#1)(2011-2#1)
from a calibration curve##2##4##(2008-10#2)
from a calibration##3##3##(2008-10#3)
from a cell##3##3##(2008-11#2)(2008-4#1)
from a central##2##3##(2008-10#2)
from a chemical##2##3##(1991-9#1)(2008-10#1)
from a chicken hybridoma##2##4##(2008-11#2)
from a clinical trial of##2##5##(1994-9#1)(2009-4#1)
from a clinical##5##3##(1994-9#1)(1995-3#1)(2009-4#1)(2009-7#1)(2013-1#1)
from a close##2##3##(1993-2#1)(2008-10#1)
from a cohort##2##3##(2008-12#1)(2010-10#1)
from a collection##4##3##(2008-10#3)(2012-3#1)
from a combination of##2##4##(2008-11#1)(2012-12#1)
from a commercial##6##3##(2008-10#4)(2012-2#2)
from a common##6##3##(1997-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)(2012-3#1)
from a community-based study##2##4##(2007-12#1)(2008-7#1)
from a comparative##2##3##(2009-8#1)(2010-8#1)
from a complex mixture##2##4##(1992-6#1)(2008-4#1)
from a complex##4##3##(1992-6#1)(2008-4#1)(2008-8#1)(2013-1#1)
from a composite##2##3##(2008-10#2)
from a comprehensive##2##3##(1994-3#1)(1997-6#1)
from a contaminated##2##3##(2008-10#2)
from a cross between a resistant##2##6##(2008-10#2)
from a cross between a##4##5##(2008-10#3)(2012-3#1)
from a cross between the resistant##3##6##(2008-10#3)
from a cross between the##7##5##(2008-10#7)
from a cross between##20##4##(2008-10#18)(2008-9#1)(2012-3#1)
from a cross of##3##4##(2008-10#3)
from a cross##24##3##(2008-10#22)(2008-9#1)(2012-3#1)
from a crude##2##3##(2008-10#1)(2008-7#1)
from a data##3##3##(2008-10#2)(2008-8#1)
from a different##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
from a direct##2##3##(1995-11#1)(2008-10#1)
from a disease##2##3##(2008-10#1)(2008-11#1)
from a diverse##2##3##(2012-3#1)(2012-4#1)
from a donor##2##3##(1997-2#1)(2008-10#1)
from a eubacterium##2##3##(2009-8#2)
from a few##7##3##(1997-6#1)(2008-10#5)(2011-2#1)
from a fiber-coupled##2##3##(2007-12#1)(2008-3#1)
from a field##5##3##(2008-10#4)(2008-9#1)
from a first##3##3##(2008-10#2)(2008-11#1)
from a flowing##2##3##(2008-10#2)
from a full-length##2##3##(1991-7#1)(2008-10#1)
from a gas##2##3##(2008-10#1)(2008-2#1)
from a gender##2##3##(2009-10#1)(2010-12#1)
from a gene##2##3##(1997-3#1)(2010-10#1)
from a genomic library of##3##5##(1990-5#1)(2008-10#2)
from a genomic library##6##4##(1990-5#1)(1993-2#1)(1993-6#1)(2008-10#3)
from a given##4##3##(1994-2#1)(2008-10#2)(2013-8#1)
from a greater##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
from a group of##5##4##(2008-1#1)(2008-10#3)(2010-12#1)
from a health##3##3##(1994-2#1)(1997-2#1)(2010-4#1)
from a higher##2##3##(1994-2#1)(2008-11#1)
from a highly##4##3##(1993-12#1)(1995-6#1)(2008-10#1)(2011-2#1)
from a human liver##2##4##(1993-3#1)(1994-11#1)
from a human lung cDNA library##2##6##(1991-5#1)(1997-2#1)
from a human##18##3##(1991-5#2)(1991-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-7#1)
from a hydrochloric acid production plant##2##6##(2008-10#2)
from a laboratory##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
from a lambda##3##3##(1993-2#1)(1997-7#1)(2008-11#1)
from a large number of##2##5##(2008-10#1)(2008-3#1)
from a large volume of aqueous##2##6##(2008-10#2)
from a large volume##3##4##(2008-10#3)
from a large##10##3##(1991-12#1)(1995-9#1)(1997-8#1)(2008-10#4)(2008-3#1)(2009-7#1)(2011-2#1)
from a larger##2##3##(2008-12#1)(2010-7#1)
from a layer##2##3##(2008-10#1)(2008-3#1)
from a library of##2##4##(1995-6#1)(2008-10#1)
from a limited##4##3##(1994-8#1)(2008-10#1)(2008-8#1)(2009-11#1)
from a line##2##3##(1993-6#1)(2008-3#1)
from a local##3##3##(1994-2#1)(2008-10#1)(2008-12#1)
from a longitudinal study##3##4##(2008-11#2)(2009-8#1)
from a longitudinal##4##3##(2008-11#2)(2009-8#1)(2010-12#1)
from a low level##2##4##(2008-10#2)
from a low##4##3##(1993-6#1)(1996-9#1)(2008-10#2)
from a mathematical##2##3##(2008-9#1)(2011-3#1)
from a mean of##2##4##(2008-1#1)(2008-5#1)
from a mean##3##3##(2008-1#1)(2008-5#1)(2013-1#1)
from a member of the family##5##6##(2011-2#5)
from a member of the##7##5##(2011-2#7)
from a mixture of##2##4##(2008-10#1)(2008-8#1)
from a mixture##4##3##(2008-10#3)(2008-8#1)
from a mouse##4##3##(1995-12#2)(1995-2#1)(1995-6#1)
from a national survey##2##4##(1994-2#1)(2012-2#1)
from a national##5##3##(1994-2#1)(1997-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
from a natural##2##3##(1997-3#1)(2008-9#1)
from a newborn##2##3##(1993-2#1)(2009-12#1)
from a number of different##4##5##(2008-10#3)(2008-12#1)
from a number of##9##4##(1993-12#1)(1993-2#1)(2008-10#5)(2008-12#1)(2008-3#1)
from a partial##2##3##(2008-10#1)(2008-8#1)
from a particular##2##3##(2008-10#1)(2008-11#1)
from a passive##2##3##(2008-11#2)
from a patient with##2##4##(1990-12#1)(1994-11#1)
from a patient##4##3##(1990-12#1)(1994-11#1)(2008-10#1)(2013-8#1)
from a patient's perspective##2##4##(2010-8#2)
from a pig##2##3##(1996-2#1)(2011-2#1)
from a plant##3##3##(2008-10#3)
from a point source##3##4##(2008-10#3)
from a population of##2##4##(2008-10#1)(2008-11#1)
from a population##4##3##(1993-11#1)(2008-10#2)(2008-11#1)
from a preliminary##3##3##(2008-10#2)(2008-12#1)
from a previous study##2##4##(1991-2#1)(2008-10#1)
from a previous##6##3##(1991-2#2)(2008-1#1)(2008-10#2)(2013-1#1)
from a previously reported##2##4##(1994-11#1)(2012-2#1)
from a previously##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
from a primary##2##3##(1993-2#1)(2010-2#1)
from a prospective##2##3##(2008-11#1)(2011-2#1)
from a pure##2##3##(2008-8#1)(2013-8#1)
from a qualitative##2##3##(2011-2#1)(2013-8#1)
from a random sample of##2##5##(1996-2#1)(2012-3#1)
from a random##5##3##(1996-2#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
from a randomized controlled trial##2##5##(1997-2#1)(2008-8#1)
from a randomized##3##3##(1996-6#1)(1997-2#1)(2008-8#1)
from a range of##5##4##(1996-12#1)(2008-10#1)(2008-11#2)(2009-6#1)
from a rat##7##3##(1991-12#1)(1992-10#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-12#1)
from a recently##2##3##(1993-2#1)(2008-3#1)
from a refuge##2##3##(2009-5#2)
from a region##3##3##(1993-9#1)(2008-1#1)(2008-10#1)
from a sample of##7##4##(1993-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#2)
from a sample##9##3##(1993-12#1)(1995-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)
from a series of##9##4##(1990-8#1)(1992-9#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)
from a set of##2##4##(2008-10#1)(2009-7#1)
from a simple##2##3##(2008-3#1)(2012-2#1)
from a single sample##3##4##(2008-10#3)
from a single species##2##4##(1993-12#1)(2011-2#1)
from a single##37##3##(1992-11#1)(1993-12#2)(1995-2#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#5)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
from a small##8##3##(1990-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-6#2)(2012-3#1)
from a solid##4##3##(2008-10#3)(2010-3#1)
from a solution containing##2##4##(2008-10#2)
from a solution##3##3##(1990-5#1)(2008-10#2)
from a source##2##3##(2008-10#2)
from a spherical##2##3##(2008-10#1)(2012-2#1)
from a squash##2##3##(2008-10#2)
from a strangulating fallopian tube##2##5##(2012-3#2)
from a stratospheric balloon##2##4##(2008-3#2)
from a strong##2##3##(2008-10#2)
from a structure##2##3##(1995-6#1)(2011-2#1)
from a study of##6##4##(1992-11#1)(1993-1#1)(1994-11#1)(1994-3#1)(2009-10#1)(2012-3#1)
from a study##8##3##(1992-11#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(2009-10#1)(2012-3#1)(2013-1#1)
from a subgroup I strain##2##5##(2008-10#2)
from a subgroup##3##3##(2008-10#3)
from a survey of 200##2##5##(1997-2#1)(2008-12#1)
from a survey of nurses##2##5##(2008-12#1)(2010-10#1)
from a survey of##6##4##(1993-12#1)(1996-3#1)(1997-2#1)(2008-12#2)(2010-10#1)
from a survey##7##3##(1993-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(2008-12#2)(2010-10#1)
from a susceptible##2##3##(2008-10#2)
from a synthetic phage display library##2##6##(2008-10#2)
from a synthetic phage display##3##5##(2008-10#3)
from a synthetic##5##3##(1991-5#1)(2008-10#4)
from a system##2##3##(2008-3#1)(2009-3#1)
from a tertiary##2##3##(2013-1#2)
from a third##2##3##(1990-11#1)(1995-11#1)
from a total of##6##4##(2008-10#4)(2008-11#1)(2008-7#1)
from a total##7##3##(1995-3#1)(2008-10#4)(2008-11#1)(2008-7#1)
from a turbid medium##2##4##(2008-3#2)
from a variety of other##2##5##(2008-10#1)(2012-2#1)
from a variety of sources##2##5##(1995-1#1)(2010-10#1)
from a variety of##17##4##(1995-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-8#1)(2012-2#1)
from a weakly acidic solution##2##5##(2008-10#2)
from a weakly##3##3##(2008-10#2)(2009-5#1)
from a wide range of host species##2##7##(2008-10#2)
from a wide range of host##3##6##(2008-10#3)
from a wide range of##6##5##(1995-2#1)(2008-10#4)(2008-11#1)
from a wide variety of##2##5##(2008-2#1)(2013-8#1)
from a wide##10##3##(1995-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2013-8#1)
from a worldwide##2##3##(2008-10#1)(2012-2#1)
from a##999##2##(1990-11#4)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#5)(1990-9#3)(1991-1#1)(1991-12#5)(1991-2#5)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#2)(1992-12#4)(1992-3#4)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#15)(1993-2#10)(1993-3#5)(1993-6#7)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#11)(1994-12#2)(1994-2#6)(1994-3#6)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#8)(1995-2#10)(1995-3#4)(1995-5#2)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#8)(1996-2#10)(1996-3#3)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#11)(1997-3#5)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#5)(1997-9#1)(2006-6#2)(2007-11#5)(2007-12#5)(2008-1#8)(2008-10#314)(2008-11#61)(2008-12#20)(2008-2#14)(2008-3#48)(2008-4#10)(2008-5#15)(2008-6#1)(2008-7#13)(2008-8#27)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#7)(2009-9#1)(2010-10#6)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#5)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#41)(2011-3#1)(2011-7#1)(2011-8#1)(2012-12#8)(2012-2#22)(2012-3#18)(2012-4#1)(2012-7#1)(2013-1#23)(2013-8#12)
from abdominal##2##2##(1990-8#1)(2010-4#1)
from about##3##2##(1990-2#1)(2007-12#1)(2008-5#1)
from abroad##2##2##(1991-2#1)(2007-12#1)
from absorption##4##2##(1992-12#1)(1997-1#1)(2008-2#1)(2008-3#1)
from academia and the pharmaceutical##2##5##(2008-5#2)
from accidental##3##2##(1996-8#1)(2007-12#1)(2008-10#1)
from acid##4##2##(2008-10#3)(2013-1#1)
from acidic waste##2##3##(2008-10#2)
from acidic##9##2##(2008-10#9)
from acidified##2##2##(2008-10#2)
from activated##8##2##(1992-6#1)(1997-1#1)(2008-11#1)(2009-10#1)(2010-3#2)(2010-8#1)(2011-2#1)
from activating the##2##3##(2008-11#1)(2009-10#1)
from active##2##2##(1995-3#1)(2010-11#1)
from actual##2##2##(2008-6#1)(2008-7#1)
from acute challenge with noradrenaline##2##5##(1996-2#2)
from acute##13##2##(1990-6#1)(1991-8#1)(1992-9#1)(1993-12#1)(1996-2#3)(2008-7#1)(2009-3#2)(2010-1#1)(2011-2#1)(2013-1#1)
from adipose tissue##2##3##(2008-6#1)(2013-1#1)
from adjacent##3##2##(2008-9#1)(2012-3#1)(2013-8#1)
from adult##11##2##(1996-2#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#2)(2009-10#1)(2012-3#1)
from adults##2##2##(2008-11#1)(2010-6#1)
from advances in##2##3##(1993-1#1)(2010-7#1)
from aerial parts of##2##4##(2008-10#2)
from aerosols##2##2##(1996-1#1)(2008-3#1)
from age##2##2##(1993-1#1)(2008-7#1)
from aged##2##2##(1990-3#1)(2008-7#1)
from agricultural##2##2##(2008-10#2)
from air##5##2##(1996-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
from airborne##2##2##(2008-10#1)(2008-3#1)
from alginate##2##2##(2008-10#1)(2011-2#1)
from alkali##2##2##(2008-10#2)
from all five##3##3##(2008-10#2)(2008-11#1)
from all four##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
from all geographic##2##3##(2008-10#1)(2011-10#1)
from all isolates of##3##4##(2008-10#3)
from all isolates##5##3##(2008-10#5)
from all locations##2##3##(2008-10#2)
from all of the##7##4##(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
from all other strains##2##4##(2008-10#2)
from all other##10##3##(1997-1#1)(2008-10#8)(2011-2#1)
from all over##2##3##(1994-9#1)(2008-10#1)
from all sites##2##3##(2008-10#2)
from all the other##3##4##(2008-10#2)(2009-8#1)
from all the provenances##2##4##(2011-10#2)
from all the##10##3##(1993-12#1)(1996-12#1)(2008-10#3)(2009-8#1)(2010-1#1)(2011-10#2)(2011-2#1)
from all three##10##3##(2008-10#7)(2008-12#1)(2010-5#1)(2011-3#1)
from all##101##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#61)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-10#3)(2011-2#5)(2011-3#1)(2012-3#1)(2013-1#1)
from alloxan-induced cell damage##2##4##(2008-11#2)
from almond and##2##3##(2008-10#2)
from almond##9##2##(2008-10#9)
from alternative##4##2##(1995-6#1)(2008-10#2)(2008-8#1)
from amino##2##2##(1993-8#1)(2012-2#1)
from ammonia##2##2##(2008-10#2)
from among##2##2##(1995-12#1)(2008-10#1)
from amplified fragment length##2##4##(2008-10#2)
from amplified##3##2##(2008-10#2)(2008-8#1)
from an Indian##2##3##(2008-5#1)(2009-11#1)
from an MDI##2##3##(1996-1#1)(1997-1#1)
from an adult##5##3##(1997-7#1)(1997-8#1)(2008-9#3)
from an airborne##2##3##(2008-2#1)(2008-3#1)
from an ancestral##2##3##(1990-7#1)(2008-11#1)
from an aqueous solution of##2##5##(2008-10#2)
from an aqueous solution onto##2##5##(2008-10#1)(2008-11#1)
from an aqueous solution##7##4##(2008-10#6)(2008-11#1)
from an aqueous##10##3##(2007-11#1)(2008-10#7)(2008-11#1)(2008-5#1)
from an area##4##3##(2008-10#3)(2013-1#1)
from an average of##3##4##(1994-12#1)(2008-10#1)(2009-3#1)
from an early stage##2##4##(2007-12#1)(2008-10#1)
from an empirical study##2##4##(1992-3#1)(2009-8#1)
from an environmental##2##3##(2008-10#2)
from an epidemiological##2##3##(1992-9#1)(2008-11#1)
from an existing##2##3##(2008-11#1)(2012-2#1)
from an external##2##3##(2008-3#1)(2008-7#1)
from an in vitro##2##4##(2008-10#1)(2012-3#1)
from an infected##2##3##(2008-10#2)
from an initial##2##3##(2008-10#1)(2011-2#1)
from an inoculum source##2##4##(2008-10#2)
from an international##3##3##(2008-10#1)(2008-11#2)
from an isotropic point source##2##5##(2008-3#2)
from an ongoing##2##3##(2008-11#1)(2008-6#1)
from an##196##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1992-12#2)(1992-3#1)(1992-9#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#71)(2008-11#16)(2008-12#3)(2008-2#4)(2008-3#13)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-11#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#7)(2012-2#2)(2012-3#8)(2013-1#4)(2013-8#1)
from analyses##2##2##(1996-3#1)(2008-10#1)
from analyte##2##2##(2008-10#2)
from and##7##2##(2008-10#2)(2008-11#2)(2008-12#1)(2009-7#1)(2011-2#1)
from anemone##2##2##(2008-10#2)
from angular static light-scattering measurements##2##5##(2008-3#2)
from angular##4##2##(2008-3#4)
from animal models##2##3##(2008-5#1)(2010-6#1)
from animal##8##2##(1994-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)
from animals##4##2##(1992-6#1)(1993-12#1)(1995-11#2)
from another population##2##3##(2008-9#2)
from another##14##2##(1993-12#1)(1994-11#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#1)
from anterior##2##2##(2008-10#1)(2008-8#1)
from antibiosis##2##2##(2008-10#2)
from antibody##2##2##(2008-11#1)(2008-4#1)
from any other##4##3##(1990-8#1)(2008-10#3)
from any##20##2##(1990-8#1)(1991-12#1)(1992-4#1)(1993-12#2)(1993-3#1)(2008-10#8)(2008-11#1)(2008-12#2)(2009-3#1)(2011-2#1)(2013-7#1)
from apoptosis##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
from apple roots##2##3##(2008-10#2)
from apple##7##2##(2008-10#6)(2008-8#1)
from appressoria##2##2##(2008-10#2)
from approx##2##2##(1997-1#1)(2008-11#1)
from approximately 0##7##3##(1991-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
from approximately 1 to##2##4##(2008-10#1)(2008-3#1)
from approximately 1##3##3##(1994-5#1)(2008-10#1)(2008-3#1)
from approximately 2##2##3##(2008-10#2)
from approximately##22##2##(1991-11#1)(1994-5#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#8)(2008-2#2)(2008-3#4)(2009-8#1)(2012-2#1)(2013-8#1)
from aqueous media##2##3##(2008-10#2)
from aqueous medium using##2##4##(2008-10#2)
from aqueous medium##3##3##(2008-10#3)
from aqueous phase##3##3##(2008-10#3)
from aqueous sample##2##3##(2008-10#2)
from aqueous samples##5##3##(2008-10#5)
from aqueous solution by##3##4##(2008-10#3)
from aqueous solution with##2##4##(2008-10#2)
from aqueous solution##9##3##(1990-5#1)(2008-10#8)
from aqueous solutions by##2##4##(2008-10#2)
from aqueous solutions containing##4##4##(2008-10#4)
from aqueous solutions into##2##4##(2008-10#2)
from aqueous solutions onto loaded##2##5##(2008-10#2)
from aqueous solutions was##2##4##(2008-10#2)
from aqueous solutions##18##3##(2008-10#17)(2010-11#1)
from aqueous##49##2##(1990-5#1)(2008-10#47)(2010-11#1)
from archaeological##3##2##(1991-2#1)(2008-10#2)
from areas##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
from around the world##2##4##(2009-6#1)(2010-5#1)
from around the##3##3##(2008-10#1)(2009-6#1)(2010-5#1)
from around##5##2##(1997-6#1)(2008-10#2)(2009-6#1)(2010-5#1)
from artificial##3##2##(1995-5#1)(2008-10#2)
from artificially infected##2##3##(2008-10#2)
from as low as##3##4##(1993-12#1)(2008-10#1)(2012-2#1)
from as##6##2##(1992-12#1)(1993-12#1)(2008-10#2)(2012-2#1)(2012-3#1)
from ascorbic acid##2##3##(2008-10#2)
from assessing the##2##3##(2008-10#1)(2008-11#1)
from assessing##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
from asthmatic individuals##2##3##(1992-3#2)
from asymmetric##2##2##(2008-8#1)(2009-10#1)
from asymptomatic##2##2##(2008-10#2)
from at least##3##3##(2008-10#2)(2008-5#1)
from atmospheric##3##2##(2008-10#2)(2008-3#1)
from atomic##2##2##(2008-10#1)(2011-2#1)
from autochthonous##2##2##(2008-9#1)(2013-1#1)
from autopsies##2##2##(1993-2#1)(2012-2#1)
from bacteria##2##2##(2008-7#1)(2008-9#1)
from bacterial##7##2##(1991-9#1)(1992-6#1)(2008-10#3)(2010-7#1)(2011-2#1)
from banana##3##2##(2008-10#3)
from bark##2##2##(2008-10#2)
from barley##3##2##(2008-10#3)
from baseline and##2##3##(1997-1#1)(2008-10#1)
from baseline in##2##3##(2008-10#1)(2011-2#1)
from baseline of##2##3##(2008-1#1)(2013-1#1)
from baseline to##2##3##(2010-4#1)(2013-1#1)
from baseline##14##2##(1993-1#1)(1997-1#1)(2008-1#2)(2008-10#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#4)
from baseline) in##2##3##(1993-1#1)(2008-10#1)
from bats##2##2##(2008-12#1)(2013-1#1)
from bean##4##2##(2008-10#4)
from being##14##2##(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2012-12#1)(2013-8#1)
from bell pepper##3##3##(2008-10#3)
from below##4##2##(1991-2#2)(2008-10#1)(2011-2#1)
from benign##2##2##(2008-12#1)(2013-1#1)
from bilateral##3##2##(2008-9#1)(2010-9#1)(2011-3#1)
from binary##3##2##(2008-10#3)
from binding media##2##3##(2008-10#2)
from bioinformatics##2##2##(2010-11#2)
from biological samples##2##3##(2008-10#2)
from biological##9##2##(2008-10#5)(2008-7#1)(2009-5#1)(2010-7#1)(2012-12#1)
from biomass##2##2##(2008-11#1)(2011-2#1)
from biopsy specimens##2##3##(1997-8#1)(2008-12#1)
from biose to decaose##2##4##(2008-10#2)
from biotic and abiotic##2##4##(2008-10#1)(2008-8#1)
from birth to one month of age##2##7##(2012-2#2)
from birth##3##2##(1996-6#1)(2012-2#2)
from blood specimen collection##2##4##(2010-6#2)
from blood##10##2##(2008-1#1)(2008-11#2)(2008-7#2)(2008-9#1)(2010-6#2)(2011-2#1)(2013-8#1)
from bloom until##2##3##(2008-10#2)
from body##3##2##(1996-8#1)(2008-1#1)(2008-8#1)
from bone marrow and##2##4##(2008-4#1)(2012-3#1)
from bone marrow##6##3##(2008-10#1)(2008-11#2)(2008-4#1)(2012-3#1)(2013-1#1)
from bone##9##2##(1997-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-4#1)(2012-3#1)(2013-1#1)
from both a##2##3##(1991-2#1)(1994-12#1)
from both inpatient and##2##4##(1997-1#1)(2013-1#1)
from both methods##3##3##(2008-10#2)(2012-3#1)
from both neighbours and professionals##2##5##(1992-3#2)
from both species##3##3##(1990-2#1)(1992-10#1)(2008-10#1)
from both the##11##3##(1995-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-8#2)(2013-1#1)
from both##100##2##(1990-2#1)(1990-8#2)(1991-2#1)(1991-5#1)(1992-10#1)(1992-3#2)(1993-12#1)(1993-6#2)(1994-12#1)(1994-5#2)(1994-8#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#35)(2008-11#6)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#6)(2009-7#1)(2009-8#2)(2010-1#2)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
from bovine brain##2##3##(1991-5#1)(1994-6#1)
from bovine neutrophils##2##3##(1992-8#1)(1993-8#1)
from bovine##13##2##(1991-5#2)(1992-8#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
from brain##5##2##(1996-2#1)(2008-11#2)(2008-12#1)(2008-4#1)
from breast cancer has##2##4##(1997-7#2)
from breast cancer##6##3##(1990-12#1)(1997-7#5)
from breast##9##2##(1990-12#1)(1990-8#1)(1993-1#1)(1993-11#1)(1997-7#5)
from breeding to helping##2##4##(2008-8#2)
from bronchial##3##2##(1992-3#1)(2008-5#2)
from bronchoalveolar lavage##2##3##(2008-12#1)(2008-5#1)
from brown spot lesions on##2##5##(2008-10#2)
from brown spot lesions##3##4##(2008-10#3)
from brown##4##2##(2008-10#4)
from buffer##2##2##(2008-10#2)
from cDNA clones##4##3##(2008-10#4)
from cDNA##8##2##(1991-6#1)(1995-2#1)(2008-10#5)(2008-9#1)
from ca##2##2##(2008-5#1)(2012-9#1)
from cacao##3##2##(2008-10#3)
from cadmium##2##2##(2008-10#2)
from california##2##2##(2008-10#2)
from cancer patients were##2##4##(1994-3#1)(2008-10#1)
from cancer patients##4##3##(1994-3#3)(2008-10#1)
from cancer##8##2##(1992-2#1)(1994-3#3)(1997-4#1)(2008-10#1)(2008-11#1)(2012-3#1)
from canine##2##2##(1994-11#1)(2013-1#1)
from cankers##3##2##(2008-10#3)
from canopy##2##2##(2008-10#2)
from cantaloupe##3##2##(2008-10#3)
from capsaicin-sensitive##2##2##(1992-6#1)(1997-4#1)
from carbohydrate##2##2##(2008-3#2)
from carcinoma of gall bladder##2##5##(2010-11#2)
from carcinoma of the cervix##2##5##(1990-8#2)
from carcinoma of the##4##4##(1990-8#2)(1995-8#2)
from carcinoma of##7##3##(1990-8#2)(1995-8#3)(2010-11#2)
from carcinoma##8##2##(1990-8#2)(1992-2#1)(1995-8#3)(2010-11#2)
from cardiac##2##2##(2008-10#1)(2010-4#1)
from cardiovascular##6##2##(1990-5#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
from case##3##2##(1996-11#1)(2011-2#1)(2013-1#1)
from case-control##2##2##(1990-8#1)(2008-9#1)
from cat##3##2##(2007-12#1)(2008-8#2)
from cattle##4##2##(1990-3#2)(2011-2#2)
from cell cultures##2##3##(2008-11#1)(2009-6#1)
from cell death##2##3##(2008-11#2)
from cell surface receptors to##2##5##(1996-2#1)(1997-7#1)
from cell##12##2##(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-9#2)(2009-6#1)(2011-2#1)
from cells that##4##3##(1994-3#1)(1995-8#1)(2008-10#1)(2008-11#1)
from cells##12##2##(1990-2#1)(1994-11#1)(1994-3#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-9#1)(2012-2#1)
from central##6##2##(1992-6#1)(2008-10#3)(2008-9#1)(2010-3#1)
from cereal##2##2##(2008-10#2)
from cerebral##2##2##(1996-3#1)(2009-8#1)
from certified##2##2##(2008-10#2)
from cervical##2##2##(2011-2#1)(2013-1#1)
from changes in the##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
from changes in##7##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
from chemical analysis##2##3##(2008-10#2)
from chemical##4##2##(1997-2#1)(2008-10#2)(2010-7#1)
from chick##2##2##(1990-8#1)(1995-11#1)
from chicken gizzard##3##3##(1993-6#1)(1993-8#2)
from chicken##7##2##(1990-11#1)(1993-6#1)(1993-8#2)(2008-5#2)(2008-8#1)
from childhood to##2##3##(2012-3#2)
from childhood##5##2##(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#2)
from children with##3##3##(2007-11#1)(2011-1#1)(2013-8#1)
from children##6##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
from chloride media##2##3##(2008-10#2)
from chloride##4##2##(2008-10#4)
from chromosome X##2##3##(1995-9#2)
from chromosome##4##2##(1995-9#2)(1996-3#1)(2009-10#1)
from chronic diseases##2##3##(1994-3#1)(2008-11#1)
from chronic renal disease##2##4##(2008-10#2)
from chronic renal##4##3##(1993-3#1)(2008-10#2)(2013-1#1)
from chronic##20##2##(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
from cigarette##2##2##(2008-10#1)(2008-5#1)
from citrus and papaya##3##4##(2008-10#3)
from citrus and##4##3##(2008-10#4)
from citrus##12##2##(2008-10#12)
from claims##2##2##(1996-3#1)(2011-2#1)
from classical##4##2##(1995-8#1)(2008-10#1)(2008-9#1)(2010-8#1)
from clear##2##2##(2008-10#1)(2008-11#1)
from clinical cases##3##3##(1996-8#1)(2013-8#2)
from clinical specimens##3##3##(2008-12#1)(2008-7#1)(2008-9#1)
from clinical studies##4##3##(2008-10#1)(2013-8#3)
from clinical trials##3##3##(1992-9#1)(1995-5#1)(2008-11#1)
from clinical##19##2##(1991-2#1)(1992-9#1)(1995-5#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#5)
from clinically##3##2##(2008-5#1)(2010-12#1)(2012-3#1)
from cloned##4##2##(2008-10#3)(2008-11#1)
from close##2##2##(2008-11#1)(2008-12#1)
from clouds##4##2##(2008-10#1)(2008-3#3)
from clusters of##2##3##(2008-3#2)
from cobalt##3##2##(2008-10#3)
from cohort studies##2##3##(1991-12#1)(1996-3#1)
from cold##2##2##(2009-3#1)(2012-7#1)
from collagen##2##2##(1995-3#1)(2012-3#1)
from colon##3##2##(2008-11#2)(2011-2#1)
from colorectal cancer##3##3##(1994-6#1)(1995-9#1)(2009-12#1)
from combinations of##2##3##(2008-5#1)(2010-7#1)
from combinations##3##2##(1995-5#1)(2008-5#1)(2010-7#1)
from combustion)##2##2##(2008-10#2)
from commensal##3##2##(2008-12#2)(2008-7#1)
from commercial potato##3##3##(2008-10#3)
from commercial##13##2##(1991-9#1)(2008-10#11)(2008-8#1)
from common bean##2##3##(2008-10#2)
from common wheat from##2##4##(2008-10#2)
from common wheat had##2##4##(2008-10#2)
from common wheat##6##3##(2008-10#6)
from common##20##2##(1995-9#1)(2008-10#15)(2008-11#1)(2010-1#1)(2012-3#1)(2013-1#1)
from commonly##4##2##(2008-10#3)(2008-12#1)
from community##4##2##(1996-1#1)(2008-1#1)(2008-12#1)(2011-1#1)
from competition##2##2##(2008-10#1)(2008-8#1)
from complementary foods##2##3##(2010-6#2)
from complementary##3##2##(2008-10#1)(2010-6#2)
from complete##3##2##(2008-12#1)(2008-3#1)(2010-3#1)
from complex matrices##2##3##(2008-10#2)
from complex mixtures##2##3##(2008-10#1)(2009-7#1)
from complex##10##2##(1993-1#1)(1996-3#1)(2008-10#7)(2009-7#1)
from computer##2##2##(1995-2#1)(2008-10#1)
from concept to action##2##4##(1993-12#2)
from conditioned##2##2##(1992-8#1)(1994-11#1)
from conidia or##2##3##(2008-10#2)
from conidia##3##2##(2008-10#3)
from conserved##3##2##(1994-11#1)(2008-10#2)
from considering##4##2##(1995-5#1)(2008-11#1)(2008-9#2)
from consumption##2##2##(1994-2#1)(2007-12#1)
from contaminating##4##2##(2008-10#3)(2011-2#1)
from continuous##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2012-5#1)
from continuum##2##2##(2009-12#1)(2009-7#1)
from control and##4##3##(1993-6#1)(1994-5#1)(2008-5#1)(2008-7#1)
from control rats##3##3##(1991-12#1)(1993-6#1)(1997-1#1)
from control##16##2##(1990-12#2)(1991-12#1)(1993-12#1)(1993-6#2)(1994-5#1)(1995-12#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)
from controls##4##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#1)
from conventional##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
from copper##2##2##(2008-10#2)
from cord blood and to determine their potential for osteogenic differentiation##2##11##(2008-11#2)
from cord blood and##3##4##(2008-11#2)(2008-9#1)
from cord blood##6##3##(2008-11#4)(2008-9#2)
from corn##3##2##(1995-3#1)(2008-10#2)
from coronary##3##2##(1991-12#1)(2008-10#1)(2012-3#1)
from corresponding##2##2##(1996-2#1)(2008-10#1)
from cosmetic##2##2##(2008-5#2)
from cotton and##2##3##(2008-10#2)
from cotton soil##2##3##(2008-10#2)
from cotton##9##2##(2008-10#8)(2008-9#1)
from countries##3##2##(1997-8#1)(2008-10#2)
from country to country##2##4##(1993-2#1)(1994-1#1)
from cows##2##2##(2012-3#1)(2013-1#1)
from crime scenes##2##3##(2008-10#2)
from cross##2##2##(2008-10#1)(2009-10#1)
from crosses between##8##3##(2008-10#6)(2008-8#1)(2012-3#1)
from crosses of##4##3##(2008-10#4)
from crosses##13##2##(2008-10#11)(2008-8#1)(2012-3#1)
from crown-6##2##2##(2008-10#2)
from crowns##3##2##(2008-10#3)
from cruciferous hosts##2##3##(2008-10#2)
from cruciferous##4##2##(2008-10#4)
from crude##3##2##(2008-10#1)(2008-4#1)(2010-3#1)
from cucumber##3##2##(2008-10#3)
from cucurbit hosts##2##3##(2008-10#2)
from cucurbit##4##2##(2008-10#4)
from cucurbits##2##2##(2008-10#2)
from cultivated potatoes and wild Solanum##2##6##(2008-10#2)
from cultivated potatoes and##3##4##(2008-10#3)
from cultivated potatoes##4##3##(2008-10#4)
from cultivated##5##2##(2008-10#5)
from culture filtrates of##3##4##(2008-10#2)(2008-11#1)
from culture##6##2##(1990-12#1)(2008-10#4)(2008-11#1)
from cultured cells##2##3##(2008-1#1)(2008-11#1)
from cultured mouse##2##3##(1995-11#1)(2008-11#1)
from cultured neonatal##2##3##(1993-6#1)(1995-11#1)
from cultured##17##2##(1991-5#1)(1993-6#1)(1995-11#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
from cultures of##2##3##(2008-10#1)(2012-2#1)
from cultures##5##2##(1995-12#1)(2008-10#2)(2010-8#1)(2012-2#1)
from current##2##2##(1992-2#1)(1993-12#1)
from cv##4##2##(2008-10#4)
from cyanide##2##2##(2008-10#2)
from cysts##2##2##(2008-10#2)
from cytochrome##2##2##(1990-5#1)(1994-5#1)
from cytoplasm to nucleus##2##4##(1991-2#2)
from cytoplasm##3##2##(1991-2#2)(1997-8#1)
from cytoplasmic##4##2##(1995-6#1)(2008-7#1)(2011-2#2)
from daily##2##2##(1992-3#1)(2008-7#1)
from dairy##2##2##(2012-2#1)(2013-1#1)
from damaged cells##2##3##(2008-10#1)(2008-11#1)
from damaged##5##2##(1990-7#1)(2008-10#2)(2008-11#1)(2008-8#1)
from data##4##2##(2008-10#4)
from date##2##2##(1994-12#1)(2008-12#1)
from day 0 to day 4##2##6##(2010-7#2)
from day 2 to day##2##5##(2008-8#1)(2010-7#1)
from day 2##3##3##(2008-10#1)(2008-8#1)(2010-7#1)
from day##11##2##(1997-3#1)(1997-7#1)(2008-10#1)(2008-8#1)(2010-7#4)(2011-2#1)(2012-3#2)
from dead##2##2##(1996-11#1)(2011-2#1)
from dead-in-shell turkey embryos##2##4##(2008-5#2)
from death certificates##2##3##(2012-12#1)(2013-8#1)
from death##5##2##(2008-11#2)(2008-9#1)(2012-12#1)(2013-8#1)
from decayed##2##2##(2008-10#2)
from decreased##2##2##(2008-10#1)(2008-7#1)
from deficient##2##2##(1990-11#1)(2012-2#1)
from degradation##3##2##(2008-10#2)(2010-4#1)
from demes of##2##3##(2008-9#2)
from dental##7##2##(1995-6#1)(1995-9#1)(1996-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
from depths of##2##3##(2008-10#2)
from developing##3##2##(1997-8#1)(2008-8#1)(2013-8#1)
from diabetic patients##2##3##(1991-12#1)(2008-10#1)
from diabetic##3##2##(1991-12#1)(2008-10#1)(2012-2#1)
from diagnostic##2##2##(1997-8#1)(2008-9#1)
from differences in##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
from different cellular##2##3##(2008-9#1)(2009-8#1)
from different countries##3##3##(2008-11#2)(2011-1#1)
from different experimental##3##3##(2008-10#2)(2008-7#1)
from different genetic backgrounds##2##4##(2008-10#1)(2012-3#1)
from different geographic##3##3##(2008-10#3)
from different geographical locations##2##4##(2008-10#1)(2011-2#1)
from different geographical regions##2##4##(2008-10#2)
from different geographical##5##3##(2008-10#4)(2011-2#1)
from different hosts and##3##4##(2008-10#2)(2012-2#1)
from different locations in##2##4##(2008-10#2)
from different locations##6##3##(2008-10#6)
from different organs##2##3##(2008-10#1)(2008-9#1)
from different origins##3##3##(2008-10#3)
from different parts of##2##4##(2008-10#2)
from different places of##2##4##(2008-10#2)
from different places##4##3##(2008-10#4)
from different regions of##4##4##(1990-3#1)(2008-10#3)
from different regions##6##3##(1990-3#1)(2008-10#5)
from different sources##5##3##(1992-12#1)(2008-10#4)
from different species##3##3##(1990-5#1)(1993-6#1)(2009-5#1)
from different studies##4##3##(2008-1#1)(2008-10#3)
from different tissues and##2##4##(1995-2#1)(1997-3#1)
from different tissues##4##3##(1995-2#1)(1997-3#1)(2008-11#1)(2009-8#1)
from different types of##3##4##(1997-2#1)(2011-2#1)(2012-2#1)
from different##147##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#85)(2008-11#6)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#2)
from differential##4##2##(2008-10#1)(2008-6#3)
from difficulties in##2##3##(1993-12#1)(2011-1#1)
from difficulties##3##2##(1993-12#1)(2009-10#1)(2011-1#1)
from diffusion##2##2##(2008-10#1)(2012-2#1)
from digital##2##2##(2008-6#1)(2009-3#1)
from diluted##2##2##(2008-10#2)
from diploid##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
from direct##7##2##(1994-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)
from discovery##2##2##(2010-5#1)(2013-8#1)
from disease##4##2##(1990-6#1)(1993-12#1)(2008-10#1)(2012-2#1)
from diseased lettuce and tomato plants##3##6##(2008-10#3)
from diseased roots##2##3##(2008-10#2)
from diseased soybean##2##3##(2008-10#2)
from diseased tissue##2##3##(2008-10#2)
from diseased##29##2##(2008-10#28)(2011-2#1)
from disks##2##2##(2008-10#2)
from diverse cultural##2##3##(2012-2#2)
from diverse##14##2##(1993-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#2)(2013-8#2)
from dog##3##2##(1991-6#1)(1993-3#2)
from dogs##4##2##(2008-10#1)(2008-11#1)(2010-12#2)
from doing##2##2##(2008-9#1)(2010-1#1)
from domestic##2##2##(1996-12#1)(2012-2#1)
from donor to recipient##2##4##(2008-11#1)(2008-12#1)
from donor##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
from dopamine##3##2##(1995-2#2)(1995-8#1)
from dormant##2##2##(2008-10#2)
from dorsal##2##2##(1994-12#1)(1996-6#1)
from drier habitats##2##3##(2012-9#2)
from drinking water##2##3##(2008-10#1)(2008-11#1)
from drinking##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
from drug##7##2##(1991-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-7#1)
from dry##2##2##(2008-10#1)(2008-7#1)
from dsRNA isolated from##2##4##(2008-10#2)
from durum wheat from Argentina##2##5##(2008-10#2)
from durum wheat from##4##4##(2008-10#4)
from durum wheat in##2##4##(2008-10#1)(2008-8#1)
from durum wheat##12##3##(2008-10#11)(2008-8#1)
from dying##2##2##(1992-12#1)(2008-10#1)
from each group were##2##4##(2008-7#1)(2011-2#1)
from each of the three##3##5##(1991-2#1)(1995-11#1)(2008-10#1)
from each of the##6##4##(1991-2#1)(1995-11#1)(2008-10#4)
from each of three##2##4##(1991-2#1)(2008-10#1)
from each of two##3##4##(2008-10#3)
from each of##15##3##(1991-2#2)(1995-11#1)(1995-5#1)(2008-10#10)(2008-5#1)
from each other and from other##2##6##(2008-10#1)(2010-10#1)
from each other and from##5##5##(2008-10#3)(2008-11#1)(2010-10#1)
from each other and##7##4##(2008-10#5)(2008-11#1)(2010-10#1)
from each other by##5##4##(1992-6#1)(2008-10#3)(2008-4#1)
from each other in the##2##5##(2008-10#1)(2008-8#1)
from each other in##6##4##(1992-12#1)(2008-10#2)(2008-8#1)(2009-8#1)(2009-9#1)
from each other##29##3##(1992-12#1)(1992-6#1)(1993-3#1)(1997-3#1)(2008-10#15)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)
from each species##2##3##(2008-10#1)(2011-2#1)
from each tree##3##3##(2008-10#3)
from each type##2##3##(2008-10#1)(2008-5#1)
from each##96##2##(1991-2#2)(1992-12#1)(1992-6#1)(1993-3#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-3#2)(1997-7#1)(2008-10#56)(2008-11#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
from earlier##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
from early to late##2##4##(1991-2#1)(2009-7#1)
from early to##3##3##(1991-2#1)(2009-7#2)
from early##12##2##(1991-2#1)(1992-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2009-7#2)(2010-11#1)(2011-2#1)
from easily##2##2##(2008-10#1)(2013-8#1)
from eastern and western North America##2##6##(2008-10#2)
from eastern##5##2##(2008-10#4)(2012-9#1)
from effects##2##2##(1994-5#1)(2008-10#1)
from egg##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
from eggs and##3##3##(2008-10#2)(2008-11#1)
from eggs##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
from eight different##2##3##(2008-10#2)
from eight##13##2##(2008-10#9)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
from either the##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
from either##12##2##(1994-12#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
from electroactive species##2##3##(2008-10#2)
from electrochemical##2##2##(2008-10#2)
from electronic##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
from electroplating##2##2##(2008-10#2)
from electrotechnical applications##2##3##(2008-10#2)
from elevated##3##2##(1992-9#1)(2012-7#1)(2013-1#1)
from eleven##2##2##(2008-10#1)(2008-11#1)
from elite##2##2##(2008-9#1)(2009-7#1)
from embryogenic calli##2##3##(2008-9#2)
from embryonic day##5##3##(1993-3#1)(1994-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
from embryonic stem cells##2##4##(2008-11#1)(2010-10#1)
from embryonic stem##3##3##(2008-11#2)(2010-10#1)
from embryonic##11##2##(1993-3#1)(1994-2#1)(1997-1#1)(2008-11#5)(2008-7#1)(2010-10#1)(2013-1#1)
from embryos##2##2##(1997-9#1)(2008-11#1)
from empirical##4##2##(1992-12#1)(2008-11#1)(2010-10#1)(2011-3#1)
from encircling lymphovasculogenesis rather than##2##5##(2011-2#2)
from endogenous##2##2##(1990-2#1)(2008-10#1)
from endothelial cells##2##3##(1991-5#1)(2008-9#1)
from endothelial##3##2##(1991-5#1)(1995-2#1)(2008-9#1)
from enrichment cultures##2##3##(2011-1#1)(2012-2#1)
from environmental samples##2##3##(2008-10#2)
from environmental water samples##3##4##(2008-10#3)
from environmental##10##2##(1994-3#1)(2008-10#8)(2010-3#1)
from epidemiologic##2##2##(1997-1#1)(2010-5#1)
from epilepsy##2##2##(1995-12#1)(2009-8#1)
from episodes of##2##3##(2009-8#1)(2012-3#1)
from equilibrium##3##2##(2010-7#1)(2012-3#2)
from erythrocytes##3##2##(1990-2#1)(1992-12#1)(1996-12#1)
from esophageal##3##2##(2010-6#3)
from ethanol-water mixtures##2##3##(2011-2#2)
from ethnocultural communities##2##3##(1995-1#2)
from excipients##5##2##(2008-10#5)
from exercise##3##2##(1993-1#1)(2013-8#2)
from existing##7##2##(2008-10#1)(2008-3#2)(2009-10#1)(2010-2#1)(2012-2#1)(2013-8#1)
from exogenous sources##3##3##(2008-10#3)
from exogenous##5##2##(2008-10#4)(2008-7#1)
from exon##2##2##(1997-8#1)(2008-12#1)
from expectations##2##2##(2008-10#1)(2008-7#1)
from experience##2##2##(2008-4#1)(2013-8#1)
from experimental data##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
from experimental studies##2##3##(2008-10#1)(2008-9#1)
from experimental##13##2##(2008-10#5)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#2)(2012-12#1)
from experimentally##2##2##(1991-5#1)(1996-12#1)
from experiments in##2##3##(2008-10#1)(2008-7#1)
from experiments##7##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2013-8#1)
from exploratory##2##2##(1993-6#1)(2008-10#1)
from exposed##2##2##(2008-3#1)(2008-5#1)
from exposure to##2##3##(1990-5#1)(1991-12#1)
from extracts##2##2##(2008-10#2)
from fabrics##2##2##(2008-10#2)
from failure##2##2##(2008-6#1)(2012-3#1)
from fall##2##2##(2008-10#1)(2008-12#1)
from family members##2##3##(2008-6#1)(2011-2#1)
from family##8##2##(1990-3#1)(1994-11#1)(1995-5#1)(1996-11#1)(2008-6#1)(2008-7#2)(2011-2#1)
from fasted##5##2##(1993-8#1)(1994-8#3)(1995-6#1)
from fat##2##2##(2008-3#1)(2013-1#1)
from fed rats##3##3##(1993-8#1)(1994-8#1)(1997-2#1)
from fed##4##2##(1993-8#1)(1994-8#2)(1997-2#1)
from female##4##2##(1990-11#1)(1994-12#1)(1995-2#1)(2008-9#1)
from fetal life##2##3##(2012-2#1)(2013-1#1)
from fetal##4##2##(1994-11#1)(1997-4#1)(2012-2#1)(2013-1#1)
from few##2##2##(2008-10#2)
from field samples##2##3##(2008-10#2)
from field##12##2##(2008-10#9)(2008-8#2)(2008-9#1)
from fields##6##2##(2008-10#4)(2010-10#1)(2011-2#1)
from fifteen##2##2##(1992-3#2)
from fifth instar##2##3##(1995-11#1)(2008-7#1)
from filter##2##2##(2008-10#2)
from fine##2##2##(2008-5#1)(2010-3#1)
from fire##2##2##(1996-12#1)(2008-10#1)
from first##2##2##(1992-3#1)(2008-10#1)
from fish calcified tissues##2##4##(2008-11#2)
from fish to##3##3##(2008-4#1)(2009-6#1)(2012-3#1)
from fish##8##2##(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-6#1)(2012-3#1)
from five different##5##3##(2008-10#5)
from five##32##2##(2008-10#23)(2008-11#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-9#1)
from flowers##2##2##(2008-10#1)(2008-12#1)
from fluorinated polyimides##4##3##(2008-2#4)
from focus groups##3##3##(2008-11#1)(2009-5#1)(2012-12#1)
from food and##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
from food##4##2##(1997-2#1)(2008-10#2)(2011-2#1)
from foreign##2##2##(2008-10#2)
from fossil##2##2##(2008-11#1)(2008-8#1)
from four different##9##3##(2008-10#6)(2008-5#1)(2008-8#1)(2010-10#1)
from four distinct##2##3##(1997-6#1)(2008-10#1)
from four non-fluorescent##2##3##(2008-10#2)
from four of##2##3##(1997-5#1)(2008-10#1)
from four other##2##3##(2008-10#2)
from four patients##2##3##(1994-12#1)(2010-8#1)
from four##45##2##(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1997-5#1)(1997-6#1)(2008-10#27)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
from free##6##2##(1992-6#1)(1995-11#1)(1997-8#1)(2008-10#3)
from fresh##6##2##(1992-6#1)(2008-10#3)(2008-9#1)(2010-8#1)
from freshwater##2##2##(2008-8#1)(2011-2#1)
from friends##3##2##(1994-1#1)(2008-6#1)(2011-2#1)
from frog skin##2##3##(1993-3#1)(1994-5#1)
from frog##4##2##(1991-5#1)(1993-3#1)(1994-5#1)(1996-2#1)
from frontal##2##2##(2008-8#1)(2012-12#1)
from fruit and##2##3##(2008-10#2)
from fruit##5##2##(2008-10#5)
from fruits##3##2##(2008-10#2)(2012-12#1)
from fullerene soot##2##3##(2008-10#2)
from functional##4##2##(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
from fungal##3##2##(2008-10#3)
from further##2##2##(1997-7#1)(2010-7#1)
from galls##2##2##(2008-10#2)
from garlic##3##2##(2008-10#2)(2008-9#1)
from gas##2##2##(2008-10#1)(2008-11#1)
from gastric##3##2##(1992-6#1)(2008-12#2)
from gavage to nipple feeding##2##5##(2010-5#2)
from gene##3##2##(2008-6#1)(2008-8#1)(2012-3#1)
from genera##2##2##(2008-10#1)(2008-12#1)
from general##4##2##(1994-3#1)(1994-6#1)(2008-12#1)(2011-2#1)
from genetic##3##2##(2008-8#1)(2009-4#1)(2013-1#1)
from genetically##3##2##(2008-10#2)(2008-5#1)
from genome##2##2##(2010-11#1)(2011-10#1)
from genomic DNA##2##3##(1994-12#1)(2008-10#1)
from genotypes##2##2##(2008-10#2)
from geographically##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
from geological##5##2##(2008-10#4)(2008-11#1)
from germinated conidia##2##3##(2008-10#2)
from germinating soybean##2##3##(1990-5#2)
from germinating##5##2##(1990-5#2)(2008-10#3)
from gestational##2##2##(2008-10#1)(2008-11#1)
from ginger##6##2##(2008-10#6)
from glass##6##2##(2007-12#1)(2008-10#3)(2009-7#2)
from global##2##2##(2008-10#1)(2010-1#1)
from glucose##3##2##(1995-8#1)(2008-11#2)
from glutamine##4##2##(2008-11#4)
from government##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
from grape##8##2##(2008-10#8)
from grapefruit##2##2##(2008-10#2)
from grapevines##2##2##(2008-10#2)
from graphite cathode##2##3##(2008-10#2)
from graphite##3##2##(2008-10#3)
from grass pea##3##3##(2011-2#3)
from grass##4##2##(2010-4#1)(2011-2#3)
from greater##2##2##(2008-10#1)(2008-7#1)
from green tea##2##3##(2008-10#1)(2008-11#1)
from green##5##2##(2008-10#2)(2008-11#1)(2012-2#2)
from group##7##2##(1990-12#1)(1996-3#2)(1997-3#1)(2008-5#1)(2013-8#2)
from groups of 10- to 19-day-old piglets##2##7##(1996-12#2)
from groups of##6##3##(1991-3#1)(1996-12#4)(2008-10#1)
from groups##7##2##(1991-3#1)(1995-1#1)(1996-12#4)(2008-10#1)
from growth##3##2##(1991-2#1)(2008-7#1)(2011-2#1)
from guinea pig##6##3##(1994-8#3)(1995-8#3)
from having##3##2##(1993-1#1)(2008-10#1)(2010-12#1)
from hazardous##2##2##(2008-10#1)(2012-2#1)
from hazelnut##4##2##(2008-10#4)
from head##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
from health care##3##3##(1993-3#1)(1996-2#1)(1996-3#1)
from health services and##2##4##(2008-1#1)(2009-3#1)
from health##8##2##(1993-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-12#1)(2009-3#1)(2011-2#1)
from healthy donors##4##3##(1994-3#1)(2008-11#2)(2008-4#1)
from healthy persons##2##3##(1992-11#1)(2008-12#1)
from healthy volunteers##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
from healthy##32##2##(1991-12#1)(1992-11#1)(1992-3#1)(1994-3#1)(1994-6#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#3)
from heart##2##2##(1991-12#1)(1996-12#1)
from heat##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
from heavy##4##2##(2008-10#4)
from heparinized##2##2##(2011-2#2)
from herbicides##2##2##(2008-11#2)
from high##7##2##(1997-2#1)(2008-10#4)(2008-7#1)(2008-9#1)
from high-predation environments have##2##4##(2008-8#2)
from high-predation environments##3##3##(2008-8#3)
from high-predation##4##2##(2008-8#4)
from higher##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
from highest to lowest##2##4##(2008-10#1)(2008-5#1)
from highly mineralised water##3##4##(2008-10#3)
from highly##8##2##(2008-10#6)(2010-4#1)(2013-1#1)
from his own##2##3##(1992-2#1)(1994-12#1)
from his##10##2##(1990-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-3#1)(2008-12#1)(2010-9#1)(2011-3#1)
from historical##2##2##(2008-10#2)
from holocycly to anholocycly##2##4##(2008-9#2)
from horse##7##2##(1990-8#1)(2008-10#4)(2008-11#1)(2011-2#1)
from horses##2##2##(1996-6#1)(2013-1#1)
from hospital##10##2##(1990-2#1)(1991-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1996-1#1)(2008-11#1)(2011-2#1)(2012-12#2)
from hospitals##2##2##(1991-11#1)(1993-2#1)
from human and##2##3##(1991-5#1)(1995-6#1)
from human brain##3##3##(1991-6#1)(1996-8#1)(2008-7#1)
from human breast##2##3##(1993-1#2)
from human cell##4##3##(1995-8#1)(1996-2#2)(2008-11#1)
from human cord blood##4##4##(2008-8#1)(2008-9#3)
from human erythrocytes##2##3##(1994-8#2)
from human immunodeficiency virus##2##4##(1990-2#1)(1992-6#1)
from human liver microsomes##2##4##(1991-5#1)(2011-3#1)
from human liver##5##3##(1991-5#1)(1993-3#1)(1994-8#2)(2011-3#1)
from human lung cell line (WI-38) cDNA library##2##8##(2008-8#1)(2008-9#1)
from human lung##3##3##(1991-5#1)(2008-8#1)(2008-9#1)
from human medullary thyroid##2##4##(1992-6#2)
from human placenta was##2##4##(1993-3#1)(1997-1#1)
from human placenta##6##3##(1993-3#1)(1993-8#1)(1997-1#2)(2008-8#2)
from human plasma using##2##4##(2008-10#2)
from human plasma##3##3##(2008-10#3)
from human skin##3##3##(1991-12#1)(1992-6#1)(2008-5#1)
from human umbilical##2##3##(2008-8#1)(2008-9#1)
from human urine##3##3##(1994-3#1)(2008-10#2)
from human##79##2##(1990-2#2)(1991-12#1)(1991-5#4)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#4)(1993-1#2)(1993-3#2)(1993-8#1)(1994-3#1)(1994-8#4)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#2)(1997-9#1)(2008-10#9)(2008-11#8)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#6)(2009-5#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
from hyaluronic acid##2##3##(1992-12#1)(1994-5#1)
from hybridoma##2##2##(2008-11#2)
from hydrochloric acid media##3##4##(2008-10#3)
from hydrochloric acid medium##2##4##(2008-10#2)
from hydrochloric acid##6##3##(2008-10#6)
from hydrogen##3##2##(2008-10#3)
from hypoxic##3##2##(1994-5#2)(1995-2#1)
from ideal##4##2##(1993-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
from idiopathic polymyositis##2##3##(2008-7#2)
from idiopathic##3##2##(2007-8#1)(2008-7#2)
from image analysis##2##3##(2008-10#2)
from immature##2##2##(2008-6#1)(2008-9#1)
from immigrant##2##2##(2008-10#1)(2013-8#1)
from immunized##2##2##(2008-10#1)(2008-9#1)
from impaired##4##2##(1991-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
from improved##2##2##(2008-12#2)
from in situ##5##3##(1996-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
from in vitro##4##3##(1996-2#1)(2008-10#1)(2008-11#2)
from in vivo studies##2##4##(2008-11#1)(2008-5#1)
from in vivo##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
from in##15##2##(1993-12#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)
from inactivation##2##2##(1993-6#1)(2008-11#1)
from inactive##3##2##(1994-3#2)(2008-10#1)
from increased##6##2##(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#3)
from incubation##2##2##(1991-12#1)(2008-10#1)
from independent##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2012-9#1)(2013-8#1)
from indica##2##2##(2008-10#2)
from indigenous##4##2##(2008-10#3)(2009-6#1)
from individual spores##2##3##(2011-2#2)
from individual##17##2##(1993-8#1)(1995-12#2)(2008-10#6)(2008-11#2)(2008-4#1)(2009-9#1)(2010-7#1)(2011-2#2)(2013-8#1)
from individuals##2##2##(1993-12#1)(1997-3#1)
from indoor##2##2##(2008-10#1)(2008-11#1)
from industrial##2##2##(1993-3#1)(2008-3#1)
from industry##4##2##(1991-3#1)(1993-12#1)(2009-4#1)(2010-12#1)
from infected fruit##2##3##(2008-10#2)
from infected pineapple##2##3##(2008-10#2)
from infected plants##8##3##(2008-10#8)
from infected roots##2##3##(2008-10#2)
from infected seed##2##3##(2008-10#2)
from infected tobacco##2##3##(2008-10#2)
from infected trees##2##3##(2008-10#2)
from infected##47##2##(1991-3#1)(2007-12#1)(2008-10#43)(2008-12#1)(2009-6#1)
from infection##3##2##(2008-10#2)(2011-2#1)
from infectious##3##2##(1996-1#1)(2008-10#2)
from infertile patients and##2##4##(2008-12#2)
from infested##2##2##(2008-10#1)(2008-12#1)
from inflammation##2##2##(2008-4#1)(2012-2#1)
from informed consent##2##3##(2009-4#2)
from initial##4##2##(2008-10#2)(2010-2#1)(2012-3#1)
from initiation of the##2##4##(2008-10#2)
from initiation of##3##3##(2008-10#2)(2009-1#1)
from injury##2##2##(1995-12#1)(2010-7#1)
from inoculated trees##2##3##(2008-10#2)
from inoculated##8##2##(2008-10#8)
from inoculation##5##2##(2008-10#5)
from inoculum sources##2##3##(2008-10#2)
from inoculum##4##2##(2008-10#4)
from inorganic##3##2##(2008-10#3)
from inpatient to outpatient##4##4##(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)
from insects##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
from inside##2##2##(2008-10#2)
from insoluble##2##2##(1994-11#1)(2008-10#1)
from institutional##2##2##(1991-1#1)(1995-1#1)
from intact##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
from interference##5##2##(2008-10#5)
from interfering##5##2##(2008-10#3)(2008-3#2)
from internal##5##2##(1990-8#1)(2008-12#1)(2010-11#1)(2010-6#1)(2013-1#1)
from interspecific##3##2##(2008-10#2)(2008-8#1)
from interviews##2##2##(2008-11#1)(2010-11#1)
from intestinal epithelial cells (IECs)##2##5##(2008-11#2)
from intestinal epithelial cells##3##4##(2008-11#3)
from intestinal##4##2##(2008-11#3)(2011-2#1)
from intracellular pools to the plasma membrane##2##7##(1994-11#2)
from intracellular stores##3##3##(1994-11#1)(1994-8#1)(1996-12#1)
from intracellular##7##2##(1994-11#3)(1994-8#1)(1996-12#1)(1997-1#1)(1997-3#1)
from investigators##2##2##(1993-12#1)(2008-4#1)
from involvement##2##2##(2009-3#1)(2010-10#1)
from iron##2##2##(2008-10#2)
from iron(III)##2##2##(2008-10#2)
from irrigation##3##2##(2008-10#3)
from isolate##3##2##(2008-10#3)
from isolated##10##2##(1990-5#1)(1991-2#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(2009-12#1)(2012-2#1)(2012-3#1)
from isolates of##7##3##(2008-10#6)(2008-5#1)
from isolates within##2##3##(2008-10#2)
from isolates##13##2##(2008-10#12)(2008-5#1)
from it by##2##3##(2008-10#2)
from it##5##2##(2008-10#3)(2009-10#1)(2011-2#1)
from its HSA binding site by DHEA##2##7##(2008-10#2)
from its affinity##2##3##(1995-11#1)(2008-11#1)
from its binding site in the##2##6##(1992-3#1)(2008-10#1)
from its first##2##3##(1991-1#1)(1991-12#1)
from its initial location##2##4##(2008-10#1)(2010-4#1)
from its origin##2##3##(2008-8#1)(2013-1#1)
from its##65##2##(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1994-11#2)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-12#2)(2008-10#23)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#3)(2013-1#5)
from juvenile##2##2##(2008-11#1)(2008-8#1)
from kidney##3##2##(1992-12#1)(2008-10#1)(2010-4#1)
from known##6##2##(1996-3#1)(2008-10#3)(2008-11#1)(2013-1#1)
from laboratory and##2##3##(2008-10#1)(2009-7#1)
from laboratory##10##2##(2008-10#7)(2008-3#1)(2008-9#1)(2009-7#1)
from lack of##2##3##(1995-12#1)(2008-4#1)
from lactate##2##2##(1991-3#1)(1994-8#1)
from lambda##2##2##(1992-6#1)(1993-9#1)
from large amounts of cadmium##2##5##(2008-10#2)
from large amounts of##7##4##(2008-10#6)(2008-11#1)
from large volume##2##3##(2008-10#2)
from large volumes of seawater##3##5##(2008-10#3)
from large volumes of##4##4##(2008-10#4)
from large##19##2##(1995-12#1)(2008-10#14)(2008-11#2)(2008-7#1)(2010-10#1)
from large-scale##2##2##(2008-11#1)(2010-11#1)
from larger##4##2##(1997-4#2)(2008-10#1)(2010-7#1)
from late March##2##3##(2008-10#2)
from late##6##2##(2008-10#5)(2008-12#1)
from lateral##2##2##(2009-11#1)(2013-1#1)
from layer##2##2##(2008-11#1)(2008-7#1)
from leaf spectra##4##3##(2008-10#4)
from leaf##10##2##(2008-10#8)(2008-11#1)(2008-12#1)
from leaves##8##2##(2008-10#7)(2008-11#1)
from leek plants##2##3##(2008-10#2)
from leek##3##2##(2008-10#3)
from lentil##2##2##(2008-10#2)
from lesion expansion##4##3##(2008-10#4)
from lesion##5##2##(2008-10#4)(2008-11#1)
from lesions on##3##3##(2008-10#3)
from lesions##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
from less than##4##3##(1990-12#1)(1994-9#1)(2008-10#2)
from less##5##2##(1990-12#1)(1994-9#1)(2008-10#2)(2013-1#1)
from lettuce to##2##3##(2008-10#2)
from lettuce##7##2##(2008-10#7)
from leukocytes##4##2##(1992-12#2)(1997-3#1)(2008-10#1)
from limb##2##2##(1991-8#1)(2010-8#1)
from linear##3##2##(2008-10#3)
from linearity at##2##3##(2008-10#1)(2008-5#1)
from linearity##3##2##(2008-10#2)(2008-5#1)
from lipid##2##2##(1991-12#1)(2013-8#1)
from literature##7##2##(2008-10#4)(2008-7#1)(2010-3#1)(2012-3#1)
from live##2##2##(1992-3#1)(2009-10#1)
from liver and brain##2##4##(1990-11#1)(2008-4#1)
from liver and##3##3##(1990-11#1)(1993-12#1)(2008-4#1)
from liver##7##2##(1990-11#1)(1990-12#1)(1993-12#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-4#1)
from local##11##2##(1991-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-8#2)(2009-11#1)(2012-3#1)(2013-1#1)
from long##2##2##(2008-10#1)(2008-5#1)
from longitudinal##2##2##(1993-12#1)(2011-2#1)
from loss of##4##3##(1995-2#1)(1996-5#1)(2008-10#1)(2008-9#1)
from low##7##2##(1990-2#1)(1996-12#2)(2008-10#2)(2009-9#1)(2013-1#1)
from low-income families##2##3##(2008-11#2)
from lower##2##2##(2008-10#1)(2008-7#1)
from lung cancer##5##3##(1990-12#1)(1992-6#2)(2008-11#2)
from lung##11##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-6#2)(1993-3#1)(1993-8#1)(2008-11#2)(2008-5#2)
from lymphocytes##2##2##(2008-11#1)(2008-9#1)
from mRNA##3##2##(1991-6#1)(1992-9#1)(2008-9#1)
from mRNAs##2##2##(1993-3#1)(1997-2#1)
from macrophages##3##2##(2008-11#3)
from main##3##2##(2008-10#2)(2008-12#1)
from mainland##2##2##(2008-10#1)(2013-8#1)
from maize was##2##3##(1995-2#1)(2008-10#1)
from maize##12##2##(1994-6#1)(1995-2#3)(2008-10#3)(2008-9#2)(2009-10#1)(2009-8#1)(2012-2#1)
from major##2##2##(2008-10#1)(2009-12#1)
from male##4##2##(1990-3#1)(1994-2#1)(1997-4#1)(2010-4#1)
from malignant##4##2##(1990-2#1)(1990-6#1)(1996-6#1)(2009-1#1)
from mammalian cells##3##3##(1995-2#1)(2008-4#1)(2009-12#1)
from mammalian##7##2##(1995-2#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-12#1)
from mammals##2##2##(1994-11#2)
from managed care##3##3##(1991-3#1)(1993-2#1)(1997-2#1)
from mango##2##2##(2008-10#2)
from manual##2##2##(2008-10#1)(2012-2#1)
from manufacturing##2##2##(1995-1#1)(2011-2#1)
from many of the##2##4##(2008-11#1)(2008-8#1)
from many parts of##2##4##(1990-6#1)(2013-8#1)
from many sources##3##3##(1994-2#1)(2008-5#1)(2008-9#1)
from many species##2##3##(1990-2#1)(2008-8#1)
from many##20##2##(1990-2#1)(1990-6#1)(1994-2#1)(1994-9#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2013-8#1)
from map##2##2##(1995-8#1)(1996-6#1)
from marine sediments##2##3##(2008-10#2)
from marine to freshwater habitats##2##5##(2010-8#2)
from marine##11##2##(2008-10#4)(2008-11#2)(2009-2#1)(2010-7#1)(2010-8#2)(2011-2#1)
from maternal##2##2##(2008-10#2)
from matrix##5##2##(2008-10#5)
from mature##3##2##(1994-8#1)(2008-11#1)(2008-5#1)
from maximum##2##2##(1995-2#1)(2008-10#1)
from measured##2##2##(1993-9#1)(2008-10#1)
from measurements of##2##3##(2008-3#2)
from measurements##5##2##(2008-10#1)(2008-11#1)(2008-3#3)
from mechanical##2##2##(2008-8#1)(2011-2#1)
from medical gas##2##3##(2011-2#2)
from medical##7##2##(1990-12#1)(1993-12#1)(1994-12#1)(2008-4#1)(2010-2#1)(2011-2#2)
from medicinal##2##2##(1996-11#1)(2008-10#1)
from members of the genus Thermus##2##6##(2011-2#2)
from members of the##3##4##(2008-10#1)(2011-2#2)
from members of##5##3##(1997-7#1)(1997-9#1)(2008-10#1)(2011-2#2)
from membrane phospholipids##3##3##(1994-3#3)
from membrane##5##2##(1994-3#3)(1994-5#1)(2009-3#1)
from menthofuran##2##2##(1991-5#2)
from mesenteric##2##2##(1992-3#1)(2008-11#1)
from metal ions##3##3##(2008-10#3)
from metal##4##2##(2008-10#4)
from metastatic##4##2##(1991-9#1)(2010-7#3)
from mice with##3##3##(2008-11#2)(2011-3#1)
from mice##11##2##(1994-8#1)(1995-9#1)(2008-10#1)(2008-11#5)(2008-8#1)(2008-9#1)(2011-3#1)
from microarray analysis##2##3##(2010-6#1)(2011-2#1)
from microarray##3##2##(2008-4#1)(2010-6#1)(2011-2#1)
from microorganisms##2##2##(1993-2#1)(2011-2#1)
from mild##4##2##(1995-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
from milk##3##2##(2008-10#2)(2008-8#1)
from millimeters to##2##3##(2008-10#1)(2008-3#1)
from minor to##2##3##(2008-10#1)(2011-2#1)
from minor##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
from mitochondria in##2##3##(1991-3#1)(2008-11#1)
from mitochondria##4##2##(1991-3#1)(1993-12#1)(2008-11#1)(2008-9#1)
from mitochondrial and nuclear##2##4##(2010-4#1)(2013-8#1)
from mitochondrial##3##2##(2008-6#1)(2010-4#1)(2013-8#1)
from mixed##4##2##(2008-10#3)(2008-6#1)
from mixtures##3##2##(2008-10#3)
from modified##2##2##(2008-10#2)
from molecular biology##2##3##(2008-10#1)(2008-4#1)
from molecular nitrogen##2##3##(2008-3#2)
from molecular##8##2##(1992-11#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-4#1)
from moor frog Rana arvalis##2##5##(2011-2#2)
from more basal to more modern##2##6##(2008-8#2)
from more than one##4##4##(2008-10#3)(2009-11#1)
from more than##5##3##(2008-10#3)(2009-11#1)(2009-3#1)
from more##15##2##(2008-10#7)(2008-11#1)(2008-8#2)(2009-11#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)
from morphological##3##2##(1991-3#1)(2008-10#1)(2008-6#1)
from most of##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
from most##8##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#2)
from mouse embryonic stem cells##2##5##(2008-11#1)(2008-9#1)
from mouse embryonic stem##3##4##(2008-11#2)(2008-9#1)
from mouse lung##2##3##(1991-8#1)(1994-8#1)
from mouse##20##2##(1991-8#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-8#1)(1997-9#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
from multiple gene##2##3##(2008-8#1)(2010-4#1)
from multiple locations##2##3##(2008-10#2)
from multiple##19##2##(1993-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2013-1#2)
from multivariate##2##2##(2008-10#1)(2012-2#1)
from mummies##2##2##(2008-10#2)
from murine##9##2##(1990-8#1)(1993-2#1)(1997-7#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-7#1)
from muscles##2##2##(2008-3#1)(2010-4#1)
from naive CD4(+) T cells##3##5##(2008-11#3)
from naive##5##2##(2008-10#1)(2008-11#4)
from national##2##2##(1992-6#1)(2008-1#1)
from native##4##2##(1994-8#1)(2008-10#3)
from natural populations##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
from natural water samples##2##4##(2008-10#2)
from natural water##3##3##(2008-10#3)
from natural##20##2##(2008-10#9)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
from naturally infected plant##2##4##(2008-10#2)
from naturally infected##8##3##(2008-10#8)
from naturally occurring##2##3##(2008-10#1)(2010-7#1)
from naturally##12##2##(1996-12#1)(2008-10#10)(2010-7#1)
from naïve##2##2##(2008-11#1)(2010-10#1)
from near neutral##2##3##(2008-10#2)
from near##4##2##(2008-10#3)(2008-3#1)
from nearby##2##2##(2008-8#2)
from needle procedures##2##3##(2008-11#2)
from negligible##2##2##(1990-9#1)(2008-11#1)
from neonatal##5##2##(1994-11#1)(1995-11#1)(1995-12#1)(2012-2#1)(2013-1#1)
from nerve##2##2##(1992-9#1)(1995-11#1)
from neural stem cells##2##4##(2008-11#1)(2011-2#1)
from neural##4##2##(1997-4#1)(2008-11#1)(2008-7#1)(2011-2#1)
from neurons##2##2##(2008-5#1)(2008-8#1)
from neutral##2##2##(2008-10#1)(2012-3#1)
from neutrality##2##2##(2012-3#1)(2013-8#1)
from newly##2##2##(1990-9#1)(2008-11#1)
from nine##9##2##(2006-6#1)(2008-10#6)(2010-12#1)(2011-2#1)
from nitric acid medium##3##4##(2008-10#3)
from nitric acid##5##3##(2008-10#5)
from no##2##2##(2008-10#2)
from non##3##2##(2008-11#1)(2008-3#1)(2010-12#1)
from non-pregnant##2##2##(1990-11#1)(1994-8#1)
from non-probabilistic examples##2##3##(2009-11#2)
from non-treated##3##2##(1996-2#1)(2008-10#2)
from noncruciferous hosts##3##3##(2008-10#3)
from none##2##2##(2008-9#1)(2010-12#1)
from noninoculated##2##2##(2008-10#2)
from nonlinear##3##2##(2008-10#1)(2008-2#1)(2009-8#1)
from nonprecooled donor cells##2##4##(2008-9#2)
from nonvector##2##2##(2008-10#2)
from normal human##2##3##(2008-10#1)(2008-11#1)
from normal individuals##3##3##(1991-9#1)(1992-3#1)(1992-9#1)
from normal tissues##2##3##(1990-5#1)(2013-1#1)
from normal to##4##3##(1994-11#1)(1996-2#1)(2008-10#1)(2013-8#1)
from normal##25##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-11#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
from northeast##2##2##(2008-10#2)
from northern##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
from northwestern Europe##2##3##(2008-10#2)
from not##2##2##(2008-10#2)
from novice to##2##3##(2008-12#2)
from nuclear##6##2##(2008-10#4)(2008-8#1)(2008-9#1)
from nuclei##2##2##(1994-8#1)(1996-2#1)
from nucleotide##2##2##(2008-10#1)(2008-11#1)
from numerous##6##2##(1995-12#1)(2008-10#2)(2008-8#1)(2011-8#1)(2013-8#1)
from nursing and##2##3##(1996-12#1)(2008-11#1)
from nursing##5##2##(1991-2#1)(1994-1#1)(1996-12#1)(2008-11#1)(2013-1#1)
from obese##2##2##(1994-11#1)(1996-12#1)
from observations of##2##3##(2010-10#1)(2012-2#1)
from observed##4##2##(2008-10#4)
from offshore petroleum exploration##2##4##(2008-10#2)
from older##2##2##(2008-2#1)(2009-10#1)
from olive trees##2##3##(2008-10#2)
from olive##5##2##(2008-10#5)
from one another##6##3##(2008-10#4)(2008-6#1)(2012-3#1)
from one climatic##2##3##(2008-10#1)(2013-1#1)
from one of##5##3##(1991-3#1)(1994-9#1)(1995-6#1)(2008-9#1)(2009-10#1)
from one or##2##3##(2008-12#1)(2011-2#1)
from one replication and##2##4##(2008-10#2)
from one species to##2##4##(2008-8#1)(2012-2#1)
from one to##3##3##(1993-12#1)(2008-10#2)
from one woman##2##3##(1990-6#1)(1995-1#1)
from one##68##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-6#1)(1997-3#1)(2007-12#1)(2008-10#29)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)
from ongoing##2##2##(2008-10#1)(2011-8#1)
from onion##4##2##(2008-10#4)
from only##4##2##(2008-10#3)(2013-1#1)
from onset of##4##3##(1991-12#1)(1996-9#1)(2013-1#2)
from onset##5##2##(1991-12#1)(1996-6#1)(1996-9#1)(2013-1#2)
from operating##2##2##(1994-2#1)(2008-9#1)
from orchards##2##2##(2008-10#2)
from ordinary##4##2##(1993-12#1)(2008-2#1)(2010-5#1)(2013-8#1)
from organic phase##3##3##(2008-10#3)
from organic##5##2##(2008-10#5)
from ornamental asparagus##3##3##(2008-10#3)
from ornamental##6##2##(2008-10#6)
from other bacterial##2##3##(2008-10#1)(2011-2#1)
from other continents##3##3##(2008-10#2)(2010-5#1)
from other countries##3##3##(1993-2#1)(1996-2#1)(2013-8#1)
from other diseases##2##3##(1992-6#1)(2010-12#1)
from other eukaryotes##2##3##(1992-8#1)(1996-3#1)
from other fungi##2##3##(2008-10#2)
from other hospitals##2##3##(1990-9#1)(1992-12#1)
from other hosts##8##3##(2008-10#8)
from other locations##2##3##(2008-10#1)(2008-5#1)
from other metal ions##2##4##(2008-10#2)
from other organisms##6##3##(1990-11#1)(1993-12#1)(1993-6#1)(1995-9#1)(1996-3#1)(1997-6#1)
from other plant##3##3##(2008-10#2)(2008-11#1)
from other plants##2##3##(2008-10#1)(2009-8#1)
from other regions##2##3##(2008-10#1)(2009-12#1)
from other related##2##3##(2008-10#2)
from other sources##2##3##(2008-11#2)
from other species##7##3##(1993-2#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-7#1)
from other strains##3##3##(2008-10#3)
from other substances##2##3##(2008-10#2)
from other types##2##3##(1990-3#1)(2008-3#1)
from other vertebrates##2##3##(1993-6#1)(1995-2#1)
from other##164##2##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-6#4)(1993-8#1)(1994-11#1)(1994-6#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#1)(1997-2#2)(1997-3#2)(1997-6#1)(2008-1#1)(2008-10#73)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
from others##4##2##(2008-11#2)(2009-9#1)(2010-10#1)
from our data##4##3##(1994-11#1)(2008-11#1)(2008-8#1)(2010-6#1)
from our group##2##3##(1995-5#1)(2013-1#1)
from our##30##2##(1994-11#1)(1995-5#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-8#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
from outside the##2##3##(2008-10#2)
from outside##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
from ovarian##2##2##(1990-2#1)(2010-3#1)
from over##5##2##(1992-3#1)(2008-10#3)(2009-9#1)
from oxidation##3##2##(1991-3#1)(2008-11#1)(2013-8#1)
from oxidative##2##2##(1992-12#1)(2012-3#1)
from pH 3##2##3##(2008-10#2)
from pH 4##2##3##(2008-10#2)
from pH##7##2##(2008-10#7)
from pain##2##2##(1996-8#1)(2008-7#1)
from paintings##2##2##(2008-10#2)
from pairs of##2##3##(2007-11#1)(2008-10#1)
from parasites##2##2##(2008-8#2)
from parent##5##2##(2008-10#5)
from parental##4##2##(2008-10#1)(2008-11#2)(2008-8#1)
from parents##2##2##(2008-10#1)(2009-7#1)
from participation##2##2##(2009-4#1)(2013-1#1)
from passiflora##2##2##(2008-10#2)
from past##5##2##(1993-3#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-7#1)
from paternity casework##3##3##(2008-12#3)
from patient##6##2##(1993-11#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#2)
from patients at##2##3##(2012-2#2)
from patients in##2##3##(1991-12#1)(2008-5#1)
from patients who##4##3##(1991-7#1)(1994-5#1)(2009-11#1)(2010-11#1)
from patients with chronic##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
from patients with the##2##4##(1992-12#1)(2008-9#1)
from patients with##28##3##(1990-2#6)(1990-5#1)(1991-11#1)(1992-12#1)(1993-11#2)(1993-2#2)(1995-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-1#1)(2009-11#1)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#1)
from patients##54##2##(1990-2#6)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#1)(1993-11#2)(1993-2#2)(1994-5#1)(1995-12#2)(1995-2#1)(1997-8#1)(1997-9#1)(2008-10#6)(2008-11#4)(2008-5#3)(2008-9#1)(2009-1#1)(2009-11#3)(2010-11#1)(2010-12#1)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#1)
from patterns of##2##3##(2008-11#1)(2008-9#1)
from pea##5##2##(2008-1#1)(2008-10#3)(2008-8#1)
from pear##2##2##(2008-10#2)
from pellets##2##2##(2008-7#2)
from people##2##2##(1993-3#1)(2011-2#1)
from peripheral blood##2##3##(2008-11#1)(2008-9#1)
from peripheral##4##2##(1994-11#1)(1996-11#1)(2008-11#1)(2008-9#1)
from persons##3##2##(1994-9#1)(1996-11#1)(2008-10#1)
from phage display libraries##2##4##(2008-10#1)(2008-9#1)
from pharmaceutical##5##2##(2008-10#5)
from phase II##2##3##(2008-8#2)
from phase##3##2##(1995-12#1)(2008-8#2)
from phosphatidylinositol##2##2##(1997-8#1)(2008-11#1)
from phospholipase C##2##3##(1993-6#1)(1995-8#1)
from phospholipids##2##2##(1997-2#1)(2008-11#1)
from physical##3##2##(1991-6#1)(2008-10#1)(2008-12#1)
from physician##2##2##(1992-1#1)(1997-1#1)
from pig##3##2##(2008-11#2)(2008-12#1)
from pistachio in##2##3##(2008-10#2)
from pistachio##6##2##(2008-10#6)
from planning##2##2##(1996-1#1)(2009-11#1)
from plant and soil samples##2##5##(2008-10#2)
from plant material##2##3##(2008-10#2)
from plant tissues##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
from plant##17##2##(1990-5#1)(2008-10#11)(2008-8#1)(2008-9#4)
from plants have been##2##4##(2008-11#1)(2009-10#1)
from plants in##2##3##(2008-10#2)
from plants##17##2##(2008-10#10)(2008-11#4)(2008-9#1)(2009-10#1)(2010-7#1)
from plasma by a##2##4##(1992-10#1)(2011-3#1)
from plasma samples##2##3##(1991-9#1)(2013-8#1)
from plasma##9##2##(1991-9#1)(1992-10#1)(1997-2#1)(2008-10#4)(2011-3#1)(2013-8#1)
from plasmids##2##2##(1993-2#1)(1996-12#1)
from plots##3##2##(2008-10#3)
from pneumococcal##2##2##(1994-9#2)
from point##2##2##(1992-6#1)(2008-11#1)
from polarization##2##2##(2008-10#1)(2008-3#1)
from pollinator##2##2##(2008-10#1)(2008-8#1)
from polluted waters##2##3##(2008-10#2)
from polymer##3##2##(2008-10#2)(2008-12#1)
from pond water##2##3##(2008-10#1)(2012-2#1)
from pond##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
from pooled##2##2##(2012-2#1)(2013-8#1)
from poor##3##2##(1997-5#1)(2008-5#1)(2012-2#1)
from poplar##3##2##(2008-10#2)(2013-1#1)
from population##3##2##(2008-8#1)(2008-9#1)(2011-3#1)
from populations##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
from porcine kidney##2##3##(2008-10#2)
from porcine##7##2##(1994-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)
from possible##2##2##(1995-5#1)(2008-3#1)
from postheparin##2##2##(1991-12#1)(1994-11#1)
from postnatal##2##2##(1991-6#1)(2008-10#1)
from potassium##2##2##(2008-10#2)
from potato and tomato##2##4##(2008-10#2)
from potato and##6##3##(2008-10#6)
from potato##16##2##(2008-10#16)
from potential##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
from poultry##2##2##(2008-5#1)(2011-2#1)
from powdered##2##2##(2008-10#2)
from pre- to##3##3##(1992-12#1)(2008-12#1)(2012-2#1)
from pre-clinical##2##2##(2008-10#1)(2013-8#1)
from pre-to posttest and##2##4##(2012-2#2)
from pre-to##3##2##(2012-2#3)
from prebloom##2##2##(2008-10#2)
from predominantly##2##2##(2008-10#1)(2013-1#1)
from pregnant##3##2##(1990-11#2)(2008-11#1)
from pretest to##2##3##(2010-10#2)
from previous studies##8##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)
from previous##20##2##(1992-10#1)(1996-2#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
from previously reported##2##3##(2008-10#1)(2011-2#1)
from previously##5##2##(2008-10#3)(2011-2#1)(2012-3#1)
from primary care##2##3##(2008-7#1)(2012-2#1)
from primary##9##2##(1990-8#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
from primary-cultured murine##2##3##(2008-11#2)
from probabilistic examples##2##3##(2009-11#2)
from production##3##2##(2008-10#1)(2008-11#2)
from products preserved with##2##4##(2008-5#2)
from programs##2##2##(1993-1#1)(2008-6#1)
from prolonged##2##2##(2013-1#2)
from prosody##3##2##(2009-10#3)
from protein and##2##3##(2008-11#1)(2008-3#1)
from protein##5##2##(2008-11#1)(2008-3#2)(2008-7#1)(2012-2#1)
from proteins##3##2##(2008-10#3)
from pseudosclerotia buried##2##3##(2008-10#2)
from psychiatrists##2##2##(2008-11#1)(2010-12#1)
from public health##2##3##(1996-11#1)(1997-3#1)
from public##5##2##(1990-6#1)(1996-11#1)(1997-3#1)(2008-10#1)(2011-2#1)
from published##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
from pulmonary##2##2##(1996-3#1)(2010-10#1)
from pulse##2##2##(1997-8#1)(2008-10#1)
from pure##7##2##(2008-10#4)(2008-11#1)(2009-8#1)(2010-4#1)
from purified human##2##3##(1991-5#1)(2008-10#1)
from purified##9##2##(1991-5#1)(1994-11#1)(2008-10#6)(2008-4#1)
from pyridine##2##2##(2008-3#2)
from pyrolysis##2##2##(2008-10#2)
from rabbit muscle enhanced IgM production##2##6##(2008-11#2)
from rabbit muscle##4##3##(2008-11#4)
from rabbit##13##2##(1993-6#1)(1993-8#1)(1995-2#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-9#1)
from race 1 isolates##2##4##(2008-10#2)
from race 1##3##3##(2008-10#3)
from race##5##2##(1991-9#1)(2008-10#4)
from rainbow trout##4##3##(1994-11#1)(1994-5#1)(1997-9#1)(2009-6#1)
from rainbow##5##2##(1994-11#1)(1994-5#1)(1997-9#1)(2008-11#1)(2009-6#1)
from random amplified polymorphic DNA##2##5##(2008-10#2)
from random##10##2##(1993-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-3#1)
from randomized##2##2##(1993-12#2)
from randomly selected##2##3##(2008-10#2)
from randomly##3##2##(2008-10#3)
from rat adipose##2##3##(2008-11#2)
from rat and##2##3##(1991-8#1)(1996-6#1)
from rat brain##5##3##(1991-5#1)(1994-8#1)(1996-2#2)(2008-7#1)
from rat liver and##4##4##(1990-5#1)(1992-6#2)(1995-6#1)
from rat liver was##2##4##(1992-6#1)(1994-11#1)
from rat liver##12##3##(1990-5#2)(1992-6#3)(1993-8#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#1)
from rat neostriatum in##2##4##(1992-3#2)
from rat##49##2##(1990-12#1)(1990-2#1)(1990-5#3)(1991-5#2)(1991-8#1)(1992-3#2)(1992-6#3)(1993-12#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-8#3)(1995-11#4)(1995-2#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(2008-10#1)(2008-11#8)(2008-7#1)(2008-8#1)(2012-4#1)
from rats at days 1##2##5##(2010-6#2)
from rats fed##3##3##(1991-12#1)(1994-5#2)
from rats orally given##2##4##(2008-11#2)
from rats treated with##3##4##(1990-12#1)(1994-5#1)(1997-1#1)
from rats##16##2##(1990-12#1)(1990-5#1)(1991-12#2)(1993-11#1)(1994-5#3)(1995-6#1)(1997-1#1)(2008-11#3)(2008-8#1)(2010-6#2)
from reaching the##2##3##(2009-12#1)(2010-1#1)
from reaching##3##2##(2009-12#1)(2010-1#1)(2012-2#1)
from reaction##2##2##(2008-10#2)
from readily available##2##3##(2008-10#2)
from real##5##2##(2008-10#5)
from recent##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
from recently##2##2##(1993-2#1)(2008-11#1)
from receptor##2##2##(1992-9#1)(1995-6#1)
from recombinant##3##2##(2008-11#3)
from recordable##2##2##(2008-10#2)
from recovered trees##2##3##(2008-10#2)
from recovery assays##2##3##(2008-10#2)
from recurrent##4##2##(1996-3#1)(2008-12#1)(2008-9#1)(2010-6#1)
from red blood cells##4##4##(1992-11#1)(1994-11#2)(2012-2#1)
from red##9##2##(1992-11#1)(1994-11#2)(2008-7#1)(2008-8#2)(2011-10#1)(2012-2#1)(2013-8#1)
from reduced##4##2##(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
from refractoriness##4##2##(1991-2#4)
from regional##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
from regions##4##2##(1992-12#1)(1992-6#1)(1995-2#1)(2008-10#1)
from regulatory##2##2##(2008-10#2)
from rehydrated French beans##2##4##(2008-10#2)
from related##4##2##(1992-12#1)(2008-10#3)
from relevant##2##2##(2009-11#1)(2011-2#1)
from remote##4##2##(2008-10#2)(2008-7#1)(2008-9#1)
from renal failure##3##3##(1995-12#2)(2008-10#1)
from renal##4##2##(1992-12#1)(1995-12#2)(2008-10#1)
from replant##2##2##(2008-10#2)
from representative##3##2##(2008-10#2)(2008-11#1)
from research##7##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-1#1)(2011-1#1)
from residues##2##2##(1990-10#1)(2008-10#1)
from resistant cultivars##2##3##(2008-10#2)
from resistant##6##2##(2008-10#6)
from respiratory distress syndrome##2##4##(1990-11#1)(2012-3#1)
from respiratory##3##2##(1990-11#1)(1997-2#1)(2012-3#1)
from response surfaces##2##3##(2008-10#2)
from restructuring##2##2##(1991-3#1)(1994-3#1)
from retrospective##2##2##(1991-3#1)(2010-8#1)
from return signals##2##3##(2008-3#2)
from rice in##3##3##(2008-10#2)(2013-8#1)
from rice##21##2##(1995-3#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-8#6)(2009-10#1)(2013-8#1)
from right##2##2##(2009-10#1)(2012-2#1)
from risk##3##2##(1994-3#1)(2008-9#1)(2012-2#1)
from room temperature to##2##4##(2008-2#1)(2008-3#1)
from room temperature##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
from root to shoot competition##2##5##(2008-9#2)
from root to##4##3##(2008-10#1)(2008-9#2)(2012-2#1)
from root##8##2##(2008-10#2)(2008-12#2)(2008-9#2)(2011-2#1)(2012-2#1)
from roots of##5##3##(2008-10#5)
from roots to##2##3##(2008-11#1)(2008-9#1)
from roots##11##2##(2008-10#9)(2008-11#1)(2008-9#1)
from rural##4##2##(1993-12#1)(1994-9#1)(2013-1#2)
from rye and##2##3##(1991-12#1)(2008-8#1)
from salicylate media##2##3##(2008-10#2)
from salivary##2##2##(2008-10#1)(2008-4#1)
from sample matrix##2##3##(2008-10#2)
from sample preparation##2##3##(2008-10#2)
from sample solution##2##3##(2008-10#2)
from sample to sample##2##4##(2008-10#2)
from sample##11##2##(2008-10#10)(2011-2#1)
from samples of##5##3##(1996-6#1)(2008-10#2)(2008-11#1)(2008-5#1)
from samples##18##2##(1996-6#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-5#1)
from sampling##2##2##(2008-10#2)
from satellite sounder##2##3##(2008-2#2)
from schools of##2##3##(1991-8#1)(2008-12#1)
from sea water##3##3##(2008-10#3)
from sea##5##2##(2008-10#4)(2010-8#1)
from seawater##4##2##(2008-10#3)(2011-2#1)
from secondary##2##2##(1996-5#1)(2008-4#1)
from sediments##2##2##(2008-10#2)
from seed of##3##3##(2008-10#2)(2013-8#1)
from seed##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
from seedling roots##2##3##(2008-10#2)
from seedling to##2##3##(2008-10#1)(2009-8#1)
from seedling##5##2##(2008-10#3)(2008-12#1)(2009-8#1)
from seedlings##6##2##(2008-10#4)(2008-8#1)(2011-10#1)
from seeds of##2##3##(1995-6#1)(2008-10#1)
from seeds##4##2##(1995-6#1)(2008-10#3)
from selected##4##2##(1994-5#1)(2008-10#1)(2009-6#1)(2011-2#1)
from selection##2##2##(2008-10#1)(2009-8#1)
from selective##4##2##(1990-5#1)(1996-2#1)(2008-7#1)(2011-2#1)
from sensitive##3##2##(2008-10#3)
from sensory##2##2##(1992-6#1)(2009-9#1)
from septic shock##2##3##(1996-3#1)(2010-5#1)
from sequence##2##2##(1997-8#1)(2011-2#1)
from sequences##2##2##(2008-10#1)(2013-1#1)
from sequential##2##2##(2008-10#1)(2010-3#1)
from serous##2##2##(1992-2#1)(2013-1#1)
from serum was##3##3##(2008-10#3)
from serum##8##2##(1993-2#1)(2008-10#6)(2008-11#1)
from service##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
from seven different##2##3##(1997-6#1)(2008-10#1)
from seven##17##2##(1991-12#1)(1993-3#1)(1997-2#1)(1997-6#1)(2008-10#10)(2008-8#1)(2010-8#1)(2013-1#1)
from several different##2##3##(2008-10#2)
from several hosts##3##3##(2008-10#3)
from several perspectives##2##3##(1996-12#1)(2008-9#1)
from several studies##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
from several##42##2##(1992-10#1)(1993-12#1)(1994-11#1)(1994-2#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#26)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#1)(2013-8#1)
from severe##4##2##(1995-2#1)(2008-10#1)(2012-3#1)(2013-8#1)
from sex##2##2##(1991-1#1)(2008-12#1)
from sexual##3##2##(2008-10#1)(2008-8#2)
from sheep##2##2##(1997-5#1)(2008-10#1)
from shoot tip##2##3##(2008-12#1)(2008-9#1)
from short##5##2##(2008-5#1)(2009-10#1)(2013-1#3)
from side##2##2##(2008-10#1)(2008-8#1)
from sign##2##2##(2008-9#1)(2010-5#1)
from similar##3##2##(2008-10#1)(2008-2#1)(2010-3#1)
from simple##6##2##(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-2#1)
from simulated##5##2##(2008-10#3)(2008-5#1)(2010-7#1)
from simulations##2##2##(1995-5#1)(2010-3#1)
from single cells##2##3##(2008-4#1)(2008-7#1)
from single##16##2##(1996-12#2)(1997-3#1)(2007-12#1)(2008-10#4)(2008-4#2)(2008-6#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
from site to site##2##4##(2008-10#2)
from site##3##2##(2008-10#2)(2010-4#1)
from sites with##3##3##(2008-10#3)
from sites##4##2##(1994-5#1)(2008-10#3)
from six indigenous communities residing in##2##6##(2012-12#2)
from six##14##2##(1991-2#1)(1991-6#1)(1995-12#1)(2008-10#4)(2008-11#1)(2010-6#1)(2012-12#2)(2012-2#3)
from skeletal##2##2##(1991-2#1)(1996-8#1)
from skin##11##2##(1994-8#1)(2008-5#7)(2008-9#1)(2011-2#1)(2012-3#1)
from small##11##2##(1993-12#2)(1995-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2012-12#1)(2013-8#1)
from small-scale##3##2##(2008-11#1)(2008-12#1)(2010-10#1)
from smokers##2##2##(2008-10#1)(2010-2#1)
from smooth muscle##2##3##(1993-6#1)(1993-8#1)
from smooth##3##2##(1993-6#1)(1993-8#1)(1996-12#1)
from social##2##2##(2008-11#1)(2011-2#1)
from sodium chloride##2##3##(2008-10#1)(2008-12#1)
from sodium##3##2##(2008-10#2)(2008-12#1)
from soil and##4##3##(2008-10#4)
from soil samples##8##3##(2008-10#8)
from soil##35##2##(2008-10#32)(2008-9#1)(2011-2#1)(2012-2#1)
from soils and##2##3##(2008-10#2)
from soils##11##2##(2008-10#11)
from solid matrices##2##3##(2008-10#2)
from solid samples##3##3##(2008-10#3)
from solid##10##2##(1996-3#1)(2008-10#8)(2008-9#1)
from solid-state##2##2##(2008-10#2)
from solution samples##5##3##(2008-10#5)
from solution##8##2##(2008-10#8)
from solutions containing##2##3##(2008-10#2)
from solutions of##2##3##(2008-10#2)
from solutions##6##2##(2008-10#6)
from somatic mutations##2##3##(2008-10#2)
from somatic##4##2##(2008-10#3)(2008-11#1)
from some of##2##3##(2008-10#2)
from some other##2##3##(2008-10#1)(2008-11#1)
from some##24##2##(1991-8#1)(1992-11#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-8#1)(2012-3#1)
from sorghum and millet##2##4##(2008-10#2)
from source##3##2##(2008-10#2)(2008-8#1)
from sources##3##2##(2008-10#2)(2008-11#1)
from south to north##2##4##(2008-10#1)(2008-9#1)
from south##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
from southern##3##2##(2008-10#2)(2008-11#1)
from soybean plants##2##3##(2008-10#2)
from soybean##16##2##(1990-5#1)(2008-10#14)(2008-8#1)
from space##2##2##(2008-3#2)
from spatially##2##2##(2008-3#1)(2008-8#1)
from species and##2##3##(2008-8#1)(2011-2#1)
from species##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
from specific##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)
from spectra##2##2##(2008-10#1)(2008-3#1)
from spectral data##2##3##(2008-10#2)
from spectral##4##2##(2008-10#3)(2008-3#1)
from spectrophotometric data##2##3##(2008-10#2)
from spectrophotometric##4##2##(2008-10#4)
from spermidine##2##2##(2013-8#2)
from spherical##3##2##(2008-3#3)
from spiked matrices##2##3##(2008-10#2)
from spiked plasma samples were##2##5##(2008-10#2)
from spiked plasma samples##3##4##(2008-10#3)
from spiked samples##2##3##(2008-10#2)
from spiked##15##2##(2008-10#14)(2009-8#1)
from spinach leaves##2##3##(1990-5#1)(2008-10#1)
from spinach##4##2##(1990-5#1)(1991-9#1)(1997-7#1)(2008-10#1)
from spinal cord synaptosomes##3##4##(1996-2#3)
from spontaneous##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
from spontaneously hypertensive rats##2##4##(1995-11#2)
from spray inoculation##2##3##(2008-10#2)
from spruce##2##2##(2008-10#1)(2013-1#1)
from sputum##2##2##(2008-5#2)
from squamous##2##2##(2009-6#1)(2011-2#1)
from staff nurse to nurse consultant##2##6##(2013-8#2)
from staff##3##2##(2011-1#1)(2013-8#2)
from stage 0-##2##3##(2008-10#2)
from stage##4##2##(1991-8#1)(1997-7#1)(2008-10#2)
from standard##5##2##(1992-4#1)(2008-10#2)(2008-11#1)(2008-9#1)
from stationary##2##2##(2008-3#1)(2011-2#1)
from stems##4##2##(2008-10#3)(2008-7#1)
from stimulated##3##2##(1992-6#1)(1994-11#1)(2008-10#1)
from stimulation of the##2##4##(1990-5#2)
from stimulation of##4##3##(1990-5#3)(1995-8#1)
from stimulation##7##2##(1990-5#3)(1995-8#1)(1996-11#1)(2008-10#2)
from storage and##2##3##(2008-10#1)(2008-3#1)
from storage##3##2##(2008-10#2)(2008-3#1)
from stored##2##2##(1992-3#1)(2008-10#1)
from strain##11##2##(1993-9#1)(2008-10#8)(2008-8#1)(2012-2#1)
from strains##7##2##(2008-10#6)(2012-3#1)
from strawberry and##3##3##(2008-10#3)
from strawberry##14##2##(2008-10#14)
from strawberry)##2##2##(2008-10#2)
from strong to##2##3##(2008-10#1)(2011-2#1)
from strong##6##2##(2008-10#2)(2008-8#2)(2008-9#1)(2011-2#1)
from structural##6##2##(1995-6#1)(2008-10#1)(2008-9#1)(2010-2#1)(2010-7#1)(2012-3#1)
from students and##2##3##(2008-11#2)
from students##4##2##(2008-11#3)(2009-6#1)
from studies of the##2##4##(2009-11#1)(2009-8#1)
from studies of##6##3##(2008-4#1)(2009-11#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)
from studies on##4##3##(1992-3#1)(2008-8#1)(2009-8#1)(2011-1#1)
from studies with##2##3##(1997-9#1)(2008-10#1)
from studies##16##2##(1992-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-8#2)(2011-1#2)(2012-12#1)
from study##2##2##(2008-3#1)(2011-2#1)
from subgroup##2##2##(2008-5#1)(2011-2#1)
from subsequent##2##2##(1995-5#1)(2008-10#1)
from substrate##2##2##(2008-7#2)
from such a##3##3##(1990-6#1)(2008-10#2)
from such##14##2##(1990-6#1)(1991-3#1)(1992-8#1)(1996-6#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-4#1)(2013-8#1)
from sulfate##3##2##(2008-10#2)(2011-2#1)
from surface contamination##2##3##(2008-10#2)
from surface water##3##3##(2008-10#2)(2012-2#1)
from surface##11##2##(1994-12#1)(2008-10#6)(2010-4#1)(2012-2#1)(2013-8#2)
from surfaces##3##2##(2008-12#2)(2008-2#1)
from surgical treatment##2##3##(2009-3#1)(2013-1#1)
from surgical##6##2##(1990-5#1)(1991-3#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
from surrounding##2##2##(2008-10#1)(2013-1#1)
from survey##2##2##(2008-10#1)(2013-1#1)
from susceptible##9##2##(1994-8#1)(2008-10#8)
from suspension##4##2##(2008-11#2)(2008-4#1)(2008-8#1)
from symmetric and##2##3##(2008-8#2)
from symptomatic plants##2##3##(2008-10#2)
from symptomatic##9##2##(1991-3#1)(2008-10#8)
from symptomless##3##2##(2008-10#3)
from symptoms##2##2##(1996-6#1)(2011-3#1)
from synthetic and##2##3##(2008-10#2)
from synthetic##6##2##(2008-10#5)(2011-3#1)
from systemic##2##2##(2008-10#2)
from systemically infected##4##3##(2008-10#4)
from tablets##4##2##(2008-10#4)
from tall fescue##3##3##(2008-10#3)
from tamarillo##3##2##(2008-10#3)
from tankships##2##2##(2008-11#2)
from targets##2##2##(2008-3#1)(2010-10#1)
from temperate##2##2##(2011-2#1)(2012-2#1)
from ten##3##2##(2008-10#2)(2012-2#1)
from tests##2##2##(2008-12#1)(2008-2#1)
from that for##5##3##(1990-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
from that found in##2##4##(1995-12#1)(2008-5#1)
from that in the##4##4##(1994-5#1)(1995-2#1)(1997-5#1)(2013-1#1)
from that in##12##3##(1993-8#1)(1994-5#2)(1995-12#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#1)
from that observed##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
from that of a##2##4##(1990-6#1)(2008-3#1)
from that of all##2##4##(2008-5#1)(2011-3#1)
from that of other##3##4##(1993-2#1)(2008-10#2)
from that of the original##2##5##(2008-10#2)
from that of the##19##4##(1992-3#1)(1992-6#1)(1993-3#1)(1994-2#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
from that of##52##3##(1990-6#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#3)(1996-2#1)(2007-12#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2009-10#2)(2010-12#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
from that##98##2##(1990-6#1)(1990-8#2)(1990-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#6)(1995-2#4)(1996-2#1)(1996-5#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#9)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#2)(2010-12#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
from the &quot##3##3##(2008-10#2)(2009-6#1)
from the 1##2##3##(1996-2#1)(2008-10#1)
from the 1940s to the##2##5##(2009-7#1)(2012-3#1)
from the 1990##2##3##(1992-12#1)(2010-7#1)
from the 2005##2##3##(2009-5#1)(2012-12#1)
from the 3' end of the completed Okazaki fragment##2##9##(1992-3#2)
from the 3' end of the##3##6##(1992-3#2)(2008-10#1)
from the 3'##4##3##(1992-3#2)(2008-10#2)
from the 5##2##3##(2008-10#1)(2008-8#1)
from the 5'##2##3##(1992-6#1)(2008-10#1)
from the American##4##3##(1996-2#1)(1997-8#1)(2008-5#1)(2011-2#1)
from the Arabidopsis##2##3##(1994-12#1)(2009-10#1)
from the B genome##2##4##(2008-10#2)
from the B##3##3##(2008-10#3)
from the British##2##3##(1992-2#1)(2012-12#1)
from the C-terminus##3##3##(1992-6#2)(1994-11#1)
from the Canadian##2##3##(2008-10#1)(2008-11#1)
from the Caribbean region##2##4##(2008-10#2)
from the Caribbean##3##3##(2008-10#3)
from the Chernobyl##2##3##(2008-10#2)
from the China##2##3##(2011-2#2)
from the Chinese##2##3##(2008-10#1)(2013-1#1)
from the Current##2##3##(1993-3#1)(2011-2#1)
from the DNA##6##3##(1991-5#1)(1993-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
from the DRR of the##2##5##(2009-11#2)
from the DRR##3##3##(2009-11#2)(2009-2#1)
from the DZ##2##3##(2009-7#2)
from the Department of##3##4##(1991-9#1)(2008-11#1)(2012-3#1)
from the E##2##3##(1990-11#1)(2009-7#1)
from the European##5##3##(1990-11#1)(1994-5#1)(2008-10#1)(2010-10#1)(2012-2#1)
from the GC-HRMS##2##3##(2008-10#2)
from the Golgi##3##3##(1994-12#1)(2008-11#1)(2012-2#1)
from the Health##2##3##(1996-8#1)(2009-7#1)
from the Indian Ocean##2##4##(2008-11#2)
from the Indian##3##3##(2008-11#2)(2011-2#1)
from the Italian##2##3##(2010-11#1)(2011-2#1)
from the Ivory Coast were##2##5##(2008-10#2)
from the Japanese##2##3##(2008-10#2)
from the Lyon area##2##4##(2008-10#2)
from the MX line##2##4##(2008-10#2)
from the Medicare Current Beneficiary Survey (MCBS) and##2##8##(1994-1#1)(1995-12#1)
from the Medicare Current Beneficiary Survey (MCBS)##4##7##(1994-1#1)(1995-12#2)(1997-2#1)
from the Medicare##8##3##(1993-1#1)(1993-3#2)(1994-1#1)(1995-12#2)(1995-2#1)(1997-2#1)
from the Middle##2##3##(2008-10#2)
from the NH(4)VO(3) solution##3##4##(2008-10#3)
from the National Cancer##2##4##(1997-3#1)(2013-8#1)
from the National Health##4##4##(1995-12#1)(1996-5#1)(2010-12#1)(2013-8#1)
from the National Survey of##2##5##(2009-5#1)(2010-10#1)
from the National##17##3##(1990-6#1)(1991-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#3)
from the New##2##3##(1996-3#1)(2008-10#1)
from the North American##2##4##(2008-10#2)
from the North Carolina sample##2##5##(2008-10#2)
from the North##8##3##(1992-5#1)(2008-10#4)(2008-6#1)(2008-9#1)(2011-2#1)
from the Norwegian##2##3##(1991-11#1)(1997-8#1)
from the P##2##3##(2008-10#2)
from the PDL##2##3##(2008-11#2)
from the Pacific Northwest of the United States and##2##9##(2008-10#2)
from the Parana River basin##2##5##(2008-12#2)
from the Quebec##2##3##(1991-12#1)(2008-3#1)
from the R to the T##2##6##(1990-8#2)
from the REE##2##3##(2008-10#2)
from the SPE cartridge##2##4##(1997-2#2)
from the SPME##2##3##(2008-10#2)
from the South##3##3##(2008-8#1)(2010-3#1)(2010-8#1)
from the Sudan and##2##4##(2008-10#2)
from the T cell line transfected with##2##7##(2008-11#2)
from the T##3##3##(2008-11#2)(2011-2#1)
from the U##5##3##(1993-2#1)(1994-1#1)(2008-10#3)
from the US##2##3##(2010-10#1)(2013-8#1)
from the United States and France##2##6##(2008-10#2)
from the United States and##5##5##(2008-10#5)
from the United States were##4##5##(2008-10#4)
from the United States##22##4##(2008-10#21)(2011-2#1)
from the United##24##3##(1991-3#1)(2008-10#22)(2011-2#1)
from the University of##2##4##(1991-1#1)(1995-3#1)
from the University##3##3##(1991-1#1)(1995-3#1)(2008-11#1)
from the VOCl(2) solution##2##4##(2008-10#2)
from the Vf cultivar##2##4##(2008-10#2)
from the Western Hemisphere##2##4##(2008-10#2)
from the Western##3##3##(2008-10#3)
from the X chromosome##2##4##(2008-11#2)
from the X##3##3##(2008-10#1)(2008-11#2)
from the abdominal##2##3##(1991-2#1)(2012-2#1)
from the absorption spectra by##2##5##(2008-3#2)
from the academic##2##3##(1991-8#1)(2008-12#1)
from the acquired##2##3##(1993-12#1)(2009-8#1)
from the activated macrophages##2##4##(2008-11#2)
from the actual##2##3##(2008-10#2)
from the adult mouse##2##4##(2008-11#2)
from the aerial##2##3##(2008-11#2)
from the affected##2##3##(1994-12#1)(2008-12#1)
from the age##2##3##(1995-12#1)(2012-3#1)
from the air##4##3##(1994-3#1)(2008-10#2)(2008-3#1)
from the airway##4##3##(1992-2#2)(1995-12#1)(1997-1#1)
from the airways##3##3##(1997-1#3)
from the alcohol or aldehyde oxidation level##2##7##(2010-7#2)
from the alcohol##4##3##(2009-8#1)(2010-7#2)(2013-8#1)
from the alpha and beta##2##5##(1992-6#1)(2008-10#1)
from the alternative##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
from the amino acid##3##4##(1994-8#1)(2008-10#2)
from the amino##4##3##(1994-8#1)(2008-10#2)(2008-11#1)
from the amygdala##2##3##(1993-6#1)(1994-2#1)
from the anaerobic##2##3##(1990-12#1)(1991-12#1)
from the analyses##2##3##(2008-10#2)
from the analysis of##5##4##(2008-10#4)(2011-8#1)
from the analysis were##2##4##(2008-11#2)
from the analysis##12##3##(1993-12#1)(1996-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2010-10#1)(2011-8#1)(2013-1#1)
from the analyte solution##2##4##(2008-10#2)
from the analytical##4##3##(2008-10#3)(2010-1#1)
from the animals##4##3##(1990-12#1)(1990-5#1)(1996-12#1)(2013-1#1)
from the anterior##2##3##(2007-12#1)(2011-2#1)
from the application of##4##4##(2008-10#3)(2010-5#1)
from the application##5##3##(2008-10#3)(2009-10#1)(2010-5#1)
from the aquatic##3##3##(2008-10#2)(2010-6#1)
from the aqueous phase##3##4##(2008-10#2)(2008-7#1)
from the aqueous##10##3##(1991-5#1)(2008-10#8)(2008-7#1)
from the area##2##3##(1995-3#1)(2008-11#1)
from the aspect of##2##4##(2008-10#2)
from the assumptions of##2##4##(2008-10#1)(2008-9#1)
from the author's##4##3##(1992-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
from the authors'##3##3##(1992-1#1)(2008-10#1)(2008-7#1)
from the available##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
from the baseline##4##3##(2008-7#2)(2010-7#1)(2013-1#1)
from the basic##2##3##(1996-1#1)(1997-2#1)
from the beginning of the##2##5##(1997-8#1)(2010-10#1)
from the beginning of##4##4##(1997-8#1)(2008-10#1)(2010-10#1)(2013-1#1)
from the beginning##5##3##(1997-8#1)(2008-10#1)(2010-1#1)(2010-10#1)(2013-1#1)
from the biliary##2##3##(1992-2#1)(2008-11#1)
from the binary power##2##4##(2008-10#2)
from the biocontrol##2##3##(2008-10#2)
from the biological##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
from the bioreactor##3##3##(2008-11#3)
from the blastocyst##2##3##(2008-10#1)(2008-9#1)
from the blood##2##3##(2008-10#1)(2008-11#1)
from the body into the brain##2##6##(2009-8#2)
from the body##5##3##(1997-3#1)(2008-10#1)(2008-5#1)(2009-8#2)
from the bone##2##3##(2008-11#1)(2010-6#1)
from the bound##2##3##(2008-10#2)
from the brachiopod Lingula reevii##2##5##(1991-10#2)
from the brachiopod Lingula##3##4##(1991-10#3)
from the brain##2##3##(1996-12#2)
from the budding yeast##3##4##(1993-8#2)(1996-6#1)
from the calibration##2##3##(2008-10#2)
from the canopy##2##3##(2008-10#2)
from the cell membrane##3##4##(1990-12#2)(2008-12#1)
from the cell##9##3##(1990-12#2)(1996-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-10#1)
from the cells##11##3##(1990-5#1)(1990-8#1)(1994-3#2)(2008-10#1)(2008-11#5)(2008-8#1)
from the center##2##3##(2008-3#1)(2013-8#1)
from the central Coastal Bend region##2##6##(2008-10#2)
from the central##5##3##(1991-12#1)(2008-10#3)(2008-6#1)
from the cervical##2##3##(2010-8#1)(2011-2#1)
from the chamber##2##3##(2008-10#2)
from the changes##2##3##(1991-6#1)(2008-10#1)
from the channel walls##2##4##(2008-12#2)
from the chicken##3##3##(1990-8#1)(1991-6#1)(2008-5#1)
from the children##2##3##(1994-6#1)(2008-9#1)
from the choice of##2##4##(1991-2#1)(2008-3#1)
from the classical##4##3##(1990-2#1)(1991-1#1)(2008-10#1)(2008-8#1)
from the clinic##2##3##(2008-10#1)(2011-2#1)
from the clinical and##2##4##(1991-6#1)(1991-8#1)
from the clinical##8##3##(1991-6#1)(1991-8#1)(1994-6#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
from the closely related##2##4##(1991-5#1)(2008-5#1)
from the column##10##3##(1990-12#1)(2008-10#9)
from the common##6##3##(1991-3#1)(1993-6#1)(2008-10#2)(2008-5#1)(2011-2#1)
from the control##3##3##(1992-12#1)(1993-1#1)(2008-10#1)
from the core##2##3##(1997-1#1)(2008-8#1)
from the corresponding##6##3##(1990-12#1)(2008-10#4)(2008-8#1)
from the cross between##6##4##(2008-10#5)(2012-3#1)
from the cross of the##2##5##(2008-10#2)
from the cross of##6##4##(2008-10#6)
from the cross##26##3##(2008-10#23)(2008-8#1)(2008-9#1)(2012-3#1)
from the crowns of##2##4##(2008-10#1)(2013-1#1)
from the crude##3##3##(1990-2#1)(2008-11#2)
from the culture medium##5##4##(1993-6#1)(1994-6#1)(2008-11#3)
from the culture##9##3##(1990-8#1)(1993-6#1)(1994-6#1)(2008-10#1)(2008-11#4)(2010-6#1)
from the cultures##3##3##(2008-10#2)(2008-11#1)
from the current study##2##4##(2008-10#1)(2012-2#1)
from the current##6##3##(1996-5#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-12#1)(2012-2#1)
from the cytosol to the##2##5##(1992-12#1)(1997-1#1)
from the cytosol to##4##4##(1992-12#1)(1992-6#1)(1997-1#1)(2011-2#1)
from the data of##2##4##(2008-10#2)
from the data##12##3##(1991-2#1)(1996-3#1)(2008-10#4)(2008-11#4)(2008-9#1)(2010-12#1)
from the date of##3##4##(1990-8#1)(2008-10#1)(2008-7#1)
from the deeper##3##3##(2008-5#3)
from the dependence of the##2##5##(2008-10#2)
from the detection##2##3##(2008-10#2)
from the developed##2##3##(2008-5#1)(2010-10#1)
from the development of##2##4##(2008-10#1)(2009-4#1)
from the diagnostic##2##3##(1997-8#1)(2011-3#1)
from the difference between the##2##5##(2008-10#2)
from the difference##4##3##(2008-10#4)
from the different##5##3##(1990-12#2)(2008-10#2)(2013-1#1)
from the direction of the##2##5##(2008-3#1)(2009-7#1)
from the disease##7##3##(1992-6#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-8#1)
from the diseased##2##3##(2008-10#2)
from the disk##4##3##(2008-10#3)(2008-11#1)
from the distal##2##3##(2008-11#1)(2008-9#1)
from the donor##3##3##(1994-5#1)(2008-10#2)
from the dorsal##3##3##(1997-3#1)(2010-8#1)(2013-8#1)
from the drop##2##3##(1991-5#1)(2008-10#1)
from the early##4##3##(1997-8#2)(2008-11#1)(2010-6#1)
from the earthworm##2##3##(2008-5#1)(2011-1#1)
from the eastern##3##3##(2008-10#3)
from the edge of##2##4##(2008-10#2)
from the effect of##2##4##(2008-7#1)(2009-8#1)
from the effects of##5##4##(1997-6#1)(2008-10#3)(2009-12#1)
from the egg##3##3##(1994-11#1)(2007-12#1)(2008-9#1)
from the electrode surface##2##4##(2008-10#2)
from the electrode##4##3##(2008-10#4)
from the eluent##2##3##(2008-10#2)
from the embryo##2##3##(2008-10#1)(2008-11#1)
from the end of##4##4##(1996-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
from the endogenous##4##3##(1992-9#1)(1997-7#1)(1997-8#1)(2010-11#1)
from the environment##4##3##(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
from the epithelium##3##3##(2007-12#2)(2012-2#1)
from the excipients##3##3##(2008-10#3)
from the experiment##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
from the experimental##7##3##(2008-10#5)(2008-3#1)(2010-8#1)
from the exponential##2##3##(2008-7#1)(2011-2#1)
from the exposed##3##3##(2008-12#1)(2008-3#1)(2009-12#1)
from the external##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
from the extraction##3##3##(1991-12#1)(2008-10#2)
from the fact that the##3##5##(1993-6#1)(2008-11#1)(2011-3#1)
from the family##4##3##(1992-2#1)(2008-10#2)(2011-2#1)
from the federal government##2##4##(1991-1#1)(1992-1#1)
from the federal##3##3##(1991-1#1)(1992-1#1)(2008-10#1)
from the female##4##3##(2008-10#3)(2010-3#1)
from the femoral##2##3##(2008-10#1)(2013-1#1)
from the fiber##4##3##(2008-10#2)(2008-3#2)
from the field of##3##4##(1994-2#1)(2011-2#1)(2013-8#1)
from the field##14##3##(1994-2#1)(2008-10#10)(2008-11#1)(2011-2#1)(2013-8#1)
from the filtrate ranged from##2##5##(2008-10#2)
from the first day of##2##5##(1992-5#1)(1993-12#1)
from the first round##2##4##(1991-6#2)
from the first two##2##4##(2008-10#2)
from the first##18##3##(1990-11#1)(1991-6#3)(1992-5#1)(1993-12#1)(1994-1#1)(2007-8#1)(2008-10#6)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
from the five##3##3##(2008-10#2)(2008-11#1)
from the flow##4##3##(1995-3#1)(2008-10#3)
from the fluorescence quenching##2##4##(2008-10#1)(2008-8#1)
from the forelimbs##2##3##(2011-2#2)
from the former##2##3##(2008-11#1)(2011-2#1)
from the four##8##3##(1991-6#1)(1992-1#1)(2008-10#5)(2008-11#1)
from the frequency##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
from the front##2##3##(1994-1#1)(1997-4#1)
from the fruit##2##3##(2008-10#1)(2008-9#1)
from the fruits of##2##4##(2008-11#1)(2012-3#1)
from the fruits##4##3##(2008-11#3)(2012-3#1)
from the future##2##3##(1996-2#1)(2012-2#1)
from the ganglia of##2##4##(1990-2#1)(1991-5#1)
from the gastrointestinal##2##3##(2008-11#1)(2012-2#1)
from the gel##2##3##(2008-10#1)(2008-11#1)
from the gene##5##3##(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)
from the general population##2##4##(1992-2#1)(2008-7#1)
from the general##8##3##(1990-11#1)(1991-12#1)(1992-2#1)(1995-5#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)
from the genetic##3##3##(2008-10#2)(2008-6#1)
from the genomic##3##3##(1991-9#1)(1996-6#1)(1997-7#1)
from the genus##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
from the global##3##3##(2008-10#2)(2012-12#1)
from the green##3##3##(1996-2#2)(2008-10#1)
from the ground##2##3##(2008-10#1)(2008-5#1)
from the group of##2##4##(1994-5#1)(2012-3#1)
from the growth medium##2##4##(1990-6#1)(2008-10#1)
from the growth##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
from the gut##3##3##(2008-10#2)(2008-5#1)
from the hair##2##3##(2008-5#2)
from the hands##2##3##(1997-5#1)(2008-5#1)
from the heads##2##3##(2008-3#1)(2008-5#1)
from the health authorities##2##4##(1994-6#1)(2012-12#1)
from the health##4##3##(1994-6#1)(2008-11#1)(2010-10#1)(2012-12#1)
from the hemolymph##4##3##(1990-5#1)(2008-6#1)(2008-7#2)
from the high##5##3##(2008-10#3)(2008-11#1)(2008-2#1)
from the higher##2##3##(2008-2#1)(2011-2#1)
from the highly##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
from the honeybee##2##3##(2008-7#1)(2008-8#1)
from the horizontal##2##3##(1993-1#1)(2008-5#1)
from the hospital##10##3##(1991-12#1)(1991-3#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
from the host cell##4##4##(2008-10#1)(2008-11#1)(2009-6#2)
from the host##9##3##(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#2)(2013-1#1)
from the human##10##3##(1991-9#1)(1993-6#1)(1995-2#2)(2008-12#1)(2008-5#1)(2009-7#2)(2012-2#1)(2013-1#1)
from the hybrid##2##3##(2008-10#2)
from the hybrids##2##3##(2008-10#1)(2008-9#1)
from the hyperthermophilic##2##3##(1993-9#1)(2008-9#1)
from the image##2##3##(2008-6#1)(2012-3#1)
from the immobilized##2##3##(2008-10#1)(2008-11#1)
from the immune##2##3##(1993-3#1)(1997-8#1)
from the immunized mice##2##4##(2008-11#1)(2008-9#1)
from the immunized##3##3##(2008-11#1)(2008-9#2)
from the implementation of##2##4##(1991-3#1)(2008-12#1)
from the implementation##3##3##(1991-3#1)(1997-2#1)(2008-12#1)
from the in situ##2##4##(2008-10#1)(2008-3#1)
from the in vitro##2##4##(2008-11#2)
from the in##5##3##(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
from the inclusion##2##3##(2008-10#1)(2008-9#1)
from the incubation medium##2##4##(1995-11#2)
from the incubation##3##3##(1991-3#1)(1995-11#2)
from the individual##4##3##(1991-12#1)(2008-2#1)(2008-5#1)(2013-1#1)
from the infected##2##3##(2008-10#2)
from the initial isolates##2##4##(2008-10#2)
from the initial##5##3##(1993-12#1)(1996-12#1)(2008-10#2)(2008-11#1)
from the initiation of##3##4##(2008-10#1)(2010-8#1)(2011-2#1)
from the initiation##4##3##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
from the injected##2##3##(2008-10#2)
from the injection site##2##4##(1996-12#1)(2008-8#1)
from the injection##4##3##(1996-12#1)(1997-2#1)(2008-8#1)(2008-9#1)
from the inner walls of##2##5##(2008-10#2)
from the inner##6##3##(1991-5#1)(2008-10#4)(2008-9#1)
from the inoculated leaf##2##4##(2008-10#2)
from the inoculated##6##3##(2008-10#5)(2008-5#1)
from the inoculation site##2##4##(2008-10#2)
from the inoculation##3##3##(2008-10#3)
from the inoculum source##3##4##(2008-10#3)
from the interaction of##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
from the interaction##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
from the interference of##5##4##(2008-10#5)
from the intermediate##2##3##(2008-10#1)(2010-10#1)
from the internal transcribed spacer##2##5##(2008-10#2)
from the international##2##3##(2007-12#1)(2010-10#1)
from the interviews were##2##4##(2008-12#1)(2011-1#1)
from the ipsilateral##2##3##(2010-3#1)(2013-8#1)
from the jellyfish Aequorea victoria##2##5##(1996-6#1)(2008-10#1)
from the kidney##3##3##(1994-5#1)(2011-2#2)
from the laboratory##2##3##(2008-11#1)(2008-2#1)
from the large volume of##2##5##(2008-10#2)
from the large##3##3##(2008-10#2)(2008-7#1)
from the larger##2##3##(1991-6#1)(2008-11#1)
from the largest##3##3##(1993-9#1)(1994-11#1)(2007-12#1)
from the laser crystal##2##4##(2008-3#2)
from the laser##3##3##(2008-10#1)(2008-3#2)
from the lateral##4##3##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
from the leaf##4##3##(2008-10#2)(2008-12#1)(2008-7#1)
from the leaves of Morus alba##2##6##(2011-3#2)
from the leaves of##5##4##(2008-11#1)(2010-2#1)(2011-3#2)(2013-1#1)
from the left arm of yeast chromosome##2##7##(1996-3#1)(1996-6#1)
from the left arm of##4##5##(1995-9#1)(1996-3#2)(1996-6#1)
from the left##11##3##(1995-9#1)(1996-3#2)(1996-6#2)(1997-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-2#1)
from the liquid##4##3##(2008-10#3)(2008-11#1)
from the literature on##3##4##(1991-2#1)(2008-9#1)(2009-5#1)
from the literature to##2##4##(2008-11#2)
from the literature##22##3##(1990-6#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-8#1)(1995-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-3#1)
from the liver and##2##4##(1991-12#1)(1995-9#1)
from the liver##5##3##(1991-12#1)(1991-7#1)(1995-9#1)(2010-11#1)(2010-5#1)
from the loading##2##3##(2008-10#2)
from the local population##2##4##(2008-10#2)
from the local##4##3##(2008-10#3)(2008-8#1)
from the locus##2##3##(2008-10#1)(2008-7#1)
from the lower##2##3##(1992-12#1)(2008-3#1)
from the lumen##2##3##(1997-1#1)(2007-12#1)
from the lung##2##3##(1991-12#2)
from the lungs##2##3##(1997-1#1)(2008-10#1)
from the main##5##3##(2008-10#4)(2008-11#1)
from the major##2##3##(2008-10#1)(2009-3#1)
from the male##2##3##(2008-10#2)
from the many##2##3##(2008-11#1)(2010-10#1)
from the marine##2##3##(2008-10#1)(2008-11#1)
from the matrix and##2##4##(2008-10#2)
from the matrix##4##3##(2008-10#4)
from the mean##2##3##(1995-8#1)(2008-10#1)
from the measured##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
from the measurement of##2##4##(2008-10#2)
from the measurement##3##3##(2008-10#3)
from the measurements##2##3##(2008-3#2)
from the mechanisms##2##3##(2009-8#2)
from the medial superior olivary nucleus##2##6##(1997-3#2)
from the medial##3##3##(1997-3#2)(2013-8#1)
from the medical##4##3##(1992-4#2)(1996-2#1)(2012-2#1)
from the membrane##4##3##(1994-11#1)(1994-8#1)(2008-10#2)
from the mesenchyme##2##3##(1993-3#1)(1995-8#1)
from the mesenteric##3##3##(1992-3#2)(2008-5#1)
from the metabolic##2##3##(1994-8#1)(2008-7#1)
from the middle##2##3##(2008-9#1)(2009-3#1)
from the minicolumn##3##3##(2008-10#3)
from the mixture##3##3##(1990-5#1)(2008-10#2)
from the model##8##3##(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
from the molecular##3##3##(2008-10#3)
from the more common##2##4##(1997-8#1)(2010-1#1)
from the more##6##3##(1995-12#1)(1996-12#1)(1997-8#1)(2010-1#1)(2010-3#1)(2013-8#1)
from the most recent##2##4##(1991-12#1)(2008-8#1)
from the most##8##3##(1991-12#1)(1996-3#1)(2008-10#4)(2008-8#1)(2012-3#1)
from the mouse##3##3##(1992-6#1)(1993-2#1)(1993-6#1)
from the mycelial##2##3##(2008-10#1)(2008-5#1)
from the native##2##3##(1993-8#1)(2009-8#1)
from the new##3##3##(2008-11#1)(2008-8#1)(2009-7#1)
from the nine-banded armadillo##2##4##(2008-5#2)
from the nonreducing terminal##2##4##(1994-5#2)
from the normal##2##3##(2008-2#1)(2011-2#1)
from the north##2##3##(2008-10#2)
from the nuclear##4##3##(1997-7#1)(2008-10#2)(2008-11#1)
from the nucleotide sequence data##4##5##(1997-6#4)
from the nucleotide sequence of the##2##6##(1990-8#1)(1991-5#1)
from the nucleotide sequence##6##4##(1990-8#1)(1991-5#1)(1997-6#4)
from the nucleotide##7##3##(1990-8#1)(1991-5#1)(1996-8#1)(1997-6#4)
from the nucleus##2##3##(2011-2#2)
from the null##2##3##(2008-10#1)(2008-8#1)
from the number##2##3##(1990-5#1)(2008-3#1)
from the observed##2##3##(2008-10#1)(2008-7#1)
from the occiput to C2##2##5##(2012-3#2)
from the oil##2##3##(2008-10#2)
from the on-line##2##3##(2008-11#2)
from the ones##4##3##(2008-10#2)(2010-8#1)(2011-2#1)
from the ongoing##3##3##(1996-2#1)(2008-5#1)(2012-2#1)
from the onset of##5##4##(1990-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
from the onset##6##3##(1990-12#1)(1994-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
from the oral##2##3##(1997-4#1)(2008-5#1)
from the orchard##2##3##(2008-10#2)
from the organic phase##3##4##(2008-10#3)
from the organic##4##3##(2008-10#4)
from the original##3##3##(2008-10#3)
from the other species##2##4##(2008-10#1)(2008-6#1)
from the other##23##3##(1991-12#1)(1992-1#1)(1992-5#1)(1994-5#1)(2008-10#8)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-3#1)
from the others##2##3##(2008-10#1)(2010-11#1)
from the outer##7##3##(2008-10#2)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
from the outset##2##3##(1993-1#1)(2008-10#1)
from the oxidation of luminol##2##5##(2008-10#2)
from the oxidation of##6##4##(2008-10#5)(2008-5#1)
from the oxidative burst##2##4##(1995-6#2)
from the oxidative##3##3##(1995-6#2)(2008-10#1)
from the parental##2##3##(2008-10#1)(2008-9#1)
from the parents##2##3##(2008-10#1)(2008-9#1)
from the participating##2##3##(2008-10#1)(2008-12#1)
from the past##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
from the pathogenic##2##3##(2008-10#2)
from the patient##11##3##(1992-8#1)(1994-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
from the patient's perspective##2##4##(2008-12#1)(2012-3#1)
from the patient's##7##3##(1990-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-3#1)(2013-1#1)
from the patients##4##3##(1992-11#1)(1994-11#1)(2008-10#1)(2013-8#1)
from the peak##4##3##(1990-11#1)(2008-10#3)
from the periphery##3##3##(1991-11#1)(2008-7#2)
from the permanent##2##3##(1996-12#1)(2009-8#1)
from the perspective of a##2##5##(1994-1#1)(1994-12#1)
from the perspective of the##3##5##(1993-12#1)(2008-11#2)
from the perspective of##16##4##(1993-12#1)(1994-1#1)(1994-12#2)(1996-3#1)(2008-1#1)(2008-11#4)(2008-9#2)(2010-10#3)(2010-6#1)
from the perspectives of##3##4##(2008-12#2)(2013-8#1)
from the plant##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
from the plants##2##3##(2008-10#2)
from the plasma##2##3##(1990-11#1)(1995-2#1)
from the plate##2##3##(2008-10#1)(2008-8#1)
from the point of view of the##3##7##(1992-3#1)(1994-2#1)(1995-11#1)
from the point of view of their##2##7##(1994-3#1)(2008-10#1)
from the point of view of##10##6##(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-10#4)(2009-12#1)(2013-8#1)
from the point of##12##4##(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-10#6)(2009-12#1)(2013-8#1)
from the point##14##3##(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-10#7)(2008-7#1)(2009-12#1)(2013-8#1)
from the population##5##3##(1994-2#1)(1997-7#1)(2008-3#1)(2008-7#1)(2013-8#1)
from the portion of##2##4##(1997-6#1)(2008-7#1)
from the prefrontal##2##3##(2008-10#1)(2008-11#1)
from the presence of##2##4##(1991-8#1)(2008-10#1)
from the present study##2##4##(2008-10#1)(2008-12#1)
from the present##3##3##(1994-8#1)(2008-10#1)(2008-12#1)
from the previous##7##3##(2008-10#5)(2011-2#1)(2011-3#1)
from the previously described##2##4##(2008-10#2)
from the previously##4##3##(2008-10#4)
from the primary##6##3##(1995-11#1)(2008-10#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
from the primate##2##3##(1995-5#2)
from the probe##2##3##(2008-10#1)(2008-9#1)
from the procedure##2##3##(2008-10#2)
from the production of##2##4##(2008-10#1)(2008-12#1)
from the production##3##3##(2008-10#2)(2008-12#1)
from the program##2##3##(1991-1#1)(2008-11#1)
from the proposed##2##3##(2008-10#2)
from the prospective payment system##2##5##(1992-2#1)(2008-11#1)
from the protein##3##3##(1990-5#1)(1990-8#2)
from the protozoan##3##3##(1993-9#2)(2009-7#1)
from the proximal##2##3##(1997-8#1)(2008-5#1)
from the public health##2##4##(2008-7#1)(2010-12#1)
from the public##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
from the published literature##3##4##(1996-2#1)(2010-12#2)
from the pulmonary artery##2##4##(2008-12#1)(2010-5#1)
from the pulmonary##3##3##(2008-12#1)(2010-5#1)(2013-8#1)
from the pure drug##2##4##(2008-10#2)
from the purified##2##3##(2008-10#1)(2008-8#1)
from the purple##3##3##(1993-8#1)(2009-9#1)(2011-2#1)
from the putative##2##3##(1993-12#1)(2008-10#1)
from the quantitative##3##3##(2008-5#1)(2012-3#1)(2013-1#1)
from the rat##4##3##(1993-6#1)(2008-8#2)(2008-9#1)
from the raw##2##3##(1994-3#1)(2011-2#1)
from the reaction between##4##4##(1990-5#1)(2008-10#3)
from the reaction mixture##2##4##(2008-10#1)(2008-8#1)
from the reaction of##6##4##(1996-5#1)(2008-10#5)
from the reaction##14##3##(1990-5#1)(1996-5#1)(2008-10#10)(2008-7#1)(2008-8#1)
from the recent##2##3##(2008-10#1)(2008-5#1)
from the recently##2##3##(1997-7#1)(2008-10#1)
from the red alga##2##4##(2008-10#1)(2008-11#1)
from the reference##2##3##(1993-2#1)(1995-12#1)
from the refractive-index##2##3##(2008-3#2)
from the relationship between the##2##5##(2008-10#1)(2010-4#1)
from the remaining##4##3##(2008-10#4)
from the research##2##3##(2007-12#1)(2009-1#1)
from the resin column##2##4##(2008-10#2)
from the resin##6##3##(2008-10#6)
from the resistance##2##3##(2011-2#1)(2012-3#1)
from the resistant##4##3##(2008-10#4)
from the rest of the##5##5##(2008-10#2)(2008-4#1)(2008-6#1)(2011-2#1)
from the result of##2##4##(2008-5#1)(2009-12#1)
from the result##3##3##(2008-11#1)(2008-5#1)(2009-12#1)
from the results obtained##4##4##(2008-10#2)(2008-5#2)
from the results of##4##4##(1993-3#1)(2008-10#2)(2008-4#1)
from the results##10##3##(1993-3#1)(2008-10#4)(2008-4#1)(2008-5#3)(2010-2#1)
from the rhizosphere of wheat##2##5##(2008-10#2)
from the rhizosphere of##3##4##(2008-10#3)
from the rhizosphere##4##3##(2008-10#4)
from the rice##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
from the right arm of##2##5##(1996-3#2)
from the right##8##3##(1996-3#2)(1996-9#2)(1997-3#1)(2008-10#1)(2009-3#1)(2011-2#1)
from the river Danube in Hungary##2##6##(2008-10#2)
from the river##5##3##(2008-10#4)(2010-8#1)
from the root##4##3##(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
from the roots of##3##4##(2008-10#2)(2010-6#1)
from the roots##5##3##(2008-10#3)(2008-11#1)(2010-6#1)
from the same gene##2##4##(1990-2#1)(1993-12#1)
from the same location##3##4##(2008-10#3)
from the same organism##2##4##(1993-6#1)(1997-6#1)
from the same pool##2##4##(2008-10#1)(2008-5#1)
from the same##59##3##(1990-2#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#31)(2008-11#4)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
from the sample matrix##3##4##(2008-10#3)
from the sample using##2##4##(2008-10#2)
from the sample##18##3##(1997-3#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-3#1)
from the samples##6##3##(2008-10#6)
from the scattering##4##3##(2008-10#1)(2008-3#3)
from the scene of##2##4##(1995-11#1)(2008-10#1)
from the second##5##3##(2008-10#3)(2012-12#1)(2012-3#1)
from the seminiferous epithelium##3##4##(2009-10#1)(2012-2#2)
from the separation##2##3##(2008-10#1)(2010-7#1)
from the sequence of the##2##5##(2008-10#2)
from the sequence of##3##4##(1992-8#1)(2008-10#2)
from the sequence##4##3##(1992-8#1)(2008-10#3)
from the side##2##3##(2008-10#1)(2008-3#1)
from the site of##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
from the site##5##3##(1993-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
from the six##2##3##(1992-1#1)(2008-1#1)
from the skin of a Korean frog##2##7##(1994-11#2)
from the skin of##5##4##(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)
from the skin surface##2##4##(2008-5#2)
from the skin##9##3##(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)(2008-5#4)
from the slope of the calibration##2##6##(2008-10#2)
from the slope of the##3##5##(2008-10#3)
from the slope of##4##4##(1991-5#1)(2008-10#3)
from the slope##5##3##(1991-5#1)(2008-10#4)
from the soil samples##2##4##(2008-10#2)
from the soil##7##3##(2008-10#7)
from the solid##2##3##(2008-10#2)
from the solution##6##3##(2008-10#6)
from the source##8##3##(1993-3#1)(2008-10#6)(2008-3#1)
from the south of Spain##2##5##(2008-10#2)
from the southern##2##3##(2008-10#2)
from the southwestern##2##3##(2008-10#2)
from the spectral##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
from the spherical##2##3##(2008-3#1)(2011-2#1)
from the spinal root of the##2##6##(2008-7#2)
from the spinal##4##3##(1996-2#2)(2008-7#2)
from the standard##3##3##(2008-10#2)(2010-7#1)
from the standpoint of##2##4##(1995-12#1)(2008-10#1)
from the start##3##3##(1991-5#1)(1991-6#2)
from the state of##2##4##(2008-10#1)(2011-2#1)
from the statistical##2##3##(2008-9#1)(2013-8#1)
from the structure##2##3##(1994-3#1)(2010-11#1)
from the students##3##3##(2008-11#3)
from the study##5##3##(2008-10#1)(2008-12#1)(2011-2#2)(2013-1#1)
from the substrate##2##3##(1992-6#1)(2008-3#1)
from the surface of the##2##5##(2008-9#1)(2009-6#1)
from the surface of##6##4##(1997-3#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-6#1)
from the surface##12##3##(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)
from the surrounding##3##3##(2008-11#1)(2008-12#1)(2008-3#1)
from the survey is##2##4##(1995-1#1)(2008-11#1)
from the survey##4##3##(1994-3#1)(1995-1#1)(1996-1#1)(2008-11#1)
from the susceptible##2##3##(2008-10#2)
from the system##3##3##(1995-3#1)(1997-7#1)(2010-6#1)
from the target##4##3##(2008-10#2)(2010-10#1)(2011-2#1)
from the teacher's perspective##2##4##(2008-11#2)
from the temperature##2##3##(2008-10#2)
from the test##3##3##(1997-5#1)(2008-10#2)
from the tested##2##3##(2008-10#1)(2013-1#1)
from the third cycle onwards##2##5##(2012-12#2)
from the third##7##3##(2007-12#1)(2008-10#2)(2008-9#1)(2012-12#2)(2013-1#1)
from the three##9##3##(1991-7#1)(1993-9#1)(2008-10#5)(2008-4#1)(2012-7#1)
from the time of##5##4##(1994-3#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)
from the time##6##3##(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)
from the tip of a microsyringe##2##6##(2008-10#2)
from the tissue##2##3##(2008-10#1)(2010-12#1)
from the top##2##3##(2008-10#1)(2010-6#1)
from the total RNA extracted from##2##6##(2008-10#2)
from the total##4##3##(2008-10#4)
from the translational##2##3##(1992-10#1)(1994-11#1)
from the treatment of##2##4##(1996-11#1)(2011-1#1)
from the tree canopy##2##4##(2008-10#2)
from the tumor##2##3##(2013-1#2)
from the tumour##2##3##(1990-5#1)(2008-7#1)
from the two droplets##2##4##(2008-3#2)
from the two##13##3##(1990-3#1)(1996-3#1)(2008-10#4)(2008-3#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)
from the typical##2##3##(2008-8#1)(2010-6#1)
from the ultraviolet to the far infrared##2##7##(2008-3#2)
from the uninsured population##2##4##(2008-11#2)
from the uninsured##5##3##(2008-11#5)
from the untreated control##2##4##(2008-10#1)(2008-11#1)
from the untreated##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
from the upper##3##3##(1995-11#1)(2008-10#1)(2010-9#1)
from the urinary##2##3##(2008-10#1)(2011-2#1)
from the urine##3##3##(1991-12#1)(2008-10#2)
from the use of a##4##5##(2008-10#3)(2011-2#1)
from the use of the##2##5##(2008-10#2)
from the use of##9##4##(1992-2#1)(2008-10#5)(2010-4#1)(2011-2#1)(2011-3#1)
from the vagina##2##3##(1991-12#2)
from the values##2##3##(1997-2#1)(2008-10#1)
from the varieties##2##3##(2008-10#1)(2008-12#1)
from the various##3##3##(1990-5#1)(2008-5#1)(2010-12#1)
from the venom of##4##4##(1990-5#1)(1994-11#1)(1995-8#1)(2008-8#1)
from the venom##5##3##(1990-5#1)(1993-6#1)(1994-11#1)(1995-8#1)(2008-8#1)
from the ventral##3##3##(1996-5#1)(2008-5#1)(2011-2#1)
from the viewpoint of##7##4##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)
from the viral##4##3##(1993-6#1)(2008-10#1)(2012-12#1)(2013-1#1)
from the water##5##3##(1990-11#1)(2008-10#4)
from the well##2##3##(1994-12#1)(2008-10#1)
from the west##2##3##(1995-10#1)(2013-8#1)
from the wheat##2##3##(2008-10#2)
from the whole##2##3##(2008-10#2)
from the wild##3##3##(2008-10#3)
from the wild-type##4##3##(1991-9#1)(1993-8#1)(1995-6#1)(2011-2#1)
from the world##2##3##(1994-9#1)(2013-8#1)
from the year##2##3##(1996-11#1)(2008-12#1)
from the yeast Candida##2##4##(1991-9#1)(1997-2#1)
from the yeast Saccharomyces cerevisiae##2##5##(1994-3#1)(1997-7#1)
from the yeast##6##3##(1991-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1997-2#1)(1997-7#1)
from the##3423##2##(1990-10#1)(1990-11#13)(1990-12#17)(1990-2#8)(1990-3#2)(1990-5#19)(1990-6#4)(1990-7#1)(1990-8#12)(1990-9#1)(1991-1#8)(1991-10#5)(1991-11#8)(1991-12#23)(1991-2#9)(1991-3#11)(1991-5#18)(1991-6#16)(1991-7#2)(1991-8#4)(1991-9#15)(1992-1#10)(1992-10#3)(1992-11#3)(1992-12#10)(1992-2#12)(1992-3#9)(1992-4#4)(1992-5#5)(1992-6#13)(1992-8#3)(1992-9#5)(1993-1#9)(1993-11#2)(1993-12#15)(1993-2#10)(1993-3#17)(1993-6#18)(1993-8#16)(1993-9#10)(1994-1#8)(1994-11#19)(1994-12#13)(1994-2#9)(1994-3#17)(1994-5#13)(1994-6#12)(1994-8#12)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#12)(1995-12#19)(1995-2#18)(1995-3#11)(1995-5#8)(1995-6#12)(1995-8#7)(1995-9#4)(1996-1#5)(1996-11#6)(1996-12#18)(1996-2#25)(1996-3#14)(1996-5#17)(1996-6#16)(1996-8#8)(1996-9#2)(1997-1#13)(1997-2#18)(1997-3#17)(1997-4#4)(1997-5#4)(1997-6#16)(1997-7#12)(1997-8#18)(2007-11#3)(2007-12#28)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#1160)(2008-11#249)(2008-12#54)(2008-2#27)(2008-3#95)(2008-4#12)(2008-5#100)(2008-6#28)(2008-7#72)(2008-8#78)(2008-9#63)(2009-1#5)(2009-10#13)(2009-11#6)(2009-12#8)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#7)(2009-6#7)(2009-7#19)(2009-8#26)(2009-9#7)(2010-1#8)(2010-10#22)(2010-11#14)(2010-12#18)(2010-2#5)(2010-3#7)(2010-4#13)(2010-5#10)(2010-6#14)(2010-7#12)(2010-8#15)(2010-9#4)(2011-1#10)(2011-2#133)(2011-3#7)(2011-8#1)(2012-12#21)(2012-2#41)(2012-3#55)(2012-7#3)(2012-9#1)(2013-1#74)(2013-2#1)(2013-3#1)(2013-7#2)(2013-8#58)
from their aqueous##2##3##(2008-10#2)
from their home##2##3##(2008-11#1)(2008-12#1)
from their own##4##3##(1992-2#1)(2008-10#1)(2010-12#1)(2012-12#1)
from their respective##2##3##(1993-12#1)(2008-10#1)
from their##67##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
from them##9##2##(1993-2#1)(1997-1#1)(2008-10#5)(2008-4#1)(2008-6#1)
from theoretical and##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
from theoretical##5##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)
from theory to clinical practice##2##5##(1993-3#2)
from theory##4##2##(1993-3#2)(2008-9#1)(2012-3#1)
from therapy##2##2##(2008-8#1)(2012-2#1)
from there##2##2##(2008-10#1)(2008-7#1)
from thermal##2##2##(2008-10#1)(2008-3#1)
from these data that##3##4##(1990-5#1)(2008-10#1)(2011-2#1)
from these data##6##3##(1990-5#1)(2008-10#3)(2010-9#1)(2011-2#1)
from these experiments##3##3##(1992-10#1)(2008-10#1)(2011-3#1)
from these findings##3##3##(1991-2#1)(2008-11#2)
from these four##3##3##(1993-6#1)(2008-10#1)(2008-7#1)
from these genes##2##3##(1992-6#1)(2008-10#1)
from these interactions##2##3##(2008-2#1)(2008-8#1)
from these issues##2##3##(1994-2#1)(2012-12#1)
from these mice##2##3##(2008-2#1)(2013-1#1)
from these plots##2##3##(2008-10#2)
from these samples##4##3##(2008-10#3)(2013-8#1)
from these studies##4##3##(1995-2#1)(2008-10#3)
from these three##3##3##(2008-10#2)(2011-1#1)
from these two##4##3##(1990-8#1)(1994-5#1)(1996-1#1)(2008-9#1)
from these##105##2##(1990-5#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#4)(1995-8#1)(1996-1#2)(1997-3#2)(2007-12#2)(2008-10#42)(2008-11#9)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
from thin##2##2##(1995-2#1)(2008-10#1)
from thiocyanate##3##2##(2008-10#3)
from this approach##4##3##(1993-2#1)(2008-10#2)(2013-8#1)
from this experience##2##3##(2008-11#2)
from this laboratory##6##3##(1990-11#1)(1991-3#1)(1992-8#1)(1995-12#1)(2008-10#2)
from this process##2##3##(2008-9#1)(2012-2#1)
from this project##2##3##(1995-3#1)(2008-12#1)
from this promoter##4##3##(1993-12#1)(1993-9#1)(1996-6#1)(2008-10#1)
from this region##5##3##(1993-3#1)(1995-6#1)(1996-3#1)(2008-10#2)
from this strain##3##3##(1995-6#1)(2008-12#1)(2012-2#1)
from this study is##2##4##(2008-10#1)(2012-3#1)
from this study show that##2##5##(2008-10#1)(2010-7#1)
from this study suggest that##3##5##(2008-10#3)
from this study##27##3##(2008-1#1)(2008-10#17)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
from this technique##3##3##(2008-12#1)(2008-3#1)(2010-7#1)
from this tissue##2##3##(1990-8#1)(2008-7#1)
from this##126##2##(1990-11#1)(1990-8#3)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-6#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#38)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
from those currently##2##3##(1994-1#1)(2008-10#1)
from those in the##2##4##(1996-3#1)(1997-8#1)
from those in##7##3##(1996-3#1)(1997-8#1)(2008-10#2)(2011-2#1)(2012-2#2)
from those obtained by##3##4##(2008-10#2)(2008-5#1)
from those of other##2##4##(2008-11#1)(2011-2#1)
from those of the other##2##5##(2008-10#1)(2008-9#1)
from those of the##9##4##(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-8#1)
from those of##27##3##(1992-1#1)(1993-8#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-8#2)(2011-2#2)(2013-8#1)
from those that##2##3##(1996-3#1)(2008-10#1)
from those with##3##3##(1991-12#1)(2012-12#1)(2013-8#1)
from those without##2##3##(2008-7#1)(2013-1#1)
from those##76##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1993-8#1)(1994-1#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-3#1)(1997-8#1)(2006-6#2)(2008-10#25)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-6#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
from three different##9##3##(2008-10#3)(2008-12#1)(2008-4#1)(2010-3#2)(2012-2#1)(2013-8#1)
from three randomized controlled trials##2##5##(2012-12#2)
from three separate##2##3##(2008-12#1)(2008-8#1)
from three sources were determined##2##5##(2008-10#2)
from three##53##2##(1990-8#1)(1991-7#1)(1993-6#1)(1995-2#1)(1995-6#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#3)(2009-7#1)(2009-8#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-7#1)(2012-9#1)(2013-8#3)
from time to time##2##4##(1997-7#1)(2012-2#1)
from tissue##5##2##(2008-10#2)(2008-5#2)(2012-2#1)
from tissues##5##2##(1990-11#1)(2008-4#1)(2008-9#2)(2012-3#1)
from tobacco##12##2##(1992-6#2)(1997-3#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
from tomato plants displaying##2##4##(2008-10#2)
from tomato plants##3##3##(2008-10#3)
from tomato were compared##2##4##(2008-10#2)
from tomato were more##2##4##(2008-10#2)
from tomato were##4##3##(2008-10#4)
from tomato##20##2##(1995-2#1)(2008-10#19)
from tomatoes##2##2##(2008-10#2)
from total##9##2##(1994-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)
from toxic##2##2##(1996-12#1)(2008-11#1)
from traditional Chinese medicines with potent anti-HIV activities##2##8##(2011-3#2)
from traditional Chinese medicines##3##4##(2011-3#3)
from traditional Chinese##5##3##(2008-9#1)(2011-3#4)
from traditional##10##2##(1993-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#4)
from transfected##3##2##(1995-2#1)(1996-12#1)(2008-10#1)
from transformed##2##2##(1993-2#1)(2008-11#1)
from transgenic##2##2##(1994-3#1)(2008-10#1)
from transient##2##2##(2008-10#1)(2008-12#1)
from transition##2##2##(2008-10#2)
from transplant##2##2##(1995-12#1)(2008-10#1)
from traumatic brain##2##3##(1994-12#1)(2012-2#1)
from treated##8##2##(1991-5#1)(1993-12#1)(2008-10#5)(2012-2#1)
from treatment with##3##3##(2008-5#1)(2009-4#1)(2010-5#1)
from treatment##6##2##(1991-8#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2011-2#1)
from trees##2##2##(2008-10#2)
from trials##2##2##(1996-6#1)(2009-11#1)
from tumor cells##4##3##(2008-11#1)(2008-9#3)
from tumor##7##2##(1990-5#1)(1992-7#1)(1994-8#1)(2008-11#1)(2008-9#3)
from tumors##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
from turfgrasses##2##2##(2008-10#2)
from turkey##2##2##(1992-6#1)(2008-5#1)
from two areas##2##3##(2008-10#2)
from two different##10##3##(1994-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-1#1)
from two distinct##2##3##(2008-10#1)(2008-9#1)
from two districts##2##3##(1994-6#1)(2010-3#1)
from two of four##2##4##(2008-10#2)
from two of the##3##4##(1991-6#1)(1996-3#1)(2008-10#1)
from two of##5##3##(1991-6#1)(1996-3#1)(2008-10#3)
from two or more##3##4##(1993-2#1)(2008-10#2)
from two overlapping##2##3##(1992-6#1)(1996-6#1)
from two patients##2##3##(1990-8#1)(1994-11#1)
from two samples ranged from##2##5##(2008-10#2)
from two samples##3##3##(2008-10#3)
from two separate##2##3##(2008-11#1)(2009-11#1)
from two sets of##2##4##(2008-8#1)(2009-10#1)
from two studies##2##3##(2008-10#1)(2008-5#1)
from two to##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
from two urban##2##3##(2008-9#1)(2010-1#1)
from two##99##2##(1990-8#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(2007-11#2)(2007-8#1)(2008-10#33)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2010-1#2)(2010-3#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
from two-dimensional##2##2##(2008-3#2)
from type##2##2##(2012-2#2)
from typical##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
from umbilical cord blood##2##4##(2008-11#2)
from umbilical##3##2##(1994-6#1)(2008-11#2)
from uncertainties##2##2##(2008-10#1)(2013-8#1)
from unconjugated Fib75##2##3##(1990-12#2)
from understanding##2##2##(2008-8#1)(2010-10#1)
from undetectable##2##2##(1994-3#1)(1997-2#1)
from unsprayed##2##2##(2008-10#2)
from untreated##4##2##(1994-8#1)(2008-10#2)(2008-11#1)
from upper##3##2##(2008-10#2)(2008-11#1)
from urine##7##2##(1991-12#1)(2008-10#6)
from use of the##2##4##(2008-10#1)(2008-3#1)
from use of##5##3##(2008-10#1)(2008-3#2)(2011-2#1)(2012-12#1)
from using the##3##3##(2008-10#3)
from using##7##2##(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
from vaccinated chickens##2##3##(1996-11#1)(2008-5#1)
from vaccinated##3##2##(1996-11#1)(2008-5#2)
from validation data##4##3##(2008-10#4)
from values##2##2##(2008-10#2)
from vanilla fragans##2##3##(2008-10#2)
from various cultural##2##3##(2009-6#1)(2011-2#1)
from various genetic##2##3##(2008-9#1)(2011-2#1)
from various geographic##2##3##(2008-10#2)
from various hosts##3##3##(2008-10#3)
from various human##2##3##(1991-5#1)(2008-9#1)
from various other##2##3##(1992-6#1)(2011-2#1)
from various parts of##3##4##(2008-10#2)(2008-12#1)
from various sources##2##3##(1993-8#1)(2008-9#1)
from various species##3##3##(1990-5#1)(1993-2#1)(1997-7#1)
from various##66##2##(1990-5#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-8#2)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-9#3)(2009-2#1)(2009-6#2)(2010-10#2)(2011-2#5)(2012-12#1)(2013-1#2)
from vascular endothelial cells##2##4##(2008-8#1)(2009-10#1)
from vascular smooth muscle##2##4##(1990-8#1)(1993-2#1)
from vascular##6##2##(1990-11#1)(1990-8#1)(1992-6#1)(1993-2#1)(2008-8#1)(2009-10#1)
from vertebrates##2##2##(1996-2#1)(2011-2#1)
from very low##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
from very##6##2##(1994-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2010-11#1)
from viable##2##2##(2008-10#1)(2008-9#1)
from viral##2##2##(2008-9#1)(2010-7#1)
from virus-infected##2##2##(2008-10#2)
from viruses in##2##3##(2008-10#2)
from visual##3##2##(1994-3#1)(2008-11#1)(2008-6#1)
from vitamin##5##2##(1991-5#1)(1994-5#3)(1995-11#1)
from waste water##2##3##(2008-10#2)
from waste##3##2##(2008-10#3)
from wastewater##4##2##(2008-10#3)(2012-2#1)
from water and##4##3##(2008-10#3)(2012-2#1)
from water by##2##3##(2008-10#1)(2011-2#1)
from water into benzene##3##4##(2008-10#3)
from water into##4##3##(2008-10#4)
from water samples with##2##4##(2008-10#2)
from water samples##7##3##(2008-10#7)
from water stress##2##3##(2008-10#1)(2008-8#1)
from water to the##2##4##(2008-10#2)
from water##40##2##(2008-10#30)(2008-3#3)(2008-8#1)(2011-2#4)(2012-2#2)
from watermelon##3##2##(2008-10#3)
from west##2##2##(2008-12#1)(2013-8#1)
from western##5##2##(2008-10#5)
from what is##2##3##(2008-10#1)(2012-3#1)
from wheat and##2##3##(2008-10#1)(2008-8#1)
from wheat bran##2##3##(1993-11#1)(2008-10#1)
from wheat##12##2##(1993-11#1)(2008-10#8)(2008-8#2)(2008-9#1)
from where they##2##3##(1996-1#1)(2008-7#1)
from where##4##2##(1996-1#1)(1996-2#1)(2008-10#1)(2008-7#1)
from which DNA##3##3##(2008-10#3)
from which a##2##3##(2008-11#1)(2008-8#1)
from which it could be eluted##3##6##(2008-10#3)
from which it##5##3##(1991-2#1)(1991-5#1)(2008-10#3)
from which the##15##3##(1995-2#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-9#1)(2013-8#1)
from which these##4##3##(1991-12#1)(1994-3#2)(2008-10#1)
from which they can generally be distinguished by their slightly lower temperature optima##2##13##(2011-2#2)
from which they originated##2##4##(2008-10#1)(2008-11#1)
from which they were isolated##2##5##(2008-10#2)
from which they were##3##4##(2008-10#3)
from which they##10##3##(1990-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#2)
from which to##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
from which##77##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-3#2)(1995-2#1)(1995-8#2)(1996-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#29)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#3)(2010-3#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-8#1)
from white##2##2##(2008-10#2)
from whole##2##2##(2008-10#1)(2008-11#1)
from whom##3##2##(2008-10#2)(2008-8#1)
from wild and cultivated sorghum##2##5##(2008-10#2)
from wild einkorn wheat##3##4##(2008-10#3)
from wild##12##2##(2008-10#10)(2008-8#1)(2013-1#1)
from wild-type##6##2##(1991-7#1)(1993-12#1)(2008-10#3)(2008-2#1)
from within the##2##3##(1992-12#1)(2008-10#1)
from within##6##2##(1992-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)
from women##2##2##(1993-2#1)(1993-3#1)
from year to year and##3##5##(2008-10#2)(2013-1#1)
from year to year##8##4##(2008-10#2)(2008-12#1)(2008-8#3)(2011-2#1)(2013-1#1)
from year##9##2##(2008-10#3)(2008-12#1)(2008-8#3)(2011-2#1)(2013-1#1)
from yeast to man##2##4##(1995-2#1)(1995-6#1)
from yeast##7##2##(1990-2#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-3#1)(2008-11#1)
from young and##3##3##(1994-8#2)(2013-7#1)
from young##7##2##(1993-12#1)(1994-8#2)(2008-11#1)(2008-7#1)(2010-4#1)(2013-7#1)
from zero##8##2##(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#1)
from zinc##2##2##(2008-10#1)(2009-12#1)
from zucchini##4##2##(2008-10#4)
from##16827##1##(1990-10#2)(1990-11#49)(1990-12#50)(1990-2#53)(1990-3#16)(1990-5#66)(1990-6#21)(1990-7#5)(1990-8#61)(1990-9#16)(1991-1#17)(1991-10#6)(1991-11#22)(1991-12#91)(1991-2#66)(1991-3#59)(1991-5#59)(1991-6#42)(1991-7#10)(1991-8#25)(1991-9#43)(1992-1#17)(1992-10#14)(1992-11#18)(1992-12#69)(1992-2#37)(1992-3#66)(1992-4#8)(1992-5#10)(1992-6#65)(1992-7#3)(1992-8#15)(1992-9#27)(1993-1#42)(1993-11#19)(1993-12#127)(1993-2#67)(1993-3#71)(1993-5#4)(1993-6#65)(1993-8#76)(1993-9#30)(1994-1#21)(1994-11#92)(1994-12#50)(1994-2#49)(1994-3#79)(1994-5#64)(1994-6#39)(1994-8#66)(1994-9#28)(1995-1#19)(1995-10#3)(1995-11#53)(1995-12#77)(1995-2#103)(1995-3#50)(1995-5#31)(1995-6#76)(1995-8#50)(1995-9#19)(1996-1#30)(1996-10#2)(1996-11#25)(1996-12#106)(1996-2#97)(1996-3#67)(1996-5#56)(1996-6#51)(1996-8#22)(1996-9#15)(1997-1#52)(1997-2#80)(1997-3#79)(1997-4#24)(1997-5#13)(1997-6#39)(1997-7#55)(1997-8#72)(1997-9#11)(2006-5#1)(2006-6#6)(2007-11#19)(2007-12#84)(2007-8#7)(2007-9#2)(2008-1#55)(2008-10#6679)(2008-11#1073)(2008-12#324)(2008-2#98)(2008-3#360)(2008-4#113)(2008-5#339)(2008-6#88)(2008-7#282)(2008-8#418)(2008-9#376)(2009-1#10)(2009-10#66)(2009-11#35)(2009-12#39)(2009-2#7)(2009-3#30)(2009-4#17)(2009-5#22)(2009-6#48)(2009-7#79)(2009-8#97)(2009-9#26)(2010-1#41)(2010-10#66)(2010-11#56)(2010-12#64)(2010-2#18)(2010-3#44)(2010-4#69)(2010-5#42)(2010-6#53)(2010-7#59)(2010-8#71)(2010-9#15)(2011-1#45)(2011-10#10)(2011-2#548)(2011-3#41)(2011-7#3)(2011-8#4)(2011-9#2)(2012-12#99)(2012-2#271)(2012-3#235)(2012-4#4)(2012-5#4)(2012-6#3)(2012-7#9)(2012-8#1)(2012-9#10)(2013-1#393)(2013-2#1)(2013-3#1)(2013-7#11)(2013-8#240)
fromCarthamus tinctorius##2##2##(2008-11#2)
fromL##2##1##(2008-11#2)
fromthe##2##1##(2008-11#2)
fronds##2##1##(2008-10#2)
front and##3##2##(1990-12#1)(2008-10#2)
front facet##4##2##(2008-3#4)
front line##2##2##(2008-11#2)
front of the##8##3##(1997-3#1)(2008-10#5)(2008-11#1)(2009-11#1)
front of##16##2##(1991-6#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-3#1)(2009-11#1)
front##47##1##(1990-12#1)(1991-2#1)(1991-6#1)(1994-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(2008-10#14)(2008-11#7)(2008-3#10)(2008-9#1)(2009-11#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
front-line staff##2##2##(1994-2#1)(2009-3#1)
front-line##5##1##(1994-2#1)(2009-3#3)(2010-1#1)
frontal and##6##2##(1995-2#1)(1996-12#2)(1997-8#1)(2008-11#1)(2008-5#1)
frontal bossing##2##2##(1997-3#1)(2011-1#1)
frontal cortex and##4##3##(1994-2#2)(1996-12#1)(1996-2#1)
frontal cortex of##2##3##(1993-6#1)(2008-8#1)
frontal cortex##14##2##(1993-6#1)(1994-2#3)(1994-3#1)(1995-5#1)(1996-12#2)(1996-2#2)(1997-2#1)(2008-10#1)(2008-8#2)
frontal cortical##2##2##(1990-8#1)(1993-6#1)
frontal eye fields##2##3##(2010-5#2)
frontal gyrus##3##2##(2008-11#3)
frontal lobe seizures##2##3##(2008-4#2)
frontal lobe##9##2##(1996-2#2)(2008-12#2)(2008-4#2)(2008-7#1)(2011-2#2)
frontal lobes##5##2##(1994-3#1)(1997-3#1)(2008-7#3)
frontal mucoceles##2##2##(2013-1#2)
frontal plane##4##2##(2010-8#4)
frontal sinus is##2##3##(2013-1#2)
frontal sinus##9##2##(2011-2#6)(2013-1#3)
frontal##74##1##(1990-8#2)(1993-6#2)(1994-2#3)(1994-3#2)(1995-2#1)(1995-5#1)(1996-12#6)(1996-2#4)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-10#2)(2008-11#7)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2010-5#2)(2010-8#4)(2011-1#1)(2011-2#11)(2012-12#1)(2012-3#1)(2013-1#6)
frontier for##2##2##(1995-1#1)(1997-2#1)
frontier##7##1##(1992-2#2)(1995-1#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
frontiers in##2##2##(1997-8#1)(2008-10#1)
frontiers##5##1##(1993-1#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-5#1)
frontline##3##1##(1993-1#1)(2010-11#1)(2012-3#1)
frontotemporal##5##1##(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)
fronts##3##1##(1997-3#1)(2007-12#1)(2008-3#1)
frost##2##1##(2008-10#2)
frozen cells##2##2##(1994-6#1)(2008-11#1)
frozen in liquid nitrogen##2##4##(2008-10#1)(2008-5#1)
frozen in##3##2##(1996-8#1)(2008-10#1)(2008-5#1)
frozen sectioning##2##2##(2008-4#2)
frozen tissue##2##2##(1991-2#1)(2008-4#1)
frozen##27##1##(1990-2#1)(1991-2#1)(1992-11#1)(1993-6#1)(1994-6#1)(1996-8#2)(1997-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#1)(2010-4#2)(2013-1#1)
fructicola and##6##2##(2008-10#6)
fructicola at##3##2##(2008-10#3)
fructicola did not##2##3##(2008-10#2)
fructicola isolates##2##2##(2008-10#2)
fructicola were##3##2##(2008-10#3)
fructicola##42##1##(2008-10#42)
fructosamine concentration##4##2##(1991-12#1)(1992-9#3)
fructosamine levels##2##2##(1991-12#2)
fructosamine##9##1##(1991-12#6)(1992-9#3)
fructose 1##2##2##(1994-8#1)(1996-6#1)
fructose 6-phosphate##2##2##(1996-6#1)(2008-7#1)
fructose and glucose##4##3##(2008-10#1)(2008-9#3)
fructose and##6##2##(1995-11#1)(2008-10#1)(2008-7#1)(2008-9#3)
fructose##30##1##(1990-2#1)(1992-12#1)(1994-3#1)(1994-8#3)(1995-11#1)(1996-2#2)(1996-6#2)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#5)
fructose-1##7##1##(2008-9#6)(2010-12#1)
frugiperda##19##1##(1992-3#1)(1993-6#1)(1994-11#1)(2008-11#12)(2008-7#4)
fruit abortion##2##2##(2008-8#2)
fruit against##3##2##(2008-10#3)
fruit age##2##2##(1993-3#1)(2008-10#1)
fruit and vegetable##2##3##(2009-5#1)(2013-1#1)
fruit and vegetables##4##3##(1994-2#2)(1997-1#1)(2009-3#1)
fruit and was##2##3##(2008-10#2)
fruit and##21##2##(1994-2#2)(1997-1#1)(2008-10#15)(2009-3#1)(2009-5#1)(2013-1#1)
fruit are##4##2##(2008-10#4)
fruit become nearly immune to infection##2##6##(2008-10#2)
fruit blotch##3##2##(2008-10#3)
fruit by##4##2##(2008-10#3)(2008-11#1)
fruit clusters##5##2##(2008-10#5)
fruit collection##2##2##(2008-10#2)
fruit decay##2##2##(2008-10#2)
fruit development##15##2##(2008-10#6)(2008-9#9)
fruit developmental stage##2##3##(2008-10#2)
fruit developmental stages##5##3##(2008-10#5)
fruit developmental##7##2##(2008-10#7)
fruit disease incidence##3##3##(2008-10#3)
fruit disease##5##2##(2008-10#5)
fruit during##5##2##(1993-3#1)(2008-10#3)(2011-2#1)
fruit extract##3##2##(2008-11#1)(2008-5#2)
fruit flies##5##2##(2010-4#1)(2013-8#4)
fruit fly (Ceratitis##2##3##(2008-11#2)
fruit fly population##2##3##(2013-8#2)
fruit fly##12##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-9#2)(2010-1#1)(2010-5#1)(2013-8#4)
fruit from the##3##3##(2008-10#3)
fruit from##4##2##(2008-10#4)
fruit have##2##2##(2008-10#2)
fruit in the tree##3##4##(2008-10#3)
fruit in the##4##3##(2008-10#4)
fruit in##11##2##(2008-10#11)
fruit infection in##2##3##(2008-10#2)
fruit infection##6##2##(2008-10#6)
fruit juice##8##2##(2008-10#8)
fruit juices and##7##3##(2008-10#6)(2009-8#1)
fruit juices##17##2##(2008-10#16)(2009-8#1)
fruit mummies##2##2##(2008-10#2)
fruit of V##2##3##(2008-10#2)
fruit of##8##2##(2008-10#6)(2008-9#1)(2013-8#1)
fruit on the ground##2##4##(2008-10#2)
fruit on the##3##3##(2008-10#3)
fruit prior to shellacking##2##4##(2008-10#2)
fruit production##2##2##(2008-10#2)
fruit pulp extract##2##3##(2008-5#2)
fruit pulp##4##2##(2008-5#3)(2008-9#1)
fruit resistance##2##2##(2008-10#2)
fruit ripening and quality##2##4##(2011-2#2)
fruit ripening##6##2##(2008-10#1)(2011-2#5)
fruit rot##5##2##(2008-10#5)
fruit russet severity##3##3##(2008-10#3)
fruit russet##7##2##(2008-10#7)
fruit scab##4##2##(2008-10#4)
fruit set##5##2##(2008-10#5)
fruit showed that##2##3##(2008-10#1)(2008-9#1)
fruit showed##3##2##(2008-10#2)(2008-9#1)
fruit softening##4##2##(2008-10#2)(2011-2#2)
fruit susceptibility to latent infection##2##5##(2008-10#2)
fruit susceptibility to##3##3##(2008-10#3)
fruit susceptibility##8##2##(2008-10#8)
fruit that##2##2##(2008-10#2)
fruit tissue##5##2##(2008-10#5)
fruit tissues##4##2##(2008-10#4)
fruit to##3##2##(2008-10#3)
fruit treated by##2##3##(2008-10#2)
fruit tree##4##2##(2008-10#4)
fruit trees##7##2##(2008-10#7)
fruit was##3##2##(2008-10#3)
fruit were inoculated with P##2##5##(2008-10#2)
fruit were inoculated with##3##4##(2008-10#3)
fruit were inoculated##4##3##(2008-10#4)
fruit were##12##2##(2008-10#12)
fruit wetness sources##2##3##(2008-10#2)
fruit wetness##3##2##(2008-10#3)
fruit with##9##2##(2008-10#9)
fruit yield##5##2##(2008-10#5)
fruit##419##1##(1993-3#4)(1994-2#2)(1996-8#1)(1997-1#1)(1997-7#1)(2008-10#346)(2008-11#5)(2008-5#5)(2008-8#2)(2008-9#18)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#13)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#10)
fruit-rotting fungi in##2##3##(2008-10#2)
fruitful##6##1##(1997-8#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-10#1)(2012-2#1)
fruiting bodies and##2##3##(2008-10#2)
fruiting bodies from##3##3##(2008-10#2)(2009-8#1)
fruiting bodies were##2##3##(2008-10#2)
fruiting bodies##12##2##(2008-10#10)(2008-8#1)(2009-8#1)
fruiting body##5##2##(2008-10#1)(2008-8#2)(2009-8#1)(2011-2#1)
fruiting of##2##2##(2008-8#1)(2012-4#1)
fruiting##24##1##(2008-10#13)(2008-12#2)(2008-8#4)(2008-9#1)(2009-8#2)(2011-2#1)(2012-4#1)
fruits and leaves##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
fruits and vegetables##9##3##(1990-8#1)(1991-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
fruits and##17##2##(1990-8#1)(1991-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
fruits are##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
fruits collected in##2##3##(2012-2#2)
fruits in##3##2##(2008-10#3)
fruits is##2##2##(2008-10#1)(2008-11#1)
fruits may##2##2##(2008-10#2)
fruits of cv##2##3##(2008-10#2)
fruits of##9##2##(2008-10#5)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
fruits or##3##2##(1994-2#1)(2008-10#1)(2010-8#1)
fruits were##2##2##(2008-10#2)
fruits with##5##2##(2008-10#5)
fruits##114##1##(1990-8#1)(1991-2#1)(1993-11#1)(1994-2#1)(2007-12#1)(2008-10#66)(2008-11#8)(2008-12#5)(2008-4#2)(2008-8#3)(2008-9#6)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#8)(2012-3#1)(2012-4#1)(2013-1#2)
frustrated##4##1##(1992-11#1)(1997-3#1)(2011-2#1)(2012-2#1)
frustrating##4##1##(1994-1#1)(1994-12#1)(2010-6#1)(2013-8#1)
frustration and##2##2##(2008-12#1)(2009-10#1)
frustration##8##1##(1993-3#1)(1993-5#1)(1994-3#1)(1997-3#1)(2008-12#2)(2009-10#1)(2009-9#1)
frustrations##2##1##(1993-2#1)(1993-3#1)
frutescens##5##1##(2008-10#5)
fruticosa##4##1##(2008-10#1)(2008-11#3)
fry were##2##2##(1992-6#2)
fry##12##1##(1992-6#4)(2008-6#2)(2010-8#6)
frying or grilling##2##3##(1994-3#1)(1997-2#1)
frying##7##1##(1994-3#1)(1997-2#1)(2008-10#4)(2008-6#1)
fréquente##3##1##(2011-2#1)(2013-1#2)
fs##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
fsDNA over##3##2##(2008-10#3)
fsDNA##4##1##(2008-10#4)
ft##2##1##(2008-10#1)(2008-3#1)
ftz##4##1##(1993-9#4)
fuberidazole and thiabendazole in water##2##5##(2008-10#2)
fuberidazole and thiabendazole##3##3##(2008-10#3)
fuberidazole and##4##2##(2008-10#4)
fuberidazole##8##1##(2008-10#8)
fuckeliana##5##1##(1997-4#3)(2008-10#2)
fucoidan extracts on##3##3##(2008-11#3)
fucoidan extracts##10##2##(2008-11#10)
fucoidan##11##1##(2008-11#11)
fucose##9##1##(1990-8#5)(2008-11#3)(2008-5#1)
fucosylated##6##1##(1994-5#1)(2008-11#3)(2008-5#1)(2008-8#1)
fuel alcohol##3##2##(2008-10#3)
fuel ethanol##4##2##(2008-10#4)
fuel in##2##2##(2008-10#2)
fuel oil##2##2##(2008-10#2)
fuel spray##3##2##(2008-3#3)
fuel the##2##2##(2010-4#1)(2011-2#1)
fuel was##2##2##(2008-10#2)
fuel##48##1##(1990-8#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-3#9)(2008-7#2)(2009-3#1)(2009-8#2)(2010-12#1)(2010-4#2)(2011-2#1)
fuel-like fractions##2##2##(2008-10#2)
fuel-like##3##1##(2008-10#3)
fueled by##2##2##(1995-2#1)(1997-1#1)
fueled##4##1##(1995-2#1)(1997-1#1)(2008-11#1)(2009-5#1)
fuels and##5##2##(2008-10#4)(2012-3#1)
fuels##20##1##(2008-10#11)(2008-11#2)(2008-3#3)(2009-3#1)(2009-4#1)(2012-3#2)
fugax is##2##2##(2011-2#2)
fugax##3##1##(1992-5#1)(2011-2#2)
fujikuroi##6##1##(2008-10#3)(2008-5#3)
fulfil the requirements##2##3##(2008-10#2)
fulfil the##3##2##(1997-2#1)(2008-10#2)
fulfil##8##1##(1991-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2010-10#1)(2012-2#1)
fulfill a##2##2##(1993-8#1)(2010-1#1)
fulfill the##3##2##(1997-8#1)(2008-2#1)(2011-2#1)
fulfill##12##1##(1993-8#1)(1995-1#1)(1995-11#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-4#1)(2010-1#1)(2011-2#1)
fulfilled the diagnostic criteria for##2##5##(2008-7#1)(2013-1#1)
fulfilled the inclusion criteria##2##4##(2008-1#1)(2011-1#1)
fulfilled the inclusion##3##3##(2008-1#1)(2011-1#1)(2011-2#1)
fulfilled the##7##2##(2008-1#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
fulfilled##19##1##(1993-6#1)(1993-8#1)(1997-1#1)(2008-1#2)(2008-10#4)(2008-7#1)(2009-3#1)(2009-6#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
fulfilling the##4##2##(1990-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
fulfilling##8##1##(1990-9#1)(1994-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
fulfillment of##3##2##(1995-1#1)(2008-10#1)(2010-8#1)
fulfillment##6##1##(1995-1#2)(2008-10#2)(2008-11#1)(2010-8#1)
fulfills##3##1##(2008-10#2)(2008-12#1)
fulfils the##2##2##(1993-6#1)(2008-11#1)
fulgidum##2##1##(2008-11#2)
fulguration##2##1##(1995-1#1)(2008-10#1)
fulica##2##1##(1991-5#2)
full activity##3##2##(1993-8#1)(1995-2#1)(2008-10#1)
full agonists##2##2##(1995-11#1)(2008-11#1)
full and##3##2##(1994-3#1)(2008-10#1)(2008-12#1)
full bloom##5##2##(2008-10#5)
full complement of##2##3##(1992-8#1)(2010-8#1)
full control of the##2##4##(2008-10#1)(2012-2#1)
full control of##3##3##(2008-10#2)(2012-2#1)
full diffraction##2##2##(2008-3#2)
full exploitation of##3##3##(2007-11#1)(2008-7#1)(2011-1#1)
full face transplantation##2##3##(2013-1#2)
full face##3##2##(2013-1#3)
full facial##2##2##(2008-5#2)
full factorial design##6##3##(2008-10#6)
full factorial##8##2##(2008-10#7)(2008-11#1)
full fixed##2##2##(2011-7#2)
full hospitalization##2##2##(1991-1#2)
full information##2##2##(2008-10#2)
full length cDNA##3##3##(1991-9#2)(1997-7#1)
full length cDNAs##2##3##(1995-8#1)(2008-8#1)
full length##15##2##(1991-5#2)(1991-9#2)(1993-6#1)(1995-12#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2010-5#1)
full liver##2##2##(2010-12#1)(2012-2#1)
full measuring range##2##3##(2008-10#1)(2008-11#1)
full model##3##2##(2008-11#1)(2011-2#2)
full or##3##2##(2008-12#1)(2008-8#1)(2009-11#1)
full potential of##2##3##(1994-3#1)(2009-4#1)
full potential##3##2##(1994-3#1)(2008-11#1)(2009-4#1)
full range of motion##2##4##(2013-1#2)
full range of##6##3##(2008-10#2)(2008-7#2)(2013-1#2)
full recovery##6##2##(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
full scale##4##2##(1996-12#1)(2008-1#1)(2008-7#2)
full scan##3##2##(2008-10#2)(2008-3#1)
full siblings##2##2##(1995-6#2)
full sunlight##2##2##(2008-8#2)
full term infants##5##3##(1990-11#2)(2007-11#1)(2011-2#2)
full term##7##2##(1990-11#2)(2007-11#2)(2011-2#3)
full text screening##2##3##(2013-1#2)
full text##3##2##(2013-1#3)
full time##2##2##(2008-10#1)(2012-2#1)
full use of the##3##4##(2008-8#1)(2010-6#1)(2013-8#1)
full use of##4##3##(2008-8#1)(2010-6#1)(2012-3#1)(2013-8#1)
full width at half-maximum##3##4##(2007-12#1)(2008-2#2)
full##249##1##(1990-11#2)(1990-9#1)(1991-1#3)(1991-2#1)(1991-3#1)(1991-5#3)(1991-9#2)(1992-2#1)(1992-8#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-11#2)(1995-12#4)(1995-2#3)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#3)(2008-10#52)(2008-11#16)(2008-12#8)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#6)(2008-7#7)(2008-8#11)(2008-9#6)(2009-11#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#16)(2011-7#2)(2012-12#2)(2012-2#8)(2012-3#9)(2013-1#13)(2013-7#1)(2013-8#6)
full- and##2##2##(2008-10#1)(2008-3#1)
full-blown PCOS##2##2##(2008-4#2)
full-blown##5##1##(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#2)
full-length LysK##2##2##(2009-6#2)
full-length PCR##2##2##(2008-9#1)(2011-2#1)
full-length cDNA clone##5##3##(1994-11#1)(1994-6#1)(1997-3#1)(2008-10#2)
full-length cDNA clones of##3##4##(1995-8#1)(2008-10#2)
full-length cDNA clones##4##3##(1992-10#1)(1995-8#1)(2008-10#2)
full-length cDNA of##6##3##(1997-7#1)(2008-10#1)(2008-8#4)
full-length cDNA sequence##2##3##(1996-2#1)(2008-10#1)
full-length cDNA sequences##2##3##(1993-8#1)(2010-5#1)
full-length cDNA was##2##3##(1995-12#1)(1997-7#1)
full-length cDNA##35##2##(1991-9#1)(1992-10#1)(1993-8#2)(1994-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#2)(1997-2#4)(1997-3#1)(1997-7#2)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#7)(2010-5#1)
full-length cDNAs##3##2##(1993-2#1)(1997-2#1)(2009-10#1)
full-length clone##2##2##(1997-9#1)(2008-9#1)
full-length human##3##2##(1991-7#1)(1994-11#1)(1996-12#1)
full-length receptor##2##2##(1993-8#2)
full-length recombinant human##2##3##(1995-12#1)(2008-11#1)
full-length transcripts##2##2##(1996-2#1)(1997-2#1)
full-length##97##1##(1990-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#5)(1994-11#3)(1994-12#1)(1994-6#1)(1995-12#3)(1995-2#2)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#2)(1997-2#6)(1997-3#1)(1997-7#3)(1997-9#1)(2008-10#20)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#7)(2009-10#1)(2009-6#2)(2010-5#1)(2011-2#2)(2012-2#1)
full-scale##2##1##(2008-11#1)(2010-10#1)
full-scan##2##1##(2008-3#2)
full-sib##2##1##(2008-10#2)
full-size##2##1##(1993-6#1)(2011-2#1)
full-swing##4##1##(2011-2#4)
full-term infants##2##2##(2008-10#1)(2012-2#1)
full-term##6##1##(2008-10#1)(2008-11#3)(2011-2#1)(2012-2#1)
full-text access to##2##3##(1991-3#2)
full-text biomedical articles##3##3##(2010-12#3)
full-text biomedical##4##2##(2010-12#4)
full-text##9##1##(1991-2#2)(1991-3#2)(2010-12#4)(2012-12#1)
full-thickness##3##1##(2011-2#1)(2013-1#1)(2013-8#1)
full-time equivalent##2##2##(1991-3#1)(1993-12#1)
full-time use within 12 months##2##5##(2012-2#2)
full-time use within##3##3##(2012-2#3)
full-time##15##1##(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1996-1#1)(1996-3#2)(2008-11#2)(2012-2#3)
fuller##3##1##(2008-1#1)(2008-11#1)(2008-8#1)
fullerene soot##3##2##(2008-10#3)
fullness##3##1##(1993-6#1)(2011-2#1)(2012-3#1)
fullterm##2##1##(1993-12#2)
fully active##6##2##(1990-2#1)(1992-6#1)(2008-10#2)(2008-7#2)
fully appreciate the##2##3##(2008-9#1)(2012-3#1)
fully assembled##2##2##(2008-8#1)(2011-2#1)
fully automated and##2##3##(2008-10#2)
fully automated flow##2##3##(2008-10#2)
fully automated##18##2##(1993-2#1)(2008-10#15)(2008-11#2)
fully automation##2##2##(2008-10#2)
fully characterized##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
fully define the##2##3##(2009-7#1)(2011-3#1)
fully defined protein-free medium##2##4##(2008-11#2)
fully defined protein-free##3##3##(2008-11#3)
fully defined##4##2##(1995-2#1)(2008-11#3)
fully developed##7##2##(1991-2#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-8#2)(2011-2#1)
fully differentiated##3##2##(1990-11#1)(2008-11#1)(2009-12#1)
fully elucidated##7##2##(1990-2#1)(1991-6#1)(2007-11#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)
fully established##6##2##(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
fully explained by##3##3##(1992-8#1)(1997-3#1)(2010-8#1)
fully explained##4##2##(1992-8#1)(1997-3#1)(2008-11#1)(2010-8#1)
fully explore##2##2##(2008-10#1)(2010-4#1)
fully explored##2##2##(2008-7#1)(2009-7#1)
fully functional##2##2##(1992-8#1)(2008-11#1)
fully hydrated##2##2##(2008-5#2)
fully investigated##2##2##(2008-10#1)(2011-2#1)
fully kindled##2##2##(1990-5#1)(1996-12#1)
fully phased-in##2##2##(1996-3#2)
fully quantitative and##2##3##(2008-10#2)
fully recombinant##2##2##(2008-10#2)
fully recovered from##2##3##(2008-12#1)(2008-7#1)
fully recovered##5##2##(2008-12#1)(2008-7#3)(2013-1#1)
fully resistant##3##2##(2008-10#3)
fully resolved##2##2##(2008-8#1)(2009-6#1)
fully reversible and##2##3##(2008-10#2)
fully reversible##7##2##(1996-2#1)(2008-10#5)(2008-11#1)
fully saturated##2##2##(2012-2#2)
fully sequenced##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
fully support##2##2##(1992-3#1)(2009-6#1)
fully susceptible to##4##3##(2008-10#4)
fully susceptible##7##2##(2008-10#6)(2008-8#1)
fully understand##4##2##(1990-12#1)(1993-3#1)(2012-12#1)(2012-2#1)
fully understood##17##2##(1991-2#1)(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
fully validated##5##2##(2008-10#4)(2011-1#1)
fully##268##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#2)(2008-10#74)(2008-11#24)(2008-12#8)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#13)(2008-8#8)(2008-9#3)(2009-1#2)(2009-10#3)(2009-12#3)(2009-3#1)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#2)(2012-12#3)(2012-2#10)(2012-3#8)(2013-1#5)(2013-8#2)
fully-grown oocytes (phase V oocytes)##2##5##(2008-8#2)
fulminant hepatic failure##2##3##(1991-11#1)(1992-5#1)
fulminant liver failure##2##3##(2008-11#1)(2013-1#1)
fulminant##10##1##(1991-11#1)(1992-5#1)(1994-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#2)
fulvellum##2##1##(2008-10#1)(2008-11#1)
fulvic acid##9##2##(2008-10#9)
fulvic acids (FA)##3##3##(2008-10#3)
fulvic acids##9##2##(2008-10#9)
fulvic and humic acids##4##4##(2008-10#4)
fulvic##23##1##(2008-10#23)
fumagillol (TNP-470)##2##2##(1994-12#2)
fumarate reductase##3##2##(1996-8#3)
fumarate##5##1##(1993-8#1)(1996-8#3)(2013-1#1)
fumaric acid##5##2##(2008-10#5)
fume##12##1##(2008-10#12)
fumes##2##1##(1992-6#1)(2008-10#1)
fumigant emissions##2##2##(2008-10#2)
fumigant##5##1##(2008-10#5)
fumigants will##2##2##(2008-10#2)
fumigants##11##1##(2008-10#11)
fumigated control##2##2##(2008-10#2)
fumigated field soil##2##3##(2008-10#2)
fumigated field##3##2##(2008-10#3)
fumigated or nonfumigated soil##2##4##(2008-10#2)
fumigated plots##3##2##(2008-10#3)
fumigated poplars##2##2##(2008-11#2)
fumigated soil##2##2##(2008-10#2)
fumigated versus##2##2##(2008-10#2)
fumigated with##2##2##(2008-10#2)
fumigated##21##1##(2008-10#19)(2008-11#2)
fumigation with methyl bromide##4##4##(2008-10#4)
fumigation with##5##2##(2008-10#5)
fumigation##11##1##(1995-3#1)(2008-10#9)(2008-11#1)
fumigatus##6##1##(2008-10#3)(2008-9#1)(2012-3#1)(2013-1#1)
fuming sulphuric acid##2##3##(2008-10#2)
fumonisin B(1)##3##2##(2008-10#3)
fumonisin B(2)##2##2##(2008-10#2)
fumonisin and aflatoxin##2##3##(2008-10#2)
fumonisin and##3##2##(2008-10#3)
fumonisin concentration in grain##2##4##(2008-10#2)
fumonisin concentration##5##2##(2008-10#3)(2013-1#2)
fumonisin contamination##6##2##(2008-10#6)
fumonisin in##2##2##(2008-10#1)(2013-1#1)
fumonisin production##4##2##(2008-10#2)(2013-1#2)
fumonisin##33##1##(2008-10#27)(2013-1#6)
fumonisin-producing fungus added##3##3##(2013-1#3)
fumonisin-producing fungus##4##2##(2013-1#4)
fumonisins##6##1##(2008-10#5)(2010-7#1)
fun##3##1##(1996-12#1)(2009-10#1)(2013-1#1)
function after##5##2##(1992-12#1)(1993-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
function against##2##2##(2008-10#1)(2008-5#1)
function also##2##2##(2013-1#2)
function alterations##2##2##(2008-7#2)
function analyses##2##2##(2008-7#1)(2012-2#1)
function analysis of##2##3##(2008-8#1)(2008-9#1)
function analysis##4##2##(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
function and a##2##3##(2008-8#1)(2012-12#1)
function and activation##2##3##(1995-8#1)(2011-1#1)
function and an##2##3##(1991-12#1)(2008-10#1)
function and clinical##2##3##(1995-12#1)(1997-1#1)
function and formation##2##3##(2008-5#2)
function and have##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
function and in##2##3##(2007-11#1)(2008-10#1)
function and integrity##2##3##(2011-2#1)(2013-1#1)
function and social##5##3##(2009-10#4)(2013-8#1)
function and the production of reactive oxygen##2##7##(1994-5#2)
function and the##7##3##(1992-12#1)(1994-5#2)(1997-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
function and##103##2##(1990-12#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-12#2)(1992-6#2)(1994-12#4)(1994-5#2)(1994-6#1)(1995-12#1)(1995-8#1)(1995-9#2)(1997-1#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#5)(2009-12#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#4)
function are associated with##2##4##(1991-10#1)(1993-12#1)
function are reviewed##2##3##(1991-1#1)(1991-6#1)
function are##12##2##(1991-1#1)(1991-10#1)(1991-6#1)(1992-12#1)(1993-12#1)(2008-11#2)(2008-3#2)(2008-9#2)(2013-1#1)
function as a##16##3##(1995-11#1)(1995-2#2)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-3#1)
function as the##2##3##(1993-12#1)(2008-5#1)
function as well as##2##4##(1996-2#1)(2008-11#1)
function as##46##2##(1992-6#1)(1992-9#2)(1993-12#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#4)(2013-1#1)
function assays##3##2##(2008-10#2)(2012-12#1)
function associated##2##2##(2007-12#1)(2013-8#1)
function at the##3##3##(1997-7#1)(2008-8#1)(2011-2#1)
function at##8##2##(1995-6#1)(1997-7#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)
function based on##3##3##(2008-10#1)(2011-3#1)(2013-1#1)
function best when##2##3##(1993-12#1)(2008-10#1)
function both##2##2##(2008-9#1)(2009-9#1)
function by##17##2##(1990-5#1)(1992-9#1)(1995-11#1)(1995-2#2)(1997-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
function can be##3##3##(1993-9#1)(1995-11#1)(2013-1#1)
function can##7##2##(1993-9#1)(1995-11#1)(2008-3#2)(2008-7#1)(2011-3#1)(2013-1#1)
function characterized the##2##3##(2008-10#2)
function coefficients##3##2##(2011-2#3)
function control##2##2##(2008-11#1)(2008-8#1)
function could be##2##3##(2008-7#1)(2012-3#1)
function could##3##2##(1992-12#1)(2008-7#1)(2012-3#1)
function derived from the##2##4##(2008-10#1)(2008-11#1)
function describing the##2##3##(2008-10#2)
function development##2##2##(1996-1#1)(2008-5#1)
function during##7##2##(1993-9#1)(1995-6#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
function following##11##2##(1991-2#3)(1992-3#1)(2008-11#1)(2008-9#1)(2010-6#3)(2013-1#2)
function for a##2##3##(1992-12#1)(2011-3#1)
function for the##9##3##(1994-3#1)(1996-1#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
function for##27##2##(1992-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
function from##3##2##(1992-3#1)(1997-8#1)(2008-6#1)
function has been##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
function has##7##2##(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
function have been##2##3##(2006-6#1)(2010-10#1)
function impairment##3##2##(1990-12#1)(1996-5#1)(2008-10#1)
function in PD##2##3##(2008-7#1)(2011-2#1)
function in a##5##3##(1991-2#1)(2008-11#1)(2008-5#2)(2013-1#1)
function in adult##2##3##(1992-12#1)(2008-10#1)
function in animals##2##3##(2008-11#1)(2009-8#1)
function in children with obesity##2##5##(2008-12#2)
function in healthy##2##3##(2008-7#1)(2011-2#1)
function in idiopathic##2##3##(1997-8#1)(2008-7#1)
function in patients with##5##4##(2008-12#1)(2009-10#1)(2011-2#2)(2013-1#1)
function in patients##8##3##(2008-12#1)(2009-10#1)(2011-2#4)(2013-1#2)
function in rats##3##3##(2008-10#1)(2008-4#1)(2010-12#1)
function in regulating##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
function in subjects with##2##4##(2011-2#1)(2012-2#1)
function in the##22##3##(1992-3#1)(1992-6#2)(1995-12#1)(1995-2#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
function in these##3##3##(1995-2#1)(2011-2#1)(2012-3#1)
function in this##3##3##(1992-11#1)(2010-4#1)(2013-1#1)
function in vivo##3##3##(1995-6#1)(2008-5#1)(2010-11#1)
function in##138##2##(1990-11#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#2)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#12)(2008-11#9)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#5)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#12)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#6)(2013-8#2)
function increases##2##2##(2008-5#1)(2008-9#1)
function indices##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
function is also##3##3##(2008-3#1)(2008-9#1)(2009-1#1)
function is discussed##2##3##(1992-9#1)(2009-8#1)
function is not##4##3##(1993-12#1)(1993-8#1)(1995-6#1)(2008-5#1)
function is now##2##3##(1993-11#1)(2008-6#1)
function is proposed##2##3##(2008-12#1)(2008-3#1)
function is the##3##3##(2008-7#1)(2010-1#1)(2011-3#1)
function is to##2##3##(2008-7#1)(2009-8#1)
function is used##2##3##(2008-2#1)(2011-2#1)
function is##51##2##(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-8#2)(2010-1#1)(2010-4#1)(2011-2#3)(2011-3#2)(2012-2#1)(2013-1#2)
function may be##2##3##(1991-5#1)(1992-12#1)
function may##3##2##(1991-5#1)(1992-12#1)(1994-2#1)
function might be##2##3##(1997-7#1)(2008-5#1)
function might##3##2##(1997-7#1)(2007-12#1)(2008-5#1)
function not##2##2##(2008-10#1)(2009-4#1)
function of Krüppel homolog 1##2##5##(2012-2#2)
function of NifA central domain##4##5##(2008-9#4)
function of NifA##5##3##(2008-9#5)
function of PurR##2##3##(2008-8#2)
function of T-CD4 T cells##2##5##(2012-12#2)
function of a##10##3##(1993-1#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)
function of age##3##3##(1995-8#2)(2010-3#1)
function of an##2##3##(2008-3#1)(2008-4#1)
function of analyte##2##3##(2008-10#2)
function of disease##3##3##(2008-1#1)(2008-10#2)
function of each##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
function of human##4##3##(1995-6#2)(2006-6#1)(2008-11#1)
function of kidneys##2##3##(2011-3#1)(2012-3#1)
function of neural##2##3##(2008-9#1)(2013-8#1)
function of pH at##2##4##(2008-10#2)
function of pH##15##3##(1990-5#1)(1996-12#1)(2008-10#13)
function of particle size##4##4##(2008-10#4)
function of proteins##2##3##(2008-2#1)(2008-7#1)
function of sawB##2##3##(2008-8#2)
function of the amount of##2##5##(1996-3#1)(2008-10#1)
function of the concentration of##2##5##(2008-10#2)
function of the density of##3##5##(2008-10#2)(2008-8#1)
function of the left##3##4##(1991-2#1)(2008-7#1)(2013-1#1)
function of the number of##4##5##(2008-5#3)(2008-8#1)
function of the plant##2##4##(2009-8#2)
function of the polarization##2##4##(2008-3#2)
function of the stratum corneum##2##5##(2008-5#2)
function of the time##3##4##(2008-10#2)(2008-11#1)
function of the##156##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-12#4)(2008-10#28)(2008-11#9)(2008-3#18)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#2)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#5)(2012-3#3)(2013-1#4)
function of these##7##3##(1995-2#1)(2008-11#1)(2008-2#1)(2008-9#2)(2013-1#1)(2013-8#1)
function of this##8##3##(1992-3#1)(1993-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#2)
function of time##18##3##(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2010-4#1)(2010-7#1)
function of total##2##3##(2008-9#1)(2010-10#1)
function of##524##2##(1990-10#1)(1990-12#2)(1990-5#4)(1991-1#3)(1991-11#3)(1991-2#3)(1991-3#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#5)(1995-8#7)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#9)(1996-3#4)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#3)(2007-12#7)(2007-8#1)(2008-1#3)(2008-10#117)(2008-11#33)(2008-12#2)(2008-2#6)(2008-3#37)(2008-4#13)(2008-5#18)(2008-6#8)(2008-7#15)(2008-8#28)(2008-9#41)(2009-10#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#8)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#7)(2011-3#4)(2012-12#2)(2012-2#12)(2012-3#9)(2012-4#1)(2013-1#11)(2013-8#5)
function on##2##2##(1994-6#1)(2008-10#1)
function optimally##2##2##(1994-2#1)(2011-2#1)
function or##4##2##(1994-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
function parameters##3##2##(2008-7#1)(2009-12#1)(2013-8#1)
function relating##2##2##(1992-12#1)(1993-6#1)
function remained##2##2##(2008-5#1)(2008-7#1)
function remains##2##2##(2008-4#1)(2010-6#1)
function represents##2##2##(2008-3#1)(2011-1#1)
function requires##2##2##(1993-8#1)(2010-12#1)
function restriction##2##2##(1990-9#2)
function resulting in##2##3##(2008-1#1)(2009-1#1)
function should be##2##3##(2008-3#1)(2009-8#1)
function specificity##3##2##(2011-2#3)
function status##2##2##(2008-7#1)(2009-8#1)
function studies##2##2##(2008-9#1)(2011-1#1)
function such as##3##3##(1995-11#1)(2008-5#1)(2010-9#1)
function suppression##2##2##(1994-2#1)(2008-8#1)
function test##3##2##(1997-2#1)(2008-4#1)(2011-1#1)
function testing in##2##3##(2008-10#1)(2008-4#1)
function testing##7##2##(1991-7#1)(2008-10#2)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
function tests and##4##3##(1996-1#1)(1996-3#1)(1997-2#1)(2008-7#1)
function tests in##2##3##(1996-11#1)(2008-4#1)
function tests were normal##3##4##(2007-12#1)(2008-7#1)(2012-12#1)
function tests##20##2##(1991-12#2)(1991-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#3)(2011-1#1)(2012-12#1)(2012-2#2)
function than##3##2##(2012-2#1)(2013-1#2)
function that is##2##3##(2008-9#1)(2010-10#1)
function that##15##2##(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)(2008-9#1)(2009-7#1)(2010-10#2)(2013-8#2)
function through##4##2##(1992-6#1)(1994-12#1)(2010-7#1)(2013-8#1)
function to##20##2##(1991-10#1)(1992-12#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#2)(2009-8#2)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
function under##2##2##(2010-10#1)(2013-1#1)
function was assessed##2##3##(2008-5#1)(2013-1#1)
function was not##2##3##(1991-9#1)(1994-5#1)
function was restored##2##3##(2012-12#1)(2012-3#1)
function was##25##2##(1991-10#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
function were##5##2##(1995-11#1)(2008-10#1)(2008-8#1)(2013-1#2)
function which##3##2##(1991-2#1)(2008-11#1)(2012-3#1)
function will##2##2##(1991-2#1)(1994-5#1)
function with##10##2##(1990-11#1)(1991-5#1)(1994-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
function within##2##2##(2009-8#1)(2013-1#1)
function##1706##1##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#1)(1990-5#8)(1990-8#1)(1990-9#4)(1991-1#6)(1991-10#3)(1991-11#4)(1991-12#8)(1991-2#11)(1991-3#4)(1991-5#8)(1991-6#5)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#17)(1992-3#10)(1992-5#1)(1992-6#16)(1992-9#10)(1993-1#1)(1993-11#3)(1993-12#11)(1993-2#2)(1993-3#5)(1993-6#9)(1993-8#6)(1993-9#5)(1994-1#1)(1994-11#1)(1994-12#9)(1994-2#4)(1994-3#4)(1994-5#21)(1994-6#2)(1994-8#3)(1994-9#5)(1995-11#8)(1995-12#6)(1995-2#15)(1995-3#3)(1995-5#5)(1995-6#15)(1995-8#11)(1995-9#5)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#17)(1996-3#9)(1996-5#4)(1996-6#2)(1996-8#1)(1997-1#6)(1997-2#8)(1997-3#7)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#5)(2006-6#8)(2007-11#3)(2007-12#14)(2007-8#2)(2008-1#10)(2008-10#247)(2008-11#80)(2008-12#15)(2008-2#10)(2008-3#93)(2008-4#36)(2008-5#50)(2008-6#22)(2008-7#62)(2008-8#75)(2008-9#100)(2009-1#4)(2009-10#22)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#2)(2009-5#7)(2009-6#5)(2009-7#11)(2009-8#26)(2009-9#5)(2010-1#5)(2010-10#18)(2010-11#12)(2010-12#11)(2010-3#2)(2010-4#7)(2010-5#8)(2010-6#8)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#6)(2011-2#85)(2011-3#15)(2011-7#1)(2012-12#12)(2012-2#64)(2012-3#33)(2012-4#1)(2013-1#77)(2013-7#3)(2013-8#36)
function&quot##3##1##(2009-10#1)(2009-5#1)(2013-1#1)
function)##8##1##(1992-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#2)(2011-2#1)
function]##3##1##(1993-11#1)(1996-3#1)(1997-6#1)
functional MRI##3##2##(2008-11#1)(2009-9#2)
functional RNA-protein complexes##2##3##(2008-2#2)
functional T-cell##2##2##(1995-2#1)(2008-10#1)
functional ability of##2##3##(2009-12#1)(2013-1#1)
functional ability##5##2##(2009-12#1)(2011-8#1)(2013-1#3)
functional activities##4##2##(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
functional activity in##2##3##(2008-5#1)(2013-1#1)
functional activity of##3##3##(1993-6#1)(2008-10#1)(2008-7#1)
functional activity##17##2##(1993-6#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#2)(2008-8#3)(2011-2#1)(2013-1#2)
functional alterations of##3##3##(1997-6#1)(2008-1#1)(2009-6#1)
functional alterations##5##2##(1991-5#1)(1995-2#1)(1997-6#1)(2008-1#1)(2009-6#1)
functional analyses##3##2##(1995-6#1)(2011-2#1)(2012-2#1)
functional analysis of a##3##4##(2008-8#3)
functional analysis of the##4##4##(2008-10#1)(2008-11#2)(2009-9#1)
functional analysis of these##2##4##(2008-10#1)(2008-4#1)
functional analysis of##15##3##(1997-7#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2011-3#1)
functional analysis##21##2##(1993-6#1)(1995-6#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-4#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-4#1)(2011-3#1)
functional and cognitive status and the##2##6##(2008-7#2)
functional and effective##2##3##(2008-12#2)
functional and##17##2##(1990-3#1)(1991-3#1)(1991-6#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2011-2#2)(2012-2#2)(2013-8#1)
functional and/or##2##2##(2008-10#1)(2008-4#1)
functional annotation##2##2##(2011-2#2)
functional applications##2##2##(2008-10#1)(2008-9#1)
functional architecture##2##2##(2009-5#2)
functional aspects of##3##3##(1992-9#1)(1995-3#1)(2008-5#1)
functional aspects##4##2##(1992-9#1)(1995-3#1)(2008-11#1)(2008-5#1)
functional assays in##2##3##(1991-5#1)(2008-9#1)
functional assays##10##2##(1991-5#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-4#3)(2008-8#1)(2008-9#1)(2012-2#1)
functional assessment of##2##3##(2012-3#1)(2013-8#1)
functional assessment##7##2##(1997-2#1)(2010-9#1)(2012-3#2)(2013-1#2)(2013-8#1)
functional assignment##2##2##(2009-8#2)
functional behavior##2##2##(2008-2#1)(2008-9#1)
functional binding##2##2##(1991-5#2)
functional bladder##3##2##(2008-10#3)
functional brain imaging##4##3##(2009-5#3)(2013-8#1)
functional capacity and##2##3##(2010-10#1)(2012-12#1)
functional capacity##5##2##(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
functional categories##2##2##(2008-10#2)
functional changes in##2##3##(2012-2#1)(2012-3#1)
functional changes##5##2##(1990-11#1)(1994-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
functional characteristics of##4##3##(1991-3#1)(1995-3#1)(2008-7#1)(2011-2#1)
functional characteristics##5##2##(1991-3#1)(1994-12#1)(1995-3#1)(2008-7#1)(2011-2#1)
functional characterization of##5##3##(1995-2#1)(2008-11#3)(2009-6#1)
functional characterization##6##2##(1995-2#1)(2008-11#3)(2009-6#1)(2009-9#1)
functional class##4##2##(2009-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
functional complementation##3##2##(1995-12#1)(2008-9#1)(2009-10#1)
functional connections##2##2##(2008-11#1)(2013-1#1)
functional connectivity##2##2##(2013-1#2)
functional consequences of##3##3##(2008-9#1)(2009-12#1)(2013-1#1)
functional consequences##5##2##(1993-8#1)(2008-9#1)(2009-12#1)(2013-1#2)
functional data##2##2##(2008-11#1)(2011-1#1)
functional defects in##2##3##(1991-2#1)(2008-10#1)
functional differences between##3##3##(1994-2#1)(1994-5#1)(2008-11#1)
functional differences##5##2##(1993-2#1)(1994-2#1)(1994-5#1)(1995-8#1)(2008-11#1)
functional disability##4##2##(1993-3#1)(1995-2#1)(2008-7#1)(2013-1#1)
functional diversity of##4##3##(1996-2#1)(2008-10#1)(2008-2#1)(2009-10#1)
functional diversity##6##2##(1996-2#1)(1997-9#1)(2008-10#2)(2008-2#1)(2009-10#1)
functional domain of##2##3##(2008-9#2)
functional domain##3##2##(2008-9#2)(2009-8#1)
functional domains##10##2##(1990-5#1)(1990-7#1)(1992-3#1)(1993-12#1)(1997-3#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
functional effects of##3##3##(1997-4#3)
functional effects##6##2##(1995-2#1)(1997-4#3)(2012-2#2)
functional endpoints##4##2##(2008-10#1)(2008-11#3)
functional enzyme##2##2##(1997-7#1)(2011-1#1)
functional equivalence##2##2##(1995-6#1)(2008-11#1)
functional evaluation##2##2##(2008-11#1)(2011-2#1)
functional examination##2##2##(1992-10#1)(2009-10#1)
functional expression of the##3##4##(1993-8#1)(1994-8#1)(2008-6#1)
functional expression of##5##3##(1993-8#1)(1994-12#1)(1994-8#1)(2008-6#1)(2011-2#1)
functional expression##7##2##(1992-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-6#1)(2011-2#1)
functional food##2##2##(2008-10#1)(2010-1#1)
functional form of##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
functional form##9##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#2)
functional genes##2##2##(1993-12#1)(1994-5#1)
functional genomics##10##2##(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#4)(2009-4#1)(2011-2#2)
functional glutamate transporters##3##3##(2008-7#3)
functional group has##2##3##(2008-10#2)
functional group in the##2##4##(2008-10#2)
functional group was##2##3##(2008-10#2)
functional group##22##2##(2008-10#13)(2008-11#1)(2008-8#6)(2011-2#2)
functional groups and##3##3##(1994-9#1)(2008-10#2)
functional groups are##2##3##(2008-10#2)
functional groups as##2##3##(2008-10#1)(2008-5#1)
functional groups in##2##3##(2008-10#1)(2008-7#1)
functional groups of the##2##4##(2008-10#1)(2009-7#1)
functional groups of##9##3##(2008-10#6)(2008-8#1)(2009-7#1)(2009-8#1)
functional groups on the##2##4##(1994-9#1)(2008-10#1)
functional groups such as##3##4##(1996-5#2)(2008-10#1)
functional groups to##2##3##(2008-10#1)(2011-2#1)
functional groups##37##2##(1994-9#4)(1996-5#2)(1997-2#1)(2008-10#22)(2008-5#1)(2008-7#1)(2008-8#3)(2009-7#1)(2009-8#1)(2011-2#1)
functional human##5##2##(1993-8#1)(2008-2#1)(2012-2#3)
functional imaging##3##2##(2008-11#1)(2009-5#1)(2012-2#1)
functional immunoglobulin##2##2##(1997-7#2)
functional impairment##8##2##(1991-6#1)(1997-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#1)
functional impairments##2##2##(2009-10#1)(2011-2#1)
functional implications for##2##3##(1996-2#1)(2011-2#1)
functional implications##4##2##(1996-2#1)(2009-10#1)(2011-2#1)(2012-2#1)
functional importance in##2##3##(2010-5#2)
functional importance of##5##3##(1994-5#1)(1995-6#1)(2009-5#1)(2012-6#1)(2013-1#1)
functional importance##9##2##(1994-5#1)(1995-6#1)(2008-9#2)(2009-5#1)(2010-5#2)(2012-6#1)(2013-1#1)
functional in##7##2##(1991-7#1)(1992-8#1)(1993-2#1)(1996-3#2)(2008-10#1)(2008-12#1)
functional inhibition##2##2##(2008-9#1)(2013-1#1)
functional interaction##2##2##(2009-8#1)(2012-3#1)
functional interactions between##3##3##(1993-6#1)(2008-4#1)(2012-3#1)
functional interactions##4##2##(1993-6#1)(2008-4#2)(2012-3#1)
functional iron##2##2##(1992-8#1)(2008-1#1)
functional level and##2##3##(1991-1#1)(2013-1#1)
functional loss##2##2##(1992-12#1)(2008-10#1)
functional magnetic resonance imaging (fMRI) study##2##6##(2008-11#1)(2013-8#1)
functional magnetic resonance imaging (fMRI)##8##5##(2008-11#5)(2009-9#1)(2010-7#1)(2013-8#1)
functional magnetic resonance imaging##14##4##(1994-3#1)(2008-11#9)(2008-5#1)(2009-9#1)(2010-7#1)(2013-8#1)
functional magnetic##15##2##(1994-3#1)(2008-11#10)(2008-5#1)(2009-9#1)(2010-7#1)(2013-8#1)
functional map##2##2##(2008-11#1)(2008-7#1)
functional maturation of the##3##4##(2008-5#1)(2011-2#2)
functional maturation##4##2##(2008-5#1)(2008-8#1)(2011-2#2)
functional monomer##5##2##(2008-10#5)
functional monomers##2##2##(2008-10#2)
functional morphology and prey selection##2##5##(2010-8#2)
functional morphology##4##2##(2007-12#1)(2010-8#3)
functional neuroimaging##6##2##(2008-11#1)(2008-4#1)(2009-9#2)(2013-8#2)
functional neuromuscular stimulation##2##3##(2013-1#2)
functional optical coherence tomography##2##4##(2007-11#2)
functional or##4##2##(1995-3#1)(2008-11#2)(2008-8#1)
functional organization of the##2##4##(2008-8#2)
functional organization of##4##3##(2008-8#3)(2009-5#1)
functional organization##6##2##(2007-12#1)(2008-11#1)(2008-8#3)(2009-5#1)
functional outcome after##2##3##(2008-7#1)(2012-3#1)
functional outcome##7##2##(2007-8#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#2)
functional outcomes in##3##3##(2009-10#1)(2012-2#1)(2013-1#1)
functional outcomes##10##2##(2009-10#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)
functional parameters of##2##3##(2008-11#1)(2008-9#1)
functional plasticity##3##2##(2008-1#1)(2008-7#2)
functional principal component analysis##2##4##(2010-7#2)
functional prognosis##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
functional properties of both the##2##5##(2008-4#1)(2008-5#1)
functional properties of the##2##4##(1991-2#1)(2008-5#1)
functional properties of##11##3##(1991-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-4#1)
functional properties##15##2##(1991-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-4#3)
functional receptor##3##2##(1993-2#1)(1993-8#1)(1995-8#1)
functional reconstitution##3##2##(1991-5#2)(1995-2#1)
functional recovery after hip fracture##2##5##(2008-8#2)
functional recovery after##3##3##(1994-8#1)(2008-8#2)
functional recovery of##2##3##(2008-7#1)(2011-3#1)
functional recovery##11##2##(1994-8#2)(1996-12#1)(2008-12#1)(2008-7#2)(2008-8#2)(2011-2#1)(2011-3#1)(2013-1#1)
functional relationship##3##2##(1994-3#1)(1995-9#1)(2008-5#1)
functional relationships among##2##3##(2008-10#1)(2008-8#1)
functional response of##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
functional response##4##2##(2008-10#1)(2008-8#2)(2010-8#1)
functional responses of##2##3##(1996-2#1)(2008-8#1)
functional responses##12##2##(1995-11#1)(1995-6#1)(1996-2#1)(2008-8#7)(2008-9#1)(2010-1#1)
functional restoration of##2##3##(1995-9#1)(2008-11#1)
functional restoration##3##2##(1995-9#1)(2008-11#1)(2008-4#1)
functional results##9##2##(1991-9#1)(2007-8#1)(2008-10#1)(2008-9#2)(2013-1#4)
functional role for##3##3##(1990-8#1)(1995-11#1)(2008-11#1)
functional role in##2##3##(2012-2#1)(2013-1#1)
functional role of CNG channels in##2##6##(2009-10#2)
functional role of the##2##4##(1994-8#1)(2008-11#1)
functional role of##19##3##(1993-3#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-6#1)(2008-11#2)(2008-8#1)(2009-10#3)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
functional role##30##2##(1990-8#1)(1993-3#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-6#1)(1997-7#1)(2008-11#4)(2008-8#1)(2009-1#1)(2009-10#3)(2009-8#1)(2009-9#1)(2011-2#4)(2012-2#2)(2013-1#2)
functional roles##5##2##(1993-3#1)(1994-5#1)(2009-10#1)(2012-2#1)(2012-3#1)
functional screen##2##2##(2008-4#1)(2011-1#1)
functional significance of##9##3##(1995-2#2)(1995-6#1)(2008-11#1)(2008-7#1)(2009-1#1)(2012-2#2)(2012-3#1)
functional sites##2##2##(1993-6#1)(2008-9#1)
functional state of##4##3##(2008-2#1)(2010-8#2)(2013-1#1)
functional status##12##2##(1992-2#1)(1994-5#1)(1995-2#2)(1995-3#1)(1997-8#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)
functional studies are##2##3##(2012-2#1)(2013-1#1)
functional studies##15##2##(1993-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#3)(2012-2#3)(2013-1#1)
functional test##3##2##(1991-3#1)(2008-10#2)
functional unit that##2##3##(2009-10#1)(2011-2#1)
functional use##2##2##(1994-8#1)(2008-4#1)
functional##889##1##(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#9)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#4)(1993-1#1)(1993-12#8)(1993-2#6)(1993-3#4)(1993-6#9)(1993-8#6)(1993-9#4)(1994-1#3)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#8)(1994-6#1)(1994-8#10)(1994-9#4)(1995-11#5)(1995-12#5)(1995-2#17)(1995-3#9)(1995-5#1)(1995-6#8)(1995-8#4)(1995-9#4)(1996-12#2)(1996-2#10)(1996-3#4)(1996-5#4)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#9)(1997-8#3)(1997-9#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-1#5)(2008-10#109)(2008-11#74)(2008-12#7)(2008-2#7)(2008-3#1)(2008-4#19)(2008-5#15)(2008-6#3)(2008-7#40)(2008-8#43)(2008-9#32)(2009-1#3)(2009-10#27)(2009-12#5)(2009-3#1)(2009-4#3)(2009-5#9)(2009-6#3)(2009-7#4)(2009-8#10)(2009-9#9)(2010-1#3)(2010-10#6)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#9)(2010-9#2)(2011-1#5)(2011-2#37)(2011-3#5)(2011-7#1)(2011-8#2)(2012-12#5)(2012-2#37)(2012-3#19)(2012-6#1)(2013-1#52)(2013-8#12)
functionalised with##4##2##(2008-10#4)
functionalised##10##1##(2008-10#9)(2009-10#1)
functionalities##6##1##(1997-2#1)(2008-10#4)(2008-5#1)
functionality and##3##2##(2008-9#1)(2009-10#1)(2013-1#1)
functionality but##2##2##(2011-1#1)(2012-3#1)
functionality of a##2##3##(2009-7#1)(2013-1#1)
functionality of##9##2##(1990-5#1)(2008-10#3)(2008-9#1)(2009-7#1)(2012-3#1)(2012-6#1)(2013-1#1)
functionality##37##1##(1990-12#1)(1990-5#1)(1991-3#1)(2008-10#6)(2008-11#3)(2008-5#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#2)
functionalization of##4##2##(2008-10#2)(2008-5#1)(2009-10#1)
functionalization##5##1##(2008-10#3)(2008-5#1)(2009-10#1)
functionalized by coupling it##2##4##(2008-10#2)
functionalized by##4##2##(2008-10#3)(2010-6#1)
functionalized nanoparticles##2##2##(2008-10#2)
functionalized on##2##2##(2011-2#2)
functionalized polymers##4##2##(2008-10#3)(2008-3#1)
functionalized resin##4##2##(2008-10#4)
functionalized with carboxylic groups##2##4##(2008-10#2)
functionalized with the##2##3##(2008-10#1)(2008-4#1)
functionalized with##16##2##(2008-10#14)(2008-4#1)(2010-1#1)
functionalized##58##1##(1994-9#1)(1996-5#2)(2008-10#45)(2008-3#1)(2008-4#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#2)
functionally active##5##2##(1992-12#1)(1996-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
functionally characterized##2##2##(2009-10#1)(2012-2#1)
functionally conserved##2##2##(1993-12#1)(2009-9#1)
functionally dependent##2##2##(1994-1#1)(2008-1#1)
functionally different##2##2##(2008-9#1)(2013-1#1)
functionally distinct##6##2##(1990-5#1)(1993-8#1)(1994-3#1)(1997-2#1)(2008-4#1)(2013-8#1)
functionally expressed in##2##3##(1994-8#1)(1996-2#1)
functionally identified##2##2##(1990-5#1)(1994-12#1)
functionally important##3##2##(1993-8#1)(2008-10#1)(2010-1#1)
functionally redundant##4##2##(1993-12#1)(2008-11#1)(2009-10#2)
functionally related##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
functionally relevant##3##2##(1992-12#1)(1995-12#1)(2009-5#1)
functionally similar##3##2##(1990-7#1)(2008-10#1)(2011-2#1)
functionally to##2##2##(1993-2#1)(2008-9#1)
functionally##94##1##(1990-5#3)(1990-7#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-8#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#4)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#9)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#4)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
functionals##3##1##(2010-7#3)
functioned as a##2##3##(1991-10#1)(2008-10#1)
functioned as##5##2##(1991-10#1)(2008-10#3)(2011-1#1)
functioned##8##1##(1991-10#1)(1992-5#1)(2008-10#4)(2008-8#1)(2011-1#1)
functioning (e##2##2##(2008-7#1)(2013-1#1)
functioning and##10##2##(1991-6#1)(2008-10#1)(2008-7#3)(2008-9#1)(2011-2#2)(2013-1#2)
functioning as##6##2##(1994-2#1)(1995-2#1)(2008-10#2)(2011-1#1)(2013-1#1)
functioning at##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
functioning in the##3##3##(2008-7#1)(2009-11#1)(2013-1#1)
functioning in##12##2##(1993-1#1)(2008-11#2)(2008-12#1)(2008-7#3)(2009-10#1)(2009-11#1)(2010-7#2)(2013-1#1)
functioning is##4##2##(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)
functioning of children##2##3##(2008-11#1)(2008-12#1)
functioning of the##10##3##(1991-3#1)(1992-1#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)(2012-6#1)
functioning of##20##2##(1991-3#1)(1992-1#1)(1993-6#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-1#1)
functioning primarily by##2##3##(2008-10#2)
functioning##124##1##(1990-11#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#2)(1995-2#3)(1995-3#1)(1997-2#1)(1997-8#2)(2008-1#2)(2008-10#10)(2008-11#14)(2008-12#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-7#4)(2010-9#3)(2011-1#3)(2011-2#7)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#14)(2013-8#2)
functions and the##3##3##(1996-2#1)(2008-11#1)(2013-7#1)
functions and their##3##3##(1995-12#2)(2009-4#1)
functions and##27##2##(1992-5#1)(1992-9#2)(1993-8#1)(1995-12#2)(1996-2#2)(1996-5#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
functions are not##2##3##(1994-8#1)(2011-2#1)
functions are##17##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
functions as a signal-anchor##2##4##(1991-10#2)
functions as a##22##3##(1990-11#1)(1991-10#2)(1991-5#1)(1991-6#1)(1995-2#2)(1995-9#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#2)
functions as an##4##3##(1995-9#1)(1996-6#1)(2008-11#2)
functions as well as##2##4##(2009-10#1)(2009-6#1)
functions as##32##2##(1990-11#2)(1991-10#2)(1991-5#1)(1991-6#1)(1995-2#2)(1995-9#2)(1996-6#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-7#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#3)
functions at##5##2##(1991-3#1)(1993-12#1)(2008-10#1)(2009-8#1)(2010-6#1)
functions by the##2##3##(1997-2#2)
functions by##7##2##(1997-2#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
functions can be##2##3##(1992-9#1)(2008-10#1)
functions characteristic##2##2##(2008-10#1)(2008-9#1)
functions derived##2##2##(1991-5#1)(2010-11#1)
functions for the##3##3##(1995-12#1)(1995-2#1)(2008-3#1)
functions for##12##2##(1995-12#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
functions from##2##2##(1992-1#1)(1992-12#1)
functions have been##5##3##(1992-9#1)(1993-6#1)(1994-3#1)(1997-7#1)(2009-10#1)
functions have##6##2##(1992-9#1)(1993-6#1)(1994-3#1)(1997-7#1)(2009-10#1)(2010-11#1)
functions in a##5##3##(1991-2#1)(1991-5#1)(2008-10#1)(2008-11#1)(2010-9#1)
functions in cell##2##3##(1994-5#1)(2008-9#1)
functions in normal##2##3##(2011-1#1)(2013-1#1)
functions in plants##2##3##(2009-6#1)(2011-2#1)
functions in the##11##3##(1993-12#1)(1996-2#2)(1996-3#1)(2008-10#2)(2008-11#2)(2009-7#1)(2012-2#1)(2012-3#1)
functions in vitro##4##3##(2008-11#3)(2011-2#1)
functions in##64##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#6)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#2)(2009-6#3)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#6)(2012-3#1)(2013-1#2)
functions include##2##2##(2008-9#1)(2013-1#1)
functions including##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
functions is##2##2##(2008-11#1)(2008-12#1)
functions may##4##2##(1992-9#1)(1995-3#1)(2008-11#1)(2008-12#1)
functions observed in##2##3##(1994-11#1)(2008-2#1)
functions of genes##3##3##(1993-9#1)(2010-12#1)(2012-3#1)
functions of rat##2##3##(1990-3#1)(1991-5#1)
functions of the##28##3##(1990-11#1)(1992-1#1)(1994-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
functions of their##2##3##(2008-9#1)(2009-7#1)
functions of this##2##3##(2007-12#1)(2008-6#1)
functions of vitamins##2##3##(1992-9#2)
functions of##104##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#7)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#7)(2009-10#2)(2009-7#3)(2009-8#6)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
functions on##3##2##(1993-3#1)(2008-5#1)(2008-6#1)
functions or##2##2##(2010-4#1)(2012-2#1)
functions such as##4##3##(2008-11#1)(2008-9#1)(2010-8#1)(2012-2#1)
functions that are##2##3##(1996-2#1)(2013-1#1)
functions that might be##2##4##(2013-1#1)(2013-8#1)
functions that##11##2##(1994-12#1)(1995-9#1)(1996-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
functions through##2##2##(2011-1#1)(2011-3#1)
functions to##10##2##(1993-3#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2011-3#1)
functions was##3##2##(1991-2#1)(1994-12#1)(2008-11#1)
functions were used in the hidden and output layers##4##9##(2008-10#4)
functions were used to##2##4##(2008-10#1)(2008-3#1)
functions were used##6##3##(2008-10#5)(2008-3#1)
functions were##17##2##(1994-8#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#9)(2008-3#1)(2008-9#2)(2012-2#1)
functions with a##2##3##(2008-10#1)(2008-2#1)
functions with##6##2##(2007-12#1)(2008-10#3)(2008-2#1)(2009-8#1)
functions within a##2##3##(1995-12#1)(2010-8#1)
functions within##3##2##(1995-12#1)(2008-7#1)(2010-8#1)
functions##536##1##(1990-11#5)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#1)(1992-1#3)(1992-12#2)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#13)(1993-12#7)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#12)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#4)(1995-9#6)(1996-1#1)(1996-12#4)(1996-2#14)(1996-3#6)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#4)(1997-7#1)(1997-8#3)(2007-12#5)(2008-1#2)(2008-10#52)(2008-11#45)(2008-12#4)(2008-2#9)(2008-3#14)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#13)(2008-9#32)(2009-1#1)(2009-10#10)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#6)(2009-7#8)(2009-8#13)(2009-9#5)(2010-1#4)(2010-10#7)(2010-11#5)(2010-12#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#26)(2011-3#2)(2012-12#2)(2012-2#20)(2012-3#12)(2012-5#1)(2013-1#22)(2013-7#3)(2013-8#9)
functions)##3##1##(2008-10#3)
fund development programs##3##3##(1992-1#1)(1995-1#2)
fund development##4##2##(1991-9#1)(1992-1#1)(1995-1#2)
fund raising##7##2##(1991-1#1)(1991-3#1)(1992-1#2)(1992-3#1)(1996-1#1)(1997-1#1)
fund##21##1##(1991-1#3)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-3#1)(1995-1#3)(1995-12#1)(1996-1#1)(1997-1#2)(2008-11#1)(2012-2#1)
fund-raising program##2##2##(1995-1#1)(1997-1#1)
fund-raising##6##1##(1991-1#1)(1991-2#1)(1991-3#1)(1995-1#1)(1997-1#1)(2009-5#1)
fundamental and first-order##2##3##(2007-12#1)(2008-3#1)
fundamental and##10##2##(1995-12#1)(2007-12#1)(2008-3#5)(2009-4#1)(2010-4#1)(2013-8#1)
fundamental changes in##3##3##(1995-6#1)(1997-5#1)(2011-2#1)
fundamental characteristic of all##2##4##(2008-12#1)(2008-8#1)
fundamental component of##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
fundamental component##4##2##(1991-3#1)(2008-10#1)(2008-11#2)
fundamental differences between##2##3##(2008-5#1)(2013-1#1)
fundamental differences in##2##3##(2008-8#1)(2008-9#1)
fundamental differences##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
fundamental equilibrium constants##4##3##(2008-10#4)
fundamental importance##6##2##(1990-2#1)(2008-10#2)(2008-5#1)(2010-7#1)(2010-9#1)
fundamental in##2##2##(1993-6#1)(2008-11#1)
fundamental influence on##2##3##(2008-11#1)(2008-8#1)
fundamental influence##3##2##(1993-6#1)(2008-11#1)(2008-8#1)
fundamental information##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
fundamental interest##3##2##(1995-3#1)(2008-3#1)(2008-8#1)
fundamental level##2##2##(1996-1#1)(2009-6#1)
fundamental mechanisms##2##2##(1992-6#1)(2012-3#1)
fundamental mode##3##2##(2008-3#3)
fundamental principle of##2##3##(2008-10#1)(2008-9#1)
fundamental principles##2##2##(2008-11#1)(2010-6#1)
fundamental problem##2##2##(1991-3#1)(1997-3#1)
fundamental processes##3##2##(2008-10#1)(2009-4#1)(2010-4#1)
fundamental questions about##2##3##(1991-2#1)(2013-1#1)
fundamental questions##3##2##(1991-2#1)(2011-2#1)(2013-1#1)
fundamental research##4##2##(1994-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
fundamental role##4##2##(2008-8#2)(2010-4#1)(2013-7#1)
fundamental studies##3##2##(2008-10#3)
fundamental study##3##2##(2008-10#2)(2008-5#1)
fundamental to##6##2##(1994-12#1)(2008-10#2)(2009-10#1)(2009-8#1)(2010-5#1)
fundamental tool##3##2##(1995-2#1)(2008-4#1)(2011-2#1)
fundamental understanding of##2##3##(2008-7#1)(2010-4#1)
fundamental vibrational band##2##3##(2008-3#2)
fundamental wavelength##2##2##(2007-12#1)(2008-10#1)
fundamental##190##1##(1990-2#2)(1991-1#1)(1991-2#1)(1991-3#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-12#4)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-3#2)(1997-5#1)(2007-11#1)(2007-12#6)(2008-10#29)(2008-11#17)(2008-12#4)(2008-2#2)(2008-3#20)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#4)(2009-7#2)(2009-8#3)(2010-11#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#9)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
fundamentally different##5##2##(1990-5#1)(1993-3#1)(1995-1#1)(2008-11#1)(2010-8#1)
fundamentally the##3##2##(1992-12#1)(1994-12#1)(2008-10#1)
fundamentally##17##1##(1990-5#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-1#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2010-8#2)(2013-1#2)
fundamentals of##5##2##(1994-12#3)(2008-10#1)(2010-1#1)
fundamentals##6##1##(1994-12#3)(2008-10#1)(2008-4#1)(2010-1#1)
funded and##2##2##(1993-3#1)(1995-2#1)
funded by the##11##3##(1992-3#1)(1995-3#3)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
funded by##12##2##(1992-3#1)(1995-3#3)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
funded programs##2##2##(1996-12#1)(2008-6#1)
funded research##4##2##(1995-2#4)
funded##38##1##(1990-6#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-2#6)(1995-3#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-5#2)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
funders##5##1##(1991-12#1)(1994-12#1)(1995-3#1)(2009-4#2)
fundic##2##1##(1990-9#2)
funding agencies to##2##3##(2009-3#2)
funding agencies##4##2##(2008-10#1)(2009-3#2)(2009-4#1)
funding and##7##2##(1993-2#1)(1996-12#1)(2008-10#1)(2009-4#1)(2010-5#2)(2013-8#1)
funding as##2##2##(1997-3#1)(2011-1#1)
funding for##9##2##(1993-2#1)(1994-1#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
funding from the##2##3##(1991-2#1)(1992-1#1)
funding from##5##2##(1991-2#1)(1992-1#1)(1995-3#1)(1997-3#1)(2010-10#1)
funding in##2##2##(1995-2#1)(1995-3#1)
funding is##2##2##(1995-2#2)
funding of##5##2##(1996-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-3#1)
funding purposes##3##2##(1991-12#2)(1995-6#1)
funding systems##2##2##(1995-12#1)(1995-2#1)
funding to the##2##3##(1997-2#1)(2012-2#1)
funding to##6##2##(1991-1#1)(1991-12#1)(1992-3#1)(1997-2#1)(2009-4#1)(2012-2#1)
funding##113##1##(1991-1#2)(1991-12#15)(1991-2#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-1#3)(1993-12#3)(1993-2#2)(1994-1#1)(1994-2#1)(1995-12#5)(1995-2#5)(1995-3#10)(1995-6#6)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-6#1)(2008-9#1)(2009-11#3)(2009-3#5)(2009-4#3)(2010-10#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#1)
fundoplication##4##1##(2008-12#3)(2011-2#1)
funds are##2##2##(1992-12#1)(2008-11#1)
funds for##2##2##(1996-5#1)(2008-10#1)
funds to##6##2##(1990-6#1)(1992-12#1)(1992-2#1)(1995-6#1)(1996-2#1)(2008-5#1)
funds will be##2##3##(1997-2#1)(2008-5#1)
funds##24##1##(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-5#2)(2009-11#2)(2013-1#2)
fundus and##2##2##(1997-1#1)(2010-6#1)
fundus examination##2##2##(2010-8#1)(2013-1#1)
fundus##10##1##(1990-9#1)(1991-12#1)(1993-1#1)(1997-1#2)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
funeral##2##1##(2008-11#1)(2008-5#1)
fungal DNA##7##2##(2008-10#5)(2008-5#1)(2011-2#1)
fungal alpha-amylase##2##2##(2008-10#2)
fungal and bacterial##2##3##(2008-10#1)(2012-2#1)
fungal and##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
fungal antagonist##2##2##(2008-10#2)
fungal attack##5##2##(2008-10#5)
fungal biocontrol agent##2##3##(2008-10#2)
fungal biomass##7##2##(2008-10#7)
fungal cell wall components##2##4##(2008-10#1)(2011-2#1)
fungal cell wall##5##3##(2008-10#4)(2011-2#1)
fungal cell walls##3##3##(2008-10#2)(2011-2#1)
fungal cell##10##2##(2008-10#8)(2011-2#2)
fungal cells##2##2##(2008-10#2)
fungal colonization##10##2##(2008-10#8)(2008-12#2)
fungal colony##3##2##(2008-10#2)(2008-11#1)
fungal community##4##2##(2008-10#4)
fungal contamination##2##2##(2008-10#1)(2012-2#1)
fungal culture##2##2##(2008-10#1)(2012-3#1)
fungal cultures##2##2##(2008-10#2)
fungal development##7##2##(2008-10#6)(2009-8#1)
fungal disease##6##2##(2008-10#3)(2008-8#2)(2011-2#1)
fungal diseases of##2##3##(2008-10#2)
fungal diseases##8##2##(1992-2#1)(1997-1#1)(2008-10#5)(2011-10#1)
fungal foliar disease##2##3##(2008-10#1)(2012-3#1)
fungal fruiting##2##2##(2008-10#2)
fungal genes##2##2##(1993-2#1)(2008-10#1)
fungal genome##5##2##(2008-10#3)(2008-11#1)(2011-1#1)
fungal genomic DNA##3##3##(2008-10#3)
fungal genomic##4##2##(2008-10#4)
fungal genotypes##3##2##(2008-10#3)
fungal growth and##3##3##(2008-10#2)(2010-7#1)
fungal growth in the##2##4##(2008-10#2)
fungal growth in##6##3##(2008-10#5)(2010-7#1)
fungal growth was##3##3##(2008-10#2)(2012-2#1)
fungal growth##25##2##(2008-10#21)(2010-7#2)(2012-2#2)
fungal host##2##2##(2008-10#2)
fungal hyphae##5##2##(2008-10#4)(2008-11#1)
fungal infection of the##2##4##(2008-10#1)(2011-2#1)
fungal infection of##3##3##(2008-10#2)(2011-2#1)
fungal infection##12##2##(2008-10#5)(2008-5#2)(2011-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
fungal infections are##2##3##(2011-2#1)(2011-3#1)
fungal infections caused by##2##4##(2008-5#1)(2012-3#1)
fungal infections##13##2##(1997-2#1)(2007-8#1)(2008-5#2)(2011-2#6)(2011-3#1)(2012-3#1)(2013-1#1)
fungal infestation levels##3##3##(2008-10#3)
fungal inoculum density##5##3##(2008-10#5)
fungal isolate##3##2##(2008-10#3)
fungal isolates were##3##3##(2008-10#1)(2011-2#2)
fungal isolates##14##2##(2008-10#12)(2011-2#2)
fungal keratitis in##2##3##(2010-10#1)(2011-2#1)
fungal laccase##3##2##(2008-10#3)
fungal metabolites##2##2##(2008-10#2)
fungal mitochondrial##2##2##(2008-10#2)
fungal morphology##2##2##(2008-7#2)
fungal mycoparasite##2##2##(2008-10#2)
fungal pathogen##17##2##(2008-10#14)(2008-9#1)(2009-8#1)(2011-10#1)
fungal pathogenicity and host resistance##2##5##(2008-10#2)
fungal pathogens and##2##3##(2008-10#2)
fungal pathogens from##2##3##(2008-10#2)
fungal pathogens of##4##3##(2008-10#4)
fungal pathogens were##2##3##(2008-10#2)
fungal pathogens##21##2##(2008-10#16)(2009-6#3)(2011-10#1)(2011-2#1)
fungal penetration##6##2##(2008-10#6)
fungal plant pathogens##4##3##(2008-10#4)
fungal population##4##2##(2008-10#3)(2008-12#1)
fungal populations in##2##3##(2008-10#1)(2008-12#1)
fungal populations on##2##3##(2008-10#2)
fungal populations##8##2##(2008-10#7)(2008-12#1)
fungal proteins##2##2##(2008-10#2)
fungal rDNA##2##2##(2008-10#2)
fungal sinusitis##3##2##(2011-2#3)
fungal species and##2##3##(2008-10#1)(2012-2#1)
fungal species##15##2##(2008-10#9)(2008-5#1)(2009-8#1)(2012-2#2)(2012-3#1)(2012-6#1)
fungal spore concentrations##2##3##(2008-5#2)
fungal spore##6##2##(2008-10#3)(2008-5#3)
fungal spores##6##2##(1994-9#1)(2008-10#2)(2008-5#2)(2010-5#1)
fungal strains##5##2##(2008-10#2)(2008-5#1)(2011-1#1)(2012-3#1)
fungal versus bacterial##2##3##(2008-10#2)
fungal##391##1##(1990-12#1)(1992-2#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-10#274)(2008-11#6)(2008-12#4)(2008-5#17)(2008-7#2)(2008-8#10)(2008-9#1)(2009-10#1)(2009-6#5)(2009-8#5)(2009-9#2)(2010-10#1)(2010-5#2)(2010-7#2)(2011-1#3)(2011-10#5)(2011-2#22)(2011-3#1)(2012-2#7)(2012-3#5)(2012-6#1)(2013-1#5)(2013-8#1)
fungemia##6##1##(2008-5#6)
fungi and A##2##3##(2009-8#2)
fungi and Oomycetes##2##3##(2008-10#2)
fungi and oomycetes##4##3##(2008-10#4)
fungi and##22##2##(1994-11#1)(2008-10#15)(2008-11#1)(2009-8#3)(2009-9#1)(2011-2#1)
fungi are able to##2##4##(2006-6#1)(2008-8#1)
fungi are##8##2##(2006-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#1)
fungi as##5##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-8#1)
fungi associated with##7##3##(2008-10#6)(2012-3#1)
fungi but##2##2##(2008-10#2)
fungi examined##2##2##(1996-6#1)(2010-7#1)
fungi have been##2##3##(2008-7#1)(2010-7#1)
fungi in the##5##3##(2008-10#5)
fungi in##13##2##(2008-10#12)(2010-3#1)
fungi including##2##2##(2008-10#2)
fungi is##7##2##(2008-10#2)(2008-11#1)(2008-5#2)(2010-7#1)(2011-10#1)
fungi isolated from##2##3##(2008-10#2)
fungi of##3##2##(2008-10#2)(2010-7#1)
fungi on##3##2##(2008-10#2)(2013-8#1)
fungi tested##2##2##(2008-10#2)
fungi that are##2##3##(1994-5#1)(2009-6#1)
fungi that##6##2##(1994-5#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-7#1)
fungi to##5##2##(2006-6#1)(2008-10#3)(2008-5#1)
fungi was##3##2##(2008-10#3)
fungi were isolated from##2##4##(2008-10#2)
fungi were##12##2##(1996-6#1)(2008-10#10)(2010-3#1)
fungi##260##1##(1993-2#1)(1994-11#1)(1994-5#1)(1994-9#2)(1996-6#2)(1997-2#1)(1997-4#1)(1997-7#1)(2006-5#1)(2006-6#2)(2008-10#172)(2008-11#10)(2008-5#11)(2008-7#1)(2008-8#8)(2008-9#2)(2009-6#4)(2009-8#7)(2009-9#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-7#9)(2011-1#1)(2011-10#1)(2011-2#6)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#2)(2013-8#2)
fungi)##3##1##(1993-12#1)(1995-2#1)(2008-10#1)
fungible##3##1##(1994-12#3)
fungicidal##7##1##(2008-10#5)(2008-5#1)(2011-2#1)
fungicide and##4##2##(2008-10#3)(2008-7#1)
fungicide application##3##2##(2008-10#3)
fungicide applications##9##2##(2008-10#9)
fungicide concentration##3##2##(2008-10#3)
fungicide concentrations##2##2##(2008-10#2)
fungicide dose##2##2##(2008-10#2)
fungicide resistance or##2##3##(2008-10#2)
fungicide resistance##8##2##(2008-10#8)
fungicide seed treatment##2##3##(2008-10#2)
fungicide sensitivity##2##2##(2008-10#2)
fungicide significantly reduced##2##3##(2008-10#2)
fungicide spray##2##2##(2008-10#2)
fungicide treatments##2##2##(2008-10#2)
fungicide use##5##2##(2008-10#5)
fungicide was applied##3##3##(2008-10#3)
fungicide was##4##2##(2008-10#4)
fungicide##108##1##(2008-10#105)(2008-11#2)(2008-7#1)
fungicide-amended medium##3##2##(2008-10#3)
fungicide-amended##4##1##(2008-10#4)
fungicide-resistant##4##1##(2008-10#4)
fungicides and##2##2##(2008-10#2)
fungicides are##3##2##(2008-10#3)
fungicides azoxystrobin##2##2##(2008-10#2)
fungicides in##8##2##(2008-10#8)
fungicides or bactericides##3##3##(2008-10#3)
fungicides used to##2##3##(2008-10#2)
fungicides was##3##2##(2008-10#3)
fungicides##82##1##(2008-10#81)(2008-5#1)
fungicola var##7##2##(2008-10#7)
fungicola##14##1##(2008-10#14)
fungistatic##2##1##(2008-10#2)
fungivorous nematodes##2##2##(2008-10#2)
fungivorous##3##1##(2008-10#3)
fungoides##4##1##(2010-6#4)
fungus Bipolaris sorokiniana (teleomorph##2##4##(2008-10#2)
fungus Botrytis cinerea##2##3##(2008-10#1)(2011-10#1)
fungus Cylindrocarpon destructans##2##3##(2008-10#2)
fungus Melampsora larici-populina on##2##4##(2008-10#2)
fungus Mycosphaerella graminicola##2##3##(2008-10#2)
fungus Oidium neolycopersici##2##3##(2008-10#2)
fungus Podosordaria tulasnei##2##3##(2008-11#2)
fungus Puccinia##4##2##(2008-10#4)
fungus Pyrenophora tritici-repentis##3##3##(2008-10#3)
fungus Trichoderma##4##2##(2008-10#4)
fungus Ustilago maydis##2##3##(2009-8#2)
fungus activity##2##2##(2008-10#2)
fungus and##7##2##(2008-10#5)(2008-11#1)(2008-12#1)
fungus behaves as a##2##4##(2008-10#2)
fungus but##3##2##(2008-10#2)(2008-11#1)
fungus can##2##2##(2008-10#2)
fungus did not##2##3##(2008-10#2)
fungus from##4##2##(2008-10#4)
fungus has been##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
fungus has##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
fungus in different##2##3##(2008-10#2)
fungus in the epidermis and outer cortex tissues##2##8##(2008-10#2)
fungus in the##4##3##(2008-10#4)
fungus in##12##2##(2008-10#12)
fungus infection##2##2##(2008-10#1)(2008-8#1)
fungus is##5##2##(2008-10#4)(2008-8#1)
fungus numbers##2##2##(2008-10#2)
fungus of##3##2##(2008-10#3)
fungus population density##2##3##(2008-10#2)
fungus produced##2##2##(2008-10#2)
fungus that##8##2##(2008-10#8)
fungus was isolated from##2##4##(2008-10#1)(2008-5#1)
fungus was isolated##3##3##(2008-10#2)(2008-5#1)
fungus was not##2##3##(2008-10#1)(2011-2#1)
fungus was##17##2##(2008-10#15)(2008-5#1)(2011-2#1)
fungus were##2##2##(2008-10#2)
fungus with##4##2##(2008-10#3)(2008-5#1)
fungus##279##1##(1993-12#2)(1993-2#1)(1995-2#1)(1996-6#1)(1997-4#1)(2008-10#217)(2008-11#8)(2008-12#9)(2008-5#8)(2008-6#1)(2008-8#6)(2008-9#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-3#1)(2010-7#2)(2011-1#4)(2011-10#1)(2011-2#1)(2012-6#1)(2013-1#6)
fungus) was##2##2##(2008-10#1)(2008-12#1)
fungus)##5##1##(1997-4#2)(2008-10#2)(2008-12#1)
fungus-fungicide interactions##3##2##(2008-10#3)
fungus-fungicide##4##1##(2008-10#4)
fungus-growing ant Trachymyrmex septentrionalis##2##4##(2012-2#2)
fungus-growing##3##1##(2008-8#1)(2012-2#2)
funnel##4##1##(1990-5#1)(2008-10#3)
funnels that##2##2##(2008-10#2)
funnels##4##1##(2008-10#4)
fur mutant##2##2##(2009-6#2)
fur mutation##3##2##(2009-6#3)
fur##9##1##(1997-7#1)(2008-10#3)(2009-6#5)
fura 2##2##2##(1990-8#2)
fura-2 and indo-1##2##3##(1991-5#2)
fura-2##7##1##(1991-5#3)(1992-6#1)(1994-2#2)(1995-11#1)
fura-2/AM##2##1##(1994-6#2)
fura-red##2##1##(2006-6#2)
furafylline inhibition##3##2##(1994-8#3)
furan and##2##2##(2008-11#1)(2013-1#1)
furan related compounds##2##3##(2008-10#2)
furan##7##1##(2008-10#3)(2008-11#2)(2008-8#1)(2013-1#1)
furanocoumarins##2##1##(2008-11#1)(2008-9#1)
furanose##4##1##(1990-9#2)(1991-3#2)
furans and##2##2##(2008-10#2)
furans##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
furfur##6##1##(2008-5#5)(2010-6#1)
furfural##4##1##(2008-10#1)(2011-1#3)
furfuraldehyde condensed resin was##2##4##(2008-10#2)
furfuraldehyde##3##1##(2008-10#3)
furfuralhydrazone##4##1##(2008-10#4)
furiosus##4##1##(1993-9#4)
furnace analysis##3##2##(2008-10#3)
furnace and##3##2##(2008-10#2)(2008-3#1)
furnace atomic absorption spectrometry (GFAAS)##23##5##(2008-10#23)
furnace atomic absorption spectrometry##59##4##(1991-12#1)(2008-10#58)
furnace atomic absorption##75##3##(1991-12#1)(2008-10#74)
furnace atomic##76##2##(1991-12#1)(2008-10#75)
furnace gas##4##2##(2008-10#4)
furnace##117##1##(1991-12#1)(2008-10#113)(2008-3#2)(2013-8#1)
furnace-AAS##2##1##(2008-10#2)
furnish the corresponding##2##3##(1996-5#2)
furnish##7##1##(1991-1#1)(1991-12#1)(1996-5#2)(1997-3#2)(2010-7#1)
furnished by##4##2##(1991-1#1)(2008-10#3)
furnished with a##2##3##(2008-10#2)
furnished with##3##2##(2008-10#3)
furnished##14##1##(1991-1#2)(1994-12#1)(1996-12#1)(1997-4#1)(2008-10#8)(2008-7#1)
furnishes##2##1##(2008-10#1)(2008-3#1)
furosemide and triamterene##3##3##(2008-10#3)
furosemide and##4##2##(1994-8#1)(2008-10#3)
furosemide in##3##2##(2008-10#3)
furosemide with##2##2##(1993-2#1)(2008-10#1)
furosemide##22##1##(1992-11#1)(1993-2#1)(1994-8#3)(1997-4#1)(2008-10#10)(2012-2#5)(2013-1#1)
furovirus##2##1##(2008-8#2)
furrow and subsurface-drip irrigation##2##4##(2008-10#2)
furrow and##3##2##(2008-10#3)
furrow irrigation##11##2##(2008-10#11)
furrow of##2##2##(2008-10#1)(2009-8#1)
furrow##20##1##(2008-10#17)(2009-8#3)
furrows##4##1##(2007-12#1)(2008-5#3)
further advances##3##2##(1990-11#1)(2008-11#1)(2012-2#1)
further analyses##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
further analysis of the##2##4##(2008-4#1)(2008-7#1)
further analysis of##3##3##(1996-2#1)(2008-4#1)(2008-7#1)
further analysis##14##2##(1991-12#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
further analyzed##4##2##(2008-10#2)(2010-6#1)(2012-2#1)
further and##3##2##(1992-3#1)(2008-10#1)(2008-9#1)
further applications##2##2##(1994-3#1)(2008-10#1)
further applied to##2##3##(2008-10#1)(2008-3#1)
further as##2##2##(2008-5#1)(2010-12#1)
further away##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
further because##2##2##(2008-10#2)
further by##7##2##(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
further cell##2##2##(1993-6#1)(2008-10#1)
further characterization of##3##3##(2008-10#3)
further characterize the##10##3##(1992-12#1)(1993-3#1)(1996-12#1)(1997-7#1)(2008-10#4)(2008-11#1)(2013-8#1)
further characterize##12##2##(1992-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#4)(2008-11#1)(2013-8#1)
further characterized by##4##3##(1994-11#1)(1994-5#1)(2008-10#2)
further characterized##11##2##(1990-5#1)(1994-11#1)(1994-5#1)(2008-10#4)(2008-11#2)(2011-1#1)(2012-3#1)
further chemical##2##2##(2008-10#1)(2008-7#1)
further clarification##2##2##(1990-9#1)(2008-12#1)
further clarified##2##2##(1994-3#1)(2013-8#1)
further clarify the##4##3##(2008-10#2)(2010-12#1)(2011-3#1)
further clinical trials##2##3##(2008-5#1)(2010-8#1)
further clinical##5##2##(1996-1#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)
further complicate##2##2##(2008-10#1)(2013-1#1)
further complicated by##2##3##(1997-1#1)(2009-5#1)
further complications##2##2##(2012-12#1)(2013-1#1)
further confirm the##2##3##(2008-10#1)(2010-2#1)
further confirm##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
further confirmed by##4##3##(1996-2#1)(1997-1#1)(2008-8#1)(2011-2#1)
further confirmed the##2##3##(2009-12#1)(2012-2#1)
further confirmed##8##2##(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
further confirms the##2##3##(2008-10#1)(2008-8#1)
further confirms##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
further consideration##2##2##(1990-6#1)(2009-3#1)
further conversion##2##2##(1990-10#1)(2008-10#1)
further critical##2##2##(2008-10#1)(2008-11#1)
further defined##2##2##(1995-6#1)(2008-8#1)
further demonstrate##3##2##(1991-1#1)(2008-10#1)(2013-8#1)
further demonstrated that##5##3##(2008-5#1)(2008-9#1)(2009-8#2)(2012-12#1)
further demonstrated##8##2##(1995-12#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-8#2)(2012-12#1)
further develop##3##2##(2007-12#1)(2008-11#1)(2008-12#1)
further developed to##2##3##(1994-3#1)(2008-10#1)
further developed##3##2##(1994-3#1)(2008-10#1)(2011-1#1)
further development of##11##3##(1991-3#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
further development##24##2##(1991-3#1)(1995-5#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2010-11#1)(2010-7#1)(2011-2#3)(2011-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
further developments and##2##3##(2008-10#2)
further developments##5##2##(2008-10#3)(2008-12#1)(2012-2#1)
further diagnostic##4##2##(1991-6#1)(1997-2#1)(2008-7#1)(2013-1#1)
further discuss##2##2##(2008-11#1)(2009-8#1)
further discussed##5##2##(2008-8#1)(2009-12#1)(2009-8#3)
further discussion##3##2##(2008-12#1)(2010-11#1)(2011-2#1)
further divided into##5##3##(2007-12#1)(2008-10#3)(2013-1#1)
further educational##2##2##(2008-11#1)(2013-1#1)
further elucidate these##2##3##(2008-10#1)(2008-11#1)
further elucidate##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)
further elucidated by##2##3##(2008-11#1)(2008-2#1)
further elucidated##3##2##(2008-11#1)(2008-2#1)(2010-10#1)
further emphasized##2##2##(1997-3#1)(2008-10#1)
further enhance the##2##3##(1992-12#1)(2011-2#1)
further enhance##6##2##(1992-12#1)(1995-12#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
further enhanced the##2##3##(2008-10#1)(2008-7#1)
further enhanced##5##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
further enhancement of##2##3##(2008-3#1)(2011-2#1)
further enhancement##3##2##(2006-6#1)(2008-3#1)(2011-2#1)
further established that##3##3##(2008-10#3)
further established##4##2##(1996-12#1)(2008-10#3)
further evaluate the##3##3##(2010-8#1)(2011-2#1)(2013-8#1)
further evaluate##5##2##(2008-5#1)(2010-8#1)(2011-2#2)(2013-8#1)
further evaluated##6##2##(1992-8#1)(1992-9#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
further evaluation##6##2##(1990-6#1)(1991-5#1)(2008-10#1)(2008-7#1)(2010-10#1)(2013-1#1)
further evidence for the##3##4##(2008-10#3)
further evidence for##6##3##(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)
further evidence of a##3##4##(2008-10#2)(2008-7#1)
further evidence of##5##3##(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
further evidence that##5##3##(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-8#1)
further evidence##18##2##(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
further examination##2##2##(1994-12#1)(2011-2#1)
further examined using##2##3##(1993-3#1)(2008-9#1)
further examined##5##2##(1993-3#1)(1997-1#1)(2008-10#2)(2008-9#1)
further experimental results revealed that##2##5##(2008-10#2)
further experimental##3##2##(2008-10#2)(2009-8#1)
further experiments##2##2##(1994-2#1)(2008-8#1)
further exploration of the##2##4##(1993-12#1)(2008-10#1)
further exploration##4##2##(1993-12#1)(2008-10#1)(2013-1#2)
further explore the##3##3##(1993-1#1)(1996-2#1)(2011-2#1)
further explore##6##2##(1993-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
further for##2##2##(2008-10#1)(2008-3#1)
further genetic and molecular##2##4##(2008-10#1)(2012-3#1)
further genetic##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
further illustrated the##2##3##(2008-10#1)(2008-9#1)
further imaging##2##2##(2010-5#1)(2012-2#1)
further improve##6##2##(1995-6#1)(2008-11#3)(2008-12#1)(2008-6#1)
further improved by##4##3##(2008-10#3)(2008-11#1)
further improved the##2##3##(2008-10#1)(2010-12#1)
further improved##9##2##(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)
further improvement of##3##3##(2008-10#1)(2008-3#2)
further improvement##7##2##(2008-10#2)(2008-3#2)(2008-6#1)(2011-2#1)(2012-3#1)
further improvements##2##2##(2008-10#1)(2010-4#1)
further in##2##2##(2008-7#1)(2010-12#1)
further increase in##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
further increase##6##2##(1991-12#1)(1996-3#1)(2008-10#2)(2008-5#1)(2013-8#1)
further increased##6##2##(1994-11#1)(1996-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
further increases##2##2##(2008-10#1)(2008-11#1)
further increasing##2##2##(1991-3#1)(2008-10#1)
further information on##2##3##(2008-5#1)(2008-7#1)
further information##5##2##(1994-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
further insight into the##3##4##(1993-12#1)(1997-9#1)(2008-11#1)
further insight into##6##3##(1993-12#1)(1996-12#1)(1997-9#1)(2008-11#3)
further insight##8##2##(1990-2#1)(1993-12#1)(1996-12#1)(1997-9#1)(2008-10#1)(2008-11#3)
further insights into the##2##4##(2008-7#1)(2011-2#1)
further insights into##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
further interest##2##2##(1997-7#1)(2009-8#1)
further into##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
further investigate the##4##3##(1995-11#1)(2008-10#1)(2008-9#2)
further investigate##7##2##(1995-11#1)(2008-10#2)(2008-8#1)(2008-9#2)(2010-3#1)
further investigated by##2##3##(1990-11#1)(2008-10#1)
further investigated##10##2##(1990-11#1)(1990-8#1)(1997-1#1)(2008-10#4)(2008-11#3)
further investigation of the##2##4##(2008-10#1)(2013-8#1)
further investigation of##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
further investigation##21##2##(1995-5#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)(2013-1#3)(2013-8#2)
further investigations will be##2##4##(1990-6#2)
further investigations##7##2##(1990-11#1)(1990-6#2)(1994-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
further model##2##2##(2008-11#2)
further on-line##2##2##(2008-10#2)
further optimization##2##2##(2008-11#1)(2013-1#1)
further optimized##2##2##(2008-11#1)(2013-8#1)
further our understanding of the##2##5##(1996-11#1)(2008-7#1)
further our understanding of##4##4##(1996-11#1)(2008-11#1)(2008-7#2)
further our##5##2##(1994-1#1)(1996-11#1)(2008-11#1)(2008-7#2)
further population##2##2##(2008-12#1)(2012-2#1)
further processing##2##2##(2008-3#1)(2008-6#1)
further progress##3##2##(1997-7#1)(2008-11#1)(2010-1#1)
further provide##2##2##(2009-11#1)(2013-8#1)
further purification##5##2##(1990-2#1)(2008-10#2)(2008-12#1)(2011-1#1)
further reduce the##6##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)
further reduce##7##2##(1990-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
further reduced the##2##3##(2008-7#1)(2011-2#1)
further reduced##8##2##(1992-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#1)
further reduction##2##2##(2008-11#1)(2008-5#1)
further refinement##3##2##(1996-2#1)(2008-10#2)
further research and##2##3##(1996-2#1)(2013-1#1)
further research are##2##3##(2008-11#1)(2012-2#1)
further research in##2##3##(2008-11#1)(2013-1#1)
further research is needed to##4##5##(2008-11#2)(2009-5#1)(2009-7#1)
further research is needed##5##4##(2008-11#2)(2008-3#1)(2009-5#1)(2009-7#1)
further research is required##2##4##(2008-11#2)
further research is##7##3##(2008-11#4)(2008-3#1)(2009-5#1)(2009-7#1)
further research on the##2##4##(2008-11#1)(2009-6#1)
further research on this##2##4##(2008-10#1)(2008-8#1)
further research on##9##3##(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2013-1#2)
further research##37##2##(1992-12#1)(1993-12#1)(1994-3#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#5)
further resolved##2##2##(2008-10#2)
further revealed that##2##3##(1993-6#1)(2008-11#1)
further revealed the##2##3##(2012-2#1)(2013-8#1)
further revealed##5##2##(1993-6#1)(2008-11#1)(2009-8#1)(2012-2#1)(2013-8#1)
further selection pressure##2##3##(2008-10#1)(2010-7#1)
further show that##5##3##(1990-2#1)(1994-8#1)(1995-2#1)(2008-11#1)(2010-12#1)
further step##4##2##(1995-2#1)(1997-3#1)(2008-10#2)
further studied in##2##3##(2008-10#1)(2012-2#1)
further studied##7##2##(1992-5#1)(1994-11#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)
further studies are##2##3##(2008-5#1)(2011-1#1)
further studies on functional##2##4##(1993-1#1)(2009-9#1)
further studies on the##4##4##(1993-8#1)(1996-12#1)(2008-10#1)(2009-8#1)
further studies on##6##3##(1993-1#1)(1993-8#1)(1996-12#1)(2008-10#1)(2009-8#1)(2009-9#1)
further studies that##2##3##(2008-10#1)(2011-2#1)
further studies with##3##3##(1990-12#1)(1993-1#1)(1994-2#1)
further studies##24##2##(1990-12#1)(1993-1#2)(1993-8#1)(1994-2#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
further study in##2##3##(1991-6#1)(2013-8#1)
further study of##3##3##(1996-8#1)(2008-11#1)(2008-7#1)
further study on##3##3##(1994-5#1)(1995-8#1)(2008-10#1)
further study the##5##3##(2008-10#2)(2008-9#2)(2009-12#1)
further study##27##2##(1991-6#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-8#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
further subcloning##3##2##(1991-12#1)(1997-7#1)(2008-4#1)
further substantiated by##2##3##(1994-11#1)(1995-3#1)
further substantiates the##2##3##(1994-12#1)(2008-10#1)
further suggest that##3##3##(2008-10#1)(2008-11#2)
further suggested that##2##3##(1995-8#1)(2008-10#1)
further suggested##3##2##(1995-8#1)(2008-10#2)
further suggests that##2##3##(2008-7#1)(2013-1#1)
further support for the##4##4##(1991-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
further support for##5##3##(1990-11#1)(1991-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
further support the##4##3##(1993-12#1)(1995-12#1)(2008-7#1)(2009-4#1)
further support##10##2##(1990-11#1)(1991-9#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-4#1)
further supported by the##3##4##(2008-10#1)(2008-8#1)(2009-9#1)
further supported by##4##3##(2008-10#2)(2008-8#1)(2009-9#1)
further supports that##2##3##(1993-3#1)(2008-9#1)
further supports##3##2##(1993-3#1)(2008-9#1)(2009-10#1)
further tested##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
further testing##3##2##(1991-3#1)(2008-10#1)(2012-12#1)
further tests##2##2##(2008-10#1)(2008-9#1)
further that##2##2##(1995-6#1)(2011-2#1)
further the##15##2##(1994-8#2)(1995-1#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2009-6#1)(2011-3#1)
further to##4##2##(1993-6#1)(2008-10#1)(2010-10#1)(2013-1#1)
further training##2##2##(2008-1#2)
further treatment##3##2##(2008-10#2)(2012-2#1)
further underscores the##2##3##(2008-10#1)(2010-10#1)
further understand the##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
further understand##7##2##(2008-10#2)(2008-11#2)(2008-9#1)(2009-9#1)(2012-12#1)
further understanding of##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
further understanding##5##2##(2008-10#1)(2008-9#2)(2011-2#1)(2013-1#1)
further use##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
further used##3##2##(2008-10#2)(2008-12#1)
further using##3##2##(1994-12#1)(2008-10#2)
further validation##2##2##(2008-5#1)(2009-12#1)
further work is##2##3##(2008-10#1)(2008-12#1)
further work##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)
further##1016##1##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#6)(1991-5#1)(1991-6#5)(1991-9#1)(1992-12#5)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#5)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#3)(1994-1#1)(1994-11#5)(1994-12#7)(1994-2#6)(1994-3#6)(1994-5#3)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#6)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#13)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#2)(1997-3#8)(1997-4#1)(1997-7#8)(1997-8#5)(1997-9#2)(2006-6#3)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#6)(2008-10#247)(2008-11#104)(2008-12#24)(2008-2#3)(2008-3#12)(2008-4#7)(2008-5#23)(2008-6#5)(2008-7#30)(2008-8#26)(2008-9#36)(2009-10#5)(2009-11#2)(2009-12#7)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#7)(2009-7#4)(2009-8#15)(2009-9#4)(2010-1#4)(2010-10#12)(2010-11#4)(2010-12#14)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#9)(2011-2#37)(2011-3#2)(2011-8#1)(2012-12#7)(2012-2#25)(2012-3#14)(2013-1#43)(2013-8#24)
furthered schizophrenia##2##2##(2011-1#2)
furthered##4##1##(2008-12#1)(2011-1#3)
furthering the##2##2##(2011-2#1)(2012-2#1)
furthering##3##1##(2008-12#1)(2011-2#1)(2012-2#1)
furthermore the##2##2##(2008-10#1)(2008-3#1)
furthermore##17##1##(2008-10#6)(2008-11#1)(2008-3#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
furthers##2##1##(2010-7#1)(2013-1#1)
furzeri##9##1##(2012-3#9)
fusaric acid production##2##3##(2008-10#2)
fusaric acid##7##2##(2008-10#7)
fusarium crown and root rot##2##5##(2008-10#2)
fusarium ear##2##2##(2008-10#2)
fusarium head blight and deoxynivalenol content##2##6##(2008-10#2)
fusarium head blight and deoxynivalenol##3##5##(2008-10#3)
fusarium head blight and##4##4##(2008-10#4)
fusarium head blight##12##3##(2008-10#12)
fusarium wilt##5##2##(2008-10#5)
fusarium##29##1##(2008-10#28)(2008-7#1)
fusca##12##1##(2008-10#10)(2008-8#2)
fusca) and##2##2##(2008-10#2)
fusca)##3##1##(2008-10#2)(2008-8#1)
fuscans strains were##3##3##(2008-10#3)
fuscans strains##6##2##(2008-10#6)
fuscans##12##1##(2008-10#12)
fuscans)##2##1##(2008-10#2)
fuscum##2##1##(2008-9#2)
fuse together##2##2##(2007-12#1)(2008-5#1)
fuse##6##1##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
fused C1-C2##2##2##(2013-1#2)
fused by##3##2##(1991-5#1)(1995-5#1)(2008-9#1)
fused ribs##2##2##(1993-12#2)
fused silica##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
fused to form##2##3##(2008-6#1)(2008-9#1)
fused to the##11##3##(1991-5#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#2)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
fused to##28##2##(1991-10#2)(1991-5#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#2)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
fused together##2##2##(2008-10#1)(2008-6#1)
fused with the##6##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)
fused with##15##2##(1997-7#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
fused##82##1##(1991-10#4)(1991-5#3)(1993-12#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#11)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#6)(2009-3#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#2)
fused-image##2##1##(2007-12#2)
fused-silica capillaries##2##2##(2008-10#2)
fused-silica capillary##6##2##(2008-10#5)(2008-5#1)
fused-silica##10##1##(1997-2#1)(2007-11#1)(2008-10#7)(2008-5#1)
fuselage##2##1##(1996-12#2)
fuses##3##1##(1991-9#1)(2008-11#1)(2013-1#1)
fushi tarazu##2##2##(1993-9#2)
fusicoccin receptors##3##2##(1995-2#3)
fusicoccin##10##1##(1995-2#10)
fusiform megalourethra with##2##3##(2008-10#2)
fusiform megalourethra##3##2##(2008-10#3)
fusiform rust##4##2##(2008-10#4)
fusiform##14##1##(1997-8#2)(2008-10#7)(2008-11#1)(2008-7#1)(2009-5#1)(2013-8#2)
fusiforme##4##1##(2008-10#4)
fusiformis##2##1##(2008-10#2)
fusing with##2##2##(2008-5#1)(2011-3#1)
fusing##10##1##(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2009-12#1)(2011-3#1)
fusion (hemi-fusion)##2##2##(1991-5#2)
fusion and fixation##2##3##(2011-2#1)(2012-3#1)
fusion and##18##2##(1991-5#1)(1996-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#3)(2013-1#2)
fusion at the##2##3##(1996-12#1)(2012-3#1)
fusion at##3##2##(1996-12#1)(2012-12#1)(2012-3#1)
fusion between##5##2##(2008-11#2)(2008-8#1)(2011-3#1)(2012-3#1)
fusion construct##2##2##(2012-3#2)
fusion does not##2##3##(2008-9#2)
fusion events##2##2##(1995-2#2)
fusion extent##2##2##(2012-2#2)
fusion for degenerative disc disease##2##5##(2008-7#1)(2012-12#1)
fusion for##5##2##(2008-10#1)(2008-7#2)(2012-12#1)(2012-3#1)
fusion from##3##2##(2008-9#1)(2012-12#1)(2012-3#1)
fusion gene was##2##3##(1997-7#1)(2008-8#1)
fusion gene##13##2##(1993-9#1)(1996-12#1)(1997-7#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-5#1)(2013-1#2)
fusion genes carrying the mutations##2##5##(1995-6#2)
fusion genes##5##2##(1995-6#2)(2008-8#3)
fusion has##2##2##(2008-11#1)(2012-12#1)
fusion in the##4##3##(2008-10#1)(2012-12#2)(2012-3#1)
fusion in##13##2##(1991-5#1)(2008-10#2)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-3#4)
fusion inhibitors are##2##3##(2011-3#2)
fusion inhibitors##4##2##(2011-2#1)(2011-3#3)
fusion is##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
fusion kinetics##2##2##(2012-2#2)
fusion laser##2##2##(2008-3#2)
fusion machinery##2##2##(2008-11#1)(2009-8#1)
fusion of the##10##3##(1990-5#1)(1996-6#1)(1997-3#1)(2008-5#2)(2009-12#2)(2009-6#1)(2011-1#1)(2013-1#1)
fusion of two##4##3##(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)
fusion of##29##2##(1990-5#1)(1991-10#1)(1991-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#2)(2009-12#2)(2009-6#2)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)
fusion operations##2##2##(2012-3#2)
fusion or##2##2##(2008-10#1)(2012-12#1)
fusion partner##2##2##(1995-2#1)(2008-11#1)
fusion plasmids##2##2##(2008-8#2)
fusion process##2##2##(2008-11#1)(2011-3#1)
fusion protein GST-IE86##3##3##(2008-9#3)
fusion protein and##2##3##(1995-12#1)(2009-8#1)
fusion protein containing a C-terminal##2##5##(1995-12#1)(2009-9#1)
fusion protein containing the##2##4##(1997-2#1)(2008-4#1)
fusion protein containing##4##3##(1995-12#1)(1997-2#1)(2008-4#1)(2009-9#1)
fusion protein in##2##3##(2008-11#1)(2008-9#1)
fusion protein was purified##2##4##(1994-8#1)(2008-10#1)
fusion protein was##8##3##(1991-10#1)(1994-8#4)(2008-10#2)(2008-9#1)
fusion protein##48##2##(1990-11#1)(1991-10#3)(1991-3#2)(1991-9#1)(1992-6#1)(1993-12#1)(1994-11#2)(1994-8#4)(1995-12#3)(1995-6#2)(1996-12#2)(1997-2#4)(2008-10#4)(2008-11#6)(2008-4#3)(2008-7#1)(2008-9#6)(2009-8#1)(2009-9#1)
fusion proteins can be##2##4##(1995-2#1)(2008-10#1)
fusion proteins containing##2##3##(1995-2#2)
fusion proteins for##2##3##(1995-12#1)(2008-10#1)
fusion proteins in##2##3##(1995-11#1)(2008-10#1)
fusion proteins were##6##3##(2008-10#5)(2009-3#1)
fusion proteins with##3##3##(1996-3#1)(2008-8#1)(2009-3#1)
fusion proteins##39##2##(1991-10#1)(1993-6#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-6#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-10#17)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#2)(2012-2#2)
fusion rate##3##2##(2008-12#1)(2008-7#1)(2009-7#1)
fusion system##3##2##(2008-7#2)(2008-8#1)
fusion transcript was detected by##2##5##(2008-10#2)
fusion using##2##2##(2009-3#1)(2012-3#1)
fusion versus##2##2##(2009-3#1)(2012-3#1)
fusion was##10##2##(1993-9#1)(1995-2#2)(2008-10#1)(2008-8#2)(2009-3#1)(2012-3#2)(2013-1#1)
fusion were##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)
fusion which##3##2##(1990-7#1)(1991-6#1)(2008-10#1)
fusion with##9##2##(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#3)(2012-12#1)(2012-3#1)
fusion##383##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-10#5)(1991-3#2)(1991-5#9)(1991-6#1)(1991-9#3)(1992-6#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#4)(1994-11#3)(1994-8#4)(1995-11#1)(1995-12#7)(1995-2#11)(1995-6#6)(1996-12#5)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-7#3)(2008-10#51)(2008-11#31)(2008-12#3)(2008-3#5)(2008-4#8)(2008-5#3)(2008-7#13)(2008-8#41)(2008-9#14)(2009-10#1)(2009-12#4)(2009-2#3)(2009-3#10)(2009-6#5)(2009-7#1)(2009-8#6)(2009-9#1)(2010-5#1)(2011-1#4)(2011-2#8)(2011-3#8)(2012-12#20)(2012-2#18)(2012-3#30)(2013-1#7)
fusions and##2##2##(2008-11#1)(2008-12#1)
fusions in##2##2##(1996-12#1)(2008-9#1)
fusions of##4##2##(1993-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
fusions with##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
fusions##30##1##(1991-10#1)(1991-6#1)(1993-12#1)(1993-9#1)(1995-2#2)(1996-12#1)(1997-7#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#4)(2008-9#3)(2011-1#3)(2012-3#3)
fusogenic##3##1##(1995-2#2)(2011-3#1)
futile##2##1##(1991-2#1)(2012-12#1)
future applications##3##2##(1994-8#1)(2008-11#2)
future approaches##2##2##(1997-1#1)(2010-5#1)
future are discussed##2##3##(1990-9#1)(1997-1#1)
future as a##2##3##(1994-1#1)(2008-5#1)
future as##4##2##(1994-1#1)(2008-5#1)(2009-6#1)(2010-11#1)
future cardiovascular events##2##3##(2012-2#1)(2013-8#1)
future cardiovascular##4##2##(2008-11#1)(2009-12#1)(2012-2#1)(2013-8#1)
future cases##2##2##(2010-6#1)(2012-3#1)
future challenge for##2##3##(1996-3#1)(2013-1#1)
future changes##3##2##(1992-1#1)(1996-2#1)(2010-1#1)
future clinical##5##2##(1993-9#1)(2008-6#1)(2010-11#1)(2010-12#1)(2013-1#1)
future columns##2##2##(1994-1#1)(1997-2#1)
future demands of##2##3##(2008-10#1)(2010-10#1)
future development in this area##2##5##(2008-10#1)(2008-12#1)
future development of##7##3##(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2011-2#1)(2011-7#1)(2012-2#1)
future development##11##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2011-2#1)(2011-7#1)(2012-2#2)
future developments in##3##3##(2008-10#2)(2008-7#1)
future developments##7##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-7#1)
future direction##3##2##(2008-11#1)(2011-7#1)(2013-1#1)
future directions for##7##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#2)
future directions of##4##3##(1996-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
future directions##27##2##(1991-2#1)(1992-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
future education in##2##3##(1993-3#2)
future evaluation of##3##3##(1990-9#1)(2010-8#1)(2012-3#1)
future experimental##2##2##(1992-9#1)(2008-12#1)
future for##9##2##(1990-2#1)(1991-6#1)(1992-11#1)(1993-3#1)(1997-5#1)(2008-10#1)(2008-11#2)(2012-2#1)
future generations##2##2##(2008-11#2)
future growth##2##2##(1992-1#1)(2008-9#1)
future health care##2##3##(1996-1#1)(1996-2#1)
future health##4##2##(1996-1#1)(1996-2#1)(2008-11#1)(2012-2#1)
future holds##2##2##(1997-1#1)(2008-10#1)
future human##2##2##(2012-2#1)(2012-3#1)
future in##3##2##(1990-6#1)(2008-10#1)(2008-12#1)
future intent to##2##3##(1993-12#1)(2008-4#1)
future interventions##2##2##(2008-12#1)(2013-1#1)
future investigations##5##2##(2008-5#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
future is##4##2##(1992-11#1)(1993-2#1)(1994-1#1)(2008-7#1)
future it is likely that##2##5##(1997-1#1)(2008-8#1)
future it##3##2##(1997-1#1)(2008-8#1)(2009-8#1)
future library##2##2##(1992-12#1)(2013-1#1)
future of general##2##3##(2008-4#1)(2010-8#1)
future of health##2##3##(1994-12#1)(1997-2#1)
future of healthcare##2##3##(1992-12#1)(1995-1#1)
future of hybrid##2##3##(2012-2#2)
future of##48##2##(1991-1#3)(1992-12#1)(1992-3#2)(1993-1#3)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#4)(2013-1#2)
future opportunities##2##2##(2008-10#1)(2011-2#1)
future performance of##2##3##(1991-3#1)(2008-11#1)
future perspectives##4##2##(2008-11#1)(2008-7#1)(2012-3#2)
future population##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
future potential##4##2##(1993-12#2)(2009-12#1)(2013-8#1)
future practice##3##2##(2008-11#2)(2008-12#1)
future production##3##2##(2008-10#2)(2010-5#1)
future prospective##2##2##(2008-1#1)(2010-11#1)
future prospects for##3##3##(1997-6#1)(2008-11#1)(2010-12#1)
future prospects##7##2##(1997-6#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-3#1)
future reproduction##4##2##(2008-8#3)(2008-9#1)
future requirement for##2##3##(1992-3#1)(2008-10#1)
future research and clinical##3##4##(2008-11#1)(2008-12#1)(2010-9#1)
future research and##6##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-9#1)
future research directions##4##3##(1994-3#1)(2008-1#1)(2008-9#1)(2009-9#1)
future research##43##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#5)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-11#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-9#1)(2012-2#4)(2013-1#1)(2013-8#1)
future role##2##2##(1993-2#1)(2008-11#1)
future roles##3##2##(1993-2#1)(2011-1#2)
future strategies##2##2##(1994-2#1)(2011-2#1)
future studies of##7##3##(1995-5#1)(1995-9#1)(2008-10#2)(2008-9#1)(2010-5#1)(2013-1#1)
future studies should##3##3##(2008-8#2)(2012-3#1)
future studies to##2##3##(2008-10#1)(2009-8#1)
future studies##26##2##(1992-2#2)(1992-3#1)(1995-5#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
future study##4##2##(2008-10#2)(2010-12#1)(2010-9#1)
future success##3##2##(1994-12#1)(1995-1#1)(1996-2#1)
future successful##2##2##(1996-12#1)(2013-1#1)
future survivorship and reproduction##2##4##(2008-9#2)
future therapeutic##2##2##(2007-8#1)(2008-11#1)
future training##2##2##(1996-2#1)(2008-9#1)
future treatment##3##2##(1993-2#1)(2008-3#1)(2013-1#1)
future use of##2##3##(2008-10#1)(2012-2#1)
future use##5##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
future work##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
future years##2##2##(1995-12#1)(2010-6#1)
future##646##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#8)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#4)(1991-6#2)(1992-1#4)(1992-11#2)(1992-12#6)(1992-2#5)(1992-3#11)(1992-9#3)(1993-1#4)(1993-11#2)(1993-12#7)(1993-2#9)(1993-3#8)(1993-9#1)(1994-1#8)(1994-11#1)(1994-12#7)(1994-2#9)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#5)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#4)(1995-9#1)(1996-1#6)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#8)(1996-6#3)(1997-1#11)(1997-2#7)(1997-3#6)(1997-4#1)(1997-5#4)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#3)(2008-10#65)(2008-11#64)(2008-12#26)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#14)(2008-8#14)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#7)(2010-12#11)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#2)(2011-2#26)(2011-3#3)(2011-7#4)(2012-12#1)(2012-2#29)(2012-3#15)(2012-4#2)(2012-5#1)(2012-9#2)(2013-1#27)(2013-7#2)(2013-8#12)
future?##4##1##(1997-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
fuzzy C-means##2##2##(2008-10#1)(2009-10#1)
fuzzy control##2##2##(2011-2#2)
fuzzy logic##5##2##(2008-12#2)(2011-2#2)(2013-1#1)
fuzzy##20##1##(1992-12#1)(1996-2#1)(2008-10#5)(2008-12#2)(2009-10#1)(2010-8#2)(2011-2#7)(2013-1#1)
fzp is##2##2##(2008-9#2)
fzp(t)##7##1##(2008-9#7)
fémoral est##2##2##(2011-2#2)
für##4##1##(2008-10#2)(2008-11#2)
fœtal##3##1##(2011-2#1)(2013-1#2)
g (range##2##2##(1996-6#1)(2013-1#1)
g L(-1)##8##2##(2008-11#3)(2008-7#3)(2011-2#2)
g L(-1))##4##2##(2008-10#1)(2008-11#1)(2008-7#2)
g SO(4) (2-)/L per day##2##5##(2008-7#2)
g after##2##2##(1993-3#2)
g and##2##2##(2008-10#1)(2008-3#1)
g cm(-3)##2##2##(2008-10#2)
g kg(-1)##11##2##(2008-10#3)(2008-12#4)(2008-3#4)
g kg(-1)) and##2##3##(2008-10#2)
g kg(-1))##14##2##(2008-10#14)
g l(-1) Cr(III))##2##3##(2008-10#2)
g l(-1) Cr(VI) and 1##2##5##(2008-10#2)
g l(-1) Pd##2##3##(2008-10#2)
g l(-1) for##2##3##(2008-10#2)
g l(-1)##19##2##(2008-10#12)(2008-11#7)
g l(-1))##3##2##(2008-10#3)
g liter(-1) for##4##3##(2008-10#4)
g m(-2)##3##2##(2008-10#2)(2008-11#1)
g ml(-1)##17##2##(2008-10#14)(2008-11#3)
g mol(-1)##3##2##(2008-10#2)(2008-5#1)
g of Al per gram of peat##2##7##(2008-10#2)
g of Al##3##3##(2008-10#3)
g of Amberlite XAD-2 resin##2##5##(2008-10#2)
g of Amberlite##3##3##(2008-10#3)
g of soil##9##3##(2008-10#9)
g of the##2##3##(2008-10#2)
g of##57##2##(1995-2#1)(2008-10#49)(2008-12#6)(2012-3#1)
g or less##2##3##(1991-6#1)(2013-1#1)
g or##4##2##(1991-6#1)(1994-1#1)(2008-11#1)(2013-1#1)
g per##2##2##(2008-10#2)
g protein(-1) (+/-##2##3##(1997-1#2)
g sucrose·kg-1·h-1##3##2##(2013-1#3)
g supernatant##2##2##(1994-11#1)(1994-8#1)
g u-PA was harvested##2##4##(2008-11#2)
g were##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
g with##2##2##(2008-10#1)(2008-11#1)
g##672##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#3)(1991-11#2)(1991-6#3)(1991-8#2)(1992-2#1)(1992-3#6)(1992-9#2)(1993-3#5)(1993-6#1)(1993-8#1)(1994-1#3)(1994-11#3)(1994-3#2)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#4)(1995-8#1)(1996-11#4)(1996-12#2)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#9)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-6#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#255)(2008-11#74)(2008-12#21)(2008-2#3)(2008-3#21)(2008-4#14)(2008-5#11)(2008-6#4)(2008-7#26)(2008-8#23)(2008-9#10)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-4#3)(2009-6#1)(2009-7#4)(2010-1#4)(2010-10#2)(2010-11#7)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#23)(2012-12#1)(2012-2#16)(2012-3#4)(2012-7#1)(2013-1#21)(2013-8#10)
g(-1) and the##2##3##(2008-10#1)(2008-5#1)
g(-1) and##13##2##(2008-10#9)(2008-5#1)(2010-11#1)(2010-5#2)
g(-1) for Co##2##3##(2008-10#2)
g(-1) for Cu##2##3##(2008-10#2)
g(-1) for Ni##3##3##(2008-10#3)
g(-1) for Pb and##2##4##(2008-10#2)
g(-1) for Pb##3##3##(2008-10#3)
g(-1) for the##4##3##(2008-10#4)
g(-1) for##34##2##(2008-10#34)
g(-1) level##8##2##(2008-10#8)
g(-1) level)##2##2##(2008-10#2)
g(-1) of dry##3##3##(2008-10#2)(2008-12#1)
g(-1) of the resin##2##4##(2008-10#2)
g(-1) of the##3##3##(2008-10#3)
g(-1) of##15##2##(2008-10#11)(2008-11#2)(2008-12#1)(2010-8#1)
g(-1) range were##2##3##(2008-10#2)
g(-1) range##3##2##(2008-10#3)
g(-1)##152##1##(2008-10#135)(2008-11#3)(2008-12#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-11#4)(2010-5#2)(2010-8#3)(2012-12#1)
g(-1))##14##1##(2008-10#14)
g) of##2##2##(1990-11#1)(2008-10#1)
g) were##4##2##(1994-3#1)(1996-6#1)(2008-10#2)
g)##18##1##(1990-11#1)(1990-12#1)(1991-11#2)(1994-11#3)(1994-3#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2009-9#1)(2013-1#1)
g-KGM and g-SA##2##3##(2011-2#2)
g-KGM was##2##2##(2011-2#2)
g-KGM##7##1##(2011-2#7)
g-SA##4##1##(2011-2#4)
g/100 ml##2##2##(1990-11#1)(1990-2#1)
g/L of##4##2##(2008-11#2)(2008-7#2)
g/L##17##1##(2007-12#1)(2008-11#4)(2008-6#1)(2008-7#9)(2008-8#2)
g/cellxday in##3##2##(2008-11#3)
g/cm(2) (SD 0##2##3##(2010-3#2)
g/cm(2)##3##1##(2010-3#3)
g/cm2##2##1##(2011-2#2)
g/d##2##1##(2013-1#2)
g/d)##2##1##(2013-1#2)
g/day##3##1##(1997-8#1)(2008-3#1)(2013-8#1)
g/day)##5##1##(1997-8#1)(2008-3#2)(2008-4#1)(2013-8#1)
g/dl##2##1##(1996-12#1)(2013-8#1)
g/g)##2##1##(2011-2#2)
g/kg raw protein)##3##3##(2011-2#3)
g/kg##6##1##(1993-12#1)(1995-11#1)(2008-10#1)(2011-2#3)
g/l with##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
g/l##14##1##(1991-12#1)(1991-6#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-5#6)
g/l)##7##1##(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)
g/m##2##1##(2008-5#2)
g/mol##2##1##(2008-10#1)(2011-2#1)
g/mol)##2##1##(2008-10#1)(2011-2#1)
g2##2##1##(1993-5#1)(2013-8#1)
gPAL1##2##1##(2008-10#2)
gRNA##2##1##(2008-10#2)
gabapentin polymorphs##2##2##(2011-3#2)
gabapentin##10##1##(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#5)(2012-3#1)
gadd genes##4##2##(1992-12#4)
gadd##6##1##(1992-12#6)
gadolinium (Gd)##2##2##(1997-8#1)(2012-2#1)
gadolinium oxide##2##2##(2008-10#1)(2008-11#1)
gadolinium##11##1##(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
gadolinium(III)##3##1##(2008-10#2)(2012-3#1)
gadolinium-enhanced##2##1##(2008-3#1)(2013-1#1)
gaegurins##2##1##(1994-11#2)
gaeumannii colonization##2##2##(2008-10#2)
gaeumannii##9##1##(2008-10#9)
gag##6##1##(1994-12#4)(2008-11#2)
gain a better understanding of the##2##6##(1995-12#1)(2010-9#1)
gain a better understanding of##3##5##(1995-12#1)(2010-9#1)(2012-3#1)
gain a better understanding##4##4##(1995-12#1)(2008-4#1)(2010-9#1)(2012-3#1)
gain a##14##2##(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-8#2)(2010-4#1)(2010-9#2)(2011-1#1)(2012-3#1)(2013-1#1)
gain access to the##4##4##(2007-12#1)(2008-10#2)(2008-12#1)
gain an insight##2##3##(1995-12#1)(2008-11#1)
gain an##4##2##(1995-12#1)(2008-11#1)(2008-8#1)(2009-6#1)
gain and##7##2##(1991-12#1)(1995-10#1)(2007-11#1)(2008-3#2)(2008-5#1)(2010-1#1)
gain better##2##2##(2008-10#1)(2010-1#1)
gain but##2##2##(2008-10#1)(2008-9#1)
gain control##3##2##(1994-3#2)(2008-3#1)
gain coupling##2##2##(2007-11#1)(2008-3#1)
gain entry##3##2##(2008-8#1)(2012-2#1)(2012-3#1)
gain from##5##2##(1996-6#1)(2008-10#1)(2008-3#1)(2008-8#2)
gain further insight into##5##4##(1996-12#1)(1997-9#1)(2008-11#3)
gain in the##2##3##(2011-2#1)(2013-1#1)
gain in##6##2##(1991-2#1)(1992-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
gain insight into the mechanism of##2##6##(2008-10#2)
gain insight into the mechanism##4##5##(1990-5#1)(2008-10#3)
gain insight into the##8##4##(1990-5#1)(2008-10#4)(2009-4#1)(2010-12#1)(2012-3#1)
gain insight into their##2##4##(2008-10#1)(2012-3#1)
gain insight into##13##3##(1990-5#1)(1993-6#1)(2008-10#6)(2008-6#1)(2009-4#1)(2010-12#1)(2012-3#2)
gain insight##14##2##(1990-5#1)(1993-6#1)(2008-10#6)(2008-11#1)(2008-6#1)(2009-4#1)(2010-12#1)(2012-3#2)
gain insights into##2##3##(2008-10#2)
gain medium above##2##3##(2008-3#2)
gain medium##5##2##(2008-3#5)
gain more##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
gain of function##2##3##(2008-4#1)(2011-2#1)
gain of##11##2##(2008-10#1)(2008-3#3)(2008-4#1)(2008-9#1)(2011-2#2)(2012-3#2)(2013-8#1)
gain or##2##2##(2008-11#1)(2008-9#1)
gain saturation##2##2##(2008-3#2)
gain than##4##2##(2008-9#1)(2011-2#1)(2013-1#2)
gain that##2##2##(2007-11#1)(2008-10#1)
gain understanding##2##2##(2008-10#1)(2010-10#1)
gain##208##1##(1990-5#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#3)(1995-10#1)(1995-12#2)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(1997-9#1)(2007-11#6)(2007-12#4)(2008-10#25)(2008-11#16)(2008-12#4)(2008-2#1)(2008-3#38)(2008-4#3)(2008-5#3)(2008-6#2)(2008-8#13)(2008-9#14)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#15)(2013-8#2)
gain)##3##1##(2008-10#1)(2011-2#2)
gain-clamped fiber amplifiers##2##3##(2008-3#2)
gain-clamped##3##1##(2008-3#3)
gain-of-function mutations in##3##3##(2012-2#1)(2012-3#2)
gain-of-function##5##1##(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#2)
gained a##4##2##(1991-2#1)(1992-3#1)(2008-10#1)(2008-11#1)
gained an##2##2##(2008-12#1)(2008-3#1)
gained by##7##2##(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-3#1)
gained from the##2##3##(2011-8#1)(2012-2#1)
gained from##6##2##(2010-10#1)(2010-4#1)(2010-9#1)(2011-10#1)(2011-8#1)(2012-2#1)
gained in##3##2##(1996-3#1)(2008-12#1)(2010-11#1)
gained increasing##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
gained more##2##2##(1991-12#1)(1992-2#1)
gained over##2##2##(2008-9#1)(2012-2#1)
gained popularity##2##2##(1992-12#1)(2010-12#1)
gained through##2##2##(1994-12#1)(2008-9#1)
gained weight##2##2##(1993-1#1)(2010-8#1)
gained##73##1##(1991-12#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-7#1)(2008-10#18)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2011-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
gaining ground##2##2##(1997-5#1)(2009-12#1)
gaining##27##1##(1991-1#1)(1991-3#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-5#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-8#2)
gains access to##2##3##(1997-6#1)(2008-10#1)
gains and losses and##2##4##(2009-10#2)
gains and losses##3##3##(2009-10#2)(2009-6#1)
gains and##6##2##(2007-11#1)(2009-10#2)(2009-6#1)(2011-7#1)(2013-1#1)
gains at##2##2##(1990-11#1)(2009-11#1)
gains from##4##2##(1993-2#1)(1994-3#2)(2012-3#1)
gains in##3##2##(2008-8#1)(2009-11#1)(2013-8#1)
gains of##4##2##(2008-9#1)(2009-11#1)(2010-3#1)(2011-2#1)
gains or losses of##2##4##(2008-10#2)
gains or losses##3##3##(2008-10#3)
gains that##2##2##(1996-5#1)(2009-11#1)
gains were##5##2##(2008-5#1)(2008-9#1)(2009-11#1)(2012-3#1)(2013-1#1)
gains##65##1##(1990-11#2)(1991-12#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#8)(2009-6#1)(2010-3#2)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
gaisen##2##1##(2008-10#2)
gait analysis##3##2##(2013-1#3)
gait and balance disorders in##2##5##(2013-1#2)
gait and balance disorders##3##4##(2008-7#1)(2013-1#2)
gait and##5##2##(2008-7#1)(2010-9#2)(2013-1#2)
gait disorders##3##2##(2013-1#3)
gait in##2##2##(2008-12#1)(2013-1#1)
gait or##2##2##(1994-8#1)(2008-7#1)
gait performance##4##2##(2012-12#1)(2013-1#3)
gait##40##1##(1994-3#1)(1994-8#3)(1997-5#1)(2008-12#2)(2008-7#5)(2010-3#1)(2010-9#3)(2011-10#1)(2012-12#1)(2012-2#1)(2013-1#21)
galactography##4##1##(1990-11#4)
galactosamine and##2##2##(1994-11#1)(2008-10#1)
galactosamine labeled with daunomycin##2##4##(2008-10#2)
galactosamine##10##1##(1994-11#1)(1994-8#1)(2008-10#8)
galactose residues##2##2##(2008-10#1)(2008-8#1)
galactose were##2##2##(1996-12#1)(2013-1#1)
galactose##26##1##(1990-2#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#3)(2008-8#2)(2013-1#3)
galactose-inducible promoter##2##2##(1993-9#1)(1995-6#1)
galactose-inducible##3##1##(1993-9#1)(1995-6#2)
galactosemia in neonate##2##3##(2012-3#2)
galactosemia##3##1##(1995-8#1)(2012-3#2)
galactosyl##2##1##(1991-12#1)(1995-2#1)
galactosyltransferase##2##1##(2008-7#1)(2008-9#1)
galah##2##1##(2008-5#2)
galanin inhibits insulin##2##3##(1994-8#2)
galanin##12##1##(1994-8#10)(1996-12#2)
galanin(-7-16)##2##1##(1994-8#2)
galanin(-9-16)##2##1##(1994-8#2)
galantamine##2##1##(2012-2#2)
galaxies##2##1##(1990-11#1)(1995-6#1)
galaxiid Galaxias##2##2##(2010-8#2)
galea##2##1##(2008-9#2)
galectin-3##2##1##(2009-3#2)
gall bladder##4##2##(1992-6#1)(2008-8#1)(2010-11#2)
gall formation##4##2##(2008-10#2)(2009-8#2)
gall induction##2##2##(2009-8#1)(2011-2#1)
gall of##3##2##(2008-10#3)
gall##33##1##(1992-6#1)(1997-8#1)(2008-10#24)(2008-8#1)(2009-8#3)(2010-11#2)(2011-2#1)
gall-insect species##2##2##(2009-8#2)
gallate and##2##2##(1996-2#1)(2008-11#1)
gallate##11##1##(1996-2#1)(2008-10#3)(2008-11#6)(2009-8#1)
gallates##2##1##(2008-11#1)(2009-8#1)
gallbladder adenocarcinoma##2##2##(1991-8#2)
gallbladder and##2##2##(1992-9#1)(2010-1#1)
gallbladder cancer##8##2##(2010-12#8)
gallbladder carcinoma##2##2##(2008-11#2)
gallbladder containing echogenic bile##2##4##(2013-1#2)
gallbladder containing##3##2##(2013-1#3)
gallbladder disease##2##2##(1991-3#1)(2008-12#1)
gallbladder size##3##2##(2011-2#3)
gallbladder##50##1##(1990-12#1)(1990-9#2)(1991-12#3)(1991-3#1)(1991-6#2)(1991-8#3)(1992-9#3)(1994-2#1)(1994-6#1)(1995-11#1)(1996-6#2)(1997-8#3)(2008-11#3)(2008-12#1)(2010-1#1)(2010-12#10)(2011-2#5)(2012-3#2)(2013-1#4)(2013-8#1)
galled tissue##2##2##(2008-10#2)
gallic acid and tannic acid are##2##6##(2008-10#2)
gallic acid and tannic acid##3##5##(2008-10#3)
gallic acid and##6##3##(2008-10#5)(2011-1#1)
gallic acid##15##2##(2008-10#12)(2008-6#2)(2011-1#1)
gallic##17##1##(2008-10#13)(2008-6#2)(2011-1#2)
gallinae##2##1##(1997-5#2)
gallisepticum and##2##2##(1993-12#2)
gallium and indium##2##3##(2008-10#2)
gallium and##5##2##(2008-10#5)
gallium##32##1##(1990-12#1)(1991-12#1)(1992-11#1)(1993-11#1)(2008-10#26)(2008-2#1)(2011-2#1)
gallium(III)##7##1##(2008-10#7)
galls on##7##2##(2008-10#6)(2009-8#1)
galls were##2##2##(2008-10#2)
galls##25##1##(2008-10#24)(2009-8#1)
gallstone disease##2##2##(1997-8#2)
gallstone ileus##2##2##(2008-12#1)(2012-12#1)
gallstone##8##1##(1990-9#1)(1997-8#2)(2008-12#4)(2012-12#1)
gallus##2##1##(2008-5#1)(2008-9#1)
galvanic cells##3##2##(2008-10#3)
galvanic detector##3##2##(2008-10#3)
galvanic skin response##2##3##(2012-3#2)
galvanic##14##1##(2008-10#10)(2010-1#1)(2012-2#1)(2012-3#2)
galvanostatic##6##1##(2008-10#5)(2009-10#1)
gamble##3##1##(1997-6#1)(2011-2#2)
gambling in##2##2##(2008-11#1)(2013-8#1)
gambling problems##2##2##(2008-11#2)
gambling##16##1##(1993-6#1)(2008-10#1)(2008-11#11)(2013-8#3)
game model of##2##3##(2008-8#1)(2008-9#1)
game reserves##2##2##(1990-3#2)
game theoretic##2##2##(2008-8#2)
game theoretical##2##2##(2008-9#1)(2012-3#1)
game##25##1##(1990-3#3)(1993-1#1)(2008-11#2)(2008-8#6)(2008-9#8)(2010-1#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
games##4##1##(1993-3#1)(2008-8#1)(2013-8#2)
gamete##3##1##(1996-9#1)(2008-12#1)(2008-8#1)
gametes##7##1##(1997-7#1)(2008-11#2)(2008-8#3)(2013-1#1)
gametic disequilibrium##5##2##(2008-10#5)
gametic equilibrium##3##2##(2008-10#3)
gametic phase disequilibrium##3##3##(2008-10#3)
gametic phase##5##2##(2008-10#4)(2012-3#1)
gametic##16##1##(2008-10#12)(2008-11#1)(2008-8#1)(2010-5#1)(2012-3#1)
gametophytic cytokinesis##3##2##(2009-10#3)
gamma 2 subunit##6##3##(1995-11#3)(1995-12#3)
gamma 2##14##2##(1994-12#6)(1995-11#5)(1995-12#3)
gamma 2L subunits##3##3##(1995-11#3)
gamma 2L##5##2##(1995-11#5)
gamma 2S and alpha##2##4##(1995-11#2)
gamma 3##6##2##(1995-11#6)
gamma S binding by##2##4##(1993-8#1)(1996-2#1)
gamma S binding was##3##4##(1996-2#3)
gamma S binding##8##3##(1993-8#2)(1996-2#6)
gamma S##20##2##(1991-6#3)(1992-8#3)(1993-8#4)(1995-8#4)(1996-2#6)
gamma and delta-tocopherols##2##3##(2008-5#2)
gamma and epsilon##2##3##(2008-8#2)
gamma and##8##2##(1995-5#1)(1996-8#1)(2008-11#1)(2008-5#2)(2008-8#3)
gamma camera to##2##3##(1996-3#1)(2010-3#1)
gamma camera##7##2##(1994-2#1)(1996-2#3)(1996-3#1)(2010-3#1)(2012-12#1)
gamma delta T cells##3##4##(1993-8#3)
gamma delta##4##2##(1993-8#4)
gamma from##2##2##(1992-6#1)(2008-2#1)
gamma glutamyl##2##2##(2007-12#1)(2009-6#1)
gamma in##2##2##(2008-2#1)(2013-8#1)
gamma interferon##3##2##(1990-5#1)(1993-8#1)(2008-10#1)
gamma irradiation##2##2##(2007-12#1)(2010-10#1)
gamma is##3##2##(1993-12#1)(2008-2#1)(2008-3#1)
gamma knife##2##2##(1997-4#1)(2008-7#1)
gamma of##2##2##(1991-3#1)(2008-3#1)
gamma radiation##2##2##(1997-4#1)(2008-5#1)
gamma rays##2##2##(1993-9#1)(1994-12#1)
gamma subunit is##3##3##(2008-8#3)
gamma subunit##5##2##(1995-11#1)(2008-8#4)
gamma subunits of##3##3##(1992-9#1)(1995-8#1)(2008-8#1)
gamma subunits##6##2##(1992-9#1)(1995-11#1)(1995-8#1)(2008-8#3)
gamma##171##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#4)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#4)(1993-6#3)(1993-8#11)(1993-9#3)(1994-12#9)(1994-2#1)(1994-3#2)(1995-11#22)(1995-12#4)(1995-2#2)(1995-5#1)(1995-8#7)(1996-2#10)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-4#3)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#8)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#5)(2008-7#1)(2008-8#18)(2008-9#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-3#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
gamma)##4##1##(1993-12#1)(1994-8#1)(1995-8#1)(2008-10#1)
gamma-3 proteobacterium##2##2##(2008-10#2)
gamma-CD##7##1##(2008-10#7)
gamma-Cry##2##1##(1993-6#2)
gamma-Fe(2)O(3)##3##1##(2008-10#3)
gamma-GTP##5##1##(1995-11#5)
gamma-IFN##8##1##(1994-5#7)(2008-11#1)
gamma-IFN--transduced##4##1##(1994-5#4)
gamma-LiAlO(2)##4##1##(2008-10#4)
gamma-alkenyl##2##1##(1996-5#2)
gamma-aminobutyric acid (GABA)##4##3##(1995-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
gamma-aminobutyric acid##17##2##(1990-5#1)(1990-7#1)(1995-11#2)(1995-12#1)(1995-2#2)(1997-2#1)(1997-3#4)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
gamma-camera##2##1##(1996-1#1)(2010-3#1)
gamma-crustacyanin##2##1##(2008-12#2)
gamma-cry##6##1##(1993-6#6)
gamma-cyclodextrin-based##2##1##(2008-10#2)
gamma-diketo##2##1##(2011-3#2)
gamma-globulin in##2##2##(2008-10#2)
gamma-globulin##6##1##(2008-10#6)
gamma-glutamyl##5##1##(1990-5#1)(1995-11#2)(2006-6#2)
gamma-glutamylcysteine synthetase##3##2##(1995-9#2)(2008-11#1)
gamma-glutamyltransferase##3##1##(1995-11#1)(2008-10#1)(2008-5#1)
gamma-interferon##4##1##(1996-12#3)(2009-12#1)
gamma-irradiated##5##1##(1995-8#1)(2008-10#4)
gamma-irradiation of##3##2##(2008-10#3)
gamma-knife and##2##2##(2008-7#2)
gamma-knife##5##1##(2008-7#5)
gamma-meso axis##2##2##(1994-5#2)
gamma-methylene-ATP##3##1##(1995-8#3)
gamma-microglobulin##2##1##(1990-12#2)
gamma-motor activity##2##2##(1996-2#2)
gamma-motor##3##1##(1996-2#3)
gamma-proteobacteria##2##1##(2009-8#2)
gamma-ray##2##1##(2008-10#1)(2010-3#1)
gamma-rays##4##1##(1995-8#1)(2008-10#2)(2008-11#1)
gamma-sultone##2##1##(2008-10#2)
gamma-terpinene##2##1##(2008-11#1)(2008-12#1)
gamma-theta oscillation##2##2##(2008-11#2)
gamma-tub##2##1##(1993-12#2)
gamma1##2##1##(2008-11#2)
gammaglobulin##5##1##(1996-1#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
gamut##2##1##(2008-3#1)(2008-8#1)
ganglia and the##2##3##(1992-12#1)(2008-5#1)
ganglia and##3##2##(1992-12#1)(2008-5#1)(2008-7#1)
ganglia are##2##2##(2008-7#2)
ganglia hemorrhage##2##2##(2013-1#2)
ganglia of the##5##3##(1990-2#1)(1994-11#1)(2008-5#1)(2008-9#1)(2009-8#1)
ganglia of##9##2##(1990-2#1)(1991-5#1)(1994-11#1)(1997-3#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
ganglia were NADPH-diaphorase positive##2##4##(1992-12#2)
ganglia##57##1##(1990-2#1)(1991-5#1)(1992-12#4)(1992-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1996-12#4)(1996-6#1)(1997-3#6)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#11)(2008-9#3)(2009-10#1)(2009-11#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-8#2)
ganglia/cm2)##2##1##(1997-3#2)
ganglion and##2##2##(1996-12#1)(1996-2#1)
ganglion cells were found##2##4##(1997-3#1)(1997-4#1)
ganglion cells##7##2##(1991-7#1)(1997-3#2)(1997-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
ganglion cyst of the##2##4##(2008-9#1)(2009-1#1)
ganglion cyst##5##2##(2008-9#1)(2009-1#1)(2013-8#3)
ganglion following##2##2##(1997-2#1)(2008-9#1)
ganglion is##2##2##(2011-2#2)
ganglion neurons##12##2##(1990-5#1)(1994-12#1)(1996-12#3)(2008-5#1)(2008-7#5)(2013-8#1)
ganglion of##2##2##(1990-5#1)(2008-8#1)
ganglion##66##1##(1990-5#2)(1991-7#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#5)(1996-2#2)(1997-2#2)(1997-3#5)(1997-4#1)(2008-4#1)(2008-5#6)(2008-7#8)(2008-8#3)(2008-9#10)(2009-1#1)(2011-2#9)(2013-8#6)
ganglioneuroblastoma##2##1##(1990-6#2)
ganglioneuromatosis##2##1##(2009-1#2)
ganglionic##2##1##(1990-8#1)(2008-5#1)
ganglions##3##1##(2008-5#2)(2008-9#1)
ganglioside##5##1##(1990-5#2)(1991-5#2)(1993-3#1)
gangliosides##5##1##(1990-5#2)(1993-3#2)(2012-3#1)
gangrene##13##1##(1997-8#2)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#7)
gangrenosum##5##1##(2010-12#4)(2013-1#1)
gap and smooth septate junctions##2##5##(2008-7#2)
gap and##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#3)(2010-7#1)
gap at##2##2##(1990-12#1)(2008-11#1)
gap between the##4##3##(2008-10#2)(2008-3#1)(2012-12#1)
gap between##20##2##(1990-2#1)(1993-12#2)(1994-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
gap by##2##2##(2008-7#1)(2012-2#1)
gap in our knowledge##2##4##(2008-8#1)(2010-5#1)
gap in##10##2##(1991-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
gap junction area##2##3##(1994-3#2)
gap junction protein##3##3##(2008-7#1)(2008-9#2)
gap junction##13##2##(1994-3#4)(2008-7#2)(2008-9#2)(2012-2#4)(2013-8#1)
gap junctional intercellular communication##2##4##(1994-11#1)(2008-11#1)
gap junctional##4##2##(1994-11#2)(2008-11#2)
gap junctions and##2##3##(1994-3#1)(2008-11#1)
gap junctions between##2##3##(2012-2#2)
gap junctions##10##2##(1994-3#2)(2008-11#1)(2008-7#4)(2009-10#1)(2012-2#2)
gap size##2##2##(2008-10#2)
gap##110##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-3#6)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#19)(2008-12#6)(2008-3#4)(2008-5#1)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#11)(2013-1#4)(2013-8#1)
gaps in knowledge##2##3##(2010-3#1)(2012-12#1)
gaps in our knowledge##2##4##(2009-10#1)(2010-12#1)
gaps in our##3##3##(2008-12#1)(2009-10#1)(2010-12#1)
gaps in the##5##3##(1992-3#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
gaps in##16##2##(1992-3#1)(1995-12#1)(2008-10#1)(2008-12#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#2)(2013-1#3)
gaps that##2##2##(1996-3#1)(1997-1#1)
gaps##34##1##(1992-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2009-10#1)(2009-3#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#5)
gaps&quot##2##1##(1993-3#2)
garamycin##2##1##(2007-11#1)(2011-2#1)
garbage##4##1##(1993-2#2)(2008-10#1)(2011-2#1)
garden##6##1##(2008-10#2)(2008-7#2)(2010-6#1)(2012-3#1)
gardening##2##1##(2009-8#1)(2010-6#1)
gardens##10##1##(1997-3#1)(2008-10#3)(2009-6#1)(2010-5#1)(2010-6#1)(2012-2#3)
garenoxacin##8##1##(2008-10#6)(2011-2#2)
garlic and leek##2##3##(2008-10#2)
garlic and##4##2##(2008-10#4)
garlic oil##5##2##(2008-9#5)
garlic##15##1##(2008-10#6)(2008-9#9)
garments##2##1##(2008-10#1)(2011-2#1)
garter snake##2##2##(2008-8#1)(2008-9#1)
garter##3##1##(2008-8#2)(2008-9#1)
gas absorption cell##2##3##(2008-10#1)(2008-3#1)
gas analysis was performed##2##4##(2008-10#1)(2011-2#1)
gas analysis was##3##3##(2008-10#2)(2011-2#1)
gas analysis##9##2##(2008-10#6)(2008-2#1)(2010-10#1)(2011-2#1)
gas and liquid chromatography##2##4##(2008-10#1)(2011-2#1)
gas and liquid##3##3##(2008-10#2)(2011-2#1)
gas and the##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
gas and##11##2##(1992-2#1)(1996-12#1)(2008-10#6)(2011-2#1)(2012-2#1)(2012-3#1)
gas are##2##2##(2008-10#1)(2012-2#1)
gas ballooning##2##2##(2008-11#2)
gas bubbles##2##2##(2008-11#1)(2012-2#1)
gas by##3##2##(2008-10#2)(2008-3#1)
gas cell and##2##3##(2008-10#1)(2008-3#1)
gas cell measurements##3##3##(2008-3#3)
gas cell of##2##3##(2008-10#2)
gas cell##13##2##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#5)
gas chromatograph##7##2##(2008-10#6)(2008-11#1)
gas chromatograph-mass spectrometer##3##3##(2008-10#3)
gas chromatographic method##4##3##(1996-12#1)(2008-10#3)
gas chromatographic retention indices##2##4##(2008-10#2)
gas chromatographic retention##3##3##(2008-10#3)
gas chromatographic##20##2##(1996-12#1)(2008-10#19)
gas chromatography (GC) with##3##4##(2008-10#3)
gas chromatography (GC) without##2##4##(2008-10#1)(2008-5#1)
gas chromatography (GC)##18##3##(2008-10#17)(2008-5#1)
gas chromatography and##6##3##(2008-10#6)
gas chromatography combined with##3##4##(2008-10#2)(2008-11#1)
gas chromatography coupled to mass spectrometry##2##6##(2008-10#2)
gas chromatography coupled to##3##4##(2008-10#3)
gas chromatography coupled##5##3##(2008-10#5)
gas chromatography of##2##3##(2008-5#1)(2008-7#1)
gas chromatography on##2##3##(1991-12#1)(2008-10#1)
gas chromatography using a##2##4##(2008-10#1)(2009-8#1)
gas chromatography using##7##3##(2008-10#6)(2009-8#1)
gas chromatography with an electron capture detector##2##7##(2008-10#2)
gas chromatography with electron capture detection##2##6##(2008-10#2)
gas chromatography with electron##4##4##(2008-10#4)
gas chromatography with##17##3##(2008-10#17)
gas chromatography##97##2##(1991-12#1)(1993-1#1)(1994-5#1)(2007-12#1)(2008-10#81)(2008-11#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#3)(2012-2#1)
gas chromatography-Fourier transform infrared spectroscopy##2##5##(2008-10#2)
gas chromatography-electron capture##2##3##(2008-10#2)
gas chromatography-high resolution mass spectrometry (GC-HRMS)##2##6##(2008-10#2)
gas chromatography-high resolution mass spectrometry##3##5##(2008-10#3)
gas chromatography-ion trap-mass##2##3##(2008-10#2)
gas chromatography-mass spectrometry (GC-MS) and##2##5##(1990-5#1)(2008-10#1)
gas chromatography-mass spectrometry (GC-MS) has been##2##6##(2008-10#1)(2008-5#1)
gas chromatography-mass spectrometry (GC-MS)##17##4##(1990-5#1)(2008-10#15)(2008-5#1)
gas chromatography-mass spectrometry (GC/MS)##2##4##(2008-10#2)
gas chromatography-mass spectrometry in##2##4##(1992-3#1)(2008-10#1)
gas chromatography-mass spectrometry##38##3##(1990-5#1)(1992-3#1)(1994-2#1)(2008-10#31)(2008-11#1)(2008-5#1)(2012-12#1)(2013-8#1)
gas chromatography-mass spectrum##2##3##(2008-10#2)
gas chromatography-mass##42##2##(1990-5#1)(1992-3#1)(1994-2#1)(2008-10#35)(2008-11#1)(2008-5#1)(2012-12#1)(2013-8#1)
gas chromatography/mass spectrometry (GC/MS)##3##4##(1995-11#1)(2008-10#2)
gas chromatography/mass spectrometry##5##3##(1995-11#1)(2008-10#4)
gas chromatography/mass##6##2##(1995-11#1)(2008-10#5)
gas concentration##2##2##(2008-10#1)(2008-3#1)
gas concentrations##4##2##(1996-12#1)(2008-10#1)(2008-11#2)
gas density##2##2##(1992-12#1)(2008-3#1)
gas detection##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
gas diffusion unit##2##3##(2008-10#2)
gas diffusion##5##2##(2008-10#5)
gas diffusion-flow injection##4##3##(2008-10#4)
gas embolism##3##2##(1991-11#1)(2012-2#2)
gas exchange in##2##3##(2010-4#1)(2012-5#1)
gas exchange is##2##3##(1997-1#1)(2007-12#1)
gas exchange patterns##3##3##(2010-4#3)
gas exchange##18##2##(1994-5#1)(1997-1#3)(2007-12#3)(2008-10#1)(2008-9#1)(2010-4#6)(2012-3#2)(2012-5#1)
gas exposures##2##2##(1996-12#2)
gas flow rate of##3##4##(2008-10#3)
gas flow rate##13##3##(2008-10#13)
gas flow rates##4##3##(2008-10#4)
gas flow to##2##3##(2011-2#2)
gas flow##27##2##(2008-10#23)(2008-9#1)(2011-2#3)
gas flows##2##2##(2008-2#1)(2008-3#1)
gas from##2##2##(2008-10#1)(2012-2#1)
gas gangrene##5##2##(2011-2#2)(2013-1#3)
gas in the##3##3##(2008-10#2)(2012-12#1)
gas in##7##2##(2008-10#3)(2008-3#1)(2010-12#1)(2012-12#2)
gas is passed##2##3##(2008-10#2)
gas is##6##2##(2008-10#5)(2008-3#1)
gas mixture##2##2##(2008-10#1)(2008-3#1)
gas on the##3##3##(2008-10#2)(2011-2#1)
gas or##3##2##(2008-10#2)(2008-4#1)
gas permeable membrane##3##3##(2008-10#3)
gas phase and particulates##3##4##(2008-10#3)
gas phase and##4##3##(2008-10#4)
gas phase molecular absorption spectrometry##6##5##(2008-10#6)
gas phase molecular absorption##9##4##(2008-10#9)
gas phase##31##2##(1990-8#1)(1992-11#1)(2008-10#22)(2008-11#3)(2008-3#1)(2008-6#1)(2009-9#1)(2010-7#1)
gas pressure is##2##3##(2008-10#1)(2008-3#1)
gas pressure##6##2##(1995-11#1)(2008-10#3)(2008-3#2)
gas sample##2##2##(2008-10#1)(2008-11#1)
gas sensing##2##2##(2007-12#1)(2008-10#1)
gas sensor##8##2##(2008-10#7)(2008-3#1)
gas sensors##5##2##(2008-10#4)(2008-11#1)
gas to##3##2##(2008-10#2)(2008-3#1)
gas using##3##2##(2008-10#3)
gas vesicles##5##2##(2008-11#5)
gas was##6##2##(2008-10#6)
gas##548##1##(1990-5#3)(1990-8#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-5#3)(1995-11#2)(1995-3#2)(1996-12#9)(1996-2#1)(1997-1#5)(1997-2#2)(1997-3#1)(2007-12#7)(2008-10#355)(2008-11#26)(2008-2#5)(2008-3#31)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#4)(2009-12#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#6)(2010-6#1)(2010-7#3)(2011-2#17)(2012-12#6)(2012-2#13)(2012-3#4)(2012-5#1)(2013-1#5)(2013-8#1)
gas-chromatographic##3##1##(2008-10#3)
gas-diffusion (GD)##3##2##(2008-10#3)
gas-diffusion separation##2##2##(2008-10#2)
gas-diffusion##8##1##(2008-10#8)
gas-exchange##2##1##(2008-10#2)
gas-lift reactors##2##2##(2008-7#2)
gas-like##3##1##(2012-2#3)
gas-liquid chromatography##2##2##(2008-10#2)
gas-liquid separator and then is swept into a##2##8##(2008-10#2)
gas-liquid separator and##4##3##(2008-10#4)
gas-liquid separator##10##2##(2008-10#10)
gas-liquid##16##1##(2008-10#16)
gas-mass spectrometry at##2##3##(2008-5#2)
gas-permeable membrane##2##2##(2008-10#2)
gas-permeable##5##1##(2008-10#4)(2008-7#1)
gas-permeation flow-injection##2##2##(2008-10#2)
gas-permeation##3##1##(2008-10#3)
gas-phase temperatures in flames##2##4##(2008-3#2)
gas-phase##9##1##(1992-6#1)(1994-5#1)(2008-10#3)(2008-3#3)(2011-2#1)
gas-related emergencies##2##2##(2011-2#2)
gas-sensing##3##1##(2008-10#1)(2008-3#1)(2012-2#1)
gas/liquid##2##1##(2008-10#2)
gas/solid##2##1##(2008-7#2)
gaseous SbH(3)##2##2##(2008-10#2)
gaseous nitric oxide##2##3##(2008-10#2)
gaseous phase is measured at##2##5##(2008-10#2)
gaseous phase is##4##3##(2008-10#4)
gaseous phase##5##2##(2008-10#5)
gaseous pollutants##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
gaseous sample##3##2##(2008-10#3)
gaseous samples##5##2##(2008-10#5)
gaseous selenium in the atmosphere##2##5##(2008-10#2)
gaseous selenium in##3##3##(2008-10#3)
gaseous selenium##4##2##(2008-10#4)
gaseous species##3##2##(2008-10#3)
gaseous##56##1##(1996-12#1)(2008-10#52)(2008-11#1)(2008-3#2)
gases and##4##2##(1993-2#1)(1996-12#2)(2008-10#1)
gases are##2##2##(1992-3#1)(2008-11#1)
gases can be##2##3##(1996-12#1)(2008-10#1)
gases in a##2##3##(2008-10#1)(2008-3#1)
gases in##4##2##(1996-12#1)(2008-10#1)(2008-3#2)
gases such as##5##3##(1992-3#1)(1997-1#1)(2008-10#2)(2009-12#1)
gases##58##1##(1991-5#1)(1991-6#1)(1992-3#2)(1993-2#1)(1993-3#2)(1996-1#1)(1996-12#8)(1997-1#6)(2008-10#17)(2008-11#3)(2008-2#2)(2008-3#9)(2009-1#1)(2009-12#1)(2012-2#2)(2012-3#1)
gasoline##14##1##(1994-3#1)(2008-10#12)(2008-3#1)
gastrectomy (PPG)##2##2##(2008-12#2)
gastrectomy##10##1##(1990-9#1)(1991-6#1)(1992-9#1)(1993-2#1)(2008-12#2)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
gastric MALT lymphoma##2##3##(1997-1#2)
gastric MALT##3##2##(1997-1#3)
gastric T cell lymphoma##3##4##(2009-8#3)
gastric acid secretion and##2##4##(1992-6#1)(1997-1#1)
gastric acid secretion##7##3##(1992-6#2)(1993-12#1)(1997-1#4)
gastric acid##9##2##(1992-6#2)(1993-12#1)(1993-3#1)(1996-11#1)(1997-1#4)
gastric adenocarcinoma MGC803 cell##2##4##(2008-9#2)
gastric adenocarcinoma and##2##3##(1990-2#1)(2008-12#1)
gastric adenocarcinoma##7##2##(1990-2#1)(1995-2#1)(1997-1#1)(2008-12#1)(2008-9#3)
gastric and duodenal ulcers##2##4##(1995-2#1)(2008-12#1)
gastric and##4##2##(1992-5#1)(1995-2#1)(2008-12#1)(2008-5#1)
gastric banding##4##2##(2012-12#4)
gastric bypass surgery##2##3##(2012-2#1)(2012-5#1)
gastric bypass##6##2##(2010-8#3)(2012-2#1)(2012-5#2)
gastric cancer and##2##3##(2011-2#2)
gastric cancer cell line##3##4##(2008-11#1)(2008-9#2)
gastric cancer cell##5##3##(2008-11#2)(2008-9#3)
gastric cancer cells##4##3##(2008-11#3)(2008-9#1)
gastric cancer in the##2##4##(2008-12#1)(2011-2#1)
gastric cancer in##7##3##(2008-12#4)(2011-2#2)(2012-3#1)
gastric cancer patients##2##3##(2011-2#2)
gastric cancer##48##2##(1990-2#1)(1990-8#1)(1990-9#5)(1992-12#1)(1992-9#1)(1997-1#3)(2008-11#5)(2008-12#10)(2008-9#4)(2010-12#2)(2011-2#13)(2012-3#2)
gastric cancer]##2##2##(1990-9#1)(2011-2#1)
gastric carcinoma##8##2##(1992-9#1)(1994-12#1)(2008-11#1)(2008-12#1)(2008-9#2)(2010-12#1)(2012-2#1)
gastric contents##3##2##(1992-12#3)
gastric diseases##2##2##(1990-9#1)(2011-2#1)
gastric distension##2##2##(2010-12#2)
gastric electrical##2##2##(2012-3#2)
gastric emptying rate of saline##2##5##(1997-4#2)
gastric emptying rate of##3##4##(1997-4#3)
gastric emptying##10##2##(1990-12#1)(1997-4#6)(2012-2#3)
gastric events##3##2##(2008-11#3)
gastric function##4##2##(1992-6#3)(1997-4#1)
gastric glands##2##2##(1990-9#1)(2009-8#1)
gastric glomus tumors##5##3##(2013-1#5)
gastric inhibitory peptide##2##3##(2008-11#2)
gastric inhibitory##3##2##(1997-4#1)(2008-11#2)
gastric juice and feces##4##4##(1993-2#4)
gastric juice##9##2##(1993-2#4)(2008-10#5)
gastric lymphoma##2##2##(2008-12#2)
gastric marginal zone##2##3##(2009-8#2)
gastric mucosa##5##2##(1990-2#1)(1990-3#1)(1996-3#1)(1997-1#1)(1997-7#1)
gastric mucosal##4##2##(1992-6#1)(1997-1#2)(2012-2#1)
gastric neoplasm##3##2##(1992-9#1)(2013-1#2)
gastric neuroendocrine tumor is##3##4##(1997-1#3)
gastric neuroendocrine tumor##6##3##(1997-1#6)
gastric neuroendocrine##7##2##(1997-1#7)
gastric outlet obstruction##3##3##(2008-12#2)(2013-1#1)
gastric pH##2##2##(1993-12#1)(2011-2#1)
gastric parietal##3##2##(1997-1#3)
gastric resection##4##2##(1991-6#3)(2012-3#1)
gastric stump cancer##2##3##(1992-9#2)
gastric stump##3##2##(1991-6#1)(1992-9#2)
gastric trichobezoar in a young female##2##6##(2008-12#2)
gastric tube placement##3##3##(2010-7#3)
gastric tumors##2##2##(1991-6#1)(1992-9#1)
gastric ulcer and##3##3##(1992-11#2)(2011-2#1)
gastric ulcer##13##2##(1990-3#2)(1992-11#2)(1992-6#1)(2007-11#1)(2008-11#2)(2008-12#3)(2011-2#2)
gastric ulcers##3##2##(1990-3#1)(1992-11#1)(2008-12#1)
gastric wall##4##2##(1992-9#2)(2009-8#1)(2010-12#1)
gastric##276##1##(1990-12#1)(1990-2#6)(1990-3#4)(1990-8#1)(1990-9#10)(1991-3#1)(1991-6#7)(1992-11#3)(1992-12#4)(1992-5#2)(1992-6#12)(1992-9#10)(1993-12#2)(1993-2#5)(1993-3#2)(1993-5#1)(1994-12#1)(1994-8#4)(1995-2#3)(1995-6#3)(1996-11#1)(1996-12#2)(1996-3#2)(1997-1#31)(1997-4#9)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#19)(2008-12#30)(2008-5#2)(2008-9#9)(2009-8#8)(2010-12#6)(2010-6#1)(2010-7#3)(2010-8#3)(2011-2#24)(2012-12#6)(2012-2#9)(2012-3#7)(2012-5#2)(2013-1#13)
gastrin on##3##2##(1994-8#3)
gastrin##16##1##(1994-8#6)(1997-1#7)(2008-1#1)(2010-6#1)(2011-2#1)
gastrin-releasing peptide##2##2##(1992-6#2)
gastrin-releasing##4##1##(1992-6#2)(1997-1#2)
gastrinoma##3##1##(1991-6#3)
gastrinomas##2##1##(1997-8#1)(2008-2#1)
gastritis are##2##2##(1997-1#2)
gastritis is##3##2##(1990-11#2)(2008-12#1)
gastritis##21##1##(1990-11#2)(1992-5#1)(1993-12#1)(1996-6#1)(1997-1#7)(1997-8#2)(2008-12#4)(2009-8#2)(2010-12#1)
gastritis/duodenitis##2##1##(2008-11#2)
gastro-esophageal##2##1##(1992-11#1)(2011-3#1)
gastro-intestinal##5##1##(1996-12#1)(2008-10#1)(2008-7#1)(2010-12#2)
gastro-oesophageal reflux##5##2##(1990-12#1)(1995-10#1)(1996-3#3)
gastro-oesophageal##6##1##(1990-12#1)(1995-10#1)(1996-3#3)(2009-8#1)
gastrocnemius and##2##2##(1993-3#1)(1995-2#1)
gastrocnemius muscle##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
gastrocnemius##8##1##(1993-3#1)(1995-2#1)(1996-2#1)(1997-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
gastroduodenal mucosal##2##2##(1997-1#2)
gastroduodenal peptic##2##2##(1990-5#2)
gastroduodenal ulcer##5##2##(1992-6#1)(1993-6#1)(2010-12#1)(2012-3#1)(2013-1#1)
gastroduodenal##14##1##(1990-5#3)(1992-6#1)(1993-6#1)(1997-1#3)(1997-4#1)(2008-12#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
gastroenteric##3##1##(1991-8#2)(2011-2#1)
gastroenteritis##8##1##(1996-2#1)(1996-6#1)(2008-10#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
gastroenterologists are##2##2##(1990-11#1)(1990-2#1)
gastroenterologists##5##1##(1990-11#1)(1990-2#2)(2008-12#1)(2013-1#1)
gastroenterology##5##1##(1990-2#1)(1993-12#1)(2012-2#1)(2013-1#2)
gastroesophageal adverse effects##2##3##(2008-11#2)
gastroesophageal problems##2##2##(2008-11#2)
gastroesophageal reflux disease in##2##4##(2009-1#1)(2011-2#1)
gastroesophageal reflux disease##5##3##(2009-1#1)(2009-11#1)(2011-2#1)(2013-1#2)
gastroesophageal reflux##9##2##(1992-11#1)(1992-3#2)(1996-3#1)(2009-1#1)(2009-11#1)(2011-2#1)(2013-1#2)
gastroesophageal##15##1##(1992-11#1)(1992-3#2)(1996-3#1)(2008-11#5)(2009-1#1)(2009-11#1)(2011-2#1)(2013-1#3)
gastrointestinal (GI)##5##2##(1991-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
gastrointestinal and##5##2##(1992-6#1)(2008-11#1)(2008-5#2)(2008-6#1)
gastrointestinal bleeding in##3##3##(2010-2#1)(2012-3#2)
gastrointestinal bleeding##15##2##(1995-11#1)(2009-8#1)(2010-2#1)(2010-6#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)
gastrointestinal cancer##5##2##(1990-9#2)(1991-12#1)(2011-2#1)(2012-3#1)
gastrointestinal disorders##6##2##(1991-3#1)(1996-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
gastrointestinal endoscopy##7##2##(1995-10#2)(1996-3#1)(2008-1#1)(2011-2#2)(2012-2#1)
gastrointestinal events##2##2##(2008-11#2)
gastrointestinal haemorrhage##2##2##(1991-8#1)(2011-2#1)
gastrointestinal mucosa##2##2##(1996-3#1)(2009-12#1)
gastrointestinal stromal tumor##3##3##(2008-10#1)(2010-12#1)(2012-12#1)
gastrointestinal stromal tumors##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
gastrointestinal stromal##7##2##(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
gastrointestinal symptoms##4##2##(1993-12#1)(1996-8#1)(1997-8#1)(2008-10#1)
gastrointestinal tract of##6##3##(2011-2#2)(2012-2#1)(2013-1#3)
gastrointestinal tract##38##2##(1990-11#1)(1990-8#1)(1994-12#1)(1997-1#1)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-10#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
gastrointestinal tumors##3##2##(1990-6#2)(1991-3#1)
gastrointestinal##169##1##(1990-11#1)(1990-2#3)(1990-6#3)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-12#3)(1995-10#3)(1995-11#1)(1996-11#3)(1996-12#3)(1996-3#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#4)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#13)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#2)(2011-2#27)(2012-12#4)(2012-2#12)(2012-3#10)(2013-1#14)(2013-7#2)(2013-8#1)
gastropathy##3##1##(1991-11#1)(1991-8#1)(1997-1#1)
gastropod##5##1##(2008-10#2)(2008-12#2)(2008-6#1)
gastropods##4##1##(2008-12#1)(2008-9#1)(2011-2#2)
gastrorrhaphy##2##1##(2009-8#2)
gastroschisis and congenital diaphragmatic hernia##2##5##(2008-11#2)
gastroschisis##4##1##(1997-3#2)(2008-11#2)
gastroscopy##2##1##(1990-3#1)(1990-9#1)
gastrostomy##2##1##(1996-3#1)(2008-12#1)
gastrula##2##1##(2008-6#1)(2010-5#1)
gate of##2##2##(2008-10#1)(2009-5#1)
gate voltage##2##2##(2008-7#1)(2009-5#1)
gate##11##1##(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#3)(2012-2#2)(2012-3#1)
gated##5##1##(1995-2#1)(2008-3#2)(2008-9#1)(2012-2#1)
gatekeeper##5##1##(1995-12#1)(2008-12#3)(2009-10#1)
gatekeeper]##2##1##(1994-12#2)
gatekeepers##3##1##(1997-2#1)(2009-4#1)(2009-6#1)
gatekeeping##2##1##(1995-11#1)(2008-12#1)
gates##8##1##(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2013-8#1)
gateway##2##1##(2008-4#1)(2013-8#1)
gather data##5##2##(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#1)
gather##15##1##(1991-1#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#5)(2012-12#1)(2013-1#1)
gathered and##2##2##(1995-2#1)(2012-2#1)
gathered from##3##2##(2009-4#1)(2009-5#1)(2010-9#1)
gathered in the##2##3##(1997-5#1)(2008-10#1)
gathered in##5##2##(1996-2#1)(1997-5#1)(2008-10#2)(2008-7#1)
gathered on##2##2##(2008-12#1)(2009-12#1)
gathered through##4##2##(1992-9#1)(1997-8#1)(2008-10#1)(2008-11#1)
gathered using##2##2##(1992-1#1)(2008-12#1)
gathered##29##1##(1991-8#1)(1992-1#1)(1992-9#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#1)
gathering of##5##2##(1996-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
gathering##14##1##(1994-12#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
gating is##2##2##(2007-11#1)(2008-9#1)
gating of##4##2##(1990-8#2)(1997-2#2)
gating technology has##2##3##(2008-11#2)
gating technology##3##2##(2008-11#3)
gating##19##1##(1990-5#1)(1990-8#2)(1997-2#3)(2007-11#2)(2008-11#3)(2008-3#2)(2008-9#5)(2010-11#1)
gattii and##2##2##(2008-5#2)
gattii infection##2##2##(2008-10#1)(2008-5#1)
gattii isolates##2##2##(2008-5#2)
gattii##16##1##(2008-10#3)(2008-5#13)
gauche##3##1##(2008-8#2)(2013-1#1)
gauge the##6##2##(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#2)
gauge##13##1##(1992-8#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
gauged by##2##2##(2008-11#1)(2008-6#1)
gaussian##2##1##(2008-2#1)(2008-3#1)
gauze##3##1##(2008-11#1)(2011-2#1)(2012-3#1)
gavage##8##1##(1992-12#1)(2008-10#4)(2010-1#1)(2010-5#2)
gave (2R##2##2##(1996-5#2)
gave a better##2##3##(2008-10#1)(2008-5#1)
gave a good##3##3##(2008-10#2)(2008-7#1)
gave a high##2##3##(1995-12#1)(2008-10#1)
gave a linear response##3##4##(2008-10#3)
gave a linear##4##3##(2008-10#4)
gave a mean absorbance of 0##3##6##(2008-10#3)
gave a mean##5##3##(2008-10#5)
gave a positive##3##3##(1997-7#1)(2008-10#2)
gave a relative##2##3##(1991-12#1)(2008-10#1)
gave a series of lectures##2##5##(1993-11#1)(2012-2#1)
gave a significant##2##3##(1996-6#1)(2008-10#1)
gave a significantly##2##3##(1991-2#1)(2008-7#1)
gave a similar##2##3##(1996-1#1)(2008-10#1)
gave a##57##2##(1990-8#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-7#2)(2008-10#31)(2008-11#2)(2008-5#2)(2008-7#4)(2008-8#1)(2011-2#1)(2012-2#2)
gave acceptable##2##2##(1997-2#1)(2008-10#1)
gave accurate results##2##3##(2008-10#2)
gave an##10##2##(1990-11#1)(1990-9#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-6#1)(2009-8#1)(2010-12#1)
gave average##2##2##(1994-8#1)(2008-10#1)
gave better##2##2##(2008-11#1)(2008-7#1)
gave birth to##2##3##(2011-2#1)(2012-3#1)
gave birth##4##2##(2008-11#1)(2011-2#1)(2012-3#2)
gave comparable results##3##3##(2008-10#3)
gave complementary##2##2##(1994-12#1)(2008-10#1)
gave evidence##2##2##(2008-11#1)(2008-5#1)
gave good results##4##3##(2008-10#4)
gave good##11##2##(2008-10#10)(2009-8#1)
gave higher##2##2##(1992-3#1)(2008-7#1)
gave more##5##2##(2008-10#5)
gave much##3##2##(2008-10#2)(2012-2#1)
gave no significant##2##3##(2008-10#1)(2008-12#1)
gave no##3##2##(2008-10#1)(2008-12#2)
gave quantitative##2##2##(2008-10#2)
gave recoveries##2##2##(2008-10#2)
gave results that compare favorably with those obtained by##2##9##(2008-10#2)
gave results that##3##3##(2008-10#3)
gave results##5##2##(2008-10#3)(2011-2#2)
gave rise to a##5##4##(1993-8#1)(1995-8#1)(2008-10#2)(2008-5#1)
gave rise to neurons##2##4##(2008-11#2)
gave rise to the##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
gave rise to##20##3##(1991-6#1)(1992-6#1)(1993-8#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
gave rise##21##2##(1991-6#1)(1992-6#1)(1993-8#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
gave satisfactory results##4##3##(2008-10#3)(2008-11#1)
gave satisfactory##5##2##(2008-10#4)(2008-11#1)
gave significantly##2##2##(2008-10#1)(2008-12#1)
gave similar##3##2##(1991-5#1)(2008-10#2)
gave the best##5##3##(1995-3#1)(2008-10#3)(2008-9#1)
gave the corresponded##2##3##(2008-11#2)
gave the final ozonides##2##4##(1996-5#2)
gave the highest##6##3##(2008-10#2)(2009-2#1)(2011-2#1)(2013-1#2)
gave the most##3##3##(1993-3#1)(2008-10#1)(2011-2#1)
gave the##41##2##(1990-9#2)(1992-12#1)(1993-3#1)(1995-3#1)(1996-5#9)(1997-2#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-2#1)(2013-1#4)
gave to##2##2##(1996-5#1)(2013-1#1)
gave very low##2##3##(1995-2#1)(2008-11#1)
gave##275##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#4)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#24)(1996-6#1)(1997-2#3)(1997-3#1)(1997-7#2)(1997-8#1)(2008-1#4)(2008-10#124)(2008-11#18)(2008-12#5)(2008-2#1)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#8)(2012-2#4)(2012-3#2)(2013-1#7)
gay and##4##2##(1995-6#1)(1996-5#1)(2008-12#2)
gay men and##4##3##(1992-9#1)(1996-5#1)(2008-12#2)
gay men in the##2##4##(2008-10#2)
gay men##7##2##(1992-9#1)(1996-5#1)(2008-10#2)(2008-12#2)(2009-12#1)
gay##29##1##(1992-1#2)(1992-9#1)(1995-12#1)(1995-6#2)(1996-11#2)(1996-5#3)(2008-10#2)(2008-12#9)(2009-12#1)(2009-5#2)(2012-2#4)
gaze cues##4##2##(2008-11#1)(2010-10#3)
gaze directions were##2##3##(2008-11#2)
gaze shift##3##2##(2008-11#3)
gaze shifts##8##2##(2008-11#8)
gaze##38##1##(1990-11#1)(2008-11#28)(2008-6#2)(2010-10#5)(2013-8#2)
gaze-evoked nystagmus##2##2##(2008-7#2)
gdh##3##1##(1993-9#3)
gear##5##1##(2008-3#4)(2008-8#1)
geared to##3##2##(2008-10#1)(2009-12#1)(2010-3#1)
geared toward##3##2##(1992-1#1)(2010-1#1)(2010-7#1)
geared towards##2##2##(2008-11#1)(2011-2#1)
geared##9##1##(1992-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)
gel (APSG)##2##2##(2008-10#2)
gel analysis of the##2##4##(1991-2#1)(1993-9#1)
gel and##25##2##(2008-10#18)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
gel as a##5##3##(2008-10#5)
gel as##9##2##(2008-10#9)
gel at pH##2##3##(1992-12#1)(2008-10#1)
gel at##3##2##(1992-12#1)(2008-10#1)(2008-4#1)
gel beads in##3##3##(2008-10#2)(2008-11#1)
gel beads##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
gel chemically##3##2##(2008-10#3)
gel containing##5##2##(1994-11#1)(2008-10#2)(2008-4#1)(2008-9#1)
gel electrophoresis (PAGE)##4##3##(1990-11#1)(1995-12#1)(2008-5#1)(2010-3#1)
gel electrophoresis (PFGE)##5##3##(1992-6#1)(1993-12#2)(2008-10#2)
gel electrophoresis (SDS-PAGE)##4##3##(1991-5#1)(1992-12#1)(2008-8#1)(2012-2#1)
gel electrophoresis analysis of##2##4##(2008-10#1)(2011-2#1)
gel electrophoresis analysis##5##3##(2008-10#4)(2011-2#1)
gel electrophoresis and##11##3##(1991-12#1)(1991-9#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-8#1)(2012-3#1)
gel electrophoresis for##3##3##(2008-10#1)(2008-4#2)
gel electrophoresis of##9##3##(1993-6#1)(1994-8#1)(2008-10#7)
gel electrophoresis or##2##3##(2008-11#1)(2008-4#1)
gel electrophoresis showed that##2##4##(2008-10#1)(2008-11#1)
gel electrophoresis showed##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
gel electrophoresis technique##2##3##(1995-8#1)(2008-10#1)
gel electrophoresis to##3##3##(1991-5#1)(1997-3#1)(2010-12#1)
gel electrophoresis##111##2##(1990-10#2)(1990-11#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-5#4)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#3)(1994-11#1)(1994-8#1)(1995-12#3)(1995-6#2)(1995-8#3)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#1)(2008-10#38)(2008-11#8)(2008-3#1)(2008-4#9)(2008-5#2)(2008-8#3)(2008-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
gel electrophoretic analysis##2##3##(1990-11#1)(1991-12#1)
gel electrophoretic##3##2##(1990-11#1)(1991-12#1)(1995-6#1)
gel entrapment carrier##3##3##(2008-7#3)
gel entrapment##4##2##(2008-7#4)
gel filtration analysis##2##3##(2008-11#1)(2011-1#1)
gel filtration and##5##3##(1992-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-8#1)
gel filtration chromatography and##4##4##(1990-2#1)(1994-8#1)(2008-10#2)
gel filtration chromatography##11##3##(1990-2#1)(1991-3#1)(1991-9#1)(1994-8#1)(2008-10#5)(2008-11#1)(2009-3#1)
gel filtration on##2##3##(1990-2#1)(1991-12#1)
gel filtration##37##2##(1990-2#2)(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#4)(1995-11#1)(1997-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-8#4)(2009-3#1)(2011-1#1)
gel for mercury##2##3##(2008-10#2)
gel for##6##2##(2008-10#5)(2008-5#1)
gel formation##2##2##(2011-2#2)
gel from##2##2##(2008-10#2)
gel has##3##2##(2008-10#2)(2010-3#1)
gel in##4##2##(2008-10#4)
gel is##7##2##(1996-9#1)(2008-10#4)(2008-4#1)(2008-9#1)
gel matrices##2##2##(2008-10#2)
gel matrix##3##2##(2008-10#2)(2008-11#1)
gel microdrop secretion assay##2##4##(2008-11#2)
gel mobility shift analysis##2##4##(1993-8#1)(2008-9#1)
gel mobility shift##3##3##(1993-8#1)(2008-8#1)(2008-9#1)
gel modified with##7##3##(2008-10#7)
gel modified##8##2##(2008-10#8)
gel monolithic column polydimethylsiloxane##2##4##(2008-10#2)
gel monolithic column##4##3##(2008-10#4)
gel network phase##3##3##(2008-5#3)
gel network##5##2##(2008-5#5)
gel of##2##2##(2008-10#2)
gel permeation chromatography##4##3##(1996-12#1)(2008-10#3)
gel permeation##5##2##(1995-3#1)(1996-12#1)(2008-10#3)
gel phase##9##2##(1993-8#4)(1994-5#1)(2008-10#4)
gel phases##6##2##(1993-8#2)(2008-10#4)
gel retardation##4##2##(1992-6#1)(1993-6#1)(2008-8#2)
gel shift assay##3##3##(1993-6#1)(1993-8#2)
gel shift##4##2##(1993-6#1)(1993-8#2)(2008-9#1)
gel showed##2##2##(2008-10#1)(2008-11#1)
gel substrata##3##2##(1994-8#3)
gel to##4##2##(1992-8#1)(2008-10#2)(2008-4#1)
gel was found##2##3##(1994-8#1)(2008-10#1)
gel was measured directly after packing the gel beads in a 1-mm silica cell##2##14##(2008-10#2)
gel was##22##2##(1994-8#2)(2008-10#19)(2008-11#1)
gel were##2##2##(1993-1#1)(2008-10#1)
gel with##4##2##(2008-10#4)
gel##498##1##(1990-10#2)(1990-11#3)(1990-2#2)(1990-5#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#5)(1991-9#3)(1992-12#5)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-12#2)(1993-3#1)(1993-6#4)(1993-8#13)(1993-9#1)(1994-11#4)(1994-5#1)(1994-6#2)(1994-8#13)(1995-11#1)(1995-12#4)(1995-3#1)(1995-6#3)(1995-8#3)(1996-12#2)(1996-9#6)(1997-1#3)(1997-2#4)(1997-3#1)(2008-10#246)(2008-11#24)(2008-2#1)(2008-3#1)(2008-4#27)(2008-5#22)(2008-7#6)(2008-8#11)(2008-9#15)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-6#1)(2011-1#1)(2011-2#10)(2011-3#5)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
gel) and##2##2##(2008-11#1)(2008-5#1)
gel)##4##1##(2008-10#2)(2008-11#1)(2008-5#1)
gel-filled capillaries##3##2##(2008-10#3)
gel-filtration##3##1##(2008-10#1)(2008-11#1)(2010-4#1)
gel-immobilized##2##1##(2008-10#2)
gel-purified##2##1##(1997-3#1)(2008-4#1)
gelatin and collagen hydrolysate as##2##5##(2008-5#2)
gelatin and collagen hydrolysate##4##4##(2008-5#4)
gelatin and##6##2##(2008-10#2)(2008-5#4)
gelatin capsules##2##2##(2008-11#1)(2008-3#1)
gelatin emulsions##2##2##(2008-3#2)
gelatin##38##1##(2007-11#1)(2008-10#14)(2008-11#5)(2008-3#7)(2008-4#1)(2008-5#4)(2008-9#1)(2009-7#2)(2012-12#1)(2012-3#2)
gelatin-isolated##2##1##(2008-11#2)
gelatine##5##1##(2008-10#5)
gelatinous clutches##3##2##(2008-9#3)
gelatinous##4##1##(2008-9#3)(2009-8#1)
gelation##7##1##(2008-10#3)(2008-7#1)(2009-7#1)(2011-3#2)
gelding##2##1##(2013-8#2)
gellike##4##1##(2008-11#4)
gelling##3##1##(2008-10#1)(2011-2#2)
gelonin and momordin##4##3##(1990-12#4)
gels and##5##2##(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#1)
gels are##3##2##(2008-10#2)(2009-9#1)
gels can be##2##3##(2008-5#1)(2008-9#1)
gels were##5##2##(2008-10#2)(2008-5#2)(2008-9#1)
gels##66##1##(1991-7#1)(1992-6#2)(1993-12#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1997-2#1)(2008-10#32)(2008-2#1)(2008-4#4)(2008-5#9)(2008-7#1)(2008-9#2)(2009-6#1)(2009-9#2)(2010-11#1)(2011-2#3)
gemcitabine and carboplatin##2##3##(2008-10#2)
gemcitabine##7##1##(2008-10#4)(2013-1#3)
geminate recombination##3##2##(1990-8#3)
geminiviral DNA replication##3##3##(2008-10#3)
geminiviral##4##1##(2008-10#4)
geminivirus from##3##2##(2008-10#3)
geminivirus species##2##2##(2008-10#2)
geminivirus that##2##2##(2008-10#2)
geminivirus with##2##2##(2008-10#2)
geminivirus##17##1##(2008-10#16)(2008-9#1)
geminiviruses##12##1##(2008-10#12)
gender and age as##2##4##(2008-11#1)(2011-2#1)
gender and age##5##3##(2008-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
gender and pubertal status##2##4##(2011-1#2)
gender and smoking status##2##4##(2011-2#2)
gender and smoking##3##3##(2011-2#2)(2012-2#1)
gender and socioeconomic status##2##4##(2011-1#2)
gender and##31##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#4)(2009-4#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
gender categorization##2##2##(2008-11#2)
gender difference in##3##3##(1996-2#1)(2008-11#2)
gender difference##4##2##(1996-2#1)(1996-6#1)(2008-11#2)
gender differences in axillary##2##4##(2008-5#2)
gender differences in health##2##4##(2008-7#2)
gender differences in the##5##4##(2008-4#2)(2009-7#1)(2010-1#2)
gender differences in##22##3##(1996-3#1)(2008-12#4)(2008-4#4)(2008-5#4)(2008-7#2)(2009-7#1)(2010-1#3)(2010-4#1)(2011-1#1)(2013-1#1)
gender differences##29##2##(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-4#5)(2008-5#4)(2008-7#2)(2009-7#1)(2010-1#3)(2010-4#1)(2011-1#3)(2011-2#1)(2013-1#1)
gender gap##2##2##(2010-7#2)
gender groups##2##2##(2009-1#1)(2011-1#1)
gender identity##3##2##(2008-12#3)
gender in the##2##3##(2009-10#1)(2012-2#1)
gender in##5##2##(1994-3#1)(2009-10#2)(2011-2#1)(2012-2#1)
gender nonconformity##2##2##(2008-12#2)
gender on the##3##3##(2010-4#1)(2012-2#2)
gender on##5##2##(1994-3#1)(2008-7#1)(2010-4#1)(2012-2#2)
gender or##3##2##(1991-9#1)(1994-6#1)(2013-1#1)
gender perspective##3##2##(2009-10#3)
gender ratio##2##2##(2008-3#1)(2012-3#1)
gender roles##2##2##(2008-11#1)(2010-2#1)
gender##201##1##(1991-12#1)(1991-9#1)(1992-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(2008-10#5)(2008-11#17)(2008-12#13)(2008-3#1)(2008-4#6)(2008-5#5)(2008-7#8)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#13)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-7#8)(2010-1#6)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#25)(2012-12#3)(2012-2#10)(2012-3#5)(2012-5#1)(2013-1#7)(2013-8#6)
gender)##2##1##(2010-4#1)(2011-2#1)
gender-based##2##1##(1990-2#1)(2008-5#1)
gender-nonconformity-related##2##1##(2008-12#2)
gender-related differences in##2##3##(2008-11#1)(2010-12#1)
gender-related differences##3##2##(2008-11#1)(2008-12#1)(2010-12#1)
gender-related##5##1##(2008-11#1)(2008-12#1)(2009-1#1)(2010-12#1)(2011-2#1)
gender-specific differences in##2##3##(2008-11#1)(2011-1#1)
gender-specific##8##1##(1994-2#1)(2008-11#5)(2010-7#1)(2011-1#1)
gendered##4##1##(2008-11#2)(2009-7#1)(2011-2#1)
genders##8##1##(1994-2#1)(2006-6#1)(2008-4#1)(2009-7#1)(2011-1#2)(2011-2#2)
gene (aprV5)##2##2##(1993-12#2)
gene (called##2##2##(1992-4#2)
gene (designated##2##2##(2008-10#2)
gene (encoding the##3##3##(1993-12#1)(1993-9#2)
gene (or allele) was##2##4##(2008-10#2)
gene (or allele)##6##3##(2008-10#6)
gene (or##7##2##(1990-5#1)(2008-10#6)
gene 1##3##2##(1994-11#2)(2008-11#1)
gene 11 (Tex11)##2##3##(2012-2#2)
gene 2##2##2##(1996-6#1)(2009-12#1)
gene 30##4##2##(1997-7#4)
gene 33 protein##2##3##(1995-6#2)
gene 49##2##2##(1995-12#2)
gene 5'##2##2##(1995-2#1)(2008-9#1)
gene Pg10##2##2##(2008-10#2)
gene PvuII polymorphism##2##3##(2011-2#2)
gene action was##3##3##(2008-10#3)
gene action##10##2##(2008-10#8)(2009-10#2)
gene activation##6##2##(2008-10#4)(2008-4#1)(2008-7#1)
gene activity##4##2##(1990-6#1)(2007-12#1)(2010-5#1)(2011-2#1)
gene against##2##2##(2008-10#1)(2008-8#1)
gene als##2##2##(2008-9#2)
gene also##4##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
gene amplification by##2##3##(1991-6#1)(1994-12#1)
gene amplification##17##2##(1991-6#2)(1994-12#4)(2008-11#7)(2008-4#1)(2009-10#1)(2012-2#1)(2013-1#1)
gene and a##6##3##(2008-10#3)(2008-8#2)(2011-2#1)
gene and has##2##3##(1997-9#1)(2008-10#1)
gene and is##2##3##(1996-6#1)(1997-7#1)
gene and its expression##3##4##(1992-12#1)(2008-8#2)
gene and its##11##3##(1990-5#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#4)
gene and production of##2##4##(2008-11#1)(2010-5#1)
gene and protein##2##3##(2008-10#2)
gene and the##16##3##(1992-3#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-8#1)(2008-10#6)(2008-4#1)(2008-9#2)(2013-1#1)
gene and their##2##3##(2008-10#1)(2008-8#1)
gene and##105##2##(1990-5#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-7#2)(1997-8#3)(1997-9#2)(2006-6#1)(2007-12#1)(2008-10#34)(2008-11#3)(2008-12#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#11)(2008-9#5)(2009-10#1)(2009-6#2)(2010-5#1)(2011-2#6)(2012-3#1)(2013-1#1)
gene are##7##2##(1992-6#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
gene arrangement##2##2##(2008-10#1)(2008-6#1)
gene array analysis##2##3##(2008-10#2)
gene as a reporter##4##4##(1992-6#1)(2008-11#2)(2008-9#1)
gene as a##7##3##(1992-6#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)
gene as the probe##2##4##(2008-8#2)
gene as the##3##3##(2008-8#2)(2010-10#1)
gene as##19##2##(1992-10#1)(1992-6#1)(1993-12#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#1)
gene assay##2##2##(2010-5#1)(2011-2#1)
gene associated with##2##3##(2008-12#1)(2013-1#1)
gene at a##2##3##(2008-10#2)
gene at the##4##3##(1993-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
gene at##9##2##(1993-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)
gene being##2##2##(2008-10#1)(2011-2#1)
gene but not##2##3##(1990-5#1)(1993-3#1)
gene but##3##2##(1990-5#1)(1993-3#1)(2008-11#1)
gene by a##2##3##(2008-11#1)(2009-10#1)
gene by polymerase chain reaction##2##5##(1992-6#1)(2012-12#1)
gene by##16##2##(1990-2#1)(1992-6#1)(1992-8#1)(1994-11#1)(1995-8#1)(1996-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
gene cDNA##2##2##(1997-3#1)(2008-10#1)
gene can be##4##3##(1993-8#1)(2008-4#1)(2008-8#1)(2009-12#1)
gene can inhibit##2##3##(1994-3#1)(2008-8#1)
gene can##6##2##(1993-8#1)(1994-3#1)(2008-4#1)(2008-8#2)(2009-12#1)
gene carrier##3##2##(2008-10#2)(2008-11#1)
gene carriers##2##2##(1995-9#1)(2009-7#1)
gene causing##2##2##(1991-12#1)(2008-10#1)
gene cloned in a multicopy plasmid is##2##7##(1990-11#1)(1997-3#1)
gene cloned##3##2##(1990-11#1)(1997-3#1)(2008-10#1)
gene cloning##5##2##(1993-8#1)(2008-10#2)(2008-4#1)(2008-8#1)
gene cluster controlling##2##3##(2008-10#2)
gene cluster in##2##3##(1993-3#1)(2008-8#1)
gene cluster is##2##3##(2008-8#1)(2011-1#1)
gene cluster##24##2##(1993-3#2)(1996-12#1)(1996-6#1)(1997-8#1)(2008-10#8)(2008-8#5)(2008-9#1)(2011-1#3)(2011-2#1)(2012-2#1)
gene clusters##6##2##(1995-6#2)(1996-12#1)(2008-10#1)(2008-8#1)(2009-9#1)
gene codes##2##2##(2008-8#1)(2013-1#1)
gene coding for##9##3##(1992-3#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-5#1)(1996-8#1)(1997-2#1)(2008-6#1)(2010-8#1)
gene coding sequence##2##3##(1993-12#1)(2012-3#1)
gene coding##12##2##(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-5#1)(1996-8#1)(1997-2#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-3#1)
gene combinations##2##2##(1997-7#1)(2008-10#1)
gene conferred resistance##2##3##(2008-10#2)
gene conferred the##2##3##(2008-10#2)
gene conferred##4##2##(2008-10#4)
gene conferring##2##2##(2008-10#2)
gene consists of##3##3##(1991-9#1)(1993-8#1)(1995-8#1)
gene construct##4##2##(1993-8#1)(2008-10#2)(2008-8#1)
gene constructs in##2##3##(1993-8#1)(2008-11#1)
gene constructs of##2##3##(2008-10#1)(2008-11#1)
gene constructs##7##2##(1993-12#1)(1993-3#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#2)
gene contain##2##2##(1995-6#1)(2008-8#1)
gene containing the##2##3##(1996-2#2)
gene containing##5##2##(1992-6#1)(1995-8#1)(1996-12#1)(1996-2#2)
gene contains a##3##3##(1993-6#2)(2008-11#1)
gene contains four exons and##2##5##(1993-2#1)(1994-11#1)
gene contains several##2##3##(1997-3#1)(2008-10#1)
gene contains##11##2##(1992-6#1)(1993-12#2)(1993-2#1)(1993-6#2)(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
gene control##4##2##(1994-11#1)(2008-10#3)
gene controlled by CaMV35S##2##4##(2008-9#2)
gene controlled##4##2##(2008-10#1)(2008-5#1)(2008-9#2)
gene controlling##4##2##(2008-8#2)(2008-9#1)(2009-10#1)
gene controls resistance to##2##4##(2008-10#2)
gene controls resistance##3##3##(2008-10#3)
gene controls##5##2##(2008-10#5)
gene copy number##2##3##(1991-9#1)(2010-10#1)
gene could be##3##3##(2008-8#1)(2008-9#2)
gene could##4##2##(2008-11#1)(2008-8#1)(2008-9#2)
gene deletion##4##2##(2012-2#1)(2012-3#2)(2013-8#1)
gene delivery system##9##3##(2008-8#8)(2008-9#1)
gene delivery systems##2##3##(1994-5#1)(2009-10#1)
gene delivery to##3##3##(2008-4#3)
gene delivery##28##2##(1994-11#1)(1994-5#1)(1995-2#1)(2008-11#4)(2008-4#4)(2008-8#11)(2008-9#2)(2009-10#2)(2010-12#1)(2012-2#1)
gene demonstrated##2##2##(1996-3#1)(2008-11#1)
gene derived from##2##3##(2008-10#2)
gene designated##2##2##(2008-8#1)(2009-8#1)
gene detection##2##2##(2008-4#1)(2008-9#1)
gene discovery##2##2##(2011-2#2)
gene diseases##2##2##(2012-3#2)
gene disorders##3##2##(2008-11#1)(2008-8#2)
gene disruption##4##2##(2008-4#1)(2008-8#3)
gene diversity analysis##2##3##(2008-10#2)
gene diversity was##6##3##(2008-10#6)
gene diversity##21##2##(2008-10#17)(2008-12#1)(2008-8#1)(2012-5#2)
gene driven by##3##3##(2008-11#2)(2009-8#1)
gene duplicates##2##2##(2009-10#1)(2009-6#1)
gene duplication##2##2##(1993-3#1)(1997-7#1)
gene during development##2##3##(1997-8#1)(2008-8#1)
gene during##6##2##(1991-5#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#2)
gene eXpression##2##2##(2008-10#2)
gene encoded by##2##3##(1997-8#1)(2008-9#1)
gene encodes a protein of##3##5##(1992-9#1)(1996-6#1)(2008-9#1)
gene encodes a protein##4##4##(1992-9#1)(1996-6#2)(2008-9#1)
gene encodes a##10##3##(1990-11#1)(1990-5#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#2)(2008-6#1)(2008-9#1)
gene encodes the##2##3##(1992-9#1)(1993-3#1)
gene encodes##14##2##(1990-11#1)(1990-5#1)(1992-9#2)(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#2)(1997-8#1)(2008-6#1)(2008-9#1)
gene encoding a##9##3##(1992-9#1)(1993-2#1)(1994-5#1)(1995-6#2)(1997-7#3)(1997-8#1)
gene encoding an##3##3##(1993-2#1)(1995-2#1)(2008-10#1)
gene encoding for##2##3##(1997-6#1)(2008-12#1)
gene encoding human##2##3##(1994-11#1)(1997-7#1)
gene encoding the 28-kDa##2##4##(1993-2#2)
gene encoding the brain specific snRNP-associated polypeptide &quot##2##8##(1993-8#2)
gene encoding the##26##3##(1991-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-9#2)(2010-6#1)(2013-1#1)
gene encoding this##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
gene encoding##81##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-6#2)(1991-7#2)(1992-4#3)(1992-9#1)(1993-12#4)(1993-2#10)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#3)(1995-6#5)(1995-9#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#6)(1997-8#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-6#1)(2011-1#2)(2013-1#1)
gene engineering##2##2##(2011-2#2)
gene existed##2##2##(1992-3#1)(2008-9#1)
gene exists##2##2##(2008-9#1)(2010-12#1)
gene expressed in##2##3##(1995-12#1)(1997-7#1)
gene expressed##3##2##(1990-12#1)(1995-12#1)(1997-7#1)
gene expression also##2##3##(1995-12#1)(2008-10#1)
gene expression among##2##3##(1992-10#1)(2012-3#1)
gene expression analysis##4##3##(2008-10#1)(2008-8#1)(2009-10#1)(2012-3#1)
gene expression and genome##2##4##(2007-12#1)(2008-10#1)
gene expression and signal transduction##2##5##(2008-4#1)(2010-5#1)
gene expression and##29##3##(1994-8#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#2)(2011-2#3)(2013-1#1)
gene expression are##5##3##(1992-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)
gene expression at the##5##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
gene expression at##6##3##(1991-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)
gene expression by the##3##4##(1995-6#1)(1997-7#1)(2008-7#1)
gene expression by##19##3##(1992-1#1)(1992-10#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
gene expression can##2##3##(1992-10#1)(2008-7#1)
gene expression data##11##3##(2008-4#2)(2009-10#2)(2009-4#1)(2010-1#1)(2010-10#3)(2011-3#1)(2012-3#1)
gene expression during##4##3##(1994-8#1)(2009-8#1)(2010-1#1)(2011-2#1)
gene expression for##5##3##(1994-11#1)(1996-2#1)(1997-2#1)(2008-10#1)(2012-3#1)
gene expression in a##5##4##(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(2009-8#1)
gene expression in human##4##4##(1990-5#1)(1993-3#1)(1995-12#1)(1995-9#1)
gene expression in mammalian cells##4##5##(1993-6#2)(2008-11#2)
gene expression in mouse##2##4##(2008-11#1)(2008-9#1)
gene expression in response to##3##5##(1996-3#1)(2010-10#1)(2010-6#1)
gene expression in the choroid plexus##2##6##(1996-12#2)
gene expression in the hypothalamic paraventricular nucleus##2##7##(1996-12#2)
gene expression in the##17##4##(1995-11#1)(1996-12#7)(1997-1#1)(2008-10#2)(2008-11#2)(2009-6#2)(2012-2#1)(2013-7#1)
gene expression in various##2##4##(1995-12#1)(2008-10#1)
gene expression in##77##3##(1990-5#1)(1992-10#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#1)(1995-11#1)(1995-12#7)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#10)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#13)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
gene expression is also##2##4##(1990-2#1)(2008-9#1)
gene expression is##5##3##(1990-2#1)(1995-12#1)(2008-11#1)(2008-9#1)(2010-12#1)
gene expression levels and##3##4##(2008-10#2)(2011-1#1)
gene expression levels##5##3##(2008-10#4)(2011-1#1)
gene expression of catecholamine##2##4##(2013-1#2)
gene expression of the##2##4##(1992-10#1)(2008-11#1)
gene expression of two##2##4##(1995-2#1)(2008-9#1)
gene expression of##23##3##(1991-5#1)(1992-10#1)(1992-6#1)(1994-12#2)(1995-2#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-3#4)(2013-1#3)(2013-7#1)
gene expression on##3##3##(1992-10#1)(2008-10#1)(2008-11#1)
gene expression pattern##3##3##(2008-8#1)(2010-12#2)
gene expression patterns##5##3##(2008-10#2)(2008-4#2)(2010-1#1)
gene expression profile of##4##4##(2010-11#1)(2010-6#1)(2011-2#2)
gene expression profile##5##3##(1997-6#1)(2010-11#1)(2010-6#1)(2011-2#2)
gene expression profiles in##3##4##(2008-10#2)(2011-2#1)
gene expression profiles of##3##4##(2008-7#1)(2009-6#1)(2012-2#1)
gene expression profiles##12##3##(2008-10#5)(2008-4#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
gene expression profiling##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2009-8#1)
gene expression remain##2##3##(1993-12#1)(2009-10#1)
gene expression showed##2##3##(1995-12#1)(2008-10#1)
gene expression studies in##2##4##(1996-6#1)(2008-4#1)
gene expression studies##5##3##(1996-6#1)(2008-11#2)(2008-4#1)(2011-2#1)
gene expression through##2##3##(2008-9#1)(2010-3#1)
gene expression to##2##3##(1996-12#1)(2010-1#1)
gene expression via the##2##4##(1995-2#1)(2008-11#1)
gene expression via##3##3##(1995-2#1)(2008-11#1)(2010-10#1)
gene expression was also##2##4##(2008-8#2)
gene expression was significantly##2##4##(1995-12#1)(2008-10#1)
gene expression was##13##3##(1992-3#1)(1995-12#1)(1995-2#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-8#4)
gene expression were##2##3##(1995-11#1)(2008-11#1)
gene expression when##2##3##(1995-12#1)(2008-11#1)
gene expression with##4##3##(1993-9#1)(1997-8#1)(2008-10#1)(2010-6#1)
gene expression within##3##3##(2008-11#1)(2009-7#1)(2010-12#1)
gene expression##424##2##(1990-2#1)(1990-5#2)(1991-5#3)(1991-6#1)(1992-1#2)(1992-10#6)(1992-12#1)(1992-3#5)(1992-6#3)(1992-8#2)(1993-12#3)(1993-3#2)(1993-6#5)(1993-8#3)(1993-9#5)(1994-11#2)(1994-12#4)(1994-5#1)(1994-6#2)(1994-8#7)(1995-11#3)(1995-12#14)(1995-2#13)(1995-6#3)(1995-8#2)(1995-9#2)(1996-12#19)(1996-2#5)(1996-3#1)(1996-6#2)(1997-1#3)(1997-2#2)(1997-3#6)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#3)(2008-10#50)(2008-11#51)(2008-2#1)(2008-4#12)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#21)(2008-9#22)(2009-10#8)(2009-12#1)(2009-4#1)(2009-6#5)(2009-7#2)(2009-8#7)(2010-1#6)(2010-10#6)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#2)(2011-1#3)(2011-10#1)(2011-2#24)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#12)(2013-1#5)(2013-7#2)(2013-8#2)
gene families##5##2##(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
gene family and##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
gene family encoding the##2##4##(1993-12#2)
gene family in the##2##4##(1993-12#2)
gene family in##4##3##(1993-12#2)(2008-9#1)(2009-10#1)
gene family members##2##3##(1990-5#1)(2011-1#1)
gene family of##3##3##(1991-5#2)(2008-8#1)
gene family with##2##3##(1993-12#1)(1993-2#1)
gene family##44##2##(1990-5#2)(1991-2#1)(1991-5#2)(1991-6#2)(1992-6#2)(1993-12#7)(1993-2#2)(1993-6#1)(1993-9#1)(1995-2#1)(1996-2#1)(1997-8#1)(2008-10#5)(2008-8#6)(2008-9#3)(2009-10#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
gene flow among these populations##2##5##(2008-10#2)
gene flow among##4##3##(2008-10#4)
gene flow and migration##2##4##(2013-1#2)
gene flow and##4##3##(2008-10#2)(2013-1#2)
gene flow between##9##3##(2008-10#4)(2012-3#4)(2013-1#1)
gene flow were##2##3##(2008-10#2)
gene flow##37##2##(1994-3#1)(2008-10#18)(2008-8#1)(2008-9#5)(2012-3#9)(2013-1#3)
gene for a##2##3##(1992-3#1)(1993-3#1)
gene for bacterial blight resistance in rice##2##7##(2008-10#2)
gene for human##3##3##(1990-8#1)(1992-1#1)(1994-11#1)
gene for insensitivity##2##3##(2008-10#2)
gene for leaf rust resistance##2##5##(2008-10#2)
gene for resistance to race 2 which segregates independently of Xa10##2##11##(2008-10#2)
gene for resistance to white pine blister rust in##2##9##(2008-10#2)
gene for resistance to white pine blister rust##3##8##(2008-10#3)
gene for resistance to white pine blister##4##7##(2008-10#4)
gene for resistance to##12##4##(2008-10#12)
gene for resistance##14##3##(2008-10#14)
gene for which##2##3##(1996-12#1)(1997-6#1)
gene for##56##2##(1990-5#1)(1990-8#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#4)(1995-6#1)(1995-9#1)(1996-12#1)(1997-6#1)(2008-10#26)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
gene found in##2##3##(1993-3#1)(2008-9#1)
gene fragment was##2##3##(2008-8#1)(2010-6#1)
gene fragment##8##2##(1994-11#1)(1994-8#1)(1997-2#3)(2008-8#1)(2008-9#1)(2010-6#1)
gene fragments in##2##3##(1993-8#1)(1997-4#1)
gene fragments##4##2##(1993-8#1)(1996-2#1)(1997-4#1)(2013-8#1)
gene from Streptomyces##2##3##(2008-8#1)(2011-2#1)
gene from a##2##3##(1995-12#1)(2008-5#1)
gene from the##8##3##(1993-12#1)(1994-11#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-8#1)
gene from##39##2##(1990-11#1)(1990-8#1)(1993-12#1)(1993-6#2)(1994-11#1)(1995-12#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-8#6)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#1)
gene function by##2##3##(1995-2#1)(2008-8#1)
gene function in##3##3##(1994-3#1)(2008-4#1)(2010-6#1)
gene function##16##2##(1993-9#2)(1994-3#1)(1995-2#2)(1997-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-3#1)
gene functions##2##2##(1993-3#1)(2012-3#1)
gene fusion which##2##3##(1990-7#1)(1991-6#1)
gene fusion##5##2##(1990-7#1)(1991-6#1)(1995-6#1)(2008-8#1)(2011-2#1)
gene fusions encoding##2##3##(1991-10#1)(1991-6#1)
gene fusions##7##2##(1991-10#1)(1991-6#1)(1997-7#2)(2008-8#1)(2008-9#2)
gene genealogies##3##2##(2008-10#3)
gene had a##2##3##(2008-10#2)
gene had##6##2##(1995-2#2)(2008-10#3)(2008-8#1)
gene has an##4##3##(1992-6#2)(1993-2#1)(1995-9#1)
gene has been cloned##2##4##(1990-5#1)(1997-8#1)
gene has been found in##2##5##(1997-7#1)(2008-8#1)
gene has been##10##3##(1990-5#1)(1991-9#1)(1993-3#1)(1994-12#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-8#2)
gene has##19##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-8#2)
gene have been##4##3##(1993-12#1)(1995-2#1)(2008-10#1)(2008-12#1)
gene have##6##2##(1993-12#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
gene homologues##2##2##(1997-3#1)(2008-8#1)
gene hph##2##2##(2008-10#2)
gene identified##4##2##(1995-8#1)(2008-10#2)(2009-6#1)
gene in A##2##3##(2008-10#1)(2008-9#1)
gene in Aspergillus##2##3##(1991-9#1)(1997-7#1)
gene in Escherichia coli##2##4##(2008-8#1)(2011-1#1)
gene in X##2##3##(2008-10#2)
gene in a##8##3##(1992-8#1)(1993-8#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-9#1)(2012-5#1)
gene in addition to##2##4##(1997-8#1)(2008-9#1)
gene in an##3##3##(1993-2#1)(1997-7#1)(2012-3#1)
gene in mammalian cells##2##4##(1997-7#1)(2008-11#1)
gene in rice##5##3##(1995-6#1)(2008-10#1)(2008-8#2)(2009-8#1)
gene in the##20##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
gene in transgenic plants##2##4##(2008-8#2)
gene in transgenic##8##3##(2008-8#3)(2008-9#5)
gene in##145##2##(1990-11#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-10#1)(1992-3#2)(1992-8#5)(1993-11#2)(1993-2#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-9#1)(1995-11#2)(1995-2#2)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#6)(1997-8#5)(2007-11#1)(2008-10#34)(2008-11#9)(2008-12#1)(2008-5#1)(2008-8#13)(2008-9#9)(2009-10#1)(2009-8#2)(2010-1#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2012-5#2)(2013-1#3)
gene indicated that the##2##4##(2008-10#1)(2008-8#1)
gene indicated that##3##3##(2008-10#2)(2008-8#1)
gene indicated##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
gene insertion##2##2##(1997-3#1)(2008-4#1)
gene interactions in##2##3##(2010-10#2)
gene interactions##4##2##(2008-10#1)(2009-5#1)(2010-10#2)
gene into a##2##3##(1993-8#1)(1997-8#1)
gene into the##5##3##(1990-11#1)(1992-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
gene into##18##2##(1990-11#1)(1990-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-5#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-8#3)(2008-9#1)
gene involved in##8##3##(1993-9#1)(1995-9#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-3#1)
gene is a##9##3##(1992-12#1)(1993-2#1)(1993-9#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
gene is attached to##2##4##(1996-6#1)(2008-4#1)
gene is composed of 18 exons##2##6##(1993-3#1)(1994-11#1)
gene is composed of##4##4##(1993-3#1)(1993-6#1)(1994-11#1)(2008-9#1)
gene is designated##5##3##(2008-10#4)(2008-9#1)
gene is expressed in##2##4##(1993-3#1)(1995-2#1)
gene is expressed##4##3##(1993-2#1)(1993-3#1)(1995-2#1)(1997-7#1)
gene is induced##2##3##(1997-7#1)(2008-10#1)
gene is involved in the##2##5##(1993-8#1)(2008-10#1)
gene is involved in##3##4##(1993-8#1)(1997-7#1)(2008-10#1)
gene is located##2##3##(1997-9#1)(2008-8#1)
gene is most##2##3##(1993-12#1)(1993-2#1)
gene is not essential for##2##5##(1993-9#1)(1995-2#1)
gene is not##5##3##(1990-11#1)(1993-9#1)(1994-12#1)(1995-2#1)(1997-7#1)
gene is present##2##3##(1993-2#1)(2008-10#1)
gene is probably##2##3##(1993-8#1)(2012-12#1)
gene is the##2##3##(1993-2#1)(1996-12#1)
gene is used as##2##4##(2008-10#1)(2008-5#1)
gene is##87##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#6)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#6)(1997-9#3)(2008-10#13)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#8)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
gene isolated from##2##3##(1996-3#1)(2008-8#1)
gene knockout mice##2##3##(2008-12#1)(2008-9#1)
gene known##2##2##(2008-10#1)(2008-7#1)
gene level##3##2##(2008-10#1)(2008-11#2)
gene library##2##2##(1995-2#1)(2008-10#1)
gene linked to the##2##4##(1993-8#1)(1994-5#1)
gene list##3##2##(2013-8#3)
gene located at##2##3##(1991-10#1)(2008-10#1)
gene located on##2##3##(1996-3#1)(2008-10#1)
gene located##5##2##(1991-10#1)(1992-9#1)(1996-3#1)(2008-10#2)
gene location##2##2##(1993-3#1)(2008-11#1)
gene loci##4##2##(1993-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
gene locus was##2##3##(2008-11#1)(2009-8#1)
gene locus##7##2##(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-8#1)
gene mapping##2##2##(2008-8#1)(2008-9#1)
gene markers##2##2##(1991-5#1)(2008-10#1)
gene may be##4##3##(1997-7#1)(2008-10#1)(2008-8#2)
gene may have##2##3##(2008-10#1)(2008-6#1)
gene may##10##2##(1993-8#1)(1994-12#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#3)
gene might##2##2##(1997-8#1)(2008-10#1)
gene models##5##2##(2008-4#1)(2008-9#1)(2009-10#2)(2012-3#1)
gene mutation##6##2##(1993-8#1)(1994-12#1)(1995-10#1)(2008-10#2)(2008-9#1)
gene mutations##2##2##(2008-5#1)(2009-8#1)
gene networks##3##2##(2008-2#1)(2010-5#1)(2012-2#1)
gene nomenclature##3##2##(2008-4#3)
gene number in##3##3##(2008-10#2)(2008-9#1)
gene number##4##2##(2008-10#3)(2008-9#1)
gene of B##2##3##(1997-4#1)(2008-10#1)
gene of Escherichia coli##2##4##(1990-11#1)(1997-7#1)
gene of Saccharomyces cerevisiae##2##4##(1995-2#1)(1996-3#1)
gene of a##5##3##(2008-10#4)(2008-8#1)
gene of human##2##3##(1997-3#1)(2008-8#1)
gene of interest and##2##4##(2008-11#2)
gene of interest##8##3##(1996-6#2)(2008-11#4)(2008-4#1)(2008-9#1)
gene of the##10##3##(1993-9#1)(1995-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-8#1)(2011-1#1)
gene of##73##2##(1990-11#1)(1991-6#1)(1993-12#1)(1993-9#1)(1994-11#2)(1995-11#1)(1995-2#1)(1995-6#3)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-3#2)(1997-4#2)(1997-7#5)(1997-8#1)(2008-10#23)(2008-11#6)(2008-12#1)(2008-4#1)(2008-8#9)(2008-9#3)(2011-1#2)(2012-3#1)
gene on chromosome 1##2##4##(1995-8#2)
gene on chromosome##8##3##(1993-12#1)(1993-2#1)(1995-8#4)(1997-7#1)(2008-10#1)
gene on the long arm of##2##6##(2008-10#2)
gene on the##5##3##(1995-9#1)(1997-3#1)(2008-10#2)(2008-9#1)
gene on##18##2##(1993-12#1)(1993-2#1)(1995-8#4)(1995-9#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)
gene ontology##3##2##(2008-8#1)(2010-5#1)(2011-2#1)
gene or genes##4##3##(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)
gene or##11##2##(1995-6#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
gene order##5##2##(1996-12#1)(1996-3#1)(2009-10#1)(2010-7#1)(2013-8#1)
gene organization of##2##3##(1996-6#1)(1997-7#1)
gene organization##5##2##(1992-10#1)(1995-11#1)(1996-6#1)(1997-7#2)
gene organizations##2##2##(1995-6#1)(1996-12#1)
gene p53##4##2##(1994-9#1)(2008-10#3)
gene pairs##2##2##(2008-6#1)(2011-3#1)
gene polymorphism##8##2##(1997-5#2)(2008-10#2)(2008-12#1)(2010-10#1)(2013-1#1)(2013-8#1)
gene polymorphisms##7##2##(2008-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
gene pool##5##2##(2008-10#4)(2009-10#1)
gene pools (Andean and##2##4##(2008-10#2)
gene pools##7##2##(2008-10#7)
gene prediction using GeneMark##2##4##(2008-4#2)
gene prioritization##3##2##(2011-2#3)
gene probe##5##2##(2008-8#5)
gene probes##2##2##(1992-3#1)(1996-6#1)
gene produces a##2##3##(1994-12#1)(1997-8#1)
gene product is a##2##4##(1993-9#1)(2008-11#1)
gene product is##7##3##(1993-12#1)(1993-9#1)(1995-2#1)(1996-3#2)(1997-2#1)(2008-11#1)
gene product that##2##3##(1990-5#1)(1991-10#1)
gene product##40##2##(1990-12#1)(1990-5#2)(1991-10#2)(1991-9#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#3)(1994-11#4)(1995-2#4)(1995-6#3)(1996-3#3)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-4#1)(2009-9#1)
gene products involved in##2##4##(1995-9#1)(1996-3#1)
gene products is##2##3##(1994-11#1)(1995-9#1)
gene products##19##2##(1990-11#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-9#3)(1996-3#1)(2008-10#1)(2008-9#3)(2010-5#1)(2012-2#1)
gene profiling##2##2##(2010-3#1)(2012-3#1)
gene promoter activity##2##3##(1995-6#1)(1995-8#1)
gene promoter and##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
gene promoter has been##2##4##(1991-5#1)(2008-5#1)
gene promoter##19##2##(1991-5#1)(1993-12#1)(1993-3#1)(1995-2#2)(1995-6#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#3)
gene promoters##5##2##(1991-5#1)(1992-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
gene provides##2##2##(1992-6#1)(2008-10#1)
gene rearrangement##5##2##(1994-11#1)(2009-8#4)
gene rearrangements##3##2##(1995-11#1)(2009-8#2)
gene recombination and transposon##2##4##(2009-10#2)
gene region##7##2##(1994-8#1)(1996-8#2)(1997-8#1)(2008-6#1)(2008-8#2)
gene regions were##2##3##(2008-10#2)
gene regions##7##2##(1996-2#1)(2008-10#3)(2008-8#1)(2010-3#1)(2010-4#1)
gene regulation and##5##3##(1993-8#1)(1995-2#2)(1997-7#1)(2008-9#1)
gene regulation by##3##3##(1995-11#1)(1995-6#1)(2011-2#1)
gene regulation in##3##3##(2008-7#2)(2010-10#1)
gene regulation is##3##3##(1997-3#1)(2008-11#1)(2008-7#1)
gene regulation##26##2##(1991-5#1)(1993-12#1)(1993-8#1)(1995-11#2)(1995-2#4)(1995-6#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-7#5)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-3#2)(2013-1#1)
gene regulatory elements##2##3##(1993-6#1)(2009-5#1)
gene regulatory network##2##3##(2008-7#1)(2010-4#1)
gene regulatory networks##2##3##(2010-10#1)(2010-4#1)
gene regulatory##6##2##(1993-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-4#2)
gene replacement##4##2##(1996-6#1)(2007-11#1)(2008-10#1)(2010-10#1)
gene required for##4##3##(1993-2#2)(1995-9#1)(2008-10#1)
gene resulted in embryonic##2##4##(2008-8#1)(2008-9#1)
gene resulted in##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
gene results in##4##3##(1994-3#1)(1995-2#1)(2008-11#1)(2008-8#1)
gene revealed##3##2##(1997-1#1)(2008-10#1)(2011-1#1)
gene segments##10##2##(1991-2#1)(1991-6#1)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2012-3#2)
gene sequence##16##2##(1991-5#1)(1996-6#1)(1997-8#1)(1997-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-6#2)(2010-6#1)(2011-2#2)(2013-1#1)
gene sequences and##2##3##(1993-9#1)(2008-5#1)
gene sequences of##3##3##(2008-10#2)(2008-12#1)
gene sequences##17##2##(1992-10#1)(1992-9#1)(1993-9#1)(2008-10#7)(2008-12#3)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)
gene sequencing##3##2##(2008-10#2)(2011-2#1)
gene sets##3##2##(1992-3#1)(2008-4#1)(2010-5#1)
gene showed that##2##3##(2008-10#2)
gene showed##6##2##(1993-3#1)(1997-7#1)(2008-10#2)(2009-8#1)(2011-2#1)
gene silencing in##2##3##(2011-1#1)(2013-1#1)
gene silencing##7##2##(2008-10#4)(2011-1#1)(2012-3#1)(2013-1#1)
gene single nucleotide##2##3##(2013-7#1)(2013-8#1)
gene spans##2##2##(1991-5#1)(1994-11#1)
gene status##2##2##(1997-7#1)(2008-10#1)
gene structure and##2##3##(1993-6#2)
gene structure##6##2##(1991-5#1)(1993-6#3)(1995-8#1)(2010-5#1)
gene systems##2##2##(2008-8#1)(2008-9#1)
gene targeting in mouse embryonic stem cells##2##7##(1995-2#1)(2008-11#1)
gene targeting in mouse embryonic stem##3##6##(1995-2#1)(2008-11#2)
gene targeting##10##2##(1993-3#1)(1995-2#1)(2008-11#4)(2008-2#1)(2008-9#3)
gene that contained##2##3##(1993-12#1)(2010-5#1)
gene that encodes the##2##4##(2008-4#1)(2008-9#1)
gene that encodes##6##3##(1993-2#1)(2008-10#3)(2008-4#1)(2008-9#1)
gene that is##7##3##(1993-12#1)(2008-10#3)(2011-2#2)(2012-2#1)
gene that##27##2##(1993-12#2)(1993-2#1)(1994-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)
gene therapy and##6##3##(1993-6#1)(2008-11#3)(2008-5#1)(2011-2#1)
gene therapy approach##2##3##(1994-5#1)(1995-2#1)
gene therapy for the##2##4##(2008-5#1)(2008-8#1)
gene therapy for##8##3##(1994-5#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-3#2)
gene therapy of##5##3##(1997-1#1)(2008-8#3)(2013-8#1)
gene therapy to##2##3##(2008-11#1)(2008-9#1)
gene therapy trials##3##3##(1997-1#1)(2008-8#2)
gene therapy##73##2##(1992-12#1)(1993-2#1)(1993-6#1)(1994-5#10)(1995-2#2)(1997-1#2)(2007-11#1)(2008-11#16)(2008-4#1)(2008-5#2)(2008-8#17)(2008-9#6)(2010-1#2)(2010-10#3)(2011-2#3)(2011-3#2)(2012-12#1)(2013-8#2)
gene to a##3##3##(1993-2#1)(1996-6#1)(2008-10#1)
gene to be##3##3##(1995-11#1)(2008-4#2)
gene to enhance##2##3##(2008-10#2)
gene to human##2##3##(1997-8#1)(2008-8#1)
gene to the##5##3##(1995-9#1)(1997-8#1)(2008-9#2)(2010-5#1)
gene to##27##2##(1991-5#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-8#3)(2008-10#6)(2008-12#1)(2008-4#3)(2008-8#2)(2008-9#2)(2010-11#1)(2010-5#1)
gene transcript##2##2##(2008-8#2)
gene transcription and##5##3##(1994-11#1)(1995-12#1)(1996-3#1)(1997-3#1)(2008-9#1)
gene transcription by##3##3##(1996-2#1)(1997-1#1)(2008-8#1)
gene transcription in##3##3##(1993-6#1)(1997-1#1)(2008-8#1)
gene transcription##32##2##(1992-3#1)(1993-6#3)(1994-11#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-12#2)(1996-2#4)(1996-3#1)(1997-1#3)(1997-3#2)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)(2011-1#1)(2012-2#2)
gene transcripts##7##2##(1997-8#1)(2008-10#2)(2008-5#3)(2013-1#1)
gene transfected stromal cells##2##4##(2008-8#2)
gene transfected##4##2##(2008-8#4)
gene transfection##9##2##(1996-12#5)(1996-2#2)(2008-9#2)
gene transfer and bone marrow transplantation##2##6##(2008-11#2)
gene transfer and##8##3##(1994-5#1)(2008-11#5)(2008-8#1)(2008-9#1)
gene transfer in##4##3##(1994-5#2)(1995-2#1)(2011-3#1)
gene transfer into##7##3##(1994-5#2)(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#2)
gene transfer may##2##3##(1994-5#1)(2008-10#1)
gene transfer methods##2##3##(1995-2#1)(2008-11#1)
gene transfer of##3##3##(1994-5#1)(2008-8#1)(2010-12#1)
gene transfer to##2##3##(1994-11#1)(1994-5#1)
gene transfer vector##3##3##(1997-3#2)(2008-8#1)
gene transfer which##2##3##(2008-11#1)(2008-8#1)
gene transfer##58##2##(1994-11#2)(1994-5#13)(1995-12#1)(1995-2#4)(1997-3#2)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#10)(2008-8#10)(2008-9#7)(2010-12#1)(2010-5#1)(2011-3#1)(2012-2#1)
gene transferred##2##2##(2008-10#2)
gene tree topologies##2##3##(2012-3#2)
gene tree##3##2##(2012-3#3)
gene under control of the##2##5##(1991-5#1)(2008-10#1)
gene under field##2##3##(2008-10#1)(2008-9#1)
gene under the control of##6##5##(1994-5#2)(2008-10#2)(2008-9#2)
gene under##11##2##(1991-5#1)(1994-5#2)(2008-10#4)(2008-2#1)(2008-9#3)
gene variants##3##2##(1993-9#1)(2012-3#1)(2013-1#1)
gene vector##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
gene was amplified by##4##4##(2008-10#2)(2008-11#1)(2008-8#1)
gene was amplified##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
gene was cloned by##2##4##(1993-2#1)(2008-8#1)
gene was cloned##4##3##(1991-6#1)(1993-2#1)(2008-10#1)(2008-8#1)
gene was confirmed##2##3##(2008-10#2)
gene was designated as##3##4##(1996-2#1)(2008-8#2)
gene was designated##4##3##(1996-2#1)(2008-10#1)(2008-8#2)
gene was detected in##5##4##(1991-5#1)(2008-10#4)
gene was detected##6##3##(1991-5#1)(2008-10#4)(2011-2#1)
gene was determined##2##3##(1997-8#1)(2008-10#1)
gene was expressed##5##3##(1990-5#1)(1997-7#1)(2008-10#2)(2008-8#1)
gene was found in##3##4##(1992-8#1)(1997-9#1)(2011-2#1)
gene was found to##3##4##(1993-2#1)(1997-7#1)(2008-8#1)
gene was found##8##3##(1992-8#1)(1993-2#1)(1997-7#2)(1997-9#1)(2008-8#2)(2011-2#1)
gene was identified##4##3##(1993-9#1)(1995-2#1)(2008-10#2)
gene was integrated##2##3##(2008-10#1)(2008-8#1)
gene was introduced into##4##4##(1997-2#1)(2008-10#2)(2008-11#1)
gene was isolated and##2##4##(1990-8#1)(1995-2#1)
gene was isolated from##2##4##(1996-8#1)(2008-8#1)
gene was isolated##5##3##(1990-8#1)(1993-3#1)(1995-2#1)(1996-8#1)(2008-8#1)
gene was located on chromosome##2##5##(1997-8#1)(2008-10#1)
gene was located on##4##4##(1992-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
gene was located##6##3##(1992-3#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
gene was mapped in##2##4##(2008-9#1)(2012-3#1)
gene was mapped##4##3##(1997-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
gene was not##4##3##(1992-1#1)(2008-10#2)(2008-8#1)
gene was screened##2##3##(1995-6#1)(2008-8#1)
gene was sequenced##2##3##(2008-10#1)(2008-12#1)
gene was studied##3##3##(1996-6#1)(2008-8#2)
gene was subcloned##2##3##(1990-5#1)(2008-9#1)
gene was successfully##2##3##(1997-8#1)(2008-10#1)
gene was used as a##2##5##(1991-5#1)(1997-7#1)
gene was##124##2##(1990-5#3)(1990-8#1)(1991-5#4)(1991-6#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-2#3)(1993-3#3)(1993-9#1)(1995-2#3)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-7#8)(1997-8#6)(1997-9#1)(2008-10#35)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#24)(2008-9#9)(2011-2#3)(2012-3#1)(2013-1#1)
gene were amplified##3##3##(2008-10#2)(2013-8#1)
gene were detected in##3##4##(1995-6#1)(2008-10#2)
gene were detected##4##3##(1995-6#1)(2008-10#2)(2008-5#1)
gene were isolated and##2##4##(2008-11#1)(2008-8#1)
gene were polymerase chain##2##4##(2008-10#2)
gene were studied##2##3##(2008-10#2)
gene were##32##2##(1991-12#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-8#3)(2011-2#1)(2013-8#1)
gene which encodes a##2##4##(1990-6#1)(1992-7#1)
gene which encodes##3##3##(1990-6#1)(1992-7#1)(1996-6#1)
gene which is##2##3##(2008-11#1)(2008-9#1)
gene which was##2##3##(1996-2#1)(1996-8#1)
gene which##14##2##(1990-6#1)(1991-11#1)(1992-7#1)(1996-2#3)(1996-6#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)
gene with a##3##3##(1993-9#1)(1996-12#1)(2008-8#1)
gene with other##2##3##(2008-10#2)
gene with the##2##3##(1997-3#1)(2008-10#1)
gene with##20##2##(1990-9#1)(1993-9#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-8#6)(2008-9#1)
gene within##2##2##(1996-12#1)(2008-10#1)
gene##3507##1##(1990-11#15)(1990-12#7)(1990-2#3)(1990-5#23)(1990-6#2)(1990-7#1)(1990-8#8)(1990-9#1)(1991-10#6)(1991-11#1)(1991-12#10)(1991-2#4)(1991-3#1)(1991-5#37)(1991-6#23)(1991-7#7)(1991-9#15)(1992-1#5)(1992-10#14)(1992-12#4)(1992-3#22)(1992-4#5)(1992-6#21)(1992-7#1)(1992-8#18)(1992-9#7)(1993-1#3)(1993-11#2)(1993-12#61)(1993-2#49)(1993-3#40)(1993-5#1)(1993-6#44)(1993-8#35)(1993-9#32)(1994-11#51)(1994-12#27)(1994-2#2)(1994-3#5)(1994-5#40)(1994-6#2)(1994-8#12)(1994-9#4)(1995-10#1)(1995-11#17)(1995-12#28)(1995-2#75)(1995-5#1)(1995-6#55)(1995-8#28)(1995-9#25)(1996-12#56)(1996-2#32)(1996-3#17)(1996-5#1)(1996-6#33)(1996-8#14)(1997-1#14)(1997-2#14)(1997-3#38)(1997-4#7)(1997-5#2)(1997-6#12)(1997-7#86)(1997-8#57)(1997-9#16)(2006-6#1)(2007-11#4)(2007-12#8)(2008-1#1)(2008-10#778)(2008-11#207)(2008-12#25)(2008-2#6)(2008-4#66)(2008-5#34)(2008-6#17)(2008-7#31)(2008-8#295)(2008-9#202)(2009-10#37)(2009-12#4)(2009-4#2)(2009-5#4)(2009-6#21)(2009-7#4)(2009-8#27)(2009-9#3)(2010-1#15)(2010-10#24)(2010-11#5)(2010-12#10)(2010-3#3)(2010-4#13)(2010-5#26)(2010-6#9)(2010-7#4)(2010-8#1)(2011-1#28)(2011-10#1)(2011-2#95)(2011-3#16)(2011-8#1)(2012-12#9)(2012-2#27)(2012-3#70)(2012-5#4)(2013-1#40)(2013-7#3)(2013-8#26)
gene&quot##2##1##(2008-10#1)(2008-4#1)
gene'##2##1##(1997-2#1)(2008-5#1)
gene's expression##3##2##(1995-2#1)(2008-8#1)(2012-3#1)
gene's##5##1##(1995-2#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-3#1)
gene(s) in target cells##3##4##(1997-8#3)
gene(s) in##4##2##(1997-8#3)(2008-8#1)
gene(s)##11##1##(1995-6#1)(1997-3#1)(1997-8#5)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)
gene) of##2##2##(1990-5#1)(2008-11#1)
gene) were##2##2##(2008-10#1)(2008-9#1)
gene)##12##1##(1990-5#1)(1997-5#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#2)
gene-##2##1##(2008-7#1)(2013-1#1)
gene-amplified##2##1##(2008-11#2)
gene-based##2##1##(1993-12#1)(2008-8#1)
gene-environment interaction##3##2##(1997-3#2)(2011-2#1)
gene-environment##4##1##(1997-3#2)(2008-7#1)(2011-2#1)
gene-expression##3##1##(2008-4#1)(2008-7#1)(2010-5#1)
gene-finding programs##2##2##(1996-12#2)
gene-finding##4##1##(1996-12#3)(1996-8#1)
gene-for-gene interaction##7##2##(2008-10#5)(2011-10#2)
gene-for-gene interactions##5##2##(2008-10#5)
gene-for-gene model based on the interaction of##2##7##(2008-10#2)
gene-for-gene model##5##2##(2008-10#5)
gene-for-gene relationship##7##2##(2008-10#7)
gene-for-gene##30##1##(2008-10#26)(2008-8#1)(2008-9#1)(2011-10#2)
gene-mediated##2##1##(2008-10#2)
gene-modified macrophages##2##2##(2008-8#2)
gene-modified##8##1##(1994-5#1)(2008-8#5)(2012-10#1)(2012-12#1)
gene-related peptide (CGRP)##3##3##(1997-3#2)(1997-4#1)
gene-related peptide in the##8##4##(1992-6#8)
gene-related peptide in##11##3##(1992-6#11)
gene-related peptide##31##2##(1992-6#24)(1994-8#1)(1997-1#1)(1997-3#3)(1997-4#1)(2013-8#1)
gene-related##34##1##(1992-6#25)(1994-8#2)(1997-1#1)(1997-3#4)(1997-4#1)(2013-8#1)
gene-silencing##3##1##(2008-10#1)(2011-2#2)
gene-specific primer##2##2##(1997-7#2)
gene-specific##6##1##(1997-7#2)(2008-10#2)(2008-9#1)(2010-4#1)
gene-trap vector##2##2##(1997-8#2)
gene-trap##3##1##(1997-8#3)
gene]##2##1##(2008-10#1)(2011-3#1)
genealogies##4##1##(2008-10#4)
genealogy##2##1##(1995-5#1)(2008-10#1)
genera and families##2##3##(2012-3#2)
genera and##6##2##(2008-10#4)(2012-3#2)
genera of##6##2##(2008-10#3)(2008-12#1)(2010-10#1)(2012-12#1)
genera tested##2##2##(2008-10#2)
genera##70##1##(1995-2#1)(2007-12#1)(2008-10#35)(2008-12#6)(2008-5#4)(2008-6#5)(2008-8#3)(2008-9#2)(2010-10#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#4)
general acid catalysis##2##3##(1993-8#1)(1994-11#1)
general agreement that##2##3##(2008-11#1)(2008-4#1)
general agreement##5##2##(1993-8#1)(2008-11#2)(2008-2#1)(2008-4#1)
general anaesthesia##8##2##(1997-6#1)(2008-7#1)(2010-7#6)
general analytical##2##2##(2008-10#1)(2008-8#1)
general and abdominal radiologists##2##4##(2012-2#2)
general and##23##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
general anesthesia and##2##3##(1993-1#1)(2011-2#1)
general anesthesia was##2##3##(1990-11#1)(1993-1#1)
general anesthesia##21##2##(1990-11#3)(1992-12#2)(1993-1#10)(1994-12#1)(1995-3#1)(2008-4#1)(2011-2#3)
general applicability##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
general approach to##2##3##(1995-8#1)(2008-10#1)
general approach##4##2##(1995-2#1)(1995-8#1)(2008-10#2)
general categories##2##2##(2008-10#1)(2009-10#1)
general characteristics##3##2##(1990-2#2)(2010-12#1)
general circulation##2##2##(2008-3#1)(2012-3#1)
general clinical##3##2##(1994-12#1)(1996-8#1)(2013-1#1)
general cognitive style##4##3##(2010-1#4)
general cognitive##5##2##(2010-1#4)(2010-5#1)
general computational##2##2##(2008-3#1)(2012-3#1)
general conclusion##3##2##(2008-9#2)(2010-11#1)
general condition##2##2##(2011-2#1)(2012-3#1)
general conditions##4##2##(2008-7#2)(2008-9#1)(2013-8#1)
general dental practitioner##3##3##(2008-1#2)(2011-2#1)
general dental practitioners##2##3##(2008-1#1)(2011-2#1)
general dental##5##2##(2008-1#3)(2011-2#2)
general education##2##2##(1993-11#1)(1994-2#1)
general effect##2##2##(1995-11#1)(2008-10#1)
general epidemics##4##2##(2008-10#4)
general features##2##2##(2008-12#1)(2009-10#1)
general form of##3##3##(2008-8#3)
general formula##2##2##(2008-10#2)
general framework##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2010-11#1)
general genetic##2##2##(1990-5#1)(2008-4#1)
general guidelines##3##2##(1993-12#1)(2008-4#1)(2008-9#1)
general health and##2##3##(2008-11#1)(2008-7#1)
general health care##4##3##(1993-3#1)(2008-11#3)
general health issues##2##3##(2010-1#2)
general health##25##2##(1991-6#1)(1992-3#2)(1993-3#1)(1994-3#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-7#7)(2008-8#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
general hospital##7##2##(1990-3#1)(1992-2#1)(2008-11#1)(2010-12#1)(2013-1#3)
general hospitals in##2##3##(1991-2#1)(2009-12#1)
general hospitals##8##2##(1990-6#1)(1991-2#2)(1994-1#3)(1997-5#1)(2009-12#1)
general hospitals]##2##2##(1991-2#1)(2013-8#1)
general host##2##2##(1994-8#1)(2008-11#1)
general information about##2##3##(1993-3#1)(1996-11#1)
general information##4##2##(1993-3#1)(1996-11#1)(2008-10#1)(2010-3#1)
general interest##3##2##(1991-2#1)(1991-3#1)(2008-11#1)
general introduction##4##2##(1997-3#1)(2008-11#1)(2008-4#2)
general laboratory##2##2##(1994-12#1)(2008-8#1)
general lack of##3##3##(1991-12#1)(1992-2#1)(2008-11#1)
general linear model##2##3##(2008-10#1)(2013-8#1)
general linear##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
general malaise##2##2##(1992-12#1)(2012-3#1)
general management##4##2##(1992-1#1)(1993-12#1)(1994-1#1)(2009-8#1)
general medical##3##2##(1991-12#1)(1996-9#1)(2013-8#1)
general method for##2##3##(2008-9#1)(2009-3#1)
general method of##2##3##(2008-10#1)(2008-9#1)
general method##5##2##(2008-10#2)(2008-9#2)(2009-3#1)
general methodology##2##2##(2008-7#1)(2009-10#1)
general model of##2##3##(1995-6#1)(2012-3#1)
general model##6##2##(1992-1#1)(1995-6#1)(2008-8#3)(2012-3#1)
general or##2##2##(2008-10#1)(2009-8#1)
general organization##2##2##(1991-2#1)(1992-2#1)
general outcomes##2##2##(2008-4#2)
general patterns##2##2##(2008-10#1)(2012-2#1)
general phenomena##2##2##(1995-3#1)(2008-7#1)
general population and##4##3##(1992-2#1)(1997-1#1)(2010-12#1)(2013-1#1)
general population##56##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#3)(1992-11#1)(1992-2#3)(1992-9#1)(1993-1#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#4)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#8)(2013-8#3)
general potentiometric##2##2##(2008-10#2)
general practice and##2##3##(1994-6#1)(2008-6#1)
general practice##45##2##(1990-3#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-2#2)(1993-6#1)(1994-12#2)(1994-6#5)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-6#1)(1996-8#2)(1997-4#2)(1997-5#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)
general practice/family medicine##2##3##(1993-11#1)(1997-5#1)
general practice]##7##2##(1990-11#1)(1993-2#1)(1994-6#2)(1997-3#1)(1997-8#2)
general practices##2##2##(1996-8#1)(2008-11#1)
general practitioner and##2##3##(1996-8#1)(1997-4#1)
general practitioner##16##2##(1990-3#2)(1992-5#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-11#2)(1995-6#1)(1996-11#1)(1996-8#1)(1997-4#2)(2009-3#1)(2010-1#1)(2012-12#1)
general practitioners (GPs) and##2##4##(2008-11#1)(2011-2#1)
general practitioners and a##2##4##(1997-4#2)
general practitioners and to##2##4##(1993-2#1)(2008-10#1)
general practitioners and##8##3##(1993-11#1)(1993-2#1)(1996-6#1)(1997-4#3)(2008-10#1)(2011-2#1)
general practitioners from##2##3##(1993-3#1)(1994-6#1)
general practitioners in the##3##4##(1997-4#1)(2008-11#1)(2013-1#1)
general practitioners in##7##3##(1991-9#1)(1994-6#1)(1997-4#1)(2008-11#1)(2008-8#2)(2013-1#1)
general practitioners to##2##3##(1997-4#1)(2011-2#1)
general practitioners with##2##3##(2008-10#1)(2011-2#1)
general practitioners'##2##2##(1990-11#1)(2008-8#1)
general principle of##2##3##(1993-9#1)(2012-3#1)
general principle##5##2##(1993-9#1)(2008-8#1)(2009-8#2)(2012-3#1)
general principles and##2##3##(2008-8#1)(2013-1#1)
general principles##5##2##(1990-5#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
general procedure##4##2##(1990-8#1)(2008-10#1)(2008-4#2)
general psychiatric##2##2##(1993-2#1)(2009-7#1)
general public health##2##3##(1997-3#1)(2012-2#1)
general public##9##2##(1993-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
general purpose##2##2##(1996-2#1)(2008-10#1)
general reducing agent##2##3##(1990-9#1)(1996-5#1)
general relationship between the##2##4##(2008-8#1)(2008-9#1)
general relationship between##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
general relationship##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#1)
general rule##2##2##(2008-10#1)(2012-3#1)
general rules governing##3##3##(2008-8#3)
general rules##4##2##(2008-5#1)(2008-8#3)
general satisfaction in the SG order##2##6##(1993-12#2)
general satisfaction##5##2##(1993-12#5)
general statistical##3##2##(2007-12#1)(2013-1#2)
general strategies##3##2##(2008-10#2)(2013-8#1)
general stress response protein##2##4##(1997-7#2)
general stress##3##2##(1997-7#2)(2008-7#1)
general surgery##7##2##(1990-3#1)(1992-5#1)(1993-2#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-3#1)
general tendency##3##2##(2008-8#3)
general terms##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
general the##3##2##(1996-9#1)(2008-11#1)(2008-2#1)
general toxicity studies##2##3##(2011-2#2)
general transcription factors##4##3##(1994-3#4)
general treatment strategies##2##3##(1996-6#2)
general trend of##2##3##(2008-10#1)(2008-11#1)
general trend##4##2##(2008-10#3)(2008-11#1)
general types##2##2##(1992-3#1)(2008-3#1)
general use##2##2##(2008-11#1)(2010-6#1)
general usefulness of##2##3##(2008-10#1)(2008-11#1)
general##910##1##(1990-11#6)(1990-12#3)(1990-2#5)(1990-3#10)(1990-5#3)(1990-6#4)(1990-8#2)(1990-9#4)(1991-1#2)(1991-11#2)(1991-12#7)(1991-2#12)(1991-3#4)(1991-6#4)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#8)(1992-3#8)(1992-5#6)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#13)(1993-11#8)(1993-12#14)(1993-2#11)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#9)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#12)(1994-5#2)(1994-6#15)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#2)(1995-8#3)(1996-1#4)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#8)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#10)(1997-4#16)(1997-5#8)(1997-6#3)(1997-7#3)(1997-8#6)(2006-6#1)(2007-11#1)(2007-12#5)(2008-1#9)(2008-10#139)(2008-11#63)(2008-12#14)(2008-2#4)(2008-3#9)(2008-4#19)(2008-5#14)(2008-6#5)(2008-7#35)(2008-8#43)(2008-9#24)(2009-10#7)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#3)(2009-6#3)(2009-7#6)(2009-8#8)(2009-9#2)(2010-1#11)(2010-10#1)(2010-11#4)(2010-12#9)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#6)(2010-8#4)(2011-1#3)(2011-2#34)(2011-3#3)(2012-12#4)(2012-2#14)(2012-3#17)(2012-7#1)(2013-1#27)(2013-8#15)
generalisable##2##1##(2008-11#1)(2008-12#1)
generalised##10##1##(1990-9#1)(1994-2#1)(2008-10#4)(2008-7#1)(2011-2#2)(2013-8#1)
generalist##18##1##(1993-2#2)(2008-10#2)(2008-8#5)(2008-9#5)(2009-8#3)(2011-10#1)
generalists are##2##2##(1993-2#1)(2008-8#1)
generalists##8##1##(1993-2#1)(2008-10#2)(2008-8#1)(2008-9#3)(2010-8#1)
generality of##6##2##(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#1)
generalizability##2##1##(1993-3#1)(2012-2#1)
generalization of the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
generalization of##13##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-9#2)(2010-8#1)
generalization to##2##2##(2008-3#1)(2012-3#1)
generalization##20##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-8#1)(2012-3#2)
generalizations##3##1##(2008-10#1)(2008-9#2)
generalize to other##3##3##(2008-11#1)(2009-10#1)(2013-8#1)
generalize to##5##2##(2008-11#1)(2009-10#1)(2009-12#1)(2010-7#1)(2013-8#1)
generalize##13##1##(1995-5#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-7#1)(2013-8#1)
generalized Lorenz-Mie theory for cylinders##2##5##(2008-3#2)
generalized Lorenz-Mie theory for##3##4##(2008-3#3)
generalized Lorenz-Mie theory##4##3##(2008-2#1)(2008-3#3)
generalized Newtonian mathematical models##2##4##(2013-8#2)
generalized Shwartzman reaction was##2##4##(1996-12#2)
generalized Shwartzman reaction##4##3##(1996-12#4)
generalized and##2##2##(2008-10#1)(2008-6#1)
generalized anxiety disorder##2##3##(2012-2#1)(2013-1#1)
generalized anxiety##3##2##(2012-2#1)(2013-1#2)
generalized from##2##2##(2008-11#1)(2008-3#1)
generalized imaging##2##2##(2008-6#2)
generalized linear model##2##3##(1995-12#1)(2008-11#1)
generalized linear models##3##3##(2008-10#3)
generalized linear##8##2##(1995-12#1)(2008-10#6)(2008-11#1)
generalized reciprocity##3##2##(2012-3#3)
generalized self-filtering unstable##2##3##(2008-2#2)
generalized to##6##2##(1992-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#2)
generalized viscous double-layer##2##3##(2009-10#2)
generalized weakness##3##2##(2009-3#1)(2010-8#1)(2012-2#1)
generalized##100##1##(1990-12#1)(1991-9#1)(1992-2#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#2)(2010-8#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#4)
generalizes##4##1##(2008-3#1)(2009-4#2)(2011-2#1)
generalizing##3##1##(2008-1#1)(2008-10#1)(2008-11#1)
generally a##5##2##(1991-1#1)(1991-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
generally accepted##13##2##(1990-12#1)(1994-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-3#2)
generally agreed##4##2##(1992-3#1)(2008-10#1)(2008-3#1)(2009-8#1)
generally applicable##3##2##(1997-7#1)(2008-10#2)
generally associated with##7##3##(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)
generally associated##8##2##(1997-1#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)
generally be##3##2##(2008-10#1)(2011-2#2)
generally believed##3##2##(2008-4#1)(2010-7#1)(2011-10#1)
generally benign##2##2##(2011-2#1)(2012-3#1)
generally considered##9##2##(1996-2#1)(1996-3#1)(2008-10#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-7#1)(2013-1#1)
generally could##2##2##(1996-9#1)(2008-10#1)
generally did not##2##3##(2008-10#1)(2008-8#1)
generally exhibit##4##2##(1996-12#1)(2008-9#2)(2012-5#1)
generally expected##2##2##(1995-11#1)(2008-5#1)
generally found##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
generally good##2##2##(1996-5#1)(2008-3#1)
generally had##2##2##(2008-10#1)(2008-8#1)
generally has##2##2##(1992-3#1)(2008-7#1)
generally have##2##2##(2009-7#1)(2011-2#1)
generally high##2##2##(1996-2#1)(2008-11#1)
generally higher##3##2##(2008-10#2)(2013-8#1)
generally in##4##2##(2008-10#3)(2010-1#1)
generally increased##2##2##(2008-10#2)
generally indicated##2##2##(2010-10#1)(2011-2#1)
generally involved in##2##3##(1993-8#1)(2008-9#1)
generally involved##3##2##(1993-8#1)(1996-1#1)(2008-9#1)
generally is##2##2##(2008-10#1)(2010-6#1)
generally known##2##2##(2008-5#1)(2009-8#1)
generally less than##2##3##(2008-3#1)(2008-9#1)
generally less##5##2##(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
generally low##2##2##(2008-10#1)(2012-2#1)
generally lower than##2##3##(1995-12#1)(2008-10#1)
generally lower##4##2##(1992-12#1)(1995-12#1)(2008-10#2)
generally mild##2##2##(1990-2#1)(2007-11#1)
generally more##5##2##(1995-5#1)(1997-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
generally not##9##2##(1992-1#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-11#1)
generally observed in##2##3##(2008-5#1)(2009-10#1)
generally observed##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2009-10#1)
generally only##3##2##(2008-11#1)(2008-4#1)(2010-11#1)
generally outperforms##2##2##(2008-5#1)(2012-3#1)
generally performed##2##2##(2008-10#1)(2011-2#1)
generally poor##4##2##(1990-11#1)(2008-1#1)(2008-7#1)(2009-4#1)
generally positive##2##2##(2008-10#2)
generally recognized as##2##3##(2008-10#1)(2008-7#1)
generally referred to as##2##4##(1996-12#1)(1997-1#1)
generally regarded##3##2##(1994-9#1)(2008-10#2)
generally reported##2##2##(1994-3#1)(2009-4#1)
generally satisfied with##2##3##(1991-1#1)(1996-2#1)
generally showed a porous layer##2##5##(2008-10#2)
generally showed##3##2##(2008-10#2)(2010-4#1)
generally similar to that##3##4##(2008-11#1)(2008-9#2)
generally similar##5##2##(2008-11#2)(2008-9#2)(2013-1#1)
generally small##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
generally used for##2##3##(2008-10#1)(2008-4#1)
generally used##6##2##(2008-10#4)(2008-4#1)(2011-2#1)
generally very##2##2##(1995-11#1)(2013-1#1)
generally was associated with##2##4##(2008-10#2)
generally was found##3##3##(2009-7#1)(2013-1#2)
generally was##10##2##(2008-10#7)(2009-7#1)(2013-1#2)
generally were more##2##3##(2008-10#2)
generally were##7##2##(2008-10#7)
generally##381##1##(1990-11#1)(1990-12#2)(1990-2#2)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2008-1#3)(2008-10#110)(2008-11#20)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#9)(2008-7#8)(2008-8#20)(2008-9#19)(2009-10#3)(2009-11#2)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#6)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#18)(2011-3#1)(2011-7#1)(2012-2#8)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#8)(2013-8#4)
generate a##24##2##(1991-9#1)(1993-12#1)(1994-8#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-8#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-3#1)
generate an##6##2##(1992-2#1)(2008-10#3)(2008-2#1)(2008-6#1)
generate different##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
generate hypotheses for##2##3##(2012-2#1)(2013-8#1)
generate hypotheses##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
generate multiple##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
generate persistent##2##2##(2008-11#1)(2008-8#1)
generate##176##1##(1990-5#3)(1991-3#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#5)(1993-2#1)(1993-8#2)(1994-1#1)(1994-3#1)(1994-8#2)(1995-2#4)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#43)(2008-11#21)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#4)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#6)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#5)(2010-1#1)(2010-10#2)(2010-12#1)(2010-5#2)(2010-7#4)(2011-1#1)(2011-2#4)(2011-3#2)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#4)
generated Ru(bpy)(3)(3+)-based chemiluminescence##2##3##(2008-10#2)
generated a signal##2##3##(2008-3#2)
generated a##10##2##(1994-9#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-3#2)(2013-1#1)(2013-8#1)
generated and##8##2##(1995-12#1)(1997-9#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-3#1)(2011-2#1)
generated as a result of##2##5##(2008-10#2)
generated as a##3##3##(1992-6#1)(2008-10#2)
generated at the##2##3##(2008-3#1)(2009-5#1)
generated at##6##2##(1994-5#1)(2008-10#2)(2008-3#1)(2009-5#1)(2012-2#1)
generated by a##12##3##(1990-11#1)(1994-6#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-8#1)(2013-8#1)
generated by an##2##3##(1994-12#1)(2008-3#1)
generated by digestion##2##3##(1992-6#1)(2008-10#1)
generated by in vitro immunization##3##5##(2008-11#3)
generated by the oxidation of##3##5##(2008-10#3)
generated by the oxidation##4##4##(2008-10#4)
generated by the##29##3##(1991-12#1)(1991-3#1)(1993-6#1)(1995-6#3)(1995-8#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-9#1)(2009-10#2)(2013-1#1)
generated by using##4##3##(2008-10#1)(2008-11#3)
generated by##123##2##(1990-11#1)(1991-12#1)(1991-3#2)(1992-6#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#4)(1995-8#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#3)(2007-12#3)(2008-1#1)(2008-10#38)(2008-11#19)(2008-2#4)(2008-3#7)(2008-8#6)(2008-9#4)(2009-10#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-8#1)
generated data##3##2##(2008-10#2)(2008-4#1)
generated droplets (nebulizer##2##3##(1995-3#2)
generated during its reaction with either##2##6##(2008-10#2)
generated during oxidation##2##3##(2008-10#2)
generated during the##3##3##(2008-10#2)(2010-2#1)
generated during##11##2##(1991-5#1)(2008-10#8)(2010-2#1)(2011-2#1)
generated enzymatically##2##2##(2008-10#2)
generated following##2##2##(2008-7#1)(2009-10#1)
generated for the##5##3##(1993-2#1)(2008-10#3)(2008-11#1)
generated for##11##2##(1993-2#1)(2008-10#7)(2008-11#1)(2008-3#2)
generated from a##2##3##(2007-11#1)(2008-3#1)
generated from membrane phospholipids##2##4##(1994-3#2)
generated from somatic##2##3##(2008-10#1)(2008-11#1)
generated from the##14##3##(1990-2#1)(1996-5#2)(1996-8#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#2)
generated from this##3##3##(2008-10#2)(2008-4#1)
generated from##56##2##(1990-2#1)(1991-3#2)(1992-6#1)(1994-3#2)(1995-6#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-6#1)(1997-9#1)(2007-11#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#3)(2009-10#1)
generated higher##2##2##(2008-10#1)(2008-8#1)
generated hydrogen peroxide##3##3##(2008-10#3)
generated in a##8##3##(2008-10#5)(2008-2#1)(2008-3#1)(2009-10#1)
generated in situ by KBr/KBrO(3) in HCl medium##2##8##(2008-10#2)
generated in situ##4##3##(1996-5#1)(2008-10#3)
generated in the##13##3##(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)
generated in this way##2##4##(2008-10#2)
generated in##38##2##(1991-5#1)(1993-8#1)(1995-2#2)(1996-5#1)(1997-2#1)(2008-10#22)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2013-8#1)
generated is##5##2##(2008-10#4)(2008-5#1)
generated nickel##2##2##(2008-10#2)
generated on##4##2##(1992-12#1)(2008-10#2)(2008-7#1)
generated or##2##2##(2008-10#1)(2008-12#1)
generated rains##2##2##(2008-10#2)
generated recombinant##2##2##(1995-8#1)(2008-11#1)
generated the##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
generated through a##2##3##(2009-8#1)(2012-3#1)
generated through##7##2##(1991-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2012-3#1)
generated to##6##2##(1996-2#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
generated transgenic##3##2##(1993-9#1)(2008-11#1)(2012-12#1)
generated using##5##2##(1991-9#1)(1997-4#1)(2008-10#2)(2008-11#1)
generated was##2##2##(2008-10#2)
generated with a##2##3##(2008-10#1)(2008-3#1)
generated with the##3##3##(1990-5#1)(1995-12#1)(2008-10#1)
generated with##12##2##(1990-5#1)(1993-6#1)(1995-12#1)(1996-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
generated##479##1##(1990-11#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-3#4)(1991-5#3)(1991-9#2)(1992-12#1)(1992-6#4)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#5)(1995-3#5)(1995-6#10)(1995-8#4)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#4)(1997-9#2)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#178)(2008-11#55)(2008-12#7)(2008-2#11)(2008-3#27)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#11)(2008-9#11)(2009-10#8)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#9)(2013-8#4)
generates a##13##2##(1990-5#1)(1991-9#1)(1992-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)
generates an##2##2##(1997-3#1)(2008-3#1)
generates the##4##2##(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
generates##47##1##(1990-5#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-9#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
generating a new##2##3##(1996-5#1)(2008-11#1)
generating a##7##2##(1993-3#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
generating an##2##2##(2008-11#1)(2011-2#1)
generating and##2##2##(2008-4#1)(2008-9#1)
generating more##2##2##(1994-1#1)(2008-2#1)
generating the##7##2##(1995-2#2)(1996-2#1)(2008-10#1)(2008-8#2)(2010-4#1)
generating transgenic##2##2##(2008-11#2)
generating##95##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-3#2)(1993-3#2)(1994-1#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#21)(2008-11#12)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#2)(2008-8#6)(2008-9#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-2#3)(2013-1#1)
generation (HG)##8##2##(2008-10#8)
generation (SHG)##2##2##(2008-10#1)(2008-2#1)
generation after hybridization##2##3##(2008-9#2)
generation and atomic fluorescence##2##4##(2008-10#2)
generation and atomic##3##3##(2008-10#3)
generation and delivery##2##3##(1992-3#2)
generation and separation properties##2##4##(1995-3#2)
generation and##44##2##(1992-3#2)(1993-8#1)(1994-8#1)(1995-3#3)(1997-1#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
generation are##2##2##(2008-3#1)(2008-9#1)
generation atomic absorption spectrometry##14##4##(2008-10#14)
generation atomic absorption##16##3##(2008-10#16)
generation atomic fluorescence spectrometry##13##4##(2008-10#13)
generation atomic fluorescence##15##3##(2008-10#15)
generation atomic##32##2##(2008-10#32)
generation by##9##2##(1991-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(2007-12#2)(2008-10#2)(2008-3#1)
generation devices##2##2##(2010-6#2)
generation following##3##2##(2008-10#3)
generation for##3##2##(2007-12#1)(2008-10#2)
generation from##7##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-10#1)
generation in a##4##3##(1994-11#1)(2008-10#1)(2008-2#1)(2010-9#1)
generation in the presence of##2##5##(1993-8#1)(2007-12#1)
generation in##19##2##(1991-3#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-8#1)(2010-9#1)(2012-2#2)
generation inductively coupled plasma##3##4##(2008-10#3)
generation interface##2##2##(2008-10#2)
generation is##10##2##(2007-11#1)(2008-10#6)(2008-11#2)(2008-3#1)
generation means##2##2##(2008-10#2)
generation of H(+)##2##3##(2008-10#2)
generation of a##9##3##(1993-8#1)(1997-8#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
generation of an##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
generation of defective##2##3##(2008-10#1)(2008-11#1)
generation of human##4##3##(1995-12#1)(2008-11#2)(2008-4#1)
generation of inositol##2##3##(1993-3#1)(1993-6#1)
generation of mercury vapour##2##4##(2008-10#2)
generation of reactive oxygen species##3##5##(2008-1#1)(2009-3#1)(2012-2#1)
generation of reactive oxygen##4##4##(1995-8#1)(2008-1#1)(2009-3#1)(2012-2#1)
generation of superoxide anion##4##4##(1993-6#3)(2008-10#1)
generation of the reactive oxygen species##2##6##(2008-10#1)(2011-2#1)
generation of the##7##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-3#1)
generation of therapeutic##2##3##(2008-11#1)(2011-9#1)
generation of transgenic mice##3##4##(2008-4#3)
generation of transgenic##4##3##(2008-11#1)(2008-4#3)
generation of volatile silicon tetrafluoride##2##5##(2008-10#2)
generation of##166##2##(1990-5#1)(1991-12#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-3#2)(1993-3#1)(1993-6#4)(1993-8#2)(1994-11#1)(1995-12#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(1997-9#1)(2007-11#3)(2008-1#2)(2008-10#36)(2008-11#27)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#7)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#8)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-2#7)(2011-9#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#2)
generation procedure##3##2##(2008-10#3)
generation process##2##2##(2008-3#2)
generation system##4##2##(2008-10#4)
generation technique##2##2##(2008-10#2)
generation techniques##4##2##(2008-10#4)
generation time##3##2##(2008-8#2)(2013-1#1)
generation under different##2##3##(2008-10#2)
generation under##3##2##(2008-10#2)(2008-11#1)
generation was determined##2##3##(1994-5#1)(2008-12#1)
generation was##9##2##(1991-6#1)(1993-6#1)(1994-5#1)(2007-11#1)(2008-10#4)(2008-12#1)
generation were investigated##3##3##(1997-1#1)(2008-10#2)
generation were##8##2##(1993-6#1)(1995-6#1)(1997-1#1)(2008-10#4)(2008-12#1)
generation when##2##2##(2008-8#1)(2009-9#1)
generation with##2##2##(2007-11#1)(2008-8#1)
generation##519##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#7)(1991-3#2)(1991-5#5)(1991-6#4)(1991-7#1)(1991-9#1)(1992-12#3)(1992-3#5)(1993-11#1)(1993-3#1)(1993-6#9)(1993-8#5)(1994-11#5)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#5)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#3)(1996-12#2)(1996-2#5)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#3)(1997-9#1)(2007-11#8)(2007-12#8)(2008-1#2)(2008-10#222)(2008-11#39)(2008-12#5)(2008-2#13)(2008-3#19)(2008-4#9)(2008-5#2)(2008-7#5)(2008-8#11)(2008-9#15)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#3)(2010-7#2)(2010-9#2)(2011-2#11)(2011-3#2)(2011-9#1)(2012-12#2)(2012-2#16)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#4)
generation)##3##1##(2008-10#1)(2008-12#1)(2008-7#1)
generation-FTIR##2##1##(2008-10#2)
generation-Fourier transform infrared##2##3##(2008-10#2)
generation-atomic absorption spectrometry##6##3##(1995-11#1)(2008-10#5)
generation-atomic fluorescence spectrometry##7##3##(2008-10#7)
generation-atomic fluorescence##8##2##(2008-10#8)
generation-atomic##14##1##(1995-11#1)(2008-10#13)
generation-gas phase##4##2##(2008-10#4)
generation/atomic absorption spectrometry##2##3##(2008-10#2)
generations in##4##2##(2008-10#2)(2009-6#1)(2012-2#1)
generations of##7##2##(1993-9#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
generations on##2##2##(2008-10#2)
generations were evaluated##2##3##(2008-10#2)
generations were##3##2##(2008-10#3)
generations##70##1##(1990-11#1)(1991-6#1)(1992-2#2)(1993-9#1)(1994-11#1)(1996-12#1)(1997-5#1)(2008-10#31)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#4)(2012-5#1)(2013-8#1)
generations)##3##1##(1997-6#1)(2008-12#2)
generative##7##1##(2008-10#2)(2009-10#1)(2009-12#1)(2011-1#1)(2013-8#2)
generator and##2##2##(2008-10#1)(2008-2#1)
generator for##2##2##(2008-10#2)
generator of##2##2##(2007-12#1)(2007-8#1)
generator settings##2##2##(1992-12#2)
generator with##2##2##(2008-10#2)
generator##40##1##(1992-12#3)(1995-3#1)(1996-12#1)(1996-2#1)(2007-12#3)(2007-8#1)(2008-10#15)(2008-11#2)(2008-2#3)(2008-3#3)(2008-7#4)(2009-10#2)(2010-1#1)
generators in##2##2##(2008-10#1)(2013-1#1)
generators##13##1##(1996-12#1)(2008-10#6)(2008-11#1)(2008-3#3)(2009-5#1)(2013-1#1)
generic Escherichia coli##2##3##(2010-4#2)
generic drugs and##2##3##(2011-3#2)
generic medicines##10##2##(2011-1#10)
generic model##3##2##(2008-11#2)(2008-6#1)
generic name##3##2##(1990-6#1)(2008-10#1)(2008-11#1)
generic stress##2##2##(1990-5#2)
generic##58##1##(1990-5#2)(1990-6#1)(1992-9#2)(1996-2#1)(1996-3#1)(2008-10#5)(2008-11#8)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-4#2)(2010-9#1)(2011-1#12)(2011-2#1)(2011-3#2)(2012-4#1)(2013-1#2)(2013-8#3)
generous##4##1##(1992-2#1)(1994-1#1)(1996-3#1)(2012-3#1)
genes (Rlm1##2##2##(2008-10#2)
genes MlRE and Pm4b##2##4##(2008-10#2)
genes among##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
genes analyzed##2##2##(1992-6#1)(2008-8#1)
genes and 13##2##3##(1996-6#2)
genes and DNA##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
genes and a##3##3##(1996-12#2)(1996-6#1)
genes and gene clusters##3##4##(1995-6#2)(1996-12#1)
genes and gene##5##3##(1995-6#2)(1996-12#1)(2008-9#1)(2012-2#1)
genes and genetic##2##3##(2008-9#1)(2012-3#1)
genes and of##2##3##(2008-10#2)
genes and one##3##3##(1993-6#1)(2008-9#1)(2009-10#1)
genes and proteins##4##3##(2008-11#3)(2010-11#1)
genes and the##6##3##(2008-10#3)(2008-9#1)(2009-10#1)(2011-2#1)
genes and their##5##3##(1993-8#1)(2008-10#2)(2011-2#2)
genes and three##2##3##(2008-11#1)(2013-8#1)
genes and##103##2##(1992-10#1)(1992-12#1)(1992-7#1)(1993-6#2)(1993-8#1)(1995-12#1)(1995-6#3)(1996-12#4)(1996-3#1)(1996-6#5)(1997-2#1)(1997-6#2)(2008-10#29)(2008-11#6)(2008-4#1)(2008-5#1)(2008-8#7)(2008-9#9)(2009-10#2)(2009-6#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#11)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
genes and/or gene segments##3##4##(1997-6#2)(1997-8#1)
genes and/or gene##4##3##(1997-6#2)(1997-8#2)
genes and/or##5##2##(1997-6#2)(1997-8#2)(2008-11#1)
genes are associated with##2##4##(1992-12#1)(1995-2#1)
genes are expressed in##2##4##(1996-2#1)(2008-10#1)
genes are expressed##7##3##(1996-2#1)(2008-10#3)(2008-6#1)(2009-10#1)(2011-2#1)
genes are identical##2##3##(1992-6#1)(2008-9#1)
genes are involved in##4##4##(1997-8#1)(2008-10#2)(2010-10#1)
genes are involved##6##3##(1992-7#1)(1997-8#1)(2008-10#2)(2008-6#1)(2010-10#1)
genes are the##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
genes are transcribed##2##3##(2011-1#1)(2011-2#1)
genes are##58##2##(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#2)(1992-7#1)(1993-3#2)(1993-6#2)(1994-11#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2008-10#10)(2008-11#1)(2008-4#1)(2008-6#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-8#4)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
genes as a##2##3##(1993-8#1)(2009-6#1)
genes as well as##2##4##(1997-8#1)(2008-10#1)
genes as##10##2##(1991-6#1)(1993-12#1)(1993-8#1)(1997-8#1)(2008-10#2)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)
genes assigned##2##2##(1995-6#1)(1996-6#1)
genes associated with##6##3##(1992-10#1)(2008-10#3)(2009-6#1)(2010-11#1)
genes at high##2##3##(2008-11#1)(2008-7#1)
genes at##4##2##(2008-11#2)(2008-7#1)(2008-9#1)
genes between##2##2##(2008-11#1)(2009-10#1)
genes both##2##2##(2008-11#1)(2012-3#1)
genes but##2##2##(1993-6#1)(2008-10#1)
genes by##11##2##(1992-6#1)(1996-12#1)(1997-2#1)(1997-8#2)(2008-10#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
genes can be##6##3##(1997-8#2)(2008-11#2)(2008-9#1)(2011-2#1)
genes can##10##2##(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-3#1)
genes carried sequences which##2##4##(1995-8#1)(1996-2#1)
genes carried##3##2##(1995-8#1)(1996-2#1)(2008-10#1)
genes coding for##7##3##(1994-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-9#1)(2012-2#1)
genes coding##8##2##(1994-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-12#1)(2008-9#1)(2012-2#1)
genes commonly##2##2##(2008-10#1)(2011-2#1)
genes conferred##2##2##(2008-10#1)(2008-8#1)
genes conferring resistance to##3##4##(2008-10#3)
genes conferring##6##2##(1994-9#1)(2008-10#5)
genes confirmed the##2##3##(2009-10#1)(2011-2#1)
genes containing##4##2##(1990-5#1)(1993-12#1)(2008-8#2)
genes contribute to##2##3##(1992-6#1)(2013-1#1)
genes contributing to##3##3##(2008-10#2)(2012-3#1)
genes control##3##2##(2008-10#1)(2009-5#1)(2009-8#1)
genes controlling##3##2##(2008-10#2)(2009-6#1)
genes could be##3##3##(2008-10#2)(2009-10#1)
genes could##4##2##(2008-10#2)(2008-6#1)(2009-10#1)
genes derived##2##2##(1997-9#1)(2008-10#1)
genes did not##2##3##(2008-10#1)(2011-2#1)
genes differentially expressed##3##3##(2008-8#1)(2010-1#1)(2012-3#1)
genes do not##2##3##(1993-6#1)(2012-2#1)
genes during##4##2##(1994-3#1)(2008-9#1)(2009-8#1)(2012-3#1)
genes either##2##2##(2008-11#2)
genes encode a family of##2##5##(1993-12#1)(2009-8#1)
genes encode##5##2##(1993-12#2)(1997-7#1)(2009-8#1)(2011-2#1)
genes encoding for##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
genes encoding proteins##3##3##(2008-4#1)(2009-6#1)(2012-3#1)
genes encoding such##2##3##(1996-12#1)(2009-8#1)
genes encoding the two##2##4##(1992-9#2)
genes encoding the##13##3##(1991-6#1)(1992-6#1)(1992-9#2)(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#1)
genes encoding##48##2##(1991-6#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#2)(1997-6#1)(1997-7#2)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
genes exhibited##2##2##(1997-8#1)(2008-10#1)
genes exist##2##2##(1995-8#1)(2008-10#1)
genes expressed in##3##3##(1997-8#1)(2008-10#1)(2008-7#1)
genes expressed##4##2##(1997-8#1)(2008-10#2)(2008-7#1)
genes for biosynthesis of the##2##5##(2008-10#2)
genes for parental investment##2##4##(2008-9#2)
genes for resistance to STB##2##5##(2008-10#2)
genes for resistance to##10##4##(2008-10#10)
genes for resistance##12##3##(2008-10#12)
genes for the##4##3##(2008-11#1)(2009-10#1)(2010-11#1)(2011-2#1)
genes for##55##2##(1991-12#1)(1993-2#1)(1994-11#2)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-7#1)(2008-10#27)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#4)(2012-3#1)
genes from the##2##3##(1997-6#1)(2009-10#1)
genes from##26##2##(1991-2#2)(1993-9#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-6#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-1#1)(2011-2#2)(2012-3#2)
genes had##2##2##(2008-8#1)(2009-8#1)
genes has been##3##3##(1997-8#1)(2008-7#1)(2011-2#1)
genes has##5##2##(1993-12#1)(1997-8#2)(2008-7#1)(2011-2#1)
genes have been identified##6##4##(2008-10#2)(2008-6#2)(2008-7#2)
genes have been##12##3##(1993-12#1)(1996-8#1)(2008-10#2)(2008-6#2)(2008-7#4)(2011-2#1)(2011-3#1)
genes have##24##2##(1992-6#1)(1993-12#1)(1993-8#1)(1996-8#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-6#3)(2008-7#5)(2008-9#2)(2009-8#1)(2011-2#1)(2011-3#1)
genes identified by##2##3##(1995-12#1)(2008-10#1)
genes identified in##2##3##(2008-10#1)(2008-7#1)
genes identified##7##2##(1995-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-8#1)
genes important##2##2##(2008-10#2)
genes in Arabidopsis##3##3##(1997-8#1)(2007-12#1)(2008-9#1)
genes in XN4##2##3##(2008-10#2)
genes in a##6##3##(1992-3#1)(1995-11#1)(1995-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
genes in both##3##3##(1996-12#1)(2008-10#2)
genes in cells##2##3##(1990-5#1)(1997-8#1)
genes in cotton##2##3##(2008-10#2)
genes in databases##2##3##(1996-6#1)(2008-9#1)
genes in eukaryotic##3##3##(2008-4#2)(2008-9#1)
genes in human##2##3##(1995-9#1)(2011-2#1)
genes in mammalian##2##3##(1991-6#1)(2008-11#1)
genes in plant development##2##4##(2009-8#2)
genes in rat##3##3##(1997-3#1)(2008-8#1)(2008-9#1)
genes in response to##3##4##(1996-12#1)(2008-10#2)
genes in rice##3##3##(2008-9#2)(2011-3#1)
genes in the human genome##2##5##(1991-6#1)(2011-2#1)
genes in the##22##3##(1990-12#1)(1991-6#2)(1992-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-9#1)(2008-10#8)(2008-11#1)(2008-6#1)(2011-2#1)
genes in these##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
genes in this region##3##4##(1996-8#1)(1997-3#1)(2008-7#1)
genes in this##5##3##(1993-12#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-7#1)
genes in tomato##2##3##(1993-12#1)(2008-10#1)
genes in##152##2##(1990-12#1)(1990-5#2)(1991-5#1)(1991-6#3)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-6#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#4)(1997-9#1)(2007-12#1)(2008-10#46)(2008-11#8)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#13)(2009-10#1)(2009-6#2)(2009-8#3)(2011-2#6)(2011-3#2)(2012-3#2)(2013-1#1)(2013-8#1)
genes including the##2##3##(1997-2#1)(2013-1#1)
genes including##5##2##(1997-2#1)(2008-10#2)(2012-2#1)(2013-1#1)
genes indicated that##2##3##(2008-11#1)(2008-8#1)
genes into a single##2##4##(2008-10#2)
genes into##13##2##(1990-5#2)(1992-6#1)(1994-5#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)
genes involved in cellular##2##4##(2008-11#1)(2010-7#1)
genes involved in defense response##2##5##(2008-9#2)
genes involved in pathogenicity##2##4##(2008-10#2)
genes involved in the##9##4##(1997-2#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-3#1)(2010-11#1)(2012-3#1)(2013-1#1)
genes involved in##36##3##(1994-11#1)(1995-12#1)(1996-6#1)(1997-2#1)(2008-10#9)(2008-11#4)(2008-9#6)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
genes involved##40##2##(1994-11#1)(1995-12#1)(1996-6#1)(1997-2#1)(2008-10#9)(2008-11#4)(2008-9#7)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
genes is##42##2##(1991-5#1)(1993-12#1)(1993-9#1)(1997-3#2)(2008-10#2)(2008-9#5)(2009-8#3)(2011-2#26)(2012-3#1)
genes known##2##2##(2008-10#1)(2012-3#1)
genes located on the left arm of##2##7##(1996-6#2)
genes located on the##3##4##(1996-6#3)
genes located##5##2##(1996-6#3)(2008-10#1)(2009-10#1)
genes may be present##2##4##(1997-2#1)(2008-9#1)
genes may be##5##3##(1993-3#1)(1997-2#1)(2008-10#1)(2008-9#2)
genes may have##2##3##(2008-10#1)(2008-11#1)
genes may##12##2##(1992-12#1)(1993-3#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#3)
genes might##2##2##(2008-10#1)(2008-9#1)
genes near the##2##3##(2008-10#1)(2008-11#1)
genes of C##2##3##(1993-9#1)(2008-8#1)
genes of a##2##3##(1994-12#2)
genes of interest##4##3##(2008-11#2)(2008-4#1)(2008-8#1)
genes of the##11##3##(1996-12#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-3#1)(2011-1#1)(2012-3#1)
genes of two##2##3##(2008-10#2)
genes of##49##2##(1991-5#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-9#1)(1995-12#2)(1996-12#2)(1997-6#2)(2008-10#13)(2008-11#2)(2008-4#1)(2008-8#7)(2008-9#3)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
genes on chromosome VI of Saccharomyces cerevisiae##2##7##(1997-6#2)
genes on chromosome VI of##3##5##(1997-6#3)
genes on chromosome##8##3##(1996-6#1)(1997-6#3)(1997-8#1)(2008-10#2)(2008-8#1)
genes on##15##2##(1996-6#2)(1997-6#3)(1997-8#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#1)
genes or##9##2##(1995-6#1)(1995-8#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#2)
genes p21##2##2##(2008-7#2)
genes play##2##2##(2008-7#1)(2011-2#1)
genes preferentially##2##2##(2009-10#1)(2010-1#1)
genes present in##4##3##(1997-6#1)(2008-10#3)
genes previously##3##2##(1996-8#1)(2008-10#2)
genes related to apoptosis##2##4##(2010-11#2)
genes related to the##2##4##(2010-5#2)
genes related to##8##3##(2008-8#1)(2008-9#2)(2010-11#2)(2010-5#2)(2011-2#1)
genes required for##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
genes responsible for the##3##4##(1995-6#1)(1996-2#1)(2011-2#1)
genes responsible for##9##3##(1994-9#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)(2011-10#1)(2011-2#1)
genes result in##2##3##(1993-12#1)(2012-3#1)
genes segregating##2##2##(2008-10#2)
genes selected##2##2##(2008-10#1)(2011-2#1)
genes share##3##2##(1993-12#1)(1993-6#1)(1997-7#1)
genes should##2##2##(1996-6#1)(2008-11#1)
genes showed that##2##3##(1991-9#1)(2009-6#1)
genes showed##7##2##(1991-9#1)(1997-2#1)(2008-8#1)(2009-6#1)(2010-1#3)
genes specifically expressed in orally tolerized T cells##2##8##(2008-11#2)
genes specifically##3##2##(2008-11#2)(2011-2#1)
genes such as##3##3##(2008-11#2)(2010-7#1)
genes suggests that##2##3##(2008-6#1)(2009-8#1)
genes tested##2##2##(2011-2#2)
genes that are##9##3##(1993-3#1)(1993-9#1)(1997-7#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
genes that could##2##3##(2008-10#2)
genes that encode##7##3##(1993-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
genes that may##2##3##(1992-9#1)(2008-10#1)
genes that were##4##3##(2008-11#2)(2010-4#1)(2013-1#1)
genes that##49##2##(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-5#1)(1995-8#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#11)(2008-11#5)(2008-4#1)(2008-7#3)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#6)(2013-1#1)(2013-8#2)
genes to a##2##3##(2008-10#1)(2008-4#1)
genes to be##3##3##(2008-10#1)(2008-7#1)(2010-11#1)
genes to identify##2##3##(2011-3#1)(2012-3#1)
genes to the##2##3##(2008-10#1)(2008-8#1)
genes to##29##2##(1992-12#1)(1994-11#1)(2008-10#12)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
genes using##5##2##(2008-10#3)(2009-10#1)(2010-10#1)
genes was determined##2##3##(1992-3#1)(2008-10#1)
genes was##19##2##(1991-6#1)(1991-9#1)(1992-3#1)(1995-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#2)(2010-6#1)(2012-2#1)
genes were also##4##3##(1997-6#1)(1997-8#2)(2008-11#1)
genes were analyzed in##2##4##(1997-6#1)(2012-2#1)
genes were analyzed##3##3##(1997-6#1)(2010-4#1)(2012-2#1)
genes were cloned##3##3##(2008-10#2)(2008-9#1)
genes were detected##5##3##(2008-10#4)(2010-5#1)
genes were expressed in a##2##5##(1993-8#1)(1995-8#1)
genes were expressed in##4##4##(1993-8#1)(1995-8#1)(2008-10#1)(2011-2#1)
genes were highly expressed in##2##5##(2008-11#1)(2008-8#1)
genes were highly##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
genes were identified##7##3##(1995-12#2)(1995-8#1)(2008-10#2)(2008-9#1)(2009-10#1)
genes were isolated##3##3##(1990-11#1)(1993-12#1)(2008-8#1)
genes were located##2##3##(2008-8#2)
genes were mapped on the##3##5##(1996-8#1)(1997-8#1)(2013-8#1)
genes were mapped##4##3##(1996-8#1)(1997-8#1)(2008-10#1)(2013-8#1)
genes were more##2##3##(2008-10#1)(2008-8#1)
genes were observed##2##3##(2008-10#1)(2008-11#1)
genes were obtained##2##3##(1997-6#1)(2008-8#1)
genes were present##2##3##(1991-6#1)(1997-6#1)
genes were significantly##2##3##(2008-8#1)(2010-11#1)
genes were subcloned##2##3##(1992-3#1)(1994-5#1)
genes were unrelated to any reported genes##2##7##(1995-8#1)(1996-2#1)
genes were up-regulated and##2##4##(2008-10#1)(2008-9#1)
genes were##100##2##(1990-11#1)(1991-6#1)(1992-3#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#2)(1995-6#1)(1995-8#3)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#4)(1997-8#6)(2008-10#30)(2008-11#3)(2008-8#15)(2008-9#6)(2009-10#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#4)
genes when##2##2##(2008-10#2)
genes which are##4##3##(2008-6#1)(2008-8#2)(2011-2#1)
genes which##10##2##(1996-8#1)(1997-2#1)(1997-7#1)(2008-6#1)(2008-8#4)(2011-2#2)
genes whose expression##3##3##(1995-11#1)(2008-10#1)(2012-3#1)
genes whose##9##2##(1992-12#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
genes with a##2##3##(2008-10#1)(2009-8#1)
genes with the##2##3##(1990-5#1)(2008-9#1)
genes with##20##2##(1990-5#1)(1991-6#1)(1994-5#1)(2008-10#6)(2008-4#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#2)(2011-2#1)(2012-3#2)
genes within the##2##3##(2008-10#2)
genes within##4##2##(1996-6#1)(2008-10#2)(2012-3#1)
genes##1830##1##(1990-11#3)(1990-12#2)(1990-5#8)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#6)(1991-5#8)(1991-6#18)(1991-9#5)(1992-10#2)(1992-12#14)(1992-3#8)(1992-4#3)(1992-6#17)(1992-7#3)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#29)(1993-2#8)(1993-3#7)(1993-6#13)(1993-8#9)(1993-9#14)(1994-11#17)(1994-12#3)(1994-3#2)(1994-5#9)(1994-6#1)(1994-8#3)(1994-9#10)(1995-11#4)(1995-12#23)(1995-2#5)(1995-5#4)(1995-6#17)(1995-8#23)(1995-9#5)(1996-12#34)(1996-2#19)(1996-3#10)(1996-6#27)(1996-8#8)(1997-2#14)(1997-3#9)(1997-6#28)(1997-7#28)(1997-8#45)(1997-9#5)(2007-12#4)(2008-1#1)(2008-10#482)(2008-11#81)(2008-12#2)(2008-2#2)(2008-4#22)(2008-5#6)(2008-6#22)(2008-7#31)(2008-8#104)(2008-9#107)(2009-10#33)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#9)(2009-7#1)(2009-8#41)(2010-1#12)(2010-10#10)(2010-11#13)(2010-12#3)(2010-3#3)(2010-4#6)(2010-5#11)(2010-6#6)(2010-7#8)(2011-1#13)(2011-10#4)(2011-2#117)(2011-3#9)(2012-12#2)(2012-2#19)(2012-3#62)(2013-1#17)(2013-7#2)(2013-8#19)
genes) was##2##2##(2008-10#2)
genes)##13##1##(1993-12#2)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#4)(2008-9#1)(2010-11#2)(2013-1#1)
genes/proteins##3##1##(2008-10#1)(2008-11#1)(2009-8#1)
genesis of the##2##3##(1991-12#1)(2007-8#1)
genesis of##8##2##(1991-12#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
genesis##14##1##(1990-9#1)(1991-12#1)(1992-5#1)(1995-8#2)(1997-2#1)(2007-8#1)(2008-10#3)(2008-7#1)(2011-2#2)(2012-2#1)
genetic aberrations##3##2##(2008-9#2)(2010-11#1)
genetic algorithm##8##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)
genetic algorithms##5##2##(1994-2#1)(2008-10#2)(2008-3#2)
genetic alteration of p53##3##4##(1994-12#3)
genetic alterations and##2##3##(2008-2#1)(2011-2#1)
genetic alterations are##2##3##(2009-4#1)(2011-3#1)
genetic alterations##8##2##(1994-12#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-8#1)(2011-2#2)(2011-3#1)
genetic analyses of##4##3##(2008-10#3)(2008-8#1)
genetic analyses##12##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-3#1)
genetic analysis of complex##2##4##(2010-5#1)(2012-3#1)
genetic analysis of the##3##4##(1997-6#1)(2008-10#1)(2011-1#1)
genetic analysis of##16##3##(1997-6#1)(2008-10#6)(2008-9#1)(2010-1#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
genetic analysis##24##2##(1997-3#1)(1997-6#1)(2008-10#9)(2008-9#2)(2010-1#2)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
genetic and biochemical##3##3##(2008-11#1)(2009-6#1)(2011-2#1)
genetic and biological##3##3##(1992-11#1)(1997-2#1)(2008-10#1)
genetic and environmental factors##8##4##(2008-10#1)(2008-11#2)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
genetic and environmental##14##3##(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
genetic and epigenetic##5##3##(2009-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
genetic and molecular analysis##2##4##(2008-8#1)(2012-3#1)
genetic and molecular##6##3##(1997-7#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#1)
genetic and pathogenic##4##3##(2008-10#4)
genetic and phenotypic diversity within##2##5##(2008-10#2)
genetic and phenotypic##4##3##(2008-10#3)(2010-12#1)
genetic and##60##2##(1992-11#1)(1997-2#1)(1997-7#1)(2008-10#23)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#2)(2011-1#1)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
genetic approach to##3##3##(1993-12#1)(1995-2#1)(2012-3#1)
genetic approaches##3##2##(1991-10#1)(2008-9#1)(2013-1#1)
genetic architecture of##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
genetic architecture##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2012-3#1)
genetic association##3##2##(2012-2#1)(2012-3#2)
genetic background of##8##3##(2008-10#3)(2008-2#1)(2008-7#1)(2009-10#1)(2012-3#2)
genetic background##22##2##(1995-12#2)(2008-10#12)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-3#3)(2013-1#1)
genetic backgrounds##8##2##(1996-8#1)(2008-10#4)(2011-2#1)(2012-3#2)
genetic basis and##2##3##(2008-5#1)(2008-9#1)
genetic basis for this##2##4##(2008-11#1)(2008-8#1)
genetic basis for##4##3##(1997-7#1)(2008-11#1)(2008-8#1)(2010-4#1)
genetic basis of the##3##4##(2008-10#2)(2012-3#1)
genetic basis of##14##3##(1995-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#2)(2010-5#1)(2012-3#3)
genetic basis##24##2##(1995-12#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#2)(2009-10#2)(2010-4#1)(2010-5#1)(2012-3#4)
genetic causes##3##2##(1995-12#1)(1997-3#2)
genetic changes during##2##3##(2008-10#2)
genetic changes##4##2##(2008-10#4)
genetic characteristics of the viruses##2##5##(2011-2#2)
genetic characteristics of##6##3##(2011-2#3)(2013-8#3)
genetic characteristics##8##2##(2011-2#3)(2013-8#5)
genetic characterization of##3##3##(2008-10#2)(2012-2#1)
genetic characterization##6##2##(2008-10#4)(2008-7#1)(2012-2#1)
genetic clusters##2##2##(2008-10#2)
genetic code##7##2##(1994-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#2)
genetic component##4##2##(2008-7#1)(2008-8#2)(2012-3#1)
genetic composition of the##2##4##(2008-10#2)
genetic composition of##5##3##(2008-10#4)(2009-8#1)
genetic composition##8##2##(2008-10#5)(2008-12#1)(2009-8#1)(2012-3#1)
genetic condition##2##2##(1991-2#1)(2008-11#1)
genetic contribution##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
genetic control and##2##3##(1991-12#1)(2008-10#1)
genetic control of resistance to##2##5##(2008-10#2)
genetic control of##7##3##(2008-10#2)(2008-8#2)(2009-10#1)(2012-3#1)(2013-8#1)
genetic control##13##2##(1991-12#1)(2008-10#4)(2008-6#1)(2008-8#2)(2009-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
genetic correlation between##3##3##(2008-8#1)(2008-9#2)
genetic correlation##4##2##(2008-8#2)(2008-9#2)
genetic correlations between##2##3##(2008-10#1)(2008-8#1)
genetic correlations##3##2##(2008-10#1)(2008-8#2)
genetic counseling##5##2##(1997-3#1)(1997-4#1)(2008-4#1)(2008-7#1)(2013-1#1)
genetic cross##2##2##(1996-12#1)(2008-10#1)
genetic damage##2##2##(2011-2#1)(2013-1#1)
genetic data in##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
genetic data##8##2##(2008-10#2)(2008-9#1)(2010-5#1)(2012-3#3)(2013-1#1)
genetic defect##4##2##(1990-5#1)(1993-6#1)(1996-12#1)(2008-7#1)
genetic defects##3##2##(1991-3#1)(1993-9#1)(2011-1#1)
genetic determinants##3##2##(2008-10#3)
genetic diagnosis##3##2##(2008-6#1)(2012-3#2)
genetic difference between##2##3##(2008-10#1)(2008-8#1)
genetic difference##3##2##(2008-10#1)(2008-8#2)
genetic differences in##2##3##(2008-10#1)(2008-11#1)
genetic differences##6##2##(2008-10#3)(2008-11#1)(2008-2#1)(2011-2#1)
genetic differentiation (G(ST) = 0##2##5##(2008-10#2)
genetic differentiation among populations##5##4##(2008-10#2)(2008-8#2)(2013-8#1)
genetic differentiation among regions##2##4##(2008-10#2)
genetic differentiation among subpopulations##2##4##(2008-10#2)
genetic differentiation among##14##3##(2008-10#11)(2008-8#2)(2013-8#1)
genetic differentiation between##3##3##(2008-10#2)(2012-3#1)
genetic differentiation of##5##3##(2008-10#4)(2008-6#1)
genetic differentiation was##2##3##(2008-10#2)
genetic differentiation##37##2##(2008-10#28)(2008-6#1)(2008-8#3)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
genetic disease##2##2##(2008-11#1)(2009-4#1)
genetic diseases##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
genetic disorder##6##2##(2008-2#1)(2008-4#1)(2011-3#1)(2013-1#3)
genetic disorders##5##2##(1995-1#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-9#1)
genetic dissection of##4##3##(1994-9#2)(2011-2#1)(2012-3#1)
genetic dissimilarity##2##2##(2008-10#2)
genetic distance among isolates##2##4##(2008-10#2)
genetic distance between the##2##4##(2008-10#1)(2008-6#1)
genetic distance between##5##3##(2008-10#4)(2008-6#1)
genetic distance of##6##3##(2008-10#4)(2008-9#1)(2011-2#1)
genetic distance was found##2##4##(2008-10#2)
genetic distance was##3##3##(2008-10#3)
genetic distance##21##2##(2008-10#17)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
genetic distances between##2##3##(2008-10#2)
genetic distances were##3##3##(2008-10#2)(2008-6#1)
genetic distances##10##2##(2008-10#7)(2008-6#1)(2013-1#2)
genetic divergence and##2##3##(2008-8#1)(2013-1#1)
genetic divergence between populations##2##4##(2008-8#2)
genetic divergence##10##2##(2008-10#1)(2008-8#5)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
genetic diversity (H)##2##3##(2008-10#2)
genetic diversity among X##2##4##(2008-10#2)
genetic diversity among##10##3##(2008-10#9)(2008-8#1)
genetic diversity and##9##3##(2008-10#6)(2010-4#1)(2010-5#1)(2013-8#1)
genetic diversity in the##2##4##(2008-10#1)(2012-3#1)
genetic diversity in##8##3##(2008-10#5)(2008-8#1)(2010-10#1)(2012-3#1)
genetic diversity of the##8##4##(2008-10#5)(2008-6#1)(2013-8#2)
genetic diversity of##19##3##(2008-10#13)(2008-6#1)(2008-8#1)(2010-7#1)(2012-3#1)(2013-8#2)
genetic diversity was attributable to##2##5##(2008-10#2)
genetic diversity was observed##2##4##(2008-10#2)
genetic diversity was##9##3##(2008-10#8)(2013-8#1)
genetic diversity within a##2##4##(2008-10#2)
genetic diversity within the##2##4##(2008-10#2)
genetic diversity within##6##3##(2008-10#6)
genetic diversity##86##2##(1995-2#1)(2008-10#62)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-3#3)(2013-1#1)(2013-8#6)
genetic drift##7##2##(2008-10#6)(2008-11#1)
genetic effect on##2##3##(2008-10#2)
genetic effects in##2##3##(2008-8#2)
genetic effects##11##2##(2008-11#1)(2008-8#8)(2008-9#1)(2012-3#1)
genetic elements that##2##3##(2012-3#2)
genetic elements##5##2##(2008-10#1)(2008-11#2)(2012-3#2)
genetic engineering and##2##3##(2008-10#1)(2009-3#1)
genetic engineering##7##2##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
genetic events##2##2##(1995-12#1)(2009-8#1)
genetic evidence##10##2##(1994-9#1)(1997-6#1)(2008-10#3)(2008-12#1)(2009-10#1)(2011-2#2)(2012-3#1)
genetic exchange in##2##3##(2008-10#1)(2008-8#1)
genetic exchange##8##2##(2008-10#6)(2008-8#1)(2013-8#1)
genetic factors are##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
genetic factors involved in the pathogenesis of##2##7##(1997-8#2)
genetic factors that##2##3##(1993-12#1)(2008-10#1)
genetic factors##19##2##(1993-12#1)(1997-5#1)(1997-8#3)(2008-10#4)(2008-11#1)(2008-7#3)(2008-9#1)(2009-8#2)(2010-12#1)(2013-1#1)(2013-8#1)
genetic heterogeneity of##2##3##(1997-3#1)(2011-1#1)
genetic heterogeneity##5##2##(1997-3#2)(2008-11#1)(2008-12#1)(2011-1#1)
genetic homogeneity of##2##3##(1995-12#1)(2008-10#1)
genetic homogeneity##5##2##(1995-12#1)(2008-10#2)(2008-9#1)(2013-8#1)
genetic homology##2##2##(2008-8#1)(2011-2#1)
genetic identification##2##2##(2008-10#1)(2008-12#1)
genetic identity between##2##3##(2008-10#2)
genetic identity##5##2##(2008-10#5)
genetic improvement##2##2##(2008-10#1)(2009-10#1)
genetic influences on##2##3##(2008-8#1)(2010-4#1)
genetic influences##6##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)
genetic information##7##2##(1993-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
genetic inheritance of##2##3##(2008-10#1)(2010-4#1)
genetic instability and##2##3##(2013-1#2)
genetic instability##4##2##(2012-3#1)(2013-1#3)
genetic interactions##3##2##(1991-2#1)(2009-3#1)(2012-3#1)
genetic inversion##3##2##(2008-3#3)
genetic investigations##2##2##(2008-10#1)(2008-12#1)
genetic isolation by distance##2##4##(2008-9#2)
genetic isolation##5##2##(2008-10#3)(2008-9#2)
genetic lesion##2##2##(1990-5#1)(1994-12#1)
genetic level##2##2##(1997-6#1)(2012-3#1)
genetic lineages##2##2##(2008-10#2)
genetic linkage analysis##2##3##(1995-2#1)(2008-10#1)
genetic linkage map of the##2##5##(1996-8#1)(2008-10#1)
genetic linkage map of##4##4##(1996-8#1)(2008-10#2)(2013-8#1)
genetic linkage map were##2##4##(2008-9#1)(2013-8#1)
genetic linkage map##11##3##(1996-8#1)(2008-10#5)(2008-9#1)(2011-3#1)(2012-3#1)(2013-8#2)
genetic linkage maps##2##3##(2008-10#2)
genetic linkage##20##2##(1995-2#1)(1995-6#1)(1996-8#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-9#1)(2011-3#1)(2012-3#1)(2013-8#2)
genetic load##2##2##(1992-10#1)(2008-10#1)
genetic loci##10##2##(1994-8#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-9#1)(2012-3#3)
genetic locus##3##2##(1995-2#1)(2008-10#1)(2010-5#1)
genetic make-up##2##2##(2008-10#1)(2013-8#1)
genetic manipulation of these##2##4##(1993-12#1)(2008-11#1)
genetic manipulation of##4##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
genetic manipulation##8##2##(1993-12#1)(2008-10#1)(2008-11#3)(2008-9#2)(2009-3#1)
genetic map of##5##3##(1996-12#2)(2008-10#3)
genetic map##19##2##(1992-4#1)(1994-9#2)(1996-12#3)(1996-6#1)(2008-10#11)(2012-3#1)
genetic map)##3##2##(1992-9#2)(1997-7#1)
genetic mapping##5##2##(1994-9#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
genetic maps##2##2##(1994-9#1)(1995-6#1)
genetic markers and##3##3##(2008-10#2)(2012-3#1)
genetic markers associated with##2##4##(2008-10#2)
genetic markers for##4##3##(2008-10#2)(2008-8#1)(2011-3#1)
genetic markers##18##2##(1994-12#1)(1997-3#1)(2008-10#7)(2008-7#1)(2008-8#1)(2010-10#1)(2011-3#2)(2012-3#2)(2013-1#1)(2013-8#1)
genetic material within##2##3##(2008-10#1)(2011-2#1)
genetic material##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
genetic mechanism##3##2##(2008-10#3)
genetic mechanisms of##3##3##(2008-10#2)(2013-8#1)
genetic mechanisms that##2##3##(2008-10#1)(2012-3#1)
genetic mechanisms##9##2##(1994-11#1)(2008-10#3)(2008-9#2)(2012-3#2)(2013-8#1)
genetic model for##2##3##(2008-10#1)(2008-8#1)
genetic model##6##2##(2008-10#1)(2008-12#1)(2008-8#4)
genetic models##5##2##(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)
genetic modification of##3##3##(1996-6#1)(2008-11#2)
genetic modification##5##2##(1996-6#1)(2008-10#1)(2008-11#2)(2013-8#1)
genetic modifications##2##2##(2008-7#1)(2011-1#1)
genetic mouse##2##2##(2011-2#1)(2012-2#1)
genetic mutations##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
genetic organization##2##2##(2008-10#1)(2008-8#1)
genetic origin##3##2##(1990-2#1)(2009-8#1)(2013-1#1)
genetic pathways##2##2##(2009-8#1)(2011-2#1)
genetic polymorphism and##2##3##(2008-10#2)
genetic polymorphism in##2##3##(2008-9#1)(2012-3#1)
genetic polymorphism with##2##3##(2008-10#1)(2008-9#1)
genetic polymorphism##10##2##(2006-6#1)(2008-10#4)(2008-9#4)(2012-3#1)
genetic polymorphisms##6##2##(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
genetic potential##2##2##(2008-12#1)(2013-8#1)
genetic predisposition to##2##3##(2008-11#1)(2008-7#1)
genetic predisposition##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
genetic profiles for##3##3##(2008-11#2)(2010-7#1)
genetic profiles##4##2##(2008-11#2)(2010-7#1)(2011-2#1)
genetic reassortment##2##2##(2011-2#1)(2013-8#1)
genetic recombination##6##2##(1990-5#1)(2008-10#4)(2010-4#1)
genetic regulation of##2##3##(2008-11#1)(2011-2#1)
genetic relationship##6##2##(2008-10#4)(2008-12#1)(2008-9#1)
genetic relationships among##5##3##(2008-10#5)
genetic relationships between##3##3##(2008-10#2)(2008-6#1)
genetic relationships##11##2##(2008-10#9)(2008-6#1)(2011-2#1)
genetic resistance##5##2##(1997-7#1)(2008-10#3)(2008-5#1)
genetic risk for##3##3##(1995-9#1)(2008-7#2)
genetic risk##6##2##(1995-9#1)(2008-7#4)(2008-8#1)
genetic screen##2##2##(2011-2#1)(2012-3#1)
genetic screening##3##2##(1995-12#1)(2008-4#1)(2012-3#1)
genetic sequences were##2##3##(2012-2#2)
genetic similarity among##2##3##(2008-10#1)(2008-8#1)
genetic similarity##4##2##(2008-10#3)(2008-8#1)
genetic spectrum of##2##3##(1994-3#1)(2008-8#1)
genetic structure and##2##3##(1993-2#1)(2008-10#1)
genetic structure of M##4##4##(2008-10#4)
genetic structure of S##2##4##(2008-10#2)
genetic structure of a##2##4##(2008-10#2)
genetic structure of field populations of##3##6##(2008-10#3)
genetic structure of the##4##4##(2008-10#3)(2013-8#1)
genetic structure of##40##3##(2008-10#30)(2008-8#3)(2008-9#1)(2011-2#2)(2012-3#2)(2013-8#2)
genetic structure##59##2##(1993-2#1)(2008-10#41)(2008-8#6)(2008-9#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
genetic structures##2##2##(2008-10#1)(2008-8#1)
genetic studies are##2##3##(2008-9#1)(2010-5#1)
genetic studies have##2##3##(1995-8#1)(2008-5#1)
genetic studies in##2##3##(2008-12#1)(2013-8#1)
genetic studies of##4##3##(1997-7#1)(2008-10#2)(2012-3#1)
genetic studies##18##2##(1995-8#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
genetic study##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
genetic susceptibility to##3##3##(1994-11#1)(1995-12#1)(2008-9#1)
genetic susceptibility##5##2##(1994-11#1)(1995-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
genetic syndrome associated with##2##4##(2010-7#1)(2012-12#1)
genetic syndrome##3##2##(2010-7#1)(2012-12#2)
genetic syndromes##2##2##(2008-11#2)
genetic systems##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
genetic techniques##4##2##(2008-8#1)(2008-9#2)(2011-2#1)
genetic test##2##2##(1995-12#1)(2008-4#1)
genetic testing and##2##3##(1995-9#1)(2013-1#1)
genetic testing of##2##3##(2011-2#2)
genetic testing##10##2##(1995-9#1)(2008-12#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#1)
genetic tests##3##2##(2011-3#1)(2012-3#1)(2013-1#1)
genetic tools##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
genetic transcription levels##2##3##(2008-10#2)
genetic tumour growth##2##3##(2008-7#2)
genetic tumours##7##2##(2008-7#7)
genetic variability of the pathogen##2##5##(2008-10#2)
genetic variability of##3##3##(2008-10#3)
genetic variability was distributed##2##4##(2008-10#2)
genetic variability was##3##3##(2008-10#3)
genetic variability##25##2##(2008-10#18)(2008-8#2)(2008-9#2)(2011-2#1)(2013-1#2)
genetic variance##6##2##(2008-10#1)(2008-8#4)(2008-9#1)
genetic variant-phenotype association##2##3##(2011-2#2)
genetic variation among##3##3##(2008-10#3)
genetic variation and##6##3##(2008-10#3)(2008-11#1)(2010-1#1)(2013-8#1)
genetic variation for##4##3##(2008-10#2)(2008-9#2)
genetic variation has been##2##4##(2008-10#1)(2012-2#1)
genetic variation in##10##3##(2008-10#6)(2008-8#3)(2008-9#1)
genetic variation of##3##3##(2008-10#1)(2011-10#1)(2012-2#1)
genetic variation was distributed among##2##5##(2008-10#2)
genetic variation was distributed within##2##5##(2008-10#2)
genetic variation was distributed##4##4##(2008-10#4)
genetic variation was##5##3##(2008-10#4)(2012-3#1)
genetic variation within##4##3##(2008-10#4)
genetic variation##62##2##(2008-10#33)(2008-11#1)(2008-8#8)(2008-9#6)(2010-1#1)(2010-4#3)(2010-5#2)(2011-10#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
genetic variations##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
genetic##1232##1##(1990-2#1)(1990-5#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-9#2)(1993-1#1)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#7)(1995-1#1)(1995-12#11)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-12#7)(1996-2#2)(1996-6#3)(1996-8#4)(1997-2#2)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#4)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#466)(2008-11#50)(2008-12#25)(2008-2#4)(2008-3#7)(2008-4#18)(2008-5#9)(2008-6#9)(2008-7#42)(2008-8#99)(2008-9#74)(2009-10#9)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#3)(2009-8#10)(2010-1#3)(2010-10#7)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#8)(2010-5#11)(2010-7#5)(2011-1#9)(2011-10#2)(2011-2#59)(2011-3#8)(2012-12#3)(2012-2#19)(2012-3#72)(2012-5#1)(2013-1#33)(2013-8#33)
genetical##2##1##(2008-10#2)
genetically and##6##2##(2008-10#5)(2011-2#1)
genetically characterized##3##2##(2008-10#3)
genetically controlled##4##2##(2008-12#1)(2008-9#1)(2009-3#1)(2011-2#1)
genetically determined##13##2##(1990-2#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#3)
genetically different##2##2##(2008-10#2)
genetically differentiated populations##2##3##(2008-10#1)(2008-12#1)
genetically differentiated##4##2##(2008-10#3)(2008-12#1)
genetically distinct from isolates##2##4##(2008-10#2)
genetically distinct from##7##3##(2008-10#7)
genetically distinct groups##2##3##(2008-10#1)(2008-6#1)
genetically distinct##19##2##(1995-6#1)(2008-10#16)(2008-6#1)(2012-5#1)
genetically diverse##10##2##(2008-10#9)(2012-3#1)
genetically engineered to##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
genetically engineered##22##2##(1995-2#3)(1997-2#1)(2008-10#4)(2008-11#4)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
genetically epilepsy-prone rat (GEPR)##2##4##(1996-12#2)
genetically isolated##2##2##(2008-10#2)
genetically linked to##2##3##(1991-12#1)(1992-3#1)
genetically linked##4##2##(1991-12#1)(1992-3#1)(2008-10#2)
genetically mapped##3##2##(2008-9#2)(2012-3#1)
genetically modified##15##2##(1994-11#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#7)(2009-5#1)(2011-2#1)
genetically normal##3##2##(2008-7#3)
genetically predetermined type of biotransformation by acetylation##2##7##(2008-10#2)
genetically programmed##2##2##(2008-11#1)(2008-5#1)
genetically related##3##2##(2008-10#2)(2012-3#1)
genetically similar##4##2##(1997-8#1)(2008-10#3)
genetically stable##3##2##(2008-10#2)(2008-9#1)
genetically susceptible##2##2##(2013-7#1)(2013-8#1)
genetically to##3##2##(2008-10#3)
genetically transmitted##2##2##(1990-2#2)
genetically uniform##2##2##(2008-10#2)
genetically very##2##2##(2008-10#2)
genetically##178##1##(1990-2#3)(1991-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-2#4)(1995-6#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#76)(2008-11#13)(2008-12#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#18)(2009-3#1)(2009-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#9)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#1)
geneticists##4##1##(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#1)
genetics and evolution##3##3##(2008-10#1)(2008-8#1)(2010-1#1)
genetics and##13##2##(2008-10#4)(2008-7#1)(2008-8#3)(2010-1#1)(2010-10#1)(2011-2#1)(2012-3#2)
genetics governing##2##2##(2009-3#2)
genetics has been##2##3##(2012-3#2)
genetics in order to##2##4##(2008-12#1)(2008-8#1)
genetics in##7##2##(1997-3#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)
genetics into a full##2##4##(2008-12#2)
genetics into##3##2##(2008-12#3)
genetics of reproductive isolation##3##4##(2008-8#3)
genetics of the##2##3##(2008-10#1)(2008-4#1)
genetics of##27##2##(1997-7#1)(2008-10#12)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-9#1)(2011-10#1)(2012-3#3)
genetics research##2##2##(1997-3#1)(2010-1#1)
genetics study##2##2##(2008-10#1)(2008-12#1)
genetics##98##1##(1991-2#1)(1994-9#1)(1995-8#1)(1995-9#2)(1996-8#1)(1997-3#2)(1997-7#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-12#7)(2008-4#2)(2008-7#5)(2008-8#17)(2008-9#4)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2011-1#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-3#12)(2013-1#6)(2013-8#1)
geniculate ganglion##4##2##(2011-2#4)
geniculate##7##1##(2008-11#1)(2011-2#5)(2013-8#1)
geniposidic and chlorogenic##2##3##(2008-10#2)
geniposidic##3##1##(2008-10#3)
genistein and daidzin enhance##2##4##(2008-11#2)
genistein and daidzin##4##3##(2008-11#4)
genistein and##6##2##(2008-10#1)(2008-11#4)(2010-3#1)
genistein or##3##2##(2008-10#2)(2008-11#1)
genistein##20##1##(1997-7#4)(2008-10#3)(2008-11#5)(2010-1#2)(2010-3#2)(2012-2#4)
genital anomaly##2##2##(2008-10#2)
genital appendages##3##2##(2008-8#3)
genital area##2##2##(1992-1#1)(2009-10#1)
genital edema##2##2##(2008-10#2)
genital herpes##2##2##(2008-12#1)(2008-8#1)
genital injuries##2##2##(2013-8#2)
genital organs##2##2##(1993-3#1)(2008-10#1)
genital system##2##2##(1993-3#1)(2007-12#1)
genital tract##15##2##(1990-2#1)(1990-8#1)(1992-3#2)(1994-1#2)(2009-2#1)(2011-2#6)(2012-2#1)(2013-8#1)
genital trauma##2##2##(2013-8#2)
genital##54##1##(1990-2#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-3#2)(1993-3#2)(1994-1#2)(1994-2#2)(1996-1#1)(1997-8#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-8#4)(2009-10#1)(2009-2#1)(2011-2#8)(2012-2#1)(2012-3#5)(2013-8#5)
genitalia is##2##2##(2007-12#1)(2008-8#1)
genitalia size##2##2##(2008-8#2)
genitalia##17##1##(1997-3#1)(2007-12#2)(2008-10#7)(2008-8#3)(2010-4#2)(2012-3#1)(2013-1#1)
genitalia)##2##1##(2008-6#1)(2012-3#1)
genitalium is##3##2##(2011-2#3)
genitalium##4##1##(2011-2#4)
genitourinary##2##1##(1997-8#1)(2008-10#1)
genomagnetic##2##1##(2008-10#2)
genome DNA##2##2##(2008-8#2)
genome RNA##2##2##(2008-10#1)(2008-11#1)
genome also##2##2##(2008-10#2)
genome amplification##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
genome analysis##9##2##(1993-9#1)(1996-12#1)(2008-10#4)(2008-4#1)(2009-10#1)(2012-3#1)
genome and is##2##3##(1992-3#1)(1993-9#1)
genome and the##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
genome and##20##2##(1992-3#1)(1993-9#1)(1995-6#1)(1996-6#2)(1997-3#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#1)
genome approach##2##2##(1995-2#1)(2008-7#1)
genome are##4##2##(1995-2#1)(2008-10#2)(2012-2#1)
genome as##3##2##(2008-11#2)(2008-4#1)
genome assembly##3##2##(2011-2#2)(2012-3#1)
genome by##8##2##(1995-6#1)(1996-6#1)(2008-11#1)(2008-8#2)(2009-10#1)(2012-3#2)
genome components were##2##3##(2008-10#2)
genome comprising##2##2##(2011-2#2)
genome containing##2##2##(1996-8#1)(2008-10#1)
genome contains two##2##3##(1993-3#1)(1996-6#1)
genome contains##8##2##(1993-3#1)(1996-6#1)(2008-10#2)(2008-8#1)(2011-2#3)
genome data##2##2##(1991-11#1)(1997-7#1)
genome duplication##3##2##(2007-12#2)(2012-3#1)
genome equivalents##2##2##(1996-12#1)(2008-8#1)
genome fragments##2##2##(2008-10#1)(2008-11#1)
genome from a member of the##2##6##(2011-2#2)
genome from a##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
genome from the##2##3##(2011-2#2)
genome from##6##2##(2008-10#1)(2011-2#4)(2012-2#1)
genome has been##2##3##(1996-8#1)(2008-7#1)
genome has##5##2##(1991-6#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-7#1)
genome in the##2##3##(2008-10#1)(2008-9#1)
genome in##6##2##(1995-6#1)(2008-10#1)(2008-12#3)(2008-9#1)
genome is##6##2##(1993-11#1)(2007-12#1)(2008-4#2)(2008-9#1)(2010-10#1)
genome level##2##2##(1995-5#1)(2008-7#1)
genome mining##2##2##(2011-1#1)(2011-2#1)
genome of Enterovirus 71 China strain##2##6##(2008-8#2)
genome of PcMV##2##3##(2008-10#2)
genome of S##3##3##(1992-6#2)(2008-9#1)
genome of Tomato##2##3##(2008-10#2)
genome of the##17##3##(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-6#3)(1997-3#1)(2008-10#2)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
genome of this##2##3##(2008-12#1)(2009-3#1)
genome of##57##2##(1992-6#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-10#14)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#2)(2009-3#1)(2010-8#2)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
genome or##2##2##(2008-4#1)(2012-3#1)
genome organization and##2##3##(2007-12#1)(2008-10#1)
genome organization of##3##3##(2008-10#2)(2008-8#1)
genome organization was##2##3##(2008-10#1)(2008-9#1)
genome organization##9##2##(2007-12#1)(2008-10#6)(2008-8#1)(2008-9#1)
genome origin##2##2##(2008-10#2)
genome project##4##2##(1994-3#1)(1995-8#1)(2008-11#1)(2008-12#1)
genome projects##2##2##(1995-2#1)(1997-7#1)
genome restructuring##3##2##(2012-3#3)
genome sequence data##2##3##(2008-11#1)(2013-8#1)
genome sequence for##3##3##(2011-10#1)(2011-2#2)
genome sequence from a member of the##2##7##(2011-2#2)
genome sequence information for##2##4##(2008-10#1)(2008-9#1)
genome sequence of a member of the family##6##8##(2011-2#6)
genome sequence of a member of the genus##4##8##(2011-2#4)
genome sequence of a member of the##11##7##(2011-2#11)
genome sequence of a member##12##5##(2011-2#12)
genome sequence of a type##2##5##(2011-2#2)
genome sequence of a##15##4##(2008-7#1)(2011-2#14)
genome sequence of the genus##4##5##(2011-2#4)
genome sequence of the##12##4##(2008-7#1)(2008-9#1)(2011-2#10)
genome sequence of##64##3##(1996-8#1)(2008-10#1)(2008-7#2)(2008-9#2)(2011-2#57)(2013-8#1)
genome sequence submission##2##3##(2011-2#2)
genome sequence##109##2##(1996-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#3)(2010-10#1)(2011-1#1)(2011-10#1)(2011-2#90)(2012-3#1)(2013-8#3)
genome sequences and##2##3##(2008-10#1)(2010-8#1)
genome sequences of##4##3##(2008-10#3)(2011-2#1)
genome sequences##16##2##(2008-10#4)(2008-4#4)(2008-7#2)(2010-11#1)(2010-8#1)(2011-2#3)(2013-1#1)
genome sequencing and##2##3##(2011-2#1)(2013-8#1)
genome sequencing projects##2##3##(2011-1#1)(2011-2#1)
genome sequencing##11##2##(1995-2#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-3#2)(2013-8#1)
genome sites##2##2##(2008-9#1)(2012-3#1)
genome size##12##2##(1997-2#2)(2008-10#2)(2008-8#5)(2008-9#1)(2011-2#2)
genome sizes in birds##2##4##(2008-8#2)
genome sizes##4##2##(1997-2#1)(2008-10#1)(2008-8#2)
genome stability##2##2##(1993-9#1)(2013-1#1)
genome structure##3##2##(1996-12#1)(2007-12#1)(2008-4#1)
genome that was##2##3##(1997-3#1)(2008-9#1)
genome that##4##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
genome to##3##2##(2008-11#2)(2011-2#1)
genome using##2##2##(1997-2#1)(2009-10#1)
genome was found##2##3##(2008-10#1)(2011-2#1)
genome was used##2##3##(2008-10#2)
genome was##13##2##(1996-6#1)(1997-3#1)(2008-10#10)(2011-2#1)
genome were##4##2##(2008-10#3)(2008-8#1)
genome with its 1##6##4##(2011-2#6)
genome with its 3##8##4##(2011-2#8)
genome with its 7##2##4##(2011-2#2)
genome with its##26##3##(2011-2#26)
genome with##30##2##(1993-8#1)(2008-8#1)(2011-2#27)(2012-3#1)
genome##612##1##(1991-11#1)(1991-2#1)(1991-5#3)(1991-6#3)(1992-3#2)(1992-6#4)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#8)(1995-3#1)(1995-5#2)(1995-6#8)(1995-8#5)(1995-9#1)(1996-12#13)(1996-2#1)(1996-3#1)(1996-6#20)(1996-8#8)(1997-2#6)(1997-3#8)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#3)(2007-12#6)(2008-10#113)(2008-11#17)(2008-12#8)(2008-2#1)(2008-4#14)(2008-5#4)(2008-7#14)(2008-8#35)(2008-9#26)(2009-10#10)(2009-12#4)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-8#5)(2011-1#6)(2011-10#3)(2011-2#159)(2012-2#5)(2012-3#31)(2013-1#5)(2013-8#7)
genome) and B##2##3##(2008-10#2)
genome) and##3##2##(2008-10#3)
genome)##12##1##(1993-12#1)(2008-10#11)
genome-transgene##2##1##(1993-6#2)
genome-wide analysis of##3##3##(2007-12#2)(2010-5#1)
genome-wide association studies##5##3##(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#1)
genome-wide association##7##2##(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#3)
genome-wide copy number analysis##2##4##(2011-2#2)
genome-wide expression##3##2##(2010-5#1)(2011-2#2)
genome-wide selection##2##2##(2012-3#2)
genome-wide studies##2##2##(2008-7#1)(2008-9#1)
genome-wide##41##1##(2007-12#2)(2008-10#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-4#2)(2009-9#1)(2010-11#1)(2010-5#3)(2011-2#10)(2012-3#14)(2013-1#1)
genomes and##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
genomes are##3##2##(1995-2#1)(2008-4#1)(2010-5#1)
genomes can##2##2##(2008-4#1)(2010-7#1)
genomes have##3##2##(2008-5#1)(2009-10#1)(2013-8#1)
genomes in##3##2##(1993-9#1)(2008-11#1)(2008-12#1)
genomes is##2##2##(1997-2#1)(2011-2#1)
genomes may##2##2##(2008-8#1)(2011-2#1)
genomes of fungal pathogens##3##4##(2009-6#3)
genomes of the##2##3##(2008-10#2)
genomes of##20##2##(1991-6#1)(1997-6#1)(2008-10#9)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#4)(2011-1#1)(2012-2#1)
genomes suggests that##2##3##(1997-2#1)(2009-6#1)
genomes to##2##2##(2008-10#1)(2013-8#1)
genomes were##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
genomes##110##1##(1991-6#2)(1992-10#1)(1993-6#1)(1993-9#1)(1994-11#3)(1995-12#1)(1995-2#3)(1996-2#2)(1996-8#1)(1997-2#3)(1997-3#3)(1997-6#2)(2008-10#20)(2008-11#3)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#7)(2008-9#5)(2009-10#4)(2009-12#1)(2009-6#7)(2010-10#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-2#3)(2012-3#6)(2013-1#3)(2013-8#4)
genomic DNA and##12##3##(1992-3#1)(1993-12#2)(1993-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-10#1)
genomic DNA as##2##3##(2008-10#1)(2008-8#1)
genomic DNA by##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
genomic DNA from##9##3##(1992-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1996-6#1)(2008-10#4)
genomic DNA in##2##3##(1997-7#1)(2008-8#1)
genomic DNA library##4##3##(1991-6#1)(1991-9#1)(1993-2#1)(1996-12#1)
genomic DNA of##9##3##(1992-6#1)(1993-12#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-7#1)
genomic DNA sequences##6##3##(1993-2#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-9#1)
genomic DNA was##5##3##(1991-7#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)
genomic DNA##96##2##(1990-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#6)(1993-2#4)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-6#2)(1997-7#4)(1997-8#1)(2008-10#25)(2008-11#5)(2008-12#1)(2008-2#3)(2008-4#6)(2008-6#1)(2008-8#5)(2008-9#6)(2009-10#1)(2010-7#2)(2011-10#1)
genomic DNAs##3##2##(1994-12#1)(2008-10#2)
genomic RNA of##3##3##(1997-3#2)(2008-10#1)
genomic RNA##13##2##(1997-3#5)(2008-10#5)(2008-11#1)(2008-8#1)(2013-1#1)
genomic RNAs of##2##3##(2008-10#2)
genomic RNAs##8##2##(1997-3#1)(2008-10#6)(2008-8#1)
genomic Southern##3##2##(1993-2#2)(1993-8#1)
genomic alterations##2##2##(2012-2#2)
genomic analysis of##2##3##(2008-10#1)(2008-7#1)
genomic analysis##5##2##(2008-10#2)(2008-7#2)(2009-10#1)
genomic and proteomic##2##3##(2008-10#1)(2008-11#1)
genomic and##8##2##(1997-4#1)(2008-10#3)(2008-11#2)(2008-8#1)(2011-2#1)
genomic approach##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
genomic clone containing##2##3##(1993-12#1)(1996-8#1)
genomic clone##13##2##(1991-5#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1996-6#1)(1996-8#1)(1997-7#1)
genomic clones of##2##3##(1993-6#1)(1997-8#1)
genomic clones##15##2##(1990-8#3)(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#3)(1995-6#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#1)(2010-5#1)
genomic data##7##2##(2008-11#1)(2008-9#1)(2009-10#1)(2011-3#3)(2013-8#1)
genomic distribution##2##2##(2009-10#1)(2011-2#1)
genomic diversity and##2##3##(2008-10#1)(2009-6#1)
genomic diversity##4##2##(2008-10#3)(2009-6#1)
genomic element##2##2##(1991-6#2)
genomic fingerprint profiles##2##3##(2008-10#2)
genomic fingerprinting##4##2##(2008-10#4)
genomic fingerprints##3##2##(2008-10#3)
genomic fragment##3##2##(1996-6#1)(1997-7#1)(2008-10#1)
genomic fragments##3##2##(1991-6#1)(1991-7#1)(2008-10#1)
genomic functional elements##2##3##(2008-7#2)
genomic functions##2##2##(2008-10#1)(2008-4#1)
genomic hybridization##7##2##(1992-3#1)(2008-4#1)(2008-9#2)(2012-3#3)
genomic instability and##3##3##(1995-6#1)(2008-11#1)(2011-2#1)
genomic instability##6##2##(1995-6#1)(2008-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
genomic level##4##2##(2008-10#2)(2009-10#1)(2011-2#1)
genomic library and##3##3##(1993-6#1)(1994-11#1)(1996-3#1)
genomic library of##5##3##(1990-5#1)(1991-9#1)(2008-10#3)
genomic library with##2##3##(1993-12#1)(2008-8#1)
genomic library##24##2##(1990-5#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#4)(2008-8#4)(2008-9#2)(2013-8#1)
genomic location of##4##3##(2008-10#3)(2008-4#1)
genomic location##6##2##(2008-10#4)(2008-2#1)(2008-4#1)
genomic organization##4##2##(1993-12#1)(2008-10#1)(2012-2#2)
genomic pectin##2##2##(1991-9#2)
genomic region##9##2##(1992-10#1)(1995-6#1)(1997-2#3)(2008-10#3)(2008-2#1)
genomic regions of##3##3##(2008-10#2)(2012-3#1)
genomic regions##18##2##(1993-8#1)(1996-12#1)(2008-10#10)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
genomic regulatory##2##2##(2008-11#1)(2008-7#1)
genomic resources##5##2##(2008-11#3)(2010-10#2)
genomic segments##2##2##(1992-6#1)(2008-7#1)
genomic sequence data of Synechocystis##2##5##(1995-12#2)
genomic sequence of##5##3##(1996-12#1)(2008-10#3)(2008-8#1)
genomic sequence respectively##2##3##(2010-7#2)
genomic sequence##28##2##(1995-12#2)(1996-12#1)(1997-9#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#2)(2010-7#3)(2012-2#1)
genomic sequences and##3##3##(1993-8#1)(2008-4#2)
genomic sequences from##3##3##(1995-6#1)(2008-11#1)(2009-10#1)
genomic sequences of##2##3##(2008-5#1)(2008-9#1)
genomic sequences##14##2##(1992-6#1)(1993-12#1)(1993-8#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)
genomic sequencing##9##2##(2008-10#7)(2011-2#1)(2013-8#1)
genomic sites##2##2##(1993-9#1)(2011-1#1)
genomic structure and the##2##4##(1997-7#1)(2008-8#1)
genomic structure and##3##3##(1997-7#1)(2008-7#1)(2008-8#1)
genomic structure##5##2##(1993-12#2)(1997-7#1)(2008-7#1)(2008-8#1)
genomic targets##2##2##(1995-2#1)(2008-11#1)
genomic techniques##2##2##(2008-11#1)(2009-8#1)
genomic tools##3##2##(2008-11#1)(2008-8#1)(2010-10#1)
genomic##423##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#3)(1991-5#1)(1991-6#6)(1991-7#2)(1991-9#4)(1992-10#2)(1992-3#2)(1992-6#3)(1993-12#16)(1993-2#11)(1993-3#2)(1993-6#15)(1993-8#5)(1993-9#2)(1994-11#4)(1994-12#2)(1994-5#1)(1994-9#1)(1995-12#5)(1995-2#2)(1995-6#4)(1995-8#3)(1996-12#6)(1996-3#1)(1996-6#5)(1996-8#3)(1997-2#4)(1997-3#7)(1997-4#1)(1997-6#2)(1997-7#10)(1997-8#4)(1997-9#1)(2007-12#1)(2008-10#116)(2008-11#27)(2008-12#2)(2008-2#5)(2008-4#12)(2008-5#2)(2008-6#1)(2008-7#13)(2008-8#20)(2008-9#17)(2009-10#7)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#4)(2010-4#2)(2010-5#1)(2010-7#6)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#11)(2011-3#3)(2012-12#1)(2012-2#6)(2012-3#8)(2013-1#4)(2013-8#5)
genomically##4##1##(2010-7#1)(2011-2#2)(2012-2#1)
genomics and proteomics##3##3##(2008-11#2)(2011-3#1)
genomics and##9##2##(2008-10#1)(2008-11#2)(2009-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
genomics approaches##2##2##(2008-8#1)(2011-2#1)
genomics initiative (PGI)##2##3##(2010-10#2)
genomics to##2##2##(2012-3#1)(2013-8#1)
genomics##52##1##(2008-10#6)(2008-11#6)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#4)(2009-4#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#4)
genomics-assisted breeding##2##2##(2010-10#2)
genomovar##2##1##(2008-10#2)
genotoxic and##2##2##(2008-11#1)(2011-2#1)
genotoxic effects of##3##3##(2008-8#1)(2010-1#1)(2010-5#1)
genotoxic effects##6##2##(2008-8#1)(2010-1#1)(2010-5#1)(2013-1#3)
genotoxic##17##1##(1993-3#1)(1995-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
genotoxicity and##2##2##(1996-1#1)(2013-1#1)
genotoxicity##9##1##(1992-6#1)(1996-1#1)(2008-11#1)(2011-1#4)(2013-1#2)
genotoxin treatment##3##2##(2010-3#3)
genotoxin-induced##2##1##(2010-3#2)
genotype (named &quot##2##3##(2012-2#2)
genotype B##2##2##(2008-10#2)
genotype C##2##2##(2008-10#1)(2013-8#1)
genotype Hawaii##2##2##(2008-10#2)
genotype I##2##2##(2008-10#2)
genotype ND##2##2##(2008-10#2)
genotype analysis##2##2##(2008-10#1)(2013-8#1)
genotype and##15##2##(1996-12#2)(2008-10#7)(2008-8#4)(2011-2#1)(2012-3#1)
genotype as##2##2##(2008-10#2)
genotype at##2##2##(2008-10#2)
genotype by##3##2##(2008-10#2)(2010-11#1)
genotype correlated with##2##3##(2008-10#2)
genotype distribution##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
genotype diversity##5##2##(2008-10#5)
genotype for##2##2##(2008-10#2)
genotype frequency of Br polymorphism##2##5##(2006-6#2)
genotype frequency##3##2##(2006-6#2)(2013-8#1)
genotype groups##2##2##(2008-10#1)(2012-2#1)
genotype in the##3##3##(2008-10#2)(2012-2#1)
genotype in##10##2##(1995-12#1)(2008-10#6)(2012-2#1)(2013-1#1)(2013-8#1)
genotype is associated with##2##4##(2011-2#2)
genotype is##5##2##(1996-12#1)(2008-5#1)(2008-8#1)(2011-2#2)
genotype isolate##2##2##(2008-10#2)
genotype mixtures##4##2##(2008-10#4)
genotype of C##2##3##(2008-10#2)
genotype of the##2##3##(2008-10#2)
genotype of##9##2##(2008-10#6)(2008-8#2)(2013-8#1)
genotype on##3##2##(2008-10#2)(2013-8#1)
genotype resistance and chemical control##2##5##(2008-10#2)
genotype resistance and##3##3##(2008-10#3)
genotype resistance##5##2##(2008-10#5)
genotype specific##2##2##(2008-10#1)(2011-10#1)
genotype than##2##2##(2008-8#1)(2011-2#1)
genotype to##3##2##(2008-10#2)(2012-2#1)
genotype unit##2##2##(2008-10#2)
genotype was detected##2##3##(2008-10#2)
genotype was found to be##2##5##(2008-10#2)
genotype was significantly higher in##2##5##(2011-2#1)(2013-1#1)
genotype was significantly##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
genotype was##16##2##(1995-12#1)(2008-10#10)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
genotype were##3##2##(2008-10#3)
genotype with##2##2##(1997-3#1)(2012-2#1)
genotype x##2##2##(2008-10#2)
genotype##252##1##(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#4)(1997-3#2)(2006-6#2)(2008-10#169)(2008-12#1)(2008-5#2)(2008-8#15)(2009-10#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#11)(2012-2#8)(2012-3#4)(2012-5#1)(2013-1#7)(2013-8#14)
genotype)##4##1##(2008-10#4)
genotype-by-environment interactions##2##2##(2008-8#2)
genotype-phenotype##3##1##(1997-3#1)(1997-6#1)(2012-3#1)
genotype-specific##4##1##(2008-10#2)(2012-5#2)
genotype-trait associations##2##2##(2012-3#2)
genotype/phenotype##3##1##(2008-9#1)(2009-12#1)(2009-8#1)
genotyped at##4##2##(2008-10#4)
genotyped by##3##2##(2008-10#2)(2013-8#1)
genotyped for##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)
genotyped using##2##2##(2008-10#1)(2013-1#1)
genotyped##19##1##(1996-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-8#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#2)
genotypes (A##3##2##(2008-10#2)(2008-12#1)
genotypes A and B##3##4##(2008-10#3)
genotypes A##4##2##(2008-10#4)
genotypes F##2##2##(2008-10#1)(2013-1#1)
genotypes PI##3##2##(2008-10#3)
genotypes among##3##2##(2008-10#3)
genotypes and phenotypes##2##3##(2010-4#2)
genotypes and##16##2##(2008-10#9)(2008-11#1)(2010-4#2)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
genotypes are resistant to P##2##5##(2008-10#2)
genotypes are##7##2##(2008-10#5)(2008-11#1)(2010-4#1)
genotypes at this##2##3##(2008-12#2)
genotypes at##3##2##(1997-7#1)(2008-12#2)
genotypes can##2##2##(2008-8#1)(2010-10#1)
genotypes carrying different resistance##2##4##(2008-10#2)
genotypes carrying##5##2##(2008-10#5)
genotypes differ##2##2##(2008-10#1)(2008-9#1)
genotypes exhibited##2##2##(2008-10#2)
genotypes from the##2##3##(2008-10#2)
genotypes from##4##2##(2008-10#4)
genotypes had##7##2##(2008-10#7)
genotypes have been##3##3##(2008-10#3)
genotypes have##6##2##(2008-10#5)(2008-8#1)
genotypes highly##2##2##(2008-10#2)
genotypes identified##3##2##(2008-10#3)
genotypes in a##2##3##(2008-10#1)(2012-3#1)
genotypes in##6##2##(2008-10#4)(2011-2#1)(2012-3#1)
genotypes indicated##2##2##(2008-10#2)
genotypes infected with the##2##4##(2008-10#2)
genotypes into##3##2##(1997-6#1)(2008-10#2)
genotypes may be##2##3##(2008-10#2)
genotypes of C##3##3##(2008-10#3)
genotypes of P##6##3##(2008-10#6)
genotypes of the##3##3##(2008-10#3)
genotypes of##18##2##(1995-6#1)(2008-10#16)(2012-3#1)
genotypes on##3##2##(2008-10#3)
genotypes or##4##2##(2008-10#4)
genotypes representing##2##2##(2008-10#2)
genotypes resistant or susceptible to##2##5##(2008-10#2)
genotypes resistant##3##2##(2008-10#2)(2010-7#1)
genotypes tested##2##2##(2008-10#2)
genotypes than in##2##3##(2008-10#2)
genotypes than##3##2##(2008-10#2)(2008-11#1)
genotypes that exhibited##2##3##(2008-10#2)
genotypes that##12##2##(2008-10#10)(2008-9#1)(2011-2#1)
genotypes to##8##2##(2008-10#7)(2008-12#1)
genotypes using##3##2##(2008-10#2)(2008-12#1)
genotypes was##5##2##(2008-10#5)
genotypes were also##2##3##(2008-10#2)
genotypes were analyzed##2##3##(2008-10#2)
genotypes were detected##2##3##(2008-10#2)
genotypes were found within##2##4##(2008-10#2)
genotypes were found##3##3##(2008-10#3)
genotypes were identified among the##2##5##(2008-10#2)
genotypes were identified##5##3##(2008-10#5)
genotypes were not##2##3##(2008-10#1)(2008-11#1)
genotypes were present##2##3##(2008-10#2)
genotypes were##35##2##(2008-10#32)(2008-11#1)(2008-12#1)(2012-5#1)
genotypes when used##2##3##(2008-10#2)
genotypes with a##2##3##(2008-10#2)
genotypes with complete resistance to Fusarium wilt##2##7##(2008-10#2)
genotypes with specific virulence to##2##5##(2008-10#2)
genotypes with##16##2##(2008-10#15)(2008-8#1)
genotypes within##3##2##(2008-10#3)
genotypes##387##1##(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-10#322)(2008-11#4)(2008-12#14)(2008-2#1)(2008-8#9)(2008-9#4)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#6)(2012-5#1)(2013-1#4)(2013-8#6)
genotypes)##4##1##(2008-10#4)
genotypic and phenotypic##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
genotypic composition of populations##2##4##(2008-10#1)(2008-8#1)
genotypic composition of##3##3##(2008-10#2)(2008-8#1)
genotypic differences were##2##3##(2008-10#1)(2012-4#1)
genotypic differences##3##2##(2008-10#2)(2012-4#1)
genotypic differentiation##2##2##(2008-10#1)(2012-3#1)
genotypic diversity was high##2##4##(2008-10#2)
genotypic diversity was##5##3##(2008-10#5)
genotypic diversity##25##2##(2008-10#25)
genotypic resistance##2##2##(1996-11#1)(2008-10#1)
genotypic specialization##2##2##(2008-8#2)
genotypic variability##2##2##(2008-10#2)
genotypic variation##2##2##(2008-10#2)
genotypic##69##1##(1993-6#1)(1996-11#1)(2008-10#49)(2008-12#4)(2008-7#1)(2008-8#5)(2011-2#2)(2012-3#3)(2012-4#1)(2012-5#2)
genotypically distinct##4##2##(2008-10#4)
genotypically diverse##2##2##(2008-10#2)
genotypically##7##1##(2008-10#7)
genotyping and##4##2##(2008-12#1)(2008-4#1)(2012-3#2)
genotyping in##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
genotyping methods##2##2##(2008-12#2)
genotyping of the##2##3##(2008-10#1)(2010-8#1)
genotyping of##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
genotyping using polymerase chain##2##4##(1990-2#1)(1997-8#1)
genotyping using##4##2##(1990-2#1)(1997-8#1)(2008-9#2)
genotyping##43##1##(1990-2#1)(1997-8#2)(2008-10#7)(2008-11#1)(2008-12#5)(2008-2#1)(2008-4#2)(2008-7#4)(2008-9#4)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-3#7)(2013-1#1)
gentamicin##6##1##(2008-10#4)(2011-2#2)
gentamycin##7##1##(2008-10#7)
gentiobioside##2##1##(2008-11#2)
gentisic acid##3##2##(2008-10#3)
gentle method##2##2##(2008-10#1)(2008-9#1)
gentle##14##1##(1991-3#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
gentleman##5##1##(2008-12#2)(2012-2#1)(2013-1#2)
gently##6##1##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
genuine##14##1##(1993-8#1)(1994-3#2)(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#1)
genus Byssochlamys##2##2##(2010-3#2)
genus Chitinophaga##2##2##(2011-2#2)
genus Ignisphaera##2##2##(2011-2#2)
genus Malassezia##2##2##(2008-5#2)
genus Microsomacanthus##5##2##(2011-2#5)
genus Platycopia##2##2##(2008-5#2)
genus Potyvirus##9##2##(2008-10#9)
genus Xanthomonas##2##2##(2008-10#2)
genus and species##2##3##(2008-10#1)(2011-2#1)
genus and##4##2##(1991-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
genus in the##2##3##(2008-10#1)(2011-2#1)
genus in##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
genus is of##3##3##(2011-2#3)
genus of plant##2##3##(2008-10#2)
genus of##7##2##(2008-10#4)(2008-9#1)(2011-2#2)
genus with##2##2##(1995-12#1)(2008-10#1)
genus##220##1##(1991-3#1)(1995-12#2)(1997-2#1)(2008-10#91)(2008-11#1)(2008-12#1)(2008-5#7)(2008-6#11)(2008-8#5)(2008-9#6)(2009-8#1)(2010-1#1)(2010-10#4)(2010-2#3)(2010-3#6)(2010-4#2)(2010-8#4)(2011-2#61)(2012-3#3)(2013-1#4)(2013-8#5)
genus-specific amplicon##3##2##(2008-10#3)
genus-specific primer pair##4##3##(1995-12#1)(2008-10#3)
genus-specific##9##1##(1995-12#1)(2008-10#7)(2011-2#1)
geochemical##6##1##(2008-10#5)(2008-11#1)
geographic adjustment##3##2##(1991-3#2)(1992-2#1)
geographic and##2##2##(1994-2#1)(2007-12#1)
geographic area and##2##3##(1994-6#1)(2010-8#1)
geographic area of##2##3##(2008-10#2)
geographic area##6##2##(1991-3#1)(1994-6#1)(2008-10#3)(2010-8#1)
geographic areas and##2##3##(1992-9#1)(2012-3#1)
geographic areas of##2##3##(1993-2#1)(2008-10#1)
geographic areas##17##2##(1991-3#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-3#1)(1996-12#1)(2008-10#6)(2010-8#1)(2011-2#1)(2012-3#1)
geographic data to##2##3##(2008-10#2)
geographic differences in##2##3##(1992-2#1)(1996-3#1)
geographic distance##6##2##(2008-10#6)
geographic distances##3##2##(2008-10#3)
geographic distribution and##2##3##(1995-12#1)(2008-10#1)
geographic distribution of##5##3##(1991-12#1)(2008-10#3)(2011-2#1)
geographic distribution##10##2##(1991-12#1)(1995-12#1)(2008-10#6)(2008-5#1)(2011-2#1)
geographic information systems##3##3##(2008-10#2)(2011-2#1)
geographic information##4##2##(1992-1#1)(2008-10#2)(2011-2#1)
geographic location##4##2##(1994-1#1)(2008-10#2)(2008-11#1)
geographic locations##13##2##(2008-10#12)(2008-9#1)
geographic origin##8##2##(1990-3#1)(2008-10#7)
geographic patterns##3##2##(1994-3#1)(2008-10#1)(2008-9#1)
geographic populations##4##2##(2008-10#3)(2013-1#1)
geographic range##5##2##(2008-10#3)(2008-8#1)(2010-10#1)
geographic ranges##2##2##(2008-10#1)(2008-6#1)
geographic region##8##2##(2008-10#6)(2008-5#1)(2008-8#1)
geographic regions of the##2##4##(2008-10#2)
geographic regions##12##2##(1993-12#1)(2008-10#8)(2008-8#1)(2011-10#1)(2012-3#1)
geographic separation##2##2##(1990-8#1)(2008-10#1)
geographic source##2##2##(2008-10#2)
geographic variation in##5##3##(1991-2#1)(2008-10#1)(2008-8#3)
geographic variation##6##2##(1991-2#1)(1994-3#1)(2008-10#1)(2008-8#3)
geographic##156##1##(1990-3#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#6)(1992-1#1)(1992-12#1)(1992-2#3)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1994-1#3)(1994-2#1)(1994-3#4)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#82)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-10#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#5)
geographical and##3##2##(2008-10#1)(2011-2#1)(2012-5#1)
geographical area##6##2##(1991-6#1)(1994-12#1)(2008-10#2)(2010-11#1)(2011-2#1)
geographical areas##3##2##(2008-10#2)(2013-1#1)
geographical distance##2##2##(2008-10#1)(2010-6#1)
geographical distribution of##4##3##(1997-7#1)(2008-10#2)(2013-8#1)
geographical distribution##8##2##(1996-1#1)(1997-7#1)(2008-10#3)(2008-9#1)(2012-3#1)(2013-8#1)
geographical information system##2##3##(2008-10#2)
geographical information systems##5##3##(2008-10#5)
geographical information##7##2##(2008-10#7)
geographical isolation##3##2##(2008-10#2)(2008-8#1)
geographical locations##4##2##(2008-10#3)(2011-2#1)
geographical origin##6##2##(2008-10#6)
geographical origins##2##2##(2008-10#1)(2008-12#1)
geographical range of##2##3##(2008-8#2)
geographical region of origin##2##4##(2008-10#2)
geographical region##10##2##(1993-1#1)(1993-11#1)(2008-10#6)(2011-2#1)(2012-3#1)
geographical regions##8##2##(2008-10#7)(2012-3#1)
geographical scale##2##2##(2008-9#1)(2012-3#1)
geographical variations##2##2##(1990-8#2)
geographical##84##1##(1990-8#2)(1991-6#1)(1993-1#1)(1993-11#1)(1994-12#1)(1996-1#1)(1997-7#1)(2008-10#47)(2008-11#1)(2008-12#3)(2008-8#4)(2008-9#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-3#5)(2012-5#2)(2013-1#1)(2013-8#2)
geographically dispersed##4##2##(2008-10#3)(2008-11#1)
geographically distant##2##2##(2008-10#1)(2013-1#1)
geographically distinct##2##2##(2008-10#2)
geographically diverse##5##2##(2008-10#4)(2010-5#1)
geographically isolated populations of##2##4##(2008-8#1)(2008-9#1)
geographically separated##4##2##(1995-11#1)(2008-10#3)
geographically##38##1##(1992-1#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#2)
geography and##2##2##(1991-2#1)(2008-11#1)
geologic##2##1##(1990-11#1)(2008-10#1)
geological and##2##2##(2008-10#2)
geological materials##4##2##(2008-10#4)
geological reference##2##2##(2008-10#2)
geological samples by electrothermal##2##4##(2008-10#2)
geological samples by##6##3##(2008-10#6)
geological samples##20##2##(2008-10#17)(2013-8#3)
geological##36##1##(2008-10#29)(2008-11#1)(2008-12#1)(2013-8#5)
geology##2##1##(2008-12#1)(2008-5#1)
geometric and##5##2##(1993-8#1)(2008-3#3)(2009-2#1)
geometric effects##2##2##(2008-3#2)
geometric features##2##2##(2008-3#1)(2008-6#1)
geometric properties of##4##3##(2008-3#2)(2008-6#2)
geometric##39##1##(1993-8#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#13)(2008-6#5)(2008-7#1)(2008-8#1)(2009-2#2)(2010-3#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
geometrical optics##6##2##(2008-2#4)(2008-3#2)
geometrical patterns were##2##3##(2008-10#2)
geometrical##24##1##(1993-8#1)(1995-5#1)(2007-11#3)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#4)(2009-3#1)(2011-2#1)(2013-8#1)
geometrical-optics##3##1##(2008-3#3)
geometrically##3##1##(1992-11#1)(2009-12#2)
geometries and##2##2##(2008-2#1)(2010-8#1)
geometries for##2##2##(1996-5#1)(2008-3#1)
geometries of##3##2##(1997-6#1)(2008-2#1)(2013-8#1)
geometries##20##1##(1990-8#1)(1991-3#2)(1996-5#1)(1997-6#2)(2008-10#3)(2008-2#3)(2008-3#3)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#2)
geometry allows##2##2##(1997-6#1)(2008-10#1)
geometry and size##2##3##(2008-10#2)
geometry and the##2##3##(2008-10#1)(2008-11#1)
geometry and##11##2##(1991-3#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-4#1)
geometry are##2##2##(2008-3#2)
geometry is##3##2##(1997-6#1)(2008-10#1)(2008-2#1)
geometry of the spectrometric microtitration chamber##2##6##(2008-10#2)
geometry of the##12##3##(1990-5#1)(1991-12#1)(2008-10#6)(2008-3#4)
geometry of##19##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-5#2)(2008-10#7)(2008-3#4)
geometry that##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
geometry to##3##2##(1997-6#1)(2008-3#1)(2011-2#1)
geometry was##2##2##(2008-11#1)(2009-9#1)
geometry with##2##2##(2008-10#1)(2008-6#1)
geometry##82##1##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-5#1)(1993-8#1)(1994-5#2)(1995-12#1)(1997-6#4)(2008-10#18)(2008-11#6)(2008-2#2)(2008-3#19)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-9#1)(2011-2#5)(2012-2#1)(2013-1#1)
geometry-based##2##1##(2008-6#2)
geostatistical analysis##2##2##(2008-10#2)
geostatistical##5##1##(2008-10#4)(2008-11#1)
geraniol##2##1##(2008-10#2)
geraniol)##2##1##(2008-10#2)
geranium plants were##2##3##(2008-10#1)(2008-5#1)
geranium plants##4##2##(2008-10#3)(2008-5#1)
geranium seedlings##4##2##(2008-10#4)
geranium##11##1##(2008-10#9)(2008-5#2)
geranylgeranyl pyrophosphate##2##2##(1994-11#1)(2008-8#1)
geranylgeranyl##3##1##(1993-3#1)(1994-11#1)(2008-8#1)
geranylgeranyltransferase type I##2##3##(1995-2#2)
gerbil##4##1##(1992-12#3)(2008-8#1)
gerbillid##2##1##(2008-8#2)
geriatric assessment unit##3##3##(1992-12#1)(1992-2#1)(2008-7#1)
geriatric medicine##3##2##(1996-3#2)(1997-4#1)
geriatric mental health##3##3##(1992-1#2)(2009-5#1)
geriatric nurse practitioners##2##3##(1991-1#2)
geriatric patients##5##2##(1990-11#2)(1992-9#1)(2011-2#1)(2013-1#1)
geriatric services##2##2##(1991-2#2)
geriatric##40##1##(1990-11#2)(1990-3#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1992-1#2)(1992-12#3)(1992-2#1)(1992-9#2)(1993-5#1)(1994-3#1)(1995-3#1)(1996-3#2)(1996-6#1)(1997-4#2)(2008-7#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#3)(2013-1#1)
geriatrics##3##1##(1991-6#1)(2008-7#1)(2010-6#1)
germ agglutinin##10##2##(1991-12#1)(1992-6#3)(1994-11#1)(2008-10#2)(2008-11#1)(2008-7#2)
germ cell development in##2##4##(2009-7#2)
germ cell development##7##3##(2009-10#1)(2009-7#2)(2012-2#4)
germ cell loss from the seminiferous epithelium##2##7##(2009-10#1)(2012-2#1)
germ cell movement##3##3##(2009-10#3)
germ cell##23##2##(2007-12#1)(2008-11#1)(2008-12#2)(2009-10#8)(2009-7#2)(2012-2#9)
germ cells and##2##3##(2009-10#1)(2010-5#1)
germ cells are the##2##4##(2012-2#2)
germ cells from##2##3##(2009-10#1)(2012-2#1)
germ cells in the cysts##2##5##(2008-7#2)
germ cells in the testis##3##5##(2008-7#2)(2009-10#1)
germ cells in the##6##4##(2008-7#4)(2009-10#1)(2012-2#1)
germ cells in##7##3##(2008-7#4)(2009-10#2)(2012-2#1)
germ cells##37##2##(1992-12#1)(1994-11#3)(1997-3#1)(2007-12#1)(2008-11#4)(2008-7#6)(2009-10#8)(2010-5#5)(2012-2#8)
germ layer##2##2##(2007-12#1)(2008-9#1)
germ layers##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
germ line##7##2##(1990-12#1)(1994-12#2)(1995-2#2)(2008-11#1)(2012-2#1)
germ plasm groups were##2##4##(2008-10#2)
germ plasm groups##3##3##(2008-10#3)
germ plasm line##2##3##(2008-10#2)
germ plasm lines##2##3##(2008-10#2)
germ plasm of##2##3##(2008-10#2)
germ plasm with##2##3##(2008-10#2)
germ plasm##25##2##(2008-10#25)
germ tube growth of##5##4##(2008-10#5)
germ tube growth##8##3##(2008-10#8)
germ tube length##2##3##(2008-10#2)
germ tube##16##2##(2008-10#15)(2008-5#1)
germ tubes and##3##3##(2008-10#2)(2008-7#1)
germ tubes increased##2##3##(2008-10#2)
germ tubes of##2##3##(2008-10#2)
germ tubes##25##2##(2008-10#23)(2008-7#2)
germ##161##1##(1990-12#1)(1991-12#1)(1992-12#1)(1992-6#3)(1993-8#1)(1994-11#4)(1994-12#2)(1995-2#2)(1997-3#2)(2007-12#3)(2008-1#1)(2008-10#69)(2008-11#10)(2008-12#3)(2008-5#1)(2008-7#10)(2008-9#2)(2009-10#17)(2009-7#2)(2010-3#1)(2010-5#5)(2012-12#1)(2012-2#18)(2013-1#1)
germ-cell##3##1##(2008-10#1)(2010-11#2)
germ-line##4##1##(1995-6#1)(1997-8#1)(2008-7#1)(2008-9#1)
germ-tube##2##1##(2008-10#1)(2008-5#1)
germanica##2##1##(2012-2#2)
germanium and molybdenum##2##3##(2008-10#2)
germanium and##3##2##(2008-10#3)
germanium were##2##2##(2008-10#2)
germanium##13##1##(1992-11#1)(2008-10#12)
germanium(IV)##2##1##(2008-10#2)
germicidal##2##1##(1990-6#1)(1996-3#1)
germinability##3##1##(2008-10#3)
germinal centers##2##2##(2008-10#1)(2010-11#1)
germinal epithelium degeneration##2##3##(2008-9#2)
germinal##11##1##(2007-12#2)(2008-10#2)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
germinant receptors##2##2##(2011-2#2)
germinate and grow out##2##4##(2011-2#2)
germinate and##5##2##(2008-10#3)(2011-2#2)
germinate on##2##2##(2008-10#1)(2010-10#1)
germinate##14##1##(2008-10#10)(2010-10#1)(2011-2#3)
germinated at 0 to##2##4##(2008-10#2)
germinated at##4##2##(2008-10#4)
germinated by##2##2##(2008-10#2)
germinated conidia##7##2##(2008-10#7)
germinated from 12 to##2##4##(2008-10#2)
germinated on##3##2##(2008-10#3)
germinated seeds extract##4##3##(2008-5#4)
germinated spores##2##2##(2008-9#1)(2011-2#1)
germinated within##2##2##(2008-10#2)
germinated##48##1##(2008-10#39)(2008-12#1)(2008-5#4)(2008-9#1)(2009-10#1)(2011-2#2)
germinating F(1) teliospores##2##3##(2008-10#2)
germinating conidia##9##2##(2008-10#9)
germinating maize##2##2##(2009-8#2)
germinating seeds##3##2##(2008-10#2)(2008-7#1)
germinating##25##1##(1990-5#2)(2008-10#19)(2008-7#1)(2009-8#3)
germination and appressorium formation##5##4##(2008-10#5)
germination and appressorium##6##3##(2008-10#5)(2009-8#1)
germination and germ tube growth of##3##6##(2008-10#3)
germination and growth##2##3##(2008-10#1)(2011-2#1)
germination and hyphal growth##3##4##(2008-10#3)
germination and outgrowth processes##3##4##(2011-2#3)
germination and outgrowth##9##3##(2011-2#9)
germination and seedling growth##4##4##(2008-12#4)
germination and sporulation of##2##4##(2008-10#2)
germination and subsequent##2##3##(2008-10#2)
germination and##44##2##(2008-10#25)(2008-12#4)(2008-7#1)(2008-8#1)(2009-8#2)(2011-2#11)
germination at##4##2##(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
germination fluid##4##2##(2008-10#4)
germination for sclerotia##2##3##(2008-10#2)
germination for##3##2##(2008-10#3)
germination frequency##3##2##(2008-10#3)
germination in the##3##3##(2008-10#3)
germination in##16##2##(2008-10#14)(2009-8#1)(2011-2#1)
germination inhibition##2##2##(2008-10#1)(2008-9#1)
germination is##4##2##(2008-10#1)(2009-8#2)(2011-2#1)
germination model##2##2##(2008-10#1)(2011-2#1)
germination occurred at##5##3##(2008-10#5)
germination occurred##8##2##(2008-10#8)
germination of B##3##3##(2008-10#3)
germination of P##5##3##(2008-10#5)
germination of S##3##3##(2008-10#3)
germination of sclerotia##7##3##(2008-10#7)
germination of spores##2##3##(2009-8#1)(2011-2#1)
germination of the##3##3##(2008-10#3)
germination of##44##2##(2008-10#40)(2008-5#1)(2009-8#1)(2011-2#2)
germination on##7##2##(2008-10#6)(2011-2#1)
germination or##2##2##(2008-10#2)
germination peaks##2##2##(2008-10#2)
germination percentage of##3##3##(2008-10#3)
germination percentage was##2##3##(2008-10#2)
germination percentage##5##2##(2008-10#5)
germination proteins##2##2##(1997-7#2)
germination rate##2##2##(2008-10#2)
germination rates##2##2##(2008-10#2)
germination remained##2##2##(2008-10#2)
germination responses##3##2##(2008-10#2)(2009-8#1)
germination stimulants##2##2##(2008-10#2)
germination to##2##2##(2008-10#2)
germination was##11##2##(2008-10#10)(2011-2#1)
germination were##3##2##(2008-10#3)
germination##262##1##(1995-6#1)(1997-7#2)(2008-10#198)(2008-12#8)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#11)(2011-2#28)(2012-3#1)
germinoma 14 years after##2##4##(2008-7#2)
germinoma##8##1##(2008-7#8)
germline gene##2##2##(2007-12#2)
germline mutation##4##2##(2009-12#1)(2009-8#1)(2012-3#2)
germline mutations##2##2##(2008-10#1)(2013-1#1)
germline sequences##2##2##(1996-12#2)
germline transmission##2##2##(2008-2#1)(2012-3#1)
germline##30##1##(1992-10#1)(1996-12#2)(2007-12#6)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-5#2)(2011-2#3)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
germlings##2##1##(2008-10#2)
germplasm##10##1##(2008-10#6)(2008-9#1)(2009-6#1)(2010-10#1)(2012-4#1)
germplasms##3##1##(2008-10#2)(2008-8#1)
germs##4##1##(2007-8#1)(2009-3#2)(2013-1#1)
gerontologic##2##1##(1992-11#1)(1993-2#1)
gerontological##5##1##(2008-11#1)(2012-12#4)
gerontology##5##1##(1991-12#1)(1992-1#1)(1994-1#1)(2008-7#2)
geropsychiatric services that##2##3##(1992-1#2)
gesneriana##4##1##(2009-12#4)
gestation and##3##2##(1993-12#3)
gestation from##2##2##(1990-5#1)(1996-11#1)
gestation have##2##2##(2012-2#1)(2013-1#1)
gestation in##4##2##(1994-3#1)(2008-11#1)(2013-1#2)
gestation is##4##2##(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
gestation to##2##2##(1990-5#2)
gestation with##3##2##(2008-7#1)(2013-1#2)
gestation##64##1##(1990-11#1)(1990-5#4)(1990-9#1)(1991-2#1)(1993-12#8)(1994-3#2)(1994-8#2)(1995-2#1)(1996-11#2)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#2)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#8)
gestation)##4##1##(1990-5#1)(2008-11#2)(2012-2#1)
gestational age##18##2##(1991-7#1)(1994-3#1)(1995-8#1)(1996-11#1)(2007-12#2)(2008-11#4)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#2)
gestational day##2##2##(1995-2#1)(1995-8#1)
gestational diabetes mellitus was##2##4##(1992-12#1)(2008-10#1)
gestational diabetes mellitus##9##3##(1992-12#5)(2008-10#4)
gestational diabetes##14##2##(1992-12#5)(1996-11#3)(2008-10#5)(2012-3#1)
gestational stress##5##2##(2008-11#5)
gestational week##2##2##(1997-8#2)
gestational##51##1##(1990-9#1)(1991-7#1)(1992-1#1)(1992-12#6)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#4)(1997-8#2)(2007-12#2)(2008-10#6)(2008-11#11)(2009-6#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
gestations##3##1##(2008-11#1)(2012-3#2)
gestodene##6##1##(2011-3#6)
gestural##2##1##(2010-5#2)
gesture with their##2##3##(2010-5#2)
gestures and##5##2##(2008-11#4)(2010-5#1)
gestures##10##1##(2008-11#5)(2010-5#4)(2010-6#1)
get a better##2##3##(1994-1#1)(2008-10#1)
get a##11##2##(1994-1#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-10#1)(2013-8#4)
get an inside##2##3##(1994-12#1)(1995-2#1)
get an##7##2##(1994-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-12#1)(2012-2#1)
get in##2##2##(1994-5#1)(2008-11#1)
get into the##2##3##(2008-5#1)(2010-4#1)
get involved##2##2##(1990-11#1)(2008-4#1)
get it##2##2##(2011-2#1)(2013-8#1)
get more##5##2##(1994-1#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-5#1)
get the most##2##3##(1994-3#1)(2008-7#1)
get the##13##2##(1993-1#1)(1993-2#1)(1994-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2013-8#1)
get their##2##2##(1995-12#1)(2009-5#1)
get##95##1##(1990-11#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#2)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#1)(2008-10#16)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#7)
gets a##2##2##(1990-8#1)(2012-2#1)
gets##10##1##(1990-8#1)(1992-9#1)(1993-5#1)(1995-12#1)(1996-5#1)(2008-10#2)(2010-1#1)(2012-2#1)(2013-1#1)
getting in##2##2##(2008-10#1)(2010-5#1)
getting the evidence straight##2##4##(1993-12#2)
getting##25##1##(1991-1#1)(1991-8#1)(1993-1#1)(1993-12#2)(1996-1#1)(1996-8#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
gfg transcripts##3##2##(1994-11#3)
gfg##5##1##(1994-11#5)
ghana##5##1##(2011-2#4)(2013-1#1)
ghost talk in##2##3##(2008-3#2)
ghost talk##4##2##(2008-3#4)
ghost##9##1##(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-9#1)
ghrelin levels##6##2##(2011-1#5)(2013-8#1)
ghrelin##14##1##(2011-1#6)(2012-3#3)(2013-8#5)
giant aneurysm##2##2##(2008-12#1)(2011-2#1)
giant back mass##2##3##(2011-2#2)
giant cell tumor of the##2##5##(2009-3#2)
giant cell tumor##4##3##(2009-3#2)(2010-12#1)(2012-3#1)
giant cell##8##2##(1997-8#1)(2008-10#2)(2008-5#1)(2009-3#2)(2010-12#1)(2012-3#1)
giant cells and##2##3##(2008-10#1)(2008-5#1)
giant cells in the##2##4##(2008-10#2)
giant cells in##3##3##(2008-10#3)
giant cells##16##2##(1991-11#1)(1991-12#1)(2008-10#8)(2008-5#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#2)
giant cystic craniopharyngiomas##2##3##(2008-7#2)
giant grouper##5##2##(2010-5#5)
giant intracranial##2##2##(2008-7#1)(2012-2#1)
giant middle cerebral##3##3##(2008-7#1)(2011-2#2)
giant neck and back masses##2##5##(2011-2#2)
giant neurons in##3##3##(2007-12#3)
giant neurons##7##2##(2007-12#7)
giant panda##7##2##(2008-8#4)(2008-9#3)
giant posterior circulation aneurysms##2##4##(2008-7#2)
giant posterior##4##2##(2008-7#2)(2011-2#1)(2013-1#1)
giant saccular aneurysm##2##3##(2008-7#2)
giant##110##1##(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#4)(1992-11#1)(1993-1#1)(1993-6#1)(1996-3#1)(1996-9#1)(1997-8#3)(2007-12#10)(2008-10#12)(2008-12#3)(2008-5#4)(2008-7#15)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#2)(2011-2#9)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#8)
gibberella ear rot##2##3##(2008-10#2)
gibberellin (GA)##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
gibberellin signaling##2##2##(2009-8#2)
gibberellin##5##1##(2008-10#1)(2008-8#1)(2009-8#3)
gibberellins##4##1##(2008-10#1)(2009-8#3)
gibbon##5##1##(1993-8#5)
gibbosa##3##1##(2008-12#3)
gift##3##1##(1994-12#1)(1995-1#1)(2007-12#1)
gifts to##2##2##(1992-3#1)(1993-5#1)
gifts##10##1##(1991-1#1)(1992-1#1)(1992-3#1)(1993-5#1)(1996-1#1)(1997-4#1)(2008-11#3)(2008-12#1)
gigahertz##3##1##(1995-3#1)(2007-12#1)(2008-3#1)
giganteus##6##1##(1991-9#2)(1993-2#2)(2008-10#2)
gigantic##3##1##(1997-7#1)(2009-10#1)(2013-1#1)
gill##12##1##(1995-12#1)(2008-10#1)(2008-11#2)(2008-7#6)(2009-7#1)(2011-2#1)
gills of the##3##3##(2008-7#3)
gills of##5##2##(2008-7#4)(2010-8#1)
gills was##2##2##(2008-7#2)
gills##17##1##(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#11)(2010-8#1)
ginbuna##4##1##(2008-5#4)
ginger##10##1##(2008-10#10)
gingiva increased the pain thresholds##2##5##(1993-1#2)
gingiva##8##1##(1993-1#3)(2012-12#1)(2013-1#4)
gingival enlargement##3##2##(2012-12#3)
gingival##16##1##(2008-1#2)(2008-5#1)(2010-12#2)(2011-2#1)(2012-12#3)(2013-1#7)
gingivalis and##4##2##(2008-12#3)(2013-1#1)
gingivalis##11##1##(2008-12#5)(2008-9#5)(2013-1#1)
gingivo-buccal complex##2##2##(2010-12#2)
ginkgo##4##1##(2008-10#3)(2010-5#1)
ginseng (Panax quinquefolius)##3##3##(2008-10#3)
ginseng and##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
ginseng leaflets##2##2##(2008-10#2)
ginseng on##2##2##(1995-8#2)
ginseng plants##2##2##(2008-10#2)
ginseng production##2##2##(2008-10#2)
ginseng roots was##2##3##(2008-10#2)
ginseng roots were##2##3##(2008-10#2)
ginseng roots##5##2##(2008-10#5)
ginseng##41##1##(1995-8#3)(2008-10#26)(2008-11#4)(2012-3#6)(2013-8#2)
ginseng-induced##2##1##(2012-3#2)
ginsenoside##2##1##(2008-11#2)
ginsenosides was##2##2##(2008-11#2)
ginsenosides##3##1##(2008-11#3)
girdle##10##1##(1994-8#1)(1997-8#1)(2008-10#2)(2008-7#1)(2011-2#3)(2012-2#2)
girdling##3##1##(2008-10#3)
girl presented with recurrent##3##4##(2008-10#2)(2010-6#1)
girl presented##4##2##(2008-10#2)(2008-8#1)(2010-6#1)
girl was##2##2##(1997-3#1)(2012-3#1)
girl who##2##2##(2008-11#1)(2008-7#1)
girl with bilateral##2##3##(2012-2#1)(2013-1#1)
girl with##7##2##(1995-8#1)(1997-3#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
girl##31##1##(1992-3#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-3#3)(2007-9#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-5#2)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
girls aged##2##2##(1996-3#1)(2008-1#1)
girls and women##2##3##(2008-10#1)(2008-12#1)
girls and##9##2##(1990-9#1)(2008-10#2)(2008-12#2)(2009-7#1)(2010-10#1)(2013-1#2)
girls at##2##2##(2013-1#2)
girls had##2##2##(2009-7#1)(2012-2#1)
girls in the##2##3##(1996-6#1)(2013-1#1)
girls in##5##2##(1996-6#1)(2008-1#1)(2008-7#1)(2013-1#2)
girls receiving the##2##3##(2013-1#2)
girls reported##4##2##(1991-9#2)(1996-6#1)(2008-10#1)
girls than##2##2##(1990-2#1)(1994-12#1)
girls were##2##2##(2008-9#1)(2010-10#1)
girls with eating##3##3##(2008-11#3)
girls with premature adrenarche##2##4##(2008-4#2)
girls with strong##3##3##(2013-1#3)
girls with##13##2##(1994-12#1)(2008-10#2)(2008-11#3)(2008-4#3)(2011-2#1)(2013-1#3)
girls##110##1##(1990-11#1)(1990-2#5)(1990-6#1)(1990-9#1)(1991-11#1)(1991-9#2)(1994-12#2)(1996-11#1)(1996-3#1)(1996-6#3)(2008-1#5)(2008-10#8)(2008-11#5)(2008-12#7)(2008-4#6)(2008-7#1)(2008-9#3)(2009-10#3)(2009-7#5)(2009-9#1)(2010-1#4)(2010-10#3)(2010-12#1)(2011-1#8)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#24)
girls' drinking##2##2##(2010-7#2)
girls' violence##2##2##(2013-1#2)
girls'##10##1##(2008-11#1)(2010-10#1)(2010-7#4)(2013-1#4)
girls) were##2##2##(1996-6#1)(2012-2#1)
girls) with a##2##3##(2008-1#1)(2011-2#1)
girls) with##3##2##(1990-12#1)(2008-1#1)(2011-2#1)
girls)##12##1##(1990-12#1)(1991-6#1)(1991-9#2)(1996-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
girth as predictors##2##3##(1996-8#1)(2008-11#1)
girth##4##1##(1996-8#2)(2008-11#1)(2008-12#1)
give a brief overview of##2##5##(1995-2#1)(2009-8#1)
give a total##2##3##(2008-10#2)
give a##41##2##(1991-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#2)(2009-9#1)(2011-3#1)(2012-3#1)(2013-1#1)
give an additional##2##3##(1995-11#1)(2008-10#1)
give an overview of the##2##5##(2010-9#1)(2011-2#1)
give an overview of##4##4##(2008-11#1)(2010-11#1)(2010-9#1)(2011-2#1)
give an##18##2##(1991-6#1)(1995-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-9#1)(2011-2#2)(2013-8#1)
give birth##2##2##(1990-9#1)(2010-2#1)
give different##2##2##(2008-10#2)
give evidence##3##2##(2008-10#2)(2009-10#1)
give high##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
give information about##2##3##(1991-5#1)(2010-8#1)
give information on the##3##4##(2008-10#2)(2008-5#1)
give information##6##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-8#1)
give insights##3##2##(2008-11#1)(2010-7#1)(2012-3#1)
give it a##2##3##(2008-7#1)(2013-1#1)
give more##7##2##(1997-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-2#1)
give new##2##2##(2008-11#1)(2008-3#1)
give rise to the##2##4##(2007-11#1)(2012-2#1)
give rise to##25##3##(1991-3#1)(1992-5#1)(1994-3#1)(1995-5#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
give rise##27##2##(1991-3#1)(1992-5#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
give satisfactory results##4##3##(1992-9#1)(2007-8#1)(2008-10#2)
give satisfactory##6##2##(1992-9#1)(2007-8#1)(2008-10#4)
give several examples##2##3##(2012-2#1)(2013-8#1)
give significant##3##2##(1994-12#1)(1995-5#1)(2008-10#1)
give similar results##2##3##(1996-2#1)(1996-3#1)
give some##2##2##(1992-9#1)(2009-10#1)
give strong##2##2##(1991-6#1)(2008-10#1)
give support##2##2##(1994-1#1)(1995-12#1)
give the best##4##3##(1992-12#1)(1996-12#1)(2008-10#2)
give the same##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
give the##32##2##(1991-12#1)(1992-12#1)(1992-2#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-5#3)(2008-10#10)(2008-11#7)(2008-5#2)(2008-9#3)(2012-2#1)
give them##2##2##(2008-1#1)(2008-10#1)
give three##2##2##(2008-10#1)(2010-11#1)
give us a##2##3##(2008-8#1)(2010-10#1)
give us##7##2##(2008-11#2)(2008-8#1)(2009-7#1)(2010-10#1)(2012-2#2)
give##268##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#4)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#9)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#76)(2008-11#25)(2008-12#2)(2008-3#4)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#4)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#3)(2013-8#4)
given 6##2##2##(1994-5#2)
given a diagnosis of##2##4##(1997-3#1)(2012-3#1)
given a##22##2##(1991-2#2)(1991-3#1)(1994-8#1)(1994-9#1)(1996-11#2)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#2)
given acquisition access periods (AAPs) ranging from##2##7##(2008-10#2)
given after##2##2##(2008-10#1)(2008-7#1)
given an##7##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2012-3#1)
given and##6##2##(1990-9#1)(2008-10#5)
given as a##4##3##(1991-6#1)(1992-12#1)(2007-12#1)(2008-5#1)
given as##12##2##(1991-6#2)(1992-12#2)(1992-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
given at birth##2##3##(1995-5#1)(2007-11#1)
given at the##3##3##(2008-12#1)(2012-3#2)
given at##13##2##(1993-3#1)(1994-8#2)(1995-5#2)(1996-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#2)
given before##2##2##(2010-8#1)(2011-2#1)
given bilateral##3##2##(1993-3#1)(1993-6#1)(1994-3#1)
given both##2##2##(2008-10#1)(2008-9#1)
given by the##15##3##(1993-2#1)(1994-9#1)(1997-8#1)(2008-10#8)(2008-3#1)(2010-10#1)(2010-4#1)(2013-1#1)
given by##30##2##(1991-3#1)(1993-12#1)(1993-2#1)(1994-9#1)(1997-1#2)(1997-8#2)(2008-10#14)(2008-11#1)(2008-3#3)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
given day##2##2##(2008-10#1)(2008-8#1)
given either##3##2##(1990-11#1)(2008-10#1)(2011-2#1)
given for the##7##3##(2007-11#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)
given for##30##2##(1990-2#1)(1990-5#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-9#4)(2013-1#2)(2013-8#1)
given genomic sequence##2##3##(2008-7#2)
given genomic##3##2##(2008-7#3)
given here##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
given host##4##2##(2008-10#4)
given i##6##2##(1990-12#1)(1992-3#5)
given immediately after##2##3##(1990-12#1)(2012-2#1)
given in the##6##3##(1993-6#1)(1994-2#1)(1994-8#1)(2008-10#3)
given in this paper##3##4##(2008-10#3)
given in this##4##3##(2008-10#3)(2008-9#1)
given in##20##2##(1990-10#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-2#2)(1994-8#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-8#1)
given is##2##2##(1992-9#1)(2010-10#1)
given its##6##2##(1990-11#1)(1991-1#1)(1995-11#1)(2008-10#2)(2008-11#1)
given little##2##2##(1994-2#1)(1997-2#1)
given membrane##2##2##(2008-10#1)(2008-7#1)
given of the##3##3##(1992-1#1)(1996-12#1)(1997-7#1)
given of##5##2##(1992-1#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-4#1)
given on##5##2##(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)
given orally##2##2##(1992-12#1)(2012-2#1)
given population##2##2##(2008-9#1)(2011-3#1)
given prior##2##2##(1997-2#1)(2010-3#1)
given protein##4##2##(1997-6#1)(2008-11#2)(2009-12#1)
given rise to##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2010-7#1)
given species##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)
given temperature##3##2##(2008-10#3)
given that the##3##3##(2008-10#2)(2012-2#1)
given that##14##2##(1996-2#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
given the current##2##3##(1997-1#1)(2008-11#1)
given the opportunity to##3##4##(2008-10#2)(2008-11#1)
given the responsibility##2##3##(1992-1#1)(1994-3#1)
given the same##2##3##(2009-11#1)(2012-3#1)
given the##52##2##(1990-11#1)(1990-9#1)(1991-11#1)(1992-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
given their##2##2##(2008-10#1)(2009-7#1)
given this##2##2##(1997-8#1)(2008-10#1)
given to different##2##3##(2008-8#1)(2009-11#1)
given to illustrate the##2##4##(2008-10#1)(2008-11#1)
given to illustrate##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
given to the##12##3##(1990-11#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#1)
given to##59##2##(1990-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
given using##2##2##(2008-4#1)(2008-5#1)
given year##3##2##(1993-12#1)(2008-10#1)(2008-9#1)
given##670##1##(1990-10#1)(1990-11#9)(1990-12#4)(1990-2#4)(1990-5#3)(1990-6#4)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#5)(1991-8#3)(1992-1#3)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#5)(1993-6#6)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#7)(1994-8#4)(1994-9#5)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#5)(1995-9#1)(1996-11#4)(1996-12#6)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#6)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#9)(1997-9#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#152)(2008-11#52)(2008-12#7)(2008-2#3)(2008-3#33)(2008-4#17)(2008-5#15)(2008-6#2)(2008-7#12)(2008-8#17)(2008-9#26)(2009-10#1)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#5)(2010-8#6)(2011-1#2)(2011-2#17)(2011-3#2)(2012-12#2)(2012-2#8)(2012-3#17)(2013-1#19)(2013-8#8)
gives a brief overview##4##4##(1994-12#1)(2008-10#2)(2011-2#1)
gives a good##4##3##(2008-10#4)
gives a##34##2##(1991-11#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-12#1)(1997-2#1)(2006-6#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
gives an insight into the##2##5##(2008-10#1)(2010-6#1)
gives an overview of the##3##5##(1997-2#1)(2008-9#1)(2010-11#1)
gives an overview of##4##4##(1997-2#1)(2008-10#1)(2008-9#1)(2010-11#1)
gives an overview on##2##4##(2008-10#2)
gives an overview##7##3##(1997-2#1)(2008-10#3)(2008-9#1)(2010-11#1)(2013-1#1)
gives an##19##2##(1997-2#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-9#2)(2010-1#1)(2010-11#1)(2010-6#1)(2013-1#1)
gives excellent##2##2##(1991-9#1)(2008-3#1)
gives good results##2##3##(2008-10#1)(2013-1#1)
gives good##5##2##(1993-11#1)(2008-10#1)(2008-3#1)(2013-1#2)
gives information##2##2##(1991-5#1)(2008-9#1)
gives insight into the##2##4##(2009-8#1)(2012-2#1)
gives more##2##2##(2008-10#1)(2008-7#1)
gives much##2##2##(2008-10#2)
gives results with##2##3##(2008-10#2)
gives results##3##2##(1994-9#1)(2008-10#2)
gives rise to a##10##4##(1991-9#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2013-8#1)
gives rise to an##2##4##(2008-10#2)
gives rise to many##2##4##(1992-3#1)(2008-5#1)
gives rise to the##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
gives rise to##26##3##(1991-9#1)(1992-3#1)(1994-8#1)(1995-6#1)(1996-3#1)(1997-6#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-8#4)
gives satisfactory##2##2##(2008-10#1)(2008-3#1)
gives the highest##2##3##(2008-10#2)
gives the same##2##3##(1996-5#1)(2008-11#1)
gives the##21##2##(1992-9#1)(1993-2#1)(1994-11#1)(1996-5#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-6#1)(2009-8#1)(2010-4#1)
gives us a##2##3##(1997-1#1)(2008-11#1)
gives very good results##2##4##(1996-11#1)(2011-3#1)
gives##182##1##(1990-11#1)(1990-2#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(2006-6#1)(2008-10#70)(2008-11#13)(2008-12#2)(2008-3#8)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#5)
giving a signal equal to three##4##6##(2008-10#4)
giving a##16##2##(1995-2#1)(1997-3#1)(2008-10#11)(2008-11#1)(2010-1#1)(2010-11#1)
giving an##4##2##(2008-10#3)(2010-11#1)
giving birth during the##2##4##(2011-1#2)
giving birth##3##2##(2009-10#1)(2011-1#2)
giving good results##2##3##(2008-10#2)
giving low##2##2##(1993-11#1)(2008-10#1)
giving rise to a##5##4##(2008-10#4)(2009-4#1)
giving rise to new##2##4##(2009-12#1)(2009-8#1)
giving rise to the##2##4##(1997-8#1)(2008-11#1)
giving rise to##22##3##(1996-12#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
giving the##11##2##(1990-5#1)(1996-3#1)(1996-5#1)(2008-10#6)(2008-8#1)(2008-9#1)
giving to the##2##3##(1992-1#1)(2009-4#1)
giving us a##2##3##(2008-11#1)(2012-2#1)
giving##106##1##(1990-11#1)(1990-2#2)(1990-5#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-3#1)(1996-5#5)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#2)(2008-10#40)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-2#1)(2011-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
gizzard##6##1##(1993-6#1)(1993-8#4)(2008-12#1)
gl(-1)##3##1##(2008-10#3)
glaA##4##1##(2008-8#1)(2008-9#3)
glaberrima##2##1##(2009-10#2)
glabrata and##2##2##(2008-10#1)(2008-5#1)
glabrata isolates##2##2##(2008-5#2)
glabrata##11##1##(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#5)
glabrescens Boiss##2##2##(2008-11#2)
glabripennis and A##2##3##(2013-8#2)
glabripennis##4##1##(2013-8#4)
glacial acetic acid##3##3##(2008-10#3)
glacial##4##1##(2008-10#3)(2008-9#1)
gladioli##4##1##(2008-10#4)
glance##5##1##(1995-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
gland and the##3##3##(2008-10#1)(2012-3#1)(2013-7#1)
gland and##16##2##(1990-5#1)(1993-12#1)(1995-12#1)(1996-2#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-7#1)
gland are##5##2##(1991-6#1)(2007-12#1)(2012-2#2)(2013-1#1)
gland at##2##2##(2008-7#2)
gland cell##3##2##(2007-12#2)(2008-9#1)
gland cells##9##2##(2007-12#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)
gland follicular cell hypertrophy##2##4##(2008-9#2)
gland in a##2##3##(1997-5#1)(2008-6#1)
gland in the##2##3##(2007-12#1)(2012-12#1)
gland in##7##2##(1997-1#1)(1997-5#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-12#1)
gland is##6##2##(1996-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-3#1)(2013-1#1)
gland of the##8##3##(1990-5#1)(1997-2#1)(2007-12#3)(2008-6#1)(2013-1#2)
gland of##17##2##(1990-5#1)(1995-11#1)(1997-2#1)(2007-12#4)(2008-11#4)(2008-6#1)(2008-7#3)(2013-1#2)
gland secretion##3##2##(2007-12#2)(2008-7#1)
gland that##2##2##(2009-12#1)(2009-3#1)
gland using##2##2##(1992-6#1)(1996-12#1)
gland was##4##2##(2008-12#2)(2008-5#1)(2011-1#1)
gland were##4##2##(2008-5#2)(2008-7#1)(2012-3#1)
gland##199##1##(1990-11#2)(1990-3#1)(1990-5#5)(1991-11#1)(1991-6#4)(1991-9#1)(1992-12#2)(1992-6#2)(1992-9#3)(1993-12#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#9)(1995-12#4)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#20)(2008-10#14)(2008-11#10)(2008-12#10)(2008-5#5)(2008-6#8)(2008-7#14)(2008-8#2)(2008-9#10)(2009-1#1)(2009-12#2)(2009-3#3)(2011-1#4)(2011-2#11)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#3)
glands after##2##2##(2007-12#1)(2008-10#1)
glands and the##2##3##(2007-12#1)(2011-2#1)
glands and##8##2##(2007-12#2)(2008-10#3)(2011-2#2)(2012-3#1)
glands are##4##2##(1995-11#1)(2007-12#2)(2008-7#1)
glands in the##3##3##(2007-12#2)(2008-7#1)
glands in##10##2##(1994-2#1)(1997-1#1)(2007-12#6)(2008-4#1)(2008-7#1)
glands of the##3##3##(1991-11#1)(1995-12#1)(2008-10#1)
glands of##19##2##(1990-11#4)(1990-2#1)(1991-11#1)(1992-12#1)(1995-12#1)(2007-12#2)(2008-10#6)(2008-4#1)(2008-8#2)
glands that##2##2##(2011-2#1)(2013-1#1)
glands tumors##2##2##(1990-6#1)(2011-2#1)
glands was##2##2##(2011-2#1)(2013-1#1)
glands were##5##2##(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#2)
glands with##4##2##(1995-11#1)(2007-12#1)(2011-2#2)
glands##131##1##(1990-11#5)(1990-12#1)(1990-2#1)(1990-6#3)(1990-9#2)(1991-11#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-2#2)(1995-11#4)(1995-12#2)(1996-1#1)(1997-1#1)(2007-12#21)(2008-10#27)(2008-11#3)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#15)(2012-3#1)(2013-1#4)
glandular and##2##2##(2007-12#2)
glandular tissues##2##2##(2008-4#2)
glandular units##2##2##(2007-12#2)
glandular##25##1##(1990-2#1)(1992-12#1)(1995-6#1)(1997-1#1)(2007-12#8)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2011-2#4)(2012-3#1)
glanular##2##1##(2008-10#2)
glass (CPG)##3##2##(2008-10#3)
glass and##11##2##(2008-10#9)(2009-7#2)
glass are##3##2##(2008-10#1)(2008-3#1)(2009-7#1)
glass as an##2##3##(2008-10#1)(2008-3#1)
glass as##5##2##(2008-10#3)(2008-3#1)(2009-7#1)
glass beads with##2##3##(2008-10#1)(2009-5#1)
glass beads##11##2##(2008-10#8)(2008-7#2)(2009-5#1)
glass by##2##2##(2008-10#2)
glass capillary##4##2##(2008-10#3)(2008-2#1)
glass cell##2##2##(2008-10#2)
glass containers##3##2##(2008-10#3)
glass electrode##23##2##(2008-10#23)
glass electrodes##6##2##(2008-10#6)
glass electrophoresis##2##2##(2008-10#2)
glass extraction##2##2##(2008-10#2)
glass fiber filter##3##3##(2008-10#3)
glass fiber filters##4##3##(2008-10#4)
glass fiber##8##2##(1997-6#1)(2008-10#7)
glass fibers##5##2##(2009-7#5)
glass formation##2##2##(1995-3#2)
glass fragments##6##2##(2008-10#6)
glass ionomer cement##2##3##(2013-1#2)
glass ionomer##4##2##(1990-2#1)(2008-10#1)(2013-1#2)
glass is##3##2##(2008-10#2)(2008-3#1)
glass laser##3##2##(2008-3#3)
glass lasers##2##2##(2008-3#2)
glass matrix##2##2##(2008-10#1)(2009-7#1)
glass membrane##3##2##(2008-10#3)
glass microchip##2##2##(2008-10#2)
glass microscope slides##2##3##(2008-4#1)(2009-12#1)
glass plate##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
glass samples##3##2##(2008-10#3)
glass slide##2##2##(2008-10#1)(2008-9#1)
glass slides##5##2##(2008-10#5)
glass specimens##2##2##(2008-10#2)
glass substrate##2##2##(2008-10#1)(2010-4#1)
glass substrates and##2##3##(2008-10#1)(2008-3#1)
glass substrates##6##2##(2008-10#3)(2008-3#3)
glass surface##2##2##(2008-10#1)(2008-3#1)
glass surfaces##6##2##(2008-10#6)
glass transition temperature##4##3##(1995-3#2)(2008-3#1)(2010-4#1)
glass transition##9##2##(1995-3#5)(2008-3#1)(2010-4#1)(2012-2#2)
glass tube##5##2##(2008-10#5)
glass tubes##2##2##(2008-10#1)(2008-12#1)
glass was##2##2##(2008-10#2)
glass waveguide gratings##3##3##(2008-3#3)
glass waveguide laser##3##3##(2008-3#3)
glass waveguide##7##2##(2008-3#7)
glass were##2##2##(2008-10#2)
glass##284##1##(1990-2#1)(1991-12#1)(1992-8#1)(1995-3#10)(1997-6#1)(2007-12#1)(2008-10#199)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#28)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#3)(2009-7#15)(2010-12#1)(2010-4#2)(2010-8#1)(2012-2#5)(2013-1#2)
glass-ceramic##5##1##(2008-10#2)(2009-7#3)
glass-ceramics##6##1##(2009-7#6)
glass-forming##3##1##(1995-3#2)(2008-10#1)
glass-ionomer powder##2##2##(2009-7#2)
glass-ionomer restorative material##3##3##(2009-7#3)
glass-ionomer##8##1##(2009-7#7)(2013-1#1)
glasses and##2##2##(2008-10#1)(2012-2#1)
glasses##22##1##(1991-1#1)(1993-11#1)(1995-3#6)(2008-10#6)(2008-12#1)(2008-3#3)(2010-8#2)(2011-7#1)(2012-2#1)
glasshouse##9##1##(2008-10#9)
glasshouse-grown##2##1##(2008-10#2)
glassware and##2##2##(2008-10#2)
glassware##4##1##(2008-10#4)
glassy carbon (GC) electrode was##2##5##(2008-10#2)
glassy carbon (GC) electrode##8##4##(2008-10#8)
glassy carbon (GC)##12##3##(2008-10#12)
glassy carbon and##4##3##(2008-10#4)
glassy carbon disk electrode##2##4##(2008-10#2)
glassy carbon disk##3##3##(2008-10#3)
glassy carbon electrode (GCE) and##2##5##(2008-10#2)
glassy carbon electrode (GCE)##14##4##(2008-10#14)
glassy carbon electrode and##4##4##(2008-10#4)
glassy carbon electrode by##4##4##(2008-10#4)
glassy carbon electrode in the presence of##2##7##(2008-10#2)
glassy carbon electrode in the presence##3##6##(2008-10#3)
glassy carbon electrode in##5##4##(2008-10#5)
glassy carbon electrode is##3##4##(1990-12#1)(2008-10#2)
glassy carbon electrode modified by##2##5##(2008-10#2)
glassy carbon electrode modified with##6##5##(2008-10#6)
glassy carbon electrode modified##8##4##(2008-10#8)
glassy carbon electrode surface at##3##5##(2008-10#3)
glassy carbon electrode surface##7##4##(2008-10#7)
glassy carbon electrode using cyclic##2##5##(2008-10#2)
glassy carbon electrode was##5##4##(2008-10#5)
glassy carbon electrode were##2##4##(2008-10#2)
glassy carbon electrode##103##3##(1990-12#1)(2008-10#102)
glassy carbon electrodes modified with##3##5##(2008-10#3)
glassy carbon electrodes##12##3##(2008-10#11)(2013-1#1)
glassy carbon##147##2##(1990-12#1)(2008-10#145)(2013-1#1)
glassy polymer##2##2##(1995-3#1)(2010-4#1)
glassy##153##1##(1990-12#1)(1995-3#2)(2008-10#147)(2010-4#2)(2013-1#1)
glatiramer acetate##2##2##(2010-12#1)(2012-3#1)
glauca##2##1##(2008-11#1)(2010-2#1)
glaucoma and##2##2##(2011-2#2)
glaucoma in##4##2##(2011-2#3)(2012-2#1)
glaucoma patients##4##2##(2009-9#1)(2011-2#3)
glaucoma progression##2##2##(2011-7#2)
glaucoma##39##1##(1990-11#3)(1997-8#1)(2009-9#1)(2011-2#29)(2011-7#3)(2012-2#1)(2013-1#1)
glaucomas##2##1##(2011-2#2)
glaucomatous damage##2##2##(2011-7#2)
glaucomatous##3##1##(2011-2#1)(2011-7#2)
glaze##2##1##(2008-10#2)
glazed##3##1##(2008-10#3)
glazes##4##1##(2008-10#4)
gld##2##1##(1997-8#2)
gleaned from##3##2##(1996-3#1)(2008-4#1)(2009-9#1)
gleaner##2##1##(2008-8#2)
glenoid fossa##2##2##(2011-2#2)
glia##8##1##(2008-5#2)(2008-7#3)(2009-8#1)(2009-9#1)(2013-7#1)
gliadin##3##1##(1991-12#1)(1992-12#2)
glial cell##5##2##(2008-11#1)(2009-8#3)(2012-2#1)
glial cells and##2##3##(2008-12#1)(2013-8#1)
glial cells are##2##3##(1994-11#1)(2008-11#1)
glial cells in the##3##4##(1994-2#1)(2008-11#1)(2012-2#1)
glial cells##19##2##(1994-11#3)(1994-2#1)(1995-12#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
glial fibrillary acidic protein (GFAP)##4##5##(1990-7#1)(1997-2#1)(1997-3#1)(2008-11#1)
glial fibrillary acidic protein##6##4##(1990-7#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-1#1)
glial##42##1##(1990-7#1)(1993-6#1)(1994-11#3)(1994-2#3)(1995-12#1)(1995-2#3)(1997-2#2)(1997-3#1)(2008-11#4)(2008-12#1)(2008-5#6)(2008-7#6)(2009-1#1)(2009-8#3)(2009-9#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
glial-precursor##2##1##(2008-7#1)(2013-1#1)
glibenclamide uptake was##2##3##(1992-3#2)
glibenclamide uptake##4##2##(1992-3#4)
glibenclamide was not##2##3##(1992-3#2)
glibenclamide was##3##2##(1992-3#3)
glibenclamide##21##1##(1992-3#13)(1994-11#1)(1994-8#7)
gliding##2##1##(2008-11#1)(2013-1#1)
glimepiride and glibenclamide##4##3##(1994-8#4)
glimepiride##6##1##(1994-8#6)
glimpse of the##2##3##(1994-12#1)(1994-3#1)
glimpse of##3##2##(1994-12#1)(1994-3#1)(1995-6#1)
glimpse##4##1##(1994-12#1)(1994-3#1)(1995-6#1)(2008-6#1)
glint##12##1##(2008-3#12)
glioblastoma cell lines##3##3##(1990-6#3)
glioblastoma in a##2##3##(2012-3#1)(2013-1#1)
glioblastoma multiforme##5##2##(1994-2#1)(2008-11#1)(2011-2#2)(2011-3#1)
glioblastoma##23##1##(1990-6#3)(1994-2#1)(2008-11#2)(2009-1#1)(2010-4#1)(2011-2#4)(2011-3#2)(2012-3#6)(2013-1#3)
glioblastomas##2##1##(1997-7#1)(2013-1#1)
glioblastomatous##3##1##(2009-1#3)
glioma cell lines##3##3##(1992-6#2)(1995-2#1)
glioma cell##6##2##(1992-6#3)(1995-2#1)(1997-7#1)(2011-2#1)
glioma cells##5##2##(1992-6#1)(1995-2#1)(1997-7#2)(2012-2#1)
glioma##34##1##(1992-6#4)(1993-9#1)(1995-2#4)(1997-7#3)(2008-11#1)(2008-7#2)(2008-8#2)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
gliomas are##2##2##(2013-1#1)(2013-8#1)
gliomas##13##1##(1993-9#1)(1994-6#1)(1995-2#1)(1997-7#1)(2008-5#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
gliosis and##2##2##(1996-12#1)(2008-7#1)
gliosis##6##1##(1990-7#1)(1996-12#1)(2008-7#3)(2013-7#1)
glisoxepide and glibenclamide##2##3##(1992-3#2)
glisoxepide and##3##2##(1992-3#3)
glisoxepide##11##1##(1992-3#11)
global AIDS##2##2##(1990-12#2)
global analysis and distribution analysis##2##5##(2008-10#2)
global analysis##3##2##(2008-10#2)(2011-2#1)
global and regional##3##3##(2008-3#1)(2012-2#1)(2013-3#1)
global and##7##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-3#1)
global budget##4##2##(1995-2#1)(2008-11#3)
global budgeting##7##2##(1993-1#3)(1993-2#2)(1994-1#1)(1994-2#1)
global budgets##7##2##(1991-12#1)(1994-1#2)(2008-11#4)
global climate change##4##3##(2008-10#1)(2008-11#1)(2010-8#1)(2013-8#1)
global distribution of##3##3##(2008-10#2)(2009-8#1)
global elimination##2##2##(2008-1#2)
global environment##2##2##(2010-7#1)(2012-7#1)
global estimates of##2##3##(2008-12#1)(2013-3#1)
global evaluation of efficacy##2##4##(1990-9#2)
global gene expression##4##3##(2008-11#1)(2009-12#1)(2011-2#2)
global gene##5##2##(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#2)
global genetic##2##2##(2008-10#2)
global health##7##2##(2008-10#1)(2009-6#2)(2011-3#1)(2012-12#2)(2012-3#1)
global level of##2##3##(2009-10#1)(2011-2#1)
global level##6##2##(2007-12#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
global network##2##2##(1995-6#1)(2009-4#1)
global objects##3##2##(2008-9#3)
global optimisation##2##2##(2008-10#2)
global pain##2##2##(2008-7#2)
global physical and general##2##4##(2009-7#2)
global positioning system##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
global positioning##4##2##(2008-10#2)(2009-10#1)(2011-2#1)
global primary##2##2##(2009-6#1)(2012-2#1)
global proteome##2##2##(2008-4#1)(2010-7#1)
global public health##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
global responses##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
global stability constant##2##3##(2008-10#2)
global value##2##2##(2008-9#2)
global view of gene##2##4##(2010-1#1)(2010-5#1)
global warming##7##2##(1992-3#1)(1996-1#1)(2008-12#1)(2012-5#2)(2012-6#1)(2012-8#1)
global world##2##2##(2008-11#1)(2008-3#1)
global##253##1##(1990-11#1)(1990-12#3)(1990-9#3)(1991-12#2)(1991-3#1)(1991-6#1)(1992-3#2)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#2)(1994-1#3)(1994-2#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-7#2)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#42)(2008-11#22)(2008-12#7)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#11)(2008-9#11)(2009-10#3)(2009-12#1)(2009-4#3)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#5)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-2#19)(2011-3#2)(2012-12#7)(2012-2#4)(2012-3#3)(2012-5#2)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#6)(2013-3#2)(2013-8#6)
global-local task##2##2##(2008-11#2)
globalisation##2##1##(2008-12#2)
globalization of the##2##3##(2007-12#1)(2008-11#1)
globalization##5##1##(2007-12#1)(2008-11#1)(2008-3#1)(2009-8#2)
globally and##2##2##(2008-10#1)(2009-9#1)
globally##24##1##(1990-8#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#3)
globe##7##1##(1990-11#1)(2008-10#2)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
globin gene##7##2##(1991-5#3)(2008-8#2)(2008-9#2)
globin##16##1##(1990-8#1)(1991-5#4)(2008-10#2)(2008-11#2)(2008-8#5)(2008-9#2)
globisporus C1027##2##2##(2008-9#2)
globosa was##2##2##(2008-5#2)
globosa##5##1##(2008-5#5)
globose##3##1##(2008-10#3)
globosum and##2##2##(2008-5#1)(2013-1#1)
globosum##6##1##(2008-5#1)(2013-1#5)
globular embryos##2##2##(2008-12#1)(2011-2#1)
globular protein##3##2##(1994-5#1)(1997-2#2)
globular state (diameter about##2##4##(2008-8#2)
globular##18##1##(1994-5#1)(1995-12#1)(1995-6#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2009-12#2)(2011-2#4)
globule##9##1##(2008-10#8)(2008-5#1)
globules##3##1##(2008-10#3)
globulin##11##1##(1990-2#1)(1991-3#3)(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-12#1)(2013-8#1)
globulins##4##1##(1990-8#1)(1991-12#1)(2008-10#1)(2008-5#1)
globulus and E##3##3##(2008-10#3)
globulus and##4##2##(2008-10#3)(2008-5#1)
globulus##5##1##(2008-10#4)(2008-5#1)
globus pallidus##3##2##(1996-12#1)(2008-7#1)(2012-2#1)
globus##4##1##(1996-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
gloeosporioides and##2##2##(2008-10#2)
gloeosporioides from citrus##2##3##(2008-10#2)
gloeosporioides from crowns##2##3##(2008-10#2)
gloeosporioides from##11##2##(2008-10#11)
gloeosporioides isolates from##2##3##(2008-10#2)
gloeosporioides or C##2##3##(2008-10#2)
gloeosporioides pathogenic on red pepper##2##5##(2008-10#2)
gloeosporioides subgroup that##2##3##(2008-10#2)
gloeosporioides were##2##2##(2008-10#2)
gloeosporioides##62##1##(2008-10#62)
gloeosporioides-specific primers##2##2##(2008-10#2)
gloeosporioides-specific##3##1##(2008-10#3)
glomerata##4##1##(2010-4#4)
glomerular and tubular##2##3##(1993-12#2)
glomerular and##3##2##(1993-12#2)(2007-12#1)
glomerular basement membrane##2##3##(1992-12#1)(1994-8#1)
glomerular basement##3##2##(1992-12#1)(1994-8#1)(2012-3#1)
glomerular diseases##2##2##(2012-2#2)
glomerular filtration rate and##2##4##(1996-6#2)
glomerular filtration rate##10##3##(1996-6#4)(2010-4#1)(2011-2#4)(2013-8#1)
glomerular filtration##12##2##(1996-6#4)(2010-4#1)(2011-2#5)(2012-2#1)(2013-8#1)
glomerular lesions##2##2##(1993-2#1)(1997-8#1)
glomerular mesangial cells##2##3##(1993-8#1)(2008-1#1)
glomerular##32##1##(1992-12#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-8#1)(1996-6#7)(1997-8#2)(2007-12#2)(2008-1#1)(2010-4#1)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
glomeruli##4##1##(2007-12#1)(2009-6#1)(2013-7#2)
glomerulonephritis (GN)##2##2##(1997-8#1)(2008-10#1)
glomerulonephritis and amyloidosis##3##3##(1997-5#1)(1997-8#1)(2012-2#1)
glomerulonephritis and##4##2##(1997-5#1)(1997-8#1)(2011-2#1)(2012-2#1)
glomerulonephritis##24##1##(1993-2#5)(1996-3#1)(1996-6#2)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#1)(2011-2#4)(2012-2#3)(2013-1#2)(2013-8#2)
glomerulonephritis]##3##1##(1991-2#1)(1994-3#1)(1996-6#1)
glomerulopathies and##2##2##(2013-1#1)(2013-8#1)
glomerulopathies##4##1##(2012-2#2)(2013-1#1)(2013-8#1)
glomerulopathy##5##1##(1992-6#1)(1996-6#1)(2008-1#1)(2013-8#2)
glomus tumors##6##2##(2013-1#6)
glomus##7##1##(2013-1#7)
glory##4##1##(2008-5#1)(2008-8#2)(2010-8#1)
glossopharyngeal##3##1##(2011-2#3)
glottic##2##1##(1993-9#1)(2013-1#1)
glove integrity test procedures and their ability to detect leaking gloves##2##11##(2012-2#2)
glove powder##2##2##(1995-3#2)
glove powder-treated HL-60##3##3##(1995-3#3)
glove powders##2##2##(1995-3#2)
glove##12##1##(1993-6#1)(1995-3#7)(2008-11#1)(2012-2#3)
gloves are##2##2##(1995-6#1)(2008-4#1)
gloves##18##1##(1995-6#7)(1996-11#1)(2008-4#1)(2012-2#9)
glow##4##1##(2008-10#3)(2008-3#1)
gluA##2##1##(2008-10#2)
gluB##2##1##(2008-10#2)
glucagon and##2##2##(2011-2#2)
glucagon in##2##2##(1996-2#1)(2008-3#1)
glucagon on##2##2##(1994-8#1)(1996-2#1)
glucagon receptor expression##3##3##(1994-11#3)
glucagon receptor##10##2##(1994-11#5)(1995-11#3)(2008-11#2)
glucagon receptors##3##2##(1994-11#1)(1995-11#2)
glucagon release##3##2##(1994-11#3)
glucagon secretion in rats##2##4##(1994-11#2)
glucagon secretion##4##2##(1991-7#1)(1994-11#3)
glucagon was##5##2##(1996-2#1)(2008-11#1)(2008-8#3)
glucagon##57##1##(1991-3#2)(1991-7#2)(1992-9#1)(1994-11#12)(1994-8#3)(1995-11#6)(1995-6#4)(1995-8#1)(1996-2#7)(1997-2#1)(2008-11#4)(2008-3#1)(2008-8#7)(2011-2#4)(2012-2#1)(2012-3#1)
glucagon)##2##1##(2008-1#1)(2008-11#1)
glucagon-degrading activity##2##2##(1995-6#2)
glucagon-induced##4##1##(1994-8#1)(1996-2#3)
glucagon-like peptide 1##2##3##(1994-11#1)(2012-3#1)
glucagon-like peptide-1 (GLP-1)##2##3##(1995-8#1)(1996-2#1)
glucagon-like peptide-1##6##2##(1994-8#1)(1995-8#1)(1996-2#2)(2011-2#2)
glucagon-like##8##1##(1994-11#1)(1994-8#1)(1995-8#1)(1996-2#2)(2011-2#2)(2012-3#1)
glucanase##4##1##(2008-10#4)
glucanases##2##1##(2008-10#2)
glucoamylase gene##2##2##(2008-5#1)(2008-9#1)
glucoamylase##11##1##(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#1)
glucocerebrosidase##4##1##(1994-5#1)(1997-7#3)
glucocorticoid deficiency##3##2##(2011-1#3)
glucocorticoid receptor##16##2##(1990-11#6)(1991-12#1)(1995-12#1)(1995-2#2)(1996-12#4)(2008-11#2)
glucocorticoid receptors##9##2##(1991-12#2)(1994-2#2)(1995-12#3)(2008-6#1)(2009-6#1)
glucocorticoid##42##1##(1990-11#6)(1991-12#4)(1991-5#1)(1993-5#1)(1994-2#2)(1995-12#6)(1995-2#2)(1995-8#1)(1996-12#4)(1997-1#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#4)(2013-7#1)
glucocorticoids (GC)##2##2##(2008-7#1)(2013-1#1)
glucocorticoids are##3##2##(1996-12#1)(1997-1#1)(2008-7#1)
glucocorticoids in the##2##3##(2008-11#2)
glucocorticoids in##3##2##(2008-11#2)(2008-8#1)
glucocorticoids##21##1##(1990-11#1)(1995-12#3)(1996-12#3)(1996-2#1)(1997-1#1)(2008-11#5)(2008-7#2)(2008-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
glucomannan##5##1##(2008-10#3)(2011-2#2)
gluconeogenesis in##3##2##(1991-3#1)(1994-8#2)
gluconeogenesis##20##1##(1991-3#4)(1994-5#2)(1994-8#8)(1995-8#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-3#1)(2012-2#1)
gluconeogenic and##2##2##(1994-8#1)(2008-11#1)
gluconeogenic enzymes##2##2##(1994-8#2)
gluconeogenic flux##2##2##(1995-8#2)
gluconeogenic##9##1##(1991-3#2)(1994-8#3)(1995-8#2)(2008-11#1)(2011-1#1)
gluconic acid##8##2##(2008-10#7)(2010-4#1)
gluconic##10##1##(2008-10#9)(2010-4#1)
glucosamine##5##1##(1991-3#1)(1994-8#1)(2008-2#1)(2010-9#1)(2011-2#1)
glucosaminidase##2##1##(1993-12#1)(2012-2#1)
glucose &lt##2##2##(2010-2#1)(2012-5#1)
glucose (0##2##2##(1990-5#1)(2008-10#1)
glucose (1##2##2##(2008-11#2)
glucose (S/N=3)##2##2##(2008-10#2)
glucose 6-phosphate##2##2##(1996-6#1)(2008-10#1)
glucose agar##3##2##(2008-10#1)(2008-5#2)
glucose and ATP##2##3##(1991-5#1)(2008-10#1)
glucose and GLP##2##3##(1995-8#2)
glucose and H(2)O(2)##2##3##(2008-10#2)
glucose and ascorbic acid##2##4##(2008-10#2)
glucose and ethanol##5##3##(2008-10#5)
glucose and fatty acid##2##4##(2008-1#1)(2012-2#1)
glucose and fructose in the##2##5##(1990-2#1)(2008-10#1)
glucose and fructose##3##3##(1990-2#1)(2008-10#2)
glucose and galactose##4##3##(2008-10#1)(2013-1#3)
glucose and glucagon##2##3##(1994-8#2)
glucose and glutamine concentrations##2##4##(2008-11#2)
glucose and glutamine metabolism##4##4##(2008-11#4)
glucose and glutamine##13##3##(2008-11#12)(2008-7#1)
glucose and insulin concentrations were##2##5##(2010-8#2)
glucose and insulin concentrations##3##4##(2010-10#1)(2010-8#2)
glucose and insulin were##2##4##(1991-2#1)(2010-8#1)
glucose and insulin##7##3##(1991-2#1)(2010-10#1)(2010-8#4)(2012-5#1)
glucose and lipid metabolism##2##4##(1994-12#1)(2008-7#1)
glucose and lipid##4##3##(1994-12#2)(2008-7#1)(2010-10#1)
glucose and oxygen##2##3##(2008-11#1)(2009-11#1)
glucose and sucrose##2##3##(2008-9#1)(2010-11#1)
glucose and the##3##3##(1994-5#1)(2008-10#2)
glucose and urea##3##3##(2008-11#3)
glucose and##96##2##(1990-2#1)(1991-2#1)(1991-5#1)(1993-3#1)(1994-12#4)(1994-5#2)(1994-8#2)(1995-8#3)(1996-11#1)(1996-3#1)(2008-1#1)(2008-10#28)(2008-11#21)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-2#1)(2012-4#1)(2012-5#1)(2013-1#4)(2013-8#1)
glucose as well as##2##4##(2008-10#1)(2012-3#1)
glucose as##3##2##(2008-10#2)(2012-3#1)
glucose assay##2##2##(2008-10#2)
glucose at##3##2##(2008-10#3)
glucose biosensor based on##3##4##(2008-10#3)
glucose biosensor was##2##3##(2008-10#2)
glucose biosensor with##2##3##(2008-10#2)
glucose biosensor##18##2##(2008-10#17)(2009-10#1)
glucose biosensors based on##2##4##(2008-10#2)
glucose biosensors##8##2##(2008-10#8)
glucose but##2##2##(2008-10#1)(2008-11#1)
glucose by##6##2##(1992-6#1)(1993-8#1)(2008-10#4)
glucose concentration at##2##3##(1991-7#1)(1993-1#1)
glucose concentration in the##2##4##(1992-9#1)(2008-10#1)
glucose concentration of##3##3##(2008-10#2)(2008-5#1)
glucose concentration on##2##3##(1992-6#1)(1994-2#1)
glucose concentration range of##2##4##(2008-10#1)(2008-11#1)
glucose concentration up to##2##4##(1992-12#1)(2008-10#1)
glucose concentration was##3##3##(2008-10#2)(2008-11#1)
glucose concentration##36##2##(1991-7#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-2#4)(2008-10#13)(2008-11#6)(2008-5#1)(2008-7#1)(2009-8#2)(2010-10#2)
glucose concentrations were##2##3##(1993-1#1)(1996-2#1)
glucose concentrations##10##2##(1990-5#1)(1993-1#2)(1994-11#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-5#1)(2010-10#1)(2013-8#1)
glucose consumption and lactate production##2##5##(2008-11#2)
glucose consumption rate##5##3##(2008-11#5)
glucose consumption##11##2##(2008-11#11)
glucose content##3##2##(2008-10#3)
glucose control in##3##3##(2010-12#1)(2011-2#1)(2012-5#1)
glucose control##4##2##(2009-10#1)(2010-12#1)(2011-2#1)(2012-5#1)
glucose could be##2##3##(2008-10#2)
glucose could##3##2##(1992-8#1)(2008-10#2)
glucose dehydrogenase##3##2##(2008-10#3)
glucose depletion##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
glucose detection##3##2##(2008-10#3)
glucose determination in drinks##2##4##(2008-10#2)
glucose determination in##6##3##(2008-10#6)
glucose determination##11##2##(1995-3#1)(2008-10#10)
glucose determinations##2##2##(2008-1#2)
glucose disposal##2##2##(1992-6#1)(2008-3#1)
glucose for##5##2##(1995-8#1)(2008-10#2)(2008-11#1)(2010-10#1)
glucose has been##2##3##(1994-12#1)(2008-10#1)
glucose homeostasis##4##2##(1991-7#1)(2008-1#2)(2010-12#1)
glucose in a##2##3##(2008-10#2)
glucose in blood##2##3##(2008-10#2)
glucose in the presence of##3##5##(2008-10#2)(2008-7#1)
glucose in the##10##3##(1991-10#1)(1994-8#1)(2008-10#7)(2008-7#1)
glucose in##33##2##(1990-3#1)(1991-10#1)(1994-12#1)(1994-8#3)(1995-8#1)(2008-10#23)(2008-11#1)(2008-7#1)(2008-9#1)
glucose induced##2##2##(2008-9#1)(2010-11#1)
glucose is##3##2##(1991-7#1)(2008-10#1)(2011-1#1)
glucose level##8##2##(1993-11#1)(2008-1#1)(2008-10#3)(2011-3#1)(2012-2#2)
glucose levels can##2##3##(2008-11#1)(2012-5#1)
glucose levels in##4##3##(2008-10#3)(2010-11#1)
glucose levels were##4##3##(2008-10#3)(2012-3#1)
glucose levels##28##2##(1991-7#2)(1994-12#2)(1997-2#1)(2008-10#11)(2008-11#1)(2008-7#1)(2010-11#4)(2010-2#1)(2011-2#1)(2012-3#2)(2012-5#2)
glucose media##2##2##(2012-5#2)
glucose metabolism in##3##3##(1993-11#1)(1994-3#1)(2013-8#1)
glucose metabolism##11##2##(1991-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1996-2#2)(2008-1#1)(2008-11#1)(2008-3#1)(2013-7#1)(2013-8#1)
glucose monitoring##8##2##(2008-1#2)(2008-10#1)(2010-2#2)(2012-4#2)(2012-5#1)
glucose on##2##2##(2008-7#1)(2010-11#1)
glucose or##7##2##(1991-12#2)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
glucose oxidase (GOD)##4##3##(2008-10#4)
glucose oxidase (GOx) and##2##4##(2008-10#2)
glucose oxidase (GOx)##5##3##(2008-10#5)
glucose oxidase immobilized on##4##4##(2008-10#4)
glucose oxidase in##2##3##(2008-10#2)
glucose oxidase was immobilized##2##4##(2008-10#2)
glucose oxidase was##4##3##(2008-10#4)
glucose oxidase##46##2##(2008-10#45)(2009-10#1)
glucose phosphate isomerase##2##3##(1997-6#2)
glucose production by##3##3##(1994-11#1)(1994-8#2)
glucose production##9##2##(1991-7#2)(1993-8#2)(1994-11#1)(1994-8#2)(2008-1#2)
glucose pulses##2##2##(2008-6#2)
glucose reduced##3##2##(2010-11#1)(2012-4#2)
glucose regulation##2##2##(2008-10#1)(2008-11#1)
glucose response##2##2##(2008-10#1)(2008-11#1)
glucose sensing##4##2##(2008-10#2)(2008-11#2)
glucose sensor##5##2##(2008-10#5)
glucose sensors##3##2##(2008-10#3)
glucose starvation##9##2##(2008-11#5)(2008-7#3)(2010-10#1)
glucose to##7##2##(1991-7#1)(1995-8#4)(2008-10#1)(2008-12#1)
glucose tolerance test##5##3##(1994-12#1)(2008-10#2)(2011-1#1)(2012-12#1)
glucose tolerance##16##2##(1994-12#4)(1995-11#1)(1995-12#1)(2008-10#2)(2008-3#1)(2010-10#2)(2011-1#2)(2012-12#1)(2012-3#2)
glucose transfer in the rat jejunum##2##6##(1991-5#2)
glucose transfer##4##2##(1991-5#4)
glucose transport in##2##3##(2008-1#1)(2008-7#1)
glucose transport into L6 myotubes##2##5##(1994-11#2)
glucose transport into L6##3##4##(1994-11#3)
glucose transport into skeletal muscle##2##5##(2008-1#1)(2008-3#1)
glucose transport into##6##3##(1994-11#3)(2008-1#2)(2008-3#1)
glucose transport##11##2##(1994-11#4)(1997-1#1)(2008-1#3)(2008-3#2)(2008-7#1)
glucose transporter 1##2##3##(1993-8#2)
glucose transporter##10##2##(1993-8#4)(1994-11#2)(1994-2#1)(2008-11#2)(2008-7#1)
glucose transporters##4##2##(1990-11#1)(1994-2#1)(2008-7#2)
glucose uptake and##3##3##(2008-1#1)(2008-11#2)
glucose uptake in##6##3##(1993-8#1)(2008-11#3)(2008-8#2)
glucose uptake##23##2##(1991-7#1)(1993-8#1)(2008-1#2)(2008-10#1)(2008-11#14)(2008-7#1)(2008-8#3)
glucose utilization rate##2##3##(2008-11#1)(2008-7#1)
glucose utilization##9##2##(1991-7#2)(1994-8#5)(2008-11#1)(2008-7#1)
glucose variability##5##2##(2012-4#4)(2012-5#1)
glucose was##15##2##(1993-1#1)(1995-6#1)(1995-8#1)(2008-10#8)(2008-11#3)(2009-11#1)
glucose with##5##2##(1992-6#1)(1994-12#1)(2008-10#3)
glucose##761##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#6)(1991-7#13)(1992-12#5)(1992-6#7)(1992-8#5)(1992-9#2)(1993-1#5)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#10)(1994-11#10)(1994-12#20)(1994-2#7)(1994-3#1)(1994-5#3)(1994-8#17)(1995-11#4)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#20)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-6#2)(2008-1#20)(2008-10#288)(2008-11#95)(2008-12#5)(2008-3#5)(2008-5#10)(2008-6#3)(2008-7#31)(2008-8#6)(2008-9#6)(2009-10#3)(2009-11#3)(2009-6#1)(2009-8#2)(2010-10#11)(2010-11#14)(2010-12#3)(2010-2#8)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#5)(2011-1#7)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#7)(2012-4#15)(2012-5#11)(2013-1#9)(2013-7#2)(2013-8#3)
glucose)##4##1##(1991-5#1)(1992-9#1)(2008-10#2)
glucose-6-P##2##1##(1991-5#1)(2013-1#1)
glucose-6-phosphatase activity and##2##3##(1994-11#2)
glucose-6-phosphatase activity in##2##3##(1993-8#1)(1994-11#1)
glucose-6-phosphatase activity##9##2##(1993-8#3)(1994-11#6)
glucose-6-phosphatase and##2##2##(1993-8#1)(2008-7#1)
glucose-6-phosphatase mRNA##2##2##(1994-11#2)
glucose-6-phosphatase##15##1##(1993-8#5)(1994-11#9)(2008-7#1)
glucose-6-phosphate dehydrogenase and the##2##4##(1991-5#1)(2008-10#1)
glucose-6-phosphate dehydrogenase and##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
glucose-6-phosphate dehydrogenase deficiency##2##3##(1990-2#1)(2007-12#1)
glucose-6-phosphate dehydrogenase##9##2##(1990-2#1)(1991-5#2)(1995-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2013-1#1)
glucose-6-phosphate isomerase and peptidase##3##4##(2008-10#3)
glucose-6-phosphate isomerase##6##2##(2008-10#6)
glucose-6-phosphate##18##1##(1990-2#1)(1991-5#2)(1991-6#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-10#8)(2008-11#1)(2013-1#1)
glucose-free buffer##2##2##(1995-8#2)
glucose-free##7##1##(1995-8#7)
glucose-oxidase##2##1##(2008-10#2)
glucose-starved##3##1##(2008-11#2)(2010-10#1)
glucose-stimulated insulin release##2##3##(1994-11#1)(2008-11#1)
glucose-stimulated insulin##3##2##(1994-11#1)(2008-11#2)
glucose-stimulated##4##1##(1994-11#1)(2008-11#3)
glucose-to-cell yield increased and##2##4##(2008-11#2)
glucose-to-lactate yield decreased##2##3##(2008-11#2)
glucosidase##3##1##(1993-8#1)(2008-10#2)
glucoside##5##1##(2008-11#4)(2008-5#1)
glucosinolate containing##2##2##(2008-10#2)
glucosinolate content##2##2##(2008-10#2)
glucosinolate##9##1##(2008-10#8)(2008-9#1)
glucosyl-3-phosphoglycerate phosphatase##2##2##(2012-2#2)
glucosyl-3-phosphoglycerate##5##1##(2012-2#5)
glucuronic acid##2##2##(2008-10#2)
glucuronidation of##2##2##(2008-11#2)
glucuronidation##6##1##(2008-11#5)(2013-8#1)
glucuronide##4##1##(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
glucuronides and##2##2##(2008-11#1)(2010-6#1)
glucuronides##3##1##(2008-11#1)(2010-6#2)
glue##13##1##(1992-3#2)(1992-5#1)(1996-3#1)(1997-3#5)(1997-6#2)(2008-10#1)(2012-12#1)
glued##2##1##(1997-3#2)
glues##4##1##(2008-10#2)(2012-3#1)(2013-1#1)
gluing##2##1##(1997-3#1)(2010-10#1)
glume##4##1##(2008-10#4)
glutamate and##7##2##(1991-12#1)(2008-11#1)(2008-7#4)(2008-8#1)
glutamate as##2##2##(2008-11#1)(2008-7#1)
glutamate concentrations##2##2##(1994-2#1)(2008-7#1)
glutamate decarboxylase##2##2##(1996-12#2)
glutamate dehydrogenase and##2##3##(2008-11#1)(2013-1#1)
glutamate dehydrogenase##13##2##(1993-2#1)(1995-11#1)(1995-3#1)(1997-1#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-8#1)(2013-1#1)
glutamate in the##3##3##(1994-2#1)(2008-7#2)
glutamate in##4##2##(1994-2#1)(2008-11#1)(2008-7#2)
glutamate levels##2##2##(2008-11#2)
glutamate neurotoxicity##5##2##(2008-7#5)
glutamate receptor##17##2##(1993-8#4)(1994-11#1)(1995-11#1)(1995-12#3)(1995-2#3)(2008-11#3)(2008-7#1)(2008-8#1)
glutamate receptors##17##2##(1994-8#1)(1995-11#4)(1995-12#2)(1995-2#3)(1996-12#3)(1996-2#1)(1997-2#1)(1997-7#1)(2009-7#1)
glutamate release##2##2##(2008-7#1)(2009-8#1)
glutamate residue##2##2##(1997-7#1)(2011-1#1)
glutamate synthase##4##2##(1997-1#2)(2008-8#2)
glutamate toxicity against dopaminergic neurons##2##5##(2008-7#2)
glutamate toxicity against##3##3##(2008-7#3)
glutamate toxicity##5##2##(2008-7#5)
glutamate transporter##5##2##(1995-11#1)(1996-2#3)(2008-7#1)
glutamate transporters##5##2##(2008-7#4)(2008-8#1)
glutamate was##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
glutamate with##2##2##(1997-1#1)(2008-7#1)
glutamate##142##1##(1991-11#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-8#6)(1993-9#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-11#8)(1995-12#5)(1995-2#6)(1995-3#1)(1996-12#6)(1996-2#4)(1997-1#6)(1997-2#1)(1997-3#2)(1997-7#2)(2008-10#9)(2008-11#21)(2008-4#2)(2008-7#37)(2008-8#8)(2009-7#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
glutamate-free medium##2##2##(2008-11#2)
glutamate-induced##3##1##(2008-11#2)(2008-7#1)
glutamate-mediated##3##1##(2008-7#3)
glutamatergic axon terminals##2##3##(2008-7#2)
glutamatergic inputs##2##2##(2012-2#2)
glutamatergic synapses##2##2##(1997-7#1)(2012-2#1)
glutamatergic##23##1##(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-7#14)(2012-12#1)(2012-2#3)
glutamic acid and##4##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
glutamic acid by##3##3##(1990-10#1)(2008-10#2)
glutamic acid on##3##3##(1990-10#1)(2008-10#2)
glutamic acid##24##2##(1990-10#2)(1990-2#1)(1993-8#1)(1994-8#1)(1995-6#2)(2008-10#11)(2008-12#2)(2008-5#2)(2011-2#1)(2013-8#1)
glutamic##30##1##(1990-10#2)(1990-2#1)(1991-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-6#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-5#3)(2010-6#1)(2011-2#1)(2013-8#1)
glutamicum to##2##2##(2008-7#2)
glutamicum##5##1##(2008-7#5)
glutaminase##3##1##(1990-7#1)(2008-11#2)
glutamine and serine##3##3##(2008-11#3)
glutamine and##12##2##(1993-8#1)(1994-8#1)(2008-11#10)
glutamine concentration##3##2##(2008-11#3)
glutamine consumption##5##2##(2008-11#5)
glutamine in the##2##3##(2008-11#2)
glutamine in##3##2##(1995-3#1)(2008-11#2)
glutamine metabolism##6##2##(2008-11#6)
glutamine synthetase (GS)##3##3##(2008-11#2)(2008-7#1)
glutamine synthetase expression##2##3##(1996-12#2)
glutamine synthetase gene##2##3##(1996-12#1)(2008-11#1)
glutamine synthetase in##2##3##(1996-12#1)(2008-11#1)
glutamine synthetase##17##2##(1996-12#6)(1997-1#2)(2008-11#7)(2008-7#1)(2009-8#1)
glutamine to##2##2##(1993-8#1)(2008-10#1)
glutamine##104##1##(1990-7#1)(1993-3#1)(1993-8#5)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#6)(1997-1#3)(2008-10#3)(2008-11#75)(2008-5#1)(2008-7#4)(2009-8#1)(2013-8#1)
glutamine)##3##1##(2008-11#3)
glutamine-free##3##1##(2008-11#2)(2008-7#1)
glutaminesynthetase##2##1##(2008-11#2)
glutamyl##4##1##(1990-2#1)(1995-6#1)(2007-12#1)(2009-6#1)
glutaraldehyde (0##2##2##(1990-12#1)(2008-10#1)
glutaraldehyde (GA) vapour##2##3##(2008-10#2)
glutaraldehyde (GA)##3##2##(2008-10#3)
glutaraldehyde and fixed on a pretreated teflon membrane##2##8##(2008-10#2)
glutaraldehyde and fixed on a pretreated##3##6##(2008-10#3)
glutaraldehyde and fixed on##4##4##(2008-10#4)
glutaraldehyde and##8##2##(2008-10#7)(2008-11#1)
glutaraldehyde in##3##2##(2008-10#2)(2009-10#1)
glutaraldehyde on##2##2##(2008-10#2)
glutaraldehyde vapours##2##2##(2008-10#2)
glutaraldehyde##53##1##(1990-12#2)(1992-12#1)(1997-2#1)(2008-10#40)(2008-11#1)(2008-5#6)(2009-10#1)(2011-2#1)
glutaric dialdehyde##2##2##(1993-8#1)(2008-10#1)
glutaric##4##1##(1993-8#1)(2008-10#3)
glutathione (GSH) and glutathione disulfide##2##5##(2008-10#1)(2008-11#1)
glutathione (GSH) or##2##3##(1992-9#1)(2008-10#1)
glutathione (GSH)##19##2##(1990-12#1)(1990-2#2)(1992-9#1)(1993-8#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
glutathione S-conjugate##2##2##(1995-2#1)(2008-11#1)
glutathione S-transferase (GST)##2##3##(1993-2#1)(2010-5#1)
glutathione S-transferase fusion##2##3##(1995-6#2)
glutathione S-transferase##11##2##(1992-6#1)(1993-2#2)(1995-2#1)(1995-6#4)(1995-8#1)(2008-10#1)(2010-5#1)
glutathione S-transferases##2##2##(1990-2#2)
glutathione and glutathione disulfide in##3##5##(2008-10#3)
glutathione and##10##2##(1993-6#1)(1995-8#1)(2008-10#5)(2008-11#1)(2012-2#1)(2013-1#1)
glutathione at##2##2##(2008-10#2)
glutathione disulfide (GSSG)##2##3##(2008-10#1)(2008-11#1)
glutathione disulfide##6##2##(2008-10#5)(2008-11#1)
glutathione in##5##2##(2008-10#5)
glutathione level##2##2##(2008-7#1)(2012-2#1)
glutathione peroxidase##7##2##(1990-3#3)(1992-9#1)(1997-5#1)(2009-10#1)(2011-2#1)
glutathione reductase and##2##3##(1992-1#1)(1993-3#1)
glutathione reductase##9##2##(1992-1#3)(1993-3#1)(2008-10#1)(2008-11#3)(2010-5#1)
glutathione##128##1##(1990-12#4)(1990-2#6)(1990-3#3)(1990-5#1)(1992-1#3)(1992-12#2)(1992-6#1)(1992-9#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1995-2#5)(1995-6#6)(1995-8#2)(1997-5#1)(2008-10#47)(2008-11#13)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-5#4)(2011-2#1)(2012-2#5)(2013-1#2)
glutathione-S-transferase##2##1##(1995-5#1)(2011-10#1)
gluteal region##4##2##(1992-2#1)(2009-9#1)(2011-2#2)
gluteal##5##1##(1992-2#1)(2009-9#1)(2011-2#2)(2013-1#1)
gluten proteins and##2##3##(1991-12#1)(2011-2#1)
gluten##6##1##(1991-12#1)(1991-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
gluten-free diet##6##2##(1991-2#4)(2011-2#2)
glutenin##2##1##(1991-12#2)
glutinis PM4##5##2##(2008-10#5)
glutinis##12##1##(2008-10#12)
glutinosa##8##1##(2008-10#8)
glutinous cultivars##3##2##(2008-10#3)
glutinous##7##1##(2008-10#7)
glycaemia##2##1##(1993-9#1)(2012-3#1)
glycaemic control##4##2##(1992-9#3)(1993-2#1)
glycan chains##3##2##(1994-5#3)
glycan structures##2##2##(1992-9#1)(2008-11#1)
glycan units##2##2##(1994-5#2)
glycan##13##1##(1991-12#1)(1992-9#1)(1994-5#6)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)
glycans are##2##2##(1991-9#1)(2008-1#1)
glycans in##3##2##(1991-12#1)(2008-5#1)(2010-11#1)
glycans##10##1##(1990-5#1)(1991-12#1)(1991-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-11#2)(2012-3#1)
glycated##4##1##(1991-5#2)(1992-11#1)(1992-12#1)
glycation end products and##2##4##(2008-1#1)(2008-7#1)
glycation end products##4##3##(2008-1#1)(2008-7#2)(2010-10#1)
glycation of##2##2##(1991-12#1)(1991-5#1)
glycation##8##1##(1991-12#1)(1991-5#1)(1992-12#2)(2008-1#1)(2008-7#2)(2010-10#1)
glycemia##4##1##(2008-1#2)(2008-10#2)
glycemic control and##2##3##(2008-3#1)(2012-2#1)
glycemic control##7##2##(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-4#1)(2012-5#1)
glycemic index and##3##3##(2008-1#2)(2013-8#1)
glycemic index##5##2##(2008-1#4)(2013-8#1)
glycemic load##4##2##(2008-1#3)(2013-8#1)
glycemic potential##2##2##(2008-10#2)
glycemic status##4##2##(2012-2#4)
glycemic variability##3##2##(2012-5#3)
glycemic##29##1##(2008-1#7)(2008-10#2)(2008-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#5)(2012-4#1)(2012-5#6)(2013-8#2)
glyceollin##2##1##(2008-10#2)
glyceraldehyde 3-phosphate dehydrogenase##3##3##(1994-8#1)(1996-12#1)(2008-10#1)
glyceraldehyde 3-phosphate##4##2##(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)
glyceraldehyde##7##1##(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-7#3)
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)##2##3##(1992-6#1)(1994-5#1)
glyceraldehyde-3-phosphate dehydrogenase##6##2##(1992-6#2)(1994-5#2)(1995-11#1)(2008-10#1)
glyceraldehyde-3-phosphate dehydrogenase-encoding gene##2##3##(1993-6#2)
glyceraldehyde-3-phosphate##8##1##(1992-6#2)(1993-6#2)(1994-5#2)(1995-11#1)(2008-10#1)
glycerin##7##1##(2008-5#7)
glycerine##4##1##(2008-10#2)(2008-5#2)
glycerol is##3##2##(2008-10#2)(2008-11#1)
glycerol or##4##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
glycerol was##2##2##(2008-11#1)(2008-7#1)
glycerol##43##1##(1990-11#2)(1990-2#1)(1991-1#1)(1991-3#1)(1994-5#1)(1994-8#2)(1995-11#2)(1996-8#1)(2008-10#13)(2008-11#8)(2008-2#1)(2008-5#2)(2008-7#6)(2008-8#1)(2012-2#1)
glycerophosphoinositol##5##1##(1990-8#2)(2012-12#1)(2013-8#2)
glyceryl##2##1##(2008-5#1)(2008-8#1)
glycidyl methacrylate (GMA) and ethylene##2##5##(2008-10#2)
glycinal diethylacetal##5##2##(1990-12#5)
glycinal##6##1##(1990-12#6)
glycinamide ribonucleotide synthetase##2##3##(1993-12#2)
glycinamide ribonucleotide##3##2##(1993-12#3)
glycinamide##5##1##(1993-12#3)(1994-8#2)
glycine (F3MBAG)##2##2##(1994-8#2)
glycine alone##3##2##(1997-1#1)(1997-2#1)(1997-3#1)
glycine and GABA##4##3##(1995-2#1)(1997-2#3)
glycine and arginine##2##3##(2008-10#2)
glycine and lysine##2##3##(1996-2#1)(2008-12#1)
glycine and##15##2##(1992-10#1)(1995-2#2)(1996-2#2)(1997-1#1)(1997-2#4)(1997-3#1)(2008-10#3)(2008-12#1)
glycine precipitation##2##2##(2008-10#2)
glycine receptor##3##2##(1996-2#3)
glycine receptors##3##2##(1995-11#3)
glycine residue in##2##3##(1994-5#1)(1995-2#1)
glycine synthesis##2##2##(1992-10#2)
glycine was the##2##3##(1997-1#2)
glycine##78##1##(1990-2#1)(1992-10#4)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#4)(1995-11#5)(1995-2#3)(1996-2#5)(1996-5#1)(1997-1#13)(1997-2#7)(1997-3#4)(1997-8#1)(2008-10#16)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-1#1)
glycine(463 and 701)##2##3##(1996-2#2)
glycine)##3##1##(2008-10#3)
glycine- and##2##2##(1997-2#1)(2010-5#1)
glycine-serine interconversion##2##2##(1997-1#2)
glycinea MAFF301683##2##2##(2008-10#2)
glycinea and phaseolicola##2##3##(2008-10#2)
glycinea##11##1##(2008-10#11)
glycinebetaine##4##1##(1997-4#4)
glycinergic##3##1##(1995-11#1)(1995-2#1)(1997-2#1)
glycines and F##2##3##(2008-10#2)
glycines and Heterodera glycines in##2##5##(2008-10#2)
glycines and##8##2##(2008-10#8)
glycines did not##2##3##(2008-10#2)
glycines in vitro##2##3##(2008-10#2)
glycines in##6##2##(2008-10#6)
glycines populations##4##2##(2008-10#4)
glycines was##2##2##(2008-10#2)
glycines were determined from##2##4##(2008-10#2)
glycines were##8##2##(2008-10#8)
glycines##68##1##(2008-10#68)
glycitein##2##1##(2010-1#2)
glycoalkaloids##8##1##(2008-10#7)(2008-9#1)
glycoconjugates##3##1##(1995-2#1)(2008-10#1)(2010-11#1)
glycoform distribution##2##2##(2008-7#2)
glycoform##6##1##(2008-7#5)(2011-2#1)
glycoforms were##2##2##(2008-11#1)(2009-8#1)
glycoforms##6##1##(2008-11#2)(2008-7#2)(2009-8#2)
glycogen and##2##2##(1994-3#1)(2008-10#1)
glycogen by light scattering technique##2##5##(2008-10#2)
glycogen by##3##2##(1993-8#1)(2008-10#2)
glycogen content##2##2##(1993-8#2)
glycogen in##3##2##(1995-8#2)(2008-10#1)
glycogen storage##2##2##(2012-2#2)
glycogen synthesis##2##2##(1992-6#1)(2012-2#1)
glycogen##42##1##(1990-2#3)(1992-6#1)(1993-8#7)(1994-3#1)(1994-8#1)(1995-8#3)(1996-2#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2012-2#5)(2013-1#1)(2013-8#1)
glycogen)##2##1##(1990-2#1)(1994-3#1)
glycol and##7##2##(1991-5#2)(2008-10#2)(2008-11#3)
glycol chitosan##2##2##(2008-10#2)
glycol dimethacrylate##3##2##(2008-10#2)(2013-1#1)
glycol donor##2##2##(2008-4#2)
glycol##57##1##(1990-12#2)(1991-5#6)(1992-11#1)(1995-3#1)(1997-5#1)(2008-10#26)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-9#1)(2012-3#2)(2013-1#1)
glycol)##11##1##(1993-6#1)(1993-8#1)(2008-10#3)(2008-4#1)(2009-5#1)(2010-6#1)(2013-1#3)
glycolate oxidase##2##2##(1997-7#1)(2008-8#1)
glycolate##3##1##(1997-7#2)(2008-8#1)
glycolic##5##1##(2008-10#4)(2008-5#1)
glycolipid##4##1##(1990-5#2)(1990-9#1)(2008-11#1)
glycolipids##6##1##(2008-11#5)(2012-2#1)
glycols)##2##1##(2008-10#2)
glycolysis and kreb cycle##3##4##(2010-7#3)
glycolysis and##4##2##(2008-11#1)(2010-7#3)
glycolysis##14##1##(1994-11#1)(1994-2#1)(1997-6#2)(2008-11#3)(2008-5#1)(2010-11#1)(2010-7#3)(2013-1#1)(2013-8#1)
glycolytic activity##3##2##(1992-9#1)(2008-11#1)(2013-1#1)
glycolytic enzymes##4##2##(1994-8#2)(1996-3#2)
glycolytic intermediates##4##2##(1996-6#1)(1997-1#3)
glycolytic pathway##5##2##(1996-6#1)(2008-11#2)(2008-7#2)
glycolytic##25##1##(1992-9#1)(1993-6#1)(1994-3#1)(1994-8#3)(1996-3#2)(1996-6#6)(1997-1#3)(2008-11#3)(2008-7#3)(2013-1#2)
glycopeptide##10##1##(1990-5#4)(1990-8#3)(2008-10#2)(2008-8#1)
glycopeptides##4##1##(1990-5#1)(1992-6#1)(2010-11#1)(2011-2#1)
glycophorin A##3##2##(1991-5#2)(1994-5#1)
glycophorin alpha##4##2##(1992-11#4)
glycophorin##11##1##(1991-5#4)(1992-11#4)(1994-5#1)(2008-9#2)
glycoprotein E##2##2##(2011-2#2)
glycoprotein IIb-IIIa complex##2##3##(1990-5#2)
glycoprotein IIb-IIIa##4##2##(1990-5#3)(2006-6#1)
glycoprotein Ib##2##2##(1994-11#2)
glycoprotein and##4##2##(1991-9#1)(1993-11#1)(1994-8#1)(2013-8#1)
glycoprotein can##2##2##(2008-7#2)
glycoprotein elicitor##2##2##(2008-10#2)
glycoprotein glycans##2##2##(2008-1#1)(2010-11#1)
glycoprotein hormones##3##2##(1990-4#1)(1991-3#1)(1995-8#1)
glycoprotein in##2##2##(1991-12#1)(2008-11#1)
glycoprotein is##2##2##(1992-6#1)(1994-8#1)
glycoprotein of##3##2##(1994-5#1)(1996-12#1)(2008-10#1)
glycoprotein produced##2##2##(2008-11#2)
glycoprotein synthesis##2##2##(1993-6#1)(1996-12#1)
glycoprotein that is##2##3##(2009-4#1)(2013-1#1)
glycoprotein that##3##2##(2008-4#1)(2009-4#1)(2013-1#1)
glycoprotein with##2##2##(1990-5#1)(2008-4#1)
glycoprotein##85##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#5)(1991-11#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#5)(1994-5#2)(1994-8#3)(1995-12#1)(1995-6#2)(1995-8#2)(1996-12#4)(1996-2#1)(1996-3#1)(1997-2#2)(2006-6#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-4#3)(2008-7#7)(2009-4#1)(2009-6#1)(2010-11#1)(2011-2#5)(2013-1#1)(2013-8#1)
glycoproteins by##2##2##(1990-5#1)(1991-5#1)
glycoproteins during meiotic maturation##2##4##(2013-1#2)
glycoproteins in##2##2##(2008-11#1)(2008-5#1)
glycoproteins occurred during meiotic maturation and##2##6##(2013-1#2)
glycoproteins of##2##2##(2008-10#1)(2008-5#1)
glycoproteins or##3##2##(1996-12#1)(1997-2#1)(2011-2#1)
glycoproteins with##5##2##(1990-5#1)(1996-12#1)(2008-1#1)(2008-7#1)(2009-8#1)
glycoproteins##50##1##(1990-2#1)(1990-5#4)(1991-5#3)(1992-10#4)(1993-6#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-5#1)(1996-12#2)(1997-2#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#2)(2013-1#4)
glycosaminoglycan##7##1##(1992-10#1)(1992-5#1)(1993-2#1)(1995-2#1)(2008-5#1)(2011-1#1)(2012-3#1)
glycosaminoglycans (GAGs)##2##2##(1990-2#1)(1993-12#1)
glycosaminoglycans##9##1##(1990-2#1)(1991-1#1)(1993-12#3)(1995-2#1)(2008-5#2)(2010-11#1)
glycosidase##5##1##(1992-10#3)(2008-8#2)
glycosidases##4##1##(1992-10#1)(2008-11#3)
glycoside from the##2##3##(2008-11#2)
glycoside##13##1##(2008-10#1)(2008-11#5)(2008-8#1)(2008-9#2)(2009-8#1)(2010-6#2)(2012-2#1)
glycosides were##3##2##(2008-11#2)(2009-8#1)
glycosides##13##1##(2008-10#2)(2008-11#7)(2008-8#1)(2009-8#1)(2010-6#2)
glycosidic bonds##2##2##(1992-12#1)(2009-10#1)
glycosidic##5##1##(1991-7#1)(1992-12#2)(1992-3#1)(2009-10#1)
glycosyl donors##2##2##(2008-12#2)
glycosyl hydrolase family##2##3##(1995-6#1)(2009-10#1)
glycosyl hydrolases##2##2##(2008-10#1)(2009-3#1)
glycosyl##10##1##(1991-3#1)(1992-12#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-10#1)(2009-3#1)
glycosylasparaginase##6##1##(1991-7#6)
glycosylated##15##1##(1990-5#1)(1992-10#3)(1992-12#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-11#1)(1997-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
glycosylation and##5##2##(1992-6#1)(1996-12#1)(2008-11#2)(2010-11#1)
glycosylation is##2##2##(1994-11#1)(2008-11#1)
glycosylation of recombinant##2##3##(2008-8#1)(2011-2#1)
glycosylation of the##2##3##(1992-12#1)(1993-1#1)
glycosylation of##11##2##(1992-12#1)(1993-1#1)(1994-11#3)(1995-3#1)(2008-11#2)(2008-8#1)(2011-2#2)
glycosylation patterns##3##2##(2008-11#2)(2013-8#1)
glycosylation process##2##2##(2008-11#1)(2008-7#1)
glycosylation profile##2##2##(2008-11#2)
glycosylation site##5##2##(1990-5#2)(1992-10#1)(1994-11#2)
glycosylation sites at##2##3##(2008-11#1)(2013-8#1)
glycosylation sites##9##2##(1992-10#1)(1993-2#1)(1993-6#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
glycosylation was##3##2##(1994-11#1)(2008-11#2)
glycosylation##69##1##(1990-5#2)(1992-10#2)(1992-12#2)(1992-6#3)(1993-1#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#9)(1995-3#1)(1996-12#1)(2008-11#26)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2010-11#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#3)
glycosylphosphatidylinositol (GPI)##3##2##(1996-3#1)(2008-9#1)(2012-2#1)
glycosylphosphatidylinositol##6##1##(1995-2#1)(1996-3#2)(2008-11#1)(2008-9#1)(2012-2#1)
glycosylphosphatidylinositol-anchored##2##1##(1995-2#1)(2008-11#1)
glycosyltransferases##2##1##(1996-6#1)(2009-10#1)
glycuronic acids##4##2##(1991-7#4)
glycyl##3##1##(1990-12#1)(1990-2#1)(2006-6#1)
glycyrrhetic acid##2##2##(2008-9#2)
glyoxal##3##1##(2008-10#3)
glyoxalase I##6##2##(1991-12#1)(1991-5#3)(2008-10#2)
glyoxalase##7##1##(1991-12#1)(1991-5#3)(2008-10#2)(2008-11#1)
glyoxime##3##1##(2008-10#3)
glyoxylate##3##1##(1997-7#1)(2008-10#1)(2008-7#1)
glyphosate and##2##2##(2008-10#1)(2008-7#1)
glyphosate were##2##2##(2010-1#2)
glyphosate##13##1##(2008-10#6)(2008-7#1)(2008-9#1)(2010-1#5)
glyptosternoid fishes##2##2##(2008-9#2)
gml(-1) vanadium##2##2##(2008-10#2)
gml(-1)##6##1##(2008-10#6)
gnotobiotic##8##1##(2008-10#4)(2008-12#2)(2008-5#2)
go a long way##2##4##(1991-2#1)(2010-7#1)
go about their daily##2##4##(2008-9#1)(2010-5#1)
go about##4##2##(1992-1#1)(2008-11#1)(2008-9#1)(2010-5#1)
go away##2##2##(1993-12#1)(1993-2#1)
go back to the##2##4##(2009-10#1)(2010-6#1)
go back to##3##3##(2009-10#1)(2010-1#1)(2010-6#1)
go back##4##2##(2009-10#1)(2010-1#1)(2010-6#1)(2011-2#1)
go beyond##2##2##(2008-11#1)(2012-3#1)
go for##2##2##(1994-12#1)(1995-9#1)
go home##4##2##(1993-1#1)(1997-3#2)(1997-7#1)
go into##2##2##(2008-5#1)(2008-7#1)
go signal-related neurons##2##3##(1991-6#2)
go to the##3##3##(1992-12#1)(1993-2#1)(1995-6#1)
go to##7##2##(1990-5#1)(1992-12#1)(1993-2#1)(1994-2#2)(1995-6#1)(2011-2#1)
go undetected##2##2##(2007-12#1)(2008-5#1)
go##61##1##(1990-5#1)(1991-2#2)(1991-6#3)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#5)
go?##4##1##(1996-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
goal disengagement and re-engagement##2##4##(2010-2#2)
goal disengagement##3##2##(2010-2#3)
goal for the##2##3##(1992-3#1)(2008-11#1)
goal for##7##2##(1991-2#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
goal in##7##2##(1991-6#1)(2008-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
goal is to improve##2##4##(2008-11#1)(2012-3#1)
goal is to##9##3##(1993-2#1)(1995-3#1)(2008-11#5)(2008-9#1)(2012-3#1)
goal is##13##2##(1992-1#1)(1993-2#1)(1995-3#2)(1996-1#1)(2008-11#5)(2008-9#1)(2009-8#1)(2012-3#1)
goal of determining##2##3##(2010-8#1)(2011-2#1)
goal of the##14##3##(1991-3#1)(1992-1#1)(1992-12#1)(1993-3#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#1)
goal of this article is to##2##6##(2013-1#2)
goal of this paper##2##4##(1996-3#1)(2008-10#1)
goal of this review is to##3##6##(2008-11#1)(2008-6#1)(2011-3#1)
goal of this##36##3##(1994-2#1)(1994-8#1)(1996-3#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#3)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#4)(2012-4#1)(2013-1#2)(2013-8#3)
goal of##90##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-8#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#3)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#7)(2011-3#1)(2011-8#1)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#5)(2013-8#4)
goal to##5##2##(1994-3#1)(2008-11#2)(2008-9#1)(2010-9#1)
goal was to identify##2##4##(1996-12#1)(2007-12#1)
goal was to##8##3##(1992-1#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
goal was##9##2##(1992-1#1)(1993-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
goal##177##1##(1990-5#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-1#3)(1992-12#2)(1992-3#2)(1993-1#2)(1993-2#2)(1993-3#4)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#17)(2008-11#24)(2008-12#2)(2008-3#2)(2008-4#2)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#4)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#7)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#2)(2011-2#12)(2011-3#1)(2011-7#1)(2011-8#1)(2012-2#8)(2012-3#7)(2012-4#1)(2013-1#7)(2013-8#4)
goal-directed##4##1##(2008-11#1)(2010-10#1)(2013-8#2)
goals and objectives##5##3##(1991-12#1)(1994-12#2)(1996-3#1)(2011-2#1)
goals and##18##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#3)(1994-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
goals are to##3##3##(1993-1#1)(2008-10#1)(2008-8#1)
goals are##4##2##(1993-1#1)(2008-1#1)(2008-10#1)(2008-8#1)
goals for##2##2##(1991-11#1)(2008-11#1)
goals has##2##2##(2012-3#1)(2013-1#1)
goals in this##2##3##(2008-10#1)(2009-8#1)
goals in##6##2##(1995-1#1)(2008-10#2)(2009-8#1)(2012-3#1)(2013-1#1)
goals may##2##2##(2008-12#1)(2009-7#1)
goals of our##3##3##(2008-3#1)(2013-1#2)
goals of the##8##3##(1991-12#1)(1994-9#1)(1995-3#1)(1996-1#1)(2008-10#3)(2013-1#1)
goals of therapy##2##3##(2010-6#2)
goals of this##2##3##(1994-3#1)(2008-11#1)
goals of##29##2##(1991-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#2)(2009-6#1)(2010-6#3)(2013-1#3)
goals should be##2##3##(2008-6#1)(2008-7#1)
goals that##2##2##(1996-2#1)(2009-12#1)
goals were to##3##3##(1993-1#1)(2013-1#1)(2013-8#1)
goals were##4##2##(1993-1#1)(2008-9#1)(2013-1#1)(2013-8#1)
goals##127##1##(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#4)(1992-1#2)(1992-12#1)(1993-1#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#5)(1994-2#2)(1994-3#4)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#6)(1996-2#3)(1996-3#4)(1996-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#11)(2008-12#3)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#1)
goat Mb has##2##3##(2010-4#2)
goat Mb##5##2##(2010-4#5)
goat and##3##2##(2008-12#1)(2010-4#1)(2011-2#1)
goat anti-mouse IgG##2##3##(1995-2#1)(2008-10#1)
goat anti-rabbit IgG##3##3##(2008-10#3)
goat anti-rabbit##4##2##(2008-10#4)
goat##29##1##(1990-12#1)(1990-3#1)(1991-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-5#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-9#2)(2010-4#9)(2011-2#2)
goats against##2##2##(1996-12#2)
goats and sheep##3##3##(2008-12#2)(2011-2#1)
goats and##4##2##(1996-12#1)(2008-12#2)(2011-2#1)
goats in##2##2##(2008-12#1)(2011-2#1)
goats was##2##2##(2008-12#1)(2008-9#1)
goats were##2##2##(2008-12#2)
goats##26##1##(1996-12#11)(2008-12#9)(2008-5#1)(2008-9#2)(2011-2#3)
goblet cell##2##2##(1994-11#2)
goblet cells##4##2##(1990-2#1)(1994-11#2)(2008-5#1)
goblet##6##1##(1990-2#1)(1994-11#4)(2008-5#1)
goby##3##1##(2010-8#3)
goes on to##4##3##(1994-3#1)(2008-12#1)(2008-9#1)(2013-7#1)
goes on##5##2##(1990-3#1)(1994-3#1)(2008-12#1)(2008-9#1)(2013-7#1)
goes through a##2##3##(2010-9#1)(2011-3#1)
goes through##4##2##(1992-11#1)(2008-10#1)(2010-9#1)(2011-3#1)
goes to##2##2##(1996-5#2)
goes##20##1##(1990-11#1)(1990-3#1)(1992-11#2)(1993-12#1)(1993-2#1)(1994-3#1)(1996-5#2)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#2)(2011-3#1)(2013-7#1)
going from##3##2##(1996-11#1)(2008-10#2)
going to be##7##3##(1991-12#1)(1996-3#1)(2008-11#1)(2008-12#3)(2011-3#1)
going to have##3##3##(1990-2#1)(2013-1#2)
going to##14##2##(1990-2#1)(1991-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#3)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#2)
going##30##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-6#1)(2008-7#2)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
goiter##6##1##(1990-6#1)(1992-5#1)(2010-7#1)(2011-1#2)(2012-3#1)
goitre##6##1##(1990-9#3)(1992-2#1)(1993-6#2)
goitrous hypothyroidism##2##2##(2011-1#2)
gold (Au)##2##2##(2008-10#2)
gold and silver##3##3##(2008-10#3)
gold and##8##2##(2008-10#7)(2008-5#1)
gold cytochemistry##2##2##(2008-10#2)
gold disk##2##2##(2008-10#2)
gold electrode and##2##3##(2008-10#2)
gold electrode modified with##8##4##(2008-10#8)
gold electrode surface##4##3##(2008-10#4)
gold electrode was##2##3##(2008-10#2)
gold electrode##41##2##(2008-10#41)
gold electrodes##15##2##(2008-10#15)
gold from##2##2##(1994-5#1)(2008-9#1)
gold in##3##2##(2008-10#2)(2008-11#1)
gold microelectrode##3##2##(2008-10#3)
gold nanoparticle##3##2##(2008-10#3)
gold nanoparticles for##2##3##(2008-10#2)
gold nanoparticles loaded with##2##4##(2008-10#2)
gold nanoparticles##16##2##(2008-10#13)(2008-11#2)(2009-7#1)
gold nanorods (GNRs)##2##3##(2010-1#1)(2012-12#1)
gold nanorods##3##2##(2010-1#1)(2012-12#1)(2013-1#1)
gold or silver##2##3##(2008-10#2)
gold or##3##2##(2008-10#3)
gold particles##5##2##(2008-10#1)(2008-11#1)(2008-9#3)
gold standard diagnostic##2##3##(2011-2#1)(2011-3#1)
gold standard in##4##3##(2011-2#2)(2011-3#1)(2012-12#1)
gold standard test##2##3##(2008-12#1)(2012-3#1)
gold standard##23##2##(1994-1#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2011-2#6)(2011-3#2)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
gold standard&quot##7##2##(1992-3#1)(1995-5#1)(2008-10#2)(2009-3#1)(2012-2#1)(2012-4#1)
gold surface and##2##3##(2008-10#2)
gold surface##9##2##(2008-10#9)
gold surfaces##4##2##(2008-10#4)
gold were##3##2##(1994-5#1)(2008-10#2)
gold working electrode##2##3##(1991-7#1)(2008-10#1)
gold##228##1##(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-1#1)(1994-5#10)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#167)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#5)(2009-3#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-6#1)(2011-2#7)(2011-3#2)(2012-12#4)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#1)
gold(I)##2##1##(2008-10#1)(2010-3#1)
gold(III)##2##1##(2008-10#2)
gold-complexed##2##1##(2008-10#2)
gold-labeled##3##1##(2008-10#2)(2008-5#1)
gold-plated##2##1##(2008-10#2)
golden age of##2##3##(1993-2#1)(2010-1#1)
golden mosaic virus##6##3##(2008-10#6)
golden mosaic##8##2##(2008-10#8)
golden##20##1##(1990-6#2)(1993-2#1)(2008-10#12)(2008-11#2)(2009-8#1)(2010-1#1)(2010-8#1)
goldeneye##2##1##(2008-9#2)
goldfish Carassius auratus morphotypes##2##4##(2010-8#2)
goldfish##29##1##(1991-2#6)(1994-11#3)(1994-8#6)(1997-7#1)(2008-12#2)(2008-6#4)(2010-8#2)(2011-2#5)
golf courses in Wisconsin##2##4##(2008-10#2)
golf courses in##3##3##(2008-10#3)
golf##6##1##(2008-10#4)(2011-2#2)
gomphocephala##2##1##(2010-3#2)
gonad and##2##2##(1994-11#1)(2010-5#1)
gonad doses##2##2##(2009-11#2)
gonad##9##1##(1994-11#1)(1994-12#1)(2008-10#1)(2009-11#2)(2010-5#3)(2011-2#1)
gonadal development##3##2##(2008-11#1)(2010-8#1)(2012-2#1)
gonadal hormones##2##2##(1991-1#1)(1993-8#1)
gonadal secretions##3##2##(2008-11#3)
gonadal steroid environment##3##3##(2008-11#3)
gonadal steroid##4##2##(2008-11#4)
gonadal steroids##3##2##(1994-2#1)(2008-11#1)(2008-4#1)
gonadal##21##1##(1991-1#1)(1993-8#1)(1994-2#1)(2008-10#1)(2008-11#11)(2008-4#2)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
gonadotropin alpha subunit##2##3##(1995-8#2)
gonadotropin##14##1##(1992-6#1)(1995-8#4)(1997-1#1)(2007-7#3)(2008-4#1)(2010-5#1)(2011-1#2)(2013-1#1)
gonadotropin-II##2##1##(1994-8#2)
gonadotropin-releasing hormone (GnRH)##3##3##(1994-8#1)(1995-11#1)(1996-2#1)
gonadotropin-releasing hormone##4##2##(1994-8#1)(1995-11#2)(1996-2#1)
gonadotropin-releasing##6##1##(1994-8#2)(1995-11#2)(1996-2#2)
gonadotropins##3##1##(2008-8#1)(2010-5#1)(2012-2#1)
gonads is##3##2##(2008-4#1)(2009-11#1)(2009-7#1)
gonads of##2##2##(2008-11#1)(2008-12#1)
gonads were##2##2##(2008-11#1)(2009-11#1)
gonads##22##1##(1993-11#1)(2007-12#1)(2008-11#8)(2008-12#1)(2008-4#1)(2009-11#4)(2009-7#1)(2010-5#2)(2011-2#3)
gondii antibodies##3##2##(2008-5#3)
gondii##17##1##(1990-9#1)(1991-11#1)(1993-9#1)(1996-3#1)(2007-12#1)(2008-5#3)(2009-6#3)(2009-7#2)(2012-2#2)(2012-3#2)
gone into##2##2##(1997-7#1)(2008-10#1)
gone through##2##2##(1996-3#1)(2009-10#1)
gone##9##1##(1993-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-3#1)
goniometer##3##1##(2008-12#2)(2009-1#1)
gonion##2##1##(2008-7#2)
gonococcal##6##1##(1993-12#1)(1994-2#2)(1995-12#1)(1996-6#1)(2011-2#1)
gonocytes##2##1##(2012-2#2)
gonorrhea##3##1##(1990-3#1)(1996-6#1)(2013-1#1)
gonorrhoea has been##2##3##(1990-3#2)
gonorrhoea##7##1##(1990-3#6)(1996-6#1)
good Nernstian##2##2##(2008-10#2)
good accuracy and precision##5##4##(2008-10#4)(2008-3#1)
good accuracy##16##2##(2008-10#13)(2008-3#2)(2013-8#1)
good activity##3##2##(1992-12#1)(2008-10#2)
good affinity##2##2##(1993-8#1)(2008-10#1)
good agreement between the predicted##2##5##(2008-10#2)
good agreement between the proposed method and##2##7##(2008-10#2)
good agreement between the results##2##5##(2008-10#2)
good agreement between the##11##4##(2008-10#11)
good agreement between##19##3##(2008-10#17)(2008-5#1)(2008-7#1)
good agreement of results##2##4##(2008-10#2)
good agreement of##4##3##(2008-10#3)(2008-3#1)
good agreement was observed between##2##5##(2008-10#2)
good agreement was obtained between##2##5##(2008-10#2)
good agreement was obtained##4##4##(2008-10#4)
good agreement was##7##3##(2008-10#7)
good agreement with certified values##5##5##(2008-10#5)
good agreement with certified##6##4##(2008-10#6)
good agreement with previous##2##4##(2008-10#1)(2008-3#1)
good agreement with reference values##2##5##(2008-10#2)
good agreement with the certified value##6##6##(2008-10#6)
good agreement with the certified values##12##6##(2008-10#12)
good agreement with the certified##18##5##(2008-10#18)
good agreement with the experimental data##2##6##(2008-10#1)(2008-3#1)
good agreement with the experimental results##2##6##(2008-2#1)(2011-2#1)
good agreement with the experimental##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
good agreement with the reference##2##5##(2008-10#2)
good agreement with the results obtained##2##6##(2008-10#2)
good agreement with the##47##4##(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#34)(2008-11#1)(2008-2#1)(2008-3#5)(2008-9#1)(2010-7#1)(2011-2#1)
good agreement with those obtained by an##3##7##(2008-10#3)
good agreement with those obtained by##17##6##(2008-10#17)
good agreement with those obtained##21##5##(2008-10#20)(2008-3#1)
good agreement with those of##2##5##(2008-10#2)
good agreement with those##29##4##(2008-10#28)(2008-3#1)
good agreement with##105##3##(1995-11#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#81)(2008-11#1)(2008-2#2)(2008-3#12)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)
good agreement##164##2##(1994-5#1)(1995-11#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#128)(2008-11#3)(2008-2#5)(2008-3#15)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)
good agricultural practice##2##3##(2013-1#2)
good alternative for the##2##4##(2008-10#2)
good alternative to##5##3##(1994-9#1)(2008-10#3)(2010-4#1)
good alternative##8##2##(1994-9#1)(2008-10#5)(2010-4#1)(2013-1#1)
good analytical precision##2##3##(2008-10#1)(2009-8#1)
good analytical##3##2##(2008-10#2)(2009-8#1)
good and bad care##2##4##(2010-10#2)
good and the##2##3##(1994-8#1)(2008-10#1)
good and##10##2##(1990-3#1)(1994-2#1)(1994-8#1)(2008-10#2)(2009-10#1)(2010-10#2)(2013-1#2)
good as##10##2##(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#1)
good assessment##2##2##(2008-10#1)(2011-2#1)
good business##2##2##(1992-12#1)(2008-11#1)
good caliber##2##2##(2008-9#2)
good candidates for##2##3##(2008-10#1)(2013-8#1)
good candidates##4##2##(2008-10#1)(2010-11#1)(2012-3#1)(2013-8#1)
good care##2##2##(2010-10#1)(2013-8#1)
good catalytic##2##2##(2008-10#2)
good characteristics##2##2##(2008-10#2)
good clinical outcome##4##3##(2007-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
good clinical##11##2##(1997-6#1)(2007-8#2)(2008-7#2)(2010-5#1)(2012-3#1)(2013-1#2)(2013-8#2)
good communication and good patient care##2##6##(1994-1#2)
good communication and good##3##4##(1994-1#2)(2010-10#1)
good compatibility##2##2##(2008-5#1)(2010-12#1)
good compliance##2##2##(1991-11#1)(2013-1#1)
good condition##2##2##(2010-12#1)(2011-3#1)
good consistency##2##2##(2008-10#1)(2013-8#1)
good continuity##2##2##(1993-1#1)(2008-11#1)
good correlation (r=0##2##3##(2008-10#2)
good correlation between##6##3##(2008-10#5)(2008-5#1)
good correlation was found between the##4##6##(1996-11#1)(1997-6#1)(2008-10#2)
good correlation was observed between the##3##6##(1994-6#1)(2008-10#1)(2008-7#1)
good correlation was##8##3##(1994-6#1)(1996-11#1)(1997-6#1)(2008-10#4)(2008-7#1)
good correlation with data obtained by##2##6##(2008-10#2)
good correlation with the##2##4##(1990-12#1)(2008-10#1)
good correlation with##4##3##(1990-12#1)(2008-10#3)
good correlation##31##2##(1990-12#1)(1994-6#1)(1996-11#1)(1997-6#1)(2008-10#25)(2008-5#1)(2008-7#1)
good cosmetic result##2##3##(1991-8#1)(2013-8#1)
good cosmetic##6##2##(1991-8#1)(2008-5#1)(2008-7#1)(2012-12#2)(2013-8#1)
good diagnostic##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
good discriminating ability towards##5##4##(2008-10#5)
good discrimination##3##2##(2008-10#2)(2008-8#1)
good distribution ratio values##2##4##(2008-10#2)
good effect##4##2##(2008-11#2)(2008-9#1)(2012-3#1)
good electrocatalytic activity##2##3##(2008-10#2)
good electrochemical##3##2##(2008-10#3)
good encounters##2##2##(2010-10#2)
good esthetic##2##2##(1990-9#1)(1993-11#1)
good estimates of##2##3##(1992-12#1)(2008-3#1)
good estimation of##3##3##(1995-9#1)(2008-10#2)
good evidence##3##2##(1996-12#1)(2008-7#1)(2010-12#1)
good fit##7##2##(1993-1#1)(1994-8#1)(2008-10#3)(2008-3#1)(2009-3#1)
good for##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
good functional##4##2##(2007-8#1)(2008-7#1)(2009-4#1)(2013-1#1)
good general health##2##3##(1995-8#1)(2013-8#1)
good general##3##2##(1995-8#1)(1996-6#1)(2013-8#1)
good growth##2##2##(2008-10#1)(2010-4#1)
good health##7##2##(1991-6#1)(1993-6#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)
good identification of the substances present in##2##7##(2008-10#2)
good in all##2##3##(1996-6#1)(2008-10#1)
good in vitro##2##3##(1994-8#1)(1997-1#1)
good in##10##2##(1991-3#1)(1992-2#1)(1994-8#1)(1996-6#1)(1996-9#2)(1997-1#1)(2007-8#1)(2008-10#1)(2013-1#1)
good knowledge##2##2##(2011-2#1)(2013-1#1)
good linear relationship with##4##4##(2008-10#4)
good linear relationship##6##3##(2008-10#6)
good linear response##2##3##(2008-10#2)
good linear##13##2##(2008-10#13)
good linearity and##2##3##(2008-10#2)
good linearity between##2##3##(2008-10#1)(2008-11#1)
good linearity in the##4##4##(2008-10#4)
good linearity in##5##3##(2008-10#4)(2011-3#1)
good linearity##20##2##(2008-10#17)(2008-11#1)(2009-8#1)(2011-3#1)
good long-term stability##3##3##(2008-10#3)
good long-term##4##2##(2008-10#3)(2013-1#1)
good model of##2##3##(1997-1#1)(2008-6#1)
good model##5##2##(1994-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
good nursing##2##2##(1994-9#1)(2011-2#1)
good nutrition##2##2##(1993-12#1)(2012-12#1)
good operational##2##2##(2008-10#2)
good or##3##2##(1991-3#1)(1996-12#1)(2008-7#1)
good oral##2##2##(1992-5#1)(2008-5#1)
good outcome##4##2##(2007-8#1)(2008-7#1)(2009-12#1)(2013-8#1)
good outcomes##3##2##(1994-12#1)(2011-2#1)(2013-1#1)
good patient##3##2##(1994-1#2)(1994-12#1)
good performance characteristics##4##3##(2008-10#4)
good performance of the##3##4##(2007-11#2)(2008-10#1)
good performance of##4##3##(2007-11#2)(2008-10#2)
good performance##18##2##(1996-12#1)(2007-11#2)(2008-10#12)(2008-3#1)(2010-3#1)(2010-8#1)
good physical##3##2##(2008-5#2)(2011-2#1)
good postoperative##2##2##(1990-9#1)(2010-5#1)
good potential##5##2##(2008-10#3)(2011-2#1)(2011-3#1)
good practice##4##2##(1996-8#1)(1997-5#1)(2008-12#1)(2011-2#1)
good precision (R##3##3##(2008-10#3)
good precision (RSD##3##3##(2008-10#3)
good precision and accuracy##4##4##(2008-10#4)
good precision and##5##3##(2008-10#5)
good precision##18##2##(2008-10#18)
good predictive##4##2##(2008-10#2)(2012-3#1)(2013-8#1)
good prognosis##9##2##(1991-8#1)(1992-5#2)(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#2)
good qualitative agreement##2##3##(2008-3#1)(2013-8#1)
good quality and##2##3##(2008-10#1)(2008-8#1)
good quality of life##4##4##(1992-11#1)(1996-3#1)(2011-3#1)(2012-3#1)
good quality of##5##3##(1992-11#1)(1996-3#1)(2010-10#1)(2011-3#1)(2012-3#1)
good quality##12##2##(1992-11#1)(1993-1#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-10#1)(2010-4#1)(2011-3#1)(2012-3#1)
good recoveries of##2##3##(2008-10#2)
good recoveries##8##2##(2008-10#8)
good recovery and##2##3##(2008-10#1)(2008-7#1)
good recovery##9##2##(1992-11#1)(1997-3#1)(2008-10#5)(2008-7#1)(2010-12#1)
good reliability of the determination was proved##2##7##(2008-10#2)
good reliability##4##2##(2008-10#3)(2010-2#1)
good repeatability (RSD##2##3##(2008-10#2)
good repeatability and##3##3##(2008-10#3)
good repeatability##15##2##(2008-10#15)
good reproducibility and##4##3##(2008-10#3)(2008-11#1)
good reproducibility of the method##2##5##(2008-10#2)
good reproducibility of the##3##4##(2008-10#2)(2009-11#1)
good reproducibility with##2##3##(2008-10#2)
good reproducibility##37##2##(1996-6#1)(2008-10#33)(2008-11#1)(2009-11#1)(2013-8#1)
good resistance to##3##3##(2008-10#2)(2013-1#1)
good resolution of the##2##4##(2008-10#2)
good resolution of##3##3##(2008-10#2)(2008-7#1)
good resolution##5##2##(2008-10#4)(2008-7#1)
good response for##4##3##(2008-10#4)
good response in##3##3##(2008-10#1)(2011-2#2)
good response to##2##3##(2008-10#1)(2012-3#1)
good response##14##2##(1992-12#1)(2008-10#8)(2008-2#1)(2011-2#3)(2012-3#1)
good result##3##2##(1996-9#1)(2008-10#1)(2008-9#1)
good results and##3##3##(1993-3#1)(2008-10#1)(2012-3#1)
good results for##2##3##(1991-9#1)(2013-1#1)
good results in the##2##4##(2008-10#1)(2011-3#1)
good results in##5##3##(1990-12#1)(2008-10#3)(2011-3#1)
good results of##2##3##(1990-9#1)(2008-10#1)
good results were obtained##5##4##(2008-10#5)
good results were##6##3##(1990-5#1)(2008-10#5)
good results when##2##3##(2008-10#2)
good results with##3##3##(2008-10#2)(2008-11#1)
good results##46##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-3#1)(1991-9#1)(1993-3#1)(1996-11#1)(2008-10#27)(2008-11#2)(2008-3#1)(2008-9#1)(2009-3#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
good selectivities for##4##3##(2008-10#4)
good selectivities##7##2##(2008-10#7)
good selectivity and sensitivity##2##4##(2008-10#2)
good selectivity and##3##3##(2008-10#3)
good selectivity for VO(2+) over##2##5##(2008-10#2)
good selectivity for##24##3##(2008-10#24)
good selectivity##36##2##(2008-10#35)(2010-11#1)
good sensitivity and stability##2##4##(2008-10#2)
good sensitivity and##4##3##(2008-10#4)
good sensitivity##13##2##(2008-10#12)(2012-2#1)
good separation of the##4##4##(2008-10#3)(2009-8#1)
good separation of##7##3##(2008-10#6)(2009-8#1)
good separation##11##2##(2008-10#10)(2009-8#1)
good separations##2##2##(2008-10#1)(2008-4#1)
good specificity##2##2##(2009-1#1)(2012-2#1)
good stability and##4##3##(2008-10#4)
good stability for##2##3##(2008-10#2)
good stability##16##2##(2008-10#14)(2008-5#1)(2012-2#1)
good statistical##2##2##(2008-10#2)
good storage stability##2##3##(2008-10#1)(2008-6#1)
good tissue##2##2##(2012-12#1)(2012-3#1)
good to very good##2##4##(1990-9#1)(1991-3#1)
good to##6##2##(1990-9#1)(1991-3#1)(1992-11#1)(2010-7#2)(2010-8#1)
good tolerability and##2##3##(1991-3#1)(2010-11#1)
good tolerability##5##2##(1990-2#1)(1991-3#1)(2008-5#1)(2010-11#1)(2013-8#1)
good treatment##3##2##(1994-12#1)(2007-8#1)(2011-2#1)
good understanding of##2##3##(2010-8#1)(2013-1#1)
good values##2##2##(2008-10#1)(2008-6#1)
good working##2##2##(2008-12#1)(2008-4#1)
good yield##7##2##(1996-5#2)(2008-10#2)(2008-11#1)(2010-3#1)(2010-7#1)
good yields##5##2##(1996-5#2)(2008-5#1)(2010-6#1)(2012-3#1)
good##1140##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-9#6)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#7)(1991-5#1)(1991-6#5)(1991-8#3)(1991-9#1)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#3)(1992-5#3)(1992-6#1)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#1)(1993-9#1)(1994-1#6)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#5)(1996-3#3)(1996-5#6)(1996-6#5)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#5)(1997-8#5)(2007-11#3)(2007-8#6)(2008-1#3)(2008-10#587)(2008-11#44)(2008-12#11)(2008-2#11)(2008-3#28)(2008-4#6)(2008-5#23)(2008-6#6)(2008-7#25)(2008-8#7)(2008-9#17)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#10)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#8)(2010-8#4)(2010-9#1)(2011-10#1)(2011-2#31)(2011-3#9)(2012-12#8)(2012-2#10)(2012-3#18)(2012-7#1)(2012-9#1)(2013-1#31)(2013-7#1)(2013-8#18)
good&quot##4##1##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
good)##2##1##(2012-2#1)(2013-1#1)
goodness-of-fit##2##1##(2008-10#1)(2011-2#1)
goods and services##3##3##(1991-2#1)(1991-3#1)(2008-11#1)
goods and##4##2##(1991-2#1)(1991-3#1)(2008-11#2)
goods##14##1##(1991-12#2)(1991-2#1)(1991-3#1)(2008-10#3)(2008-11#2)(2009-10#4)(2013-8#1)
gossypii##9##1##(2008-10#6)(2012-3#3)
gossypol##10##1##(1990-11#5)(2008-10#1)(2008-8#4)
got##7##1##(1992-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-7#1)(2013-1#1)
gourd##7##1##(2008-10#1)(2013-8#6)
gout##5##1##(1991-8#1)(2009-10#2)(2011-2#2)
govern##10##1##(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#1)
governance and##4##2##(1993-12#1)(2008-11#1)(2012-2#2)
governance in##3##2##(1995-12#1)(1996-1#1)(2012-3#1)
governance##29##1##(1991-1#6)(1991-12#1)(1992-3#1)(1993-12#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#5)(1996-3#1)(2008-11#2)(2010-12#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
governates in##2##2##(2008-10#2)
governed by a##3##3##(2008-10#2)(2008-5#1)
governed by the##8##3##(2008-10#6)(2008-7#1)(2012-3#1)
governed by##19##2##(1992-3#1)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#3)(2013-1#1)
governed##21##1##(1992-3#1)(1995-2#1)(1997-2#1)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#3)(2013-1#1)
governing boards##6##2##(1991-1#4)(1991-12#1)(1992-1#1)
governing stem cell fate decisions##2##5##(2008-11#2)
governing the##7##2##(1990-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-1#1)
governing this##2##2##(2008-9#1)(2009-10#1)
governing##40##1##(1990-2#1)(1991-1#4)(1991-12#2)(1991-2#1)(1992-1#1)(1994-5#1)(1995-5#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#2)
government actions##2##2##(1992-2#1)(1993-3#1)
government agencies##2##2##(1996-2#1)(2010-12#1)
government and##14##2##(1991-12#1)(1994-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2009-4#1)
government effort to##2##3##(1991-2#1)(1992-1#1)
government has##3##2##(1992-12#1)(1992-2#1)(1995-3#1)
government hospitals##2##2##(1992-12#1)(1992-3#1)
government in the##2##3##(1996-3#1)(2008-12#1)
government in##3##2##(1996-3#1)(2008-12#1)(2012-2#1)
government is##5##2##(1995-3#1)(1997-1#1)(1997-2#1)(1997-6#2)
government officials##4##2##(1994-3#1)(1995-6#1)(2008-11#1)(2011-2#1)
government policy##4##2##(1992-1#1)(2007-12#1)(2008-11#1)(2010-10#1)
government regulation in##2##3##(1995-3#1)(1997-1#1)
government regulation##4##2##(1995-3#2)(1997-1#1)(2008-11#1)
government regulations##2##2##(1993-3#1)(2008-11#1)
government to##5##2##(1991-1#1)(1994-1#1)(1995-3#1)(2008-10#1)(2008-11#1)
government will##2##2##(1997-3#1)(2008-11#1)
government##122##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1992-1#4)(1992-12#2)(1992-2#5)(1992-3#1)(1993-12#1)(1993-3#3)(1994-1#2)(1994-12#4)(1994-2#3)(1994-3#3)(1994-9#3)(1995-12#2)(1995-2#2)(1995-3#10)(1995-6#2)(1996-2#4)(1996-3#3)(1996-5#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-6#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#21)(2008-12#3)(2008-3#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-7#1)
government's##16##1##(1991-3#1)(1992-3#1)(1995-8#1)(1996-3#1)(1996-5#2)(2008-11#7)(2009-10#1)(2010-11#1)(2012-3#1)
government-owned##2##1##(1992-12#1)(1994-12#1)
government-sponsored##2##1##(1995-12#1)(1995-3#1)
governmental agencies##2##2##(1992-12#1)(1993-3#1)
governmental and##3##2##(1996-1#1)(2008-5#1)(2010-11#1)
governmental policy##2##2##(1993-3#1)(1997-3#1)
governmental##22##1##(1991-11#1)(1991-2#1)(1992-12#1)(1993-3#2)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-11#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#2)
governments and##2##2##(1996-1#1)(2008-11#1)
governments are##3##2##(1992-1#1)(2008-11#2)
governments in##2##2##(1996-2#1)(2008-10#1)
governments##23##1##(1991-12#1)(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2009-11#1)(2010-12#1)
governor##3##1##(1990-3#1)(1991-8#1)(1993-5#1)
governs the##3##2##(1996-3#1)(1996-5#1)(2008-11#1)
governs##5##1##(1996-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-10#1)
gox2 transcripts##2##2##(2008-10#2)
gox2##3##1##(2008-10#3)
gp##4##1##(1991-5#3)(1996-2#1)
gp120##6##1##(1990-2#1)(1994-11#1)(1995-2#1)(1995-5#1)(2013-8#2)
gp130-Related cytokines##2##2##(2008-4#2)
gp130-Related##3##1##(2008-4#3)
gp32##3##1##(1997-3#3)
gp41##3##1##(2011-3#3)
gp58##2##1##(1996-12#2)
gp64 promoter##3##2##(2008-11#3)
gp64##4##1##(2008-11#4)
gracilis##2##1##(2008-10#1)(2008-6#1)
grade 1##3##2##(1996-6#1)(2012-2#2)
grade 2##2##2##(2012-2#1)(2013-1#1)
grade 3 and 4##2##4##(2008-10#2)
grade 3 and##3##3##(2008-10#2)(2010-7#1)
grade 3##10##2##(1991-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)
grade 4##3##2##(1991-8#2)(2009-7#1)
grade C##4##2##(2008-7#1)(2012-3#3)
grade I in##2##3##(2008-8#2)
grade I##8##2##(1990-3#1)(1991-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-7#1)
grade II in##2##3##(2008-8#2)
grade II##7##2##(1990-12#1)(1990-3#1)(2008-7#2)(2008-8#2)(2008-9#1)
grade III##9##2##(1990-12#1)(1990-3#1)(1991-2#1)(1995-11#1)(1997-7#1)(2008-7#1)(2008-8#2)(2013-1#1)
grade IV and##2##3##(2008-7#1)(2012-3#1)
grade IV##8##2##(2008-12#3)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#2)
grade V##2##2##(2008-7#1)(2012-3#1)
grade and##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
grade level##4##2##(2010-5#1)(2011-1#2)(2013-1#1)
grade of##9##2##(1990-12#1)(1996-1#1)(2008-10#5)(2011-2#1)(2013-8#1)
grade on##2##2##(2008-12#1)(2008-7#1)
grade or##3##2##(2011-1#1)(2011-2#2)
grade retention##3##2##(2008-12#3)
grade students##5##2##(1991-9#1)(1994-5#1)(2008-12#2)(2009-7#1)
grade##163##1##(1990-12#4)(1990-3#4)(1991-2#1)(1991-6#1)(1991-8#4)(1991-9#6)(1992-1#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#2)(1996-1#1)(1996-6#2)(1997-7#1)(2008-10#23)(2008-11#4)(2008-12#20)(2008-5#2)(2008-6#1)(2008-7#13)(2008-8#6)(2008-9#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-11#1)(2010-5#2)(2010-7#3)(2011-1#3)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#9)(2013-1#6)(2013-8#6)
graded as##3##2##(1997-3#1)(2010-7#1)(2013-8#1)
graded##20##1##(1990-3#1)(1993-12#1)(1993-6#1)(1996-6#1)(1997-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-7#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
graded-index POF's##3##2##(2008-3#3)
graded-index multimode fiber##3##3##(2008-3#3)
graded-index##9##1##(2007-12#2)(2008-3#7)
graders##3##1##(2008-5#1)(2010-1#1)(2013-1#1)
grades in##2##2##(2010-9#1)(2013-1#1)
grades of##5##2##(2008-10#1)(2011-2#2)(2013-1#2)
grades##27##1##(1990-12#1)(1997-3#1)(2008-10#1)(2008-12#4)(2008-7#2)(2009-7#2)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#4)(2013-1#5)
gradient across the##2##3##(1990-2#1)(1993-8#1)
gradient and##4##2##(2008-11#2)(2008-7#1)(2012-2#1)
gradient at a##2##3##(2008-10#2)
gradient between##3##2##(2008-10#2)(2008-3#1)
gradient centrifugation##14##2##(1993-8#3)(1994-8#2)(1995-12#1)(1997-3#2)(2008-10#1)(2008-4#1)(2008-9#3)(2011-2#1)
gradient chamber and##2##3##(2008-10#2)
gradient dilution##3##2##(2008-10#3)
gradient elution was##3##3##(2008-10#3)
gradient elution##17##2##(2008-10#17)
gradient flow##5##2##(2008-10#3)(2008-4#1)(2010-8#1)
gradient for##2##2##(2008-10#1)(2008-8#1)
gradient fractionation of##2##3##(1993-8#1)(2008-11#1)
gradient gel electrophoresis (DGGE)##6##4##(2008-10#3)(2008-9#2)(2010-6#1)
gradient gel electrophoresis##9##3##(1991-12#1)(2008-10#4)(2008-3#1)(2008-9#2)(2010-6#1)
gradient in##10##2##(2008-10#2)(2008-8#2)(2008-9#4)(2009-10#1)(2012-3#1)
gradient is##5##2##(1990-2#1)(1994-8#1)(2008-10#1)(2008-2#2)
gradient of increasing##2##3##(2008-10#1)(2008-4#1)
gradient of##11##2##(1992-12#3)(2008-10#5)(2008-4#1)(2008-8#1)(2013-8#1)
gradient on##4##2##(1993-2#1)(2008-10#3)
gradient that##3##2##(2008-10#2)(2008-3#1)
gradient was##5##2##(2008-10#5)
gradient with##2##2##(2008-10#2)
gradient##193##1##(1990-11#2)(1990-2#4)(1991-12#1)(1992-12#3)(1993-2#1)(1993-8#5)(1994-6#3)(1994-8#3)(1995-12#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#89)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-7#4)(2008-8#10)(2008-9#15)(2009-10#1)(2009-8#4)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#3)(2012-5#1)(2012-6#1)(2013-8#1)
gradient-echo##2##1##(1997-8#1)(2012-2#1)
gradient-enriched##3##1##(1997-3#3)
gradients and##5##2##(1990-11#1)(1995-6#2)(2008-8#1)(2012-6#1)
gradients are##2##2##(2008-10#1)(2008-7#1)
gradients in a##2##3##(1997-3#1)(2008-7#1)
gradients in##7##2##(1997-3#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-7#1)
gradients of##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
gradients or##3##2##(1995-2#1)(2008-4#1)(2008-8#1)
gradients were##3##2##(2008-10#2)(2008-7#1)
gradients within the central nervous system##2##6##(2008-7#2)
gradients within##3##2##(2008-10#1)(2008-7#2)
gradients##65##1##(1990-11#2)(1992-3#1)(1993-8#2)(1994-6#1)(1995-2#1)(1995-6#3)(1997-3#1)(2008-10#15)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#8)(2008-8#13)(2008-9#3)(2009-6#1)(2009-7#1)(2011-2#1)(2012-6#1)(2013-8#1)
grading and##2##2##(2008-6#1)(2011-2#1)
grading of##4##2##(1995-9#1)(2010-8#1)(2011-2#1)(2011-3#1)
grading scale##2##2##(2012-3#2)
grading system##2##2##(2008-10#1)(2008-7#1)
grading systems were##3##3##(2011-2#3)
grading##26##1##(1995-3#1)(1995-9#1)(1997-8#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-8#3)(2011-2#5)(2011-3#1)(2012-3#2)
gradual and##3##2##(2008-10#2)(2011-2#1)
gradual growth##2##2##(2008-12#1)(2008-3#1)
gradual increase in##5##3##(1994-11#1)(1994-8#1)(2008-10#3)
gradual increase of osmotic pressure##4##5##(2008-11#4)
gradual increase##9##2##(1994-11#1)(1994-8#1)(2008-10#3)(2008-11#4)
gradual##58##1##(1990-5#1)(1991-11#1)(1993-6#2)(1994-11#1)(1994-8#1)(1995-10#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2012-7#1)
gradually after##3##2##(2008-10#2)(2008-11#1)
gradually and##3##2##(1991-12#1)(2008-9#1)(2010-8#1)
gradually became##4##2##(1997-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
gradually change##2##2##(2008-11#1)(2008-6#1)
gradually declined##2##2##(2008-10#1)(2008-9#1)
gradually decreased to##2##3##(2008-7#1)(2011-2#1)
gradually decreased##7##2##(1991-8#1)(1994-11#1)(2008-11#3)(2008-7#1)(2011-2#1)
gradually from##3##2##(1996-3#1)(2008-10#1)(2013-8#1)
gradually in the##3##3##(1990-12#1)(2008-2#1)(2013-8#1)
gradually in##5##2##(1990-12#1)(1995-8#1)(2008-10#1)(2008-2#1)(2013-8#1)
gradually increased during the##2##4##(2008-10#1)(2013-1#1)
gradually increased##10##2##(1995-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
gradually over##2##2##(2011-1#1)(2012-12#1)
gradually with the##2##3##(2008-9#1)(2013-8#1)
gradually with##4##2##(1995-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
gradually##88##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-8#2)(1996-3#1)(1997-1#1)(1997-8#3)(2007-11#1)(2008-10#17)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#6)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#6)
graduate and undergraduate##2##3##(1991-1#1)(2008-12#1)
graduate health administration##3##3##(1991-2#1)(1996-1#2)
graduate medical education##6##3##(1991-8#4)(2008-11#2)
graduate nurse program##2##3##(2008-11#2)
graduate nurse##4##2##(2008-11#4)
graduate programs in health##3##4##(1996-1#1)(1996-2#1)(1996-3#1)
graduate student##3##2##(1996-1#1)(2008-10#2)
graduate students and##2##3##(1996-2#1)(2010-9#1)
graduate students##5##2##(1991-1#1)(1996-1#2)(1996-2#1)(2010-9#1)
graduate year 1##2##3##(1991-8#2)
graduate year##3##2##(1991-8#2)(2008-11#1)
graduate##43##1##(1991-1#2)(1991-2#1)(1991-8#6)(1992-1#1)(1993-1#1)(1994-12#3)(1996-1#6)(1996-2#2)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#9)(2008-12#3)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#2)
graduated from##2##2##(1991-2#1)(2008-10#1)
graduated in##2##2##(1993-6#1)(1994-12#1)
graduated##9##1##(1991-2#1)(1993-6#1)(1994-12#1)(2008-10#2)(2008-11#3)(2008-8#1)
graduates at the##2##3##(2013-8#2)
graduates from##3##2##(1991-2#1)(1991-6#1)(1991-8#1)
graduates in##3##2##(1991-8#1)(1995-2#1)(1996-3#1)
graduates of##3##2##(1991-2#1)(1995-1#1)(2008-11#1)
graduates to##2##2##(1993-11#1)(1996-3#1)
graduates with##2##2##(1994-12#1)(2012-2#1)
graduates##39##1##(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-8#1)(1993-11#1)(1993-2#3)(1994-12#6)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-3#2)(1997-2#1)(2008-11#8)(2009-10#1)(2012-2#1)(2013-8#2)
graduating in 2005##2##3##(2013-1#2)
graduating##3##1##(2009-10#1)(2013-1#2)
graduation of##2##2##(1990-5#1)(1994-12#1)
graduation##5##1##(1990-5#1)(1994-12#2)(1995-2#1)(2012-3#1)
graellsii##3##1##(2012-3#3)
graft allocation##2##2##(2011-3#2)
graft and##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
graft diameter##2##2##(2013-1#2)
graft failure##2##2##(2006-6#1)(2011-3#1)
graft for##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
graft from##2##2##(1995-12#2)
graft function##2##2##(1994-5#1)(2013-1#1)
graft in##2##2##(2008-7#1)(2010-5#1)
graft infection##2##2##(2011-3#2)
graft inoculation methods##2##3##(2008-10#2)
graft inoculation##4##2##(2008-10#4)
graft material##2##2##(2008-11#1)(2008-7#1)
graft materials##2##2##(2011-3#1)(2012-12#1)
graft on##2##2##(1993-1#1)(1996-3#1)
graft surgery##7##2##(1993-12#1)(1995-2#1)(1997-3#1)(2008-11#1)(2009-6#1)(2012-12#1)(2013-8#1)
graft survival##4##2##(1990-10#1)(1995-2#1)(1995-9#2)
graft to##3##2##(2008-10#2)(2010-6#1)
graft was##3##2##(2011-2#2)(2012-12#1)
graft with##2##2##(2009-10#2)
graft##140##1##(1990-10#1)(1991-11#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-12#3)(1995-2#2)(1995-9#2)(1996-2#1)(1996-3#3)(1997-3#1)(1997-8#3)(2006-6#2)(2007-11#1)(2008-10#12)(2008-11#5)(2008-12#4)(2008-5#1)(2008-7#5)(2008-9#6)(2009-1#1)(2009-10#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#3)(2011-2#15)(2011-3#16)(2011-7#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#15)(2013-8#3)
graft-inoculated with##2##2##(2008-10#2)
graft-inoculated##4##1##(2008-10#4)
graft-inoculation##2##1##(2008-10#2)
graft-versus-host disease##3##2##(1997-8#1)(2010-11#1)(2013-8#1)
graft-versus-host reaction##2##2##(1997-8#2)
graft-versus-host##5##1##(1997-8#3)(2010-11#1)(2013-8#1)
graftectomy##3##1##(2011-3#3)
grafted BSA protein##2##3##(2008-10#2)
grafted and##2##2##(2008-10#2)
grafted cellulose membrane##4##3##(2008-10#4)
grafted on silica##2##3##(2008-10#2)
grafted on##7##2##(2008-10#7)
grafted polymer is##2##3##(2008-10#2)
grafted polymer##7##2##(2008-10#6)(2009-5#1)
grafted to##2##2##(1993-12#1)(2008-10#1)
grafted with##6##2##(1991-2#1)(2008-10#3)(2009-7#1)(2010-6#1)
grafted##44##1##(1991-2#1)(1993-12#1)(1996-2#1)(1997-5#1)(2008-10#36)(2009-5#2)(2009-7#1)(2010-6#1)
grafting experiments##3##2##(1993-12#1)(2008-10#2)
grafting is##4##2##(2008-9#1)(2009-1#1)(2010-3#1)(2013-1#1)
grafting of##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
grafting process##4##2##(2008-10#4)
grafting through##2##2##(2008-10#1)(2011-2#1)
grafting to##2##2##(1991-2#1)(2013-1#1)
grafting with##2##2##(2008-11#1)(2013-1#1)
grafting##66##1##(1991-2#1)(1993-12#2)(1996-3#1)(1997-2#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#1)(2010-3#2)(2010-6#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#3)
grafts and##5##2##(1996-2#1)(2009-10#1)(2011-3#1)(2012-2#1)(2013-1#1)
grafts from##2##2##(1997-8#1)(2010-11#1)
grafts have been##3##3##(1991-3#1)(2010-12#1)(2011-3#1)
grafts in##4##2##(1990-5#1)(1991-2#1)(2010-12#1)(2011-3#1)
grafts were##6##2##(1995-2#1)(2006-6#1)(2009-1#1)(2009-3#1)(2011-2#2)
grafts when##2##2##(1997-8#1)(2008-11#1)
grafts with##2##2##(2008-11#1)(2009-10#1)
grafts##61##1##(1990-5#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-4#1)(1993-5#1)(1994-8#1)(1995-2#1)(1996-2#3)(1997-2#3)(1997-5#1)(1997-8#3)(2006-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#1)(2010-11#1)(2010-12#3)(2010-6#2)(2011-2#10)(2011-3#6)(2012-2#1)(2012-3#2)(2013-1#1)
grain and Fusarium##2##3##(2008-10#2)
grain and##7##2##(2008-10#6)(2008-11#1)
grain by##2##2##(2008-10#2)
grain filling##4##2##(2008-9#4)
grain in##2##2##(2008-10#2)
grain incubated in vitro##3##4##(2008-10#3)
grain intake##2##2##(2010-1#2)
grain sizes##3##2##(2008-10#3)
grain sorghum##2##2##(2008-10#2)
grain was##2##2##(2008-10#1)(2013-1#1)
grain weight##2##2##(2008-10#1)(2008-12#1)
grain were##2##2##(2008-10#2)
grain yield in##2##3##(2008-10#2)
grain yield##7##2##(2008-10#4)(2008-12#1)(2008-8#1)(2012-2#1)
grain##91##1##(1991-12#1)(1991-9#1)(2008-10#53)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#4)(2009-7#2)(2010-1#6)(2012-2#1)(2013-1#5)
grains and##8##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#2)(2010-1#1)
grains are##2##2##(2008-10#1)(2010-1#1)
grains by##2##2##(2008-10#2)
grains for##2##2##(1995-3#1)(2008-9#1)
grains is##2##2##(2010-1#2)
grains of##2##2##(2008-11#1)(2009-10#1)
grains were##2##2##(2008-10#1)(2008-7#1)
grains##47##1##(1995-3#1)(2008-10#20)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-1#9)(2010-7#1)(2012-2#2)(2013-1#1)
gram negative bacteria##3##3##(1997-8#1)(2008-11#1)(2008-12#1)
gram negative##7##2##(1991-2#1)(1996-2#2)(1997-8#2)(2008-11#1)(2008-12#1)
gram of a##2##3##(2008-11#2)
gram of##30##2##(1993-11#1)(2008-10#23)(2008-11#4)(2011-2#2)
gram positive bacteria##2##3##(1997-8#1)(2008-12#1)
gram positive##5##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
gram##48##1##(1991-2#1)(1993-11#1)(1996-2#2)(1997-8#3)(2008-10#25)(2008-11#8)(2008-12#2)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
gram-negative bacteria##4##2##(2008-10#3)(2008-11#1)
gram-negative rods##2##2##(2009-8#1)(2012-2#1)
gram-negative##14##1##(1996-12#1)(1997-4#1)(2008-10#6)(2008-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)
gram-positive bacterium##2##2##(2008-10#2)
gram-positive##9##1##(2008-1#1)(2008-10#6)(2009-6#1)(2010-2#1)
graminearum and F##2##3##(2008-10#2)
graminearum and##4##2##(2008-10#2)(2009-6#1)(2010-7#1)
graminearum in##3##2##(2008-10#3)
graminearum infection##2##2##(2008-10#2)
graminearum treatment##3##2##(2008-10#3)
graminearum##44##1##(2008-10#39)(2009-6#1)(2010-7#2)(2011-10#2)
graminicola and##4##2##(2008-10#3)(2011-10#1)
graminicola ascocarps##2##2##(2008-10#2)
graminicola at##2##2##(2008-10#2)
graminicola fruiting bodies##2##3##(2008-10#2)
graminicola in wheat##2##3##(2008-10#1)(2011-10#1)
graminicola in##5##2##(2008-10#4)(2011-10#1)
graminicola is##2##2##(2008-10#2)
graminicola populations##4##2##(2008-10#4)
graminicola to##2##2##(2008-10#2)
graminicola was##2##2##(2008-10#2)
graminicola##72##1##(2008-10#70)(2011-10#2)
graminis f##23##2##(2008-10#23)
graminis var##7##2##(2008-10#7)
graminis##41##1##(2008-10#41)
graminis-infested##2##1##(2008-10#2)
graminum biotypes##3##2##(2008-10#3)
graminum##12##1##(1996-12#2)(2008-10#10)
grammar learning##2##2##(2008-5#2)
grammar##4##1##(2008-5#4)
grammars##2##1##(2011-3#2)
grammatical##6##1##(1991-2#2)(2008-11#1)(2008-5#1)(2009-8#2)
grammatical-class##2##1##(1991-2#2)
grammaticality##2##1##(2008-2#1)(2011-1#1)
grams of##3##2##(1993-11#1)(1994-5#1)(2011-2#1)
grams##6##1##(1990-8#1)(1993-11#1)(1994-5#1)(2008-10#2)(2011-2#1)
grand##3##1##(1993-11#1)(1995-12#1)(1997-3#1)
grandchild's death##2##2##(2010-9#2)
grande##3##1##(2008-11#1)(2013-1#2)
grandis##4##1##(2008-10#3)(2013-8#1)
grandmothers##2##1##(2009-12#2)
grandparent##4##1##(2008-10#1)(2010-9#3)
grandparents##2##1##(2010-9#2)
granisetron##18##1##(2010-12#14)(2010-7#4)
granite##8##1##(2008-1#1)(2008-10#4)(2013-8#3)
granites containing numerous debris of red beds and granites##2##9##(2013-8#2)
granites containing numerous debris of red beds##3##7##(2013-8#3)
granites##7##1##(2008-10#1)(2013-8#6)
granitic##2##1##(2008-10#2)
grant management##3##2##(2010-7#3)
grant##21##1##(1992-12#1)(1995-12#1)(1995-3#1)(1995-6#4)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(2008-12#2)(2010-12#1)(2010-7#3)(2011-2#1)(2013-1#1)
granted a##3##2##(1996-12#1)(2008-5#1)(2012-3#1)
granted an injunction##2##3##(1995-6#1)(1997-7#1)
granted an##3##2##(1995-6#1)(1996-1#1)(1997-7#1)
granted that##2##2##(2008-11#1)(2008-9#1)
granted##14##1##(1990-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-7#1)(2008-11#3)(2008-5#1)(2008-9#1)(2012-3#1)
granting the##2##2##(1995-6#2)
granting##3##1##(1991-9#1)(1995-6#2)
grants##15##1##(1991-1#1)(1996-3#5)(1997-1#1)(1997-2#3)(2008-10#2)(2009-4#1)(2012-3#1)(2013-1#1)
grantwrite##2##1##(1996-1#2)
granular and##2##2##(1995-3#1)(2013-8#1)
granular cell tumor##2##3##(2007-12#1)(2011-2#1)
granular cell##3##2##(2007-12#1)(2011-2#2)
granular component##2##2##(1995-3#2)
granular endoplasmic reticulum##2##3##(2008-12#1)(2008-7#1)
granular material##2##2##(2008-10#1)(2008-7#1)
granular##35##1##(1992-11#1)(1992-5#1)(1992-8#2)(1995-3#3)(2007-12#3)(2008-10#6)(2008-12#1)(2008-5#3)(2008-7#7)(2010-1#2)(2010-11#1)(2011-2#3)(2013-1#1)(2013-8#1)
granularity##6##1##(2008-11#2)(2009-12#1)(2011-2#3)
granulated##5##1##(2007-12#1)(2008-11#2)(2010-1#1)(2011-2#1)
granulating##2##1##(1992-2#1)(2008-9#1)
granulation tissue##3##2##(2008-12#1)(2008-9#1)(2012-3#1)
granulation##6##1##(2008-11#2)(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
granule and##2##2##(1992-6#2)
granule cell degeneration induced by intragyral##2##6##(1994-8#2)
granule cell degeneration induced by##3##5##(1994-8#3)
granule cell degeneration##4##3##(1994-8#4)
granule cell##7##2##(1994-8#5)(2008-11#1)(2013-8#1)
granule cells##9##2##(1990-5#2)(1994-2#1)(1994-8#1)(1996-12#2)(2008-9#2)(2012-2#1)
granule##30##1##(1990-5#3)(1992-6#4)(1994-2#1)(1994-8#6)(1995-8#3)(1996-12#2)(2007-12#1)(2008-11#1)(2008-6#2)(2008-9#2)(2010-11#2)(2012-2#1)(2012-3#1)(2013-8#1)
granules and##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
granules are##2##2##(2007-12#1)(2008-7#1)
granules containing##2##2##(1992-12#1)(2008-5#1)
granules during the##2##3##(2007-12#1)(2008-7#1)
granules for##2##2##(2008-4#1)(2011-2#1)
granules in##5##2##(1992-12#1)(1997-7#2)(2009-8#1)(2013-1#1)
granules of##3##2##(1991-12#1)(1992-10#1)(2008-5#1)
granules were##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
granules with##3##2##(1992-12#1)(2008-7#2)
granules##83##1##(1990-5#10)(1991-12#1)(1991-8#1)(1992-10#1)(1992-12#6)(1992-2#2)(1994-11#1)(1995-3#1)(1995-8#3)(1997-7#9)(2007-12#9)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#7)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
granulocyte colony-stimulating factor##7##3##(1994-12#1)(2008-11#4)(2010-6#1)(2012-3#1)
granulocyte transfusions##2##2##(2011-2#2)
granulocyte##13##1##(1990-2#1)(1994-12#1)(2008-11#4)(2008-5#1)(2010-6#1)(2011-2#4)(2012-3#1)
granulocyte-macrophage colony-stimulating factor##5##3##(1993-11#1)(1995-6#1)(2008-11#1)(2009-7#2)
granulocyte-macrophage##8##1##(1991-11#1)(1991-5#1)(1992-3#1)(1993-11#1)(1995-6#1)(2008-11#1)(2009-7#2)
granulocytes and##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
granulocytes##15##1##(1992-12#1)(1992-3#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-6#2)(2011-2#1)(2013-1#1)
granulocytic anaplasmosis##6##2##(2008-12#2)(2013-1#4)
granulocytic sarcoma##2##2##(1993-2#2)
granulocytic##10##1##(1993-2#2)(1997-7#1)(2008-12#3)(2013-1#4)
granuloma##20##1##(1991-11#1)(1991-9#2)(1993-2#1)(2008-10#3)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#4)(2012-3#6)
granulomas##6##1##(1990-5#1)(1993-6#1)(1997-8#1)(2008-7#2)(2010-6#1)
granulomatosis##7##1##(2008-1#1)(2008-7#1)(2010-11#3)(2010-6#1)(2012-3#1)
granulomatous areas in##2##3##(2011-2#2)
granulomatous disease is##2##3##(2007-8#1)(2013-1#1)
granulomatous disease##5##2##(2007-8#1)(2012-12#1)(2013-1#3)
granulomatous diseases##3##2##(1997-8#1)(2008-9#1)(2012-3#1)
granulomatous infections##2##2##(2012-3#1)(2013-1#1)
granulomatous inflammation##4##2##(1990-3#3)(2008-5#1)
granulomatous mastitis##2##2##(1997-8#2)
granulomatous myositis##2##2##(2008-7#2)
granulomatous reaction##3##2##(1991-11#1)(2008-5#1)(2011-2#1)
granulomatous##37##1##(1990-3#3)(1991-11#1)(1993-6#1)(1997-8#3)(2007-8#2)(2008-1#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#9)
granulometer##2##1##(2008-3#2)
granulosa and theca##2##3##(2008-12#1)(2008-9#1)
granulosa cell apoptosis##2##3##(2008-11#2)
granulosa cell tumors of the ovary##2##6##(2007-8#2)
granulosa cell##5##2##(1995-12#1)(2007-8#2)(2008-11#2)
granulosa cells of##2##3##(2008-11#1)(2008-9#1)
granulosa cells##15##2##(1995-12#4)(2008-11#5)(2008-8#5)(2008-9#1)
granulosa layer##3##2##(2008-12#3)
granulosa##32##1##(1995-12#6)(1995-8#2)(2007-8#2)(2008-11#8)(2008-12#6)(2008-8#5)(2008-9#2)(2013-8#1)
granulosus##7##1##(1996-12#2)(2010-11#1)(2011-2#3)(2013-1#1)
grape and##3##2##(2008-10#3)
grape berries##6##2##(2008-10#6)
grape necrosis##2##2##(2008-10#2)
grape powdery mildew##3##3##(2008-10#3)
grape skin##3##2##(2008-10#3)
grape strains##2##2##(2008-10#2)
grape varieties##5##2##(2008-10#5)
grape##56##1##(2008-10#54)(2008-7#1)(2012-3#1)
grapefruit and##3##2##(2008-10#3)
grapefruit##17##1##(2008-10#17)
grapes and##3##2##(2008-10#3)
grapes are##2##2##(2008-10#2)
grapes in##4##2##(2008-10#4)
grapes##25##1##(2008-10#22)(2008-11#1)(2012-12#1)(2013-1#1)
grapevine downy mildew##3##3##(2008-10#3)
grapevine leaf disks##2##3##(2008-10#2)
grapevine leaf##4##2##(2008-10#4)
grapevine leaves##9##2##(2008-10#9)
grapevine powdery mildew##2##3##(2008-10#2)
grapevine rupestris##2##2##(2008-10#2)
grapevine to##2##2##(2008-10#2)
grapevine viruses##3##2##(2008-10#3)
grapevine##44##1##(2008-10#42)(2009-8#1)(2011-10#1)
grapevines (Vitis vinifera##2##3##(2008-10#2)
grapevines##16##1##(2008-10#16)
graph (in which females are connected to males##2##8##(2008-9#2)
graph for the##3##3##(2008-10#2)(2008-9#1)
graph for##8##2##(2008-10#7)(2008-9#1)
graph in##2##2##(2008-10#2)
graph is linear in the range 0##2##7##(2008-10#2)
graph is linear in the range##6##6##(2008-10#6)
graph is linear##12##3##(2008-10#12)
graph is##19##2##(2008-10#18)(2009-3#1)
graph of##4##2##(2008-10#4)
graph was linear in the range##11##6##(2008-10#11)
graph was linear in the##14##5##(2008-10#14)
graph was linear##29##3##(2008-10#29)
graph was##45##2##(2008-10#45)
graph##111##1##(2008-10#99)(2008-11#2)(2008-6#1)(2008-9#3)(2009-3#2)(2011-2#2)(2011-3#1)(2012-2#1)
graphene##5##1##(2010-7#1)(2012-2#3)(2013-1#1)
graphic##6##1##(2008-10#2)(2008-9#2)(2009-11#1)(2010-3#1)
graphical analysis##2##2##(2008-10#2)
graphical and##2##2##(2008-10#1)(2013-1#1)
graphical method##3##2##(1995-12#1)(2008-10#2)
graphical model of##2##3##(2008-9#1)(2012-2#1)
graphical user interface##2##3##(2008-4#1)(2008-9#1)
graphical user##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
graphical##32##1##(1992-12#1)(1995-12#1)(1995-6#1)(1995-9#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-7#1)(2010-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#1)
graphics##9##1##(2008-4#1)(2008-6#6)(2010-8#1)(2012-3#1)
graphite and##3##2##(1991-5#1)(2008-10#2)
graphite atomizer (THGA)##3##3##(2008-10#3)
graphite atomizer##10##2##(2008-10#10)
graphite carbon electrode##2##3##(2008-10#2)
graphite cathode##3##2##(2008-10#3)
graphite coated##2##2##(2008-10#2)
graphite composite##3##2##(2008-10#3)
graphite electrode##7##2##(2008-10#7)
graphite electrodes##5##2##(2008-10#5)
graphite furnace atomic absorption spectrometer##5##5##(2008-10#5)
graphite furnace atomic absorption spectrometric (GFAAS)##2##6##(2008-10#2)
graphite furnace atomic absorption spectrometric##5##5##(2008-10#5)
graphite furnace atomic absorption spectrometry (GFAAS) is##2##7##(2008-10#2)
graphite furnace atomic absorption spectrometry (GFAAS)##22##6##(2008-10#22)
graphite furnace atomic absorption spectrometry##54##5##(1991-12#1)(2008-10#53)
graphite furnace atomic absorption spectroscopy##2##5##(2008-10#2)
graphite furnace atomic absorption##70##4##(1991-12#1)(2008-10#69)
graphite furnace atomic##71##3##(1991-12#1)(2008-10#70)
graphite furnace##86##2##(1991-12#1)(2008-10#85)
graphite inks##2##2##(2008-10#2)
graphite morphology##2##2##(2008-10#2)
graphite paste##4##2##(2008-10#4)
graphite powder##2##2##(2008-10#2)
graphite tube atomizer##3##3##(2008-10#3)
graphite tube##20##2##(2008-10#20)
graphite tubes (GTs)##2##3##(2008-10#2)
graphite tubes##5##2##(2008-10#5)
graphite##191##1##(1991-12#1)(1991-5#2)(2007-12#1)(2008-10#182)(2008-3#3)(2008-8#1)(2010-4#1)
graphite-based inks##2##2##(2008-10#2)
graphite-castor oil polyurethane composite electrode##2##5##(2008-10#2)
graphite-epoxy ion-selective electrode for the determination of##2##7##(2008-10#2)
graphite-epoxy ion-selective electrode for##3##4##(2008-10#3)
graphite-epoxy##4##1##(2008-10#4)
graphite/polyester composite electrodes##2##3##(2008-10#2)
graphitic##3##1##(2008-10#2)(2013-1#1)
graphitized carbon##2##2##(2008-10#1)(2010-11#1)
graphs are linear##2##3##(2008-10#2)
graphs are##3##2##(2008-10#3)
graphs for##5##2##(2008-10#5)
graphs obtained by##2##3##(2008-10#2)
graphs obtained##3##2##(2008-10#3)
graphs of##3##2##(1995-3#1)(2008-10#2)
graphs were linear from##2##4##(2008-10#2)
graphs were linear over the range 0##2##7##(2008-10#2)
graphs were linear over the##3##5##(2008-10#3)
graphs were linear##14##3##(2008-10#14)
graphs were obtained for##4##4##(2008-10#4)
graphs were obtained##11##3##(2008-10#11)
graphs were##37##2##(1993-2#1)(2008-10#36)
graphs##74##1##(1993-2#1)(1995-3#1)(2008-10#70)(2008-4#1)(2010-10#1)
grapple##2##1##(1993-12#1)(2008-12#1)
grasp##6##1##(1992-12#1)(1996-2#3)(2011-2#1)(2013-1#1)
grasping movements##2##2##(1996-2#1)(2012-2#1)
grasping##8##1##(1996-2#5)(2008-7#1)(2012-2#1)(2012-3#1)
grass and##5##2##(2008-10#3)(2008-9#1)(2012-12#1)
grass pea (Lathyrus##2##3##(2008-7#1)(2011-2#1)
grass pea seedlings##2##3##(2011-2#2)
grass pea##5##2##(2008-7#1)(2011-2#4)
grass pollen allergens##2##3##(2011-2#2)
grass pollen##6##2##(2011-2#3)(2012-2#3)
grass shrimp##3##2##(2010-4#3)
grass species##2##2##(2008-10#2)
grass##45##1##(1996-12#1)(2008-10#17)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-4#3)(2011-2#8)(2012-12#1)(2012-2#3)(2013-1#1)
grasses and woody##2##3##(2008-8#1)(2008-9#1)
grasses and##6##2##(2008-10#2)(2008-8#3)(2008-9#1)
grasses##22##1##(2008-10#9)(2008-8#8)(2008-9#2)(2009-10#1)(2012-3#1)(2013-1#1)
grasshopper species##2##2##(2008-9#2)
grasshopper##8##1##(1993-12#1)(2007-12#4)(2008-9#3)
grassland##4##1##(2008-9#3)(2013-8#1)
grasslands##3##1##(2008-8#2)(2011-2#1)
grassroots##3##1##(1993-3#1)(1996-3#1)(2012-2#1)
grateful##2##1##(2008-12#2)
grating about the axis##3##4##(2008-3#3)
grating and##3##2##(2008-3#3)
grating as a##3##3##(2007-12#2)(2008-3#1)
grating as##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
grating by##2##2##(2008-3#2)
grating from##2##2##(2007-12#1)(2008-3#1)
grating in##2##2##(2008-3#2)
grating is##3##2##(2008-2#1)(2008-3#2)
grating period##3##2##(2008-2#1)(2008-3#2)
grating spectrometer##2##2##(2008-10#1)(2013-8#1)
grating that##2##2##(2008-2#1)(2008-3#1)
grating was##3##2##(2008-2#1)(2008-3#2)
grating with a##2##3##(2007-12#1)(2008-3#1)
grating with##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
grating##88##1##(2007-11#2)(2007-12#10)(2008-10#6)(2008-11#1)(2008-2#15)(2008-3#48)(2008-5#1)(2013-8#5)
grating's##2##1##(2008-3#2)
gratings and##2##2##(2008-3#2)
gratings are##4##2##(2007-12#1)(2008-3#3)
gratings as##2##2##(2008-2#1)(2008-3#1)
gratings by a##2##3##(2008-2#1)(2008-3#1)
gratings by##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
gratings for##2##2##(2007-11#1)(2008-3#1)
gratings in the##2##3##(2008-2#2)
gratings in##4##2##(2007-11#1)(2008-2#2)(2013-8#1)
gratings is##5##2##(2008-2#1)(2008-3#2)(2013-8#2)
gratings were fabricated##2##3##(2008-3#1)(2013-8#1)
gratings with##3##2##(2007-12#1)(2008-3#2)
gratings written in##3##3##(2007-11#1)(2007-12#2)
gratings written##5##2##(2007-11#1)(2007-12#4)
gratings##81##1##(1996-2#2)(2007-11#5)(2007-12#11)(2008-10#1)(2008-2#7)(2008-3#42)(2008-8#4)(2013-8#9)
gratitude and##2##2##(2008-12#2)
gratitude##6##1##(2008-12#6)
grave##6##1##(1991-3#1)(1993-2#1)(1996-3#1)(2008-10#1)(2013-1#2)
gravid##4##1##(2008-10#1)(2008-9#1)(2009-1#1)(2013-1#1)
gravidity##2##1##(1996-3#1)(2011-1#1)
gravimetric analysis##3##2##(2008-10#3)
gravimetric and volumetric dilution procedures##2##5##(2008-10#2)
gravimetric and##3##2##(1994-3#1)(2008-10#2)
gravimetric determination of##2##3##(2008-10#2)
gravimetric estimation of intraoperative blood loss##2##6##(1994-3#2)
gravimetric method##4##2##(1994-3#2)(2008-10#2)
gravimetric##19##1##(1993-2#1)(1994-3#5)(2008-10#12)(2008-11#1)
gravimetry and##2##2##(2008-10#2)
gravimetry##3##1##(2008-10#3)
gravis and##2##2##(1997-8#1)(2009-11#1)
gravis##13##1##(1991-11#1)(1991-2#1)(1996-3#1)(1997-5#3)(1997-8#1)(2009-11#1)(2012-3#5)
gravitational field-flow fractionation##2##3##(2008-10#2)
gravitational##8##1##(1991-9#1)(1996-2#1)(2008-10#4)(2008-3#2)
gravitational-wave##3##1##(2007-12#1)(2008-3#2)
gravitropic##2##1##(2009-8#2)
gravitropism##2##1##(2008-9#1)(2009-8#1)
gravity and the##2##3##(1991-1#1)(2008-10#1)
gravity levels##2##2##(2008-7#2)
gravity##21##1##(1991-1#2)(1991-12#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#2)(2010-10#1)(2010-9#1)(2013-8#1)
gray MTA##2##2##(2013-1#2)
gray MTA+5%CaO##2##2##(2013-1#2)
gray leaf spot in##2##4##(2008-10#2)
gray leaf spot of maize##7##5##(2008-10#7)
gray leaf spot of##11##4##(2008-10#11)
gray leaf spot severity##4##4##(2008-10#4)
gray leaf spot##34##3##(2008-10#34)
gray level##2##2##(2008-6#1)(2010-8#1)
gray marketers##2##2##(1996-3#2)
gray mold##6##2##(1997-4#1)(2008-10#5)
gray pineapple##2##2##(2008-10#2)
gray value-based symmetry##2##3##(2008-6#2)
gray##66##1##(1990-9#1)(1995-6#2)(1996-3#3)(1997-4#1)(1997-8#1)(2008-10#45)(2008-3#1)(2008-6#3)(2010-8#1)(2011-2#1)(2013-1#7)
gray-scale photolithography##2##2##(2007-11#2)
gray-scale##5##1##(2007-11#3)(2008-3#2)
gray-tone##2##1##(2008-3#2)
grazed##5##1##(1996-12#2)(2008-8#3)
grazers##4##1##(2008-8#3)(2009-8#1)
grazing in areas below 1000 m##2##6##(1996-12#2)
grazing in areas##3##3##(1996-12#3)
grazing in##5##2##(1996-12#3)(2008-8#2)
grazing period##3##2##(1996-12#3)
grazing systems##2##2##(2008-8#2)
grazing##18##1##(1991-8#1)(1996-12#10)(1997-7#1)(2008-3#1)(2008-8#5)
grazing-incidence##3##1##(2008-3#3)
greasy##3##1##(2008-10#1)(2008-5#1)(2013-1#1)
great amount of##3##3##(2008-10#3)
great and##2##2##(2008-10#1)(2008-11#1)
great ape species##2##3##(1997-6#2)
great cardiac vein##2##3##(2013-2#2)
great care##2##2##(2011-2#1)(2012-12#1)
great challenge##3##2##(1990-6#1)(2010-12#1)(2011-2#1)
great concern##5##2##(2008-10#4)(2012-2#1)
great deal better&quot##2##3##(2008-12#2)
great deal of##17##3##(1991-1#1)(1992-9#1)(1994-2#1)(1994-9#1)(1996-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
great deal##23##2##(1991-1#2)(1991-2#1)(1992-9#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-5#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
great difference in##2##3##(1995-3#1)(2008-10#1)
great diversity##4##2##(1994-12#1)(2008-10#1)(2009-10#1)(2009-7#1)
great extent##10##2##(1990-12#2)(1995-8#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-6#2)
great impact##2##2##(2008-1#1)(2011-2#1)
great importance for##4##3##(1991-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
great importance to##3##3##(1996-1#1)(2008-9#1)(2009-1#1)
great importance##21##2##(1990-11#1)(1991-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-7#1)(2008-9#2)(2009-1#1)(2011-1#1)(2011-2#2)(2013-1#2)
great in##2##2##(2008-4#1)(2008-5#1)
great influence on the##2##4##(1992-6#1)(1996-5#1)
great influence on##4##3##(1992-6#1)(1996-5#1)(2008-10#1)(2008-3#1)
great influence##5##2##(1992-6#1)(1996-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
great interest in##5##3##(1995-5#1)(2008-10#2)(2008-11#1)(2009-7#1)
great interest##14##2##(1993-12#1)(1995-5#1)(2008-10#5)(2008-11#2)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#1)
great majority of##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2010-12#1)
great majority##8##2##(1991-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-12#1)
great mean##3##2##(2008-10#3)
great need to##2##3##(2008-10#2)
great need##5##2##(1994-9#1)(2008-10#3)(2013-1#1)
great number of##7##3##(1994-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
great opportunity##2##2##(2008-8#1)(2010-11#1)
great part##4##2##(2008-6#2)(2011-2#2)
great potential as##2##3##(2008-10#2)
great potential for##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)
great potential in##4##3##(2008-10#2)(2008-11#1)(2008-6#1)
great potential##16##2##(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)
great progress in the development of##2##6##(2008-10#2)
great progress##3##2##(2008-10#2)(2008-11#1)
great promise for##9##3##(1997-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-12#1)(2012-2#1)
great promise in##2##3##(2008-10#1)(2010-6#1)
great promise##12##2##(1997-1#1)(2008-10#6)(2008-3#1)(2008-8#1)(2010-12#1)(2010-6#1)(2012-2#1)
great sensitivity##4##2##(2008-10#2)(2008-3#1)(2008-4#1)
great strides##2##2##(2008-11#1)(2012-3#1)
great tits##3##2##(2008-5#1)(2008-8#2)
great toe##3##2##(2010-11#2)(2010-6#1)
great value in##3##3##(1991-6#1)(2009-8#1)(2013-1#1)
great value##4##2##(1991-6#1)(1996-11#1)(2009-8#1)(2013-1#1)
great variability##2##2##(1994-3#1)(2008-11#1)
great variation##2##2##(1997-3#1)(2009-7#1)
great variety of##3##3##(1993-11#1)(1997-6#1)(2011-2#1)
great##305##1##(1990-11#3)(1990-12#3)(1990-6#1)(1991-1#2)(1991-2#3)(1991-6#2)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#3)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#5)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#83)(2008-11#17)(2008-12#8)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#10)(2008-9#11)(2009-1#1)(2009-10#3)(2009-12#2)(2009-3#2)(2009-6#2)(2009-7#3)(2009-8#3)(2010-11#4)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#6)(2010-9#1)(2011-1#2)(2011-2#15)(2011-3#1)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#8)(2013-2#2)(2013-8#2)
greater (P &lt##4##3##(2008-10#4)
greater (P##6##2##(2008-10#5)(2010-12#1)
greater ability to##2##3##(1995-2#1)(2008-10#1)
greater access to##2##3##(2008-11#1)(2011-1#1)
greater accuracy##2##2##(2008-10#1)(2008-6#1)
greater activation in the##3##4##(2008-11#3)
greater activation##4##2##(2008-11#4)
greater affinity##2##2##(1990-5#1)(1995-6#1)
greater after##3##2##(1992-9#1)(1996-2#1)(2008-5#1)
greater agreement##2##2##(2008-11#1)(2010-11#1)
greater among##3##2##(1995-1#2)(2012-3#1)
greater amounts##2##2##(2008-10#2)
greater amygdala activity##2##3##(2008-11#2)
greater at 25 degrees C##2##5##(1991-5#1)(2008-10#1)
greater at##10##2##(1991-5#1)(2008-10#6)(2008-8#1)(2008-9#1)(2013-1#1)
greater attention##2##2##(1995-3#1)(1997-8#1)
greater availability of##3##3##(2008-10#1)(2008-8#1)(2010-11#1)
greater awareness of##2##3##(1992-9#1)(2008-5#1)
greater awareness##3##2##(1992-9#1)(2008-12#1)(2008-5#1)
greater benefits##2##2##(2009-4#1)(2009-8#1)
greater body weight and##2##4##(2008-10#1)(2008-7#1)
greater body##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
greater cell##2##2##(1995-8#1)(2008-10#1)
greater clarity##2##2##(1997-1#1)(2010-12#1)
greater collaboration and##2##3##(2008-11#1)(2009-3#1)
greater concentration of##2##3##(1992-2#1)(2008-10#1)
greater consideration##2##2##(2011-1#1)(2012-2#1)
greater control over##3##3##(1994-2#1)(2008-11#1)(2009-10#1)
greater control##4##2##(1994-2#1)(2008-11#1)(2008-8#1)(2009-10#1)
greater cost##2##2##(1995-2#1)(1997-2#1)
greater decrease in##2##3##(2008-4#1)(2008-7#1)
greater degree of##5##3##(1991-2#1)(1994-11#1)(2008-10#1)(2009-8#2)
greater degree than##4##3##(1991-6#1)(1993-8#1)(1995-11#1)(2008-10#1)
greater degree##10##2##(1991-2#1)(1991-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-11#1)(2008-10#2)(2009-8#2)
greater demands##2##2##(1994-1#1)(1996-2#1)
greater density##2##2##(2008-8#1)(2012-12#1)
greater differentiation##2##2##(2008-10#1)(2008-11#1)
greater difficulty##3##2##(2008-5#2)(2013-1#1)
greater diversity##4##2##(1997-7#1)(2008-10#2)(2008-8#1)
greater ease##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
greater effect##2##2##(2008-10#1)(2008-4#1)
greater effects##2##2##(2008-10#1)(2009-7#1)
greater efficacy and##2##3##(1996-2#1)(2013-1#1)
greater efficacy##3##2##(1996-2#1)(2008-11#1)(2013-1#1)
greater emphasis on##6##3##(1991-12#1)(1993-11#1)(1994-2#1)(1996-3#1)(2008-11#1)(2012-3#1)
greater emphasis should be##2##4##(2008-10#1)(2008-11#1)
greater emphasis##12##2##(1991-12#1)(1993-11#1)(1994-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2012-3#1)(2013-1#2)
greater equity##2##2##(1993-1#1)(2012-2#1)
greater extent##11##2##(1990-3#1)(1990-9#1)(1991-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1997-9#1)(2008-11#1)(2009-8#1)(2009-9#1)(2013-1#1)
greater flexibility in##2##3##(2007-11#1)(2011-2#1)
greater flow##2##2##(2008-10#2)
greater for the##6##3##(1993-6#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
greater for##23##2##(1993-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-9#5)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
greater growth##2##2##(2008-10#1)(2008-9#1)
greater health##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
greater height##2##2##(2008-10#1)(2011-1#1)
greater heterogeneity##2##2##(2008-10#1)(2008-9#1)
greater impact on##5##3##(1992-1#1)(2008-10#1)(2012-5#1)(2013-1#2)
greater impact##6##2##(1992-1#1)(2008-10#1)(2008-9#1)(2012-5#1)(2013-1#2)
greater importance##2##2##(1997-1#1)(2008-8#1)
greater improvement in##3##3##(2008-11#1)(2008-12#1)(2010-4#1)
greater improvement##4##2##(2008-11#1)(2008-12#1)(2009-11#1)(2010-4#1)
greater improvements in##2##3##(2008-12#1)(2012-12#1)
greater improvements##3##2##(2008-12#1)(2008-8#1)(2012-12#1)
greater in organic than in conventional plots##3##7##(2008-10#3)
greater in the##16##3##(1992-6#2)(1995-6#1)(1997-7#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#1)(2013-1#1)
greater in these##2##3##(2008-10#1)(2013-1#1)
greater in##54##2##(1992-12#2)(1992-6#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#31)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#2)(2013-1#3)
greater incidence of##3##3##(1990-6#1)(2008-10#1)(2012-3#1)
greater increase in##6##3##(1991-3#1)(1995-1#1)(2008-12#2)(2009-11#1)(2011-10#1)
greater increases in##4##3##(2008-10#1)(2008-12#2)(2010-1#1)
greater inhibition##2##2##(1995-11#1)(2008-10#1)
greater initial fear levels during repeated exposure##2##7##(2012-2#2)
greater insight into the##2##4##(2008-10#1)(2008-11#1)
greater knowledge of##2##3##(1995-1#2)
greater knowledge##3##2##(1995-1#2)(2008-4#1)
greater log/(log##2##2##(2008-10#2)
greater losses##2##2##(2008-10#2)
greater number of individuals##2##4##(2008-8#2)
greater number of##15##3##(1992-9#1)(1993-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)
greater number##16##2##(1992-9#1)(1993-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-9#1)
greater numbers of##3##3##(2008-10#2)(2013-1#1)
greater numbers##5##2##(1997-2#1)(2008-10#2)(2008-8#1)(2013-1#1)
greater on##4##2##(2008-10#4)
greater past month use##2##4##(2010-9#2)
greater peak knee##2##3##(2011-2#2)
greater peak##3##2##(2011-2#3)
greater percentage of##2##3##(1993-8#1)(1996-2#1)
greater proportion of##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2013-8#1)
greater range##2##2##(1991-12#1)(2008-8#1)
greater rate of##3##3##(2009-8#1)(2012-2#1)(2013-1#1)
greater recovery##3##2##(2008-10#3)
greater reduction in##2##3##(1994-3#1)(2010-4#1)
greater relevance##2##2##(2008-10#1)(2008-5#1)
greater risk for##3##3##(2008-11#2)(2010-6#1)
greater risk of complications##2##4##(1991-6#1)(2013-1#1)
greater risk of##9##3##(1990-11#1)(1991-6#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)(2013-1#1)
greater risk##16##2##(1990-11#1)(1991-6#1)(1995-2#1)(1996-11#2)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#1)(2010-10#1)(2010-6#1)(2013-1#1)
greater severity##2##2##(1997-3#1)(1997-7#1)
greater specificity##3##2##(1991-12#1)(2008-10#1)(2012-3#1)
greater spending##2##2##(2012-3#2)
greater spore##2##2##(2008-10#2)
greater stability##4##2##(2007-11#1)(2008-10#3)
greater success as##2##3##(1994-2#1)(2008-8#1)
greater success##6##2##(1994-1#2)(1994-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
greater suppression##2##2##(2008-10#2)
greater susceptibility##2##2##(2008-9#1)(2012-2#1)
greater than 0##10##3##(1991-8#1)(2008-10#9)
greater than 1##5##3##(1992-3#1)(2008-10#2)(2008-7#1)(2012-3#1)
greater than 10 units/ml##2##4##(2008-10#2)
greater than 10##10##3##(1990-5#1)(1990-9#1)(1991-5#1)(1997-2#1)(2008-10#6)
greater than 10% of##2##4##(1992-3#1)(2010-11#1)
greater than 10%##4##3##(1992-3#1)(2008-10#1)(2010-11#1)(2010-6#1)
greater than 2##5##3##(1991-5#1)(1992-2#1)(2008-10#1)(2010-6#1)(2013-1#1)
greater than 20##4##3##(1990-12#1)(1992-3#1)(2008-3#1)(2010-5#1)
greater than 20%##2##3##(2008-11#1)(2011-2#1)
greater than 3##4##3##(1991-12#1)(1992-3#1)(2008-10#1)(2008-3#1)
greater than 40##2##3##(1991-2#1)(2008-7#1)
greater than 50% of##3##4##(1990-2#1)(1997-1#1)(2009-10#1)
greater than 50%##5##3##(1990-2#1)(1997-1#1)(2008-9#1)(2009-10#1)(2012-2#1)
greater than 6##3##3##(1990-6#1)(2008-10#1)(2010-6#1)
greater than 70%##2##3##(1992-10#1)(2011-2#1)
greater than 80%##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
greater than 90%##3##3##(2008-10#2)(2008-7#1)
greater than 93%##2##3##(2008-10#2)
greater than 95%##6##3##(1994-8#1)(2008-10#3)(2008-11#2)
greater than 97%##2##3##(2008-10#2)
greater than 99 percent##2##4##(1992-12#1)(1997-2#1)
greater than 99##3##3##(1992-12#1)(1997-2#1)(2008-10#1)
greater than 99%##5##3##(2008-10#4)(2012-3#1)
greater than additive effects on##2##5##(2008-10#2)
greater than additive##5##3##(2008-10#5)
greater than for##3##3##(2008-10#2)(2013-1#1)
greater than in the##3##4##(2008-11#1)(2008-7#2)
greater than in##6##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#2)
greater than is##2##3##(1994-3#1)(2008-11#1)
greater than its##2##3##(2008-8#2)
greater than or equal to 50 mg M/kg##2##8##(2008-5#2)
greater than or equal to 50##3##6##(2008-5#3)
greater than or equal to##15##5##(1990-11#2)(1991-6#1)(1991-8#4)(1992-4#1)(1992-5#1)(1992-6#1)(2008-10#2)(2008-5#3)
greater than that in##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
greater than that of the wild type##2##7##(2008-10#1)(2008-8#1)
greater than that of the##9##5##(1990-10#1)(1992-12#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)
greater than that of##20##4##(1990-10#1)(1992-12#1)(1994-11#2)(1995-6#1)(1997-3#1)(2008-10#9)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)
greater than that to##2##4##(2008-10#1)(2008-8#1)
greater than that##34##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-8#1)(1994-11#2)(1995-6#1)(1997-3#1)(2008-10#12)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2009-9#1)
greater than the##18##3##(1990-12#1)(1991-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)
greater than those of the##2##5##(2008-5#1)(2008-9#1)
greater than those of##5##4##(2008-10#1)(2008-5#2)(2008-9#1)(2010-4#1)
greater than those##6##3##(1993-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-4#1)
greater than##262##2##(1990-10#2)(1990-11#7)(1990-12#4)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#14)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#6)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#3)(1995-6#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(2007-12#2)(2008-1#2)(2008-10#91)(2008-11#9)(2008-2#1)(2008-3#5)(2008-5#8)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
greater tolerance to##2##3##(2008-10#1)(2012-7#1)
greater tolerance##3##2##(2008-10#2)(2012-7#1)
greater total##6##2##(1996-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-1#1)
greater understanding of the##5##4##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
greater understanding of##10##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
greater understanding##11##2##(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
greater use of##2##3##(2010-4#1)(2012-2#1)
greater variation##2##2##(1996-6#1)(2009-7#1)
greater vulnerability to##2##3##(1995-11#1)(2009-4#1)
greater weight loss per calorie##2##5##(2008-3#2)
greater when the##2##3##(2008-10#2)
greater when##6##2##(2008-10#4)(2008-11#1)(2008-12#1)
greater with the supplement than placebo##2##6##(2013-8#2)
greater with##5##2##(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
greater yield##4##2##(2008-10#1)(2008-8#1)(2009-7#2)
greater##921##1##(1990-10#3)(1990-11#9)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#3)(1990-8#3)(1990-9#16)(1991-11#1)(1991-12#7)(1991-2#5)(1991-3#4)(1991-5#3)(1991-6#6)(1991-8#7)(1992-1#1)(1992-10#1)(1992-12#6)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#4)(1993-1#7)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#3)(1994-1#7)(1994-11#5)(1994-2#4)(1994-3#7)(1994-5#4)(1994-8#2)(1994-9#1)(1995-1#5)(1995-11#4)(1995-12#4)(1995-2#6)(1995-3#4)(1995-6#4)(1995-8#4)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#2)(1997-9#1)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#259)(2008-11#55)(2008-12#22)(2008-2#2)(2008-3#11)(2008-4#9)(2008-5#27)(2008-6#2)(2008-7#28)(2008-8#34)(2008-9#31)(2009-10#4)(2009-11#4)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#8)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#4)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#4)(2011-10#1)(2011-2#26)(2011-3#1)(2012-12#6)(2012-2#17)(2012-3#18)(2012-4#1)(2012-5#1)(2012-7#1)(2013-1#34)(2013-8#10)
greatest at##4##2##(2008-10#3)(2008-12#1)
greatest between##4##2##(1992-4#1)(2008-10#3)
greatest concern##2##2##(2008-2#1)(2012-2#1)
greatest decrease##2##2##(2008-10#2)
greatest for##5##2##(2008-10#4)(2009-7#1)
greatest genetic distance##3##3##(2008-10#3)
greatest genetic##4##2##(2008-10#4)
greatest in the##3##3##(2008-10#1)(2008-9#1)(2009-7#1)
greatest in##8##2##(1996-5#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-7#1)
greatest number of##4##3##(1992-9#1)(2008-10#2)(2012-12#1)
greatest proportion of##2##3##(2008-10#1)(2008-7#1)
greatest risk##5##2##(2008-7#2)(2011-2#1)(2013-8#2)
greatest sensitivity##3##2##(2008-10#3)
greatest when##6##2##(1990-9#1)(2008-10#4)(2008-9#1)
greatest with##2##2##(1995-2#1)(2013-1#1)
greatest##154##1##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-4#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#80)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-7#2)(2010-10#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#3)
greatly advanced##2##2##(1992-9#1)(2010-4#1)
greatly affect the##2##3##(2008-11#1)(2008-8#1)
greatly affected by detuning the##2##5##(2008-3#2)
greatly affected by##5##3##(2008-10#2)(2008-3#2)(2008-7#1)
greatly affected##6##2##(2008-10#3)(2008-3#2)(2008-7#1)
greatly affects the##2##3##(2008-8#1)(2011-2#1)
greatly affects##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
greatly alter the##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
greatly at##2##2##(2008-10#2)
greatly by the##2##3##(2008-10#1)(2011-3#1)
greatly by##3##2##(2008-10#2)(2011-3#1)
greatly decreased##2##2##(2008-11#2)
greatly depends##2##2##(2008-10#1)(2008-11#1)
greatly diminished##3##2##(1992-4#1)(1993-12#1)(1993-8#1)
greatly enhance the##4##3##(2008-10#3)(2008-6#1)
greatly enhanced by the##3##4##(1997-8#1)(2008-10#2)
greatly enhanced by##14##3##(1997-8#1)(2008-10#11)(2008-9#1)(2013-1#1)
greatly enhanced in##2##3##(2008-10#2)
greatly enhanced our##2##3##(2008-10#1)(2011-2#1)
greatly enhanced the##2##3##(2008-10#1)(2010-12#1)
greatly enhanced##33##2##(1991-12#1)(1997-6#1)(1997-8#1)(2008-10#24)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#1)
greatly enhances the##2##3##(1995-2#1)(2008-10#1)
greatly exceed those##2##3##(1996-12#1)(2008-9#1)
greatly expanded##4##2##(1991-12#2)(2008-9#2)
greatly facilitate the##3##3##(1996-8#2)(2008-3#1)
greatly facilitate##4##2##(1996-8#2)(2008-10#1)(2008-3#1)
greatly facilitated in##2##3##(2008-10#1)(2013-1#1)
greatly facilitated##5##2##(1993-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
greatly improve the##7##3##(1994-1#1)(2008-10#3)(2008-6#1)(2010-8#1)(2012-2#1)
greatly improved the##2##3##(2008-10#1)(2008-11#1)
greatly improved##12##2##(2008-10#6)(2008-11#3)(2008-3#1)(2009-11#1)(2009-9#1)
greatly improves the##2##3##(2008-10#1)(2008-3#1)
greatly improves##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
greatly in##3##2##(1991-12#1)(2008-12#1)(2008-8#1)
greatly increased the##2##3##(1996-2#1)(2008-10#1)
greatly increased##11##2##(1993-9#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
greatly increases the##4##3##(2008-10#4)
greatly increases##5##2##(2008-10#4)(2008-8#1)
greatly influenced by the##2##4##(2008-10#1)(2009-5#1)
greatly influenced by##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2011-3#1)
greatly influenced##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-1#1)(2011-3#1)
greatly on the##2##3##(2008-10#1)(2008-2#1)
greatly reduce the##2##3##(2008-11#1)(2008-7#1)
greatly reduced in##2##3##(2008-7#1)(2008-9#1)
greatly reduced##14##2##(1990-5#2)(1991-5#2)(1996-3#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
greatly reduces the##2##3##(2008-10#1)(2013-8#1)
greatly reduces##4##2##(2008-10#2)(2012-3#1)(2013-8#1)
greatly simplifies the##3##3##(2008-10#2)(2008-3#1)
greatly the##2##2##(1990-5#1)(2008-8#1)
greatly to the##2##3##(2011-2#1)(2012-3#1)
greatly to##6##2##(1997-1#1)(2008-11#1)(2010-6#2)(2011-2#1)(2012-3#1)
greatly varies##2##2##(2007-12#1)(2012-3#1)
greatly##222##1##(1990-12#1)(1990-2#1)(1990-5#3)(1991-11#1)(1991-12#5)(1991-5#2)(1992-4#1)(1992-9#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-1#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#88)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#14)(2008-9#9)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#5)(2013-8#1)
green alga##3##2##(2008-11#1)(2010-10#1)(2012-3#1)
green algae##2##2##(2008-7#1)(2009-4#1)
green and roasted coffee##2##4##(2008-10#2)
green and roasted##3##3##(2008-10#3)
green and yellow vegetables##2##4##(2008-10#2)
green and yellow##3##3##(2008-10#2)(2008-3#1)
green and##11##2##(2008-10#7)(2008-12#1)(2008-3#1)(2009-8#2)
green area##2##2##(2008-10#2)
green areas##2##2##(2008-10#2)
green chromatographic##2##2##(2008-10#2)
green coffee beans and##2##4##(2008-10#2)
green coffee beans##5##3##(2008-10#5)
green coffee##8##2##(2008-10#8)
green dye##2##2##(2008-10#2)
green emission##2##2##(2008-3#2)
green fluorescence protein##2##3##(2008-9#1)(2011-2#1)
green fluorescence was##3##3##(2008-9#3)
green fluorescence##9##2##(2008-11#1)(2008-9#6)(2011-2#1)(2013-8#1)
green fluorescent protein (GFP) as##2##5##(2008-7#1)(2011-3#1)
green fluorescent protein (GFP) from##2##5##(1996-6#1)(2008-10#1)
green fluorescent protein (GFP) gene##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
green fluorescent protein (GFP)##15##4##(1996-6#1)(2008-10#5)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#1)(2011-3#1)
green fluorescent protein in##2##4##(2008-11#1)(2008-7#1)
green fluorescent protein##43##3##(1996-6#1)(1997-8#1)(2008-10#11)(2008-11#13)(2008-7#6)(2008-8#4)(2008-9#3)(2009-8#1)(2009-9#1)(2011-3#1)(2012-3#1)
green fluorescent##44##2##(1996-6#1)(1997-8#1)(2008-10#12)(2008-11#13)(2008-7#6)(2008-8#4)(2008-9#3)(2009-8#1)(2009-9#1)(2011-3#1)(2012-3#1)
green laser##2##2##(2007-12#1)(2008-2#1)
green leaf odours##2##3##(2008-10#2)
green leaf##7##2##(2008-10#6)(2011-10#1)
green leaves##2##2##(2008-10#1)(2008-11#1)
green light##4##2##(2008-10#2)(2008-7#2)
green mold disease##2##3##(2008-10#2)
green mold epidemics##2##3##(2008-10#2)
green mold##6##2##(2008-10#6)
green mottle mosaic virus##6##4##(2008-10#6)
green on black##2##3##(2008-10#2)
green on##3##2##(2008-10#2)(2010-5#1)
green or##2##2##(2008-10#1)(2008-11#1)
green output##3##2##(2007-12#1)(2008-3#2)
green plants##2##2##(2008-9#2)
green synthesis##2##2##(2011-2#1)(2012-3#1)
green tea catechins##2##3##(2008-11#2)
green tea##8##2##(1995-9#1)(2008-10#3)(2008-11#3)(2009-8#1)
green upconversion lasing of Er(3+)##2##5##(2007-11#2)
green##221##1##(1990-6#2)(1990-8#1)(1992-2#1)(1993-8#1)(1995-9#1)(1996-2#2)(1996-6#1)(1997-8#1)(2007-11#2)(2007-12#3)(2008-10#106)(2008-11#26)(2008-12#4)(2008-2#2)(2008-3#6)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#12)(2009-4#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-5#3)(2010-6#1)(2011-10#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#5)
green-emitting CdTe quantum dots##2##4##(2008-10#2)
green-fluorescent##2##1##(2008-11#2)
green-sensitive##2##1##(2008-8#2)
green-yellow##4##1##(2011-2#4)
greener##2##1##(2008-10#2)
greenhouse and field studies##2##4##(2008-10#2)
greenhouse and field##4##3##(2008-10#3)(2008-12#1)
greenhouse and growth chamber experiments##2##5##(2008-10#2)
greenhouse and##17##2##(2008-10#16)(2008-12#1)
greenhouse conditions##17##2##(2008-10#17)
greenhouse effect##6##2##(1991-6#5)(2008-10#1)
greenhouse experiment##5##2##(2008-10#5)
greenhouse experiments and##2##3##(2008-10#1)(2008-8#1)
greenhouse experiments##20##2##(2008-10#19)(2008-8#1)
greenhouse for##4##2##(2008-10#4)
greenhouse isolates##6##2##(2008-10#6)
greenhouse or in##2##3##(2008-10#2)
greenhouse or##5##2##(2008-10#5)
greenhouse seedling resistance##2##3##(2008-10#2)
greenhouse seedling##5##2##(2008-10#5)
greenhouse studies with##3##3##(2008-10#3)
greenhouse studies##9##2##(2008-10#8)(2013-8#1)
greenhouse tests##5##2##(2008-10#5)
greenhouse with##2##2##(2008-10#2)
greenhouse##170##1##(1991-6#5)(2008-10#162)(2008-12#1)(2008-8#1)(2013-8#1)
greenhouse-grown plants##3##2##(2008-10#3)
greenhouse-grown##9##1##(2008-10#9)
greenhouses in##3##2##(2008-10#3)
greenhouses##8##1##(2008-10#8)
greening##2##1##(2008-11#1)(2013-8#1)
greenish##2##1##(2008-10#2)
gregarious clutches##2##2##(2008-9#2)
gregarious##4##1##(2008-9#4)
gregata f##3##2##(2008-10#3)
gregata##8##1##(2008-10#8)
gregata)##3##1##(2008-10#3)
grew actively##2##2##(2008-10#2)
grew and##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
grew at##5##2##(1996-1#1)(2008-10#3)(2010-4#1)
grew faster##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
grew from##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
grew in##6##2##(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)
grew more rapidly##3##3##(1993-3#1)(1996-12#1)(2008-10#1)
grew more slowly than##2##4##(1993-3#1)(2008-8#1)
grew more slowly##4##3##(1993-3#1)(2008-10#2)(2008-8#1)
grew more##7##2##(1993-3#2)(1996-12#1)(2008-10#3)(2008-8#1)
grew on##3##2##(2008-10#2)(2008-7#1)
grew out of##3##3##(1995-3#1)(2008-10#1)(2008-4#1)
grew significantly##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
grew slightly##2##2##(1993-6#1)(2008-10#1)
grew through##3##2##(2008-10#3)
grew up##2##2##(2008-8#1)(2008-9#1)
grew well##3##2##(2008-10#2)(2008-11#1)
grew with an average specific growth rate of 0##2##9##(2008-11#2)
grew with##3##2##(2008-11#3)
grew##82##1##(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(2008-10#38)(2008-11#12)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
grey hair##2##2##(2011-1#2)
grey##16##1##(1994-6#1)(1996-11#1)(1997-4#1)(2008-10#6)(2008-8#2)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)
greywater##3##1##(2008-10#3)
grid cells is##2##3##(2008-10#2)
grid cells##3##2##(2008-10#3)
grid of##2##2##(2008-10#2)
grid was##2##2##(1996-1#1)(2008-10#1)
grid##31##1##(1996-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#4)(2010-9#1)(2012-2#1)(2013-1#7)
gridded##3##1##(1996-8#1)(2008-6#1)(2012-3#1)
grids in##2##2##(2013-1#2)
grids##3##1##(2008-11#1)(2013-1#2)
grief and##2##2##(2008-12#1)(2010-2#1)
grief##8##1##(2008-11#1)(2008-12#2)(2010-2#4)(2011-1#1)
grieving##4##1##(2008-12#1)(2010-9#3)
grinding oil##2##2##(2008-10#2)
grinding##8##1##(2008-10#7)(2009-12#1)
grip force control##4##3##(2013-1#4)
grip strength after diagnostic##2##4##(2008-9#2)
grip strength after##5##3##(2008-9#5)
grip strength##13##2##(2008-9#13)
grip##21##1##(1996-2#2)(2008-9#14)(2013-1#5)
gripping##6##1##(2008-10#4)(2008-12#1)(2008-5#1)
grisea Isolates##2##2##(2008-10#2)
grisea and##6##2##(2008-10#6)
grisea by##2##2##(2008-10#2)
grisea in Korea##2##3##(2008-10#2)
grisea in##7##2##(2008-10#7)
grisea infection##2##2##(2008-10#2)
grisea isolates##4##2##(2008-10#4)
grisea lineages##2##2##(2008-10#2)
grisea populations##4##2##(2008-10#4)
grisea strains##3##2##(2008-10#3)
grisea toward foxtail millet##2##4##(2008-10#2)
grisea##94##1##(1997-4#1)(2008-10#87)(2008-9#1)(2009-10#2)(2010-7#3)
grisea)##2##1##(2008-10#2)
griseola isolates##2##2##(2008-10#2)
griseola##7##1##(2008-10#7)
griseus##7##1##(2008-10#2)(2008-11#1)(2010-8#4)
groE##3##1##(1996-12#1)(2008-10#2)
groEL##3##1##(1996-12#2)(2008-10#1)
grocery##2##1##(1990-3#1)(2010-9#1)
groin##7##1##(1992-5#2)(1996-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
grooming and vacuous chewing movements##2##5##(1996-2#2)
grooming behavior##2##2##(1994-8#2)
grooming##11##1##(1994-8#5)(1995-9#1)(1996-2#4)(2008-8#1)
groove and##2##2##(1995-8#1)(2008-5#1)
groove##32##1##(1992-3#1)(1992-4#2)(1993-1#2)(1993-8#1)(1994-5#3)(1995-8#3)(1996-3#3)(2007-12#3)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#1)
groove)##2##1##(1994-5#1)(2008-3#1)
grooved##3##1##(2008-3#2)(2008-7#1)
grooves on##2##2##(2008-10#1)(2008-8#1)
grooves##10##1##(1991-2#1)(1993-8#1)(1993-9#1)(1995-8#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
gross and##3##2##(2008-5#3)
gross domestic product (GDP)##3##4##(1991-2#1)(1993-3#1)(1996-2#1)
gross domestic product##6##3##(1991-2#1)(1992-12#1)(1993-3#2)(1996-2#1)(2012-12#1)
gross hematuria is##2##3##(2008-11#2)
gross hematuria##12##2##(2008-10#7)(2008-11#4)(2011-2#1)
gross instability##3##2##(2012-3#3)
gross lesion scores##2##3##(2008-5#2)
gross lesions##4##2##(2008-5#2)(2008-9#1)(2011-2#1)
gross national product##2##3##(1991-12#1)(1993-1#1)
gross tumor volume##2##3##(2009-2#2)
gross tumours##2##2##(2008-5#2)
gross##70##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#3)(1996-2#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-11#5)(2008-12#4)(2008-5#10)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-3#4)
gross-exposure##2##1##(2013-1#2)
grossesse##10##1##(2011-2#2)(2013-1#8)
grossly##9##1##(1993-12#1)(1995-6#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-11#1)(2009-3#1)(2010-5#1)(2013-1#1)
ground and##11##2##(1997-7#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-9#1)
ground beef##3##2##(2010-4#3)
ground crickets##2##2##(2008-8#2)
ground for##2##2##(2008-10#1)(2012-2#1)
ground in##3##2##(2008-10#3)
ground of##2##2##(2008-10#1)(2009-6#1)
ground samples##2##2##(2008-10#2)
ground squirrel##12##2##(1990-5#3)(2008-8#9)
ground squirrels##2##2##(2008-8#2)
ground state##4##2##(1991-5#1)(1991-9#1)(2008-10#1)(2008-3#1)
ground substance##2##2##(2008-7#1)(2009-7#1)
ground surfaces##2##2##(2008-11#1)(2008-3#1)
ground water samples##3##3##(2008-10#3)
ground water##13##2##(2008-10#13)
ground##105##1##(1990-5#3)(1990-8#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-8#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#47)(2008-11#1)(2008-2#2)(2008-3#11)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#14)(2008-9#3)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#3)(2012-12#1)(2012-2#1)(2013-1#1)
ground-based##12##1##(2008-10#3)(2008-2#1)(2008-3#8)
ground-glass##2##1##(2010-10#1)(2013-1#1)
ground-state##5##1##(2008-10#2)(2008-3#3)
ground-truth##2##1##(2008-6#1)(2010-12#1)
grounded in a##2##3##(2008-11#1)(2008-12#1)
grounded in the##2##3##(1993-1#1)(2008-11#1)
grounded in##6##2##(1993-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-7#1)
grounded on##2##2##(2012-3#2)
grounded theory approach##3##3##(2008-11#1)(2008-12#1)(2012-3#1)
grounded theory methodology##2##3##(2008-12#2)
grounded theory##12##2##(2008-11#3)(2008-12#5)(2012-3#2)(2013-1#2)
grounded##22##1##(1993-1#1)(2008-11#6)(2008-12#6)(2008-6#1)(2010-7#1)(2012-3#4)(2013-1#2)(2013-8#1)
grounded-theory study##2##2##(2008-11#2)
groundnut rosette disease agents##2##4##(2008-10#2)
groundnut rosette disease##6##3##(2008-10#6)
groundnut rosette##8##2##(2008-10#8)
groundnut##15##1##(2008-10#15)
grounds for##3##2##(1992-3#1)(2008-10#2)
grounds##18##1##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-5#1)(1995-12#2)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
groundwater contamination##2##2##(2008-10#2)
groundwater samples##9##2##(2008-10#4)(2013-1#5)
groundwater##38##1##(2008-10#26)(2008-8#2)(2010-4#1)(2011-2#1)(2013-1#8)
groundwork##3##1##(1997-1#1)(2008-12#1)(2012-2#1)
group &quot##2##2##(2009-5#1)(2012-2#1)
group (0##4##2##(2008-12#2)(2008-7#2)
group (1##2##2##(2008-12#2)
group (10 women)##2##3##(2010-9#2)
group (10##3##2##(2010-9#2)(2011-2#1)
group (15##2##2##(2013-1#1)(2013-8#1)
group (20##2##2##(2008-1#1)(2008-10#1)
group (31##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
group (Group##2##2##(1992-11#2)
group (N =##2##3##(2008-10#1)(2011-2#1)
group (P &lt##8##3##(1994-3#1)(2008-7#4)(2011-3#2)(2012-3#1)
group (P = 0##6##4##(1994-2#1)(2008-7#3)(2012-2#1)(2012-3#1)
group (P##14##2##(1994-2#1)(1994-3#1)(2008-7#7)(2011-3#2)(2012-2#1)(2012-3#2)
group (P = 0##2##2##(2012-2#2)
group (grade##2##2##(2008-12#2)
group (group##2##2##(2008-10#1)(2011-2#1)
group (n = 10)##2##4##(1995-2#1)(2008-9#1)
group (n =##16##3##(1991-2#2)(1991-5#1)(1993-2#1)(1995-12#2)(1995-2#1)(1997-8#1)(2008-3#1)(2008-9#2)(2010-4#2)(2012-3#3)
group (p &lt##2##3##(2009-12#1)(2011-2#1)
group (p = 0##2##4##(2008-8#1)(2011-2#1)
group (p##6##2##(2008-8#1)(2009-12#1)(2011-2#4)
group (p&lt##3##2##(1994-12#1)(2010-12#1)(2010-9#1)
group (p = 0##2##2##(2013-8#2)
group 1 and##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
group 1##21##2##(1991-3#1)(2008-10#12)(2008-11#2)(2008-9#1)(2009-6#2)(2011-2#3)
group 2##18##2##(1991-3#1)(2008-10#9)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#5)
group 3##8##2##(2008-10#2)(2008-11#2)(2008-9#1)(2010-10#2)(2011-2#1)
group 4##4##2##(2008-10#2)(2008-11#2)
group 5##3##2##(2008-10#3)
group 7##2##2##(2008-8#1)(2011-2#1)
group A strains##2##3##(2008-10#2)
group A##18##2##(1990-6#1)(1991-8#1)(1993-12#1)(1996-6#2)(2008-10#2)(2008-5#1)(2009-9#1)(2010-12#1)(2010-7#4)(2011-2#2)(2012-2#1)(2013-8#1)
group B strains were##2##4##(2008-10#2)
group B strains##3##3##(2008-10#3)
group B streptococcus and##2##4##(1995-5#1)(2007-12#1)
group B##16##2##(1990-6#2)(1995-5#1)(1996-6#2)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-1#2)(2011-2#1)
group C was##2##3##(2010-7#1)(2011-2#1)
group C##7##2##(1990-12#1)(2008-12#1)(2010-7#3)(2011-2#1)(2012-2#1)
group D##6##2##(1996-1#1)(2008-12#3)(2011-2#1)(2013-1#1)
group I intron##4##3##(1993-1#1)(1995-6#2)(2008-10#1)
group I isolates formed##2##4##(2008-10#2)
group I isolates were##2##4##(2008-10#2)
group I isolates##5##3##(2008-10#5)
group I##28##2##(1991-3#1)(1993-1#1)(1994-11#1)(1995-6#3)(1996-12#2)(2006-6#2)(2008-10#12)(2009-10#1)(2009-3#2)(2009-8#1)(2010-1#2)
group II and##2##3##(2006-6#2)
group II isolates##4##3##(2008-10#4)
group II##24##2##(1991-3#1)(1994-11#1)(1997-3#3)(2006-6#4)(2008-10#11)(2008-9#1)(2009-8#1)(2010-1#2)
group III##13##2##(2006-6#2)(2008-10#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2012-2#2)
group L##11##2##(1996-3#11)
group N##5##2##(2013-1#5)
group S##7##2##(1996-3#7)
group a##2##2##(1990-5#1)(2008-10#1)
group after##2##2##(2010-4#1)(2011-2#1)
group against##2##2##(2011-1#1)(2011-2#1)
group also##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
group analyses##2##2##(2008-10#1)(2008-11#1)
group analysis##2##2##(2008-10#2)
group and 1##2##3##(2008-12#1)(2013-1#1)
group and 2##2##3##(2011-2#1)(2013-1#1)
group and 5##2##3##(2008-12#1)(2009-3#1)
group and a##2##3##(2008-10#2)
group and in##4##3##(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
group and individual##3##3##(1991-1#1)(2008-11#2)
group and its##2##3##(1992-10#1)(2008-10#1)
group and no##2##3##(2013-1#2)
group and that##2##3##(2008-11#1)(2008-9#1)
group and the##12##3##(1991-12#1)(1993-3#1)(1994-5#2)(2008-1#1)(2008-10#3)(2008-7#1)(2010-4#1)(2010-5#2)
group and##96##2##(1990-2#2)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-5#2)(1995-6#1)(1996-1#1)(1997-1#1)(1997-7#3)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#6)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#3)(2009-7#1)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#13)(2012-3#1)(2013-1#6)
group are subjected to##2##4##(2012-3#2)
group are##7##2##(1990-12#1)(2008-10#4)(2012-3#2)
group as a##2##3##(1996-1#1)(2008-10#1)
group as##8##2##(1996-1#1)(1996-5#2)(2008-10#2)(2008-12#1)(2008-8#1)(2013-1#1)
group at the##7##3##(1991-12#1)(1991-3#1)(1996-5#1)(2008-10#4)
group at##22##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-2#1)(1993-8#2)(1996-5#3)(1997-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)
group because##2##2##(2008-8#1)(2011-1#1)
group but##5##2##(2008-10#3)(2011-2#1)(2012-3#1)
group by##4##2##(1994-8#1)(2008-10#2)(2013-1#1)
group can##2##2##(1993-12#1)(2010-12#1)
group children exhibited##2##3##(2008-12#2)
group cohesion##2##2##(2008-9#1)(2010-8#1)
group compared to the##2##4##(1994-12#1)(2009-7#1)
group compared to##5##3##(1990-11#1)(1994-12#1)(1994-8#1)(2009-7#1)(2010-6#1)
group compared with the##6##4##(1996-6#1)(2009-8#1)(2010-1#1)(2011-2#3)
group compared with##8##3##(1996-6#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-3#2)
group compared##13##2##(1990-11#1)(1994-12#1)(1994-8#1)(1996-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#3)(2012-3#2)
group comprised##6##2##(1991-12#1)(2008-10#1)(2008-12#1)(2009-6#1)(2012-3#1)(2013-1#1)
group consisted of##6##3##(1994-3#2)(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
group consisting of##2##3##(2008-10#1)(2008-12#1)
group consists of##3##3##(2008-10#2)(2008-8#1)
group contained##3##2##(2008-10#2)(2011-3#1)
group containing##5##2##(2008-10#5)
group content##2##2##(2008-10#2)
group could be##3##3##(2008-10#2)(2008-5#1)
group could##4##2##(1993-1#1)(2008-10#2)(2008-5#1)
group demonstrated a##2##3##(2008-12#2)
group design##2##2##(1996-3#1)(2013-1#1)
group developed##2##2##(2011-1#1)(2011-2#1)
group did not##5##3##(1994-12#1)(1995-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
group differences in the##3##4##(1993-3#1)(1994-8#1)(2009-3#1)
group differences in##5##3##(1993-3#1)(1994-8#1)(2009-3#1)(2012-2#1)(2013-1#1)
group differences##10##2##(1992-12#1)(1993-3#1)(1994-8#1)(2008-12#1)(2008-6#2)(2009-3#1)(2012-2#1)(2013-1#2)
group discussions##7##2##(1994-6#1)(2008-11#3)(2009-3#1)(2010-2#1)(2012-2#1)
group displayed##2##2##(1995-1#1)(2013-1#1)
group during the##2##3##(1997-3#1)(2008-11#1)
group elements##11##2##(2008-10#8)(2008-11#2)(2009-12#1)
group examined##2##2##(2008-11#1)(2008-7#1)
group exhibited##4##2##(1990-3#1)(2008-10#2)(2012-2#1)
group experienced##2##2##(1993-1#1)(2008-7#1)
group fMRI data##3##3##(2008-11#3)
group fission##2##2##(2010-4#2)
group focused on##2##3##(1993-6#1)(2008-8#1)
group for the##5##3##(2008-10#1)(2008-11#1)(2008-4#2)(2009-5#1)
group for##22##2##(1991-12#2)(1992-3#1)(1993-12#1)(1993-3#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
group format##2##2##(2009-5#1)(2012-2#1)
group formation##2##2##(2008-10#1)(2008-8#1)
group from the##3##3##(1996-5#1)(2008-10#2)
group from##9##2##(1996-5#1)(2008-10#3)(2008-4#1)(2009-12#1)(2009-8#2)(2011-2#1)
group functionalized##2##2##(2008-10#1)(2011-2#1)
group had a significantly##2##4##(2008-3#1)(2011-1#1)
group had a##7##3##(2008-11#2)(2008-3#1)(2009-3#2)(2011-1#1)(2011-2#1)
group had better##2##3##(2011-2#2)
group had significantly lower levels of##2##6##(2008-10#1)(2013-8#1)
group had##24##2##(1990-12#1)(1991-2#1)(1993-1#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-3#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
group has a##4##3##(1994-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
group has##9##2##(1994-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#2)
group have been##2##3##(2008-10#2)
group have##6##2##(1991-12#1)(1995-12#1)(1995-5#1)(2008-10#3)
group health##2##2##(1991-9#1)(2008-11#1)
group home##3##2##(1995-12#1)(2010-8#2)
group in all##2##3##(2008-10#1)(2008-8#1)
group in aqueous solution##2##4##(1997-2#2)
group in both##2##3##(2008-9#1)(2012-2#1)
group in the##10##3##(1991-5#1)(1993-3#1)(2008-10#7)(2010-1#1)
group in##45##2##(1990-5#1)(1991-5#1)(1992-4#1)(1993-3#1)(1994-1#1)(1994-12#1)(1996-5#1)(1997-1#1)(1997-2#3)(2008-10#17)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#2)
group included 40 patients##2##4##(2011-2#2)
group included 50 patients (N = 100 eyes) who underwent##2##10##(2011-2#2)
group included those diagnosed with##2##5##(2011-2#2)
group included##11##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#6)(2013-1#1)
group includes isolates of races##2##5##(2008-10#2)
group includes isolates of##3##4##(2008-10#3)
group includes##4##2##(2008-10#3)(2011-2#1)
group increases##2##2##(2007-12#1)(2008-10#1)
group interview##4##2##(1992-2#2)(2008-11#2)
group interviews were conducted##2##4##(2008-11#2)
group interviews were##3##3##(2008-11#3)
group interviews##11##2##(2008-11#6)(2008-12#2)(2010-10#2)(2011-2#1)
group into##2##2##(2008-10#1)(2008-11#1)
group is not##3##3##(1990-5#1)(2008-7#1)(2010-12#1)
group is##26##2##(1990-5#1)(1991-5#1)(1993-8#2)(1994-2#1)(1997-1#1)(2008-10#9)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#2)
group level##4##2##(2008-10#1)(2009-10#1)(2012-2#1)(2013-8#1)
group living and##2##3##(2008-8#1)(2008-9#1)
group living##3##2##(2008-8#1)(2008-9#2)
group mean##4##2##(1991-11#1)(1991-12#1)(1991-3#1)(2008-1#1)
group medical practices##3##3##(1993-12#3)
group members##14##2##(1996-3#1)(2008-10#1)(2008-8#2)(2008-9#8)(2010-1#1)(2011-2#1)
group of 10##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
group of 102##2##3##(2008-10#1)(2008-9#1)
group of 12 patients##2##4##(2011-2#1)(2011-3#1)
group of 12##4##3##(2011-2#2)(2011-3#1)(2012-2#1)
group of 15##2##3##(1996-3#1)(2008-10#1)
group of 19 patients##2##4##(2012-3#2)
group of 20 patients##2##4##(1994-12#1)(1996-9#1)
group of 22##2##3##(2008-9#1)(2012-3#1)
group of 25##2##3##(1990-9#1)(2013-1#1)
group of 29##2##3##(1996-9#1)(2010-12#1)
group of 30##2##3##(2008-7#1)(2011-2#1)
group of adult##3##3##(2008-10#1)(2008-9#2)
group of animals##2##3##(1993-3#1)(2008-11#1)
group of cells##2##3##(2008-10#1)(2010-6#1)
group of diseases##2##3##(2011-2#1)(2012-3#1)
group of disorders##3##3##(2008-7#1)(2012-2#2)
group of drugs##2##3##(2011-2#2)
group of elderly##2##3##(1993-1#1)(2011-2#1)
group of fungi##2##3##(2008-5#1)(2011-1#1)
group of genetic##2##3##(2010-2#1)(2011-2#1)
group of healthy##2##3##(1990-2#1)(2010-12#1)
group of highly##2##3##(1991-2#1)(1991-5#1)
group of isolates from##2##4##(2008-10#2)
group of isolates##4##3##(2008-10#4)
group of patient##2##3##(2012-3#2)
group of patients were##2##4##(1990-2#1)(2012-3#1)
group of patients whose cerebellar symptoms##2##6##(2011-2#2)
group of patients with##4##4##(1992-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
group of patients##26##3##(1990-2#1)(1990-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1995-2#2)(1996-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#6)(2011-3#1)(2012-3#3)(2013-1#4)
group of plants##2##3##(2008-11#1)(2009-8#1)
group of proteins that##2##4##(2008-10#1)(2011-2#1)
group of rats##3##3##(1993-8#1)(1994-8#1)(2008-10#1)
group of seven##2##3##(1993-3#1)(2008-11#1)
group of students##3##3##(1996-2#1)(2008-11#2)
group of the##7##3##(1990-5#1)(1992-3#1)(1994-5#1)(1996-5#1)(2008-1#1)(2008-10#2)
group of tumors##2##3##(2010-12#1)(2011-2#1)
group of users##2##3##(2008-11#1)(2012-3#1)
group of women##2##3##(1992-3#1)(2012-3#1)
group of##343##2##(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#3)(1992-3#6)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#46)(2008-11#23)(2008-12#11)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#14)(2009-10#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2011-1#1)(2011-10#1)(2011-2#30)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#11)(2012-3#21)(2013-1#16)(2013-8#3)
group on corms of##2##4##(2008-10#2)
group on the##8##3##(1993-2#1)(1993-8#1)(1994-11#1)(1996-5#1)(2008-10#4)
group on##17##2##(1990-5#1)(1993-2#1)(1993-8#1)(1994-11#2)(1996-5#1)(2008-10#10)(2008-12#1)
group one##3##2##(2013-8#3)
group onto the##2##3##(1997-7#1)(2013-8#1)
group onto##3##2##(1997-7#1)(2013-8#2)
group or##7##2##(1992-12#1)(1993-1#1)(2008-10#3)(2008-12#1)(2010-4#1)
group parameters##4##2##(1996-3#1)(2008-10#3)
group patients##4##2##(1994-3#1)(1995-12#2)(2010-12#1)
group practice setting##3##3##(1994-3#2)(1996-1#1)
group practice##10##2##(1993-1#2)(1994-3#3)(1995-1#1)(1996-1#2)(1997-2#1)(1997-3#1)
group practices##5##2##(1992-3#1)(1993-1#1)(1995-1#1)(1997-1#1)(1997-3#1)
group process and##2##3##(1994-3#1)(2008-12#1)
group process##3##2##(1994-3#1)(2008-12#2)
group processes##2##2##(2008-11#2)
group provides##2##2##(2008-10#1)(2008-9#1)
group received##5##2##(2008-11#1)(2008-12#1)(2009-12#2)(2011-2#1)
group receiving single##2##3##(2008-10#2)
group receiving##8##2##(1991-1#3)(1991-2#1)(2008-10#4)
group refractive index##3##3##(2008-2#2)(2008-3#1)
group reported that they would##4##5##(2010-4#4)
group reported##7##2##(2008-10#1)(2008-11#1)(2010-4#4)(2011-2#1)
group reproductive##2##2##(2008-8#2)
group scored significantly higher than##2##5##(2010-8#2)
group scores##2##2##(1992-2#1)(2008-2#1)
group seeks to##2##3##(1992-11#2)
group selection##5##2##(2008-8#1)(2008-9#1)(2010-4#3)
group sequential##2##2##(1994-9#2)
group showed a##4##3##(1990-2#1)(2009-3#1)(2011-2#1)(2012-12#1)
group showed significantly##4##3##(1990-12#1)(1991-12#1)(2008-8#1)(2009-12#1)
group showed##16##2##(1990-12#2)(1990-2#1)(1991-12#1)(1994-3#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-12#1)
group size and##5##3##(1994-3#2)(2008-8#3)
group size is##4##3##(2008-8#3)(2009-8#1)
group size##25##2##(1994-3#2)(2008-8#13)(2008-9#2)(2009-8#5)(2012-2#3)
group sizes##2##2##(2008-8#2)
group sustainability##2##2##(2009-5#2)
group system##5##2##(1991-3#1)(2012-2#2)(2013-1#2)
group testing##3##2##(2008-10#3)
group than in the CAF+FT##2##5##(1997-7#2)
group than in the##8##4##(1994-8#1)(1997-7#2)(2008-7#1)(2011-2#4)
group than##12##2##(1994-8#1)(1996-6#1)(1997-7#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#4)
group that received##2##3##(1993-1#1)(2008-12#1)
group that was##3##3##(2008-10#1)(2013-1#2)
group that##14##2##(1993-1#1)(1994-3#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#1)(2013-1#3)
group the##5##2##(1990-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
group therapy##5##2##(2008-11#3)(2008-4#1)(2013-1#1)
group there##2##2##(1994-8#1)(2013-1#1)
group to a##2##3##(2008-10#2)
group to the##2##3##(1995-2#1)(2008-10#1)
group to##22##2##(1990-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#2)(2008-10#8)(2008-11#1)(2010-4#2)(2011-1#1)
group together##2##2##(1996-11#1)(2008-11#1)
group treatment##4##2##(2008-11#1)(2009-11#3)
group under##2##2##(1990-12#2)
group underwent an##2##3##(2008-11#2)
group underwent the procedure##2##4##(2008-8#2)
group underwent##5##2##(2008-11#2)(2008-8#2)(2012-3#1)
group using##2##2##(2008-10#2)
group versus##2##2##(2012-12#1)(2013-1#1)
group was (0##2##3##(2008-8#2)
group was characterized by##2##4##(2008-10#2)
group was found to##2##4##(1993-12#1)(2008-10#1)
group was found##5##3##(1993-12#1)(2008-10#3)(2008-9#1)
group was greater##3##3##(2008-10#2)(2008-11#1)
group was higher than##3##4##(1990-12#2)(2008-12#1)
group was injected with##2##4##(1994-5#1)(2008-12#1)
group was injected##3##3##(1994-5#1)(2008-12#1)(2008-9#1)
group was more##3##3##(1990-12#1)(1997-3#1)(2013-1#1)
group was significantly higher than that of##2##7##(2011-2#1)(2011-3#1)
group was significantly higher than that##3##6##(1997-7#1)(2011-2#1)(2011-3#1)
group was significantly lower##2##4##(2011-2#1)(2013-1#1)
group was significantly##6##3##(1997-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
group was treated with##3##4##(1990-2#1)(2013-1#2)
group was##69##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-9#2)(1992-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#15)(2008-11#9)(2008-12#3)(2008-6#1)(2008-8#2)(2008-9#3)(2010-6#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
group were compared##2##3##(2008-12#1)(2008-7#1)
group were identified##2##3##(2008-10#2)
group were in the##2##4##(2008-10#2)
group were injected i##2##4##(2010-1#2)
group were significantly higher than##2##5##(2011-2#2)
group were significantly##3##3##(2008-12#1)(2011-2#2)
group were treated##2##3##(1991-8#1)(2013-1#1)
group were##39##2##(1991-8#1)(1992-5#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(2006-6#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#2)(2010-1#2)(2010-4#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
group when compared with predialysis##2##5##(2008-12#2)
group when compared with the##2##5##(2010-1#1)(2010-12#1)
group when compared with##5##4##(2008-12#2)(2010-1#1)(2010-12#1)(2011-2#1)
group when##9##2##(1993-8#1)(2008-10#1)(2008-12#2)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
group which##4##2##(1991-2#2)(2008-5#1)(2011-2#1)
group while##2##2##(2008-12#1)(2009-3#1)
group will##3##2##(1997-1#1)(1997-6#1)(2012-3#1)
group with a##3##3##(1993-8#1)(1994-6#1)(2010-11#1)
group with no HMEs##2##4##(1992-2#2)
group with the##5##3##(1990-2#1)(1992-12#1)(1995-2#1)(1996-5#1)(2012-12#1)
group with##38##2##(1990-2#1)(1990-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-2#2)(1996-5#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-9#4)(2009-6#1)(2010-11#1)(2012-12#1)(2012-3#4)(2013-1#2)
group without##4##2##(1993-8#1)(1994-12#2)(2013-1#1)
group##2421##1##(1990-11#8)(1990-12#16)(1990-2#15)(1990-3#6)(1990-5#9)(1990-6#8)(1990-8#2)(1990-9#5)(1991-1#11)(1991-11#4)(1991-12#20)(1991-2#17)(1991-3#9)(1991-5#7)(1991-6#3)(1991-7#2)(1991-8#7)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#7)(1992-12#13)(1992-2#11)(1992-3#14)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#5)(1993-1#20)(1993-11#4)(1993-12#17)(1993-2#10)(1993-3#24)(1993-6#6)(1993-8#17)(1994-1#6)(1994-11#7)(1994-12#17)(1994-2#10)(1994-3#28)(1994-5#11)(1994-6#3)(1994-8#18)(1994-9#7)(1995-1#7)(1995-11#5)(1995-12#16)(1995-2#15)(1995-3#4)(1995-5#4)(1995-6#11)(1995-8#2)(1995-9#1)(1996-1#14)(1996-11#7)(1996-12#6)(1996-2#4)(1996-3#27)(1996-5#20)(1996-6#11)(1996-9#6)(1997-1#12)(1997-2#7)(1997-3#13)(1997-5#1)(1997-6#2)(1997-7#14)(1997-8#5)(2006-5#1)(2006-6#10)(2007-11#4)(2007-12#10)(2007-8#10)(2008-1#10)(2008-10#482)(2008-11#133)(2008-12#94)(2008-2#8)(2008-3#7)(2008-4#12)(2008-5#28)(2008-6#9)(2008-7#53)(2008-8#63)(2008-9#82)(2009-1#2)(2009-10#10)(2009-11#7)(2009-12#17)(2009-3#24)(2009-4#1)(2009-5#9)(2009-6#7)(2009-7#7)(2009-8#25)(2009-9#3)(2010-1#20)(2010-10#8)(2010-11#3)(2010-12#17)(2010-2#3)(2010-3#3)(2010-4#30)(2010-5#5)(2010-6#10)(2010-7#14)(2010-8#7)(2010-9#4)(2011-1#28)(2011-10#1)(2011-2#191)(2011-3#20)(2011-7#1)(2012-12#11)(2012-2#58)(2012-3#70)(2013-1#127)(2013-7#1)(2013-8#31)
group&quot##3##1##(2008-10#1)(2008-6#2)
group's##9##1##(1993-1#2)(1993-3#1)(1994-3#2)(1995-3#1)(1997-3#1)(2008-10#1)(2010-4#1)
group) and##7##2##(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
group) or##3##2##(1993-6#1)(2011-2#2)
group) showed a##2##3##(1991-8#1)(2012-3#1)
group)##47##1##(1991-8#1)(1993-2#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-1#1)(2010-6#3)(2011-1#1)(2011-2#10)(2012-2#1)(2012-3#1)(2013-1#8)
group-based##2##1##(2008-12#1)(2013-1#1)
group-specific##3##1##(1995-2#1)(2008-10#2)
group-velocity##2##1##(2007-11#1)(2008-2#1)
grouped according to##4##3##(1997-8#1)(2008-10#2)(2011-2#1)
grouped as##3##2##(2008-10#2)(2012-2#1)
grouped by##4##2##(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
grouped in two##3##3##(1996-3#1)(2008-10#2)
grouped in##8##2##(1996-3#1)(2008-10#7)
grouped into six##2##3##(2008-10#2)
grouped into three##6##3##(1991-2#1)(1991-5#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-1#1)
grouped into two##3##3##(2008-10#2)(2008-11#1)
grouped into##20##2##(1991-2#1)(1991-5#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
grouped on the##2##3##(2008-10#2)
grouped the##6##2##(2008-10#5)(2009-10#1)
grouped together##6##2##(2008-10#5)(2008-11#1)
grouped under the##3##3##(2008-1#1)(2009-10#1)(2011-2#1)
grouped with other##2##3##(2008-10#2)
grouped with##3##2##(2008-10#3)
grouped##77##1##(1991-2#1)(1991-5#1)(1993-2#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#49)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
grouper##15##1##(2010-5#15)
groupers##4##1##(2010-5#4)
grouping and##2##2##(1995-3#1)(2009-10#1)
grouping at##2##2##(2008-11#1)(2011-2#1)
grouping by##2##2##(2008-10#1)(2008-9#1)
grouping of the##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
grouping of##10##2##(2008-10#5)(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
grouping##44##1##(1991-12#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-3#1)(2008-10#23)(2008-11#1)(2008-5#2)(2008-9#4)(2009-10#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#3)(2013-8#1)
groupings based##2##2##(2008-10#2)
groupings that##2##2##(1993-3#1)(2008-10#1)
groupings##10##1##(1993-3#1)(1994-1#1)(1995-1#1)(1996-1#1)(2008-10#6)
groups (P &lt##3##3##(2011-3#2)(2012-3#1)
groups (P##4##2##(2011-3#3)(2012-3#1)
groups (e##2##2##(2008-10#1)(2008-8#1)
groups (n =##2##3##(2008-10#1)(2013-1#1)
groups (n=10)##2##2##(2013-1#2)
groups (p &lt##2##3##(2008-10#1)(2013-1#1)
groups (p##6##2##(1991-2#1)(2008-10#1)(2011-2#3)(2013-1#1)
groups 1##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
groups 3##2##2##(2008-11#1)(2009-6#1)
groups A##5##2##(2008-10#2)(2010-12#2)(2010-7#1)
groups II##2##2##(2009-3#1)(2010-1#1)
groups according to the##7##4##(1996-12#1)(1996-6#1)(2008-10#4)(2011-2#1)
groups according to##10##3##(1996-12#1)(1996-6#1)(2008-10#4)(2008-7#1)(2011-2#3)
groups after##3##2##(2008-4#1)(2009-12#1)(2011-2#1)
groups and a##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)
groups and ammonium##2##3##(2008-10#2)
groups and by##2##3##(2008-10#1)(2009-7#1)
groups and different##2##3##(1990-12#1)(2008-10#1)
groups and individuals##2##3##(1991-2#1)(1997-8#1)
groups and subgroups##2##3##(1993-2#1)(2008-10#1)
groups and the##7##3##(1991-1#1)(1994-8#1)(2008-10#3)(2008-7#1)(2012-3#1)
groups and to##3##3##(1995-6#1)(2008-10#1)(2010-5#1)
groups and##87##2##(1990-12#1)(1991-1#2)(1991-2#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#4)(1993-2#3)(1994-1#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-3#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
groups are discussed##2##3##(1993-1#1)(2008-5#1)
groups are##21##2##(1991-11#1)(1991-5#1)(1993-1#1)(1994-8#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-7#1)
groups as a##3##3##(1992-4#1)(2008-10#1)(2008-5#1)
groups as##11##2##(1990-9#1)(1992-4#1)(2008-10#6)(2008-5#1)(2010-4#1)(2012-4#1)
groups associated with##3##3##(2008-10#2)(2008-11#1)
groups at the##6##3##(1996-5#2)(2008-11#2)(2008-4#1)(2011-2#1)
groups at##14##2##(1991-12#1)(1996-5#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2011-2#2)(2013-1#1)
groups based on the##2##4##(2008-10#2)
groups based on their##6##4##(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
groups based on##15##3##(2008-10#8)(2008-11#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#3)
groups based##17##2##(1991-3#2)(2008-10#8)(2008-11#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#3)
groups because##2##2##(2008-10#1)(2010-12#1)
groups but##4##2##(1993-2#1)(2008-7#1)(2008-8#1)(2010-8#1)
groups by##13##2##(1990-12#1)(1992-12#1)(1994-12#1)(1995-12#1)(2008-10#6)(2008-8#1)(2008-9#1)(2011-2#1)
groups can be##3##3##(1995-12#1)(2008-10#2)
groups can##6##2##(1993-3#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#1)
groups combined##3##2##(1992-12#1)(1994-2#1)(2008-12#1)
groups compared to##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
groups compared with##2##3##(1995-5#1)(2008-11#1)
groups compared##5##2##(1995-5#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)
groups corresponding to the##2##4##(2008-10#2)
groups corresponding to##3##3##(2008-10#2)(2008-9#1)
groups could be##2##3##(2008-10#1)(2008-11#1)
groups demonstrated##4##2##(1993-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
groups depending on the##3##4##(1991-9#1)(2008-7#1)(2010-1#1)
groups designated##2##2##(1996-3#1)(2008-10#1)
groups did not differ significantly##2##5##(2010-7#1)(2011-1#1)
groups did not differ##5##4##(2008-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)
groups did not##7##3##(1991-2#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)
groups differed in their##2##4##(2008-10#1)(2010-5#1)
groups different##2##2##(2008-10#1)(2008-4#1)
groups displayed##2##2##(2008-10#1)(2009-10#1)
groups do##2##2##(1993-1#1)(2009-5#1)
groups each##2##2##(2008-10#1)(2008-11#1)
groups except##2##2##(2008-5#1)(2009-7#1)
groups exhibited##2##2##(2008-10#1)(2013-1#1)
groups for the##3##3##(1996-6#1)(1997-8#1)(2013-1#1)
groups for##18##2##(1990-11#1)(1991-1#1)(1991-12#1)(1993-8#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2013-1#1)
groups found##2##2##(2008-9#1)(2013-1#1)
groups from a##2##3##(1997-2#1)(2008-1#1)
groups from the##3##3##(2008-10#2)(2008-7#1)
groups from##11##2##(1993-1#1)(1994-3#2)(1997-2#1)(2008-1#1)(2008-10#3)(2008-7#2)(2011-1#1)
groups generally##2##2##(2009-4#1)(2010-10#1)
groups had##4##2##(1995-8#1)(1996-2#1)(2006-6#1)(2008-7#1)
groups have been##3##3##(1991-11#1)(1997-2#1)(2008-11#1)
groups have demonstrated that##2##4##(1992-1#1)(2006-6#1)
groups have##15##2##(1991-11#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-3#2)(1995-1#1)(1997-2#1)(2006-6#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2011-7#1)
groups identified##2##2##(2008-10#1)(2008-7#1)
groups in a##5##3##(1992-1#1)(2008-10#2)(2008-11#1)(2008-4#1)
groups in both##6##3##(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#3)
groups in comparison##2##3##(2008-10#1)(2008-12#1)
groups in order to##2##4##(2008-10#1)(2008-12#1)
groups in the##21##3##(1990-2#1)(1991-5#1)(1994-12#2)(2008-10#12)(2008-11#2)(2008-7#1)(2010-8#1)(2013-1#1)
groups in these##2##3##(2008-10#2)
groups in which##2##3##(1997-3#1)(2008-8#1)
groups in##83##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-3#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#2)(2008-10#29)(2008-11#3)(2008-12#4)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-1#1)(2009-11#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
groups including the##2##3##(1997-8#1)(2010-8#1)
groups including##7##2##(1997-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
groups is##6##2##(2008-10#2)(2008-11#1)(2008-8#2)(2009-3#1)
groups may##4##2##(1991-12#1)(1993-1#1)(2008-10#1)(2008-8#1)
groups necessary##2##2##(2008-11#1)(2008-7#1)
groups not##2##2##(2008-5#1)(2009-12#1)
groups of 10##6##3##(2008-9#6)
groups of C##2##3##(2008-10#2)
groups of P##2##3##(2008-10#2)
groups of compounds##2##3##(2008-10#1)(2009-4#1)
groups of females##2##3##(2008-11#1)(2008-9#1)
groups of four##2##3##(1996-12#1)(2008-10#1)
groups of individuals##2##3##(1991-2#1)(2008-10#1)
groups of isolates##6##3##(2008-10#5)(2011-2#1)
groups of males and##2##4##(2008-9#2)
groups of males at##2##4##(2008-9#2)
groups of males##5##3##(2008-11#1)(2008-9#4)
groups of mice##4##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-7#1)
groups of mothers and##2##4##(2009-11#2)
groups of organisms##3##3##(2008-10#2)(2008-9#1)
groups of patients in##2##4##(2008-11#1)(2013-1#1)
groups of patients were studied##2##5##(1991-3#1)(1992-2#1)
groups of patients with##2##4##(1991-2#1)(2012-2#1)
groups of patients##13##3##(1990-5#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-9#1)(1995-2#1)(2007-8#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
groups of proteins##2##3##(2008-10#1)(2008-7#1)
groups of rats##10##3##(1990-5#1)(1994-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
groups of species##2##3##(2008-8#1)(2008-9#1)
groups of strains##3##3##(2008-10#3)
groups of students##4##3##(1997-2#1)(2008-11#2)(2008-12#1)
groups of subjects##2##3##(2008-7#1)(2012-2#1)
groups of the##17##3##(1992-6#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-5#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-9#1)(2009-7#1)
groups of these##4##3##(1993-12#1)(2008-10#1)(2008-12#1)(2009-8#1)
groups of women##2##3##(1992-2#1)(2013-1#1)
groups of##237##2##(1990-5#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-7#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#10)(1996-2#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-8#1)(2008-10#69)(2008-11#18)(2008-12#5)(2008-3#1)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#18)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#2)
groups on a 7-deoxycholic amide##2##5##(2008-10#2)
groups on a##3##3##(2008-10#2)(2008-12#1)
groups on the biomass##2##4##(2008-10#2)
groups on the##14##3##(1994-5#1)(1994-9#1)(1996-5#1)(2008-1#2)(2008-10#8)(2011-2#1)
groups on##27##2##(1993-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#1)(2009-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
groups or##5##2##(1996-1#1)(2008-1#1)(2008-10#2)(2012-2#1)
groups per##2##2##(1991-5#1)(2008-10#1)
groups provided##2##2##(2008-12#1)(2010-10#1)
groups received##4##2##(1993-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
groups receiving##3##2##(1993-6#1)(1996-12#1)(2008-5#1)
groups revealed##2##2##(2008-11#1)(2009-11#1)
groups seemed to##2##3##(2008-10#1)(2008-11#1)
groups should##2##2##(1991-3#1)(2008-10#1)
groups showed a##5##3##(1990-12#1)(1994-3#1)(1994-8#1)(2008-9#1)(2010-5#1)
groups showed similar##2##3##(1997-1#1)(2009-6#1)
groups showed##11##2##(1990-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-5#1)(1997-1#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-5#1)
groups such as##4##3##(1996-5#2)(2008-10#1)(2013-1#1)
groups that are##2##3##(2008-10#2)
groups that corresponded to##2##4##(2008-10#2)
groups that differed significantly##2##4##(2008-10#2)
groups that differed##3##3##(2008-10#3)
groups that elicit##2##3##(2008-11#2)
groups that have##4##3##(1993-12#1)(1996-2#1)(2008-10#1)(2010-12#1)
groups that were##2##3##(2008-10#2)
groups that##35##2##(1990-3#1)(1991-2#1)(1993-12#1)(1994-1#6)(1994-12#1)(1995-11#1)(1996-2#2)(2008-10#15)(2008-11#3)(2008-12#1)(2010-12#2)(2013-1#1)
groups the##2##2##(1993-3#1)(2011-2#1)
groups throughout##4##2##(1993-12#1)(2008-9#3)
groups to form##3##3##(2008-10#2)(2011-2#1)
groups to the##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
groups to##26##2##(1991-1#1)(1991-12#1)(1992-3#3)(1994-12#2)(1994-2#1)(1996-5#1)(1997-3#2)(2008-10#9)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#1)
groups under the##2##3##(2008-11#1)(2010-10#1)
groups using the##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
groups using##8##2##(1991-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-2#2)
groups versus##2##2##(1993-12#1)(2011-2#1)
groups was conducted##2##3##(2008-10#1)(2008-12#1)
groups was estimated##2##3##(1994-2#1)(2008-10#1)
groups was not##2##3##(1991-11#1)(2008-10#1)
groups was significantly##2##3##(1994-12#1)(1995-8#1)
groups was similar to that of##4##6##(2008-9#4)
groups was similar##5##3##(1996-12#1)(2008-9#4)
groups was##31##2##(1991-11#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-8#1)(2013-1#1)
groups were all##2##3##(2008-10#2)
groups were also##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
groups were combined##2##3##(1992-11#1)(2012-3#1)
groups were compared##4##3##(2008-11#1)(2009-12#1)(2011-1#1)(2011-2#1)
groups were formed##3##3##(2008-11#1)(2010-4#1)(2012-5#1)
groups were found in##2##4##(1990-2#1)(2011-2#1)
groups were found to be##4##5##(1993-12#2)(2008-10#1)(2009-12#1)
groups were found to##6##4##(1993-12#2)(1994-3#1)(2008-10#1)(2008-11#1)(2009-12#1)
groups were found##8##3##(1990-2#1)(1993-12#2)(1994-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
groups were less##2##3##(2008-8#1)(2009-11#1)
groups were not significantly different##2##5##(2008-5#1)(2012-3#1)
groups were not##3##3##(1992-2#1)(2008-5#1)(2012-3#1)
groups were observed##4##3##(1992-12#1)(1994-3#1)(2008-10#1)(2013-1#1)
groups were significantly##3##3##(1991-1#1)(1993-3#1)(2008-12#1)
groups were similar##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
groups were studied##2##3##(2008-10#1)(2012-3#1)
groups were used to explore##2##5##(1997-3#1)(2009-5#1)
groups were used to##3##4##(1997-3#1)(2008-11#1)(2009-5#1)
groups were used##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2009-5#1)
groups were##99##2##(1990-2#1)(1991-1#2)(1991-12#2)(1991-2#2)(1992-11#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#2)(1993-3#3)(1994-3#2)(1995-5#1)(1996-1#1)(1996-5#3)(1997-3#2)(2008-10#23)(2008-11#9)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#2)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#6)(2012-5#1)(2013-1#5)(2013-8#2)
groups when##2##2##(2008-10#1)(2010-7#1)
groups where##2##2##(1991-6#1)(2008-10#1)
groups whose##2##2##(1996-2#1)(2008-10#1)
groups with a##2##3##(1994-9#1)(2011-2#1)
groups with different##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
groups with respect to##2##4##(2009-12#1)(2013-1#1)
groups with##26##2##(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-3#1)(1994-9#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2011-2#2)(2013-1#1)
groups within the##2##3##(2008-10#1)(2008-8#1)
groups within##5##2##(2008-10#3)(2008-8#1)(2010-10#1)
groups##1761##1##(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#8)(1990-8#1)(1990-9#4)(1991-1#8)(1991-11#12)(1991-12#11)(1991-2#13)(1991-3#13)(1991-5#6)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#5)(1992-11#2)(1992-12#9)(1992-2#14)(1992-3#8)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#5)(1993-1#11)(1993-11#1)(1993-12#20)(1993-2#7)(1993-3#12)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-1#12)(1994-11#3)(1994-12#16)(1994-2#9)(1994-3#14)(1994-5#3)(1994-8#9)(1994-9#13)(1995-1#6)(1995-11#3)(1995-12#12)(1995-2#7)(1995-3#7)(1995-5#7)(1995-6#3)(1995-8#4)(1996-1#7)(1996-11#3)(1996-12#15)(1996-2#7)(1996-3#15)(1996-5#16)(1996-6#7)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#11)(1997-3#15)(1997-6#2)(1997-7#6)(1997-8#9)(1997-9#1)(2006-6#4)(2007-12#6)(2007-8#4)(2008-1#14)(2008-10#466)(2008-11#92)(2008-12#46)(2008-2#2)(2008-3#2)(2008-4#14)(2008-5#30)(2008-6#10)(2008-7#53)(2008-8#35)(2008-9#66)(2009-1#4)(2009-10#11)(2009-11#10)(2009-12#13)(2009-3#11)(2009-4#2)(2009-5#7)(2009-6#4)(2009-7#10)(2009-8#9)(2009-9#3)(2010-1#9)(2010-10#8)(2010-11#3)(2010-12#9)(2010-4#13)(2010-5#7)(2010-6#3)(2010-7#13)(2010-8#9)(2011-1#17)(2011-2#100)(2011-3#9)(2011-7#1)(2012-12#7)(2012-2#37)(2012-3#25)(2012-4#1)(2012-5#4)(2013-1#72)(2013-8#25)
groups'##2##1##(1994-1#1)(2010-12#1)
groups) were##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
groups)##12##1##(2008-10#3)(2008-11#1)(2008-12#3)(2009-1#1)(2010-1#1)(2010-2#1)(2012-2#1)(2012-3#1)
groups]##3##1##(1990-11#1)(1990-2#1)(2013-1#1)
grove##6##1##(2008-10#5)(2013-8#1)
groves in##2##2##(2008-10#2)
groves##7##1##(2008-10#6)(2013-8#1)
grow and##8##2##(1993-1#1)(2008-10#2)(2008-11#2)(2011-1#1)(2012-2#1)(2012-3#1)
grow as##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
grow at a##2##3##(1992-12#1)(2008-11#1)
grow at temperatures##2##3##(2008-10#2)
grow at##8##2##(1991-12#1)(1992-12#1)(2008-10#3)(2008-11#1)(2011-2#2)
grow either##2##2##(2008-11#1)(2009-6#1)
grow faster than##2##3##(1996-2#1)(2010-8#1)
grow faster##3##2##(1996-2#1)(2008-8#1)(2010-8#1)
grow in the##4##3##(2008-11#1)(2008-7#2)(2010-4#1)
grow in##19##2##(2008-10#3)(2008-11#10)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)
grow larger##2##2##(2008-8#1)(2008-9#1)
grow on the##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
grow on##15##2##(1997-3#2)(2008-10#6)(2008-7#1)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
grow to##2##2##(2008-11#2)
grow under##3##2##(2008-10#1)(2008-11#2)
grow well at 37 degrees C##2##6##(1991-2#1)(2008-11#1)
grow well at##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
grow well##5##2##(1991-2#1)(2008-10#1)(2008-11#2)(2009-8#1)
grow with##2##2##(1995-9#1)(2009-8#1)
grow##111##1##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#1)(1993-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-3#2)(2007-12#1)(2008-10#20)(2008-11#27)(2008-4#1)(2008-5#5)(2008-7#8)(2008-8#6)(2008-9#6)(2009-10#1)(2009-6#2)(2009-8#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#3)
grow-out tests##2##2##(2008-10#2)
grower effect##2##2##(2008-10#2)
grower##4##1##(2008-10#4)
growers in##3##2##(2008-10#3)
growers##11##1##(2008-10#11)
growing Saccharomyces cerevisiae##2##3##(1995-9#1)(2012-3#1)
growing and##3##2##(1996-2#1)(1996-8#1)(2008-10#1)
growing area of##2##3##(2008-10#1)(2008-12#1)
growing area##3##2##(2008-10#2)(2008-12#1)
growing areas##3##2##(2008-10#3)
growing at##2##2##(1991-3#1)(2008-8#1)
growing awareness of the##2##4##(2010-1#1)(2011-2#1)
growing body of data suggests that##2##6##(2008-11#1)(2008-8#1)
growing body of data##3##4##(2008-11#1)(2008-7#1)(2008-8#1)
growing body of evidence##4##4##(1990-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
growing body of##14##3##(1990-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
growing cells##4##2##(1991-2#1)(1997-6#1)(2008-11#2)
growing concern##4##2##(2007-12#1)(2008-11#2)(2008-8#1)
growing context-sensitive##2##2##(2009-12#2)
growing demand for##3##3##(1995-1#1)(2008-10#1)(2010-12#1)
growing evidence##7##2##(2006-6#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
growing field of##2##3##(2008-5#1)(2009-10#1)
growing field##3##2##(2008-5#1)(2009-10#1)(2010-5#1)
growing in a##3##3##(2008-10#2)(2008-11#1)
growing in the##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
growing in##32##2##(2008-10#17)(2008-11#6)(2008-12#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2012-3#1)(2012-5#1)(2013-8#1)
growing interest in the development of##2##6##(2008-11#1)(2009-7#1)
growing interest in the##7##4##(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-1#1)(2010-11#1)
growing interest in##15##3##(1997-7#1)(2008-10#3)(2008-11#3)(2008-7#2)(2009-7#1)(2010-1#2)(2010-11#1)(2011-3#1)(2013-1#1)
growing interest##17##2##(1997-7#1)(2008-10#3)(2008-11#3)(2008-7#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2011-3#1)(2013-1#1)(2013-8#1)
growing need for##3##3##(1991-10#1)(2008-11#1)(2013-8#1)
growing need##4##2##(1991-10#1)(2008-11#1)(2010-12#1)(2013-8#1)
growing number of studies##4##4##(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)
growing number of##15##3##(1991-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-2#5)(2011-3#1)(2012-12#1)
growing on the##2##3##(2008-10#2)
growing on##9##2##(2008-10#5)(2008-11#1)(2011-2#2)(2012-6#1)
growing pigs##2##2##(2008-9#1)(2013-1#1)
growing plants in##2##3##(2008-10#2)
growing points##3##2##(2008-10#3)
growing population of##2##3##(1997-6#1)(2007-12#1)
growing population##4##2##(1997-6#2)(2007-12#1)(2008-9#1)
growing practice##2##2##(1996-1#2)
growing pressure##3##2##(1997-1#1)(2008-11#1)(2008-12#1)
growing rapidly##4##2##(1992-12#1)(1995-3#1)(2008-10#1)(2009-3#1)
growing regions##3##2##(2008-10#2)(2010-10#1)
growing season##37##2##(2008-10#32)(2009-8#1)(2010-8#1)(2012-5#2)(2012-7#1)
growing seasons in##2##3##(2008-10#2)
growing seasons##12##2##(2008-10#12)
growing trend##4##2##(1994-1#1)(1994-3#2)(1996-1#1)
growing tumor##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
growing under##2##2##(2011-2#1)(2012-7#1)
growing use##2##2##(1996-2#1)(2009-10#1)
growing##346##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#3)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#7)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-9#2)(1996-1#5)(1996-2#2)(1996-3#3)(1996-8#2)(1997-1#2)(1997-2#1)(1997-6#5)(1997-7#1)(2006-6#1)(2007-12#5)(2008-1#1)(2008-10#109)(2008-11#31)(2008-12#13)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#7)(2009-10#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#5)(2010-10#2)(2010-11#3)(2010-12#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#21)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#4)(2012-5#4)(2012-6#1)(2012-7#2)(2013-1#11)(2013-8#10)
grown as##2##2##(2008-10#1)(2008-11#1)
grown at 0##3##3##(1991-11#2)(1994-3#1)
grown at##16##2##(1991-11#3)(1992-2#2)(1994-3#2)(2008-10#6)(2008-11#1)(2008-5#2)
grown by molecular beam epitaxy##3##5##(1995-3#1)(2007-12#1)(2009-11#1)
grown by##5##2##(1995-3#1)(2007-12#1)(2008-8#1)(2009-11#2)
grown dramatically##2##2##(1991-3#1)(2008-11#1)
grown during##2##2##(1996-1#1)(2008-10#1)
grown for##5##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-6#1)
grown from##4##2##(2008-10#4)
grown in a##8##3##(2008-10#4)(2008-11#2)(2008-12#1)(2012-2#1)
grown in both##3##3##(2008-10#2)(2008-7#1)
grown in culture##5##3##(1993-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
grown in glucose##2##3##(1996-12#1)(2008-10#1)
grown in growth chambers##2##4##(2008-10#1)(2012-5#1)
grown in high##2##3##(2008-11#1)(2012-7#1)
grown in media##3##3##(2008-11#1)(2008-7#1)(2012-7#1)
grown in medium##3##3##(1991-11#2)(2008-10#1)
grown in noncultivated##2##3##(2008-10#2)
grown in nonfumigated##2##3##(2008-10#2)
grown in nutrient##2##3##(2008-10#1)(2008-11#1)
grown in potting mix##2##4##(2008-10#2)
grown in serum-free##7##3##(2008-11#7)
grown in soil##7##3##(2008-10#6)(2010-11#1)
grown in the United States##5##5##(2008-10#5)
grown in the peat mix##3##5##(2008-10#3)
grown in the presence of##7##5##(1990-5#1)(1992-11#1)(2008-10#4)(2011-1#1)
grown in the##30##3##(1990-5#1)(1992-11#1)(1994-11#1)(2008-10#24)(2008-7#1)(2011-1#1)(2013-8#1)
grown in these##3##3##(2008-10#3)
grown in vitro##5##3##(1990-6#1)(2008-10#1)(2008-5#2)(2013-1#1)
grown in##158##2##(1990-5#1)(1990-6#1)(1991-11#2)(1992-11#1)(1993-12#1)(1994-11#1)(1995-2#1)(1996-12#2)(2008-10#92)(2008-11#27)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#2)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-5#2)(2012-7#3)(2012-9#1)(2013-1#1)(2013-8#1)
grown on a##2##3##(2008-10#2)
grown on microcarriers##3##3##(2008-11#3)
grown on plastic and##2##4##(2008-11#2)
grown on plastic##3##3##(2008-11#3)
grown on##31##2##(1990-5#1)(1991-9#1)(1994-3#1)(1995-9#1)(2008-10#12)(2008-11#10)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2013-1#1)
grown over##2##2##(2008-10#1)(2008-11#1)
grown separately##3##2##(2008-10#3)
grown to##4##2##(2007-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
grown together##2##2##(2008-10#2)
grown under a##2##3##(2008-10#1)(2008-11#1)
grown under elevated CO(2) concentration##2##5##(2008-10#2)
grown under##13##2##(1997-1#1)(2008-10#7)(2008-11#4)(2008-7#1)
grown with##7##2##(1992-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
grown##296##1##(1990-5#2)(1990-6#1)(1991-11#6)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#3)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#2)(2008-10#149)(2008-11#49)(2008-12#5)(2008-4#1)(2008-5#7)(2008-7#11)(2008-8#3)(2008-9#4)(2009-11#3)(2009-12#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-6#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-5#2)(2012-6#1)(2012-7#3)(2012-9#1)(2013-1#3)(2013-8#1)
grows as##2##2##(2007-11#1)(2008-8#1)
grows##14##1##(1991-12#1)(1996-3#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#1)(2012-3#2)
growth after##3##2##(1995-3#1)(2008-10#1)(2008-9#1)
growth and DNA synthesis##2##4##(1995-12#2)
growth and antibody production in##2##5##(2008-11#2)
growth and antibody production##4##4##(2008-11#4)
growth and cell##3##3##(1995-8#1)(2009-8#2)
growth and change##2##3##(1994-12#1)(1995-3#1)
growth and death##3##3##(1997-7#1)(2008-11#1)(2011-2#1)
growth and detachment##2##3##(2008-11#1)(2008-7#1)
growth and development and##2##4##(1994-3#1)(2009-6#1)
growth and development of##7##4##(1994-1#1)(1996-3#1)(2008-12#3)(2008-8#1)(2009-8#1)
growth and development##28##3##(1990-6#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#3)(2010-5#1)(2012-12#1)(2012-3#1)
growth and differentiation of##3##4##(1991-6#1)(2008-11#2)
growth and differentiation##10##3##(1991-6#1)(1993-3#1)(1994-6#1)(2008-10#1)(2008-11#5)(2010-7#1)
growth and induced##3##3##(2008-11#1)(2010-1#1)(2012-5#1)
growth and its##2##3##(2008-8#1)(2013-8#1)
growth and metabolism of##3##4##(2008-11#3)
growth and metabolism##4##3##(2008-11#3)(2009-8#1)
growth and metabolite##2##3##(2012-5#2)
growth and metastasis of##2##4##(1994-12#1)(2013-1#1)
growth and metastasis##9##3##(1994-12#3)(2009-3#3)(2012-3#1)(2013-1#1)(2013-8#1)
growth and monoclonal antibody production##2##5##(2008-11#1)(2011-2#1)
growth and monoclonal antibody##3##4##(2008-11#2)(2011-2#1)
growth and production of##2##4##(2008-11#2)
growth and production##3##3##(2008-11#3)
growth and productivity of##4##4##(2008-11#2)(2008-12#2)
growth and productivity##6##3##(2008-11#4)(2008-12#2)
growth and proliferation##5##3##(1992-8#1)(1996-3#1)(2008-11#2)(2008-8#1)
growth and protein##2##3##(2008-11#2)
growth and recombinant protein production##4##5##(2008-11#4)
growth and reproduction##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
growth and subsequent##2##3##(2008-10#1)(2012-2#1)
growth and survival of the##2##5##(2008-11#1)(2011-2#1)
growth and survival##5##3##(2008-11#3)(2008-5#1)(2011-2#1)
growth and the##3##3##(1995-12#1)(2013-1#2)
growth and tissue##3##3##(1990-11#1)(1993-12#1)(2012-2#1)
growth and transport##2##3##(2013-1#1)(2013-8#1)
growth and viability##2##3##(1995-9#1)(2008-11#1)
growth and##240##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#2)(2008-1#1)(2008-10#29)(2008-11#61)(2008-12#8)(2008-4#1)(2008-5#7)(2008-7#7)(2008-8#12)(2008-9#7)(2009-10#1)(2009-3#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#8)(2010-1#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#2)(2012-5#4)(2013-1#11)(2013-7#1)(2013-8#7)
growth are##2##2##(1997-1#1)(2008-11#1)
growth arrest and##3##3##(1992-12#1)(2008-11#1)(2012-3#1)
growth arrest##16##2##(1992-12#3)(1997-3#1)(1997-7#1)(2008-11#4)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
growth as well as##4##4##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
growth as##6##2##(2008-10#1)(2008-11#2)(2011-2#1)(2013-8#2)
growth associated production##6##3##(2008-11#6)
growth associated##11##2##(2008-11#11)
growth at 0##3##3##(2008-10#3)
growth at a##2##3##(1994-8#1)(2008-11#1)
growth at##19##2##(1990-11#2)(1993-9#2)(1994-8#1)(2008-10#7)(2008-11#3)(2010-4#1)(2010-8#1)(2011-2#2)
growth behavior##3##2##(2008-11#2)(2008-9#1)
growth but##6##2##(2008-10#3)(2008-11#1)(2009-8#1)(2011-2#1)
growth by##11##2##(1994-8#1)(1994-9#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#2)
growth cabinets##4##2##(2008-10#3)(2008-11#1)
growth can##2##2##(1994-12#1)(2008-7#1)
growth capability##3##2##(2009-6#3)
growth chamber and##3##3##(2008-10#3)
growth chamber experiments##6##3##(2008-10#6)
growth chamber with##2##3##(2008-10#2)
growth chamber##25##2##(2008-10#25)
growth chambers##8##2##(2008-10#7)(2012-5#1)
growth characteristics of##4##3##(2008-11#4)
growth characteristics##7##2##(2008-11#5)(2008-8#1)(2010-11#1)
growth charts##2##2##(1991-2#1)(2010-7#1)
growth conditions and##3##3##(2008-10#2)(2008-8#1)
growth conditions##21##2##(1990-5#1)(1996-6#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-3#1)
growth cone##3##2##(1993-12#1)(2008-7#1)(2008-9#1)
growth control##4##2##(1997-4#1)(2008-11#1)(2011-2#2)
growth costs of reproduction##2##4##(2008-9#2)
growth curve analyses##2##3##(2009-7#1)(2012-12#1)
growth curve##8##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
growth curves obtained##2##3##(2011-2#2)
growth data##2##2##(2010-7#1)(2013-8#1)
growth defects##3##2##(1996-6#1)(2011-2#2)
growth delay##3##2##(1996-6#1)(1997-3#1)(2011-1#1)
growth during##4##2##(2008-7#2)(2009-8#2)
growth dynamics##3##2##(1991-3#1)(2013-8#2)
growth even##2##2##(2008-10#1)(2008-7#1)
growth factor (10##2##3##(2008-11#2)
growth factor (EGF)##11##3##(1990-12#2)(1991-12#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
growth factor (HGF)##4##3##(1993-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
growth factor (NGF)##12##3##(1991-12#2)(1996-12#2)(1996-2#1)(1997-2#1)(2008-11#3)(2008-5#1)(2010-8#2)
growth factor 2##2##3##(2010-4#1)(2010-6#1)
growth factor I (IGF-I)##2##4##(2008-11#1)(2012-12#1)
growth factor I##3##3##(2008-11#1)(2008-8#1)(2012-12#1)
growth factor and its receptor##2##5##(1991-7#1)(2008-9#1)
growth factor and##4##3##(1990-12#1)(1991-7#2)(2008-9#1)
growth factor beta (TGF-beta)##5##4##(1995-2#1)(2008-1#1)(2008-11#2)(2008-12#1)
growth factor beta receptor##3##4##(1995-12#1)(1995-2#1)(1997-7#1)
growth factor beta##11##3##(1990-5#1)(1993-12#1)(1995-12#1)(1995-2#2)(1997-7#1)(2008-1#1)(2008-11#3)(2008-12#1)
growth factor binding and##2##4##(1990-12#1)(1993-3#1)
growth factor binding##4##3##(1990-12#2)(1992-4#1)(1993-3#1)
growth factor expression in##2##4##(2011-2#1)(2012-3#1)
growth factor expression##3##3##(1997-1#1)(2011-2#1)(2012-3#1)
growth factor genes##2##3##(2008-9#1)(2013-7#1)
growth factor has##2##3##(2008-8#2)
growth factor in##3##3##(1992-3#1)(1995-12#1)(2008-9#1)
growth factor into cells##2##4##(1997-7#2)
growth factor is##2##3##(1995-12#1)(2008-8#1)
growth factor on##4##3##(1990-2#1)(1994-8#1)(1995-11#1)(1997-1#1)
growth factor receptor (EGFR)##2##4##(1995-11#1)(2013-1#1)
growth factor receptor and##2##4##(1994-2#1)(2008-11#1)
growth factor receptor##22##3##(1990-12#2)(1991-7#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#1)(2008-11#1)(2008-8#2)(2009-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
growth factor receptors##4##3##(1991-7#1)(2008-11#1)(2008-4#1)(2008-8#1)
growth factor was##3##3##(2008-11#1)(2008-9#1)(2010-1#1)
growth factor##225##2##(1990-12#8)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#5)(1991-12#5)(1991-3#2)(1991-7#5)(1992-10#1)(1992-3#2)(1992-4#1)(1993-1#1)(1993-12#1)(1993-3#5)(1993-6#2)(1993-8#1)(1994-11#8)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#9)(1995-12#9)(1995-2#4)(1995-6#3)(1995-8#5)(1995-9#1)(1996-12#4)(1996-2#1)(1997-1#5)(1997-2#1)(1997-4#1)(1997-7#7)(2008-1#3)(2008-10#1)(2008-11#35)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#16)(2008-9#11)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
growth factor)##3##2##(2008-11#2)(2008-9#1)
growth factor- and##2##3##(1991-5#1)(1995-6#1)
growth factor-1##4##2##(1990-12#1)(2008-8#1)(2011-1#1)(2013-1#1)
growth factor-I (IGF-I) and##2##4##(2008-11#2)
growth factor-I (IGF-I)##6##3##(1991-12#1)(1995-12#1)(1997-1#1)(2008-11#3)
growth factor-I##10##2##(1991-12#1)(1994-6#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-11#3)(2008-8#2)
growth factor-beta##10##2##(1990-2#3)(1991-12#1)(1995-11#1)(2008-11#2)(2008-9#1)(2013-1#2)
growth factor-induced##2##2##(1992-10#1)(1997-1#1)
growth factors and##6##3##(1992-10#1)(1992-12#1)(1994-3#1)(2008-11#1)(2009-8#1)(2010-8#1)
growth factors in##4##3##(1990-12#2)(1991-12#1)(1994-11#1)
growth factors such as##3##4##(1995-11#1)(2008-11#2)
growth factors that##2##3##(1994-5#1)(2008-6#1)
growth factors which##2##3##(1991-6#1)(1994-11#1)
growth factors##61##2##(1990-12#3)(1990-5#1)(1991-12#3)(1991-3#4)(1991-5#2)(1991-6#1)(1992-10#1)(1992-12#1)(1993-12#2)(1993-2#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#2)(1995-6#1)(1996-11#1)(1996-2#1)(2006-6#1)(2008-1#1)(2008-11#10)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
growth for##3##2##(1994-1#1)(2008-10#1)(2009-8#1)
growth forms##2##2##(1996-6#1)(2012-6#1)
growth fostering##5##2##(1990-12#5)
growth from the##2##3##(2008-10#1)(2008-7#1)
growth from##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
growth habit##4##2##(2008-10#1)(2012-3#3)
growth has been##3##3##(1991-3#1)(2008-11#1)(2008-12#1)
growth has##5##2##(1991-3#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#1)
growth hormone (GH)##6##3##(1994-8#1)(1995-12#1)(2010-5#2)(2011-1#1)(2013-1#1)
growth hormone and##3##3##(1993-2#2)(1996-2#1)
growth hormone deficiency##8##3##(2008-5#1)(2011-1#2)(2012-3#4)(2013-1#1)
growth hormone receptor##7##3##(1993-2#1)(2008-8#2)(2008-9#2)(2010-5#2)
growth hormone releasing hormone##2##4##(1992-6#1)(1992-9#1)
growth hormone##45##2##(1991-3#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-2#4)(1994-8#2)(1995-11#1)(1995-12#1)(1996-11#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#4)(2010-5#4)(2011-1#3)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)
growth hormone-releasing factor##2##3##(1991-9#2)
growth hormone-releasing hormone 1-44 NH2 and 1-40 OH##3##8##(1992-9#3)
growth hormone-releasing hormone 1-44 NH2##5##5##(1992-9#5)
growth hormone-releasing hormone##6##3##(1992-9#6)
growth hormone-releasing##8##2##(1991-9#2)(1992-9#6)
growth in Medicaid##2##3##(1992-12#1)(1995-6#1)
growth in S##3##3##(1996-2#1)(1996-6#1)(1997-3#1)
growth in a##13##3##(2008-11#7)(2008-7#3)(2008-9#1)(2010-4#1)(2013-8#1)
growth in all##2##3##(1994-1#1)(2008-10#1)
growth in both##2##3##(2008-9#1)(2011-2#1)
growth in children##3##3##(1996-6#1)(2007-11#1)(2010-7#1)
growth in food##2##3##(2010-7#1)(2011-2#1)
growth in hospital##3##3##(1992-1#1)(1992-2#1)(1993-1#1)
growth in liquid media##2##4##(2008-10#1)(2008-8#1)
growth in response to##2##4##(1992-8#1)(2008-11#1)
growth in serum-free##3##3##(2008-11#3)
growth in the host##2##4##(2008-10#2)
growth in the presence of##3##5##(1993-8#1)(2008-10#2)
growth in the##25##3##(1992-12#2)(1992-2#1)(1993-8#1)(1994-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
growth in vitro and##2##4##(2008-5#1)(2013-1#1)
growth in vitro##6##3##(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
growth in##143##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-1#2)(1992-12#4)(1992-2#3)(1992-3#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#4)(1997-3#2)(2007-11#1)(2008-10#28)(2008-11#26)(2008-12#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#9)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
growth increment and the##2##4##(2008-9#2)
growth increment and##3##3##(2008-9#3)
growth increment##4##2##(2008-9#4)
growth inhibition activity##2##3##(1994-5#1)(2009-6#1)
growth inhibition and differentiation##2##4##(1997-7#2)
growth inhibition and##4##3##(1997-7#2)(2011-2#1)(2012-7#1)
growth inhibition by##3##3##(2008-11#2)(2011-2#1)
growth inhibition effects##4##3##(2008-11#4)
growth inhibition in##2##3##(1993-11#1)(1994-8#1)
growth inhibition of##3##3##(2008-11#1)(2008-5#1)(2010-6#1)
growth inhibition##35##2##(1993-11#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-2#1)(1997-7#2)(2008-10#2)(2008-11#13)(2008-5#3)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#4)(2012-7#1)(2013-1#1)
growth inhibitor##2##2##(1990-2#1)(1993-8#1)
growth inhibitory effect of##3##4##(1995-2#1)(2008-11#1)(2008-12#1)
growth inhibitory effect##4##3##(1993-1#1)(1995-2#1)(2008-11#1)(2008-12#1)
growth inhibitory effects##5##3##(1997-3#1)(2008-11#4)
growth inhibitory factor##3##3##(1996-2#3)
growth inhibitory##14##2##(1993-1#1)(1995-2#1)(1996-2#3)(1997-3#1)(2008-11#7)(2008-12#1)
growth is determined by##2##4##(1994-8#1)(2008-7#1)
growth is regulated by##2##4##(1994-8#1)(2009-8#1)
growth is##16##2##(1992-12#1)(1994-8#2)(1995-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2012-3#2)
growth kinetics of##2##3##(2008-11#2)
growth kinetics##9##2##(2008-11#8)(2008-7#1)
growth media evaluated##2##3##(2008-10#2)
growth media using##2##3##(2008-10#2)
growth media##12##2##(2008-10#10)(2008-11#1)(2008-8#1)
growth medium##18##2##(1990-6#1)(1991-10#1)(1991-11#3)(1995-2#1)(1996-6#1)(2008-10#5)(2008-11#4)(2011-2#1)(2012-4#1)
growth model##11##2##(1995-8#1)(2008-10#2)(2008-9#3)(2010-7#1)(2013-8#4)
growth models##2##2##(2008-1#1)(2008-12#1)
growth occurred##3##2##(2008-10#1)(2010-11#1)(2010-8#1)
growth of A##8##3##(2008-10#6)(2011-2#2)
growth of B##5##3##(2008-10#1)(2011-2#4)
growth of CHO cells##3##4##(2008-11#2)(2011-2#1)
growth of Chinese##2##3##(2008-11#1)(2008-8#1)
growth of Escherichia coli K12##2##5##(2008-7#2)
growth of Escherichia coli##3##4##(2008-7#3)
growth of Escherichia##4##3##(2008-10#1)(2008-7#3)
growth of Fusarium spp##2##4##(2008-10#2)
growth of L##2##3##(1996-12#2)
growth of M##3##3##(1995-2#1)(2008-10#1)(2013-1#1)
growth of NB1-RGB cells on the##2##6##(2008-11#2)
growth of P##4##3##(2008-10#4)
growth of Phytophthora##2##3##(2008-10#2)
growth of R##7##3##(2008-10#7)
growth of S##2##3##(2008-10#2)
growth of a##5##3##(2008-10#2)(2008-11#2)(2012-3#1)
growth of aligned##2##3##(2008-7#2)
growth of apple in replant soils##2##6##(2008-10#2)
growth of apple in##4##4##(2008-10#4)
growth of apple trees in##2##5##(2008-10#2)
growth of apple##10##3##(2008-10#10)
growth of bacteria##2##3##(2008-10#1)(2008-7#1)
growth of both cell lines##2##5##(1994-8#1)(1997-1#1)
growth of both##8##3##(1994-8#1)(1997-1#2)(2008-10#3)(2008-5#1)(2008-9#1)
growth of breast##2##3##(2011-2#1)(2012-3#1)
growth of cancer cell##2##4##(2008-9#1)(2013-8#1)
growth of cancer##4##3##(1994-11#1)(2008-9#1)(2009-9#1)(2013-8#1)
growth of cells##6##3##(1995-2#1)(1995-9#2)(2008-10#1)(2008-11#2)
growth of different##2##3##(2008-10#1)(2008-11#1)
growth of four##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
growth of human##12##3##(1994-8#1)(2008-10#1)(2008-11#5)(2008-8#2)(2010-6#1)(2011-2#1)(2013-1#1)
growth of insect##2##3##(2008-11#2)
growth of malignant tumour##2##4##(2008-9#2)
growth of mycelia##2##3##(2008-10#2)
growth of mycelium##2##3##(2008-10#2)
growth of neural stem cells##2##5##(1994-11#1)(2008-10#1)
growth of new##2##3##(1994-12#1)(2012-3#1)
growth of normal cells##2##4##(2008-11#2)
growth of normal##4##3##(2008-11#3)(2011-2#1)
growth of rats##2##3##(1993-11#1)(1993-12#1)
growth of several##2##3##(2008-10#2)
growth of the arterial##2##4##(1995-8#1)(2009-1#1)
growth of the cells##3##4##(1995-9#1)(2008-10#1)(2008-11#1)
growth of the fungus in the##2##6##(2008-10#2)
growth of the human##3##4##(1995-8#1)(2008-11#1)(2013-1#1)
growth of the pathogen##4##4##(2008-10#4)
growth of the##47##3##(1990-5#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-8#2)(1995-9#3)(1996-12#1)(1996-2#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2011-2#2)(2013-1#1)
growth of these##6##3##(1993-8#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#2)
growth of tumor##2##3##(2008-8#1)(2008-9#1)
growth of tumors##4##3##(2010-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
growth of vascular smooth muscle cells##2##6##(1994-11#1)(2008-1#1)
growth of vascular##3##3##(1993-3#1)(1994-11#1)(2008-1#1)
growth of which is##2##4##(1994-8#2)
growth of##352##2##(1990-11#4)(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-11#2)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#1)(1994-8#4)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#2)(1995-9#6)(1996-12#3)(1996-2#3)(1996-3#2)(1997-1#4)(1997-3#4)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#114)(2008-11#45)(2008-12#10)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#11)(2008-9#10)(2009-1#1)(2009-10#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#19)(2012-2#5)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#5)
growth on acetate##2##3##(2008-7#2)
growth on mixtures##2##3##(2008-7#2)
growth on##16##2##(1991-9#1)(1993-9#1)(2008-10#5)(2008-7#6)(2008-9#1)(2011-1#1)(2011-2#1)
growth or##16##2##(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-8#2)(2009-10#1)(2010-8#1)(2011-2#1)
growth over##2##2##(2008-9#1)(2012-2#1)
growth parameters were##2##3##(2008-10#2)
growth parameters##10##2##(1996-3#1)(2008-10#5)(2008-11#2)(2008-3#1)(2012-9#1)
growth pattern and##2##3##(1992-2#1)(2013-1#1)
growth pattern##7##2##(1992-2#1)(2008-1#1)(2008-7#2)(2010-11#1)(2013-1#2)
growth patterns of##2##3##(1992-8#1)(2010-7#1)
growth patterns##4##2##(1992-8#1)(2008-10#1)(2010-12#1)(2010-7#1)
growth period##4##2##(2008-10#2)(2008-11#1)(2010-11#1)
growth phase and##4##3##(2008-11#3)(2008-7#1)
growth phase in##2##3##(2008-11#2)
growth phase##20##2##(2008-10#1)(2008-11#13)(2008-7#4)(2009-6#1)(2011-2#1)
growth phases##4##2##(1991-8#1)(2008-11#2)(2012-3#1)
growth potential##2##2##(2010-8#1)(2012-3#1)
growth promoting activities##3##3##(2008-11#2)(2008-9#1)
growth promoting##4##2##(2008-11#3)(2008-9#1)
growth promotion##11##2##(2008-10#5)(2008-11#3)(2013-8#3)
growth rate and a##2##4##(1990-8#1)(1992-8#1)
growth rate and nutrient##2##4##(2008-12#1)(2008-7#1)
growth rate and##17##3##(1990-8#1)(1992-8#1)(1996-3#2)(2008-11#8)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)
growth rate at##3##3##(2008-10#2)(2008-11#1)
growth rate in##4##3##(1991-12#1)(1993-11#1)(2008-10#1)(2008-11#1)
growth rate increases##2##3##(2008-11#1)(2008-9#1)
growth rate of a##2##4##(2008-8#2)
growth rate of the isolates##2##5##(2008-12#2)
growth rate of the##7##4##(1995-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)
growth rate of##33##3##(1990-6#1)(1992-2#1)(1995-9#1)(2007-11#1)(2008-10#2)(2008-11#7)(2008-12#4)(2008-7#4)(2008-8#4)(2008-9#4)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
growth rate on##3##3##(2008-10#2)(2008-7#1)
growth rate per##2##3##(2008-8#2)
growth rate than##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
growth rate was observed##2##4##(2008-11#2)
growth rate was##6##3##(2008-10#1)(2008-11#2)(2008-8#1)(2010-11#1)(2010-12#1)
growth rate were##3##3##(1993-11#1)(2008-7#1)(2012-3#1)
growth rate with##2##3##(2008-7#1)(2009-10#1)
growth rate##144##2##(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#2)(1994-8#1)(1995-9#2)(1996-3#2)(2007-11#8)(2008-10#19)(2008-11#38)(2008-12#5)(2008-5#1)(2008-7#17)(2008-8#12)(2008-9#9)(2009-10#2)(2009-11#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#5)
growth rates and##6##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#3)
growth rates in##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
growth rates of##15##3##(2008-10#4)(2008-11#4)(2008-8#4)(2008-9#2)(2011-1#1)
growth rates through the stylar canal##2##6##(2008-10#2)
growth rates were##7##3##(1993-12#1)(2008-10#3)(2008-11#3)
growth rates##65##2##(1991-12#1)(1993-12#3)(1996-12#1)(2008-10#13)(2008-11#15)(2008-12#1)(2008-7#3)(2008-8#20)(2008-9#3)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
growth reaction##2##2##(2008-11#1)(2008-7#1)
growth reduction##3##2##(2008-10#2)(2012-5#1)
growth regulation##2##2##(1990-5#1)(2012-3#1)
growth regulator##3##2##(2008-12#1)(2009-8#1)(2013-1#1)
growth regulators##4##2##(2008-10#3)(2008-12#1)
growth response##5##2##(1994-6#1)(2008-10#4)
growth responses to##2##3##(2008-10#2)
growth responses##6##2##(1992-12#2)(2008-10#3)(2012-5#1)
growth retardation and##4##3##(1995-2#1)(2008-10#1)(2013-1#2)
growth retardation##7##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-1#2)
growth signal was observed in##2##5##(2008-11#2)
growth signal##3##2##(2008-11#3)
growth slowed##2##2##(2008-10#1)(2010-1#1)
growth stage##10##2##(2008-10#10)
growth stages of##2##3##(2008-10#2)
growth stages##19##2##(2008-10#18)(2011-2#1)
growth state##2##2##(2008-9#1)(2011-2#1)
growth status##2##2##(2008-10#1)(2009-8#1)
growth stimulation##6##2##(1991-5#1)(1992-12#1)(1994-3#1)(2008-10#1)(2008-11#2)
growth substrate##4##2##(2008-7#4)
growth suppression##4##2##(1996-2#1)(2007-11#3)
growth suppressor##2##2##(1991-5#1)(2008-9#1)
growth temperature##4##2##(2008-10#1)(2008-5#1)(2011-2#2)
growth temperatures##2##2##(2008-5#2)
growth that##2##2##(1993-11#1)(2012-12#1)
growth the##2##2##(2007-12#1)(2008-10#1)
growth through##2##2##(2008-10#1)(2011-2#1)
growth to the##2##3##(2008-10#1)(2008-7#1)
growth to##10##2##(1994-11#1)(2008-10#4)(2008-11#1)(2008-7#3)(2011-2#1)
growth under##8##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#3)
growth using##3##2##(1994-6#1)(2011-2#1)(2012-2#1)
growth was achieved##2##3##(2008-10#1)(2012-3#1)
growth was observed when##2##4##(2008-10#1)(2008-11#1)
growth was observed##6##3##(2008-10#2)(2008-11#3)(2008-3#1)
growth was reduced##2##3##(2008-5#1)(2010-1#1)
growth was restricted to the epidermis and##2##7##(2008-10#2)
growth was restricted##4##3##(2008-10#4)
growth was##40##2##(1996-12#1)(2008-10#12)(2008-11#10)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
growth were observed##2##3##(2008-11#1)(2010-8#1)
growth were##9##2##(2008-10#3)(2008-11#3)(2008-5#1)(2010-8#1)(2012-3#1)
growth which##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
growth while##2##2##(2008-11#1)(2009-8#1)
growth with##7##2##(2008-11#4)(2008-8#1)(2013-1#1)(2013-8#1)
growth within the##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
growth within##5##2##(2008-10#2)(2008-9#1)(2009-3#1)(2013-1#1)
growth without##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
growth##2435##1##(1990-11#9)(1990-12#20)(1990-2#5)(1990-5#7)(1990-6#6)(1990-7#2)(1990-8#7)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#18)(1991-2#3)(1991-3#13)(1991-5#8)(1991-6#4)(1991-7#5)(1991-8#1)(1991-9#4)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#16)(1992-2#6)(1992-3#4)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#7)(1992-9#9)(1993-1#11)(1993-11#9)(1993-12#13)(1993-2#7)(1993-3#10)(1993-6#2)(1993-8#7)(1993-9#5)(1994-1#4)(1994-11#18)(1994-12#8)(1994-2#12)(1994-3#14)(1994-5#4)(1994-6#9)(1994-8#24)(1994-9#1)(1995-1#3)(1995-11#21)(1995-12#16)(1995-2#17)(1995-3#7)(1995-6#9)(1995-8#15)(1995-9#12)(1996-1#3)(1996-11#6)(1996-12#10)(1996-2#17)(1996-3#9)(1996-6#10)(1996-8#1)(1997-1#18)(1997-2#7)(1997-3#13)(1997-4#2)(1997-6#1)(1997-7#16)(1997-8#3)(2006-6#1)(2007-11#17)(2007-12#2)(2007-8#1)(2008-1#14)(2008-10#470)(2008-11#461)(2008-12#44)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#39)(2008-6#8)(2008-7#94)(2008-8#108)(2008-9#88)(2009-1#1)(2009-10#8)(2009-11#5)(2009-12#3)(2009-3#8)(2009-4#1)(2009-5#2)(2009-6#10)(2009-7#6)(2009-8#45)(2009-9#6)(2010-1#10)(2010-10#3)(2010-11#8)(2010-12#7)(2010-3#3)(2010-4#9)(2010-5#9)(2010-6#5)(2010-7#12)(2010-8#18)(2010-9#1)(2011-1#23)(2011-10#1)(2011-2#110)(2011-7#1)(2012-12#8)(2012-2#25)(2012-3#36)(2012-4#1)(2012-5#10)(2012-6#1)(2012-7#2)(2012-9#1)(2013-1#70)(2013-7#8)(2013-8#46)
growth)##3##1##(1995-9#1)(2008-11#1)(2013-8#1)
growth-arrest and##2##2##(1997-7#2)
growth-arrest genes##3##2##(1992-12#3)
growth-arrest##6##1##(1992-12#4)(1997-7#2)
growth-arrested##2##1##(1997-1#1)(2008-7#1)
growth-associated protein##2##2##(2008-7#2)
growth-associated##4##1##(2008-11#2)(2008-7#2)
growth-chamber studies##2##2##(2008-10#2)
growth-chamber##4##1##(2008-10#4)
growth-factor##2##1##(1996-10#1)(2008-4#1)
growth-phase-dependent protein regulation##2##3##(2009-6#2)
growth-phase-dependent##3##1##(2009-6#3)
growth-promoting rhizobacteria (PGPR)##3##3##(2008-10#3)
growth-promoting rhizobacteria##6##2##(2008-10#6)
growth-promoting##14##1##(1997-3#1)(2008-10#7)(2008-11#2)(2009-8#2)(2011-1#1)(2012-3#1)
growth-related##3##1##(1995-2#1)(2009-9#1)(2010-8#1)
growth-room assay##2##2##(2008-10#2)
growth-room##3##1##(2008-10#3)
growth-stimulating activity##2##2##(1995-8#2)
growth-stimulating effect of##2##3##(1995-8#1)(1996-11#1)
growth-stimulating effect##3##2##(1995-8#2)(1996-11#1)
growth-stimulating##5##1##(1995-8#4)(1996-11#1)
growtharrest##2##1##(2008-11#2)
growthfactor##3##1##(2008-10#1)(2008-11#2)
growthrate##3##1##(2008-11#3)
gsa-1 gene##4##2##(1997-7#4)
guaiac test##2##2##(1993-3#2)
guaiphenesin##2##1##(2008-10#2)
guanethidine##5##1##(1990-5#1)(1995-12#1)(1997-4#3)
guanidine hydrochloride##7##2##(1990-2#1)(1993-3#4)(2008-10#1)(2012-2#1)
guanidine##11##1##(1990-2#1)(1992-6#1)(1993-3#4)(2008-10#3)(2008-5#1)(2012-2#1)
guanine and##5##2##(1994-8#1)(2008-10#1)(2008-11#2)(2010-11#1)
guanine at##2##2##(1993-8#1)(2008-10#1)
guanine bases in DNA##2##4##(1990-5#2)
guanine bases in##3##3##(1990-5#2)(1994-5#1)
guanine bases##5##2##(1990-5#3)(1994-5#1)(2008-10#1)
guanine nucleotide exchange##3##3##(1995-2#2)(1996-2#1)
guanine nucleotide##8##2##(1993-9#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#2)(1996-2#1)
guanine nucleotide-binding##2##2##(1992-9#1)(1997-7#1)
guanine residues##2##2##(1993-8#1)(2008-10#1)
guanine was##2##2##(1990-5#1)(2008-10#1)
guanine##43##1##(1990-5#4)(1991-5#2)(1992-9#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#2)(1996-2#1)(1997-7#1)(2008-10#18)(2008-11#2)(2010-11#1)(2011-2#1)
guanines##3##1##(1993-8#2)(1994-8#1)
guanines)##2##1##(1992-4#2)
guanosine 3'##3##2##(1995-2#1)(1995-8#2)
guanosine 5'-0-(3-thiotriphosphate) (GTP gamma##2##4##(1991-6#1)(1995-8#1)
guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S)##2##5##(1993-8#1)(1994-3#1)
guanosine 5'-O-(3-thiotriphosphate)##3##2##(1993-8#2)(1994-3#1)
guanosine##25##1##(1991-6#1)(1991-7#1)(1992-3#2)(1992-8#2)(1993-8#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#3)(1997-2#1)(2008-4#4)(2009-12#4)
guanylyl cyclase##2##2##(1994-8#1)(1995-2#1)
guanylyl##3##1##(1994-8#1)(1995-2#1)(2009-10#1)
guarantee of the##2##3##(1993-3#1)(2010-8#1)
guarantee##17##1##(1991-3#1)(1992-6#1)(1993-1#1)(1993-3#2)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)
guaranteed by the##2##3##(1993-9#1)(2008-10#1)
guaranteed by##3##2##(1993-9#1)(1996-6#1)(2008-10#1)
guaranteed##6##1##(1993-3#1)(1993-9#1)(1996-6#1)(2008-10#2)(2008-5#1)
guaranteeing##4##1##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
guarantees##13##1##(1991-2#1)(1993-1#2)(1993-3#2)(1994-2#1)(1995-6#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)
guard against##3##2##(1994-2#1)(1997-7#1)(2009-1#1)
guard cell protoplasts##5##3##(2008-8#5)
guard cell##6##2##(2008-10#1)(2008-8#5)
guard cells and##2##3##(2008-10#1)(2008-8#1)
guard cells##3##2##(2008-10#2)(2008-8#1)
guard##17##1##(1991-3#1)(1994-2#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#5)(2008-8#6)(2009-1#1)
guarded prognosis##2##2##(2010-7#1)(2012-3#1)
guarded##4##1##(2008-10#1)(2010-7#1)(2010-8#1)(2012-3#1)
guardian with##2##2##(1994-12#2)
guardian##5##1##(1990-11#1)(1994-12#2)(1995-2#1)(2011-2#1)
guardians##3##1##(1991-12#1)(2008-11#2)
guardianship##2##1##(1994-1#2)
guarding##2##1##(2008-9#1)(2010-8#1)
guards##9##1##(1995-6#6)(1996-12#1)(2008-12#1)(2008-9#1)
guess of the##2##3##(2008-10#1)(2008-2#1)
guesses##2##1##(1996-2#1)(2008-10#1)
guest editors##2##2##(2012-2#1)(2013-8#1)
guest metal cations##2##3##(2008-10#2)
guest molecules##5##2##(2008-10#4)(2010-12#1)
guest salts##2##2##(2008-10#2)
guest##21##1##(1995-1#1)(2008-10#14)(2008-3#2)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
guest-host##2##1##(2008-10#2)
guests##7##1##(1995-6#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-4#1)(2012-3#1)
guevarai##3##1##(2008-12#3)
guidance and support##2##3##(1996-3#1)(2008-12#1)
guidance and##8##2##(1990-12#1)(1994-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#2)
guidance for future##2##3##(2008-9#1)(2013-1#1)
guidance for##16##2##(1992-12#1)(1992-3#1)(1996-3#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
guidance from##2##2##(2008-11#1)(2008-6#1)
guidance in##4##2##(1993-3#1)(2008-11#2)(2008-8#1)
guidance is##2##2##(1997-8#1)(2011-2#1)
guidance on the##4##3##(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)
guidance on##8##2##(1993-1#1)(2008-10#1)(2008-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2012-12#1)
guidance speeds##2##2##(2009-5#2)
guidance to##5##2##(1993-1#1)(1993-12#1)(1997-8#1)(2008-11#1)(2012-12#1)
guidance##86##1##(1990-12#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-12#3)(1993-3#1)(1994-2#1)(1994-3#1)(1996-3#2)(1997-8#2)(2008-1#1)(2008-10#3)(2008-11#14)(2008-12#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#3)(2009-8#2)(2010-11#3)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#9)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
guide a##2##2##(1996-2#1)(2012-2#1)
guide catheter##2##2##(2011-2#2)
guide for selecting##2##3##(1995-12#1)(2012-5#1)
guide for the##2##3##(1991-12#1)(2008-9#1)
guide for##13##2##(1991-12#1)(1991-2#2)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-5#1)
guide in##2##2##(2008-10#1)(2011-1#1)
guide is a##2##3##(1996-2#1)(2011-2#1)
guide is##3##2##(1996-2#1)(2011-2#2)
guide on##3##2##(1996-2#2)(2008-7#1)
guide star##5##2##(2007-12#2)(2008-3#3)
guide the choice##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
guide the##21##2##(1994-1#1)(1994-3#2)(1996-12#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
guide their##2##2##(1993-12#1)(2008-11#1)
guide to health##2##3##(1995-2#1)(2008-11#1)
guide to the##3##3##(1993-3#1)(1994-3#1)(2008-7#1)
guide to##20##2##(1990-8#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-3#1)(1995-11#1)(1995-2#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2011-2#3)(2012-12#1)
guide tube##2##2##(2008-10#2)
guide##139##1##(1990-8#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-3#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#4)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#11)(1996-3#2)(1996-6#2)(1997-8#1)(2007-12#2)(2008-10#15)(2008-11#17)(2008-12#4)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#5)
guided biopsy##2##2##(2012-3#1)(2013-1#1)
guided by##14##2##(2008-8#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
guided modes##2##2##(2007-12#2)
guided the##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
guided##50##1##(1990-5#1)(1990-9#1)(1993-1#1)(1993-2#1)(1996-3#1)(1996-9#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#7)
guideline development and##2##3##(1996-1#1)(2008-8#1)
guideline development##7##2##(1996-1#1)(2008-7#1)(2008-8#3)(2012-2#2)
guideline for the##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
guideline for##11##2##(1990-11#1)(1993-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-9#1)(2012-3#1)(2013-8#1)
guideline implementation##2##2##(2013-1#2)
guideline on the##2##3##(2008-10#1)(2010-10#1)
guideline values for recreational##2##4##(2008-10#2)
guideline values for##4##3##(2008-10#4)
guideline##48##1##(1990-11#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1996-1#2)(2008-10#12)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-7#1)(2010-10#3)(2010-12#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
guidelines and training##2##3##(1993-1#1)(2008-1#1)
guidelines and##12##2##(1990-9#1)(1993-1#1)(1993-3#1)(1997-1#1)(2008-1#1)(2008-12#1)(2008-3#3)(2008-4#1)(2009-10#1)(2010-11#1)
guidelines are##3##2##(2008-11#1)(2010-5#1)(2013-1#1)
guidelines as##2##2##(1991-12#1)(1993-12#1)
guidelines for evaluating the##2##4##(1991-1#1)(2008-10#1)
guidelines for evaluating##5##3##(1991-1#1)(1997-7#1)(2008-10#1)(2008-7#2)
guidelines for infant##2##3##(1996-12#1)(2012-2#1)
guidelines for its##2##3##(1993-12#1)(2010-12#1)
guidelines for selecting##2##3##(2008-9#1)(2009-4#1)
guidelines for the management of##3##5##(2008-3#2)(2010-12#1)
guidelines for the treatment of##4##5##(1995-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
guidelines for the##14##3##(1993-2#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#1)
guidelines for##69##2##(1990-6#1)(1991-1#2)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#2)(1993-2#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#2)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
guidelines has##2##2##(2008-10#1)(2009-4#1)
guidelines have##2##2##(1997-8#1)(2008-11#1)
guidelines in##11##2##(1991-12#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-12#1)
guidelines of the##2##3##(1994-6#1)(1997-2#1)
guidelines of##6##2##(1990-3#1)(1991-3#1)(1994-6#1)(1997-2#1)(2008-7#1)(2012-3#1)
guidelines on clinical##2##3##(2008-11#1)(2012-2#1)
guidelines on the management of##2##5##(2008-3#2)
guidelines on##9##2##(1992-8#1)(1994-12#1)(1996-8#1)(2008-11#1)(2008-3#2)(2010-12#1)(2012-2#1)(2013-8#1)
guidelines provide##2##2##(2008-10#1)(2012-2#1)
guidelines recommend##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2009-1#1)(2013-1#1)
guidelines represent##2##2##(1994-1#1)(2013-7#1)
guidelines that##5##2##(1993-12#1)(1995-6#1)(1997-6#1)(2008-5#1)(2012-2#1)
guidelines to assist##2##3##(1992-3#1)(2008-10#1)
guidelines to##10##2##(1991-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2012-12#1)(2013-1#1)
guidelines was##2##2##(1996-3#1)(2012-2#1)
guidelines were##2##2##(1990-6#2)
guidelines will##2##2##(2008-8#1)(2013-7#1)
guidelines##234##1##(1990-3#1)(1990-6#7)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#4)(1993-1#1)(1993-12#10)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-9#2)(2008-1#4)(2008-10#19)(2008-11#24)(2008-12#11)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#4)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-10#1)(2011-2#5)(2011-3#1)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#2)
guidelines?##3##1##(2008-3#1)(2012-12#1)(2012-3#1)
guidelines]##3##1##(1997-4#1)(2008-10#1)(2011-3#1)
guides and##2##2##(1991-3#1)(2011-2#1)
guides the##4##2##(1993-3#1)(2008-12#1)(2009-4#1)(2011-2#1)
guides to##2##2##(1994-3#1)(1996-2#1)
guides##18##1##(1991-3#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#5)
guidewire##6##1##(1997-3#1)(1997-6#1)(2010-12#4)
guidewires##3##1##(1997-3#2)(2013-1#1)
guiding catheters##2##2##(2011-2#2)
guiding percutaneous##2##2##(2010-12#1)(2011-2#1)
guiding principles for complementary feeding##2##5##(2010-6#2)
guiding principles for##3##3##(1994-3#1)(2010-6#2)
guiding principles##5##2##(1994-3#1)(1997-1#1)(2008-11#1)(2010-6#2)
guiding questions##2##2##(2008-11#1)(2012-3#1)
guiding the development of##2##4##(1993-1#1)(2008-9#1)
guiding the##7##2##(1993-1#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#2)
guiding##31##1##(1993-1#1)(1994-3#1)(1994-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#4)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-6#3)(2011-2#6)(2012-3#1)
guild structure##2##2##(2010-8#1)(2012-2#1)
guild##5##1##(2008-8#1)(2010-8#2)(2012-2#1)(2012-3#1)
guilds of##2##2##(2008-8#1)(2008-9#1)
guilds##14##1##(1993-1#1)(2008-8#6)(2008-9#3)(2010-8#4)
guilt##6##1##(1990-6#1)(1996-11#1)(2009-10#1)(2010-1#1)(2011-1#2)
guilt-proneness##2##1##(2009-11#2)
guilty##3##1##(1994-12#1)(1996-5#2)
guinea pig chief cells by##2##5##(1995-8#2)
guinea pig chief cells##5##4##(1995-8#5)
guinea pig ileum##3##3##(1991-5#1)(1992-6#1)(1995-3#1)
guinea pig tissues##2##3##(1992-3#1)(2013-1#1)
guinea pig##34##2##(1990-9#2)(1991-5#1)(1992-12#1)(1992-3#3)(1992-6#4)(1993-3#1)(1994-11#1)(1994-8#3)(1995-2#1)(1995-3#1)(1995-8#5)(1997-3#3)(2008-10#2)(2008-5#1)(2008-8#3)(2009-9#1)(2013-1#1)
guinea pigs##14##2##(1991-12#1)(1995-11#1)(1995-12#5)(1996-8#1)(1997-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-1#1)
guinea##49##1##(1990-9#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#3)(1992-6#4)(1993-3#1)(1994-11#1)(1994-8#3)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-8#5)(1996-8#1)(1997-3#3)(1997-8#1)(2008-10#3)(2008-5#4)(2008-8#3)(2008-9#1)(2009-9#1)(2013-1#2)
guinea-pig colon##2##2##(1997-4#2)
guinea-pig##10##1##(1990-5#2)(1994-11#1)(1994-8#3)(1995-11#1)(1997-4#3)
guinea-pigs##3##1##(1994-11#2)(2008-5#1)
gulf between##2##2##(2010-4#1)(2011-3#1)
gum and##2##2##(2008-5#2)
gum of acacia##4##3##(2008-5#4)
gum xanthan##2##2##(2008-10#2)
gum##16##1##(2008-10#4)(2008-5#6)(2011-2#2)(2011-3#1)(2012-2#3)
gumming##3##1##(2008-10#3)
gun##5##1##(1997-8#1)(2008-10#1)(2011-2#2)(2013-1#1)
guns##2##1##(1996-1#1)(1997-3#1)
gunshot##4##1##(1995-11#1)(2010-12#1)(2012-2#2)
guppies from high-predation environments##2##4##(2008-8#2)
guppies from##4##2##(2008-8#3)(2012-3#1)
guppies in##2##2##(2008-8#2)
guppies##13##1##(2008-8#11)(2012-3#2)
guppy populations##2##2##(2008-8#2)
guppy##7##1##(2008-8#6)(2012-3#1)
gustatory neurons in the##2##4##(2009-10#2)
gustatory neurons##5##2##(2009-10#5)
gustatory##8##1##(2008-11#2)(2008-2#1)(2009-10#5)
gut and##2##2##(2008-12#1)(2008-5#1)
gut bacteria##2##2##(2011-2#2)
gut barrier##3##2##(2008-10#3)
gut commensal microflora##2##3##(2011-2#2)
gut commensal##3##2##(2011-2#3)
gut microbiota##5##2##(2011-2#4)(2012-2#1)
gut or##2##2##(2008-10#2)
gut retention time##2##3##(2008-9#2)
gut##58##1##(1990-5#1)(1992-6#3)(1994-11#2)(1994-8#1)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#2)(2009-1#1)(2010-1#2)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#16)(2012-2#2)(2012-3#2)(2013-1#2)
gut-associated##3##1##(2012-2#3)
gutD##2##1##(2008-8#2)
gutta-percha##2##1##(1991-3#1)(2013-1#1)
guttation fluid##4##2##(2008-10#4)
guttation##9##1##(2008-10#9)
gymnasts##2##1##(2011-2#2)
gymnasts'##2##1##(2011-2#2)
gymnotiform##2##1##(1995-12#2)
gynaecological##2##1##(2011-2#1)(2012-2#1)
gynecologic malignancy##4##2##(1991-3#2)(2010-7#1)(2013-8#1)
gynecologic##21##1##(1991-3#4)(1992-1#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-3#1)(1994-1#1)(1995-12#1)(1996-3#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-8#1)
gynecological##11##1##(1990-2#1)(1993-3#1)(1996-9#1)(2008-12#2)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
gynecologists##4##1##(1991-3#1)(1991-6#1)(1992-2#1)(2011-2#1)
gynecology##4##1##(1992-12#1)(1993-12#1)(1994-3#2)
gynecology]##3##1##(1991-11#1)(2011-1#1)(2012-3#1)
gynodioecious##3##1##(2008-9#3)
gynoecial##2##1##(2008-10#2)
gynogenetic##3##1##(2008-5#1)(2008-8#1)(2010-8#1)
gypsum application##4##2##(2008-12#4)
gypsum##11##1##(2008-10#1)(2008-12#10)
gyri##2##1##(2008-9#1)(2013-7#1)
gyrus and##6##2##(1994-8#1)(1996-12#2)(1996-2#1)(2008-11#2)
gyrus of the##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
gyrus of##6##2##(1994-8#2)(1995-12#2)(2008-11#1)(2008-7#1)
gyrus##36##1##(1990-5#2)(1994-2#1)(1994-8#3)(1995-12#2)(1995-8#1)(1996-12#6)(1996-2#3)(2008-11#13)(2008-12#1)(2008-7#2)(2013-8#2)
gz = 2##3##3##(1993-8#3)
gz = 3##4##3##(1993-8#4)
gz =##7##2##(1993-8#7)
généralement##2##1##(2011-2#1)(2013-1#1)
h BDL##2##2##(1995-11#2)
h PI##3##2##(2008-10#3)
h after CCl4##3##3##(1994-5#3)
h after UV-C treatment##2##4##(2008-10#2)
h after a##4##3##(1995-12#3)(2008-10#1)
h after application##2##3##(2008-10#2)
h after birth##2##3##(2008-10#2)
h after drug##2##3##(1994-2#2)
h after inoculation and##4##4##(2008-10#4)
h after inoculation were##2##4##(2008-10#1)(2008-5#1)
h after inoculation##31##3##(2008-10#28)(2008-11#1)(2008-5#2)
h after serum stimulation##2##4##(1997-1#2)
h after the beginning of##2##5##(2008-10#2)
h after the incubation##2##4##(2008-11#2)
h after the operation##2##4##(1992-12#1)(2008-7#1)
h after the##20##3##(1990-5#1)(1992-10#1)(1992-12#2)(1994-5#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-11#4)(2008-7#1)(2008-8#1)(2010-10#1)
h after treatment##7##3##(1990-10#1)(2008-10#5)(2012-3#1)
h after##128##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-2#3)(1991-9#1)(1992-10#1)(1992-12#2)(1993-8#1)(1994-2#3)(1994-5#5)(1995-11#5)(1995-12#4)(1995-3#2)(1995-8#1)(1996-12#3)(1996-2#1)(1997-1#2)(1997-2#2)(1997-7#1)(2008-10#61)(2008-11#9)(2008-12#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
h and 3##2##3##(2008-10#1)(2008-12#1)
h and the R##2##4##(2008-10#2)
h and the##4##3##(2008-10#4)
h and then##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
h and##43##2##(1992-3#1)(1995-12#2)(1995-3#2)(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#20)(2008-11#2)(2008-12#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2012-2#1)
h at 20 degrees C##3##5##(2008-10#3)
h at 25##2##3##(2008-10#1)(2008-5#1)
h at all##2##3##(2008-10#2)
h at##30##2##(1990-12#2)(1995-8#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2011-2#1)(2013-1#3)
h before inoculation with R##2##5##(2008-10#2)
h before inoculation with##3##4##(2008-10#3)
h before inoculation##4##3##(2008-10#4)
h before##14##2##(1991-2#1)(2008-10#7)(2008-12#1)(2008-7#2)(2010-8#2)(2012-2#1)
h but not##2##3##(1994-5#1)(1997-1#1)
h but##4##2##(1990-12#1)(1994-5#1)(1997-1#1)(2008-7#1)
h by a##2##3##(1993-1#1)(1997-4#1)
h by##6##2##(1993-1#1)(1997-4#1)(2008-10#3)(2009-6#1)
h compared with##2##3##(2008-10#1)(2012-2#1)
h dark##2##2##(2008-10#1)(2008-11#1)
h exposure to##2##3##(2008-11#1)(2013-1#1)
h exposure##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
h following HI##2##3##(1996-12#2)
h following inoculation##4##3##(2008-10#4)
h following the##2##3##(2008-7#2)
h following##12##2##(1994-8#1)(1996-12#2)(1996-2#1)(2008-10#5)(2008-7#2)(2010-8#1)
h for a##2##3##(1994-2#1)(2008-10#1)
h for##11##2##(1992-3#1)(1994-2#1)(1995-12#3)(2008-10#3)(2008-7#1)(2008-8#1)(2010-8#1)
h from##3##2##(2008-10#2)(2010-8#1)
h groups##2##2##(2008-9#2)
h in a flow-injection system##2##5##(2008-10#2)
h in a##4##3##(2008-10#2)(2008-8#1)(2012-3#1)
h in duration##2##3##(2008-10#2)
h in the presence of##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
h in the##8##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
h in vitro##2##3##(1995-11#2)
h in##26##2##(1994-3#1)(1995-11#2)(1995-6#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
h incubation##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)
h later##3##2##(1994-2#1)(2008-11#2)
h of air drying##2##4##(2008-10#2)
h of continuous##2##3##(2008-10#2)
h of cultivation##2##3##(2008-11#1)(2008-7#1)
h of culture##2##3##(2008-11#1)(2008-9#1)
h of exposure to##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
h of exposure##6##3##(2008-10#4)(2008-11#1)(2008-12#1)
h of hypoxia##2##3##(1994-2#1)(1996-12#1)
h of incubation with##2##4##(2008-10#1)(2008-11#1)
h of incubation##9##3##(1994-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2012-2#1)
h of inoculation##4##3##(2008-10#4)
h of leaf wetness##2##4##(2008-10#2)
h of light##2##3##(2008-10#1)(2008-11#1)
h of the##4##3##(1992-6#1)(1993-3#1)(2008-10#2)
h of treatment with 50##2##5##(1995-8#2)
h of treatment##3##3##(1995-8#3)
h of wetness for##2##4##(2008-10#2)
h of wetness##5##3##(2008-10#5)
h of##75##2##(1990-10#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#3)(1995-9#1)(1996-12#3)(1996-2#1)(1997-2#2)(2008-10#29)(2008-11#10)(2008-12#2)(2008-7#5)(2008-8#4)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
h on##4##2##(1993-12#1)(2008-10#2)(2013-1#1)
h or greater##2##3##(2008-10#2)
h or more before##2##4##(2008-10#2)
h or##10##2##(1990-12#1)(1995-11#1)(2008-10#5)(2008-11#1)(2008-2#2)
h per day##3##3##(2008-10#3)
h period##2##2##(2008-10#2)
h post administration##2##3##(2008-10#2)
h post infection##2##3##(2008-11#2)
h post##4##2##(2008-10#2)(2008-11#2)
h post-infection in##3##3##(1996-12#3)
h post-infection##6##2##(1996-12#4)(2008-11#2)
h postinoculation (hpi)##2##3##(2008-10#2)
h postinoculation##6##2##(2008-10#6)
h prior to##7##3##(1995-12#1)(2008-10#4)(2008-7#1)(2011-2#1)
h resulted in##2##3##(2008-10#1)(2008-7#1)
h show little##2##3##(1995-11#2)
h significantly##2##2##(2008-10#2)
h than##2##2##(1996-2#1)(2008-10#1)
h to determine##3##3##(1997-1#1)(2008-11#1)(2008-7#1)
h to##9##2##(1993-12#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)
h treatment##2##2##(1994-2#1)(2008-12#1)
h under##3##2##(1994-8#1)(2008-11#1)(2008-7#1)
h was##8##2##(1990-2#1)(2008-10#6)(2008-7#1)
h were##3##2##(2008-10#2)(2008-7#1)
h when a##3##3##(2008-10#2)(2008-11#1)
h when##4##2##(2008-10#3)(2008-11#1)
h which##2##2##(1995-11#1)(2008-10#1)
h with##12##2##(1995-11#1)(1995-12#1)(1995-8#2)(2008-10#5)(2008-11#3)
h without##2##2##(1994-3#1)(2008-10#1)
h##801##1##(1990-10#2)(1990-11#1)(1990-12#9)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-2#5)(1991-3#2)(1991-5#1)(1991-9#3)(1992-10#1)(1992-12#2)(1992-3#3)(1992-6#1)(1992-8#5)(1993-1#1)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#4)(1994-12#3)(1994-2#10)(1994-3#4)(1994-5#12)(1994-8#4)(1995-11#21)(1995-12#16)(1995-3#7)(1995-6#2)(1995-8#8)(1995-9#1)(1996-12#19)(1996-2#16)(1997-1#4)(1997-2#10)(1997-4#1)(1997-7#4)(2008-10#352)(2008-11#65)(2008-12#20)(2008-2#5)(2008-5#17)(2008-6#4)(2008-7#35)(2008-8#21)(2008-9#22)(2009-11#1)(2009-12#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-5#2)(2010-6#1)(2010-8#6)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#17)(2013-8#4)
h(-1) and a relative standard deviation of less than 0##2##10##(2008-10#2)
h(-1) and a relative standard deviation of##3##7##(2008-10#3)
h(-1) and a##4##3##(2008-10#4)
h(-1) and##9##2##(2008-10#8)(2008-7#1)
h(-1) at##2##2##(2008-10#1)(2011-2#1)
h(-1) can be##3##3##(2008-10#3)
h(-1) for##6##2##(2008-10#6)
h(-1) was##4##2##(2008-10#4)
h(-1) were achieved##4##3##(2008-10#4)
h(-1) were##6##2##(2008-10#6)
h(-1) with##4##2##(2008-10#4)
h(-1) without##2##2##(2008-10#1)(2011-2#1)
h(-1)##133##1##(2008-10#118)(2008-11#5)(2008-12#2)(2008-7#5)(2011-2#2)(2011-3#1)
h(-1)) and##2##2##(2008-10#2)
h(-1))##11##1##(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)
h(0)##2##1##(2011-2#2)
h(1)/t(1)##2##1##(2008-10#2)
h(3)/h(1)##2##1##(2008-10#2)
h(4)/h(1)##2##1##(2008-10#2)
h(5)/h(1)##2##1##(2008-10#2)
h(i)##2##1##(2008-10#1)(2012-2#1)
h) and##8##2##(1994-3#1)(1996-2#1)(2008-10#4)(2011-3#1)(2012-2#1)
h) exposure to 1 microM RO 11-2933##2##7##(1990-2#2)
h) for##3##2##(1995-11#1)(2008-10#1)(2011-2#1)
h) in##2##2##(1994-2#1)(2008-10#1)
h) is##2##2##(1997-1#1)(2008-10#1)
h) with##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
h)##54##1##(1990-12#1)(1990-2#2)(1991-3#2)(1992-8#1)(1993-12#2)(1993-6#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#2)(2008-10#20)(2008-11#1)(2008-12#2)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
h)anthracene##2##1##(2008-10#2)
h-1 (mu_max = 0##2##4##(2008-11#2)
h-1 and 0##3##3##(2008-11#3)
h-1##8##1##(2008-11#8)
h-1)##2##1##(2008-11#2)
h-TR beta 1 was##2##4##(1993-8#2)
h-TR beta 1##5##3##(1993-8#5)
h/72##2##1##(1996-12#2)
hASCs##3##1##(2012-5#3)
hAT2R cDNA##2##2##(1994-11#2)
hAT2R##5##1##(1994-11#5)
hBD-2 mRNA induction##2##3##(2008-11#2)
hBD-2 mRNA##4##2##(2008-11#4)
hBD-2##5##1##(2008-11#5)
hCG##11##1##(1993-6#1)(1994-3#1)(1995-8#1)(1997-1#3)(2008-5#2)(2008-9#1)(2011-1#2)
hCGalpha cDNA##2##2##(1995-8#2)
hCMV##2##1##(2008-11#1)(2008-9#1)
hCaT1 in the CHO cells##2##5##(2008-11#2)
hCaT1 was##3##2##(2008-11#3)
hCaT1##10##1##(2008-11#10)
hEPO##3##1##(2008-8#3)
hER##3##1##(1995-11#3)
hERO##3##1##(1993-6#3)
hESC developmental potential are##2##4##(2008-9#2)
hESC lines##3##2##(2008-11#3)
hESC##13##1##(2008-11#5)(2008-9#6)(2009-3#2)
hESCs##3##1##(2009-3#2)(2012-5#1)
hEp cDNA##2##2##(1993-6#2)
hEp genomic##3##2##(1993-12#1)(1993-6#2)
hEp##13##1##(1993-12#4)(1993-6#9)
hFGF-10##5##1##(2011-3#5)
hFIX expression##3##2##(2008-8#3)
hFIX##7##1##(2008-8#5)(2008-9#2)
hFIXR338A##6##1##(2008-9#6)
hFSH-beta-(33-53)##2##1##(1990-4#2)
hGH##5##1##(1995-11#2)(2008-11#1)(2013-1#2)
hIL-6 R##2##2##(2008-8#2)
hIL-6 and hIL-6R is##2##4##(2008-8#2)
hIL-6 and hIL-6R##3##3##(2008-8#3)
hIL-6 and##5##2##(2008-8#5)
hIL-6 gene##4##2##(2008-11#4)
hIL-6 production##2##2##(2008-11#2)
hIL-6 protein##2##2##(2008-11#2)
hIL-6##26##1##(2008-11#17)(2008-8#9)
hIL-6R##9##1##(2008-8#9)
hKGF##4##1##(1994-11#4)
hMPV##5##1##(2011-2#5)
hMSC##3##1##(2008-11#1)(2010-8#2)
hMSCs were##2##2##(2008-11#2)
hMSCs##12##1##(2008-11#7)(2010-8#5)
hMab##4##1##(2008-11#4)
hNE-Na##2##1##(1996-12#2)
hPC##2##1##(2008-12#2)
hPRL##3##1##(2008-11#3)
hPa##3##1##(2008-10#3)
hR##6##1##(1994-5#6)
hRNA##2##1##(2008-9#2)
hSIM2##5##1##(1996-6#5)
hTERT alone##2##2##(2008-11#2)
hTERT as##2##2##(2008-11#2)
hTERT mRNA and##3##3##(2008-11#3)
hTERT to immortalize##2##3##(2008-11#2)
hTERT##20##1##(2008-11#20)
hTNF cDNA##2##2##(2008-8#2)
hTNF##3##1##(2008-8#3)
hTR##3##1##(1991-6#2)(2008-9#1)
hTREK1##2##1##(2012-2#2)
hVEGF(165)##4##1##(2008-8#4)
hVN1R1##3##1##(2012-2#3)
ha of##3##2##(2008-10#3)
ha##8##1##(2008-10#7)(2008-9#1)
ha(-1) with##2##2##(2008-12#2)
ha(-1)##15##1##(2008-12#15)
ha)##2##1##(2008-10#2)
habit formation##2##2##(2009-7#2)
habit in##2##2##(1993-9#1)(2012-3#1)
habit of##3##2##(2008-12#1)(2008-9#1)(2010-12#1)
habit##17##1##(1991-12#1)(1993-9#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-12#1)(2012-3#6)
habitat amount##3##2##(2008-8#3)
habitat and##3##2##(2008-8#1)(2009-8#1)(2010-8#1)
habitat arrangement##2##2##(2008-8#2)
habitat destruction##3##2##(2008-8#1)(2009-8#2)
habitat for##3##2##(2008-10#3)
habitat heterogeneity##2##2##(2008-8#2)
habitat in the##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
habitat in##6##2##(2008-10#1)(2008-8#2)(2008-9#3)
habitat is##4##2##(2008-10#2)(2008-9#2)
habitat loss##6##2##(2008-8#1)(2008-9#3)(2009-8#2)
habitat networks##2##2##(2008-8#2)
habitat of##4##2##(2008-11#1)(2008-5#2)(2013-1#1)
habitat patch network##2##3##(2008-8#2)
habitat patch##3##2##(2008-8#3)
habitat patches##13##2##(2008-8#9)(2008-9#4)
habitat preference##2##2##(2008-8#2)
habitat preferences##2##2##(2008-8#2)
habitat quality##7##2##(2008-8#5)(2008-9#2)
habitat saturation##5##2##(2008-8#5)
habitat selection behavior##2##3##(2008-8#2)
habitat selection##7##2##(2008-8#5)(2008-9#2)
habitat specialization##2##2##(2008-8#2)
habitat use and##2##3##(2010-8#2)
habitat use##3##2##(2010-8#3)
habitat was##2##2##(2010-8#1)(2013-1#1)
habitat##141##1##(1992-1#1)(1995-3#1)(2008-10#14)(2008-11#1)(2008-5#3)(2008-8#78)(2008-9#23)(2009-2#1)(2009-5#1)(2009-8#6)(2010-8#6)(2011-2#1)(2012-3#1)(2013-1#4)
habitation of##2##2##(2008-10#1)(2011-2#1)
habitats and##4##2##(2008-12#1)(2008-9#1)(2011-2#1)(2012-9#1)
habitats by##2##2##(2008-8#1)(2013-8#1)
habitats for##4##2##(2008-8#2)(2010-8#1)(2012-2#1)
habitats may be##2##3##(2008-11#1)(2008-8#1)
habitats of##2##2##(2008-10#1)(2008-9#1)
habitats were##4##2##(2008-10#2)(2010-8#1)(2012-9#1)
habitats with##2##2##(2008-10#2)
habitats##60##1##(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-8#23)(2008-9#5)(2009-6#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-2#3)(2012-9#2)(2013-8#1)
habits and##9##2##(1994-6#1)(2008-1#2)(2008-12#1)(2008-5#1)(2010-7#1)(2012-2#2)(2013-1#1)
habits are##3##2##(1997-8#1)(2008-11#1)(2010-6#1)
habits as##2##2##(1991-2#1)(1996-3#1)
habits in##4##2##(1992-2#1)(1993-2#1)(1993-9#1)(1995-5#1)
habits of the##4##3##(1990-8#1)(2008-5#1)(2010-1#1)(2011-1#1)
habits of##10##2##(1990-2#1)(1990-8#1)(2008-1#1)(2008-5#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-3#1)
habits were##2##2##(1990-2#1)(1991-2#1)
habits##67##1##(1990-12#1)(1990-2#6)(1990-8#2)(1991-11#1)(1991-2#4)(1991-6#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-8#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-1#5)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
habitual##3##1##(1996-8#1)(2008-11#2)
habitually##3##1##(1992-2#1)(2008-10#1)(2008-11#1)
habituated##2##1##(1992-2#1)(2008-6#1)
habituation to the##2##3##(2008-11#1)(2008-6#1)
habituation to##4##2##(1994-2#1)(1994-3#1)(2008-11#1)(2008-6#1)
habituation##12##1##(1994-2#2)(1994-3#4)(1997-2#3)(2008-11#1)(2008-6#1)(2012-2#1)
had &gt##3##2##(2008-10#2)(2012-3#1)
had &quot##4##2##(2008-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
had 1##3##2##(1992-8#1)(2009-7#1)(2011-2#1)
had AIDS##3##2##(1993-11#1)(1995-12#1)(1995-6#1)
had CIN##4##2##(1994-2#1)(2011-2#3)
had DD and PD##6##4##(2008-12#6)
had IAA##2##2##(1994-12#2)
had MICs##2##2##(2008-5#2)
had PSA greater than##2##4##(1990-9#2)
had RD##2##2##(2008-7#2)
had SAH##2##2##(2012-3#1)(2013-8#1)
had a LOD of##2##4##(2008-10#2)
had a beneficial effect on##2##5##(2009-7#1)(2011-2#1)
had a beneficial##3##3##(2008-11#1)(2009-7#1)(2011-2#1)
had a buoyant density##2##4##(2008-10#2)
had a decrease in##2##4##(2008-7#1)(2013-8#1)
had a detection limit of##2##5##(2008-10#2)
had a detrimental effect on##2##5##(2008-10#1)(2010-1#1)
had a detrimental##3##3##(1996-3#1)(2008-10#1)(2010-1#1)
had a diagnosis##2##3##(2008-7#1)(2012-12#1)
had a different##2##3##(2008-10#2)
had a duration##2##3##(1993-1#1)(2012-2#1)
had a family history of##2##5##(2010-6#1)(2011-2#1)
had a faster##2##3##(1993-2#1)(1994-2#1)
had a full skeletal survey##2##5##(2011-1#2)
had a full##3##3##(2008-11#1)(2011-1#2)
had a good##5##3##(1991-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
had a great##2##3##(2008-5#1)(2013-1#1)
had a greater##7##3##(2008-10#4)(2008-11#1)(2009-7#1)(2012-4#1)
had a heterozygote frequency of##2##5##(1991-12#2)
had a high##10##3##(1991-5#1)(1992-11#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2013-1#1)
had a higher mortality##2##4##(2011-2#2)
had a higher sensitivity in the##2##6##(2011-2#2)
had a higher##24##3##(1990-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#1)(2011-2#6)(2012-6#1)(2013-1#1)
had a history of##7##4##(1996-6#1)(2010-1#1)(2010-4#1)(2010-6#2)(2012-3#1)(2013-1#1)
had a homogeneous##2##3##(2008-10#1)(2012-2#1)
had a large##2##3##(2008-12#1)(2012-3#1)
had a limited##2##3##(2008-9#1)(2011-1#1)
had a linear##4##3##(2008-10#3)(2008-8#1)
had a long##2##3##(1990-5#1)(1991-8#1)
had a longer##3##3##(1991-6#1)(2011-2#2)
had a loss##2##3##(2008-10#1)(2013-1#1)
had a low##7##3##(1990-11#1)(1990-3#1)(1996-2#1)(2008-10#3)(2010-6#1)
had a lower##6##3##(2008-10#2)(2008-11#1)(2009-10#1)(2010-11#2)
had a major impact on the##2##6##(1993-12#1)(2008-11#1)
had a major impact on##4##5##(1993-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
had a mammography##2##3##(1990-6#2)
had a maximum average of##2##5##(1996-12#2)
had a mean##10##3##(1990-2#1)(1994-12#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-11#1)(2013-8#1)
had a molecular mass of##6##5##(1995-6#1)(2008-10#4)(2013-1#1)
had a molecular##7##3##(1995-6#1)(2008-10#5)(2013-1#1)
had a more##2##3##(1995-3#1)(1997-2#1)
had a much##2##3##(2008-10#2)
had a negative effect on##5##5##(1991-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
had a negative effect##7##4##(1991-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
had a negative impact on##2##5##(2008-11#1)(2008-12#1)
had a negative##11##3##(1991-2#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
had a normal plasma##2##4##(1992-9#2)
had a normal##5##3##(1992-9#2)(2008-10#1)(2008-9#1)(2013-8#1)
had a positive effect on##6##5##(1990-9#1)(2008-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
had a positive impact on the##2##6##(2008-11#1)(2008-12#1)
had a positive impact on##3##5##(2008-11#1)(2008-12#1)(2011-2#1)
had a positive##14##3##(1990-9#1)(1996-6#1)(1997-2#1)(2008-11#3)(2008-12#1)(2009-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
had a previous##2##3##(2013-1#1)(2013-8#1)
had a profound influence on##2##5##(2008-11#2)
had a rapid##2##3##(1991-1#1)(2008-11#1)
had a recent##2##3##(2009-4#1)(2013-8#1)
had a relative standard deviation##2##5##(2008-10#2)
had a relative##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
had a satisfactory##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
had a sensitivity##2##3##(1997-8#1)(2008-12#1)
had a shorter##2##3##(2008-8#2)
had a significant effect on the##5##6##(1991-6#1)(1996-2#1)(2008-10#2)(2011-2#1)
had a significant effect on##13##5##(1990-6#1)(1991-6#1)(1996-12#1)(1996-2#1)(2008-10#7)(2008-7#1)(2011-2#1)
had a significant effect##18##4##(1990-6#1)(1991-6#1)(1996-12#1)(1996-2#1)(2008-10#11)(2008-11#1)(2008-7#1)(2011-2#1)
had a significant impact on##2##5##(2008-10#1)(2013-1#1)
had a significant influence on##3##5##(2008-10#1)(2008-11#1)(2011-2#1)
had a significant##32##3##(1990-6#1)(1991-6#1)(1996-12#1)(1996-2#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-7#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#2)(2013-1#1)
had a significantly higher frequency of the AA genotype##2##9##(2011-2#2)
had a significantly higher frequency of the##3##7##(2011-2#3)
had a significantly higher percentage of stomata##2##7##(2008-10#2)
had a significantly higher##13##4##(1996-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2011-1#1)(2011-2#3)(2012-2#1)
had a significantly lower##4##4##(1992-6#1)(2008-10#2)(2008-3#1)
had a significantly##20##3##(1992-6#1)(1996-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
had a similar##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
had a single evolutionary origin##2##5##(2008-10#1)(2011-3#1)
had a single##5##3##(1990-5#1)(2008-10#3)(2011-3#1)
had a slightly higher##2##4##(1991-12#1)(2008-8#1)
had a slightly##3##3##(1991-12#1)(2008-10#1)(2008-8#1)
had a small##2##3##(2008-10#1)(2013-8#1)
had a smaller##2##3##(2008-10#1)(2008-7#1)
had a spontaneous##2##3##(1991-2#1)(2010-11#1)
had a stable##2##3##(1990-2#1)(2008-12#1)
had a statistically significant##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
had a statistically##6##3##(1993-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#2)
had a strong negative##2##4##(1994-12#1)(2009-8#1)
had a strong##11##3##(1994-11#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-8#3)(2009-8#1)(2010-5#1)
had a stronger##2##3##(2008-8#1)(2010-2#1)
had a successful result##4##4##(2009-3#4)
had a successful##5##3##(2009-3#4)(2013-1#1)
had a unique##2##3##(1996-12#1)(2008-10#1)
had a very##6##3##(1993-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2013-1#1)
had a weak##3##3##(1996-2#2)(2008-8#1)
had a worsening of##2##4##(1996-9#1)(2013-1#1)
had a##478##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#3)(1990-6#5)(1990-8#2)(1990-9#4)(1991-1#3)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#4)(1991-8#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-6#4)(1993-8#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#5)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#4)(1997-8#5)(2007-12#2)(2007-8#3)(2008-1#3)(2008-10#117)(2008-11#36)(2008-12#17)(2008-2#4)(2008-3#5)(2008-5#6)(2008-6#2)(2008-7#18)(2008-8#13)(2008-9#10)(2009-1#1)(2009-10#4)(2009-3#6)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#10)(2011-10#1)(2011-2#28)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#5)(2012-4#1)(2012-6#1)(2013-1#25)(2013-8#9)
had abnormal##5##2##(1991-12#1)(1994-12#2)(2008-11#2)
had access to##3##3##(1993-3#1)(2008-11#1)(2009-5#1)
had accumulated##3##2##(1994-3#1)(2008-10#1)(2008-12#1)
had acquired##4##2##(1993-1#1)(1996-11#2)(2011-2#1)
had adequate##2##2##(2008-7#1)(2013-1#1)
had agreed to##3##3##(1995-6#1)(1996-3#1)(2011-1#1)
had already been##4##3##(1995-8#1)(2008-12#1)(2009-6#1)(2013-1#1)
had already##10##2##(1995-8#1)(1996-6#1)(1997-6#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
had also##2##2##(2008-1#1)(2008-5#1)
had altered##2##2##(2008-10#1)(2008-5#1)
had amino acid##2##3##(2011-3#1)(2013-8#1)
had an abnormal##2##3##(1993-11#1)(2008-12#1)
had an additional##2##3##(2010-1#1)(2010-2#1)
had an allocatable##2##3##(2008-8#2)
had an apparent molecular mass##2##5##(1993-8#1)(2008-10#1)
had an average similarity in virulence of##2##7##(2008-10#2)
had an average##3##3##(1995-3#1)(2008-10#2)
had an effect on##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
had an effect##4##3##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)
had an emergency##2##3##(1996-6#1)(2011-2#1)
had an impact on##3##4##(2008-10#2)(2013-1#1)
had an increased##6##3##(1992-5#1)(2008-8#1)(2011-2#4)
had an influence on the##2##5##(1991-1#1)(2009-1#1)
had an influence on##3##4##(1991-1#1)(2008-12#1)(2009-1#1)
had an intermediate##2##3##(2008-10#1)(2011-2#1)
had an intraparenchymal##2##3##(2012-3#2)
had an##109##2##(1990-11#1)(1990-5#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-6#2)(1992-2#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-8#2)(1994-2#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-2#2)(1996-6#1)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2009-1#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)
had another##2##2##(2008-7#1)(2013-8#1)
had anterior##2##2##(2008-11#1)(2008-7#1)
had any effect on the##4##5##(1991-3#1)(1995-8#1)(2008-10#1)(2008-7#1)
had any effect on##6##4##(1991-3#1)(1995-8#1)(2008-10#2)(2008-7#1)(2008-8#1)
had any effect##7##3##(1990-11#1)(1991-3#1)(1995-8#1)(2008-10#2)(2008-7#1)(2008-8#1)
had any##15##2##(1990-11#1)(1991-3#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-7#1)
had approximately##2##2##(2008-11#1)(2009-7#1)
had arteriovenous fistulae##2##3##(2008-7#2)
had at least one##8##4##(1990-6#1)(1990-8#1)(1993-8#1)(1994-6#1)(1997-3#1)(2008-9#1)(2012-12#1)(2012-3#1)
had at least##14##3##(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#1)
had basic##2##2##(2008-10#1)(2012-12#1)
had become##11##2##(1991-6#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2010-1#1)
had been a##2##3##(1991-5#1)(1995-9#1)
had been achieved##2##3##(1991-2#1)(2011-4#1)
had been applied to the determination of trace##3##8##(2008-10#3)
had been applied to the determination of##4##7##(2008-10#4)
had been applied to the##5##5##(2008-10#5)
had been applied##8##3##(2008-10#6)(2008-5#2)
had been assessed by##2##4##(1994-3#1)(2008-11#1)
had been carried out##2##4##(2008-10#1)(2012-3#1)
had been coated with##2##4##(1995-12#1)(2008-10#1)
had been completed##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
had been damaged##2##3##(2008-8#1)(2008-9#1)
had been diagnosed at##2##4##(1994-12#1)(2008-9#1)
had been diagnosed with##3##4##(2010-10#1)(2013-1#2)
had been diagnosed##6##3##(1991-9#1)(1994-12#1)(2008-9#1)(2010-10#1)(2013-1#2)
had been employed##2##3##(1991-12#1)(2008-11#1)
had been established##4##3##(2008-10#1)(2010-1#1)(2011-3#2)
had been found##4##3##(1990-3#1)(2008-10#2)(2011-2#1)
had been identified##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-9#1)
had been induced##3##3##(1994-8#1)(1995-12#1)(2008-11#1)
had been infected##2##3##(1995-9#1)(1996-11#1)
had been made##2##3##(1995-3#1)(2008-10#1)
had been met##2##3##(1995-2#1)(1996-1#1)
had been on##2##3##(2008-7#1)(2010-11#1)
had been passed##2##3##(1990-5#1)(1997-2#1)
had been previously treated with##2##5##(1991-6#1)(2008-10#1)
had been previously##6##3##(1991-6#1)(2008-10#5)
had been reported as having##2##5##(1996-11#2)
had been reported as##3##4##(1996-11#3)
had been reported##5##3##(1996-11#3)(2011-2#1)(2013-1#1)
had been shown to have##2##5##(1993-8#1)(1997-1#1)
had been shown to##4##4##(1993-8#1)(1997-1#1)(2008-10#1)(2010-3#1)
had been successfully applied##3##4##(2008-10#3)
had been successfully##5##3##(1996-6#1)(2008-10#4)
had been suffering##2##3##(2008-11#1)(2013-8#1)
had been the##2##3##(1994-6#1)(2008-8#1)
had been thought to be##2##5##(1996-12#1)(2008-6#1)
had been treated with wide spectrum antibiotics##2##7##(2008-5#2)
had been treated with##6##4##(1994-3#1)(1995-11#1)(2008-10#1)(2008-5#2)(2012-3#1)
had been treated##10##3##(1994-3#1)(1995-11#1)(2008-10#3)(2008-5#2)(2011-2#1)(2012-3#2)
had been visualized by##2##4##(1995-12#1)(2008-9#1)
had been well##2##3##(1994-12#1)(2007-12#1)
had been##231##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-6#1)(1995-9#4)(1996-1#2)(1996-11#6)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#68)(2008-11#17)(2008-12#4)(2008-2#1)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#4)(2011-3#3)(2011-4#1)(2012-12#1)(2012-3#4)(2013-1#6)(2013-8#2)
had begun to##2##3##(2010-10#1)(2012-12#1)
had begun##3##2##(1991-12#1)(2010-10#1)(2012-12#1)
had benign##2##2##(1994-12#2)
had better##12##2##(1992-1#1)(1994-12#2)(1996-6#1)(2008-10#2)(2008-5#1)(2010-9#1)(2011-2#4)
had bilateral##2##2##(2008-10#1)(2010-3#1)
had biopsies##2##2##(1990-12#1)(1994-12#1)
had bone##2##2##(1991-8#1)(1997-7#1)
had both##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2012-5#1)
had breast##2##2##(1993-11#1)(2011-2#1)
had changed their diet##2##4##(1990-6#2)
had changed##3##2##(1990-6#2)(1991-5#1)
had clinical##3##2##(2008-10#1)(2008-7#1)(2010-11#1)
had colonized##2##2##(2008-10#2)
had complete##9##2##(1990-8#1)(1995-2#1)(1995-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-3#1)(2012-3#1)
had considerable##2##2##(2008-9#1)(2012-3#1)
had dark##2##2##(1995-11#1)(2010-6#1)
had decreased and##2##3##(2010-7#1)(2012-2#1)
had decreased##6##2##(1991-6#1)(1994-12#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-2#1)
had developed a##2##3##(1993-1#1)(2008-9#1)
had developed##12##2##(1993-1#1)(1994-12#1)(1996-11#3)(2008-10#3)(2008-11#1)(2008-9#1)(2010-6#1)(2013-8#1)
had died from AIDS##3##4##(1996-11#3)
had died##6##2##(1996-11#3)(2008-10#1)(2008-11#1)(2013-1#1)
had different##15##2##(1992-2#1)(1993-8#1)(1995-2#1)(2008-10#5)(2008-8#2)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
had difficulty##2##2##(2008-11#1)(2010-4#1)
had direct contact with##2##4##(2008-10#1)(2008-12#1)
had disappeared and##2##3##(2012-2#1)(2013-1#1)
had disappeared##4##2##(1993-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
had disease 6-15 mm in##2##5##(1995-12#2)
had disease##4##2##(1995-12#4)
had distant##2##2##(1992-12#1)(2008-10#1)
had distinct##5##2##(2008-10#2)(2008-8#1)(2013-1#2)
had dramatic##2##2##(1991-4#1)(2008-11#1)
had early##2##2##(2011-3#1)(2012-3#1)
had either##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
had elevated levels of##3##4##(1991-12#1)(1992-3#1)(2009-10#1)
had elevated##7##2##(1991-12#1)(1992-3#1)(1996-12#1)(2008-5#1)(2008-9#1)(2009-10#2)
had encountered##2##2##(1991-8#2)
had enlarged##2##2##(2008-7#1)(2011-1#1)
had entered##2##2##(2008-10#1)(2008-5#1)
had equal##4##2##(2008-8#3)(2012-3#1)
had eutectic phase behavior##2##4##(1993-8#2)
had ever##2##2##(2008-11#1)(2008-12#1)
had evidence of##3##3##(1997-3#1)(2008-3#1)(2012-2#1)
had evolved##2##2##(2008-10#1)(2008-12#1)
had excellent##3##2##(1990-12#1)(1994-12#1)(2011-2#1)
had experienced##11##2##(1992-1#3)(1992-2#1)(1994-6#2)(1997-5#1)(2007-12#1)(2008-12#1)(2010-7#1)(2011-2#1)
had failed##5##2##(1990-6#1)(1991-4#1)(1994-6#1)(1997-8#1)(2013-1#1)
had fairly##2##2##(2008-10#1)(2008-7#1)
had few##4##2##(1997-6#1)(2008-10#3)
had fewer##4##2##(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)
had first##2##2##(2008-7#1)(2010-6#1)
had formed##3##2##(2008-10#2)(2008-11#1)
had four##4##2##(2008-10#1)(2008-12#2)(2011-2#1)
had frequent##2##2##(1994-6#1)(2011-2#1)
had from##2##2##(1994-2#1)(1996-8#1)
had gone##3##2##(1993-2#1)(1997-7#1)(2009-10#1)
had good##7##2##(2008-10#4)(2008-2#1)(2010-2#1)(2012-3#1)
had greater odds of a positive discography##2##7##(2012-12#2)
had greater##14##2##(1990-6#1)(1994-1#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#3)(2012-12#2)(2012-7#1)
had grown into##2##3##(2008-10#1)(2010-6#1)
had had a##5##3##(1990-6#3)(1991-6#1)(1992-5#1)
had had at least one##2##5##(1990-6#1)(1990-8#1)
had had at least##3##4##(1990-6#2)(1990-8#1)
had had their##2##3##(1990-6#1)(2008-11#1)
had had##22##2##(1990-6#7)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
had healthy##2##2##(1996-3#1)(2008-5#1)
had high EI scores##2##4##(2013-1#2)
had high##23##2##(1994-12#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#3)(2010-6#1)(2012-3#1)(2013-1#3)(2013-8#1)
had higher HbA1c##2##3##(1994-6#2)
had higher body mass##2##4##(2010-4#1)(2012-2#1)
had higher sCysC (1##2##4##(2013-1#2)
had higher sensitivity##2##3##(2008-10#1)(2013-8#1)
had higher total##2##3##(1992-8#1)(2013-1#1)
had higher##46##2##(1991-12#1)(1992-1#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-2#2)(1996-2#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-7#2)(2008-9#3)(2010-4#3)(2011-2#3)(2012-2#1)(2012-7#1)(2013-1#6)(2013-8#1)
had histories of##3##3##(1993-2#1)(1993-3#1)(2008-7#1)
had history of##3##3##(2011-2#1)(2012-3#1)(2013-7#1)
had hypothyroidism##2##2##(2011-2#1)(2013-1#1)
had identical##3##2##(2008-10#2)(2008-5#1)
had important effects on##2##4##(1992-1#1)(2008-10#1)
had improved##6##2##(1996-3#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-2#2)
had in##2##2##(1995-12#1)(2010-1#1)
had increased##9##2##(1997-8#1)(2008-10#1)(2010-7#1)(2011-2#4)(2012-3#1)(2012-7#1)
had indicated that##2##3##(1993-1#1)(2008-10#1)
had initial##2##2##(2008-1#2)
had initially##3##2##(2008-8#1)(2010-6#1)(2011-2#1)
had integrated##2##2##(2008-11#1)(2008-8#1)
had intermediate##3##2##(2008-10#1)(2011-2#2)
had invasive##2##2##(2008-5#1)(2013-8#1)
had its##5##2##(1993-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
had just completed a##2##4##(2008-11#2)
had just completed##3##3##(2008-11#3)
had just##4##2##(1996-5#1)(2008-11#3)
had large##2##2##(1992-10#1)(2008-10#1)
had largely##2##2##(1995-12#1)(2008-7#1)
had larger##6##2##(1994-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2013-1#1)
had led to##2##3##(1997-8#1)(2008-1#1)
had led##3##2##(1993-3#1)(1997-8#1)(2008-1#1)
had left##3##2##(1991-12#1)(1996-3#1)(2008-9#1)
had less post-cessation weight gain than##2##6##(2013-1#2)
had less##9##2##(1992-12#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#2)
had limited effect##2##3##(1994-12#1)(2008-1#1)
had limited##6##2##(1992-10#1)(1992-3#1)(1994-12#1)(1996-1#1)(2008-1#1)(2013-1#1)
had linear##3##2##(2008-10#3)
had little effect on the##5##5##(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#1)(2011-2#1)
had little effect on##11##4##(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#2)(2011-2#1)(2012-5#1)
had little effect##12##3##(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#3)(2011-2#1)(2012-5#1)
had little influence on the##4##5##(1997-8#1)(2008-10#1)(2010-4#2)
had little influence on##5##4##(1997-8#1)(2008-10#2)(2010-4#2)
had little or no effect on##2##6##(2008-10#2)
had little or no##4##4##(1991-6#1)(1994-8#1)(2008-10#2)
had little##35##2##(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1993-11#1)(1994-2#1)(1994-8#3)(1995-12#1)(1995-6#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2010-4#2)(2011-2#1)(2012-2#1)(2012-5#1)
had longer LTFs##2##3##(1991-5#2)
had longer##4##2##(1991-5#2)(1993-12#1)(2012-3#1)
had lost the ability to##2##5##(1994-12#1)(2008-10#1)
had lost##5##2##(1991-11#1)(1993-12#1)(1994-12#1)(2008-10#1)(2009-5#1)
had low##11##2##(1994-12#1)(1996-6#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#2)
had lower values of##2##4##(2010-4#1)(2011-2#1)
had lower##17##2##(1992-10#1)(1995-2#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#3)(2012-3#1)
had lymph node metastasis##2##4##(2011-2#2)
had made a##2##3##(1997-3#1)(2008-7#1)
had made##3##2##(1996-6#1)(1997-3#1)(2008-7#1)
had major##2##2##(1992-1#1)(2008-9#1)
had many##2##2##(2008-10#2)
had mated and##2##3##(2008-5#1)(2008-8#1)
had mean##3##2##(1993-2#1)(2008-10#1)(2012-2#1)
had minimal##3##2##(1994-8#1)(2008-10#1)(2012-3#1)
had moderate##3##2##(1995-12#1)(2008-8#1)(2013-1#1)
had more than##6##3##(1990-6#1)(1991-11#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
had more##26##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-1#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#1)
had much lower##2##3##(2012-3#2)
had much##4##2##(1993-8#1)(2008-10#1)(2012-3#2)
had multiple##5##2##(1991-11#1)(1993-12#1)(1997-3#1)(2013-1#1)(2013-8#1)
had negative##5##2##(1994-12#3)(2008-10#2)
had never been##2##3##(2008-10#2)
had never##12##2##(1990-6#2)(1992-1#1)(1997-3#1)(2008-10#3)(2008-7#1)(2013-1#3)(2013-8#1)
had no activity##2##3##(1992-1#1)(2008-11#1)
had no adverse effect on##2##5##(2008-10#1)(2013-1#1)
had no apparent##2##3##(1996-6#1)(2008-10#1)
had no common##2##3##(2008-10#1)(2008-6#1)
had no complications##2##3##(1996-3#1)(2012-12#1)
had no demonstrable##2##3##(1991-3#1)(1996-6#1)
had no detectable##2##3##(1992-6#1)(2008-8#1)
had no effect at##2##4##(1993-12#1)(2008-10#1)
had no effect in##4##4##(1996-2#1)(2008-11#1)(2011-2#1)(2012-3#1)
had no effect on either##2##5##(1993-6#1)(2008-7#1)
had no effect on fungal##2##5##(2008-10#2)
had no effect on growth of##2##6##(1995-2#1)(2008-10#1)
had no effect on lesion##2##5##(1995-12#1)(2008-10#1)
had no effect on platelet##2##5##(1992-4#1)(2008-8#1)
had no effect on the recovery of##2##7##(2008-10#2)
had no effect on the release of##2##7##(1995-11#1)(2006-6#1)
had no effect on the##20##5##(1990-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-6#1)(2008-10#4)(2008-11#2)(2013-8#1)
had no effect on##71##4##(1990-5#3)(1991-7#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#4)(1993-6#3)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#6)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#4)(1996-6#1)(1997-2#1)(1997-4#1)(2006-6#2)(2008-10#15)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#1)
had no effect upon##2##4##(1993-6#1)(2008-5#1)
had no effect##95##3##(1990-11#1)(1990-5#3)(1991-7#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#5)(1993-6#4)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#3)(1995-12#1)(1995-2#6)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#6)(1996-6#1)(1997-2#1)(1997-4#2)(2006-6#2)(2008-10#21)(2008-11#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
had no effects on##2##4##(2008-9#1)(2012-4#1)
had no effects##3##3##(2008-9#1)(2012-3#1)(2012-4#1)
had no impact on the##2##5##(2008-9#1)(2011-10#1)
had no impact on##3##4##(2008-4#1)(2008-9#1)(2011-10#1)
had no influence on survival##2##5##(1995-2#2)
had no influence on##5##4##(1994-3#1)(1995-2#2)(2008-11#2)
had no inhibitory##2##3##(1994-8#2)
had no measurable effect on##3##5##(1992-12#1)(1993-3#1)(2008-10#1)
had no risk##2##3##(2007-12#1)(2008-12#1)
had no significant effect on the rate of##2##8##(1995-3#1)(2008-10#1)
had no significant effect on the##9##6##(1990-5#1)(1993-1#1)(1994-5#1)(1995-3#1)(2008-10#3)(2008-7#1)(2011-3#1)
had no significant effect on##16##5##(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#1)
had no significant effect##22##4##(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
had no significant influence on##2##5##(1990-2#1)(2008-10#1)
had no significant##35##3##(1990-2#1)(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
had no symptoms##2##3##(2008-7#1)(2008-9#1)
had no##225##2##(1990-11#1)(1990-2#1)(1990-5#4)(1990-6#2)(1991-11#2)(1991-3#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#5)(1993-3#4)(1993-6#5)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1995-11#5)(1995-12#2)(1995-2#8)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#7)(1996-3#2)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-6#2)(2007-12#2)(2008-1#2)(2008-10#40)(2008-11#14)(2008-12#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#7)(2009-10#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-10#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2012-4#1)(2013-1#4)(2013-8#1)
had normal vitD levels##2##4##(2011-1#2)
had normal##11##2##(1992-3#1)(2007-11#1)(2008-5#1)(2009-10#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#2)
had not been reported##2##4##(2008-10#1)(2011-3#1)
had not been subjected to##2##5##(2008-11#2)
had not been validated##3##4##(2011-2#1)(2013-1#2)
had not been##18##3##(2008-10#4)(2008-11#4)(2009-8#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#3)
had not changed##2##3##(1991-6#1)(2011-2#1)
had not had##2##3##(1991-2#1)(2009-1#1)
had not previously##2##3##(2008-10#1)(2008-8#1)
had not received##3##3##(1990-2#1)(1991-4#1)(2008-7#1)
had not taken##2##3##(1996-5#1)(2013-1#1)
had not undergone##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
had not yet##2##3##(2008-10#1)(2010-1#1)
had not##45##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(2008-10#7)(2008-11#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
had oICH of##2##3##(2012-3#2)
had occurred##13##2##(1990-6#1)(1990-9#1)(1991-5#1)(1993-6#1)(1994-3#2)(1997-3#1)(1997-5#1)(2008-10#4)(2008-8#1)
had on##5##2##(2008-10#1)(2008-9#2)(2011-2#1)(2013-7#1)
had one or more##5##4##(1997-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
had one or##6##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
had one##11##2##(1992-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
had only 0##2##3##(1990-10#1)(2008-10#1)
had only a marginal##2##4##(1990-2#1)(1990-6#1)
had only a minor##2##4##(2008-10#2)
had only a##10##3##(1990-2#1)(1990-6#1)(1997-4#1)(2008-10#6)(2008-5#1)
had only minor effects##2##4##(2008-10#2)
had only##22##2##(1990-10#1)(1990-2#1)(1990-6#1)(1993-12#1)(1996-11#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
had partial##3##2##(1990-2#1)(2009-1#1)(2012-12#1)
had penetrated the##2##3##(1991-12#1)(2008-10#1)
had persistent##5##2##(1993-1#1)(1993-3#1)(2008-10#1)(2009-10#1)(2011-1#1)
had placed a##2##3##(2013-1#2)
had poor##3##2##(1994-6#1)(2008-7#1)(2013-1#1)
had positive##9##2##(1993-2#1)(1994-12#2)(2008-11#1)(2008-5#1)(2011-2#2)(2012-3#2)
had postoperative##2##2##(1996-3#1)(2011-2#1)
had prevented##2##2##(2008-11#1)(2010-12#1)
had previous##2##2##(1995-3#1)(2013-1#1)
had previously been##4##3##(1996-12#1)(2008-11#1)(2010-1#1)(2011-2#1)
had previously##16##2##(1994-8#2)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-1#2)(2010-12#1)(2010-4#1)(2011-2#1)
had progressive##2##2##(1994-12#1)(2008-7#1)
had protective effects##2##3##(2008-11#1)(2009-7#1)
had protective##4##2##(2008-11#1)(2008-12#2)(2009-7#1)
had pulmonary##2##2##(1991-11#1)(1997-8#1)
had reactions##2##2##(2008-11#1)(2012-12#1)
had received##12##2##(1990-2#2)(1991-3#1)(1994-8#1)(2008-11#2)(2008-5#1)(2008-9#2)(2011-2#1)(2013-1#2)
had recently##3##2##(1997-3#1)(2008-12#1)(2009-8#1)
had recovered from##3##3##(1990-5#1)(2008-10#1)(2012-3#1)
had recurrent##5##2##(1992-6#1)(1994-3#1)(1997-5#1)(2010-6#1)(2011-2#1)
had reduced##10##2##(1990-12#1)(1990-6#1)(1994-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
had reflux##2##2##(2008-10#2)
had relatively##2##2##(1995-8#1)(2008-10#1)
had repeat##2##2##(1995-12#1)(2012-3#1)
had reported##2##2##(1992-9#1)(1997-6#1)
had returned to control levels##2##5##(1996-12#2)
had returned to control##3##4##(1994-5#1)(1996-12#2)
had returned to##4##3##(1994-5#1)(1996-12#2)(2008-8#1)
had revealed##2##2##(1996-11#1)(2008-11#1)
had risk factors##2##3##(1992-1#1)(2012-2#1)
had seizures##2##2##(1997-3#1)(2008-7#1)
had serious##3##2##(1991-11#1)(1994-9#1)(2012-3#1)
had several##5##2##(2008-10#2)(2008-11#1)(2009-1#1)(2013-8#1)
had severe##6##2##(2008-1#1)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)
had short##2##2##(2008-12#1)(2011-1#1)
had shown##4##2##(1997-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
had significant effects on the##2##5##(1991-9#1)(2013-8#1)
had significant effects on##6##4##(1991-9#1)(2008-10#3)(2008-5#1)(2013-8#1)
had significant impact on##2##4##(1996-1#1)(2008-10#1)
had significant##17##2##(1991-12#1)(1991-9#1)(1995-12#1)(1996-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
had significantly (P &lt##2##4##(2008-10#1)(2012-3#1)
had significantly fewer##3##3##(1995-12#1)(2008-10#2)
had significantly greater##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
had significantly higher##15##3##(1993-11#1)(1993-2#1)(1994-12#1)(2008-10#5)(2008-11#2)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2013-1#1)
had significantly less disease##3##4##(2008-10#3)
had significantly lower##16##3##(1993-12#1)(2008-10#6)(2008-5#1)(2008-7#3)(2009-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
had significantly more concerns##2##4##(1993-3#2)
had significantly more##7##3##(1993-3#2)(2008-10#3)(2011-2#1)(2012-2#1)
had significantly reduced##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
had significantly##57##2##(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1995-12#1)(2008-10#24)(2008-11#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-6#2)(2010-10#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
had similar amounts of##2##4##(2008-11#2)
had similar effects on##2##4##(1996-2#1)(2008-8#1)
had similar topologies##2##3##(2008-10#2)
had similar##22##2##(1991-3#1)(1992-3#1)(1993-11#1)(1996-1#1)(1996-2#2)(2007-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-8#3)(2013-1#2)(2013-8#1)
had small bowel##2##3##(1995-10#1)(1995-12#1)
had smaller##2##2##(1993-3#1)(2008-10#1)
had smoked##2##2##(1991-11#2)
had some##4##2##(1991-1#1)(2008-9#1)(2012-12#1)(2013-7#1)
had stable disease and##3##4##(1991-6#1)(1992-12#1)(2008-10#1)
had stable##4##2##(1991-6#1)(1992-12#1)(2008-10#1)(2013-8#1)
had stage##2##2##(1995-12#2)
had started##3##2##(2008-10#1)(2012-12#1)(2013-8#1)
had still##2##2##(1996-3#1)(2011-2#1)
had strong##3##2##(1994-12#1)(2008-8#1)(2013-1#1)
had subcortical##2##2##(2008-7#2)
had substantial##3##2##(1991-3#1)(2008-10#1)(2008-9#1)
had successful##2##2##(1995-8#1)(2010-5#1)
had suffered a##2##3##(1997-3#1)(2010-7#1)
had suffered##5##2##(1990-12#1)(1997-3#1)(2009-5#1)(2010-7#1)(2012-3#1)
had surgical##2##2##(1992-9#1)(2008-7#1)
had sustained##2##2##(2008-12#1)(2013-1#1)
had symptoms of##2##3##(1991-2#1)(2013-1#1)
had symptoms##3##2##(1991-2#1)(2008-10#1)(2013-1#1)
had the ability to##2##4##(1993-8#1)(2008-10#1)
had the best clinical##2##4##(2008-7#1)(2013-1#1)
had the best##5##3##(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#1)
had the following##3##3##(1994-3#1)(2008-10#1)(2012-12#1)
had the greatest effect##2##4##(2008-10#2)
had the greatest##5##3##(1993-12#1)(2008-10#4)
had the highest mean score for the##2##7##(1990-2#2)
had the highest##28##3##(1990-2#2)(1991-2#1)(1996-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
had the largest effect##2##4##(2008-10#2)
had the largest##3##3##(2008-10#3)
had the least##2##3##(2008-10#2)
had the lowest##8##3##(1996-12#1)(2008-10#6)(2013-1#1)
had the mat1-1##2##3##(2008-10#2)
had the mat1-2 allele##2##4##(2008-10#2)
had the more##2##3##(2008-10#1)(2008-11#1)
had the most##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2010-4#1)
had the opportunity to study##2##5##(1993-11#1)(2009-8#1)
had the opportunity to##3##4##(1993-11#1)(2009-8#1)(2012-2#1)
had the same effect##2##4##(1995-12#2)
had the same##14##3##(1990-6#1)(1993-8#1)(1995-12#2)(1997-2#1)(2006-6#1)(2008-10#5)(2008-12#1)(2008-9#2)
had the##115##2##(1990-2#2)(1990-6#2)(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-3#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#51)(2008-11#6)(2008-12#4)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-8#2)(2010-1#2)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
had their growth unaffected by##2##5##(2008-11#2)
had their##8##2##(1990-6#1)(1994-2#1)(2008-11#4)(2009-5#1)(2010-1#1)
had this##2##2##(2009-3#1)(2010-6#1)
had three##6##2##(2008-10#3)(2011-1#1)(2011-2#1)(2013-8#1)
had time to##2##3##(2008-8#1)(2013-1#1)
had to be removed##3##4##(2008-10#1)(2011-2#2)
had to be##24##3##(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1994-8#1)(1996-1#1)(1996-3#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#2)(2013-1#2)
had to##39##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1993-11#3)(1994-12#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-10#11)(2008-11#2)(2008-5#1)(2009-10#1)(2009-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#5)
had total abdominal hysterectomy##2##4##(2013-1#1)(2013-8#1)
had total##4##2##(1994-3#1)(2010-10#1)(2013-1#1)(2013-8#1)
had treatment failure##2##3##(2008-10#1)(2013-8#1)
had treatment##3##2##(1994-2#1)(2008-10#1)(2013-8#1)
had tremor##2##2##(2008-7#2)
had tried##2##2##(1991-9#2)
had two or more##2##4##(1991-2#1)(2011-1#1)
had two##9##2##(1991-2#1)(1993-12#1)(1994-12#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
had type 2 diabetes##2##4##(2012-4#2)
had type##4##2##(1997-8#1)(2012-4#3)
had undergone a##4##3##(2008-10#1)(2008-12#1)(2008-9#2)
had undergone##27##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-6#1)(1994-12#1)(1994-3#4)(1996-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#2)(2009-11#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#3)
had unique##5##2##(2008-10#5)
had used##3##2##(2008-10#1)(2011-10#1)(2013-8#1)
had various##2##2##(1994-3#1)(2008-9#1)
had very high##2##3##(1990-5#1)(2013-1#1)
had very##5##2##(1990-5#1)(1994-12#1)(1996-6#1)(2008-9#1)(2013-1#1)
had worked##4##2##(1991-12#1)(1991-2#1)(1997-5#1)(2012-12#1)
had##2886##1##(1990-10#1)(1990-11#9)(1990-12#14)(1990-2#14)(1990-3#10)(1990-5#13)(1990-6#37)(1990-8#8)(1990-9#13)(1991-1#7)(1991-10#1)(1991-11#16)(1991-12#34)(1991-2#20)(1991-3#12)(1991-4#3)(1991-5#10)(1991-6#17)(1991-7#2)(1991-8#9)(1991-9#8)(1992-1#14)(1992-10#3)(1992-11#3)(1992-12#10)(1992-2#7)(1992-3#8)(1992-4#2)(1992-5#8)(1992-6#5)(1992-8#2)(1992-9#8)(1993-1#13)(1993-11#13)(1993-12#17)(1993-2#10)(1993-3#16)(1993-6#14)(1993-8#22)(1993-9#1)(1994-1#4)(1994-11#5)(1994-12#49)(1994-2#11)(1994-3#26)(1994-5#4)(1994-6#12)(1994-8#19)(1994-9#5)(1995-1#4)(1995-10#6)(1995-11#9)(1995-12#31)(1995-2#23)(1995-3#10)(1995-6#16)(1995-8#14)(1995-9#7)(1996-1#10)(1996-11#17)(1996-12#20)(1996-2#22)(1996-3#15)(1996-5#6)(1996-6#24)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#9)(1997-3#32)(1997-4#6)(1997-5#7)(1997-6#7)(1997-7#5)(1997-8#22)(1997-9#1)(2006-6#4)(2007-11#2)(2007-12#9)(2007-8#4)(2008-1#21)(2008-10#615)(2008-11#176)(2008-12#87)(2008-2#10)(2008-3#10)(2008-4#3)(2008-5#58)(2008-6#6)(2008-7#105)(2008-8#65)(2008-9#72)(2009-1#10)(2009-10#14)(2009-11#1)(2009-12#1)(2009-3#13)(2009-4#2)(2009-5#4)(2009-6#8)(2009-7#9)(2009-8#9)(2010-1#21)(2010-10#10)(2010-11#9)(2010-12#6)(2010-2#3)(2010-3#7)(2010-4#17)(2010-5#4)(2010-6#19)(2010-7#11)(2010-8#5)(2010-9#3)(2011-1#24)(2011-10#3)(2011-2#159)(2011-3#11)(2011-4#1)(2012-12#35)(2012-2#39)(2012-3#85)(2012-4#5)(2012-5#2)(2012-6#1)(2012-7#3)(2012-9#1)(2013-1#131)(2013-7#6)(2013-8#45)
haem a and##2##3##(1997-7#2)
haem a##3##2##(1997-7#3)
haem##5##1##(1994-3#1)(1997-7#4)
haemagglutination##4##1##(2008-5#3)(2008-7#1)
haemagglutinin##2##1##(2008-11#1)(2008-8#1)
haemangioma of##3##2##(2010-5#3)
haemangioma##7##1##(1997-6#1)(2010-5#4)(2013-1#2)
haemangiomas##6##1##(2008-5#3)(2008-7#1)(2013-1#2)
haemangiopericytoma of the##2##3##(1997-6#1)(2008-7#1)
haemangiopericytoma##5##1##(1997-6#2)(2008-7#2)(2010-11#1)
haematemesis##3##1##(1995-10#1)(2009-8#1)(2011-2#1)
haematocrit##2##1##(1993-3#1)(2008-5#1)
haematogenous##2##1##(2008-5#1)(2012-2#1)
haematological malignancies##2##2##(2008-12#1)(2013-1#1)
haematological malignancy##2##2##(2009-3#1)(2010-10#1)
haematological##9##1##(1990-10#1)(2006-6#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-3#1)(2010-10#1)(2013-1#1)
haematology##2##1##(1994-12#2)
haematoma##10##1##(1997-3#2)(2008-7#6)(2011-2#1)(2013-1#1)
haematopoietic##2##1##(2010-8#1)(2012-4#1)
haematoporphyrin##2##1##(1990-6#2)
haematuria##11##1##(1995-5#5)(1996-6#1)(2008-10#3)(2009-1#1)(2011-2#1)
haemochromatosis##4##1##(1997-7#1)(2008-5#3)
haemodialysis patients##3##2##(1990-2#1)(2008-12#2)
haemodialysis##6##1##(1990-2#1)(2008-10#2)(2008-12#3)
haemodialyzed patients were##2##3##(2008-12#2)
haemodialyzed patients##3##2##(2008-12#3)
haemodialyzed##4##1##(2008-12#4)
haemodynamic response to surgical##2##4##(2011-2#2)
haemodynamic responses##2##2##(2009-5#1)(2011-2#1)
haemodynamic##13##1##(1996-3#1)(2008-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#4)(2012-2#1)
haemodynamics and##3##2##(2010-10#2)(2010-7#1)
haemoglobin##14##1##(1990-2#1)(1990-3#1)(1993-2#2)(1994-6#1)(1994-8#1)(2008-10#2)(2008-8#1)(2009-3#2)(2009-5#1)(2013-1#2)
haemolymph##3##1##(1995-12#1)(1997-8#1)(2008-6#1)
haemolysis and##3##2##(1990-6#1)(1994-8#2)
haemolysis in##2##2##(1991-12#1)(2008-10#1)
haemolysis##11##1##(1990-6#1)(1991-12#3)(1994-8#3)(2008-10#4)
haemolytic##6##1##(1991-8#1)(1995-12#1)(2011-2#3)(2013-1#1)
haemolyticus##2##1##(2008-7#2)
haemophilia B##3##2##(1990-5#3)
haemophilia##6##1##(1990-5#3)(2009-3#3)
haemopoiesis##2##1##(2008-11#1)(2010-8#1)
haemopoietic cells##2##2##(2008-11#2)
haemopoietic stem cells##2##3##(2008-11#2)
haemopoietic stem##3##2##(2008-11#3)
haemopoietic##7##1##(1990-12#1)(2008-11#5)(2010-11#1)
haemorrhage and was##2##3##(2008-7#2)
haemorrhage and##12##2##(1992-6#3)(1996-9#1)(2008-7#6)(2011-2#2)
haemorrhage due to a##2##4##(1997-3#1)(2008-7#1)
haemorrhage during##2##2##(1991-8#1)(2008-7#1)
haemorrhage in##4##2##(2008-7#3)(2012-12#1)
haemorrhage with mass effect and oedema##2##6##(1996-6#2)
haemorrhage##74##1##(1991-8#1)(1992-6#5)(1994-3#1)(1996-6#6)(1996-9#4)(1997-3#3)(1997-6#2)(2008-7#36)(2008-8#4)(2009-3#1)(2010-10#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)
haemorrhages##6##1##(1990-9#2)(1996-6#1)(1997-5#1)(2008-7#1)(2008-8#1)
haemorrhagic##17##1##(1991-8#1)(1996-9#2)(1997-6#1)(1997-8#1)(2008-7#7)(2008-8#1)(2011-2#4)
haemorrhoidal##2##1##(2013-1#2)
haemorrhoidalis##8##1##(2008-8#8)
haemorrhoidectomy##2##1##(1990-3#2)
haemosiderin##2##1##(2008-7#1)(2010-3#1)
haemostatic##2##1##(1993-2#1)(2010-7#1)
haemothorax##4##1##(2011-2#3)(2013-7#1)
haems##2##1##(1994-3#2)
hafnia-silica multilayer coatings##3##3##(2008-3#3)
hafnium##4##1##(2008-10#4)
hagfishes##3##1##(2012-2#3)
hair after##2##2##(2008-5#2)
hair and blood##4##3##(2008-10#4)
hair and nails##2##3##(2008-5#2)
hair and skin##2##3##(2008-5#2)
hair and the##2##3##(2008-10#1)(2008-5#1)
hair and##23##2##(2007-12#1)(2008-10#12)(2008-5#8)(2010-11#1)(2012-3#1)
hair breakage##3##2##(2008-5#3)
hair by##4##2##(2008-10#3)(2008-5#1)
hair care products##2##3##(2008-10#1)(2008-5#1)
hair care##4##2##(2008-10#1)(2008-5#3)
hair cell##2##2##(2009-8#1)(2012-2#1)
hair cells across their apical membranes##2##6##(2009-8#1)(2012-2#1)
hair cells##9##2##(2009-8#3)(2009-9#2)(2012-2#4)
hair color##2##2##(2008-5#2)
hair dye##5##2##(2008-10#1)(2010-5#2)(2012-3#2)
hair dyeing##3##2##(2011-1#3)
hair dyes##4##2##(2008-10#2)(2008-5#1)(2012-3#1)
hair fibre##3##2##(2008-10#1)(2008-5#2)
hair follicle##9##2##(2008-5#6)(2008-8#1)(2012-2#2)
hair follicles##2##2##(2008-5#1)(2008-9#1)
hair growth and##3##3##(2008-5#3)
hair growth##4##2##(2008-5#3)(2008-8#1)
hair have##2##2##(2008-5#2)
hair in##3##2##(2008-10#1)(2008-5#2)
hair is##5##2##(2008-5#4)(2010-6#1)
hair keratin homologs##3##3##(2011-2#3)
hair keratin research##2##3##(2008-5#2)
hair keratin##6##2##(2008-5#3)(2011-2#3)
hair keratins and##2##3##(2008-5#2)
hair keratins##8##2##(2008-5#6)(2011-2#2)
hair loss and##2##3##(2008-5#2)
hair loss is##3##3##(2008-5#2)(2008-8#1)
hair loss##19##2##(2008-5#9)(2008-8#5)(2010-6#2)(2012-3#3)
hair on##2##2##(2008-5#1)(2010-6#1)
hair reference##2##2##(2008-10#2)
hair root##2##2##(2013-8#2)
hair samples by##2##3##(2008-10#2)
hair samples was##3##3##(2008-10#3)
hair samples##19##2##(2008-10#14)(2008-5#5)
hair shaft diameter##2##3##(2008-5#2)
hair shaft##4##2##(2008-12#1)(2008-5#3)
hair shedding##3##2##(2008-5#3)
hair styling products##2##3##(2008-5#2)
hair styling##3##2##(2008-5#3)
hair thinning##2##2##(2008-5#1)(2012-3#1)
hair transverse sections##2##3##(2008-5#2)
hair transverse##3##2##(2008-5#3)
hair using##2##2##(2008-10#1)(2008-5#1)
hair was##3##2##(2012-3#3)
hair were##2##2##(2008-9#1)(2012-3#1)
hair##269##1##(1990-8#4)(2007-12#1)(2008-10#49)(2008-12#1)(2008-4#1)(2008-5#142)(2008-7#1)(2008-8#9)(2008-9#5)(2009-8#4)(2009-9#2)(2010-11#1)(2010-5#2)(2010-6#7)(2011-1#5)(2011-2#5)(2012-2#9)(2012-3#19)(2013-8#2)
hair)##2##1##(2008-10#1)(2008-12#1)
hair-care products##2##2##(2008-10#2)
hair-care##4##1##(2008-10#3)(2008-5#1)
hairiness##2##1##(2008-8#2)
hairless##3##1##(2008-5#3)
hairpin RNA##3##2##(2011-2#1)(2013-1#2)
hairpin formation##2##2##(1991-5#2)
hairpin##14##1##(1991-5#2)(1992-3#2)(1993-12#1)(1997-7#1)(2008-10#2)(2008-4#1)(2011-1#2)(2011-2#1)(2013-1#2)
hairpins varied in loop sequence##2##5##(1992-3#2)
hairpins##7##1##(1992-3#4)(2008-10#2)(2008-4#1)
hairs##15##1##(2008-10#7)(2008-5#4)(2009-8#1)(2011-2#2)(2012-12#1)
hairy length##3##2##(2008-7#3)
hairy root##2##2##(2008-10#1)(2008-8#1)
hairy roots of##2##3##(2008-10#1)(2008-6#1)
hairy roots##8##2##(2008-10#6)(2008-6#1)(2008-8#1)
hairy##18##1##(1990-9#2)(2008-10#10)(2008-6#1)(2008-7#3)(2008-8#2)
hake##3##1##(2010-8#2)(2011-2#1)
half a year##2##3##(2008-10#2)
half a##6##2##(2008-10#2)(2008-11#2)(2012-3#1)(2013-1#1)
half also##2##2##(2007-12#1)(2010-8#1)
half an hour##2##3##(2008-10#1)(2012-12#1)
half and##3##2##(1992-9#1)(2008-10#1)(2009-10#1)
half as##2##2##(1996-12#1)(2008-5#1)
half century##4##2##(1993-2#1)(1994-1#1)(1997-1#1)(2009-5#1)
half had##2##2##(1991-9#1)(2008-7#1)
half life of##2##3##(2008-10#1)(2008-9#1)
half life##3##2##(2008-10#2)(2008-9#1)
half million##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
half of France##2##3##(2008-10#1)(2010-1#1)
half of all##3##3##(1992-12#1)(2008-10#1)(2012-2#1)
half of patients##2##3##(1996-11#1)(2012-3#1)
half of the RTD##3##4##(2008-10#3)
half of the cell##2##4##(2007-12#1)(2008-7#1)
half of the nineteenth century##2##5##(2010-1#1)(2011-2#1)
half of the patients##5##4##(1990-9#1)(1992-6#1)(2007-12#1)(2008-11#2)
half of the protein##2##4##(1994-5#1)(2011-1#1)
half of the women##2##4##(2009-4#1)(2010-3#1)
half of the##70##3##(1990-2#1)(1990-9#3)(1991-5#1)(1991-6#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-7#1)(1997-8#2)(2007-12#3)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
half of them had##2##4##(2011-2#1)(2013-7#1)
half of them##4##3##(1997-8#1)(2008-10#1)(2011-2#1)(2013-7#1)
half of these##4##3##(1992-2#1)(1997-2#1)(2008-6#1)(2012-2#1)
half of##105##2##(1990-2#1)(1990-9#3)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#3)(2007-12#4)(2008-10#19)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#4)(2010-11#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
half the##17##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-6#1)(1993-12#1)(1994-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
half time##4##2##(1996-1#1)(2008-10#3)
half was##2##2##(1997-8#1)(2009-8#1)
half were##2##2##(1996-1#1)(1996-3#1)
half year##2##2##(1992-5#1)(2010-5#1)
half years##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#2)
half##210##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#3)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-12#3)(1995-5#2)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#4)(2007-12#5)(2008-10#40)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#3)(2010-1#4)(2010-11#5)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#4)
half-Cauchy##3##1##(2008-10#3)
half-cycle##2##1##(1994-8#1)(2008-5#1)
half-life and##3##2##(1993-8#1)(2008-10#1)(2011-3#1)
half-life is##2##2##(2008-10#1)(2010-10#1)
half-life of the##4##3##(2008-11#4)
half-life of##11##2##(1993-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2011-1#1)(2011-3#1)
half-life##33##1##(1991-3#1)(1993-8#2)(1995-12#1)(1995-6#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-5#2)(2009-11#1)(2010-10#2)(2010-11#1)(2010-7#1)(2011-1#2)(2011-3#2)(2012-2#1)
half-lives##9##1##(1995-2#1)(2008-10#2)(2008-11#4)(2008-4#1)(2013-1#1)
half-maximal##5##1##(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-8#1)
half-maximum##4##1##(1990-5#1)(2007-12#1)(2008-2#2)
half-resonator##2##1##(2008-3#2)
half-sib families of##2##3##(2008-8#1)(2011-10#1)
half-site saturation##2##2##(1994-5#2)
half-site##3##1##(1993-6#1)(1994-5#2)
half-visor##6##1##(2010-1#6)
half-visors##4##1##(2010-1#4)
half-wave potential##2##2##(2008-10#2)
half-wave##3##1##(2008-10#3)
halftone##4##1##(2008-3#4)
halide sensitized gelatin##3##3##(2007-11#1)(2008-3#2)
halide##19##1##(1994-5#2)(2007-11#1)(2008-10#10)(2008-3#6)
halides in##2##2##(2008-10#1)(2009-5#1)
halides##7##1##(2008-10#5)(2009-5#1)(2012-2#1)
halitosis##3##1##(1997-4#1)(2008-10#2)
hallmark of B16 2F2##2##4##(2008-11#2)
hallmark of apoptosis##2##3##(1993-8#1)(2008-9#1)
hallmark of the##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
hallmark of##17##2##(1991-2#1)(1993-8#1)(2008-11#6)(2008-9#2)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#1)
hallmark##22##1##(1991-2#1)(1993-8#1)(2008-11#8)(2008-9#2)(2009-8#2)(2010-11#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
hallmarks of##8##2##(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
hallucinations and##2##2##(2008-7#1)(2013-8#1)
hallucinations in patients##2##3##(2012-3#1)(2013-8#1)
hallucinations##14##1##(1995-2#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#5)(2012-3#1)(2013-8#3)
hallucinogenic##4##1##(2008-10#1)(2008-12#2)(2013-8#1)
hallucinogens##2##1##(2008-10#2)
hallucis##5##1##(2009-10#2)(2010-7#2)(2012-2#1)
hallux rigidus##3##2##(2010-3#1)(2012-2#1)(2012-3#1)
hallux valgus deformity##5##3##(2010-11#1)(2012-2#4)
hallux valgus##8##2##(2010-11#1)(2012-2#7)
hallux##11##1##(2010-11#1)(2010-3#1)(2012-2#8)(2012-3#1)
halo effect##2##2##(2012-2#2)
halo nevi are##2##3##(2011-2#2)
halo nevi##5##2##(2011-2#5)
halo##17##1##(2008-10#1)(2008-3#4)(2011-2#7)(2012-2#4)(2013-1#1)
haloacetic acids##5##2##(2008-10#4)(2008-9#1)
haloacetic##6##1##(2008-10#5)(2008-9#1)
haloacetonitriles##2##1##(2008-10#2)
halobium##3##1##(1990-5#3)
halogen##4##1##(1991-9#1)(2008-10#3)
halogenated aliphatic hydrocarbons in anaerobic##2##5##(2008-11#2)
halogenated compounds##3##2##(2009-8#3)
halogenated fatty##2##2##(2008-11#2)
halogenated hydrocarbons##2##2##(1993-12#1)(2008-7#1)
halogenated monoterpenes##2##2##(2008-11#2)
halogenated organic##3##2##(2008-10#3)
halogenated pyrimidines##2##2##(2008-9#2)
halogenated##26##1##(1993-12#1)(1996-12#1)(2008-10#10)(2008-11#8)(2008-7#1)(2008-9#2)(2009-8#3)
halogens##3##1##(1996-1#1)(2008-10#2)
haloperidol and droperidol##2##3##(2008-10#2)
haloperidol##6##1##(1995-2#1)(1996-12#1)(2008-10#3)(2009-10#1)
halophilic proteins##3##2##(2011-2#3)
halophilic##4##1##(1990-5#1)(2011-2#3)
halorhodopsin##2##1##(1994-5#2)
halos##2##1##(2008-10#1)(2008-3#1)
halothane##2##1##(1991-6#1)(1992-3#1)
halstedii##3##1##(2008-10#3)
halt##3##1##(1995-6#1)(2008-7#1)(2011-2#1)
halted##7##1##(1996-3#1)(2008-10#5)(2012-3#1)
haltere##2##1##(2012-2#2)
halts##2##1##(2008-10#1)(2008-8#1)
halves and##2##2##(2008-10#1)(2008-11#1)
halves of the##2##3##(1994-5#1)(2008-11#1)
halves of##3##2##(1994-5#1)(2008-11#1)(2011-3#1)
halves##13##1##(1990-7#1)(1992-9#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#4)(2011-3#1)(2012-3#2)
hamartoma##4##1##(2008-7#2)(2009-11#1)(2009-5#1)
hamartomas##2##1##(1997-3#1)(2008-7#1)
hamartomatous##2##1##(2009-12#1)(2013-1#1)
hamatum 382 consistently##2##3##(2008-10#2)
hamatum 382##8##2##(2008-10#8)
hamatum GD12##3##2##(2013-8#3)
hamatum##15##1##(2008-10#10)(2013-8#5)
hammerhead ribozyme##2##2##(2008-9#2)
hammerhead##3##1##(2008-9#3)
hamper the##5##2##(1993-8#1)(1995-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
hamper##6##1##(1993-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
hampered by the lack of##4##5##(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
hampered by the##7##3##(1990-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-3#1)(2013-1#1)
hampered by##18##2##(1990-12#1)(1990-2#1)(1992-9#1)(1993-2#1)(1995-2#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2010-1#1)(2010-8#1)(2011-3#1)(2013-1#1)
hampered the##2##2##(2008-10#1)(2010-10#1)
hampered##26##1##(1990-12#1)(1990-2#1)(1992-9#1)(1993-2#1)(1995-2#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
hampering##3##1##(2008-4#1)(2008-7#1)(2012-12#1)
hamster and rat##2##3##(1993-6#1)(1994-8#1)
hamster and##3##2##(1993-6#1)(1994-8#1)(1995-6#1)
hamster cardiomyopathy##2##2##(1996-8#2)
hamster liver##2##2##(1996-2#1)(2008-9#1)
hamster livers##3##2##(1996-2#3)
hamster lung##2##2##(1990-6#1)(1997-3#1)
hamster ovary (CHO) cells##21##4##(1992-10#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#12)(2008-7#3)
hamster ovary (CHO)##29##3##(1991-6#1)(1992-10#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#17)(2008-7#5)
hamster ovary cell##10##3##(2008-11#9)(2008-7#1)
hamster ovary cells##22##3##(1991-5#2)(1993-3#1)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-12#1)(2008-11#10)(2008-7#1)(2008-8#1)(2011-2#1)
hamster ovary##68##2##(1991-5#2)(1991-6#1)(1992-10#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#3)(1995-6#2)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#43)(2008-7#7)(2008-8#1)(2011-2#1)
hamster##106##1##(1990-6#3)(1990-7#2)(1991-5#2)(1991-6#1)(1992-10#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-11#3)(1995-12#1)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#7)(1996-8#5)(1997-3#1)(1997-7#2)(2008-10#1)(2008-11#47)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#4)(2011-1#1)(2011-2#1)(2011-3#1)
hamsters were##2##2##(1993-11#1)(1996-2#1)
hamsters##9##1##(1993-11#1)(1994-2#2)(1996-2#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
hamstring graft##2##2##(2008-11#1)(2013-1#1)
hamstring##4##1##(2008-11#2)(2013-1#1)(2013-7#1)
hamstrings##5##1##(2013-1#5)
hand OA##3##2##(2013-1#3)
hand abnormalities##4##2##(1997-3#4)
hand and wrist##4##3##(2012-2#3)(2013-1#1)
hand and##16##2##(1991-6#1)(1994-8#1)(1995-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#2)(2010-9#1)(2012-2#4)(2013-1#3)
hand as a##2##3##(1997-4#2)
hand at##2##2##(1997-6#1)(2012-3#1)
hand eczema##2##2##(2013-1#2)
hand function and##2##3##(2012-3#1)(2013-1#1)
hand function##4##2##(2010-9#1)(2012-3#1)(2013-1#2)
hand gestures and object-directed hand movements##3##6##(2008-11#3)
hand gestures and##4##3##(2008-11#4)
hand gestures##5##2##(2008-11#5)
hand hygiene compliance##3##3##(2008-12#2)(2010-4#1)
hand hygiene##9##2##(2007-12#1)(2008-12#5)(2010-4#1)(2012-2#1)(2012-3#1)
hand in##2##2##(2008-10#1)(2009-7#1)
hand movements activated the##2##4##(2008-11#2)
hand movements to##2##3##(2008-11#2)
hand movements##10##2##(2008-11#9)(2011-2#1)
hand surgeons##4##2##(2008-9#4)
hand trauma##2##2##(2008-9#2)
hand washing##3##2##(2008-5#2)(2013-8#1)
hand with##2##2##(1991-6#1)(2008-11#1)
hand##336##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#2)(1993-2#2)(1993-8#4)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-11#4)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#6)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#7)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#4)(2007-12#2)(2008-10#59)(2008-11#50)(2008-12#13)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#13)(2008-6#6)(2008-7#8)(2008-8#1)(2008-9#27)(2009-10#2)(2009-3#2)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#12)(2011-3#1)(2011-7#1)(2012-2#6)(2012-3#4)(2013-1#16)(2013-8#6)
hand-held##9##1##(2008-10#5)(2008-11#2)(2011-2#1)(2012-2#1)
handball##3##1##(1990-6#2)(2009-1#1)
handcycling##3##1##(2013-1#3)
handed##2##1##(1997-1#1)(2010-9#1)
handedness##2##1##(1994-8#1)(2007-11#1)
handful of##3##2##(1994-1#1)(2010-7#1)(2011-3#1)
handgrip##2##1##(1994-3#1)(2013-8#1)
handheld SD-OCT##2##2##(2011-7#2)
handheld##7##1##(2008-10#3)(2011-7#3)(2013-1#1)
handicap or##2##2##(1996-6#1)(2011-3#1)
handicap##9##1##(1994-1#1)(1996-6#1)(2008-8#5)(2008-9#1)(2011-3#1)
handicapped##8##1##(1991-12#1)(1991-2#1)(1992-12#1)(1995-5#1)(1997-8#1)(2008-1#1)(2008-7#1)(2010-7#1)
handicaps of##2##2##(2008-9#2)
handicaps##8##1##(1991-6#1)(1993-11#1)(1994-9#1)(2008-7#1)(2008-9#4)
handle a##5##2##(2008-10#1)(2008-11#2)(2012-2#2)
handle the##3##2##(2008-11#1)(2010-9#1)(2011-3#1)
handle##25##1##(1991-1#1)(1994-1#1)(2008-10#6)(2008-11#5)(2008-4#3)(2008-6#1)(2009-12#1)(2010-9#1)(2011-3#1)(2012-2#4)(2013-8#1)
handled in##3##2##(1990-2#1)(1995-11#1)(2008-11#1)
handled##12##1##(1990-2#1)(1994-1#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)(2009-11#1)
handles##6##1##(2008-10#5)(2009-12#1)
handling and##11##2##(2007-12#1)(2008-10#7)(2008-4#1)(2008-9#1)(2012-2#1)
handling as##2##2##(1996-1#1)(2008-10#1)
handling by##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
handling in##4##2##(1997-6#1)(2008-10#2)(2008-9#1)
handling of##17##2##(1990-2#1)(1993-2#1)(1994-6#1)(2008-10#8)(2008-11#1)(2008-9#2)(2010-8#1)(2010-9#1)(2012-2#1)
handling than the##2##3##(2008-10#2)
handling the##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
handling was##2##2##(1992-2#1)(2010-9#1)
handling##88##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#37)(2008-11#9)(2008-3#1)(2008-4#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-2#2)(2013-8#1)
hands and feet##3##3##(1994-8#1)(2010-9#1)(2012-3#1)
hands and for##2##3##(1994-6#1)(2007-12#1)
hands and##8##2##(1994-6#1)(1994-8#1)(2007-12#2)(2010-6#1)(2010-9#1)(2012-3#2)
hands##34##1##(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-5#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
hands-on##7##1##(1991-3#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-8#1)
handwashing##3##1##(2008-12#2)(2009-6#1)
hang##3##1##(1996-5#1)(2008-10#2)
hanging drop cultures##2##3##(2008-11#2)
hanging drop technique for stem cell differentiation and cytotoxicity##2##9##(2008-11#2)
hanging drop##5##2##(2008-10#1)(2008-11#4)
hanging mercury drop electrode (HMDE) in##2##6##(2008-10#2)
hanging mercury drop electrode (HMDE)##13##5##(2008-10#13)
hanging mercury drop electrode in##2##5##(2008-10#2)
hanging mercury drop electrode##41##4##(2008-10#41)
hanging##53##1##(2008-10#44)(2008-11#5)(2008-8#1)(2010-7#2)(2013-1#1)
hantavirus infection##2##2##(2008-10#2)
hantavirus##4##1##(2008-10#4)
hap##2##1##(2008-9#2)
hapla race A##2##3##(2008-10#2)
hapla race##3##2##(2008-10#3)
hapla##16##1##(2008-10#16)
haplodiploid##2##1##(2008-9#2)
haplogroup##3##1##(2008-12#3)
haplogroups##2##1##(2008-12#2)
haploid genome##2##2##(1996-12#1)(2008-8#1)
haploid##35##1##(1994-11#1)(1994-6#1)(1996-12#1)(1996-6#1)(2008-10#20)(2008-11#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2012-2#1)(2012-3#2)
haploid)##2##1##(2008-10#1)(2009-10#1)
haploids##12##1##(1995-9#1)(2008-10#9)(2008-11#2)
haploinsufficiency of##2##2##(1997-3#1)(2012-12#1)
haploinsufficiency##6##1##(1997-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
haplotype and##4##2##(1997-9#2)(2008-10#1)(2012-3#1)
haplotype frequencies##3##2##(2008-10#2)(2008-12#1)
haplotype of##2##2##(1997-8#1)(2008-10#1)
haplotype was##2##2##(2008-10#2)
haplotype##49##1##(1995-12#3)(1997-8#1)(1997-9#3)(2008-10#31)(2008-12#5)(2008-8#2)(2012-3#4)
haplotypes and##5##2##(2008-10#4)(2008-6#1)
haplotypes from##2##2##(2008-10#2)
haplotypes identified##3##2##(2008-10#3)
haplotypes in the##2##3##(2008-10#1)(2010-5#1)
haplotypes that##3##2##(2008-10#2)(2012-3#1)
haplotypes were found among the##2##5##(2008-10#2)
haplotypes were found among##3##4##(2008-10#3)
haplotypes were found##6##3##(2008-10#5)(2008-12#1)
haplotypes were geographically dispersed##2##4##(2008-10#2)
haplotypes were identified##4##3##(2008-10#4)
haplotypes were not##2##3##(2008-10#2)
haplotypes were observed##2##3##(2008-10#2)
haplotypes were##23##2##(2008-10#21)(2008-12#1)(2013-8#1)
haplotypes##85##1##(1997-9#1)(2008-10#63)(2008-12#4)(2008-2#1)(2008-6#2)(2008-8#2)(2010-12#1)(2010-5#3)(2011-2#1)(2012-3#5)(2013-8#2)
haplotypes)##3##1##(2008-10#3)
haplotypic diversity##2##2##(2008-10#2)
haplotyping##4##1##(2008-12#2)(2012-3#2)
happen in the##2##3##(2008-10#2)
happen in##4##2##(1995-12#1)(2008-10#2)(2008-9#1)
happen##13##1##(1991-12#1)(1991-2#3)(1994-2#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-3#1)
happened to##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
happened##7##1##(2008-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#2)
happens to##2##2##(2008-12#1)(2010-1#1)
happens##15##1##(1991-3#1)(1993-1#1)(1997-5#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-1#1)(2012-12#1)
happy puppet&quot##2##2##(1990-9#2)
happy##8##1##(1990-9#2)(1996-9#1)(2008-11#3)(2008-7#1)(2010-4#1)
hapten##11##1##(1993-8#3)(2008-10#2)(2008-11#6)
haptens##6##1##(2008-10#6)
haptotyla##3##1##(2008-10#3)
harassment among nursing professionals##2##4##(1996-3#2)
harassment and discrimination##2##3##(1996-3#2)
harassment##9##1##(1996-2#1)(1996-3#6)(1996-5#1)(2008-9#1)
harbor a##2##2##(2009-8#1)(2012-3#1)
harbor##15##1##(1993-1#1)(1994-12#1)(2008-10#3)(2008-6#1)(2008-9#2)(2009-7#1)(2009-8#1)(2012-3#4)(2013-1#1)
harbored##9##1##(1994-11#1)(2008-10#4)(2008-7#1)(2012-2#2)(2013-1#1)
harboring a##4##2##(1996-12#1)(2008-10#3)
harboring the##4##2##(1997-9#1)(2008-10#2)(2008-11#1)
harboring##24##1##(1993-12#2)(1993-8#1)(1996-12#1)(1997-6#1)(1997-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-6#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
harbors a##4##2##(1997-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
harbors##10##1##(1991-1#1)(1991-2#1)(1993-1#2)(1997-8#1)(2008-10#3)(2012-3#1)(2013-8#1)
harbour##5##1##(2008-10#3)(2011-1#2)
harbouring##6##1##(1997-6#1)(2008-11#3)(2011-1#1)(2013-1#1)
harbours##3##1##(2008-1#1)(2011-2#1)(2013-1#1)
hard and soft##5##3##(1991-2#1)(1993-11#1)(2008-10#3)
hard and##6##2##(1991-2#1)(1993-11#1)(2008-10#3)(2010-11#1)
hard coal##2##2##(2008-10#2)
hard of hearing##9##3##(2011-2#9)
hard red spring wheat##2##4##(2008-10#2)
hard red##3##2##(2008-10#3)
hard to##13##2##(1990-3#1)(1994-12#1)(1995-5#1)(1996-1#1)(1997-4#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-9#1)(2010-8#2)(2012-2#1)
hard##72##1##(1990-3#1)(1991-11#3)(1991-2#1)(1993-11#2)(1993-3#1)(1994-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#6)(2008-2#1)(2008-7#1)(2008-8#4)(2008-9#3)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#15)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
hard)##2##1##(1995-3#1)(2008-9#1)
hard-target##2##1##(2008-2#1)(2008-3#1)
hard-tissue##3##1##(2008-7#3)
hard-to-reach populations in##2##3##(2012-2#2)
hard-to-reach populations##3##2##(2012-2#2)(2013-1#1)
hardened##2##1##(1995-6#1)(2013-1#1)
hardening process##2##2##(2008-10#1)(2008-3#1)
hardening with##2##2##(2008-10#2)
hardening##17##1##(1993-2#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-7#2)
harder to##6##2##(1994-9#1)(1996-5#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-3#1)
harder##12##1##(1994-9#1)(1995-12#1)(1996-5#2)(1996-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#2)(2012-3#1)
hardly extracted##4##2##(2008-10#4)
hardly##29##1##(1990-12#1)(1992-11#1)(1993-12#1)(1993-6#1)(1995-11#2)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
hardness and##5##2##(2008-10#2)(2008-5#1)(2010-10#1)(2013-1#1)
hardness##16##1##(2008-10#7)(2008-5#2)(2009-7#2)(2010-10#2)(2010-4#1)(2011-2#1)(2013-1#1)
hardship##2##1##(1996-5#1)(2008-10#1)
hardware and software##4##3##(1994-2#1)(1996-12#1)(2008-9#1)(2010-12#1)
hardware and##8##2##(1992-1#1)(1994-2#1)(1996-12#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
hardware is##3##2##(2008-12#1)(2008-2#1)(2008-6#1)
hardware##25##1##(1992-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-6#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-6#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
hardwood##3##1##(2008-6#2)(2013-8#1)
hardy C57BL/6ByJ##2##2##(2008-11#2)
hare density##2##2##(2013-1#2)
hare##5##1##(2013-1#5)
hares##4##1##(2013-1#4)
harm the##3##2##(1996-9#1)(2008-10#1)(2008-9#1)
harm to##2##2##(1993-1#1)(2008-12#1)
harm##19##1##(1993-1#1)(1993-12#2)(1995-12#1)(1995-9#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-7#2)
harmane and harmine with beta-cyclodextrin##2##5##(2008-10#2)
harmane or harmine##2##3##(2008-10#2)
harmane##5##1##(2008-10#5)
harmful effect##2##2##(2008-5#1)(2009-12#1)
harmful effects of##3##3##(1991-6#1)(2011-2#1)(2013-1#1)
harmful effects on##2##3##(1991-6#1)(2008-10#1)
harmful effects##8##2##(1991-6#2)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
harmful for human##2##3##(2008-10#1)(2012-3#1)
harmful for the##2##3##(2011-2#1)(2012-3#1)
harmful for##4##2##(2008-10#1)(2011-2#1)(2012-3#2)
harmful influence of##2##3##(2011-2#2)
harmful to the##2##3##(1990-11#1)(2008-11#1)
harmful to##5##2##(1990-11#1)(1994-3#1)(2008-11#2)(2008-12#1)
harmful##50##1##(1990-11#1)(1991-6#3)(1993-11#1)(1994-2#1)(1994-3#2)(1997-5#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#2)(2009-11#3)(2009-12#2)(2009-7#1)(2010-1#1)(2011-2#9)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
harmine##6##1##(2008-10#6)
harmless##4##1##(1996-9#1)(1997-4#1)(2008-10#1)(2012-3#1)
harmonic US##3##2##(2010-12#3)
harmonic generation##3##2##(2008-10#2)(2008-2#1)
harmonic of a Nd##2##4##(2008-3#2)
harmonic of a##3##3##(2008-3#3)
harmonic of##4##2##(2008-3#4)
harmonic##25##1##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#13)(2008-8#1)(2010-12#5)
harmonics of the##3##3##(2008-10#1)(2008-3#2)
harmonics of##5##2##(2008-10#1)(2008-3#3)(2008-8#1)
harmonics##9##1##(2008-10#2)(2008-2#1)(2008-3#5)(2008-8#1)
harmonisation##2##1##(1991-3#1)(2008-10#1)
harmonization of##2##2##(2008-10#1)(2010-8#1)
harmonization##4##1##(2008-10#3)(2010-8#1)
harmony##3##1##(1997-6#1)(2008-10#1)(2008-11#1)
harnessing the##2##2##(2008-11#1)(2008-12#1)
harnessing##4##1##(2008-11#3)(2008-12#1)
harpin protein gene##4##3##(2008-8#4)
harpin protein##5##2##(2008-8#5)
harpin##10##1##(2008-10#5)(2008-8#5)
harpins##2##1##(2008-10#2)
harpoon over left##3##3##(2008-10#3)
harsh and fluctuating conditions##2##4##(2008-9#2)
harsh conditions##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
harsh discipline##4##2##(2009-7#2)(2009-9#1)(2010-11#1)
harsh##13##1##(2008-10#3)(2008-8#1)(2008-9#2)(2009-7#2)(2009-9#1)(2010-11#2)(2011-2#1)(2012-3#1)
harshness##3##1##(2008-9#3)
harvest (greater than##2##3##(2008-10#2)
harvest and##6##2##(2008-10#5)(2008-11#1)
harvest date##3##2##(2008-10#3)
harvest in##2##2##(2008-10#2)
harvest process##5##2##(2008-11#5)
harvest the##2##2##(2008-10#1)(2008-12#1)
harvest time##6##2##(2008-11#4)(2008-7#2)
harvest to##2##2##(2008-11#1)(2008-8#1)
harvest was##3##2##(2008-10#2)(2008-11#1)
harvest were##2##2##(2008-10#2)
harvest##78##1##(2008-10#50)(2008-11#17)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-3#1)(2011-2#1)(2011-3#1)
harvested after##3##2##(2008-11#2)(2012-2#1)
harvested and the##2##3##(1997-5#1)(2008-10#1)
harvested and##9##2##(1990-8#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)
harvested at##6##2##(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)(2013-1#1)
harvested during##2##2##(2008-10#1)(2009-6#1)
harvested from the##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
harvested from##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
harvested grain##2##2##(2008-10#2)
harvested in##2##2##(2008-10#1)(2013-1#1)
harvested within##2##2##(2008-10#1)(2012-3#1)
harvested##64##1##(1990-8#1)(1994-5#2)(1997-5#1)(2008-10#31)(2008-11#13)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
harvesting and##2##2##(2008-4#1)(2011-2#1)
harvesting the##2##2##(2008-12#1)(2009-10#1)
harvesting##23##1##(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#8)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#2)
harvestmen##5##1##(2007-12#5)
harvests##3##1##(2008-10#2)(2008-11#1)
harzianum P1 conidia##3##3##(2008-10#3)
harzianum and##3##2##(2008-10#2)(2008-5#1)
harzianum##35##1##(2008-10#34)(2008-5#1)
has 3##2##2##(1993-3#1)(2008-8#1)
has Ala153 (GCC) and##2##4##(1997-8#2)
has a beneficial effect##2##4##(2008-11#1)(2013-1#1)
has a bipartite##2##3##(1993-2#1)(2008-10#1)
has a central role##2##4##(2008-9#1)(2009-8#1)
has a central##3##3##(2008-9#1)(2009-8#1)(2011-2#1)
has a certain##2##3##(2008-11#1)(2008-9#1)
has a characteristic##2##3##(2008-10#1)(2009-8#1)
has a clear##5##3##(1990-2#1)(1993-8#1)(1997-3#1)(2008-12#1)(2008-7#1)
has a closer relationship with##2##5##(2008-8#2)
has a consistent##2##3##(2008-10#1)(2008-5#1)
has a detection limit of 0##4##6##(2008-10#4)
has a detection limit of##8##5##(2008-10#7)(2008-2#1)
has a detection limit##9##4##(2008-10#8)(2008-2#1)
has a detection##10##3##(1992-12#1)(2008-10#8)(2008-2#1)
has a different##5##3##(1993-12#1)(1994-12#1)(1997-2#1)(2008-10#2)
has a direct impact on##2##5##(1993-2#1)(2008-7#1)
has a direct##5##3##(1993-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
has a dominant##2##3##(2008-10#2)
has a fast response time of about##4##7##(2008-10#4)
has a fast response time of##8##6##(2008-10#8)
has a fast##9##3##(2008-10#8)(2008-7#1)
has a functional##2##3##(2008-10#1)(2009-1#1)
has a good##8##3##(1992-5#1)(2008-10#4)(2008-9#1)(2010-7#1)(2012-2#1)
has a great influence on##2##5##(2008-10#1)(2008-3#1)
has a great##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
has a greater##3##3##(1991-8#1)(2008-8#1)(2008-9#1)
has a high affinity for##2##5##(2008-10#1)(2008-6#1)
has a high degree of##3##5##(1992-12#1)(1992-8#1)(2008-10#1)
has a high##17##3##(1992-12#1)(1992-8#1)(1994-12#1)(2008-10#6)(2008-5#2)(2008-6#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
has a higher##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
has a key##2##3##(2009-8#1)(2013-7#1)
has a large##5##3##(1991-3#1)(1992-3#1)(2007-12#1)(2008-10#1)(2009-1#1)
has a limited##2##3##(1994-2#1)(2008-10#1)
has a linear dynamic range##3##5##(2008-10#3)
has a linear range##2##4##(1991-2#1)(2008-10#1)
has a linear##9##3##(1991-2#1)(2008-10#8)
has a linearity interval between 0##3##6##(2008-10#3)
has a long history##4##4##(1997-1#1)(2008-9#1)(2013-1#1)(2013-8#1)
has a long##7##3##(1993-12#1)(1997-1#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
has a lot##2##3##(1994-3#1)(2012-2#1)
has a low incidence of##2##5##(1993-11#1)(1995-5#1)
has a low##9##3##(1993-11#1)(1993-12#1)(1995-5#1)(2008-10#4)(2009-7#1)(2009-8#1)
has a lower##6##3##(1991-5#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
has a major##5##3##(1992-6#1)(1995-2#1)(1996-1#1)(2008-7#1)(2008-9#1)
has a marked##2##3##(1993-11#1)(2012-12#1)
has a minor##2##3##(1992-10#1)(2008-3#1)
has a molecular weight of##4##5##(1992-8#1)(2008-8#1)(2010-3#1)(2011-2#1)
has a more complex##2##4##(2008-10#1)(2008-11#1)
has a more##4##3##(2008-10#3)(2008-11#1)
has a much##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
has a negative##2##3##(2008-11#1)(2011-7#1)
has a new##2##3##(1991-12#1)(2008-10#1)
has a number of##8##4##(1991-3#1)(1992-9#1)(1993-6#1)(2008-10#1)(2008-9#3)(2013-1#1)
has a physiological role##2##4##(1997-4#1)(2008-5#1)
has a positive##6##3##(1994-5#1)(1995-11#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
has a potential role in##2##5##(1995-12#1)(2009-6#1)
has a potential##4##3##(1995-12#1)(2008-9#1)(2009-6#1)(2012-3#1)
has a practical##2##3##(2008-5#1)(2009-3#1)
has a predicted##2##3##(1992-8#1)(2011-2#1)
has a profound##3##3##(2008-10#1)(2010-11#1)(2013-7#1)
has a protective effect##2##4##(1993-2#1)(1995-11#1)
has a putative##2##3##(1991-7#1)(2008-10#1)
has a reduced##2##3##(1993-8#1)(2008-5#1)
has a relative##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
has a relatively fast response time and can be used for##2##11##(2008-10#2)
has a relatively##5##3##(1993-2#1)(2008-10#4)
has a response time of##5##5##(2008-10#5)
has a role in the##3##5##(1990-5#1)(1996-2#1)(2013-1#1)
has a role in##9##4##(1990-5#1)(1996-2#2)(2008-10#2)(2008-2#1)(2011-2#2)(2013-1#1)
has a role##10##3##(1990-5#1)(1995-9#1)(1996-2#2)(2008-10#2)(2008-2#1)(2011-2#2)(2013-1#1)
has a sample frequency of##2##5##(2008-10#2)
has a secondary##2##3##(2008-2#1)(2012-2#1)
has a sensitive##2##3##(2008-10#2)
has a sensitivity of##3##4##(2008-1#2)(2008-10#1)
has a serious##2##3##(2007-11#1)(2008-8#1)
has a short##2##3##(2008-10#1)(2008-5#1)
has a significant effect on the##4##6##(2008-10#3)(2008-11#1)
has a significant impact on##3##5##(2009-8#1)(2011-2#1)(2013-1#1)
has a significant##12##3##(1990-5#1)(2008-10#4)(2008-11#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
has a significantly##2##3##(2008-3#1)(2008-4#1)
has a similar##2##3##(2012-3#1)(2013-7#1)
has a single##2##3##(1996-9#1)(2008-3#1)
has a small##2##3##(1995-3#1)(1996-5#1)
has a striking##2##3##(1991-5#1)(1996-6#1)
has a strong influence on the##2##6##(2008-10#1)(2012-8#1)
has a strong influence on##3##5##(2008-10#1)(2011-2#1)(2012-8#1)
has a strong##7##3##(1990-11#1)(1994-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-8#1)
has a tendency to##2##4##(2008-5#1)(2010-12#1)
has a unique##5##3##(1993-12#1)(2008-11#3)(2012-2#1)
has a value##2##3##(1991-5#1)(2009-12#1)
has a very good##2##4##(2008-10#1)(2011-3#1)
has a very high##2##4##(2013-1#1)(2013-8#1)
has a very low##2##4##(2008-10#1)(2011-2#1)
has a very##13##3##(1991-11#1)(1992-12#1)(1996-6#1)(2008-10#5)(2008-11#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
has a wide##6##3##(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#1)
has a##443##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#4)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#5)(1993-6#1)(1993-8#4)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#4)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#139)(2008-11#19)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#12)(2008-8#12)(2008-9#17)(2009-1#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#10)(2010-11#2)(2010-12#3)(2010-3#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#21)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#9)(2012-3#7)(2012-8#1)(2013-1#15)(2013-7#4)(2013-8#12)
has accumulated which##2##3##(2008-5#1)(2012-2#1)
has accumulated##7##2##(1992-3#1)(1993-12#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
has achieved its##2##3##(1995-2#1)(2010-1#1)
has achieved##3##2##(1995-2#1)(2010-1#1)(2010-7#1)
has acted##2##2##(1994-3#1)(2012-3#1)
has addressed##2##2##(2012-2#1)(2013-1#1)
has adopted##2##2##(1993-3#1)(2008-10#1)
has advanced##5##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
has advantages in##2##3##(2008-10#1)(2008-11#1)
has advantages of being##2##4##(2008-10#2)
has advantages of##3##3##(2008-10#3)
has advantages##6##2##(2008-10#4)(2008-11#1)(2010-11#1)
has affected##3##2##(1991-3#1)(2008-10#1)(2011-2#1)
has allowed the##7##3##(1993-12#1)(1997-3#1)(2008-10#3)(2008-4#1)(2011-2#1)
has allowed to##4##3##(2008-10#2)(2008-11#1)(2010-12#1)
has allowed us to##4##4##(2008-10#2)(2010-4#1)(2010-7#1)
has allowed##23##2##(1993-12#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
has almost##2##2##(1993-3#1)(2008-7#1)
has already been##13##3##(1994-8#1)(1996-3#1)(2008-10#2)(2008-11#6)(2012-2#1)(2012-3#1)(2013-8#1)
has already##18##2##(1994-8#1)(1996-3#1)(2008-10#3)(2008-11#6)(2008-4#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
has also been associated with##2##5##(2008-9#1)(2012-2#1)
has also been criticized##2##4##(1996-2#1)(2013-1#1)
has also been demonstrated##2##4##(2008-5#1)(2011-2#1)
has also been determined##2##4##(2008-10#1)(2009-8#1)
has also been developed##2##4##(1993-3#1)(2008-10#1)
has also been discussed##3##4##(2008-10#3)
has also been identified##2##4##(1993-8#1)(2008-11#1)
has also been investigated##5##4##(2008-10#3)(2008-3#1)(2011-2#1)
has also been made##3##4##(2008-10#3)
has also been observed##4##4##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
has also been proposed##2##4##(2010-3#1)(2013-8#1)
has also been reported##4##4##(2008-11#1)(2008-7#1)(2010-6#1)(2013-8#1)
has also been shown to##7##5##(1993-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)
has also been shown##10##4##(1993-8#1)(1994-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)
has also been studied##4##4##(2008-10#4)
has also been used for##2##5##(2008-3#1)(2008-4#1)
has also been used##5##4##(1994-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
has also been##91##3##(1993-3#1)(1993-8#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-5#1)(1996-2#2)(1997-3#1)(1997-7#1)(1997-9#1)(2008-10#33)(2008-11#7)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#2)
has also shown##2##3##(2010-1#1)(2010-4#1)
has also##112##2##(1990-6#1)(1993-3#1)(1993-8#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-5#1)(1996-2#2)(1996-9#1)(1997-3#2)(1997-7#1)(1997-9#1)(2007-11#1)(2008-10#36)(2008-11#8)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#3)(2010-1#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#2)
has always been##9##3##(1991-12#1)(1991-3#1)(1994-5#1)(1995-12#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-3#1)(2012-7#1)
has always##12##2##(1990-9#1)(1991-12#1)(1991-3#1)(1994-5#1)(1995-12#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2012-7#1)
has an additional##3##3##(1991-6#1)(1994-11#1)(2008-10#1)
has an affinity for the##2##5##(2009-7#1)(2010-10#1)
has an average##2##3##(1990-6#1)(2010-10#1)
has an effect on the##2##5##(1992-9#1)(2008-10#1)
has an excellent##3##3##(1997-1#1)(2008-10#2)
has an extensive##2##3##(2008-10#1)(2008-7#1)
has an important impact##2##4##(2010-2#1)(2013-8#1)
has an important influence on##2##5##(1990-12#1)(2008-5#1)
has an important##9##3##(1990-12#1)(1993-12#1)(1996-3#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-8#1)
has an intuitive##2##3##(2011-2#1)(2013-1#1)
has an opposite effect on##2##5##(1990-12#1)(2008-10#1)
has an optimal pH##2##4##(1990-2#1)(2008-10#1)
has an overall##3##3##(1992-6#1)(1994-2#1)(2008-10#1)
has an unusually##2##3##(1993-2#1)(1997-7#1)
has an##91##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#2)(1994-2#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#2)(1997-9#1)(2007-11#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-2#3)(2013-1#3)(2013-8#2)
has any##2##2##(1994-6#1)(2009-1#1)
has appeared##2##2##(1990-2#1)(2012-3#1)
has argued##2##2##(1995-6#1)(2009-10#1)
has arisen##4##2##(2008-10#2)(2008-8#1)(2009-6#1)
has as##4##2##(1994-2#1)(2008-10#2)(2011-1#1)
has at least##4##3##(2008-5#1)(2008-8#2)(2008-9#1)
has attempted to##2##3##(1991-1#1)(2008-10#1)
has attracted##3##2##(1991-2#1)(1996-6#1)(2008-4#1)
has averaged##3##2##(1991-12#1)(2008-6#1)(2008-8#1)
has become a frequently used##2##5##(2008-5#1)(2012-12#1)
has become a major##2##4##(2008-10#1)(2009-11#1)
has become a much more versatile and environmentally attractive technology that can handle a variety of complicated problems in pharmaceuticals##2##20##(2012-2#2)
has become a popular##3##4##(1996-3#1)(2008-10#1)(2008-11#1)
has become a powerful analytical tool##3##6##(2008-10#2)(2008-7#1)
has become a powerful##4##4##(2008-10#2)(2008-4#1)(2008-7#1)
has become a##32##3##(1990-9#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2013-8#2)
has become an established##2##4##(2008-8#1)(2011-3#1)
has become an important issue##2##5##(2008-10#1)(2011-2#1)
has become an important##5##4##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2011-3#1)
has become an indispensable##2##4##(1994-2#1)(2012-3#1)
has become an##16##3##(1992-1#1)(1994-2#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)
has become apparent that##3##4##(1997-8#1)(2008-11#1)(2008-9#1)
has become apparent##4##3##(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
has become common##2##3##(2008-10#1)(2011-2#1)
has become increasingly apparent##2##4##(2008-9#1)(2012-3#1)
has become increasingly important##3##4##(1995-1#1)(2008-10#1)(2010-12#1)
has become increasingly##9##3##(1995-1#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-12#1)(2012-3#1)
has become more complex##2##4##(1992-3#1)(1996-1#1)
has become more##9##3##(1992-3#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2013-1#1)
has become one of the##3##5##(2008-10#1)(2008-11#1)(2011-2#1)
has become one##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
has become so##2##3##(1992-3#1)(2011-2#1)
has become the major##2##4##(2008-10#1)(2008-7#1)
has become the most##2##4##(2008-10#2)
has become the##15##3##(1991-9#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
has become widely used##2##4##(2008-11#1)(2013-1#1)
has become##118##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2008-10#24)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#4)(2011-2#11)(2011-3#3)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#2)
has been a fundamental##2##4##(1995-12#1)(2008-8#1)
has been a major##2##4##(2008-10#1)(2008-5#1)
has been a significant##3##4##(1995-1#1)(2008-12#1)(2011-2#1)
has been a##64##3##(1990-11#1)(1990-6#1)(1992-1#2)(1992-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-3#2)(1997-1#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-10#7)(2008-11#10)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-4#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
has been able to##5##4##(1992-9#1)(1996-11#1)(2008-12#1)(2008-7#1)(2010-8#1)
has been accompanied by##4##4##(1996-2#1)(2008-10#2)(2008-11#1)
has been accomplished by using partial##2##6##(2008-10#2)
has been accomplished by##6##4##(1997-6#1)(2008-10#4)(2012-3#1)
has been accomplished using##2##4##(2008-10#2)
has been accomplished##9##3##(1991-6#1)(1997-6#1)(2008-10#6)(2012-3#1)
has been achieved and##2##4##(2008-10#2)
has been achieved by##2##4##(1992-9#1)(2008-10#1)
has been achieved in##5##4##(1997-6#1)(1997-7#1)(2008-12#1)(2008-7#1)(2012-3#1)
has been achieved using##3##4##(2008-10#2)(2008-11#1)
has been achieved##29##3##(1992-9#1)(1997-6#1)(1997-7#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-7#2)(2010-4#1)(2012-12#1)(2012-3#1)
has been acknowledged##2##3##(2008-11#2)
has been adapted##2##3##(2008-10#1)(2008-12#1)
has been added##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
has been addressed by##2##4##(2008-9#1)(2012-2#1)
has been addressed##4##3##(2008-10#1)(2008-9#2)(2012-2#1)
has been administered##3##3##(1990-9#1)(1995-5#1)(2010-8#1)
has been adopted##2##3##(1994-9#1)(2010-8#1)
has been advanced##2##3##(1990-3#1)(2011-1#1)
has been advocated as##2##4##(2008-11#1)(2010-2#1)
has been advocated##6##3##(1991-6#1)(1996-3#2)(2008-11#2)(2010-2#1)
has been also applied##2##4##(2008-10#2)
has been also investigated##2##4##(2008-10#2)
has been also##9##3##(2008-10#8)(2008-8#1)
has been always##2##3##(1990-9#1)(2008-11#1)
has been an increased##3##4##(1996-1#1)(2012-3#1)(2013-1#1)
has been an increasing##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
has been an ongoing##2##4##(1996-3#1)(2008-11#1)
has been an##23##3##(1992-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(2006-5#1)(2008-10#2)(2008-11#6)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
has been analysed##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
has been analyzed by##2##4##(2008-10#1)(2008-8#1)
has been analyzed##7##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)
has been applied for analysis of##2##6##(2008-10#2)
has been applied for the determination of##2##7##(2008-10#2)
has been applied for the##5##5##(2008-10#5)
has been applied for##13##4##(2008-10#12)(2012-3#1)
has been applied in##7##4##(2008-10#6)(2008-11#1)
has been applied satisfactorily to##4##5##(2008-10#4)
has been applied satisfactorily##5##4##(2008-10#5)
has been applied successfully to the analysis of##2##8##(2008-10#2)
has been applied successfully to the determination of##4##8##(2008-10#4)
has been applied successfully to the##7##6##(2008-10#7)
has been applied successfully to##9##5##(2008-10#9)
has been applied successfully##11##4##(2008-10#11)
has been applied to determine the##2##6##(2008-10#2)
has been applied to determine##7##5##(2008-10#7)
has been applied to several##2##5##(1990-5#1)(2008-10#1)
has been applied to the analysis of##8##7##(2008-10#8)
has been applied to the determination of these##3##8##(2008-10#3)
has been applied to the determination of total##4##8##(2008-10#4)
has been applied to the determination of##45##7##(2008-10#45)
has been applied to the direct determination of##2##8##(2008-10#2)
has been applied to the investigation of##2##7##(1991-2#1)(2008-10#1)
has been applied to the simultaneous determination of##2##8##(2008-10#2)
has been applied to the spectrophotometric determination of##2##8##(2008-10#2)
has been applied to the##72##5##(1991-2#1)(2008-10#70)(2010-7#1)
has been applied to two##2##5##(2008-10#1)(2008-3#1)
has been applied to##106##4##(1990-5#1)(1991-2#1)(2008-10#99)(2008-3#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)
has been applied##149##3##(1990-5#1)(1990-9#1)(1991-2#1)(2008-10#137)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
has been approved##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
has been argued##2##3##(2008-8#1)(2008-9#1)
has been assessed with##2##4##(2008-10#2)
has been assessed##5##3##(1995-3#1)(2008-10#3)(2008-6#1)
has been assigned##3##3##(1995-6#1)(2010-6#1)(2011-2#1)
has been associated with a##4##5##(2008-10#2)(2008-6#1)(2013-8#1)
has been associated with an##4##5##(1994-5#1)(2008-5#1)(2012-5#1)(2013-1#1)
has been associated with the##4##5##(1997-1#1)(2008-10#1)(2010-5#1)(2013-8#1)
has been associated with##25##4##(1992-3#1)(1993-3#1)(1994-5#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-5#1)(2013-1#1)(2013-8#4)
has been associated##26##3##(1992-3#1)(1993-3#1)(1994-5#1)(1995-12#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-5#1)(2013-1#1)(2013-8#4)
has been assumed that the##2##5##(2008-10#1)(2008-11#1)
has been assumed that##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
has been attempted##2##3##(2008-10#1)(2008-11#1)
has been attributed to the##3##5##(2008-10#2)(2008-8#1)
has been attributed to##10##4##(1991-2#1)(1994-5#1)(1995-6#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-1#1)
has been attributed##11##3##(1991-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-1#1)
has been available##3##3##(1996-3#1)(2008-10#1)(2008-6#1)
has been briefly##2##3##(2008-10#2)
has been built##3##3##(2008-3#2)(2008-8#1)
has been calculated by##2##4##(2008-10#1)(2008-3#1)
has been calculated##6##3##(1993-2#1)(1994-5#1)(2008-10#3)(2008-3#1)
has been called##2##3##(1990-5#1)(1994-1#1)
has been carried out by the##3##6##(1990-3#1)(2008-10#2)
has been carried out by##12##5##(1990-3#1)(2008-10#10)(2012-3#1)
has been carried out for##3##5##(2008-10#2)(2008-3#1)
has been carried out in##6##5##(2008-10#5)(2008-11#1)
has been carried out on##3##5##(2008-10#2)(2008-3#1)
has been carried out using##4##5##(2008-10#3)(2009-3#1)
has been carried out within##2##5##(2008-3#1)(2010-7#1)
has been carried out##42##4##(1990-3#1)(1990-9#2)(2008-10#29)(2008-11#1)(2008-3#3)(2008-5#2)(2009-3#1)(2010-7#1)(2012-3#2)
has been changing##2##3##(1990-9#1)(2007-12#1)
has been characterized as##3##4##(1992-6#1)(2009-10#1)(2013-1#1)
has been characterized by##5##4##(1993-1#1)(2008-10#3)(2011-2#1)
has been characterized in##3##4##(1990-11#1)(1991-7#1)(2009-8#1)
has been characterized##17##3##(1990-11#1)(1991-7#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-5#1)(2008-10#6)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
has been classified##2##3##(2008-6#1)(2008-7#1)
has been clearly##3##3##(2008-10#2)(2011-2#1)
has been cloned and sequenced##4##5##(1995-12#1)(1997-7#1)(2008-10#1)(2008-5#1)
has been cloned and##6##4##(1990-5#1)(1992-10#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-5#1)
has been cloned by screening##2##5##(1997-4#1)(1997-8#1)
has been cloned from##2##4##(1994-11#1)(2008-9#1)
has been cloned##13##3##(1990-5#1)(1992-10#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
has been combined##2##3##(2008-10#2)
has been compared to##2##4##(1993-9#1)(2008-11#1)
has been compared with that of a##2##7##(1996-2#1)(2008-10#1)
has been compared with that of##3##6##(1996-2#1)(2008-10#2)
has been compared with##7##4##(1990-9#1)(1996-2#1)(2008-10#5)
has been compared##10##3##(1990-9#1)(1993-9#1)(1995-6#1)(1996-2#1)(2008-10#5)(2008-11#1)
has been compiled##2##3##(2008-10#2)
has been completed##4##3##(1991-2#1)(2008-4#1)(2008-5#1)(2009-4#1)
has been concluded that##4##4##(1990-9#1)(2008-10#3)
has been conducted on##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
has been conducted##10##3##(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
has been confirmed by the##2##5##(2008-10#1)(2008-8#1)
has been confirmed by##4##4##(1990-9#1)(2008-10#2)(2008-8#1)
has been confirmed in##2##4##(2008-10#1)(2008-12#1)
has been confirmed##11##3##(1990-9#1)(1995-8#1)(2008-10#6)(2008-12#1)(2008-8#1)(2013-1#1)
has been conserved in##2##4##(2009-6#1)(2012-2#1)
has been considered a##2##4##(2008-10#2)
has been considered as##2##4##(2008-12#1)(2010-6#1)
has been considered##11##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-6#1)
has been constructed by##2##4##(1996-3#1)(2009-10#1)
has been constructed##11##3##(1991-6#1)(1996-3#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)
has been controlled by##2##4##(2008-10#1)(2008-7#1)
has been controlled##3##3##(2008-10#2)(2008-7#1)
has been controversial##2##3##(1990-5#1)(2010-6#1)
has been converted##2##3##(2008-3#1)(2008-8#1)
has been correlated with##2##4##(2008-10#2)
has been coupled to##3##4##(1992-9#1)(2008-10#2)
has been critically##3##3##(2008-10#2)(2011-3#1)
has been crystallized in##2##4##(2008-8#1)(2008-9#1)
has been decreasing in##2##4##(1990-3#1)(1992-2#1)
has been deduced##2##3##(1992-10#1)(1995-8#1)
has been defined as##2##4##(2008-11#1)(2011-2#1)
has been defined by##2##4##(1996-2#1)(2008-5#1)
has been defined##9##3##(1992-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2011-2#1)
has been demonstrated as##2##4##(1990-8#1)(2008-10#1)
has been demonstrated by the##2##5##(1993-6#1)(2008-8#1)
has been demonstrated by##5##4##(1993-6#1)(2008-10#3)(2008-8#1)
has been demonstrated for the##2##5##(2008-10#2)
has been demonstrated for##3##4##(2008-10#3)
has been demonstrated in several##2##5##(1992-12#1)(2010-5#1)
has been demonstrated in##14##4##(1990-8#1)(1991-12#1)(1992-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-5#1)(2012-12#1)(2012-3#1)
has been demonstrated that this##2##5##(1997-2#1)(2008-9#1)
has been demonstrated that##16##4##(1991-5#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#3)
has been demonstrated to be a##3##6##(2008-10#2)(2008-11#1)
has been demonstrated to be##4##5##(2008-10#2)(2008-11#1)(2010-12#1)
has been demonstrated to##8##4##(1992-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2012-2#1)(2013-7#1)
has been demonstrated up to##2##5##(2008-11#1)(2008-2#1)
has been demonstrated using##2##4##(2008-10#1)(2008-3#1)
has been demonstrated with##3##4##(2008-10#1)(2008-3#1)(2009-8#1)
has been demonstrated##72##3##(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-5#1)(1993-6#1)(1996-12#1)(1997-2#2)(2008-10#23)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
has been described as##5##4##(1994-2#1)(2008-10#2)(2008-12#1)(2009-8#1)
has been described for the direct determination of##3##8##(2008-10#3)
has been described for the direct##4##6##(2008-10#4)
has been described for the##6##5##(2008-10#6)
has been described for##11##4##(2007-12#1)(2008-10#7)(2008-7#1)(2008-9#1)(2013-1#1)
has been described in a##2##5##(2008-10#2)
has been described in##7##4##(2008-10#6)(2008-11#1)
has been described that##2##4##(1994-5#1)(2008-12#1)
has been described##47##3##(1990-2#1)(1991-12#1)(1994-2#1)(1994-5#1)(1996-3#1)(2007-12#1)(2008-10#29)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
has been designed and##4##4##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
has been designed for##2##4##(1995-3#1)(2008-10#1)
has been designed to##2##4##(1993-3#1)(2008-10#1)
has been designed##12##3##(1993-3#1)(1995-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2010-8#1)
has been detected in several##2##5##(1994-2#1)(2013-1#1)
has been detected in##6##4##(1994-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
has been detected##11##3##(1994-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
has been determined and##3##4##(1993-3#1)(1996-3#1)(2008-10#1)
has been determined at 2##2##5##(1993-8#1)(1994-12#1)
has been determined at##4##4##(1993-8#1)(1994-12#1)(2008-10#2)
has been determined by##6##4##(1990-8#1)(1993-2#1)(1994-5#1)(2008-10#3)
has been determined in the##2##5##(2008-10#2)
has been determined in##8##4##(1992-6#1)(2008-10#7)
has been determined that##2##4##(2008-10#1)(2010-10#1)
has been determined using##3##4##(1992-7#1)(1994-5#2)
has been determined##46##3##(1990-5#1)(1990-8#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#4)(1996-2#1)(1996-3#2)(1996-8#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#2)
has been developed and applied for the determination of##2##9##(2008-10#2)
has been developed and evaluated##3##5##(2008-10#2)(2008-3#1)
has been developed and shown to be##2##7##(1993-11#1)(2008-11#1)
has been developed and tested##2##5##(2008-10#2)
has been developed and used##2##5##(2008-10#1)(2008-11#1)
has been developed and##18##4##(1992-1#1)(1993-11#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2010-11#1)
has been developed as an alternative to##2##7##(2008-5#1)(2012-12#1)
has been developed as an##3##5##(2008-3#1)(2008-5#1)(2012-12#1)
has been developed as##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
has been developed based on the##2##6##(2008-10#2)
has been developed based on##5##5##(2008-10#5)
has been developed by a##2##5##(2008-10#2)
has been developed by the##2##5##(2008-10#1)(2013-1#1)
has been developed by using##2##5##(2008-10#2)
has been developed by##11##4##(2008-10#10)(2013-1#1)
has been developed for determination of##5##6##(2008-10#5)
has been developed for preconcentration of##2##6##(2008-10#2)
has been developed for preconcentration##3##5##(2008-10#3)
has been developed for simultaneous##2##5##(2008-10#2)
has been developed for the detection##2##6##(2008-10#2)
has been developed for the determination of As##2##8##(2008-10#2)
has been developed for the determination of trace amounts of##2##10##(2008-10#2)
has been developed for the determination of trace##8##8##(2008-10#8)
has been developed for the determination of##34##7##(2008-10#33)(2008-3#1)
has been developed for the determination##35##6##(2008-10#34)(2008-3#1)
has been developed for the direct determination of##5##8##(2008-10#5)
has been developed for the direct##6##6##(2008-10#6)
has been developed for the on-line##2##6##(2008-10#2)
has been developed for the purpose of##2##7##(2008-10#2)
has been developed for the quantitative determination of##3##8##(2008-10#3)
has been developed for the rapid and##2##7##(2008-10#2)
has been developed for the rapid##3##6##(2008-10#3)
has been developed for the simultaneous determination of##7##8##(2008-10#7)
has been developed for the simultaneous##9##6##(2008-10#8)(2008-5#1)
has been developed for the##90##5##(1994-2#1)(2008-10#82)(2008-11#2)(2008-3#3)(2008-5#1)(2009-12#1)
has been developed for trace##3##5##(2008-10#3)
has been developed for##131##4##(1994-2#1)(1995-8#1)(2008-10#117)(2008-11#2)(2008-3#7)(2008-5#1)(2009-12#1)(2010-10#1)
has been developed in order to##3##6##(2008-10#1)(2008-11#1)(2010-7#1)
has been developed in this study##2##6##(2008-10#2)
has been developed in this work##3##6##(2008-10#3)
has been developed in this##5##5##(2008-10#5)
has been developed in##12##4##(2008-10#9)(2008-11#1)(2010-7#1)(2011-2#1)
has been developed on the basis of##2##7##(2008-10#1)(2008-3#1)
has been developed on##3##4##(2008-10#2)(2008-3#1)
has been developed that##2##4##(2008-2#1)(2008-3#1)
has been developed to determine##4##5##(2008-10#3)(2011-2#1)
has been developed to separate##2##5##(2008-10#2)
has been developed to simulate##2##5##(2008-10#1)(2008-5#1)
has been developed to study the##3##6##(2008-11#1)(2008-2#1)(2011-2#1)
has been developed to study##5##5##(2008-11#1)(2008-2#1)(2008-7#2)(2011-2#1)
has been developed to##32##4##(1991-9#1)(1992-12#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
has been developed using##8##4##(2008-10#8)
has been developed which##3##4##(2008-10#3)
has been developed with a##2##5##(2008-10#1)(2008-11#1)
has been developed with the##2##5##(1990-2#1)(2008-10#1)
has been developed with##6##4##(1990-2#1)(1994-5#1)(2008-10#3)(2008-11#1)
has been developed##367##3##(1990-12#1)(1990-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#300)(2008-11#8)(2008-2#2)(2008-3#15)(2008-5#5)(2008-7#4)(2008-9#2)(2009-12#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
has been devised##2##3##(2008-10#1)(2010-3#1)
has been devoted to improving##2##5##(1993-3#1)(2008-9#1)
has been devoted to##5##4##(1993-3#1)(2008-10#1)(2008-11#2)(2008-9#1)
has been difficult to##7##4##(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2013-8#1)
has been difficult##10##3##(1993-12#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-7#1)(2013-8#1)
has been directed to##2##4##(2008-1#1)(2008-11#1)
has been directed##4##3##(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)
has been discovered in##3##4##(1991-7#1)(2008-10#1)(2010-7#1)
has been discovered##6##3##(1991-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)
has been discussed in the##2##5##(2008-10#1)(2011-3#1)
has been discussed in##3##4##(2008-10#1)(2008-11#1)(2011-3#1)
has been discussed##9##3##(2008-10#6)(2008-11#1)(2011-3#1)(2013-1#1)
has been documented##7##3##(1997-3#1)(1997-4#1)(2008-10#1)(2008-9#1)(2012-2#2)(2013-1#1)
has been done in##4##4##(1991-3#1)(1997-7#1)(2013-1#2)
has been done to##2##4##(1994-3#1)(1996-1#1)
has been done with##2##4##(2008-10#1)(2008-3#1)
has been done##11##3##(1991-3#2)(1994-3#1)(1996-1#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2013-1#2)
has been dramatically##2##3##(2010-7#1)(2013-8#1)
has been drastically reduced##2##4##(1991-3#1)(2008-10#1)
has been easily##2##3##(2008-10#1)(2008-11#1)
has been elaborated##2##3##(2008-10#2)
has been emphasized##3##3##(2008-10#2)(2012-2#1)
has been employed as##2##4##(2008-10#2)
has been employed for##5##4##(1990-12#1)(1992-12#1)(2008-10#3)
has been employed to determine SjAb in serum samples##2##9##(2008-10#2)
has been employed to determine##3##5##(1993-8#1)(2008-10#2)
has been employed to##6##4##(1993-8#1)(2008-10#5)
has been employed with##2##4##(2008-10#1)(2008-12#1)
has been employed##19##3##(1990-12#1)(1992-12#1)(1993-8#1)(1996-1#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
has been endorsed##2##3##(2008-1#1)(2013-8#1)
has been established and##2##4##(2008-10#1)(2010-6#1)
has been established as a##2##5##(1994-8#1)(2010-12#1)
has been established at##2##4##(2008-1#2)
has been established by##2##4##(2008-10#2)
has been established for the##2##5##(1990-11#1)(2008-10#1)
has been established for##3##4##(1990-11#1)(2008-10#1)(2011-3#1)
has been established in##2##4##(2008-1#1)(2008-10#1)
has been established that the##2##5##(1990-8#1)(2011-2#1)
has been established that##6##4##(1990-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#2)
has been established##30##3##(1990-11#1)(1990-8#1)(1991-2#1)(1994-8#1)(1997-6#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-3#1)
has been estimated that##3##4##(1994-2#1)(2008-11#1)(2011-2#1)
has been estimated##8##3##(1991-2#1)(1994-2#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)
has been evaluated by##5##4##(2008-10#4)(2009-7#1)
has been evaluated for determination of##2##6##(2008-10#2)
has been evaluated for the measurement##2##6##(2008-10#2)
has been evaluated for the##3##5##(2008-10#3)
has been evaluated for##8##4##(2008-10#7)(2008-5#1)
has been evaluated in a##2##5##(2008-11#1)(2010-1#1)
has been evaluated in##4##4##(1994-8#1)(2008-10#1)(2008-11#1)(2010-1#1)
has been evaluated using##4##4##(1990-12#1)(2008-10#2)(2008-9#1)
has been evaluated##32##3##(1990-12#1)(1991-3#1)(1993-2#1)(1994-8#1)(1995-3#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-1#1)
has been evidenced in##2##4##(1996-1#1)(2012-3#1)
has been examined as a##2##5##(2008-10#2)
has been examined by##2##4##(2008-10#1)(2008-8#1)
has been examined in##3##4##(2008-10#2)(2010-1#1)
has been examined##23##3##(1991-9#1)(1993-2#1)(1995-11#1)(1997-2#1)(2008-10#12)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-2#1)
has been explained by##2##4##(2008-11#1)(2008-2#1)
has been exploited for##2##4##(2008-10#1)(2009-12#1)
has been exploited##5##3##(1990-8#1)(2008-10#2)(2008-4#1)(2009-12#1)
has been explored for##3##4##(2008-10#3)
has been explored##7##3##(1990-8#1)(2008-10#4)(2008-11#1)(2008-9#1)
has been expressed in Escherichia coli##2##6##(1991-3#1)(1995-2#1)
has been expressed##3##3##(1991-3#1)(1995-2#1)(2012-2#1)
has been extended to##3##4##(2008-10#2)(2008-7#1)
has been extended##6##3##(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)
has been extensively studied in##2##5##(2008-10#1)(2008-8#1)
has been extensively##3##3##(1994-2#1)(2008-10#1)(2008-8#1)
has been extremely##2##3##(1994-9#1)(2008-10#1)
has been fabricated##2##3##(2008-10#2)
has been focused on##3##4##(2008-10#2)(2013-8#1)
has been focused##4##3##(2008-10#2)(2009-8#1)(2013-8#1)
has been formed by##2##4##(1996-1#1)(2008-10#1)
has been found in the##2##5##(2008-10#1)(2008-3#1)
has been found in various##2##5##(2012-2#2)
has been found in##15##4##(1996-2#1)(1997-7#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#2)
has been found that in##2##5##(2008-10#2)
has been found that the##5##5##(2008-10#4)(2008-5#1)
has been found that##13##4##(2008-10#8)(2008-5#2)(2008-9#1)(2009-11#1)(2010-4#1)
has been found to be##15##5##(1992-5#1)(2008-10#9)(2008-11#2)(2008-2#1)(2011-2#1)(2013-8#1)
has been found to##23##4##(1990-5#1)(1991-12#1)(1992-5#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#1)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-8#1)
has been found##67##3##(1990-5#1)(1990-6#1)(1991-12#1)(1992-5#1)(1996-2#1)(1997-7#2)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
has been frequently##4##3##(1994-12#1)(2008-11#1)(2011-2#1)(2012-7#1)
has been fully validated and##2##5##(2008-10#1)(2011-1#1)
has been fully validated##4##4##(2008-10#3)(2011-1#1)
has been functionalized##2##3##(2008-10#2)
has been further##4##3##(1990-3#1)(1994-11#1)(1994-3#1)(2011-1#1)
has been gathered##2##3##(2009-12#1)(2009-4#1)
has been generated by##3##4##(1996-5#1)(2008-2#1)(2009-10#1)
has been generated##4##3##(1992-9#1)(1996-5#1)(2008-2#1)(2009-10#1)
has been given to##6##4##(1992-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-8#1)
has been given##7##3##(1992-1#1)(1995-12#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-8#1)
has been greatly##2##3##(1997-6#1)(2008-9#1)
has been growing interest in the##4##6##(2008-10#1)(2008-11#1)(2008-7#2)
has been growing##6##3##(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#2)
has been hampered by##2##4##(2008-11#2)
has been highlighted##4##3##(1992-12#1)(2008-11#1)(2013-1#2)
has been highly conserved##2##4##(1992-12#1)(1997-9#1)
has been hindered by the##2##5##(1997-7#1)(2010-5#1)
has been hindered##4##3##(1996-3#1)(1997-7#1)(2008-11#1)(2010-5#1)
has been historically##2##3##(2008-8#1)(2009-4#1)
has been hypothesized that##4##4##(2008-8#1)(2009-12#1)(2009-8#1)(2011-3#1)
has been hypothesized to be the##2##6##(2008-10#1)(2012-3#1)
has been hypothesized to be##5##5##(2008-10#1)(2008-8#2)(2011-1#1)(2012-3#1)
has been hypothesized to##6##4##(2008-10#2)(2008-8#2)(2011-1#1)(2012-3#1)
has been hypothesized##10##3##(2008-10#2)(2008-8#3)(2009-12#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-3#1)
has been identified as a##13##5##(1993-3#1)(1993-6#1)(2008-10#1)(2008-11#5)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2013-8#1)
has been identified as an##3##5##(1991-3#1)(1997-4#1)(2012-2#1)
has been identified as##19##4##(1991-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1997-4#1)(2008-10#2)(2008-11#5)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2012-2#1)(2013-8#1)
has been identified by##3##4##(1995-11#1)(1997-8#1)(2012-5#1)
has been identified in a patient##2##6##(1995-6#1)(2012-3#1)
has been identified in a##5##5##(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2012-3#1)
has been identified in##8##4##(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-7#1)
has been identified##47##3##(1990-8#1)(1991-3#3)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-7#1)(2013-8#1)
has been implemented in##2##4##(2008-2#1)(2012-3#1)
has been implemented##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
has been implicated as a##4##5##(2008-8#1)(2009-8#1)(2011-2#2)
has been implicated as##6##4##(1995-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#2)
has been implicated in a variety of##2##7##(1996-12#1)(2008-4#1)
has been implicated in a##3##5##(1992-11#1)(1996-12#1)(2008-4#1)
has been implicated in binding to##2##6##(1992-10#1)(1994-5#1)
has been implicated in the regulation of##2##7##(1992-9#1)(2012-2#1)
has been implicated in the##8##5##(1992-10#2)(1992-9#1)(1996-12#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-2#1)
has been implicated in##18##4##(1992-10#3)(1992-11#1)(1992-9#1)(1993-3#1)(1994-5#1)(1996-12#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#4)
has been implicated##24##3##(1992-10#3)(1992-11#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-12#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#4)
has been improved by##3##4##(2008-10#3)
has been improved##6##3##(2008-10#5)(2008-5#1)
has been in effect##2##4##(1993-3#1)(1996-5#1)
has been in##9##3##(1991-2#1)(1993-3#1)(1996-11#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
has been included in the##3##5##(1995-12#1)(2008-11#1)(2008-5#1)
has been included##5##3##(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
has been incorporated into a##2##5##(2008-10#1)(2008-5#1)
has been incorporated##3##3##(2008-10#2)(2008-5#1)
has been increasing in##2##4##(2008-10#1)(2011-2#1)
has been increasing##8##3##(1991-2#1)(1991-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
has been increasingly##2##3##(1992-1#1)(2008-11#1)
has been initiated to##2##4##(2010-8#1)(2011-2#1)
has been initiated##4##3##(1997-6#1)(2010-8#1)(2011-2#2)
has been inserted##2##3##(2008-10#1)(2008-9#1)
has been installed##2##3##(2008-3#2)
has been integrated##2##3##(2008-10#1)(2008-12#1)
has been intensively studied##2##4##(2008-9#1)(2011-2#1)
has been interpreted##2##3##(2008-10#1)(2009-6#1)
has been introduced into##3##4##(1990-12#1)(1997-6#1)(2008-8#1)
has been introduced##11##3##(1990-12#1)(1997-5#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
has been investigated and##4##4##(2008-10#3)(2008-7#1)
has been investigated at##2##4##(2008-10#2)
has been investigated by means of UV-Vis spectroscopy##2##8##(2008-10#2)
has been investigated by means of##3##6##(2008-10#2)(2011-2#1)
has been investigated by using##2##5##(1991-9#1)(2008-10#1)
has been investigated by##14##4##(1991-9#1)(1993-8#1)(1994-5#1)(2008-10#7)(2008-3#1)(2008-5#1)(2009-11#1)(2011-2#1)
has been investigated for##2##4##(1997-7#1)(2008-10#1)
has been investigated in detail##6##5##(1994-5#1)(2008-10#5)
has been investigated in the##2##5##(1994-8#1)(2009-10#1)
has been investigated in##11##4##(1994-5#1)(1994-8#1)(2008-10#8)(2009-10#1)
has been investigated through##2##4##(2008-10#1)(2011-2#1)
has been investigated using##4##4##(2008-10#3)(2009-8#1)
has been investigated##78##3##(1990-11#1)(1991-12#1)(1991-9#1)(1993-8#1)(1994-5#2)(1994-8#1)(1996-5#1)(1997-7#1)(2008-10#53)(2008-11#2)(2008-3#4)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#1)(2011-2#2)(2013-1#2)
has been isolated and##4##4##(1992-4#1)(1995-6#1)(1997-3#1)(2008-10#1)
has been isolated from a##2##5##(1992-10#1)(1993-2#1)
has been isolated from the##4##5##(1990-8#1)(1991-9#1)(1992-6#1)(2008-11#1)
has been isolated from##15##4##(1990-2#1)(1990-8#2)(1991-9#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
has been isolated##23##3##(1990-2#1)(1990-8#2)(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(2008-10#2)(2008-11#2)(2008-8#1)(2011-2#1)
has been known as##2##4##(2008-10#1)(2013-1#1)
has been known for some time##3##6##(2008-3#1)(2009-6#1)(2012-2#1)
has been known for##5##4##(2008-2#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
has been known to be##3##5##(1997-8#1)(2008-11#1)(2008-12#1)
has been known to##5##4##(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)
has been known##13##3##(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
has been largely ignored##3##4##(1997-8#1)(2008-7#1)(2008-8#1)
has been largely##9##3##(1992-11#1)(1997-8#1)(2008-10#3)(2008-7#1)(2008-8#2)(2010-10#1)
has been limited by a lack of##2##7##(2008-12#1)(2009-7#1)
has been limited by##6##4##(2008-12#1)(2008-9#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
has been limited to##3##4##(1994-6#1)(2011-7#1)(2013-1#1)
has been limited##19##3##(1992-2#1)(1994-6#1)(2008-10#3)(2008-12#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
has been linked to##5##4##(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
has been linked##7##3##(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
has been little##4##3##(1996-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
has been localized##2##3##(1990-8#1)(1995-2#1)
has been long##2##3##(2008-1#1)(2011-2#1)
has been made by means of##2##6##(2008-10#1)(2010-8#1)
has been made for##2##4##(2008-10#2)
has been made in the##5##5##(2008-11#3)(2009-12#1)(2010-7#1)
has been made in understanding##2##5##(2008-11#1)(2011-2#1)
has been made in##13##4##(1997-1#1)(2008-10#1)(2008-11#7)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)
has been made on##2##4##(2007-8#1)(2008-10#1)
has been made to##7##4##(1995-2#1)(2008-10#2)(2009-8#1)(2012-3#1)(2013-1#2)
has been made##36##3##(1991-12#1)(1992-6#1)(1995-2#1)(1997-1#1)(1997-6#1)(2007-8#1)(2008-10#11)(2008-11#7)(2008-3#1)(2009-12#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
has been maintained##3##3##(1994-9#1)(2012-3#1)(2013-1#1)
has been mapped##3##3##(1993-9#1)(2008-10#1)(2012-3#1)
has been measured in##2##4##(2008-10#2)
has been measured##8##3##(1996-2#1)(2008-10#4)(2008-3#2)(2011-2#1)
has been modified by##2##4##(1995-6#1)(2008-10#1)
has been modified##6##3##(1995-6#1)(2008-1#1)(2008-10#3)(2008-11#1)
has been monitored##4##3##(2008-10#4)
has been much##2##3##(1990-9#1)(2008-9#1)
has been named##3##3##(1996-3#1)(2008-8#1)(2011-1#1)
has been no report##2##4##(2008-11#1)(2011-2#1)
has been no##10##3##(1990-6#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#2)
has been noted##4##3##(1991-2#1)(2008-10#1)(2010-10#1)(2010-11#1)
has been observed and##2##4##(1991-5#1)(1993-2#1)
has been observed for##2##4##(2008-10#1)(2008-5#1)
has been observed in the##2##5##(1997-6#1)(2007-12#1)
has been observed in##7##4##(1992-2#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
has been observed that##7##4##(1991-2#1)(2008-10#5)(2010-1#1)
has been observed to be##2##5##(1993-12#1)(2012-12#1)
has been observed to##3##4##(1993-12#1)(2008-11#1)(2012-12#1)
has been observed up to##2##5##(2008-10#1)(2011-2#1)
has been observed##40##3##(1990-6#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-12#1)(1993-2#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
has been obtained by##5##4##(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
has been obtained for##3##4##(2008-10#2)(2008-3#1)
has been obtained from##4##4##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
has been obtained##23##3##(1994-11#1)(1995-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#3)(2009-3#1)(2010-4#1)(2010-8#1)
has been on the##2##4##(2008-1#1)(2013-1#1)
has been on##6##3##(1993-2#1)(1996-2#2)(1996-6#1)(2008-1#1)(2013-1#1)
has been only##5##3##(1991-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#1)
has been optimised##3##3##(2008-10#3)
has been optimized and##2##4##(2008-10#1)(2009-8#1)
has been optimized##8##3##(1991-5#1)(2008-10#6)(2009-8#1)
has been partially##2##3##(2008-10#1)(2009-9#1)
has been particularly##3##3##(1990-3#1)(1995-2#1)(2008-10#1)
has been partly##2##3##(1993-9#1)(2012-3#1)
has been performed and##2##4##(2009-9#1)(2010-6#1)
has been performed by a##2##5##(2008-10#2)
has been performed by##6##4##(2008-10#5)(2008-9#1)
has been performed in##7##4##(1990-12#1)(1990-9#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-2#1)
has been performed##29##3##(1990-12#1)(1990-9#1)(1993-6#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
has been placed in the##2##5##(2008-10#1)(2010-12#1)
has been placed on the importance of##2##7##(1996-3#1)(2008-12#1)
has been placed on##3##4##(1996-3#1)(2008-12#1)(2013-8#1)
has been placed##6##3##(1996-3#1)(2008-10#2)(2008-12#1)(2010-12#1)(2013-8#1)
has been possible##8##3##(1993-8#1)(1996-8#1)(2008-10#3)(2008-3#1)(2009-12#1)(2010-6#1)
has been postulated that##5##4##(1990-5#1)(1991-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
has been postulated##8##3##(1990-5#1)(1991-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
has been prepared and used##2##5##(1992-3#1)(2008-10#1)
has been prepared and##7##4##(1992-3#1)(2008-10#5)(2008-4#1)
has been prepared by##3##4##(2008-10#3)
has been prepared##15##3##(1992-3#1)(2008-1#1)(2008-10#12)(2008-4#1)
has been presented##8##3##(1991-3#1)(1993-3#1)(2008-10#4)(2008-8#1)(2010-11#1)
has been previously reported##5##4##(1994-2#1)(2008-10#1)(2009-1#1)(2012-3#2)
has been previously##16##3##(1994-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-1#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
has been problematic##2##3##(2008-10#1)(2009-3#1)
has been produced##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
has been proposed and its##2##5##(2008-10#2)
has been proposed and##4##4##(1996-5#1)(2008-10#2)(2012-3#1)
has been proposed as a##6##5##(1990-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-7#1)
has been proposed as an##3##5##(2008-10#1)(2008-8#1)(2012-2#1)
has been proposed as##9##4##(1990-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2011-7#1)(2012-2#1)
has been proposed based on the##2##6##(2008-10#2)
has been proposed for the determination of##2##7##(2008-10#2)
has been proposed for the##3##5##(2008-10#3)
has been proposed for##4##4##(2008-10#3)(2009-5#1)
has been proposed that the##4##5##(1990-5#1)(1994-2#1)(1994-3#1)(1995-2#1)
has been proposed that##10##4##(1990-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(2008-11#2)(2008-7#1)(2008-8#2)(2009-8#1)
has been proposed to explain##2##5##(2008-10#1)(2008-7#1)
has been proposed to play a critical role in##2##9##(1990-11#1)(2011-2#1)
has been proposed to play a##3##6##(1990-11#1)(2011-2#1)(2013-8#1)
has been proposed to##9##4##(1990-11#1)(2008-10#2)(2008-7#2)(2008-9#1)(2011-2#2)(2013-8#1)
has been proposed with##2##4##(2008-10#2)
has been proposed##66##3##(1990-11#1)(1990-5#2)(1991-12#2)(1991-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-5#2)(2008-10#29)(2008-11#5)(2008-3#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
has been proved that##5##4##(1992-5#1)(2008-10#2)(2008-9#1)(2011-2#1)
has been proved to be##4##5##(2008-10#4)
has been proved##12##3##(1992-5#1)(2008-10#8)(2008-3#1)(2008-9#1)(2011-2#1)
has been proven to be##2##5##(2008-10#1)(2008-11#1)
has been proven to##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
has been proven##7##3##(1996-11#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-1#1)
has been published on##2##4##(1991-2#1)(2008-10#1)
has been purified to homogeneity from##2##6##(1990-11#1)(2008-8#1)
has been purified to homogeneity##3##5##(1990-11#1)(1991-12#1)(2008-8#1)
has been purified to##4##4##(1990-11#1)(1991-12#1)(1994-8#1)(2008-8#1)
has been purified##7##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-9#1)(1994-5#1)(1994-8#1)(2008-8#1)
has been put##2##3##(2008-11#2)
has been questioned because##2##4##(2008-10#2)
has been questioned##6##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)
has been rarely##3##3##(2007-12#1)(2008-7#1)(2010-8#1)
has been reached##5##3##(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#1)
has been receiving##2##3##(2008-10#1)(2013-8#1)
has been recent##3##3##(1995-5#1)(1997-8#1)(2010-1#1)
has been recently developed##2##4##(2008-11#1)(2008-5#1)
has been recently##17##3##(1990-5#1)(1991-6#1)(1994-5#1)(1994-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2011-1#1)(2011-2#1)(2012-2#1)
has been recognized as a##2##5##(1997-1#1)(2012-2#1)
has been recognized as##4##4##(1997-1#1)(2008-3#1)(2012-2#1)(2012-3#1)
has been recognized that##2##4##(2008-7#2)
has been recognized##6##3##(1997-1#1)(2008-3#1)(2008-7#2)(2012-2#1)(2012-3#1)
has been recommended##8##3##(1991-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
has been recorded##3##3##(2008-3#1)(2009-10#1)(2010-8#1)
has been recovered##3##3##(2008-10#2)(2008-5#1)
has been referred to as the &quot##2##7##(1996-1#1)(2011-2#1)
has been related to##3##4##(1993-9#1)(1994-6#1)(2011-2#1)
has been relatively##2##3##(2008-11#1)(2008-5#1)
has been released in##2##4##(2008-10#1)(2009-12#1)
has been removed##2##3##(1992-9#1)(2008-11#1)
has been replaced by##2##4##(1996-11#1)(2010-5#1)
has been reported by##3##4##(1992-6#1)(2008-10#1)(2012-2#1)
has been reported in the##2##5##(1994-3#1)(2010-7#1)
has been reported in##11##4##(1990-6#1)(1991-12#1)(1994-3#1)(1997-7#1)(2008-10#2)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)
has been reported previously##3##4##(1995-6#1)(2009-11#1)(2011-1#1)
has been reported that##12##4##(1991-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2011-2#2)(2013-8#1)
has been reported to be##4##5##(2008-10#2)(2008-9#1)(2011-2#1)
has been reported to have##2##5##(1994-12#1)(2012-3#1)
has been reported to increase##2##5##(2008-10#2)
has been reported to occur in##2##6##(1995-10#1)(2011-2#1)
has been reported to occur##3##5##(1995-10#1)(2008-11#1)(2011-2#1)
has been reported to##23##4##(1991-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#4)(2012-2#1)(2012-3#2)
has been reported##77##3##(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#16)(2008-11#2)(2008-12#4)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#9)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
has been responsible for##2##4##(1992-2#1)(2008-10#1)
has been restricted##2##3##(2008-11#2)
has been revealed##4##3##(1991-9#1)(2008-1#1)(2008-9#1)(2010-11#1)
has been revised##2##3##(2008-11#2)
has been running##2##3##(2008-11#1)(2012-3#1)
has been satisfactorily applied for the determination of##2##8##(2008-10#2)
has been satisfactorily applied for the##3##6##(2008-10#3)
has been satisfactorily applied to##11##5##(2008-10#11)
has been satisfactorily applied##14##4##(2008-10#14)
has been satisfactorily##15##3##(2008-10#15)
has been seen##4##3##(1994-2#1)(2008-11#1)(2008-12#1)(2013-1#1)
has been selected for clinical##2##5##(1992-12#1)(1996-9#1)
has been selected for##3##4##(1992-12#1)(1996-9#1)(2008-10#1)
has been selected##5##3##(1992-12#1)(1996-9#1)(2008-10#3)
has been separated from a##2##5##(2008-11#1)(2008-8#1)
has been separated from##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
has been separated##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
has been set up##2##4##(2008-1#1)(2008-7#1)
has been shown by##3##4##(1993-9#1)(2008-10#1)(2008-3#1)
has been shown in##2##4##(2008-10#1)(2010-5#1)
has been shown that the##7##5##(1990-11#1)(1997-7#1)(2008-10#4)(2013-8#1)
has been shown that##22##4##(1990-11#1)(1994-8#1)(1995-9#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
has been shown to activate the##2##6##(1992-4#1)(2008-11#1)
has been shown to activate##5##5##(1992-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
has been shown to be a major##2##7##(1990-8#1)(1993-11#1)
has been shown to be a promising##2##7##(2008-5#1)(2009-8#1)
has been shown to be a##9##6##(1990-11#1)(1990-8#1)(1993-11#1)(1994-2#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#2)
has been shown to be activated by##2##7##(1995-6#1)(2013-8#1)
has been shown to be an##2##6##(1997-1#1)(2008-10#1)
has been shown to be capable of##3##7##(2008-10#2)(2008-11#1)
has been shown to be effective##2##6##(2008-11#2)
has been shown to be involved in##2##7##(1994-5#1)(2008-10#1)
has been shown to be of##3##6##(1993-2#1)(2008-10#1)(2008-9#1)
has been shown to be the##2##6##(1991-6#1)(2008-11#1)
has been shown to be useful##2##6##(2008-8#1)(2011-1#1)
has been shown to be##50##5##(1990-11#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#10)(2008-11#4)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
has been shown to bind to##2##6##(1994-5#1)(2008-5#1)
has been shown to cause##3##5##(1993-12#1)(2008-9#1)(2011-2#1)
has been shown to correlate with##2##6##(2009-11#1)(2009-12#1)
has been shown to exert##2##5##(2008-7#1)(2010-9#1)
has been shown to have a##3##6##(1993-3#1)(2008-11#1)(2009-7#1)
has been shown to improve the##3##6##(2007-8#1)(2010-12#1)(2011-2#1)
has been shown to improve##5##5##(2007-8#1)(2008-11#2)(2010-12#1)(2011-2#1)
has been shown to increase the##2##6##(1996-2#1)(2008-1#1)
has been shown to increase##3##5##(1996-2#1)(1997-1#1)(2008-1#1)
has been shown to induce##2##5##(1997-3#1)(2008-11#1)
has been shown to influence##2##5##(1991-6#1)(2008-7#1)
has been shown to lower##2##5##(1993-2#1)(2008-6#1)
has been shown to modulate##2##5##(2008-10#1)(2013-8#1)
has been shown to play##3##5##(2008-11#1)(2008-7#1)(2008-9#1)
has been shown to promote the##2##6##(1995-8#1)(2013-1#1)
has been shown to promote##3##5##(1995-8#1)(2008-10#1)(2013-1#1)
has been shown to provide a##2##6##(1994-12#1)(2008-10#1)
has been shown to provide##5##5##(1994-12#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-12#1)
has been shown to reduce##2##5##(1994-6#1)(1996-6#1)
has been shown to regulate##3##5##(2008-11#1)(2008-9#1)(2011-2#1)
has been shown to##130##4##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#15)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#3)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#1)(2013-8#3)
has been shown##165##3##(1990-11#3)(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-2#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#31)(2008-11#18)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#3)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#5)
has been significantly##2##3##(2011-2#1)(2012-2#1)
has been slow##4##3##(2008-10#1)(2008-12#1)(2013-1#2)
has been solved##2##3##(1992-4#1)(1995-2#1)
has been sparse##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
has been speculated that##3##4##(2008-10#1)(2008-5#1)(2009-6#1)
has been speculated##4##3##(2008-10#1)(2008-5#1)(2009-6#1)(2012-2#1)
has been studied and the optimized conditions developed were utilized for##2##11##(2008-10#2)
has been studied and the##3##5##(2008-10#3)
has been studied and##8##4##(2008-10#8)
has been studied as a function of##2##7##(2008-10#2)
has been studied as a##4##5##(2008-10#3)(2008-4#1)
has been studied at the##2##5##(2008-10#1)(2011-10#1)
has been studied at##7##4##(2008-10#6)(2011-10#1)
has been studied by means of##3##6##(2008-10#3)
has been studied by polarography##2##5##(2008-10#2)
has been studied by##22##4##(1990-5#1)(1990-8#1)(1992-4#1)(1992-9#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-8#1)
has been studied extensively##2##4##(2008-10#1)(2008-6#1)
has been studied for##3##4##(2008-10#3)
has been studied in detail to optimize the conditions for##2##10##(2008-10#2)
has been studied in detail##3##5##(2008-10#3)
has been studied in the##2##5##(1992-12#1)(2008-10#1)
has been studied in##9##4##(1992-12#1)(1993-2#1)(2008-10#5)(2008-8#1)(2010-3#1)
has been studied on##2##4##(2008-10#2)
has been studied to##2##4##(2008-10#2)
has been studied using a##2##5##(2008-10#2)
has been studied using##7##4##(1994-5#1)(2008-10#6)
has been studied with##2##4##(2008-3#1)(2011-2#1)
has been studied##107##3##(1990-5#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-5#1)(1996-3#1)(1997-6#1)(2008-10#78)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-3#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
has been submitted to##2##4##(1997-2#1)(2013-1#1)
has been submitted##4##3##(1997-2#1)(2008-5#1)(2013-1#2)
has been substituted by##2##4##(1996-9#1)(2008-10#1)
has been successful in##4##4##(1992-2#1)(1996-3#1)(1997-2#1)(2013-1#1)
has been successfully applied for the determination of##2##8##(2008-10#2)
has been successfully applied for the##9##6##(2008-10#8)(2009-6#1)
has been successfully applied for##12##5##(2008-10#11)(2009-6#1)
has been successfully applied to the determination of the##2##9##(2008-10#2)
has been successfully applied to the determination of##20##8##(2008-10#20)
has been successfully applied to the##25##6##(2008-10#25)
has been successfully applied to##39##5##(2008-10#38)(2012-12#1)
has been successfully applied##52##4##(2008-10#50)(2009-6#1)(2012-12#1)
has been successfully employed for##3##5##(2008-10#2)(2012-12#1)
has been successfully employed to##2##5##(2008-10#1)(2008-7#1)
has been successfully employed##5##4##(2008-10#3)(2008-7#1)(2012-12#1)
has been successfully tested##2##4##(2008-10#2)
has been successfully used for##3##5##(2008-10#3)
has been successfully used in##2##5##(2008-10#1)(2008-3#1)
has been successfully used to##3##5##(2008-10#2)(2008-11#1)
has been successfully used##10##4##(2008-10#8)(2008-11#1)(2008-3#1)
has been successfully##80##3##(1996-1#1)(2008-10#69)(2008-11#3)(2008-3#1)(2008-7#2)(2009-6#1)(2012-12#2)(2013-8#1)
has been suggested as a##2##5##(2008-9#1)(2012-2#1)
has been suggested as##5##4##(1997-2#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
has been suggested for##2##4##(1997-8#1)(2008-10#1)
has been suggested in##2##4##(1991-11#1)(2012-2#1)
has been suggested that a##2##5##(1991-2#1)(2013-1#1)
has been suggested that the##3##5##(1997-3#1)(2008-8#1)(2008-9#1)
has been suggested that##27##4##(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#3)(2013-7#1)
has been suggested to be an##2##6##(1994-8#1)(2009-11#1)
has been suggested to be##6##5##(1991-2#1)(1994-8#1)(1995-3#1)(2009-11#1)(2009-7#1)(2009-9#1)
has been suggested to occur via an associative or dissociative mechanism dependent upon the surrounding environment##2##16##(2013-1#2)
has been suggested to##13##4##(1991-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
has been suggested##55##3##(1990-5#1)(1990-8#1)(1991-11#2)(1991-2#2)(1992-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#6)(2013-7#1)
has been suspected##3##3##(2008-10#1)(2010-1#1)(2010-4#1)
has been synthesized and characterized##2##5##(2008-10#2)
has been synthesized and used##2##5##(2008-10#2)
has been synthesized and##5##4##(2008-10#5)
has been synthesized by##2##4##(2008-10#2)
has been synthesized in##2##4##(1990-8#1)(2008-10#1)
has been synthesized##16##3##(1990-8#1)(1994-3#1)(1994-8#1)(1996-5#1)(2008-10#12)
has been taken into account##2##5##(2008-3#2)
has been taken to##2##4##(1992-6#1)(2008-10#1)
has been taken##5##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-3#2)
has been termed##4##3##(2008-10#2)(2008-11#1)(2010-6#1)
has been tested by##2##4##(2008-10#2)
has been tested for##7##4##(1996-2#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-3#1)
has been tested in##2##4##(1997-1#1)(2008-10#1)
has been tested on##5##4##(2007-12#1)(2008-10#3)(2010-8#1)
has been tested##24##3##(1991-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-12#1)(2008-3#1)(2010-8#1)
has been the lack of##2##5##(2008-9#1)(2010-12#1)
has been the##25##3##(1991-3#1)(1992-1#1)(1994-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
has been thoroughly##2##3##(2008-10#1)(2012-2#1)
has been to##8##3##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#1)
has been transferred##2##3##(2008-10#1)(2008-9#1)
has been treated with##2##4##(1991-9#1)(2012-2#1)
has been treated##6##3##(1991-9#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
has been tried##2##3##(2008-10#1)(2010-8#1)
has been unclear##2##3##(2008-10#1)(2008-4#1)
has been undertaken to##2##4##(2008-10#1)(2008-7#1)
has been undertaken##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
has been used as a##7##5##(1996-12#1)(1997-6#1)(2008-10#4)(2008-11#1)
has been used as an indicator electrode in the potentiometric##2##10##(2008-10#2)
has been used as an##5##5##(2008-10#4)(2008-7#1)
has been used as the##2##5##(2008-10#2)
has been used as##19##4##(1996-12#1)(1997-6#1)(2008-10#14)(2008-11#1)(2008-7#1)(2008-9#1)
has been used by##2##4##(2008-11#1)(2008-12#1)
has been used extensively to##2##5##(2008-10#1)(2008-7#1)
has been used extensively##3##4##(1995-12#1)(2008-10#1)(2008-7#1)
has been used for a##2##5##(2008-10#2)
has been used for determination of##2##6##(2008-10#2)
has been used for the determination of##7##7##(2008-10#7)
has been used for the##15##5##(2008-10#14)(2010-12#1)
has been used for##40##4##(1992-3#1)(1996-9#1)(2007-8#1)(2008-10#29)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-8#1)
has been used in the identification of##2##7##(1995-11#1)(2012-2#1)
has been used in the treatment of##2##7##(1994-5#1)(1996-3#1)
has been used in the##10##5##(1994-5#1)(1995-11#1)(1996-3#1)(2008-10#3)(2008-9#1)(2010-8#2)(2012-2#1)
has been used in##20##4##(1991-1#1)(1991-11#1)(1992-5#1)(1994-5#1)(1995-11#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
has been used mainly##2##4##(2008-8#1)(2011-2#1)
has been used safely##2##4##(1995-8#1)(2010-6#1)
has been used successfully for the##2##6##(1997-2#1)(2008-10#1)
has been used successfully for##4##5##(1997-2#1)(2008-10#3)
has been used successfully in##2##5##(2009-10#1)(2010-11#1)
has been used successfully##6##4##(1997-2#1)(2008-10#3)(2009-10#1)(2010-11#1)
has been used to construct##2##5##(2008-10#2)
has been used to detect##2##5##(2008-10#2)
has been used to determine the##4##6##(1991-2#1)(2008-10#2)(2008-7#1)
has been used to determine##9##5##(1991-2#1)(2008-10#7)(2008-7#1)
has been used to examine the##2##6##(2008-10#1)(2008-5#1)
has been used to identify the##2##6##(2008-10#1)(2012-3#1)
has been used to investigate the##2##6##(1994-5#1)(2008-4#1)
has been used to measure##2##5##(1994-9#1)(2008-10#1)
has been used to monitor##2##5##(2008-10#2)
has been used to refer to##2##6##(2011-2#1)(2012-2#1)
has been used to study##4##5##(1991-12#1)(1994-5#1)(1994-8#1)(2008-10#1)
has been used to##60##4##(1990-11#2)(1991-12#1)(1991-2#1)(1991-7#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-5#3)(1994-8#1)(1994-9#1)(1996-1#1)(2008-10#31)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
has been used with##2##4##(1992-11#1)(2008-10#1)
has been used##166##3##(1990-11#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#91)(2008-11#8)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#3)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#2)(2013-8#1)
has been utilized as a##2##5##(1996-5#1)(2008-11#1)
has been utilized as##5##4##(1996-5#1)(2008-10#3)(2008-11#1)
has been utilized for##3##4##(1990-12#1)(2008-10#2)
has been utilized to##5##4##(1995-3#1)(1997-1#1)(2008-10#2)(2012-12#1)
has been utilized##14##3##(1990-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(2008-10#8)(2008-11#1)(2012-12#1)
has been validated by##3##4##(2008-10#3)
has been validated for##2##4##(2008-10#1)(2008-7#1)
has been validated##10##3##(1990-2#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-9#1)
has been verified by on-line interfacing of a rotating biosensor and continuous flow/stopped-flow/continuous-flow processing##2##14##(2008-10#2)
has been verified by on-line interfacing of a rotating##3##9##(2008-10#3)
has been verified by##5##4##(2008-10#5)
has been verified##7##3##(1997-6#1)(2008-10#6)
has been very##2##3##(2008-10#1)(2012-2#1)
has been virtually##2##3##(1991-2#1)(1994-9#1)
has been well documented and##2##5##(1994-12#1)(2008-10#1)
has been well documented##4##4##(1994-12#1)(2008-10#2)(2013-1#1)
has been well##7##3##(1991-12#1)(1994-12#1)(2008-1#1)(2008-10#3)(2013-1#1)
has been widely disseminated##2##4##(1995-6#1)(1996-1#1)
has been widely used as##2##5##(2008-10#1)(2008-5#1)
has been widely used for the##3##6##(1997-8#1)(2008-10#2)
has been widely used for##4##5##(1997-8#1)(2008-10#3)
has been widely used in##3##5##(2008-1#1)(2008-5#1)(2012-3#1)
has been widely used##10##4##(1997-8#1)(2008-1#1)(2008-10#4)(2008-5#2)(2012-3#2)
has been widely##21##3##(1994-2#1)(1995-6#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-5#2)(2010-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
has been written about the##4##5##(1992-1#1)(1994-8#1)(2008-11#1)(2010-10#1)
has been written about##7##4##(1992-1#1)(1994-8#1)(2008-11#2)(2010-10#1)(2012-2#2)
has been written##10##3##(1992-1#1)(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-10#1)(2012-2#2)
has been##3404##2##(1990-11#15)(1990-12#8)(1990-2#7)(1990-3#7)(1990-5#16)(1990-6#6)(1990-8#14)(1990-9#12)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#16)(1991-2#18)(1991-3#20)(1991-5#7)(1991-6#10)(1991-7#3)(1991-9#8)(1992-1#11)(1992-10#6)(1992-11#6)(1992-12#12)(1992-2#7)(1992-3#5)(1992-4#5)(1992-5#4)(1992-6#7)(1992-7#1)(1992-9#12)(1993-1#2)(1993-11#5)(1993-12#8)(1993-2#13)(1993-3#13)(1993-6#7)(1993-8#7)(1993-9#9)(1994-1#4)(1994-11#5)(1994-12#10)(1994-2#14)(1994-3#9)(1994-5#23)(1994-6#5)(1994-8#15)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#12)(1995-2#16)(1995-3#8)(1995-5#3)(1995-6#15)(1995-8#7)(1995-9#1)(1996-1#11)(1996-11#5)(1996-12#8)(1996-2#15)(1996-3#22)(1996-5#12)(1996-6#4)(1996-8#3)(1996-9#4)(1997-1#14)(1997-2#12)(1997-3#6)(1997-4#7)(1997-5#5)(1997-6#14)(1997-7#13)(1997-8#16)(1997-9#1)(2006-5#2)(2007-11#4)(2007-12#10)(2007-8#5)(2008-1#27)(2008-10#1485)(2008-11#212)(2008-12#40)(2008-2#16)(2008-3#88)(2008-4#23)(2008-5#62)(2008-6#12)(2008-7#71)(2008-8#63)(2008-9#71)(2009-1#3)(2009-10#16)(2009-11#7)(2009-12#12)(2009-3#6)(2009-4#5)(2009-5#3)(2009-6#7)(2009-7#8)(2009-8#19)(2009-9#5)(2010-1#9)(2010-10#12)(2010-11#14)(2010-12#21)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#9)(2010-6#16)(2010-7#14)(2010-8#19)(2010-9#4)(2011-1#11)(2011-10#1)(2011-2#97)(2011-3#11)(2011-4#1)(2011-7#3)(2012-12#11)(2012-2#54)(2012-3#53)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#62)(2013-2#1)(2013-7#3)(2013-8#34)
has begun to##4##3##(2006-6#1)(2008-10#1)(2010-1#1)(2011-9#1)
has better##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
has both##7##2##(1992-10#1)(1996-5#1)(1997-8#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-8#1)
has brought##7##2##(1993-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
has caused##6##2##(1995-3#1)(2008-10#4)(2013-1#1)
has changed in##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
has changed little##2##3##(1991-9#1)(2008-10#1)
has changed the##3##3##(1995-1#1)(1996-1#1)(2009-3#1)
has changed##16##2##(1990-6#1)(1991-9#1)(1995-1#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-2#2)(2012-2#1)
has characterized##2##2##(1996-3#1)(2008-5#1)
has clearly##2##2##(2008-11#1)(2013-1#1)
has coincided with##2##3##(2008-10#1)(2008-11#1)
has come a long way##2##5##(2008-10#1)(2009-10#1)
has come a##3##3##(2008-10#1)(2008-11#1)(2009-10#1)
has come from##4##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
has come to a##2##4##(1997-5#1)(2012-2#1)
has come to##4##3##(1997-5#1)(1997-7#1)(2008-7#1)(2012-2#1)
has come##15##2##(1991-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2010-9#1)(2012-2#1)
has commenced##2##2##(2008-5#1)(2008-8#1)
has compared##2##2##(2008-10#1)(2008-8#1)
has considerably##3##2##(1993-3#1)(2008-5#1)(2012-2#1)
has consisted of##3##3##(1992-3#1)(1993-1#1)(1997-3#1)
has consistently been found to##2##5##(2008-11#1)(2008-6#1)
has consistently been##3##3##(2008-11#2)(2008-6#1)
has consistently##5##2##(2008-11#3)(2008-5#1)(2008-6#1)
has continued to##2##3##(2011-1#1)(2011-2#1)
has contributed to increased##2##4##(1995-2#1)(2009-10#1)
has contributed to##5##3##(1995-2#1)(1997-1#1)(2008-1#1)(2009-10#1)(2009-7#1)
has contributed##7##2##(1993-6#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-7#1)
has created a need for##2##5##(1994-6#1)(2008-9#1)
has created a##4##3##(1994-6#1)(1995-1#1)(2008-9#1)(2012-2#1)
has created the##3##3##(1991-6#1)(1995-6#1)(1997-6#1)
has created##7##2##(1991-6#1)(1994-6#1)(1995-1#1)(1995-6#1)(1997-6#1)(2008-9#1)(2012-2#1)
has currently not been##2##4##(2011-2#1)(2012-3#1)
has currently##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
has dealt with the##2##4##(1990-3#1)(1995-11#1)
has dealt with##3##3##(1990-3#1)(1995-11#1)(2008-7#1)
has dealt##4##2##(1990-3#1)(1995-11#1)(2008-11#1)(2008-7#1)
has declined from##2##3##(1991-2#2)
has declined##6##2##(1990-6#1)(1991-11#1)(1991-2#2)(1996-2#1)(2008-4#1)
has decreased##6##2##(1991-3#1)(1996-11#1)(1997-3#1)(2008-11#2)(2012-7#1)
has definite##2##2##(1991-6#1)(2011-2#1)
has demonstrated a##8##3##(1996-12#1)(1997-3#2)(2008-5#2)(2008-8#1)(2012-2#1)(2013-1#1)
has demonstrated high##2##3##(2008-5#1)(2010-9#1)
has demonstrated that the##3##4##(2008-10#2)(2011-2#1)
has demonstrated that this##2##4##(2008-11#1)(2010-3#1)
has demonstrated that##13##3##(1993-6#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-7#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)
has demonstrated the##5##3##(1990-11#1)(1990-8#1)(1997-6#1)(2008-5#1)(2011-2#1)
has demonstrated##37##2##(1990-11#1)(1990-8#1)(1992-12#1)(1993-6#1)(1996-12#2)(1997-3#2)(1997-6#1)(2008-10#3)(2008-11#2)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-2#3)(2013-1#2)
has described the##2##3##(1991-3#1)(2013-1#1)
has described##3##2##(1991-3#1)(2011-2#1)(2013-1#1)
has detected##2##2##(2008-11#1)(2012-2#1)
has detection##2##2##(2008-10#1)(2010-4#1)
has developed a##2##3##(1991-12#1)(2011-3#1)
has developed and##2##3##(2010-5#1)(2013-1#1)
has developed in##2##3##(1991-11#1)(2008-11#1)
has developed##16##2##(1990-9#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-5#1)(1994-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-3#1)(2013-1#2)
has direct##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
has distinct advantages##2##3##(1994-1#1)(2008-3#1)
has documented##3##2##(1995-12#2)(2008-12#1)
has dramatically improved the##2##4##(2010-12#1)(2011-2#1)
has dramatically increased##2##3##(2008-11#1)(2010-6#1)
has dramatically##4##2##(2008-11#1)(2010-12#1)(2010-6#1)(2011-2#1)
has driven##2##2##(2011-2#1)(2012-3#1)
has dropped##4##2##(1992-2#1)(1994-9#1)(2008-10#1)(2011-2#1)
has embarked on a##2##4##(1991-2#1)(1996-2#1)
has emerged as a major##2##5##(2008-9#1)(2013-1#1)
has emerged as a powerful##2##5##(2008-4#1)(2011-2#1)
has emerged as a##13##4##(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
has emerged as an important##3##5##(2008-5#1)(2010-7#1)(2013-3#1)
has emerged as an##8##4##(1995-11#1)(1997-6#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-7#1)(2012-2#1)(2013-3#1)
has emerged as one of the most##2##7##(2007-11#1)(2008-10#1)
has emerged as one of the##3##6##(2007-11#1)(2008-10#1)(2008-9#1)
has emerged as the##3##4##(1997-1#1)(2008-9#1)(2011-7#1)
has emerged as##27##3##(1995-11#1)(1995-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-1#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-3#1)(2013-8#2)
has emerged in recent years##2##5##(1994-12#1)(2010-6#1)
has emerged in##3##3##(1994-12#1)(2010-6#1)(2012-2#1)
has emerged##40##2##(1994-12#2)(1995-11#1)(1995-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-1#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-3#1)(2013-8#2)
has enabled the##8##3##(1997-4#1)(2008-10#1)(2008-11#2)(2009-5#1)(2010-3#1)(2010-7#1)(2013-1#1)
has enabled##13##2##(1991-3#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
has encouraged the development of##2##5##(2010-11#1)(2010-5#1)
has encouraged##5##2##(1994-3#1)(2010-11#1)(2010-5#1)(2011-3#1)(2013-8#1)
has enhanced##2##2##(2008-11#1)(2008-12#1)
has enough##2##2##(2008-10#1)(2008-11#1)
has ensured##2##2##(2008-10#1)(2008-6#1)
has entered##3##2##(1996-3#1)(2008-11#1)(2008-5#1)
has established itself##2##3##(2008-10#1)(2011-4#1)
has established##6##2##(1996-2#1)(1997-7#1)(2008-10#1)(2008-9#1)(2011-4#1)(2013-1#1)
has evaluated the##3##3##(1995-2#1)(2008-10#2)
has evolved as##2##3##(2009-8#1)(2012-2#1)
has evolved from##2##3##(2008-8#1)(2008-9#1)
has evolved into##3##3##(2008-10#2)(2013-1#1)
has evolved over##2##3##(1997-1#1)(2012-2#1)
has evolved##18##2##(1993-12#1)(1997-1#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-8#2)(2012-2#2)(2013-1#1)(2013-7#1)
has examined the##2##3##(2008-10#1)(2008-11#1)
has examined##5##2##(1995-1#1)(2008-10#1)(2008-11#3)
has excellent##6##2##(2008-10#4)(2008-7#1)(2008-8#1)
has expanded##6##2##(1991-2#1)(1992-3#1)(1994-1#1)(1995-3#1)(2008-12#1)(2010-12#1)
has experienced##2##2##(2010-8#1)(2013-1#1)
has explored the##2##3##(2008-11#1)(2008-9#1)
has explored##3##2##(2008-11#1)(2008-9#1)(2012-2#1)
has facilitated the##3##3##(1996-1#1)(2008-10#1)(2010-4#1)
has facilitated##5##2##(1996-1#1)(2008-10#2)(2008-7#1)(2010-4#1)
has failed to##2##3##(1994-2#1)(2009-9#1)
has failed##6##2##(1990-11#1)(1991-12#1)(1994-2#1)(1996-8#1)(2008-11#1)(2009-9#1)
has fallen from##2##3##(1993-6#1)(2008-7#1)
has few##2##2##(2008-12#1)(2012-12#1)
has firstly been##2##3##(2008-10#2)
has flexibility##2##2##(2008-6#2)
has flexuous##2##2##(2008-10#2)
has focused on the##5##4##(1995-1#1)(1997-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
has focused on##20##3##(1991-12#1)(1992-1#1)(1994-3#1)(1995-1#1)(1995-3#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
has focused primarily on##2##4##(1995-12#1)(2012-2#1)
has focused##23##2##(1991-12#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
has followed##2##2##(2008-10#1)(2008-11#1)
has for the##2##3##(2009-6#2)
has for##3##2##(1995-5#1)(2009-6#2)
has found its##2##3##(1994-3#1)(2008-11#1)
has found##7##2##(1991-9#1)(1993-12#1)(1994-3#1)(1997-2#1)(2008-11#1)(2010-7#1)(2011-2#1)
has four##2##2##(1991-6#1)(1997-7#1)
has frequently been##2##3##(1992-9#1)(2011-2#1)
has frequently##3##2##(1992-9#1)(1994-1#1)(2011-2#1)
has fuelled##2##2##(2008-11#1)(2008-12#1)
has functional##2##2##(1993-8#1)(2011-2#1)
has further been##2##3##(2008-8#1)(2008-9#1)
has further##4##2##(2008-8#2)(2008-9#1)(2010-10#1)
has gained increasing##2##3##(2008-12#1)(2011-2#1)
has gained##10##2##(2008-10#4)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#1)
has generally been##2##3##(2008-12#1)(2008-9#1)
has generated much##3##3##(1997-2#1)(2012-2#1)(2013-1#1)
has generated##8##2##(1993-9#1)(1994-1#1)(1997-2#1)(2008-3#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
has given rise to##2##4##(2008-11#1)(2009-8#1)
has given##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-10#2)(2010-8#1)
has gone##3##2##(1996-3#1)(2008-8#1)(2012-3#1)
has good##7##2##(2008-10#5)(2008-9#1)(2013-8#1)
has got##2##2##(2008-12#1)(2013-1#1)
has gradually##3##2##(1997-1#1)(2008-5#1)(2013-8#1)
has great##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
has greater##2##2##(2008-10#1)(2008-12#1)
has greatly contributed to the understanding of##2##7##(1997-8#1)(2012-2#1)
has greatly enhanced##2##3##(2010-12#1)(2011-2#1)
has greatly##8##2##(1991-5#1)(1997-8#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
has grown##7##2##(1991-8#1)(1992-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)
has had a##4##3##(1991-1#1)(2008-11#2)(2013-1#1)
has had an effect on##2##5##(1995-12#1)(2008-11#1)
has had an##4##3##(1995-12#1)(2008-11#1)(2008-7#1)(2013-1#1)
has had##20##2##(1990-6#1)(1991-1#1)(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#2)(1996-1#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2011-3#1)(2012-12#1)(2013-1#2)
has held##2##2##(2008-7#1)(2010-5#1)
has helped to##5##3##(1992-2#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
has helped##6##2##(1992-2#1)(1995-1#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
has high affinity for##3##4##(1994-8#1)(2011-2#1)(2013-1#1)
has high sensitivity##2##3##(2008-10#2)
has high##21##2##(1994-8#1)(1997-2#1)(2008-10#9)(2008-8#2)(2008-9#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
has higher##6##2##(2008-10#4)(2008-4#1)(2008-8#1)
has highlighted the##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
has highlighted##5##2##(1991-3#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
has historically##2##2##(1997-1#1)(2009-9#1)
has identified a##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
has identified##12##2##(1991-3#1)(1992-6#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2010-10#1)(2010-3#1)(2012-3#1)
has illustrated##2##2##(1991-3#1)(2008-10#1)
has implemented a##2##3##(1995-12#1)(1996-3#1)
has implications for##2##3##(1991-2#1)(2008-11#1)
has important implications for the##2##5##(2008-11#1)(2008-8#1)
has important implications for##6##4##(1995-12#1)(2008-11#2)(2008-8#1)(2009-8#1)(2011-2#1)
has important##12##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
has improved##10##2##(1991-3#1)(1996-1#1)(1997-1#1)(2008-10#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
has in##2##2##(2008-11#1)(2008-7#1)
has increased by##5##3##(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#2)
has increased dramatically##2##3##(1995-12#1)(2009-7#1)
has increased in the##2##4##(2008-11#1)(2012-2#1)
has increased in##11##3##(1990-11#1)(1991-11#1)(1993-1#1)(2007-12#1)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#3)
has increased over the##2##4##(1997-7#1)(2011-2#1)
has increased significantly##2##3##(2008-10#1)(2008-7#1)
has increased the##4##3##(1992-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
has increased##52##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#2)(1992-3#2)(1993-1#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
has indicated that the##2##4##(1995-1#1)(2011-2#1)
has indicated that##4##3##(1995-1#1)(1996-1#1)(2010-9#1)(2011-2#1)
has indicated##7##2##(1995-1#1)(1996-1#1)(2008-2#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
has inherent##2##2##(2008-1#1)(2008-12#1)
has initiated a##2##3##(1992-12#1)(2011-1#1)
has initiated##4##2##(1992-12#1)(1995-11#1)(2010-7#1)(2011-1#1)
has inspired##2##2##(2008-8#1)(2009-5#1)
has intensified##2##2##(1996-2#1)(2013-1#1)
has intrigued##2##2##(2009-6#1)(2009-8#1)
has investigated##2##2##(1993-12#1)(2008-9#1)
has issued##3##2##(1991-6#1)(1992-8#1)(2008-5#1)
has it##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
has its advantages and##2##4##(2008-10#1)(2008-9#1)
has its limitations##2##3##(1992-3#1)(2008-11#1)
has its own##2##3##(1995-10#1)(2008-11#1)
has its roots in the##3##5##(1993-2#1)(1997-2#1)(2008-9#1)
has its roots##4##3##(1993-2#1)(1997-2#1)(2008-9#1)(2013-8#1)
has its##18##2##(1992-3#1)(1993-2#1)(1995-10#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-9#2)(2010-7#1)(2013-1#1)(2013-8#1)
has lacked##2##2##(1997-3#1)(2010-5#1)
has largely focused on##2##4##(2008-10#1)(2012-3#1)
has largely##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
has launched##2##2##(1990-6#1)(2012-12#1)
has lead to a##3##4##(2008-10#1)(2010-1#1)(2011-2#1)
has lead to##5##3##(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
has led researchers to##2##4##(2008-11#1)(2011-2#1)
has led the##3##3##(1994-1#1)(2008-12#1)(2009-3#1)
has led to a##13##4##(1993-6#1)(1994-12#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2013-8#2)
has led to an increase##2##5##(1991-6#1)(2011-3#1)
has led to increasing##2##4##(1992-5#1)(2011-2#1)
has led to the development of##3##6##(2008-10#1)(2008-4#1)(2010-12#1)
has led to the##8##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)
has led to##45##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-6#1)(1994-12#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#2)
has led##54##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-6#1)(1994-1#1)(1994-12#3)(1996-6#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#2)
has left##2##2##(2008-10#1)(2008-8#1)
has less##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
has limitations##2##2##(2008-7#1)(2011-2#1)
has limited ability to##2##4##(2011-2#1)(2012-3#1)
has limited##5##2##(2008-11#1)(2009-9#1)(2011-2#1)(2012-3#2)
has little effect on##2##4##(1995-8#1)(2009-5#1)
has little##15##2##(1992-3#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#2)(2010-10#1)(2011-2#2)
has long been a##2##4##(2008-10#1)(2008-11#1)
has long been an important##2##5##(2008-8#1)(2008-9#1)
has long been observed##2##4##(1995-6#1)(2008-10#1)
has long been recognized##4##4##(2008-11#1)(2008-5#1)(2010-1#1)(2013-1#1)
has long been regarded as##3##5##(1995-2#1)(2008-11#1)(2010-5#1)
has long been##24##3##(1993-12#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
has long##29##2##(1993-12#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)
has lost##4##2##(1990-5#1)(2008-12#1)(2009-6#1)(2010-8#1)
has lower##3##2##(1997-2#1)(2008-9#1)(2011-2#1)
has made a significant##2##4##(2009-6#1)(2013-1#1)
has made a##5##3##(1996-2#1)(2008-10#1)(2008-7#1)(2009-6#1)(2013-1#1)
has made it possible for##2##5##(1992-3#1)(2010-12#1)
has made it possible to##7##5##(1995-8#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)
has made it possible##9##4##(1992-3#1)(1995-8#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)
has made it##11##3##(1992-3#1)(1994-6#1)(1995-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)
has made much progress##2##4##(1996-11#1)(2008-10#1)
has made substantial##2##3##(1995-5#1)(2009-3#1)
has made the##4##3##(1993-3#1)(1995-6#1)(2008-11#1)(2012-2#1)
has made##39##2##(1991-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
has mainly##2##2##(1994-12#1)(2012-12#1)
has major##3##2##(1991-1#1)(2008-11#1)(2010-8#1)
has many characteristics of##2##4##(2008-7#1)(2008-9#1)
has many##12##2##(1993-1#1)(1997-2#1)(2008-11#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
has meant##2##2##(1996-12#1)(2013-1#1)
has merit##2##2##(1992-8#1)(2008-10#1)
has met##3##2##(2008-9#2)(2012-3#1)
has minimal##4##2##(2008-10#1)(2008-12#2)(2008-9#1)
has more recently been##2##4##(1995-2#1)(1997-8#1)
has more than##2##3##(1991-9#1)(2008-9#1)
has more##7##2##(1991-9#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#2)
has moved##4##2##(1996-11#1)(2008-10#1)(2009-12#1)(2010-7#1)
has much##7##2##(1990-8#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
has near##2##2##(2008-10#1)(2009-6#1)
has negative##2##2##(2008-11#1)(2012-2#1)
has neuroprotective##2##2##(2008-11#1)(2011-2#1)
has never been applied to##2##5##(2008-10#2)
has never been published##2##4##(1991-12#1)(1992-12#1)
has never been reported before in the##2##7##(1997-8#1)(2008-11#1)
has never been##15##3##(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-5#1)
has never##17##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-12#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-5#1)(2013-1#1)
has no advantage over those##2##5##(1994-2#2)
has no effect on the##3##5##(1990-5#1)(2008-8#1)(2013-8#1)
has no effect on##11##4##(1990-2#1)(1990-5#2)(1994-8#1)(1995-3#1)(1995-6#1)(2008-12#1)(2008-8#3)(2013-8#1)
has no effect##13##3##(1990-2#1)(1990-5#2)(1994-8#1)(1995-3#1)(1995-6#1)(1997-7#1)(2008-12#1)(2008-5#1)(2008-8#3)(2013-8#1)
has no known##2##3##(2006-6#1)(2010-6#1)
has no meaning##2##3##(2008-5#1)(2013-1#1)
has no significant##2##3##(2008-5#1)(2012-12#1)
has no##48##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-12#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-1#2)(1997-3#1)(1997-7#2)(2006-6#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
has normal##3##2##(1993-2#1)(1997-3#1)(2010-6#1)
has not become##2##3##(1990-9#1)(2010-7#1)
has not been addressed##2##4##(2008-11#1)(2010-1#1)
has not been characterized##2##4##(1990-11#1)(2008-9#1)
has not been clearly##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
has not been cloned##2##4##(1993-12#1)(1995-6#1)
has not been confirmed##2##4##(2008-9#1)(2009-5#1)
has not been demonstrated##2##4##(1991-10#1)(2008-10#1)
has not been described previously##2##5##(1995-6#1)(2008-10#1)
has not been described##6##4##(1991-6#1)(1995-6#1)(2008-10#1)(2008-11#2)(2012-2#1)
has not been determined##6##4##(1992-10#1)(1992-12#1)(2008-10#2)(2010-4#1)(2012-3#1)
has not been established##3##4##(1995-12#1)(1996-6#1)(2013-1#1)
has not been evaluated##2##4##(2009-11#1)(2013-1#1)
has not been extensively studied##2##5##(2008-11#1)(2008-8#1)
has not been extensively##3##4##(2008-11#1)(2008-8#1)(2013-8#1)
has not been fully established##2##5##(2008-7#1)(2010-8#1)
has not been fully##8##4##(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-8#1)
has not been identified##2##4##(1992-6#1)(2008-6#1)
has not been investigated##4##4##(2008-11#2)(2008-12#1)(2009-10#1)
has not been observed##4##4##(1993-2#1)(2008-11#1)(2008-2#1)(2012-2#1)
has not been previously described##2##5##(2008-7#2)
has not been previously reported in the##2##7##(2009-7#1)(2010-6#1)
has not been previously reported##6##5##(1996-12#1)(2008-10#3)(2009-7#1)(2010-6#1)
has not been previously##12##4##(1996-12#1)(2008-10#5)(2008-7#3)(2009-7#1)(2010-6#1)(2012-3#1)
has not been proven##2##4##(1993-2#1)(1993-3#1)
has not been reported for##2##5##(2008-10#2)
has not been reported in any other##2##7##(2008-10#1)(2008-5#1)
has not been reported in##5##5##(1997-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
has not been reported##12##4##(1997-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#2)(2012-2#1)(2013-1#1)
has not been rigorously##2##4##(2008-10#1)(2009-7#1)
has not been studied##3##4##(1996-1#1)(2008-10#1)(2013-1#1)
has not been subjected to rigorous study##2##7##(2012-3#2)
has not been tested##3##4##(2008-8#2)(2013-8#1)
has not been well##4##4##(1991-12#1)(2008-11#1)(2008-12#1)(2009-8#1)
has not been##133##3##(1990-11#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-9#1)(2007-11#1)(2008-10#27)(2008-11#17)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#5)(2012-7#1)(2013-1#4)(2013-8#2)
has not changed##2##3##(1996-3#1)(2012-3#1)
has not had##2##3##(1992-2#1)(2010-6#1)
has not occurred##2##3##(2008-10#2)
has not only##2##3##(2008-1#1)(2013-1#1)
has not previously been reported##2##5##(2008-10#1)(2013-8#1)
has not previously been##4##4##(1994-1#1)(2008-10#1)(2008-12#1)(2013-8#1)
has not previously##5##3##(1994-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-8#1)
has not received##3##3##(1996-6#1)(2008-6#1)(2013-1#1)
has not shown any##2##4##(2012-3#2)
has not shown##3##3##(2012-3#2)(2013-1#1)
has not yet been detected##2##5##(2008-10#1)(2008-11#1)
has not yet been##16##4##(1993-3#1)(1993-9#1)(1996-12#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
has not yet##18##3##(1993-3#1)(1993-9#1)(1996-12#1)(1996-3#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
has not##196##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-6#2)(1995-12#3)(1995-2#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-9#1)(2007-11#1)(2008-1#1)(2008-10#40)(2008-11#22)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-6#4)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#10)(2012-7#1)(2013-1#10)(2013-8#4)
has now become##2##3##(2008-11#1)(2008-9#1)
has now been##7##3##(2008-10#1)(2008-11#1)(2009-12#1)(2010-12#3)(2011-2#1)
has now##14##2##(1992-5#1)(1994-11#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-12#2)(2010-12#3)(2011-2#2)
has occurred after##2##3##(1991-6#1)(1995-11#1)
has occurred in##3##3##(2008-10#1)(2009-7#1)(2011-1#1)
has occurred with the##2##4##(2008-10#1)(2009-7#1)
has occurred##18##2##(1991-6#1)(1992-1#1)(1994-2#1)(1995-11#1)(1997-1#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#2)(2011-1#1)
has offered##3##2##(2008-2#1)(2010-8#1)(2013-1#1)
has often been##6##3##(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2012-2#1)(2012-3#1)
has often##8##2##(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2012-2#1)(2012-3#1)
has on##7##2##(1994-3#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)
has one of the##2##4##(2008-10#1)(2008-11#1)
has one##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
has only a##2##3##(1997-6#1)(2008-8#1)
has only been reported##2##4##(2008-9#1)(2013-1#1)
has only been##4##3##(1991-11#1)(2008-9#1)(2009-7#1)(2013-1#1)
has only one##2##3##(2008-10#1)(2008-9#1)
has only recently been##3##4##(2007-12#1)(2008-5#1)(2011-1#1)
has only recently##5##3##(1992-1#1)(1993-1#1)(2007-12#1)(2008-5#1)(2011-1#1)
has only##18##2##(1990-11#1)(1991-11#1)(1992-1#1)(1993-1#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
has passed##3##2##(1995-12#1)(2008-10#2)
has permitted##2##2##(2008-10#1)(2008-11#1)
has played a##2##3##(2008-8#1)(2010-3#1)
has played##3##2##(2008-8#2)(2010-3#1)
has poor##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
has potent##3##2##(1994-2#1)(2008-5#1)(2013-7#1)
has potential applications in##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
has potential as a biological control agent for##2##8##(2008-10#2)
has potential as a##5##4##(2008-10#4)(2009-5#1)
has potential as##6##3##(2008-10#4)(2008-11#1)(2009-5#1)
has potential in##2##3##(2008-10#1)(2012-2#1)
has potential##17##2##(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)
has precluded##2##2##(2008-10#1)(2010-12#1)
has presented a##2##3##(1993-11#1)(2008-2#1)
has presented##4##2##(1993-11#1)(2008-10#2)(2008-2#1)
has prevailed##2##2##(2009-8#1)(2011-2#1)
has previously been described##2##4##(1990-6#1)(2008-10#1)
has previously been shown to be##2##6##(1993-12#1)(2008-6#1)
has previously been shown to##7##5##(1990-12#1)(1993-12#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
has previously been shown##8##4##(1990-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
has previously been##19##3##(1990-11#1)(1990-12#1)(1990-6#1)(1993-1#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)
has previously##21##2##(1990-11#1)(1990-12#1)(1990-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)
has probably##3##2##(1992-12#1)(2008-5#1)(2010-1#1)
has produced a##2##3##(1996-1#1)(2011-2#1)
has produced##8##2##(1996-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
has profound##2##2##(1995-2#1)(2009-9#1)
has progressed##3##2##(1992-3#1)(1995-2#1)(2008-10#1)
has promoted##2##2##(1997-2#1)(2011-2#1)
has prompted##9##2##(1993-12#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
has proposed a##2##3##(1995-6#1)(2010-8#1)
has proposed##3##2##(1992-2#1)(1995-6#1)(2010-8#1)
has proved to be a##4##5##(1991-11#1)(2008-10#1)(2008-9#1)(2011-7#1)
has proved to be the##2##5##(2008-10#1)(2010-8#1)
has proved to be##11##4##(1991-11#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-9#1)(2010-8#1)(2011-7#2)
has proved##22##2##(1991-11#1)(1991-12#1)(1997-7#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-8#1)(2011-2#1)(2011-7#2)
has proven a##2##3##(2008-11#1)(2008-9#1)
has proven the##2##3##(2008-10#1)(2011-1#1)
has proven to be a##6##5##(2008-10#2)(2008-11#1)(2008-9#1)(2010-7#1)(2012-2#1)
has proven to be more##2##5##(2008-6#1)(2012-2#1)
has proven to be##13##4##(1997-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#2)
has proven useful in##3##4##(2008-11#1)(2008-5#1)(2011-7#1)
has proven very difficult##2##4##(2008-4#1)(2008-9#1)
has proven##28##2##(1997-2#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#5)(2009-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-2#2)
has provided a##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
has provided an##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
has provided new##3##3##(1993-2#1)(1997-8#1)(2008-10#1)
has provided the##5##3##(1997-7#1)(2008-10#1)(2008-4#2)(2013-1#1)
has provided##26##2##(1991-2#2)(1993-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-6#2)(2008-9#2)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
has raised the##2##3##(1996-3#1)(2008-10#1)
has raised##7##2##(1992-9#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-3#1)
has rapidly##3##2##(2008-10#2)(2012-12#1)
has rarely been reported##4##4##(1991-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
has rarely been##7##3##(1991-8#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2013-8#1)
has reached a##3##3##(1991-3#1)(2008-11#1)(2008-3#1)
has reached the##2##3##(2008-10#1)(2010-12#1)
has reached##9##2##(1991-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#1)
has received attention##2##3##(2012-2#2)
has received little attention in##2##5##(2008-10#1)(2008-11#1)
has received no##2##3##(1991-5#1)(2013-1#1)
has received##18##2##(1990-6#1)(1991-5#1)(1992-8#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-2#2)(2013-1#2)
has recently become##2##3##(2008-8#1)(2008-9#1)
has recently been demonstrated##3##4##(1991-11#1)(1991-6#1)(2012-2#1)
has recently been identified as a##2##6##(1994-11#1)(1994-12#1)
has recently been identified as##3##5##(1994-11#1)(1994-12#1)(1996-2#1)
has recently been implicated in##2##5##(2008-10#1)(2011-2#1)
has recently been shown to##5##5##(1993-8#1)(1995-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
has recently been suggested##2##4##(2010-12#1)(2013-1#1)
has recently been##41##3##(1990-11#1)(1991-11#1)(1991-6#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1995-6#2)(1996-2#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-4#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-4#1)(2013-1#3)(2013-7#1)
has recently emerged##2##3##(2008-11#1)(2012-12#1)
has recently received##2##3##(2008-11#1)(2010-10#1)
has recently##62##2##(1990-11#1)(1991-11#1)(1991-6#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-4#1)(2013-1#3)(2013-7#1)
has reduced the##4##3##(1996-11#1)(1997-6#1)(2008-9#1)(2012-2#1)
has reduced##6##2##(1994-2#1)(1996-11#1)(1997-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
has relatively##3##2##(1992-12#1)(2008-10#1)(2012-2#1)
has relied##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
has remained a##2##3##(2010-10#1)(2010-12#1)
has remained at##2##3##(1996-11#1)(1997-8#1)
has remained constant##2##3##(1992-12#1)(1994-6#1)
has remained obscure##2##3##(1993-9#1)(2009-10#1)
has remained##19##2##(1991-11#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-11#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)
has repeatedly been##2##3##(1993-11#1)(2011-2#1)
has required##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)
has resulted in a##3##4##(2008-9#1)(2009-4#1)(2013-1#1)
has resulted in significant##2##4##(1996-3#1)(2009-10#1)
has resulted in the##6##4##(1996-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)
has resulted in##24##3##(1991-3#1)(1996-3#1)(1996-9#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
has revealed a##2##3##(2009-9#1)(2011-2#1)
has revealed only##2##3##(2008-10#1)(2010-5#1)
has revealed that##6##3##(1993-11#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-1#1)(2008-11#1)
has revealed the##2##3##(1997-3#1)(2008-6#1)
has revealed##21##2##(1993-11#1)(1993-6#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#3)
has revolutionized the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
has revolutionized##4##2##(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
has risen##5##2##(1995-1#1)(1997-7#1)(2008-12#1)(2008-3#2)
has ruled that the##2##4##(1995-12#1)(1995-6#1)
has ruled that##3##3##(1995-12#2)(1995-6#1)
has seen the##2##3##(1995-12#1)(2008-11#1)
has seen##6##2##(1992-1#1)(1995-12#1)(2008-11#2)(2011-2#1)(2012-12#1)
has serious##3##2##(1991-2#1)(2010-7#1)(2013-1#1)
has served as##2##3##(2008-4#1)(2011-1#1)
has several advantages over conventional##3##5##(2008-10#2)(2011-2#1)
has several advantages over##4##4##(2008-10#3)(2011-2#1)
has several characteristics that##2##4##(2008-8#1)(2012-3#1)
has several##17##2##(1991-6#1)(1995-5#1)(1996-2#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-3#3)(2013-1#1)
has severe##2##2##(2008-10#1)(2010-11#1)
has shifted to##2##3##(2007-11#1)(2013-8#1)
has shifted##4##2##(1994-3#1)(1995-12#1)(2007-11#1)(2013-8#1)
has shown a##4##3##(1991-12#1)(1994-8#1)(2008-10#1)(2008-12#1)
has shown in his##2##4##(2009-10#1)(2010-7#1)
has shown that the##7##4##(1992-2#1)(1996-2#1)(2008-10#3)(2008-5#1)(2010-6#1)
has shown that this##2##4##(1994-11#1)(1995-8#1)
has shown that##41##3##(1990-11#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
has shown the best##2##4##(2008-10#2)
has shown the##3##3##(2008-10#3)
has shown to##2##3##(2008-10#1)(2010-11#1)
has shown##67##2##(1990-11#1)(1991-12#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-8#3)(1995-1#1)(1995-5#1)(1995-8#1)(1996-2#3)(1997-2#1)(1997-3#2)(1997-4#1)(2007-11#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
has significant##12##2##(1992-4#1)(1992-7#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
has significantly higher##2##3##(2010-6#1)(2011-2#1)
has significantly##7##2##(2008-10#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#1)
has similar##4##2##(2008-10#3)(2008-8#1)
has similarities to##2##3##(1990-5#1)(1996-6#1)
has similarities##3##2##(1990-5#1)(1996-2#1)(1996-6#1)
has since been##2##3##(2008-1#1)(2012-3#1)
has since##8##2##(1991-2#1)(1992-2#1)(1996-11#1)(1996-5#1)(2008-1#1)(2010-1#2)(2012-3#1)
has slowed##2##2##(1994-11#1)(1997-2#1)
has so##2##2##(1993-2#1)(2009-10#1)
has some##8##2##(1992-2#1)(1993-3#2)(2008-10#3)(2008-7#1)(2013-1#1)
has sparked##2##2##(1994-11#1)(1995-1#1)
has specific##2##2##(2008-10#1)(2010-4#1)
has specified##2##2##(1995-9#1)(2008-8#1)
has spread##3##2##(1996-11#1)(2008-10#1)(2010-7#1)
has spurred the##2##3##(2008-4#1)(2008-8#1)
has spurred##3##2##(1990-8#1)(2008-4#1)(2008-8#1)
has still##3##2##(2008-11#2)(2010-12#1)
has stimulated research##2##3##(1991-12#1)(1994-12#1)
has stimulated##4##2##(1991-12#1)(1994-12#1)(2008-10#1)(2010-11#1)
has strong implications##2##3##(2010-10#1)(2011-2#1)
has strong influence on##2##4##(2008-10#2)
has strong##7##2##(1995-12#1)(2008-10#2)(2010-10#2)(2010-4#1)(2011-2#1)
has stronger##3##2##(1997-1#2)(2008-10#1)
has structural##2##2##(1990-10#1)(2009-10#1)
has subsequently been##2##3##(1995-8#1)(2011-2#1)
has subsequently##4##2##(1995-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
has substantial##4##2##(1995-8#1)(2008-11#1)(2008-8#1)(2010-10#1)
has suffered from##2##3##(1993-6#1)(1996-3#1)
has suffered##4##2##(1993-6#1)(1996-3#2)(2012-3#1)
has suggested that the##3##4##(1994-2#1)(2009-7#1)(2011-2#1)
has suggested that##7##3##(1994-2#2)(2008-11#1)(2009-7#1)(2011-2#2)(2013-8#1)
has suggested##10##2##(1994-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-2#1)(2011-2#2)(2013-8#1)
has survived##2##2##(1990-6#1)(2008-10#1)
has taken##5##2##(1995-2#1)(1995-3#1)(2008-10#2)(2008-12#1)
has tended to##2##3##(2008-11#1)(2008-12#1)
has the ability to##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
has the ability##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
has the advantage of a##2##5##(2008-10#1)(2013-1#1)
has the advantage of being##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
has the advantage of reduced access site complications but is associated with specific technical challenges in comparison with the transfemoral approach##2##21##(2011-2#2)
has the advantage of##21##4##(1991-3#1)(1994-3#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2011-2#3)(2013-1#1)
has the advantage that##2##4##(2008-10#1)(2008-9#1)
has the advantage##23##3##(1991-3#1)(1994-3#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#3)(2011-2#3)(2013-1#1)
has the advantages of##10##4##(1990-12#1)(1997-3#1)(2008-10#6)(2009-10#1)(2010-6#1)
has the best##2##3##(1993-1#1)(1997-3#1)
has the capacity for##2##4##(2008-10#2)
has the capacity to##2##4##(1997-3#1)(2011-2#1)
has the capacity##4##3##(1997-3#1)(2008-10#2)(2011-2#1)
has the following##3##3##(2008-12#1)(2008-6#1)(2008-8#1)
has the highest cleavage##2##4##(2008-9#2)
has the highest incidence##2##4##(1991-11#1)(1994-9#1)
has the highest sensitivity##2##4##(2008-10#1)(2012-2#1)
has the highest##14##3##(1991-11#1)(1994-9#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#4)(2012-2#1)(2013-8#1)
has the lowest##2##3##(2008-3#1)(2008-9#1)
has the most##2##3##(2008-10#1)(2011-2#1)
has the possibility of##3##4##(2011-3#1)(2013-1#2)
has the possibility##4##3##(2008-10#1)(2011-3#1)(2013-1#2)
has the potential for##5##4##(2008-11#2)(2008-5#1)(2008-9#1)(2010-5#1)
has the potential of##3##4##(2008-10#2)(2012-2#1)
has the potential to be a##2##6##(2008-10#1)(2012-2#1)
has the potential to be##6##5##(2008-10#4)(2012-2#2)
has the potential to become##2##5##(2008-10#1)(2011-7#1)
has the potential to provide a##2##6##(2011-7#1)(2012-2#1)
has the potential to provide##3##5##(2008-9#1)(2011-7#1)(2012-2#1)
has the potential to reduce##3##5##(2008-10#1)(2010-1#1)(2013-1#1)
has the potential to significantly##2##5##(2008-11#1)(2008-2#1)
has the potential to##37##4##(1994-11#1)(1995-12#1)(1995-2#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-9#1)(2011-2#2)(2011-7#4)(2012-2#3)(2012-3#2)(2013-1#1)
has the potential##45##3##(1994-11#1)(1995-12#1)(1995-2#1)(2008-10#12)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#4)(2009-10#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-7#4)(2012-2#4)(2012-3#2)(2013-1#1)
has the same spectral characteristics as##2##6##(2008-2#1)(2008-9#1)
has the same##8##3##(1994-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)
has the unique##2##3##(2008-4#1)(2012-2#1)
has the##171##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-7#2)(1991-11#1)(1991-3#1)(1993-1#1)(1993-12#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-9#1)(1997-3#3)(1997-8#1)(2007-12#1)(2008-10#48)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#16)(2009-10#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#7)(2011-3#1)(2011-7#4)(2012-2#7)(2012-3#2)(2013-1#9)(2013-8#3)
has therapeutic##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
has therefore been##10##3##(2008-10#1)(2008-11#6)(2008-7#1)(2010-10#1)(2012-3#1)
has therefore##11##2##(1991-12#1)(2008-10#1)(2008-11#6)(2008-7#1)(2010-10#1)(2012-3#1)
has three goals##3##3##(1995-12#1)(1996-1#1)(2008-9#1)
has three##7##2##(1991-6#1)(1994-5#1)(1995-12#2)(1996-1#1)(2008-5#1)(2008-9#1)
has thus##3##2##(1990-2#1)(2008-10#1)(2008-9#1)
has to be considered##4##4##(1993-11#1)(2008-10#1)(2008-11#2)
has to be established##2##4##(1997-8#1)(2008-11#1)
has to be estimated##2##4##(1996-3#1)(2008-11#1)
has to be made##2##4##(1996-3#1)(2009-10#1)
has to be taken into account##3##6##(1994-3#1)(2008-11#1)(2008-5#1)
has to be##50##3##(1990-6#1)(1990-9#2)(1993-11#2)(1994-3#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-8#1)(2008-10#12)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#3)
has to##64##2##(1990-6#1)(1990-9#2)(1991-3#1)(1993-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#12)(2008-11#12)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2013-1#3)(2013-8#1)
has traditionally been a##2##4##(1991-2#1)(1991-3#1)
has traditionally been##9##3##(1991-2#1)(1991-3#1)(2008-10#1)(2008-7#2)(2008-9#2)(2010-6#1)(2011-2#1)
has traditionally##10##2##(1991-2#1)(1991-3#1)(2008-10#1)(2008-7#2)(2008-9#2)(2009-11#1)(2010-6#1)(2011-2#1)
has turned##4##2##(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#1)
has two##20##2##(1992-6#1)(1994-2#1)(1994-5#1)(1997-7#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)
has undergone a##2##3##(1996-3#1)(2008-11#1)
has undergone##8##2##(1994-12#1)(1996-3#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)
has undoubtedly##2##2##(2008-12#1)(2008-7#1)
has until##2##2##(2008-10#1)(2008-11#1)
has used##6##2##(1993-2#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-3#1)
has ushered in##2##3##(2008-9#1)(2010-12#1)
has ushered##3##2##(2008-3#1)(2008-9#1)(2010-12#1)
has usually been##2##3##(1996-11#1)(2008-10#1)
has usually##3##2##(1996-11#1)(2008-10#2)
has validated the##2##3##(2008-10#1)(2008-11#1)
has very high##2##3##(2008-10#1)(2008-2#1)
has very low##2##3##(2008-10#1)(2012-12#1)
has very##9##2##(1997-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2012-12#1)(2012-2#1)
has worked##3##2##(1994-1#1)(1996-3#1)(2013-1#1)
has yet been##5##3##(2008-1#1)(2008-10#2)(2010-10#1)(2013-8#1)
has yet to be determined##3##5##(1994-8#1)(1995-2#1)(2009-12#1)
has yet to be established##2##5##(2009-5#1)(2012-12#1)
has yet to be identified##2##5##(1995-2#1)(2011-2#1)
has yet to be##12##4##(1994-8#1)(1995-2#2)(1995-5#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
has yet to##15##3##(1994-8#1)(1995-2#2)(1995-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
has yet##21##2##(1994-8#1)(1995-2#2)(1995-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
has yielded##6##2##(1990-8#1)(1994-5#1)(2008-10#2)(2012-2#2)
has##6818##1##(1990-10#1)(1990-11#30)(1990-12#15)(1990-2#14)(1990-3#9)(1990-5#26)(1990-6#20)(1990-7#2)(1990-8#18)(1990-9#19)(1991-1#4)(1991-10#2)(1991-11#17)(1991-12#35)(1991-2#36)(1991-3#39)(1991-4#1)(1991-5#18)(1991-6#25)(1991-7#4)(1991-8#4)(1991-9#12)(1992-1#21)(1992-10#9)(1992-11#8)(1992-12#24)(1992-2#21)(1992-3#22)(1992-4#6)(1992-5#9)(1992-6#15)(1992-7#3)(1992-8#9)(1992-9#19)(1993-1#12)(1993-11#15)(1993-12#30)(1993-2#30)(1993-3#29)(1993-6#15)(1993-8#17)(1993-9#14)(1994-1#14)(1994-11#18)(1994-12#40)(1994-2#30)(1994-3#23)(1994-5#32)(1994-6#12)(1994-8#25)(1994-9#14)(1995-1#15)(1995-10#2)(1995-11#13)(1995-12#49)(1995-2#36)(1995-3#19)(1995-5#13)(1995-6#38)(1995-8#15)(1995-9#8)(1996-1#28)(1996-11#15)(1996-12#18)(1996-2#38)(1996-3#50)(1996-5#18)(1996-6#17)(1996-8#7)(1996-9#9)(1997-1#34)(1997-2#31)(1997-3#31)(1997-4#16)(1997-5#11)(1997-6#26)(1997-7#41)(1997-8#36)(1997-9#4)(2006-5#2)(2006-6#4)(2007-11#11)(2007-12#24)(2007-8#6)(2008-1#45)(2008-10#2167)(2008-11#475)(2008-12#103)(2008-2#33)(2008-3#137)(2008-4#61)(2008-5#148)(2008-6#38)(2008-7#168)(2008-8#159)(2008-9#192)(2009-1#11)(2009-10#40)(2009-11#12)(2009-12#29)(2009-3#14)(2009-4#13)(2009-5#18)(2009-6#21)(2009-7#24)(2009-8#48)(2009-9#14)(2010-1#23)(2010-10#34)(2010-11#29)(2010-12#60)(2010-2#4)(2010-3#12)(2010-4#20)(2010-5#18)(2010-6#36)(2010-7#40)(2010-8#39)(2010-9#11)(2011-1#25)(2011-10#2)(2011-2#260)(2011-3#27)(2011-4#2)(2011-7#15)(2011-9#1)(2012-12#36)(2012-2#154)(2012-3#118)(2012-4#2)(2012-5#4)(2012-7#5)(2012-8#1)(2013-1#194)(2013-2#1)(2013-3#1)(2013-7#10)(2013-8#92)
hasn't been##2##2##(1992-5#1)(1996-3#1)
hastened the##2##2##(1997-2#1)(2009-8#1)
hastened##3##1##(1995-6#1)(1997-2#1)(2009-8#1)
hasty##2##1##(1990-11#1)(2008-10#1)
hatch##7##1##(1991-9#1)(1996-8#1)(2008-12#3)(2008-6#1)(2010-8#1)
hatchability and##2##2##(2008-12#2)
hatched##13##1##(1992-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#2)(2010-8#2)
hatchery##3##1##(1990-3#1)(2009-6#1)(2010-8#1)
hatching rate##2##2##(2010-8#2)
hatching success##2##2##(2008-8#2)
hatching##18##1##(1993-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#5)(2010-8#3)
hatchling##3##1##(2008-8#3)
hatchlings##3##1##(2008-8#3)
hausmannite##2##1##(2008-10#2)
haustoria##8##1##(2008-10#8)
haustorium##6##1##(2008-10#6)
have a beneficial effect on##3##5##(1991-11#1)(2011-2#1)(2012-3#1)
have a beneficial##4##3##(1991-11#1)(2009-8#1)(2011-2#1)(2012-3#1)
have a better understanding of the##2##6##(1990-9#1)(2008-10#1)
have a better##4##3##(1990-9#1)(1991-2#1)(2008-10#1)(2009-3#1)
have a biochemical##2##3##(1997-7#1)(2008-4#1)
have a broad range of##2##5##(1996-2#1)(2008-5#1)
have a broad##4##3##(1996-2#1)(2008-5#1)(2011-2#1)(2011-3#1)
have a common##3##3##(1995-8#1)(2008-4#1)(2008-8#1)
have a comprehensive##2##3##(1996-8#1)(2012-2#1)
have a defined##3##3##(1996-12#1)(2009-6#1)(2012-2#1)
have a different##2##3##(2008-10#1)(2012-2#1)
have a direct##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
have a distinct##3##3##(2008-11#2)(2011-2#1)
have a fast##2##3##(2008-10#2)
have a favorable##2##3##(1992-11#1)(2013-1#1)
have a favourable##2##3##(1991-6#1)(1996-6#1)
have a genetic##2##3##(1994-11#1)(2012-2#1)
have a good##6##3##(1994-3#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
have a great##4##3##(1992-6#1)(2008-10#2)(2008-11#1)
have a greater##6##3##(1992-9#1)(1997-1#1)(1997-6#1)(2008-10#1)(2009-8#1)(2012-2#1)
have a high index of suspicion##2##6##(2008-9#1)(2013-8#1)
have a high##18##3##(1990-3#1)(1992-6#1)(1993-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
have a higher risk of##7##5##(1996-9#1)(2008-12#2)(2009-5#1)(2010-10#1)(2010-12#1)(2013-1#1)
have a higher##20##3##(1995-3#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
have a history of##3##4##(1993-3#1)(2010-10#1)(2011-2#1)
have a known##2##3##(2008-10#1)(2008-7#1)
have a large impact##2##4##(1994-12#1)(2008-10#1)
have a large##7##3##(1993-3#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
have a left##2##3##(1996-2#1)(2011-2#1)
have a limited role##2##4##(1995-10#1)(2008-10#1)
have a limited##3##3##(1992-3#1)(1995-10#1)(2008-10#1)
have a long history of##2##5##(2008-11#1)(2013-1#1)
have a low##5##3##(1991-11#1)(1997-1#1)(2008-10#1)(2009-7#1)(2013-1#1)
have a lower##2##3##(1991-3#1)(2012-2#1)
have a major role in the##2##6##(1996-12#1)(1997-3#1)
have a major role in##4##5##(1996-12#1)(1997-3#1)(2010-4#1)(2011-3#1)
have a major##7##3##(1996-12#1)(1997-3#1)(1997-8#1)(2010-4#2)(2011-3#1)(2013-1#1)
have a minor##2##3##(2008-10#1)(2011-1#1)
have a more##6##3##(1990-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-9#1)
have a much greater##2##4##(1993-8#1)(2012-5#1)
have a much##4##3##(1993-8#1)(2008-3#1)(2012-5#1)(2013-8#1)
have a negative effect on##3##5##(1992-5#1)(1993-6#1)(2008-10#1)
have a negative##4##3##(1992-5#1)(1993-6#1)(2007-12#1)(2008-10#1)
have a number of##3##4##(1994-12#1)(2008-6#1)(2012-3#1)
have a poor##2##3##(1996-1#1)(1996-11#1)
have a positive##9##3##(1995-5#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
have a potential role##2##4##(2011-2#1)(2013-1#1)
have a potential##4##3##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
have a prevalence##2##3##(2008-8#1)(2013-8#1)
have a profound##3##3##(2008-7#1)(2010-6#1)(2010-7#1)
have a protective effect on##3##5##(1992-12#1)(2008-12#1)(2008-7#1)
have a protective effect##5##4##(1992-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
have a protective role##2##4##(1997-2#1)(2011-2#1)
have a protective##7##3##(1992-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)
have a reduced level of##2##5##(2010-1#1)(2012-12#1)
have a reduced##4##3##(2008-7#1)(2010-1#1)(2010-4#1)(2012-12#1)
have a relatively##3##3##(1990-8#1)(2008-8#2)
have a residual##3##3##(2008-10#2)(2009-3#1)
have a right to##3##4##(1994-8#1)(1995-12#1)(2008-12#1)
have a role in the##3##5##(1993-11#1)(1996-2#1)(2008-10#1)
have a role in##18##4##(1992-12#1)(1993-11#1)(1994-11#1)(1996-2#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#2)(2013-8#3)
have a role to play in##3##6##(1997-2#1)(2008-5#1)(2010-10#1)
have a role to##4##4##(1997-2#1)(2008-5#1)(2009-6#1)(2010-10#1)
have a role##22##3##(1992-12#1)(1993-11#1)(1994-11#1)(1996-2#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#2)(2009-6#2)(2010-10#1)(2011-2#2)(2013-8#3)
have a selective##3##3##(1995-6#1)(2008-8#2)
have a significant effect on##3##5##(1995-12#1)(2007-11#1)(2008-2#1)
have a significant effect##4##4##(1995-12#1)(2007-11#1)(2008-11#1)(2008-2#1)
have a significant impact on the##3##6##(2008-1#1)(2008-3#1)(2008-5#1)
have a significant impact on##5##5##(2008-1#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
have a significant influence on##3##5##(2008-5#2)(2013-8#1)
have a significant role in##2##5##(2011-1#1)(2013-1#1)
have a significant##18##3##(1995-12#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-1#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
have a significantly##2##3##(2008-7#1)(2012-2#1)
have a similar##4##3##(1997-3#1)(2008-10#2)(2010-11#1)
have a single##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
have a slightly##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
have a small##5##3##(1991-6#1)(1994-5#1)(2008-10#2)(2013-1#1)
have a smaller##2##3##(2008-11#1)(2008-9#1)
have a specific##4##3##(1993-12#1)(1997-2#2)(2008-11#1)
have a strong##6##3##(1994-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)
have a synergistic effect##2##4##(2008-11#2)
have a tendency to##4##4##(1997-8#1)(2008-1#1)(2008-8#1)(2011-2#1)
have a variety of##3##4##(1991-12#1)(2011-2#1)(2012-3#1)
have a very##3##3##(2008-10#2)(2008-3#1)
have a wide##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
have a##453##2##(1990-2#1)(1990-3#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#4)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#5)(1993-6#2)(1993-8#6)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#3)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#56)(2008-11#30)(2008-12#12)(2008-2#6)(2008-3#10)(2008-4#5)(2008-5#16)(2008-6#3)(2008-7#16)(2008-8#11)(2008-9#10)(2009-1#1)(2009-10#6)(2009-3#2)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#28)(2011-3#3)(2012-12#5)(2012-2#15)(2012-3#11)(2012-5#1)(2013-1#15)(2013-8#12)
have abnormal##2##2##(2006-5#1)(2008-9#1)
have absorption##2##2##(2008-10#1)(2008-3#1)
have accelerated the##2##3##(2008-10#1)(2008-11#1)
have accelerated##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
have acceptable##2##2##(2009-7#1)(2010-7#1)
have access to the##3##4##(1994-5#1)(1996-2#1)(2008-10#1)
have access to##10##3##(1994-5#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)
have accounted for##3##3##(1991-12#1)(1991-2#1)(1992-1#1)
have accumulated##5##2##(1992-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
have achieved the##2##3##(1995-2#1)(2010-7#1)
have achieved##9##2##(1993-3#1)(1995-2#1)(2008-11#1)(2008-3#2)(2008-6#1)(2010-10#1)(2010-7#1)(2010-8#1)
have acquired##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
have actually##2##2##(2008-9#1)(2013-1#1)
have adapted##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
have added##2##2##(1994-1#1)(1997-1#1)
have additional##2##2##(2008-10#1)(2012-3#1)
have addressed##3##2##(1994-6#1)(1995-11#1)(2008-9#1)
have adequate##5##2##(1990-2#1)(1992-2#1)(2008-11#1)(2008-12#1)(2010-1#1)
have adopted a##2##3##(2008-9#1)(2009-3#1)
have adopted this##2##3##(2008-12#1)(2008-7#1)
have adopted##8##2##(1994-12#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-5#1)
have advanced to##2##3##(2010-4#1)(2013-8#1)
have advanced##3##2##(2009-3#1)(2010-4#1)(2013-8#1)
have advantages##6##2##(1997-3#1)(2008-10#3)(2008-7#1)(2009-1#1)
have adverse effects on##2##4##(1994-12#1)(2008-7#1)
have adverse##4##2##(1992-2#1)(1994-12#1)(2008-10#1)(2008-7#1)
have affected##2##2##(1991-3#1)(2012-2#1)
have all been##5##3##(1990-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
have all##8##2##(1990-11#1)(1992-7#1)(1993-12#1)(1994-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
have allowed the##2##3##(2008-11#1)(2008-3#1)
have allowed##5##2##(1991-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
have already been cloned##2##4##(1996-2#1)(2011-1#1)
have already been##11##3##(1990-12#1)(1993-8#1)(1996-2#2)(1997-6#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
have already##19##2##(1990-12#1)(1993-11#1)(1993-8#1)(1996-2#3)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-6#1)
have also been applied##2##4##(2008-10#2)
have also been compared##2##4##(2008-10#2)
have also been described##4##4##(2008-11#1)(2008-7#1)(2011-2#2)
have also been determined##2##4##(2008-10#2)
have also been found##2##4##(1996-9#1)(2008-11#1)
have also been implicated in##2##5##(2011-2#1)(2013-8#1)
have also been investigated##3##4##(2008-10#2)(2010-1#1)
have also been observed in##2##5##(1994-3#1)(2008-11#1)
have also been observed##3##4##(1994-3#1)(2008-10#1)(2008-11#1)
have also been reported##2##4##(2008-10#1)(2008-5#1)
have also been shown to##4##5##(2008-9#1)(2009-8#1)(2010-7#1)(2012-12#1)
have also been studied extensively##2##5##(2010-5#1)(2012-2#1)
have also been studied##6##4##(2008-10#3)(2008-6#1)(2010-5#1)(2012-2#1)
have also been used as##2##5##(2008-10#2)
have also been used##4##4##(2008-10#3)(2009-10#1)
have also been##65##3##(1992-2#1)(1994-3#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-9#1)(2007-11#1)(2008-10#25)(2008-11#10)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
have also demonstrated a##2##4##(2008-2#1)(2012-12#1)
have also demonstrated the##2##4##(2008-10#1)(2008-5#1)
have also demonstrated##6##3##(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)
have also evolved##2##3##(2008-8#1)(2010-6#1)
have also found##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
have also observed##2##3##(2008-3#1)(2009-1#1)
have also played an important role in##2##7##(2008-1#1)(2012-2#1)
have also shown that##2##4##(2008-10#2)
have also shown##4##3##(1993-11#1)(2008-10#2)(2012-3#1)
have also##105##2##(1990-11#1)(1991-5#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#32)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
have altered##4##2##(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
have always##4##2##(1993-12#1)(2008-10#1)(2008-12#2)
have an N-terminal##2##3##(1993-12#1)(1997-4#1)
have an abundance of##2##4##(1992-7#1)(2008-5#1)
have an advantage##2##3##(2008-11#1)(2008-8#1)
have an adverse effect on the##2##6##(2008-10#1)(2012-2#1)
have an adverse effect on##3##5##(1997-2#1)(2008-10#1)(2012-2#1)
have an adverse effect##4##4##(1995-3#1)(1997-2#1)(2008-10#1)(2012-2#1)
have an aggressive##2##3##(2008-9#1)(2013-7#1)
have an effect on the##3##5##(1996-11#1)(2008-12#1)(2012-2#1)
have an effect on##6##4##(1996-11#1)(2008-11#1)(2008-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
have an effect##7##3##(1996-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
have an enhanced##2##3##(1994-8#1)(2010-8#1)
have an established##2##3##(2008-5#1)(2011-2#1)
have an impact on the##4##5##(2008-11#2)(2012-2#2)
have an impact on##10##4##(1991-7#1)(2008-11#3)(2008-5#1)(2011-2#1)(2012-2#4)
have an important role in the##2##6##(1993-2#1)(2008-11#1)
have an important role in##5##5##(1993-2#1)(1994-2#1)(2008-11#1)(2008-8#1)(2009-6#1)
have an important role to play in the##3##8##(1992-3#1)(2008-11#1)(2012-12#1)
have an important role##9##4##(1992-3#1)(1993-2#1)(1994-2#1)(2008-11#2)(2008-8#1)(2009-6#1)(2012-12#1)(2012-3#1)
have an important##16##3##(1992-3#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-6#1)(2012-12#1)(2012-3#1)
have an increased risk of##4##5##(1990-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
have an increased risk##6##4##(1990-12#1)(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#1)(2012-3#1)
have an increased##8##3##(1990-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
have an influence on##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
have an inhibitory effect on##2##5##(1994-8#1)(2008-10#1)
have an interfering effect##2##4##(2008-10#2)
have an unusual##2##3##(1995-6#1)(2008-7#1)
have an##121##2##(1990-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-4#3)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#15)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#7)(2008-7#5)(2008-8#4)(2008-9#3)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#2)(2013-7#1)
have analysed the##5##3##(1994-12#1)(1995-11#1)(1996-3#1)(1997-7#1)(2009-12#1)
have analysed##6##2##(1994-12#1)(1995-11#1)(1996-3#1)(1997-7#2)(2009-12#1)
have analyzed the effects of##2##5##(2008-11#1)(2008-3#1)
have analyzed the##7##3##(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(2008-11#1)(2008-3#1)(2010-5#1)
have analyzed##10##2##(1990-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
have and##2##2##(2008-10#1)(2013-8#1)
have any adverse##2##3##(2008-11#2)
have any effect on the##3##5##(1994-5#1)(1994-6#1)(2008-10#1)
have any##17##2##(1990-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-11#1)(2008-10#6)(2008-11#3)(2008-12#1)(2011-3#1)
have apparently##2##2##(1993-12#1)(1997-3#1)
have applications in##2##3##(2011-7#1)(2012-2#1)
have applied##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)
have approximately 50%##2##3##(1992-6#1)(1995-2#1)
have approximately##5##2##(1990-11#1)(1992-6#1)(1994-6#1)(1995-2#1)(2009-3#1)
have argued that##3##3##(1995-5#2)(2008-11#1)
have argued##4##2##(1995-2#1)(1995-5#2)(2008-11#1)
have arisen from##5##3##(1995-3#1)(2008-10#2)(2010-11#1)(2010-3#1)
have arisen independently##3##3##(1997-7#1)(2008-10#2)
have arisen##13##2##(1994-11#1)(1995-3#1)(1997-7#1)(2008-10#6)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#1)
have assayed##2##2##(1990-5#1)(2008-11#1)
have assessed the##2##3##(2008-12#1)(2012-2#1)
have assessed##3##2##(1993-2#1)(2008-12#1)(2012-2#1)
have associated##2##2##(2008-10#1)(2012-2#1)
have assumed##3##2##(1994-9#1)(1997-7#1)(2008-10#1)
have asthma##2##2##(2012-12#2)
have at least one##3##4##(1993-2#1)(2008-10#1)(2008-11#1)
have at least##5##3##(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
have at##6##2##(1993-2#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
have attempted to##9##3##(1990-5#1)(1991-3#1)(1995-12#1)(2008-11#1)(2011-2#2)(2012-12#2)(2012-3#1)
have attempted##10##2##(1990-5#1)(1991-3#1)(1994-11#1)(1995-12#1)(2008-11#1)(2011-2#2)(2012-12#2)(2012-3#1)
have average##2##2##(1992-12#1)(2009-3#1)
have become a major##2##4##(2008-11#1)(2010-7#1)
have become a##5##3##(1996-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)
have become available to##2##4##(2008-11#1)(2010-7#1)
have become available##6##3##(2008-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
have become increasingly##7##3##(1995-3#1)(2008-10#3)(2008-9#1)(2009-6#1)(2012-2#1)
have become more##4##3##(1991-12#1)(2009-12#1)(2012-12#1)(2012-2#1)
have become of##2##3##(2008-11#1)(2011-2#1)
have become the##6##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#2)
have become widely##2##3##(1996-1#1)(2011-2#1)
have become##52##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-3#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#3)(2010-9#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#2)
have been a number of##5##5##(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
have been a##14##3##(1990-6#1)(1994-3#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
have been able to##7##4##(1994-9#1)(2008-11#2)(2008-5#2)(2010-8#1)(2012-2#1)
have been achieved in##2##4##(2008-11#1)(2011-2#1)
have been achieved##19##3##(1993-1#1)(1995-12#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#1)
have been acquired##7##3##(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)
have been adapted to##2##4##(2008-11#1)(2010-7#1)
have been adapted##3##3##(1995-12#1)(2008-11#1)(2010-7#1)
have been added to##4##4##(2008-10#2)(2008-3#1)(2013-7#1)
have been also studied##2##4##(2008-10#1)(2010-7#1)
have been also##6##3##(2008-10#5)(2010-7#1)
have been an##2##3##(1990-3#1)(2013-8#1)
have been analysed by##2##4##(2008-10#2)
have been analysed for##2##4##(2008-10#2)
have been analysed##8##3##(2008-10#8)
have been analyzed by##3##4##(1992-2#1)(1992-9#1)(2008-10#1)
have been analyzed in##2##4##(1991-5#1)(1994-3#1)
have been analyzed##9##3##(1991-5#1)(1992-2#1)(1992-9#1)(1994-3#1)(2008-10#4)(2008-3#1)
have been applied in the##3##5##(2008-10#3)
have been applied in##7##4##(2008-10#5)(2008-8#1)(2010-12#1)
have been applied to the##5##5##(1992-3#1)(2008-10#3)(2008-8#1)
have been applied to##14##4##(1992-3#2)(2008-10#8)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)
have been applied##28##3##(1992-3#2)(1996-3#1)(2008-10#18)(2008-11#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)
have been appreciated for##2##4##(2008-8#1)(2008-9#1)
have been approved by the##2##5##(2011-2#2)
have been approved##6##3##(2009-8#1)(2011-2#2)(2011-3#1)(2012-2#2)
have been assayed##2##3##(2008-10#2)
have been assessed in##2##4##(2008-10#1)(2008-5#1)
have been assessed##5##3##(2008-10#3)(2008-5#1)(2008-9#1)
have been assigned to the##3##5##(1996-6#1)(2007-12#1)(2008-7#1)
have been assigned to##5##4##(1996-6#1)(2007-12#1)(2008-5#2)(2008-7#1)
have been assigned##7##3##(1993-8#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)
have been associated with##5##4##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
have been associated##7##3##(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
have been attracting##2##3##(2009-8#1)(2010-7#1)
have been attributed to##7##4##(1991-3#1)(1995-3#1)(2008-10#2)(2008-5#1)(2009-3#1)(2012-2#1)
have been available for##4##4##(1994-2#1)(1995-11#1)(2008-5#1)(2008-9#1)
have been available##6##3##(1991-12#1)(1994-2#1)(1995-11#1)(2008-5#1)(2008-9#1)(2010-12#1)
have been born##2##3##(1991-6#1)(1993-12#1)
have been built##2##3##(2008-11#1)(2008-3#1)
have been calculated and##2##4##(2008-10#1)(2008-3#1)
have been calculated##10##3##(1992-9#1)(1997-4#1)(2008-10#7)(2008-3#1)
have been carefully##2##3##(1990-5#1)(2008-10#1)
have been carried out at##2##5##(1997-6#1)(2008-10#1)
have been carried out in the##2##6##(2008-10#1)(2011-2#1)
have been carried out in##5##5##(1994-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
have been carried out on##2##5##(2008-10#2)
have been carried out to##2##5##(2008-11#1)(2008-7#1)
have been carried out using##2##5##(2008-10#1)(2010-7#1)
have been carried out##23##4##(1990-3#1)(1994-5#1)(1997-6#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)
have been carried##24##3##(1990-3#1)(1994-5#1)(1997-6#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)
have been categorized##2##3##(2008-10#1)(2013-1#1)
have been caused by##3##4##(1993-1#1)(2007-9#1)(2008-8#1)
have been characterised##3##3##(1996-2#1)(2008-10#2)
have been characterized by##5##4##(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)
have been characterized for##2##4##(2008-10#1)(2010-4#1)
have been characterized in##3##4##(1993-2#1)(2008-10#1)(2012-2#1)
have been characterized with##2##4##(2008-10#2)
have been characterized##18##3##(1993-2#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-4#1)(2011-1#1)(2012-2#1)
have been chosen as##2##4##(1991-5#1)(2008-10#1)
have been chosen##3##3##(1991-5#1)(2008-10#2)
have been classified##2##3##(2012-3#2)
have been clearly##2##3##(1990-11#1)(2008-10#1)
have been cloned and sequenced##2##5##(1993-12#1)(2008-8#1)
have been cloned and##3##4##(1993-12#1)(2008-7#1)(2008-8#1)
have been cloned from##2##4##(1996-2#1)(2008-8#1)
have been cloned##11##3##(1993-12#2)(1996-2#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)
have been collected and##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
have been collected during##2##4##(1994-8#1)(2008-12#1)
have been collected##10##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
have been compared at the same##2##6##(2008-3#2)
have been compared for##4##4##(1995-11#1)(2008-10#3)
have been compared to##4##4##(2008-10#2)(2008-11#2)
have been compared with##5##4##(2008-10#4)(2008-3#1)
have been compared##20##3##(1995-11#1)(2008-10#13)(2008-11#3)(2008-3#3)
have been completely##2##3##(2012-3#1)(2013-1#1)
have been conducted in##4##4##(2008-10#1)(2011-2#1)(2013-1#2)
have been conducted on##2##4##(2008-10#1)(2011-2#1)
have been conducted to##2##4##(2008-6#1)(2010-12#1)
have been conducted##14##3##(2008-10#5)(2008-11#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#3)
have been confirmed##3##3##(2008-10#2)(2009-12#1)
have been conflicting##2##3##(2009-12#1)(2010-12#1)
have been considered a##2##4##(2011-2#1)(2013-1#1)
have been considered as##3##4##(2008-11#1)(2009-6#1)(2010-5#1)
have been considered##8##3##(1995-2#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
have been constructed for##2##4##(1997-6#1)(2011-2#1)
have been constructed to##3##4##(2008-11#1)(2008-12#1)(2008-8#1)
have been constructed##9##3##(1993-12#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)
have been correlated with##4##4##(1991-6#1)(1997-6#1)(2008-9#1)(2012-3#1)
have been correlated##5##3##(1991-6#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-3#1)
have been created that##2##4##(2008-11#1)(2010-6#1)
have been created##3##3##(2008-11#1)(2010-6#2)
have been criticized##4##3##(1991-1#1)(1994-12#1)(1996-1#1)(2008-10#1)
have been debated##2##3##(1996-3#1)(2008-8#1)
have been deduced by non-linear regression analysis##2##7##(2008-10#2)
have been deduced##3##3##(2008-10#3)
have been defined in##2##4##(2012-2#1)(2012-3#1)
have been defined##6##3##(1991-11#1)(2008-3#1)(2010-8#2)(2012-2#1)(2012-3#1)
have been demonstrated by##2##4##(1994-5#1)(2008-3#1)
have been demonstrated in##2##4##(1992-5#1)(1993-11#1)
have been demonstrated to be##4##5##(1995-6#1)(2008-10#2)(2010-5#1)
have been demonstrated to##5##4##(1995-6#1)(2008-10#2)(2009-3#1)(2010-5#1)
have been demonstrated##17##3##(1992-5#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-6#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
have been deposited##2##3##(2008-10#1)(2008-3#1)
have been derived from##5##4##(1992-12#1)(1997-2#1)(2008-10#2)(2010-8#1)
have been derived##9##3##(1992-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2010-11#1)(2010-7#1)(2010-8#1)
have been described and##3##4##(2008-10#2)(2009-7#1)
have been described as##3##4##(1990-11#1)(1990-5#1)(1992-6#1)
have been described by##2##4##(1996-1#1)(2008-10#1)
have been described for the assay of##2##7##(2008-10#2)
have been described for the##6##5##(1994-9#1)(2008-10#5)
have been described for##12##4##(1994-9#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-10#2)(2013-1#2)
have been described in plants##2##5##(2009-5#1)(2009-6#1)
have been described in##10##4##(1992-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-8#1)
have been described so far in the##2##7##(2008-5#1)(2013-1#1)
have been described to##3##4##(1993-6#1)(2008-11#1)(2010-8#1)
have been described##57##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-8#2)(2008-10#12)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-1#4)(2013-8#1)
have been designed to##2##4##(2010-1#1)(2012-2#1)
have been designed##5##3##(2008-10#2)(2008-5#1)(2010-1#1)(2012-2#1)
have been detected in##6##4##(1990-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2010-12#1)
have been detected##13##3##(1990-12#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-12#1)
have been determined as##2##4##(1991-11#1)(2008-5#1)
have been determined at 25 degrees C##4##7##(2008-10#4)
have been determined at##7##4##(2008-10#6)(2008-3#1)
have been determined by means of##2##6##(2008-10#1)(2008-3#1)
have been determined by##15##4##(1991-12#1)(1992-3#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
have been determined simultaneously##2##4##(2008-10#2)
have been determined using##3##4##(2008-10#3)
have been determined with the##2##5##(2008-10#2)
have been determined with##3##4##(2008-10#3)
have been determined##50##3##(1991-11#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-9#2)(1997-2#1)(2008-10#35)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-7#1)
have been developed and are##2##5##(2008-10#1)(2010-12#1)
have been developed and##9##4##(1991-2#1)(1996-1#1)(2008-10#3)(2008-9#1)(2010-12#2)(2013-1#1)
have been developed based##2##4##(1992-3#1)(2008-4#1)
have been developed for a##2##5##(1996-5#1)(2008-9#1)
have been developed for detection and##2##6##(2008-10#2)
have been developed for the determination of##3##7##(2008-10#3)
have been developed for the##12##5##(1996-12#1)(2008-10#8)(2008-11#2)(2010-6#1)
have been developed for##28##4##(1990-6#1)(1996-12#1)(1996-5#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-3#1)(2012-12#1)
have been developed over##2##4##(2008-10#1)(2008-4#1)
have been developed that##3##4##(1994-12#1)(1997-1#1)(2012-2#1)
have been developed to allow##2##5##(1992-3#1)(2008-10#1)
have been developed to improve the##2##6##(2008-11#1)(2013-1#1)
have been developed to##19##4##(1991-12#1)(1992-3#1)(1994-12#1)(1996-2#1)(2008-10#5)(2008-11#4)(2008-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
have been developed using##2##4##(2008-10#2)
have been developed which##2##4##(2009-10#1)(2009-12#1)
have been developed##108##3##(1990-6#2)(1991-12#1)(1991-2#1)(1992-3#3)(1993-2#1)(1994-12#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#41)(2008-11#9)(2008-12#2)(2008-4#3)(2008-5#1)(2008-9#4)(2009-10#1)(2009-12#3)(2009-7#1)(2010-1#1)(2010-10#3)(2010-12#3)(2010-6#1)(2010-7#4)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
have been devised##2##3##(1992-11#1)(2008-11#1)
have been differentiated##2##3##(2008-10#1)(2013-1#1)
have been directed towards##2##4##(2008-10#1)(2011-2#1)
have been directed##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
have been discovered in##3##4##(1990-11#2)(2008-7#1)
have been discovered##6##3##(1990-11#2)(1994-9#1)(2008-11#1)(2008-4#1)(2008-7#1)
have been discussed in the##2##5##(2008-10#1)(2011-2#1)
have been discussed in this##2##5##(2008-10#1)(2009-8#1)
have been discussed in##6##4##(2008-10#4)(2009-8#1)(2011-2#1)
have been discussed##13##3##(2008-10#9)(2008-12#1)(2009-8#1)(2009-9#1)(2011-2#1)
have been documented##2##3##(1994-9#1)(1997-1#1)
have been done##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
have been elaborated##2##3##(1992-11#1)(2008-10#1)
have been elucidated##5##3##(1995-12#1)(1995-9#1)(2008-10#2)(2012-2#1)
have been embedded in##2##4##(2008-10#2)
have been employed for##2##4##(2008-9#1)(2012-2#1)
have been employed in##2##4##(2008-10#1)(2013-1#1)
have been employed to##2##4##(2008-9#1)(2012-3#1)
have been employed##8##3##(2008-10#3)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
have been established##18##3##(1994-9#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#1)(2009-8#1)(2012-2#1)(2012-3#3)
have been estimated##4##3##(1992-2#1)(1997-7#1)(2008-10#2)
have been evaluated and compared##2##5##(2008-10#2)
have been evaluated and##5##4##(2008-10#5)
have been evaluated as##2##4##(2008-10#1)(2012-3#1)
have been evaluated by##2##4##(1994-3#1)(2008-10#1)
have been evaluated for##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)
have been evaluated in##7##4##(1993-2#1)(2008-10#2)(2008-11#1)(2009-1#1)(2009-7#1)(2013-1#1)
have been evaluated to##2##4##(1990-6#1)(2011-2#1)
have been evaluated##34##3##(1990-6#1)(1992-2#1)(1993-2#1)(1994-3#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#1)(2009-1#1)(2009-7#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
have been evidenced##2##3##(2008-7#1)(2012-5#1)
have been examined and##2##4##(2008-10#2)
have been examined for##2##4##(1997-7#1)(2008-5#1)
have been examined in##2##4##(1993-3#1)(1995-5#1)
have been examined using##2##4##(2008-10#1)(2010-12#1)
have been examined##18##3##(1991-2#1)(1991-3#1)(1993-3#1)(1995-5#1)(1997-7#1)(2008-10#9)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)
have been experimenting with##2##4##(1994-3#1)(2013-1#1)
have been explained##2##3##(2008-10#1)(2008-2#1)
have been exploited for##2##4##(2008-10#1)(2009-3#1)
have been exploited##3##3##(2008-10#2)(2009-3#1)
have been explored##4##3##(1992-9#1)(2008-10#1)(2009-12#1)(2013-1#1)
have been exposed to##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
have been exposed##6##3##(1990-9#1)(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
have been expressed##2##3##(1995-6#1)(1997-1#1)
have been extensively investigated to##2##5##(2009-11#2)
have been extensively studied##2##4##(2006-6#1)(2011-2#1)
have been extensively used##3##4##(2008-10#1)(2008-9#1)(2012-2#1)
have been extensively##10##3##(2006-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-11#2)(2011-2#1)(2012-2#1)
have been fabricated from##2##4##(2008-10#1)(2008-7#1)
have been fabricated##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
have been fed##2##3##(1990-11#1)(2011-2#1)
have been few##5##3##(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
have been focused##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
have been followed##2##3##(1996-3#1)(1997-8#1)
have been formulated##3##3##(1992-1#1)(2008-5#2)
have been found in##11##4##(1994-8#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2013-1#1)(2013-7#1)
have been found to be necessary for##2##7##(2009-1#1)(2011-2#1)
have been found to be##9##5##(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-1#1)(2010-11#1)(2010-7#1)(2011-2#1)
have been found to exhibit##2##5##(2008-10#1)(2009-5#1)
have been found to##22##4##(1990-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
have been found##43##3##(1990-12#1)(1994-8#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
have been fundamental##2##3##(1993-6#1)(2008-11#1)
have been further##2##3##(2008-10#1)(2011-1#1)
have been gained##2##3##(2008-10#1)(2013-1#1)
have been generated by##2##4##(1993-6#1)(2008-10#1)
have been generated##8##3##(1993-6#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-10#1)(2012-2#1)
have been genetically engineered to##3##5##(2008-10#1)(2008-4#1)(2008-5#1)
have been genetically##5##3##(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
have been given##5##3##(1992-1#1)(1996-3#1)(1997-5#1)(2008-4#1)(2012-3#1)
have been grouped##2##3##(2008-11#1)(2011-7#1)
have been grown in##2##4##(1992-11#1)(2008-10#1)
have been grown on##2##4##(2008-10#1)(2008-11#1)
have been grown##5##3##(1992-11#1)(1995-3#1)(2008-10#2)(2008-11#1)
have been hampered by the lack of##2##7##(2008-10#1)(2008-4#1)
have been hampered##3##3##(2008-10#2)(2008-4#1)
have been highly conserved##2##4##(1993-6#1)(1995-2#1)
have been hindered by##2##4##(1996-9#1)(2008-11#1)
have been identified and are##2##5##(2008-4#1)(2010-11#1)
have been identified and characterized##2##5##(1995-12#1)(2008-7#1)
have been identified and##8##4##(1993-11#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-11#1)
have been identified as##9##4##(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#2)
have been identified by the##2##5##(1996-2#1)(1996-9#1)
have been identified by##5##4##(1996-2#1)(1996-9#1)(2008-10#3)
have been identified for##2##4##(2008-8#1)(2011-1#1)
have been identified from##2##4##(2008-10#1)(2010-7#1)
have been identified in the##2##5##(2008-10#1)(2010-5#1)
have been identified in##9##4##(1994-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-5#2)(2012-3#1)
have been identified that##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
have been identified to##4##4##(1991-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
have been identified##74##3##(1990-12#1)(1991-12#2)(1991-9#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-5#1)(2008-10#24)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
have been immobilized##2##3##(2008-10#2)
have been implanted##2##3##(2008-7#1)(2008-9#1)
have been implemented##7##3##(2008-10#2)(2008-11#2)(2008-3#2)(2010-5#1)
have been implicated in several##2##5##(2009-12#1)(2012-2#1)
have been implicated in the pathogenesis of##2##7##(1996-12#1)(2013-8#1)
have been implicated in the##8##5##(1993-3#1)(1993-6#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
have been implicated in various##2##5##(2008-4#1)(2013-7#1)
have been implicated in##21##4##(1993-3#1)(1993-6#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
have been implicated##24##3##(1993-3#1)(1993-6#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
have been improved##2##3##(2008-10#1)(2008-7#1)
have been in the##2##4##(2008-10#1)(2008-11#1)
have been in##3##3##(2008-10#1)(2008-11#1)(2011-3#1)
have been included in##2##4##(2008-10#2)
have been included##3##3##(2008-10#2)(2008-11#1)
have been inconsistent##2##3##(2010-1#1)(2013-8#1)
have been increased##2##3##(2008-7#1)(2012-12#1)
have been increasingly##2##3##(2008-10#1)(2012-2#1)
have been induced##2##3##(2008-11#1)(2008-8#1)
have been initiated##2##3##(2008-5#1)(2012-2#1)
have been integrated##4##3##(1994-2#1)(2008-11#2)(2012-3#1)
have been introduced as##2##4##(2008-5#1)(2013-8#1)
have been introduced to##5##4##(1997-8#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-2#1)
have been introduced##11##3##(1992-9#1)(1997-8#2)(2008-10#3)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
have been investigated and##7##4##(1995-11#1)(2008-10#4)(2011-2#1)(2011-3#1)
have been investigated as##7##4##(2008-10#3)(2008-11#2)(2009-9#1)(2012-2#1)
have been investigated by##9##4##(1994-3#2)(2008-10#5)(2008-11#1)(2008-3#1)
have been investigated for##5##4##(2008-10#4)(2010-12#1)
have been investigated in detail##2##5##(2008-10#2)
have been investigated in the##4##5##(1991-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
have been investigated in##13##4##(1991-6#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
have been investigated using##2##4##(1993-6#1)(2008-10#1)
have been investigated with##3##4##(2007-12#1)(2008-10#2)
have been investigated##88##3##(1991-6#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-11#3)(1997-4#1)(2007-12#1)(2008-10#56)(2008-11#6)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
have been involved in the##4##5##(1990-5#1)(1996-6#1)(2008-10#1)(2012-2#1)
have been isolated and characterized##2##5##(1991-5#1)(2008-11#1)
have been isolated and##3##4##(1991-5#1)(1991-6#1)(2008-11#1)
have been isolated from##8##4##(1995-3#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
have been isolated##15##3##(1991-5#1)(1991-6#1)(1995-3#1)(1995-6#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
have been known to##3##4##(1997-3#1)(2008-11#1)(2011-2#1)
have been known##5##3##(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
have been learned##2##3##(2008-10#1)(2010-1#1)
have been limited to##3##4##(2008-10#1)(2008-11#2)
have been limited##5##3##(2008-10#1)(2008-11#3)(2011-2#1)
have been linked to##5##4##(2008-10#2)(2012-12#1)(2013-1#2)
have been linked with##4##4##(2007-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
have been linked##9##3##(2007-12#1)(2008-10#2)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#3)
have been lost##3##3##(1996-3#1)(2008-7#2)
have been made in the##3##5##(1990-9#1)(2010-10#1)(2011-2#1)
have been made in##12##4##(1990-9#1)(1992-2#1)(1995-12#1)(2008-11#3)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
have been made on##2##4##(1992-12#1)(2008-11#1)
have been made to adopt##2##5##(2008-10#1)(2013-1#1)
have been made to##9##4##(1991-1#1)(1991-2#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#3)(2013-1#1)
have been made##39##3##(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(2008-10#8)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#3)(2013-1#2)
have been maintained##2##3##(2008-11#1)(2008-7#1)
have been managed##2##3##(1996-3#1)(2008-9#1)
have been mapped##3##3##(1990-7#1)(1996-8#1)(2008-10#1)
have been measured in the##3##5##(2008-10#1)(2008-3#1)(2010-11#1)
have been measured in##9##4##(1994-2#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
have been measured##14##3##(1994-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2010-11#1)(2010-4#1)(2013-1#1)
have been modified##4##3##(2008-10#2)(2010-8#1)(2011-3#1)
have been more##6##3##(1990-11#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
have been named##2##3##(1995-12#1)(2008-10#1)
have been no cases of##2##5##(1997-8#1)(2008-7#1)
have been no##12##3##(1994-2#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
have been noted in##4##4##(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
have been noted##6##3##(1991-2#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
have been objects of##2##4##(2010-1#2)
have been observed by##2##4##(1995-6#1)(2008-4#1)
have been observed in##7##4##(1992-6#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
have been observed to##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
have been observed##24##3##(1990-8#1)(1992-6#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-8#1)
have been obtained at##2##4##(1991-5#1)(1997-7#1)
have been obtained for##2##4##(2008-10#2)
have been obtained from##2##4##(1991-5#1)(2010-4#1)
have been obtained using##3##4##(1990-5#1)(2008-10#2)
have been obtained with##2##4##(2008-10#1)(2013-1#1)
have been obtained##28##3##(1990-5#2)(1991-5#2)(1997-5#2)(1997-7#1)(2008-10#15)(2008-2#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-3#1)(2013-1#1)
have been occurring on##2##4##(2008-10#1)(2008-9#1)
have been offered##3##3##(1994-9#1)(2008-10#2)
have been on the##2##4##(2008-10#1)(2013-8#1)
have been only##4##3##(1992-2#1)(2008-9#1)(2013-7#1)(2013-8#1)
have been optimised and the##3##5##(2008-10#3)
have been optimised and##4##4##(2008-10#4)
have been optimised##7##3##(2008-10#7)
have been optimized and the##3##5##(2008-10#3)
have been optimized to##4##4##(2008-10#3)(2008-4#1)
have been optimized##15##3##(2008-10#14)(2008-4#1)
have been overcome##2##3##(2008-10#1)(2008-4#1)
have been performed by##3##4##(2008-10#3)
have been performed for##2##4##(2008-3#1)(2012-2#1)
have been performed in##6##4##(1994-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#1)
have been performed on##3##4##(1995-11#1)(2008-10#1)(2008-5#1)
have been performed to##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
have been performed##28##3##(1992-2#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-5#2)(2007-12#1)(2008-10#7)(2008-11#4)(2008-3#3)(2008-5#2)(2008-9#1)(2012-2#2)(2012-3#1)
have been postulated to##2##4##(1995-2#1)(2008-7#1)
have been postulated##4##3##(1990-3#1)(1995-2#1)(2008-7#1)(2008-9#1)
have been predicted by##2##4##(1991-10#1)(2008-10#1)
have been predicted##4##3##(1991-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
have been prepared and##6##4##(2008-10#6)
have been prepared by##2##4##(2008-10#2)
have been prepared##16##3##(1992-2#1)(1992-3#1)(2008-10#11)(2008-4#1)(2008-5#1)(2012-3#1)
have been presented for##2##4##(2008-12#1)(2009-11#1)
have been presented in##2##4##(1991-3#1)(2008-9#1)
have been presented##7##3##(1991-12#1)(1991-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-11#1)
have been previously identified##2##4##(1993-6#1)(1996-6#1)
have been previously##8##3##(1993-6#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
have been processed##4##3##(1997-5#1)(2008-10#3)
have been produced and##3##4##(1995-5#1)(2008-2#1)(2011-3#1)
have been produced##7##3##(1995-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-3#1)
have been proposed and##2##4##(2009-4#1)(2010-6#1)
have been proposed as##7##4##(1995-5#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
have been proposed for##12##4##(1990-5#1)(1993-1#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
have been proposed in the literature##2##6##(2008-7#2)
have been proposed in the##3##5##(2008-7#2)(2011-1#1)
have been proposed in##5##4##(1997-8#1)(2008-7#2)(2008-9#1)(2011-1#1)
have been proposed to explain the##2##6##(2009-12#1)(2012-3#1)
have been proposed to explain##3##5##(2008-9#1)(2009-12#1)(2012-3#1)
have been proposed to##12##4##(1992-3#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-7#1)(2011-7#1)(2012-3#1)
have been proposed##53##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-6#1)(1995-5#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
have been proved to be##2##5##(2008-8#1)(2013-1#1)
have been proved##3##3##(2008-8#1)(2010-5#1)(2013-1#1)
have been provided to##2##4##(1997-1#1)(2009-6#1)
have been provided##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2009-6#1)
have been published on the##2##5##(2008-11#1)(2010-12#1)
have been published previously##2##4##(2008-10#1)(2008-7#1)
have been published##18##3##(1993-6#1)(1994-8#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
have been purified to homogeneity##2##5##(1990-11#1)(1993-12#1)
have been quantified in##2##4##(2008-10#2)
have been quantified##3##3##(2008-10#3)
have been reached##2##3##(1990-6#1)(2008-8#1)
have been realized##2##3##(1997-6#1)(2008-10#1)
have been recently developed##2##4##(2010-11#1)(2011-3#1)
have been recently##10##3##(2008-10#3)(2008-11#1)(2008-4#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-3#1)
have been recognized as##3##4##(1995-8#1)(1997-2#1)(2008-10#1)
have been recognized##5##3##(1995-8#1)(1997-2#1)(2008-10#2)(2010-5#1)
have been recommended##2##3##(2008-1#1)(2008-9#1)
have been recorded by##2##4##(2008-3#1)(2010-8#1)
have been recorded in##2##4##(2011-2#1)(2013-8#1)
have been recorded##7##3##(2007-11#1)(2008-10#2)(2008-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
have been regarded as##3##4##(1993-3#1)(2008-9#1)(2010-11#1)
have been registered##3##3##(1995-2#1)(1995-8#1)(1997-2#1)
have been related to##2##4##(2008-10#1)(2008-9#1)
have been repeatedly##4##3##(2008-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
have been reported as##3##4##(2010-6#1)(2011-2#1)(2013-1#1)
have been reported for the##2##5##(2008-9#1)(2009-11#1)
have been reported for##4##4##(1995-6#1)(2008-9#1)(2009-11#1)(2012-2#1)
have been reported in a##2##5##(2012-2#1)(2012-3#1)
have been reported in the literature##6##6##(1990-12#1)(1996-11#1)(2008-7#1)(2008-8#1)(2013-1#2)
have been reported in the##13##5##(1990-12#1)(1990-8#1)(1996-11#1)(1997-2#1)(1997-8#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#3)(2013-8#1)
have been reported in##31##4##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-6#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-8#3)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#2)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
have been reported on##4##4##(1990-11#1)(2008-10#3)
have been reported previously##3##4##(2008-10#3)
have been reported since the##2##5##(2008-12#1)(2010-1#1)
have been reported so far##3##5##(2008-7#1)(2012-12#1)(2013-8#1)
have been reported to be increased##2##6##(1994-12#1)(2008-10#1)
have been reported to be##7##5##(1992-8#1)(1994-12#2)(1994-5#1)(1995-8#1)(2008-10#1)(2008-5#1)
have been reported to cause##2##5##(2008-10#2)
have been reported to##24##4##(1991-11#1)(1992-6#1)(1992-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#3)
have been reported with##5##4##(2008-10#3)(2012-3#1)(2013-8#1)
have been reported##118##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#2)(1992-6#2)(1992-8#1)(1993-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1997-2#2)(1997-8#3)(2008-10#28)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#14)(2013-8#5)
have been researched##2##3##(2008-8#1)(2012-3#1)
have been resolved##3##3##(2008-10#3)
have been selected##4##3##(2008-10#3)(2008-7#1)
have been separated by##2##4##(2008-10#2)
have been separated within 130s at a separation voltage of##2##10##(2008-10#2)
have been separated##7##3##(2008-10#6)(2008-11#1)
have been sequenced##2##3##(2008-10#2)
have been several##4##3##(1992-2#1)(2008-7#1)(2010-6#1)(2012-3#1)
have been shown to act##2##5##(2008-8#1)(2009-3#1)
have been shown to be essential for##2##7##(2008-5#2)
have been shown to be more##2##6##(2008-2#1)(2009-8#1)
have been shown to be##19##5##(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#2)(2008-10#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
have been shown to cause##2##5##(2008-10#2)
have been shown to confer##2##5##(1993-11#1)(2011-2#1)
have been shown to have##3##5##(1993-12#1)(2009-11#1)(2009-3#1)
have been shown to improve##2##5##(2008-4#1)(2013-8#1)
have been shown to induce##2##5##(1995-5#1)(2013-1#1)
have been shown to influence##2##5##(1997-1#1)(2009-10#1)
have been shown to interact##2##5##(1994-5#1)(2008-4#1)
have been shown to modulate##2##5##(2008-11#1)(2008-7#1)
have been shown to play##2##5##(2008-7#1)(2009-10#1)
have been shown to provide##2##5##(1996-2#1)(2010-10#1)
have been shown to##61##4##(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-5#2)(1996-12#4)(1996-2#3)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
have been shown##63##3##(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-12#4)(1996-2#3)(1997-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
have been significantly##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
have been simultaneously determined##2##4##(2008-10#2)
have been so##2##3##(2008-10#1)(2008-11#1)
have been specifically designed##2##4##(1996-1#1)(2008-4#1)
have been specifically##3##3##(1996-1#1)(2008-3#1)(2008-4#1)
have been structurally##2##3##(1994-5#1)(2011-2#1)
have been studied and compared##2##5##(2008-10#1)(2008-3#1)
have been studied and##3##4##(1990-11#1)(2008-10#1)(2008-3#1)
have been studied by##9##4##(1990-9#1)(1993-8#1)(2008-10#4)(2008-2#1)(2008-8#1)(2012-3#1)
have been studied extensively##4##4##(2008-8#1)(2009-12#1)(2009-8#1)(2012-2#1)
have been studied for decades##2##5##(2008-10#2)
have been studied for##7##4##(2008-10#6)(2008-8#1)
have been studied in detail to optimize the conditions for determination##2##11##(2008-10#2)
have been studied in detail to optimize the conditions for##3##10##(2008-10#3)
have been studied in detail##6##5##(2008-10#6)
have been studied in the##2##5##(1997-3#1)(2008-10#1)
have been studied in##15##4##(1990-5#1)(1994-5#1)(1995-11#1)(1996-2#1)(1997-3#1)(2008-10#9)(2008-11#1)
have been studied to##2##4##(2008-10#1)(2010-7#1)
have been studied using##6##4##(1994-11#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-7#1)
have been studied with a##2##5##(1997-4#1)(2008-10#1)
have been studied with##5##4##(1993-6#1)(1997-4#1)(2008-10#2)(2008-3#1)
have been studied##97##3##(1990-11#1)(1990-5#3)(1990-7#1)(1990-9#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-5#2)(1995-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#51)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#4)
have been subjected to##3##4##(2008-10#1)(2009-7#1)(2010-7#1)
have been successful in##3##4##(1994-12#1)(2008-11#1)(2010-10#1)
have been successful##4##3##(1994-12#1)(2008-11#1)(2010-10#2)
have been successfully applied to the determination of trace amount of##2##11##(2008-10#2)
have been successfully applied to the##3##6##(2008-10#3)
have been successfully applied to##5##5##(2008-10#5)
have been successfully applied##7##4##(2008-10#6)(2011-2#1)
have been successfully tested##2##4##(2008-10#1)(2011-2#1)
have been successfully##17##3##(1993-2#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
have been suggested as##2##4##(2008-10#1)(2008-11#1)
have been suggested to##4##4##(2008-10#1)(2008-12#1)(2009-4#1)(2009-5#1)
have been suggested##14##3##(1990-6#1)(1993-6#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2009-4#1)(2009-5#1)
have been summarized##2##3##(2008-10#2)
have been synthesized and##2##4##(1995-3#1)(2008-10#1)
have been synthesized as##2##4##(1991-5#1)(1996-5#1)
have been synthesized in##3##4##(1995-6#1)(2012-2#1)(2012-3#1)
have been synthesized##14##3##(1991-5#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#2)(2008-10#5)(2012-2#1)(2012-3#1)
have been systematically investigated##2##4##(2008-10#2)
have been tabulated##2##3##(1991-3#1)(1994-1#1)
have been taken##6##3##(1990-8#1)(1996-1#1)(2008-11#2)(2010-8#1)(2012-3#1)
have been tested as##2##4##(2008-10#2)
have been tested for the##2##5##(2008-10#2)
have been tested for##3##4##(2008-10#3)
have been tested##10##3##(1992-9#1)(2008-10#9)
have been the most##2##4##(1994-12#1)(2010-11#1)
have been the subject of intense research##2##7##(2008-5#1)(2008-9#1)
have been the##9##3##(1994-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2010-10#1)(2010-11#1)
have been to##2##3##(1995-12#1)(1996-3#1)
have been trained to##3##4##(2008-10#3)
have been trained##4##3##(1996-5#1)(2008-10#3)
have been treated by##2##4##(2008-10#1)(2008-7#1)
have been treated with##3##4##(1995-2#1)(2011-1#1)(2011-2#1)
have been treated##9##3##(1990-5#1)(1991-2#1)(1991-3#1)(1995-2#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
have been tried##2##3##(2008-10#1)(2010-7#1)
have been under##3##3##(2010-10#1)(2012-2#1)(2013-1#1)
have been undertaken to##2##4##(2008-11#1)(2013-1#1)
have been undertaken##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
have been used as##8##4##(2008-10#5)(2008-11#1)(2010-4#2)
have been used because##2##4##(1997-1#1)(2008-10#1)
have been used for sodium##2##5##(2008-10#2)
have been used for the determination of##2##7##(2008-10#2)
have been used for the##5##5##(2008-10#5)
have been used for this purpose##2##6##(1995-5#1)(2008-10#1)
have been used for##17##4##(1995-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-1#1)(2012-2#1)
have been used in##8##4##(1997-1#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
have been used to characterize##2##5##(1994-11#1)(2008-3#1)
have been used to determine the##2##6##(1990-9#1)(1994-5#1)
have been used to determine##3##5##(1990-9#1)(1994-5#1)(2008-10#1)
have been used to investigate the##3##6##(1996-5#1)(2008-10#1)(2008-3#1)
have been used to monitor the##2##6##(1994-5#1)(2008-11#1)
have been used to probe the##2##6##(1995-6#1)(2008-10#1)
have been used to study the##7##6##(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#2)
have been used to study##10##5##(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-9#2)
have been used to treat##2##5##(1993-11#1)(2008-8#1)
have been used to##46##4##(1990-9#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-5#3)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
have been used##105##3##(1990-9#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#3)(1995-1#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#2)(2008-1#1)(2008-10#43)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#5)(2009-1#1)(2009-7#1)(2010-10#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
have been utilized##4##3##(1990-5#1)(2008-12#1)(2008-9#1)(2009-10#1)
have been validated by##2##4##(2008-10#2)
have been validated##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
have been verified##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
have been very##3##3##(1990-5#1)(2008-10#1)(2008-7#1)
have been visualized##2##3##(1996-2#1)(2008-11#1)
have been well established##3##4##(2008-10#1)(2009-10#1)(2009-4#1)
have been well##10##3##(1996-11#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)
have been well-documented##2##3##(1997-1#1)(2010-3#1)
have been widely used for##3##5##(2008-11#2)(2008-3#1)
have been widely used in South East Asia##2##8##(2013-1#2)
have been widely used in##4##5##(2008-11#1)(2008-7#1)(2013-1#2)
have been widely used##8##4##(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2013-1#2)
have been widely##13##3##(1991-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#2)
have been working##2##3##(2008-10#1)(2008-6#1)
have been##2351##2##(1990-11#10)(1990-12#4)(1990-2#2)(1990-3#6)(1990-5#14)(1990-6#8)(1990-7#2)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#12)(1991-2#6)(1991-3#8)(1991-5#7)(1991-6#8)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#3)(1992-12#4)(1992-2#9)(1992-3#9)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#8)(1993-1#3)(1993-11#6)(1993-12#9)(1993-2#5)(1993-3#8)(1993-6#11)(1993-8#6)(1994-1#3)(1994-11#3)(1994-12#10)(1994-2#6)(1994-3#8)(1994-5#13)(1994-6#5)(1994-8#7)(1994-9#12)(1995-1#2)(1995-11#10)(1995-12#13)(1995-2#14)(1995-3#5)(1995-5#11)(1995-6#12)(1995-8#5)(1995-9#3)(1996-1#6)(1996-11#6)(1996-12#10)(1996-2#13)(1996-3#10)(1996-5#7)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#14)(1997-2#14)(1997-3#6)(1997-4#4)(1997-5#7)(1997-6#6)(1997-7#9)(1997-8#18)(1997-9#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#11)(2007-9#1)(2008-1#8)(2008-10#791)(2008-11#145)(2008-12#31)(2008-2#13)(2008-3#57)(2008-4#30)(2008-5#55)(2008-6#8)(2008-7#69)(2008-8#43)(2008-9#64)(2009-1#4)(2009-10#9)(2009-11#7)(2009-12#15)(2009-3#11)(2009-4#5)(2009-5#7)(2009-6#7)(2009-7#12)(2009-8#18)(2009-9#3)(2010-1#19)(2010-10#17)(2010-11#10)(2010-12#22)(2010-3#3)(2010-4#9)(2010-5#10)(2010-6#10)(2010-7#22)(2010-8#15)(2010-9#3)(2011-1#13)(2011-2#76)(2011-3#15)(2011-7#2)(2012-12#10)(2012-2#46)(2012-3#43)(2012-5#1)(2012-6#1)(2013-1#70)(2013-7#5)(2013-8#23)
have begun to be##2##4##(2008-11#1)(2012-2#1)
have begun to##10##3##(1993-3#1)(1994-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
have begun##12##2##(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
have beneficial effects on##2##4##(2009-3#1)(2010-3#1)
have beneficial effects##4##3##(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)
have beneficial##7##2##(2008-7#3)(2009-10#1)(2009-3#2)(2010-3#1)
have benefited from##4##3##(1991-6#1)(1997-3#1)(2008-10#1)(2010-7#1)
have better##8##2##(1995-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#2)
have both been##2##3##(2011-2#1)(2013-8#1)
have both##11##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#2)(2013-8#1)
have briefly##2##2##(2008-10#1)(2009-12#1)
have broad##4##2##(2008-10#2)(2008-2#1)(2012-3#1)
have brought##2##2##(1995-1#1)(2011-2#1)
have called##2##2##(2008-11#1)(2009-10#1)
have cancer##2##2##(1992-3#1)(2009-3#1)
have carried out##5##3##(1993-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2012-2#1)
have caused##8##2##(1991-3#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-8#1)
have cell##2##2##(1992-11#1)(2008-11#1)
have certain##5##2##(1991-6#1)(1994-2#1)(2008-11#1)(2008-9#1)(2011-3#1)
have challenged##2##2##(1993-12#1)(2009-3#1)
have changed very little##2##4##(1992-5#1)(1996-3#1)
have changed##11##2##(1990-6#1)(1991-3#1)(1992-5#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-9#1)
have characteristics##2##2##(2008-10#1)(2009-10#1)
have characterized the##5##3##(1993-8#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-10#1)
have characterized##13##2##(1991-2#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-5#1)(2012-2#1)
have chosen to##3##3##(1994-2#1)(2008-10#1)(2009-5#1)
have chosen##5##2##(1994-2#1)(2008-10#2)(2009-5#1)(2009-7#1)
have chronic##3##2##(1997-2#1)(1997-8#1)(2013-1#1)
have claimed that##3##3##(1995-11#1)(2008-8#1)(2010-8#1)
have clearly demonstrated that##2##4##(2008-10#1)(2010-4#1)
have clearly##3##2##(2008-10#2)(2010-4#1)
have clinical##3##2##(2008-4#1)(2010-1#1)(2010-9#1)
have cloned and sequenced the##2##5##(1993-9#1)(1997-7#1)
have cloned and sequenced##4##4##(1991-6#1)(1993-9#1)(1997-7#1)(2008-10#1)
have cloned##15##2##(1991-6#2)(1991-7#1)(1991-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-6#2)(1996-6#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-5#1)
have combined##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
have come from##2##3##(1993-12#1)(2008-9#1)
have come to light##2##4##(2008-6#1)(2009-10#1)
have come to##5##3##(1991-1#1)(1992-5#1)(1993-6#1)(2008-6#1)(2009-10#1)
have come##12##2##(1991-1#3)(1992-5#1)(1993-12#1)(1993-6#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)
have communication related impairments##2##4##(2011-1#2)
have compared##9##2##(1991-3#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)
have completed##6##2##(1990-7#1)(1996-12#1)(1996-3#2)(1997-2#1)(2013-1#1)
have completely##2##2##(1997-7#1)(2009-4#1)
have complex##3##2##(2007-12#1)(2008-11#2)
have concluded that##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
have conducted a##2##3##(2010-11#1)(2011-2#1)
have conducted##3##2##(2008-3#1)(2010-11#1)(2011-2#1)
have confirmed the hypothesis##2##4##(1994-2#1)(2008-10#1)
have confirmed the##7##3##(1994-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
have confirmed##12##2##(1994-2#1)(1995-11#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)(2011-2#2)(2013-8#1)
have considerable##6##2##(1995-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-5#1)
have consistently##3##2##(2008-3#1)(2008-6#1)(2009-7#1)
have constructed a##8##3##(1995-6#1)(1997-2#1)(2008-11#4)(2008-3#1)(2008-9#1)
have constructed##16##2##(1991-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-9#2)
have continued to##3##3##(1993-12#1)(1996-3#1)(2008-11#1)
have continued##4##2##(1993-12#1)(1996-3#1)(2008-11#1)(2008-4#1)
have contributed to control##2##4##(1996-11#1)(2008-10#1)
have contributed to the success of##2##6##(2010-7#1)(2010-8#1)
have contributed to the##13##4##(1991-2#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-10#1)(2012-2#1)(2012-7#1)
have contributed to##22##3##(1991-2#1)(1992-2#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-5#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
have contributed##24##2##(1991-2#1)(1992-2#1)(1994-3#1)(1996-11#1)(1996-2#2)(1997-2#2)(1997-5#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
have created##6##2##(1993-12#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-2#1)(2010-9#1)
have dealt with##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
have decided##2##2##(1990-6#1)(1997-3#1)
have declined##2##2##(1994-12#1)(1995-5#1)
have decreased the##2##3##(2008-11#1)(2012-2#1)
have decreased##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
have defined##2##2##(1993-6#1)(2008-10#1)
have demonstrated a##8##3##(1994-3#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)
have demonstrated in##2##3##(1990-11#1)(1993-8#1)
have demonstrated potential##2##3##(2010-6#1)(2013-1#1)
have demonstrated previously that##2##4##(1990-11#1)(2008-5#1)
have demonstrated that a##2##4##(2008-1#1)(2008-11#1)
have demonstrated that an##2##4##(1995-5#1)(2008-11#1)
have demonstrated that in##2##4##(2009-3#1)(2010-1#1)
have demonstrated that the##9##4##(1991-2#1)(1994-8#1)(2006-6#1)(2008-10#2)(2008-7#2)(2011-3#1)(2012-3#1)
have demonstrated that this##3##4##(1996-2#1)(2012-2#1)(2012-3#1)
have demonstrated that##43##3##(1991-2#2)(1992-1#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-2#1)(2006-6#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
have demonstrated the##15##3##(1992-1#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-2#2)(2013-8#1)
have demonstrated##87##2##(1990-11#2)(1991-2#2)(1992-1#2)(1992-6#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#1)(1996-2#1)(1997-6#1)(2006-6#1)(2007-12#3)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-6#1)(2010-8#3)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
have derived##2##2##(2008-10#1)(2008-3#1)
have described the##5##3##(1994-5#1)(1995-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
have described##12##2##(1991-3#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
have designed##7##2##(1990-12#1)(1995-5#1)(2008-10#2)(2008-3#3)
have detected##2##2##(1993-12#1)(1995-9#1)
have determined the##6##3##(1993-2#1)(1993-6#1)(1995-9#1)(1997-3#1)(2008-10#1)(2011-2#1)
have determined##14##2##(1992-10#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-8#1)(2011-2#1)
have detrimental effects on the##2##5##(1991-3#1)(2013-1#1)
have detrimental effects##3##3##(1991-3#1)(1993-1#1)(2013-1#1)
have detrimental##5##2##(1991-3#1)(1993-1#1)(2008-11#1)(2009-9#1)(2013-1#1)
have devastating effects on##2##4##(2007-11#1)(2008-8#1)
have devastating##4##2##(2007-11#1)(2008-8#1)(2011-2#2)
have developed a method##3##4##(2008-5#1)(2008-7#1)(2009-12#1)
have developed a new method for##3##6##(2008-10#2)(2008-2#1)
have developed a new##6##4##(1991-12#1)(1995-8#1)(2008-10#3)(2008-2#1)
have developed a unique##2##4##(1991-3#1)(1996-3#1)
have developed a##58##3##(1991-12#1)(1991-3#1)(1993-2#2)(1993-3#1)(1994-11#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#6)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
have developed an in vitro##2##5##(1994-12#1)(2008-5#1)
have developed an##13##3##(1993-8#2)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-5#1)(2011-2#2)(2011-3#1)
have developed and##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
have developed the##2##3##(1996-2#1)(2008-9#1)
have developed two##2##3##(1993-6#1)(2008-10#1)
have developed##95##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#3)(2009-12#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
have devised##4##2##(1996-12#1)(1996-8#1)(2008-10#1)(2008-7#1)
have died##7##2##(1990-6#1)(1992-6#1)(1995-12#1)(2008-10#3)(2008-5#1)
have different developmental##2##3##(1993-12#1)(2008-12#1)
have different effects on##2##4##(2008-10#1)(2008-8#1)
have different perceptions of##2##4##(2008-8#1)(2011-1#1)
have different##30##2##(1990-11#1)(1990-12#1)(1992-3#1)(1993-12#1)(1996-2#2)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
have differential##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
have direct##3##2##(2008-8#1)(2010-7#1)(2012-2#1)
have directly##2##2##(1995-2#1)(2008-5#1)
have disadvantages##2##2##(1997-7#1)(2008-5#1)
have discovered##4##2##(1991-3#1)(2008-8#1)(2010-4#1)(2013-1#1)
have discussed##4##2##(1991-2#1)(2008-10#1)(2010-3#1)(2012-2#1)
have distinct##11##2##(1991-3#1)(1992-3#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-8#1)(2009-10#2)(2013-8#2)
have documented the##2##3##(2008-11#1)(2013-1#1)
have documented##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
have dominated##2##2##(2008-4#1)(2009-7#1)
have done##2##2##(2008-11#1)(2008-5#1)
have dramatically##2##2##(1993-3#1)(2008-9#1)
have drawn##2##2##(2008-11#1)(2008-12#1)
have effects on##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
have either##4##2##(1991-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
have elucidated##3##2##(1996-2#1)(2008-5#1)(2008-6#1)
have emerged as a##2##4##(1993-3#1)(2009-8#1)
have emerged as##6##3##(1993-3#1)(2008-10#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
have emerged##12##2##(1993-3#1)(2008-10#2)(2008-11#3)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-8#2)
have emotional##2##2##(2009-10#1)(2009-7#1)
have emphasized the importance of##2##5##(2008-11#1)(2008-9#1)
have emphasized the##3##3##(2008-11#1)(2008-9#2)
have employed the##2##3##(2008-11#1)(2008-9#1)
have employed##5##2##(1990-6#1)(1994-12#1)(2008-11#1)(2008-9#1)(2013-8#1)
have enabled the##2##3##(2008-10#1)(2013-8#1)
have enabled##6##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
have encountered##2##2##(2008-8#1)(2012-3#1)
have entered##2##2##(2008-6#1)(2012-2#1)
have established a##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
have established that##4##3##(1990-2#1)(1995-5#1)(2008-5#1)(2011-2#1)
have established the##3##3##(1997-1#1)(2008-10#1)(2010-1#1)
have established two##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
have established##19##2##(1990-2#1)(1994-8#1)(1995-5#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-8#1)
have estimated##2##2##(2008-11#1)(2009-4#1)
have evaluated the##8##3##(1993-6#1)(1994-1#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
have evaluated##12##2##(1993-6#1)(1994-1#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-3#1)
have evolved from the##2##4##(1995-6#1)(2012-12#1)
have evolved from##4##3##(1995-6#1)(1997-9#1)(2008-8#1)(2012-12#1)
have evolved in response to##2##5##(2008-8#1)(2010-5#1)
have evolved to##4##3##(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#1)
have evolved under##2##3##(1997-9#1)(2009-6#1)
have evolved##28##2##(1995-11#1)(1995-6#1)(1997-9#2)(2008-10#3)(2008-11#3)(2008-8#4)(2008-9#2)(2009-6#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
have examined the effects of##2##5##(1992-1#1)(2008-7#1)
have examined the##16##3##(1991-3#1)(1992-1#1)(1992-11#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-7#3)(2009-5#1)(2011-2#1)(2013-8#1)
have examined this##2##3##(1990-5#1)(2009-6#1)
have examined##28##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#2)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
have excellent##4##2##(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
have expanded its##2##3##(2008-10#1)(2011-7#1)
have experienced##8##2##(1990-6#1)(1996-1#1)(1996-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
have exploited##3##2##(1992-4#1)(2008-8#1)(2011-1#1)
have explored the##5##3##(2008-10#2)(2008-9#1)(2009-10#1)(2010-1#1)
have explored##7##2##(2008-10#3)(2008-9#2)(2009-10#1)(2010-1#1)
have expressed##4##2##(1994-11#1)(1995-11#1)(1995-6#1)(1997-7#1)
have extended the##2##3##(1995-11#1)(2008-11#1)
have extended##4##2##(1992-2#1)(1995-11#1)(2008-11#2)
have extensive##2##2##(1996-1#2)
have failed to##9##3##(1993-3#1)(1994-2#1)(1996-3#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-2#1)
have failed##13##2##(1993-3#1)(1994-2#1)(1994-5#1)(1996-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
have fallen##4##2##(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)
have features##2##2##(1992-9#1)(2008-12#1)
have few##2##2##(2008-11#1)(2010-8#1)
have fewer##2##2##(1994-3#1)(2008-9#1)
have focused on the##7##4##(1994-1#1)(1996-3#1)(1997-1#1)(2008-8#1)(2009-9#1)(2010-10#1)(2012-2#1)
have focused on##18##3##(1991-2#1)(1994-1#1)(1996-3#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
have focused##21##2##(1991-2#1)(1992-12#1)(1994-1#1)(1996-3#1)(1997-1#2)(2008-10#2)(2008-11#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
have followed##2##2##(1993-12#1)(2008-3#1)
have for the##3##3##(1991-1#1)(2008-12#1)(2013-1#1)
have for##6##2##(1991-1#2)(1991-6#1)(2008-11#1)(2008-12#1)(2013-1#1)
have formed##3##2##(1992-11#1)(2008-12#1)(2009-5#1)
have found few##2##3##(1996-5#1)(2008-4#1)
have found that a##2##4##(1995-2#1)(2013-1#1)
have found that the##4##4##(1991-5#1)(1994-11#1)(2008-11#1)(2010-11#1)
have found that##23##3##(1991-3#1)(1991-5#1)(1994-11#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-5#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-5#1)(2012-2#2)(2013-1#1)
have found the##2##3##(1994-2#1)(2012-3#1)
have found##43##2##(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#2)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
have frequently##3##2##(1991-3#1)(2008-11#1)(2010-1#1)
have functional##2##2##(1996-2#1)(2008-7#1)
have fundamentally##4##2##(1993-3#1)(1995-1#1)(2013-1#2)
have further##2##2##(1996-12#1)(2010-12#1)
have gained##5##2##(1992-12#1)(1992-3#1)(2008-10#1)(2008-9#1)(2010-12#1)
have general##2##2##(1991-2#1)(2008-10#1)
have generally##3##2##(2010-11#1)(2012-2#2)
have generated mice##2##3##(1993-12#1)(1995-2#1)
have generated##8##2##(1993-12#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
have given rise to the##2##5##(2008-10#1)(2010-7#1)
have given##7##2##(1992-2#1)(1996-5#1)(2008-10#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-2#1)
have good##8##2##(1994-9#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
have great potential##4##3##(2008-10#3)(2009-3#1)
have great##8##2##(1996-5#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-3#1)(2010-7#1)
have greater##11##2##(1990-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2011-2#1)
have greatly increased##2##3##(1996-2#1)(2013-1#1)
have greatly##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2010-1#1)(2013-1#1)
have grown##7##2##(1991-3#1)(1992-2#2)(1996-3#1)(1997-2#1)(2008-5#1)(2008-9#1)
have had a negative##2##4##(1991-2#1)(2008-12#1)
have had a##7##3##(1991-2#1)(1991-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
have had an##2##3##(2008-10#1)(2011-2#1)
have had high##2##3##(2007-8#1)(2012-3#1)
have had limited##3##3##(1992-3#1)(1996-1#1)(2008-1#1)
have had no##2##3##(1996-1#1)(2009-10#1)
have had significant##2##3##(1991-12#1)(2008-10#1)
have had to##4##3##(1994-12#1)(1996-1#1)(2009-6#1)(2013-1#1)
have had##36##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#2)(1992-3#1)(1994-12#1)(1995-8#1)(1996-1#3)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2009-10#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)
have helped to##5##3##(1990-12#1)(1992-12#1)(1997-6#1)(2008-10#2)
have helped##7##2##(1990-12#1)(1992-12#1)(1997-6#1)(2008-10#2)(2012-2#2)
have high##20##2##(1991-3#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-3#1)(2013-1#2)
have higher rates of##2##4##(2008-4#1)(2012-12#1)
have higher rates##3##3##(1995-2#1)(2008-4#1)(2012-12#1)
have higher##18##2##(1992-2#1)(1993-11#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#2)(2009-7#1)(2012-12#1)(2013-1#2)(2013-8#2)
have highlighted the##2##3##(1997-7#1)(2008-10#1)
have highlighted##5##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
have highly##4##2##(1995-1#1)(2009-10#1)(2010-8#1)(2012-12#1)
have homologues##2##2##(1996-3#1)(1996-6#1)
have hypothesized##2##2##(2009-8#1)(2011-2#1)
have identified a##5##3##(1990-5#1)(1993-12#1)(1993-8#1)(1995-9#1)(2010-11#1)
have identified an##2##3##(1991-5#1)(1996-2#1)
have identified and characterized a##2##5##(1995-2#1)(2008-10#1)
have identified and##4##3##(1995-2#2)(2008-10#2)
have identified the##12##3##(1990-7#1)(1993-3#1)(1995-2#1)(1995-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)
have identified two types of##2##5##(1992-6#1)(1994-3#1)
have identified##50##2##(1990-5#1)(1990-7#1)(1991-5#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-3#1)(1995-2#6)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
have illustrated##2##2##(2008-8#1)(2009-10#1)
have implemented##5##2##(1994-3#1)(1996-2#1)(1996-8#1)(2008-3#2)
have implicated##4##2##(2008-11#2)(2012-3#1)(2013-1#1)
have implications for the management of##2##6##(2008-9#1)(2013-1#1)
have implications for the##5##4##(1995-6#1)(2008-9#1)(2009-10#1)(2013-1#1)(2013-7#1)
have implications for##23##3##(1992-2#1)(1992-9#1)(1994-1#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
have implications##25##2##(1992-2#1)(1992-9#1)(1994-1#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
have important implications for##13##4##(1993-3#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2013-1#1)
have important implications##16##3##(1993-3#1)(1994-11#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2013-1#1)
have important##24##2##(1990-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
have improved the##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
have improved their##2##3##(1990-11#1)(1997-6#1)
have improved##12##2##(1990-11#1)(1994-6#1)(1997-2#1)(1997-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-10#1)(2010-6#1)(2012-12#1)(2012-2#1)
have in common##2##3##(1997-3#1)(2008-6#1)
have in the##2##3##(1996-6#1)(2008-7#1)
have in##11##2##(1993-12#1)(1993-2#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-1#1)(2013-1#1)
have included##4##2##(1997-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
have incorporated the##2##3##(2008-9#1)(2010-1#1)
have incorporated##3##2##(2008-9#2)(2010-1#1)
have increased by##3##3##(1992-3#1)(1997-6#1)(1997-8#1)
have increased the need for##2##5##(1994-1#1)(2008-11#1)
have increased the##9##3##(1991-12#1)(1994-1#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
have increased##21##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-5#1)(1994-6#1)(1995-12#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#1)(2013-8#1)
have increasingly been##2##3##(2011-2#1)(2012-2#1)
have independently##2##2##(2008-11#1)(2011-2#1)
have indicated that the##4##4##(1996-11#1)(2008-10#2)(2008-9#1)
have indicated that##19##3##(1992-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(1996-9#1)(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)
have indicated##26##2##(1990-2#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
have influenced##2##2##(2008-10#1)(2008-11#1)
have inherent##2##2##(2008-10#1)(2013-8#1)
have initially##2##2##(2008-10#1)(2008-4#1)
have initiated a study of##2##5##(1993-9#1)(1995-11#1)
have initiated a##3##3##(1993-9#1)(1995-11#1)(2012-3#1)
have initiated##6##2##(1993-9#1)(1995-11#2)(2008-10#1)(2008-7#1)(2012-3#1)
have interesting##2##2##(2008-5#1)(2010-11#1)
have internal##2##2##(2008-6#2)
have intrinsic##2##2##(2008-10#1)(2008-11#1)
have introduced##2##2##(2008-10#1)(2010-6#1)
have investigated how##3##3##(1996-2#1)(2009-8#1)(2011-2#1)
have investigated the effect of##3##5##(1994-11#1)(2008-10#1)(2013-1#1)
have investigated the role of##3##5##(2008-10#1)(2008-7#2)
have investigated the##32##3##(1990-3#1)(1991-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-7#3)(2012-2#1)(2013-1#1)
have investigated whether##3##3##(1994-2#1)(1995-2#1)(2012-2#1)
have investigated##42##2##(1990-3#1)(1991-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(2008-10#6)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#3)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
have isolated a##7##3##(1993-12#1)(1993-2#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-5#1)
have isolated and characterised##2##4##(1993-2#1)(2008-11#1)
have isolated##19##2##(1990-8#1)(1992-10#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-6#2)(1993-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)
have large##5##2##(1994-5#1)(2008-10#1)(2008-11#2)(2010-8#1)
have largely been##4##3##(2008-10#1)(2008-9#1)(2012-2#1)(2012-4#1)
have largely##10##2##(1990-11#1)(2008-10#1)(2008-9#3)(2009-8#1)(2009-9#1)(2012-2#2)(2012-4#1)
have lead to the##2##4##(2008-11#1)(2008-5#1)
have lead##3##2##(1994-2#1)(2008-11#1)(2008-5#1)
have learned##5##2##(2008-11#1)(2008-3#2)(2009-8#1)(2010-12#1)
have led to a##6##4##(1993-8#1)(2008-5#1)(2010-10#1)(2010-6#1)(2012-2#1)(2012-3#1)
have led to an increase in the##2##7##(2008-10#1)(2008-11#1)
have led to an##3##4##(1992-2#1)(2008-10#1)(2008-11#1)
have led to significant advances in##2##6##(2009-3#1)(2011-1#1)
have led to the development of##2##6##(2008-5#1)(2010-1#1)
have led to the discovery of the##2##7##(2008-11#1)(2013-8#1)
have led to the##13##4##(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
have led to##36##3##(1990-6#1)(1992-2#1)(1993-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-10#2)(2010-6#2)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
have led##39##2##(1990-6#1)(1992-2#1)(1993-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#2)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
have left##2##2##(1991-2#1)(2011-2#1)
have less##4##2##(1997-6#1)(2008-1#1)(2008-10#1)(2010-7#1)
have limitations##6##2##(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
have limited the##2##3##(1997-8#1)(2008-8#1)
have limited##9##2##(1990-2#1)(1991-3#1)(1992-2#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
have little control over##2##4##(2008-1#2)
have little effect on##2##4##(1993-1#1)(1994-6#1)
have little effect##3##3##(1993-1#1)(1994-12#1)(1994-6#1)
have little or no##2##4##(1995-5#1)(2008-10#1)
have little##13##2##(1991-7#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
have lived##2##2##(2008-11#1)(2008-8#1)
have localized##2##2##(1995-12#1)(1995-6#1)
have long been implicated in##2##5##(2008-11#1)(2009-6#1)
have long been known to##2##5##(2008-9#1)(2010-7#1)
have long been##13##3##(1994-3#1)(1996-12#1)(2008-11#3)(2008-9#2)(2009-6#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
have long##18##2##(1993-2#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-9#2)(2009-6#1)(2010-10#2)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#2)
have long-term##2##2##(2011-2#1)(2013-1#1)
have longer##2##2##(1996-2#1)(2008-10#1)
have looked at##2##3##(2008-5#1)(2008-7#1)
have lost the##2##3##(2008-10#1)(2011-2#1)
have lost##6##2##(1994-12#1)(2007-12#2)(2008-10#1)(2008-6#1)(2011-2#1)
have low genetic##2##3##(2008-10#1)(2013-1#1)
have low##15##2##(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
have lower##10##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
have made an attempt to##2##5##(2008-10#1)(2009-7#1)
have made an##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
have made it possible to##2##5##(1994-6#1)(2008-3#1)
have made it possible##3##4##(1994-6#1)(2008-10#1)(2008-3#1)
have made it##5##3##(1994-6#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
have made progress in##2##4##(2009-7#1)(2013-1#1)
have made the##4##3##(1993-12#1)(1994-2#1)(2008-11#1)(2012-3#1)
have made##26##2##(1993-12#1)(1994-2#1)(1994-6#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-7#1)(2011-2#2)(2011-3#2)(2012-2#2)(2012-3#1)(2013-1#1)
have maintained##2##2##(1992-12#1)(2010-5#1)
have major##2##2##(1996-12#1)(2008-7#1)
have many advantages##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
have many##11##2##(1991-5#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)
have measured the##2##3##(1991-5#1)(2008-8#1)
have measured##4##2##(1991-5#2)(2008-3#1)(2008-8#1)
have moderate##2##2##(2008-1#1)(2008-5#1)
have modified the##4##3##(2008-10#1)(2008-11#3)
have modified##5##2##(2008-10#1)(2008-11#3)(2008-2#1)
have more physical##2##3##(2013-8#2)
have more species##2##3##(2008-9#2)
have more than##3##3##(1996-2#1)(2008-10#2)
have more##24##2##(1991-1#1)(1992-3#2)(1993-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#2)(2010-5#1)(2010-6#2)(2013-8#4)
have mostly##2##2##(2008-11#1)(2009-1#1)
have moved##2##2##(1994-2#1)(2011-2#1)
have much in common##2##4##(1996-1#1)(2008-10#1)
have much to contribute to##2##5##(2008-11#1)(2008-9#1)
have much to##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
have much##7##2##(1994-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)
have multiple##9##2##(2008-10#1)(2008-9#3)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)
have necessitated##3##2##(2008-1#1)(2008-2#1)(2009-10#1)
have negative##2##2##(1997-2#1)(2008-11#1)
have negligible##2##2##(2008-3#1)(2010-6#1)
have never been##3##3##(1993-11#1)(2008-7#1)(2009-6#1)
have never heard of##2##4##(2009-5#1)(2013-1#1)
have never##6##2##(1993-11#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-6#1)(2013-1#1)
have new##2##2##(2008-10#2)
have no apparent##2##3##(2008-11#1)(2008-8#1)
have no effect on the##5##5##(1994-8#1)(2008-10#4)
have no effect on##7##4##(1994-8#1)(1995-8#1)(2008-10#4)(2012-2#1)
have no known sexual##2##4##(2008-10#2)
have no##32##2##(1990-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-7#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-12#1)(2012-2#1)
have normal##8##2##(1995-8#1)(1997-3#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#1)
have not always been##2##4##(1993-12#1)(1994-12#1)
have not been adequately##2##4##(2008-11#1)(2010-5#1)
have not been clearly##2##4##(2011-2#1)(2012-2#1)
have not been conclusively##2##4##(2008-11#1)(2008-8#1)
have not been described##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
have not been extensively##2##4##(2008-7#1)(2012-2#1)
have not been found##3##4##(1993-6#1)(2008-10#1)(2008-4#1)
have not been fully elucidated##2##5##(1990-2#1)(2008-6#1)
have not been fully##4##4##(1990-2#1)(2008-6#1)(2010-10#1)(2011-2#1)
have not been identified##4##4##(2008-10#2)(2008-7#1)(2008-9#1)
have not been observed##2##4##(1993-2#1)(2008-10#1)
have not been previously reported##2##5##(2008-3#1)(2008-9#1)
have not been previously##3##4##(2008-3#1)(2008-9#1)(2010-1#1)
have not been reported##8##4##(2008-10#5)(2008-5#1)(2008-8#1)(2011-2#1)
have not been studied in##2##5##(2008-5#1)(2011-1#1)
have not been studied##5##4##(1997-1#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-1#1)
have not been tested##2##4##(1990-6#1)(2013-1#1)
have not been well##2##4##(1997-8#1)(2008-10#1)
have not been widely##3##4##(2009-4#1)(2009-6#1)(2010-6#1)
have not been##82##3##(1990-11#1)(1990-2#1)(1990-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#2)
have not found##2##3##(2008-9#1)(2012-2#1)
have not fully##2##3##(2008-7#1)(2009-10#1)
have not had##2##3##(1995-3#1)(2008-6#1)
have not only##3##3##(2008-12#1)(2008-5#1)(2009-3#1)
have not previously been##3##4##(1996-1#1)(2008-10#1)(2008-8#1)
have not yet been widely##2##5##(2008-11#1)(2012-2#1)
have not yet been##9##4##(1990-8#1)(1993-1#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#2)(2012-3#1)
have not yet##14##3##(1990-8#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2012-2#2)(2012-3#1)
have not##134##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#8)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#6)(2012-3#3)(2013-1#3)
have noted##2##2##(2009-10#1)(2011-2#1)
have noticed##2##2##(2009-10#1)(2013-1#1)
have novel##2##2##(1993-6#1)(2008-10#1)
have now been shown to##2##5##(1995-6#1)(1995-8#1)
have now been##6##3##(1995-6#1)(1995-8#1)(1997-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
have now demonstrated that##3##4##(1997-1#1)(2008-11#1)(2009-6#1)
have now identified##2##3##(1993-2#1)(1997-7#1)
have now##21##2##(1990-9#1)(1992-3#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-7#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#1)(2012-3#1)
have observed that##5##3##(1996-2#1)(2008-11#2)(2010-5#1)(2013-1#1)
have observed##12##2##(1990-3#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-5#1)(2013-1#1)
have obtained##10##2##(1992-9#1)(1993-8#1)(1994-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)
have occurred by##2##3##(2010-5#1)(2011-2#1)
have occurred in the##5##4##(2008-10#3)(2008-11#1)(2010-12#1)
have occurred in##11##3##(1995-2#1)(1996-11#1)(2008-10#5)(2008-11#3)(2010-12#1)
have occurred##31##2##(1991-1#1)(1994-11#1)(1995-2#1)(1996-11#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#3)
have often been##2##3##(2008-9#1)(2013-1#1)
have often##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
have on the##4##3##(1995-3#1)(1997-2#1)(2008-11#1)(2008-9#1)
have on##19##2##(1991-2#1)(1992-1#1)(1993-3#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#2)
have one##4##2##(1991-10#1)(1996-1#1)(2007-12#1)(2008-5#1)
have only a minor##2##4##(2008-10#1)(2013-8#1)
have only a##6##3##(1992-6#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
have only recently begun##2##4##(2008-11#1)(2013-8#1)
have only recently##3##3##(2008-11#2)(2013-8#1)
have only##18##2##(1991-1#1)(1991-3#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-8#3)
have opened##2##2##(2008-11#1)(2008-12#1)
have originated##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
have other##3##2##(2008-12#1)(2008-5#1)(2008-8#1)
have overlapping##2##2##(2013-1#2)
have participated in##2##3##(2008-1#1)(2012-2#1)
have performed a##3##3##(2012-3#1)(2013-1#2)
have performed##10##2##(1990-2#1)(2008-11#1)(2008-3#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
have permitted##2##2##(2008-11#1)(2010-8#1)
have played##3##2##(1991-6#1)(2008-7#1)(2009-10#1)
have poorer##2##2##(1994-12#1)(2008-11#1)
have positive##4##2##(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
have potential for##3##3##(2008-10#2)(2013-1#1)
have potential to##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
have potential##14##2##(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-1#1)(2011-2#1)(2013-1#2)
have potentially##2##2##(2008-11#2)
have practical implications for##2##4##(2008-8#1)(2010-5#1)
have predicted the##2##3##(2008-8#1)(2010-7#1)
have predicted##3##2##(2008-3#1)(2008-8#1)(2010-7#1)
have prepared##4##2##(1991-12#1)(1994-11#1)(2008-10#1)(2008-11#1)
have presented##3##2##(1991-2#1)(1997-3#1)(2008-8#1)
have prevalence rates that are intermediate to those of the two corresponding monoracial/ethnic rates##2##14##(2013-8#2)
have previously been identified##2##4##(1996-3#1)(2008-10#1)
have previously been reported##2##4##(1993-8#1)(2008-11#1)
have previously been shown to##2##5##(1993-12#1)(2008-10#1)
have previously been##10##3##(1991-6#1)(1992-10#1)(1993-12#1)(1993-8#1)(1994-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
have previously isolated##2##3##(1997-8#1)(2008-5#1)
have previously reported the##4##4##(1994-8#1)(1997-8#1)(2008-10#1)(2010-3#1)
have previously reported##5##3##(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#1)(2010-3#1)
have previously shown that##13##4##(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
have previously shown##15##3##(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
have previously##52##2##(1991-6#1)(1992-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#5)(2008-11#6)(2008-5#3)(2008-8#2)(2009-6#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
have primarily##2##2##(2008-11#1)(2012-3#1)
have private##3##2##(1991-2#1)(1992-2#1)(1996-3#1)
have problems##3##2##(1992-5#1)(2008-3#1)(2008-9#1)
have produced a##3##3##(1994-3#1)(2008-11#1)(2010-11#1)
have produced##15##2##(1990-11#1)(1991-12#1)(1991-5#1)(1994-3#1)(1995-12#2)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)
have profound effects on##2##4##(2008-8#1)(2010-1#1)
have profound##3##2##(2008-8#2)(2010-1#1)
have progressed through##2##3##(1996-3#1)(2008-10#1)
have progressed##4##2##(1991-1#1)(1993-2#1)(1996-3#1)(2008-10#1)
have prolonged##2##2##(2008-10#1)(2008-11#1)
have prompted##2##2##(2008-7#1)(2012-3#1)
have proper##2##2##(1994-9#1)(2009-12#1)
have properties##3##2##(1995-3#1)(2008-3#1)(2008-8#1)
have proposed that##4##3##(2008-11#1)(2008-4#1)(2009-6#1)(2013-1#1)
have proposed##6##2##(1996-5#1)(2008-11#2)(2008-4#1)(2009-6#1)(2013-1#1)
have protective effects on##2##4##(2008-5#1)(2011-3#1)
have proved to be##2##4##(1991-3#1)(1997-1#1)
have proved##10##2##(1991-3#1)(1992-1#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
have proven to be very##3##5##(2008-10#2)(2008-7#1)
have proven to be##6##4##(1996-2#1)(2008-10#3)(2008-7#1)(2013-8#1)
have proven to##7##3##(1996-2#1)(2008-10#3)(2008-7#1)(2012-2#1)(2013-8#1)
have proven useful in##2##4##(2008-11#1)(2008-12#1)
have proven useful##3##3##(2008-11#1)(2008-12#1)(2010-7#1)
have proven##18##2##(1994-12#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
have provided a##5##3##(1992-2#1)(1992-3#1)(1997-7#1)(2008-1#1)(2009-12#1)
have provided an##3##3##(1997-6#1)(2008-9#2)
have provided further##2##3##(2008-12#1)(2011-2#1)
have provided insight##2##3##(1995-5#1)(2008-9#1)
have provided new insight into##2##5##(1993-2#1)(2010-4#1)
have provided new insights##2##4##(2008-10#1)(2011-2#1)
have provided new##5##3##(1993-2#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#1)
have provided the first##2##4##(2008-4#1)(2008-8#1)
have provided##38##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-2#1)(1995-5#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2010-1#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
have provoked##2##2##(2010-12#1)(2012-2#1)
have public health implications##2##4##(2009-6#1)(2011-2#1)
have pulmonary##3##2##(1991-12#2)(2009-10#1)
have purified##3##2##(1992-8#1)(1994-3#1)(1996-2#1)
have put##2##2##(1994-8#1)(2009-10#1)
have quantified##2##2##(2008-10#1)(2008-9#1)
have raised questions##2##3##(2008-9#1)(2013-1#1)
have raised the##2##3##(1992-12#1)(2008-11#1)
have raised##6##2##(1991-9#1)(1992-12#1)(2008-11#2)(2008-9#1)(2013-1#1)
have rapidly increased##2##3##(2008-11#1)(2011-2#1)
have reached##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
have received increasing attention##2##4##(1994-2#1)(2008-8#1)
have received little attention##3##4##(2008-8#1)(2009-3#1)(2010-1#1)
have received little##4##3##(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)
have received much##2##3##(2008-5#1)(2008-9#1)
have received##20##2##(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2013-8#1)
have recently been described##2##4##(1990-5#1)(2010-12#1)
have recently been developed##4##4##(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
have recently been proposed##3##4##(1994-6#1)(1995-12#1)(2013-1#1)
have recently been##18##3##(1990-5#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
have recently characterized##2##3##(2009-8#1)(2011-2#1)
have recently demonstrated##6##3##(1994-2#1)(2008-11#1)(2009-8#2)(2011-2#1)(2012-2#1)
have recently found##2##3##(1991-12#1)(2008-11#1)
have recently gained##2##3##(2008-10#2)
have recently identified##2##3##(1991-5#1)(2009-8#1)
have recently reported that##4##4##(1995-6#1)(1997-3#1)(2009-8#1)(2012-2#1)
have recently reported##5##3##(1995-6#1)(1997-3#1)(2008-11#1)(2009-8#1)(2012-2#1)
have recently shown that##12##4##(1990-5#1)(1994-5#1)(2008-1#1)(2008-11#1)(2009-8#7)(2011-2#1)
have recently##64##2##(1990-5#2)(1991-12#1)(1991-5#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-5#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#14)(2010-12#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)
have recognized the##2##3##(1991-3#1)(1997-2#1)
have reduced##6##2##(1991-11#1)(1994-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
have relatively##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
have relied on##3##3##(1991-3#1)(1997-1#1)(2011-2#1)
have relied##4##2##(1991-3#1)(1995-1#1)(1997-1#1)(2011-2#1)
have remained largely##2##3##(1991-8#1)(2008-9#1)
have remained##10##2##(1991-8#1)(1993-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-6#1)
have reported a new##2##4##(2008-10#1)(2012-12#1)
have reported a##5##3##(1993-3#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
have reported that the##4##4##(1995-11#1)(2008-11#1)(2009-11#1)(2011-2#1)
have reported that##9##3##(1995-11#1)(2008-10#2)(2008-11#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
have reported the##7##3##(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#2)(2013-1#1)(2013-8#1)
have reported##34##2##(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(2008-10#7)(2008-11#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
have represented the##2##3##(2009-5#1)(2009-6#1)
have represented##3##2##(2009-5#1)(2009-6#2)
have required##2##2##(1994-12#1)(1997-3#1)
have responded##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
have resulted from##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2010-3#1)
have resulted in a##2##4##(1994-12#1)(2008-10#1)
have resulted in the##5##4##(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
have resulted in##16##3##(1994-12#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)
have resulted##21##2##(1994-12#2)(1997-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
have retained##2##2##(2008-11#1)(2009-8#1)
have revealed a##4##3##(1993-3#1)(1995-12#1)(2009-7#1)(2011-2#1)
have revealed that the##3##4##(1990-5#1)(2008-12#1)(2009-9#1)
have revealed that##15##3##(1990-12#1)(1990-5#1)(1992-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#2)(2010-10#1)(2011-2#1)(2012-3#1)
have revealed the existence of##2##5##(2008-10#1)(2010-7#1)
have revealed the##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2010-7#1)
have revealed##34##2##(1990-12#1)(1990-5#1)(1992-10#1)(1993-3#1)(1995-12#2)(1995-5#1)(1996-9#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
have reviewed the##5##3##(1990-2#1)(1991-9#1)(1995-12#1)(1996-6#1)(2008-10#1)
have reviewed##7##2##(1990-2#1)(1991-9#1)(1994-12#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-11#1)
have revolutionized##2##2##(2008-5#1)(2010-5#1)
have searched for##2##3##(1991-5#1)(2008-11#1)
have seen##6##2##(1997-6#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
have sequenced the##2##3##(1990-5#1)(2011-2#1)
have sequenced##3##2##(1990-5#1)(2008-5#1)(2011-2#1)
have serious##2##2##(1995-2#1)(2013-1#1)
have several##5##2##(1992-6#1)(1993-1#1)(2008-5#2)(2012-3#1)
have shed light on##2##4##(2008-8#1)(2009-7#1)
have shed##3##2##(2008-8#1)(2009-7#1)(2011-2#1)
have shifted to##2##3##(2010-7#1)(2011-2#1)
have shifted##4##2##(1992-2#1)(2008-12#1)(2010-7#1)(2011-2#1)
have short##2##2##(2008-11#2)
have showed##2##2##(2009-8#1)(2012-2#1)
have shown a positive correlation##2##5##(1995-9#1)(2011-2#1)
have shown a positive##3##4##(1993-3#1)(1995-9#1)(2011-2#1)
have shown a##9##3##(1992-12#1)(1993-3#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#1)
have shown an##3##3##(1991-6#1)(2008-10#2)
have shown no##2##3##(1993-1#1)(2008-11#1)
have shown some##3##3##(2008-10#1)(2008-11#2)
have shown that a##7##4##(1994-8#1)(2008-11#1)(2008-7#2)(2011-2#3)
have shown that loss of##2##5##(2013-1#1)(2013-7#1)
have shown that the presence of##2##6##(2008-1#1)(2013-1#1)
have shown that the two##2##5##(1993-11#1)(2008-10#1)
have shown that the##27##4##(1993-11#1)(1993-8#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
have shown that there is##2##5##(1991-3#1)(2008-9#1)
have shown that these##3##4##(1995-2#1)(2006-6#1)(2010-11#1)
have shown that this##7##4##(1993-6#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)
have shown that##129##3##(1991-3#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-4#1)(2006-6#1)(2007-12#1)(2008-1#4)(2008-10#14)(2008-11#12)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#12)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#3)
have shown the##9##3##(1992-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-2#1)
have shown##197##2##(1990-6#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#4)(1997-2#3)(1997-4#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-1#5)(2008-10#29)(2008-11#19)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#3)(2009-10#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#4)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#18)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#5)
have significant effects on##3##4##(2008-10#1)(2008-9#1)(2009-5#1)
have significant impacts on##2##4##(1991-12#1)(2008-10#1)
have significant implications##2##3##(2008-10#1)(2008-7#1)
have significant##22##2##(1991-12#1)(1992-3#1)(1993-2#1)(1994-8#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#3)
have significantly increased##2##3##(1990-12#1)(1993-3#1)
have significantly##8##2##(1990-12#1)(1991-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-3#1)(2008-10#1)(2012-2#1)
have signs##2##2##(1991-8#1)(2008-3#1)
have similar precompetitive distributions##2##4##(2008-8#2)
have similar##13##2##(1996-8#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#2)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
have since been##2##3##(1996-3#1)(2008-9#1)
have since##4##2##(1996-3#1)(2008-12#2)(2008-9#1)
have small##3##2##(1990-6#1)(2008-10#1)(2008-11#1)
have so far been##7##4##(1990-11#1)(1991-12#1)(1991-6#1)(2008-11#1)(2009-8#1)(2009-9#1)(2011-2#1)
have some##12##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-1#1)(1997-3#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#1)
have sought to determine##2##4##(2008-11#1)(2008-8#1)
have sought to##4##3##(1993-12#1)(2008-11#2)(2008-8#1)
have sought##5##2##(1993-12#1)(2008-11#2)(2008-8#1)(2013-1#1)
have special##2##2##(2008-10#1)(2008-12#1)
have specific resistance to##2##4##(2008-10#2)
have specific##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-12#1)(2009-6#1)(2012-3#1)
have spread##4##2##(1996-1#1)(1997-6#1)(2008-10#1)(2008-7#1)
have stabilized##2##2##(2011-1#1)(2013-1#1)
have standardized##2##2##(2008-11#1)(2008-7#1)
have started to##2##3##(2008-10#1)(2008-11#1)
have stressed the##2##3##(2008-11#1)(2010-10#1)
have strong##7##2##(1996-8#1)(2008-10#3)(2008-11#1)(2008-8#2)
have studied a##2##3##(1997-3#1)(2008-8#1)
have studied the effect of##4##5##(1993-1#1)(1994-11#1)(1995-6#1)(1997-7#1)
have studied the##20##3##(1990-12#1)(1991-11#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
have studied##30##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
have studies##2##2##(1996-2#1)(2013-1#1)
have substantial##3##2##(1993-11#1)(1993-12#1)(2012-3#1)
have substantially##3##2##(1993-1#1)(1995-2#1)(2008-10#1)
have successfully been##2##3##(2008-10#1)(2008-7#1)
have successfully##6##2##(2008-10#2)(2008-11#3)(2008-7#1)
have such##4##2##(2008-11#1)(2008-12#1)(2012-2#1)(2013-7#1)
have suffered##5##2##(1995-11#1)(1996-11#1)(2008-12#1)(2008-9#1)(2009-10#1)
have sufficient##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
have suggested a##7##3##(1996-11#1)(2008-10#1)(2008-5#1)(2013-1#4)
have suggested that a##2##4##(1992-1#1)(2009-10#1)
have suggested that the##2##4##(1992-12#1)(1992-2#1)
have suggested that##21##3##(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-6#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#2)
have suggested##31##2##(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#6)
have suitably##2##2##(2009-7#1)(2012-12#1)
have summarized##2##2##(2008-10#1)(2008-5#1)
have supported##3##2##(2009-8#1)(2010-6#1)(2010-7#1)
have surfaced##2##2##(2011-2#2)
have survived##2##2##(1991-12#1)(2009-5#1)
have synthesized##3##2##(2008-5#1)(2009-7#1)(2012-2#1)
have systematically##2##2##(1995-6#1)(2008-9#1)
have taken place in##3##4##(1991-2#1)(1991-3#1)(2008-2#1)
have taken place##5##3##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(2008-2#1)
have taken##15##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1995-11#1)(1997-3#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-9#1)(2013-1#1)
have tended to##2##3##(1992-1#1)(2008-9#1)
have tested the##5##3##(1995-2#1)(2008-10#1)(2008-11#2)(2012-3#1)
have tested##9##2##(1995-2#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-9#1)(2012-3#1)
have the ability to induce##2##5##(2008-10#1)(2011-2#1)
have the ability to##10##4##(1993-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2011-2#1)
have the additional##2##3##(1992-12#1)(2008-10#1)
have the advantage of##2##4##(1990-11#1)(2008-11#1)
have the advantage that they##2##5##(1992-3#1)(2008-10#1)
have the advantage##4##3##(1990-11#1)(1992-3#1)(2008-10#1)(2008-11#1)
have the best##4##3##(1995-2#1)(2008-10#2)(2009-8#1)
have the capacity to##5##4##(1997-3#2)(1997-8#1)(2008-11#1)(2008-5#1)
have the disadvantage##2##3##(1990-2#1)(2008-11#1)
have the disease##2##3##(1996-2#2)
have the greatest impact##2##4##(2008-8#1)(2011-2#1)
have the greatest##6##3##(1991-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
have the highest##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
have the most##5##3##(1994-2#1)(1994-3#1)(2008-4#2)(2011-2#1)
have the opportunity to##2##4##(1994-1#1)(2008-11#1)
have the potential for##2##4##(2008-10#1)(2009-8#1)
have the potential to be##4##5##(1997-7#1)(2008-12#1)(2008-3#1)(2012-2#1)
have the potential to enhance##2##5##(2008-1#1)(2008-10#1)
have the potential to improve##2##5##(1994-12#1)(2009-8#1)
have the potential to induce##2##5##(2008-8#1)(2011-2#1)
have the potential to##29##4##(1994-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
have the potential##32##3##(1993-9#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#2)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
have the prerogative##2##3##(1994-3#1)(1995-6#1)
have the responsibility##2##3##(1993-11#1)(2012-3#1)
have the same genotype##2##4##(2008-10#2)
have the same##22##3##(1992-12#1)(1992-3#1)(1992-7#1)(1993-6#1)(1993-8#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-10#2)(2010-5#2)(2013-1#1)(2013-8#1)
have the##152##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#3)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#4)(1996-5#2)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#23)(2008-11#12)(2008-12#4)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#8)(2008-9#4)(2009-10#2)(2009-12#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#3)
have their own##4##3##(1992-6#1)(1996-9#1)(2006-6#1)(2008-5#1)
have their##16##2##(1990-2#1)(1992-6#1)(1996-2#1)(1996-9#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)
have therapeutic implications##3##3##(1997-1#1)(2011-2#1)(2012-2#1)
have therapeutic##6##2##(1994-2#1)(1997-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
have therefore##5##2##(1993-3#1)(1995-8#1)(2008-11#1)(2008-6#1)(2008-9#1)
have three##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
have thus##4##2##(1994-9#1)(1995-6#1)(2008-10#1)(2011-2#1)
have to be considered##2##4##(2008-10#1)(2011-2#1)
have to be developed##2##4##(2008-3#1)(2008-4#1)
have to be identified##2##4##(2008-10#1)(2011-1#1)
have to be met##2##4##(1996-2#1)(2013-8#1)
have to be taken without the benefit of##2##8##(2010-12#2)
have to be taken##4##4##(2010-12#3)(2012-2#1)
have to be##52##3##(1991-2#1)(1991-8#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-4#2)(2008-8#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#4)(2011-1#1)(2011-2#4)(2012-2#6)(2012-3#1)(2012-9#1)(2013-8#1)
have to do##2##3##(1991-1#1)(2010-12#1)
have to make##3##3##(1991-11#1)(1995-2#1)(2013-1#1)
have to rely##2##3##(1997-7#1)(2008-12#1)
have to##83##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#6)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#6)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
have traditionally been##5##3##(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
have traditionally##8##2##(1994-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#2)(2013-1#1)
have treated##2##2##(1997-4#1)(2008-8#1)
have two types of##3##4##(1990-11#1)(2008-5#1)(2013-8#1)
have two##11##2##(1990-11#1)(1994-11#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-6#1)(2009-9#1)(2013-8#1)
have uncovered##2##2##(2008-11#1)(2009-9#1)
have undergone##12##2##(1990-9#1)(1991-3#1)(1992-2#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-6#1)(2012-12#1)(2013-1#2)
have undertaken a##4##3##(1993-3#1)(1997-3#1)(2008-11#1)(2010-9#1)
have undertaken##6##2##(1993-12#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-9#1)
have unique advantages and##2##4##(2011-3#1)(2013-1#1)
have unique##4##2##(2008-11#1)(2010-5#1)(2011-3#1)(2013-1#1)
have until##2##2##(1996-5#1)(2010-7#1)
have unusual##3##2##(1991-3#1)(2008-7#1)(2012-2#1)
have used 13C##2##3##(1992-10#1)(1992-3#1)
have used a##8##3##(1990-2#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)
have used in##2##3##(1995-2#1)(1996-12#1)
have used the##10##3##(1995-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2010-9#1)
have used this technique##3##4##(1991-12#1)(2008-10#1)(2008-11#1)
have used this##5##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
have used##58##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#2)(1995-2#4)(1996-12#2)(1996-3#1)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#10)(2008-11#8)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#3)
have utility##2##2##(1995-5#1)(2008-10#1)
have variable##2##2##(1997-3#1)(2008-11#1)
have various##2##2##(1993-3#1)(1997-2#1)
have very little##2##3##(1995-2#1)(2008-10#1)
have very low##2##3##(2009-10#1)(2010-4#1)
have very##10##2##(1994-9#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-10#1)(2010-4#1)(2012-2#1)
have we##4##2##(2008-10#1)(2008-8#1)(2009-4#1)(2012-2#1)
have witnessed##3##2##(2009-12#1)(2010-10#1)(2013-8#1)
have worked##2##2##(1994-12#1)(1995-3#1)
have yet to be##9##4##(1991-2#1)(1991-7#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#2)(2010-5#1)(2010-7#1)
have yet to##10##3##(1991-2#1)(1991-7#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-5#1)(2010-7#1)
have yet##11##2##(1991-2#1)(1991-7#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-5#1)(2010-7#1)(2011-2#1)
have yielded##5##2##(1994-5#1)(2010-5#1)(2011-2#1)(2013-1#2)
have##7149##1##(1990-11#26)(1990-12#16)(1990-2#16)(1990-3#11)(1990-5#29)(1990-6#22)(1990-7#4)(1990-8#11)(1990-9#10)(1991-1#19)(1991-10#2)(1991-11#9)(1991-12#40)(1991-2#35)(1991-3#41)(1991-5#19)(1991-6#25)(1991-7#4)(1991-8#6)(1991-9#10)(1992-1#16)(1992-10#5)(1992-11#8)(1992-12#23)(1992-2#34)(1992-3#41)(1992-4#1)(1992-5#8)(1992-6#18)(1992-7#3)(1992-8#6)(1992-9#20)(1993-1#14)(1993-11#22)(1993-12#55)(1993-2#33)(1993-3#50)(1993-6#32)(1993-8#32)(1993-9#7)(1994-1#17)(1994-11#33)(1994-12#49)(1994-2#34)(1994-3#35)(1994-5#31)(1994-6#21)(1994-8#22)(1994-9#19)(1995-1#12)(1995-10#1)(1995-11#31)(1995-12#47)(1995-2#68)(1995-3#18)(1995-5#33)(1995-6#44)(1995-8#21)(1995-9#10)(1996-1#24)(1996-11#17)(1996-12#42)(1996-2#59)(1996-3#42)(1996-5#25)(1996-6#11)(1996-8#9)(1996-9#8)(1997-1#54)(1997-2#54)(1997-3#49)(1997-4#11)(1997-5#11)(1997-6#25)(1997-7#41)(1997-8#45)(1997-9#4)(2006-5#3)(2006-6#9)(2007-11#12)(2007-12#40)(2007-8#3)(2007-9#4)(2008-1#48)(2008-10#1456)(2008-11#576)(2008-12#132)(2008-2#42)(2008-3#151)(2008-4#71)(2008-5#176)(2008-6#44)(2008-7#213)(2008-8#177)(2008-9#229)(2009-1#11)(2009-10#56)(2009-11#12)(2009-12#30)(2009-3#32)(2009-4#17)(2009-5#31)(2009-6#38)(2009-7#42)(2009-8#76)(2009-9#13)(2010-1#47)(2010-10#50)(2010-11#43)(2010-12#64)(2010-2#3)(2010-3#16)(2010-4#28)(2010-5#39)(2010-6#32)(2010-7#55)(2010-8#42)(2010-9#18)(2011-1#47)(2011-10#2)(2011-2#300)(2011-3#35)(2011-7#5)(2012-12#47)(2012-2#186)(2012-3#133)(2012-4#1)(2012-5#3)(2012-6#2)(2012-7#1)(2012-9#1)(2013-1#231)(2013-7#12)(2013-8#102)
have?##2##1##(1997-3#1)(2009-5#1)
having HIV infection##2##3##(1996-11#1)(2010-12#1)
having M(n) (NMR) =##2##4##(2008-12#2)
having a C20 ketone##2##4##(1997-1#2)
having a high##5##3##(1991-5#1)(2010-11#2)(2010-12#1)(2010-8#1)
having a low##2##3##(1990-9#1)(1991-5#1)
having a mentor##3##3##(2008-11#3)
having a molecular##2##3##(1990-11#1)(2008-10#1)
having a negative##3##3##(1992-1#2)(2010-12#1)
having a role in##2##4##(1992-7#1)(1995-6#1)
having a sensitive absorption peak at##2##6##(2008-10#2)
having a usual source of health care##2##7##(2008-10#2)
having a usual source of##3##5##(1995-12#1)(2008-10#2)
having a##92##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#2)(1992-1#3)(1992-3#1)(1992-7#1)(1993-8#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-9#1)(1997-1#5)(1997-2#1)(2008-10#16)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-8#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
having access to a##2##4##(2008-12#2)
having an##18##2##(1992-2#1)(1993-6#1)(1994-2#1)(1994-9#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-3#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)
having at least##2##3##(2008-10#1)(2013-1#1)
having been##12##2##(1990-5#1)(1991-12#1)(1991-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#2)(2010-8#1)(2013-1#1)(2013-8#1)
having chelating functionalities##2##3##(2008-10#2)
having complex##2##2##(2011-1#1)(2011-2#1)
having different##9##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-8#1)
having had##3##2##(1991-12#1)(2007-12#1)(2008-1#1)
having high##2##2##(1993-1#1)(2013-1#1)
having higher##4##2##(1993-12#1)(2008-5#1)(2009-11#1)(2011-2#1)
having identical##3##2##(1997-7#1)(2008-10#2)
having low##7##2##(1991-12#1)(1996-12#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-8#1)
having molar absorptivity##2##3##(2008-10#2)
having more than one##3##4##(1992-9#1)(1997-2#1)(2011-2#1)
having more##5##2##(1992-9#1)(1997-2#1)(2008-10#1)(2010-11#1)(2011-2#1)
having multiple##3##2##(2008-10#1)(2009-10#1)(2012-2#1)
having no##3##2##(1997-1#1)(2008-10#1)(2008-9#1)
having positive##2##2##(2008-11#1)(2011-2#1)
having private##2##2##(1992-2#1)(1995-12#1)
having received##3##2##(2008-12#1)(2008-5#1)(2008-8#1)
having sex##2##2##(2013-1#2)
having similar##2##2##(2010-12#1)(2012-2#1)
having the highest##4##3##(1995-2#1)(1996-12#1)(2008-10#2)
having the most##2##3##(2008-10#2)
having the same##3##3##(1991-10#1)(2008-10#1)(2013-1#1)
having the##28##2##(1991-10#1)(1991-11#1)(1992-12#1)(1992-9#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2009-1#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
having their own##2##3##(1991-12#1)(2011-2#1)
having their##5##2##(1991-12#1)(1994-2#1)(1995-11#1)(2009-6#1)(2011-2#1)
having to##9##2##(1993-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)
having undergone##2##2##(1994-9#1)(1995-12#1)
having used##2##2##(2008-10#1)(2008-11#1)
having various##2##2##(2010-8#1)(2012-2#1)
having##422##1##(1990-11#1)(1990-3#3)(1990-5#4)(1990-8#2)(1990-9#4)(1991-10#1)(1991-11#4)(1991-12#4)(1991-3#2)(1991-4#1)(1991-5#3)(1992-1#4)(1992-12#1)(1992-2#3)(1992-3#3)(1992-7#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#4)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-6#3)(1996-9#1)(1997-1#8)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#80)(2008-11#29)(2008-12#14)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#1)(2011-2#29)(2012-12#9)(2012-2#12)(2012-3#8)(2012-8#1)(2013-1#12)(2013-8#6)
hawkmoths##3##1##(2009-6#1)(2009-8#2)
hay##2##1##(2008-10#1)(2010-4#1)
hazard assessment##2##2##(1996-12#2)
hazard evaluation##2##2##(2008-11#2)
hazard for##2##2##(1992-9#1)(2012-12#1)
hazard function##2##2##(1992-9#1)(2008-10#1)
hazard identification and/or risk assessment##2##5##(2008-10#2)
hazard identification##7##2##(2008-10#5)(2008-9#1)(2011-2#1)
hazard in a##2##3##(1996-12#1)(2009-10#1)
hazard in##5##2##(1994-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
hazard models##2##2##(2011-2#2)
hazard ratios##2##2##(2008-7#1)(2011-2#1)
hazard to##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
hazard##48##1##(1991-12#1)(1992-1#1)(1992-9#3)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-12#3)(1997-3#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2011-2#11)(2012-12#1)(2013-1#2)
hazard-control##2##1##(1992-2#2)
hazardous and##2##2##(2008-10#1)(2008-11#1)
hazardous chemicals in##2##3##(1993-3#1)(2010-7#1)
hazardous chemicals##5##2##(1992-1#1)(1993-3#2)(2008-9#1)(2010-7#1)
hazardous materials##5##2##(1995-12#1)(2008-10#1)(2009-10#3)
hazardous to##4##2##(1992-5#1)(1997-3#1)(2008-10#1)(2008-11#1)
hazardous waste sites##3##3##(2008-10#2)(2008-11#1)
hazardous##40##1##(1992-1#1)(1992-5#1)(1993-3#2)(1995-12#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#4)(2010-7#1)(2012-2#2)(2012-3#1)
hazards are##3##2##(1992-3#1)(2008-11#1)(2008-5#1)
hazards for##2##2##(1991-3#1)(2008-11#1)
hazards of##14##2##(1990-11#1)(1991-6#1)(1992-3#2)(1993-12#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2013-1#1)
hazards that arise from non-proteolytic Clostridium botulinum##2##7##(2011-2#2)
hazards to human health##2##4##(2008-10#1)(2008-11#1)
hazards to human##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
hazards to##4##2##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#1)
hazards##48##1##(1990-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#5)(1993-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(2008-10#5)(2008-11#8)(2008-12#1)(2008-5#2)(2008-9#1)(2009-12#2)(2009-6#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#3)
hazelnut (Corylus avellana)##2##3##(2008-10#2)
hazelnut orchards##3##2##(2008-10#3)
hazelnut##16##1##(2008-10#16)
hazmat##4##1##(2009-10#4)
hdf##2##1##(2008-11#2)
he could not##2##3##(1995-6#1)(1996-5#1)
he described##2##2##(1995-6#1)(2011-2#1)
he describes##2##2##(1993-3#1)(1995-5#1)
he developed a##4##3##(1995-1#1)(2007-12#1)(2008-7#1)(2012-12#1)
he developed##7##2##(1991-1#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
he did not##3##3##(1995-12#1)(1996-5#1)(2008-12#1)
he does not##2##3##(1991-6#1)(1996-5#1)
he experienced##2##2##(2011-2#1)(2012-3#1)
he had a##3##3##(1991-6#1)(2008-12#1)(2010-5#1)
he had been##2##3##(1995-6#1)(2008-11#1)
he had to##2##3##(1993-11#1)(1996-2#1)
he had##15##2##(1991-11#1)(1991-6#1)(1993-11#1)(1994-3#1)(1995-6#2)(1996-2#1)(1996-5#1)(2008-11#1)(2008-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
he has##4##2##(1993-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
he is##6##2##(1990-11#1)(1993-11#2)(1996-5#1)(2008-11#1)(2011-2#1)
he or she##3##3##(1993-6#1)(1994-12#1)(2008-4#1)
he presented a##2##3##(2007-8#1)(2013-1#1)
he presented with##2##3##(2008-12#1)(2011-2#1)
he presented##5##2##(2007-12#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
he reported##3##2##(2008-12#2)(2008-7#1)
he says##4##2##(1993-12#1)(1993-2#1)(1996-12#2)
he showed##2##2##(2008-12#1)(2008-7#1)
he took##2##2##(2007-12#1)(2008-10#1)
he underwent##4##2##(2008-12#1)(2011-2#1)(2013-1#2)
he was able to##2##4##(1996-12#1)(2009-1#1)
he was diagnosed with##4##4##(1997-3#1)(2010-3#1)(2010-6#1)(2011-2#1)
he was diagnosed##5##3##(1997-3#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
he was not##2##3##(1992-3#1)(1995-6#1)
he was taking##2##3##(1995-6#2)
he was##31##2##(1990-11#1)(1992-3#1)(1995-6#4)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-10#2)(2008-12#1)(2009-1#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)
he will##2##2##(1990-11#1)(1996-5#1)
he would##4##2##(1995-12#2)(1995-6#2)
he##165##1##(1990-11#7)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#4)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#5)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-5#1)(1995-6#11)(1996-12#4)(1996-2#2)(1996-5#10)(1997-3#2)(1997-4#2)(1997-5#1)(2007-12#5)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#15)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-1#1)(2009-11#1)(2010-1#5)(2010-12#1)(2010-3#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#10)(2012-12#4)(2012-3#1)(2013-1#11)
he/she##3##1##(1992-5#1)(2012-3#2)
head and neck area##2##4##(2011-2#2)
head and neck cancer patients##5##5##(1990-12#2)(2008-5#3)
head and neck cancer##18##4##(1990-12#2)(1990-6#2)(1993-9#2)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#4)(2010-4#2)(2013-1#3)
head and neck carcinoma##3##4##(1990-12#2)(1990-6#1)
head and neck carcinomas##2##4##(2011-2#2)
head and neck contrast-enhanced CT##3##5##(2013-1#3)
head and neck contrast-enhanced##4##4##(2013-1#4)
head and neck tumors##3##4##(1990-12#1)(2009-11#1)(2011-2#1)
head and neck##57##3##(1990-12#5)(1990-6#5)(1992-5#1)(1993-9#4)(1994-6#1)(1997-6#2)(1997-7#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-12#2)(2008-5#5)(2008-7#1)(2009-11#1)(2010-4#3)(2011-2#9)(2012-2#1)(2013-1#9)(2013-8#2)
head and the##3##3##(1990-9#1)(2008-10#1)(2011-2#1)
head and##69##2##(1990-12#5)(1990-6#5)(1990-9#1)(1992-5#1)(1993-9#4)(1994-6#1)(1995-11#2)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-5#6)(2008-7#1)(2008-8#2)(2009-11#1)(2010-4#3)(2011-2#10)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#2)
head blight and deoxynivalenol##4##4##(2008-10#4)
head blight and##5##3##(2008-10#5)
head blight epidemics##2##3##(2008-10#2)
head blight in##2##3##(2008-10#2)
head blight of##3##3##(2008-10#3)
head blight##40##2##(2008-10#39)(2011-10#1)
head circumference##4##2##(2008-11#1)(2011-1#3)
head contains##2##2##(1993-9#1)(2008-7#1)
head group spacing##2##3##(2008-8#2)
head group##4##2##(1995-2#1)(2008-10#1)(2008-8#2)
head groups##3##2##(1992-9#2)(2008-11#1)
head impact##3##2##(2008-7#3)
head injuries##6##2##(1990-3#1)(1990-6#1)(1992-6#1)(2008-11#3)
head injury in##2##3##(2012-3#2)
head injury##20##2##(1991-12#1)(1992-6#3)(2008-12#2)(2008-7#6)(2010-8#1)(2012-3#3)(2013-1#1)(2013-8#3)
head kidney##2##2##(2010-5#2)
head magnetic stimulation was##2##4##(2008-7#2)
head magnetic stimulation##4##3##(2008-7#4)
head movement##3##2##(1990-5#2)(1995-5#1)
head of the##12##3##(1990-9#1)(1991-3#1)(1995-11#1)(2008-10#4)(2008-6#1)(2008-9#1)(2012-2#2)(2013-1#1)
head of##18##2##(1990-9#1)(1991-3#1)(1994-12#1)(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-6#1)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
head or##3##2##(2008-10#1)(2008-11#1)(2009-11#1)
head posture##4##2##(2010-9#4)
head rot in##2##3##(2008-10#2)
head rot##9##2##(2008-10#9)
head space##3##2##(2008-10#1)(2008-5#2)
head specimen##2##2##(2012-3#2)
head to##4##2##(2008-11#2)(2008-5#1)(2010-6#1)
head trauma##9##2##(2008-12#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
head was##2##2##(1992-9#1)(2008-10#1)
head weight##3##2##(2008-10#3)
head##302##1##(1990-11#1)(1990-12#5)(1990-3#1)(1990-5#3)(1990-6#6)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#7)(1992-9#3)(1993-3#1)(1993-9#5)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#8)(1995-2#1)(1995-5#2)(1996-12#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#80)(2008-11#13)(2008-12#7)(2008-3#2)(2008-5#12)(2008-6#2)(2008-7#19)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2010-1#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#7)(2011-1#3)(2011-10#1)(2011-2#20)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#14)(2013-7#1)(2013-8#9)
head-and-neck cancer##2##2##(2009-2#2)
head-and-neck##3##1##(2009-2#3)
head-down tilt position##2##3##(1993-1#2)
head-down tilt##5##2##(1993-1#5)
head-space method##2##2##(2008-5#2)
head-to-tail##3##1##(1992-4#1)(2008-8#1)(2011-2#1)
head/neck##4##1##(1995-11#1)(2011-3#1)(2012-3#2)
headache and##7##2##(1995-12#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#2)(2012-3#1)
headache of##2##2##(1992-2#1)(2010-12#1)
headache pain intensity##2##3##(2008-12#2)
headache pain##3##2##(2008-12#2)(2008-9#1)
headache##70##1##(1990-12#1)(1990-2#1)(1992-12#1)(1992-2#2)(1994-6#1)(1994-9#3)(1995-12#1)(1996-11#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#16)(2008-4#3)(2008-5#1)(2008-7#10)(2008-9#5)(2010-12#2)(2010-9#3)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
headache)##2##1##(2008-4#1)(2008-9#1)
headache]##2##1##(1992-2#1)(1994-9#1)
headaches and backaches are growing faster than any other occupational injury as a by-product of our computerized work environment##2##19##(1994-3#2)
headaches and##4##2##(1994-3#2)(2008-11#1)(2009-1#1)
headaches##16##1##(1994-3#2)(2008-11#2)(2008-12#1)(2008-4#6)(2008-6#1)(2008-7#2)(2009-1#1)(2012-3#1)
headed##3##1##(2008-1#1)(2008-11#1)(2008-8#1)
headgroup and##2##2##(2008-5#1)(2012-12#1)
headgroup structure##2##2##(1994-5#2)
headgroup##9##1##(1994-5#4)(2008-10#2)(2008-5#1)(2012-12#2)
headgroups##2##1##(1991-3#1)(2008-5#1)
heading &quot##2##2##(2008-1#1)(2009-10#1)
heading date##5##2##(2008-10#4)(2008-9#1)
heading in##2##2##(2008-4#1)(2008-9#1)
heading##20##1##(1991-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#6)(2009-10#1)
heading?##2##1##(1992-12#1)(2013-1#1)
headings of##2##2##(2008-11#1)(2009-5#1)
headings##5##1##(1992-12#1)(2008-11#2)(2009-5#1)(2010-11#1)
headquarters##4##1##(1994-1#1)(2008-11#1)(2009-10#1)(2010-8#1)
heads and##2##2##(1994-5#1)(2008-3#1)
heads of##5##2##(1991-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
heads were##5##2##(1991-5#1)(1995-2#1)(2008-10#3)
heads##30##1##(1991-3#1)(1991-5#3)(1992-1#1)(1992-8#1)(1994-5#1)(1995-2#2)(2008-10#12)(2008-3#3)(2008-5#1)(2011-2#1)(2012-2#3)(2013-1#1)
headspace (HS)##3##2##(2008-10#3)
headspace SPME##6##2##(2008-10#5)(2012-12#1)
headspace above##3##2##(2008-10#3)
headspace analysis##3##2##(2008-10#2)(2008-5#1)
headspace and dissolved##2##3##(2011-2#2)
headspace and##4##2##(2008-10#2)(2011-2#2)
headspace gas chromatography##2##3##(2008-10#2)
headspace gas##4##2##(2008-10#4)
headspace liquid-phase microextraction (HS-LPME)##2##4##(2008-10#2)
headspace mode##2##2##(2008-10#2)
headspace or dissolved O(2) levels##2##5##(2011-2#2)
headspace or dissolved O(2)##3##4##(2011-2#3)
headspace samples##2##2##(2008-10#1)(2011-10#1)
headspace solid-phase microextraction (HS-SPME)##2##4##(2008-10#2)
headspace solid-phase microextraction (SPME)##2##4##(2008-10#2)
headspace solid-phase microextraction##7##3##(2008-10#7)
headspace solvent microextraction##3##3##(2008-10#3)
headspace volume##3##2##(2008-10#3)
headspace##64##1##(2008-10#52)(2008-11#2)(2008-5#1)(2009-8#1)(2011-10#1)(2011-2#6)(2012-12#1)
heal##5##1##(1996-1#1)(2008-6#1)(2010-6#2)(2011-2#1)
healed in##3##2##(1992-2#2)(1997-8#1)
healed with##3##2##(2008-9#1)(2013-1#2)
healed##20##1##(1990-12#1)(1992-2#2)(1997-8#1)(2008-12#1)(2008-9#3)(2011-2#3)(2012-3#2)(2013-1#7)
healers##4##1##(2008-12#1)(2008-8#1)(2009-3#1)(2010-1#1)
healing and##8##2##(1993-3#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)
healing in##3##2##(1992-6#1)(2008-12#2)
healing of the##3##3##(1992-3#1)(2011-2#2)
healing of##10##2##(1992-3#1)(2007-8#1)(2008-11#1)(2009-3#1)(2010-1#1)(2011-2#4)(2012-3#1)
healing process##4##2##(1996-12#1)(2009-5#1)(2011-3#1)(2013-1#1)
healing processes##2##2##(2009-12#1)(2011-2#1)
healing properties##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
healing was##5##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2013-1#1)
healing were##2##2##(1990-3#1)(2013-1#1)
healing##73##1##(1990-3#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-8#3)(2008-10#5)(2008-11#6)(2008-12#4)(2008-4#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-2#11)(2011-3#1)(2012-12#1)(2012-3#6)(2013-1#6)(2013-7#1)
healing&quot##2##1##(2008-11#2)
health (P = 0##3##4##(2008-7#1)(2008-8#2)
health -##2##2##(2008-11#1)(2012-2#1)
health accounts##3##2##(1993-2#2)(1997-1#1)
health actions##2##2##(1997-3#1)(2010-9#1)
health administration and##2##3##(1991-2#1)(1996-3#1)
health administration curriculum##6##3##(1991-1#1)(1992-3#1)(1993-1#1)(1996-1#1)(1996-2#2)
health administration education in##2##4##(1991-1#1)(1997-3#1)
health administration education programs##3##4##(1992-2#1)(1993-2#1)(1996-3#1)
health administration education##18##3##(1991-1#3)(1991-2#1)(1992-2#2)(1993-2#2)(1996-2#1)(1996-3#4)(1997-3#4)(2009-8#1)
health administration program##2##3##(1993-1#1)(1996-1#1)
health administration programs##11##3##(1991-1#1)(1992-3#1)(1993-1#2)(1993-2#2)(1995-1#1)(1996-1#1)(1996-2#1)(1997-2#2)
health administration students##4##3##(1992-3#1)(1996-1#3)
health administration##68##2##(1991-1#8)(1991-2#5)(1992-2#2)(1992-3#3)(1993-1#6)(1993-2#7)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#11)(1996-2#6)(1996-3#7)(1997-2#2)(1997-3#6)(2009-8#1)
health administrators##4##2##(1994-2#1)(1997-3#1)(2008-11#1)(2008-12#1)
health advisors as part of the community health team##2##9##(1997-2#2)
health advocates##3##2##(1992-2#1)(2008-11#1)(2009-7#1)
health agencies and##3##3##(1996-1#1)(1997-3#2)
health agencies in##3##3##(1995-12#2)(1997-3#1)
health agencies to focus##2##4##(1995-12#1)(1997-1#1)
health agencies to##5##3##(1995-12#2)(1997-1#3)
health agencies##30##2##(1991-2#2)(1995-12#6)(1995-3#1)(1996-1#6)(1996-2#1)(1996-3#3)(1997-1#5)(1997-2#1)(1997-3#5)
health agency##7##2##(1993-1#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2010-8#2)
health agenda##3##2##(1997-1#2)(2008-1#1)
health among##6##2##(2008-11#1)(2008-7#1)(2009-5#2)(2011-2#1)(2012-2#1)
health and behavior##2##3##(1993-3#1)(2008-7#1)
health and dental##2##3##(2008-5#1)(2008-7#1)
health and disease##20##3##(1992-5#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#3)(2013-8#1)
health and economic##2##3##(2009-8#1)(2013-1#1)
health and environment##2##3##(2010-12#2)
health and environmental##2##3##(2008-10#1)(2009-11#1)
health and functional characteristics of##2##5##(1991-3#1)(1995-3#1)
health and functional##4##3##(1991-3#1)(1995-3#2)(2013-1#1)
health and functioning after##2##4##(2010-9#2)
health and health care##4##4##(1995-12#1)(2008-12#1)(2008-7#1)(2012-3#1)
health and health##9##3##(1991-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
health and how##2##3##(1996-6#1)(2010-12#1)
health and illness##2##3##(2010-10#1)(2010-2#1)
health and mental health##2##4##(1995-2#1)(2008-12#1)
health and more##2##3##(2008-8#1)(2012-2#1)
health and other##2##3##(1996-3#1)(2008-1#1)
health and safety##3##3##(1993-3#1)(2008-11#1)(2010-7#1)
health and skilled nursing facility##2##5##(1995-3#2)
health and social care professionals##2##5##(2008-11#1)(2008-12#1)
health and social care##11##4##(2008-11#8)(2008-12#3)
health and social services##5##4##(1994-1#1)(1996-3#1)(2008-1#1)(2008-11#2)
health and social##20##3##(1992-3#1)(1994-1#1)(1995-3#1)(1996-3#1)(2008-1#2)(2008-11#10)(2008-12#3)(2011-2#1)
health and the##2##3##(1991-12#1)(1991-3#1)
health and welfare##2##3##(1996-3#2)
health and well-being##4##3##(1997-3#1)(2009-5#1)(2010-7#1)(2010-9#1)
health and##154##2##(1991-12#2)(1991-2#2)(1991-3#4)(1992-2#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-3#3)(1994-1#2)(1994-12#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#5)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#5)(1996-6#2)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#1)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#18)(2008-12#6)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#4)(2010-2#4)(2010-4#2)(2010-7#5)(2010-9#4)(2011-2#6)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#5)
health approaches to##2##3##(1997-1#1)(2008-11#1)
health are discussed##2##3##(2009-5#1)(2010-3#1)
health are##5##2##(1991-2#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-3#1)
health area##2##2##(1997-3#1)(2008-11#1)
health as##5##2##(1991-6#1)(1995-2#1)(1996-1#1)(1996-6#1)(2010-2#1)
health assessment and##2##3##(1996-12#1)(2009-11#1)
health assessment##4##2##(1996-1#2)(1996-12#1)(2009-11#1)
health at##5##2##(1995-2#1)(1996-2#1)(1997-6#1)(2008-11#2)
health authorities and##2##3##(1994-3#1)(2008-11#1)
health authorities##14##2##(1990-3#1)(1990-6#1)(1991-6#1)(1992-1#1)(1994-3#1)(1994-6#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-11#2)(2010-5#1)(2012-12#1)
health behavior change##2##3##(2008-4#2)
health behaviors and##2##3##(2008-11#1)(2010-9#1)
health behaviors of##2##3##(2008-11#2)
health behaviors##14##2##(2008-11#4)(2009-5#1)(2009-6#1)(2010-5#3)(2010-9#1)(2013-1#4)
health benefit##6##2##(1992-3#1)(1994-2#1)(1995-1#1)(1995-3#2)(2011-2#1)
health benefits##10##2##(1996-5#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-1#1)(2010-2#1)(2011-1#1)(2012-12#1)
health campaign##3##2##(1996-3#1)(2008-1#2)
health campaigns##2##2##(2008-1#1)(2011-2#1)
health capital##2##2##(1992-3#1)(2013-8#1)
health care access##2##3##(1993-3#1)(2009-5#1)
health care administration##2##3##(1991-12#1)(1996-2#1)
health care administrators and##2##4##(1992-2#2)
health care administrators##9##3##(1992-2#4)(1993-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2009-8#1)
health care and the##2##4##(1995-3#1)(2008-10#1)
health care and##16##3##(1990-2#1)(1990-6#1)(1991-6#1)(1992-1#1)(1993-3#1)(1994-1#1)(1995-1#2)(1995-2#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2013-1#2)
health care are##3##3##(1992-3#1)(1995-3#1)(2008-11#1)
health care benefits##2##3##(1994-2#1)(1995-12#1)
health care bill##2##3##(1995-3#1)(1997-2#1)
health care can be##2##4##(1994-2#1)(1994-3#1)
health care center##3##3##(1991-3#1)(2007-8#1)(2008-10#1)
health care centers##4##3##(1995-3#1)(2007-8#1)(2011-2#2)
health care computing##3##3##(1996-2#1)(2010-8#2)
health care cost containment##2##4##(1991-2#1)(1994-1#1)
health care cost##3##3##(1991-2#1)(1994-1#1)(1994-2#1)
health care costs and##7##4##(1994-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#1)(2008-11#1)
health care costs##30##3##(1991-12#3)(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#3)(1994-12#4)(1994-2#2)(1995-1#1)(1995-2#1)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#3)(2008-11#1)(2010-8#1)(2012-2#1)(2013-8#1)
health care crisis##2##3##(1997-3#2)
health care datafiles##2##3##(1995-12#2)
health care decisions##3##3##(1992-1#1)(2010-10#1)(2010-9#1)
health care delivered##2##3##(1996-2#1)(2010-8#1)
health care delivery and##3##4##(1993-2#1)(2008-11#1)(2008-6#1)
health care delivery system##6##4##(1991-1#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2012-3#1)
health care delivery systems##4##4##(1993-12#1)(1995-1#1)(1995-12#1)(1996-1#1)
health care delivery##28##3##(1991-1#1)(1991-2#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#4)(1996-12#1)(1996-3#2)(1997-2#1)(2008-11#2)(2008-6#1)(2010-12#2)(2010-8#2)(2012-3#1)
health care do not##2##4##(1993-12#1)(1997-4#1)
health care dollars##3##3##(1993-12#2)(1995-2#1)
health care employees##3##3##(2008-11#3)
health care environment has##2##4##(1991-2#1)(1993-12#1)
health care environment##12##3##(1991-12#1)(1991-2#1)(1991-3#2)(1993-12#1)(1993-3#3)(1994-3#1)(1996-3#1)(1997-3#1)(2008-11#1)
health care even##2##3##(2008-1#1)(2008-10#1)
health care executives##5##3##(1994-1#1)(1996-2#3)(1996-3#1)
health care expenditures##12##3##(1991-2#1)(1992-1#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-11#2)
health care facilities##8##3##(1991-12#2)(1994-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2012-3#1)
health care facility construction##3##4##(1991-2#3)
health care facility##6##3##(1991-1#1)(1991-12#2)(1991-2#3)
health care financial management##3##4##(2008-11#3)
health care financing and##2##4##(1993-2#1)(1994-1#1)
health care financing##6##3##(1991-2#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)
health care for children##2##4##(1995-2#1)(1996-12#1)
health care for the##3##4##(1992-2#1)(2008-11#1)(2010-10#1)
health care for##16##3##(1992-2#1)(1994-3#4)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2010-10#3)(2012-3#1)
health care fraud and abuse##2##5##(1991-1#2)
health care fraud##4##3##(1991-1#2)(1993-12#2)
health care has##3##3##(1993-12#1)(1995-1#1)(2008-12#1)
health care in the United States##3##6##(1995-3#1)(1996-2#1)(1997-3#1)
health care in the##10##4##(1992-12#1)(1994-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-8#2)(2008-1#1)(2008-10#1)
health care in##25##3##(1991-2#1)(1992-12#1)(1993-2#1)(1994-1#1)(1994-12#2)(1995-11#1)(1995-2#3)(1995-3#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2013-8#1)
health care industry##18##3##(1991-1#1)(1991-12#1)(1992-3#1)(1993-12#3)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-3#2)(2008-11#5)
health care informatics##2##3##(1994-12#2)
health care information##6##3##(1992-12#1)(1993-1#1)(1994-2#1)(1996-2#1)(1997-3#1)(2008-11#1)
health care institution##2##3##(1992-2#1)(1996-3#1)
health care institutions and##2##4##(1993-1#1)(2008-11#1)
health care institutions##5##3##(1992-12#1)(1993-1#1)(1994-12#1)(2008-11#1)(2010-8#1)
health care is##14##3##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#2)(1997-3#1)(1997-5#1)(1997-8#1)(2008-11#2)(2008-4#1)(2011-2#1)(2013-1#1)
health care leaders##4##3##(1993-12#1)(1994-1#2)(1997-1#1)
health care management is##2##4##(1994-1#1)(1996-2#1)
health care management##6##3##(1991-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-2#2)
health care managers##2##3##(1996-2#1)(1997-2#1)
health care market##3##3##(1991-1#1)(1994-12#1)(1997-1#1)
health care markets##2##3##(1991-3#1)(1996-1#1)
health care needs##13##3##(1994-2#1)(1995-12#6)(1995-3#2)(1997-2#2)(2010-11#2)
health care networks##2##3##(1995-2#2)
health care organization##10##3##(1990-6#1)(1991-2#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-12#1)(1996-1#2)(1997-3#1)
health care organization's##2##3##(1994-1#1)(1995-1#1)
health care organizations and##4##4##(1993-3#1)(1995-2#2)(2008-11#1)
health care organizations in##2##4##(1996-1#1)(1997-2#1)
health care organizations to##3##4##(1992-3#1)(1994-12#1)(1994-2#1)
health care organizations will##2##4##(1994-1#1)(1996-3#1)
health care organizations##31##3##(1991-3#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-1#3)(1994-12#4)(1994-2#1)(1995-12#1)(1995-2#3)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(2008-11#6)(2010-7#1)(2011-2#2)
health care personnel##3##3##(1990-2#1)(1991-12#1)(2008-7#1)
health care physicians##2##3##(1993-6#1)(2011-1#1)
health care plan##2##3##(1992-3#1)(1995-12#1)
health care planners##3##3##(1991-1#1)(1992-2#1)(1996-3#1)
health care policy reform##3##4##(1994-1#1)(1997-2#2)
health care policy##6##3##(1993-12#1)(1994-1#1)(1994-12#1)(1997-2#3)
health care practice##2##3##(1994-1#1)(2008-11#1)
health care prices##3##3##(1991-1#1)(1991-2#1)(1993-2#1)
health care problems in##2##4##(1997-8#1)(2011-2#1)
health care professionals in Canada today is that they##2##9##(1991-2#2)
health care professionals in##4##4##(1991-2#2)(2008-1#1)(2008-12#1)
health care professionals##19##3##(1991-2#3)(1992-12#1)(1992-3#1)(1993-1#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)
health care program##2##3##(1991-12#1)(1995-3#1)
health care provider to##2##4##(1992-2#1)(2008-11#1)
health care provider##8##3##(1992-2#1)(1994-1#2)(1995-12#1)(2008-11#2)(2010-1#1)(2013-1#1)
health care providers and##4##4##(1992-12#1)(1996-2#1)(2008-11#1)(2013-1#1)
health care providers are##6##4##(1994-12#1)(1996-3#1)(1997-8#1)(2008-11#1)(2010-10#1)(2010-2#1)
health care providers in their##2##5##(1995-3#1)(2010-7#1)
health care providers in##5##4##(1992-2#1)(1995-3#1)(1996-3#1)(2008-11#1)(2010-7#1)
health care providers need to##2##5##(2010-4#1)(2012-3#1)
health care providers to##4##4##(1991-2#1)(1994-12#1)(1996-3#1)(2009-5#1)
health care providers##42##3##(1991-12#1)(1991-2#2)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#2)(1994-12#3)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-3#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-11#6)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
health care providers'##2##3##(1994-3#1)(2010-10#1)
health care purchasers##2##3##(1994-12#1)(1995-2#1)
health care quality management##2##4##(1993-3#1)(1995-1#1)
health care quality##15##3##(1993-3#5)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#2)(2010-8#1)
health care reform and##3##4##(1993-12#1)(1994-12#1)(2010-8#1)
health care reform have##2##4##(1994-8#1)(1996-3#1)
health care reform in##2##4##(1996-6#1)(1997-1#1)
health care reform initiatives##2##4##(1994-1#1)(1996-1#1)
health care reform legislation##2##4##(1994-8#1)(2012-3#1)
health care reform##57##3##(1993-12#6)(1993-5#1)(1994-1#3)(1994-12#4)(1994-2#4)(1994-8#4)(1995-1#1)(1995-12#13)(1995-2#4)(1996-1#2)(1996-2#2)(1996-3#5)(1996-6#1)(1997-1#1)(1997-3#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-3#2)
health care reform?##2##3##(1993-3#1)(1996-2#1)
health care reimbursement##3##3##(1991-1#1)(1994-3#1)(1997-1#1)
health care resources##5##3##(1994-3#1)(1997-2#1)(2008-1#1)(2011-2#1)(2012-3#1)
health care satisfaction##2##3##(1995-2#1)(1997-2#1)
health care sector##8##3##(1992-12#1)(1992-2#1)(1996-2#1)(2008-11#2)(2008-12#1)(2010-7#1)(2012-2#1)
health care services and##2##4##(1994-1#1)(2008-11#1)
health care services##24##3##(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#4)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-1#2)(2008-11#1)(2008-7#1)(2010-8#1)
health care setting##5##3##(1994-1#1)(1994-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
health care settings##3##3##(1992-2#1)(1996-12#1)(2007-12#1)
health care spending and##2##4##(1993-3#1)(2008-11#1)
health care spending by##2##4##(1994-1#1)(1997-3#1)
health care spending##10##3##(1993-3#1)(1994-1#1)(1995-2#1)(1995-3#1)(1997-2#2)(1997-3#2)(2008-11#2)
health care staff##3##3##(2010-10#1)(2011-2#2)
health care system and##8##4##(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1996-2#1)(1997-6#1)(2010-4#1)(2011-1#1)
health care system have##2##4##(1991-2#1)(1996-3#1)
health care system##55##3##(1991-2#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-1#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-3#2)(1997-6#2)(2007-12#1)(2008-11#2)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
health care system?##2##3##(1994-9#1)(1995-1#1)
health care system]##2##3##(1997-3#1)(2008-10#1)
health care systems has##2##4##(1995-1#1)(2008-1#1)
health care systems##16##3##(1992-12#1)(1993-12#2)(1993-6#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#4)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
health care team##9##3##(1993-12#1)(1995-2#2)(1996-2#1)(2008-11#2)(2008-7#2)(2010-4#1)
health care technology##2##3##(1994-1#1)(2008-11#1)
health care to##5##3##(1995-12#1)(1997-3#1)(2008-11#3)
health care transition##4##3##(1992-12#1)(1995-2#1)(1996-2#1)(2010-11#1)
health care use##4##3##(1995-12#1)(1997-3#1)(2013-1#2)
health care utilization##8##3##(1996-2#3)(1997-1#2)(2009-5#1)(2013-1#2)
health care were##2##3##(1993-3#1)(2008-11#1)
health care will##2##3##(1994-12#1)(2008-10#1)
health care workers in##3##4##(1992-2#1)(1993-2#1)(1996-12#1)
health care workers to##2##4##(2007-12#1)(2010-11#1)
health care workers##15##3##(1992-2#2)(1993-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-11#3)(2010-11#3)(2011-2#1)
health care##982##2##(1990-11#1)(1990-2#3)(1990-6#2)(1991-1#11)(1991-12#15)(1991-2#23)(1991-3#12)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#7)(1992-12#19)(1992-2#22)(1992-3#9)(1993-1#8)(1993-11#3)(1993-12#43)(1993-2#12)(1993-3#31)(1993-5#1)(1993-6#2)(1994-1#47)(1994-12#46)(1994-2#32)(1994-3#22)(1994-6#3)(1994-8#5)(1994-9#2)(1995-1#17)(1995-11#2)(1995-12#39)(1995-2#47)(1995-3#21)(1995-5#2)(1995-6#1)(1996-1#16)(1996-11#1)(1996-12#7)(1996-2#41)(1996-3#29)(1996-5#2)(1996-6#1)(1996-8#12)(1996-9#1)(1997-1#19)(1997-2#31)(1997-3#31)(1997-4#5)(1997-5#4)(1997-6#3)(1997-8#7)(2007-12#3)(2007-8#2)(2008-1#10)(2008-10#10)(2008-11#84)(2008-12#14)(2008-4#4)(2008-6#2)(2008-7#7)(2008-8#3)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#5)(2009-8#1)(2010-1#2)(2010-10#8)(2010-11#7)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#16)(2010-9#3)(2011-1#4)(2011-2#15)(2012-12#2)(2012-2#7)(2012-3#18)(2013-1#13)(2013-8#5)
health care?##3##2##(1991-3#1)(1993-12#1)(1995-2#1)
health care]##7##2##(1990-9#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-6#1)(1997-5#1)(1997-8#1)
health center in##5##3##(1994-3#4)(2008-1#1)
health center##19##2##(1990-2#1)(1990-9#1)(1993-3#1)(1994-3#8)(1996-3#1)(1996-6#1)(1997-2#1)(2008-1#2)(2008-12#1)(2009-10#1)(2010-6#1)
health center]##13##2##(1991-11#1)(1993-3#2)(1994-9#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#3)
health centers in##2##3##(2008-10#2)
health centers##12##2##(1993-2#1)(1994-3#2)(1995-12#2)(1997-2#3)(1997-3#1)(2008-10#2)(2008-6#1)
health centre##5##2##(1990-9#1)(1991-11#1)(1993-9#1)(1997-4#1)(2013-1#1)
health challenges##5##2##(2008-1#4)(2008-11#1)
health characteristics##3##2##(1991-3#1)(1994-3#1)(2011-2#1)
health claims##2##2##(2009-7#1)(2012-2#1)
health clinicians##2##2##(2008-11#1)(2010-4#1)
health clinics##2##2##(1995-12#1)(1995-6#1)
health concern##5##2##(2008-11#2)(2011-3#1)(2012-3#1)(2013-1#1)
health concerns##8##2##(1995-12#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-7#1)(2012-2#1)(2013-8#1)
health condition##3##2##(1994-6#2)(2008-1#1)
health conditions##4##2##(1995-2#1)(2010-10#1)(2013-7#2)
health consciousness##2##2##(2008-10#1)(2011-2#1)
health consequences of##4##3##(1990-6#1)(1994-6#1)(2008-10#1)(2008-11#1)
health consequences##10##2##(1990-6#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
health considerations##2##2##(1991-6#2)
health consumers##6##2##(1995-1#3)(2008-11#1)(2008-12#1)(2011-2#1)
health control##3##2##(1991-12#1)(1994-6#1)(2008-10#1)
health costs of##2##3##(2008-11#1)(2010-1#1)
health costs##4##2##(1996-2#1)(2008-11#1)(2010-1#1)(2013-1#1)
health data collection##2##3##(2010-8#2)
health data##6##2##(1994-2#1)(1996-1#1)(1997-3#1)(2008-7#1)(2010-8#2)
health decisions##2##2##(1997-3#2)
health delivery##5##2##(1992-1#2)(1994-1#1)(2008-11#1)(2011-2#1)
health department##10##2##(1995-12#2)(1996-12#4)(1997-2#1)(1997-3#1)(2008-9#1)(2011-9#1)
health departments have##2##3##(1996-1#1)(1997-3#1)
health departments in##4##3##(1995-3#3)(1996-3#1)
health departments##25##2##(1992-1#1)(1995-12#1)(1995-3#3)(1996-1#2)(1996-12#2)(1996-2#5)(1996-3#2)(1997-1#3)(1997-2#2)(1997-3#2)(2011-9#2)
health disciplines##2##2##(2008-11#2)
health disorders##8##2##(2008-11#4)(2013-8#4)
health disparities##3##2##(2009-5#1)(2012-2#1)(2013-1#1)
health disparity##2##2##(2011-1#2)
health district##5##2##(2007-8#1)(2008-7#1)(2013-1#3)
health domains##2##2##(2008-7#1)(2010-10#1)
health due to##2##3##(2008-10#2)
health economic studies##3##3##(2011-2#3)
health economic##4##2##(2011-2#4)
health economics##3##2##(1996-2#1)(1997-8#1)(2008-6#1)
health education and##2##3##(1997-6#1)(2013-1#1)
health education has##2##3##(1997-3#1)(2008-1#1)
health education in##2##3##(1996-6#1)(2010-12#1)
health education##19##2##(1990-11#1)(1991-6#1)(1992-1#1)(1993-12#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#3)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#2)
health educator##2##2##(1997-2#2)
health educators##3##2##(1993-3#1)(2008-12#1)(2009-5#1)
health effects of##7##3##(1994-9#1)(1996-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#1)(2013-8#1)
health effects##17##2##(1994-9#2)(1996-12#1)(1997-1#2)(2008-10#2)(2008-11#4)(2008-7#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
health expenditure performance##2##3##(1993-2#2)
health expenditure##5##2##(1991-2#1)(1993-2#2)(1996-2#1)(1996-3#1)
health expenditures as a share of##2##6##(1992-12#1)(1995-3#1)
health expenditures##15##2##(1991-2#3)(1992-12#2)(1993-2#1)(1993-3#2)(1995-3#3)(1996-2#2)(1997-2#1)(1997-3#1)
health fair##2##2##(1991-2#2)
health field##6##2##(1991-2#1)(1994-1#1)(1995-1#1)(1997-3#2)(2008-11#1)
health financing##2##2##(1995-2#1)(2013-8#1)
health for##8##2##(1990-2#1)(1993-2#1)(1996-1#1)(1996-6#1)(2008-1#1)(2009-6#2)(2010-1#1)
health goals##5##2##(1991-2#2)(1992-1#1)(1996-2#2)
health had##2##2##(1996-1#1)(2008-7#1)
health has been##2##3##(1992-12#1)(2012-3#1)
health has##6##2##(1992-12#1)(1996-3#2)(2012-12#1)(2012-3#1)(2013-1#1)
health have##4##2##(1996-1#1)(1997-2#1)(2008-11#1)(2011-1#1)
health hazard##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
health hazards##4##2##(1996-3#1)(2008-10#1)(2009-12#2)
health hospital##2##2##(1991-3#1)(1992-2#1)
health impacts of##2##3##(2008-11#2)
health impacts##3##2##(2008-11#2)(2013-1#1)
health implications of##3##3##(2009-7#1)(2011-2#1)(2013-1#1)
health implications##8##2##(1996-1#1)(2008-10#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
health improvement##2##2##(2010-8#1)(2013-1#1)
health in a##2##3##(2008-1#1)(2008-10#1)
health in older women##2##4##(2012-12#2)
health in older##3##3##(2008-1#1)(2012-12#2)
health in the##2##3##(2008-1#1)(2012-12#1)
health in##24##2##(1991-6#1)(1993-1#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#3)(2008-10#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-12#5)(2013-1#3)
health indicators##5##2##(2009-10#1)(2013-1#4)
health industry##2##2##(1995-3#1)(2008-7#1)
health information and##4##3##(1995-12#1)(1997-2#1)(1997-3#1)(2008-1#1)
health information infrastructure##3##3##(1994-12#1)(1997-3#2)
health information is##2##3##(1997-3#1)(2009-5#1)
health information management##3##3##(1995-2#1)(2007-12#1)(2010-8#1)
health information on the Internet##2##5##(2008-11#2)
health information systems##6##3##(1996-3#1)(1997-3#4)(2008-7#1)
health information##47##2##(1991-3#1)(1993-1#3)(1993-3#1)(1994-12#1)(1995-12#3)(1995-2#1)(1996-1#10)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#9)(2007-12#2)(2008-1#2)(2008-11#2)(2008-7#1)(2009-5#1)(2010-4#1)(2010-8#2)(2013-1#2)
health infrastructure##3##2##(1995-12#1)(1997-1#1)(2008-11#1)
health initiative##2##2##(1995-3#1)(2008-6#1)
health initiatives##5##2##(1995-12#1)(1996-3#3)(1997-2#1)
health input##3##2##(2008-11#2)(2010-12#1)
health institutions##4##2##(1993-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
health insurance and##2##3##(1992-3#1)(1997-3#1)
health insurance coverage to##2##4##(1995-12#1)(2008-11#1)
health insurance coverage##10##3##(1991-2#1)(1993-3#2)(1994-3#1)(1995-12#2)(2008-11#2)(2009-5#1)(2011-2#1)
health insurance files##2##3##(2008-11#2)
health insurance for##3##3##(1991-2#1)(1992-3#1)(2011-2#1)
health insurance in##5##3##(1992-12#1)(1995-2#1)(1997-8#1)(2008-11#1)(2012-12#1)
health insurance organization##3##3##(1994-2#2)(2008-11#1)
health insurance programs##2##3##(1993-1#1)(1995-3#1)
health insurance##72##2##(1991-2#9)(1991-3#2)(1992-12#2)(1992-2#2)(1992-3#4)(1993-1#2)(1993-3#3)(1994-12#1)(1994-2#8)(1994-3#1)(1994-8#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-8#1)(2008-1#1)(2008-11#10)(2008-7#3)(2009-5#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#2)
health insurers##2##2##(1993-2#1)(2012-12#1)
health intervention##2##2##(1994-1#1)(2010-9#1)
health interventions##4##2##(1993-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
health into##2##2##(1991-6#1)(1993-2#1)
health is##14##2##(1992-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-12#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
health issue##5##2##(1991-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2010-7#1)
health issues in##4##3##(1995-12#1)(2008-12#2)(2013-1#1)
health issues##20##2##(1992-12#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#3)(2008-12#2)(2009-12#1)(2010-1#4)(2012-2#1)(2013-1#1)
health knowledge##3##2##(1996-2#1)(2009-5#1)(2009-6#1)
health law##3##2##(1992-3#1)(2012-3#2)
health leaders##2##2##(1996-3#1)(1997-3#1)
health legislation##4##2##(1990-9#1)(1994-1#2)(1997-8#1)
health literacy levels and their perceived##2##6##(2010-9#2)
health literacy##13##2##(2009-8#8)(2010-9#4)(2013-8#1)
health maintenance organization (HMO) enrollees##2##5##(1996-2#1)(1997-2#1)
health maintenance organization (HMO) for##2##5##(1993-1#1)(1994-12#1)
health maintenance organization (HMO)##11##4##(1993-1#1)(1994-12#2)(1994-3#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)
health maintenance organization##23##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#5)(1994-3#4)(1995-3#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#1)
health maintenance organizations (HMOs)##8##4##(1991-1#1)(1991-3#3)(1993-3#1)(1994-1#1)(1994-3#1)(1996-3#1)
health maintenance organizations##18##3##(1991-1#2)(1991-3#6)(1993-1#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-3#1)(1997-2#1)
health maintenance##45##2##(1991-1#2)(1991-2#1)(1991-3#7)(1991-7#1)(1992-1#2)(1992-2#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#5)(1994-2#1)(1994-3#6)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#3)(1997-1#2)(1997-2#2)(2009-6#1)(2010-10#1)
health management and##2##3##(1993-1#1)(1996-2#1)
health management education##2##3##(1996-1#2)
health management##8##2##(1993-1#1)(1994-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(2008-4#1)
health managers##3##2##(1994-2#2)(1996-1#1)
health mandate##2##2##(2010-8#1)(2011-2#1)
health measures##6##2##(1990-6#1)(1997-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)
health ministry##3##2##(1992-1#1)(1993-12#1)(1997-6#1)
health need##2##2##(2009-6#1)(2012-12#1)
health needs and##2##3##(2008-11#2)
health needs have##3##3##(1992-2#1)(1994-3#2)
health needs of##3##3##(1996-3#1)(2008-11#1)(2010-10#1)
health needs##16##2##(1992-2#1)(1994-3#3)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-11#5)(2010-10#1)
health network##2##2##(1996-3#1)(1997-4#1)
health networks##3##2##(1997-2#2)(2008-10#1)
health nurses and##5##3##(2008-11#1)(2010-9#4)
health nurses##21##2##(1995-3#1)(1996-2#2)(1997-6#1)(2008-11#3)(2008-12#3)(2009-6#2)(2010-5#3)(2010-9#6)
health nursing within##2##3##(1996-2#2)
health nursing##21##2##(1990-2#1)(1996-2#6)(1997-6#1)(2008-11#9)(2008-12#3)(2009-6#1)
health of children##5##3##(1995-1#1)(2008-11#2)(2012-12#1)(2012-3#1)
health of the nation##2##4##(1991-8#1)(2008-11#1)
health of the##11##3##(1991-6#1)(1991-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
health of##50##2##(1991-1#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-2#2)(1996-3#1)(1996-9#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-6#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
health officials to##2##3##(1996-5#1)(2009-5#1)
health officials##11##2##(1995-12#3)(1996-1#1)(1996-3#1)(1996-5#2)(1997-6#1)(2008-10#1)(2009-5#2)
health on the##2##3##(2008-1#1)(2008-11#1)
health on##3##2##(1993-1#1)(2008-1#1)(2008-11#1)
health operations##2##2##(1991-9#1)(1997-3#1)
health or##5##2##(1992-3#2)(2008-11#1)(2011-1#1)(2011-2#1)
health organizations##3##2##(1997-3#1)(2009-5#1)(2012-3#1)
health outcomes are##3##3##(1995-2#1)(2008-10#1)(2012-2#1)
health outcomes##30##2##(1991-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(2008-1#2)(2008-10#3)(2008-11#5)(2009-5#2)(2010-10#1)(2010-3#1)(2010-4#2)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
health personnel##4##2##(1993-3#1)(1996-9#1)(2008-10#2)
health plan performance##2##3##(1995-2#1)(1997-3#1)
health plan##12##2##(1991-2#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-3#6)(2011-2#1)
health planning and##2##3##(1990-12#1)(1997-3#1)
health planning##4##2##(1990-12#2)(1996-1#1)(1997-3#1)
health plans can##2##3##(1997-2#2)
health plans##12##2##(1991-3#1)(1994-2#2)(1995-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(2008-11#1)(2008-6#1)
health policies##2##2##(1997-1#1)(2009-12#1)
health policy and##6##3##(1992-12#1)(1993-2#1)(1994-2#1)(2008-1#1)(2012-12#1)(2012-2#1)
health policy makers and##2##4##(1996-2#1)(1997-1#1)
health policy of Pakistan##2##4##(2012-2#2)
health policy##39##2##(1991-1#1)(1991-12#1)(1992-1#5)(1992-12#1)(1992-2#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#5)(1997-1#1)(1997-2#1)(1997-3#3)(2008-1#1)(2008-7#2)(2010-9#1)(2012-12#1)(2012-2#5)
health practice and##2##3##(1996-1#1)(1996-3#1)
health practice in##3##3##(1996-2#1)(1997-3#1)(2008-1#1)
health practice##19##2##(1995-12#1)(1996-1#5)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#3)(1997-3#2)(2008-1#1)(2012-2#1)
health practitioners##8##2##(1995-12#2)(1997-2#3)(2008-1#1)(2008-11#1)(2008-12#1)
health problem and##2##3##(2011-2#1)(2012-12#1)
health problem in the##6##4##(1997-1#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#2)
health problem in##9##3##(1991-6#1)(1997-1#1)(2008-11#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
health problem with##2##3##(2008-10#1)(2013-1#1)
health problem##30##2##(1991-6#1)(1994-1#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
health problems and##3##3##(1997-1#1)(2010-9#1)(2011-2#1)
health problems are##3##3##(1990-2#1)(2008-1#1)(2008-7#1)
health problems in##8##3##(1992-2#1)(1993-1#1)(1997-5#1)(2008-1#1)(2009-1#1)(2010-12#1)(2010-7#1)(2011-2#1)
health problems than##2##3##(1996-6#1)(2008-7#1)
health problems were##3##3##(1994-6#1)(2008-11#1)(2008-7#1)
health problems##56##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#2)(1993-1#4)(1993-3#1)(1994-6#1)(1996-1#4)(1996-2#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-5#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#5)(2009-1#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
health products##2##2##(2008-8#1)(2010-3#1)
health profession##3##2##(1993-3#1)(1993-6#1)(2008-1#1)
health professional##3##2##(2008-12#3)
health professionals and the general public##2##6##(1993-2#1)(2010-12#1)
health professionals and##7##3##(1993-2#1)(1997-1#1)(2008-11#2)(2010-12#1)(2012-3#2)
health professionals has been##2##4##(2008-11#2)
health professionals in##2##3##(1993-12#1)(1996-2#1)
health professionals should##2##3##(1993-12#1)(2013-1#1)
health professionals to##7##3##(2008-11#4)(2008-12#1)(2009-9#2)
health professionals##53##2##(1991-1#1)(1992-1#1)(1993-12#2)(1993-2#1)(1994-1#4)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-11#17)(2008-12#6)(2009-9#2)(2010-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
health professions##8##2##(1991-6#2)(1992-3#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2012-2#1)
health program##10##2##(1991-3#1)(1993-3#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-5#2)
health programmes##6##2##(1991-6#2)(1997-7#1)(2008-10#1)(2012-12#1)(2013-7#1)
health programs##8##2##(1993-3#1)(1995-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(2008-12#1)(2009-6#1)
health promotion activities##2##3##(1990-9#1)(2008-11#1)
health promotion and disease prevention initiative##2##6##(1995-12#1)(2008-7#1)
health promotion and disease prevention##3##5##(1995-12#2)(2008-7#1)
health promotion and##6##3##(1993-12#1)(1995-12#2)(2008-12#2)(2008-7#1)
health promotion are##2##3##(2008-11#1)(2010-2#1)
health promotion in##4##3##(1994-9#1)(2008-11#1)(2008-12#1)(2013-8#1)
health promotion nursing tutors##2##4##(2008-12#2)
health promotion of##2##3##(2010-10#1)(2010-12#1)
health promotion theory##2##3##(2008-11#1)(2008-12#1)
health promotion##53##2##(1990-9#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-12#2)(1996-2#1)(1997-1#1)(1997-4#1)(2008-1#3)(2008-10#2)(2008-11#8)(2008-12#11)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
health promotion'##2##2##(2008-11#2)
health promotion/education##2##2##(2008-11#2)
health protection##3##2##(1997-2#1)(2008-1#1)(2012-12#1)
health protective##2##2##(2008-10#1)(2013-1#1)
health providers and##3##3##(1997-2#2)(2010-5#1)
health providers##7##2##(1996-3#2)(1997-2#2)(1997-3#1)(2010-5#1)(2011-2#1)
health records##8##2##(1993-3#1)(2010-4#2)(2010-8#3)(2012-2#1)(2012-3#1)
health reform##21##2##(1993-3#1)(1994-1#2)(1994-2#2)(1995-1#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-3#1)(2013-1#1)
health reforms##3##2##(1993-3#1)(1994-2#1)(2013-8#1)
health regions##2##2##(2008-12#1)(2012-2#1)
health regulation##2##2##(1994-1#1)(1995-2#1)
health regulations##3##2##(1995-2#3)
health related##2##2##(1996-1#1)(2008-10#1)
health research##4##2##(1996-9#1)(1997-1#1)(2008-1#1)(2013-7#1)
health resources and##2##3##(1996-1#1)(1997-2#1)
health resources##4##2##(1991-12#1)(1996-1#1)(1997-2#1)(2008-7#1)
health risk and##2##3##(1992-12#1)(2009-9#1)
health risk assessment##2##3##(2008-11#1)(2008-7#1)
health risk due to##2##4##(1991-12#1)(1992-3#1)
health risk##12##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-9#1)(2012-3#1)
health risks associated with##2##4##(2008-7#1)(2009-7#1)
health risks##12##2##(2008-10#2)(2008-3#1)(2008-7#2)(2009-12#2)(2009-7#1)(2010-2#1)(2010-6#1)(2012-12#1)(2012-2#1)
health science##2##2##(1995-12#1)(1997-3#1)
health sciences##7##2##(1991-12#2)(1994-3#2)(2008-11#2)(2008-12#1)
health sector decentralization in Nepal##2##5##(2012-3#2)
health sector decentralization in##3##4##(2012-3#3)
health sector decentralization##4##3##(2012-3#4)
health sector##17##2##(1991-2#1)(1992-1#1)(1992-2#1)(1994-2#1)(1997-1#5)(1997-2#1)(2008-11#1)(2012-3#5)(2013-8#1)
health sectors##3##2##(1990-12#1)(2008-12#2)
health sequelae##2##2##(2008-1#1)(2008-11#1)
health service and the##2##4##(1996-11#1)(1997-8#1)
health service and##3##3##(1996-11#1)(1997-3#1)(1997-8#1)
health service delivery##6##3##(1992-1#1)(1992-3#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-12#1)
health service for##2##3##(1990-6#1)(2009-12#1)
health service managers##3##3##(1992-1#3)
health service provision for##2##4##(2008-11#1)(2008-7#1)
health service use##2##3##(1997-2#1)(2011-1#1)
health service users##2##3##(2008-12#2)
health service##39##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#4)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1995-2#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-11#5)(2008-12#6)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#1)
health services administration education##3##4##(1993-1#1)(1993-2#1)(1994-2#1)
health services administration in##2##4##(1996-3#1)(1997-3#1)
health services administration programs##2##4##(1996-3#1)(1997-2#1)
health services administration##11##3##(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)
health services and health##2##4##(1991-2#1)(1996-3#1)
health services and the##3##4##(1992-5#1)(1996-11#1)(2008-1#1)
health services and##9##3##(1991-2#1)(1991-6#1)(1992-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(2008-1#1)(2009-3#1)
health services are##2##3##(1997-1#1)(2008-11#1)
health services by##3##3##(1992-2#1)(1994-2#1)(1995-3#1)
health services delivery##2##3##(1992-3#1)(1993-2#1)
health services for##6##3##(1991-3#2)(1992-2#1)(1994-1#1)(1995-12#1)(1996-6#1)
health services in Norway##2##4##(1990-11#1)(1995-2#1)
health services in##8##3##(1990-11#1)(1991-3#1)(1993-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-11#1)
health services management##5##3##(1992-1#4)(1996-1#1)
health services managers##2##3##(1992-1#1)(1994-3#1)
health services research##4##3##(1991-1#1)(1992-3#1)(1993-12#1)(1996-2#1)
health services than##2##3##(1993-2#1)(1996-3#1)
health services to##2##3##(1994-1#2)
health services will##2##3##(1997-1#1)(2012-2#1)
health services##136##2##(1990-11#1)(1990-6#1)(1991-1#1)(1991-2#4)(1991-3#6)(1991-6#4)(1991-9#1)(1992-1#5)(1992-12#1)(1992-2#4)(1992-3#3)(1992-5#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#1)(1993-6#1)(1994-1#5)(1994-12#3)(1994-2#6)(1994-3#2)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#6)(1995-6#1)(1996-1#4)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#9)(1996-6#1)(1997-1#3)(1997-2#9)(1997-3#4)(1997-4#1)(1997-5#1)(2008-1#4)(2008-11#9)(2008-12#3)(2009-3#2)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
health services]##3##2##(1992-5#1)(1994-6#1)(1996-11#1)
health settings##3##2##(2008-12#1)(2008-6#1)(2010-3#1)
health spending##10##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2013-8#1)
health staff##3##2##(2008-10#2)(2012-12#1)
health state##2##2##(1995-2#1)(2009-10#1)
health states##2##2##(2008-1#1)(2011-2#1)
health statistics##5##2##(1990-11#1)(1997-3#1)(2008-1#1)(2008-11#2)
health status and##13##3##(1994-3#1)(1996-2#1)(1997-1#1)(2008-1#3)(2008-10#2)(2008-7#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-12#1)
health status is##2##3##(2010-10#2)
health status measures##2##3##(1994-3#2)
health status of older##3##4##(2008-5#1)(2010-10#2)
health status of the##2##4##(1997-5#1)(2008-10#1)
health status of##16##3##(1993-1#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)(2010-10#2)(2013-1#1)
health status with##2##3##(2008-5#1)(2010-10#1)
health status##67##2##(1991-2#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-3#4)(1994-9#1)(1995-1#1)(1995-12#4)(1996-1#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(2008-1#5)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-12#1)(2009-5#2)(2010-10#7)(2010-2#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
health statutes##2##2##(1994-1#2)
health study##2##2##(1991-2#1)(2009-10#1)
health such as##2##3##(2008-10#1)(2013-7#1)
health surveillance systems##6##3##(1997-3#2)(2008-7#4)
health surveillance##27##2##(1992-2#1)(1997-3#18)(2008-1#1)(2008-7#5)(2012-12#1)(2012-2#1)
health survey##5##2##(1992-1#1)(1992-12#1)(2008-1#1)(2009-10#1)(2011-2#1)
health system is a##2##4##(1994-2#1)(2013-8#1)
health system performance##3##3##(2008-11#1)(2013-8#2)
health system reform##6##3##(1993-12#2)(1993-3#2)(1995-2#1)(2012-12#1)
health system to##3##3##(1992-11#1)(1996-2#1)(2013-8#1)
health system##45##2##(1992-1#1)(1992-11#1)(1993-12#3)(1993-3#3)(1994-1#2)(1994-2#1)(1995-12#4)(1995-2#1)(1996-2#4)(1996-3#1)(1997-2#2)(1997-3#2)(2008-1#4)(2008-11#2)(2008-6#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-8#7)
health systems management##2##3##(1993-1#2)
health systems that##2##3##(1995-12#1)(2008-7#1)
health systems##19##2##(1991-3#1)(1992-1#1)(1993-1#2)(1993-3#1)(1995-12#1)(1997-1#1)(1997-3#2)(2008-1#1)(2008-11#3)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
health team##4##2##(1991-6#1)(1997-2#2)(2008-12#1)
health technology assessment##2##3##(2008-2#1)(2009-3#1)
health technology##4##2##(2008-2#1)(2009-3#3)
health tests##2##2##(2008-10#2)
health than##4##2##(1996-11#1)(1997-5#1)(2013-1#2)
health threat##6##2##(1996-3#1)(2007-12#1)(2008-10#3)(2011-2#1)
health throughout##2##2##(2008-4#1)(2011-2#1)
health to##5##2##(1991-12#1)(1996-11#1)(1996-6#1)(1997-2#1)(2008-7#1)
health unit##2##2##(2010-2#1)(2011-2#1)
health utility##3##2##(2008-7#2)(2011-2#1)
health visit##2##2##(1990-6#1)(1995-3#1)
health visiting##2##2##(2008-11#1)(2008-12#1)
health visitor##2##2##(1993-12#1)(2008-12#1)
health visitors in##2##3##(1992-2#1)(2008-12#1)
health visitors##4##2##(1990-12#1)(1992-2#1)(2008-11#1)(2008-12#1)
health was##6##2##(1996-3#1)(1997-2#1)(2008-11#1)(2009-5#1)(2010-1#1)(2011-2#1)
health were##2##2##(2011-1#1)(2012-12#1)
health will##3##2##(1995-2#1)(1996-12#1)(1997-2#1)
health workers##8##2##(1993-12#2)(1996-11#1)(2008-10#1)(2009-5#1)(2010-1#1)(2013-1#2)
health workforce in##2##3##(2008-1#1)(2013-1#1)
health workforce##4##2##(1997-3#1)(2008-1#1)(2009-6#1)(2013-1#1)
health##3610##1##(1990-11#6)(1990-12#7)(1990-2#8)(1990-3#1)(1990-6#9)(1990-9#5)(1991-1#26)(1991-11#3)(1991-12#29)(1991-2#70)(1991-3#54)(1991-6#27)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#52)(1992-11#1)(1992-12#31)(1992-2#47)(1992-3#36)(1992-5#4)(1993-1#36)(1993-11#9)(1993-12#63)(1993-2#43)(1993-3#71)(1993-5#2)(1993-6#9)(1993-9#3)(1994-1#80)(1994-12#61)(1994-2#71)(1994-3#69)(1994-6#19)(1994-8#7)(1994-9#10)(1995-1#33)(1995-11#4)(1995-12#118)(1995-2#75)(1995-3#59)(1995-5#5)(1995-6#4)(1995-8#1)(1996-1#102)(1996-11#13)(1996-12#28)(1996-2#114)(1996-3#115)(1996-5#6)(1996-6#16)(1996-8#14)(1996-9#6)(1997-1#67)(1997-2#118)(1997-3#146)(1997-4#16)(1997-5#10)(1997-6#11)(1997-7#2)(1997-8#13)(2007-11#1)(2007-12#8)(2007-8#3)(2008-1#96)(2008-10#106)(2008-11#301)(2008-12#94)(2008-2#1)(2008-3#1)(2008-4#14)(2008-5#10)(2008-6#14)(2008-7#74)(2008-8#20)(2008-9#7)(2009-1#3)(2009-10#10)(2009-11#6)(2009-12#12)(2009-3#7)(2009-4#2)(2009-5#35)(2009-6#21)(2009-7#9)(2009-8#11)(2009-9#4)(2010-1#22)(2010-10#29)(2010-11#9)(2010-12#19)(2010-2#21)(2010-3#5)(2010-4#17)(2010-5#11)(2010-6#4)(2010-7#14)(2010-8#40)(2010-9#27)(2011-1#15)(2011-2#100)(2011-3#1)(2011-9#3)(2012-12#45)(2012-2#58)(2012-3#50)(2013-1#111)(2013-7#9)(2013-8#56)
health)##4##1##(2008-4#2)(2008-7#1)(2012-3#1)
health-care##12##1##(1993-2#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-11#1)(2013-8#1)
health-information seeking##3##2##(2009-5#3)
health-information##4##1##(2009-5#4)
health-related behaviors##2##2##(2010-8#1)(2010-9#1)
health-related quality of life in patients with##2##7##(2008-7#1)(2013-8#1)
health-related quality of life in##4##5##(2008-7#1)(2009-3#1)(2013-1#1)(2013-8#1)
health-related quality of life##14##4##(1995-2#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-5#1)(2011-2#1)(2011-7#1)(2012-12#3)(2013-1#1)(2013-8#2)
health-related quality of##15##3##(1995-2#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-5#1)(2011-2#2)(2011-7#1)(2012-12#3)(2013-1#1)(2013-8#2)
health-related websites##2##2##(2008-8#1)(2013-1#1)
health-related##35##1##(1991-3#1)(1991-6#1)(1995-2#2)(1996-1#1)(1997-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#3)(2013-1#3)(2013-8#3)
health-risk behaviors##3##2##(2010-5#2)(2010-7#1)
health-status measures##2##2##(1997-2#2)
health?##2##1##(2008-10#1)(2008-8#1)
health]##7##1##(1990-3#1)(1992-5#1)(1995-2#1)(1997-4#2)(2012-12#1)(2012-3#1)
healthcare administrators##3##2##(1991-9#1)(2009-8#2)
healthcare and##6##2##(2008-10#1)(2009-11#2)(2009-6#1)(2010-10#1)(2012-12#1)
healthcare delivery##5##2##(1992-2#1)(2007-12#1)(2008-12#1)(2013-1#2)
healthcare education##3##2##(2008-12#3)
healthcare environment##3##2##(1993-12#1)(1993-2#1)(1997-3#1)
healthcare expenditures##6##2##(2013-1#6)
healthcare experience##2##2##(2012-2#2)
healthcare facilities##8##2##(1992-12#1)(1992-2#2)(1993-2#1)(2007-12#2)(2009-11#1)(2009-8#1)
healthcare facility##3##2##(1993-12#1)(1994-12#1)(1994-3#1)
healthcare improvement##2##2##(2013-1#2)
healthcare in##7##2##(1995-1#1)(1996-3#1)(1997-3#2)(2007-12#1)(2008-10#1)(2013-1#1)
healthcare information##3##2##(2010-8#2)(2011-2#1)
healthcare institutions##4##2##(1993-2#1)(1994-12#1)(1994-3#1)(1997-3#1)
healthcare management##3##2##(2009-3#1)(2009-8#2)
healthcare market##2##2##(1997-5#1)(1997-6#1)
healthcare needs##2##2##(2010-1#1)(2011-1#1)
healthcare organizations##6##2##(1996-1#1)(2009-8#1)(2010-8#1)(2013-1#2)(2013-8#1)
healthcare practitioners##2##2##(2008-12#2)
healthcare professionals##8##2##(1991-1#1)(1991-2#1)(2008-11#1)(2008-12#2)(2010-12#1)(2011-2#1)(2013-8#1)
healthcare provider##2##2##(2009-3#1)(2013-1#1)
healthcare providers to##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
healthcare providers##12##2##(1991-2#1)(1993-2#1)(1997-5#1)(2008-11#1)(2008-12#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#2)
healthcare quality##6##2##(1992-11#1)(2010-4#1)(2013-1#4)
healthcare reform##4##2##(1993-12#1)(1995-1#2)(2013-1#1)
healthcare resources##5##2##(2012-2#2)(2013-1#2)(2013-8#1)
healthcare security management##3##3##(1992-12#1)(1993-2#2)
healthcare security##11##2##(1992-12#4)(1992-2#2)(1993-12#1)(1993-2#2)(1995-12#1)(1996-12#1)
healthcare service##2##2##(1991-3#1)(1992-1#1)
healthcare services##7##2##(1994-3#1)(2008-1#1)(2008-12#1)(2009-11#1)(2009-6#1)(2009-8#1)(2012-2#1)
healthcare setting##4##2##(1993-2#1)(1996-12#1)(2011-1#1)(2011-2#1)
healthcare settings##3##2##(1994-3#1)(2008-12#2)
healthcare system is##2##3##(1997-3#1)(2013-8#1)
healthcare system##12##2##(1991-3#2)(1992-11#1)(1997-3#2)(2009-8#1)(2010-8#1)(2011-7#1)(2013-1#3)(2013-8#1)
healthcare systems in##2##3##(2009-3#1)(2013-8#1)
healthcare systems##4##2##(1997-2#1)(2009-3#1)(2012-2#1)(2013-8#1)
healthcare teams##3##2##(2009-6#2)(2010-1#1)
healthcare training##2##2##(2008-9#1)(2011-2#1)
healthcare workers in##4##3##(2012-12#2)(2013-1#2)
healthcare workers##11##2##(1996-12#1)(1996-8#1)(1997-2#1)(2008-12#1)(2008-9#1)(2012-12#3)(2013-1#3)
healthcare##254##1##(1991-1#2)(1991-2#4)(1991-3#4)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#6)(1992-2#7)(1992-8#1)(1993-1#1)(1993-12#4)(1993-2#9)(1993-3#1)(1993-5#2)(1994-12#4)(1994-2#1)(1994-3#4)(1995-1#6)(1995-12#3)(1996-1#1)(1996-12#5)(1996-3#2)(1996-8#1)(1997-2#3)(1997-3#10)(1997-5#2)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#22)(2008-7#1)(2008-9#3)(2009-11#6)(2009-3#8)(2009-6#8)(2009-8#14)(2010-1#3)(2010-10#2)(2010-12#2)(2010-4#2)(2010-6#1)(2010-8#6)(2011-1#4)(2011-2#10)(2011-7#1)(2012-12#4)(2012-2#6)(2013-1#40)(2013-8#11)
healthier##5##1##(1994-12#1)(2008-11#1)(2010-9#1)(2013-1#2)
healthy Japanese##2##2##(2008-5#2)
healthy Norwegians##2##2##(1990-2#1)(1991-6#1)
healthy adult##6##2##(1994-12#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
healthy adults##7##2##(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
healthy ageing##2##2##(1992-11#1)(2010-10#1)
healthy and AYP-infected shoots##2##4##(2008-10#2)
healthy and AYP-infected##3##3##(2008-10#3)
healthy and diseased##3##3##(2008-10#3)
healthy and infected##3##3##(2008-10#3)
healthy and##21##2##(1993-3#1)(1997-2#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)
healthy antral follicles##2##3##(1995-12#1)(2008-11#1)
healthy behaviors##2##2##(2010-5#1)(2013-1#1)
healthy cats##2##2##(1996-6#2)
healthy centenarians##2##2##(2008-7#2)
healthy child##2##2##(2008-11#2)
healthy children and##2##3##(2008-12#1)(2010-1#1)
healthy children with##2##3##(2008-10#1)(2011-1#1)
healthy children##13##2##(1991-6#2)(1993-12#1)(1994-6#1)(1995-2#3)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-1#1)(2011-1#1)
healthy control##7##2##(1990-12#1)(1995-5#1)(2008-12#1)(2008-7#2)(2009-6#1)(2011-1#1)
healthy controls and##6##3##(1991-12#1)(2008-10#4)(2009-6#1)
healthy controls from##2##3##(1992-11#1)(1997-8#1)
healthy controls were##2##3##(1996-11#1)(2008-12#1)
healthy controls##29##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-2#1)(1995-12#1)(1996-11#1)(1997-8#2)(2008-10#5)(2008-12#2)(2008-4#1)(2008-7#3)(2009-6#1)(2010-12#2)(2011-2#3)(2013-1#2)
healthy development of children##2##4##(2008-11#2)
healthy development##3##2##(2008-11#2)(2011-2#1)
healthy diet##5##2##(2008-3#1)(2010-12#1)(2011-1#2)(2011-2#1)
healthy dogs##2##2##(2008-12#1)(2013-1#1)
healthy donors and##3##3##(2008-11#2)(2008-4#1)
healthy donors showed##2##3##(2008-11#1)(2008-7#1)
healthy donors##13##2##(1994-3#1)(1996-12#1)(2008-11#7)(2008-4#1)(2008-7#2)(2010-12#1)
healthy eating##3##2##(2009-6#1)(2011-2#1)(2013-1#1)
healthy elderly##2##2##(1991-8#1)(2008-7#1)
healthy female##5##2##(1994-12#1)(1995-11#1)(2008-10#3)
healthy heart##2##2##(1996-3#1)(2008-10#1)
healthy human skin##2##3##(2008-5#1)(2012-3#1)
healthy human##7##2##(1991-2#2)(1992-6#1)(2008-5#2)(2012-2#1)(2012-3#1)
healthy individuals in a##2##4##(2008-10#1)(2008-5#1)
healthy individuals in##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
healthy individuals##22##2##(1991-7#1)(1992-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
healthy leaf area##4##3##(2008-10#4)
healthy leaves##2##2##(2008-10#2)
healthy male and##3##3##(2008-10#3)
healthy male##6##2##(1991-12#1)(2008-10#3)(2008-5#1)(2009-8#1)
healthy man##4##2##(1994-9#1)(2010-1#1)(2013-8#2)
healthy mango##2##2##(2008-10#2)
healthy men and women##2##4##(1996-8#1)(2010-12#1)
healthy men##5##2##(1996-8#1)(2008-12#2)(2009-3#1)(2010-12#1)
healthy mice##2##2##(2008-8#2)
healthy newborn infant##2##3##(2008-11#1)(2011-2#1)
healthy newborn##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
healthy newborns and##3##3##(2008-10#2)(2011-1#1)
healthy newborns##4##2##(1996-3#1)(2008-10#2)(2011-1#1)
healthy normal skin##2##3##(2012-3#2)
healthy obese##2##2##(2013-1#1)(2013-7#1)
healthy or APP-infected##2##3##(2008-10#2)
healthy or##4##2##(2008-10#3)(2011-2#1)
healthy oral cavity##2##3##(2008-12#2)
healthy oral##3##2##(2008-12#2)(2013-1#1)
healthy participants##3##2##(2008-11#2)(2010-9#1)
healthy patients##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
healthy peach seedlings##3##3##(2008-10#3)
healthy people##3##2##(2011-2#2)(2013-1#1)
healthy periwinkle shoots##2##3##(2008-10#2)
healthy plant extracts##2##3##(2008-10#2)
healthy plant##4##2##(2008-10#4)
healthy plants##4##2##(2008-10#4)
healthy roots##3##2##(2008-10#3)
healthy schoolchildren to##2##3##(1994-12#1)(2011-2#1)
healthy seedling stand##2##3##(2008-10#2)
healthy seedlings##4##2##(2008-10#4)
healthy skin##11##2##(2008-5#8)(2012-3#3)
healthy state##2##2##(2011-2#1)(2012-2#1)
healthy subject##3##2##(2008-10#2)(2008-12#1)
healthy subjects and patients with chronic neck pain##2##8##(2010-12#2)
healthy subjects and##10##3##(1994-6#1)(1996-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#3)(2011-2#1)
healthy subjects were enrolled in##2##5##(2010-12#1)(2013-1#1)
healthy subjects were##4##3##(2008-12#1)(2010-12#2)(2013-1#1)
healthy subjects##45##2##(1990-2#2)(1990-5#1)(1992-9#1)(1994-6#1)(1996-1#3)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-12#7)(2010-9#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
healthy sugarcane##2##2##(2008-10#2)
healthy tissues##2##2##(2008-10#2)
healthy tits##3##2##(2008-5#3)
healthy trees##4##2##(2008-10#4)
healthy volunteers##18##2##(1991-8#1)(1992-3#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
healthy white##2##2##(1990-3#1)(2011-2#1)
healthy women##9##2##(1991-8#1)(1993-2#2)(2008-5#2)(2010-9#2)(2012-3#1)(2013-1#1)
healthy yaks were##2##3##(2011-2#2)
healthy yaks##4##2##(2011-2#4)
healthy young adults##2##3##(1990-12#1)(2008-7#1)
healthy young##6##2##(1990-12#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
healthy##507##1##(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-6#4)(1991-7#1)(1991-8#4)(1992-11#3)(1992-12#3)(1992-3#3)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#3)(2006-6#2)(2007-8#1)(2008-1#2)(2008-10#124)(2008-11#30)(2008-12#21)(2008-3#2)(2008-4#2)(2008-5#26)(2008-7#20)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2009-6#5)(2009-8#9)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#14)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#5)(2011-1#5)(2011-2#45)(2012-12#1)(2012-2#14)(2012-3#15)(2013-1#26)(2013-3#1)(2013-7#4)(2013-8#12)
hear the##2##2##(1995-6#1)(1996-5#1)
hear##4##1##(1994-2#1)(1995-6#1)(1996-5#1)(2009-10#1)
heard of##3##2##(1993-12#1)(2009-5#1)(2013-1#1)
heard##10##1##(1992-3#1)(1993-12#1)(1996-5#1)(1997-4#2)(1997-8#1)(2008-2#1)(2009-5#1)(2013-1#2)
hearing aid##4##2##(2008-9#2)(2011-2#1)(2012-2#1)
hearing aids##3##2##(1990-12#1)(2008-9#1)(2012-2#1)
hearing and equilibrium##4##3##(2011-2#4)
hearing and##11##2##(1990-12#1)(1996-11#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#5)
hearing children##5##2##(2008-9#1)(2011-2#4)
hearing impairment and##2##3##(2008-9#2)
hearing impairment##7##2##(2008-9#6)(2011-1#1)
hearing loss and##5##3##(2008-9#2)(2011-2#2)(2013-1#1)
hearing loss in##2##3##(1994-9#1)(2012-2#1)
hearing loss##25##2##(1992-2#1)(1994-9#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-9#9)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
hearing peers##2##2##(2012-2#2)
hearing students##4##2##(2011-2#4)
hearing##98##1##(1990-12#7)(1992-12#1)(1992-2#1)(1994-9#4)(1995-12#1)(1995-6#1)(1996-11#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#34)(2009-6#1)(2009-8#1)(2011-1#3)(2011-2#26)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#2)
hearing-impaired patients##4##2##(1995-1#4)
hearing-impaired##6##1##(1995-1#4)(2008-9#2)
hearings##4##1##(1995-12#3)(2012-2#1)
heart and brain##5##3##(1990-12#1)(1993-12#1)(1994-3#1)(1994-5#1)(2012-3#1)
heart and liver##2##3##(1996-12#1)(2008-10#1)
heart and respiratory##2##3##(2011-2#1)(2012-3#1)
heart and##20##2##(1990-12#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
heart are##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
heart attack and##2##3##(2008-5#1)(2011-2#1)
heart attack symptoms##2##3##(2010-12#2)
heart attack##13##2##(1995-2#1)(2008-11#1)(2008-3#3)(2008-5#2)(2009-5#1)(2010-12#2)(2011-2#2)(2013-8#1)
heart block in##2##3##(2008-10#1)(2010-6#1)
heart block##3##2##(1992-5#1)(2008-10#1)(2010-6#1)
heart catheterisation##2##2##(2010-10#2)
heart defect##2##2##(2012-12#2)
heart defects##4##2##(1997-8#2)(2010-10#1)(2012-2#1)
heart disease (CHD)##6##3##(2008-11#1)(2008-6#1)(2010-10#1)(2010-9#1)(2012-2#2)
heart disease (IHD)##4##3##(1995-12#1)(2008-3#1)(2012-3#2)
heart disease and cerebrovascular disease##2##5##(2008-10#1)(2008-8#1)
heart disease and the##2##4##(2008-10#1)(2008-12#1)
heart disease and##15##3##(1991-11#1)(1992-9#1)(1993-12#2)(1993-2#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-8#1)(2009-10#1)
heart disease in##9##3##(1990-3#1)(1990-6#1)(1996-8#2)(2008-11#1)(2008-12#2)(2012-2#1)(2013-8#1)
heart disease is##3##3##(1991-2#1)(1993-2#1)(2010-12#1)
heart disease patients##2##3##(2010-12#1)(2010-4#1)
heart disease risk##4##3##(1991-6#2)(2008-1#1)(2008-3#1)
heart disease##126##2##(1990-11#1)(1990-3#4)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#3)(1991-8#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#3)(1995-12#2)(1995-2#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#10)(2008-3#4)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2009-10#7)(2009-12#1)(2009-6#3)(2010-1#2)(2010-10#3)(2010-12#5)(2010-4#2)(2010-6#4)(2010-9#3)(2011-2#4)(2012-2#7)(2012-3#9)(2013-1#2)(2013-8#2)
heart diseases and##3##3##(1990-3#1)(2008-10#1)(2012-3#1)
heart diseases in##3##3##(1990-3#1)(1995-12#1)(2012-2#1)
heart diseases##10##2##(1990-3#2)(1993-2#1)(1995-12#1)(1996-11#1)(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
heart electrical activity vector##2##4##(2010-8#2)
heart failure (CHF)##2##3##(1995-12#1)(2009-10#1)
heart failure and##3##3##(1990-9#1)(2008-10#1)(2008-11#1)
heart failure in the##2##4##(1994-6#1)(2009-10#1)
heart failure in##4##3##(1994-6#1)(2008-11#1)(2008-7#1)(2009-10#1)
heart failure or##3##3##(1997-5#1)(2012-3#2)
heart failure##73##2##(1990-9#4)(1991-6#1)(1993-2#1)(1994-6#1)(1995-12#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#6)(2008-3#3)(2008-7#11)(2009-10#10)(2010-6#9)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#2)
heart failure]##2##2##(2010-12#1)(2013-8#1)
heart function in##2##3##(2010-12#1)(2013-1#1)
heart function##6##2##(2010-12#1)(2010-6#1)(2013-1#4)
heart in the##4##3##(1993-12#2)(2010-6#2)
heart in##5##2##(1993-12#2)(2010-6#2)(2013-1#1)
heart is##4##2##(1991-3#1)(1994-11#1)(1995-3#1)(2008-12#1)
heart meridian##3##2##(2008-9#3)
heart mitochondria##3##2##(1994-5#2)(2008-8#1)
heart mitochondrial##2##2##(1994-5#1)(2008-11#1)
heart monitoring##2##2##(2010-8#2)
heart muscle##4##2##(1990-2#1)(1992-9#1)(2008-5#1)(2010-12#1)
heart of##13##2##(1994-3#1)(1996-12#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2010-11#1)(2010-5#1)(2010-8#1)(2013-1#2)
heart or##2##2##(1993-1#1)(1997-5#1)
heart rate (HR) and##2##4##(1992-12#1)(2013-8#1)
heart rate (HR)##8##3##(1992-12#1)(2008-11#2)(2009-8#1)(2012-2#1)(2013-8#3)
heart rate and##6##3##(1993-2#1)(2008-7#1)(2010-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
heart rate response##2##3##(2008-5#1)(2008-7#1)
heart rate variability (HRV)##4##4##(2008-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
heart rate variability and##3##4##(2008-12#1)(2008-7#1)(2010-12#1)
heart rate variability##9##3##(2008-12#3)(2008-7#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
heart rate##52##2##(1990-10#1)(1990-5#1)(1990-9#2)(1991-6#2)(1992-12#1)(1993-1#2)(1993-2#1)(1994-3#2)(2008-10#1)(2008-11#2)(2008-12#4)(2008-5#1)(2008-7#7)(2009-11#1)(2009-8#1)(2010-12#2)(2010-5#3)(2010-6#2)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#6)
heart rate)##2##2##(1991-8#1)(2008-3#1)
heart rhythm##2##2##(2008-8#1)(2012-3#1)
heart surgery##4##2##(1990-2#1)(1997-3#2)(1997-8#1)
heart syndrome##2##2##(2010-6#1)(2013-1#1)
heart tissue##3##2##(1994-5#1)(2008-7#1)(2012-3#1)
heart transplant##3##2##(1995-9#1)(2008-10#2)
heart valve##3##2##(1993-12#1)(2010-12#1)(2011-2#1)
heart valves##6##2##(1991-3#1)(2006-6#1)(2008-8#1)(2010-12#2)(2010-6#1)
heart was##4##2##(1993-12#1)(2013-1#3)
heart##526##1##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#2)(1990-3#7)(1990-5#1)(1990-6#1)(1990-9#6)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#8)(1991-8#2)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#11)(1993-2#7)(1993-3#1)(1993-6#1)(1994-11#6)(1994-2#3)(1994-3#5)(1994-5#9)(1994-6#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-5#2)(1997-8#7)(2006-6#1)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#21)(2008-12#19)(2008-3#13)(2008-5#11)(2008-6#4)(2008-7#33)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#17)(2009-11#1)(2009-12#4)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#23)(2010-4#3)(2010-5#4)(2010-6#21)(2010-7#3)(2010-8#10)(2010-9#4)(2011-1#2)(2011-2#22)(2011-3#1)(2012-12#6)(2012-2#22)(2012-3#23)(2013-1#23)(2013-8#13)
heart-lung transplantation##2##2##(1994-3#1)(2010-10#1)
heart-lung transplantations##2##2##(1997-5#1)(2011-3#1)
heart-lung##5##1##(1990-2#1)(1994-3#1)(1997-5#1)(2010-10#1)(2011-3#1)
heart-shaped##2##1##(2010-3#1)(2012-12#1)
heart/lung##2##1##(2008-5#1)(2010-10#1)
heartbeat##2##1##(2010-8#2)
hearts and##2##2##(1991-3#1)(2010-6#1)
hearts of vitamin E##2##4##(1994-5#2)
hearts of##3##2##(1994-5#3)
hearts##19##1##(1991-3#1)(1992-6#2)(1994-12#1)(1994-5#7)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)
heartwater##7##1##(1996-12#1)(2010-1#6)
heat and acid##3##3##(1994-11#2)(1996-2#1)
heat and humidity at the airway##2##6##(1992-2#2)
heat and moisture exchangers##2##4##(1992-2#2)
heat and moisture##3##3##(1992-2#2)(2008-2#1)
heat and##17##2##(1992-2#4)(1994-11#2)(1996-12#2)(1996-2#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
heat capacities of##3##3##(1997-2#3)
heat capacity of##2##3##(1997-2#2)
heat capacity##3##2##(1993-8#1)(1997-2#2)
heat conservation##2##2##(1992-2#2)
heat curing##2##2##(2008-10#2)
heat damage##3##2##(2008-10#3)
heat denaturation##2##2##(2008-11#1)(2008-7#1)
heat dissipation##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
heat flow##2##2##(2008-11#1)(2008-3#1)
heat flux##5##2##(2008-11#5)
heat fluxes##2##2##(2008-11#1)(2011-1#1)
heat in##2##2##(2008-7#1)(2013-1#1)
heat inactivation##4##2##(1990-12#1)(1994-11#2)(1995-8#1)
heat injury##2##2##(1994-5#2)
heat is##4##2##(1996-12#1)(2011-1#2)(2011-2#1)
heat loss from the airway##2##5##(1992-2#2)
heat loss##4##2##(1992-2#3)(1992-3#1)
heat of solvation##3##3##(2008-10#3)
heat of##8##2##(2008-10#4)(2008-11#1)(2010-4#3)
heat production in##2##3##(2009-8#2)
heat production##3##2##(2009-8#3)
heat pump##4##2##(2008-10#1)(2011-2#3)
heat resistance##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
heat resistant and##2##3##(2008-10#1)(2010-3#1)
heat resistant##7##2##(2008-10#2)(2010-3#2)(2011-2#3)
heat shock and##2##3##(1997-4#1)(2012-3#1)
heat shock element##2##3##(1993-8#2)
heat shock protein 70##6##4##(1995-11#1)(2008-10#3)(2010-12#1)(2013-8#1)
heat shock protein hsp90##2##4##(1990-11#1)(1996-12#1)
heat shock protein of##4##4##(1995-6#1)(1996-12#3)
heat shock protein##21##3##(1990-11#1)(1992-12#1)(1994-8#1)(1995-11#1)(1995-6#2)(1996-12#4)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
heat shock proteins##2##3##(1990-11#1)(1997-4#1)
heat shock response of##2##4##(2008-7#2)
heat shock response##4##3##(1993-8#1)(2008-7#3)
heat shock transcription factor##2##4##(1993-8#1)(1994-8#1)
heat shock##49##2##(1990-11#2)(1992-12#2)(1993-8#5)(1994-8#5)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#6)(1997-4#4)(1997-7#3)(2008-10#7)(2008-11#1)(2008-7#6)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
heat shocked cultures##2##3##(1995-12#2)
heat shocked##3##2##(1995-12#3)
heat stability and##2##3##(1990-10#1)(2011-2#1)
heat stability##3##2##(1990-10#1)(1997-4#1)(2011-2#1)
heat stable##4##2##(1997-8#1)(2008-10#2)(2008-11#1)
heat stress##11##2##(1991-12#2)(1991-9#1)(1994-11#1)(2008-11#1)(2008-5#5)(2010-7#1)
heat tolerance of##3##3##(2010-4#3)
heat tolerance##4##2##(2008-10#1)(2010-4#3)
heat transfer##3##2##(2008-10#2)(2011-2#1)
heat treatment and##2##3##(2008-10#2)
heat treatment at##2##3##(2010-4#1)(2012-2#1)
heat treatment on the##2##4##(2011-2#1)(2012-2#1)
heat treatment##20##2##(2008-10#8)(2008-11#1)(2008-7#3)(2010-4#1)(2011-2#3)(2012-2#4)
heat##253##1##(1990-10#1)(1990-11#2)(1990-12#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#9)(1992-3#6)(1993-11#2)(1993-8#7)(1994-11#5)(1994-3#1)(1994-5#2)(1994-8#5)(1995-11#1)(1995-12#4)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#12)(1996-2#2)(1997-2#5)(1997-3#1)(1997-4#5)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#50)(2008-11#17)(2008-12#1)(2008-2#3)(2008-3#9)(2008-5#6)(2008-7#11)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#5)(2010-12#1)(2010-3#2)(2010-4#9)(2010-7#1)(2011-1#4)(2011-2#22)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#7)
heat-##2##1##(1996-2#1)(2008-10#1)
heat-hyperalgesia##3##1##(2008-9#3)
heat-inactivated##4##1##(1990-12#1)(1996-12#1)(2008-10#1)(2008-5#1)
heat-induced##2##1##(1994-11#2)
heat-inducible##2##1##(1993-9#1)(1995-6#1)
heat-killed##2##1##(2008-10#2)
heat-labile toxin##2##2##(1995-2#2)
heat-labile##3##1##(1995-2#3)
heat-shock and##2##2##(1993-6#1)(1997-7#1)
heat-shock protein 70##3##3##(1993-9#1)(2010-5#1)(2012-3#1)
heat-shock protein##9##2##(1990-5#1)(1993-6#3)(1993-9#2)(2010-5#2)(2012-3#1)
heat-shock proteins##2##2##(1992-5#1)(2008-10#1)
heat-shock##16##1##(1990-5#1)(1992-5#1)(1993-6#5)(1993-9#2)(1997-7#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-5#2)(2012-3#1)
heat-stable and##2##2##(2008-10#1)(2008-11#1)
heat-stable growth factor##2##3##(2008-8#2)
heat-stable##5##1##(2008-10#1)(2008-11#2)(2008-8#2)
heat-stress##2##1##(1994-11#1)(2008-10#1)
heat-transfer##2##1##(2008-11#1)(2008-3#1)
heat-treated##10##1##(1997-7#1)(2008-10#8)(2010-4#1)
heated at##6##2##(1994-8#1)(2008-10#3)(2010-4#2)
heated graphite atomizer##5##3##(2008-10#5)
heated graphite##8##2##(2008-10#8)
heated in a##3##3##(2008-10#2)(2008-3#1)
heated to##4##2##(1991-7#1)(2008-10#3)
heated##47##1##(1991-7#1)(1992-8#1)(1993-6#1)(1994-8#2)(2008-10#28)(2008-11#1)(2008-3#3)(2010-4#2)(2010-9#3)(2011-2#4)(2013-1#1)
heated-wire breathing circuits and heated humidifiers##2##6##(2010-9#2)
heater##2##1##(2008-10#2)
heath##3##1##(2007-8#1)(2008-1#1)(2008-10#1)
heating and cooling##3##3##(2008-10#3)
heating and##12##2##(1990-9#1)(2008-10#9)(2008-11#1)(2008-3#1)
heating at 80 degrees C for##2##6##(2008-10#2)
heating at 80 degrees C##3##5##(2008-10#3)
heating at##10##2##(1994-8#1)(2008-10#6)(2008-2#1)(2011-2#2)
heating cycles##5##2##(2008-10#5)
heating for the##2##3##(2008-10#2)
heating for##3##2##(2008-10#3)
heating in H(2)##2##3##(2010-4#2)
heating in##6##2##(1990-5#1)(1994-5#1)(2008-10#2)(2010-4#2)
heating of the##2##3##(2008-10#1)(2008-9#1)
heating of##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
heating program##4##2##(2008-10#4)
heating the##2##2##(2008-10#1)(2008-2#1)
heating time##2##2##(2008-10#2)
heating times##2##2##(2008-10#1)(2008-3#1)
heating to##6##2##(1991-5#1)(2008-10#5)
heating was##2##2##(2008-10#2)
heating with##2##2##(2008-10#2)
heating##107##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-3#1)(1992-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-1#1)(2008-10#74)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#2)(2009-8#2)(2010-4#2)(2011-2#5)(2012-2#1)
heats of##2##2##(2008-11#1)(2010-4#1)
heats##3##1##(1995-3#1)(2008-11#1)(2010-4#1)
heavier##9##1##(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
heavily contaminated##2##2##(2008-10#2)
heavily dependent upon##2##3##(2008-7#1)(2010-8#1)
heavily dependent##4##2##(2008-10#1)(2008-7#1)(2009-7#1)(2010-8#1)
heavily infected needles##2##3##(2008-10#2)
heavily infected##4##2##(2008-10#4)
heavily infested##3##2##(1996-12#2)(2008-10#1)
heavily on##6##2##(1995-1#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-8#1)
heavily pretreated##3##2##(1992-2#3)
heavily##42##1##(1990-8#1)(1992-2#3)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#2)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
heavy and light chain##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
heavy and light chains of factor Va##2##7##(1994-5#2)
heavy and light chains##4##4##(1994-11#1)(1994-5#2)(2011-2#1)
heavy and light##8##3##(1994-11#1)(1994-5#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)
heavy and##10##2##(1994-11#1)(1994-5#2)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#2)
heavy atom derivatives##2##3##(1992-4#1)(2008-9#1)
heavy atom##9##2##(1992-4#2)(2008-10#4)(2008-9#3)
heavy atom-induced room temperature##2##4##(2008-10#2)
heavy care##2##2##(1991-2#1)(1993-3#1)
heavy chain contact##2##3##(1997-9#2)
heavy chain gene##10##3##(1991-2#2)(1992-3#5)(1995-2#1)(2008-11#2)
heavy chain of the##3##4##(1994-5#2)(2008-9#1)
heavy chain of##6##3##(1990-5#1)(1994-5#2)(1995-2#1)(2008-4#1)(2008-9#1)
heavy chain##40##2##(1990-5#2)(1991-2#2)(1992-3#7)(1993-6#1)(1994-11#2)(1994-5#2)(1995-2#4)(1995-6#1)(1995-8#1)(1997-9#5)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#2)
heavy chains that##2##3##(1993-9#1)(1997-9#1)
heavy chains##9##2##(1992-12#1)(1993-8#1)(1993-9#1)(1997-9#4)(2008-11#1)(2012-2#1)
heavy ewes##2##2##(2008-9#2)
heavy fuel##2##2##(2008-10#2)
heavy lanthanide##3##2##(2008-10#3)
heavy metal contaminants##2##3##(2008-10#2)
heavy metal ions and##4##4##(2008-10#4)
heavy metal ions was##2##4##(2008-10#2)
heavy metal ions##39##3##(1994-6#1)(2008-10#38)
heavy metal##62##2##(1993-12#1)(1994-6#1)(2008-10#49)(2008-11#1)(2008-12#2)(2008-7#2)(2009-12#2)(2013-1#4)
heavy metals and##2##3##(1994-6#1)(2008-10#1)
heavy metals are##3##3##(2008-10#1)(2008-12#1)(2009-12#1)
heavy metals by##2##3##(2008-10#2)
heavy metals in contaminated##2##4##(2008-10#2)
heavy metals in sediments##2##4##(2008-10#2)
heavy metals in the environment##2##5##(2008-10#1)(2011-2#1)
heavy metals in the##3##4##(2008-10#2)(2011-2#1)
heavy metals in##22##3##(2008-10#15)(2008-11#2)(2008-12#4)(2011-2#1)
heavy metals on##2##3##(2008-10#2)
heavy metals was##2##3##(2008-10#2)
heavy metals##71##2##(1994-3#1)(1994-6#1)(2008-10#49)(2008-11#4)(2008-12#7)(2008-7#1)(2009-12#2)(2011-2#3)(2013-1#3)
heavy smokers##2##2##(1993-2#1)(1994-6#1)
heavy traffic##2##2##(1995-1#1)(2008-10#1)
heavy##259##1##(1990-5#2)(1991-12#1)(1991-2#3)(1992-12#1)(1992-3#7)(1992-4#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-3#2)(1994-5#6)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-9#9)(2007-8#1)(2008-10#125)(2008-11#11)(2008-12#9)(2008-4#2)(2008-7#6)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#4)(2011-2#9)(2012-2#2)(2013-1#10)(2013-8#2)
heavy-chain gene fragment##2##3##(1997-2#2)
heavy-chain gene##4##2##(1997-2#2)(2008-9#1)(2009-8#1)
heavy-chain joining##2##2##(1991-6#2)
heavy-chain##11##1##(1991-6#2)(1994-5#1)(1995-2#3)(1995-6#1)(1997-2#2)(2008-9#1)(2009-8#1)
hebraeum##3##1##(1996-12#3)
hederae##3##1##(2008-10#3)
hedgehog (hh)##2##2##(1993-12#1)(1993-2#1)
hedgehog##18##1##(1993-12#9)(1993-2#2)(1994-12#6)(2013-1#1)
heel of##2##2##(2008-5#1)(2008-8#1)
heel##6##1##(1990-5#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#1)(2012-3#1)
height SDS##3##2##(2011-1#3)
height and the##6##3##(2008-10#4)(2013-1#2)
height and weight##3##3##(1991-6#1)(1997-8#1)(2008-11#1)
height and##27##2##(1991-6#1)(1997-8#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#4)
height at##2##2##(2008-10#1)(2013-1#1)
height changes##3##2##(2010-3#2)(2011-2#1)
height decreased##2##2##(1993-8#1)(2008-11#1)
height factor##2##2##(2007-8#2)
height for##2##2##(2008-10#1)(2009-1#1)
height from##2##2##(2007-11#1)(2013-1#1)
height in the##2##3##(2008-10#1)(2013-1#1)
height in##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
height is proportional to##2##4##(2008-10#2)
height is##6##2##(1996-8#1)(2008-10#4)(2008-3#1)
height loss##4##2##(2011-2#4)
height mode##2##2##(2007-12#1)(2008-10#1)
height of occipital##2##3##(2013-1#2)
height of the##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
height of##28##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2009-1#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
height on the##2##3##(2008-10#1)(2011-2#1)
height or##3##2##(2007-11#1)(2008-9#1)(2013-8#1)
height patterns##2##2##(2011-2#2)
height relative##2##2##(2008-10#2)
height resolution of##2##3##(2008-3#2)
height structure##2##2##(2008-8#2)
height was##6##2##(2008-10#4)(2009-1#1)(2009-3#1)
height were##3##2##(2008-10#2)(2008-9#1)
height##204##1##(1991-6#1)(1993-8#2)(1995-3#2)(1996-11#1)(1996-8#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#94)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#5)(2008-8#6)(2008-9#6)(2009-1#6)(2009-12#1)(2009-3#1)(2009-5#1)(2010-3#4)(2011-1#8)(2011-2#13)(2012-12#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#13)(2013-8#1)
height) and##4##2##(2007-11#1)(2008-10#2)(2011-2#1)
height)##7##1##(2007-11#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-1#1)
heighten the##2##2##(1997-4#1)(2009-11#1)
heightened risk of##2##3##(2008-7#1)(2011-2#1)
heightened risk##3##2##(2008-12#1)(2008-7#1)(2011-2#1)
heightened##15##1##(1991-3#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
heights of##3##2##(2008-10#2)(2013-1#1)
heights with##2##2##(2008-10#2)
heights##23##1##(2008-10#18)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
heilgymnasts##2##1##(2008-12#2)
held at the##7##3##(2008-11#1)(2009-4#1)(2011-2#4)(2013-8#1)
held at##12##2##(1993-2#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-11#1)(2011-2#4)(2013-8#1)
held by##5##2##(1994-12#1)(2008-8#3)(2012-2#1)
held constant##5##2##(1996-3#1)(2008-10#3)(2008-6#1)
held in a##2##3##(1994-1#1)(2008-10#1)
held in an optical##2##4##(2009-5#1)(2012-2#1)
held in##21##2##(1994-1#1)(1994-6#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#2)(2009-11#1)(2009-5#2)(2010-10#1)(2010-5#1)(2011-2#1)(2011-4#2)(2012-2#1)
held responsible for##3##3##(1996-1#1)(2008-7#1)(2012-3#1)
held responsible##4##2##(1995-6#1)(1996-1#1)(2008-7#1)(2012-3#1)
held that##4##2##(1993-9#1)(1994-12#2)(2010-5#1)
held the##2##2##(2008-10#1)(2010-3#1)
held to##2##2##(1995-12#1)(2008-3#1)
held##79##1##(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-6#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#3)(2010-11#3)(2010-3#2)(2010-5#2)(2011-2#5)(2011-4#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
helenium L##6##2##(2008-10#1)(2008-5#5)
helianthi isolates##2##2##(2008-10#2)
helianthi##6##1##(2008-10#6)
helical CT##2##2##(1995-11#1)(2009-5#1)
helical filament##2##2##(1991-1#1)(1997-3#1)
helical sense##2##2##(1995-6#2)
helical structure##3##2##(2008-10#2)(2010-7#1)
helical##33##1##(1990-8#1)(1991-1#1)(1991-5#1)(1992-4#2)(1992-6#2)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#8)(1997-3#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)
helicase consensus motifs##2##3##(1995-6#2)
helicase domain##2##2##(2008-10#2)
helicase required for##2##3##(2012-3#2)
helicase##17##1##(1991-12#3)(1993-12#1)(1995-6#4)(1997-7#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-3#2)
helices of##2##2##(1990-5#1)(1993-8#1)
helices that##2##2##(1991-12#1)(1993-8#1)
helices##19##1##(1990-5#2)(1991-12#3)(1991-6#1)(1993-1#3)(1993-3#3)(1993-8#2)(1994-5#2)(1995-2#2)(2008-10#1)
helicobacter##2##1##(2009-12#1)(2010-12#1)
heliconia##2##1##(2008-10#2)
helicopter##2##1##(1990-9#1)(2009-10#1)
helium in##2##2##(2008-10#2)
helium##9##1##(1997-1#1)(2008-10#4)(2008-3#2)(2008-7#2)
helix 4##3##2##(2008-9#3)
helix VIII##2##2##(1995-2#2)
helix and##3##2##(1991-6#1)(2008-10#1)(2010-7#1)
helix are##2##2##(2008-11#1)(2008-8#1)
helix of the##2##3##(1994-12#1)(2008-9#1)
helix of##5##2##(1993-8#1)(1994-12#1)(2008-8#1)(2008-9#1)(2010-6#1)
helix strains##2##2##(2008-10#2)
helix to##2##2##(1994-5#1)(2012-2#1)
helix##52##1##(1990-5#2)(1991-12#1)(1991-6#1)(1993-8#2)(1994-12#1)(1994-5#5)(1995-2#2)(1995-6#3)(1995-8#2)(2008-10#14)(2008-11#2)(2008-2#1)(2008-8#4)(2008-9#4)(2009-7#2)(2010-6#1)(2010-7#3)(2012-2#2)
helix-turn-helix##2##1##(1992-4#1)(2012-2#1)
helminth control##2##2##(1997-7#2)
helminth##5##1##(1997-7#2)(2007-12#1)(2011-2#2)
helminth-naive calves##2##2##(1996-12#2)
helminthes##4##1##(2011-2#4)
helminths##4##1##(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
helodermin &gt##2##2##(1994-3#2)
helophoroides parasitized A##2##3##(2013-8#2)
helophoroides##7##1##(2013-8#7)
help allay##2##2##(2008-12#1)(2008-7#1)
help clarify##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
help clinicians to##2##3##(2008-10#1)(2012-2#1)
help clinicians##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#1)
help college##2##2##(2009-11#1)(2013-8#1)
help define the##2##3##(1991-6#1)(2010-1#1)
help determine the##2##3##(1992-11#1)(1996-6#1)
help determine##4##2##(1992-11#1)(1996-6#1)(2008-10#1)(2009-12#1)
help develop##2##2##(2010-6#1)(2013-1#1)
help elucidate##3##2##(1997-7#1)(2008-10#1)(2012-2#1)
help ensure that##3##3##(1993-1#1)(1996-9#1)(2010-5#1)
help ensure##5##2##(1993-1#1)(1994-12#1)(1996-9#1)(2010-5#2)
help explain the##4##3##(1992-2#1)(2008-10#1)(2008-9#1)(2012-3#1)
help explain##8##2##(1992-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-3#1)
help guide the##4##3##(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
help hospitals##2##2##(1991-2#1)(1997-2#1)
help identify potential##2##3##(2011-2#1)(2012-12#1)
help identify##10##2##(1991-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
help improve##4##2##(1994-12#1)(2008-10#1)(2011-2#1)(2013-7#1)
help in deciding##2##3##(1997-8#1)(2008-10#1)
help in differentiating##2##3##(2008-7#1)(2013-1#1)
help in selecting##2##3##(2009-10#1)(2013-1#1)
help in the identification of##2##5##(1990-2#1)(2011-2#1)
help in the search for##2##5##(1995-6#1)(2008-5#1)
help in the##6##3##(1990-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
help in##27##2##(1990-2#1)(1994-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#2)(2010-10#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
help increase##2##2##(2008-11#1)(2010-4#1)
help nurses##2##2##(2008-11#1)(2010-8#1)
help of a##5##3##(2008-10#3)(2008-11#1)(2012-3#1)
help of##17##2##(1993-1#1)(1993-8#1)(1994-3#1)(1996-3#1)(1997-6#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#2)(2012-3#2)
help patients##4##2##(2008-11#1)(2008-6#1)(2011-2#2)
help physicians##2##2##(2008-11#1)(2008-3#1)
help prevent##7##2##(1991-7#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-12#1)(2010-2#1)(2013-1#1)
help reduce the##2##3##(2008-10#1)(2009-5#1)
help reduce##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2009-5#1)
help researchers and##2##3##(2010-11#1)(2013-1#1)
help researchers##6##2##(2008-10#2)(2008-4#1)(2008-8#1)(2010-11#1)(2013-1#1)
help stem##2##2##(1996-3#1)(2009-5#1)
help students##3##2##(2008-11#2)(2009-12#1)
help the clinician##2##3##(1991-2#1)(1993-1#1)
help the search##2##3##(2008-8#2)
help the##17##2##(1991-2#2)(1992-2#1)(1993-1#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-8#2)(2010-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
help their##2##2##(1992-12#1)(2008-11#1)
help them##9##2##(1990-12#1)(1991-2#1)(1993-2#1)(1994-12#1)(1995-1#1)(2008-10#1)(2008-6#1)(2010-10#1)(2013-8#1)
help to avoid##2##3##(2011-2#1)(2012-12#1)
help to create##2##3##(1995-3#1)(2008-3#1)
help to define##2##3##(2008-10#1)(2013-1#1)
help to develop##4##3##(1994-5#1)(2008-10#1)(2008-9#1)(2011-10#1)
help to elucidate##2##3##(2008-10#1)(2009-7#1)
help to explain##6##3##(1994-2#1)(1994-5#1)(2008-4#1)(2009-12#2)(2012-2#1)
help to further##2##3##(1992-2#1)(2008-9#1)
help to guide##2##3##(2008-12#1)(2013-1#1)
help to identify##6##3##(2008-11#1)(2008-12#1)(2009-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
help to improve the##3##4##(2008-10#1)(2009-8#1)(2012-8#1)
help to improve##5##3##(2008-10#2)(2009-8#1)(2010-12#1)(2012-8#1)
help to prevent##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
help to reduce##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
help to understand the##2##4##(2008-11#1)(2008-7#1)
help to understand##3##3##(2008-11#1)(2008-7#1)(2011-1#1)
help to##83##2##(1990-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#3)(2009-7#1)(2009-8#3)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#3)(2011-10#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#4)(2012-8#1)(2012-9#1)(2013-1#5)(2013-8#1)
help understand##3##2##(1996-3#1)(2008-12#1)(2012-3#1)
help us to understand##2##4##(1994-11#1)(2009-7#1)
help us to##6##3##(1991-6#1)(1993-12#1)(1994-11#1)(2009-7#1)(2010-5#1)(2011-2#1)
help us understand##2##3##(2008-10#1)(2009-10#1)
help us##13##2##(1991-6#1)(1993-12#1)(1994-11#1)(2008-10#1)(2009-1#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-5#1)(2011-2#3)
help with the##2##3##(1995-3#1)(2010-12#1)
help with##4##2##(1992-2#1)(1995-3#1)(2010-12#1)(2010-8#1)
help you##5##2##(1993-1#1)(1994-1#1)(1995-2#1)(1996-2#1)(2011-2#1)
help##403##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#6)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#7)(1992-3#1)(1992-5#2)(1993-1#4)(1993-12#1)(1993-2#3)(1993-8#1)(1994-1#6)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#7)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#42)(2008-11#36)(2008-12#10)(2008-3#3)(2008-4#4)(2008-5#8)(2008-6#5)(2008-7#9)(2008-8#13)(2008-9#6)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#7)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2010-1#4)(2010-10#5)(2010-11#4)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#7)(2010-8#8)(2010-9#3)(2011-1#3)(2011-10#1)(2011-2#23)(2011-3#1)(2012-12#6)(2012-2#9)(2012-3#10)(2012-8#1)(2012-9#1)(2013-1#19)(2013-7#1)(2013-8#8)
helped by##6##2##(1993-2#1)(1995-8#1)(2008-7#1)(2008-8#1)(2012-3#2)
helped the##2##2##(2010-7#1)(2013-8#1)
helped them##3##2##(1993-3#1)(1996-1#1)(2011-2#1)
helped to define##2##3##(1990-12#1)(2010-4#1)
helped to identify##2##3##(2008-12#1)(2011-2#1)
helped to reduce the##2##4##(2008-10#1)(2013-1#1)
helped to shape##2##3##(2008-12#2)
helped to##21##2##(1990-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1997-6#1)(2008-10#4)(2008-12#3)(2008-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
helped us##2##2##(2010-10#1)(2012-2#1)
helped with##2##2##(1992-2#1)(2008-10#1)
helped##52##1##(1990-11#1)(1990-12#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-1#1)(1997-6#1)(2008-10#6)(2008-11#3)(2008-12#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
helper T cell##3##3##(1995-5#1)(2008-11#2)
helper T cells##2##3##(1991-11#1)(2008-10#1)
helper T##7##2##(1991-11#1)(1995-5#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-3#1)
helper T-lymphocytes##2##2##(1997-8#1)(2008-11#1)
helper cells##3##2##(1993-8#1)(1995-12#1)(2012-3#1)
helper component (HC)##3##3##(2008-10#3)
helper component##6##2##(2008-10#6)
helper component-protease (HC-Pro)##2##3##(2008-10#2)
helper functions##2##2##(2008-8#2)
helper virus##13##2##(1990-5#1)(2008-10#10)(2008-8#1)(2008-9#1)
helper viruses##3##2##(2008-10#2)(2008-11#1)
helper##54##1##(1990-5#1)(1991-11#1)(1991-6#1)(1992-3#1)(1993-8#1)(1995-12#1)(1995-5#2)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#24)(2008-11#8)(2008-4#1)(2008-8#4)(2008-9#2)(2011-2#2)(2012-3#2)
helper-dependent virus##2##2##(2008-10#2)
helpers in##2##2##(2008-8#1)(2008-9#1)
helpers of the same sex##2##5##(2008-9#2)
helpers##13##1##(1992-3#1)(1996-11#1)(1996-3#1)(2008-8#6)(2008-9#4)
helpful for##8##2##(1994-12#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
helpful in identifying##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
helpful in the diagnosis##2##4##(1990-3#1)(1997-8#1)
helpful in the##6##3##(1990-3#1)(1992-12#1)(1997-2#1)(1997-8#1)(2008-11#1)(2011-2#1)
helpful in##27##2##(1990-3#1)(1991-2#1)(1992-12#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-5#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
helpful to##12##2##(1994-3#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#1)(2010-8#1)(2012-2#1)
helpful##65##1##(1990-3#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#4)(2008-11#4)(2008-12#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
helping patients##5##2##(2008-7#2)(2010-11#1)(2010-7#1)(2011-2#1)
helping the##4##2##(1992-3#1)(2008-11#1)(2010-11#1)(2012-2#1)
helping their##2##2##(2008-11#1)(2010-8#1)
helping to maintain##2##3##(2008-11#1)(2010-8#1)
helping to##10##2##(1997-2#1)(2008-10#1)(2008-11#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
helping##50##1##(1991-12#1)(1991-2#2)(1992-3#1)(1993-1#2)(1993-2#1)(1994-1#3)(1997-2#4)(2008-10#1)(2008-11#8)(2008-12#2)(2008-7#3)(2008-8#5)(2009-11#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-7#1)
helps identify##2##2##(1993-1#1)(2008-11#1)
helps in##3##2##(1990-6#1)(2008-10#1)(2013-8#1)
helps them##2##2##(2010-5#1)(2010-8#1)
helps to reduce the##3##4##(2008-10#1)(2008-3#1)(2009-9#1)
helps to reduce##4##3##(2008-10#2)(2008-3#1)(2009-9#1)
helps to##14##2##(1991-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#2)
helps##47##1##(1990-6#1)(1991-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#2)(1997-2#3)(1997-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#2)
helveticus 130B4##2##2##(2013-1#2)
hemagglutinin (HA)##5##2##(1990-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
hemagglutinin##11##1##(1990-5#1)(1992-3#1)(1992-9#3)(2008-9#1)(2011-2#3)(2012-2#2)
hemangioblastoma in a##2##3##(2012-3#1)(2013-8#1)
hemangioblastoma##3##1##(2011-2#1)(2012-3#1)(2013-8#1)
hemangioblastomas##2##1##(2011-2#1)(2013-8#1)
hemangioendothelioma##3##1##(2009-9#1)(2011-1#2)
hemangioma##9##1##(1990-9#1)(1997-8#2)(2007-8#1)(2008-10#1)(2009-1#1)(2009-7#1)(2011-2#2)
hemangiomas of##2##2##(1995-8#1)(2013-8#1)
hemangiomas##4##1##(1995-8#1)(2013-1#1)(2013-8#2)
hemangiopericytoma##4##1##(1993-6#3)(2011-2#1)
hemangiopericytoma-like vascular pattern##2##3##(2010-6#2)
hematein##3##1##(2008-10#3)
hematite##2##1##(2008-10#2)
hematocrit (r = -0##2##4##(1993-2#2)
hematocrit and hemoglobin##3##3##(2008-9#1)(2013-1#2)
hematocrit and##4##2##(2008-9#1)(2012-12#1)(2013-1#2)
hematocrit was##2##2##(1990-2#1)(2008-1#1)
hematocrit##17##1##(1990-2#1)(1993-2#4)(1995-1#1)(1996-3#1)(2008-1#2)(2008-3#1)(2008-8#1)(2008-9#2)(2012-12#1)(2013-1#2)(2013-8#1)
hematogenous spread of HCC cells##2##5##(2008-10#2)
hematogenous##6##1##(2008-10#2)(2010-6#2)(2011-2#1)(2012-3#1)
hematologic malignancies##7##2##(2008-7#5)(2010-11#1)(2013-1#1)
hematologic##16##1##(1990-12#1)(1990-8#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-7#5)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
hematological and##3##2##(1992-9#1)(1993-2#1)(2013-8#1)
hematological diseases##2##2##(1992-6#1)(1993-3#1)
hematological malignancies##12##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
hematological##26##1##(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-11#2)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#3)
hematologists##3##1##(2008-11#1)(2010-11#2)
hematology and immunology##2##3##(1994-12#1)(2008-9#1)
hematology##7##1##(1994-12#1)(1997-5#1)(2008-10#1)(2008-9#3)(2011-2#1)
hematoma after##2##2##(2008-12#1)(2013-1#1)
hematoma formation##2##2##(1997-8#1)(2011-2#1)
hematoma in##2##2##(1991-11#1)(2008-12#1)
hematoma is##2##2##(2008-11#1)(2011-2#1)
hematoma of liver##2##3##(2010-11#2)
hematoma of the esophagus##4##4##(2011-2#4)
hematoma of##6##2##(2010-11#2)(2011-2#4)
hematoma was##6##2##(2008-7#2)(2010-11#1)(2011-2#2)(2012-12#1)
hematoma##50##1##(1991-11#1)(1991-12#1)(1991-3#1)(1996-11#1)(1997-8#1)(2008-11#1)(2008-12#5)(2008-7#14)(2008-8#1)(2010-11#3)(2011-2#13)(2012-12#4)(2012-3#2)(2013-1#2)
hematoma-related##2##1##(2012-3#2)
hematomas##6##1##(1996-11#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-12#1)
hematopoiesis##11##1##(1993-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#4)
hematopoietic and lymphoid##2##3##(2008-7#1)(2008-9#1)
hematopoietic cell##8##2##(1994-5#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)
hematopoietic cells but##2##3##(2008-11#1)(2010-8#1)
hematopoietic cells##17##2##(1993-8#2)(1995-2#2)(1996-2#1)(1997-7#1)(2008-11#7)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
hematopoietic culture##2##2##(2008-11#2)
hematopoietic differentiation##3##2##(2008-10#1)(2008-11#2)
hematopoietic growth factors##2##3##(1991-6#1)(2008-7#1)
hematopoietic growth##3##2##(1991-6#1)(2008-11#1)(2008-7#1)
hematopoietic malignancies##2##2##(2008-10#1)(2009-12#1)
hematopoietic progenitor cells##7##3##(2008-11#5)(2008-7#1)(2010-8#1)
hematopoietic progenitor##10##2##(2008-11#7)(2008-7#2)(2010-8#1)
hematopoietic progenitors##7##2##(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#2)(2011-2#1)
hematopoietic regeneration##2##2##(2013-1#2)
hematopoietic stem cell transplantation in##2##5##(2010-11#1)(2012-12#1)
hematopoietic stem cell transplantation##8##4##(1997-8#1)(2008-11#1)(2008-7#1)(2010-11#2)(2011-2#1)(2012-12#1)(2013-1#1)
hematopoietic stem cell##12##3##(1997-8#1)(2008-11#1)(2008-7#1)(2009-12#2)(2010-11#2)(2011-2#1)(2012-12#2)(2013-1#2)
hematopoietic stem cells (HSCs)##3##4##(1993-8#1)(2008-10#1)(2008-4#1)
hematopoietic stem cells can survive in vitro for several months##2##10##(2009-12#2)
hematopoietic stem cells##28##3##(1991-11#1)(1993-2#2)(1993-8#2)(1994-5#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-9#9)(2009-12#5)(2012-10#1)
hematopoietic stem##41##2##(1991-11#1)(1993-2#2)(1993-8#2)(1994-5#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#10)(2009-12#7)(2010-11#2)(2011-2#1)(2012-10#1)(2012-12#2)(2013-1#2)
hematopoietic##109##1##(1990-5#1)(1991-11#1)(1991-6#1)(1993-2#3)(1993-8#5)(1994-5#2)(1995-2#2)(1996-2#1)(1997-7#2)(1997-8#1)(2008-10#6)(2008-11#30)(2008-4#4)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#15)(2009-12#8)(2009-7#1)(2010-11#3)(2010-8#5)(2011-2#2)(2012-10#1)(2012-12#2)(2013-1#4)
hematopoietic/lymphoid tissues##2##2##(2008-7#2)
hematoporphyrin derivatives##2##2##(2008-9#2)
hematoporphyrin##6##1##(1991-5#1)(2008-10#1)(2008-8#2)(2008-9#2)
hematoxylin and eosin##3##3##(2011-2#2)(2013-1#1)
hematuria and##4##2##(1990-11#2)(2008-10#2)
hematuria in a##2##3##(2008-10#2)
hematuria in##3##2##(2008-10#3)
hematuria with##2##2##(2008-10#2)
hematuria##27##1##(1990-11#2)(1994-5#1)(2008-10#13)(2008-11#6)(2011-2#2)(2013-1#2)(2013-8#1)
heme binding##2##2##(1991-9#1)(1994-5#1)
heme methyl##2##2##(1994-5#2)
heme oxygenase##3##2##(1994-5#2)(1995-2#1)
heme oxygenase-1##2##2##(2011-2#2)
heme pocket##2##2##(1990-8#1)(1994-5#1)
heme polymerase activity##2##3##(1993-8#2)
heme polymerase##4##2##(1993-8#4)
heme protein subunit##2##3##(1993-8#2)
heme##46##1##(1990-8#3)(1991-9#2)(1993-8#12)(1994-11#1)(1994-5#14)(1995-2#1)(2008-10#2)(2008-8#2)(2008-9#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)
heme-containing enzyme##2##2##(1992-10#1)(1995-12#1)
heme-protein##3##1##(2008-10#3)
heme-proximal histidine linkage##2##3##(1990-8#2)
hemerythrin by##2##2##(1992-8#2)
hemerythrin##5##1##(1991-10#2)(1992-8#3)
hemes##2##1##(1993-8#1)(2008-11#1)
hemi-fusion in##4##2##(1991-5#4)
hemi-fusion##10##1##(1991-5#10)
hemianopia in##2##2##(2011-2#1)(2013-1#1)
hemianopia##4##1##(1996-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
hemiballismus##2##1##(2008-7#2)
hemicellulose##2##1##(2008-10#1)(2011-2#1)
hemidesmosome##2##1##(2009-10#1)(2012-2#1)
hemidesmosomes##3##1##(2008-12#1)(2008-7#1)(2012-2#1)
hemilabyrinthectomy (HL)##2##2##(1991-2#2)
hemimetabolous##3##1##(2012-2#3)
hemin electronic structure##2##3##(1994-5#2)
hemin is##2##2##(2008-10#2)
hemin substrate##2##2##(1994-5#2)
hemin was##3##2##(2008-10#3)
hemin##22##1##(1994-5#9)(2008-10#11)(2008-8#1)(2008-9#1)
hemineglect##2##1##(2013-8#2)
heminephrectomy in##2##2##(2008-10#2)
hemiparesis and##3##2##(2008-7#2)(2011-2#1)
hemiparesis following stroke as a model for disuse osteoporosis##2##9##(2008-7#2)
hemiparesis in##3##2##(2008-7#1)(2011-2#2)
hemiparesis##18##1##(1991-6#2)(1997-3#1)(2008-12#2)(2008-7#7)(2010-9#1)(2011-2#3)(2013-8#2)
hemiparetic##2##1##(2008-7#1)(2010-7#1)
hemiplegia##3##1##(1997-5#1)(2013-1#1)(2013-8#1)
hemiplegic##2##1##(1997-3#1)(2010-9#1)
hemipopulation##3##1##(2011-2#3)
hemipteran##7##1##(2007-12#3)(2008-10#4)
hemisphere in lobectomized patients##2##4##(2008-11#2)
hemisphere in the##2##3##(1996-2#1)(2013-8#1)
hemisphere in##5##2##(1996-2#1)(2008-11#3)(2013-8#1)
hemisphere is specialized for##2##4##(2008-11#2)
hemisphere is##3##2##(2008-11#3)
hemisphere was##2##2##(1991-11#1)(2008-11#1)
hemisphere##36##1##(1990-11#1)(1991-11#2)(1993-6#2)(1996-12#2)(1996-2#5)(2008-11#8)(2008-3#1)(2008-5#1)(2008-7#4)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#3)
hemispheres##9##1##(1996-12#1)(1996-2#1)(2007-12#1)(2008-7#2)(2010-7#1)(2011-2#2)(2012-2#1)
hemithorax##4##1##(2009-4#1)(2010-12#1)(2013-1#1)(2013-7#1)
hemizygous##28##1##(2008-9#27)(2009-8#1)
hemo- and##2##2##(1994-5#1)(2010-12#1)
hemobilia and intestinal hemorrhage##2##4##(1997-8#2)
hemocholecyst in##2##2##(2013-1#2)
hemocholecyst##3##1##(2013-1#3)
hemocoel##2##1##(2008-10#1)(2008-7#1)
hemocyanin##6##1##(2008-10#4)(2008-7#1)(2008-9#1)
hemocyte adhesion##2##2##(1995-8#2)
hemocyte with##2##2##(2008-5#2)
hemocyte##9##1##(1995-8#2)(2008-5#4)(2008-7#2)(2010-4#1)
hemocytes in the##3##3##(2008-5#1)(2008-7#2)
hemocytes in##5##2##(2008-5#2)(2008-7#3)
hemocytes##19##1##(1995-8#3)(2007-12#1)(2008-5#8)(2008-7#6)(2010-4#1)
hemocytic differentiation in##2##3##(2008-5#2)
hemodialysis (HD)##3##2##(2008-1#1)(2011-2#2)
hemodialysis and peritoneal dialysis##3##4##(2008-10#3)
hemodialysis and##4##2##(2008-10#3)(2012-3#1)
hemodialysis in##3##2##(1991-6#1)(1993-6#1)(2013-1#1)
hemodialysis is##2##2##(2008-10#1)(2013-1#1)
hemodialysis patients##9##2##(1996-2#2)(2008-1#6)(2011-2#1)
hemodialysis solutions##4##2##(2008-10#4)
hemodialysis treatment##2##2##(2011-2#1)(2013-1#1)
hemodialysis##62##1##(1991-11#2)(1991-12#2)(1991-6#2)(1992-3#1)(1993-6#1)(1995-12#1)(1996-2#2)(1996-3#1)(2008-1#12)(2008-10#16)(2009-3#1)(2010-10#1)(2011-2#10)(2011-3#2)(2012-3#1)(2013-1#7)
hemodilution and##2##2##(1992-3#2)
hemodilution##4##1##(1992-3#3)(1995-11#1)
hemodynamic alterations##2##2##(2013-8#2)
hemodynamic and##4##2##(1993-9#1)(1996-2#2)(2012-12#1)
hemodynamic changes were##2##3##(2008-12#1)(2009-8#1)
hemodynamic changes##4##2##(1997-5#1)(2008-12#1)(2008-7#1)(2009-8#1)
hemodynamic data and##2##3##(2011-2#2)
hemodynamic factors##2##2##(2009-1#1)(2013-1#1)
hemodynamic less than##2##3##(2012-3#2)
hemodynamic less##3##2##(2012-3#3)
hemodynamic monitoring##2##2##(2009-1#1)(2011-2#1)
hemodynamic parameters##3##2##(2007-8#1)(2013-8#2)
hemodynamic##47##1##(1990-8#1)(1993-9#1)(1994-3#1)(1996-2#5)(1997-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-1#4)(2009-8#2)(2010-12#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#9)(2013-1#4)(2013-8#4)
hemodynamically stable##3##2##(2008-3#1)(2011-2#2)
hemodynamically##4##1##(2008-3#1)(2011-2#3)
hemodynamics and##4##2##(1996-2#2)(2008-7#1)(2011-2#1)
hemodynamics are##2##2##(1996-2#1)(2011-2#1)
hemodynamics##15##1##(1991-6#1)(1996-2#3)(1996-3#2)(1997-5#1)(2008-12#1)(2008-7#1)(2009-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
hemoglobin (Hb) and##2##3##(2008-10#1)(2008-8#1)
hemoglobin (Hb)##8##2##(1990-8#1)(1994-5#1)(1996-12#1)(2008-10#4)(2008-8#1)
hemoglobin A1c##6##2##(2008-1#1)(2012-5#5)
hemoglobin and##5##2##(2008-1#1)(2008-10#2)(2008-9#2)
hemoglobin as##2##2##(2008-10#2)
hemoglobin concentration values##3##3##(2008-9#3)
hemoglobin concentration##8##2##(1992-12#2)(1996-9#2)(2008-9#4)
hemoglobin concentrations##2##2##(2008-10#1)(2008-3#1)
hemoglobin from##4##2##(1990-8#1)(2008-9#2)(2010-11#1)
hemoglobin in##6##2##(1991-2#1)(2008-10#3)(2008-9#1)(2013-1#1)
hemoglobin level##3##2##(1990-11#1)(2007-12#1)(2009-8#1)
hemoglobin levels##3##2##(2008-7#1)(2010-11#1)(2011-2#1)
hemoglobin synthesis##2##2##(2008-8#2)
hemoglobin was##4##2##(1990-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
hemoglobin were##5##2##(2008-1#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
hemoglobin##109##1##(1990-11#1)(1990-2#1)(1990-8#14)(1990-9#1)(1991-2#1)(1992-11#1)(1992-12#2)(1993-2#1)(1993-8#5)(1994-3#2)(1994-5#1)(1995-2#1)(1995-3#5)(1996-12#1)(1996-9#3)(2007-12#1)(2008-1#4)(2008-10#23)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#9)(2009-12#1)(2009-3#4)(2009-8#1)(2010-11#3)(2011-2#3)(2012-12#1)(2012-5#5)(2013-1#3)(2013-7#1)(2013-8#1)
hemoglobinopathies##2##1##(2008-10#1)(2011-2#1)
hemolymph and##4##2##(1995-11#1)(1997-8#1)(2008-10#1)(2008-6#1)
hemolymph by the##2##3##(2008-5#1)(2008-7#1)
hemolymph by##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
hemolymph of the##2##3##(1995-11#1)(2008-10#1)
hemolymph of##7##2##(1990-5#2)(1995-11#1)(2008-10#4)
hemolymph##35##1##(1990-5#2)(1995-11#2)(1997-8#4)(2008-10#14)(2008-11#1)(2008-5#1)(2008-6#6)(2008-7#3)(2012-2#2)
hemolysis index##2##2##(2013-1#2)
hemolysis of##2##2##(2008-10#1)(2013-1#1)
hemolysis##10##1##(2007-12#2)(2008-10#2)(2011-2#1)(2013-1#5)
hemolytic anemia##7##2##(1991-2#1)(1996-3#1)(1997-6#4)(2008-10#1)
hemolytic toxin##2##2##(2008-10#1)(2008-8#1)
hemolytic##14##1##(1991-2#1)(1994-11#1)(1996-3#1)(1997-6#4)(2008-10#2)(2008-12#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
hemoperfusion##2##1##(2008-11#1)(2011-2#1)
hemophilia A##4##2##(2012-12#4)
hemophilia B##6##2##(2008-8#2)(2008-9#4)
hemophilia##15##1##(1996-5#1)(2008-11#3)(2008-8#2)(2008-9#4)(2009-3#1)(2012-12#4)
hemophiliac patients##2##2##(2008-5#2)
hemophiliacs who##2##2##(1996-5#2)
hemophiliacs##9##1##(1996-5#7)(2008-5#1)(2012-12#1)
hemoplasma##2##1##(2012-3#2)
hemopoietic cells##2##2##(1991-5#1)(1993-3#1)
hemopoietic progenitor cells##2##3##(1994-5#2)
hemopoietic##7##1##(1991-5#2)(1992-12#1)(1993-3#1)(1994-5#2)(2008-5#1)
hemoptysis##5##1##(1997-8#1)(2007-8#1)(2008-5#1)(2012-3#2)
hemorphins##2##1##(1995-3#2)
hemorrhage after##3##2##(2008-12#1)(2013-1#2)
hemorrhage and##3##2##(2008-7#1)(2012-12#1)(2012-3#1)
hemorrhage as##3##2##(2010-10#1)(2011-2#2)
hemorrhage associated with livedo racemosa##2##5##(2007-9#2)
hemorrhage associated with##3##3##(1992-12#1)(2007-9#2)
hemorrhage due to##2##3##(1991-6#1)(2012-3#1)
hemorrhage in the##2##3##(2011-2#1)(2012-12#1)
hemorrhage in##4##2##(1991-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
hemorrhage is##4##2##(1991-11#1)(2011-2#1)(2013-1#2)
hemorrhage of##2##2##(1992-2#1)(1992-5#1)
hemorrhage on##3##2##(2012-3#2)(2013-1#1)
hemorrhage was##2##2##(2008-7#2)
hemorrhage within the cyst##2##4##(2008-12#2)
hemorrhage##94##1##(1990-2#1)(1990-5#1)(1991-11#2)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#3)(1994-2#1)(1995-1#1)(1995-11#4)(1997-8#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-12#5)(2008-7#8)(2008-9#1)(2009-11#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#7)(2011-3#1)(2012-12#4)(2012-3#21)(2013-1#11)(2013-8#3)
hemorrhage]##2##1##(1990-9#1)(1992-6#1)
hemorrhages and##3##2##(1994-9#1)(2008-12#1)(2013-1#1)
hemorrhages were##2##2##(2012-12#1)(2012-3#1)
hemorrhages##12##1##(1994-9#1)(1995-11#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#3)
hemorrhagic colitis caused by Escherichia coli##2##6##(2010-6#2)
hemorrhagic colitis##3##2##(2008-9#1)(2010-6#2)
hemorrhagic pancreatitis##2##2##(2009-12#2)
hemorrhagic shock##2##2##(2012-3#1)(2013-1#1)
hemorrhagic telangiectasia##4##2##(2009-10#1)(2010-6#3)
hemorrhagic##38##1##(1990-5#1)(1991-11#1)(1991-6#3)(1992-2#1)(1996-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-5#1)(2010-6#8)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#2)
hemorrhoidal lesions of the third##2##5##(1990-3#2)
hemorrhoidal##5##1##(1990-3#2)(2013-1#3)
hemorrhoidectomy##3##1##(1990-3#3)
hemosiderin deposits##2##2##(2008-12#1)(2013-1#1)
hemosiderin-stained##2##1##(2012-3#2)
hemostasis achieved##2##2##(1994-1#1)(2011-2#1)
hemostasis and##3##2##(1993-12#1)(1994-5#1)(2013-1#1)
hemostasis##19##1##(1991-6#1)(1993-12#1)(1994-1#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#8)
hemostatic##2##1##(1993-12#1)(2008-10#1)
hemosuccus pancreaticus##2##2##(2011-2#2)
hen##6##1##(1997-2#1)(2008-12#3)(2008-5#2)
hence a##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
hence it##6##2##(1997-1#1)(2008-10#4)(2012-2#1)
hence the need for##2##4##(1992-9#1)(2010-10#1)
hence the##11##2##(1992-9#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)
hence##86##1##(1990-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-5#1)(1996-3#1)(1997-1#2)(1997-7#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#3)(2008-8#7)(2008-9#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-8#1)
hens##11##1##(1991-11#3)(2008-10#3)(2008-12#1)(2008-5#4)
hentscheli##2##1##(2008-9#2)
hepa 1 cells##5##3##(2008-11#5)
hepa 1##6##2##(2008-11#6)
heparan sulfate proteoglycan##2##3##(1992-11#1)(2008-7#1)
heparan sulfate proteoglycans##2##3##(1995-6#2)
heparan sulfate##9##2##(1992-11#1)(1995-12#3)(1995-6#2)(1997-1#1)(2008-5#1)(2008-7#1)
heparan##11##1##(1992-11#1)(1995-12#4)(1995-6#2)(1996-8#1)(1997-1#1)(2008-5#1)(2008-7#1)
heparin and##2##2##(2008-10#1)(2008-11#1)
heparin as##2##2##(1994-6#1)(2008-10#1)
heparin by##2##2##(2008-10#2)
heparin concentration##2##2##(1992-10#1)(2008-10#1)
heparin in##8##2##(1992-1#1)(1992-10#2)(1993-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
heparin to##3##2##(1992-10#1)(1997-1#1)(2008-11#1)
heparin use##2##2##(1994-3#1)(2008-3#1)
heparin was##2##2##(2008-11#2)
heparin##66##1##(1990-12#1)(1991-6#1)(1992-1#5)(1992-10#7)(1992-3#1)(1992-5#1)(1993-8#2)(1994-12#1)(1994-3#4)(1994-6#2)(1996-6#1)(1997-1#5)(2008-10#14)(2008-11#9)(2008-3#2)(2008-4#1)(2010-3#3)(2011-2#1)(2013-1#5)
heparin-Sepharose##2##1##(1992-11#1)(1995-8#1)
heparin-binding peptide##2##2##(2008-7#2)
heparin-binding##4##1##(1992-10#1)(1997-1#1)(2008-7#2)
heparinase##3##1##(1993-3#1)(1995-3#1)(1995-6#1)
heparinized and ACD blood##4##4##(2011-2#4)
heparinized blood and##2##3##(2011-2#2)
heparinized blood##3##2##(2011-2#3)
heparinized##9##1##(1996-12#1)(2011-2#8)
heparins##2##1##(2008-10#1)(2008-3#1)
hepatectomy and##3##2##(2012-2#1)(2013-1#1)(2013-7#1)
hepatectomy##6##1##(1996-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
hepatic L-FABP##2##2##(1994-8#2)
hepatic LDL##2##2##(2012-2#2)
hepatic and renal##2##3##(2008-10#1)(2013-1#1)
hepatic and##7##2##(1990-11#1)(1994-8#1)(1997-8#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
hepatic antioxidant status##2##3##(2008-10#2)
hepatic antioxidant##3##2##(2008-10#3)
hepatic apo B secretion##2##4##(1994-11#2)
hepatic arterial##4##2##(1997-8#1)(2012-2#1)(2013-1#2)
hepatic artery##4##2##(1997-8#1)(2012-2#2)(2013-1#1)
hepatic cell##2##2##(1994-11#1)(2008-11#1)
hepatic cells##5##2##(1994-5#1)(2008-10#1)(2008-8#1)(2010-11#2)
hepatic cirrhosis##2##2##(2009-8#1)(2012-3#1)
hepatic clearance of##2##3##(1991-1#1)(1992-2#1)
hepatic dysfunction##2##2##(2012-3#2)
hepatic endosomes##2##2##(1995-6#2)
hepatic enzymes##2##2##(2008-11#1)(2010-2#1)
hepatic expression of##3##3##(1995-8#1)(2008-6#1)(2013-8#1)
hepatic failure##6##2##(1991-11#1)(1992-5#1)(1994-8#1)(2008-11#1)(2009-7#1)(2012-3#1)
hepatic glucagon receptor##2##3##(1994-11#2)
hepatic glucagon##3##2##(1994-11#3)
hepatic gluconeogenesis##3##2##(1991-3#1)(1994-8#1)(1996-2#1)
hepatic glucose production##6##3##(1991-7#2)(1993-8#2)(2008-1#2)
hepatic glucose##7##2##(1991-7#3)(1993-8#2)(2008-1#2)
hepatic hydatid##2##2##(1991-8#1)(2013-1#1)
hepatic induction##2##2##(2008-6#2)
hepatic involvement##4##2##(1996-11#1)(1997-8#1)(2008-7#1)(2012-3#1)
hepatic lesion##4##2##(1991-6#1)(1997-8#3)
hepatic lesions##2##2##(1997-8#1)(2010-12#1)
hepatic lipid##3##2##(2008-10#2)(2013-1#1)
hepatic long-chain acyl-CoA concentrations##2##4##(1994-8#2)
hepatic long-chain acyl-CoA levels##2##4##(1994-8#2)
hepatic long-chain acyl-CoA##5##3##(1994-8#5)
hepatic long-chain##6##2##(1994-8#6)
hepatic macrophages##2##2##(1997-4#2)
hepatic malignancies##3##2##(1995-10#1)(1997-8#1)(2013-1#1)
hepatic microsomal##5##2##(1993-12#2)(1994-11#1)(1994-6#1)(1994-8#1)
hepatic or##2##2##(1991-8#1)(1993-12#1)
hepatic reticuloendothelial cells##2##3##(1992-10#2)
hepatic secretion of##2##3##(2008-6#2)
hepatic stellate cells##2##3##(2009-7#1)(2013-8#1)
hepatic stellate##3##2##(2008-11#1)(2009-7#1)(2013-8#1)
hepatic uptake of##3##3##(1992-3#3)
hepatic uptake##4##2##(1992-3#3)(2011-2#1)
hepatic vein##2##2##(1991-6#1)(2009-9#1)
hepatic zinc##2##2##(1990-5#2)
hepatic##214##1##(1990-11#4)(1990-5#3)(1991-1#1)(1991-11#3)(1991-12#3)(1991-3#1)(1991-6#2)(1991-7#4)(1991-8#3)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-8#3)(1994-11#9)(1994-2#1)(1994-5#3)(1994-6#3)(1994-8#14)(1995-10#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-4#2)(1997-8#12)(2007-12#1)(2008-1#5)(2008-10#14)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#9)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2011-1#5)(2011-2#10)(2012-12#1)(2012-2#9)(2012-3#8)(2013-1#14)(2013-7#1)(2013-8#5)
hepatica infection##3##2##(2009-8#3)
hepatica##8##1##(1995-5#1)(1997-8#1)(2008-12#1)(2009-8#5)
hepatitis A has##2##3##(1997-3#1)(2007-12#1)
hepatitis A virus (HAV)##2##4##(2008-7#1)(2009-5#1)
hepatitis A virus##3##3##(2008-7#2)(2009-5#1)
hepatitis A##8##2##(1995-5#1)(1997-3#1)(2007-12#2)(2008-7#3)(2009-5#1)
hepatitis B and C##2##4##(2013-1#1)(2013-7#1)
hepatitis B and##5##3##(1990-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
hepatitis B in##3##3##(2009-8#1)(2011-2#2)
hepatitis B infection##2##3##(1996-3#1)(2009-6#1)
hepatitis B surface antigen (HBsAg)##4##5##(1995-2#1)(2013-1#1)(2013-8#2)
hepatitis B surface antigen##7##4##(1995-2#1)(2008-11#1)(2008-8#1)(2009-12#1)(2013-1#1)(2013-8#2)
hepatitis B surface##9##3##(1994-11#1)(1995-2#2)(2008-11#1)(2008-8#1)(2009-12#1)(2013-1#1)(2013-8#2)
hepatitis B vaccination responses##2##4##(2008-10#2)
hepatitis B vaccination##4##3##(1993-2#1)(2008-10#2)(2009-12#1)
hepatitis B vaccine##4##3##(1995-3#1)(2009-12#2)(2012-3#1)
hepatitis B virus (HBV) infection##5##5##(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#2)
hepatitis B virus (HBV) infections##2##5##(1995-2#1)(2013-1#1)
hepatitis B virus (HBV)##15##4##(1990-8#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#4)(2013-1#2)(2013-8#1)
hepatitis B virus surface antigen (HBsAg)##2##6##(1994-11#1)(2008-8#1)
hepatitis B virus surface antigen##5##5##(1994-11#2)(2008-8#3)
hepatitis B virus##34##3##(1990-8#2)(1993-8#2)(1994-11#2)(1994-8#2)(1995-2#2)(1996-12#1)(1996-3#2)(2008-10#2)(2008-12#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#4)(2013-1#4)(2013-8#2)
hepatitis B with##2##3##(1995-5#1)(2013-1#1)
hepatitis B##90##2##(1990-12#1)(1990-8#2)(1993-2#2)(1993-8#2)(1994-11#3)(1994-8#2)(1995-10#1)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-3#7)(1997-4#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-8#6)(2008-9#1)(2009-12#5)(2009-5#1)(2009-6#2)(2009-8#13)(2011-2#6)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#4)
hepatitis B&quot##2##2##(2009-8#1)(2011-2#1)
hepatitis C and##3##3##(2010-10#1)(2013-8#2)
hepatitis C virus (HCV) infection##4##5##(2009-8#1)(2013-1#3)
hepatitis C virus (HCV)##12##4##(2008-1#1)(2008-10#1)(2008-8#1)(2009-7#1)(2009-8#2)(2011-2#1)(2013-1#4)(2013-8#1)
hepatitis C virus infection##4##4##(2009-8#1)(2013-1#3)
hepatitis C virus##27##3##(1992-12#1)(1994-11#1)(1994-6#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-8#1)(2009-7#1)(2009-8#3)(2011-2#1)(2013-1#7)(2013-8#1)
hepatitis C##49##2##(1992-12#1)(1994-11#2)(1994-6#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-8#1)(2009-10#1)(2009-5#2)(2009-7#2)(2009-8#5)(2010-10#1)(2010-4#2)(2011-2#3)(2013-1#10)(2013-7#1)(2013-8#6)
hepatitis E infection##4##3##(2007-12#3)(2010-8#1)
hepatitis E##5##2##(2007-12#3)(2009-8#1)(2010-8#1)
hepatitis and##3##2##(2008-6#1)(2009-8#1)(2011-2#1)
hepatitis cases##2##2##(1996-3#1)(2008-5#1)
hepatitis delta virus##3##3##(1994-11#2)(2009-8#1)
hepatitis in##6##2##(1994-8#1)(1995-2#2)(2007-12#2)(2008-5#1)
hepatitis infection##2##2##(2008-6#1)(2009-5#1)
hepatitis is##4##2##(1992-5#1)(1996-11#1)(2008-5#2)
hepatitis##207##1##(1990-12#1)(1990-8#2)(1991-8#1)(1992-12#2)(1992-5#3)(1993-2#2)(1993-5#1)(1993-8#2)(1994-11#7)(1994-6#1)(1994-8#4)(1995-10#2)(1995-2#8)(1995-3#1)(1995-5#4)(1995-6#1)(1996-11#5)(1996-12#1)(1996-3#11)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#8)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#6)(2009-5#5)(2009-6#2)(2009-7#5)(2009-8#24)(2010-1#1)(2010-10#1)(2010-4#2)(2010-8#1)(2011-2#11)(2012-12#1)(2012-3#1)(2013-1#21)(2013-7#3)(2013-8#10)
hepatobiliary##3##1##(1990-3#1)(2012-3#1)(2013-8#1)
hepatoblastoma and##2##2##(2011-1#1)(2013-1#1)
hepatoblastoma specimens##2##2##(2013-1#2)
hepatoblastoma##12##1##(2008-11#3)(2011-1#4)(2012-3#1)(2013-1#4)
hepatoblasts##4##1##(2013-1#4)
hepatocarcinogenesis##6##1##(1990-12#1)(1990-5#2)(2008-10#1)(2011-2#2)
hepatocarcinoma##7##1##(1993-6#1)(2008-9#1)(2010-1#3)(2013-1#2)
hepatocellular carcinoma (HCC) is##4##4##(2008-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
hepatocellular carcinoma (HCC)##11##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-12#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
hepatocellular carcinoma and##2##3##(1990-9#1)(2013-7#1)
hepatocellular carcinoma from metastatic tumors in the liver##2##8##(2010-7#2)
hepatocellular carcinoma from metastatic##3##4##(2010-7#3)
hepatocellular carcinoma in##3##3##(1993-2#1)(2011-2#1)(2013-8#1)
hepatocellular carcinoma or##2##3##(2010-12#1)(2010-7#1)
hepatocellular carcinoma##37##2##(1990-9#1)(1993-2#2)(1994-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#5)(2009-8#3)(2010-12#4)(2010-7#5)(2011-2#3)(2013-1#2)(2013-7#3)(2013-8#2)
hepatocellular degeneration##2##2##(2012-2#2)
hepatocellular##50##1##(1990-2#1)(1990-9#1)(1992-3#3)(1993-12#1)(1993-2#3)(1994-12#1)(1995-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#5)(2009-8#4)(2010-12#4)(2010-7#6)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#2)
hepatocyte cell lines##3##3##(2008-11#3)
hepatocyte cell##5##2##(2008-11#5)
hepatocyte cylindroids##2##2##(2008-11#2)
hepatocyte death and##2##3##(1995-2#2)
hepatocyte differentiation##2##2##(2008-6#2)
hepatocyte growth factor (HGF)##3##4##(2008-11#1)(2008-8#1)(2011-2#1)
hepatocyte growth factor gene##2##4##(2008-11#1)(2010-12#1)
hepatocyte growth factor##9##3##(1993-3#1)(2008-11#3)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)
hepatocyte plasma##2##2##(2008-7#2)
hepatocyte receptor##2##2##(1993-8#1)(1994-8#1)
hepatocyte specific functions##2##3##(1994-8#2)
hepatocyte spheroids##6##2##(2008-11#6)
hepatocyte##60##1##(1990-5#1)(1991-12#1)(1993-3#2)(1993-8#1)(1994-8#5)(1995-11#2)(1995-2#2)(1996-11#1)(1996-2#1)(2008-11#27)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#9)(2010-12#1)(2011-2#1)(2012-2#1)
hepatocyte-like cells##3##2##(2008-9#3)
hepatocytes and a human hepatocyte cell line##2##7##(2008-11#2)
hepatocytes and a##3##3##(2008-11#3)
hepatocytes and##12##2##(1990-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(2008-11#6)(2012-12#1)
hepatocytes are##2##2##(1994-8#1)(2008-11#1)
hepatocytes cultured on##2##3##(1993-3#1)(2008-11#1)
hepatocytes derived from##2##3##(1994-11#2)
hepatocytes following liver injury##2##4##(2013-1#2)
hepatocytes for##2##2##(2008-11#2)
hepatocytes from fed##2##3##(1994-8#2)
hepatocytes from##4##2##(1994-8#3)(1996-2#1)
hepatocytes have##2##2##(2008-11#1)(2011-2#1)
hepatocytes in##4##2##(1994-8#1)(2008-11#2)(2012-5#1)
hepatocytes isolated from##2##3##(1994-8#2)
hepatocytes may##2##2##(2008-11#1)(2008-8#1)
hepatocytes on##4##2##(1994-8#1)(2008-11#3)
hepatocytes to##4##2##(1994-8#1)(1996-2#1)(2008-11#2)
hepatocytes was##8##2##(1990-5#1)(1993-8#1)(1994-8#1)(1995-8#1)(2008-11#2)(2008-6#1)(2008-9#1)
hepatocytes were##4##2##(1990-5#1)(1993-3#1)(1995-11#1)(1995-12#1)
hepatocytes with##8##2##(1993-3#1)(1994-8#1)(1995-2#1)(1996-2#2)(2008-11#2)(2013-1#1)
hepatocytes##155##1##(1990-11#1)(1990-2#3)(1990-3#5)(1990-5#5)(1991-12#3)(1992-3#5)(1992-6#2)(1993-12#1)(1993-3#10)(1993-8#6)(1994-11#3)(1994-8#22)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#5)(1996-2#6)(2008-10#1)(2008-11#46)(2008-6#1)(2008-8#1)(2008-9#5)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#7)(2012-5#2)(2013-1#6)(2013-7#1)
hepatoma 3924A##3##2##(1990-5#2)(1992-8#1)
hepatoma and##3##2##(1990-5#1)(1994-3#1)(2008-11#1)
hepatoma cell invasion##3##3##(2008-11#3)
hepatoma cell line of AH109A##4##5##(2008-11#4)
hepatoma cell line##9##3##(1997-1#1)(2008-11#6)(2008-8#1)(2013-8#1)
hepatoma cell##14##2##(1997-1#1)(2008-11#10)(2008-8#2)(2013-8#1)
hepatoma cells by##3##3##(2008-11#3)
hepatoma cells in##4##3##(2008-11#4)
hepatoma cells with##3##3##(1993-8#1)(1995-2#1)(2008-11#1)
hepatoma cells##21##2##(1992-10#2)(1992-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(2008-11#12)(2008-8#3)
hepatoma##58##1##(1990-5#4)(1992-10#2)(1992-3#1)(1992-8#2)(1993-8#5)(1994-11#2)(1994-3#1)(1995-2#2)(1997-1#1)(2008-11#29)(2008-8#6)(2008-9#1)(2013-8#2)
hepatoma-derived##3##1##(1997-1#3)
hepatomas##8##1##(1990-5#5)(1990-6#2)(1993-8#1)
hepatomegaly##2##1##(1991-8#1)(2013-1#1)
hepatopancreas##9##1##(2008-10#1)(2008-12#2)(2008-6#4)(2008-7#2)
hepatoprotective action of##2##3##(2013-1#2)
hepatoprotective activity of##2##3##(2010-2#1)(2013-1#1)
hepatoprotective activity##3##2##(2010-2#1)(2013-1#2)
hepatoprotective##7##1##(2008-10#1)(2008-11#1)(2010-2#1)(2013-1#4)
hepatosplenomegaly##3##1##(2008-12#1)(2010-1#1)(2011-2#1)
hepatotoxic##5##1##(1994-5#1)(2008-11#2)(2012-3#1)(2013-1#1)
hepatotoxicity in##5##2##(1994-5#1)(2008-10#1)(2009-8#1)(2013-1#2)
hepatotoxicity##9##1##(1991-8#1)(1994-5#2)(2008-10#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#2)
hephaestin##2##1##(2012-2#2)
heptane##3##1##(2008-10#3)
heptapeptide##3##1##(1994-2#2)(2008-9#1)
heptapeptides##3##1##(1994-11#1)(2008-10#2)
her conviction##2##2##(1992-9#2)
her giant##2##2##(2011-2#2)
her left##4##2##(1996-11#1)(1996-8#1)(2008-12#1)(2012-3#1)
her neck##2##2##(2008-12#2)
her own##4##2##(1995-12#2)(2008-2#1)(2008-8#1)
her pregnancy##3##2##(1993-12#1)(2008-11#1)(2013-1#1)
her right foot##2##3##(2010-3#1)(2013-1#1)
her right lower extremity##2##4##(1991-12#1)(2012-3#1)
her right##10##2##(1991-12#1)(1997-8#1)(2008-12#2)(2008-5#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
her role as##2##3##(1995-6#1)(2010-5#1)
her symptoms##4##2##(2008-7#2)(2013-1#1)(2013-8#1)
her##135##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#3)(1991-3#1)(1992-2#1)(1992-9#2)(1993-12#1)(1993-9#3)(1994-1#2)(1994-12#4)(1995-11#1)(1995-12#9)(1995-6#3)(1996-11#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-3#3)(1997-8#1)(2008-1#1)(2008-11#7)(2008-12#10)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#4)(2009-3#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-2#8)(2012-12#2)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#6)
her-2/neu overexpression##2##2##(2008-10#2)
her-2/neu##7##1##(2008-10#6)(2008-11#1)
herald##2##1##(2011-10#1)(2013-8#1)
heraldoi##4##1##(2008-12#4)
heralds##3##1##(1995-8#1)(2010-6#1)(2011-2#1)
herb and supplement use##3##4##(2008-10#3)
herb##24##1##(1994-11#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-9#3)(2009-3#1)(2013-1#2)
herba##2##1##(2008-10#1)(2012-3#1)
herbaceous hosts and##2##3##(2008-10#2)
herbaceous species##3##2##(2008-8#1)(2009-12#1)(2012-6#1)
herbaceous##5##1##(2008-10#2)(2008-8#1)(2009-12#1)(2012-6#1)
herbal and##2##2##(2008-10#1)(2008-8#1)
herbal extract##2##2##(2008-10#1)(2013-1#1)
herbal extracts##2##2##(2008-5#1)(2013-1#1)
herbal ingredients##2##2##(2009-12#2)
herbal medicine##10##2##(2008-10#3)(2008-11#1)(2010-2#1)(2011-2#3)(2013-7#1)(2013-8#1)
herbal medicines##5##2##(2008-10#1)(2008-11#3)(2008-12#1)
herbal product##2##2##(2008-10#2)
herbal products##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
herbal shampoos are##2##3##(2008-5#2)
herbal shampoos##6##2##(2008-5#6)
herbal##55##1##(2008-10#19)(2008-11#6)(2008-12#1)(2008-5#8)(2008-8#3)(2009-12#3)(2009-6#1)(2010-2#1)(2011-2#5)(2011-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
herbarium##6##1##(2008-10#5)(2008-9#1)
herbicide 2##5##2##(2008-10#4)(2008-11#1)
herbicide and##2##2##(2008-10#2)
herbicide application##3##2##(1996-3#1)(2008-10#2)
herbicide glyphosate##2##2##(2008-9#1)(2010-1#1)
herbicide recovery##2##2##(2008-11#2)
herbicide series##2##2##(2008-10#2)
herbicide treatments##2##2##(2008-10#2)
herbicide used##2##2##(2008-10#1)(2008-11#1)
herbicide##56##1##(1995-8#1)(1996-3#2)(2008-10#43)(2008-11#5)(2008-9#2)(2010-1#2)(2011-1#1)
herbicide-resistant##3##1##(2008-9#3)
herbicides and##6##2##(1996-3#1)(2008-10#4)(2008-7#1)
herbicides are##2##2##(1996-3#1)(2008-11#1)
herbicides based on##2##3##(2008-10#2)
herbicides from##7##2##(2008-10#4)(2008-11#3)
herbicides in##8##2##(2008-10#6)(2008-11#2)
herbicides on##3##2##(1996-3#1)(2008-10#2)
herbicides using##2##2##(2008-10#2)
herbicides was##3##2##(2008-10#3)
herbicides were##3##2##(2008-10#3)
herbicides##70##1##(1996-3#5)(2008-10#52)(2008-11#11)(2008-7#2)
herbicola##4##1##(1993-8#1)(2008-10#3)
herbimycin A##3##2##(1993-8#3)
herbimycin##4##1##(1993-8#4)
herbivore population dynamics##2##3##(2008-8#2)
herbivore populations##2##2##(2008-8#2)
herbivore##17##1##(2008-8#11)(2008-9#6)
herbivore-induced plant##2##2##(1990-11#1)(2009-8#1)
herbivore-induced##3##1##(1990-11#1)(2008-9#1)(2009-8#1)
herbivores and##3##2##(2008-9#2)(2009-8#1)
herbivores have##2##2##(2008-8#1)(2008-9#1)
herbivores##22##1##(1990-11#2)(2008-8#10)(2008-9#9)(2009-8#1)
herbivorous insects##4##2##(2008-8#1)(2008-9#3)
herbivorous##8##1##(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#3)
herbivory by##2##2##(2008-8#1)(2009-8#1)
herbivory has##2##2##(2008-9#2)
herbivory in##2##2##(2008-8#1)(2008-9#1)
herbivory on##6##2##(2008-8#2)(2008-9#4)
herbivory##18##1##(2008-8#7)(2008-9#8)(2009-6#1)(2009-8#2)
herbs and other##2##3##(2008-10#1)(2008-8#1)
herbs and##5##2##(2008-10#4)(2008-8#1)
herbs in##5##2##(2008-10#4)(2011-2#1)
herbs was##2##2##(2008-5#1)(2008-9#1)
herbs##35##1##(2008-10#20)(2008-5#5)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#3)(2011-3#1)(2013-1#2)
herd##11##1##(1992-2#1)(1996-12#6)(1997-5#1)(2008-10#1)(2011-2#2)
herding communities##2##2##(2009-8#2)
herding##4##1##(2009-8#4)
herds and##2##2##(1990-6#1)(2012-3#1)
herds in##3##2##(1996-8#2)(2012-3#1)
herds were##2##2##(1990-6#1)(1995-9#1)
herds with##4##2##(1990-6#1)(1996-8#2)(2013-8#1)
herds##23##1##(1990-6#3)(1992-2#3)(1995-9#1)(1996-12#1)(1996-8#4)(2011-2#3)(2012-3#7)(2013-8#1)
here a case of##2##4##(2010-1#1)(2010-6#1)
here a##19##2##(1995-5#1)(1997-7#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)
here also##4##2##(2008-11#1)(2008-4#2)(2008-8#1)
here an##3##2##(1997-2#1)(2010-10#1)(2011-2#1)
here and##6##2##(1995-11#1)(1996-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
here applied##2##2##(2008-10#2)
here are in##2##3##(2008-10#1)(2013-8#1)
here are##8##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2010-7#1)(2013-8#1)
here as a##3##3##(2008-10#2)(2008-3#1)
here as##13##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
here at##2##2##(2008-10#1)(2012-5#1)
here called##2##2##(2008-10#2)
here can##2##2##(2008-10#2)
here compared##2##2##(1997-3#1)(2012-2#1)
here could##2##2##(1993-12#1)(2007-11#1)
here described##4##2##(2008-10#4)
here for the first time##4##5##(2008-10#3)(2010-8#1)
here for the##6##3##(1993-2#1)(2008-10#4)(2010-8#1)
here for##14##2##(1990-8#1)(1992-2#1)(1993-2#1)(1996-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-3#1)(2012-2#1)
here has##2##2##(2008-3#1)(2008-5#1)
here how##3##2##(2009-8#1)(2010-11#1)(2013-8#1)
here illustrates##2##2##(2008-11#1)(2008-3#1)
here in terms of##2##4##(1994-5#1)(2008-10#1)
here in the##2##3##(2008-3#1)(2012-2#1)
here in##7##2##(1990-11#1)(1994-5#1)(1997-6#1)(2008-10#2)(2008-3#1)(2012-2#1)
here is a##5##3##(2008-10#2)(2010-8#3)
here is an##2##3##(1995-2#1)(2008-12#1)
here is based on##2##4##(1996-3#1)(2008-11#1)
here is of##2##3##(2008-10#1)(2013-1#1)
here is one##2##3##(2010-8#1)(2011-1#1)
here is rapid##2##3##(2008-10#2)
here is simple##2##3##(2008-10#1)(2008-11#1)
here is the##2##3##(2008-3#1)(2010-5#1)
here is to##2##3##(2008-11#1)(2008-7#1)
here is##31##2##(1991-5#1)(1995-2#1)(1996-3#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2010-8#4)(2011-1#1)(2013-1#1)
here may be##3##3##(1991-1#1)(2008-10#1)(2008-12#1)
here may##5##2##(1991-1#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-9#1)
here on the##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
here on##11##2##(1993-12#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-6#2)(2012-2#2)(2012-3#1)
here our##2##2##(2008-7#1)(2013-1#1)
here presented##2##2##(2008-10#2)
here provide##5##2##(1994-11#1)(2008-11#1)(2008-12#1)(2009-10#1)(2013-8#1)
here provides##4##2##(1990-5#1)(1994-8#1)(2008-12#1)(2013-8#1)
here represents a##2##3##(2008-10#2)
here requires##2##2##(1994-1#1)(1994-2#1)
here should be##2##3##(1997-2#1)(2008-11#1)
here show that##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
here studied##2##2##(2008-10#2)
here suggest that##6##3##(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
here suggest##7##2##(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-1#1)
here that the##9##3##(1990-5#1)(1991-5#2)(1991-9#1)(1993-8#2)(1993-9#1)(1997-7#1)(2008-3#1)
here that this##5##3##(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
here that##37##2##(1990-12#1)(1990-5#2)(1991-5#2)(1991-9#1)(1992-3#1)(1993-8#2)(1993-9#2)(1994-12#1)(1995-12#2)(1995-2#2)(1995-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-10#5)(2008-11#4)(2008-3#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
here the backbone##2##3##(2009-7#2)
here the case of a##2##5##(2008-10#1)(2013-1#1)
here the first##3##3##(1994-3#1)(2008-11#1)(2011-2#1)
here the##33##2##(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1997-9#1)(2008-10#8)(2008-11#5)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-8#1)(2013-1#2)
here to the##2##3##(1994-5#1)(2008-10#1)
here to##8##2##(1994-11#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-4#1)
here used##2##2##(2008-10#1)(2012-3#1)
here using##2##2##(2010-6#1)(2013-1#1)
here was the##2##3##(1993-1#1)(2008-11#1)
here was##6##2##(1993-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)
here we provide##2##3##(2008-7#1)(2011-2#1)
here we report##2##3##(2010-12#1)(2012-4#1)
here we##9##2##(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-4#1)
here were##2##2##(1995-2#1)(2008-10#1)
here will##2##2##(2008-11#1)(2012-2#1)
here with##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
here##446##1##(1990-11#1)(1990-12#1)(1990-5#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#2)(1997-2#4)(1997-3#4)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#112)(2008-11#46)(2008-12#11)(2008-2#1)(2008-3#18)(2008-4#17)(2008-5#8)(2008-6#2)(2008-7#13)(2008-8#8)(2008-9#6)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#4)(2011-2#13)(2011-3#1)(2011-8#1)(2012-12#2)(2012-2#10)(2012-3#5)(2012-4#1)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#10)
hereby report a##2##3##(2012-12#1)(2012-2#1)
hereby report##4##2##(2012-12#1)(2012-2#1)(2013-1#2)
hereby##10##1##(2008-10#2)(2009-10#1)(2009-11#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
hereditary breast cancer##2##3##(1993-1#1)(1995-12#1)
hereditary breast##3##2##(1993-1#1)(1995-12#1)(2011-2#1)
hereditary cancer##3##2##(2011-2#2)(2012-3#1)
hereditary cardiopathies##2##2##(1996-11#2)
hereditary diffuse gastric cancer##2##4##(2011-2#1)(2012-3#1)
hereditary haemochromatosis##2##2##(1997-7#1)(2008-5#1)
hereditary hemorrhagic telangiectasia##3##3##(2009-10#1)(2010-6#2)
hereditary melanoma families##2##3##(1997-7#2)
hereditary melanoma kindreds##2##3##(1997-7#2)
hereditary melanoma##4##2##(1997-7#4)
hereditary nonpolyposis colon cancer##2##4##(2009-12#1)(2011-2#1)
hereditary nonpolyposis##3##2##(2009-12#2)(2011-2#1)
hereditary osteodystrophy##3##2##(2010-6#2)(2011-1#1)
hereditary syndrome##2##2##(1994-12#1)(2011-2#1)
hereditary##54##1##(1993-1#2)(1994-12#2)(1994-8#1)(1995-12#1)(1996-11#2)(1997-3#1)(1997-4#1)(1997-7#5)(1997-8#2)(2006-6#1)(2008-12#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#5)(2009-4#1)(2010-11#1)(2010-4#1)(2010-6#4)(2010-9#1)(2011-1#1)(2011-2#8)(2012-3#4)(2013-1#2)(2013-8#2)
heredity##5##1##(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)
herein can be##2##3##(2008-10#2)
herein described##2##2##(2008-10#1)(2011-1#1)
herein report##5##2##(1992-12#1)(1997-2#1)(2009-8#1)(2010-6#2)
herein##54##1##(1990-2#1)(1991-1#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1997-2#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-4#2)(2008-7#1)(2009-10#2)(2009-12#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
heretofore##4##1##(1991-12#1)(1995-8#1)(2008-8#1)(2009-6#1)
herewith##3##1##(2008-1#1)(2008-10#2)
heritabilities for ear rot and aflatoxin production were##2##8##(2008-10#2)
heritabilities for##4##2##(2008-10#3)(2008-9#1)
heritabilities of apothecia development##2##4##(2008-10#2)
heritabilities of##4##2##(2008-10#3)(2008-8#1)
heritabilities##14##1##(2008-10#8)(2008-8#5)(2008-9#1)
heritability and##3##2##(2008-10#1)(2012-3#2)
heritability estimates were##2##3##(2008-10#2)
heritability estimates##4##2##(2008-10#4)
heritability for##5##2##(2008-10#3)(2008-8#2)
heritability of resistance to##2##4##(2008-10#2)
heritability of##10##2##(1997-7#1)(2008-10#4)(2008-2#1)(2008-8#3)(2008-9#1)
heritability was##4##2##(2008-10#3)(2008-8#1)
heritability##41##1##(1997-7#5)(2008-10#20)(2008-2#1)(2008-8#8)(2008-9#3)(2009-4#1)(2010-12#1)(2012-3#2)
heritable mutations##5##2##(2008-7#5)
heritable##20##1##(1994-11#1)(1995-6#1)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#1)(2010-4#2)(2012-3#2)
heritage of##5##2##(1993-3#1)(1995-5#1)(2008-10#2)(2012-2#1)
heritage##11##1##(1991-2#1)(1993-11#1)(1993-3#1)(1995-5#1)(2008-10#4)(2008-11#1)(2010-7#1)(2012-2#1)
hermaphrodite##3##1##(1994-12#1)(2008-8#1)(2008-9#1)
hermaphrodites##4##1##(2008-8#1)(2008-9#2)(2010-5#1)
hermaphroditic animals##2##2##(2008-8#2)
hermaphroditic gonad##2##2##(2010-5#1)(2011-2#1)
hermaphroditic groupers##2##2##(2010-5#2)
hermaphroditic plant##2##2##(2008-8#1)(2008-9#1)
hermaphroditic##10##1##(2008-8#4)(2008-9#2)(2010-5#3)(2011-2#1)
hermaphroditism in animals##3##3##(2008-8#3)
hermaphroditism##6##1##(2008-8#5)(2008-9#1)
hermeneutic##2##1##(2008-11#1)(2010-9#1)
hermeneutical##2##1##(2009-9#1)(2010-9#1)
hermeneutics##2##1##(2012-3#2)
hermonthica##13##1##(2008-10#13)
hernia in##5##2##(2008-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
hernia is a very##2##4##(2008-12#1)(2012-3#1)
hernia is a##3##3##(1990-5#1)(2008-12#1)(2012-3#1)
hernia is one of the most##2##6##(2008-7#1)(2010-8#1)
hernia is one##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
hernia is##11##2##(1990-5#4)(2008-12#3)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
hernia repair##3##2##(2010-8#1)(2012-12#2)
hernia sac is##2##3##(2012-12#2)
hernia surgery##2##2##(1992-5#1)(1996-3#1)
hernia with##6##2##(2011-2#5)(2012-3#1)
hernia##58##1##(1990-12#1)(1990-5#5)(1992-5#2)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#14)(2008-7#2)(2009-8#5)(2010-8#3)(2011-2#7)(2012-12#10)(2012-3#2)(2013-1#2)
hernia--a##2##1##(2008-12#1)(2012-3#1)
hernias are##4##2##(2008-12#2)(2009-8#1)(2012-12#1)
hernias##15##1##(1990-5#1)(1990-9#2)(1991-8#1)(1992-5#1)(1996-6#1)(2008-12#2)(2009-8#1)(2010-8#5)(2012-12#1)
herniated intervertebral##2##2##(1996-8#1)(2008-7#1)
herniated##6##1##(1990-9#1)(1995-12#1)(1996-8#1)(2008-12#1)(2008-7#1)(2012-12#1)
herniation##24##1##(1992-2#1)(1997-3#2)(2008-11#2)(2008-12#4)(2008-7#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
herniorrhaphy##2##1##(2011-2#2)
heroin##13##1##(1990-3#1)(1991-1#1)(1993-3#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-6#1)(2009-7#1)(2010-1#1)(2013-8#2)
heroin/cocaine##2##1##(2013-8#2)
herpes simplex virus DNA polymerase##3##5##(1995-2#3)
herpes simplex virus type 1##2##5##(2008-11#1)(2008-9#1)
herpes simplex virus type##3##4##(2008-11#2)(2008-9#1)
herpes simplex virus##9##3##(1995-2#3)(1996-12#2)(2008-11#3)(2008-9#1)
herpes simplex##12##2##(1994-11#1)(1995-2#5)(1996-12#2)(2008-11#3)(2008-9#1)
herpes virus##4##2##(2008-5#3)(2012-3#1)
herpes zoster##3##2##(1991-6#1)(1994-3#1)(2008-5#1)
herpes##22##1##(1991-6#1)(1994-11#1)(1994-3#1)(1995-2#5)(1996-12#2)(2008-11#3)(2008-12#1)(2008-5#4)(2008-8#2)(2008-9#1)(2012-3#1)
herpesvirus##5##1##(1993-11#2)(2008-5#1)(2011-2#2)
herpesvirus-1##2##1##(1995-9#1)(2013-8#1)
herpesviruses##3##1##(1993-11#1)(1994-6#1)(2010-1#1)
herring##2##1##(2008-11#2)
herself##2##1##(1996-5#1)(2008-7#1)
herzi##6##1##(2010-8#6)
hesitation##2##1##(2010-11#1)(2011-2#1)
hetero poly acid##2##3##(2008-10#2)
hetero-##2##1##(2008-5#1)(2011-1#1)
hetero-sexual transfer of PGCs had abnormal gonads##2##7##(2008-11#2)
hetero-sexual transfer of PGCs##3##4##(2008-11#3)
hetero-sexual transfer##4##2##(2008-11#4)
heteroaryl##3##1##(2008-8#3)
heterochromatic regions##6##2##(2008-12#1)(2009-10#5)
heterochromatic##11##1##(2008-12#3)(2009-10#7)(2010-8#1)
heterochromatin formation##2##2##(2011-2#1)(2012-3#1)
heterochromatin##14##1##(1993-12#1)(2008-12#7)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
heterocycles##2##1##(2008-11#2)
heterocyclic amine carcinogens##2##3##(1992-6#2)
heterocyclic amines##7##2##(1992-6#1)(1997-2#4)(2008-10#2)
heterocyclic aromatic##2##2##(1997-2#2)
heterocyclic ring##3##2##(1992-3#1)(2008-10#1)(2012-2#1)
heterocyclic##19##1##(1992-3#1)(1992-6#3)(1996-5#1)(1997-2#6)(2008-10#4)(2008-11#2)(2009-5#1)(2012-2#1)
heterodimer in##2##2##(2008-9#2)
heterodimer##17##1##(1991-6#2)(1993-3#1)(1993-9#1)(1995-6#2)(1995-8#2)(2008-11#2)(2008-9#4)(2010-6#2)(2011-2#1)
heterodimeric##11##1##(1993-8#1)(1993-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2010-6#2)(2011-2#1)
heterodimerization##3##1##(1995-2#1)(1995-8#1)(2008-11#1)
heterodimers and##2##2##(1996-2#1)(2012-2#1)
heterodimers with##3##2##(1990-4#1)(1995-8#2)
heterodimers##10##1##(1990-4#1)(1994-5#1)(1995-8#3)(1996-2#3)(2008-11#1)(2012-2#1)
heteroduplex mobility assay (HMA)##2##4##(2008-10#2)
heteroduplex mobility assay##3##3##(2008-10#3)
heteroduplex##5##1##(1992-8#1)(2008-10#4)
heterodyne detection to##2##3##(2007-12#1)(2008-3#1)
heterodyne detection##3##2##(2007-12#1)(2008-3#2)
heterodyne holography##2##2##(2007-12#2)
heterodyne##16##1##(2007-12#3)(2008-3#10)(2008-8#1)(2013-8#2)
heterodyned##2##1##(2008-3#2)
heterogeneities in##2##2##(1991-6#1)(2010-8#1)
heterogeneities##4##1##(1990-6#1)(1991-6#1)(1992-9#1)(2010-8#1)
heterogeneity among##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
heterogeneity and##8##2##(1990-8#1)(2008-10#4)(2008-8#2)(2010-2#1)
heterogeneity between##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-11#1)
heterogeneity by##2##2##(2008-11#1)(2011-2#1)
heterogeneity in aortic##2##3##(2013-3#2)
heterogeneity in the##4##3##(1995-12#1)(2008-10#2)(2011-2#1)
heterogeneity in##20##2##(1992-2#1)(1994-8#2)(1995-12#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#4)(2009-6#1)(2010-5#1)(2011-2#1)(2013-3#2)
heterogeneity is##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
heterogeneity of cell##2##3##(2008-10#1)(2013-8#1)
heterogeneity of disease##4##3##(2008-10#3)(2013-8#1)
heterogeneity of samples##2##3##(2008-4#1)(2012-12#1)
heterogeneity of the disease##2##4##(2010-12#1)(2011-2#1)
heterogeneity of the##15##3##(2008-10#9)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
heterogeneity of this##2##3##(1992-10#1)(2011-2#1)
heterogeneity of##59##2##(1992-10#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#2)(2006-6#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
heterogeneity on##2##2##(2008-10#1)(2008-8#1)
heterogeneity that##6##2##(1991-6#1)(1994-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
heterogeneity was##2##2##(2008-10#2)
heterogeneity within##2##2##(2008-10#1)(2008-7#1)
heterogeneity##158##1##(1990-8#1)(1991-6#1)(1992-10#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-9#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#4)(2006-6#1)(2008-10#45)(2008-11#9)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#22)(2008-9#14)(2009-12#3)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-3#2)(2013-8#3)
heterogeneous and##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
heterogeneous electron transfer rate constant##2##5##(2008-10#2)
heterogeneous electron transfer rate##3##4##(2008-10#3)
heterogeneous electron transfer##5##3##(2008-10#5)
heterogeneous environment##2##2##(2008-10#1)(2008-4#1)
heterogeneous group of disorders##2##4##(2008-7#1)(2012-2#1)
heterogeneous group of##10##3##(1991-11#1)(1997-5#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#3)
heterogeneous group##12##2##(1991-11#1)(1997-5#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#3)
heterogeneous mixture##2##2##(2008-10#1)(2008-5#1)
heterogeneous mixtures of##2##3##(2008-10#1)(2011-2#1)
heterogeneous nuclear ribonucleoprotein##3##3##(2008-8#2)(2008-9#1)
heterogeneous nuclear##4##2##(2007-12#1)(2008-8#2)(2008-9#1)
heterogeneous population##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
heterogeneous populations of clusters##2##4##(2010-10#2)
heterogeneous populations of##3##3##(2008-10#1)(2010-10#2)
heterogeneous populations##7##2##(2008-10#4)(2008-4#1)(2010-10#2)
heterogeneous response##3##2##(1990-2#1)(2006-6#1)(2012-3#1)
heterogeneous set of##2##3##(1993-3#1)(2011-2#1)
heterogeneous systems##5##2##(2008-10#1)(2008-5#2)(2010-8#2)
heterogeneous with##3##2##(1992-11#1)(1997-8#1)(2011-2#1)
heterogeneous##126##1##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-6#2)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#30)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#14)(2008-9#4)(2009-8#2)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#7)(2012-2#3)(2012-3#8)(2013-1#4)(2013-8#4)
heterogeneously##3##1##(1997-2#1)(2008-10#1)(2008-11#1)
heterogenous##12##1##(1991-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#1)(2012-2#1)
heterokaryons##3##1##(2008-10#3)
heterologous CTV##2##2##(2008-10#2)
heterologous antigen##2##2##(2008-10#1)(2008-5#1)
heterologous antigenic determinants##2##3##(2008-8#2)
heterologous antigens##3##2##(1995-5#2)(2008-10#1)
heterologous expression in##2##3##(1996-3#1)(2008-11#1)
heterologous expression of##3##3##(2008-10#1)(2009-9#1)(2011-1#1)
heterologous expression##6##2##(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-1#1)
heterologous gene expression##3##3##(1993-9#2)(1994-8#1)
heterologous gene##5##2##(1993-9#2)(1994-8#1)(2008-11#2)
heterologous protein expression in##2##4##(2008-11#2)
heterologous protein expression##3##3##(2008-11#3)
heterologous protein production##3##3##(2008-11#2)(2008-7#1)
heterologous protein##9##2##(2008-11#7)(2008-7#2)
heterologous proteins##6##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
heterologous strains##3##2##(2008-10#3)
heterologous viral##2##2##(1993-8#1)(1996-12#1)
heterologous##83##1##(1990-8#1)(1991-6#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#3)(1996-12#3)(1996-3#1)(1997-3#2)(1997-7#2)(1997-8#1)(1997-9#1)(2008-10#23)(2008-11#16)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#4)
heterologously expressed in##2##3##(2008-5#1)(2009-9#1)
heterologously expressed##4##2##(1996-3#2)(2008-5#1)(2009-9#1)
heteromeric G-protein##2##2##(1996-2#2)
heteromeric##11##1##(1991-5#1)(1995-11#5)(1995-2#1)(1996-2#3)(2008-9#1)
heteronuclear correlation##3##2##(1990-5#1)(2012-2#2)
heteronuclear##5##1##(1990-5#1)(1992-4#1)(2008-4#1)(2012-2#2)
heterophilic##3##1##(1993-8#2)(2008-5#1)
heterophils##2##1##(2008-5#2)
heteroplasmy##6##1##(2013-8#6)
heteropoly acid##2##2##(2008-10#2)
heteropoly acids##3##2##(2008-10#3)
heteropoly anions##6##2##(2008-10#6)
heteropoly blue##2##2##(2008-10#2)
heteropoly compounds##3##2##(2008-10#3)
heteropoly##18##1##(2008-10#18)
heteroreceptors##2##1##(2008-7#2)
heterosexual African American males who are seropositive##2##7##(2010-7#2)
heterosexual HIV transmission##2##3##(2013-1#2)
heterosexual HIV##3##2##(1996-11#1)(2013-1#2)
heterosexual##20##1##(1990-3#1)(1992-9#3)(1995-12#1)(1996-11#2)(1997-6#1)(2008-12#2)(2010-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
heterosexually##4##1##(1996-11#3)(1997-6#1)
heterosexuals##3##1##(1990-3#1)(1992-9#1)(2008-5#1)
heterosis and##3##2##(2008-8#2)(2009-10#1)
heterosis in rice##3##3##(2008-8#2)(2009-10#1)
heterosis in##4##2##(2008-8#2)(2009-10#1)(2012-3#1)
heterosis##17##1##(2008-10#1)(2008-8#6)(2009-10#3)(2012-3#7)
heterospheroids##2##1##(2008-11#2)
heterostrophus race O##3##3##(2008-10#3)
heterostrophus##7##1##(2008-10#7)
heterostructured electrode##2##2##(2012-2#2)
heterostructured##4##1##(2012-2#4)
heterothallic##4##1##(2008-10#4)
heterothallicum##3##1##(2008-10#3)
heterotic crosses##2##2##(2009-10#2)
heterotic gene##3##2##(2009-10#3)
heterotic##5##1##(2009-10#5)
heterotopia##2##1##(1990-9#1)(1997-8#1)
heterotopias##3##1##(1995-5#2)(2011-2#1)
heterotopic ossification##5##2##(1994-8#2)(2012-12#3)
heterotopic##10##1##(1994-3#1)(1994-8#2)(1997-8#2)(2012-12#3)(2013-1#1)(2013-8#1)
heterotrimeric G proteins##5##3##(1995-6#3)(1995-8#1)(2008-7#1)
heterotrimeric G-protein##2##2##(1996-2#1)(2008-8#1)
heterotrimeric laminins##2##2##(2008-11#2)
heterotrimeric##11##1##(1995-6#3)(1995-8#1)(1996-2#2)(1997-7#1)(2008-11#2)(2008-7#1)(2008-8#1)
heterotrophic bacteria##2##2##(2008-9#1)(2009-8#1)
heterotrophic growth##2##2##(2010-11#2)
heterotrophic##8##1##(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#3)(2011-2#2)
heterotrophically##2##1##(2009-10#1)(2010-11#1)
heterotrophs##2##1##(2008-7#1)(2009-4#1)
heterozygosities ranged from 0##2##4##(2008-10#1)(2013-8#1)
heterozygosity##16##1##(1993-11#1)(1995-12#1)(1997-2#1)(1997-5#1)(2008-10#4)(2008-8#2)(2012-3#4)(2013-8#2)
heterozygote frequency##3##2##(1991-12#2)(2008-10#1)
heterozygote##9##1##(1991-12#2)(1997-8#2)(2008-10#2)(2008-5#1)(2009-10#1)(2013-8#1)
heterozygotes##14##1##(1990-8#2)(1994-12#1)(1995-2#2)(2008-10#4)(2008-12#2)(2008-6#1)(2008-8#1)(2012-3#1)
heterozygous and##2##2##(1995-2#1)(2008-10#1)
heterozygous for the##2##3##(1995-2#1)(2008-7#1)
heterozygous for##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
heterozygous mice##2##2##(1995-2#2)
heterozygous##24##1##(1990-8#1)(1995-2#5)(2008-10#7)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#3)(2013-1#2)
heuristic##8##1##(2007-8#1)(2008-10#3)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
hexachlorobenzene (HCB)##2##2##(2008-10#1)(2008-11#1)
hexachlorobenzene##4##1##(2008-10#2)(2008-11#2)
hexacyanoferrate (III) in##2##3##(2008-10#2)
hexacyanoferrate (III)##3##2##(2008-10#3)
hexacyanoferrate modified##2##2##(2008-10#2)
hexacyanoferrate##16##1##(2008-10#16)
hexacyanoferrate(III) and##2##2##(2008-10#2)
hexacyanoferrate(III) in alkaline##2##3##(2008-10#2)
hexacyanoferrate(III) in##3##2##(2008-10#3)
hexacyanoferrate(III)##16##1##(2008-10#16)
hexacyanoferrate(III)-hexacyanoferrate(II) potential buffer##2##3##(2008-10#2)
hexacyanoferrates##2##1##(2008-10#2)
hexacyanomanganate(IV)##2##1##(2008-10#2)
hexadecanoic acid##7##2##(2008-11#1)(2008-12#1)(2008-5#5)
hexadecyltrimethylammonium bromide##2##2##(2008-10#2)
hexadecyltrimethylammonium##3##1##(2008-10#3)
hexaflumuron##2##1##(2008-10#2)
hexafluorophosphate##4##1##(2008-10#4)
hexagonal column is##3##3##(2008-3#3)
hexagonal column##10##2##(2008-3#10)
hexagonal columns##4##2##(2008-3#4)
hexagonal ice column##3##3##(2008-3#3)
hexagonal plates##2##2##(2008-3#2)
hexagonal##30##1##(1990-2#1)(1991-5#1)(1995-3#1)(1995-6#1)(2008-2#1)(2008-3#22)(2008-5#2)(2008-7#1)
hexahydro-1##4##1##(2008-10#3)(2008-3#1)
hexamer##3##1##(1995-8#1)(1997-7#1)(2008-8#1)
hexameric##2##1##(1997-7#1)(2008-8#1)
hexamers##2##1##(1990-5#2)
hexametaphosphate##2##1##(2008-10#2)
hexamethyldisiloxane##2##1##(2008-10#2)
hexanal##3##1##(2008-10#3)
hexandrum##3##1##(2008-11#3)
hexane and acetone##3##3##(2008-10#1)(2013-8#2)
hexane and##8##2##(2008-10#2)(2008-11#2)(2008-12#1)(2013-8#3)
hexane extraction##5##2##(2008-10#5)
hexane extracts##2##2##(2013-8#2)
hexane##33##1##(2008-10#22)(2008-11#3)(2008-12#1)(2008-7#1)(2013-8#6)
hexane-acetone##2##1##(2008-10#2)
hexane/acetone (1##2##2##(2008-10#2)
hexane/dichloromethane##2##1##(2008-10#1)(2008-11#1)
hexane/methanol (4##2##2##(2008-10#2)
hexanes##2##1##(2008-10#2)
hexanethiol##2##1##(2008-10#2)
hexanol##3##1##(2008-10#3)
hexanucleotide##2##1##(1994-11#1)(2008-10#1)
hexapeptide PS-SCL##2##2##(2008-4#2)
hexapeptide##8##1##(1992-4#1)(2008-10#1)(2008-4#2)(2008-5#4)
hexaplex real-time##2##2##(2011-2#2)
hexaploid wheat##5##2##(2008-10#4)(2012-3#1)
hexaploid##11##1##(2008-10#7)(2010-8#3)(2012-3#1)
hexarelin administration##2##2##(2010-5#2)
hexarelin##3##1##(2010-5#3)
hexasaccharides##3##1##(1994-5#3)
hexavalent chromium##10##2##(2008-10#6)(2008-12#2)(2011-2#2)
hexavalent##14##1##(2008-10#9)(2008-12#3)(2011-2#2)
hexokinase I##2##2##(1991-5#2)
hexokinase II##3##2##(1994-11#3)
hexokinase##12##1##(1991-5#6)(1994-11#3)(2008-10#3)
hexose sugars##3##2##(2011-2#2)(2012-3#1)
hexose##8##1##(1993-3#1)(1994-11#1)(1994-3#1)(1996-6#1)(2008-9#1)(2011-2#2)(2012-3#1)
hexyl##4##1##(2008-10#4)
hexyloxy-1##2##1##(1992-10#2)
hfNSCs##5##1##(2009-10#5)
hgiDIIM gene##2##2##(1991-9#2)
hgiDIIM##5##1##(1991-9#5)
hh expression##2##2##(1993-2#2)
hh mRNA was##2##3##(1993-2#2)
hh##6##1##(1993-12#2)(1993-2#4)
hiatal hernia with nonspecific esophageal motility disorder (NEMD)##2##8##(2011-2#2)
hiatal hernia with##3##3##(2011-2#3)
hiatal hernia##7##2##(1990-12#1)(2008-12#1)(2011-2#3)(2013-1#2)
hiatal##8##1##(1990-12#1)(2008-12#1)(2011-2#4)(2013-1#2)
hibernating phases##3##2##(2008-8#3)
hibernation##6##1##(2008-10#1)(2008-8#5)
hidden and output##5##3##(2008-10#5)
hidden and##8##2##(2008-10#6)(2010-10#1)(2010-8#1)
hidden layer##8##2##(2008-10#4)(2010-8#4)
hidden local##2##2##(2010-8#2)
hidden##45##1##(1993-2#2)(1994-3#1)(1995-5#2)(1996-12#2)(1997-2#2)(2008-1#1)(2008-10#16)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-10#1)(2010-8#7)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
hide##2##1##(2008-10#1)(2010-8#1)
hides##2##1##(1990-6#1)(2011-2#1)
hidradenitis##2##1##(1993-8#2)
hierarchical analysis of##3##3##(1994-9#1)(2008-10#2)
hierarchical analysis##4##2##(1994-9#1)(2008-10#3)
hierarchical and##3##2##(2008-11#1)(2008-5#1)(2010-4#1)
hierarchical arrangement##2##2##(1990-8#1)(2009-7#1)
hierarchical classification##2##2##(2010-7#1)(2013-1#1)
hierarchical cluster analysis##3##3##(2008-10#3)
hierarchical cluster##4##2##(2008-10#4)
hierarchical clustering and##2##3##(2008-10#2)
hierarchical levels##2##2##(1997-2#1)(2008-11#1)
hierarchical models##4##2##(1994-9#1)(2008-12#1)(2010-1#1)(2010-11#1)
hierarchical regression##2##2##(2008-11#1)(2013-1#1)
hierarchical sampling##2##2##(2008-10#2)
hierarchical structure##2##2##(2009-7#1)(2011-2#1)
hierarchical##45##1##(1990-8#1)(1991-6#1)(1992-5#2)(1994-9#4)(1997-2#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
hierarchically organized##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
hierarchically##9##1##(1992-5#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-11#1)(2013-1#1)(2013-8#1)
hierarchies##6##1##(2008-11#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#1)
hierarchy and##3##2##(2008-10#1)(2008-12#1)(2010-1#1)
hierarchy are##2##2##(2008-10#2)
hierarchy of##10##2##(1990-8#1)(1992-4#1)(2008-10#1)(2008-11#3)(2009-10#1)(2009-5#1)(2012-2#2)
hierarchy##36##1##(1990-8#1)(1992-4#1)(1995-2#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-1#1)(2011-2#3)(2012-2#4)(2013-1#1)
high (##2##2##(2008-10#1)(2010-11#1)
high (&gt##5##2##(2008-10#3)(2013-1#2)
high (0##4##2##(1990-6#1)(2008-10#3)
high (1##2##2##(1995-11#1)(2008-10#1)
high (8% w/w) levels of dietary fiber from##2##8##(1993-11#2)
high (96%)##2##2##(1995-3#1)(2008-10#1)
high (beta-)##3##2##(2008-10#3)
high (r = 0##2##4##(1995-5#1)(2013-8#1)
high ACTH##2##2##(2011-1#2)
high BP##2##2##(2010-4#2)
high C-peptide values##2##3##(1994-12#2)
high CO(2) plants##2##3##(2008-10#2)
high CO(2)##4##2##(2008-10#4)
high Ca##2##2##(2008-10#1)(2009-6#1)
high EI scores##3##3##(2013-1#3)
high IGF-I##2##2##(2008-5#1)(2012-3#1)
high K(+)-evoked##2##2##(1992-6#2)
high K(+)-induced##2##2##(1995-11#2)
high NaCl concentrations##2##3##(2012-7#2)
high RH##6##2##(2008-10#6)
high SPF##3##2##(1993-11#2)(2008-5#1)
high ability##2##2##(2008-10#1)(2010-5#1)
high abundance##2##2##(1992-6#1)(1997-4#1)
high accuracy and precision##3##4##(2008-10#3)
high accuracy and##6##3##(2008-10#4)(2010-9#1)(2011-2#1)
high accuracy##19##2##(2007-11#1)(2008-10#11)(2008-3#2)(2010-9#1)(2011-2#3)(2013-8#1)
high acid concentration##2##3##(2008-10#1)(2013-1#1)
high acid##3##2##(1997-1#1)(2008-10#1)(2013-1#1)
high activities of##2##3##(1995-11#2)
high activities##3##2##(1995-11#2)(2013-1#1)
high activity##4##2##(1990-5#1)(1994-8#1)(1997-8#1)(2008-7#1)
high affinity (Kd = 0##3##5##(1994-8#2)(1995-12#1)
high affinity (Kd =##4##4##(1994-8#2)(1995-12#1)(1996-2#1)
high affinity (Kd##5##3##(1990-11#1)(1994-8#2)(1995-12#1)(1996-2#1)
high affinity IgE receptor##2##4##(2008-11#2)
high affinity and low capacity##2##5##(1993-1#2)
high affinity and##6##3##(1993-1#3)(1995-11#1)(1995-2#1)(2012-2#1)
high affinity binding##3##3##(1994-8#1)(1997-4#2)
high affinity for the motilin receptor##2##6##(1994-11#2)
high affinity for the##7##4##(1992-11#1)(1994-11#2)(1994-8#1)(1995-11#1)(2008-11#1)(2008-6#1)
high affinity for##16##3##(1991-5#1)(1992-11#1)(1994-11#3)(1994-8#1)(1995-11#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
high affinity of##3##3##(2008-10#1)(2008-9#1)(2010-1#1)
high affinity receptor##2##3##(1990-11#1)(1993-3#1)
high affinity site##2##3##(1995-11#1)(1996-2#1)
high affinity to##2##3##(1996-12#1)(2008-10#1)
high affinity uptake##2##3##(1996-12#1)(2008-7#1)
high affinity##67##2##(1990-11#4)(1990-12#2)(1990-8#1)(1991-5#1)(1992-11#1)(1992-6#2)(1993-1#3)(1993-3#1)(1993-6#2)(1994-11#4)(1994-8#5)(1995-11#5)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-4#2)(2006-6#1)(2008-10#5)(2008-11#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
high after##2##2##(2008-10#1)(2011-2#1)
high alcohol##2##2##(1996-6#1)(2009-7#1)
high amino acid##2##3##(1993-8#1)(2008-9#1)
high among##5##2##(2008-10#2)(2008-11#1)(2010-4#1)(2012-2#1)
high amount of##5##3##(2008-10#4)(2013-1#1)
high amounts of##12##3##(1991-5#1)(1994-11#1)(2008-10#6)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
high amounts##13##2##(1991-5#1)(1994-11#1)(2008-10#6)(2008-11#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
high analytical##3##2##(2008-10#3)
high and low##16##3##(1993-8#1)(1995-11#1)(2008-10#7)(2008-12#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-2#2)
high and##29##2##(1990-9#1)(1993-8#1)(1993-9#1)(1995-11#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
high antibody titer##2##3##(2008-12#2)
high anxiety##2##2##(2009-7#2)
high aqueous##2##2##(2008-10#1)(2010-7#1)
high as 10##2##3##(1995-2#1)(2007-11#1)
high as##57##2##(1990-11#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#9)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
high aspect##2##2##(2008-10#1)(2008-3#1)
high at the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
high at##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
high atmospheric##2##2##(2008-3#2)
high attrition##2##2##(2008-11#1)(2008-8#1)
high background##6##2##(1990-12#1)(1994-12#1)(2008-1#1)(2008-10#2)(2010-6#1)
high between##2##2##(2008-10#1)(2011-2#1)
high binding affinity##2##3##(1995-6#1)(2008-8#1)
high binding##3##2##(1995-6#1)(2008-5#1)(2008-8#1)
high blood pressure##11##3##(1993-2#2)(1994-6#1)(1997-2#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-1#1)
high blood##13##2##(1993-2#2)(1994-6#1)(1997-2#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-1#1)(2012-12#1)(2013-1#1)
high but##3##2##(1996-2#1)(2008-8#1)(2013-1#1)
high calcium##2##2##(1990-2#1)(2008-10#1)
high calorie##2##2##(2008-10#1)(2011-2#1)
high capacity for##2##3##(2010-6#1)(2013-1#1)
high capacity##7##2##(1993-1#1)(2008-10#3)(2008-7#1)(2010-6#1)(2013-1#1)
high carbohydrate##3##2##(1996-12#1)(2008-3#2)
high catalytic##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-3#1)
high cell densities##4##3##(2008-11#3)(2008-7#1)
high cell density perfusion culture##3##5##(2008-11#3)
high cell density perfusion##4##4##(2008-11#4)
high cell density##11##3##(2008-11#9)(2008-7#1)(2011-1#1)
high cell growth##2##3##(2008-11#2)
high cell viability##3##3##(2008-11#3)
high cell##22##2##(2008-11#18)(2008-7#2)(2011-1#1)(2011-2#1)
high cellular##2##2##(2008-11#1)(2010-6#1)
high chances of##2##3##(2013-8#2)
high cholesterol##2##2##(2013-1#2)
high clinical##2##2##(2008-5#1)(2010-11#1)
high compared to##2##3##(2012-12#1)(2012-3#1)
high compatibility with##2##3##(2008-10#1)(2008-11#1)
high complexity##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
high concentration in##2##3##(2008-10#2)
high concentration of##21##3##(1993-3#1)(1994-5#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#2)(2009-12#1)
high concentration##35##2##(1993-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#4)(2008-9#5)(2009-12#1)
high concentrations in the##3##4##(1990-9#1)(2008-10#1)(2008-7#1)
high concentrations in##6##3##(1990-9#1)(1991-12#1)(1996-12#1)(2008-10#2)(2008-7#1)
high concentrations of drug##2##4##(1997-1#1)(2012-3#1)
high concentrations of flavonoids##2##4##(2008-10#1)(2012-12#1)
high concentrations of glucose##2##4##(1990-5#1)(2008-11#1)
high concentrations of the##2##4##(1992-3#1)(1996-12#1)
high concentrations of##34##3##(1990-12#1)(1990-2#2)(1990-5#2)(1991-2#1)(1992-3#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-4#1)(2008-10#11)(2008-11#4)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
high concentrations##54##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-12#2)(1997-1#1)(1997-4#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)
high conductance##2##2##(2008-10#1)(2008-7#1)
high conservation of##2##3##(2010-11#1)(2013-8#1)
high content of##7##3##(1996-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-4#1)
high content##8##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)
high copy number##4##3##(1993-9#1)(2008-10#1)(2008-11#1)(2009-10#1)
high copy##5##2##(1993-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
high correlation between##6##3##(2008-10#3)(2008-9#2)(2009-12#1)
high correlation coefficient##4##3##(2008-10#2)(2011-2#1)(2011-3#1)
high correlation with##2##3##(1991-2#1)(2010-8#1)
high correlation##14##2##(1991-2#1)(2008-10#6)(2008-9#2)(2009-12#1)(2010-8#1)(2011-2#2)(2011-3#1)
high cost of##2##3##(2008-10#1)(2008-11#1)
high cost##7##2##(2008-10#2)(2008-11#3)(2008-7#1)(2012-2#1)
high costs of##3##3##(2008-8#3)
high costs##7##2##(1992-2#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-8#3)
high coverage##2##2##(2008-10#1)(2013-1#1)
high current##2##2##(2008-10#2)
high degree of homology##6##4##(1992-8#1)(1993-2#2)(1994-11#1)(1997-1#1)(2008-10#1)
high degree of stability##2##4##(1996-6#1)(2008-10#1)
high degree of structural##2##4##(1991-6#1)(1997-2#1)
high degree of##76##3##(1990-11#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
high degree##78##2##(1990-11#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
high demand##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
high densities##2##2##(2008-10#1)(2013-1#1)
high density culture##2##3##(2008-11#2)
high density linkage map##2##4##(1995-6#1)(2013-8#1)
high density lipoprotein (HDL)##2##4##(1994-11#1)(2008-3#1)
high density lipoprotein##5##3##(1991-11#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
high density of inoculum##2##4##(2008-10#2)
high density of##5##3##(1993-2#1)(2008-10#2)(2008-3#1)(2010-7#1)
high density on##2##3##(2008-11#2)
high density perfusion##2##3##(2008-11#2)
high density polyethylene##3##3##(2008-10#1)(2009-3#2)
high density##33##2##(1990-5#1)(1991-10#1)(1991-11#1)(1993-2#2)(1994-11#2)(1995-6#1)(2008-10#7)(2008-11#8)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-7#1)(2013-8#1)
high detection limit##2##3##(2008-10#2)
high detection limits##2##3##(2008-10#2)
high detection sensitivity##2##3##(2008-10#1)(2012-12#1)
high detection##7##2##(2008-10#6)(2012-12#1)
high dielectric constant##2##3##(2008-10#1)(2013-1#1)
high dimensional##2##2##(2008-10#1)(2011-3#1)
high dipole##2##2##(1997-6#1)(2008-10#1)
high discrimination##2##2##(2007-12#1)(2008-10#1)
high disease##5##2##(2008-10#5)
high dose of##6##3##(1991-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2013-8#1)
high dose oral corticosteroids##3##4##(2008-11#3)
high dose##25##2##(1990-12#1)(1991-9#2)(1995-11#2)(1996-8#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#5)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
high doses and##2##3##(1994-9#1)(2013-1#1)
high doses of vitamin##2##4##(1992-9#1)(2010-1#1)
high doses of##16##3##(1991-6#1)(1992-9#1)(1993-1#1)(1994-3#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-1#1)(2010-10#1)(2012-12#1)(2012-2#1)
high doses##23##2##(1991-6#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-9#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#3)(2010-1#1)(2010-10#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
high due to##2##3##(2008-10#1)(2009-10#1)
high during##3##2##(1991-5#1)(1993-2#1)(2012-2#1)
high dynamic range##2##3##(2008-10#1)(2008-3#1)
high efficacy and##2##3##(2008-12#1)(2010-10#1)
high efficacy##6##2##(2008-10#1)(2008-12#2)(2008-8#1)(2010-10#1)(2013-1#1)
high efficiency##12##2##(1990-5#1)(2008-10#4)(2008-11#3)(2008-8#4)
high electrocatalytic##2##2##(2008-10#2)
high energy and##2##3##(2008-10#2)
high energy##11##2##(1991-2#1)(1991-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2010-1#1)(2013-8#1)
high enough to##2##3##(1993-9#1)(2008-10#1)
high enough##4##2##(1991-11#1)(1993-9#1)(2008-10#1)(2008-11#1)
high enrichment factor##2##3##(2008-10#2)
high enzymatic##2##2##(2008-6#1)(2012-6#1)
high enzyme activity##3##3##(1993-3#1)(1994-11#2)
high excess##2##2##(2008-10#2)
high expectations##4##2##(1995-3#1)(2008-10#1)(2008-12#1)(2009-7#1)
high expression levels of##2##4##(2008-10#1)(2008-11#1)
high expression levels##3##3##(2008-10#1)(2008-11#2)
high expression of FLIP##2##4##(2009-9#2)
high expression of the##3##4##(1992-12#1)(1996-12#1)(2009-8#1)
high expression of##12##3##(1992-12#1)(1996-12#2)(1997-8#1)(2008-12#1)(2009-8#2)(2009-9#4)(2011-2#1)
high expression##18##2##(1992-12#1)(1995-2#1)(1996-12#2)(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-8#2)(2009-9#4)(2011-2#1)(2013-1#1)
high extraction efficiency##2##3##(2008-10#1)(2008-12#1)
high extraction##4##2##(2008-10#3)(2008-12#1)
high fat diet##2##3##(1996-12#2)
high fat##6##2##(1993-11#2)(1996-12#3)(2008-11#1)
high fever##2##2##(2006-5#1)(2012-3#1)
high fidelity of##3##3##(2008-10#1)(2010-7#1)(2012-3#1)
high fidelity##5##2##(2008-10#1)(2010-1#1)(2010-7#1)(2012-3#1)(2013-1#1)
high field##3##2##(1996-2#1)(1997-6#1)(2008-10#1)
high flow##5##2##(1995-3#1)(1996-6#1)(1996-9#2)(2008-10#1)
high food##2##2##(2010-8#2)
high for those##2##3##(2008-10#1)(2009-7#1)
high for##8##2##(1995-12#1)(2008-10#4)(2009-3#1)(2009-7#1)(2012-3#1)
high frequencies of##2##3##(2008-7#1)(2011-2#1)
high frequencies##6##2##(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
high frequency of##9##3##(1997-5#1)(1997-9#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
high frequency ventilation##3##3##(1994-6#3)
high frequency##39##2##(1992-6#1)(1993-8#1)(1994-6#5)(1996-12#1)(1997-2#1)(1997-5#1)(1997-9#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
high genetic differentiation among populations##2##5##(2008-8#2)
high genetic differentiation##3##3##(2008-10#1)(2008-8#2)
high genetic diversity in##2##4##(2008-10#2)
high genetic diversity##5##3##(2008-10#3)(2010-5#1)(2013-8#1)
high genetic##11##2##(2008-10#5)(2008-8#2)(2010-5#1)(2013-1#1)(2013-8#2)
high genotypic diversity##3##3##(2008-10#3)
high glass##2##2##(1995-3#1)(2009-7#1)
high glucose conditions##2##3##(1992-8#1)(2012-4#1)
high glucose reduced##2##3##(2012-4#2)
high glucose##16##2##(1992-6#5)(1992-8#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-4#5)(2012-5#1)
high glucose-induced damage in##2##4##(2012-4#2)
high glucose-induced damage##3##3##(2012-4#3)
high grade endometrial carcinomas##3##4##(2011-2#3)
high grade##7##2##(1992-1#2)(2010-11#1)(2011-2#4)
high gradient##2##2##(2007-12#1)(2008-11#1)
high growth##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
high heritability##3##2##(2008-8#1)(2012-3#2)
high heterogeneity##3##2##(1992-2#1)(2008-9#1)(2013-8#1)
high homology to the##2##4##(1993-12#1)(1996-8#1)
high homology to##6##3##(1990-5#1)(1993-12#2)(1996-8#1)(1997-2#1)(2008-9#1)
high homology with##4##3##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
high homology##14##2##(1990-5#1)(1991-9#1)(1993-12#2)(1993-8#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2012-2#1)
high humidity##7##2##(2008-10#6)(2010-4#1)
high hydrophobicity##2##2##(2008-12#1)(2010-4#1)
high in all populations##2##4##(2008-10#2)
high in all##4##3##(2008-10#4)
high in both##2##3##(2008-9#1)(2011-2#1)
high in patients with##3##4##(1994-9#1)(1995-10#1)(2008-7#1)
high in patients##4##3##(1994-9#1)(1995-10#1)(2008-7#1)(2011-2#1)
high in the##9##3##(1990-11#1)(1990-5#1)(1992-5#1)(1993-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
high in##34##2##(1990-11#1)(1990-5#1)(1991-6#1)(1992-5#1)(1993-3#1)(1994-9#1)(1995-10#1)(2008-1#1)(2008-10#7)(2008-7#1)(2008-8#4)(2008-9#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
high incidence of##14##3##(1992-2#1)(1993-3#1)(1994-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
high incidence##17##2##(1992-2#1)(1993-3#2)(1994-12#2)(1997-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
high infection rate of##2##4##(1996-8#1)(2008-10#1)
high infratemporal fossa##2##3##(2012-3#2)
high initial##6##2##(1990-3#1)(1995-3#1)(2008-10#3)(2008-8#1)
high inoculum density##2##3##(2008-10#2)
high inoculum##6##2##(2008-10#6)
high input##2##2##(2008-5#1)(2013-1#1)
high insertion torque##2##3##(2013-1#2)
high insertion##3##2##(2013-1#3)
high intake of marine n-3##2##5##(2010-6#2)
high intake of##4##3##(2008-10#1)(2010-4#1)(2010-6#2)
high intensity probe##2##3##(2008-10#2)
high intensity##10##2##(1992-3#2)(1996-5#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
high interest##3##2##(2008-10#2)(2008-5#1)
high internal##2##2##(2008-3#1)(2013-1#1)
high intrinsic##2##2##(2008-10#1)(2008-3#1)
high ionic strength##4##3##(1992-4#1)(2008-10#3)
high iron##2##2##(1997-7#1)(2008-1#1)
high level expression##3##3##(2008-11#1)(2008-8#2)
high level of IGF-IR mRNA##2##5##(2008-8#2)
high level of genetic##3##4##(2008-10#3)
high level of##58##3##(1991-6#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-11#2)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#20)(2008-11#7)(2008-8#5)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
high level##77##2##(1991-6#1)(1993-3#1)(1993-6#2)(1994-8#2)(1995-11#2)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#22)(2008-11#15)(2008-5#1)(2008-8#8)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
high levels in the##4##4##(1995-2#1)(1996-2#1)(2008-1#1)(2008-11#1)
high levels in##8##3##(1992-10#1)(1994-11#1)(1995-2#2)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
high levels of expression##2##4##(1996-12#1)(2008-11#1)
high levels of genetic diversity##2##5##(2008-10#1)(2013-1#1)
high levels of genetic##3##4##(2008-10#2)(2013-1#1)
high levels of genotypic diversity##2##5##(2008-10#2)
high levels of genotypic##3##4##(2008-10#3)
high levels of partial resistance##2##5##(2008-10#2)
high levels of recombinant protein##2##5##(2008-11#2)
high levels of satisfaction##2##4##(2008-10#2)
high levels of serum##2##4##(1995-2#1)(2010-1#1)
high levels of the##3##4##(1995-6#1)(2008-10#2)
high levels of transcripts##2##4##(1996-12#1)(2008-10#1)
high levels of##101##3##(1991-2#1)(1991-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#4)(1995-6#1)(1996-1#2)(1996-12#4)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#33)(2008-11#10)(2008-12#1)(2008-5#1)(2008-8#9)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#4)(2010-1#3)(2010-2#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
high levels##120##2##(1991-2#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-12#1)(1995-2#6)(1995-6#1)(1996-1#2)(1996-12#5)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-1#2)(2008-10#35)(2008-11#13)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#4)(2010-1#3)(2010-2#1)(2010-6#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
high light##3##2##(2008-11#1)(2009-10#1)(2009-8#1)
high linear##3##2##(2008-3#3)
high loading##2##2##(2008-10#2)
high local concentration of##2##4##(2008-10#1)(2008-11#1)
high local concentration##3##3##(2008-10#2)(2008-11#1)
high local##7##2##(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-3#1)
high mannose##2##2##(1991-9#1)(2008-10#1)
high matrix##2##2##(2008-10#2)
high mean##3##2##(2008-9#2)(2012-2#1)
high metabolic##2##2##(2008-11#1)(2010-7#1)
high metal##2##2##(2008-10#2)
high mobility group##2##3##(1990-3#1)(1992-6#1)
high mobility##3##2##(1990-3#1)(1992-6#1)(2008-10#1)
high molar##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
high molecular weight (HMW)##3##4##(2008-10#2)(2010-8#1)
high molecular weight EGFs##2##4##(1990-12#2)
high molecular weight compounds##2##4##(2008-10#2)
high molecular weight##31##3##(1990-12#3)(1991-9#1)(1992-10#2)(1995-6#1)(1996-12#2)(1996-2#2)(2008-10#11)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-11#2)(2010-8#1)
high molecular##35##2##(1990-12#3)(1991-9#1)(1992-10#2)(1994-2#1)(1995-6#1)(1996-12#2)(1996-2#2)(2008-10#13)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-8#1)
high morbidity and mortality##6##4##(1996-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
high morbidity and##7##3##(1996-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
high mortality rate##11##3##(1993-6#1)(1996-3#1)(2008-11#1)(2008-12#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
high mortality rates##2##3##(2008-11#1)(2008-4#1)
high mortality##22##2##(1990-12#1)(1993-6#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#2)
high myopia##2##2##(1991-2#1)(2011-2#1)
high noise##2##2##(2008-10#1)(2008-3#1)
high nonlinearity##2##2##(2007-12#1)(2008-3#1)
high number of##12##3##(1993-6#1)(2008-10#4)(2008-7#3)(2011-1#1)(2011-2#1)(2012-3#2)
high numbers##5##2##(2008-10#3)(2008-12#1)(2012-2#1)
high numerical aperture##4##3##(2007-12#2)(2008-3#1)(2009-12#1)
high nutrient##2##2##(2008-10#1)(2008-11#1)
high on##2##2##(2009-11#1)(2010-2#1)
high optical##2##2##(2008-2#1)(2013-8#1)
high or low##12##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-8#1)
high or##16##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2010-1#1)(2010-8#1)(2013-8#1)
high osmolality##2##2##(2008-11#2)
high osmotic##2##2##(2008-11#1)(2008-7#1)
high output##2##2##(2008-2#2)
high overall##2##2##(1996-11#1)(2008-10#1)
high oxidative##2##2##(2010-5#1)(2011-2#1)
high oxygen##3##2##(2008-11#1)(2008-7#1)(2010-10#1)
high pH (D)##2##3##(1991-9#2)
high pH##13##2##(1991-9#2)(1992-9#1)(1994-11#1)(1995-6#1)(2008-10#8)
high partition coefficients##2##3##(2008-10#2)
high peak power##2##3##(2008-3#2)
high percent##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
high percentage of##9##3##(1991-12#1)(1991-6#1)(1996-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-3#2)
high percentage##10##2##(1991-12#1)(1991-6#1)(1996-3#1)(2008-10#3)(2008-11#1)(2011-1#1)(2012-3#2)
high performance liquid chromatographic method##3##5##(2008-10#2)(2012-2#1)
high performance liquid chromatographic##8##4##(2008-10#7)(2012-2#1)
high performance liquid chromatography (HPLC) and##5##6##(2008-10#5)
high performance liquid chromatography (HPLC) coupled##2##6##(2008-10#2)
high performance liquid chromatography (HPLC) method##4##6##(2008-10#3)(2008-5#1)
high performance liquid chromatography (HPLC) technique##2##6##(2008-10#2)
high performance liquid chromatography (HPLC) with##4##6##(1997-2#1)(2008-10#3)
high performance liquid chromatography (HPLC)##36##5##(1997-2#1)(2008-10#31)(2008-11#1)(2008-5#2)(2008-8#1)
high performance liquid chromatography analysis##2##5##(2008-10#2)
high performance liquid chromatography and##3##5##(2008-10#3)
high performance liquid chromatography method##2##5##(2008-10#1)(2008-5#1)
high performance liquid chromatography separation##2##5##(2008-10#1)(2008-9#1)
high performance liquid chromatography with diode array detector##2##8##(2008-10#2)
high performance liquid chromatography with fluorescence##5##6##(1993-2#1)(2008-10#4)
high performance liquid chromatography with##12##5##(1993-2#1)(1995-6#1)(2008-10#10)
high performance liquid chromatography##84##4##(1990-8#2)(1993-2#1)(1993-6#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#69)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#1)(2012-2#1)
high performance liquid chromatography-electrospray ionization##2##5##(2008-10#2)
high performance liquid chromatography-electrospray##4##4##(2008-10#2)(2008-8#2)
high performance liquid chromatography-inductively coupled plasma##2##6##(2008-10#2)
high performance liquid chromatography-inductively coupled##3##5##(2008-10#3)
high performance liquid chromatography-microwave digestion-hydride generation-atomic absorption spectrometry##2##8##(2008-10#2)
high performance liquid chromatography/electrospray/mass spectrometry##3##5##(2008-10#3)
high performance liquid immunoaffinity chromatography##2##5##(1990-12#2)
high performance liquid##112##3##(1990-12#2)(1990-5#1)(1990-8#2)(1991-3#1)(1993-2#1)(1993-6#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#90)(2008-11#2)(2008-5#3)(2008-8#3)(2008-9#1)(2012-2#2)
high performance runner who##2##4##(2011-2#2)
high performance runner##3##3##(2011-2#3)
high performance##126##2##(1990-12#2)(1990-5#1)(1990-8#2)(1991-3#1)(1993-2#1)(1993-6#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#97)(2008-11#2)(2008-2#1)(2008-5#3)(2008-8#3)(2008-9#1)(2011-2#5)(2012-2#3)
high plasma concentrations##2##3##(1991-1#1)(2008-6#1)
high population##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
high porosity and##2##3##(2009-12#1)(2009-7#1)
high positive##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
high potency##2##2##(1995-11#1)(2011-2#1)
high potential for##2##3##(2010-11#1)(2013-1#1)
high potential of##2##3##(1995-12#1)(2008-10#1)
high potential##5##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-1#1)
high power density##2##3##(1992-12#1)(2008-3#1)
high power##8##2##(1992-12#1)(1994-2#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
high precision and accuracy##4##4##(2008-10#4)
high precision and##7##3##(2008-10#6)(2008-3#1)
high precision##15##2##(2008-10#13)(2008-3#1)(2009-7#1)
high predictive##4##2##(2008-10#1)(2009-8#1)(2011-2#1)(2012-3#1)
high pressure and##3##3##(1995-6#2)(1996-5#1)
high pressure liquid chromatography (HPLC) with##2##6##(2008-10#2)
high pressure liquid chromatography (HPLC)##3##5##(2008-10#2)(2011-1#1)
high pressure liquid chromatography##4##4##(2008-10#2)(2011-1#2)
high pressure liquid##7##3##(2008-10#5)(2011-1#2)
high pressure system##2##3##(2008-10#2)
high pressure##23##2##(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#11)(2008-7#3)(2011-1#2)
high pressures##2##2##(1994-6#1)(2008-10#1)
high prevalence in##2##3##(2008-8#1)(2013-1#1)
high prevalence of##15##3##(1992-5#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
high prevalence##19##2##(1990-6#1)(1992-5#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#2)(2009-6#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
high priority##9##2##(1994-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-3#1)(2013-1#2)
high probability of##4##3##(1997-8#1)(2008-11#2)(2013-1#1)
high probability##7##2##(1990-5#1)(1997-8#1)(2008-10#1)(2008-11#2)(2011-3#1)(2013-1#1)
high producing##2##2##(2008-11#2)
high production of##2##3##(2008-11#1)(2009-10#1)
high production##3##2##(2008-11#1)(2008-7#1)(2009-10#1)
high productivity##5##2##(2008-11#3)(2008-9#1)(2012-9#1)
high proliferative##4##2##(1994-8#1)(1995-12#1)(2008-11#2)
high propensity##2##2##(2008-8#1)(2013-8#1)
high proportion of##12##3##(1990-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
high proportion##15##2##(1990-12#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
high proportions##2##2##(2008-10#2)
high protein##5##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)
high pulse energy##2##3##(2008-3#2)
high pulse##3##2##(2008-3#2)(2010-1#1)
high purity Gd(2)O(3)##2##3##(2008-10#2)
high purity##19##2##(1994-5#1)(2008-10#17)(2008-11#1)
high quality care##2##3##(1996-3#1)(1997-2#1)
high quality predictions##2##3##(2008-10#1)(2008-11#1)
high quality##25##2##(1993-12#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-2#2)(2008-10#3)(2008-11#6)(2008-12#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-7#1)(2013-8#1)
high quantum yield##2##3##(2008-10#2)
high quantum##3##2##(2008-10#2)(2008-3#1)
high rainfall##2##2##(2008-10#1)(2012-9#1)
high rate of##22##3##(1991-1#1)(1991-6#1)(1991-9#1)(1993-3#1)(1994-1#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#2)
high rate##24##2##(1991-1#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-3#1)(1994-1#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#2)
high rates of##12##3##(1991-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-8#3)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)
high rates##13##2##(1991-11#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-8#3)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)
high ratio of##2##3##(2008-10#1)(2010-4#1)
high recoveries##2##2##(2008-10#1)(2008-11#1)
high recovery##4##2##(2008-10#4)
high recurrence##3##2##(2011-2#1)(2013-1#2)
high relative humidity##4##3##(2008-10#4)
high reliability##6##2##(2008-10#4)(2012-2#1)(2013-1#1)
high removal##2##2##(2011-2#1)(2013-1#1)
high repetition rate##3##3##(2007-11#1)(2008-3#1)(2010-1#1)
high repetition##4##2##(2007-11#1)(2008-3#2)(2010-1#1)
high reproducibility##6##2##(2008-10#6)
high resistance to##4##3##(2008-10#2)(2009-3#1)(2011-10#1)
high resistance##5##2##(2008-10#2)(2008-12#1)(2009-3#1)(2011-10#1)
high resolution GC-MS##2##3##(2008-10#2)
high resolution and##4##3##(1995-6#1)(2008-10#1)(2008-3#1)(2011-7#1)
high resolution in##2##3##(2008-10#1)(2008-3#1)
high resolution mass spectrometry##2##4##(2008-10#1)(2008-11#1)
high resolution mass##3##3##(2008-10#2)(2008-11#1)
high resolution of##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
high resolution separation##2##3##(2008-10#2)
high resolution separations##2##3##(2008-10#1)(2008-7#1)
high resolution##42##2##(1994-6#1)(1995-3#1)(1995-6#1)(1995-8#2)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-3#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#2)(2011-3#1)(2011-7#1)(2012-2#1)
high risk and##3##3##(1991-6#1)(2008-10#1)(2012-3#1)
high risk for##7##3##(1992-9#1)(1995-1#1)(2008-4#1)(2010-10#1)(2011-2#1)(2013-1#2)
high risk group##2##3##(2009-8#1)(2012-3#1)
high risk of losing##2##4##(1992-5#1)(1996-11#1)
high risk of malignant transformation##2##5##(2009-12#1)(2012-12#1)
high risk of##32##3##(1990-2#1)(1990-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1994-9#2)(1995-5#1)(1996-11#1)(1997-6#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-12#3)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
high risk patients##5##3##(1996-11#1)(2008-10#1)(2008-7#1)(2010-10#2)
high risk##76##2##(1990-2#1)(1990-3#3)(1991-1#2)(1991-6#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-5#1)(1995-9#2)(1996-11#2)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-4#3)(2008-6#1)(2008-7#3)(2009-12#3)(2009-8#1)(2010-10#4)(2010-11#3)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#1)
high robustness of##2##3##(2010-8#1)(2011-2#1)
high safety##2##2##(2008-11#1)(2012-3#1)
high saline##4##2##(2008-10#4)
high salinity##2##2##(2008-10#1)(2009-8#1)
high salt content##3##3##(2008-10#3)
high salt contents##2##3##(2008-10#2)
high salt##13##2##(1990-5#1)(1994-11#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
high sample throughput##7##3##(1992-11#1)(2008-10#6)
high sample##8##2##(1992-11#1)(2008-10#7)
high sampling frequency##3##3##(2008-10#3)
high sampling rate##2##3##(2008-10#2)
high sampling##6##2##(2008-10#5)(2008-5#1)
high school students in Tehran##2##5##(2008-12#2)
high school students in the Tiko health district##3##8##(2013-1#3)
high school students in##5##4##(2008-12#2)(2013-1#3)
high school students##9##3##(1990-12#1)(1993-3#1)(2008-12#2)(2009-5#1)(2012-3#1)(2013-1#3)
high school##21##2##(1990-12#3)(1990-3#1)(1990-6#1)(1993-1#1)(1993-3#1)(2008-12#3)(2009-5#1)(2010-10#2)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
high schools##4##2##(1995-12#1)(2008-12#1)(2011-1#1)(2013-1#1)
high score##3##2##(2008-8#1)(2013-1#2)
high secretion##2##2##(2008-11#2)
high security##3##2##(1997-5#2)(2008-10#1)
high seed##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
high selectivity and sensitivity to##2##5##(2008-10#2)
high selectivity and sensitivity##8##4##(2008-10#8)
high selectivity and##9##3##(2008-10#9)
high selectivity for##10##3##(1991-3#1)(1994-11#1)(2008-10#8)
high selectivity of the##4##4##(2008-10#4)
high selectivity of##7##3##(2008-10#6)(2010-7#1)
high selectivity to##2##3##(2008-10#2)
high selectivity toward##4##3##(2008-10#3)(2013-1#1)
high selectivity towards##3##3##(2008-10#3)
high selectivity##45##2##(1991-3#1)(1994-11#1)(2008-10#40)(2008-11#1)(2010-7#1)(2013-1#1)
high sensitive##5##2##(2008-10#5)
high sensitivities##5##2##(2008-10#3)(2012-12#1)(2012-3#1)
high sensitivity C-reactive protein##2##4##(2010-12#1)(2013-1#1)
high sensitivity and fast response time##2##6##(2007-11#1)(2008-10#1)
high sensitivity and good selectivity##2##5##(2008-10#2)
high sensitivity and good##4##4##(2008-10#4)
high sensitivity and##15##3##(2007-11#1)(2008-10#12)(2008-3#1)(2008-9#1)
high sensitivity for##4##3##(2008-10#3)(2008-3#1)
high sensitivity is##4##3##(2008-10#3)(2008-3#1)
high sensitivity of the##5##4##(2008-10#3)(2008-2#1)(2008-3#1)
high sensitivity of##12##3##(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-5#1)(2013-8#1)
high sensitivity to##4##3##(2008-10#3)(2009-5#1)
high sensitivity##89##2##(1992-11#1)(1996-2#1)(2007-11#1)(2008-10#68)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-5#1)(2012-2#2)(2013-1#2)(2013-8#1)
high separation efficiency##2##3##(2008-10#2)
high separation##5##2##(2008-10#4)(2008-9#1)
high sequence identity to##2##4##(2008-10#2)
high sequence similarity##4##3##(1994-11#1)(2008-10#3)
high sequence##6##2##(1994-11#1)(2008-10#5)
high serum##4##2##(1991-11#1)(1991-6#1)(2008-8#1)(2008-9#1)
high shear##2##2##(2008-11#1)(2009-7#1)
high signal intensity on T##2##5##(1997-8#2)
high signal intensity on##5##4##(1991-11#1)(1997-8#3)(2011-2#1)
high signal intensity##6##3##(1991-11#1)(1997-8#3)(2011-2#1)(2013-8#1)
high signal-to-noise ratio##2##3##(2008-3#2)
high signal-to-noise##3##2##(2008-10#1)(2008-3#2)
high similarity to##2##3##(1991-5#1)(1996-3#1)
high similarity##6##2##(1991-5#1)(1996-3#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-6#1)
high social##4##2##(1993-3#2)(2008-12#1)(2011-2#1)
high socioeconomic status##2##3##(2012-2#1)(2013-8#1)
high soil moisture##2##3##(2008-10#2)
high soil##3##2##(2008-10#3)
high solvent##2##2##(1992-9#1)(2013-1#1)
high spatial and temporal resolutions##2##5##(2008-10#2)
high spatial and temporal##3##4##(2008-10#2)(2008-11#1)
high spatial resolution##3##3##(2009-1#1)(2010-12#1)(2012-2#1)
high spatial##8##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-1#1)(2010-12#1)(2012-2#1)
high specific activity##2##3##(1994-11#1)(2008-7#1)
high specific surface##2##3##(2008-10#1)(2008-5#1)
high specific##8##2##(1990-12#2)(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
high specificity and##3##3##(1993-8#1)(1997-2#1)(2008-12#1)
high specificity for##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
high specificity##18##2##(1991-5#1)(1993-8#3)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
high spectral resolution##3##3##(2008-2#2)(2008-3#1)
high spectral##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
high speed##10##2##(1997-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)
high spider fearful##2##3##(2009-9#2)
high stability of the##2##4##(2008-10#1)(2011-1#1)
high stability##12##2##(1990-12#1)(1990-5#1)(2008-10#6)(2008-2#1)(2008-3#2)(2011-1#1)
high substrate##3##2##(1992-3#1)(2008-12#1)(2008-7#1)
high success rate of##2##4##(2009-7#1)(2012-12#1)
high success rate##6##3##(1994-12#1)(1995-11#1)(1996-11#1)(1997-4#1)(2009-7#1)(2012-12#1)
high surface area##3##3##(2008-10#2)(2009-7#1)
high surface##8##2##(2008-10#5)(2008-5#1)(2008-9#1)(2009-7#1)
high surgical##2##2##(2008-11#1)(2008-12#1)
high survival##2##2##(2008-8#1)(2008-9#1)
high susceptibility to##2##3##(1993-8#1)(2008-10#1)
high temperature and##3##3##(2008-10#2)(2008-6#1)
high temperature##26##2##(1991-5#1)(1995-6#1)(1997-2#1)(2008-10#12)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-9#1)(2013-8#3)
high temperatures##15##2##(1995-3#1)(2008-10#11)(2008-12#1)(2008-8#1)(2008-9#1)
high temporal##3##2##(1996-2#1)(2008-3#1)(2010-12#1)
high thermal stability##3##3##(2008-10#2)(2008-2#1)
high thermal##4##2##(2008-10#3)(2008-2#1)
high throughout the##3##3##(2008-10#2)(2008-8#1)
high throughput methods##2##3##(2008-10#2)
high throughput screening##3##3##(2008-10#3)
high throughput##21##2##(1997-6#1)(2008-10#11)(2008-11#1)(2008-4#2)(2009-4#1)(2009-7#1)(2011-2#1)(2012-3#3)
high titer##6##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
high titre##5##2##(1995-12#1)(1996-12#1)(2008-11#3)
high to##3##2##(2008-10#1)(2008-7#1)(2010-6#1)
high tolerance##2##2##(2008-10#2)
high toxicity##4##2##(1997-2#1)(2008-10#3)
high transfection efficiency##2##3##(2008-11#2)
high transfection##3##2##(2008-11#3)
high transmission##3##2##(2007-12#1)(2008-8#2)
high treatment##2##2##(2012-12#1)(2013-1#1)
high tumor##2##2##(1993-11#1)(2010-6#1)
high under##2##2##(2008-10#1)(2008-6#1)
high valine##2##2##(2008-10#2)
high value of##3##3##(1995-12#1)(2008-10#2)
high values for the##2##4##(2008-10#2)
high values of##5##3##(1993-11#1)(2008-10#4)
high values##8##2##(1993-11#1)(2008-10#6)(2011-2#1)
high vapour##3##2##(2008-10#1)(2008-5#2)
high variability of##2##3##(2008-10#1)(2008-9#1)
high variability##7##2##(1991-12#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#1)
high versus##2##2##(1990-6#1)(2008-4#1)
high viability##3##2##(2008-11#3)
high viable##2##2##(2008-11#1)(2013-1#1)
high virulence##5##2##(2008-10#5)
high virus##2##2##(2008-10#1)(2011-2#1)
high voltage##8##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(2008-10#2)(2008-11#1)(2012-2#1)
high volume##8##2##(1991-3#1)(1992-11#1)(1992-2#1)(2008-11#4)(2013-1#1)
high water content##2##3##(2009-6#1)(2009-9#1)
high water##4##2##(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)
high when##2##2##(2008-10#1)(2009-8#1)
high yield of##3##3##(1990-3#1)(2008-9#1)(2012-2#1)
high yield##10##2##(1990-3#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2012-2#1)
high yields of##3##3##(2008-4#2)(2011-2#1)
high yields##5##2##(1996-5#1)(2008-4#2)(2011-1#1)(2011-2#1)
high##3172##1##(1990-11#9)(1990-12#20)(1990-2#8)(1990-3#9)(1990-5#14)(1990-6#11)(1990-8#5)(1990-9#7)(1991-1#4)(1991-10#1)(1991-11#8)(1991-12#6)(1991-2#7)(1991-3#7)(1991-5#9)(1991-6#14)(1991-8#4)(1991-9#9)(1992-1#2)(1992-10#3)(1992-11#7)(1992-12#10)(1992-2#9)(1992-3#11)(1992-4#1)(1992-5#6)(1992-6#13)(1992-8#3)(1992-9#8)(1993-1#10)(1993-11#10)(1993-12#7)(1993-2#12)(1993-3#16)(1993-5#1)(1993-6#9)(1993-8#13)(1993-9#5)(1994-1#2)(1994-11#19)(1994-12#8)(1994-2#6)(1994-3#4)(1994-5#7)(1994-6#11)(1994-8#11)(1994-9#6)(1995-1#4)(1995-10#2)(1995-11#19)(1995-12#14)(1995-2#12)(1995-3#11)(1995-5#2)(1995-6#11)(1995-8#5)(1995-9#3)(1996-1#6)(1996-11#7)(1996-12#24)(1996-2#27)(1996-3#7)(1996-5#11)(1996-6#4)(1996-8#3)(1996-9#3)(1997-1#12)(1997-2#19)(1997-3#8)(1997-4#8)(1997-5#4)(1997-6#7)(1997-7#9)(1997-8#13)(1997-9#1)(2006-5#1)(2006-6#3)(2007-11#10)(2007-12#9)(2007-8#1)(2008-1#10)(2008-10#1050)(2008-11#234)(2008-12#57)(2008-2#17)(2008-3#83)(2008-4#20)(2008-5#57)(2008-6#17)(2008-7#73)(2008-8#115)(2008-9#63)(2009-1#3)(2009-10#12)(2009-11#12)(2009-12#8)(2009-3#11)(2009-4#1)(2009-5#6)(2009-6#6)(2009-7#18)(2009-8#18)(2009-9#9)(2010-1#19)(2010-10#14)(2010-11#23)(2010-12#15)(2010-2#3)(2010-3#5)(2010-4#16)(2010-5#8)(2010-6#14)(2010-7#14)(2010-8#16)(2010-9#9)(2011-1#25)(2011-10#2)(2011-2#116)(2011-3#9)(2011-7#1)(2012-12#25)(2012-2#49)(2012-3#52)(2012-4#9)(2012-5#1)(2012-6#2)(2012-7#3)(2012-9#5)(2013-1#106)(2013-7#2)(2013-8#47)
high- and low-predation localities##2##4##(2008-8#2)
high- and low-predation##3##3##(2008-8#3)
high- and##6##2##(2008-10#1)(2008-12#1)(2008-8#3)(2013-1#1)
high-##9##1##(2008-10#1)(2008-12#1)(2008-8#3)(2012-3#1)(2013-1#1)(2013-8#2)
high-GC##2##1##(2008-7#1)(2012-2#1)
high-Tc##2##1##(1992-8#1)(1993-5#1)
high-Verticillium soil##3##2##(2008-10#3)
high-accuracy##5##1##(2008-10#3)(2008-3#2)
high-affinity GTPase activity in##2##4##(1995-11#2)
high-affinity GTPase activity##4##3##(1995-11#4)
high-affinity binding##6##2##(1993-6#1)(1994-5#1)(1996-2#1)(1997-8#1)(2008-4#1)(2012-2#1)
high-affinity receptor##2##2##(1996-12#1)(2008-9#1)
high-affinity##37##1##(1991-6#1)(1992-10#1)(1993-1#1)(1993-6#3)(1993-8#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#5)(1995-2#1)(1996-12#3)(1996-2#2)(1997-8#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-9#2)(2009-6#2)(2009-7#1)(2010-5#1)(2012-2#1)
high-birefringent##4##1##(2008-2#4)
high-contrast##6##1##(1993-5#1)(2008-2#3)(2008-9#2)
high-copy##2##1##(1995-2#1)(1997-8#1)
high-cost##2##1##(1995-1#1)(1995-2#1)
high-degree##2##1##(2010-11#1)(2011-2#1)
high-density lipoprotein (HDL)##4##3##(1993-6#1)(2008-6#2)(2010-4#1)
high-density lipoprotein cholesterol##2##3##(2008-3#1)(2013-1#1)
high-density lipoprotein##13##2##(1993-6#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#4)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
high-density oligonucleotide microarrays were used to##2##6##(2008-10#1)(2009-12#1)
high-density##25##1##(1993-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#4)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
high-depositing ZnPTO shampoo##2##3##(2008-5#2)
high-dose chemotherapy##4##2##(1996-11#1)(2008-7#3)
high-dose##21##1##(1990-12#1)(1990-9#1)(1992-6#1)(1993-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(2008-12#1)(2008-7#4)(2008-8#1)(2010-10#2)(2010-11#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
high-efficiency double compound parabolic concentrator##2##5##(2013-8#2)
high-efficiency sample##3##2##(2008-10#3)
high-efficiency##8##1##(1991-6#1)(2008-10#3)(2008-2#1)(2010-7#1)(2013-8#2)
high-energy##12##1##(1990-12#1)(1992-12#1)(1993-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-4#1)
high-fat diet##2##2##(2010-12#1)(2010-7#1)
high-fat##5##1##(2008-4#1)(2010-12#2)(2010-7#1)(2012-2#1)
high-finesse optical##2##2##(2008-3#2)
high-finesse##3##1##(2008-3#3)
high-flow cerebral arteriovenous malformation##2##4##(2008-7#2)
high-flow cerebral arteriovenous##3##3##(2008-7#3)
high-flow##8##1##(2008-10#4)(2008-7#4)
high-frequency conductance##2##2##(2008-5#2)
high-frequency ultrasonic##2##2##(2012-3#2)
high-frequency ultrasound##2##2##(2009-5#1)(2012-3#1)
high-frequency##18##1##(1991-12#1)(1992-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#4)
high-grade glioma##2##2##(2013-1#2)
high-grade##21##1##(1994-12#1)(1997-1#2)(2008-10#3)(2008-12#1)(2010-12#1)(2011-2#6)(2012-12#2)(2013-1#5)
high-incidence group##2##2##(1997-3#2)
high-income##3##1##(2009-10#1)(2012-12#1)(2012-2#1)
high-intensity##6##1##(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#2)
high-level expression of##5##3##(1996-3#1)(2008-9#4)
high-level expression##8##2##(1996-3#1)(2008-11#1)(2008-8#2)(2008-9#4)
high-level production##2##2##(2008-11#1)(2008-7#1)
high-level resistance##2##2##(2008-10#2)
high-level##27##1##(1990-8#1)(1991-3#1)(1993-9#1)(1994-1#1)(1996-3#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#3)(2008-9#4)(2010-1#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
high-line##2##1##(2008-8#2)
high-mobility##2##1##(1997-6#1)(2010-5#1)
high-molecular##3##1##(1991-12#1)(2008-10#2)
high-molecular-weight##7##1##(1994-11#2)(2008-11#1)(2008-4#1)(2010-3#1)(2011-1#2)
high-mountain Mediterranean pastures##2##3##(2012-7#2)
high-mountain##3##1##(2012-7#3)
high-order##4##1##(2008-10#1)(2008-3#2)(2008-6#1)
high-performance anion-exchange chromatography##3##3##(1991-7#1)(2008-10#2)
high-performance capillary zone electrophoresis##2##4##(2008-10#2)
high-performance capillary##3##2##(1997-2#1)(2008-10#2)
high-performance liquid chromatographic determination of##3##5##(2008-10#3)
high-performance liquid chromatographic method for##2##5##(1997-2#1)(2008-10#1)
high-performance liquid chromatographic method##5##4##(1997-2#3)(2008-10#2)
high-performance liquid chromatographic##15##3##(1997-2#4)(2008-10#11)
high-performance liquid chromatography (HPLC) in##2##5##(2008-10#2)
high-performance liquid chromatography (HPLC) method with##2##6##(2008-10#2)
high-performance liquid chromatography (HPLC) method##3##5##(2008-10#3)
high-performance liquid chromatography (HPLC) with a photo-diode array detector##2##9##(2008-10#2)
high-performance liquid chromatography (HPLC) with a##4##6##(2008-10#4)
high-performance liquid chromatography (HPLC) with##7##5##(2008-10#7)
high-performance liquid chromatography (HPLC)##38##4##(1992-11#1)(1995-3#1)(2008-10#33)(2008-4#1)(2008-5#1)(2009-8#1)
high-performance liquid chromatography (RP-HPLC)##4##4##(2008-10#4)
high-performance liquid chromatography analysis##2##4##(2008-10#2)
high-performance liquid chromatography and##5##4##(1992-11#1)(1992-6#1)(2008-10#3)
high-performance liquid chromatography coupled with##3##5##(1995-11#1)(2008-10#2)
high-performance liquid chromatography on##2##4##(1997-2#1)(2008-10#1)
high-performance liquid chromatography using##2##4##(2008-10#2)
high-performance liquid chromatography with fluorescence detection and enhance mass spectrometric identification##2##11##(2008-10#2)
high-performance liquid chromatography with fluorescence detection and##3##7##(2008-10#3)
high-performance liquid chromatography with fluorescence detection##4##6##(2008-10#4)
high-performance liquid chromatography with##14##4##(1991-7#1)(1992-1#1)(1997-2#1)(2008-10#10)(2008-5#1)
high-performance liquid chromatography##103##3##(1991-12#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-6#2)(1994-3#1)(1995-11#1)(1995-3#1)(1997-2#6)(1997-3#1)(2008-10#79)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#3)
high-performance liquid chromatography/tandem electrospray ionization mass detector##2##7##(2008-10#2)
high-performance liquid##127##2##(1991-12#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-6#2)(1994-3#1)(1995-11#1)(1995-3#1)(1997-2#10)(1997-3#1)(2008-10#98)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#3)
high-performance liquid-chromatographic##2##2##(1997-2#1)(2008-10#1)
high-performance players##2##2##(2011-2#2)
high-performance thin layer##2##3##(2008-10#1)(2008-4#1)
high-performance thin-layer chromatography##2##3##(2008-10#1)(2012-2#1)
high-performance thin-layer##3##2##(2008-10#2)(2012-2#1)
high-performance##153##1##(1991-12#1)(1991-7#2)(1992-1#1)(1992-11#2)(1992-6#2)(1994-3#1)(1995-11#1)(1995-3#1)(1997-2#12)(1997-3#1)(2008-10#108)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#3)(2010-12#1)(2011-2#3)(2012-2#1)
high-power diode##2##2##(2008-3#2)
high-power laser##2##2##(2008-2#1)(2008-3#1)
high-power##16##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#11)(2010-1#1)
high-powered##2##1##(1995-2#1)(2012-2#1)
high-precision##3##1##(2008-10#3)
high-predation environments##5##2##(2008-8#5)
high-predation##6##1##(2008-8#6)
high-pressure liquid chromatography##3##3##(1990-5#1)(1991-3#1)(2008-5#1)
high-pressure liquid##4##2##(1990-5#1)(1991-3#1)(2008-10#1)(2008-5#1)
high-pressure##9##1##(1990-5#1)(1991-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-8#2)
high-pressure-temperature##2##1##(1995-6#2)
high-protein##2##1##(2008-3#2)
high-purity water##2##2##(2008-10#2)
high-purity##4##1##(2008-10#4)
high-quality and##2##2##(2008-5#1)(2009-12#1)
high-quality articles via an open-access online publishing model##3##8##(2010-12#3)
high-quality##32##1##(1991-2#1)(1993-12#2)(1995-6#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#4)(2010-6#1)(2010-9#1)(2011-2#2)(2013-1#3)(2013-8#1)
high-quality/low-cost##2##1##(2008-11#2)
high-rainfall##2##1##(2008-10#2)
high-reflection filters##2##2##(2008-3#2)
high-repetition-rate##3##1##(2007-12#1)(2008-3#2)
high-resolution (HR)##2##2##(2008-10#1)(2012-2#1)
high-resolution computed tomography (HRCT) and##2##5##(2011-2#2)
high-resolution computed tomography (HRCT)##3##4##(1991-12#1)(2011-2#2)
high-resolution fourier transform##2##3##(2008-3#2)
high-resolution images##2##2##(2007-12#1)(2010-9#1)
high-resolution##76##1##(1991-12#2)(1991-6#1)(1994-3#1)(1994-5#2)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#20)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#5)(2011-7#1)(2012-2#3)(2012-3#5)
high-risk alleles##2##2##(2012-12#2)
high-risk differentiated thyroid##2##3##(2013-1#2)
high-risk individuals and##2##3##(1997-1#1)(2011-2#1)
high-risk individuals##5##2##(1997-1#1)(2011-2#3)(2013-1#1)
high-risk patient##2##2##(1992-3#1)(2011-2#1)
high-risk patients##8##2##(1994-6#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
high-risk population##2##2##(1996-3#1)(2013-1#1)
high-risk sexual##3##2##(2013-1#3)
high-risk strategy##2##2##(1991-6#2)
high-risk##64##1##(1991-6#2)(1992-3#2)(1993-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-3#2)(1997-1#1)(2008-10#1)(2008-11#8)(2008-6#2)(2008-7#2)(2009-12#1)(2009-5#3)(2009-6#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#11)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#13)
high-school students##2##2##(2011-2#2)
high-sensitivity C-reactive protein (hs-CRP)##2##4##(2012-5#1)(2013-1#1)
high-sensitivity##8##1##(1997-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-5#1)(2013-1#1)
high-spectral-resolution##4##1##(2008-2#1)(2008-3#3)
high-speed gas##2##2##(2008-10#1)(2008-3#1)
high-speed modulation##3##2##(2007-11#3)
high-speed##18##1##(2007-11#4)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2009-7#1)(2011-2#3)(2011-3#1)(2012-3#1)
high-spin##3##1##(1994-5#1)(2008-10#2)
high-stakes##2##1##(2008-12#1)(2011-2#1)
high-strain-rate##2##1##(2012-2#2)
high-technology##4##1##(1991-9#1)(1993-3#1)(1994-3#1)(2011-2#1)
high-temperature H(2)O##2##2##(2008-2#1)(2008-3#1)
high-temperature superconductors##2##2##(1992-8#1)(1994-9#1)
high-temperature##15##1##(1990-12#1)(1992-8#1)(1994-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-8#1)(2011-2#1)
high-threat##2##1##(2008-10#2)
high-throughput method##2##2##(2010-11#1)(2013-8#1)
high-throughput methods##3##2##(2011-2#2)(2012-3#1)
high-throughput molecular##2##2##(2009-4#1)(2011-2#1)
high-throughput screening##7##2##(1997-6#1)(2008-10#4)(2011-3#1)(2013-1#1)
high-throughput sequencing##2##2##(2009-6#1)(2012-3#1)
high-throughput##40##1##(1994-3#1)(1997-6#1)(2008-10#8)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#3)(2009-6#1)(2009-7#3)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
high-titer##4##1##(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
high-value##3##1##(2008-10#2)(2008-11#1)
high-velocity##2##1##(2012-3#1)(2013-1#1)
high-voltage##4##1##(1991-12#2)(2008-11#1)(2012-2#1)
high-volume##3##1##(1994-12#1)(2008-10#2)
high-yield##3##1##(1992-11#1)(2008-3#1)(2008-4#1)
high-yielding##5##1##(2008-11#1)(2008-9#2)(2009-10#1)(2011-2#1)
higher (P &lt##2##3##(1995-12#1)(1996-12#1)
higher (p&lt##2##2##(2010-12#1)(2013-1#1)
higher DS##2##2##(2008-10#1)(2010-4#1)
higher accuracy##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
higher activity than##2##3##(1992-6#1)(2008-10#1)
higher activity##5##2##(1992-6#1)(2008-10#2)(2008-12#1)(2011-3#1)
higher affinities##2##2##(1990-11#1)(1995-11#1)
higher affinity for##3##3##(1992-6#1)(1995-11#1)(2008-10#1)
higher affinity##6##2##(1992-6#1)(1993-8#1)(1995-11#1)(2008-10#2)(2008-8#1)
higher after##2##2##(1991-12#1)(1995-5#1)
higher age##3##2##(1990-6#1)(2008-11#1)(2013-1#1)
higher aluminium hydroxo##2##3##(2008-10#2)
higher among##12##2##(1991-1#1)(1993-11#1)(1994-6#1)(1995-12#2)(1996-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
higher amongst##2##2##(2008-11#1)(2011-2#1)
higher amount of##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
higher amounts of##8##3##(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)
higher and more##2##3##(2010-8#1)(2011-2#1)
higher and the##2##3##(1995-12#1)(2008-10#1)
higher and##15##2##(1990-12#1)(1992-12#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2013-8#1)
higher antibody##2##2##(2008-11#1)(2008-9#1)
higher as##2##2##(2007-11#1)(2008-11#1)
higher at higher##2##3##(2008-10#1)(2008-8#1)
higher at##11##2##(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
higher average##4##2##(1993-1#1)(1996-3#1)(2008-11#2)
higher basic##2##2##(1993-8#1)(2008-10#1)
higher before##2##2##(2010-7#1)(2012-3#1)
higher blood##2##2##(1993-12#1)(2008-7#1)
higher body mass index##3##4##(2008-11#1)(2008-7#1)(2010-4#1)
higher body mass##4##3##(2008-11#1)(2008-7#1)(2010-4#1)(2012-2#1)
higher body##5##2##(2008-11#1)(2008-7#1)(2010-4#1)(2012-2#2)
higher by##4##2##(1996-5#1)(2008-10#3)
higher cell death rate##2##4##(2008-11#2)
higher cell##7##2##(1994-2#1)(2008-10#1)(2008-11#4)(2011-2#1)
higher cessation rates##2##3##(2008-11#2)
higher compared to those##2##4##(1994-8#1)(2011-1#1)
higher compared to##5##3##(1994-8#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)
higher compared with##2##3##(2008-10#1)(2008-8#1)
higher compared##7##2##(1994-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#1)
higher concentration of##8##3##(1992-6#1)(1994-12#1)(2008-10#1)(2008-11#3)(2008-8#1)(2011-1#1)
higher concentration##16##2##(1992-6#1)(1993-1#1)(1993-8#1)(1994-12#1)(2008-10#6)(2008-11#4)(2008-8#1)(2011-1#1)
higher concentrations in the##2##4##(2008-10#1)(2008-11#1)
higher concentrations in##6##3##(2008-10#3)(2008-11#1)(2010-11#2)
higher concentrations of the##2##4##(2008-10#1)(2008-5#1)
higher concentrations of##14##3##(1993-11#1)(1993-6#1)(1996-2#1)(2008-10#5)(2008-11#3)(2008-5#1)(2011-2#2)
higher concentrations than##3##3##(1994-3#1)(1997-3#1)(2008-11#1)
higher concentrations##36##2##(1991-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#14)(2008-11#5)(2008-5#1)(2008-8#1)(2009-6#1)(2010-11#2)(2011-2#2)
higher content of##3##3##(1994-2#1)(2008-10#2)
higher cost##2##2##(1990-9#1)(2008-8#1)
higher costs##3##2##(1992-3#1)(1993-12#1)(2008-11#1)
higher degree of##5##3##(1996-3#1)(2008-10#1)(2008-11#2)(2012-3#1)
higher degree##6##2##(1991-6#1)(1996-3#1)(2008-10#1)(2008-11#2)(2012-3#1)
higher densities##2##2##(2008-10#1)(2008-8#1)
higher density##2##2##(1994-8#1)(2008-7#1)
higher detection##3##2##(2008-10#2)(2013-8#1)
higher dilution##2##2##(2008-11#1)(2008-7#1)
higher disease##5##2##(2008-10#4)(2011-2#1)
higher dose of##4##3##(1991-7#1)(1996-12#1)(1997-4#1)(2012-3#1)
higher dose##11##2##(1990-2#1)(1991-6#1)(1991-7#1)(1994-2#1)(1994-5#1)(1996-12#1)(1997-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
higher doses are##2##3##(1991-2#1)(1994-9#1)
higher doses of##6##3##(1994-8#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#2)
higher doses##14##2##(1991-2#1)(1993-1#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#2)
higher during##3##2##(1995-11#1)(2008-11#2)
higher education and##2##3##(1992-1#1)(2008-11#1)
higher education in the##2##4##(2008-11#2)
higher education in##3##3##(2008-11#2)(2008-12#1)
higher education institutions##3##3##(2008-12#3)
higher education##27##2##(1991-1#2)(1992-1#1)(1994-2#1)(1995-3#1)(2008-11#9)(2008-12#13)
higher educational##5##2##(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#1)(2012-3#1)
higher effect than##2##3##(1994-11#1)(2008-10#1)
higher efficacy##2##2##(2008-8#1)(2013-1#1)
higher efficiency##5##2##(1993-2#1)(2008-10#2)(2008-6#1)(2011-2#1)
higher elastic##2##2##(2009-7#2)
higher enzyme##2##2##(2008-10#2)
higher ethanol##2##2##(2008-11#1)(2011-2#1)
higher eukaryotes##3##2##(2008-8#2)(2011-2#1)
higher eukaryotic##2##2##(1990-5#1)(2008-11#1)
higher excited##2##2##(2008-10#1)(2008-3#1)
higher expression levels##2##3##(1995-12#1)(2010-7#1)
higher expression##5##2##(1995-12#2)(1997-8#1)(2008-11#1)(2010-7#1)
higher extraction##3##2##(2008-10#2)(2011-2#1)
higher family functioning was associated with##2##6##(2013-1#2)
higher family functioning##3##3##(2013-1#3)
higher feed##2##2##(2008-11#2)
higher fitness##2##2##(2008-8#2)
higher for the##7##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-2#1)(2013-8#1)
higher for##32##2##(1992-12#2)(1993-2#1)(1995-1#2)(1995-12#1)(1996-12#2)(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2011-2#3)(2011-7#1)(2012-3#1)(2013-8#2)
higher fraction of##2##3##(1994-8#1)(2008-7#1)
higher frequencies##3##2##(1993-8#1)(2008-10#2)
higher frequency of##10##3##(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#5)
higher frequency##13##2##(1992-3#1)(1993-2#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#5)
higher genetic##2##2##(2008-10#1)(2011-2#1)
higher growth##3##2##(1990-8#1)(2008-11#1)(2008-9#1)
higher harmonics##3##2##(2008-10#2)(2008-3#1)
higher in Gbogbe than##2##4##(2008-10#2)
higher in group##2##3##(2008-12#1)(2009-6#1)
higher in inoculated##2##3##(2008-10#2)
higher in males than in females##2##6##(2008-11#1)(2010-8#1)
higher in men##2##3##(2011-2#1)(2013-8#1)
higher in old##2##3##(2008-7#2)
higher in patients with##7##4##(1990-8#1)(1992-12#1)(1993-11#1)(1994-12#1)(2010-4#1)(2013-1#2)
higher in patients##8##3##(1990-8#1)(1991-6#1)(1992-12#1)(1993-11#1)(1994-12#1)(2010-4#1)(2013-1#2)
higher in resistant##2##3##(2008-10#2)
higher in studies with mean##2##5##(2008-10#2)
higher in studies##4##3##(2008-10#4)
higher in the first##2##4##(2008-10#1)(2011-2#1)
higher in the production trial compared with##2##7##(2013-8#2)
higher in the##38##3##(1991-12#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1995-6#1)(1997-7#2)(2008-10#8)(2008-11#6)(2008-7#2)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
higher in those who##2##4##(2008-11#1)(2012-3#1)
higher in those##3##3##(2008-11#1)(2009-6#1)(2012-3#1)
higher in younger##2##3##(2011-2#1)(2012-3#1)
higher in##173##2##(1990-11#1)(1990-8#2)(1991-12#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-2#3)(1997-7#2)(1997-8#3)(2008-1#2)(2008-10#48)(2008-11#12)(2008-12#3)(2008-3#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-3#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#14)(2012-12#1)(2012-2#2)(2012-3#9)(2012-5#1)(2013-1#8)(2013-3#1)(2013-8#5)
higher incidence of##15##3##(1990-5#1)(1993-12#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
higher incidence##18##2##(1990-5#1)(1993-12#1)(1996-3#2)(1996-8#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
higher increase in##2##3##(1997-3#1)(2011-2#1)
higher infection##4##2##(2008-10#3)(2008-11#1)
higher initial##4##2##(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
higher inoculum##3##2##(2008-10#3)
higher insulin##2##2##(1994-11#1)(2008-7#1)
higher intensity of##5##3##(1995-12#1)(2008-7#2)(2010-4#1)(2013-1#1)
higher intensity##7##2##(1995-12#1)(2007-11#1)(2008-7#2)(2010-4#1)(2013-1#2)
higher level of care##2##4##(2008-10#1)(2013-8#1)
higher level of genetic##2##4##(2008-10#2)
higher level of##22##3##(1991-5#1)(1994-3#1)(1995-8#1)(1997-8#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
higher level##30##2##(1991-5#1)(1994-3#1)(1995-8#1)(1997-8#2)(2008-10#10)(2008-11#5)(2008-12#2)(2008-5#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
higher levels in##4##3##(1992-2#1)(1996-12#1)(2008-10#1)(2010-7#1)
higher levels of F##2##4##(2008-10#2)
higher levels of IFN-gamma##2##4##(1996-12#1)(2008-11#1)
higher levels of education##2##4##(2008-1#1)(2009-11#1)
higher levels of resource availability##2##5##(2008-8#2)
higher levels of##58##3##(1991-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-12#2)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#5)(2009-11#1)(2009-12#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
higher levels##73##2##(1991-1#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-2#1)(1996-12#3)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
higher lifetime##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
higher light##2##2##(2008-8#1)(2008-9#1)
higher lipophilicity##4##2##(2008-10#1)(2008-4#1)(2008-5#2)
higher maximal##2##2##(2008-11#2)
higher maximum##2##2##(2008-11#2)
higher mean age##3##3##(2008-10#1)(2013-8#2)
higher mean##9##2##(1991-12#1)(1993-11#1)(2008-10#3)(2008-7#1)(2013-1#1)(2013-8#2)
higher mechanical##2##2##(1997-3#1)(2008-10#1)
higher median##3##2##(1991-12#1)(1993-1#1)(2008-12#1)
higher moisture##2##2##(2008-10#1)(2010-4#1)
higher molecular weight##4##3##(1991-5#1)(1995-8#1)(2008-10#2)
higher molecular##5##2##(1991-12#1)(1991-5#1)(1995-8#1)(2008-10#2)
higher mortality##6##2##(1995-3#1)(2008-8#2)(2011-2#2)(2013-1#1)
higher multimers and##2##3##(1993-3#2)
higher number of##7##3##(2008-10#2)(2009-8#1)(2010-10#1)(2012-3#2)(2013-1#1)
higher numbers of##2##3##(2008-5#1)(2013-1#1)
higher odds##2##2##(2008-11#1)(2008-3#1)
higher on CTA##2##3##(2008-10#2)
higher on the##5##3##(1991-2#1)(2008-11#1)(2008-5#2)(2008-8#1)
higher on##10##2##(1991-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2012-9#1)
higher or##3##2##(2006-6#1)(2008-10#2)
higher order correlations##2##3##(2008-11#1)(2013-8#1)
higher order tracheae##2##3##(2007-12#2)
higher order##9##2##(1990-12#1)(2007-12#2)(2008-11#4)(2008-7#1)(2013-8#1)
higher organic##2##2##(2008-10#2)
higher organisms##2##2##(2008-11#1)(2013-8#1)
higher osmotic potential##2##3##(2008-9#1)(2012-7#1)
higher overall##2##2##(2008-6#1)(2013-8#1)
higher pH and##2##3##(1991-9#1)(2008-10#1)
higher pH##7##2##(1991-9#1)(2008-10#5)(2010-4#1)
higher peak##5##2##(1994-12#1)(2008-10#2)(2008-3#2)
higher penetration##2##2##(2008-5#2)
higher percent##4##2##(1995-12#1)(2008-10#2)(2008-6#1)
higher percentage of##12##3##(1991-2#1)(1993-6#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-10#1)(2013-8#1)
higher performance##2##2##(2008-10#1)(2008-3#1)
higher photostability##3##2##(2008-5#3)
higher plant plastocyanins##2##3##(1994-5#2)
higher plant##10##2##(1994-12#1)(1994-5#2)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-1#1)
higher plants##8##2##(1993-6#1)(1995-2#3)(2008-9#1)(2009-10#1)(2009-8#2)
higher potency##2##2##(1994-8#1)(1995-11#1)
higher power##3##2##(2008-10#1)(2008-12#1)(2010-2#1)
higher precision##2##2##(2008-10#2)
higher prevalence of##8##3##(1992-9#1)(1996-12#1)(2008-12#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
higher prevalence##9##2##(1990-2#1)(1992-9#1)(1996-12#1)(2008-12#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
higher probabilities of##2##3##(1995-2#1)(2009-7#1)
higher probability of##2##3##(1994-12#1)(2012-3#1)
higher production of##2##3##(2007-11#1)(2008-7#1)
higher productivity##4##2##(1991-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
higher proliferation##2##2##(2008-11#1)(2010-3#1)
higher proportion of children##2##4##(2008-2#2)
higher proportion of patients##2##4##(2011-2#1)(2012-3#1)
higher proportion of##16##3##(1990-3#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
higher proportions of##3##3##(2012-2#1)(2012-3#1)(2013-8#1)
higher proton translocation activity##2##4##(2008-8#2)
higher quality##6##2##(1992-11#1)(1992-3#1)(1993-2#1)(2008-10#1)(2008-11#1)(2011-1#1)
higher rate of##7##3##(1997-8#1)(2008-10#3)(2008-11#1)(2012-12#2)
higher rate##15##2##(1990-8#1)(1994-6#1)(1995-5#1)(1997-8#1)(2008-10#5)(2008-11#4)(2012-12#2)
higher rates of deaths##2##4##(2013-1#2)
higher rates of##12##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
higher rates than##2##3##(1995-2#1)(2012-12#1)
higher rates##17##2##(1995-2#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-12#2)(2012-2#2)(2013-1#3)
higher relative##6##2##(1991-12#1)(1992-12#1)(2008-10#2)(2008-11#1)(2012-7#1)
higher resistance to photoinhibition and##2##5##(2008-9#2)
higher resistance to##3##3##(2008-5#1)(2008-9#2)
higher resistance##5##2##(2008-5#1)(2008-9#2)(2012-3#1)(2013-8#1)
higher resolution and##2##3##(2008-10#1)(2012-2#1)
higher resolution##5##2##(2007-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
higher response##3##2##(1991-3#1)(2008-10#2)
higher results##2##2##(2008-10#1)(2011-2#1)
higher risk for##7##3##(1991-2#1)(1992-2#1)(1993-1#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
higher risk of developing##5##4##(2008-12#2)(2008-8#2)(2012-3#1)
higher risk of##19##3##(1993-3#1)(1995-2#1)(1996-11#1)(1996-6#1)(1996-9#1)(2008-12#2)(2008-8#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
higher risk##31##2##(1991-2#1)(1992-2#2)(1993-1#1)(1993-3#1)(1995-2#1)(1996-11#1)(1996-6#1)(1996-9#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-8#3)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
higher scale##2##2##(2008-10#2)
higher scores for##2##3##(2008-8#1)(2013-1#1)
higher scores on the##2##4##(2008-12#1)(2012-5#1)
higher scores##6##2##(2008-12#1)(2008-8#1)(2009-4#1)(2012-5#1)(2013-1#2)
higher selectivity for##2##3##(2008-10#2)
higher selectivity##3##2##(2008-10#3)
higher sensitivities##2##2##(2008-10#2)
higher sensitivity and##4##3##(2008-10#4)
higher sensitivity for##2##3##(1995-2#1)(2008-7#1)
higher sensitivity in##3##3##(2008-11#1)(2011-2#2)
higher sensitivity of##5##3##(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)
higher sensitivity than##2##3##(2008-10#1)(2008-11#1)
higher sensitivity to##2##3##(2008-10#2)
higher sensitivity##22##2##(1995-2#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
higher serum##4##2##(1990-8#1)(2008-11#1)(2011-1#1)(2012-3#1)
higher socioeconomic##2##2##(2008-10#1)(2012-3#1)
higher soil##2##2##(1995-3#1)(2011-1#1)
higher specific production rate of##2##5##(2008-11#1)(2011-2#1)
higher specific##6##2##(1997-2#1)(2008-11#4)(2011-2#1)
higher speeds##2##2##(1997-2#1)(2011-2#1)
higher stability##4##2##(2008-10#2)(2008-2#1)(2008-4#1)
higher surface##2##2##(2008-10#2)
higher susceptibility##2##2##(2007-8#1)(2011-2#1)
higher temperatures##13##2##(2008-10#11)(2008-6#1)(2012-5#1)
higher than 0##14##3##(1992-9#1)(2008-10#10)(2010-4#1)(2013-8#2)
higher than 1##5##3##(2008-10#3)(2008-3#1)(2010-1#1)
higher than 301 variety##3##4##(2008-12#3)
higher than 301##6##3##(2008-12#6)
higher than 5##2##3##(2008-10#1)(2009-2#1)
higher than 60##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
higher than 7##2##3##(1990-3#1)(2008-10#1)
higher than 90%##4##3##(2008-10#3)(2008-11#1)
higher than at##2##3##(1993-3#1)(2013-8#1)
higher than control##5##3##(1997-3#1)(2008-11#2)(2008-12#1)(2009-11#1)
higher than dominants only##2##4##(1992-1#2)
higher than expected##3##3##(1990-5#1)(2008-10#2)
higher than for##5##3##(1993-1#1)(2008-8#1)(2008-9#2)(2011-2#1)
higher than in the control##2##5##(2008-10#1)(2011-2#1)
higher than in the##8##4##(1994-11#1)(1996-11#1)(1997-8#1)(2008-10#3)(2008-7#1)(2011-2#1)
higher than in##37##3##(1990-11#2)(1991-5#1)(1992-8#1)(1994-11#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-7#2)(2008-9#2)(2010-3#2)(2011-2#3)(2012-3#1)(2013-1#1)
higher than normal##4##3##(1991-12#1)(2008-1#1)(2008-5#1)(2013-1#1)
higher than other##5##3##(2008-10#3)(2008-2#1)(2010-7#1)
higher than previously##3##3##(2008-10#2)(2008-12#1)
higher than that for the##3##5##(1997-7#1)(2008-2#1)(2008-8#1)
higher than that for##5##4##(1997-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
higher than that in Xieyou 63##2##6##(2008-9#2)
higher than that in the##2##5##(1994-12#1)(2008-11#1)
higher than that in##9##4##(1993-8#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-9#2)
higher than that of a##2##5##(2008-10#2)
higher than that of normal control##2##6##(2011-3#2)
higher than that of normal##4##5##(2008-5#1)(2008-8#1)(2011-3#2)
higher than that of the##12##5##(1994-11#1)(1994-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2011-3#1)
higher than that of##41##4##(1990-2#1)(1991-5#1)(1991-8#1)(1992-8#1)(1994-11#1)(1994-8#1)(1997-8#1)(2008-10#13)(2008-11#4)(2008-5#2)(2008-8#3)(2008-9#3)(2009-7#2)(2010-3#2)(2011-2#2)(2011-3#3)
higher than that on the##2##5##(2008-11#2)
higher than that reported##2##4##(2008-10#1)(2012-12#1)
higher than that using a serum-supplemented medium on untreated dishes##2##10##(2008-11#2)
higher than that##80##3##(1990-2#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#24)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#7)(2008-9#6)(2009-7#2)(2010-3#2)(2011-2#2)(2011-3#4)(2012-12#1)
higher than the SGD group##2##5##(2013-8#2)
higher than the control##3##4##(2008-8#2)(2009-10#1)
higher than the conventional##2##4##(2008-11#1)(2008-7#1)
higher than the critical##2##4##(2008-11#1)(2008-7#1)
higher than the limit of##2##5##(2008-10#1)(2011-2#1)
higher than the maximum##2##4##(2008-10#1)(2008-12#1)
higher than the mean##2##4##(2011-1#1)(2011-2#1)
higher than the national average##3##5##(2008-10#3)
higher than the threshold##2##4##(2008-10#1)(2011-2#1)
higher than the##64##3##(1990-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-2#1)(1996-11#1)(2007-11#1)(2008-10#17)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
higher than those for##3##4##(1992-3#1)(2008-10#1)(2008-9#1)
higher than those from##3##4##(2008-11#3)
higher than those in the##5##5##(1990-5#1)(1994-3#1)(2008-10#2)(2011-2#1)
higher than those in##11##4##(1990-5#1)(1993-3#1)(1994-3#1)(1995-8#2)(2008-10#3)(2008-11#2)(2011-2#1)
higher than those obtained with##2##5##(2008-10#2)
higher than those obtained##5##4##(2008-10#4)(2008-11#1)
higher than those of the##3##5##(1993-8#1)(2008-10#1)(2011-1#1)
higher than those of##21##4##(1992-1#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)
higher than those with##2##4##(2008-10#2)
higher than those##56##3##(1990-5#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-3#2)(1992-6#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-8#2)(1997-8#1)(2008-10#20)(2008-11#10)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
higher than when the##2##4##(1995-5#1)(2008-10#1)
higher than with##3##3##(2008-10#2)(2011-1#1)
higher than##399##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1991-12#1)(1991-3#2)(1991-5#4)(1991-8#1)(1992-1#3)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#6)(1993-6#2)(1993-8#4)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#3)(2007-11#1)(2008-1#1)(2008-10#132)(2008-11#41)(2008-12#19)(2008-2#3)(2008-3#10)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#12)(2008-9#15)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#5)(2010-4#1)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#13)(2011-3#4)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#2)(2013-1#4)(2013-8#7)
higher the##12##2##(1991-2#1)(1991-5#1)(1993-11#1)(1993-8#1)(1996-1#1)(2008-10#4)(2008-5#1)(2012-2#1)(2013-8#1)
higher then control##3##3##(2008-12#3)
higher throughput##2##2##(2007-11#1)(2012-2#1)
higher tissue##2##2##(1993-11#1)(1993-12#1)
higher tobacco##2##2##(2009-7#1)(2010-11#1)
higher total##10##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
higher treatment##2##2##(2008-7#1)(2010-12#1)
higher trophic levels##3##3##(2008-8#2)(2008-9#1)
higher tumor##2##2##(2011-2#1)(2013-1#1)
higher under elevated##2##3##(2008-10#2)
higher under##5##2##(1991-12#1)(1991-5#1)(2008-10#3)
higher use of drugs##2##4##(1996-6#2)
higher utilization##2##2##(1995-3#1)(2010-5#1)
higher value##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
higher values##7##2##(2008-10#4)(2008-5#3)
higher vertebrates##2##2##(2008-7#2)
higher water content##2##3##(2008-10#1)(2008-5#1)
higher water##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
higher when the##4##3##(1991-3#1)(2008-6#1)(2009-5#1)(2012-2#1)
higher when##10##2##(1991-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#2)
higher with the##2##3##(2008-11#1)(2013-8#1)
higher with##14##2##(1992-12#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-8#1)
higher yield##3##2##(2008-10#2)(2008-9#1)
higher yields##4##2##(1996-5#1)(2008-10#1)(2008-11#2)
higher##1984##1##(1990-11#5)(1990-12#7)(1990-2#6)(1990-3#2)(1990-5#6)(1990-6#2)(1990-8#6)(1990-9#2)(1991-1#4)(1991-12#11)(1991-2#8)(1991-3#4)(1991-5#10)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#6)(1992-11#2)(1992-12#12)(1992-2#6)(1992-3#13)(1992-5#1)(1992-6#6)(1992-8#6)(1992-9#5)(1993-1#11)(1993-11#9)(1993-12#12)(1993-2#15)(1993-3#12)(1993-6#11)(1993-8#12)(1994-1#1)(1994-11#11)(1994-12#11)(1994-2#9)(1994-3#6)(1994-5#4)(1994-6#5)(1994-8#10)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#12)(1995-2#13)(1995-3#5)(1995-5#3)(1995-6#3)(1995-8#5)(1996-1#4)(1996-11#3)(1996-12#14)(1996-2#6)(1996-3#6)(1996-5#2)(1996-6#6)(1996-8#2)(1996-9#1)(1997-2#12)(1997-3#5)(1997-4#1)(1997-5#4)(1997-7#3)(1997-8#15)(2006-5#1)(2006-6#1)(2007-11#6)(2007-12#4)(2007-8#2)(2008-1#7)(2008-10#532)(2008-11#196)(2008-12#65)(2008-2#8)(2008-3#29)(2008-4#5)(2008-5#43)(2008-6#11)(2008-7#68)(2008-8#74)(2008-9#61)(2009-1#2)(2009-10#9)(2009-11#3)(2009-12#8)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#6)(2009-6#6)(2009-7#13)(2009-8#9)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#6)(2010-12#10)(2010-2#1)(2010-3#7)(2010-4#13)(2010-5#3)(2010-6#3)(2010-7#9)(2010-8#10)(2010-9#1)(2011-1#19)(2011-10#1)(2011-2#109)(2011-3#5)(2011-7#2)(2012-12#11)(2012-2#24)(2012-3#38)(2012-5#5)(2012-6#3)(2012-7#3)(2012-9#2)(2013-1#59)(2013-3#1)(2013-8#45)
higher)##5##1##(2008-10#3)(2008-5#1)(2012-2#1)
higher-order Stokes##2##2##(2007-12#2)
higher-order correlation properties##2##3##(2008-11#2)
higher-order correlation##4##2##(2008-11#4)
higher-order modes##2##2##(2007-12#1)(2008-3#1)
higher-order##16##1##(2007-12#3)(2008-11#5)(2008-2#2)(2008-3#4)(2008-4#1)(2009-8#1)
higher-quality##3##1##(2008-8#2)(2011-7#1)
highest accuracy##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
highest activity##4##2##(1994-8#1)(2008-12#1)(2009-6#1)(2013-1#1)
highest among the##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
highest among##7##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
highest amount##3##2##(2008-5#2)(2013-1#1)
highest and##6##2##(2008-10#3)(2008-12#1)(2008-7#1)(2012-3#1)
highest at##7##2##(2008-10#5)(2011-2#1)(2013-1#1)
highest concentration of##6##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
highest concentration##10##2##(1990-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2013-1#1)
highest concentrations##3##2##(1997-1#1)(2008-12#1)(2009-5#1)
highest dose##8##2##(1993-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-2#2)(2013-8#1)
highest during the first##2##4##(2008-11#1)(2008-7#1)
highest during##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
highest enzyme##2##2##(2008-10#1)(2011-2#1)
highest for##4##2##(1993-1#1)(2008-10#2)(2008-9#1)
highest frequency##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
highest in U##2##3##(2009-7#2)
highest in the##18##3##(1990-9#1)(1993-3#1)(1996-12#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-9#1)(2010-10#1)(2013-3#1)(2013-8#1)
highest in##45##2##(1990-8#1)(1990-9#1)(1993-3#1)(1995-8#1)(1996-12#3)(2008-10#13)(2008-11#6)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#4)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-3#1)(2013-8#1)
highest incidence of##5##3##(1990-3#1)(1994-9#1)(2008-10#1)(2008-11#2)
highest incidence##8##2##(1990-3#1)(1991-11#1)(1994-9#2)(1996-12#1)(2008-10#1)(2008-11#2)
highest irritation##2##2##(2008-5#2)
highest level of##9##3##(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#2)(2010-3#1)
highest level##12##2##(1993-3#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#2)(2010-3#1)
highest levels in##2##3##(2008-8#1)(2008-9#1)
highest levels of##13##3##(1993-6#1)(1993-8#1)(1995-12#1)(1997-1#1)(2008-10#8)(2009-7#1)
highest levels##19##2##(1993-6#1)(1993-8#1)(1995-12#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
highest mortality##2##2##(1992-5#1)(2013-1#1)
highest nucleotide##5##2##(2008-10#4)(2013-8#1)
highest number of##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
highest number##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)
highest numbers of##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
highest on##4##2##(1993-2#1)(1993-3#1)(2008-5#1)(2012-5#1)
highest percentage of##3##3##(1994-11#1)(1996-12#1)(2008-10#1)
highest percentage##6##2##(1994-11#1)(1996-12#1)(2008-10#2)(2012-7#1)(2013-1#1)
highest priority##2##2##(2012-12#1)(2012-2#1)
highest production##4##2##(2008-11#4)
highest proportion of##2##3##(1996-12#1)(2008-9#1)
highest proportion##4##2##(1996-12#1)(2008-9#1)(2013-8#2)
highest rate##7##2##(1997-8#1)(2006-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
highest risk of developing##2##4##(1996-6#1)(2011-2#1)
highest risk of##5##3##(1996-5#1)(1996-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
highest risk##11##2##(1991-6#1)(1996-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
highest selectivity##3##2##(2008-10#3)
highest sensitivity##11##2##(2008-10#9)(2008-11#1)(2012-2#1)
highest susceptibility to##2##3##(2008-10#1)(2009-6#1)
highest total##3##2##(1996-12#1)(2008-9#1)(2011-2#1)
highest value##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
highest values of##3##3##(2008-10#2)(2008-7#1)
highest values##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
highest with##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
highest µSBS##2##2##(2013-1#2)
highest##484##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#9)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#3)(2006-6#1)(2008-1#2)(2008-10#170)(2008-11#33)(2008-12#25)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#21)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#20)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#4)(2009-7#7)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#23)(2012-12#3)(2012-2#10)(2012-3#7)(2012-5#1)(2012-7#1)(2013-1#25)(2013-3#1)(2013-8#14)
highland##2##1##(2008-10#2)
highlands of##5##2##(2008-10#3)(2011-2#2)
highlands##8##1##(2008-10#6)(2011-2#2)
highlight a##4##2##(2008-10#1)(2012-2#2)(2013-1#1)
highlight how##2##2##(2008-8#1)(2008-9#1)
highlight recent##2##2##(1992-12#1)(2010-7#1)
highlight some##3##2##(1996-11#1)(2008-11#1)(2012-3#1)
highlight that##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
highlight the importance of##8##4##(1990-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
highlight the need for further##2##5##(2013-1#2)
highlight the need for##7##4##(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#3)
highlight the need to##3##4##(1991-12#1)(2008-10#1)(2012-12#1)
highlight the need##10##3##(1991-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#3)
highlight the potential role of##2##5##(1993-3#1)(2013-8#1)
highlight the potential##3##3##(1993-3#1)(2013-1#1)(2013-8#1)
highlight the promise of##2##4##(2012-2#1)(2013-1#1)
highlight the role of##3##4##(1997-5#1)(2009-9#1)(2013-1#1)
highlight the value of##2##4##(2008-7#1)(2012-3#1)
highlight the##57##2##(1990-5#1)(1991-12#1)(1992-10#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-5#1)(2006-6#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#3)
highlight##96##1##(1990-5#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-5#1)(2006-6#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#12)(2013-8#3)
highlighted as an example of the##2##6##(2008-10#1)(2010-12#1)
highlighted as an##3##3##(2008-10#2)(2010-12#1)
highlighted as##6##2##(2008-10#3)(2008-11#2)(2010-12#1)
highlighted by the##5##3##(2008-1#1)(2008-11#1)(2009-4#1)(2010-5#1)(2013-1#1)
highlighted by##6##2##(2008-1#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-5#1)(2013-1#1)
highlighted in a##2##3##(1990-2#1)(2008-11#1)
highlighted in the literature##2##4##(2008-11#1)(2013-1#1)
highlighted in the##5##3##(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)(2013-7#1)
highlighted in##7##2##(1990-2#1)(2008-10#1)(2008-11#2)(2010-7#1)(2013-1#1)(2013-7#1)
highlighted that##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2013-8#1)
highlighted the importance of##3##4##(2008-11#2)(2009-8#1)
highlighted the##19##2##(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
highlighted with##2##2##(2008-11#1)(2010-2#1)
highlighted##95##1##(1990-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-6#1)(2008-1#2)(2008-10#13)(2008-11#19)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
highlighting the need for##3##4##(1997-6#1)(2008-10#1)(2008-9#1)
highlighting the need##4##3##(1997-6#1)(2008-10#2)(2008-9#1)
highlighting the##9##2##(1997-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
highlighting##24##1##(1993-3#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#4)
highlights a##5##2##(2008-12#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
highlights of the##3##3##(1997-7#1)(2009-5#1)(2010-4#1)
highlights of##4##2##(1997-7#1)(2009-5#1)(2010-4#1)(2013-1#1)
highlights several##2##2##(1997-2#1)(2013-1#1)
highlights some of the##4##4##(1997-2#1)(2008-11#1)(2010-7#1)(2013-1#1)
highlights some##7##2##(1997-2#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
highlights that##3##2##(2008-11#1)(2008-12#1)(2012-3#1)
highlights the importance of early##2##5##(2008-11#1)(2013-1#1)
highlights the importance of##8##4##(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-3#1)(2013-1#1)
highlights the most##2##3##(1996-12#1)(2011-2#1)
highlights the need for##5##4##(2008-10#1)(2008-11#2)(2010-7#1)(2011-2#1)
highlights the need to##2##4##(2008-5#1)(2013-1#1)
highlights the need##7##3##(2008-10#1)(2008-11#2)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
highlights the role of##2##4##(1992-9#1)(2011-2#1)
highlights the##48##2##(1992-12#1)(1992-9#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#2)(2008-5#2)(2008-7#2)(2009-3#2)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#6)(2012-3#1)(2013-1#3)(2013-8#2)
highlights their##2##2##(1993-12#1)(2013-1#1)
highlights##99##1##(1992-12#1)(1992-9#1)(1993-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#15)(2008-12#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2011-2#11)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#3)
highly absorbing##3##2##(2008-10#2)(2008-3#1)
highly abundant##2##2##(1990-12#1)(1997-6#1)
highly acceptable##3##2##(1994-12#1)(1994-2#1)(2008-11#1)
highly accurate##4##2##(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)
highly acidic##4##2##(1990-5#1)(2008-10#2)(2008-12#1)
highly active anti-retroviral therapy##2##4##(2008-1#2)
highly active antiretroviral therapy (HAART)##4##5##(2009-7#1)(2010-5#1)(2011-2#2)
highly active antiretroviral therapy##6##4##(2008-10#1)(2009-7#1)(2010-5#1)(2011-2#3)
highly active##14##2##(1990-3#1)(2008-1#2)(2008-10#3)(2008-4#1)(2009-7#1)(2010-5#2)(2011-2#3)(2012-2#1)
highly aggressive##10##2##(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#2)
highly aligned alliances##4##3##(2013-1#4)
highly aligned##6##2##(2007-12#1)(2013-1#5)
highly and weakly##2##3##(2008-10#2)
highly and##4##2##(2008-10#3)(2008-11#1)
highly asymmetrical##3##2##(1991-2#1)(1993-3#1)(2012-3#1)
highly cellular##2##2##(2008-12#1)(2011-2#1)
highly charged##5##2##(1991-12#1)(1991-5#1)(1995-6#2)(1997-2#1)
highly chlorinated biphenyls##3##3##(1993-12#3)
highly chlorinated##4##2##(1993-12#4)
highly competitive##2##2##(1992-11#1)(2008-7#1)
highly complex##8##2##(2008-10#1)(2008-11#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
highly complicated##2##2##(2009-10#1)(2012-3#1)
highly concentrated##8##2##(2008-10#6)(2008-9#1)(2011-2#1)
highly conserved among##4##3##(1993-3#1)(1994-11#1)(2008-10#2)
highly conserved and##5##3##(1994-11#1)(1997-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
highly conserved between the##2##4##(1991-6#1)(2012-2#1)
highly conserved during##2##3##(1992-12#1)(2008-9#1)
highly conserved in##3##3##(1995-2#1)(1997-9#1)(2008-10#1)
highly conserved region##3##3##(1994-11#1)(1994-5#1)(2008-10#1)
highly conserved regions of##2##4##(1995-2#1)(1995-6#1)
highly conserved regions##3##3##(1991-6#1)(1995-2#1)(1995-6#1)
highly conserved throughout evolution##2##4##(1993-12#1)(2012-2#1)
highly conserved throughout##3##3##(1993-12#1)(1997-7#1)(2012-2#1)
highly conserved##62##2##(1991-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#3)(1995-6#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#3)(2008-10#13)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
highly controversial##4##2##(1991-8#1)(1994-1#2)(1995-1#1)
highly convergent##2##2##(2008-7#2)
highly correlated to the##2##4##(1990-2#1)(1990-8#1)
highly correlated to##3##3##(1990-2#1)(1990-8#1)(2008-10#1)
highly correlated with C levels##2##5##(2008-9#2)
highly correlated with their##2##4##(1995-11#1)(2008-10#1)
highly correlated with##11##3##(1995-11#1)(2008-1#1)(2008-10#5)(2008-9#3)(2011-9#1)
highly correlated##24##2##(1990-2#1)(1990-5#1)(1990-8#1)(1995-11#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#3)(2010-10#1)(2011-9#1)
highly dependent on the##7##4##(1990-2#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
highly dependent on##9##3##(1990-2#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
highly dependent##10##2##(1990-2#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
highly desirable##8##2##(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
highly differentiated SNPs##2##3##(2013-1#2)
highly differentiated##7##2##(1990-9#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-1#2)
highly divergent##2##2##(1995-6#1)(2008-10#1)
highly diverse low-PDT##2##3##(2008-12#2)
highly diverse##6##2##(2008-10#3)(2008-12#2)(2008-9#1)
highly dynamic but confined##2##4##(2012-2#2)
highly dynamic##5##2##(2008-8#1)(2009-6#1)(2010-8#1)(2012-2#2)
highly effective and##4##3##(1995-5#1)(2008-10#3)
highly effective in limiting##2##4##(2008-10#1)(2008-5#1)
highly effective in##6##3##(2008-10#4)(2008-5#2)
highly effective treatment##2##3##(2012-3#1)(2013-1#1)
highly effective##22##2##(1991-2#1)(1993-12#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#9)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
highly efficacious##2##2##(2008-11#1)(2011-2#1)
highly efficient##20##2##(1993-2#1)(1994-5#1)(1996-5#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#1)(2012-3#1)
highly elevated##2##2##(1992-3#1)(2008-11#1)
highly emetogenic chemotherapy##2##3##(2008-7#1)(2010-12#1)
highly endemic area##2##3##(1995-12#1)(2013-8#1)
highly enriched##2##2##(1993-8#1)(2008-7#1)
highly expressed in a##2##4##(1994-8#1)(2011-2#1)
highly expressed in cancer cells##2##5##(2008-8#1)(2011-2#1)
highly expressed in leaf##2##4##(2013-8#2)
highly expressed in the##5##4##(1993-3#1)(1993-8#1)(1995-8#1)(2008-11#1)(2010-12#1)
highly expressed in##22##3##(1993-3#1)(1993-8#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-11#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#2)(2011-2#3)(2012-3#1)(2013-8#4)
highly expressed##32##2##(1993-3#2)(1993-8#1)(1994-8#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-9#1)(2008-11#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#2)(2010-5#1)(2011-2#4)(2012-3#1)(2013-8#4)
highly expressing recombinant##2##3##(2008-11#2)
highly flexible and adaptive##2##4##(1994-12#1)(2008-10#1)
highly flexible##4##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
highly fluorescent##5##2##(2008-10#4)(2010-4#1)
highly fragmented##2##2##(2008-8#1)(2012-3#1)
highly heritable##2##2##(2008-8#1)(2012-3#1)
highly heterogeneous##5##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-8#1)
highly homogeneous##2##2##(2008-10#1)(2012-3#1)
highly homologous to that of the##2##6##(1991-9#1)(1994-11#1)
highly homologous to the##5##4##(1991-6#1)(1993-12#1)(1993-6#1)(2008-8#2)
highly homologous to##11##3##(1991-6#1)(1991-9#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-8#2)
highly homologous##23##2##(1990-5#2)(1991-6#1)(1991-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-8#2)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)
highly hydrophobic##3##2##(2008-10#1)(2008-8#1)(2009-9#1)
highly identical##2##2##(1993-12#1)(2010-5#1)
highly immunogenic in##2##3##(1995-5#1)(2009-6#1)
highly immunogenic##4##2##(1995-5#3)(2009-6#1)
highly important##2##2##(1991-5#1)(2012-2#1)
highly increased in##3##3##(1993-3#1)(1993-8#1)(2011-10#1)
highly increased##4##2##(1993-3#1)(1993-8#1)(1995-12#1)(2011-10#1)
highly individualized##2##2##(2008-8#1)(2009-10#1)
highly induced##2##2##(1995-11#1)(2008-10#1)
highly infectious##4##2##(1997-3#1)(2008-10#2)(2012-2#1)
highly interrelated##2##2##(1997-1#1)(2011-2#1)
highly invasive##3##2##(1990-6#1)(1997-3#1)(2008-11#1)
highly linear##2##2##(2008-10#2)
highly localized##3##2##(2008-10#2)(2008-8#1)
highly luminescent##2##2##(2008-10#2)
highly malignant##2##2##(1993-8#1)(2008-11#1)
highly metastatic##3##2##(1997-7#1)(2008-8#1)(2008-9#1)
highly mobile##2##2##(2008-9#1)(2011-2#1)
highly motivated##2##2##(1995-11#1)(2008-11#1)
highly ordered##2##2##(2008-5#1)(2008-8#1)
highly organized##2##2##(2007-12#1)(2009-10#1)
highly oriented##3##2##(2007-12#1)(2008-8#1)(2010-4#1)
highly overlapping##2##2##(2008-10#1)(2008-11#1)
highly pathogenic##6##2##(2008-10#5)(2011-3#1)
highly penicillin- or cephalosporin-resistant strains##2##5##(2011-2#2)
highly phosphorylated when expressed alone in COS-1 cells##2##8##(1995-2#2)
highly phosphorylated##7##2##(1995-2#3)(1995-6#2)(1995-8#1)(2010-12#1)
highly pleasurable foods##2##3##(2012-2#2)
highly pleasurable##3##2##(2012-2#3)
highly polar##2##2##(2008-10#1)(2008-11#1)
highly polarized##2##2##(1992-10#1)(2012-2#1)
highly polymorphic##7##2##(1995-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#2)
highly predictive of##2##3##(2008-10#1)(2008-6#1)
highly predictive##6##2##(1993-11#1)(2008-10#2)(2008-6#1)(2009-3#1)(2013-1#1)
highly prevalent##8##2##(2008-12#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#3)(2013-1#1)
highly productive##7##2##(2008-10#1)(2008-11#5)(2010-12#1)
highly promising##3##2##(1997-6#1)(2008-10#2)
highly pure##2##2##(2008-11#1)(2008-9#1)
highly purified and functional##2##4##(2008-2#2)
highly purified from##4##3##(1990-5#1)(1993-3#1)(2008-9#2)
highly purified##12##2##(1990-5#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-8#1)(2008-2#2)(2008-7#1)(2008-9#3)
highly qualified##2##2##(2008-10#1)(2008-11#1)
highly quantitative##2##2##(2008-10#1)(2008-11#1)
highly reactive##9##2##(1992-3#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-9#1)(2010-11#1)
highly reduced##2##2##(1991-6#1)(2008-10#1)
highly refined##2##2##(1994-5#1)(2011-2#1)
highly regulated##3##2##(2008-7#1)(2009-10#1)(2009-8#1)
highly related##3##2##(1992-3#1)(1996-2#1)(1997-6#1)
highly relevant##2##2##(2008-10#1)(2008-3#1)
highly reliable and##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
highly reliable##5##2##(2008-10#3)(2011-2#1)(2012-2#1)
highly repetitive##2##2##(2008-10#2)
highly reproducible and##2##3##(2008-10#2)
highly reproducible##14##2##(1995-12#1)(1995-3#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
highly resistant lines##2##3##(2008-10#2)
highly resistant to bacterial blight##2##5##(2008-8#1)(2009-10#1)
highly resistant to the fungicide##2##5##(2008-10#2)
highly resistant to##17##3##(2008-10#9)(2008-11#1)(2008-8#3)(2009-10#1)(2011-2#3)
highly resistant##32##2##(2008-10#22)(2008-11#1)(2008-8#3)(2009-10#1)(2011-2#4)(2013-1#1)
highly satisfactory##2##2##(2008-10#1)(2008-7#1)
highly selected##2##2##(2011-2#2)
highly selective and sensitive##10##4##(2008-10#8)(2008-12#2)
highly selective and##13##3##(2008-10#11)(2008-12#2)
highly selective determination of##2##4##(2008-10#2)
highly selective for##7##3##(1990-8#1)(1991-7#1)(1994-12#1)(2008-10#3)(2010-1#1)
highly selective to##5##3##(2008-10#5)
highly selective##52##2##(1990-8#1)(1991-7#1)(1994-12#1)(1996-2#1)(1996-5#1)(2008-10#43)(2008-12#2)(2008-7#1)(2010-1#1)
highly sensitive and selective method##3##5##(2008-10#3)
highly sensitive and selective##13##4##(2008-10#13)
highly sensitive and specific##2##4##(2008-10#2)
highly sensitive and##23##3##(1994-11#1)(2008-10#21)(2008-3#1)
highly sensitive detection of##3##4##(2008-10#3)
highly sensitive detection##7##3##(2008-10#5)(2008-3#1)(2010-7#1)
highly sensitive method for the determination of##2##7##(2008-10#2)
highly sensitive method##3##3##(2008-10#3)
highly sensitive optical##3##3##(2008-10#3)
highly sensitive to the##2##4##(2008-3#2)
highly sensitive to##12##3##(1992-4#1)(1997-7#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)
highly sensitive##104##2##(1992-12#1)(1992-4#1)(1994-11#1)(1995-8#1)(1997-7#1)(2008-10#78)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
highly significant (P &lt##5##4##(2008-10#5)
highly significant (P##7##3##(2008-10#7)
highly significant in the##2##4##(2008-10#1)(2010-3#1)
highly significant reduction##2##3##(2012-2#2)
highly significant relationship between##2##4##(2008-10#1)(2008-8#1)
highly significant##36##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-6#1)(1993-2#1)(1994-2#1)(1994-3#1)(2008-10#16)(2008-5#2)(2008-8#3)(2010-3#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
highly similar sequences##2##3##(1995-2#1)(2008-4#1)
highly similar to##3##3##(1995-6#1)(2008-10#2)
highly similar##8##2##(1991-6#1)(1995-2#1)(1995-6#1)(2008-10#3)(2008-4#1)(2012-2#1)
highly social species##2##3##(2008-8#1)(2008-9#1)
highly soluble##2##2##(1997-1#1)(2008-5#1)
highly specialized##8##2##(1991-1#1)(1997-4#1)(2008-10#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)
highly specific and sensitive##2##4##(1997-3#1)(2008-10#1)
highly specific and##5##3##(1997-3#1)(2008-10#3)(2009-6#1)
highly specific for##5##3##(1990-12#1)(1990-2#1)(1996-2#1)(2008-10#1)(2008-4#1)
highly specific to##2##3##(2008-10#2)
highly specific##28##2##(1990-12#1)(1990-2#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
highly stable in##2##3##(2008-10#2)
highly stable##7##2##(2008-10#5)(2008-3#1)(2009-8#1)
highly strained##2##2##(1990-8#2)
highly structured##3##2##(1997-4#1)(2008-9#1)(2013-8#1)
highly substituted##2##2##(1996-5#1)(2008-10#1)
highly successful##3##2##(1992-2#1)(1995-11#1)(2008-11#1)
highly suggestive of##2##3##(2008-10#1)(2012-12#1)
highly suitable for##2##3##(1991-5#1)(2008-10#1)
highly susceptible cultivars and 12##2##5##(2008-10#2)
highly susceptible cv##3##3##(2008-10#3)
highly susceptible cvs##2##3##(2008-10#2)
highly susceptible to infection##2##4##(2008-10#2)
highly susceptible to##10##3##(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)
highly susceptible##32##2##(1995-2#1)(2008-10#28)(2008-11#1)(2008-3#1)(2008-8#1)
highly thermostable##2##2##(1994-11#1)(2008-9#1)
highly toxic##2##2##(1995-12#1)(2008-10#1)
highly toxigenic##2##2##(2008-10#2)
highly transcribed##2##2##(1997-7#1)(2009-10#1)
highly transparent##2##2##(2008-10#1)(2008-2#1)
highly unlikely##2##2##(1996-12#1)(2008-7#1)
highly unstable##4##2##(1992-2#1)(1996-3#1)(2008-11#1)(2013-8#1)
highly valued##2##2##(1991-12#1)(1993-12#1)
highly variable and##3##3##(2008-10#2)(2013-8#1)
highly variable##24##2##(1995-8#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-8#4)(2008-9#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
highly vascular##2##2##(2008-7#1)(2012-2#1)
highly versatile##2##2##(2008-10#1)(2008-11#1)
highly virulent and##2##3##(2008-10#2)
highly virulent isolate##3##3##(2008-10#3)
highly virulent isolates##6##3##(2008-10#6)
highly virulent##20##2##(2008-10#17)(2008-5#2)(2009-6#1)
highly##1119##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#7)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#14)(1993-2#4)(1993-3#8)(1993-6#3)(1993-8#8)(1993-9#1)(1994-1#2)(1994-11#6)(1994-12#5)(1994-2#5)(1994-3#1)(1994-5#4)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#6)(1995-2#9)(1995-3#4)(1995-5#5)(1995-6#11)(1995-8#6)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#6)(1996-8#1)(1997-1#6)(1997-2#8)(1997-3#5)(1997-4#5)(1997-6#6)(1997-7#5)(1997-8#3)(1997-9#4)(2007-12#5)(2008-1#3)(2008-10#423)(2008-11#59)(2008-12#16)(2008-2#9)(2008-3#24)(2008-4#8)(2008-5#17)(2008-6#4)(2008-7#20)(2008-8#38)(2008-9#36)(2009-10#9)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#6)(2009-7#7)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#6)(2010-7#5)(2010-8#6)(2011-1#3)(2011-10#1)(2011-2#45)(2011-3#3)(2011-9#2)(2012-12#3)(2012-2#29)(2012-3#17)(2013-1#25)(2013-8#16)
highs and lows##2##3##(1994-1#1)(1994-2#1)
highway##2##1##(2008-5#2)
hilA##2##1##(2008-11#2)
hilar biliary stricture##2##3##(2013-1#2)
hilar biliary##5##2##(2012-2#1)(2013-1#4)
hilar##11##1##(1996-1#1)(1997-8#1)(2008-1#1)(2012-2#3)(2013-1#5)
hilum##2##1##(1997-1#1)(2008-11#1)
him to##5##2##(1990-11#1)(1992-3#2)(1996-5#1)(2010-5#1)
him##17##1##(1990-11#2)(1992-3#4)(1995-6#3)(1996-5#5)(2008-10#1)(2008-12#1)(2010-5#1)
him/her##2##1##(1995-11#1)(2012-3#1)
himself##8##1##(1990-11#1)(1991-12#1)(1992-3#1)(1993-11#2)(2008-10#1)(2008-7#1)(2011-2#1)
hind leg##3##2##(1995-2#1)(1997-2#1)(2008-9#1)
hind##6##1##(1995-2#1)(1997-2#1)(2008-9#2)(2010-12#1)(2011-2#1)
hinder##9##1##(1994-1#1)(1994-2#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-12#1)
hindered by the lack of##2##5##(1997-7#1)(2008-11#1)
hindered by the##5##3##(1997-7#1)(2008-10#1)(2008-11#2)(2010-5#1)
hindered by##7##2##(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#2)(2010-5#1)(2012-2#1)
hindered the##2##2##(2008-10#1)(2012-2#1)
hindered##19##1##(1996-3#1)(1996-5#3)(1996-9#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-8#1)(2010-5#1)(2012-2#2)
hindering##2##1##(2008-11#1)(2012-2#1)
hinders the##4##2##(1995-8#1)(2008-10#1)(2010-4#1)(2011-2#1)
hindfoot##4##1##(2011-2#2)(2012-2#1)(2012-3#1)
hindlimb##3##1##(1990-11#1)(1992-12#2)
hindlimbs but##2##2##(1992-12#1)(1993-3#1)
hindlimbs##4##1##(1992-12#2)(1993-3#1)(1996-6#1)
hindrance and##2##2##(1993-8#1)(2008-10#1)
hindrance to##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
hindrance##10##1##(1993-8#1)(2008-10#6)(2010-10#1)(2013-1#1)(2013-8#1)
hindrances to##2##2##(2008-10#1)(2008-11#1)
hinge region of##2##3##(1995-6#2)
hinge region##4##2##(1995-6#3)(1997-2#1)
hinge##7##1##(1995-6#3)(1996-12#1)(1997-2#1)(2009-1#1)(2013-8#1)
hinges on##2##2##(1992-1#1)(2008-10#1)
hinges or##2##2##(2009-5#2)
hinges##4##1##(1992-1#1)(2008-10#1)(2009-5#2)
hinnavin I##2##2##(1997-8#2)
hint##3##1##(2008-11#1)(2008-7#1)(2011-2#1)
hints for##3##2##(1990-2#1)(1994-12#1)(1994-3#1)
hints on##4##2##(1997-4#1)(2008-9#1)(2010-11#1)(2010-4#1)
hints##9##1##(1990-2#1)(1994-12#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-4#1)(2013-1#1)
hip abductor torque##2##3##(2008-12#2)
hip and knee arthroplasty##2##4##(2009-3#1)(2013-1#1)
hip and knee##3##3##(1995-5#1)(2009-3#1)(2013-1#1)
hip and the##2##3##(2011-2#1)(2013-1#1)
hip and##11##2##(1994-3#1)(1995-5#1)(2008-11#3)(2009-3#2)(2011-2#2)(2013-1#2)
hip arthroplasty in##2##3##(2012-2#1)(2013-1#1)
hip arthroplasty##20##2##(1994-3#1)(1997-6#1)(2008-8#3)(2009-3#2)(2009-4#1)(2012-2#6)(2013-1#6)
hip circumference##3##2##(2008-12#1)(2011-2#2)
hip dislocation in##2##3##(2009-3#1)(2011-2#1)
hip dislocation##3##2##(2009-3#1)(2011-2#2)
hip flexion##2##2##(2011-2#2)
hip fracture and##2##3##(2008-12#2)
hip fracture##10##2##(2008-12#4)(2008-8#5)(2009-3#1)
hip fractures##5##2##(2008-11#1)(2008-12#1)(2010-9#1)(2011-2#2)
hip joint##7##2##(1997-6#2)(2008-12#3)(2008-8#1)(2011-2#1)
hip or knee replacement##2##4##(1990-6#1)(2013-1#1)
hip or knee##3##3##(1990-6#1)(2013-1#2)
hip pain##2##2##(2008-8#1)(2013-1#1)
hip prosthesis##3##2##(2008-10#1)(2009-4#1)(2010-6#1)
hip replacement##17##2##(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#2)(2009-4#1)(2010-10#9)(2013-1#2)
hip surgery##3##2##(2011-2#1)(2013-1#2)
hip was##2##2##(2010-3#1)(2013-7#1)
hip##135##1##(1990-6#1)(1991-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-9#1)(1997-6#3)(1997-8#1)(2008-10#2)(2008-11#5)(2008-12#12)(2008-8#10)(2009-11#1)(2009-3#8)(2009-4#5)(2010-1#1)(2010-10#10)(2010-3#2)(2010-6#1)(2010-9#2)(2011-2#24)(2012-12#1)(2012-2#6)(2013-1#23)(2013-7#5)
hippocampal 5-HT1A receptors##2##3##(1994-2#2)
hippocampal 5-HT1A##4##2##(1994-2#4)
hippocampal CA1##8##2##(1990-12#1)(1991-10#1)(1993-12#1)(1996-5#1)(2008-11#4)
hippocampal CA3 nerve cells##2##4##(1995-8#2)
hippocampal CA3##4##2##(1995-8#3)(2008-11#1)
hippocampal activity##2##2##(2008-11#1)(2013-8#1)
hippocampal and##5##2##(1994-2#1)(1996-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
hippocampal dentate##2##2##(2008-7#1)(2013-7#1)
hippocampal formation##2##2##(1990-11#1)(1996-12#1)
hippocampal lipofuscin##2##2##(1995-3#2)
hippocampal long-term potentiation##3##3##(1993-12#1)(2008-7#1)(2013-8#1)
hippocampal membranes##2##2##(1995-12#1)(1995-6#1)
hippocampal network##2##2##(2013-8#2)
hippocampal neural##2##2##(1991-2#1)(2008-11#1)
hippocampal neurones##2##2##(1996-2#1)(1996-5#1)
hippocampal neurons were##2##3##(1997-2#1)(2012-2#1)
hippocampal neurons##8##2##(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#2)(2010-12#1)(2012-2#2)
hippocampal pyramidal##2##2##(1991-7#1)(1995-8#1)
hippocampal slice preparations##2##3##(2008-4#1)(2008-7#1)
hippocampal slice##3##2##(2008-4#2)(2008-7#1)
hippocampal slices##7##2##(1990-12#2)(1995-12#2)(1995-2#1)(1996-2#1)(2008-7#1)
hippocampal structure and##2##3##(2008-7#1)(2012-2#1)
hippocampal synaptic plasticity##3##3##(1993-12#1)(2008-7#2)
hippocampal system##3##2##(1993-3#1)(1993-6#2)
hippocampal##96##1##(1990-11#3)(1990-12#3)(1991-10#1)(1991-2#2)(1991-7#1)(1992-12#1)(1993-12#3)(1993-3#2)(1993-6#3)(1994-2#7)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-6#1)(1995-8#5)(1996-12#5)(1996-2#2)(1996-5#2)(1997-2#2)(1997-7#2)(2008-11#14)(2008-4#2)(2008-7#10)(2010-12#1)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#9)
hippocampectomy##2##1##(1993-3#2)
hippocampi##2##1##(1991-2#1)(1995-12#1)
hippocampus after##2##2##(1990-5#1)(1997-3#1)
hippocampus and cerebellar cortex##2##4##(1997-2#2)
hippocampus and striatum##2##3##(1995-11#1)(1996-2#1)
hippocampus and##17##2##(1990-11#1)(1993-6#2)(1994-2#2)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-2#4)(2008-11#1)(2012-3#1)
hippocampus are##2##2##(1997-2#1)(2013-8#1)
hippocampus following##2##2##(1991-2#1)(1996-12#1)
hippocampus in the##2##3##(1996-12#1)(2008-7#1)
hippocampus in##6##2##(1996-12#1)(2008-12#1)(2008-7#3)(2013-8#1)
hippocampus of the##4##3##(1992-10#1)(1993-3#2)(2010-12#1)
hippocampus of##10##2##(1991-2#1)(1992-10#1)(1993-3#2)(1996-12#3)(2008-11#1)(2010-12#1)(2012-2#1)
hippocampus##114##1##(1990-11#3)(1990-5#2)(1991-10#2)(1991-12#1)(1991-2#3)(1991-4#1)(1992-1#1)(1992-10#1)(1993-12#1)(1993-3#2)(1993-6#7)(1994-2#5)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1996-11#1)(1996-12#17)(1996-2#2)(1997-2#12)(1997-3#2)(2008-11#16)(2008-12#4)(2008-7#7)(2010-12#1)(2012-2#2)(2012-3#2)(2013-8#11)
hippocampus-dependent##2##1##(1993-12#1)(2008-7#1)
hips healed without complications##2##4##(2013-1#2)
hips without##2##2##(2012-2#2)
hips##11##1##(2008-11#1)(2009-3#2)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-7#1)
hirame##4##1##(2010-8#4)
hircus)##2##1##(2008-9#2)
hire##7##1##(1992-12#1)(1992-3#1)(1994-1#2)(1997-2#1)(1997-3#1)(2008-10#1)
hiring##4##1##(1994-1#2)(1994-12#1)(1994-2#1)
hirsutum L##3##2##(1993-3#1)(2008-8#2)
hirsutum LA407##2##2##(2008-10#2)
hirsutum##12##1##(1993-3#1)(2008-10#7)(2008-8#2)(2008-9#2)
his AIDS diagnosis##2##3##(1995-12#1)(1995-6#1)
his HIV status##3##3##(1995-6#1)(1996-5#2)
his HIV##4##2##(1995-6#2)(1996-5#2)
his ODI##2##2##(2008-12#2)
his ability to##2##3##(1990-5#1)(1992-3#1)
his book##3##2##(1993-3#1)(2009-10#1)(2013-1#1)
his childhood##2##2##(1995-5#1)(2008-7#1)
his clinical practice##2##3##(2010-5#1)(2013-1#1)
his clinical##3##2##(2010-5#1)(2011-2#1)(2013-1#1)
his death##4##2##(1995-5#1)(1995-6#1)(2008-7#1)(2010-1#1)
his doctors##2##2##(1995-6#2)
his early years of##2##4##(2008-10#1)(2010-1#1)
his efforts to##2##3##(1990-11#1)(1991-8#1)
his employer##2##2##(1995-12#1)(1995-6#1)
his experience##2##2##(1990-9#1)(2011-3#1)
his first##3##2##(1995-6#1)(1997-6#1)(2011-2#1)
his hospital##7##2##(1991-1#1)(1992-2#2)(1993-12#2)(1994-2#1)(1996-12#1)
his house##2##2##(2010-5#1)(2013-1#1)
his last##2##2##(2010-1#1)(2013-1#1)
his left ankle##2##3##(2009-1#2)
his left flank##2##3##(2008-12#2)
his left##7##2##(1996-6#1)(2008-12#2)(2009-1#3)(2010-9#1)
his life and work##2##4##(2008-11#1)(2008-9#1)
his life and##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
his life##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2012-3#1)
his main##2##2##(1993-11#1)(2008-12#1)
his medical##2##2##(1992-3#1)(1995-6#1)
his or her goals##2##4##(2008-7#2)
his or her##12##3##(1992-2#1)(1994-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2010-2#1)(2010-5#1)
his or##13##2##(1992-2#1)(1994-1#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2010-2#1)(2010-5#1)
his own##5##2##(1992-2#1)(1994-12#1)(1995-5#1)(2008-12#1)(2011-2#1)
his patient##2##2##(1993-11#1)(1993-12#1)
his patients##2##2##(1993-11#1)(2008-10#1)
his physician##3##2##(1990-6#1)(2008-7#1)(2013-1#1)
his power of##2##3##(1997-5#1)(2012-3#1)
his previous##2##2##(2008-12#1)(2011-2#1)
his right eye##3##3##(2010-10#2)(2011-2#1)
his right##13##2##(1991-11#1)(1991-6#1)(1995-6#1)(1996-2#1)(2010-10#2)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#2)
his security##2##2##(1996-12#1)(2008-12#1)
his sexual##2##2##(1995-12#2)
his students that##2##3##(2008-10#2)
his symptoms##3##2##(2008-7#1)(2010-1#1)(2011-2#1)
his therapy##2##2##(2011-2#1)(2013-1#1)
his two##2##2##(1996-5#1)(2013-1#1)
his view of##2##3##(1993-11#1)(2008-12#1)
his view that the##2##4##(2008-12#2)
his view##4##2##(1993-11#1)(2008-12#3)
his work##3##2##(1991-6#1)(1997-3#1)(2008-12#1)
his##299##1##(1990-11#4)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#4)(1991-11#1)(1991-6#5)(1991-8#2)(1992-2#5)(1992-3#4)(1993-11#9)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#11)(1995-2#1)(1995-5#5)(1995-6#17)(1996-1#1)(1996-12#3)(1996-2#2)(1996-5#9)(1996-6#3)(1996-8#1)(1996-9#3)(1997-3#4)(1997-5#2)(1997-6#3)(1997-8#2)(2007-12#5)(2007-8#1)(2008-10#15)(2008-11#7)(2008-12#30)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#16)(2008-8#2)(2008-9#4)(2009-1#4)(2009-10#3)(2009-11#1)(2009-8#2)(2010-1#14)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-2#21)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#15)(2013-8#1)
his/her##7##1##(1992-12#1)(1996-2#1)(2008-12#1)(2010-6#1)(2012-3#3)
histamine concentration##2##2##(1994-6#1)(2008-10#1)
histamine in##4##2##(1994-6#1)(1995-12#1)(1996-2#1)(2008-10#1)
histamine release##2##2##(2008-11#2)
histamine was##2##2##(1995-12#1)(2008-12#1)
histamine##49##1##(1990-5#1)(1992-6#1)(1993-6#1)(1994-6#5)(1995-12#8)(1996-1#1)(1996-2#1)(1997-1#5)(2007-12#1)(2008-10#10)(2008-11#5)(2008-12#9)(2008-5#1)
histamine-orthophthalaldehyde##2##1##(2008-10#2)
histamine-releasing activity##2##2##(1995-11#2)
histidase##9##1##(1994-5#9)
histidine and its metabolites##3##4##(2008-10#3)
histidine and##6##2##(2008-10#5)(2008-8#1)
histidine by##2##2##(1992-6#1)(2008-10#1)
histidine decarboxylase##2##2##(1997-1#2)
histidine residue##3##2##(1990-12#1)(1996-8#1)(2008-10#1)
histidine residues##2##2##(1991-12#1)(2010-4#1)
histidine tag##3##2##(2008-10#3)
histidine##48##1##(1990-12#1)(1990-8#3)(1991-12#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-5#4)(1995-3#1)(1995-8#2)(1996-8#1)(1997-1#2)(1997-3#1)(2008-10#26)(2008-8#2)(2010-4#1)
histiocytes##3##1##(2010-10#1)(2010-12#1)(2012-12#1)
histiocytic##4##1##(1991-3#1)(1993-3#1)(2012-12#1)(2012-3#1)
histiocytosis##3##1##(2009-5#1)(2012-12#1)(2012-3#1)
histochemical and ultrastructural##2##3##(2007-12#1)(2009-7#1)
histochemical and##3##2##(2007-12#1)(2009-7#1)(2012-3#1)
histochemical investigations##2##2##(1990-2#1)(1996-12#1)
histochemical method##2##2##(2008-4#1)(2008-7#1)
histochemical staining for##2##3##(1997-3#2)
histochemical staining##5##2##(1992-1#1)(1993-12#1)(1997-3#2)(2008-9#1)
histochemical##27##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-12#1)(1995-12#2)(1996-12#1)(1997-3#2)(2007-12#3)(2008-10#4)(2008-4#1)(2008-7#2)(2008-9#2)(2009-7#2)(2012-3#1)
histochemistry was##2##2##(1992-12#1)(1994-11#1)
histochemistry##18##1##(1992-12#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#4)(1996-2#1)(1997-2#3)(1997-3#1)(2008-11#2)(2008-7#1)
histocompatibility and##2##2##(2008-1#1)(2012-3#1)
histocompatibility complex (MHC)##6##3##(1990-5#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-1#1)(2008-9#1)
histocompatibility complex##15##2##(1990-5#2)(1995-12#1)(1995-2#2)(1997-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
histocompatibility##26##1##(1990-5#2)(1995-12#2)(1995-2#2)(1995-5#1)(1997-9#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#5)(2013-1#1)
histogenetic##3##1##(2009-4#2)(2011-2#1)
histogram##11##1##(2008-6#9)(2008-9#2)
histograms of##5##2##(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#1)
histograms##11##1##(1994-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#3)(2008-9#1)(2011-2#1)
histologic and immunohistochemical##2##3##(1994-6#1)(2009-3#1)
histologic changes##2##2##(1993-12#2)
histologic criteria##2##2##(2011-2#2)
histologic diagnosis of##2##3##(1991-2#1)(1995-3#1)
histologic diagnosis##4##2##(1991-2#1)(1992-12#2)(1995-3#1)
histologic evidence of##3##3##(1992-3#1)(1993-12#1)(1995-8#1)
histologic examination##6##2##(1990-6#1)(1991-6#1)(1993-6#1)(1997-5#1)(2008-10#1)(2010-6#1)
histologic features##7##2##(1991-6#1)(1994-12#3)(2009-12#2)(2011-2#1)
histologic findings##3##2##(1991-12#1)(2009-3#1)(2010-6#1)
histologic grade##3##2##(1990-12#2)(2011-2#1)
histologic specimens##2##2##(1994-12#1)(1997-8#1)
histologic subtypes##2##2##(1991-8#1)(2013-1#1)
histologic##62##1##(1990-12#3)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-6#2)(1991-8#3)(1991-9#1)(1992-12#4)(1992-3#1)(1993-12#3)(1993-6#1)(1994-1#1)(1994-12#4)(1994-6#1)(1995-3#1)(1995-8#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#3)(2009-3#2)(2010-6#2)(2011-2#5)(2012-3#1)(2013-1#1)
histological and immunohistochemical analysis##2##4##(2008-7#1)(2013-8#1)
histological and immunohistochemical##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
histological and ultrastructural##2##3##(2008-7#2)
histological and##14##2##(1995-2#1)(1997-5#1)(2008-11#1)(2008-5#2)(2008-7#3)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#2)(2013-8#1)
histological changes of diabetic rats' skin and the effects on the percutaneous absorption of##2##14##(2011-3#2)
histological changes##4##2##(2008-10#1)(2011-3#3)
histological classification##2##2##(2010-9#1)(2011-2#1)
histological criteria##2##2##(2008-10#1)(2011-2#1)
histological diagnosis of renal##2##4##(2008-10#2)
histological diagnosis of##3##3##(2008-10#2)(2011-7#1)
histological diagnosis was##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
histological diagnosis##11##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#2)(2011-1#1)(2011-2#1)(2011-7#2)(2013-1#1)
histological differentiation##3##2##(1991-6#1)(2008-9#1)(2011-2#1)
histological evaluation##2##2##(1991-8#1)(2008-11#1)
histological examination of the##4##4##(1996-6#1)(2008-10#1)(2010-12#1)(2010-6#1)
histological examination##13##2##(1992-5#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#1)
histological features##7##2##(1991-11#1)(1991-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-3#1)
histological finding##2##2##(1991-8#1)(2008-9#1)
histological findings of the discolored##2##5##(1995-11#2)
histological findings##9##2##(1995-11#2)(2008-10#2)(2008-5#1)(2009-7#1)(2010-9#1)(2012-3#1)(2013-1#1)
histological investigation##2##2##(1995-11#1)(2011-2#1)
histological lesions##2##2##(2008-5#2)
histological methods##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
histological parameters##2##2##(2008-6#1)(2011-2#1)
histological sections of##2##3##(1994-11#1)(2011-2#1)
histological sections##8##2##(1991-6#1)(1994-11#1)(2008-10#1)(2011-2#4)(2013-1#1)
histological specimens##2##2##(2008-7#1)(2010-4#1)
histological studies##2##2##(2008-10#1)(2008-7#1)
histological study##2##2##(2008-10#1)(2012-3#1)
histological subtype##2##2##(2011-2#1)(2013-1#1)
histological type of##2##3##(1993-11#1)(2008-1#1)
histological type##5##2##(1993-11#1)(2008-1#3)(2008-2#1)
histological types of##2##3##(2011-2#1)(2012-3#1)
histological types##3##2##(2009-8#1)(2011-2#1)(2012-3#1)
histological##138##1##(1991-11#3)(1991-6#2)(1991-8#4)(1992-5#1)(1993-11#1)(1994-11#1)(1995-11#3)(1995-2#1)(1996-6#2)(1997-2#1)(1997-5#1)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#9)(2008-9#3)(2009-5#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#4)(2011-1#1)(2011-2#21)(2011-3#6)(2011-7#2)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#11)(2013-8#1)
histological)##2##1##(2011-2#1)(2012-3#1)
histologically and##3##2##(1990-12#1)(1995-12#1)(2013-1#1)
histologically benign##2##2##(2011-2#1)(2012-3#1)
histologically confirmed##4##2##(1990-2#1)(1991-2#1)(1994-12#1)(2011-2#1)
histologically diagnosed in##2##3##(1990-2#1)(2008-5#1)
histologically diagnosed##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
histologically different tumours##2##3##(2012-3#2)
histologically different##3##2##(1993-12#1)(2012-3#2)
histologically proven##5##2##(1990-2#1)(1991-2#1)(1994-1#1)(1997-8#1)(2008-7#1)
histologically##41##1##(1990-12#1)(1990-2#3)(1990-9#1)(1991-2#2)(1993-12#1)(1993-6#1)(1994-1#4)(1994-12#1)(1995-12#1)(1995-2#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#3)(2009-1#1)(2010-12#1)(2010-3#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#2)
histologies##2##1##(2008-11#1)(2011-2#1)
histology of##8##2##(1994-1#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-1#1)(2009-12#1)(2013-7#1)
histology##42##1##(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#2)(1991-9#1)(1994-1#1)(1995-12#1)(1996-11#1)(1996-8#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-12#2)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
histolytica##11##1##(1991-7#1)(2007-12#1)(2009-7#2)(2009-8#5)(2012-3#2)
histone H1##5##2##(1990-5#1)(1992-9#1)(1993-9#2)(1994-11#1)
histone H1(0) promoter##2##3##(1993-6#2)
histone H2AX##3##2##(2008-9#3)
histone H3##5##2##(1991-5#3)(1997-2#1)(2009-8#1)
histone deacetylase##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
histone homologue##3##2##(1993-9#3)
histone modifications##4##2##(2009-12#1)(2009-8#1)(2011-2#2)
histone##41##1##(1990-2#1)(1990-5#1)(1991-5#3)(1992-9#1)(1993-6#2)(1993-9#5)(1994-11#3)(1997-2#1)(2008-10#4)(2008-11#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#3)(2011-2#3)(2011-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
histones##3##1##(1990-2#1)(1996-6#1)(2008-8#1)
histopathologic analysis##2##2##(1997-7#1)(2008-10#1)
histopathologic assessment of##2##3##(2013-8#2)
histopathologic examination##2##2##(1996-3#1)(2010-6#1)
histopathologic study##4##2##(1995-3#1)(2008-5#2)(2010-6#1)
histopathologic##25##1##(1990-8#1)(1992-5#1)(1995-3#2)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-5#2)(2010-6#4)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
histopathological analysis##2##2##(2008-10#2)
histopathological and##2##2##(2013-1#1)(2013-8#1)
histopathological changes in##2##3##(2008-10#1)(2008-5#1)
histopathological changes##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
histopathological confirmation##2##2##(2008-1#1)(2011-2#1)
histopathological diagnosis was##2##3##(1997-8#2)
histopathological diagnosis##5##2##(1997-8#2)(2009-4#1)(2011-2#2)
histopathological examination##9##2##(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
histopathological features of##2##3##(2008-1#1)(2011-2#1)
histopathological features##4##2##(2008-1#1)(2011-2#2)(2013-1#1)
histopathological findings##12##2##(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
histopathological study##3##2##(1991-3#1)(2008-7#1)(2013-1#1)
histopathological##62##1##(1991-3#1)(1992-5#1)(1997-8#4)(2008-1#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#4)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#15)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
histopathologically and##2##2##(1994-12#1)(2008-5#1)
histopathologically##10##1##(1991-8#1)(1994-12#1)(1997-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
histopathology and##2##2##(2012-2#1)(2013-1#1)
histopathology##20##1##(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#3)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
histoplasmin##5##1##(2008-5#5)
historians of##2##2##(2008-12#2)
historians##5##1##(2008-12#3)(2010-1#1)(2010-3#1)
historic##17##1##(1991-12#1)(1992-2#1)(1993-1#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-2#4)(2011-2#3)(2012-12#1)
historical and##7##2##(1996-1#1)(1996-2#1)(1997-4#1)(2008-10#1)(2009-11#1)(2012-2#1)(2013-8#1)
historical data on##2##3##(2008-10#1)(2008-9#1)
historical data##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
historical development##3##2##(1996-3#1)(2008-11#1)(2013-1#1)
historical factors##2##2##(1992-1#1)(2008-3#1)
historical overview##3##2##(2009-10#1)(2010-1#1)(2011-2#1)
historical perspective on##2##3##(1991-1#1)(2008-11#1)
historical perspective##6##2##(1991-1#1)(1996-1#1)(2008-11#2)(2008-4#1)(2010-4#1)
historical processes that##2##3##(1991-3#1)(2012-3#1)
historical review##3##2##(2008-10#2)(2009-10#1)
historical weather##3##2##(2008-10#3)
historical##85##1##(1991-1#3)(1991-12#1)(1991-3#1)(1991-8#2)(1992-1#1)(1992-12#2)(1993-11#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#4)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
historically##11##1##(1992-2#2)(1997-1#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#1)
histories and##2##2##(1991-8#1)(2008-11#1)
histories of plant##2##3##(2008-8#1)(2012-3#1)
histories of the##2##3##(1996-11#1)(2012-3#1)
histories of##15##2##(1993-2#1)(1993-3#1)(1996-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
histories##49##1##(1991-12#3)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1996-11#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#3)(2009-4#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
history and clinical examination##2##4##(2008-12#1)(2009-12#1)
history and clinical##4##3##(2008-11#1)(2008-12#1)(2009-12#1)(2012-3#1)
history and examination##2##3##(2008-12#2)
history and its##2##3##(1990-3#1)(2010-3#1)
history and physical examination are##2##5##(2010-1#1)(2013-8#1)
history and physical examination##7##4##(2008-10#1)(2008-11#1)(2010-1#1)(2010-7#1)(2011-2#2)(2013-8#1)
history and physical##10##3##(2008-10#1)(2008-11#1)(2009-6#1)(2010-1#3)(2010-7#1)(2011-2#2)(2013-8#1)
history and the##4##3##(1996-3#1)(1997-3#1)(2008-11#1)(2008-4#1)
history and with the##2##4##(2010-10#1)(2010-6#1)
history and##51##2##(1990-3#1)(1990-8#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-12#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
history are##2##2##(2008-10#1)(2008-8#1)
history as a##2##3##(2008-12#1)(2008-4#1)
history as well as##2##4##(2008-8#1)(2011-4#1)
history as##4##2##(2008-12#1)(2008-4#1)(2008-8#1)(2011-4#1)
history can##3##2##(2008-4#1)(2008-8#1)(2010-3#1)
history documented##2##2##(2013-1#2)
history from##2##2##(2008-7#1)(2013-1#1)
history in##4##2##(2008-8#1)(2010-5#1)(2013-1#2)
history included##2##2##(2009-3#1)(2013-1#1)
history is not##2##3##(2010-5#1)(2011-7#1)
history is##5##2##(1993-2#1)(2008-11#1)(2010-5#1)(2011-7#1)(2012-2#1)
history of HIV##2##3##(1994-9#1)(2013-1#1)
history of a##10##3##(1991-8#1)(1992-2#1)(1994-12#1)(1996-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#3)
history of adolescent##2##3##(2013-8#2)
history of an##2##3##(2010-3#1)(2012-3#1)
history of arterial hypertension##2##4##(2008-7#1)(2011-2#1)
history of arterial##3##3##(2008-7#1)(2011-2#2)
history of breast cancer##2##4##(1992-2#1)(1993-1#1)
history of breast##3##3##(1992-2#1)(1993-1#1)(2008-1#1)
history of cancer##2##3##(2008-12#1)(2011-2#1)
history of chile pepper cropping and##2##6##(2008-10#2)
history of chronic##2##3##(2009-8#1)(2012-2#1)
history of clinical##2##3##(1996-12#2)
history of depression##3##3##(2008-6#1)(2010-4#1)(2013-8#1)
history of fever##2##3##(2008-10#1)(2012-3#1)
history of head##3##3##(2010-1#1)(2010-8#1)(2013-7#1)
history of headache##3##3##(1996-9#1)(2008-7#1)(2013-1#1)
history of hypertension##6##3##(1994-12#1)(2008-7#3)(2010-4#2)
history of intermittent##3##3##(2011-2#2)(2012-2#1)
history of medicine##5##3##(1993-11#1)(1993-6#1)(2008-9#1)(2010-6#1)(2011-2#1)
history of multiple##3##3##(1990-2#1)(2008-11#1)(2008-12#1)
history of neonatal##2##3##(1996-12#1)(2008-11#1)
history of patients##3##3##(2011-2#3)
history of previous##5##3##(1991-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-6#1)
history of progressive##4##3##(1997-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
history of recent##2##3##(1993-8#1)(2012-3#1)
history of slowly progressive##2##4##(2008-7#1)(2012-3#1)
history of the patient##2##4##(2008-12#1)(2010-6#1)
history of the species##2##4##(2012-3#1)(2012-5#1)
history of the##31##3##(1990-11#1)(1991-6#1)(1991-9#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-1#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-7#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)
history of trauma##4##3##(2008-12#1)(2008-9#1)(2011-2#1)(2013-8#1)
history of use##2##3##(1997-1#1)(2013-1#1)
history of##287##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-1#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-6#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#4)(1994-9#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#5)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#18)(2008-11#22)(2008-12#14)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#14)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#6)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#13)(2010-7#3)(2010-8#3)(2010-9#3)(2011-2#23)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#8)(2012-3#22)(2012-5#1)(2013-1#19)(2013-7#2)(2013-8#10)
history or##3##2##(1996-9#1)(2008-8#1)(2012-2#1)
history revealed##2##2##(2008-10#1)(2013-1#1)
history showed##2##2##(2008-10#1)(2010-4#1)
history taking##2##2##(1995-5#1)(2011-2#1)
history that##2##2##(2008-6#1)(2011-2#1)
history to##3##2##(1997-8#1)(2008-8#1)(2011-2#1)
history was##5##2##(2008-11#1)(2008-7#1)(2010-6#1)(2012-5#1)(2013-1#1)
history##511##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#1)(1991-1#4)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#2)(1993-11#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#7)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#7)(1996-6#5)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#5)(2006-5#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#33)(2008-11#33)(2008-12#24)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#21)(2008-8#29)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#3)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#9)(2010-10#8)(2010-11#1)(2010-12#3)(2010-3#5)(2010-4#5)(2010-5#6)(2010-6#17)(2010-7#4)(2010-8#8)(2010-9#4)(2011-2#41)(2011-3#1)(2011-4#1)(2011-7#2)(2012-12#9)(2012-2#14)(2012-3#27)(2012-5#2)(2013-1#34)(2013-7#3)(2013-8#19)
histotype##4##1##(1990-2#3)(1991-12#1)
hit compounds##3##2##(2013-1#3)
hit##13##1##(1994-12#2)(1995-8#1)(1996-3#1)(2008-6#1)(2011-2#2)(2013-1#6)
hitherto reported##2##2##(2008-1#1)(2008-7#1)
hitherto unknown##4##2##(1992-9#1)(2008-11#1)(2009-9#1)(2013-1#1)
hitherto unnoticed##2##2##(1991-3#1)(2008-7#1)
hitherto##25##1##(1990-8#1)(1991-3#1)(1992-9#1)(1995-6#2)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#2)(2009-9#1)(2010-10#1)(2011-1#2)(2012-2#2)(2013-1#1)
hits##4##1##(2009-8#1)(2010-4#1)(2010-8#1)(2013-8#1)
hive##3##1##(2008-10#3)
hmm##6##1##(2008-4#6)
hnRNP I/PTB##2##2##(1993-8#2)
hnRNP M4##3##2##(2008-8#3)
hnRNP##7##1##(1993-8#2)(2008-8#5)
hoarding##5##1##(1993-6#1)(1994-3#1)(2008-9#3)
hoarseness##5##1##(1990-12#1)(2008-11#1)(2010-12#1)(2010-7#2)
hoc##10##1##(1992-3#1)(1993-12#1)(1997-3#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2011-9#1)
hockey##2##1##(2010-1#2)
hold a great##2##3##(2008-11#1)(2011-2#1)
hold a##5##2##(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#1)
hold for##4##2##(1990-8#1)(1997-5#1)(2008-3#1)(2008-5#1)
hold great promise for##3##4##(2008-10#2)(2012-2#1)
hold great promise##4##3##(2008-10#3)(2012-2#1)
hold only##2##2##(1994-12#1)(2008-9#1)
hold promise for##2##3##(2008-11#1)(2012-3#1)
hold promise##3##2##(2008-11#2)(2012-3#1)
hold the key##2##3##(2009-12#2)
hold the promise of##2##4##(2008-11#2)
hold the##5##2##(1997-4#1)(2008-11#2)(2009-12#2)
hold true##2##2##(2008-10#1)(2011-2#1)
hold##48##1##(1990-12#1)(1990-8#2)(1992-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#4)(2009-12#2)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
holder of##2##2##(2008-10#2)
holder##4##1##(2008-10#4)
holding beams##3##2##(2007-11#3)
holding chambers##2##2##(1996-2#1)(1997-1#1)
holding coil##9##2##(2008-10#9)
holding duration##2##2##(2013-8#2)
holding of##2##2##(2008-10#1)(2009-5#1)
holding time##2##2##(2008-10#1)(2013-8#1)
holding##38##1##(1990-8#1)(1991-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#13)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2013-1#1)(2013-8#7)
holdings##2##1##(1996-3#1)(2011-2#1)
holds great promise for##2##4##(1997-1#1)(2008-10#1)
holds great promise##3##3##(1997-1#1)(2008-10#1)(2010-6#1)
holds promise for##2##3##(2008-10#2)
holds promise##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
holds the##4##2##(1995-5#1)(2009-7#1)(2010-4#1)(2011-2#1)
holds##23##1##(1991-3#1)(1993-8#1)(1994-3#1)(1995-5#1)(1996-2#2)(1997-1#1)(1997-3#2)(1997-8#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#2)
hole and##2##2##(2009-7#1)(2011-2#1)
hole burning##4##2##(2008-3#4)
hole doping##2##2##(1990-12#1)(2008-10#1)
hole in the##2##3##(2011-2#1)(2012-12#1)
hole in##3##2##(1992-8#1)(2011-2#1)(2012-12#1)
hole was##2##2##(2008-7#1)(2013-1#1)
hole##20##1##(1990-12#1)(1991-3#1)(1991-5#2)(1992-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-3#4)(2008-7#2)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
hole?##2##1##(1993-11#1)(1993-3#1)
holes in##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
holes of##2##2##(2008-3#2)
holes##18##1##(2007-12#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-4#1)
holiday season##2##2##(2008-11#1)(2010-12#1)
holiday##6##1##(1995-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)
holistic and##2##2##(1997-3#1)(2008-10#1)
holistic care##6##2##(2008-11#5)(2011-1#1)
holistic caring##2##2##(2008-11#2)
holistic healthcare##3##2##(2009-11#3)
holistic mode of cognition##2##4##(2009-8#2)
holistic##33##1##(1991-2#1)(1997-3#1)(2008-10#2)(2008-11#11)(2008-12#3)(2009-11#3)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
hollow cube-corner retroreflector for a geosynchronous satellite##2##7##(2008-3#2)
hollow fiber bioreactor system##2##4##(2008-11#2)
hollow fiber bioreactor##5##3##(2008-11#5)
hollow fiber system##2##3##(2008-11#2)
hollow fiber##16##2##(2008-10#3)(2008-11#11)(2008-2#1)(2008-7#1)
hollow fiberbioreactor##2##2##(2008-11#2)
hollow fibre##2##2##(2008-11#2)
hollow waveguide##6##2##(2007-11#2)(2007-12#2)(2008-3#1)(2008-7#1)
hollow waveguides##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
hollow##43##1##(1993-6#1)(1995-10#1)(2007-11#2)(2007-12#5)(2008-10#8)(2008-11#16)(2008-2#2)(2008-3#5)(2008-7#2)(2013-1#1)
hollow-fiber##4##1##(1995-3#1)(2008-11#1)(2008-7#2)
hollowfiber bioreactor system##2##3##(2008-11#2)
holo human transferrin in##3##4##(2008-11#3)
holo human transferrin##5##3##(2008-11#5)
holo-PKC epsilon##2##2##(1995-2#2)
holocycly to##3##2##(2008-9#3)
holoenzyme is##2##2##(1994-3#2)
holoenzyme##12##1##(1990-5#1)(1992-3#2)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#4)(2008-11#1)(2008-9#1)
hologram##10##1##(2007-12#2)(2008-2#1)(2008-3#7)
holograms are##2##2##(2007-12#1)(2008-3#1)
holograms by##2##2##(2008-3#2)
holograms in##2##2##(2008-3#2)
holograms were##2##2##(2008-3#2)
holograms##16##1##(2007-12#2)(2008-3#14)
holographic data storage##2##3##(2007-12#1)(2008-3#1)
holographic interferometry##3##2##(2008-3#3)
holographic memory system##3##3##(2008-3#3)
holographic memory##5##2##(2008-3#5)
holographic optical elements##2##3##(2008-3#2)
holographic recording##2##2##(2007-12#1)(2008-3#1)
holographic storage##4##2##(2007-12#1)(2008-3#3)
holographic telescope##2##2##(2007-11#2)
holographic##31##1##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#25)
holographically formed polymer dispersed##2##4##(2007-11#2)
holographically recorded##2##2##(2008-3#2)
holographically##5##1##(2007-11#2)(2008-3#3)
holography and##2##2##(2007-11#1)(2008-3#1)
holography is##2##2##(2007-12#2)
holography with##2##2##(2007-12#1)(2008-3#1)
holography##21##1##(2007-11#2)(2007-12#9)(2008-2#1)(2008-3#9)
holometabolous species##3##2##(2012-2#3)
holoprosencephaly (HPE)##2##2##(2011-1#1)(2013-1#1)
holoprosencephaly##3##1##(2011-1#1)(2012-3#1)(2013-1#1)
holoprotein##3##1##(1993-8#3)
holotoxin##3##1##(1993-11#2)(1995-2#1)
holy##2##1##(1991-3#1)(2008-12#1)
homatropine methylbromide##3##2##(2008-10#3)
home and community##2##3##(1991-1#1)(1997-1#1)
home and community-based##3##3##(1993-1#1)(1994-2#1)(1996-2#1)
home and##20##2##(1991-1#1)(1991-8#1)(1993-1#2)(1993-12#1)(1994-2#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-5#1)(2007-12#1)(2008-11#1)(2009-10#1)(2009-5#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
home blood glucose monitoring##2##4##(2010-2#2)
home care and##3##3##(1991-3#1)(1992-2#1)(1995-2#1)
home care for the##2##4##(1991-2#1)(1993-1#1)
home care for##3##3##(1991-2#1)(1993-1#1)(2009-3#1)
home care is##2##3##(1991-2#1)(2008-11#1)
home care quality##3##3##(1991-3#1)(1995-3#2)
home care##54##2##(1991-1#3)(1991-2#2)(1991-3#7)(1992-1#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-2#5)(1995-3#12)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2008-10#1)(2008-11#1)(2009-3#1)(2012-2#3)
home dialysis##3##2##(1994-1#1)(1995-12#2)
home environment##3##2##(1991-1#1)(1991-11#1)(1997-7#1)
home for the##4##3##(1996-2#1)(2008-7#2)(2008-8#1)
home for##7##2##(1995-12#1)(1996-2#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
home health agencies##2##3##(1991-2#1)(1995-3#1)
home health benefit##2##3##(1995-3#2)
home health care in##3##4##(1991-2#1)(1995-3#2)
home health care##13##3##(1991-12#1)(1991-2#1)(1995-2#1)(1995-3#9)(1997-3#1)
home health services##6##3##(1994-2#1)(1995-3#5)
home health use##3##3##(1994-2#3)
home health users##3##3##(1994-2#1)(1995-3#2)
home health##47##2##(1991-12#2)(1991-2#2)(1992-2#1)(1994-2#8)(1995-2#1)(1995-3#28)(1997-3#1)(1997-6#3)(2012-3#1)
home in##7##2##(2007-12#2)(2008-12#1)(2010-10#1)(2010-8#1)(2011-3#1)(2013-1#1)
home is the##2##3##(2007-12#1)(2010-10#1)
home is##5##2##(1991-1#1)(2007-12#2)(2009-3#1)(2010-10#1)
home made##6##2##(2008-10#5)(2008-11#1)
home nursing##2##2##(2010-7#2)
home on the##2##3##(1993-1#1)(2008-12#1)
home ownership##2##2##(2008-1#2)
home oxygen in Bogota##2##4##(2012-12#2)
home oxygen##4##2##(2012-12#4)
home program##2##2##(1994-12#1)(2008-12#1)
home quality##5##2##(1996-2#1)(1997-1#1)(2008-11#3)
home range area##3##3##(2008-8#3)
home range overlap##2##3##(2008-8#1)(2010-4#1)
home range size##2##3##(2008-8#2)
home range##12##2##(2008-8#6)(2010-4#4)(2010-8#2)
home ranges than##2##3##(2008-8#2)
home ranges##11##2##(2008-8#5)(2008-9#2)(2010-4#4)
home residents##8##2##(1991-3#1)(1995-2#2)(1996-2#1)(2008-1#2)(2010-10#2)
home setting##3##2##(2009-10#1)(2009-11#1)(2009-3#1)
home support##5##2##(1994-2#1)(1997-4#4)
home test kit##2##3##(1996-5#2)
home test##3##2##(1996-5#3)
home testing##3##2##(1996-5#3)
home to##3##2##(1994-3#1)(1995-5#1)(2008-8#1)
home visitors##5##2##(1992-2#4)(2010-9#1)
home visitors' and nurses'##2##4##(1992-2#2)
home visits##3##2##(1997-2#1)(2010-7#1)(2012-3#1)
home were##2##2##(1995-3#1)(2011-2#1)
home with##5##2##(1992-2#1)(1992-3#1)(1995-3#1)(2010-5#1)(2010-7#1)
home##389##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-1#10)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#12)(1991-8#3)(1991-9#1)(1992-1#4)(1992-2#10)(1992-3#4)(1993-1#5)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#3)(1994-1#1)(1994-12#5)(1994-2#21)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#8)(1995-2#18)(1995-3#45)(1995-5#2)(1996-1#1)(1996-11#2)(1996-2#6)(1996-3#1)(1996-5#7)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#1)(2007-12#14)(2008-1#6)(2008-10#7)(2008-11#18)(2008-12#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#13)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#13)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#8)(2010-5#2)(2010-7#4)(2010-8#7)(2010-9#2)(2011-2#16)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#2)
home-based##6##1##(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#2)(2010-8#1)
home-care services##2##2##(2008-5#2)
home-care##3##1##(2008-5#2)(2010-7#1)
home-made cell##2##2##(2008-10#2)
home-made##15##1##(2008-10#14)(2008-7#1)
home-produced eggs##2##2##(2008-10#2)
homebound elderly##2##2##(1994-1#1)(1997-2#1)
homebound##5##1##(1992-2#1)(1994-1#1)(1995-2#1)(1996-3#1)(1997-2#1)
homeless##6##1##(1992-2#1)(1996-3#1)(2008-10#1)(2012-3#1)(2013-8#2)
homelessness##5##1##(1996-11#1)(1997-3#1)(2009-11#1)(2013-1#2)
homemade##5##1##(2008-1#1)(2008-10#4)
homeobox##5##1##(1993-2#1)(2008-8#3)(2013-1#1)
homeobox-containing##4##1##(1994-11#2)(2008-8#2)
homeodomain transcription factor##2##3##(2008-9#1)(2012-3#1)
homeodomain transcription##3##2##(2008-9#2)(2012-3#1)
homeodomain##7##1##(1995-6#4)(2008-9#2)(2012-3#1)
homeologous recombination##2##2##(1996-6#2)
homeologous##4##1##(1996-6#4)
homeopathic products (&quot##2##3##(2008-10#2)
homeopathic##6##1##(2008-10#6)
homeostasis and in##2##3##(2008-10#1)(2012-2#1)
homeostasis and##17##2##(1994-12#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-11#1)(2011-9#1)(2012-2#4)(2013-1#1)(2013-8#2)
homeostasis as##2##2##(2010-1#1)(2013-8#1)
homeostasis but##2##2##(2009-9#1)(2011-2#1)
homeostasis can be##2##3##(2012-2#2)
homeostasis in the##2##3##(2009-3#1)(2013-1#1)
homeostasis in##5##2##(2009-3#1)(2010-12#1)(2012-3#1)(2013-1#2)
homeostasis is##3##2##(1994-11#1)(1994-2#1)(1994-8#1)
homeostasis model assessment for insulin resistance (HOMA-IR)##2##7##(2011-1#1)(2013-8#1)
homeostasis model assessment##4##3##(2011-1#2)(2012-5#1)(2013-8#1)
homeostasis of the##4##3##(2008-12#1)(2009-10#1)(2013-1#1)(2013-8#1)
homeostasis of##6##2##(1992-5#1)(2008-12#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
homeostasis provides##2##2##(2012-2#1)(2013-1#1)
homeostasis system##4##2##(2011-2#1)(2013-1#3)
homeostasis under##2##2##(2008-1#1)(2008-11#1)
homeostasis##111##1##(1990-5#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-5#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#2)(1996-2#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2011-9#1)(2012-2#18)(2012-3#1)(2012-5#1)(2013-1#13)(2013-7#2)(2013-8#5)
homeostatic confocal microscopy##2##3##(2008-11#2)
homeostatic system##2##2##(1990-9#1)(2010-11#1)
homeostatic##10##1##(1990-9#1)(1995-3#1)(2008-11#4)(2008-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
homeotic gene##2##2##(2008-8#2)
homeotic genes##2##2##(2008-8#1)(2008-9#1)
homeotic##6##1##(2008-8#5)(2008-9#1)
homeownership##7##1##(2011-2#7)
homes and communities##2##3##(2012-2#2)
homes and##10##2##(1991-1#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-11#2)(2009-9#1)(2012-2#2)
homes in##10##2##(1995-3#1)(1996-3#1)(2008-12#1)(2008-7#1)(2010-10#4)(2010-11#1)(2011-2#1)
homes to##2##2##(1997-1#1)(2012-12#1)
homes##78##1##(1990-12#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#2)(1992-3#8)(1994-12#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-2#5)(1995-3#1)(1996-1#1)(1996-2#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-9#1)(2010-10#13)(2010-11#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)
homes)##2##1##(1993-12#1)(2010-5#1)
homes]##2##1##(1994-9#1)(1996-6#1)
homicide rates##4##2##(2008-12#4)
homicide##15##1##(1992-2#1)(2008-12#5)(2011-2#9)
homing pigeons##2##2##(1990-11#2)
homing##7##1##(1990-11#4)(2008-10#1)(2010-1#1)(2012-2#1)
hominid##3##1##(1994-3#3)
homo- and##4##2##(1990-5#1)(1992-12#1)(1995-11#2)
homo- or##3##2##(1996-2#1)(2008-11#1)(2011-1#1)
homo-##7##1##(1990-5#1)(1992-12#1)(1995-11#2)(1996-2#1)(2008-11#1)(2011-1#1)
homo-sexual transfer##2##2##(2008-11#2)
homobasidiomycetes##2##1##(2011-1#2)
homocyst(e)ine levels##2##2##(1995-2#2)
homocyst(e)ine##5##1##(1995-2#5)
homocysteine and##2##2##(2008-10#1)(2010-1#1)
homocysteine concentrations higher than 15 micromol/l were associated with##2##9##(2008-7#2)
homocysteine concentrations##4##2##(2008-7#3)(2012-3#1)
homocysteine in##4##2##(2008-10#3)(2008-7#1)
homocysteine is##3##2##(1991-12#1)(1992-9#1)(2008-8#1)
homocysteine level##2##2##(1992-9#1)(2008-11#1)
homocysteine levels##5##2##(1992-9#2)(2008-11#3)
homocysteine methyltransferase##3##2##(1991-12#3)
homocysteine will##2##2##(1992-9#1)(2008-8#1)
homocysteine##51##1##(1991-12#7)(1992-9#7)(2008-10#17)(2008-11#5)(2008-7#5)(2008-8#6)(2010-1#2)(2011-2#1)(2012-3#1)
homodimer in yeast##2##3##(2008-9#2)
homodimer of##2##2##(1995-6#1)(2008-9#1)
homodimer##7##1##(1995-6#1)(1995-8#1)(1997-7#1)(2008-9#4)
homodimeric##5##1##(1992-6#1)(2008-11#2)(2008-5#1)(2008-8#1)
homodimerization of##2##2##(1995-8#1)(2009-10#1)
homodimers##2##1##(1994-5#1)(2009-10#1)
homoeocarpa##11##1##(2008-10#11)
homoeologous group##4##2##(2008-10#3)(2008-8#1)
homoeostasis##2##1##(1993-6#1)(2009-8#1)
homogalacturonan##3##1##(2008-10#3)
homogenate in##2##2##(2008-10#1)(2013-7#1)
homogenate of##5##2##(1994-8#2)(2008-10#1)(2008-5#1)(2012-3#1)
homogenate was##2##2##(2008-10#1)(2010-4#1)
homogenate##25##1##(1991-1#1)(1991-12#2)(1994-8#2)(1996-2#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#3)(2010-4#1)(2010-8#2)(2012-3#1)(2013-7#1)
homogenates and soluble fractions##2##4##(1990-11#2)
homogenates and##3##2##(1990-11#3)
homogenates of##2##2##(1993-6#1)(2008-10#1)
homogenates were##2##2##(1993-8#1)(1994-8#1)
homogenates with##2##2##(1994-11#1)(2008-10#1)
homogenates##21##1##(1990-11#3)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-8#2)(1995-11#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#4)
homogeneity and##5##2##(1997-7#1)(2008-10#3)(2008-8#1)
homogeneity by a##2##3##(1993-6#1)(2008-8#1)
homogeneity by##10##2##(1991-12#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-8#1)(2008-8#3)(2009-3#1)(2010-4#1)
homogeneity from the##2##3##(1990-5#1)(1990-8#1)
homogeneity from##11##2##(1990-11#1)(1990-5#2)(1990-8#1)(1992-8#1)(1994-5#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-8#2)
homogeneity in##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
homogeneity of the##5##3##(2008-10#4)(2008-3#1)
homogeneity of##10##2##(1995-12#1)(2008-10#8)(2008-3#1)
homogeneity within##2##2##(2008-10#2)
homogeneity##64##1##(1990-10#1)(1990-11#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#3)(1995-12#3)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#16)(2008-11#2)(2008-3#3)(2008-8#7)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
homogeneous T1-SI identical to the SI of subcutaneous fat##3##9##(2012-2#3)
homogeneous and heterogeneous##2##3##(2008-10#1)(2008-8#1)
homogeneous and isointense to##2##4##(1997-8#1)(2012-2#1)
homogeneous and##9##2##(1990-5#1)(1995-12#1)(1997-8#1)(2008-10#4)(2008-8#1)(2012-2#1)
homogeneous group##4##2##(1996-12#1)(2008-10#3)
homogeneous groups of cases##2##4##(1992-12#1)(1993-12#1)
homogeneous histidase##2##2##(1994-5#2)
homogeneous immunoassay##2##2##(2008-10#2)
homogeneous mixture of##2##3##(2008-10#2)
homogeneous particles with##2##3##(2008-3#2)
homogeneous particles##3##2##(2008-3#3)
homogeneous pattern##2##2##(1991-11#1)(2008-10#1)
homogeneous phase##2##2##(2008-10#2)
homogeneous population of##2##3##(1995-2#1)(1996-12#1)
homogeneous population##5##2##(1995-2#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
homogeneous populations##2##2##(2008-8#1)(2012-3#1)
homogeneous porous##2##2##(2008-10#2)
homogeneous solution##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
homogeneous spherical##2##2##(2008-2#2)
homogeneous strains of##2##3##(2012-3#2)
homogeneous ternary solvent system##2##4##(2008-10#2)
homogeneous with##2##2##(1995-12#1)(2008-10#1)
homogeneous##133##1##(1990-11#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-5#4)(1995-11#1)(1995-12#3)(1995-2#1)(1996-12#2)(1997-8#1)(2008-10#56)(2008-11#1)(2008-2#3)(2008-3#14)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#8)(2008-9#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-7#1)
homogeneously distributed in##2##3##(1994-2#1)(2008-10#1)
homogeneously distributed##4##2##(1994-2#1)(2008-10#2)(2008-11#1)
homogeneously##8##1##(1994-2#2)(2008-10#4)(2008-11#1)(2008-5#1)
homogenisation##2##1##(2008-10#2)
homogenised##2##1##(2008-10#2)
homogenization##6##1##(2008-10#2)(2008-7#3)(2011-3#1)
homogenized and##2##2##(1992-12#1)(2008-5#1)
homogenized tissue##3##2##(1994-8#1)(2008-10#2)
homogenized##15##1##(1992-12#1)(1994-8#1)(1995-8#1)(2008-10#10)(2008-5#1)(2009-7#1)
homogenizer##5##1##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
homogenizers##2##1##(2008-3#2)
homogenizing##3##1##(2008-10#2)(2008-9#1)
homogenous##19##1##(1994-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
homogentisic acid##2##2##(2008-10#2)
homokaryons##2##1##(2008-10#2)
homolog of human##2##3##(1993-12#1)(2008-9#1)
homolog of the Drosophila segment polarity gene##2##7##(1993-12#1)(1994-12#1)
homolog of the##4##3##(1993-12#1)(1993-3#1)(1994-12#1)(2008-10#1)
homolog of##11##2##(1992-9#1)(1993-12#2)(1993-3#1)(1994-12#1)(1996-12#1)(2008-10#2)(2008-9#1)(2009-7#1)(2012-2#1)
homolog##32##1##(1992-9#1)(1993-12#2)(1993-3#1)(1994-12#2)(1996-12#1)(1996-6#2)(1996-8#1)(1997-4#2)(2008-10#11)(2008-6#1)(2008-9#3)(2009-7#1)(2012-2#3)(2013-8#1)
homological##2##1##(2008-8#2)
homologies of##2##2##(1990-11#1)(1993-6#1)
homologies to the##2##3##(1991-9#1)(1993-6#1)
homologies##13##1##(1990-11#1)(1991-9#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-4#1)
homologous DNA##3##2##(1992-6#2)(1993-9#1)
homologous DNA-pairing activities##2##3##(1995-2#2)
homologous and##2##2##(2008-5#1)(2010-8#1)
homologous antigens##2##2##(2008-10#2)
homologous blood##4##2##(1990-2#3)(1992-3#1)
homologous cDNA##2##2##(1995-8#1)(2009-10#1)
homologous chromosomes##2##2##(2008-12#1)(2011-2#1)
homologous gene##2##2##(2008-8#1)(2008-9#1)
homologous genes##3##2##(1997-7#1)(2008-9#2)
homologous halves##2##2##(1994-5#1)(2008-11#1)
homologous human##2##2##(1993-2#1)(2008-4#1)
homologous in##2##2##(1996-12#1)(2007-12#1)
homologous or heterologous##2##3##(1994-8#1)(2008-10#1)
homologous protein##4##2##(1994-5#1)(1995-9#1)(1997-7#1)(2013-8#1)
homologous proteins##2##2##(1994-5#1)(1997-6#1)
homologous recombination in##5##3##(1995-2#1)(2008-4#3)(2010-1#1)
homologous recombination within##2##3##(2008-11#1)(2013-8#1)
homologous recombination##19##2##(1990-5#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-4#6)(2008-8#2)(2008-9#3)(2010-1#1)(2013-1#1)(2013-8#1)
homologous regions##4##2##(1991-12#1)(1992-12#1)(1993-2#1)(2008-8#1)
homologous sequence##4##2##(1995-8#1)(1996-6#1)(2008-4#1)(2008-9#1)
homologous sequences##7##2##(1991-9#1)(1993-2#1)(1993-8#1)(1995-2#1)(2008-8#2)(2008-9#1)
homologous to a region##2##4##(1995-6#1)(2008-10#1)
homologous to a##4##3##(1993-12#1)(1995-6#1)(2008-10#1)(2008-8#1)
homologous to known##3##3##(1991-6#1)(1997-8#1)(2008-10#1)
homologous to other known genes##3##5##(1996-12#2)(1996-6#1)
homologous to previously characterized##2##4##(2008-10#1)(2013-1#1)
homologous to that of the##3##5##(1991-9#1)(1994-11#1)(2013-1#1)
homologous to the corresponding##2##4##(1996-6#1)(2008-8#1)
homologous to the##15##3##(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#1)(2007-12#2)(2008-10#1)(2008-8#2)(2008-9#1)
homologous to those##2##3##(1990-5#1)(2008-10#1)
homologous to##55##2##(1990-2#1)(1990-5#1)(1991-6#2)(1991-9#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-9#2)(1994-11#1)(1995-2#1)(1995-6#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#4)(1997-2#1)(1997-7#2)(1997-8#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-8#5)(2008-9#3)(2009-6#2)(2011-2#1)(2013-1#2)
homologous virus##2##2##(2008-10#1)(2008-8#1)
homologous with##2##2##(2008-10#1)(2008-9#1)
homologous##183##1##(1990-11#1)(1990-2#4)(1990-4#1)(1990-5#5)(1991-12#3)(1991-6#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#4)(1993-2#4)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-5#6)(1994-8#2)(1995-11#1)(1995-2#7)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#6)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#6)(1997-8#2)(2007-12#3)(2008-10#24)(2008-11#4)(2008-12#1)(2008-4#8)(2008-5#5)(2008-7#2)(2008-8#12)(2008-9#16)(2009-10#2)(2009-6#3)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#3)
homologs in the##3##3##(2008-10#2)(2011-2#1)
homologs in##11##2##(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
homologs of##3##2##(2008-12#1)(2012-2#1)(2012-3#1)
homologs were##3##2##(1997-4#1)(2008-10#1)(2010-10#1)
homologs##31##1##(1997-3#1)(1997-4#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#5)(2010-10#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-8#1)
homologue in##2##2##(1995-2#1)(2008-8#1)
homologue of Drosophila##2##3##(1995-6#1)(1997-7#1)
homologue of the Drosophila##2##4##(1995-6#1)(1997-3#1)
homologue of the##6##3##(1995-2#1)(1995-6#1)(1997-3#2)(1997-7#1)(2007-12#1)
homologue of yeast##2##3##(1993-9#1)(1995-2#1)
homologue of##15##2##(1993-2#1)(1993-9#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-3#1)(1997-3#2)(1997-7#2)(2007-12#1)(2008-10#1)(2009-9#1)
homologue was##2##2##(1991-6#1)(1996-12#1)
homologue##45##1##(1991-6#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#6)(1995-2#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-3#3)(1997-7#4)(1997-9#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-8#1)(2009-9#1)(2011-1#1)
homologues and##2##2##(1993-2#1)(2008-10#1)
homologues from##2##2##(1997-7#1)(2008-4#1)
homologues in##2##2##(1997-3#1)(2008-8#1)
homologues of the##3##3##(1993-8#1)(1997-3#2)
homologues of##8##2##(1992-11#1)(1993-8#1)(1994-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(2008-7#1)
homologues was##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
homologues##36##1##(1991-6#1)(1992-11#3)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-3#2)(1996-6#2)(1997-3#4)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)
homology analysis##3##2##(2008-10#1)(2008-9#1)(2009-6#1)
homology and##2##2##(1993-2#1)(1993-6#1)
homology at the##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
homology at##4##2##(1996-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
homology between the##4##3##(1991-9#1)(1993-12#1)(2008-8#1)(2008-9#1)
homology between##8##2##(1990-7#1)(1991-9#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)
homology in their##2##3##(1990-5#1)(2012-2#1)
homology in##6##2##(1990-5#1)(1991-12#1)(1994-11#1)(2008-4#2)(2012-2#1)
homology is##2##2##(1993-2#1)(2011-2#1)
homology model##2##2##(2008-8#2)
homology modeling##4##2##(1994-5#1)(2008-8#2)(2012-2#1)
homology of the##4##3##(1997-6#1)(2008-9#2)(2011-2#1)
homology of##7##2##(1992-3#1)(1997-6#1)(2008-8#2)(2008-9#2)(2011-2#1)
homology search##5##2##(1995-12#1)(1996-8#1)(1997-7#1)(2008-10#2)
homology searches##2##2##(1996-2#1)(2010-11#1)
homology to a##3##3##(1990-5#1)(2008-10#1)(2008-8#1)
homology to each##2##3##(1993-12#1)(1993-3#1)
homology to other##3##3##(1991-5#1)(1992-8#1)(1996-3#1)
homology to that of##2##4##(1993-12#1)(1997-7#1)
homology to the##9##3##(1993-12#3)(1995-12#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-8#2)
homology to##39##2##(1990-11#1)(1990-5#2)(1991-5#1)(1992-8#1)(1993-12#5)(1993-2#1)(1993-3#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-7#3)(2008-10#4)(2008-8#4)(2008-9#2)(2009-10#1)
homology was##2##2##(2008-9#2)
homology with any##4##3##(1996-2#1)(1996-3#1)(2008-8#1)(2008-9#1)
homology with genes##3##3##(1997-6#1)(2008-10#1)(2008-9#1)
homology with known##2##3##(1993-9#1)(2008-9#1)
homology with other##3##3##(1996-3#1)(1997-7#1)(2008-8#1)
homology with the human##2##4##(1993-12#1)(1993-3#1)
homology with the##11##3##(1990-11#1)(1990-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
homology with##46##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-8#5)(2008-9#8)(2010-5#1)(2011-2#1)
homology##171##1##(1990-11#3)(1990-12#1)(1990-5#4)(1990-7#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#11)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#4)(1995-6#3)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#5)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#5)(1997-8#3)(2008-10#21)(2008-11#3)(2008-4#3)(2008-5#1)(2008-8#20)(2008-9#17)(2009-10#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#4)(2013-8#1)
homology-directed repair##2##2##(2013-1#2)
homomeric##2##1##(1995-11#2)
homonuclear##3##1##(1990-5#1)(1992-4#1)(1994-5#1)
homophobia##2##1##(1995-12#1)(1996-11#1)
homopolymer##4##1##(2010-8#2)(2011-1#2)
homopolymers##4##1##(2009-10#2)(2013-1#2)
homopyrimidine##3##1##(1993-6#1)(1993-8#2)
homoscedastic##4##1##(1995-9#3)(2008-10#1)
homoscedasticity##2##1##(2008-10#2)
homoserine##3##1##(2008-10#1)(2008-9#2)
homosexual men##4##2##(1996-11#4)
homosexual##8##1##(1992-9#1)(1996-11#4)(2007-12#1)(2008-5#1)(2011-2#1)
homosexuals##5##1##(1990-2#2)(1995-12#2)(1996-11#1)
homothallic##4##1##(2008-10#3)(2010-3#1)
homovanillic acid##3##2##(1993-1#1)(2008-10#2)
homozygosis##2##1##(2012-3#2)
homozygosity at##2##2##(2008-10#1)(2012-3#1)
homozygosity##3##1##(1994-11#1)(2008-10#1)(2012-3#1)
homozygote class 1##2##3##(1990-2#2)
homozygote##4##1##(1990-2#2)(1997-8#2)
homozygotes and##2##2##(1994-12#1)(1995-2#1)
homozygotes were##3##2##(1995-2#2)(2008-10#1)
homozygotes##5##1##(1994-12#1)(1995-2#3)(2008-10#1)
homozygotic familial hypercholesterolemia##3##3##(1991-11#3)
homozygous deletion at chromosome 2q33 in a small cell lung carcinoma##2##11##(1996-12#2)
homozygous deletion##5##2##(1996-12#3)(1997-2#1)(2011-1#1)
homozygous deletions##2##2##(1997-7#1)(2011-2#1)
homozygous for the##11##3##(1994-11#1)(1995-12#2)(1995-2#2)(2008-10#4)(2012-3#2)
homozygous for##20##2##(1994-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-9#1)(1997-8#1)(2008-10#6)(2008-9#2)(2011-2#2)(2012-3#2)
homozygous phenotype##2##2##(2008-6#2)
homozygous resistant##3##2##(2008-10#2)(2008-8#1)
homozygous susceptible##2##2##(2008-10#2)
homozygous##61##1##(1990-8#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-12#2)(1995-2#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#4)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#18)(2008-12#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#3)
homozygously deleted##2##2##(1997-2#2)
honest##3##1##(1995-5#2)(2008-9#1)
honesty##8##1##(1992-3#1)(1995-5#4)(2008-9#2)(2010-10#1)
honey and##3##2##(2008-10#3)
honey bee##4##2##(2008-10#1)(2008-6#2)(2013-1#1)
honey bees##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
honey samples using##2##3##(2008-10#2)
honey samples##11##2##(2008-10#11)
honey with##5##2##(2008-10#4)(2011-2#1)
honey##48##1##(2008-10#38)(2008-6#3)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#2)
honeybee##12##1##(1994-8#2)(2008-10#1)(2008-7#5)(2008-8#4)
honeybees##8##1##(2008-10#6)(2008-7#1)(2008-8#1)
honeycomb##3##1##(1994-2#1)(2008-10#2)
honeydew##4##1##(2008-10#3)(2011-2#1)
honeys formed a##2##3##(2008-10#2)
honeys from##2##2##(2008-10#1)(2011-2#1)
honeys were##2##2##(2008-10#1)(2011-2#1)
honeys##13##1##(2008-10#7)(2011-2#6)
honokiol and magnolol##5##3##(2008-10#5)
honokiol and##6##2##(2008-10#6)
honor of##3##2##(1993-2#1)(2011-2#1)(2013-1#1)
honor##7##1##(1992-12#1)(1993-2#1)(1996-2#1)(2008-11#2)(2011-2#1)(2013-1#1)
honors##6##1##(1992-3#1)(2008-10#5)
hooked##3##1##(2008-10#2)(2008-12#1)
hoop stress##2##2##(2009-7#2)
hop powdery mildew was##2##4##(2008-10#2)
hop powdery mildew##4##3##(2008-10#4)
hop##8##1##(2008-10#8)
hope and expectancy##4##3##(2008-11#4)
hope and wellbeing##2##3##(2010-10#2)
hope and##7##2##(1996-3#1)(2008-11#4)(2010-10#2)
hope for##2##2##(2008-12#1)(2011-3#1)
hope in##4##2##(1997-5#1)(2010-10#2)(2012-3#1)
hope that this##2##3##(2008-10#1)(2008-11#1)
hope that##13##2##(1990-2#1)(1993-11#1)(1993-3#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-8#1)(2013-1#1)
hope to##2##2##(1991-1#1)(1991-12#1)
hope##46##1##(1990-2#1)(1991-1#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-5#2)(2008-10#3)(2008-11#10)(2008-12#4)(2008-8#1)(2008-9#1)(2010-10#7)(2010-12#1)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#2)
hoped that##22##2##(1991-1#1)(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
hoped##25##1##(1991-1#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
hopefully##7##1##(1991-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)(2010-4#1)
hopes and expectancies##3##3##(2008-11#3)
hopes and##5##2##(2008-11#4)(2013-1#1)
hopes of##3##2##(1992-2#1)(2008-9#1)(2011-2#1)
hopes to##2##2##(1990-11#2)
hopes##12##1##(1990-11#3)(1992-2#1)(1995-6#1)(2008-11#4)(2008-9#1)(2011-2#1)(2013-1#1)
hopping##6##1##(1991-3#1)(1992-12#2)(2008-3#2)(2010-7#1)
hordei DNA##2##2##(2008-10#2)
hordei and U##2##3##(2008-10#2)
hordei and##6##2##(2008-10#6)
hordei in##3##2##(2008-10#3)
hordei isolate VA90-34##2##3##(2008-10#2)
hordei##45##1##(2008-10#45)
hordei)##4##1##(2008-10#4)
horizon of##4##2##(2008-11#1)(2008-12#1)(2010-8#1)(2012-2#1)
horizon##11##1##(2008-11#2)(2008-12#1)(2008-9#2)(2009-8#3)(2010-8#1)(2011-2#1)(2012-2#1)
horizons for##2##2##(1996-2#1)(2008-11#1)
horizons of##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
horizons##7##1##(1993-2#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-7#1)
horizontal and vertical##2##3##(1996-1#1)(2008-9#1)
horizontal distance##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
horizontal distribution of##2##3##(2008-10#1)(2008-5#1)
horizontal edges##2##2##(2008-9#2)
horizontal orientation##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
horizontal resistance to##2##3##(2008-8#1)(2009-6#1)
horizontal resistance##3##2##(2008-8#1)(2009-6#2)
horizontal transfer of##3##3##(2008-10#2)(2009-6#1)
horizontal transfers##2##2##(2009-6#2)
horizontal transmission of##2##3##(2008-10#1)(2008-9#1)
horizontal transmission##4##2##(2008-10#1)(2008-9#1)(2012-3#2)
horizontal##66##1##(1990-11#1)(1991-5#1)(1993-1#2)(1993-3#1)(1996-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-12#2)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#12)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#1)(2009-6#5)(2011-2#2)(2012-3#3)(2013-1#1)
horizontally and##2##2##(2008-10#2)
horizontally oriented##2##2##(2008-3#2)
horizontally##12##1##(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2011-1#1)
hormesis in##6##2##(2008-7#4)(2013-1#2)
hormesis##17##1##(2008-12#1)(2008-7#13)(2013-1#3)
hormetic effects of##2##3##(2008-7#2)
hormetic effects##3##2##(2008-7#3)
hormetic response##2##2##(2008-7#2)
hormetic##11##1##(2008-12#1)(2008-7#10)
hormonal and metabolic##3##3##(1991-2#1)(2008-3#1)(2013-7#1)
hormonal and##6##2##(1991-2#1)(1995-11#1)(2008-10#2)(2008-3#1)(2013-7#1)
hormonal changes##2##2##(1991-3#1)(2008-11#1)
hormonal effects on##2##3##(1990-12#1)(2008-11#1)
hormonal effects##4##2##(1990-12#1)(1991-3#1)(1995-11#1)(2008-11#1)
hormonal milieu##3##2##(2008-11#2)(2008-7#1)
hormonal regulation of##2##3##(1995-11#2)
hormonal regulation##3##2##(1995-11#3)
hormonal responses of##2##3##(1994-12#1)(2008-3#1)
hormonal responses##4##2##(1994-12#2)(2008-3#1)(2013-1#1)
hormonal secretions##2##2##(1991-6#1)(2012-2#1)
hormonal stimuli##2##2##(1990-2#1)(2008-4#1)
hormonal systems##2##2##(2008-3#2)
hormonal treatment##3##2##(1991-11#1)(1994-8#1)(2008-6#1)
hormonal##63##1##(1990-12#1)(1990-2#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#2)(1994-8#2)(1995-11#7)(1995-2#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#5)
hormonally induced##2##2##(1991-3#1)(2008-9#1)
hormonally##5##1##(1991-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
hormone (CRH)##2##2##(1992-6#1)(2008-11#1)
hormone (FSH) in##3##3##(1993-11#2)(2010-5#1)
hormone (FSH)##5##2##(1993-11#2)(2010-5#2)(2011-1#1)
hormone (GH)##8##2##(1991-9#1)(1994-8#1)(1995-12#1)(1996-11#1)(2010-5#2)(2011-1#1)(2013-1#1)
hormone (GnRH)##5##2##(1992-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-2#1)
hormone (JH)##4##2##(1992-6#1)(1995-11#1)(2012-2#2)
hormone (TRH)##3##2##(1992-6#1)(2008-4#1)(2013-7#1)
hormone (TSH)##3##2##(2008-6#1)(2012-12#1)(2012-3#1)
hormone 1-44 NH2 and 1-40 OH##4##6##(1992-9#4)
hormone 1-44 NH2##6##3##(1992-9#6)
hormone action##2##2##(2011-2#2)
hormone and prolactin##4##3##(1991-3#1)(1993-2#3)
hormone and##17##2##(1990-2#1)(1991-3#1)(1993-2#3)(1994-11#1)(1995-11#1)(1996-2#1)(2007-7#1)(2008-4#2)(2008-6#1)(2009-10#1)(2010-10#1)(2010-5#2)(2011-2#1)
hormone at##3##2##(1990-3#1)(2008-12#1)(2009-8#1)
hormone balance##2##2##(1997-6#1)(2008-7#1)
hormone binding globulin##3##3##(1991-3#3)
hormone binding##6##2##(1990-4#1)(1991-3#3)(1993-6#1)(2013-1#1)
hormone concentrations##2##2##(1990-3#1)(2013-1#1)
hormone deficiencies##3##2##(2013-1#3)
hormone deficiency##12##2##(1996-11#1)(2008-5#1)(2011-1#3)(2012-3#6)(2013-1#1)
hormone dependency##2##2##(1990-2#1)(1997-7#1)
hormone for##2##2##(1991-10#1)(1995-12#1)
hormone in the##2##3##(1991-5#1)(2013-1#1)
hormone in##11##2##(1990-2#1)(1991-5#1)(1992-6#2)(1993-6#1)(1995-12#1)(2008-5#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
hormone index level##2##3##(2008-3#2)
hormone induced##2##2##(1991-3#1)(1993-6#1)
hormone is##5##2##(1995-2#1)(2008-10#2)(2008-8#1)(2012-3#1)
hormone led to the##2##4##(1995-2#1)(1996-2#1)
hormone led to##3##3##(1995-2#2)(1996-2#1)
hormone levels##3##2##(2008-7#2)(2012-3#1)
hormone manipulations##2##2##(1990-11#1)(2008-11#1)
hormone on##2##2##(1990-11#1)(2008-9#1)
hormone receptor superfamily##2##3##(1995-12#1)(1995-2#1)
hormone receptor##23##2##(1993-2#1)(1993-3#1)(1993-8#4)(1994-12#1)(1995-11#2)(1995-12#1)(1995-2#3)(1997-1#2)(2008-10#1)(2008-8#3)(2008-9#2)(2010-5#2)
hormone receptors##5##2##(1993-6#1)(1995-2#1)(2008-10#1)(2008-9#1)(2013-7#1)
hormone regulated##2##2##(1997-7#1)(2008-10#1)
hormone related peptide##2##3##(2013-7#2)
hormone replacement therapy in##3##4##(1993-2#1)(2012-3#2)
hormone replacement therapy##7##3##(1993-2#1)(1996-6#1)(2008-11#2)(2010-12#1)(2012-3#2)
hormone replacement##9##2##(1993-2#1)(1996-6#1)(2008-11#2)(2010-12#1)(2011-1#2)(2012-3#2)
hormone response element##2##3##(1992-6#1)(1993-8#1)
hormone response##3##2##(1992-6#1)(1993-8#1)(2013-1#1)
hormone secretion in##2##3##(1991-9#1)(1992-8#1)
hormone secretion##3##2##(1991-9#1)(1992-8#1)(2011-2#1)
hormone sensitive##2##2##(1990-11#1)(2008-7#1)
hormone signals##3##2##(2009-8#3)
hormone therapy and##2##3##(1993-1#1)(2010-8#1)
hormone therapy##10##2##(1990-12#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-11#1)(2008-11#4)(2010-8#1)
hormone##348##1##(1990-11#6)(1990-12#1)(1990-2#10)(1990-3#2)(1990-4#2)(1990-5#3)(1991-10#1)(1991-12#1)(1991-3#15)(1991-5#1)(1991-6#7)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-6#12)(1992-8#3)(1992-9#8)(1993-1#3)(1993-11#4)(1993-12#1)(1993-2#6)(1993-3#1)(1993-5#1)(1993-6#8)(1993-8#5)(1994-11#3)(1994-12#1)(1994-2#2)(1994-8#3)(1995-11#11)(1995-12#12)(1995-2#10)(1995-8#5)(1995-9#1)(1996-11#3)(1996-12#2)(1996-2#5)(1996-6#1)(1997-1#5)(1997-6#1)(1997-7#3)(2007-11#1)(2007-7#3)(2008-10#15)(2008-11#11)(2008-12#4)(2008-3#2)(2008-4#9)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#6)(2009-10#2)(2009-6#3)(2009-8#8)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#10)(2010-6#1)(2010-8#1)(2011-1#13)(2011-10#1)(2011-2#7)(2012-12#2)(2012-2#5)(2012-3#17)(2013-1#13)(2013-7#10)(2013-8#2)
hormone)##2##1##(2008-4#1)(2010-1#1)
hormone- and##3##2##(1994-2#1)(2011-2#2)
hormone-binding##3##1##(1990-2#1)(2008-3#1)(2012-2#1)
hormone-dependent breast cancer##2##3##(2013-8#2)
hormone-dependent##9##1##(1993-1#2)(1993-8#1)(2008-10#1)(2008-11#3)(2013-8#2)
hormone-regulated##2##1##(1995-11#1)(2009-8#1)
hormone-related peptide##2##2##(1993-3#2)
hormone-related##6##1##(1990-6#1)(1993-3#2)(1995-9#1)(2008-11#1)(2009-8#1)
hormone-releasing hormone##8##2##(1992-9#6)(1993-1#2)
hormone-releasing##10##1##(1991-9#2)(1992-9#6)(1993-1#2)
hormone-specific##2##1##(1995-11#1)(1995-8#1)
hormones and cytokines##2##3##(1996-2#2)
hormones and growth factors##2##4##(1993-12#2)
hormones and the##2##3##(2008-11#1)(2013-7#1)
hormones and##22##2##(1990-11#1)(1993-12#2)(1995-8#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-7#1)
hormones are##7##2##(1990-4#1)(1991-3#1)(1992-10#1)(1993-3#1)(1995-2#2)(2008-3#1)
hormones as##3##2##(1995-2#1)(2011-1#1)(2012-2#1)
hormones in the##2##3##(1990-3#1)(2009-10#1)
hormones in##10##2##(1990-3#1)(1991-1#1)(1993-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-2#1)(2012-3#2)
hormones on the##3##3##(1993-8#1)(2008-6#1)(2012-3#1)
hormones such as##2##3##(2008-11#1)(2011-2#1)
hormones that##4##2##(1995-8#1)(2008-9#1)(2011-2#1)(2013-7#1)
hormones were##4##2##(1990-3#1)(1991-3#1)(2008-8#1)(2012-2#1)
hormones##124##1##(1990-11#8)(1990-2#1)(1990-3#3)(1990-4#1)(1991-1#1)(1991-3#2)(1992-10#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#8)(1995-12#2)(1995-2#3)(1995-8#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#5)(2012-3#3)(2013-1#1)(2013-7#3)
horn is##2##2##(2013-1#2)
horn melon##2##2##(2008-10#2)
horn of the##3##3##(1990-9#1)(1994-2#1)(1995-12#1)
horn##34##1##(1990-9#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-6#1)(1994-2#3)(1995-12#4)(1996-12#1)(1997-3#8)(1997-5#1)(2008-10#2)(2008-7#2)(2008-8#1)(2010-5#1)(2013-1#4)
horny##2##1##(1990-6#1)(2008-5#1)
horse chestnut##3##2##(2008-5#3)
horse heart##3##2##(1994-5#2)(2008-7#1)
horse kidney##3##2##(2008-10#3)
horse liver##2##2##(1990-5#1)(2008-11#1)
horse myoglobin##2##2##(1990-8#2)
horse serum##2##2##(2008-10#2)
horse was##2##2##(2013-1#1)(2013-8#1)
horse##35##1##(1990-5#3)(1990-8#2)(1994-5#2)(1996-1#1)(1996-3#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2010-4#3)(2011-2#1)(2013-1#2)(2013-8#1)
horse-radish peroxidase##6##2##(2008-10#6)
horseradish peroxidase (HRP) in##2##4##(1990-5#1)(2008-10#1)
horseradish peroxidase (HRP)##21##3##(1990-5#1)(2008-10#19)(2012-2#1)
horseradish peroxidase (HRP)-labeled##2##3##(2008-10#2)
horseradish peroxidase and hydrogen##2##4##(2008-10#2)
horseradish peroxidase and##5##3##(1990-12#1)(2008-10#3)(2008-9#1)
horseradish peroxidase##52##2##(1990-12#1)(1990-5#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#39)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
horseradish##53##1##(1990-12#1)(1990-5#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#40)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
horses by##2##2##(1996-3#1)(2013-1#1)
horses with##2##2##(1996-6#1)(2013-8#1)
horses##29##1##(1990-3#2)(1992-5#1)(1996-3#2)(1996-6#1)(1996-8#1)(2011-2#2)(2012-3#7)(2013-1#7)(2013-8#6)
horseshoe kidney##3##2##(2008-10#3)
horticultural crops##3##2##(2008-10#3)
horticultural##8##1##(2008-10#8)
horticulture##3##1##(2008-10#2)(2010-6#1)
hortorum##3##1##(2008-10#3)
hoshin planning##2##2##(1994-2#2)
hoshin##3##1##(1994-2#3)
hospice benefit##4##2##(1991-3#2)(1993-12#1)(1994-12#1)
hospice care##8##2##(1993-12#3)(1994-12#1)(1996-3#1)(2008-6#1)(2009-3#1)(2012-12#1)
hospice expenditure##2##2##(1994-12#2)
hospice##24##1##(1991-2#1)(1991-3#2)(1993-12#5)(1993-2#1)(1994-12#8)(1996-3#1)(1997-2#1)(2008-6#1)(2009-3#1)(2012-12#2)(2013-8#1)
hospital administrators and##2##3##(1992-2#1)(1994-2#1)
hospital administrators##5##2##(1991-1#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-2#1)
hospital admission##9##2##(1994-12#1)(2007-8#1)(2009-6#2)(2011-2#3)(2012-12#1)(2012-3#1)
hospital admissions##2##2##(1990-11#1)(1991-3#1)
hospital and general practice##2##4##(1992-2#1)(2008-3#1)
hospital and physician##2##3##(1992-1#1)(1992-2#1)
hospital and the##5##3##(1991-1#1)(1991-11#1)(1996-3#1)(2008-10#1)(2011-2#1)
hospital and##31##2##(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-2#3)(1993-1#1)(1993-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-3#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-3#2)
hospital antibiotic use and##2##4##(2013-1#2)
hospital as a##2##3##(1991-1#1)(1994-3#1)
hospital as##3##2##(1991-1#1)(1994-3#1)(1996-3#1)
hospital at##2##2##(1994-3#1)(2012-12#1)
hospital based case-control study##2##4##(1991-2#2)
hospital based##10##2##(1991-2#2)(1992-2#1)(2008-1#1)(2008-10#2)(2010-11#1)(2012-3#2)(2013-8#1)
hospital because of##3##3##(1993-6#1)(2008-7#1)(2012-2#1)
hospital because##4##2##(1993-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
hospital beds##2##2##(1997-5#1)(1997-6#1)
hospital behavior##3##2##(1991-2#1)(1994-12#1)(2008-11#1)
hospital board effectiveness##2##3##(1991-1#2)
hospital board##3##2##(1991-1#2)(1991-12#1)
hospital boards##2##2##(2008-11#2)
hospital by##3##2##(1990-9#1)(1992-2#1)(2009-8#1)
hospital cafeterias##2##2##(1992-1#2)
hospital care are##2##3##(1991-3#1)(1992-2#1)
hospital care were##2##3##(1991-2#1)(1996-2#1)
hospital care##27##2##(1991-2#2)(1991-3#4)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
hospital center##2##2##(1993-2#1)(2010-6#1)
hospital chief executive##2##3##(1996-2#2)
hospital closures##2##2##(1996-3#2)
hospital competition##3##2##(2008-11#3)
hospital cost per adjusted##2##4##(2008-11#2)
hospital cost##4##2##(1992-12#1)(1995-2#1)(2008-11#2)
hospital costs were##2##3##(1994-2#1)(1995-3#1)
hospital costs##12##2##(1992-2#3)(1993-1#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-3#2)(2008-11#1)(2012-3#2)
hospital data##2##2##(1991-3#1)(1995-12#1)
hospital days##2##2##(1994-2#1)(1995-2#1)
hospital departments##4##2##(1990-3#1)(1991-11#1)(1991-3#1)(1996-1#1)
hospital discharge##5##2##(1992-2#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
hospital discharges##3##2##(1992-2#1)(2013-1#1)(2013-8#1)
hospital emergency departments##2##3##(2008-11#1)(2009-9#1)
hospital emergency##5##2##(1993-11#1)(2008-11#2)(2009-1#1)(2009-9#1)
hospital employee##3##2##(1992-2#1)(1993-1#1)(1996-5#1)
hospital employees##5##2##(1992-3#1)(1992-5#1)(1993-3#2)(1994-12#1)
hospital environment##7##2##(1991-1#1)(1992-2#1)(1992-3#1)(1996-1#1)(2008-11#1)(2010-11#1)(2013-8#1)
hospital expenses##2##2##(2008-11#1)(2011-2#1)
hospital faces##2##2##(1991-3#1)(1992-3#1)
hospital facility##4##2##(1991-1#1)(1993-1#1)(1993-3#1)(2011-2#1)
hospital financial performance##2##3##(1993-1#1)(2008-11#1)
hospital financial##3##2##(1992-12#1)(1993-1#1)(2008-11#1)
hospital for##10##2##(1991-12#1)(1993-12#1)(1993-2#1)(2008-7#3)(2011-2#2)(2012-2#1)(2013-8#1)
hospital from##2##2##(1993-11#1)(2012-12#1)
hospital fund##2##2##(1992-1#1)(1992-3#1)
hospital funding##3##2##(1991-12#3)
hospital governing##3##2##(1991-1#1)(1991-12#1)(2008-11#1)
hospital has##3##2##(1994-2#1)(1995-12#1)(2010-8#1)
hospital in a##3##3##(1992-2#1)(2008-7#1)(2013-1#1)
hospital in the##4##3##(1991-2#1)(1993-1#1)(1993-3#1)(1995-12#1)
hospital in##35##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(1993-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-6#3)(2010-7#1)(2011-2#1)(2013-1#5)(2013-8#1)
hospital increased##2##2##(1992-5#1)(2013-1#1)
hospital information platform design##2##4##(2012-3#2)
hospital information##3##2##(1996-2#1)(2012-3#2)
hospital inpatient services##3##3##(1991-3#1)(1994-12#1)(2008-11#1)
hospital inpatient##6##2##(1991-1#1)(1991-3#1)(1993-12#1)(1994-12#2)(2008-11#1)
hospital input price##2##3##(1992-1#2)
hospital is a##2##3##(1991-11#1)(2008-11#1)
hospital is##14##2##(1991-1#1)(1991-11#1)(1992-1#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-3#2)(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)
hospital laboratory##4##2##(1994-12#1)(1997-1#1)(1997-3#1)(2008-10#1)
hospital leaders##2##2##(1994-2#1)(1997-2#1)
hospital level##3##2##(1991-2#1)(1993-12#1)(2008-11#1)
hospital management##6##2##(1991-12#1)(1991-2#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-1#1)
hospital managers##2##2##(1991-2#1)(1995-1#1)
hospital market##4##2##(1991-2#1)(1992-1#1)(1994-12#1)(2008-11#1)
hospital medical staff##2##3##(1992-1#1)(1993-12#1)
hospital medical##4##2##(1991-8#1)(1992-1#1)(1993-12#1)(1996-3#1)
hospital mortality and morbidity##3##4##(2011-2#3)
hospital network##3##2##(1996-3#1)(2012-2#1)(2012-3#1)
hospital networks##2##2##(1996-3#2)
hospital nursing practice##4##3##(2013-1#4)
hospital of##5##2##(1992-5#1)(2008-12#1)(2008-5#1)(2010-6#1)(2012-3#1)
hospital operations##2##2##(1996-2#1)(2008-11#1)
hospital or##5##2##(1994-12#1)(1995-2#1)(2008-11#1)(2011-2#2)
hospital outpatient services##4##3##(1991-2#3)(1992-12#1)
hospital outpatient##5##2##(1991-2#3)(1992-12#2)
hospital patient##4##2##(1992-2#1)(1994-12#1)(1997-2#1)(2008-11#1)
hospital patients##4##2##(1995-2#1)(1996-9#1)(2008-6#1)(2008-7#1)
hospital payments##2##2##(1992-12#2)
hospital performance##3##2##(2008-11#3)
hospital physicians##2##2##(1994-2#1)(1995-1#1)
hospital profitability##5##2##(2008-11#5)
hospital profits##2##2##(1993-1#2)
hospital program##2##2##(1991-1#1)(1993-2#1)
hospital programs##2##2##(1991-1#2)
hospital quality##2##2##(2010-12#2)
hospital radiology departments##3##3##(1993-3#1)(2012-2#2)
hospital records##3##2##(1990-12#1)(1995-2#1)(2008-11#1)
hospital revenue##2##2##(1992-12#1)(1996-2#1)
hospital risk##2##2##(1992-1#1)(2008-11#1)
hospital security##15##2##(1991-1#1)(1991-12#3)(1992-12#1)(1992-2#1)(1993-2#4)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#2)
hospital services for##6##3##(1991-1#1)(1997-5#5)
hospital services in##3##3##(1991-2#1)(1992-1#1)(1993-2#1)
hospital services##18##2##(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-2#2)(1994-3#2)(1995-2#2)(1997-5#5)
hospital setting##6##2##(1991-1#1)(1991-12#1)(1994-2#1)(2008-11#1)(2010-9#1)(2011-2#1)
hospital settings##3##2##(2008-11#2)(2010-8#1)
hospital spending##5##2##(1992-2#3)(1993-1#1)(2008-11#1)
hospital staff##3##2##(1991-12#1)(2013-1#2)
hospital staffs##2##2##(1994-12#1)(1994-3#1)
hospital statistics##5##2##(1991-1#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-2#1)
hospital status##2##2##(2008-11#2)
hospital stay and##2##3##(2011-2#1)(2012-3#1)
hospital stay for operable breast cancer##2##6##(1992-12#2)
hospital stay of##3##3##(1991-12#1)(2011-2#2)
hospital stay##21##2##(1990-9#1)(1991-12#3)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
hospital stays for total hip replacement##2##6##(1996-1#2)
hospital stays##7##2##(1991-12#1)(1992-12#1)(1993-1#1)(1996-1#2)(2008-12#1)(2012-3#1)
hospital strategic##2##2##(1991-1#1)(1991-2#1)
hospital system has##2##3##(1991-9#1)(2008-11#1)
hospital system##5##2##(1991-9#1)(1993-12#1)(1996-3#1)(2008-11#1)(2010-8#1)
hospital systems##3##2##(2008-11#3)
hospital tax exemption and##2##4##(2008-11#2)
hospital tax exemption##5##3##(1996-2#1)(2008-11#4)
hospital the##2##2##(1992-2#1)(1995-11#1)
hospital to maintain the##2##4##(1994-12#1)(1995-12#1)
hospital to##16##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#2)
hospital transitional funding initiative##2##4##(1991-12#2)
hospital treatment##3##2##(1993-1#1)(2009-6#1)(2009-8#1)
hospital types##3##2##(1992-12#2)(1994-3#1)
hospital use##2##2##(1991-3#1)(1994-2#1)
hospital utilization##3##2##(1992-12#1)(1995-5#1)(1996-1#1)
hospital valuation expert##2##3##(2008-11#2)
hospital visits##3##2##(1993-1#1)(1994-2#1)(2009-12#1)
hospital wage##2##2##(1992-1#1)(1992-2#1)
hospital waiting lists##3##3##(1991-11#3)
hospital was##4##2##(1995-5#1)(1997-8#1)(2008-7#1)(2008-8#1)
hospital were##3##2##(1996-12#1)(1997-2#1)(2009-5#1)
hospital will##2##2##(1994-2#1)(2008-11#1)
hospital with a##4##3##(1992-2#1)(2012-12#1)(2013-1#2)
hospital with##20##2##(1992-2#1)(1993-6#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#5)(2012-12#3)(2013-1#3)
hospital workers##3##2##(1991-3#1)(1996-3#1)(2008-10#1)
hospital##911##1##(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#5)(1990-6#1)(1990-9#5)(1991-1#32)(1991-11#10)(1991-12#22)(1991-2#27)(1991-3#28)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#22)(1992-11#4)(1992-12#19)(1992-2#42)(1992-3#13)(1992-5#5)(1992-8#2)(1993-1#15)(1993-11#2)(1993-12#20)(1993-2#25)(1993-3#14)(1993-5#2)(1993-6#7)(1994-1#6)(1994-12#33)(1994-2#19)(1994-3#17)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#7)(1995-10#1)(1995-11#3)(1995-12#15)(1995-2#16)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#8)(1996-11#1)(1996-12#4)(1996-2#11)(1996-3#23)(1996-5#6)(1996-9#2)(1997-1#3)(1997-2#13)(1997-3#3)(1997-4#6)(1997-5#6)(1997-6#2)(1997-8#7)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#90)(2008-12#5)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#19)(2008-8#4)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#7)(2010-12#4)(2010-2#1)(2010-6#12)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#7)(2011-2#41)(2011-3#2)(2012-12#15)(2012-2#9)(2012-3#25)(2013-1#41)(2013-7#1)(2013-8#12)
hospital's##20##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#4)(1993-2#1)(1994-12#3)(1994-2#1)(1996-1#1)(1996-3#1)(2009-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
hospital-acquired infection##2##2##(2010-12#1)(2013-1#1)
hospital-acquired##3##1##(2008-10#1)(2010-12#1)(2013-1#1)
hospital-based managed##3##2##(1991-3#3)
hospital-based##14##1##(1990-8#1)(1991-1#1)(1991-3#4)(1992-1#2)(1993-1#1)(1994-1#2)(1994-12#1)(2008-7#1)(2010-1#1)
hospital-wide##3##1##(1994-3#1)(1996-1#2)
hospital? The##3##2##(1994-6#2)(1995-3#1)
hospital?##4##1##(1993-6#1)(1994-6#2)(1995-3#1)
hospital]##15##1##(1993-6#1)(1994-5#1)(1994-6#1)(1995-2#1)(1997-4#2)(1997-5#1)(2009-1#1)(2009-10#1)(2012-3#2)(2013-1#4)
hospitalisation##3##1##(1994-5#1)(1995-2#1)(2008-11#1)
hospitalised for##2##2##(2007-8#2)
hospitalised##6##1##(1991-11#1)(1992-5#1)(1992-9#1)(2007-8#3)
hospitality##2##1##(2008-1#1)(2008-11#1)
hospitalization and##12##2##(1991-2#1)(1992-1#1)(1992-2#1)(1995-1#1)(1995-2#2)(2008-10#1)(2008-11#3)(2011-2#1)(2013-1#1)
hospitalization charges##2##2##(1991-12#2)
hospitalization for asthma##2##3##(2008-11#2)
hospitalization for##7##2##(1992-1#2)(1992-2#1)(1995-12#1)(2008-11#2)(2009-10#1)
hospitalization had##2##2##(1994-12#2)
hospitalization in##2##2##(1992-1#1)(2013-1#1)
hospitalization is##3##2##(1991-1#1)(1992-1#2)
hospitalization of##3##2##(1991-2#1)(1992-3#1)(1993-3#1)
hospitalization on##3##2##(1991-2#1)(1993-1#1)(2008-11#1)
hospitalization or##3##2##(1991-1#1)(1991-2#1)(2008-11#1)
hospitalization period##2##2##(2008-10#1)(2010-4#1)
hospitalization was##4##2##(2010-10#2)(2011-2#1)(2012-3#1)
hospitalization were##2##2##(1991-1#1)(2013-1#1)
hospitalization with##2##2##(1993-2#1)(2008-7#1)
hospitalization##109##1##(1991-1#9)(1991-12#2)(1991-2#7)(1991-3#1)(1992-1#12)(1992-2#6)(1992-3#1)(1993-1#1)(1993-2#3)(1993-3#1)(1994-12#2)(1994-2#1)(1995-1#5)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-3#2)(2008-10#2)(2008-11#9)(2008-12#1)(2008-7#1)(2009-10#1)(2010-10#3)(2010-4#1)(2011-2#12)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#10)
hospitalizations and##6##2##(1990-12#1)(1991-2#1)(1995-1#1)(2008-11#2)(2012-3#1)
hospitalizations for##6##2##(1991-12#1)(1995-12#3)(2008-11#1)(2011-2#1)
hospitalizations were##2##2##(1996-3#2)
hospitalizations##24##1##(1990-12#1)(1991-12#2)(1991-2#2)(1992-2#1)(1993-1#1)(1993-3#1)(1995-1#1)(1995-12#4)(1996-3#2)(2008-11#4)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
hospitalized children##8##2##(1991-2#1)(1992-3#1)(2008-11#3)(2013-1#3)
hospitalized for##11##2##(1990-8#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-7#2)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
hospitalized in a##3##3##(1991-1#1)(1992-2#1)(2009-1#1)
hospitalized in the##4##3##(1990-3#1)(2007-8#1)(2012-12#1)(2013-1#1)
hospitalized in##12##2##(1990-3#1)(1991-1#1)(1992-12#1)(1992-2#2)(1995-1#1)(2007-8#2)(2009-1#1)(2012-12#2)(2013-1#1)
hospitalized patients were##2##3##(1991-2#1)(2008-10#1)
hospitalized patients with##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
hospitalized patients##10##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
hospitalized with##4##2##(2009-12#1)(2010-4#1)(2012-12#2)
hospitalized##65##1##(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#6)(2008-3#1)(2008-7#3)(2009-1#1)(2009-12#2)(2009-4#1)(2010-4#2)(2011-2#4)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#7)
hospitals across##2##2##(1995-1#1)(2008-11#1)
hospitals and other##3##3##(1992-12#1)(1993-1#1)(1993-2#1)
hospitals and physicians##2##3##(1991-3#1)(1992-1#1)
hospitals and the##3##3##(1991-2#1)(2013-1#1)(2013-8#1)
hospitals and their##3##3##(1991-1#1)(1995-1#1)(2008-11#1)
hospitals and##42##2##(1990-11#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#3)(1993-6#1)(1994-1#3)(1995-1#2)(1995-2#2)(2008-10#3)(2008-11#8)(2009-12#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
hospitals are facing##2##3##(1991-9#1)(2008-11#1)
hospitals are implementing##2##3##(1994-1#1)(2012-2#1)
hospitals are in the##2##4##(1996-11#1)(2008-11#1)
hospitals are##24##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#2)(1993-12#2)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-11#3)(2012-2#1)
hospitals around the country##2##4##(1994-1#1)(1995-2#1)
hospitals being##2##2##(1992-2#1)(2008-11#1)
hospitals by rural beneficiaries##2##4##(1992-12#2)
hospitals do##2##2##(1992-12#1)(1996-3#1)
hospitals during the period##2##4##(1992-12#1)(2008-11#1)
hospitals during##3##2##(1990-2#1)(1992-12#1)(2008-11#1)
hospitals following##2##2##(1996-3#1)(2008-11#1)
hospitals for what they##3##4##(1992-12#3)
hospitals for##6##2##(1992-12#3)(1993-12#1)(1995-2#1)(1996-12#1)
hospitals from the##2##3##(1992-2#1)(2008-11#1)
hospitals has##3##2##(1992-12#2)(2013-8#1)
hospitals have##9##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-11#1)
hospitals in Canada##2##3##(2008-11#2)
hospitals in Seoul##2##3##(1990-12#1)(1991-2#1)
hospitals in the##5##3##(1991-1#1)(1992-3#1)(1996-2#1)(2008-11#1)(2012-12#1)
hospitals in##34##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-2#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#2)(2008-10#1)(2008-11#5)(2009-10#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
hospitals into##2##2##(1991-1#1)(1992-12#1)
hospitals is##6##2##(1990-6#1)(1991-12#2)(1993-2#1)(1996-2#1)(1996-3#1)
hospitals located in##4##3##(1992-12#1)(1994-3#1)(1996-3#1)(2008-1#1)
hospitals need to##2##3##(1991-1#1)(2008-11#1)
hospitals need##3##2##(1991-1#1)(1994-1#1)(2008-11#1)
hospitals of##4##2##(1991-3#1)(1993-12#1)(2008-1#1)(2011-2#1)
hospitals on the##2##3##(1992-2#1)(1995-2#1)
hospitals or##3##2##(1991-3#1)(2008-11#2)
hospitals serving##3##2##(1991-6#1)(1992-2#1)(1994-1#1)
hospitals should##3##2##(1997-8#1)(2011-1#1)(2011-2#1)
hospitals that operate joint ventures##3##5##(2008-11#3)
hospitals that##11##2##(1992-11#1)(1993-3#1)(1995-1#2)(2008-11#5)(2008-3#1)(2013-1#1)
hospitals to consider##2##3##(1993-1#1)(1993-12#1)
hospitals to the##2##3##(1991-11#1)(1992-2#1)
hospitals to##20##2##(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#2)(1993-12#1)(1996-2#1)(1996-3#1)(2008-11#3)(2010-9#1)
hospitals toward##2##2##(1991-3#1)(1993-1#1)
hospitals was##5##2##(1992-2#1)(1994-12#1)(1995-6#1)(2008-11#1)(2012-2#1)
hospitals were##15##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#2)
hospitals will##2##2##(1992-2#1)(1996-2#1)
hospitals with higher##2##3##(1993-1#1)(1995-2#1)
hospitals with##11##2##(1991-2#1)(1992-12#2)(1993-1#2)(1994-1#2)(1994-3#1)(1995-2#1)(2013-1#2)
hospitals without##2##2##(1992-12#1)(2008-3#1)
hospitals##473##1##(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-6#8)(1990-9#4)(1991-1#8)(1991-11#5)(1991-12#9)(1991-2#14)(1991-3#15)(1991-6#6)(1991-9#7)(1992-1#6)(1992-11#3)(1992-12#32)(1992-2#20)(1992-3#10)(1992-5#2)(1992-6#1)(1992-8#7)(1993-1#13)(1993-11#1)(1993-12#16)(1993-2#8)(1993-3#5)(1993-5#3)(1993-6#3)(1994-1#15)(1994-12#11)(1994-2#4)(1994-3#15)(1995-1#9)(1995-12#6)(1995-2#11)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#6)(1996-3#16)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#5)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#58)(2008-3#5)(2008-5#2)(2008-7#3)(2009-10#1)(2009-12#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#9)(2013-8#6)
hospitals'##7##1##(1992-2#2)(1994-12#1)(1994-2#1)(1997-5#1)(2008-11#2)
hospitals]##7##1##(1991-2#1)(1993-11#1)(1995-5#1)(2010-6#1)(2012-3#2)(2013-8#1)
host DNA##3##2##(2008-10#3)
host adaptation and##2##3##(2008-10#2)
host adaptation##3##2##(2008-10#3)
host and disease##2##3##(1995-5#2)
host and is##2##3##(2008-10#1)(2013-8#1)
host and non-host##2##3##(2007-12#1)(2008-10#1)
host and parasite life-history traits##2##5##(2008-8#2)
host and parasite##6##3##(2008-8#4)(2010-8#1)(2012-3#1)
host and parasitoid##2##3##(2008-8#2)
host and pathogen##4##3##(2008-10#4)
host and##31##2##(1995-5#2)(2007-12#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-8#7)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
host antitumor response##2##3##(1992-12#2)
host axons##4##2##(2011-2#4)
host bacterium##2##2##(2011-2#1)(2013-1#1)
host cell changes##2##3##(2008-10#2)
host cell for##2##3##(2008-11#2)
host cell line##4##3##(2008-11#4)
host cell lines##4##3##(2008-11#4)
host cell wall##8##3##(2008-10#7)(2010-3#1)
host cell##42##2##(1997-3#1)(2008-10#17)(2008-11#16)(2008-9#2)(2009-6#2)(2010-1#1)(2010-3#1)(2011-2#2)
host cells##23##2##(1994-6#1)(1996-12#4)(1997-3#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-8#1)
host cells)##2##2##(2008-6#1)(2013-8#1)
host chromosomal gene products##2##4##(1995-9#2)
host cultivar and##2##3##(2008-10#2)
host cultivar##7##2##(2008-10#7)
host cytoplasm##5##2##(1996-12#2)(2008-10#3)
host defense is##2##3##(2008-9#2)
host defense reactions##2##3##(2008-10#2)
host defense responses##2##3##(2008-10#2)
host defense##16##2##(1992-10#1)(1993-3#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2013-1#1)
host defenses##7##2##(2008-10#2)(2008-5#1)(2008-9#4)
host defensive##2##2##(1994-8#1)(2008-11#1)
host density but##2##3##(2008-10#2)
host density##11##2##(2008-10#4)(2008-8#1)(2008-9#6)
host differential lines##2##3##(2008-10#2)
host differential##3##2##(2008-10#3)
host differentials##3##2##(2008-10#3)
host diversity##7##2##(2008-10#7)
host epidermal cells directly##2##4##(2008-10#2)
host extinction##3##2##(2008-8#3)
host factors that##2##3##(1996-2#1)(2008-10#1)
host factors##7##2##(1996-2#1)(2006-6#1)(2008-10#3)(2008-9#1)(2010-6#1)
host fecundity##2##2##(2008-8#1)(2008-9#1)
host female##2##2##(2008-8#2)
host fitness##3##2##(2008-10#1)(2008-9#2)
host for##9##2##(2008-10#4)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#2)
host genetic background##4##3##(2008-10#4)
host genetic##6##2##(1997-7#1)(2008-10#5)
host genotype in##3##3##(2008-10#3)
host genotype mixtures##2##3##(2008-10#2)
host genotype##14##2##(2008-10#14)
host genotypes##11##2##(2008-10#11)
host growth and##4##3##(2008-10#4)
host growth##6##2##(2008-10#6)
host hyphae##4##2##(2008-10#4)
host immune responses##3##3##(1994-5#1)(2008-10#2)
host immune##4##2##(1994-5#1)(2008-10#2)(2011-2#1)
host immunity##3##2##(2007-12#1)(2010-1#1)(2013-1#1)
host in##4##2##(2008-10#3)(2011-2#1)
host infection process##6##3##(2010-10#6)
host infection##9##2##(2008-10#2)(2008-8#1)(2010-10#6)
host is##10##2##(1996-3#1)(2008-10#4)(2008-8#2)(2008-9#3)
host leaf##3##2##(2008-10#3)
host life-history traits##2##3##(2008-8#2)
host miRNA##2##2##(2013-1#2)
host miRNAs##2##2##(2013-1#2)
host mixtures##4##2##(2008-10#4)
host molecules##2##2##(2008-10#2)
host mortality##2##2##(2008-9#2)
host of origin##7##3##(2008-10#6)(2008-9#1)
host of the##2##3##(2008-10#2)
host of##18##2##(2008-10#11)(2008-11#2)(2008-8#1)(2008-9#2)(2011-1#1)(2013-7#1)
host or nonhost##2##3##(2008-10#2)
host or pathogen##2##3##(2008-10#2)
host or vector##2##3##(2008-8#2)
host or##11##2##(2008-10#7)(2008-11#1)(2008-8#3)
host organisms##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
host origin##2##2##(2008-10#2)
host pH##2##2##(2008-10#2)
host penetration##2##2##(2008-10#2)
host phenology##3##2##(2008-10#3)
host physiology##2##2##(2010-1#1)(2011-2#1)
host plant genotype##2##3##(2008-10#2)
host plant resistance##2##3##(2008-10#2)
host plant species and##2##4##(2008-10#1)(2009-8#1)
host plant species##8##3##(2008-10#6)(2009-8#2)
host plant##49##2##(1990-8#1)(2007-12#1)(2008-10#36)(2008-8#2)(2008-9#1)(2009-8#4)(2010-3#1)(2011-2#2)(2012-3#1)
host plants and##3##3##(2008-10#3)
host plants by##2##3##(2007-12#1)(2008-10#1)
host plants were##2##3##(2008-10#2)
host plants with##3##3##(2008-10#3)
host plants##39##2##(2007-12#2)(2008-10#29)(2008-8#3)(2008-9#4)(2009-8#1)
host population##16##2##(1994-2#1)(2008-10#8)(2008-8#2)(2008-9#3)(2011-2#2)
host populations##9##2##(2008-10#4)(2008-8#2)(2011-2#1)(2012-2#2)
host preference##8##2##(2008-10#4)(2008-8#1)(2008-9#2)(2010-10#1)
host proteins for##2##3##(2013-1#2)
host proteins##4##2##(2010-10#1)(2013-1#3)
host races##3##2##(2008-8#1)(2008-9#2)
host range and##3##3##(2008-10#2)(2008-5#1)
host range expanded viruses##2##4##(2008-11#2)
host range expanded##4##3##(2008-11#4)
host range of##8##3##(2008-10#6)(2008-11#1)(2008-8#1)
host range studies##2##3##(2008-10#2)
host range was##4##3##(2008-10#4)
host range##46##2##(1993-12#1)(2008-10#35)(2008-11#6)(2008-5#1)(2008-8#2)(2012-2#1)
host ranges of these pathogens##2##5##(2008-10#2)
host ranges of##4##3##(2008-10#3)(2012-2#1)
host ranges##9##2##(2008-10#8)(2012-2#1)
host reactions##3##2##(2008-10#3)
host receptor-binding affinity##2##3##(2012-2#2)
host reproduction##4##2##(2008-10#1)(2008-8#3)
host reproductive effort##3##3##(2008-8#3)
host reproductive##4##2##(2008-8#4)
host resistance and stress tolerance##2##5##(2008-10#2)
host resistance and##7##3##(2008-10#5)(2008-8#2)
host resistance is##2##3##(2008-10#1)(2008-8#1)
host resistance to aflatoxin##2##4##(2008-10#2)
host resistance to##7##3##(2008-10#5)(2008-8#1)(2009-10#1)
host resistance was##2##3##(2008-10#2)
host resistance##49##2##(1996-12#2)(2008-10#35)(2008-8#11)(2009-10#1)
host response to infection##2##4##(2008-10#2)
host response to##4##3##(1990-2#1)(2008-10#3)
host response##7##2##(1990-2#1)(2008-10#5)(2011-2#1)
host shift##4##2##(2008-8#4)
host sites##2##2##(2008-10#2)
host size##7##2##(2008-10#3)(2008-9#4)
host specialization in##5##3##(2008-10#4)(2008-9#1)
host specialization to##2##3##(2008-10#2)
host specialization##13##2##(2008-10#12)(2008-9#1)
host species and##3##3##(2008-10#3)
host species is##2##3##(2008-10#1)(2008-9#1)
host species##37##2##(2008-10#20)(2008-8#8)(2008-9#6)(2010-8#1)(2012-3#1)(2013-1#1)
host specific##6##2##(2008-10#6)
host specificity exists in##2##4##(2008-10#2)
host specificity##10##2##(2008-10#10)
host strain##4##2##(1995-12#1)(2008-8#1)(2008-9#1)(2009-3#1)
host susceptibility##5##2##(2008-10#5)
host symptoms and##2##3##(2008-10#2)
host symptoms##3##2##(2008-10#3)
host tissue and##2##3##(2008-10#2)
host tissue by##2##3##(2008-10#2)
host tissue##13##2##(2008-10#13)
host tissues##7##2##(2008-10#5)(2008-9#1)(2011-1#1)
host to##4##2##(2008-10#3)(2008-8#1)
host translation inhibitory##2##3##(2010-4#2)
host was##4##2##(2008-10#4)
host were##5##2##(2008-10#4)(2012-2#1)
host##999##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-12#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-9#2)(1996-12#9)(1996-2#2)(1996-3#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-12#5)(2008-10#579)(2008-11#35)(2008-12#3)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#2)(2008-8#104)(2008-9#70)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#12)(2010-1#4)(2010-10#12)(2010-11#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#3)(2011-1#6)(2011-2#40)(2012-2#11)(2012-3#6)(2013-1#20)(2013-7#1)(2013-8#7)
host's##7##1##(2006-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-7#1)
host)##3##1##(2008-8#2)(2011-2#1)
host-adapted##3##1##(2008-10#3)
host-associated##2##1##(2008-10#1)(2011-2#1)
host-derived##2##1##(2008-10#1)(2011-2#1)
host-diversity effect for reduced disease##2##5##(2008-10#2)
host-diversity effect for reduced##3##4##(2008-10#3)
host-diversity effect##4##2##(2008-10#4)
host-diversity effects for##2##3##(2008-10#2)
host-diversity effects on##3##3##(2008-10#3)
host-diversity effects##9##2##(2008-10#9)
host-diversity##13##1##(2008-10#13)
host-free period##4##2##(2008-10#4)
host-guest##5##1##(2008-10#4)(2010-4#1)
host-parasite coevolution##2##2##(2008-10#1)(2012-3#1)
host-parasite interactions##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
host-parasite relatedness##2##2##(2008-8#2)
host-parasite##17##1##(1997-7#1)(2008-10#4)(2008-8#7)(2011-2#1)(2012-3#3)(2013-1#1)
host-parasitoid##4##1##(2008-8#4)
host-pathogen combinations##2##2##(2008-10#2)
host-pathogen interaction##2##2##(2008-10#2)
host-pathogen interactions has##2##3##(2008-9#1)(2010-8#1)
host-pathogen interactions##9##2##(2008-10#6)(2008-9#2)(2010-8#1)
host-pathogen systems##2##2##(2008-10#1)(2008-9#1)
host-pathogen##20##1##(2008-10#13)(2008-8#2)(2008-9#3)(2010-8#1)(2013-1#1)
host-plant##3##1##(2008-8#2)(2009-6#1)
host-seeking##2##1##(1990-11#1)(2009-8#1)
host-selective toxin##4##2##(2008-10#4)
host-selective toxins##2##2##(2008-10#2)
host-selective##7##1##(2008-10#7)
host-specialized forms of##2##3##(2008-10#2)
host-specialized##4##1##(2008-10#4)
host-specific toxin##2##2##(2008-10#2)
host-specific toxins##4##2##(2008-10#4)
host-specific##15##1##(2008-10#12)(2009-8#1)(2012-2#1)(2013-1#1)
host-vector##3##1##(1993-12#2)(2008-4#1)
hostae clade##2##2##(2008-10#2)
hostae##4##1##(2008-10#4)
hostage##4##1##(1994-2#1)(1996-12#1)(2008-1#2)
hostages##2##1##(2008-1#2)
hosted a##2##2##(2008-10#1)(2009-6#1)
hosted##4##1##(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#1)
hostile##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
hostility and##2##2##(2008-4#2)
hostility##9##1##(1990-11#1)(2008-4#7)(2010-7#1)
hosting##3##1##(1991-2#1)(2008-11#1)(2010-7#1)
hosts and habitats##2##3##(2008-10#2)
hosts and parasites##2##3##(2012-3#1)(2013-1#1)
hosts and the##3##3##(2008-10#2)(2013-8#1)
hosts and##23##2##(2008-10#17)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
hosts are##5##2##(2008-10#3)(2008-8#2)
hosts as##4##2##(2008-10#4)
hosts at##2##2##(2008-10#2)
hosts by##3##2##(2008-10#1)(2008-8#2)
hosts caused##2##2##(2008-10#2)
hosts for##8##2##(1993-9#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
hosts have##2##2##(2008-9#1)(2011-2#1)
hosts in the genus Solanum##2##5##(2008-10#2)
hosts in the##5##3##(2008-10#4)(2013-8#1)
hosts in##11##2##(2008-10#8)(2008-8#1)(2012-3#1)(2013-8#1)
hosts is##6##2##(2008-10#4)(2008-8#1)(2008-9#1)
hosts may be##2##3##(2008-10#1)(2008-8#1)
hosts of C##2##3##(2008-10#2)
hosts of origin##2##3##(2008-10#2)
hosts of##10##2##(2008-10#7)(2008-12#1)(2011-2#2)
hosts or##5##2##(1990-11#1)(2008-10#2)(2011-2#1)(2012-2#1)
hosts other than##2##3##(2008-10#2)
hosts parasitized by##3##3##(2008-9#3)
hosts such as##2##3##(2008-10#1)(2011-2#1)
hosts that are##2##3##(1997-7#1)(2008-8#1)
hosts that##5##2##(1997-7#1)(2008-10#3)(2008-8#1)
hosts to##5##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
hosts varied##2##2##(2008-10#2)
hosts was##2##2##(2008-10#2)
hosts were##8##2##(2008-10#8)
hosts with##2##2##(2008-10#1)(2008-8#1)
hosts##259##1##(1990-11#2)(1993-8#1)(1993-9#1)(1994-3#1)(1996-12#1)(1997-7#3)(2008-10#178)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-8#17)(2008-9#14)(2009-6#1)(2010-8#1)(2011-2#13)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#7)
hosts'##4##1##(1996-12#1)(2008-10#2)(2008-8#1)
hosts)##4##1##(2008-10#1)(2008-9#1)(2011-2#2)
hot and##2##2##(2007-12#1)(2008-10#1)
hot flash experience in men is##2##6##(2009-5#2)
hot flashes##3##2##(2008-11#1)(2008-7#1)(2009-5#1)
hot pepper##4##2##(2008-10#4)
hot plate##8##2##(1992-3#1)(1994-3#1)(1996-2#2)(2008-10#4)
hot spot##2##2##(1995-8#1)(2011-2#1)
hot spots##4##2##(1993-11#1)(2008-10#1)(2009-10#1)(2011-2#1)
hot spring##6##2##(2008-10#5)(2008-8#1)
hot water##6##2##(2008-10#5)(2008-11#1)
hot wax##4##2##(1992-6#4)
hot##67##1##(1991-6#1)(1992-3#3)(1992-6#4)(1993-11#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-2#2)(2007-12#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-5#3)(2011-2#3)(2013-8#3)
hot-carrier luminescence##3##2##(2007-12#3)
hot-filament##2##1##(2008-3#2)
hot-pepper paste##3##2##(2010-4#3)
hot-plate##2##1##(1992-3#2)
hot-pressing##2##1##(2010-4#2)
hot-water extract of spruce wood##2##5##(2013-1#2)
hot-wire##2##1##(2008-10#2)
hotel##4##1##(1991-12#1)(1994-2#1)(1994-3#1)(2008-11#1)
hotspot##4##1##(2008-10#1)(2012-3#3)
hotspots and##2##2##(2008-10#1)(2012-3#1)
hotspots##3##1##(2008-10#1)(2011-1#1)(2012-3#1)
hougasii##3##1##(2008-10#3)
hour after##5##2##(1993-11#1)(1994-8#2)(1997-3#1)(2008-7#1)
hour and##11##2##(1992-3#1)(2008-10#10)
hour for##3##2##(2008-10#2)(2012-3#1)
hour in##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
hour of##4##2##(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#1)
hour##133##1##(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-6#2)(1993-8#4)(1994-8#2)(1996-3#1)(1996-6#2)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#83)(2008-11#5)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
hourly measurements of##2##3##(2008-11#1)(2010-10#1)
hourly##11##1##(1990-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)
hours after discharge##2##3##(2012-12#2)
hours after injection##2##3##(1993-11#1)(2008-7#1)
hours after surgery##2##3##(1997-3#1)(2009-1#1)
hours after the accident##2##4##(1990-9#2)
hours after the##8##3##(1990-9#2)(1991-6#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-1#1)
hours after##40##2##(1990-12#1)(1990-5#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-6#2)(1992-5#1)(1993-11#1)(1993-3#1)(1993-8#3)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-6#2)(2008-7#2)(2009-1#1)(2009-11#1)(2010-1#1)(2010-12#1)(2012-12#4)(2013-1#2)(2013-8#2)
hours and the##2##3##(1990-2#1)(2010-8#1)
hours and##10##2##(1990-2#1)(1991-12#1)(1991-9#1)(1993-11#1)(1995-12#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-3#1)
hours before##5##2##(1993-11#1)(2008-10#1)(2010-6#1)(2011-2#2)
hours by##3##2##(1992-3#1)(2008-5#1)(2008-7#1)
hours daily##2##2##(2011-2#1)(2012-2#1)
hours for##2##2##(1993-1#1)(2008-10#1)
hours in##4##2##(1990-6#1)(1994-3#1)(2008-10#1)(2010-8#1)
hours later##7##2##(1990-6#1)(1992-5#1)(2008-12#1)(2008-5#1)(2008-6#1)(2013-1#2)
hours of admission##2##3##(1990-9#1)(2013-1#1)
hours of incubation##2##3##(1990-5#1)(1994-11#1)
hours of the day##2##4##(2008-10#1)(2011-2#1)
hours of the##3##3##(2008-10#1)(2011-2#2)
hours of##32##2##(1990-5#1)(1990-9#1)(1993-2#2)(1994-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-7#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
hours on##2##2##(2007-12#1)(2010-6#1)
hours or##4##2##(1996-9#1)(1997-3#1)(2010-8#1)(2013-1#1)
hours per day##2##3##(2008-10#1)(2013-8#1)
hours per##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2013-8#1)
hours postoperatively in##2##3##(1993-12#2)
hours postoperatively##3##2##(1993-12#3)
hours to##7##2##(1995-6#2)(1997-1#1)(2008-10#2)(2008-12#1)(2011-2#1)
hours was##2##2##(1996-6#1)(2010-6#1)
hours when relative humidity was##2##5##(2008-10#2)
hours when##3##2##(2008-10#2)(2010-6#1)
hours with##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
hours##248##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#4)(1990-5#3)(1990-6#4)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-6#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#4)(1993-1#3)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#6)(1994-11#3)(1994-12#1)(1994-3#2)(1995-12#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-5#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#32)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#8)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#9)(2010-7#4)(2010-8#5)(2011-1#3)(2011-2#12)(2011-3#1)(2012-12#6)(2012-2#3)(2012-3#1)(2012-5#2)(2013-1#11)(2013-8#5)
hours) and##3##2##(1996-2#1)(2008-10#2)
hours)##7##1##(1990-12#1)(1996-2#1)(1996-8#1)(2008-10#2)(2009-5#1)(2011-2#1)
hours/week)##3##1##(2010-7#3)
house and##2##2##(2008-10#1)(2010-5#1)
house dust##4##2##(1994-9#1)(2011-2#2)(2012-12#1)
house finch##2##2##(2008-8#2)
house finches (Carpodacus mexicanus)##2##4##(2008-8#2)
house finches##4##2##(2008-8#4)
house officers##4##2##(1990-3#1)(1991-3#1)(2008-3#1)(2013-8#1)
house sparrows (Passer domesticus) and##2##5##(2008-5#2)
house to the hospital##2##4##(2009-10#1)(2010-2#1)
house##37##1##(1990-11#1)(1990-3#1)(1991-3#1)(1993-1#3)(1994-9#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#6)(2008-9#1)(2009-10#2)(2010-2#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
house-to-house survey##2##2##(1994-9#1)(2008-11#1)
housed beef cattle##2##3##(1991-3#2)
housed in##2##2##(1993-6#1)(2010-1#1)
housed tethered for 2##2##4##(2008-11#2)
housed##10##1##(1991-2#1)(1991-3#2)(1993-6#1)(1996-12#1)(2008-11#3)(2010-1#1)(2010-8#1)
household and##3##2##(1991-1#1)(1991-12#1)(2008-5#1)
household contacts##2##2##(1991-12#2)
household labor##3##2##(2011-2#3)
household products##2##2##(2008-10#1)(2008-5#1)
household trajectories##2##2##(2011-2#2)
household waste##2##2##(2008-12#2)
household##40##1##(1991-1#1)(1991-12#3)(1994-2#2)(1994-6#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-5#2)(2009-5#2)(2010-5#2)(2011-2#15)(2012-12#1)(2012-3#2)(2013-8#2)
household-level##4##1##(2011-2#4)
households and##2##2##(2010-5#1)(2011-2#1)
households in Sidama##2##3##(2010-6#2)
households in##4##2##(2009-7#1)(2010-6#2)(2013-1#1)
households with##2##2##(1994-2#1)(2011-2#1)
households##29##1##(1991-12#2)(1994-1#1)(1994-2#1)(1997-2#2)(2008-11#2)(2009-12#2)(2009-7#1)(2010-5#1)(2010-6#3)(2011-2#10)(2012-12#3)(2013-1#1)
housekeeping genes##6##2##(1995-11#1)(1997-6#1)(2008-10#3)(2011-1#1)
housekeeping##8##1##(1995-11#1)(1995-6#2)(1997-6#1)(2008-10#3)(2011-1#1)
houses and the##2##3##(1996-12#1)(1996-6#1)
houses were##2##2##(1996-12#1)(2011-2#1)
houses##14##1##(1990-3#2)(1996-12#3)(1996-6#1)(2007-12#2)(2010-6#1)(2011-2#3)(2012-12#2)
housing and##3##2##(1996-5#1)(2008-11#1)(2009-5#1)
housing##21##1##(1993-1#3)(1995-12#1)(1996-5#1)(1997-1#2)(2008-11#6)(2008-3#1)(2008-7#2)(2009-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
housing)##2##1##(1993-1#1)(2008-11#1)
how &quot##2##2##(2008-10#1)(2008-12#1)
how a full##2##3##(1995-12#1)(2010-10#1)
how a laboratory##2##3##(1993-2#2)
how a##25##2##(1990-2#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-2#2)(1995-12#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
how advances in##2##3##(2008-7#1)(2011-2#1)
how an##5##2##(1992-9#1)(1993-12#1)(1997-2#1)(2008-11#1)(2008-3#1)
how and why##3##3##(1994-12#1)(1997-1#1)(2010-1#1)
how and##6##2##(1991-6#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-9#1)(2010-1#1)
how appearance##2##2##(2008-11#2)
how are##3##2##(1996-6#1)(2008-7#1)(2011-2#1)
how best to##5##3##(2008-10#1)(2008-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
how both##3##2##(2008-10#1)(2009-1#1)(2013-8#1)
how by##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
how can we##2##3##(2008-11#1)(2012-2#1)
how can##4##2##(1997-1#1)(2008-11#1)(2009-10#1)(2012-2#1)
how confident##2##2##(2009-10#1)(2010-8#1)
how consumers view##2##3##(1997-3#2)
how consumers##3##2##(1997-3#3)
how data##2##2##(2008-10#1)(2008-8#1)
how different##5##2##(1991-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-3#1)
how do##4##2##(1994-3#1)(1997-2#1)(2008-12#1)(2008-8#1)
how each##4##2##(1994-12#1)(1995-2#1)(1996-2#1)(2010-5#1)
how effectively##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
how energy##2##2##(2008-11#1)(2008-8#1)
how families##2##2##(2008-11#1)(2012-12#1)
how far##5##2##(1993-2#1)(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
how formal##2##2##(2009-12#1)(2009-5#1)
how genetic##2##2##(2008-8#1)(2011-2#1)
how health care##2##3##(1991-12#1)(2008-11#1)
how health##3##2##(1991-12#1)(2008-1#1)(2008-11#1)
how high##2##2##(1993-2#1)(1996-2#1)
how hospital##2##2##(1991-2#1)(2013-8#1)
how hospitals##2##2##(1993-12#1)(2008-11#1)
how host##2##2##(2008-10#2)
how human##2##2##(2013-1#2)
how important##2##2##(1997-4#1)(2012-3#1)
how interactions between##2##3##(2011-2#1)(2013-8#1)
how is it##2##3##(1994-12#1)(2008-7#1)
how it has##2##3##(1993-2#1)(1995-12#1)
how it is possible to##2##5##(1996-3#1)(2008-11#1)
how it is##4##3##(1996-3#1)(2008-11#1)(2008-12#1)(2008-6#1)
how it should be aligned for different applications (e##2##9##(2008-4#2)
how it should be##5##4##(2008-4#4)(2008-9#1)
how it##26##2##(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
how its##2##2##(1993-3#1)(2008-11#1)
how knowledge and##2##3##(2010-1#1)(2012-2#1)
how learning##2##2##(2008-11#1)(2011-1#1)
how lecturers##2##2##(2008-11#2)
how likely##2##2##(2008-10#1)(2008-7#1)
how long##5##2##(1991-2#1)(1996-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
how low##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
how managed care organizations##2##4##(2008-6#2)
how managed care##3##3##(1996-1#1)(2008-6#2)
how many times?##2##3##(1992-1#1)(2011-2#1)
how many##10##2##(1992-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
how mental health##2##3##(2009-6#1)(2013-1#1)
how metal##2##2##(1997-7#1)(2008-10#1)
how microtubules are reorganized##2##4##(2011-2#2)
how model##2##2##(2008-8#1)(2013-1#1)
how molecular##2##2##(2008-7#1)(2009-6#1)
how much of##4##3##(1994-3#1)(1995-6#1)(2008-11#1)(2011-2#1)
how much##14##2##(1990-3#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#3)(2010-12#1)(2011-2#1)
how nurse##3##2##(2008-11#3)
how occupational##2##2##(2010-9#2)
how older##2##2##(1997-3#1)(2010-1#1)
how our##5##2##(2008-8#2)(2009-5#1)(2009-8#1)(2010-9#1)
how physicians##2##2##(1992-2#1)(2008-6#1)
how progress monitoring is being used##2##6##(2011-2#2)
how progress##3##2##(1993-2#1)(2011-2#2)
how quickly foragers##2##3##(2008-8#1)(2008-9#1)
how quickly##3##2##(2008-12#1)(2008-8#1)(2008-9#1)
how rapidly##6##2##(1993-3#1)(1994-1#1)(1997-1#1)(1997-7#1)(2008-10#1)(2011-2#1)
how researchers##2##2##(2008-8#1)(2008-9#1)
how satisfied##2##2##(1991-2#1)(1992-1#1)
how should##2##2##(1993-11#1)(2008-10#1)
how social##2##2##(2008-8#2)
how some##4##2##(2008-11#2)(2008-9#1)(2011-2#1)
how spatial##2##2##(2008-9#1)(2010-6#1)
how specific##2##2##(2008-10#1)(2011-2#1)
how students##2##2##(2008-11#1)(2008-12#1)
how such##6##2##(1992-1#1)(1994-12#1)(2008-11#2)(2009-10#1)(2013-8#1)
how the approach##2##3##(2008-4#1)(2010-7#1)
how the brain##2##3##(2008-11#1)(2008-4#1)
how the chronic##2##3##(1995-3#1)(2012-12#1)
how the concept##2##3##(2008-12#1)(2010-11#1)
how the data##2##3##(1992-3#1)(2010-12#1)
how the government##2##3##(1995-6#1)(2008-10#1)
how the measures##2##3##(2008-10#1)(2008-11#1)
how the number of##2##4##(2008-8#1)(2011-2#1)
how the program##2##3##(1997-2#1)(2008-11#1)
how the technique##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
how the use of##2##4##(1993-2#1)(2008-10#1)
how the various##2##3##(2008-3#2)
how the##151##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#3)(1994-3#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#3)(1997-2#3)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#15)(2008-11#19)(2008-12#5)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#13)(2008-9#6)(2009-10#2)(2009-12#3)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#4)
how their##7##2##(1991-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-8#1)(2012-3#1)(2013-1#1)
how these approaches##2##3##(2008-4#1)(2010-12#1)
how these new##2##3##(2008-3#1)(2012-2#1)
how these proteins##2##3##(1997-7#1)(2008-11#1)
how these##46##2##(1990-5#1)(1992-12#1)(1993-3#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#3)
how they are##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-3#1)
how they can##3##3##(1997-2#1)(2008-8#1)(2010-12#1)
how they have##2##3##(2008-7#1)(2008-8#1)
how they interact##3##3##(2008-8#1)(2010-5#1)(2011-2#1)
how they may be##2##4##(1991-3#1)(2008-7#1)
how they may##4##3##(1991-3#1)(1995-2#1)(2008-7#2)
how they might be##2##4##(2009-11#1)(2012-2#1)
how they were##3##3##(1994-1#1)(2008-10#1)(2009-10#1)
how they##45##2##(1991-2#1)(1991-3#2)(1992-12#1)(1993-2#1)(1994-1#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
how this is##2##3##(2008-9#1)(2011-2#1)
how this##25##2##(1991-3#1)(1994-3#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#4)(2011-1#1)(2011-2#2)(2012-2#1)
how those##3##2##(1994-12#1)(1995-2#1)(2013-8#1)
how to acquire and##2##4##(2008-4#1)(2012-3#1)
how to best##3##3##(2008-11#1)(2009-1#1)(2010-8#1)
how to calculate the##4##4##(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)
how to calculate##5##3##(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
how to combine##2##3##(1996-6#2)
how to deal with##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
how to define##2##3##(2008-3#1)(2012-2#1)
how to develop##2##3##(1991-12#1)(2013-1#1)
how to estimate the##2##4##(1997-2#1)(2008-10#1)
how to handle##3##3##(2008-11#1)(2012-2#2)
how to improve##2##3##(1994-1#1)(2008-5#1)
how to live with##2##4##(1995-9#1)(2008-8#1)
how to obtain##2##3##(1997-2#1)(2007-12#1)
how to optimize##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
how to plan##2##3##(1992-2#1)(2008-11#1)
how to prevent##3##3##(1990-9#1)(1995-5#1)(1997-1#1)
how to promote##2##3##(2008-8#1)(2011-2#1)
how to quantify##2##3##(2008-10#1)(2010-11#1)
how to reduce the##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
how to reduce##4##3##(1996-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
how to report##2##3##(1993-3#1)(2008-11#1)
how to set up##2##4##(1991-3#1)(2008-4#1)
how to take##2##3##(1996-5#1)(2012-2#1)
how to treat##2##3##(1993-1#1)(2013-1#1)
how to use the##5##4##(1990-2#2)(2008-11#1)(2008-4#2)
how to use##12##3##(1990-2#2)(1993-12#1)(1994-3#1)(1996-6#1)(1997-3#1)(2008-11#1)(2008-4#3)(2008-9#2)
how to##154##2##(1990-2#2)(1990-9#1)(1991-1#2)(1991-12#2)(1991-3#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#3)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-9#2)(1996-1#2)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#13)(2008-12#6)(2008-3#4)(2008-4#19)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#7)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#3)
how various##2##2##(1996-3#1)(1997-3#1)
how we##4##2##(1994-3#1)(1997-3#1)(2008-12#1)(2008-6#1)
how well do##2##3##(2008-10#1)(2008-8#1)
how well the##5##3##(1990-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
how well##16##2##(1990-11#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)
how you##2##2##(2008-11#1)(2010-10#1)
how your##2##2##(1995-2#1)(2011-2#1)
how youth##2##2##(2009-7#1)(2010-1#1)
how##1053##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#2)(1990-9#2)(1991-1#6)(1991-12#5)(1991-2#7)(1991-3#9)(1991-6#2)(1992-1#4)(1992-10#1)(1992-12#4)(1992-2#7)(1992-3#3)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#8)(1993-2#13)(1993-3#8)(1994-1#7)(1994-11#1)(1994-12#10)(1994-2#11)(1994-3#8)(1994-6#1)(1995-1#3)(1995-11#1)(1995-12#8)(1995-2#11)(1995-3#2)(1995-5#7)(1995-6#3)(1995-9#3)(1996-1#7)(1996-12#2)(1996-2#8)(1996-3#5)(1996-5#1)(1996-6#6)(1996-9#1)(1997-1#8)(1997-2#15)(1997-3#14)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#78)(2008-11#122)(2008-12#36)(2008-2#1)(2008-3#16)(2008-4#46)(2008-5#5)(2008-6#21)(2008-7#29)(2008-8#68)(2008-9#46)(2009-1#2)(2009-10#9)(2009-11#3)(2009-12#10)(2009-3#4)(2009-4#1)(2009-5#8)(2009-6#10)(2009-7#7)(2009-8#16)(2009-9#3)(2010-1#10)(2010-10#8)(2010-11#14)(2010-12#8)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#7)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#11)(2011-1#5)(2011-2#57)(2011-3#1)(2012-12#6)(2012-2#33)(2012-3#17)(2013-1#35)(2013-8#25)
how&quot##3##1##(1994-2#3)
howardi##2##1##(2008-10#2)
however a##2##2##(2008-11#1)(2008-12#1)
however in##4##2##(2008-1#1)(2008-12#1)(2011-2#1)(2012-3#1)
however it##4##2##(2008-11#1)(2009-12#1)(2010-6#1)(2013-8#1)
however its##2##2##(2008-7#1)(2009-1#1)
however only##3##2##(1990-8#1)(1995-11#1)(2008-10#1)
however small##2##2##(2008-12#1)(2009-8#1)
however the##7##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-12#1)
however there is##2##3##(2008-12#1)(2013-1#1)
however there##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
however they were##2##3##(2008-10#1)(2013-1#1)
however they##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
however this##4##2##(1992-8#1)(2008-1#1)(2008-11#1)(2009-8#1)
however until##2##2##(2008-10#1)(2011-2#1)
however was##2##2##(2008-10#1)(2008-8#1)
however##821##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#6)(1990-6#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#7)(1991-3#4)(1991-6#4)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#1)(1992-9#4)(1993-1#3)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#2)(1994-11#3)(1994-12#2)(1994-2#7)(1994-3#8)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#6)(1995-3#2)(1995-5#6)(1995-6#7)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#5)(1996-12#10)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#7)(1997-4#3)(1997-5#2)(1997-7#4)(1997-8#2)(2007-11#3)(2007-12#2)(2008-1#11)(2008-10#177)(2008-11#56)(2008-12#24)(2008-2#3)(2008-3#5)(2008-4#8)(2008-5#18)(2008-6#6)(2008-7#28)(2008-8#34)(2008-9#18)(2009-1#6)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#14)(2009-9#2)(2010-1#5)(2010-10#4)(2010-11#3)(2010-12#5)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#6)(2010-7#2)(2010-8#6)(2011-1#7)(2011-2#37)(2011-3#3)(2012-12#12)(2012-2#18)(2012-3#20)(2012-5#1)(2012-6#1)(2013-1#32)(2013-8#19)
hoxG gene##3##2##(1990-11#3)
hoxG##4##1##(1990-11#4)
hoxK and hoxG##2##3##(1990-11#2)
hoxK##4##1##(1990-11#4)
hph##4##1##(2008-10#4)
hpi##2##1##(2008-10#2)
hr after the##3##3##(2008-11#1)(2008-6#2)
hr after##12##2##(1994-8#1)(1995-2#1)(2008-11#4)(2008-5#1)(2008-6#4)(2011-2#1)
hr and the##2##3##(2008-5#2)
hr and##6##2##(2008-11#2)(2008-5#2)(2008-6#2)
hr of##4##2##(2008-11#4)
hr was##3##2##(2008-11#3)
hr##61##1##(1993-1#1)(1993-8#1)(1994-11#1)(1994-8#5)(1995-2#7)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#18)(2008-12#1)(2008-5#7)(2008-6#13)(2011-2#3)(2013-8#1)
hr(-1))##2##1##(2008-11#2)
hr)##6##1##(1995-2#2)(2008-12#1)(2008-5#2)(2013-8#1)
hr-1##3##1##(2008-11#3)
hrIL-1 alpha##4##2##(1994-8#4)
hrIL-1##5##1##(1994-8#5)
hrp##6##1##(2008-10#6)
hrpL gene##2##2##(2008-10#2)
hrpL##6##1##(2008-10#6)
hrpS##2##1##(2008-10#2)
hrs after##2##2##(2008-12#1)(2011-2#1)
hrs and##2##2##(1991-3#1)(1995-12#1)
hrs##17##1##(1991-3#2)(1993-8#2)(1995-12#2)(2008-12#5)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
hrs)##2##1##(1993-8#1)(2008-12#1)
hs-CRP##7##1##(2011-2#5)(2012-5#2)
hsc 70##3##2##(1995-11#3)
hsc70 proteins##2##2##(1993-6#2)
hsp110 and##2##2##(1995-6#2)
hsp110##6##1##(1995-6#6)
hsp25 pseudogene##2##2##(1993-6#2)
hsp25##7##1##(1993-6#7)
hsp90 is##2##2##(1996-12#2)
hsp90##7##1##(1990-11#2)(1996-12#5)
html##2##1##(2008-8#1)(2009-2#1)
html)##2##1##(2008-7#1)(2010-12#1)
http##23##1##(1997-6#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#7)(2013-8#7)
huasteco virus (PHV)##2##3##(2008-10#2)
huasteco virus##4##2##(2008-10#4)
huasteco##5##1##(2008-10#5)
hub##2##1##(1992-1#1)(2009-8#1)
hubs##2##1##(2008-11#1)(2013-8#1)
hue of the##2##3##(2008-5#2)
hue of##3##2##(2008-5#2)(2013-8#1)
hue##6##1##(2008-5#3)(2008-8#1)(2011-2#1)(2013-8#1)
huge##25##1##(1995-10#1)(1995-12#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-9#1)(2009-4#2)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
hugely##2##1##(1992-9#1)(2008-6#1)
hull##7##1##(2008-10#1)(2008-12#3)(2008-6#1)(2008-8#2)
hulls##2##1##(2008-11#1)(2008-12#1)
human 293 cells##2##3##(2008-11#2)
human AML blasts##2##3##(2006-6#1)(2011-2#1)
human B cell line##4##4##(1995-2#1)(2008-8#3)
human B cell##9##3##(1991-3#1)(1995-2#1)(2008-11#3)(2008-4#1)(2008-8#3)
human B cells##2##3##(2008-11#2)
human B lymphocytes##4##3##(1991-3#1)(1992-8#2)(1994-3#1)
human B##15##2##(1991-3#2)(1992-8#2)(1994-3#1)(1995-2#1)(2008-11#5)(2008-4#1)(2008-8#3)
human DDK##3##2##(2012-3#3)
human DNA##6##2##(1995-6#1)(1996-6#2)(1997-7#1)(2008-12#1)(2008-5#1)
human E2 conjugating enzyme##2##4##(2009-7#2)
human ER##3##2##(1993-6#2)(2008-6#1)
human ES cells##2##3##(2008-8#1)(2008-9#1)
human ESC##2##2##(2008-10#1)(2008-11#1)
human FLN29##2##2##(2009-7#2)
human GABAA receptors##2##3##(1995-11#2)
human GABAA##4##2##(1995-11#4)
human HBV##2##2##(1993-8#1)(1995-2#1)
human HP1##2##2##(2013-1#2)
human IA2##2##2##(1990-5#2)
human ICAM-1##2##2##(2008-10#2)
human IL-13##2##2##(2008-4#2)
human IL-6##2##2##(1990-5#1)(2008-8#1)
human IgG##8##2##(1990-12#1)(1996-12#3)(2008-10#4)
human KU812##2##2##(1990-5#2)
human L17A##2##2##(1991-6#2)
human LCAT##2##2##(1993-6#2)
human LPL cDNA##2##3##(1995-6#1)(2008-11#1)
human LPL##4##2##(1995-6#1)(2008-11#3)
human MAbs##2##2##(2008-11#2)
human MCF-7##2##2##(1993-6#1)(2012-2#1)
human MDS##2##2##(2010-8#2)
human MHC##2##2##(2008-8#1)(2008-9#1)
human MTHFR##2##2##(2008-8#2)
human Mss4##2##2##(1995-8#2)
human NGF gene##2##3##(1990-8#2)
human NGF##7##2##(1990-8#7)
human NK cells##3##3##(2008-8#3)
human NK##4##2##(2008-4#1)(2008-8#3)
human P2##2##2##(1995-12#2)
human PAR1 genes##2##3##(2008-7#2)
human PBL##2##2##(2008-11#2)
human Schwann##3##2##(1995-2#3)
human T cell clones exhibiting natural killer-like activity##3##8##(2008-11#3)
human T cell lines##2##4##(1995-12#1)(2008-4#1)
human T cell##9##3##(1995-12#2)(2008-11#5)(2008-4#1)(2008-8#1)
human T cells##5##3##(2008-11#4)(2008-4#1)
human T##17##2##(1992-6#1)(1995-12#2)(1995-2#1)(2008-11#10)(2008-4#2)(2008-8#1)
human T-cell lines##2##3##(1993-6#1)(1997-3#1)
human T-cell##4##2##(1990-10#1)(1993-6#1)(1997-3#1)(2008-11#1)
human TIMP-2##3##2##(2010-1#3)
human TNF##2##2##(1997-2#1)(2008-11#1)
human VEGF##2##2##(2008-8#1)(2013-8#1)
human VLDL receptor##2##3##(1995-6#2)
human VLDL##4##2##(1995-6#4)
human X##3##2##(1990-3#1)(2008-7#1)(2010-5#1)
human acidic fibroblast growth factor##2##5##(1990-8#2)
human activities##3##2##(2008-12#1)(2008-9#1)(2012-9#1)
human acute monocytic##2##3##(1993-6#1)(1997-1#1)
human acute##6##2##(1991-9#1)(1993-6#1)(1997-1#1)(1997-7#1)(2006-6#1)(2011-2#1)
human acylamino acid-releasing enzyme##2##4##(1996-2#2)
human adenovirus##7##2##(1992-9#1)(2013-8#6)
human adult lung##2##3##(1994-11#2)
human adult##5##2##(1994-11#3)(2008-9#1)(2013-1#1)
human aging##6##2##(2008-11#1)(2008-7#1)(2009-8#2)(2010-1#2)
human airway##2##2##(1994-11#1)(1996-12#1)
human albumin##3##2##(1990-12#1)(1996-1#1)(2013-1#1)
human alpha##7##2##(1991-12#1)(1993-12#1)(1995-11#5)
human amniotic##2##2##(1993-3#1)(2008-8#1)
human and animal health##2##4##(2008-10#1)(2013-1#1)
human and animal##14##3##(2008-10#4)(2008-12#1)(2008-9#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
human and bovine##3##3##(1992-10#1)(1995-8#1)(2008-10#1)
human and chimpanzee##3##3##(1991-12#1)(2008-11#1)(2010-5#1)
human and mouse##9##3##(2008-4#4)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
human and murine interleukin##2##4##(1993-8#1)(2008-4#1)
human and murine##10##3##(1990-12#1)(1992-2#2)(1993-8#2)(1994-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
human and rat liver##3##4##(1994-3#1)(1994-8#2)
human and rat##8##3##(1992-10#1)(1993-8#1)(1994-3#2)(1994-8#2)(1995-2#1)(1996-12#1)
human and rodent##4##3##(1992-6#2)(1993-12#1)(2008-10#1)
human and##67##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-10#2)(1992-2#2)(1992-6#2)(1993-12#1)(1993-8#4)(1994-11#1)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-6#2)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-11#1)(2010-5#3)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
human androgen receptor##2##3##(1991-5#1)(2008-4#1)
human angiotensin II type 2 receptor##2##6##(1994-11#2)
human angiotensin II type##3##4##(1992-3#1)(1994-11#2)
human antibodies##2##2##(2008-11#2)
human antibody##4##2##(2008-10#1)(2008-11#3)
human antigen-specific T cells##2##4##(2008-9#2)
human antithrombin III##3##3##(1992-10#1)(2008-7#2)
human antithrombin##4##2##(1992-10#2)(2008-7#2)
human apoE##2##2##(1995-6#1)(2008-9#1)
human apolipoprotein B##2##3##(1995-2#2)
human apolipoprotein##4##2##(1991-12#1)(1995-2#2)(2008-6#1)
human arterial smooth-muscle##2##3##(1995-8#2)
human arterial##3##2##(1995-8#2)(2010-7#1)
human astrocytes##2##2##(2013-1#2)
human astrocytoma cells##2##3##(1993-8#1)(1995-12#1)
human astrocytoma##3##2##(1993-8#1)(1995-12#2)
human atherosclerotic##2##2##(1997-8#1)(2012-2#1)
human autoimmune##2##2##(1995-2#1)(1996-2#1)
human autopsy##2##2##(1995-3#1)(2013-1#1)
human axillary skin##2##3##(2008-5#2)
human behavior##2##2##(2008-11#1)(2008-12#1)
human behaviors##2##2##(2008-11#2)
human being##4##2##(2010-10#1)(2010-8#2)(2011-3#1)
human beings##9##2##(1992-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-1#1)(2012-2#1)(2013-1#1)
human beta##3##2##(1993-8#2)(1995-11#1)
human beta-1##2##2##(2008-9#2)
human beta-actin##2##2##(1996-2#1)(2008-11#1)
human beta-globin gene##2##3##(2008-8#2)
human beta-globin##3##2##(1993-6#1)(2008-8#2)
human beta2-microglobulin##2##2##(1997-9#2)
human beta2m##3##2##(1997-9#3)
human bladder##2##2##(2008-10#2)
human blood and##2##3##(1997-2#1)(2008-10#1)
human blood plasma samples##3##4##(2008-10#3)
human blood plasma##7##3##(2008-10#7)
human blood##23##2##(1993-3#2)(1994-6#1)(1997-2#1)(2008-10#16)(2008-8#2)(2008-9#1)
human body is##2##3##(2008-10#1)(2008-7#1)
human body##17##2##(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
human bone marrow##11##3##(2008-11#8)(2008-9#2)(2010-6#1)
human bone##12##2##(2008-11#8)(2008-9#2)(2010-6#1)(2011-2#1)
human bone-marrow-derived side population cells##2##5##(2010-6#2)
human brain cDNA libraries##2##4##(1996-8#1)(1997-2#1)
human brain cDNA##3##3##(1993-8#1)(1996-8#1)(1997-2#1)
human brain progenitor cells##2##4##(2008-7#2)
human brain tumor##2##3##(1990-6#1)(1995-2#1)
human brain##33##2##(1990-6#2)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-2#3)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#1)(2013-1#1)
human breast and ovarian cancer cells##2##6##(1997-7#2)
human breast and ovarian cancer##3##5##(1997-7#3)
human breast and##4##3##(1993-1#1)(1997-7#3)
human breast cancer MCF-7##2##4##(2008-11#1)(2011-2#1)
human breast cancer and estrogen independent MXT##2##7##(1993-1#2)
human breast cancer and##4##4##(1993-1#3)(1997-7#1)
human breast cancer cell line##3##5##(1990-11#1)(2008-11#2)
human breast cancer cell lines##5##5##(1992-4#1)(1997-7#1)(2008-11#3)
human breast cancer cell##10##4##(1990-11#1)(1992-4#1)(1997-7#1)(2008-11#7)
human breast cancer cells in##4##5##(1994-12#2)(1994-8#1)(2008-11#1)
human breast cancer cells##14##4##(1992-4#1)(1994-12#2)(1994-8#1)(1995-10#1)(2008-11#6)(2011-2#1)(2013-1#2)
human breast cancer##38##3##(1990-11#1)(1992-4#2)(1993-1#5)(1993-11#2)(1994-12#3)(1994-8#1)(1995-10#1)(1995-9#1)(1997-7#2)(2008-11#14)(2011-2#3)(2012-3#1)(2013-1#2)
human breast carcinoma##2##3##(1992-7#1)(2011-2#1)
human breast##55##2##(1990-11#1)(1992-4#2)(1992-7#1)(1993-1#8)(1993-11#4)(1994-12#3)(1994-8#1)(1995-10#2)(1995-9#1)(1996-10#1)(1997-7#5)(2008-10#1)(2008-11#14)(2009-12#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)
human c-myc##4##2##(1993-3#1)(1993-8#1)(1997-7#1)(2008-11#1)
human cDNA clone##2##3##(1991-5#1)(2008-11#1)
human cDNA##6##2##(1991-5#1)(1991-6#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-9#1)
human cancer cell lines##8##4##(1995-12#1)(2008-11#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
human cancer cells##8##3##(1990-2#1)(1994-11#1)(2008-11#4)(2008-8#1)(2008-9#1)
human cancer tissues##2##3##(2008-11#1)(2013-1#1)
human cancer##24##2##(1990-2#1)(1994-11#1)(1994-9#1)(1995-12#1)(2008-11#8)(2008-8#1)(2008-9#2)(2009-4#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
human cancers##14##2##(1997-7#2)(2008-11#2)(2008-8#1)(2011-2#5)(2013-1#4)
human carcinoma cell lines##2##4##(1995-9#1)(2013-1#1)
human cell line KG-1##5##4##(1995-8#2)(1996-2#3)
human cell line##12##3##(1990-5#1)(1994-11#1)(1994-8#1)(1995-8#2)(1996-2#3)(2008-11#2)(2008-9#2)
human cell lines##11##3##(1996-2#1)(1997-7#2)(2008-11#6)(2008-8#1)(2008-9#1)
human cell##27##2##(1990-5#1)(1994-11#1)(1994-8#1)(1995-8#2)(1996-2#4)(1997-7#3)(2008-11#9)(2008-4#1)(2008-8#1)(2008-9#3)(2012-2#1)
human cells and##3##3##(2008-11#3)
human cells to##2##3##(1993-3#1)(1994-5#1)
human cells##29##2##(1991-5#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-9#1)(1997-3#2)(1997-7#2)(2008-11#12)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)
human cervical cancer HeLa cells and##2##6##(2008-8#2)
human cervical cancer##5##3##(2008-11#1)(2008-8#2)(2010-12#1)(2010-3#1)
human chondrocytes##4##2##(2008-11#3)(2011-2#1)
human chorionic gonadotropin (hCG)##2##4##(1997-1#1)(2011-1#1)
human chorionic gonadotropin##3##3##(1995-8#1)(1997-1#1)(2011-1#1)
human chorionic##4##2##(1995-8#1)(1996-3#1)(1997-1#1)(2011-1#1)
human chromosome 1##2##3##(1997-8#1)(2008-9#1)
human chromosome 21##3##3##(1995-8#1)(1997-2#1)(1997-8#1)
human chromosome 21q22##2##3##(1997-2#1)(1997-8#1)
human chromosome 4p16##2##3##(1996-8#2)
human chromosome 7##3##3##(1996-6#3)
human chromosome##26##2##(1990-5#1)(1994-11#1)(1994-12#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-6#3)(1996-8#2)(1997-2#2)(1997-7#1)(1997-8#4)(2008-8#1)(2008-9#2)(2009-9#1)(2012-3#1)
human clinical trials##2##3##(2008-11#1)(2008-5#1)
human clinical##3##2##(2008-11#2)(2008-5#1)
human clotting factor IX##2##4##(2008-8#2)
human coagulation factor XIII##2##4##(2008-11#2)
human coagulation factor##4##3##(2008-11#2)(2008-8#1)(2008-9#1)
human collagen type IV##2##4##(2008-11#2)
human colligin-2##2##2##(1997-7#2)
human colon adenocarcinoma##2##3##(1990-12#1)(2008-11#1)
human colon cancer cell line##2##5##(1993-3#1)(1997-2#1)
human colon cancer cell lines##2##5##(1994-8#2)
human colon cancer cell##4##4##(1993-3#1)(1994-8#2)(1997-2#1)
human colon cancer cells##3##4##(1993-3#1)(1994-8#2)
human colon cancer##7##3##(1993-3#2)(1994-8#4)(1997-2#1)
human colon##11##2##(1990-12#1)(1993-3#2)(1994-8#5)(1997-2#1)(2008-11#2)
human complement##3##2##(1993-11#1)(1995-11#1)(1997-9#1)
human cord blood by##2##4##(2008-10#1)(2008-9#1)
human cord blood##8##3##(2008-10#3)(2008-8#2)(2008-9#3)
human cutaneous##3##2##(1995-2#1)(2008-5#1)(2012-2#1)
human cytomegalovirus (HCMV)##4##3##(1993-8#1)(1996-12#1)(1997-3#1)(2008-9#1)
human cytomegalovirus##8##2##(1993-8#2)(1996-12#2)(1997-3#2)(2008-11#1)(2008-9#1)
human cytosolic phospholipase A2 (cPLA2)##2##5##(1993-6#1)(1994-11#1)
human cytosolic phospholipase A2##4##4##(1993-6#2)(1994-11#2)
human cytosolic##6##2##(1993-6#2)(1994-11#4)
human dendritic cells##3##3##(2008-8#2)(2012-2#1)
human dendritic##4##2##(2008-10#1)(2008-8#2)(2012-2#1)
human dermal fibroblasts##2##3##(1990-5#2)
human dermis##2##2##(2008-5#2)
human development##3##2##(1995-3#1)(1995-8#1)(2008-11#1)
human digestive tract##2##3##(2012-2#2)
human dihydrolipoamide dehydrogenase##3##3##(1995-6#3)
human diploid fibroblasts##2##3##(1997-1#1)(2008-11#1)
human diploid##3##2##(1997-1#2)(2008-11#1)
human disease##11##2##(1994-5#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-9#3)(2011-2#1)(2012-2#1)(2013-8#1)
human diseases##16##2##(1990-5#1)(1994-11#1)(1994-5#1)(2008-4#3)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2011-2#3)(2013-8#1)
human embryo##2##2##(2008-11#1)(2008-9#1)
human embryonic lung##2##3##(2008-11#2)
human embryonic stem cell lines##3##5##(2008-8#2)(2008-9#1)
human embryonic stem cell##6##4##(2008-11#1)(2008-8#3)(2008-9#2)
human embryonic stem cells##6##4##(2008-11#2)(2008-9#2)(2012-3#1)(2012-5#1)
human embryonic stem##13##3##(2008-11#3)(2008-8#4)(2008-9#4)(2012-3#1)(2012-5#1)
human embryonic##17##2##(1992-3#1)(2008-11#6)(2008-8#4)(2008-9#4)(2012-3#1)(2012-5#1)
human endometrial##2##2##(1995-12#2)
human endonexin II##3##3##(1994-11#3)
human endothelial cells by##2##4##(1994-8#1)(2010-1#1)
human endothelial cells##6##3##(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(2008-11#1)(2010-1#1)
human endothelial##7##2##(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-11#1)(2010-1#1)
human epidermal growth factor receptor##2##5##(2011-2#1)(2012-3#1)
human epidermal growth factor##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
human epidermal##5##2##(1992-3#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
human epidermis##11##2##(2008-5#10)(2012-2#1)
human epithelial cells##2##3##(1990-2#2)
human epithelial##4##2##(1990-2#2)(2008-11#2)
human erythrocyte membranes##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
human erythrocyte##12##2##(1990-12#1)(1992-1#1)(1992-8#1)(1994-8#1)(2008-10#2)(2008-11#3)(2008-8#2)(2009-8#1)
human erythrocytes##11##2##(1991-5#3)(1994-8#2)(1995-6#3)(2008-10#1)(2008-11#2)
human erythroleukemia cell line##2##4##(1990-2#2)
human erythroleukemia##3##2##(1990-2#2)(2009-9#1)
human erythropoietin (hEp)-encoding##2##3##(1993-12#1)(1993-6#1)
human erythropoietin##9##2##(1993-12#1)(1993-6#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#1)
human erythropoietin-encoding gene contains##2##4##(1993-12#1)(1993-6#1)
human esophageal##3##2##(1992-8#3)
human estrogen receptor##5##3##(1992-3#2)(1993-6#1)(1995-11#2)
human evolution##3##2##(1996-5#2)(2008-12#1)
human ex vivo##2##3##(2006-6#2)
human experimental exposure##3##3##(2008-7#3)
human exposure to##2##3##(1992-3#1)(2008-11#1)
human exposure##4##2##(1992-3#1)(2008-11#1)(2008-9#1)(2013-1#1)
human exposures##2##2##(2010-11#1)(2011-2#1)
human factor IX##4##3##(2008-9#4)
human factor##6##2##(1990-5#1)(2008-11#1)(2008-9#4)
human fetal brain##3##3##(1995-6#1)(1996-2#1)(2008-8#1)
human fetal hepatocytes##4##3##(2008-11#4)
human fetal liver##3##3##(2008-8#2)(2008-9#1)
human fetal##18##2##(1992-5#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-11#5)(2008-8#3)(2008-9#2)(2009-10#3)
human fibrinogen##3##2##(2006-6#1)(2008-10#2)
human fibroblast cell##2##3##(2008-5#1)(2013-1#1)
human fibroblast##3##2##(2008-12#1)(2008-5#1)(2013-1#1)
human fibroblasts and##2##3##(1993-8#1)(1995-12#1)
human fibroblasts by##3##3##(1992-9#1)(1995-12#1)(2008-12#1)
human fibroblasts##20##2##(1990-5#2)(1992-9#2)(1993-8#1)(1994-3#1)(1995-12#2)(1995-6#2)(1997-7#3)(2008-10#1)(2008-12#1)(2008-5#3)(2012-2#1)(2013-1#1)
human fibrosarcoma cells##2##3##(2008-11#1)(2011-2#1)
human fibrosarcoma##4##2##(2008-11#2)(2011-2#1)(2012-2#1)
human fluids##2##2##(2008-10#2)
human foetal liver Zn-metallothioneins##3##4##(2008-10#3)
human foetal##4##2##(2008-10#4)
human food##2##2##(2008-10#1)(2011-2#1)
human gastric cancer##2##3##(2008-11#1)(2008-9#1)
human gastric##8##2##(1991-6#2)(1997-1#1)(2008-10#2)(2008-11#2)(2008-9#1)
human gastrointestinal##3##2##(2008-11#1)(2010-10#1)(2012-2#1)
human gene therapy##3##3##(1993-2#1)(2008-9#2)
human gene##16##2##(1991-6#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-7#2)(1997-8#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)
human geneGJB5 encoding gap junction protein beta-5##2##7##(2008-9#2)
human genes##11##2##(1993-12#1)(1993-3#1)(1993-6#1)(1995-8#2)(1996-2#3)(1997-6#1)(2008-4#1)(2008-9#1)
human genome and##2##3##(1992-3#1)(2008-7#1)
human genome##17##2##(1991-6#1)(1992-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-11#2)(2008-4#4)(2008-5#2)(2008-7#3)(2011-2#1)
human genomic DNA sequences##2##4##(1997-6#1)(2008-9#1)
human genomic DNA##4##3##(1993-6#1)(1997-6#1)(2008-9#2)
human genomic##7##2##(1990-8#1)(1992-10#1)(1993-6#1)(1994-11#1)(1997-6#1)(2008-9#2)
human glioblastoma cell lines##2##4##(1990-6#2)
human glucagon##5##2##(2008-11#1)(2008-8#4)
human glucocerebrosidase##2##2##(1994-5#1)(1997-7#1)
human granulocyte colony-stimulating factor##2##4##(2008-11#1)(2010-6#1)
human granulocytic anaplasmosis##4##3##(2008-12#1)(2013-1#3)
human growth hormone receptor##2##4##(2008-8#2)
human growth hormone##4##3##(1991-3#1)(1995-11#1)(2008-8#2)
human growth##7##2##(1991-3#1)(1991-6#1)(1992-9#1)(1995-11#1)(2008-11#1)(2008-8#2)
human gut##2##2##(2010-1#1)(2011-2#1)
human hair and##8##3##(2008-10#7)(2012-3#1)
human hair by##3##3##(2008-10#2)(2008-5#1)
human hair follicle grown in vitro##2##6##(2008-5#2)
human hair samples##2##3##(2008-10#2)
human hair with##3##3##(2008-10#2)(2012-3#1)
human hair##37##2##(2008-10#17)(2008-5#15)(2012-3#5)
human head##2##2##(2008-5#1)(2012-3#1)
human health and##3##3##(2010-4#1)(2011-2#1)(2012-2#1)
human health in##2##3##(2011-2#1)(2013-1#1)
human health is##2##3##(2011-2#1)(2013-1#1)
human health of##2##3##(2008-10#1)(2008-5#1)
human health##39##2##(1991-2#1)(1992-2#1)(1994-3#3)(2008-10#11)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
human heart##8##2##(1993-12#1)(1994-11#1)(2008-10#2)(2009-10#1)(2010-12#3)
human hematopoietic progenitor cells##2##4##(2008-11#2)
human hematopoietic progenitor##3##3##(2008-11#3)
human hematopoietic stem cells##3##4##(2008-11#1)(2009-12#2)
human hematopoietic##12##2##(1994-5#1)(2008-11#8)(2008-4#1)(2009-12#2)
human hepatic##2##2##(2008-11#1)(2010-11#1)
human hepatitis B##2##3##(1995-2#2)
human hepatoblastoma HepG2##2##3##(2008-11#2)
human hepatoblastoma##4##2##(2008-11#3)(2013-1#1)
human hepatocellular carcinoma (HCC)##2##4##(2008-8#1)(2011-2#1)
human hepatocellular carcinoma##3##3##(2008-8#2)(2011-2#1)
human hepatocellular##4##2##(2008-8#2)(2011-2#2)
human hepatocyte##3##2##(2008-11#2)(2008-9#1)
human hepatocytes with##2##3##(1995-2#1)(2013-1#1)
human hepatocytes##6##2##(1994-11#1)(1995-2#1)(2008-11#1)(2012-5#2)(2013-1#1)
human hepatoma cell line##3##4##(1997-1#1)(2008-8#1)(2013-8#1)
human hepatoma##9##2##(1995-2#1)(1997-1#1)(2008-11#3)(2008-8#2)(2008-9#1)(2013-8#1)
human hepatoma-derived cell line##2##4##(1997-1#2)
human homologue##3##2##(1993-3#1)(1997-3#1)(1997-7#1)
human hsp27##4##2##(1993-6#4)
human hypertrophic##2##2##(1996-8#1)(2008-9#1)
human immune system##5##3##(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
human immune##8##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-7#1)
human immunodeficiency virus (HIV) infection##6##5##(1993-12#1)(1996-9#1)(1997-8#1)(2008-2#1)(2009-8#1)(2013-8#1)
human immunodeficiency virus (HIV)##19##4##(1990-6#1)(1991-2#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2012-3#1)(2013-8#1)
human immunodeficiency virus (HIV-1)##2##4##(2009-8#1)(2010-11#1)
human immunodeficiency virus infection##6##4##(1991-3#1)(1996-2#1)(1997-7#1)(2008-12#1)(2011-2#1)(2012-3#1)
human immunodeficiency virus infection]##2##4##(1993-2#1)(1996-11#1)
human immunodeficiency virus type 1 (HIV-1) infection is##3##8##(2008-2#3)
human immunodeficiency virus type 1 (HIV-1)##5##6##(1995-2#1)(2008-11#1)(2008-2#3)
human immunodeficiency virus type 1 protease##2##6##(1991-9#2)
human immunodeficiency virus type 1##11##5##(1991-9#2)(1992-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-11#2)(2008-2#3)
human immunodeficiency virus type##12##4##(1991-9#2)(1992-6#2)(1993-8#1)(1995-2#1)(1997-3#1)(2008-11#2)(2008-2#3)
human immunodeficiency virus##56##3##(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-6#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-11#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-7#2)(1997-8#1)(2008-11#3)(2008-12#1)(2008-2#4)(2008-5#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
human immunodeficiency virus-1##2##3##(1992-12#1)(2008-11#1)
human immunodeficiency##62##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1996-11#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-7#2)(1997-8#1)(2008-11#4)(2008-12#1)(2008-2#4)(2008-5#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
human immunoglobulin G##3##3##(1996-12#1)(2008-10#2)
human immunoglobulin##5##2##(1996-12#1)(1997-8#1)(2008-10#2)(2011-2#1)
human induced pluripotent##2##3##(2012-5#2)
human infections##2##2##(2012-2#2)
human influenza##2##2##(2008-9#1)(2012-12#1)
human insulin##6##2##(1990-12#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-6#1)
human interaction##3##2##(2008-10#1)(2008-11#2)
human interface##2##2##(2008-10#1)(2010-8#1)
human interleukin##2##2##(2008-11#1)(2008-4#1)
human interleukin-1 beta##2##3##(1990-10#1)(1993-8#1)
human interleukin-1##3##2##(1990-10#1)(1993-8#1)(2008-5#1)
human interleukin-6 (hIL-6)##2##3##(2008-11#1)(2008-8#1)
human interleukin-6 receptor##2##3##(2008-8#2)
human interleukin-6##5##2##(2008-11#1)(2008-8#4)
human internal mammary artery##2##4##(1993-8#2)
human intestinal bacteria##4##3##(2008-11#4)
human intestinal epithelial cells##2##4##(1990-2#1)(2008-6#1)
human intestinal epithelial##3##3##(1990-2#1)(2008-11#1)(2008-6#1)
human intestinal mucin##3##3##(1990-8#1)(1991-12#2)
human intestinal##15##2##(1990-2#1)(1990-8#1)(1991-12#2)(2008-11#9)(2008-6#1)(2011-2#1)
human keratinocyte##4##2##(1992-3#1)(1994-11#1)(2008-11#1)(2008-7#1)
human keratinocytes##12##2##(1994-3#2)(1996-2#2)(1997-1#2)(2008-11#3)(2008-5#3)
human kidney and##2##3##(1991-5#1)(2011-2#1)
human kidney soluble##2##3##(1990-2#2)
human kidney##6##2##(1990-2#3)(1991-5#1)(2008-9#1)(2011-2#1)
human lecithin##2##2##(1993-8#2)
human leucocyte##4##2##(1993-8#1)(2007-11#1)(2008-4#1)(2011-2#1)
human leukemia KU812 cells##2##4##(2008-11#2)
human leukemia##6##2##(2008-11#5)(2008-7#1)
human leukemic cells##2##3##(2008-9#1)(2011-2#1)
human leukemic##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
human leukocyte elastase (HLE)##2##4##(1992-12#1)(2008-5#1)
human leukocyte elastase##3##3##(1992-12#1)(2008-5#2)
human leukocyte##8##2##(1990-12#1)(1990-5#1)(1992-12#1)(1992-6#1)(1993-6#1)(2008-11#1)(2008-5#2)
human leukocytes##3##2##(1991-5#3)
human lipoprotein lipase##2##3##(1994-11#1)(2008-11#1)
human liver UDP-glucuronosyltransferase cDNA##4##4##(2008-11#4)
human liver and##2##3##(1993-3#1)(1994-8#1)
human liver cDNA library##2##4##(1992-3#1)(1994-11#1)
human liver cDNA##3##3##(1992-3#1)(1994-11#1)(2008-11#1)
human liver cell line##2##4##(1994-6#1)(2008-11#1)
human liver cells##3##3##(1997-1#1)(2008-11#1)(2008-9#1)
human liver microsomes##7##3##(1990-5#1)(1991-5#3)(1994-8#1)(2011-3#2)
human liver##35##2##(1990-5#1)(1991-12#1)(1991-5#5)(1992-3#1)(1993-3#3)(1994-11#1)(1994-3#3)(1994-6#1)(1994-8#4)(1995-2#1)(1997-1#1)(2008-11#8)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#2)
human livers##2##2##(1991-5#1)(2008-8#1)
human lung adenocarcinoma cell line##2##5##(2008-11#2)
human lung adenocarcinoma##4##3##(2008-11#3)(2008-9#1)
human lung cDNA library##3##4##(1991-5#2)(1997-2#1)
human lung cancer cell line##2##5##(2008-8#1)(2013-1#1)
human lung cancer##5##3##(1990-5#1)(1991-12#1)(2008-8#2)(2013-1#1)
human lung cell line##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
human lung fibroblasts##3##3##(1990-5#1)(1995-8#1)(2008-11#1)
human lung##25##2##(1990-5#2)(1991-12#1)(1991-5#2)(1992-12#1)(1995-8#3)(1996-2#1)(1997-2#1)(2008-11#7)(2008-12#1)(2008-8#3)(2008-9#2)(2013-1#1)
human lungs##3##2##(1992-12#2)(1995-8#1)
human lymphoblastoid B cell line through sphingosine production##2##8##(1994-3#2)
human lymphoblastoid##3##2##(1994-3#2)(1996-12#1)
human lymphocyte##5##2##(1992-6#1)(1995-12#1)(2008-11#3)
human lymphocytes##10##2##(1990-8#1)(1992-6#1)(1993-8#2)(2008-11#3)(2008-7#1)(2011-2#2)
human lymphoid cells##2##3##(1995-12#2)
human mAbs##4##2##(2008-11#4)
human malaria parasite##2##3##(1993-2#2)
human malignancies##7##2##(2008-11#1)(2009-3#2)(2009-4#1)(2011-2#1)(2013-1#2)
human malignant glioma##2##3##(1995-2#1)(1997-7#1)
human malignant##4##2##(1995-2#1)(1997-7#1)(2008-4#1)(2011-3#1)
human mammary##6##2##(1990-12#1)(1993-11#2)(1995-9#2)(2009-12#1)
human marrow##3##2##(1993-12#2)(2008-8#1)
human mast cell##2##3##(1993-3#1)(2011-2#1)
human mast##3##2##(1993-3#1)(2008-9#1)(2011-2#1)
human medullary thyroid carcinoma cells##2##5##(1992-6#2)
human medullary thyroid##3##3##(1992-6#3)
human melanocytes##5##2##(1995-2#5)
human melanoma cell line##2##4##(1997-9#1)(2008-8#1)
human melanoma cell##4##3##(1992-2#2)(1997-9#1)(2008-8#1)
human melanoma cells##2##3##(1994-5#1)(2011-2#1)
human melanoma##13##2##(1992-2#4)(1994-5#4)(1997-9#1)(2008-11#2)(2008-8#1)(2011-2#1)
human menin from##2##3##(2008-11#2)
human menopausal gonadotropin for##2##4##(2007-7#2)
human mesenchymal stem##3##3##(2008-11#2)(2010-8#1)
human metaphase##2##2##(1995-12#1)(2008-9#1)
human milk##8##2##(2008-10#2)(2008-11#1)(2012-2#5)
human mirror neuron system##2##4##(2008-11#2)
human monoclonal antibodies##4##3##(2008-11#4)
human monoclonal antibody AE6F4##3##4##(2008-11#3)
human monoclonal antibody##13##3##(2008-10#1)(2008-11#11)(2012-3#1)
human monoclonal##18##2##(2008-10#1)(2008-11#16)(2012-3#1)
human monocytes##7##2##(1991-7#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-8#3)
human monocytic##2##2##(1995-6#1)(2008-10#1)
human movement##2##2##(2010-6#1)(2013-1#1)
human mucin##2##2##(1990-8#2)
human multiple##2##2##(2010-12#1)(2011-2#1)
human muscle cells##3##3##(1990-5#2)(2008-11#1)
human mutant##2##2##(2008-4#1)(2008-9#1)
human myeloid##3##2##(1993-3#2)(1993-8#1)
human myometrial##3##2##(1992-6#1)(1994-3#1)(1994-8#1)
human myometrium##3##2##(1994-3#1)(1994-8#2)
human nasopharyngeal carcinoma##2##3##(2008-8#2)
human nebulin##5##2##(2008-6#5)
human nerve growth factor##2##4##(1990-8#1)(2008-5#1)
human neuroblastoma cells##2##3##(1995-12#1)(2008-8#1)
human neutrophil##2##2##(1994-11#1)(2008-5#1)
human neutrophils in##2##3##(2008-1#1)(2008-10#1)
human neutrophils was##3##3##(1992-12#1)(1993-6#1)(1994-6#1)
human neutrophils##20##2##(1992-12#3)(1993-3#1)(1993-6#4)(1994-6#2)(1994-8#1)(1995-6#1)(1996-12#1)(2008-1#3)(2008-10#2)(2008-11#1)(2011-2#1)
human non-pancreatic phospholipase A2##2##4##(1992-8#2)
human non-small cell lung cancer##2##5##(2008-11#1)(2013-1#1)
human normal##3##2##(2008-11#1)(2008-9#2)
human nutrition and health##2##4##(2008-10#2)
human nutrition##3##2##(2008-10#2)(2011-1#1)
human observer##2##2##(2008-11#1)(2010-8#1)
human occupants##2##2##(2008-9#2)
human ocular diseases##2##3##(2008-8#1)(2010-10#1)
human or bovine collagen type I##2##6##(2008-11#2)
human or mouse IL-18##2##4##(2008-4#2)
human or##7##2##(1995-11#1)(1996-12#1)(2008-11#3)(2008-4#2)
human oral squamous cell carcinoma##2##5##(2010-12#2)
human oral##4##2##(1993-1#1)(2010-12#2)(2010-2#1)
human organs##4##2##(2007-11#1)(2008-10#2)(2010-12#1)
human origin in##2##3##(1995-2#1)(2008-8#1)
human osteoblast-like cells##3##3##(2008-11#3)
human osteoblast-like##4##2##(2008-11#4)
human osteoblasts##3##2##(1993-3#2)(2008-11#1)
human ovarian cancer##3##3##(1990-2#1)(1996-10#1)(2008-8#1)
human ovarian##5##2##(1990-2#1)(1993-8#2)(1996-10#1)(2008-8#1)
human papilloma virus##3##3##(2007-8#1)(2011-1#2)
human papillomavirus and##2##3##(2013-1#1)(2013-8#1)
human papillomavirus type 16##2##4##(1995-2#2)
human papillomavirus##13##2##(1992-3#2)(1995-2#2)(2008-12#1)(2010-7#1)(2011-2#3)(2013-1#3)(2013-8#1)
human pathogen associated with##2##4##(1995-2#1)(2008-7#1)
human pathogen##8##2##(1992-8#1)(1995-2#1)(2007-12#1)(2008-7#1)(2008-9#2)(2011-2#2)
human pathogenic##3##2##(1992-3#1)(2008-11#1)(2012-2#1)
human pathogens##3##2##(2008-4#1)(2008-9#1)(2012-3#1)
human patients and##2##3##(2011-9#1)(2012-12#1)
human patients##4##2##(2008-11#1)(2010-7#1)(2011-9#1)(2012-12#1)
human performance##3##2##(2008-11#1)(2013-1#2)
human periodontal ligament (PDL)##2##4##(1995-8#1)(2013-1#1)
human periodontal ligament##3##3##(1995-8#1)(2013-1#2)
human peripheral blood T##2##4##(1992-6#1)(1995-2#1)
human peripheral blood lymphocytes##14##4##(1991-12#1)(1993-8#2)(1995-12#2)(2008-11#8)(2008-9#1)
human peripheral blood mononuclear cells##3##5##(1990-2#1)(2008-11#1)(2008-9#1)
human peripheral blood mononuclear##4##4##(1990-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
human peripheral blood##24##3##(1990-2#1)(1991-12#1)(1992-6#1)(1993-8#2)(1994-11#1)(1995-12#2)(1995-2#1)(2008-11#9)(2008-7#1)(2008-8#1)(2008-9#3)(2012-2#1)
human peripheral##26##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-8#2)(1994-11#1)(1995-12#3)(1995-2#1)(2008-11#9)(2008-7#1)(2008-8#1)(2008-9#3)(2012-2#1)
human perturbations##4##2##(2008-10#4)
human physiology and##2##3##(2010-7#1)(2011-2#1)
human physiology##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
human placenta cDNA##3##3##(1991-7#1)(1994-11#1)(2008-8#1)
human placenta##13##2##(1991-7#1)(1992-10#1)(1993-3#1)(1993-8#1)(1994-11#2)(1997-1#2)(2008-10#2)(2008-8#3)
human placental alkaline phosphatase (SEAP)##2##5##(2008-11#2)
human placental choriocarcinoma cells##2##4##(1994-6#2)
human placental##9##2##(1990-12#1)(1991-5#1)(1994-3#1)(1994-6#2)(2008-11#2)(2008-8#2)
human plasma and urine##2##4##(2008-10#1)(2008-11#1)
human plasma and##8##3##(1991-12#1)(1992-12#1)(2008-10#4)(2008-11#1)(2011-2#1)
human plasma by##5##3##(2008-10#5)
human plasma samples##3##3##(2008-10#3)
human plasma using##4##3##(2008-10#4)
human plasma##45##2##(1990-12#4)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(2008-10#32)(2008-11#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#1)
human plasminogen and##2##3##(1993-8#1)(1994-11#1)
human plasminogen##9##2##(1993-8#4)(1994-11#1)(1995-6#2)(2013-1#2)
human platelet##5##2##(1992-3#1)(1992-8#1)(2006-6#2)(2008-11#1)
human platelets##8##2##(1990-5#1)(1990-8#2)(1993-8#1)(2006-6#4)
human poly(A)+ RNA##2##3##(1992-6#1)(1995-12#1)
human polymorphonuclear##3##2##(1992-10#1)(1993-8#1)(1995-6#1)
human population##3##2##(2011-3#1)(2013-1#2)
human populations##7##2##(1993-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-10#1)(2012-3#1)
human potential##2##2##(2008-12#1)(2008-7#1)
human preadipocytes##4##2##(2008-5#4)
human pregnancy##2##2##(1990-11#1)(1995-8#1)
human primary##3##2##(2008-9#1)(2013-8#2)
human prion disease##2##3##(2010-12#2)
human prostate cancer cells##3##4##(2008-6#1)(2011-2#2)
human prostate cancer##5##3##(2008-4#1)(2008-6#1)(2011-2#3)
human prostate##6##2##(2008-4#1)(2008-6#1)(2011-2#4)
human prostatic##3##2##(1990-11#1)(1991-2#2)
human protein C##3##3##(2008-12#3)
human protein##4##2##(2008-10#1)(2008-12#3)
human proteins##3##2##(1994-5#1)(2008-11#1)(2013-1#1)
human pseudocathepsin D##2##3##(2008-4#2)
human pseudocathepsin##3##2##(2008-4#3)
human purH gene##2##3##(1995-12#2)
human r-IgG##2##2##(2008-10#2)
human recombinant##9##2##(1994-11#1)(1994-8#2)(2008-10#1)(2008-11#3)(2008-7#1)(2011-2#1)
human remains##2##2##(1995-11#1)(2013-1#1)
human renal##3##2##(1992-3#2)(2011-2#1)
human renin##3##2##(1993-6#3)
human research##3##2##(2009-4#1)(2009-7#1)(2011-2#1)
human resources##8##2##(1994-1#1)(1994-12#2)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
human respiratory tract##6##3##(1995-12#1)(1995-3#1)(1997-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
human retinal pigment epithelial cells##3##5##(1993-3#3)
human retinal##4##2##(1993-3#3)(2012-4#1)
human retroviral replication##3##3##(1995-2#3)
human retroviral##5##2##(1992-6#1)(1995-2#4)
human rhinovirus##3##2##(2008-10#1)(2013-8#2)
human rights##7##2##(1990-6#1)(1991-3#1)(1995-11#2)(2008-11#2)(2008-8#1)
human risk##2##2##(2008-11#1)(2010-9#1)
human saliva##5##2##(2008-10#4)(2010-12#1)
human samples##2##2##(1990-3#1)(2008-10#1)
human seminal gamma-glutamyl transpeptidase##2##4##(1995-11#2)
human sera from##2##3##(1993-8#1)(2008-10#1)
human sera##8##2##(1990-12#1)(1993-8#1)(2008-10#5)(2008-5#1)
human serum IgG##2##3##(2008-11#2)
human serum albumin (HSA) and human##2##6##(2008-10#2)
human serum albumin (HSA) and##4##5##(2008-10#4)
human serum albumin (HSA) is##2##5##(2008-10#2)
human serum albumin (HSA) was studied using##2##7##(2008-10#2)
human serum albumin (HSA)##16##4##(1997-2#1)(2008-10#15)
human serum albumin##23##3##(1990-12#1)(1997-2#1)(2008-10#20)(2008-7#1)
human serum and urine##4##4##(2008-10#4)
human serum and##8##3##(2008-10#6)(2008-11#2)
human serum at##3##3##(2008-10#3)
human serum by##5##3##(1991-5#1)(2008-10#4)
human serum samples are##2##4##(2008-10#2)
human serum samples were##5##4##(2008-10#5)
human serum samples##15##3##(2008-10#15)
human serum was##4##3##(2008-10#3)(2008-11#1)
human serum with##4##3##(2008-10#4)
human serum##107##2##(1990-12#1)(1991-5#3)(1992-12#1)(1993-11#1)(1993-3#1)(1994-8#2)(1995-12#1)(1995-8#1)(1997-2#1)(2008-10#86)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
human service##10##2##(1991-12#1)(1991-3#1)(1992-3#1)(1994-1#1)(1994-12#2)(1995-3#1)(1996-2#1)(2011-2#2)
human services##6##2##(1992-1#1)(1992-3#2)(1996-3#1)(2008-11#2)
human skeletal muscle##8##3##(1990-2#1)(1994-11#2)(2008-1#1)(2008-11#2)(2008-6#2)
human skeletal muscles##2##3##(1994-11#1)(2011-2#1)
human skeletal##11##2##(1990-2#1)(1994-11#3)(2008-1#1)(2008-11#2)(2008-6#2)(2011-2#1)(2012-2#1)
human skin and##2##3##(2008-5#2)
human skin fibroblast##2##3##(1995-3#1)(2008-11#1)
human skin fibroblasts and##4##4##(1991-12#1)(1995-3#1)(2008-5#2)
human skin fibroblasts##14##3##(1991-12#2)(1995-3#1)(2008-11#1)(2008-5#10)
human skin in vivo##3##4##(2008-5#3)
human skin in##4##3##(2008-5#4)
human skin was##2##3##(2008-10#1)(2008-5#1)
human skin were##2##3##(2008-11#1)(2008-5#1)
human skin##68##2##(1990-2#1)(1991-12#2)(1992-6#1)(1995-3#2)(2007-11#3)(2008-10#3)(2008-11#4)(2008-5#45)(2008-6#2)(2011-2#2)(2012-2#2)(2012-3#1)
human small cell lung carcinoma##2##5##(1994-8#2)
human small##3##2##(1990-8#1)(1994-8#2)
human solid tumors##2##3##(1992-10#1)(2008-11#1)
human space exploration##2##3##(2012-3#2)
human spaceflight##3##2##(2012-3#3)
human stem cell research##2##4##(2008-9#2)
human stem cell##4##3##(2008-9#3)(2012-5#1)
human stomach##2##2##(1997-1#1)(2008-8#1)
human stratum corneum##2##3##(2008-5#2)
human studies##11##2##(1993-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-7#1)(2012-2#1)(2012-3#1)
human subject##2##2##(2008-9#1)(2009-7#1)
human subjects##24##2##(1991-12#1)(1992-3#2)(1992-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#5)(2008-5#3)(2009-4#3)(2013-1#1)
human tRNA gene##3##3##(1997-7#3)
human teeth##2##2##(1991-2#2)
human telomerase reverse transcriptase (hTERT)##2##5##(2008-11#2)
human telomerase reverse transcriptase##3##4##(2008-11#3)
human telomerase##7##2##(2008-11#6)(2008-9#1)
human testing##2##2##(2008-5#2)
human testis##7##2##(1990-2#3)(1995-8#1)(2008-8#2)(2008-9#1)
human tetherin##2##2##(2013-1#2)
human therapeutic##2##2##(2008-11#2)
human thrombospondin 1##2##3##(1994-5#2)
human thromboxane synthase##2##3##(1991-5#2)
human thyroid##5##2##(1990-2#1)(1994-11#4)
human thyrotropin receptor##3##3##(1991-5#1)(1995-12#2)
human thyrotropin##6##2##(1991-5#2)(1995-12#2)(2013-1#2)
human thyrotropin-releasing hormone receptor##2##4##(1993-8#2)
human tissue inhibitor of metalloproteinase##2##5##(1990-8#1)(2010-1#1)
human tissue inhibitor of##3##4##(1990-8#1)(2010-1#2)
human tissue plasminogen activator##2##4##(2008-7#2)
human tissue##8##2##(1990-8#1)(1992-3#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-1#2)
human tissues##13##2##(1991-5#3)(1991-6#1)(1994-11#1)(1995-6#1)(2008-11#2)(2008-12#1)(2008-8#2)(2008-9#2)
human topoisomerase II alpha##2##4##(1995-6#2)
human topoisomerase II beta##3##4##(1995-6#3)
human topoisomerase II##5##3##(1995-6#5)
human traits##2##2##(1994-3#1)(2008-12#1)
human transcript##2##2##(1995-12#2)
human transferrin##11##2##(1991-6#1)(1992-1#1)(2008-11#8)(2008-7#1)
human transforming growth factor##4##4##(1990-8#1)(1993-12#1)(2008-8#2)
human treatment##2##2##(2008-10#1)(2012-3#1)
human trials##4##2##(1995-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
human tumor cell lines##5##4##(1993-9#1)(1994-5#1)(2008-11#1)(2008-9#2)
human tumor cell##6##3##(1990-5#1)(1993-9#1)(1994-5#1)(2008-11#1)(2008-9#2)
human tumor cells##7##3##(1990-5#1)(1994-5#2)(2008-11#1)(2008-8#1)(2009-4#2)
human tumor##19##2##(1990-5#2)(1993-9#1)(1994-12#1)(1994-5#3)(2008-11#3)(2008-8#3)(2008-9#3)(2009-4#2)(2013-8#1)
human tumors and##2##3##(2008-11#1)(2008-9#1)
human tumors##8##2##(2008-10#1)(2008-11#3)(2008-9#1)(2011-2#2)(2013-1#1)
human tumour cell##2##3##(1994-3#1)(1997-7#1)
human type I##5##3##(1990-2#1)(1991-7#2)(1995-12#1)(2008-5#1)
human type##7##2##(1990-2#1)(1991-7#2)(1994-11#1)(1995-12#1)(2008-5#1)(2012-3#1)
human umbilical cord blood##2##4##(2008-8#2)
human umbilical cord##4##3##(1995-2#1)(2008-11#1)(2008-8#2)
human umbilical vein endothelial cells (HUVEC)##7##6##(1994-8#1)(1997-1#1)(2008-8#1)(2008-9#2)(2010-3#1)(2012-2#1)
human umbilical vein endothelial cells##17##5##(1991-5#1)(1994-8#2)(1997-1#2)(2008-10#1)(2008-11#3)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
human umbilical vein endothelial##19##4##(1991-5#1)(1994-8#2)(1997-1#2)(2008-10#1)(2008-11#5)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
human umbilical vein##20##3##(1991-5#1)(1993-6#1)(1994-8#2)(1997-1#2)(2008-10#1)(2008-11#5)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
human umbilical veins##2##3##(2008-8#1)(2008-9#1)
human umbilical##27##2##(1991-5#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-2#1)(1997-1#2)(2008-10#1)(2008-11#6)(2008-8#5)(2008-9#4)(2010-3#1)(2012-2#2)
human urine and hair samples##2##5##(2008-10#2)
human urine and pharmaceuticals##2##4##(2008-10#2)
human urine and serum##10##4##(2008-10#10)
human urine and##20##3##(2008-10#20)
human urine by##8##3##(2008-10#7)(2008-11#1)
human urine has been developed##2##5##(2008-10#2)
human urine samples##12##3##(2008-10#11)(2010-11#1)
human urine##72##2##(1994-3#1)(1997-2#1)(2008-10#67)(2008-11#2)(2010-11#1)
human uterine LMS##3##3##(2012-2#3)
human uterine##5##2##(2008-11#1)(2012-2#3)(2013-1#1)
human vascular endothelial growth factor##2##5##(2008-8#2)
human vascular endothelial growth##3##4##(1997-7#1)(2008-8#2)
human vascular endothelial##5##3##(1994-11#1)(1997-7#1)(2008-8#2)(2010-1#1)
human visual##2##2##(2009-10#1)(2009-8#1)
human volunteer##4##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
human volunteers##12##2##(1992-6#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-5#5)
human vomeronasal##3##2##(1994-2#1)(2012-2#2)
human whole blood##2##3##(2008-10#2)
human whole##3##2##(1997-8#1)(2008-10#2)
human##3066##1##(1990-10#2)(1990-11#5)(1990-12#21)(1990-2#22)(1990-3#5)(1990-5#27)(1990-6#11)(1990-8#23)(1991-1#1)(1991-10#3)(1991-12#15)(1991-2#10)(1991-3#11)(1991-5#35)(1991-6#22)(1991-7#9)(1991-9#6)(1992-1#3)(1992-10#12)(1992-11#2)(1992-12#13)(1992-2#8)(1992-3#28)(1992-4#2)(1992-5#3)(1992-6#25)(1992-7#1)(1992-8#12)(1992-9#7)(1993-1#11)(1993-11#11)(1993-12#24)(1993-2#14)(1993-3#32)(1993-6#41)(1993-8#45)(1993-9#3)(1994-1#3)(1994-11#57)(1994-12#13)(1994-2#5)(1994-3#26)(1994-5#19)(1994-6#9)(1994-8#39)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#22)(1995-12#40)(1995-2#49)(1995-3#7)(1995-5#6)(1995-6#42)(1995-8#32)(1995-9#8)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#27)(1996-2#29)(1996-3#4)(1996-5#3)(1996-6#8)(1996-8#5)(1996-9#1)(1997-1#22)(1997-2#21)(1997-3#10)(1997-4#1)(1997-6#11)(1997-7#45)(1997-8#20)(1997-9#12)(2006-6#13)(2007-11#7)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#374)(2008-11#422)(2008-12#32)(2008-2#7)(2008-3#4)(2008-4#51)(2008-5#135)(2008-6#15)(2008-7#41)(2008-8#127)(2008-9#117)(2009-10#10)(2009-11#2)(2009-12#9)(2009-2#1)(2009-3#2)(2009-4#9)(2009-5#2)(2009-6#2)(2009-7#25)(2009-8#14)(2009-9#5)(2010-1#16)(2010-10#6)(2010-11#13)(2010-12#12)(2010-2#2)(2010-3#5)(2010-4#1)(2010-5#10)(2010-6#11)(2010-7#7)(2010-8#13)(2010-9#2)(2011-1#9)(2011-2#112)(2011-3#15)(2011-7#1)(2011-9#1)(2012-12#7)(2012-2#61)(2012-3#48)(2012-4#1)(2012-5#8)(2012-9#3)(2013-1#85)(2013-7#4)(2013-8#34)
human-derived##2##1##(2008-9#1)(2010-11#1)
human-friendly&quot##2##1##(1994-3#2)
human-human hybridoma cell line##2##4##(2008-11#2)
human-human hybridoma cell##3##3##(2008-11#3)
human-human hybridoma##5##2##(2008-11#5)
human-human hybridomas##2##2##(2008-11#2)
human-human##7##1##(2008-11#7)
human-induced##2##1##(2012-3#1)(2012-9#1)
human-mouse##3##1##(1990-12#1)(2008-11#1)(2008-4#1)
human/rodent##3##1##(1997-2#2)(1997-8#1)
humanistic##6##1##(1997-3#1)(2010-6#3)(2012-2#1)(2012-3#1)
humanities in the##3##3##(2008-11#2)(2011-2#1)
humanities in##4##2##(1997-3#1)(2008-11#2)(2011-2#1)
humanities is##2##2##(1997-3#1)(2011-2#1)
humanities##13##1##(1997-3#2)(2008-11#4)(2011-2#6)(2013-8#1)
humanity##2##1##(2008-11#2)
humanization##2##1##(1995-5#1)(2008-5#1)
humanized antibody##2##2##(2008-11#2)
humanized##6##1##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)
humanoid##2##1##(2008-11#1)(2009-11#1)
humans and animals and##2##4##(2013-8#2)
humans and animals##7##3##(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
humans and dogs##2##3##(2010-12#1)(2011-2#1)
humans and other##5##3##(1993-3#1)(1994-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
humans and rats##6##3##(1994-2#1)(2008-10#1)(2008-7#4)
humans and yeast##2##3##(2010-4#2)
humans and##45##2##(1991-12#1)(1992-11#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-9#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
humans are not##2##3##(2008-10#1)(2012-2#1)
humans are##6##2##(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#2)
humans as a##2##3##(1993-11#1)(2010-5#1)
humans as well as in##2##5##(1995-5#1)(2012-2#1)
humans as well as##3##4##(1995-5#1)(2012-2#2)
humans as##7##2##(1993-11#1)(1995-5#1)(2008-7#1)(2010-5#1)(2012-2#3)
humans by##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
humans can be##2##3##(1990-5#1)(2008-4#1)
humans from##2##2##(1995-2#1)(2010-1#1)
humans have##2##2##(1996-2#1)(2008-6#1)
humans in##3##2##(1994-5#1)(2006-6#1)(2011-2#1)
humans is##11##2##(1995-2#1)(1996-2#1)(1997-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
humans of##3##2##(1991-9#1)(2008-8#1)(2011-2#1)
humans that##3##2##(2008-9#2)(2010-5#1)
humans through the##2##3##(2008-10#1)(2013-8#1)
humans to##4##2##(1992-3#1)(1994-5#1)(2011-2#2)
humans with##5##2##(1991-1#1)(1994-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
humans##258##1##(1990-11#1)(1990-5#4)(1991-1#8)(1991-12#5)(1991-2#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#3)(1996-2#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#2)(1997-9#1)(2006-6#1)(2007-12#1)(2008-10#27)(2008-11#17)(2008-12#7)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#2)(2009-5#1)(2009-8#5)(2010-1#2)(2010-11#7)(2010-12#1)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#31)(2012-12#6)(2012-2#14)(2012-3#8)(2013-1#5)(2013-8#11)
humans]##2##1##(1997-5#1)(2012-12#1)
humectancies of d-tagatose and d-sorbitol##2##5##(2008-5#2)
humectancy##6##1##(2008-5#6)
humectant##2##1##(2008-5#2)
humeral##9##1##(1997-6#1)(2008-8#2)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
humerus fractures##5##2##(2008-9#1)(2009-3#2)(2013-1#2)
humerus##12##1##(1996-11#1)(2008-9#1)(2009-3#2)(2009-4#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#3)
humic (HA) and fulvic##2##4##(2008-10#2)
humic acid (HA)##2##3##(2008-10#2)
humic acid and cations Ca(II)##2##5##(2008-10#2)
humic acid##22##2##(2008-10#22)
humic acids (HAs)##2##3##(2008-10#2)
humic acids and##3##3##(2008-10#3)
humic acids##24##2##(2008-10#24)
humic and fulvic acids##2##4##(2008-10#2)
humic and fulvic##3##3##(2008-10#3)
humic compounds##5##2##(2008-10#5)
humic materials##3##2##(2008-10#3)
humic matter by##2##3##(2008-10#2)
humic matter##5##2##(2008-10#5)
humic solutes##2##2##(2008-10#2)
humic substance-metal##2##2##(2008-10#2)
humic substances (HS)##4##3##(2008-10#4)
humic substances and##3##3##(2008-10#3)
humic substances##20##2##(2008-10#20)
humic##102##1##(2008-10#102)
humic-solute bulks##2##2##(2008-10#2)
humic-solute##3##1##(2008-10#3)
humics##2##1##(2008-10#2)
humid conditions##2##2##(1996-2#1)(2008-10#1)
humid tropics##2##2##(2010-7#2)
humid##10##1##(1993-3#1)(1996-2#1)(2008-10#4)(2010-7#2)(2011-2#1)(2013-1#1)
humidified##2##1##(2008-5#1)(2013-1#1)
humidities##12##1##(1996-12#2)(2008-10#10)
humidity &gt##3##2##(2008-10#3)
humidity (RH)##19##2##(1996-12#1)(2008-10#18)
humidity and##7##2##(1996-12#1)(2008-10#4)(2008-5#1)(2013-1#1)
humidity as the##2##3##(2008-10#2)
humidity at the##3##3##(1992-2#2)(2008-10#1)
humidity at##8##2##(1992-2#2)(2008-10#3)(2008-2#2)(2008-5#1)
humidity during##3##2##(2008-10#2)(2008-5#1)
humidity for##2##2##(2008-10#2)
humidity in the##2##3##(2008-10#1)(2008-3#1)
humidity in##3##2##(2008-10#2)(2008-3#1)
humidity level##2##2##(2008-10#2)
humidity levels##2##2##(2008-10#2)
humidity of the##2##3##(1995-3#1)(2008-10#1)
humidity of##3##2##(1992-2#1)(1995-3#1)(2008-10#1)
humidity on##5##2##(2008-10#5)
humidity profiles##3##2##(1996-12#3)
humidity sensing##5##2##(2008-10#5)
humidity sensor##4##2##(2008-10#4)
humidity##138##1##(1992-2#3)(1995-3#3)(1996-12#5)(1996-3#1)(2008-10#106)(2008-2#3)(2008-3#2)(2008-5#6)(2009-3#1)(2009-5#2)(2010-4#1)(2013-1#3)(2013-8#2)
humidity)##4##1##(1996-2#1)(2008-10#2)(2008-11#1)
hummingbird##4##1##(2008-8#1)(2008-9#2)(2012-12#1)
hummingbirds##2##1##(2008-9#2)
humor##8##1##(2008-12#6)(2009-10#1)(2011-3#1)
humoral and cellular immune responses##3##5##(1991-12#1)(1995-5#1)(2008-12#1)
humoral and cellular immune##4##4##(1991-12#2)(1995-5#1)(2008-12#1)
humoral and cellular##5##3##(1991-12#2)(1995-5#2)(2008-12#1)
humoral and##7##2##(1991-12#2)(1995-5#2)(2008-10#1)(2008-11#1)(2008-12#1)
humoral immune response##8##3##(1997-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
humoral immune responses of##2##4##(2008-11#1)(2008-12#1)
humoral immune responses##8##3##(1995-2#2)(2008-10#2)(2008-11#3)(2008-12#1)
humoral immune##19##2##(1995-2#2)(1996-9#1)(1997-8#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#2)
humoral immunity##13##2##(1993-12#1)(1995-12#2)(1995-5#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#2)(2012-3#1)
humoral response##4##2##(1991-12#2)(1993-12#1)(2008-10#1)
humoral responses##5##2##(1991-12#2)(1995-5#1)(2008-10#2)
humoral responsiveness##2##2##(1993-12#2)
humoral##57##1##(1991-12#6)(1993-12#4)(1993-3#1)(1995-12#3)(1995-2#2)(1995-5#5)(1996-12#1)(1996-9#1)(1997-8#2)(2008-10#11)(2008-11#6)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#4)(2012-3#1)
humour and##2##2##(2008-11#1)(2008-5#1)
hundred and fifty##5##3##(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)(2012-3#1)
hundred and ninety-seven##2##3##(1993-12#1)(2012-12#1)
hundred and##45##2##(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-10#1)(1995-12#1)(1996-8#2)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2010-1#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#2)
hundred fold##2##2##(2008-10#1)(2008-11#1)
hundred genes##2##2##(2008-7#1)(2013-8#1)
hundred isolates##2##2##(2008-10#2)
hundred patients##2##2##(1992-2#1)(2011-2#1)
hundred sixty##2##2##(1991-12#1)(2013-8#1)
hundred sixty-four##2##2##(2008-10#1)(2013-1#1)
hundred thirty##2##2##(1995-3#1)(1997-2#1)
hundred thirty-five##2##2##(1992-1#1)(2012-2#1)
hundred years##6##2##(1990-6#1)(1991-12#1)(1997-2#1)(2008-2#1)(2013-1#1)(2013-8#1)
hundred##118##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#3)(1992-12#2)(1992-2#2)(1993-1#1)(1993-12#3)(1993-2#1)(1994-3#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-8#2)(1997-2#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#24)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2010-1#1)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#7)
hundreds of genes##2##3##(2008-10#2)
hundreds of thousands of##2##4##(2008-7#1)(2009-8#1)
hundreds of years##2##3##(1996-9#1)(2011-2#1)
hundreds of##19##2##(1996-9#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2013-8#2)
hundreds to thousands of##2##4##(1991-2#1)(2008-4#1)
hundreds##22##1##(1991-2#1)(1996-9#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2013-8#2)
hunger##2##1##(1991-1#1)(2008-3#1)
hungry##2##1##(1993-6#1)(2011-2#1)
hunt##3##1##(2008-11#1)(2008-9#2)
hunting##4##1##(1992-11#1)(2008-8#1)(2013-1#2)
hurdle##2##1##(1993-12#1)(1997-7#1)
hurdles have##2##2##(2008-4#1)(2010-12#1)
hurdles that##3##2##(1994-2#1)(2008-4#1)(2012-3#1)
hurdles to##3##2##(1994-3#1)(2010-5#1)(2013-8#1)
hurdles##16##1##(1994-2#1)(1994-3#1)(1995-3#1)(2008-10#2)(2008-4#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#2)
hurt##4##1##(1993-1#1)(2008-11#1)(2010-4#1)(2010-9#1)
husbandry and##2##2##(2008-11#1)(2010-10#1)
husbandry conditions for maintaining multi-generation populations of this species##2##9##(2008-11#2)
husbandry conditions for maintaining multi-generation populations##3##6##(2008-11#3)
husbandry##10##1##(2008-11#7)(2008-9#1)(2010-10#1)(2011-2#1)
husk extension##2##2##(2008-10#2)
husk##3##1##(2008-10#3)
hvmyb##3##1##(2008-8#3)
hy926 cells##2##2##(1995-2#2)
hy926 human##2##2##(1995-2#1)(2008-10#1)
hy926##4##1##(1995-2#3)(2008-10#1)
hyacinthi##2##1##(2008-10#2)
hyalin##3##1##(2013-7#3)
hyaline cartilage##2##2##(2011-2#1)(2013-8#1)
hyaline##5##1##(1991-12#1)(1991-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
hyalinizing granuloma in HIV/AIDS##2##4##(2008-10#2)
hyalinizing granuloma##3##2##(2008-10#3)
hyaluronan is##2##2##(2011-1#2)
hyaluronan##10##1##(1993-6#2)(1995-10#1)(2008-9#1)(2011-1#6)
hyaluronate##2##1##(2008-10#2)
hyaluronic acid (HA)##2##3##(2008-10#1)(2010-10#1)
hyaluronic acid##17##2##(1992-12#1)(1994-5#1)(2008-10#4)(2008-5#1)(2010-10#2)(2011-2#1)(2012-2#2)(2013-1#5)
hyaluronic acid/dextranomer##2##2##(2008-10#2)
hyaluronic##19##1##(1992-12#1)(1994-5#1)(2008-10#6)(2008-5#1)(2010-10#2)(2011-2#1)(2012-2#2)(2013-1#5)
hyaluronidase activity##3##2##(2008-5#3)
hyaluronidase using##2##2##(1994-5#1)(2008-10#1)
hyaluronidase##11##1##(1994-5#4)(1994-8#1)(2008-10#2)(2008-5#4)
hybrid HBcAg particles##2##3##(1995-5#2)
hybrid PDMS-glass devices##2##3##(2008-10#2)
hybrid VLPs carrying##2##3##(1995-5#2)
hybrid abundance##2##2##(2012-3#2)
hybrid and##5##2##(2008-12#2)(2008-8#1)(2008-9#1)(2012-3#1)
hybrid artificial liver##5##3##(2008-11#5)
hybrid became infected##2##3##(2008-10#2)
hybrid between##3##2##(1994-5#1)(2008-10#1)(2008-9#1)
hybrid cell##3##2##(1991-6#1)(1997-2#1)(1997-8#1)
hybrid clones regenerated from##2##4##(2008-8#2)
hybrid containing the##2##3##(2008-10#2)
hybrid cultivars##2##2##(2008-10#2)
hybrid films##2##2##(2008-10#2)
hybrid fitness##2##2##(2008-8#2)
hybrid hemoglobin##3##2##(1990-8#1)(1993-8#2)
hybrid imaging##2##2##(2012-2#2)
hybrid individuals##3##2##(2008-8#1)(2008-9#2)
hybrid is##2##2##(1990-8#1)(2008-10#1)
hybrid isolates##3##2##(2008-10#3)
hybrid laser##3##2##(2008-2#3)
hybrid linear analysis (HLA)##4##4##(2008-10#4)
hybrid linear##5##2##(2008-10#5)
hybrid mapping panel##2##3##(1997-2#1)(1997-8#1)
hybrid membrane##2##2##(2008-10#2)
hybrid mesoporous##2##2##(2010-4#2)
hybrid method is introduced as a combination of the four-flux method with coefficients##2##13##(2008-3#2)
hybrid method##6##2##(2008-3#5)(2008-4#1)
hybrid microlens##2##2##(2008-3#2)
hybrid nafion/sol-gel silicate film##2##4##(2008-10#2)
hybrid nafion/sol-gel silicate##3##3##(2008-10#3)
hybrid of##5##2##(1993-1#1)(2008-10#3)(2008-9#1)
hybrid offspring##2##2##(2012-3#2)
hybrid poplar##6##2##(2008-10#6)
hybrid populations and##2##3##(2008-10#2)
hybrid rice##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
hybrid seed##3##2##(1997-5#1)(2008-10#2)
hybrid sterility##2##2##(2008-9#1)(2012-3#1)
hybrid strategy##2##2##(2012-12#2)
hybrid system##4##2##(2008-11#3)(2008-7#1)
hybrid systems##2##2##(2013-1#2)
hybrid technique&quot##2##2##(2008-8#2)
hybrid was##2##2##(2008-10#1)(2008-7#1)
hybrid zones with##2##3##(2012-3#1)(2013-1#1)
hybrid zones##9##2##(2008-8#4)(2012-3#2)(2013-1#3)
hybrid##241##1##(1990-8#2)(1991-6#1)(1992-6#1)(1993-1#1)(1993-8#5)(1993-9#1)(1994-11#2)(1994-5#2)(1995-2#1)(1995-5#6)(1996-12#2)(1996-6#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#3)(2007-12#1)(2008-10#87)(2008-11#10)(2008-12#5)(2008-2#3)(2008-3#13)(2008-4#1)(2008-7#5)(2008-8#26)(2008-9#14)(2009-10#2)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#4)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#14)(2013-1#6)
hybrid-level##2##1##(2008-3#2)
hybrida##6##1##(2008-10#3)(2008-9#3)
hybridation##2##1##(2008-10#2)
hybridisation reactions##2##2##(2008-10#2)
hybridisation##12##1##(1995-12#1)(1996-12#3)(2008-10#6)(2008-12#2)
hybridisation-RNase protection assay##4##3##(1996-12#4)
hybridisation-RNase protection##5##2##(1996-12#5)
hybridizable##3##1##(2008-9#3)
hybridization (FISH)##11##2##(1993-12#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2012-3#1)
hybridization analyses showed that the##2##5##(1997-8#1)(2008-6#1)
hybridization analyses##5##2##(1997-8#1)(2008-10#3)(2008-6#1)
hybridization analysis of the##2##4##(2008-10#2)
hybridization analysis of##4##3##(2008-10#4)
hybridization analysis revealed that##2##4##(1996-12#1)(1996-6#1)
hybridization analysis using cloned cDNA probes to##2##7##(2008-10#2)
hybridization analysis using##3##3##(2008-10#2)(2008-4#1)
hybridization analysis with##4##3##(1997-2#1)(2008-10#2)(2008-4#1)
hybridization analysis##27##2##(1991-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#17)(2008-4#2)(2008-9#1)(2012-3#1)
hybridization and DNA##2##3##(2008-10#1)(2008-8#1)
hybridization and hybrid##2##3##(2008-8#1)(2008-9#1)
hybridization and##26##2##(1994-12#1)(1996-12#2)(1997-3#1)(1997-7#1)(1997-8#3)(2008-10#10)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2012-3#2)
hybridization assay##5##2##(1995-8#1)(2008-10#4)
hybridization assays##2##2##(1990-5#1)(2008-10#1)
hybridization between##7##2##(2008-10#3)(2008-8#1)(2008-9#2)(2012-3#1)
hybridization detection##2##2##(2008-10#1)(2008-8#1)
hybridization event##4##2##(2008-10#4)
hybridization events##3##2##(2008-10#3)
hybridization experiments showed that##2##4##(2008-10#1)(2008-9#1)
hybridization experiments##5##2##(1996-12#1)(1997-6#1)(2008-10#2)(2008-9#1)
hybridization for the##2##3##(2008-10#1)(2008-4#1)
hybridization for##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
hybridization group was found##2##4##(2008-10#2)
hybridization group was##3##3##(2008-10#3)
hybridization group##4##2##(2008-10#4)
hybridization groups##2##2##(2008-10#2)
hybridization in the##2##3##(2008-8#1)(2010-8#1)
hybridization in##9##2##(1996-12#1)(2008-10#2)(2008-8#1)(2009-1#1)(2010-1#1)(2010-8#1)(2012-3#2)
hybridization indicated that##4##3##(1991-9#1)(1993-3#1)(2008-8#1)(2008-9#1)
hybridization indicator##2##2##(2008-10#2)
hybridization is##2##2##(2008-10#1)(2008-4#1)
hybridization method##2##2##(1991-9#1)(2008-10#1)
hybridization of RNA##2##3##(2008-4#2)
hybridization of immobilized##2##3##(2008-10#2)
hybridization of the##6##3##(1995-11#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-7#1)
hybridization of##21##2##(1993-6#1)(1995-11#1)(1996-12#3)(2008-10#9)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2012-2#1)
hybridization on##2##2##(2008-10#1)(2008-2#1)
hybridization pattern##2##2##(2008-10#2)
hybridization patterns that were##2##4##(2008-10#2)
hybridization patterns##3##2##(2008-10#3)
hybridization probes for##2##3##(1992-6#1)(2008-10#1)
hybridization probes##6##2##(1992-6#1)(2008-10#3)(2008-4#1)(2008-9#1)
hybridization properties of##2##3##(2008-10#1)(2008-4#1)
hybridization revealed##3##2##(2008-10#1)(2008-8#2)
hybridization showed that##3##3##(1996-12#1)(1997-1#1)(2008-10#1)
hybridization signal##4##2##(1994-11#1)(1995-2#1)(1996-12#1)(1997-3#1)
hybridization signals to the##2##4##(1997-6#2)
hybridization signals##6##2##(1991-6#1)(1995-2#1)(1997-6#2)(2008-8#1)(2012-3#1)
hybridization studies##5##2##(1996-12#1)(2008-10#2)(2008-4#1)(2009-8#1)
hybridization technique##3##2##(1994-1#1)(2008-11#1)(2008-8#1)
hybridization techniques##6##2##(1990-12#1)(1991-5#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-9#1)
hybridization to the##3##3##(1992-6#1)(2008-10#1)(2008-4#1)
hybridization to##16##2##(1991-5#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)
hybridization using an##2##3##(1991-5#1)(1995-12#1)
hybridization using the##2##3##(1992-3#1)(2008-10#1)
hybridization using##9##2##(1991-5#1)(1992-3#1)(1993-3#1)(1995-12#1)(1996-12#2)(1996-6#1)(2008-10#2)
hybridization was##6##2##(1990-12#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-6#1)
hybridization with a##3##3##(1996-6#1)(2008-10#2)
hybridization with cDNA##2##3##(2008-10#1)(2008-9#1)
hybridization with complementary DNA##2##4##(2008-10#2)
hybridization with complementary##3##3##(2008-10#2)(2008-9#1)
hybridization with the target DNA##2##5##(2008-10#2)
hybridization with the##5##3##(2008-10#4)(2008-8#1)
hybridization with##17##2##(1995-6#1)(1996-6#1)(1996-8#1)(2008-10#11)(2008-8#1)(2008-9#2)
hybridization##364##1##(1990-12#5)(1990-5#1)(1991-12#1)(1991-5#4)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#4)(1993-12#2)(1993-3#2)(1993-6#2)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#1)(1994-2#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-6#3)(1995-8#3)(1996-12#23)(1996-2#3)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#3)(1997-7#2)(1997-8#4)(2008-10#135)(2008-11#8)(2008-2#1)(2008-3#1)(2008-4#22)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#24)(2008-9#34)(2009-1#1)(2009-10#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#13)(2013-1#2)
hybridization)##4##1##(1995-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
hybridizations##7##1##(1996-6#1)(2008-10#6)
hybridize to##5##2##(1995-2#2)(1997-6#1)(2008-4#1)(2008-8#1)
hybridize with the##2##3##(2008-10#2)
hybridize with##5##2##(2008-10#4)(2008-4#1)
hybridize##13##1##(1995-2#2)(1997-6#1)(2008-10#7)(2008-4#2)(2008-8#1)
hybridized to a##4##3##(1993-2#2)(1996-6#2)
hybridized to dsRNA from##2##4##(2008-10#2)
hybridized to the##7##3##(1996-12#1)(1996-6#2)(1997-6#1)(2008-10#2)(2008-9#1)
hybridized to##23##2##(1990-8#1)(1993-2#2)(1996-12#1)(1996-6#4)(1997-6#1)(2008-10#13)(2008-9#1)
hybridized with a##2##3##(2008-10#2)
hybridized with##8##2##(1997-8#1)(2008-10#6)(2008-12#1)
hybridized##37##1##(1990-8#1)(1992-6#1)(1993-2#2)(1996-12#1)(1996-6#4)(1997-6#1)(1997-8#1)(2008-10#24)(2008-12#1)(2008-9#1)
hybridizes to##2##2##(1993-8#1)(1995-11#1)
hybridizes##3##1##(1993-8#1)(1995-11#1)(1995-6#1)
hybridizing to the##2##3##(1993-8#1)(2008-10#1)
hybridizing to##3##2##(1993-8#1)(2008-10#2)
hybridizing##9##1##(1990-8#1)(1993-8#1)(2008-10#6)(2008-4#1)
hybridoma and##3##2##(2008-11#3)
hybridoma cell cultures##3##3##(2008-11#3)
hybridoma cell line in chemically defined protein-free media##2##8##(2008-11#2)
hybridoma cell line##12##3##(1990-8#1)(2008-10#1)(2008-11#10)
hybridoma cell lines##9##3##(2008-10#2)(2008-11#7)
hybridoma cell##29##2##(1990-8#1)(2008-10#3)(2008-11#25)
hybridoma cells and##2##3##(2008-10#1)(2008-11#1)
hybridoma cells grown in##2##4##(2008-11#2)
hybridoma cells in##2##3##(2008-11#2)
hybridoma cells under##2##3##(2008-11#2)
hybridoma cells##32##2##(2008-10#1)(2008-11#31)
hybridoma cultivation##2##2##(2008-11#2)
hybridoma culture##5##2##(1990-12#1)(2008-11#3)(2008-7#1)
hybridoma cultures##3##2##(2008-11#3)
hybridoma growth and##2##3##(2008-11#2)
hybridoma line##2##2##(2008-11#2)
hybridoma lines##3##2##(1991-12#2)(2008-9#1)
hybridoma##114##1##(1990-12#1)(1990-8#1)(1991-12#2)(2008-10#4)(2008-11#100)(2008-7#1)(2008-8#1)(2008-9#4)
hybridomas by##3##2##(1991-12#1)(2008-11#2)
hybridomas for##2##2##(2008-11#2)
hybridomas fused with##2##3##(2008-11#2)
hybridomas is##2##2##(2008-11#2)
hybridomas producing##2##2##(2008-11#2)
hybridomas secreting antibodies against##2##4##(2008-11#2)
hybridomas secreting##3##2##(1996-12#1)(2008-11#2)
hybridomas with##2##2##(2008-11#2)
hybridomas##26##1##(1990-12#1)(1991-12#1)(1996-12#1)(2008-11#22)(2008-8#1)
hybrids and##9##2##(2008-10#4)(2008-11#1)(2008-8#2)(2012-3#2)
hybrids are##5##2##(2007-12#1)(2008-10#2)(2013-1#2)
hybrids between##5##2##(2008-9#4)(2012-3#1)
hybrids by##2##2##(2008-8#1)(2008-9#1)
hybrids have##2##2##(2008-10#1)(2010-10#1)
hybrids in##3##2##(2008-10#2)(2008-9#1)
hybrids of##5##2##(2008-10#4)(2008-12#1)
hybrids that contained##2##3##(1996-6#2)
hybrids that##3##2##(1996-6#2)(2008-10#1)
hybrids was##5##2##(2008-10#4)(2008-9#1)
hybrids were##9##2##(2008-10#7)(2008-11#1)(2008-12#1)
hybrids with##6##2##(2008-10#1)(2008-12#1)(2008-8#1)(2011-3#1)(2012-3#2)
hybrids##114##1##(1990-2#1)(1995-2#1)(1996-6#3)(1997-9#1)(2007-12#1)(2008-10#58)(2008-11#3)(2008-12#5)(2008-8#12)(2008-9#9)(2009-10#2)(2010-10#1)(2010-4#4)(2011-3#2)(2012-3#8)(2013-1#3)
hydantoin##2##1##(1995-3#1)(2008-5#1)
hydantoins to##3##2##(1995-3#3)
hydatid cyst in##2##3##(2008-10#1)(2010-11#1)
hydatid cyst of the##2##4##(1991-8#1)(2008-12#1)
hydatid cyst of##3##3##(1991-8#1)(2008-12#1)(2013-1#1)
hydatid cyst##12##2##(1991-8#1)(2008-10#1)(2008-12#2)(2009-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#4)
hydatid cysts##11##2##(1991-8#1)(2008-7#6)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
hydatid disease is##2##3##(2008-7#1)(2011-2#1)
hydatid disease##10##2##(1991-8#1)(2008-10#2)(2008-7#2)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
hydatid##35##1##(1991-8#3)(2008-10#3)(2008-12#3)(2008-7#8)(2009-5#1)(2009-9#1)(2010-11#3)(2010-12#2)(2011-2#3)(2012-2#2)(2013-1#6)
hydatidosis##7##1##(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-2#1)
hydatidosis]##2##1##(1991-8#1)(2010-12#1)
hydatique##2##1##(2011-2#2)
hydei##4##1##(1993-12#4)
hydra##2##1##(1993-12#2)
hydranencephaly##5##1##(1997-3#5)
hydrate and##2##2##(2008-10#2)
hydrate##14##1##(1990-9#1)(1991-9#2)(1994-2#1)(1994-5#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-12#1)
hydrated collagen I##2##3##(1992-6#2)
hydrated iron(III) oxide##2##3##(2008-10#2)
hydrated##19##1##(1992-6#2)(1995-3#1)(2008-10#11)(2008-5#3)(2009-7#1)(2010-8#1)
hydrates##2##1##(2008-10#2)
hydration and##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
hydration in##3##2##(1994-3#1)(2008-5#2)
hydration level##4##2##(2008-5#4)
hydration of the skin##2##4##(2008-10#1)(2008-5#1)
hydration of the##4##3##(1994-3#1)(2008-10#1)(2008-5#2)
hydration of##5##2##(1994-3#1)(2008-10#2)(2008-5#2)
hydration state##3##2##(2008-5#2)(2008-7#1)
hydration with##2##2##(2008-5#2)
hydration##50##1##(1990-11#2)(1991-11#1)(1991-12#1)(1994-3#2)(2008-10#16)(2008-5#20)(2008-7#4)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
hydraulic and mechanical stress adaptations##2##5##(2009-8#2)
hydraulic and mechanical##4##3##(2009-8#4)
hydraulic conductance of##2##3##(2008-10#1)(2009-8#1)
hydraulic conductance##7##2##(2008-10#2)(2009-8#5)
hydraulic high-pressure##2##2##(2008-10#2)
hydraulic oils##2##2##(2008-10#2)
hydraulic resistance and fouling percentage##2##5##(2008-7#2)
hydraulic##26##1##(2008-10#8)(2008-7#3)(2008-8#1)(2009-8#11)(2010-6#1)(2012-5#2)
hydraulics##3##1##(2008-7#1)(2009-8#1)(2010-3#1)
hydrazide in##3##2##(2008-10#3)
hydrazide##12##1##(1997-1#1)(2008-10#11)
hydrazine and hydroxylamine##2##3##(2008-10#2)
hydrazine and phenylhydrazine##6##3##(2008-10#6)
hydrazine and##10##2##(2008-10#10)
hydrazine by##3##2##(2008-10#3)
hydrazine compounds##3##2##(2008-10#3)
hydrazine hydrate##2##2##(2008-11#2)
hydrazine in the presence of##2##5##(2008-10#2)
hydrazine in the##3##3##(2008-10#2)(2010-5#1)
hydrazine in##12##2##(2008-10#11)(2010-5#1)
hydrazine is##3##2##(2008-10#3)
hydrazine to##2##2##(2008-10#2)
hydrazine was##2##2##(2008-10#2)
hydrazine with##3##2##(2008-10#3)
hydrazine##63##1##(1991-3#1)(1996-5#1)(1997-2#1)(2008-10#56)(2008-11#2)(2010-5#2)
hydrazinolysis##2##1##(1991-12#1)(2009-8#1)
hydrazone (MBTH) in##2##3##(2008-10#2)
hydrazone (MBTH)##3##2##(2008-10#3)
hydrazone derivatives##2##2##(2008-10#2)
hydrazone##16##1##(1996-5#1)(1997-1#2)(2008-10#12)(2010-4#1)
hydrazones##2##1##(2009-10#1)(2010-7#1)
hydric##2##1##(1996-12#1)(2012-7#1)
hydride by adding a sodium tetrahydroborate (III) solution##2##8##(2008-10#2)
hydride generated##5##2##(2008-10#5)
hydride generation (HG)##7##3##(2008-10#7)
hydride generation - atomic absorption spectrometry##2##6##(2008-10#2)
hydride generation and##8##3##(2008-10#8)
hydride generation atomic absorption spectrometry (HGAAS)##3##6##(2008-10#3)
hydride generation atomic absorption spectrometry##10##5##(2008-10#10)
hydride generation atomic absorption##11##4##(2008-10#11)
hydride generation atomic fluorescence spectrometry (HG-AFS)##3##6##(2008-10#3)
hydride generation atomic fluorescence spectrometry##11##5##(2008-10#11)
hydride generation atomic fluorescence##13##4##(2008-10#13)
hydride generation atomic##25##3##(2008-10#25)
hydride generation efficiency##2##3##(2008-10#2)
hydride generation for##2##3##(2008-10#2)
hydride generation from##2##3##(2008-10#2)
hydride generation gas phase molecular absorption spectrometry (HG-GPMAS)##2##8##(2008-10#2)
hydride generation gas phase molecular absorption spectrometry##4##7##(2008-10#4)
hydride generation inductively coupled plasma atomic emission spectrometry##2##8##(2008-10#2)
hydride generation is described##2##4##(2008-10#2)
hydride generation method##2##3##(2008-10#2)
hydride generation or##2##3##(2008-10#2)
hydride generation procedure##2##3##(2008-10#2)
hydride generation procedures for##2##4##(2008-10#2)
hydride generation system##3##3##(2008-10#3)
hydride generation techniques##3##3##(2008-10#3)
hydride generation the##2##3##(2008-10#2)
hydride generation##98##2##(2008-10#98)
hydride generation-atomic absorption spectrometry (HG-AAS)##2##5##(2008-10#2)
hydride generation-atomic fluorescence spectrometry##4##4##(2008-10#4)
hydride generation-atomic fluorescence##5##3##(2008-10#5)
hydride generation-atomic##7##2##(2008-10#7)
hydride generation-electrothermal atomic absorption##2##4##(2008-10#2)
hydride generator##5##2##(2008-10#5)
hydride##147##1##(1992-3#1)(1996-5#4)(2008-10#141)(2009-7#1)
hydride-forming species##2##2##(2008-10#2)
hydride-forming##3##1##(2008-10#3)
hydride-generation atomic absorption spectrometry##2##4##(2008-10#2)
hydride-generation##4##1##(2008-10#4)
hydrides##6##1##(2008-10#6)
hydro-alcoholic extract##2##2##(2010-2#1)(2013-1#1)
hydro-alcoholic##4##1##(2008-10#2)(2010-2#1)(2013-1#1)
hydroalcoholic extract of##3##3##(2008-12#2)(2012-12#1)
hydroalcoholic root extract of Rubia cordifolia##3##6##(2012-2#3)
hydroalcoholic##6##1##(2008-12#2)(2012-12#1)(2012-2#3)
hydrobromide##3##1##(1994-5#2)(1996-5#1)
hydrocarbon chain##2##2##(2008-10#2)
hydrocarbon chains##2##2##(1992-9#1)(2008-11#1)
hydrocarbon components##2##2##(2008-8#2)
hydrocarbon mixtures##2##2##(2008-10#2)
hydrocarbon receptor (AhR)##2##3##(2008-10#2)
hydrocarbon receptor##4##2##(2008-10#3)(2013-1#1)
hydrocarbon##43##1##(1992-9#1)(1993-12#1)(1995-11#1)(2008-10#23)(2008-11#2)(2008-8#6)(2008-9#1)(2011-1#2)(2012-2#1)(2013-1#5)
hydrocarbons (PAHs) in##11##3##(2008-10#11)
hydrocarbons (PAHs)##31##2##(1994-3#1)(2008-10#29)(2010-5#1)
hydrocarbons and##10##2##(1995-11#1)(2008-10#6)(2008-11#1)(2010-7#1)(2012-3#1)
hydrocarbons are##3##2##(2008-10#3)
hydrocarbons by##4##2##(2008-10#4)
hydrocarbons dissolved in seawater##2##4##(2008-10#2)
hydrocarbons dissolved in##3##3##(2008-10#3)
hydrocarbons from##5##2##(2008-10#5)
hydrocarbons in##24##2##(2008-10#19)(2008-11#5)
hydrocarbons on a##2##3##(2008-10#2)
hydrocarbons were##4##2##(2008-10#3)(2008-9#1)
hydrocarbons##150##1##(1991-12#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-11#2)(2008-10#108)(2008-11#16)(2008-7#2)(2008-8#1)(2008-9#6)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#4)(2013-8#2)
hydrocele fluid##3##2##(2008-7#3)
hydrocele##6##1##(2008-10#2)(2008-7#4)
hydrocephalus and##3##2##(1996-11#1)(2008-7#2)
hydrocephalus secondary to##2##3##(2008-7#2)
hydrocephalus was##2##2##(2008-12#1)(2008-7#1)
hydrocephalus##17##1##(1996-11#1)(2008-12#2)(2008-7#9)(2011-2#3)(2012-2#1)(2012-3#1)
hydrochloric acid (HCl)##2##3##(2008-10#2)
hydrochloric acid and potassium##2##4##(2008-10#2)
hydrochloric acid and sodium tetrahydroborate##2##5##(2008-10#2)
hydrochloric acid and sodium##3##4##(2008-10#3)
hydrochloric acid and##14##3##(2008-10#14)
hydrochloric acid as##2##3##(2008-10#2)
hydrochloric acid concentration##4##3##(2008-10#4)
hydrochloric acid in##3##3##(2008-10#3)
hydrochloric acid media##7##3##(2008-10#7)
hydrochloric acid medium##3##3##(2008-10#3)
hydrochloric acid solution##6##3##(2008-10#6)
hydrochloric acid solutions##3##3##(1992-12#1)(2008-10#2)
hydrochloric acid was used for##2##5##(1997-2#1)(2008-10#1)
hydrochloric acid##84##2##(1992-12#1)(1996-5#1)(1997-2#1)(2008-10#81)
hydrochloric and##2##2##(2008-10#2)
hydrochloric##93##1##(1992-12#1)(1996-5#1)(1997-2#1)(2008-10#90)
hydrochloride and 0##3##3##(2008-10#2)(2013-1#1)
hydrochloride and##16##2##(2008-10#14)(2013-1#2)
hydrochloride by##3##2##(2008-10#2)(2012-3#1)
hydrochloride in pharmaceutical preparations##3##4##(2008-10#3)
hydrochloride in pharmaceutical##8##3##(2008-10#8)
hydrochloride in the##2##3##(2008-10#1)(2009-7#1)
hydrochloride in##20##2##(2008-10#18)(2009-7#1)(2012-3#1)
hydrochloride injection##2##2##(2008-10#2)
hydrochloride is described##2##3##(2008-10#2)
hydrochloride is##3##2##(2008-10#3)
hydrochloride using##4##2##(2008-10#3)(2012-2#1)
hydrochloride was##2##2##(1995-11#1)(2013-1#1)
hydrochloride were##2##2##(2008-10#2)
hydrochloride with##7##2##(1993-3#3)(2008-10#4)
hydrochloride##125##1##(1990-2#1)(1991-1#1)(1992-3#2)(1993-3#5)(1995-11#4)(1996-5#1)(2008-10#97)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#2)(2012-2#4)(2012-3#2)(2013-1#3)
hydrochlorothiazide and##3##2##(2008-10#1)(2012-2#2)
hydrochlorothiazide##11##1##(2008-10#7)(2011-3#2)(2012-2#2)
hydrocolloid occlusive bandage##2##3##(1991-2#2)
hydrocolloid occlusive##3##2##(1991-2#3)
hydrocolloids##2##1##(2011-2#2)
hydrocortisone##14##1##(1993-1#1)(1995-11#1)(2008-10#1)(2008-11#6)(2011-2#2)(2011-3#1)(2012-3#2)
hydrodistillation##3##1##(2008-10#2)(2012-2#1)
hydrodynamic and##2##2##(1990-8#1)(2008-10#1)
hydrodynamic chromatography##2##2##(2008-10#2)
hydrodynamic conditions were##2##3##(2008-10#2)
hydrodynamic conditions##8##2##(1990-12#1)(2008-10#4)(2008-11#1)(2008-7#2)
hydrodynamic sizes##2##2##(2008-10#1)(2011-1#1)
hydrodynamic voltammetry##3##2##(2008-10#3)
hydrodynamic##30##1##(1990-12#1)(1990-8#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)
hydrodynamically##2##1##(2008-10#2)
hydrofluoric acid (HF)##2##3##(2008-10#2)
hydrofluoric acid##9##2##(2008-10#9)
hydrofluoric and##2##2##(2008-10#2)
hydrofluoric##17##1##(2008-10#17)
hydrofluoroalkane##2##1##(1996-1#1)(1996-2#1)
hydrogel and##5##2##(2008-10#3)(2008-5#1)(2009-7#1)
hydrogel films##2##2##(2008-10#2)
hydrogel microwell##2##2##(2009-12#2)
hydrogel patch##2##2##(2008-5#2)
hydrogel patches##3##2##(2008-5#3)
hydrogel was##2##2##(2009-7#2)
hydrogel##40##1##(2008-10#8)(2008-5#9)(2009-12#2)(2009-7#9)(2011-2#1)(2012-3#11)
hydrogels##10##1##(2008-5#1)(2009-7#1)(2009-9#5)(2012-3#3)
hydrogen abstraction##2##2##(1996-5#1)(2008-11#1)
hydrogen and##6##2##(1993-1#1)(2008-10#2)(2008-11#2)(2008-3#1)
hydrogen at##2##2##(1991-3#1)(2008-10#1)
hydrogen atom##2##2##(1991-3#1)(1995-11#1)
hydrogen atoms in##2##3##(1996-12#1)(2008-3#1)
hydrogen bond acceptor##3##3##(1994-5#1)(2010-7#2)
hydrogen bond between##2##3##(1993-1#2)
hydrogen bond donor##2##3##(2010-7#2)
hydrogen bond donors and acceptors##2##5##(2010-7#2)
hydrogen bond##19##2##(1992-12#1)(1993-1#2)(1994-5#1)(1997-7#1)(2008-10#4)(2008-8#2)(2010-4#1)(2010-7#6)(2012-3#1)
hydrogen bonding between##2##3##(2008-10#1)(2008-5#1)
hydrogen bonding interaction##3##3##(2008-10#3)
hydrogen bonding interactions##3##3##(1993-8#1)(2008-10#1)(2010-7#1)
hydrogen bonding##15##2##(1993-8#1)(1994-3#1)(2008-10#11)(2008-5#1)(2010-7#1)
hydrogen bonds##8##2##(1992-12#1)(1993-3#1)(1994-5#2)(1995-3#1)(2008-10#2)(2008-8#1)
hydrogen carbonate##2##2##(2008-10#2)
hydrogen catalytic##2##2##(2008-10#2)
hydrogen chloride##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
hydrogen cyanide (HCN)##2##3##(1996-12#1)(2008-10#1)
hydrogen cyanide gas##2##3##(2008-10#2)
hydrogen cyanide sensor##3##3##(2008-10#3)
hydrogen cyanide##8##2##(1996-12#1)(2008-10#7)
hydrogen evolution##2##2##(2008-10#2)
hydrogen exchange##2##2##(1991-6#1)(2013-1#1)
hydrogen excretion##6##2##(1996-6#6)
hydrogen fluoride##2##2##(1992-12#1)(1996-12#1)
hydrogen ion concentration##5##3##(2008-10#5)
hydrogen ion in##3##3##(2008-10#3)
hydrogen ion##14##2##(1993-12#1)(2008-10#13)
hydrogen ion-selective##3##2##(2008-10#3)
hydrogen ions##7##2##(2008-10#6)(2010-5#1)
hydrogen peroxide (H(2)O(2)) and##2##4##(2008-10#1)(2013-1#1)
hydrogen peroxide (H(2)O(2)) in##2##4##(2008-10#2)
hydrogen peroxide (H(2)O(2))##11##3##(2008-10#8)(2009-8#1)(2012-2#1)(2013-1#1)
hydrogen peroxide (H2O2)##2##3##(1997-4#1)(2012-3#1)
hydrogen peroxide and glucose##2##4##(2008-10#2)
hydrogen peroxide and##19##3##(2008-10#17)(2009-4#1)(2011-2#1)
hydrogen peroxide as##2##3##(2008-10#2)
hydrogen peroxide at##5##3##(2008-10#5)
hydrogen peroxide based on##2##4##(2008-10#2)
hydrogen peroxide biosensor##5##3##(2008-10#4)(2009-3#1)
hydrogen peroxide by##2##3##(2008-10#2)
hydrogen peroxide catalyzed by##4##4##(1994-5#1)(2008-10#3)
hydrogen peroxide catalyzed##5##3##(1994-5#1)(2008-10#4)
hydrogen peroxide concentration##3##3##(2008-10#3)
hydrogen peroxide concentrations##3##3##(2008-10#2)(2008-5#1)
hydrogen peroxide electrode##2##3##(2008-10#2)
hydrogen peroxide formed in the##2##5##(2008-10#2)
hydrogen peroxide has been##2##4##(2008-10#1)(2009-8#1)
hydrogen peroxide in a##4##4##(2008-10#4)
hydrogen peroxide in an##2##4##(2008-10#2)
hydrogen peroxide in the absence##2##5##(1995-8#1)(2008-10#1)
hydrogen peroxide in the presence of##2##6##(2008-10#2)
hydrogen peroxide in the##7##4##(1994-8#1)(1995-8#1)(2008-10#5)
hydrogen peroxide in##32##3##(1994-8#1)(1995-8#1)(2008-10#29)(2009-5#1)
hydrogen peroxide is##4##3##(2008-10#4)
hydrogen peroxide produced##2##3##(2008-10#2)
hydrogen peroxide under##2##3##(2008-10#2)
hydrogen peroxide using##4##3##(2008-10#4)
hydrogen peroxide was developed##2##4##(2008-10#2)
hydrogen peroxide was##5##3##(2008-10#5)
hydrogen peroxide were investigated##2##4##(2008-10#2)
hydrogen peroxide were##4##3##(2008-10#4)
hydrogen peroxide with##5##3##(2008-10#5)
hydrogen peroxide##209##2##(1991-5#1)(1992-12#2)(1994-5#2)(1994-8#1)(1995-8#1)(1997-4#1)(2008-10#182)(2008-11#2)(2008-5#3)(2008-6#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
hydrogen peroxide)##2##2##(2008-10#2)
hydrogen peroxide-based##2##2##(2008-5#2)
hydrogen phosphate##3##2##(2008-10#2)(2009-7#1)
hydrogen sulfide determination##3##3##(2008-10#3)
hydrogen sulfide##20##2##(2008-10#15)(2008-6#2)(2009-12#1)(2011-2#1)(2013-8#1)
hydrogen sulphide##3##2##(1997-4#1)(2008-10#2)
hydrogen was exhaled##3##3##(1996-6#3)
hydrogen was##5##2##(1996-6#3)(2008-10#2)
hydrogen##400##1##(1991-3#3)(1991-5#1)(1991-6#1)(1992-12#6)(1993-1#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#5)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#5)(1996-5#2)(1996-6#9)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#293)(2008-11#7)(2008-3#4)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#7)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
hydrogen)##2##1##(2008-10#1)(2008-11#1)
hydrogen-air##2##1##(2008-10#1)(2008-3#1)
hydrogen-bond##2##1##(1991-3#1)(2008-8#1)
hydrogen-bonding##10##1##(1991-3#1)(1993-8#1)(1996-5#1)(2008-10#6)(2012-2#1)
hydrogenase small##2##2##(1990-11#2)
hydrogenase##3##1##(1990-11#3)
hydrogenation of##3##2##(1992-3#1)(1996-5#2)
hydrogenation##7##1##(1992-3#1)(1996-5#3)(2008-4#1)(2010-7#2)
hydrogenophosphate##2##1##(2008-10#2)
hydrogenotrophic##5##1##(2008-7#5)
hydrogenphthalate##2##1##(2008-10#2)
hydrolase activity##6##2##(1992-3#1)(1992-6#1)(1994-11#4)
hydrolase##31##1##(1992-12#1)(1992-3#4)(1992-6#5)(1993-12#1)(1993-2#1)(1994-11#4)(1994-8#1)(1995-6#2)(1996-8#1)(1997-2#1)(2008-10#3)(2008-5#1)(2009-10#1)(2011-1#3)(2011-2#1)(2012-2#1)
hydrolases##10##1##(1992-12#3)(1992-6#3)(1995-6#1)(2008-10#2)(2009-3#1)
hydrolitic##2##1##(2008-10#2)
hydrolysable##2##1##(2008-10#1)(2008-5#1)
hydrolysate and##3##2##(2008-10#1)(2008-11#2)
hydrolysate of iodinated casein##2##4##(2008-10#2)
hydrolysate of##5##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
hydrolysate was##2##2##(2008-10#1)(2008-11#1)
hydrolysate with##2##2##(2008-10#1)(2008-11#1)
hydrolysate##30##1##(1995-3#1)(2008-10#6)(2008-11#11)(2008-5#6)(2008-7#1)(2011-1#3)(2013-1#2)
hydrolysates derived from##2##3##(1995-3#1)(2008-11#1)
hydrolysates from##3##2##(2008-11#1)(2008-5#2)
hydrolysates were##2##2##(2008-5#2)
hydrolysates##29##1##(1995-3#1)(2008-10#2)(2008-11#12)(2008-5#10)(2011-1#3)(2013-1#1)
hydrolysed in##2##2##(2008-10#2)
hydrolysed##8##1##(1993-2#1)(1994-8#1)(2008-10#4)(2008-5#1)(2010-4#1)
hydrolyses in more alkaline sweat##2##5##(2008-5#2)
hydrolyses##4##1##(1994-8#1)(2008-10#1)(2008-5#2)
hydrolysis and synthesis of##2##4##(1997-1#2)
hydrolysis and synthesis##3##3##(1997-1#3)
hydrolysis and transglycosylation##2##3##(1994-5#2)
hydrolysis and##18##2##(1991-12#1)(1994-11#2)(1994-5#2)(1997-1#4)(1997-2#1)(2008-10#4)(2008-11#1)(2008-8#2)(2009-8#1)
hydrolysis by##5##2##(1990-2#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-5#1)
hydrolysis constants##2##2##(2008-10#2)
hydrolysis in##8##2##(1991-5#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#2)
hydrolysis is##4##2##(1991-5#1)(1991-9#1)(2013-1#2)
hydrolysis of 10##2##3##(1992-7#1)(1994-5#1)
hydrolysis of IP3##3##3##(1993-8#3)
hydrolysis of short##3##3##(2008-5#2)(2008-7#1)
hydrolysis of the##17##3##(1991-9#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-6#1)(1996-5#1)(2008-10#7)(2008-5#1)(2011-2#2)
hydrolysis of urea##3##3##(2008-10#3)
hydrolysis of##85##2##(1990-5#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-8#10)(1994-11#4)(1994-3#1)(1994-5#8)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2011-1#1)(2011-2#5)(2013-1#1)
hydrolysis on##2##2##(2008-7#1)(2008-8#1)
hydrolysis process##5##2##(2008-10#4)(2008-11#1)
hydrolysis product##3##2##(2008-10#3)
hydrolysis products##3##2##(2008-10#3)
hydrolysis rate##8##2##(1990-5#1)(2008-10#5)(2008-5#1)(2008-7#1)
hydrolysis reaction##3##2##(2008-10#2)(2008-7#1)
hydrolysis reactions##4##2##(2008-10#2)(2008-7#2)
hydrolysis to##2##2##(2008-10#1)(2008-5#1)
hydrolysis was##4##2##(1991-3#1)(1997-7#1)(2008-10#1)(2011-1#1)
hydrolysis were##3##2##(2008-10#1)(2008-5#2)
hydrolysis with##4##2##(1992-7#1)(1994-11#1)(2008-10#2)
hydrolysis yields##3##2##(2011-2#3)
hydrolysis##234##1##(1990-2#1)(1990-5#3)(1991-12#1)(1991-3#3)(1991-5#5)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#3)(1993-6#1)(1993-8#12)(1994-11#8)(1994-3#1)(1994-5#10)(1994-8#2)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#4)(1997-7#1)(1997-8#1)(2008-10#93)(2008-11#3)(2008-12#1)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-8#3)(2011-1#3)(2011-2#13)(2013-1#13)
hydrolysis)##4##1##(1996-12#1)(2008-10#2)(2008-3#1)
hydrolytic activity of##2##3##(1995-2#1)(2008-5#1)
hydrolytic activity##6##2##(1992-3#2)(1994-11#1)(1995-2#1)(2008-5#1)(2011-1#1)
hydrolytic enzymes##3##2##(1992-3#1)(2008-10#1)(2012-2#1)
hydrolytic species##2##2##(2008-10#2)
hydrolytic##20##1##(1990-10#1)(1990-2#1)(1992-3#3)(1994-11#1)(1995-2#1)(2008-10#6)(2008-12#1)(2008-5#1)(2011-1#2)(2011-2#1)(2012-2#2)
hydrolyzates##4##1##(1997-2#4)
hydrolyze##10##1##(1990-2#1)(1991-3#1)(1992-3#1)(1993-8#2)(1995-6#1)(2008-10#2)(2008-11#1)(2012-2#1)
hydrolyzed and##2##2##(2008-10#1)(2008-11#1)
hydrolyzed at##2##2##(2006-6#2)
hydrolyzed by##3##2##(2008-10#2)(2008-11#1)
hydrolyzed under##2##2##(1990-8#1)(2008-10#1)
hydrolyzed##31##1##(1990-8#1)(1992-3#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-5#1)(2006-6#2)(2008-10#16)(2008-11#2)(2008-5#1)(2010-3#1)(2010-4#1)(2013-1#1)
hydrolyzes##9##1##(1990-8#1)(1992-12#1)(1994-5#1)(1994-8#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-8#1)
hydrolyzing the##2##2##(1992-10#1)(2008-10#1)
hydrolyzing##4##1##(1992-10#1)(1995-3#1)(2008-10#1)(2013-1#1)
hydrometeors##2##1##(2008-3#2)
hydronephrosis##12##1##(2008-10#11)(2013-1#1)
hydropathy analysis##2##2##(1990-5#2)
hydropathy profile##2##2##(1990-5#1)(1991-6#1)
hydropathy profiles##2##2##(1990-5#1)(1995-6#1)
hydropathy##8##1##(1990-5#4)(1991-6#1)(1993-2#1)(1993-3#1)(1995-6#1)
hydroperoxide##10##1##(1993-8#1)(1995-11#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2009-8#1)
hydroperoxides are##2##2##(2008-10#1)(2008-5#1)
hydroperoxides##15##1##(2008-10#5)(2008-5#3)(2009-7#1)(2009-8#4)(2010-6#1)(2013-1#1)
hydrophilia##2##1##(2008-5#2)
hydrophilic and hydrophobic##4##3##(2008-10#1)(2009-9#1)(2010-10#2)
hydrophilic and##7##2##(1992-12#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-10#2)
hydrophilic membrane##2##2##(2008-10#2)
hydrophilic surfaces##3##2##(2008-10#2)(2010-10#1)
hydrophilic synthetic##2##2##(2008-10#1)(2012-2#1)
hydrophilic##59##1##(1992-12#1)(1992-3#1)(1994-5#1)(1995-12#2)(1995-6#1)(1996-12#1)(1997-1#2)(1997-3#2)(1997-8#1)(2008-10#24)(2008-11#4)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#4)(2010-7#1)(2012-2#2)
hydrophilic-interaction##3##1##(2008-10#3)
hydrophilicity of the##2##3##(1994-11#1)(2008-11#1)
hydrophilicity##3##1##(1992-6#1)(1994-11#1)(2008-11#1)
hydrophobia##2##1##(2008-5#2)
hydrophobic analytes##2##2##(2008-10#2)
hydrophobic and hydrophilic##2##3##(1994-5#1)(1995-6#1)
hydrophobic and##5##2##(1994-5#1)(1995-6#2)(1997-2#1)(2008-10#1)
hydrophobic cavity##3##2##(2008-10#2)(2008-11#1)
hydrophobic compounds##3##2##(2008-10#3)
hydrophobic domain##2##2##(2008-7#1)(2011-2#1)
hydrophobic domains##2##2##(1991-5#1)(2009-9#1)
hydrophobic groups##2##2##(1992-3#1)(2008-10#1)
hydrophobic interaction chromatography (HIC)##2##4##(2008-10#2)
hydrophobic interaction chromatography##5##3##(1991-5#1)(2008-10#4)
hydrophobic interaction##15##2##(1991-5#1)(2008-10#14)
hydrophobic interactions##5##2##(1990-5#1)(1996-12#1)(2008-10#2)(2008-5#1)
hydrophobic leader sequence##2##3##(1991-10#1)(1993-6#1)
hydrophobic natural polymers##2##3##(2012-2#2)
hydrophobic peptides##2##2##(1994-5#1)(2008-10#1)
hydrophobic pocket##2##2##(2008-8#2)
hydrophobic protein##3##2##(1997-9#1)(2008-10#1)(2009-9#1)
hydrophobic proteins##2##2##(2008-10#2)
hydrophobic residues##2##2##(1994-5#1)(1997-7#1)
hydrophobic surfaces##4##2##(1992-12#1)(2008-10#1)(2010-10#2)
hydrophobic##131##1##(1990-11#2)(1990-2#1)(1990-5#3)(1991-10#3)(1991-5#4)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#5)(1994-8#1)(1995-6#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#2)(1997-8#4)(1997-9#1)(2008-10#61)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2009-7#1)(2009-9#4)(2010-10#4)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
hydrophobically##2##1##(1995-2#1)(2008-8#1)
hydrophobicity and##6##2##(1991-5#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
hydrophobicity in##2##2##(2008-10#1)(2008-5#1)
hydrophobicity of the##5##3##(2008-10#3)(2008-6#1)(2008-7#1)
hydrophobicity of##6##2##(1993-3#1)(2008-10#3)(2008-6#1)(2008-7#1)
hydrophobicity##28##1##(1991-5#1)(1993-3#1)(1996-12#2)(2008-10#14)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#2)
hydroponic culture##3##2##(2008-10#2)(2008-11#1)
hydroponic nutrient solution##4##3##(2008-10#4)
hydroponic nutrient##6##2##(2008-10#6)
hydroponic##14##1##(2008-10#13)(2008-11#1)
hydroponically##6##1##(2008-10#5)(2008-9#1)
hydroprimed seeds##2##2##(2008-10#2)
hydropriming##5##1##(2008-10#1)(2008-12#4)
hydrops fetalis##2##2##(2012-3#2)
hydrops##3##1##(1994-9#1)(2012-3#2)
hydroquinone and 1##2##3##(2008-10#2)
hydroquinone and##4##2##(2008-10#3)(2008-5#1)
hydroquinone as a mediator##2##4##(2008-10#2)
hydroquinone by##2##2##(2008-10#1)(2008-6#1)
hydroquinone in cosmetic creams##2##4##(2008-10#2)
hydroquinone in cosmetic##3##3##(2008-10#3)
hydroquinone in##10##2##(2008-10#10)
hydroquinone is##2##2##(2008-10#2)
hydroquinone##48##1##(2008-10#40)(2008-5#4)(2008-6#4)
hydrosalpinges and##2##2##(1991-12#1)(1993-1#1)
hydrosilylation##2##1##(2008-10#2)
hydrosoluble##3##1##(2008-10#2)(2008-5#1)
hydrostatic pressure##5##2##(2008-10#4)(2008-3#1)
hydrostatic##7##1##(1991-5#1)(2008-10#4)(2008-3#2)
hydrothermal influence##2##2##(2013-8#2)
hydrothermal process##2##2##(2009-11#2)
hydrothermal##21##1##(1995-3#2)(2008-10#11)(2008-6#1)(2009-11#2)(2011-2#1)(2013-8#4)
hydrotropic agents##3##2##(2012-2#3)
hydrotropic response##2##2##(2009-8#2)
hydrotropic##6##1##(2009-8#2)(2012-2#4)
hydrotropism##2##1##(2009-8#2)
hydrotropy##2##1##(2012-2#2)
hydrous manganese(IV) oxide##2##3##(2008-10#2)
hydrous oxide##2##2##(2008-10#2)
hydrous##7##1##(2008-10#7)
hydroxamic acid biosynthesis in##2##4##(1997-2#2)
hydroxamic acid##13##2##(1997-2#2)(2008-10#8)(2013-1#3)
hydroxamic##14##1##(1997-2#2)(2008-10#9)(2013-1#3)
hydroxide and sodium##2##3##(2008-10#2)
hydroxide and##13##2##(2008-10#13)
hydroxide by##2##2##(2008-10#2)
hydroxide concentration##2##2##(2008-10#2)
hydroxide for##2##2##(2008-10#2)
hydroxide in##4##2##(2008-10#3)(2009-5#1)
hydroxide medium##2##2##(2008-10#2)
hydroxide precipitate##2##2##(2008-10#2)
hydroxide precipitation##2##2##(2008-10#2)
hydroxide solution##9##2##(2008-10#9)
hydroxide were##2##2##(2008-10#2)
hydroxide##101##1##(1991-7#1)(2008-10#90)(2008-4#1)(2008-5#3)(2009-5#1)(2010-4#1)(2013-1#4)
hydroxide)##4##1##(2008-10#4)
hydroxide-4##2##1##(2008-10#2)
hydroxides##8##1##(2008-10#7)(2010-4#1)
hydroxo##4##1##(2008-10#4)
hydroxy group##2##2##(1996-5#1)(2008-10#1)
hydroxy groups##2##2##(2008-10#2)
hydroxy##9##1##(1993-6#1)(1996-5#1)(2008-10#7)
hydroxy-propyl-beta-cyclodextrin##2##1##(2008-10#2)
hydroxyanthraquinones##4##1##(2008-10#4)
hydroxyapatite (HA)##2##2##(2008-12#1)(2009-7#1)
hydroxyapatite cement and##2##3##(2011-2#2)
hydroxyapatite cement##4##2##(2011-2#4)
hydroxyapatite##21##1##(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#1)(2009-7#5)(2011-2#6)
hydroxybenzoic acids##3##2##(2008-10#2)(2011-2#1)
hydroxybenzoic##4##1##(2008-10#3)(2011-2#1)
hydroxychloroquine##6##1##(2012-3#1)(2013-1#5)
hydroxycinnamic##2##1##(2008-5#1)(2013-1#1)
hydroxyl group in the##2##4##(1991-5#1)(2008-10#1)
hydroxyl group##9##2##(1991-5#1)(2008-10#5)(2008-11#2)(2011-3#1)
hydroxyl groups and##2##3##(2008-10#2)
hydroxyl groups of the##2##4##(2008-10#1)(2008-11#1)
hydroxyl groups of##4##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
hydroxyl groups##15##2##(1990-9#2)(1996-5#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-9#1)
hydroxyl radical footprinting##2##3##(2008-4#2)
hydroxyl radical is##2##3##(2008-10#1)(2008-4#1)
hydroxyl radical##18##2##(2008-10#7)(2008-11#1)(2008-4#5)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)
hydroxyl radicals##9##2##(2008-10#5)(2008-4#2)(2009-11#1)(2013-8#1)
hydroxyl##66##1##(1990-9#2)(1991-5#1)(1996-5#2)(2008-10#33)(2008-11#6)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-8#1)
hydroxyl-terminated##5##1##(2008-10#5)
hydroxylamide##3##1##(2008-12#3)
hydroxylamine hydrochloride##4##2##(2008-10#4)
hydroxylamine##13##1##(1991-3#1)(1991-5#1)(1995-2#1)(1997-2#3)(2008-10#7)
hydroxylase##17##1##(1990-11#1)(1990-7#1)(1994-3#1)(1996-12#4)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)
hydroxylated##3##1##(1991-5#1)(2008-10#1)(2011-2#1)
hydroxylation of##2##2##(1992-6#1)(1993-11#1)
hydroxylation##9##1##(1990-5#1)(1990-6#2)(1991-9#1)(1992-6#2)(1993-11#1)(1994-3#1)(2008-10#1)
hydroxylations##2##1##(1992-9#1)(2008-4#1)
hydroxylpropyl-beta-CD##2##1##(2008-10#2)
hydroxyls##2##1##(2008-10#1)(2009-12#1)
hydroxymetabolites##2##1##(2008-10#2)
hydroxymethanesulfonate##2##1##(2008-10#2)
hydroxymethylpyrimidine is##2##2##(1990-2#2)
hydroxymethylpyrimidine uptake was##2##3##(1990-2#2)
hydroxymethylpyrimidine##4##1##(1990-2#4)
hydroxyproline##3##1##(1990-2#1)(2008-5#1)(2013-8#1)
hydroxypropylmethylcellulose##2##1##(2008-10#2)
hydroxyscopolamine##3##1##(2008-10#3)
hydroxyurea (HU)##2##2##(1994-11#1)(2012-3#1)
hydroxyurea augmentation (p=0##2##3##(2008-11#2)
hydroxyurea augmentation of##3##3##(2008-11#3)
hydroxyurea augmentation##6##2##(2008-11#6)
hydroxyurea##15##1##(1993-9#2)(1994-11#2)(2008-11#7)(2008-7#2)(2012-3#2)
hygB(R) strains##3##2##(2008-10#3)
hygiene and##2##2##(2008-11#1)(2013-1#1)
hygiene products##2##2##(2007-12#1)(2013-1#1)
hygiene##24##1##(1991-12#1)(1991-8#1)(1996-3#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#5)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
hygienic aspects##2##2##(2010-8#2)
hygienic##8##1##(1996-3#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#2)(2013-8#1)
hygienists who##3##2##(1993-1#3)
hygienists##9##1##(1993-1#5)(2008-4#3)(2011-2#1)
hygroma##2##1##(2009-9#1)(2011-2#1)
hygromas##2##1##(1997-6#2)
hygrometer##2##1##(2008-3#2)
hygromycin B (hygB)##2##3##(2008-10#2)
hygromycin B resistance##8##3##(2008-10#8)
hygromycin B##14##2##(2008-10#14)
hygromycin B-resistant##2##2##(2008-10#2)
hygromycin resistance##3##2##(2008-10#2)(2011-1#1)
hygromycin selection##2##2##(2008-11#2)
hygromycin##23##1##(2008-10#20)(2008-11#2)(2011-1#1)
hygroscopic##8##1##(1994-12#1)(1996-12#3)(2013-1#4)
hyicus and Staphylococcus aureus isolated from clinical cases##2##8##(2013-8#2)
hyicus##4##1##(2013-8#4)
hymenopteran societies##2##2##(2008-8#2)
hymenopteran##3##1##(2008-8#3)
hypanthia##2##1##(2008-10#2)
hypanthium increased##2##2##(2008-10#2)
hyper mobile##2##2##(2013-1#2)
hyper##7##1##(2008-11#2)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
hyper-IgM##2##1##(2008-9#1)(2011-2#1)
hyper-osmotically elevated K+##2##3##(1997-1#2)
hyper-osmotically##3##1##(1997-1#3)
hyper-producing cell line##3##3##(2008-11#3)
hyper-producing cell##6##2##(2008-11#6)
hyper-producing##9##1##(2008-11#9)
hyperaccumulator##3##1##(2008-10#2)(2010-11#1)
hyperactivity and##5##2##(1991-2#2)(1996-6#1)(2008-11#1)(2008-2#1)
hyperactivity disorder (ADHD)##3##3##(1996-6#1)(2008-9#1)(2009-9#1)
hyperactivity disorder##9##2##(1996-6#1)(2008-11#2)(2008-9#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)
hyperactivity in adolescent##2##3##(2013-8#2)
hyperactivity in##3##2##(2009-11#1)(2013-8#2)
hyperactivity##19##1##(1991-2#2)(1993-6#1)(1996-6#2)(2008-11#3)(2008-2#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-8#3)
hyperaggregability##3##1##(1990-11#1)(1991-12#1)(1997-6#1)
hyperalgesia and##2##2##(1995-12#1)(2008-9#1)
hyperalgesia##9##1##(1995-12#5)(1997-2#2)(2008-9#2)
hyperammonemia##3##1##(2009-8#3)
hyperammonemic##2##1##(2009-8#2)
hyperandrogenism and anovulation##2##3##(2008-4#1)(2010-11#1)
hyperandrogenism and insulin resistance##2##4##(2008-4#2)
hyperandrogenism and##4##2##(2008-4#3)(2010-11#1)
hyperandrogenism of##3##2##(2008-4#3)
hyperandrogenism##10##1##(2008-4#9)(2010-11#1)
hyperbaric bupivacaine##2##2##(2011-2#2)
hyperbaric##4##1##(2011-2#3)(2012-12#1)
hyperbilirubinemia##7##1##(1994-6#1)(2008-11#5)(2012-12#1)
hyperbolic expression##2##2##(2008-7#2)
hyperbolic saturation##3##2##(2008-10#3)
hyperbolic##12##1##(2008-10#5)(2008-3#3)(2008-6#1)(2008-7#2)(2009-12#1)
hyperbranched##3##1##(2008-10#3)
hypercalcaemia##5##1##(2008-12#1)(2012-12#1)(2013-7#3)
hypercalcemia in##3##2##(1991-8#1)(1993-3#1)(2008-12#1)
hypercalcemia of malignancy##3##3##(1990-2#3)
hypercalcemia of##4##2##(1990-2#4)
hypercalcemia##15##1##(1990-2#5)(1991-12#1)(1991-8#4)(1993-3#1)(1996-9#1)(2008-1#2)(2008-12#1)
hypercalcemic##2##1##(1991-12#2)
hypercalciuria in##3##2##(1991-11#2)(2008-10#1)
hypercalciuria##7##1##(1991-11#4)(2008-10#3)
hypercarbia##2##1##(2010-8#2)
hypercholesteremic animals##2##2##(2008-10#2)
hypercholesteremic##7##1##(2008-10#7)
hypercholesterolaemia##6##1##(1990-9#1)(1992-12#1)(2008-6#4)
hypercholesterolemia in##2##2##(1995-2#1)(1997-8#1)
hypercholesterolemia##11##1##(1990-2#1)(1991-11#3)(1991-2#1)(1991-6#1)(1995-2#2)(1997-8#1)(2008-7#1)(2013-1#1)
hypercholesterolemia]##3##1##(1991-3#1)(1993-5#1)(1996-2#1)
hypercholesterolemic patients##4##2##(1991-12#2)(1991-2#2)
hypercholesterolemic##6##1##(1991-12#2)(1991-2#2)(1997-8#1)(2008-7#1)
hyperchylomicronaemia##2##1##(2008-10#2)
hypercoagulability##2##1##(1993-9#1)(2010-3#1)
hypercortisolism##2##1##(2008-7#1)(2011-2#1)
hyperekplexia##2##1##(1996-2#2)
hyperendemic township##2##2##(2013-8#2)
hyperendemic##3##1##(2013-1#1)(2013-8#2)
hypereosinophilia##4##1##(2008-11#3)(2008-7#1)
hypereosinophilic syndrome##3##2##(2008-7#3)
hypereosinophilic##4##1##(2008-7#4)
hyperfine structure##4##2##(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
hyperfine##5##1##(1991-9#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
hyperfunctioning##2##1##(1990-6#1)(2008-10#1)
hypergastrinemia##2##1##(1997-1#2)
hyperglycaemia and##2##2##(1996-11#1)(2011-1#1)
hyperglycaemia##4##1##(1994-12#1)(1996-11#1)(2011-1#2)
hyperglycemia and##2##2##(1992-8#1)(2012-4#1)
hyperglycemia but##2##2##(1991-7#1)(2010-11#1)
hyperglycemia may be##2##3##(1992-8#1)(2009-11#1)
hyperglycemia may##3##2##(1992-8#1)(1994-12#1)(2009-11#1)
hyperglycemia or ketoacidosis##2##3##(1994-6#2)
hyperglycemia##30##1##(1991-7#6)(1992-8#2)(1994-12#1)(1994-6#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2011-2#1)(2012-4#2)(2013-7#1)
hyperglycemic piglets##2##2##(1994-2#2)
hyperglycemic rebound##2##2##(1990-5#2)
hyperglycemic##9##1##(1990-5#2)(1994-2#3)(2008-5#1)(2010-11#2)(2011-2#1)
hyperhomocysteinemia##2##1##(1992-9#1)(2008-8#1)
hypericin##4##1##(2009-3#4)
hyperinsulinemia##6##1##(1996-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-11#1)
hyperinsulinism and##2##2##(2008-4#2)
hyperinsulinism##5##1##(1991-2#2)(2008-4#2)(2013-1#1)
hyperintense##3##1##(1997-8#1)(2011-2#1)(2012-2#1)
hyperintensity##5##1##(2009-11#2)(2011-2#1)(2012-12#1)(2012-3#1)
hyperkalemia##3##1##(2008-12#1)(2008-7#2)
hyperkalemic periodic paralysis##2##3##(1991-12#2)
hyperkeratosis and##6##2##(2008-5#1)(2008-9#2)(2012-3#3)
hyperkeratosis of the##2##3##(2008-5#1)(2008-9#1)
hyperkeratosis##12##1##(2008-5#2)(2008-9#5)(2010-6#1)(2012-3#4)
hyperkeratotic##2##1##(2008-5#1)(2010-6#1)
hyperkinetic atrial arrhythmia##2##3##(1990-9#2)
hyperkinetic##4##1##(1990-9#2)(1991-8#1)(1996-3#1)
hyperlipidaemia##9##1##(1992-12#1)(2008-11#4)(2008-3#3)(2011-2#1)
hyperlipidaemic##2##1##(1992-12#2)
hyperlipidemia##12##1##(1994-5#1)(1996-11#1)(2008-9#1)(2009-12#3)(2009-6#2)(2009-9#1)(2010-12#1)(2011-3#1)(2013-1#1)
hyperlipidemic##2##1##(1995-6#1)(2008-4#1)
hypermethylation##2##1##(2008-4#1)(2009-8#1)
hyperoside##3##1##(2008-10#3)
hyperosmolar diabetic##2##2##(1990-3#2)
hyperosmolar saline##2##2##(1997-1#2)
hyperosmolar state and continuous seizure##2##5##(2013-8#2)
hyperosmolar##8##1##(1990-3#2)(1994-12#1)(1995-11#1)(1997-1#2)(2013-8#2)
hyperosmotic cultures##5##2##(2008-11#5)
hyperosmotic stress##4##2##(2008-11#3)(2009-6#1)
hyperosmotic##9##1##(2008-11#8)(2009-6#1)
hyperoxaluria##2##1##(2009-3#1)(2012-2#1)
hyperoxia##2##1##(2009-11#2)
hyperparasite##8##1##(2008-10#3)(2008-9#5)
hyperparasites##2##1##(2008-9#2)
hyperparathyroidism and##4##2##(1990-2#2)(1991-11#2)
hyperparathyroidism##30##1##(1990-2#5)(1991-11#7)(1991-12#1)(1991-8#1)(1993-3#3)(1993-9#1)(1996-2#1)(1996-9#3)(2008-10#2)(2008-12#2)(2011-2#2)(2012-12#1)(2013-1#1)
hyperperfusion in##2##2##(2008-7#1)(2012-2#1)
hyperperfusion##3##1##(2008-7#2)(2012-2#1)
hyperphosphatemia in##2##2##(1991-8#2)
hyperphosphatemia##5##1##(1991-8#2)(2008-7#2)(2012-12#1)
hyperphosphorylated##4##1##(1996-12#1)(1996-2#1)(2008-4#1)(2009-6#1)
hyperpigmentation##4##1##(1996-11#1)(2008-5#1)(2011-1#1)(2012-12#1)
hyperpigmented##3##1##(2010-6#1)(2011-2#1)(2012-3#1)
hyperplasia and##5##2##(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
hyperplasia as##2##2##(2008-7#1)(2011-2#1)
hyperplasia at the site of application in##2##7##(2008-9#2)
hyperplasia in##3##2##(2006-6#2)(2012-2#1)
hyperplasia is a##2##3##(2006-6#1)(2011-2#1)
hyperplasia is##4##2##(1991-8#1)(2006-6#1)(2008-12#1)(2011-2#1)
hyperplasia of the##3##3##(2008-12#1)(2009-1#1)(2010-11#1)
hyperplasia of##6##2##(2008-10#1)(2008-12#1)(2009-1#1)(2010-11#1)(2012-3#1)(2013-1#1)
hyperplasia or##2##2##(1992-9#1)(2008-10#1)
hyperplasia to##2##2##(2008-5#2)
hyperplasia was##2##2##(1990-12#1)(2006-6#1)
hyperplasia##67##1##(1990-11#1)(1990-12#2)(1990-9#5)(1991-8#1)(1992-9#1)(1994-12#2)(2006-6#7)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-4#3)(2008-5#8)(2008-7#1)(2008-9#4)(2009-1#1)(2009-3#1)(2010-11#1)(2010-2#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
hyperplastic glands##3##2##(2008-5#3)
hyperplastic##14##1##(1990-12#1)(1992-8#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-5#4)(2009-12#2)(2010-6#1)(2012-3#1)(2013-1#1)
hyperpnea##2##1##(1997-1#1)(2012-3#1)
hyperpolarity and##2##2##(2008-8#2)
hyperpolarity##3##1##(2008-8#3)
hyperpolarization and##4##2##(1990-12#1)(1992-6#1)(1997-4#2)
hyperpolarization of the##2##3##(1990-12#1)(1993-3#1)
hyperpolarization of##3##2##(1990-12#1)(1993-3#1)(1994-11#1)
hyperpolarization##12##1##(1990-12#2)(1990-8#2)(1992-6#1)(1993-3#1)(1994-11#3)(1997-4#2)(2010-4#1)
hyperpolarizing##2##1##(1990-8#1)(1993-8#1)
hyperprolactinemia##3##1##(2008-8#1)(2011-2#2)
hyperreactivity##3##1##(1992-12#1)(2008-10#1)(2011-2#1)
hyperresponsiveness and##2##2##(1997-1#1)(2010-5#1)
hyperresponsiveness##4##1##(1993-9#1)(1997-1#1)(2008-10#1)(2010-5#1)
hypersaline environments##2##2##(2011-2#1)(2012-2#1)
hypersaline##3##1##(2011-2#1)(2012-2#2)
hypersensitive cell death##2##3##(2008-10#2)
hypersensitive reaction (HR) in##2##4##(2008-10#2)
hypersensitive reaction (HR)##4##3##(2008-10#4)
hypersensitive reaction##13##2##(2008-10#13)
hypersensitive reactions##3##2##(2008-10#3)
hypersensitive response (HR)##9##3##(2008-10#9)
hypersensitive response##15##2##(2008-10#13)(2008-8#2)
hypersensitive responses##2##2##(2008-10#2)
hypersensitive site##5##2##(1992-6#2)(2008-8#3)
hypersensitive sites##3##2##(1990-7#1)(1994-11#2)
hypersensitive to##2##2##(2009-8#1)(2012-3#1)
hypersensitive##49##1##(1990-7#1)(1992-6#2)(1993-11#1)(1994-11#2)(1997-7#1)(2008-10#34)(2008-11#1)(2008-8#5)(2009-8#1)(2012-3#1)
hypersensitivity (DTH)##3##2##(2008-10#3)
hypersensitivity and##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
hypersensitivity pneumonitis##2##2##(2007-12#1)(2011-2#1)
hypersensitivity reaction##3##2##(2008-8#3)
hypersensitivity reactions in##2##3##(2008-7#1)(2008-8#1)
hypersensitivity reactions to chemotherapy agents##2##5##(2008-8#2)
hypersensitivity reactions to##4##3##(2008-7#1)(2008-8#3)
hypersensitivity reactions##11##2##(2008-10#1)(2008-7#2)(2008-8#8)
hypersensitivity responses##2##2##(2008-10#2)
hypersensitivity syndrome##4##2##(2008-8#4)
hypersensitivity to##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
hypersensitivity##54##1##(1991-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#18)(2011-2#9)(2012-12#1)(2013-1#1)
hyperspectral data##2##2##(2008-3#1)(2013-8#1)
hyperspectral##8##1##(2008-3#5)(2013-8#3)
hypertelorism##3##1##(1997-3#1)(2012-12#1)(2013-8#1)
hypertension (EH)##2##2##(2008-9#1)(2011-2#1)
hypertension (PH) is##2##3##(2008-1#1)(2010-10#1)
hypertension (PH)##3##2##(2008-1#1)(2010-10#2)
hypertension and atherosclerosis##3##3##(2008-7#3)
hypertension and cerebrovascular##2##3##(1991-6#1)(2008-5#1)
hypertension and diabetes mellitus##2##4##(1996-11#1)(2013-1#1)
hypertension and diabetes##5##3##(1996-11#1)(2007-8#1)(2008-1#1)(2012-2#1)(2013-1#1)
hypertension and the##3##3##(1991-8#1)(1994-6#1)(1997-8#1)
hypertension and##47##2##(1991-6#1)(1991-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#6)(2009-10#1)(2010-4#3)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
hypertension are##2##2##(2012-2#1)(2013-1#1)
hypertension as##2##2##(2008-11#1)(2010-10#1)
hypertension can##3##2##(1994-12#1)(1995-11#1)(2008-5#1)
hypertension caused by##2##3##(1990-12#1)(2012-3#1)
hypertension during##2##2##(2009-1#1)(2012-3#1)
hypertension in the elderly##2##4##(2008-7#2)
hypertension in the##5##3##(1993-3#1)(1997-5#1)(2008-7#2)(2012-3#1)
hypertension in##33##2##(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-10#1)(1996-6#1)(1997-5#1)(2008-1#2)(2008-11#7)(2008-7#3)(2008-9#2)(2009-8#1)(2010-10#2)(2010-4#2)(2011-2#2)(2012-3#1)(2013-7#1)
hypertension is a##3##3##(1995-2#1)(2008-11#1)(2011-2#1)
hypertension is##10##2##(1994-8#1)(1994-9#1)(1995-2#1)(2008-11#3)(2009-1#1)(2009-7#1)(2010-10#1)(2011-2#1)
hypertension may be##2##3##(2008-11#1)(2008-7#1)
hypertension of##3##2##(1993-8#1)(2008-10#1)(2011-2#1)
hypertension on##3##2##(2008-7#1)(2010-4#1)(2012-2#1)
hypertension or##5##2##(2008-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-2#1)
hypertension should be##2##3##(1996-11#1)(2008-7#1)
hypertension suggest##2##2##(2009-1#1)(2009-10#1)
hypertension was##6##2##(1990-11#1)(1994-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)
hypertension were##2##2##(2008-7#1)(2010-1#1)
hypertension##324##1##(1990-11#2)(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-1#1)(1993-11#4)(1993-2#3)(1993-3#2)(1993-8#4)(1993-9#1)(1994-12#6)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#4)(1995-2#3)(1996-11#3)(1996-3#3)(1996-6#3)(1997-2#5)(1997-5#3)(1997-8#5)(2007-8#2)(2008-1#4)(2008-10#7)(2008-11#33)(2008-12#5)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#27)(2008-8#3)(2008-9#5)(2009-1#10)(2009-10#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#3)(2010-10#22)(2010-12#3)(2010-4#18)(2010-5#4)(2010-6#2)(2011-1#2)(2011-2#22)(2011-3#4)(2012-12#4)(2012-2#13)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#6)
hypertension)##3##1##(1996-6#1)(2008-1#1)(2011-2#1)
hypertension]##8##1##(1991-11#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-2#1)(1997-4#1)(2013-8#1)
hypertensive and##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
hypertensive compared to##2##3##(2008-11#1)(2012-2#1)
hypertensive patient##3##2##(1993-11#2)(2012-3#1)
hypertensive patients for##2##3##(2008-11#1)(2009-1#1)
hypertensive patients##14##2##(1993-8#1)(2008-11#2)(2008-8#3)(2009-1#3)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#1)
hypertensive patients]##2##2##(1996-3#1)(2013-8#1)
hypertensive rats##12##2##(1991-5#2)(1991-6#2)(1994-2#2)(1995-11#2)(1997-2#2)(2008-11#1)(2009-8#1)
hypertensive##61##1##(1991-5#2)(1991-6#2)(1993-11#2)(1993-8#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#2)(1996-3#1)(1997-2#3)(1997-8#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-1#4)(2009-8#2)(2010-1#2)(2010-4#7)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
hypertensives and##2##2##(2008-10#1)(2012-2#1)
hypertensives##11##1##(1997-2#1)(2008-10#5)(2008-11#1)(2012-2#4)
hyperthermia by##2##2##(2013-8#2)
hyperthermia on##2##2##(2008-5#1)(2008-7#1)
hyperthermia treatment##2##2##(2008-11#1)(2012-2#1)
hyperthermia##20##1##(1991-5#1)(1993-9#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-11#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#6)
hyperthermia-induced##2##1##(2013-8#2)
hyperthermic##3##1##(1991-5#2)(2008-7#1)
hyperthermophilic archaeon##3##2##(1993-9#2)(2011-2#1)
hyperthermophilic archaeonSulfolobus shibatae##2##3##(2008-9#2)
hyperthermophilic cocultures##2##2##(2008-7#2)
hyperthermophilic##12##1##(1993-9#2)(2008-7#5)(2008-9#2)(2011-2#3)
hyperthyroidism##4##1##(1996-8#1)(2008-4#1)(2011-1#1)(2013-1#1)
hypertonic saline##5##2##(2008-5#1)(2010-1#2)(2010-12#2)
hypertonic##8##1##(1994-8#1)(1996-8#1)(2008-5#1)(2010-1#2)(2010-12#2)(2013-7#1)
hypertrichosis##2##1##(2010-6#2)
hypertriglyceridaemia##2##1##(1996-3#1)(2013-1#1)
hypertriglyceridemia##3##1##(1993-2#1)(2008-10#1)(2008-3#1)
hypertrophic cardiomyopathy##6##2##(1996-8#1)(1997-7#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
hypertrophic pyloric##2##2##(1990-9#1)(2010-12#1)
hypertrophic scars##2##2##(2008-9#1)(2009-4#1)
hypertrophic##26##1##(1990-9#2)(1991-2#2)(1992-3#1)(1992-8#1)(1994-5#1)(1996-8#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2010-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
hypertrophy and hyperplasia of##2##4##(2008-10#1)(2010-11#1)
hypertrophy and##11##2##(1990-11#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
hypertrophy in patients with cardiac syndrome X##2##7##(2008-12#2)
hypertrophy in patients with##3##4##(2008-12#2)(2012-12#1)
hypertrophy in the##2##3##(1996-12#1)(2008-12#1)
hypertrophy in##8##2##(1996-12#1)(2008-12#3)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
hypertrophy is associated with##2##4##(2008-7#1)(2010-12#1)
hypertrophy is##6##2##(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-12#1)
hypertrophy of the##4##3##(1996-3#1)(2008-8#1)(2010-10#1)(2010-12#1)
hypertrophy of##7##2##(1996-3#1)(2008-10#2)(2008-8#1)(2010-10#1)(2010-12#2)
hypertrophy or##2##2##(2009-1#1)(2012-2#1)
hypertrophy through##2##2##(2011-2#1)(2013-8#1)
hypertrophy were significantly increased in##2##5##(2008-9#2)
hypertrophy were##3##2##(2008-9#2)(2011-2#1)
hypertrophy with##2##2##(2008-5#1)(2010-6#1)
hypertrophy##77##1##(1990-11#1)(1991-5#1)(1994-12#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#5)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-1#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#13)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-2#8)(2012-12#6)(2012-2#3)(2013-1#3)(2013-8#2)
hypertrophy]##2##1##(1992-9#1)(1995-11#1)
hypervariable region##2##2##(1995-2#1)(2008-10#1)
hypervariable regions of##2##3##(1993-8#1)(2008-10#1)
hypervariable##5##1##(1993-8#1)(1995-2#1)(2008-10#3)
hypervascular HCC##2##2##(2010-12#2)
hypervascular##6##1##(1992-3#1)(1997-6#2)(2008-10#1)(2010-12#2)
hypervascularity##2##1##(1997-6#1)(2011-2#1)
hypervelocity photoelectric modulation interferometer##2##4##(2013-8#2)
hyperventilation##6##1##(1994-9#1)(2008-7#4)(2012-3#1)
hyphae and##4##2##(2008-10#3)(2008-8#1)
hyphae appeared##2##2##(2008-10#1)(2008-11#1)
hyphae are##3##2##(2008-10#3)
hyphae began to##2##3##(2008-10#2)
hyphae colonized the##2##3##(2008-10#2)
hyphae grew##3##2##(2008-10#3)
hyphae had##2##2##(2008-10#2)
hyphae in the##2##3##(2008-10#1)(2008-11#1)
hyphae in##10##2##(2008-10#8)(2008-11#1)(2008-5#1)
hyphae may##2##2##(2008-10#2)
hyphae of P##2##3##(2008-10#2)
hyphae of R##4##3##(2008-10#4)
hyphae of both##4##3##(2008-10#4)
hyphae of the##3##3##(2008-10#3)
hyphae of##18##2##(2008-10#18)
hyphae or##2##2##(2008-10#1)(2008-7#1)
hyphae to##3##2##(2008-10#3)
hyphae was##4##2##(2008-10#4)
hyphae were designated##2##3##(2008-10#2)
hyphae were found##2##3##(2008-10#2)
hyphae were##12##2##(2008-10#11)(2008-8#1)
hyphae##126##1##(2008-10#113)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#2)(2010-3#1)(2012-2#2)
hyphal anastomosis##5##2##(2008-10#5)
hyphal biomass##2##2##(2008-10#2)
hyphal diameter##3##2##(2008-10#2)(2008-7#1)
hyphal elongation and##2##3##(2008-10#2)
hyphal growth of##4##3##(2008-10#3)(2012-2#1)
hyphal growth rates##3##3##(2008-10#3)
hyphal growth##22##2##(1996-6#1)(2008-10#16)(2009-8#4)(2012-2#1)
hyphal interactions##3##2##(2008-10#3)
hyphal length##4##2##(2008-10#1)(2008-7#3)
hyphal tips##2##2##(2008-10#2)
hyphal##70##1##(1996-6#1)(2008-10#50)(2008-11#2)(2008-7#6)(2008-8#4)(2009-8#6)(2012-2#1)
hyphenated techniques##8##2##(2008-10#8)
hyphenated##16##1##(2008-10#14)(2010-11#1)(2011-2#1)
hyphenation of##3##2##(2008-10#2)(2008-12#1)
hyphenation##7##1##(2008-10#6)(2008-12#1)
hyphomycetes##2##1##(2008-10#2)
hypnotic##2##1##(2008-11#1)(2009-10#1)
hypo- and hypercalcemia##2##3##(1991-8#2)
hypo- and##3##2##(1991-8#2)(2012-3#1)
hypo- versus##2##2##(1991-8#2)
hypo-##6##1##(1991-8#4)(2012-3#1)(2013-1#1)
hypobaric hypoxia on##2##3##(1996-12#1)(2010-12#1)
hypobaric hypoxia##4##2##(1996-12#3)(2010-12#1)
hypobromite##5##1##(2008-10#5)
hypocalcaemia##2##1##(2008-12#1)(2008-6#1)
hypocalcemia and##3##2##(1991-8#2)(2012-3#1)
hypocalcemia##9##1##(1991-8#2)(2008-7#2)(2011-2#4)(2012-3#1)
hypocellularity##2##1##(2008-10#2)
hypochlorite (NaOCl)##3##2##(2012-3#1)(2013-1#2)
hypochlorite and chlorate##2##3##(2008-10#2)
hypochlorite and##9##2##(2008-10#9)
hypochlorite in##2##2##(2008-10#2)
hypochlorite ion##2##2##(2008-10#2)
hypochlorite was##2##2##(2008-10#1)(2011-2#1)
hypochlorite##34##1##(2008-10#30)(2011-2#1)(2012-3#1)(2013-1#2)
hypocotyl##7##1##(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)
hypocotyls and##3##2##(2008-10#2)(2008-8#1)
hypocotyls grown##2##2##(2008-10#2)
hypocotyls##10##1##(2008-10#9)(2008-8#1)
hypocrellins##2##1##(2008-8#2)
hypodense##2##1##(2008-12#1)(2013-1#1)
hypodermis##3##1##(2008-10#2)(2008-5#1)
hypodermosis##2##1##(2008-12#2)
hypodiploidy##2##1##(1990-3#2)
hypoechoic and##2##2##(2008-10#1)(2011-2#1)
hypoechoic##4##1##(2008-10#2)(2011-2#1)(2012-3#1)
hypogammaglobulinemia with##2##2##(2011-2#2)
hypogastric artery##2##2##(1994-1#2)
hypogastric##3##1##(1992-12#1)(1994-1#2)
hypoglossal canal##3##2##(2011-2#3)
hypoglossal nerve palsy##2##3##(2011-2#2)
hypoglossal nerve##3##2##(2011-2#3)
hypoglossal##12##1##(1991-12#1)(2011-2#10)(2013-1#1)
hypoglycaemia##3##1##(1991-11#1)(1996-11#1)(2008-1#1)
hypoglycemia and##2##2##(2008-1#1)(2010-11#1)
hypoglycemia caused by hyperinsulinism##2##4##(1991-2#2)
hypoglycemia during##3##2##(1994-2#1)(2010-2#2)
hypoglycemia in##2##2##(1991-1#1)(2013-1#1)
hypoglycemia##21##1##(1990-5#2)(1991-1#1)(1991-2#2)(1994-2#1)(1994-6#2)(1996-8#1)(1997-2#2)(1997-4#1)(2008-1#1)(2010-11#1)(2010-2#2)(2011-1#3)(2012-4#1)(2013-1#1)
hypoglycemic episodes##3##2##(2010-10#1)(2010-12#1)(2012-4#1)
hypoglycemic piglets##3##2##(1994-2#3)
hypoglycemic##14##1##(1990-5#1)(1994-2#3)(1994-8#2)(1997-2#1)(2010-10#1)(2010-12#1)(2011-1#3)(2012-4#1)(2013-1#1)
hypogonadism in##2##2##(2008-3#1)(2009-6#1)
hypogonadism##8##1##(2008-3#3)(2009-6#1)(2011-2#1)(2012-3#3)
hypokalaemia##2##1##(1997-8#1)(2008-6#1)
hypokalemia##4##1##(1996-6#1)(1997-8#1)(2008-1#1)(2008-12#1)
hypokalemic##2##1##(2008-1#2)
hypolipidemic##5##1##(1990-12#2)(1991-2#1)(2008-10#1)(2013-1#1)
hypomagnesaemia and##2##2##(1997-8#1)(2008-6#1)
hypomagnesaemia##3##1##(1997-8#1)(2008-6#2)
hypomagnesemia##2##1##(1996-6#1)(1997-8#1)
hypomobility##3##1##(2008-12#3)
hyponatremia##11##1##(1990-9#1)(2009-10#1)(2009-11#2)(2010-1#4)(2011-2#3)
hypoosmotic pressure##6##2##(2008-11#6)
hypoparathyroidism##3##1##(1997-3#1)(2012-3#2)
hypoperfusion##8##1##(1996-3#1)(2008-7#6)(2009-6#1)
hypopharyngeal gland##4##2##(2008-6#4)
hypopharyngeal##5##1##(2008-1#1)(2008-6#4)
hypophysis##2##1##(2009-8#2)
hypopituitarism##2##1##(2011-2#1)(2013-1#1)
hypoplasia and##3##2##(2011-1#2)(2013-1#1)
hypoplasia##16##1##(1994-3#2)(1994-6#1)(1997-3#2)(2008-7#1)(2008-9#2)(2011-1#4)(2012-3#1)(2013-1#3)
hypoplastic##11##1##(1994-6#1)(2008-10#3)(2008-7#1)(2010-6#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
hypopnoea episodes##2##2##(2010-8#2)
hypopnoea##3##1##(2010-8#3)
hypospadia##4##1##(2013-1#4)
hypospadias and bifid scrotum##2##4##(2008-10#2)
hypospadias and##3##2##(2008-10#3)
hypospadias in##2##2##(2008-10#2)
hypospadias repair##7##2##(2008-10#7)
hypospadias surgery##3##2##(2008-10#3)
hypospadias##23##1##(2008-10#23)
hypotaurine##2##1##(2008-5#2)
hypotension and other##2##3##(2008-6#1)(2011-2#1)
hypotension and##6##2##(1990-5#2)(2008-6#1)(2009-12#1)(2011-2#1)(2013-8#1)
hypotension in##2##2##(1990-8#1)(2011-2#1)
hypotension##29##1##(1990-12#1)(1990-5#2)(1990-8#3)(1990-9#1)(1991-11#1)(1994-11#2)(1996-12#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
hypotensive##7##1##(1990-9#2)(1991-5#1)(1994-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
hypothalamic and##2##2##(1994-2#1)(2008-4#1)
hypothalamic area##5##2##(1993-6#1)(1994-2#1)(2008-9#2)(2013-7#1)
hypothalamic cultures##2##2##(1994-2#2)
hypothalamic gene expression##2##3##(1996-12#2)
hypothalamic nuclei##2##2##(1994-2#1)(1996-12#1)
hypothalamic nucleus##4##2##(1994-2#1)(1997-3#1)(2008-8#2)
hypothalamic stimulation##2##2##(1991-2#1)(1994-2#1)
hypothalamic##41##1##(1991-11#1)(1991-2#4)(1991-9#2)(1993-6#2)(1994-2#7)(1994-8#4)(1995-12#1)(1995-5#1)(1996-12#8)(1997-3#1)(2008-4#1)(2008-8#3)(2008-9#2)(2009-6#1)(2012-3#2)(2013-7#1)
hypothalamic-pituitary-adrenal##7##1##(1996-12#1)(1997-2#1)(2008-4#1)(2008-8#1)(2010-7#1)(2013-1#1)(2013-8#1)
hypothalamo-pituitary adrenal axis##2##3##(1995-12#2)
hypothalamus and##9##2##(1991-2#1)(1994-2#3)(1995-12#1)(1996-12#2)(1997-3#1)(2008-8#1)
hypothalamus in##2##2##(1997-2#1)(2009-10#1)
hypothalamus is##2##2##(1993-6#1)(1996-2#1)
hypothalamus were##2##2##(1994-2#1)(2008-8#1)
hypothalamus##49##1##(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#2)(1993-6#5)(1994-2#9)(1994-8#1)(1995-12#2)(1995-2#2)(1996-12#5)(1996-2#5)(1997-2#1)(1997-3#2)(2008-10#1)(2008-8#6)(2008-9#1)(2009-10#2)(2010-6#1)(2013-7#1)
hypothermia and##4##2##(1995-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
hypothermia has##2##2##(1991-3#2)
hypothermia is##2##2##(2011-2#1)(2013-8#1)
hypothermia##30##1##(1990-5#1)(1990-9#1)(1991-3#3)(1992-3#1)(1995-11#1)(1996-12#4)(2008-7#1)(2008-9#3)(2010-1#2)(2011-2#9)(2013-8#4)
hypothermic response##2##2##(1994-2#2)
hypothermic##7##1##(1994-2#2)(1996-12#3)(2013-1#2)
hypotheses about the##5##3##(2008-10#2)(2008-8#1)(2008-9#2)
hypotheses about##8##2##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-8#1)
hypotheses and##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)
hypotheses are##6##2##(2008-8#2)(2008-9#3)(2011-2#1)
hypotheses concerning##3##2##(2008-10#3)
hypotheses for the##2##3##(2008-10#1)(2009-6#1)
hypotheses for##5##2##(2008-10#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-8#1)
hypotheses have been proposed to explain##2##6##(2008-9#1)(2012-3#1)
hypotheses have been proposed##3##4##(2008-9#1)(2011-1#1)(2012-3#1)
hypotheses have##4##2##(1990-6#1)(2008-9#1)(2011-1#1)(2012-3#1)
hypotheses of##2##2##(1990-9#1)(2011-1#1)
hypotheses regarding the##4##3##(1991-6#1)(2008-10#1)(2008-9#1)(2009-10#1)
hypotheses regarding##7##2##(1991-6#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-1#1)
hypotheses that##8##2##(2008-10#3)(2008-11#1)(2008-7#1)(2010-6#1)(2012-3#2)
hypotheses to explain##2##3##(2008-8#1)(2008-9#1)
hypotheses to##3##2##(2008-8#1)(2008-9#1)(2009-6#1)
hypotheses using##2##2##(2008-8#1)(2012-3#1)
hypotheses##80##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-2#1)(2008-10#12)(2008-11#9)(2008-12#1)(2008-7#1)(2008-8#12)(2008-9#16)(2009-10#1)(2009-11#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-6#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#6)(2013-8#2)
hypothesis and##2##2##(2008-7#1)(2010-1#1)
hypothesis by##5##2##(1993-6#1)(2008-8#2)(2009-10#1)(2009-7#1)
hypothesis for##7##2##(2008-10#2)(2008-11#1)(2008-8#2)(2013-1#1)(2013-8#1)
hypothesis has been##2##3##(1994-2#1)(2013-1#1)
hypothesis has##7##2##(1994-2#2)(1997-7#1)(2008-8#2)(2013-1#2)
hypothesis in vivo##2##3##(2008-5#1)(2008-7#1)
hypothesis in##6##2##(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
hypothesis is that the##2##4##(1995-5#1)(2008-10#1)
hypothesis is that##6##3##(1995-5#1)(2008-10#3)(2008-7#1)(2009-9#1)
hypothesis is##11##2##(1995-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)
hypothesis of a##10##3##(1991-12#1)(1991-2#1)(1991-5#1)(1995-9#1)(2008-10#5)(2013-1#1)
hypothesis of random mating##3##4##(2008-10#3)
hypothesis of##33##2##(1991-12#1)(1991-2#1)(1991-5#1)(1993-9#1)(1995-5#1)(1995-9#2)(2007-12#1)(2008-10#15)(2008-11#1)(2008-8#3)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
hypothesis on the##2##3##(2008-12#1)(2010-1#1)
hypothesis predicts that##2##3##(2008-11#1)(2008-9#1)
hypothesis predicts##3##2##(2008-11#2)(2008-9#1)
hypothesis proposed##2##2##(1990-11#1)(2008-9#1)
hypothesis suggests that##2##3##(2008-11#1)(2013-1#1)
hypothesis tested##2##2##(1997-3#1)(2013-1#1)
hypothesis testing in##2##3##(1994-9#1)(1995-5#1)
hypothesis testing##8##2##(1994-9#1)(1995-5#2)(1995-9#1)(2008-10#2)(2010-11#1)(2011-2#1)
hypothesis tests##2##2##(1994-9#1)(2008-10#1)
hypothesis that a##8##3##(1990-5#1)(1992-6#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-8#1)(2013-8#1)
hypothesis that populations##2##3##(2008-10#2)
hypothesis that the##41##3##(1990-6#1)(1991-2#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-1#2)(2012-12#1)(2012-3#2)(2013-1#2)
hypothesis that there are##2##4##(2008-10#1)(2008-5#1)
hypothesis that there##5##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
hypothesis that##153##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#2)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#41)(2008-11#6)(2008-12#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#5)(2013-8#2)
hypothesis was tested##3##3##(1996-3#1)(2008-11#1)(2008-9#1)
hypothesis was that##4##3##(2008-8#2)(2009-8#1)(2011-1#1)
hypothesis was##13##2##(1996-3#1)(2008-10#3)(2008-11#2)(2008-8#3)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
hypothesis##369##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#3)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-2#4)(1994-3#1)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#4)(1995-5#7)(1995-8#1)(1995-9#4)(1996-2#1)(1996-3#3)(1997-1#5)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#3)(1997-9#1)(2007-12#3)(2008-1#1)(2008-10#82)(2008-11#21)(2008-12#9)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#40)(2008-9#21)(2009-10#3)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#5)(2012-5#2)(2012-7#1)(2013-1#15)(2013-8#6)
hypothesis&quot##2##1##(2008-8#1)(2009-6#1)
hypothesised as a##2##3##(2008-7#1)(2009-4#1)
hypothesised that##2##2##(2006-6#1)(2011-10#1)
hypothesised##5##1##(2006-6#1)(2008-7#1)(2009-4#1)(2011-10#1)(2011-2#1)
hypothesize that an##2##3##(2008-11#1)(2008-4#1)
hypothesize that the##4##3##(1995-6#1)(1997-3#1)(2009-8#2)
hypothesize that##25##2##(1992-6#2)(1995-6#1)(1996-9#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#3)(2010-1#1)(2012-12#1)
hypothesize##28##1##(1992-6#2)(1995-6#1)(1996-9#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-7#1)(2009-8#3)(2010-1#2)(2012-12#1)
hypothesized that the##11##3##(1993-3#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
hypothesized that this##5##3##(1995-11#1)(2008-10#1)(2008-8#1)(2009-1#1)(2009-8#1)
hypothesized that##47##2##(1992-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-1#1)(2009-12#2)(2009-7#1)(2009-8#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#2)(2013-7#1)
hypothesized to be##11##3##(1992-3#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2011-1#1)(2012-3#1)
hypothesized to##16##2##(1992-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2011-1#2)(2012-3#2)
hypothesized##77##1##(1990-2#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-2#1)(2008-10#13)(2008-11#6)(2008-12#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#8)(2008-9#5)(2009-1#1)(2009-12#2)(2009-7#1)(2009-8#4)(2010-11#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-3#4)(2013-1#2)(2013-7#1)
hypothetical and##2##2##(1997-3#1)(2008-10#1)
hypothetical genes registered in databases##3##5##(1996-12#2)(1996-6#1)
hypothetical genes##5##2##(1995-8#1)(1996-12#2)(1996-6#2)
hypothetical model of##2##3##(2008-12#1)(2008-9#1)
hypothetical model##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
hypothetical##41##1##(1990-11#1)(1990-8#1)(1992-2#1)(1994-5#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#2)(2008-10#7)(2008-11#1)(2008-12#6)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2012-2#1)(2013-1#1)
hypothetically##2##1##(2008-10#1)(2013-1#1)
hypothyroidism and##3##2##(1991-8#1)(1996-8#1)(2011-1#1)
hypothyroidism by##2##2##(2011-1#1)(2011-2#1)
hypothyroidism in##3##2##(2008-11#1)(2011-1#2)
hypothyroidism##37##1##(1991-8#2)(1993-9#1)(1996-8#1)(1997-3#1)(2008-11#2)(2008-4#1)(2008-6#1)(2010-7#1)(2011-1#18)(2011-2#5)(2012-3#3)(2013-1#1)
hypotonic solution##2##2##(1990-2#1)(2008-9#1)
hypotonic##9##1##(1990-2#5)(1992-11#1)(2008-11#1)(2008-9#1)(2010-1#1)
hypotrophic##2##1##(1993-3#2)
hypovirulence by##2##2##(2008-9#2)
hypovirulence factor##2##2##(2008-10#2)
hypovirulence in##3##2##(2008-10#2)(2008-9#1)
hypovirulence##13##1##(2008-10#10)(2008-9#3)
hypovirulence-associated double-stranded RNA (dsRNA)##2##4##(2008-10#2)
hypovirulence-associated##3##1##(2008-10#3)
hypovirulent isolate##4##2##(2008-10#4)
hypovirulent isolates##5##2##(2008-10#5)
hypovirulent phenotype were##2##3##(2008-10#2)
hypovirulent phenotype##5##2##(2008-10#5)
hypovirulent strains##5##2##(2008-10#5)
hypovirulent##28##1##(2008-10#27)(2008-9#1)
hypovirus##9##1##(2008-10#9)
hypovirus-infected##3##1##(2008-10#3)
hypoxanthine (HX)##2##2##(1990-5#1)(2008-11#1)
hypoxanthine##8##1##(1990-5#2)(1994-8#2)(2008-10#2)(2008-11#2)
hypoxemia and##3##2##(1990-11#1)(2009-5#1)(2010-5#1)
hypoxemia##6##1##(1990-11#1)(1993-11#1)(2008-1#1)(2009-5#1)(2010-5#1)(2013-1#1)
hypoxia and the##3##3##(2009-4#1)(2010-8#1)(2011-2#1)
hypoxia and##9##2##(1994-2#2)(2008-10#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)
hypoxia are##2##2##(2010-11#1)(2012-2#1)
hypoxia in##3##2##(1994-5#1)(1996-12#1)(2010-11#1)
hypoxia is##2##2##(2010-7#1)(2012-2#1)
hypoxia on##4##2##(1996-12#1)(2010-12#3)
hypoxia##61##1##(1991-2#2)(1994-2#8)(1994-5#4)(1996-12#6)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-7#1)(2009-4#3)(2009-9#1)(2010-11#8)(2010-12#3)(2010-4#4)(2010-7#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#1)
hypoxia-inducible##2##1##(2010-7#1)(2013-1#1)
hypoxia/reoxygenation##4##1##(2008-11#4)
hypoxic cells##2##2##(2010-7#1)(2011-2#1)
hypoxic or##2##2##(2008-7#1)(2011-2#1)
hypoxic regions##2##2##(2008-11#1)(2010-7#1)
hypoxic stress##2##2##(2010-11#1)(2010-7#1)
hypoxic water was##2##3##(2010-8#2)
hypoxic water##3##2##(2010-8#3)
hypoxic##26##1##(1990-5#1)(1994-5#3)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-7#5)(2010-8#4)(2010-9#1)(2011-2#3)
hypoxic-ischemic encephalopathy##2##2##(2008-11#2)
hypoxic-ischemic##6##1##(1996-12#2)(2008-11#2)(2010-7#1)(2013-1#1)
hypsochromic##2##1##(2008-10#2)
hypusine##3##1##(1994-3#3)
hysterectomies##16##1##(1993-12#4)(1995-1#8)(1995-12#1)(1996-2#1)(1996-9#2)
hysterectomy and##8##2##(1993-12#2)(1994-2#2)(1995-12#1)(2010-12#1)(2010-3#1)(2013-1#1)
hysterectomy is##4##2##(1991-12#1)(1991-3#1)(1993-12#1)(2012-3#1)
hysterectomy or##2##2##(1994-2#1)(2012-3#1)
hysterectomy to##2##2##(1993-12#1)(2008-8#1)
hysterectomy was performed##2##3##(1994-2#1)(1995-12#1)
hysterectomy was##3##2##(1994-2#2)(1995-12#1)
hysterectomy with##6##2##(1993-2#1)(1994-2#2)(1995-1#1)(2008-10#1)(2013-1#1)
hysterectomy##91##1##(1991-1#1)(1991-12#2)(1991-3#5)(1992-12#1)(1993-12#13)(1993-2#4)(1993-3#4)(1994-1#1)(1994-12#2)(1994-2#19)(1995-1#3)(1995-12#9)(1995-3#3)(1996-1#3)(1996-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-3#6)(2012-3#3)(2013-1#5)(2013-8#1)
hysteresis##5##1##(2008-10#4)(2012-2#1)
hysterosalpingography##2##1##(1991-3#1)(2011-2#1)
hysteroscope##7##1##(1991-12#1)(1991-2#3)(1992-1#1)(1996-1#2)
hysteroscopic examination under##2##3##(1992-12#2)
hysteroscopic removal##2##2##(1991-2#2)
hysteroscopic##8##1##(1991-2#3)(1992-1#2)(1992-12#2)(1994-2#1)
hysteroscopy under local anesthesia##2##4##(1992-12#2)
hysteroscopy##9##1##(1991-11#1)(1992-12#4)(1993-12#3)(1993-2#1)
hystopathology##2##1##(2008-10#1)(2013-8#1)
i##500##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1991-1#6)(1991-11#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#5)(1991-8#4)(1992-11#1)(1992-12#10)(1992-2#3)(1992-3#16)(1992-8#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#8)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#7)(1995-11#6)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#2)(1996-11#2)(1996-12#5)(1996-2#18)(1997-2#8)(1997-3#3)(1997-4#12)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#6)(2008-10#151)(2008-11#27)(2008-12#14)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#23)(2008-7#12)(2008-8#5)(2008-9#8)(2009-10#2)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#5)(2010-10#1)(2010-3#2)(2010-5#1)(2010-7#7)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#8)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#4)
i) the##2##2##(1997-4#1)(2009-8#1)
i)##9##1##(1997-4#1)(2008-10#2)(2008-11#1)(2009-8#1)(2009-9#2)(2012-2#2)
i)perylene and##2##2##(2008-10#2)
iGenomicViewer##3##1##(2011-3#3)
iHPlg was converted to##2##4##(1993-8#2)
iHPlg##5##1##(1993-8#5)
iHPlm##2##1##(1993-8#2)
iNOS and##3##2##(1996-12#1)(2008-9#1)(2011-2#1)
iNOS expression##5##2##(1996-12#3)(2008-7#1)(2008-9#1)
iNOS gene expression##3##3##(2011-2#3)
iNOS gene##4##2##(2011-2#4)
iNOS##18##1##(1996-12#5)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2011-1#1)(2011-2#5)
iR drop##2##2##(2008-10#2)
iView-GT##3##1##(2009-11#3)
iaaM##4##1##(2008-10#4)
iatrogenic foreign body in the airway##2##6##(2008-12#2)
iatrogenic##21##1##(1990-3#1)(1990-9#1)(1991-6#1)(1993-1#1)(1995-11#2)(1995-8#1)(2008-10#1)(2008-12#3)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
ibandronic acid##4##2##(2011-2#4)
ibo##3##1##(1991-9#3)
ibogaine-induced##2##1##(1997-2#2)
ibotenic acid lesions of##2##4##(1993-6#1)(1994-3#1)
ibotenic acid lesions##3##3##(1993-6#2)(1994-3#1)
ibotenic acid nucleus##2##3##(1991-9#1)(1993-6#1)
ibotenic acid##9##2##(1990-5#2)(1991-9#1)(1993-3#1)(1993-6#4)(1994-3#1)
ibotenic##10##1##(1990-5#2)(1991-9#2)(1993-3#1)(1993-6#4)(1994-3#1)
ibuprofen and chlorzoxazone in formulations##2##5##(2008-10#2)
ibuprofen and chlorzoxazone##3##3##(2008-10#3)
ibuprofen and##5##2##(1995-11#1)(2008-10#3)(2012-12#1)
ibuprofen in##8##2##(1997-3#1)(2008-10#7)
ibuprofen##29##1##(1991-3#2)(1994-8#1)(1995-11#1)(1997-3#1)(1997-5#1)(2008-10#17)(2008-11#3)(2011-2#2)(2012-12#1)
icEEG data##3##2##(2013-8#3)
ice core samples##2##3##(2008-10#2)
ice core##3##2##(2008-10#3)
ice cream##5##2##(2011-2#5)
ice crystal##4##2##(2008-3#4)
ice crystals##2##2##(2008-3#2)
ice nucleation activity##2##3##(2008-10#2)
ice nucleation and antifreeze activities##2##5##(2008-10#2)
ice nucleation##5##2##(2008-10#5)
ice spheroids with##2##3##(2008-3#2)
ice##41##1##(1992-1#1)(1993-6#1)(2008-10#13)(2008-11#1)(2008-3#18)(2008-8#1)(2008-9#1)(2011-2#5)
ice-like water##7##2##(2008-5#7)
ice-like##8##1##(2008-5#8)
ice-nucleation##2##1##(2008-10#2)
iceberg##3##1##(1994-2#1)(2008-10#1)(2008-5#1)
icepick-like##2##1##(1992-2#2)
ichthyosiform##2##1##(2010-6#2)
iconic gestures##2##2##(2010-5#2)
iconic##4##1##(2010-5#4)
icosahedral##5##1##(2008-10#1)(2008-8#4)
ictal##2##1##(2009-9#1)(2010-8#1)
ictus##2##1##(2008-7#1)(2012-3#1)
idea about the##2##3##(2008-1#1)(2008-10#1)
idea about##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
idea and##2##2##(2012-3#1)(2013-8#1)
idea is that##2##3##(2011-2#1)(2013-8#1)
idea is to##3##3##(1997-2#1)(2009-8#1)(2010-5#1)
idea is##7##2##(1995-6#1)(1997-2#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
idea of a##5##3##(1994-12#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
idea of the##2##3##(2008-10#1)(2008-8#1)
idea of##21##2##(1992-11#1)(1994-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#2)
idea that##33##2##(1990-10#1)(1990-11#1)(1992-3#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#2)
idea was##2##2##(2008-10#2)
idea##83##1##(1990-10#1)(1990-11#1)(1991-2#1)(1992-11#1)(1992-3#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#14)(2008-11#7)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#5)
ideal and##2##2##(2010-10#1)(2013-1#1)
ideal body weight##2##3##(2008-11#1)(2008-12#1)
ideal conditions##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
ideal data##2##2##(2008-4#2)
ideal extraction##2##2##(2008-10#2)
ideal for##9##2##(1992-3#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-9#1)(2009-5#1)(2012-2#1)
ideal framework for##2##3##(1996-1#1)(2013-1#1)
ideal of##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
ideal target##2##2##(2008-1#1)(2012-2#1)
ideal##95##1##(1991-12#1)(1991-2#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-4#1)(2008-1#2)(2008-10#15)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
ideal&quot##3##1##(2008-8#1)(2009-4#1)(2011-2#1)
ideality##3##1##(1992-4#1)(2008-10#1)(2008-4#1)
idealized##2##1##(2008-3#1)(2008-9#1)
ideally suited for##2##3##(1990-12#1)(2012-3#1)
ideally suited to##3##3##(1990-9#1)(2008-9#1)(2009-10#1)
ideally suited##6##2##(1990-12#1)(1990-8#1)(1990-9#1)(2008-9#1)(2009-10#1)(2012-3#1)
ideally##13##1##(1990-12#1)(1990-8#1)(1990-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
ideals##2##1##(2009-12#1)(2010-7#1)
ideas and##8##2##(1992-12#1)(1996-1#1)(2008-11#3)(2008-12#1)(2008-3#1)(2012-2#1)
ideas behind##2##2##(2008-4#1)(2008-6#1)
ideas concerning##2##2##(2008-8#1)(2010-1#1)
ideas have##3##2##(2008-10#1)(2009-8#1)(2010-1#1)
ideas in##2##2##(2008-3#1)(2011-3#1)
ideas of##2##2##(2008-12#2)
ideas on the##2##3##(1993-6#1)(2009-10#1)
ideas on##4##2##(1993-6#1)(1995-2#1)(2008-11#1)(2009-10#1)
ideas that##2##2##(2008-11#1)(2008-12#1)
ideas to##2##2##(1997-2#1)(2008-10#1)
ideas##59##1##(1990-11#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#9)(2008-12#5)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-10#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-5#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#3)
ideation##8##1##(1992-1#2)(2008-11#2)(2008-4#1)(2010-6#3)
identical aggregates##2##2##(2008-3#2)
identical amino acid##2##3##(2008-4#1)(2010-11#1)
identical and##7##2##(1995-6#1)(1995-9#2)(1996-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
identical at the##3##3##(1993-6#2)(1994-11#1)
identical at##6##2##(1993-6#2)(1994-11#1)(2008-10#1)(2008-11#2)
identical conditions##5##2##(1990-5#1)(1993-8#1)(2008-10#2)(2010-7#1)
identical except for##2##3##(1990-8#1)(2008-11#1)
identical for##5##2##(2008-10#5)
identical haplotypes##2##2##(2008-10#2)
identical in both cases##2##4##(1990-5#1)(2008-7#1)
identical in both##3##3##(1990-3#1)(1990-5#1)(2008-7#1)
identical in sequence##2##3##(1994-11#1)(2008-10#1)
identical in these##2##3##(2008-11#1)(2010-12#1)
identical in##11##2##(1990-3#1)(1990-5#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
identical nucleotide##2##2##(1993-6#1)(2008-10#1)
identical or similar to##3##4##(1996-12#2)(1996-6#1)
identical or##6##2##(1996-12#2)(1996-6#1)(2008-10#3)
identical overall##2##2##(2008-11#1)(2008-5#1)
identical sequences and##2##3##(1993-8#1)(2008-10#1)
identical to a##2##3##(1991-5#1)(1996-8#1)
identical to that in##3##4##(1991-11#1)(2008-10#2)
identical to that observed##2##4##(1997-3#1)(2008-10#1)
identical to that of a##2##5##(1996-12#1)(2008-10#1)
identical to that of the##6##5##(1990-5#2)(1990-8#1)(1994-12#1)(1997-2#1)(1997-8#1)
identical to that of##15##4##(1990-5#3)(1990-8#1)(1992-8#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-8#1)
identical to that##24##3##(1990-5#3)(1990-8#1)(1991-11#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-8#1)
identical to the previously##2##4##(1992-10#1)(2008-10#1)
identical to the sequence##2##4##(1993-6#1)(2008-12#1)
identical to the##31##3##(1990-2#1)(1991-6#2)(1992-10#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#2)(1995-9#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2012-2#3)
identical to those in##3##4##(1990-8#1)(1992-11#1)(2008-9#1)
identical to those obtained##3##4##(1992-3#1)(2008-10#2)
identical to those of##6##4##(1993-1#1)(1995-6#1)(2008-10#3)(2008-7#1)
identical to those##23##3##(1990-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#9)(2008-7#2)(2008-9#1)(2010-7#1)
identical to##108##2##(1990-2#1)(1990-5#4)(1990-8#3)(1991-11#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-9#4)(1996-12#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#3)(1997-9#1)(2007-12#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#2)(2010-7#1)(2012-2#3)
identical with those of##2##4##(1997-7#1)(2008-10#1)
identical with those##3##3##(1997-7#1)(2008-10#2)
identical with##9##2##(1990-5#1)(1992-6#1)(1997-7#1)(2008-10#5)(2013-1#1)
identical##292##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#9)(1990-8#5)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-12#5)(1993-2#2)(1993-6#8)(1993-8#5)(1993-9#2)(1994-11#5)(1994-12#3)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#6)(1995-8#2)(1995-9#6)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#3)(1997-7#3)(1997-8#4)(1997-9#4)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#99)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#7)(2008-8#5)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#3)(2011-1#2)(2011-2#8)(2012-2#5)(2012-3#1)(2013-1#4)
identical) and##2##2##(1995-6#2)
identical)##4##1##(1991-7#1)(1993-9#1)(1995-6#2)
identically##6##1##(1990-2#1)(1993-8#1)(1995-9#1)(1997-2#1)(2008-10#2)
identifiability and##2##2##(1995-9#1)(2008-11#1)
identifiable disabilities##2##2##(1995-1#2)
identifiable using##2##2##(2008-3#1)(2010-6#1)
identifiable##21##1##(1990-8#1)(1991-12#1)(1993-12#1)(1994-2#1)(1995-1#3)(1995-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-6#1)(2011-2#2)
identification and analysis of##2##4##(2008-9#1)(2009-10#1)
identification and characterization of##4##4##(1997-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
identification and classification of##2##4##(2008-10#1)(2008-9#1)
identification and classification##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
identification and detection##2##3##(2008-10#1)(2008-9#1)
identification and determination of##3##4##(2008-10#2)(2009-8#1)
identification and differentiation of phytoplasmas##2##5##(2008-10#2)
identification and differentiation of##3##4##(2008-10#3)
identification and enumeration of##4##4##(2008-10#1)(2008-9#3)
identification and follow-up##2##3##(1996-3#2)
identification and isolation of##2##4##(1995-12#1)(2008-8#1)
identification and management of##2##4##(1991-3#1)(2008-10#1)
identification and management##3##3##(1991-3#1)(2008-10#1)(2009-4#1)
identification and quantification of##6##4##(2008-10#4)(2008-9#1)(2013-8#1)
identification and quantification##8##3##(2008-10#5)(2008-9#1)(2010-7#1)(2013-8#1)
identification and quantitation of##2##4##(2008-10#2)
identification and quantitation##3##3##(2008-10#3)
identification and quantitative analysis of##2##5##(2008-10#2)
identification and quantitative determination##3##4##(2008-5#3)
identification and quantitative##6##3##(2008-10#2)(2008-5#4)
identification and##97##2##(1990-5#1)(1991-2#1)(1991-3#2)(1991-6#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#10)(2009-10#2)(2009-11#2)(2009-4#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#4)(2013-1#3)(2013-8#4)
identification are##2##2##(1994-9#1)(2008-10#1)
identification assay##2##2##(2008-10#1)(2008-7#1)
identification by the##2##3##(2008-12#1)(2010-5#1)
identification by##8##2##(1991-12#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-5#1)
identification for the##2##3##(2008-10#1)(2008-11#1)
identification for##3##2##(2008-10#2)(2008-11#1)
identification has##2##2##(2008-10#1)(2013-1#1)
identification have##2##2##(1993-12#1)(2008-10#1)
identification in##9##2##(2008-10#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)
identification is##4##2##(2008-12#2)(2008-9#1)(2011-2#1)
identification may##2##2##(2008-10#1)(2008-12#1)
identification of QTL##2##3##(2008-10#1)(2012-3#1)
identification of a mutation##2##4##(1997-7#1)(2013-1#1)
identification of a new##2##4##(2008-10#1)(2012-3#1)
identification of a novel##3##4##(2008-10#1)(2009-6#1)(2012-2#1)
identification of a unique##2##4##(1995-11#1)(2008-10#1)
identification of a##30##3##(1991-11#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-2#1)(1995-11#1)(1997-7#2)(2008-10#6)(2008-11#1)(2009-12#1)(2009-6#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
identification of all##4##3##(1993-12#1)(2008-9#1)(2011-3#1)(2012-2#1)
identification of an##4##3##(2008-10#3)(2012-2#1)
identification of children##2##3##(1990-12#1)(2008-11#1)
identification of critical##2##3##(1997-7#1)(2009-10#1)
identification of different##2##3##(1993-1#1)(1997-2#1)
identification of each##2##3##(2008-10#1)(2008-5#1)
identification of female##2##3##(2008-12#1)(2011-2#1)
identification of functional##2##3##(1990-5#1)(1992-12#1)
identification of gene##2##3##(2011-2#2)
identification of genes##3##3##(2008-10#1)(2011-2#2)
identification of genetic##2##3##(2011-3#1)(2012-2#1)
identification of major##2##3##(1995-2#1)(2013-8#1)
identification of new##5##3##(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
identification of nitrogen compounds in crude oil##2##7##(2008-10#2)
identification of patients at risk##3##5##(1992-12#1)(2008-8#1)(2012-2#1)
identification of patients at##5##4##(1992-12#2)(2007-11#1)(2008-8#1)(2012-2#1)
identification of patients##8##3##(1990-3#1)(1992-12#2)(2007-11#1)(2008-6#1)(2008-8#1)(2010-10#1)(2012-2#1)
identification of potential##4##3##(1991-12#1)(2008-10#1)(2010-12#1)(2010-5#1)
identification of some##2##3##(2008-10#2)
identification of species##2##3##(2008-10#2)
identification of specific##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
identification of the causal##2##4##(2008-10#2)
identification of the characteristic##2##4##(2008-10#1)(2011-2#1)
identification of the##51##3##(1990-12#1)(1990-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(2008-10#20)(2008-11#4)(2008-5#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
identification of their##2##3##(2008-2#1)(2009-10#1)
identification of these##4##3##(1993-12#1)(1993-6#1)(2008-10#1)(2009-6#1)
identification of this##4##3##(1996-12#1)(2009-10#1)(2010-12#1)(2012-12#1)
identification of three##3##3##(1995-2#1)(2008-11#1)(2009-4#1)
identification of two##10##3##(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(2008-10#3)(2008-11#2)(2011-2#1)
identification of##351##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#3)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-3#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#4)(1997-7#3)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#113)(2008-11#19)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#11)(2009-10#4)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#5)(2009-8#3)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#5)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-9#3)(2011-1#1)(2011-2#20)(2011-3#4)(2012-12#2)(2012-2#16)(2012-3#11)(2013-1#10)(2013-8#5)
identification tasks##2##2##(2010-7#1)(2013-8#1)
identification tests in##2##3##(2008-9#2)
identification to##2##2##(2008-5#1)(2010-8#1)
identification using the##2##3##(1993-2#1)(2008-12#1)
identification using##4##2##(1993-2#1)(2008-11#2)(2008-12#1)
identification was##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
identification##573##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-6#3)(1991-9#1)(1992-12#4)(1992-3#2)(1992-9#2)(1993-1#2)(1993-12#8)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#3)(1997-1#3)(1997-2#5)(1997-3#1)(1997-7#5)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#189)(2008-11#30)(2008-12#23)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#17)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#32)(2009-10#7)(2009-11#3)(2009-12#2)(2009-4#3)(2009-5#2)(2009-6#7)(2009-8#5)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#27)(2011-3#6)(2012-12#2)(2012-2#16)(2012-3#13)(2013-1#14)(2013-8#12)
identifications were made##2##3##(1995-11#1)(2008-10#1)
identifications were##3##2##(1995-11#1)(2008-10#2)
identifications##5##1##(1995-11#1)(2008-10#2)(2008-4#1)(2010-4#1)
identified 12##2##2##(2011-2#1)(2012-3#1)
identified 24##2##2##(2008-10#1)(2010-12#1)
identified 33##2##2##(2009-10#1)(2013-1#1)
identified 45##2##2##(2008-10#1)(2012-2#1)
identified a gene##2##3##(1995-9#1)(2008-2#1)
identified a new##2##3##(1996-12#1)(1997-7#1)
identified a number of##3##4##(2008-11#1)(2008-9#1)(2009-7#1)
identified a region##2##3##(1993-8#1)(2008-11#1)
identified a single##3##3##(1995-6#1)(2008-10#2)
identified a##47##2##(1990-5#1)(1992-3#1)(1993-12#2)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#1)(1997-7#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
identified across##2##2##(2008-10#1)(2009-9#1)
identified all##4##2##(1993-2#1)(1996-12#1)(2008-10#1)(2012-12#1)
identified among##16##2##(2008-10#13)(2012-2#1)(2013-8#2)
identified an##5##2##(1991-5#1)(1992-6#1)(1995-2#1)(1996-2#1)(2008-10#1)
identified and assessed##2##3##(1994-1#1)(2008-10#1)
identified and characterized##6##3##(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-7#1)
identified and cloned##2##3##(1993-6#1)(2008-9#1)
identified and described by##2##4##(1993-11#1)(1993-6#1)
identified and designated##2##3##(2008-10#1)(2008-9#1)
identified and isolated##2##3##(1995-12#1)(1995-2#1)
identified and provided##2##3##(1996-1#1)(2012-3#1)
identified and quantified##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
identified and their##2##3##(2008-10#1)(2010-11#1)
identified and##60##2##(1990-8#1)(1992-2#2)(1993-11#1)(1993-6#2)(1994-1#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#2)(1996-1#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#17)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
identified are##2##2##(1990-12#1)(2008-10#1)
identified as Alternaria##2##3##(2008-10#2)
identified as Bacillus##2##3##(2008-10#1)(2013-1#1)
identified as C##6##3##(2008-10#3)(2008-5#1)(2010-3#2)
identified as Pseudomonas##3##3##(2008-10#2)(2012-2#1)
identified as R##2##3##(1995-12#1)(2008-10#1)
identified as a major##2##4##(1991-2#1)(2008-11#1)
identified as a potential##2##4##(1995-6#1)(2008-11#1)
identified as a##40##3##(1990-12#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
identified as actin##2##3##(1993-3#2)
identified as an important##2##4##(2008-10#1)(2012-2#1)
identified as an##6##3##(1991-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
identified as being##2##3##(1993-6#1)(2008-11#1)
identified as belonging to the##2##5##(2008-10#2)
identified as having##2##3##(2008-9#1)(2012-12#1)
identified as important in##3##4##(1996-3#1)(2008-11#1)(2012-3#1)
identified as important##4##3##(1996-3#1)(2008-11#1)(2010-10#1)(2012-3#1)
identified as key##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
identified as one##2##3##(2008-10#2)
identified as potential##3##3##(2008-10#2)(2009-6#1)
identified as the major##2##4##(1994-1#1)(1994-11#1)
identified as the##22##3##(1991-5#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-3#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)
identified as##221##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#84)(2008-11#17)(2008-12#2)(2008-3#4)(2008-5#9)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)(2013-8#5)
identified at least nine##2##4##(2008-10#1)(2011-1#1)
identified at the molecular level##2##5##(2008-9#2)
identified at the##4##3##(1992-12#1)(2008-9#2)(2011-2#1)
identified at##10##2##(1992-12#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-1#1)(2010-4#1)(2011-1#1)(2011-2#1)
identified barriers##3##2##(2008-11#3)
identified based on##3##3##(1997-6#1)(2008-10#1)(2008-12#1)
identified based##5##2##(1997-6#1)(2008-10#3)(2008-12#1)
identified between##5##2##(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
identified binding##2##2##(1990-11#1)(1993-3#1)
identified by AFLP##2##3##(2008-10#2)
identified by GC-MS##3##3##(1991-5#1)(2008-10#2)
identified by a##4##3##(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
identified by an##2##3##(2008-11#1)(2010-8#1)
identified by its##3##3##(1992-2#1)(2008-10#1)(2008-5#1)
identified by microarray##2##3##(2008-10#1)(2013-8#1)
identified by restriction##2##3##(2008-10#2)
identified by the##18##3##(1992-1#1)(1992-2#1)(1995-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
identified by their##5##3##(1996-12#1)(2008-10#2)(2008-11#2)
identified by using##4##3##(2008-10#1)(2008-12#2)(2013-8#1)
identified by##121##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2008-10#41)(2008-11#8)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-8#6)
identified cells from the median domain in the##2##8##(2007-12#2)
identified cells##3##2##(2007-12#3)
identified chronic##2##2##(2010-10#1)(2010-3#1)
identified compounds##2##2##(2008-10#2)
identified either##2##2##(1993-9#1)(2008-10#1)
identified explicitly##2##2##(1996-2#1)(2011-2#1)
identified five##4##2##(1993-12#1)(2008-10#1)(2010-11#1)(2011-1#1)
identified for the##4##3##(2008-10#1)(2008-12#1)(2009-12#1)(2013-1#1)
identified for##19##2##(1991-12#1)(1991-9#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-3#2)(2013-1#2)
identified four##8##2##(1992-1#1)(1994-11#1)(2008-1#1)(2008-10#2)(2010-3#1)(2012-3#2)
identified from the##12##3##(1993-3#1)(1995-12#1)(1996-12#1)(2008-10#7)(2008-11#1)(2013-8#1)
identified from##34##2##(1990-5#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-10#16)(2008-11#3)(2008-9#4)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#3)(2013-8#1)
identified gene##5##2##(1993-6#1)(1995-12#1)(2008-10#2)(2008-7#1)
identified genes##6##2##(1996-3#1)(1997-8#1)(2008-10#2)(2011-2#1)(2012-3#1)
identified here##2##2##(1995-12#1)(1995-2#1)
identified in 2##2##3##(2008-10#1)(2008-11#1)
identified in a patient##3##4##(1995-6#1)(2012-3#2)
identified in a##14##3##(1993-8#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2012-3#2)
identified in an##3##3##(2008-10#2)(2008-9#1)
identified in humans##2##3##(1994-8#1)(2010-7#1)
identified in many##2##3##(1996-2#1)(2008-11#1)
identified in other##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
identified in the 5'-flanking region##2##5##(1991-6#1)(1991-7#1)
identified in the proximal##2##4##(1991-5#1)(1991-7#1)
identified in the##40##3##(1991-5#1)(1991-6#1)(1991-7#3)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#1)(2009-10#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
identified in this study may##2##5##(2008-10#1)(2010-12#1)
identified in this study##6##4##(2008-10#4)(2008-8#1)(2010-12#1)
identified in this##8##3##(1997-7#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-12#1)
identified in##143##2##(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#3)(1992-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-6#3)(1995-8#1)(1996-2#4)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#3)(2008-10#61)(2008-11#7)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#4)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#2)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#2)
identified iron##2##2##(2008-5#1)(2011-2#1)
identified key##3##2##(2008-9#1)(2009-11#1)(2013-1#1)
identified more##2##2##(2008-5#1)(2012-2#1)
identified morphologically##2##2##(2008-10#1)(2008-4#1)
identified novel##2##2##(2011-1#1)(2011-2#1)
identified on chromosomes 1##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
identified on chromosomes##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
identified on the##2##3##(2007-12#1)(2008-10#1)
identified on##16##2##(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-8#1)(2008-9#2)(2009-3#1)(2012-12#1)
identified only in##2##3##(2008-10#1)(2010-11#1)
identified only##4##2##(1997-2#1)(2008-10#1)(2010-11#1)(2012-3#1)
identified polymorphisms between##2##3##(2008-10#2)
identified potential##2##2##(2008-10#1)(2011-2#1)
identified previously in the##2##4##(1993-9#1)(2008-10#1)
identified proteins##2##2##(2008-10#1)(2010-12#1)
identified regions of##2##3##(1995-2#1)(2009-9#1)
identified several##5##2##(2008-10#2)(2012-3#1)(2013-1#2)
identified significant##2##2##(1995-1#1)(1997-3#1)
identified six##4##2##(1992-3#1)(1993-2#1)(2011-2#1)(2012-2#1)
identified so far##2##3##(2008-10#1)(2009-8#1)
identified some##2##2##(2008-7#1)(2011-2#1)
identified specific##2##2##(2008-10#1)(2011-2#1)
identified that##18##2##(2008-10#8)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)
identified the causal##2##3##(2008-10#2)
identified the need for a##2##5##(2008-10#1)(2008-11#1)
identified the need##3##3##(2008-10#1)(2008-11#2)
identified the##49##2##(1990-11#1)(1990-7#1)(1991-6#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-9#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
identified them as##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
identified themselves as##2##3##(1993-3#1)(2010-2#1)
identified three##3##2##(1991-5#1)(1995-12#1)(2012-12#1)
identified through the##2##3##(1995-12#1)(1996-3#1)
identified through##14##2##(1992-1#1)(1995-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#2)(2013-1#1)
identified thus far in##2##4##(2008-10#2)
identified to be##5##3##(1993-8#2)(2008-11#1)(2008-12#1)(2008-9#1)
identified to date##2##3##(1992-3#1)(1995-8#1)
identified to have##2##3##(1991-12#1)(2013-8#1)
identified to##22##2##(1991-12#1)(1992-3#1)(1993-8#2)(1995-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-6#1)(2008-9#3)(2010-1#1)(2010-11#1)(2013-1#1)(2013-8#1)
identified transcription factors##2##3##(2012-3#2)
identified two##9##2##(1990-11#1)(1992-6#1)(1993-12#1)(1994-3#1)(1997-3#1)(2008-10#3)(2012-3#1)
identified using##19##2##(1993-12#1)(1995-2#1)(2008-10#10)(2008-11#2)(2008-9#2)(2010-8#1)(2011-2#1)(2012-3#1)
identified was##2##2##(1991-12#1)(2008-10#1)
identified were##9##2##(2008-10#4)(2008-11#3)(2009-4#1)(2011-2#1)
identified which##6##2##(1991-9#1)(1994-11#1)(1995-2#1)(2008-11#2)(2008-7#1)
identified who##2##2##(2008-12#1)(2008-9#1)
identified with a##5##3##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
identified with the##3##3##(1997-9#1)(2008-10#2)
identified with##26##2##(1991-11#1)(1992-3#1)(1995-12#1)(1997-2#1)(1997-6#1)(1997-9#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#2)(2011-2#1)(2011-3#1)(2012-3#1)
identified within the##9##3##(1995-8#1)(1996-3#1)(2008-10#4)(2010-6#1)(2012-2#1)(2013-8#1)
identified within##12##2##(1995-8#1)(1996-3#1)(2008-10#6)(2008-11#1)(2010-6#1)(2012-2#1)(2013-8#1)
identified##1471##1##(1990-11#4)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#5)(1990-7#1)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#3)(1991-3#4)(1991-5#10)(1991-6#5)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#7)(1992-12#1)(1992-2#6)(1992-3#7)(1992-6#5)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#9)(1993-2#4)(1993-3#10)(1993-6#13)(1993-8#9)(1993-9#4)(1994-1#2)(1994-11#10)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#2)(1995-1#4)(1995-11#4)(1995-12#19)(1995-2#20)(1995-5#1)(1995-6#10)(1995-8#11)(1995-9#5)(1996-1#5)(1996-11#2)(1996-12#16)(1996-2#11)(1996-3#8)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#9)(1997-7#9)(1997-8#7)(1997-9#2)(2006-5#1)(2007-12#13)(2008-1#5)(2008-10#486)(2008-11#89)(2008-12#29)(2008-2#6)(2008-3#8)(2008-4#5)(2008-5#18)(2008-6#7)(2008-7#29)(2008-8#19)(2008-9#41)(2009-1#2)(2009-10#15)(2009-11#2)(2009-12#3)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#9)(2009-7#3)(2009-8#14)(2009-9#3)(2010-1#3)(2010-10#9)(2010-11#7)(2010-12#10)(2010-2#1)(2010-3#7)(2010-4#7)(2010-5#9)(2010-6#1)(2010-7#7)(2010-8#7)(2010-9#1)(2011-1#12)(2011-2#59)(2011-3#4)(2012-12#15)(2012-2#29)(2012-3#43)(2012-5#2)(2013-1#39)(2013-7#3)(2013-8#26)
identifiers##2##1##(1995-12#1)(2008-10#1)
identifies a##5##2##(1992-3#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
identifies many##2##2##(1996-1#1)(2012-3#1)
identifies the##9##2##(1994-1#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-10#1)(2010-2#1)(2012-2#1)
identifies##37##1##(1990-12#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#3)(2012-3#2)
identify a##19##2##(1990-11#1)(1990-12#1)(1991-12#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
identify all##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
identify an##2##2##(1997-8#1)(2013-8#1)
identify and characterize the##2##4##(2008-10#1)(2008-12#1)
identify and differentiate##3##3##(2008-10#3)
identify and##43##2##(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1997-1#2)(1997-2#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
identify any##4##2##(1995-1#1)(2008-9#1)(2011-1#1)(2012-4#1)
identify apoptotic##3##2##(2008-7#2)(2008-9#1)
identify areas for practice change##2##5##(2008-11#2)
identify areas##4##2##(2008-11#3)(2013-8#1)
identify at-risk##2##2##(1997-1#1)(2008-11#1)
identify barriers to##2##3##(1997-1#1)(2013-1#1)
identify candidate##3##2##(2008-10#2)(2008-11#1)
identify cells##3##2##(2008-4#1)(2008-9#2)
identify combinations##2##2##(2009-12#1)(2012-3#1)
identify conserved##2##2##(1995-2#1)(2008-4#1)
identify different##2##2##(2008-10#1)(2009-10#1)
identify differentially expressed##3##3##(2008-2#1)(2008-8#1)(2010-12#1)
identify environmental##2##2##(1991-1#1)(2008-8#1)
identify factors that##6##3##(1994-12#1)(2008-9#1)(2013-1#2)(2013-8#2)
identify factors##13##2##(1994-12#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-11#1)(2013-1#3)(2013-8#4)
identify functional##2##2##(2009-10#1)(2009-8#1)
identify genes involved in##2##4##(2008-9#1)(2010-1#1)
identify genes##12##2##(1992-9#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-3#2)
identify health##3##2##(1996-1#2)(2008-11#1)
identify important##3##2##(1992-3#1)(2008-1#1)(2008-11#1)
identify incident##2##2##(1997-3#2)
identify key##3##2##(1994-1#1)(2008-11#1)(2013-8#1)
identify novel##4##2##(2008-10#1)(2010-11#1)(2010-6#1)(2012-3#1)
identify opportunities for##2##3##(1995-12#1)(2008-11#1)
identify patients at##2##3##(2008-7#1)(2012-2#1)
identify patients who##2##3##(2009-4#1)(2010-5#1)
identify patients##11##2##(1992-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
identify possible##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
identify potential##13##2##(1990-8#1)(1993-2#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-3#2)
identify rodent and human cell##2##5##(1997-7#1)(2008-11#1)
identify six##2##2##(2008-10#1)(2012-2#1)
identify some of the##2##4##(1991-1#1)(2013-8#1)
identify some##6##2##(1991-1#1)(1991-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
identify specific##8##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#2)
identify strategies to##2##3##(2008-11#1)(2012-3#1)
identify strategies##3##2##(1993-2#1)(2008-11#1)(2012-3#1)
identify the best##3##3##(1993-12#1)(1995-2#1)(2008-8#1)
identify the exact##2##3##(1995-2#1)(2008-7#1)
identify the functional##2##3##(1996-2#1)(2009-5#1)
identify the key##2##3##(2008-11#1)(2013-8#1)
identify the most important##2##4##(2008-10#2)
identify the most##4##3##(1995-12#1)(2008-10#2)(2011-2#1)
identify the presence of##2##4##(2008-9#1)(2009-9#1)
identify the specific##2##3##(2008-11#1)(2008-8#1)
identify the##140##2##(1990-11#1)(1990-2#2)(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2008-1#2)(2008-10#31)(2008-11#11)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#5)(2009-1#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#9)(2013-1#8)(2013-8#3)
identify their##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
identify these##5##2##(1990-6#1)(1991-6#1)(1992-12#1)(2009-10#1)(2009-8#1)
identify two##4##2##(2008-10#2)(2008-9#1)(2013-8#1)
identify unknown##4##2##(2008-10#2)(2009-9#1)(2012-3#1)
identify which##6##2##(1992-6#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-10#1)
identify##658##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-6#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#6)(1993-2#4)(1993-3#4)(1993-8#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#5)(1995-5#1)(1995-6#5)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#3)(1997-1#5)(1997-2#2)(1997-3#4)(1997-7#2)(1997-8#2)(2007-12#3)(2008-1#3)(2008-10#131)(2008-11#60)(2008-12#18)(2008-2#3)(2008-3#7)(2008-4#12)(2008-5#4)(2008-6#4)(2008-7#15)(2008-8#13)(2008-9#29)(2009-1#2)(2009-10#10)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-8#3)(2009-9#2)(2010-1#4)(2010-10#7)(2010-11#11)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#5)(2011-2#28)(2011-3#6)(2011-8#1)(2012-12#14)(2012-2#17)(2012-3#38)(2012-4#2)(2012-8#1)(2013-1#35)(2013-8#25)
identifying a##5##2##(1995-12#1)(2008-11#2)(2011-2#1)(2012-2#1)
identifying and##6##2##(1995-2#1)(2008-10#2)(2008-7#1)(2012-2#1)(2012-3#1)
identifying genes##2##2##(2008-7#1)(2010-5#1)
identifying novel##5##2##(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#2)
identifying plant##3##2##(2008-11#3)
identifying potential##5##2##(2008-10#1)(2008-7#3)(2013-7#1)
identifying potentially##2##2##(2008-5#1)(2012-2#1)
identifying proteins##2##2##(1993-8#1)(2012-3#1)
identifying that##2##2##(2008-10#1)(2010-2#1)
identifying the purpose of##2##4##(1995-12#1)(2008-11#1)
identifying the##31##2##(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(2008-10#7)(2008-11#4)(2008-3#1)(2008-8#1)(2008-9#4)(2009-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
identifying their##2##2##(2008-11#1)(2012-12#1)
identifying these##2##2##(2008-12#1)(2011-2#1)
identifying those##6##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#2)
identifying##167##1##(1991-12#1)(1991-3#1)(1992-1#2)(1992-3#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#6)(1997-7#1)(2008-10#27)(2008-11#18)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#9)(2009-1#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#5)
identities among##2##2##(1990-7#1)(2008-10#1)
identities and the##2##3##(2008-10#1)(2008-9#1)
identities and##9##2##(2008-10#6)(2008-8#1)(2008-9#2)
identities between the##2##3##(2008-10#2)
identities in##3##2##(2008-11#1)(2008-8#2)
identities of the##3##3##(2008-10#3)
identities of##8##2##(2008-10#6)(2008-8#1)(2011-2#1)
identities to##3##2##(1997-3#1)(2008-10#1)(2013-8#1)
identities with##3##2##(2008-10#2)(2008-8#1)
identities##44##1##(1990-7#1)(1997-3#1)(1997-5#1)(2008-10#30)(2008-11#1)(2008-8#5)(2008-9#2)(2009-12#1)(2011-2#1)(2013-8#1)
identity among##4##2##(1993-2#1)(2008-10#3)
identity and the##2##3##(1991-2#1)(2008-7#1)
identity and##22##2##(1991-2#1)(1992-3#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-10#1)(2012-2#2)
identity as a##2##3##(1995-1#1)(2009-7#1)
identity as##3##2##(1995-1#1)(2008-10#1)(2009-7#1)
identity between isolates of##2##4##(2008-10#2)
identity between the##3##3##(1991-5#1)(2008-10#2)
identity between##10##2##(1991-5#1)(2008-10#7)(2008-5#1)(2012-3#1)
identity cards##2##2##(2008-10#2)
identity development##4##2##(2008-12#1)(2009-7#3)
identity in the##4##3##(1991-10#1)(1993-6#1)(2008-10#2)
identity in##10##2##(1991-10#1)(1993-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)
identity is##2##2##(1993-3#1)(1994-12#1)
identity of a##5##3##(1990-8#1)(1993-8#1)(1996-5#1)(2008-10#2)
identity of the##16##3##(1990-5#1)(1992-9#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-8#1)
identity of##37##2##(1990-5#1)(1990-8#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-5#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-8#1)
identity on##2##2##(1993-2#1)(2008-12#1)
identity or##3##2##(1996-3#1)(2008-10#1)(2010-8#1)
identity over the entire##2##4##(1992-3#1)(1996-6#1)
identity should be##2##3##(2008-11#1)(2008-8#1)
identity to the##9##3##(1993-12#2)(1993-6#1)(1996-12#1)(1996-6#1)(2008-10#4)
identity to##20##2##(1993-12#2)(1993-2#1)(1993-6#1)(1996-12#3)(1996-3#1)(1996-6#2)(1997-3#1)(1997-7#1)(2008-10#8)
identity was##5##2##(2008-10#1)(2009-7#1)(2010-7#2)(2013-8#1)
identity were##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
identity with a##2##3##(1995-9#1)(1996-2#1)
identity with each other##3##4##(1991-10#1)(1995-8#1)(2008-5#1)
identity with the Streptococcus##2##4##(2009-6#2)
identity with the##14##3##(1993-2#1)(1993-3#1)(1994-11#1)(1995-11#2)(1995-6#2)(2008-10#4)(2009-6#2)(2009-8#1)
identity with##43##2##(1991-10#1)(1993-2#1)(1993-3#1)(1994-11#2)(1995-11#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#19)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#2)(2009-8#1)(2010-5#2)(2013-8#1)
identity##244##1##(1990-5#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-9#1)(1993-12#3)(1993-2#5)(1993-3#5)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#95)(2008-11#8)(2008-12#7)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#3)(2009-7#9)(2009-8#4)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2011-2#3)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#4)
identity) and##3##2##(1993-12#1)(1994-12#1)(1997-9#1)
identity) with##2##2##(1996-3#1)(2008-10#1)
identity)##13##1##(1990-7#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-6#1)(1996-3#2)(1997-9#1)(2008-10#2)(2010-7#1)
ideological##3##1##(1993-12#1)(2008-11#1)(2010-1#1)
idiogram##2##1##(2008-9#2)
idiomorph##2##1##(2008-10#2)
idiopathic Parkinson's disease (PD)##2##4##(2008-7#2)
idiopathic Parkinson's disease##3##3##(2008-7#3)
idiopathic arthritis##3##2##(2011-2#1)(2012-3#2)
idiopathic central DI and##2##4##(1997-8#2)
idiopathic central DI##3##3##(1997-8#3)
idiopathic central##4##2##(1997-8#4)
idiopathic granulomatous##2##2##(1997-8#1)(2008-7#1)
idiopathic hypercalciuria in##2##3##(1991-11#1)(2008-10#1)
idiopathic hypercalciuria##4##2##(1991-11#1)(2008-10#3)
idiopathic pulmonary arterial hypertension (PAH)##2##5##(2010-10#2)
idiopathic pulmonary arterial hypertension##4##4##(2010-10#4)
idiopathic pulmonary fibrosis##3##3##(1994-3#1)(2009-10#1)(2010-5#1)
idiopathic pulmonary##8##2##(1994-3#1)(2008-11#1)(2009-10#1)(2010-10#4)(2010-5#1)
idiopathic ulcerative colitis##3##3##(1995-10#2)(1997-8#1)
idiopathic##72##1##(1990-9#3)(1991-11#1)(1991-5#3)(1992-2#1)(1993-6#2)(1994-3#1)(1994-9#1)(1995-10#2)(1997-3#1)(1997-8#8)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#12)(2009-10#2)(2009-3#1)(2009-8#1)(2010-10#6)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#3)
idiosyncratic##4##1##(2008-8#3)(2013-8#1)
idiotype##2##1##(1993-6#1)(2008-4#1)
idler beam##2##2##(2008-3#2)
idler output##2##2##(2007-12#1)(2008-3#1)
idler##11##1##(2007-12#3)(2008-2#2)(2008-3#6)
ie##3##1##(1990-12#1)(1997-7#2)
ie-2##4##1##(1997-3#4)
if I##3##2##(2008-4#1)(2008-8#1)(2010-12#1)
if a detectable signal is too##2##6##(2008-9#2)
if a particular##2##3##(2008-4#1)(2009-11#1)
if a##27##2##(1990-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
if all##10##2##(1994-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-11#1)(2011-2#1)
if an##8##2##(1990-9#1)(1991-12#1)(1993-1#1)(1994-2#2)(2008-10#1)(2008-2#1)(2013-8#1)
if and only if##3##4##(2008-6#1)(2008-7#1)(2010-7#1)
if and##4##2##(2008-12#1)(2008-6#1)(2008-7#1)(2010-7#1)
if any##24##2##(1990-11#1)(1990-2#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-12#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-7#1)
if applied to##2##3##(2008-10#2)
if applied##5##2##(1991-3#1)(2008-10#3)(2011-2#1)
if appropriate##2##2##(2008-3#1)(2008-9#1)
if associated with##2##3##(2010-12#1)(2013-1#1)
if at all##4##3##(1993-6#1)(1997-3#1)(2008-3#1)(2008-8#1)
if at least##2##3##(1993-8#1)(2008-11#1)
if at##6##2##(1993-6#1)(1993-8#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-8#1)
if both##2##2##(2008-10#2)
if combination##2##2##(1997-5#1)(2013-1#1)
if combined with##2##3##(2008-1#1)(2008-6#1)
if consumers##2##2##(1997-3#1)(2008-8#1)
if diagnosed in##2##3##(2010-12#1)(2010-8#1)
if diagnosed##3##2##(2010-12#1)(2010-8#1)(2012-3#1)
if dichlorofluorescein##2##2##(2008-10#2)
if different##2##2##(2009-7#1)(2013-8#1)
if ever##3##2##(1997-2#1)(2008-11#1)(2012-12#1)
if feasible##2##2##(2010-12#1)(2011-2#1)
if further##2##2##(2008-10#2)
if high##2##2##(1990-3#1)(2008-8#1)
if it improves##2##3##(2008-4#2)
if it is not##3##4##(1996-12#1)(2008-10#1)(2008-3#1)
if it is to##2##4##(1993-2#1)(2008-10#1)
if it is##14##3##(1990-5#1)(1992-1#1)(1993-2#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
if it persists##2##3##(2013-1#2)
if it was##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
if it##31##2##(1990-5#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-2#2)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#3)
if its##4##2##(1996-12#1)(2008-10#1)(2009-12#1)(2009-7#1)
if left untreated##2##3##(2012-3#2)
if necessary##10##2##(1990-8#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#2)(2011-3#1)(2013-1#1)
if needed##3##2##(1996-3#1)(2008-1#1)(2011-2#1)
if no##7##2##(1990-3#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#2)
if not all##5##3##(1995-6#2)(2008-9#2)(2010-7#1)
if not treated##2##3##(1990-9#1)(2012-3#1)
if not##20##2##(1990-9#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-9#1)(1995-6#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#2)(2009-8#1)(2010-7#1)(2012-3#1)(2013-1#2)
if nuclear##3##2##(1993-6#1)(2008-7#1)(2008-9#1)
if one focuses on##2##4##(2008-8#2)
if one of the##2##4##(2008-11#1)(2008-8#1)
if one##11##2##(1992-9#1)(1995-2#1)(1997-2#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)
if only##3##2##(1991-2#1)(1992-3#1)(1996-5#1)
if para-hydrogen##2##2##(2008-10#2)
if patients are##2##3##(2008-1#1)(2011-2#1)
if patients##5##2##(2008-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
if possible##4##2##(1991-12#1)(1996-11#1)(2008-10#1)(2010-11#1)
if present at##2##3##(2008-10#2)
if present in##2##3##(2008-10#1)(2012-3#1)
if present##5##2##(2008-10#3)(2008-5#1)(2012-3#1)
if required##2##2##(2008-10#2)
if research##2##2##(1997-7#1)(2013-1#1)
if several##2##2##(2008-10#1)(2010-12#1)
if so##11##2##(1990-5#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-10#1)(2011-2#1)(2012-3#2)(2012-7#1)
if some##2##2##(1996-3#1)(2012-2#1)
if such##4##2##(2008-10#3)(2008-8#1)
if supplied##2##2##(2008-11#2)
if the amount of##2##4##(2008-10#2)
if the clinical##2##3##(1996-9#1)(1997-4#1)
if the dispersal##2##3##(2008-8#2)
if the distribution##2##3##(1992-2#1)(2008-10#1)
if the effective recombination rate is##2##6##(2008-8#2)
if the group size is##2##5##(2008-8#2)
if the immigrants##2##3##(2008-8#2)
if the lesion##2##3##(1994-12#1)(2012-2#1)
if the measured##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
if the number of##2##4##(1992-9#1)(2008-10#1)
if the organism is##2##4##(2007-12#1)(2011-2#1)
if the original##2##3##(1997-1#1)(2008-9#1)
if the parasite##2##3##(2008-8#1)(2008-9#1)
if the patient has##2##4##(1997-5#1)(2010-6#1)
if the patient is##4##4##(1994-3#2)(2010-7#1)(2011-2#1)
if the patient##9##3##(1994-3#2)(1996-9#1)(1997-5#1)(2008-10#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#1)
if the sample is##2##4##(2008-10#2)
if the test##2##3##(1996-5#1)(2008-10#1)
if the two##2##3##(2008-10#1)(2008-7#1)
if the water##2##3##(2008-10#2)
if the##216##2##(1990-2#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-5#3)(1992-9#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2007-12#2)(2008-10#51)(2008-11#15)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#25)(2008-9#7)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#14)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#5)
if their serum-cholesterol was high##2##5##(1990-6#2)
if their##7##2##(1990-6#2)(2008-10#1)(2008-2#1)(2008-9#1)(2010-10#1)(2010-8#1)
if there are##6##3##(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#2)
if there is a##4##4##(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
if there is##11##3##(1995-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
if there##19##2##(1994-12#1)(1995-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#1)(2010-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
if these##13##2##(1997-3#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)
if they are to##7##4##(1994-2#2)(1994-9#1)(1996-3#1)(2008-1#1)(2008-12#2)
if they are##17##3##(1991-12#1)(1994-2#2)(1994-9#1)(1996-3#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2012-3#1)
if they do not##3##4##(1992-3#1)(2008-7#1)(2011-3#1)
if they do##4##3##(1992-3#1)(2008-7#2)(2011-3#1)
if they have##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
if they show##2##3##(2008-10#2)
if they were##8##3##(1993-12#1)(1995-12#1)(1996-5#1)(1997-8#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-2#1)
if they##56##2##(1991-12#1)(1992-3#1)(1993-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
if this is not##2##4##(1997-8#1)(2010-3#1)
if this problem##2##3##(1993-12#1)(2012-2#1)
if this##13##2##(1993-12#1)(1994-8#1)(1997-3#1)(1997-8#2)(2008-10#2)(2008-5#1)(2010-3#1)(2012-2#1)(2012-7#1)(2013-1#2)
if those##2##2##(1992-2#1)(2011-2#1)
if used##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
if we are to##2##4##(1992-9#1)(2013-1#1)
if we##6##2##(1992-9#1)(1995-5#1)(1997-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
if you##3##2##(1992-1#2)(2010-12#1)
if##839##1##(1990-11#2)(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#2)(1990-8#1)(1990-9#4)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#7)(1991-6#2)(1991-7#1)(1992-1#3)(1992-12#3)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#3)(1992-9#5)(1993-1#4)(1993-11#1)(1993-12#10)(1993-2#4)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#7)(1994-2#12)(1994-3#7)(1994-5#2)(1994-6#3)(1994-8#7)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#13)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-3#7)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#7)(1997-3#7)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#3)(2007-11#1)(2007-12#2)(2008-1#5)(2008-10#158)(2008-11#60)(2008-12#13)(2008-2#10)(2008-3#16)(2008-4#11)(2008-5#9)(2008-6#8)(2008-7#27)(2008-8#63)(2008-9#30)(2009-1#2)(2009-10#2)(2009-11#4)(2009-12#4)(2009-4#3)(2009-5#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#8)(2010-12#10)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#11)(2010-8#4)(2011-1#3)(2011-2#45)(2011-3#4)(2012-12#7)(2012-2#12)(2012-3#16)(2012-7#2)(2012-9#2)(2013-1#26)(2013-7#4)(2013-8#14)
ifenprodil##4##1##(1996-2#4)
igneous rock##2##2##(2008-10#2)
igneous##3##1##(2008-10#3)
igniarius##2##1##(2008-10#2)
ignition##4##1##(2008-3#2)(2010-9#1)(2013-8#1)
ignorance about the##2##3##(1993-12#1)(2009-10#1)
ignorance of##3##2##(2008-9#1)(2011-2#1)(2011-3#1)
ignorance##7##1##(1993-12#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#2)(2011-3#1)
ignore a##2##2##(2008-8#1)(2011-3#1)
ignore the##8##2##(1990-6#1)(1991-12#1)(1993-2#1)(1994-1#2)(1995-12#1)(2008-10#1)(2008-11#1)
ignore##16##1##(1990-6#1)(1991-12#1)(1993-2#1)(1994-1#2)(1995-12#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-3#2)
ignored in##2##2##(1995-5#1)(2008-8#1)
ignored the##2##2##(2008-8#1)(2008-9#1)
ignored##28##1##(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
ignores##3##1##(2008-3#1)(2013-1#2)
ignoring the##2##2##(1995-12#1)(2008-10#1)
ignoring##5##1##(1995-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-6#1)
ii)##9##1##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2009-9#2)(2012-2#2)
iii)##5##1##(1997-4#1)(2008-11#1)(2009-9#1)(2012-2#2)
ilarviruses affecting stone fruit trees##2##5##(2008-10#2)
ilarviruses##3##1##(2008-10#3)
ileal pouch##4##2##(2009-12#4)
ileal##18##1##(1990-3#2)(1991-9#4)(1992-8#2)(1996-12#1)(2008-10#1)(2009-12#5)(2009-5#1)(2013-1#2)
ileocecal##5##1##(1990-8#1)(1994-5#1)(1994-8#1)(2009-7#1)(2010-12#1)
ileum##19##1##(1990-5#1)(1991-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#6)(2008-5#1)(2010-12#1)(2013-1#1)
ileus in a##2##3##(2008-12#1)(2013-1#1)
ileus##10##1##(1997-8#3)(2008-12#2)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
ilex and Q##2##3##(2008-10#2)
ilex##4##1##(2008-10#2)(2011-10#2)
iliac artery##9##2##(2006-6#1)(2008-12#2)(2008-3#2)(2011-2#3)(2013-1#1)
iliac bone##2##2##(2008-11#1)(2010-3#1)
iliac crest##11##2##(1991-6#1)(2008-7#2)(2009-10#3)(2009-9#2)(2010-3#1)(2010-6#1)(2010-8#1)
iliac screws##2##2##(2008-12#2)
iliac vessels##2##2##(1996-6#2)
iliac##34##1##(1991-11#2)(1991-6#1)(1996-6#2)(1997-3#1)(2006-6#1)(2008-11#1)(2008-12#6)(2008-3#2)(2008-7#2)(2009-10#3)(2009-9#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#5)(2012-3#1)(2013-1#1)
ill infants##2##2##(1994-6#1)(2011-1#1)
ill patient##3##2##(2008-11#1)(2009-8#1)(2012-3#1)
ill patients in##2##3##(1996-9#1)(2013-1#1)
ill patients##19##2##(1991-3#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-9#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#2)
ill##69##1##(1990-11#1)(1990-2#1)(1991-11#1)(1991-3#2)(1991-6#2)(1992-1#2)(1992-2#1)(1992-3#4)(1993-12#1)(1994-12#2)(1994-2#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-8#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#2)
ill-conditioned##2##1##(2008-10#2)
ill-defined##5##1##(1992-6#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)
ill-posed##3##1##(2008-11#2)(2008-2#1)
illegal drugs##2##2##(1996-1#1)(2008-1#1)
illegal##5##1##(1993-1#1)(1996-1#1)(2008-1#1)(2008-10#1)(2013-1#1)
illegally##2##1##(1995-12#1)(2008-10#1)
illicit amphetamines##5##2##(2008-10#5)
illicit drug##7##2##(2008-1#2)(2008-10#3)(2008-12#1)(2012-12#1)
illicit drugs##4##2##(2008-10#1)(2012-12#2)(2013-8#1)
illicit heroin##2##2##(2008-10#2)
illicit substances##2##2##(2008-10#1)(2013-8#1)
illicit##23##1##(1991-12#1)(2008-1#2)(2008-10#14)(2008-12#1)(2012-12#3)(2013-8#2)
illiteracy##2##1##(1991-12#1)(1997-5#1)
illiterate##2##1##(2009-9#1)(2012-12#1)
illiterates in##2##2##(2009-9#2)
illiterates##5##1##(2009-9#5)
illness and the##6##3##(1994-6#1)(2008-12#1)(2008-7#1)(2010-10#1)(2012-12#1)(2012-3#1)
illness and##23##2##(1993-12#1)(1993-3#1)(1994-6#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2010-10#3)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
illness during##3##2##(2008-4#1)(2011-2#1)(2012-12#1)
illness features##2##2##(2008-11#1)(2008-6#1)
illness in Nepal##2##3##(2012-3#2)
illness in##12##2##(1993-12#1)(1993-5#1)(2007-12#1)(2008-11#1)(2008-12#2)(2010-2#3)(2012-3#3)
illness is##6##2##(1993-2#1)(2008-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-3#1)
illness of##3##2##(1994-12#1)(2011-2#2)
illness or disability##2##3##(1992-2#1)(2012-3#1)
illness or injury##2##3##(1997-2#1)(2012-12#1)
illness or##7##2##(1992-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-12#2)(2012-3#1)
illness representation##2##2##(2010-2#2)
illness that##2##2##(1996-11#1)(2008-10#1)
illness to##2##2##(1991-9#1)(2013-8#1)
illness was##2##2##(2009-4#1)(2012-12#1)
illness which##2##2##(2010-8#1)(2011-2#1)
illness##191##1##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-6#2)(1994-9#3)(1995-12#2)(1995-2#4)(1995-5#1)(1996-1#1)(1996-11#2)(1997-2#2)(1997-7#1)(1997-8#1)(2007-12#6)(2008-1#1)(2008-10#6)(2008-11#15)(2008-12#7)(2008-2#1)(2008-4#4)(2008-6#6)(2008-7#11)(2009-10#4)(2009-12#1)(2009-4#1)(2009-6#3)(2009-9#1)(2010-1#1)(2010-10#6)(2010-12#4)(2010-2#11)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#10)(2011-2#14)(2011-3#1)(2011-9#1)(2012-12#5)(2012-2#2)(2012-3#11)(2013-1#7)(2013-8#2)
illnesses and##7##2##(1993-3#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
illnesses are##4##2##(1993-3#1)(2009-4#1)(2010-12#2)
illnesses##43##1##(1991-1#2)(1991-2#1)(1993-1#1)(1993-3#6)(1995-1#1)(1995-5#1)(1997-4#1)(1997-6#1)(2008-11#5)(2008-12#4)(2008-4#1)(2008-7#5)(2009-4#2)(2010-1#1)(2010-12#3)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
illuminate the##4##2##(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
illuminate##6##1##(2008-11#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-11#1)
illuminated by a##6##3##(1991-2#1)(2007-12#1)(2008-2#3)(2008-3#1)
illuminated by##8##2##(1991-2#1)(2007-12#1)(2008-2#3)(2008-3#2)(2011-3#1)
illuminated liquid core waveguide##2##4##(2008-10#2)
illuminated##16##1##(1991-2#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#6)(2011-3#1)
illuminating the##2##2##(2008-10#1)(2010-11#1)
illuminating##6##1##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-11#1)
illumination and##2##2##(2008-3#2)
illumination conditions##2##2##(2008-3#2)
illumination intensity##2##2##(2008-3#2)
illumination is##2##2##(2008-3#2)
illumination of a##2##3##(2008-3#1)(2010-12#1)
illumination of##5##2##(1993-3#2)(2008-3#2)(2010-12#1)
illumination with##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
illumination##49##1##(1991-2#7)(1993-3#4)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#25)(2008-6#2)(2008-7#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-2#1)
illuminative##2##1##(2008-11#2)
illuminator##8##1##(2008-11#1)(2008-3#7)
illus##10##1##(1990-11#6)(1990-8#4)
illusion##3##1##(2008-10#1)(2013-8#2)
illusory##3##1##(2008-8#2)(2013-8#1)
illustrate a##2##2##(2008-7#1)(2010-11#1)
illustrate how it##2##3##(1994-3#1)(1996-3#1)
illustrate how##10##2##(1994-3#1)(1996-3#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#1)(2013-1#1)
illustrate several##2##2##(2008-2#1)(2009-12#1)
illustrate that##10##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#3)
illustrate the importance of##4##4##(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)
illustrate the method##2##3##(1994-9#1)(1997-3#1)
illustrate the methods##2##3##(1995-12#1)(1995-9#1)
illustrate the need##2##3##(2008-10#1)(2008-7#1)
illustrate the potential for##3##4##(2008-10#1)(2008-3#2)
illustrate the potential##6##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-3#3)
illustrate the process of##2##4##(2008-11#1)(2008-9#1)
illustrate the success of##2##4##(2008-11#2)
illustrate the##75##2##(1990-8#1)(1992-9#1)(1993-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-1#1)(2011-2#5)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
illustrate their##5##2##(1993-2#1)(1994-12#1)(2010-1#1)(2010-4#1)(2011-2#1)
illustrate this##5##2##(2008-10#3)(2008-3#1)(2008-8#1)
illustrate##134##1##(1990-5#1)(1990-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#23)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#6)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#7)(2012-2#15)(2012-3#2)(2013-1#6)(2013-8#2)
illustrated and##4##2##(1995-1#1)(2008-11#1)(2010-9#1)(2012-3#1)
illustrated by a recent##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
illustrated by a##10##3##(1991-6#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-8#1)(2010-8#1)
illustrated by an##2##3##(2008-10#1)(2008-11#1)
illustrated by the##5##3##(2008-10#3)(2008-3#1)(2012-2#1)
illustrated by##27##2##(1990-12#1)(1991-6#1)(1995-12#1)(1996-6#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
illustrated for##3##2##(2008-10#2)(2010-5#1)
illustrated in the##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
illustrated in this##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
illustrated in##11##2##(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-2#1)
illustrated on##3##2##(2008-10#2)(2013-1#1)
illustrated that the##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
illustrated that##8##2##(2008-10#5)(2008-11#2)(2012-2#1)
illustrated the##5##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2013-1#1)
illustrated through a##2##3##(2009-4#1)(2013-8#1)
illustrated through##4##2##(1997-4#1)(2009-4#1)(2010-6#1)(2013-8#1)
illustrated with##14##2##(1990-12#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2011-7#1)(2012-2#1)
illustrated##108##1##(1990-12#2)(1991-3#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-6#1)(1997-4#1)(2007-12#1)(2008-10#43)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-7#1)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
illustrates a##4##2##(1992-9#1)(1996-2#1)(2008-10#1)(2009-10#1)
illustrates how to use##2##4##(2008-11#1)(2008-9#1)
illustrates how to##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
illustrates how##7##2##(1991-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
illustrates that a##2##3##(2008-10#1)(2008-3#1)
illustrates that the##2##3##(2008-10#1)(2011-2#1)
illustrates that##10##2##(1996-3#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#2)
illustrates the need##2##3##(2008-11#1)(2008-7#1)
illustrates the potential##2##3##(1992-2#1)(2008-1#1)
illustrates the##24##2##(1990-9#1)(1991-3#2)(1992-12#2)(1992-2#1)(1995-12#1)(1996-1#1)(1996-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
illustrates##56##1##(1990-9#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-2#2)(1992-9#1)(1993-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
illustrating that the##2##3##(1995-6#1)(2008-8#1)
illustrating that##3##2##(1995-6#1)(2008-8#1)(2009-7#1)
illustrating the##10##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2009-6#1)(2011-2#2)
illustrating##19##1##(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#3)
illustration of the##3##3##(1990-5#1)(1991-3#1)(2009-5#1)
illustration of##4##2##(1990-5#1)(1991-3#1)(2008-7#1)(2009-5#1)
illustration purposes##2##2##(1997-2#1)(2008-11#1)
illustration##17##1##(1990-5#1)(1991-3#1)(1993-3#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-5#1)(2010-8#4)(2013-8#1)
illustrations##5##1##(1991-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
illustrative examples##2##2##(1997-2#1)(2008-10#1)
illustrative##10##1##(1992-2#1)(1996-12#1)(1997-2#1)(2008-10#3)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
illustrators'##2##1##(2013-8#2)
iloprost##7##1##(2009-10#1)(2011-2#6)
image acquisition##2##2##(2008-10#1)(2011-7#1)
image analysis and##2##3##(2008-10#1)(2011-7#1)
image analysis of##5##3##(1995-2#1)(2008-10#3)(2012-2#1)
image analysis software##2##3##(1995-12#1)(2008-10#1)
image analysis system##5##3##(2008-10#4)(2008-7#1)
image analysis techniques##2##3##(2008-10#2)
image analysis to##2##3##(2009-10#1)(2010-10#1)
image analysis was##2##3##(2008-10#1)(2012-2#1)
image analysis##36##2##(1995-12#2)(1995-2#1)(1997-2#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-10#1)(2010-8#1)(2011-7#1)(2012-2#2)(2013-1#1)
image and##9##2##(1992-2#1)(1994-8#1)(1995-5#1)(2008-3#2)(2009-5#2)(2012-2#2)
image appeared##2##2##(2012-2#1)(2013-8#1)
image contrast##2##2##(2009-10#1)(2012-12#1)
image cytometry##4##2##(2008-9#3)(2010-8#1)
image data##5##2##(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
image data-patching method##2##3##(2008-3#2)
image for##2##2##(1991-1#1)(2008-3#1)
image guided##2##2##(2009-12#1)(2011-2#1)
image has a##2##3##(2007-12#1)(2013-8#1)
image has##3##2##(2007-12#1)(2008-2#1)(2013-8#1)
image in##3##2##(2007-11#1)(2008-3#2)
image interpretation##3##2##(2008-3#1)(2010-12#1)(2012-2#1)
image is##10##2##(1996-2#1)(2007-11#1)(2008-3#8)
image of the##12##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-8#1)(2013-8#1)
image of##19##2##(1993-3#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-8#1)(2013-8#1)
image plane##3##2##(2008-3#3)
image processing techniques##2##3##(1992-9#1)(2008-10#1)
image processing##9##2##(1992-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#2)(2013-8#1)
image quality and##2##3##(2012-12#1)(2012-3#1)
image quality##11##2##(1997-8#5)(2007-9#1)(2008-3#2)(2012-12#1)(2012-3#1)(2013-8#1)
image recognition##2##2##(2008-11#1)(2008-3#1)
image reconstruction##4##2##(2008-10#1)(2008-3#3)
image resolution##2##2##(2007-12#1)(2008-6#1)
image resolutions##2##2##(2007-12#1)(2008-6#1)
image restoration##3##2##(2008-3#3)
image sequence##2##2##(2008-11#1)(2008-3#1)
image sequences##2##2##(2008-3#2)
image showed##2##2##(2008-12#1)(2012-3#1)
image space##3##2##(2007-12#1)(2008-6#1)(2011-2#1)
image storage##3##2##(1995-6#2)(2008-3#1)
image that##2##2##(2008-12#1)(2009-10#1)
image the spatial distribution of##2##5##(1995-3#1)(2008-2#1)
image the##8##2##(1995-3#1)(2008-10#3)(2008-2#1)(2009-12#1)(2010-12#1)(2011-7#1)
image to##3##2##(2008-6#1)(2009-10#1)(2013-8#1)
image was##2##2##(2009-2#1)(2010-12#1)
image##283##1##(1990-11#1)(1990-5#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-6#1)(1992-1#2)(1992-2#1)(1992-9#1)(1993-3#3)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#5)(2007-11#5)(2007-12#7)(2007-9#2)(2008-1#1)(2008-10#35)(2008-11#7)(2008-12#7)(2008-2#4)(2008-3#58)(2008-4#2)(2008-5#5)(2008-6#21)(2008-7#5)(2008-8#1)(2008-9#8)(2009-10#5)(2009-12#3)(2009-2#2)(2009-5#5)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-6#1)(2010-8#5)(2011-2#7)(2011-7#3)(2012-12#4)(2012-2#13)(2012-3#4)(2013-1#3)(2013-8#10)
image-based rendering##2##2##(2008-6#2)
image-correction grating##2##2##(2008-3#2)
image-guided radiotherapy##2##2##(2009-11#2)
image-guided surgery applications##2##3##(2009-12#2)
image-guided surgery##4##2##(2009-12#4)
image-guided##9##1##(2009-11#3)(2009-12#4)(2010-7#1)(2013-1#1)
image-processing##3##1##(2008-10#1)(2008-3#2)
image-quality equation##2##2##(2008-3#2)
imaged by##3##2##(2008-3#2)(2010-1#1)
imaged using##2##2##(2009-10#1)(2009-12#1)
imaged##15##1##(1990-11#1)(1994-11#1)(2008-11#1)(2008-3#3)(2008-5#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-8#3)
imager is##2##2##(2008-10#1)(2013-8#1)
imager##8##1##(2008-10#1)(2008-3#3)(2013-8#4)
imagery of##2##2##(2008-3#2)
imagery or##2##2##(1992-12#1)(2008-6#1)
imagery##31##1##(1992-12#14)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#1)(2009-10#2)(2013-8#5)
images acquired##2##2##(1995-5#1)(2008-3#1)
images allowed##2##2##(2011-2#2)
images and the##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
images and##14##2##(1991-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
images are encrypted##2##3##(2008-3#2)
images are obtained##2##3##(2007-12#1)(2013-8#1)
images are##14##2##(1991-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#6)(2012-2#1)(2012-3#1)(2013-8#2)
images as well as##2##4##(1994-12#1)(2008-3#1)
images by use of##4##4##(2008-3#4)
images by##8##2##(2008-11#1)(2008-3#6)(2012-2#1)
images can be acquired##2##4##(2008-10#1)(2011-7#1)
images can be obtained##2##4##(2013-8#2)
images can be##6##3##(2008-10#1)(2008-4#1)(2008-6#1)(2011-7#1)(2013-8#2)
images can##7##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-7#1)(2013-8#2)
images for##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-7#1)
images formed##2##2##(2008-6#1)(2008-7#1)
images has##3##2##(2008-3#1)(2013-1#2)
images have been##2##3##(2008-10#1)(2012-3#1)
images in a##2##3##(1997-8#1)(2011-7#1)
images in the##2##3##(1991-2#1)(1992-12#1)
images in##10##2##(1991-2#1)(1992-12#1)(1997-8#4)(2008-3#1)(2011-7#1)(2012-2#1)(2013-8#1)
images is proposed##3##3##(2008-6#1)(2010-8#1)(2013-8#1)
images is##10##2##(1995-5#1)(2008-3#1)(2008-6#1)(2010-8#3)(2012-2#3)(2013-8#1)
images obtained##2##2##(1995-11#1)(2008-7#1)
images of men##2##3##(2009-9#1)(2013-8#1)
images of nursing##2##3##(2008-12#1)(2010-10#1)
images of the##16##3##(1995-6#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#2)(2008-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#2)
images of##54##2##(1990-3#1)(1992-11#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-8#5)(2007-11#3)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
images over##2##2##(2008-3#1)(2011-2#1)
images remain##2##2##(2008-3#1)(2011-7#1)
images revealed that the##2##4##(2008-10#1)(2013-1#1)
images revealed##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
images showed better lesion conspicuity than##2##6##(1997-8#2)
images showed that##2##3##(2008-10#1)(2013-8#1)
images showed##6##2##(1997-8#2)(2008-10#2)(2008-7#1)(2013-8#1)
images that##2##2##(1994-9#1)(2008-3#1)
images to##3##2##(1995-11#1)(2009-12#1)(2010-8#1)
images using##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-3#1)
images were analyzed##2##3##(2008-10#1)(2013-1#1)
images were obtained by##2##4##(2007-11#2)
images were obtained##4##3##(1997-8#1)(2007-11#2)(2008-10#1)
images were taken##2##3##(2010-12#1)(2013-1#1)
images were##20##2##(1997-8#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#2)(2011-7#2)(2012-2#1)(2013-1#2)
images with a##2##3##(2008-3#2)
images with##4##2##(2007-12#1)(2008-3#2)(2010-8#1)
images##283##1##(1990-3#1)(1991-11#3)(1991-2#2)(1992-11#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#4)(1996-3#1)(1997-8#24)(2007-11#7)(2007-12#6)(2008-1#1)(2008-10#21)(2008-11#8)(2008-12#2)(2008-3#45)(2008-4#2)(2008-5#8)(2008-6#9)(2008-7#9)(2008-8#4)(2008-9#5)(2009-10#3)(2009-12#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#1)(2011-2#11)(2011-3#3)(2011-7#8)(2012-12#5)(2012-2#13)(2012-3#7)(2013-1#17)(2013-8#11)
imaginal discs##2##2##(1993-2#1)(2008-10#1)
imaginal##6##1##(1993-2#1)(1995-11#1)(2008-10#1)(2008-6#2)(2012-3#1)
imaginary parts of the##2##4##(2008-2#1)(2008-3#1)
imaginary##8##1##(2008-2#1)(2008-3#5)(2008-7#1)(2009-10#1)
imagination and##3##2##(1992-1#1)(2008-5#1)(2011-2#1)
imagination##10##1##(1992-1#1)(2008-5#3)(2009-10#2)(2010-7#1)(2011-2#2)(2013-8#1)
imaginative##2##1##(2013-1#1)(2013-8#1)
imagined exercise##3##2##(1992-12#3)
imagined##7##1##(1992-12#3)(1997-3#1)(2008-11#1)(2013-1#1)(2013-8#1)
imaging (MRI) and##2##3##(1992-3#1)(2008-7#1)
imaging (MRI)##42##2##(1992-3#1)(1995-5#1)(1996-11#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-11#1)(2010-12#2)(2010-3#1)(2010-9#3)(2011-2#1)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
imaging and laboratory##2##3##(1992-12#1)(2008-7#1)
imaging and spectroscopy techniques##2##4##(2008-11#1)(2012-12#1)
imaging and spectroscopy##4##3##(2008-11#1)(2012-12#3)
imaging and the##3##3##(2009-11#1)(2009-9#1)(2010-12#1)
imaging and therapy##3##3##(1996-1#1)(2010-6#1)(2012-12#1)
imaging and##49##2##(1991-12#1)(1992-12#1)(1992-3#1)(1996-1#1)(1996-9#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#2)(2010-12#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#4)(2011-7#1)(2012-12#7)(2012-2#11)(2013-1#2)
imaging appearances of##2##3##(2008-1#1)(2012-2#1)
imaging appearances##5##2##(2008-1#1)(2011-2#1)(2012-2#3)
imaging applications##3##2##(2008-3#1)(2009-7#1)(2010-8#1)
imaging are discussed##2##3##(2010-9#1)(2011-2#1)
imaging are##6##2##(2008-11#1)(2010-12#2)(2010-9#1)(2011-2#1)(2011-7#1)
imaging at##5##2##(1993-3#1)(1996-2#1)(1997-8#1)(2008-3#2)
imaging based on##4##3##(2008-3#1)(2013-8#3)
imaging but##3##2##(2008-7#1)(2009-11#1)(2011-7#1)
imaging by##8##2##(1994-9#1)(2007-12#1)(2009-11#1)(2010-5#1)(2010-9#2)(2012-2#2)
imaging can be used##2##4##(2012-2#2)
imaging can##3##2##(2011-2#1)(2012-2#2)
imaging centers##3##2##(1991-1#3)
imaging characteristics of##3##3##(1997-8#1)(2012-2#2)
imaging characteristics##6##2##(1997-8#1)(2011-2#2)(2012-2#3)
imaging confirmed##2##2##(2011-2#1)(2013-1#1)
imaging data to##2##3##(2009-8#1)(2013-1#1)
imaging data##6##2##(2009-8#1)(2009-9#1)(2013-1#3)(2013-8#1)
imaging demonstrated##4##2##(1992-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
imaging detector##3##2##(2008-3#2)(2010-3#1)
imaging device##4##2##(1991-2#1)(1993-9#1)(2008-6#1)(2009-2#1)
imaging devices##3##2##(2008-6#3)
imaging during resection of##2##4##(2008-7#2)
imaging during##4##2##(2008-7#2)(2009-10#1)(2013-1#1)
imaging examination##2##2##(1990-8#1)(1995-12#1)
imaging features##12##2##(1997-8#3)(2008-1#1)(2008-7#1)(2009-4#1)(2012-2#4)(2012-3#1)(2013-8#1)
imaging fiber-based nanoarrays##2##3##(2008-10#2)
imaging findings of##4##3##(1997-8#2)(2012-2#1)(2012-3#1)
imaging findings were##2##3##(2011-2#2)
imaging findings##13##2##(1997-8#3)(2008-7#1)(2008-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
imaging for diagnosis##2##3##(2008-2#1)(2010-7#1)
imaging for##9##2##(1997-8#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#1)
imaging has##2##2##(2009-10#1)(2010-12#1)
imaging in a##2##3##(2008-12#1)(2013-3#1)
imaging in multiple##2##3##(2009-11#1)(2010-12#1)
imaging in patients##2##3##(2008-1#1)(2012-2#1)
imaging in the diagnosis##3##4##(1990-12#1)(2009-10#1)(2012-2#1)
imaging in the##6##3##(1990-12#1)(1997-8#1)(2009-10#1)(2010-12#1)(2012-2#2)
imaging in##36##2##(1990-11#1)(1990-12#1)(1996-2#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-11#3)(2010-12#4)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#6)(2013-3#1)
imaging is##17##2##(1990-12#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-9#2)(2010-6#2)(2010-8#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)
imaging may##3##2##(2007-11#1)(2009-10#1)(2012-2#1)
imaging measurements##3##2##(1994-3#1)(2008-11#1)(2008-7#1)
imaging method and##2##3##(2008-10#2)
imaging method##7##2##(2008-10#4)(2008-11#2)(2012-2#1)
imaging methodology##2##2##(2008-4#1)(2011-1#1)
imaging methods for##4##3##(2008-10#2)(2008-9#1)(2012-2#1)
imaging methods##10##2##(2008-10#2)(2008-9#1)(2010-12#1)(2012-2#5)(2013-8#1)
imaging modalities##8##2##(2008-9#1)(2010-7#1)(2010-9#3)(2011-2#1)(2012-2#1)(2013-1#1)
imaging modality for the##2##4##(2010-6#1)(2012-2#1)
imaging modality to##2##3##(2008-10#1)(2010-6#1)
imaging modality##11##2##(2008-10#1)(2010-6#2)(2010-8#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
imaging of a##5##3##(2007-12#1)(2008-2#1)(2009-12#1)(2011-2#1)(2013-1#1)
imaging of breast cancer##2##4##(1994-12#1)(2010-6#1)
imaging of cancer##2##3##(2010-6#1)(2012-12#1)
imaging of fluorescent##2##3##(2009-6#1)(2010-12#1)
imaging of intracellular##2##3##(2009-8#2)
imaging of surfaces##2##3##(2008-10#1)(2008-3#1)
imaging of the posterior##2##4##(1997-8#1)(2011-7#1)
imaging of the##18##3##(1990-11#1)(1990-3#1)(1994-11#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-3#2)(2009-3#1)(2010-12#2)(2010-9#1)(2011-2#3)(2011-7#2)(2013-1#1)
imaging of##72##2##(1990-11#2)(1990-3#1)(1991-11#1)(1994-11#1)(1994-12#1)(1997-8#5)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#8)(2010-6#3)(2010-9#3)(2011-2#4)(2011-7#6)(2012-12#1)(2012-2#8)(2013-1#2)(2013-8#1)
imaging on##3##2##(2008-2#2)(2012-3#1)
imaging or##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
imaging plays##2##2##(2010-12#1)(2011-2#1)
imaging procedure##2##2##(1993-6#1)(1997-8#1)
imaging procedures##2##2##(1993-1#1)(2012-2#1)
imaging requires##2##2##(2010-1#1)(2012-2#1)
imaging scanning##2##2##(2008-10#1)(2008-7#1)
imaging showed##8##2##(1997-6#1)(2008-7#2)(2010-10#1)(2011-2#2)(2013-7#2)
imaging shows##2##2##(1996-2#1)(2013-8#1)
imaging spectrometer based on toroidal##2##5##(2013-8#2)
imaging spectrometer##4##2##(2007-12#1)(2013-8#3)
imaging spectrometers##2##2##(2008-3#1)(2013-8#1)
imaging strategies for##2##3##(2010-12#1)(2010-7#1)
imaging strategies##4##2##(2008-2#2)(2010-12#1)(2010-7#1)
imaging studies with##2##3##(1995-2#1)(2011-1#1)
imaging studies##11##2##(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
imaging study##4##2##(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#1)
imaging system is##2##3##(2008-3#2)
imaging system##16##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-9#1)(2010-5#2)(2011-3#1)(2013-8#2)
imaging systems##6##2##(2007-12#3)(2008-3#1)(2012-2#2)
imaging technique and##2##3##(2012-2#1)(2013-1#1)
imaging technique for##2##3##(1997-8#1)(2012-2#1)
imaging technique##17##2##(1994-1#1)(1994-9#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#6)(2013-1#1)
imaging techniques and##2##3##(2009-10#1)(2013-1#1)
imaging techniques are##2##3##(1997-8#1)(2010-8#1)
imaging techniques available##2##3##(2012-2#1)(2013-1#1)
imaging techniques for##4##3##(2008-10#1)(2008-3#1)(2010-6#1)(2012-2#1)
imaging techniques have been##2##4##(2008-8#1)(2009-11#1)
imaging techniques have##3##3##(2008-8#1)(2009-11#1)(2011-1#1)
imaging techniques in##3##3##(1991-2#1)(2010-12#1)(2011-2#1)
imaging techniques may##2##3##(1991-12#1)(2008-12#1)
imaging techniques to##2##3##(2008-7#1)(2012-2#1)
imaging techniques##36##2##(1991-12#1)(1991-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#7)(2013-1#2)
imaging technologies##5##2##(1992-11#1)(2008-6#1)(2008-9#1)(2010-9#1)(2012-2#1)
imaging technology for##2##3##(1994-9#1)(2012-2#1)
imaging technology##7##2##(1994-9#1)(2008-10#1)(2008-3#1)(2011-7#1)(2012-2#3)
imaging tests##2##2##(1992-12#1)(2012-3#1)
imaging that##2##2##(1997-6#1)(2008-3#1)
imaging the##5##2##(1991-12#1)(2011-7#3)(2012-2#1)
imaging to##9##2##(1990-12#1)(2008-11#2)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
imaging using##2##2##(2008-11#1)(2011-7#1)
imaging was performed##4##3##(2007-11#1)(2011-2#1)(2012-12#2)
imaging was##10##2##(1996-2#1)(1997-8#2)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#2)
imaging were##4##2##(1995-11#1)(1997-8#2)(2011-2#1)
imaging will##2##2##(2008-1#1)(2012-2#1)
imaging with CT and MRI##2##5##(2008-1#1)(2008-2#1)
imaging with a##3##3##(2008-1#1)(2008-3#1)(2012-2#1)
imaging with an##2##3##(2008-3#1)(2010-12#1)
imaging with##19##2##(1992-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#3)(2008-3#2)(2010-12#1)(2010-7#1)(2010-9#2)(2011-2#1)(2011-7#1)(2012-2#2)
imaging##838##1##(1990-11#4)(1990-12#3)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#4)(1991-11#2)(1991-12#3)(1991-2#3)(1992-11#1)(1992-12#5)(1992-3#8)(1992-6#1)(1993-1#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1996-1#1)(1996-11#1)(1996-2#5)(1996-9#2)(1997-4#1)(1997-6#5)(1997-7#1)(1997-8#33)(2007-11#8)(2007-12#12)(2007-8#1)(2008-1#11)(2008-10#32)(2008-11#28)(2008-12#6)(2008-2#30)(2008-3#57)(2008-4#4)(2008-5#6)(2008-6#10)(2008-7#30)(2008-8#8)(2008-9#16)(2009-1#1)(2009-10#12)(2009-11#10)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#11)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#5)(2010-1#3)(2010-10#2)(2010-12#38)(2010-3#3)(2010-4#2)(2010-5#7)(2010-6#15)(2010-7#7)(2010-8#7)(2010-9#22)(2011-1#7)(2011-2#55)(2011-3#1)(2011-7#26)(2012-12#24)(2012-2#120)(2012-3#11)(2013-1#34)(2013-3#2)(2013-7#3)(2013-8#23)
imatinib mesylate and hydroxyurea##2##4##(2008-7#2)
imatinib mesylate##4##2##(2008-7#2)(2009-4#1)(2010-11#1)
imatinib##7##1##(2008-7#2)(2009-4#1)(2009-7#2)(2010-11#1)(2011-2#1)
imazalil##4##1##(2008-10#4)
imazethapyr##3##1##(2008-10#3)
imbalance and##3##2##(2008-11#1)(2008-7#1)(2012-7#1)
imbalance between##7##2##(1993-2#1)(2008-10#2)(2008-7#2)(2009-7#1)(2013-8#1)
imbalance in the##4##3##(1990-2#1)(1991-2#1)(1997-7#1)(2008-10#1)
imbalance in##7##2##(1990-2#1)(1991-2#1)(1997-7#1)(2008-10#1)(2012-2#2)(2012-3#1)
imbalance of##2##2##(1997-3#1)(2008-7#1)
imbalance##33##1##(1990-2#1)(1991-2#1)(1993-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#2)
imbalances##5##1##(1997-3#2)(2008-5#1)(2009-8#1)(2013-1#1)
imbedded##3##1##(1991-2#1)(2008-10#1)(2008-9#1)
imbricata##2##1##(2013-1#2)
imidacloprid##3##1##(2008-10#3)
imidazole as the##2##3##(2008-10#2)
imidazole as##3##2##(2008-10#3)
imidazole carboxamide##2##2##(1992-2#2)
imidazole derivatives##5##2##(2008-10#4)(2008-8#1)
imidazole in##2##2##(1994-5#1)(2008-10#1)
imidazole##30##1##(1991-5#1)(1992-2#2)(1992-6#1)(1994-5#7)(2008-10#13)(2008-8#4)(2010-12#1)(2012-12#1)
imiglucerase##7##1##(2008-10#7)
imine##2##1##(1991-3#1)(1996-5#1)
imino##3##1##(1990-8#2)(1996-5#1)
iminodiacetate chelating##3##2##(2008-10#3)
iminodiacetate groups##2##2##(2008-10#2)
iminodiacetate resin##3##2##(2008-10#3)
iminodiacetate##9##1##(2008-10#9)
iminodiacetate-agarose adsorbent##2##2##(2008-10#2)
iminodiacetic acid##3##2##(1997-2#1)(2008-10#2)
iminodiacetic groups##2##2##(2008-10#2)
iminodiacetic##5##1##(1997-2#1)(2008-10#4)
iminodipeptide##2##1##(1994-11#2)
imipenem##2##1##(2008-7#1)(2012-2#1)
imipramine administration##4##2##(1994-2#4)
imipramine##15##1##(1990-5#4)(1994-2#6)(2008-10#4)(2008-7#1)
imitated##3##1##(2008-11#1)(2008-8#1)(2012-12#1)
immature CEs##6##2##(2008-5#6)
immature and mature##3##3##(2008-10#1)(2008-11#2)
immature and##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
immature bone##2##2##(2008-11#1)(2013-1#1)
immature forms were##2##3##(2011-2#2)
immature fruit##3##2##(2008-10#3)
immature fruits##2##2##(2008-10#1)(2012-2#1)
immature internodes##2##2##(2011-2#2)
immature lymphocytes##2##2##(1994-3#1)(1997-9#1)
immature or##3##2##(2008-10#3)
immature particles##2##2##(2009-7#2)
immature pear##2##2##(2008-10#2)
immature secretory granules##2##3##(1992-12#2)
immature teratoma##2##2##(2009-5#2)
immature##69##1##(1990-11#1)(1990-5#1)(1991-12#1)(1992-12#3)(1993-12#1)(1994-3#1)(1995-12#1)(1995-8#2)(1997-9#1)(2006-5#1)(2007-12#1)(2008-10#18)(2008-11#7)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#2)(2010-6#1)(2011-2#7)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#3)
immaturity of##3##2##(1995-8#1)(2008-5#1)(2013-1#1)
immaturity##6##1##(1991-6#1)(1995-3#1)(1995-8#1)(2008-5#1)(2010-3#1)(2013-1#1)
immeasurable##2##1##(1994-9#1)(2013-8#1)
immediate and delayed##4##3##(1992-9#1)(1993-11#1)(2008-7#1)(2013-8#1)
immediate and long-term results##2##4##(1991-6#2)
immediate and long-term##3##3##(1991-6#2)(2011-2#1)
immediate and##15##2##(1990-5#1)(1991-6#2)(1992-9#1)(1993-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#2)(2013-8#2)
immediate early protein##2##3##(1993-8#2)
immediate early##7##2##(1992-7#1)(1993-8#2)(1994-11#1)(1996-12#1)(1997-8#1)(2008-11#1)
immediate effects of traditional Thai massage##2##6##(2010-12#2)
immediate effects of##4##3##(2008-12#2)(2010-12#2)
immediate feedback##2##2##(1996-1#1)(2013-1#1)
immediate loading##6##2##(2008-11#1)(2010-12#1)(2011-7#1)(2013-1#3)
immediate postoperative##3##2##(1990-9#1)(2008-7#1)(2008-8#1)
immediate reconstruction with##2##3##(1993-11#1)(2011-2#1)
immediate release MT##3##3##(2008-11#3)
immediate release##4##2##(2008-11#4)
immediate surgical##2##2##(1994-12#1)(2012-12#1)
immediate##132##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#14)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#3)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-4#1)(2010-5#1)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#14)(2013-8#2)
immediate-early gene##4##2##(1991-10#1)(1991-7#1)(1996-12#1)(2008-11#1)
immediate-early genes##6##2##(1992-12#1)(1996-12#1)(1997-3#3)(2008-11#1)
immediate-early##10##1##(1991-10#1)(1991-7#1)(1992-12#1)(1996-12#2)(1997-3#3)(2008-11#2)
immediately adjacent trees##3##3##(2008-10#3)
immediately adjacent##4##2##(2008-10#4)
immediately after R2##2##3##(2013-1#2)
immediately after instruction##2##3##(2013-1#2)
immediately after reperfusion##2##3##(2011-2#2)
immediately after sample collection##2##4##(2008-10#2)
immediately after the##6##3##(1990-2#1)(2008-11#1)(2009-11#1)(2012-2#2)(2013-8#1)
immediately after##44##2##(1990-12#1)(1990-2#1)(1992-10#1)(1993-1#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-5#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#8)(2013-8#2)
immediately and##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
immediately before the##4##3##(1990-12#1)(1995-8#1)(2009-8#1)(2012-2#1)
immediately before##7##2##(1990-12#1)(1995-8#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
immediately by a##2##3##(1991-2#1)(2008-11#1)
immediately discharged##2##2##(2008-3#2)
immediately downstream of##4##3##(1992-9#1)(1996-6#1)(2008-11#1)(2008-3#1)
immediately followed by a##2##4##(2008-10#1)(2013-1#1)
immediately followed by##3##3##(2008-10#2)(2013-1#1)
immediately following the##3##3##(1992-12#1)(2008-11#1)(2008-4#1)
immediately following##8##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-1#1)
immediately loaded mini dental implants##2##5##(2013-1#2)
immediately loaded##4##2##(2011-7#1)(2013-1#3)
immediately or##3##2##(1992-9#1)(2008-7#1)(2013-1#1)
immediately preceding##2##2##(2008-10#1)(2010-6#1)
immediately prior to##2##3##(1993-6#1)(2008-10#1)
immediately to##2##2##(2008-11#1)(2008-12#1)
immediately upon##2##2##(1995-2#1)(2012-12#1)
immediately upstream##3##2##(1993-9#1)(2008-11#1)(2011-1#1)
immediately##139##1##(1990-12#2)(1990-2#1)(1991-2#3)(1991-3#1)(1992-10#1)(1992-12#2)(1992-9#2)(1993-1#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-5#1)(1997-6#1)(2007-12#2)(2008-10#27)(2008-11#10)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#4)(2013-1#19)(2013-8#2)
immense##4##1##(2007-12#1)(2008-10#1)(2008-11#2)
immersed in a##2##3##(2008-10#2)
immersed in the##3##3##(2008-10#2)(2008-7#1)
immersed in##17##2##(2008-10#8)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2013-1#2)(2013-8#1)
immersed into##3##2##(2008-10#3)
immersed##20##1##(2008-10#11)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2013-1#2)(2013-8#1)
immersing the electrode##2##3##(2008-10#2)
immersing the##5##2##(2008-10#5)
immersing##11##1##(2008-10#9)(2009-7#2)
immersion and##2##2##(2008-10#1)(2008-5#1)
immersion in 0##4##3##(2013-1#4)
immersion in##9##2##(1992-4#1)(2008-10#1)(2012-2#1)(2013-1#6)
immersion##20##1##(1992-4#1)(2008-10#6)(2008-5#3)(2008-7#1)(2012-2#2)(2013-1#7)
immigrant students##2##2##(2008-12#2)
immigrant##10##1##(2008-10#1)(2008-11#2)(2008-12#3)(2010-11#2)(2013-1#1)(2013-8#1)
immigrants and##2##2##(2008-8#1)(2013-1#1)
immigrants from##4##2##(1997-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
immigrants##22##1##(1997-2#1)(1997-8#1)(2008-10#4)(2008-8#3)(2008-9#2)(2010-12#4)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#3)
immigrating##2##1##(2008-10#1)(2008-8#1)
immigration and##2##2##(1990-3#1)(2008-10#1)
immigration from##2##2##(1995-3#1)(2008-8#1)
immigration in##2##2##(2008-10#2)
immigration of##3##2##(2008-10#1)(2008-8#2)
immigration to##2##2##(2008-10#2)
immigration##24##1##(1990-3#1)(1995-3#1)(2008-10#11)(2008-12#1)(2008-8#7)(2008-9#1)(2012-2#1)(2013-8#1)
immigrations##2##1##(2008-10#1)(2008-9#1)
imminent##8##1##(1992-2#1)(1993-6#1)(1997-5#1)(2008-10#1)(2009-6#1)(2011-2#1)(2013-8#2)
immiscible##7##1##(1993-5#1)(1993-8#1)(2008-10#4)(2008-8#1)
immobile##4##1##(1991-5#1)(1993-12#1)(2008-10#1)(2008-8#1)
immobilisation and##2##2##(2008-10#2)
immobilisation in##2##2##(2008-10#1)(2008-11#1)
immobilisation methods##2##2##(2008-10#2)
immobilisation of##4##2##(2008-10#3)(2008-11#1)
immobilisation##24##1##(2008-10#21)(2008-11#2)(2008-12#1)
immobilised antibody##2##2##(2008-10#2)
immobilised in##2##2##(2008-10#2)
immobilised metal ion affinity##3##4##(1997-2#3)
immobilised on a##4##3##(2008-10#4)
immobilised on the##4##3##(2008-10#4)
immobilised on##15##2##(2008-10#15)
immobilised onto the##2##3##(2008-10#2)
immobilised onto##5##2##(1997-2#3)(2008-10#2)
immobilised##53##1##(1990-12#1)(1993-8#2)(1997-2#7)(2008-10#42)(2008-12#1)
immobility than##2##2##(2008-11#2)
immobility##3##1##(2008-11#3)
immobilization and##7##2##(1994-2#1)(2008-10#5)(2010-7#1)
immobilization in##3##2##(2008-10#2)(2008-11#1)
immobilization is##5##2##(2008-10#3)(2008-9#1)(2009-3#1)
immobilization matrix##2##2##(2008-10#2)
immobilization method##4##2##(2008-10#4)
immobilization methods##2##2##(2008-10#2)
immobilization of a##4##3##(2008-10#3)(2009-3#1)
immobilization of horseradish peroxidase##2##4##(2008-10#2)
immobilization of the enzyme##2##4##(2008-10#2)
immobilization of the##13##3##(1995-5#1)(2008-10#8)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)
immobilization of##57##2##(1995-5#1)(2008-10#45)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-2#1)
immobilization on the##4##3##(2008-10#1)(2009-3#2)(2011-2#1)
immobilization on##11##2##(1997-2#2)(2008-10#6)(2009-3#2)(2011-2#1)
immobilization technique##2##2##(2008-10#2)
immobilization was##2##2##(2008-9#1)(2011-2#1)
immobilization##123##1##(1990-2#1)(1993-6#2)(1994-2#1)(1995-5#1)(1997-2#2)(2008-10#87)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#4)(2009-3#4)(2010-11#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
immobilize single##2##2##(2008-10#1)(2008-7#1)
immobilize##14##1##(1990-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-4#1)
immobilized Ru(bpy)(3)(2+) were##2##3##(2008-10#2)
immobilized Ru(bpy)(3)(2+)##4##2##(2008-10#4)
immobilized and##8##2##(2008-10#5)(2008-11#2)(2008-7#1)
immobilized antibodies##2##2##(2008-10#1)(2008-4#1)
immobilized at the##3##3##(2008-10#3)
immobilized at##4##2##(2008-10#3)(2009-3#1)
immobilized by##5##2##(2008-10#4)(2008-4#1)
immobilized cells in##2##3##(2008-11#1)(2008-7#1)
immobilized cells##8##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)
immobilized covalently on##2##3##(2008-10#2)
immobilized enzymatic reactors##3##3##(2008-12#3)
immobilized enzyme reactor##2##3##(2008-10#2)
immobilized enzyme##10##2##(1994-11#1)(2008-10#7)(2008-7#1)(2009-10#1)
immobilized enzymes##2##2##(1995-3#1)(2008-10#1)
immobilized human serum albumin##2##4##(2008-10#2)
immobilized human##5##2##(1993-8#3)(2008-10#2)
immobilized in a##12##3##(1990-5#1)(1996-12#1)(2008-10#8)(2008-11#2)
immobilized in chitosan##2##3##(2008-10#2)
immobilized in mesoporous MCM-41##2##4##(2010-4#2)
immobilized in the fibrous##2##4##(2008-11#2)
immobilized in the##3##3##(2008-10#1)(2008-11#2)
immobilized in##35##2##(1990-5#1)(1996-12#1)(2008-10#23)(2008-11#5)(2008-5#1)(2008-6#1)(2010-3#1)(2010-4#2)
immobilized into##2##2##(2008-10#1)(2008-6#1)
immobilized lipase##2##2##(2008-7#2)
immobilized metal##3##2##(1995-8#1)(2008-10#1)(2011-2#1)
immobilized nanometer TiO(2)##3##3##(2008-10#3)
immobilized on 2 Celite derivatives##2##5##(1997-2#2)
immobilized on Amberlite IRA-743 resin##2##5##(2008-10#2)
immobilized on Amberlite##3##3##(2008-10#3)
immobilized on a rotating disk##3##5##(2008-10#3)
immobilized on a silica support##2##5##(2008-10#2)
immobilized on a##17##3##(2008-10#14)(2008-11#1)(2008-4#1)(2008-7#1)
immobilized on an anion-exchange##4##4##(2008-10#4)
immobilized on an eggshell membrane##2##5##(2008-10#2)
immobilized on an##10##3##(2008-10#9)(2008-12#1)
immobilized on chitosan membranes##2##4##(2008-10#2)
immobilized on controlled pore glass (CPG) by##2##7##(2008-10#2)
immobilized on controlled pore glass##5##5##(2008-10#5)
immobilized on sepiolite##6##3##(2008-10#6)
immobilized on silica gel as##2##5##(2008-10#2)
immobilized on silica gel##4##4##(2008-10#4)
immobilized on silica##7##3##(2008-10#7)
immobilized on the surface of a##2##6##(2008-10#2)
immobilized on the surface of the##2##6##(2008-10#1)(2008-11#1)
immobilized on the surface of##6##5##(2008-10#5)(2008-11#1)
immobilized on the##21##3##(2008-10#18)(2008-11#2)(2008-4#1)
immobilized on top of##2##4##(2008-10#2)
immobilized on##106##2##(1990-8#1)(1997-2#4)(2008-10#87)(2008-11#6)(2008-12#2)(2008-4#2)(2008-7#3)(2009-10#1)
immobilized onto a##3##3##(2008-10#3)
immobilized onto an##2##3##(2008-10#2)
immobilized onto the##2##3##(2008-10#2)
immobilized onto##19##2##(2008-10#19)
immobilized pH##2##2##(2008-10#2)
immobilized protein##3##2##(1996-12#1)(2008-10#2)
immobilized proteinase##2##2##(1990-5#2)
immobilized reactor##2##2##(2008-10#2)
immobilized recombinant##2##2##(1995-6#1)(2008-10#1)
immobilized redox indicators##2##3##(2008-10#2)
immobilized redox##3##2##(2008-10#3)
immobilized silica gel##3##3##(2008-10#3)
immobilized the##3##2##(1993-8#1)(2008-10#2)
immobilized through##2##2##(2008-10#2)
immobilized to##3##2##(2008-10#3)
immobilized urease##3##2##(1994-11#2)(2008-10#1)
immobilized with gelatin by##2##4##(2008-10#2)
immobilized with gelatin##3##3##(2008-10#3)
immobilized with##5##2##(2008-10#5)
immobilized##366##1##(1990-12#2)(1990-2#1)(1990-5#3)(1990-8#1)(1992-6#1)(1993-8#4)(1994-11#3)(1995-2#2)(1995-3#5)(1995-6#1)(1995-8#1)(1996-12#2)(1997-2#6)(2008-10#272)(2008-11#22)(2008-12#6)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#16)(2009-10#2)(2009-3#2)(2010-3#1)(2010-4#2)(2011-2#1)
immobilizing a##2##2##(2008-10#1)(2010-7#1)
immobilizing antibodies##2##2##(2008-10#2)
immobilizing the##4##2##(2008-10#3)(2008-9#1)
immobilizing##25##1##(2008-10#22)(2008-11#1)(2008-9#1)(2010-7#1)
immoral##2##1##(2008-8#1)(2013-8#1)
immortal cell##2##2##(2008-11#2)
immortal cells##2##2##(1990-5#1)(2008-9#1)
immortal##7##1##(1990-5#1)(1997-7#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#1)
immortalised##5##1##(2008-11#5)
immortalization and carcinogenesis##2##3##(2008-11#2)
immortalization of##6##2##(1993-11#1)(2008-11#2)(2008-2#3)
immortalization##10##1##(1993-11#1)(2008-11#6)(2008-2#3)
immortalize human T cells##3##4##(2008-11#3)
immortalize primary human cells##2##4##(2008-11#2)
immortalize primary##3##2##(2008-11#2)(2008-2#1)
immortalize##8##1##(2008-11#7)(2008-2#1)
immortalized T cells##3##3##(2008-11#3)
immortalized T##6##2##(2008-11#6)
immortalized and##2##2##(1992-10#1)(2009-12#1)
immortalized rat##2##2##(1992-1#2)
immortalized##22##1##(1992-1#2)(1992-10#1)(1997-7#2)(2008-10#1)(2008-11#14)(2009-12#1)(2013-1#1)
immune activation##6##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#2)(2013-8#1)
immune activity##2##2##(2008-7#1)(2009-12#1)
immune and##4##2##(1995-12#1)(2009-6#1)(2012-3#1)(2013-7#1)
immune cell activation##3##3##(2008-4#1)(2012-3#2)
immune cell##10##2##(2008-10#5)(2008-4#1)(2008-9#1)(2012-3#2)(2013-1#1)
immune cells have##2##3##(1991-2#1)(2013-8#1)
immune cells in the##2##4##(2008-10#1)(2012-3#1)
immune cells in##5##3##(2008-10#1)(2008-9#1)(2009-3#1)(2012-3#2)
immune cells involved in##2##4##(1992-12#1)(1994-5#1)
immune cells##30##2##(1991-1#2)(1991-2#1)(1992-12#1)(1994-11#1)(1994-5#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#1)
immune complexes##7##2##(1990-12#2)(1991-2#1)(1997-8#2)(2008-10#1)(2012-3#1)
immune defects##2##2##(2012-3#1)(2013-8#1)
immune defense##10##2##(2008-6#1)(2008-8#4)(2008-9#3)(2009-9#1)(2012-3#1)
immune deficiencies##2##2##(2009-12#1)(2011-2#1)
immune deficiency##2##2##(2008-4#1)(2011-2#1)
immune dysfunction##2##2##(1995-6#1)(2008-10#1)
immune effector##2##2##(2008-10#1)(2011-2#1)
immune effects##4##2##(2008-10#4)
immune from##3##2##(1995-6#1)(1997-6#1)(2009-8#1)
immune function and##4##3##(2008-10#3)(2008-8#1)
immune function in##8##3##(2008-10#4)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)
immune function of lymphocytes##2##4##(1995-8#2)
immune function testing##2##3##(2008-10#2)
immune function tests##2##3##(2008-10#2)
immune function##39##2##(1993-12#1)(1995-12#1)(1995-8#2)(2008-10#20)(2008-11#1)(2008-8#5)(2008-9#4)(2010-1#1)(2010-12#1)(2011-2#2)(2012-3#1)
immune functioning##3##2##(2008-11#2)(2008-2#1)
immune functions of##2##3##(1993-12#2)
immune functions##8##2##(1992-9#1)(1993-12#4)(1994-11#1)(1995-12#1)(2009-3#1)
immune gene##2##2##(2012-3#2)
immune genes##3##2##(2012-3#2)(2013-1#1)
immune inflammatory##3##2##(1995-2#1)(2013-1#2)
immune mechanisms##2##2##(2011-2#1)(2012-2#1)
immune memory##2##2##(2012-12#2)
immune modulation##2##2##(2008-10#2)
immune physiology##3##2##(2010-3#3)
immune privilege##5##2##(2010-1#5)
immune profile of##2##3##(1995-12#2)
immune reaction##7##2##(1996-11#1)(2008-10#4)(2008-11#1)(2008-12#1)
immune reactions##4##2##(1996-3#1)(2008-10#2)(2012-3#1)
immune reactivity##2##2##(2008-7#1)(2010-12#1)
immune recognition of the bacterium##2##5##(2008-7#2)
immune reconstitution inflammatory syndrome (IRIS) is a##2##7##(2009-7#1)(2010-5#1)
immune reconstitution inflammatory syndrome##4##4##(2008-10#1)(2009-7#1)(2010-5#2)
immune reconstitution##6##2##(2008-1#1)(2008-10#1)(2009-7#2)(2010-5#2)
immune regulation##3##2##(2008-9#1)(2010-1#1)(2011-2#1)
immune regulators##2##2##(2011-2#2)
immune response against##4##3##(2008-9#3)(2013-1#1)
immune response and##6##3##(1992-9#1)(1993-1#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
immune response are##2##3##(1991-2#1)(1997-7#1)
immune response by intramuscular injection of##2##6##(1997-8#2)
immune response by##3##3##(1997-8#3)
immune response in an##2##4##(2008-11#1)(2008-8#1)
immune response in the##2##4##(2008-10#1)(2008-7#1)
immune response in##11##3##(1991-2#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#1)
immune response is##2##3##(2008-8#1)(2011-2#1)
immune response of the##2##4##(1996-3#1)(2008-7#1)
immune response of##6##3##(1991-12#1)(1992-9#1)(1996-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
immune response through##2##3##(2010-5#1)(2013-1#1)
immune response to a##3##4##(1995-2#1)(1995-5#1)(2008-4#1)
immune response to scabies##2##4##(1996-12#2)
immune response to the##2##4##(1993-8#1)(2008-11#1)
immune response to##16##3##(1990-12#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2009-12#1)(2009-3#1)(2010-1#1)(2011-2#1)(2013-7#1)
immune response was##4##3##(1995-12#2)(1997-8#2)
immune response##98##2##(1990-12#1)(1991-12#1)(1991-2#2)(1992-9#3)(1993-1#1)(1993-12#2)(1993-8#1)(1995-12#2)(1995-2#1)(1995-5#4)(1996-12#2)(1996-3#1)(1997-7#1)(1997-8#6)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-1#2)(2010-5#3)(2011-2#7)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#3)
immune responses against bacterial infections##2##5##(1992-5#1)(2012-12#1)
immune responses against##7##3##(1992-5#1)(1995-5#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-12#1)
immune responses and##7##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-9#1)(2013-7#1)
immune responses are##4##3##(2008-10#1)(2008-9#1)(2009-8#1)(2010-12#1)
immune responses in the##3##4##(1995-12#1)(2008-10#2)
immune responses in##9##3##(1995-12#1)(2008-10#5)(2008-5#1)(2009-8#1)(2013-8#1)
immune responses of bats##2##4##(2013-1#2)
immune responses of##5##3##(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#2)
immune responses than##2##3##(2007-12#1)(2008-9#1)
immune responses to##9##3##(1991-12#1)(1995-2#1)(1995-5#2)(2007-11#1)(2008-10#2)(2010-5#1)(2011-2#1)
immune responses##80##2##(1991-12#1)(1992-5#1)(1994-5#1)(1995-12#1)(1995-2#3)(1995-5#5)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#11)(2008-12#3)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#7)(2009-3#1)(2009-8#5)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#3)
immune sera##2##2##(1990-12#1)(1995-12#1)
immune serum##2##2##(1991-9#1)(1996-12#1)
immune status##5##2##(1990-2#1)(1992-9#1)(2008-5#1)(2008-9#1)(2013-8#1)
immune stimulating##2##2##(2008-10#2)
immune stimulation##3##2##(1996-2#1)(2008-10#2)
immune stimulatory effects##2##3##(2008-10#1)(2011-2#1)
immune stimulatory##4##2##(2008-10#3)(2011-2#1)
immune suppression##2##2##(2008-12#1)(2008-8#1)
immune suppressive##2##2##(2010-1#1)(2012-3#1)
immune surveillance##2##2##(2008-1#1)(2008-10#1)
immune system and the##2##4##(1995-12#1)(2009-12#1)
immune system and##10##3##(1990-11#1)(1990-9#1)(1995-12#1)(1996-11#1)(2008-7#1)(2009-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
immune system can##2##3##(2008-10#1)(2008-4#1)
immune system in##5##3##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
immune system##89##2##(1990-11#1)(1990-9#1)(1993-12#3)(1993-3#2)(1995-12#3)(1996-11#1)(1996-12#1)(1997-7#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-2#2)(2008-4#5)(2008-5#5)(2008-7#5)(2008-9#2)(2009-1#1)(2009-12#2)(2010-1#1)(2010-3#2)(2011-2#7)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#4)
immune system's##2##2##(2013-7#2)
immune systems##5##2##(1992-12#1)(2006-5#1)(2008-4#1)(2008-5#1)(2013-1#1)
immune to##8##2##(2008-10#8)
immune tolerance##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
immune##553##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-9#1)(1992-1#1)(1992-12#3)(1992-5#1)(1992-9#5)(1993-1#1)(1993-12#10)(1993-3#3)(1993-8#1)(1994-11#2)(1994-5#2)(1995-12#12)(1995-2#5)(1995-5#9)(1995-6#2)(1995-8#2)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#12)(1997-9#2)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#3)(2008-1#4)(2008-10#124)(2008-11#33)(2008-12#5)(2008-2#3)(2008-4#14)(2008-5#13)(2008-6#3)(2008-7#13)(2008-8#14)(2008-9#26)(2009-1#1)(2009-10#3)(2009-12#6)(2009-3#4)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#12)(2010-10#1)(2010-12#3)(2010-3#6)(2010-5#6)(2011-2#34)(2012-12#6)(2012-2#9)(2012-3#30)(2013-1#30)(2013-7#12)(2013-8#11)
immune-competent patient##2##2##(2013-8#2)
immune-competent##4##1##(1994-5#1)(2013-8#3)
immune-complex##2##1##(1993-6#1)(1997-8#1)
immune-compromised##2##1##(2010-12#1)(2013-8#1)
immune-mediated disorders##2##2##(2008-10#2)
immune-mediated inflammatory responses in##2##4##(2008-10#2)
immune-mediated inflammatory responses##3##3##(2008-10#3)
immune-mediated inflammatory##9##2##(2008-10#3)(2011-2#6)
immune-mediated##16##1##(2008-10#6)(2008-11#1)(2011-2#9)
immunisation coverage##3##2##(2011-2#3)
immunisation of##2##2##(1996-12#2)
immunisation##7##1##(1991-3#1)(1996-12#2)(2008-7#1)(2011-2#3)
immunised##3##1##(1995-12#2)(1996-12#1)
immunising##4##1##(1995-12#3)(2010-1#1)
immunity against##3##2##(1995-2#2)(2009-6#1)
immunity and protect##2##3##(2011-2#1)(2013-8#1)
immunity and##10##2##(1995-12#1)(1996-12#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-3#3)(2013-8#1)
immunity are##2##2##(2008-9#1)(2012-3#1)
immunity as##2##2##(2008-12#1)(2012-3#1)
immunity by##4##2##(2008-7#2)(2009-8#1)(2011-2#1)
immunity in mice##2##3##(1995-12#1)(2008-10#1)
immunity in the##4##3##(1996-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
immunity in##12##2##(1995-12#1)(1996-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-3#1)
immunity induced by##2##3##(1995-12#1)(2011-2#1)
immunity is##4##2##(2008-4#1)(2008-5#1)(2013-1#2)
immunity of##2##2##(1990-8#1)(2008-12#1)
immunity or##3##2##(1995-5#1)(1996-11#1)(2008-8#1)
immunity to##4##2##(1995-5#1)(1996-3#1)(2008-10#1)(2008-5#1)
immunity was##2##2##(2008-10#1)(2008-9#1)
immunity were reflected##2##3##(2008-10#1)(2008-5#1)
immunity were##3##2##(2008-10#2)(2008-5#1)
immunity##115##1##(1990-8#1)(1991-12#1)(1993-12#1)(1994-1#1)(1994-9#1)(1995-12#4)(1995-2#2)(1995-5#7)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#5)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#2)(2009-10#1)(2009-12#3)(2009-3#1)(2009-6#2)(2009-8#4)(2010-1#1)(2010-3#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#5)(2013-8#1)
immunization and##6##2##(1995-12#1)(1995-5#1)(2008-10#2)(2008-4#1)(2008-9#1)
immunization can##2##2##(1994-9#1)(2008-11#1)
immunization completion##2##2##(1996-12#2)
immunization coverage in##2##3##(1996-12#2)
immunization coverage##4##2##(1996-12#3)(2013-1#1)
immunization is##4##2##(1994-9#4)
immunization levels and##2##3##(1996-12#2)
immunization levels##4##2##(1996-12#4)
immunization of mice with##3##4##(1995-5#1)(2009-6#2)
immunization of mice##4##3##(1995-5#2)(2009-6#2)
immunization of rabbits with##4##4##(1995-5#1)(1996-2#1)(2008-10#2)
immunization of rabbits##5##3##(1995-5#1)(1996-2#1)(2008-10#3)
immunization of##11##2##(1995-5#3)(1996-2#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-6#2)
immunization programs##5##2##(1996-12#3)(2007-12#1)(2013-1#1)
immunization rates##8##2##(1996-12#8)
immunization records##2##2##(1996-1#1)(1996-12#1)
immunization schedule##2##2##(1995-5#2)
immunization schedules##3##2##(1995-5#3)
immunization services##2##2##(1996-12#1)(2010-3#1)
immunization status##6##2##(1996-1#1)(1996-12#4)(2008-12#1)
immunization with a##3##3##(1995-2#1)(2008-11#1)(2008-4#1)
immunization with one or more doses of##2##7##(1995-5#2)
immunization with the##2##3##(1995-12#1)(1995-2#1)
immunization with##19##2##(1995-12#2)(1995-2#2)(1995-5#4)(1996-11#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)
immunization##139##1##(1990-12#2)(1992-5#1)(1993-2#2)(1994-9#13)(1995-12#4)(1995-2#2)(1995-5#16)(1996-1#3)(1996-11#1)(1996-12#33)(1996-2#1)(1996-3#2)(1997-8#4)(2007-12#1)(2008-10#8)(2008-11#19)(2008-12#1)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#6)(2009-12#1)(2009-6#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
immunizations##15##1##(1992-6#1)(1995-5#2)(1996-12#8)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
immunized animals##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
immunized by##2##2##(1995-12#1)(2008-9#1)
immunized mice##4##2##(1990-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
immunized with EP-IPV##2##3##(1995-5#2)
immunized with a##2##3##(1990-12#1)(1995-5#1)
immunized with sheep red blood cells##2##6##(2008-10#1)(2008-7#1)
immunized with##19##2##(1990-12#1)(1995-11#3)(1995-12#1)(1995-5#5)(2008-10#1)(2008-11#6)(2008-7#1)(2008-8#1)
immunized##45##1##(1990-12#4)(1991-11#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-5#5)(1995-6#1)(2008-10#3)(2008-11#13)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#5)(2011-2#1)
immunizing the##2##2##(2008-4#1)(2008-8#1)
immunizing##10##1##(1991-5#1)(1995-5#1)(1996-1#1)(1996-12#2)(2008-4#1)(2008-8#2)(2008-9#1)(2010-12#1)
immuno-PCR##4##1##(2008-8#4)
immuno-chromatographic assay##2##2##(2008-11#2)
immuno-gold##2##1##(2008-10#1)(2008-8#1)
immuno-modulation##2##1##(2008-10#1)(2010-12#1)
immuno-modulatory##2##1##(1997-4#1)(2008-11#1)
immuno-sorbent assay##2##2##(2008-10#2)
immuno-suppressed##2##1##(2008-12#1)(2008-5#1)
immunoaffinity chromatography##10##2##(1990-11#1)(1990-12#2)(1993-9#2)(1994-11#1)(1995-6#1)(2008-11#3)
immunoaffinity column##8##2##(1992-3#1)(2008-10#4)(2008-11#3)
immunoaffinity purification##2##2##(1993-6#1)(1993-9#1)
immunoaffinity##26##1##(1990-11#1)(1990-12#2)(1992-3#1)(1993-6#1)(1993-9#3)(1994-11#1)(1995-6#1)(1997-1#1)(2008-10#8)(2008-11#7)
immunoanalysis##3##1##(2008-10#2)(2010-5#1)
immunoassay and##4##2##(1993-2#1)(2008-10#2)(2008-3#1)
immunoassay based on##2##3##(2008-10#1)(2010-6#1)
immunoassay for clenbuterol (CLB)##2##4##(2008-10#2)
immunoassay for clenbuterol##3##3##(2008-10#3)
immunoassay for the##3##3##(1990-12#1)(2008-10#2)
immunoassay for##18##2##(1990-12#1)(1992-12#1)(1996-12#1)(2008-10#15)
immunoassay format##4##2##(2008-10#3)(2008-11#1)
immunoassay in##5##2##(2008-10#4)(2008-4#1)
immunoassay is##2##2##(2008-10#2)
immunoassay method##3##2##(2008-10#3)
immunoassay of antibody activity##2##4##(2008-10#2)
immunoassay of##9##2##(1990-11#1)(2008-10#7)(2008-11#1)
immunoassay system##4##2##(2008-10#4)
immunoassay to##2##2##(2008-10#2)
immunoassay using##5##2##(2008-10#4)(2008-6#1)
immunoassay was##8##2##(1991-12#1)(2008-10#6)(2008-11#1)
immunoassay with a##2##3##(1992-11#1)(2008-10#1)
immunoassay with##3##2##(1992-11#1)(2008-10#2)
immunoassay##115##1##(1990-11#1)(1990-12#4)(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-2#1)(1995-8#1)(1996-12#3)(1997-2#1)(2008-10#87)(2008-11#5)(2008-3#1)(2008-4#2)(2008-6#1)(2010-6#1)(2011-2#1)
immunoassay)##2##1##(1990-12#1)(1995-11#1)
immunoassays to##2##2##(2008-10#2)
immunoassays using##3##2##(2008-10#2)(2008-12#1)
immunoassays##30##1##(1990-11#1)(1990-12#1)(1993-11#1)(1993-2#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-6#1)(2010-11#3)
immunoblot analyses##2##2##(2008-10#2)
immunoblot analysis of##2##3##(1993-8#1)(2008-10#1)
immunoblot analysis##8##2##(1990-12#1)(1993-8#1)(1995-8#1)(2008-10#3)(2008-11#2)
immunoblot and##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
immunoblot assay##2##2##(2008-1#1)(2008-10#1)
immunoblot##21##1##(1990-12#1)(1990-5#1)(1990-7#1)(1992-9#1)(1993-3#1)(1993-8#2)(1995-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-8#1)
immunoblots of##3##2##(1990-5#1)(1991-9#1)(1995-6#1)
immunoblots##8##1##(1990-5#2)(1991-9#2)(1995-6#2)(2008-10#2)
immunoblotting analysis##3##2##(1996-12#2)(2008-10#1)
immunoblotting and##3##2##(1995-11#1)(2008-11#1)(2008-4#1)
immunoblotting##30##1##(1990-5#1)(1991-12#2)(1991-5#1)(1992-4#1)(1992-6#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-12#2)(1997-1#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#3)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#2)
immunocapture##6##1##(2008-10#4)(2011-2#2)
immunochemical analyses##2##2##(1994-8#1)(2013-1#1)
immunochemical method##2##2##(2008-10#2)
immunochemical methods##2##2##(1995-12#1)(2008-10#1)
immunochemical##14##1##(1993-8#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-6#1)(2008-10#7)(2013-1#1)
immunochemiluminometric##2##1##(1992-9#1)(2008-10#1)
immunochemistry##5##1##(2008-10#3)(2009-3#1)(2010-11#1)
immunocompetence handicap hypothesis##2##3##(2008-8#2)
immunocompetence##4##1##(2008-10#1)(2008-8#3)
immunocompetent cells##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
immunocompetent##15##1##(1996-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#5)(2012-12#1)(2013-1#2)
immunocomplex##5##1##(1993-8#1)(2008-10#4)
immunocomposite##3##1##(2008-10#3)
immunocompromised patients##12##2##(1990-12#1)(1990-5#1)(2008-5#1)(2009-11#1)(2009-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
immunocompromised##22##1##(1990-12#1)(1990-5#1)(1995-8#1)(1997-5#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-9#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#2)
immunocompromized##2##1##(2011-2#2)
immunoconjugates##2##1##(2008-11#1)(2008-7#1)
immunocytes to##2##2##(1995-12#2)
immunocytes##5##1##(1995-12#5)
immunocytochemical and##6##2##(1991-1#1)(1991-8#1)(2007-12#2)(2008-11#1)(2012-3#1)
immunocytochemical detection of##4##3##(2008-7#1)(2008-9#3)
immunocytochemical detection##6##2##(2008-7#1)(2008-9#5)
immunocytochemical localization of##2##3##(2007-12#1)(2011-2#1)
immunocytochemical staining##2##2##(2008-5#1)(2008-8#1)
immunocytochemical studies##2##2##(1996-12#1)(2007-12#1)
immunocytochemical techniques##2##2##(1997-3#1)(2008-11#1)
immunocytochemical##25##1##(1991-1#1)(1991-8#1)(1993-11#1)(1993-3#1)(1996-12#1)(1997-3#1)(2007-12#5)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#1)(2011-2#1)(2012-3#1)
immunocytochemically##3##1##(1995-6#1)(2008-6#1)(2008-9#1)
immunocytochemistry and in situ hybridization##3##5##(1992-6#2)(2008-9#1)
immunocytochemistry and##4##2##(1992-6#2)(2008-8#1)(2008-9#1)
immunocytochemistry in##2##2##(1991-10#1)(2008-7#1)
immunocytochemistry##18##1##(1990-5#1)(1991-10#1)(1992-6#2)(1994-2#4)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)
immunodeficiency and##2##2##(2008-10#2)
immunodeficiency disease##2##2##(2011-2#1)(2012-12#1)
immunodeficiency diseases##3##2##(2012-12#3)
immunodeficiency syndrome (AIDS)##14##3##(1990-6#1)(1991-12#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#1)(2011-3#1)
immunodeficiency syndrome and##2##3##(1994-5#1)(2010-12#1)
immunodeficiency syndrome##25##2##(1990-6#1)(1991-12#3)(1991-9#1)(1993-1#2)(1993-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#1)(2008-12#1)(2008-2#2)(2010-12#1)(2011-3#1)(2013-1#1)
immunodeficiency virus (HIV)##24##3##(1990-6#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2012-3#1)(2013-8#1)
immunodeficiency virus infection in##2##4##(1991-3#1)(2008-4#1)
immunodeficiency virus infection##7##3##(1991-3#1)(1996-2#1)(1997-7#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
immunodeficiency virus protease##3##3##(1991-9#2)(1992-6#1)
immunodeficiency virus type 1 (HIV-1)##6##5##(1995-2#1)(2008-11#1)(2008-2#3)(2011-2#1)
immunodeficiency virus type 1##12##4##(1991-9#2)(1992-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-11#2)(2008-2#3)(2011-2#1)
immunodeficiency virus type##13##3##(1991-9#2)(1992-6#2)(1993-8#1)(1995-2#1)(1997-3#1)(2008-11#2)(2008-2#3)(2011-2#1)
immunodeficiency virus type-1##2##3##(1994-11#1)(1997-3#1)
immunodeficiency virus##77##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#5)(1992-6#4)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-11#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#8)(1997-7#2)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-8#3)(2010-11#1)(2010-3#1)(2011-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
immunodeficiency virus-1##5##2##(1991-9#2)(1992-12#1)(1994-5#1)(2008-11#1)
immunodeficiency viruses##3##2##(1997-6#1)(2008-9#2)
immunodeficiency##128##1##(1990-2#1)(1990-3#1)(1990-6#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#8)(1992-12#1)(1992-6#4)(1993-1#3)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-5#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#5)(1996-1#1)(1996-11#2)(1996-2#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#10)(1997-6#1)(1997-7#2)(1997-8#2)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#4)(2009-11#2)(2009-12#1)(2009-8#3)(2010-11#1)(2010-12#3)(2010-3#2)(2011-2#4)(2011-3#1)(2012-12#6)(2012-3#3)(2013-1#3)(2013-8#1)
immunodeficient mice##4##2##(2008-5#2)(2009-12#1)(2013-1#1)
immunodeficient##8##1##(1991-6#1)(2008-11#1)(2008-12#1)(2008-5#3)(2009-12#1)(2013-1#1)
immunodetection##3##1##(1995-11#1)(2008-10#1)(2008-12#1)
immunodiffusion and##2##2##(1993-2#1)(1996-12#1)
immunodiffusion##4##1##(1990-2#1)(1993-2#1)(1996-12#1)(2008-10#1)
immunodominant##2##1##(1995-2#1)(1996-12#1)
immunoelectron microscopy##5##2##(1995-6#3)(1996-3#1)(2011-1#1)
immunofluorescence and##5##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-9#2)
immunofluorescence microassay##3##2##(1990-12#3)
immunofluorescence microscopy##4##2##(1995-6#2)(2008-10#1)(2008-7#1)
immunofluorescence using a monoclonal antibody##2##5##(2008-10#1)(2008-5#1)
immunofluorescence using a##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
immunofluorescence with FITC##2##3##(2008-4#2)
immunofluorescence with##3##2##(2008-4#2)(2008-5#1)
immunofluorescence##38##1##(1990-12#3)(1990-2#1)(1991-3#2)(1995-12#1)(1995-6#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#7)(2011-2#3)(2012-2#2)(2012-3#2)
immunofluorescence/flow cytometry##2##2##(2008-9#2)
immunofluorescent antibody##2##2##(1991-3#2)
immunofluorescent labeling##4##2##(2008-10#3)(2008-4#1)
immunofluorescent##14##1##(1991-3#2)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)
immunogen##10##1##(1991-9#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#2)
immunogenetics##2##1##(1995-5#1)(2008-1#1)
immunogenic and##3##2##(1995-5#1)(1997-4#1)(2011-2#1)
immunogenic in##3##2##(1995-5#1)(2007-11#1)(2009-6#1)
immunogenic##18##1##(1994-5#1)(1995-5#3)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-6#1)(2011-2#2)(2013-1#2)
immunogenicity and##3##2##(1995-12#2)(2008-10#1)
immunogenicity is##2##2##(2008-10#2)
immunogenicity of biotherapeutics##2##3##(2008-10#2)
immunogenicity of new##2##3##(2007-11#1)(2008-10#1)
immunogenicity of##17##2##(1994-8#1)(1995-5#2)(2007-11#3)(2008-10#7)(2008-8#3)(2013-1#1)
immunogenicity risk assessment##2##3##(2008-10#2)
immunogenicity##55##1##(1994-8#1)(1995-11#2)(1995-12#2)(1995-5#8)(1996-12#1)(2007-11#4)(2008-10#24)(2008-11#2)(2008-4#1)(2008-8#5)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
immunogens##5##1##(1995-5#1)(2008-10#3)(2008-5#1)
immunoglobulin (Ig)##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
immunoglobulin A (IgA)##4##3##(2008-10#1)(2008-11#1)(2010-4#1)(2013-8#1)
immunoglobulin A##8##2##(2008-10#2)(2008-11#1)(2010-4#2)(2013-1#2)(2013-8#1)
immunoglobulin G (IgG)##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
immunoglobulin G##14##2##(1996-12#1)(2008-1#1)(2008-10#8)(2008-7#2)(2009-6#1)(2012-3#1)
immunoglobulin M##3##2##(1992-12#1)(1994-3#1)(1995-2#1)
immunoglobulin and T-cell receptor##3##4##(1994-3#1)(1997-7#1)(1997-9#1)
immunoglobulin and T-cell##4##3##(1994-3#1)(1997-5#1)(1997-7#1)(1997-9#1)
immunoglobulin constant region##2##3##(2008-4#2)
immunoglobulin gene##2##2##(1992-10#1)(1997-7#1)
immunoglobulin heavy chain##5##3##(2008-11#4)(2008-7#1)
immunoglobulin heavy##6##2##(2008-11#4)(2008-7#1)(2011-2#1)
immunoglobulin heavy-chain##2##2##(1995-2#1)(2009-8#1)
immunoglobulin kappa##2##2##(1993-2#1)(1997-8#1)
immunoglobulin light##3##2##(1995-2#2)(2008-9#1)
immunoglobulin pool size##3##3##(2008-11#3)
immunoglobulin pool##4##2##(2008-11#4)
immunoglobulin production stimulating activity of##2##5##(2008-11#2)
immunoglobulin production##4##2##(2008-11#4)
immunoglobulin##100##1##(1990-12#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-2#2)(1994-3#4)(1995-12#2)(1995-2#5)(1995-5#1)(1995-6#1)(1996-12#3)(1996-3#3)(1997-1#1)(1997-5#1)(1997-7#2)(1997-8#1)(1997-9#2)(2008-1#1)(2008-10#13)(2008-11#20)(2008-4#5)(2008-7#5)(2008-9#2)(2009-6#2)(2009-8#2)(2010-11#1)(2010-4#2)(2010-8#2)(2011-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
immunoglobulins and##3##2##(1995-12#1)(2008-11#1)(2012-3#1)
immunoglobulins##17##1##(1990-12#2)(1995-12#2)(1996-2#1)(2008-10#2)(2008-11#5)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
immunogold electron microscopy##2##3##(2007-12#1)(2008-9#1)
immunogold labeling##6##2##(2008-10#5)(2011-2#1)
immunogold labelling##2##2##(2008-11#1)(2008-5#1)
immunogold##14##1##(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-9#2)(2011-2#1)
immunohistochemical analyses##2##2##(1995-6#1)(1996-12#1)
immunohistochemical analysis of##3##3##(1995-2#1)(2008-7#1)(2013-8#1)
immunohistochemical analysis##11##2##(1995-2#1)(2008-10#1)(2008-7#3)(2009-3#1)(2013-1#3)(2013-8#2)
immunohistochemical and clinical##2##3##(1990-8#1)(1993-6#1)
immunohistochemical and in situ hybridization##2##5##(1991-5#2)
immunohistochemical and ultrastructural##2##3##(1992-2#1)(2008-5#1)
immunohistochemical and##8##2##(1990-8#1)(1991-5#2)(1992-2#1)(1993-6#1)(1997-3#1)(2008-5#1)(2008-7#1)
immunohistochemical findings##3##2##(1994-8#1)(2009-3#1)(2013-8#1)
immunohistochemical staining##9##2##(1991-7#1)(1992-3#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#2)(2012-12#1)
immunohistochemical stains##2##2##(1993-6#1)(2009-1#1)
immunohistochemical studies##3##2##(1995-12#1)(2008-12#1)(2011-2#1)
immunohistochemical study of##3##3##(1991-6#1)(2007-12#1)(2012-3#1)
immunohistochemical study##11##2##(1991-6#1)(1992-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-3#1)(2007-12#1)(2010-7#1)(2011-2#1)(2012-3#2)
immunohistochemical techniques##2##2##(2011-2#1)(2012-3#1)
immunohistochemical##69##1##(1990-5#1)(1990-8#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-6#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#3)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#6)(2008-8#1)(2009-1#1)(2009-3#2)(2010-7#1)(2011-2#6)(2012-12#1)(2012-3#4)(2013-1#3)(2013-8#3)
immunohistochemically positive for##2##3##(2010-6#1)(2011-2#1)
immunohistochemically reacted##2##2##(2008-11#2)
immunohistochemically##12##1##(1992-6#1)(1994-12#2)(1995-12#1)(1995-8#1)(1997-3#1)(1997-8#1)(2008-11#2)(2008-5#1)(2010-6#1)(2011-2#1)
immunohistochemistry (IHC)##3##2##(2008-4#1)(2009-8#1)(2011-2#1)
immunohistochemistry and##7##2##(1997-2#2)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
immunohistochemistry for##2##2##(2008-7#1)(2011-2#1)
immunohistochemistry in##3##2##(2008-12#2)(2008-5#1)
immunohistochemistry##42##1##(1991-10#1)(1991-8#1)(1994-11#1)(1996-5#1)(1997-2#4)(2007-12#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#3)(2010-12#1)(2010-6#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
immunohistological studies##2##2##(1991-2#1)(2012-3#1)
immunohistological##3##1##(1991-2#1)(2008-12#1)(2012-3#1)
immunohistology##2##1##(2008-4#1)(2008-5#1)
immunoinhibitory##3##1##(1995-12#2)(2012-3#1)
immunolabeled##2##1##(1997-2#1)(2013-8#1)
immunolabeling##2##1##(1997-2#1)(2008-10#1)
immunolabelling##4##1##(1995-8#1)(1997-2#1)(2007-12#1)(2009-12#1)
immunoliposomes##2##1##(2008-10#2)
immunolocalization of##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
immunolocalization studies##2##2##(2008-10#1)(2008-11#1)
immunolocalization##7##1##(1994-2#1)(2008-10#3)(2008-11#1)(2008-9#2)
immunolocalized to##2##2##(1994-2#1)(1995-12#1)
immunolocalized##3##1##(1994-2#1)(1995-12#2)
immunologic factors##3##2##(1992-10#1)(1997-8#1)(2013-1#1)
immunologic memory##4##2##(1991-12#1)(1995-5#2)(2012-3#1)
immunologic state##2##2##(1991-6#1)(2008-10#1)
immunologic##31##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-3#1)(1995-5#5)(1997-8#3)(2008-10#3)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)
immunological analysis##2##2##(1996-3#1)(2009-8#1)
immunological and molecular##2##3##(1992-6#1)(1997-7#1)
immunological and##5##2##(1992-6#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#1)
immunological assays##6##2##(2008-10#5)(2008-4#1)
immunological effects##3##2##(1991-1#1)(2007-11#1)(2008-11#1)
immunological methods##4##2##(2008-10#4)
immunological reactivity##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
immunological response##2##2##(2007-11#1)(2013-1#1)
immunological surveillance##2##2##(2013-7#2)
immunological tolerance##2##2##(2010-1#1)(2012-3#1)
immunological##75##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-3#1)(1992-6#2)(1993-12#1)(1994-3#1)(1994-5#1)(1995-5#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#4)(2007-12#1)(2008-10#15)(2008-11#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)
immunologically privileged##3##2##(2008-4#1)(2009-10#2)
immunologically relevant##2##2##(2008-4#2)
immunologically##14##1##(1995-12#2)(1996-12#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#2)(2012-3#1)(2013-1#2)
immunology and##2##2##(1994-12#1)(2008-7#1)
immunology##20##1##(1992-12#1)(1994-12#3)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
immunomagnetic bead##2##2##(2008-10#2)
immunomagnetic separation##2##2##(2008-10#1)(2012-2#1)
immunomagnetic##6##1##(2008-10#3)(2008-11#1)(2010-12#1)(2012-2#1)
immunomodulating##7##1##(1991-3#1)(1991-6#2)(1994-3#1)(1995-12#1)(1997-5#1)(2012-3#1)
immunomodulation##8##1##(1993-12#1)(1995-12#1)(2008-10#5)(2011-1#1)
immunomodulator##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
immunomodulatory activity##2##2##(2008-10#2)
immunomodulatory effects on##2##3##(2008-10#2)
immunomodulatory effects##6##2##(1997-4#1)(2008-10#4)(2008-11#1)
immunomodulatory potential##4##2##(2008-10#2)(2012-2#2)
immunomodulatory##22##1##(1993-12#2)(1997-4#1)(2008-10#13)(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#2)
immunopathogenesis of##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)
immunoperoxidase##7##1##(1991-3#3)(1991-8#1)(1993-11#1)(1995-12#1)(2008-10#1)
immunophenotype in##3##2##(1991-2#1)(2008-11#1)(2008-9#1)
immunophenotype##8##1##(1991-2#3)(2008-11#2)(2008-9#2)(2009-8#1)
immunophenotyped##2##1##(2008-9#2)
immunophenotypic analysis of##2##3##(2008-9#2)
immunophenotypic identification and##2##3##(2008-9#2)
immunophenotypic##8##1##(1995-12#1)(1997-1#1)(2008-9#5)(2011-2#1)
immunophenotypically##2##1##(2008-12#1)(2010-1#1)
immunophenotyping is##2##2##(2008-9#2)
immunophenotyping##12##1##(2008-12#1)(2008-5#1)(2008-9#9)(2012-3#1)
immunopositive##3##1##(1992-9#1)(2008-6#1)(2013-8#1)
immunoprecipitate##3##1##(1991-5#1)(1992-2#1)(1992-9#1)
immunoprecipitated##9##1##(1990-5#1)(1992-9#1)(1993-3#1)(1995-6#2)(1996-2#2)(2008-2#2)
immunoprecipitates##3##1##(1992-10#1)(1993-8#1)(2008-3#1)
immunoprecipitation of##2##2##(1997-1#1)(2008-11#1)
immunoprecipitation##14##1##(1990-5#1)(1993-3#1)(1997-1#1)(1997-5#1)(2008-11#4)(2008-2#3)(2008-9#1)(2009-8#1)(2011-2#1)
immunoradiometric assay##4##2##(1990-6#1)(1991-3#1)(1993-2#2)
immunoreaction of##2##2##(2008-10#2)
immunoreaction##15##1##(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#12)
immunoreactions##3##1##(2008-10#3)
immunoreactive cells##2##2##(1990-2#1)(1997-3#1)
immunoreactive for GABA##2##3##(1997-2#2)
immunoreactive for glycine##2##3##(1997-2#2)
immunoreactive for##6##2##(1991-8#1)(1997-2#5)
immunoreactive insulin##2##2##(1991-7#1)(1994-12#1)
immunoreactive to##4##2##(1996-12#2)(1997-3#1)(2008-9#1)
immunoreactive##37##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-2#9)(1997-3#4)(2007-12#2)(2008-10#1)(2008-6#1)(2008-9#2)
immunoreactivities##5##1##(1990-5#1)(1997-2#2)(2011-2#2)
immunoreactivity (IR)##2##2##(1990-5#1)(1995-8#1)
immunoreactivity and##6##2##(1992-3#1)(1992-6#1)(1995-12#1)(2008-5#1)(2009-7#1)(2011-2#1)
immunoreactivity for##4##2##(1997-2#1)(1997-3#1)(2008-10#1)(2010-12#1)
immunoreactivity in the rat##3##4##(1990-5#2)(1995-8#1)
immunoreactivity in the##8##3##(1990-5#4)(1992-6#1)(1995-8#1)(1997-2#2)
immunoreactivity in##19##2##(1990-5#5)(1992-6#1)(1994-2#4)(1994-8#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-2#3)(1997-4#1)
immunoreactivity is##2##2##(1994-2#1)(2008-7#1)
immunoreactivity of the antibody##4##4##(2008-7#4)
immunoreactivity of the##5##3##(1990-5#1)(2008-7#4)
immunoreactivity to##2##2##(1994-12#1)(1996-2#1)
immunoreactivity was detected##2##3##(1990-5#1)(1994-2#1)
immunoreactivity was##8##2##(1990-5#2)(1994-2#3)(1995-12#1)(2008-11#1)(2008-7#1)
immunoreactivity##74##1##(1990-5#10)(1992-3#1)(1992-6#3)(1993-3#1)(1994-12#1)(1994-2#12)(1994-8#2)(1995-12#8)(1995-8#2)(1996-12#4)(1996-2#2)(1997-2#6)(1997-3#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#7)(2009-1#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-3#1)
immunoreactor##4##1##(2008-10#4)
immunoregulation##5##1##(1990-5#1)(1991-2#1)(1995-12#1)(2011-2#1)(2011-3#1)
immunoregulatory##3##1##(1993-8#1)(2009-10#1)(2013-1#1)
immunoscintigraphy##2##1##(1990-6#2)
immunosensing system##4##2##(2008-10#4)
immunosensing##10##1##(2008-10#10)
immunosensor based on##6##3##(2008-10#6)
immunosensor can be regenerated by simply##2##6##(2008-10#2)
immunosensor can be##3##3##(2008-10#3)
immunosensor for detection of##2##4##(2008-10#2)
immunosensor for the detection of##3##5##(2008-10#3)
immunosensor for the direct determination of##2##6##(2008-10#2)
immunosensor for the##7##3##(2008-10#7)
immunosensor for##13##2##(2008-10#13)
immunosensor has##3##2##(2008-10#3)
immunosensor was developed for the##2##5##(2008-10#2)
immunosensor was developed for##3##4##(2008-10#3)
immunosensor was successfully##2##3##(2008-10#2)
immunosensor was##6##2##(2008-10#6)
immunosensor with##4##2##(2008-10#1)(2008-7#3)
immunosensor##53##1##(2008-10#49)(2008-7#3)(2010-11#1)
immunosensors for##3##2##(2008-10#3)
immunosensors##12##1##(2008-10#9)(2010-11#3)
immunosorbent assay (ELISA) and##4##4##(2008-1#1)(2008-10#3)
immunosorbent assay (ELISA) for the##3##5##(1990-2#1)(2008-10#2)
immunosorbent assay (ELISA) for##7##4##(1990-2#1)(1994-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
immunosorbent assay (ELISA)##33##3##(1990-2#1)(1994-3#2)(1995-11#1)(1996-9#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-4#2)(2011-2#1)(2011-3#1)
immunosorbent assay and##4##3##(2008-10#4)
immunosorbent assay for##7##3##(1995-11#1)(1995-8#1)(2008-10#4)(2011-2#1)
immunosorbent assay using##6##3##(2008-10#5)(2010-4#1)
immunosorbent assay##90##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#2)(1994-3#2)(1995-11#2)(1995-8#1)(1996-9#1)(2008-1#1)(2008-10#65)(2008-11#2)(2008-4#2)(2010-4#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)
immunosorbent assay)##3##2##(1993-2#1)(2008-10#1)(2008-8#1)
immunosorbent assays (ELISA)##3##3##(2008-10#2)(2011-2#1)
immunosorbent assays##7##2##(2008-10#6)(2011-2#1)
immunosorbent electron microscopy##3##3##(2008-10#3)
immunosorbent##104##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#2)(1993-2#1)(1994-3#2)(1995-11#2)(1995-8#1)(1996-9#1)(2008-1#1)(2008-10#76)(2008-11#2)(2008-4#2)(2008-8#1)(2010-4#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#1)
immunostained##3##1##(1997-2#1)(1997-3#1)(2008-9#1)
immunostaining as##2##2##(1997-3#1)(2008-7#1)
immunostaining for Mac-1##3##3##(1997-3#3)
immunostaining for##6##2##(1997-3#4)(2008-10#1)(2008-9#1)
immunostaining in##2##2##(1997-2#1)(2008-7#1)
immunostaining was##2##2##(1995-12#1)(2008-7#1)
immunostaining##25##1##(1991-8#1)(1995-12#4)(1997-2#1)(1997-3#5)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-1#1)(2012-2#1)(2013-1#2)
immunostimulatory##2##1##(1994-5#1)(1995-12#1)
immunosuppressant##7##1##(1993-8#1)(1994-3#1)(2007-11#1)(2008-5#1)(2010-12#2)(2010-3#1)
immunosuppressants##4##1##(1991-9#1)(2010-10#1)(2010-12#1)(2013-1#1)
immunosuppressed with##2##2##(2008-5#2)
immunosuppressed##9##1##(2007-12#2)(2008-5#4)(2009-8#1)(2013-1#2)
immunosuppression and##3##2##(1993-12#1)(2008-5#1)(2010-4#1)
immunosuppression on the##3##3##(2008-5#2)(2011-3#1)
immunosuppression##29##1##(1991-1#1)(1992-12#1)(1993-12#2)(1994-5#1)(2008-10#9)(2008-5#6)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
immunosuppressive agents##4##2##(1994-5#1)(2008-10#2)(2012-3#1)
immunosuppressive drug##2##2##(1994-3#1)(2011-2#1)
immunosuppressive drugs have##2##3##(1994-5#1)(2010-7#1)
immunosuppressive drugs with##2##3##(2008-9#1)(2013-1#1)
immunosuppressive drugs##10##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
immunosuppressive therapy##7##2##(1994-5#2)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
immunosuppressive treatment##4##2##(2011-3#3)(2012-3#1)
immunosuppressive##41##1##(1990-5#4)(1993-8#1)(1994-3#1)(1994-5#4)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#5)(2011-3#4)(2012-3#2)(2013-1#2)
immunosuppressives##2##1##(2012-3#2)
immunotherapeutic approach##2##2##(2012-3#1)(2013-8#1)
immunotherapeutic effects##2##2##(2013-1#2)
immunotherapeutic##7##1##(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
immunotherapies##2##1##(2012-3#1)(2013-8#1)
immunotherapy for##5##2##(2008-11#2)(2010-5#2)(2013-1#1)
immunotherapy of##4##2##(1990-12#1)(1990-8#1)(1993-11#1)(1994-5#1)
immunotherapy with##3##2##(1990-12#1)(1994-12#1)(2008-11#1)
immunotherapy##38##1##(1990-12#2)(1990-8#1)(1991-6#1)(1993-11#1)(1994-12#1)(1994-5#2)(2008-11#11)(2009-10#1)(2009-3#2)(2010-12#1)(2010-5#2)(2011-2#7)(2012-2#4)(2012-3#1)(2013-1#1)
immunotoxic potential##3##2##(2008-10#3)
immunotoxic potentials of##2##3##(2008-10#2)
immunotoxic##9##1##(2008-10#9)
immunotoxicants##2##1##(2008-10#2)
immunotoxicities##2##1##(2008-10#2)
immunotoxicity in mice##2##3##(2008-10#2)
immunotoxicity in##4##2##(2008-10#4)
immunotoxicity of##3##2##(1993-12#1)(2008-10#2)
immunotoxicity studies##2##2##(2008-10#2)
immunotoxicity##25##1##(1992-12#1)(1993-12#1)(2008-10#22)(2008-4#1)
immunotoxicological potential of##3##3##(2008-10#3)
immunotoxicological studies##2##2##(2008-10#2)
immunotoxicological##7##1##(2008-10#7)
immunotoxicology of##2##2##(2008-10#2)
immunotoxicology##12##1##(2008-10#12)
immunotoxins##5##1##(1990-12#4)(1990-8#1)
immunoturbidimetric##2##1##(1992-12#1)(2011-2#1)
immunovesicle##2##1##(2008-11#2)
immunovesicles##2##1##(2008-11#2)
immutable##2##1##(2008-12#2)
impact analysis##2##2##(1991-2#1)(2008-10#1)
impact and implications for pediatric nurses##2##6##(2011-1#2)
impact and##9##2##(1996-11#1)(2008-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
impact as##2##2##(2011-2#1)(2013-8#1)
impact at##2##2##(2008-11#1)(2010-12#1)
impact evaluation##2##2##(2008-11#2)
impact factors##5##2##(1995-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
impact for##3##2##(1994-1#1)(2008-9#1)(2012-2#1)
impact in the##3##3##(2008-3#1)(2008-7#2)
impact in##7##2##(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
impact is##2##2##(1996-12#1)(2011-2#1)
impact of HMO##2##3##(2008-11#2)
impact of IDHR##2##3##(2008-10#2)
impact of Medicaid##3##3##(1994-1#1)(1994-3#1)(1995-12#1)
impact of a##14##3##(1991-2#1)(1992-1#1)(1993-12#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2009-2#1)(2012-3#1)
impact of an##2##3##(2011-2#1)(2012-2#1)
impact of cancer##2##3##(1992-2#1)(2010-2#1)
impact of clinical decision-making##2##4##(2008-11#2)
impact of clinical##4##3##(1994-12#2)(2008-11#2)
impact of different##3##3##(2008-11#1)(2012-2#1)(2012-4#1)
impact of exposure to##3##4##(2008-11#1)(2010-12#1)(2011-2#1)
impact of health care reform on##2##6##(1995-12#2)
impact of health##3##3##(1995-12#2)(2013-1#1)
impact of new##2##3##(1995-12#1)(1996-1#1)
impact of primary##2##3##(1994-3#1)(1996-6#1)
impact of spontaneous activity##2##4##(2013-8#2)
impact of stress on##2##4##(2012-3#2)
impact of surgical##2##3##(1994-12#1)(2010-3#1)
impact of the##47##3##(1991-1#1)(1991-12#2)(1991-2#2)(1992-1#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-1#3)(1994-2#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#5)(2008-11#7)(2008-12#2)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
impact of these programs##2##4##(2013-1#2)
impact of these##10##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
impact of this disease##3##4##(2008-10#1)(2008-11#1)(2009-5#1)
impact of this##11##3##(1991-3#1)(2008-10#3)(2008-11#3)(2008-12#2)(2009-5#1)(2011-2#1)
impact of treatment##3##3##(1992-9#1)(2008-2#1)(2011-2#1)
impact of##318##2##(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#3)(1991-2#4)(1991-3#5)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#4)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-1#6)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#4)(1995-12#9)(1995-2#2)(1995-3#2)(1995-6#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-5#1)(2007-12#3)(2008-1#2)(2008-10#37)(2008-11#42)(2008-12#6)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#9)(2009-11#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#18)(2011-8#1)(2012-12#5)(2012-2#8)(2012-3#9)(2012-4#1)(2012-9#1)(2013-1#20)(2013-7#1)(2013-8#13)
impact on all##3##3##(1996-1#1)(2008-10#1)(2013-8#1)
impact on basic##2##3##(2008-10#1)(2008-11#1)
impact on both##2##3##(2008-10#1)(2012-2#1)
impact on cell##3##3##(2008-11#2)(2009-6#1)
impact on cortical cells##2##4##(2008-11#2)
impact on health##3##3##(1991-2#1)(1992-3#1)(2012-12#1)
impact on human health and##2##5##(2010-4#1)(2011-2#1)
impact on human health##3##4##(2008-10#1)(2010-4#1)(2011-2#1)
impact on immunization##2##3##(1995-5#1)(1996-12#1)
impact on nuclear##2##3##(2008-10#1)(2011-2#1)
impact on nursing##2##3##(2008-11#2)
impact on our##2##3##(2008-7#1)(2010-1#1)
impact on overall##2##3##(1992-1#1)(2008-10#1)
impact on patient##4##3##(1994-3#1)(2007-12#1)(2010-2#1)(2010-8#1)
impact on patient's##2##3##(1992-2#1)(2011-2#1)
impact on patients##2##3##(2008-12#1)(2008-7#1)
impact on patients'##2##3##(2010-2#1)(2011-2#1)
impact on payment##2##3##(1992-12#1)(1993-3#1)
impact on prognosis##3##3##(1990-8#1)(2010-11#1)(2012-3#1)
impact on quality of life##3##5##(2012-12#1)(2013-1#2)
impact on relationships##2##3##(2008-11#1)(2013-1#1)
impact on resistance##2##3##(2008-10#1)(2013-1#1)
impact on the development of##2##5##(1995-5#1)(1996-3#1)
impact on the environment##3##4##(2008-10#3)
impact on the health##2##4##(2008-7#1)(2012-12#1)
impact on the quality of life##3##6##(2010-11#1)(2011-2#1)(2013-1#1)
impact on the quality of##5##5##(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
impact on the way##3##4##(1996-1#1)(2011-2#1)(2013-8#1)
impact on the##70##3##(1991-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-5#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#1)(1997-3#1)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-7#2)(2009-8#2)(2010-11#1)(2011-1#1)(2011-10#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#4)
impact on their##2##3##(1992-1#1)(2011-1#1)
impact on these##2##3##(1996-6#1)(2009-12#1)
impact on##229##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-3#2)(1994-5#1)(1995-3#2)(1995-5#3)(1996-1#5)(1996-11#1)(1996-12#4)(1996-3#3)(1996-6#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#32)(2008-11#26)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#12)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#18)(2011-7#1)(2012-12#7)(2012-2#8)(2012-3#4)(2012-5#2)(2013-1#14)(2013-8#7)
impact scale##2##2##(1995-3#1)(2008-7#1)
impact than##2##2##(2012-2#1)(2012-3#1)
impact that##5##2##(1992-1#1)(2008-10#1)(2008-12#1)(2010-7#1)(2013-8#1)
impact the quality##2##3##(2012-2#1)(2013-8#1)
impact the##17##2##(1994-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
impact these##2##2##(2008-7#1)(2008-9#1)
impact upon the##2##3##(2008-12#1)(2010-2#1)
impact upon##8##2##(1994-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-2#1)(2013-1#1)
impact was##2##2##(1995-1#1)(2008-10#1)
impact xylose utilization##2##3##(2012-3#2)
impact##699##1##(1990-6#1)(1990-8#2)(1991-1#2)(1991-12#3)(1991-2#7)(1991-3#7)(1991-6#2)(1991-7#1)(1992-1#9)(1992-12#4)(1992-2#5)(1992-3#6)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#1)(1993-6#2)(1994-1#11)(1994-12#8)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#1)(1995-1#6)(1995-12#10)(1995-2#3)(1995-3#6)(1995-5#3)(1995-6#2)(1995-8#2)(1996-1#9)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#6)(1996-5#1)(1996-6#2)(1997-1#5)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#2)(2007-11#1)(2007-12#4)(2008-1#5)(2008-10#90)(2008-11#75)(2008-12#12)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#24)(2008-8#10)(2008-9#16)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#9)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#6)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#5)(2010-9#1)(2011-1#8)(2011-10#1)(2011-2#49)(2011-4#1)(2011-7#1)(2011-8#1)(2012-12#15)(2012-2#29)(2012-3#18)(2012-4#1)(2012-5#2)(2012-9#1)(2013-1#45)(2013-7#1)(2013-8#26)
impact)##2##1##(2008-12#1)(2011-2#1)
impact?##2##1##(1997-3#1)(2010-3#1)
impacted and##2##2##(2008-7#1)(2009-7#1)
impacted by##4##2##(2008-2#1)(2009-7#1)(2009-9#1)(2012-12#1)
impacted lower##2##2##(1991-3#1)(2013-1#1)
impacted on the##2##3##(2008-11#2)
impacted on##3##2##(2008-11#3)
impacted stone##2##2##(2010-12#2)
impacted teeth##2##2##(1990-2#1)(2013-1#1)
impacted the##2##2##(2008-10#1)(2010-10#1)
impacted##30##1##(1990-2#1)(1991-3#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2009-7#2)(2009-9#2)(2010-10#1)(2010-12#4)(2012-12#1)(2012-3#1)(2013-1#6)
impacting on##4##2##(2008-10#2)(2008-11#2)
impacting the##7##2##(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-8#2)
impacting with##2##2##(1995-6#1)(2008-10#1)
impacting##19##1##(1995-6#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-7#1)(2012-2#1)(2013-8#2)
impaction and##3##2##(1996-2#1)(2008-11#1)(2013-8#1)
impaction of##3##2##(2008-12#2)(2013-1#1)
impaction##14##1##(1992-2#1)(1995-3#2)(1996-2#1)(2008-11#1)(2008-12#2)(2010-12#1)(2013-1#2)(2013-8#4)
impactions##2##1##(2008-10#2)
impactor was fixed##2##3##(2008-10#2)
impactor##10##1##(1992-2#1)(1994-12#1)(1995-3#1)(1997-2#1)(2008-10#5)(2008-5#1)
impactors##3##1##(1992-3#2)(2008-5#1)
impacts and##3##2##(1995-6#1)(1996-1#1)(2010-12#1)
impacts are##3##2##(1992-3#1)(2008-11#1)(2011-2#1)
impacts in##2##2##(1991-12#1)(2013-1#1)
impacts of the##4##3##(2008-11#3)(2008-9#1)
impacts of##27##2##(1991-1#1)(1992-3#1)(1994-2#2)(1995-3#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-5#1)(2008-9#2)(2009-9#1)(2010-11#2)(2011-1#3)(2012-6#1)(2013-1#1)
impacts on the##3##3##(1991-6#1)(1997-7#1)(2009-9#1)
impacts on##13##2##(1991-11#1)(1991-12#1)(1991-6#1)(1994-12#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#2)(2009-9#1)(2012-2#1)
impacts the##3##2##(1996-2#1)(1997-6#1)(2012-3#1)
impacts upon##2##2##(2007-12#1)(2008-5#1)
impacts##73##1##(1991-1#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-3#3)(1992-8#1)(1994-12#1)(1994-2#2)(1995-3#2)(1995-6#4)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#3)(2008-10#8)(2008-11#10)(2008-12#2)(2008-5#2)(2008-9#3)(2009-9#3)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2012-6#2)(2013-1#3)
impair the##5##2##(1991-12#1)(2008-10#2)(2008-4#1)(2012-3#1)
impair##23##1##(1991-12#1)(1992-12#1)(1993-1#1)(1993-9#1)(1995-11#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#3)(2013-1#1)
impaired and##5##2##(1993-3#1)(1994-1#1)(2008-1#1)(2010-4#1)(2013-1#1)
impaired anorectal motor##2##3##(2011-2#2)
impaired both##2##2##(1993-6#1)(2008-10#1)
impaired by##13##2##(1990-2#1)(1992-1#1)(1992-12#1)(1993-6#1)(1997-8#1)(2008-5#1)(2010-11#1)(2011-3#3)(2012-12#3)
impaired fertility##2##2##(1993-8#1)(2012-3#1)
impaired glucose tolerance (IGT)##5##4##(1994-12#1)(2008-3#1)(2011-1#1)(2012-3#2)
impaired glucose tolerance##8##3##(1994-12#2)(1995-12#1)(2008-3#1)(2010-10#1)(2011-1#1)(2012-3#2)
impaired glucose##10##2##(1994-12#2)(1995-12#1)(2008-11#1)(2008-3#2)(2010-10#1)(2011-1#1)(2012-3#2)
impaired growth##4##2##(1996-6#2)(2008-10#1)(2010-6#1)
impaired in the##4##3##(1990-2#1)(1995-6#1)(2008-10#1)(2008-8#1)
impaired in their##4##3##(2008-10#3)(2008-11#1)
impaired in##21##2##(1990-2#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-7#3)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
impaired or##2##2##(1997-1#1)(2012-3#1)
impaired patients##2##2##(1992-3#1)(2011-2#1)
impaired renal function##2##3##(2008-10#1)(2008-5#1)
impaired than##4##2##(1994-8#1)(2008-12#3)
impaired the##4##2##(1993-3#1)(1994-8#1)(1996-2#1)(2008-8#1)
impaired when the##2##3##(1994-3#1)(1995-11#1)
impaired when##3##2##(1990-11#1)(1994-3#1)(1995-11#1)
impaired##159##1##(1990-11#2)(1990-2#2)(1990-5#1)(1990-9#1)(1991-3#1)(1991-7#3)(1992-1#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#5)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-6#2)(1997-1#3)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#13)(2008-12#7)(2008-3#3)(2008-5#5)(2008-7#12)(2008-8#2)(2008-9#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#3)(2010-6#1)(2010-7#4)(2011-1#1)(2011-2#6)(2011-3#3)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#8)(2013-7#1)
impairing##3##1##(2008-10#1)(2010-11#1)(2010-5#1)
impairment after##2##2##(1991-11#1)(2009-10#1)
impairment and subsequent##2##3##(2008-9#1)(2012-12#1)
impairment and##13##2##(1991-1#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
impairment as##2##2##(1997-2#1)(2008-2#1)
impairment associated with##2##3##(2008-2#1)(2008-4#1)
impairment during the##2##3##(2010-7#1)(2012-12#1)
impairment during##3##2##(2010-7#1)(2012-12#1)(2013-1#1)
impairment in a##2##3##(1997-2#1)(2009-6#1)
impairment in the##5##3##(1995-8#1)(2008-7#1)(2008-9#1)(2009-10#2)
impairment in##20##2##(1991-1#1)(1992-12#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#3)(2009-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
impairment is##7##2##(1993-3#1)(1996-5#1)(2008-11#1)(2008-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
impairment most##2##2##(1997-2#1)(2013-8#1)
impairment observed##2##2##(2008-2#1)(2013-8#1)
impairment of LTP##2##3##(2008-7#2)
impairment of quality of life##2##5##(2011-2#1)(2013-1#1)
impairment of quality##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
impairment of the##7##3##(1990-9#1)(1995-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2012-6#1)(2013-8#1)
impairment of##40##2##(1990-11#2)(1990-9#1)(1991-6#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#8)(2008-8#2)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#2)
impairment was##5##2##(1990-12#1)(1997-6#1)(2008-11#1)(2011-1#1)(2011-2#1)
impairment##179##1##(1990-11#3)(1990-12#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#2)(1991-7#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#10)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#2)(2008-2#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#14)(2008-8#3)(2008-9#6)(2009-10#9)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#5)(2010-8#1)(2011-1#4)(2011-2#12)(2012-12#4)(2012-2#6)(2012-3#9)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#9)
impairment-based##2##1##(2008-12#1)(2010-7#1)
impairments and##4##2##(1991-3#1)(1993-3#1)(2008-12#1)(2011-1#1)
impairments as##2##2##(2009-10#1)(2011-1#1)
impairments in patients with##2##4##(2008-12#1)(2013-1#1)
impairments in the##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
impairments in##18##2##(1991-2#1)(1992-3#1)(1993-3#1)(1997-2#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
impairments of##2##2##(1991-7#1)(2008-12#1)
impairments that##2##2##(1993-3#1)(2011-1#1)
impairments##54##1##(1991-1#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-3#1)(1993-3#3)(1993-6#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-3#1)(1997-2#4)(2008-1#1)(2008-11#4)(2008-12#5)(2008-5#1)(2008-7#1)(2009-10#2)(2010-4#1)(2011-1#8)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
impairs endothelial function##2##3##(2008-8#1)(2013-8#1)
impairs induction of##2##3##(2008-7#2)
impairs the##4##2##(1992-3#1)(2008-8#1)(2011-1#1)(2013-7#1)
impairs##19##1##(1992-3#1)(1994-3#1)(1994-8#2)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
impala as##2##2##(2008-10#2)
impala##8##1##(2008-10#8)
impalpable testis##2##2##(2008-10#2)
impalpable##4##1##(2008-10#4)
impart##5##1##(2008-10#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-4#1)
imparted##5##1##(1997-8#2)(2008-10#2)(2008-5#1)
imparting resistance to##2##3##(2008-10#2)
imparting##7##1##(1994-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2011-1#1)
impatiens##6##1##(2008-10#6)
impedance analysis##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
impedance and##4##2##(2008-10#4)
impedance at##3##2##(2008-10#3)
impedance is##2##2##(2008-11#1)(2010-4#1)
impedance measurement##2##2##(2008-10#2)
impedance measurements##2##2##(2008-10#2)
impedance of##3##2##(2008-10#2)(2009-5#1)
impedance spectra##2##2##(2008-10#2)
impedance spectroscopy (EIS)##5##3##(2008-10#5)
impedance spectroscopy and##3##3##(2008-10#3)
impedance spectroscopy##21##2##(2008-10#19)(2009-9#1)(2012-2#1)
impedance technique##2##2##(2008-10#2)
impedance values##2##2##(2008-9#2)
impedance was##2##2##(2008-10#1)(2011-2#1)
impedance##78##1##(2008-10#57)(2008-11#1)(2008-5#1)(2008-9#5)(2009-1#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-8#1)
impedances##4##1##(2008-10#1)(2008-9#3)
impede successful##2##2##(2007-12#1)(2010-12#1)
impede the##2##2##(1995-3#1)(1996-2#1)
impede##12##1##(1995-12#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2010-12#1)(2011-1#1)(2011-2#1)
impeded the##2##2##(2008-11#1)(2008-7#1)
impeded##12##1##(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
impedes##2##1##(1992-3#1)(1997-4#1)
impediment to##2##2##(1996-3#1)(2010-12#1)
impediment##4##1##(1996-3#1)(2008-10#1)(2010-12#1)(2012-3#1)
impediments##2##1##(1995-1#1)(2008-12#1)
impedimetric##2##1##(2008-10#1)(2009-9#1)
impeller##4##1##(1992-1#2)(2008-8#2)
impending##6##1##(1992-3#1)(1995-1#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
imperative and##2##2##(1992-1#1)(2010-10#1)
imperative of##3##2##(1996-1#1)(1996-2#1)(1997-1#1)
imperative to improve##2##3##(2008-11#1)(2013-8#1)
imperative to prevent##2##3##(2010-8#1)(2012-2#1)
imperative to##12##2##(1997-2#2)(2008-11#3)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
imperative##31##1##(1992-1#2)(1993-3#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-11#6)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
imperfect base pairing with the##2##5##(2011-2#2)
imperfect##11##1##(1993-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-3#2)
imperfections##2##1##(2008-3#1)(2013-8#1)
imperfectly##2##1##(1993-2#1)(2008-8#1)
imperial##3##1##(2010-1#2)(2012-2#1)
impermeable##3##1##(1996-2#1)(1997-1#1)(2009-8#1)
impersonal##4##1##(2008-11#4)
impetigo##2##1##(1997-5#1)(2010-6#1)
impetus for##3##2##(1997-7#1)(2008-12#1)(2009-7#1)
impetus##6##1##(1997-1#1)(1997-7#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-11#1)
impingement syndromes are##2##3##(2011-2#2)
impingement##10##1##(2008-12#1)(2011-2#8)(2013-1#1)
impinges##3##1##(1992-1#1)(2008-1#1)(2010-7#1)
impinging on##2##2##(2012-12#1)(2012-2#1)
impinging##3##1##(2008-10#1)(2012-12#1)(2012-2#1)
implant and##2##2##(1995-12#1)(2008-9#1)
implant as##2##2##(2008-9#1)(2013-1#1)
implant at##3##2##(2008-9#3)
implant biocompatibility##2##2##(2009-7#2)
implant design##2##2##(2008-9#1)(2009-7#1)
implant failures##2##2##(2013-1#2)
implant in##2##2##(2008-9#1)(2012-3#1)
implant outcomes##2##2##(2008-9#2)
implant placement##4##2##(2012-12#1)(2013-1#3)
implant programme##5##2##(2008-9#5)
implant recipients##7##2##(2008-9#6)(2012-2#1)
implant removal##3##2##(2009-7#2)(2012-2#1)
implant restorations##2##2##(2010-12#1)(2013-1#1)
implant success##3##2##(2013-1#3)
implant surgery in##2##3##(2008-9#1)(2013-1#1)
implant surgery##7##2##(2008-9#4)(2013-1#3)
implant system##7##2##(2008-8#1)(2008-9#5)(2010-12#1)
implant systems were##2##3##(1996-3#1)(2008-9#1)
implant systems##3##2##(1996-3#1)(2008-9#2)
implant technology##3##2##(2008-9#3)
implant treatment##3##2##(2008-11#1)(2011-7#1)(2013-1#1)
implant use##4##2##(2008-9#3)(2012-2#1)
implant users to##2##3##(2008-9#2)
implant users##26##2##(2008-9#23)(2011-2#2)(2012-2#1)
implant was##5##2##(1992-9#1)(2008-9#1)(2013-1#3)
implant were##3##2##(2008-9#3)
implant with a##2##3##(2008-9#2)
implant##224##1##(1991-1#1)(1992-9#4)(1995-12#1)(1996-3#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#137)(2009-4#2)(2009-7#6)(2010-12#4)(2010-6#1)(2011-2#15)(2011-7#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#33)
implant-supported single crown##2##3##(2013-1#2)
implant-supported##5##1##(2013-1#5)
implantable cardioverter defibrillator implantation##2##4##(2008-12#2)
implantable cardioverter-defibrillator##2##2##(2008-12#2)
implantable drug delivery systems##2##4##(2008-7#2)
implantable##18##1##(2008-11#3)(2008-12#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)(2010-8#1)(2012-3#2)
implantation and##13##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-9#4)(2009-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
implantation has##3##2##(2008-11#1)(2008-9#2)
implantation in a child with##2##5##(2008-9#2)
implantation in a##6##3##(2008-9#5)(2013-1#1)
implantation in paediatric##2##3##(2008-9#2)
implantation in the##2##3##(2008-11#1)(2008-9#1)
implantation in##24##2##(1993-9#1)(2008-11#1)(2008-9#19)(2012-12#1)(2013-1#2)
implantation into##2##2##(2008-12#1)(2009-3#1)
implantation is a##2##3##(2008-9#2)
implantation is##9##2##(1990-8#1)(2008-9#7)(2010-6#1)
implantation may##2##2##(2008-9#1)(2010-12#1)
implantation of Verisyse##2##3##(2011-2#2)
implantation of a##11##3##(1994-2#1)(1994-8#1)(2008-11#1)(2008-12#2)(2008-7#2)(2010-5#1)(2011-2#2)(2012-3#1)
implantation of the##2##3##(1993-8#1)(2011-2#1)
implantation of##34##2##(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#10)(2012-3#1)(2013-1#2)
implantation on the##2##3##(2008-10#1)(2008-9#1)
implantation on##3##2##(2008-10#1)(2008-9#1)(2009-3#1)
implantation period##2##2##(2012-3#2)
implantation sites##2##2##(2008-11#1)(2008-9#1)
implantation surgery##2##2##(2008-9#1)(2010-9#1)
implantation was##8##2##(1994-12#1)(2008-11#1)(2008-9#6)
implantation with##3##2##(1997-6#1)(2008-9#2)
implantation##192##1##(1990-5#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-11#1)(1996-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#4)(2008-11#8)(2008-12#5)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#90)(2009-10#2)(2009-3#3)(2010-12#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#22)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#7)(2013-8#1)
implantation]##2##1##(1991-2#1)(2011-3#1)
implantations##3##1##(1993-6#1)(2008-9#2)
implanted after external fixation of##2##5##(2009-4#2)
implanted children##5##2##(2008-9#4)(2012-2#1)
implanted device##2##2##(1994-9#1)(2010-6#1)
implanted in the##4##3##(2008-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
implanted in##8##2##(1990-8#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-3#1)(2012-3#1)(2013-1#1)
implanted into the##4##3##(1997-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
implanted into##8##2##(1993-1#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#2)(2011-2#1)(2013-1#1)
implanted under##2##2##(2008-9#1)(2010-7#1)
implanted with the##3##3##(1997-2#1)(2008-9#2)
implanted with##8##2##(1997-2#1)(2008-11#2)(2008-8#1)(2008-9#3)(2010-8#1)
implanted younger##2##2##(2008-9#2)
implanted##82##1##(1990-8#1)(1992-3#1)(1993-1#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#24)(2009-3#2)(2009-4#3)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
implantees##11##1##(2008-9#11)
implanting a##2##2##(2008-12#1)(2011-2#1)
implanting##5##1##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
implants and##10##2##(1993-2#1)(2008-9#2)(2009-7#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#1)
implants are##3##2##(2008-5#1)(2008-9#2)
implants at 2 months##2##4##(2012-2#2)
implants at##5##2##(2008-9#1)(2012-2#4)
implants by##2##2##(2008-9#1)(2013-1#1)
implants for##4##2##(1991-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
implants had##2##2##(2008-8#1)(2013-1#1)
implants have##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
implants in the##5##3##(2008-9#2)(2010-5#1)(2013-1#2)
implants in##10##2##(2008-11#1)(2008-5#1)(2008-9#3)(2010-5#2)(2013-1#3)
implants inserted with a torque##2##5##(2013-1#2)
implants inserted with##3##3##(2013-1#3)
implants inserted##5##2##(2011-7#1)(2013-1#4)
implants is##3##2##(1996-3#1)(2012-2#2)
implants may##2##2##(2008-9#1)(2012-12#1)
implants placed in the##2##4##(2013-1#2)
implants showed a##2##3##(2008-5#2)
implants showed##3##2##(2008-5#2)(2008-8#1)
implants to##2##2##(2008-9#1)(2012-2#1)
implants used##2##2##(2013-1#2)
implants using##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
implants were##6##2##(1992-9#1)(2008-9#1)(2009-7#2)(2013-1#2)
implants with##2##2##(2008-11#1)(2013-1#1)
implants##160##1##(1991-5#2)(1992-9#1)(1993-2#1)(1996-3#3)(1997-6#1)(2008-11#5)(2008-5#8)(2008-7#2)(2008-8#3)(2008-9#45)(2009-4#4)(2009-7#5)(2010-5#4)(2010-6#2)(2011-2#11)(2011-7#6)(2012-12#3)(2012-2#22)(2012-3#1)(2013-1#31)
implants]##3##1##(1991-2#1)(1991-3#1)(2013-1#1)
implement a new##3##3##(1994-9#1)(1996-1#1)(2012-3#1)
implement a##16##2##(1991-12#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#3)
implement an##3##2##(1993-2#1)(2008-10#1)(2008-12#1)
implement and##5##2##(1995-2#1)(2008-10#2)(2008-3#1)(2008-8#1)
implement effective##2##2##(2008-11#1)(2012-3#1)
implement strategies##3##2##(2008-11#1)(2010-10#1)(2012-3#1)
implement the new##2##3##(2008-11#1)(2008-3#1)
implement the##14##2##(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2010-9#1)(2011-2#2)
implement these##2##2##(1993-1#1)(2008-11#1)
implement##97##1##(1991-12#1)(1991-2#1)(1992-1#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#4)(1994-2#2)(1994-3#3)(1994-9#1)(1995-12#1)(1995-2#4)(1996-1#2)(1996-3#2)(1997-1#2)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#12)(2008-12#2)(2008-3#4)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#1)
implementation activities##2##2##(1993-12#2)
implementation and evaluation of the##2##5##(2008-11#1)(2008-7#1)
implementation and evaluation of##3##4##(2008-11#2)(2008-7#1)
implementation and evaluation##4##3##(1996-2#1)(2008-11#2)(2008-7#1)
implementation and##16##2##(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
implementation are##2##2##(1993-12#1)(2008-3#1)
implementation date##2##2##(1997-2#1)(2012-12#1)
implementation in a##2##3##(1997-2#1)(2008-3#1)
implementation in the##4##3##(2010-10#1)(2013-1#3)
implementation in##10##2##(1994-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-12#1)(2008-3#1)(2010-10#1)(2013-1#3)
implementation is##5##2##(1995-2#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
implementation issues##4##2##(1994-3#1)(1996-3#1)(2007-12#2)
implementation of a new##2##4##(1996-2#1)(2012-2#1)
implementation of a##18##3##(1991-2#1)(1993-3#2)(1994-3#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#2)(2010-7#1)(2012-2#2)(2013-1#3)
implementation of an##4##3##(2008-11#2)(2008-3#1)(2008-7#1)
implementation of continuous##3##3##(1994-1#2)(2008-10#1)
implementation of evidence-based policies##2##4##(2008-11#2)
implementation of first aid##2##4##(2010-8#2)
implementation of linear scale up##2##5##(2008-7#2)
implementation of new##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
implementation of programs##3##3##(1992-1#1)(1994-1#1)(1994-2#1)
implementation of the Medicare##2##4##(1991-3#1)(1995-12#1)
implementation of the prospective payment system##2##6##(1991-1#1)(1991-2#1)
implementation of the system##2##4##(1992-3#1)(2008-3#1)
implementation of the##39##3##(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#5)(2008-6#1)(2010-2#1)(2012-2#1)
implementation of these##7##3##(1994-1#2)(1997-7#1)(2008-10#1)(2008-11#1)(2011-3#1)(2013-1#1)
implementation of this##6##3##(2008-11#2)(2008-9#1)(2010-10#1)(2010-8#1)(2013-1#1)
implementation of##156##2##(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#2)(1992-1#3)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#4)(1994-1#5)(1994-12#1)(1994-2#3)(1994-3#4)(1995-12#3)(1995-2#3)(1995-3#3)(1996-1#2)(1996-2#3)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#17)(2008-12#2)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#4)(2008-9#3)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#4)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#11)(2013-8#2)
implementation preparation##4##2##(1997-2#4)
implementation strategies##5##2##(2013-1#5)
implementation##288##1##(1991-1#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#3)(1992-2#3)(1992-3#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#4)(1994-1#7)(1994-12#3)(1994-2#5)(1994-3#5)(1995-12#3)(1995-2#5)(1995-3#5)(1995-5#1)(1996-1#5)(1996-12#1)(1996-2#7)(1996-3#4)(1997-1#1)(1997-2#13)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#29)(2008-11#32)(2008-12#7)(2008-2#1)(2008-3#13)(2008-4#1)(2008-6#3)(2008-7#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#9)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#13)(2012-3#4)(2013-1#28)(2013-8#5)
implementations of##3##2##(2008-4#1)(2008-6#1)(2009-12#1)
implemented a##5##2##(1995-12#1)(1996-3#1)(1997-2#1)(2008-9#1)(2010-5#1)
implemented and##5##2##(1994-12#1)(2008-10#1)(2008-3#2)(2011-3#1)
implemented as##3##2##(2008-10#3)
implemented at pilot scale in##2##5##(2008-11#2)
implemented at##6##2##(1996-1#1)(2008-10#1)(2008-11#2)(2013-1#2)
implemented by the##2##3##(1996-12#1)(2008-11#1)
implemented by##13##2##(1992-2#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#4)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
implemented for##9##2##(1994-3#1)(1995-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-8#2)(2011-2#1)
implemented in a##8##3##(1996-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2012-3#1)(2013-8#1)
implemented in the SeaWiFS##2##4##(2008-2#1)(2008-3#1)
implemented in the United##2##4##(1994-1#1)(2008-10#1)
implemented in the##13##3##(1994-1#2)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2010-5#1)(2012-3#1)
implemented in##35##2##(1991-2#1)(1994-1#3)(1995-2#1)(1996-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
implemented on a##2##3##(1992-3#1)(1993-9#1)
implemented on the##2##3##(2008-3#1)(2010-2#1)
implemented on##7##2##(1992-3#1)(1993-9#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-2#1)(2012-12#1)
implemented that##2##2##(1997-1#1)(2008-7#1)
implemented the##2##2##(2008-12#1)(2008-3#1)
implemented through##3##2##(1995-6#1)(1996-12#1)(2008-10#1)
implemented to reduce##2##3##(2013-1#1)(2013-8#1)
implemented to##12##2##(1996-8#1)(1997-1#1)(2008-10#2)(2008-11#2)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
implemented with a##2##3##(2008-3#1)(2008-7#1)
implemented with the##2##3##(2007-12#1)(2008-10#1)
implemented with##9##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
implemented##165##1##(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-9#1)(1994-1#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#3)(1997-1#2)(1997-2#3)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#28)(2008-11#18)(2008-12#6)(2008-2#1)(2008-3#11)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#3)(2010-11#2)(2010-2#1)(2010-5#3)(2010-8#2)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#11)(2013-8#2)
implementing TQM##3##2##(1994-1#1)(1994-2#2)
implementing a##9##2##(1991-2#1)(1992-2#2)(1994-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
implementing an##3##2##(1992-3#1)(1994-2#1)(1995-3#1)
implementing and evaluating the use of##2##6##(2008-11#1)(2008-12#1)
implementing and evaluating the##3##4##(2008-11#2)(2008-12#1)
implementing and##6##2##(2008-11#4)(2008-12#1)(2010-8#1)
implementing the##9##2##(1991-2#1)(1994-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
implementing them##2##2##(1994-3#1)(2008-11#1)
implementing this##3##2##(2008-12#1)(2008-6#1)(2010-9#1)
implementing##87##1##(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#1)(1994-1#5)(1994-12#2)(1994-2#5)(1994-3#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-3#2)(2008-1#1)(2008-10#4)(2008-11#13)(2008-12#8)(2008-3#2)(2008-6#3)(2009-12#1)(2010-10#1)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-8#1)
implements a##2##2##(1995-12#1)(2008-4#1)
implements the##2##2##(2008-11#1)(2008-3#1)
implements##15##1##(1991-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2011-2#1)
implicate##14##1##(1992-3#1)(1993-3#1)(1995-11#1)(1995-6#1)(1997-2#2)(2008-10#1)(2008-11#2)(2009-7#1)(2011-2#1)(2011-9#1)(2012-2#2)
implicated as an##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
implicated as the##5##3##(1990-3#1)(1991-5#1)(2008-4#1)(2008-7#1)(2013-1#1)
implicated as##16##2##(1990-3#1)(1991-5#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2011-2#3)(2013-1#2)
implicated in its pathogenesis##2##4##(1991-3#1)(2010-10#1)
implicated in the control of##2##5##(1993-3#1)(2009-9#1)
implicated in the etiology of##2##5##(2008-10#1)(2011-2#1)
implicated in the pathogenesis of##6##5##(1996-12#2)(2008-1#1)(2008-7#2)(2013-8#1)
implicated in the pathophysiology of##2##5##(2008-11#1)(2013-1#1)
implicated in the regulation of##4##5##(1992-9#1)(2008-4#1)(2008-9#1)(2012-2#1)
implicated in the##40##3##(1991-8#1)(1991-9#1)(1992-10#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-12#3)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
implicated in##101##2##(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-5#2)(1994-9#1)(1995-2#6)(1995-6#2)(1996-12#4)(1996-2#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#4)
implicated##141##1##(1990-3#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#7)(1995-6#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#11)(2008-11#10)(2008-12#2)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#10)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
implicating##8##1##(1995-2#1)(1995-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-8#1)
implication and##2##2##(2008-10#1)(2012-2#1)
implication in##5##2##(1993-3#1)(1996-2#1)(2008-4#1)(2008-5#1)(2012-3#1)
implication is that##4##3##(1993-9#1)(1996-1#1)(2007-12#1)(2008-10#1)
implication of the##2##3##(1995-11#1)(2011-2#1)
implication of this##2##3##(2008-3#1)(2008-7#1)
implication of##13##2##(1992-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-2#3)
implication on##4##2##(2008-10#1)(2008-11#2)(2011-1#1)
implication##33##1##(1992-6#1)(1993-1#1)(1993-3#1)(1993-9#1)(1995-11#1)(1996-1#1)(1996-2#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
implications and##11##2##(1990-8#1)(1991-3#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)
implications are also##2##3##(1996-1#1)(2010-10#1)
implications are discussed##6##3##(1991-2#1)(1991-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-5#1)
implications are##10##2##(1991-2#1)(1991-3#1)(1992-3#1)(1996-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-5#1)
implications for biological##2##3##(1992-12#1)(2008-5#1)
implications for cell##2##3##(2009-8#1)(2011-2#1)
implications for clinical practice and##2##5##(2008-7#1)(2012-2#1)
implications for clinical##4##3##(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
implications for conservation and##2##4##(2008-8#2)
implications for design##2##3##(1992-9#1)(1997-3#1)
implications for disease control strategies##2##5##(2008-10#2)
implications for disease management##2##4##(2008-10#2)
implications for disease##6##3##(2008-10#5)(2008-11#1)
implications for functional brain imaging##2##5##(2009-5#2)
implications for future##3##3##(1993-11#1)(2008-10#1)(2008-7#1)
implications for health care##4##4##(1991-12#1)(1995-2#1)(1997-3#1)(2010-2#1)
implications for health##6##3##(1991-12#1)(1993-1#1)(1995-2#1)(1997-3#1)(2008-12#1)(2010-2#1)
implications for hospital##2##3##(1995-12#1)(1995-2#1)
implications for intervention##3##3##(1992-12#1)(1994-6#1)(2011-2#1)
implications for interventions##2##3##(2009-5#1)(2013-1#1)
implications for nursing##2##3##(1994-2#1)(2008-11#1)
implications for policy##2##3##(1994-1#1)(2010-10#1)
implications for seed dispersal##2##4##(2008-9#2)
implications for the development of##2##5##(2008-11#1)(2010-12#1)
implications for the evolution of##2##5##(2008-8#1)(2008-9#1)
implications for the##29##3##(1991-2#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
implications for their##2##3##(2008-11#1)(2009-10#1)
implications for treatment and##4##4##(2008-12#1)(2008-6#1)(2009-12#1)(2010-7#1)
implications for treatment##5##3##(2008-12#1)(2008-6#2)(2009-12#1)(2010-7#1)
implications for undergraduate education##2##4##(1991-1#1)(2013-1#1)
implications for##186##2##(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#4)(1992-2#2)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#3)(1995-2#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#3)(1997-3#4)(1997-8#1)(2007-12#1)(2008-10#15)(2008-11#14)(2008-12#8)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#6)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#4)(2010-12#1)(2010-2#3)(2010-5#3)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#7)(2012-2#4)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#2)
implications from##4##2##(1991-1#1)(1992-12#1)(2008-10#2)
implications in the##5##3##(2008-1#1)(2008-10#2)(2009-8#1)(2011-2#1)
implications in##19##2##(1991-6#1)(1993-11#1)(1993-5#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
implications of a##5##3##(1994-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(2012-12#1)
implications of its##2##3##(2008-11#1)(2011-2#1)
implications of our study##2##4##(2008-10#1)(2008-9#1)
implications of our##4##3##(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
implications of the##15##3##(1991-1#1)(1991-9#1)(1994-3#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-2#1)
implications of these findings for the##2##6##(1991-5#1)(2009-11#1)
implications of these findings for##5##5##(1991-5#1)(2008-10#1)(2009-11#1)(2009-7#1)(2012-2#1)
implications of these findings##14##4##(1991-2#1)(1991-5#1)(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#3)(2009-11#1)(2009-7#1)(2010-1#1)(2010-9#1)(2012-2#1)
implications of these results for the##2##6##(1994-1#1)(2008-10#1)
implications of these results for##3##5##(1994-1#1)(2008-10#1)(2008-8#1)
implications of these results##5##4##(1994-1#1)(2008-10#2)(2008-11#1)(2008-8#1)
implications of these##28##3##(1991-2#2)(1991-5#1)(1991-6#1)(1994-1#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-8#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-9#2)(2012-2#1)
implications of this result##2##4##(1992-3#1)(2008-9#1)
implications of this##13##3##(1991-12#1)(1992-3#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-9#1)(2011-2#2)
implications of using##5##3##(1992-1#1)(1994-1#1)(2008-11#1)(2008-4#1)(2009-7#1)
implications of##121##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#3)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#3)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-10#15)(2008-11#16)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#2)(2009-5#2)(2009-7#3)(2009-8#2)(2010-1#4)(2010-2#1)(2010-3#2)(2010-9#2)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
implications on##5##2##(1991-12#1)(1992-12#1)(2008-11#1)(2009-5#1)(2011-2#1)
implications that##5##2##(1991-1#1)(1991-12#1)(2008-11#2)(2013-1#1)
implications the##2##2##(2008-12#1)(2013-1#1)
implications to##3##2##(1994-11#1)(2008-11#1)(2008-5#1)
implications##427##1##(1990-6#1)(1990-8#1)(1991-1#5)(1991-12#7)(1991-2#6)(1991-3#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#3)(1992-12#7)(1992-2#5)(1992-3#2)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#6)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#4)(1994-6#1)(1994-8#1)(1995-1#3)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#3)(1996-2#8)(1996-3#5)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-5#1)(1997-8#2)(2007-12#6)(2008-1#2)(2008-10#38)(2008-11#41)(2008-12#15)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#8)(2008-8#13)(2008-9#12)(2009-1#2)(2009-10#4)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#9)(2009-9#3)(2010-1#6)(2010-10#7)(2010-11#5)(2010-12#2)(2010-2#5)(2010-3#2)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#4)(2011-1#4)(2011-2#20)(2012-12#1)(2012-2#11)(2012-3#3)(2013-1#20)(2013-7#2)(2013-8#5)
implicit attitudes##2##2##(2009-9#2)
implicit##17##1##(1991-12#1)(1991-5#1)(1993-1#1)(2008-10#1)(2009-12#1)(2009-9#4)(2010-10#1)(2012-2#1)(2012-3#5)(2013-1#1)
implicitly##7##1##(1993-2#1)(1994-3#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-2#1)
implied by##2##2##(1991-2#1)(2008-8#1)
implied in the##2##3##(2007-8#1)(2008-10#1)
implied in##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
implied that the##4##3##(1990-5#1)(1996-5#1)(2008-5#1)(2008-8#1)
implied that##16##2##(1990-5#1)(1992-9#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-5#3)(2008-8#2)(2008-9#2)
implied##30##1##(1990-5#1)(1991-2#1)(1991-3#1)(1992-9#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#4)(2008-9#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
implies a##6##2##(1992-12#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2009-10#1)
implies that the##6##3##(1990-11#1)(1992-12#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-10#1)
implies that##36##2##(1990-11#1)(1990-8#1)(1992-12#1)(1993-3#1)(1993-8#1)(1996-12#1)(1996-6#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-7#1)(2010-10#1)(2010-5#2)(2011-10#1)(2011-2#1)(2012-3#1)
implies the##7##2##(1997-3#1)(2008-10#3)(2008-5#1)(2008-8#1)(2013-1#1)
implies##66##1##(1990-11#2)(1990-8#1)(1992-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-3#2)(2013-1#2)
imply a##3##2##(1997-5#1)(2008-9#1)(2009-6#1)
imply that multiple##2##3##(1995-2#1)(1997-2#1)
imply that the##9##3##(1995-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
imply that##35##2##(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
imply##51##1##(1990-11#1)(1991-2#2)(1992-3#1)(1993-12#1)(1994-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-6#1)(2009-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
implying an##2##2##(1997-3#1)(2008-11#1)
implying different##2##2##(2008-8#1)(2010-12#1)
implying that the##3##3##(1991-12#1)(1996-2#1)(2008-11#1)
implying that##16##2##(1991-12#1)(1992-6#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)
implying the##3##2##(1995-2#2)(2012-2#1)
implying##30##1##(1991-12#1)(1992-6#1)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
import and##2##2##(1995-2#1)(2008-10#1)
import of##4##2##(1991-2#1)(2008-1#1)(2008-8#1)(2009-9#1)
import substrate##3##2##(1995-2#3)
import##17##1##(1991-2#1)(1995-2#4)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-9#1)(2012-2#3)
importance and##13##2##(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)
importance as a##4##3##(2008-5#1)(2008-9#2)(2011-2#1)
importance as##6##2##(2008-5#2)(2008-7#1)(2008-9#2)(2011-2#1)
importance due to##2##3##(2008-12#1)(2008-5#1)
importance for the##8##3##(1991-2#1)(1991-9#1)(2008-11#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-3#1)
importance for##22##2##(1991-2#2)(1991-9#1)(1992-12#1)(1994-8#1)(2006-6#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#4)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
importance in the process of##2##5##(1992-9#1)(2013-1#1)
importance in the##16##3##(1990-11#1)(1992-9#1)(1993-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
importance in these##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
importance in##54##2##(1990-11#1)(1990-2#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#15)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
importance is##6##2##(1991-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2012-12#1)
importance of a##13##3##(1991-6#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#2)
importance of accurate##2##3##(2008-10#1)(2010-8#1)
importance of age##2##3##(2008-7#1)(2009-12#1)
importance of an accurate##2##4##(1991-11#1)(1995-11#1)
importance of an##3##3##(1991-11#1)(1995-11#1)(2008-4#1)
importance of cell##2##3##(2008-11#1)(2008-5#1)
importance of clinical##4##3##(1990-2#1)(2008-11#1)(2011-1#1)(2012-2#1)
importance of considering##7##3##(1995-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-8#2)(2012-12#1)
importance of experiential##2##3##(1996-1#1)(2008-11#1)
importance of having##2##3##(2008-10#1)(2008-12#1)
importance of health for persons with psychiatric disabilities##2##8##(2009-6#2)
importance of health##3##3##(2009-6#2)(2010-10#1)
importance of high##2##3##(2008-10#1)(2013-1#1)
importance of information##2##3##(1995-5#1)(2008-11#1)
importance of integrating##3##3##(2008-10#1)(2010-7#1)(2012-3#1)
importance of its##2##3##(2008-10#1)(2012-3#1)
importance of learning##2##3##(2008-11#1)(2012-3#1)
importance of local##4##3##(2008-10#1)(2008-12#1)(2010-6#1)(2012-2#1)
importance of primary and secondary infection##2##6##(2008-10#2)
importance of proper##2##3##(1993-1#1)(2007-12#1)
importance of regular##3##3##(1997-4#1)(2011-2#1)(2013-8#1)
importance of screening and##2##4##(2012-3#2)
importance of social support from##2##5##(2009-7#2)
importance of social support##3##4##(2009-7#3)
importance of social##5##3##(2008-11#1)(2009-7#3)(2010-6#1)
importance of the close##2##4##(1991-6#1)(2008-11#1)
importance of the disease##2##4##(2010-1#1)(2013-1#1)
importance of the immune##2##4##(2013-1#2)
importance of the parameters##2##4##(2008-10#2)
importance of the##49##3##(1991-12#1)(1991-3#2)(1991-6#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#4)
importance of these##7##3##(2008-10#2)(2008-11#1)(2010-10#1)(2011-1#1)(2013-8#2)
importance of this##16##3##(1990-5#1)(1994-5#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-2#1)(2013-1#2)
importance of various##2##3##(2009-4#1)(2011-2#1)
importance of##408##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#4)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#5)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#4)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#3)(1997-9#1)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#68)(2008-11#49)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#14)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#8)(2009-8#5)(2010-1#5)(2010-10#8)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#21)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#13)(2012-4#1)(2012-6#1)(2013-1#13)(2013-8#8)
importance on##2##2##(1996-3#1)(2008-12#1)
importance that##2##2##(2008-11#1)(2010-4#1)
importance to the##2##3##(2008-10#1)(2008-5#1)
importance to##17##2##(1990-6#1)(1991-6#1)(1993-3#1)(1994-9#1)(1996-1#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-1#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
importance within##2##2##(2007-12#1)(2008-11#1)
importance##614##1##(1990-10#1)(1990-11#3)(1990-2#3)(1990-3#2)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#6)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#6)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#7)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#5)(1997-9#1)(2006-6#3)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#104)(2008-11#65)(2008-12#12)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#17)(2008-6#2)(2008-7#21)(2008-8#18)(2008-9#26)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#5)(2009-7#8)(2009-8#6)(2010-1#6)(2010-10#9)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#5)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#38)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#19)(2012-4#1)(2012-6#1)(2013-1#20)(2013-8#10)
important activities##4##2##(2008-10#1)(2012-12#3)
important activity##2##2##(1996-1#1)(2012-12#1)
important after##2##2##(1992-5#1)(2008-5#1)
important analytical parameters##3##3##(2008-10#3)
important analytical##6##2##(2008-10#5)(2008-9#1)
important and essential##2##3##(2008-8#1)(2013-1#1)
important and may##2##3##(2008-12#1)(2009-7#1)
important and widely##2##3##(2008-4#1)(2011-2#1)
important and##24##2##(1992-4#1)(1993-1#1)(1994-8#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-10#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
important antitumor##2##2##(1990-2#1)(1995-6#1)
important applications of##2##3##(2008-4#1)(2008-7#1)
important are the##2##3##(1991-11#1)(2008-6#1)
important are##3##2##(1991-11#1)(2008-10#1)(2008-6#1)
important area of##3##3##(2008-12#1)(2008-9#1)(2013-8#1)
important area##5##2##(2008-12#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-8#1)
important areas in##2##3##(2009-3#1)(2010-11#1)
important areas##3##2##(1996-2#1)(2009-3#1)(2010-11#1)
important as a##2##3##(1993-11#1)(2009-6#1)
important as the##5##3##(2008-10#1)(2008-11#3)(2008-12#1)
important as##11##2##(1993-11#1)(2008-10#2)(2008-11#5)(2008-12#1)(2009-6#1)(2010-10#1)
important aspect in##2##3##(2010-11#1)(2013-8#1)
important aspect of the##3##4##(1991-1#1)(1997-4#1)(2008-10#1)
important aspect of##10##3##(1991-1#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-2#1)
important aspect##13##2##(1991-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
important aspects of the##3##4##(1995-5#1)(2008-4#1)(2013-1#1)
important aspects of##6##3##(1994-2#1)(1995-5#1)(2008-4#1)(2011-7#1)(2013-1#2)
important aspects##9##2##(1994-2#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-7#1)(2012-2#1)(2013-1#2)
important because of##3##3##(1993-11#1)(2008-7#1)(2013-1#1)
important because##14##2##(1992-3#1)(1993-11#1)(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-4#1)(2010-8#1)(2013-1#1)
important biological function##2##3##(1995-12#1)(2012-2#1)
important biological processes##2##3##(2008-8#1)(2008-9#1)
important biological##8##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)
important biomarkers##2##2##(2008-10#1)(2008-7#1)
important both##3##2##(1996-2#1)(2008-10#2)
important causal agent of the disease in##2##7##(2008-10#2)
important cell##2##2##(1993-2#1)(2008-11#1)
important cellular processes##2##3##(1995-2#1)(2009-8#1)
important cellular##3##2##(1995-2#1)(2008-11#1)(2009-8#1)
important changes in##2##3##(1994-12#1)(1997-2#1)
important changes##4##2##(1994-12#1)(1996-3#1)(1997-2#1)(2013-1#1)
important character##2##2##(2007-12#1)(2008-12#1)
important characteristics##3##2##(2008-3#1)(2012-4#1)(2013-8#1)
important clinical##6##2##(1992-2#1)(1994-5#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-3#1)
important clues about##2##3##(1991-2#1)(2008-10#1)
important clues##3##2##(1991-2#1)(2008-10#1)(2008-9#1)
important cofactor##2##2##(1992-9#1)(2008-12#1)
important component of the##5##4##(1996-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
important component of##10##3##(1993-3#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
important component##13##2##(1993-3#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
important components of the##2##4##(1997-1#1)(2008-5#1)
important components##4##2##(1997-1#1)(2008-5#1)(2008-9#1)(2009-10#1)
important compound##2##2##(2008-10#2)
important compounds##3##2##(1991-5#1)(2008-10#2)
important conclusions##2##2##(2008-10#2)
important consequences for##2##3##(2008-11#1)(2008-9#1)
important consideration##7##2##(1993-1#1)(2008-10#2)(2008-9#1)(2010-11#1)(2010-6#1)(2013-1#1)
important considerations##2##2##(2008-11#1)(2008-4#1)
important constituent of##2##3##(2008-9#1)(2009-8#1)
important constituent##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
important contaminants##3##2##(1991-3#1)(2008-10#2)
important contribution##4##2##(2008-10#2)(2008-9#1)(2010-7#1)
important contributions to##2##3##(2008-10#1)(2011-2#1)
important correlates of##2##3##(2008-11#1)(2008-8#1)
important demographic##2##2##(2009-8#1)(2012-2#1)
important determinants of##4##3##(1990-12#1)(2008-8#1)(2009-7#1)(2011-2#1)
important determinants##6##2##(1990-12#1)(1993-12#1)(1994-6#1)(2008-8#1)(2009-7#1)(2011-2#1)
important diagnostic and##2##3##(1991-2#1)(2013-8#1)
important diagnostic##5##2##(1991-2#1)(2008-12#1)(2009-9#1)(2011-2#1)(2013-8#1)
important difference##2##2##(1993-9#1)(1994-3#1)
important differences between##3##3##(1993-6#1)(2008-3#1)(2009-4#1)
important differences exist between commonly prescribed antidepressants##2##7##(2012-3#2)
important differences in##4##3##(1992-4#1)(1995-3#1)(2008-11#1)(2008-9#1)
important differences##11##2##(1992-4#1)(1993-6#1)(1995-3#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-3#2)
important disease of##10##3##(2008-10#10)
important disease##13##2##(2008-10#12)(2008-11#1)
important diseases of wheat##3##4##(2008-10#2)(2011-10#1)
important diseases of##5##3##(2008-10#4)(2011-10#1)
important diseases##10##2##(2008-10#7)(2010-1#1)(2011-10#1)(2013-8#1)
important due to the##2##4##(2008-7#1)(2012-2#1)
important ecological##3##2##(2008-8#2)(2009-8#1)
important effects##4##2##(1990-12#1)(1992-1#1)(2008-10#2)
important elements in##2##3##(1994-3#1)(2011-2#1)
important environmental##4##2##(1994-3#1)(2008-10#1)(2008-12#2)
important enzymes##2##2##(2008-12#1)(2011-1#1)
important epidemiological##2##2##(2008-10#1)(2013-1#1)
important ethical##2##2##(2008-11#1)(2011-2#1)
important factor for##4##3##(1992-10#1)(2008-10#1)(2011-3#1)(2013-7#1)
important factor in the##5##4##(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2012-2#1)
important factor in##11##3##(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-3#1)(2010-6#1)(2012-2#1)
important factor##26##2##(1992-10#1)(1993-11#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-11#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
important factors for##2##3##(2008-10#1)(2013-8#1)
important factors in##6##3##(1994-1#2)(2008-11#1)(2008-7#2)(2011-2#1)
important factors that##2##3##(1993-1#1)(2008-9#1)
important factors##25##2##(1993-1#1)(1994-1#2)(2008-10#7)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#2)(2011-2#1)(2013-1#2)(2013-8#1)
important feature of the##4##4##(1992-4#1)(2009-4#1)(2012-3#1)(2013-1#1)
important feature of##7##3##(1992-4#1)(2008-11#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
important feature##8##2##(1992-4#1)(2008-11#1)(2008-6#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
important features in##2##3##(2008-11#1)(2010-8#1)
important features of##2##3##(2008-10#2)
important features##8##2##(2008-10#3)(2008-11#1)(2009-4#1)(2010-8#1)(2012-3#1)(2012-5#1)
important field##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
important finding##3##2##(2008-10#1)(2010-5#1)(2011-1#1)
important fish pathogen##2##3##(2010-4#1)(2013-1#1)
important fish##3##2##(2008-9#1)(2010-4#1)(2013-1#1)
important foliar##3##2##(2008-10#3)
important food##2##2##(2008-12#1)(2010-10#1)
important for determining the##2##4##(2008-3#1)(2010-12#1)
important for future##3##3##(1992-3#1)(2008-11#1)(2008-12#1)
important for health##2##3##(1991-2#1)(1993-2#1)
important for many##2##3##(2008-9#1)(2012-3#1)
important for protection against##2##4##(2008-5#2)
important for the diagnosis##2##4##(1990-11#1)(2012-2#1)
important for the##44##3##(1990-11#1)(1990-2#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#2)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#4)(2013-1#4)(2013-8#1)
important for understanding the##5##4##(1995-2#1)(2008-10#3)(2011-2#1)
important for understanding##6##3##(1995-2#1)(2008-10#3)(2009-7#1)(2011-2#1)
important for##160##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#5)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#14)(2008-12#3)(2008-3#3)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#6)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#2)(2011-10#1)(2011-2#11)(2011-7#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#8)(2013-8#1)
important from##3##2##(2008-10#2)(2008-3#1)
important functional domains of##2##4##(1992-3#1)(2013-1#1)
important functional##3##2##(1992-3#1)(1994-11#1)(2013-1#1)
important functions in##4##3##(1997-2#1)(2008-11#1)(2008-9#1)(2011-1#1)
important functions##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
important gene##2##2##(2008-7#1)(2013-8#1)
important genes and##3##3##(1996-12#1)(2008-11#1)(2008-5#1)
important genes##5##2##(1996-12#1)(2008-11#1)(2008-5#1)(2008-8#2)
important goal##2##2##(2012-2#1)(2013-8#1)
important goals##2##2##(1993-6#1)(2008-11#1)
important groups##4##2##(1990-2#1)(2008-10#1)(2010-1#1)(2011-1#1)
important health##2##2##(1997-2#1)(2012-12#1)
important implications for the##3##4##(1993-3#1)(2008-11#1)(2008-8#1)
important implications for##20##3##(1993-3#1)(1995-12#2)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
important implications##24##2##(1992-3#1)(1993-3#1)(1994-11#1)(1995-12#2)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
important in assessing##3##3##(2008-10#2)(2010-12#1)
important in determining the##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
important in determining##4##3##(2008-10#1)(2008-8#2)(2009-8#1)
important in order to##2##4##(1995-2#1)(2008-10#1)
important in providing##2##3##(1995-11#1)(2011-1#1)
important in regulating##2##3##(1996-3#1)(2008-8#1)
important in the regulation of##2##5##(1993-8#1)(2011-2#1)
important in the##29##3##(1990-2#1)(1991-11#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-5#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#5)
important in these##2##3##(1990-5#1)(2008-10#1)
important in this##2##3##(1994-9#1)(1995-2#1)
important in tumor##2##3##(2008-10#1)(2013-8#1)
important in##114##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#2)(1996-3#1)(1997-1#1)(2007-12#2)(2008-10#24)(2008-11#3)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#2)(2009-8#2)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#5)
important indication##2##2##(1996-3#1)(2010-6#1)
important indicator of the##2##4##(1990-9#1)(2008-12#1)
important influence of##2##3##(2008-5#2)
important influence on##5##3##(1990-12#1)(1996-1#1)(2008-10#1)(2008-5#2)
important influence##7##2##(1990-12#1)(1996-1#1)(2008-10#1)(2008-5#4)
important information##12##2##(1990-3#1)(1990-8#2)(1991-2#1)(1992-12#1)(1992-5#1)(1997-2#1)(2008-10#1)(2009-6#1)(2013-1#3)
important insect##2##2##(2008-10#1)(2010-1#1)
important insights##2##2##(1993-3#1)(2008-4#1)
important is##4##2##(1997-5#1)(2008-11#1)(2011-3#1)(2012-3#1)
important issue in the##2##4##(2008-10#1)(2008-8#1)
important issue in##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)
important issue##7##2##(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#1)
important issues##7##2##(1992-9#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)
important it##2##2##(1997-4#1)(2013-1#1)
important items were##2##3##(1991-2#2)
important key##2##2##(2009-8#1)(2010-12#1)
important lessons##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
important losses##2##2##(2008-10#2)
important means of##4##3##(1993-1#1)(2008-10#2)(2010-1#1)
important means##5##2##(1993-1#1)(1995-5#1)(2008-10#2)(2010-1#1)
important mediator of##2##3##(1994-11#1)(2008-10#1)
important mediator##3##2##(1994-11#1)(2008-10#2)
important metabolic##2##2##(1992-5#1)(2008-1#1)
important modifications in##2##3##(1990-8#1)(1991-5#1)
important natural##2##2##(2008-12#1)(2013-8#1)
important new##2##2##(2011-1#1)(2013-8#1)
important ones were##4##3##(1991-2#4)
important or##2##2##(1993-2#1)(2008-8#1)
important organ##2##2##(2008-11#1)(2010-10#1)
important outcome##3##2##(1991-11#1)(1996-1#1)(2012-12#1)
important parameter for the##2##4##(2008-10#2)
important parameter##6##2##(2008-10#2)(2008-5#1)(2008-8#2)(2010-11#1)
important parameters##6##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-9#1)
important parasite##2##2##(1993-2#1)(2009-7#1)
important part of##15##3##(1993-12#1)(1993-3#1)(1995-2#1)(1996-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-7#1)
important part##18##2##(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-7#1)
important pathogen of##2##3##(2008-10#2)
important pathogen##7##2##(1992-8#1)(2008-10#6)
important pathogens in##2##3##(2011-2#1)(2012-2#1)
important pathogens of##2##3##(2008-10#1)(2010-10#1)
important pathogens##4##2##(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)
important physiological functions##2##3##(2008-8#2)
important physiological##6##2##(1992-12#1)(1995-2#1)(2008-6#1)(2008-8#3)
important place in##3##3##(1992-5#1)(2008-11#1)(2011-2#1)
important point is that##2##4##(2008-11#2)
important point##3##2##(2008-10#1)(2008-11#2)
important policy implications##2##3##(1991-12#1)(1994-12#1)
important potential##2##2##(2008-10#1)(2008-3#1)
important predictor of##2##3##(1995-2#1)(1996-3#1)
important predictors of##2##3##(2008-12#1)(2011-2#1)
important predictors##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
important problem in##2##3##(1996-8#1)(2011-1#1)
important processes##2##2##(2008-8#1)(2009-8#1)
important prognostic information and##2##4##(2009-4#1)(2011-2#1)
important prognostic##5##2##(2008-7#2)(2009-4#1)(2011-2#1)(2012-2#1)
important properties##2##2##(2008-3#1)(2010-7#1)
important property##3##2##(2008-10#2)(2008-5#1)
important public health problem##2##4##(2011-2#1)(2012-12#1)
important public health##6##3##(1991-6#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
important question##5##2##(2008-11#2)(2008-8#1)(2011-1#1)(2011-3#1)
important questions as to##2##4##(1993-12#1)(2008-9#1)
important questions that##3##3##(1993-12#1)(2008-11#1)(2009-6#1)
important questions##6##2##(1993-12#2)(2008-11#1)(2008-9#1)(2009-11#1)(2009-6#1)
important reactive##2##2##(2008-10#2)
important reason for##2##3##(2008-8#1)(2012-2#1)
important recent##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
important regulators of the##2##4##(2008-3#1)(2013-1#1)
important regulators of##3##3##(1995-2#1)(2008-3#1)(2013-1#1)
important regulatory mechanism##3##3##(1992-8#1)(1996-12#1)(2008-2#1)
important regulatory##7##2##(1991-5#1)(1992-8#1)(1993-12#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-2#1)
important research##2##2##(2008-9#1)(2010-10#1)
important risk factor for##2##4##(2008-8#1)(2012-3#1)
important risk factors##2##3##(1991-8#1)(2013-7#1)
important risk##6##2##(1991-8#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
important role during##4##3##(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
important role in regulating the##3##5##(1994-11#1)(2008-11#2)
important role in the##74##4##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-5#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#1)(2013-3#1)
important role in this##4##4##(1993-11#1)(1996-2#1)(2008-7#1)(2008-9#1)
important role in##183##3##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#3)(1991-12#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#3)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-8#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#23)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#13)(2008-9#12)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#16)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#3)(2013-3#1)(2013-8#1)
important role of##13##3##(1991-7#1)(1995-12#2)(1995-3#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#2)(2013-1#1)
important role to play in##4##5##(1992-3#1)(2008-11#2)(2012-12#1)
important role to play##5##4##(1992-3#1)(1993-12#1)(2008-11#2)(2012-12#1)
important role to##6##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#2)(2012-12#1)
important role##229##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#3)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#30)(2008-11#14)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#5)(2008-8#14)(2008-9#14)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#18)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#6)(2012-7#1)(2013-1#4)(2013-3#1)(2013-8#2)
important roles in the regulation of##3##6##(2008-5#1)(2009-8#1)(2013-1#1)
important roles in the##10##4##(1995-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
important roles in##27##3##(1995-11#1)(1996-12#1)(1997-8#2)(2006-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
important roles##35##2##(1994-12#1)(1995-11#1)(1996-12#1)(1997-8#2)(2006-6#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
important signaling##3##2##(1993-3#1)(2009-8#1)(2011-1#1)
important similarities##2##2##(2008-10#1)(2012-9#1)
important since##5##2##(1992-2#1)(1993-2#1)(2008-10#1)(2012-2#1)(2013-8#1)
important site##2##2##(2008-8#1)(2013-8#1)
important source of##2##3##(2008-10#1)(2008-8#1)
important source##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
important sources of##4##3##(1995-1#1)(2008-1#1)(2008-9#1)(2011-3#1)
important step in the##3##4##(2008-11#1)(2009-7#1)(2009-8#1)
important step in##8##3##(1996-2#1)(2008-11#3)(2008-5#1)(2009-7#1)(2009-8#2)
important step##11##2##(1996-2#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-7#1)(2009-8#2)(2012-3#1)
important steps##2##2##(2008-4#1)(2012-2#1)
important structural##6##2##(1995-6#1)(2008-10#2)(2008-9#1)(2009-7#1)(2009-8#1)
important structure##2##2##(2008-11#1)(2008-8#1)
important structures##2##2##(2008-12#1)(2011-2#1)
important survival##2##2##(2008-10#1)(2012-3#1)
important target##6##2##(1995-2#1)(2008-10#1)(2008-5#1)(2012-2#2)(2013-8#1)
important task of the##2##4##(1995-11#1)(2011-4#1)
important task##4##2##(1995-11#1)(2008-2#1)(2010-8#1)(2011-4#1)
important technique##2##2##(2008-10#1)(2008-5#1)
important than##10##2##(1995-1#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-3#1)(2010-6#1)(2013-8#1)
important that doctors##2##3##(1995-2#1)(2011-2#1)
important that the##4##3##(1996-1#1)(2008-12#1)(2008-7#1)(2010-8#1)
important that##20##2##(1991-1#1)(1992-1#1)(1992-6#1)(1995-2#2)(1996-1#1)(1996-12#1)(1997-8#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
important to assess##4##3##(2008-10#1)(2009-11#1)(2013-1#2)
important to avoid##4##3##(1991-6#1)(1997-5#1)(2008-7#1)(2012-2#1)
important to consider##5##3##(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
important to define##2##3##(1994-2#1)(2011-2#1)
important to determine##6##3##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
important to develop##2##3##(1992-9#1)(2008-12#1)
important to distinguish##2##3##(2008-10#1)(2011-2#1)
important to establish##5##3##(1993-1#1)(1996-11#1)(2008-10#2)(2010-11#1)
important to evaluate the##2##4##(2008-7#1)(2012-2#1)
important to evaluate##4##3##(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
important to investigate##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
important to maintaining##2##3##(2010-7#1)(2011-2#1)
important to perform##3##3##(2008-7#2)(2012-3#1)
important to provide##2##3##(1993-6#1)(2013-1#1)
important to recognize the##3##4##(2010-6#1)(2011-2#1)(2013-1#1)
important to recognize##4##3##(2010-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
important to the##9##3##(1991-7#1)(2007-12#1)(2008-11#2)(2008-8#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-8#1)
important to understand the##6##4##(1994-3#2)(1997-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
important to understand##11##3##(1994-3#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-8#1)
important to##135##2##(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-6#2)(1994-2#2)(1994-3#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#8)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#2)(2009-6#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#3)(2011-2#11)(2011-3#1)(2012-2#9)(2012-3#3)(2013-1#9)(2013-8#2)
important tools in##3##3##(2008-10#2)(2011-2#1)
important tools##6##2##(2008-10#2)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
important topic##3##2##(2008-10#1)(2008-12#1)(2009-12#1)
important traits##2##2##(2008-8#1)(2013-8#1)
important transcription##2##2##(2008-1#1)(2012-2#1)
important treatment##2##2##(1990-9#1)(2010-12#1)
important types##2##2##(2008-10#1)(2008-8#1)
important variable##2##2##(2008-10#2)
important variables in##2##3##(2008-10#1)(2008-11#1)
important variables##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
important when the##2##3##(2008-3#1)(2008-7#1)
important when##7##2##(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-1#1)
important with##2##2##(2008-11#1)(2008-5#1)
important##1917##1##(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#4)(1990-9#6)(1991-1#3)(1991-11#4)(1991-12#4)(1991-2#14)(1991-3#5)(1991-5#5)(1991-6#6)(1991-7#2)(1991-8#3)(1992-1#5)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#6)(1992-3#12)(1992-4#3)(1992-5#6)(1992-6#4)(1992-8#5)(1992-9#4)(1993-1#9)(1993-11#6)(1993-12#9)(1993-2#9)(1993-3#13)(1993-6#4)(1993-8#4)(1993-9#2)(1994-1#4)(1994-11#7)(1994-12#8)(1994-2#7)(1994-3#9)(1994-5#9)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#6)(1995-11#7)(1995-12#14)(1995-2#22)(1995-3#2)(1995-5#11)(1995-6#11)(1995-8#7)(1995-9#4)(1996-1#9)(1996-11#2)(1996-12#14)(1996-2#9)(1996-3#8)(1996-5#2)(1996-6#4)(1996-8#2)(1997-1#12)(1997-2#9)(1997-3#5)(1997-4#7)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#11)(1997-9#2)(2006-5#1)(2006-6#3)(2007-11#4)(2007-12#8)(2007-8#1)(2008-1#20)(2008-10#344)(2008-11#135)(2008-12#42)(2008-2#6)(2008-3#26)(2008-4#25)(2008-5#52)(2008-6#9)(2008-7#51)(2008-8#94)(2008-9#75)(2009-1#2)(2009-10#8)(2009-11#6)(2009-12#9)(2009-2#1)(2009-3#5)(2009-4#6)(2009-5#2)(2009-6#9)(2009-7#11)(2009-8#25)(2009-9#4)(2010-1#15)(2010-10#23)(2010-11#17)(2010-12#17)(2010-2#5)(2010-3#4)(2010-4#6)(2010-5#9)(2010-6#11)(2010-7#16)(2010-8#8)(2010-9#3)(2011-1#16)(2011-10#3)(2011-2#100)(2011-3#12)(2011-4#2)(2011-7#6)(2012-12#13)(2012-2#54)(2012-3#41)(2012-4#1)(2012-5#2)(2012-7#1)(2012-9#2)(2013-1#71)(2013-3#2)(2013-7#3)(2013-8#42)
important]##2##1##(1993-3#1)(1994-8#1)
importante##2##1##(2008-5#1)(2011-2#1)
importantly involved in the##2##4##(1991-9#1)(1992-6#1)
importantly##28##1##(1991-9#1)(1992-6#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-5#1)(1997-2#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-7#2)(2011-2#1)(2011-7#1)(2013-8#1)
importation of foods##2##3##(2007-12#2)
importation of##4##2##(2007-12#3)(2008-10#1)
imported from an Asian country##2##5##(2008-10#2)
imported from##3##2##(2008-10#3)
imported into the##2##3##(2011-1#1)(2011-2#1)
imported systems##2##2##(2008-10#2)
imported warning systems##2##3##(2008-10#2)
imported##19##1##(1991-11#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#1)(2011-1#1)(2011-2#3)(2013-8#1)
imports##2##1##(2008-10#2)
impose##4##1##(2008-10#1)(2008-8#1)(2010-5#1)(2012-2#1)
imposed by the##6##3##(1997-1#1)(2008-10#2)(2008-11#1)(2012-2#2)
imposed by##13##2##(1994-2#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#3)(2012-3#1)
imposed in##3##2##(1991-2#1)(2008-3#1)(2012-7#1)
imposed on##6##2##(1991-5#1)(1996-5#1)(2008-10#1)(2008-8#2)(2011-2#1)
imposed##34##1##(1991-2#1)(1991-5#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#5)(2009-12#1)(2009-8#1)(2010-10#2)(2011-2#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-8#1)
imposes##2##1##(1997-7#1)(2007-12#1)
imposing##6##1##(1994-3#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2012-7#1)
imposition of##4##2##(1994-12#1)(1997-2#1)(2008-11#1)(2009-8#1)
impossible dream?##2##2##(1996-2#1)(1997-1#1)
impossible to##14##2##(1991-1#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
impossible##33##1##(1990-11#1)(1990-12#2)(1991-1#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
impotence##2##1##(1994-12#1)(2008-8#1)
impoverished##3##1##(2011-2#3)
impractical for##2##2##(2008-10#1)(2009-5#1)
impractical##8##1##(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-10#1)(2011-2#1)
imprecision for##2##2##(1994-9#1)(2008-10#1)
imprecision##7##1##(1991-12#1)(1994-9#1)(2008-10#4)(2008-8#1)
impregnated activated carbon##2##3##(2008-10#2)
impregnated resin##4##2##(2008-10#4)
impregnated with a##2##3##(2008-10#2)
impregnated with##10##2##(2008-10#10)
impregnated##21##1##(2008-10#21)
impregnation of##3##2##(2008-10#3)
impregnation##8##1##(2008-10#4)(2008-12#2)(2008-7#1)(2012-2#1)
impressed##2##1##(2009-10#1)(2011-2#1)
impression of##4##2##(2008-11#2)(2009-4#1)(2012-2#1)
impression that##3##2##(1990-6#1)(1994-6#1)(1995-6#1)
impression##17##1##(1990-6#1)(1994-6#1)(1995-6#1)(2008-11#5)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#2)(2012-2#3)(2013-1#1)
impressions##5##1##(1990-9#1)(2008-10#2)(2008-12#1)(2010-11#1)
impressive results##2##2##(1993-3#1)(2008-7#1)
impressive##8##1##(1991-11#1)(1992-1#1)(1993-3#1)(1994-12#1)(1996-6#1)(2008-7#1)(2010-11#1)(2011-3#1)
imprint##2##1##(2008-5#1)(2008-9#1)
imprinted electrode##2##2##(2008-10#2)
imprinted in##2##2##(2008-10#1)(2008-11#1)
imprinted polymer##16##2##(2008-10#16)
imprinted polymers##4##2##(2008-10#4)
imprinted sol-gel film##4##3##(2008-10#4)
imprinted##38##1##(2008-10#35)(2008-11#1)(2008-8#1)(2011-2#1)
imprinting and##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
imprinting effect are##2##3##(2008-10#2)
imprinting may##2##2##(2008-8#2)
imprinting technology##2##2##(2008-10#2)
imprinting##21##1##(1993-1#1)(2008-10#15)(2008-11#1)(2008-8#3)(2010-7#1)
imprisoned##2##1##(1990-5#1)(1996-6#1)
improper treatment##2##2##(2008-10#2)
improper##10##1##(1993-1#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2012-3#1)(2013-8#1)
improperly##8##1##(1990-3#1)(1993-1#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
improve SNR of##2##3##(2013-8#2)
improve access and##2##3##(1994-3#1)(1997-2#1)
improve adherence to##3##3##(2008-3#1)(2010-12#1)(2013-1#1)
improve and##4##2##(1997-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
improve care for##2##3##(2013-1#2)
improve care##12##2##(1994-2#1)(1996-2#1)(2008-6#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#5)
improve clinical##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
improve communication about##2##3##(2008-3#1)(2010-4#1)
improve control##2##2##(1993-9#1)(2008-10#1)
improve cost efficiency##2##3##(1996-3#1)(2012-2#1)
improve diagnosis##2##2##(1996-12#1)(2011-2#1)
improve diagnostic accuracy##3##3##(1991-3#1)(2008-10#1)(2010-12#1)
improve diagnostic##4##2##(1991-3#1)(2008-10#2)(2010-12#1)
improve disease##3##2##(2008-10#3)
improve dyspnea##3##2##(2013-8#3)
improve efficiency##2##2##(1995-3#1)(2008-9#1)
improve functional##2##2##(2008-8#1)(2011-2#1)
improve health care##5##3##(1993-3#1)(1997-2#1)(1997-3#1)(2008-6#1)(2013-8#1)
improve health##7##2##(1993-3#1)(1997-2#1)(1997-3#1)(2008-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
improve hospital##4##2##(1991-1#1)(1992-5#1)(1997-8#1)(2008-11#1)
improve in##5##2##(1994-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
improve insulin sensitivity and##2##4##(1993-2#1)(2010-10#1)
improve insulin sensitivity##3##3##(1993-2#1)(2008-11#1)(2010-10#1)
improve its##5##2##(1995-12#1)(1997-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
improve knowledge##2##2##(2008-1#1)(2010-4#1)
improve long-term##3##2##(1994-1#2)(2010-12#1)
improve many##2##2##(2008-11#1)(2013-1#1)
improve on##3##2##(1991-4#1)(2011-2#1)(2013-1#1)
improve our understanding of how##2##5##(1993-12#1)(2008-10#1)
improve our understanding of the##3##5##(2008-10#2)(2008-11#1)
improve our understanding of##6##4##(1993-12#1)(2008-10#3)(2008-11#1)(2009-6#1)
improve our##8##2##(1993-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-6#1)(2012-3#1)
improve outcomes for##4##3##(2008-3#1)(2008-6#1)(2009-10#1)(2013-1#1)
improve outcomes##8##2##(2008-11#2)(2008-3#1)(2008-6#2)(2009-10#1)(2013-1#1)(2013-8#1)
improve overall##2##2##(1995-1#1)(2010-1#1)
improve oxygenation##2##2##(1994-6#1)(2012-3#1)
improve patient##6##2##(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
improve performance##3##2##(1994-1#1)(2012-3#1)(2013-1#1)
improve preventive##2##2##(2010-9#1)(2012-2#1)
improve professional##2##2##(1993-3#1)(2008-12#1)
improve provider##2##2##(1996-1#1)(1997-3#1)
improve quality and##3##3##(1994-2#1)(1996-2#1)(2010-8#1)
improve quality of life##5##4##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
improve quality of##9##3##(1993-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
improve quality##15##2##(1993-12#1)(1994-2#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
improve rehabilitation##2##2##(1991-12#1)(2013-1#1)
improve research##2##2##(2009-4#1)(2010-5#1)
improve resistance##3##2##(2008-10#2)(2012-5#1)
improve sensitivity##2##2##(2008-10#2)
improve significantly the##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
improve significantly##8##2##(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
improve skin##3##2##(2008-5#2)(2012-2#1)
improve strategic##2##2##(1994-12#1)(1994-2#1)
improve survival##5##2##(1994-6#1)(2011-2#1)(2011-3#1)(2012-3#2)
improve symptoms##2##2##(2008-7#1)(2009-6#1)
improve the ability of##2##4##(1997-1#1)(2008-10#1)
improve the ability##3##3##(1995-3#1)(1997-1#1)(2008-10#1)
improve the analytical sensitivity##2##4##(2008-10#2)
improve the care##2##3##(1994-2#1)(2008-3#1)
improve the detection of##2##4##(2008-10#1)(2012-2#1)
improve the detection##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
improve the effectiveness of##2##4##(1997-7#1)(2008-9#1)
improve the efficacy of##3##4##(1994-5#1)(2008-10#2)
improve the efficiency##4##3##(2008-11#1)(2008-5#1)(2010-8#1)(2011-7#1)
improve the final##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
improve the health##5##3##(1991-6#1)(1993-3#1)(1995-1#1)(2008-7#1)(2013-1#1)
improve the long-term##2##3##(2008-10#1)(2008-11#1)
improve the patient's##2##3##(1996-3#1)(2009-9#1)
improve the performance of##6##4##(1993-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
improve the performance##7##3##(1993-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)
improve the prognosis##2##3##(1990-5#1)(2011-2#1)
improve the quality of life##4##5##(1990-12#1)(1990-2#1)(2009-6#1)(2010-11#1)
improve the quality of the##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
improve the quality of##21##4##(1990-12#1)(1990-2#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
improve the quality##23##3##(1990-12#1)(1990-2#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-3#2)(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
improve the reliability of##3##4##(1997-7#1)(2008-10#1)(2011-2#1)
improve the selectivity and##2##4##(2008-10#2)
improve the selectivity##3##3##(2008-10#3)
improve the sensitivity and##2##4##(2008-10#2)
improve the sensitivity of##5##4##(2008-10#4)(2008-9#1)
improve the sensitivity##8##3##(2008-10#7)(2008-9#1)
improve the separation##4##3##(2008-10#4)
improve the survival of##2##4##(2008-5#1)(2010-12#1)
improve the survival##3##3##(2008-11#1)(2008-5#1)(2010-12#1)
improve the use##2##3##(2008-10#1)(2013-1#1)
improve the##226##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#5)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-1#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#3)(1997-3#1)(1997-7#2)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#73)(2008-11#25)(2008-12#3)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#2)(2012-8#1)(2013-1#12)(2013-7#1)(2013-8#2)
improve their quality of life##2##5##(2011-2#2)
improve their##19##2##(1992-12#1)(1993-2#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#4)(2012-3#1)
improve these##3##2##(1991-12#1)(1997-3#1)(2008-5#1)
improve treatment##3##2##(2008-11#1)(2008-6#1)(2013-8#1)
improve tumour kill##2##3##(2008-7#2)
improve understanding of##3##3##(2008-10#2)(2011-2#1)
improve##634##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1991-1#3)(1991-11#2)(1991-12#3)(1991-3#3)(1991-4#1)(1991-6#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#11)(1993-6#1)(1993-9#1)(1994-1#8)(1994-12#5)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#5)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#3)(1995-6#3)(1996-1#4)(1996-11#1)(1996-12#6)(1996-2#8)(1996-3#4)(1997-1#6)(1997-2#3)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#5)(2008-10#120)(2008-11#62)(2008-12#15)(2008-2#1)(2008-3#22)(2008-4#3)(2008-5#13)(2008-6#10)(2008-7#8)(2008-8#10)(2008-9#11)(2009-10#4)(2009-12#4)(2009-3#2)(2009-4#1)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#7)(2010-11#3)(2010-12#9)(2010-3#1)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#3)(2011-1#2)(2011-2#30)(2011-3#1)(2011-7#1)(2011-9#1)(2012-12#6)(2012-2#15)(2012-3#14)(2012-5#1)(2012-8#1)(2013-1#47)(2013-7#2)(2013-8#14)
improved IR##2##2##(2013-8#2)
improved access to##2##3##(1996-3#1)(1997-2#1)
improved access##5##2##(1996-3#1)(1997-2#1)(1997-3#1)(2009-3#1)(2012-2#1)
improved accuracy##4##2##(2008-10#1)(2008-3#2)(2010-7#1)
improved activities##2##2##(2008-5#1)(2011-1#1)
improved after embolisation##2##3##(1995-11#1)(1996-6#1)
improved after the##2##3##(2008-7#1)(2010-11#1)
improved after treatment##2##3##(1992-12#1)(1996-6#1)
improved after##12##2##(1990-11#1)(1991-8#1)(1992-12#1)(1995-11#1)(1996-6#2)(2008-10#1)(2008-12#1)(2008-7#2)(2010-11#1)(2012-3#1)
improved analytical##3##2##(2008-10#3)
improved and##10##2##(1992-3#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2013-8#1)
improved as##3##2##(2007-12#1)(2008-12#1)(2012-2#1)
improved at##2##2##(1997-2#1)(2008-10#1)
improved biocontrol activity##2##3##(2008-10#2)
improved but##2##2##(2008-5#1)(2009-12#1)
improved by a##4##3##(2008-10#1)(2009-7#2)(2011-2#1)
improved by increasing##3##3##(1996-3#1)(2008-10#2)
improved by the addition of##2##5##(1992-2#1)(2008-10#1)
improved by the##4##3##(1992-2#1)(2008-10#2)(2011-3#1)
improved by using##5##3##(2008-10#4)(2010-7#1)
improved by##53##2##(1992-2#1)(1993-1#1)(1993-6#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-7#2)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
improved care##3##2##(1991-12#1)(1995-2#1)(1996-2#1)
improved catalytic##2##2##(2008-10#2)
improved clearly##2##2##(2008-11#1)(2012-2#1)
improved compared##2##2##(2008-11#1)(2010-7#1)
improved control of##2##3##(2008-10#1)(2011-2#1)
improved control##6##2##(2008-10#5)(2011-2#1)
improved cultivars##2##2##(2008-10#1)(2010-10#1)
improved data##2##2##(1997-2#1)(2008-10#1)
improved design of##2##3##(2013-8#2)
improved design##3##2##(2013-8#3)
improved detection##7##2##(2008-10#4)(2008-2#1)(2010-12#1)(2012-12#1)
improved diagnostics##2##2##(2008-5#1)(2011-2#1)
improved dramatically##3##2##(2009-12#1)(2010-8#1)(2013-1#1)
improved efficacy##3##2##(2008-11#1)(2008-5#1)(2012-12#1)
improved flexibility##3##2##(2008-10#3)
improved for##3##2##(1992-3#1)(2008-10#1)(2008-12#1)
improved from##7##2##(1991-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-6#1)
improved growth##2##2##(2008-11#1)(2011-2#1)
improved health##3##2##(2010-1#1)(2012-2#1)(2013-1#1)
improved healthcare performance##2##3##(2010-8#2)
improved if the##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
improved in all##2##3##(2008-10#1)(2008-7#1)
improved in the presence of##2##5##(2008-10#2)
improved in the##10##3##(1994-3#1)(2008-10#4)(2009-3#1)(2012-3#1)(2013-1#3)
improved in##25##2##(1991-6#1)(1994-3#1)(1994-9#1)(1996-1#1)(2008-10#9)(2008-7#4)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#3)
improved its##2##2##(2008-10#1)(2013-1#1)
improved liver##2##2##(2008-11#1)(2012-3#1)
improved measurement##2##2##(2008-3#1)(2012-2#1)
improved mechanical##2##2##(2009-7#2)
improved medical##2##2##(1993-12#1)(2013-8#1)
improved method for##2##3##(2008-11#1)(2012-3#1)
improved method##7##2##(2008-10#4)(2008-11#1)(2008-5#1)(2012-3#1)
improved microwave##2##2##(2008-10#2)
improved more for##2##3##(2008-12#1)(2009-11#1)
improved more##3##2##(2008-12#1)(2008-7#1)(2009-11#1)
improved or##3##2##(1992-5#1)(2011-1#1)(2012-3#1)
improved outcome##2##2##(2008-12#1)(2008-8#1)
improved outcomes for##3##3##(1997-2#1)(2008-11#1)(2012-2#1)
improved outcomes##8##2##(1997-2#1)(2008-11#1)(2008-12#3)(2008-9#1)(2011-2#1)(2012-2#1)
improved pain##2##2##(2008-10#1)(2013-1#1)
improved performance over##2##3##(2008-3#1)(2008-7#1)
improved performance##10##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)
improved plant##2##2##(2008-10#1)(2011-10#1)
improved prevention##2##2##(1997-8#1)(2008-1#1)
improved quality of life##2##4##(1992-3#1)(2010-12#1)
improved quality of##3##3##(1992-3#1)(2008-11#1)(2010-12#1)
improved recovery method##2##3##(2008-10#1)(2012-12#1)
improved response to##2##3##(2008-6#1)(2008-9#1)
improved response##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
improved safety##2##2##(2008-8#1)(2012-2#1)
improved selectivity##5##2##(2008-10#4)(2010-7#1)
improved sensitivity and##2##3##(1996-2#1)(2008-10#1)
improved sensitivity##7##2##(1996-2#1)(2008-10#5)(2010-11#1)
improved significantly over time##2##4##(2008-9#1)(2011-3#1)
improved significantly##14##2##(1990-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-3#1)(2012-2#2)(2013-1#2)
improved specificity##2##2##(2008-10#1)(2012-2#1)
improved speed##2##2##(2008-12#1)(2011-7#1)
improved survival##9##2##(1994-6#1)(2008-11#2)(2008-7#5)(2013-1#1)
improved symptoms##2##2##(2008-8#1)(2011-2#1)
improved technique##2##2##(1994-5#1)(1996-1#1)
improved technology##2##2##(2008-10#1)(2008-12#1)
improved the overall##2##3##(2008-10#1)(2008-5#1)
improved the quality of##3##4##(1993-3#1)(2010-12#1)(2012-12#1)
improved the stability##2##3##(2008-10#2)
improved the##47##2##(1991-3#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1997-6#1)(2008-10#21)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
improved their##5##2##(1990-11#1)(1993-11#1)(1997-6#1)(2008-10#1)(2011-2#1)
improved therapeutic##2##2##(1995-2#1)(2008-7#1)
improved through the##3##3##(2008-10#1)(2009-9#1)(2010-7#1)
improved to##9##2##(1990-11#1)(2008-10#3)(2008-7#1)(2010-10#1)(2013-1#3)
improved traits##2##2##(2008-11#1)(2011-2#1)
improved understanding of##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
improved upon##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2010-12#1)
improved using##6##2##(1992-12#1)(2008-10#4)(2008-11#1)
improved viability##2##2##(2008-11#1)(2009-6#1)
improved when the##2##3##(2008-10#1)(2008-11#1)
improved when##3##2##(2008-10#2)(2008-11#1)
improved with the##3##3##(2008-7#1)(2008-9#1)(2009-11#1)
improved with##10##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)
improved xylose##2##2##(2012-3#2)
improved##682##1##(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#2)(1991-3#3)(1991-6#1)(1991-8#2)(1992-12#5)(1992-2#3)(1992-3#4)(1992-5#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#4)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-6#3)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#1)(1997-5#1)(1997-6#3)(1997-8#4)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#195)(2008-11#50)(2008-12#18)(2008-2#3)(2008-3#23)(2008-4#1)(2008-5#16)(2008-6#4)(2008-7#34)(2008-8#8)(2008-9#11)(2009-1#1)(2009-11#5)(2009-12#5)(2009-2#1)(2009-3#7)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#8)(2010-3#1)(2010-4#4)(2010-6#3)(2010-7#9)(2010-8#8)(2011-1#8)(2011-10#1)(2011-2#30)(2011-3#6)(2011-7#1)(2012-12#10)(2012-2#18)(2012-3#13)(2012-4#1)(2013-1#30)(2013-8#15)
improvement activities##2##2##(1994-2#1)(2010-8#1)
improvement and##16##2##(1993-12#2)(1993-3#2)(1994-3#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
improvement are##2##2##(1995-2#1)(2010-10#1)
improvement assessment##2##2##(2008-11#2)
improvement at##3##2##(1993-3#1)(2008-6#1)(2010-6#1)
improvement because of##2##3##(2008-11#1)(2009-10#1)
improvement compared##2##2##(2008-10#1)(2008-3#1)
improvement efforts##3##2##(1993-1#1)(1997-1#1)(2013-1#1)
improvement for the##2##3##(1994-2#1)(1996-2#1)
improvement for##8##2##(1994-2#1)(1996-2#1)(1997-2#1)(2008-2#2)(2010-12#1)(2011-2#1)(2012-2#1)
improvement has been##2##3##(1993-1#1)(2012-3#1)
improvement has##4##2##(1993-1#1)(1997-1#1)(2008-7#1)(2012-3#1)
improvement in S/N ratio was achieved##2##6##(2008-10#2)
improvement in blood##2##3##(1993-2#1)(2009-1#1)
improvement in both##2##3##(1994-5#1)(2013-1#1)
improvement in clinical##3##3##(1991-12#1)(1994-12#1)(2011-2#1)
improvement in grip strength after##2##5##(2008-9#2)
improvement in grip strength##3##4##(2008-9#3)
improvement in health care##2##4##(1994-1#1)(1994-3#1)
improvement in his##2##3##(2008-12#2)
improvement in long-term##2##3##(1997-1#1)(2010-4#1)
improvement in metal##2##3##(2008-10#1)(2008-7#1)
improvement in overall##2##3##(1991-2#1)(2008-11#1)
improvement in pain and##2##4##(2008-12#2)
improvement in pain##4##3##(2008-12#2)(2008-7#1)(2012-3#1)
improvement in performance##2##3##(1993-3#1)(2008-11#1)
improvement in precision##2##3##(2008-10#2)
improvement in resolution##2##3##(2008-10#1)(2008-3#1)
improvement in sensitivity##3##3##(2008-10#3)
improvement in stability##2##3##(1995-3#1)(2008-5#1)
improvement in subjective pain rating##2##5##(2008-9#2)
improvement in the amount of energy delivered##2##7##(2013-1#2)
improvement in the quality of care##3##6##(1996-2#1)(1997-1#1)(2008-7#1)
improvement in the quality of##6##5##(1996-2#2)(1997-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
improvement in the sensitivity##3##4##(2008-10#3)
improvement in the##42##3##(1991-2#1)(1993-11#1)(1993-3#2)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#4)(2008-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#5)
improvement in time##2##3##(1990-2#1)(2011-2#1)
improvement in##172##2##(1990-2#4)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#2)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#4)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#28)(2008-11#11)(2008-12#6)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#6)(2009-1#1)(2009-2#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#12)(2013-8#4)
improvement initiative##5##2##(2010-2#1)(2013-1#4)
improvement initiatives##3##2##(1997-1#1)(1997-3#1)(2010-8#1)
improvement is still##2##3##(2010-12#1)(2011-2#1)
improvement is##10##2##(1993-11#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-12#1)(2011-2#2)(2013-1#1)
improvement of a##2##3##(2008-11#1)(2008-2#1)
improvement of function##2##3##(2011-2#1)(2013-8#1)
improvement of health care##2##4##(1994-3#2)
improvement of medical##2##3##(1993-12#1)(1997-4#1)
improvement of pain##3##3##(1991-3#1)(2008-9#2)
improvement of quality##2##3##(1994-12#1)(2010-12#1)
improvement of the##30##3##(1990-9#1)(1991-11#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-8#1)(2006-6#1)(2008-10#16)(2008-11#2)(2008-3#1)(2013-1#2)(2013-8#2)
improvement of##101##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-3#2)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#2)(2006-6#1)(2008-10#27)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#4)(2008-9#4)(2009-1#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#5)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
improvement on the##2##3##(2008-10#1)(2011-1#1)
improvement on##6##2##(2008-10#2)(2008-12#1)(2009-11#2)(2011-1#1)
improvement opportunities##2##2##(1995-2#1)(1997-1#1)
improvement or##2##2##(1991-1#1)(2008-7#1)
improvement over current##2##3##(2008-11#1)(2010-5#1)
improvement over the standard##2##4##(1994-9#1)(2008-3#1)
improvement over the##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
improvement over##11##2##(1994-1#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-2#1)
improvement process##4##2##(1995-2#2)(1996-1#1)(2008-3#1)
improvement programs##3##2##(2008-10#2)(2012-2#1)
improvement strategies to##2##3##(1994-3#1)(2013-1#1)
improvement strategies##4##2##(1994-3#3)(2013-1#1)
improvement teams##8##2##(1993-12#6)(1994-1#1)(1994-12#1)
improvement that##2##2##(2008-7#1)(2012-2#1)
improvement the##2##2##(2008-3#1)(2013-1#1)
improvement to##5##2##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2010-9#1)
improvement upon##2##2##(1990-2#1)(2013-8#1)
improvement using##2##2##(2012-2#1)(2012-3#1)
improvement was observed in##3##4##(2010-9#1)(2013-1#2)
improvement was observed##6##3##(2008-10#2)(2010-9#1)(2013-1#3)
improvement was##15##2##(1990-11#1)(1991-3#1)(1993-6#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-9#2)(2011-2#1)(2013-1#3)
improvement with NSS)##2##3##(2008-9#2)
improvement with the##2##3##(2008-7#1)(2011-2#1)
improvement with##10##2##(1996-2#1)(1997-2#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#2)
improvement within##2##2##(2008-6#1)(2011-2#1)
improvement##547##1##(1990-11#1)(1990-12#2)(1990-2#7)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#16)(1993-2#1)(1993-3#15)(1993-6#1)(1993-8#1)(1994-1#10)(1994-12#12)(1994-2#7)(1994-3#9)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#9)(1995-3#6)(1995-6#1)(1996-1#3)(1996-11#3)(1996-2#11)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#14)(1997-2#4)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#77)(2008-11#33)(2008-12#15)(2008-2#8)(2008-3#15)(2008-5#13)(2008-6#6)(2008-7#24)(2008-8#2)(2008-9#14)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#2)(2011-2#33)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#9)(2012-3#14)(2013-1#40)(2013-8#14)
improvement&quot##2##1##(2008-3#1)(2011-2#1)
improvements and##3##2##(1994-3#1)(1997-2#1)(2008-10#1)
improvements are##6##2##(2008-3#3)(2013-1#2)(2013-8#1)
improvements can##3##2##(1990-11#1)(1992-3#1)(1993-9#1)
improvements have been##3##3##(1997-8#1)(2010-10#1)(2010-5#1)
improvements have##4##2##(1997-8#1)(2008-10#1)(2010-10#1)(2010-5#1)
improvements in clinical##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
improvements in functional##2##3##(2008-7#2)
improvements in pain##2##3##(2008-12#2)
improvements in specificity##2##3##(1992-3#1)(2008-10#1)
improvements in the quality##2##4##(2008-11#1)(2012-3#1)
improvements in the##11##3##(1991-12#1)(1991-2#1)(1994-2#1)(1996-3#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
improvements in##76##2##(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)
improvements of the##3##3##(2008-11#2)(2011-2#1)
improvements of##5##2##(1996-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
improvements on##2##2##(1995-2#1)(2012-3#1)
improvements to the##2##3##(1991-12#1)(2008-4#1)
improvements to##6##2##(1991-12#1)(1994-12#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-4#1)
improvements were sustained##2##3##(1991-12#1)(2008-8#1)
improvements were##4##2##(1991-12#1)(1991-2#1)(2008-8#1)(2013-1#1)
improvements with regard to##2##4##(2008-12#1)(2009-3#1)
improvements with##3##2##(2008-12#1)(2008-7#1)(2009-3#1)
improvements##135##1##(1990-11#1)(1991-12#3)(1991-2#2)(1992-1#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#4)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#1)
improves quality of life##3##4##(2008-4#1)(2013-1#1)(2013-8#1)
improves quality##4##2##(2008-4#1)(2009-9#1)(2013-1#1)(2013-8#1)
improves reading efficiency##2##3##(2012-2#2)
improves reading##3##2##(2010-7#1)(2012-2#2)
improves significantly##3##2##(2008-10#1)(2008-9#1)(2011-3#1)
improves the accuracy##2##3##(2010-7#1)(2010-8#1)
improves the quality of##3##4##(1993-6#1)(2008-10#1)(2008-9#1)
improves the robustness##2##3##(1994-9#1)(2008-11#1)
improves the##36##2##(1991-9#1)(1992-1#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#2)(2011-7#1)(2013-8#1)
improves their##2##2##(2008-12#1)(2008-5#1)
improves##96##1##(1990-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#4)(2010-8#2)(2011-2#6)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#3)
improving access to##2##3##(1994-12#1)(1996-3#1)
improving both##3##2##(1991-3#1)(1997-2#1)(2008-10#1)
improving conditions of production medium##2##5##(2012-2#2)
improving health care quality##2##4##(1996-2#1)(2010-8#1)
improving health care##3##3##(1996-2#1)(2010-8#1)(2012-2#1)
improving health##6##2##(1996-12#1)(1996-2#1)(2008-1#1)(2010-5#1)(2010-8#1)(2012-2#1)
improving healthcare delivery##2##3##(2013-1#2)
improving healthcare##3##2##(2013-1#3)
improving its##3##2##(1994-2#1)(1995-6#1)(2011-2#1)
improving knowledge about##2##3##(1991-6#1)(2010-10#1)
improving long-term##2##2##(1997-1#1)(2010-11#1)
improving patient##4##2##(2010-3#1)(2010-4#1)(2010-8#1)(2013-1#1)
improving quality of##3##3##(2008-1#2)(2009-10#1)
improving quality##4##2##(1996-2#1)(2008-1#2)(2009-10#1)
improving road safety##2##3##(2011-2#2)
improving rural##2##2##(1996-3#1)(2011-2#1)
improving sensitivity##3##2##(2008-10#3)
improving the effectiveness of##2##4##(1991-1#1)(1991-7#1)
improving the efficiency of##3##4##(1992-2#1)(2008-12#1)(2010-8#1)
improving the level of##2##4##(2011-2#1)(2013-1#1)
improving the patient's##2##3##(2008-7#1)(2011-2#1)
improving the quality of care##2##5##(1996-2#1)(2008-11#1)
improving the quality of##4##4##(1993-2#1)(1996-2#2)(2008-11#1)
improving the quality##5##3##(1993-2#1)(1996-2#2)(2008-11#1)(2013-1#1)
improving the sensitivity of##2##4##(1994-1#1)(2010-7#1)
improving the sensitivity##3##3##(1994-1#1)(2009-11#1)(2010-7#1)
improving the##59##2##(1990-11#1)(1991-1#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-3#2)(1994-1#1)(1996-2#4)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-11#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
improving their##3##2##(2008-12#1)(2008-7#1)(2009-9#1)
improving##213##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#1)(1994-12#2)(1994-2#3)(1994-6#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#6)(1996-3#3)(1997-1#3)(1997-2#5)(1997-3#2)(2008-1#4)(2008-10#33)(2008-11#14)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#2)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#6)(2010-9#2)(2011-2#11)(2012-12#4)(2012-2#12)(2012-3#3)(2013-1#15)(2013-8#4)
improvisation##2##1##(1991-1#1)(1991-12#1)
impulse activity##5##2##(2008-5#5)
impulse control##3##2##(2008-4#1)(2012-12#1)(2013-8#1)
impulse discharge from##2##3##(2008-8#2)
impulse##15##1##(1991-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#2)(2012-12#1)(2012-3#1)(2013-8#1)
impulses##4##1##(2008-7#1)(2008-8#2)(2009-9#1)
impulsive##5##1##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-12#1)
impulsiveness##6##1##(1990-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#1)
impulsivity##2##1##(2011-2#1)(2012-2#1)
impurities are##2##2##(2008-10#2)
impurities for a stavudine synthesis control##3##6##(2008-10#3)
impurities from##2##2##(2008-10#1)(2008-11#1)
impurities in the##2##3##(2008-10#1)(2010-2#1)
impurities in##14##2##(2008-10#12)(2008-3#1)(2010-2#1)
impurities of similar structure##2##4##(2008-10#2)
impurities of##6##2##(2008-10#6)
impurities was##4##2##(2008-10#2)(2010-2#2)
impurities were##3##2##(2010-2#2)(2012-2#1)
impurities##57##1##(1994-3#1)(1996-1#1)(2008-10#37)(2008-11#2)(2008-3#1)(2008-7#2)(2010-2#9)(2012-2#2)(2013-8#2)
impurity of##2##2##(2008-11#1)(2008-5#1)
impurity profile##3##2##(2008-10#3)
impurity was##3##2##(2008-10#3)
impurity##18##1##(1992-11#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#3)(2010-2#2)
imputation##3##1##(2012-3#2)(2013-1#1)
in &gt##10##2##(2008-10#3)(2008-7#4)(2011-2#2)(2013-1#1)
in &lt##3##2##(2008-10#2)(2008-11#1)
in &quot##19##2##(1990-2#1)(1992-2#1)(1993-2#1)(1996-1#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-11#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
in 'Burley 21'##2##3##(2008-10#2)
in (1)##2##2##(2008-12#1)(2010-8#1)
in (1)D##2##2##(2008-10#2)
in (13)C##2##2##(2010-3#2)
in (i)##2##2##(2008-10#1)(2008-11#1)
in 0##91##2##(1990-2#1)(1990-5#1)(1992-10#1)(1993-6#1)(1993-8#2)(1996-2#1)(2008-10#73)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#6)
in 1 (3##2##3##(2011-1#2)
in 1 M##2##3##(2008-10#2)
in 1 case##4##3##(1990-6#1)(1991-3#1)(1994-1#1)(2008-11#1)
in 1 h##3##3##(2008-10#3)
in 1 min##4##3##(2008-10#4)
in 1 ml of##3##4##(2008-10#3)
in 1 patient##6##3##(1990-3#1)(1992-1#1)(1994-12#3)(2010-7#1)
in 1 second (FEV1)##2##4##(2008-1#1)(2011-2#1)
in 1##77##2##(1990-3#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-11#1)(1991-3#1)(1992-1#1)(1993-3#2)(1994-1#1)(1994-12#3)(1994-3#2)(1994-6#1)(1996-8#1)(1997-1#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#6)(2013-1#2)
in 1% Triton X-100 plus 0##2##6##(2008-10#2)
in 1% of##2##3##(2008-8#1)(2011-2#1)
in 1%##6##2##(1990-12#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
in 1-##2##2##(2008-10#1)(2008-6#1)
in 10 cases##2##3##(2008-9#1)(2011-2#1)
in 10 days##2##3##(1992-12#1)(2008-12#1)
in 10 min##4##3##(2008-10#3)(2008-11#1)
in 10 ml of##4##4##(2008-10#4)
in 10 non-chemotactic mutants##2##4##(1995-8#2)
in 10 of the##2##4##(2008-10#2)
in 10 of##5##3##(1996-1#1)(2008-10#3)(2013-1#1)
in 10 patients##7##3##(1990-12#1)(1995-11#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
in 10 s##2##3##(2008-10#2)
in 10 states##2##3##(1995-2#1)(2008-10#1)
in 10##52##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-12#1)(1993-1#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-1#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-2#5)(2012-12#1)(2013-1#3)(2013-8#1)
in 10% of patients##2##4##(1996-11#1)(2008-7#1)
in 10% of##6##3##(1991-8#1)(1996-11#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
in 10% pear juice##2##4##(2008-10#2)
in 10%##16##2##(1991-8#1)(1996-11#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#2)(2013-1#1)
in 10(6) volume-mixing##2##3##(2008-3#2)
in 10(6)##3##2##(2008-3#3)
in 10(9)##5##2##(2007-12#1)(2008-3#4)
in 100 consecutive##2##3##(2008-7#1)(2011-2#1)
in 100 patients##2##3##(1991-1#1)(2010-4#1)
in 100##14##2##(1991-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-2#3)
in 100% of##4##3##(1990-3#1)(1991-2#1)(2008-11#2)
in 100% oxygen##2##3##(2011-2#1)(2012-3#1)
in 100%##8##2##(1990-3#1)(1991-2#1)(2008-11#2)(2011-2#1)(2012-3#2)(2013-1#1)
in 1031 healthy##2##3##(1994-12#1)(2012-3#1)
in 1031##3##2##(1994-12#2)(2012-3#1)
in 105##2##2##(1997-3#1)(2013-1#1)
in 109##2##2##(1992-3#1)(2008-12#1)
in 11 cases##3##3##(1992-12#1)(1995-5#1)(2007-8#1)
in 11 of the##2##4##(2008-1#1)(2008-7#1)
in 11 of##4##3##(1994-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
in 11 patients##7##3##(1996-9#1)(2008-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
in 11##35##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-12#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
in 11%##2##2##(1997-3#1)(2013-1#1)
in 112##2##2##(1990-3#1)(1992-9#1)
in 12 min##2##3##(2008-10#2)
in 12 patients##4##3##(1993-2#1)(1994-12#1)(2011-2#1)(2013-1#1)
in 12##26##2##(1993-2#1)(1994-12#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
in 12% of the##2##4##(1991-9#1)(2012-3#1)
in 12% of##4##3##(1991-9#1)(1996-1#1)(2011-2#1)(2012-3#1)
in 12%##6##2##(1991-9#1)(1996-1#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
in 120##2##2##(1996-3#1)(2008-10#1)
in 121##2##2##(1992-5#1)(2008-8#1)
in 122 children##2##3##(2008-12#1)(2013-1#1)
in 128 and 256 mg/kg females##2##6##(2008-9#2)
in 128 mg/kg females and 256 mg/kg males and females##2##10##(2008-9#2)
in 128##4##2##(2008-9#4)
in 13 cases##3##3##(1997-8#1)(2007-11#1)(2008-5#1)
in 13 of##3##3##(1993-3#1)(2008-10#1)(2012-3#1)
in 13 out of##3##4##(2008-10#2)(2011-1#1)
in 13 patients with##2##4##(1995-11#1)(2010-7#1)
in 13 patients##6##3##(1991-8#1)(1994-12#1)(1995-11#1)(1996-6#1)(1997-6#1)(2010-7#1)
in 13##27##2##(1990-8#1)(1991-8#1)(1992-5#2)(1993-3#1)(1994-12#1)(1995-11#2)(1995-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-5#2)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
in 13%##2##2##(1997-3#1)(2011-2#1)
in 1321N1 cells##2##3##(1997-7#2)
in 1321N1##3##2##(1997-7#3)
in 137##2##2##(1993-2#1)(2008-9#1)
in 14 cases##3##3##(1990-2#1)(1991-11#1)(2008-5#1)
in 14 cities##2##3##(2008-10#2)
in 14 of##4##3##(1991-6#1)(1995-12#1)(1995-3#1)(2008-9#1)
in 14 patients##2##3##(1993-1#1)(1997-8#1)
in 14##28##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#2)(1993-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
in 14-3-3 proteins and##2##4##(2008-11#2)
in 142##2##2##(1990-2#1)(2008-9#1)
in 144##2##2##(2008-5#1)(2010-7#1)
in 145##2##2##(1990-3#1)(2012-12#1)
in 147##2##2##(2011-2#1)(2012-12#1)
in 15 min##2##3##(1992-2#1)(2008-10#1)
in 15 out of##2##4##(1990-6#1)(2008-10#1)
in 15 patients with##2##4##(1990-2#1)(1990-9#1)
in 15 patients##6##3##(1990-2#2)(1990-9#1)(1992-1#1)(2008-7#1)(2012-3#1)
in 15##26##2##(1990-2#2)(1990-6#1)(1990-9#1)(1992-1#1)(1992-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#3)(2012-3#1)
in 15% of##2##3##(2008-10#1)(2011-2#1)
in 15%##6##2##(1997-3#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
in 150 mM##2##3##(1991-5#1)(1994-5#1)
in 150##3##2##(1991-5#1)(1994-5#1)(2008-5#1)
in 154##2##2##(2008-5#1)(2013-8#1)
in 155##2##2##(2008-10#1)(2011-1#1)
in 156##2##2##(1996-6#1)(2011-2#1)
in 16 cases##2##3##(1990-2#1)(2007-11#1)
in 16 h##2##3##(2008-10#1)(2012-2#1)
in 16 of##3##3##(1994-1#1)(2008-10#1)(2011-2#1)
in 16 patients with##3##4##(2008-5#1)(2010-1#1)(2011-2#1)
in 16 patients##4##3##(1997-8#1)(2008-5#1)(2010-1#1)(2011-2#1)
in 16##26##2##(1990-2#2)(1991-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-9#1)(2013-1#1)(2013-8#1)
in 16% of the cases##2##5##(1997-8#1)(2008-5#1)
in 16% of##3##3##(1993-12#1)(1997-8#1)(2008-5#1)
in 16%##4##2##(1993-12#1)(1997-8#1)(2008-5#1)(2008-8#1)
in 163##2##2##(2010-7#1)(2011-2#1)
in 16th-century##2##2##(2008-11#2)
in 17 patients##7##3##(1990-11#1)(1990-8#1)(1991-3#1)(2008-1#1)(2008-7#2)(2011-2#1)
in 17##22##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1993-8#1)(1995-5#2)(1996-11#1)(2008-1#3)(2008-6#1)(2008-7#2)(2008-9#3)(2010-3#1)(2011-2#3)
in 1760##2##2##(2011-2#1)(2013-1#1)
in 178##2##2##(1990-3#1)(2011-2#1)
in 18 out of##2##4##(2009-8#1)(2011-2#1)
in 18 patients##3##3##(1996-6#1)(2008-7#1)(2013-1#1)
in 18##14##2##(1995-5#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
in 18% of the##2##4##(1990-2#1)(2008-10#1)
in 18% of##4##3##(1990-2#1)(1993-8#1)(2008-10#1)(2013-1#1)
in 184##2##2##(1993-11#1)(2011-2#1)
in 19 cases##3##3##(1990-2#1)(1991-11#1)(2007-8#1)
in 19 of the##2##4##(2011-2#2)
in 19##12##2##(1990-2#1)(1991-11#1)(1991-6#1)(1996-11#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)
in 1902##2##2##(2008-10#1)(2010-1#1)
in 1918##2##2##(2010-1#1)(2010-5#1)
in 192##2##2##(2008-10#1)(2012-2#1)
in 1921##3##2##(1991-3#1)(2011-2#2)
in 1956##3##2##(1996-1#1)(2008-10#2)
in 1962##2##2##(1996-8#1)(2008-10#1)
in 1965##2##2##(1992-6#1)(2012-12#1)
in 1966##3##2##(1990-3#1)(2008-10#1)(2010-8#1)
in 1968##2##2##(2008-9#1)(2009-4#1)
in 1970 to##2##3##(1994-9#1)(1997-4#1)
in 1970##4##2##(1994-9#1)(1997-4#2)(1997-5#1)
in 1972##5##2##(1991-12#1)(1991-9#1)(2008-10#1)(2010-8#1)(2013-1#1)
in 1975##6##2##(1992-6#1)(1993-1#1)(1994-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
in 1976##2##2##(2008-10#2)
in 1978##7##2##(1990-6#1)(1991-12#1)(1994-12#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
in 1979##2##2##(1990-6#1)(2009-4#1)
in 1980##2##2##(1990-3#1)(2008-10#1)
in 1981##4##2##(1992-8#1)(1994-1#1)(2008-10#1)(2012-12#1)
in 1982##7##2##(1990-12#1)(1991-3#1)(1993-1#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-11#1)
in 1983##9##2##(1990-3#2)(1991-12#1)(1991-3#1)(1995-2#1)(2008-10#3)(2011-2#1)
in 1984 and##2##3##(1993-1#1)(1996-11#1)
in 1984##6##2##(1992-3#2)(1993-1#1)(1995-12#1)(1995-6#1)(1996-11#1)
in 1985##8##2##(1990-3#1)(1991-1#1)(1991-9#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-1#1)(1996-11#1)
in 1986 and##4##3##(1990-3#1)(1991-2#1)(1994-6#1)(2008-10#1)
in 1986 to##4##3##(1992-2#1)(1993-3#1)(1996-11#1)(2008-10#1)
in 1986##15##2##(1990-11#1)(1990-3#1)(1991-2#2)(1992-2#2)(1993-3#1)(1994-2#1)(1994-6#2)(1996-11#1)(2008-10#4)
in 1987##5##2##(1991-2#1)(1992-9#1)(1993-12#1)(1994-6#1)(2011-3#1)
in 1988 to##2##3##(1997-6#1)(2008-10#1)
in 1988##18##2##(1990-6#2)(1991-3#5)(1994-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(2008-10#2)(2008-5#1)
in 1989 and##2##3##(1995-1#2)
in 1989 to##3##3##(1995-1#1)(1996-3#1)(2008-10#1)
in 1989##22##2##(1990-6#4)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#3)(1996-3#1)(1996-5#1)(2008-10#3)(2008-11#1)
in 199##2##2##(1994-12#1)(2008-9#1)
in 1990 and##3##3##(1994-2#1)(2008-10#2)
in 1990 to##2##3##(1992-2#1)(2008-11#1)
in 1990##17##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-2#2)(1994-9#1)(1996-6#1)(1997-6#1)(2008-10#3)(2008-11#1)(2009-10#1)(2013-8#1)
in 1991 and 1992##2##4##(2008-10#2)
in 1991 and##5##3##(2007-12#1)(2008-10#3)(2008-5#1)
in 1991 to##3##3##(1994-9#1)(1996-1#1)(2010-12#1)
in 1991##22##2##(1992-11#1)(1992-12#1)(1994-1#2)(1994-12#1)(1994-9#3)(1995-1#3)(1995-12#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-2#1)
in 1992 and 1993##4##4##(2008-10#4)
in 1992 and##5##3##(1996-2#1)(2008-10#4)
in 1992##29##2##(1992-2#1)(1993-11#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#3)(1997-3#2)(2008-10#5)(2008-12#1)(2008-5#1)(2009-10#1)
in 1992-93##2##2##(1994-3#1)(1994-9#1)
in 1993 and##2##3##(1996-3#1)(1996-6#1)
in 1993 were##2##3##(1997-4#1)(2008-10#1)
in 1993##19##2##(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2008-10#7)(2011-1#1)(2011-2#1)
in 1994 and 1995##3##4##(2008-10#3)
in 1994 and##5##3##(2008-10#4)(2008-11#1)
in 1994##19##2##(1992-9#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-5#1)
in 1995 and 1996##6##4##(2008-10#6)
in 1995 and##8##3##(2008-10#7)(2012-2#1)
in 1995 in##2##3##(2008-10#2)
in 1995##25##2##(1992-6#1)(1994-6#1)(1995-12#1)(1996-11#3)(1997-3#1)(2008-10#16)(2012-2#2)
in 1995)##2##2##(1996-11#1)(2008-10#1)
in 1996 and 1997##6##4##(2008-10#6)
in 1996 and##10##3##(2008-10#10)
in 1996 were##2##3##(1997-6#1)(2008-10#1)
in 1996##23##2##(1997-6#3)(2008-10#17)(2008-11#3)
in 1997 and 1998##6##4##(2008-10#6)
in 1997 and##11##3##(2008-10#9)(2008-11#1)(2009-12#1)
in 1997 but##2##3##(2008-10#2)
in 1997 to##2##3##(2008-10#2)
in 1997 were##2##3##(2008-10#2)
in 1997##42##2##(1994-12#1)(2008-10#32)(2008-11#3)(2008-12#2)(2009-12#3)(2010-6#1)
in 1998 and 1999##2##4##(2008-10#2)
in 1998 and##4##3##(2008-10#4)
in 1998 to##2##3##(2008-10#2)
in 1998##24##2##(2008-10#20)(2008-5#1)(2010-10#1)(2010-5#1)(2011-2#1)
in 1999 and 2000##2##4##(2008-10#2)
in 1999 and##3##3##(2008-10#3)
in 1999 to 2000##3##4##(2008-10#3)
in 1999 to##4##3##(2008-10#3)(2010-5#1)
in 1999##20##2##(2008-10#12)(2008-3#1)(2008-9#3)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
in 1M HCl##2##3##(2008-10#2)
in 2 M##3##3##(2008-10#3)
in 2 and##3##3##(1990-6#1)(1993-3#1)(2008-11#1)
in 2 cases##7##3##(1991-11#1)(1992-12#1)(1996-6#1)(2007-8#1)(2008-11#1)(2013-1#2)
in 2 out of##2##4##(1990-6#1)(2010-2#1)
in 2 patients##9##3##(1990-12#1)(1990-6#1)(1991-1#1)(1993-3#1)(2007-11#1)(2008-7#2)(2011-2#1)(2012-3#1)
in 2 weeks##2##3##(1997-8#1)(2010-11#1)
in 2 years##3##3##(2008-10#3)
in 2##60##2##(1990-12#3)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-8#2)(1992-12#1)(1992-5#1)(1992-8#1)(1993-3#3)(1993-8#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
in 2%##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)
in 2-3##3##2##(1990-6#1)(2008-10#1)(2008-12#1)
in 2-HPbetaCD##3##2##(2008-11#3)
in 2-oxoglutarate levels##3##3##(1991-3#3)
in 2-year-old##3##2##(1996-2#1)(1997-9#1)(2009-5#1)
in 20 and##2##3##(2008-1#1)(2013-8#1)
in 20 black##2##3##(1991-11#2)
in 20 min##4##3##(2008-10#2)(2008-5#2)
in 20 patients with##3##4##(1991-11#1)(2010-4#1)(2013-1#1)
in 20 patients##7##3##(1991-11#1)(1993-1#1)(1994-12#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
in 20##34##2##(1990-2#1)(1991-11#3)(1991-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-5#3)(2008-7#2)(2009-6#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
in 20% of##2##3##(1996-3#1)(2013-1#1)
in 20%##4##2##(1996-3#1)(1997-3#1)(2008-11#1)(2013-1#1)
in 200##3##2##(2008-1#1)(2008-12#1)(2008-5#1)
in 2000 and 2001##4##4##(2008-10#4)
in 2000 and##8##3##(2008-10#6)(2008-11#1)(2010-12#1)
in 2000##20##2##(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)
in 2001 and 2002##2##4##(2008-10#2)
in 2001 to##4##3##(2013-8#4)
in 2001##13##2##(2008-10#7)(2010-12#1)(2012-12#1)(2013-8#4)
in 2002 and 2003##3##4##(2008-10#2)(2008-11#1)
in 2002 and##6##3##(2008-10#3)(2008-11#1)(2010-4#1)(2012-2#1)
in 2002##14##2##(2008-10#5)(2008-11#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#1)
in 2003 and 2004##3##4##(2008-10#3)
in 2003 and##7##3##(2008-10#5)(2008-11#1)(2010-8#1)
in 2003##14##2##(2008-10#5)(2008-11#4)(2008-12#2)(2010-10#1)(2010-8#1)(2011-3#1)
in 2004 and 2005##3##4##(2008-10#2)(2008-12#1)
in 2004##21##2##(2008-1#1)(2008-10#8)(2008-12#2)(2009-12#3)(2010-12#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
in 2005 and##2##3##(2008-10#1)(2012-12#1)
in 2005##17##2##(1994-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
in 2006 and##2##3##(2011-2#1)(2013-1#1)
in 2006 to##2##3##(2010-4#1)(2012-12#1)
in 2006##15##2##(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
in 2007 and##3##3##(2010-12#1)(2012-12#1)(2013-8#1)
in 2007##12##2##(2008-10#1)(2008-11#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#2)
in 2008##16##2##(2009-8#1)(2010-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#6)
in 2009##9##2##(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
in 2010##9##2##(2012-12#2)(2013-1#3)(2013-8#4)
in 2011##2##2##(2012-3#1)(2013-8#1)
in 2012##2##2##(2011-4#1)(2012-12#1)
in 20min##2##2##(2008-10#2)
in 21 cases##3##3##(1990-12#1)(1991-11#1)(1991-8#1)
in 21 patients with##2##4##(2008-7#1)(2009-3#1)
in 21 patients##5##3##(1990-9#1)(1991-3#1)(1992-1#1)(2008-7#1)(2009-3#1)
in 21##19##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-1#1)(1996-11#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
in 21% of the##2##4##(1996-3#1)(2008-10#1)
in 21% of##4##3##(1991-8#1)(1992-2#1)(1996-3#1)(2008-10#1)
in 21%##5##2##(1991-8#1)(1992-2#1)(1995-12#1)(1996-3#1)(2008-10#1)
in 22 patients with##3##4##(1991-12#1)(1997-3#1)(2013-8#1)
in 22 patients##4##3##(1991-12#1)(1992-2#1)(1997-3#1)(2013-8#1)
in 22##19##2##(1991-12#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-3#1)(1997-3#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#2)
in 22% of##2##3##(1990-3#1)(1995-11#1)
in 22%##3##2##(1990-3#1)(1995-11#1)(2010-11#1)
in 23 patients##3##3##(1996-12#1)(1996-6#1)(1997-7#1)
in 23##10##2##(1996-11#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
in 24 h##6##3##(1991-3#2)(2008-12#2)(2008-8#1)(2012-2#1)
in 24 patients##3##3##(1990-3#1)(1993-3#1)(2008-7#1)
in 24##23##2##(1990-3#1)(1991-12#1)(1991-3#2)(1991-5#1)(1993-3#1)(1994-8#1)(2008-10#1)(2008-12#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
in 24-h##4##2##(1995-11#3)(2008-10#1)
in 25 cases##2##3##(1990-6#1)(1995-5#1)
in 25 patients##3##3##(1990-6#1)(2008-7#1)(2011-2#1)
in 25##18##2##(1990-6#2)(1993-12#2)(1995-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
in 25%##6##2##(2008-10#3)(2008-11#1)(2013-1#2)
in 250##3##2##(1991-1#1)(1991-5#1)(1992-11#1)
in 256 mg/kg females were##2##5##(2008-9#2)
in 256 mg/kg males##4##4##(2008-9#4)
in 256 mg/kg##6##3##(2008-9#6)
in 256##7##2##(2008-9#6)(2010-8#1)
in 26 patients##5##3##(1994-9#1)(1997-8#1)(2009-10#1)(2013-1#2)
in 26##12##2##(1991-2#1)(1991-8#1)(1994-9#1)(1997-8#1)(2007-11#1)(2008-10#2)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
in 26%##2##2##(1993-2#1)(1997-3#1)
in 265##2##2##(1994-12#1)(2008-12#1)
in 27 cases##3##3##(1990-8#1)(1997-3#1)(1997-8#1)
in 27 patients with##2##4##(1990-11#1)(1997-3#1)
in 27 patients##3##3##(1990-11#1)(1992-9#1)(1997-3#1)
in 27##9##2##(1990-11#1)(1990-8#1)(1992-9#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
in 27% of##2##3##(2011-1#1)(2013-1#1)
in 27%##3##2##(1997-3#1)(2011-1#1)(2013-1#1)
in 28##10##2##(1990-12#1)(1990-8#1)(1991-8#1)(1994-2#1)(2008-10#4)(2008-7#1)(2013-8#1)
in 28% of##2##3##(1991-12#1)(1992-12#1)
in 29 patients##2##3##(1997-4#1)(2008-7#1)
in 29##12##2##(1990-8#1)(1991-8#1)(1992-3#1)(1994-3#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-3#1)
in 293 cells and##3##4##(1992-10#1)(1995-2#1)(2008-9#1)
in 293 cells##5##3##(1992-10#2)(1995-2#1)(2008-11#1)(2008-9#1)
in 293(EBNA) cells##2##3##(2008-11#2)
in 3 cases of##2##4##(2008-9#1)(2011-2#1)
in 3 cases##7##3##(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1997-8#1)(2008-9#1)(2011-2#1)
in 3 of##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
in 3 patients and##2##4##(1990-12#1)(1992-1#1)
in 3 patients##9##3##(1990-12#1)(1991-8#2)(1992-1#1)(1995-11#1)(1997-7#1)(1997-8#1)(2007-11#1)(2011-2#1)
in 3 with##2##3##(1990-9#2)
in 3##54##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#2)(1991-11#3)(1991-3#2)(1991-6#1)(1991-8#4)(1992-1#1)(1992-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-7#1)(1997-8#3)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-2#1)
in 3% of##2##3##(1991-8#1)(1997-8#1)
in 3-D##4##2##(2008-10#1)(2008-11#3)
in 30 min##2##3##(2008-10#1)(2008-9#1)
in 30 patients##4##3##(1990-6#1)(1990-8#1)(1996-6#1)(2013-1#1)
in 30##22##2##(1990-2#1)(1990-6#1)(1990-8#1)(1992-2#1)(1994-8#1)(1996-11#3)(1996-6#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in 30% of the##3##4##(1992-6#1)(2008-1#1)(2008-5#1)
in 30% of##4##3##(1992-6#1)(1993-11#1)(2008-1#1)(2008-5#1)
in 30%##6##2##(1992-6#1)(1993-11#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)
in 301##2##2##(1997-2#1)(2008-12#1)
in 31 patients##3##3##(1992-1#1)(2008-5#1)(2011-2#1)
in 31##7##2##(1992-1#1)(1992-8#1)(1993-9#1)(1995-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
in 32##10##2##(1990-11#1)(1991-12#1)(1993-8#1)(1994-12#1)(1995-5#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)
in 32%##3##2##(1996-5#1)(1997-6#1)(2008-5#1)
in 33##5##2##(1991-11#1)(1996-12#1)(2008-11#1)(2011-2#2)
in 33% of##2##3##(1990-3#1)(2008-12#1)
in 34 cases##2##3##(1992-5#1)(2012-3#1)
in 34##7##2##(1992-5#1)(1997-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
in 35 patients with##2##4##(1990-3#1)(1990-9#1)
in 35##4##2##(1990-3#1)(1990-9#1)(1991-2#1)(2008-10#1)
in 36 patients##2##3##(1997-8#1)(2008-7#1)
in 36##7##2##(1991-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-3#1)
in 37 patients##2##3##(1995-12#1)(2008-7#1)
in 37##5##2##(1995-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
in 37% of##3##3##(1994-3#1)(1995-11#1)(2008-7#1)
in 37%##4##2##(1994-3#1)(1995-11#1)(1996-5#1)(2008-7#1)
in 38##9##2##(1991-11#1)(1991-2#1)(1994-1#1)(1995-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-11#1)(2012-12#1)
in 38% of##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
in 38%##4##2##(1991-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
in 39##8##2##(1997-2#1)(1997-8#1)(2008-10#3)(2011-2#1)(2012-3#1)(2013-1#1)
in 3D##4##2##(2008-11#1)(2011-2#1)(2012-3#2)
in 3MC-induced##2##2##(1994-8#2)
in 3T3-L1 adipocytes and##2##4##(1995-8#2)
in 3T3-L1 adipocytes##5##3##(1993-8#1)(1995-8#4)
in 4 cases##5##3##(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#1)(2008-11#1)
in 4 min##2##3##(2008-10#2)
in 4 out of##2##4##(1997-7#1)(2008-10#1)
in 4 patients##9##3##(1990-12#1)(1990-6#1)(1997-3#1)(1997-8#2)(2007-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
in 4##49##2##(1990-12#1)(1990-3#2)(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#3)(1993-6#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#3)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in 4%##2##2##(2008-10#1)(2013-8#1)
in 4/15 cases (26##2##4##(2008-10#2)
in 40 cases##2##3##(1997-3#1)(2008-7#1)
in 40 of##2##3##(1990-8#1)(2008-10#1)
in 40 patients##2##3##(1991-3#1)(1997-8#1)
in 40##14##2##(1990-8#1)(1991-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-5#2)(2008-7#1)(2012-2#1)
in 40% cases##2##3##(2007-8#1)(2010-7#1)
in 40% of the##2##4##(1991-11#1)(2009-8#1)
in 40% of##3##3##(1991-11#1)(2008-10#1)(2009-8#1)
in 40%##6##2##(1991-11#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-7#1)(2012-2#1)
in 400 and 800 mg/L females at 27 weeks##2##9##(2008-9#2)
in 400 and 800 mg/L females##3##6##(2008-9#3)
in 400 and 800 mg/L##4##5##(2008-9#4)
in 400 and 800##5##4##(2008-9#5)
in 400##8##2##(2008-11#1)(2008-9#7)
in 41 cases##2##3##(1990-2#1)(2007-11#1)
in 41##5##2##(1990-2#1)(1991-12#1)(2007-11#1)(2008-10#2)
in 42 patients with##2##4##(1990-9#1)(1992-6#1)
in 42 patients##4##3##(1990-9#1)(1992-6#1)(2013-1#1)(2013-8#1)
in 42##6##2##(1990-2#1)(1990-9#1)(1992-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
in 42%##2##2##(1997-3#1)(2008-8#1)
in 429##2##2##(1996-8#2)
in 43 days##2##3##(2008-11#1)(2008-12#1)
in 43##5##2##(1996-6#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-2#1)
in 43%##2##2##(2008-11#1)(2013-1#1)
in 44##9##2##(1990-12#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-5#1)(1996-1#1)(2008-10#1)(2011-1#1)(2012-3#1)
in 44% of the##2##4##(1992-2#1)(2008-10#1)
in 44% of##4##3##(1992-2#1)(1993-8#1)(2008-10#1)(2011-1#1)
in 44%##5##2##(1992-2#1)(1993-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
in 45 of##2##3##(1994-1#2)
in 45##7##2##(1990-9#1)(1991-11#1)(1993-6#1)(1994-1#2)(2008-10#1)(2011-1#1)
in 46##4##2##(1991-3#1)(1991-6#1)(1996-2#1)(2012-2#1)
in 46% of##2##3##(2010-12#1)(2010-4#1)
in 46%##3##2##(1990-9#1)(2010-12#1)(2010-4#1)
in 47##3##2##(1995-12#1)(1997-2#1)(2008-8#1)
in 47% of the##2##4##(2008-1#1)(2008-10#1)
in 47%##3##2##(1996-5#1)(2008-1#1)(2008-10#1)
in 48 h##2##3##(1994-2#1)(2008-12#1)
in 48##8##2##(1990-6#1)(1991-3#1)(1994-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2012-3#1)
in 49##2##2##(2009-11#1)(2012-12#1)
in 5 cases##4##3##(1990-2#1)(1990-6#1)(1991-11#1)(2007-8#1)
in 5 min##2##3##(2008-10#2)
in 5 ml of the final DMF solution##2##8##(2008-10#2)
in 5 ml of##5##4##(2008-10#5)
in 5 of the##4##4##(1997-7#1)(2011-2#2)(2012-12#1)
in 5 of##7##3##(1997-7#1)(1997-8#1)(2008-8#1)(2011-2#3)(2012-12#1)
in 5 patients##4##3##(1990-12#1)(1992-9#1)(1994-12#1)(2011-2#1)
in 5##39##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#1)(1991-11#1)(1992-9#2)(1993-6#1)(1994-12#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#12)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)
in 5% and##2##3##(1996-12#1)(1996-3#1)
in 5% of##2##3##(2008-10#1)(2008-9#1)
in 5%##7##2##(1996-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-9#1)
in 5' upstream##2##3##(2008-9#2)
in 5'##3##2##(1993-6#1)(2008-9#2)
in 5-10 ml##2##3##(1994-9#1)(2008-10#1)
in 5-HT-induced proliferation of rat##3##5##(2011-3#3)
in 50 patients##3##3##(1991-2#1)(1997-3#1)(2009-3#1)
in 50##13##2##(1991-2#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
in 50% of cases with##2##5##(1991-2#1)(1997-3#1)
in 50% of patients##2##4##(2011-2#1)(2012-2#1)
in 50% of##7##3##(1991-2#1)(1997-3#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
in 50%##15##2##(1991-2#1)(1994-9#1)(1997-3#2)(2008-1#1)(2008-10#6)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
in 5000##2##2##(1990-9#1)(2008-8#1)
in 503##2##2##(2008-10#1)(2012-3#1)
in 51 patients##2##3##(1995-3#1)(2008-7#1)
in 51##8##2##(1990-9#1)(1991-6#1)(1993-12#1)(1995-3#1)(2008-12#1)(2008-7#1)(2011-2#2)
in 52##4##2##(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#1)
in 53##2##2##(1995-2#1)(2012-3#1)
in 54##5##2##(1996-2#1)(1997-3#1)(2008-10#1)(2011-1#1)(2012-3#1)
in 54%##2##2##(1992-2#1)(1997-3#1)
in 55##3##2##(1991-11#1)(2006-6#1)(2011-2#1)
in 56##4##2##(1993-12#1)(1997-3#1)(2011-2#1)(2013-1#1)
in 56%##3##2##(1990-9#1)(2008-10#1)(2011-2#1)
in 57 patients##2##3##(1993-1#1)(2012-3#1)
in 57##7##2##(1990-3#1)(1993-1#1)(1997-8#1)(2010-1#1)(2012-3#2)(2013-8#1)
in 58 patients##2##3##(2008-1#1)(2008-7#1)
in 58##8##2##(1990-2#1)(2008-1#1)(2008-7#2)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#1)
in 58%##2##2##(1994-8#1)(2008-11#1)
in 59##4##2##(1992-1#1)(1997-8#1)(2012-3#1)(2013-1#1)
in 6 M HCl##2##4##(2008-10#2)
in 6 cases##3##3##(1991-1#1)(1992-12#1)(2008-10#1)
in 6 different##2##3##(2012-3#1)(2013-1#1)
in 6 of##3##3##(1990-3#1)(1994-1#1)(1997-3#1)
in 6 patients##4##3##(1990-12#1)(1991-3#1)(1994-12#1)(2013-1#1)
in 6% of##2##3##(1991-3#1)(2008-1#1)
in 6%##3##2##(1991-3#1)(1993-2#1)(2008-1#1)
in 6/8##2##2##(2008-8#1)(2010-1#1)
in 60##5##2##(1992-2#1)(1996-11#1)(2008-7#1)(2011-2#2)
in 60% of##6##3##(1993-2#1)(2008-7#2)(2011-2#2)(2013-1#1)
in 60%##8##2##(1993-1#1)(1993-2#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
in 61 patients##3##3##(1991-11#1)(1994-12#1)(2008-1#1)
in 61##5##2##(1991-11#1)(1994-12#1)(2008-1#1)(2008-10#2)
in 62##5##2##(1991-3#1)(1993-1#1)(2008-1#1)(2008-10#1)(2008-11#1)
in 63##6##2##(1990-6#1)(1991-3#1)(1994-1#1)(1996-12#1)(2008-10#1)(2012-2#1)
in 64##5##2##(1991-12#1)(1992-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
in 65##3##2##(1991-8#1)(1996-11#1)(2008-10#1)
in 65%##2##2##(1997-3#1)(2008-10#1)
in 66##2##2##(1990-2#1)(1997-8#1)
in 66%##2##2##(1997-3#1)(2013-1#1)
in 67##2##2##(1996-2#1)(2008-10#1)
in 68##2##2##(1991-3#1)(2013-1#1)
in 69##4##2##(1990-11#1)(1997-3#1)(2007-8#1)(2008-1#1)
in 7 (6##2##3##(1997-8#2)
in 7 cases##4##3##(1991-11#1)(1991-6#1)(1992-5#1)(1997-8#1)
in 7 of 11##2##4##(2008-10#1)(2011-2#1)
in 7 of##4##3##(2008-10#2)(2011-2#2)
in 7 patients and##2##4##(1991-2#1)(2011-2#1)
in 7 patients with##2##4##(1993-11#1)(2012-12#1)
in 7 patients##9##3##(1991-2#1)(1993-11#1)(1994-1#1)(1994-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in 7##32##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-11#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-8#3)(2008-10#4)(2008-7#2)(2008-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in 7%##6##2##(1990-3#1)(1991-1#1)(1994-12#1)(2008-1#1)(2008-5#1)(2008-7#1)
in 70##4##2##(1991-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
in 70% of##3##3##(1990-6#1)(1991-12#1)(2008-7#1)
in 70%##5##2##(1990-6#1)(1991-12#1)(2007-8#1)(2008-10#1)(2008-7#1)
in 704 var##2##3##(2008-12#2)
in 704 variety##2##3##(2008-12#2)
in 704##5##2##(2008-12#5)
in 72 h##2##3##(2008-12#2)
in 72##7##2##(1993-1#1)(1993-6#1)(1995-12#1)(1997-8#1)(2008-12#2)(2011-2#1)
in 73##5##2##(2007-11#1)(2007-8#1)(2008-1#2)(2010-7#1)
in 73%##2##2##(2008-1#1)(2008-7#1)
in 74##2##2##(2008-7#1)(2013-1#1)
in 75##3##2##(1994-12#1)(2008-10#1)(2010-4#1)
in 75% of patients##2##4##(1990-3#1)(1993-6#1)
in 75% of##3##3##(1990-3#1)(1993-6#1)(2013-1#1)
in 75%##4##2##(1990-3#1)(1993-6#1)(2008-10#1)(2013-1#1)
in 76##3##2##(1997-8#1)(2011-2#1)(2012-3#1)
in 76%##2##2##(1994-2#1)(2008-7#1)
in 77##2##2##(1990-6#1)(2011-2#1)
in 77%##2##2##(1991-2#1)(2012-3#1)
in 78##4##2##(1992-9#1)(1996-3#1)(2008-12#1)(2010-11#1)
in 79%##2##2##(1992-2#1)(2011-1#1)
in 8 cases##2##3##(1991-11#1)(2011-3#1)
in 8 of 16##2##4##(1994-11#1)(2008-11#1)
in 8 of##3##3##(1994-11#1)(2008-10#1)(2008-11#1)
in 8 patients##6##3##(1991-3#1)(1996-3#1)(1997-8#2)(2008-7#1)(2013-1#1)
in 8##31##2##(1990-8#1)(1991-11#1)(1991-3#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-3#2)(1997-8#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
in 8%##3##2##(1994-3#1)(2008-11#1)(2013-1#1)
in 8/15 cases (53##2##4##(2008-10#2)
in 80##7##2##(1992-2#1)(1997-8#1)(2008-10#2)(2010-3#1)(2011-2#1)(2012-3#1)
in 80% after##2##3##(1993-6#2)
in 80% of the##2##4##(2010-5#1)(2013-1#1)
in 80% of##4##3##(2007-8#1)(2010-5#1)(2013-1#2)
in 80%##9##2##(1990-12#1)(1993-6#2)(1997-3#1)(2007-8#1)(2008-5#1)(2010-5#1)(2013-1#2)
in 800 mg/L females##3##4##(2008-9#3)
in 800 mg/L males and females##2##6##(2008-9#2)
in 800 mg/L males at 43 weeks##3##7##(2008-9#3)
in 800 mg/L males##5##4##(2008-9#5)
in 800 mg/L##8##3##(2008-9#8)
in 800##9##2##(1994-2#1)(2008-9#8)
in 81##3##2##(1990-8#1)(1997-8#1)(2011-2#1)
in 82 patients##2##3##(1997-8#1)(2013-1#1)
in 82##3##2##(1997-8#2)(2013-1#1)
in 82% of##2##3##(1990-2#1)(1993-2#1)
in 83##4##2##(1994-12#1)(2008-1#1)(2008-12#1)(2011-2#1)
in 83% of the##2##4##(1990-2#1)(2008-10#1)
in 83%##3##2##(1990-2#1)(2008-10#2)
in 84##3##2##(1990-6#1)(2008-5#1)(2008-7#1)
in 85##2##2##(2011-2#1)(2012-3#1)
in 85%##2##2##(1996-11#1)(1996-5#1)
in 86##3##2##(1997-2#1)(2008-11#1)(2008-12#1)
in 87##4##2##(1991-6#1)(2007-8#1)(2008-5#1)(2012-3#1)
in 87%##2##2##(1997-3#1)(2008-11#1)
in 88##2##2##(2008-11#1)(2009-3#1)
in 89 patients##2##3##(1990-2#1)(1992-9#1)
in 89% after laser##2##4##(1993-6#2)
in 9 cases##3##3##(1991-11#1)(1997-8#1)(2009-3#1)
in 9 of##6##3##(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
in 9 patients##3##3##(2008-7#2)(2011-2#1)
in 9##17##2##(1991-11#2)(1997-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#1)(2011-2#3)(2013-1#1)(2013-8#1)
in 9/10##2##2##(2008-8#1)(2012-3#1)
in 90##2##2##(1993-6#1)(2008-11#1)
in 90% of cases##2##4##(1990-6#1)(2007-8#1)
in 90% of patients##2##4##(1991-6#1)(2013-1#1)
in 90% of the##2##4##(1992-1#1)(2008-10#1)
in 90% of##7##3##(1990-6#1)(1991-6#1)(1992-1#1)(2007-8#1)(2008-10#2)(2013-1#1)
in 90%##10##2##(1990-6#1)(1991-6#1)(1992-1#1)(2007-8#1)(2008-10#4)(2012-12#1)(2013-1#1)
in 91##2##2##(1991-8#1)(2013-1#1)
in 91%##2##2##(1990-8#1)(2008-7#1)
in 92##4##2##(1990-9#1)(1992-9#1)(2008-10#1)(2011-2#1)
in 93##3##2##(1991-3#1)(1995-12#1)(2008-11#1)
in 94##3##2##(1994-3#1)(2009-8#1)(2011-2#1)
in 95 patients##2##3##(1997-8#2)
in 95##4##2##(1992-5#1)(1997-8#2)(2008-8#1)
in 95%##2##2##(1996-1#1)(2008-10#1)
in 96 well##2##3##(2008-11#2)
in 96##6##2##(1993-6#1)(2008-10#1)(2008-11#2)(2012-3#2)
in 96% of##2##3##(2008-10#2)
in 96-well##2##2##(2008-4#1)(2011-2#1)
in 960##2##2##(2008-10#2)
in 97##2##2##(1993-6#1)(2008-6#1)
in 99%##2##2##(1992-2#1)(1996-5#1)
in A and##2##3##(1992-12#1)(2008-6#1)
in A beta##2##3##(1995-12#1)(1996-2#1)
in A##25##2##(1992-12#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-2#1)(2007-12#3)(2008-10#10)(2008-12#1)(2008-6#1)(2008-9#3)(2011-2#1)(2012-3#1)
in A1##2##2##(2008-10#1)(2008-11#1)
in ABA concentration in##2##4##(2008-8#2)
in ABA##3##2##(2008-8#2)(2009-8#1)
in AC Taber##2##3##(2008-10#2)
in ACS##2##2##(2008-4#1)(2010-4#1)
in AD##9##2##(1991-1#1)(1995-12#1)(1997-2#1)(2008-7#4)(2009-10#1)(2011-2#1)
in AF patients##2##3##(2008-10#1)(2010-12#1)
in AGS##3##2##(2008-12#3)
in AIDS patients##2##3##(2007-12#1)(2008-5#1)
in AIDS##10##2##(1993-12#2)(1994-11#1)(1996-3#2)(1997-8#1)(2007-12#1)(2008-5#2)(2008-8#1)
in AILT##2##2##(2009-8#2)
in ALT/d-LDH##2##2##(2008-10#2)
in AMD##2##2##(2011-2#2)
in AML##2##2##(2011-2#2)
in APP mRNA levels##2##4##(1996-12#2)
in ARDS##3##2##(1993-2#1)(1997-1#2)
in ARG1(+/-)##2##2##(2013-8#2)
in AROM##2##2##(2008-12#2)
in ASM-treated leaves##2##3##(2008-10#2)
in AVM##2##2##(2012-3#2)
in AcNPV##2##2##(1997-3#2)
in AcOEC2##2##2##(2008-10#2)
in Acala NemX##2##3##(2008-10#2)
in Acute##2##2##(1997-3#1)(2012-12#1)
in Adolescents##2##2##(2013-1#2)
in Adult##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
in Advanced##2##2##(2010-2#1)(2013-1#1)
in Africa and##4##3##(1997-7#1)(2008-10#3)
in Africa south of Sahara##2##5##(1990-12#2)
in Africa##29##2##(1990-12#3)(1993-3#1)(1994-3#1)(1995-1#1)(1997-7#1)(2008-1#1)(2008-10#12)(2010-1#1)(2012-2#4)(2012-3#1)(2013-1#3)
in African Americans##2##3##(2013-1#2)
in African##6##2##(1995-12#1)(2008-9#1)(2009-5#1)(2010-5#1)(2013-1#2)
in AgGaS(2)##2##2##(2008-2#1)(2008-3#1)
in Agricultural Systems##2##3##(2008-10#2)
in Alberta and##2##3##(1995-2#1)(2008-11#1)
in Alberta##5##2##(1992-12#1)(1995-2#1)(1997-2#1)(2008-11#1)(2012-12#1)
in Alfalfa##2##2##(2008-10#2)
in Algeria##3##2##(2010-1#3)
in Alzheimer disease##3##3##(1997-2#1)(2008-7#1)(2013-7#1)
in Alzheimer's disease and##3##4##(1993-2#1)(2008-7#1)(2013-1#1)
in Alzheimer's disease##15##3##(1991-10#1)(1992-12#2)(1993-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#4)(2008-7#3)(2013-1#1)
in Alzheimer's##17##2##(1991-10#1)(1992-12#3)(1993-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#4)(2008-7#3)(2013-1#1)
in Amberlite##2##2##(2008-10#2)
in America##3##2##(1992-5#1)(1995-2#1)(2008-11#1)
in American health care##3##4##(1992-2#1)(1994-1#1)(1995-12#1)
in American##5##2##(1991-3#1)(1992-2#1)(1994-1#1)(1995-12#1)(2011-2#1)
in Amsterdam##4##2##(1990-3#2)(1990-6#2)
in Analytical##3##2##(2008-10#3)
in Angelica dahurica Benth and its##2##6##(2008-10#2)
in Angelica##3##2##(2008-10#2)(2013-8#1)
in Aotearoa##3##2##(2008-1#3)
in Apartadó##2##2##(2012-12#2)
in Aplysia##2##2##(2008-10#1)(2008-4#1)
in Apple##3##2##(2008-10#3)
in April and May##4##4##(2008-10#4)
in April and##5##3##(2008-10#5)
in April##12##2##(1993-1#1)(2008-10#7)(2008-12#1)(2010-6#1)(2011-2#2)
in Ar##2##2##(2008-10#2)
in Arabidopsis and##3##3##(2009-5#1)(2009-8#1)(2011-10#1)
in Arabidopsis thaliana##9##3##(1997-8#1)(2008-10#3)(2008-9#3)(2009-8#1)(2011-2#1)
in Arabidopsis##38##2##(1997-8#3)(2007-12#3)(2008-10#10)(2008-9#5)(2009-10#1)(2009-5#1)(2009-8#9)(2011-10#2)(2011-2#2)(2012-2#2)
in Argentina##6##2##(1996-12#1)(2008-10#4)(2009-10#1)
in Arizona##7##2##(1995-12#2)(2008-10#2)(2008-5#1)(2011-2#2)
in As##2##2##(2008-10#2)
in Asellus aquaticus##2##3##(2008-12#2)
in Asia Pacific##2##3##(2012-12#2)
in Asia and##2##3##(2008-6#1)(2011-2#1)
in Asia##12##2##(2008-10#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#2)
in Asian countries##4##3##(1997-8#1)(2013-1#2)(2013-8#1)
in Asian##9##2##(1997-8#2)(2008-3#1)(2009-10#1)(2010-10#1)(2010-3#1)(2013-1#2)(2013-8#1)
in Asians##3##2##(2010-1#1)(2010-6#1)(2011-2#1)
in Aspergillus nidulans and Aspergillus terreus##2##6##(2008-5#2)
in Aspergillus nidulans and##3##4##(1997-4#1)(2008-5#2)
in Aspergillus nidulans##6##3##(1997-4#1)(1997-7#1)(1997-8#1)(2008-5#2)(2010-7#1)
in Aspergillus niger##2##3##(1991-9#1)(1993-2#1)
in Aspergillus##10##2##(1991-9#1)(1992-12#1)(1993-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-5#2)(2010-7#1)
in Aswan Governorate##2##3##(1994-9#2)
in AtT-20 cells##3##3##(1990-12#3)
in Atlanta##2##2##(1997-2#1)(2008-11#1)
in August 2008##2##3##(2011-2#1)(2013-1#1)
in August##9##2##(1993-12#1)(2008-10#5)(2011-2#1)(2012-12#1)(2013-1#1)
in Augustine's##2##2##(2008-12#2)
in Australia and##2##3##(1992-1#1)(2008-10#1)
in Australia in##2##3##(2008-10#1)(2008-11#1)
in Australia using##2##3##(2008-10#2)
in Australia##38##2##(1991-2#1)(1991-8#1)(1992-1#5)(1994-12#1)(1994-2#1)(1997-7#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-7#2)(2010-10#1)(2010-3#2)(2011-2#3)(2012-12#1)(2013-8#1)
in Australian Aboriginal##2##3##(1996-12#1)(2008-6#1)
in Australian nursing homes##2##4##(2008-11#2)
in Australian##13##2##(1992-1#2)(1996-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#1)
in Austria##3##2##(1994-12#1)(2009-10#1)(2010-4#1)
in B cells##2##3##(1991-1#1)(1995-6#1)
in B decays##2##3##(1990-12#1)(1992-11#1)
in B##23##2##(1990-11#1)(1990-12#1)(1991-1#1)(1992-11#1)(1995-6#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
in B(6)C(3)F(1) mice##3##3##(2008-10#3)
in B(6)C(3)F(1) than in MRL(+/+) mice##2##6##(2008-10#2)
in B(6)C(3)F(1)##5##2##(2008-10#5)
in B-##2##2##(1994-3#1)(2008-10#1)
in B-DNA##2##2##(1993-8#2)
in B-cell##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
in B16##3##2##(1993-5#1)(2008-11#1)(2008-5#1)
in BALB mice##3##3##(1994-5#3)
in BALB/c mice##3##3##(1995-12#1)(2008-10#1)(2008-12#1)
in BALB/c##5##2##(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
in BBA 2890##3##3##(2008-10#3)
in BBA##5##2##(2008-10#5)
in BCF##2##2##(2008-12#2)
in BDNF mRNA##2##3##(1997-2#1)(2012-2#1)
in BDNF##3##2##(1997-2#1)(2012-2#1)(2013-8#1)
in BGM cell cultures##2##4##(2008-5#2)
in BMD##3##2##(2010-1#1)(2011-2#2)
in BMV-infected##2##2##(2008-10#2)
in BN rats##2##3##(2008-10#2)
in BV##2##2##(2008-11#2)
in BYDV-PAV-infected##2##2##(2008-10#2)
in BaTiO(3)##4##2##(2008-2#2)(2008-3#2)
in Bacillus subtilis##7##3##(1990-11#1)(1990-12#2)(1995-6#1)(2008-10#1)(2009-3#1)(2009-8#1)
in Bacillus##12##2##(1990-11#1)(1990-12#2)(1995-6#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-2#1)
in Bangladesh##8##2##(1991-8#2)(1994-9#1)(2008-10#4)(2010-11#1)
in Barcelona##3##2##(2008-10#2)(2008-5#1)
in Barley##6##2##(2008-10#6)
in Barrett's esophagus##3##3##(2008-12#2)(2010-12#1)
in Barrett's##5##2##(2008-12#3)(2010-12#2)
in Basal##2##2##(2008-11#1)(2012-3#1)
in Beijing##2##2##(2008-10#2)
in Belarus##2##2##(2008-10#1)(2012-3#1)
in Belgium##4##2##(2008-10#1)(2008-12#1)(2011-2#2)
in Beltsville##2##2##(2008-10#2)
in Benghazi##2##2##(1994-12#2)
in Biological##3##2##(2008-10#2)(2008-11#1)
in BmN cells##3##3##(1997-3#2)(1997-8#1)
in BmN##4##2##(1997-3#2)(1997-8#2)
in Bmax##2##2##(1991-6#1)(1997-2#1)
in Bogota##4##2##(2011-2#1)(2012-12#3)
in Bogotá##6##2##(2011-2#2)(2012-12#4)
in Bombyx##3##2##(2008-6#3)
in Borrelia##2##2##(1990-12#1)(1992-3#1)
in Boston##5##2##(1992-3#1)(1997-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
in Botryosphaeria dothidea##2##3##(2008-10#2)
in Botrytis cinerea##3##3##(2008-10#3)
in Botrytis##4##2##(2008-10#4)
in Bragg##4##2##(2007-12#1)(2013-8#3)
in Brassica napus##4##3##(2008-10#3)(2008-12#1)
in Brassica##10##2##(2008-10#7)(2008-12#1)(2011-10#1)(2012-3#1)
in Brazil and##3##3##(2008-10#1)(2011-2#2)
in Brazil##32##2##(1996-12#1)(2008-10#17)(2008-11#2)(2008-5#1)(2008-8#1)(2010-1#4)(2010-10#1)(2011-2#3)(2012-3#1)(2013-8#1)
in Brazilian##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
in Breast Cancer##5##3##(1994-12#1)(1997-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
in Britain##7##2##(1990-6#1)(1996-8#1)(2008-5#2)(2010-1#3)
in British Columbia##10##3##(1994-1#2)(1997-2#1)(2007-12#2)(2008-10#3)(2008-11#1)(2009-5#1)
in British##12##2##(1990-6#1)(1994-1#2)(1997-2#1)(2007-12#2)(2008-10#3)(2008-11#2)(2009-5#1)
in Britton Robinson##2##3##(2008-10#2)
in Britton-Robinson (BR) buffer##3##4##(2008-10#3)
in Britton-Robinson buffer solution##2##4##(2008-10#2)
in Britton-Robinson buffer##7##3##(2008-10#7)
in Britton-Robinson buffers##2##3##(2008-10#2)
in Britton-Robinson##12##2##(2008-10#12)
in Brugge##2##2##(2008-10#2)
in Buenos Aires##3##3##(2008-5#1)(2009-10#2)
in Buerger's##2##2##(1990-2#1)(1997-8#1)
in Buffalo rats##2##3##(1993-12#2)
in Buffon's##2##2##(2008-12#2)
in Bulgaria##4##2##(2008-11#1)(2013-1#3)
in Burkina Faso##2##3##(1990-6#1)(2010-6#1)
in C##32##2##(1991-2#1)(1991-9#1)(1992-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#20)(2008-5#1)(2008-6#2)(2008-8#2)(2012-8#1)
in C(18) columns##2##3##(2008-10#2)
in C(18)##3##2##(2008-10#3)
in C2##2##2##(1995-6#1)(2008-9#1)
in C3H/HeJ mice##2##3##(2008-10#2)
in C6##2##2##(1993-6#1)(1994-11#1)
in CA 1##2##3##(1995-3#2)
in CA##5##2##(1995-11#1)(1995-3#2)(2008-10#2)
in CA1##2##2##(2008-12#1)(2008-7#1)
in CA4##2##2##(1996-12#2)
in CAB2 expression##2##3##(1995-2#2)
in CAB2##3##2##(1995-2#3)
in CAT##4##2##(1993-8#1)(1995-6#1)(2008-11#1)(2008-7#1)
in CAdSV##2##2##(2008-10#2)
in CB##2##2##(1994-5#1)(2009-12#1)
in CCD##2##2##(2008-3#1)(2011-1#1)
in CCH5##3##2##(2012-3#3)
in CCI rats##2##3##(2008-9#2)
in CCl(4)##3##2##(1996-5#2)(2008-10#1)
in CD##2##2##(1990-9#1)(2012-2#1)
in CD-1##2##2##(1991-6#1)(2008-11#1)
in CD133-high cells##2##3##(2009-9#2)
in CD4(+) T-lymphocytes##2##3##(2008-10#2)
in CD4(+)##3##2##(2008-10#2)(2010-1#1)
in CD4+##3##2##(1991-1#2)(2008-10#1)
in CDCl(3) at -78 degrees C##2##6##(1996-5#2)
in CDCl(3)##3##2##(1996-5#2)(2008-10#1)
in CE##5##2##(2008-10#3)(2008-5#1)(2011-1#1)
in CH(2)Cl(2) at -78 degrees C followed by reduction with dimethyl sulfide gave the##2##14##(1996-5#2)
in CH(2)Cl(2) at -78 degrees C followed by##3##8##(1996-5#3)
in CH(2)Cl(2)##4##2##(1996-5#3)(2009-9#1)
in CHCl(3)##2##2##(2008-10#2)
in CHO Cells##2##3##(2008-11#2)
in CHO cells by##3##4##(1995-2#1)(2008-11#2)
in CHO cells overexpressing the##2##5##(1995-6#2)
in CHO cells overexpressing##3##4##(1994-11#1)(1995-6#2)
in CHO cells was##2##4##(2008-11#1)(2008-7#1)
in CHO cells##28##3##(1992-10#1)(1994-11#1)(1995-2#2)(1995-6#2)(2008-11#20)(2008-7#2)
in CHO##34##2##(1992-10#1)(1994-11#1)(1995-2#2)(1995-6#2)(2008-11#25)(2008-7#2)(2011-2#1)
in CHO-K1##2##2##(2008-11#2)
in CKD patients##2##3##(2011-2#1)(2012-12#1)
in CKD##5##2##(2009-1#2)(2011-2#2)(2012-12#1)
in CL##5##2##(2008-10#3)(2008-5#1)(2008-8#1)
in CL-treated##2##2##(2008-12#2)
in CLL##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
in CLS resistance##2##3##(2012-3#2)
in CMC##2##2##(2008-10#1)(2010-11#1)
in CNS##6##2##(1990-9#1)(1991-12#1)(1995-12#1)(1996-2#1)(2008-7#2)
in COPD##3##2##(2010-5#2)(2013-8#1)
in COS 1 cells##5##4##(1995-12#1)(2008-11#4)
in COS cells##8##3##(1992-3#1)(1992-9#1)(1993-6#1)(1997-9#1)(2008-11#3)(2008-8#1)
in COS##14##2##(1992-3#1)(1992-9#1)(1993-6#1)(1995-12#1)(1997-9#1)(2008-11#8)(2008-8#1)
in COS-1 cells##6##3##(1991-7#1)(1992-10#1)(1992-6#1)(1993-3#1)(1995-2#2)
in COS-7 cells##2##3##(1993-12#1)(2008-9#1)
in CP##4##2##(2008-10#3)(2008-12#1)
in CPA##2##2##(2011-2#1)(2012-3#1)
in CRP##3##2##(2008-10#1)(2008-8#2)
in CSF and plasma##2##4##(1994-8#2)
in CSF##7##2##(1991-2#2)(1992-3#1)(1994-8#3)(2011-2#1)
in CT##2##2##(1997-8#1)(2009-5#1)
in CTAB micelle##2##3##(2008-10#2)
in CTAB##4##2##(2008-10#4)
in CXB H mice##2##4##(1994-5#2)
in Ca(2+)##2##2##(2006-6#1)(2008-11#1)
in Ca(2+)-free##2##2##(1995-11#2)
in Caco-2 cell monolayer##2##4##(2011-3#2)
in Caco-2##4##2##(2008-11#2)(2011-3#2)
in Caenorhabditis elegans##2##3##(1990-5#1)(2008-10#1)
in Cairo in##2##3##(1997-8#1)(2008-11#1)
in Cairo##3##2##(1997-8#1)(2008-11#1)(2010-10#1)
in Calabar##3##2##(2008-10#1)(2013-1#2)
in California and the##2##4##(2008-10#2)
in California and##7##3##(1992-2#1)(2008-10#6)
in California in##5##3##(1992-2#1)(1997-3#1)(2008-10#3)
in California was##2##3##(2008-10#2)
in California##57##2##(1991-12#1)(1992-2#3)(1995-12#1)(1997-3#1)(2008-10#48)(2008-8#1)(2008-9#2)
in Cambridge to##2##3##(2008-4#1)(2008-9#1)
in Canada and the United States##2##6##(1993-3#2)
in Canada and the##3##4##(1993-3#2)(1996-12#1)
in Canada and##8##3##(1993-3#2)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#3)
in Canada is##4##3##(1993-12#1)(1995-1#1)(2007-12#1)(2008-11#1)
in Canada##73##2##(1991-1#1)(1991-2#2)(1991-3#1)(1993-12#3)(1993-2#1)(1993-3#2)(1994-2#1)(1995-1#3)(1995-2#2)(1996-1#1)(1996-12#1)(1996-3#4)(1996-6#1)(1996-9#2)(1997-3#2)(2007-12#7)(2008-10#16)(2008-11#17)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
in Canadian children##2##3##(2007-12#1)(2008-11#1)
in Canadian paediatric##2##3##(2008-11#2)
in Canadian##10##2##(1994-12#2)(2007-12#1)(2008-10#1)(2008-11#4)(2013-1#2)
in Cancer##3##2##(2008-11#1)(2009-8#2)
in Candida albicans##4##3##(2008-5#3)(2011-2#1)
in Candida maltosa##2##3##(1991-9#1)(1993-12#1)
in Candida##8##2##(1991-9#1)(1993-12#1)(2008-5#3)(2011-2#2)(2013-1#1)
in Canton##3##2##(1996-11#3)
in Capsicum##2##2##(2008-10#2)
in Cartagena##4##2##(2011-2#4)
in Castilla y León##2##4##(2008-10#2)
in Caucasian women##2##3##(2010-3#2)
in Caucasian##5##2##(1997-3#1)(1997-8#1)(2010-3#3)
in Central America##2##3##(2008-10#2)
in Central Asia and the Caucasus##2##6##(2008-10#2)
in Central Coastal California##2##4##(2008-10#2)
in Central Spain##2##3##(2008-10#2)
in Central##11##2##(1995-3#1)(2008-10#8)(2008-12#1)(2012-9#1)
in Cercospora##2##2##(2008-10#2)
in Chadoora##2##2##(2013-8#2)
in Chemical##2##2##(2008-12#1)(2008-2#1)
in Chemistry##3##2##(2010-7#1)(2012-2#1)(2013-1#1)
in Chengdu##2##2##(2008-8#1)(2011-2#1)
in Chicago##3##2##(1996-5#1)(1997-3#1)(2009-6#1)
in Chickpea##5##2##(2008-10#5)
in Child's grade C##3##4##(2012-3#3)
in Children and Adolescents##3##4##(2012-2#1)(2013-1#1)(2013-8#1)
in Children##8##2##(1996-9#1)(2008-1#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
in Chile##12##2##(2008-8#1)(2013-1#3)(2013-8#8)
in Chile]##4##2##(2013-1#2)(2013-8#2)
in Chilean##2##2##(2008-10#1)(2013-1#1)
in China and##2##3##(2008-10#1)(2011-2#1)
in China##33##2##(1997-5#2)(2008-10#5)(2008-8#1)(2008-9#8)(2010-10#4)(2010-12#3)(2010-5#1)(2011-2#3)(2012-2#2)(2013-8#4)
in Chinese Hamster Ovary (CHO)##2##5##(2008-11#2)
in Chinese artichoke (Stachys Sieboldii Miq##2##6##(2008-10#2)
in Chinese artichoke##4##3##(2008-10#4)
in Chinese hamster ovary (CHO) cells##3##6##(1994-11#1)(2008-11#1)(2008-7#1)
in Chinese hamster ovary cells##7##5##(1991-5#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-11#1)(2008-8#1)
in Chinese hamster ovary##10##4##(1991-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-11#2)(2008-7#1)(2008-8#1)
in Chinese hamster##11##3##(1991-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-3#1)(2008-11#2)(2008-7#1)(2008-8#1)
in Chinese medicine##2##3##(2011-2#1)(2013-8#1)
in Chinese##35##2##(1991-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-3#1)(2008-10#7)(2008-11#4)(2008-7#2)(2008-8#4)(2008-9#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-8#4)
in Chlor-alkali cell effluents##2##4##(2008-10#2)
in Chongqing##2##2##(2011-2#1)(2013-8#1)
in Chronic##2##2##(2010-7#1)(2013-8#1)
in Citrus##2##2##(2008-10#2)
in Clinical##3##2##(1994-12#1)(2009-10#1)(2012-12#1)
in Clostridium##2##2##(2008-6#1)(2011-2#1)
in Cochliobolus sativus##2##3##(2008-10#2)
in Cochliobolus##3##2##(2008-10#3)
in Colima##2##2##(2011-2#2)
in Colletotrichum gloeosporioides infecting species of the tropical##2##8##(2008-10#2)
in Colletotrichum gloeosporioides##5##3##(2008-10#5)
in Colletotrichum graminicola##2##3##(2008-10#2)
in Colletotrichum##11##2##(2008-10#11)
in Colombia and##4##3##(2008-10#2)(2011-2#1)(2012-12#1)
in Colombia##33##2##(2008-10#4)(2008-5#1)(2011-2#4)(2012-12#24)
in Colombian municipalities##3##3##(2012-12#3)
in Colombian##5##2##(2012-12#4)(2013-1#1)
in Colorectal Cancer##2##3##(2008-10#2)
in Columbia##2##2##(2008-10#1)(2013-1#1)
in Common Bean##3##3##(2008-10#3)
in Connecticut##5##2##(1992-2#1)(1993-12#1)(1996-3#3)
in Copenhagen##4##2##(1993-3#1)(2011-4#2)(2013-1#1)
in Corn##3##2##(2008-10#3)
in Corsica##2##2##(1991-12#2)
in Cortex fraxini##2##3##(2008-10#2)
in Cosmetic##2##2##(2008-5#2)
in Costa Rica and##2##4##(2008-10#2)
in Costa Rica##4##3##(2008-10#4)
in Croatia##7##2##(2008-10#3)(2011-2#4)
in Croatia]##2##2##(2008-10#2)
in Croatian##2##2##(2008-10#2)
in Crohn's disease##8##3##(1994-6#1)(2008-4#1)(2010-12#5)(2012-2#1)
in Cronartium ribicola##2##3##(2008-10#2)
in CsCl media##2##3##(2008-10#2)
in Cuba##3##2##(1997-5#1)(2007-12#1)(2008-5#1)
in Cucumber##4##2##(2008-10#4)
in Cucurbits##2##2##(2008-10#2)
in Culture##3##2##(2008-10#1)(2008-11#2)
in Czochralski-grown##2##2##(2008-2#2)
in Côte d'Ivoire##2##3##(2008-10#2)
in D islets##5##3##(1995-8#5)
in D##17##2##(1995-6#1)(1995-8#5)(1997-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
in D(2)O##2##2##(1996-5#1)(2008-10#1)
in D-penicillamine-induced autoimmunity##3##3##(2008-10#3)
in D29 cells##4##3##(2008-11#4)
in DA##2##2##(1995-12#1)(2011-1#1)
in DCs##2##2##(2012-3#2)
in DHH children##2##3##(2011-2#2)
in DMF##3##2##(2008-10#2)(2011-2#1)
in DMF-water mixture##2##3##(2008-10#2)
in DMSO##7##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-5#1)
in DMSO-water##2##2##(2008-10#2)
in DNA and##2##3##(1994-11#1)(1994-8#1)
in DNA content in##2##4##(2008-10#1)(2008-11#1)
in DNA content##3##3##(2008-10#1)(2008-11#2)
in DNA damage##3##3##(1994-8#1)(2008-9#2)
in DNA repair##5##3##(1993-12#1)(1996-2#1)(2008-11#1)(2009-4#1)(2010-6#1)
in DNA samples##2##3##(2008-10#2)
in DNA sequence##3##3##(1997-8#1)(2008-4#1)(2011-2#1)
in DNA##44##2##(1990-5#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-8#3)(1995-12#1)(1995-2#1)(1996-2#2)(1996-3#1)(1997-8#1)(2008-10#10)(2008-11#5)(2008-4#4)(2008-9#2)(2009-4#1)(2010-6#1)(2011-2#2)
in DNA-DNA interactions##3##3##(1995-12#3)
in DNCB-treated cells##2##3##(2008-10#2)
in DOCA-salt WT##2##3##(2013-8#2)
in DOS##2##2##(2008-10#2)
in DPPC and##2##3##(1991-5#2)
in DR##2##2##(2008-1#1)(2008-11#1)
in DRG neurons##2##3##(1996-12#1)(2008-8#1)
in DRG##4##2##(1996-12#1)(1997-2#1)(2008-8#1)(2008-9#1)
in De##2##2##(2008-11#2)
in December 1995##2##3##(1995-12#1)(2008-7#1)
in December##8##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-2#1)
in Denmark and Norway##2##4##(1990-11#2)
in Denmark##7##2##(1990-11#3)(1990-12#1)(1997-3#2)(2013-1#1)
in Department of##2##3##(2008-10#1)(2011-2#1)
in Developing##2##2##(2008-10#2)
in Diesel##2##2##(2008-3#1)(2009-8#1)
in Different##4##2##(2008-10#3)(2008-11#1)
in Dordogne##2##2##(2008-10#2)
in Douglas-fir##3##2##(2008-10#3)
in Down syndrome##3##3##(1996-6#2)(2008-11#1)
in Drosophila and##2##3##(2008-10#1)(2009-7#1)
in Drosophila innubila##2##3##(2012-3#2)
in Drosophila melanogaster##16##3##(1993-2#4)(1994-9#1)(1995-6#1)(1997-7#4)(1997-8#1)(2008-8#1)(2008-9#3)(2012-3#1)
in Drosophila##53##2##(1990-3#1)(1993-12#2)(1993-2#4)(1993-8#1)(1993-9#2)(1994-9#1)(1995-6#1)(1997-7#5)(1997-8#2)(2007-12#1)(2008-10#6)(2008-8#4)(2008-9#6)(2009-7#1)(2010-5#1)(2012-2#4)(2012-3#11)
in Dutch TAD soils##2##4##(2008-10#2)
in Dutch##5##2##(2008-10#3)(2008-5#1)(2009-12#1)
in E##28##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-5#2)(1993-12#2)(1993-8#1)(1993-9#2)(1994-11#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2012-2#1)(2012-3#1)
in E1 activity##2##3##(2008-9#2)
in EC deprived of L-arginine##2##5##(1990-12#2)
in EC deprived of##3##4##(1990-12#3)
in EC##4##2##(1990-12#3)(2013-8#1)
in EC50##2##2##(1995-2#1)(2008-11#1)
in ECM##2##2##(1993-3#1)(2011-2#1)
in ECW123##2##2##(2008-10#2)
in ECW12346##2##2##(2008-10#2)
in ED##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
in EDL (P &lt##2##4##(1995-12#2)
in EDL##4##2##(1995-12#3)(2008-9#1)
in EEG##2##2##(1991-1#1)(2013-8#1)
in ELISA##4##2##(1993-2#1)(2008-10#2)(2008-5#1)
in EMG activity##2##3##(2013-1#2)
in EMG##3##2##(2010-8#1)(2013-1#2)
in EMT6-S##2##2##(2008-11#2)
in EPO##2##2##(2008-11#2)
in ER##2##2##(1990-5#1)(2008-11#1)
in ET##2##2##(2008-7#2)
in Early##4##2##(2008-1#1)(2008-10#2)(2010-9#1)
in East Asia##3##3##(2008-10#2)(2008-8#1)
in East##8##2##(2008-10#6)(2008-8#2)
in Eastern##4##2##(2008-10#4)
in Ecuador##8##2##(2008-10#8)
in Egypt in##2##3##(2008-10#1)(2011-2#1)
in Egypt##13##2##(2008-1#2)(2008-10#6)(2010-10#2)(2011-2#1)(2013-1#2)
in Elderly##3##2##(2011-2#1)(2012-3#2)
in England and Wales##3##4##(1990-6#1)(2008-12#1)(2008-8#1)
in England and##4##3##(1990-6#1)(2008-12#1)(2008-8#1)(2012-12#1)
in England##12##2##(1990-6#1)(1995-5#1)(2008-11#5)(2008-12#2)(2008-8#1)(2010-1#1)(2012-12#1)
in English##9##2##(2008-11#3)(2008-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in Enugu##2##2##(2013-1#2)
in Erie County##2##3##(1996-1#2)
in Escherichia coli and##7##4##(1991-3#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#1)(2011-1#1)
in Escherichia coli by##2##4##(1993-9#1)(2008-11#1)
in Escherichia coli from a##2##5##(1991-5#1)(1993-12#1)
in Escherichia coli from##3##4##(1991-5#1)(1993-12#1)(2011-1#1)
in Escherichia coli to##2##4##(1993-12#1)(2009-3#1)
in Escherichia coli was##3##4##(1990-5#2)(1993-9#1)
in Escherichia coli##61##3##(1990-11#1)(1990-5#3)(1991-12#1)(1991-3#2)(1991-5#3)(1991-9#1)(1992-6#1)(1993-12#3)(1993-6#2)(1993-8#2)(1993-9#4)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#4)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)
in Essex County##2##3##(2008-10#2)
in EtOH##2##2##(2008-10#2)
in Ethiopia##3##2##(1994-3#1)(2008-10#2)
in Eucalyptus##2##2##(2008-10#2)
in Europe and North America##2##5##(2008-10#1)(2008-7#1)
in Europe and the##4##4##(2008-10#1)(2008-12#1)(2008-8#1)(2010-11#1)
in Europe and##9##3##(1991-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)
in Europe##59##2##(1991-12#1)(1991-3#1)(1992-1#2)(1992-2#1)(1995-3#1)(1997-3#1)(2008-10#24)(2008-11#3)(2008-12#4)(2008-5#1)(2008-7#1)(2008-8#4)(2009-4#2)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-3#1)(2013-8#2)
in European hazelnut orchards##2##4##(2008-10#2)
in European##9##2##(1991-12#1)(1992-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
in Eutypa##2##2##(2008-10#2)
in Evaluating##2##2##(2008-10#1)(2010-7#1)
in Experiment 1##3##3##(2008-11#1)(2008-6#1)(2013-8#1)
in Experiment 3##3##3##(1994-2#1)(2008-5#2)
in Experiment##10##2##(1994-2#2)(2008-11#1)(2008-5#4)(2008-6#2)(2013-8#1)
in Express Five SFM##2##4##(2008-7#2)
in Ezafluor mouth wash##2##4##(2008-10#2)
in F islets##2##3##(1995-8#2)
in F##12##2##(1995-8#3)(2008-10#7)(2011-10#1)(2013-1#1)
in F(2) population##2##3##(2008-8#2)
in F(2)##3##2##(2008-10#1)(2008-8#2)
in F1 and F2##2##4##(2008-12#2)
in FA##2##2##(1997-3#2)
in FALS mice##2##3##(1996-5#2)
in FDC-P2##2##2##(1997-7#2)
in FHB##2##2##(2008-10#2)
in FIA mode##2##3##(2008-10#2)
in FIA##5##2##(2008-10#5)
in FM patients##2##3##(2009-11#1)(2010-12#1)
in FM##3##2##(2009-11#1)(2010-12#2)
in FMS##3##2##(2011-2#3)
in Family##2##2##(2008-11#1)(2009-12#1)
in Fao##2##2##(1992-10#2)
in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice compared to p48(Cre/+)-LSL-Kras(G12D/+) mice##2##7##(2013-1#2)
in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+)##3##2##(2013-1#3)
in Fe##3##2##(2008-10#1)(2010-11#1)(2013-1#1)
in February 2008##2##3##(2011-2#2)
in February and March##2##4##(2008-10#1)(2013-8#1)
in February and##3##3##(2008-10#1)(2013-8#2)
in February##11##2##(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#2)(2011-2#4)(2013-8#2)
in Field Populations of Mycosphaerella graminicola##2##6##(2008-10#2)
in Field Populations of##3##4##(2008-10#3)
in Field##8##2##(2008-10#8)
in Fiji##14##2##(2008-1#12)(2008-10#1)(2013-8#1)
in Finland and##2##3##(1990-11#1)(2011-1#1)
in Finland##7##2##(1990-11#2)(2008-10#2)(2008-8#1)(2010-5#1)(2011-1#1)
in Finnmark##3##2##(1993-11#1)(1993-6#2)
in Finnmark]##2##2##(1993-11#1)(1993-6#1)
in Florida and Texas##2##4##(2008-10#2)
in Florida and##9##3##(2008-10#8)(2013-8#1)
in Florida##29##2##(1996-12#1)(1997-2#1)(2008-10#26)(2013-8#1)
in France and##2##3##(2008-10#1)(2013-8#1)
in France for##2##3##(2008-10#1)(2008-5#1)
in France from##2##3##(2008-10#1)(2010-1#1)
in France##31##2##(1990-8#1)(1994-12#1)(1997-5#2)(2008-1#1)(2008-10#15)(2008-5#2)(2008-8#1)(2010-1#3)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in France]##2##2##(1996-3#1)(2010-6#1)
in French Soudan##2##3##(2010-1#2)
in French beans##2##3##(2008-10#2)
in French children##2##3##(2009-7#2)
in French##9##2##(1990-8#1)(2008-10#4)(2009-7#2)(2010-1#2)
in Fusarium oxysporum f##4##4##(2008-10#4)
in Fusarium##5##2##(2008-10#5)
in G protein##2##3##(1997-2#1)(2009-12#1)
in G##7##2##(1993-12#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)
in G1 and##2##3##(1997-3#1)(1997-8#1)
in G1 phase##2##3##(2008-11#2)
in G1##7##2##(1997-3#1)(1997-8#1)(2008-11#3)(2008-7#1)(2008-9#1)
in G2##2##2##(1996-3#1)(1997-3#1)
in G6PD-deficient subjects##2##3##(1991-2#2)
in GABAergic inhibition##2##3##(2013-8#2)
in GAD67##2##2##(1996-12#1)(2013-8#1)
in GBM##2##2##(2011-2#2)
in GBW##2##2##(2008-10#2)
in GBW07401##2##2##(2008-10#2)
in GC##2##2##(2008-10#2)
in GC/ECD##3##2##(2008-10#3)
in GC/MS##2##2##(2008-10#2)
in GEPR-3 compared to SD rats and GEPR-9##2##8##(1996-12#2)
in GEPR-3##3##2##(1996-12#3)
in GEPR-9##2##2##(1996-12#2)
in GFAP##4##2##(1990-7#4)
in GH3 cells##3##3##(1992-8#2)(1996-2#1)
in GH3 pituitary cells##2##4##(1992-8#1)(1993-8#1)
in GH3##5##2##(1992-8#3)(1993-8#1)(1996-2#1)
in GH4C1 cells##2##3##(1991-6#2)
in GLP-1##2##2##(2011-2#2)
in GR##2##2##(1994-2#2)
in GVA-infected##2##2##(2008-10#2)
in GaAs for##2##3##(2008-3#2)
in GaAs##6##2##(1990-12#1)(2008-2#1)(2008-3#4)
in Gansu Province during 2011##2##5##(2013-8#2)
in Gansu Province during##3##4##(2013-8#3)
in Gansu Province##6##3##(2013-8#6)
in GenBank##8##2##(1996-2#1)(2008-10#3)(2008-8#1)(2008-9#3)
in Georgia##7##2##(1996-12#1)(2008-10#6)
in Germany and the##2##4##(1992-12#1)(2008-10#1)
in Germany and##7##3##(1992-12#1)(2008-10#4)(2011-2#1)(2013-1#1)
in Germany in##2##3##(2008-10#1)(2008-11#1)
in Germany##28##2##(1992-12#2)(1994-12#1)(1994-3#1)(1995-11#1)(1996-3#1)(1997-8#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
in Ginkgo biloba##2##3##(2008-11#2)
in Gorski Kotar##2##3##(2011-2#2)
in Gossypium##2##2##(2008-10#1)(2008-9#1)
in Grace's medium with##2##4##(2008-11#2)
in Grace's medium##3##3##(2008-11#3)
in Granada##2##2##(2008-5#1)(2009-10#1)
in Grapevine##3##2##(2008-10#3)
in Graves' disease##3##3##(1992-5#1)(1994-11#1)(2008-4#1)
in Graves'##6##2##(1992-5#1)(1994-11#1)(2008-4#1)(2008-7#3)
in Great Britain##4##3##(1991-2#1)(1996-11#1)(2008-5#2)
in Great##5##2##(1991-2#1)(1996-11#1)(2008-5#2)(2012-3#1)
in Greece##2##2##(2008-10#1)(2009-10#1)
in Greek offspring##2##3##(2010-4#2)
in Greek##3##2##(2010-4#2)(2010-6#1)
in Group 1##5##3##(2008-12#1)(2011-1#2)(2011-2#2)
in Group 3##2##3##(2011-2#2)
in Group A##2##3##(2010-12#1)(2010-7#1)
in Group I##5##3##(1992-11#3)(2007-8#2)
in Group II##5##3##(1992-11#2)(2007-8#2)(2008-10#1)
in Group##24##2##(1992-11#5)(2007-8#4)(2008-10#1)(2008-12#1)(2010-12#1)(2010-7#4)(2011-1#3)(2011-2#5)
in Groups##3##2##(2008-10#1)(2009-10#1)(2010-12#1)
in Guadalajara##2##2##(2012-12#2)
in Guadeloupe in 2005##2##4##(2008-10#2)
in Guadeloupe##7##2##(2008-10#7)
in Guangzhou##5##2##(2011-2#1)(2013-8#4)
in Guatemala##2##2##(2008-10#1)(2010-1#1)
in H##13##2##(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-12#2)(2012-2#1)(2013-1#1)
in H(2)##4##2##(2008-7#1)(2010-12#1)(2010-4#2)
in H295R##2##2##(1995-12#2)
in HA##2##2##(2008-10#2)
in HASTs was##2##3##(2013-1#2)
in HASTs##3##2##(2013-1#3)
in HBeAg-negative patients##2##3##(2013-1#2)
in HC##4##2##(2008-11#2)(2012-3#2)
in HCC development##2##3##(2013-8#2)
in HCC patients##3##3##(2008-10#3)
in HCC##10##2##(2008-10#4)(2008-8#2)(2010-12#1)(2011-2#1)(2013-8#2)
in HCT116 colon cancer cells##2##5##(2011-2#2)
in HCT116##3##2##(2011-2#3)
in HCV##2##2##(2013-1#2)
in HCl and##2##3##(2008-10#2)
in HCl medium##3##3##(2008-10#3)
in HCl solution##2##3##(2008-10#2)
in HCl##8##2##(2008-10#8)
in HD##2##2##(2011-10#1)(2011-8#1)
in HDL-C##2##2##(2013-1#2)
in HEC##2##2##(1995-12#1)(2008-5#1)
in HEK 293##2##3##(2008-11#1)(2011-2#1)
in HEK293 cells##3##3##(2010-1#2)(2011-2#1)
in HEK293##4##2##(2008-11#1)(2010-1#2)(2011-2#1)
in HEPES##2##2##(2008-10#2)
in HG mode##3##3##(2008-10#3)
in HG##7##2##(1992-8#4)(2008-10#3)
in HIIE (p##2##3##(2013-8#2)
in HIV infection##6##3##(1990-6#1)(2008-11#1)(2012-12#1)(2013-8#3)
in HIV infection]##2##3##(1996-6#1)(1997-4#1)
in HIV positive patients##2##4##(2008-5#1)(2010-12#1)
in HIV positive##3##3##(2008-5#1)(2010-12#2)
in HIV##24##2##(1990-2#1)(1990-6#1)(1992-9#1)(1994-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2010-12#2)(2012-12#1)(2013-8#3)
in HIV-1 infected individuals##3##4##(2008-11#3)
in HIV-1 infected##5##3##(2008-11#5)
in HIV-1##10##2##(2008-11#5)(2008-2#1)(2009-8#2)(2013-8#2)
in HIV-infected patients##3##3##(1996-11#1)(2008-1#1)(2010-5#1)
in HIV-infected##6##2##(1996-11#1)(2008-1#1)(2009-12#1)(2009-7#2)(2010-5#1)
in HIV/AIDS##4##2##(1997-3#1)(2008-10#2)(2012-12#1)
in HL-60 cells##10##3##(1994-11#2)(1994-8#2)(1995-6#1)(1996-2#2)(2008-8#2)(2011-2#1)
in HL-60##14##2##(1994-11#2)(1994-8#3)(1995-6#2)(1995-8#1)(1996-2#2)(2008-8#2)(2011-2#2)
in HMO##2##2##(1993-12#1)(1996-3#1)
in HMOs##5##2##(1993-3#1)(1994-3#2)(1997-2#2)
in HNO(3)##2##2##(2008-10#2)
in HOMA-IR##2##2##(2013-8#2)
in HPB##2##2##(2013-1#2)
in HPLC##8##2##(2008-10#7)(2008-5#1)
in HR##4##2##(2010-7#1)(2013-8#3)
in HSCs##2##2##(2009-7#2)
in HSP70 mRNA##2##3##(2008-6#2)
in HT-29##2##2##(1994-8#1)(2010-1#1)
in HUH7-ins##2##2##(2010-11#2)
in HUVEC##2##2##(1997-1#1)(2012-2#1)
in Hacinas##3##2##(2009-10#3)
in Han Chinese populations##2##4##(2008-8#2)
in Han Chinese##4##3##(2008-8#2)(2008-9#2)
in Hawaii##7##2##(1994-2#1)(2008-1#1)(2008-10#5)
in HcNPV##2##2##(2008-11#2)
in HeLa cells##10##3##(1990-5#1)(1994-11#1)(1997-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#2)(2012-2#1)
in HeLa##11##2##(1990-5#1)(1994-11#1)(1997-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#1)(2012-2#1)
in Head##2##2##(2011-2#1)(2012-2#1)
in Health Care##2##3##(2008-11#1)(2012-2#1)
in Health##9##2##(1991-1#2)(1996-2#1)(1997-2#3)(2008-11#1)(2012-2#2)
in Healthy##4##2##(2008-10#1)(2010-9#1)(2012-2#1)(2012-3#1)
in Helicobacter pylori##3##3##(1996-11#1)(2009-6#1)(2012-12#1)
in Helicobacter##4##2##(1996-11#1)(2008-8#1)(2009-6#1)(2012-12#1)
in Heliconius##2##2##(2013-1#2)
in Hep G2 cells##3##4##(2008-11#3)
in Hep-2 cells##2##3##(2011-2#2)
in High Five cell cultures##3##5##(2008-7#3)
in High##5##2##(2008-7#4)(2010-7#1)
in Higher Education##3##3##(2008-11#1)(2012-3#2)
in Higher##4##2##(1996-9#1)(2008-11#1)(2012-3#2)
in Ho Chi Minh City##2##5##(2008-7#2)
in Hong Kong##14##3##(2008-10#2)(2008-7#3)(2008-9#1)(2009-5#2)(2010-11#4)(2011-2#1)(2013-8#1)
in Houston##2##2##(1994-3#1)(2008-10#1)
in Houttuynia cordata Thunb##2##4##(2008-10#2)
in Human##7##2##(2008-11#3)(2008-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
in Hungary##12##2##(1991-3#3)(1996-6#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2013-8#1)
in Huntington's disease##3##3##(2008-5#1)(2011-10#1)(2011-2#1)
in Huntington's##4##2##(2008-5#1)(2011-10#2)(2011-2#1)
in Hybrid Poplars##3##3##(2008-10#3)
in Hybrid##4##2##(2008-10#3)(2008-3#1)
in I##3##2##(2008-10#1)(2013-7#1)(2013-8#1)
in ICC 14216 K##2##4##(2008-10#2)
in ICP-AES##2##2##(2008-10#2)
in ICU patients##2##3##(2008-5#1)(2011-2#1)
in ICU##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
in ICUs##2##2##(2012-2#2)
in IL-3##2##2##(1995-6#2)
in IL-6##2##2##(1995-12#1)(2008-10#1)
in IMR-90##2##2##(1995-12#1)(1997-1#1)
in IMS##2##2##(2008-10#2)
in IP differs from##2##4##(2008-7#2)
in IP##4##2##(2008-7#4)
in IPD##2##2##(2008-7#2)
in IPL-41 medium##2##3##(2008-11#2)
in IPMN##2##2##(2012-2#2)
in IVMD101 medium##3##3##(2008-11#3)
in Ibadan##3##2##(2009-10#1)(2011-2#2)
in Illinois##7##2##(1994-12#1)(2008-10#6)
in India and##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
in India is##2##3##(1995-10#1)(2009-12#1)
in India to##2##3##(1996-9#2)
in India##47##2##(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#2)(1996-9#3)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#4)(2008-7#1)(2009-10#1)(2009-12#3)(2009-4#1)(2009-9#3)(2010-10#1)(2010-12#2)(2010-2#1)(2011-2#4)(2012-2#1)(2013-1#4)
in Indian patients##2##3##(1997-8#2)
in Indian population##3##3##(2012-2#3)
in Indian##8##2##(1997-8#2)(2008-11#1)(2012-2#3)(2013-1#2)
in Indiana and##2##3##(2008-10#2)
in Indiana##4##2##(2008-10#4)
in Infected##3##2##(2008-10#2)(2008-11#1)
in Inflammatory Bowel##2##3##(2010-12#1)(2012-12#1)
in Inner Mongolia in 2010##2##5##(2013-8#2)
in Inner Mongolia##6##3##(2013-8#6)
in Inoculated##2##2##(2008-10#2)
in Internal##2##2##(2008-10#1)(2013-1#1)
in Iowa from##2##3##(2008-10#2)
in Iowa##11##2##(1995-2#1)(1996-2#1)(2008-10#9)
in Ipomoea nil##2##3##(2008-10#2)
in Iran##16##2##(2008-10#2)(2008-12#3)(2010-8#2)(2012-12#2)(2012-2#4)(2013-1#3)
in Iranian##3##2##(2012-12#2)(2013-1#1)
in Ireland##4##2##(2008-11#3)(2012-2#1)
in Irish##2##2##(1991-11#1)(2008-11#1)
in Irrigation Water##2##3##(2008-10#2)
in Israel##15##2##(1997-1#1)(2008-10#12)(2008-5#1)(2008-8#1)
in Istanbul##2##2##(1996-5#1)(2010-11#1)
in Italian##13##2##(1990-8#2)(1992-2#1)(1994-12#1)(1994-2#2)(2008-10#2)(2008-7#1)(2013-1#4)
in Italy and##4##3##(1992-9#1)(1994-8#1)(2008-12#1)(2011-2#1)
in Italy was##2##3##(2008-12#1)(2008-8#1)
in Italy##29##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-9#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(2008-10#4)(2008-12#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)(2011-2#3)(2011-3#1)(2013-8#2)
in Ivory Coast##3##3##(2008-10#2)(2013-1#1)
in J774 cells##3##3##(1994-8#3)
in J774##4##2##(1994-8#3)(1996-12#1)
in Jack##2##2##(2008-10#2)
in Jamaica##5##2##(2009-7#2)(2011-2#3)
in Jamaican children##2##3##(2011-2#2)
in Jamaican##3##2##(2009-7#1)(2011-2#2)
in January##11##2##(1990-3#1)(1992-2#1)(1992-5#1)(1994-3#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2009-6#1)(2011-2#1)
in Japan and##4##3##(1997-8#1)(2008-11#1)(2011-3#1)(2012-2#1)
in Japan by##2##3##(2008-10#1)(2008-5#1)
in Japan during the##2##4##(2011-2#2)
in Japan for##2##3##(2008-11#1)(2008-5#1)
in Japan were##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
in Japan##69##2##(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-7#2)(1997-8#4)(2008-1#1)(2008-10#20)(2008-11#2)(2008-5#9)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-6#2)(2010-8#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#3)(2013-8#1)
in Japanese Black cows##3##4##(2013-1#3)
in Japanese flounder##2##3##(2008-6#1)(2010-8#1)
in Japanese patients##2##3##(1997-8#1)(2009-8#1)
in Japanese##16##2##(1997-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#2)(2009-8#1)(2010-2#2)(2010-8#1)(2011-2#1)(2013-1#3)
in Journal of##2##3##(2009-8#1)(2013-1#1)
in July and##3##3##(2008-10#3)
in July##10##2##(1991-11#1)(1995-12#1)(2008-10#8)
in June 2004##2##3##(2008-10#1)(2008-12#1)
in June##11##2##(1990-2#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-10#6)(2008-12#1)
in K562 cells and modulated self-renewal##2##6##(2008-8#1)(2008-9#1)
in K562 cells and##3##4##(2008-8#1)(2008-9#2)
in K562 cells##8##3##(2008-8#3)(2008-9#5)
in KMB17 cells##5##3##(2013-8#5)
in KOH##2##2##(2008-10#2)
in KTP##3##2##(2008-3#3)
in Kaliningrad##2##2##(1997-6#2)
in Kansas and##2##3##(2008-10#2)
in Kansas##5##2##(1995-3#2)(2008-10#3)
in Kashmir##2##2##(2011-2#2)
in Kc cells##3##3##(1995-6#3)
in Kent County fields##2##4##(2008-10#2)
in Kent County##4##3##(2008-10#4)
in Kentucky##3##2##(1991-1#1)(2008-10#2)
in Kern##2##2##(2008-10#1)(2011-2#1)
in Khartoum##4##2##(2013-1#4)
in Kinston##2##2##(2008-10#2)
in Korea and##4##3##(2008-10#3)(2013-8#1)
in Korea##23##2##(1997-8#1)(2008-10#12)(2008-8#1)(2009-8#1)(2010-4#2)(2010-6#4)(2013-8#2)
in Korea]##3##2##(1990-12#1)(1991-2#2)
in Korean##4##2##(1997-8#2)(2011-2#1)(2013-1#1)
in Koreans##2##2##(1997-8#2)
in L##5##2##(2007-12#1)(2008-10#3)(2010-8#1)
in L24 mutant##3##3##(2008-8#1)(2008-9#2)
in L6 myotubes##6##3##(2008-11#6)
in L6##8##2##(1993-3#1)(2008-11#7)
in LB and##2##3##(2008-10#2)
in LB##4##2##(2008-10#3)(2008-9#1)
in LDL cholesterol##2##3##(1991-2#1)(2008-3#1)
in LDL##8##2##(1991-12#2)(1991-2#1)(1993-6#2)(1994-11#1)(2008-3#2)
in LFD tests##2##3##(2008-10#2)
in LGSCs##2##2##(2012-12#2)
in LNCaP##2##2##(2010-1#1)(2011-2#1)
in LOS for##2##3##(1993-12#2)
in LR of##3##3##(2008-10#3)
in LSCs of CML##2##4##(2011-2#2)
in LSCs of##3##3##(2011-2#3)
in La Dorada##4##3##(2011-2#4)
in La##6##2##(1996-9#1)(2008-10#1)(2011-2#4)
in Laboratory##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
in Laccaria##2##2##(2011-1#2)
in Lactococcus##3##2##(1993-12#2)(2008-6#1)
in Lagos##2##2##(2012-12#1)(2013-1#1)
in Lake Tahoe##4##3##(2008-10#4)
in Lake##6##2##(2008-10#4)(2008-5#1)(2013-8#1)
in Latin America and the##2##5##(1991-3#1)(2008-5#1)
in Latin America##4##3##(1990-6#1)(1991-3#1)(1992-5#1)(2008-5#1)
in Latin##5##2##(1990-6#1)(1991-3#1)(1992-5#2)(2008-5#1)
in Latin-America##2##2##(2011-2#2)
in Lebanon##3##2##(1993-2#3)
in Leishmania spp##2##3##(2012-2#2)
in Lemhi##2##2##(2008-10#2)
in Lettuce##2##2##(2008-10#2)
in LiNbO(3)##2##2##(2008-3#2)
in Lisbon##2##2##(2008-10#1)(2008-5#1)
in Liver##2##2##(2008-6#1)(2013-1#1)
in Lombardy##2##2##(1994-8#1)(2011-2#1)
in London##5##2##(1996-8#1)(2008-9#1)(2010-1#2)(2010-5#1)
in Long-term##2##2##(2011-2#1)(2013-1#1)
in Los Angeles and##2##4##(1992-2#1)(2013-8#1)
in Los Angeles##5##3##(1991-2#1)(1992-2#1)(1995-3#1)(2013-1#1)(2013-8#1)
in Louisiana##3##2##(2008-10#3)
in M##18##2##(2008-10#12)(2010-10#2)(2010-8#1)(2011-10#2)(2012-2#1)
in MAP##2##2##(2009-8#1)(2013-8#1)
in MB##2##2##(2008-10#2)
in MCF-7 cells##6##3##(1992-4#1)(2008-11#4)(2008-9#1)
in MCF-7##7##2##(1992-4#1)(2008-11#5)(2008-9#1)
in MCL##2##2##(2009-8#2)
in MCT-treated##2##2##(1994-5#2)
in MDI##2##2##(1992-3#2)
in MDIs##4##2##(1992-3#2)(1996-1#2)
in MDSS2##3##2##(2008-11#3)
in MDSS2N##2##2##(2008-11#2)
in MGLP biosynthesis##2##3##(2012-2#2)
in MNG##2##2##(2012-3#2)
in MPTP-induced##3##2##(1990-7#1)(2013-7#2)
in MRI##4##2##(2009-11#1)(2010-12#2)(2011-2#1)
in MRL(+/+) mice##7##3##(2008-10#7)
in MRL(+/+)##8##2##(2008-10#8)
in MRL/lpr##2##2##(1992-9#1)(1997-8#1)
in MS medium containing##2##4##(2008-10#2)
in MS medium##6##3##(2008-10#4)(2008-12#2)
in MS##9##2##(2008-10#4)(2008-12#3)(2010-12#1)(2011-7#1)
in Madrid##3##2##(2008-10#1)(2008-11#2)
in Magnaporthe grisea##2##3##(2008-10#2)
in Mahlavu cells##2##3##(1997-1#2)
in Maine##6##2##(1992-2#1)(1992-3#1)(1996-3#1)(1997-2#3)
in Mainland China during##2##4##(2013-8#2)
in Mainland China##4##3##(2013-8#4)
in Maize##5##2##(2008-10#4)(2012-3#1)
in Malawi##2##2##(2008-10#1)(2010-12#1)
in Malaysia##4##2##(2008-12#3)(2013-1#1)
in Manitoba##2##2##(2008-10#2)
in March##4##2##(1991-2#1)(2008-10#2)(2012-12#1)
in Marek's disease##2##3##(2008-5#2)
in Maryland##3##2##(1992-3#1)(1996-1#1)(2008-10#1)
in Mashad##3##2##(2008-12#3)
in May 2011##2##3##(2010-11#1)(2012-2#1)
in May and##2##3##(2008-10#2)
in May##16##2##(1992-1#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-5#2)(2010-11#2)(2010-4#1)(2010-6#1)(2012-2#1)
in MeOH##3##2##(1996-5#1)(2008-10#2)
in Medicago truncatula##3##3##(2008-10#2)(2009-8#1)
in Medicaid spending##2##3##(1995-1#1)(1995-6#1)
in Medicaid##10##2##(1991-12#2)(1992-12#1)(1993-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-2#1)
in Medical##3##2##(1994-12#1)(2009-4#1)(2013-1#1)
in Medicare and##3##3##(1992-2#1)(1997-2#2)
in Medicare patients##2##3##(1994-12#1)(1996-2#1)
in Medicare payment##2##3##(1991-2#1)(1993-1#1)
in Medicare reimbursement##2##3##(1994-3#1)(1995-3#1)
in Medicare##25##2##(1991-1#3)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-3#1)(1996-2#1)(1997-2#4)
in Medicine##5##2##(1994-12#1)(1996-2#1)(2008-7#1)(2013-1#2)
in Medline##2##2##(2011-2#1)(2013-1#1)
in Meloidogyne##2##2##(2008-10#2)
in Metropolitan Toronto##3##3##(1991-2#1)(1993-1#1)(1994-1#1)
in Metropolitan##4##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-1#1)
in Mexican##2##2##(2008-10#1)(2012-3#1)
in Mexico and##2##3##(1997-8#1)(2008-11#1)
in Mexico since##2##3##(2008-10#2)
in Mexico##22##2##(1997-8#4)(2008-10#6)(2008-11#5)(2008-5#3)(2009-8#1)(2012-12#1)(2012-3#2)
in Mexico]##3##2##(2008-11#2)(2012-3#1)
in Mice##4##2##(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
in Michigan and##2##3##(1991-1#1)(2008-10#1)
in Michigan from##2##3##(2008-10#2)
in Michigan##16##2##(1991-1#1)(1992-2#1)(2008-10#13)(2008-12#1)
in Milan##2##2##(1990-8#1)(1991-6#1)
in Minnesota and##2##3##(2008-10#2)
in Minnesota##10##2##(1995-12#1)(2008-10#7)(2012-12#2)
in Missouri##5##2##(2008-10#3)(2013-8#2)
in Moghan##2##2##(2008-12#2)
in Monilinia fructicola##3##3##(2008-10#3)
in Morocco##2##2##(2008-10#1)(2009-9#1)
in Mozambique##5##2##(1997-6#5)
in Munich##2##2##(1994-3#1)(2008-10#1)
in Muscle##2##2##(2008-10#1)(2008-3#1)
in Mycosphaerella##2##2##(2008-10#2)
in Mäori##3##2##(2008-1#3)
in N composition##2##3##(2012-8#2)
in N##16##2##(2007-12#1)(2008-10#5)(2008-8#3)(2008-9#1)(2012-3#2)(2012-8#3)(2013-8#1)
in N(2)##2##2##(2008-3#2)
in N1E-115##2##2##(1992-6#1)(1994-11#1)
in NC##3##2##(2008-10#3)
in NCA##2##2##(2011-2#2)
in NCH##3##2##(2012-3#3)
in NG##2##2##(1992-8#2)
in NH(3)-NH(4)Cl##2##2##(2008-10#2)
in NHK grown at##2##4##(1994-3#2)
in NI and##2##3##(2013-8#2)
in NI##3##2##(2013-8#3)
in NIST SRM##2##3##(2008-10#2)
in NK cells##2##3##(1991-6#1)(2008-9#1)
in NMR spectra##2##3##(2008-7#2)
in NMR##3##2##(1992-4#1)(2008-7#2)
in NO##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
in NR##2##2##(2008-11#2)
in NYC drug##2##3##(1991-1#2)
in NYC##5##2##(1991-1#2)(1996-3#3)
in Na(+)##3##2##(2008-10#3)
in NaCl solution##2##3##(2008-10#1)(2013-1#1)
in NaCl##6##2##(2008-10#4)(2011-1#1)(2013-1#1)
in NaClO(4)##3##2##(2008-10#3)
in NaOH##2##2##(2008-10#2)
in Nafion##4##2##(2008-10#4)
in NahG##2##2##(2008-10#2)
in Namibia##3##2##(1997-6#3)
in Nd##4##2##(1993-1#2)(2008-3#2)
in Nef##4##2##(1997-3#4)
in Nepal and##2##3##(2008-11#1)(2012-3#1)
in Nepal##30##2##(2008-10#7)(2008-11#2)(2010-11#3)(2010-8#9)(2012-3#8)(2013-8#1)
in Nepalese##3##2##(2010-8#1)(2012-3#2)
in Neurospora crassa##2##3##(2008-10#1)(2012-3#1)
in Neurospora##3##2##(2008-10#1)(2012-3#2)
in Neurosurgery##2##2##(2010-7#1)(2012-3#1)
in New Brunswick##2##3##(1991-2#1)(1995-1#1)
in New Caledonia##2##3##(2008-1#2)
in New Castle County##2##4##(2013-1#2)
in New Delhi##3##3##(1994-8#1)(1995-12#1)(2008-11#1)
in New Jersey compared to##2##5##(2008-8#2)
in New Jersey##9##3##(1992-2#1)(1993-1#1)(2008-10#3)(2008-8#4)
in New Mexico##2##3##(2008-10#2)
in New South Wales##2##4##(2008-12#1)(2011-2#1)
in New York City (NYC)##3##5##(1996-1#1)(1996-3#2)
in New York City##18##4##(1991-1#2)(1991-12#1)(1992-3#1)(1994-9#2)(1996-1#1)(1996-3#5)(2008-12#1)(2009-5#4)(2011-2#1)
in New York State##4##4##(1991-3#1)(1996-3#1)(2008-10#2)
in New York##34##3##(1991-1#2)(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-9#2)(1996-1#2)(1996-12#1)(1996-3#6)(2008-10#8)(2008-12#1)(2008-8#1)(2009-5#4)(2010-10#1)(2011-2#1)
in New Zealand (Aotearoa)##2##4##(2008-1#2)
in New Zealand and##4##4##(2008-1#2)(2008-12#1)(2011-2#1)
in New Zealand##31##3##(1991-2#1)(1992-1#1)(1993-1#1)(1996-12#2)(2008-1#13)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2010-6#2)(2011-1#3)(2011-2#1)
in New##92##2##(1991-1#2)(1991-12#2)(1991-2#3)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#3)(1996-3#6)(2008-1#15)(2008-10#17)(2008-11#2)(2008-12#4)(2008-5#1)(2008-8#5)(2009-5#4)(2010-10#1)(2010-6#2)(2011-1#3)(2011-2#3)(2013-1#2)
in Nicotiana benthamiana plants##2##4##(2008-10#1)(2011-2#1)
in Nicotiana benthamiana##5##3##(2008-10#4)(2011-2#1)
in Nicotiana##7##2##(2008-10#5)(2008-7#1)(2011-2#1)
in Nigeria##15##2##(1990-3#2)(1992-5#1)(2008-10#1)(2008-5#1)(2009-10#3)(2009-6#3)(2011-2#1)(2013-1#3)
in North America and##4##4##(1992-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
in North America that##2##4##(2008-10#1)(2011-2#1)
in North America were##2##4##(2008-10#2)
in North America##36##3##(1992-1#1)(1994-2#1)(1996-1#1)(1997-8#1)(2008-10#20)(2008-11#6)(2008-8#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2011-2#1)
in North Carolina##8##3##(2008-10#8)
in North Dakota and western##2##5##(2008-10#2)
in North Dakota and##4##4##(2008-10#4)
in North Dakota##5##3##(2008-10#5)
in North and South##2##4##(1996-1#1)(2012-3#1)
in North##60##2##(1991-8#3)(1992-1#1)(1994-2#1)(1996-1#2)(1996-6#1)(1997-8#1)(2008-10#36)(2008-11#6)(2008-12#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
in Northeast##3##2##(2008-12#2)(2011-2#1)
in Northern Chile##2##3##(1993-12#1)(2008-3#1)
in Northern Ontario##2##3##(1994-3#2)
in Northern blot##2##3##(2008-10#1)(2008-8#1)
in Northern##13##2##(1993-12#1)(1994-3#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#2)
in Norway (population 4##3##4##(1996-11#3)
in Norway and##3##3##(1991-9#1)(1996-11#1)(2008-10#1)
in Norway as##2##3##(1991-9#1)(1993-6#1)
in Norway during the##2##4##(1990-9#1)(1991-9#1)
in Norway have##2##3##(1990-11#1)(1994-6#1)
in Norway in 1985##2##4##(1991-9#1)(1995-2#1)
in Norway in the##3##4##(1991-6#1)(1995-2#1)(1996-11#1)
in Norway in##7##3##(1991-6#1)(1991-9#1)(1994-6#1)(1995-2#2)(1996-11#2)
in Norway increased##2##3##(1995-2#1)(1996-11#1)
in Norway were##2##3##(1996-11#1)(1997-8#1)
in Norway##69##2##(1990-11#3)(1990-2#1)(1990-6#3)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#2)(1991-6#6)(1991-9#6)(1993-11#1)(1993-2#2)(1993-6#4)(1994-2#1)(1994-6#4)(1994-9#1)(1995-2#4)(1996-11#15)(1996-6#3)(1997-4#1)(1997-8#1)(2008-10#2)(2008-12#1)
in Norway]##7##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1996-11#3)
in Norwegian##4##2##(1990-9#1)(1991-6#2)(1996-6#1)
in November 1996##2##3##(2008-10#1)(2008-5#1)
in November##5##2##(1991-9#1)(1994-9#1)(2008-10#1)(2008-5#2)
in Nursing##8##2##(2008-11#5)(2012-3#3)
in O##2##2##(2008-10#1)(2009-10#1)
in ODA##2##2##(2008-10#2)
in OEC##2##2##(2008-8#2)
in ON and##2##3##(2008-10#1)(2008-7#1)
in OSCC##2##2##(2010-12#2)
in OY-M##2##2##(2008-10#2)
in Oats##3##2##(2008-10#3)
in Obese##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
in October 1997##2##3##(2008-10#2)
in October##12##2##(1992-2#1)(1993-6#1)(1995-12#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)(2012-2#1)(2013-1#1)
in Ohio and##2##3##(2008-10#2)
in Ohio##12##2##(2008-10#11)(2010-9#1)
in Okinawa##10##2##(2008-10#10)
in Older Adults##2##3##(2012-12#1)(2013-1#1)
in Older##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
in Ontario soils##2##3##(2008-10#2)
in Ontario##20##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#2)(1997-1#1)(2007-12#4)(2008-10#5)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
in Ontario's##4##2##(1991-2#1)(1995-1#1)(1997-3#1)(2009-3#1)
in Ophiostoma##2##2##(2008-10#2)
in Opole##2##2##(2012-3#2)
in Orange##2##2##(1991-9#1)(1992-2#1)
in Orchards##2##2##(2008-10#2)
in Oregon##10##2##(1992-2#3)(1995-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#2)
in Oryza sativa L##2##4##(2008-9#2)
in Osaka City##2##3##(2013-8#2)
in Osijek-Baranya County##4##3##(2011-2#4)
in Oslo in##2##3##(1993-6#1)(1995-2#1)
in Oslo##7##2##(1990-11#1)(1992-5#2)(1993-6#1)(1995-2#1)(1997-4#1)(1997-8#1)
in Ottawa##2##2##(2007-12#1)(2013-1#1)
in P##44##2##(1995-2#2)(1995-8#1)(2008-10#22)(2008-12#3)(2008-7#2)(2008-9#2)(2009-6#4)(2009-9#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#2)
in P19 teratocarcinoma cells##2##4##(1994-11#2)
in P19##3##2##(1994-11#3)
in P2##2##2##(2008-8#1)(2013-1#1)
in P3##2##2##(1994-5#1)(2008-10#1)
in PA##3##2##(2008-8#2)(2012-2#1)
in PACS-2 and MESS-2##3##4##(2008-10#3)
in PACS-2##5##2##(2008-10#5)
in PAH##3##2##(2008-10#1)(2010-10#2)
in PAM##2##2##(1993-8#1)(2008-10#1)
in PBS##2##2##(2008-8#1)(2012-3#1)
in PC##3##2##(1994-3#1)(2009-8#1)(2013-1#1)
in PC12 cells were##2##4##(2008-11#2)
in PC12 cells##14##3##(1993-8#2)(1995-12#1)(1997-2#1)(2008-11#10)
in PC12 pheochromocytoma cells##2##4##(1997-2#1)(2008-11#1)
in PC12##19##2##(1993-8#2)(1995-12#1)(1997-2#2)(2008-11#14)
in PCOS##3##2##(2008-4#3)
in PCR products##2##3##(1992-8#1)(1994-11#1)
in PCR##4##2##(1992-8#1)(1994-11#1)(1995-11#1)(2008-10#1)
in PCa cells##3##3##(2013-1#3)
in PD and##3##3##(2008-6#1)(2013-7#1)(2013-8#1)
in PD is##3##3##(2008-6#1)(2010-12#1)(2013-8#1)
in PD patients##8##3##(2008-7#3)(2011-2#5)
in PD##28##2##(2008-10#1)(2008-6#4)(2008-7#13)(2010-12#1)(2011-2#5)(2013-7#2)(2013-8#2)
in PEI##3##2##(2008-10#3)
in PG##2##2##(2008-10#1)(2008-11#1)
in PI 88788##4##3##(2008-10#4)
in PI##7##2##(1992-12#1)(2008-10#5)(2009-8#1)
in PIH##2##2##(2012-2#2)
in PKC##3##2##(1991-5#1)(1993-12#1)(1993-3#1)
in PMA-containing medium##2##3##(1995-2#2)
in PMBCL##2##2##(2009-8#2)
in PMC##2##2##(1992-3#2)
in PN mode and##2##4##(2008-10#2)
in PPS 7##3##3##(1993-3#3)
in PPS##4##2##(1992-2#1)(1993-3#3)
in PS##3##2##(1990-2#2)(2008-7#1)
in PSA##3##2##(2010-1#2)(2010-12#1)
in PT cells##2##3##(1995-11#2)
in PT##4##2##(1995-11#3)(2012-2#1)
in PVA medium##2##3##(2008-10#2)
in PVA##3##2##(2008-10#3)
in PVC matrix##4##3##(2008-10#4)
in PVC membrane##2##3##(2008-10#2)
in PVC##11##2##(2008-10#11)
in PaO2##2##2##(1997-3#1)(2011-2#1)
in Pacific countries##2##3##(2008-1#2)
in Pacific##4##2##(2008-1#4)
in Pakistan##5##2##(2008-10#2)(2009-4#1)(2012-2#2)
in Pakistani##2##2##(2012-2#1)(2013-8#1)
in Panum's limiting case##3##4##(2008-9#3)
in Papua New Guinea##2##4##(2008-1#2)
in Paramecium primaurelia##2##3##(2008-12#2)
in Paramecium##3##2##(2008-12#3)
in Paris##3##2##(2010-1#3)
in Parkinson##3##2##(2008-7#2)(2013-1#1)
in Parkinson's disease (PD) patients##2##5##(2008-7#2)
in Parkinson's disease (PD)##7##4##(2008-7#5)(2010-12#1)(2013-8#1)
in Parkinson's disease##46##3##(1992-9#1)(1995-8#1)(2008-6#1)(2008-7#33)(2009-11#2)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
in Parma##2##2##(2008-2#1)(2011-2#1)
in Part##5##2##(1993-2#1)(2008-11#1)(2008-12#3)
in Pathogenicity##3##2##(2008-10#3)
in Patients with##10##3##(1997-7#1)(2008-11#2)(2008-3#1)(2009-6#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
in Patients##11##2##(1997-7#1)(2008-11#2)(2008-3#1)(2009-6#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
in Pea##3##2##(2008-10#3)
in Peach Orchards##3##3##(2008-10#3)
in Peach##4##2##(2008-10#4)
in Peanut##2##2##(2008-10#2)
in Pennsylvania healthcare facilities##2##4##(2007-12#2)
in Pennsylvania##6##2##(2007-12#2)(2008-10#3)(2010-11#1)
in Perth##2##2##(2008-10#1)(2008-5#1)
in Peru##9##2##(1992-5#3)(2008-10#5)(2008-11#1)
in Peyer's##2##2##(2008-11#2)
in Phase I##2##3##(1997-1#1)(2012-3#1)
in Phase##3##2##(1997-1#1)(2008-3#1)(2012-3#1)
in Phaseolus vulgaris##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
in Phaseolus##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
in Philadelphia##2##2##(1991-12#1)(2009-5#1)
in Phytophthora infestans##5##3##(2008-10#5)
in Phytophthora melonis##2##3##(2008-10#2)
in Phytophthora##9##2##(2008-10#9)
in Pima S-7##2##3##(2008-10#2)
in Pinus monticola##3##3##(2008-10#3)
in Pinus##4##2##(2008-10#3)(2011-10#1)
in Piriformospora indica-colonized##2##3##(2008-10#2)
in Plagioscion squamosissimus##2##3##(2008-7#2)
in Plants##5##2##(2008-10#3)(2011-2#2)
in Plasmodium falciparum##2##3##(1990-12#1)(2012-12#1)
in Poisson##2##2##(2008-11#1)(2008-3#1)
in Poland and worldwide##2##4##(2013-1#2)
in Poland and##3##3##(2008-5#1)(2013-1#2)
in Poland##10##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#5)
in Poplar##3##2##(2008-10#3)
in Populations of the##2##4##(2008-10#2)
in Populations of##10##3##(2008-10#10)
in Populus deltoides##2##3##(2008-10#2)
in Populus##3##2##(2008-10#2)(2012-3#1)
in Port##2##2##(2008-10#1)(2010-5#1)
in Portugal##2##2##(2008-11#1)(2011-2#1)
in Posterior##2##2##(2012-3#1)(2013-1#1)
in Potato##5##2##(2008-10#5)
in Practice##3##2##(2008-11#2)(2008-12#1)
in Prahova County##2##3##(2008-10#2)
in Primary##2##2##(1997-5#1)(2008-11#1)
in Primorsko-Goranska County##5##3##(2011-2#5)
in Primorsko-Goranska##7##2##(2011-2#7)
in Prunus##2##2##(2008-10#1)(2008-9#1)
in Pseudomonas aeruginosa##4##3##(2008-10#1)(2008-7#2)(2009-6#1)
in Pseudomonas fluorescens##2##3##(2008-10#2)
in Pseudomonas syringae pv##2##4##(2008-10#2)
in Pseudomonas syringae##4##3##(2008-10#4)
in Pseudomonas##12##2##(2008-10#8)(2008-7#2)(2008-8#1)(2009-6#1)
in Psychiatric##3##2##(1997-8#1)(2008-11#1)(2012-2#1)
in Pt##2##2##(2008-10#2)
in Public Health##5##3##(1991-2#1)(1996-2#1)(1997-2#1)(2008-7#1)(2012-2#1)
in Punjab##4##2##(2008-10#3)(2010-11#1)
in PurR##2##2##(2008-8#2)
in Pyricularia grisea##2##3##(2008-10#2)
in Pythium##3##2##(2008-10#3)
in Q##5##2##(2008-10#1)(2012-5#1)(2012-7#3)
in Quebec##2##2##(1992-1#1)(2008-11#1)
in Quercus##2##2##(2008-10#1)(2012-5#1)
in R##10##2##(1995-8#2)(2008-10#6)(2011-2#1)(2012-8#1)
in RAPD##3##2##(2008-10#3)
in RAW 264##2##3##(2011-2#2)
in RCC##4##2##(1990-2#1)(2011-2#3)
in RH##5##2##(2008-10#5)
in RHR than in##2##4##(2008-11#2)
in RLC-16 hepatocytes##2##3##(2008-11#2)
in RLC-16##3##2##(2008-11#3)
in RNA processing##2##3##(1993-12#1)(1995-2#1)
in RNA##16##2##(1992-3#1)(1993-1#2)(1993-12#1)(1995-2#1)(1995-6#3)(1996-2#1)(1997-6#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-3#1)
in ROM##2##2##(2008-12#2)
in ROS##6##2##(1991-3#1)(1993-3#1)(1997-1#2)(2010-12#1)(2012-3#1)
in RP##2##2##(2008-10#1)(2011-2#1)
in RPMI 1640##2##3##(2008-11#2)
in RPMI medium##2##3##(1992-6#1)(2008-11#1)
in RPMI##4##2##(1992-6#1)(2008-11#3)
in Ragusa##2##2##(1991-2#1)(1992-12#1)
in Rana temporaria##2##3##(2011-2#2)
in Raphidia##2##2##(2008-12#2)
in Ras control of##2##4##(1996-2#2)
in Ras##3##2##(1995-8#1)(1996-2#2)
in Rats##6##2##(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
in Recreational##2##2##(2012-2#1)(2012-3#1)
in Relation to##7##3##(2008-10#7)
in Replica 2##2##3##(1992-12#2)
in Replica##3##2##(1992-12#3)
in Research##2##2##(2008-10#1)(2009-3#1)
in Resistant and Susceptible##3##4##(2008-10#3)
in Resistant##4##2##(2008-10#4)
in Response to##10##3##(1997-3#1)(2008-10#8)(2013-1#1)
in Reye's syndrome##3##3##(1991-12#3)
in Reye's##4##2##(1991-12#4)
in Rhipicephalus (Boophilus)##2##3##(2010-10#1)(2013-1#1)
in Rice##2##2##(2008-10#2)
in Rio de Janeiro##2##4##(2012-3#2)
in Rio##3##2##(2008-5#1)(2012-3#2)
in Ripley and Rps2 in L76-1988##2##6##(2008-10#2)
in Riyadh##2##2##(2008-1#1)(2013-1#1)
in Rochester##3##2##(1992-12#1)(1996-2#2)
in Roman##3##2##(2008-10#3)
in Romania##3##2##(1991-6#1)(2008-10#2)
in Rome##2##2##(1990-8#1)(2008-11#1)
in Rumania##2##2##(1991-6#2)
in Russia##12##2##(1994-12#1)(1997-1#7)(1997-6#2)(2010-12#2)
in S strain incidence in##2##5##(2008-10#2)
in S strain incidence##4##4##(2008-10#4)
in S##41##2##(1990-2#2)(1991-9#1)(1993-2#1)(1996-2#1)(1996-3#3)(1996-6#3)(1997-3#1)(1997-7#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
in S(0) state##2##3##(2008-8#2)
in S-D##2##2##(2008-11#2)
in SAMP8##2##2##(2008-7#2)
in SB##2##2##(2008-11#2)
in SC##2##2##(2008-5#2)
in SCLP##2##2##(2012-3#2)
in SD rats and##2##4##(1996-12#1)(2010-1#1)
in SD rats##4##3##(1996-12#1)(2008-10#2)(2010-1#1)
in SF900II##2##2##(2008-11#2)
in SFM##3##2##(2008-11#3)
in SLE##5##2##(2013-1#5)
in SMC##3##2##(1994-11#1)(1995-8#1)(2008-10#1)
in SR and##2##3##(2008-8#2)
in SR##4##2##(2008-8#4)
in SRIF release##2##3##(1997-2#2)
in SSG GIP gene expression##2##5##(1995-11#2)
in ST2 cells was##2##4##(2008-11#2)
in ST2 cells##4##3##(2008-11#4)
in SW eels##2##3##(2008-5#2)
in Saccharomyces cerevisiae and##2##4##(1996-3#2)
in Saccharomyces cerevisiae is##2##4##(1993-9#2)
in Saccharomyces cerevisiae##22##3##(1990-2#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-8#1)(1993-9#4)(1995-6#1)(1995-9#1)(1996-3#3)(1996-6#2)(1997-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#2)
in Saccharomyces##24##2##(1990-2#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#4)(1995-6#1)(1995-9#1)(1996-3#3)(1996-6#2)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#2)
in Salmonella typhimurium strains##2##4##(2008-9#2)
in Salmonella typhimurium##3##3##(2008-8#1)(2008-9#2)
in Salmonella##4##2##(2008-8#1)(2008-9#2)(2012-3#1)
in Samoa##3##2##(2008-1#3)
in San Joaquin##2##3##(2008-10#2)
in San##4##2##(1996-3#1)(2008-10#3)
in Santa##2##2##(2008-10#1)(2008-3#1)
in Sarawak##2##2##(2008-12#2)
in Sardinia##2##2##(2013-8#2)
in Saudi Arabia##4##3##(1994-2#1)(2008-1#2)(2008-10#1)
in Saxony (Germany)##2##3##(2008-11#2)
in ScA##3##2##(2008-11#3)
in Scandinavia##3##2##(1990-11#1)(1991-11#1)(2008-10#1)
in Sclerotinia sclerotiorum##2##3##(2008-10#2)
in Scotland##5##2##(2008-10#2)(2008-9#3)
in Se##2##2##(2012-2#2)
in Senegal##2##2##(2008-10#1)(2008-5#1)
in Seoul##3##2##(1990-12#2)(1991-2#1)
in September##2##2##(1995-12#1)(2013-1#1)
in Serbia##5##2##(2008-10#1)(2008-11#2)(2011-2#2)
in Serratia marcescens##2##3##(2008-10#1)(2009-6#1)
in Sertoli cells##4##3##(2009-10#2)(2012-2#2)
in Sertoli##5##2##(1990-4#1)(2009-10#2)(2012-2#2)
in Sf##2##2##(1993-8#1)(1997-8#1)
in Sf-21##2##2##(2008-11#2)
in Sf-9 cell cultures##2##4##(2008-7#2)
in Sf-900 II##2##3##(2008-7#2)
in Sf9 cells##3##3##(2008-11#1)(2008-8#2)
in Sf9 insect cells##2##4##(1992-10#1)(2008-11#1)
in Sf9 insect##3##3##(1992-10#1)(2008-11#2)
in Sf9##6##2##(1992-10#1)(2008-11#3)(2008-8#2)
in SfB than in ScA##2##5##(2008-11#2)
in SfB##3##2##(2008-11#3)
in Shanghai##4##2##(1990-2#1)(2011-2#2)(2013-8#1)
in Shimane##2##2##(2010-8#1)(2010-9#1)
in Shiraz##3##2##(2008-12#3)
in Singapore##3##2##(1997-2#1)(2008-10#1)(2009-4#1)
in Soccer##2##2##(2012-3#2)
in Soil and##4##3##(2008-10#4)
in Soil##7##2##(2008-10#7)
in South Africa are##2##4##(1997-7#1)(2011-2#1)
in South Africa##21##3##(1992-9#1)(1997-6#1)(1997-7#3)(2008-10#4)(2008-12#2)(2008-5#1)(2010-1#3)(2010-5#1)(2011-2#2)(2013-1#3)
in South America and##2##4##(2008-10#1)(2011-2#1)
in South America##6##3##(2008-10#4)(2011-2#1)(2013-8#1)
in South Carolina##5##3##(1991-8#1)(2008-11#1)(2012-12#3)
in South East Asia##4##4##(2008-10#1)(2013-1#3)
in South Korea##2##3##(2010-1#1)(2011-2#1)
in South Texas##5##3##(2008-10#5)
in South##53##2##(1991-8#1)(1992-9#1)(1997-6#1)(1997-7#3)(2008-10#19)(2008-11#1)(2008-12#2)(2008-5#2)(2009-10#1)(2010-1#4)(2010-5#1)(2011-2#5)(2012-12#3)(2013-1#7)(2013-8#2)
in Southeast Asia##4##3##(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)
in Southeast##5##2##(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
in Southern Spain##4##3##(2008-10#4)
in Southern##11##2##(2008-10#9)(2008-11#1)(2012-2#1)
in Soxhlet##2##2##(2008-10#2)
in Soybean##4##2##(2008-10#4)
in Spain in##2##3##(2008-10#1)(2012-2#1)
in Spain that##3##3##(1991-11#1)(2008-10#1)(2013-1#1)
in Spain##23##2##(1990-3#1)(1991-11#1)(1994-12#2)(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#1)(2009-10#1)(2012-2#1)(2013-1#1)
in Spain]##4##2##(1990-3#1)(1993-9#1)(1994-9#1)(1995-11#1)
in Spanish##5##2##(2008-10#1)(2008-11#3)(2009-10#1)
in Spirulina platensis##2##3##(2008-8#2)
in Spodoptera frugiperda (Sf9)##2##4##(1992-3#1)(2008-11#1)
in Spodoptera frugiperda##3##3##(1992-3#1)(2008-11#1)(2008-7#1)
in Spodoptera##4##2##(1992-3#1)(2008-11#1)(2008-7#2)
in Sprague-Dawley rats##2##3##(1993-12#1)(2008-10#1)
in Sprague-Dawley##4##2##(1993-12#1)(2008-10#2)(2008-11#1)
in Sri Lanka##2##3##(2008-10#2)
in Srinagarind Hospital##2##3##(2011-2#2)
in St##11##2##(1991-9#1)(1994-1#1)(1995-12#1)(2008-10#5)(2008-12#3)
in Staphylococcus##2##2##(2008-7#2)
in Stockholm##2##2##(2011-2#1)(2011-4#1)
in Stored##2##2##(2008-10#2)
in Strasbourg##2##2##(2008-1#2)
in Streptomyces coelicolor##2##3##(2008-8#2)
in Streptomyces##3##2##(2008-8#2)(2012-3#1)
in Study 1##2##3##(1991-2#1)(2008-12#1)
in Study 2##2##3##(1991-2#1)(2008-12#1)
in Study##4##2##(1991-2#2)(2008-12#2)
in Sub-Saharan Africa##2##3##(1997-7#1)(2008-11#1)
in Subsaharan##2##2##(2008-10#1)(2012-2#1)
in Sugar Beet##2##3##(2008-10#1)(2012-3#1)
in Sugar##3##2##(2008-10#2)(2012-3#1)
in Sunflower##3##2##(2008-10#3)
in Super-CHO##2##2##(2008-11#2)
in Suwon 92##4##3##(2008-10#4)
in Sweden##12##2##(1993-1#1)(1993-2#1)(1994-6#1)(1995-1#1)(2008-11#2)(2010-10#4)(2012-3#1)(2013-8#1)
in Sweden]##2##2##(1991-2#1)(1993-3#1)
in Sweet##2##2##(2008-10#2)
in Swiss##2##2##(1991-12#1)(2008-12#1)
in Switzerland and##2##3##(1990-3#1)(2008-10#1)
in Switzerland##13##2##(1990-3#1)(1991-2#1)(1993-8#1)(1996-11#2)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#3)(2012-5#1)
in Sydney##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
in São Paulo##3##3##(2008-10#2)(2008-5#1)
in Sør-Trøndelag county##2##3##(1991-6#1)(1994-6#1)
in T##15##2##(1995-12#1)(1996-12#1)(2008-10#5)(2008-11#2)(2009-12#1)(2009-6#1)(2012-3#2)(2012-5#1)(2013-8#1)
in T-cell##2##2##(1994-12#1)(1997-9#1)
in T-flask##2##2##(2008-11#2)
in T-flasks##4##2##(2008-11#4)
in T-lymphocyte##2##2##(1991-2#1)(2008-10#1)
in T1##3##2##(1991-8#1)(2010-9#1)(2011-2#1)
in T2D##2##2##(2012-3#2)
in T4##2##2##(1990-2#1)(1991-8#1)
in TA##2##2##(1997-8#2)
in TAI-27##2##2##(2008-9#2)
in TDI controls##2##3##(2008-10#2)
in TDI##3##2##(2008-10#3)
in TGF-beta-treated SFME cells##2##4##(2008-11#2)
in THF/water##3##2##(2008-10#3)
in TJ permeability##2##3##(2008-11#2)
in TNM-FH##2##2##(2008-11#2)
in TPO2##2##2##(1995-12#2)
in TRM##4##2##(2008-1#4)
in TSWV##2##2##(2008-10#2)
in Tabasco##4##2##(2012-12#4)
in Taiwan and##2##3##(2008-10#2)
in Taiwan##16##2##(2008-10#6)(2008-12#3)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
in Takayasu arteritis##2##3##(1997-8#2)
in Talbot##3##2##(2008-3#3)
in Tc##2##2##(1994-2#2)
in Teaching##2##2##(2008-11#1)(2013-1#1)
in Tedlar bags##2##3##(2008-10#2)
in Tehran##4##2##(2008-12#2)(2012-2#1)(2013-8#1)
in Tetrahymena##2##2##(2008-12#1)(2012-3#1)
in Tetraploid Wheat##3##3##(2008-10#2)(2012-3#1)
in Texas##8##2##(1991-1#1)(1995-2#1)(1996-2#2)(1996-5#1)(1997-3#2)(2008-10#1)
in Tg##3##2##(2008-9#3)
in Thai##2##2##(2011-2#2)
in Thailand##7##2##(1995-12#2)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
in The Netherlands##7##3##(1990-3#2)(1991-8#1)(1994-12#1)(1996-11#2)(2008-11#1)
in The Netherlands?]##2##3##(1990-3#1)(1996-11#1)
in The Netherlands]##3##3##(1995-12#2)(1996-11#1)
in The##16##2##(1990-3#3)(1991-8#1)(1994-12#2)(1995-12#2)(1996-11#4)(2008-11#2)(2009-8#2)
in Thurgau##5##2##(1996-11#5)
in TiO(2)##2##2##(2008-10#2)
in Tobacco##3##2##(2008-10#3)
in Tomato by##2##3##(2008-10#2)
in Tomato##6##2##(2008-10#6)
in Toronto##3##2##(1993-12#1)(1993-3#1)(2008-11#1)
in Total##2##2##(2008-11#1)(2013-1#1)
in Transgenic Soybean##2##3##(2008-10#2)
in Transgenic##7##2##(2008-10#7)
in Trichoderma##2##2##(2008-10#2)
in Trichoplusia ni##2##3##(1995-12#1)(2008-7#1)
in Ts65Dn mice##2##3##(1997-2#2)
in Ts65Dn##4##2##(1997-2#4)
in Tulipa spp##3##3##(2009-12#3)
in Tunisia##4##2##(1992-5#1)(2008-10#1)(2009-1#1)(2009-5#1)
in Turkey##8##2##(1995-12#1)(1997-5#1)(1997-8#2)(2008-12#1)(2009-8#1)(2010-4#1)(2011-1#1)
in Turkish orthopedic patients##2##4##(2010-6#2)
in Turkish##8##2##(2009-12#1)(2010-10#1)(2010-6#2)(2011-1#3)(2011-2#1)
in Tuscany##2##2##(2008-10#1)(2008-12#1)
in Tween 80 medium##2##4##(2008-10#2)
in Tween 80##3##3##(2008-10#3)
in Two##3##2##(1996-9#1)(2008-10#1)(2012-3#1)
in Type 2 diabetes##2##4##(2008-1#1)(2010-10#1)
in Type 2##4##3##(2008-1#2)(2010-10#1)(2012-3#1)
in U##9##2##(1991-2#1)(1993-1#1)(1996-3#1)(2008-10#3)(2009-7#3)
in U937##2##2##(2008-10#1)(2012-12#1)
in UC##2##2##(2008-10#1)(2011-2#1)
in US##4##2##(1991-3#1)(2008-9#1)(2010-12#1)(2013-1#1)
in USA##3##2##(1992-5#1)(2008-10#1)(2008-11#1)
in USM##2##2##(2008-10#2)
in UV##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
in UV-vis##2##2##(2008-10#2)
in Uganda##5##2##(1993-3#1)(2008-10#3)(2008-8#1)
in United Kingdom##2##3##(2008-10#1)(2008-11#1)
in Urban##2##2##(2012-2#1)(2013-1#1)
in Urbana##3##2##(2008-10#3)
in Urmia##2##2##(2008-12#1)(2013-1#1)
in Uruguay##2##2##(2011-2#2)
in Utero##2##2##(1991-3#1)(2012-12#1)
in V##15##2##(1995-2#1)(1997-8#1)(2008-10#12)(2011-2#1)
in V1##3##2##(2008-11#3)
in VAM##3##2##(2008-10#3)
in VCG 0030##2##3##(2008-10#2)
in VCG 0031##2##3##(2008-10#2)
in VCG 0080##2##3##(2008-10#2)
in VCG 0082##2##3##(2008-10#2)
in VCG##10##2##(2008-10#10)
in VCG2B##2##2##(2008-10#2)
in VCGs##2##2##(2008-10#2)
in VLDL##2##2##(1991-12#1)(2012-2#1)
in Vancouver##2##2##(2008-12#2)
in Varanasi##2##2##(2008-10#1)(2012-2#1)
in Various##2##2##(2008-10#2)
in Venezuela##5##2##(2008-5#5)
in Venezuelan##2##2##(2011-2#2)
in Venice##2##2##(2008-11#2)
in Vermont##2##2##(1992-2#1)(2010-8#1)
in Verticillium##2##2##(2008-10#2)
in Vest-Agder##2##2##(1997-8#2)
in Vicia faba##2##3##(2008-8#2)
in Victoria##6##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)
in Vietnam##2##2##(2010-10#1)(2010-3#1)
in Vietnamese women is comparable to##2##6##(2010-3#2)
in Vietnamese women##5##3##(2010-3#5)
in Virginia##3##2##(1995-12#1)(1995-6#1)(2008-8#1)
in Virulence##4##2##(2008-10#4)
in Vmax##2##2##(1990-10#1)(1994-8#1)
in WB##2##2##(2008-10#2)
in WI-38 human lung cells##2##5##(1995-8#2)
in WKY##2##2##(1994-2#2)
in WT##3##2##(2013-1#1)(2013-8#2)
in Washington State##5##3##(1996-2#1)(2008-10#2)(2013-8#2)
in Washington##14##2##(1996-2#1)(2008-10#9)(2008-6#1)(2008-8#1)(2013-8#2)
in Werner's syndrome##3##3##(1994-12#3)
in West##4##2##(1996-5#1)(2008-10#3)
in Western Australia##14##3##(2008-10#10)(2008-11#2)(2010-3#2)
in Western blots##2##3##(1995-12#1)(2008-10#1)
in Western countries##4##3##(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
in Western society##2##3##(2008-12#1)(2011-2#1)
in Western##35##2##(1991-5#1)(1994-12#1)(1995-12#2)(2008-10#17)(2008-11#3)(2008-12#3)(2008-9#1)(2010-3#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
in Wheat##9##2##(2008-10#9)
in Wisconsin and##2##3##(2008-10#2)
in Wisconsin##11##2##(1991-12#1)(2008-10#10)
in Wistar rats##7##3##(1991-5#1)(1993-12#2)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
in World##2##2##(2012-2#1)(2012-3#1)
in X##7##2##(1993-12#1)(2008-10#6)
in X-ray##2##2##(1992-9#1)(2008-10#1)
in Xanthomonas##2##2##(2008-10#2)
in Xenopus laevis oocytes##3##4##(1992-3#1)(1994-8#2)
in Xenopus laevis##8##3##(1992-3#1)(1994-8#2)(1997-7#3)(2008-11#1)(2008-9#1)
in Xenopus oocytes##6##3##(1994-12#1)(1995-11#4)(1995-2#1)
in Xenopus##16##2##(1992-3#1)(1993-3#1)(1994-12#1)(1994-8#2)(1995-11#4)(1995-2#1)(1997-7#4)(2008-11#1)(2008-9#1)
in Xhosa-speaking families in South Africa##2##6##(2008-12#2)
in Xieyou 63##3##3##(2008-9#3)
in Xieyou 9308##3##3##(2008-9#3)
in Xieyou##6##2##(2008-9#6)
in Xq28##2##2##(1993-3#2)
in YBa2Cu3O7##2##2##(1993-5#1)(1994-2#1)
in Yemen##6##2##(2010-6#6)
in Yolo##2##2##(2008-10#2)
in Young##3##2##(2008-11#1)(2013-1#2)
in Yunnan Province##2##3##(2008-8#1)(2008-9#1)
in Yunnan##4##2##(2008-8#1)(2008-9#2)(2013-8#1)
in Zagreb in##2##3##(2008-10#2)
in Zaire##2##2##(1995-9#1)(1996-8#1)
in Zaragoza city##2##3##(1996-12#2)
in Zea mays##3##3##(2008-10#2)(2008-12#1)
in Zhejiang Province##2##3##(2008-10#1)(2008-9#1)
in Zn##2##2##(2012-2#2)
in [Ca2+]i and##2##3##(1994-3#1)(1997-1#1)
in [Ca2+]i in response to##2##5##(1992-6#1)(1994-2#1)
in [Ca2+]i in##3##3##(1992-6#2)(1994-2#1)
in [Ca2+]i were##2##3##(1994-6#1)(1995-11#1)
in [Ca2+]i##13##2##(1992-6#3)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-11#2)(1997-1#2)
in [cAMP]i##3##2##(1991-3#3)
in a &quot##6##3##(1990-8#1)(1994-1#1)(1997-1#1)(2008-11#1)(2008-5#1)(2011-2#1)
in a 0##7##3##(2008-10#7)
in a 1##20##3##(1990-5#1)(1993-8#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#12)(2008-11#2)(2008-7#1)
in a 1-mm silica cell##3##5##(2008-10#3)
in a 10-year-old boy##2##4##(2008-7#1)(2013-1#1)
in a 100##3##3##(2008-10#2)(2008-11#1)
in a 14-year-old##2##3##(2008-12#1)(2013-1#1)
in a 2##6##3##(1994-3#1)(2008-10#3)(2008-11#1)(2008-3#1)
in a 23 year##2##4##(2010-11#1)(2012-2#1)
in a 23-year-old woman##2##4##(2008-7#1)(2010-12#1)
in a 23-year-old##4##3##(1997-8#1)(2008-7#1)(2010-12#1)(2013-1#1)
in a 28-year-old man##2##4##(2008-12#2)
in a 29-year-old male##2##4##(1990-3#1)(2010-7#1)
in a 29-year-old##4##3##(1990-3#1)(2008-11#1)(2010-7#1)(2011-2#1)
in a 3##6##3##(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
in a 32-year-old man##2##4##(2009-1#1)(2012-3#1)
in a 32-year-old##3##3##(2008-11#1)(2009-1#1)(2012-3#1)
in a 36-year-old##2##3##(2009-11#1)(2012-3#1)
in a 41-year-old##2##3##(2008-12#1)(2013-1#1)
in a 48-year-old woman##2##4##(2009-1#1)(2012-3#1)
in a 48-year-old##3##3##(2009-1#1)(2012-3#1)(2013-1#1)
in a 5##3##3##(2008-10#2)(2008-2#1)
in a 5-year##2##3##(2008-10#1)(2008-7#1)
in a 5-year-old##2##3##(1990-6#1)(2013-8#1)
in a 50##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
in a 50%##3##3##(2008-10#3)
in a 500##2##3##(1990-9#1)(2008-11#1)
in a 52-year-old##2##3##(2012-12#1)(2013-1#1)
in a 59-year-old##2##3##(2009-8#1)(2012-12#1)
in a 60##2##3##(2008-10#1)(2008-11#1)
in a 60-year-old##2##3##(2012-3#1)(2013-1#1)
in a 62-year-old woman##2##4##(1991-11#1)(1994-6#1)
in a 62-year-old##3##3##(1991-11#1)(1994-6#1)(2008-12#1)
in a 63##2##3##(2007-8#1)(2010-12#1)
in a 66-year-old##2##3##(1992-2#1)(2009-1#1)
in a 67-year-old man##2##4##(1991-8#1)(2008-7#1)
in a 7##2##3##(2008-10#1)(2012-2#1)
in a 70-year-old##3##3##(1991-12#1)(1992-2#1)(2008-12#1)
in a 71-year-old##3##3##(1992-12#1)(1992-2#1)(2010-12#1)
in a 72-year-old woman##2##4##(2007-8#1)(2010-7#1)
in a AgGaSe(2)##2##3##(2008-2#2)
in a Ca(2+)-free##3##3##(1994-6#1)(1996-2#1)(2008-8#1)
in a California##2##3##(1992-2#1)(2008-10#1)
in a Canadian##5##3##(1992-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
in a Child with##2##4##(1996-6#1)(2010-9#1)
in a Chinese Han population##3##5##(2011-2#3)
in a Chinese population##2##4##(2011-2#2)
in a Chinese##6##3##(2008-11#1)(2011-2#5)
in a Community##2##3##(2008-11#1)(2011-2#1)
in a DNA duplex##3##4##(1995-12#2)(2008-4#1)
in a DNA##4##3##(1995-12#2)(2008-10#1)(2008-4#1)
in a European##2##3##(2008-10#2)
in a FIA assembly##3##4##(2008-10#3)
in a FIA##5##3##(2008-10#5)
in a French hospital##3##4##(2008-7#2)(2011-2#1)
in a French##4##3##(2008-3#1)(2008-7#2)(2011-2#1)
in a Nigerian##3##3##(2012-12#2)(2013-1#1)
in a PVC matrix##2##4##(2008-10#2)
in a PVC##4##3##(2008-10#4)
in a Patient with##3##4##(1994-12#1)(2008-12#2)
in a Plexiglas##2##3##(2008-10#1)(2008-5#1)
in a Rat##2##3##(2008-10#1)(2012-3#1)
in a Southeastern##2##3##(1996-1#1)(2012-2#1)
in a T-maze##4##3##(1991-2#1)(1993-3#2)(1994-8#1)
in a U##2##3##(2010-6#1)(2013-8#1)
in a UV-sensitive##2##3##(1993-3#2)
in a baculovirus##2##3##(1992-3#1)(2008-11#1)
in a basal-to-apical direction##2##4##(2008-9#2)
in a basic##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
in a batch##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
in a benign##2##3##(1994-5#1)(2008-11#1)
in a better##6##3##(1991-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
in a biocontrol experiment##2##4##(2008-10#2)
in a biological assay##2##4##(1994-5#1)(2008-11#1)
in a biological##5##3##(1994-5#1)(1995-5#1)(2008-11#1)(2008-3#1)(2013-8#1)
in a bioprocess##2##3##(2008-10#1)(2008-11#1)
in a bioreactor##3##3##(2008-10#1)(2008-11#2)
in a biphasic##6##3##(1991-10#2)(1992-7#1)(1995-6#1)(1997-2#1)(2008-1#1)
in a blind##3##3##(1990-5#1)(1997-2#1)(2008-6#1)
in a boy with##2##4##(1994-3#1)(2008-10#1)
in a breast##2##3##(1995-6#1)(2008-9#1)
in a broad range of##3##5##(2008-10#2)(2008-7#1)
in a broad sense##3##4##(2008-10#2)(2009-9#1)
in a broad##7##3##(1993-1#1)(2008-10#4)(2008-7#1)(2009-9#1)
in a buffer##3##3##(2008-10#2)(2009-3#1)
in a bundle##2##3##(2008-4#1)(2008-9#1)
in a busy##2##3##(1996-2#1)(2012-2#1)
in a cancer##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
in a capillary##3##3##(2008-10#3)
in a caring##2##3##(1990-6#1)(2008-12#1)
in a carrier stream of##2##5##(2008-10#2)
in a carrier##3##3##(2008-10#3)
in a case of##12##4##(1991-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-11#1)(2010-10#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
in a case##15##3##(1991-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-10#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
in a cat##2##3##(1992-5#1)(2012-3#1)
in a cationic micellar solution of##2##6##(2008-10#2)
in a cell density-dependent manner##2##5##(1993-8#1)(1995-2#1)
in a cell line##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
in a cell type-specific manner##2##5##(1995-11#1)(1995-8#1)
in a cell##17##3##(1993-8#1)(1994-11#1)(1995-11#2)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)
in a cell-cycle##2##3##(2008-11#1)(2008-9#1)
in a cell-free system##8##4##(1990-5#2)(1991-5#1)(1993-8#1)(1995-6#1)(1996-2#1)(1997-7#2)
in a cellulose##3##3##(1991-11#1)(2008-10#2)
in a centrifugal##2##3##(2008-2#1)(2013-1#1)
in a certain##5##3##(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
in a certified##2##3##(2008-10#2)
in a changing health care##2##5##(1993-12#1)(1997-3#1)
in a changing##4##3##(1991-2#1)(1993-12#1)(1997-3#1)(2012-7#1)
in a chemically##2##3##(2008-10#1)(2008-5#1)
in a child who##2##4##(2010-6#1)(2011-2#1)
in a child with##6##4##(2007-8#1)(2008-10#2)(2008-9#3)
in a child##27##3##(1995-11#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-9#4)(2009-9#2)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
in a chromatographic system##2##4##(2008-10#2)
in a chromatographic##3##3##(2008-10#3)
in a chromatomembrane cell##2##4##(2008-10#2)
in a circular##2##3##(2008-3#2)
in a civil##2##3##(1994-3#1)(2012-3#1)
in a clade##2##3##(2008-8#1)(2011-2#1)
in a classical##4##3##(1994-5#1)(2008-11#2)(2008-5#1)
in a climate chamber##2##4##(2008-10#1)(2008-5#1)
in a clinic or##2##4##(1997-3#1)(2009-5#1)
in a clinic##3##3##(1996-5#1)(1997-3#1)(2009-5#1)
in a clinical laboratory##2##4##(2008-10#1)(2011-2#1)
in a clinical setting##3##4##(2008-3#1)(2008-9#1)(2012-2#1)
in a clinical trial##2##4##(2010-6#1)(2012-3#1)
in a clinical##13##3##(2008-10#2)(2008-11#1)(2008-3#4)(2008-9#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
in a clinostat##2##3##(2008-11#1)(2008-8#1)
in a closed form##2##4##(1993-3#1)(2008-3#1)
in a closed system##2##4##(2008-10#2)
in a closed##6##3##(1993-3#1)(2008-10#3)(2008-3#1)(2008-9#1)
in a coherent##5##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)
in a cohort of##5##4##(1994-12#1)(2008-3#1)(2009-10#1)(2009-5#1)(2011-2#1)
in a cold##2##3##(1995-11#1)(2008-10#1)
in a collaborative##2##3##(2008-1#1)(2008-7#1)
in a collection of##2##4##(2008-10#2)
in a college##2##3##(2008-11#1)(2011-1#1)
in a colony##2##3##(1992-1#1)(2008-9#1)
in a column##14##3##(2008-10#14)
in a comfortable##2##3##(1991-2#1)(2011-2#1)
in a commercial##5##3##(2008-10#5)
in a common##8##3##(1991-9#1)(2008-10#3)(2008-11#1)(2009-12#1)(2011-1#1)(2013-1#1)
in a community of##2##4##(2008-12#1)(2008-8#1)
in a community sample##2##4##(1992-1#1)(2013-8#1)
in a community setting##3##4##(2008-1#1)(2008-11#1)(2011-2#1)
in a community##14##3##(1992-1#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#3)(2009-11#1)(2009-8#1)(2011-2#2)(2013-8#1)
in a community-based sample##2##4##(2008-11#1)(2008-7#1)
in a comparative##2##3##(2008-10#2)
in a comparison##2##3##(1990-2#1)(2011-2#1)
in a competitive##4##3##(1992-3#2)(2008-10#1)(2008-4#1)
in a complete##3##3##(1997-3#1)(2008-10#1)(2010-4#1)
in a complex manner##4##4##(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)
in a complex mixture##3##4##(2008-10#2)(2008-4#1)
in a complex##12##3##(1994-12#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)(2012-3#2)
in a composite rod##2##4##(2008-2#2)
in a composite##4##3##(2008-2#2)(2008-9#1)(2012-2#1)
in a comprehensive manner##2##4##(2008-10#1)(2008-9#1)
in a comprehensive##3##3##(1995-5#1)(2008-10#1)(2008-9#1)
in a computer##3##3##(2008-10#1)(2008-4#1)(2009-11#1)
in a concentration dependent manner##3##5##(1990-5#1)(2012-2#1)(2013-8#1)
in a concentration of##2##4##(2008-10#2)
in a concentration range from##2##5##(2008-10#2)
in a concentration range of##5##5##(2008-10#4)(2011-3#1)
in a concentration range##7##4##(2008-10#6)(2011-3#1)
in a concentration##15##3##(1990-5#1)(1993-3#1)(1994-6#1)(2008-10#9)(2011-3#1)(2012-2#1)(2013-8#1)
in a concentration-dependent manner at##2##5##(1991-6#1)(1992-6#1)
in a concentration-dependent manner##14##4##(1990-5#1)(1991-6#1)(1992-6#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-11#2)(2008-11#1)(2009-3#1)
in a concentration-dependent##15##3##(1990-5#2)(1991-6#1)(1992-6#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-11#2)(2008-11#1)(2009-3#1)
in a considerable##3##3##(2008-10#3)
in a consistent manner##2##4##(1991-1#1)(2009-10#1)
in a constant##3##3##(1994-5#1)(2008-10#1)(2008-9#1)
in a contaminated##2##3##(2008-10#2)
in a context of##3##4##(1991-11#1)(2008-10#1)(2011-2#1)
in a context##4##3##(1991-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
in a continuous flow system##5##5##(2008-10#5)
in a continuous flow##6##4##(2008-10#6)
in a continuous mode##3##4##(2008-10#3)
in a continuous##18##3##(1996-1#1)(2008-10#11)(2008-11#3)(2008-7#2)(2011-2#1)
in a continuously##2##3##(2008-10#2)
in a controlled environment##5##4##(2008-10#5)
in a controlled##8##3##(1996-3#1)(2008-10#5)(2009-12#2)
in a convenience sample of##2##5##(2009-5#1)(2010-6#1)
in a conventional##4##3##(1990-6#1)(2008-10#2)(2011-7#1)
in a cool##2##3##(1994-2#1)(2008-10#1)
in a cooperative manner##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
in a cost-effective manner##2##4##(1993-12#1)(1993-9#1)
in a cost-effective##3##3##(1993-12#1)(1993-9#1)(1997-7#1)
in a counting task##2##4##(2013-8#2)
in a country where##2##4##(1997-6#1)(2008-10#1)
in a county##2##3##(1990-11#1)(1991-3#1)
in a cross-sectional##2##3##(1997-4#1)(2008-7#1)
in a crystalline##2##3##(1990-2#1)(2010-12#1)
in a culturally##2##3##(2008-1#1)(2008-7#1)
in a culture medium##2##4##(1995-3#1)(2008-10#1)
in a culture of##2##4##(2008-11#2)
in a culture##6##3##(1995-3#1)(2008-10#2)(2008-11#3)
in a cv##2##3##(2008-10#2)
in a cylindrical##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
in a database##2##3##(2008-11#2)
in a day##3##3##(1994-6#1)(2012-3#2)
in a decrease in the##3##5##(2006-6#1)(2008-10#1)(2008-7#1)
in a decrease in##8##4##(1993-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2013-1#1)
in a decrease##9##3##(1993-8#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-11#1)(2013-1#1)
in a decreased##4##3##(1997-6#1)(2008-10#1)(2008-11#2)
in a deep##2##3##(2008-11#1)(2009-3#1)
in a defined##3##3##(1991-12#1)(2008-10#1)(2012-2#1)
in a dental##2##3##(1994-12#1)(2013-8#1)
in a department of##3##4##(1991-11#2)(1997-4#1)
in a developer##7##3##(2008-10#7)
in a developing country##3##4##(2011-2#1)(2012-12#1)(2013-7#1)
in a developmentally regulated##2##4##(1993-3#1)(2012-3#1)
in a developmentally##3##3##(1993-3#1)(2008-11#1)(2012-3#1)
in a different light##2##4##(1993-5#1)(1997-8#1)
in a different way##2##4##(2008-10#2)
in a different##7##3##(1993-5#1)(1993-8#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-3#1)
in a differential manner##2##4##(1996-12#1)(2009-3#1)
in a differential pulse##2##4##(2008-10#2)
in a differential##6##3##(1996-12#1)(2008-10#3)(2008-3#1)(2009-3#1)
in a dilution##2##3##(2008-10#1)(2012-3#1)
in a diode-pumped##2##3##(2007-12#1)(2008-3#1)
in a direct##2##3##(2008-10#1)(2008-12#1)
in a dispersive##2##3##(2007-11#2)
in a distinct##5##3##(2008-10#5)
in a diverse##2##3##(2008-5#1)(2010-1#1)
in a dog##7##3##(1995-9#1)(1997-5#1)(2006-6#1)(2008-5#1)(2012-3#1)(2013-8#2)
in a domestic microwave oven##2##5##(2008-10#2)
in a domestic##3##3##(2008-10#2)(2011-2#1)
in a dose dependent manner##2##5##(1994-11#1)(1994-3#1)
in a dose of##2##4##(1994-8#1)(2012-2#1)
in a dose range of##2##5##(1992-6#1)(2008-9#1)
in a dose related manner##2##5##(1993-8#1)(1994-11#1)
in a dose related##3##4##(1993-8#1)(1994-11#1)(2008-10#1)
in a dose##10##3##(1992-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(2008-10#2)(2008-9#1)(2012-2#1)
in a dose- and time-dependent manner##4##6##(1996-2#1)(2008-11#2)(2011-2#1)
in a dose- and##5##4##(1996-2#1)(2008-11#2)(2008-12#1)(2011-2#1)
in a dose-dependent fashion##5##4##(1992-12#3)(1994-6#1)(1995-2#1)
in a dose-dependent manner up to##2##6##(1993-3#1)(2008-11#1)
in a dose-dependent manner##42##4##(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#3)(1995-8#4)(1996-2#1)(1997-1#2)(1997-3#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-5#2)(2009-12#1)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
in a dose-dependent##50##3##(1992-12#3)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-8#4)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
in a dose-related manner##7##4##(1994-2#1)(1995-11#1)(1997-2#2)(2008-11#1)(2008-6#2)
in a double-blind study##3##4##(1991-2#1)(1996-1#1)(2008-5#1)
in a double-blind trial##2##4##(2008-5#2)
in a double-blind##7##3##(1991-2#1)(1996-1#1)(2008-5#4)(2013-1#1)
in a doubled haploid##2##4##(2008-10#1)(2012-3#1)
in a drastic##4##3##(1997-5#1)(2008-10#2)(2011-1#1)
in a drop of the##2##5##(1991-3#1)(2008-10#1)
in a dry##2##3##(2008-10#1)(2008-11#1)
in a dynamic##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-8#1)
in a factorial##2##3##(2008-10#1)(2008-11#1)
in a family##4##3##(1997-5#1)(2008-11#1)(2008-12#1)(2008-6#1)
in a fashion##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
in a fast and##2##4##(2008-10#2)
in a fast##4##3##(1994-5#1)(1994-6#1)(2008-10#2)
in a faster##2##3##(1992-12#1)(2008-11#1)
in a female patient##2##4##(1992-12#1)(2008-12#1)
in a female##6##3##(1992-12#1)(2008-10#4)(2008-12#1)
in a few cases##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
in a few weeks##2##4##(1996-5#1)(2008-10#1)
in a few##14##3##(1990-6#1)(1994-1#1)(1994-3#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in a field environment##2##4##(2008-10#1)(2008-3#1)
in a field experiment##4##4##(2008-10#3)(2008-8#1)
in a field trial##3##4##(1990-6#1)(2008-10#2)
in a field##21##3##(1990-6#1)(2008-10#18)(2008-3#1)(2008-8#1)
in a film##2##3##(2008-10#2)
in a final##2##3##(2008-10#1)(2008-7#1)
in a first step##2##4##(2008-10#2)
in a first##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
in a fish##2##3##(2008-10#1)(2013-1#1)
in a fixed bed bioreactor##2##5##(2008-11#2)
in a fixed bed##3##4##(2008-11#3)
in a fixed orientation##2##4##(2008-3#1)(2008-8#1)
in a fixed##7##3##(1991-2#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)
in a fixed-bed##2##3##(2008-11#1)(2008-12#1)
in a flat plate##2##4##(2008-7#2)
in a flat##3##3##(2008-11#1)(2008-7#2)
in a flow cell##5##4##(2008-10#5)
in a flow injection analysis##4##5##(2008-10#4)
in a flow injection system coupled##2##6##(2008-10#2)
in a flow injection system for the determination of##2##9##(2008-10#2)
in a flow injection system with##3##6##(2008-10#3)
in a flow injection system##15##5##(2008-10#15)
in a flow injection##25##4##(2008-10#25)
in a flow system##7##4##(2008-10#7)
in a flow##41##3##(2008-10#41)
in a flow-injection system with the electrodes polarized at##2##9##(2008-10#2)
in a flow-injection system##8##4##(2008-10#8)
in a flow-injection##9##3##(2008-10#9)
in a flow-through##4##3##(2008-10#4)
in a flowing##2##3##(2008-10#2)
in a fluidized bed##2##4##(2008-11#1)(2008-7#1)
in a focused##3##3##(2008-10#1)(2008-3#2)
in a food##2##3##(1997-2#1)(2008-9#1)
in a forced##2##3##(1990-11#1)(2008-11#1)
in a form##2##3##(1996-12#1)(2008-10#1)
in a formal##3##3##(1996-6#1)(2008-11#2)
in a format that can be##2##6##(1994-2#1)(2008-10#1)
in a format that##3##4##(1994-2#1)(2008-10#2)
in a four species mixed oak forest##2##7##(2012-5#2)
in a four##3##3##(2008-11#1)(2012-5#2)
in a free-living##2##3##(1992-9#1)(1995-5#1)
in a fully##2##3##(2008-11#1)(2012-3#1)
in a functional##3##3##(1992-9#1)(2008-4#1)(2011-2#1)
in a future##2##3##(2008-10#1)(2008-11#1)
in a gamma##2##3##(1993-11#1)(2008-11#1)
in a gas-liquid separator##2##4##(2008-10#2)
in a gene##4##3##(1994-5#1)(1995-8#1)(1997-6#1)(2011-2#1)
in a general hospital##3##4##(2013-1#3)
in a general population sample of##2##6##(2008-11#2)
in a general population sample##3##5##(2008-11#3)
in a general population##4##4##(1991-1#1)(2008-11#3)
in a general##11##3##(1991-1#1)(2008-10#3)(2008-11#3)(2013-1#4)
in a genetically##3##3##(2008-4#1)(2012-3#1)(2013-8#1)
in a genomically##2##3##(2011-2#2)
in a geriatric##3##3##(1992-12#1)(2008-7#1)(2011-2#1)
in a given area##2##4##(2008-8#2)
in a given##13##3##(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#1)(2010-6#1)(2012-3#1)
in a glass column##2##4##(2008-10#2)
in a glass##3##3##(1995-3#1)(2008-10#2)
in a glasshouse##2##3##(2008-10#2)
in a goat##2##3##(1990-3#1)(1997-5#1)
in a good agreement with the##4##6##(2008-10#4)
in a good agreement with##5##5##(2008-10#5)
in a good clinical##2##4##(2008-7#1)(2013-1#1)
in a good##10##3##(2008-10#5)(2008-12#1)(2008-7#2)(2011-3#1)(2013-1#1)
in a graduate##3##3##(1996-1#1)(2013-1#2)
in a graphite##3##3##(2008-10#3)
in a great##2##3##(1993-11#1)(2010-5#1)
in a greater##2##3##(1997-1#1)(2010-4#1)
in a greenhouse test##2##4##(2008-10#2)
in a greenhouse##10##3##(2008-10#10)
in a group of 17 patients##2##6##(2013-1#2)
in a group of equal##2##5##(2008-9#2)
in a group of##24##4##(1990-12#1)(1991-8#1)(1993-11#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#6)(2009-4#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
in a group##30##3##(1990-12#1)(1991-8#1)(1993-1#1)(1993-11#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#8)(2009-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
in a growing number of##2##5##(1995-2#1)(2011-2#1)
in a growing##5##3##(1995-2#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)
in a growth chamber at##2##5##(2008-10#2)
in a growth chamber##6##4##(2008-10#6)
in a growth##9##3##(1995-2#1)(2008-10#7)(2010-1#1)
in a habitat##2##3##(2008-10#1)(2009-8#1)
in a health administration curriculum##2##5##(1996-1#1)(1996-2#1)
in a health administration##3##4##(1993-1#1)(1996-1#1)(1996-2#1)
in a health care center##2##5##(1991-3#1)(2008-10#1)
in a health care##5##4##(1991-3#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
in a health center]##2##4##(1994-9#1)(1997-2#1)
in a health##15##3##(1991-12#1)(1991-3#1)(1993-1#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
in a healthcare##2##3##(1993-2#2)
in a healthy volunteer##2##4##(1993-2#1)(2008-10#1)
in a healthy##6##3##(1993-2#1)(2008-10#1)(2010-1#1)(2013-1#1)(2013-3#1)(2013-8#1)
in a heated##2##3##(2008-10#1)(2008-3#1)
in a hen##2##3##(2008-5#2)
in a hepatitis##2##3##(2013-8#2)
in a heterogeneous##6##3##(1997-5#1)(2008-11#2)(2008-8#1)(2010-2#1)(2012-2#1)
in a heterologous##2##3##(1997-8#1)(2008-10#1)
in a high performance##2##4##(2011-2#2)
in a high proportion of##2##5##(2008-10#1)(2008-7#1)
in a high throughput##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
in a high##20##3##(1992-9#1)(1996-2#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-3#2)
in a high-performance##2##3##(2008-10#1)(2008-3#1)
in a high-risk##4##3##(1992-3#1)(2008-11#2)(2009-5#1)
in a higher##6##3##(1994-12#1)(2008-10#4)(2008-7#1)
in a highly conserved##2##4##(1993-8#1)(2008-10#1)
in a highly purified##2##4##(1996-3#1)(2008-2#1)
in a highly##16##3##(1991-12#1)(1993-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-8#1)
in a holistic##2##3##(2008-12#1)(2013-8#1)
in a hollow fiber bioreactor##2##5##(2008-11#2)
in a hollow fiber##3##4##(2008-10#1)(2008-11#2)
in a hollow waveguide##2##4##(2007-12#2)
in a hollow##5##3##(2007-12#2)(2008-10#1)(2008-11#2)
in a hollow-fiber bioreactor##2##4##(2008-7#2)
in a home##2##3##(1996-2#1)(2008-10#1)
in a home-based pulmonary maintenance program##2##6##(2010-10#2)
in a hospital##11##3##(1992-2#1)(1994-12#2)(1994-3#1)(2008-11#2)(2008-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
in a human##9##3##(1990-10#1)(1995-10#1)(1995-12#1)(1996-3#1)(1997-1#2)(2008-11#1)(2012-2#1)(2012-3#1)
in a hybrid PBL curriculum##2##5##(2008-10#2)
in a hybrid##4##3##(2008-10#3)(2008-11#1)
in a knotted##2##3##(2008-10#2)
in a laboratory##11##3##(1996-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)
in a lack of##4##4##(1997-6#1)(2008-11#1)(2008-12#1)(2011-2#1)
in a laminar methane jet##2##5##(2008-3#2)
in a laminar##3##3##(2008-3#3)
in a large amount of##2##5##(2008-10#1)(2010-8#1)
in a large cohort##2##4##(2011-2#2)
in a large number of##7##5##(1994-12#1)(1995-12#1)(1996-2#2)(2008-10#2)(2008-9#1)
in a large population of##2##5##(1994-8#1)(1997-3#1)
in a large population##4##4##(1994-8#1)(1997-3#1)(2008-12#1)(2008-7#1)
in a large sample of##2##5##(2008-11#1)(2008-12#1)
in a large sample##3##4##(2008-11#1)(2008-12#1)(2008-8#1)
in a large scale##2##4##(2008-10#1)(2008-11#1)
in a large##45##3##(1992-1#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2008-10#9)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
in a larger##2##3##(2008-10#1)(2008-11#1)
in a laser##3##3##(2008-3#2)(2009-12#1)
in a late preterm infant##2##5##(2010-11#2)
in a level III academic##2##5##(2008-10#2)
in a level III##3##4##(2008-10#2)(2008-11#1)
in a level##4##3##(2008-10#2)(2008-11#2)
in a limited##4##3##(1994-2#1)(2008-10#3)
in a linear##7##3##(2007-11#2)(2008-10#3)(2008-2#1)(2013-8#1)
in a lipid##3##3##(1991-5#1)(1994-11#1)(2008-10#1)
in a liquid##5##3##(2008-10#3)(2008-3#2)
in a local population of##2##5##(2008-9#2)
in a local##4##3##(2008-8#1)(2008-9#2)(2011-2#1)
in a long-term##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
in a longer##5##3##(2008-11#2)(2008-7#1)(2009-10#1)(2011-2#1)
in a longitudinal study##2##4##(1990-2#1)(2009-11#1)
in a longitudinal##5##3##(1990-2#1)(2009-11#1)(2012-2#1)(2012-5#1)(2013-8#1)
in a loss of##3##4##(1997-3#1)(2008-10#1)(2010-10#1)
in a low##7##3##(1992-3#1)(1996-3#1)(2008-10#3)(2008-11#1)(2012-2#1)
in a low-birefringence##2##3##(2008-3#2)
in a low-income##2##3##(1995-3#1)(1997-2#1)
in a lower detection limit##2##5##(2008-10#1)(2008-11#1)
in a lower##6##3##(1992-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-12#1)
in a luminol solution##2##4##(2008-10#2)
in a lung##2##3##(1997-2#2)
in a maize##2##3##(2008-10#2)
in a major##4##3##(1991-2#1)(1995-3#1)(2008-11#1)(2008-7#1)
in a managed care##2##4##(1996-12#1)(1997-2#1)
in a managed##4##3##(1991-12#1)(1995-2#1)(1996-12#1)(1997-2#1)
in a manner analogous to##3##5##(1991-12#1)(1994-11#1)(2008-10#1)
in a manner consistent with##2##5##(2011-2#1)(2012-3#1)
in a manner indicative of##2##5##(2008-10#1)(2008-11#1)
in a manner similar to##6##5##(1991-5#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)
in a manner that##5##4##(1995-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
in a manner which##2##4##(1993-8#1)(2010-9#1)
in a manner##27##3##(1991-12#1)(1991-5#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-11#1)(1995-5#1)(2008-10#7)(2008-11#5)(2008-9#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
in a marked reduction in##3##5##(1993-8#1)(1996-12#1)(2010-10#1)
in a marked##5##3##(1993-8#1)(1996-12#2)(2008-10#1)(2010-10#1)
in a matter of##2##4##(1991-3#1)(2008-3#1)
in a mature##3##3##(2012-3#2)(2013-8#1)
in a mean duration of##2##5##(2008-1#2)
in a mean##4##3##(2008-1#3)(2008-10#1)
in a medical research##2##4##(1991-2#1)(2010-1#1)
in a medical##5##3##(1991-2#1)(1992-2#1)(1996-11#1)(2010-1#1)(2010-8#1)
in a medium containing##6##4##(2008-10#4)(2008-11#1)(2008-9#1)
in a medium##12##3##(1997-4#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-9#1)(2009-8#1)
in a membrane##6##3##(2008-10#5)(2009-8#1)
in a metallic##2##3##(1991-9#1)(2012-2#1)
in a metapopulation of##2##4##(2008-8#1)(2008-9#1)
in a metapopulation##4##3##(2008-8#1)(2008-9#3)
in a methyl methacrylate##2##4##(2008-10#2)
in a micellar medium##2##4##(2008-10#2)
in a micellar##3##3##(2008-10#3)
in a microemulsion##3##3##(2008-10#3)
in a microfluidic flow injection##2##5##(2008-10#2)
in a microfluidic##5##3##(2008-10#4)(2009-12#1)
in a microwave oven##3##4##(2008-10#3)
in a microwave##5##3##(2008-10#5)
in a mini-column##4##3##(2008-10#4)
in a minicolumn and##2##4##(2008-10#2)
in a minicolumn##9##3##(2008-10#9)
in a minimal medium##2##4##(2008-10#2)
in a minimal##4##3##(2008-10#3)(2009-6#1)
in a mixed##5##3##(1992-6#1)(2008-10#4)
in a mixing coil##2##4##(2008-10#2)
in a mixture of amino acids##2##6##(2008-10#2)
in a mixture of##9##4##(2008-10#8)(2008-7#1)
in a mixture solution##2##4##(2008-10#2)
in a mixture##20##3##(1990-12#1)(2008-10#18)(2008-7#1)
in a model of##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
in a model system##4##4##(2008-10#3)(2012-3#1)
in a model##13##3##(1996-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
in a moderately##2##3##(2008-10#2)
in a modified slump test position##2##6##(2008-12#2)
in a modified slump##3##4##(2008-12#3)
in a modified##5##3##(1996-12#1)(2008-10#1)(2008-12#3)
in a molar ratio of##2##5##(1993-6#1)(2008-10#1)
in a molecular##2##3##(1992-11#1)(2008-9#1)
in a molecule##2##3##(1991-5#1)(2008-7#1)
in a more detailed##2##4##(1992-9#1)(2013-8#1)
in a more##18##3##(1991-3#1)(1992-1#1)(1992-9#1)(1993-1#1)(1994-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
in a mouse model##4##4##(1994-5#1)(2008-10#1)(2009-6#1)(2011-2#1)
in a mouse##6##3##(1990-8#1)(1994-5#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
in a muffle furnace##2##4##(2008-10#2)
in a multi-analyte##2##3##(2008-10#1)(2013-1#1)
in a multi-pumping flow system##2##5##(2008-10#2)
in a multicellular organism##2##4##(2008-9#1)(2012-3#1)
in a multidimensional vector space##2##5##(2008-11#2)
in a multimode##2##3##(2008-3#2)
in a multiplex##3##3##(2008-10#3)
in a multispecialty group##2##4##(1996-1#1)(2008-11#1)
in a multispecialty##3##3##(1995-2#1)(1996-1#1)(2008-11#1)
in a multitude of##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
in a murine model of##2##5##(2010-6#1)(2012-2#1)
in a murine model##3##4##(2008-11#1)(2010-6#1)(2012-2#1)
in a murine##4##3##(2008-11#2)(2010-6#1)(2012-2#1)
in a narrower##2##3##(1994-5#1)(2008-10#1)
in a nasal spray##2##4##(2008-10#1)(2008-5#1)
in a national##5##3##(1991-12#1)(1993-12#1)(1996-2#1)(2008-1#2)
in a natural population##3##4##(2008-12#1)(2008-8#1)(2008-9#1)
in a natural system##2##4##(2008-9#2)
in a natural water##2##4##(2008-10#2)
in a natural##8##3##(1995-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#3)
in a naturally##2##3##(1995-9#1)(2008-8#1)
in a negative##2##3##(2008-10#2)
in a neonatal intensive care unit##3##6##(1991-1#1)(2008-11#1)(2010-8#1)
in a neonatal intensive care##4##5##(1991-1#1)(2008-11#2)(2010-8#1)
in a neonate##2##3##(2012-3#1)(2013-1#1)
in a nested##2##3##(2008-10#2)
in a network##2##3##(2008-11#1)(2008-7#1)
in a neutral##4##3##(2008-10#3)(2008-2#1)
in a new assay##3##4##(2008-10#3)
in a new era of##2##5##(2008-9#1)(2011-7#1)
in a new family##2##4##(1991-9#1)(1995-5#1)
in a new##18##3##(1991-3#1)(1991-9#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-9#1)(2011-7#1)
in a newborn intensive care unit##2##6##(1991-12#2)
in a newborn##6##3##(1991-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
in a newly discovered##2##4##(2008-10#2)
in a newly##4##3##(1995-2#1)(2008-10#2)(2013-1#1)
in a non-competitive way##4##4##(1990-5#2)(1992-3#2)
in a nonlinear##2##3##(2008-3#2)
in a normal##4##3##(1990-6#1)(1994-8#1)(2008-10#1)(2008-6#1)
in a novel##11##3##(1993-6#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#1)(2013-1#1)
in a nuclear##4##3##(1992-4#1)(1995-2#1)(2008-10#1)(2009-10#1)
in a number of ways##3##5##(1996-3#1)(1997-4#1)(2008-5#1)
in a number of##32##4##(1991-5#1)(1993-2#1)(1993-9#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2012-3#1)
in a nursing home##4##4##(2008-7#1)(2010-10#3)
in a nursing##7##3##(2008-11#2)(2008-5#1)(2008-7#1)(2010-10#3)
in a nutrient##2##3##(2008-12#1)(2008-7#1)
in a pH range of##8##5##(2008-10#8)
in a pH##14##3##(1990-12#1)(2008-10#12)(2009-12#1)
in a packed bed##2##4##(2008-11#2)
in a packed##3##3##(2008-10#1)(2008-11#2)
in a packed-bed bioreactor##3##4##(2008-11#2)(2008-7#1)
in a paediatric##2##3##(2008-11#2)
in a pair of blind##2##5##(2012-3#2)
in a pair of monozygotic twins##3##6##(2008-7#3)
in a pair of##8##4##(1997-7#1)(2008-12#1)(2008-7#3)(2010-8#1)(2012-3#2)
in a palliative care##2##4##(2008-12#1)(2010-2#1)
in a panel##2##3##(1995-3#1)(2013-1#1)
in a panmictic population##2##4##(2008-9#2)
in a paracrine manner##2##4##(2008-4#1)(2013-1#1)
in a paracrine##3##3##(2008-4#1)(2013-1#1)(2013-8#1)
in a parallel##2##3##(1993-8#1)(2008-10#1)
in a particular##12##3##(1991-2#2)(1992-12#1)(1995-11#1)(2008-10#1)(2008-7#1)(2008-8#2)(2011-2#2)(2011-3#1)(2012-3#1)
in a patient presenting with##2##5##(2008-12#1)(2011-2#1)
in a patient presenting##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
in a patient treated for##2##5##(1991-11#1)(1996-3#1)
in a patient with a history of##2##7##(2009-4#1)(2012-3#1)
in a patient with a##6##5##(1994-12#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-3#1)(2012-3#1)
in a patient with an##2##5##(2008-7#1)(2009-11#1)
in a patient with chronic whiplash syndrome##2##7##(2008-12#2)
in a patient with chronic##4##5##(2008-12#2)(2011-2#1)(2013-1#1)
in a patient with end-stage renal##2##6##(2008-1#1)(2013-1#1)
in a patient with familial##2##5##(1992-8#1)(2011-2#1)
in a patient with metastatic##2##5##(1992-2#1)(2008-11#1)
in a patient with multiple##2##5##(1992-12#1)(1997-8#1)
in a patient with##74##4##(1991-11#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#7)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#7)(2012-3#11)(2013-1#4)(2013-7#2)(2013-8#2)
in a patient##96##3##(1990-12#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#8)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#13)(2013-1#4)(2013-7#2)(2013-8#2)
in a patient's##3##3##(1991-12#1)(1993-12#1)(2012-3#1)
in a pediatric##3##3##(1992-2#1)(1993-2#1)(1995-11#1)
in a perinuclear##2##3##(1995-3#1)(2009-10#1)
in a period of##3##4##(1990-12#1)(1993-3#1)(1997-5#1)
in a period##4##3##(1990-12#1)(1993-3#1)(1996-3#1)(1997-5#1)
in a persistent manner##4##4##(2008-10#4)
in a persistent vegetative state##2##5##(1990-11#1)(1991-12#1)
in a persistent##6##3##(1990-11#1)(1991-12#1)(2008-10#4)
in a pharmaceutical preparation##2##4##(2008-10#2)
in a pharmaceutical##6##3##(2008-10#4)(2008-11#2)
in a pharmacokinetic##2##3##(2008-10#1)(2013-1#1)
in a phosphate buffer##4##4##(2008-10#4)
in a phosphate##5##3##(2008-10#5)
in a photographic developing solution##6##5##(2008-10#6)
in a photographic##7##3##(2008-10#7)
in a photorefractive crystal##2##4##(2008-3#2)
in a photorefractive##6##3##(2007-11#1)(2008-3#5)
in a pilot plant##2##4##(2008-10#2)
in a pilot##3##3##(1992-5#1)(2008-10#2)
in a plant##2##3##(2008-10#1)(2008-12#1)
in a plasmid##2##3##(1990-8#1)(2008-10#1)
in a plasticized##3##3##(2008-10#3)
in a polar##2##3##(2008-10#1)(2008-3#1)
in a poly(vinyl chloride) membrane##2##5##(2008-10#2)
in a poly(vinyl##3##3##(2008-10#3)
in a polyacrylamide##2##3##(2008-10#2)
in a polymer matrix##2##4##(2008-7#1)(2012-2#1)
in a polymer##5##3##(2008-10#1)(2008-3#1)(2008-7#2)(2012-2#1)
in a polymeric##3##3##(2008-10#2)(2008-11#1)
in a poor##2##3##(2010-9#1)(2012-2#1)
in a population in##2##4##(2008-8#1)(2012-3#1)
in a population of viruliferous##2##5##(2008-10#2)
in a population of##20##4##(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1995-12#1)(1997-3#1)(2008-10#5)(2008-9#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in a population with##2##4##(1990-3#1)(1994-12#1)
in a population##33##3##(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#1)(1994-12#1)(1995-12#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-8#2)(2008-9#2)(2010-10#2)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
in a population-based sample of##2##5##(2008-7#2)
in a population-based##5##3##(1991-6#1)(2008-7#2)(2011-2#1)(2012-3#1)
in a position##3##3##(1997-7#1)(2008-11#1)(2012-12#1)
in a potential##3##3##(2008-10#2)(2013-1#1)
in a practical##3##3##(2008-3#1)(2009-1#1)(2013-1#1)
in a practice context##2##4##(2008-11#2)
in a precisely##2##3##(2008-7#1)(2008-9#1)
in a preclinical##2##3##(2008-10#1)(2010-6#1)
in a predictable##2##3##(1993-3#1)(1997-1#1)
in a pregnancy##2##3##(1996-8#1)(2009-3#1)
in a pregnant woman##2##4##(1990-6#1)(2008-7#1)
in a prevention##2##3##(2008-12#1)(2008-7#1)
in a previous paper##2##4##(2008-10#2)
in a previous study##3##4##(1994-8#1)(2008-10#2)
in a previous##12##3##(1994-8#1)(1995-1#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-9#2)(2010-4#1)
in a previously healthy##2##4##(2009-8#2)
in a previously##3##3##(2008-9#1)(2009-8#2)
in a primary care##4##4##(1993-12#1)(1997-5#2)(2008-4#1)
in a primary##8##3##(1991-6#1)(1993-12#1)(1997-5#2)(2008-12#1)(2008-4#1)(2012-12#1)(2013-1#1)
in a problem-based learning##2##4##(2008-10#1)(2011-1#1)
in a process##2##3##(2008-11#1)(2008-12#1)
in a program##2##3##(2012-3#1)(2013-8#1)
in a programmed##2##3##(2008-10#2)
in a project##2##3##(2008-12#2)
in a proportion of &gt##2##5##(2008-10#2)
in a proportion of##3##4##(2008-10#3)
in a proportion##4##3##(2008-10#4)
in a prospective payment system##2##5##(1992-12#1)(1994-3#1)
in a prospective##9##3##(1992-12#1)(1994-3#2)(1997-8#1)(2008-3#1)(2008-7#2)(2010-6#1)(2013-1#1)
in a protein##3##3##(1994-5#1)(2008-10#1)(2011-2#1)
in a province##2##3##(1993-2#1)(2009-6#1)
in a psychiatric hospital##2##4##(1991-2#1)(1993-2#1)
in a psychiatric##4##3##(1991-2#1)(1993-2#1)(2012-3#2)
in a public university##2##4##(1993-1#1)(2012-3#1)
in a public##9##3##(1991-3#1)(1993-1#1)(1993-5#1)(1996-5#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
in a punctuate pattern##2##4##(2008-11#2)
in a qualitative manner##3##4##(2008-10#3)
in a qualitative##4##3##(2008-10#3)(2008-9#1)
in a quantitative##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
in a questionnaire##2##3##(1991-6#1)(1994-9#1)
in a rabbit model##2##4##(2009-3#1)(2012-3#1)
in a rabbit##3##3##(2009-3#2)(2012-3#1)
in a random##4##3##(1992-9#1)(1996-8#1)(2008-7#1)(2013-8#1)
in a randomized complete block design##3##6##(2008-10#3)
in a randomized trial##2##4##(1993-11#1)(2012-2#1)
in a randomized##12##3##(1991-8#1)(1993-11#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
in a range from 0##3##5##(2008-10#2)(2010-4#1)
in a range from##4##4##(1995-3#1)(2008-10#2)(2010-4#1)
in a range of##20##4##(1995-12#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
in a range##27##3##(1993-9#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
in a rapid##12##3##(1990-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1995-6#1)(2008-10#2)(2008-11#3)(2010-5#1)(2010-7#1)
in a rapidly changing##2##4##(1995-12#1)(2008-10#1)
in a rat model of chronic##2##6##(2009-6#1)(2011-2#1)
in a rat model of##7##5##(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
in a rat model##9##4##(1990-12#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
in a rat##15##3##(1990-12#1)(1994-11#1)(1996-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
in a ratio of##2##4##(1992-6#1)(2008-10#1)
in a reaction##4##3##(2008-10#2)(2009-6#1)(2009-8#1)
in a real sample##2##4##(2008-10#2)
in a real##3##3##(2008-10#2)(2008-12#1)
in a recent study##3##4##(1990-11#1)(2011-2#2)
in a recent##9##3##(1990-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#3)
in a recently##2##3##(1991-11#1)(2010-11#1)
in a reciprocal##3##3##(1994-12#1)(2008-8#1)(2011-2#1)
in a recombinant##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
in a reconstituted##3##3##(1996-3#1)(2008-5#2)
in a rectangular##2##3##(1992-12#1)(2008-10#1)
in a recurrent neural network model##3##6##(2008-11#3)
in a recycle batch##2##4##(2008-7#2)
in a reduced number of##2##5##(1996-2#1)(2008-10#1)
in a reduced##6##3##(1996-2#1)(2008-10#2)(2008-7#3)
in a reduction in##3##4##(1994-8#1)(2012-2#1)(2013-1#1)
in a reduction##4##3##(1994-8#1)(1996-5#1)(2012-2#1)(2013-1#1)
in a reference##2##3##(2008-10#1)(2012-3#1)
in a region##5##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)
in a regulatory##2##3##(2008-10#1)(2008-11#1)
in a relatively high##2##4##(2008-10#1)(2008-3#1)
in a relatively small##2##4##(1995-11#1)(2008-10#1)
in a relatively##10##3##(1991-12#1)(1995-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
in a reproducible##2##3##(2008-5#1)(2013-1#1)
in a residency##2##3##(1993-12#1)(1995-1#1)
in a resistant##2##3##(2008-10#2)
in a restricted##2##3##(2008-10#1)(2012-3#1)
in a restructured##2##3##(1996-3#2)
in a retrospective##2##3##(1994-6#1)(2012-2#1)
in a reversed##2##3##(2008-10#1)(2008-3#1)
in a revised##2##3##(1991-9#1)(2008-3#1)
in a ring##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
in a routine laboratory##2##4##(1990-2#1)(1994-1#1)
in a rural community in##4##5##(2008-11#1)(2009-10#1)(2010-6#2)
in a rural community##5##4##(1994-1#1)(2008-11#1)(2009-10#1)(2010-6#2)
in a rural region of##2##5##(1992-2#1)(2011-2#1)
in a rural##11##3##(1991-1#1)(1992-2#1)(1994-1#1)(1997-3#1)(2008-11#1)(2009-10#1)(2010-4#1)(2010-6#2)(2011-2#2)
in a safe and##2##4##(2008-10#1)(2013-8#1)
in a sample of##31##4##(2008-10#5)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#3)(2011-2#4)(2012-2#1)(2013-8#2)
in a sample volume of##4##5##(2008-10#4)
in a sample volume##5##4##(2008-10#5)
in a sample##50##3##(1995-5#1)(2008-10#22)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#3)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
in a satisfactory##2##3##(1996-12#1)(2008-7#1)
in a school##2##3##(1991-12#1)(2011-2#1)
in a season##2##3##(2008-10#2)
in a second##10##3##(1993-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2009-10#1)(2013-8#1)
in a segregating population from a cross between a##2##9##(2008-10#1)(2012-3#1)
in a segregating population##3##4##(2008-10#2)(2012-3#1)
in a selected group of##2##5##(1990-9#1)(2013-1#1)
in a selected##4##3##(1990-9#1)(1996-6#1)(2008-11#1)(2013-1#1)
in a sensitive##4##3##(1995-11#1)(2008-10#2)(2008-11#1)
in a separate##6##3##(1993-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)
in a sequence of##2##4##(2008-10#2)
in a sequential injection analysis system##3##6##(2008-10#3)
in a sequential injection##7##4##(2008-10#7)
in a sequential##9##3##(2008-10#8)(2008-8#1)
in a series of 36##2##5##(1994-2#1)(2008-7#1)
in a series of four units##2##6##(2008-4#2)
in a series of##28##4##(1991-11#1)(1991-8#1)(1992-10#1)(1993-1#1)(1994-2#2)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-4#1)(2012-3#1)
in a series##29##3##(1991-11#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-12#1)(1994-2#2)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-4#1)(2012-3#1)
in a serum-free medium##5##4##(1990-11#1)(2008-11#4)
in a set of##2##4##(2008-4#1)(2008-9#1)
in a severe##3##3##(1992-5#1)(2008-2#1)(2009-1#1)
in a short period##2##4##(2008-11#1)(2010-11#1)
in a short time##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
in a short##9##3##(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2010-11#1)(2010-7#1)
in a significant decrease in##4##5##(1991-6#1)(1995-3#1)(2008-10#1)(2008-5#1)
in a significant decrease##5##4##(1991-6#1)(1995-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
in a significant improvement in##2##5##(2008-10#1)(2012-2#1)
in a significant increase in##7##5##(1992-12#1)(2008-10#3)(2008-11#2)(2009-6#1)
in a significant increase##9##4##(1992-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-6#1)
in a significant proportion of##2##5##(2008-11#1)(2008-9#1)
in a significant##35##3##(1991-6#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-3#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#3)(2013-1#1)
in a significantly lower##3##4##(1997-3#1)(2008-10#1)(2012-3#1)
in a significantly##5##3##(1997-3#1)(2008-10#2)(2009-8#1)(2012-3#1)
in a similar fashion in##2##5##(1993-8#1)(2008-9#1)
in a similar fashion##7##4##(1990-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-9#1)
in a similar manner##6##4##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
in a similar way to##4##5##(2008-10#2)(2008-8#1)(2008-9#1)
in a similar way##8##4##(1990-12#1)(1992-11#1)(2008-10#4)(2008-8#1)(2008-9#1)
in a similar##29##3##(1990-12#1)(1990-2#1)(1991-10#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1996-12#1)(1997-2#1)(2008-10#10)(2008-11#4)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
in a simple and##3##4##(2007-12#1)(2008-10#1)(2012-2#1)
in a simple##10##3##(1990-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2012-2#1)
in a simulation##3##3##(1995-9#1)(2008-11#1)(2008-3#1)
in a simultaneous##2##3##(2008-10#2)
in a single assay##2##4##(2008-10#2)
in a single cell##3##4##(1997-7#1)(2008-4#1)(2010-12#1)
in a single experiment##2##4##(2008-4#1)(2008-9#1)
in a single operation##2##4##(2008-7#1)(2008-8#1)
in a single patient##3##4##(1990-12#1)(2008-9#1)(2012-2#1)
in a single reaction##2##4##(2008-9#1)(2012-2#1)
in a single scan##2##4##(2008-10#1)(2012-2#1)
in a single step##6##4##(2008-10#3)(2008-11#2)(2013-8#1)
in a single tube##2##4##(1992-3#1)(2008-10#1)
in a single##87##3##(1990-12#1)(1992-3#2)(1993-2#1)(1993-6#2)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#29)(2008-11#7)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#4)(2010-10#1)(2010-12#2)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#3)
in a situation of##2##4##(2008-7#1)(2010-4#1)
in a slight##3##3##(2008-10#2)(2011-2#1)
in a slightly##2##3##(2008-10#2)
in a slow##2##3##(2008-7#1)(2012-3#1)
in a small##20##3##(1992-2#1)(1992-3#1)(1993-8#1)(1995-11#1)(1996-11#2)(1996-12#2)(1997-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
in a smaller degree##2##4##(2009-8#2)
in a smaller##3##3##(2008-10#1)(2009-8#2)
in a soil sample##2##4##(2008-10#2)
in a soil##6##3##(2008-10#6)
in a soluble form##4##4##(1994-8#1)(2008-7#1)(2012-2#2)
in a solution containing##5##4##(2008-10#5)
in a solution of##6##4##(2008-10#6)
in a solution##15##3##(2008-10#15)
in a solvent##2##3##(2008-10#2)
in a source-sink##2##3##(2008-8#2)
in a spatial##3##3##(2008-10#2)(2013-8#1)
in a spatially##3##3##(2008-8#1)(2008-9#1)(2009-8#1)
in a special##4##3##(1993-3#1)(2008-10#2)(2008-3#1)
in a specialist##2##3##(2010-10#1)(2011-2#1)
in a specific##6##3##(1994-3#1)(1995-6#1)(1996-2#1)(2008-11#1)(2010-12#1)(2011-2#1)
in a spiked##2##3##(2008-10#2)
in a spinner flask##2##4##(2008-11#2)
in a spinner##3##3##(2008-11#3)
in a stable transformed Sf9 insect cell line##2##8##(2008-11#2)
in a stable##6##3##(1997-7#1)(2008-10#1)(2008-11#3)(2008-3#1)
in a standard reference##2##4##(2008-10#2)
in a standard##10##3##(1996-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
in a state of##4##4##(2008-12#1)(2008-8#1)(2010-6#1)(2013-1#1)
in a state##8##3##(1990-11#1)(1993-2#1)(1996-9#1)(1997-1#1)(2008-12#1)(2008-8#1)(2010-6#1)(2013-1#1)
in a step-by-step way##2##4##(2008-10#1)(2011-2#1)
in a stepwise##2##3##(2008-10#2)
in a still##2##3##(2008-10#2)
in a stirred tank bioreactor##3##5##(2008-11#3)
in a stirred tank##4##4##(2008-11#3)(2008-7#1)
in a stirred##6##3##(2008-11#4)(2008-7#2)
in a stochastic environment##2##4##(2008-8#2)
in a stochastic##3##3##(2008-8#2)(2008-9#1)
in a straight segment of an artery##2##7##(2008-9#2)
in a straightforward manner##2##4##(2008-10#1)(2008-4#1)
in a strain##2##3##(1992-10#1)(1997-7#1)
in a strictly##2##3##(2008-7#1)(2011-2#1)
in a strong##3##3##(1990-11#1)(1994-1#1)(2008-9#1)
in a strongly##2##3##(2008-10#1)(2008-3#1)
in a study to##2##4##(2008-10#2)
in a study##7##3##(1992-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
in a sub-sample of##2##4##(2010-8#1)(2013-1#1)
in a subject with##2##4##(1995-8#2)
in a subsequent##2##3##(1990-2#1)(2008-9#1)
in a subset of##5##4##(1992-8#1)(1993-12#1)(2008-10#1)(2009-8#1)(2010-12#1)
in a substantial proportion of##3##5##(2010-1#1)(2010-12#1)(2013-1#1)
in a substantial##6##3##(1993-8#1)(2007-12#1)(2008-10#1)(2010-1#1)(2010-12#1)(2013-1#1)
in a suburban##2##3##(2008-11#1)(2013-1#1)
in a suitable##4##3##(1990-2#1)(2008-10#3)
in a survey of##3##4##(1991-8#1)(2008-10#2)
in a survey##5##3##(1991-8#1)(1997-4#1)(2008-10#2)(2012-12#1)
in a susceptible cultivar##3##4##(2008-10#3)
in a susceptible##6##3##(2008-10#6)
in a suspension##3##3##(2008-10#2)(2008-11#1)
in a switch##2##3##(2008-10#1)(2008-8#1)
in a synthetic##7##3##(2008-10#6)(2008-5#1)
in a system of two##2##5##(2008-8#1)(2009-8#1)
in a system##6##3##(1990-11#1)(2008-10#2)(2008-8#2)(2009-8#1)
in a systematic way##2##4##(2008-10#1)(2008-3#1)
in a table##2##3##(1996-1#1)(2008-4#1)
in a tablet##2##3##(2008-10#1)(2012-2#1)
in a taxonomic##2##3##(2008-8#1)(2012-2#1)
in a teaching hospital##6##4##(1994-2#1)(2008-11#1)(2009-1#1)(2009-5#1)(2012-3#2)
in a temporally##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
in a terminal##3##3##(2008-7#1)(2011-2#2)
in a tertiary care hospital in##2##6##(2008-11#2)
in a tertiary care hospital##6##5##(2008-11#2)(2010-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
in a tertiary care##9##4##(2008-11#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#1)
in a tertiary##13##3##(2008-10#1)(2008-11#2)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)
in a third##2##3##(1991-12#1)(2011-1#1)
in a three##3##3##(2008-1#1)(2008-7#1)(2010-11#1)
in a three-dimensional##2##3##(2008-10#1)(2008-11#1)
in a time and##2##4##(1994-11#1)(2008-11#1)
in a time of##5##4##(1993-12#1)(1997-2#1)(1997-3#2)(2008-3#1)
in a time##11##3##(1993-12#1)(1994-11#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#3)(2008-3#1)
in a time- and concentration-dependent manner##3##6##(1997-1#2)(2008-9#1)
in a time- and concentration-dependent##4##5##(1993-11#1)(1997-1#2)(2008-9#1)
in a time- and dose-dependent##2##5##(1992-8#1)(1995-8#1)
in a time- and##6##4##(1992-8#1)(1993-11#1)(1995-8#1)(1997-1#2)(2008-9#1)
in a time-dependent fashion##2##4##(2008-8#1)(2008-9#1)
in a time-dependent manner##5##4##(1996-2#1)(1997-8#1)(2008-11#1)(2008-9#1)(2012-12#1)
in a time-dependent##7##3##(1996-2#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#2)(2012-12#1)
in a timely fashion##3##4##(1994-2#1)(2008-10#1)(2010-11#1)
in a timely manner##3##4##(1994-12#1)(1997-3#1)(2008-10#1)
in a timely##6##3##(1994-12#1)(1994-2#1)(1997-3#1)(2008-10#2)(2010-11#1)
in a tissue specific manner##2##5##(1993-11#1)(2010-7#1)
in a tissue-specific##2##3##(1995-2#1)(1997-7#1)
in a total of##6##4##(2008-10#2)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#1)
in a total##8##3##(2008-10#3)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2013-1#1)
in a traditional Chinese##2##4##(2008-10#2)
in a transient##2##3##(2008-10#2)
in a transition##2##3##(1996-12#1)(1996-2#1)
in a transmission##2##3##(2007-11#1)(2008-3#1)
in a tropical##2##3##(2008-10#1)(2008-9#1)
in a true##2##3##(2008-7#1)(2009-3#1)
in a tubular adenoma##2##4##(2009-1#2)
in a tumor##4##3##(1995-1#1)(2008-11#1)(2009-12#1)(2011-2#1)
in a tungsten coil atomizer##2##5##(2008-10#2)
in a tungsten coil##3##4##(2008-10#3)
in a two##2##3##(2008-11#1)(2010-8#1)
in a two-step##2##3##(2008-10#1)(2012-3#1)
in a uniform##2##3##(2008-9#1)(2012-3#1)
in a unique position to##3##5##(1996-1#1)(2008-11#1)(2010-4#1)
in a unique##8##3##(1996-1#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-4#1)
in a univariate##2##3##(1991-2#1)(2008-10#1)
in a useful##2##3##(1994-8#1)(2008-7#1)
in a vaccine##2##3##(2008-11#1)(2012-3#1)
in a vacuum##3##3##(1994-2#1)(2008-1#1)(2011-2#1)
in a variety of animal##2##5##(1992-6#1)(2008-11#1)
in a variety of applications##3##5##(1996-1#1)(2008-10#1)(2008-6#1)
in a variety of cells##3##5##(1992-7#1)(1995-6#1)(2012-2#1)
in a variety of settings##3##5##(1996-8#1)(2008-11#1)(2012-12#1)
in a variety of situations##2##5##(1996-3#1)(2008-9#1)
in a variety of ways##8##5##(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2012-3#1)
in a variety of##63##4##(1990-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
in a vector##2##3##(2008-11#1)(2013-8#1)
in a vein of Galen malformation##2##6##(1996-6#2)
in a vein of##3##4##(1996-6#3)
in a very##11##3##(1990-12#1)(1990-8#1)(1992-2#1)(1995-3#2)(2008-10#4)(2008-11#2)
in a virtual reality##2##4##(2011-7#2)
in a virtual##3##3##(2008-10#1)(2011-7#2)
in a visual##2##3##(1996-2#1)(2008-10#1)
in a vitamin C tablet##2##5##(2008-10#2)
in a wall-jet##3##3##(2008-10#3)
in a water bath##2##4##(2008-10#2)
in a water sample##3##4##(2008-10#3)
in a water##7##3##(2008-10#6)(2008-5#1)
in a waterworks##2##3##(2008-10#2)
in a way that is##3##5##(2008-10#1)(2008-9#1)(2009-4#1)
in a way that##11##4##(1991-2#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)
in a way##12##3##(1991-2#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)
in a weak##2##3##(2008-10#2)
in a well##2##3##(2008-11#1)(2008-7#1)
in a well-characterized model of##2##5##(1996-12#1)(2010-6#1)
in a wheat field##2##4##(2008-10#2)
in a wheat##6##3##(2008-10#6)
in a whole cell##3##4##(1990-11#1)(1991-12#1)(2008-11#1)
in a whole##4##3##(1990-11#1)(1991-12#1)(2008-11#1)(2008-7#1)
in a wide concentration range##4##5##(2008-10#4)
in a wide range of pH##3##6##(2008-10#3)
in a wide range of##10##5##(1992-11#1)(2008-10#7)(2011-2#1)(2012-3#1)
in a wide variety of##16##5##(1990-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-8#2)(2010-5#1)(2011-2#2)
in a wide##33##3##(1990-2#1)(1992-11#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-9#1)(2009-8#3)(2010-5#1)(2011-2#3)(2012-3#1)
in a wider##2##3##(2008-5#1)(2008-6#1)
in a woman##3##3##(1990-6#1)(2010-12#1)(2013-1#1)
in a year##2##3##(2008-8#1)(2012-3#1)
in a yeast##2##3##(1995-6#1)(1997-7#1)
in a yet unidentified##2##4##(2008-10#1)(2008-5#1)
in a young female##5##4##(2008-12#3)(2010-10#1)(2011-2#1)
in a young patient##3##4##(2011-2#2)(2013-1#1)
in a young woman##2##4##(1991-3#1)(1992-12#1)
in a young##19##3##(1990-3#1)(1991-3#1)(1992-12#1)(1993-3#2)(1995-12#1)(1997-5#1)(2008-12#3)(2010-10#2)(2011-2#5)(2012-3#1)(2013-1#1)
in a zigzag pattern##3##4##(2008-10#3)
in a##4492##2##(1990-10#1)(1990-11#17)(1990-12#15)(1990-2#11)(1990-3#9)(1990-5#22)(1990-6#12)(1990-8#9)(1990-9#4)(1991-1#5)(1991-10#4)(1991-11#14)(1991-12#18)(1991-2#17)(1991-3#16)(1991-5#9)(1991-6#11)(1991-7#2)(1991-8#9)(1991-9#6)(1992-1#7)(1992-10#3)(1992-11#4)(1992-12#20)(1992-2#13)(1992-3#16)(1992-4#2)(1992-5#3)(1992-6#12)(1992-7#2)(1992-8#8)(1992-9#8)(1993-1#11)(1993-11#10)(1993-12#18)(1993-2#12)(1993-3#23)(1993-5#8)(1993-6#17)(1993-8#28)(1993-9#6)(1994-1#8)(1994-11#16)(1994-12#23)(1994-2#17)(1994-3#15)(1994-5#17)(1994-6#12)(1994-8#13)(1994-9#4)(1995-1#8)(1995-10#2)(1995-11#24)(1995-12#26)(1995-2#23)(1995-3#17)(1995-5#10)(1995-6#18)(1995-8#17)(1995-9#4)(1996-1#19)(1996-11#6)(1996-12#35)(1996-2#28)(1996-3#20)(1996-5#8)(1996-6#12)(1996-8#5)(1996-9#6)(1997-1#18)(1997-2#22)(1997-3#22)(1997-4#5)(1997-5#14)(1997-6#7)(1997-7#15)(1997-8#12)(2006-6#3)(2007-11#11)(2007-12#30)(2007-8#4)(2007-9#1)(2008-1#18)(2008-10#1360)(2008-11#374)(2008-12#95)(2008-2#36)(2008-3#140)(2008-4#36)(2008-5#91)(2008-6#20)(2008-7#146)(2008-8#88)(2008-9#117)(2009-1#13)(2009-10#21)(2009-11#12)(2009-12#13)(2009-3#15)(2009-4#9)(2009-5#9)(2009-6#15)(2009-7#6)(2009-8#39)(2009-9#12)(2010-1#15)(2010-10#24)(2010-11#17)(2010-12#19)(2010-2#7)(2010-3#7)(2010-4#15)(2010-5#9)(2010-6#19)(2010-7#16)(2010-8#13)(2010-9#11)(2011-1#17)(2011-2#162)(2011-3#6)(2011-4#1)(2011-7#6)(2012-12#26)(2012-2#75)(2012-3#113)(2012-5#3)(2012-7#2)(2013-1#134)(2013-3#1)(2013-7#4)(2013-8#66)
in aMCI and AD CSF##2##5##(2011-2#2)
in abdominal##4##2##(1993-2#1)(2007-12#1)(2012-3#1)(2013-8#1)
in ability to##2##3##(1990-4#1)(2008-10#1)
in ablation therapy for##2##4##(2010-12#2)
in ablation##3##2##(2010-12#2)(2013-1#1)
in abnormal##2##2##(1997-2#1)(2012-2#1)
in about 15##3##3##(1992-9#1)(2008-5#1)(2011-2#1)
in about 20% of##2##4##(1996-5#1)(2008-11#1)
in about 50%##2##3##(2011-2#2)
in about half##2##3##(2008-9#1)(2010-5#1)
in about##31##2##(1990-12#2)(1991-6#1)(1992-9#1)(1996-5#1)(1997-8#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-12#1)
in absence of any##2##4##(1991-8#1)(2013-8#1)
in absence of##11##3##(1991-8#1)(1997-8#1)(2008-10#3)(2011-2#4)(2012-2#1)(2013-8#1)
in absence##12##2##(1991-8#1)(1997-8#1)(2008-10#4)(2011-2#4)(2012-2#1)(2013-8#1)
in absolute numbers##2##3##(1991-3#1)(2008-10#1)
in absolute##5##2##(1991-3#1)(2008-10#2)(2010-6#1)(2012-2#1)
in absorbance at##4##3##(2008-10#3)(2008-11#1)
in absorbance measurements##2##3##(2008-10#2)
in absorbance of the##4##4##(2008-10#4)
in absorbance of##13##3##(2008-10#13)
in absorbance##29##2##(2008-10#26)(2008-11#1)(2008-3#2)
in absorption spectrum##2##3##(2008-10#1)(2008-2#1)
in absorption##4##2##(2008-10#3)(2008-2#1)
in abundance##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
in academia##2##2##(2008-11#2)
in academic##9##2##(1993-6#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-7#1)(2010-8#1)
in accelerated##3##2##(2008-10#3)
in accelerating##2##2##(1994-5#1)(2013-8#1)
in access to##3##3##(1994-12#1)(1995-12#2)
in access##4##2##(1992-2#1)(1994-12#1)(1995-12#2)
in accessing and utilising##2##4##(2008-11#1)(2013-8#1)
in accessing##4##2##(2008-11#2)(2008-12#1)(2013-8#1)
in accident##2##2##(1991-3#1)(2013-1#1)
in accord with the##3##4##(1991-9#2)(2008-9#1)
in accord with##7##3##(1991-6#1)(1991-9#3)(1992-6#1)(2008-10#1)(2008-9#1)
in accordance with a##2##4##(2008-7#1)(2012-3#1)
in accordance with the ISO##2##5##(2008-10#1)(2008-12#1)
in accordance with the##23##4##(1993-8#2)(1994-8#1)(1995-11#1)(1996-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
in accordance with##35##3##(1990-3#1)(1990-5#1)(1993-8#2)(1994-8#1)(1995-11#1)(1996-11#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in accordance##36##2##(1990-3#1)(1990-5#1)(1993-8#2)(1994-8#1)(1995-11#1)(1996-11#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in account the##2##3##(2008-10#1)(2009-10#1)
in account##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)
in accounting for##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
in accreditation##2##2##(1995-3#1)(2012-2#1)
in accumulation of##4##3##(1994-5#1)(2008-10#2)(2012-3#1)
in accumulation##5##2##(1994-5#1)(2008-10#2)(2008-12#1)(2012-3#1)
in accuracy##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
in acetate buffer (0##2##4##(2008-10#2)
in acetate buffer at pH 4##2##6##(2008-10#2)
in acetate buffer at pH##3##5##(2008-10#3)
in acetate buffer at##4##4##(2008-10#4)
in acetate buffer##12##3##(2008-10#12)
in acetate##13##2##(2008-10#12)(2008-7#1)
in acetic##5##2##(2008-10#5)
in acetone##4##2##(2008-10#3)(2008-5#1)
in acetonitrile##9##2##(1995-6#1)(1996-5#1)(2008-10#7)
in acetonitrile-water mixtures##2##3##(2008-10#2)
in acetonitrile-water##3##2##(2008-10#3)
in acetylcholine##5##2##(1992-6#1)(1994-8#2)(2008-8#2)
in achieving the##4##3##(2008-12#1)(2009-12#2)(2011-2#1)
in achieving##10##2##(1992-1#1)(1995-2#1)(1995-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#2)(2011-2#1)(2013-1#1)
in acid media##2##3##(2008-10#2)
in acid medium##4##3##(2008-10#4)
in acid mine drainage##2##4##(2008-10#2)
in acid##17##2##(1994-11#1)(2008-10#16)
in acid-base equilibria##2##3##(2008-10#2)
in acid-base##3##2##(1993-8#1)(2008-10#2)
in acid-digested##3##2##(2008-10#3)
in acidic and##2##3##(2008-10#2)
in acidic media##9##3##(2008-10#8)(2010-6#1)
in acidic medium to form##5##5##(2008-10#5)
in acidic medium was##2##4##(2008-10#2)
in acidic medium##21##3##(2008-10#21)
in acidic solution##5##3##(2008-10#5)
in acidic solutions##2##3##(2008-10#2)
in acidic##44##2##(1990-9#1)(1992-7#1)(1995-6#1)(1995-8#1)(2008-10#39)(2010-6#1)
in acidified soil##2##3##(2008-10#2)
in acidified##3##2##(2008-10#3)
in acini and chief cells##2##5##(1994-8#2)
in acini##3##2##(1994-8#2)(1995-11#1)
in acquisition##4##2##(1992-12#1)(1994-8#1)(1995-8#1)(2008-10#1)
in acrylic##2##2##(2008-10#2)
in action##6##2##(1995-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-2#1)
in activated B cells##2##4##(1995-6#2)
in activated lymphocytes##2##3##(2008-4#1)(2008-7#1)
in activated##6##2##(1994-5#1)(1995-6#2)(2006-6#1)(2008-4#1)(2008-7#1)
in activating##5##2##(1990-5#1)(1991-9#1)(1995-12#1)(2008-11#2)
in activation of##6##3##(1994-5#1)(1995-6#1)(1996-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
in activation##9##2##(1993-8#1)(1994-5#1)(1995-6#1)(1996-12#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
in active##13##2##(1991-1#2)(2008-10#3)(2008-3#1)(2008-5#3)(2010-12#1)(2010-7#2)(2011-2#1)
in activities of daily living##2##5##(1991-12#1)(1993-3#1)
in activities of##3##3##(1991-12#1)(1993-3#1)(2013-1#1)
in activities##11##2##(1991-12#1)(1992-1#1)(1993-3#1)(2008-11#1)(2008-12#2)(2009-12#1)(2010-10#2)(2012-2#1)(2013-1#1)
in activity##12##2##(1995-2#1)(1995-8#1)(2008-10#4)(2008-7#2)(2008-8#2)(2009-9#1)(2012-2#1)
in activity-dependent##2##2##(2008-1#1)(2009-8#1)
in actual sample##2##3##(2008-10#2)
in actual samples##2##3##(2008-10#2)
in actual##12##2##(1992-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
in acupuncture##2##2##(2008-10#2)
in acute KD##2##3##(2011-2#2)
in acute and chronic##4##4##(1992-6#1)(1994-11#1)(2008-12#1)(2011-2#1)
in acute and##6##3##(1992-6#1)(1994-11#1)(1995-11#1)(2008-12#1)(2008-4#1)(2011-2#1)
in acute carbon monoxide poisoning##2##5##(1990-5#1)(2009-11#1)
in acute care hospitals##5##4##(1992-2#1)(1997-1#1)(2008-11#1)(2010-10#1)(2010-8#1)
in acute care##6##3##(1991-12#1)(1992-2#1)(1997-1#1)(2008-11#1)(2010-10#1)(2010-8#1)
in acute coronary syndromes##3##4##(2008-3#1)(2010-3#1)(2011-2#1)
in acute exacerbations of chronic##2##5##(1996-11#1)(2007-12#1)
in acute hospital stroke units##2##5##(2011-1#2)
in acute ischemic stroke##2##4##(2009-11#1)(2012-12#1)
in acute leukemia##4##3##(1997-7#1)(2008-9#2)(2011-2#1)
in acute myeloid##2##3##(2011-2#1)(2011-3#1)
in acute myocardial infarction##8##4##(1993-12#2)(1995-12#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-3#1)
in acute myocardial##9##3##(1993-12#2)(1994-6#1)(1995-12#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-3#1)
in acute pancreatitis##5##3##(2008-5#1)(2013-1#4)
in acute pulmonary##2##3##(1991-11#1)(2011-2#1)
in acute stroke units##2##4##(2011-1#2)
in acute stroke##5##3##(2008-8#2)(2009-11#1)(2011-1#2)
in acute##76##2##(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#4)(2009-5#1)(2010-10#1)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
in acutely##2##2##(2010-12#1)(2011-2#1)
in adaptation to##3##3##(2008-10#1)(2012-6#1)(2013-8#1)
in adapting##3##2##(1992-2#1)(2012-2#2)
in adaptive designs##2##3##(2012-2#2)
in adaptive##3##2##(1995-5#1)(2012-2#2)
in adding the##3##3##(2008-11#3)
in adding##7##2##(1990-12#1)(2008-11#6)
in addition also##2##3##(1990-8#1)(2008-5#1)
in addition to a##5##4##(1990-2#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#1)
in addition to its role in##2##6##(1997-6#1)(2008-10#1)
in addition to its##6##4##(1993-8#1)(1997-6#2)(2008-10#1)(2008-4#1)(2008-5#1)
in addition to other##2##4##(2008-6#1)(2011-2#1)
in addition to preventing##2##4##(2008-10#1)(2009-11#1)
in addition to that of##2##5##(1991-7#1)(2008-10#1)
in addition to the fact that##2##6##(2008-10#1)(2008-11#1)
in addition to the previously##4##5##(1992-3#1)(1997-4#1)(2008-10#1)(2011-2#1)
in addition to the##37##4##(1990-5#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in addition to their##3##4##(1994-8#1)(1997-1#1)(2009-1#1)
in addition to##130##3##(1990-2#1)(1990-5#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#3)(1997-8#3)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#10)(2008-12#4)(2008-2#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-1#1)(2009-11#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
in addition##157##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#4)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#3)(1997-8#3)(2007-8#1)(2008-1#2)(2008-10#35)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
in additional##3##2##(1990-12#1)(1996-6#1)(2010-7#1)
in additive##2##2##(2008-10#1)(2013-8#1)
in addressing the##2##3##(2012-2#1)(2013-1#1)
in addressing##4##2##(2008-10#1)(2012-2#2)(2013-1#1)
in adefovir refractory patients##2##4##(2013-1#2)
in adenoma tissues##3##3##(2010-12#3)
in adenoma##4##2##(2010-12#4)
in adenomas##2##2##(2008-1#2)
in adenosine##2##2##(1994-6#1)(2009-8#1)
in adequate amounts##2##3##(1995-8#1)(2011-2#1)
in adequate##3##2##(1995-8#1)(2011-2#2)
in adherent##5##2##(1991-7#1)(1994-6#1)(2008-11#1)(2010-10#1)(2011-2#1)
in adhesion##4##2##(1995-8#1)(1997-1#1)(2008-11#1)(2012-2#1)
in adipose tissue##4##3##(1993-6#1)(1996-12#1)(2008-11#1)(2010-7#1)
in adipose##6##2##(1990-11#1)(1993-6#2)(1996-12#1)(2008-11#1)(2010-7#1)
in adjacent##5##2##(1991-2#1)(1992-9#1)(2008-10#2)(2012-12#1)
in adjusting##2##2##(2008-11#1)(2008-7#1)
in administering##3##2##(1993-6#1)(2010-7#1)(2011-2#1)
in administration##2##2##(2008-11#1)(2011-2#1)
in adolescence##11##2##(1995-3#1)(1997-8#1)(2008-11#2)(2008-4#1)(2009-7#4)(2012-2#1)(2013-1#1)
in adolescent health##3##3##(2008-8#3)
in adolescent##11##2##(1991-1#1)(1995-1#1)(2008-11#1)(2008-4#1)(2008-8#3)(2012-12#1)(2013-1#1)(2013-8#2)
in adolescents and##2##3##(2008-8#1)(2013-1#1)
in adolescents from##2##3##(2010-9#1)(2013-1#1)
in adolescents with low SES##2##5##(2011-1#2)
in adolescents with##4##3##(2008-4#1)(2011-1#2)(2012-2#1)
in adolescents##21##2##(1993-3#1)(1997-5#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#1)
in adolescents?##3##2##(2008-8#1)(2009-7#1)(2011-2#1)
in adrenal##4##2##(1990-11#2)(1991-3#1)(1992-6#1)
in adrenoleukodystrophy##2##2##(1993-3#1)(1995-2#1)
in adriamycin##2##2##(1990-2#1)(1993-12#1)
in adult cochlear implant users##2##5##(2008-9#2)
in adult human##2##3##(2008-9#1)(2010-8#1)
in adult life##8##3##(1995-12#4)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
in adult male##3##3##(1994-11#1)(2008-10#1)(2008-11#1)
in adult mouse urine##2##4##(1990-12#2)
in adult pancreas##2##3##(2013-7#2)
in adult patients with##2##4##(2008-9#1)(2011-2#1)
in adult patients##4##3##(2008-9#2)(2011-2#1)(2012-3#1)
in adult plants##3##3##(2008-10#3)
in adult rat##2##3##(1996-12#2)
in adult rats##7##3##(1991-12#1)(1992-12#2)(1994-2#1)(1997-2#1)(2008-11#1)(2008-7#1)
in adult tissues##3##3##(1993-8#1)(1997-7#1)(2008-6#1)
in adult##89##2##(1990-12#2)(1990-5#2)(1991-12#1)(1992-12#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1995-12#4)(1995-6#1)(1996-11#1)(1996-12#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#8)(2009-10#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#6)(2013-1#2)(2013-7#3)(2013-8#1)
in adulthood##18##2##(1992-2#2)(1993-3#2)(1994-8#1)(1997-8#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#2)(2009-10#1)(2012-2#2)
in adults and children##3##4##(1996-2#1)(2008-9#1)(2012-2#1)
in adults and##8##3##(1996-2#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#2)
in adults have##2##3##(2008-9#1)(2010-5#1)
in adults in##2##3##(1991-11#1)(2013-1#1)
in adults is##4##3##(1996-11#2)(1997-8#1)(2013-7#1)
in adults with##16##3##(1991-8#1)(1997-4#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#2)
in adults##79##2##(1990-11#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-5#1)(1996-11#4)(1996-2#1)(1997-4#1)(1997-8#3)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#6)(2009-1#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#3)
in adults]##3##2##(1994-12#1)(1996-11#1)(1997-8#1)
in advance of the##2##4##(2008-10#2)
in advance of##3##3##(2008-10#2)(2008-7#1)
in advance##13##2##(1991-1#1)(1991-12#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#3)
in advanced breast cancer##2##4##(1991-6#1)(1994-8#1)
in advanced cancer patients##2##4##(2010-2#2)
in advanced cancer##4##3##(2008-7#2)(2010-2#2)
in advanced stages##2##3##(1997-6#1)(2008-5#1)
in advanced##23##2##(1990-12#2)(1991-6#2)(1992-2#2)(1993-1#2)(1993-2#1)(1994-8#1)(1996-10#1)(1997-6#1)(2008-5#1)(2008-7#3)(2009-10#2)(2010-10#1)(2010-2#2)(2011-2#1)(2011-3#1)
in advancing the##2##3##(2008-11#1)(2012-3#1)
in advising##3##2##(1993-3#1)(2008-11#1)(2011-2#1)
in aerated##2##2##(2008-10#2)
in aerosol by##2##3##(2008-10#2)
in aerosol studies##2##3##(1994-1#2)
in aerosol##13##2##(1992-3#1)(1994-1#3)(1994-12#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-3#1)
in aerosols##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
in affected##7##2##(1990-12#1)(1995-8#1)(2008-11#1)(2010-11#2)(2011-2#1)(2012-12#1)
in affecting##5##2##(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
in affinity##4##2##(1993-8#1)(1995-11#1)(2008-10#2)
in aflatoxin##2##2##(2008-10#2)
in agar##5##2##(1990-6#1)(2008-10#2)(2008-7#1)(2012-2#1)
in agarose gel electrophoresis##2##4##(1991-5#1)(2008-10#1)
in agarose gel##3##3##(1991-5#1)(2008-10#2)
in agarose##5##2##(1991-5#1)(2008-10#2)(2008-4#2)
in age from##4##3##(1994-2#1)(1997-3#1)(2008-11#1)(2008-9#1)
in age of##3##3##(1990-9#1)(2009-7#1)(2013-1#1)
in age##15##2##(1990-9#1)(1994-2#1)(1994-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-5#1)(2013-1#1)
in age-matched##3##2##(1995-5#1)(2008-10#2)
in aged brains##2##3##(1990-5#2)
in aged care##2##3##(2010-10#2)
in aged humans and rats##3##5##(2008-7#3)
in aged rats##2##3##(1995-8#1)(2008-7#1)
in aged##18##2##(1990-5#3)(1994-11#1)(1995-8#1)(2008-10#1)(2008-7#5)(2009-1#1)(2009-8#1)(2010-10#2)(2010-12#1)(2013-1#1)(2013-7#1)
in aged-care##3##2##(2010-10#3)
in ageing##3##2##(2012-2#1)(2013-7#2)
in aggregate##2##2##(1992-2#1)(2008-9#1)
in aggressive PCa##2##3##(2013-1#2)
in aggressive##6##2##(2008-7#1)(2009-3#1)(2011-2#2)(2013-1#2)
in aggressiveness between##2##3##(2008-10#2)
in aggressiveness##10##2##(2008-10#10)
in aging mice##2##3##(2013-7#2)
in aging##11##2##(1992-5#1)(1994-11#1)(1994-8#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-6#1)(2013-7#2)
in agitated##2##2##(2008-11#2)
in agreement at the 95% confidence level##4##7##(2008-10#4)
in agreement at##6##3##(2008-10#6)
in agreement with a##2##4##(2008-10#2)
in agreement with certified values of standard reference materials##2##9##(2008-10#2)
in agreement with certified values##3##5##(2008-10#3)
in agreement with certified##4##4##(2008-10#4)
in agreement with previous studies##2##5##(2008-10#1)(2009-8#1)
in agreement with previous work##2##5##(1996-12#1)(2008-10#1)
in agreement with previous##7##4##(1994-5#1)(1996-12#1)(2008-10#3)(2008-7#1)(2009-8#1)
in agreement with that##2##4##(2008-10#2)
in agreement with the certified value of##2##7##(2008-10#2)
in agreement with the certified values##2##6##(2008-10#2)
in agreement with the certified##6##5##(2008-10#6)
in agreement with the literature##2##5##(1990-3#1)(1993-3#1)
in agreement with the predicted##2##5##(2008-3#1)(2008-7#1)
in agreement with the##25##4##(1990-3#1)(1993-3#1)(1995-2#1)(2008-10#17)(2008-3#2)(2008-7#1)(2013-1#2)
in agreement with those obtained by a##3##7##(2008-10#3)
in agreement with those obtained by##8##6##(2008-10#8)
in agreement with those obtained##11##5##(2008-10#10)(2008-5#1)
in agreement with those##16##4##(1992-1#1)(2008-10#14)(2008-5#1)
in agreement with##74##3##(1990-3#1)(1990-5#1)(1992-1#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-2#1)(1996-12#1)(2006-6#1)(2007-11#1)(2008-10#49)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-8#1)(2013-1#2)
in agreement##83##2##(1990-3#1)(1990-5#1)(1992-1#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-2#1)(1996-12#1)(2006-6#1)(2007-11#1)(2008-10#57)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-8#1)(2010-11#1)(2013-1#2)
in agricultural fields##3##3##(2008-10#3)
in agricultural practices##2##3##(2008-10#1)(2008-11#1)
in agricultural production##2##3##(2008-10#2)
in agricultural soils##2##3##(2008-10#2)
in agricultural systems##2##3##(2008-10#1)(2008-8#1)
in agricultural##16##2##(2008-10#11)(2008-11#2)(2008-8#1)(2011-2#1)(2012-2#1)
in agriculture##14##2##(1990-6#1)(2008-10#4)(2008-11#4)(2008-8#1)(2010-7#2)(2012-3#1)(2013-1#1)
in aiding##2##2##(2011-2#1)(2012-2#1)
in air and##2##3##(2008-10#2)
in air at##4##3##(2008-10#2)(2012-2#2)
in air by using##2##4##(2008-10#2)
in air by##3##3##(2008-10#3)
in air samples were##2##4##(2008-10#2)
in air samples##4##3##(2008-10#4)
in air was##3##3##(2008-10#3)
in air with##2##3##(2008-10#2)
in air##55##2##(1996-2#1)(2007-12#1)(2008-10#41)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#2)(2012-7#1)(2013-1#2)
in airborne particulate matter##7##4##(2008-10#7)
in airborne particulate##8##3##(2008-10#8)
in airborne##11##2##(2008-10#11)
in airlift reactors##2##3##(2008-7#2)
in airway##5##2##(1995-11#1)(1997-1#2)(1997-4#1)(2012-3#1)
in airways##2##2##(1992-3#1)(1994-12#1)
in alcohol##6##2##(1990-2#2)(1994-8#1)(2008-10#2)(2009-7#1)
in alcoholic beverages##4##3##(2008-10#4)
in alcoholic##7##2##(1996-11#1)(2008-10#6)
in alcoholism##3##2##(1993-12#2)(2008-11#1)
in alfalfa##11##2##(2008-10#9)(2008-8#2)
in alga samples##2##3##(2008-10#2)
in algae##2##2##(2008-10#2)
in alginate##2##2##(2008-10#1)(2012-2#1)
in aliphatic##2##2##(2008-10#1)(2008-11#1)
in alkaline conditions##2##3##(1995-8#1)(2008-10#1)
in alkaline media##5##3##(2008-10#5)
in alkaline medium has been##2##5##(2008-10#2)
in alkaline medium##13##3##(2008-10#13)
in alkaline phosphatase activity##2##4##(2008-11#2)
in alkaline solution##5##3##(2008-10#5)
in alkaline solutions##2##3##(2008-10#2)
in alkaline##33##2##(1995-8#1)(2008-10#30)(2008-11#2)
in all 10##2##3##(1991-1#1)(2011-2#1)
in all 15##2##3##(2008-10#1)(2010-12#1)
in all 24##2##3##(2008-7#2)
in all 3##3##3##(1996-11#1)(2008-10#1)(2009-3#1)
in all adult##2##3##(1993-6#1)(2008-5#1)
in all age groups##2##4##(1996-9#1)(2009-10#1)
in all age##3##3##(1996-9#1)(2009-10#1)(2013-1#1)
in all animals##3##3##(1995-11#2)(2008-12#1)
in all areas of##3##4##(1997-3#1)(2008-11#1)(2008-7#1)
in all but 3##2##4##(2008-12#1)(2009-3#1)
in all but one##2##4##(2009-10#1)(2011-2#1)
in all but two##2##4##(1993-2#1)(2012-3#1)
in all but##9##3##(1993-2#1)(1995-8#1)(2008-12#2)(2009-10#1)(2009-3#1)(2011-2#2)(2012-3#1)
in all cases and##3##4##(1990-12#1)(2008-7#1)(2011-2#1)
in all cases the##2##4##(2008-10#1)(2008-5#1)
in all cases##59##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-3#2)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-4#1)(2013-1#2)
in all categories##2##3##(2008-7#1)(2010-8#1)
in all cell types##2##4##(1995-12#1)(2009-12#1)
in all cell##3##3##(1995-12#2)(2009-12#1)
in all cells##2##3##(1993-8#1)(2008-10#1)
in all cellular##2##3##(1994-5#1)(2008-10#1)
in all conditions##3##3##(2008-11#2)(2010-4#1)
in all countries##2##3##(1997-1#1)(2009-6#1)
in all crosses##2##3##(2008-10#2)
in all cultures##2##3##(1990-8#1)(2008-11#1)
in all data sets##2##4##(2008-10#1)(2008-9#1)
in all directions##3##3##(2008-10#2)(2008-8#1)
in all dopaminergic neurons##2##4##(1996-12#2)
in all dosed groups of males##2##6##(2008-9#2)
in all eight##3##3##(1996-12#1)(2008-10#2)
in all experimental##2##3##(1991-2#1)(2008-10#1)
in all experiments##3##3##(2008-10#2)(2008-7#1)
in all five##5##3##(1990-12#1)(1990-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
in all four cases##2##4##(1996-12#1)(2008-10#1)
in all four limbs##2##4##(2008-7#1)(2010-8#1)
in all four##8##3##(1996-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
in all groups##6##3##(1994-11#1)(2008-10#2)(2008-7#1)(2009-7#1)(2011-2#1)
in all instances##6##3##(2008-10#6)
in all known##2##3##(1994-5#1)(2008-10#1)
in all layers##2##3##(1997-3#1)(2011-2#1)
in all locations##2##3##(2008-10#1)(2013-8#1)
in all major##3##3##(1997-5#1)(2008-12#1)(2011-7#1)
in all mammalian##3##3##(1993-12#1)(2008-11#1)(2013-7#1)
in all materials in##2##4##(2013-1#2)
in all media##2##3##(1995-8#1)(2008-10#1)
in all mouse##2##3##(1995-6#1)(2013-8#1)
in all of the cases##2##5##(2008-10#1)(2008-7#1)
in all of the##11##4##(1990-8#1)(1994-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
in all of them##2##4##(1996-6#1)(1997-8#1)
in all of these##3##4##(1994-2#1)(2008-9#1)(2013-7#1)
in all of##16##3##(1990-8#1)(1994-11#1)(1994-2#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-7#1)
in all other aspects##2##4##(2008-10#2)
in all other##8##3##(1994-1#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)
in all parts of the##2##5##(1997-8#1)(2008-10#1)
in all patients regardless of tumour grade##2##7##(2011-2#2)
in all patients with##3##4##(1992-5#1)(2011-2#2)
in all patients##18##3##(1990-6#1)(1990-9#1)(1991-2#1)(1992-5#1)(1993-3#2)(1997-8#2)(2008-7#2)(2010-1#1)(2011-2#5)(2013-1#2)
in all phases of the cell cycle##2##7##(2008-11#2)
in all phases of##4##4##(1992-1#1)(1992-2#1)(2008-11#2)
in all phases##5##3##(1992-1#1)(1992-2#1)(2008-11#3)
in all plots##2##3##(2008-10#2)
in all plum cultivars##2##4##(2011-2#2)
in all populations##6##3##(2008-10#4)(2013-8#2)
in all prokaryotes##2##3##(2011-2#2)
in all regions##3##3##(1994-3#1)(2008-10#2)
in all samples##9##3##(2008-10#7)(2009-4#1)(2011-2#1)
in all six##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
in all size classes##2##4##(1996-12#2)
in all specimens##2##3##(2007-12#1)(2013-1#1)
in all stages of##2##4##(1997-8#1)(2011-2#1)
in all strains##2##3##(2008-10#2)
in all studies##2##3##(2011-2#1)(2012-12#1)
in all subjects##3##3##(2008-7#2)(2011-2#1)
in all tested##4##3##(1990-12#1)(1996-8#1)(2008-10#2)
in all tests##3##3##(1994-8#1)(2008-10#2)
in all the cases##4##4##(2008-10#2)(2010-7#1)(2012-12#1)
in all the four##2##4##(1990-11#1)(2008-10#1)
in all the groups##3##4##(1994-8#1)(2008-5#1)(2008-8#1)
in all the patients##3##4##(2010-7#3)
in all the samples##5##4##(2008-10#2)(2011-2#1)(2012-12#1)(2013-1#1)
in all the studied##2##4##(2008-10#1)(2011-2#1)
in all the three groups##2##5##(2012-2#2)
in all the three##3##4##(2012-2#2)(2013-1#1)
in all the tissues##2##4##(2008-5#1)(2009-7#1)
in all the##48##3##(1990-11#1)(1991-5#1)(1992-2#1)(1993-2#1)(1994-8#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-12#2)(2009-7#1)(2010-7#4)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
in all these##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
in all three cell lines##2##5##(1995-6#1)(2008-11#1)
in all three soils##2##4##(2008-10#2)
in all three##34##3##(1990-5#1)(1991-12#2)(1991-3#1)(1993-8#1)(1994-2#2)(1995-6#1)(1996-6#1)(1997-3#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#2)
in all tissues##4##3##(1990-11#1)(1993-3#1)(2008-10#1)(2010-5#1)
in all types of##4##4##(2008-10#2)(2012-3#1)(2013-8#1)
in all years##2##3##(2008-10#2)
in all##515##2##(1990-11#4)(1990-12#5)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#3)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#3)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#8)(1996-3#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#6)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#5)(1997-9#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#176)(2008-11#22)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-7#21)(2008-8#11)(2008-9#11)(2009-10#3)(2009-12#3)(2009-3#4)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#36)(2011-3#2)(2011-7#1)(2012-12#5)(2012-2#4)(2012-3#7)(2012-4#1)(2012-8#1)(2013-1#17)(2013-7#2)(2013-8#7)
in allele frequencies##5##3##(2008-10#3)(2008-8#1)(2010-4#1)
in allele##7##2##(2008-10#3)(2008-12#1)(2008-8#1)(2010-4#1)(2012-3#1)
in allergic##5##2##(1992-5#1)(1994-11#1)(2008-11#1)(2008-5#1)(2013-1#1)
in allocating##2##2##(1995-12#1)(1995-2#1)
in allocation##3##2##(2008-8#1)(2008-9#2)
in allopatry##3##2##(2008-10#3)
in alloy samples##2##3##(2008-10#2)
in alloy steels and industrial effluents##2##6##(2008-10#2)
in alloy##4##2##(2008-10#4)
in alloys and environmental samples##2##5##(2008-10#2)
in alloys and##3##3##(2008-10#3)
in alloys by##2##3##(2008-10#2)
in alloys##10##2##(2008-10#10)
in almost all##12##3##(1990-6#1)(1991-12#1)(1993-1#1)(1993-8#1)(1995-3#1)(2008-10#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-8#1)(2012-2#1)
in almost complete##4##3##(1990-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
in almost every##2##3##(2008-11#1)(2008-8#1)
in almost##22##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-8#1)(1993-1#1)(1993-8#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
in alpha##3##2##(1992-8#1)(1994-3#1)(1996-12#1)
in alpha-helix##2##2##(2008-10#2)
in altered##2##2##(1992-6#1)(1997-3#1)
in alternative 3' splice-site selection##2##5##(1993-6#2)
in alternative##4##2##(1993-11#1)(1993-6#2)(2008-12#1)
in altitude##2##2##(2008-3#1)(2012-6#1)
in aluminium##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
in aluminum##2##2##(2008-10#2)
in alveolar macrophages##2##3##(1993-3#1)(1993-8#1)
in alveolar##3##2##(1993-3#1)(1993-8#1)(1994-3#1)
in ambient air##11##3##(1991-12#1)(2008-10#9)(2008-3#1)
in ambient##19##2##(1991-12#1)(1991-6#1)(2008-10#13)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)
in ambulatory##6##2##(1990-9#1)(1992-6#1)(2008-11#1)(2011-2#1)(2013-1#2)
in amended##2##2##(2008-10#2)
in amino acid sequence##2##4##(2008-9#1)(2013-1#1)
in amino acid sequences##2##4##(2008-4#1)(2008-5#1)
in amino acid##9##3##(1990-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2012-9#1)(2013-1#1)
in amino acids##3##3##(2008-10#2)(2010-4#1)
in amino##14##2##(1990-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-8#2)(2012-9#1)(2013-1#1)
in ammonium##4##2##(2008-10#4)
in amniotic fluid##2##3##(1995-8#2)
in amorphous##3##2##(2007-12#1)(2008-10#2)
in amount##2##2##(2008-10#1)(2008-12#1)
in amounts##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
in amperometric##4##2##(2008-10#3)(2009-10#1)
in amphibians##4##2##(1996-5#1)(1997-3#1)(1997-7#1)(2008-8#1)
in amygdala##2##2##(1997-2#1)(1997-7#1)
in amygdala-kindled rats##3##3##(1992-3#2)(1994-2#1)
in an &quot##2##3##(1996-1#1)(2008-10#1)
in an 11 year old boy##2##6##(1996-6#1)(2012-3#1)
in an 11-month-old infant##2##4##(2008-12#2)
in an 11-month-old##3##3##(2008-12#3)
in an Alpine valley##2##4##(2008-10#2)
in an Arab-Israeli community##2##4##(2008-6#2)
in an Escherichia coli##2##4##(1994-5#1)(2008-7#1)
in an F(2) population##2##4##(2008-10#2)
in an HBV- and HCV-endemic area##2##6##(2013-8#2)
in an HIV##2##3##(1993-12#1)(2010-12#1)
in an Irish##3##3##(1991-12#1)(2008-11#1)(2008-12#1)
in an RNA##2##3##(1997-6#1)(2008-4#1)
in an ablative-wall##2##3##(2008-2#2)
in an absorbing solution was##2##5##(2008-10#2)
in an absorbing##3##3##(2008-10#2)(2008-3#1)
in an academic medical##2##4##(1991-1#1)(2008-3#1)
in an academic##12##3##(1991-1#1)(1992-1#2)(1994-3#4)(1995-2#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
in an accredited##2##3##(1994-12#1)(2008-11#1)
in an acetic##2##3##(2008-10#2)
in an acid medium##2##4##(2008-10#2)
in an acidic media##2##4##(2008-10#2)
in an acidic medium##5##4##(2008-10#5)
in an acidic##11##3##(1994-5#1)(2008-10#10)
in an active##4##3##(1990-2#1)(1991-9#1)(2008-10#1)(2008-9#1)
in an acute care hospital##3##5##(2010-10#2)(2010-11#1)
in an acute care##5##4##(1994-2#1)(1994-3#1)(2010-10#2)(2010-11#1)
in an acute##9##3##(1992-2#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-7#1)(2010-10#2)(2010-11#1)(2013-1#1)
in an additive fashion##2##4##(2011-2#1)(2013-8#1)
in an additive manner##2##4##(1996-2#1)(2008-6#1)
in an additive##5##3##(1996-2#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
in an adult with##4##4##(1997-3#1)(2010-11#1)(2012-3#1)(2013-8#1)
in an adult##12##3##(1990-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-12#1)(2008-7#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
in an advanced##2##3##(1994-12#1)(2008-11#1)
in an agency setting##2##4##(1996-2#2)
in an alkaline medium##9##4##(2008-10#9)
in an alkaline##14##3##(2008-10#14)
in an ambisense arrangement##2##4##(2008-10#2)
in an ambisense##3##3##(2008-10#3)
in an ambulatory##2##3##(2008-11#2)
in an amino acid substitution##3##5##(1994-11#1)(2008-10#2)
in an amino acid##4##4##(1994-11#1)(1997-7#1)(2008-10#2)
in an amount##2##3##(1996-9#1)(2008-5#1)
in an amperometric##2##3##(2008-10#2)
in an analogous##2##3##(2006-6#1)(2008-11#1)
in an analytical procedure##2##4##(2008-10#2)
in an analytical##4##3##(2008-10#4)
in an animal model##6##4##(1995-11#1)(1997-8#1)(2008-12#1)(2008-4#1)(2010-1#1)(2011-2#1)
in an animal##7##3##(1995-11#1)(1997-8#1)(2008-12#1)(2008-4#1)(2010-1#1)(2011-2#1)(2013-8#1)
in an antigen##3##3##(2008-11#3)
in an appropriate##3##3##(1995-5#1)(2008-10#1)(2008-9#1)
in an aqueous medium##3##4##(2008-10#3)
in an aqueous solution##4##4##(2008-10#3)(2008-3#1)
in an aqueous##14##3##(2008-10#13)(2008-3#1)
in an area of##2##4##(1996-1#1)(2010-4#1)
in an area##13##3##(1991-12#2)(1992-12#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-1#1)(2008-10#3)(2009-8#1)(2010-4#1)(2013-1#1)
in an artificial##4##3##(2008-10#2)(2008-5#1)(2010-8#1)
in an atmosphere of 5% CO2 in air##2##8##(2008-5#1)(2013-1#1)
in an atmospheric##2##3##(2008-3#2)
in an attempt to develop##2##5##(2008-10#1)(2008-11#1)
in an attempt to elucidate##2##5##(1996-2#1)(2008-9#1)
in an attempt to##17##4##(1992-3#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#2)(2010-6#1)(2012-3#1)(2013-1#1)
in an automated##3##3##(2008-10#3)
in an earlier study##4##4##(1991-3#1)(1995-8#1)(2008-10#1)(2008-5#1)
in an earlier##6##3##(1991-3#1)(1994-3#1)(1995-8#1)(2008-10#1)(2008-5#1)(2010-1#1)
in an early##2##3##(2008-10#1)(2012-2#1)
in an ecosystem##2##3##(1997-7#2)
in an effort to assess##2##5##(1996-2#1)(2012-3#1)
in an effort to better##2##5##(2009-9#1)(2010-9#1)
in an effort to identify##2##5##(1997-1#1)(2008-11#1)
in an effort to##15##4##(1990-11#1)(1992-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-9#1)(2010-9#1)(2012-12#1)(2012-3#4)
in an elderly population##3##4##(2008-7#3)
in an elderly##7##3##(2008-6#1)(2008-7#6)
in an electrochemical##2##3##(2008-10#2)
in an electronic health record##4##5##(2013-1#4)
in an electronic##6##3##(1996-3#1)(2008-11#1)(2013-1#4)
in an elevated##2##3##(1990-5#1)(2008-10#1)
in an endemic area for paracoccidioidomycosis in##2##7##(2008-5#2)
in an endemic##3##3##(2008-5#2)(2012-3#1)
in an enhanced##2##3##(1990-5#1)(2008-12#1)
in an enhancement##2##3##(2008-11#2)
in an enrichment factor of##2##5##(2008-10#2)
in an environment to which##2##5##(1997-7#2)
in an environment##7##3##(1991-12#1)(1995-6#1)(1997-7#2)(2008-8#1)(2010-11#1)(2013-8#1)
in an environmentally##2##3##(2008-8#2)
in an era of health care reform##2##7##(1993-12#1)(1997-3#1)
in an era of health reform##2##6##(1996-3#2)
in an era of health##4##5##(1993-12#1)(1996-3#2)(1997-3#1)
in an era of##7##4##(1993-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(2008-12#1)(2010-12#1)
in an established##2##3##(1997-7#1)(2008-11#1)
in an evolutionary##2##3##(2008-8#2)
in an experimental animal model##2##5##(1996-3#1)(2012-2#1)
in an experimental system##2##4##(1996-2#1)(2008-8#1)
in an experimental##12##3##(1996-2#2)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
in an exposed##2##3##(1994-11#1)(1995-6#1)
in an extended##2##3##(2008-12#1)(2012-2#1)
in an extensive##2##3##(1992-4#1)(2007-12#1)
in an external##2##3##(1993-12#1)(2008-2#1)
in an identical##2##3##(1995-6#1)(2008-10#1)
in an immunocompetent patient##2##4##(2011-2#1)(2013-1#1)
in an immunocompetent##3##3##(1996-3#1)(2011-2#1)(2013-1#1)
in an improvement of##2##4##(2008-10#1)(2008-11#1)
in an in vitro system##2##5##(1995-11#1)(2008-11#1)
in an in vitro##4##4##(1995-11#1)(1997-2#1)(2008-11#1)(2008-5#1)
in an in vivo##2##4##(1990-11#1)(2008-12#1)
in an in##7##3##(1990-11#1)(1995-11#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)
in an inactive##2##3##(1991-10#1)(2013-8#1)
in an increase in the##6##5##(1995-3#1)(1997-6#1)(2008-10#4)
in an increase in##18##4##(1992-6#1)(1993-3#1)(1995-3#1)(1996-12#2)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#2)
in an increase of the##3##5##(1993-8#1)(2008-10#1)(2008-5#1)
in an increase of##6##4##(1991-5#1)(1993-8#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-5#1)
in an increase##24##3##(1991-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)
in an increased##7##3##(1990-2#1)(1991-12#1)(1995-12#1)(1995-6#1)(2008-11#1)(2010-4#1)(2013-7#1)
in an increasing##2##3##(2008-10#1)(2008-8#1)
in an increasingly competitive##2##4##(1994-12#1)(2008-10#1)
in an increasingly##4##3##(1994-12#1)(2008-10#1)(2009-8#1)(2012-3#1)
in an incubator without CO(2) addition##2##6##(2008-11#2)
in an incubator##5##3##(2008-10#1)(2008-11#3)(2008-5#1)
in an industrial environment##2##4##(2007-11#1)(2008-10#1)
in an industrial##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
in an infant##6##3##(1995-6#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#2)
in an innovative##2##3##(1992-5#1)(2008-12#1)
in an insect cell line##2##5##(2008-7#2)
in an institution for##2##4##(1991-6#1)(1992-12#1)
in an integrated curriculum##2##4##(2012-3#2)
in an integrated delivery##2##4##(1996-3#1)(1997-1#1)
in an integrated##5##3##(1996-3#1)(1997-1#1)(2012-2#1)(2012-3#2)
in an intensive care##3##4##(1991-3#1)(1992-2#1)(2009-1#1)
in an intensive##4##3##(1991-3#1)(1992-2#1)(2009-1#1)(2013-8#1)
in an inter-laboratory study##2##4##(2008-10#2)
in an interdisciplinary##2##3##(2008-1#1)(2013-1#1)
in an international##5##3##(1997-4#1)(2008-10#3)(2008-12#1)
in an irregular labeling of Penicillium cell walls##2##8##(2008-10#2)
in an irreversible##3##3##(1990-12#1)(2008-10#1)(2012-3#1)
in an objective##2##3##(1990-12#1)(2008-2#1)
in an office environment##3##4##(1991-1#3)
in an office-based plastic surgery practice with an already high standard of care##2##13##(2013-1#2)
in an oil-in-water##2##3##(2008-10#1)(2008-5#1)
in an old##3##3##(2008-9#1)(2010-11#1)(2013-1#1)
in an older##2##3##(2010-10#1)(2012-12#1)
in an on-line preconcentration system for##2##6##(2008-10#2)
in an on-line##6##3##(2008-10#6)
in an open field##3##4##(1992-12#2)(2008-11#1)
in an open##11##3##(1991-2#1)(1992-12#2)(1993-2#1)(2008-10#5)(2008-11#1)(2010-7#1)
in an optical##5##3##(2008-3#3)(2009-5#1)(2012-2#1)
in an optically accessible##2##4##(2008-3#2)
in an optically##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
in an oral##2##3##(2007-11#1)(2008-12#1)
in an ordered fashion##2##4##(1994-3#1)(1994-5#1)
in an organ##3##3##(1993-12#1)(2008-12#1)(2008-8#1)
in an organic solvent##2##4##(2008-10#2)
in an organization##2##3##(2012-3#2)
in an outpatient##2##3##(1991-1#1)(2012-12#1)
in an overall##3##3##(1993-9#1)(1996-5#1)(2008-3#1)
in an ulcerative colitis patient##2##5##(2010-11#1)(2010-12#1)
in an ultrafiltration##3##3##(1995-2#1)(1995-3#1)(2011-2#1)
in an ultrasonic bath##4##4##(2008-10#4)
in an undergraduate##4##3##(2008-11#4)
in an unusual##2##3##(1990-3#1)(2009-8#1)
in an urban area##2##4##(2008-10#1)(2009-10#1)
in an urban population of##2##5##(1991-1#1)(2008-11#1)
in an urban population##3##4##(1990-2#1)(1991-1#1)(2008-11#1)
in an urban##12##3##(1990-2#1)(1991-1#1)(1994-1#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-10#3)
in an##771##2##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#4)(1990-5#2)(1990-6#3)(1991-1#7)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#4)(1993-12#6)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#9)(1994-5#5)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#5)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#8)(1996-3#10)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#1)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#4)(2006-6#2)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#214)(2008-11#65)(2008-12#21)(2008-2#10)(2008-3#22)(2008-4#5)(2008-5#17)(2008-6#6)(2008-7#23)(2008-8#11)(2008-9#10)(2009-1#2)(2009-10#5)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#6)(2010-12#4)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#21)(2012-12#6)(2012-2#11)(2012-3#25)(2013-1#25)(2013-3#1)(2013-7#1)(2013-8#13)
in anaerobic##9##2##(2008-10#1)(2008-11#2)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#2)
in anaesthesiology##3##2##(2009-5#2)(2010-7#1)
in anaesthetic##2##2##(2010-7#1)(2011-2#1)
in analogy to##2##3##(2008-10#1)(2008-11#1)
in analyses of##3##3##(1993-12#1)(2008-10#2)
in analyses##5##2##(1993-12#1)(1997-7#1)(2008-10#3)
in analysis of the##2##4##(1991-6#1)(2013-8#1)
in analysis of##4##3##(1991-6#1)(2008-8#1)(2012-2#1)(2013-8#1)
in analysis##6##2##(1991-6#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-8#1)
in analyte##3##2##(2008-10#3)
in analytical and environmental chemistry##2##5##(2008-10#2)
in analytical and##3##3##(2008-10#3)
in analytical chemistry and##2##4##(2008-10#2)
in analytical chemistry is##2##4##(2008-10#1)(2010-7#1)
in analytical chemistry##24##3##(2008-10#19)(2010-7#5)
in analytical development##2##3##(2008-10#1)(2010-7#1)
in analytical##37##2##(2008-10#31)(2010-7#6)
in analyzing the##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
in analyzing##7##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2013-8#2)
in anastomosis##2##2##(2008-10#2)
in ancient##2##2##(2008-10#2)
in and around##5##3##(1990-6#1)(1995-6#1)(2008-12#1)(2008-5#1)(2010-5#1)
in and out of the nucleus##2##6##(2011-2#2)
in and out of##3##4##(2008-12#1)(2011-2#2)
in and##20##2##(1990-6#1)(1991-10#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#2)
in androgen##2##2##(1991-5#1)(1994-2#1)
in anemia##2##2##(2008-1#1)(2008-8#1)
in anesthetized rats##3##3##(1992-3#1)(1995-11#1)(2009-8#1)
in anesthetized##4##2##(1992-3#1)(1995-11#1)(1997-1#1)(2009-8#1)
in angiosperms##2##2##(2009-8#2)
in angular##2##2##(1993-5#1)(2011-2#1)
in anhydrous acetic##2##3##(2008-10#1)(2008-11#1)
in anhydrous##5##2##(2008-10#3)(2008-11#1)(2010-12#1)
in animal and##2##3##(2008-10#1)(2008-8#1)
in animal cell culture##5##4##(2008-11#4)(2008-7#1)
in animal cell##11##3##(2008-10#1)(2008-11#7)(2008-7#2)(2009-8#1)
in animal cells##4##3##(1993-2#2)(1994-11#1)(2008-11#1)
in animal faeces by tungsten coil electrothermal atomic absorption spectrometry##2##10##(2008-10#2)
in animal feed##3##3##(2008-10#3)
in animal feeds##3##3##(2008-10#2)(2011-2#1)
in animal model##2##3##(2008-12#1)(2011-3#1)
in animal models as well as in##2##7##(2008-11#1)(2010-6#1)
in animal models of##11##4##(1995-5#1)(1996-12#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
in animal models##22##3##(1994-5#1)(1995-5#1)(1996-11#1)(1996-12#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#2)
in animal##65##2##(1990-9#1)(1992-6#1)(1993-2#2)(1994-11#1)(1994-5#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-9#1)(2006-6#1)(2008-10#17)(2008-11#10)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-6#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#2)
in animals and humans##3##4##(2008-10#1)(2008-12#2)
in animals and##5##3##(2008-10#1)(2008-12#2)(2009-8#1)(2013-1#1)
in animals that were##2##4##(1993-6#1)(2008-11#1)
in animals that##3##3##(1993-6#1)(2008-11#1)(2012-3#1)
in animals with##2##3##(1993-6#1)(2008-8#1)
in animals##34##2##(1990-11#1)(1990-5#2)(1992-3#1)(1993-2#1)(1993-6#2)(1995-2#2)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-5#1)(2008-8#4)(2009-6#2)(2009-8#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in anionic##2##2##(1996-5#1)(2008-10#1)
in anisotropic##2##2##(2008-3#2)
in annual plant assemblages##2##4##(2008-8#2)
in annual plant##3##3##(2008-8#3)
in annual##8##2##(1994-3#1)(2008-10#3)(2008-8#3)(2008-9#1)
in anodic##3##2##(2008-10#3)
in another group of##2##4##(1991-5#1)(2009-8#1)
in another species##2##3##(1994-8#1)(2012-2#1)
in another##23##2##(1990-6#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-8#1)(1994-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#1)
in anoxic##2##2##(2008-11#2)
in antagonistic##2##2##(2008-9#1)(2012-3#1)
in antagonizing the##2##3##(1994-2#1)(1994-8#1)
in antecedents##2##2##(1993-3#1)(2009-12#1)
in anterior pituitary cells##3##4##(1990-12#1)(1996-2#2)
in anterior##8##2##(1990-12#1)(1995-5#1)(1996-2#2)(2008-8#1)(2011-2#1)(2013-1#2)
in anti-HIV-1##2##2##(2011-2#1)(2011-3#1)
in anti-cancer##2##2##(2008-9#1)(2012-3#1)
in antibiotic##3##2##(1996-11#1)(2008-10#1)(2010-6#1)
in antibody##5##2##(1991-5#1)(1993-12#1)(1995-12#1)(2008-11#1)(2012-3#1)
in antigen##4##2##(1997-2#1)(1997-9#1)(2008-10#1)(2008-8#1)
in antimicrobial stewardship programs##2##4##(2013-1#2)
in antimicrobial##3##2##(2008-10#1)(2013-1#2)
in antioxidant##3##2##(2008-5#1)(2009-8#1)(2013-1#1)
in antisocial##2##2##(2008-11#1)(2013-8#1)
in anuric patients##3##3##(2011-2#3)
in anxiety##5##2##(1993-3#1)(2008-11#1)(2013-8#3)
in any brain region##2##4##(1996-12#2)
in any case##2##3##(1995-3#1)(1997-6#1)
in any combination##2##3##(1995-11#1)(1996-1#1)
in any given year##2##4##(1993-12#1)(2008-10#1)
in any given##3##3##(1993-12#1)(2008-10#1)(2008-8#1)
in any group##2##3##(1993-1#1)(2011-2#1)
in any of the##14##4##(1994-8#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#8)(2009-7#1)(2010-11#1)
in any of these##2##4##(1995-6#1)(2008-7#1)
in any of##16##3##(1994-8#1)(1995-6#2)(1997-8#1)(2008-1#1)(2008-10#8)(2008-7#1)(2009-7#1)(2010-11#1)
in any other country##2##4##(1995-12#1)(2008-10#1)
in any other##5##3##(1995-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
in any part of the##2##5##(2008-10#1)(2013-1#1)
in any species##3##3##(1995-8#1)(2008-10#2)
in any system##2##3##(2008-10#2)
in any##86##2##(1990-6#1)(1991-6#1)(1993-1#1)(1993-11#2)(1993-12#3)(1994-1#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-12#2)(1996-6#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
in aorta and##2##3##(1993-12#1)(1997-8#1)
in aorta##4##2##(1993-12#1)(1997-8#1)(2013-8#2)
in aortic##3##2##(1995-11#1)(2013-3#2)
in aphid transmission##2##3##(2008-10#2)
in aphid##3##2##(1996-12#1)(2008-10#2)
in apoE##2##2##(1995-6#1)(2008-6#1)
in apocrine sweat##2##3##(2008-5#2)
in apoptosis of##2##3##(2008-8#1)(2010-12#1)
in apoptosis##18##2##(1997-7#1)(2008-10#1)(2008-11#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2013-1#1)
in apoptotic cells##2##3##(2008-9#1)(2010-1#1)
in apoptotic##7##2##(2008-12#1)(2008-7#2)(2008-9#1)(2010-1#1)(2012-2#1)(2013-8#1)
in apparent##6##2##(1990-6#1)(1991-5#1)(1993-6#1)(1997-1#1)(2008-9#1)(2009-11#1)
in apparently healthy##2##3##(2010-12#1)(2010-3#1)
in apparently##3##2##(2008-10#1)(2010-12#1)(2010-3#1)
in appearance##8##2##(1991-1#2)(1993-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
in appetite regulation##2##3##(2009-8#2)
in appetite##3##2##(2009-8#2)(2013-8#1)
in apple breeding programs##3##4##(2008-10#3)
in apple trees##2##3##(2008-10#2)
in apple wounds##4##3##(2008-10#4)
in apple##22##2##(2008-10#21)(2011-10#1)
in application of the##2##4##(2008-10#1)(2012-3#1)
in application of##3##3##(2008-10#2)(2012-3#1)
in application##7##2##(2008-10#4)(2008-11#1)(2008-12#1)(2012-3#1)
in applications##2##2##(2008-10#1)(2008-11#1)
in applied##2##2##(1997-3#1)(2013-1#1)
in applying this##2##3##(2008-11#2)
in applying##7##2##(1993-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-11#1)(2013-1#1)
in appreciable##2##2##(2008-10#2)
in appressorium differentiation in M##2##5##(2008-10#2)
in appressorium##3##2##(2008-10#3)
in approach to##2##3##(2008-11#1)(2008-7#1)
in approach##3##2##(1993-1#1)(2008-11#1)(2008-7#1)
in appropriate##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
in approved injectable products##3##4##(2012-2#3)
in approximately 30%##2##3##(2008-5#1)(2011-2#1)
in approximately##18##2##(1991-10#1)(1991-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
in apricot##7##2##(2008-10#2)(2012-8#5)
in aquaculture##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
in aquatic environments by##2##4##(2008-10#1)(2008-9#1)
in aquatic environments##6##3##(2008-10#5)(2008-9#1)
in aquatic systems##3##3##(2008-10#3)
in aquatic##14##2##(2008-10#9)(2008-8#1)(2008-9#3)(2012-2#1)
in aqueous TiO(2) dispersions##2##4##(2008-10#2)
in aqueous ammonia##2##3##(2008-10#2)
in aqueous and urine##2##4##(2008-10#2)
in aqueous and##8##3##(2008-10#8)
in aqueous extracts of##3##4##(2008-10#2)(2008-11#1)
in aqueous humor##4##3##(2008-12#4)
in aqueous media by##2##4##(2008-10#1)(2008-6#1)
in aqueous media have been studied by##2##7##(2008-10#2)
in aqueous media using##4##4##(2008-10#4)
in aqueous media##23##3##(1990-2#2)(2008-10#18)(2008-6#2)(2012-2#1)
in aqueous medium in the##2##5##(1997-2#1)(2008-10#1)
in aqueous medium is##2##4##(2008-10#2)
in aqueous medium##22##3##(1997-2#2)(2008-10#20)
in aqueous micellar solutions of##2##5##(2008-10#1)(2008-7#1)
in aqueous micellar##6##3##(2008-10#5)(2008-7#1)
in aqueous phase##9##3##(2008-10#9)
in aqueous sample##2##3##(2008-10#2)
in aqueous samples by##3##4##(2008-10#3)
in aqueous samples is described##2##5##(2008-10#2)
in aqueous samples is##3##4##(2008-10#3)
in aqueous samples##18##3##(2008-10#18)
in aqueous sodium##2##3##(2008-10#1)(2009-5#1)
in aqueous solution and in blood##2##6##(2008-10#2)
in aqueous solution and to##2##5##(2008-10#1)(2008-5#1)
in aqueous solution and##12##4##(1990-5#1)(2008-10#10)(2008-5#1)
in aqueous solution at 25 degrees C##2##7##(2008-10#2)
in aqueous solution at pH##2##5##(2008-10#2)
in aqueous solution at##5##4##(2008-10#5)
in aqueous solution containing##2##4##(2008-10#2)
in aqueous solution for##2##4##(2008-10#1)(2008-11#1)
in aqueous solution have been determined##2##6##(2008-10#1)(2008-5#1)
in aqueous solution have been##3##5##(1990-9#1)(2008-10#1)(2008-5#1)
in aqueous solution in##2##4##(2008-10#2)
in aqueous solution of##2##4##(2008-10#2)
in aqueous solution was##3##4##(2008-10#3)
in aqueous solution were##4##4##(2008-10#3)(2008-8#1)
in aqueous solution with##2##4##(2008-10#2)
in aqueous solution##82##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1997-2#4)(2008-10#68)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)
in aqueous solutions and##2##4##(2008-10#1)(2008-11#1)
in aqueous solutions at##2##4##(2008-10#2)
in aqueous solutions containing##5##4##(2008-10#5)
in aqueous solutions has been##2##5##(2008-10#2)
in aqueous solutions is extended##2##5##(2008-10#2)
in aqueous solutions is##4##4##(2008-10#4)
in aqueous solutions shows an average recovery of##2##8##(2008-10#2)
in aqueous solutions was studied##2##5##(2008-10#2)
in aqueous solutions##48##3##(2008-10#43)(2008-11#2)(2008-3#2)(2011-2#1)
in aqueous##258##2##(1990-2#2)(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-9#1)(1995-3#1)(1997-2#6)(2008-10#218)(2008-11#6)(2008-12#4)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
in archaeological##2##2##(2008-10#2)
in area 18 of##2##4##(2008-8#2)
in area##6##2##(1995-2#1)(2008-10#1)(2008-8#2)(2012-2#1)(2012-3#1)
in areas in which##2##4##(2008-8#1)(2011-2#1)
in areas of low transmission##2##5##(2008-8#1)(2012-12#1)
in areas of##10##3##(1997-1#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)(2012-12#1)
in areas such as##5##4##(1994-3#1)(1995-11#1)(2008-12#1)(2010-12#1)(2012-2#1)
in areas that##2##3##(1990-9#1)(1994-1#1)
in areas where##3##3##(2008-10#2)(2012-3#1)
in areas with##4##3##(1990-11#1)(2008-10#3)
in areas##41##2##(1990-11#1)(1990-9#1)(1994-1#1)(1994-3#1)(1995-11#1)(1996-1#2)(1996-12#4)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
in argon##2##2##(2008-10#2)
in arid##2##2##(2008-10#1)(2008-8#1)
in aromatic##2##2##(2008-10#2)
in arsenic##2##2##(2008-10#1)(2010-1#1)
in arterial and##2##3##(1994-3#1)(1997-8#1)
in arterial plasma##2##3##(2008-10#2)
in arterial##12##2##(1994-3#1)(1996-3#1)(1997-4#1)(1997-8#2)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#2)
in arteriosclerotic lesions##5##3##(1994-11#5)
in artificial##14##2##(1993-6#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#1)
in artificially inoculated##2##3##(2008-10#2)
in artificially##5##2##(2008-10#4)(2008-9#1)
in as little as##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
in as much as##2##4##(2009-7#1)(2012-12#1)
in as##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
in ascertaining##2##2##(2008-12#1)(2008-9#1)
in ascites##2##2##(2008-11#2)
in ascomycete##2##2##(2008-10#2)
in ascospore##2##2##(2008-10#2)
in aseptic##2##2##(1992-9#1)(2011-2#1)
in asexual##2##2##(2008-10#2)
in ash##3##2##(2008-10#3)
in assays of##2##3##(1992-4#1)(2008-10#1)
in assays##4##2##(1992-4#1)(2008-10#3)
in assessing effectiveness##2##3##(1995-3#1)(2008-10#1)
in assessing for##2##3##(2011-2#1)(2012-3#1)
in assessing patients##2##3##(2008-10#1)(2008-11#1)
in assessing the risk of##2##5##(2008-10#2)
in assessing the##8##3##(1994-1#1)(1995-11#1)(1997-2#1)(2008-10#3)(2009-1#1)(2010-10#1)
in assessing##28##2##(1991-11#1)(1992-12#1)(1994-1#1)(1995-11#2)(1995-3#1)(1997-2#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-8#1)(2009-1#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#3)(2011-7#1)(2012-3#1)(2013-7#1)
in assessment of##2##3##(2008-9#1)(2013-8#1)
in assessment##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
in assigning##2##2##(1994-12#1)(2008-7#1)
in assisted living##2##3##(2008-12#1)(2010-8#1)
in assisted##3##2##(2007-7#1)(2008-12#1)(2010-8#1)
in assisting##3##2##(1995-6#1)(2008-12#1)(2010-10#1)
in association with a##4##4##(1993-1#1)(2008-10#2)(2010-5#1)
in association with flow injection analysis##2##6##(2008-10#2)
in association with other##2##4##(2008-10#1)(2013-1#1)
in association with the##5##4##(1994-12#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
in association with##57##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-1#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-8#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-7#7)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)
in association##61##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-1#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-8#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-7#8)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#4)
in aster##3##2##(2008-10#3)
in asthma##7##2##(1992-3#1)(1994-1#1)(1996-1#1)(2008-6#1)(2008-7#1)(2012-12#2)
in asthmatic##3##2##(1997-1#1)(2008-1#1)(2010-1#1)
in astrocytes##7##2##(1995-12#1)(1995-2#2)(1997-1#1)(1997-3#1)(2008-12#1)(2008-7#1)
in asymptomatic patients##2##3##(1991-12#1)(2013-1#1)
in asymptomatic subjects##2##3##(2008-12#2)
in asymptomatic##9##2##(1991-12#1)(2008-12#2)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in asynchronous##3##2##(1995-9#1)(1997-8#1)(2009-12#1)
in at least one##5##4##(2008-10#1)(2008-11#1)(2010-11#1)(2010-8#1)(2013-8#1)
in at least some##2##4##(1995-8#1)(1996-1#1)
in at least two##2##4##(2008-5#1)(2012-3#1)
in at least##12##3##(1993-12#1)(1994-3#1)(1995-8#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
in at##15##2##(1990-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
in at-risk##2##2##(2009-12#1)(2009-9#1)
in atherosclerosis plaques##2##3##(2012-3#2)
in atherosclerosis##7##2##(1996-2#1)(1997-8#1)(2008-6#1)(2010-9#1)(2012-3#3)
in atherosclerotic plaques##2##3##(2008-7#1)(2013-8#1)
in atherosclerotic##5##2##(1992-5#1)(2008-7#1)(2012-2#2)(2013-8#1)
in athletes##5##2##(1996-6#1)(2010-1#2)(2010-7#1)(2013-1#1)
in atmosphere##2##2##(2008-10#2)
in atmospheres##2##2##(2008-10#2)
in atmospheric aerosol##2##3##(2008-10#2)
in atmospheric particulate matter##2##4##(2008-10#2)
in atmospheric##13##2##(2008-10#8)(2008-11#1)(2008-3#3)(2013-8#1)
in atomic absorption spectrometry##2##4##(2008-10#2)
in atomic##3##2##(2008-10#2)(2013-1#1)
in atopic and nonatopic##2##4##(2012-3#2)
in atopic##3##2##(1994-9#1)(2012-3#2)
in atria##3##2##(1992-6#1)(2013-1#2)
in atrial fibrillation##2##3##(2009-12#1)(2013-7#1)
in atrial##4##2##(1997-3#1)(2009-12#1)(2012-3#1)(2013-7#1)
in attending##3##2##(1993-12#2)(2013-8#1)
in attention##4##2##(1994-12#1)(2008-11#1)(2008-2#1)(2012-3#1)
in attitude##2##2##(2010-1#1)(2013-8#1)
in attracting the##2##3##(1990-11#1)(2010-9#1)
in attracting##5##2##(1990-11#1)(1996-8#1)(2008-10#1)(2008-11#1)(2010-9#1)
in attractive traits##2##3##(2008-8#2)
in auditory cortex##3##3##(1996-2#1)(2008-11#1)(2013-8#1)
in auditory##5##2##(1996-2#1)(2008-11#1)(2008-9#1)(2010-5#1)(2013-8#1)
in autism can##2##3##(2012-3#2)
in autism is##2##3##(1997-8#1)(2008-11#1)
in autism##5##2##(1997-8#1)(2008-11#2)(2012-3#2)
in autoclaved##5##2##(2008-10#5)
in autoimmune##6##2##(1991-2#1)(1993-3#1)(1995-3#1)(2011-2#1)(2012-2#2)
in automation of##2##3##(2008-10#1)(2011-2#1)
in automobile exhaust##2##3##(2008-10#1)(2008-11#1)
in automotive fuel ethanol##2##4##(2008-10#2)
in automotive fuel##3##3##(2008-10#3)
in automotive##4##2##(2008-10#4)
in autophagy##2##2##(2012-3#1)(2013-1#1)
in autumn and winter##2##4##(2008-10#1)(2008-5#1)
in autumn and##3##3##(2008-10#2)(2008-5#1)
in autumn##10##2##(1996-12#1)(2008-10#4)(2008-5#1)(2010-8#3)(2011-9#1)
in available##2##2##(1993-1#1)(2012-2#1)
in average cost##2##3##(1992-12#2)
in average temperature factors##2##4##(2008-9#2)
in average torque##2##3##(2008-12#2)
in average##15##2##(1992-12#3)(2008-11#4)(2008-12#2)(2008-9#3)(2010-10#1)(2010-8#1)(2012-3#1)
in avirulence##2##2##(2008-10#2)
in avoiding##5##2##(1996-9#1)(2008-10#1)(2009-6#1)(2010-9#1)(2011-2#1)
in axenic media##2##3##(2008-10#2)
in axenic##3##2##(2008-10#3)
in axial##3##2##(1995-11#2)(2012-12#1)
in axillary skin surface pH##3##5##(2008-5#3)
in axillary skin##5##3##(2008-5#5)
in axillary##11##2##(2008-5#9)(2008-8#1)(2009-8#1)
in axonal length were##2##4##(2008-7#2)
in babies##3##2##(1996-2#1)(2008-11#1)(2012-3#1)
in baccalaureate nursing##2##3##(2008-11#1)(2008-12#1)
in bacilli##2##2##(2011-2#2)
in background##2##2##(1994-12#1)(2008-11#1)
in bacteria and##5##3##(1993-12#1)(1995-6#1)(2008-10#1)(2013-8#2)
in bacteria are##2##3##(1990-8#1)(2008-9#1)
in bacteria that##2##3##(2008-11#1)(2009-6#1)
in bacteria##17##2##(1990-8#1)(1993-12#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#3)(2009-6#1)(2011-1#2)(2013-8#3)
in bacterial levels##2##3##(2008-10#1)(2008-5#1)
in bacterial populations##2##3##(2008-10#2)
in bacterial##21##2##(1993-8#1)(1995-2#1)(2008-10#10)(2008-4#1)(2008-5#2)(2010-6#1)(2011-2#4)(2013-1#1)
in bags##2##2##(2008-10#1)(2012-2#1)
in banana##2##2##(2008-10#2)
in bark samples##2##3##(2008-10#2)
in bark##4##2##(2008-10#4)
in barley aleurone##2##3##(2008-8#2)
in barley and##2##3##(2008-10#2)
in barley is##2##3##(2008-10#1)(2008-9#1)
in barley##27##2##(2008-10#23)(2008-12#1)(2008-8#2)(2008-9#1)
in barrier function##2##3##(2008-5#1)(2008-7#1)
in basal and##2##3##(2008-11#1)(2011-2#1)
in basal medium##2##3##(1994-3#2)
in basal##20##2##(1993-6#1)(1993-8#1)(1994-3#2)(1995-11#2)(1995-6#1)(1995-8#2)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#2)
in baseline##3##2##(2008-10#3)
in basic medium##5##3##(2008-10#5)
in basic##13##2##(1990-5#1)(2008-10#7)(2008-7#1)(2008-9#2)(2010-10#1)(2010-7#1)
in basolateral membranes##2##3##(1993-3#2)
in batch and continuous##3##4##(2008-11#1)(2008-12#1)(2008-6#1)
in batch and fed-batch cultures##3##5##(2008-11#3)
in batch and fed-batch##5##4##(2008-11#5)
in batch and##9##3##(2008-10#1)(2008-11#6)(2008-12#1)(2008-6#1)
in batch culture and##2##4##(2008-11#2)
in batch culture of##2##4##(1994-8#1)(2008-11#1)
in batch culture##11##3##(1994-8#1)(2008-11#10)
in batch cultures of##2##4##(2008-11#1)(2012-3#1)
in batch cultures##4##3##(1995-9#1)(2008-11#2)(2012-3#1)
in batch fecundity##2##3##(2010-8#2)
in batch mode##2##3##(2008-10#1)(2008-11#1)
in batch systems##2##3##(2008-7#2)
in batch##40##2##(1994-8#1)(1995-9#1)(2008-10#10)(2008-11#20)(2008-12#1)(2008-6#1)(2008-7#2)(2010-8#2)(2012-3#2)
in beam quality##2##3##(2008-2#1)(2008-3#1)
in bean and##2##3##(2008-10#2)
in bean##7##2##(2008-10#7)
in beer samples##3##3##(2008-10#3)
in beer using##2##3##(2008-10#2)
in beer##12##2##(2008-10#11)(2008-7#1)
in beers##3##2##(2008-10#3)
in behavior##2##2##(1990-11#1)(2008-10#1)
in behavioral##6##2##(2008-4#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-9#1)
in behaviour##3##2##(1991-2#1)(2008-11#1)(2008-7#1)
in being##2##2##(1996-12#1)(2007-12#1)
in bell pepper##2##3##(2008-10#2)
in below##3##2##(2010-3#1)(2012-2#1)(2012-3#1)
in beneficiary costs##2##3##(1991-3#1)(1993-3#1)
in benign and malignant##2##4##(1993-11#2)
in benign##9##2##(1993-1#1)(1993-11#3)(1994-8#1)(1995-11#2)(1997-7#1)(2013-1#1)
in benzene##2##2##(2008-10#2)
in berries##2##2##(2008-10#2)
in beryllium##2##2##(1990-5#1)(2008-10#1)
in beta-1##2##2##(2008-10#2)
in beta-CD##3##2##(2008-10#3)
in beta-cyclodextrin##4##2##(2008-10#4)
in better##7##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
in between the##3##3##(2008-12#1)(2008-3#1)(2008-9#1)
in between##10##2##(1990-12#1)(1991-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#2)
in beverages by##2##3##(2008-10#2)
in beverages##10##2##(2008-10#8)(2010-9#2)
in bigger##2##2##(1995-12#1)(2010-10#1)
in bilateral cleft lip and palate patient##2##7##(2013-1#2)
in bilateral cochlear implant##2##4##(2008-9#2)
in bilateral##11##2##(1996-12#1)(2008-9#2)(2010-5#1)(2011-2#3)(2013-1#2)(2013-8#2)
in bile##2##2##(1993-3#1)(2012-2#1)
in biliary##3##2##(1990-8#1)(1994-6#1)(2012-2#1)
in binary mixtures of##2##4##(2008-10#2)
in binary mixtures were studied##3##5##(2008-10#3)
in binary mixtures##7##3##(2008-10#6)(2008-3#1)
in binary##10##2##(2008-10#9)(2008-3#1)
in binding of##2##3##(1990-11#1)(1994-5#1)
in binding to the##4##4##(1991-5#1)(1995-6#2)(2008-11#1)
in binding to##10##3##(1991-5#1)(1992-10#1)(1992-12#2)(1993-3#1)(1994-5#1)(1995-6#3)(2008-11#1)
in binding##19##2##(1990-10#1)(1990-11#1)(1991-5#1)(1992-10#1)(1992-12#2)(1993-3#1)(1994-5#3)(1995-6#3)(1996-12#1)(2008-11#3)(2008-9#1)(2012-2#1)
in bioanalysis##4##2##(2008-10#2)(2010-11#2)
in bioanalytical##2##2##(2008-10#1)(2010-11#1)
in bioassays##4##2##(2008-10#4)
in biochemical##5##2##(1994-12#1)(2008-7#2)(2011-2#1)(2011-3#1)
in biochemistry##3##2##(1992-11#1)(1997-2#1)(2008-11#1)
in biocontrol efficacy##2##3##(2008-10#2)
in biocontrol##3##2##(2008-10#3)
in biodiesel blends##2##3##(2008-10#2)
in bioethical decision-making##3##3##(1994-12#3)
in biofilm formation##2##3##(2008-10#1)(2009-6#1)
in biofilm##4##2##(2008-10#1)(2009-6#2)(2012-2#1)
in biological and environmental samples##3##5##(2008-10#3)
in biological and##5##3##(1991-6#1)(2008-10#4)
in biological control of##2##4##(2008-10#2)
in biological control##5##3##(2008-10#5)
in biological fluid##2##3##(2008-10#2)
in biological fluids by##2##4##(1992-1#1)(2008-10#1)
in biological fluids is##2##4##(2008-10#2)
in biological fluids##12##3##(1992-1#1)(1992-12#1)(1997-7#1)(2008-10#8)(2008-11#1)
in biological materials and waters##2##5##(2008-10#2)
in biological materials and##3##4##(2008-10#3)
in biological materials by##5##4##(1991-7#1)(2008-10#4)
in biological materials##10##3##(1991-7#1)(2008-10#9)
in biological matrices by##2##4##(2008-10#2)
in biological matrices##6##3##(2008-10#4)(2010-11#1)(2012-12#1)
in biological media##2##3##(2008-10#1)(2010-7#1)
in biological membranes##2##3##(1992-9#1)(1994-5#1)
in biological neural networks##2##4##(2008-11#2)
in biological processes##2##3##(2008-10#2)
in biological reference materials##2##4##(2008-10#2)
in biological samples by##4##4##(2008-10#4)
in biological samples using##2##4##(2008-10#2)
in biological samples##32##3##(2008-10#31)(2009-12#1)
in biological systems##12##3##(1990-3#1)(1994-9#1)(1997-6#1)(2008-10#5)(2008-8#1)(2008-9#1)(2010-11#1)(2013-1#1)
in biological tissue##2##3##(2007-12#1)(2009-8#1)
in biological tissues##5##3##(2008-10#4)(2013-8#1)
in biological##114##2##(1990-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-9#2)(1994-5#1)(1994-9#1)(1995-12#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#83)(2008-11#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#3)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
in biology##8##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-3#1)(2012-5#1)
in biomass##2##2##(2008-12#1)(2013-1#1)
in biomedical##5##2##(1994-3#1)(2009-12#1)(2009-7#1)(2010-11#1)(2013-1#1)
in biopharmaceutical process##2##3##(2008-11#1)(2010-11#1)
in biopharmaceutical production##2##3##(2008-11#2)
in biopharmaceutical##4##2##(2008-11#3)(2010-11#1)
in bioreactor##4##2##(2008-11#4)
in bioreactors##6##2##(2008-11#6)
in biotechnology##2##2##(2008-11#1)(2008-9#1)
in birds and mammals is##2##5##(2008-8#1)(2008-9#1)
in birds##17##2##(1992-2#1)(1995-9#1)(2008-5#1)(2008-8#6)(2008-9#8)
in birth##2##2##(2008-11#1)(2012-12#1)
in black women##2##3##(2013-1#2)
in black##7##2##(2008-1#1)(2008-10#1)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
in bladder cancer##3##3##(2009-4#1)(2013-8#2)
in bladder##5##2##(1992-12#1)(2008-10#1)(2009-4#1)(2013-8#2)
in blank##2##2##(2008-10#1)(2012-3#1)
in bleeding##3##2##(2009-3#2)(2012-3#1)
in blood and##5##3##(2008-10#3)(2008-5#2)
in blood flow##4##3##(1996-3#2)(2008-12#1)(2013-1#1)
in blood glucose##2##3##(2008-10#1)(2012-5#1)
in blood plasma##8##3##(2008-10#6)(2011-2#1)(2013-1#1)
in blood pressure##10##3##(1993-1#1)(1994-11#1)(1995-11#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-8#1)(2009-1#1)
in blood samples##6##3##(1990-8#1)(1992-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
in blood serum of patients of different age##2##8##(2013-1#2)
in blood serum samples##4##4##(2008-10#4)
in blood serum##15##3##(2008-10#11)(2013-1#4)
in blood was##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
in blood##85##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-11#1)(1996-3#3)(1997-6#1)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#42)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2011-2#5)(2012-5#1)(2013-1#9)
in blubber of##2##3##(2008-10#2)
in blue tit nests##2##4##(2008-8#2)
in blue##3##2##(2008-8#3)
in blunt##4##2##(1990-2#2)(2009-6#1)(2012-2#1)
in body fluids##3##3##(2008-10#3)
in body mass##2##3##(2008-9#1)(2011-1#1)
in body size##5##3##(2008-8#2)(2008-9#1)(2010-8#1)(2012-3#1)
in body weight##5##3##(1993-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
in body##24##2##(1992-3#1)(1993-8#1)(1994-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#2)(2013-1#1)
in bone banks##2##3##(1996-3#2)
in bone marrow cells of##2##5##(2010-1#2)
in bone marrow cells##5##4##(1990-6#1)(1992-8#1)(2010-1#2)(2010-8#1)
in bone marrow##12##3##(1990-6#1)(1992-8#1)(1993-8#1)(1994-6#1)(2008-5#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-8#2)(2011-2#1)
in bone metabolism##3##3##(1991-11#1)(2008-11#1)(2013-1#1)
in bone turnover##2##3##(2008-11#1)(2010-10#1)
in bone##30##2##(1990-6#1)(1991-11#2)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-3#2)(1997-1#2)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2013-1#1)
in border##3##2##(1994-3#1)(2008-10#2)
in borderline personality##2##3##(2009-10#1)(2009-9#1)
in boron##2##2##(1990-3#1)(2008-10#1)
in botanical##3##2##(2008-10#3)
in both English and Spanish##2##5##(2008-12#1)(2012-12#1)
in both States##2##3##(1991-1#2)
in both a##4##3##(1991-3#1)(1994-8#1)(1994-9#1)(1995-9#1)
in both animal and##2##4##(1991-12#1)(2008-7#1)
in both animal##4##3##(1991-12#1)(1993-11#1)(2008-10#1)(2008-7#1)
in both animals and humans##2##5##(2008-11#1)(2012-2#1)
in both aqueous and non-aqueous mediums is##2##7##(2008-10#2)
in both aqueous and non-aqueous##3##5##(2008-10#3)
in both aqueous and##4##4##(2008-10#4)
in both assays##2##3##(1991-12#1)(2012-2#1)
in both basic and clinical research##2##6##(2008-9#2)
in both batch and fed-batch##2##5##(2008-11#1)(2008-7#1)
in both calves##2##3##(1996-11#1)(2013-1#1)
in both cases##20##3##(1990-5#1)(1995-11#1)(2008-10#9)(2008-7#3)(2009-1#1)(2010-12#2)(2011-2#2)(2012-3#1)
in both cell lines##5##4##(1994-11#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
in both cell##8##3##(1994-11#1)(1996-12#1)(1997-1#1)(2008-11#2)(2010-1#1)(2011-2#1)(2012-12#1)
in both cells##4##3##(1993-8#1)(1994-12#1)(1997-8#1)(2011-2#1)
in both cerebral hemispheres using surface EMG recording in bilateral SHM##2##11##(2011-2#2)
in both children and adults##2##5##(2008-12#1)(2008-9#1)
in both clinical and##2##4##(1993-12#1)(2008-11#1)
in both clinical##4##3##(1993-12#1)(1995-5#1)(2008-11#2)
in both conditions##2##3##(2008-4#1)(2009-11#1)
in both cultivars and in##2##5##(2008-10#2)
in both cultivars##6##3##(2008-10#6)
in both cultures##2##3##(2008-11#1)(2013-8#1)
in both diagnostic and##2##4##(1993-1#1)(2008-9#1)
in both directions##5##3##(1993-12#1)(2008-10#1)(2008-8#2)(2011-2#1)
in both domestic##2##3##(1996-12#1)(2010-8#1)
in both environments##2##3##(2008-10#1)(2008-9#1)
in both epithelial##2##3##(2008-10#1)(2013-1#1)
in both experiments##5##3##(1993-3#1)(2008-10#4)
in both eyes##5##3##(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
in both fed and fasted rats##2##6##(1994-8#2)
in both fed and fasted##3##5##(1994-8#2)(2008-7#1)
in both female and male##2##5##(1992-8#1)(2010-8#1)
in both flag leaves and##2##5##(2008-9#2)
in both flag##3##3##(2008-9#3)
in both groups of##4##4##(1997-2#1)(1997-3#1)(2008-10#1)(2012-2#1)
in both groups were##3##4##(2008-11#1)(2012-3#2)
in both groups##36##3##(1990-2#1)(1991-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-1#2)(1997-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-12#1)(2009-3#3)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
in both human and##3##4##(1994-3#1)(1997-8#1)(2008-9#1)
in both human##4##3##(1990-2#1)(1994-3#1)(1997-8#1)(2008-9#1)
in both humans and##3##4##(1997-9#1)(2008-11#1)(2013-8#1)
in both intervention##2##3##(2010-7#1)(2012-2#1)
in both laboratory##2##3##(2008-10#1)(2008-5#1)
in both loading##2##3##(2009-3#2)
in both lobes##2##3##(2010-11#1)(2011-1#1)
in both media##2##3##(2008-10#1)(2008-11#1)
in both men and women##4##5##(2008-10#1)(2009-12#1)(2013-1#2)
in both methods##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
in both models##2##3##(2008-10#1)(2012-12#1)
in both modes##3##3##(2008-10#3)
in both mouse##2##3##(2008-5#1)(2012-2#1)
in both muscles##5##3##(1995-12#1)(2009-3#1)(2010-4#3)
in both normal and##2##4##(1992-3#1)(2009-8#1)
in both of the treatment groups##3##6##(1994-12#3)
in both of the##6##4##(1994-12#3)(2008-10#2)(2008-7#1)
in both of##8##3##(1994-12#3)(2008-10#2)(2008-7#1)(2010-5#1)(2013-1#1)
in both pharmacological and##2##4##(2008-11#1)(2009-7#1)
in both plant##2##3##(2008-10#2)
in both plants##2##3##(2008-10#2)
in both populations##6##3##(1990-8#4)(1993-3#1)(2008-10#1)
in both prairie and##2##4##(2008-8#1)(2008-9#1)
in both prokaryotes and eukaryotes##2##5##(1996-12#1)(2012-3#1)
in both rats and mice##2##5##(2008-10#1)(2008-9#1)
in both rats##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
in both reference##2##3##(2008-10#2)
in both rural and urban##2##5##(2009-7#1)(2012-2#1)
in both samples##2##3##(2008-10#1)(2009-11#1)
in both serum-free media##2##4##(2008-11#2)
in both sexes##15##3##(1990-3#1)(1991-6#2)(1992-12#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-7#2)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
in both sides##2##3##(2010-6#1)(2011-2#1)
in both situation##3##3##(1990-12#3)
in both solvents##2##3##(1992-4#1)(1996-5#1)
in both species##7##3##(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)
in both strains of mice##3##5##(1993-12#1)(2008-10#1)(2008-11#1)
in both strains of##5##4##(1993-12#2)(1996-12#1)(2008-10#1)(2008-11#1)
in both strains##7##3##(1993-12#2)(1994-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
in both studies and##2##4##(2008-10#1)(2008-9#1)
in both studies##15##3##(2008-10#1)(2008-9#13)(2010-1#1)
in both suspension and##3##4##(2008-11#3)
in both systems##6##3##(1994-8#1)(2008-10#4)(2008-11#1)
in both the absence##2##4##(2008-10#2)
in both the aqueous and organic##2##6##(2010-4#2)
in both the cases##2##4##(2008-10#1)(2008-7#1)
in both the presence and absence of##2##7##(2008-10#1)(2008-11#1)
in both the##74##3##(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#22)(2008-11#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-4#4)(2010-5#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)
in both these##2##3##(1991-12#1)(2008-7#1)
in both tissues##2##3##(1996-12#1)(2008-6#1)
in both treatments##4##3##(2008-10#1)(2008-9#3)
in both trials were##2##4##(2008-10#1)(2010-12#1)
in both types of##5##4##(1993-8#2)(2007-12#1)(2008-10#2)
in both untreated and##2##4##(1995-11#1)(2008-10#1)
in both urban##2##3##(1993-12#1)(2008-12#1)
in both years##17##3##(2008-10#12)(2008-11#4)(2011-2#1)
in both##699##2##(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#1)(1990-8#4)(1991-1#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#10)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#12)(1994-11#3)(1994-12#6)(1994-2#5)(1994-3#3)(1994-5#4)(1994-8#8)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#11)(1996-2#5)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#6)(1997-9#2)(2006-6#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#191)(2008-11#50)(2008-12#14)(2008-3#9)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#23)(2008-8#12)(2008-9#34)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#8)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#7)(2010-4#10)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#35)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#19)(2012-3#14)(2012-4#1)(2013-1#21)(2013-7#2)(2013-8#11)
in bovine adrenal chromaffin cells##2##5##(1994-5#1)(1995-11#1)
in bovine adrenal##3##3##(1994-5#1)(1994-8#1)(1995-11#1)
in bovine brain##3##3##(1990-8#1)(1994-11#1)(1996-12#1)
in bovine liver and##2##4##(1992-10#1)(2008-10#1)
in bovine liver##3##3##(1992-10#1)(2008-10#2)
in bovine ovarian##2##3##(1990-8#1)(1995-12#1)
in bovine serum##2##3##(2008-10#2)
in bovine skeletal muscle##2##4##(1991-9#2)
in bovine##30##2##(1990-8#2)(1991-9#3)(1992-10#3)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#2)(1996-12#2)(1997-1#1)(2008-10#7)(2008-11#3)(2008-12#1)
in boys and##5##3##(2011-1#4)(2013-8#1)
in boys##7##2##(1994-12#1)(2008-10#1)(2011-1#4)(2013-8#1)
in brachytherapy##2##2##(2008-10#2)
in brackets##2##2##(2008-10#2)
in brain and##3##3##(1993-12#1)(1994-11#1)(1995-2#1)
in brain cells of##2##4##(2008-8#2)
in brain is##2##3##(1993-8#2)
in brain regions and spinal cord of##2##7##(1997-2#2)
in brain regions and spinal cord##3##6##(1997-2#3)
in brain regions##6##3##(1996-12#2)(1997-2#3)(2008-11#1)
in brain slices##2##3##(2008-4#1)(2008-5#1)
in brain stem##2##3##(1992-6#1)(1993-9#1)
in brain tissue##5##3##(1994-11#3)(2008-7#1)(2010-11#1)
in brain tissues##2##3##(1990-5#1)(1994-11#1)
in brain##63##2##(1990-3#4)(1990-5#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#7)(1995-2#1)(1995-6#1)(1996-12#4)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-7#3)(2010-11#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#2)
in brains##2##2##(2008-7#1)(2008-8#1)
in brass##4##2##(2008-10#4)
in bread wheat##2##3##(2008-10#2)
in bread##3##2##(1991-6#1)(2008-10#2)
in breast cancer and##2##4##(2010-8#1)(2011-1#1)
in breast cancer cell##2##4##(1993-11#1)(2012-2#1)
in breast cancer cells##2##4##(1990-12#1)(2012-3#1)
in breast cancer patients##8##4##(1990-12#1)(1993-11#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
in breast cancer xenografts##2##4##(2013-1#1)(2013-8#1)
in breast cancer##41##3##(1990-12#4)(1991-3#1)(1991-6#1)(1993-1#1)(1993-11#12)(1994-12#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#3)(1997-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in breast cancers##4##3##(1993-11#1)(1994-2#1)(1995-12#1)(2011-2#1)
in breast carcinogenesis##2##3##(1990-6#1)(1993-11#1)
in breast carcinoma##2##3##(1991-2#1)(1993-1#1)
in breast cyst fluid##2##4##(2008-12#2)
in breast milk##4##3##(2008-10#3)(2013-1#1)
in breast##71##2##(1990-11#1)(1990-12#4)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-9#1)(1993-1#3)(1993-11#14)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#3)(1997-1#1)(1997-7#1)(2008-10#5)(2008-12#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
in breeding programs##6##3##(2008-10#5)(2012-3#1)
in breeding##8##2##(2008-10#7)(2012-3#1)
in brief##5##2##(1991-1#1)(1993-1#1)(1997-1#1)(1997-8#1)(2013-1#1)
in bright##2##2##(2008-10#1)(2008-11#1)
in bringing##3##2##(1995-5#1)(2008-11#1)(2010-6#1)
in brittle##2##2##(2009-7#1)(2013-8#1)
in broad##2##2##(2008-10#1)(2008-9#1)
in broilers##2##2##(1991-11#1)(1995-9#1)
in bronchial##2##2##(1992-5#1)(1992-9#1)
in bronchoalveolar lavage fluid##4##4##(1990-2#1)(1994-11#1)(1994-5#1)(1994-8#1)
in brown##4##2##(2008-10#2)(2009-8#1)(2013-1#1)
in brush-border##2##2##(1991-5#1)(2013-1#1)
in budding yeast##5##3##(1995-2#1)(1996-3#1)(1996-6#2)(2012-3#1)
in budding##6##2##(1995-2#1)(1996-3#1)(1996-6#2)(2009-8#1)(2012-3#1)
in buffer solution##4##3##(2008-10#3)(2008-4#1)
in buffer solutions##2##3##(2008-4#1)(2008-8#1)
in buffer##13##2##(1990-12#1)(1997-1#1)(2008-10#8)(2008-4#2)(2008-8#1)
in buffered##4##2##(2008-10#4)
in building##4##2##(1991-12#1)(2008-10#2)(2008-11#1)
in buildings##5##2##(1991-12#5)
in bulk and dosage forms##2##5##(2008-10#2)
in bulk and##4##3##(2008-10#4)
in bulk##22##2##(2007-11#1)(2007-12#2)(2008-10#14)(2008-2#2)(2008-3#1)(2008-5#1)(2009-12#1)
in bullying##2##2##(2008-11#1)(2008-12#1)
in burbot##2##2##(2008-10#1)(2008-11#1)
in buried##2##2##(2008-10#2)
in burned and unburned Venezuelan crude oil##2##7##(2008-10#2)
in burned##3##2##(2008-10#2)(2008-11#1)
in burnout##2##2##(1997-1#1)(2008-11#1)
in burst volume##2##3##(2010-4#2)
in business school##2##3##(1996-3#2)
in business##4##2##(1991-2#1)(1996-3#2)(1997-3#1)
in butterfly##2##2##(2008-8#2)
in by##2##2##(1993-1#1)(2008-5#1)
in c-fos##2##2##(1996-12#2)
in cAMP##2##2##(1995-8#1)(1997-2#1)
in ca##2##2##(2008-10#1)(2008-12#1)
in cafeteria diet induced obesity in##2##6##(2013-1#2)
in cages##3##2##(2008-10#3)
in calcific##2##2##(2008-12#1)(2008-8#1)
in calcium##11##2##(1990-11#1)(1991-12#1)(1992-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2012-2#1)(2013-1#1)
in calculations##2##2##(2008-10#1)(2008-3#1)
in calibration##4##2##(2008-10#2)(2008-3#1)(2008-6#1)
in california##4##2##(1990-11#1)(2008-10#3)
in calves##5##2##(1996-11#1)(1997-5#1)(2012-2#1)(2012-3#2)
in camels (Camelus dromedarius)##2##4##(1996-12#1)(2011-2#1)
in camels##5##2##(1996-12#1)(2011-2#4)
in cancer and##3##3##(2008-11#2)(2009-7#1)
in cancer care##2##3##(2010-10#1)(2012-3#1)
in cancer cell##2##3##(1997-7#1)(2010-8#1)
in cancer cells##9##3##(1994-11#1)(1995-12#1)(2008-4#2)(2008-8#1)(2009-4#1)(2011-2#2)(2012-3#1)
in cancer chemotherapy##2##3##(1995-6#1)(2008-11#1)
in cancer development##3##3##(2011-2#2)(2013-1#1)
in cancer mortality##3##3##(1990-8#2)(1996-6#1)
in cancer patients##15##3##(1991-3#1)(1991-6#1)(1994-8#1)(2008-1#1)(2008-4#1)(2009-12#1)(2010-11#2)(2010-7#1)(2011-2#3)(2013-1#3)
in cancer research##2##3##(1990-2#1)(2009-4#1)
in cancer therapy##3##3##(1994-12#1)(2011-2#1)(2013-8#1)
in cancer tissues##2##3##(2008-10#1)(2010-12#1)
in cancer treatment##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
in cancer##75##2##(1990-2#1)(1990-8#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-7#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#5)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#11)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
in cancers of##2##3##(1991-8#1)(2011-2#1)
in cancers with##2##3##(1990-9#1)(2013-1#1)
in cancers##5##2##(1990-9#1)(1991-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in canine##9##2##(1991-6#1)(1992-3#1)(1992-5#1)(1994-8#1)(1996-12#1)(2008-10#1)(2011-2#3)
in canola##2##2##(2008-10#2)
in capillary electrokinetic chromatography##2##4##(2008-10#2)
in capillary electrophoresis##2##3##(2008-10#2)
in capillary zone electrophoresis##2##4##(2008-10#2)
in capillary##8##2##(2008-10#7)(2008-3#1)
in capital##7##2##(1992-2#1)(1994-3#6)
in capsaicin-treated##3##2##(2008-11#3)
in capsules and human##2##4##(2008-10#2)
in capsules and plasma##3##4##(2008-10#3)
in capsules and##6##3##(2008-10#6)
in capsules##9##2##(2008-10#9)
in captive##6##2##(1991-3#1)(1996-12#1)(2008-5#1)(2008-7#1)(2008-8#2)
in captivity##3##2##(1996-12#1)(2008-7#1)(2012-3#1)
in carbohydrate##3##2##(1997-2#1)(2008-10#2)
in carbon paste##2##3##(2008-10#2)
in carbon tetrachloride##2##3##(2010-2#1)(2013-1#1)
in carbon##10##2##(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
in carboxylated##2##2##(2008-10#2)
in carcinoma of##2##3##(1993-9#1)(2011-2#1)
in cardiac and##2##3##(1992-6#1)(1995-2#1)
in cardiac cells##3##3##(2008-7#3)
in cardiac myocytes from##2##4##(2008-8#2)
in cardiac myocytes##4##3##(2008-8#2)(2008-9#2)
in cardiac patients##2##3##(2008-10#1)(2009-5#1)
in cardiac surgery##3##3##(2008-11#1)(2010-7#1)(2013-1#1)
in cardiac##26##2##(1991-5#1)(1991-6#1)(1992-6#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
in cardiology]##2##2##(1991-2#1)(1992-5#1)
in cardiomyocytes##2##2##(1994-3#1)(1996-2#1)
in cardiovascular and##2##3##(2008-10#1)(2008-8#1)
in cardiovascular disease##8##3##(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-6#1)(2010-9#1)(2013-1#1)
in cardiovascular diseases##4##3##(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)
in cardiovascular function##2##3##(1992-3#1)(2013-8#1)
in cardiovascular research##2##3##(2010-4#1)(2010-5#1)
in cardiovascular risk##2##3##(1994-6#1)(2010-10#1)
in cardiovascular systems##2##3##(2009-10#2)
in cardiovascular##28##2##(1992-3#2)(1992-5#1)(1994-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#3)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
in care and##2##3##(1994-1#1)(2013-1#1)
in care##6##2##(1994-1#1)(2008-11#1)(2008-6#1)(2010-10#1)(2013-1#2)
in caring for the##2##4##(2008-11#2)
in caring for##12##3##(1996-9#1)(2008-11#4)(2010-10#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-3#1)
in caring##14##2##(1996-9#1)(2008-11#4)(2010-10#2)(2010-7#2)(2010-8#1)(2011-2#2)(2012-3#2)
in carnivores##3##2##(2008-11#1)(2012-3#2)
in carpal tunnel##3##3##(1997-2#1)(2008-9#2)
in carrot##5##2##(2008-10#4)(2008-9#1)
in cartilage and bone##2##4##(2007-11#1)(2011-2#1)
in cartilage##3##2##(2007-11#1)(2008-12#1)(2011-2#1)
in case mix##2##3##(1991-3#1)(1994-12#1)
in case of the##8##4##(2008-10#6)(2008-11#1)(2008-5#1)
in case of##47##3##(1990-8#1)(1993-3#1)(1996-3#1)(2008-1#3)(2008-10#24)(2008-11#4)(2008-5#1)(2009-4#1)(2010-8#2)(2011-2#2)(2011-3#2)(2013-1#5)
in case##53##2##(1990-8#1)(1991-1#1)(1991-3#1)(1993-3#1)(1994-12#1)(1996-3#1)(2008-1#4)(2008-10#24)(2008-11#4)(2008-3#1)(2008-5#1)(2009-4#1)(2010-8#2)(2011-2#2)(2011-3#2)(2013-1#6)
in case-control##2##2##(1994-2#1)(1995-9#1)
in cases in which##4##4##(1991-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
in cases of severe##2##4##(2010-5#1)(2011-2#1)
in cases of##34##3##(1991-11#2)(1991-3#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#3)(1995-11#1)(1995-12#1)(1996-3#1)(1996-5#2)(1997-8#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-8#1)
in cases that##2##3##(2008-1#1)(2011-2#1)
in cases when##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
in cases where##4##3##(1990-2#1)(1990-9#1)(2008-11#1)(2008-7#1)
in cases with ER-rich tumors vs##2##6##(1993-1#2)
in cases with severe##2##4##(1990-12#1)(2011-1#1)
in cases with##14##3##(1990-11#1)(1990-12#1)(1990-8#1)(1993-1#2)(1997-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#5)
in cases##68##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-11#3)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-1#3)(1993-2#1)(1994-12#1)(1994-2#3)(1995-11#2)(1995-12#1)(1996-3#1)(1996-5#2)(1997-8#3)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-3#3)(2013-1#1)(2013-8#1)
in castrated males##2##3##(1993-8#1)(1994-2#1)
in castrated##4##2##(1990-11#1)(1993-8#1)(1994-2#1)(1996-2#1)
in cat##6##2##(1990-11#1)(1990-5#1)(1991-10#1)(2008-11#2)(2008-8#1)
in catalysis##2##2##(1995-6#1)(1997-8#1)
in catalytic##3##2##(1992-6#1)(1994-5#1)(2008-10#1)
in cation##2##2##(2008-10#1)(2008-7#1)
in cationic micellar medium##2##4##(2008-10#2)
in cationic micellar##3##3##(2008-10#3)
in cats with GBS##2##4##(2012-3#2)
in cats##11##2##(1993-1#1)(1996-11#1)(1997-2#1)(2012-3#6)(2013-8#2)
in cattle##12##2##(1991-8#1)(1992-12#1)(1993-2#1)(1995-9#1)(1996-12#3)(1996-6#1)(1997-5#2)(2012-3#1)(2013-1#1)
in cauliflower##4##2##(2008-10#4)
in causing a##2##3##(2008-10#1)(2008-11#1)
in causing##13##2##(1990-11#1)(1992-12#1)(1995-11#1)(2008-10#4)(2008-11#2)(2009-8#1)(2011-2#2)(2011-3#1)
in caveolin##2##2##(1995-2#2)
in cell adhesion##2##3##(1994-5#1)(2008-1#1)
in cell and##2##3##(2008-11#1)(2008-4#1)
in cell biology##2##3##(2008-9#1)(2012-2#1)
in cell culture systems##2##4##(2008-11#2)
in cell culture##19##3##(1994-2#2)(1997-3#1)(2008-10#2)(2008-11#13)(2008-5#1)
in cell cultures##7##3##(2008-11#6)(2008-4#1)
in cell death##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
in cell density##2##3##(1995-3#1)(2008-11#1)
in cell extracts##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
in cell growth and##3##4##(2008-10#1)(2008-11#1)(2013-7#1)
in cell growth##6##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-7#1)
in cell lines##8##3##(1993-6#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
in cell membranes##2##3##(1991-5#2)
in cell migration##2##3##(2011-2#1)(2013-8#1)
in cell morphology##3##3##(2008-11#2)(2008-8#1)
in cell number##3##3##(1995-2#1)(1996-2#1)(2008-11#1)
in cell numbers##3##3##(1995-3#1)(2008-11#1)(2011-2#1)
in cell proliferation and differentiation##2##5##(1993-3#1)(2008-9#1)
in cell proliferation and##6##4##(1993-3#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-9#2)
in cell proliferation##10##3##(1990-6#1)(1993-3#1)(1994-9#1)(1995-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2013-7#1)
in cell shape##2##3##(1993-8#1)(2012-2#1)
in cell size##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
in cell suspension cultures of wheat##2##6##(2008-11#2)
in cell suspension cultures##3##4##(2008-11#3)
in cell viability##2##3##(2008-11#1)(2008-6#1)
in cell volume and##2##4##(1993-8#1)(2013-8#1)
in cell wall##3##3##(2008-10#2)(2012-2#1)
in cell walls##2##3##(2008-10#2)
in cell##141##2##(1990-5#2)(1990-6#1)(1991-11#1)(1991-5#2)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#45)(2008-12#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#9)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
in cell-free##2##2##(2008-7#1)(2008-8#1)
in cells and##3##3##(1990-5#1)(2009-7#1)(2013-1#1)
in cells exposed to##2##4##(1994-3#1)(1995-6#1)
in cells expressing the##3##4##(1995-2#1)(1995-6#1)(1997-7#1)
in cells expressing##5##3##(1995-11#1)(1995-2#2)(1995-6#1)(1997-7#1)
in cells grown at##2##4##(1991-11#2)
in cells grown##4##3##(1990-5#1)(1991-11#3)
in cells maintained##2##3##(1994-8#1)(1995-2#1)
in cells of the##2##4##(1995-12#1)(1997-7#1)
in cells of##5##3##(1995-12#1)(1995-6#1)(1997-7#1)(1997-8#1)(2011-1#1)
in cells that##3##3##(1993-3#1)(1995-12#1)(2008-10#1)
in cells transfected with##6##4##(1995-6#2)(1995-8#1)(2008-11#2)(2009-8#1)
in cells treated with##5##4##(1995-8#5)
in cells treated##6##3##(1995-8#5)(2008-11#1)
in cells with##5##3##(1992-6#1)(1993-12#1)(1993-8#1)(2008-10#1)(2010-1#1)
in cells##75##2##(1990-5#2)(1990-8#1)(1991-11#3)(1991-5#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-6#5)(1995-8#7)(1997-1#2)(1997-7#4)(1997-8#1)(2008-10#6)(2008-11#6)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#2)
in cellular and##2##3##(1997-2#1)(2012-3#1)
in cellular environments##2##3##(2008-10#1)(2008-4#1)
in cellular function##2##3##(2011-2#1)(2012-2#1)
in cellular senescence##2##3##(2008-11#2)
in cellular##25##2##(1991-5#1)(1995-2#1)(1997-2#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
in cementless##2##2##(2009-3#2)
in central and peripheral neurons##2##5##(1996-12#2)
in central and southern##2##4##(2008-10#1)(2011-2#1)
in central and##5##3##(1996-12#2)(2008-10#2)(2011-2#1)
in central##24##2##(1991-3#1)(1994-12#1)(1996-12#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
in centric occlusion##3##3##(2010-9#3)
in ceramic##3##2##(2008-10#3)
in cereals##7##2##(2008-10#2)(2008-11#1)(2009-10#1)(2009-8#2)(2013-8#1)
in cerebellar##4##2##(1993-8#1)(1995-8#1)(2008-9#1)(2013-8#1)
in cerebellum##7##2##(1994-2#1)(1995-11#1)(1995-2#1)(1996-2#2)(1997-2#2)
in cerebral AVM##2##3##(2012-3#2)
in cerebral AVMs##2##3##(1997-3#1)(2012-3#1)
in cerebral arteriovenous malformations##2##4##(1997-3#2)
in cerebral arteriovenous##3##3##(1997-3#2)(2008-7#1)
in cerebral blood flow##3##4##(2008-7#2)(2013-1#1)
in cerebral cortex##3##3##(1995-11#1)(1997-2#2)
in cerebral endovascular##2##3##(1996-6#2)
in cerebral vascular##2##3##(1996-11#1)(2008-7#1)
in cerebral##27##2##(1990-11#1)(1994-11#1)(1994-2#2)(1995-11#2)(1996-11#1)(1996-6#2)(1997-2#2)(1997-3#3)(2008-7#5)(2009-3#1)(2009-9#1)(2011-2#1)(2012-3#3)(2013-1#2)
in cerebrospinal fluid (CSF)##2##4##(1990-2#1)(1993-1#1)
in cerebrospinal fluid of##2##4##(2010-12#1)(2011-2#1)
in cerebrospinal fluid##7##3##(1990-2#2)(1993-1#1)(1993-2#1)(1994-8#1)(2010-12#1)(2011-2#1)
in cerebrospinal liquor##2##3##(2013-1#2)
in cerebrospinal##9##2##(1990-2#2)(1993-1#1)(1993-2#1)(1994-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
in certain cell##2##3##(1993-6#1)(2013-1#1)
in certain nomadic localities in Sudan##2##6##(2011-2#2)
in certain##32##2##(1991-11#1)(1991-2#1)(1991-5#1)(1993-6#2)(1994-12#1)(1994-2#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#2)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
in certified reference materials of##2##5##(2008-10#2)
in certified reference materials##5##4##(2008-10#5)
in certified reference##7##3##(2008-10#7)
in certified##10##2##(2008-10#10)
in cervical cancer##2##3##(2011-2#1)(2012-3#1)
in cervical##6##2##(1992-10#1)(1995-2#1)(1996-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
in cesarean##2##2##(1997-1#1)(2013-1#1)
in cesium ion selective electrodes##3##5##(2008-10#3)
in cesium##4##2##(2008-10#4)
in chain##2##2##(2008-12#2)
in chains##2##2##(1991-5#1)(2008-8#1)
in changes in##4##3##(1992-6#1)(2008-10#2)(2008-9#1)
in changes##7##2##(1992-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
in changing##2##2##(1995-12#1)(2008-10#1)
in characterizing the##2##3##(2008-10#2)
in characterizing##4##2##(1995-11#1)(2008-10#3)
in charge of the##2##4##(1994-9#1)(2008-10#1)
in charge of##7##3##(1994-9#1)(1995-2#1)(2008-10#2)(2010-1#1)(2011-3#1)(2013-1#1)
in charge##8##2##(1994-9#1)(1995-2#1)(2008-10#3)(2010-1#1)(2011-3#1)(2013-1#1)
in charges##2##2##(1992-12#2)
in chemical analysis##9##3##(2008-10#7)(2010-7#2)
in chemical and##2##3##(2008-10#1)(2008-3#1)
in chemical##23##2##(2008-10#15)(2008-3#1)(2008-7#1)(2009-7#2)(2010-1#1)(2010-7#2)(2013-8#1)
in chemically defined medium##2##4##(1993-6#1)(2008-5#1)
in chemically defined##4##3##(1993-6#1)(2008-11#2)(2008-5#1)
in chemosensitivity##2##2##(1991-8#1)(1997-7#1)
in chemotherapy##2##2##(2008-11#1)(2008-7#1)
in chemotherapy-induced##2##2##(2008-11#1)(2010-12#1)
in cherry##2##2##(2008-10#1)(2008-2#1)
in chick##4##2##(1995-12#1)(1996-2#2)(1997-1#1)
in chicken brain##2##3##(1993-6#2)
in chicken eggs##2##3##(1997-7#1)(2008-10#1)
in chicken plasma##2##3##(2008-10#2)
in chicken##17##2##(1990-9#1)(1992-6#1)(1993-12#1)(1993-6#2)(1997-7#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)
in chickens##7##2##(1991-9#1)(2008-12#1)(2008-5#4)(2008-8#1)
in chickpea##8##2##(2008-10#8)
in chicks##6##2##(1990-3#1)(1992-9#1)(2008-5#2)(2008-6#1)(2008-9#1)
in chicory##2##2##(2008-10#2)
in child care##2##3##(2009-4#1)(2012-3#1)
in child##10##2##(1992-1#2)(2008-10#1)(2008-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2012-3#1)(2013-1#1)
in childbearing age##2##3##(2009-8#1)(2013-1#1)
in childhood and adolescence that##2##5##(2009-12#1)(2011-2#1)
in childhood and adolescence##6##4##(1995-2#1)(1996-11#1)(2008-11#1)(2009-12#2)(2011-2#1)
in childhood and##13##3##(1990-6#1)(1995-2#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-11#2)(2009-12#3)(2011-1#1)(2011-2#2)
in childhood are##2##3##(2008-11#1)(2013-1#1)
in childhood cancer##2##3##(2008-11#1)(2012-2#1)
in childhood in##2##3##(1992-11#1)(2012-2#1)
in childhood is rare##2##4##(1991-6#1)(2012-3#1)
in childhood is##4##3##(1991-6#1)(1996-11#1)(2011-2#1)(2012-3#1)
in childhood##54##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-5#1)(1993-9#1)(1995-2#2)(1996-11#3)(1996-3#1)(1997-8#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#3)(2010-1#1)(2011-1#4)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#2)
in childhood]##4##2##(1990-9#1)(1991-3#1)(1992-3#1)(1994-6#1)
in children after##3##3##(2008-10#2)(2013-1#1)
in children aged##4##3##(2008-9#2)(2012-12#2)
in children and adolescents with##4##5##(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
in children and adolescents##21##4##(1990-6#1)(1991-2#1)(1994-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#3)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)
in children and adults with##2##5##(2008-8#1)(2010-12#1)
in children and adults##7##4##(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2013-8#1)
in children and its##2##4##(2011-2#1)(2012-3#1)
in children and to##2##4##(2008-11#1)(2010-5#1)
in children and young adults##2##5##(2011-2#1)(2012-2#1)
in children and##44##3##(1990-6#1)(1991-2#1)(1992-2#1)(1994-8#1)(1997-8#1)(2008-1#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#7)(2011-5#1)(2012-2#4)(2012-3#5)(2013-1#1)(2013-8#1)
in children below##2##3##(2008-1#1)(2008-12#1)
in children by##2##3##(1994-12#1)(2010-11#1)
in children in##5##3##(1996-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2011-2#1)
in children is##2##3##(2008-12#1)(2013-1#1)
in children may##2##3##(2008-10#1)(2008-11#1)
in children of all ages##2##5##(2008-11#1)(2012-2#1)
in children of##8##3##(2008-11#5)(2012-2#1)(2012-3#2)
in children over##2##3##(1995-12#1)(2012-12#1)
in children treated with inhaled##2##5##(2007-11#2)
in children treated with##3##4##(2007-11#3)
in children under##2##3##(2012-12#2)
in children using cochlear implants##2##5##(2008-9#2)
in children using##4##3##(2008-10#1)(2008-9#3)
in children who clutter##3##4##(2011-1#3)
in children who##6##3##(1994-6#1)(1994-9#1)(2011-1#3)(2013-7#1)
in children with CDGP compared to##2##6##(2011-1#2)
in children with CDGP##3##4##(2011-1#3)
in children with acute respiratory infections in Gansu Province##2##9##(2013-8#2)
in children with acute##3##4##(2008-1#1)(2013-8#2)
in children with cancer##3##4##(2010-9#1)(2012-2#2)
in children with constitutional delay of growth and puberty##2##9##(2011-1#2)
in children with nephrotic syndrome##2##5##(2008-1#2)
in children with obesity##4##4##(2008-12#3)(2012-3#1)
in children with##60##3##(1990-11#1)(1992-11#1)(1992-2#1)(1994-3#1)(1994-6#2)(1996-8#1)(1997-4#1)(2007-12#1)(2008-1#4)(2008-10#8)(2008-11#1)(2008-12#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#1)(2010-2#2)(2010-9#1)(2011-1#12)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
in children##275##2##(1990-11#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-11#2)(1992-2#2)(1992-7#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-11#5)(2007-12#3)(2008-1#7)(2008-10#37)(2008-11#24)(2008-12#10)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#5)(2008-9#11)(2009-1#1)(2009-12#4)(2009-3#6)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#17)(2011-2#29)(2011-5#1)(2012-12#8)(2012-2#14)(2012-3#11)(2013-1#15)(2013-7#4)(2013-8#7)
in children's##5##2##(1995-2#1)(2008-11#1)(2010-9#1)(2011-2#2)
in children?##2##2##(2008-11#1)(2012-2#1)
in children]##8##2##(1990-11#1)(1991-2#2)(1992-5#1)(1996-6#1)(2008-11#1)(2009-5#1)(2012-3#1)
in chimeric##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
in chitin##2##2##(2008-10#2)
in chitosan film##2##3##(2008-10#2)
in chitosan membrane##2##3##(2008-10#2)
in chitosan##5##2##(2008-10#5)
in chloride rich##2##3##(2008-10#2)
in chloride##3##2##(2008-10#3)
in chloride-free##2##2##(1990-5#1)(2008-10#1)
in chlorinated sea water samples##2##5##(2008-10#2)
in chlorinated sea water##3##4##(2008-10#3)
in chloroform solution##2##3##(2008-10#2)
in chloroform was##2##3##(2008-10#2)
in chloroform##26##2##(2008-10#26)
in chlorophyll##2##2##(2008-10#2)
in chloroplast##4##2##(1994-11#1)(2008-10#2)(2012-3#1)
in chloroquine-induced##3##2##(1995-12#3)
in choice of##2##3##(1991-6#1)(2008-10#1)
in choice##3##2##(1991-6#1)(1993-3#1)(2008-10#1)
in cholestatic liver diseases##2##4##(1995-10#1)(2013-1#1)
in cholesterol and##2##3##(1991-12#1)(1993-2#1)
in cholesterol##6##2##(1991-12#1)(1993-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
in cholesteryl##2##2##(1990-8#1)(2009-8#1)
in chondrocytes##2##2##(2007-11#1)(2013-8#1)
in chromaffin cells##3##3##(1990-5#2)(1997-7#1)
in chromaffin granules##2##3##(1990-5#2)
in chromaffin##5##2##(1990-5#4)(1997-7#1)
in chromatin##3##2##(1990-2#1)(1995-2#1)(1997-6#1)
in chrome tanning liquors after its breakdown to 2-mercaptobenzothiazole##2##9##(2008-10#2)
in chromosomal##3##2##(1991-12#1)(2008-7#1)(2009-7#1)
in chromosome##12##2##(1996-6#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-12#1)(2009-8#1)(2012-3#2)
in chronic HBV##2##3##(2009-8#1)(2013-1#1)
in chronic cerebral hypoperfusion##3##4##(2008-7#3)
in chronic heart failure##2##4##(1991-6#1)(2013-8#1)
in chronic hepatitis C##3##4##(2009-8#1)(2013-1#2)
in chronic hepatitis##4##3##(1995-10#1)(2009-8#1)(2013-1#2)
in chronic obstructive pulmonary disease##2##5##(2011-2#2)
in chronic obstructive pulmonary disease]##3##5##(2011-2#3)
in chronic obstructive pulmonary##6##4##(2011-2#5)(2013-8#1)
in chronic patients##2##3##(1997-2#1)(2008-12#1)
in chronic renal failure##2##4##(2008-1#1)(2008-12#1)
in chronic suppurative lung##2##4##(1994-12#2)
in chronic tension type headache##2##5##(2010-9#2)
in chronic wounds##3##3##(2008-9#3)
in chronic##65##2##(1990-2#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-9#1)(1994-12#2)(1995-10#1)(1995-11#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-12#6)(2008-5#1)(2008-7#4)(2008-9#6)(2009-10#1)(2009-8#3)(2010-5#2)(2010-7#2)(2010-9#2)(2011-2#9)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#5)
in chronically##2##2##(2008-11#1)(2008-7#1)
in cigarettes##3##2##(2008-10#3)
in circulating##7##2##(1994-8#2)(2008-1#1)(2008-10#3)(2012-2#1)
in circulation##4##2##(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
in circumpolar indigenous##2##3##(2013-1#2)
in circumscribed##3##2##(1995-8#1)(1997-3#1)(2008-11#1)
in cirrhotic liver##2##3##(2010-12#2)
in cirrhotic patients##3##3##(1993-3#1)(2009-8#2)
in cirrhotic##5##2##(1993-3#1)(2009-8#2)(2010-12#2)
in cis##3##2##(1991-6#1)(1993-2#1)(1995-6#1)
in citrus fruit##4##3##(2008-10#4)
in citrus##7##2##(2008-10#7)
in clade##2##2##(2008-10#2)
in clarifying##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
in class##3##2##(1990-2#1)(1995-8#1)(2008-11#1)
in classical##8##2##(2008-5#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-3#2)(2013-8#1)
in classifying##2##2##(1992-12#1)(2010-9#1)
in classroom teaching##3##3##(2008-11#3)
in classroom##5##2##(2008-11#3)(2008-12#2)
in clay loam##3##3##(2008-10#3)
in clay##4##2##(2008-10#4)
in cleanroom environments##2##3##(2012-2#2)
in clear##4##2##(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
in cleavage##2##2##(1994-5#1)(1997-7#1)
in clients with##2##3##(2008-7#1)(2013-8#1)
in climate-controlled rooms##2##3##(2008-10#2)
in clinic for##2##3##(2008-10#1)(2008-9#1)
in clinic##6##2##(2008-10#1)(2008-9#1)(2011-3#2)(2013-1#1)(2013-7#1)
in clinical analysis##3##3##(2008-10#3)
in clinical and##8##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-6#1)(2010-9#1)(2011-7#1)
in clinical assessment##2##3##(1990-6#1)(2008-11#1)
in clinical biochemistry##4##3##(1994-12#4)
in clinical blood samples##2##4##(1991-12#1)(2008-10#1)
in clinical cardiac electrophysiology##2##4##(2008-12#2)
in clinical cardiology##3##3##(1991-2#1)(2006-6#1)(2008-12#1)
in clinical chemistry##8##3##(1994-12#8)
in clinical decision-making##2##3##(2008-11#1)(2010-8#1)
in clinical laboratory##3##3##(1994-12#2)(2008-10#1)
in clinical medicine##7##3##(1992-3#1)(1994-3#1)(1994-6#3)(1995-8#1)(1997-7#1)
in clinical oncology##5##3##(1994-6#1)(2008-7#2)(2008-9#1)(2011-2#1)
in clinical penetrance##2##3##(2008-5#2)
in clinical practice and##6##4##(1995-11#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
in clinical practice for##3##4##(1997-8#1)(2008-7#1)(2011-1#1)
in clinical practice in##2##4##(2010-11#1)(2010-12#1)
in clinical practice is##2##4##(1994-12#1)(2008-12#1)
in clinical practice to##2##4##(2009-8#1)(2010-12#1)
in clinical practice##56##3##(1991-2#1)(1991-3#1)(1993-12#1)(1994-12#1)(1995-11#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#7)(2008-12#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
in clinical practice]##4##3##(1991-3#1)(1993-5#1)(2009-5#1)(2013-1#1)
in clinical research##2##3##(2008-10#1)(2010-8#1)
in clinical routine##3##3##(2012-2#3)
in clinical settings##11##3##(2008-11#5)(2008-12#2)(2008-2#1)(2009-3#1)(2010-9#1)(2011-2#1)
in clinical studies##10##3##(1992-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
in clinical trials and##3##4##(1996-3#1)(2009-12#1)(2010-12#1)
in clinical trials##34##3##(1992-9#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-12#4)(1996-3#1)(1996-6#1)(2008-11#5)(2008-5#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#2)
in clinical use for##2##4##(1996-11#1)(2009-7#1)
in clinical use##5##3##(1996-11#1)(2008-10#1)(2008-5#2)(2009-7#1)
in clinical##228##2##(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#18)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1995-11#1)(1995-12#4)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#3)(2006-6#1)(2007-8#1)(2008-10#15)(2008-11#26)(2008-12#15)(2008-2#1)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#11)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#4)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#14)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#10)(2013-8#2)
in clinics##5##2##(1990-2#1)(2008-6#1)(2010-5#1)(2010-8#1)(2011-3#1)
in clonal##4##2##(1994-11#1)(1997-8#1)(2008-10#1)(2012-3#1)
in close agreement with##3##4##(2008-10#2)(2008-8#1)
in close analogy to the##2##5##(1997-6#2)
in close association with each other##2##6##(2007-12#1)(2008-10#1)
in close association with##5##4##(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-9#1)
in close connection with##2##4##(1994-12#1)(2008-8#1)
in close connection##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
in close contact with the##2##5##(2009-10#2)
in close contact with##4##4##(2008-10#1)(2008-5#1)(2009-10#2)
in close correlation with##2##4##(1996-3#1)(2008-3#1)
in close proximity to##4##4##(2008-10#3)(2009-12#1)
in close proximity##8##3##(2008-10#5)(2008-3#1)(2009-12#1)(2010-11#1)
in close relationship with##2##4##(1994-12#2)
in close##31##2##(1994-12#3)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#2)(2007-12#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#1)(2010-7#1)
in closed##5##2##(1990-2#1)(2008-10#2)(2009-10#1)(2011-2#1)
in clusters##3##2##(1991-9#1)(2008-10#2)
in clutches with##2##3##(1991-5#1)(2008-9#1)
in co-culture##3##2##(2008-11#1)(2012-2#1)(2012-4#1)
in coal by##4##3##(2008-10#4)
in coal##10##2##(2008-10#10)
in coastal California##2##3##(2008-10#2)
in coastal waters##4##3##(2008-10#2)(2008-3#1)(2010-4#1)
in coastal##14##2##(2008-10#9)(2008-3#1)(2010-4#1)(2010-8#1)(2013-8#2)
in cochlear implant users##4##4##(2008-9#4)
in cochlear implant##7##3##(2008-9#7)
in cochlear implantation##3##3##(2008-9#3)
in cochlear##12##2##(2008-9#11)(2012-2#1)
in coconut##3##2##(2008-10#3)
in coding region##2##3##(2010-7#2)
in coding##4##2##(2007-12#1)(2010-7#2)(2012-12#1)
in coeliac disease##4##3##(1991-12#2)(1992-12#1)(2008-10#1)
in coeliac patients##2##3##(1991-12#1)(2011-7#1)
in coeliac##6##2##(1991-12#3)(1992-12#1)(2008-10#1)(2011-7#1)
in coffee and tea##2##4##(2008-10#2)
in coffee##6##2##(2008-10#4)(2008-11#2)
in cognition##2##2##(1996-2#1)(2013-8#1)
in cognitive##5##2##(1990-8#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
in coherent##3##2##(2008-3#3)
in cohort##2##2##(1995-9#1)(2008-7#1)
in coiled high-birefringent fibers##2##4##(2008-2#2)
in cold##9##2##(1990-9#1)(1995-11#1)(2008-10#4)(2008-5#1)(2012-2#1)(2012-3#1)
in collaboration with the National Agricultural Statistics Service##3##8##(2008-10#3)
in collaboration with the National##4##5##(2008-10#3)(2008-5#1)
in collaboration with the##6##4##(1996-2#1)(2008-10#3)(2008-12#1)(2008-5#1)
in collaboration with##16##3##(1996-1#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2011-2#1)
in collagen biosynthesis##2##3##(1997-7#1)(2008-5#1)
in collagen##6##2##(1997-7#1)(2008-5#3)(2008-7#1)(2009-8#1)
in collections of##2##3##(2008-10#1)(2008-7#1)
in collections##4##2##(2008-10#3)(2008-7#1)
in college students##3##3##(2008-4#1)(2012-2#1)(2013-8#1)
in college##7##2##(2008-11#2)(2008-4#1)(2012-2#2)(2013-1#1)(2013-8#1)
in college-age individuals##2##3##(2009-3#2)
in colon cancer##3##3##(1995-12#1)(2007-8#1)(2008-5#1)
in colon##6##2##(1995-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)
in colonic##2##2##(1992-6#1)(1994-2#1)
in colonies##2##2##(2008-8#1)(2008-9#1)
in colonization and infection##2##4##(2008-10#1)(2008-5#1)
in colonization##5##2##(2008-10#3)(2008-5#1)(2008-9#1)
in colony morphology##2##3##(2008-11#1)(2013-1#1)
in color##6##2##(2008-10#3)(2008-6#1)(2010-1#1)(2011-1#1)
in colorectal cancer##11##3##(1990-2#1)(1991-12#1)(1991-3#1)(1994-2#1)(1997-4#1)(2008-10#2)(2009-9#1)(2012-3#2)(2013-1#1)
in colorectal surgery##2##3##(1992-9#1)(2013-1#1)
in colorectal##18##2##(1990-2#1)(1991-12#2)(1991-3#1)(1992-5#1)(1992-9#1)(1994-2#1)(1995-9#1)(1997-4#1)(2008-10#3)(2009-9#1)(2010-12#1)(2012-3#2)(2013-1#2)
in colostrum##2##2##(1991-11#1)(2012-2#1)
in column##2##2##(2008-10#2)
in coma##2##2##(1991-12#1)(2011-1#1)
in combating##2##2##(2008-1#1)(2012-2#1)
in combination for the##2##4##(1997-2#1)(2009-12#1)
in combination for##3##3##(1997-2#1)(2008-11#1)(2009-12#1)
in combination in##2##3##(2008-10#1)(2008-12#1)
in combination to the##2##4##(2008-10#2)
in combination to##6##3##(2008-10#4)(2008-9#1)(2010-11#1)
in combination with DNA##2##4##(2008-9#1)(2010-7#1)
in combination with a dissolved oxygen probe##2##7##(2008-10#2)
in combination with a##19##4##(1994-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
in combination with an##2##4##(2008-3#1)(2008-9#1)
in combination with measurements##2##4##(2008-10#1)(2008-9#1)
in combination with other##4##4##(1994-9#1)(1995-2#1)(2008-11#1)(2008-3#1)
in combination with prostanoids##2##4##(2010-10#2)
in combination with the##12##4##(1992-1#1)(1994-2#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
in combination with##128##3##(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-6#1)(2008-10#44)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-3#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#1)
in combination##163##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-6#1)(2008-10#55)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#4)(2008-7#4)(2008-8#4)(2008-9#6)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#4)(2012-3#5)(2012-6#1)(2013-1#6)(2013-8#1)
in combinations##3##2##(2008-10#3)
in combined##6##2##(2007-8#1)(2008-10#2)(2008-8#1)(2012-2#2)
in combustion##3##2##(1996-12#1)(2008-2#2)
in coming##3##2##(1996-1#1)(2012-3#1)(2013-8#1)
in commercial citrus plantings##2##4##(2008-10#2)
in commercial fields##3##3##(2008-10#3)
in commercial formulations##3##3##(2008-10#3)
in commercial greenhouses##2##3##(2008-10#2)
in commercial hemodialysis##2##3##(2008-10#2)
in commercial juices##2##3##(2008-10#2)
in commercial orchards##3##3##(2008-10#3)
in commercial pharmaceutical preparations##2##4##(2008-10#2)
in commercial pharmaceutical##3##3##(2008-10#3)
in commercial samples of##2##4##(2008-10#1)(2008-5#1)
in commercial samples##3##3##(2008-10#2)(2008-5#1)
in commercial tablets##2##3##(2008-10#2)
in commercial##56##2##(1990-3#1)(2008-10#50)(2008-5#3)(2008-8#2)
in commercially available##6##3##(2008-10#6)
in committing suicide##2##3##(1993-9#2)
in common bean##7##3##(2008-10#6)(2013-8#1)
in common wheat##4##3##(2008-10#3)(2008-8#1)
in common wheat-Th##2##3##(2008-9#2)
in common with##3##3##(1993-11#1)(2008-10#1)(2008-4#1)
in common##29##2##(1993-11#1)(1996-1#1)(1996-6#1)(1997-3#1)(2008-10#14)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2012-2#1)(2012-3#2)(2013-8#2)
in communicating##4##2##(1993-2#2)(2010-4#1)(2013-8#1)
in communication between##2##3##(2008-9#1)(2009-8#1)
in communication skills##3##3##(1997-3#1)(2012-2#2)
in communication with##2##3##(2008-9#1)(2013-8#1)
in communication##8##2##(1997-3#1)(2008-10#1)(2008-9#2)(2009-8#1)(2012-2#2)(2013-8#1)
in communities##5##2##(1995-6#1)(1997-1#1)(2008-11#1)(2008-9#1)(2010-1#1)
in community and##2##3##(2008-11#2)
in community based##2##3##(1993-12#1)(2013-7#1)
in community health##3##3##(1995-1#1)(1996-1#2)
in community pharmacies##2##3##(2008-11#2)
in community structure##2##3##(2008-9#2)
in community##22##2##(1990-6#1)(1990-9#1)(1993-12#1)(1995-1#1)(1996-1#2)(2008-11#4)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
in community-based##2##2##(2009-4#1)(2013-1#1)
in community-dwelling elders in Korea##2##5##(2010-4#2)
in community-dwelling elders##3##3##(2008-12#1)(2010-4#2)
in compact islets##2##3##(2008-5#2)
in company with##2##3##(2008-11#1)(2008-8#1)
in comparable##2##2##(1990-5#1)(2008-10#1)
in comparative studies##3##3##(2008-10#2)(2008-9#1)
in comparison to other##5##4##(2008-10#2)(2008-11#1)(2008-2#1)(2013-8#1)
in comparison to that in##2##5##(2008-8#1)(2013-7#1)
in comparison to that##5##4##(2008-5#1)(2008-8#1)(2012-3#2)(2013-7#1)
in comparison to the control##2##5##(2008-12#1)(2009-12#1)
in comparison to the other##2##5##(2008-10#2)
in comparison to the##24##4##(1990-9#1)(1994-3#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-5#1)(2009-12#1)(2012-2#1)(2013-1#2)
in comparison to their##3##4##(2008-10#1)(2008-12#1)(2009-7#1)
in comparison to those of##2##5##(2008-10#2)
in comparison to those##4##4##(2008-10#3)(2013-1#1)
in comparison to##75##3##(1990-12#1)(1990-9#1)(1991-12#1)(1993-2#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#24)(2008-11#10)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
in comparison with baseline##2##4##(1996-6#1)(2013-1#1)
in comparison with conventional##2##4##(2008-10#2)
in comparison with other##6##4##(1996-3#1)(2008-10#3)(2008-11#1)(2010-5#1)
in comparison with that encoded by##2##6##(2008-8#2)
in comparison with that of the##2##6##(2008-12#1)(2008-8#1)
in comparison with that of##5##5##(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)
in comparison with that##9##4##(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#4)(2008-9#1)
in comparison with the control##3##5##(1993-3#2)(2008-12#1)
in comparison with the##27##4##(1991-2#1)(1992-8#1)(1993-2#1)(1993-3#2)(1995-12#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#3)
in comparison with those##2##4##(1995-8#1)(1997-8#1)
in comparison with water control##2##5##(2008-12#2)
in comparison with##104##3##(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-6#1)(1995-12#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#35)(2008-11#11)(2008-12#7)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#7)(2011-3#1)(2012-2#1)(2012-5#1)(2013-1#3)
in comparison##182##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-3#1)(1995-12#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#60)(2008-11#21)(2008-12#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#7)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#9)(2011-3#1)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
in comparisons##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
in compatible##2##2##(2008-10#2)
in compensatory##2##2##(1995-6#1)(2010-11#1)
in competing##2##2##(2008-10#1)(2008-8#1)
in competition with##3##3##(2008-10#2)(2008-12#1)
in competition##9##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#2)(2012-2#1)
in competitive ability##2##3##(2008-8#1)(2008-9#1)
in competitive##6##2##(1997-4#1)(2008-8#4)(2008-9#1)
in complementary##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
in complete Freund's adjuvant##2##4##(1995-12#1)(2008-4#1)
in complete absence of##2##4##(1995-6#1)(1995-8#1)
in complete visual##2##3##(2011-2#2)
in complete##16##2##(1991-8#1)(1992-12#1)(1993-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)
in complex environmental matrices##2##4##(2008-10#2)
in complex matrices by##3##4##(2008-10#2)(2008-5#1)
in complex matrices such as##2##5##(2008-10#2)
in complex matrices##15##3##(2008-10#13)(2008-5#2)
in complex mixtures##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
in complex sample##2##3##(2008-10#2)
in complex samples##3##3##(2008-10#3)
in complex ways##2##3##(2008-10#1)(2013-8#1)
in complex with##3##3##(2009-7#3)
in complex##52##2##(1992-6#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-7#3)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in compliance with##4##3##(1991-12#1)(2008-10#2)(2010-8#1)
in complicated##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
in complications##3##2##(2008-5#1)(2008-7#1)(2012-3#1)
in composite PEO-based polymer electrolytes by##2##6##(2008-10#2)
in composite##7##2##(1990-9#1)(2008-10#5)(2011-2#1)
in composites##2##2##(2008-10#1)(2013-1#1)
in composition##7##2##(2008-10#4)(2008-11#1)(2012-8#1)(2013-8#1)
in compost##3##2##(2008-10#3)
in compounds##2##2##(1994-3#1)(1994-8#1)
in comprehensive##2##2##(2008-10#1)(2008-12#1)
in computational##3##2##(2010-10#1)(2012-2#1)(2013-1#1)
in computer##6##2##(1995-3#1)(1996-12#1)(2008-10#1)(2008-6#1)(2010-12#2)
in computing##3##2##(1994-1#1)(1996-2#1)(2008-10#1)
in concentrated nitric acid##2##4##(2008-10#2)
in concentrated##11##2##(2008-10#10)(2008-11#1)
in concentration range of##2##4##(2008-10#2)
in concentration ranges##3##3##(2008-10#3)
in concentration##11##2##(1995-3#1)(2008-10#7)(2008-11#2)(2008-3#1)
in concentrations between##2##3##(1992-12#1)(2008-11#1)
in concentrations of##5##3##(1992-3#1)(2008-10#2)(2008-7#1)(2009-8#1)
in concentrations ranging from##5##4##(1997-8#1)(2008-10#4)
in concentrations##18##2##(1992-12#1)(1992-3#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-7#1)(2009-8#1)
in concert to##2##3##(2011-2#1)(2011-3#1)
in concert with the##2##4##(2008-11#1)(2010-7#1)
in concert with##10##3##(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2012-2#2)
in concert##14##2##(1995-12#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)
in concordance##2##2##(2008-12#1)(2013-1#1)
in conditioned##2##2##(2008-11#2)
in conditions of low##2##4##(2008-10#1)(2011-2#1)
in conditions of##6##3##(2008-10#1)(2010-9#1)(2011-2#2)(2012-3#2)
in conditions such as##2##4##(2011-2#1)(2013-1#1)
in conditions##13##2##(1992-9#1)(1993-6#1)(1994-9#1)(2008-10#2)(2008-7#1)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#1)
in conducting##8##2##(1994-3#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-9#1)(2012-3#1)
in conductivity##2##2##(2008-10#2)
in conferring##3##2##(2008-10#1)(2010-8#1)(2011-1#1)
in confirming##2##2##(1997-8#1)(2008-12#1)
in conflict with##3##3##(1995-2#1)(2008-3#1)(2011-2#1)
in conflict##4##2##(1995-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
in conformation##2##2##(1993-8#1)(2008-5#1)
in congenital heart disease##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
in congenital heart##4##3##(1990-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
in congenital##7##2##(1990-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-11#1)(2012-3#1)
in congestive heart failure##6##4##(1990-9#1)(1997-8#1)(2008-7#4)
in congruence##2##2##(2010-4#2)
in conidia##4##2##(2008-10#3)(2008-5#1)
in conidial##2##2##(2008-10#2)
in conifer##2##2##(2008-10#2)
in conifers##2##2##(2009-8#2)
in conjunction with a##15##4##(1992-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
in conjunction with an##5##4##(1991-3#1)(1993-12#1)(1996-2#1)(2008-11#1)(2008-3#1)
in conjunction with detailed##2##4##(1990-3#1)(2008-9#1)
in conjunction with the use of##2##6##(1994-3#1)(2008-10#1)
in conjunction with the##17##4##(1994-3#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2013-1#1)
in conjunction with three##2##4##(2008-10#1)(2008-11#1)
in conjunction with##92##3##(1990-3#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#36)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-2#2)(2013-1#1)
in connecting to##2##3##(2008-11#1)(2009-9#1)
in connection with a##2##4##(2008-10#1)(2011-2#1)
in connection with the##5##4##(1990-2#1)(1991-3#1)(2008-10#2)(2008-2#1)
in connection with##14##3##(1990-2#1)(1991-3#1)(1993-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2011-2#1)
in connective tissues and##2##4##(1993-3#1)(2008-11#1)
in consecutive##4##2##(1992-9#1)(1995-2#1)(2008-10#2)
in conservation tillage##2##3##(2008-10#2)
in conservation##3##2##(2008-10#2)(2013-1#1)
in conservation-till than in conventional-till fields in all states except##2##10##(2008-10#2)
in considerable amounts##4##3##(2008-10#4)
in considerable##8##2##(2008-10#7)(2011-2#1)
in consideration of##2##3##(1993-6#1)(2012-3#1)
in considering##3##2##(1996-5#1)(2008-10#1)(2010-10#1)
in constant darkness##2##3##(1994-8#1)(1995-11#1)
in constant##9##2##(1992-9#1)(1994-8#1)(1995-11#1)(2008-10#4)(2008-9#1)(2011-2#1)
in constitutive##2##2##(1991-9#1)(1995-12#1)
in constructing##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
in construction of##2##3##(2008-10#2)
in construction##4##2##(1991-12#1)(1991-2#1)(2008-10#2)
in consultation with##2##3##(1996-5#1)(2008-11#1)
in consultation##3##2##(1993-5#1)(1996-5#1)(2008-11#1)
in consumer##4##2##(1997-3#2)(2008-11#1)(2008-12#1)
in contact with 0##2##4##(2008-10#2)
in contact with a##3##4##(2008-10#2)(2009-5#1)
in contact with the##7##4##(1992-3#1)(1994-5#1)(1997-3#1)(2008-10#2)(2008-5#2)
in contact with##24##3##(1992-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#13)(2008-11#2)(2008-5#2)(2009-5#1)(2010-1#1)
in contact##26##2##(1990-9#1)(1992-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#14)(2008-11#2)(2008-5#2)(2009-5#1)(2010-1#1)
in containers##2##2##(2008-11#1)(2009-7#1)
in containing##2##2##(1992-2#1)(1994-5#1)
in contaminated soil and##2##4##(2008-10#2)
in contaminated soil##3##3##(2008-10#2)(2008-11#1)
in contaminated soils##3##3##(2008-10#2)(2008-12#1)
in contaminated##11##2##(1990-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-3#1)(2011-1#1)
in contemporary healthcare##2##3##(2008-7#1)(2009-8#1)
in contemporary##9##2##(1993-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-8#1)(2011-2#3)
in context with##2##3##(1997-8#1)(2010-11#1)
in context##5##2##(1991-1#1)(1997-1#1)(1997-8#1)(2009-7#1)(2010-11#1)
in continuing care retirement communities##3##5##(1991-2#1)(1994-2#2)
in continuing##4##2##(1991-2#1)(1994-2#2)(2008-8#1)
in continuity of##2##3##(1994-3#1)(2012-12#1)
in continuous culture##5##3##(2008-11#5)
in continuous flow##4##3##(2008-10#3)(2008-7#1)
in continuous growth##2##3##(2008-10#1)(2008-11#1)
in continuous hybridoma cell##2##4##(2008-11#2)
in continuous use##3##3##(2008-10#3)
in continuous##29##2##(2008-1#1)(2008-10#11)(2008-11#10)(2008-12#2)(2008-3#1)(2008-7#4)
in contracting##2##2##(1991-3#1)(1996-2#1)
in contrast to a##2##4##(1992-10#1)(2008-10#1)
in contrast to control##2##4##(2008-10#1)(2008-11#1)
in contrast to controls##2##4##(1996-12#1)(2008-7#1)
in contrast to other##3##4##(1995-6#1)(2008-11#1)(2009-7#1)
in contrast to that##2##4##(2008-10#1)(2009-12#1)
in contrast to the##24##4##(1991-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2011-9#1)(2012-12#1)
in contrast to##69##3##(1990-2#1)(1991-5#3)(1992-10#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#18)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#2)(2011-2#3)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
in contrast with##11##3##(1992-12#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-8#2)(2010-3#1)
in contrast##95##2##(1990-2#1)(1991-1#1)(1991-5#3)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#26)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#8)(2008-9#1)(2009-12#1)(2009-7#2)(2010-3#1)(2010-4#1)(2011-2#3)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
in contributing##2##2##(2008-11#1)(2008-7#1)
in control and##4##3##(1991-12#2)(1993-8#1)(2008-11#1)
in control cells##4##3##(1991-5#1)(1994-6#1)(2010-1#1)(2010-11#1)
in control group##5##3##(1996-3#1)(2008-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
in control mice##3##3##(1997-2#2)(2008-8#1)
in control of the##3##4##(1996-1#1)(1996-2#1)(2009-6#1)
in control of##6##3##(1996-1#1)(1996-2#1)(1997-7#2)(2008-8#1)(2009-6#1)
in control or##2##3##(1991-5#1)(2008-9#1)
in control plants##2##3##(2008-10#2)
in control rats##2##3##(1995-11#1)(2008-10#1)
in control##47##2##(1990-5#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-8#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-7#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
in controlled environment chambers##2##4##(2008-10#2)
in controlled environment##4##3##(2008-10#4)
in controlled##11##2##(1992-5#1)(1995-12#1)(1996-11#1)(1997-4#1)(2008-10#7)
in controlling the##12##3##(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-11#1)(2009-6#1)(2013-1#1)(2013-8#1)
in controlling##43##2##(1991-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-1#2)(1997-5#1)(1997-8#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#4)(2013-8#1)
in controls and##2##3##(1991-12#1)(2011-2#1)
in controls##24##2##(1991-12#2)(1992-11#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-8#1)(2008-10#2)(2008-11#3)(2008-7#2)(2009-6#1)(2011-2#6)(2012-3#1)(2012-7#1)
in conventional tillage##2##3##(2008-10#2)
in conventional##13##2##(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2013-8#1)
in cooked##4##2##(1997-2#1)(2008-10#2)(2010-4#1)
in cooler##4##2##(2008-10#3)(2008-8#1)
in cooperation with the##2##4##(1993-6#1)(2008-10#1)
in cooperation with##6##3##(1993-2#1)(1993-6#1)(2008-10#1)(2010-7#1)(2011-1#1)(2013-1#1)
in cooperative##2##2##(2008-8#2)
in copper##3##2##(2008-10#3)
in copper-sensitive strains##2##3##(2008-10#2)
in coppice##2##2##(2008-10#2)
in coral##2##2##(2008-9#1)(2012-2#1)
in cord blood##4##3##(2008-11#2)(2008-9#2)
in core temperature##3##3##(1992-3#3)
in core##4##2##(1992-3#3)(1997-2#1)
in cores of##2##3##(2008-10#1)(2008-9#1)
in corn kernels##2##3##(2008-10#2)
in corn##8##2##(2008-10#7)(2009-5#1)
in coronary artery bypass##3##4##(2011-2#2)(2012-12#1)
in coronary artery disease##3##4##(2008-11#1)(2008-6#1)(2011-2#1)
in coronary artery##8##3##(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#4)(2012-12#1)
in coronary bypass surgery##2##4##(2012-3#2)
in coronary care units at##2##5##(2007-8#2)
in coronary heart##2##3##(1991-6#1)(1995-12#1)
in coronary##23##2##(1990-8#2)(1991-6#1)(1992-6#1)(1995-12#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#1)
in corpora lutea##2##3##(1995-12#1)(2008-8#1)
in correction of##2##3##(2010-11#1)(2012-2#1)
in correctly##2##2##(2009-9#1)(2010-11#1)
in correlation with##2##3##(2011-2#2)
in correlation##3##2##(2008-10#1)(2011-2#2)
in correspondence##2##2##(1997-4#1)(2008-10#1)
in corresponding##2##2##(1995-2#1)(2008-10#1)
in corrosive##2##2##(2008-10#1)(2008-11#1)
in cortex##4##2##(1993-3#2)(2008-4#1)(2008-8#1)
in cortical and##2##3##(2008-10#1)(2013-8#1)
in cortical bone##2##3##(2008-10#1)(2009-7#1)
in cortical cells##5##3##(1996-2#1)(2008-10#4)
in cortical##15##2##(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-7#1)(2013-8#1)
in cortisol##2##2##(2010-2#1)(2012-2#1)
in cosmetic formulations##6##3##(2008-5#6)
in cosmetic products by##2##4##(2008-5#2)
in cosmetic products##7##3##(2008-10#3)(2008-5#4)
in cosmetic##27##2##(2008-10#8)(2008-5#19)
in cosmetics##15##2##(2008-5#15)
in cost##3##2##(2008-10#1)(2008-11#1)(2009-1#1)
in costly##2##2##(2008-11#1)(2008-8#1)
in costs##5##2##(1996-3#2)(2008-10#1)(2008-11#1)(2008-12#1)
in cotton roots by##2##4##(2008-10#2)
in cotton roots##3##3##(2008-10#3)
in cotton##11##2##(2008-10#8)(2008-8#1)(2008-9#2)
in cotyledons##2##2##(2008-10#1)(2008-8#1)
in cough##3##2##(2008-10#3)
in cough-cold##3##2##(2008-10#3)
in counseling##3##2##(2009-9#1)(2013-1#1)(2013-8#1)
in countries of the##2##4##(2008-10#1)(2011-2#1)
in countries where##3##3##(1990-6#1)(1995-3#1)(2008-11#1)
in countries##8##2##(1990-6#1)(1995-3#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#2)
in couple therapy and relationship education##2##6##(2012-2#2)
in couple therapy##3##3##(2012-2#3)
in couple##4##2##(2008-10#1)(2012-2#3)
in couples##2##2##(2008-11#1)(2010-10#1)
in coupling and##2##3##(2008-10#2)
in coupling phase##4##3##(2008-10#4)
in coupling with##2##3##(2008-10#1)(2008-12#1)
in coupling##11##2##(2008-10#9)(2008-12#1)(2008-9#1)
in course##2##2##(1994-12#1)(2012-12#1)
in courses of##2##3##(1994-12#1)(2013-1#1)
in court##2##2##(1993-12#1)(2008-12#1)
in coverage of##2##3##(1994-8#1)(2008-11#1)
in coverage##4##2##(1994-3#1)(1994-8#1)(2008-11#1)(2011-2#1)
in cow##2##2##(1995-11#1)(2008-10#1)
in cow's milk##2##3##(2008-10#2)
in cow's##3##2##(2008-10#3)
in creating##6##2##(1992-1#1)(1992-11#1)(1994-3#1)(1997-2#1)(2009-3#1)(2012-3#1)
in credentialing##2##2##(1991-12#1)(1995-12#1)
in creeping bentgrass##3##3##(2008-10#3)
in crime##3##2##(1994-12#1)(1996-12#1)(2008-10#1)
in criminal##2##2##(2008-12#2)
in critical ill##2##3##(2012-3#2)
in critical thinking skills between##2##5##(2008-11#2)
in critical##10##2##(1992-3#1)(1996-12#1)(2008-11#4)(2012-3#3)(2013-1#1)
in critically ill patients##7##4##(1991-3#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
in critically ill patients]##2##4##(2009-5#1)(2013-1#1)
in critically ill##12##3##(1991-3#1)(1991-6#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#3)(2013-1#2)
in crop rotation##3##3##(2008-12#3)
in crop##9##2##(2008-10#4)(2008-12#3)(2012-2#2)
in crops##3##2##(2008-10#2)(2008-9#1)
in cross##3##2##(2008-10#3)
in cross-sectional##2##2##(2008-2#1)(2011-2#1)
in crosses of race 2##2##5##(2008-10#2)
in crosses with the##2##4##(2008-10#2)
in crosses with##3##3##(2008-10#3)
in crosses##7##2##(2008-10#7)
in crowded plant populations##2##4##(2008-8#2)
in crowded##4##2##(1996-3#1)(2008-8#2)(2012-3#1)
in crude oil##3##3##(2008-10#3)
in crude##10##2##(1994-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-3#2)(2012-2#1)
in crystal form##2##3##(2008-8#2)
in crystal##4##2##(1994-5#1)(2008-10#1)(2008-8#2)
in crystalline##4##2##(1992-9#1)(2008-10#1)(2008-12#1)(2012-2#1)
in cucumber (Cucumis sativus)##2##4##(2008-10#2)
in cucumber##12##2##(2008-10#12)
in cucurbits##6##2##(2008-10#6)
in cultivar##7##2##(2008-10#7)
in cultivars##2##2##(2008-10#2)
in cultivated##3##2##(1994-11#1)(2008-10#1)(2010-10#1)
in cultivation##2##2##(2008-10#2)
in cultural##3##2##(2008-10#1)(2008-11#2)
in culture and in##2##4##(1993-12#1)(2008-10#1)
in culture and##5##3##(1993-12#1)(1995-8#1)(2008-10#2)(2012-2#1)
in culture as##3##3##(2008-11#2)(2008-9#1)
in culture but##2##3##(1995-6#1)(2008-10#1)
in culture filtrates##2##3##(2008-10#2)
in culture in##2##3##(1995-2#1)(2008-11#1)
in culture media containing##2##4##(2008-10#1)(2013-8#1)
in culture media supplemented with##2##5##(2008-10#2)
in culture media##5##3##(2008-10#3)(2011-2#1)(2013-8#1)
in culture supernatants##2##3##(2008-10#1)(2008-11#1)
in culture##103##2##(1991-2#1)(1993-12#1)(1993-8#2)(1994-3#2)(1995-12#5)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-7#2)(2008-10#25)(2008-11#34)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
in cultured bovine aortic endothelial cells##3##6##(1990-12#2)(1993-8#1)
in cultured cells##7##3##(1990-12#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)
in cultured fibroblasts##2##3##(1993-12#1)(1994-11#1)
in cultured human keratinocytes##3##4##(1994-3#1)(1996-2#2)
in cultured human umbilical vein endothelial cells##3##7##(1997-1#1)(2008-11#2)
in cultured human##13##3##(1990-2#1)(1990-5#1)(1990-6#1)(1993-3#1)(1994-3#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#3)(2008-5#1)
in cultured lymphocytes##2##3##(1990-8#2)
in cultured primary##2##3##(1996-12#1)(2013-1#1)
in cultured rat mesangial cells##3##5##(1992-6#1)(1993-8#1)(1995-11#1)
in cultured rat##6##3##(1992-6#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)
in cultured##60##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-5#2)(1992-6#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#5)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1997-1#2)(2008-10#2)(2008-11#9)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
in cultures and##2##3##(2008-10#1)(2009-12#1)
in cultures of the##2##4##(2008-10#1)(2008-11#1)
in cultures of##5##3##(1994-3#1)(2008-10#1)(2008-11#3)
in cultures##13##2##(1994-3#1)(2008-10#3)(2008-11#5)(2008-7#3)(2009-12#1)
in cumulative##2##2##(2008-10#2)
in curative##2##2##(1993-9#1)(2013-8#1)
in cured meat products##2##4##(2008-10#2)
in curing##2##2##(1991-9#1)(2011-2#1)
in current##13##2##(1990-5#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
in curriculum##2##2##(1993-2#1)(2008-11#1)
in custody##3##2##(2008-1#1)(2010-1#2)
in cutaneous##2##2##(2008-5#2)
in cv##17##2##(2008-10#17)
in cvs##2##2##(2008-10#2)
in cycle##2##2##(1993-12#1)(2008-9#1)
in cyclic AMP##2##3##(1994-2#1)(1995-11#1)
in cyclic voltammetry##2##3##(2008-10#2)
in cyclic##5##2##(1994-2#1)(1995-11#1)(2008-10#3)
in cyclohexane##2##2##(2008-10#2)
in cyst##3##2##(1993-1#1)(1996-3#1)(2008-7#1)
in cystathionine beta-synthase##2##3##(1995-2#2)
in cystic##4##2##(1991-12#1)(1991-2#1)(1997-8#2)
in cystine##2##2##(2008-10#1)(2008-11#1)
in cysts##2##2##(2008-10#1)(2008-7#1)
in cytochrome c##2##3##(1995-2#1)(2008-10#1)
in cytochrome##3##2##(1995-2#1)(2008-10#2)
in cytogenetics##2##2##(2008-9#2)
in cytokinesis##3##2##(2008-11#1)(2009-8#2)
in cytological##2##2##(1990-2#1)(2008-10#1)
in cytology##2##2##(2008-9#1)(2013-8#1)
in cytoplasm##7##2##(1992-6#1)(1993-11#1)(2008-10#1)(2008-8#2)(2009-10#1)(2010-4#1)
in cytoplasmic Ca2+##2##3##(1992-6#1)(1995-11#1)
in cytoplasmic##7##2##(1992-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(2006-6#1)(2008-11#1)
in cytosol##2##2##(1993-3#1)(2008-9#1)
in cytosolic Ca2+##3##3##(1992-4#1)(1994-8#1)(1996-2#1)
in cytosolic##9##2##(1992-4#1)(1994-8#1)(1995-11#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
in cytotoxicity##3##2##(1994-3#1)(2008-11#2)
in d' or arcsine terms##2##5##(1991-2#2)
in daily clinical practice##4##4##(2011-2#3)(2013-8#1)
in daily life##2##3##(2008-11#1)(2009-6#1)
in daily practice##7##3##(1993-11#1)(1997-4#1)(2008-11#3)(2008-6#1)(2012-2#1)
in daily##21##2##(1991-9#1)(1993-11#3)(1994-2#1)(1997-4#1)(2008-10#3)(2008-11#4)(2008-6#1)(2009-1#1)(2009-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
in dairy goats##2##3##(2008-12#1)(2008-9#1)
in dairy##9##2##(1996-3#1)(1996-8#1)(2008-12#1)(2008-9#1)(2012-12#2)(2012-3#3)
in dark##2##2##(2008-10#1)(2008-7#1)
in dark-skinned##2##2##(2008-5#1)(2011-2#1)
in data monitoring##2##3##(1996-6#2)
in data##7##2##(1993-9#1)(1995-2#1)(1995-9#1)(1996-6#2)(2006-6#1)(2013-8#1)
in database##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
in databases##6##2##(1996-12#2)(1996-6#2)(2008-9#1)(2012-3#1)
in day care centres##2##4##(1994-6#2)
in day care##4##3##(1994-6#3)(1997-5#1)
in day##7##2##(1994-6#3)(1997-5#1)(2008-8#1)(2012-3#2)
in daycare##3##2##(2007-12#1)(2008-11#1)(2010-6#1)
in db/db mice##3##3##(2012-3#3)
in db/db##5##2##(2012-3#5)
in de novo##5##3##(1990-7#1)(1994-11#1)(2008-10#1)(2008-11#1)(2010-1#1)
in dead##2##2##(1991-12#1)(2008-10#1)
in deaf##2##2##(2008-9#1)(2012-2#1)
in dealing with##3##3##(1992-1#1)(1992-3#1)(2008-11#1)
in decapods##2##2##(2007-12#2)
in deciding whether##2##3##(2008-10#1)(2008-9#1)
in deciding##5##2##(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)
in decision making for##3##4##(1993-12#1)(2010-2#1)(2011-2#1)
in decision making##5##3##(1992-3#1)(1993-12#1)(2008-12#1)(2010-2#1)(2011-2#1)
in decision##6##2##(1992-3#1)(1993-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-2#1)
in decision-making##2##2##(2008-11#1)(2010-7#1)
in decisions##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
in decomposing leaves##2##3##(2008-10#2)
in decomposing##3##2##(2008-10#3)
in decomposition of##2##3##(2008-3#1)(2013-8#1)
in decomposition##4##2##(2008-11#2)(2008-3#1)(2013-8#1)
in decreased##10##2##(1990-12#1)(1994-6#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
in decreasing order##2##3##(2008-10#1)(2012-2#1)
in decreasing##6##2##(2008-10#3)(2010-10#1)(2012-2#1)(2012-3#1)
in deep sediment cores##2##4##(2013-8#2)
in deep##7##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-8#2)
in deeper##2##2##(1990-6#1)(2008-10#1)
in defects##2##2##(1995-2#1)(2008-6#1)
in defending##2##2##(2008-8#1)(2008-9#1)
in defense against##2##3##(1990-11#1)(2008-10#1)
in defense responses##2##3##(2008-10#2)
in defense##9##2##(1990-11#1)(2007-12#1)(2008-10#4)(2008-9#2)(2010-7#1)
in defined##2##2##(2008-9#1)(2011-1#1)
in defining the##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)
in defining##14##2##(1990-11#1)(1993-6#1)(1996-1#1)(1997-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-1#1)(2012-2#1)
in definitive##3##2##(1991-2#1)(1993-9#1)(2008-9#1)
in degenerative diseases##2##3##(2008-7#1)(2013-1#1)
in degenerative##3##2##(1993-2#1)(2008-7#1)(2013-1#1)
in degradation of##2##3##(1993-8#1)(2008-7#1)
in dehydrated##3##2##(2008-10#1)(2008-9#2)
in deionized water##5##3##(2008-10#2)(2008-3#1)(2009-7#1)(2013-1#1)
in delayed##2##2##(1997-8#1)(2008-10#1)
in delaying##2##2##(2008-10#1)(2010-11#1)
in deletion##2##2##(2008-7#1)(2008-9#1)
in delirium##3##2##(2010-10#2)(2011-2#1)
in delivering##4##2##(1993-2#1)(2008-11#1)(2011-3#1)(2013-1#1)
in delivery of##2##3##(2009-6#1)(2011-2#1)
in delta##2##2##(2013-8#2)
in deltamethrin##2##2##(2008-10#2)
in demand##3##2##(1990-2#1)(1992-2#1)(1994-12#1)
in demented patients##2##3##(2008-7#2)
in demented##4##2##(2008-7#4)
in dementia##10##2##(2008-5#1)(2008-7#4)(2008-8#1)(2013-1#1)(2013-8#3)
in demonstrating the##3##3##(1990-12#1)(1990-2#1)(2008-10#1)
in demonstrating##5##2##(1990-12#1)(1990-2#1)(1992-8#1)(2008-10#1)(2008-5#1)
in denaturing conditions##2##3##(2008-10#1)(2008-12#1)
in dendritic##3##2##(2008-10#2)(2012-2#1)
in denervated neuropil regions##3##4##(1997-3#3)
in denervated neuropil##5##3##(1997-3#5)
in density##4##2##(1995-6#1)(2008-10#1)(2008-8#2)
in dental office was very important##2##6##(2008-1#2)
in dental settings##2##3##(1993-1#1)(2012-2#1)
in dental##10##2##(1993-1#1)(2008-1#4)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
in dentin##2##2##(2011-2#1)(2012-12#1)
in dentistry##7##2##(1990-3#1)(1990-5#1)(1990-9#1)(1993-3#2)(2009-7#1)(2013-1#1)
in dependence of##2##3##(2008-10#2)
in dependence on##2##3##(2008-10#1)(2008-7#1)
in dependence##4##2##(2008-10#3)(2008-7#1)
in depressed adolescents##3##3##(2008-11#3)
in depressed##5##2##(2008-11#3)(2008-7#1)(2009-11#1)
in depression##10##2##(2008-4#2)(2008-6#1)(2010-1#2)(2011-2#1)(2012-3#3)(2013-8#1)
in depressive symptoms and##3##4##(2009-7#2)(2010-4#1)
in depressive symptoms##4##3##(2009-7#2)(2010-4#2)
in depressive##5##2##(2008-10#1)(2009-7#2)(2010-4#2)
in depth in##2##3##(2008-10#1)(2008-11#1)
in depth##8##2##(1992-3#1)(1993-1#1)(2008-10#3)(2008-11#2)(2008-8#1)
in dermal##2##2##(2008-7#1)(2012-2#1)
in describing##4##2##(1991-3#1)(1996-2#1)(2008-10#1)(2010-6#1)
in design and##2##3##(2008-10#1)(2012-3#1)
in design of##3##3##(1995-5#1)(2007-11#1)(2009-7#1)
in design##7##2##(1992-9#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-3#1)
in designing a##4##3##(1994-3#2)(1997-2#1)(2010-12#1)
in designing##14##2##(1994-3#2)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)
in detached flowers##2##3##(2008-10#2)
in detached leaf tissues##3##4##(2008-10#1)(2008-8#2)
in detached leaves##2##3##(2008-10#2)
in detached##8##2##(2008-10#6)(2008-8#2)
in detail a##2##3##(1995-8#1)(2008-10#1)
in detail and##8##3##(2008-1#1)(2008-10#6)(2011-2#1)
in detail are##2##3##(1991-1#1)(1997-6#1)
in detail by using##2##4##(2008-10#2)
in detail by##5##3##(1996-5#1)(2008-10#4)
in detail in the##2##4##(2008-10#1)(2008-4#1)
in detail in this##2##4##(2008-10#1)(2011-2#1)
in detail in##5##3##(2008-10#3)(2008-4#1)(2011-2#1)
in detail the##13##3##(1991-6#1)(1995-5#1)(1996-6#1)(1997-3#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in detail##145##2##(1990-2#1)(1991-1#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#2)(2007-12#2)(2008-1#1)(2008-10#89)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
in details##7##2##(1996-3#1)(2008-10#4)(2008-12#1)(2008-7#1)
in detecting the##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
in detecting##21##2##(1991-3#2)(1992-1#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#3)(2012-3#1)
in detection and##4##3##(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
in detection of##8##3##(1991-3#1)(1994-9#1)(2008-1#1)(2008-10#4)(2012-12#1)
in detection##17##2##(1991-3#1)(1994-9#1)(2008-1#2)(2008-10#9)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
in detergents##3##2##(2008-10#3)
in determination of##15##3##(2008-10#13)(2008-3#1)(2008-8#1)
in determination##16##2##(2008-10#13)(2008-3#1)(2008-7#1)(2008-8#1)
in determining best##2##3##(2008-11#1)(2008-8#1)
in determining the response to##2##5##(2008-6#1)(2008-8#1)
in determining the specificity of the##2##6##(2009-10#1)(2009-8#1)
in determining the##43##3##(1990-8#1)(1991-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-8#1)
in determining whether##3##3##(1993-1#1)(2008-7#1)(2010-10#1)
in determining##86##2##(1990-8#1)(1991-12#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#20)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#12)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in developed countries are##3##4##(1992-6#1)(2009-8#1)(2012-2#1)
in developed countries##20##3##(1992-6#5)(1996-1#1)(2008-11#3)(2008-3#1)(2009-8#1)(2010-7#1)(2011-2#5)(2012-2#3)
in developed##24##2##(1991-3#1)(1992-6#5)(1996-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#3)
in developing a##10##3##(1991-12#1)(1992-1#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#1)(2013-8#2)
in developing and testing##2##4##(1997-3#1)(2009-8#1)
in developing and##7##3##(1991-7#1)(1995-3#1)(1997-2#1)(1997-3#1)(2008-11#1)(2009-8#1)(2012-2#1)
in developing apple fruit##2##4##(2008-9#2)
in developing apple##3##3##(2008-9#3)
in developing bolls##2##3##(2008-10#2)
in developing countries and##2##4##(2010-6#1)(2011-2#1)
in developing countries should##2##4##(1991-8#1)(1993-3#1)
in developing countries##29##3##(1990-12#1)(1991-6#2)(1991-8#1)(1992-5#1)(1993-3#3)(1994-12#1)(1996-3#1)(1997-7#3)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)
in developing effective##2##3##(1997-3#1)(2008-10#1)
in developing new##4##3##(1997-3#1)(2008-10#1)(2011-3#1)(2012-3#1)
in developing professional confidence##2##4##(2008-11#2)
in developing the##7##3##(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-11#1)
in developing##122##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-3#4)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#1)(1997-3#5)(1997-7#4)(2008-1#1)(2008-10#19)(2008-11#14)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
in development and##8##3##(1993-8#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-2#1)
in development of##7##3##(2008-10#1)(2008-8#2)(2010-10#1)(2010-11#1)(2011-2#2)
in development##23##2##(1993-8#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#5)(2012-3#1)(2013-1#1)
in developmental##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
in diabetes may be##2##4##(1993-3#1)(2008-1#1)
in diabetes##26##2##(1993-3#2)(1994-8#2)(2008-1#4)(2008-11#2)(2008-12#2)(2008-7#1)(2009-1#1)(2010-10#4)(2010-7#2)(2011-2#4)(2012-3#1)(2012-5#1)
in diabetic brain##2##3##(1996-2#2)
in diabetic liver##3##3##(1993-3#3)
in diabetic mice##2##3##(1994-11#1)(2011-2#1)
in diabetic patients in##2##4##(2011-2#1)(2012-4#1)
in diabetic patients was##2##4##(2011-2#1)(2012-2#1)
in diabetic patients with##2##4##(1995-2#1)(1997-8#1)
in diabetic patients##23##3##(1990-5#1)(1991-6#1)(1993-2#1)(1994-12#1)(1995-2#1)(1997-8#1)(2008-1#6)(2008-10#1)(2011-2#6)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
in diabetic rats##2##3##(1994-8#1)(2008-12#1)
in diabetic retinopathy##6##3##(1996-8#1)(2010-10#4)(2011-2#1)
in diabetic##55##2##(1990-5#1)(1991-6#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-8#1)(1994-11#2)(1994-12#4)(1994-8#3)(1995-2#1)(1996-2#2)(1996-8#1)(1997-8#1)(2008-1#7)(2008-10#2)(2008-12#1)(2009-11#1)(2010-10#4)(2010-12#1)(2011-2#9)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
in diabetics##4##2##(2008-7#1)(2012-2#3)
in diagnosing lung cancer##2##4##(1991-8#2)
in diagnosing##5##2##(1991-8#2)(2012-2#3)
in diagnosis and##7##3##(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-8#1)
in diagnosis of##5##3##(1996-11#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
in diagnosis##25##2##(1990-12#1)(1991-11#1)(1995-5#1)(1996-11#1)(1997-5#1)(2008-10#3)(2008-12#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-12#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
in diagnostic accuracy##2##3##(1997-8#1)(2012-2#1)
in diagnostic##14##2##(1990-12#1)(1990-2#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)
in diagnostics##4##2##(1997-7#1)(2010-7#1)(2013-1#2)
in dialysis patients in##2##4##(2008-1#1)(2011-2#1)
in dialysis patients##6##3##(2008-1#3)(2011-2#3)
in dialysis##12##2##(1993-6#1)(2008-1#3)(2008-10#4)(2011-2#3)(2013-1#1)
in diameter and##6##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
in diameter in##3##3##(1994-6#1)(2008-10#1)(2008-12#1)
in diameter were##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
in diameter with##2##3##(2008-10#1)(2012-3#1)
in diameter##40##2##(1991-12#1)(1992-2#1)(1994-6#1)(1995-12#4)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
in diameter) and##4##3##(2008-10#3)(2012-3#1)
in diameter) usually##2##3##(2008-10#2)
in diameter) were##2##3##(2008-10#1)(2013-1#1)
in diameter)##14##2##(2008-10#10)(2008-5#2)(2012-3#1)(2013-1#1)
in diastole##2##2##(2013-1#2)
in diastolic blood pressure##2##4##(1990-5#1)(2012-2#1)
in diastolic##3##2##(1990-5#1)(1996-3#1)(2012-2#1)
in dichloromethane##6##2##(2008-10#5)(2008-5#1)
in diesel lubricating oil##2##4##(2008-10#2)
in diesel##3##2##(2008-10#2)(2009-8#1)
in diet##3##2##(2008-10#2)(2009-8#1)
in dietary##5##2##(1990-8#1)(2010-1#1)(2010-6#1)(2012-2#2)
in different age##2##3##(1990-6#1)(2008-9#1)
in different areas of##5##4##(2008-10#3)(2008-11#1)(2013-1#1)
in different areas##8##3##(1992-12#1)(1994-6#1)(2008-10#3)(2008-11#1)(2013-1#2)
in different buffer solutions##2##4##(2008-10#2)
in different cell types##3##4##(1994-11#1)(1995-11#1)(1997-7#1)
in different combinations##2##3##(2008-10#1)(2008-11#1)
in different components of cow milk##2##6##(2008-10#2)
in different concentrations##2##3##(2008-10#1)(2009-7#1)
in different conditions##2##3##(2008-10#1)(2009-7#1)
in different countries to##2##4##(2008-11#2)
in different countries##6##3##(1992-3#1)(2008-11#3)(2010-12#1)(2011-2#1)
in different degrees##3##3##(2008-8#2)(2008-9#1)
in different developmental stages##2##4##(1997-1#1)(1997-6#1)
in different directions##2##3##(2008-11#1)(2008-6#1)
in different environments##8##3##(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
in different experimental##2##3##(2008-11#1)(2009-7#1)
in different fields##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
in different formats##2##3##(2010-10#2)
in different functional states##2##4##(2008-9#2)
in different geographic locations##2##4##(2008-10#1)(2008-9#1)
in different groups##2##3##(2007-12#1)(2008-10#1)
in different hospitals##2##3##(1992-2#1)(2008-1#1)
in different kinds of##4##4##(2008-10#1)(2008-11#1)(2008-9#2)
in different lineages##2##3##(2013-8#2)
in different locations##3##3##(2008-10#3)
in different matrices##5##3##(2008-10#5)
in different organs##2##3##(2008-5#1)(2013-8#1)
in different oxidation states##2##4##(2008-10#2)
in different parts of the Alps##2##6##(2008-11#2)
in different parts of the##7##5##(1990-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2011-1#1)
in different pepper genotypes##2##4##(2008-10#2)
in different physiological##2##3##(2009-8#1)(2011-2#1)
in different populations##2##3##(2008-12#1)(2010-5#1)
in different proportions##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
in different ratios##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
in different regions of##4##4##(2008-10#3)(2013-1#1)
in different samples of natural water##2##6##(2008-10#2)
in different samples of natural##3##5##(2008-10#3)
in different samples of##5##4##(2008-10#5)
in different samples##8##3##(2008-10#8)
in different seasons and hibernating phases##2##6##(2008-8#2)
in different seasons##3##3##(2008-8#2)(2012-2#1)
in different settings##3##3##(2009-10#1)(2009-12#1)(2012-3#1)
in different solvents are reported##2##5##(2008-10#1)(2008-5#1)
in different stages of##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2010-6#1)
in different studies##3##3##(2008-5#1)(2012-2#2)
in different tissues of##4##4##(2008-10#2)(2008-12#2)
in different tissues##7##3##(1993-11#1)(2008-10#2)(2008-12#2)(2009-8#1)(2013-8#1)
in different trimester##2##3##(2012-3#2)
in different types of##7##4##(2008-10#6)(2008-11#1)
in different water samples##7##4##(2008-10#7)
in different water types##2##4##(2008-10#2)
in different water##10##3##(2008-10#10)
in different ways##6##3##(1990-3#1)(1993-12#1)(2008-10#2)(2009-8#1)(2013-1#1)
in different years##4##3##(2008-10#3)(2008-12#1)
in different##301##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#3)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#135)(2008-11#17)(2008-12#10)(2008-3#2)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#9)(2009-10#4)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#6)(2012-3#4)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#11)
in differential diagnosis of##2##4##(1991-3#1)(2013-1#1)
in differential diagnosis##4##3##(1991-3#1)(1991-8#1)(2012-3#1)(2013-1#1)
in differential pulse##3##3##(2008-10#3)
in differential##10##2##(1991-3#1)(1991-8#1)(2008-10#5)(2012-12#1)(2012-3#1)(2013-1#1)
in differentiated and nondifferentiated##2##4##(1993-8#2)
in differentiated##12##2##(1990-11#1)(1993-8#2)(1994-11#3)(1995-6#2)(2008-8#2)(2011-2#1)(2012-2#1)
in differentiating between##4##3##(1990-2#1)(2011-2#1)(2012-2#2)
in differentiating the##2##3##(2008-10#1)(2009-5#1)
in differentiating##19##2##(1990-2#1)(1994-11#1)(2008-10#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)
in differentiation##6##2##(1990-5#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-7#1)
in differing##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
in difficult##4##2##(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#1)
in diffraction##2##2##(2008-3#2)
in diffuse connective tissue diseases##2##5##(1995-5#2)
in diffuse connective tissue##3##4##(1995-5#3)
in diffuse##7##2##(1995-5#3)(2008-10#1)(2008-3#1)(2009-8#1)(2009-9#1)
in digestion##2##2##(2008-11#1)(2008-7#1)
in digestive##2##2##(2012-3#1)(2013-1#1)
in digests of##2##3##(2008-10#2)
in digital##5##2##(1997-8#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-12#1)
in dilated##2##2##(1993-6#1)(2010-10#1)
in dill (Anethum graveolens L##2##5##(2008-10#2)
in dilute aqueous##3##3##(2008-10#3)
in dilute nitric acid##3##4##(2008-10#3)
in dilute nitric##4##3##(2008-10#4)
in dilute##15##2##(1990-5#1)(1995-6#1)(2008-10#11)(2008-11#1)(2009-8#1)
in diluted##4##2##(2008-10#4)
in dimension##2##2##(2008-10#1)(2012-2#1)
in dimethyl sulfoxide (DMSO)##2##4##(2008-10#2)
in dimethylformamide##4##2##(2008-10#4)
in diode-end-pumped##2##2##(2008-2#2)
in diphthamide biosynthesis##2##3##(1993-9#2)
in diploid##2##2##(1996-6#1)(2008-12#1)
in diplopods##2##2##(2007-12#2)
in direct contact with the##3##5##(2007-12#1)(2008-10#2)
in direct contact with##4##4##(2007-12#1)(2008-10#2)(2011-2#1)
in direct relation to the##2##5##(2008-9#1)(2009-8#1)
in direct relation to##3##4##(1993-9#1)(2008-9#1)(2009-8#1)
in direct##16##2##(1990-6#1)(1993-6#1)(1993-9#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
in directing the##3##3##(1992-1#1)(1995-6#1)(2008-7#1)
in directing##4##2##(1992-1#1)(1994-5#1)(1995-6#1)(2008-7#1)
in direction##3##2##(2008-10#2)(2008-8#1)
in disagreement with##2##3##(1991-2#1)(2010-10#1)
in discovering##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
in discrete##8##2##(1991-7#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)
in discriminating between##2##3##(2008-10#1)(2008-7#1)
in discriminating##4##2##(2008-10#3)(2008-7#1)
in discussing##3##2##(1991-1#1)(2008-11#1)(2010-4#1)
in discussions of##4##3##(1996-2#1)(2008-12#1)(2008-3#1)(2008-9#1)
in discussions##6##2##(1996-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-4#1)
in disease control##3##3##(2008-10#3)
in disease development##2##3##(2008-10#2)
in disease incidence among##3##4##(2008-10#3)
in disease incidence and##2##4##(2008-10#2)
in disease incidence##9##3##(1997-3#1)(2008-10#8)
in disease management##4##3##(2008-10#4)
in disease phenotypes##2##3##(2008-10#1)(2008-9#1)
in disease prevalence##2##3##(2008-10#2)
in disease resistance and##2##4##(2008-10#1)(2009-8#1)
in disease resistance##5##3##(2008-10#4)(2009-8#1)
in disease severity##13##3##(2008-10#13)
in disease suppression##2##3##(2008-10#2)
in disease##67##2##(1991-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#53)(2008-11#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#1)
in diseased plants##2##3##(2008-10#2)
in diseased##9##2##(2008-10#9)
in diseases##5##2##(2008-4#1)(2010-8#1)(2012-2#2)(2013-1#1)
in disordered##2##2##(2010-8#1)(2012-2#1)
in disorders of the##2##4##(2008-7#1)(2011-2#1)
in dispersal##2##2##(2008-8#2)
in disseminated##2##2##(1990-8#2)
in disseminating##3##2##(2008-10#2)(2012-12#1)
in dissociated##3##2##(1996-12#1)(1996-2#2)
in dissolution studies##2##3##(2008-10#2)
in dissolution##3##2##(2008-10#2)(2012-2#1)
in distal radius##2##3##(2011-2#2)
in distal##8##2##(2008-11#1)(2010-11#1)(2010-12#1)(2011-2#4)(2013-1#1)
in distance education##2##3##(2012-3#2)
in distilled water##8##3##(2008-10#4)(2008-5#3)(2013-1#1)
in distilled##9##2##(2008-10#5)(2008-5#3)(2013-1#1)
in distinct##6##2##(1990-8#1)(1995-2#1)(1996-6#1)(2008-10#2)(2011-2#1)
in distinctive##2##2##(2008-9#1)(2011-2#1)
in distinguishing##7##2##(1994-12#1)(1995-5#1)(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
in distributed environments##2##3##(2010-8#2)
in distributed##3##2##(2007-12#1)(2010-8#2)
in distribution##2##2##(1993-2#1)(2008-7#1)
in district##2##2##(2013-8#2)
in disturbed habitats##2##3##(2008-8#2)
in divergent light##2##3##(2008-3#2)
in diverse human cancer cell lines##2##6##(2011-2#1)(2012-2#1)
in diverse human##3##3##(2011-2#2)(2012-2#1)
in diverse##18##2##(1995-12#1)(1995-2#2)(2008-10#5)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
in diversity##4##2##(2008-10#2)(2008-8#2)
in dividing cells##2##3##(2008-10#1)(2008-9#1)
in dividing##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
in dodecane##2##2##(1997-2#1)(2008-10#1)
in dogs and##2##3##(1994-8#1)(2012-3#1)
in dogs##15##2##(1991-3#1)(1994-11#1)(1994-8#2)(1995-2#1)(1996-12#1)(1996-6#1)(2008-12#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
in doing so##2##3##(2008-11#1)(2008-9#1)
in doing##4##2##(1995-3#1)(2008-11#1)(2008-9#2)
in domains with higher##2##4##(1996-2#2)
in domains with##3##3##(1996-2#3)
in domains##4##2##(1992-4#1)(1996-2#3)
in domestic homicide cases##3##4##(2011-2#3)
in domestic homicide##4##3##(2011-2#4)
in domestic##9##2##(1994-3#1)(1997-3#1)(2008-10#2)(2010-4#1)(2011-2#4)
in domesticated##2##2##(1996-3#1)(2008-10#1)
in donor##2##2##(2008-10#1)(2011-3#1)
in dopamine cell##2##3##(1994-2#1)(1995-2#1)
in dopamine levels##2##3##(2008-5#1)(2009-8#1)
in dopamine receptor##2##3##(1992-12#1)(1995-2#1)
in dopamine##10##2##(1992-12#1)(1993-6#1)(1994-2#1)(1995-2#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
in dopaminergic neurons##7##3##(1995-11#1)(1996-12#3)(2008-7#3)
in dopaminergic##8##2##(1995-11#1)(1996-12#3)(1996-2#1)(2008-7#3)
in dormant##2##2##(2008-10#1)(2011-2#1)
in dorsal##2##2##(1996-2#1)(2008-11#1)
in dosage form##5##3##(2008-10#4)(2012-2#1)
in dosage forms##5##3##(2008-10#5)
in dosage##10##2##(2008-10#9)(2012-2#1)
in dose##2##2##(2008-11#1)(2011-2#1)
in doses of##2##3##(2008-12#1)(2008-7#1)
in doses##4##2##(2007-11#1)(2008-12#1)(2008-7#1)(2011-3#1)
in dot blot hybridizations##2##4##(2008-10#2)
in dot##4##2##(1990-5#1)(2008-10#2)(2008-8#1)
in double transgenic##2##3##(2008-10#2)
in double##7##2##(1995-6#1)(2008-10#4)(2009-10#1)(2009-12#1)
in doubling##2##2##(2008-11#1)(2011-2#1)
in doubt##2##2##(2011-2#2)
in doubtful##2##2##(2009-5#1)(2012-2#1)
in downstream##2##2##(2008-3#1)(2010-9#1)
in drawing##2##2##(1991-12#1)(2009-8#1)
in dried blood spots##3##4##(1991-2#2)(1992-12#1)
in dried press juice##2##4##(2008-10#2)
in dried##8##2##(1991-2#2)(1992-12#1)(2008-10#5)
in drinking water and##3##4##(2008-10#3)
in drinking water as##2##4##(2008-10#1)(2008-9#1)
in drinking water by##6##4##(2008-10#6)
in drinking water for 27 or 43 weeks##2##8##(2008-9#2)
in drinking water for 27##3##5##(2008-9#3)
in drinking water for##5##4##(2008-5#1)(2008-9#4)
in drinking water has been##3##5##(2008-10#3)
in drinking water is##6##4##(2008-10#6)
in drinking water samples by##3##5##(2008-10#3)
in drinking water samples##4##4##(2008-10#4)
in drinking water with satisfactory results##3##6##(2008-10#3)
in drinking water with##4##4##(2008-10#4)
in drinking water##50##3##(1994-3#1)(2008-10#43)(2008-5#1)(2008-9#5)
in drinking waters##3##3##(2008-10#3)
in drinking##58##2##(1994-3#1)(1996-2#1)(2008-10#50)(2008-5#1)(2008-9#5)
in driving##3##2##(2010-3#1)(2010-4#1)(2012-3#1)
in drought##2##2##(2008-12#2)
in drug abuse research##2##4##(2008-10#1)(2008-2#1)
in drug abuse##4##3##(2008-10#1)(2008-2#1)(2008-6#1)(2009-7#1)
in drug analysis##2##3##(2008-10#2)
in drug development##4##3##(1995-12#1)(2008-10#1)(2010-8#1)(2011-1#1)
in drug discovery##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
in drug formulations##6##3##(2008-10#6)
in drug resistance##5##3##(2008-11#5)
in drug samples##3##3##(2008-10#3)
in drug therapy##2##3##(1997-1#1)(2008-11#1)
in drug use##3##3##(1992-12#1)(2008-1#1)(2011-1#1)
in drug##50##2##(1991-3#1)(1992-12#1)(1992-2#1)(1994-2#2)(1994-5#1)(1995-12#1)(1997-1#3)(2008-1#1)(2008-10#16)(2008-11#13)(2008-2#1)(2008-6#1)(2009-7#2)(2010-8#2)(2011-1#2)(2013-1#1)(2013-8#1)
in drug-induced##2##2##(1995-6#1)(2008-10#1)
in drugs and##4##3##(2008-10#4)
in drugs##11##2##(2008-10#10)(2010-9#1)
in dry bean##2##3##(2008-10#2)
in dry nitrogen##2##3##(2008-10#2)
in dry skin##3##3##(2008-5#3)
in dry##20##2##(2008-10#15)(2008-2#1)(2008-5#3)(2012-5#1)
in dual##2##2##(2008-10#1)(2008-3#1)
in duodenal ulcer##2##3##(1997-1#2)
in duodenal##3##2##(1992-11#1)(1997-1#2)
in duplicate##3##2##(2008-10#1)(2008-5#2)
in duration##8##2##(1995-8#1)(1996-12#1)(2008-10#3)(2008-11#1)(2011-2#2)
in dust and orange juice##3##5##(2010-5#3)
in dust and##6##3##(2008-10#1)(2010-5#5)
in dust##8##2##(2008-10#1)(2008-11#1)(2010-5#6)
in dye-doped##2##2##(2008-10#1)(2008-3#1)
in dynamic mode##2##3##(2008-10#2)
in dynamic##7##2##(1992-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
in dynamically##2##2##(2008-10#1)(2008-8#1)
in e##2##2##(1996-12#2)
in eIF-5A##2##2##(1994-3#2)
in each State##2##3##(1992-2#1)(1996-3#1)
in each area##2##3##(2008-10#2)
in each brain##2##3##(1996-12#1)(2013-1#1)
in each case##8##3##(1995-2#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2011-2#1)
in each cell##2##3##(2008-10#1)(2013-8#1)
in each comparison)##2##3##(1994-12#2)
in each experiment##2##3##(2008-10#1)(2008-11#1)
in each field##4##3##(2008-10#3)(2009-12#1)
in each fraction##2##3##(2008-10#2)
in each funnel##2##3##(2008-10#2)
in each group were sacrificed##2##5##(2006-6#1)(2008-11#1)
in each group##14##3##(1991-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-1#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#2)
in each group)##3##3##(1994-3#1)(2008-5#1)(2012-2#1)
in each of the four##2##5##(1994-2#1)(2008-10#1)
in each of the three##2##5##(2008-10#1)(2008-8#1)
in each of the##14##4##(1991-3#1)(1994-2#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#1)
in each of these##8##4##(1991-1#1)(1991-5#1)(1992-4#1)(2008-3#2)(2008-4#1)(2009-11#1)(2009-12#1)
in each of three##4##4##(1992-2#1)(1995-8#1)(2008-10#2)
in each of two##3##4##(2008-10#3)
in each of##35##3##(1991-1#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-4#1)(1994-2#1)(1995-8#1)(1996-12#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-12#1)(2011-3#1)
in each orchard##2##3##(2008-10#2)
in each patient##6##3##(1991-3#1)(1991-5#1)(1996-1#1)(1997-3#1)(2008-10#1)(2013-7#1)
in each plot was##3##4##(2008-10#3)
in each plot##4##3##(2008-10#4)
in each population##3##3##(2008-10#2)(2009-8#1)
in each reaction##2##3##(2008-10#2)
in each region##3##3##(1995-3#1)(2008-10#1)(2012-3#1)
in each state##2##3##(1996-2#1)(2008-10#1)
in each strain##2##3##(1993-9#1)(2012-3#1)
in each subunit##3##3##(1990-5#1)(1992-6#1)(1994-5#1)
in each tissue##2##3##(1990-2#1)(2012-2#1)
in each treatment group##2##4##(1992-6#1)(2012-3#1)
in each##189##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-3#3)(1991-5#3)(1991-6#1)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#2)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-9#1)(2006-6#1)(2007-12#1)(2008-10#69)(2008-11#7)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#1)
in ear##2##2##(2008-10#1)(2008-11#1)
in earlier studies##2##3##(2008-10#2)
in earlier##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)
in early adolescence##4##3##(2009-7#2)(2010-1#2)
in early adolescents##2##3##(2008-12#2)
in early adulthood##4##3##(1996-9#1)(2008-11#1)(2009-12#1)(2009-9#1)
in early and##2##3##(2008-10#1)(2012-7#1)
in early childhood##7##3##(2008-11#3)(2008-4#1)(2009-8#1)(2011-1#1)(2011-2#1)
in early detection of prostate cancer in##2##7##(1994-12#1)(1995-9#1)
in early detection of##3##4##(1994-12#1)(1995-9#1)(2009-12#1)
in early embryogenesis##2##3##(1997-8#1)(2008-6#1)
in early embryonic##2##3##(1995-2#1)(2012-3#1)
in early infancy##3##3##(2008-11#1)(2010-11#1)(2010-6#1)
in early juveniles##4##3##(2007-12#4)
in early labor##2##3##(1994-3#2)
in early life##2##3##(2008-7#1)(2012-2#1)
in early modern##2##3##(2008-11#2)
in early onset##2##3##(1996-2#1)(2008-7#1)
in early postoperative period##2##4##(2007-11#1)(2012-3#1)
in early postoperative##3##3##(2007-11#1)(2012-3#2)
in early pregnancy##5##3##(1990-11#2)(1993-12#3)
in early pupae##2##3##(2008-9#2)
in early spring##2##3##(2008-10#1)(2011-2#1)
in early stage of##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
in early stage##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
in early stages##3##3##(2009-1#1)(2010-7#1)(2010-8#1)
in early##106##2##(1990-11#2)(1992-12#1)(1993-12#3)(1993-3#2)(1994-12#1)(1994-3#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-8#2)(2007-11#1)(2007-12#4)(2008-10#7)(2008-11#12)(2008-12#4)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-1#1)(2009-12#2)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#2)(2013-8#1)
in early-stage##2##2##(1995-9#1)(2010-11#1)
in ears##2##2##(2008-10#1)(2012-3#1)
in eastern Canada and##2##4##(2008-10#1)(2009-6#1)
in eastern Germany##2##3##(2008-11#1)(2009-10#1)
in eastern North America##4##4##(2008-10#3)(2008-8#1)
in eastern North##5##3##(2008-10#4)(2008-8#1)
in eastern Washington in##2##4##(2008-10#2)
in eastern Washington##4##3##(2008-10#4)
in eastern##27##2##(1996-6#1)(2008-10#16)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2012-3#1)(2012-5#1)(2013-1#1)
in easy##2##2##(2008-9#1)(2012-2#1)
in eating##3##2##(2010-11#1)(2010-8#1)(2012-2#1)
in eccrine sweat##3##3##(2008-5#3)
in ecological##6##2##(2008-10#1)(2008-8#3)(2008-9#2)
in ecology##5##2##(2008-8#3)(2008-9#1)(2013-8#1)
in economic growth##2##3##(1994-2#2)
in economic##6##2##(1994-2#2)(2008-10#2)(2008-8#1)(2013-1#1)
in ecosystem##2##2##(1990-8#1)(2008-10#1)
in edible oils and seeds##2##5##(2008-10#2)
in edible oils##4##3##(2008-10#4)
in edible##6##2##(2008-10#6)
in education and##2##3##(1990-2#1)(2008-11#1)
in education##14##2##(1990-2#1)(1995-9#1)(1996-6#1)(2008-11#7)(2008-12#3)(2012-2#1)
in educational##2##2##(2008-12#1)(2009-10#1)
in effect in##2##3##(2008-10#1)(2008-11#1)
in effect##12##2##(1992-1#1)(1993-3#1)(1993-8#1)(1994-1#1)(1996-5#1)(2008-10#3)(2008-11#2)(2008-9#1)(2010-4#1)
in effective##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
in effector##2##2##(2008-10#1)(2008-4#1)
in efficacy and##2##3##(2011-2#1)(2013-1#1)
in efficacy##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
in efficient##4##2##(1991-2#1)(2007-12#1)(2010-11#1)(2012-2#1)
in effluent##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
in effluents##3##2##(2008-10#3)
in egg white##2##3##(2008-10#2)
in egg##5##2##(2008-10#5)
in eggs and##4##3##(2008-10#2)(2008-12#2)
in eggs from free range hens##2##6##(2008-10#2)
in eggs##8##2##(2008-10#5)(2008-11#1)(2008-12#2)
in eight dogs##2##3##(1992-5#2)
in eight of##2##3##(2008-10#1)(2008-7#1)
in eight patients##2##3##(1991-6#1)(2008-5#1)
in eight##31##2##(1991-6#1)(1992-11#1)(1992-5#2)(1993-1#1)(1993-2#2)(1994-12#1)(1995-1#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#2)
in ein2-1##3##2##(2008-10#3)
in either a##2##3##(2008-10#2)
in either case the##2##4##(2008-10#1)(2011-1#1)
in either case##4##3##(2008-10#2)(2009-4#1)(2011-1#1)
in either of the##7##4##(1990-11#1)(1991-2#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
in either of these##2##4##(1991-9#1)(2008-10#1)
in either of##10##3##(1990-11#1)(1991-2#1)(1991-9#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-7#1)(2008-8#1)
in either sex##2##3##(1994-2#1)(2008-8#1)
in either strain##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
in either study##2##3##(2008-6#1)(2008-9#1)
in either the##7##3##(1995-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#1)
in either##75##2##(1990-11#2)(1990-2#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#4)(1997-7#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#1)
in elderly donors##3##3##(2011-2#3)
in elderly patients with##6##4##(1990-2#1)(1994-12#1)(2008-7#4)
in elderly patients##19##3##(1990-2#1)(1990-3#1)(1991-11#1)(1994-12#1)(1996-11#1)(1996-2#1)(1997-8#2)(2008-11#1)(2008-7#6)(2009-8#1)(2011-2#2)(2012-3#1)
in elderly people##2##3##(1994-9#1)(2011-2#1)
in elderly persons##2##3##(1990-3#1)(1997-4#1)
in elderly women##2##3##(1991-8#1)(1994-12#1)
in elderly##45##2##(1990-2#1)(1990-3#2)(1991-11#1)(1991-8#1)(1993-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#11)(2009-12#1)(2009-8#1)(2011-2#11)(2012-12#1)(2012-3#1)
in elective and##3##3##(1990-11#1)(1991-3#1)(2010-8#1)
in elective##4##2##(1990-11#2)(1991-3#1)(2010-8#1)
in electric##2##2##(2008-10#1)(2009-8#1)
in electrical##3##2##(1994-5#1)(2008-5#2)
in electrically insulating oil##2##4##(2009-5#2)
in electrically##4##2##(1992-8#1)(2009-5#2)(2010-7#1)
in electrochemical##5##2##(2008-10#3)(2010-11#1)(2013-1#1)
in electrochemically##3##2##(2008-10#3)
in electrode##3##2##(2008-10#1)(2008-9#2)
in electrolyte leakage##4##3##(2008-10#4)
in electrolyte##9##2##(2008-10#9)
in electrolytic manganese##2##3##(2008-10#2)
in electron transfer##2##3##(2008-5#1)(2008-8#1)
in electron##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
in electronic health##2##3##(2010-8#2)
in electronic##4##2##(2008-10#2)(2010-8#2)
in electronics##2##2##(2008-10#1)(2008-7#1)
in electrophoresis##2##2##(2008-10#1)(2008-5#1)
in electrophoretic##2##2##(1992-8#1)(2008-10#1)
in electroplating##4##2##(2008-10#4)
in electrothermal atomic absorption##2##4##(2008-10#2)
in electrothermal##3##2##(2008-10#3)
in elemental analysis##2##3##(2008-10#2)
in eliciting##4##2##(1995-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
in eliminating##4##2##(2008-10#2)(2008-9#1)(2010-5#1)
in elimination of##2##3##(2008-10#2)
in elimination##3##2##(2008-10#3)
in elite##4##2##(1996-8#1)(2008-10#1)(2009-1#1)(2010-1#1)
in elliptical cylinder coordinates##2##4##(2008-3#2)
in eloquent areas##3##3##(1996-3#1)(2008-7#1)(2012-3#1)
in eluates##3##2##(2008-10#3)
in elucidating##2##2##(2009-7#2)
in elution##2##2##(1990-11#1)(2008-10#1)
in embryo##4##2##(1990-3#1)(1994-8#1)(1995-11#1)(2008-11#1)
in embryonic lethality##2##3##(1995-2#1)(2008-9#1)
in embryonic stem cells##4##4##(1995-2#1)(1997-8#1)(2008-11#1)(2008-4#1)
in embryonic stem##6##3##(1995-2#1)(1997-8#2)(2008-11#2)(2008-4#1)
in embryonic##18##2##(1994-11#1)(1995-2#2)(1996-12#1)(1997-8#2)(2008-11#4)(2008-4#1)(2008-8#2)(2008-9#2)(2010-7#1)(2012-3#1)(2013-1#1)
in embryos and##2##3##(2008-10#1)(2008-6#1)
in embryos of##2##3##(1997-7#1)(2008-10#1)
in embryos##9##2##(1993-12#1)(1993-2#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)
in emergencies##2##2##(2011-1#1)(2013-1#1)
in emergency departments and##2##4##(2008-11#1)(2013-8#1)
in emergency departments##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
in emergency nursing##4##3##(2008-11#2)(2013-1#2)
in emergency surgery##4##3##(1991-3#2)(1992-9#2)
in emergency##24##2##(1991-3#3)(1992-9#2)(1993-2#1)(1994-1#1)(1994-9#1)(2008-11#3)(2008-7#2)(2009-6#4)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
in emergent literacy##2##3##(2011-2#2)
in emerging##2##2##(2010-7#1)(2012-3#1)
in emission##2##2##(2008-10#2)
in emissions and working areas##3##5##(2008-10#3)
in emotion-focused##2##2##(1991-1#1)(2008-1#1)
in emotional##3##2##(1996-5#1)(2008-11#1)(2013-8#1)
in empirical##2##2##(2010-8#1)(2011-2#1)
in employees##2##2##(1991-12#1)(2009-10#1)
in employing##2##2##(2008-10#1)(2008-11#1)
in employment##2##2##(1993-1#1)(1996-2#1)
in encouraging##2##2##(1994-12#1)(2008-11#1)
in end of life care##2##5##(2008-12#1)(2010-10#1)
in end##3##2##(1996-3#1)(2008-12#1)(2010-10#1)
in end-of-life##4##2##(2009-11#1)(2010-10#1)(2010-4#2)
in endemic regions##2##3##(2010-12#1)(2012-3#1)
in endemic##3##2##(1996-11#1)(2010-12#1)(2012-3#1)
in endocrine##4##2##(1990-11#1)(1990-3#1)(1994-11#1)(2012-12#1)
in endocrinology##3##2##(2008-4#1)(2013-1#2)
in endocytosis##2##2##(1995-6#1)(2009-8#1)
in endogenous##4##2##(1995-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
in endometrial##2##2##(2011-2#2)
in endometriosis cells##2##3##(1995-12#2)
in endoplasmic reticulum##2##3##(1995-3#1)(2008-8#1)
in endoscopic surgery##2##3##(2011-2#1)(2013-1#1)
in endoscopic##4##2##(2009-8#1)(2011-2#1)(2013-1#2)
in endosomes##4##2##(1995-6#4)
in endosperm##2##2##(2008-9#1)(2009-10#1)
in endothelial cells##5##3##(1992-10#1)(1994-6#1)(2008-9#1)(2012-2#2)
in endothelial##8##2##(1992-10#1)(1994-6#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-2#2)(2013-8#1)
in endothelium##2##2##(1993-8#2)
in endovascular##2##2##(2008-7#1)(2009-9#1)
in endurance capacity##3##3##(1991-8#2)(2013-8#1)
in endurance##5##2##(1991-8#2)(2010-1#1)(2013-1#1)(2013-8#1)
in energy than##2##3##(1996-5#1)(2008-8#1)
in energy##9##2##(1993-11#1)(1994-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
in enhanced##6##2##(1992-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)
in enhancement##2##2##(2008-10#1)(2008-9#1)
in enhancing the##4##3##(1997-1#1)(2008-11#1)(2009-12#1)(2010-12#1)
in enhancing their##2##3##(1997-1#1)(2008-12#1)
in enhancing##13##2##(1995-2#1)(1997-1#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-1#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
in enlarging##2##2##(2008-10#1)(2013-1#1)
in ensuring that##3##3##(2008-11#1)(2012-12#1)(2012-2#1)
in ensuring##9##2##(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#4)(2012-12#1)(2012-2#1)
in enthalpy##3##2##(1997-2#1)(2008-10#2)
in entorhinal cortex##3##3##(1992-1#1)(1994-2#1)(2008-11#1)
in environment and##2##3##(1996-2#1)(2008-10#1)
in environment##3##2##(1996-2#1)(2008-10#2)
in environmental analysis##4##3##(2008-10#3)(2008-11#1)
in environmental and biological samples##11##5##(2008-10#11)
in environmental and biological##12##4##(2008-10#12)
in environmental and food##2##4##(2008-10#1)(2010-5#1)
in environmental and##21##3##(2008-10#18)(2008-11#1)(2009-8#1)(2010-5#1)
in environmental conditions##2##3##(2008-4#1)(2008-9#1)
in environmental matrices##5##3##(2008-10#4)(2008-11#1)
in environmental samples by graphite furnace atomic absorption spectrometry after##2##10##(2008-10#2)
in environmental samples by##5##4##(2008-10#5)
in environmental samples using##2##4##(2008-10#2)
in environmental samples##39##3##(2008-10#38)(2011-2#1)
in environmental solid samples##2##4##(2008-10#2)
in environmental water samples##6##4##(2008-10#6)
in environmental water##7##3##(2008-10#7)
in environmental waters##5##3##(2008-10#5)
in environmental##102##2##(2008-10#87)(2008-11#4)(2008-4#1)(2008-8#3)(2008-9#1)(2009-8#3)(2010-5#1)(2010-8#1)(2011-2#1)
in enzymatic##3##2##(2008-10#1)(2009-6#1)(2011-2#1)
in enzyme##4##2##(1992-9#1)(2008-10#2)(2008-5#1)
in enzymes##2##2##(2012-2#2)
in epidemics##2##2##(2008-10#2)
in epidemiologic studies##3##3##(1991-12#1)(2010-5#1)(2013-8#1)
in epidemiological data##3##3##(2008-7#3)
in epidemiological studies##2##3##(2008-10#1)(2008-12#1)
in epidemiological##6##2##(2008-10#2)(2008-12#1)(2008-7#3)
in epidemiology and##2##3##(1997-1#1)(2011-2#1)
in epidemiology##4##2##(1997-1#1)(2008-10#1)(2010-4#1)(2011-2#1)
in epidermal and##2##3##(2008-10#1)(2008-9#1)
in epidermal cell walls##2##4##(2008-10#2)
in epidermal cell##3##3##(1993-12#1)(2008-10#2)
in epidermal cells##5##3##(2008-10#5)
in epidermal##10##2##(1993-12#1)(2008-10#8)(2008-9#1)
in epithelial cells of##2##4##(1994-2#1)(2008-10#1)
in epithelial cells##6##3##(1990-11#1)(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
in epoxy##2##2##(2008-10#2)
in equal amounts##3##3##(2008-10#1)(2008-11#2)
in equal##9##2##(2008-10#6)(2008-11#2)(2013-1#1)
in equilibrium##4##2##(1992-3#1)(2008-10#2)(2012-2#1)
in equine urine##2##3##(2008-10#2)
in equine##3##2##(2008-10#3)
in eradicating##2##2##(2008-8#1)(2011-2#1)
in erosive OLP##3##3##(2013-1#3)
in error##5##2##(2008-9#1)(2009-11#1)(2010-1#1)(2011-1#2)
in erythrocyte membranes##2##3##(1992-9#1)(2009-8#1)
in erythrocyte##7##2##(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(2008-7#1)(2008-9#1)(2009-8#1)
in erythrocytes and##2##3##(1991-2#1)(1995-8#1)
in erythrocytes is##2##3##(1993-6#2)
in erythrocytes##12##2##(1990-2#1)(1991-2#1)(1991-5#1)(1993-6#2)(1995-8#1)(2008-10#3)(2008-11#2)(2013-1#1)
in erythroid##3##2##(1991-5#1)(2008-9#2)
in essence##2##2##(2008-10#1)(2008-6#1)
in essential hypertension##3##3##(2009-1#1)(2010-4#2)
in essential##8##2##(2008-10#2)(2008-7#1)(2008-9#1)(2009-1#1)(2010-4#2)(2013-1#1)
in essentially##2##2##(2008-10#1)(2009-10#1)
in establishing a##3##3##(2008-11#2)(2013-8#1)
in establishing the##2##3##(1992-2#1)(2010-9#1)
in establishing##13##2##(1992-2#1)(1993-6#1)(1995-3#1)(1996-6#1)(1997-1#2)(1997-3#1)(2008-10#1)(2008-11#3)(2010-9#1)(2013-8#1)
in estimated##3##2##(2008-10#2)(2011-2#1)
in estimates##2##2##(2008-9#1)(2010-11#1)
in estimating the##6##3##(1991-11#1)(1992-3#1)(2008-10#1)(2008-3#2)(2011-2#1)
in estimating##8##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-3#3)(2010-1#1)(2011-2#1)
in estrogen receptor##2##3##(1990-12#1)(1990-5#1)
in estrogen responsive##2##3##(2008-10#1)(2011-2#1)
in estrogen##7##2##(1990-12#1)(1990-5#1)(2008-10#1)(2008-11#2)(2011-2#2)
in estuarine and coastal waters##2##5##(2008-10#2)
in estuarine and##4##3##(2008-10#4)
in estuarine sediments##2##3##(2008-10#2)
in estuarine waters##5##3##(2008-10#5)
in estuarine##11##2##(2008-10#11)
in ethanol fuel##2##3##(2008-10#2)
in ethanol reinforcement##2##3##(2009-7#2)
in ethanol##16##2##(2008-10#7)(2008-11#1)(2008-9#4)(2009-12#1)(2009-7#2)(2012-3#1)
in ethanol-water##3##2##(2008-10#1)(2013-1#2)
in ethanolic##3##2##(2008-10#3)
in ethics##2##2##(1996-8#1)(2013-8#1)
in ethnic##2##2##(2009-7#2)
in ethnically diverse##2##3##(2008-12#1)(2010-1#1)
in ethnically heterogeneous classes##2##4##(2010-1#2)
in ethnically##4##2##(2008-12#1)(2010-1#3)
in ethyl##2##2##(2008-10#2)
in ethylene glycol##2##3##(2008-10#1)(2008-3#1)
in ethylene##3##2##(2008-10#1)(2008-3#2)
in ethylene-insensitive##2##2##(2008-10#2)
in etiology##2##2##(2008-12#1)(2012-2#1)
in eukaryotes##9##2##(1993-12#1)(1997-2#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2012-2#3)
in eukaryotic cells##5##3##(1993-9#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
in eukaryotic genomes##3##3##(1996-2#1)(2008-9#1)(2010-5#1)
in eukaryotic##14##2##(1993-8#1)(1993-9#1)(1994-12#1)(1996-2#1)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#2)(2010-5#1)(2011-2#1)(2013-1#1)
in eusocial##3##2##(2008-8#3)
in evaluating the clinical##2##4##(1993-12#1)(2011-2#1)
in evaluating the##5##3##(1993-12#1)(2008-10#2)(2011-2#2)
in evaluating##16##2##(1991-12#1)(1993-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#4)
in evaluation of##3##3##(2008-7#1)(2008-9#1)(2011-1#1)
in evaluation##6##2##(1990-3#1)(1994-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-3#1)
in evaluations##2##2##(2008-10#1)(2011-2#1)
in every case##3##3##(1992-5#1)(1992-9#1)(1996-3#1)
in every patient##2##3##(1990-3#1)(2008-7#1)
in every##21##2##(1990-3#1)(1992-5#1)(1992-9#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-12#2)(2010-8#2)(2011-2#3)(2012-3#1)(2013-1#1)
in everyday##5##2##(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
in evidence##3##2##(1990-9#1)(1995-8#1)(2008-11#1)
in evolution and##2##3##(2009-8#1)(2010-4#1)
in evolution##8##2##(1993-6#1)(1994-3#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
in evolutionary terms##2##3##(1991-6#1)(2010-5#1)
in evolutionary##5##2##(1991-6#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
in evolving##2##2##(1997-6#1)(1997-7#1)
in ewes##2##2##(1991-8#1)(2010-12#1)
in ex vivo##3##3##(2006-6#1)(2008-5#1)(2013-1#1)
in examining interfering compounds##2##4##(2008-10#2)
in examining##3##2##(2008-10#3)
in excellent agreement with the##5##5##(1990-8#1)(1995-2#1)(2008-10#3)
in excellent agreement with##9##4##(1990-8#1)(1995-2#1)(2007-11#1)(2008-10#5)(2008-3#1)
in excellent agreement##12##3##(1990-8#1)(1995-2#1)(2007-11#1)(2008-10#6)(2008-3#3)
in excellent##18##2##(1990-8#1)(1995-2#1)(1997-6#1)(2007-11#1)(2008-10#8)(2008-3#3)(2008-5#1)(2011-1#1)(2012-3#1)
in excess of 10##3##4##(2008-10#2)(2008-3#1)
in excess of that##2##4##(1996-2#1)(2008-5#1)
in excess of the##2##4##(1993-1#1)(1994-11#1)
in excess of##20##3##(1991-12#1)(1993-1#1)(1994-11#1)(1994-5#2)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-7#1)
in excess##27##2##(1991-12#1)(1991-5#2)(1993-1#1)(1994-11#1)(1994-5#2)(1996-2#1)(1996-3#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-7#1)
in excessive##2##2##(2008-10#2)
in exchange for##2##3##(1993-12#1)(1997-1#1)
in exchange##3##2##(1993-12#1)(1997-1#1)(2008-10#1)
in excised leaf tissues##4##4##(2008-10#4)
in excised leaves##3##3##(2008-10#3)
in excised##10##2##(1994-11#1)(2008-10#8)(2012-8#1)
in excitatory##2##2##(1995-6#2)
in excited##2##2##(2008-10#1)(2009-12#1)
in excitotoxicity##2##2##(1995-12#2)
in exercise##3##2##(1991-6#1)(1991-8#1)(2010-10#1)
in exhaled##2##2##(2008-10#1)(2011-2#1)
in existence for##2##3##(2008-10#1)(2011-2#1)
in existence##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
in existing##4##2##(2008-10#2)(2010-10#1)(2013-1#1)
in exocytosis##2##2##(1995-11#2)
in exogenous##2##2##(2010-10#1)(2012-3#1)
in exon 7##2##3##(2008-7#1)(2009-8#1)
in exon##8##2##(1991-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
in exons 3##2##3##(1994-12#2)
in exons##3##2##(1994-12#3)
in expanding##2##2##(2008-10#1)(2012-3#1)
in expenditures##4##2##(1991-3#1)(1993-12#1)(2008-11#1)(2013-1#1)
in experienced##2##2##(1994-2#1)(2008-9#1)
in experiment 1##3##3##(2008-10#3)
in experiment 2##3##3##(2008-10#3)
in experiment##7##2##(2008-10#6)(2008-8#1)
in experimental and##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
in experimental animal models##3##4##(1992-6#1)(1993-11#1)(1995-5#1)
in experimental animal##5##3##(1991-12#1)(1992-6#1)(1993-11#1)(1995-5#1)(2008-7#1)
in experimental animals##2##3##(2006-6#1)(2008-11#1)
in experimental conditions##3##3##(1991-6#1)(2008-10#1)(2008-9#1)
in experimental models of##2##4##(1996-6#1)(2009-6#1)
in experimental plots##2##3##(2008-10#2)
in experimental populations of##2##4##(1997-7#1)(2008-8#1)
in experimental##36##2##(1991-12#2)(1991-6#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-5#1)(1996-6#1)(1997-7#1)(2006-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
in experiments conducted##2##3##(2008-3#1)(2010-8#1)
in experiments with##2##3##(1992-3#1)(1994-2#1)
in experiments##9##2##(1992-3#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-8#1)(2011-2#1)
in explaining population size##2##4##(2008-8#2)
in explaining##6##2##(1991-2#1)(1997-8#1)(2008-8#2)(2008-9#1)(2009-9#1)
in exploratory##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
in exploring the##2##3##(2008-11#1)(2010-11#1)
in exponentially growing##2##3##(2008-11#1)(2012-3#1)
in exposed##2##2##(1991-12#1)(2008-10#1)
in exposure##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
in expressed##2##2##(2008-10#1)(2012-3#1)
in expression levels##3##3##(2008-11#2)(2008-7#1)
in expression of##9##3##(1993-12#1)(1993-8#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-3#1)
in expression##21##2##(1990-5#1)(1993-12#1)(1993-8#1)(1994-12#1)(1996-12#2)(1996-2#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#3)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
in extant##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
in extension and##2##3##(2008-9#1)(2010-11#1)
in extension##3##2##(1997-2#1)(2008-9#1)(2010-11#1)
in extensive##5##2##(1991-5#1)(1992-3#1)(1996-12#1)(2008-10#2)
in extensively##2##2##(1990-11#1)(2013-8#1)
in external##2##2##(2008-10#1)(2008-9#1)
in extracellular##5##2##(1994-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
in extracted##3##2##(2008-10#3)
in extracting##4##2##(2008-10#3)(2012-2#1)
in extraction##8##2##(2008-10#7)(2012-2#1)
in extracts from##2##3##(2008-10#1)(2011-2#1)
in extracts of infected##3##4##(2008-10#3)
in extracts of##7##3##(1994-8#1)(1995-11#1)(2008-10#4)(2008-11#1)
in extracts##9##2##(1994-8#1)(1995-11#1)(2008-10#5)(2008-11#1)(2011-2#1)
in extravascular lung water##2##4##(1994-8#2)
in extreme##2##2##(2008-10#1)(2008-8#1)
in extremely##4##2##(1990-11#1)(2008-10#1)(2008-9#1)(2010-7#1)
in eye care##2##3##(1992-11#1)(2011-2#1)
in eye##6##2##(1992-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
in fMRI##2##2##(2009-9#1)(2013-8#1)
in facet joints##2##3##(2011-2#1)(2013-8#1)
in facial##4##2##(2008-11#1)(2008-5#2)(2013-1#1)
in facilitating##5##2##(1991-1#1)(1997-1#1)(2008-11#1)(2010-1#1)(2013-8#1)
in fact be##2##3##(1994-5#1)(2011-2#1)
in fact explained by##2##4##(2008-10#1)(2008-9#1)
in fact##28##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-5#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
in factorial greenhouse##2##3##(2008-10#2)
in factorial##3##2##(2008-10#3)
in faculty##2##2##(2008-12#2)
in faecal samples##2##3##(1996-12#2)
in faecal##5##2##(1995-11#1)(1996-12#4)
in faeces##3##2##(1991-11#1)(2008-5#2)
in failure##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
in fall##7##2##(2008-10#5)(2008-9#1)(2010-11#1)
in familial##4##2##(1992-8#1)(1992-9#1)(2010-4#1)(2010-7#1)
in families of##2##3##(2008-10#1)(2008-9#1)
in families with##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
in families##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)
in family and community##2##4##(1993-3#1)(1993-5#1)
in family and##3##3##(1993-3#1)(1993-5#1)(2010-11#1)
in family medicine]##2##3##(1994-9#1)(1996-11#1)
in family practice##2##3##(1996-11#1)(1996-8#1)
in family##15##2##(1993-3#1)(1993-5#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-11#2)(1996-6#1)(1996-8#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-4#1)(2012-2#1)
in far-field##2##2##(2008-3#2)
in farmers##2##2##(1996-12#1)(1996-8#1)
in farms##2##2##(1996-12#1)(2012-3#1)
in fasted##2##2##(1992-12#1)(1994-8#1)
in fasting and postprandial ghrelin levels##2##6##(2011-1#2)
in fasting##5##2##(1991-3#1)(1992-9#1)(2011-1#2)(2012-3#1)
in fat##4##2##(1995-2#2)(1997-8#1)(2008-10#1)
in fatal##2##2##(1995-5#1)(2009-7#1)
in fatigue##4##2##(2008-7#3)(2009-7#1)
in fatty acid##3##3##(1990-5#1)(1996-3#1)(2008-10#1)
in fatty##4##2##(1990-5#1)(1996-3#1)(2008-10#1)(2008-5#1)
in favor of the##4##4##(1991-2#1)(2008-12#1)(2008-7#1)(2008-8#1)
in favor of##15##3##(1991-1#2)(1991-2#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
in favour of SLIT##2##4##(2011-2#2)
in favour of the##2##4##(1991-2#1)(2013-1#1)
in favour of##14##3##(1991-2#1)(1993-3#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-3#1)(2011-2#3)(2013-1#1)
in febrile##2##2##(2008-10#1)(2013-1#1)
in fed rats##2##3##(1992-12#1)(1994-8#1)
in fed-batch##3##2##(2008-11#3)
in fedbatch##2##2##(2008-7#2)
in federal##3##2##(1991-2#1)(2008-10#1)(2012-2#1)
in feed and food##3##4##(2008-10#3)
in feed and##4##3##(2008-10#4)
in feed##6##2##(2008-10#6)
in feeding situation##3##3##(1990-12#3)
in feeds##2##2##(2008-10#2)
in female and male##2##4##(1994-2#1)(2010-8#1)
in female patient##2##3##(2013-1#2)
in female rats##6##3##(1990-11#1)(1994-2#2)(1995-11#1)(1995-12#2)
in female##33##2##(1990-11#1)(1990-6#1)(1991-1#1)(1992-1#1)(1994-12#2)(1994-2#3)(1995-11#1)(1995-12#3)(2007-12#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
in females and##4##3##(1993-8#1)(1994-2#2)(2008-8#1)
in females than in males##2##5##(2008-11#1)(2010-4#1)
in females was##2##3##(1997-7#1)(2008-9#1)
in females##46##2##(1990-12#1)(1991-6#4)(1992-12#1)(1993-8#2)(1994-2#2)(1994-6#3)(1996-3#2)(1997-7#3)(2007-12#1)(2008-11#3)(2008-12#2)(2008-7#4)(2008-8#3)(2008-9#3)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#2)
in females)##2##2##(1991-6#1)(2008-11#1)
in fermentation##2##2##(2008-10#1)(2008-8#1)
in ferric anguibactin##2##3##(2011-2#2)
in fertilisers##2##2##(2008-10#2)
in fertility##3##2##(1995-12#1)(1997-1#2)
in fertilization##2##2##(1994-5#1)(2008-8#1)
in fetal##5##2##(1990-11#1)(1995-12#1)(1995-8#1)(1995-9#1)(2008-11#1)
in fetuses with##2##3##(2008-11#1)(2011-2#1)
in fetuses##5##2##(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#2)
in fibers with polarization mode dispersion##2##6##(2007-12#2)
in fibers with##3##3##(2007-12#2)(2008-3#1)
in fibroblasts from##4##3##(1990-8#1)(1991-7#1)(1994-11#1)(1995-11#1)
in fibroblasts##8##2##(1990-2#1)(1990-8#1)(1991-7#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-8#1)(2012-2#1)
in fibromyalgia##4##2##(1997-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
in field conditions##2##3##(2008-10#2)
in field experiments conducted##3##4##(2008-10#3)
in field experiments from##2##4##(2008-10#2)
in field experiments##11##3##(2008-10#10)(2008-8#1)
in field microplots##4##3##(2008-10#4)
in field plots of##2##4##(2008-10#2)
in field plots##5##3##(2008-10#5)
in field populations of##2##4##(2008-10#1)(2008-9#1)
in field populations##3##3##(2008-10#2)(2008-9#1)
in field samples##4##3##(2008-10#4)
in field soil##4##3##(2008-10#4)
in field studies##3##3##(2008-10#3)
in field trials in##2##4##(2008-10#2)
in field trials##6##3##(2008-10#6)
in field##50##2##(1997-7#1)(2008-10#46)(2008-8#1)(2008-9#2)
in fields as##2##3##(2008-10#1)(2012-2#1)
in fields before##2##3##(2008-10#2)
in fields of##2##3##(1991-6#2)
in fields such as##2##4##(1993-2#1)(2008-12#1)
in fields with##2##3##(2008-10#2)
in fields##18##2##(1991-6#2)(1993-2#1)(2008-10#12)(2008-12#1)(2008-9#1)(2012-2#1)
in fig##2##2##(2008-10#2)
in final cell##2##3##(2008-11#2)
in final##6##2##(2008-10#3)(2008-11#2)(2011-2#1)
in financial and##3##3##(1994-1#2)(1997-3#1)
in financial status##2##3##(2008-11#2)
in financial##5##2##(1994-1#2)(1997-3#1)(2008-11#2)
in finding##5##2##(1992-1#1)(1993-12#1)(1994-3#1)(1995-2#1)(2008-11#1)
in finite##2##2##(2008-3#1)(2013-1#1)
in firing##3##2##(1996-2#1)(2008-11#2)
in first grade##3##3##(2008-12#3)
in first##13##2##(1991-8#1)(1992-1#1)(2007-12#1)(2008-12#3)(2008-6#1)(2010-12#1)(2011-10#1)(2012-3#2)(2013-1#2)
in fiscal##2##2##(1991-12#1)(1997-1#1)
in fish and##3##3##(2008-10#2)(2008-11#1)
in fish cells and fry##2##5##(1992-6#2)
in fish exposed to##2##4##(2010-8#2)
in fish muscle##2##3##(2008-10#2)
in fish samples##3##3##(2008-10#3)
in fish tissues##2##3##(2008-10#1)(2012-12#1)
in fish##38##2##(1991-8#1)(1992-6#3)(1994-11#1)(2008-10#15)(2008-11#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-5#7)(2010-8#2)(2012-12#1)
in fishes and##2##3##(1995-12#1)(2010-8#1)
in fishes##5##2##(1995-12#1)(2008-7#2)(2010-8#1)(2011-2#1)
in fission yeast##4##3##(1993-9#1)(1995-2#2)(2011-2#1)
in fitness components##2##3##(2008-8#1)(2008-9#1)
in fitness##8##2##(2008-8#6)(2008-9#2)
in five cases##5##3##(1991-6#1)(1997-3#2)(1997-8#1)(2013-8#1)
in five different##4##3##(1992-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
in five of six##2##4##(2008-10#2)
in five of the seven##2##5##(1996-6#1)(2008-8#1)
in five of##5##3##(1996-6#1)(2006-6#1)(2008-10#2)(2008-8#1)
in five patients with##3##4##(1990-9#1)(2012-3#1)(2013-1#1)
in five##48##2##(1990-9#1)(1991-6#1)(1992-12#1)(1992-6#1)(1994-1#1)(1995-12#1)(1995-3#2)(1996-6#2)(1997-3#3)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#17)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
in fixed##7##2##(1990-5#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-8#1)(2013-8#1)
in flag leaves in Xieyou##2##5##(2008-9#2)
in flames##3##2##(2008-3#3)
in flasks##4##2##(2008-5#1)(2008-8#1)(2011-2#2)
in flexor##2##2##(2009-11#1)(2012-3#1)
in flies##2##2##(2008-9#1)(2012-3#1)
in flight##3##2##(1991-2#1)(1996-12#1)(2008-3#1)
in floral##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
in flow analysis##7##3##(2008-10#7)
in flow cytometry and##2##4##(2008-9#2)
in flow cytometry##6##3##(1995-8#1)(2008-9#5)
in flow injection analysis system##2##5##(2008-10#2)
in flow injection analysis##8##4##(2008-10#8)
in flow injection mode##2##4##(2008-10#2)
in flow injection##13##3##(2008-10#13)
in flow systems##5##3##(2008-10#5)
in flow##40##2##(1995-3#1)(1995-8#1)(1997-1#2)(2008-10#27)(2008-11#1)(2008-9#8)
in flow-injection analysis##3##3##(2008-10#3)
in flow-injection##4##2##(2008-10#4)
in flower##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)
in flowering plants##2##3##(2008-8#1)(2008-9#1)
in flowers##4##2##(2008-10#4)
in flowing##5##2##(2008-10#4)(2008-11#1)
in fluidity of##2##3##(1991-5#1)(2008-9#1)
in fluorescence intensity##6##3##(1995-11#1)(2008-10#5)
in fluorescence quenching##2##3##(1997-8#1)(2008-10#1)
in fluorescence##14##2##(1994-5#1)(1995-11#1)(1997-8#1)(2006-6#1)(2008-10#9)(2008-11#1)
in fluorescent intensity##2##3##(2008-10#2)
in fluoride##2##2##(1991-6#1)(2008-10#1)
in flux##3##2##(1990-5#1)(1991-3#1)(1995-6#1)
in fly ash##3##3##(2008-10#3)
in fly##4##2##(2008-10#3)(2008-9#1)
in focal##3##2##(1996-11#1)(2008-10#1)(2013-1#1)
in focus##6##2##(1993-12#1)(2008-10#1)(2008-11#3)(2009-7#1)
in focusing##3##2##(1996-6#1)(2008-8#1)(2011-2#1)
in fog-water##3##2##(2008-10#3)
in folding##2##2##(2008-8#2)
in foliar##2##2##(2008-10#1)(2011-10#1)
in follicle cells of##2##4##(2008-7#2)
in follicle cells##3##3##(2008-7#3)
in follicular##5##2##(1990-8#1)(2008-11#1)(2010-11#1)(2010-8#1)(2012-3#1)
in follow up##2##3##(2013-1#1)(2013-8#1)
in follow-up##2##2##(2008-11#1)(2011-2#1)
in food analysis and environmental research##2##6##(2008-10#2)
in food analysis##4##3##(2008-10#4)
in food and feed##4##4##(2008-10#4)
in food and##9##3##(2008-10#5)(2010-5#2)(2010-6#1)(2010-7#1)
in food products##6##3##(2007-12#1)(2008-10#3)(2009-8#1)(2011-2#1)
in food samples##12##3##(2008-10#12)
in food webs##2##3##(2008-9#1)(2012-12#1)
in food##70##2##(1993-6#1)(1994-3#2)(2007-12#1)(2008-10#45)(2008-9#6)(2009-8#1)(2010-5#2)(2010-6#2)(2010-7#4)(2011-2#3)(2012-12#1)(2012-2#2)
in foods by##2##3##(2008-10#2)
in foods rich in##2##4##(1997-8#2)
in foods##23##2##(1994-3#3)(1997-8#2)(2007-12#2)(2008-10#12)(2011-2#3)(2012-2#1)
in foodstuffs##7##2##(2008-10#6)(2011-2#1)
in for##4##2##(1991-2#1)(1992-8#2)(2010-8#1)
in foraging##2##2##(2008-5#1)(2008-9#1)
in forced##3##2##(2012-2#2)(2012-3#1)
in forensic psychiatry##2##3##(2011-2#2)
in forensic##12##2##(1997-8#1)(2008-10#5)(2008-12#2)(2011-2#3)(2012-3#1)
in forest pathology##3##3##(2008-10#3)
in forest trees##2##3##(2008-8#2)
in forest##14##2##(2008-10#6)(2008-11#1)(2008-8#5)(2008-9#1)(2012-3#1)
in forests##4##2##(2008-10#3)(2008-9#1)
in form and##2##3##(1995-2#1)(2008-8#1)
in form of##2##3##(2007-12#1)(2008-10#1)
in form##4##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
in formal##3##2##(1996-6#1)(2008-12#1)(2012-2#1)
in formaldehyde##2##2##(2008-10#2)
in formation of the##2##4##(1992-3#1)(2006-6#1)
in formation of##7##3##(1992-3#1)(1995-2#1)(2006-6#1)(2008-10#3)(2008-9#1)
in formation##8##2##(1992-3#1)(1995-2#1)(2006-6#1)(2008-10#3)(2008-9#2)
in forming##5##2##(1994-11#1)(1997-3#1)(2008-8#1)(2008-9#1)(2010-3#1)
in formulating##4##2##(1994-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
in formulations##7##2##(2008-10#6)(2008-5#1)
in forward##3##2##(2006-6#1)(2008-10#1)(2012-3#1)
in fossil##2##2##(2007-12#1)(2012-9#1)
in foster children##2##3##(2008-12#2)
in foster##4##2##(1995-5#1)(2008-12#2)(2009-9#1)
in fostering##2##2##(1996-3#1)(2008-11#1)
in four Danish counties##2##4##(1997-3#2)
in four Norwegian##2##3##(1991-6#1)(1994-6#1)
in four age groups (4##3##5##(2008-7#3)
in four cases##5##3##(1990-9#1)(1994-12#1)(1997-3#1)(2008-5#1)(2008-7#1)
in four different##10##3##(1990-2#1)(2008-10#8)(2010-10#1)
in four distinct##2##3##(2011-2#1)(2012-2#1)
in four experiments##2##3##(2011-1#1)(2013-8#1)
in four field experiments##2##4##(2008-10#2)
in four groups##2##3##(2008-12#1)(2013-1#1)
in four individuals##2##3##(2008-10#1)(2013-1#1)
in four locations##2##3##(2008-10#1)(2010-12#1)
in four of six##3##4##(2008-5#2)(2008-7#1)
in four of the five##4##5##(1991-6#1)(1995-5#1)(2008-10#2)
in four of##9##3##(1991-6#1)(1995-5#1)(2008-10#4)(2008-5#2)(2008-7#1)
in four oral locations##2##4##(2010-12#2)
in four out of##2##4##(2008-10#1)(2008-5#1)
in four patients##6##3##(1993-1#1)(1997-8#1)(2008-5#2)(2008-7#1)(2008-9#1)
in four sampling##2##3##(2008-10#2)
in four##113##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-6#2)(1991-8#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-2#1)(1995-5#1)(1995-9#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#41)(2008-11#2)(2008-12#4)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#1)(2010-10#1)(2010-12#3)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-3#1)(2013-8#1)
in fourteen##2##2##(2008-7#1)(2011-2#1)
in fractal environments##2##3##(2008-8#2)
in fraction##2##2##(1992-12#1)(2008-10#1)
in fractions##3##2##(1990-5#1)(2008-10#2)
in fragmented landscapes##4##3##(2008-8#2)(2008-9#2)
in fragmented##6##2##(2008-8#2)(2008-9#4)
in frame##4##2##(1996-3#1)(1997-3#1)(1997-9#1)(2008-10#1)
in free space##2##3##(2007-12#1)(2008-3#1)
in free time##2##3##(2011-2#2)
in free##9##2##(1991-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#2)
in freely moving rats##2##4##(1994-8#1)(1997-3#1)
in freely##3##2##(1991-2#1)(1994-8#1)(1997-3#1)
in frequencies of##2##3##(2008-10#2)
in frequency and##2##3##(1990-3#1)(1992-3#1)
in frequency of##7##3##(1993-8#2)(2008-10#3)(2008-11#1)(2011-2#1)
in frequency##20##2##(1990-3#1)(1992-3#1)(1993-8#2)(1997-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)
in fresh and marine waters##2##5##(2008-10#2)
in fresh and##5##3##(2008-10#4)(2008-11#1)
in fresh medium##3##3##(2008-11#3)
in fresh water##4##3##(2008-10#4)
in fresh##24##2##(1997-1#1)(2008-10#15)(2008-11#4)(2008-5#1)(2008-7#1)(2009-6#2)
in freshly collected##3##3##(2008-10#3)
in freshly isolated##2##3##(1995-11#1)(1997-1#1)
in freshly##9##2##(1995-11#1)(1995-8#1)(1997-1#1)(2008-10#5)(2008-7#1)
in freshwater samples##4##3##(2008-10#4)
in freshwater##12##2##(2008-10#9)(2008-5#1)(2012-12#2)
in frog##2##2##(1991-5#1)(1993-3#1)
in front of a##2##4##(1991-6#1)(2008-3#1)
in front of the##6##4##(1997-3#1)(2008-10#3)(2008-11#1)(2009-11#1)
in front of##13##3##(1991-6#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2009-11#1)
in front##14##2##(1991-6#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2009-11#1)(2010-11#1)
in frontal cortex and##2##4##(1994-2#1)(1996-2#1)
in frontal cortex##4##3##(1994-2#1)(1996-2#2)(2008-8#1)
in frontal##5##2##(1994-2#1)(1996-12#1)(1996-2#2)(2008-8#1)
in fruit development##2##3##(2008-10#2)
in fruit juices and##2##4##(2008-10#2)
in fruit juices##7##3##(2008-10#7)
in fruit##21##2##(2008-10#18)(2009-3#1)(2010-4#1)(2011-2#1)
in fruits and##2##3##(2008-12#1)(2013-1#1)
in fruits##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
in fuel alcohol by##2##4##(2008-10#2)
in fuel##3##2##(2008-10#3)
in full##5##2##(1996-12#1)(2007-11#1)(2008-4#1)(2010-5#1)(2011-2#1)
in full-text biomedical articles##2##4##(2010-12#2)
in fully##5##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-6#1)
in fumigated##4##2##(2008-10#4)
in function of storage time and##2##6##(2008-10#2)
in function of time##2##4##(2007-8#1)(2008-10#1)
in function of##7##3##(1991-11#1)(2007-8#1)(2008-1#2)(2008-10#3)
in function##15##2##(1991-11#1)(1994-5#1)(1995-3#1)(1996-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2009-10#1)(2010-10#1)(2010-6#1)
in functional##13##2##(1991-5#1)(1994-1#1)(1997-7#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#2)(2012-12#1)
in fundamental##2##2##(1995-6#1)(2008-5#1)
in funding##2##2##(1995-6#1)(1996-12#1)
in fungal populations##2##3##(2008-10#2)
in fungal##9##2##(2008-10#7)(2008-5#1)(2012-2#1)
in further detail##2##3##(1997-8#1)(2009-8#1)
in further##11##2##(1993-1#1)(1993-8#1)(1997-8#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
in fusarium head blight##2##4##(2008-10#2)
in future investigations##3##3##(2008-5#1)(2009-11#1)(2012-2#1)
in future studies of##4##4##(1995-9#1)(2008-10#1)(2008-9#1)(2013-1#1)
in future studies##6##3##(1995-9#1)(2008-10#2)(2008-9#1)(2009-7#1)(2013-1#1)
in future##29##2##(1992-9#1)(1993-12#1)(1995-12#1)(1995-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
in gaining##2##2##(1991-1#1)(2008-11#1)
in gait##3##2##(2010-9#1)(2012-2#1)(2013-1#1)
in gallbladder##2##2##(1996-6#1)(2008-11#1)
in gallium##3##2##(1990-12#1)(2008-10#2)
in gambling##2##2##(2008-11#2)
in gas phase and particulates##2##5##(2008-10#2)
in gas##9##2##(2007-12#1)(2008-10#6)(2008-3#1)(2013-1#1)
in gaseous samples##4##3##(2008-10#4)
in gaseous##5##2##(2008-10#5)
in gasoline##6##2##(2008-10#6)
in gastric cancer cell##2##4##(2008-9#2)
in gastric cancer##5##3##(1990-2#1)(2008-9#3)(2011-2#1)
in gastric parietal cells##2##4##(1997-1#2)
in gastric units##2##3##(1995-6#2)
in gastric##15##2##(1990-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1995-6#2)(1997-1#2)(2008-11#1)(2008-9#4)(2011-2#1)(2012-3#1)
in gastroenterology##3##2##(1993-12#1)(2012-2#1)(2013-1#1)
in gastrointestinal##5##2##(1991-3#1)(1992-6#1)(2008-8#1)(2010-1#1)(2011-2#1)
in gelatin##2##2##(2008-10#1)(2008-11#1)
in gels##3##2##(2008-10#1)(2008-4#2)
in gene expression are##3##4##(2008-7#1)(2009-8#1)(2010-5#1)
in gene expression for##2##4##(1996-2#1)(1997-2#1)
in gene expression##21##3##(1993-12#1)(1993-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-11#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
in gene pyramiding##2##3##(2008-10#2)
in gene regulation##2##3##(2009-7#1)(2012-3#1)
in gene therapy for##3##4##(2008-8#1)(2010-1#1)(2011-3#1)
in gene therapy##7##3##(1993-6#1)(2008-8#3)(2010-1#2)(2011-3#1)
in gene##43##2##(1993-12#1)(1993-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#6)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-5#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#5)
in general agreement with##2##4##(1993-8#1)(2008-2#1)
in general and##8##3##(1990-9#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-8#1)
in general be##2##3##(1990-8#1)(2008-8#1)
in general health##2##3##(2008-11#1)(2008-8#1)
in general population##2##3##(2008-11#1)(2011-2#1)
in general practice were##2##4##(1991-11#1)(1994-6#1)
in general practice##26##3##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-5#2)(1993-11#1)(1993-2#2)(1993-6#1)(1994-6#4)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1997-4#1)(1997-5#1)(2008-6#1)(2008-7#1)(2012-3#2)
in general practice]##5##3##(1993-2#1)(1994-6#2)(1997-3#1)(1997-8#1)
in general surgery##2##3##(1990-3#1)(1993-2#1)
in general##122##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-6#7)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#2)
in general/family practice##2##3##(1993-11#2)
in generally##2##2##(1996-5#1)(2008-2#1)
in generating##12##2##(1991-5#1)(1994-1#2)(1995-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#1)
in generation##2##2##(1993-3#1)(2008-12#1)
in genes##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
in genetic diversity##3##3##(2008-10#2)(2008-12#1)
in genetic##9##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#1)
in genetically modified (FVB Tg##3##5##(2008-9#3)
in genetically modified [B6##3##4##(2008-9#3)
in genetically modified##6##3##(2008-9#6)
in genetically##9##2##(1993-12#1)(2008-10#1)(2008-9#6)(2011-2#1)
in genetics##2##2##(2008-12#1)(2011-2#1)
in genome size##2##3##(2008-10#1)(2008-8#1)
in genome##7##2##(2008-10#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
in genotype distribution##2##3##(2011-2#2)
in genotype##7##2##(2006-6#1)(2008-10#4)(2011-2#2)
in genotypic##2##2##(2008-10#1)(2012-5#1)
in geographic##2##2##(1992-9#1)(2008-10#1)
in geological samples by flame##2##5##(2008-10#2)
in geological samples by##5##4##(2008-10#5)
in geological samples##8##3##(2008-10#6)(2013-8#2)
in geological##11##2##(2008-10#7)(2013-8#4)
in geriatric medicine##2##3##(1996-3#1)(1997-4#1)
in geriatric patients##2##3##(1990-11#1)(1992-9#1)
in geriatric##8##2##(1990-11#1)(1991-11#1)(1992-9#2)(1994-3#1)(1996-3#1)(1997-4#1)(2009-5#1)
in germinated kernels##3##3##(2008-10#3)
in germinating##3##2##(2008-10#2)(2009-8#1)
in germination##2##2##(2011-2#2)
in gerontology##3##2##(1991-12#1)(1992-1#1)(1994-1#1)
in gestation##2##2##(1995-2#1)(2008-10#1)
in gestational##2##2##(1992-12#2)
in getting##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
in ghana##2##2##(2011-2#2)
in ghrelin##2##2##(2013-8#2)
in giant##5##2##(1991-5#1)(1997-8#1)(2008-10#1)(2008-8#2)
in gill##2##2##(2008-11#1)(2008-7#1)
in ginkgo##2##2##(2008-10#2)
in girls with##5##3##(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
in girls##17##2##(1994-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)
in given##2##2##(2008-11#1)(2011-3#1)
in giving##3##2##(1997-8#1)(2008-11#1)(2013-1#1)
in glass##6##2##(2008-10#6)
in glasses##2##2##(1995-3#1)(2010-8#1)
in glasshouse##3##2##(2008-10#3)
in glaucoma patients##3##3##(2011-2#3)
in glaucoma##4##2##(1990-11#1)(2011-2#3)
in glial cells##2##3##(2009-9#1)(2012-2#1)
in glial##3##2##(2009-9#1)(2012-12#1)(2012-2#1)
in glioblastoma##3##2##(1990-6#1)(2011-2#1)(2012-3#1)
in global##10##2##(1990-12#1)(1995-5#1)(2008-7#2)(2009-6#2)(2009-8#1)(2010-12#1)(2011-2#2)
in glomerular filtration rate##2##4##(1996-6#1)(2011-2#1)
in glomerulonephritis##3##2##(1993-2#3)
in glucagon##2##2##(2011-2#2)
in glucose and##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
in glucose metabolism##2##3##(1996-2#1)(2013-7#1)
in glucose transfer##2##3##(1991-5#2)
in glucose##16##2##(1991-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2010-11#1)(2011-2#2)(2013-7#1)
in glucose-free medium##5##3##(1995-8#5)
in glucose-free##6##2##(1995-8#6)
in glucose-starved Sl cells##2##4##(2008-11#2)
in glutamate##2##2##(2008-11#1)(2009-8#1)
in glutamine##2##2##(1996-12#1)(2008-11#1)
in glutaralaldehyde##2##2##(2008-10#2)
in glycerol gradients##2##3##(1990-11#2)
in glycerol##3##2##(1990-11#2)(1991-3#1)
in glycosylation##2##2##(1992-12#1)(2008-11#1)
in gnotobiotic##3##2##(2008-12#1)(2008-5#2)
in go as compared to nogo##2##6##(2013-8#2)
in goats##4##2##(1996-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
in goldfish##7##2##(1991-2#1)(1994-8#4)(2008-6#1)(2011-2#1)
in golf##2##2##(2008-10#1)(2011-2#1)
in gonadal##2##2##(1993-8#1)(2012-3#1)
in gonorrhoea##2##2##(1990-3#2)
in good agreement with certified values##4##6##(2008-10#4)
in good agreement with certified##5##5##(2008-10#5)
in good agreement with data##2##5##(2008-10#1)(2008-8#1)
in good agreement with that obtained by the##2##8##(2008-10#2)
in good agreement with the certified value##3##7##(2008-10#3)
in good agreement with the certified values and##3##8##(2008-10#3)
in good agreement with the certified values##7##7##(2008-10#7)
in good agreement with the certified##10##6##(2008-10#10)
in good agreement with the experimental##2##6##(2008-2#1)(2008-3#1)
in good agreement with the##30##5##(1995-11#1)(2007-11#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#4)(2010-7#1)
in good agreement with those obtained by the standard##2##9##(2008-10#2)
in good agreement with those obtained by the##5##8##(2008-10#5)
in good agreement with those obtained by using##2##8##(2008-10#2)
in good agreement with those obtained by##16##7##(2008-10#16)
in good agreement with those obtained##19##6##(2008-10#18)(2008-3#1)
in good agreement with those##26##5##(2008-10#25)(2008-3#1)
in good agreement with##76##4##(1995-11#1)(2007-11#1)(2008-10#60)(2008-11#1)(2008-2#2)(2008-3#8)(2008-8#2)(2010-7#1)
in good agreement##92##3##(1994-5#1)(1995-11#1)(2007-11#1)(2008-10#71)(2008-11#2)(2008-2#3)(2008-3#10)(2008-8#2)(2010-7#1)
in good health##4##3##(1991-6#1)(1993-6#1)(2008-12#1)(2008-4#1)
in good physical condition##2##4##(2008-5#1)(2011-2#1)
in good to excellent##3##4##(2010-7#2)(2010-8#1)
in good yield##3##3##(1996-5#1)(2008-10#1)(2010-7#1)
in good yields by##2##4##(1996-5#2)
in good yields##3##3##(1996-5#2)(2012-3#1)
in good##121##2##(1991-6#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-5#4)(2007-11#1)(2008-10#76)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-7#4)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in government##2##2##(1993-3#1)(1994-1#1)
in grade II##2##3##(1990-12#1)(2008-9#1)
in grade##5##2##(1990-12#2)(2008-12#1)(2008-9#2)
in grades##3##2##(2008-12#1)(2009-7#2)
in graduate##4##2##(1991-8#2)(1992-1#1)(1993-1#1)
in grain and##4##3##(2008-10#4)
in grain##17##2##(2008-10#17)
in grains and##3##3##(2008-10#2)(2008-3#1)
in granulosa cells##4##3##(2008-8#3)(2008-9#1)
in grape berries##3##3##(2008-10#3)
in grape##4##2##(2008-10#3)(2008-7#1)
in grapes##4##2##(2008-10#3)(2008-11#1)
in grapevine leaves##3##3##(2008-10#3)
in grapevine##7##2##(2008-10#7)
in grapevines##2##2##(2008-10#2)
in graphite##5##2##(2008-10#3)(2008-3#2)
in great part##3##3##(2008-6#2)(2011-2#1)
in great##7##2##(2008-10#1)(2008-11#1)(2008-6#2)(2009-10#1)(2010-11#1)(2011-2#1)
in greater depth##4##3##(1992-5#1)(2008-11#1)(2008-12#1)(2012-3#1)
in greater detail##6##3##(1993-1#1)(1997-3#1)(2008-11#2)(2008-8#1)(2013-1#1)
in greater##19##2##(1992-3#1)(1992-5#1)(1993-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#3)(2010-1#1)(2010-11#1)(2012-3#1)(2013-1#1)
in green##9##2##(2008-10#6)(2008-11#1)(2008-6#2)
in greenhouse and##2##3##(2008-10#2)
in greenhouse assays##2##3##(2008-10#2)
in greenhouse experiments##4##3##(2008-10#4)
in greenhouse tests##3##3##(2008-10#3)
in greenhouse trials##3##3##(2008-10#3)
in greenhouse##20##2##(2008-10#20)
in greenhouse-grown##2##2##(2008-10#2)
in greywater##2##2##(2008-10#2)
in grip strength after##3##4##(2008-9#3)
in grip strength##5##3##(2008-9#5)
in ground water samples##2##4##(2008-10#2)
in ground water##6##3##(2008-10#6)
in ground##8##2##(1990-5#1)(2008-10#7)
in groundwater samples##2##3##(2008-10#2)
in groundwater##9##2##(2008-10#9)
in group 1 and##2##4##(2008-10#1)(2011-2#1)
in group 2##3##3##(2009-6#1)(2011-2#2)
in group A##5##3##(1990-6#1)(1996-6#2)(2010-12#1)(2010-7#1)
in group B##3##3##(1990-6#1)(1996-6#2)
in group C##3##3##(2008-12#1)(2010-7#2)
in group D##2##3##(1996-1#1)(2008-12#1)
in group I##2##3##(1991-3#1)(2010-1#1)
in group II##3##3##(1991-3#1)(2006-6#1)(2010-1#1)
in group III compared to##2##5##(2009-3#1)(2012-2#1)
in group III##4##3##(2006-6#1)(2009-3#1)(2012-2#2)
in group L required##2##4##(1996-3#2)
in group L##9##3##(1996-3#9)
in group S##4##3##(1996-3#4)
in group##52##2##(1990-6#2)(1991-3#3)(1996-1#1)(1996-3#13)(1996-6#4)(2006-6#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-7#3)(2010-8#1)(2011-2#4)(2012-2#4)(2013-1#1)(2013-8#1)
in groups 1 and##2##4##(2008-11#1)(2008-12#1)
in groups 1##3##3##(2008-11#1)(2008-12#2)
in groups C and E##2##5##(2011-2#2)
in groups##15##2##(1990-11#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-9#2)(2009-6#1)(2011-2#3)
in growing##5##2##(2008-9#1)(2011-2#2)(2012-7#1)(2013-1#1)
in growth and##2##3##(1997-1#1)(2012-5#1)
in growth cabinets##3##3##(2008-10#2)(2008-11#1)
in growth chambers and##2##4##(2008-10#2)
in growth chambers##7##3##(2008-10#6)(2012-5#1)
in growth of##3##3##(2009-9#1)(2011-2#2)
in growth rate##5##3##(2008-11#2)(2008-12#1)(2008-8#1)(2013-8#1)
in growth rates##3##3##(2008-10#1)(2008-8#2)
in growth##37##2##(1995-8#1)(1996-11#1)(1997-1#1)(1997-3#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#3)(2009-6#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-4#1)(2012-5#2)(2013-1#1)(2013-8#1)
in guideline##2##2##(2008-8#1)(2012-2#1)
in guidelines for##2##3##(2009-4#1)(2011-3#1)
in guiding##4##2##(2008-11#1)(2009-10#1)(2009-2#1)(2011-2#1)
in guinea pigs##2##3##(2008-5#1)(2008-9#1)
in guinea-pig ventricular myocytes##2##4##(1994-8#2)
in guinea-pig##3##2##(1994-8#3)
in guppies (Poecilia reticulata)##2##4##(2008-8#2)
in guppies##4##2##(2008-8#4)
in gynecologic##3##2##(1992-12#2)(1996-3#1)
in gynecology]##2##2##(1991-11#1)(2011-1#1)
in gynodioecious plants##2##3##(2008-9#2)
in hEp should##2##3##(1993-12#1)(1993-6#1)
in habitat quality##3##3##(2008-8#3)
in habitat##4##2##(2008-8#4)
in habitats##2##2##(2007-12#1)(2008-9#1)
in hair and##3##3##(2008-10#3)
in hair dyeing##2##3##(2011-1#2)
in hair##15##2##(2008-10#4)(2008-5#5)(2008-9#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-8#1)
in hair-care##2##2##(2008-10#2)
in hairy roots##2##3##(2008-10#2)
in half##2##2##(1996-12#1)(2008-10#1)
in hallux##2##2##(2010-3#1)(2012-2#1)
in hamster##4##2##(1990-6#1)(1995-6#1)(1996-2#2)
in hand##4##2##(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
in handling##5##2##(1996-12#1)(2008-10#3)(2009-12#1)
in haploid invasive growth##2##4##(2008-11#2)
in haploids##2##2##(2008-11#2)
in hardware##3##2##(1992-1#1)(1997-6#1)(2008-10#1)
in harmony##2##2##(1997-6#1)(2008-10#1)
in harvested apple fruit##2##4##(2008-10#2)
in harvested##4##2##(1994-5#1)(2008-10#3)
in having a##2##3##(2008-11#1)(2011-2#1)
in having##4##2##(1995-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
in head and neck##3##4##(1990-12#1)(1997-7#1)(2008-1#1)
in head magnetic stimulation##3##4##(2008-7#3)
in head##10##2##(1990-12#1)(1990-6#1)(1997-7#1)(2008-1#1)(2008-7#3)(2010-5#1)(2010-9#2)
in headache##2##2##(2008-12#1)(2008-9#1)
in health administration education programs##2##5##(1993-2#1)(1996-3#1)
in health administration education##9##4##(1992-2#1)(1993-2#1)(1996-2#1)(1996-3#3)(1997-3#2)(2009-8#1)
in health administration programs##4##4##(1993-1#1)(1995-1#1)(1996-1#1)(1997-2#1)
in health administration##28##3##(1991-1#3)(1991-2#2)(1992-2#1)(1993-1#2)(1993-2#1)(1994-1#1)(1995-1#1)(1996-1#4)(1996-2#2)(1996-3#5)(1997-2#1)(1997-3#4)(2009-8#1)
in health among##2##3##(2008-11#1)(2008-7#1)
in health and behavioral sciences##2##5##(2010-7#2)
in health and disease##11##4##(2008-10#1)(2008-11#1)(2008-8#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#3)
in health and social care##2##5##(2008-11#1)(2008-12#1)
in health and##18##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-7#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#3)
in health behaviors##3##3##(2010-5#2)(2013-1#1)
in health care and##4##4##(1995-1#1)(1997-2#1)(2008-10#1)(2013-1#1)
in health care costs##2##4##(1996-2#1)(1997-2#1)
in health care delivery##3##4##(1993-12#1)(2010-12#1)(2010-8#1)
in health care environments##2##4##(1994-2#1)(2008-11#1)
in health care has##2##4##(1993-12#1)(2008-12#1)
in health care in##2##4##(1994-12#1)(1997-8#1)
in health care management##2##4##(1994-12#1)(1994-2#1)
in health care organizations and##2##5##(1995-2#2)
in health care organizations##5##4##(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#2)
in health care policy##3##4##(1993-12#1)(1997-2#2)
in health care quality##6##4##(1993-3#4)(1994-3#1)(1995-1#1)
in health care reform##4##4##(1995-12#2)(1996-2#1)(2008-8#1)
in health care##96##3##(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#3)(1993-12#4)(1993-2#1)(1993-3#5)(1994-1#2)(1994-12#8)(1994-2#9)(1994-3#4)(1995-1#3)(1995-12#3)(1995-2#5)(1996-1#1)(1996-2#6)(1996-3#1)(1997-2#6)(1997-3#2)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#8)(2008-12#4)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in health centers##2##3##(1997-3#1)(2008-10#1)
in health insurance##2##3##(1994-12#1)(1995-12#1)
in health maintenance organizations##2##4##(1991-3#1)(1997-2#1)
in health maintenance##3##3##(1991-3#1)(1996-3#1)(1997-2#1)
in health outcomes##3##3##(2008-11#1)(2010-4#1)(2012-2#1)
in health policy and##2##4##(1994-2#1)(2012-2#1)
in health policy##5##3##(1992-1#1)(1994-2#1)(2012-2#3)
in health promotion##5##3##(1991-6#1)(2008-11#1)(2010-10#1)(2010-2#1)(2012-3#1)
in health sector##2##3##(1997-1#2)
in health services administration education##2##5##(1993-1#1)(1993-2#1)
in health services administration##5##4##(1993-1#1)(1993-2#1)(1994-1#1)(1996-2#1)(1996-3#1)
in health services management##3##4##(1992-1#3)
in health services##13##3##(1991-2#1)(1992-1#3)(1992-3#1)(1993-1#1)(1993-2#2)(1994-1#1)(1996-2#1)(1996-3#2)(2013-8#1)
in health systems##2##3##(1993-1#1)(2013-8#1)
in health##212##2##(1990-12#1)(1991-1#3)(1991-12#2)(1991-2#6)(1991-3#2)(1991-6#1)(1992-1#5)(1992-2#3)(1992-3#5)(1993-1#4)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#5)(1994-1#4)(1994-12#9)(1994-2#10)(1994-3#4)(1994-6#1)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#5)(1996-1#8)(1996-2#10)(1996-3#10)(1997-1#2)(1997-2#8)(1997-3#8)(1997-5#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#15)(2008-12#8)(2008-7#8)(2008-8#3)(2009-12#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-2#4)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#3)
in health-related quality of life##2##5##(1995-2#1)(2009-12#1)
in healthcare security##2##3##(1992-12#1)(1992-2#1)
in healthcare settings##2##3##(1994-3#1)(2008-12#1)
in healthcare##26##2##(1992-12#2)(1992-2#2)(1993-2#2)(1993-5#1)(1994-3#1)(1995-1#1)(2007-12#1)(2008-12#3)(2009-11#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#5)(2013-8#2)
in healthy adult##2##3##(1994-12#1)(2011-2#1)
in healthy adults##3##3##(2011-2#1)(2013-8#2)
in healthy and##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
in healthy humans##2##3##(2010-4#1)(2012-2#1)
in healthy individuals##5##3##(2008-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
in healthy medical##2##3##(2008-12#1)(2010-12#1)
in healthy people##2##3##(2011-2#1)(2013-1#1)
in healthy subjects and##3##4##(1996-1#2)(2010-12#1)
in healthy subjects##8##3##(1996-1#3)(2008-10#1)(2010-1#1)(2010-12#2)(2010-9#1)
in healthy##58##2##(1991-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-1#3)(1996-6#1)(2006-6#1)(2007-8#1)(2008-10#12)(2008-12#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#2)(2010-12#3)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#3)(2013-8#3)
in heart disease##3##3##(2008-10#1)(2009-10#1)(2010-12#1)
in heart failure patients##2##4##(2012-2#2)
in heart failure##4##3##(2008-7#1)(2012-2#3)
in heart rate##4##3##(1990-10#1)(2012-3#1)(2013-8#2)
in heart##23##2##(1990-10#1)(1992-3#1)(1994-11#2)(1995-6#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-8#2)
in heat production##2##3##(2009-8#2)
in heat shocked##2##3##(1995-12#2)
in heat##8##2##(1995-12#2)(2008-10#3)(2009-8#2)(2011-2#1)
in heat-treated##2##2##(2008-10#2)
in heated##3##2##(2011-2#3)
in heavily##5##2##(1992-2#2)(2007-12#1)(2008-10#2)
in heavy##6##2##(1994-3#1)(1995-1#1)(2008-10#2)(2009-10#1)(2013-1#1)
in height and##2##3##(2008-11#1)(2009-12#1)
in height##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
in helping patients##2##3##(2008-7#1)(2010-11#1)
in helping students##2##3##(2008-11#1)(2010-9#1)
in helping the##2##3##(1992-3#1)(2010-11#1)
in helping to##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
in helping##16##2##(1992-3#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#1)(2010-10#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-2#1)(2013-7#1)
in hematologic##2##2##(2010-11#1)(2011-2#1)
in hematological malignancies##3##3##(2008-9#1)(2012-12#1)(2013-8#1)
in hematopoietic cells##2##3##(1995-2#2)
in hematopoietic##4##2##(1993-8#1)(1995-2#2)(2008-7#1)
in hemodialysis patients##5##3##(2008-1#4)(2011-2#1)
in hemodialysis##10##2##(2008-1#5)(2008-10#4)(2011-2#1)
in hemoglobin##4##2##(2008-10#1)(2008-7#3)
in hemorrhagic##2##2##(1996-6#1)(2009-12#1)
in heparin##2##2##(1992-5#1)(2008-10#1)
in hepatic gluconeogenesis##2##3##(1994-8#1)(1996-2#1)
in hepatic##15##2##(1990-11#1)(1992-10#1)(1992-6#1)(1994-11#2)(1994-8#3)(1996-2#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)
in hepatitis B##3##3##(1995-2#1)(1996-3#1)(2011-2#1)
in hepatitis##4##2##(1995-2#1)(1996-3#1)(2011-2#1)(2013-8#1)
in hepatocarcinogenesis##3##2##(1990-5#2)(2011-2#1)
in hepatocellular##2##2##(2010-7#1)(2013-8#1)
in hepatocyte##2##2##(1993-3#1)(2008-7#1)
in hepatocytes and##2##3##(1990-3#1)(1994-8#1)
in hepatocytes by##2##3##(1993-3#1)(1995-8#1)
in hepatocytes##13##2##(1990-3#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-8#2)(1995-8#3)(2008-11#1)(2008-8#1)(2012-2#1)
in hepatopancreatobilliary##2##2##(2011-2#2)
in her pregnancy##2##3##(2008-11#1)(2013-1#1)
in her right##3##3##(2010-9#1)(2012-3#1)(2013-7#1)
in her##15##2##(1997-3#1)(2008-11#2)(2008-12#2)(2008-5#1)(2009-3#1)(2010-11#1)(2010-9#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)
in herbal##2##2##(2008-10#1)(2008-8#1)
in herbicide##2##2##(2008-10#1)(2008-11#1)
in herds with a##2##4##(1996-8#2)
in hereditary##3##2##(2009-10#1)(2009-4#1)(2012-3#1)
in heterochromatic regions##3##3##(2009-10#3)
in heterochromatin##2##2##(2011-1#1)(2013-1#1)
in heterogeneous landscapes##3##3##(2008-8#2)(2008-9#1)
in heterogeneous systems##3##3##(2008-10#1)(2008-5#2)
in heterogeneous##8##2##(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)
in heterologous##4##2##(1996-12#1)(1997-7#1)(2008-10#1)(2011-2#1)
in hexane##4##2##(2008-10#2)(2013-8#2)
in hibernation##2##2##(2008-8#2)
in high cell density##3##4##(2008-11#2)(2008-7#1)
in high concentrations in##2##4##(2008-10#1)(2008-7#1)
in high concentrations##5##3##(1991-12#1)(2008-10#2)(2008-7#1)(2009-3#1)
in high density##3##3##(2008-11#2)(2013-8#1)
in high glucose##2##3##(1992-8#1)(2012-4#1)
in high humidity##2##3##(2008-10#2)
in high levels of##2##4##(2008-10#2)
in high performance##3##3##(2008-10#2)(2011-2#1)
in high purity grade##2##4##(2008-10#2)
in high purity##8##3##(2008-10#8)
in high quantities##2##3##(1995-12#1)(2008-10#1)
in high risk##2##3##(1993-12#1)(2008-7#1)
in high saline##3##3##(2008-10#3)
in high soil##2##3##(2008-10#2)
in high throughput##3##3##(2009-4#1)(2009-7#1)(2012-3#1)
in high yields##2##3##(1996-5#1)(2008-4#1)
in high##78##2##(1990-12#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#33)(2008-11#9)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-4#1)(2012-7#1)(2013-1#1)(2013-8#1)
in high-density lipoprotein (HDL)##2##4##(1993-6#1)(2010-4#1)
in high-density##3##2##(1993-6#1)(2008-8#1)(2010-4#1)
in high-performance liquid chromatography (HPLC)##3##5##(2008-10#3)
in high-performance liquid chromatography##5##4##(2008-10#5)
in high-performance##7##2##(2008-10#5)(2008-3#2)
in high-risk patients##3##3##(1994-8#1)(2008-10#1)(2013-1#1)
in high-risk##9##2##(1994-8#1)(2008-10#1)(2009-12#1)(2009-5#1)(2010-4#1)(2013-1#4)
in high-speed##3##2##(2008-3#2)(2011-2#1)
in high-temperature##2##2##(1992-8#1)(2011-2#1)
in higher doses##2##3##(2008-12#1)(2010-7#1)
in higher education##5##3##(1995-3#1)(2008-11#2)(2008-12#2)
in higher plants##5##3##(1995-2#2)(2008-9#1)(2009-8#2)
in higher##33##2##(1990-5#1)(1993-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#6)(2008-11#4)(2008-12#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#2)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
in higher-plant cells##2##3##(2008-11#2)
in highly concentrated##2##3##(2008-10#2)
in highly saline##2##3##(2008-10#2)
in highly susceptible##2##3##(2008-10#2)
in highly##19##2##(1995-12#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-8#3)(2011-2#1)(2011-3#1)(2012-2#1)
in hip and##2##3##(2008-11#1)(2009-3#1)
in hip##4##2##(2008-11#1)(2008-12#1)(2009-3#1)(2013-1#1)
in hippocampal##10##2##(1991-7#1)(1994-2#1)(1995-12#1)(1995-8#1)(2008-11#1)(2008-7#2)(2012-2#1)(2013-8#2)
in hippocampus and##2##3##(1995-2#1)(1997-2#1)
in hippocampus##6##2##(1995-2#2)(1997-2#2)(2008-7#1)(2010-12#1)
in his clinical##2##3##(2011-2#1)(2013-1#1)
in his right##2##3##(2010-10#1)(2011-2#1)
in his##26##2##(1990-5#1)(1991-8#1)(1997-3#1)(2008-12#7)(2008-7#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2013-1#3)
in histological sections##2##3##(1991-6#1)(1994-11#1)
in histological##3##2##(1991-6#1)(1994-11#1)(1995-2#1)
in holding##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
in home care##5##3##(1992-1#1)(1993-1#1)(1995-3#1)(1996-1#1)(1996-2#1)
in home health care##2##4##(1995-3#2)
in home range##2##3##(2010-4#2)
in home##11##2##(1992-1#1)(1993-1#1)(1995-3#3)(1996-1#1)(1996-2#1)(1997-1#1)(2008-10#1)(2010-4#2)
in homes and##2##3##(2008-11#1)(2012-2#1)
in homes##4##2##(2008-11#1)(2011-2#2)(2012-2#1)
in homogenates##2##2##(1990-11#1)(2008-10#1)
in homogeneous solution##2##3##(2008-10#1)(2008-5#1)
in homogeneous##6##2##(2008-10#4)(2008-5#1)(2008-8#1)
in homogenous##2##2##(2008-10#1)(2013-1#1)
in homologous##2##2##(1993-12#1)(1997-7#1)
in homozygous##3##2##(1990-8#1)(2008-12#1)(2008-7#1)
in honey by##2##3##(2008-10#2)
in honey samples##2##3##(2008-10#2)
in honey using##2##3##(2008-10#2)
in honey##12##2##(2008-10#11)(2008-9#1)
in honeybees##4##2##(2008-10#3)(2008-8#1)
in honor of##2##3##(2011-2#1)(2013-1#1)
in hormone##3##2##(1990-5#1)(2011-2#1)(2012-3#1)
in horses in##2##3##(1992-5#1)(2011-2#1)
in horses##7##2##(1992-5#1)(2011-2#2)(2012-3#2)(2013-8#2)
in hospice##2##2##(1993-12#1)(2013-8#1)
in hospital and##3##3##(1992-2#1)(1994-8#1)(1996-1#1)
in hospital discharges and##2##4##(2013-1#1)(2013-8#1)
in hospital is##3##3##(1991-11#1)(1993-6#1)(2008-8#1)
in hospital or##2##3##(1995-2#1)(2011-2#1)
in hospital##46##2##(1990-3#1)(1991-11#2)(1991-12#1)(1991-3#2)(1992-1#2)(1992-12#2)(1992-2#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-4#2)(1997-5#1)(1997-8#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#4)(2013-1#7)(2013-8#1)
in hospitalizations for CHF##2##4##(1995-12#2)
in hospitalizations for##3##3##(1991-12#1)(1995-12#2)
in hospitalized patients##2##3##(2007-12#1)(2011-2#1)
in hospitalized##4##2##(1994-3#1)(2007-12#1)(2011-2#1)(2013-1#1)
in hospitals are##2##3##(1996-11#1)(1997-4#1)
in hospitals##20##2##(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1993-2#1)(1994-1#1)(1994-12#3)(1995-12#2)(1995-2#1)(1996-11#1)(1997-4#1)(2008-11#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
in hospitals'##2##2##(1992-2#1)(1994-12#1)
in hospitals]##4##2##(1993-11#1)(1995-5#1)(2012-3#2)
in host and##3##3##(1995-5#1)(2008-8#1)(2013-8#1)
in host density##3##3##(2008-9#3)
in host fitness##2##3##(2008-9#2)
in host mixtures##3##3##(2008-10#3)
in host plant##2##3##(2008-10#1)(2008-9#1)
in host plants##3##3##(2008-10#3)
in host range##2##3##(2008-10#2)
in host tissue##2##3##(2008-10#2)
in host##34##2##(1992-12#1)(1995-5#1)(1996-12#2)(2008-10#18)(2008-4#1)(2008-8#1)(2008-9#8)(2009-10#1)(2013-8#1)
in host-parasitoid coevolution##2##3##(2008-8#2)
in host-pathogen##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
in hosts##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
in hot spring water##2##4##(2008-10#2)
in hot spring waters##2##4##(2008-10#2)
in hot spring##4##3##(2008-10#4)
in hot##9##2##(2008-10#5)(2008-11#1)(2008-5#1)(2013-8#2)
in hours##3##2##(1993-2#1)(1995-12#1)(2009-12#1)
in house##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
in how the##2##3##(1997-2#1)(2008-7#1)
in how##15##2##(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-7#2)(2008-8#2)(2010-1#2)(2010-2#1)(2013-1#1)
in human acute##3##3##(1991-9#1)(1997-7#1)(2011-2#1)
in human adult##2##3##(1994-11#2)
in human and animal##3##4##(2010-5#1)(2010-7#1)(2012-12#1)
in human and rat liver##2##5##(1994-8#2)
in human and rat##3##4##(1994-3#1)(1994-8#2)
in human and##10##3##(1991-12#1)(1993-12#1)(1994-3#1)(1994-8#2)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
in human beings##2##3##(1992-9#1)(2008-10#1)
in human blood plasma samples##2##5##(2008-10#2)
in human blood plasma##5##4##(2008-10#5)
in human blood serum##4##4##(2008-10#4)
in human blood##13##3##(1993-3#1)(1994-6#1)(1997-2#1)(2008-10#10)
in human body##4##3##(2008-1#1)(2008-10#2)(2013-8#1)
in human bones of##2##4##(2008-10#2)
in human brain##3##3##(1990-6#1)(1992-12#1)(2008-9#1)
in human breast cancer cells##6##5##(1992-4#1)(1995-10#1)(2008-11#3)(2013-1#1)
in human breast cancer##10##4##(1992-4#1)(1993-1#1)(1993-11#1)(1995-10#1)(1995-9#1)(2008-11#4)(2013-1#1)
in human breast##16##3##(1992-4#1)(1992-7#1)(1993-1#3)(1993-11#2)(1995-10#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-11#4)(2013-1#1)
in human breath##3##3##(2008-10#2)(2008-3#1)
in human cancer cells##3##4##(1994-11#1)(2008-11#1)(2008-9#1)
in human cancer##7##3##(1994-11#1)(1994-9#1)(1995-12#1)(2008-11#2)(2008-9#1)(2013-1#1)
in human cancers##5##3##(1997-7#1)(2008-11#1)(2011-2#3)
in human cell##2##3##(2008-9#2)
in human cells##5##3##(1991-5#1)(2008-11#1)(2011-2#1)(2011-3#1)(2012-2#1)
in human colon##2##3##(1990-12#1)(1994-8#1)
in human cord blood##2##4##(2008-10#2)
in human cutaneous##2##3##(2008-5#1)(2012-2#1)
in human diseases##3##3##(1994-11#1)(2009-9#1)(2011-2#1)
in human embryonic##2##3##(1992-3#1)(2008-11#1)
in human endothelial cells##3##4##(1993-6#1)(1994-6#1)(2010-1#1)
in human fibroblasts##3##3##(1990-5#1)(1995-6#1)(2008-12#1)
in human gastric juice##2##4##(2008-10#2)
in human gastric##5##3##(1991-6#2)(2008-10#2)(2008-9#1)
in human genome##2##3##(2008-7#2)
in human hair and animal fur##2##6##(2008-10#2)
in human hair and##3##4##(2008-10#3)
in human hair by##2##4##(2008-10#2)
in human hair##7##3##(2008-10#6)(2008-5#1)
in human health##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
in human heart##2##3##(2010-12#2)
in human immunodeficiency virus (HIV)##3##5##(2009-11#1)(2012-3#1)(2013-8#1)
in human immunodeficiency virus##7##4##(1993-2#1)(1994-9#1)(2009-11#2)(2012-3#2)(2013-8#1)
in human immunodeficiency##8##3##(1993-2#1)(1994-9#1)(1995-2#1)(2009-11#2)(2012-3#2)(2013-8#1)
in human liver##7##3##(1991-5#2)(1994-3#3)(1997-1#1)(2008-8#1)
in human lymphoblastoid##2##3##(1994-3#1)(1996-12#1)
in human lymphocytes##7##3##(1990-8#1)(1992-6#1)(1993-8#2)(2008-11#2)(2011-2#1)
in human milk##5##3##(2008-10#2)(2008-11#1)(2012-2#2)
in human myometrial##2##3##(1992-6#1)(1994-3#1)
in human myometrium##2##3##(1994-3#1)(1994-8#1)
in human neutrophils##5##3##(1992-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)
in human normal##2##3##(2008-9#2)
in human ovarian##2##3##(1990-2#1)(1993-8#1)
in human pathology##2##3##(2008-10#1)(2008-5#1)
in human patients##2##3##(2010-7#1)(2011-9#1)
in human peripheral blood lymphocytes##3##5##(1993-8#2)(2008-11#1)
in human plasma and##5##4##(2008-10#4)(2011-2#1)
in human plasma by high-performance liquid chromatography##2##7##(2008-10#2)
in human plasma by##3##4##(2008-10#3)
in human plasma using##2##4##(2008-10#2)
in human plasma were##3##4##(2008-10#3)
in human plasma with##3##4##(2008-10#3)
in human plasma##30##3##(1990-12#2)(1992-3#1)(1992-6#1)(2008-10#23)(2010-11#1)(2011-2#1)(2011-3#1)
in human platelets##5##3##(1990-8#1)(2006-6#4)
in human populations##5##3##(1993-11#1)(2008-10#2)(2008-12#1)(2010-10#1)
in human primary fibroblasts##2##4##(2013-8#2)
in human renal cell carcinoma##2##5##(1992-3#2)
in human saliva##4##3##(2008-10#3)(2010-12#1)
in human sera##4##3##(1990-12#1)(2008-10#3)
in human serum and##2##4##(2008-10#2)
in human serum by##4##4##(2008-10#4)
in human serum samples##4##4##(2008-10#4)
in human serum using##3##4##(2008-10#3)
in human serum was##3##4##(2008-10#3)
in human serum with##3##4##(2008-10#3)
in human serum##39##3##(1991-5#1)(1994-8#1)(1995-8#1)(2008-10#35)(2012-12#1)
in human skin##7##3##(2007-11#3)(2008-10#2)(2008-5#1)(2011-2#1)
in human subjects##8##3##(1992-3#1)(1997-1#2)(2008-11#5)
in human testis##2##3##(1990-2#1)(2008-8#1)
in human thyroid##4##3##(1990-2#1)(1994-11#3)
in human tissues##5##3##(1991-5#2)(1994-11#1)(2008-12#1)(2008-9#1)
in human tumor cell lines##2##5##(2008-9#2)
in human tumor##3##3##(2008-9#2)(2009-4#1)
in human tumors##3##3##(2008-11#2)(2011-2#1)
in human umbilical vein endothelial cells##3##6##(1997-1#1)(2008-8#1)(2012-2#1)
in human urine and serum samples##3##6##(2008-10#3)
in human urine and serum##6##5##(2008-10#6)
in human urine and##11##4##(2008-10#11)
in human urine by high performance liquid##2##7##(2008-10#2)
in human urine by##6##4##(2008-10#5)(2008-11#1)
in human urine samples by##2##5##(2008-10#1)(2010-11#1)
in human urine samples##7##4##(2008-10#6)(2010-11#1)
in human urine with##3##4##(2008-10#3)
in human urine without any##2##5##(2008-10#2)
in human urine##48##3##(1997-2#1)(2008-10#44)(2008-11#2)(2010-11#1)
in human uterine LMS##2##4##(2012-2#2)
in human uterine##3##3##(2012-2#2)(2013-1#1)
in human vascular endothelial cells##2##5##(1994-11#1)(2010-1#1)
in human volunteers##4##3##(1992-6#1)(2008-10#2)(2008-5#1)
in human##480##2##(1990-12#5)(1990-2#4)(1990-5#5)(1990-6#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#6)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#10)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#5)(1993-8#8)(1994-11#10)(1994-12#1)(1994-3#10)(1994-6#4)(1994-8#6)(1994-9#3)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#2)(1996-12#2)(1996-2#2)(1997-1#8)(1997-2#4)(1997-6#1)(1997-7#4)(1997-8#1)(2006-6#6)(2007-11#3)(2008-1#2)(2008-10#158)(2008-11#32)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#13)(2009-11#2)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#6)(2010-5#2)(2010-7#2)(2011-1#3)(2011-2#18)(2011-3#4)(2011-9#1)(2012-12#2)(2012-2#10)(2012-3#5)(2012-9#1)(2013-1#8)(2013-8#6)
in humans and animals##3##4##(2011-1#1)(2012-3#1)(2013-8#1)
in humans and in animal models##2##6##(2008-10#2)
in humans and in##3##4##(1991-12#1)(2008-10#2)
in humans and other animals##2##5##(1993-3#1)(2008-10#1)
in humans and other##3##4##(1993-3#1)(1994-8#1)(2008-10#1)
in humans and rats##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
in humans and##20##3##(1991-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in humans as well as##2##5##(1995-5#1)(2012-2#1)
in humans by##2##3##(2012-12#1)(2013-8#1)
in humans has not##2##4##(1994-6#1)(2009-5#1)
in humans has##3##3##(1994-6#1)(2008-4#1)(2009-5#1)
in humans in##2##3##(1994-5#1)(2006-6#1)
in humans is##9##3##(1995-2#1)(1996-2#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
in humans the##2##3##(1990-11#1)(1991-6#1)
in humans with##2##3##(1991-1#1)(2008-10#1)
in humans##127##2##(1990-11#1)(1990-5#4)(1991-1#6)(1991-12#3)(1991-2#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#2)(1996-2#2)(1997-7#1)(2006-6#1)(2008-10#13)(2008-11#8)(2008-12#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-8#3)(2010-11#5)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#14)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#3)(2013-8#4)
in humic##2##2##(2008-10#2)
in humic-rich##2##2##(2008-10#2)
in humidity##2##2##(2008-10#2)
in hybrid maize##2##3##(2008-10#2)
in hybrid##13##2##(1997-3#1)(2008-10#6)(2008-12#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-3#1)
in hybridoma cells##4##3##(2008-11#4)
in hybridoma cultures##2##3##(2008-11#2)
in hybridoma##10##2##(1991-12#1)(2008-11#9)
in hydrated ethanol##2##3##(2008-10#2)
in hydrocarbon##2##2##(2008-10#1)(2008-8#1)
in hydrochloric acid media##3##4##(2008-10#3)
in hydrochloric acid solutions##2##4##(1992-12#1)(2008-10#1)
in hydrochloric acid to##2##4##(2008-10#2)
in hydrochloric acid##10##3##(1992-12#1)(2008-10#9)
in hydrochloric##11##2##(1992-12#1)(2008-10#10)
in hydrogen##3##2##(2008-10#2)(2008-5#1)
in hydrolysis of##2##3##(1993-8#1)(1995-8#1)
in hydrolysis yields##2##3##(2011-2#2)
in hydrolysis##4##2##(1993-8#1)(1995-8#1)(2011-2#2)
in hydrolyzed##2##2##(2008-10#1)(2008-5#1)
in hydroponic##4##2##(2008-10#4)
in hydrothermal##3##2##(1995-3#1)(2008-10#2)
in hypercalcemia of##2##3##(1990-2#2)
in hypercholesteremic rats##2##3##(2008-10#2)
in hypercholesteremic##4##2##(2008-10#4)
in hypercholesterolemic rabbits##2##3##(1997-8#1)(2008-7#1)
in hypercholesterolemic##3##2##(1991-12#1)(1997-8#1)(2008-7#1)
in hypertension and##2##3##(2008-7#1)(2013-8#1)
in hypertension##4##2##(2008-7#1)(2008-9#1)(2009-1#1)(2013-8#1)
in hypertensive patients##6##3##(1993-8#1)(2008-8#1)(2009-1#3)(2010-4#1)
in hypertensive##7##2##(1993-8#1)(2008-12#1)(2008-8#1)(2009-1#3)(2010-4#1)
in hypertrophic##2##2##(2009-10#1)(2010-12#1)
in hyphal##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
in hypoglycemic##2##2##(1994-2#1)(2010-10#1)
in hypogonadal men##2##3##(2013-8#2)
in hypospadias repair##2##3##(2008-10#2)
in hypospadias surgery##2##3##(2008-10#2)
in hypospadias##4##2##(2008-10#4)
in hypothalamus##9##2##(1990-9#1)(1992-1#2)(2008-8#6)
in hypovirulent isolate Sh12B of##2##5##(2008-10#2)
in hypovirulent isolates##2##3##(2008-10#2)
in hypovirulent##4##2##(2008-10#4)
in hypoxic##2##2##(2010-7#1)(2011-2#1)
in hypoxic-ischemic##2##2##(1996-12#1)(2010-7#1)
in identical##2##2##(2008-10#1)(2010-1#1)
in identification of##5##3##(1990-12#1)(1991-12#1)(2008-10#2)(2008-12#1)
in identifying the##12##3##(1994-2#1)(2008-10#4)(2008-11#2)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#1)
in identifying those##4##3##(2008-10#1)(2008-3#1)(2011-1#2)
in identifying##35##2##(1992-1#2)(1994-2#1)(1994-6#1)(1997-2#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-1#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in idiopathic hypercalciuria##2##3##(1991-11#1)(2008-10#1)
in idiopathic##9##2##(1991-11#1)(1997-8#2)(2007-8#1)(2008-10#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-8#1)
in illicit##3##2##(2008-1#1)(2008-10#2)
in illumination##2##2##(2008-3#1)(2008-6#1)
in image processing##2##3##(2008-3#1)(2008-6#1)
in image##9##2##(2007-12#1)(2008-3#2)(2008-6#1)(2008-9#2)(2009-12#1)(2011-7#2)
in imaging##3##2##(2008-6#1)(2011-7#1)(2012-2#1)
in immature or##2##3##(2008-10#2)
in immature##5##2##(2008-10#4)(2011-2#1)
in immediate and##2##3##(1993-11#1)(2010-11#1)
in immediate##5##2##(1993-11#1)(2008-11#1)(2010-11#2)(2012-2#1)
in immobilized##2##2##(1994-11#1)(2008-12#1)
in immortalized T##2##3##(2008-11#2)
in immortalized##3##2##(1992-1#1)(2008-11#2)
in immune cells##2##3##(1991-1#2)
in immune defense##3##3##(2008-9#2)(2009-9#1)
in immune function##9##3##(1993-12#1)(2008-10#4)(2008-8#2)(2008-9#2)
in immune response##2##3##(2008-8#1)(2011-2#1)
in immune responses##3##3##(1995-12#1)(2008-9#1)(2010-5#1)
in immune##28##2##(1991-1#2)(1991-11#1)(1993-12#2)(1995-12#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)
in immune-competent##2##2##(1994-5#1)(2013-8#1)
in immune-mediated##2##2##(2008-10#1)(2011-2#1)
in immunity##4##2##(2008-10#1)(2009-6#1)(2010-3#1)(2012-3#1)
in immunization##2##2##(1994-9#1)(1996-12#1)
in immunized rabbits##2##3##(1990-12#2)
in immunoassays##6##2##(2008-10#5)(2008-11#1)
in immunoblot and##2##3##(2008-10#1)(2008-8#1)
in immunoblot##3##2##(2008-10#2)(2008-8#1)
in immunoblotting##2##2##(1990-5#1)(2008-10#1)
in immunocompetent mice##2##3##(2011-2#1)(2013-1#1)
in immunocompetent patients##2##3##(2011-2#1)(2012-12#1)
in immunocompetent##6##2##(2009-9#1)(2011-2#3)(2012-12#1)(2013-1#1)
in immunocompromised patients##6##3##(2008-5#1)(2009-11#1)(2009-9#1)(2011-2#2)(2013-1#1)
in immunodeficient##3##2##(1991-6#1)(2008-12#1)(2008-5#1)
in immunogenicity##2##2##(1995-5#1)(2008-10#1)
in immunohistochemistry##2##2##(2009-8#1)(2011-2#1)
in immunomodulation##2##2##(1995-12#1)(2011-1#1)
in immunoregulation##2##2##(1995-12#1)(2011-2#1)
in immunostaining##2##2##(1997-3#2)
in immunotoxicology##2##2##(2008-10#2)
in impaired##2##2##(2008-11#1)(2008-3#1)
in imparting information##2##3##(2008-12#1)(2011-1#1)
in implant technology##2##3##(2008-9#2)
in implant##3##2##(2008-9#2)(2011-2#1)
in implantation##2##2##(1994-9#1)(2012-3#1)
in implants##2##2##(1991-5#2)
in implementation##2##2##(1996-2#1)(2008-11#1)
in implementing TQM##2##3##(1994-1#1)(1994-2#1)
in implementing an##2##3##(1992-3#1)(1995-3#1)
in implementing##16##2##(1991-12#1)(1991-2#1)(1992-3#1)(1994-1#2)(1994-2#1)(1995-3#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-10#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
in importance##5##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)
in improved##11##2##(1993-3#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#2)
in improvements##2##2##(1996-3#1)(2013-1#1)
in improving patient##2##3##(2010-4#1)(2013-1#1)
in improving the##8##3##(1993-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
in improving##23##2##(1993-2#1)(1994-12#2)(1995-1#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#3)
in impulsive##2##2##(2008-11#1)(2012-12#1)
in in vitro and in vivo##2##6##(2008-10#1)(2008-11#1)
in in vitro assays##2##4##(2008-10#2)
in in vitro binding assays##2##5##(2008-10#1)(2010-5#1)
in in vitro##16##3##(1990-12#1)(1993-1#1)(1995-2#1)(2008-10#6)(2008-11#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-5#1)(2013-1#1)
in in vivo and##2##4##(1993-6#1)(2008-10#1)
in in vivo##7##3##(1992-12#1)(1993-6#1)(2008-10#2)(2008-11#2)(2008-3#1)
in in##24##2##(1990-12#1)(1992-12#1)(1993-1#1)(1993-6#1)(1995-2#1)(2008-10#9)(2008-11#4)(2008-3#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-5#1)(2013-1#1)
in incidence of##5##3##(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#1)
in incidence##14##2##(1990-11#1)(1991-12#1)(1994-9#1)(1995-2#2)(1996-11#1)(2008-10#3)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
in inclusion##2##2##(1994-9#1)(1995-8#1)
in incorporating##3##2##(2008-10#2)(2008-11#1)
in increased expression##2##3##(2008-9#1)(2010-1#1)
in increased##35##2##(1990-11#1)(1993-6#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)
in increasing concentrations##2##3##(2008-11#1)(2013-1#1)
in increasing the##9##3##(1990-5#1)(1993-3#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
in increasing##19##2##(1990-5#1)(1993-3#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#3)
in incubation##2##2##(1990-11#1)(2008-10#1)
in independent##2##2##(1992-2#1)(1995-9#1)
in indicator##2##2##(1997-3#1)(2008-10#1)
in indigenous##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
in indirect enzyme-linked immunosorbent assay##2##5##(2008-10#2)
in indirect##4##2##(2008-10#4)
in individual patients##3##3##(2011-3#1)(2012-5#1)(2013-1#1)
in individual presynaptic boutons##2##4##(1997-7#2)
in individual subjects##3##3##(2008-11#3)
in individual##38##2##(1991-5#1)(1995-5#1)(1997-7#2)(1997-8#1)(2008-10#13)(2008-11#7)(2008-7#2)(2008-8#2)(2009-6#1)(2009-7#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-5#1)(2013-1#2)
in individuals from##2##3##(2008-12#1)(2013-1#1)
in individuals of##2##3##(2011-2#1)(2012-2#1)
in individuals with##13##3##(2008-11#1)(2008-12#1)(2008-7#2)(2010-1#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
in individuals##23##2##(1991-1#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-3#1)(2010-9#2)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
in indoor air##2##3##(2008-10#2)
in indoor and outdoor air##4##5##(2008-10#4)
in indoor and outdoor##5##4##(2008-10#5)
in indoor##8##2##(2008-10#8)
in induced cells##2##3##(1993-9#1)(2008-10#1)
in induced##4##2##(1993-9#1)(2008-10#2)(2008-12#1)
in inducing a##2##3##(1990-12#1)(1996-3#1)
in inducing##10##2##(1990-12#1)(1994-8#1)(1995-5#2)(1996-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
in induction of##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
in induction##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
in inductively coupled plasma optical emission spectrometry##2##7##(2008-10#2)
in inductively coupled plasma##4##4##(2008-10#4)
in inductively coupled##5##3##(2008-10#5)
in industrial and##4##3##(1995-2#1)(2008-10#3)
in industrial applications##3##3##(2008-10#2)(2008-11#1)
in industrial areas##2##3##(1996-3#1)(2008-10#1)
in industrial waste##2##3##(2008-10#2)
in industrial##40##2##(1993-3#1)(1995-2#1)(1996-3#1)(1996-6#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
in industrialized countries##2##3##(1990-6#1)(1994-12#1)
in industrialized societies##3##3##(2009-12#1)(2010-7#1)(2013-1#1)
in industrialized##9##2##(1990-6#1)(1994-12#1)(1994-3#1)(2008-10#2)(2009-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
in industries##3##2##(1994-3#1)(2008-9#1)(2009-12#1)
in industry for##2##3##(1994-12#1)(2008-7#1)
in industry##8##2##(1993-12#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-7#1)
in infancy and##5##3##(1996-9#1)(2008-11#1)(2009-9#1)(2010-12#1)(2010-5#1)
in infancy##15##2##(1991-3#1)(1996-9#1)(2008-11#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)
in infant formulas##2##3##(2008-10#2)
in infant##6##2##(1990-11#1)(1990-12#1)(1991-1#1)(2008-10#2)(2012-2#1)
in infantile##2##2##(1991-2#1)(2009-4#1)
in infants and children##5##4##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
in infants and small children##2##5##(2008-1#2)
in infants and toddlers with##3##5##(2012-2#3)
in infants and toddlers##4##4##(2012-2#4)
in infants and young children##2##5##(1997-1#1)(2008-11#1)
in infants and##15##3##(1991-12#1)(1992-3#1)(1997-1#2)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#4)
in infants in##3##3##(1995-12#1)(2008-11#1)(2011-2#1)
in infants who##2##3##(1991-3#1)(1995-5#1)
in infants with##5##3##(1995-5#1)(2007-11#1)(2010-9#2)(2012-3#1)
in infants##46##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1994-6#1)(1995-12#3)(1995-3#1)(1995-5#3)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-8#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#4)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)
in infected barley leaves##2##4##(2008-10#2)
in infected leaves##3##3##(2008-10#3)
in infected plant##2##3##(2008-10#2)
in infected plants##4##3##(2008-10#4)
in infected tissue##2##3##(2008-10#2)
in infected##37##2##(1990-2#1)(1993-6#1)(1997-1#1)(2008-10#28)(2008-11#3)(2008-6#1)(2008-9#1)(2009-8#1)
in infection in##2##3##(2008-10#1)(2010-8#1)
in infection##11##2##(2008-10#8)(2009-8#1)(2010-8#2)
in infections##2##2##(2008-10#1)(2011-2#1)
in infectious mononucleosis##2##3##(2008-5#1)(2011-2#1)
in infectious##3##2##(1992-12#1)(2008-5#1)(2011-2#1)
in infective endocarditis##2##3##(2006-6#1)(2011-2#1)
in infective##4##2##(2006-6#1)(2008-10#1)(2011-2#2)
in inferotemporal and prefrontal association##2##5##(1997-2#2)
in infertile##2##2##(2008-12#1)(2011-1#1)
in infertility##3##2##(1991-3#1)(1992-3#1)(2010-3#1)
in infested##6##2##(2008-10#6)
in inflammation and##2##3##(2008-10#1)(2013-8#1)
in inflammation##4##2##(1990-9#1)(2008-10#1)(2013-8#2)
in inflammatory arthritis##3##3##(2008-5#2)(2008-8#1)
in inflammatory bowel disease##2##4##(1992-6#1)(2010-12#1)
in inflammatory bowel##3##3##(1992-6#1)(2010-12#2)
in inflammatory##18##2##(1990-2#1)(1992-6#1)(1993-3#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#2)(2013-1#2)(2013-8#1)
in influencing##7##2##(1993-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2010-10#1)
in information retrieval##2##3##(1992-1#1)(1994-8#1)
in information##4##2##(1992-1#1)(1994-8#1)(2008-11#1)(2008-5#1)
in inhibiting the##7##3##(1992-3#3)(1995-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
in inhibiting##12##2##(1992-3#3)(1994-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)
in inhibition of##3##3##(1995-12#1)(1996-2#1)(2008-10#1)
in inhibition##5##2##(1990-7#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-5#1)
in inhibitory##3##2##(1994-2#1)(2008-10#1)(2008-7#1)
in initial##4##2##(1990-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
in initially##2##2##(2008-10#1)(2008-11#1)
in initiating and##2##3##(1994-8#1)(1995-3#1)
in initiating##7##2##(1994-11#1)(1994-8#1)(1995-3#1)(2008-10#2)(2010-5#1)(2011-2#1)
in initiation##2##2##(1993-3#1)(2008-10#1)
in injection##4##2##(2008-10#4)
in inoculated and##3##3##(2008-10#2)(2011-10#1)
in inoculated leaves##4##3##(2008-10#4)
in inoculated plants##2##3##(2008-10#2)
in inoculated##14##2##(2008-10#12)(2011-10#1)(2011-2#1)
in inoculation tests##2##3##(2008-10#2)
in inoculation##4##2##(2008-10#4)
in inoculum##7##2##(2008-10#7)
in inorganic##2##2##(1994-2#1)(2008-10#1)
in inositol##3##2##(1993-8#1)(1996-12#1)(1997-7#1)
in inpatient##4##2##(1991-2#1)(1993-12#1)(1993-2#1)(2009-5#1)
in insect cell##3##3##(1997-8#1)(2008-11#2)
in insect cells##6##3##(1993-6#2)(1993-8#1)(2008-7#3)
in insect##18##2##(1993-6#2)(1993-8#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-7#5)(2008-8#1)(2012-2#1)(2013-8#1)
in insects##5##2##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)
in instant##2##2##(2008-10#1)(2011-2#1)
in institutionalised##2##2##(2008-10#1)(2008-7#1)
in institutions##3##2##(1990-6#2)(1991-6#1)
in instrument design##2##3##(2008-10#2)
in instrument##3##2##(2008-10#3)
in instrumentation##3##2##(2008-10#3)
in insulin##10##2##(1992-10#1)(1996-2#1)(1997-1#1)(2008-4#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-1#1)
in insulin-producing liver cells##2##4##(2010-11#2)
in insurance##2##2##(1992-3#1)(2011-2#1)
in intact and##2##3##(1994-2#1)(1994-8#1)
in intact cells##4##3##(1992-9#1)(1994-3#1)(1995-6#1)(1996-2#1)
in intact plants of the water mossFontinalis antipyretica##2##8##(2008-11#2)
in intact plants##4##3##(2008-10#1)(2008-11#3)
in intact##22##2##(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-4#1)(2012-2#1)
in integrated pest management##4##4##(2008-10#3)(2013-8#1)
in integrated photoelasticity##3##3##(2008-3#3)
in integrated##13##2##(1996-1#1)(1996-3#1)(1997-7#1)(2008-10#5)(2008-3#4)(2013-8#1)
in intense##2##2##(2008-10#2)
in intensity of##3##3##(2008-10#2)(2008-9#1)
in intensity##9##2##(1995-10#1)(1995-12#1)(2008-10#5)(2008-9#1)(2010-1#1)
in intensive care patients##2##4##(1990-2#1)(2008-7#1)
in intensive care units##3##4##(2010-12#1)(2011-2#1)(2012-3#1)
in intensive care##7##3##(1990-2#1)(1997-1#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-3#1)
in intensive##9##2##(1990-2#1)(1997-1#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#2)
in inter-##2##2##(1991-2#1)(2008-10#1)
in interaction with##2##3##(1990-4#1)(2008-10#1)
in interaction##4##2##(1990-4#1)(2008-10#2)(2008-8#1)
in interactions with##2##3##(2008-10#1)(2008-4#1)
in interactions##6##2##(2008-10#4)(2008-4#1)(2008-8#1)
in intercellular spaces of##2##4##(2008-10#2)
in intercellular spaces##3##3##(2008-10#3)
in intercellular##6##2##(2008-10#5)(2009-10#1)
in intermediate##2##2##(1997-8#1)(2008-10#1)
in internal combustion engines##2##4##(2008-2#2)
in internal##8##2##(1990-5#1)(1993-6#1)(1994-3#1)(2008-10#2)(2008-2#2)(2010-10#1)
in international contexts##3##3##(2010-9#3)
in international journals##2##3##(1993-6#1)(1994-12#1)
in international##9##2##(1993-2#1)(1993-6#1)(1994-12#1)(2008-10#1)(2010-9#3)(2011-2#1)(2012-12#1)
in interphase##3##2##(2008-4#1)(2011-2#2)
in interpretation of##3##3##(1991-12#1)(1995-11#1)(2008-4#1)
in interpreting the##4##3##(1995-5#1)(1996-3#1)(2011-2#1)(2012-3#1)
in interpreting##8##2##(1993-12#1)(1995-5#1)(1996-3#1)(2008-10#1)(2011-2#1)(2012-3#2)(2013-1#1)
in interspecific##2##2##(2008-10#1)(2008-8#1)
in intervention group##2##3##(2008-12#2)
in intervention vs##2##3##(2012-3#2)
in intervention##8##2##(1992-2#1)(2008-12#2)(2011-2#1)(2012-2#2)(2012-3#2)
in interventional radiology##5##3##(2012-2#5)
in interventional##6##2##(2008-11#1)(2012-2#5)
in intestinal##5##2##(1990-3#1)(1996-12#1)(2008-11#1)(2011-2#1)(2011-3#1)
in intestine##2##2##(2011-3#1)(2013-1#1)
in intracellular Ca(2+)##3##3##(2006-6#1)(2008-11#1)(2012-2#1)
in intracellular Ca2+##3##3##(1991-5#1)(1994-2#1)(1996-2#1)
in intracellular calcium##3##3##(1991-3#1)(1995-12#1)(1995-8#1)
in intracellular cyclic AMP##2##4##(1995-11#2)
in intracellular##23##2##(1991-3#1)(1991-5#1)(1993-8#1)(1994-2#2)(1994-3#2)(1995-11#2)(1995-12#1)(1995-8#2)(1996-2#1)(1997-3#1)(2006-6#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
in intracerebral##2##2##(1996-6#1)(2013-8#1)
in intracranial EEG##2##3##(2013-8#2)
in intracranial##6##2##(1991-2#1)(1993-9#1)(2012-2#1)(2013-8#3)
in intraoperative##6##2##(1993-1#1)(2007-8#1)(2008-7#1)(2009-12#1)(2011-7#2)
in intrauterine##2##2##(1994-12#1)(2012-3#1)
in intravenous drug##2##3##(1991-1#1)(2008-12#1)
in intrinsic##5##2##(1992-8#1)(1995-6#1)(2008-11#1)(2008-3#1)(2009-5#1)
in introducing##2##2##(1994-1#1)(2008-12#1)
in intron 3 of##2##4##(2010-4#1)(2011-1#1)
in intron size##2##3##(2008-8#2)
in intron##7##2##(2008-7#1)(2008-8#3)(2008-9#1)(2010-4#1)(2011-1#1)
in introns##2##2##(1994-12#1)(2011-2#1)
in invasion of##2##3##(2008-10#1)(2008-11#1)
in invertebrates##2##2##(2008-8#1)(2012-2#1)
in inverted and rotated cultures##2##5##(2008-11#2)
in inverted##3##2##(1993-12#1)(2008-11#2)
in investigating this##2##3##(1992-2#1)(2008-12#1)
in investigating##6##2##(1992-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)
in investigations of##2##3##(2008-10#1)(2008-8#1)
in ion and water##2##4##(2007-12#2)
in ion chromatography##3##3##(2008-10#3)
in ion mobility spectrometry##4##4##(2008-10#4)
in ion##12##2##(1993-3#1)(2007-12#2)(2008-10#9)
in ion-exchange##2##2##(2008-10#1)(2008-6#1)
in ion-pair extraction##2##3##(2008-10#2)
in ionic##3##2##(1997-2#1)(2008-10#2)
in ipsilateral##2##2##(2008-5#1)(2011-2#1)
in iran##3##2##(2012-2#1)(2013-1#2)
in iron##16##2##(1990-5#1)(1994-5#1)(1995-8#3)(2008-10#7)(2008-11#1)(2012-2#2)(2013-8#1)
in iron-rich##2##2##(2008-10#2)
in irradiated cells##3##3##(1995-6#1)(2011-2#2)
in irradiated##5##2##(1993-8#1)(1995-6#1)(2011-2#3)
in irradiation##2##2##(2012-2#1)(2013-1#1)
in irrigation water##7##3##(2008-10#7)
in ischaemic##3##2##(2008-10#1)(2008-7#2)
in ischemic##2##2##(1993-6#1)(2012-12#1)
in islet##6##2##(1995-8#2)(1996-2#1)(2008-11#2)(2010-11#1)
in islets##4##2##(1995-8#2)(2008-5#1)(2010-11#1)
in isocratic mode##2##3##(2008-10#1)(2010-11#1)
in isocratic##3##2##(2008-10#2)(2010-11#1)
in isolate##2##2##(2008-10#2)
in isolated hepatocytes##3##3##(1993-3#1)(1994-8#1)(1995-11#1)
in isolated mitochondria##2##3##(1991-3#1)(1995-11#1)
in isolated rat hepatocytes##4##4##(1992-3#1)(1993-3#1)(1996-2#2)
in isolated rat##6##3##(1992-3#1)(1993-3#1)(1995-8#2)(1996-2#2)
in isolated##28##2##(1990-11#1)(1991-3#1)(1992-3#1)(1993-3#3)(1994-11#4)(1994-8#2)(1995-11#3)(1995-8#2)(1996-2#2)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#1)
in isolates from##5##3##(2008-10#5)
in isolates of##3##3##(2008-10#3)
in isolates##14##2##(2008-10#14)
in isolation##15##2##(1996-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#5)(2012-2#1)(2012-3#1)
in isopropanol##4##2##(1991-5#2)(2008-10#1)(2008-11#1)
in isozyme##2##2##(2008-10#2)
in it##4##2##(1995-5#1)(1996-12#1)(1997-2#1)(2008-12#1)
in its N-terminus##2##3##(1991-5#1)(2012-2#1)
in its ability to##7##4##(1991-3#1)(2008-10#3)(2009-8#1)(2011-2#1)(2012-3#1)
in its absence##3##3##(1993-8#1)(2008-10#2)
in its anti-invasive action##2##4##(2008-11#2)
in its early##2##3##(2010-8#1)(2011-2#1)
in its environment##2##3##(2008-3#1)(2009-12#1)
in its first##2##3##(1995-1#1)(2008-5#1)
in its functional##2##3##(2008-9#1)(2009-9#1)
in its infancy##5##3##(1995-5#1)(1996-2#1)(1997-7#1)(2008-10#1)(2012-2#1)
in its management##2##3##(1991-2#1)(2013-1#1)
in its natural##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
in its own right##2##4##(2008-11#1)(2013-1#1)
in its own##7##3##(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-3#1)(2013-1#1)
in its pathogenesis##3##3##(1991-3#1)(2008-7#1)(2010-10#1)
in its pharmaceutical formulation##2##4##(2008-10#2)
in its pharmaceutical formulations##2##4##(2008-10#2)
in its pharmaceutical##4##3##(2008-10#4)
in its pure form##2##4##(2008-10#2)
in its pure##3##3##(2008-10#3)
in its regulation##2##3##(1994-11#1)(2006-6#1)
in its response##2##3##(2008-10#1)(2009-12#1)
in its##172##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-1#2)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#3)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#37)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#9)(2008-9#4)(2009-10#5)(2009-12#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)
in itself##6##2##(1994-1#1)(1996-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
in jasmonic acid production##2##4##(2008-5#2)
in jet turbines##2##3##(2008-11#2)
in job##2##2##(2008-11#1)(2008-12#1)
in joint##2##2##(2010-10#1)(2011-2#1)
in juice##2##2##(2008-10#2)
in jujube fruit##3##3##(2008-10#3)
in junD##2##2##(1996-12#2)
in junction dynamics##2##3##(2009-10#1)(2012-2#1)
in junction##3##2##(2009-10#2)(2012-2#1)
in just##4##2##(2008-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
in juvenile##4##2##(1993-5#1)(1997-3#1)(2010-8#1)(2012-2#1)
in keeping with the##4##4##(1994-1#1)(1995-1#1)(2008-12#1)(2009-8#1)
in keeping with##6##3##(1994-1#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)
in keeping##9##2##(1992-9#1)(1994-1#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2013-1#1)
in keratinocytes##2##2##(2008-11#1)(2011-2#1)
in kernels of##4##3##(2008-10#4)
in kernels##7##2##(2008-10#7)
in kerosene##6##2##(2008-10#6)
in khuzestan##2##2##(2012-2#1)(2013-1#1)
in kidney and##3##3##(1994-11#1)(1997-8#1)(2008-6#1)
in kidney failure##2##3##(2008-11#1)(2012-12#1)
in kidney##16##2##(1990-12#1)(1990-5#1)(1993-12#2)(1994-11#2)(1994-5#1)(1997-8#1)(2008-11#1)(2008-6#1)(2009-3#1)(2012-12#1)(2013-1#1)(2013-8#3)
in kidneys with##2##3##(1996-6#2)
in kidneys##5##2##(1994-5#2)(1996-6#2)(2009-6#1)
in killing##3##2##(2008-4#1)(2012-3#1)(2013-1#1)
in kindergarten##3##2##(2008-12#2)(2013-1#1)
in kindled rats##2##3##(1990-5#1)(1992-12#1)
in kinetic##2##2##(2008-10#1)(2009-6#1)
in kitten heart##2##3##(1995-11#2)
in knee##2##2##(1992-3#1)(2008-12#1)
in knowledge##8##2##(1992-2#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-12#1)(2013-8#1)
in lab##2##2##(2008-10#1)(2012-3#1)
in labeling##2##2##(1997-3#1)(2013-1#1)
in laboratories##2##2##(2008-11#1)(2008-8#1)
in laboratory conditions##3##3##(2008-10#3)
in laboratory experiments and the##2##5##(2008-10#2)
in laboratory experiments##3##3##(2008-10#3)
in laboratory medicine##2##3##(1994-12#2)
in laboratory or##3##3##(1995-9#1)(2007-11#1)(2008-10#1)
in laboratory##36##2##(1991-12#1)(1994-12#3)(1995-9#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#17)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#1)
in lacquer##2##2##(2008-10#2)
in lactate##4##2##(1990-8#1)(1994-2#1)(1994-3#1)(1995-12#1)
in lactating##4##2##(1990-11#1)(2011-2#3)
in lake sediment samples##2##4##(2008-10#2)
in lake water samples##3##4##(2008-10#3)
in lake water##4##3##(2008-10#4)
in lake##8##2##(2008-10#8)
in lambda##2##2##(1992-6#1)(1993-9#1)
in lambs##6##2##(1990-6#1)(1991-8#1)(1996-12#4)
in lamin##2##2##(2011-2#2)
in lamina##3##2##(1997-3#2)(2008-7#1)
in laminae I and II##2##5##(1995-12#2)
in land##3##2##(2008-10#1)(2009-6#1)(2010-7#1)
in landfill gas##3##3##(2008-10#3)
in landfill leachates##2##3##(2008-10#2)
in landfill##5##2##(2008-10#5)
in landscape##2##2##(2008-10#1)(2013-1#1)
in laparoscopic surgery##3##3##(1993-12#1)(1995-1#1)(2008-10#1)
in laparoscopic##8##2##(1993-12#2)(1995-1#2)(2008-10#2)(2012-12#2)
in large amounts##3##3##(2008-11#1)(2008-6#1)(2011-1#1)
in large antral follicles##2##4##(2008-9#2)
in large excess##3##3##(2008-10#3)
in large neurons than##2##4##(1996-12#2)
in large neurons##3##3##(1996-12#3)
in large part to##2##4##(1995-12#1)(2008-9#1)
in large part##5##3##(1993-2#1)(1995-12#1)(2008-9#1)(2012-12#1)(2013-1#1)
in large quantities##6##3##(2008-10#4)(2008-11#2)
in large scale##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
in large urban##2##3##(1992-12#1)(1995-5#1)
in large##63##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#3)(2008-10#14)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#4)(2008-9#4)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
in large-scale production##2##3##(2008-11#2)
in large-scale##6##2##(2008-11#4)(2009-6#1)(2009-8#1)
in larger groups##2##3##(2008-8#2)
in larger##9##2##(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-5#1)
in larvae##2##2##(1993-9#1)(2010-8#1)
in larval##6##2##(2008-1#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
in laryngeal##2##2##(2011-2#1)(2012-3#1)
in laser resonators##3##3##(2008-2#1)(2008-3#2)
in laser##11##2##(1993-6#1)(2008-10#1)(2008-2#2)(2008-3#7)
in laser-enhanced ionization##2##3##(2008-10#2)
in laser-induced##2##2##(2008-10#1)(2008-3#1)
in last##3##2##(2008-11#1)(2009-3#1)(2010-8#1)
in late blight##2##3##(2008-10#2)
in late stages of##3##4##(1994-12#1)(2011-3#2)
in late stages##4##3##(1994-12#1)(2010-12#1)(2011-3#2)
in late##28##2##(1992-6#1)(1994-12#1)(1994-2#1)(1997-3#2)(2007-12#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-3#2)(2012-2#1)
in latent period##2##3##(2008-10#2)
in latent##3##2##(2008-10#3)
in later life##3##3##(1995-12#1)(2008-11#1)(2009-8#1)
in later stages##2##3##(2008-2#1)(2013-8#1)
in later##9##2##(1993-6#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2012-2#1)(2013-8#1)
in lateral##7##2##(1993-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#3)
in layer##6##2##(1994-2#2)(1997-3#1)(2008-11#2)(2008-5#1)
in layers II and##2##4##(1994-2#2)
in layers II##5##3##(1994-2#4)(1997-2#1)
in layers##6##2##(1994-2#5)(1997-2#1)
in leading##2##2##(1993-6#1)(2008-11#1)
in leaf and##3##3##(2008-10#2)(2013-8#1)
in leaf discs of##2##4##(2008-10#2)
in leaf extracts from##2##4##(2008-10#2)
in leaf lesions##2##3##(2008-10#2)
in leaf temperature##2##3##(2008-10#2)
in leaf tissue##2##3##(2008-10#1)(2013-8#1)
in leaf tissues##2##3##(2008-10#2)
in leaf##32##2##(2008-10#24)(2008-12#1)(2010-3#1)(2012-5#1)(2012-7#1)(2012-9#1)(2013-8#3)
in leafhoppers##2##2##(2008-10#2)
in lean##2##2##(2008-10#1)(2008-3#1)
in learning and memory##9##4##(1993-12#1)(1993-3#1)(2008-5#2)(2008-7#2)(2009-8#1)(2012-2#2)
in learning and##11##3##(1993-12#1)(1993-3#1)(2008-11#2)(2008-5#2)(2008-7#2)(2009-8#1)(2012-2#2)
in learning is##2##3##(2008-11#1)(2009-7#1)
in learning##20##2##(1993-12#1)(1993-3#1)(1995-8#1)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-2#2)
in leather##3##2##(2008-10#2)(2009-12#1)
in leaves and roots##2##4##(2008-12#1)(2009-8#1)
in leaves and stems##2##4##(2008-10#2)
in leaves and##7##3##(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)
in leaves from##2##3##(2008-10#2)
in leaves of##8##3##(2008-10#5)(2008-12#1)(2008-8#1)(2012-3#1)
in leaves##35##2##(2008-10#21)(2008-12#2)(2008-8#3)(2008-9#3)(2009-8#1)(2011-10#4)(2012-3#1)
in left##5##2##(1994-12#1)(2008-11#1)(2008-9#1)(2009-10#1)(2013-1#1)
in left-to-right##2##2##(2008-11#1)(2010-10#1)
in leg##2##2##(1997-4#1)(2008-5#1)
in legume##2##2##(2008-10#2)
in length and contains an open reading frame of##2##9##(1993-2#2)
in length and contains an##3##5##(1993-2#2)(2008-8#1)
in length and contains##4##4##(1993-2#2)(1997-7#1)(2008-8#1)
in length and##9##3##(1993-2#2)(1997-7#1)(1997-9#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)
in length of stay##4##4##(1993-12#1)(1994-12#1)(1994-3#2)
in length of##7##3##(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1997-4#2)
in length##47##2##(1991-3#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-2#5)(1993-8#1)(1994-12#1)(1994-3#2)(1995-12#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-8#9)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
in length)##4##2##(1990-2#1)(2008-10#2)(2010-12#1)
in leptin and##2##3##(2013-8#2)
in leptin##4##2##(2008-10#1)(2013-8#3)
in lesion area##2##3##(2012-3#2)
in lesion size##2##3##(2008-10#2)
in lesion##8##2##(1997-8#1)(2008-10#4)(2010-12#1)(2012-3#2)
in lesion-induced##2##2##(1991-2#1)(1993-3#1)
in lesions##3##2##(2008-10#3)
in less than 1##4##4##(2008-10#1)(2008-11#1)(2012-3#2)
in less than 10 min##4##5##(2008-10#4)
in less than 10##5##4##(2008-10#4)(2008-11#1)
in less than 2 min##2##5##(2008-10#2)
in less than 2##4##4##(2008-10#3)(2008-11#1)
in less than 4 min##2##5##(2008-10#2)
in less than 5 min##2##5##(1993-3#1)(2008-10#1)
in less than 5##3##4##(1993-3#1)(2008-10#2)
in less than 5% of##2##5##(2008-5#1)(2009-8#1)
in less than a##2##4##(2008-11#1)(2012-3#1)
in less than##40##3##(1993-3#1)(1995-11#1)(1996-11#1)(1997-4#1)(2008-10#22)(2008-11#4)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#4)(2013-1#1)
in less##50##2##(1993-3#1)(1995-11#1)(1996-11#1)(1997-4#1)(2008-10#25)(2008-11#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#3)
in lettuce and##4##3##(2008-10#4)
in lettuce##11##2##(2008-10#10)(2013-8#1)
in leukemia##2##2##(1991-3#1)(2011-2#1)
in leukemic cells from##2##4##(1991-9#1)(2008-9#1)
in leukemic cells##3##3##(1991-9#1)(1995-2#1)(2008-9#1)
in leukocyte##3##2##(2009-12#1)(2009-6#1)(2010-5#1)
in level and##2##3##(1996-3#1)(2010-5#1)
in level of##3##3##(1990-5#1)(2012-3#2)
in level##5##2##(1990-5#1)(1996-3#1)(2010-5#1)(2012-3#2)
in levels of##9##3##(1991-12#1)(1992-3#1)(1993-11#1)(1995-12#1)(1996-12#2)(2008-10#2)(2010-12#1)
in levels##11##2##(1991-12#1)(1992-3#1)(1993-11#1)(1994-3#2)(1995-12#1)(1996-12#2)(2008-10#2)(2010-12#1)
in lichen samples##3##3##(2008-10#3)
in lichen##5##2##(2008-10#3)(2010-6#2)
in lichens and plants##2##4##(2008-10#2)
in lidar##2##2##(2008-2#1)(2008-3#1)
in lieu of##3##3##(1996-12#1)(1997-3#1)(2013-8#1)
in life##19##2##(1990-3#1)(1991-6#1)(1995-5#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#2)(2010-6#1)(2012-2#1)(2013-1#1)
in life-history traits##4##3##(2008-8#3)(2008-9#1)
in life-history##5##2##(2008-8#4)(2008-9#1)
in ligand-dependent##2##2##(1995-2#1)(2008-10#1)
in light of current##2##4##(1991-12#1)(2008-11#1)
in light of previous##2##4##(1994-5#1)(2008-10#1)
in light of the##9##4##(1994-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-7#1)(2012-2#1)(2012-3#1)
in light of##24##3##(1991-1#1)(1991-12#1)(1993-1#1)(1994-2#2)(1994-5#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-8#1)
in light##31##2##(1991-1#1)(1991-12#1)(1993-1#1)(1994-2#2)(1994-5#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-8#1)
in lignifying##2##2##(2008-11#2)
in limb reconstruction##2##3##(1996-3#1)(2008-8#1)
in limb##3##2##(1995-8#1)(1996-3#1)(2008-8#1)
in limbic and cortical##2##4##(1991-10#2)
in limbic and##3##3##(1991-10#3)
in limbs in which the main arteries##2##7##(1997-8#2)
in limited##5##2##(1993-2#1)(2008-10#2)(2009-12#1)(2011-2#1)
in limiting##6##2##(2008-10#3)(2008-3#2)(2008-5#1)
in line with the hypothesis that##2##6##(1990-12#1)(2008-10#1)
in line with the##6##4##(1990-12#1)(2008-10#3)(2009-11#1)(2010-11#1)
in line with##17##3##(1990-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1995-12#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)(2009-11#1)(2010-11#1)(2012-3#1)
in line##24##2##(1990-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1995-12#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-9#1)(2009-11#1)(2010-11#1)(2012-3#2)
in lineages##4##2##(2008-10#3)(2012-3#1)
in linear##7##2##(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)
in lines##2##2##(2008-10#2)
in linkage disequilibrium##2##3##(2008-12#1)(2012-3#1)
in lipid and##2##3##(2008-10#1)(2008-11#1)
in lipid metabolism##2##3##(1996-3#1)(2008-11#1)
in lipid packing##2##3##(2008-10#1)(2008-5#1)
in lipid##15##2##(1992-9#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#3)(2008-8#1)(2009-8#1)
in lipoprotein##2##2##(2008-5#1)(2008-6#1)
in liposomal##2##2##(2008-8#2)
in lipstick##2##2##(2008-5#2)
in liquid and solid##2##4##(2008-10#2)
in liquid chromatography##3##3##(2008-10#2)(2010-7#1)
in liquid crystal materials##2##4##(2008-10#2)
in liquid crystal##3##3##(2008-10#3)
in liquid culture##5##3##(2008-10#4)(2013-1#1)
in liquid cultures##2##3##(2008-10#1)(2011-2#1)
in liquid egg##2##3##(2011-2#2)
in liquid media##3##3##(1990-8#1)(2008-10#1)(2008-8#1)
in liquid medium##4##3##(1990-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
in liquid nitrogen and##2##4##(2008-10#2)
in liquid nitrogen##5##3##(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)
in liquid phase##3##3##(2008-10#3)
in liquid whole##2##3##(2011-2#2)
in liquid##55##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-8#1)(2008-10#32)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-2#1)(2013-1#1)
in liquid-liquid extraction##2##3##(2008-10#2)
in liquid-solid interface##2##3##(2008-10#2)
in liquids##2##2##(1995-3#1)(2008-10#1)
in liquified##2##2##(1996-1#2)
in listener perceptions##2##3##(2011-1#2)
in literature##23##2##(1992-9#1)(1996-3#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-7#1)
in live cells##5##3##(2008-10#3)(2008-11#1)(2009-6#1)
in live wheat leaves##2##4##(2008-10#2)
in live##10##2##(1995-5#1)(1997-7#1)(2008-10#5)(2008-11#1)(2009-6#1)(2013-1#1)
in liver ID1 mRNA levels##2##5##(1995-12#2)
in liver ID1##3##3##(1995-12#3)
in liver and##5##3##(1990-12#1)(1994-11#1)(1996-12#1)(2008-10#1)(2012-2#1)
in liver cells##5##3##(1994-6#1)(1995-6#1)(1997-1#1)(2008-10#1)(2010-5#1)
in liver microsomes##3##3##(1994-8#1)(2011-3#2)
in liver stroma and##2##4##(2013-1#2)
in liver tissue and##2##4##(1990-2#1)(2008-10#1)
in liver##50##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-12#4)(1995-2#1)(1995-6#1)(1996-12#2)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#5)(2011-2#2)(2011-3#3)(2012-2#1)(2013-1#5)
in livestock##4##2##(1994-3#1)(1997-7#2)(2011-2#1)
in living cells##13##3##(1995-11#1)(2008-1#2)(2008-11#1)(2008-8#2)(2008-9#2)(2009-7#2)(2013-1#2)(2013-8#1)
in living flies##2##3##(1995-6#2)
in living yeast cells##2##4##(1996-6#2)
in living##27##2##(1995-11#1)(1995-6#2)(1996-6#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-8#2)(2008-9#2)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
in lizards##4##2##(1991-5#1)(2008-10#2)(2008-7#1)
in local bacterial resistance##2##4##(2008-10#2)
in local##24##2##(1990-5#1)(1990-8#1)(1992-6#1)(1993-1#2)(1994-11#1)(1994-2#1)(1995-2#1)(1996-1#2)(1997-7#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#1)
in localization##2##2##(1990-3#1)(2010-5#1)
in localized##7##2##(1991-2#1)(1992-2#1)(1992-9#1)(2008-10#2)(2008-7#1)(2011-2#1)
in localizing##2##2##(1995-6#1)(2009-9#1)
in locally advanced##4##3##(1990-6#1)(1991-8#1)(1994-6#1)(2008-10#1)
in locally##6##2##(1990-6#1)(1991-8#1)(1993-1#1)(1994-6#1)(2008-10#1)(2011-2#1)
in locating##2##2##(1993-12#1)(1995-1#1)
in locomotion##2##2##(2008-7#1)(2013-1#1)
in log##4##2##(2008-10#4)
in long term care##3##4##(1993-2#1)(1994-12#1)(2008-12#1)
in long term##7##3##(1993-2#1)(1994-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
in long##14##2##(1993-2#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
in long-lived##2##2##(2008-8#1)(2008-9#1)
in long-term care facilities##3##4##(1991-1#1)(1993-3#1)(1997-2#1)
in long-term care for##2##4##(1993-3#1)(1996-2#1)
in long-term care settings##3##4##(1997-1#2)(2009-4#1)
in long-term care##20##3##(1991-1#1)(1992-3#1)(1993-3#3)(1996-2#1)(1997-1#6)(1997-2#1)(2008-12#1)(2008-7#1)(2009-3#2)(2009-4#2)(2010-10#1)
in long-term cultures##3##3##(2008-11#3)
in long-term memory##2##3##(2009-6#1)(2013-8#1)
in long-term##39##2##(1991-1#1)(1992-3#1)(1993-3#3)(1995-11#1)(1996-2#1)(1997-1#6)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-4#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
in longevity##2##2##(2008-10#1)(2012-3#1)
in longitudinal models##2##3##(2013-1#2)
in longitudinal studies##2##3##(1992-12#1)(1994-9#1)
in longitudinal##4##2##(1992-12#1)(1994-9#1)(2013-1#2)
in loose islets##3##3##(2008-5#3)
in loss of##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
in low and intermediate##2##4##(2008-10#1)(2012-2#1)
in low and middle-income countries##2##5##(2008-10#2)
in low and##5##3##(2008-10#3)(2008-8#1)(2012-2#1)
in low concentration in##2##4##(2008-10#2)
in low concentration##4##3##(2008-10#3)(2008-12#1)
in low concentrations in##2##4##(2008-10#1)(2013-8#1)
in low resource##2##3##(2011-2#1)(2013-1#1)
in low serum##3##3##(2008-11#3)
in low##42##2##(1990-12#1)(1990-5#1)(1993-3#1)(1994-2#1)(1994-3#1)(1997-3#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-8#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
in low- and middle-income##2##4##(2010-11#1)(2011-2#1)
in low-grade astrocytomas##2##3##(1994-8#1)(2008-7#1)
in low-income##4##2##(2008-11#2)(2012-2#1)(2013-1#1)
in lower concentrations##2##3##(2008-10#1)(2013-8#1)
in lower elevation populations##2##4##(2012-7#2)
in lower eukaryotes##3##3##(1995-2#1)(2008-11#1)(2012-2#1)
in lower extremities showing a##2##5##(1997-8#2)
in lower extremity##2##3##(2008-12#1)(2008-9#1)
in lower limb##2##3##(2013-1#2)
in lower##28##2##(1992-12#1)(1995-2#1)(1997-3#1)(1997-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-7#2)(2013-1#2)(2013-8#1)
in lowering the##2##3##(1993-1#1)(1995-2#1)
in lubricating oils##6##3##(2008-10#6)
in lubricating##7##2##(2008-10#7)
in lumen##3##2##(2009-1#1)(2011-3#2)
in lung cancer##4##3##(1993-8#1)(1994-6#1)(2009-4#1)(2013-8#1)
in lung cancers##2##3##(1993-8#1)(2009-11#1)
in lung deposition##2##3##(1997-1#1)(2008-11#1)
in lung function##2##3##(1997-1#1)(2008-11#1)
in lung immune##3##3##(2008-10#2)(2008-6#1)
in lung parenchyma##3##3##(1991-12#2)(1992-1#1)
in lung transplantation##2##3##(2011-3#2)
in lung##31##2##(1991-12#4)(1992-1#1)(1993-8#2)(1994-1#1)(1994-5#1)(1994-6#1)(1995-8#1)(1997-1#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2009-11#1)(2009-4#1)(2011-2#2)(2011-3#3)(2012-2#1)(2013-8#1)
in lungs##2##2##(1996-3#1)(2011-3#1)
in lymph##2##2##(1997-8#1)(2012-3#1)
in lymphocyte##5##2##(1991-6#1)(1992-12#2)(2011-3#1)(2013-8#1)
in lymphocytes of##3##3##(1993-1#2)(2008-7#1)
in lymphocytes##10##2##(1990-8#1)(1993-1#2)(1993-8#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#2)
in lymphocytic##2##2##(2007-11#1)(2012-2#1)
in lymphoid##3##2##(2008-4#1)(2008-5#1)(2008-7#1)
in lysates of##2##3##(1993-9#1)(1994-6#1)
in lysosomal##2##2##(1992-12#1)(2009-8#1)
in mRNA expression##2##3##(1996-12#2)
in mRNA levels##2##3##(1994-11#1)(1996-12#1)
in mRNA stability##2##3##(2008-11#2)
in mRNA##8##2##(1994-11#1)(1995-2#1)(1996-12#4)(2008-11#2)
in macaques with##2##3##(1991-2#2)
in macaques##3##2##(1991-2#2)(1991-9#1)
in macrophage##3##2##(1992-5#1)(1995-2#1)(2008-11#1)
in macrophages##7##2##(1990-6#1)(1991-5#1)(1994-8#1)(1995-12#1)(1996-2#1)(2008-11#1)(2013-8#1)
in macular##2##2##(2008-7#1)(2013-1#1)
in magnetic resonance##2##3##(1995-5#1)(2013-1#1)
in magnetic##3##2##(1995-5#1)(2008-9#1)(2013-1#1)
in magnitude with##2##3##(1997-2#1)(2008-5#1)
in magnitude##9##2##(1990-10#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#1)(2012-6#1)
in mainland##2##2##(2008-9#1)(2013-8#1)
in mainstream##4##2##(1996-1#1)(2011-2#2)(2013-8#1)
in maintaining the##8##3##(1990-2#1)(1995-6#2)(1995-9#1)(2008-10#1)(2009-10#1)(2009-8#1)(2012-2#1)
in maintaining##30##2##(1990-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-6#2)(1995-9#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2011-2#2)(2012-2#1)(2013-7#1)
in maintenance##2##2##(2009-6#1)(2013-7#1)
in maize ears##2##3##(2008-10#2)
in maize kernels##2##3##(2008-10#2)
in maize silage##3##3##(2008-10#3)
in maize##31##2##(2008-10#24)(2008-12#1)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#3)
in major abdominal and thoracic surgical patients##2##7##(1993-12#2)
in major##13##2##(1991-2#1)(1992-4#1)(1993-12#2)(2008-10#3)(2008-11#2)(2008-4#3)(2008-9#1)
in majority of##3##3##(2008-11#1)(2010-7#1)(2010-8#1)
in making##14##2##(1990-2#1)(1994-3#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
in malaria parasites##2##3##(2012-3#2)
in malaria##5##2##(1994-8#1)(2010-1#1)(2012-12#1)(2012-3#2)
in male Fischer 344 rats##3##5##(1992-12#1)(1994-3#1)(2008-7#1)
in male Fischer##5##3##(1990-3#1)(1992-12#1)(1993-12#1)(1994-3#1)(2008-7#1)
in male Tg##2##3##(2008-9#2)
in male and female Tg##4##5##(2008-9#4)
in male and female##10##4##(1994-2#1)(1995-11#1)(2008-12#1)(2008-9#6)(2012-2#1)
in male dogs##2##3##(1996-11#2)
in male germ cells##2##4##(1997-3#1)(2012-2#1)
in male mice##2##3##(2008-9#1)(2011-2#1)
in male or female Tg##4##5##(2008-9#4)
in male or female p53 haploinsufficient mice exposed to##2##9##(2008-9#2)
in male or female p53 haploinsufficient mice##3##7##(2008-9#3)
in male or female p53##4##5##(2008-9#4)
in male or female##8##4##(2008-9#8)
in male patients##3##3##(2009-11#1)(2011-2#2)
in male rats##8##3##(1994-2#2)(1995-11#1)(1995-12#2)(1995-8#1)(1997-6#1)(2008-10#1)
in male##68##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#5)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-8#1)(1996-11#3)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#18)(2009-10#1)(2009-11#1)(2009-5#1)(2011-2#5)(2012-2#4)(2012-3#2)
in males and females exposed to dichloroacetic acid##2##8##(2008-9#2)
in males and females exposed to##3##6##(2008-9#3)
in males and females##6##4##(1990-8#1)(2008-9#5)
in males and##11##3##(1990-8#1)(1991-6#1)(2008-10#2)(2008-11#1)(2008-9#5)(2012-2#1)
in males but##2##3##(1994-6#1)(2013-8#1)
in males in##3##3##(1997-7#1)(2008-9#1)(2009-1#1)
in males than in females##5##5##(1990-12#1)(1992-12#1)(2008-11#1)(2008-8#1)(2010-8#1)
in males was##3##3##(1993-8#1)(2011-2#2)
in males while##2##3##(1997-7#1)(2007-12#1)
in males##54##2##(1990-11#1)(1990-12#2)(1990-8#2)(1991-6#5)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#1)(1995-2#1)(1997-3#1)(1997-7#4)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-1#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#1)
in malignancy##4##2##(1991-8#2)(1994-11#2)
in malignant cells##3##3##(1993-1#1)(2012-2#2)
in malignant glioma##2##3##(2011-2#2)
in malignant##13##2##(1990-3#1)(1990-8#1)(1992-2#1)(1993-1#1)(1997-5#1)(2010-12#1)(2011-2#4)(2012-2#3)
in malnourished##2##2##(1992-9#1)(2008-11#1)
in malpractice##3##2##(1993-12#1)(1993-2#1)(1995-5#1)
in mammalian cell culture##3##4##(2008-11#2)(2008-7#1)
in mammalian cell cultures##3##4##(2008-11#3)
in mammalian cell##9##3##(2008-11#7)(2008-7#1)(2013-8#1)
in mammalian cells and##3##4##(2008-11#2)(2008-8#1)
in mammalian cells has##2##4##(2008-11#1)(2008-7#1)
in mammalian cells##32##3##(1990-5#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-6#3)(1994-11#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-7#2)(2008-11#12)(2008-7#1)(2008-8#5)(2011-2#1)
in mammalian genomes##3##3##(1991-6#1)(1995-2#1)(2008-11#1)
in mammalian species##2##3##(1993-6#1)(2008-4#1)
in mammalian systems##3##3##(1994-5#1)(2008-11#1)(2008-8#1)
in mammalian##62##2##(1990-5#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#3)(1995-6#1)(1995-8#2)(1997-3#1)(1997-7#3)(2008-10#1)(2008-11#22)(2008-4#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
in mammals and##3##3##(2008-12#1)(2008-8#2)
in mammals are##2##3##(2008-8#2)
in mammals is##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
in mammals##23##2##(1990-5#1)(1992-10#1)(1994-5#1)(1995-2#1)(1997-7#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#6)(2008-9#1)(2009-8#1)(2012-2#2)(2013-1#2)
in mammary carcinogenesis##2##3##(1995-9#2)
in mammary epithelial cells##2##4##(1995-9#1)(2008-8#1)
in mammary gland##3##3##(1992-9#2)(1995-11#1)
in mammary glands##2##3##(2011-2#1)(2012-3#1)
in mammary##12##2##(1990-2#2)(1991-11#1)(1992-9#2)(1995-11#1)(1995-9#3)(2008-8#1)(2011-2#1)(2012-3#1)
in man##10##2##(1990-8#1)(1991-1#1)(1992-12#1)(1994-11#4)(1996-2#2)(1996-6#1)
in managed care is##2##4##(1997-3#2)
in managed care plans##2##4##(1995-12#1)(1997-3#1)
in managed care##16##3##(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#5)(2008-11#1)(2008-12#2)
in management of##7##3##(1993-11#1)(2008-10#2)(2008-11#2)(2010-11#1)(2010-12#1)
in management##18##2##(1991-12#1)(1992-1#1)(1993-11#1)(1994-1#1)(1994-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-12#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
in managing the##3##3##(1995-1#1)(1997-8#1)(2008-10#1)
in managing##17##2##(1991-1#1)(1994-12#1)(1995-1#1)(1996-11#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
in manufacturing industries##2##3##(1995-2#1)(2008-10#1)
in manufacturing##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
in many areas##2##3##(1992-12#1)(2007-12#1)
in many aspects of##5##4##(1996-6#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
in many aspects##8##3##(1996-6#1)(2008-11#3)(2008-9#2)(2012-2#1)(2013-1#1)
in many biological##4##3##(2008-2#1)(2008-8#1)(2008-9#1)(2009-7#1)
in many cases##16##3##(1991-6#1)(1992-2#1)(1992-5#1)(1993-6#1)(2008-10#6)(2008-7#1)(2008-9#2)(2009-10#1)(2011-2#1)(2013-1#1)
in many chemical##2##3##(2008-10#2)
in many countries##9##3##(1991-6#2)(1993-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2011-2#1)
in many different##4##3##(2008-10#2)(2008-3#1)(2009-11#1)
in many diseases##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
in many eukaryotic##2##3##(1995-2#1)(1996-2#1)
in many fields##3##3##(2008-10#2)(2008-9#1)
in many forms##2##3##(1997-8#1)(2008-5#1)
in many human##2##3##(2011-2#1)(2012-2#1)
in many important##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
in many instances##4##3##(2008-11#1)(2011-2#2)(2012-3#1)
in many medical##4##3##(1996-3#1)(1997-3#1)(2010-5#1)(2013-1#1)
in many neurodegenerative##2##3##(2008-12#1)(2013-8#1)
in many of its##2##4##(2008-6#1)(2009-8#1)
in many of##3##3##(1990-12#1)(2008-6#1)(2009-8#1)
in many other regions##2##4##(2008-10#2)
in many other##4##3##(1997-2#1)(2008-10#2)(2010-5#1)
in many parts of the world##2##6##(2008-10#1)(2012-2#1)
in many patients##5##3##(1994-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
in many primate species##2##4##(2008-11#1)(2008-8#1)
in many real##2##3##(2008-10#2)
in many regions of the##2##5##(1995-2#1)(2008-5#1)
in many regions##4##3##(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
in many settings##2##3##(1996-12#1)(2012-2#1)
in many studies##3##3##(1992-3#1)(2012-2#1)(2013-8#1)
in many systems##2##3##(2008-8#2)
in many tissues##4##3##(1992-3#1)(1994-11#1)(1995-2#1)(2008-11#1)
in many ways##4##3##(1996-3#1)(1997-6#1)(2010-4#1)(2013-1#1)
in many##195##2##(1990-12#1)(1990-5#2)(1991-5#1)(1991-6#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#4)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#5)(1996-12#2)(1996-2#2)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#3)(2007-12#3)(2008-1#1)(2008-10#49)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#10)(2008-9#12)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#10)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#4)
in marine sediment samples##2##4##(2008-10#2)
in marine sediment##4##3##(2008-10#4)
in marine waters##4##3##(2008-10#4)
in marine##25##2##(1991-6#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#3)
in marked suppression of##2##4##(2008-5#1)(2010-4#1)
in marked##4##2##(1993-12#1)(1996-12#1)(2008-5#1)(2010-4#1)
in marker-assisted selection##2##3##(2008-10#1)(2012-3#1)
in marker-assisted##3##2##(2008-10#2)(2012-3#1)
in markets##3##2##(1993-12#2)(2008-11#1)
in mass spectrometry##2##3##(2008-4#1)(2010-7#1)
in mass##11##2##(1990-8#2)(1992-12#1)(1992-2#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-7#2)
in massive##2##2##(1996-3#1)(2012-2#1)
in mastocytosis##2##2##(2008-9#1)(2011-2#1)
in mate choice within##2##4##(2008-9#2)
in mate choice##3##3##(2008-9#3)
in mate recognition##2##3##(2008-8#1)(2008-9#1)
in mate##5##2##(2008-8#1)(2008-9#4)
in materials science##2##3##(2008-10#1)(2012-2#1)
in maternal##8##2##(1995-8#2)(2008-8#3)(2010-11#1)(2012-3#1)(2013-8#1)
in mating and##2##3##(2008-11#1)(2008-8#1)
in mating##5##2##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
in matrices##5##2##(2008-10#5)
in matrix##4##2##(2008-10#3)(2008-8#1)
in mature internodes##2##3##(2011-2#2)
in mature##15##2##(1992-12#1)(1995-6#1)(2008-10#4)(2008-11#2)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
in matured##2##2##(1993-12#1)(2008-5#1)
in maximal##4##2##(1995-2#1)(2008-11#1)(2008-7#1)(2010-9#1)
in maximum##6##2##(1994-3#1)(2008-10#1)(2008-7#2)(2010-6#1)(2011-2#1)
in mean cell hemoglobin and mean cell hemoglobin concentration values##2##10##(2008-9#2)
in mean cycle duration##2##4##(1990-9#2)
in mean##13##2##(1990-9#2)(1991-12#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#2)(2011-2#1)
in measles epidemics##2##3##(1995-5#1)(2008-9#1)
in measles##3##2##(1995-5#1)(1996-1#1)(2008-9#1)
in measured##5##2##(2008-10#2)(2008-3#3)
in measurement##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
in measurements##4##2##(1991-9#1)(2008-10#2)(2008-3#1)
in measures of##2##3##(2008-11#1)(2009-7#1)
in measuring and improving the quality of##2##7##(1996-2#2)
in measuring and improving##3##4##(1996-2#3)
in measuring and##4##3##(1996-2#3)(1997-1#1)
in measuring the##3##3##(1996-3#1)(2008-11#1)(2008-9#1)
in measuring##13##2##(1992-2#1)(1994-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
in meat by##2##3##(2008-10#2)
in meat food products using ion mobility spectrometry##2##8##(2008-10#2)
in meat products##2##3##(2008-10#2)
in meat##13##2##(2008-10#11)(2010-4#2)
in mechanics##2##2##(2008-5#1)(2011-2#1)
in mecobalamin-deficient rats##2##3##(1995-11#2)
in media##12##2##(1991-12#1)(1991-5#1)(1995-12#2)(2008-11#3)(2008-12#1)(2008-7#1)(2010-7#1)(2012-7#1)(2013-1#1)
in medial##2##2##(1991-2#1)(2008-11#1)
in mediating the effects of##2##5##(1993-6#1)(1996-12#1)
in mediating the oxidative burst##2##5##(2008-10#2)
in mediating the##15##3##(1991-12#1)(1992-8#1)(1993-6#3)(1996-12#2)(1996-5#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)
in mediating this##3##3##(1993-12#1)(2008-9#1)(2009-10#1)
in mediating##28##2##(1991-12#1)(1992-8#1)(1993-12#1)(1993-6#3)(1994-3#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(2006-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-6#1)(2011-2#2)(2011-9#1)(2012-3#1)(2013-1#1)
in medical and##2##3##(1993-12#1)(2010-5#1)
in medical audit##2##3##(1991-8#1)(1992-2#1)
in medical care##7##3##(1991-2#1)(1992-1#1)(1993-2#1)(1994-1#1)(1995-8#1)(1996-9#1)(2013-1#1)
in medical education##6##3##(1991-8#1)(1995-2#1)(1997-4#1)(2008-1#1)(2008-11#1)(2013-1#1)
in medical ethics##2##3##(2008-8#1)(2013-8#1)
in medical journals##2##3##(1994-12#1)(2008-11#1)
in medical literature##2##3##(2011-2#1)(2013-8#1)
in medical practices##2##3##(2008-7#1)(2012-2#1)
in medical schools##4##3##(1993-1#1)(1993-11#1)(1994-12#1)(1997-3#1)
in medical staff credentialing##2##4##(1994-3#1)(1997-2#1)
in medical##64##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#1)(1994-12#4)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
in medical-scientific##2##2##(1997-5#2)
in medically##2##2##(1993-1#1)(1994-12#1)
in medicinal plant##2##3##(2008-10#2)
in medicinal##4##2##(2008-10#3)(2008-11#1)
in medicine and human urine##2##5##(2008-10#2)
in medicine and##4##3##(1996-6#1)(2008-10#3)
in medicine##27##2##(1991-2#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-6#2)(1996-6#1)(1997-3#2)(2008-10#3)(2008-11#6)(2008-5#1)(2008-8#1)(2009-1#1)(2009-8#1)(2010-10#1)(2013-8#2)
in medicine]##2##2##(1992-5#1)(1997-3#1)
in medieval##2##2##(2008-12#1)(2010-6#1)
in medium and##2##3##(1993-8#1)(1994-3#1)
in medium containing##9##3##(1991-12#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-8#2)
in medium of##4##3##(1991-11#2)(2008-10#2)
in medium##23##2##(1991-11#2)(1991-12#1)(1993-12#1)(1993-8#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#1)
in meeting future##2##3##(2008-7#1)(2008-8#1)
in meeting the##4##3##(1997-3#1)(2008-11#1)(2010-11#1)(2010-4#1)
in meeting##9##2##(1994-1#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
in meiosis##2##2##(1995-9#1)(2008-9#1)
in meiotic recombination##2##3##(1995-6#1)(2008-9#1)
in melancholia##2##2##(2010-6#2)
in melanocytes##2##2##(2008-9#1)(2013-1#1)
in melanoma##9##2##(2008-11#1)(2008-9#2)(2009-3#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
in melon##3##2##(2008-10#3)
in membrane composition##2##3##(1991-5#1)(2008-10#1)
in membrane potential##4##3##(1996-2#1)(1997-1#1)(2008-9#2)
in membrane preparations##2##3##(1993-1#1)(2008-11#1)
in membrane##20##2##(1990-5#1)(1991-5#1)(1993-1#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-9#3)(2009-6#1)
in membrane-bound##2##2##(2008-10#1)(2008-6#1)
in membranes from##4##3##(1993-1#2)(1993-6#1)(1994-11#1)
in membranes##9##2##(1990-8#1)(1993-1#3)(1993-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1997-1#1)
in memory formation##2##3##(1994-8#2)
in memory##7##2##(1994-8#2)(2008-12#1)(2008-9#1)(2009-10#1)(2009-11#1)(2013-8#1)
in men and in##2##4##(2008-5#1)(2013-8#1)
in men and women##4##4##(2008-4#1)(2009-8#1)(2011-2#2)
in men and##11##3##(1991-6#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-1#1)(2011-2#2)(2013-8#1)
in men in the##2##4##(2008-11#1)(2010-10#1)
in men of##2##3##(2008-1#1)(2008-3#1)
in men than in women##4##5##(1990-12#1)(2011-2#2)(2013-1#1)
in men than in##5##4##(1990-12#1)(1992-3#1)(2011-2#2)(2013-1#1)
in men with##4##3##(1990-11#1)(1992-3#1)(2008-3#1)(2013-1#1)
in men##44##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-6#3)(1991-8#2)(1992-3#3)(1993-2#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#4)(2009-8#2)(2010-1#1)(2010-10#3)(2010-4#1)(2011-2#4)(2013-1#2)(2013-8#2)
in mental health service delivery##2##5##(1992-3#1)(2008-11#1)
in mental health settings##2##4##(2008-12#1)(2010-3#1)
in mental health##10##3##(1992-3#1)(2008-11#2)(2008-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
in mental well-being##3##3##(1991-8#3)
in mental##16##2##(1991-8#3)(1992-3#1)(1996-2#1)(2008-11#2)(2008-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
in merchant seamen##3##3##(1991-12#3)
in mesenchymal##2##2##(2009-4#1)(2013-1#1)
in mesenteric##2##2##(2011-2#1)(2011-3#1)
in mesoporous##3##2##(2008-10#1)(2010-4#2)
in metabolic control##3##3##(1994-12#3)
in metabolic##16##2##(1994-12#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2009-11#1)(2010-4#2)
in metabolically active##2##3##(1993-1#1)(2008-11#1)
in metabolism##5##2##(1994-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)
in metal##11##2##(1993-2#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-8#1)
in metallic##3##2##(2008-10#2)(2012-2#1)
in metalloproteins and##3##3##(2010-11#3)
in metaphase##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
in metapopulation##2##2##(2008-8#1)(2008-9#1)
in metapopulations##3##2##(2008-8#1)(2008-9#2)
in metastases##2##2##(1992-12#1)(2008-9#1)
in metastatic colorectal cancer patients##2##5##(1990-2#1)(1992-12#1)
in metastatic colorectal cancer##3##4##(1990-2#2)(1992-12#1)
in metastatic colorectal##4##3##(1990-2#2)(1992-12#2)
in metastatic melanoma##2##3##(1992-2#1)(2009-3#1)
in metastatic##11##2##(1990-2#2)(1992-12#3)(1992-2#1)(1995-9#1)(1996-11#1)(2009-3#1)(2011-2#1)(2011-3#1)
in metered dose inhalers (MDI)##2##5##(1992-3#1)(1996-1#1)
in metered dose inhalers##5##4##(1992-3#3)(1996-1#2)
in methadone maintenance program##2##4##(2008-10#2)
in methadone treatment##2##3##(1991-1#1)(2008-10#1)
in methadone##5##2##(1991-1#2)(2008-10#3)
in methane-air##2##2##(2008-10#1)(2008-3#1)
in methanol and##2##3##(2008-10#1)(2008-5#1)
in methanol at##2##3##(1990-9#1)(2008-10#1)
in methanol##15##2##(1990-9#1)(1996-5#2)(2008-10#11)(2008-5#1)
in methanol)##2##2##(2008-10#1)(2008-5#1)
in methanol/water##2##2##(2008-10#2)
in methanolic##3##2##(2008-10#3)
in methionine##2##2##(1992-6#1)(1993-9#1)
in methyl##3##2##(2008-10#3)
in methylene chloride##3##3##(1996-5#1)(2008-10#2)
in methylene##4##2##(1996-5#1)(1997-1#1)(2008-10#2)
in metropolitan areas##2##3##(2011-2#2)
in metropolitan##5##2##(2008-1#1)(2008-8#1)(2011-2#2)(2012-12#1)
in mice after##2##3##(2010-11#1)(2013-8#1)
in mice and guinea pigs##4##5##(1995-12#4)
in mice and rats##3##4##(1993-12#1)(2008-10#2)
in mice and##16##3##(1993-12#1)(1994-12#1)(1995-12#4)(2008-10#4)(2008-11#1)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
in mice bearing##2##3##(1997-3#1)(1997-7#1)
in mice but##2##3##(2008-10#1)(2008-11#1)
in mice by administration of##2##5##(1992-12#1)(2008-10#1)
in mice by##7##3##(1991-1#1)(1992-12#1)(1993-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-2#1)
in mice carrying a mutation (Wld(S)) that causes delayed Wallerian degeneration##2##11##(1997-3#2)
in mice carrying##4##3##(1996-2#1)(1997-3#3)
in mice of##2##3##(1995-12#2)
in mice using##2##3##(2008-10#1)(2008-4#1)
in mice with an MRL background##2##6##(1997-8#2)
in mice with##6##3##(1997-3#1)(1997-8#3)(2010-7#2)
in mice##132##2##(1990-5#3)(1990-6#2)(1991-1#2)(1992-12#2)(1992-8#2)(1993-12#2)(1993-2#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#6)(1995-2#2)(1995-5#2)(1996-12#7)(1996-2#3)(1997-3#5)(1997-7#2)(1997-8#3)(2008-10#19)(2008-11#9)(2008-12#9)(2008-4#5)(2008-5#3)(2008-7#2)(2008-9#2)(2009-12#1)(2009-6#3)(2010-11#2)(2010-2#1)(2010-7#3)(2011-2#9)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#5)
in micellar electrokinetic chromatography##2##4##(2008-10#2)
in micellar media##6##3##(2008-10#6)
in micellar medium##4##3##(2008-10#4)
in micellar##19##2##(2008-10#19)
in micro##2##2##(2008-11#2)
in microarray format##2##3##(2008-10#2)
in microarray##3##2##(2008-10#2)(2008-4#1)
in microbial##5##2##(2008-10#3)(2008-9#1)(2011-2#1)
in microbodies##3##2##(2008-10#1)(2011-1#2)
in microcarrier cultures##2##3##(2008-11#2)
in microcarrier##3##2##(2008-11#3)
in microcirculatory##2##2##(1997-2#1)(2009-7#1)
in microfluidic devices##2##3##(2008-10#2)
in microfluidic##6##2##(2008-10#5)(2008-12#1)
in microorganisms##2##2##(2010-12#1)(2012-3#1)
in microplates##2##2##(1990-12#1)(2008-11#1)
in microreactors##2##2##(2008-10#2)
in microsamples##2##2##(2008-10#2)
in microsomes##5##2##(1991-5#2)(1994-11#1)(1997-1#1)(2008-8#1)
in microsporocytes##2##2##(2009-10#1)(2009-12#1)
in microstructures##2##2##(1997-6#2)
in microvascular##2##2##(1997-2#1)(2009-10#1)
in midbrain and##3##3##(1992-1#1)(1997-2#2)
in midbrain##4##2##(1992-1#1)(1997-2#3)
in middle##3##2##(1993-1#1)(2008-10#1)(2010-5#1)
in middle-aged##4##2##(1991-6#2)(2011-2#1)(2013-1#1)
in migrants##4##2##(1994-12#1)(1994-2#3)
in migration##2##2##(1994-8#1)(2008-10#1)
in migratory##2##2##(2009-8#1)(2011-2#1)
in mild and##2##3##(2008-7#1)(2013-1#1)
in mild to moderate##2##4##(1995-2#1)(1996-1#1)
in mild traumatic##2##3##(1991-12#1)(2009-8#1)
in mild##10##2##(1991-12#1)(1995-2#1)(1996-1#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in military##5##2##(1990-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(2011-2#1)
in milk and in coconut water##2##6##(2008-10#2)
in milk and##4##3##(2008-10#3)(2013-1#1)
in milk by##4##3##(2008-10#4)
in milk powder and##2##4##(2008-10#2)
in milk samples by hydride generation atomic fluorescence spectrometry##2##9##(2008-10#2)
in milk samples##5##3##(2008-10#5)
in milk were##2##3##(2008-10#1)(2013-1#1)
in milk##31##2##(1991-11#1)(2008-10#23)(2008-11#1)(2008-8#3)(2011-2#1)(2013-1#2)
in millimeters##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
in mind in##3##3##(2010-6#1)(2011-1#1)(2013-8#1)
in mind that the##2##4##(1992-3#1)(2011-3#1)
in mind that##7##3##(1992-3#1)(2009-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in mind the##6##3##(1995-3#1)(2008-11#1)(2009-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
in mind when##2##3##(2008-1#1)(2008-7#1)
in mind##34##2##(1990-11#1)(1992-3#1)(1994-6#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
in mindfulness-based##2##2##(2013-1#2)
in mineral and##2##3##(2008-10#2)
in mineral waters##5##3##(2008-10#5)
in mineral##16##2##(2008-10#13)(2008-7#1)(2009-8#2)
in mineralized##2##2##(2008-11#1)(2013-8#1)
in mini-orchards of##2##3##(2008-10#2)
in minimal medium##3##3##(2008-10#1)(2012-2#2)
in minimal##6##2##(2008-10#1)(2008-11#1)(2011-2#1)(2011-3#1)(2012-2#2)
in minimally##2##2##(1995-5#1)(2011-2#1)
in minimum-till##2##2##(2008-10#2)
in minor##5##2##(1990-6#1)(1991-3#1)(1996-9#1)(2008-10#1)(2008-11#1)
in mist##2##2##(2008-10#2)
in mitochondria from hypoxic hearts##2##5##(1994-5#2)
in mitochondria from##4##3##(1994-5#4)
in mitochondria##10##2##(1990-5#1)(1994-5#4)(1997-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
in mitochondrial##8##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
in mitotic##4##2##(1993-8#1)(2008-11#1)(2010-1#1)(2012-2#1)
in mixed infections of##2##4##(2008-10#2)
in mixed infections##6##3##(2008-10#6)
in mixed protic solvents##2##4##(2008-10#2)
in mixed##23##2##(1990-8#1)(2008-10#18)(2008-11#1)(2008-7#1)(2008-9#2)
in mixture samples##2##3##(2008-10#2)
in mixture##9##2##(2008-10#9)
in mixtures by##2##3##(2008-10#2)
in mixtures containing##2##3##(2008-10#2)
in mixtures of##5##3##(1994-5#1)(2008-10#3)(2012-7#1)
in mixtures using##3##3##(2008-10#3)
in mixtures with##4##3##(2008-10#3)(2008-5#1)
in mixtures##30##2##(1994-5#1)(2008-1#1)(2008-10#26)(2008-5#1)(2012-7#1)
in mobile phase##2##3##(2008-10#2)
in mobility##6##2##(2008-7#5)(2011-2#1)
in mobilizing##2##2##(1992-12#2)
in model organisms##2##3##(2008-8#1)(2012-2#1)
in model##14##2##(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#4)(2009-8#1)(2011-3#1)(2012-2#1)(2012-9#1)
in modeling##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)(2013-8#1)
in modelling##2##2##(1995-12#1)(2008-7#1)
in models##4##2##(2008-11#1)(2008-12#1)(2010-7#1)(2011-3#1)
in moderate or##2##3##(1993-8#1)(2010-11#1)
in moderate##7##2##(1993-8#1)(1996-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)
in moderately##3##2##(2008-10#2)(2008-9#1)
in modern life sciences##2##4##(2010-11#1)(2011-2#1)
in modern society##2##3##(2010-7#1)(2012-2#1)
in modern##24##2##(1993-6#1)(1994-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
in modified##5##2##(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
in modifying##4##2##(2008-10#1)(2008-5#1)(2011-3#1)(2013-1#1)
in modulating gene expression##2##4##(1994-6#2)
in modulating the##4##3##(1992-1#1)(2008-11#1)(2012-12#1)(2013-7#1)
in modulating##15##2##(1990-5#1)(1992-1#1)(1993-12#1)(1994-6#2)(1996-12#1)(2008-10#1)(2008-11#1)(2009-10#3)(2012-12#1)(2013-7#2)(2013-8#1)
in modulation of##2##3##(1996-2#1)(2008-11#1)
in moist chambers##2##3##(2008-10#2)
in moist##4##2##(2008-10#4)
in mol(-1)dm(3)) of##2##3##(2008-10#2)
in molecular biology have##3##4##(2009-1#1)(2010-5#1)(2012-3#1)
in molecular biology##9##3##(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-5#1)(2012-3#2)(2013-1#1)
in molecular dynamics simulations of##2##5##(1993-5#1)(2012-2#1)
in molecular masses##2##3##(1993-3#1)(2008-10#1)
in molecular weight##2##3##(1991-10#1)(2008-8#1)
in molecular##35##2##(1991-10#1)(1992-6#1)(1993-3#1)(1993-5#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
in molecules##2##2##(1997-6#1)(2010-7#1)
in molluscan hemocytes##2##3##(2008-7#2)
in molten alkali metal carbonates##2##5##(2008-10#2)
in molten##3##2##(2008-10#3)
in monitoring of waste water systems##2##6##(2008-10#2)
in monitoring the##3##3##(2008-10#2)(2008-11#1)
in monitoring##19##2##(1991-1#1)(1994-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-12#1)
in monkey##3##2##(1992-6#1)(1993-6#1)(2008-11#1)
in monkeys##7##2##(1994-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#2)
in monoculture##2##2##(2008-10#2)
in monolayer and##3##3##(2008-11#2)(2011-2#1)
in monolayer culture##9##3##(1990-8#1)(1997-1#1)(2008-11#7)
in monolayer##22##2##(1990-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1997-1#1)(2008-11#15)(2008-5#1)(2011-2#1)
in monoterpene##2##2##(2008-10#1)(2011-10#1)
in monozygotic##2##2##(2010-1#1)(2010-12#1)
in month 1##2##3##(2008-11#2)
in month 10)##2##3##(2008-11#2)
in month##4##2##(2008-11#4)
in monthly##2##2##(2008-12#1)(2012-2#1)
in mood##5##2##(1991-1#1)(1991-8#1)(1993-2#1)(1995-5#1)(2008-11#1)
in moral##3##2##(2008-11#1)(2010-11#1)(2013-8#1)
in morbidity##3##2##(1990-11#1)(1992-11#1)(2008-7#1)
in morbidly obese patients##2##4##(2012-5#2)
in more accurate##2##3##(1990-3#1)(1994-3#1)
in more advanced stages of##2##5##(2008-4#1)(2009-8#1)
in more advanced stages##3##4##(2008-4#1)(2009-8#1)(2012-3#1)
in more detail##8##3##(1991-2#1)(1995-6#1)(1997-5#1)(2008-10#3)(2008-3#1)(2011-2#1)
in more recent##2##3##(1990-9#1)(1991-12#1)
in more than 50% of the cases##2##7##(1997-6#1)(2012-12#1)
in more than 50% of##4##5##(1993-3#1)(1997-6#1)(2010-12#1)(2012-12#1)
in more than 90% of##2##5##(1994-9#1)(2008-12#1)
in more than one##7##4##(1992-12#1)(1995-12#1)(1997-6#2)(2010-7#1)(2010-8#1)(2013-1#1)
in more than##18##3##(1990-7#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-12#1)(1997-3#1)(1997-6#3)(2008-10#1)(2008-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-12#1)(2013-1#1)
in more##50##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-5#1)(1997-6#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in morphine antinociception##2##3##(1997-2#2)
in morphine##4##2##(1997-2#4)
in morphological##4##2##(1994-11#1)(2008-10#1)(2008-8#1)(2010-5#1)
in morphologically##2##2##(2009-12#1)(2011-2#1)
in morphology of##2##3##(2008-11#1)(2012-2#1)
in morphology##7##2##(1997-7#1)(2008-10#1)(2008-11#1)(2010-6#1)(2012-2#1)(2013-1#2)
in mortality from##2##3##(1990-8#1)(1995-12#1)
in mortality or##2##3##(2008-7#1)(2008-9#1)
in mortality rates##2##3##(1993-12#1)(2013-8#1)
in mortality##21##2##(1990-8#1)(1991-3#1)(1993-12#1)(1995-12#2)(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#3)(2009-7#1)(2010-12#1)(2013-1#1)(2013-8#2)
in moss##2##2##(2008-10#2)
in most DRG neurons##2##4##(1996-12#2)
in most cases of##2##4##(1991-11#1)(2008-5#1)
in most cases##42##3##(1990-8#1)(1990-9#1)(1991-11#1)(1992-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
in most children##2##3##(2008-11#2)
in most clinical##2##3##(2008-9#1)(2009-10#1)
in most countries##4##3##(1992-11#1)(1994-3#1)(1997-8#1)(2008-11#1)
in most eukaryotic cells##2##4##(2011-2#1)(2011-3#1)
in most instances##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
in most natural waters##2##4##(2008-10#2)
in most of the cases##3##5##(2008-10#2)(2008-8#1)
in most of the samples##2##5##(2008-10#2)
in most of the##19##4##(1993-6#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
in most of these##3##4##(1991-10#1)(1992-2#1)(2012-3#1)
in most of##24##3##(1991-10#1)(1992-2#1)(1993-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
in most other##2##3##(1997-6#1)(2009-10#1)
in most patients with##2##4##(2008-7#1)(2008-9#1)
in most patients##4##3##(1992-12#1)(2008-7#1)(2008-9#1)(2009-12#1)
in most plants##2##3##(2008-10#2)
in most regions##2##3##(2008-10#2)
in most samples##2##3##(2008-10#1)(2008-11#1)
in most situations##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
in most##150##2##(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#40)(2008-11#12)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#3)(2009-12#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#4)(2012-3#7)(2013-1#5)(2013-8#3)
in mothers and##2##3##(2011-1#1)(2012-3#1)
in mothers who##2##3##(2008-11#2)
in mothers##6##2##(1996-11#1)(2008-11#2)(2010-6#1)(2011-1#1)(2012-3#1)
in motion##2##2##(2008-10#1)(2012-2#1)
in motor initiation and execution##2##5##(1991-6#2)
in motor##9##2##(1991-6#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#2)
in mountain##2##2##(1991-2#1)(2008-11#1)
in mouse C2 myotubes##2##4##(1995-6#2)
in mouse and human##2##4##(2012-2#2)
in mouse and rat##2##4##(1993-12#1)(1993-2#1)
in mouse and##4##3##(1993-12#1)(1993-2#1)(2012-2#2)
in mouse anterior pituitary##3##4##(1990-5#3)
in mouse brain by##2##4##(1995-2#1)(1996-12#1)
in mouse brain##7##3##(1991-1#1)(1993-8#1)(1995-2#2)(1995-6#1)(1996-12#1)(2008-7#1)
in mouse cells##2##3##(1992-6#1)(1993-12#1)
in mouse embryonic stem cells##3##5##(1995-2#2)(2008-11#1)
in mouse embryonic stem##4##4##(1995-2#2)(2008-11#2)
in mouse embryonic##6##3##(1995-2#3)(2008-11#2)(2013-1#1)
in mouse epidermis in vivo##2##5##(1993-8#2)
in mouse macrophages##2##3##(1995-2#2)
in mouse models of##3##4##(2010-7#1)(2011-2#1)(2012-2#1)
in mouse models##4##3##(1997-1#1)(2010-7#1)(2011-2#1)(2012-2#1)
in mouse peripheral blood erythrocytes##2##5##(2008-9#2)
in mouse peritoneal##3##3##(1992-5#1)(2008-10#1)(2008-11#1)
in mouse##67##2##(1990-12#1)(1990-5#3)(1991-1#2)(1991-6#1)(1992-5#1)(1992-6#2)(1993-12#2)(1993-2#1)(1993-8#4)(1995-12#1)(1995-2#7)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-7#2)(2008-10#3)(2008-11#7)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
in mouth air##2##3##(2008-10#2)
in movement##4##2##(2008-10#1)(2010-5#1)(2010-8#1)(2013-8#1)
in moving##3##2##(2008-10#2)(2013-1#1)
in much of##2##3##(2008-4#1)(2010-10#1)
in much##5##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)
in mucosal##3##2##(1997-1#1)(2008-11#1)(2012-2#1)
in mulch layers##2##3##(2008-10#2)
in mulch##3##2##(2008-10#3)
in mulches##2##2##(2008-10#2)
in multi-layered protein films##2##4##(2008-12#2)
in multicellular organisms##2##3##(2008-2#1)(2008-8#1)
in multicolor##2##2##(2008-9#1)(2009-9#1)
in multicomponent##2##2##(2008-10#2)
in multimode circular fibers##2##4##(2008-3#2)
in multimode##4##2##(2008-2#1)(2008-3#2)(2013-1#1)
in multiple myeloma##2##3##(1991-12#1)(2009-3#1)
in multiple organ##2##3##(2009-5#1)(2012-3#1)
in multiple pregnancies##2##3##(2008-11#1)(2010-8#1)
in multiple sclerosis (MS)##3##4##(1995-12#1)(2008-5#1)(2012-2#1)
in multiple sclerosis and##2##4##(1995-12#1)(2010-12#1)
in multiple sclerosis##10##3##(1995-12#2)(2008-5#1)(2009-11#1)(2010-12#3)(2010-4#1)(2012-2#2)
in multiple system atrophy##2##4##(2008-7#1)(2009-11#1)
in multiple ways##2##3##(2008-11#1)(2013-1#1)
in multiple##49##2##(1990-6#1)(1991-12#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-8#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
in multivariable logistic regression##2##4##(2013-1#2)
in multivariable##3##2##(2008-10#1)(2013-1#2)
in multivariate##2##2##(1994-12#1)(2013-1#1)
in municipalities with##2##3##(2013-8#2)
in municipalities##4##2##(1994-6#1)(2012-12#1)(2013-8#2)
in murine and##2##3##(1992-2#2)
in murine macrophages##3##3##(1990-8#2)(1994-6#1)
in murine models##3##3##(1995-5#2)(2011-2#1)
in murine##27##2##(1990-8#2)(1992-2#3)(1992-5#1)(1993-2#1)(1993-8#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-5#2)(2008-11#3)(2008-8#3)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
in muscle by using##2##4##(1997-8#2)
in muscle tone were##3##4##(1995-2#3)
in muscle##17##2##(1991-5#1)(1992-3#1)(1995-12#1)(1995-2#3)(1997-2#1)(1997-8#2)(2008-11#1)(2008-3#2)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#2)
in muscles##5##2##(1990-8#1)(1995-8#2)(1997-8#1)(2010-6#1)
in muscovy duckling##2##3##(1997-1#2)
in muscular##2##2##(2012-2#2)
in music##3##2##(2008-11#1)(2013-8#2)
in mussel##4##2##(2008-10#4)
in mussels by tungsten coil electrothermal atomic absorption spectrometry##2##9##(2008-10#2)
in mussels by##4##3##(2008-10#4)
in mussels##6##2##(2008-10#6)
in mutant##8##2##(1990-8#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)
in mutual##2##2##(2008-11#1)(2012-2#1)
in my##7##2##(1991-8#1)(1994-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-12#1)
in mycelial##3##2##(2008-10#3)
in mycobacteria##4##2##(1995-5#2)(2008-7#1)(2013-1#1)
in mycoplasmas##2##2##(1993-12#2)
in mycorrhizal##2##2##(2008-10#1)(2010-10#1)
in myelodysplastic syndromes and##2##4##(1992-12#1)(2010-11#1)
in myelodysplastic syndromes##4##3##(1992-12#1)(2010-11#3)
in myeloma cells##3##3##(1995-8#1)(2013-1#2)
in myeloma##4##2##(1995-8#1)(2008-9#1)(2013-1#2)
in myocard##2##2##(2012-3#2)
in myogenesis##2##2##(1993-12#2)
in myogenic##2##2##(1993-3#1)(1993-8#1)
in myoglobin (Mb)##2##3##(1994-5#1)(2010-4#1)
in myometrial##2##2##(1994-3#2)
in naive##2##2##(1994-2#1)(2013-1#1)
in nanogram##2##2##(1991-2#1)(2008-10#1)
in nanopatterning##2##2##(2008-10#2)
in narcolepsy##2##2##(1997-9#2)
in nasal##4##2##(1993-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
in national##4##2##(1994-2#1)(2008-10#1)(2013-1#2)
in native##9##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
in natural and industrial##2##4##(2008-10#2)
in natural and tap##2##4##(2008-10#2)
in natural and##11##3##(2008-10#11)
in natural ecosystems##2##3##(2008-10#2)
in natural environments##2##3##(2008-10#2)
in natural pathosystems##2##3##(2008-10#2)
in natural populations of the##2##5##(2008-10#1)(2008-9#1)
in natural populations of##6##4##(2008-10#3)(2008-8#1)(2008-9#1)(2012-3#1)
in natural populations##13##3##(2008-10#3)(2008-8#3)(2008-9#3)(2012-3#4)
in natural soil##2##3##(2008-10#1)(2008-11#1)
in natural systems##4##3##(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)
in natural water after##2##4##(2008-10#2)
in natural water and##5##4##(2008-10#5)
in natural water by##5##4##(2008-10#5)
in natural water samples by##2##5##(2008-10#2)
in natural water samples using##2##5##(2008-10#2)
in natural water samples##21##4##(2008-10#21)
in natural water##47##3##(2008-10#47)
in natural waters and aluminium alloys##2##6##(2008-10#2)
in natural waters and biological samples##2##6##(2008-10#2)
in natural waters and##9##4##(2008-10#9)
in natural waters by##4##4##(2008-10#4)
in natural waters is##2##4##(2008-10#2)
in natural waters using##3##4##(2008-10#3)
in natural waters were##3##4##(2008-10#3)
in natural waters with##4##4##(2008-10#4)
in natural waters##61##3##(2008-10#60)(2008-12#1)
in natural##169##2##(1991-5#1)(1996-12#1)(1996-5#1)(2008-10#146)(2008-11#3)(2008-12#1)(2008-8#5)(2008-9#3)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#5)
in naturally infected##5##3##(2008-10#5)
in naturally infested fields##2##4##(2008-10#2)
in naturally infested##5##3##(2008-10#5)
in naturally occurring and certified##2##5##(2008-10#2)
in naturally occurring##5##3##(2008-10#4)(2008-9#1)
in naturally##17##2##(2008-10#16)(2008-9#1)
in nature and may##2##4##(2008-8#2)
in nature and that##2##4##(1993-2#1)(2008-10#1)
in nature and##11##3##(1993-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-8#1)(2010-10#1)(2011-1#1)(2013-1#1)
in nature in##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
in nature is##2##3##(2008-10#1)(2008-8#1)
in nature##67##2##(1991-12#2)(1991-3#1)(1992-6#1)(1993-2#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#23)(2008-12#3)(2008-3#1)(2008-7#4)(2008-8#14)(2008-9#2)(2009-8#2)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
in near infrared noninvasive biochemical analysis##2##6##(2013-8#2)
in near infrared noninvasive biochemical##3##5##(2013-8#3)
in near##8##2##(2008-10#2)(2013-7#1)(2013-8#5)
in nearly 50% of##2##4##(1992-3#1)(2011-2#1)
in nearly 50%##3##3##(1992-3#1)(2011-2#1)(2013-1#1)
in nearly all##2##3##(2008-10#1)(2008-4#1)
in nearly##9##2##(1992-3#1)(1994-9#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#2)
in neck##2##2##(2008-7#1)(2010-9#1)
in necrotic##5##2##(2008-10#4)(2008-7#1)
in need of##18##3##(1990-11#1)(1991-6#1)(1991-8#1)(1994-3#2)(1994-6#1)(1995-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-9#1)(2010-9#1)(2011-2#3)(2013-1#1)
in need##19##2##(1990-11#1)(1991-6#1)(1991-8#1)(1994-3#2)(1994-6#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-9#1)(2010-9#1)(2011-2#3)(2013-1#1)
in needle##2##2##(2008-10#2)
in negative mode##2##3##(2008-10#2)
in negative##7##2##(2008-10#4)(2008-8#1)(2010-6#1)(2012-2#1)
in negatively##2##2##(2008-2#1)(2008-9#1)
in neglect patients##3##3##(1996-2#2)(2009-10#1)
in neighboring##3##2##(1997-6#1)(2007-11#1)(2008-10#1)
in neither##2##2##(1994-8#1)(1996-6#1)
in nematode##4##2##(2008-10#4)
in neonatal and senescent rats##2##5##(1991-2#2)
in neonatal follow-up##2##3##(2008-11#2)
in neonatal intensive care units##2##5##(1994-3#1)(2010-8#1)
in neonatal intensive care##3##4##(1994-3#1)(2008-11#1)(2010-8#1)
in neonatal rats##3##3##(1992-8#1)(2013-1#2)
in neonatal##14##2##(1991-2#2)(1992-8#1)(1994-3#2)(2008-11#4)(2009-12#1)(2010-12#1)(2010-8#1)(2013-1#2)
in neonate##5##2##(1990-11#1)(2008-5#2)(2012-3#2)
in neonates##8##2##(1994-2#1)(1994-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2013-1#1)
in neoplastic cells##2##3##(1990-6#2)
in neoplastic##3##2##(1990-6#2)(2012-3#1)
in nephrolithiasis##2##2##(2008-12#2)
in nerve fibers##2##3##(1990-5#1)(1997-4#1)
in nerve growth factor##2##4##(1991-12#1)(1996-12#1)
in nerve##6##2##(1990-5#1)(1991-12#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-8#1)
in nervous system##2##3##(1990-8#1)(2008-9#1)
in net##5##2##(2008-10#3)(2008-11#1)(2012-5#1)
in neural cells##2##3##(1995-12#1)(2009-7#1)
in neural tissues##3##3##(1992-9#1)(1997-4#1)(2008-6#1)
in neural##19##2##(1992-9#1)(1994-2#2)(1995-12#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#5)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2013-8#2)
in neurobiology##2##2##(2008-4#2)
in neuroblastoma##2##2##(2008-8#1)(2011-2#1)
in neurodegeneration##2##2##(1992-9#1)(2013-8#1)
in neuroendocrine##2##2##(1995-2#1)(2012-2#1)
in neurogenesis##2##2##(1993-9#1)(2008-7#1)
in neuroimaging##3##2##(2008-11#2)(2008-8#1)
in neurologic##3##2##(2008-7#1)(2012-3#2)
in neurological##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
in neurology##4##2##(2008-7#1)(2010-12#1)(2010-7#1)(2010-9#1)
in neuromuscular stimulation systems##2##4##(2010-8#2)
in neuromuscular##4##2##(2010-8#2)(2013-1#2)
in neuronal cells##2##3##(1994-11#1)(1995-6#1)
in neuronal##20##2##(1990-5#1)(1991-12#1)(1994-11#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-7#1)(2008-7#4)(2008-9#1)(2009-8#1)(2012-2#3)(2012-3#1)(2013-8#1)
in neurons in##2##3##(1994-2#1)(2008-7#1)
in neurons of##2##3##(1996-6#1)(1997-4#1)
in neurons##16##2##(1990-7#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-2#2)(1995-2#1)(1996-6#1)(1997-4#1)(2008-1#1)(2008-7#4)(2008-8#1)
in neuropathic pain##2##3##(2008-12#1)(2011-2#1)
in neuroscience##5##2##(2008-11#1)(2008-4#3)(2009-6#1)
in neurosurgery##3##2##(2010-7#1)(2012-3#1)(2013-1#1)
in neurosurgical##2##2##(1996-11#1)(2010-7#1)
in neutral and alkaline##3##4##(2008-10#3)
in neutral and##5##3##(2008-10#5)
in neutral##14##2##(2008-10#12)(2008-11#2)
in neutrophils from##2##3##(2008-10#2)
in neutrophils##4##2##(1993-6#1)(2008-10#3)
in new and##3##3##(2008-10#2)(2009-11#1)
in new areas##2##3##(2010-3#1)(2012-2#1)
in new jersey##2##3##(2008-10#2)
in new types of human##2##5##(2013-8#2)
in new##23##2##(1993-12#2)(1993-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2009-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in newborn piglets##2##3##(1990-5#2)
in newborn##6##2##(1990-11#1)(1990-5#2)(1991-12#1)(1994-6#1)(2011-1#1)
in newborns with Down syndrome##2##5##(2008-12#2)
in newborns with##3##3##(2008-12#2)(2011-2#1)
in newborns##11##2##(1994-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
in newly diagnosed##2##3##(1991-2#1)(2010-4#1)
in newly##6##2##(1991-2#1)(1994-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
in ng##2##2##(2008-10#2)
in nigral cell##2##3##(2008-7#2)
in nigral dopamine neurons##2##4##(1996-2#2)
in nigral##4##2##(1996-2#2)(2008-7#2)
in nikkomycin biosynthesis##2##3##(2008-9#2)
in nine patients##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
in nine##19##2##(1991-9#1)(1993-1#1)(1993-8#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-5#1)(2008-9#1)(2009-3#1)(2013-1#1)
in nitric acid medium##2##4##(2008-10#2)
in nitric acid##4##3##(2008-10#4)
in nitrobenzene solvent##3##3##(2008-10#3)
in nitrogen##3##2##(1997-1#1)(2007-12#1)(2008-10#1)
in no case##4##3##(1991-3#1)(1991-8#1)(2008-7#1)(2008-9#1)
in no significant##2##3##(2008-5#1)(2013-1#1)
in no##13##2##(1991-3#1)(1991-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2013-1#1)
in no-till fields##3##3##(2008-10#3)
in no-till##6##2##(2008-10#6)
in nociceptive##2##2##(2008-11#1)(2009-12#1)
in nodular##2##2##(1990-5#1)(2008-10#1)
in noise##8##2##(2007-11#1)(2008-9#4)(2011-2#1)(2012-2#2)
in nomadic pastoral##2##3##(2011-2#2)
in nomadic##3##2##(2011-2#3)
in nomenclature##2##2##(2008-10#2)
in non##5##2##(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#2)
in non-acute##2##2##(2010-5#1)(2011-3#1)
in non-alcoholic##3##2##(2007-8#1)(2012-2#2)
in non-aqueous media##3##3##(2008-10#3)
in non-aqueous medium##2##3##(2008-10#2)
in non-aqueous##8##2##(2008-10#8)
in non-diabetic##2##2##(1994-12#1)(2010-11#1)
in non-insulin-dependent diabetes mellitus##2##4##(1992-9#1)(1995-8#1)
in non-ionic micellar medium##2##4##(2008-10#2)
in non-ionic micellar##3##3##(2008-10#3)
in non-islet cells##2##3##(1995-8#2)
in non-neoplastic##2##2##(1992-2#1)(2008-10#1)
in non-neural##3##2##(1994-2#2)(2008-9#1)
in non-neurological##3##2##(1997-2#2)(2008-7#1)
in non-neuronal##2##2##(1995-8#1)(2009-10#1)
in non-rodent##3##2##(2008-10#2)(2012-2#1)
in non-small##2##2##(1993-9#1)(2008-5#1)
in non-smokers and non-alcoholic drinkers##2##5##(2013-1#2)
in non-smokers and##3##3##(2013-1#3)
in non-smokers##5##2##(1996-3#1)(2008-10#1)(2013-1#3)
in non-survivors##2##2##(2009-6#1)(2011-2#1)
in nonaqueous##2##2##(2008-7#2)
in nonautoclaved##3##2##(2008-10#3)
in noncultivated soil but significantly##2##5##(2008-10#2)
in noncultivated soil##3##3##(2008-10#3)
in noncultivated##6##2##(2008-10#6)
in nondopaminergic neurons##2##3##(2008-7#2)
in nonfumigated soil##2##3##(2008-10#2)
in nonfumigated##3##2##(2008-10#3)
in nonhepatocytes##2##2##(2008-9#2)
in noninoculated leaves##2##3##(2008-10#2)
in noninoculated##4##2##(2008-10#4)
in nonionic microemulsion medium##2##4##(2008-10#2)
in nonpigmented##2##2##(1992-8#1)(1993-8#1)
in nonprofit nursing homes##2##4##(1992-3#2)
in nonprofit##5##2##(1992-3#2)(1993-12#2)(2008-11#1)
in nonrhizosphere##2##2##(2008-10#2)
in nonsterile soil##2##3##(2008-10#2)
in nontransgenic##2##2##(1992-8#1)(2008-10#1)
in nontreated soil##2##3##(2008-10#2)
in nontreated##7##2##(2008-10#6)(2008-11#1)
in normal adult##2##3##(1990-5#1)(1991-7#1)
in normal ageing##3##3##(2009-10#3)
in normal and cancer cells##2##5##(2008-10#1)(2008-11#1)
in normal and cancer##4##4##(2008-10#3)(2008-11#1)
in normal and diabetic##2##4##(1994-8#1)(2013-8#1)
in normal and neoplastic##2##4##(1995-12#1)(2011-2#1)
in normal and second-derivative electrophoregrams were##2##6##(2008-10#2)
in normal and transformed human##2##5##(1992-3#1)(1993-11#1)
in normal and##24##3##(1991-5#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-8#2)(1995-12#2)(1995-8#1)(2008-10#7)(2008-11#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in normal animals##4##3##(1991-2#2)(1993-6#1)(1995-12#1)
in normal brain##2##3##(2008-7#1)(2013-1#1)
in normal cells##2##3##(2008-11#1)(2013-1#1)
in normal cellular##2##3##(2008-5#1)(2011-1#1)
in normal condition##3##3##(2012-3#3)
in normal controls##2##3##(1992-12#1)(2008-7#1)
in normal development##2##3##(2008-7#1)(2010-11#1)
in normal feet##2##3##(2012-2#2)
in normal fibroblasts##2##3##(1992-8#1)(1997-7#1)
in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas##2##10##(2012-12#2)
in normal fimbrial epithelial cells of##3##6##(2012-12#3)
in normal hepatocytes but##2##4##(1994-8#2)
in normal hepatocytes##3##3##(1992-6#1)(1994-8#2)
in normal human##7##3##(1994-11#1)(1995-9#1)(1997-7#1)(2008-10#1)(2011-2#2)(2013-1#1)
in normal mice##6##3##(1993-8#1)(1994-11#1)(1995-2#1)(1997-3#2)(2008-11#1)
in normal physiologic circumstances##2##4##(2011-2#2)
in normal rat##3##3##(1991-5#1)(1992-6#1)(2008-9#1)
in normal skin##4##3##(2008-5#2)(2012-3#2)
in normal subjects##6##3##(1991-1#1)(1991-2#1)(1992-6#1)(1995-8#1)(2008-9#1)(2012-3#1)
in normal tissue##2##3##(1990-5#1)(2008-11#1)
in normal tissues##4##3##(2008-11#1)(2008-9#2)(2011-2#1)
in normal##138##2##(1990-12#4)(1990-5#4)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-5#2)(1991-7#1)(1992-12#2)(1992-3#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-8#6)(1995-12#3)(1995-2#1)(1995-8#3)(1995-9#1)(1997-3#3)(1997-7#2)(2008-10#11)(2008-11#10)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#4)(2009-8#1)(2010-10#1)(2010-11#3)(2011-1#3)(2011-2#10)(2012-12#3)(2012-2#2)(2012-3#9)(2013-1#6)(2013-8#2)
in normalizing##2##2##(2008-7#1)(2013-1#1)
in normotensive females##2##3##(2010-7#2)
in normotensive##4##2##(2008-11#1)(2010-4#1)(2010-7#2)
in normoxic##2##2##(1997-1#1)(2009-11#1)
in north america##5##3##(2008-10#5)
in north eastern##2##3##(2011-2#1)(2013-1#1)
in north of##2##3##(2008-10#1)(2011-1#1)
in north##12##2##(1996-8#1)(2008-10#6)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
in northeast##2##2##(2008-10#1)(2008-9#1)
in northern California##3##3##(1991-7#1)(1992-2#1)(2008-10#1)
in northern Italy##4##3##(1990-2#1)(1990-8#1)(1994-8#1)(2011-2#1)
in northern##26##2##(1990-2#1)(1990-8#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-9#1)(2010-9#4)(2011-2#2)
in not only##2##3##(2008-10#1)(2008-11#1)
in not##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
in novel##6##2##(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2011-3#1)
in nuclear DNA##2##3##(1995-6#1)(2008-9#1)
in nuclear emergency tablets##2##4##(2008-10#2)
in nuclear##20##2##(1991-6#1)(1993-3#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)
in nuclear-transferred embryos##3##3##(2008-8#3)
in nuclei of##2##3##(1993-8#1)(1994-2#1)
in nuclei##4##2##(1993-8#1)(1994-2#1)(2011-2#2)
in nucleic acid##3##3##(2008-10#2)(2008-9#1)
in nucleic##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
in nucleotide sequence##2##3##(2008-10#2)
in nucleotide##3##2##(2008-10#2)(2008-9#1)
in nucleus##3##2##(1993-6#1)(2008-9#2)
in nude mice##11##3##(1993-1#1)(1994-12#1)(1995-2#1)(2008-8#5)(2010-1#1)(2011-2#1)(2013-1#1)
in number and##2##3##(1993-12#1)(1994-2#1)
in number in the##2##4##(2008-8#1)(2011-2#1)
in number in##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
in number of##7##3##(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
in number##21##2##(1991-12#1)(1993-12#1)(1994-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#1)(2013-8#1)
in numbers of##8##3##(1994-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-5#1)(2010-1#1)
in numbers##10##2##(1991-7#1)(1994-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-1#1)
in numerous##15##2##(1990-11#1)(1992-5#1)(1993-6#1)(1995-2#1)(2008-10#5)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
in nurse education is##2##4##(2008-11#2)
in nurse education##21##3##(2008-11#17)(2008-12#4)
in nurse##25##2##(2008-11#18)(2008-12#6)(2009-6#1)
in nurseries##2##2##(2008-10#2)
in nursery##4##2##(1996-12#1)(2008-10#3)
in nurses##2##2##(2008-11#1)(2010-3#1)
in nursing and##5##3##(2008-10#1)(2008-11#2)(2008-12#1)(2012-12#1)
in nursing course##2##3##(2008-11#2)
in nursing education and##3##4##(2008-11#2)(2008-12#1)
in nursing education are##2##4##(2008-11#1)(2008-12#1)
in nursing education research##2##4##(2008-12#2)
in nursing education##21##3##(2008-11#8)(2008-12#13)
in nursing home patients##2##4##(1994-2#1)(2008-7#1)
in nursing home##5##3##(1994-12#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-7#1)
in nursing homes##10##3##(1991-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(2009-3#1)(2010-10#3)(2010-11#1)
in nursing students##2##3##(2008-12#2)
in nursing##71##2##(1991-12#1)(1991-2#1)(1994-12#1)(1994-2#1)(1995-2#3)(1996-1#1)(1996-2#1)(1997-2#2)(2008-10#1)(2008-11#24)(2008-12#23)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#3)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in nutrient broth##2##3##(2008-10#2)
in nutrient##10##2##(1994-12#1)(2008-10#5)(2008-11#2)(2008-8#1)(2008-9#1)
in nutrition##5##2##(1992-12#1)(1995-3#1)(2011-2#2)(2012-2#1)
in nutritional##2##2##(2008-10#1)(2012-12#1)
in o##3##2##(2008-10#3)
in oat (Avena##2##3##(2008-10#2)
in oat##8##2##(1990-5#1)(2008-10#7)
in oats##2##2##(2008-10#2)
in obese animals##2##3##(2012-3#2)
in obese group##2##3##(2012-2#2)
in obese individuals##4##3##(2012-2#2)(2012-3#1)(2013-8#1)
in obese patients##2##3##(2011-2#1)(2012-12#1)
in obese##23##2##(1992-12#1)(1993-3#1)(1993-5#1)(1996-12#2)(2008-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#2)
in obesity##2##2##(2008-10#1)(2012-2#1)
in objective##3##2##(1992-12#1)(2009-10#1)(2011-2#1)
in observed##2##2##(2008-10#1)(2012-2#1)
in obstetrics and##5##3##(1990-3#1)(1993-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
in obtaining##14##2##(1992-9#1)(1994-11#1)(1994-2#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-3#1)
in occasional##2##2##(1994-3#1)(2008-10#1)
in occupational medicine]##2##3##(1990-3#1)(1997-8#1)
in occupational##6##2##(1990-3#1)(1991-12#1)(1991-3#1)(1997-8#1)(2010-9#1)(2012-3#1)
in occupations##2##2##(1991-12#1)(1994-3#1)
in octogenarians##2##2##(1995-3#1)(2011-2#1)
in odour perception##3##3##(2008-7#3)
in of##2##2##(2008-3#2)
in offering a##2##3##(1992-1#1)(2010-5#1)
in offering##3##2##(1992-1#1)(2008-10#1)(2010-5#1)
in offspring of##2##3##(2008-10#1)(2008-8#1)
in offspring##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)
in oil##5##2##(2008-10#2)(2008-11#1)(2008-3#2)
in oil-in-water emulsions##2##3##(2008-10#1)(2008-5#1)
in old age is##2##4##(1990-11#1)(2013-7#1)
in old age##9##3##(1990-11#2)(1990-3#2)(1996-3#1)(2008-7#2)(2008-9#1)(2013-7#1)
in old male rats##2##4##(2008-7#2)
in old male##3##3##(2008-7#2)(2013-1#1)
in old mice##2##3##(2013-7#2)
in old rats of both sexes##2##6##(2008-7#2)
in old rats##6##3##(2008-7#6)
in old than in young##2##5##(2008-7#2)
in old##31##2##(1990-11#2)(1990-2#1)(1990-3#3)(1992-11#1)(1996-3#1)(2008-10#2)(2008-7#15)(2008-9#1)(2013-1#1)(2013-7#3)(2013-8#1)
in old-field interaction webs##2##4##(2008-9#2)
in older adults with OA##2##5##(2010-11#2)
in older adults with##4##4##(2010-11#3)(2012-3#1)
in older adults##10##3##(2009-5#1)(2010-11#3)(2010-7#2)(2012-12#1)(2012-3#1)(2013-1#2)
in older age groups##2##4##(2008-9#1)(2013-1#1)
in older age##3##3##(2008-9#1)(2010-10#1)(2013-1#1)
in older athletes taking statins##3##5##(2013-1#3)
in older children##4##3##(1994-12#1)(1996-2#1)(2008-10#1)(2009-3#1)
in older dogs##2##3##(2012-3#2)
in older individuals##2##3##(2007-12#1)(2009-8#1)
in older patients##7##3##(1991-1#1)(1995-5#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
in older subjects##2##3##(1995-5#1)(2008-7#1)
in older women##6##3##(2008-7#1)(2010-10#2)(2011-2#1)(2012-12#2)
in older##52##2##(1990-3#1)(1991-1#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-5#2)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#3)(2009-8#1)(2010-10#3)(2010-11#3)(2010-7#2)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#1)
in olfactory bulb##2##3##(2013-1#2)
in olfactory learning##2##3##(2012-2#2)
in olfactory##8##2##(1996-12#1)(2007-12#3)(2012-2#2)(2013-1#2)
in oligodendrocyte progenitors##2##3##(1996-12#2)
in oligodendrocyte##3##2##(1996-12#3)
in olive oil##3##3##(1995-11#1)(2008-10#2)
in olive##5##2##(1994-5#1)(1995-11#1)(2008-10#3)
in oman##2##2##(2008-10#1)(2012-12#1)
in on##2##2##(1993-2#1)(1997-6#1)
in on-line##2##2##(2008-10#2)
in oncologic##2##2##(2008-1#1)(2013-1#1)
in oncology and##3##3##(1997-8#1)(2010-10#1)(2011-3#1)
in oncology##10##2##(1997-8#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
in oncolytic##2##2##(2013-1#2)
in one (4##3##3##(2013-1#3)
in one and##3##3##(1995-12#1)(2008-5#1)(2008-9#1)
in one case##13##3##(1992-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#4)(2009-1#1)
in one dimension##2##3##(2007-11#1)(2008-3#1)
in one experiment##2##3##(2008-10#1)(2008-8#1)
in one eye##2##3##(2008-7#1)(2013-8#1)
in one format##2##3##(2008-4#1)(2010-10#1)
in one group##6##3##(2008-10#4)(2011-2#1)(2013-8#1)
in one mouse##3##3##(2008-10#1)(2008-8#2)
in one of five##2##4##(2008-10#1)(2008-11#1)
in one of the two##2##5##(2008-10#2)
in one of the##14##4##(1990-2#1)(1991-6#1)(1992-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#2)
in one of these##2##4##(2008-10#1)(2011-1#1)
in one of three##2##4##(2008-10#2)
in one of two##2##4##(1995-8#1)(2013-1#1)
in one of##24##3##(1990-2#1)(1991-6#1)(1992-2#1)(1995-8#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-1#1)(2013-1#3)
in one or both##4##4##(2008-10#1)(2008-7#1)(2010-8#1)(2013-7#1)
in one or more of##2##5##(2008-10#1)(2009-6#1)
in one or more##6##4##(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
in one or two##2##4##(1990-11#1)(2008-5#1)
in one or##12##3##(1990-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
in one patient##12##3##(1994-12#1)(1995-11#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)
in one piece##3##3##(2008-12#2)(2011-2#1)
in one population##3##3##(2008-10#3)
in one sample##3##3##(2008-10#2)(2008-11#1)
in one single##5##3##(1992-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-6#1)
in one species##2##3##(2012-2#1)(2012-3#1)
in one step##5##3##(1996-5#1)(2008-10#2)(2008-4#1)(2008-8#1)
in one study##3##3##(1992-3#1)(2013-1#1)(2013-8#1)
in one university##2##3##(2008-11#2)
in one year##5##3##(1994-3#1)(2008-10#2)(2012-3#2)
in one##213##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-5#1)(1997-6#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#51)(2008-11#17)(2008-12#6)(2008-3#1)(2008-4#4)(2008-5#7)(2008-7#12)(2008-8#13)(2008-9#8)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-2#3)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#5)
in one)##2##2##(1990-8#1)(1992-5#1)
in one-dimensional##3##2##(2008-8#1)(2010-11#1)(2013-8#1)
in one-pot##2##2##(2008-10#2)
in ongoing##2##2##(2008-11#1)(2011-7#1)
in onion##3##2##(1993-12#1)(2008-10#2)
in only 1##2##3##(1990-12#1)(1990-9#1)
in only 13##2##3##(2008-10#1)(2008-9#1)
in only 4##2##3##(1991-11#1)(2008-7#1)
in only 8##2##3##(2008-10#1)(2009-8#1)
in only a small percentage of##2##6##(1991-3#1)(2011-2#1)
in only a small##3##4##(1991-3#1)(1997-1#1)(2011-2#1)
in only a##4##3##(1990-2#1)(1991-3#1)(1997-1#1)(2011-2#1)
in only one case##2##4##(1990-9#1)(1991-8#1)
in only one of four##2##5##(2008-10#1)(2008-7#1)
in only one of##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
in only one##13##3##(1990-9#1)(1991-8#1)(1993-12#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-4#1)(2010-7#1)
in only two of##3##4##(1996-11#1)(2008-10#2)
in only two##5##3##(1996-11#1)(1996-9#1)(2008-10#2)(2011-1#1)
in only##58##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#2)(1996-11#2)(1996-9#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#2)
in ontogeny and##2##3##(1991-5#1)(2013-7#1)
in oocyte##2##2##(1994-9#1)(2008-8#1)
in oocytes and##2##3##(2008-8#1)(2008-9#1)
in oocytes##9##2##(1995-11#1)(1996-2#1)(1997-2#1)(2008-8#1)(2008-9#5)
in oogenesis##2##2##(2009-7#1)(2010-5#1)
in op/op##3##2##(1991-5#3)
in open heart##2##3##(1990-2#1)(2008-5#1)
in open##10##2##(1990-2#1)(1992-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
in operable breast cancer##2##4##(1993-11#1)(1994-6#1)
in operable##4##2##(1993-11#1)(1994-6#1)(1997-8#2)
in operation##7##2##(1994-12#1)(1997-3#1)(1997-5#1)(2008-10#2)(2012-3#1)(2013-8#1)
in operational##2##2##(2008-3#1)(2012-2#1)
in operative laparoscopy##5##3##(1992-12#1)(1993-12#4)
in operative##8##2##(1992-12#1)(1993-12#4)(1995-1#1)(2010-6#1)(2013-1#1)
in ophthalmic##2##2##(2008-10#1)(2010-10#1)
in ophthalmology##4##2##(1991-9#1)(1992-5#1)(2010-10#1)(2011-2#1)
in opioid##4##2##(1995-3#1)(2008-11#1)(2008-6#1)(2008-7#1)
in opposing##2##2##(2011-2#1)(2012-9#1)
in opposite directions##6##3##(1997-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
in opposite##9##2##(1993-12#1)(1997-3#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
in optical and##2##3##(2008-10#2)
in optical coherence tomography (OCT)##2##5##(2011-7#2)
in optical coherence tomography##3##4##(2008-3#1)(2011-7#2)
in optical##19##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#7)(2010-12#1)(2011-7#2)(2012-2#1)(2013-8#1)
in optically##4##2##(2007-12#1)(2008-3#2)(2008-5#1)
in optimal conditions##2##3##(2008-10#1)(2008-5#1)
in optimal##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
in optimization of##3##3##(2008-10#2)(2008-3#1)
in optimizing the##2##3##(2008-6#1)(2013-1#1)
in optimizing##3##2##(2008-6#2)(2013-1#1)
in or adjacent to the##2##5##(1997-3#1)(2008-7#1)
in or##10##2##(1993-3#1)(1996-2#1)(1997-3#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#1)
in oral and##2##3##(1991-2#1)(2008-7#1)
in oral cancer##2##3##(1991-6#1)(2013-1#1)
in oral health##2##3##(2013-1#1)(2013-7#1)
in oral##20##2##(1991-2#2)(1991-6#1)(1993-6#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#4)(2013-7#1)
in orchard soils##2##3##(2008-10#2)
in orchard##5##2##(2008-10#5)
in orchards with##2##3##(2008-10#2)
in orchards##6##2##(2008-10#6)
in order for##3##3##(2008-4#1)(2010-9#1)(2012-2#1)
in order of frequency##2##4##(1991-2#1)(2008-10#1)
in order of##6##3##(1991-2#2)(1994-1#1)(2008-10#2)(2008-3#1)
in order that##4##3##(2008-11#2)(2008-12#1)(2008-5#1)
in order to achieve high##2##5##(2008-10#2)
in order to achieve the##4##5##(2008-10#2)(2009-8#1)(2011-2#1)
in order to achieve##13##4##(1992-3#1)(1992-9#1)(1994-2#1)(1994-5#1)(2008-10#5)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#1)
in order to adapt##2##4##(2008-10#1)(2011-1#1)
in order to allow the determination of##2##7##(2008-10#2)
in order to allow the##4##5##(2008-10#3)(2013-1#1)
in order to analyse##2##4##(2010-10#1)(2010-6#1)
in order to analyze##2##4##(2008-10#1)(2008-11#1)
in order to ascertain##2##4##(2008-10#1)(2008-11#1)
in order to assess the##7##5##(1991-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-3#1)
in order to assess##12##4##(1991-11#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2009-3#1)(2011-2#1)
in order to avoid possible##2##5##(1991-12#1)(2008-10#1)
in order to avoid the##4##5##(2008-10#3)(2008-11#1)
in order to avoid##11##4##(1991-12#1)(1992-12#1)(2008-10#6)(2008-11#1)(2011-2#2)
in order to be able##2##5##(2008-10#1)(2008-11#1)
in order to be##9##4##(1994-3#1)(1994-6#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-7#1)
in order to become##3##4##(2008-11#2)(2011-2#1)
in order to characterize the##3##5##(2008-10#2)(2008-7#1)
in order to characterize##4##4##(1994-8#1)(2008-10#2)(2008-7#1)
in order to check##3##4##(2008-10#2)(2012-7#1)
in order to collect##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
in order to compare and##2##5##(2008-10#2)
in order to compare the##2##5##(2008-10#2)
in order to compare##6##4##(1991-7#1)(2008-10#4)(2011-2#1)
in order to confirm the##3##5##(1992-12#1)(1994-2#1)(2008-5#1)
in order to confirm##4##4##(1990-2#1)(1992-12#1)(1994-2#1)(2008-5#1)
in order to control the##2##5##(2008-10#2)
in order to control##3##4##(2008-10#2)(2013-8#1)
in order to correlate##3##4##(2008-10#1)(2008-5#1)(2012-9#1)
in order to define a##2##5##(2011-2#1)(2012-2#1)
in order to demonstrate the##2##5##(2008-10#2)
in order to demonstrate##4##4##(2008-10#4)
in order to describe##2##4##(2008-10#1)(2008-11#1)
in order to detect and##2##5##(1993-2#1)(2008-10#1)
in order to detect##10##4##(1992-9#1)(1993-2#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#1)
in order to determine the depth of anesthesia in the continuation stage of the anesthesia and to estimate the amount of medicine to be applied at that moment##2##28##(2010-8#2)
in order to determine the optimum conditions for##2##8##(2008-10#2)
in order to determine the##17##5##(1990-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2010-8#2)(2013-1#1)
in order to determine their##2##5##(2007-12#1)(2011-1#1)
in order to determine##29##4##(1990-11#1)(1991-3#2)(1993-9#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2009-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
in order to develop a##4##5##(1990-5#1)(2008-10#1)(2008-7#1)(2009-7#1)
in order to develop more##2##5##(2010-5#1)(2011-2#1)
in order to develop##11##4##(1990-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)
in order to differentiate##2##4##(2008-10#2)
in order to discover##2##4##(1994-12#1)(2012-3#1)
in order to distinguish##5##4##(2008-10#4)(2012-2#1)
in order to elucidate the##3##5##(1993-3#1)(2008-10#2)
in order to enable##2##4##(2008-10#1)(2008-6#1)
in order to enhance the##2##5##(2008-11#1)(2011-1#1)
in order to enhance##3##4##(2008-11#1)(2008-5#1)(2011-1#1)
in order to ensure##8##4##(2008-10#5)(2008-11#2)(2009-5#1)
in order to establish the##7##5##(1991-6#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)
in order to establish##11##4##(1991-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
in order to estimate the##2##5##(2008-10#1)(2013-8#1)
in order to evaluate the effect of##2##7##(1997-4#1)(2008-10#1)
in order to evaluate the effects of##2##7##(2008-10#2)
in order to evaluate the##16##5##(1990-2#1)(1992-5#1)(1993-3#1)(1997-4#1)(2008-10#11)(2013-8#1)
in order to evaluate their##2##5##(2008-10#1)(2008-7#1)
in order to evaluate whether##2##5##(2008-10#1)(2008-12#1)
in order to evaluate##22##4##(1990-2#1)(1992-5#1)(1993-3#1)(1997-4#1)(2008-10#13)(2008-12#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
in order to examine the##3##5##(2008-11#2)(2008-5#1)
in order to examine##5##4##(2008-11#3)(2008-5#1)(2010-8#1)
in order to expand the##2##5##(2008-10#2)
in order to explain the##2##5##(1994-5#1)(2008-10#1)
in order to explain##3##4##(1994-5#1)(2008-10#1)(2012-2#1)
in order to explore##2##4##(2010-10#1)(2012-3#1)
in order to facilitate##10##4##(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2009-11#1)(2013-1#1)
in order to find out##3##5##(1991-11#1)(2013-1#2)
in order to find the##2##5##(2008-10#2)
in order to find##7##4##(1991-11#1)(1997-6#1)(2008-10#3)(2013-1#2)
in order to further##3##4##(1994-1#1)(2008-10#1)(2008-11#1)
in order to gain##3##4##(2008-5#1)(2008-9#2)
in order to get##5##4##(2008-10#4)(2008-7#1)
in order to give##2##4##(2008-11#2)
in order to have##2##4##(1993-11#1)(2008-12#1)
in order to help##2##4##(1992-2#1)(2008-12#1)
in order to identify the##2##5##(2008-10#2)
in order to identify##10##4##(1995-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)
in order to improve the##12##5##(1991-6#1)(2008-10#9)(2012-3#1)(2013-8#1)
in order to improve their##3##5##(1993-2#1)(2009-7#1)(2010-3#1)
in order to improve##21##4##(1991-3#1)(1991-6#1)(1993-2#1)(2008-10#12)(2009-7#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
in order to increase the##4##5##(2008-10#2)(2008-5#1)(2012-2#1)
in order to increase##9##4##(2008-10#6)(2008-5#1)(2011-7#1)(2012-2#1)
in order to investigate the##5##5##(1994-3#2)(1996-12#2)(2008-10#1)
in order to investigate their##2##5##(1990-12#1)(2008-11#1)
in order to investigate##9##4##(1990-12#1)(1994-3#2)(1996-12#2)(2008-10#2)(2008-11#2)
in order to keep##3##4##(1990-3#1)(1992-1#1)(1993-11#1)
in order to know the##3##5##(2008-10#2)(2013-8#1)
in order to learn##2##4##(1996-12#1)(2011-2#1)
in order to maintain the integrity of##2##7##(2008-1#1)(2008-12#1)
in order to maintain the##3##5##(2008-1#1)(2008-12#1)(2008-9#1)
in order to maintain##4##4##(2008-1#1)(2008-12#1)(2008-9#1)(2011-2#1)
in order to make the##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
in order to make##11##4##(1991-2#1)(1993-9#1)(1994-1#1)(2008-10#3)(2008-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
in order to maximize the##4##5##(2008-10#2)(2008-11#1)(2008-8#1)
in order to maximize##7##4##(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)
in order to measure##5##4##(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#1)
in order to meet the##4##5##(1994-2#1)(2008-11#1)(2009-12#1)(2010-7#1)
in order to minimize the##2##5##(2008-10#2)
in order to minimize##3##4##(1993-8#1)(2008-10#2)
in order to observe##3##4##(2008-10#2)(2009-10#1)
in order to obtain a##6##5##(2008-10#5)(2012-2#1)
in order to obtain accurate##2##5##(2008-10#2)
in order to obtain an##2##5##(2008-10#1)(2009-7#1)
in order to obtain better##2##5##(2008-10#2)
in order to obtain high##2##5##(2008-11#1)(2013-1#1)
in order to obtain the##9##5##(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)
in order to obtain##32##4##(1991-2#1)(2008-10#21)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#2)(2012-2#1)(2013-1#1)
in order to operate##2##4##(2008-11#1)(2010-8#1)
in order to optimize the##3##5##(2008-10#2)(2008-4#1)
in order to optimize##5##4##(2008-10#3)(2008-11#1)(2008-4#1)
in order to perform##3##4##(2008-10#2)(2010-11#1)
in order to prepare##4##4##(2008-10#2)(2010-7#1)(2012-3#1)
in order to preserve the##2##5##(2008-10#1)(2010-8#1)
in order to prevent##6##4##(1991-6#1)(1993-11#1)(1995-2#1)(1996-11#1)(1997-6#1)(2011-3#1)
in order to promote##5##4##(1991-3#1)(2008-1#1)(2008-10#1)(2011-2#2)
in order to propose##2##4##(2008-11#1)(2009-3#1)
in order to protect##2##4##(1996-12#1)(2008-11#1)
in order to prove##2##4##(2008-10#1)(2008-5#1)
in order to provide a##2##5##(2008-11#1)(2011-2#1)
in order to provide the##2##5##(2008-10#2)
in order to provide##11##4##(1995-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2010-5#1)(2011-2#2)
in order to quantify##3##4##(2008-10#3)
in order to raise##2##4##(2011-2#2)
in order to reach##4##4##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
in order to reduce the risk of##3##7##(1990-2#1)(2013-8#2)
in order to reduce the##8##5##(1990-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
in order to reduce##12##4##(1990-2#1)(1991-6#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#2)
in order to remove the##3##5##(2008-10#3)
in order to remove##5##4##(2008-10#3)(2008-6#1)(2013-1#1)
in order to select##2##4##(2008-10#2)
in order to separate##2##4##(2008-10#2)
in order to simulate the##2##5##(2008-10#2)
in order to simulate##3##4##(1995-3#1)(2008-10#2)
in order to study the##3##5##(2008-5#1)(2009-1#1)(2011-2#1)
in order to study##4##4##(2008-11#1)(2008-5#1)(2009-1#1)(2011-2#1)
in order to supply##2##4##(2008-11#2)
in order to support##4##4##(2008-11#1)(2010-6#1)(2010-8#1)(2012-3#1)
in order to suppress##2##4##(2008-10#2)
in order to sustain##3##4##(1993-6#1)(2008-11#1)(2013-7#1)
in order to take into account the##2##7##(2008-10#2)
in order to take##3##4##(2008-10#2)(2010-5#1)
in order to test the##3##5##(2008-10#1)(2009-9#1)(2012-2#1)
in order to test##5##4##(1996-2#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-2#1)
in order to understand how##2##5##(1997-6#1)(2008-8#1)
in order to understand the##3##5##(2008-10#3)
in order to understand##9##4##(1995-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-1#1)(2013-1#1)
in order to validate the##2##5##(2008-10#1)(2010-12#1)
in order to verify##2##4##(2008-10#1)(2008-7#1)
in order to yield##2##4##(2008-5#1)(2013-1#1)
in order to##599##3##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#4)(1991-6#4)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#3)(1993-11#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#4)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#5)(2008-10#238)(2008-11#61)(2008-12#19)(2008-2#1)(2008-4#6)(2008-5#13)(2008-6#3)(2008-7#17)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#6)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#4)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#6)(2011-1#3)(2011-2#26)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#9)(2012-3#6)(2012-7#1)(2012-9#1)(2013-1#16)(2013-7#1)(2013-8#9)
in order##614##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#4)(1991-6#4)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#3)(1993-11#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#5)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#5)(2008-10#241)(2008-11#64)(2008-12#20)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#14)(2008-6#3)(2008-7#17)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#6)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#4)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#26)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#10)(2012-3#6)(2012-7#1)(2012-9#1)(2013-1#16)(2013-7#1)(2013-8#9)
in ordinary##3##2##(1991-6#1)(1993-2#1)(2013-1#1)
in ore##3##2##(2008-10#3)
in organ culture##3##3##(1994-2#1)(1995-8#2)
in organ##10##2##(1993-8#1)(1994-2#1)(1995-8#2)(1997-3#1)(1997-8#1)(2008-10#2)(2008-9#1)(2013-1#1)
in organic and conventional##2##4##(2008-10#2)
in organic media##5##3##(2008-7#5)
in organic orchards##2##3##(2008-10#2)
in organic phase##3##3##(2008-10#3)
in organic plots##2##3##(2008-10#2)
in organic solvents##9##3##(1990-5#1)(1994-8#2)(1995-3#1)(2008-10#5)
in organic than##4##3##(2008-10#4)
in organic##37##2##(1990-5#1)(1992-8#1)(1994-8#2)(1995-3#1)(2008-10#26)(2008-3#1)(2008-7#5)
in organically modified##2##3##(2008-10#2)
in organically##3##2##(2008-10#3)
in organisms with##2##3##(1997-7#1)(2008-9#1)
in organisms##5##2##(1997-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
in organization##3##2##(1995-2#1)(2008-12#1)(2013-8#1)
in organizational##3##2##(1991-3#1)(1996-1#1)(2008-7#1)
in organizations##6##2##(1992-1#1)(1993-12#2)(2008-11#1)(2008-7#1)(2012-3#1)
in organs and tissues##2##4##(2008-10#1)(2012-2#1)
in organs and##3##3##(1994-5#1)(2008-10#1)(2012-2#1)
in organs##7##2##(1994-5#1)(2008-10#3)(2012-12#1)(2012-2#2)
in origin##4##2##(1990-3#1)(1997-3#1)(2009-4#1)(2009-8#1)
in orthopaedic surgery##2##3##(2008-11#1)(2011-2#1)
in orthopaedic##4##2##(1994-3#1)(2007-11#1)(2008-11#1)(2011-2#1)
in orthorhombic crystal form I##2##5##(2008-8#2)
in osmotic##3##2##(2008-10#2)(2009-6#1)
in osteoblastic metastases##2##3##(1991-8#2)
in osteoblasts##3##2##(1990-11#1)(2008-11#1)(2011-1#1)
in osteogenic##3##2##(1992-12#1)(2008-11#2)
in osteomyelitis##3##2##(2010-6#3)
in osteoporosis##6##2##(1991-11#1)(1991-12#1)(1992-6#2)(1996-11#1)(2008-11#1)
in other areas of##4##4##(1991-2#1)(2008-10#2)(2008-6#1)
in other areas##6##3##(1991-2#1)(2008-10#3)(2008-6#1)(2010-12#1)
in other cases##2##3##(2008-10#1)(2008-3#1)
in other cell##3##3##(2008-11#2)(2008-7#1)
in other cells##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
in other countries##9##3##(1993-6#1)(2008-11#1)(2008-5#3)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)
in other groups##2##3##(1990-6#1)(2008-9#1)
in other host##2##3##(2008-10#2)
in other layers##4##3##(1994-2#3)(1997-3#1)
in other organisms##2##3##(2008-10#1)(2009-10#1)
in other parts of the##3##5##(2008-10#1)(2008-7#1)(2010-5#1)
in other plant##5##3##(2008-10#2)(2008-8#1)(2010-11#1)(2011-2#1)
in other proteins##2##3##(1992-3#1)(1996-2#1)
in other regions of the##2##5##(1993-12#1)(2008-11#1)
in other settings##2##3##(2008-7#1)(2013-1#1)
in other situations##2##3##(2008-10#1)(2011-10#1)
in other species##6##3##(1991-3#1)(1992-9#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-11#1)
in other strains##2##3##(1995-9#1)(2008-7#1)
in other studies##4##3##(1990-5#1)(2008-5#2)(2013-1#1)
in other systems##2##3##(1997-7#1)(2008-10#1)
in other tissues##3##3##(1993-3#1)(1997-1#1)(2008-10#1)
in other##186##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-2#5)(1994-5#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#35)(2008-11#16)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#8)(2009-10#3)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#3)(2010-8#1)(2011-10#3)(2011-2#8)(2011-3#1)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#4)
in others a##2##3##(2008-11#1)(2008-12#1)
in others##8##2##(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#1)
in otherwise healthy##3##3##(1991-8#1)(1997-6#1)(2012-2#1)
in otherwise##6##2##(1991-8#1)(1997-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
in otoliths##2##2##(2008-10#1)(2008-7#1)
in our County##3##3##(2011-2#3)
in our analysis##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
in our case##8##3##(1990-8#1)(1991-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#1)
in our clinic##2##3##(2011-1#1)(2012-3#1)
in our community##2##3##(1994-12#1)(2012-3#1)
in our country##5##3##(1990-9#1)(1995-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
in our department in##2##4##(1991-11#1)(2008-9#1)
in our department##10##3##(1991-11#1)(1993-6#1)(1997-4#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
in our environment##2##3##(2008-10#1)(2013-8#1)
in our experimental conditions##2##4##(2008-10#1)(2008-7#1)
in our experimental##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
in our field##2##3##(2008-10#1)(2009-10#1)
in our hospital##11##3##(1991-2#1)(1997-8#1)(2008-12#1)(2010-6#4)(2010-7#1)(2012-3#1)(2013-1#2)
in our hospitals##2##3##(1990-6#1)(2011-2#1)
in our institution##4##3##(1991-8#1)(1996-3#1)(2010-11#1)(2011-2#1)
in our knowledge about##2##4##(2008-8#1)(2009-10#1)
in our knowledge##6##3##(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2013-7#1)
in our lab##3##3##(2008-10#2)(2008-7#1)
in our laboratory and##2##4##(1997-2#1)(2008-10#1)
in our laboratory##22##3##(1991-2#1)(1993-1#2)(1996-1#1)(1997-2#1)(2008-10#11)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in our model##3##3##(1992-9#1)(1996-2#1)(2007-12#1)
in our own##4##3##(1991-11#1)(1991-8#1)(1994-1#1)(2008-12#1)
in our patient##5##3##(1996-8#2)(2011-2#1)(2013-1#1)(2013-7#1)
in our patients were##2##4##(2008-1#2)
in our patients##4##3##(2008-1#2)(2008-12#1)(2011-2#1)
in our previous study##3##4##(2008-10#2)(2008-9#1)
in our previous##5##3##(1994-2#1)(1997-8#1)(2008-10#2)(2008-9#1)
in our residency##2##3##(1995-1#2)
in our results##2##3##(2008-5#1)(2010-6#1)
in our sample##3##3##(2008-10#1)(2009-5#1)(2013-8#1)
in our series##5##3##(1997-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#1)
in our setting##2##3##(1995-10#1)(2011-2#1)
in our society##5##3##(1995-3#1)(1996-1#1)(1997-2#1)(2008-9#1)(2009-9#1)
in our study##16##3##(1990-2#1)(1991-6#1)(1994-3#1)(1994-6#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-3#2)
in our understanding of how##2##5##(2008-7#1)(2011-2#1)
in our understanding of the##4##5##(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
in our understanding of##9##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
in our understanding##10##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
in our work##2##3##(1993-8#1)(2008-10#1)
in our##218##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-5#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#4)(1995-10#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#37)(2008-11#10)(2008-12#6)(2008-3#4)(2008-5#5)(2008-7#8)(2008-8#6)(2008-9#9)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#19)(2012-2#1)(2012-3#6)(2013-1#9)(2013-7#4)(2013-8#4)
in outbreak##2##2##(2008-7#1)(2008-8#1)
in outbred rodents##2##3##(2008-10#2)
in outbred##3##2##(2008-10#3)
in outcome##6##2##(1990-2#1)(1993-3#1)(1995-11#1)(1996-2#1)(1997-3#1)(2012-3#1)
in outdoor##5##2##(2008-10#2)(2008-5#1)(2008-8#2)
in outer##6##2##(2008-11#2)(2008-7#1)(2008-8#2)(2011-2#1)
in outpatient##7##2##(1992-6#1)(1992-7#1)(1995-1#1)(1997-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
in outpatients##2##2##(2007-11#1)(2008-10#1)
in ovarian cancer##2##3##(2013-8#2)
in ovarian##5##2##(1992-3#1)(2011-2#1)(2012-12#1)(2013-8#2)
in ovaries##3##2##(2008-10#2)(2012-3#1)
in over##7##2##(2008-10#2)(2008-7#3)(2013-1#2)
in overall##11##2##(1991-2#1)(1994-6#1)(1995-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#2)
in overcoming##2##2##(2009-12#1)(2009-8#1)
in overseas##2##2##(1995-6#1)(2010-1#1)
in overweight##5##2##(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#2)
in ovine neutrophils##2##3##(2008-11#2)
in ovo##4##2##(1996-12#3)(2008-12#1)
in oxalic##2##2##(2008-10#2)
in oxidative stress##3##3##(2008-5#1)(2009-8#1)(2013-1#1)
in oxidative##7##2##(2008-10#4)(2008-5#1)(2009-8#1)(2013-1#1)
in oxygen##3##2##(1990-5#1)(2008-10#1)(2012-3#1)
in oyster tissue##3##3##(2008-10#3)
in p53 and nuclear##2##4##(2010-10#2)
in p53##4##2##(1991-5#1)(1997-7#1)(2010-10#2)
in pEA29##2##2##(2008-10#2)
in pEJ30##2##2##(2008-10#2)
in pEP36##2##2##(2008-10#2)
in pH 2##2##3##(2008-10#2)
in pH 3##2##3##(2008-10#2)
in pH 5##4##3##(2008-10#4)
in pH 7##3##3##(2008-10#3)
in pH 9##3##3##(2008-10#3)
in pH and##4##3##(2008-11#2)(2008-5#1)(2008-9#1)
in pH range of 3-9##2##5##(2008-10#2)
in pH range of##3##4##(2008-10#3)
in pH range##6##3##(2008-10#5)(2008-11#1)
in pH##34##2##(1995-6#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-2#1)
in pK(a)##2##2##(2008-10#2)
in pachytene##2##2##(2012-2#2)
in packing##2##2##(1993-8#1)(1994-5#1)
in paediatric and##3##3##(2008-11#1)(2010-10#1)(2012-3#1)
in paediatric cochlear implantation##2##4##(2008-9#2)
in paediatric patients##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
in paediatric urology##2##3##(2008-10#2)
in paediatric##25##2##(2008-1#1)(2008-10#4)(2008-11#9)(2008-9#4)(2010-10#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#2)
in paediatrics##4##2##(1990-3#2)(2008-11#1)(2010-7#1)
in paid employment##2##3##(1991-9#1)(1995-1#1)
in pain and##3##3##(2008-12#3)
in pain assessment##2##3##(2008-11#1)(2012-2#1)
in pain management##3##3##(2008-11#1)(2012-3#2)
in pain score##2##3##(1994-3#2)
in pain##21##2##(1993-2#1)(1994-3#2)(1996-12#1)(2008-11#2)(2008-12#5)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#3)
in pairs##5##2##(1997-3#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-8#1)
in palliative care##5##3##(1992-2#1)(2008-11#2)(2011-2#1)(2012-3#1)
in palliative##7##2##(1992-2#1)(2008-11#2)(2011-2#1)(2012-12#2)(2012-3#1)
in pancreas##3##2##(2013-1#1)(2013-7#2)
in pancreatic beta-cells##3##3##(1994-11#2)(2013-1#1)
in pancreatic cancer##2##3##(2009-7#1)(2013-1#1)
in pancreatic islet##2##3##(2010-11#2)
in pancreatic islets and##2##4##(1995-8#1)(2008-10#1)
in pancreatic islets##4##3##(1995-8#1)(2008-10#2)(2009-8#1)
in pancreatic tissues##2##3##(2013-1#1)(2013-8#1)
in pancreatic##17##2##(1994-11#3)(1995-8#1)(2008-10#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2013-1#4)(2013-7#1)(2013-8#1)
in papaya##2##2##(2008-10#2)
in papillae##3##2##(2008-10#3)
in paracetamol##2##2##(2008-10#2)
in paraffin##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
in parallel by the##2##4##(2008-10#1)(2008-11#1)
in parallel by##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
in parallel on##2##3##(2008-12#1)(2008-5#1)
in parallel to##4##3##(1994-11#1)(2008-10#1)(2008-9#1)(2009-8#1)
in parallel with the##4##4##(1994-11#1)(1995-8#1)(1996-2#1)(2008-10#1)
in parallel with##11##3##(1992-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)
in parallel##40##2##(1992-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
in parasites##4##2##(1996-12#1)(2008-8#1)(2008-9#1)(2009-6#1)
in parasitic##3##2##(2008-10#2)(2012-2#1)
in parenchymal##2##2##(2010-3#1)(2011-2#1)
in parent-adolescent##2##2##(2009-7#1)(2013-1#1)
in parental##4##2##(1992-2#1)(1997-6#1)(2008-8#1)(2012-12#1)
in parenteral solutions##2##3##(2008-10#2)
in parenteral##5##2##(2008-10#5)
in parenthesis)##2##2##(1990-2#1)(2008-10#1)
in parents of children with##2##5##(2008-9#1)(2010-7#1)
in parents of##3##3##(2008-9#1)(2010-7#2)
in parietal cells##2##3##(1997-1#2)
in parietal##4##2##(1991-12#1)(1997-1#2)(2010-7#1)
in parkinsonian##2##2##(2008-7#1)(2012-2#1)
in part I##2##3##(2008-3#2)
in part at##2##3##(1994-8#1)(2008-5#1)
in part because of the##2##5##(1990-11#1)(2013-8#1)
in part because of##4##4##(1990-11#1)(2008-1#1)(2008-8#1)(2013-8#1)
in part because the##2##4##(1994-1#1)(2008-10#1)
in part because##9##3##(1990-11#1)(1994-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
in part by the##2##4##(2008-4#1)(2008-8#1)
in part by##4##3##(1992-9#1)(2008-4#1)(2008-5#1)(2008-8#1)
in part due to a##2##5##(1991-6#1)(1997-6#1)
in part due to##5##4##(1991-6#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)
in part from the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
in part from##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
in part the##2##3##(1997-8#1)(2013-1#1)
in part through##5##3##(1995-1#1)(1997-1#1)(2009-12#1)(2011-2#1)(2013-1#1)
in part to the##8##4##(1990-8#1)(1995-9#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
in part to##15##3##(1990-8#1)(1992-1#1)(1994-6#1)(1995-9#1)(1996-1#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-1#1)
in part##115##2##(1990-11#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#12)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#9)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
in partial hospitalization##2##3##(1992-1#2)
in partial##5##2##(1992-1#2)(2008-10#1)(2010-6#1)(2011-2#1)
in partially non-aqueous medium##4##4##(2008-10#4)
in partially##6##2##(1995-2#1)(2008-10#4)(2010-12#1)
in participating##2##2##(2011-2#1)(2012-2#1)
in participatory research##2##3##(1997-3#2)
in particle##3##2##(2008-10#2)(2011-3#1)
in particles##2##2##(1995-3#1)(1996-2#1)
in particular and##2##3##(2008-10#1)(2008-8#1)
in particular for##4##3##(2008-10#3)(2012-2#1)
in particular how##2##3##(1995-5#1)(2008-11#1)
in particular if##2##3##(2011-2#1)(2013-1#1)
in particular in the##4##4##(1995-5#1)(2008-10#1)(2010-11#1)(2010-5#1)
in particular in##6##3##(1995-5#1)(2008-10#2)(2010-11#1)(2010-5#1)(2012-12#1)
in particular is##2##3##(2008-3#1)(2011-2#1)
in particular of##2##3##(1994-5#1)(2008-2#1)
in particular the##11##3##(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-3#1)(2012-2#2)(2013-8#1)
in particular those##5##3##(1994-9#1)(2008-10#3)(2008-12#1)
in particular to##2##3##(1993-11#1)(2008-10#1)
in particular when##3##3##(1991-12#1)(1997-2#1)(2013-1#1)
in particular with##4##3##(1991-6#2)(2008-10#1)(2008-11#1)
in particular##146##2##(1990-11#2)(1990-3#2)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#5)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#3)(1995-6#1)(1996-11#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2008-1#3)(2008-10#30)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#4)
in particulate##2##2##(1996-12#1)(2008-10#1)
in partnership with the##4##4##(2008-11#2)(2008-12#2)
in partnership with##7##3##(1993-12#1)(2008-11#3)(2008-12#3)
in partnership##9##2##(1993-12#1)(1996-2#1)(2008-11#4)(2008-12#3)
in parts of the##2##4##(1995-3#1)(2008-11#1)
in parts of##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
in passive##3##2##(1991-2#1)(1991-5#1)(2008-10#1)
in past##5##2##(1997-8#1)(2008-10#1)(2011-2#2)(2012-7#1)
in patch##4##2##(2008-8#2)(2008-9#2)
in patches of##3##3##(2008-8#1)(2008-9#2)
in patches##6##2##(1991-2#1)(1994-9#1)(2008-8#2)(2008-9#2)
in paternal care##2##3##(2008-9#2)
in paternal##3##2##(2008-9#3)
in paternity testing##2##3##(2008-12#2)
in paternity##4##2##(2008-12#3)(2008-8#1)
in pathogen populations##2##3##(2008-10#2)
in pathogen##11##2##(2008-10#9)(2008-9#1)(2009-8#1)
in pathogenesis and##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
in pathogenesis of##2##3##(2009-1#1)(2013-1#1)
in pathogenesis##9##2##(2008-10#2)(2008-12#1)(2009-1#1)(2011-1#1)(2011-2#2)(2013-1#2)
in pathogenicity in##2##3##(2008-10#2)
in pathogenicity tests##2##3##(2008-10#2)
in pathogenicity was##2##3##(2008-10#2)
in pathogenicity were##2##3##(2008-10#2)
in pathogenicity##17##2##(2008-10#17)
in patient blood after myocardial damage##2##6##(2008-10#2)
in patient care##7##3##(1992-12#1)(1995-2#1)(2010-8#3)(2012-2#1)(2013-1#1)
in patient populations##2##3##(2010-6#1)(2013-1#1)
in patient with##4##3##(2008-1#1)(2008-12#1)(2011-2#1)(2012-3#1)
in patient##29##2##(1992-12#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-6#1)(2010-8#3)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
in patients above##2##3##(2008-12#1)(2012-3#1)
in patients affected by##5##4##(2008-10#2)(2008-5#1)(2013-1#2)
in patients affected##6##3##(2008-10#2)(2008-5#2)(2013-1#2)
in patients after cardiac surgery##2##5##(2012-3#2)
in patients after##7##3##(1993-12#2)(2011-2#2)(2012-3#2)(2013-1#1)
in patients aged &lt##2##4##(2013-1#2)
in patients aged##4##3##(1990-6#1)(2012-2#1)(2013-1#2)
in patients being treated with##2##5##(1993-2#1)(2008-11#1)
in patients exposed to##2##4##(2008-7#1)(2010-5#1)
in patients from##4##3##(1996-3#1)(1997-8#1)(2008-1#1)(2012-12#1)
in patients in the##2##4##(1992-9#1)(2011-2#1)
in patients in whom##3##4##(1991-11#2)(2008-1#1)
in patients in##8##3##(1991-11#2)(1991-3#1)(1992-9#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
in patients may##2##3##(2008-11#1)(2011-2#1)
in patients of##4##3##(1990-5#1)(2010-12#1)(2010-2#1)(2011-2#1)
in patients older than##7##4##(2008-7#1)(2009-1#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
in patients older##8##3##(2008-7#1)(2009-1#1)(2009-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
in patients on dialysis##2##4##(2008-1#1)(2011-2#1)
in patients on##4##3##(1993-6#1)(2008-1#1)(2011-2#1)(2013-1#1)
in patients operated on for endometrial cancer##2##7##(1992-12#2)
in patients operated##6##3##(1990-11#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-12#2)
in patients over##4##3##(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
in patients presenting with##5##4##(1995-5#1)(2007-12#1)(2008-10#1)(2010-1#1)(2011-2#1)
in patients presenting##6##3##(1990-11#1)(1995-5#1)(2007-12#1)(2008-10#1)(2010-1#1)(2011-2#1)
in patients receiving##12##3##(1990-12#1)(1990-6#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#3)(2010-12#1)(2012-12#1)(2013-1#2)
in patients subjected to##2##4##(2008-11#1)(2011-2#1)
in patients suffering from##2##4##(2008-10#2)
in patients suffering##3##3##(2008-10#2)(2009-5#1)
in patients taking##3##3##(1995-11#1)(2008-11#2)
in patients that##4##3##(2010-12#1)(2011-2#3)
in patients treated by##2##4##(1994-6#1)(2008-7#1)
in patients treated with high-dose chemotherapy##2##6##(2008-7#2)
in patients treated with##9##4##(1992-12#1)(1993-1#1)(1994-12#1)(2008-10#1)(2008-7#4)(2012-12#1)
in patients treated##13##3##(1992-12#1)(1993-1#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-7#6)(2012-12#2)
in patients under##4##3##(1994-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
in patients undergoing coronary##2##4##(2008-12#1)(2008-5#1)
in patients undergoing lumbar spine surgery##3##6##(2008-7#3)
in patients undergoing##21##3##(1990-6#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-7#3)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in patients when##2##3##(1990-9#1)(2008-7#1)
in patients who did##2##4##(1993-1#2)
in patients who had##5##4##(1992-12#1)(1994-3#1)(2010-7#1)(2012-3#1)(2013-1#1)
in patients who have##3##4##(1993-1#1)(2012-12#2)
in patients who underwent##6##4##(2008-9#1)(2011-2#4)(2012-3#1)
in patients who##28##3##(1990-3#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-1#3)(1994-3#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
in patients whose##2##3##(1993-1#1)(2012-3#1)
in patients with &quot##2##4##(1990-11#1)(2011-2#1)
in patients with AR##3##4##(2011-2#3)
in patients with Alzheimer's disease##3##5##(2008-5#1)(2008-7#1)(2009-9#1)
in patients with COPD##4##4##(1997-1#1)(2013-8#3)
in patients with HIV infection##2##5##(1996-11#1)(1996-3#1)
in patients with HIV##5##4##(1996-11#1)(1996-3#1)(2008-10#1)(2010-12#2)
in patients with HIV-1 infection##2##5##(1990-2#1)(2010-11#1)
in patients with MS##2##4##(2010-12#2)
in patients with PD##2##4##(2008-10#1)(2013-1#1)
in patients with Parkinson's disease##3##5##(1993-2#1)(2008-7#2)
in patients with RM##2##4##(1994-12#2)
in patients with SS##5##4##(2007-11#5)
in patients with Takayasu arteritis and severe aortic regurgitation##2##9##(1997-8#2)
in patients with a##12##4##(1990-12#1)(1992-5#1)(1996-1#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
in patients with abdominal pain##2##5##(2011-2#1)(2012-12#1)
in patients with abdominal##4##4##(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
in patients with abnormal thermograms##2##5##(1993-11#2)
in patients with abnormal##3##4##(1990-6#1)(1993-11#2)
in patients with acute bacterial prostatitis##2##6##(2008-10#2)
in patients with acute coronary syndrome##3##6##(2008-11#1)(2011-2#2)
in patients with acute coronary##4##5##(2008-11#1)(2009-10#1)(2011-2#2)
in patients with acute myocardial infarction##2##6##(1992-9#1)(2008-3#1)
in patients with acute myocardial##3##5##(1990-12#1)(1992-9#1)(2008-3#1)
in patients with acute##20##4##(1990-12#1)(1992-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2009-10#2)(2011-2#4)(2012-3#2)(2013-1#2)
in patients with adult##2##4##(1992-2#1)(2012-12#1)
in patients with advanced##5##4##(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)
in patients with an##2##4##(2008-10#1)(2012-3#1)
in patients with and without##2##5##(1997-7#1)(2011-2#1)
in patients with ankylosing##2##4##(2008-10#2)
in patients with asthma and##3##5##(2012-12#3)
in patients with asthma##4##4##(2012-12#4)
in patients with atrial fibrillation##2##5##(2008-3#1)(2009-12#1)
in patients with back pain associated with myofascial trigger points##2##10##(2010-12#2)
in patients with back pain##4##5##(2007-11#1)(2009-1#1)(2010-12#2)
in patients with blunt##2##4##(1990-2#1)(2011-2#1)
in patients with breast cancer and##2##6##(1992-12#1)(1993-11#1)
in patients with breast cancer##9##5##(1992-12#1)(1993-11#3)(1997-7#1)(1997-8#2)(2008-10#1)(2008-7#1)
in patients with breast##10##4##(1992-12#1)(1993-11#3)(1997-7#1)(1997-8#2)(2008-10#1)(2008-7#2)
in patients with cancer##8##4##(1990-6#1)(2008-7#2)(2010-11#1)(2010-4#1)(2013-1#3)
in patients with chronic heart failure##2##6##(2009-10#1)(2012-2#1)
in patients with chronic heart##3##5##(2009-10#1)(2012-2#1)(2013-8#1)
in patients with chronic hepatitis C##2##6##(2009-10#1)(2013-1#1)
in patients with chronic hepatitis##3##5##(2009-10#1)(2011-2#1)(2013-1#1)
in patients with chronic kidneys disease##2##6##(2013-1#2)
in patients with chronic obstructive##2##5##(1993-11#1)(2008-1#1)
in patients with chronic renal failure##2##6##(1992-6#1)(1993-1#1)
in patients with chronic renal##3##5##(1992-6#1)(1993-1#1)(2008-1#1)
in patients with chronic wrist pain##2##6##(2008-9#2)
in patients with chronic##27##4##(1992-6#1)(1993-1#1)(1993-11#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#2)(2009-8#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
in patients with cirrhosis and##2##5##(2011-2#1)(2013-1#1)
in patients with congenital heart disease##4##6##(2009-10#2)(2010-10#1)(2012-2#1)
in patients with congenital##6##4##(1994-11#1)(2009-10#2)(2010-10#1)(2012-2#2)
in patients with coronary heart disease##2##6##(1992-5#1)(1993-2#1)
in patients with coronary##4##4##(1992-5#1)(1993-2#1)(2013-7#1)(2013-8#1)
in patients with cystic fibrosis##2##5##(1994-12#1)(2008-10#1)
in patients with diabetes##3##4##(2008-7#2)(2009-1#1)
in patients with different##2##4##(1993-2#1)(2011-2#1)
in patients with dysthymic disorder##2##5##(2011-2#2)
in patients with dysthymic##3##4##(2011-2#3)
in patients with environmental exposures##2##5##(1991-12#2)
in patients with gastric##2##4##(1990-2#1)(2008-12#1)
in patients with gastroesophageal##2##4##(2009-11#1)(2013-1#1)
in patients with heart failure##2##5##(2011-2#1)(2013-8#1)
in patients with heart##4##4##(2008-5#1)(2011-2#1)(2011-3#1)(2013-8#1)
in patients with hematologic malignancies##2##5##(2008-7#2)
in patients with high-risk acute myeloid leukemia##2##7##(2011-2#2)
in patients with high-risk##6##4##(2011-2#5)(2013-1#1)
in patients with hyperlipidaemia##2##4##(2008-3#2)
in patients with idiopathic##2##4##(1995-10#1)(2009-10#1)
in patients with increased##2##4##(2008-12#1)(2011-2#1)
in patients with inflammatory bowel disease##4##6##(2008-10#1)(2012-12#1)(2013-1#2)
in patients with inflammatory bowel##5##5##(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
in patients with inoperable oesophageal##2##5##(1993-6#2)
in patients with intracerebral##2##4##(2008-7#2)
in patients with liver cirrhosis##2##5##(1992-2#1)(2010-8#1)
in patients with liver disease##2##5##(2013-1#2)
in patients with liver##4##4##(1992-2#1)(2010-8#1)(2013-1#2)
in patients with locally##2##4##(1990-8#1)(2008-10#1)
in patients with low##2##4##(2008-11#1)(2013-1#1)
in patients with lumbar##3##4##(2011-2#1)(2012-12#2)
in patients with mechanical neck pain##2##6##(2008-12#2)
in patients with metabolic syndrome##2##5##(2008-11#1)(2012-2#1)
in patients with metastatic##2##4##(1990-2#1)(2013-8#1)
in patients with moderate and severe airways obstruction##2##8##(2008-7#2)
in patients with multiple##2##4##(2008-11#1)(2012-12#1)
in patients with neck pain##4##5##(2008-12#3)(2010-12#1)
in patients with neuroendocrine##2##4##(1992-11#2)
in patients with non-small cell lung cancer##2##7##(2008-1#1)(2013-1#1)
in patients with non-small##3##4##(2008-1#1)(2009-4#1)(2013-1#1)
in patients with normal##4##4##(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
in patients with other##3##4##(1994-12#1)(1997-8#1)(2011-2#1)
in patients with patellofemoral pain syndrome##2##6##(2008-12#2)
in patients with persistent##3##4##(1991-8#1)(2008-12#1)(2008-3#1)
in patients with pneumococcal meningitis##2##5##(2011-2#2)
in patients with pneumococcal##3##4##(2011-2#3)
in patients with primary##2##4##(1990-8#1)(1995-10#1)
in patients with renal##2##4##(1996-6#1)(2013-1#1)
in patients with schizophrenia##5##4##(1995-12#1)(2009-12#1)(2010-1#2)(2012-3#1)
in patients with severe##8##4##(2008-10#1)(2008-12#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
in patients with spinal##2##4##(1993-2#1)(2012-3#1)
in patients with stable##3##4##(1992-12#1)(2008-10#1)(2008-12#1)
in patients with suspected##3##4##(2010-7#1)(2011-2#1)(2012-2#1)
in patients with systemic##2##4##(2010-10#1)(2011-2#1)
in patients with the##3##4##(1991-12#1)(2008-1#1)(2010-4#1)
in patients with this##3##4##(1991-11#1)(1993-9#1)(2008-12#1)
in patients with thyroid##2##4##(2011-1#1)(2013-1#1)
in patients with type 1 and type 2 diabetes##2##9##(2012-4#2)
in patients with type 2 diabetes##6##6##(2008-3#1)(2010-10#1)(2011-2#3)(2012-5#1)
in patients with type 2##7##5##(2008-3#1)(2010-10#1)(2011-2#3)(2012-5#2)
in patients with type##10##4##(2008-3#1)(2010-10#1)(2011-2#3)(2012-3#1)(2012-4#2)(2012-5#2)
in patients with underlying##2##4##(1990-3#1)(2011-2#1)
in patients with unstable angina pectoris##2##6##(1990-12#2)
in patients with untreated Graves' disease##2##6##(2012-3#2)
in patients with##517##3##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#3)(1990-6#3)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-6#2)(1991-7#1)(1991-8#2)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-5#3)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#6)(1993-2#7)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#8)(1994-9#1)(1995-10#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-3#3)(1997-5#1)(1997-7#3)(1997-8#11)(1997-9#1)(2007-11#7)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#8)(2008-10#29)(2008-11#9)(2008-12#24)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#25)(2008-8#6)(2008-9#7)(2009-1#2)(2009-10#9)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#4)(2009-6#2)(2009-7#2)(2009-8#10)(2009-9#1)(2010-1#5)(2010-10#6)(2010-11#5)(2010-12#14)(2010-3#1)(2010-4#4)(2010-6#5)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#67)(2011-3#1)(2012-12#21)(2012-2#14)(2012-3#23)(2012-4#2)(2012-5#2)(2013-1#37)(2013-7#1)(2013-8#11)
in patients without##10##3##(1990-3#1)(1990-9#1)(1994-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-3#1)
in patients##726##2##(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#5)(1990-5#1)(1990-6#6)(1990-8#3)(1990-9#5)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#5)(1991-6#5)(1991-7#1)(1991-8#2)(1992-11#3)(1992-12#8)(1992-2#2)(1992-3#4)(1992-5#3)(1992-6#2)(1992-9#3)(1993-1#7)(1993-11#6)(1993-12#2)(1993-2#8)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#9)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#4)(1996-6#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-5#1)(1997-7#3)(1997-8#14)(1997-9#1)(2007-11#7)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#12)(2008-10#42)(2008-11#19)(2008-12#27)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#8)(2008-7#42)(2008-8#7)(2008-9#9)(2009-1#3)(2009-10#10)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#13)(2009-9#1)(2010-1#6)(2010-10#6)(2010-11#5)(2010-12#21)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#5)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#94)(2011-3#1)(2012-12#30)(2012-2#20)(2012-3#35)(2012-4#2)(2012-5#2)(2013-1#54)(2013-3#1)(2013-7#1)(2013-8#13)
in pattern##3##2##(2008-5#1)(2008-6#1)(2011-3#1)
in patterns of##2##3##(2008-1#1)(2008-8#1)
in patterns##4##2##(1992-2#1)(2008-1#1)(2008-11#1)(2008-8#1)
in pea plants##2##3##(2008-10#2)
in pea##5##2##(2008-10#4)(2011-2#1)
in peach##2##2##(2008-10#2)
in peak##3##2##(2008-10#2)(2008-7#1)
in peanut seed##3##3##(2008-10#3)
in peanut##6##2##(2008-10#6)
in pear##2##2##(2008-10#2)
in pears##3##2##(2008-10#3)
in peat##3##2##(2008-10#3)
in peatlands##2##2##(2008-8#2)
in pediatric patients with##3##4##(2010-11#2)(2011-2#1)
in pediatric patients##4##3##(2010-11#2)(2011-2#2)
in pediatric surgery]##2##3##(1990-5#1)(1991-3#1)
in pediatric urology##2##3##(2008-10#2)
in pediatric##19##2##(1990-5#1)(1991-3#1)(1994-1#1)(2008-10#2)(2008-9#1)(2010-11#3)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)
in pediatrics and##2##3##(2009-10#2)
in pediatrics##6##2##(1991-3#1)(2008-5#1)(2009-10#2)(2011-2#2)
in peninsular Malaysia##5##3##(2008-10#1)(2008-12#3)(2008-8#1)
in people with spinal##2##4##(2008-12#1)(2013-1#1)
in people with##8##3##(2008-12#1)(2009-7#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in people##14##2##(1993-9#1)(1995-12#1)(2008-10#1)(2008-12#2)(2009-7#2)(2010-10#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in pepper##7##2##(2008-10#7)
in pepsinogen secretion from##3##4##(1995-8#3)
in pepsinogen secretion##4##3##(1995-8#4)
in peptide##2##2##(1995-12#1)(1996-12#1)
in percent body fat and##2##5##(2008-11#1)(2008-4#1)
in percent##6##2##(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#1)
in percentage cover##2##3##(2008-9#2)
in percentage of##2##3##(2008-10#1)(2011-2#1)
in percentage##6##2##(2008-10#1)(2008-12#1)(2008-9#2)(2010-5#1)(2011-2#1)
in perception of##3##3##(2008-9#1)(2011-2#2)
in perception##6##2##(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#2)(2012-2#1)
in perceptions##2##2##(2008-9#1)(2010-1#1)
in perchloric acid##2##3##(2008-10#2)
in perchloric##3##2##(2008-10#3)
in percutaneous coronary intervention##2##4##(2008-3#1)(2009-10#1)
in percutaneous coronary##3##3##(2008-11#1)(2008-3#1)(2009-10#1)
in percutaneous##4##2##(1996-6#1)(2008-11#1)(2008-3#1)(2009-10#1)
in perennial##5##2##(2008-10#3)(2008-8#2)
in performance in##2##3##(2008-11#2)
in performance##13##2##(1993-3#3)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-9#1)(2010-7#1)(2011-2#1)
in performing##6##2##(1991-3#1)(1996-2#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
in perfused##2##2##(1991-3#2)
in perfusion cultures##2##3##(2008-11#2)
in perfusion pressure##2##3##(1993-3#2)
in perfusion##10##2##(1993-3#3)(1997-2#1)(2008-11#5)(2008-12#1)
in perinatal care##2##3##(2013-1#2)
in perinatal##3##2##(2012-3#1)(2013-1#2)
in perinatology##2##2##(1993-12#1)(1994-3#1)
in periodically poled KTP##2##4##(2007-11#2)
in periodically poled##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
in periodontal##3##2##(1990-9#1)(2008-5#1)(2013-1#1)
in periods##2##2##(2008-10#1)(2010-1#1)
in peripheral blood mononuclear cells##2##5##(2008-10#1)(2008-7#1)
in peripheral blood##12##3##(1991-2#1)(1995-2#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#2)(2013-1#2)
in peripheral lymphocytes##2##3##(2008-8#1)(2012-3#1)
in peripheral nerve##2##3##(2011-2#2)
in peripheral nerves##2##3##(1997-4#1)(2011-2#1)
in peripheral tissues of fetal rhesus##2##6##(1990-11#2)
in peripheral tissues##3##3##(1990-11#2)(2012-2#1)
in peripheral##27##2##(1990-11#2)(1991-2#2)(1995-2#1)(1997-4#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#3)
in peritoneal dialysis patients##2##4##(2011-2#2)
in peritoneal dialysis##4##3##(2008-5#1)(2011-2#3)
in peritoneal##9##2##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#5)
in periwinkles infected with AYP##2##5##(2008-10#2)
in periwinkles infected with##4##4##(2008-10#4)
in permanent maxillary incisors##2##4##(2013-1#2)
in permanent##6##2##(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#3)
in permeability##2##2##(1990-5#1)(2008-11#1)
in permeabilized##5##2##(1993-8#2)(1994-5#1)(2008-7#2)
in persimmon##2##2##(2008-10#2)
in persistent##3##2##(1997-3#1)(2008-8#1)(2011-2#1)
in personal moral dilemmas##2##4##(2008-11#2)
in personal moral judgment##2##4##(2008-11#2)
in personal moral##4##3##(2008-11#4)
in personal##6##2##(1993-1#1)(2008-11#5)
in personalized medicine##2##3##(2010-5#1)(2013-8#1)
in persons with##5##3##(1993-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
in persons##7##2##(1993-2#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
in perspective##2##2##(2012-2#2)
in pesticide formulations##6##3##(2008-10#6)
in pesticide##9##2##(2008-10#8)(2008-11#1)
in pet##2##2##(1995-9#1)(2012-3#1)
in petri dishes##3##3##(2008-10#2)(2008-11#1)
in petri##4##2##(2008-10#3)(2008-11#1)
in petrolatum##2##2##(2008-5#1)(2012-3#1)
in petroleum oils##4##3##(2008-10#4)
in petroleum products##2##3##(2008-10#2)
in petroleum##8##2##(2008-10#7)(2013-1#1)
in phagocytes##2##2##(1993-8#1)(1994-8#1)
in phagocytic##3##2##(2008-10#1)(2012-2#2)
in phakic##2##2##(2011-2#2)
in pharmaceutical and##2##3##(2008-10#1)(2008-11#1)
in pharmaceutical dosage form##3##4##(2008-10#3)
in pharmaceutical dosage forms and biological fluids##2##7##(2008-10#2)
in pharmaceutical dosage forms##8##4##(2008-10#8)
in pharmaceutical dosage##11##3##(2008-10#11)
in pharmaceutical formulation and##4##4##(2008-10#4)
in pharmaceutical formulation##10##3##(2008-10#10)
in pharmaceutical formulations and biological fluids using##2##7##(2008-10#2)
in pharmaceutical formulations and##5##4##(2008-10#5)
in pharmaceutical formulations by using a##2##6##(2008-10#2)
in pharmaceutical formulations by using##3##5##(2008-10#3)
in pharmaceutical formulations by##6##4##(2008-10#6)
in pharmaceutical formulations is described##3##5##(2008-10#3)
in pharmaceutical formulations is##6##4##(2008-10#6)
in pharmaceutical formulations using a sequential injection##2##7##(2008-10#2)
in pharmaceutical formulations using a##3##5##(2008-10#3)
in pharmaceutical formulations using silicotungstic acid as precipitant reagent##2##9##(2008-10#2)
in pharmaceutical formulations using##11##4##(2008-10#11)
in pharmaceutical formulations with##2##4##(2008-10#2)
in pharmaceutical formulations##62##3##(2008-10#61)(2008-5#1)
in pharmaceutical preparation and##3##4##(2008-10#3)
in pharmaceutical preparation##7##3##(2008-10#7)
in pharmaceutical preparations and biological fluids##3##6##(2008-10#3)
in pharmaceutical preparations and the results##2##6##(2008-10#2)
in pharmaceutical preparations and##15##4##(2008-10#15)
in pharmaceutical preparations by##9##4##(2008-10#9)
in pharmaceutical preparations in##2##4##(2008-10#2)
in pharmaceutical preparations is##2##4##(2008-10#2)
in pharmaceutical preparations using##6##4##(2008-10#6)
in pharmaceutical preparations##73##3##(2008-10#73)
in pharmaceutical products are in##2##5##(2008-10#2)
in pharmaceutical products by micellar electrokinetic chromatography (MEKC) is described##2##10##(2008-10#2)
in pharmaceutical products by##3##4##(2008-10#3)
in pharmaceutical products##14##3##(2008-10#14)
in pharmaceutical samples##7##3##(2008-10#6)(2012-2#1)
in pharmaceutical##199##2##(2008-10#193)(2008-11#1)(2008-5#1)(2012-2#4)
in pharmaceuticals and biological fluids##3##5##(2008-10#3)
in pharmaceuticals and foods##2##4##(2008-10#2)
in pharmaceuticals and human serum##2##5##(2008-10#2)
in pharmaceuticals and##9##3##(2008-10#9)
in pharmaceuticals using##2##3##(2008-10#2)
in pharmaceuticals with##2##3##(2008-10#2)
in pharmaceuticals##37##2##(2008-10#34)(2012-2#3)
in pharmacokinetic##4##2##(2008-10#1)(2010-10#1)(2011-3#2)
in pharmacological##2##2##(2008-10#1)(2009-7#1)
in pharmacotherapy##2##2##(1990-6#1)(2012-2#1)
in pharmacovigilance##2##2##(2008-11#2)
in phase 2##2##3##(1993-3#1)(2013-1#1)
in phase I##2##3##(2008-5#1)(2011-2#1)
in phase II clinical trials##2##5##(2008-5#2)
in phase II##4##3##(2008-5#4)
in phase III clinical trials##2##5##(2008-11#1)(2008-5#1)
in phase III clinical##3##4##(2008-11#1)(2008-5#1)(2011-3#1)
in phase III##5##3##(2007-11#1)(2008-11#1)(2008-5#2)(2011-3#1)
in phase##17##2##(1993-3#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-5#7)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
in pheasant poults##2##3##(1990-6#1)(1992-2#1)
in phenotype##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#1)
in phenotypic##5##2##(2008-10#1)(2008-8#3)(2008-9#1)
in phloem and xylem of##2##5##(2012-8#2)
in phloem of##2##3##(2008-10#1)(2012-8#1)
in phloem tissues##3##3##(2008-10#3)
in phloem##10##2##(2008-10#5)(2008-9#1)(2012-8#4)
in phosphate and acetate buffer##2##5##(2009-10#2)
in phosphate buffer (pH 7##2##5##(2008-10#2)
in phosphate buffer (pH##4##4##(2008-10#4)
in phosphate buffer at pH 6##2##6##(2008-10#1)(2008-5#1)
in phosphate buffer solution##3##4##(2008-10#2)(2009-7#1)
in phosphate buffer with##2##4##(2008-10#2)
in phosphate buffer##21##3##(1990-12#1)(1992-10#1)(2008-10#17)(2008-5#1)(2009-7#1)
in phosphate##26##2##(1990-12#1)(1992-10#1)(1995-8#1)(2008-10#19)(2008-5#1)(2009-10#2)(2009-7#1)
in phosphatidylinositol##3##2##(1992-12#1)(1994-3#1)(2008-8#1)
in phospholipid##3##2##(1991-5#1)(1994-3#1)(1994-5#1)
in photodynamic therapy##2##3##(2008-7#2)
in photonic##3##2##(2007-12#1)(2008-3#2)
in photoprotection##2##2##(2011-2#1)(2012-2#1)
in photoresist##2##2##(2008-2#1)(2008-3#1)
in photosynthesis##4##2##(2008-10#4)
in photosynthetic##3##2##(1996-6#1)(2008-10#1)(2009-10#1)
in photosystem II##2##3##(2008-8#2)
in phthirapterans##2##2##(2007-12#2)
in phylogenetic##3##2##(2008-10#2)(2010-3#1)
in physical activity##5##3##(2009-6#1)(2010-1#1)(2010-11#2)(2012-12#1)
in physical and##3##3##(2010-9#1)(2012-12#1)(2012-3#1)
in physical fitness##2##3##(1991-8#1)(2012-2#1)
in physical##19##2##(1991-8#1)(1993-6#1)(1995-6#1)(2008-10#1)(2008-12#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
in physician payment policy##2##4##(1994-1#2)
in physician payment##3##3##(1994-1#3)
in physician##5##2##(1994-1#3)(2010-8#1)(2013-1#1)
in physiological and##2##3##(2008-10#1)(2011-1#1)
in physiological concentrations##2##3##(2008-10#2)
in physiological conditions##3##3##(1990-9#1)(2008-10#1)(2012-2#1)
in physiological##19##2##(1990-9#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-8#1)
in physiologically##3##2##(1992-7#1)(2008-12#1)(2012-9#1)
in physiotherapy##4##2##(1991-6#1)(1993-1#2)(2012-3#1)
in phytopathogenic##2##2##(2008-10#1)(2009-8#1)
in phytophagous insects##2##3##(2008-9#2)
in phytophagous##3##2##(2008-9#3)
in pig and##2##3##(1990-5#1)(2012-2#1)
in pig##6##2##(1990-5#1)(1990-9#1)(1994-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
in pigeonpea##4##2##(2010-10#4)
in pigeons##2##2##(2008-5#1)(2008-8#1)
in piglets##2##2##(2011-2#2)
in pigment##2##2##(2008-8#2)
in pigmentation##2##2##(2008-6#1)(2008-9#1)
in pigs##4##2##(1990-9#1)(1997-8#1)(2011-2#2)
in pilot scale##3##3##(2008-11#3)
in pilot##4##2##(2008-11#4)
in pituitary##3##2##(2010-5#2)(2013-1#1)
in place and##2##3##(2008-11#1)(2012-12#1)
in place by##2##3##(1991-1#1)(2008-10#1)
in place for##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)
in place in##3##3##(1991-1#1)(1991-12#2)
in place of a##2##4##(1994-8#1)(2008-10#1)
in place of the##6##4##(1995-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-2#1)(2012-3#1)
in place of##16##3##(1991-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-11#3)(2008-9#2)(2009-12#1)(2012-2#1)(2012-3#1)
in place to##6##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-1#1)
in place##61##2##(1990-8#1)(1991-1#2)(1991-12#6)(1991-3#3)(1994-8#1)(1994-9#1)(1995-2#3)(1995-6#1)(1996-2#1)(1997-3#1)(1997-5#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-5#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
in placement##2##2##(1996-2#1)(2011-2#1)
in placenta and##2##3##(1990-5#1)(2012-3#1)
in placenta##3##2##(1990-5#1)(2012-2#1)(2012-3#1)
in places##2##2##(1995-6#1)(2008-12#1)
in placing##2##2##(1992-8#1)(1995-5#1)
in planar##5##2##(2008-11#1)(2008-3#3)(2012-3#1)
in planning and##2##3##(1995-3#1)(1996-3#1)
in planning##12##2##(1991-2#1)(1993-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(2008-12#1)(2008-9#1)(2009-11#1)(2013-1#4)
in plant breeding##3##3##(2008-10#2)(2008-8#1)
in plant cells##11##3##(1994-11#1)(2008-11#2)(2008-8#4)(2009-6#1)(2009-8#2)(2011-2#1)
in plant defense against##3##4##(2008-10#3)
in plant defense##4##3##(2008-10#4)
in plant development and##3##4##(2008-9#1)(2009-8#1)(2012-3#1)
in plant development##6##3##(2008-10#1)(2008-9#1)(2009-8#3)(2012-3#1)
in plant disease##6##3##(2008-10#6)
in plant evolution##2##3##(2009-6#2)
in plant genomes##2##3##(2009-6#1)(2012-3#1)
in plant growth and##2##4##(2008-9#1)(2013-8#1)
in plant growth##7##3##(2008-10#2)(2008-12#1)(2008-9#1)(2009-8#1)(2013-8#2)
in plant material##5##3##(2008-10#5)
in plant pathogens##3##3##(2008-10#2)(2009-8#1)
in plant pathology##10##3##(2008-10#10)
in plant responses to##3##4##(2008-8#1)(2009-8#2)
in plant responses##4##3##(2008-10#1)(2008-8#1)(2009-8#2)
in plant samples##8##3##(2008-10#8)
in plant tissue##4##3##(2008-10#3)(2008-11#1)
in plant tissues##3##3##(2008-10#3)
in plant##117##2##(1994-11#1)(1995-8#1)(2008-10#62)(2008-11#4)(2008-12#3)(2008-8#7)(2008-9#7)(2009-6#4)(2009-8#17)(2010-11#2)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#2)
in planta and##3##3##(2008-10#3)
in planta##43##2##(1997-3#1)(2008-10#35)(2008-9#1)(2009-12#4)(2010-11#1)(2011-2#1)
in plantar##2##2##(2011-2#1)(2012-2#1)
in plants and the##2##4##(1997-3#1)(2011-2#1)
in plants and##7##3##(1997-3#2)(2008-10#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)
in plants as##2##3##(1997-3#1)(1997-8#1)
in plants at##2##3##(2008-10#2)
in plants by tissue##2##4##(2008-10#2)
in plants by##6##3##(2008-10#6)
in plants can##2##3##(2008-10#1)(2009-8#1)
in plants from##2##3##(2008-10#1)(2012-7#1)
in plants grown in the##3##5##(2008-10#3)
in plants grown##4##3##(2008-10#4)
in plants in##2##3##(2008-10#2)
in plants infected with##3##4##(2008-10#3)
in plants infected##4##3##(2008-10#4)
in plants inoculated with##3##4##(2008-10#2)(2008-12#1)
in plants is##2##3##(2009-6#1)(2012-3#1)
in plants not##2##3##(2008-10#2)
in plants was##2##3##(2008-10#1)(2008-8#1)
in plants with##4##3##(2008-10#3)(2009-8#1)
in plants##117##2##(1994-11#1)(1995-2#6)(1997-3#5)(1997-8#1)(2008-10#52)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#6)(2008-9#4)(2009-10#5)(2009-5#1)(2009-6#8)(2009-8#13)(2010-11#1)(2010-5#1)(2011-2#4)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#1)
in plaque##2##2##(1991-10#1)(1993-11#1)
in plaques##3##2##(1991-1#1)(1991-10#2)
in plasma and in##2##4##(1993-2#1)(2008-10#1)
in plasma and urine##2##4##(1991-12#1)(2013-1#1)
in plasma and##15##3##(1990-12#1)(1991-12#3)(1991-5#1)(1992-11#1)(1993-2#1)(1995-8#1)(2008-10#4)(2008-8#1)(2012-3#1)(2013-1#1)
in plasma are##2##3##(1992-3#1)(2012-3#1)
in plasma by##4##3##(2008-10#2)(2011-3#2)
in plasma from healthy##2##4##(1992-3#1)(2008-8#1)
in plasma from##4##3##(1992-3#1)(1993-2#1)(2008-10#1)(2008-8#1)
in plasma glucose concentration##2##4##(2010-10#2)
in plasma glucose##3##3##(2010-10#2)(2010-7#1)
in plasma is##6##3##(1990-12#1)(1991-12#1)(1993-2#1)(2008-10#2)(2008-9#1)
in plasma levels of##2##4##(1996-12#1)(2008-6#1)
in plasma membrane##3##3##(1990-5#1)(2008-7#1)(2011-2#1)
in plasma samples of##2##4##(2008-10#1)(2013-1#1)
in plasma samples##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
in plasma were##2##3##(2008-10#2)
in plasma##94##2##(1990-12#2)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#5)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#5)(1994-2#1)(1995-12#1)(1995-2#2)(1995-8#2)(1996-12#1)(1997-2#2)(1997-3#1)(2008-10#24)(2008-11#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#3)(2010-11#1)(2010-7#1)(2011-2#1)(2011-3#2)(2012-2#3)(2012-3#4)(2013-1#2)
in plasma-enhanced chemical vapor deposition##2##5##(2008-3#2)
in plasmid##4##2##(1993-9#1)(1994-8#1)(2008-8#2)
in plastic##5##2##(1996-3#1)(2008-10#4)
in plasticised PVC##2##3##(2008-10#2)
in plasticized PVC membranes##2##4##(2008-10#2)
in plasticized PVC##5##3##(2008-10#5)
in plasticized poly(vinyl chloride)##3##4##(2008-10#3)
in plasticized##10##2##(2008-10#10)
in plastids##4##2##(2008-10#1)(2008-9#3)
in plate assays##2##3##(2008-10#2)
in plate##3##2##(2008-10#3)
in platelet aggregation##2##3##(1991-12#1)(2008-4#1)
in platelet counts##3##3##(1990-10#1)(2010-3#2)
in platelet##12##2##(1990-10#1)(1991-12#1)(1992-12#1)(1992-3#1)(2006-6#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-3#2)(2011-2#1)
in platelets and##2##3##(1992-12#2)
in platelets##8##2##(1990-10#1)(1991-12#1)(1992-12#3)(1992-6#2)(1995-11#1)
in plots irrigated with saline water##2##6##(2008-10#2)
in plots receiving##2##3##(2008-10#2)
in plots where##4##3##(2008-10#4)
in plots with##2##3##(2008-10#2)
in plots##13##2##(2008-10#13)
in poeciliid fishes##2##3##(2008-8#2)
in polar non aqueous solvents##2##5##(2008-10#2)
in polar##7##2##(2008-10#5)(2008-11#2)
in polarity##2##2##(2008-10#2)
in polarization##2##2##(2008-3#2)
in police##5##2##(2010-1#4)(2012-3#1)
in policy##5##2##(1994-12#1)(1994-2#1)(1996-3#1)(1997-2#1)(2008-11#1)
in political##3##2##(1996-3#1)(1997-2#1)(2012-2#1)
in pollen grains and pollen tubes##2##6##(2008-8#2)
in pollen##6##2##(2008-10#1)(2008-8#2)(2009-10#2)(2012-7#1)
in polluted##5##2##(2008-10#3)(2008-11#2)
in pollution##2##2##(2008-10#2)
in poly(vinyl chloride) membrane electrodes##2##5##(2008-10#2)
in poly(vinyl chloride)##4##3##(2008-10#4)
in polyacrylamide gel##2##3##(2008-10#1)(2013-1#1)
in polyacrylamide##5##2##(2008-10#4)(2013-1#1)
in polyethylene##2##2##(2008-7#2)
in polygenic##2##2##(1991-2#1)(2012-3#1)
in polymer##6##2##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
in polymerase chain reactions##3##4##(1993-8#1)(1997-4#1)(2008-10#1)
in polymerase chain##4##3##(1993-8#1)(1997-4#1)(2008-10#2)
in polymeric##3##2##(2008-10#2)(2008-3#1)
in polymers##2##2##(1995-3#1)(2008-2#1)
in polyploid##2##2##(2012-3#2)
in polypropylene##2##2##(2008-10#1)(2012-3#1)
in polystyrene layer##2##3##(2008-10#2)
in polystyrene##4##2##(2008-10#3)(2008-11#1)
in poor responders##2##3##(2012-3#2)
in poor##7##2##(1990-2#1)(1990-5#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#2)
in poorer##4##2##(1994-1#1)(1995-12#1)(2008-11#1)(2009-9#1)
in popularity##2##2##(2008-11#1)(2011-2#1)
in population density and##3##4##(2008-8#2)(2008-9#1)
in population density##7##3##(1994-5#1)(2008-8#5)(2008-9#1)
in population growth rate and##2##5##(2008-8#1)(2008-9#1)
in population growth rate##3##4##(2008-8#2)(2008-9#1)
in population over 65 years old##2##6##(2011-2#2)
in population over 65 years##3##5##(2011-2#3)
in population size##6##3##(2008-12#1)(2008-8#5)
in population##31##2##(1991-2#1)(1994-5#1)(1994-8#1)(2008-10#4)(2008-12#1)(2008-8#13)(2008-9#2)(2011-2#5)(2012-12#1)(2013-7#1)(2013-8#1)
in populations living near nuclear facilities##2##6##(1991-3#2)
in populations of C##3##4##(2008-10#3)
in populations of##14##3##(2008-10#12)(2008-5#1)(2008-8#1)
in populations##24##2##(1991-3#2)(2008-10#14)(2008-5#1)(2008-8#3)(2009-5#1)(2010-10#1)(2011-2#1)(2012-7#1)
in porcine platelets##2##3##(1992-6#2)
in porcine##8##2##(1991-11#1)(1992-6#2)(1992-8#1)(1994-11#1)(1996-12#1)(2008-8#1)(2013-1#1)
in porous carriers##2##3##(2008-11#2)
in porous##4##2##(1992-11#1)(2008-11#3)
in portal##4##2##(1993-3#1)(2009-8#1)(2009-9#1)(2010-12#1)
in position##7##2##(1990-12#1)(1992-1#1)(1995-8#1)(1997-7#1)(2008-2#1)(2009-11#2)
in positions##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
in positive ion##2##3##(2008-10#2)
in positive##8##2##(2008-10#3)(2008-11#2)(2008-12#1)(2010-6#1)(2013-1#1)
in post##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)
in post-menopausal women##4##3##(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
in post-menopausal##8##2##(2008-10#1)(2008-11#3)(2008-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
in post-mortem##2##2##(1992-3#2)
in post-translational modification##2##3##(2008-8#1)(2013-1#1)
in post-translational##3##2##(1992-8#1)(2008-8#1)(2013-1#1)
in posterior urethral##2##3##(2008-10#2)
in posterior##4##2##(2008-10#2)(2008-12#1)(2010-5#1)
in postmenopausal women##6##3##(1992-1#2)(1992-3#2)(2008-11#1)(2010-12#1)
in postmenopausal##10##2##(1992-1#2)(1992-3#2)(1993-11#1)(1994-12#1)(2008-11#1)(2010-12#1)(2012-3#2)
in postnatal##4##2##(1991-2#1)(2008-12#1)(2010-4#1)(2012-2#1)
in postoperative patients##2##3##(2011-2#2)
in postoperative##9##2##(1992-3#1)(1994-3#1)(1996-3#1)(2008-11#1)(2011-2#4)(2013-1#1)
in poststroke##2##2##(2013-1#2)
in postsynaptic##4##2##(1995-2#1)(2008-11#1)(2009-8#1)(2012-2#1)
in pot experiments##2##3##(2008-10#2)
in potable water##3##3##(2008-10#3)
in potassium hydroxide solution##2##4##(2008-10#2)
in potassium hydroxide##3##3##(2008-10#3)
in potassium##7##2##(2008-10#7)
in potato cv##2##3##(2008-10#2)
in potato dextrose broth##3##4##(2008-10#3)
in potato##19##2##(2008-10#16)(2008-12#1)(2009-6#2)
in potential##10##2##(2008-10#10)
in potentially##2##2##(1995-2#1)(2008-10#1)
in potentiometric titration of##11##4##(2008-10#11)
in potentiometric titrations of##3##4##(2008-10#3)
in potentiometric titrations##6##3##(2008-10#6)
in potentiometric##20##2##(2008-10#20)
in pots##3##2##(2008-10#2)(2008-12#1)
in poults fed greater than or equal to 50##2##9##(2008-5#2)
in poults fed##4##3##(2008-5#4)
in poverty##5##2##(1995-1#1)(2008-11#4)
in powder##2##2##(2008-10#2)
in powdered##2##2##(2008-10#1)(2009-8#1)
in power##8##2##(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-3#1)(2010-9#1)(2011-2#1)
in practical##4##2##(1990-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
in practice and##3##3##(2008-11#1)(2008-12#2)
in practice are##2##3##(2008-11#1)(2010-12#1)
in practice has been##2##4##(2008-11#2)
in practice management##3##3##(1991-12#1)(1994-3#2)
in practice placements##2##3##(2008-11#2)
in practice settings##3##3##(2008-11#3)
in practice##74##2##(1990-3#1)(1991-12#1)(1993-1#1)(1993-2#1)(1994-3#2)(1994-9#1)(1996-6#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#36)(2008-12#12)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
in practice]##2##2##(1993-2#1)(1994-8#1)
in prairie and##2##3##(2008-8#1)(2008-9#1)
in prairie##3##2##(2008-8#2)(2008-9#1)
in pre- and postsynaptic##3##4##(2009-8#1)(2009-9#2)
in pre-clinical##3##2##(2011-2#2)(2013-1#1)
in pre-registration##5##2##(2008-11#4)(2012-3#1)
in preadipocytes and adipocytes##2##4##(1993-6#2)
in preantral and##2##3##(2008-8#2)
in precision##3##2##(2008-10#3)
in preclinical studies##2##3##(2008-5#1)(2010-10#1)
in preclinical##7##2##(2008-11#1)(2008-5#1)(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
in preconcentration##2##2##(2008-10#2)
in predialysis patients##2##3##(2008-1#2)
in predicting long term##2##4##(2013-1#2)
in predicting the outcome##2##4##(2008-9#1)(2012-3#1)
in predicting the##15##3##(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
in predicting##37##2##(1991-11#1)(1992-3#2)(1994-3#1)(1995-11#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
in prediction of##5##3##(1994-12#1)(1994-3#1)(2008-10#2)(2010-11#1)
in prediction##6##2##(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#1)(2010-11#1)
in predisposing##2##2##(2008-10#1)(2011-2#1)
in predominantly##2##2##(2010-12#1)(2011-1#1)
in pregnancy and##6##3##(2008-11#3)(2012-3#3)
in pregnancy has been##2##4##(1990-6#1)(1995-6#1)
in pregnancy has##3##3##(1990-6#1)(1995-6#1)(2008-7#1)
in pregnancy is##4##3##(1990-9#1)(2008-7#1)(2013-1#2)
in pregnancy##44##2##(1990-6#1)(1990-9#2)(1991-12#2)(1991-2#1)(1992-12#1)(1994-3#3)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#5)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2012-3#6)(2013-1#5)(2013-8#1)
in pregnancy-induced##2##2##(1994-3#1)(2012-2#1)
in pregnancy]##7##2##(1991-3#1)(1993-9#1)(1994-6#1)(1996-11#3)(2013-1#1)
in pregnant women##8##3##(1990-6#1)(1993-9#1)(1994-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
in pregnant##11##2##(1990-6#1)(1993-9#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
in preimplantation##2##2##(2008-5#2)
in preliminary##2##2##(2008-10#2)
in premature infants##3##3##(2007-11#3)
in premature##4##2##(1996-11#1)(2007-11#3)
in premenopausal##6##2##(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#1)(1997-7#1)(2010-6#1)
in prenatal care##2##3##(2008-10#1)(2008-11#1)
in prenatal##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
in preoperative##5##2##(1994-3#1)(2009-3#1)(2011-2#3)
in preovulatory follicles##3##3##(2008-8#3)
in prepaid plans##2##3##(1991-2#2)
in prepaid##3##2##(1991-2#2)(1994-2#1)
in preparation for##6##3##(1994-1#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
in preparation##9##2##(1994-1#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#1)
in preparing the##2##3##(2010-5#1)(2013-1#1)
in preparing##5##2##(2008-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
in prepubertal male calves##2##4##(2013-1#2)
in prepubertal##4##2##(2008-4#1)(2012-3#1)(2013-1#2)
in preschool children##2##3##(2008-11#2)
in prescribing##2##2##(1997-5#1)(2008-11#1)
in prescription drug##2##3##(1995-1#2)
in prescription##3##2##(1993-1#1)(1995-1#2)
in presence of 1##2##4##(2008-10#2)
in presence of PMS##3##4##(2008-10#3)
in presence of a##3##4##(2008-10#3)
in presence of hydrogen peroxide catalyses the oxidation of##2##9##(2008-10#2)
in presence of hydrogen peroxide##3##5##(2008-10#3)
in presence of other##2##4##(2008-10#2)
in presence of the##2##4##(2008-10#2)
in presence of##70##3##(1991-8#1)(1994-11#1)(1997-5#1)(2008-10#58)(2008-11#4)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
in presence##72##2##(1991-8#1)(1994-11#1)(1997-5#1)(2008-10#59)(2008-11#5)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
in presentation##3##2##(2008-12#1)(2010-12#1)(2013-1#1)
in press]##2##2##(2008-10#2)
in pressure##3##2##(2008-10#1)(2008-7#1)(2010-6#1)
in presumed##2##2##(1993-12#1)(2006-5#1)
in presynaptic##3##2##(1996-12#2)(2009-9#1)
in preteen and teen patients##3##5##(2013-1#3)
in preterm infants##3##3##(1993-12#2)(2011-2#1)
in preterm##6##2##(1993-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
in pretreated advanced breast cancer##2##5##(1993-2#1)(1994-8#1)
in pretreated##4##2##(1991-6#1)(1993-2#1)(1994-8#2)
in prevalence in##2##3##(2008-10#1)(2012-2#1)
in prevalence of##2##3##(2008-10#1)(2011-1#1)
in prevalence with age##2##4##(2008-7#1)(2013-1#1)
in prevalence##12##2##(1996-12#1)(2008-10#2)(2008-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
in preventing cardiovascular##2##3##(1993-2#1)(2008-8#1)
in preventing diarrhea##2##3##(1991-3#1)(1992-12#1)
in preventing postoperative shivering##2##4##(2010-7#2)
in preventing the##5##3##(1992-12#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)
in preventing##44##2##(1990-6#3)(1991-3#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-9#4)(1993-2#1)(1995-3#1)(2008-10#4)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
in prevention and treatment of##2##5##(2011-2#1)(2011-3#1)
in prevention of postoperative##2##4##(2012-3#2)
in prevention of##9##3##(1991-3#1)(2007-8#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#1)
in prevention##16##2##(1991-3#1)(1994-9#1)(1995-12#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#2)(2011-3#2)(2012-3#3)(2013-1#1)
in preventive health##2##3##(2009-5#2)
in preventive services##2##3##(1995-12#1)(2009-5#1)
in preventive##5##2##(1991-11#1)(1995-12#1)(2009-5#3)
in preverbal children##2##3##(2008-9#2)
in previous literature##2##3##(2008-11#1)(2013-2#1)
in previous studies##10##3##(1993-8#1)(1994-8#1)(2008-10#4)(2008-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
in previous work##3##3##(2008-10#2)(2008-7#1)
in previous years##2##3##(1990-12#1)(2008-8#1)
in previous##28##2##(1990-12#1)(1993-8#1)(1994-6#1)(1994-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-2#1)
in previously##6##2##(1994-12#1)(1994-5#2)(2008-10#2)(2010-7#1)
in previtellogenic##2##2##(2008-8#2)
in prey##4##2##(1995-12#1)(2008-9#3)
in primary auditory cortex##2##4##(1996-2#1)(2008-11#1)
in primary care settings##4##4##(2008-11#2)(2009-12#1)(2009-9#1)
in primary care##37##3##(1992-8#1)(1993-11#1)(1993-2#1)(1993-5#2)(1993-9#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#3)(2008-11#7)(2008-12#1)(2008-4#1)(2009-1#1)(2009-12#1)(2009-9#1)(2010-4#2)(2011-2#1)
in primary care?]##2##3##(1995-5#1)(1996-11#1)
in primary care]##19##3##(1993-11#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-11#2)(1996-11#1)(1996-3#3)(1996-6#2)
in primary cell cultures##2##4##(1996-12#1)(2008-7#1)
in primary culture of adult rat hepatocytes##2##7##(1993-8#2)
in primary culture##7##3##(1993-3#1)(1993-8#2)(1994-8#3)(2008-6#1)
in primary cultured human preadipocytes##2##5##(2008-5#2)
in primary cultures of mouse##3##5##(1990-5#1)(1994-2#2)
in primary cultures of##8##4##(1990-5#1)(1993-3#1)(1994-2#2)(1995-8#1)(2008-11#1)(2009-9#1)(2011-2#1)
in primary health care##9##4##(1995-11#1)(1995-5#2)(1997-4#1)(2007-8#1)(2011-2#3)(2012-3#1)
in primary health care]##3##4##(1993-3#1)(1997-5#1)(1997-8#1)
in primary health##12##3##(1993-3#1)(1995-11#1)(1995-5#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-8#1)(2011-2#3)(2012-3#1)
in primary healthcare##2##3##(2009-3#2)
in primary human##5##3##(1992-8#1)(1997-7#1)(2008-11#1)(2008-9#1)(2012-5#1)
in primary prevention groups##2##4##(2010-12#2)
in primary visual cortex##2##4##(2008-11#2)
in primary##129##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#4)(1993-5#3)(1993-8#3)(1993-9#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-11#4)(1995-12#1)(1995-5#4)(1995-8#1)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#4)(1996-6#3)(1996-8#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#4)(2007-8#1)(2008-10#3)(2008-11#14)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#2)(2009-8#1)(2009-9#2)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-3#1)(2012-5#1)(2013-8#1)
in primate##2##2##(1997-2#1)(2012-3#1)
in primates##4##2##(2008-7#1)(2012-3#3)
in priming##5##2##(1995-2#2)(2008-10#2)(2012-2#1)
in principle##14##2##(1992-3#2)(2008-10#5)(2008-3#2)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
in prison##5##2##(1992-2#1)(1996-5#4)
in private practice##4##3##(1993-2#1)(1996-12#1)(2008-8#1)(2009-10#1)
in private##12##2##(1990-6#1)(1992-2#1)(1993-2#2)(1994-1#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-8#1)(2009-10#1)(2013-8#2)
in pro-active safety surveillance##2##4##(2008-11#2)
in probe angle##2##3##(1994-5#2)
in problem solving##3##3##(1992-2#1)(2008-10#1)(2008-2#1)
in problem##4##2##(1992-2#1)(2008-10#1)(2008-12#1)(2008-2#1)
in procedures##2##2##(2008-10#1)(2011-2#1)
in process##6##2##(1993-12#1)(1995-6#1)(2008-10#3)(2008-8#1)
in processes##5##2##(1996-5#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
in processing##5##2##(2008-10#3)(2008-11#1)(2009-4#1)
in prodromal##2##2##(2011-8#2)
in producing a##2##3##(2008-12#1)(2011-2#1)
in producing##14##2##(1990-6#1)(1992-12#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#2)(2013-1#3)
in product##5##2##(2008-11#2)(2008-5#1)(2008-7#1)(2013-1#1)
in production of##8##3##(1990-8#1)(1992-9#1)(1995-2#1)(2008-10#4)(2008-12#1)
in production##15##2##(1990-8#1)(1991-12#1)(1992-9#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)
in productivity##5##2##(1992-3#1)(2008-11#1)(2008-7#1)(2011-2#2)
in products##5##2##(2008-10#4)(2012-2#1)
in professional education##2##3##(2008-12#2)
in professional##5##2##(2008-11#1)(2008-12#2)(2010-10#1)(2010-3#1)
in profoundly deaf children##2##4##(2008-9#2)
in progeny derived from the cross between##2##7##(2008-10#2)
in progeny derived from##3##4##(2008-10#3)
in progeny##7##2##(2008-10#6)(2012-3#1)
in prognostic##2##2##(2008-10#1)(2008-7#1)
in program decision making##2##4##(1995-3#2)
in program##4##2##(1995-3#2)(1996-1#1)(2013-1#1)
in programs##3##2##(2008-10#2)(2008-11#1)
in progress to##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
in progress##14##2##(1991-2#1)(1993-11#1)(1994-3#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
in progression of##2##3##(2008-1#2)
in progression##3##2##(1994-8#1)(2008-1#2)
in progressive##5##2##(1994-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
in prokaryotic##3##2##(2008-8#1)(2010-4#1)(2011-2#1)
in proliferating and quiescent cultures of murine##2##7##(1992-3#2)
in proliferating##4##2##(1992-3#2)(1992-6#1)(2009-8#1)
in proliferation of##2##3##(1991-3#1)(1996-3#1)
in proliferation##6##2##(1991-3#1)(1993-12#1)(1996-3#1)(2008-11#1)(2009-12#1)(2012-3#1)
in prolonged##4##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
in prolonging##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
in promoter##4##2##(1991-6#1)(1996-12#1)(2008-9#1)(2012-3#1)
in promoting the##2##3##(1994-3#1)(2009-10#1)
in promoting##10##2##(1994-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-2#1)
in proper##3##2##(2008-10#2)(2008-5#1)
in properties##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
in prophylactic##2##2##(1990-2#1)(1995-5#1)
in proportion of##4##3##(1992-12#1)(2008-10#2)(2012-3#1)
in proportion to the concentration of##6##6##(1994-8#1)(2008-10#4)(2010-3#1)
in proportion to the##8##4##(1994-8#1)(2008-10#5)(2008-7#1)(2010-3#1)
in proportion to##10##3##(1994-8#1)(2008-10#5)(2008-11#2)(2008-7#1)(2010-3#1)
in proportion##17##2##(1992-12#1)(1994-8#1)(2008-10#9)(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)
in proportions of##2##3##(1992-9#1)(2008-10#1)
in proportions##4##2##(1992-9#1)(2008-10#2)(2013-1#1)
in propylene glycol and##2##4##(1991-5#1)(2008-11#1)
in propylene glycol##6##3##(1991-5#4)(2008-11#2)
in prospective##5##2##(1993-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)
in prostate cancer cells##2##4##(2011-2#2)
in prostate cancer detection##2##4##(2011-2#2)
in prostate cancer diagnostics##3##4##(2011-2#3)
in prostate cancer patients##2##4##(1994-8#1)(2009-5#1)
in prostate cancer##21##3##(1994-8#1)(2008-5#1)(2008-6#1)(2009-5#2)(2010-12#1)(2011-2#15)
in prostate##28##2##(1994-8#1)(2008-5#1)(2008-6#3)(2008-9#2)(2009-5#2)(2010-12#1)(2011-2#18)
in prosthesis##2##2##(1991-2#1)(1993-6#1)
in protecting against##4##3##(1994-5#1)(2008-10#1)(2008-7#1)(2009-12#1)
in protecting cells##2##3##(1992-7#1)(2008-11#1)
in protecting##11##2##(1992-7#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-12#1)(2013-8#2)
in protection against##4##3##(1992-5#1)(1995-5#1)(2009-6#1)(2013-8#1)
in protection##5##2##(1992-5#1)(1995-5#2)(2009-6#1)(2013-8#1)
in protective##2##2##(2008-10#1)(2008-12#1)
in protein analysis##2##3##(2008-10#1)(2010-7#1)
in protein degradation##2##3##(1995-2#1)(2011-2#1)
in protein##27##2##(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-6#3)(1997-8#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#2)(2011-2#4)
in protein-free culture##3##3##(2008-11#3)
in protein-free medium##5##3##(2008-11#5)
in protein-free##12##2##(2008-11#12)
in protein-freeculture##2##2##(2008-11#2)
in proteins##10##2##(1994-11#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-10#4)(2008-7#1)(2010-11#1)
in proteoliposomes##2##2##(1995-8#2)
in proteome analysis##2##3##(2008-12#2)
in proteome##4##2##(2008-12#3)(2012-3#1)
in protoplast##3##2##(2008-8#2)(2008-9#1)
in protoplasts were##2##3##(1997-3#2)
in protoplasts##4##2##(1997-3#2)(2008-8#1)(2009-8#1)
in providing a##2##3##(1997-2#1)(2008-12#1)
in providing care to##3##4##(2009-5#1)(2010-9#1)(2011-1#1)
in providing care##4##3##(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
in providing health##2##3##(1996-12#1)(2011-2#1)
in providing##26##2##(1991-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)
in proximal tubular##2##3##(1993-3#1)(1994-5#1)
in proximal##4##2##(1993-3#1)(1994-5#1)(2008-11#1)(2012-3#1)
in proximity to##2##3##(2008-10#1)(2010-6#1)
in pseudophakic group##2##3##(2011-2#2)
in psoriasis##3##2##(2007-11#1)(2008-6#1)(2013-1#1)
in psychiatric hospitals##2##3##(1992-2#1)(1992-3#1)
in psychiatric nursing##2##3##(2008-11#2)
in psychiatric patients##3##3##(2008-4#2)(2009-9#1)
in psychiatric##12##2##(1992-2#1)(1992-3#1)(2008-11#2)(2008-12#1)(2008-4#4)(2009-9#2)(2012-2#1)
in psychiatry##4##2##(1997-8#1)(2008-4#2)(2010-6#1)
in psychological##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
in psychology##4##2##(1990-2#1)(1994-12#1)(1996-6#1)(2008-11#1)
in psychopharmacology##2##2##(2008-11#1)(2008-4#1)
in puberty is##2##3##(2009-6#1)(2011-1#1)
in puberty##4##2##(2009-6#2)(2011-1#1)(2013-8#1)
in public and##2##3##(1996-1#1)(1996-5#1)
in public health insurance##3##4##(1995-3#1)(2008-7#2)
in public health is##2##4##(2010-8#1)(2012-12#1)
in public health##20##3##(1991-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#3)(2008-11#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
in public##33##2##(1991-2#1)(1991-3#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#3)(2008-11#3)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
in publications##2##2##(2008-11#1)(2011-2#1)
in published##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
in pulmonary arterial hypertension##3##4##(2010-10#3)
in pulmonary arterial##5##3##(1991-6#1)(2008-11#1)(2010-10#3)
in pulmonary function##2##3##(1992-6#1)(2012-2#1)
in pulmonary hypertension##2##3##(2008-1#1)(2010-10#1)
in pulmonary##13##2##(1991-6#1)(1992-2#1)(1992-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#4)(2012-2#1)(2012-3#1)
in pulp##2##2##(2008-10#1)(2008-7#1)
in pulsed##2##2##(2007-12#1)(2009-5#1)
in pure form and in##2##5##(2008-10#2)
in pure form or in##3##5##(2008-10#3)
in pure form##8##3##(2008-10#7)(2010-5#1)
in pure water##2##3##(2008-10#2)
in pure##23##2##(2008-10#19)(2008-11#1)(2008-5#1)(2010-5#1)(2012-2#1)
in purified##6##2##(1992-8#1)(1994-11#1)(1997-3#1)(2008-10#2)(2008-7#1)
in putamen##2##2##(2008-7#2)
in quail myotubes##2##3##(1995-6#2)
in quail##6##2##(1995-6#3)(2008-12#2)(2008-6#1)
in qualitative analysis of aromatic fraction of##2##7##(2008-10#2)
in qualitative research##6##3##(1997-1#1)(1997-3#1)(2008-11#3)(2008-12#1)
in qualitative##9##2##(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-12#1)
in quality assessment##2##3##(1996-1#1)(2010-9#1)
in quality control##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
in quality of care##2##4##(1992-2#1)(1997-8#1)
in quality of life##3##4##(2007-9#1)(2010-12#1)(2013-1#1)
in quality of##7##3##(1992-2#2)(1997-8#1)(2007-9#1)(2010-12#1)(2013-1#2)
in quality##24##2##(1992-2#2)(1993-3#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-9#1)(2013-1#2)(2013-8#1)
in quantifying##4##2##(1992-9#1)(2008-10#2)(2008-3#1)
in quantitative##7##2##(1992-9#1)(2008-10#4)(2008-4#1)(2008-8#1)
in quantities##3##2##(1992-8#1)(2008-10#2)
in quantity##3##2##(2008-10#1)(2008-8#2)
in quantum##2##2##(2008-10#1)(2010-10#1)
in question##11##2##(1990-8#1)(1991-12#1)(1994-6#1)(1996-5#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-12#1)(2013-1#1)
in quiescent##3##2##(1993-12#1)(1994-9#1)(2008-10#1)
in rRNA##2##2##(2008-8#1)(2010-4#1)
in rabbit ooplasm and support early##2##6##(2008-9#2)
in rabbit platelets##4##3##(1994-3#2)(1995-11#2)
in rabbit skin##2##3##(1992-6#2)
in rabbit##27##2##(1991-5#2)(1992-6#4)(1993-12#1)(1994-3#2)(1994-8#2)(1995-11#2)(1996-2#1)(1997-1#1)(2008-10#7)(2008-8#1)(2008-9#2)(2011-3#1)(2013-1#1)
in rabbits and rats##2##4##(2008-9#1)(2010-7#1)
in rabbits and##4##3##(2008-10#1)(2008-9#2)(2010-7#1)
in rabbits which received##2##4##(1995-12#2)
in rabbits##21##2##(1995-12#4)(1997-8#1)(2008-10#3)(2008-5#3)(2008-9#3)(2009-3#1)(2010-10#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#2)
in race##2##2##(2008-10#2)
in radial##2##2##(2008-10#1)(2011-2#1)
in radiation protection##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
in radiation##7##2##(1990-12#1)(1995-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
in radiobiology##2##2##(2008-10#1)(2008-7#1)
in radiology##8##2##(1991-1#1)(1993-3#2)(1996-1#1)(1997-8#1)(2009-9#1)(2012-2#2)
in radioreceptor##2##2##(1991-3#1)(1995-8#1)
in radioresistance##2##2##(2008-5#1)(2013-1#1)
in radish##5##2##(2008-10#5)
in railroads##4##2##(1991-12#4)
in rain##5##2##(2008-10#4)(2008-3#1)
in rainwater samples##2##3##(2008-10#2)
in rainwater varied##2##3##(2008-10#2)
in rainwater##11##2##(2008-10#11)
in random dot patterns##2##4##(2008-8#2)
in random order##2##3##(1994-12#1)(2013-8#1)
in random##6##2##(1994-12#1)(2008-3#1)(2008-8#3)(2013-8#1)
in randomized clinical trials##2##4##(1992-9#1)(2008-12#1)
in randomized clinical##3##3##(1992-9#1)(2008-12#1)(2012-3#1)
in randomized##7##2##(1991-8#1)(1992-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#2)
in range of##4##3##(2008-10#3)(2008-9#1)
in range##6##2##(2008-10#5)(2008-9#1)
in raphe##3##2##(1996-12#1)(2008-7#2)
in rapid##4##2##(1996-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
in rare cases##2##3##(2011-2#2)
in rare##4##2##(1991-12#1)(2008-10#1)(2011-2#2)
in rat CL##3##3##(2008-9#3)
in rat UMR-106##2##3##(1994-11#2)
in rat adipocytes##4##3##(1997-1#2)(2008-8#1)(2011-2#1)
in rat and mouse##5##4##(1991-12#1)(1991-6#1)(1992-6#2)(2008-4#1)
in rat and##9##3##(1991-12#1)(1991-6#1)(1992-6#2)(1995-2#1)(1997-1#1)(2008-10#2)(2008-4#1)
in rat aortic##2##3##(1991-5#1)(1994-5#1)
in rat blood##2##3##(2008-10#2)
in rat brain by in situ hybridization##2##7##(1992-12#1)(1996-12#1)
in rat brain by in##3##5##(1992-12#1)(1996-12#1)(1997-1#1)
in rat brain by##4##4##(1992-12#1)(1996-12#1)(1997-1#2)
in rat brain combined with##2##5##(2008-10#2)
in rat brain cortical membranes##2##5##(1993-6#2)
in rat brain cortical##3##4##(1993-6#2)(1997-1#1)
in rat brain were##2##4##(1996-2#1)(2008-10#1)
in rat brain##23##3##(1991-10#1)(1992-12#1)(1993-6#2)(1995-11#1)(1995-6#1)(1996-12#3)(1996-2#3)(1997-1#3)(2008-10#7)(2008-4#1)
in rat cultures##2##3##(1996-2#2)
in rat heart##2##3##(1994-11#1)(1995-11#1)
in rat hepatocytes##2##3##(1991-12#2)
in rat hepatoma##2##3##(1994-11#2)
in rat hippocampal slices##2##4##(1990-12#1)(1996-2#1)
in rat hippocampal##4##3##(1990-12#1)(1996-2#2)(1996-5#1)
in rat kidney##3##3##(1991-5#1)(2008-11#2)
in rat liver by##3##4##(1994-6#1)(1994-8#2)
in rat liver cells by##2##5##(1995-6#1)(2008-8#1)
in rat liver cells##3##4##(1995-6#1)(2008-8#2)
in rat liver plasma membranes##2##5##(1995-8#2)
in rat liver##16##3##(1993-8#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-6#1)(1995-8#3)(1995-9#1)(2008-10#1)(2008-11#1)(2008-8#3)
in rat lungs##2##3##(2008-12#2)
in rat models of##2##4##(1997-2#2)
in rat ovary during pregnancy##2##5##(2008-9#2)
in rat plasma##8##3##(1991-3#2)(1991-5#1)(1997-2#1)(2008-10#4)
in rat primary hepatocyte##2##4##(1990-5#1)(2008-11#1)
in rat skeletal muscle##3##4##(2008-8#2)(2008-9#1)
in rat striatum##2##3##(1995-11#1)(1995-6#1)
in rat synoviocytes##2##3##(2008-10#2)
in rat tissues##3##3##(1992-9#1)(1993-3#1)(1994-11#1)
in rat urine##4##3##(1994-8#1)(2008-10#3)
in rat##169##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#3)(1991-3#3)(1991-5#6)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#8)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-6#2)(1993-8#4)(1994-11#6)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#5)(1995-12#4)(1995-2#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-12#4)(1996-2#9)(1996-5#2)(1997-1#10)(1997-2#3)(1997-3#1)(2008-10#24)(2008-11#5)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#8)(2008-9#13)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
in rate##2##2##(1990-5#1)(2008-12#1)
in rates of##4##3##(1993-6#1)(1995-12#1)(2009-8#1)(2013-8#1)
in rates##8##2##(1991-1#2)(1993-6#1)(1994-2#1)(1995-12#1)(2009-8#1)(2013-8#2)
in ratios of##2##3##(1997-8#1)(2010-8#1)
in ratios##3##2##(1997-8#1)(2009-8#1)(2010-8#1)
in rats after##2##3##(1994-8#1)(2008-8#1)
in rats and dogs##2##4##(1992-6#1)(2008-5#1)
in rats and mice##8##4##(1991-1#1)(1996-1#1)(2008-10#1)(2008-4#5)
in rats and rabbits##2##4##(1990-11#2)
in rats and##16##3##(1990-11#2)(1990-12#1)(1991-1#1)(1991-5#1)(1992-6#1)(1993-11#1)(1996-1#1)(2008-10#1)(2008-4#5)(2008-5#1)(2011-2#1)
in rats at##2##3##(1990-2#1)(1994-5#1)
in rats exposed to##2##4##(1993-12#1)(2008-11#1)
in rats fed ethanol##2##4##(2008-11#2)
in rats fed##3##3##(1993-12#1)(2008-11#2)
in rats given##2##3##(1994-5#1)(2008-11#1)
in rats in the##2##4##(1990-5#1)(2011-2#1)
in rats is##3##3##(1994-11#1)(1995-12#1)(2013-8#1)
in rats using##2##3##(2008-10#1)(2008-4#1)
in rats were investigated##2##4##(1994-5#1)(1996-2#1)
in rats with##13##3##(1993-2#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-5#1)(2008-11#1)(2009-6#2)(2009-8#1)(2010-12#1)(2013-1#2)(2013-8#1)
in rats##153##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-6#4)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#5)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#6)(1994-8#7)(1995-11#2)(1995-12#3)(1995-2#2)(1995-6#1)(1996-1#2)(1996-2#6)(1996-5#1)(1997-1#1)(1997-2#6)(1997-4#2)(2008-10#8)(2008-11#14)(2008-12#5)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-12#1)(2010-2#1)(2010-7#2)(2011-2#10)(2011-3#1)(2012-2#8)(2013-1#5)(2013-8#3)
in rats]##4##2##(2010-12#4)
in raw and##3##3##(2008-12#2)(2010-4#1)
in raw materials##2##3##(2008-5#1)(2011-2#1)
in raw##11##2##(2008-10#5)(2008-12#2)(2008-5#1)(2010-4#2)(2011-2#1)
in reaching##3##2##(2008-10#1)(2010-7#2)
in reaction mixtures##2##3##(1992-3#1)(2008-10#1)
in reaction with##3##3##(1993-8#2)(1996-5#1)
in reaction##10##2##(1992-3#1)(1993-8#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)
in reactions##3##2##(1993-8#1)(2009-9#1)(2011-1#1)
in reactive##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
in reactivity##2##2##(2008-10#2)
in reactor##4##2##(2008-10#3)(2008-7#1)
in reading rates##2##3##(2007-12#2)
in reading##5##2##(2007-12#2)(2008-12#1)(2012-2#1)(2013-1#1)
in reagent##2##2##(2008-10#2)
in real and##2##3##(1996-2#1)(2008-10#1)
in real samples by##2##4##(2008-10#2)
in real samples such as##2##5##(2008-10#2)
in real samples were##2##4##(2008-10#2)
in real samples##36##3##(2008-10#36)
in real solution samples##3##4##(2008-10#3)
in real systems##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
in real time and##2##4##(2008-3#1)(2011-1#1)
in real time by##2##4##(2008-10#1)(2008-3#1)
in real time to##2##4##(2008-10#1)(2008-4#1)
in real time using##4##4##(1995-12#1)(1997-6#1)(2008-10#1)(2008-9#1)
in real time##29##3##(1995-12#1)(1995-2#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
in real water samples##2##4##(2008-10#2)
in real water##4##3##(2008-10#3)(2010-4#1)
in real##93##2##(1993-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#63)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-4#3)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
in real-time PCR assays##2##4##(2008-10#1)(2008-9#1)
in real-time##16##2##(1992-3#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#3)
in real-world##2##2##(2008-10#1)(2010-7#1)
in reality##2##2##(2008-10#1)(2013-8#1)
in reasonable agreement with the##3##5##(2008-10#2)(2008-5#1)
in reasonable##4##2##(2008-10#3)(2008-5#1)
in reasonably##2##2##(2008-10#2)
in receiving##2##2##(1997-3#1)(2008-12#1)
in recent decades##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
in recent times##2##3##(1996-1#1)(2008-11#1)
in recent years and##4##4##(2008-11#1)(2008-12#1)(2010-12#1)(2011-7#1)
in recent years have##2##4##(2008-1#1)(2011-2#1)
in recent years on##2##4##(2008-10#1)(2011-3#1)
in recent years##49##3##(1990-11#1)(1992-1#1)(1993-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-11#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2010-12#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#3)(2011-7#1)(2013-1#4)(2013-8#1)
in recent##59##2##(1990-11#1)(1992-1#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-11#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#4)(2010-12#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#4)(2011-3#3)(2011-7#1)(2012-2#2)(2013-1#4)(2013-8#1)
in recently##3##2##(1991-3#1)(2008-5#1)(2008-9#1)
in receptor binding##3##3##(1992-12#1)(1994-5#1)(1995-6#1)
in receptor##10##2##(1992-12#1)(1993-8#3)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)
in recessive dystrophic epidermolysis bullosa##2##5##(2012-3#2)
in recognition of##4##3##(1991-10#1)(1995-2#1)(1996-3#1)(2008-7#1)
in recognition##6##2##(1991-10#1)(1995-2#1)(1996-3#1)(2008-6#1)(2008-7#1)(2008-9#1)
in recognizing##7##2##(1990-2#1)(1991-12#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
in recombinant Chinese hamster ovary (CHO)##2##6##(2008-11#2)
in recombinant Chinese hamster ovary##3##5##(2008-11#3)
in recombinant##15##2##(1990-8#1)(1995-2#1)(1996-12#1)(2008-11#6)(2008-5#1)(2008-7#3)(2008-8#2)
in reconstructed##2##2##(2008-5#1)(2008-9#1)
in reconstruction##3##2##(1992-5#1)(2008-10#1)(2013-1#1)
in recovery of##4##3##(1991-2#2)(2008-10#1)(2013-1#1)
in recovery##6##2##(1991-2#3)(2008-10#1)(2012-3#1)(2013-1#1)
in recreational##2##2##(2011-2#1)(2013-1#1)
in recruiting and##2##3##(1991-2#1)(2012-2#1)
in recruitment and##2##3##(1991-11#1)(2008-12#1)
in recruitment##3##2##(1991-11#1)(2008-12#1)(2010-4#1)
in recruits##2##2##(2013-1#2)
in rectal lumen and to remove outside through the anus##2##10##(2013-1#2)
in rectal##5##2##(1996-8#1)(2009-11#2)(2013-1#2)
in recurrent##5##2##(1990-12#1)(1992-5#1)(1993-1#1)(2008-1#1)(2008-7#1)
in red blood##2##3##(1990-2#1)(1995-8#1)
in red wine##2##3##(2008-10#1)(2008-7#1)
in red##8##2##(1990-2#1)(1995-8#1)(2008-10#4)(2008-7#1)(2008-8#1)
in redox##2##2##(1994-3#1)(2008-10#1)
in reduced##14##2##(1993-9#1)(1994-5#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-5#2)(2009-6#1)(2010-1#1)
in reducing disease symptoms##2##4##(2008-10#2)
in reducing disease##4##3##(2008-10#4)
in reducing resistance##2##3##(2008-11#1)(2013-1#1)
in reducing the disease##2##4##(2008-10#2)
in reducing the risk##4##4##(1991-12#1)(2008-10#2)(2008-11#1)
in reducing the severity##3##4##(2008-10#2)(2008-5#1)
in reducing the##20##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
in reducing##74##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#2)(1993-2#1)(1994-5#1)(1995-12#1)(1997-1#1)(2008-10#23)(2008-11#7)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
in reduction of##9##3##(1992-1#1)(2008-10#3)(2008-9#1)(2011-2#1)(2012-3#2)(2013-8#1)
in reduction##11##2##(1990-5#1)(1990-9#1)(1992-1#1)(2008-10#3)(2008-9#1)(2011-2#1)(2012-3#2)(2013-8#1)
in reference memory##2##3##(2008-12#2)
in reference to##2##3##(1990-12#1)(1990-3#1)
in reference##11##2##(1990-12#1)(1990-3#1)(2008-10#6)(2008-11#1)(2008-12#2)
in reflection##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
in refractive##2##2##(2008-3#1)(2011-2#1)
in refugee##2##2##(1994-9#1)(2011-2#1)
in regard to the##5##4##(1990-5#1)(1990-8#1)(1996-3#1)(2008-12#1)(2008-7#1)
in regard to##17##3##(1990-5#1)(1990-8#1)(1992-3#2)(1993-1#1)(1994-3#1)(1994-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#2)
in regards to##2##3##(2008-8#1)(2012-12#1)
in regenerating##4##2##(1990-5#1)(1995-12#1)(2013-1#2)
in regeneration##2##2##(1993-3#1)(2011-2#1)
in regenerative##2##2##(2009-12#1)(2010-6#1)
in regional##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
in regions of the##2##4##(2008-10#1)(2008-3#1)
in regions where##3##3##(2008-10#2)(2013-1#1)
in regions with##2##3##(2008-10#2)
in regions##12##2##(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#5)(2008-3#2)(2008-5#1)(2013-1#1)
in registered##2##2##(1994-2#1)(2011-2#1)
in regression models##2##3##(1992-9#1)(2013-8#1)
in regression##4##2##(1992-9#1)(1997-1#1)(2009-8#1)(2013-8#1)
in regular##6##2##(2008-10#3)(2010-12#1)(2011-2#2)
in regulated##2##2##(2008-8#1)(2012-2#1)
in regulating cell##3##3##(2008-11#1)(2008-9#1)(2009-9#1)
in regulating fruit##2##3##(2009-8#1)(2011-2#1)
in regulating spermatogenesis##2##3##(1996-2#1)(2009-10#1)
in regulating the expression of the##2##6##(1997-7#1)(1997-8#1)
in regulating the expression of##4##5##(1997-7#1)(1997-8#1)(2010-7#1)(2011-2#1)
in regulating the level##2##4##(2008-11#1)(2009-8#1)
in regulating the##20##3##(1994-11#2)(1994-5#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-8#2)(2009-8#2)(2010-7#1)(2011-2#3)(2012-3#1)
in regulating##56##2##(1994-11#5)(1994-5#1)(1995-12#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#2)(1997-9#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#5)
in regulation of the##3##4##(1995-8#1)(2008-1#1)(2008-9#1)
in regulation of##15##3##(1991-7#1)(1994-11#1)(1995-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-8#1)(2013-1#3)
in regulation##17##2##(1991-7#1)(1994-11#1)(1995-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-8#1)(2013-1#3)
in rehabilitation of##2##3##(2008-10#1)(2010-9#1)
in rehabilitation##8##2##(1992-2#1)(1994-3#1)(1996-11#1)(2008-10#1)(2010-9#1)(2012-2#2)(2013-1#1)
in related to activity intensity##2##5##(2009-3#2)
in related to##3##3##(2009-3#2)(2010-6#1)
in related##4##2##(2009-3#2)(2010-6#1)(2013-7#1)
in relating##3##2##(1992-9#1)(1993-5#1)(1994-12#1)
in relation to a previously##2##5##(1992-3#1)(1992-6#1)
in relation to a##4##4##(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)
in relation to both##2##4##(1995-1#1)(2008-12#1)
in relation to changes in##2##5##(1997-2#1)(2012-12#1)
in relation to follicular##2##4##(2008-12#1)(2008-8#1)
in relation to host##3##4##(2008-10#2)(2012-3#1)
in relation to infection by##2##5##(2008-10#2)
in relation to infection##3##4##(2008-10#3)
in relation to other##3##4##(1993-11#1)(2008-10#1)(2013-8#1)
in relation to smoking##2##4##(2010-2#2)
in relation to the need##2##5##(2009-8#1)(2012-2#1)
in relation to the results##2##5##(1990-9#1)(1994-2#1)
in relation to the##60##4##(1990-11#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-6#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-8#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-1#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
in relation to their##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
in relation to those of##2##5##(1994-6#1)(1996-1#1)
in relation to time##2##4##(2008-10#2)
in relation to women##2##4##(2011-2#1)(2012-3#1)
in relation to##205##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-9#3)(1991-11#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#3)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#53)(2008-11#22)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#4)(2008-8#5)(2008-9#7)(2009-1#1)(2009-11#1)(2009-4#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#14)(2013-8#2)
in relation with the##2##4##(1990-5#1)(2008-10#1)
in relation with##6##3##(1990-5#1)(1990-8#1)(2008-10#3)(2008-5#1)
in relation##211##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-8#1)(1990-9#3)(1991-11#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#3)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#56)(2008-11#22)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#4)(2008-8#5)(2008-9#7)(2009-1#1)(2009-11#1)(2009-4#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#14)(2013-8#2)
in relationship to##2##3##(2008-12#1)(2013-1#1)
in relationship##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
in relative##8##2##(1992-9#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-3#1)
in relatively high##2##3##(2008-10#1)(2008-11#1)
in relatively large##3##3##(2008-10#3)
in relatively##13##2##(1991-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-9#1)(2012-2#1)
in relaxed##2##2##(1990-2#1)(1993-8#1)
in relevant##2##2##(1997-4#1)(2008-8#1)
in reliance on##2##3##(1991-2#1)(1994-3#1)
in relieving##3##2##(1994-12#1)(2011-2#2)
in religious##2##2##(2008-12#1)(2010-10#1)
in remaining vegetated patches##2##4##(2008-8#2)
in remaining##4##2##(1996-12#1)(2008-8#3)
in remission from acute myeloid leukaemia##2##6##(2009-3#2)
in remission##5##2##(1992-3#1)(1992-5#2)(2009-3#2)
in remote areas##2##3##(1990-6#1)(2008-10#1)
in remote##7##2##(1990-6#1)(1997-4#1)(2008-10#2)(2008-11#2)(2010-6#1)
in removal of##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
in renal hypertensive rats##2##4##(1991-5#1)(2008-11#1)
in renal tissue##3##3##(1990-12#1)(2011-2#2)
in renal##18##2##(1990-12#1)(1991-5#1)(1992-3#2)(1994-5#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#4)(2013-1#2)(2013-8#2)
in repair of##3##3##(1994-5#1)(2008-10#1)(2012-3#1)
in repeated batch cultures##2##4##(2008-11#2)
in repeated measures##2##3##(1992-9#1)(1994-9#1)
in repeated##9##2##(1992-9#1)(1994-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-3#2)
in replant orchard soils##2##4##(2008-10#2)
in replant##4##2##(2008-10#4)
in replicated field trials##2##4##(2008-10#2)
in replicated field##3##3##(2008-10#3)
in replicated trials##2##3##(2008-10#2)
in replicated##6##2##(2008-10#6)
in replication##4##2##(1991-12#1)(2008-10#2)(2008-5#1)
in reported health##2##3##(1994-1#1)(1996-6#1)
in reported##8##2##(1991-9#1)(1992-2#2)(1994-1#1)(1996-6#1)(2008-4#1)(2011-2#1)(2013-8#1)
in reporting##3##2##(2010-5#3)
in reports of##2##3##(2008-4#2)
in representative##2##2##(2008-10#1)(2010-7#1)
in reproduction##2##2##(2008-8#1)(2009-6#1)
in reproductive##6##2##(2008-1#1)(2008-8#3)(2011-2#1)(2011-3#1)
in repulsion phase##2##3##(2008-10#2)
in repulsion##5##2##(2008-10#5)
in research and##6##3##(1992-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-7#1)(2010-8#1)
in research in##4##3##(1993-11#1)(1994-3#1)(1995-11#1)(2008-1#1)
in research on##4##3##(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
in research related to##2##4##(1992-12#1)(2010-11#1)
in research##40##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-11#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
in researcher-managed##2##2##(2008-12#2)
in residential aged care##2##4##(2010-10#2)
in residential settings##2##3##(2008-10#1)(2008-7#1)
in residential##6##2##(1993-12#1)(2008-10#1)(2008-7#1)(2010-10#2)(2013-1#1)
in residents of##2##3##(1995-12#1)(2008-12#1)
in residues of##2##3##(2008-10#2)
in resin##3##2##(2008-10#1)(2013-1#2)
in resistance against##2##3##(1992-7#1)(2008-10#1)
in resistance to LSD##2##4##(2008-10#2)
in resistance to##10##3##(1994-8#1)(1996-1#1)(2008-10#7)(2011-2#1)
in resistance##21##2##(1992-7#1)(1994-8#1)(1996-1#1)(2008-10#15)(2011-2#1)(2013-1#2)
in resistant and susceptible##5##4##(1996-12#1)(2008-10#4)
in resistant cells##4##3##(1994-8#1)(2008-11#3)
in resistant genotypes##2##3##(2008-10#2)
in resistant isolates##2##3##(2008-10#2)
in resistant maize##2##3##(2008-10#2)
in resistant plants##6##3##(2008-10#6)
in resistant##34##2##(1994-8#1)(1996-12#2)(2008-10#28)(2008-11#3)
in resolution##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
in resolving the##3##3##(2008-11#1)(2008-3#1)(2012-12#1)
in resolving##8##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
in resource availability##2##3##(2008-8#1)(2012-2#1)
in resource##7##2##(1992-4#1)(1993-12#1)(2008-8#3)(2012-2#1)(2013-8#1)
in resource-constrained countries##2##3##(2012-2#2)
in resource-constrained##3##2##(2011-2#1)(2012-2#2)
in resource-poor##2##2##(2008-11#1)(2009-8#1)
in respect of##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
in respect to the##2##4##(2008-10#2)
in respect to##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2010-12#1)
in respect##10##2##(1995-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)
in respectively##3##2##(1992-2#2)(2007-8#1)
in respiratory tract##2##3##(2011-2#2)
in respiratory##6##2##(1994-3#1)(2008-7#1)(2009-1#1)(2011-2#3)
in responding for##2##3##(1993-6#2)
in responding to##2##3##(2008-11#1)(2010-2#1)
in responding##7##2##(1993-6#4)(2008-11#1)(2010-2#1)(2012-3#1)
in response characteristics##2##3##(2008-10#2)
in response of##2##3##(2008-10#1)(2008-11#1)
in response to 'correct' and 'social' compared with 'incorrect' and 'unsocial' gaze shifts##2##13##(2008-11#2)
in response to C##2##4##(2008-10#2)
in response to IGF-I production##2##5##(2008-11#2)
in response to IGF-I##3##4##(1997-1#1)(2008-11#2)
in response to TNF##2##4##(1995-2#1)(2011-2#1)
in response to a##19##4##(1992-6#1)(1993-12#1)(1994-11#1)(1996-2#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
in response to activation of the##2##6##(2008-11#2)
in response to activation of##3##5##(1996-2#1)(2008-11#2)
in response to activation with##2##5##(1993-6#2)
in response to activation##5##4##(1993-6#2)(1996-2#1)(2008-11#2)
in response to acute##3##4##(1993-2#1)(1995-6#1)(1996-2#1)
in response to all##3##4##(2008-10#2)(2008-5#1)
in response to an##4##4##(2008-8#1)(2009-1#1)(2009-10#2)
in response to apple##2##4##(2008-10#2)
in response to both##2##4##(1992-4#1)(1992-8#1)
in response to cage transfer##2##5##(2008-11#2)
in response to changes in##2##5##(2008-10#1)(2009-8#1)
in response to changing##2##4##(1992-2#1)(2009-6#1)
in response to different##3##4##(2008-10#1)(2010-10#1)(2012-2#1)
in response to environmental and##2##5##(2008-8#1)(2011-1#1)
in response to environmental changes##2##5##(2009-6#1)(2013-8#1)
in response to environmental##4##4##(2008-8#1)(2009-6#1)(2011-1#1)(2013-8#1)
in response to external##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
in response to extracellular stimuli##2##5##(1996-2#2)
in response to glucose and##2##5##(1995-8#1)(1996-3#1)
in response to glucose##3##4##(1995-8#1)(1996-3#1)(2010-11#1)
in response to growth factors##3##5##(1990-12#1)(1991-5#1)(1994-5#1)
in response to infection##2##4##(2008-10#2)
in response to injury##2##4##(2008-1#2)
in response to low doses of##2##6##(2008-7#2)
in response to low doses##3##5##(2008-7#3)
in response to low##4##4##(2008-7#3)(2009-8#1)
in response to phorbol ester##2##5##(1994-11#1)(1994-8#1)
in response to several##3##4##(1995-8#1)(2008-10#1)(2010-5#1)
in response to specific##2##4##(2008-10#1)(2009-12#1)
in response to stimulation with brucella##2##6##(1996-12#2)
in response to stimulation##3##4##(1996-12#2)(2008-10#1)
in response to the##21##4##(1993-6#2)(1994-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-5#1)(2012-3#1)
in response to various stimuli##2##5##(1995-8#1)(2009-3#1)
in response to various##3##4##(1995-8#1)(2009-3#1)(2011-1#1)
in response to water##2##4##(2009-8#2)
in response to##266##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1991-5#3)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#5)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#6)(1994-1#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-6#3)(1995-8#5)(1996-12#6)(1996-2#9)(1996-3#3)(1997-1#5)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#53)(2008-11#19)(2008-12#3)(2008-5#3)(2008-7#8)(2008-8#9)(2008-9#12)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-2#4)(2012-3#3)(2012-8#2)(2013-1#6)(2013-8#4)
in response##276##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1991-5#3)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#5)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#7)(1994-1#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-6#3)(1995-8#5)(1996-12#6)(1996-2#9)(1996-3#3)(1997-1#5)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#58)(2008-11#21)(2008-12#3)(2008-5#3)(2008-7#8)(2008-8#10)(2008-9#12)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-2#4)(2012-3#3)(2012-8#2)(2013-1#6)(2013-8#4)
in responses to##2##3##(2009-4#1)(2012-3#1)
in responses##3##2##(2008-10#1)(2009-4#1)(2012-3#1)
in resting T cells##2##4##(1992-6#2)
in resting platelets##3##3##(1992-6#1)(1993-8#1)(2006-6#1)
in resting##7##2##(1990-2#1)(1992-6#3)(1993-8#1)(1996-2#1)(2006-6#1)
in restorative##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
in restoring##2##2##(2012-2#2)
in restriction##2##2##(1997-8#1)(2008-10#1)
in restrictive anorexia nervosa##2##4##(2012-3#2)
in restructuring##2##2##(1993-1#1)(1995-3#1)
in retention##3##2##(1992-12#1)(1994-8#1)(2009-5#1)
in reticular##3##2##(2013-1#3)
in retinal##3##2##(1993-8#1)(1997-1#1)(2011-9#1)
in retroperitoneal##2##2##(1992-12#1)(2012-12#1)
in return##2##2##(1994-3#1)(1995-12#1)
in returning travelers##2##3##(2011-2#2)
in revealing##4##2##(1990-6#1)(2008-12#1)(2008-5#2)
in reverse##10##2##(1993-2#1)(1995-3#2)(1996-2#1)(2008-10#5)(2011-1#1)
in reversed micellar systems##2##4##(1990-5#2)
in reversed micelles##3##3##(1995-3#1)(2008-10#2)
in reversed phase liquid chromatography (RPLC)##2##6##(2008-10#2)
in reversed phase##3##3##(2008-10#3)
in reversed##9##2##(1990-5#2)(1995-3#1)(2008-10#5)(2008-8#1)
in reversed-phase##2##2##(1992-6#1)(2008-10#1)
in revision surgery##2##3##(2009-7#1)(2011-2#1)
in revision##3##2##(2009-7#1)(2011-2#2)
in reward##2##2##(1994-8#1)(2013-8#1)
in rhesus monkeys##6##3##(1991-1#2)(1996-2#4)
in rheumatic##2##2##(1991-2#1)(2008-10#1)
in rheumatoid arthritis##9##3##(1993-2#1)(1995-5#1)(2007-11#4)(2007-8#1)(2008-8#1)(2012-2#1)
in rheumatoid##10##2##(1993-2#2)(1995-5#1)(2007-11#4)(2007-8#1)(2008-8#1)(2012-2#1)
in rheumatology##2##2##(1997-3#1)(1997-4#1)
in rhizosphere##3##2##(2008-10#2)(2013-8#1)
in rhumatoid##2##2##(2007-8#2)
in ribosome##5##2##(1991-6#1)(2008-9#1)(2011-2#2)(2012-3#1)
in rice (Oryza sativa L##2##5##(2008-9#2)
in rice (Oryza sativa##3##4##(2008-9#2)(2009-10#1)
in rice (Oryza##4##3##(2008-9#2)(2009-10#2)
in rice and##5##3##(2008-10#2)(2008-12#1)(2009-10#1)(2011-3#1)
in rice flour##2##3##(2008-10#2)
in rice genome##5##3##(2008-8#2)(2008-9#3)
in rice grain##2##3##(2013-1#2)
in rice improvement##2##3##(2009-10#2)
in rice leaves##2##3##(2008-10#2)
in rice plants##2##3##(2008-10#2)
in rice wines##2##3##(2008-10#2)
in rice##82##2##(1995-6#1)(1996-8#1)(1997-2#1)(2008-10#25)(2008-12#2)(2008-8#10)(2008-9#15)(2009-10#20)(2009-8#1)(2011-3#3)(2013-1#2)(2013-8#1)
in rich##2##2##(2008-10#1)(2008-11#1)
in right##3##2##(2010-9#1)(2012-3#1)(2013-1#1)
in risk assessment##6##3##(1991-12#1)(1993-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
in risk##20##2##(1991-12#1)(1991-6#1)(1993-1#1)(1993-11#2)(1993-2#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#2)(2010-4#1)(2010-7#1)(2011-2#3)(2013-1#1)
in risky##3##2##(2009-10#1)(2013-8#2)
in river and reservoir water##3##5##(2008-10#3)
in river and seawater##2##4##(2008-10#2)
in river and tap water##2##5##(2008-10#2)
in river and##10##3##(2008-10#10)
in river sediment##2##3##(2008-10#2)
in river water by##4##4##(2008-10#4)
in river water is##2##4##(2008-10#2)
in river water samples and in technical formulations##2##8##(2008-10#2)
in river water samples and##3##5##(2008-10#3)
in river water samples##6##4##(2008-10#6)
in river water##32##3##(2008-10#32)
in river waters##6##3##(2008-10#6)
in river##55##2##(2008-10#55)
in roach##2##2##(2008-11#1)(2010-8#1)
in rockwool##2##2##(2008-10#2)
in rodent and human##2##4##(1994-12#1)(1995-9#1)
in rodent and##3##3##(1992-12#1)(1994-12#1)(1995-9#1)
in rodent##8##2##(1991-5#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-9#1)(1996-12#1)(2008-10#1)(2008-9#1)
in rodents and##2##3##(2008-10#1)(2013-8#1)
in rodents##14##2##(1990-3#1)(1997-2#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2010-4#1)(2012-2#1)(2013-8#1)
in role##2##2##(1995-3#1)(2011-2#1)
in roller bottles##2##3##(2008-11#2)
in room##2##2##(2008-10#1)(2008-3#1)
in root coverage##2##3##(2013-1#2)
in root cultures##2##3##(2008-11#2)
in root tissues##2##3##(2008-10#2)
in root##18##2##(1993-2#1)(2008-10#11)(2008-11#2)(2009-8#1)(2013-1#3)
in roots and leaves of##3##5##(2008-12#2)(2012-7#1)
in roots and shoots##2##4##(2008-12#2)
in roots and##6##3##(2008-10#1)(2008-12#4)(2012-7#1)
in roots of##6##3##(2008-10#4)(2008-9#1)(2013-8#1)
in roots were##3##3##(2008-10#2)(2008-12#1)
in roots##25##2##(2008-10#11)(2008-11#1)(2008-12#6)(2008-9#2)(2011-10#2)(2012-7#2)(2013-8#1)
in rotation##3##2##(1997-3#1)(2008-10#1)(2008-7#1)
in routine analysis##3##3##(2008-10#3)
in routine clinical##2##3##(2012-2#1)(2012-3#1)
in routine laboratories##2##3##(2008-10#2)
in routine##17##2##(1997-2#1)(2008-10#6)(2008-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
in ruling out##2##3##(2006-5#1)(2012-2#1)
in rural America##2##3##(1996-3#1)(2009-8#1)
in rural areas##9##3##(1994-1#1)(1996-3#2)(1996-5#1)(1997-2#2)(2010-10#2)(2012-2#1)
in rural counties##2##3##(1996-3#2)
in rural health##2##3##(1995-2#1)(2012-12#1)
in rural##32##2##(1994-1#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-3#7)(1996-5#1)(1997-2#2)(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-12#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
in rust##3##2##(2008-10#3)
in safe##2##2##(2008-11#1)(2011-1#1)
in safety testing##3##3##(2008-5#2)(2010-11#1)
in safety##6##2##(2008-5#3)(2009-10#1)(2010-11#1)(2011-1#1)
in saline matrices##4##3##(2008-10#4)
in saline##9##2##(1994-5#1)(2008-10#7)(2013-1#1)
in saliva and##2##3##(2008-10#2)
in saliva by##2##3##(2008-10#2)
in saliva flow rate##2##4##(2013-1#1)(2013-8#1)
in saliva##13##2##(2008-10#9)(2013-1#1)(2013-8#3)
in salivary##4##2##(2008-10#1)(2013-8#3)
in salmon egg cell cytoplasm##3##5##(2008-10#3)
in salmon##4##2##(2008-10#3)(2008-8#1)
in salmonids##4##2##(2008-10#1)(2008-7#1)(2009-6#2)
in salt##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
in sample preparation##4##3##(2008-10#3)(2008-9#1)
in sample solution##2##3##(2008-10#2)
in sample##20##2##(2008-10#16)(2008-12#1)(2008-4#1)(2008-9#2)
in samples and##3##3##(2008-10#3)
in samples collected in##2##4##(2008-10#2)
in samples collected##3##3##(2008-10#3)
in samples containing high amounts of various organic compounds##2##9##(2008-10#1)(2009-8#1)
in samples containing##4##3##(2008-10#3)(2009-8#1)
in samples from Si+ plants##3##5##(2008-10#3)
in samples from a##2##4##(2008-10#2)
in samples from##13##3##(2008-10#12)(2011-2#1)
in samples of##17##3##(1991-2#1)(2008-10#11)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2013-1#1)
in samples such as particulate matter##2##6##(2008-10#2)
in samples such as##3##4##(2008-10#3)
in samples that##2##3##(2008-10#2)
in samples was##2##3##(2008-10#2)
in samples with##5##3##(2008-10#3)(2008-9#1)(2011-2#1)
in samples##70##2##(1991-2#1)(2008-10#54)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#2)(2009-8#1)(2011-2#2)(2013-1#1)
in sampling##4##2##(1992-3#1)(2008-10#2)(2013-8#1)
in sand##2##2##(2008-10#2)
in sandy loam##2##3##(2008-10#1)(2011-1#1)
in sandy soil at##3##4##(2008-10#3)
in sandy soil##4##3##(2008-10#4)
in sandy##8##2##(2008-10#6)(2011-1#1)(2013-1#1)
in satisfactory agreement with##2##4##(2008-10#2)
in satisfactory##4##2##(2008-10#4)
in saturated glutaraldehyde##2##3##(2008-10#2)
in saturated##4##2##(1990-8#1)(2008-10#2)(2008-8#1)
in savings##2##2##(1994-9#1)(1996-1#1)
in sawdust##2##2##(2008-12#2)
in scale##2##2##(2007-12#1)(2008-5#1)
in scanning electron##2##3##(2008-10#1)(2008-11#1)
in scattering media##3##3##(2008-2#1)(2008-3#2)
in scattering##4##2##(2008-2#2)(2008-3#2)
in scavenging##2##2##(1995-6#1)(2008-10#1)
in schizophrenia and##2##3##(2010-1#1)(2010-9#1)
in schizophrenia##16##2##(1990-2#1)(1993-9#7)(1995-5#1)(2009-12#1)(2009-7#2)(2010-1#2)(2010-9#1)(2012-3#1)
in schizophrenic patients##4##3##(1995-12#1)(1995-5#3)
in school and##2##3##(2008-11#1)(2009-7#1)
in school##15##2##(1991-12#3)(1995-12#1)(2008-11#2)(2008-12#1)(2009-7#5)(2011-2#1)(2012-2#1)(2012-3#1)
in school-age children in##2##4##(2009-9#1)(2011-2#1)
in school-age children##4##3##(1995-1#1)(2009-9#1)(2011-2#2)
in schools of public health##2##5##(1996-3#2)
in schools##8##2##(1991-12#1)(1996-3#2)(1997-6#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
in scid mice##2##3##(1994-3#2)
in science##9##2##(1990-11#1)(1990-8#2)(1994-9#1)(1995-3#1)(1995-6#1)(2008-11#1)(2009-6#1)(2012-2#1)
in scientific##2##2##(2010-1#1)(2010-12#1)
in scleroderma fibroblasts##3##3##(1992-8#3)
in scope##4##2##(1994-3#1)(2008-1#1)(2008-10#1)(2008-12#1)
in scoring##2##2##(2009-5#1)(2010-11#1)
in screening and##2##3##(1996-12#1)(2008-10#1)
in screening##7##2##(1996-12#1)(1996-3#1)(2008-10#3)(2008-7#1)(2012-3#1)
in screw##2##2##(2008-10#1)(2008-8#1)
in sea water by##3##4##(2008-10#3)
in sea water samples##3##4##(2008-10#3)
in sea water##12##3##(2008-10#12)
in sea##14##2##(2008-10#14)
in seabream##2##2##(2008-11#1)(2010-5#1)
in seafood by inductively coupled plasma atomic emission spectrometry with##2##10##(2008-10#2)
in seafood##3##2##(2008-10#3)
in search of the##2##4##(2010-5#1)(2012-3#1)
in search of##4##3##(2010-2#1)(2010-5#1)(2012-3#1)(2013-8#1)
in searching##2##2##(1992-12#1)(1995-2#1)
in seawater and##2##3##(2008-10#2)
in seawater by ion-exclusion##2##4##(2008-10#2)
in seawater by##6##3##(2008-10#6)
in seawater is##2##3##(2008-10#2)
in seawater samples##4##3##(2008-10#4)
in seawater using##5##3##(2008-10#5)
in seawater were##2##3##(2008-10#2)
in seawater##46##2##(2008-10#43)(2008-5#1)(2009-6#2)
in seborrheic keratosis##2##3##(2007-8#1)(2012-12#1)
in second degree##2##3##(1994-12#1)(2013-7#1)
in second##6##2##(1994-12#1)(2009-6#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
in secondary schools##2##3##(2008-10#1)(2013-1#1)
in secondary##11##2##(1991-5#1)(1993-2#1)(1993-9#2)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2013-1#1)
in secretion of##2##3##(1997-1#1)(2008-9#1)
in secretion##5##2##(1991-6#1)(1994-12#1)(1997-1#1)(2008-6#1)(2008-9#1)
in secretory##4##2##(1993-2#1)(1995-8#1)(2007-12#1)(2008-11#1)
in sections of##2##3##(1990-5#1)(2008-9#1)
in security##2##2##(1996-12#1)(2009-6#1)
in sedentary##5##2##(2008-3#1)(2008-9#2)(2012-2#1)(2013-1#1)
in sediment and##3##3##(2008-10#2)(2008-11#1)
in sediment pore waters and extracts##2##6##(2008-10#2)
in sediment samples##3##3##(2008-10#3)
in sediment##13##2##(2008-10#11)(2008-11#2)
in sediments using##3##3##(2008-10#3)
in sediments##14##2##(2008-10#14)
in seed output##3##3##(2008-9#3)
in seed production fields##2##4##(2008-10#2)
in seed production##4##3##(2008-10#2)(2008-9#2)
in seed##18##2##(2008-10#12)(2008-9#5)(2009-8#1)
in seedling##5##2##(2008-10#5)
in seedlings of##3##3##(2008-10#2)(2008-8#1)
in seedlings##10##2##(2008-10#8)(2008-8#2)
in seeds and##2##3##(2008-10#2)
in seeds##4##2##(2008-10#3)(2008-9#1)
in seizure##2##2##(1990-5#1)(1994-2#1)
in seizure-naive GEPR-3##2##3##(1996-12#2)
in seizure-naive##3##2##(1996-12#3)
in select##4##2##(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
in selected brain regions of subordinate##2##6##(1992-1#2)
in selected cases##5##3##(1990-9#1)(1991-2#1)(1995-3#1)(1997-8#1)(2010-12#1)
in selected ion monitoring##2##4##(2008-10#2)
in selected patients##6##3##(1994-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-8#1)
in selected##31##2##(1990-9#1)(1991-2#1)(1992-1#2)(1993-2#1)(1994-1#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-8#1)
in selecting patients##2##3##(2008-8#1)(2012-3#1)
in selecting the##2##3##(2008-12#1)(2013-1#1)
in selecting##13##2##(1991-12#1)(1994-12#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
in selection for##2##3##(2008-10#1)(2008-9#1)
in selection##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#1)
in selective##4##2##(2008-10#2)(2008-11#1)(2010-8#1)
in selectivity##4##2##(2008-10#4)
in selenite##3##2##(2008-10#3)
in selenium##3##2##(1997-8#1)(2008-10#2)
in self-control##2##2##(2008-12#2)
in self-esteem##2##2##(2008-5#1)(2009-7#1)
in self-reported##3##2##(1991-9#1)(1994-6#1)(2010-12#1)
in semen##4##2##(1992-6#1)(1996-9#1)(2008-12#2)
in semi-closed##2##2##(2011-2#2)
in semiarid grasslands##2##3##(2008-8#2)
in semiarid##3##2##(2008-8#3)
in semiconductor##4##2##(1990-12#1)(2007-11#2)(2008-3#1)
in semicontinuous##2##2##(2008-11#1)(2008-6#1)
in senescent rats##2##3##(1991-2#1)(2013-7#1)
in senescent##6##2##(1991-2#1)(1992-9#2)(2009-10#1)(2013-7#2)
in senile##2##2##(1991-7#1)(2008-7#1)
in sensitive and##2##3##(2008-10#1)(2008-11#1)
in sensitive cultivars##2##3##(2008-10#2)
in sensitive##9##2##(1990-2#1)(2008-10#7)(2008-11#1)
in sensitivity of##2##3##(2008-10#2)
in sensitivity to##3##3##(2008-10#1)(2008-12#1)(2012-6#1)
in sensitivity was##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
in sensitivity##24##2##(1991-6#1)(1997-8#1)(2008-10#16)(2008-12#1)(2008-3#1)(2011-2#3)(2012-6#1)
in sensor##2##2##(2008-10#1)(2011-1#1)
in sensory##3##2##(1992-6#1)(2008-11#1)(2008-5#1)
in separate##14##2##(2007-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#3)(2012-2#1)(2012-4#1)(2013-1#1)
in separating##2##2##(2008-10#1)(2012-3#1)
in separation of##2##3##(2008-10#2)
in separation##6##2##(1997-2#1)(2008-10#5)
in sepsis##6##2##(1991-3#1)(1996-3#1)(2008-7#1)(2010-7#2)(2011-2#1)
in septo-hippocampal##2##2##(1996-2#2)
in sequence databases##2##3##(1996-8#1)(2010-11#1)
in sequence homology##2##3##(2008-10#1)(2008-9#1)
in sequence##11##2##(1994-11#1)(1996-12#1)(1996-8#1)(1997-6#1)(2008-10#4)(2008-9#1)(2010-11#1)(2012-2#1)
in sera from##5##3##(1992-11#3)(1993-2#2)
in sera##8##2##(1990-8#1)(1992-11#3)(1993-1#1)(1993-2#2)(2008-10#1)
in series with##2##3##(2008-10#1)(2008-11#1)
in series##15##2##(2008-10#13)(2008-11#1)(2008-2#1)
in serious##2##2##(2008-10#1)(2011-2#1)
in serotonergic signaling##5##3##(2012-3#5)
in serum T##3##3##(2013-8#3)
in serum and rat brain##2##5##(2008-10#2)
in serum and urine##5##4##(1991-12#1)(1992-11#1)(2008-10#3)
in serum and##17##3##(1990-12#1)(1991-12#1)(1992-11#1)(2008-10#12)(2008-11#1)(2013-1#1)
in serum are##2##3##(1990-2#1)(2008-10#1)
in serum by##7##3##(1992-3#1)(2008-10#5)(2008-4#1)
in serum containing medium##4##4##(2008-11#4)
in serum containing##5##3##(2008-11#5)
in serum from##2##3##(2008-9#1)(2011-2#1)
in serum of patients with##2##5##(1990-6#1)(1996-10#1)
in serum of##6##3##(1990-6#1)(1996-10#1)(2008-10#2)(2013-1#2)
in serum samples from##2##4##(1996-12#1)(2008-5#1)
in serum samples##9##3##(1996-12#1)(2008-10#7)(2008-5#1)
in serum triglyceride of##2##4##(2008-3#2)
in serum was##2##3##(2008-10#2)
in serum##111##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#6)(1994-3#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#1)(2008-10#46)(2008-11#8)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#6)
in serum-containing media##2##3##(2008-11#2)
in serum-containing medium##6##3##(2008-11#6)
in serum-containing##9##2##(2008-11#9)
in serum-free culture##4##3##(2008-11#4)
in serum-free media for mammalian##2##5##(2008-11#2)
in serum-free media for##3##4##(2008-11#3)
in serum-free media##7##3##(2008-11#7)
in serum-free medium in##3##4##(2008-11#3)
in serum-free medium##10##3##(2008-11#9)(2008-9#1)
in serum-free suspension culture##5##4##(2008-11#5)
in serum-free suspension##6##3##(2008-11#6)
in serum-free##33##2##(2008-11#31)(2008-7#1)(2008-9#1)
in serum-supplemented##3##2##(2008-11#3)
in service delivery##2##3##(2008-1#1)(2008-11#1)
in service use##2##3##(1991-1#2)
in service##8##2##(1991-1#2)(1993-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#2)
in set shifting##2##3##(2008-11#2)
in setting up##2##3##(1990-2#1)(2007-12#1)
in setting##5##2##(1990-2#1)(1993-9#1)(1997-1#1)(1997-3#1)(2007-12#1)
in settings##3##2##(1993-1#1)(2007-12#1)(2008-8#1)
in seven different##2##3##(2008-10#1)(2008-3#1)
in seven of the##2##4##(1991-12#1)(1997-3#1)
in seven of##4##3##(1990-5#1)(1991-12#1)(1994-9#1)(1997-3#1)
in seven patients and##2##4##(1993-2#1)(2011-2#1)
in seven patients##3##3##(1993-2#1)(2011-2#2)
in seven##39##2##(1990-5#1)(1991-12#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-7#2)(2010-8#1)(2011-2#3)(2013-1#1)
in several areas##4##3##(1993-3#1)(2008-10#2)(2009-4#1)
in several cases##2##3##(2008-8#1)(2011-2#1)
in several cell##2##3##(1992-12#1)(2013-8#1)
in several different##4##3##(1991-5#1)(2008-10#1)(2011-1#1)(2011-2#1)
in several disciplines##2##3##(1996-1#1)(2008-10#1)
in several fish species##2##4##(2010-8#2)
in several human##3##3##(1991-6#1)(1995-5#1)(2011-2#1)
in several laboratories##3##3##(1995-12#1)(1996-2#1)(2008-10#1)
in several other##2##3##(1995-8#1)(2008-10#1)
in several regions of##2##4##(2008-10#1)(2008-4#1)
in several samples##3##3##(2008-10#3)
in several soil samples that yielded a relative error of 1% in the concentrations##2##14##(2008-10#2)
in several species##2##3##(1990-3#1)(1992-6#1)
in several standard reference materials (alloys and steels)##2##8##(2008-10#2)
in several strains##2##3##(2008-4#1)(2008-8#1)
in several studies##2##3##(2010-5#1)(2012-4#1)
in several synthetic mixtures containing different concentration ratios of##2##9##(2008-10#2)
in several synthetic mixtures containing different concentration##3##7##(2008-10#3)
in several synthetic mixtures##4##4##(2008-10#4)
in several synthetic##7##3##(2008-10#7)
in several taxa##2##3##(2008-8#1)(2008-9#1)
in several types of##2##4##(2008-10#2)
in several water samples##2##4##(2008-10#2)
in several ways##2##3##(2009-12#1)(2010-2#1)
in several##137##2##(1990-3#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#61)(2008-11#4)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-12#3)(2009-4#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#5)(2012-4#1)(2013-1#4)(2013-8#2)
in severe cases##3##3##(2008-8#1)(2013-1#2)
in severe sepsis and septic shock##3##6##(2011-2#3)
in severe sepsis##7##3##(2009-5#1)(2009-6#2)(2009-9#1)(2011-2#3)
in severe##22##2##(1991-2#1)(1993-8#1)(1994-6#1)(1996-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#3)(2011-2#5)(2013-1#2)
in severely damaged##2##3##(2008-10#1)(2010-10#1)
in severely##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
in severity of##4##3##(1993-12#1)(2008-10#2)(2008-12#1)
in severity##8##2##(1993-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2010-12#1)
in sewage samples have been##2##5##(2008-10#2)
in sewage sludge##4##3##(2008-10#4)
in sewage##8##2##(2008-10#6)(2008-11#1)(2009-12#1)
in sex ratio##2##3##(2008-8#1)(2008-9#1)
in sex##6##2##(2008-10#1)(2008-8#2)(2008-9#1)(2012-3#2)
in sexual assault##2##3##(1996-5#1)(2012-3#1)
in sexual##14##2##(1991-3#1)(1993-9#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-8#2)(2012-2#2)(2012-3#4)(2013-1#1)
in shake flasks##3##3##(2008-11#2)(2008-12#1)
in shake##6##2##(2008-10#2)(2008-11#3)(2008-12#1)
in shake-flask##3##2##(2008-11#1)(2008-7#2)
in shallow-flooded plots##2##3##(2013-8#2)
in shampoo##2##2##(2008-10#1)(2008-5#1)
in shampoos##3##2##(2008-5#3)
in shape and size##2##4##(2007-12#1)(2009-5#1)
in shape and##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)
in shape##8##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#1)
in shaping the##3##3##(1997-1#1)(2008-8#1)(2011-3#1)
in shaping##6##2##(1997-1#1)(2008-8#3)(2011-3#1)(2012-3#1)
in sharp contrast##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
in shear##2##2##(2008-8#1)(2013-1#1)
in sheep and##2##3##(2008-12#1)(2008-8#1)
in sheep was##2##3##(2008-12#1)(2008-8#1)
in sheep##11##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-8#1)(1996-12#1)(2008-10#1)(2008-12#2)(2008-8#2)
in shifting##2##2##(2008-10#1)(2013-1#1)
in shiitake mushroom##4##3##(2008-10#4)
in shoots##4##2##(2008-10#1)(2008-12#3)
in short supply##2##3##(2008-10#1)(2008-12#1)
in short term##2##3##(2012-2#1)(2013-1#1)
in short time##2##3##(2008-11#1)(2011-3#1)
in short##11##2##(2008-10#5)(2008-11#1)(2008-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
in short)##2##2##(2008-5#2)
in short-circuit current##2##3##(1990-5#1)(1991-5#1)
in short-term##8##2##(1991-10#1)(1992-9#1)(2008-11#3)(2011-2#1)(2012-2#1)(2013-1#1)
in showing##2##2##(2008-11#1)(2009-7#1)
in sickle cell##2##3##(2013-1#2)
in sieve##2##2##(2008-10#2)
in sight for##3##3##(1990-3#1)(1995-8#1)(1996-3#1)
in sight##4##2##(1990-3#1)(1991-2#1)(1995-8#1)(1996-3#1)
in signal processing##2##3##(2008-10#1)(2008-3#1)
in signal transduction##6##3##(1993-8#1)(1994-12#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-5#1)
in signal transmission##3##3##(1993-9#1)(1994-11#1)(2011-7#1)
in signal##13##2##(1990-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-7#1)
in signaling##4##2##(2008-11#1)(2008-5#1)(2009-6#2)
in signals##3##2##(2008-4#1)(2008-8#2)
in significant amounts##2##3##(1990-11#1)(1995-2#1)
in significant decreases in##2##4##(1993-6#1)(2008-5#1)
in significant differences##2##3##(1993-2#1)(1994-3#1)
in significant##29##2##(1990-11#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-10#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-5#2)
in significantly higher##2##3##(2008-10#2)
in significantly##9##2##(1996-12#1)(2008-10#7)(2008-9#1)
in silage##3##2##(1990-6#1)(2008-10#2)
in silica##3##2##(2008-10#3)
in silico##12##2##(2008-10#2)(2008-4#1)(2008-7#2)(2010-11#1)(2011-1#1)(2011-2#4)(2013-8#1)
in silicon##6##2##(1991-9#1)(1992-11#1)(1994-2#1)(2008-10#2)(2008-7#1)
in silicon-treated plants##2##3##(2008-10#2)
in silkworm##2##2##(1997-3#1)(2008-9#1)
in silt loam soil##2##4##(2008-10#2)
in silt loam##3##3##(2008-10#3)
in silver halide##2##3##(2008-3#2)
in silver##4##2##(2008-10#1)(2008-3#2)(2010-5#1)
in similar##10##2##(1991-12#1)(1995-6#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-11#1)(2009-7#1)(2010-4#1)
in simple##11##2##(1996-2#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-8#3)(2013-1#1)
in simulated mixtures##3##3##(2008-10#3)
in simulated##12##2##(1994-5#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
in simulation experiments##2##3##(1995-9#1)(2008-10#1)
in simulation##3##2##(1995-9#1)(2008-10#1)(2009-7#1)
in simultaneous determination of##2##4##(2008-10#2)
in single cells##3##3##(1991-5#1)(1994-11#1)(2008-10#1)
in single or##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
in single pyramidal cells of##2##5##(2008-11#2)
in single pyramidal cells##3##4##(2008-11#3)
in single rat trigeminal ganglion neurons##2##6##(1996-12#2)
in single subjects##2##3##(1991-8#1)(2008-11#1)
in single##39##2##(1991-5#1)(1991-8#1)(1994-11#1)(1994-6#1)(1996-12#2)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#2)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
in single-crystal##2##2##(2008-2#2)
in single-genotype plots##2##3##(2008-10#2)
in single-genotype##3##2##(2008-10#3)
in sink##2##2##(2008-10#2)
in sinus##2##2##(1996-6#1)(2008-11#1)
in sitting position##4##3##(2012-3#4)
in sitting##6##2##(2011-2#1)(2012-3#5)
in situ DNA##2##3##(2008-11#1)(2008-9#1)
in situ analysis of##3##4##(2008-10#2)(2008-3#1)
in situ analysis##6##3##(2008-10#5)(2008-3#1)
in situ and in##2##4##(1993-5#1)(2008-10#1)
in situ and##11##3##(1990-2#1)(1993-5#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2013-8#1)
in situ applications##2##3##(2008-10#1)(2008-3#1)
in situ at the##2##4##(2008-10#2)
in situ at##3##3##(2008-10#3)
in situ by##7##3##(1993-12#1)(2008-10#6)
in situ cell##2##3##(2008-11#1)(2008-8#1)
in situ chemical##2##3##(2008-10#2)
in situ conservation##3##3##(2008-8#3)
in situ data##2##3##(2008-3#2)
in situ detection of##3##4##(1993-12#1)(2008-11#1)(2008-9#1)
in situ detection##4##3##(1993-12#1)(2008-11#1)(2008-9#2)
in situ determination of##2##4##(2008-10#2)
in situ end labeling##2##4##(2008-7#2)
in situ fluorescent##2##3##(2010-8#1)(2013-7#1)
in situ hybridisation##4##3##(1996-12#2)(2008-12#2)
in situ hybridization (FISH)##8##4##(1993-12#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)
in situ hybridization (ISH)##2##4##(1996-12#1)(2010-1#1)
in situ hybridization analysis##2##4##(1991-5#1)(2008-9#1)
in situ hybridization and##5##4##(1996-12#1)(1997-8#2)(2008-10#1)(2008-11#1)
in situ hybridization as well as##2##6##(1997-1#1)(2008-9#1)
in situ hybridization experiments##2##4##(1996-12#1)(2008-10#1)
in situ hybridization histochemistry##10##4##(1992-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#1)
in situ hybridization in##3##4##(1996-12#1)(2009-1#1)(2010-1#1)
in situ hybridization methods##2##4##(1996-12#1)(2008-9#1)
in situ hybridization of##3##4##(1996-12#3)
in situ hybridization showed that##2##5##(1996-12#1)(1997-1#1)
in situ hybridization studies##2##4##(2008-4#1)(2009-8#1)
in situ hybridization study##2##4##(1996-12#1)(2009-8#1)
in situ hybridization techniques##3##4##(1991-5#1)(1995-12#1)(2008-9#1)
in situ hybridization##85##3##(1991-5#2)(1992-12#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#17)(1996-2#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#4)(2008-11#4)(2008-4#5)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#13)(2009-1#1)(2009-7#1)(2009-8#3)(2010-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
in situ in the##3##4##(1991-9#1)(1997-1#1)(2010-8#1)
in situ in##6##3##(1991-9#1)(1997-1#2)(2008-10#2)(2010-8#1)
in situ monitoring of##2##4##(2008-10#1)(2008-3#1)
in situ monitoring##4##3##(2008-10#3)(2008-3#1)
in situ nick translation##3##4##(2008-4#3)
in situ of##2##3##(1993-9#1)(2008-10#1)
in situ plated in thiocyanate media##2##6##(2008-10#2)
in situ quantitative##2##3##(2008-2#1)(2008-3#1)
in situ sampling of##2##4##(2008-10#2)
in situ spectrometer with##2##4##(2008-10#2)
in situ study##2##3##(2008-10#2)
in situ thermal hydrolysis/methylation##2##4##(2008-10#2)
in situ to invasive##2##4##(2010-6#1)(2011-2#1)
in situ to##5##3##(2008-3#1)(2008-9#1)(2010-6#2)(2011-2#1)
in situ using padlock probes##3##5##(2008-4#2)(2008-9#1)
in situ using##6##3##(2008-10#2)(2008-4#3)(2008-9#1)
in situ was developed##2##4##(1991-3#1)(2008-7#1)
in situ with##3##3##(1997-8#1)(2008-10#2)
in situ##309##2##(1990-12#1)(1990-2#2)(1991-3#2)(1991-5#2)(1991-9#1)(1992-12#2)(1992-6#2)(1993-12#4)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-6#2)(1996-12#21)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#3)(1997-3#3)(1997-7#1)(1997-8#3)(2007-11#2)(2008-10#103)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#25)(2008-4#11)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#11)(2008-9#23)(2009-1#1)(2009-12#1)(2009-7#1)(2009-8#4)(2010-1#3)(2010-10#1)(2010-6#5)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
in situations##5##2##(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#1)
in six animals##2##3##(1994-8#1)(1996-3#1)
in six areas##2##3##(1993-3#1)(2008-10#1)
in six different##3##3##(2008-10#2)(2008-5#1)
in six dogs##2##3##(1996-12#1)(2012-3#1)
in six of seven##3##4##(1991-2#1)(2008-10#2)
in six of the##2##4##(2008-10#1)(2011-2#1)
in six of##6##3##(1991-2#1)(2008-10#4)(2011-2#1)
in six patients##2##3##(2008-10#1)(2008-7#1)
in six states##2##3##(1995-12#1)(2012-2#1)
in six##44##2##(1990-8#2)(1991-2#3)(1992-12#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-2#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-7#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
in sixteen##2##2##(2008-10#1)(2011-2#1)
in sixteenth-century##3##2##(2008-11#3)
in size and each##2##4##(1994-2#1)(2008-12#1)
in size and##10##3##(1994-11#1)(1994-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#2)(2010-11#1)(2012-3#1)
in size as the##2##4##(1992-12#1)(2008-10#1)
in size but##2##3##(2012-3#1)(2013-7#1)
in size from##7##3##(1990-12#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#2)
in size of the##4##4##(1993-12#1)(2008-10#1)(2008-8#1)(2013-8#1)
in size of##5##3##(1993-12#1)(2008-10#2)(2008-8#1)(2013-8#1)
in size to those##2##4##(2008-10#2)
in size with##2##3##(2008-5#1)(2010-5#1)
in size##72##2##(1990-12#1)(1990-2#2)(1990-7#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#2)(2007-12#4)(2008-10#16)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-6#1)(2010-11#2)(2010-5#1)(2010-6#1)(2010-7#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
in size) and##2##3##(2008-10#1)(2012-12#1)
in size)##4##2##(1996-6#1)(2008-10#1)(2012-12#2)
in skeletal muscle##5##3##(1992-6#1)(2008-11#1)(2008-8#1)(2013-1#2)
in skeletal muscles##2##3##(1990-8#1)(2008-11#1)
in skeletal##11##2##(1990-11#1)(1990-8#1)(1992-6#1)(1994-5#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#3)
in skin of##2##3##(2008-9#2)
in skin surface pH##4##4##(2008-5#4)
in skin##26##2##(1993-3#1)(2008-4#1)(2008-5#14)(2008-9#5)(2009-6#1)(2011-2#3)(2012-3#1)
in skin-whitening##2##2##(2008-5#2)
in skull base surgery##2##4##(2011-2#2)
in skull##3##2##(2011-2#2)(2012-12#1)
in slalom chromatography##3##3##(2008-10#3)
in slaughtered##2##2##(2008-12#1)(2011-2#1)
in slaughterhouse##2##2##(2008-12#1)(2013-1#1)
in sleep and##2##3##(2008-11#1)(2012-2#1)
in sleep regulation##2##3##(1991-9#2)
in sleep##11##2##(1991-9#2)(1997-4#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-8#1)(2010-6#1)(2010-8#2)(2012-2#1)
in slightly##5##2##(1992-2#1)(2008-10#3)(2009-7#1)
in slope##3##2##(1995-8#1)(2008-10#2)
in slowing##2##2##(2008-10#2)
in sludges##2##2##(2008-10#2)
in slurried##2##2##(2008-10#2)
in slurry reactors was##2##4##(2008-7#2)
in slurry reactors##3##3##(2008-7#3)
in small and##3##3##(1994-1#1)(1996-12#1)(2008-9#1)
in small children##4##3##(1990-11#1)(1996-11#1)(2008-10#1)(2012-12#1)
in small communities##2##3##(2008-10#1)(2010-9#1)
in small samples##2##3##(2008-10#2)
in small scale experiments##2##4##(2008-11#2)
in small scale##4##3##(2008-11#4)
in small volumes##2##3##(2008-10#1)(2008-9#1)
in small##49##2##(1990-11#1)(1990-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-11#1)(1996-12#3)(1997-5#1)(2008-1#1)(2008-10#11)(2008-11#6)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-1#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
in smaller##5##2##(1995-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)
in smoke##3##2##(1996-12#1)(2008-11#2)
in smoker men##2##3##(2008-12#2)
in smoker##3##2##(2008-12#2)(2012-12#1)
in smokers than non-smokers##2##4##(2008-10#2)
in smokers##9##2##(1992-9#4)(1993-2#1)(1994-6#1)(2008-10#3)
in smoking prevalence suggest##2##4##(1996-3#2)
in smoking prevalence##4##3##(1994-6#1)(1996-3#2)(2011-2#1)
in smoking##11##2##(1992-2#1)(1994-6#2)(1996-3#2)(2008-10#1)(2010-11#2)(2011-2#1)(2013-1#2)
in smooth muscle cells##2##4##(1994-11#1)(1995-2#1)
in smooth muscle relaxation##2##4##(1992-6#1)(1993-6#1)
in smooth muscle##6##3##(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)
in snails##2##2##(2010-4#2)
in snap bean##4##3##(2008-10#4)
in snap##5##2##(2008-10#5)
in so##2##2##(1990-9#1)(1992-2#1)
in so-called##2##2##(1991-3#1)(2008-9#1)
in social insects##2##3##(2008-8#1)(2008-9#1)
in social memory/recognition##2##3##(1994-3#2)
in social surveys##2##3##(2010-1#2)
in social##28##2##(1994-3#2)(1996-12#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-7#1)(2010-1#3)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
in society##4##2##(2008-1#1)(2009-6#1)(2010-10#2)
in sodium dodecyl##2##3##(2008-10#2)
in sodium hydroxide##2##3##(2008-10#2)
in sodium##9##2##(2008-10#8)(2009-7#1)
in soft agar##3##3##(1995-2#1)(2008-11#2)
in soft drink##5##3##(2008-10#5)
in soft drinks##5##3##(2008-10#5)
in soft tissues##2##3##(2008-12#2)
in soft##19##2##(1995-2#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#1)(2012-2#2)
in soil and plant##2##4##(2008-10#2)
in soil and sediment samples##2##5##(2008-10#2)
in soil and sediment##7##4##(2008-10#7)
in soil and water##4##4##(2008-10#4)
in soil and##28##3##(2008-10#27)(2008-11#1)
in soil aqua regia extracts##2##5##(2008-10#2)
in soil at##3##3##(2008-10#3)
in soil by##7##3##(2008-10#6)(2008-11#1)
in soil disks equilibrated at##2##5##(2008-10#2)
in soil extract##2##3##(2008-10#2)
in soil extracts##8##3##(2008-10#8)
in soil from plots with##2##5##(2008-10#2)
in soil from the##3##4##(2008-10#3)
in soil from##10##3##(2008-10#10)
in soil infested with##4##4##(2008-10#4)
in soil is##2##3##(2008-10#1)(2008-11#1)
in soil layers##3##3##(2008-10#3)
in soil leachates and runoff waters##2##6##(2008-10#2)
in soil of##2##3##(2008-10#2)
in soil samples by##4##4##(2008-10#4)
in soil samples from##3##4##(2008-10#3)
in soil samples was##2##4##(2008-10#2)
in soil samples were##2##4##(2008-10#2)
in soil samples##20##3##(2008-10#18)(2008-11#2)
in soil so##3##3##(2008-10#3)
in soil solution##3##3##(2008-10#2)(2008-11#1)
in soil taken from##2##4##(2008-10#2)
in soil that##2##3##(2008-10#2)
in soil using##2##3##(2008-10#2)
in soil was##4##3##(2008-10#4)
in soil##174##2##(2008-10#157)(2008-11#11)(2008-9#1)(2010-11#1)(2011-2#2)(2012-5#1)(2013-8#1)
in soilless##3##2##(2008-10#3)
in soils amended with##3##4##(2008-10#3)
in soils and sediments by##2##5##(2008-10#2)
in soils and sediments##4##4##(2008-10#4)
in soils and##11##3##(2008-10#11)
in soils by##3##3##(2008-10#3)
in soils from##4##3##(2008-10#4)
in soils have##2##3##(2008-10#2)
in soils infested with##2##4##(2008-10#2)
in soils were in the##2##5##(2008-10#2)
in soils##54##2##(2008-10#51)(2008-11#2)(2010-7#1)
in sol-gel derived##2##3##(2008-10#2)
in sol-gel##5##2##(2008-10#5)
in solid and##2##3##(2008-10#2)
in solid pharmaceutical formulations##2##4##(2008-10#2)
in solid phase extraction##2##4##(2008-10#2)
in solid phase##4##3##(2008-10#4)
in solid samples##6##3##(2008-10#6)
in solid tumor##2##3##(1994-12#1)(2008-9#1)
in solid tumors##3##3##(2008-7#3)
in solid##34##2##(1991-9#1)(1994-12#1)(2008-10#25)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)
in solid-phase##2##2##(2008-10#1)(2008-4#1)
in solubility##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
in soluble##4##2##(1990-11#1)(2008-10#3)
in solution and##7##3##(1991-3#1)(2008-10#6)
in solution by##4##3##(1991-3#1)(1994-5#1)(2008-10#2)
in solution has been##2##4##(2008-10#2)
in solution of##2##3##(2008-10#1)(2012-2#1)
in solution or##2##3##(2008-10#2)
in solution phase##3##3##(2008-10#3)
in solution to##3##3##(2008-10#3)
in solution was##3##3##(2008-10#3)
in solution were studied##2##4##(2008-10#2)
in solution were##4##3##(2008-10#4)
in solution##107##2##(1991-3#2)(1992-4#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-6#2)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#85)(2008-3#1)(2008-4#1)(2008-9#3)(2009-7#1)(2010-7#1)(2012-2#1)(2013-1#2)
in solution)##2##2##(2008-10#2)
in solutions containing a##2##4##(2008-10#2)
in solutions containing##8##3##(2008-10#7)(2011-2#1)
in solutions obtained after digestion of##2##6##(2008-10#2)
in solutions obtained##3##3##(2008-10#3)
in solutions of##8##3##(2008-10#7)(2010-1#1)
in solutions that##2##3##(2008-10#2)
in solutions with##3##3##(2008-10#3)
in solutions##33##2##(2008-10#30)(2008-11#1)(2010-1#1)(2011-2#1)
in solvent polymeric##3##3##(2008-10#3)
in solvent##7##2##(2008-10#7)
in solvents##3##2##(2008-3#3)
in solving##4##2##(1992-1#1)(2008-10#1)(2009-12#1)(2010-11#1)
in somatic cells of##2##4##(1994-11#2)
in somatic cells##5##3##(1994-11#2)(2008-11#1)(2009-10#1)(2011-2#1)
in somatic##9##2##(1993-12#1)(1994-11#2)(2008-11#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
in some affected##2##3##(2008-10#1)(2009-6#1)
in some areas##8##3##(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2013-1#1)
in some biological##2##3##(2008-10#2)
in some cancers##2##3##(2011-2#1)(2013-8#1)
in some cases for##2##4##(2008-10#1)(2011-2#1)
in some cases of##2##4##(1997-6#1)(2011-1#1)
in some cases the##3##4##(1991-2#1)(2008-10#2)
in some cases##47##3##(1991-11#1)(1991-12#1)(1991-2#1)(1993-12#2)(1994-12#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
in some cell##2##3##(1996-12#1)(2011-2#1)
in some cells##2##3##(1992-6#1)(2008-10#1)
in some circumstances##2##3##(2011-1#1)(2012-3#1)
in some countries##4##3##(1993-11#1)(2008-11#1)(2011-2#1)(2012-12#1)
in some degree##2##3##(1997-8#1)(2008-5#1)
in some detail##4##3##(1992-1#1)(2008-10#1)(2008-5#1)(2009-8#1)
in some drugs##2##3##(1991-1#1)(2008-10#1)
in some experimental##2##3##(1990-2#1)(2008-10#1)
in some experiments##3##3##(1994-8#1)(2008-10#1)(2008-3#1)
in some industrial##2##3##(2008-10#1)(2008-3#1)
in some instances##9##3##(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-1#1)
in some lines##2##3##(2008-10#1)(2008-9#1)
in some natural##3##3##(2008-10#3)
in some of the groups investigated##2##6##(2008-11#2)
in some of the##13##4##(1994-5#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)(2013-1#1)
in some of##17##3##(1994-5#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)
in some other##4##3##(2007-12#1)(2008-11#2)(2010-3#1)
in some parts of the##2##5##(2008-11#1)(2010-12#1)
in some patients with##3##4##(1992-6#1)(1994-11#1)(1997-8#1)
in some patients##9##3##(1991-2#1)(1992-6#1)(1994-11#2)(1997-1#1)(1997-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
in some pharmaceutical##4##3##(2008-10#3)(2008-11#1)
in some plants##2##3##(2008-10#2)
in some relatively##2##3##(1991-12#1)(2008-10#1)
in some samples##4##3##(2008-10#4)
in some situations##2##3##(2008-10#1)(2008-8#1)
in some specific##2##3##(1996-12#1)(2010-5#1)
in some synthetic mixtures and##2##5##(2008-10#2)
in some synthetic##3##3##(2008-10#3)
in some tissues##2##3##(1992-9#1)(2008-12#1)
in some way##2##3##(1991-6#1)(2008-11#1)
in some##247##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#2)(1992-1#1)(1992-2#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#4)(1997-1#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-1#3)(2008-10#91)(2008-11#18)(2008-12#9)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#4)(2008-8#7)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#13)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#3)
in song##3##2##(2008-8#3)
in sonicated##2##2##(1994-5#1)(2008-10#1)
in sorghum##2##2##(2008-9#1)(2009-10#1)
in south##5##2##(1996-8#1)(2008-10#1)(2009-5#1)(2010-10#1)(2012-2#1)
in south-west##2##2##(2010-3#1)(2011-2#1)
in southeast##3##2##(1994-9#1)(2008-10#1)(2010-1#1)
in southeastern##3##2##(2008-10#2)(2011-2#1)
in southern Africa##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
in southern Arizona##2##3##(2008-10#1)(2009-8#1)
in southern Europe##2##3##(2011-2#2)
in southern Italy##2##3##(1997-5#1)(2008-7#1)
in southern New##2##3##(2008-10#2)
in southern Spain and##2##4##(2008-10#2)
in southern Spain##6##3##(2008-10#6)
in southern Taiwan##3##3##(2008-10#1)(2013-8#2)
in southern##37##2##(1991-6#2)(1994-9#1)(1997-5#1)(2008-10#18)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#3)
in southwest##5##2##(2008-10#4)(2008-8#1)
in southwestern##2##2##(2008-10#2)
in soy sauce##2##3##(2010-4#2)
in soy##3##2##(2010-1#1)(2010-4#2)
in soya##3##2##(1990-3#1)(2008-10#2)
in soybean##12##2##(2008-10#10)(2008-8#1)(2011-10#1)
in soybeans##3##2##(2008-10#3)
in space and time##3##4##(2008-8#1)(2008-9#1)(2013-8#1)
in space and##4##3##(2008-8#1)(2008-9#1)(2013-8#2)
in space##11##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)(2012-2#1)(2013-8#3)
in sparsely populated##2##3##(1991-1#1)(1994-8#1)
in spatial and temporal##2##4##(2008-2#1)(2012-2#1)
in spatial and##3##3##(1993-12#1)(2008-2#1)(2012-2#1)
in spatial##8##2##(1993-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
in spatially##7##2##(2007-11#1)(2008-10#2)(2008-8#3)(2009-8#1)
in special cases##2##3##(2008-10#1)(2012-2#1)
in special##10##2##(1996-3#1)(2008-10#3)(2008-12#1)(2009-6#1)(2009-8#2)(2012-2#1)(2013-8#1)
in specialized##8##2##(1994-11#1)(1995-11#2)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)
in specially designed##2##3##(2007-11#1)(2010-8#1)
in speciation analysis of##2##4##(2008-10#1)(2010-11#1)
in speciation##7##2##(2008-10#4)(2008-9#1)(2010-11#1)(2012-3#1)
in species from##2##3##(1995-2#1)(2008-10#1)
in species in which##2##4##(2008-8#1)(2013-1#1)
in species of##3##3##(2008-10#3)
in species richness is##2##4##(2008-8#2)
in species richness with productivity##2##5##(2008-9#2)
in species richness##13##3##(2008-8#10)(2008-9#3)
in species that exhibit##2##4##(2008-8#1)(2008-9#1)
in species that##4##3##(2008-8#2)(2008-9#1)(2010-8#1)
in species with##2##3##(2008-8#1)(2008-9#1)
in species##31##2##(1995-2#1)(2008-10#6)(2008-8#15)(2008-9#6)(2009-6#1)(2010-8#1)(2013-1#1)
in species'##4##2##(2008-8#2)(2008-9#2)
in specific clinical situations##2##4##(1997-4#1)(2008-8#1)
in specific clinical##3##3##(1997-4#1)(2008-8#1)(2010-4#1)
in specific regions of##2##4##(1996-12#1)(2008-6#1)
in specific regions##3##3##(1996-12#1)(2008-10#1)(2008-6#1)
in specific##35##2##(1991-11#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-8#2)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
in specificity##4##2##(1992-3#1)(2008-10#1)(2008-6#1)(2012-2#1)
in spectral##6##2##(2008-10#1)(2008-3#3)(2008-7#2)
in spectrophotometric and spectrofluorimetric##2##4##(2008-10#2)
in spectrophotometric##6##2##(2008-10#6)
in spectrophotometry##2##2##(2008-10#2)
in spectroscopy##2##2##(2008-10#2)
in speech##6##2##(1991-3#1)(2008-9#2)(2009-10#2)(2011-1#1)
in speed##3##2##(1994-8#1)(2008-10#1)(2009-12#1)
in spending##2##2##(1996-5#1)(1997-3#1)
in spent CAPD fluids##3##4##(2008-10#3)
in spent male##2##3##(2010-4#2)
in spent##7##2##(2008-10#5)(2010-4#2)
in sperm and##2##3##(1996-9#1)(2009-10#1)
in sperm cells##2##3##(1997-6#1)(2008-8#1)
in sperm##7##2##(1996-9#1)(1997-6#1)(2008-8#1)(2009-10#1)(2013-1#3)
in sperm-ZP interactions##2##3##(2013-1#2)
in spermatid##2##2##(2008-7#2)
in spermatogenesis##6##2##(2009-10#4)(2010-5#1)(2012-3#1)
in spermatogonia##3##2##(2008-9#1)(2010-5#1)(2012-2#1)
in spheroid culture##3##3##(2008-11#3)
in spheroid##4##2##(2008-11#4)
in spiked human serum##3##4##(2008-10#3)
in spiked human urine and##3##5##(2008-10#3)
in spiked human urine##4##4##(2008-10#4)
in spiked human##7##3##(2008-10#7)
in spiked natural water samples##2##5##(2008-10#2)
in spiked river and tap water##2##6##(2008-10#2)
in spiked river water##2##4##(2008-10#2)
in spiked river##4##3##(2008-10#4)
in spiked samples##3##3##(2008-10#3)
in spiked urine##2##3##(2008-10#2)
in spiked water and##2##4##(2008-10#2)
in spiked water samples##2##4##(2008-10#2)
in spiked water##4##3##(2008-10#4)
in spiked waters##2##3##(2008-10#2)
in spiked##42##2##(2008-10#42)
in spin##2##2##(1992-11#1)(2008-11#1)
in spinach and##2##3##(2008-10#2)
in spinach##7##2##(1994-11#1)(2008-10#5)(2012-2#1)
in spinal anesthesia##3##3##(2011-2#2)(2012-12#1)
in spinal cord##4##3##(1990-11#1)(1992-12#1)(1996-2#1)(2013-8#1)
in spinal ganglion neurons of##2##5##(2008-7#2)
in spinal ganglion neurons##3##4##(2008-7#3)
in spinal##16##2##(1990-11#1)(1992-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-12#2)(2008-7#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
in spinner##4##2##(2008-11#4)
in spite of a##2##4##(1990-5#1)(2008-10#1)
in spite of its##5##4##(1992-9#1)(1994-6#1)(1995-3#1)(2008-10#1)(2009-6#1)
in spite of many##2##4##(2008-10#1)(2008-8#1)
in spite of the fact that##3##6##(1991-2#1)(2008-10#1)(2008-11#1)
in spite of the##19##4##(1991-2#1)(1992-3#1)(1992-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
in spite of##50##3##(1990-11#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#3)(1994-6#1)(1995-3#2)(1996-2#1)(1996-3#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)
in spleen##4##2##(2007-8#1)(2008-10#1)(2008-8#1)(2009-9#1)
in splenic##4##2##(2008-10#3)(2012-2#1)
in spoken##2##2##(2008-11#1)(2009-10#1)
in spontaneous##4##2##(1990-11#1)(2008-12#1)(2009-6#1)(2009-8#1)
in spontaneously hypertensive##2##3##(1994-2#1)(2013-8#1)
in spontaneously##5##2##(1994-12#1)(1994-2#1)(1994-3#1)(1997-3#1)(2013-8#1)
in spore density##2##3##(2008-10#2)
in spore##6##2##(2008-10#4)(2008-8#1)(2011-2#1)
in sport##5##2##(2009-11#1)(2009-3#1)(2010-11#2)(2010-7#1)
in sports##2##2##(1996-6#1)(2012-2#1)
in spreading##2##2##(1991-5#1)(2008-10#1)
in spring and winter##2##4##(2008-10#1)(2008-12#1)
in spring and##6##3##(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)
in spring wheat than in winter wheat##2##7##(2008-10#2)
in spring##15##2##(2008-10#9)(2008-12#2)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#1)
in sputum##4##2##(1997-1#2)(2008-1#1)(2008-5#1)
in squamous cell##2##3##(2012-2#1)(2013-1#1)
in squash##2##2##(2008-10#2)
in sri lanka##2##3##(2009-10#2)
in stability##6##2##(1991-6#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-5#1)
in stabilizing the##2##3##(1993-8#1)(2013-8#1)
in stable##6##2##(1991-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)
in stably transfected##2##3##(1994-2#1)(2008-11#1)
in staffing##2##2##(1991-1#1)(1994-12#1)
in stage III##2##3##(1993-2#1)(2008-8#1)
in stage##9##2##(1990-2#1)(1993-1#2)(1993-2#1)(1997-7#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
in stages##5##2##(1990-2#1)(1990-8#2)(2008-10#1)(2013-1#1)
in staging##2##2##(1992-9#1)(2008-2#1)
in stainless steel##2##3##(2008-10#2)
in standard alloys and##2##4##(2008-10#2)
in standard alloys##5##3##(2008-10#5)
in standard and##4##3##(2008-10#2)(2008-11#2)
in standard mixtures##2##3##(2008-10#2)
in standard reference materials and##2##5##(2008-10#2)
in standard reference materials##4##4##(2008-10#4)
in standard solution##3##3##(2008-10#3)
in standard solutions##2##3##(2008-10#2)
in standard##32##2##(1993-6#1)(2008-10#23)(2008-11#3)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#1)
in standing##2##2##(2010-10#1)(2013-8#1)
in stands with##2##3##(2008-10#2)
in stands##3##2##(2008-10#3)
in starch##4##2##(1997-5#1)(2008-10#1)(2008-9#2)
in state##8##2##(1990-2#2)(1996-3#2)(1997-3#2)(2008-9#1)(2010-6#1)
in states##3##2##(1996-1#1)(1997-2#1)(2011-2#1)
in static and##2##3##(1992-3#1)(2010-7#1)
in static##5##2##(1992-3#1)(2008-11#2)(2010-7#1)(2013-1#1)
in stationary batch culture##3##4##(2008-11#3)
in stationary##4##2##(2008-11#3)(2012-3#1)
in statistical theory##2##3##(2008-10#2)
in steady state##2##3##(2008-10#1)(2011-2#1)
in steady##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
in steady-state##3##2##(2008-11#1)(2009-7#1)(2013-8#1)
in steel alloys##4##3##(2008-10#4)
in steel and##2##3##(2008-10#2)
in steel samples##2##3##(2008-10#2)
in steel##14##2##(2008-10#14)
in steels##5##2##(2008-10#5)
in steels)##2##2##(2008-10#2)
in stem and##2##3##(2008-10#1)(2011-3#1)
in stem cell biology##3##4##(2008-11#3)
in stem cell therapy##2##4##(2008-10#1)(2010-12#1)
in stem cell##7##3##(2008-10#2)(2008-11#3)(2010-11#1)(2010-12#1)
in stem##15##2##(2008-10#8)(2008-11#3)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)
in stems##6##2##(2008-10#4)(2008-11#1)(2011-10#1)
in sterile##2##2##(2008-10#1)(2008-8#1)
in steroidogenic tissues##2##3##(1995-2#1)(2012-2#1)
in stimulated##2##2##(2007-12#1)(2008-9#1)
in stimulating the oxidative burst##2##5##(2008-10#2)
in stimulating the##3##3##(1997-1#1)(2008-10#2)
in stimulating##10##2##(1990-8#1)(1994-5#1)(1994-8#1)(1997-1#1)(2008-10#5)(2008-8#1)
in stimulation##2##2##(1995-8#1)(2013-1#1)
in stimulatory##2##2##(2008-11#2)
in stirred tank##2##3##(2008-11#2)
in stirred##6##2##(2008-10#1)(2008-11#3)(2008-7#2)
in stochastic environments##3##3##(2008-8#3)
in stomach cancer cells##2##4##(2009-9#2)
in stomach##3##2##(2009-9#2)(2011-2#1)
in stone formers##4##3##(1991-12#4)
in stone fruit##2##3##(2008-10#2)
in stone##6##2##(1991-12#4)(2008-10#2)
in stool specimens##4##3##(2012-2#3)(2013-8#1)
in stool##6##2##(1993-3#1)(2012-2#4)(2013-8#1)
in storage##4##2##(2008-10#3)(2010-4#1)
in strain##4##2##(2008-10#4)
in strains##6##2##(1992-10#1)(1993-9#2)(2008-10#2)(2008-2#1)
in strategic##2##2##(1995-12#1)(2008-11#1)
in stratified##2##2##(1995-9#1)(2010-3#1)
in stratifying the##2##3##(2011-2#2)
in stratifying##3##2##(2011-2#3)
in stratum corneum##4##3##(2008-5#4)
in stratum##5##2##(2008-5#5)
in strawberry##4##2##(2008-10#4)
in strength and##2##3##(2008-3#1)(2013-1#1)
in strength##3##2##(2008-3#1)(2009-11#1)(2013-1#1)
in strengthening##2##2##(2008-10#2)
in streptozotocin##2##2##(2008-12#1)(2010-2#1)
in stress and##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
in stress##10##2##(2008-10#1)(2008-11#1)(2008-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2013-1#2)
in striatal synaptosomes##2##3##(1995-11#2)
in striatal##4##2##(1990-7#1)(1995-11#2)(1996-12#1)
in striatum##5##2##(1990-9#1)(1996-2#2)(1997-2#2)
in strip-tilled than conventionally tilled##2##5##(2008-10#2)
in strip-tilled##3##2##(2008-10#3)
in stripping##2##2##(2008-10#2)
in stroke patients##4##3##(2008-8#2)(2010-3#1)(2011-2#1)
in stroke prevention##3##3##(1994-9#1)(2011-2#1)(2012-2#1)
in stroke##9##2##(1994-9#1)(2008-8#4)(2010-3#1)(2011-2#2)(2012-2#1)
in stromal##4##2##(1993-11#1)(2008-11#1)(2013-1#2)
in strong acidic##3##3##(2008-10#2)(2008-11#1)
in strong##8##2##(1995-3#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)
in stronger##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
in strongly acidic solution##2##4##(2008-10#2)
in strongly acidic##4##3##(2008-10#4)
in strongly dispersion-managed optical##2##4##(2007-11#2)
in strongly##11##2##(1992-8#1)(1997-2#1)(2007-11#2)(2008-10#5)(2008-3#2)
in structural##4##2##(1997-8#1)(2008-10#1)(2009-11#1)(2013-8#1)
in structure and##5##3##(1995-11#1)(1997-7#1)(2008-6#1)(2009-7#1)(2011-3#1)
in structure##11##2##(1991-2#1)(1995-11#1)(1997-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
in structured##2##2##(2008-8#2)
in structures with##2##3##(2008-2#1)(2008-7#1)
in structuring##6##2##(1991-1#1)(1993-12#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
in student##2##2##(2008-12#1)(2008-8#1)
in students##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
in students'##2##2##(1996-1#1)(2012-2#1)
in studies aimed at##2##4##(1991-5#1)(2008-7#1)
in studies conducted using spring wheat cultivars##2##7##(2008-10#2)
in studies conducted using##3##4##(2008-10#3)
in studies conducted##4##3##(2008-10#4)
in studies of the##3##4##(2008-4#1)(2008-8#1)(2009-8#1)
in studies of##18##3##(1992-6#1)(1993-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#2)(2010-9#1)(2012-2#1)(2013-8#1)
in studies with mean DON##2##5##(2008-10#2)
in studies with mean IND##2##5##(2008-10#2)
in studies with mean##4##4##(2008-10#4)
in studies with##5##3##(2008-10#5)
in studies##33##2##(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-8#2)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
in study design##2##3##(2012-2#2)
in study##6##2##(1991-1#1)(1996-3#1)(2011-2#1)(2012-2#3)
in studying the##4##3##(1993-6#1)(1995-11#1)(2008-10#1)(2008-4#1)
in studying##10##2##(1993-6#1)(1995-11#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#2)(2010-8#1)
in sub-Saharan Africa##4##3##(1996-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
in sub-Saharan##5##2##(1996-8#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
in subgroups##2##2##(2008-10#1)(2008-7#1)
in subjective##3##2##(2008-11#1)(2008-9#2)
in subjects immunized with##2##4##(1995-5#2)
in subjects of##2##3##(1991-11#1)(2008-11#1)
in subjects who were##2##4##(1994-3#1)(2008-3#1)
in subjects who##3##3##(1994-3#1)(2008-10#1)(2008-3#1)
in subjects with##13##3##(1991-7#1)(1992-11#1)(1994-12#1)(1995-8#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
in subjects##28##2##(1991-1#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
in submerged##2##2##(2008-10#1)(2008-5#1)
in subsequent##10##2##(1990-6#2)(1991-12#1)(1993-11#1)(1993-6#1)(2008-10#4)(2010-4#1)
in substance abuse##3##3##(1991-1#1)(2009-9#1)(2010-11#1)
in substance##7##2##(1991-1#2)(2008-12#1)(2008-6#2)(2009-9#1)(2010-11#1)
in substantia nigra##2##3##(1994-2#1)(1996-12#1)
in substitope algorithms##2##3##(2008-6#2)
in substrate binding##2##3##(1993-8#1)(1994-5#1)
in substrate##6##2##(1993-8#1)(1994-5#2)(2008-10#1)(2008-7#1)(2011-1#1)
in subsurface##2##2##(2008-10#2)
in subterranean##2##2##(2008-10#1)(2012-3#1)
in subtle##2##2##(2008-10#1)(2009-8#1)
in subunit I of cytochrome c oxidase from Saccharomyces cerevisiae##2##10##(1997-7#2)
in successive##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
in such a manner##2##4##(2008-10#1)(2008-9#1)
in such a setting##2##4##(1993-1#1)(2009-6#1)
in such a way as to##2##6##(2008-10#1)(2008-4#1)
in such a way that it##2##6##(2008-3#1)(2011-2#1)
in such a way that the##4##6##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
in such a way that they can##2##7##(1997-5#1)(2013-8#1)
in such a way that they##3##6##(1997-5#2)(2013-8#1)
in such a way that##14##5##(1990-12#1)(1997-5#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
in such a way##17##4##(1990-12#1)(1997-5#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
in such a##31##3##(1990-12#1)(1992-2#1)(1993-1#1)(1995-11#1)(1995-5#1)(1997-5#2)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
in such cases##5##3##(2008-12#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
in such environments##2##3##(2008-8#1)(2012-5#1)
in such patients##6##3##(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
in such samples##3##3##(2008-10#2)(2008-12#1)
in such settings##2##3##(2008-1#1)(2010-7#1)
in such##89##2##(1990-12#1)(1992-2#1)(1993-1#1)(1994-1#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-3#1)(1997-5#2)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#6)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
in sucrose##2##2##(1997-3#1)(2008-12#1)
in sudden##2##2##(1991-9#1)(2011-2#1)
in sufficient##4##2##(1995-6#1)(2008-11#2)(2008-3#1)
in sufficiently##2##2##(2008-10#1)(2008-5#1)
in sugar and##3##3##(2008-10#2)(2010-6#1)
in sugar beet and wheat##2##5##(2008-10#2)
in sugar beet and##3##4##(2008-10#3)
in sugar beet##8##3##(2008-10#5)(2008-12#2)(2012-3#1)
in sugar beets##2##3##(2008-10#2)
in sugar pine (P##2##4##(2008-10#2)
in sugar pine##4##3##(2008-10#4)
in sugar##18##2##(2008-10#14)(2008-12#2)(2010-6#1)(2012-3#1)
in sugarcane##4##2##(2008-10#2)(2011-2#2)
in suitable##3##2##(1990-12#1)(2007-11#1)(2008-11#1)
in sulfur##2##2##(2008-10#1)(2010-4#1)
in sulfuric acid media##3##4##(2008-10#3)
in sulfuric acid medium##6##4##(2008-10#6)
in sulfuric acid solution##2##4##(2008-10#2)
in sulfuric acid##13##3##(2008-10#13)
in sulphuric acid##5##3##(2008-10#5)
in summer and##2##3##(2008-10#1)(2008-11#1)
in summer##12##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#2)(2012-2#1)
in sunflower plants##2##3##(2008-10#2)
in sunflower##3##2##(1991-5#1)(2008-10#2)
in sunlight##2##2##(2008-10#1)(2008-5#1)
in sunny##2##2##(2008-11#1)(2012-3#1)
in sunscreen##4##2##(2008-10#1)(2008-5#3)
in supercritical CO(2)##3##3##(2008-10#3)
in supercritical carbon dioxide##4##4##(2008-10#4)
in supercritical##7##2##(2008-10#7)
in superficial##6##2##(1991-3#1)(2008-5#2)(2009-8#1)(2011-2#2)
in supernatant##5##2##(2008-11#2)(2008-8#2)(2008-9#1)
in superoxide##3##2##(1993-6#1)(1994-11#1)(2012-2#1)
in supine position##3##3##(2012-3#3)
in supine posture##2##3##(2012-3#2)
in supine##5##2##(2012-3#5)
in supply##2##2##(2011-2#2)
in support of the quality##2##5##(2008-10#2)
in support of the##8##4##(1994-12#1)(1996-11#1)(2008-10#3)(2011-1#2)(2011-2#1)
in support of##13##3##(1994-12#1)(1996-11#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#1)
in support##15##2##(1994-12#1)(1996-11#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)
in supporting electrolyte##3##3##(2008-10#3)
in supporting the student##2##4##(2008-11#2)
in supporting the##3##3##(2008-11#2)(2008-9#1)
in supporting##14##2##(1997-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#1)(2008-9#1)(2009-10#1)(2013-8#1)
in suppressing the##2##3##(1994-2#1)(2008-10#1)
in suppressing##11##2##(1994-11#1)(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2011-3#1)(2012-12#1)
in suppression of##5##3##(2008-10#4)(2008-11#1)
in suppressive##2##2##(2008-10#2)
in surface Brillouin light scattering##2##5##(2008-2#2)
in surface area##3##3##(2008-10#2)(2013-1#1)
in surface roughness##2##3##(2008-10#1)(2008-3#1)
in surface water samples##3##4##(2008-10#3)
in surface water##9##3##(2008-10#9)
in surface waters##2##3##(2008-10#2)
in surface##29##2##(1991-3#1)(1992-2#1)(1992-3#1)(1994-5#1)(2008-10#20)(2008-2#2)(2008-3#1)(2009-8#1)(2013-1#1)
in surfactant micelles##2##3##(2008-10#2)
in surfactant##3##2##(2008-10#2)(2008-5#1)
in surgery##5##2##(1992-11#1)(1992-5#1)(1994-8#1)(2012-12#1)(2013-8#1)
in surgery]##4##2##(1992-3#1)(1992-9#2)(1996-3#1)
in surgical procedures##2##3##(1996-9#1)(2013-1#1)
in surgical prophylaxis in childhood##2##5##(1990-5#1)(1991-3#1)
in surgical##13##2##(1990-5#1)(1991-3#2)(1996-9#1)(1997-7#1)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
in surimi##2##2##(2011-2#2)
in surveillance##2##2##(1997-3#1)(2011-2#1)
in survey##2##2##(2008-10#1)(2010-1#1)
in survival of##2##3##(2008-10#1)(2008-12#1)
in survival rate##3##3##(1990-8#2)(2008-10#1)
in survival##16##2##(1990-6#1)(1990-8#3)(1991-8#1)(1992-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
in susceptibility and##2##3##(2008-10#2)
in susceptibility to##7##3##(2008-10#6)(2008-7#1)
in susceptibility##11##2##(2008-10#9)(2008-7#1)(2011-3#1)
in susceptible and##2##3##(2008-10#2)
in susceptible cultivars and##2##4##(2008-10#2)
in susceptible cultivars##5##3##(2008-10#5)
in susceptible or##2##3##(2008-10#2)
in susceptible plants##4##3##(2008-10#2)(2009-8#2)
in susceptible##32##2##(1995-5#1)(2008-10#29)(2009-8#2)
in suspected##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
in suspending##2##2##(1993-3#1)(2008-8#1)
in suspension and##3##3##(2008-11#3)
in suspension culture and##2##4##(1997-1#1)(2008-11#1)
in suspension culture##10##3##(1997-1#1)(2008-11#9)
in suspension cultures in##2##4##(2008-11#1)(2008-7#1)
in suspension cultures##5##3##(2008-11#2)(2008-7#3)
in suspension in a##2##4##(2008-11#2)
in suspension in##5##3##(2008-11#5)
in suspension or##2##3##(2008-11#1)(2008-9#1)
in suspension##45##2##(1997-1#1)(2008-10#2)(2008-11#34)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)
in sweet##3##2##(2008-10#3)
in swimming pool water##3##4##(2008-10#3)
in swimming##5##2##(2008-10#3)(2009-1#2)
in swine populations##2##3##(2011-2#1)(2013-8#1)
in swine##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
in swiss##2##2##(2008-10#1)(2008-12#1)
in sympathetic##2##2##(2008-7#1)(2010-5#1)
in sympatry##8##2##(2008-10#3)(2008-8#5)
in symptom development and##2##4##(2008-10#2)
in symptom development##4##3##(2008-10#4)
in symptom##7##2##(2008-10#4)(2008-7#1)(2009-11#1)(2011-2#1)
in symptomatic beets##4##3##(2008-10#4)
in symptomatic##9##2##(1993-1#1)(2008-10#6)(2009-4#1)(2010-7#1)
in symptomatology##2##2##(2008-10#2)
in symptomless pine shoots##2##4##(2008-10#2)
in symptomless##3##2##(2008-10#3)
in synaptic plasma membranes##5##4##(1995-6#2)(1997-1#3)
in synaptic plasticity and##2##4##(2008-11#1)(2008-7#1)
in synaptic plasticity##4##3##(1993-12#1)(1997-7#1)(2008-11#1)(2008-7#1)
in synaptic##20##2##(1993-12#2)(1995-6#2)(1996-12#1)(1997-1#3)(1997-3#2)(1997-7#1)(2008-1#1)(2008-11#2)(2008-7#4)(2009-8#1)(2009-9#1)
in sync##2##2##(1994-1#1)(1994-3#1)
in synchronized##2##2##(2008-11#1)(2013-8#1)
in synergism with##2##3##(1990-2#1)(2008-4#1)
in synovial##2##2##(1996-9#1)(2013-1#1)
in synthesizing##2##2##(1996-12#1)(2013-8#1)
in synthetic and real##2##4##(2008-10#2)
in synthetic gene##2##3##(2008-11#2)
in synthetic mixture and##2##4##(2008-10#2)
in synthetic mixtures and##4##4##(2008-10#4)
in synthetic mixtures##9##3##(2008-10#9)
in synthetic samples and practical samples##2##6##(2008-10#2)
in synthetic samples and##5##4##(2008-10#5)
in synthetic samples with satisfactory results##2##6##(2008-10#2)
in synthetic samples##18##3##(2008-10#18)
in synthetic wine##2##3##(2008-10#2)
in synthetic##47##2##(2008-10#40)(2008-11#2)(2008-4#1)(2008-5#1)(2011-3#1)(2012-2#1)(2013-1#1)
in syrups##2##2##(2008-10#2)
in systemic infection of##2##4##(2008-10#2)
in systemic lupus erythematosus##2##4##(2011-2#1)(2013-1#1)
in systemic sclerosis##2##3##(1992-8#1)(2010-10#1)
in systemic##16##2##(1991-11#1)(1991-4#1)(1992-8#1)(1996-12#2)(1997-1#1)(2008-10#4)(2008-12#3)(2010-10#1)(2011-2#1)(2013-1#1)
in systemically infected##2##3##(2008-10#2)
in systemically##3##2##(2008-10#3)
in systems of##2##3##(2008-10#1)(2013-8#1)
in systems that are##2##4##(2013-8#2)
in systems that##4##3##(2008-11#2)(2013-8#2)
in systems with##2##3##(2008-10#1)(2008-5#1)
in systems##13##2##(2008-10#3)(2008-11#3)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#4)
in systolic##3##2##(1990-9#1)(1992-12#1)(2008-11#1)
in table salt samples##4##4##(2008-10#4)
in table salt##9##3##(2008-10#9)
in table##11##2##(2008-10#11)
in tables##2##2##(1995-1#1)(2008-10#1)
in tablet dosage form##2##4##(2008-10#2)
in tablet##5##2##(2008-10#5)
in tablets and biological fluids##3##5##(2008-10#3)
in tablets and##8##3##(2008-10#8)
in tablets with##3##3##(2008-10#3)
in tablets##21##2##(2008-10#21)
in tail length##2##3##(2008-8#2)
in take-all suppression##2##3##(2008-10#2)
in take-all##3##2##(2008-10#3)
in taking##4##2##(1991-6#1)(1993-3#1)(2008-11#1)(2008-3#1)
in tall fescue##2##3##(2008-10#2)
in tandem with the##2##4##(1995-2#1)(2010-7#1)
in tandem##12##2##(1993-12#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-1#1)(2010-7#1)(2010-8#1)
in tannery wastewaters##2##3##(2008-10#2)
in tannery##5##2##(2008-10#5)
in tap and##4##3##(2008-10#4)
in tap water and total arsenic in biological samples##2##9##(2008-10#2)
in tap water and##6##4##(2008-10#6)
in tap water was##2##4##(2008-10#2)
in tap water##16##3##(2008-10#15)(2011-2#1)
in tap##27##2##(2008-10#26)(2011-2#1)
in tapwater and##3##3##(2008-10#3)
in tapwater##4##2##(2008-10#4)
in target##5##2##(1997-8#3)(2008-3#1)(2009-11#1)
in targeted##2##2##(2010-3#1)(2013-1#1)
in targeting##3##2##(1992-12#1)(1997-2#1)(2009-12#1)
in task##2##2##(2008-11#1)(2009-10#1)
in tasks##2##2##(2008-11#1)(2009-10#1)
in taxa##2##2##(2008-8#1)(2010-3#1)
in tea and##3##3##(2008-10#3)
in tea samples##2##3##(2008-10#2)
in tea##9##2##(2008-10#9)
in teaching and##4##3##(1990-12#1)(2008-11#2)(2008-12#1)
in teaching situation and##2##4##(1990-12#2)
in teaching situation##4##3##(1990-12#4)
in teaching##20##2##(1990-12#5)(1995-12#1)(1996-2#2)(2008-10#1)(2008-11#7)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
in teams##2##2##(1993-12#1)(2013-8#1)
in technical formulations##3##3##(2008-10#3)
in technical##7##2##(1996-2#1)(2008-10#4)(2008-11#1)(2010-8#1)
in techniques##3##2##(1995-1#1)(2008-9#1)(2009-12#1)
in technology##5##2##(1992-1#1)(1994-1#1)(2008-11#1)(2010-6#1)(2013-1#1)
in telemedicine##2##2##(1996-2#2)
in telephone##2##2##(2008-10#1)(2008-11#1)
in telotrophic ovaries##2##3##(2008-12#2)
in temperate and##2##3##(2008-10#1)(2008-12#1)
in temperate cereals##2##3##(2009-8#1)(2012-3#1)
in temperate regions##2##3##(2008-10#2)
in temperate##9##2##(2008-10#6)(2008-12#1)(2009-8#1)(2012-3#1)
in temperature##15##2##(1996-2#2)(1997-2#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-7#1)(2010-8#1)(2012-6#2)
in temporal lobectomy##2##3##(1992-12#2)
in temporal##9##2##(1992-12#2)(1994-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
in temporary##2##2##(1993-9#1)(1997-3#1)
in ten municipalities of##2##4##(2012-12#2)
in ten years##2##3##(1995-6#1)(2008-3#1)
in ten##9##2##(1995-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
in tension##2##2##(2008-10#1)(2009-7#1)
in terahertz imaging and spectroscopy##2##5##(2012-12#2)
in term of##4##3##(2008-10#3)(2008-11#1)
in term##7##2##(2008-10#4)(2008-11#3)
in terminal##4##2##(1990-3#1)(1993-2#1)(2008-10#1)(2008-11#1)
in terms of a##10##4##(1993-8#2)(1994-5#1)(1995-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-8#1)(2013-8#1)
in terms of accuracy##2##4##(2008-10#2)
in terms of an##2##4##(2008-3#1)(2008-9#1)
in terms of association##2##4##(2008-10#1)(2009-8#1)
in terms of both##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
in terms of cell##4##4##(2008-10#1)(2008-11#2)(2008-7#1)
in terms of changes in##2##5##(2008-10#1)(2008-2#1)
in terms of detection##3##4##(2008-10#2)(2010-12#1)
in terms of high##2##4##(1994-5#1)(2008-12#1)
in terms of host##2##4##(2008-10#2)
in terms of information##3##4##(1990-8#1)(2008-10#1)(2010-5#1)
in terms of its##10##4##(1990-11#1)(2008-10#5)(2008-5#2)(2009-7#1)(2011-2#1)
in terms of linear##2##4##(2008-10#2)
in terms of linearity##2##4##(2008-10#1)(2012-2#1)
in terms of mean##2##4##(2008-10#1)(2009-2#1)
in terms of membrane##2##4##(2008-10#2)
in terms of mortality##2##4##(1995-3#1)(1996-12#1)
in terms of optical##2##4##(2008-2#1)(2008-9#1)
in terms of pain##2##4##(2010-10#1)(2011-2#1)
in terms of patient##2##4##(2008-8#1)(2011-2#1)
in terms of plant##2##4##(2008-10#2)
in terms of probability##2##4##(2008-10#2)
in terms of pyrolysis and atomization temperatures##2##7##(2008-10#2)
in terms of relative standard deviation##2##6##(2008-10#2)
in terms of relative##3##4##(2008-10#3)
in terms of repeatability##2##4##(2008-10#2)
in terms of resolution##2##4##(1991-7#1)(2008-9#1)
in terms of sample##3##4##(2008-10#2)(2008-4#1)
in terms of sensitivity and##2##5##(2008-10#2)
in terms of sensitivity##8##4##(2008-10#7)(2012-2#1)
in terms of speed##2##4##(2008-10#1)(2008-4#1)
in terms of surface##2##4##(1997-2#1)(2008-10#1)
in terms of the amount of##2##6##(2008-11#2)
in terms of the distribution of##2##6##(2008-8#1)(2008-9#1)
in terms of the effects of##2##6##(2008-10#1)(2008-6#1)
in terms of the mass##2##5##(2008-10#1)(2010-7#1)
in terms of the molecular##2##5##(1997-2#1)(2008-10#1)
in terms of the rate##2##5##(1990-8#1)(1992-3#1)
in terms of the relative##3##5##(1992-2#1)(2008-10#1)(2008-11#1)
in terms of the##74##4##(1990-7#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(2008-10#26)(2008-11#7)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
in terms of their##22##4##(1990-7#1)(1991-2#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-4#1)(2013-1#1)
in terms of time##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
in terms of##393##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-2#3)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#3)(1992-3#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-2#2)(1994-5#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-8#2)(2007-12#3)(2008-1#2)(2008-10#134)(2008-11#27)(2008-12#10)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#11)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#3)(2012-2#10)(2012-3#3)(2012-4#2)(2013-1#13)(2013-8#7)
in terms##396##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-2#3)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#3)(1992-3#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-8#2)(2007-12#3)(2008-1#2)(2008-10#136)(2008-11#27)(2008-12#10)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#11)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#3)(2012-2#10)(2012-3#3)(2012-4#2)(2013-1#13)(2013-8#7)
in terpene emission rates##2##4##(2011-10#2)
in terrestrial##6##2##(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)
in territorial##3##2##(2008-8#2)(2008-9#1)
in test##7##2##(1991-1#1)(2008-10#6)
in testes##3##2##(1993-12#1)(2008-8#1)(2013-7#1)
in testicular##4##2##(2008-10#2)(2009-10#1)(2011-2#1)
in testing##2##2##(2009-5#1)(2013-8#1)
in testis##4##2##(1995-6#1)(1995-8#2)(2008-8#1)
in tests of##3##3##(1992-5#1)(2010-10#1)(2012-2#1)
in tests##9##2##(1992-5#1)(1993-3#1)(2008-10#4)(2008-9#1)(2010-10#1)(2012-2#1)
in tetrahydrofuran##5##2##(1996-5#2)(2008-10#1)(2008-5#1)(2009-5#1)
in tetramethylammonium chloride##2##3##(2008-10#2)
in tetraploid##3##2##(2008-10#2)(2012-3#1)
in text##5##2##(1995-1#1)(2010-7#2)(2012-2#1)(2012-3#1)
in textbooks##2##2##(2008-9#1)(2009-6#1)
in texture##2##2##(2008-10#2)
in that a##2##3##(2008-10#2)
in that case##2##3##(2008-10#1)(2010-7#1)
in that it is##5##4##(1990-11#1)(1992-3#1)(1993-2#1)(2008-10#1)(2009-10#1)
in that it##15##3##(1990-11#1)(1992-10#1)(1992-3#1)(1993-2#1)(1993-6#2)(1995-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
in that of the##2##4##(1990-11#1)(2010-1#1)
in that region##2##3##(1990-5#1)(2008-5#1)
in that sample##2##3##(2008-10#2)
in that state##2##3##(1992-2#1)(1995-3#1)
in that the##12##3##(1992-2#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2010-1#1)(2010-10#1)(2012-2#1)
in that they were##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)
in that they##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-10#1)(2011-2#1)
in that this##2##3##(1994-5#1)(2013-1#1)
in that way##2##3##(2008-10#1)(2008-11#1)
in that year##2##3##(1991-1#1)(1993-12#1)
in that##94##2##(1990-11#2)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-10#1)(1992-2#4)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-9#1)(1996-12#2)(1997-3#1)(2008-10#24)(2008-11#12)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
in the &lt##2##3##(1994-12#1)(2008-10#1)
in the &quot##4##3##(1990-6#1)(2008-10#1)(2008-11#2)
in the 0##13##3##(1991-3#1)(1994-11#1)(1994-5#2)(2008-10#5)(2008-11#1)(2008-3#2)(2012-2#1)
in the 1 x##2##4##(2008-8#2)
in the 1##16##3##(1993-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#3)
in the 10##5##3##(1995-1#1)(2008-10#2)(2008-12#2)
in the 12th##2##3##(1992-8#2)
in the 133##2##3##(2008-1#1)(2008-10#1)
in the 16##2##3##(1994-3#1)(2008-11#1)
in the 16S rRNA gene##2##5##(2008-10#1)(2013-8#1)
in the 18th century##2##4##(1993-11#1)(2010-1#1)
in the 19##3##3##(1991-1#2)(2008-12#1)
in the 1930s##2##3##(2008-8#1)(2013-8#1)
in the 1960s and##2##4##(2008-10#1)(2013-1#1)
in the 1960s##5##3##(1996-3#1)(2008-10#3)(2013-1#1)
in the 1970s and 1980s##2##5##(1996-9#1)(2008-10#1)
in the 1970s##8##3##(1991-3#2)(1993-2#1)(1995-2#1)(1996-9#1)(2007-11#1)(2008-10#2)
in the 1980s by##2##4##(2008-4#1)(2008-7#1)
in the 1980s##8##3##(1991-11#1)(1991-3#1)(1993-3#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)
in the 1990's]##2##3##(1990-6#1)(1995-2#1)
in the 1990s##12##3##(1990-11#1)(1991-1#2)(1991-11#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-9#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)
in the 1996##2##3##(2008-10#2)
in the 1999-2000##3##3##(2008-10#2)(2011-3#1)
in the 19th##2##3##(1993-11#1)(2012-2#1)
in the 1st##2##3##(1993-11#1)(2010-12#1)
in the 2 groups##3##4##(1991-11#2)(1997-3#1)
in the 2##6##3##(1991-11#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
in the 2+##2##3##(1993-8#2)
in the 2-position##2##3##(1994-5#1)(1997-1#1)
in the 20##2##3##(1997-5#1)(2008-12#1)
in the 21st century##9##4##(1990-12#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)
in the 24 h##3##4##(1996-12#1)(1996-2#1)(2008-10#1)
in the 24##4##3##(1996-12#1)(1996-2#1)(2008-10#1)(2012-12#1)
in the 26-week study##2##4##(2008-9#2)
in the 26-week##3##3##(2008-9#3)
in the 2nd and 3rd trimesters##2##6##(2010-12#2)
in the 3' end##2##4##(1990-2#1)(1997-7#1)
in the 3' expression##2##4##(2012-3#2)
in the 3'##8##3##(1990-2#1)(1993-12#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2012-3#2)
in the 3-D model##2##4##(2008-3#1)(2008-8#1)
in the 3-D##4##3##(2008-11#2)(2008-3#1)(2008-8#1)
in the 30##2##3##(2008-10#1)(2012-2#1)
in the 39-week study##2##4##(2008-9#2)
in the 3rd##3##3##(1991-8#1)(1992-9#1)(1996-11#1)
in the 4th##2##3##(1992-9#1)(2009-8#1)
in the 5##6##3##(1997-8#1)(2008-10#2)(2008-5#2)(2010-10#1)
in the 5' exonuclease##2##4##(1997-8#2)
in the 5' flanking region##2##5##(1992-3#1)(1993-12#1)
in the 5' flanking##4##4##(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#1)
in the 5' proximal##2##4##(1994-11#1)(2008-10#1)
in the 5'##15##3##(1991-6#3)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-6#1)(1997-8#4)(2008-10#2)
in the 5'-flanking region##3##4##(1991-6#1)(1991-7#1)(2010-5#1)
in the 5'-flanking##4##3##(1991-6#1)(1991-7#1)(1995-6#1)(2010-5#1)
in the 6 months##2##4##(2008-1#1)(2013-1#1)
in the 6##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
in the 65##2##3##(2008-12#1)(2008-7#1)
in the 7##2##3##(2007-8#1)(2008-10#1)
in the 900-1100-nm range##2##4##(2008-3#2)
in the A##4##3##(1997-8#1)(2008-11#1)(2008-3#1)(2008-6#1)
in the AD cases##2##4##(1991-1#2)
in the AD##4##3##(1991-1#2)(2008-7#1)(2011-2#1)
in the AFLP##2##3##(2008-10#2)
in the AIDS-associated##2##3##(2009-8#2)
in the ATP##2##3##(1994-11#1)(2008-11#1)
in the Americas##2##3##(1994-9#1)(2008-10#1)
in the Andean##2##3##(2008-10#1)(2008-11#1)
in the Asia-Pacific##4##3##(2008-10#4)
in the Atp7a gene##3##4##(2008-12#3)
in the Authie##2##3##(2008-10#2)
in the B##8##3##(1994-1#1)(2008-10#6)(2008-11#1)
in the B73 genome##2##4##(2012-3#2)
in the B73##3##3##(2008-10#1)(2012-3#2)
in the BM25 group##2##4##(2011-2#2)
in the BTH-treated##2##3##(2008-10#2)
in the Baltic##2##3##(2008-10#1)(2010-8#1)
in the Barley##2##3##(2008-10#2)
in the Belgian##2##3##(2008-10#2)
in the Belousov-Zhabotinskii##2##3##(2008-10#2)
in the Biceps femoris##2##4##(2010-4#2)
in the Biocontrol##2##3##(2008-10#2)
in the British##3##3##(1991-1#1)(2008-10#1)(2010-2#1)
in the Brown Norway rat##2##5##(2008-10#2)
in the C##5##3##(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
in the C-ADR group##3##4##(2012-12#3)
in the C-terminal domains##2##4##(2008-10#2)
in the C-terminal region##2##4##(1995-2#1)(2008-10#1)
in the C-terminal##6##3##(1994-5#1)(1995-2#1)(2008-10#4)
in the CA1 subfield##2##4##(1990-5#2)
in the CA1##4##3##(1990-5#2)(1996-12#2)
in the CAF+FT group##2##4##(1997-7#2)
in the CAF+FT##3##3##(1997-7#3)
in the CAF+FT+TAM group##2##4##(1997-7#2)
in the CCA group##2##4##(2011-2#2)
in the CEF and##2##4##(2008-10#2)
in the CER3 acyl chains##2##5##(2008-10#2)
in the CH region##2##4##(2008-10#2)
in the CHO##3##3##(1993-8#1)(2008-11#2)
in the CL##5##3##(2008-10#2)(2008-9#3)
in the CNC##4##3##(2013-8#4)
in the CNS and##3##4##(1996-12#1)(2008-7#2)
in the CNS of##2##4##(1994-2#1)(2008-7#1)
in the CNS##18##3##(1991-12#2)(1992-10#3)(1994-2#1)(1995-12#1)(1996-12#4)(2008-11#1)(2008-5#1)(2008-7#4)(2013-1#1)
in the CP##4##3##(2008-10#3)(2008-9#1)
in the CP/PPn##2##3##(1995-12#2)
in the CS group##2##4##(2008-10#1)(2012-3#1)
in the CSF##2##3##(1996-12#1)(2011-2#1)
in the Caenorhabditis elegans RNA##2##5##(2012-3#2)
in the California##2##3##(1995-8#1)(2008-10#1)
in the Canadian##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
in the Canton of Zurich##3##5##(1996-11#3)
in the Caribbean##6##3##(2008-10#5)(2011-2#1)
in the Center and##2##4##(1992-2#2)
in the Center##3##3##(1992-2#3)
in the Central Ciscaucasia##2##4##(2011-2#2)
in the Central##5##3##(1996-5#1)(2008-10#1)(2011-2#3)
in the Chinese##2##3##(2008-10#1)(2008-12#1)
in the Cincinnati##2##3##(1994-12#1)(2008-5#1)
in the Clinic of##2##4##(1996-11#1)(2012-3#1)
in the Columbia Basin of Washington##2##6##(2008-10#2)
in the Columbia Basin##5##4##(2008-10#5)
in the Control##4##3##(2008-4#2)(2011-2#2)
in the Cricket##2##3##(2008-5#1)(2008-6#1)
in the Cu##2##3##(1997-8#1)(2008-12#1)
in the DDR##2##3##(2011-2#1)(2013-1#1)
in the DDR2 kinase gene##2##5##(2012-2#2)
in the DG##2##3##(1996-12#2)
in the DNA##6##3##(1993-8#2)(1995-8#1)(1996-2#1)(2008-10#1)(2011-2#1)
in the DRG and##3##4##(1997-2#1)(2008-9#2)
in the DRG##4##3##(1997-2#2)(2008-9#2)
in the DSM##2##3##(1996-9#1)(2009-10#1)
in the Del Fuerte Valley##6##5##(2008-10#6)
in the Department of Obstetrics and##2##6##(1996-1#1)(1996-9#1)
in the Department of##7##4##(1995-11#1)(1996-1#1)(1996-9#1)(2008-5#1)(2011-2#2)(2013-1#1)
in the Diels-Alder reaction of##2##5##(1996-5#2)
in the Diels-Alder##3##3##(1996-5#3)
in the Differential##2##3##(2008-10#2)
in the Dominican Republic##5##4##(2008-10#5)
in the Drosophila##2##3##(2008-9#2)
in the Dutch##2##3##(2008-10#2)
in the E##2##3##(2010-5#1)(2011-2#1)
in the EBL##2##3##(2008-11#1)(2008-12#1)
in the ED##14##3##(1997-2#2)(2008-11#5)(2009-6#2)(2010-8#1)(2012-2#2)(2013-1#2)
in the EMBL database##2##4##(1991-9#1)(1996-8#1)
in the ER##2##3##(1993-2#1)(1995-2#1)
in the ERP##2##3##(2013-8#2)
in the EU##2##3##(2008-10#1)(2013-8#1)
in the Earth's atmosphere##2##4##(2008-11#1)(2008-3#1)
in the Earth's##3##3##(2008-11#1)(2008-3#2)
in the East##3##3##(2008-10#2)(2011-2#1)
in the Elderly##3##3##(2008-7#1)(2012-3#2)
in the Emergency Department (ED)##2##5##(2008-11#1)(2008-3#1)
in the Emergency Department##3##4##(1991-12#1)(2008-11#1)(2008-3#1)
in the English literature##4##4##(2008-12#1)(2009-3#1)(2010-6#1)(2011-2#1)
in the English##7##3##(1995-2#1)(2008-12#1)(2008-2#1)(2009-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
in the European Community and##2##5##(1993-2#1)(2008-10#1)
in the European Union and the United States##2##8##(2008-10#2)
in the European Union##6##4##(1996-3#1)(2008-10#4)(2008-5#1)
in the European##10##3##(1993-2#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-5#1)
in the Evaluation##2##3##(2010-9#1)(2012-3#1)
in the F##4##3##(2008-10#4)
in the F(1)##3##3##(2008-10#3)
in the F(2) population##2##4##(2008-10#2)
in the F(2)##3##3##(2008-10#3)
in the F(3)##2##3##(2008-10#2)
in the F-dish##4##3##(2008-11#4)
in the F1##2##3##(2008-10#1)(2008-12#1)
in the FTIR spectra##2##4##(2008-10#2)
in the Federal Republic of Germany##3##6##(1991-12#1)(1992-1#2)
in the Federal##5##3##(1991-12#1)(1992-1#3)(2013-1#1)
in the Felipe Angeles##2##4##(2012-12#2)
in the Field##2##3##(2008-10#2)
in the Foster/CIho##3##3##(2008-10#3)
in the French samples##2##4##(1990-8#2)
in the French##5##3##(1990-8#2)(2008-10#1)(2008-11#1)(2012-3#1)
in the Fusarium##2##3##(2008-10#2)
in the G0/G1##2##3##(1993-8#1)(2008-11#1)
in the G1 cell cycle phase##2##6##(2008-11#2)
in the G1 phase##3##4##(1993-3#1)(1994-11#1)(2008-11#1)
in the G1##5##3##(1993-3#1)(1994-11#1)(2008-11#3)
in the G1-phase##3##3##(1997-1#1)(2008-11#1)(2008-7#1)
in the GC##2##3##(1993-3#1)(2008-10#1)
in the German##5##3##(1990-11#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the Golgi apparatus##3##4##(1990-5#1)(1992-12#1)(2008-11#1)
in the Golgi##4##3##(1990-5#1)(1992-12#1)(2008-11#2)
in the Government##2##3##(2008-10#1)(2008-11#1)
in the Great Plains region of the United States##2##9##(2008-10#2)
in the Great Plains##4##4##(2008-10#4)
in the Great##5##3##(2008-10#5)
in the H group##3##4##(2011-2#3)
in the H##6##3##(2011-2#6)
in the HA group and##2##5##(2011-2#2)
in the HA group##3##4##(2011-2#3)
in the HA##4##3##(2008-10#1)(2011-2#3)
in the Health Care Financing Administration##2##6##(1991-2#1)(1994-1#1)
in the Health##6##3##(1990-2#1)(1991-2#1)(1994-1#1)(1996-2#1)(1997-2#2)
in the Hg(II)##2##3##(2008-10#2)
in the Human##2##3##(1994-9#1)(2008-10#1)
in the IBM##2##3##(2008-8#1)(2012-3#1)
in the ICU##3##3##(1991-2#2)(2010-12#1)
in the III-IV cytoplasmic loop##2##5##(1992-3#2)
in the ITS region##2##4##(2008-10#2)
in the IVB##2##3##(2011-2#2)
in the IVB/IVT##2##3##(2011-2#2)
in the Iberian##2##3##(2008-10#2)
in the Indian subcontinent##2##4##(2008-10#2)
in the Indian##4##3##(2008-10#2)(2008-5#1)(2010-5#1)
in the Indo-Pacific##2##3##(2008-5#2)
in the Interaction##2##3##(2008-10#2)
in the International##2##3##(1991-12#1)(2008-10#1)
in the Intervention practices##2##4##(2008-4#2)
in the Intervention##3##3##(2008-4#3)
in the Italian samples##2##4##(1990-8#2)
in the Italian##3##3##(1990-8#2)(1994-12#1)
in the Jackson Heart Study##2##5##(2011-2#1)(2013-8#1)
in the Japanese population##3##4##(1993-3#2)(1997-8#1)
in the Japanese##4##3##(1993-3#2)(1997-8#2)
in the Joban area##2##4##(2010-8#2)
in the Journal of##2##4##(1990-6#1)(2010-7#1)
in the Kingdom##2##3##(2009-6#1)(2013-1#1)
in the LA and L groups##3##6##(2011-2#3)
in the LA##4##3##(2011-2#4)
in the LAD group##2##4##(2013-1#2)
in the LC##2##3##(2008-4#1)(2011-2#1)
in the LC-DECD##2##3##(2008-10#2)
in the LDL##3##3##(1991-12#1)(2008-6#1)(2011-1#1)
in the LV vent line##2##5##(1991-3#2)
in the Latin American##2##4##(2008-10#2)
in the Ligasure group##2##4##(2011-2#2)
in the Longissimus##2##3##(2010-4#2)
in the MS##3##3##(1996-12#2)(2008-10#1)
in the MTX##2##3##(1994-2#1)(2008-11#1)
in the MZ##2##3##(2009-7#2)
in the Management of##2##4##(2008-1#1)(2011-2#1)
in the Maximizer##3##3##(2008-11#3)
in the Medicaid##2##3##(1994-2#1)(1997-2#1)
in the Medicare##6##3##(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-3#1)
in the Mediterranean##4##3##(2008-10#3)(2011-2#1)
in the Mexican##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
in the Middle East and##2##5##(1997-8#1)(2008-10#1)
in the Middle East##5##4##(1997-8#1)(2008-10#3)(2011-2#1)
in the Middle##6##3##(1997-8#1)(2008-10#3)(2011-2#1)(2013-8#1)
in the Midwest##2##3##(2008-10#2)
in the Mitochondrial##2##3##(2008-10#2)
in the Mongolian gerbil##2##4##(1992-12#2)
in the Morris water maze##2##5##(1993-3#1)(2008-12#1)
in the Morris##3##3##(1993-3#2)(2008-12#1)
in the Murcia##2##3##(1993-11#1)(1994-6#1)
in the Mycosphaerella##2##3##(2008-10#2)
in the N-terminal arm##2##4##(2008-9#2)
in the N-terminal##5##3##(1994-5#2)(2008-10#1)(2008-9#2)
in the NHS##3##3##(1991-8#1)(2008-11#1)(2013-8#1)
in the NILs##2##3##(2008-10#2)
in the NIR##3##3##(2008-10#3)
in the NIb##2##3##(2008-10#2)
in the National Health##2##4##(1995-11#1)(2008-11#1)
in the National##3##3##(1995-11#1)(2007-8#1)(2008-11#1)
in the Nepalese Himalayas##2##4##(2008-8#2)
in the Netherlands and##2##4##(1996-1#1)(2008-10#1)
in the Netherlands in the##3##5##(2008-12#3)
in the Netherlands in##6##4##(1995-12#1)(1997-5#1)(2008-11#1)(2008-12#3)
in the Netherlands##28##3##(1992-12#1)(1994-12#1)(1995-12#2)(1996-1#1)(1996-11#1)(1997-5#2)(2008-10#8)(2008-11#1)(2008-12#5)(2008-7#1)(2009-9#1)(2010-1#1)(2012-3#1)(2013-8#2)
in the New##2##3##(1997-1#1)(2008-10#1)
in the Nile River Delta##2##5##(2008-10#2)
in the Nordic countries##2##4##(1990-11#1)(2008-10#1)
in the North Sea##3##4##(2009-10#3)
in the North##12##3##(1991-1#1)(1992-2#4)(2008-10#2)(2008-6#2)(2009-10#3)
in the Northern Guinea Savanna##2##5##(2008-12#2)
in the Northern##5##3##(1992-2#1)(2008-10#1)(2008-12#2)(2013-8#1)
in the Norwegian##2##3##(1990-6#1)(2010-6#1)
in the O##2##3##(2008-10#2)
in the Oregon Coast Range##2##5##(2008-10#2)
in the Oregon##3##3##(2008-10#3)
in the P##6##3##(2008-10#6)
in the P1 position##2##4##(1994-5#2)
in the P1##4##3##(1994-5#2)(1995-6#1)(2008-10#1)
in the P3 position directs##2##5##(1994-5#2)
in the P3##3##3##(1994-5#2)(2008-10#1)
in the PBL group##2##4##(2013-8#2)
in the PD##2##3##(2008-7#2)
in the PDB##2##3##(2011-3#2)
in the PDS gene##2##4##(2011-1#2)
in the PEG-rich phase##2##4##(2011-2#2)
in the PEP group##2##4##(2009-12#2)
in the PFC of##2##4##(1997-2#2)
in the PFC##5##3##(1996-5#1)(1997-2#3)(2013-8#1)
in the PLNA##2##3##(2008-10#2)
in the PM 1648 and PM(2##2##6##(2008-10#2)
in the PM##4##3##(2008-10#2)(2008-7#2)
in the PNW##2##3##(2008-10#2)
in the PSD##2##3##(1996-12#2)
in the Pacific Northwest##6##4##(2008-10#6)
in the Pacific##11##3##(2008-1#5)(2008-10#6)
in the Phytophthora##2##3##(2008-10#2)
in the Pilates##2##3##(2009-3#2)
in the Plant##2##3##(2008-10#2)
in the Plzen Surgical Clinic##2##5##(2011-3#2)
in the Population##3##3##(1996-8#1)(2008-10#2)
in the Presence of##2##4##(1996-5#1)(2008-10#1)
in the Programme of Action##2##5##(2008-11#2)
in the Q-switched##2##3##(2008-3#2)
in the Qualified##2##3##(1995-12#2)
in the R##2##3##(2008-10#1)(2009-7#1)
in the RCC1-related protein pim1##2##5##(1995-2#2)
in the RNA##3##3##(1993-8#1)(1997-7#1)(2008-11#1)
in the RP##2##3##(2010-1#1)(2012-2#1)
in the RVC matrix##2##4##(2008-10#2)
in the Republic of##5##4##(2008-1#1)(2008-10#1)(2010-11#1)(2011-2#2)
in the Republic##6##3##(2008-1#1)(2008-10#1)(2010-11#1)(2011-2#2)(2012-3#1)
in the Rhizosphere of Wheat##2##5##(2008-10#2)
in the Rhizosphere##5##3##(2008-10#5)
in the Russian Federation##2##4##(1995-3#1)(1997-1#1)
in the S##5##3##(1993-2#1)(1994-3#1)(2008-11#2)(2008-9#1)
in the S1##2##3##(2008-5#2)
in the SA##2##3##(1995-11#1)(2008-10#1)
in the SC##9##3##(2008-10#2)(2008-5#7)
in the SCLP##2##3##(2012-3#2)
in the SCN##2##3##(1994-2#2)
in the SE##2##3##(2008-10#1)(2008-11#1)
in the SF-CO(2)##2##3##(2008-10#2)
in the SN##2##3##(1994-2#2)
in the SSG##3##3##(1995-11#3)
in the SZ##3##3##(2009-7#3)
in the Salinas Valley##2##4##(2008-10#2)
in the Salinas##4##3##(2008-10#4)
in the San Joaquin Valley##2##5##(2008-10#2)
in the Schaffer##2##3##(2008-7#2)
in the School of##3##4##(1996-1#1)(2008-10#1)(2008-12#1)
in the Sierra Nevada##2##4##(2008-10#2)
in the Sonoran Desert##2##4##(2008-10#1)(2009-8#1)
in the Soret band##2##4##(1990-8#2)
in the South Pacific##2##4##(2008-1#2)
in the South##9##3##(1992-2#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
in the State of##4##4##(1990-11#1)(2008-10#2)(2010-10#1)
in the Study of##2##4##(1995-11#1)(2008-10#1)
in the Surgical##2##3##(1990-9#1)(1994-12#1)
in the T##4##3##(1990-8#2)(1992-8#1)(2008-8#1)
in the TCA cycle##2##4##(2008-11#1)(2011-2#1)
in the TIMI##2##3##(2008-3#2)
in the Texas Panhandle##3##4##(2008-10#3)
in the Texas##5##3##(2008-10#5)
in the Toluca Valley##4##4##(2008-10#4)
in the Toluca##5##3##(2008-10#5)
in the Treatment of##4##4##(1997-3#1)(2008-12#1)(2012-3#2)
in the U##28##3##(1990-11#1)(1990-6#1)(1991-2#1)(1992-1#2)(1992-3#1)(1993-1#1)(1994-1#2)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-1#4)(2008-10#4)(2008-5#1)(2009-5#1)(2009-7#1)(2010-6#1)(2012-12#2)(2013-8#1)
in the UK and the##2##5##(2008-12#1)(2008-5#1)
in the UK and##7##4##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)
in the UK in##2##4##(2008-11#1)(2013-1#1)
in the UK were##2##4##(2008-5#1)(2008-9#1)
in the UK##39##3##(2008-10#4)(2008-11#15)(2008-12#4)(2008-5#4)(2008-9#2)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#3)(2013-1#2)(2013-8#1)
in the US and##2##4##(2008-11#1)(2010-12#1)
in the US##26##3##(1990-2#1)(1990-9#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-9#4)(2008-10#4)(2008-11#1)(2008-5#4)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-12#1)
in the USA and##2##4##(2008-5#1)(2010-12#1)
in the USA##5##3##(1997-8#1)(2008-5#1)(2010-11#1)(2010-12#1)(2013-8#1)
in the USSR##2##3##(1990-3#2)
in the UV##6##3##(1996-5#1)(2008-10#3)(2008-3#1)(2009-12#1)
in the UniformMu##2##3##(2012-3#2)
in the United Kingdom and##2##5##(2008-10#1)(2008-9#1)
in the United Kingdom in##2##5##(2008-10#1)(2011-2#1)
in the United Kingdom##22##4##(1991-8#2)(1994-12#1)(1995-2#1)(2008-10#6)(2008-11#6)(2008-12#3)(2008-9#2)(2011-2#1)
in the United States Pharmacopeia (USP)##2##6##(2008-10#2)
in the United States and Canada were##2##7##(2007-12#1)(2008-10#1)
in the United States and Canada##8##6##(1991-12#1)(2007-12#1)(2008-10#4)(2012-2#2)
in the United States and Western Europe##2##7##(2008-1#1)(2011-2#1)
in the United States and##23##5##(1991-12#2)(1992-6#1)(1993-1#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#9)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
in the United States are##2##5##(1993-1#1)(2011-2#1)
in the United States by##2##5##(1995-3#1)(2012-12#1)
in the United States for##2##5##(1992-12#1)(2008-10#1)
in the United States have##3##5##(1993-3#1)(2008-10#1)(2013-1#1)
in the United States in 1990 and##2##7##(1994-2#1)(2008-10#1)
in the United States in##6##5##(1994-1#1)(1994-2#1)(2008-10#4)
in the United States since##3##5##(1995-3#1)(2008-10#1)(2012-3#1)
in the United States to##2##5##(2008-10#1)(2013-1#1)
in the United States were##3##5##(2008-10#3)
in the United States will##3##5##(1993-3#1)(1995-12#1)(1995-2#1)
in the United States with##2##5##(1993-2#1)(2010-10#1)
in the United States##180##4##(1991-1#1)(1991-12#4)(1991-3#2)(1991-8#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#4)(1993-3#4)(1994-1#1)(1994-12#3)(1994-2#3)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#57)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2009-5#4)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#9)(2013-8#4)
in the United##206##3##(1991-1#1)(1991-12#4)(1991-3#2)(1991-8#4)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#5)(1993-3#4)(1994-1#1)(1994-12#4)(1994-2#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#64)(2008-11#11)(2008-12#5)(2008-4#1)(2008-5#3)(2008-9#2)(2009-5#4)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#13)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#9)(2013-8#4)
in the University Hospital##2##4##(2008-10#1)(2011-2#1)
in the Vector Nematode Xiphinema americanum##2##6##(2008-10#2)
in the Venus##2##3##(1991-5#1)(2009-8#1)
in the Veterans##2##3##(2008-7#1)(2012-12#1)
in the Vmax##2##3##(1990-2#1)(1991-5#1)
in the Wave Bioreactor##2##4##(2008-11#2)
in the West and the East##2##6##(2008-10#1)(2010-8#1)
in the West##3##3##(2008-10#2)(2010-8#1)
in the Western Cape##2##4##(2010-3#1)(2011-2#1)
in the Western world##3##4##(1997-8#1)(2008-1#1)(2010-10#1)
in the Western##10##3##(1997-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
in the Wisconsin##2##3##(2008-10#1)(2008-7#1)
in the World Health Organization##2##5##(2011-7#1)(2013-1#1)
in the World##3##3##(2011-3#1)(2011-7#1)(2013-1#1)
in the X-ray##2##3##(1992-12#1)(2008-10#1)
in the Zurich Oberland##2##4##(1996-11#2)
in the abdomen##2##3##(1990-9#1)(1992-5#1)
in the abdominal cavity##2##4##(1993-6#1)(2013-1#1)
in the abdominal##5##3##(1993-6#1)(1997-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
in the ability of the##3##5##(2008-10#2)(2011-1#1)
in the ability of##6##4##(2008-10#3)(2008-5#1)(2011-1#2)
in the ability to##2##4##(1991-12#1)(2008-10#1)
in the ability##8##3##(1991-12#1)(2008-10#4)(2008-5#1)(2011-1#2)
in the above##6##3##(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-3#1)
in the absence and presence of##9##6##(1994-11#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2012-5#1)
in the absence and##10##4##(1994-11#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#2)(2012-5#1)
in the absence of HEL##2##5##(2008-11#2)
in the absence of a##8##5##(1995-6#1)(1997-7#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)
in the absence of added##2##5##(1994-8#1)(2008-10#1)
in the absence of aminoacylation##2##5##(1997-3#2)
in the absence of any##6##5##(1997-8#1)(2008-10#1)(2008-9#2)(2009-10#1)(2012-12#1)
in the absence of diacylglycerol##3##5##(1994-5#3)
in the absence of disease##2##5##(2008-10#1)(2013-1#1)
in the absence of external##3##5##(1990-5#1)(1993-3#1)(2008-10#1)
in the absence of fungicides##2##5##(2008-10#2)
in the absence of mating##2##5##(1991-5#1)(2008-8#1)
in the absence of other cytokines##2##6##(2008-4#2)
in the absence of other##4##5##(1991-12#1)(2008-4#2)(2013-1#1)
in the absence of serum##3##5##(2008-11#3)
in the absence of such##3##5##(1991-12#1)(2008-11#1)(2013-8#1)
in the absence of symptoms##4##5##(1990-6#3)(1991-6#1)
in the absence of the##12##5##(1992-3#1)(1993-9#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2013-8#1)
in the absence of##192##4##(1990-11#4)(1990-2#1)(1990-5#2)(1990-6#3)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#4)(1993-8#4)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#3)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#38)(2008-11#23)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#2)(2009-5#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
in the absence or presence of##4##6##(1995-8#1)(2008-11#1)(2008-9#1)(2011-2#1)
in the absence or##6##4##(1990-2#1)(1994-8#1)(1995-8#1)(2008-11#1)(2008-9#1)(2011-2#1)
in the absence##209##3##(1990-11#4)(1990-2#2)(1990-5#2)(1990-6#3)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#4)(1993-8#4)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#4)(1995-8#5)(1996-11#1)(1996-12#1)(1996-2#3)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#41)(2008-11#25)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#10)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#2)(2009-5#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#3)
in the absolute##3##3##(2008-5#1)(2008-8#2)
in the absorbance##10##3##(2008-10#10)
in the absorbing solution##2##4##(2008-10#2)
in the absorption##3##3##(2008-10#2)(2008-2#1)
in the abundance of##3##4##(1994-6#1)(2008-10#1)(2008-9#1)
in the abundance##4##3##(1994-5#1)(1994-6#1)(2008-10#1)(2008-9#1)
in the academic setting##2##4##(2008-11#1)(2010-1#1)
in the academic##3##3##(2008-11#2)(2010-1#1)
in the acceptor stream##2##4##(2008-10#2)
in the acceptor##5##3##(2008-10#5)
in the accumulation of ammonia##2##5##(2008-10#2)
in the accumulation of##9##4##(1995-6#3)(2008-10#4)(2008-7#1)(2009-8#1)
in the accumulation##10##3##(1995-6#3)(2008-10#5)(2008-7#1)(2009-8#1)
in the accuracy and precision##2##5##(2008-10#2)
in the accuracy of##2##4##(2008-10#1)(2012-2#1)
in the accuracy##4##3##(2008-10#3)(2012-2#1)
in the acid##4##3##(2008-10#4)
in the acidic##4##3##(2008-10#4)
in the acquired group##3##4##(2009-3#3)
in the acquisition of##4##4##(1993-6#1)(2008-11#2)(2008-9#1)
in the acquisition##5##3##(1993-6#1)(2008-11#3)(2008-9#1)
in the acrosome##4##3##(2008-7#2)(2008-8#2)
in the action of##4##4##(1992-3#1)(1992-6#1)(2008-11#1)(2008-5#1)
in the action##5##3##(1992-3#1)(1992-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
in the activated##3##3##(2008-10#1)(2008-9#1)(2010-11#1)
in the activation of protein##2##5##(1990-8#1)(1995-11#1)
in the activation of##10##4##(1990-8#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-11#1)(1996-2#2)(2008-10#1)(2011-2#1)
in the activation##11##3##(1990-8#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-11#1)(1996-2#2)(2008-10#1)(2011-2#1)
in the active site of##4##5##(1992-6#1)(1994-5#2)(1995-6#1)
in the active site##9##4##(1991-3#2)(1992-6#1)(1994-5#4)(1995-6#2)
in the active##13##3##(1991-3#2)(1992-6#1)(1994-5#4)(1995-6#2)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
in the activities of the##2##5##(1992-2#1)(2012-2#1)
in the activities of##6##4##(1990-3#2)(1992-2#1)(1994-8#1)(2008-10#1)(2012-2#1)
in the activities##7##3##(1990-3#2)(1992-2#1)(1994-5#1)(1994-8#1)(2008-10#1)(2012-2#1)
in the activity of the##3##5##(1994-11#1)(2007-12#1)(2011-2#1)
in the activity of##10##4##(1994-11#1)(1994-5#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
in the acute phase of a cerebral infarction##4##8##(1997-5#4)
in the acute phase of##6##5##(1997-5#6)
in the acute stage of##2##5##(1990-9#1)(2008-12#1)
in the acute stage##5##4##(1990-12#1)(1990-9#1)(2008-12#1)(2008-7#1)(2009-11#1)
in the acute##17##3##(1990-12#1)(1990-9#2)(1991-9#1)(1996-2#1)(1997-5#6)(2008-12#1)(2008-7#1)(2009-11#1)(2009-5#1)(2011-2#2)
in the acylation of##2##4##(1990-5#2)
in the adaptive##3##3##(1994-2#1)(2008-1#1)(2009-11#1)
in the adenosinergic modulation##2##4##(1997-2#2)
in the adrenal##6##3##(1990-5#2)(1991-5#2)(2011-2#1)(2012-12#1)
in the adult and##2##4##(1991-12#1)(2013-7#1)
in the adult population##2##4##(2008-8#1)(2013-1#1)
in the adult rat striatum##3##5##(1996-12#3)
in the adult rat##5##4##(1996-12#3)(1997-3#2)
in the adult##45##3##(1990-11#1)(1990-5#2)(1991-12#2)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#1)(1996-12#6)(1997-3#3)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-7#2)
in the advanced management of prostate cancer##2##7##(2010-12#2)
in the advanced##3##3##(2008-10#1)(2010-12#2)
in the adventitial##2##3##(1992-12#1)(2010-4#1)
in the aerosol##4##3##(1991-1#2)(1992-2#1)(2008-3#1)
in the aetiology of##3##4##(2008-4#1)(2008-5#1)(2009-8#1)
in the aetiology##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
in the affected##5##3##(1990-3#1)(1991-8#1)(1996-8#1)(1997-3#1)(2008-1#1)
in the affinity of##2##4##(1990-2#1)(1993-8#1)
in the affinity##4##3##(1990-2#1)(1991-5#1)(1993-8#1)(2008-9#1)
in the aforementioned##2##3##(2008-7#1)(2012-12#1)
in the afternoon##3##3##(1993-12#1)(2008-3#1)(2008-5#1)
in the age group##4##4##(1990-12#1)(1990-6#1)(1993-11#1)(2008-11#1)
in the age of##3##4##(1992-5#1)(2008-10#1)(2011-2#1)
in the age range##2##4##(2008-7#1)(2013-1#1)
in the age##10##3##(1990-12#1)(1990-6#1)(1992-5#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
in the aged##3##3##(1990-11#1)(1992-12#1)(1995-8#1)
in the aging##2##3##(1995-6#1)(1996-11#1)
in the agricultural##2##3##(1991-6#1)(2008-10#1)
in the air and##3##4##(2008-10#1)(2009-7#1)(2010-4#1)
in the air sample##2##4##(2008-10#2)
in the air samples##3##4##(2008-10#3)
in the air was##2##4##(2008-10#2)
in the air with##2##4##(2008-10#2)
in the air##23##3##(1990-3#1)(1995-2#1)(1997-4#1)(2008-10#16)(2008-11#1)(2008-2#1)(2009-7#1)(2010-4#1)
in the airway##6##3##(1994-6#1)(1997-1#1)(1997-2#1)(2008-12#3)
in the airways of##4##4##(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#1)
in the airways##7##3##(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#3)(1997-2#1)
in the albino rat##2##4##(1994-8#2)
in the alimentary##2##3##(2008-10#1)(2008-5#1)
in the alkaline solution##2##4##(2008-10#2)
in the alkaline##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
in the alligator gar##2##4##(2008-7#2)
in the alpha##4##3##(1991-5#1)(1993-8#1)(1994-2#1)(2008-3#1)
in the alpha2##2##3##(2008-11#2)
in the altered##2##3##(1990-5#1)(2008-7#1)
in the alveolar region of the##2##6##(1992-12#1)(1997-1#1)
in the alveolar region##4##4##(1992-12#1)(1994-12#1)(1995-12#1)(1997-1#1)
in the alveolar##5##3##(1992-12#1)(1994-12#1)(1995-12#1)(1997-1#1)(2013-1#1)
in the ambient##3##3##(2008-10#3)
in the amino acid sequence of##2##6##(1991-12#1)(2008-9#1)
in the amino acid sequence##4##5##(1991-12#1)(1992-9#1)(2008-9#1)(2011-2#1)
in the amino##5##3##(1991-12#1)(1992-9#1)(2008-11#1)(2008-9#1)(2011-2#1)
in the amount of food##2##5##(2008-9#2)
in the amount of##20##4##(1990-7#1)(1992-1#1)(1992-6#2)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#2)(2013-1#2)
in the amount##22##3##(1990-7#1)(1992-1#1)(1992-6#2)(1995-11#1)(1995-8#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#2)(2013-1#2)
in the amplification##2##3##(1997-7#1)(2008-10#1)
in the amplitude and##2##4##(1990-12#1)(2011-2#1)
in the amygdala in##2##4##(1991-1#1)(1992-6#1)
in the amygdala##7##3##(1991-1#1)(1992-6#3)(1993-6#1)(1996-12#1)(2008-11#1)
in the analysed samples##2##4##(2008-10#2)
in the analyses were##2##4##(2008-10#1)(2011-2#1)
in the analyses##6##3##(2008-10#4)(2011-2#1)(2013-8#1)
in the analysis of a##2##5##(2008-10#2)
in the analysis of certified reference materials##3##7##(2008-10#3)
in the analysis of pharmaceutical formulations##2##6##(2008-10#2)
in the analysis of the##5##5##(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)
in the analysis of##55##4##(1990-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#36)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
in the analysis##63##3##(1990-2#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#41)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the analytical##10##3##(2008-10#8)(2008-6#1)(2010-10#1)
in the analyzed##3##3##(2008-10#3)
in the animal pole##2##4##(2013-1#2)
in the animal##8##3##(1992-6#1)(1993-6#1)(1996-12#1)(1997-7#1)(2010-11#1)(2012-2#1)(2013-1#2)
in the animals##3##3##(2008-11#1)(2008-7#2)
in the ankle##2##3##(2011-2#2)
in the annotation of##2##4##(2008-9#2)
in the anodic##3##3##(2008-10#3)
in the antagonism##2##3##(2008-10#2)
in the anterior lobe##2##4##(1992-9#2)
in the anterior region of the##2##6##(2008-7#1)(2009-1#1)
in the anterior##12##3##(1991-8#1)(1992-10#1)(1992-9#2)(1993-12#1)(2008-12#1)(2008-7#1)(2009-1#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
in the anticonvulsant##3##3##(1990-5#1)(1994-2#1)(1994-8#1)
in the antiproliferative##2##3##(1990-12#1)(1995-2#1)
in the apex of spine curve##2##6##(2007-8#2)
in the apex##3##3##(2007-8#2)(2008-10#1)
in the apical##3##3##(1997-1#1)(2008-7#1)(2012-2#1)
in the apo##2##3##(1991-12#1)(2009-7#1)
in the apoptotic##4##3##(1995-6#1)(2008-7#1)(2008-9#2)
in the apparent##3##3##(1997-2#1)(2008-7#1)(2011-1#1)
in the appearance of##2##4##(1992-8#1)(1995-2#1)
in the application of the##2##5##(1997-1#1)(2008-10#1)
in the application of##12##4##(1995-3#1)(1997-1#2)(2008-10#6)(2008-7#1)(2008-8#1)(2010-11#1)
in the application##13##3##(1995-3#1)(1997-1#2)(2008-10#7)(2008-7#1)(2008-8#1)(2010-11#1)
in the appropriate##4##3##(1995-12#1)(1996-8#1)(2008-10#1)(2008-5#1)
in the approval##2##3##(1993-12#1)(2008-10#1)
in the aquatic##2##3##(2008-9#1)(2011-2#1)
in the aqueous phase and##4##5##(2008-10#3)(2010-4#1)
in the aqueous phase was##2##5##(2008-10#1)(2008-5#1)
in the aqueous phase##11##4##(1991-5#1)(2008-10#7)(2008-5#1)(2008-7#1)(2010-4#1)
in the aqueous solution##4##4##(1997-2#1)(2008-10#3)
in the aqueous solutions##2##4##(2008-10#2)
in the aqueous##24##3##(1991-5#1)(1997-2#1)(2008-10#19)(2008-5#1)(2008-7#1)(2010-4#1)
in the arctic##2##3##(1991-5#1)(2012-3#1)
in the area around##2##4##(1992-1#1)(2008-10#1)
in the area of Ioannina##2##5##(2008-10#2)
in the area of the##5##5##(1997-3#1)(2008-10#1)(2011-2#2)(2013-1#1)
in the area of##28##4##(1992-1#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
in the area where##2##4##(2008-10#2)
in the area##42##3##(1991-6#1)(1992-1#2)(1994-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-6#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-3#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-9#1)(2013-1#3)
in the areas of patient##2##5##(1995-3#1)(2010-10#1)
in the areas of##8##4##(1994-3#1)(1995-2#1)(1995-3#1)(2008-11#1)(2008-12#3)(2010-10#1)
in the areas##11##3##(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2010-10#1)
in the arena of##2##4##(2009-3#1)(2012-3#1)
in the army##2##3##(2013-1#2)
in the array##2##3##(2008-10#1)(2008-4#1)
in the arsenal##2##3##(2008-10#2)
in the arterial system##2##4##(2008-9#2)
in the arterial##6##3##(1997-8#1)(2006-6#1)(2008-9#2)(2013-1#2)
in the article##3##3##(2010-11#1)(2011-3#1)(2012-3#1)
in the artificial mouth##3##4##(2008-10#3)
in the artificial seawater##2##4##(2008-10#2)
in the artificial##5##3##(2008-10#5)
in the ascending##2##3##(1997-8#1)(2008-10#1)
in the assay of##2##4##(2008-10#2)
in the assay##7##3##(1990-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-1#1)
in the assays##2##3##(1993-2#1)(2008-9#1)
in the assembly and##2##4##(1990-5#1)(1995-8#1)
in the assembly of##3##4##(1995-8#1)(2011-2#1)(2013-1#1)
in the assembly##7##3##(1990-5#1)(1995-8#2)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
in the assessment of this##2##5##(1991-6#1)(2011-2#1)
in the assessment of##16##4##(1990-2#1)(1991-6#1)(1997-8#2)(2008-11#5)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#3)
in the assessment##19##3##(1990-2#1)(1991-6#1)(1997-8#2)(2008-11#6)(2008-12#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#2)(2011-2#3)
in the associated##3##3##(2008-10#1)(2008-5#1)(2010-11#1)
in the association##3##3##(1990-5#1)(2008-10#2)
in the aster yellows##3##4##(2008-10#3)
in the asymmetric unit was##2##5##(2008-8#1)(2008-9#1)
in the asymmetric unit##8##4##(1992-4#2)(1992-9#1)(1993-8#1)(2008-8#3)(2008-9#1)
in the asymmetric##9##3##(1992-4#2)(1992-9#1)(1993-8#1)(2008-11#1)(2008-8#3)(2008-9#1)
in the asymptomatic phase##2##4##(1990-8#2)
in the asymptomatic##3##3##(1990-8#2)(2008-10#1)
in the atmosphere above##2##4##(2008-10#1)(2008-3#1)
in the atmosphere and##3##4##(2008-10#1)(2008-3#2)
in the atmosphere in##2##4##(2008-11#1)(2008-3#1)
in the atmosphere of the city of Granada (South of Spain)##2##11##(2008-5#2)
in the atmosphere of##3##4##(2008-10#1)(2008-5#2)
in the atmosphere##23##3##(1996-1#1)(2008-10#7)(2008-11#4)(2008-3#9)(2008-5#2)
in the authors'##2##3##(1990-9#1)(2008-4#1)
in the autosampler cup##2##4##(2008-10#2)
in the autosampler##4##3##(2008-10#4)
in the autumn##5##3##(1994-12#1)(2008-10#1)(2008-11#1)(2010-8#2)
in the average##4##3##(2008-10#1)(2009-11#1)(2013-8#2)
in the aviation industry##2##4##(2009-10#2)
in the avrBs1##2##3##(2008-10#2)
in the awareness##2##3##(2010-12#1)(2013-7#1)
in the axilla##7##3##(2008-5#7)
in the back direction##2##4##(2008-3#2)
in the back##4##3##(1997-4#1)(1997-7#1)(2008-3#2)
in the background##4##3##(2008-10#3)(2013-8#1)
in the backscattered##2##3##(2008-10#1)(2008-2#1)
in the bacterial##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
in the baculovirus expression##2##4##(1995-6#1)(2008-7#1)
in the baculovirus##3##3##(1995-6#1)(2008-7#2)
in the baking##2##3##(1990-3#1)(2010-7#1)
in the band##2##3##(2008-10#2)
in the barn##2##3##(1990-5#1)(2008-9#1)
in the barrel##2##3##(1991-3#1)(1997-3#1)
in the basal ganglia##5##4##(2008-7#4)(2012-2#1)
in the basal layer and##2##5##(2008-5#1)(2011-2#1)
in the basal layer of the epidermis##2##7##(1996-2#1)(2010-6#1)
in the basal layer##4##4##(1996-2#1)(2008-5#1)(2010-6#1)(2011-2#1)
in the basal##12##3##(1991-9#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#5)(2010-6#1)(2011-2#1)(2012-2#1)
in the base##2##3##(2008-9#1)(2013-1#1)
in the baseline##2##3##(2008-7#1)(2012-2#1)
in the basic##4##3##(1995-11#1)(2008-10#1)(2008-4#2)
in the basolateral##2##3##(2008-11#2)
in the batch##4##3##(1994-8#1)(2008-10#3)
in the battle##2##3##(1995-2#1)(2012-2#1)
in the beam##3##3##(1997-8#2)(2008-3#1)
in the bean##2##3##(2008-10#1)(2010-11#1)
in the bed##5##3##(1994-2#1)(2008-11#1)(2008-7#3)
in the behaviour of##2##4##(2008-11#1)(2011-2#1)
in the best##7##3##(1990-12#1)(1997-1#1)(2008-10#2)(2010-9#2)(2011-2#1)
in the beta 2 strand of##2##6##(2008-11#2)
in the bibliography##2##3##(2008-10#2)
in the bilateral##4##3##(1996-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
in the biliary system##3##4##(2010-12#3)
in the biliary##4##3##(2010-12#3)(2012-2#1)
in the binding of##4##4##(1991-8#1)(1994-8#1)(1995-2#1)(2008-10#1)
in the binding process##2##4##(1997-2#1)(2008-10#1)
in the binding##16##3##(1991-8#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-2#1)(1997-2#1)(2008-10#7)(2010-7#1)(2013-8#1)
in the biofilm##2##3##(2008-7#1)(2013-8#1)
in the biological control##2##4##(2008-10#2)
in the biological samples##3##4##(2008-10#3)
in the biological##10##3##(1991-11#1)(1992-9#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-3#1)
in the biology of the##2##5##(2008-10#1)(2008-12#1)
in the biology##3##3##(1993-11#1)(2008-10#1)(2008-12#1)
in the biomass and##2##4##(2008-12#2)
in the biomass##3##3##(2008-10#1)(2008-12#2)
in the biomechanical##2##3##(2008-5#1)(2013-1#1)
in the bioreactor##8##3##(2008-11#8)
in the biosynthesis of##7##4##(1994-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)
in the biotechnology industry##2##4##(2008-7#2)
in the bladder##5##3##(1991-9#1)(1993-11#1)(2008-10#2)(2010-12#1)
in the blood is##2##4##(1991-11#1)(2008-10#1)
in the blood of living rabbits##2##6##(2008-10#2)
in the blood of living##3##5##(2008-10#3)
in the blood of##7##4##(1990-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
in the blood samples##2##4##(2008-5#1)(2011-1#1)
in the blood were##2##4##(1993-8#1)(2008-10#1)
in the blood##28##3##(1990-12#2)(1991-11#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
in the blubber of ringed##2##5##(2008-10#2)
in the blubber##3##3##(2008-10#3)
in the blue and in the red##2##7##(2008-3#2)
in the blue##7##3##(1990-9#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-3#3)
in the body and##4##4##(1992-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
in the body fluids##3##4##(2008-10#3)
in the body of the##2##5##(2008-10#1)(2008-5#1)
in the body of##5##4##(2008-10#3)(2008-5#1)(2011-2#1)
in the body##29##3##(1992-3#1)(1996-12#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-9#1)(2010-6#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
in the bone marrow##9##4##(1993-8#2)(1996-3#1)(2008-10#1)(2008-7#1)(2010-6#3)(2011-2#1)
in the bone##13##3##(1991-11#1)(1993-8#2)(1996-3#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-6#3)(2011-2#1)(2013-1#1)
in the border of##2##4##(2008-10#1)(2012-2#1)
in the boundary layer##2##4##(2008-11#2)
in the boundary##3##3##(2008-11#2)(2008-3#1)
in the bowel##3##3##(1991-3#1)(1996-3#1)(2009-12#1)
in the brain and spinal cord##3##6##(1996-12#1)(1997-3#1)(2010-12#1)
in the brain and##9##4##(1991-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)
in the brain associated with##2##5##(2008-11#1)(2013-1#1)
in the brain is##2##4##(1995-12#1)(2009-5#1)
in the brain of the##5##5##(1994-2#1)(1996-12#1)(1997-3#1)(2008-6#2)
in the brain of##9##4##(1993-3#1)(1994-2#2)(1996-12#1)(1997-3#1)(2008-6#3)(2008-7#1)
in the brain parenchyma##2##4##(1992-12#1)(2008-8#1)
in the brain stem##3##4##(1990-5#1)(2008-7#1)(2012-3#1)
in the brain##79##3##(1990-5#2)(1991-2#2)(1992-12#1)(1992-6#3)(1993-1#1)(1993-3#1)(1994-2#4)(1994-5#2)(1994-9#1)(1995-12#7)(1996-12#6)(1996-2#1)(1997-2#3)(1997-3#2)(2007-12#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#3)(2009-7#3)(2009-8#2)(2010-1#1)(2010-12#1)(2010-6#2)(2010-9#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
in the brains and##2##4##(2008-6#2)
in the brains of##4##4##(1995-12#1)(1997-3#1)(2007-12#1)(2008-11#1)
in the brains##6##3##(1995-12#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-6#2)
in the brainstem##2##3##(1992-3#1)(2012-3#1)
in the breast##2##3##(1997-7#1)(2008-12#1)
in the breeding season##3##4##(2008-8#2)(2010-8#1)
in the budding##2##3##(2008-9#1)(2011-2#1)
in the buffer##3##3##(1990-5#1)(2008-10#2)
in the buffering##2##3##(2008-10#2)
in the bulk of the##3##5##(2008-10#3)
in the bulk solution##4##4##(2008-10#4)
in the bulk##12##3##(2008-10#10)(2008-12#1)(2008-7#1)
in the cDNA##3##3##(1993-6#1)(1995-6#1)(2008-12#1)
in the calculation of##3##4##(2008-10#1)(2008-3#2)
in the calibration model##2##4##(2008-10#2)
in the calibration set##2##4##(2008-10#2)
in the calibration stage##2##4##(2008-10#2)
in the calibration##9##3##(2008-10#9)
in the callus##2##3##(2008-12#2)
in the calyptra##2##3##(2008-10#2)
in the cambium##3##3##(2008-10#3)
in the canine##2##3##(2008-9#1)(2013-1#1)
in the canopy##3##3##(2008-10#3)
in the capacity##2##3##(2009-8#1)(2012-3#1)
in the capillary##3##3##(2008-10#3)
in the capsid##2##3##(2008-10#2)
in the carbohydrate##2##3##(1997-6#1)(2008-9#1)
in the carbon paste##2##4##(2008-10#2)
in the carbon##3##3##(2008-10#2)(2008-11#1)
in the carcinoid cells##3##4##(2011-2#3)
in the cardiovascular system##2##4##(2009-10#1)(2013-1#1)
in the cardiovascular##4##3##(2008-11#2)(2009-10#1)(2013-1#1)
in the care and##2##4##(1992-1#1)(2008-11#1)
in the care of elderly##2##5##(1992-3#1)(2008-11#1)
in the care of older people##2##6##(2010-10#2)
in the care of##9##4##(1992-3#1)(1995-5#1)(1997-4#1)(2008-11#3)(2008-7#1)(2010-10#2)
in the care##13##3##(1992-1#1)(1992-3#1)(1993-3#1)(1995-5#1)(1997-4#1)(2008-11#4)(2008-7#1)(2010-10#2)(2011-2#1)
in the carotid##2##3##(1996-6#1)(2006-6#1)
in the carpal tunnel##2##4##(2008-12#1)(2008-9#1)
in the carrier solution##5##4##(2008-10#5)
in the carrier stream##3##4##(2008-10#3)
in the carrier##9##3##(2008-10#9)
in the cascade of##2##4##(2012-2#1)(2012-3#1)
in the case of Cu##2##5##(2008-10#2)
in the case of a##10##5##(1993-6#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-7#1)
in the case of an##2##5##(2008-10#1)(2008-3#1)
in the case of high##2##5##(2008-3#1)(2012-2#1)
in the case of rat liver##2##6##(2008-10#2)
in the case of the##12##5##(1991-11#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#6)
in the case of very high##2##6##(2008-10#2)
in the case of##125##4##(1990-2#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#4)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#63)(2008-11#9)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
in the case where##2##4##(1995-9#1)(2008-11#1)
in the case##136##3##(1990-2#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#4)(1995-6#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(2008-10#64)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
in the cases of##2##4##(2011-1#1)(2013-1#1)
in the cases where##2##4##(2008-10#1)(2008-11#1)
in the cases##5##3##(1993-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
in the cat##2##3##(1991-2#1)(2008-8#1)
in the catabolism of##3##4##(1991-9#1)(1994-8#1)(2008-11#1)
in the catalytic##7##3##(1992-6#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-6#1)(2009-7#1)(2010-4#1)
in the caudal##2##3##(2012-3#1)(2013-8#1)
in the caudate nucleus of##2##5##(2008-10#1)(2008-7#1)
in the caudate nucleus##3##4##(2008-10#1)(2008-7#2)
in the caudate putamen##3##4##(1995-6#1)(1996-12#2)
in the caudate##7##3##(1991-4#1)(1995-6#1)(1996-12#2)(2008-10#1)(2008-7#2)
in the cavernous sinus##4##4##(2008-7#2)(2011-2#2)
in the cavernous##5##3##(1996-9#1)(2008-7#2)(2011-2#2)
in the cavity and##2##4##(2008-3#2)
in the cavity##4##3##(1996-5#1)(2008-2#1)(2008-3#2)
in the cell and##2##4##(1994-6#1)(2009-5#1)
in the cell cycle##6##4##(2008-11#4)(2008-9#1)(2011-2#1)
in the cell cytoplasm##2##4##(2007-12#1)(2008-10#1)
in the cell surface##2##4##(1992-2#1)(2008-5#1)
in the cell wall fraction##2##5##(2008-10#2)
in the cell wall##7##4##(1990-5#1)(2008-10#3)(2008-11#2)(2011-2#1)
in the cell##53##3##(1990-5#2)(1991-2#1)(1992-2#1)(1992-9#1)(1994-6#1)(1995-8#2)(1997-1#1)(2007-12#1)(2008-10#9)(2008-11#14)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#6)(2013-1#1)(2013-8#1)
in the cell-free##2##3##(2008-8#1)(2011-2#1)
in the cells of##3##4##(2007-12#1)(2008-11#1)(2013-1#1)
in the cells with##2##4##(2008-11#1)(2008-7#1)
in the cells##14##3##(1994-11#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-11#4)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)(2013-7#1)
in the cellular environment##2##4##(2008-11#1)(2011-2#1)
in the cellular##11##3##(1993-11#1)(1995-8#1)(1997-1#1)(1997-3#2)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#2)
in the center of the##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
in the center of##6##4##(1991-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
in the center##8##3##(1991-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
in the centers of##2##4##(1991-10#1)(2008-10#1)
in the central and peripheral nervous system##3##7##(1996-12#1)(2008-7#1)(2013-8#1)
in the central and##4##4##(1996-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
in the central cell##2##4##(2008-9#2)
in the central nervous system (CNS)##8##6##(1994-2#1)(1996-12#2)(1997-2#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
in the central nervous system and##4##6##(1996-12#2)(1997-8#1)(2008-7#1)
in the central nervous system are##2##6##(1995-2#1)(2012-2#1)
in the central nervous system of the##2##7##(1992-6#1)(1997-3#1)
in the central nervous system of##3##6##(1992-6#1)(1995-2#1)(1997-3#1)
in the central nervous system##29##5##(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-2#1)(1995-2#2)(1995-8#1)(1996-12#5)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the central region of the##2##6##(2008-7#1)(2008-9#1)
in the central##59##3##(1990-2#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-3#3)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#6)(1996-2#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#1)(2008-10#12)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-6#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#4)
in the cerebellar cortex##3##4##(1992-6#1)(1995-8#1)(2013-8#1)
in the cerebellar##4##3##(1992-6#1)(1995-8#1)(2013-7#1)(2013-8#1)
in the cerebellum and##2##4##(1993-6#1)(2013-8#1)
in the cerebellum##14##3##(1992-9#1)(1993-6#1)(1993-8#2)(1995-2#1)(1996-12#5)(1997-8#1)(2013-1#2)(2013-8#1)
in the cerebral cortex and the##2##6##(1996-12#1)(2008-11#1)
in the cerebral cortex and##3##5##(1996-12#1)(2008-11#1)(2008-7#1)
in the cerebral cortex of##2##5##(1994-2#1)(2008-7#1)
in the cerebral cortex##12##4##(1994-2#1)(1995-11#1)(1996-12#1)(1997-2#2)(2008-11#3)(2008-7#4)
in the cerebral cortical mantle##2##5##(2008-7#2)
in the cerebral ganglion##2##4##(1990-5#1)(2008-5#1)
in the cerebral hemisphere##2##4##(2008-7#1)(2013-8#1)
in the cerebral white matter##2##5##(2008-7#1)(2010-12#1)
in the cerebral##24##3##(1990-5#1)(1994-2#1)(1995-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(2008-11#4)(2008-5#2)(2008-7#9)(2010-12#1)(2013-8#1)
in the cerebrospinal fluid##4##4##(1997-5#1)(2009-11#1)(2010-5#1)(2011-2#1)
in the certified##3##3##(2008-10#3)
in the cervical and##2##4##(2008-12#1)(2013-8#1)
in the cervical spine##4##4##(1995-11#1)(2012-12#3)
in the cervical##11##3##(1992-9#1)(1995-11#1)(1996-3#1)(1997-6#1)(2008-12#1)(2008-7#1)(2012-12#3)(2013-1#1)(2013-8#1)
in the chalazal##2##3##(2008-11#2)
in the chalcogenide glass##2##4##(2008-10#2)
in the channel##2##3##(2008-12#1)(2012-2#1)
in the characterization of##3##4##(1992-3#1)(1997-1#1)(2008-10#1)
in the characterization##4##3##(1992-3#1)(1997-1#1)(2008-10#1)(2010-12#1)
in the cheeks##3##3##(2008-5#3)
in the chemical and##2##4##(1994-12#1)(2009-10#1)
in the chemical properties of##2##5##(1997-2#1)(2008-10#1)
in the chemical##6##3##(1991-5#1)(1994-12#1)(1997-2#1)(2008-10#2)(2009-10#1)
in the chest##3##3##(1990-5#1)(2008-3#2)
in the chicken ureter##2##4##(1997-3#2)
in the chicken##9##3##(1997-3#3)(1997-9#2)(2008-11#1)(2008-5#3)
in the child##4##3##(1991-6#1)(2008-10#1)(2010-12#1)(2010-6#1)
in the chitosan##2##3##(2008-10#2)
in the chlorination and caustic extraction stage##2##7##(2008-10#2)
in the chloroplast##5##3##(1994-11#1)(2008-10#1)(2010-10#1)(2012-3#2)
in the chosen##2##3##(2008-10#1)(2008-11#1)
in the chromatin##2##3##(2012-3#1)(2013-1#1)
in the chromatograms##2##3##(2008-10#2)
in the chromatographic determination##2##4##(2008-10#2)
in the chromatographic##3##3##(2008-10#3)
in the chronic##3##3##(2009-1#1)(2009-11#1)(2011-2#1)
in the circuits##2##3##(1995-3#1)(2013-8#1)
in the circulating reagent solution##2##5##(2008-10#2)
in the circulating##5##3##(1993-11#1)(1994-8#1)(2008-10#2)(2008-7#1)
in the circulation of##2##4##(1992-3#1)(2008-1#1)
in the circulation##3##3##(1992-3#1)(2008-1#1)(2008-6#1)
in the cities of##3##4##(2012-12#2)(2013-8#1)
in the citrus##2##3##(2008-10#2)
in the city of##7##4##(1991-6#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-12#2)(2012-3#1)
in the city##8##3##(1991-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#2)(2012-3#1)
in the class##4##3##(2008-10#2)(2008-11#2)
in the classic##2##3##(2009-10#1)(2013-1#1)
in the classical##3##3##(2007-12#1)(2008-11#1)(2008-5#1)
in the classification of##2##4##(1996-3#1)(2008-10#1)
in the classroom##8##3##(2008-11#3)(2008-12#5)
in the cleavage##2##3##(1994-9#1)(2008-10#1)
in the clinic is##2##4##(2010-12#1)(2013-8#1)
in the clinic##8##3##(1992-3#1)(2008-10#1)(2008-11#3)(2010-12#1)(2012-2#1)(2013-8#1)
in the clinical area##5##4##(2008-11#5)
in the clinical environment##2##4##(2008-12#2)
in the clinical laboratory##5##4##(1994-1#2)(1994-12#1)(2008-12#1)(2008-9#1)
in the clinical management##2##4##(2008-11#1)(2011-2#1)
in the clinical practice##2##4##(2011-2#1)(2013-1#1)
in the clinical setting and##2##5##(2008-11#1)(2008-12#1)
in the clinical setting of##2##5##(2008-10#1)(2011-2#1)
in the clinical setting##18##4##(1991-11#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-11#4)(2008-12#4)(2008-9#3)(2009-9#1)(2011-2#1)(2012-12#1)
in the clinical##54##3##(1991-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#2)(1995-11#1)(1997-3#3)(2008-1#1)(2008-10#2)(2008-11#11)(2008-12#9)(2008-7#1)(2008-9#5)(2009-9#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)
in the close vicinity##2##4##(1994-8#1)(2012-3#1)
in the cluster##2##3##(2008-10#1)(2008-6#1)
in the coastal##2##3##(2008-10#1)(2013-8#1)
in the coat protein##2##4##(2008-10#2)
in the cockroach##2##3##(1995-11#1)(2008-8#1)
in the coding region##6##4##(1993-2#2)(1995-6#1)(2008-11#1)(2008-12#1)(2010-5#1)
in the coding##11##3##(1993-2#3)(1995-6#1)(1997-7#2)(1997-8#1)(2008-11#1)(2008-12#1)(2010-5#1)(2012-12#1)
in the cognitive##2##3##(2008-1#1)(2008-10#1)
in the cold##2##3##(2008-10#1)(2010-8#1)
in the collagen##2##3##(1992-6#2)
in the collection of airborne##2##5##(2008-10#2)
in the collection of##4##4##(2008-10#4)
in the collection##7##3##(2008-10#6)(2008-5#1)
in the colloid phase##2##4##(2008-10#2)
in the colloid##3##3##(2008-10#2)(2008-2#1)
in the colon of rats##2##5##(2008-12#2)
in the colon of##4##4##(2008-12#4)
in the colon##14##3##(1991-6#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-12#8)(2009-1#1)(2013-1#1)
in the column##5##3##(1993-6#1)(2008-10#3)(2008-9#1)
in the combination of##2##4##(2008-10#1)(2011-2#1)
in the combination##5##3##(2008-10#2)(2008-7#1)(2011-2#2)
in the combined therapy group##2##5##(2013-1#2)
in the combined treatment##3##4##(2012-6#3)
in the combined##8##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-6#3)(2013-1#2)
in the combustion region above a flat-flame burner##2##8##(2008-3#2)
in the commentary##2##3##(2008-4#2)
in the commercial##5##3##(2008-10#3)(2008-12#1)(2008-5#1)
in the common iliac artery and##2##6##(2011-2#2)
in the common##5##3##(1993-12#1)(2008-10#1)(2010-4#1)(2011-2#2)
in the community setting##3##4##(2008-11#2)(2012-12#1)
in the community##28##3##(1991-3#1)(1993-1#1)(1993-11#1)(1994-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
in the comparison##2##3##(1994-2#1)(1995-1#1)
in the competitive##2##3##(2008-10#1)(2008-12#1)
in the complete##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
in the complex##12##3##(1991-3#1)(1993-8#1)(1995-12#1)(2008-10#6)(2008-3#1)(2011-2#1)(2012-3#1)
in the complexation in##2##4##(2008-10#2)
in the complexation##3##3##(2008-10#3)
in the complexity of##2##4##(1994-2#1)(2010-8#1)
in the composite##2##3##(2008-10#2)
in the composition of their##2##5##(2008-5#1)(2010-7#1)
in the composition of##8##4##(1995-12#1)(1995-3#1)(2008-10#3)(2008-5#1)(2010-7#1)(2011-2#1)
in the composition##10##3##(1995-12#1)(1995-3#1)(2008-10#5)(2008-5#1)(2010-7#1)(2011-2#1)
in the compost mix##4##4##(2008-10#4)
in the compost##5##3##(2008-10#5)
in the compound##4##3##(2007-12#1)(2008-10#2)(2013-1#1)
in the concentration of the##3##5##(1995-3#1)(2008-10#1)(2008-12#1)
in the concentration of##9##4##(1993-3#1)(1995-3#1)(1996-2#1)(2008-10#4)(2008-12#1)(2012-2#1)
in the concentration range 0##10##5##(2008-10#10)
in the concentration range 2##2##5##(2008-10#2)
in the concentration range 5##3##5##(2008-10#3)
in the concentration range between##3##5##(2008-10#3)
in the concentration range from 1##2##6##(2008-10#2)
in the concentration range from 5 to##3##7##(2008-10#3)
in the concentration range from 5##5##6##(2008-10#5)
in the concentration range from##18##5##(2008-10#18)
in the concentration range of 0##13##6##(2008-10#13)
in the concentration range of 1##2##6##(1995-11#1)(2008-10#1)
in the concentration range of 2##4##6##(2008-10#4)
in the concentration range of##36##5##(1995-11#1)(2008-10#35)
in the concentration range studied##2##5##(2008-10#2)
in the concentration range##94##4##(1995-11#1)(2008-10#93)
in the concentration ranges of##5##5##(2008-10#5)
in the concentration ranges##8##4##(2008-10#8)
in the concentration##115##3##(1993-3#1)(1995-11#1)(1995-3#1)(1996-2#1)(2008-10#108)(2008-12#1)(2011-2#1)(2012-2#1)
in the concentrations of##3##4##(1992-9#1)(2008-10#1)(2008-5#1)
in the concentrations##7##3##(1992-9#1)(2008-10#4)(2008-5#1)(2010-3#1)
in the concept of##3##4##(1991-12#1)(1995-5#1)(2010-12#1)
in the condensed phase##2##4##(2008-10#2)
in the conditioned##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
in the conditions of##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
in the configuration##2##3##(2008-10#1)(2012-2#1)
in the congenital group and##2##5##(2009-3#2)
in the congenital group##3##4##(2009-3#3)
in the consequences of##2##4##(2009-10#1)(2009-12#1)
in the conservative##2##3##(1993-9#1)(2013-1#1)
in the construction of##3##4##(2008-10#2)(2008-8#1)
in the construction##4##3##(2008-10#2)(2008-8#1)(2011-1#1)
in the contact##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
in the contamination of##2##4##(1997-5#1)(2008-11#1)
in the contamination##3##3##(1997-5#1)(2008-10#1)(2008-11#1)
in the content of##3##4##(2008-10#1)(2009-8#2)
in the content##4##3##(2008-10#1)(2008-7#1)(2009-8#2)
in the context of a##8##5##(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-2#1)(2012-2#1)
in the context of an##3##5##(1992-1#1)(2008-1#1)(2008-6#1)
in the context of current##2##5##(2008-7#1)(2011-1#1)
in the context of family##2##5##(2010-8#1)(2012-3#1)
in the context of previous##3##5##(2008-9#2)(2012-2#1)
in the context of recent##2##5##(2008-8#1)(2009-8#1)
in the context of the##15##5##(1994-3#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#1)
in the context of##97##4##(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1996-2#1)(1996-3#2)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-2#6)(2012-3#4)(2012-8#1)(2013-1#1)(2013-8#2)
in the continuity of##2##4##(1995-3#1)(2012-12#1)
in the continuous##5##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
in the contour##3##3##(1991-2#2)(2008-10#1)
in the contralateral cortex##2##4##(2008-5#2)
in the contralateral side##2##4##(2008-9#2)
in the contralateral##9##3##(1994-12#1)(2008-5#3)(2008-9#2)(2009-11#1)(2011-2#1)(2013-8#1)
in the control and##5##4##(1991-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
in the control cell line##2##5##(2008-11#2)
in the control group (p##2##5##(2009-12#1)(2011-2#1)
in the control group##34##4##(1990-11#1)(1992-9#1)(1993-2#1)(1994-12#3)(1994-8#3)(2008-10#1)(2008-11#3)(2008-12#3)(2009-12#4)(2010-12#1)(2010-4#3)(2011-1#2)(2011-2#4)(2013-1#4)
in the control groups##3##4##(2008-11#1)(2011-2#2)
in the control of energy##2##5##(2008-1#1)(2008-4#1)
in the control of the##3##5##(1995-6#1)(2008-7#1)(2009-8#1)
in the control of##22##4##(1990-11#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#2)(2013-8#2)
in the control over behaviour by conditioned##2##7##(1993-6#2)
in the control subjects##2##4##(1996-12#1)(2011-2#1)
in the control with 10% fat to 0##2##8##(2010-4#2)
in the control##87##3##(1990-11#2)(1991-3#1)(1991-8#2)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-12#5)(1994-2#1)(1994-5#1)(1994-8#3)(1995-6#2)(1996-12#2)(1996-3#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#4)(2008-4#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#5)(2011-1#2)(2011-2#7)(2012-2#2)(2013-1#4)(2013-8#3)
in the controls##14##3##(1991-12#1)(1993-12#1)(2008-10#5)(2008-11#1)(2008-7#2)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the conventional loading group##2##5##(2013-1#2)
in the conventional tillage##3##4##(2008-10#3)
in the conventional##12##3##(1995-6#1)(2008-10#5)(2008-11#2)(2009-12#1)(2011-2#1)(2013-1#2)
in the conversion of##4##4##(1993-3#1)(1993-9#1)(1995-6#1)(2008-5#1)
in the conversion##6##3##(1993-3#1)(1993-9#1)(1994-8#1)(1995-6#1)(2008-5#2)
in the cooperatively breeding acorn woodpecker##2##6##(2008-9#2)
in the coordination##3##3##(2008-10#3)
in the coral##2##3##(2008-6#1)(2010-8#1)
in the cord##2##3##(2008-10#1)(2008-7#1)
in the core##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
in the corn##2##3##(2008-10#1)(2009-8#1)
in the coronary##2##3##(2008-10#1)(2012-2#1)
in the corpora##2##3##(1995-11#1)(2008-9#1)
in the correct##3##3##(1994-3#2)(2008-9#1)
in the correlation##3##3##(2008-10#3)
in the corresponding##11##3##(1993-8#1)(1994-11#1)(1995-9#1)(1996-2#1)(2006-6#1)(2008-10#4)(2008-5#1)(2011-2#1)
in the cortex and##2##4##(1994-2#1)(1995-6#1)
in the cortex of the central cell##2##7##(2008-11#1)(2008-9#1)
in the cortex of the##3##5##(2008-11#1)(2008-9#1)(2011-2#1)
in the cortex of##6##4##(2008-10#2)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
in the cortex##18##3##(1994-2#2)(1995-6#1)(1996-12#1)(2008-10#4)(2008-11#5)(2008-5#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)
in the cortical##6##3##(1991-10#1)(1994-11#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)
in the cosmetic##2##3##(2008-5#2)
in the cost of##2##4##(1995-2#1)(2008-9#1)
in the country##13##3##(1991-6#1)(1993-3#1)(1996-11#1)(1996-3#1)(1997-6#3)(2008-10#2)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)
in the course had##2##4##(1996-1#1)(2008-11#1)
in the course of Crohn's disease##2##6##(2010-12#2)
in the course of a trial##2##6##(1996-6#1)(2008-10#1)
in the course of a##5##5##(1991-3#1)(1996-6#1)(2008-10#2)(2008-7#1)
in the course of the##10##5##(1991-11#1)(1991-3#1)(1991-6#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-9#1)(2013-1#1)
in the course of their##3##5##(1991-12#1)(2008-12#1)(2008-9#1)
in the course of##41##4##(1990-12#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-6#1)(1992-3#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#4)(2010-12#2)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)
in the course##47##3##(1990-12#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-6#1)(1992-3#1)(1995-12#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#4)(2010-12#2)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
in the cranial##2##3##(2008-1#1)(2013-8#1)
in the creation of##3##4##(2008-10#1)(2008-3#1)(2010-1#1)
in the criminal justice system##4##5##(1996-1#1)(2008-11#3)
in the criminal##6##3##(1996-1#1)(2008-11#3)(2011-2#2)
in the critical##2##3##(1994-2#1)(1997-3#1)
in the cross##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
in the crosses##2##3##(2008-10#2)
in the crude extracts##2##4##(2008-10#1)(2008-8#1)
in the crude oil##2##4##(2008-10#2)
in the crude##13##3##(1994-5#1)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#1)
in the crystal##9##3##(1992-4#1)(1992-9#1)(1994-5#1)(1997-7#4)(2013-8#2)
in the crystals##2##3##(1992-9#1)(2008-10#1)
in the cultivar with the##2##5##(2008-10#2)
in the cultivar##5##3##(2008-10#5)
in the cultivation of##2##4##(2008-11#2)
in the cultural##2##3##(2008-11#1)(2009-10#1)
in the culture filtrate##2##4##(2008-10#1)(2008-8#1)
in the culture medium##9##4##(1990-8#1)(1992-6#1)(2008-11#4)(2008-7#1)(2010-10#1)(2011-2#1)
in the culture of##2##4##(2008-11#2)
in the culture using FC##2##5##(2008-11#2)
in the culture##27##3##(1990-2#1)(1990-8#1)(1992-5#1)(1992-6#1)(2008-10#1)(2008-11#13)(2008-6#1)(2008-7#4)(2008-8#1)(2010-10#1)(2010-3#1)(2011-2#1)
in the cultured cells##2##4##(2009-12#1)(2012-2#1)
in the cultured##6##3##(1993-3#2)(1995-11#1)(1995-6#1)(2009-12#1)(2012-2#1)
in the cultures of##2##4##(1996-2#1)(2008-11#1)
in the cultures##7##3##(1996-12#1)(1996-2#1)(2008-11#4)(2008-5#1)
in the currency of##2##4##(1992-3#1)(2008-8#1)
in the current##14##3##(1992-12#1)(1993-3#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
in the curriculum##3##3##(1995-2#1)(2008-11#1)(2011-2#1)
in the cyst cells##3##4##(2012-2#3)
in the cyst##6##3##(2008-7#1)(2012-2#4)(2013-1#1)
in the cystic duct remnant##2##5##(2010-12#2)
in the cysts##4##3##(1993-1#1)(2008-10#1)(2008-7#2)
in the cytoplasm and##3##4##(2008-11#1)(2009-8#1)(2011-2#1)
in the cytoplasm of the##6##5##(1991-2#1)(1992-2#1)(2008-11#2)(2008-9#1)(2012-2#1)
in the cytoplasm of##17##4##(1991-11#1)(1991-2#1)(1992-2#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#2)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
in the cytoplasm##45##3##(1991-11#1)(1991-2#2)(1992-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#3)(1995-6#1)(1995-8#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#8)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-8#1)(2011-2#3)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
in the cytoplasmic##3##3##(1993-3#1)(2011-2#1)(2013-1#1)
in the cytosol and##3##4##(1990-2#1)(1990-5#1)(2008-11#1)
in the cytosol of##2##4##(1997-4#1)(2013-1#1)
in the cytosol##11##3##(1990-2#1)(1990-5#1)(1992-10#1)(1992-6#1)(1993-8#1)(1995-9#1)(1997-4#1)(1997-7#1)(2008-11#2)(2013-1#1)
in the cytosolic##3##3##(1990-2#1)(1992-6#1)(1994-6#1)
in the cytotoxic##2##3##(1992-10#1)(1995-8#1)
in the daily##3##3##(1991-12#1)(1993-12#1)(2008-11#1)
in the damaged##2##3##(1991-2#1)(2010-1#1)
in the dark at##2##4##(2008-10#1)(2008-5#1)
in the dark for##2##4##(2008-10#2)
in the dark period##2##4##(1997-2#2)
in the dark##18##3##(1993-6#1)(1997-2#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)
in the data##13##3##(1992-9#1)(1993-12#1)(1994-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)(2011-3#1)
in the database##3##3##(1995-12#1)(1997-3#1)(2008-7#1)
in the databases##6##3##(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2013-8#1)
in the days##2##3##(2008-10#1)(2011-2#1)
in the dead##2##3##(2008-10#1)(2008-11#1)
in the debate##4##3##(1992-2#1)(1994-12#1)(1996-5#1)(2008-12#1)
in the decade##2##3##(1992-6#1)(2008-11#1)
in the decision##5##3##(1992-3#1)(2008-5#1)(2010-3#1)(2012-3#2)
in the decision-making process##3##4##(2008-12#1)(2009-1#1)(2011-2#1)
in the decoration of##2##4##(1995-2#1)(2008-10#1)
in the decrease of##2##4##(2008-10#1)(2009-10#1)
in the decrease##3##3##(1995-11#1)(2008-10#1)(2009-10#1)
in the deep##4##3##(2008-10#1)(2009-8#1)(2010-12#1)(2012-2#1)
in the defense response##3##4##(2008-10#2)(2008-9#1)
in the defense##6##3##(2008-10#3)(2008-9#2)(2010-7#1)
in the definition of##3##4##(1993-2#1)(2008-11#2)
in the degradation of##2##4##(1992-10#1)(1994-2#1)
in the degradation##3##3##(1992-10#1)(1994-2#1)(2010-4#1)
in the degree of##7##4##(1990-6#1)(1992-9#1)(2008-10#2)(2008-5#2)(2011-1#1)
in the delayed##2##3##(2013-1#2)
in the delivery of health services##2##6##(1993-2#1)(2009-3#1)
in the delivery of health##3##5##(1993-2#1)(1994-12#1)(2009-3#1)
in the delivery of##12##4##(1991-2#1)(1991-3#1)(1992-1#1)(1993-2#1)(1994-12#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-3#1)
in the delivery##14##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-12#1)(1996-6#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-3#1)
in the delta##3##3##(2008-11#2)(2013-8#1)
in the demand for##3##4##(1990-6#2)(2006-6#1)
in the denervated laminae was##2##5##(1997-3#2)
in the denervated neuropil##3##4##(1997-3#3)
in the denervated##7##3##(1995-11#1)(1997-3#6)
in the denominator##2##3##(1992-12#1)(2013-1#1)
in the density of##2##4##(1995-8#1)(2008-11#1)
in the density##4##3##(1995-8#1)(2008-11#1)(2008-5#2)
in the dental##6##3##(1990-9#1)(1991-3#1)(1993-1#1)(2008-7#1)(2013-1#2)
in the dentate gyrus and##3##5##(1996-12#2)(2008-11#1)
in the dentate gyrus of##4##5##(1994-8#2)(1995-12#2)
in the dentate gyrus##11##4##(1990-5#1)(1994-8#2)(1995-12#2)(1996-12#4)(2008-11#1)(2013-8#1)
in the department##2##3##(1991-11#1)(1993-3#1)
in the deposition##3##3##(2008-10#3)
in the dermal##2##3##(2008-5#2)
in the dermis and##4##4##(1996-12#1)(2008-5#2)(2010-6#1)
in the dermis##11##3##(1996-12#5)(2008-5#2)(2010-6#3)(2012-3#1)
in the descriptive epidemiology of##2##5##(1991-6#2)
in the desert##2##3##(1996-12#1)(2008-10#1)
in the design and implementation of##3##6##(1991-1#1)(2008-10#1)(2010-11#1)
in the design and monitoring of##2##6##(1996-6#2)
in the design and##8##4##(1991-1#1)(1996-6#2)(2008-10#2)(2008-7#1)(2010-11#1)(2013-8#1)
in the design of##11##4##(1992-9#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-2#2)
in the design##21##3##(1991-1#1)(1992-9#1)(1995-3#1)(1996-6#2)(1997-6#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2012-2#2)(2013-8#2)
in the destruction of##2##4##(2007-11#1)(2013-1#1)
in the details of##2##4##(1996-6#1)(1997-5#1)
in the detection and##6##4##(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#2)(2011-2#1)
in the detection cell##2##4##(2008-10#2)
in the detection of pancreatic islet cell tumours##2##8##(2008-2#2)
in the detection of##15##4##(1994-12#1)(1997-8#1)(2008-10#6)(2008-2#4)(2008-3#1)(2010-5#1)(2011-7#1)
in the detection##27##3##(1994-12#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#5)(2008-3#1)(2010-12#2)(2010-5#1)(2011-2#1)(2011-7#1)
in the determination of Cu(2+)##2##5##(2008-10#2)
in the determination of acid volatile sulfide##2##7##(2008-10#2)
in the determination of nitrite in saliva##2##7##(2008-10#2)
in the determination of rutin##2##5##(2008-10#2)
in the determination of thallium##2##5##(2008-10#2)
in the determination of the##10##5##(1995-11#1)(2008-10#8)(2011-1#1)
in the determination of these##3##5##(2008-10#3)
in the determination of trace amounts of##2##7##(2008-10#2)
in the determination of trace##3##5##(2008-10#3)
in the determination of##74##4##(1991-11#1)(1995-11#1)(1997-7#1)(2008-10#70)(2011-1#1)
in the determination##78##3##(1991-11#1)(1995-11#1)(1997-7#1)(2008-10#74)(2011-1#1)
in the determinations##2##3##(2008-10#2)
in the developed countries##2##4##(2008-3#1)(2010-8#1)
in the developed world##2##4##(1994-9#1)(2010-12#1)
in the developed##6##3##(1994-9#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#1)
in the developing CNS##2##4##(2008-7#2)
in the developing Drosophila##2##4##(1993-12#1)(2008-9#1)
in the developing and adult##2##5##(1996-12#1)(2008-1#1)
in the developing brain##3##4##(1994-2#1)(1995-12#2)
in the developing countries##2##4##(2008-11#1)(2011-2#1)
in the developing limb##2##4##(2008-11#2)
in the developing world##6##4##(1997-7#2)(2008-12#1)(2011-2#1)(2013-8#2)
in the developing##34##3##(1991-7#1)(1993-12#1)(1994-2#2)(1994-8#1)(1995-12#3)(1996-12#3)(1997-3#1)(1997-7#2)(1997-9#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
in the development and implementation of##2##6##(1994-2#1)(2008-11#1)
in the development and progression of##3##6##(2011-2#1)(2013-1#2)
in the development and##11##4##(1994-2#1)(1996-2#1)(2008-11#3)(2008-12#1)(2011-2#2)(2013-1#3)
in the development of a##10##5##(1994-11#1)(1996-6#1)(1997-6#1)(2008-10#3)(2008-11#2)(2011-2#2)
in the development of an##2##5##(1995-8#1)(2008-10#1)
in the development of analytical##2##5##(2008-10#1)(2011-2#1)
in the development of apple replant disease##2##7##(2008-10#2)
in the development of autoimmunity##2##5##(2008-10#1)(2010-5#1)
in the development of clinical##2##5##(2008-12#1)(2008-5#1)
in the development of more##2##5##(2008-7#1)(2012-2#1)
in the development of new##6##5##(1993-3#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-4#1)
in the development of the##7##5##(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the development of##128##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#5)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#28)(2008-11#11)(2008-12#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#14)(2011-3#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#6)
in the development##141##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#28)(2008-11#14)(2008-12#10)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#16)(2011-3#2)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#6)
in the developmental##3##3##(1996-12#1)(2008-5#1)(2008-9#1)
in the diabetes group##2##4##(1996-11#2)
in the diabetes##3##3##(1996-11#3)
in the diabetic##8##3##(1991-12#1)(1994-11#1)(2008-1#2)(2008-12#1)(2008-7#1)(2012-2#2)
in the diagnosis and follow-up of##4##6##(2011-1#1)(2011-2#1)(2012-2#2)
in the diagnosis and management of##12##6##(2008-12#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#2)(2011-7#4)
in the diagnosis and treatment of this##2##7##(2011-7#1)(2013-1#1)
in the diagnosis and treatment of##7##6##(1992-2#1)(1997-8#1)(2008-5#1)(2010-12#1)(2011-7#2)(2013-1#1)
in the diagnosis and treatment##8##5##(1992-2#1)(1997-8#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-7#2)(2013-1#1)
in the diagnosis and##29##4##(1992-2#1)(1996-11#1)(1997-8#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#3)(2009-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-7#6)(2012-2#3)(2013-1#1)
in the diagnosis of ICR##2##5##(2013-1#2)
in the diagnosis of patients##2##5##(2011-2#1)(2013-1#1)
in the diagnosis of the##2##5##(1990-3#1)(2008-12#1)
in the diagnosis of##39##4##(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1994-1#1)(1994-12#1)(1996-11#1)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-6#1)(2011-2#6)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#4)
in the diagnosis##71##3##(1990-12#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1994-1#1)(1994-12#1)(1996-11#2)(1997-4#1)(1997-8#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#4)(2008-9#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#9)(2011-3#1)(2011-7#6)(2012-2#7)(2012-3#3)(2013-1#6)
in the diagnostic process##2##4##(2008-10#1)(2013-1#1)
in the diagnostic work-up##2##4##(1997-3#1)(2012-2#1)
in the diagnostic##8##3##(1992-12#1)(1997-3#1)(2008-10#2)(2011-2#1)(2012-2#2)(2013-1#1)
in the dialysate##4##3##(2008-10#3)(2011-2#1)
in the diencephalic##2##3##(1993-8#1)(2008-7#1)
in the diet of##2##4##(2012-12#1)(2012-2#1)
in the diet##4##3##(1991-2#1)(2008-9#1)(2012-12#1)(2012-2#1)
in the dietary##3##3##(1990-8#1)(1994-12#1)(2008-10#1)
in the diets##2##3##(2010-8#1)(2011-2#1)
in the different cell##2##4##(2008-11#2)
in the different rockwool treatments##2##5##(2008-10#2)
in the different##27##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-2#2)(1996-3#1)(2006-6#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
in the differential diagnosis for##2##5##(2010-11#1)(2011-2#1)
in the differential diagnosis of a##2##6##(2009-1#1)(2010-12#1)
in the differential diagnosis of an##2##6##(2008-12#1)(2012-12#1)
in the differential diagnosis of any##2##6##(1997-3#1)(2012-3#1)
in the differential diagnosis of culture-negative##2##6##(1996-11#1)(2011-2#1)
in the differential diagnosis of##25##5##(1990-6#2)(1990-9#1)(1991-6#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-5#3)(2009-1#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in the differential diagnosis##31##4##(1990-6#2)(1990-9#1)(1991-6#1)(1993-2#2)(1996-11#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#3)(2009-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
in the differential##37##3##(1990-6#2)(1990-9#1)(1991-6#1)(1993-2#2)(1996-11#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-12#1)(2008-5#3)(2009-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
in the differentiating##2##3##(1990-5#2)
in the differentiation of##3##4##(2008-7#1)(2012-2#1)(2013-1#1)
in the differentiation##6##3##(1995-6#2)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
in the diffusion##3##3##(1997-6#1)(2008-10#1)(2008-7#1)
in the digested and slurry samples##2##6##(2008-10#2)
in the digestive gland##2##4##(2008-10#2)
in the digestive tract of##2##5##(2008-11#1)(2012-2#1)
in the digestive tract##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
in the digestive##8##3##(2007-12#1)(2008-10#3)(2008-11#1)(2009-7#1)(2011-2#1)(2012-2#1)
in the diluted##3##3##(2008-10#3)
in the direct##6##3##(2008-10#5)(2008-11#1)
in the direction of natural selection##2##6##(2012-3#2)
in the direction of the##2##5##(2008-10#2)
in the direction of##8##4##(1990-9#1)(1997-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-3#2)
in the direction##11##3##(1990-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#2)
in the disability##2##3##(1991-1#1)(1995-3#1)
in the disappearance of##2##4##(1997-5#1)(2009-9#1)
in the discovery of##2##4##(2008-10#1)(2010-7#1)
in the discussion##3##3##(1995-3#1)(2007-12#1)(2008-12#1)
in the disease##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
in the diseased organ##2##4##(1992-3#2)
in the disruption of##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
in the dissolved##2##3##(2008-10#2)
in the distal part of the##2##6##(2008-7#1)(2013-1#1)
in the distal##12##3##(1991-5#1)(1991-9#1)(1994-12#1)(1994-5#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2013-1#3)(2013-8#1)
in the distribution of the##5##5##(1991-1#1)(1992-2#1)(2008-10#2)(2012-12#1)
in the distribution of##12##4##(1991-1#1)(1992-12#1)(1992-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)
in the distribution##13##3##(1991-1#1)(1992-12#1)(1992-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)
in the diversity##2##3##(2008-10#1)(2008-9#1)
in the division##2##3##(1994-3#1)(2009-12#1)
in the domestic hen##2##4##(2008-12#2)
in the domestic##3##3##(2008-12#2)(2011-2#1)
in the donor##2##3##(2008-10#1)(2008-9#1)
in the dorsal and##2##4##(1996-12#2)
in the dorsal horn##3##4##(1994-2#1)(1995-12#1)(1997-3#1)
in the dorsal raphe##2##4##(1994-2#2)
in the dorsal root ganglion (DRG)##2##6##(1997-2#1)(2008-8#1)
in the dorsal root ganglion##4##5##(1995-12#1)(1997-2#2)(2008-8#1)
in the dorsal root##5##4##(1995-12#1)(1997-2#2)(2008-8#1)(2008-9#1)
in the dorsal##21##3##(1991-2#1)(1993-3#1)(1994-2#3)(1994-8#1)(1995-12#2)(1996-12#2)(1996-2#1)(1997-2#2)(1997-3#2)(2007-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
in the dorsolateral##2##3##(2008-12#1)(2008-7#1)
in the dorsoventral plane##2##4##(1990-3#1)(1997-3#1)
in the dosage##2##3##(2008-10#1)(2010-5#1)
in the dose##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
in the double##4##3##(1997-1#2)(2009-8#1)(2010-5#1)
in the downstream##3##3##(2008-4#1)(2008-8#1)(2013-1#1)
in the draining##2##3##(1997-3#1)(2008-10#1)
in the drinking water##8##4##(1990-6#1)(2008-10#1)(2008-9#5)(2013-7#1)
in the drop##2##3##(1991-5#1)(2008-10#1)
in the drug substance##2##4##(1997-2#1)(2008-10#1)
in the drug##6##3##(1991-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-2#1)
in the duodenum##2##3##(1995-11#1)(2013-1#1)
in the duplex oligomers containing##2##5##(2008-11#2)
in the duration##2##3##(1993-1#1)(2008-9#1)
in the dynamic##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
in the dynamics of##3##4##(2008-9#3)
in the dynamics##4##3##(2008-8#1)(2008-9#3)
in the ear##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
in the earlier##3##3##(1990-3#1)(1991-12#1)(1991-6#1)
in the earliest stages of##2##5##(2008-10#1)(2012-7#1)
in the earliest##5##3##(1994-3#1)(1995-1#1)(2008-10#1)(2008-9#1)(2012-7#1)
in the early 1900s##2##4##(2008-10#1)(2008-3#1)
in the early 1950s##2##4##(2008-9#1)(2010-1#1)
in the early 1960s##3##4##(1996-12#1)(2009-7#1)(2010-7#1)
in the early 1970s##2##4##(1996-3#1)(2008-12#1)
in the early 1980s##3##4##(1994-2#1)(1996-11#1)(1996-5#1)
in the early 1990s as##2##5##(1993-3#1)(2008-6#1)
in the early 1990s##5##4##(1993-3#1)(2008-10#2)(2008-6#1)(2010-12#1)
in the early detection of##2##5##(2008-7#1)(2011-2#1)
in the early diagnosis of##2##5##(1990-9#1)(1993-3#1)
in the early diagnosis##3##4##(1990-9#1)(1993-3#1)(2013-1#1)
in the early embryo##4##4##(2007-12#2)(2009-8#1)(2012-3#1)
in the early period##2##4##(2008-11#1)(2010-11#1)
in the early phase of##2##5##(1994-11#1)(2010-1#1)
in the early phase##3##4##(1994-11#1)(2010-1#1)(2011-2#1)
in the early phases of##2##5##(1995-3#1)(2012-12#1)
in the early postoperative period##2##5##(1994-3#1)(2011-2#1)
in the early sixteenth century##2##5##(2008-11#1)(2012-2#1)
in the early stage of##6##5##(1992-12#1)(1993-12#1)(2008-10#1)(2008-9#2)(2009-12#1)
in the early stages of##8##5##(1996-3#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#3)
in the early stages##11##4##(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#3)
in the early to##3##4##(2008-10#2)(2008-11#1)
in the early##86##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-3#1)(2007-12#4)(2008-10#13)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#4)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)
in the earth's crust##2##4##(2008-10#1)(2013-8#1)
in the east##3##3##(2008-10#3)
in the eastern United States##3##5##(2008-10#3)
in the eastern##9##3##(2008-10#7)(2009-8#1)(2012-3#1)
in the ecological##2##3##(2008-8#1)(2008-9#1)
in the ecosystem##3##3##(1997-7#1)(2008-12#2)
in the ectoderm##2##3##(2007-12#1)(2008-7#1)
in the education of health##3##5##(1993-2#1)(2008-11#2)
in the education of##5##4##(1993-2#1)(2008-11#3)(2008-12#1)
in the educational##2##3##(2008-12#1)(2010-9#1)
in the effect##3##3##(1995-11#1)(2008-10#1)(2008-9#1)
in the effective##2##3##(1996-6#1)(2013-8#1)
in the effectiveness of##2##4##(2012-12#1)(2012-2#1)
in the efficiency of##2##4##(2008-10#1)(2008-11#1)
in the effluent##4##3##(2008-10#3)(2008-7#1)
in the effort to##3##4##(1994-9#1)(2008-11#1)(2012-3#1)
in the effort##4##3##(1991-3#1)(1994-9#1)(2008-11#1)(2012-3#1)
in the efforts to##2##4##(1993-3#1)(1996-11#1)
in the egg##5##3##(2008-10#1)(2008-11#3)(2008-9#1)
in the eighties##2##3##(1994-11#1)(2012-12#1)
in the elaboration of##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
in the elderly and##2##4##(1997-8#1)(2012-3#1)
in the elderly patient##2##4##(1990-11#1)(1992-3#1)
in the elderly patients##4##4##(2008-10#1)(2008-7#3)
in the elderly population##4##4##(1993-3#1)(2008-12#1)(2008-8#1)(2012-3#1)
in the elderly##63##3##(1990-11#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-12#4)(1993-3#1)(1993-9#1)(1994-5#1)(1995-8#2)(1996-2#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#12)(2008-8#7)(2008-9#1)(2009-1#3)(2009-10#1)(2009-9#1)(2011-2#3)(2012-3#4)(2013-1#2)
in the elderly]##4##3##(1990-3#1)(1993-3#1)(1993-5#1)(1994-6#1)
in the electrical activity of##2##5##(1994-2#1)(2010-8#1)
in the electrochemical detection of##2##5##(2008-12#2)
in the electrochemical##4##3##(2008-10#2)(2008-12#2)
in the electrode potential##2##4##(2008-10#2)
in the electrode##7##3##(2008-10#7)
in the electrolyte##2##3##(2008-10#1)(2010-7#1)
in the electron##2##3##(2008-10#1)(2008-11#1)
in the electronic##4##3##(1997-5#1)(2011-2#1)(2013-1#2)
in the elevated plus-maze test##2##5##(1993-3#1)(2008-11#1)
in the elevated plus-maze##5##4##(1993-3#2)(2008-11#3)
in the elimination of the##2##5##(1991-3#1)(2012-12#1)
in the elimination of##4##4##(1991-3#1)(2008-9#1)(2009-12#1)(2012-12#1)
in the eluant##2##3##(2008-10#2)
in the embryo##3##3##(2008-10#1)(2008-11#2)
in the embryonic##2##3##(1993-6#1)(2007-12#1)
in the emergence of##3##4##(2008-11#3)
in the emergency department (ED)##2##5##(2009-6#1)(2010-8#1)
in the emergency department##18##4##(1991-12#1)(2006-5#2)(2008-11#2)(2008-3#4)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
in the emergency room##2##4##(2007-12#1)(2011-2#1)
in the emergency setting##3##4##(2006-5#2)(2012-2#1)
in the emergency##24##3##(1991-12#1)(2006-5#4)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
in the emission##3##3##(2008-10#3)
in the emulsion##2##3##(2008-10#1)(2008-5#1)
in the end##3##3##(1994-2#1)(2008-10#1)(2009-10#1)
in the endemic##2##3##(2011-2#2)
in the endocrine##2##3##(1990-11#1)(1994-8#1)
in the endometrium##3##3##(2008-9#2)(2012-3#1)
in the endoplasmic reticulum (ER)##3##5##(1995-2#1)(2008-11#1)(2009-8#1)
in the endoplasmic reticulum##9##4##(1995-2#3)(1995-6#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-8#1)
in the endoplasmic reticulum-Golgi##2##4##(1993-8#1)(1994-11#1)
in the endoplasmic##12##3##(1993-8#1)(1994-11#1)(1995-2#3)(1995-6#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#1)
in the endosperm##3##3##(2008-10#2)(2009-12#1)
in the endothelium of##2##4##(2012-3#2)
in the endothelium##4##3##(1995-2#1)(2012-3#3)
in the energy##3##3##(2008-10#2)(2009-8#1)
in the enhancement of##3##4##(1993-3#1)(2008-10#1)(2012-2#1)
in the enhancement##4##3##(1993-3#1)(1997-8#1)(2008-10#1)(2012-2#1)
in the entire##6##3##(1996-2#1)(2008-10#3)(2008-9#1)(2011-2#1)
in the environment and##2##4##(2011-1#1)(2011-2#1)
in the environment at trace##2##5##(2008-10#2)
in the environment##49##3##(1994-3#1)(1996-2#1)(1996-3#1)(2008-10#25)(2008-11#7)(2008-8#3)(2009-8#1)(2010-5#1)(2011-1#5)(2011-2#2)(2012-2#1)(2012-3#1)
in the environmental and##3##4##(2008-10#3)
in the environmental##15##3##(2008-10#12)(2008-8#2)(2009-8#1)
in the enzymatic reaction##2##4##(1991-5#1)(2008-10#1)
in the enzymatic##5##3##(1991-5#1)(2008-10#3)(2009-5#1)
in the enzyme active site##2##5##(1995-6#2)
in the enzyme activity##6##4##(1994-8#2)(1995-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
in the enzyme##11##3##(1994-8#2)(1995-11#1)(1995-6#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
in the epidemic##4##3##(2008-10#3)(2011-2#1)
in the epidemiology of##7##4##(1995-9#1)(2008-10#4)(2011-2#1)(2011-3#1)
in the epidemiology##8##3##(1995-9#1)(2008-10#4)(2010-12#1)(2011-2#1)(2011-3#1)
in the epidermal##2##3##(2008-9#2)
in the epidermis and##3##4##(2008-10#3)
in the epidermis of##2##4##(1996-12#1)(2008-5#1)
in the epidermis##11##3##(1995-11#1)(1996-12#3)(2008-10#3)(2008-5#2)(2010-6#1)(2010-7#1)
in the epithelial##2##3##(2007-12#1)(2008-12#1)
in the epithelium and in##2##5##(2013-1#2)
in the epithelium of the##2##5##(2008-12#1)(2010-11#1)
in the epithelium##6##3##(2008-12#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
in the era of health care reform##2##7##(2010-5#1)(2010-8#1)
in the era of health##3##5##(1996-1#1)(2010-5#1)(2010-8#1)
in the era of##5##4##(1993-1#2)(1996-1#1)(2010-5#1)(2010-8#1)
in the eradication of##2##4##(1995-5#1)(2010-1#1)
in the eradication##3##3##(1995-5#1)(2008-10#1)(2010-1#1)
in the esophagus##2##3##(2008-11#1)(2010-12#1)
in the essential oil of##2##5##(2008-11#2)
in the established##2##3##(1996-9#1)(2013-1#1)
in the establishment of##3##4##(1992-1#1)(2008-10#2)
in the estimation##2##3##(2008-3#2)
in the etching solution##2##4##(2008-10#2)
in the etiology and##2##4##(1990-11#1)(2008-8#1)
in the etiology of many##2##5##(1990-8#1)(2008-5#1)
in the etiology of##21##4##(1990-8#1)(1995-2#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the etiology##23##3##(1990-11#1)(1990-8#1)(1995-2#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the euryarchaeal##2##3##(2011-2#2)
in the evaluation and treatment##2##5##(2008-9#1)(2009-1#1)
in the evaluation and##4##4##(1995-5#1)(2008-10#1)(2008-9#1)(2009-1#1)
in the evaluation of patients with a##2##7##(2008-9#2)
in the evaluation of patients with##3##6##(2008-9#2)(2012-2#1)
in the evaluation of the##4##5##(1990-5#1)(1991-3#1)(2008-7#1)(2008-9#1)
in the evaluation of##23##4##(1990-11#1)(1990-5#1)(1991-3#1)(1993-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#4)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#3)(2013-1#1)
in the evaluation##27##3##(1990-11#1)(1990-5#1)(1991-3#1)(1993-2#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#5)(2009-1#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#3)(2013-1#1)
in the event of##4##4##(1991-6#1)(2010-1#1)(2011-2#2)
in the event##5##3##(1991-6#1)(1997-8#1)(2010-1#1)(2011-2#2)
in the events that##2##4##(2008-11#2)
in the events##3##3##(1995-11#1)(2008-11#2)
in the evolution of many##2##5##(2008-8#1)(2009-10#1)
in the evolution of the##4##5##(1992-11#1)(2008-11#1)(2008-12#1)(2012-3#1)
in the evolution of##22##4##(1990-7#1)(1992-11#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-1#1)(2013-8#1)
in the evolutionary##4##3##(2008-8#1)(2008-9#2)(2009-6#1)
in the examination of##2##4##(1995-11#1)(2008-12#1)
in the examination##3##3##(1995-11#2)(2008-12#1)
in the examples##2##3##(2008-10#1)(2010-7#1)
in the excited state##3##4##(1995-11#1)(2008-10#2)
in the excited##4##3##(1995-11#1)(2008-10#3)
in the exhaust duct##2##4##(2008-3#2)
in the exhaust##4##3##(2008-3#4)
in the existing##6##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-3#1)(2012-2#1)
in the exocarp##3##3##(2008-10#3)
in the exoskeleton##2##3##(2007-12#2)
in the experiment##4##3##(1996-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
in the experimental and control groups##2##6##(1991-12#1)(2011-2#1)
in the experimental and##3##4##(1991-12#1)(2011-2#1)(2013-8#1)
in the experimental conditions##2##4##(2008-10#2)
in the experimental field##2##4##(2008-10#1)(2010-1#1)
in the experimental group##11##4##(1992-9#1)(1993-6#1)(1995-1#1)(2008-11#3)(2008-12#3)(2010-4#1)(2012-3#1)
in the experimental model##2##4##(1997-6#1)(2008-12#1)
in the experimental than##3##4##(1995-6#3)
in the experimental##30##3##(1990-6#1)(1991-12#1)(1992-9#1)(1993-6#1)(1995-1#2)(1995-6#3)(1997-6#1)(2008-10#8)(2008-11#3)(2008-12#4)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
in the experiments##6##3##(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)
in the exploration##2##3##(2008-8#1)(2009-12#1)
in the exponential phase of##3##5##(1994-8#1)(2008-11#2)
in the exponential##5##3##(1994-8#1)(1995-9#1)(2008-11#2)(2008-7#1)
in the exposed##3##3##(1993-12#1)(2008-9#1)(2009-12#1)
in the exposure##2##3##(1990-5#1)(1993-8#1)
in the expression of this##2##5##(1994-8#1)(1996-2#1)
in the expression of##25##4##(1992-3#2)(1993-3#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#3)
in the expression vector##2##4##(1990-5#1)(2008-10#1)
in the expression##29##3##(1990-5#1)(1991-5#1)(1992-3#2)(1993-3#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#3)
in the extended##2##3##(1990-8#1)(2009-4#1)
in the extent of##5##4##(1995-5#1)(2008-10#3)(2008-11#1)
in the extent##7##3##(1995-5#1)(2008-10#4)(2008-11#2)
in the external##6##3##(1993-12#1)(2008-10#2)(2008-8#1)(2010-4#1)(2013-8#1)
in the extinction##2##3##(2008-10#1)(2008-8#1)
in the extracellular concentrations of acetylcholine in neostriatum##2##8##(1994-8#2)
in the extracellular matrix##4##4##(1995-2#1)(1995-8#1)(2008-11#1)(2008-5#1)
in the extracellular space##2##4##(1992-11#1)(1994-8#1)
in the extracellular##15##3##(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-8#1)(1997-9#1)(2008-11#1)(2008-5#1)(2008-8#1)
in the extracorporeal##2##3##(1991-11#1)(1992-1#1)
in the extract of##2##4##(1992-3#1)(2008-5#1)
in the extract##7##3##(1992-3#1)(2008-10#3)(2008-5#2)(2008-8#1)
in the extraction of##2##4##(2008-10#2)
in the extraction process##3##4##(2008-10#3)
in the extraction solution##2##4##(2008-10#2)
in the extraction time of IPB relative to##2##8##(2008-10#2)
in the extraction time of##3##5##(2008-10#3)
in the extraction vessel##2##4##(2008-10#2)
in the extraction##21##3##(2008-10#21)
in the extracts by##2##4##(2008-10#2)
in the extracts of##2##4##(2008-10#2)
in the extracts were##2##4##(2008-10#2)
in the extracts##12##3##(2008-10#11)(2013-8#1)
in the extreme##2##3##(2008-10#2)
in the extremely##2##3##(1995-6#1)(2008-11#1)
in the eye##9##3##(1994-2#2)(2008-12#1)(2008-9#2)(2010-1#2)(2011-2#1)(2013-8#1)
in the eyes of##4##4##(1994-3#1)(2008-6#1)(2010-8#1)(2013-1#1)
in the fabrication of##4##4##(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)
in the face of##10##4##(1993-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
in the face##13##3##(1993-1#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-11#2)(2008-5#3)(2008-7#1)(2010-7#1)(2011-2#1)
in the faeces of##2##4##(2008-11#1)(2008-5#1)
in the failure of##2##4##(2008-11#2)
in the failure##3##3##(2008-11#2)(2013-8#1)
in the fall issue of Radiology Management##2##7##(1991-2#1)(1995-2#1)
in the fall of 1994##2##5##(2008-10#2)
in the fall of##5##4##(1996-1#1)(2008-10#4)
in the fall##11##3##(1991-2#1)(1995-2#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-8#1)
in the families##2##3##(2007-12#1)(2008-10#1)
in the family Cucurbitaceae##2##4##(2008-10#2)
in the family and##3##4##(2008-10#1)(2008-12#1)(2009-12#1)
in the family##21##3##(1990-11#1)(1997-3#1)(2008-10#6)(2008-12#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-6#2)(2011-2#5)(2012-3#2)
in the far-field##2##3##(2008-3#2)
in the fasted state##2##4##(1991-3#2)
in the fasting##2##3##(1991-7#1)(2008-6#1)
in the fat##3##3##(1995-2#3)
in the fed-batch##2##3##(2008-11#2)
in the fee-for-service sector##2##4##(1993-1#1)(1993-3#1)
in the feed solution and##2##5##(2008-10#2)
in the feed solution##3##4##(2008-10#3)
in the feed##6##3##(1995-11#1)(2008-10#4)(2008-12#1)
in the feeder##2##3##(1997-3#2)
in the feeding##5##3##(1996-6#1)(2008-10#2)(2008-11#1)(2008-6#1)
in the female genital tract##2##5##(2009-2#1)(2011-2#1)
in the female##8##3##(1991-11#1)(1992-3#4)(2008-10#1)(2009-2#1)(2011-2#1)
in the females##4##3##(1994-2#1)(2008-12#1)(2008-7#1)(2008-9#1)
in the femoral neck##2##4##(2009-3#1)(2011-2#1)
in the femoral##3##3##(2009-3#1)(2011-2#2)
in the fermentation##2##3##(2008-10#1)(2008-7#1)
in the fetal##5##3##(1994-3#1)(1995-8#1)(2008-1#1)(2008-10#1)(2013-1#1)
in the fiber##3##3##(2008-10#1)(2008-3#2)
in the fibre##5##3##(2008-10#2)(2011-2#2)(2013-1#1)
in the fibrous matrix##2##4##(2008-11#2)
in the fibrous##3##3##(2008-11#3)
in the field and greenhouse##2##5##(2008-10#2)
in the field and##11##4##(2008-10#8)(2008-5#1)(2010-12#1)(2011-2#1)
in the field at##2##4##(2008-10#2)
in the field experiments##2##4##(2008-10#1)(2008-9#1)
in the field for##3##4##(2008-10#2)(2008-8#1)
in the field in##5##4##(2008-10#5)
in the field is##2##4##(2008-10#2)
in the field of Health Services Research in##2##8##(2012-2#2)
in the field of cancer##2##5##(2008-11#2)
in the field of environmental##2##5##(2008-10#2)
in the field of health##2##5##(1992-3#1)(2011-2#1)
in the field of microbiology##3##5##(2008-10#1)(2008-9#2)
in the field of oncology##2##5##(1991-8#1)(2010-5#1)
in the field of ophthalmology##2##5##(1995-9#1)(2011-7#1)
in the field of##77##4##(1990-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-1#1)(1994-9#2)(1995-1#1)(1995-9#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-10#14)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#3)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#4)
in the field to##2##4##(1995-6#1)(2008-10#1)
in the field was##3##4##(2008-10#3)
in the field were##5##4##(2008-10#5)
in the field which##2##4##(2008-10#1)(2012-2#1)
in the field with##4##4##(2008-10#3)(2008-11#1)
in the field##234##3##(1990-3#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#2)(1993-1#1)(1994-1#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#133)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#3)(2009-4#2)(2009-6#3)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#7)(2012-8#1)(2013-1#2)(2013-8#4)
in the fields of##6##4##(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#1)(2013-8#1)
in the fields##8##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#1)(2013-8#1)
in the fifth##3##3##(1994-12#1)(1996-6#1)(2012-3#1)
in the fight against##3##4##(1993-12#1)(1995-1#1)(2012-3#1)
in the figure-of-8 construct compared with 0##2##7##(2009-3#2)
in the film##5##3##(1997-2#2)(2008-10#3)
in the filters##2##3##(1992-5#1)(2008-10#1)
in the filtrate##5##3##(2008-10#5)
in the final model##2##4##(2008-10#1)(2009-7#1)
in the final##28##3##(1990-5#1)(1992-3#1)(1992-6#1)(1995-1#2)(1997-3#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#1)(2011-2#1)(2011-7#1)(2013-1#3)
in the financial##2##3##(1997-1#1)(2010-5#1)
in the fine structure##2##4##(1992-1#1)(2007-12#1)
in the fine##3##3##(1992-1#1)(1997-5#1)(2007-12#1)
in the finite##2##3##(2010-11#1)(2013-1#1)
in the firing##3##3##(2008-10#1)(2008-11#2)
in the first 2##2##4##(2008-7#2)
in the first 3##3##4##(1991-3#1)(2010-6#1)(2011-2#1)
in the first 5##2##4##(1993-12#1)(2008-3#1)
in the first and second##4##5##(1996-3#1)(1996-6#1)(2008-10#2)
in the first and##5##4##(1996-3#1)(1996-6#1)(2008-10#3)
in the first case and##2##5##(2008-5#1)(2010-12#1)
in the first case##6##4##(1993-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
in the first experiment##2##4##(2008-10#2)
in the first few hours after##2##6##(2008-11#1)(2008-6#1)
in the first few hours##3##5##(2008-11#1)(2008-6#1)(2011-2#1)
in the first few months of##2##6##(1996-9#1)(2012-2#1)
in the first few##9##4##(1996-9#2)(1997-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
in the first group (n =##2##6##(1991-5#1)(2012-3#1)
in the first group##7##4##(1990-2#1)(1991-5#1)(1994-12#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the first half of the##4##6##(2008-11#1)(2008-12#1)(2010-1#2)
in the first half of##5##5##(1993-3#1)(2008-11#1)(2008-12#1)(2010-1#2)
in the first intron##5##4##(1991-6#1)(1992-6#1)(1993-2#2)(2012-3#1)
in the first period##2##4##(1996-11#1)(2011-2#1)
in the first place##2##4##(2008-9#1)(2011-2#1)
in the first three##2##4##(2008-10#1)(2009-7#1)
in the first trimester##4##4##(1990-6#1)(1993-3#2)(2011-1#1)
in the first two years##2##5##(2011-2#1)(2012-2#1)
in the first two##4##4##(1994-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the first upper true leaves at 14 dpi##2##9##(2008-10#2)
in the first upper##3##4##(2008-10#2)(2008-8#1)
in the first year of the##3##6##(1991-2#1)(1991-3#1)(2008-10#1)
in the first year of##5##5##(1991-2#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
in the first year##6##4##(1991-2#2)(1991-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
in the first##131##3##(1990-2#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#3)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-5#1)(2008-10#23)(2008-11#12)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-1#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
in the fish##2##3##(2008-10#1)(2011-2#1)
in the fission yeast Schizosaccharomyces pombe##2##6##(1995-9#1)(1997-3#1)
in the fitness##2##3##(2008-10#1)(2008-11#1)
in the flame##2##3##(2008-10#1)(2008-3#1)
in the floral##4##3##(2008-10#1)(2008-8#3)
in the flow cell and##2##5##(2008-10#2)
in the flow cell##7##4##(2008-10#7)
in the flow injection system##3##5##(2008-10#3)
in the flow injection##4##4##(2008-10#4)
in the flow system##13##4##(2008-10#13)
in the flow##29##3##(2008-10#26)(2008-3#1)(2008-7#1)(2008-9#1)
in the flow-through##2##3##(2008-10#2)
in the flowing##2##3##(2008-10#2)
in the fluid##3##3##(2008-10#1)(2008-7#2)
in the fluorescence intensity of the##2##6##(1995-6#1)(2008-10#1)
in the fluorescence intensity##4##4##(1995-6#1)(2008-10#3)
in the fluorescence##11##3##(1995-6#1)(2008-10#10)
in the flux##2##3##(1994-8#1)(2008-11#1)
in the fly##2##3##(2008-10#1)(2008-11#1)
in the focal##2##3##(2008-2#1)(2008-3#1)
in the foetal livers##2##4##(1990-5#2)
in the foetal##3##3##(1990-5#3)
in the folding and maturation of##2##6##(2009-6#2)
in the foliage##2##3##(2008-10#2)
in the follicle##2##3##(2008-7#1)(2008-8#1)
in the follow-up of patients with##2##6##(1990-6#1)(1997-8#1)
in the follow-up of##4##4##(1990-6#1)(1997-8#2)(2011-2#1)
in the follow-up##8##3##(1990-6#1)(1997-3#1)(1997-8#3)(2008-11#1)(2011-2#1)(2012-12#1)
in the following order##8##4##(2008-10#7)(2008-11#1)
in the following##26##3##(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2013-1#3)
in the food chain##5##4##(1994-3#1)(2008-10#3)(2011-2#1)
in the food industry##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
in the food##11##3##(1994-3#1)(2008-10#5)(2010-6#1)(2010-7#2)(2011-2#2)
in the foot and ankle##4##5##(2010-7#1)(2011-2#2)(2012-2#1)
in the foot##6##3##(2008-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
in the forearm##2##3##(1994-6#1)(2008-9#1)
in the forensic##2##3##(2008-10#2)
in the foreseeable future##2##4##(2007-12#1)(2008-8#1)
in the forest##2##3##(2008-10#1)(2009-8#1)
in the forests of this region##2##6##(1996-11#1)(2012-12#1)
in the form of a##16##5##(1991-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the form of an##4##5##(1994-5#1)(2008-10#3)
in the form of its##2##5##(2008-10#2)
in the form of the##2##5##(2008-10#1)(2008-12#1)
in the form of##80##4##(1991-12#1)(1993-12#1)(1994-5#2)(1994-9#1)(1995-3#2)(2008-10#33)(2008-11#6)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-3#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
in the formal##4##3##(1997-3#1)(2008-10#3)
in the formation of a##3##5##(2007-12#1)(2008-10#2)
in the formation of ion##2##5##(2008-10#1)(2008-9#1)
in the formation of oospores##2##5##(2008-10#2)
in the formation of the##4##5##(1991-3#1)(1996-5#1)(2008-10#1)(2009-10#1)
in the formation of two##2##5##(2008-10#2)
in the formation of##31##4##(1990-11#1)(1991-3#1)(1995-2#1)(1996-5#4)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)
in the formation##35##3##(1990-11#1)(1991-3#1)(1994-5#1)(1995-2#1)(1996-5#4)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)
in the former##11##3##(1993-12#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)
in the forms##2##3##(1991-3#1)(2008-10#1)
in the formulation of##3##4##(1995-12#1)(2008-11#1)(2008-5#1)
in the formulation##6##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#2)
in the formulations##3##3##(2008-10#2)(2008-5#1)
in the forward direction##2##4##(2008-10#1)(2008-2#1)
in the forward##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
in the four##11##3##(1995-6#1)(2006-6#1)(2008-10#6)(2008-3#1)(2009-4#1)(2011-2#1)
in the fourth ventricle##2##4##(2008-7#1)(2013-1#1)
in the fourth##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#2)
in the fraction were##3##4##(2008-11#3)
in the fraction##6##3##(2008-10#2)(2008-11#3)(2008-8#1)
in the fractions of##2##4##(1992-6#1)(2008-10#1)
in the fractions##4##3##(1992-6#1)(1997-3#1)(2008-10#1)(2008-11#1)
in the frame of a##2##5##(2008-10#1)(2012-2#1)
in the frame of##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
in the framework of the##3##5##(2008-11#1)(2008-7#1)(2013-1#1)
in the framework of##6##4##(1990-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
in the free##3##3##(1990-12#1)(2008-10#1)(2008-12#1)
in the frequencies of##3##4##(2008-10#3)
in the frequency and the##2##5##(2008-3#2)
in the frequency and##4##4##(2008-11#1)(2008-3#2)(2009-11#1)
in the frequency domain##2##4##(2008-3#1)(2008-8#1)
in the frequency of##12##4##(1990-6#2)(1996-6#1)(2008-10#4)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
in the frequency##19##3##(1990-6#2)(1996-6#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-8#1)(2009-10#1)(2009-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
in the freshwater##2##3##(2008-10#1)(2010-6#1)
in the front##2##3##(1995-6#1)(2008-10#1)
in the frontal##5##3##(1996-12#2)(2008-7#2)(2010-8#1)
in the fruit of##2##4##(2008-10#1)(2013-8#1)
in the fruit##4##3##(1997-7#1)(2008-10#2)(2013-8#1)
in the fully##2##3##(2012-2#2)
in the function of##3##4##(1997-2#1)(2011-2#1)(2012-3#1)
in the function##4##3##(1996-2#1)(1997-2#1)(2011-2#1)(2012-3#1)
in the functional phloem##2##4##(2008-10#2)
in the functional##9##3##(1995-11#1)(2008-10#3)(2008-11#1)(2008-7#2)(2011-2#2)
in the functioning of the##2##5##(1992-1#1)(2008-7#1)
in the fungal genome##2##4##(2008-10#1)(2011-1#1)
in the fungal##6##3##(2008-10#3)(2008-11#1)(2009-8#1)(2011-1#1)
in the further##2##3##(1996-2#1)(1997-8#1)
in the future as##2##4##(2009-6#1)(2010-11#1)
in the future of##3##4##(1994-1#1)(1996-3#1)(2008-11#1)
in the future##63##3##(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#3)(1997-3#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
in the gain medium##2##4##(2008-3#2)
in the gallbladder##5##3##(1990-9#1)(1996-6#1)(1997-8#3)
in the gas phase##7##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)
in the gas##9##3##(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)
in the gastric mucosa##2##4##(1990-3#1)(1997-7#1)
in the gastric##7##3##(1990-3#1)(1991-6#1)(1992-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2010-12#1)
in the gastrointestinal tract of##3##5##(2013-1#3)
in the gastrointestinal tract##9##4##(1994-12#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#4)
in the gastrointestinal##12##3##(1992-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
in the gel shift assay##2##5##(1993-8#2)
in the gel##7##3##(1993-8#2)(2008-10#5)
in the gender##2##3##(2010-7#1)(2011-2#1)
in the gene encoding the##2##5##(1994-12#1)(2013-1#1)
in the gene encoding##4##4##(1993-12#1)(1994-11#1)(1994-12#1)(2013-1#1)
in the gene expression of##2##5##(1991-5#1)(2013-7#1)
in the gene expression##3##4##(1991-5#1)(2008-10#1)(2013-7#1)
in the gene##16##3##(1990-5#1)(1991-12#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-4#2)(2008-6#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
in the genera##3##3##(2008-10#3)
in the general population of##3##5##(2007-12#1)(2008-1#1)(2008-7#1)
in the general population##19##4##(1990-11#1)(1991-12#1)(1992-11#1)(1992-9#1)(1995-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-9#1)(2010-12#1)(2013-1#4)
in the general public##2##4##(2008-7#1)(2012-3#1)
in the general##29##3##(1990-11#1)(1990-6#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-11#1)(1995-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#6)(2009-9#1)(2010-12#3)(2012-3#1)(2013-1#4)
in the generalized Shwartzman reaction##3##5##(1996-12#3)
in the generalized##4##3##(1996-12#3)(2008-3#1)
in the generation and##2##4##(2008-4#1)(2011-2#1)
in the generation of moral##2##5##(2008-11#2)
in the generation of##12##4##(2008-10#2)(2008-11#6)(2008-5#1)(2009-12#1)(2010-11#1)(2013-8#1)
in the generation##15##3##(2008-10#3)(2008-11#6)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#1)(2013-8#1)
in the genes##3##3##(2007-12#1)(2008-6#1)(2009-8#1)
in the genesis of##5##4##(1991-12#1)(1995-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
in the genetic analysis of schizophrenia##2##6##(2010-1#2)
in the genetic background of##3##5##(2008-10#2)(2009-10#1)
in the genetic code##2##4##(2012-2#2)
in the genetic##11##3##(1996-12#1)(2008-10#3)(2008-8#1)(2009-10#1)(2010-1#2)(2012-2#2)(2012-3#1)
in the genetics of##2##4##(2008-8#1)(2012-3#1)
in the genome of the##2##5##(1996-12#1)(2010-8#1)
in the genome of transgenic##2##5##(2008-8#1)(2008-9#1)
in the genome of##6##4##(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-8#1)
in the genome##17##3##(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-4#1)(2008-10#4)(2008-8#1)(2008-9#3)(2009-8#1)(2010-8#1)(2011-2#1)
in the genomes of fungal pathogens##2##6##(2009-6#2)
in the genomes of##3##4##(2008-10#1)(2009-6#2)
in the genomic DNA##2##4##(1992-6#1)(2010-7#1)
in the genomic region##2##4##(1997-2#2)
in the genomic##5##3##(1992-6#1)(1997-2#2)(2008-8#1)(2010-7#1)
in the genomics##2##3##(2008-2#1)(2011-2#1)
in the genus Solanum##3##4##(2008-10#3)
in the genus Tospovirus##3##4##(2008-10#3)
in the genus Trichoderma##2##4##(2008-10#2)
in the genus##25##3##(2008-10#18)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#2)(2013-1#1)
in the geriatric population##2##4##(1993-5#1)(2009-8#1)
in the geriatric##5##3##(1990-9#1)(1992-1#1)(1993-5#1)(2009-8#1)(2011-2#1)
in the germ line##2##4##(1995-2#2)
in the germ##3##3##(1995-2#2)(2008-10#1)
in the giant grouper##2##4##(2010-5#2)
in the giant##3##3##(2008-8#1)(2010-5#2)
in the gills and##2##4##(2008-10#1)(2008-12#1)
in the glandular##2##3##(1995-6#1)(2008-7#1)
in the glass##2##3##(2008-10#1)(2012-2#1)
in the global##4##3##(1990-11#1)(2009-4#1)(2009-5#1)(2013-1#1)
in the globin##2##3##(1990-8#1)(2008-9#1)
in the glucose##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
in the gluteal region##2##4##(2009-9#1)(2011-2#1)
in the glycolytic pathway##2##4##(2008-11#1)(2008-7#1)
in the goldfish##6##3##(1991-2#5)(2011-2#1)
in the granule neurons##2##4##(1995-8#2)
in the granule##3##3##(1992-6#1)(1995-8#2)
in the granulosa layer of the##2##6##(2008-12#2)
in the granulosa##4##3##(2008-12#2)(2008-8#1)(2008-9#1)
in the graphite tube##4##4##(2008-10#4)
in the graphite##6##3##(2008-10#6)
in the great##3##3##(1997-6#2)(2011-2#1)
in the greater Milan area##2##5##(1990-12#1)(1990-8#1)
in the greenhouse and at##2##5##(2008-10#2)
in the greenhouse and in##3##5##(2008-10#3)
in the greenhouse and##9##4##(2008-10#9)
in the greenhouse or##2##4##(2008-10#2)
in the greenhouse##43##3##(2008-10#43)
in the ground squirrel##3##4##(1990-5#1)(2008-8#2)
in the ground##8##3##(1990-5#1)(2007-12#1)(2008-10#3)(2008-8#3)
in the group of##8##4##(1992-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the group treated with##3##5##(1991-2#1)(1993-2#1)(2013-1#1)
in the group who##2##4##(1991-6#1)(1997-3#1)
in the group with##5##4##(1990-8#1)(1994-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
in the group without bone metastasis##2##6##(1994-12#2)
in the group##31##3##(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#3)(1994-3#2)(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#5)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
in the groups##2##3##(1993-6#1)(2008-6#1)
in the growing season##4##4##(2008-10#4)
in the growth medium##4##4##(1991-10#1)(2008-10#2)(2008-11#1)
in the growth of##3##4##(1995-3#1)(1996-3#1)(2008-10#1)
in the growth rate of##2##5##(2008-9#1)(2012-2#1)
in the growth rates of##2##5##(2008-11#2)
in the growth##19##3##(1990-11#1)(1990-8#1)(1991-10#1)(1995-3#1)(1995-8#1)(1996-3#1)(2008-10#5)(2008-11#3)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
in the guidelines##2##3##(1990-6#1)(2013-1#1)
in the guinea pig##2##4##(1990-9#1)(2008-10#1)
in the guinea##3##3##(1990-9#1)(2008-10#1)(2008-5#1)
in the gut##7##3##(1992-6#1)(2008-10#4)(2010-1#1)(2011-2#1)
in the habitat##2##3##(2008-8#2)
in the hair##3##3##(2008-5#2)(2008-8#1)
in the hamster##2##3##(2008-9#2)
in the hand##2##3##(2008-12#1)(2012-2#1)
in the hands of##2##4##(1997-4#1)(2008-11#1)
in the head and hemolymph##2##5##(1995-11#2)
in the head and neck region##3##6##(1992-5#1)(1997-6#1)(2011-2#1)
in the head and neck##5##5##(1992-5#1)(1997-6#1)(2008-12#1)(2011-2#2)
in the head and##7##4##(1992-5#1)(1995-11#2)(1997-6#1)(2008-12#1)(2011-2#2)
in the head of the##3##5##(1991-3#1)(1995-11#1)(2013-1#1)
in the head of##4##4##(1991-3#1)(1995-11#1)(2008-10#1)(2013-1#1)
in the head region##2##4##(1992-6#1)(2008-5#1)
in the head##14##3##(1991-3#1)(1992-5#1)(1992-6#1)(1995-11#4)(1997-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#2)(2013-1#1)
in the headspace##5##3##(2008-10#4)(2008-11#1)
in the health administration curriculum##2##5##(1992-3#1)(1996-2#1)
in the health care environment##2##5##(1991-3#1)(1993-3#1)
in the health care industry##4##5##(1992-3#1)(1995-3#1)(1996-2#1)(2008-11#1)
in the health care sector##2##5##(1996-2#1)(2010-7#1)
in the health care system##7##5##(1991-2#1)(1993-11#1)(1994-3#2)(1996-2#1)(2011-2#1)(2012-2#1)
in the health care##22##4##(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-2#4)(2008-11#4)(2010-7#1)(2011-2#1)(2012-2#1)
in the health sciences##2##4##(2008-11#1)(2008-12#1)
in the health services##2##4##(1991-6#1)(1992-12#1)
in the health##38##3##(1990-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-12#2)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-2#5)(1996-3#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
in the healthcare industry##3##4##(1991-2#1)(1994-2#1)(2009-8#1)
in the healthcare setting##3##4##(1996-12#1)(2011-1#1)(2011-2#1)
in the healthcare system##3##4##(1991-3#1)(2009-8#1)(2013-1#1)
in the healthcare##13##3##(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-2#1)(1996-12#1)(2008-12#1)(2008-9#1)(2009-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
in the healthy##4##3##(1997-8#1)(2008-7#1)(2013-7#2)
in the heart of##2##4##(2008-9#1)(2013-1#1)
in the heart##7##3##(1991-5#1)(1992-6#1)(1996-12#1)(2008-9#1)(2010-12#1)(2013-1#2)
in the heat##3##3##(2008-3#1)(2013-8#2)
in the hemolymph after##2##4##(2008-10#2)
in the hemolymph and##2##4##(2008-10#1)(2008-6#1)
in the hemolymph of##2##4##(2008-10#2)
in the hemolymph##9##3##(2008-10#6)(2008-6#2)(2012-2#1)
in the hepatocyte##5##3##(2008-11#4)(2008-7#1)
in the hepatopancreas##3##3##(2008-6#2)(2008-7#1)
in the hidden layer and the##3##6##(2008-10#1)(2010-8#2)
in the hidden layer and##4##5##(2008-10#1)(2010-8#3)
in the hidden layer##6##4##(2008-10#3)(2010-8#3)
in the hidden##11##3##(2008-10#8)(2010-8#3)
in the high elevations##2##4##(2008-10#2)
in the high##14##3##(1992-3#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
in the higher##4##3##(1990-5#1)(1993-6#1)(2008-10#1)(2008-12#1)
in the highest##6##3##(1993-6#1)(1994-12#1)(2008-10#1)(2008-8#1)(2009-2#1)(2012-12#1)
in the highly metastatic##2##4##(1997-7#1)(2008-9#1)
in the highly susceptible##2##4##(1995-2#1)(2008-10#1)
in the highly##6##3##(1995-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
in the hippocampal CA1##3##4##(1991-10#1)(2008-11#2)
in the hippocampal##7##3##(1991-10#1)(1995-8#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)
in the hippocampus and##3##4##(1996-11#1)(1997-2#1)(2012-3#1)
in the hippocampus of amygdala-kindled##2##5##(1996-12#2)
in the hippocampus of##4##4##(1992-10#1)(1996-12#2)(2008-11#1)
in the hippocampus##28##3##(1991-10#1)(1991-12#1)(1992-10#1)(1993-12#1)(1994-2#1)(1996-11#1)(1996-12#6)(1997-2#2)(2008-11#7)(2008-7#4)(2012-3#1)(2013-8#2)
in the history of medicine##2##5##(1993-6#1)(2008-9#1)
in the history of the##2##5##(1990-11#1)(2008-10#1)
in the history of##8##4##(1990-11#1)(1993-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
in the home and##2##4##(1991-1#1)(2007-12#1)
in the home setting##2##4##(2009-10#1)(2009-11#1)
in the home##12##3##(1991-1#2)(1991-8#2)(1995-2#1)(2007-12#3)(2009-10#1)(2009-11#1)(2011-2#2)
in the honey samples##2##4##(2008-10#2)
in the honeybee##3##3##(1994-8#2)(2008-8#1)
in the hope of##2##4##(1996-3#1)(2013-8#1)
in the hope##3##3##(1996-3#1)(2008-11#1)(2013-8#1)
in the horizontal plane##3##4##(2008-3#3)
in the hormonal##2##3##(1990-2#1)(2010-7#1)
in the hospital and##2##4##(1992-2#1)(2008-3#1)
in the hospital environment##2##4##(2010-11#1)(2013-8#1)
in the hospital industry##3##4##(1994-12#1)(1995-12#1)(2008-11#1)
in the hospital sector##2##4##(1992-12#1)(1997-2#1)
in the hospital setting##3##4##(1991-1#1)(1991-12#1)(2008-11#1)
in the hospital##33##3##(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-2#2)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-9#1)(2008-11#4)(2008-3#1)(2008-7#3)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
in the host plant##4##4##(2008-10#4)
in the host##31##3##(1990-2#1)(1993-11#1)(1993-6#1)(1994-6#2)(2008-10#17)(2008-4#1)(2008-9#1)(2010-10#3)(2011-2#3)(2013-8#1)
in the house##2##3##(2009-10#1)(2011-2#1)
in the human body##2##4##(2008-10#1)(2013-1#1)
in the human brain##3##4##(1992-6#1)(1997-2#1)(2008-11#1)
in the human diet##3##4##(1993-11#1)(2008-10#1)(2011-2#1)
in the human genome##7##4##(1991-6#1)(1992-3#1)(1996-12#1)(2008-11#1)(2008-4#2)(2011-2#1)
in the human knee##2##4##(2009-7#2)
in the human liver##2##4##(1993-3#1)(1994-6#1)
in the human population##2##4##(2011-3#1)(2013-1#1)
in the human serum##2##4##(2008-10#2)
in the human services##2##4##(1992-1#1)(2008-11#1)
in the human##56##3##(1990-11#1)(1990-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-9#1)(2008-10#7)(2008-11#8)(2008-4#2)(2008-5#1)(2008-9#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-8#2)(2011-2#3)(2011-3#2)(2013-1#2)(2013-8#1)
in the hybrid##3##3##(2008-11#1)(2008-8#1)(2012-3#1)
in the hybridization##2##3##(2008-10#1)(2008-7#1)
in the hydraulic##2##3##(2008-10#1)(2009-8#1)
in the hydrolysis of##2##4##(1992-3#1)(2011-1#1)
in the hydrolysis##3##3##(1992-3#1)(2008-5#1)(2011-1#1)
in the hypothalamic homogenate of the##2##6##(1994-8#2)
in the hypothalamic##5##3##(1994-8#2)(1995-5#1)(1996-12#2)
in the hypothalamus##3##3##(1994-2#1)(1996-12#1)(1997-3#1)
in the hypothermic##2##3##(1996-12#2)
in the identification of the##5##5##(1990-2#1)(1995-11#1)(2008-10#1)(2012-3#2)
in the identification of##17##4##(1990-2#1)(1995-11#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)
in the identification##19##3##(1990-2#1)(1991-2#1)(1995-11#1)(1997-1#1)(1997-2#1)(2008-10#5)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)
in the ileal##2##3##(1996-12#1)(2009-12#1)
in the iliac##2##3##(2008-3#1)(2010-3#1)
in the image##4##3##(1995-12#1)(2008-6#1)(2009-10#1)(2011-2#1)
in the images##3##3##(2007-12#1)(2008-3#1)(2010-1#1)
in the imaging##7##3##(1997-8#1)(2008-5#2)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
in the immediate loading group and##2##6##(2013-1#2)
in the immediate loading group##3##5##(2013-1#3)
in the immediate vicinity of the##2##6##(1990-3#1)(2008-7#1)
in the immediate vicinity of##5##5##(1990-3#1)(2008-10#3)(2008-7#1)
in the immediate##10##3##(1990-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#3)
in the immobilized##2##3##(2008-10#1)(2008-11#1)
in the immune system of##2##5##(2008-11#1)(2008-7#1)
in the immune system##7##4##(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#3)(2011-2#1)
in the immune##12##3##(1991-2#1)(1993-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2011-2#2)(2013-1#1)
in the immunoassay##2##3##(2008-10#2)
in the immunocompromised##2##3##(2008-12#1)(2012-3#1)
in the immunoglobulin##2##3##(1997-9#1)(2011-2#1)
in the impairment of##3##4##(1995-11#1)(2008-10#1)(2008-7#1)
in the implementation of the##2##5##(2008-10#1)(2008-11#1)
in the implementation of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
in the implementation##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
in the importance of##2##4##(1996-1#1)(2008-8#1)
in the improvement of##4##4##(2006-6#1)(2008-10#1)(2008-11#1)(2011-7#1)
in the in situ##2##4##(2008-3#1)(2009-12#1)
in the in vitro##7##4##(1992-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-8#1)
in the in##10##3##(1992-3#1)(1995-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#2)(2013-8#1)
in the incidence of breast cancer##2##6##(2008-7#1)(2013-7#1)
in the incidence of##23##4##(1990-6#1)(1991-11#1)(1992-9#1)(1994-2#1)(1994-3#1)(1996-6#2)(1997-7#1)(2008-1#2)(2008-10#5)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2013-1#2)(2013-7#1)
in the incidence##24##3##(1990-6#1)(1991-11#1)(1992-9#1)(1994-2#1)(1994-3#1)(1996-6#2)(1997-7#1)(2008-1#2)(2008-10#6)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2013-1#2)(2013-7#1)
in the inclusion##2##3##(2008-10#2)
in the incorporation of##3##4##(1993-8#1)(2008-7#1)(2010-12#1)
in the increase in##2##4##(2008-7#1)(2010-12#1)
in the increased##7##3##(1995-2#1)(1996-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
in the incubation media##3##4##(1994-2#2)(2008-10#1)
in the incubation medium##3##4##(1990-11#1)(1990-5#1)(1991-5#1)
in the incubation##11##3##(1990-11#2)(1990-5#1)(1991-5#1)(1992-9#1)(1994-2#2)(1994-5#1)(1995-8#1)(2008-10#2)
in the indirect##2##3##(2011-2#1)(2012-2#1)
in the individual##6##3##(1990-12#1)(1991-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
in the induction of LTP##2##5##(1995-12#1)(2008-7#1)
in the induction of the##2##5##(1992-8#2)
in the induction of##19##4##(1991-12#1)(1991-5#1)(1992-8#2)(1994-9#1)(1995-12#1)(1995-5#1)(2008-10#7)(2008-11#3)(2008-7#1)(2012-3#1)
in the induction##20##3##(1991-12#1)(1991-5#1)(1992-8#2)(1994-9#1)(1995-12#1)(1995-5#1)(2008-10#8)(2008-11#3)(2008-7#1)(2012-3#1)
in the inductively coupled plasma##2##5##(2008-10#2)
in the industrial##3##3##(2008-10#2)(2010-6#1)
in the industrialized##2##3##(2008-10#1)(2011-2#1)
in the industry##5##3##(1995-3#1)(1996-2#1)(2008-11#2)(2008-6#1)
in the infant##2##3##(2008-10#1)(2012-2#1)
in the infected seed of##2##5##(2008-10#2)
in the infected##12##3##(1995-2#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-12#1)
in the infection process##2##4##(2008-10#2)
in the infection##4##3##(2008-10#4)
in the inflammatory##5##3##(1995-12#1)(2008-5#1)(2009-12#1)(2013-1#2)
in the infrared##2##3##(1991-1#1)(2008-3#1)
in the inhibition of cell##2##5##(1995-2#1)(1997-7#1)
in the inhibition of##10##4##(1990-8#2)(1992-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-7#1)(2012-2#1)
in the inhibition##12##3##(1990-8#2)(1992-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-9#1)(2012-2#1)
in the inhibitor##2##3##(1991-3#2)
in the inhibitory##3##3##(1990-12#1)(1995-11#1)(1995-2#1)
in the initial solution##2##4##(2008-10#2)
in the initial stages of##3##5##(2007-12#1)(2008-1#1)(2008-10#1)
in the initial stages##4##4##(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)
in the initial##20##3##(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2013-1#1)
in the initiation and##2##4##(2011-1#1)(2011-2#1)
in the initiation of##6##4##(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)
in the initiation##10##3##(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
in the injection##3##3##(2008-10#2)(2011-2#1)
in the inner cortex and stele tissues##2##7##(2008-10#2)
in the inner mitochondrial##2##4##(1990-11#1)(1994-5#1)
in the inner nuclear##2##4##(1991-10#1)(2008-9#1)
in the inner##12##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-5#1)(1994-5#1)(1996-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-9#2)
in the inoculated cotyledonary leaves but##2##6##(2008-10#2)
in the inoculated leaf##2##4##(2008-10#2)
in the inoculated##8##3##(2008-10#7)(2008-8#1)
in the inoculum##2##3##(2008-10#1)(2008-11#1)
in the inpatient##2##3##(1993-2#1)(2013-1#1)
in the input layer##3##4##(2008-10#2)(2010-8#1)
in the input##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2010-8#1)
in the insect##7##3##(1992-6#1)(1995-11#1)(2008-10#4)(2008-11#1)
in the institution##2##3##(1993-6#1)(2011-2#1)
in the instrument##3##3##(2008-10#1)(2008-3#2)
in the insulin##2##3##(1994-12#1)(2008-11#1)
in the intact male rat##2##5##(1994-2#2)
in the intact##9##3##(1991-2#1)(1992-4#1)(1994-2#2)(1996-2#1)(2008-7#1)(2008-8#1)(2008-9#2)
in the integrated##2##3##(2008-11#1)(2012-2#1)
in the integration of##2##4##(1997-2#1)(2008-11#1)
in the intended##2##3##(2008-10#1)(2010-6#1)
in the intensity and##2##4##(2008-10#1)(2008-7#1)
in the intensity of##4##4##(1997-2#1)(2008-10#2)(2010-8#1)
in the intensity##8##3##(1995-12#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-8#1)
in the intensive care unit (ICU)##2##6##(2011-2#1)(2012-3#1)
in the intensive care unit##5##5##(1991-2#1)(2010-12#1)(2011-2#2)(2012-3#1)
in the inter-war##2##3##(2008-12#2)
in the interaction between##2##4##(2008-10#1)(2008-9#1)
in the interaction of##7##4##(1991-1#1)(1991-9#1)(1993-6#1)(1994-5#1)(2008-10#2)(2008-8#1)
in the interaction##13##3##(1991-1#1)(1991-9#1)(1993-6#1)(1994-5#1)(2008-10#6)(2008-3#1)(2008-8#1)(2008-9#1)
in the intercellular##2##3##(2008-10#2)
in the intergenic spacer##2##4##(2008-10#2)
in the intergenic##3##3##(1994-11#1)(2008-10#2)
in the interior of the##2##5##(2008-10#1)(2010-10#1)
in the interior of##3##4##(2008-10#2)(2010-10#1)
in the intermediate##2##3##(1992-6#1)(2010-8#1)
in the internal##8##3##(1996-12#1)(2008-10#4)(2008-5#2)(2008-8#1)
in the international literature##3##4##(1997-8#1)(2008-11#1)(2011-3#1)
in the international##6##3##(1990-12#1)(1991-3#1)(1997-8#1)(2008-11#2)(2011-3#1)
in the interphase##2##3##(1990-3#1)(2008-9#1)
in the interpretation of the##3##5##(2008-11#1)(2008-4#1)(2008-5#1)
in the interpretation of##6##4##(1996-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-9#1)
in the interpretation##7##3##(1993-3#1)(1996-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-9#1)
in the interstitial##2##3##(1991-12#1)(2008-10#1)
in the interval##3##3##(2008-10#2)(2008-7#1)
in the intervention group##4##4##(2010-4#3)(2013-1#1)
in the intervention##6##3##(2010-4#4)(2011-1#1)(2013-1#1)
in the interventions##2##3##(2008-10#1)(2008-11#1)
in the intervertebral foramen##2##4##(2013-8#2)
in the interwar period##2##4##(2008-12#1)(2013-1#1)
in the intestinal##7##3##(1990-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
in the intestine and##4##4##(1995-5#1)(2008-10#2)(2008-11#1)
in the intestine##8##3##(1992-6#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
in the intracellular##10##3##(1992-5#1)(1993-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-11#3)(2008-7#2)
in the intramolecular##2##3##(1996-5#1)(2008-10#1)
in the intraoperative##3##3##(1993-1#1)(1996-1#1)(2011-7#1)
in the introduction of##3##4##(2008-10#1)(2008-12#1)(2010-4#1)
in the introduction##4##3##(1991-3#1)(2008-10#1)(2008-12#1)(2010-4#1)
in the invasion of##3##4##(2008-11#2)(2012-2#1)
in the investigated##2##3##(2008-10#2)
in the investigation of##10##4##(1991-1#1)(1995-11#1)(1996-6#1)(1997-8#2)(2008-12#2)(2008-9#2)(2010-1#1)
in the ion-pair extraction##2##4##(2008-10#2)
in the ionic##2##3##(2008-11#1)(2009-5#1)
in the ipsilateral##10##3##(1993-3#1)(1996-12#3)(1997-3#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
in the iron##6##3##(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#1)
in the ischemic##2##3##(1992-9#1)(1996-12#1)
in the islet##4##3##(1992-6#2)(1995-8#2)
in the islets and##2##4##(2010-11#2)
in the islets##4##3##(1995-8#1)(2010-11#3)
in the isolated##3##3##(1993-6#1)(2008-8#1)(2008-9#1)
in the isolation##4##3##(1994-11#1)(1997-3#1)(2008-11#2)
in the jet nebulizer##2##4##(1991-1#2)
in the joint analyses##2##4##(2008-10#2)
in the joint##5##3##(2007-11#1)(2008-10#2)(2008-12#1)(2011-1#1)
in the journal##2##3##(1996-3#1)(2013-1#1)
in the juice sac area##4##5##(2008-10#4)
in the juice##6##3##(2008-10#6)
in the junctional foot protein##2##5##(1995-6#2)
in the karyoplasm##2##3##(2007-12#1)(2008-7#1)
in the kidney and##2##4##(1994-5#1)(2008-11#1)
in the kidney##15##3##(1990-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-11#5)(2009-6#3)(2012-12#1)(2012-3#1)
in the kidneys of##3##4##(1994-5#1)(2008-5#1)(2009-6#1)
in the kidneys##4##3##(1994-5#1)(2008-5#2)(2009-6#1)
in the kinetic##4##3##(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
in the knee##6##3##(1991-6#1)(2008-12#1)(2011-2#3)(2013-1#1)
in the laboratory and##5##4##(2008-10#3)(2008-5#2)
in the laboratory by##4##4##(2008-10#3)(2008-11#1)
in the laboratory for use in ecotoxicological testing##2##8##(2008-11#2)
in the laboratory for##4##4##(2008-10#1)(2008-11#2)(2013-8#1)
in the laboratory population##2##4##(2008-10#2)
in the laboratory using##4##4##(2008-10#3)(2012-2#1)
in the laboratory with##3##4##(2008-2#1)(2008-3#1)(2008-9#1)
in the laboratory##50##3##(1990-3#1)(1992-3#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-10#26)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#3)(2010-4#1)(2012-2#2)(2013-8#1)
in the lake sediments##2##4##(2008-10#2)
in the lamellar##3##3##(2008-5#1)(2012-2#2)
in the lamin##2##3##(2008-8#1)(2011-2#1)
in the lamina##3##3##(1997-1#1)(2008-10#1)(2008-7#1)
in the lamprey##2##3##(1997-3#2)
in the large##4##3##(1995-10#1)(2012-2#2)(2013-8#1)
in the larger##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
in the largest##3##3##(1992-12#1)(1992-8#1)(2008-12#1)
in the laser##8##3##(1992-12#1)(1993-3#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#3)
in the last 10 years##4##5##(1991-6#1)(1995-12#1)(2008-10#1)(2011-2#1)
in the last 20##2##4##(1994-3#1)(2008-8#1)
in the last 5 years##2##5##(2008-12#1)(2012-3#1)
in the last decade##15##4##(1990-12#2)(1990-8#1)(1991-6#1)(1994-3#2)(2008-11#2)(2008-5#2)(2009-3#1)(2009-7#1)(2010-5#1)(2011-3#1)(2013-1#1)
in the last decades##3##4##(1994-12#1)(2008-10#1)(2008-12#1)
in the last few years##7##5##(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#2)(2012-2#1)
in the last phases of##2##5##(1990-6#1)(2008-11#1)
in the last several years##2##5##(1992-3#1)(2011-2#1)
in the last several##3##4##(1992-3#1)(1997-4#1)(2011-2#1)
in the last ten years##2##5##(2008-8#1)(2012-3#1)
in the last two decades##3##5##(1994-3#1)(1995-12#1)(2012-2#1)
in the last two##4##4##(1993-12#1)(1994-3#1)(1995-12#1)(2012-2#1)
in the last years##2##4##(2008-11#1)(2010-12#1)
in the last##60##3##(1990-12#2)(1990-6#2)(1990-8#1)(1991-3#1)(1991-6#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-8#1)(1995-12#3)(1997-4#1)(2008-10#6)(2008-11#5)(2008-12#3)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-5#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#2)
in the late 1960s##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
in the late nineteenth century##2##5##(2010-1#1)(2011-2#1)
in the late phase of##2##5##(1990-6#1)(1995-12#1)
in the late phase##3##4##(1990-6#1)(1995-11#1)(1995-12#1)
in the late##18##3##(1990-6#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-12#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-6#1)
in the late-preterm infant##2##4##(2012-2#2)
in the later stages##2##4##(1993-9#1)(2008-10#1)
in the later##5##3##(1993-9#1)(1997-7#1)(2008-10#1)(2008-7#2)
in the lateral hypothalamus##2##4##(1993-6#2)
in the lateral##11##3##(1992-3#1)(1993-6#2)(1997-3#1)(2007-12#1)(2008-7#2)(2008-8#1)(2011-2#2)(2013-1#1)
in the latest##2##3##(2011-2#2)
in the latter case##5##4##(1990-2#1)(1995-6#1)(2008-10#3)
in the latter##19##3##(1990-12#1)(1990-2#1)(1991-12#1)(1995-6#2)(1996-2#1)(1997-7#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
in the lead##5##3##(2008-10#5)
in the leader##3##3##(1991-9#1)(2008-8#1)(2008-9#1)
in the leaf##6##3##(2008-10#3)(2008-8#1)(2009-6#2)
in the learning##2##3##(2008-12#1)(2008-7#1)
in the least##2##3##(2008-7#1)(2008-8#1)
in the leather industry##2##4##(2008-10#2)
in the leather##4##3##(2008-10#3)(2009-12#1)
in the leaves and##2##4##(2008-10#2)
in the leaves##6##3##(2008-10#4)(2008-12#1)(2011-10#1)
in the left breast##2##4##(2008-10#2)
in the left colon##2##4##(1991-6#1)(2011-2#1)
in the left eye##3##4##(2010-10#1)(2013-1#2)
in the left lower lid##2##5##(2010-11#2)
in the left lower##4##4##(2008-7#1)(2010-11#3)
in the left pleural##2##4##(1990-5#2)
in the left ventricle##2##4##(2008-10#1)(2013-1#1)
in the left##42##3##(1990-3#1)(1990-5#2)(1990-8#1)(1991-6#1)(1993-2#1)(1996-2#1)(1996-3#1)(1996-6#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#4)(2013-1#8)(2013-8#2)
in the leg##2##3##(2008-5#1)(2013-8#1)
in the legal##2##3##(1991-12#1)(2008-10#1)
in the lens##2##3##(1993-3#1)(2012-2#1)
in the lesion##7##3##(1990-5#1)(1993-3#1)(1994-8#1)(2008-5#1)(2009-11#1)(2013-8#2)
in the less##2##3##(2008-9#1)(2012-3#1)
in the level of##10##4##(1994-2#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2009-8#3)(2010-12#1)(2010-4#1)
in the levels of##14##4##(1990-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#2)(2013-8#1)
in the levels##16##3##(1990-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2012-2#2)(2013-8#1)
in the liberation of##2##4##(1995-11#1)(2008-10#1)
in the life history##2##4##(2008-8#1)(2009-10#1)
in the life of##3##4##(1995-5#1)(2010-8#1)(2012-3#1)
in the life sciences##2##4##(2008-9#1)(2010-7#1)
in the life##14##3##(1994-11#1)(1995-1#1)(1995-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#1)(2012-3#1)
in the ligand##4##3##(1990-8#1)(2008-10#3)
in the light and##2##4##(2008-10#1)(2009-8#1)
in the light of a##3##5##(1993-11#1)(1993-3#1)(2008-10#1)
in the light of recent##2##5##(1991-6#1)(2009-8#1)
in the light of the##8##5##(1990-3#1)(1993-3#1)(1997-7#1)(2008-10#2)(2008-11#3)
in the light of##30##4##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#2)(1993-11#1)(1993-3#2)(1997-7#1)(2008-10#8)(2008-11#6)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#3)
in the light##37##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-3#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#6)(2008-8#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-3#3)
in the limb##2##3##(1993-12#2)
in the limit of##2##4##(1995-3#1)(2011-2#1)
in the line RE714##2##4##(2008-10#2)
in the line##3##3##(2008-10#2)(2008-3#1)
in the linear range##3##4##(2008-10#3)
in the linear##8##3##(1991-5#1)(2008-10#6)(2008-6#1)
in the lipid phase##2##4##(1991-5#1)(1994-5#1)
in the lipid##7##3##(1990-5#1)(1991-5#1)(1994-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-8#1)
in the liquid##9##3##(2008-10#6)(2008-3#1)(2009-10#1)(2012-2#1)
in the list of##3##4##(1997-3#2)(2012-12#1)
in the literature and##8##4##(1993-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)
in the literature are##3##4##(1992-12#1)(1994-6#1)(2008-7#1)
in the literature as a##2##5##(2008-5#1)(2013-1#1)
in the literature as##4##4##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
in the literature for the##2##5##(2008-10#1)(2008-11#1)
in the literature for##6##4##(1991-3#2)(2008-10#3)(2008-11#1)
in the literature in##3##4##(1991-3#1)(2008-10#1)(2013-1#1)
in the literature of##3##4##(2008-11#1)(2008-9#1)(2010-1#1)
in the literature regarding##3##4##(2008-5#1)(2012-2#2)
in the literature that##3##4##(2008-11#1)(2010-1#1)(2010-3#1)
in the literature which##2##4##(2012-3#1)(2013-8#1)
in the literature##162##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-11#2)(1997-3#1)(1997-8#1)(2008-10#25)(2008-11#15)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-1#4)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#17)(2013-8#3)
in the liver and##7##4##(1995-2#1)(1997-8#1)(2008-12#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-8#1)
in the liver by##3##4##(1995-2#1)(2008-5#1)(2010-5#1)
in the liver following##2##4##(2008-10#1)(2008-8#1)
in the liver microsomes##2##4##(2011-3#2)
in the liver of##7##4##(1990-3#2)(1991-8#1)(1995-8#1)(2008-5#1)(2010-11#1)(2013-1#1)
in the liver was##2##4##(1990-11#1)(2008-6#1)
in the liver##55##3##(1990-11#2)(1990-3#2)(1990-5#1)(1991-12#1)(1991-8#1)(1993-12#1)(1994-8#2)(1995-2#2)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-5#5)(2008-6#3)(2008-8#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#4)(2010-7#4)(2011-3#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
in the livers of##2##4##(2008-10#2)
in the lives of##2##4##(2008-8#1)(2010-10#1)
in the living##3##3##(2008-10#1)(2008-11#2)
in the local##12##3##(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
in the localization of##2##4##(2008-9#1)(2009-5#1)
in the localization##4##3##(1997-8#1)(2008-11#1)(2008-9#1)(2009-5#1)
in the location of##2##4##(2008-7#1)(2011-2#1)
in the locomotor##2##3##(1993-6#1)(2007-8#1)
in the locus control region (LCR) of the human beta-like globin gene cluster##2##13##(2008-8#2)
in the locus##3##3##(2008-8#2)(2011-2#1)
in the locust##4##3##(1994-2#2)(2007-12#2)
in the long run##5##4##(1997-3#1)(1997-5#1)(2009-12#1)(2010-4#1)(2013-8#1)
in the long term##5##4##(1993-11#1)(1994-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
in the long##13##3##(1991-2#1)(1993-11#1)(1994-1#1)(1997-3#1)(1997-5#2)(2008-10#1)(2008-3#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-8#2)
in the long-run##2##3##(2010-12#1)(2012-12#1)
in the long-term##3##3##(1994-12#1)(2008-11#1)(2009-3#1)
in the longer-term##2##3##(2008-1#1)(2008-11#1)
in the longitudinal##3##3##(1997-3#1)(2008-9#1)(2009-11#1)
in the loop##2##3##(1993-8#1)(2008-9#1)
in the loss of##9##4##(1990-2#1)(1993-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the loss##11##3##(1990-2#1)(1993-6#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the low back##2##4##(2008-12#1)(2013-8#1)
in the low##13##3##(1990-5#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#2)(2010-11#1)(2012-3#1)(2013-8#1)
in the lower chamber##2##4##(2008-11#2)
in the lower extremities##3##4##(1993-6#1)(2008-12#1)(2008-7#1)
in the lower extremity and##2##5##(2012-2#1)(2013-1#1)
in the lower extremity##3##4##(2009-1#1)(2012-2#1)(2013-1#1)
in the lower genital tract##2##5##(2011-2#2)
in the lower##31##3##(1990-2#1)(1993-6#1)(1996-5#1)(1996-6#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#1)(2009-1#1)(2010-11#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#3)
in the lowest excited singlet state##2##6##(2008-10#2)
in the lowest##4##3##(2008-10#4)
in the lumbar##8##3##(1996-3#1)(2008-7#2)(2011-2#3)(2012-12#2)
in the lumbosacral paravertebral muscle##2##5##(2013-8#2)
in the lumbosacral##3##3##(2013-8#3)
in the lumen of##3##4##(2008-10#3)
in the lumen##5##3##(2008-10#3)(2008-7#2)
in the lung and##2##4##(1995-12#1)(2010-10#1)
in the lung##13##3##(1992-12#1)(1992-2#1)(1992-3#2)(1995-12#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)
in the lungs and##2##4##(1991-12#1)(1995-2#1)
in the lungs by##2##4##(2008-8#1)(2013-1#1)
in the lungs of##4##4##(1991-12#1)(1994-11#1)(2013-1#2)
in the lungs##20##3##(1991-12#3)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-3#3)(1997-2#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-7#1)(2013-1#3)
in the lymphocyte##2##3##(2008-11#1)(2008-4#1)
in the lymphoid##2##3##(1992-12#1)(2008-9#1)
in the m/z##2##3##(2008-10#2)
in the mRNA##4##3##(2008-11#1)(2010-1#1)(2012-2#1)(2013-1#1)
in the macroalbuminuric##2##3##(1992-9#2)
in the magnitude of##7##4##(1995-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-10#1)
in the magnitude##8##3##(1995-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-10#1)
in the magnoliids##2##3##(2008-10#2)
in the main##10##3##(1993-9#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-1#1)(2010-10#3)
in the maintenance of a##3##5##(2008-5#1)(2010-12#1)(2013-1#1)
in the maintenance of the##2##5##(1991-2#1)(2008-9#1)
in the maintenance of##18##4##(1991-2#1)(1995-12#2)(1997-1#1)(1997-2#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#2)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#2)
in the maintenance##21##3##(1991-2#1)(1995-12#2)(1997-1#1)(1997-2#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2010-10#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#2)
in the maize##2##3##(2008-10#2)
in the major##5##3##(1990-5#1)(1992-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
in the majority of cases##3##5##(1990-5#1)(1990-9#1)(2008-10#1)
in the majority of patients##3##5##(1994-5#1)(2008-7#1)(2011-2#1)
in the majority of samples##2##5##(2008-10#1)(2011-2#1)
in the majority of the##2##5##(1994-12#1)(2008-10#1)
in the majority of##20##4##(1990-5#1)(1990-9#2)(1992-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
in the majority##21##3##(1990-5#1)(1990-9#2)(1992-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
in the male Fischer##2##4##(1993-12#1)(1994-3#1)
in the male##10##3##(1992-3#1)(1993-12#1)(1993-3#2)(1994-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
in the mammalian central nervous system##2##6##(1993-12#1)(2012-2#1)
in the mammalian##11##3##(1990-12#1)(1991-6#1)(1992-6#1)(1993-12#1)(1997-2#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-2#3)
in the mammary gland##2##4##(1994-12#1)(1995-9#1)
in the managed care setting##3##5##(1992-2#2)(2009-11#1)
in the managed##4##3##(1992-2#2)(2008-8#1)(2009-11#1)
in the management of a patient##2##6##(2008-12#2)
in the management of acute##3##5##(1995-8#1)(2008-3#1)(2012-12#1)
in the management of children##2##5##(2008-10#1)(2008-9#1)
in the management of end-stage##2##5##(2007-11#1)(2011-3#1)
in the management of locally advanced##2##6##(1990-6#1)(1993-9#1)
in the management of ovarian masses##3##6##(1996-1#3)
in the management of ovarian##4##5##(1996-1#3)(2008-1#1)
in the management of pain##2##5##(2008-10#1)(2009-12#1)
in the management of patients with##10##6##(1990-8#1)(1996-11#1)(2008-11#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in the management of pediatric thyroid nodules##2##7##(2011-1#2)
in the management of pediatric##4##5##(2011-1#2)(2012-3#1)(2013-8#1)
in the management of severe##2##5##(2008-11#1)(2008-9#1)
in the management of the##3##5##(1997-8#1)(2008-9#1)(2012-2#1)
in the management of these patients##2##6##(1991-2#1)(2011-2#1)
in the management of##93##4##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-9#2)(1995-11#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#1)
in the mandible##5##3##(2011-7#1)(2013-1#4)
in the manifestation of##2##4##(2008-11#1)(2012-2#1)
in the manipulation category##2##4##(2008-12#2)
in the manipulation of##2##4##(2008-4#1)(2008-7#1)
in the manipulation##4##3##(2008-12#2)(2008-4#1)(2008-7#1)
in the manner##2##3##(1995-12#1)(2008-3#1)
in the manual##2##3##(2008-10#1)(2008-4#1)
in the manufacture##3##3##(1996-9#1)(2008-10#1)(2008-11#1)
in the manufacturing##3##3##(2008-10#2)(2008-5#1)
in the manure##3##3##(2008-10#3)
in the marine environment##2##4##(2008-10#1)(2008-11#1)
in the market##8##3##(1991-3#1)(1993-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-12#2)
in the marketplace##2##3##(1997-1#1)(2008-6#1)
in the mass spectra##2##4##(2008-10#2)
in the mass##3##3##(1992-2#1)(2008-10#2)
in the massage group##2##4##(2008-10#1)(2008-12#1)
in the mastoid##5##3##(1990-12#1)(2008-7#2)(2008-9#2)
in the material from##2##4##(1991-9#1)(2008-10#1)
in the material##4##3##(1991-9#1)(2008-10#1)(2008-3#1)(2009-7#1)
in the maternal##2##3##(1992-5#1)(1994-11#1)
in the matrix##4##3##(1990-2#1)(2008-10#3)
in the mature##3##3##(1993-2#1)(2008-5#1)(2009-12#1)
in the maxillary##2##3##(2012-12#1)(2013-1#1)
in the maximum##7##3##(1994-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)
in the mean##8##3##(1990-9#2)(1993-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-2#1)
in the measured##10##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)(2013-1#2)
in the measurement of##6##4##(1993-2#1)(2008-10#2)(2008-3#1)(2013-1#2)
in the measurement##15##3##(1992-3#1)(1993-2#1)(2008-1#1)(2008-10#8)(2008-3#2)(2013-1#2)
in the measurements##4##3##(2008-10#3)(2010-7#1)
in the measuring##3##3##(2008-10#3)
in the meat##4##3##(2008-10#3)(2010-4#1)
in the mechanism by which##2##5##(1997-1#1)(2008-8#1)
in the mechanism of##10##4##(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-2#1)(2008-10#2)(2011-2#1)
in the mechanism##12##3##(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
in the mechanisms of##3##4##(2008-10#1)(2009-7#1)(2009-8#1)
in the media##9##3##(1991-9#1)(1993-8#1)(1994-2#1)(2008-11#3)(2008-3#1)(2009-1#1)(2011-2#1)
in the medial prefrontal cortex##2##5##(2008-11#2)
in the medial superior olivary nucleus##2##6##(1997-3#2)
in the medial##12##3##(1990-9#1)(1991-10#1)(1992-12#1)(1992-3#2)(1997-3#2)(2006-6#1)(2008-11#2)(2008-8#1)(2008-9#1)
in the median##2##3##(1995-12#1)(2011-2#1)
in the mediation of##4##4##(1997-1#1)(1997-4#1)(2008-4#1)(2011-2#1)
in the medical and##2##4##(1991-11#1)(2008-10#1)
in the medical literature##5##4##(1990-8#1)(2010-6#3)(2013-1#1)
in the medical##22##3##(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-2#1)(1993-6#2)(1994-5#1)(1995-12#1)(1997-3#2)(2008-10#2)(2008-3#1)(2009-10#1)(2010-6#3)(2011-2#2)(2013-1#1)
in the medium and##5##4##(1996-2#1)(2008-11#1)(2008-2#1)(2011-3#1)(2013-1#1)
in the medium containing 5 mM aspirin##2##7##(2008-11#2)
in the medium containing##8##4##(2008-11#7)(2008-6#1)
in the medium term##2##4##(2008-10#1)(2010-5#1)
in the medium was##2##4##(2008-11#2)
in the medium with FGF-2##2##5##(2008-11#2)
in the medium with##3##4##(2008-11#3)
in the medium##46##3##(1990-6#1)(1993-12#1)(1994-8#1)(1996-2#1)(1997-2#2)(2008-10#5)(2008-11#24)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-7#1)(2013-1#1)
in the medium- and##2##4##(2008-10#1)(2011-2#1)
in the melanogenic##2##3##(2008-11#1)(2008-5#1)
in the membrane and##2##4##(2008-10#2)
in the membrane of the##3##5##(1990-12#2)(2008-9#1)
in the membrane of##4##4##(1990-12#2)(1994-8#1)(2008-9#1)
in the membrane was##3##4##(1994-11#1)(2008-10#2)
in the membrane##24##3##(1990-12#2)(1990-5#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-10#14)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
in the membranes##3##3##(1995-11#2)(2011-2#1)
in the mental health field##5##5##(1994-1#1)(1995-1#1)(1997-3#2)(2008-11#1)
in the mental health##6##4##(1994-1#1)(1995-1#1)(1997-3#2)(2008-11#1)(2009-6#1)
in the mental##8##3##(1992-2#1)(1994-1#1)(1995-1#1)(1996-9#1)(1997-3#2)(2008-11#1)(2009-6#1)
in the mesophyll##2##3##(2008-10#2)
in the mesorectum##2##3##(2009-12#2)
in the metabolic activation of##2##5##(1991-5#1)(2008-8#1)
in the metabolic syndrome is##2##5##(2008-1#1)(2008-6#1)
in the metabolic syndrome##7##4##(2008-1#1)(2008-6#5)(2012-5#1)
in the metabolic##13##3##(1991-5#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-6#5)(2008-8#2)(2012-5#2)
in the metabolism and##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
in the metabolism of##3##4##(1994-8#1)(2009-6#1)(2013-1#1)
in the metabolism##6##3##(1994-8#1)(2008-10#1)(2008-7#1)(2009-6#1)(2013-1#2)
in the metal##2##3##(2008-10#2)
in the metapopulation##4##3##(2008-8#1)(2008-9#3)
in the metastatic##2##3##(1990-6#1)(1994-12#1)
in the methanol extract##2##4##(2008-11#2)
in the method described here generalizes##2##6##(2009-4#2)
in the method##5##3##(1994-12#1)(2008-10#1)(2008-3#1)(2009-4#2)
in the methods of##3##4##(1992-2#1)(1993-11#1)(2009-7#1)
in the methods##5##3##(1992-2#1)(1993-11#1)(2008-10#1)(2008-2#1)(2009-7#1)
in the methylation##2##3##(1995-12#1)(2009-7#1)
in the methylotrophic yeast Pichia pastoris##2##6##(1994-11#1)(1997-7#1)
in the methylotrophic yeast##3##4##(1994-11#2)(1997-7#1)
in the micellar##4##3##(1990-5#1)(1996-5#1)(2008-10#2)
in the micrometer range##2##4##(1997-2#1)(2008-10#1)
in the micromolar##2##3##(2008-10#2)
in the micron##2##3##(2008-10#1)(2009-5#1)
in the microsomal fraction##3##4##(1993-3#1)(1994-11#1)(1996-3#1)
in the microsomal##5##3##(1993-3#2)(1993-8#1)(1994-11#1)(1996-3#1)
in the microsomes##2##3##(1994-11#1)(1994-8#1)
in the microwave##3##3##(2008-10#2)(2010-4#1)
in the mid IR##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
in the mid to##2##4##(2011-2#1)(2012-3#1)
in the mid##7##3##(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-3#2)
in the mid- and##2##4##(2008-10#2)
in the mid-1970s##2##3##(1991-9#1)(1995-8#1)
in the mid-IR##3##3##(2007-12#1)(2008-10#2)
in the mid-infrared##4##3##(2008-2#1)(2008-3#3)
in the midbrain##4##3##(1996-12#1)(1997-3#1)(2008-7#2)
in the middle and##2##4##(2008-7#1)(2008-9#1)
in the middle cerebral##2##4##(1996-2#1)(2010-11#1)
in the middle elevations##2##4##(2008-10#2)
in the middle infrared region##2##5##(2008-10#2)
in the middle of an##2##5##(1991-12#1)(1994-11#1)
in the middle of the##6##5##(1993-2#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-10#1)
in the middle of##10##4##(1991-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-3#1)
in the middle##27##3##(1990-11#1)(1991-12#1)(1991-3#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-11#1)(2011-3#1)(2012-12#1)(2013-8#1)
in the midgut epithelium##2##4##(2008-12#2)
in the midgut##7##3##(2007-12#1)(2008-10#3)(2008-12#2)(2008-6#1)
in the midline##2##3##(2007-12#1)(2013-1#1)
in the midst of##3##4##(1993-12#2)(1993-2#1)
in the migration of##3##4##(1995-8#1)(2008-9#1)(2013-8#1)
in the migration##4##3##(1995-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
in the milk and##3##4##(2008-12#1)(2009-8#1)(2013-1#1)
in the milk of##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
in the milk##6##3##(2008-10#1)(2008-12#2)(2009-8#1)(2013-1#2)
in the minicolumn##3##3##(2008-10#3)
in the minimal##2##3##(2008-10#1)(2011-2#1)
in the minimum##2##3##(2008-8#1)(2009-7#1)
in the minor groove of the##2##6##(1993-1#1)(1994-5#1)
in the minor groove of##3##5##(1993-1#1)(1994-5#1)(1996-3#1)
in the minor groove##6##4##(1993-1#2)(1994-5#2)(1995-8#1)(1996-3#1)
in the minor##8##3##(1993-1#2)(1994-5#3)(1995-8#1)(1996-3#1)(2008-10#1)
in the mitochondria##2##3##(1995-6#1)(1997-2#1)
in the mitochondrial genome##2##4##(1995-6#2)
in the mitochondrial membrane##2##4##(1990-2#1)(2008-7#1)
in the mitochondrial##11##3##(1990-2#1)(1991-6#1)(1995-6#3)(2008-10#2)(2008-12#1)(2008-7#2)(2013-8#1)
in the mitotic spindle##2##4##(2008-1#1)(2011-2#1)
in the mitotic##4##3##(2008-1#1)(2008-11#1)(2011-2#2)
in the mixed cultures##3##4##(2013-1#3)
in the mixed inoculation##2##4##(2008-10#2)
in the mixed sample##4##4##(2008-10#4)
in the mixed solvents##4##4##(2008-10#4)
in the mixed##20##3##(1990-2#1)(1992-8#1)(2008-10#14)(2008-12#1)(2013-1#3)
in the mixture of##5##4##(1990-5#1)(2008-10#2)(2008-11#1)(2008-12#1)
in the mixture##6##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-12#1)
in the mixtures##6##3##(2008-10#5)(2008-11#1)
in the mobile phase and##4##5##(2008-10#4)
in the mobile phase was##3##5##(2008-10#3)
in the mobile phase##17##4##(2008-10#17)
in the mobile##18##3##(2008-10#18)
in the mode of##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
in the mode##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
in the model as##2##4##(1996-3#1)(2013-1#1)
in the model by##2##4##(1995-9#1)(2008-10#1)
in the model##32##3##(1992-4#1)(1995-9#1)(1996-3#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-7#4)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#3)
in the models##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
in the modern##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
in the modification of##2##4##(2008-10#1)(2010-12#1)
in the modified##4##3##(2008-10#2)(2008-9#1)(2009-10#1)
in the modulation of##11##4##(1992-2#1)(1993-3#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the molecular genetics of##2##5##(2008-4#1)(2008-7#1)
in the molecular##8##3##(1991-5#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-8#1)
in the molecule##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
in the monkey##6##3##(1991-2#1)(1993-6#1)(1997-2#1)(2008-8#3)
in the monolayer culture##2##4##(2008-11#2)
in the monolayer##4##3##(1991-3#1)(1994-5#1)(2008-11#2)
in the more resistant##3##4##(1990-2#1)(1996-12#1)(2008-10#1)
in the more##12##3##(1990-2#1)(1994-9#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-5#2)
in the morning##5##3##(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)
in the morphological##2##3##(1994-12#1)(2008-5#1)
in the morphology of##3##4##(1994-2#1)(2008-10#1)(2011-2#1)
in the mortality##2##3##(2011-2#1)(2012-12#1)
in the most productive patches##2##5##(2008-9#2)
in the most productive##3##4##(1992-8#1)(2008-9#2)
in the most recent##2##4##(1996-11#1)(2010-8#1)
in the most##17##3##(1992-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-8#1)
in the mother##2##3##(2011-2#1)(2012-3#1)
in the motor cortex##3##4##(2008-7#2)(2010-7#1)
in the motor##4##3##(2008-7#2)(2010-7#2)
in the mouse genome##4##4##(1993-6#1)(1995-2#1)(1995-6#1)(2012-2#1)
in the mouse##23##3##(1990-12#1)(1990-8#1)(1992-3#2)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
in the mouth##6##3##(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
in the mouths of##2##4##(2008-10#2)
in the mucosa##2##3##(1990-5#1)(2013-8#1)
in the mucosal##2##3##(1990-5#1)(1996-3#1)
in the multiphoton##2##3##(1992-11#1)(2008-3#1)
in the municipality of##3##4##(1991-9#1)(1997-4#1)(2012-12#1)
in the municipality##4##3##(1991-6#1)(1991-9#1)(1997-4#1)(2012-12#1)
in the murine##2##3##(2012-2#1)(2013-8#1)
in the muscle##5##3##(1997-4#1)(2008-10#1)(2008-8#1)(2010-7#1)(2013-8#1)
in the muscular##2##3##(2008-9#1)(2012-12#1)
in the mutant##8##3##(1990-5#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-8#1)
in the mutants##3##3##(1995-6#1)(2008-10#1)(2008-12#1)
in the mutation frequency##2##4##(1997-3#2)
in the mutation##3##3##(1997-3#3)
in the myocardial##2##3##(2008-12#1)(2013-1#1)
in the myocardium##3##3##(2008-7#2)(2011-2#1)
in the myogenic##2##3##(1990-8#1)(1993-12#1)
in the nanomolar##2##3##(2008-10#2)
in the nasal airway##2##4##(2013-1#2)
in the nasal cavity##3##4##(1993-8#1)(2008-10#1)(2013-1#1)
in the nasal##8##3##(1993-8#2)(2008-10#1)(2008-11#1)(2013-1#4)
in the nasopharynx##2##3##(1995-5#2)
in the nation's##2##3##(1992-2#1)(1996-2#1)
in the national##3##3##(1994-2#1)(2008-9#1)(2010-11#1)
in the native##4##3##(1990-5#1)(1994-8#1)(2008-10#1)(2008-9#1)
in the natural environment##3##4##(2008-10#3)
in the natural##9##3##(1993-1#1)(2008-10#6)(2010-10#1)(2010-5#1)
in the nature##6##3##(2008-10#5)(2011-3#1)
in the near future##18##4##(1991-1#1)(1994-12#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#1)
in the near##25##3##(1991-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
in the near-infrared spectral region##2##5##(2008-3#2)
in the near-infrared##3##3##(2008-3#3)
in the neck region##3##4##(1992-6#1)(2008-12#1)(2010-11#1)
in the neck##5##3##(1991-8#1)(1992-6#1)(2008-12#1)(2008-7#1)(2010-11#1)
in the necrotic##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
in the negative direction##2##4##(2008-10#1)(2008-12#1)
in the negative##10##3##(1997-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2010-10#1)(2012-2#1)
in the neighbourhood##2##3##(1996-6#1)(1997-1#1)
in the nematode Caenorhabditis elegans##2##5##(1990-5#1)(1997-7#1)
in the nematode##4##3##(1990-5#1)(1993-12#1)(1997-7#1)(2008-10#1)
in the neoadjuvant##2##3##(1993-11#1)(2013-8#1)
in the neocortex##4##3##(1994-3#1)(1997-2#1)(2008-11#1)(2010-7#1)
in the neonatal age group##2##5##(1996-9#2)
in the neonatal intensive care unit##2##6##(1997-3#1)(2008-5#1)
in the neonatal intensive care##4##5##(1990-6#1)(1997-3#1)(2008-5#1)(2010-8#1)
in the neonatal period##3##4##(1996-3#1)(2008-10#1)(2011-2#1)
in the neonatal##12##3##(1990-6#1)(1992-8#1)(1996-3#1)(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
in the neonate##2##3##(2011-1#1)(2012-3#1)
in the nerve##3##3##(1990-5#1)(1991-10#1)(1997-3#1)
in the nervous system##11##4##(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-2#1)(2013-1#1)
in the net##3##3##(2008-10#2)(2013-8#1)
in the network##8##3##(1996-3#1)(2008-11#4)(2008-7#1)(2009-8#1)(2012-2#1)
in the neural##11##3##(1990-11#1)(1994-3#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-6#1)
in the neuronal cell##2##4##(1993-8#2)
in the neuronal##4##3##(1993-8#2)(1995-12#1)(2008-11#1)
in the neurosurgical##2##3##(2008-7#1)(2011-2#1)
in the neutral condition##2##4##(2008-4#1)(2012-2#1)
in the neutral##5##3##(2008-10#2)(2008-4#1)(2012-2#1)(2013-1#1)
in the new race##2##4##(2008-10#2)
in the new##18##3##(1992-1#1)(1993-1#1)(1993-12#1)(1995-12#2)(1995-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2012-2#1)
in the newborn##7##3##(1990-11#1)(1990-9#1)(1993-12#1)(1995-8#1)(2008-7#1)(2008-9#1)(2013-1#1)
in the newly described VCG##2##5##(2008-10#2)
in the newly described##3##4##(2008-10#2)(2011-1#1)
in the newly##7##3##(2008-10#4)(2008-11#1)(2011-1#1)(2013-8#1)
in the next century##3##4##(1995-12#1)(2008-4#2)
in the next issue##2##4##(1993-2#1)(2010-5#1)
in the next millennium##2##4##(2008-4#2)
in the next##15##3##(1992-6#1)(1993-2#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
in the nigrostriatal system##2##4##(2012-2#2)
in the nigrostriatal##3##3##(1996-12#1)(2012-2#2)
in the no tillage##2##4##(2008-10#2)
in the no##3##3##(2008-10#2)(2008-12#1)
in the non-ischaemic group (r = 0##2##7##(2008-10#2)
in the non-ischaemic group##3##4##(2008-10#3)
in the non-pregnant state##2##4##(1990-11#1)(1994-8#1)
in the nonobese##3##3##(2011-2#3)
in the normal EF group##3##5##(2011-2#3)
in the normal fimbrial epithelial cells##2##6##(2012-12#2)
in the normal liver##2##4##(1990-5#2)
in the normal population##3##4##(1995-5#1)(1996-6#1)(2008-12#1)
in the normal range##3##4##(1992-9#2)(2008-9#1)
in the normal rat##2##4##(1996-2#1)(2008-9#1)
in the normal##33##3##(1990-5#2)(1991-5#1)(1992-3#1)(1992-9#2)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-8#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
in the normothermic##3##3##(1996-12#2)(2008-7#1)
in the north of##4##4##(2008-10#1)(2008-12#1)(2010-7#1)(2012-2#1)
in the north##8##3##(2008-10#3)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the north-central United States##3##5##(2008-10#3)
in the north-central region of the United States##3##8##(2008-10#3)
in the north-central##6##3##(2008-10#6)
in the northeastern United States##2##5##(1996-1#1)(2008-10#1)
in the northeastern##5##3##(1996-1#1)(2008-10#1)(2008-11#2)(2009-7#1)
in the northern Great Plains##2##5##(2008-10#2)
in the northern##8##3##(2008-10#6)(2008-5#1)(2011-2#1)
in the nu(4)##2##3##(2008-3#2)
in the nuclear genome##2##4##(1995-6#1)(2009-10#1)
in the nuclear##9##3##(1990-12#1)(1993-8#1)(1995-6#2)(1995-8#1)(2008-10#1)(2009-10#1)(2011-2#2)
in the nuclei of##4##4##(1994-6#2)(2008-7#1)(2009-12#1)
in the nuclei##9##3##(1990-3#1)(1994-6#2)(1996-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)
in the nucleus accumbens##6##4##(1993-6#1)(1994-2#2)(1994-8#2)(1995-2#1)
in the nucleus and##2##4##(2008-10#1)(2008-7#1)
in the nucleus of the##2##5##(1991-2#1)(2008-11#1)
in the nucleus##25##3##(1991-2#1)(1992-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#3)(1994-8#2)(1995-2#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the number and size of##3##6##(1995-8#1)(2008-10#1)(2010-12#1)
in the number and variety of##2##6##(1995-5#1)(1997-2#1)
in the number and##5##4##(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2010-12#1)
in the number of patients##2##5##(1994-5#1)(2008-7#1)
in the number of propagules##2##5##(2008-10#2)
in the number of species##2##5##(2008-10#1)(2008-8#1)
in the number of##63##4##(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-9#1)(1996-11#1)(1997-2#5)(1997-3#1)(1997-6#3)(1997-7#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
in the number##70##3##(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-2#6)(1997-3#1)(1997-6#3)(1997-7#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
in the numbers of##3##4##(1996-12#1)(2008-10#2)
in the nursery##2##3##(2008-10#2)
in the nursing curricula##3##4##(2008-11#3)
in the nursing home##3##4##(1997-2#1)(2008-11#1)(2009-3#1)
in the nursing##13##3##(1997-2#1)(2008-11#8)(2009-3#1)(2010-10#1)(2013-1#2)
in the nutrient media##2##4##(2013-1#2)
in the obese than the nonobese patients##2##7##(2011-2#2)
in the obese##6##3##(1996-12#1)(2011-1#2)(2011-2#3)
in the observed##5##3##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-7#1)
in the occipital lobe##2##4##(2008-7#1)(2011-2#1)
in the occipital##3##3##(1991-12#1)(2008-7#1)(2011-2#1)
in the occupational health service##2##5##(1995-2#2)
in the occurrence of##6##4##(1991-11#1)(1997-3#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the ocean##4##3##(2008-3#2)(2008-9#1)(2012-2#1)
in the office##3##3##(1991-2#1)(1995-12#1)(2008-4#1)
in the offspring of##2##4##(2008-7#1)(2008-8#1)
in the offspring##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
in the oil phase##2##4##(2008-5#2)
in the oil##4##3##(2008-12#1)(2008-5#3)
in the old##7##3##(1990-3#5)(2008-11#1)(2010-8#1)
in the older DS##3##4##(1991-1#3)
in the older##7##3##(1991-1#3)(1994-5#1)(2008-10#1)(2010-10#1)(2010-8#1)
in the oldest##3##3##(1990-3#1)(2008-7#2)
in the olfactory bulb of SAMP8 and SAMR1##2##8##(2008-7#2)
in the olfactory bulb of##3##5##(2008-7#3)
in the olfactory bulb##9##4##(1997-3#1)(2008-6#2)(2008-7#4)(2009-12#1)(2012-2#1)
in the olfactory##13##3##(1997-3#1)(2007-12#3)(2008-6#2)(2008-7#4)(2009-12#2)(2012-2#1)
in the one##3##3##(1995-12#1)(1997-3#1)(2008-10#1)
in the only##3##3##(1991-6#1)(1994-12#1)(2012-12#1)
in the onset of##7##4##(1994-5#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in the oocyte nucleus##2##4##(2007-12#2)
in the oocyte##4##3##(1993-6#1)(2007-12#2)(2008-8#1)
in the oocytes of##2##4##(2007-12#1)(2008-8#1)
in the oocytes##4##3##(2007-12#1)(2008-8#3)
in the open reading frame##2##5##(1996-12#1)(1997-7#1)
in the open##10##3##(1996-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2009-10#3)(2011-2#1)
in the operating conditions##2##4##(2008-10#2)
in the operating room##3##4##(1996-3#1)(2011-2#1)(2012-3#1)
in the operating##8##3##(1996-3#1)(2008-10#3)(2011-2#3)(2012-3#1)
in the operative##2##3##(2008-10#1)(2011-2#1)
in the opposite direction##4##4##(1991-5#1)(1997-3#1)(2008-10#1)(2009-7#1)
in the opposite##6##3##(1991-5#2)(1997-3#1)(2008-10#1)(2008-3#1)(2009-7#1)
in the optic tectum##2##4##(1990-5#1)(2008-6#1)
in the optic##5##3##(1990-5#1)(2008-5#1)(2008-6#1)(2008-7#2)
in the optical path##3##4##(2008-10#3)
in the optical system##2##4##(2008-3#2)
in the optical##8##3##(2007-12#1)(2008-10#3)(2008-3#4)
in the optimal##5##3##(1992-9#1)(2008-10#2)(2008-9#1)(2011-2#1)
in the optimisation##2##3##(2008-10#2)
in the optimization of##6##4##(2008-10#3)(2008-7#2)(2013-8#1)
in the optimization process##2##4##(2008-10#2)
in the optimization##14##3##(2008-10#11)(2008-7#2)(2013-8#1)
in the optimized##2##3##(2008-10#1)(2008-11#1)
in the oral cavity of##3##5##(2013-1#3)
in the oral cavity##11##4##(1990-9#1)(1997-4#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#5)
in the orchard and##2##4##(2008-10#2)
in the orchard##13##3##(2008-10#13)
in the order of the##2##5##(2008-10#1)(2010-1#1)
in the order of their##2##5##(2008-10#1)(2010-3#1)
in the order of##16##4##(1996-12#1)(2008-10#10)(2008-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2013-1#1)
in the order##37##3##(1990-9#1)(1993-8#1)(1995-8#1)(1996-12#1)(2008-10#23)(2008-5#4)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#2)(2013-1#1)
in the organic fraction##2##4##(2008-10#2)
in the organic phase on##2##5##(2008-10#2)
in the organic phase##10##4##(2008-10#10)
in the organic solvent##2##4##(1992-3#1)(2008-10#1)
in the organic##17##3##(1992-3#1)(1994-8#1)(2008-10#15)
in the organisation##2##3##(1996-12#1)(2008-12#1)
in the organism##3##3##(1993-2#1)(2008-5#1)(2010-4#1)
in the organization and##2##4##(1997-1#1)(2008-9#1)
in the organization of the##2##5##(1992-3#1)(2013-8#1)
in the organization##6##3##(1992-3#1)(1994-2#1)(1996-2#1)(1997-1#1)(2008-9#1)(2013-8#1)
in the orientation of##4##4##(1994-5#2)(2008-11#1)(2008-9#1)
in the origin##2##3##(2008-10#1)(2008-8#1)
in the original data##2##4##(1995-5#1)(2008-10#1)
in the original sample##4##4##(2008-10#1)(2008-11#2)(2008-12#1)
in the original samples##2##4##(2008-10#2)
in the original##19##3##(1994-8#1)(1995-5#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2012-12#1)
in the oscillation amplitude of the chemical system and the concentration of##2##12##(2008-10#2)
in the oscillation amplitude##4##4##(2008-10#4)
in the other one##2##4##(2008-10#1)(2008-5#1)
in the other species##2##4##(2008-8#1)(2011-2#1)
in the other three##2##4##(2008-10#1)(2008-5#1)
in the other two groups##2##5##(1991-11#1)(2008-10#1)
in the other##36##3##(1991-11#1)(1991-2#1)(1993-12#2)(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-5#5)(2008-7#1)(2008-8#3)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#3)(2013-8#1)
in the others##2##3##(1992-12#1)(1992-5#1)
in the otoliths of##2##4##(2008-10#1)(2010-8#1)
in the outcome of##2##4##(1993-11#1)(2011-2#1)
in the outer membrane of##2##5##(1990-11#1)(2009-8#1)
in the outer mitochondrial membrane##2##5##(2012-2#2)
in the outer##12##3##(1990-11#1)(1990-2#1)(1991-10#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#2)
in the outermost##2##3##(2008-5#2)
in the outpatient##3##3##(1991-9#1)(1995-2#1)(2011-2#1)
in the output layer##3##4##(2008-10#2)(2010-8#1)
in the output##5##3##(2008-10#2)(2008-3#2)(2010-8#1)
in the outskirts of Madrid##2##5##(2008-10#1)(2008-11#1)
in the ovary and##2##4##(2008-6#2)
in the ovary##7##3##(2008-12#1)(2008-6#2)(2010-5#2)(2010-8#2)
in the overall##9##3##(1992-12#1)(1994-6#1)(1995-5#1)(2008-10#1)(2008-7#2)(2011-10#1)(2012-12#1)(2012-3#1)
in the overlapping##2##3##(2008-10#1)(2013-1#1)
in the oviduct##4##3##(2008-11#2)(2008-12#2)
in the oxidation of##4##4##(1994-5#2)(2008-10#1)(2008-9#1)
in the oxidation reaction##2##4##(2008-10#2)
in the oxidation##9##3##(1994-5#2)(2008-10#6)(2008-9#1)
in the oxidative burst##2##4##(1995-6#1)(2008-10#1)
in the oxidative##5##3##(1990-2#2)(1995-6#1)(2008-10#1)(2008-5#1)
in the oxygen##2##3##(2008-10#1)(2013-8#1)
in the p53##2##3##(2008-9#1)(2010-10#1)
in the pH range 3##5##5##(2008-10#5)
in the pH range 4##3##5##(2008-10#3)
in the pH range 6##2##5##(2008-10#2)
in the pH range from 1##2##6##(2008-10#2)
in the pH range from##6##5##(2008-10#6)
in the pH range of 2##3##6##(2008-10#3)
in the pH range of 4##2##6##(2008-10#2)
in the pH range of 6##3##6##(2008-10#3)
in the pH range of fresh waters##2##7##(2008-10#2)
in the pH range of##14##5##(2008-10#14)
in the pH range##43##4##(2008-10#43)
in the pH ranges##2##4##(2008-10#2)
in the pH##48##3##(2008-10#48)
in the pacific northwest##2##4##(2008-10#2)
in the paediatric emergency department##2##5##(2008-11#2)
in the paediatric population##7##4##(1996-6#1)(2008-10#2)(2008-11#2)(2013-1#2)
in the paediatric##12##3##(1996-6#1)(2008-10#2)(2008-11#5)(2008-9#1)(2010-7#1)(2013-1#2)
in the pancreas of##2##4##(2008-10#1)(2008-7#1)
in the pancreas##10##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#2)(2012-2#1)(2013-7#2)
in the pancreatic##3##3##(1991-7#1)(2010-10#1)(2011-2#1)
in the paper##7##3##(2008-10#3)(2008-12#1)(2011-2#1)(2011-3#1)(2012-3#1)
in the papillary dermis##2##4##(2010-6#2)
in the parallel wire construct##2##5##(2009-3#2)
in the parameter##2##3##(2008-10#1)(2010-10#1)
in the parasite##2##3##(1997-6#1)(2012-3#1)
in the paraventricular##2##3##(1996-12#2)
in the parental##3##3##(1997-7#1)(2008-11#1)(2008-9#1)
in the parents##5##3##(2008-10#5)
in the parietal##3##3##(2008-7#1)(2010-7#1)(2013-8#1)
in the partial##2##3##(2008-10#2)
in the partially resistant##2##4##(2008-10#2)
in the partially##3##3##(1995-2#1)(2008-10#2)
in the particulate matter of emissions and##2##7##(2008-10#2)
in the past 10 years##4##5##(2008-10#1)(2008-11#1)(2009-1#1)(2009-4#1)
in the past 12 months##3##5##(2008-10#1)(2009-5#2)
in the past 30 days##2##5##(2013-1#2)
in the past decade##6##4##(1993-3#1)(1994-1#1)(2007-12#1)(2008-10#1)(2009-10#1)(2010-12#1)
in the past few decades##2##5##(2008-10#2)
in the past few years##7##5##(2008-1#1)(2008-10#1)(2008-11#2)(2010-7#1)(2011-2#1)(2012-2#1)
in the past few##9##4##(2008-1#1)(2008-10#3)(2008-11#2)(2010-7#1)(2011-2#1)(2012-2#1)
in the past##62##3##(1990-11#1)(1990-6#1)(1991-12#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#2)(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#3)(2010-10#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-7#1)(2013-1#3)(2013-8#1)
in the paste##4##3##(2008-10#4)
in the patch##4##3##(2008-8#1)(2008-9#3)
in the pathogen population##6##4##(2008-10#6)
in the pathogen##16##3##(1995-5#1)(2008-10#14)(2009-6#1)
in the pathogenesis and##3##4##(1991-11#1)(2010-10#1)(2013-8#1)
in the pathogenesis of Alzheimer's##2##5##(1996-12#1)(2011-3#1)
in the pathogenesis of IBD##2##5##(2009-12#2)
in the pathogenesis of atherosclerosis##2##5##(1994-11#1)(1997-8#1)
in the pathogenesis of cervical cancer##2##6##(2011-2#2)
in the pathogenesis of diabetic vascular##2##6##(2008-1#2)
in the pathogenesis of the##4##5##(1992-6#1)(1995-5#1)(2008-1#1)(2008-7#1)
in the pathogenesis of##54##4##(1990-9#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-12#2)(1997-2#1)(1997-8#4)(2008-1#3)(2008-10#2)(2008-5#2)(2008-7#5)(2009-1#1)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#4)
in the pathogenesis##60##3##(1990-9#1)(1991-11#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-12#2)(1997-2#1)(1997-8#4)(2008-1#3)(2008-10#2)(2008-5#4)(2008-7#5)(2009-1#1)(2009-12#2)(2009-8#2)(2010-1#1)(2010-10#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#5)
in the pathogenic##2##3##(2008-10#2)
in the pathogenicity##2##3##(2008-10#2)
in the pathological##3##3##(2008-12#1)(2011-2#1)(2012-3#1)
in the pathology of##2##4##(2009-4#1)(2009-8#1)
in the pathology##3##3##(2009-4#1)(2009-8#1)(2013-1#1)
in the pathophysiology of this##2##5##(2009-8#1)(2012-2#1)
in the pathophysiology of##10##4##(2008-11#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#4)(2013-1#1)
in the pathophysiology##11##3##(2008-11#1)(2008-7#3)(2009-8#1)(2011-2#1)(2012-2#4)(2013-1#1)
in the pathotype##2##3##(2008-10#2)
in the pathway##5##3##(1994-11#1)(2008-11#1)(2011-3#3)
in the patient group##2##4##(1997-8#1)(2011-2#1)
in the patient with##2##4##(1991-12#1)(2012-2#1)
in the patient##8##3##(1991-12#1)(1997-8#2)(2008-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
in the patient's best##2##4##(1997-8#2)
in the patient's##7##3##(1997-8#2)(2008-10#1)(2010-10#2)(2010-9#1)(2011-2#1)
in the patients than in the controls##2##7##(2008-7#1)(2011-2#1)
in the patients with##5##4##(1997-8#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-3#1)
in the patients##16##3##(1991-2#1)(1993-3#1)(1993-6#2)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
in the pattern##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
in the pePOA of##3##4##(1992-3#3)
in the pePOA##5##3##(1992-3#5)
in the pea##2##3##(1993-8#1)(2008-10#1)
in the peak##6##3##(1993-1#1)(2008-10#4)(2008-11#1)
in the peat mix but##2##5##(2008-10#2)
in the peat mix##4##4##(2008-10#4)
in the pectin layer of##2##5##(2008-10#2)
in the pediatric intensive care unit##2##6##(2012-2#2)
in the pediatric##7##3##(1995-5#1)(2008-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
in the pelvic cavity##2##4##(1992-3#1)(2008-12#1)
in the pelvis##2##3##(1991-11#1)(2009-12#1)
in the penumbra##2##3##(1997-2#2)
in the perceived##2##3##(2008-11#1)(2009-4#1)
in the percentage of cells##2##5##(2008-10#2)
in the percentage of residents with##2##6##(2011-2#2)
in the percentage of residents##3##5##(2011-2#3)
in the percentage of##10##4##(1992-6#1)(2008-10#4)(2008-9#1)(2011-2#4)
in the percentage##11##3##(1992-6#1)(2008-10#5)(2008-9#1)(2011-2#4)
in the perception of##2##4##(1992-3#1)(2012-3#1)
in the performance of##2##4##(2008-10#1)(2013-8#1)
in the perinuclear##2##3##(2008-9#1)(2012-3#1)
in the period from##2##4##(2007-8#1)(2011-3#1)
in the period##14##3##(1990-6#2)(1992-2#1)(1993-6#2)(1994-2#1)(1995-12#2)(1995-9#1)(2007-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2011-3#1)
in the perioperative##5##3##(1992-5#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the peripheral blood##8##4##(1990-3#1)(1994-11#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#2)
in the peripheral circulation##3##4##(2008-5#1)(2008-9#1)(2013-8#1)
in the peripheral part##2##4##(1994-12#1)(1996-3#1)
in the peripheral##17##3##(1990-3#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-3#2)(2013-8#1)
in the periphery##4##3##(1996-12#1)(2007-12#1)(2009-12#1)(2012-3#1)
in the peritoneal cavity##2##4##(2008-1#1)(2008-10#1)
in the permanent calves##2##4##(1996-12#2)
in the permanent##3##3##(1996-12#2)(2010-12#1)
in the permeability of##2##4##(1990-5#1)(2008-10#1)
in the petioles of inoculated leaves##2##6##(2008-10#2)
in the petioles of##3##4##(2008-10#3)
in the pharmaceutical dosage forms##2##5##(2008-10#2)
in the pharmaceutical industry##7##4##(1995-5#1)(1997-1#1)(2008-11#3)(2010-11#1)(2012-2#1)
in the pharmaceutical##12##3##(1995-5#1)(1997-1#1)(2008-10#5)(2008-11#3)(2010-11#1)(2012-2#1)
in the phase##3##3##(2008-10#2)(2008-3#1)
in the pheromone##2##3##(1996-2#1)(2008-10#1)
in the phloem##4##3##(2008-10#3)(2008-11#1)
in the phonological and orthographic##2##5##(1991-2#2)
in the phospholipid##2##3##(2008-8#1)(2010-11#1)
in the photo-symbiotic clams##2##4##(2008-5#2)
in the photochemical reaction##2##4##(2008-10#1)(2008-8#1)
in the photochemical##3##3##(2008-10#2)(2008-8#1)
in the phylogenetic##2##3##(2010-3#1)(2013-8#1)
in the physical##4##3##(1992-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
in the physiological##2##3##(2008-11#1)(2010-6#1)
in the pigeon##2##3##(2008-8#2)
in the pilot##2##3##(2008-11#1)(2011-2#1)
in the pim1-d1ts mutant##2##4##(1995-2#2)
in the pineal gland##3##4##(1995-11#1)(2008-5#1)(2013-7#1)
in the pituitary##4##3##(1992-10#1)(1995-12#1)(2008-4#2)
in the placebo group##3##4##(2008-5#2)(2012-2#1)
in the placebo##4##3##(2008-5#2)(2011-2#1)(2012-2#1)
in the placement##2##3##(2008-11#1)(2008-12#1)
in the plane##2##3##(1995-2#1)(2012-12#1)
in the planning and implementation of##2##6##(1993-3#1)(2008-10#1)
in the planning##3##3##(1993-3#1)(1994-2#1)(2008-10#1)
in the plant kingdom and##2##5##(2008-10#1)(2009-12#1)
in the plant kingdom##5##4##(2008-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
in the plant tissue##2##4##(2008-10#2)
in the plant##19##3##(2008-10#11)(2008-11#2)(2009-12#1)(2009-6#1)(2009-8#1)(2011-10#1)(2011-2#1)(2013-8#1)
in the plants##3##3##(2008-10#3)
in the plasma following##2##4##(2008-10#2)
in the plasma for##3##4##(2008-10#2)(2008-11#1)
in the plasma membrane of##3##5##(1994-12#1)(2010-11#1)(2010-12#1)
in the plasma membrane##7##4##(1993-8#1)(1994-12#1)(1994-6#1)(2008-11#1)(2010-11#1)(2010-12#1)(2012-3#1)
in the plasma of##4##4##(1992-6#2)(2008-10#1)(2012-2#1)
in the plasma torch##3##4##(2008-10#3)
in the plasma##26##3##(1992-6#2)(1992-9#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(2008-10#11)(2008-11#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
in the plasmid##2##3##(1994-12#1)(2008-8#1)
in the plus-maze##3##3##(1993-3#1)(1994-2#1)(2008-11#1)
in the polymer matrix##2##4##(2008-10#1)(2008-7#1)
in the polymer##3##3##(2008-10#2)(2008-7#1)
in the polymeric matrix##2##4##(2008-10#2)
in the poor##2##3##(2009-5#1)(2011-2#1)
in the population is##2##4##(1991-9#1)(2011-2#1)
in the population of##7##4##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
in the population structure of##2##5##(2008-10#2)
in the population##39##3##(1991-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-3#2)(1996-6#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#4)(2010-10#1)(2011-2#2)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
in the populations##2##3##(2008-10#1)(2008-8#1)
in the porcine##3##3##(1995-8#1)(2011-2#1)(2012-2#1)
in the pore water at##2##5##(2008-10#1)(2013-8#1)
in the pore##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
in the pores of the##2##5##(2008-10#2)
in the pores##4##3##(2008-10#4)
in the porous##2##3##(2008-3#1)(2012-2#1)
in the position of##2##4##(1997-3#1)(2008-8#1)
in the position##4##3##(1990-12#1)(1997-3#1)(2008-10#1)(2008-8#1)
in the positive ion mode##3##5##(2008-10#1)(2011-3#2)
in the positive##8##3##(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2011-3#2)(2012-12#1)
in the post##3##3##(2008-11#1)(2008-12#1)(2010-7#1)
in the post-genomic era##2##4##(2011-2#1)(2012-3#1)
in the post-translational##2##3##(1992-6#1)(2008-5#1)
in the posterior fossa##7##4##(1996-6#2)(2008-7#4)(2011-2#1)
in the posterior lobe##2##4##(1992-9#2)
in the posterior##18##3##(1992-9#2)(1993-2#1)(1996-6#2)(2008-12#1)(2008-5#1)(2008-7#5)(2010-12#1)(2011-2#3)(2011-7#1)(2012-3#1)
in the postnatal##2##3##(1990-5#1)(2009-8#1)
in the postoperative period##3##4##(1990-2#1)(2010-10#2)
in the postoperative##5##3##(1990-2#1)(1994-3#1)(2010-10#2)(2012-2#1)
in the postpartum period##3##4##(2011-2#1)(2012-2#2)
in the postpartum##4##3##(2010-6#1)(2011-2#1)(2012-2#2)
in the postsynaptic##2##3##(1996-12#2)
in the potential##8##3##(1992-9#1)(2008-10#4)(2010-7#1)(2011-2#1)(2012-2#1)
in the potentiometric titration of Cu(2+)##3##6##(2008-10#3)
in the potentiometric titration of##10##5##(2008-10#10)
in the potentiometric##11##3##(2008-10#11)
in the practice of##14##4##(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-6#1)(2008-10#3)(2008-12#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)
in the practice##17##3##(1990-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)
in the pre- and##2##4##(2012-12#2)
in the preceding##6##3##(1996-6#1)(1997-6#1)(2008-10#2)(2009-5#1)(2013-8#1)
in the precipitate##3##3##(2008-10#2)(2008-11#1)
in the precipitates##2##3##(2008-10#2)
in the precision##2##3##(2008-10#2)
in the preconcentration##2##3##(2008-10#2)
in the predicted##3##3##(1991-6#1)(2008-10#2)
in the prediction of##4##4##(1990-5#1)(2008-11#1)(2008-4#1)(2008-5#1)
in the prediction##5##3##(1990-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
in the predominant##2##3##(2008-10#1)(2008-3#1)
in the prefrontal cortex##2##4##(1996-2#1)(1997-2#1)
in the prefrontal##3##3##(1996-2#1)(1997-2#1)(2008-11#1)
in the premammillary##2##3##(1994-2#2)
in the preoperative##4##3##(1990-11#1)(1990-9#1)(1997-2#1)(2012-3#1)
in the preoptic area##3##4##(1992-1#1)(1992-3#1)(2008-8#1)
in the preparation and##2##4##(2008-10#2)
in the preparation of##7##4##(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
in the preparation##9##3##(1992-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
in the prepubertal period##2##4##(2008-4#1)(2011-1#1)
in the presence and absence of other##2##7##(2008-8#2)
in the presence and absence of the##4##7##(1990-5#1)(2008-10#2)(2011-1#1)
in the presence and absence of##27##6##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-7#1)(2008-8#2)(2011-1#1)(2012-3#1)(2013-1#1)
in the presence and the absence of##2##7##(2008-10#2)
in the presence and##29##4##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1997-1#1)(2008-10#12)(2008-11#2)(2008-7#1)(2008-8#2)(2011-1#1)(2012-3#1)(2013-1#1)
in the presence of 0##6##5##(1993-8#1)(1995-8#2)(2008-10#2)(2008-11#1)
in the presence of 1 mol##2##6##(1994-5#1)(2008-10#1)
in the presence of 1##9##5##(1991-12#1)(1994-11#1)(1994-5#1)(1997-2#1)(2008-10#5)
in the presence of 10% calf serum##2##7##(1991-5#1)(2008-11#1)
in the presence of 10%##4##5##(1991-5#1)(1995-3#1)(2008-10#1)(2008-11#1)
in the presence of 2##5##5##(1990-8#1)(1993-8#1)(2008-10#3)
in the presence of 200##2##5##(1990-5#1)(2008-10#1)
in the presence of 5##3##5##(1995-11#1)(2008-10#1)(2008-7#1)
in the presence of 8##2##5##(2008-10#2)
in the presence of ATP##3##5##(1993-6#3)
in the presence of Ba(2+)##2##5##(2008-10#2)
in the presence of CH##2##5##(2008-10#2)
in the presence of Ca(2+)##2##5##(2008-10#1)(2008-11#1)
in the presence of Ca2+ and phosphatidylserine##3##7##(1994-11#3)
in the presence of DNA using##2##6##(2008-10#2)
in the presence of DNA##5##5##(2008-10#5)
in the presence of EGTA##2##5##(1990-10#2)
in the presence of FUTHAN was##2##6##(1990-5#2)
in the presence of Fe(II)##4##5##(2008-10#4)
in the presence of GSH##2##5##(1993-8#1)(2013-1#1)
in the presence of H(2)O(2)##3##5##(2008-10#3)
in the presence of HGF##2##5##(2008-11#2)
in the presence of HS##4##5##(2008-10#4)
in the presence of NADPH##3##5##(1991-5#2)(2009-9#1)
in the presence of NO (-) (3) N##2##8##(2008-10#2)
in the presence of RepK##2##5##(1997-6#2)
in the presence of Ru(bpy)(3)(2+)##2##5##(2008-10#2)
in the presence of T22##2##5##(2008-10#2)
in the presence of UA##2##5##(2008-10#2)
in the presence of UV##3##5##(2008-10#1)(2008-11#2)
in the presence of a cationic surfactant##2##7##(2008-10#2)
in the presence of a given##2##6##(2008-10#1)(2009-12#1)
in the presence of a high##2##6##(2008-10#2)
in the presence of a large##2##6##(2008-10#2)
in the presence of a##40##5##(1990-12#1)(1990-5#1)(1991-5#2)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-5#3)(1997-7#2)(1997-8#1)(2008-10#18)(2008-11#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-6#2)(2010-4#1)
in the presence of acetone##2##5##(2008-10#2)
in the presence of alkali##2##5##(2008-10#2)
in the presence of alpha-##2##5##(1991-3#1)(2008-10#1)
in the presence of alpha-CD##2##5##(2008-10#2)
in the presence of ammonia##2##5##(2008-10#2)
in the presence of ammonium##3##5##(2008-10#3)
in the presence of an excess of sodium ion##2##9##(2008-10#2)
in the presence of an excess of##3##7##(2008-10#3)
in the presence of an##16##5##(1991-12#1)(1991-5#1)(1996-5#1)(2008-10#10)(2008-12#1)(2008-7#1)(2010-1#1)
in the presence of ascorbic acid##8##6##(2008-10#8)
in the presence of atmospherical particulate matter sampled in a laboratory of the Department##2##14##(2008-10#2)
in the presence of atmospherical particulate matter sampled in a laboratory of the##3##13##(2008-10#3)
in the presence of atmospherical particulate matter##4##7##(2008-10#4)
in the presence of atropine (1 microM) and guanethidine (3 microM)##2##11##(1997-4#2)
in the presence of beta-CD was##2##6##(2008-10#2)
in the presence of beta-CD##4##5##(2008-10#4)
in the presence of both##2##5##(2008-11#1)(2008-7#1)
in the presence of bovine serum albumin##3##7##(1993-8#1)(2008-10#2)
in the presence of bromate##2##5##(2008-10#2)
in the presence of calcium and##2##6##(1990-8#1)(1992-12#1)
in the presence of calcium##3##5##(1990-8#1)(1992-12#1)(2011-2#1)
in the presence of cardiolipin##2##5##(1991-5#2)
in the presence of cationic##2##5##(2008-10#2)
in the presence of cell walls from##3##7##(2008-10#3)
in the presence of cetylpyridinium chloride##4##6##(2008-10#4)
in the presence of cetyltrimethylammonium bromide (CTAB)##2##7##(2008-10#2)
in the presence of chloride##2##5##(2008-10#2)
in the presence of copper by##2##6##(2008-10#2)
in the presence of copper##8##5##(2008-10#8)
in the presence of cysteine##2##5##(2008-10#2)
in the presence of diagnostic uncertainty##2##6##(2008-12#2)
in the presence of different##6##5##(1991-5#1)(2008-10#4)(2010-4#1)
in the presence of epicatechin##2##5##(2008-10#2)
in the presence of ethanol##2##5##(1991-5#1)(2008-10#1)
in the presence of excess of##2##6##(2008-10#2)
in the presence of excess##7##5##(1990-5#1)(1991-9#1)(2008-10#5)
in the presence of extrinsic phospholipid##2##6##(2008-9#2)
in the presence of folimycin##2##5##(1993-6#2)
in the presence of free##2##5##(2008-10#2)
in the presence of genistein##3##5##(1997-7#2)(2008-11#1)
in the presence of glucose##3##5##(1995-8#1)(2008-10#2)
in the presence of high##6##5##(1991-9#1)(2008-10#3)(2008-11#1)(2008-5#1)
in the presence of horseradish peroxidase (HRP)##2##7##(2008-10#2)
in the presence of human##2##5##(1990-12#1)(2008-10#1)
in the presence of hydrogen peroxide##7##6##(2008-10#7)
in the presence of imidazole##2##5##(1994-5#2)
in the presence of interferents##2##5##(2008-10#2)
in the presence of interfering##2##5##(2008-10#1)(2013-1#1)
in the presence of iron##2##5##(1991-5#1)(2013-1#1)
in the presence of large##4##5##(2008-10#4)
in the presence of liposomes##2##5##(2008-10#2)
in the presence of low##2##5##(1994-5#1)(2008-11#1)
in the presence of magnesium##2##5##(1997-3#1)(2008-4#1)
in the presence of molybdate##2##5##(1990-11#1)(2008-10#1)
in the presence of nitrate##2##5##(2008-10#1)(2008-11#1)
in the presence of noise##3##5##(2008-9#2)(2010-10#1)
in the presence of nonionic##2##5##(2008-10#2)
in the presence of one another##2##6##(2008-10#2)
in the presence of other##5##5##(2008-10#4)(2009-12#1)
in the presence of oxygen##5##5##(1997-1#1)(2008-10#3)(2008-9#1)
in the presence of phenol##4##5##(2008-10#4)
in the presence of polyethylene glycol##2##6##(1992-11#1)(2008-10#1)
in the presence of reactive##2##5##(2008-10#1)(2009-8#1)
in the presence of several interfering##2##6##(2008-10#2)
in the presence of several substances##2##6##(2008-10#2)
in the presence of several##5##5##(2008-10#5)
in the presence of sodium chloride higher than 0##2##9##(2008-10#2)
in the presence of sodium dodecyl sulfate and##2##8##(1996-12#1)(2008-10#1)
in the presence of sodium dodecyl sulfate##3##7##(1990-11#1)(1996-12#1)(2008-10#1)
in the presence of sodium tartrate##2##6##(2008-10#2)
in the presence of sodium##17##5##(1990-11#1)(1996-12#1)(2008-10#14)(2008-9#1)
in the presence of strongly##2##5##(2008-10#2)
in the presence of sufficient##2##5##(1995-2#1)(2008-10#1)
in the presence of surfactants##4##5##(2008-10#4)
in the presence of the neutral##2##6##(2008-10#2)
in the presence of the other##2##6##(2008-10#1)(2008-12#1)
in the presence of the##46##5##(1990-5#2)(1991-12#1)(1992-3#1)(1992-4#1)(1993-8#2)(1994-11#1)(1994-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#29)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-3#1)
in the presence of their degradates##2##6##(2008-10#2)
in the presence of this##3##5##(1993-8#1)(2008-10#2)
in the presence of trifluoroethanol##2##5##(1995-2#2)
in the presence of tunicamycin##3##5##(1993-6#1)(1994-8#1)(2008-11#1)
in the presence of two##2##5##(2008-10#2)
in the presence of uric acid##2##6##(2008-10#2)
in the presence of various##3##5##(1996-5#2)(2008-10#1)
in the presence of varying##2##5##(2008-10#2)
in the presence of##761##4##(1990-10#4)(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#10)(1990-7#1)(1990-8#5)(1991-12#3)(1991-3#1)(1991-5#12)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#8)(1993-8#16)(1994-11#7)(1994-3#1)(1994-5#9)(1994-6#2)(1994-8#3)(1995-11#5)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#13)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#5)(1997-8#3)(2007-11#1)(2007-12#3)(2008-10#453)(2008-11#47)(2008-12#5)(2008-3#10)(2008-4#5)(2008-5#3)(2008-7#5)(2008-8#7)(2008-9#9)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#8)
in the presence or absence of the##2##7##(1991-5#1)(1995-8#1)
in the presence or absence of##13##6##(1991-11#1)(1991-5#1)(1993-3#1)(1995-11#1)(1995-8#1)(2008-10#5)(2008-2#1)(2008-8#2)
in the presence or absence##14##5##(1991-11#1)(1991-5#1)(1993-3#1)(1995-11#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#2)
in the presence##808##3##(1990-10#4)(1990-11#3)(1990-12#4)(1990-2#2)(1990-5#11)(1990-6#1)(1990-7#1)(1990-8#5)(1991-11#1)(1991-12#3)(1991-3#2)(1991-5#13)(1991-6#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#4)(1993-6#8)(1993-8#16)(1994-11#7)(1994-3#1)(1994-5#9)(1994-6#2)(1994-8#3)(1995-11#6)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#5)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#13)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#5)(1997-8#3)(2007-11#1)(2007-12#3)(2008-10#472)(2008-11#52)(2008-12#5)(2008-2#1)(2008-3#10)(2008-4#5)(2008-5#3)(2008-7#6)(2008-8#11)(2008-9#9)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#9)
in the present article##2##4##(2008-10#1)(2008-11#1)
in the present case the##2##5##(1990-5#1)(2011-2#1)
in the present case##5##4##(1990-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
in the present investigation##2##4##(2008-10#1)(2008-11#1)
in the present paper##6##4##(2008-10#5)(2008-11#1)
in the present study that##2##5##(1994-8#1)(1995-12#1)
in the present study we##2##5##(2011-2#1)(2012-2#1)
in the present study were##2##5##(1993-3#1)(2009-8#1)
in the present study##27##4##(1990-6#1)(1992-12#1)(1993-3#2)(1994-8#2)(1995-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-5#1)(2013-8#1)
in the present work##6##4##(2008-10#3)(2008-11#1)(2009-10#1)(2013-8#1)
in the present##62##3##(1990-12#2)(1990-5#1)(1990-6#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-3#2)(1994-8#4)(1995-12#1)(2008-10#20)(2008-11#6)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#2)(2013-8#3)
in the presentation of##2##4##(1991-11#1)(2010-12#1)
in the presentation##3##3##(1991-11#1)(2010-12#1)(2013-1#1)
in the preservation##2##3##(2008-10#1)(2008-11#1)
in the prevalence of##6##4##(1996-12#1)(2008-10#1)(2008-7#1)(2009-7#2)(2013-1#1)
in the prevention and treatment of##2##6##(2008-10#1)(2012-12#1)
in the prevention and##3##4##(1991-6#1)(2008-10#1)(2012-12#1)
in the prevention of##11##4##(1990-3#1)(1990-5#1)(1990-9#1)(1992-9#1)(1993-2#1)(1996-12#1)(1997-8#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-5#1)
in the prevention##14##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-9#1)(1993-2#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-12#1)
in the previous paper##3##4##(1994-5#1)(2008-10#1)(2008-2#1)
in the previous study##2##4##(1993-12#1)(2008-9#1)
in the previous year##2##4##(2008-10#2)
in the previous##15##3##(1993-12#1)(1994-12#1)(1994-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
in the previously sprayed##2##4##(2008-10#2)
in the previously##3##3##(2008-10#2)(2009-6#1)
in the prg pathogens##2##4##(2008-10#2)
in the primary and##2##4##(2011-2#1)(2013-1#1)
in the primary care setting##6##5##(2008-11#2)(2010-1#2)(2013-1#2)
in the primary care##7##4##(1995-11#1)(2008-11#2)(2010-1#2)(2013-1#2)
in the primary structure of##2##5##(2008-4#1)(2011-2#1)
in the primary##27##3##(1992-3#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-8#1)(2010-1#2)(2011-2#6)(2013-1#3)
in the primate brain##2##4##(1997-2#2)
in the primate##3##3##(1995-11#1)(1997-2#2)
in the principal##2##3##(2008-3#2)
in the prior##2##3##(1995-2#1)(2008-5#1)
in the private sector##2##4##(1991-1#1)(2008-1#1)
in the private##6##3##(1991-1#1)(1991-2#1)(1992-2#1)(1994-1#1)(1996-1#1)(2008-1#1)
in the probability of##4##4##(1995-1#1)(2008-8#1)(2008-9#1)(2009-8#1)
in the procedure##6##3##(1993-3#1)(2008-10#3)(2011-2#1)(2012-3#1)
in the process and##2##4##(2008-10#1)(2008-11#1)
in the process of the##2##5##(2008-8#1)(2012-3#1)
in the process of##36##4##(1990-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#4)(2008-9#1)(2010-4#1)(2010-7#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
in the process##45##3##(1990-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-6#1)(2010-4#1)(2010-7#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
in the processes of##3##4##(1993-8#1)(1997-3#1)(2012-3#1)
in the processes##5##3##(1993-3#1)(1993-8#1)(1997-3#1)(2008-12#1)(2012-3#1)
in the processing of as many as 25 samples per hour##2##11##(2008-10#2)
in the processing of as many as 25##3##8##(2008-10#3)
in the processing of##6##4##(2008-10#4)(2008-4#1)(2013-8#1)
in the product##3##3##(2008-10#1)(2008-5#2)
in the production of a##2##5##(2008-10#1)(2011-3#1)
in the production of##20##4##(1993-12#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-10#7)(2008-11#2)(2008-8#1)(2010-4#1)(2011-3#1)(2013-1#3)
in the production##26##3##(1993-12#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(2006-6#1)(2008-10#7)(2008-11#5)(2008-8#1)(2010-4#1)(2011-3#1)(2013-1#3)(2013-8#2)
in the professional##3##3##(1992-3#1)(1993-1#1)(2011-2#1)
in the progeny of##4##4##(2008-10#2)(2008-9#1)(2010-8#1)
in the progeny##6##3##(2008-10#3)(2008-5#1)(2008-9#1)(2010-8#1)
in the program##3##3##(1995-12#1)(1997-2#1)(2012-3#1)
in the progression of gastric##2##5##(2011-2#2)
in the progression of##9##4##(1991-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-1#1)(2009-7#1)(2011-2#2)(2013-1#1)
in the project##4##3##(1997-3#1)(2008-11#2)(2013-1#1)
in the proliferating primary rat hepatocytes##2##6##(1993-8#2)
in the promoter and##2##4##(1990-11#1)(1994-11#1)
in the promoter of##3##4##(2008-11#1)(2008-9#2)
in the promoter region of##2##5##(1995-11#1)(2011-2#1)
in the promoter region##3##4##(1991-6#1)(1995-11#1)(2011-2#1)
in the promoter##12##3##(1990-11#1)(1991-6#1)(1994-11#1)(1995-11#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the promotion of##2##4##(2008-11#1)(2011-1#1)
in the propagation of##2##4##(1990-5#1)(2008-10#1)
in the propagation##3##3##(1990-5#1)(2008-10#1)(2008-3#1)
in the proper##2##3##(1994-6#1)(2013-1#1)
in the prophylaxis of##2##4##(1991-3#1)(2008-7#1)
in the prophylaxis##3##3##(1991-3#1)(2008-7#1)(2010-8#1)
in the proportion of##13##4##(1991-12#1)(1996-12#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#2)
in the proposed method##2##4##(2008-10#2)
in the proposed system##2##4##(2008-10#2)
in the proposed##10##3##(1994-11#1)(2008-10#7)(2008-3#1)(2008-7#1)
in the propranolol group##2##4##(2009-8#2)
in the protected##2##3##(1990-11#1)(2008-10#1)
in the protection against the##2##5##(2008-10#1)(2013-8#1)
in the protection against##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
in the protection of##2##4##(2008-10#1)(2008-5#1)
in the protection##7##3##(2008-10#3)(2008-11#1)(2008-5#2)(2013-8#1)
in the protein##17##3##(1990-12#1)(1990-8#1)(1993-6#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-8#1)(2008-9#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#1)
in the proteins##2##3##(2008-10#2)
in the proteolytic##2##3##(1990-8#1)(2013-1#1)
in the protocerebrum##3##3##(2007-12#3)
in the province of Alberta##2##5##(2008-11#1)(2012-12#1)
in the province of Huelva##2##5##(1996-6#1)(2008-10#1)
in the province of##9##4##(1994-9#1)(1996-3#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#1)
in the province##11##3##(1994-9#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#1)
in the provision of##6##4##(1994-1#1)(1995-3#1)(1997-2#1)(2008-11#1)(2008-12#2)
in the provision##7##3##(1994-1#1)(1995-3#2)(1997-2#1)(2008-11#1)(2008-12#2)
in the proximal tubular##2##4##(1994-5#1)(2011-2#1)
in the proximal##11##3##(1990-8#1)(1991-5#1)(1991-7#1)(1994-5#1)(1995-12#1)(1997-7#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the proximity##2##3##(2008-7#1)(2012-3#1)
in the psychiatric setting##2##4##(1992-2#2)
in the psychiatric##3##3##(1991-12#1)(1992-2#2)
in the pubertal period##2##4##(2011-1#2)
in the public and private##2##5##(1997-3#1)(2013-7#1)
in the public debate##2##4##(2008-11#1)(2010-11#1)
in the public domain##2##4##(1996-1#1)(2009-12#1)
in the public##9##3##(1996-1#1)(1996-12#1)(1997-3#1)(2008-11#1)(2009-12#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-7#1)
in the publication##2##3##(2007-12#1)(2008-10#1)
in the published literature##2##4##(1991-3#1)(2012-12#1)
in the pulmonary##2##3##(2008-10#1)(2008-11#1)
in the pulp##3##3##(1991-2#3)
in the purified##5##3##(1990-11#1)(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#1)
in the purple##2##3##(1993-8#1)(1997-8#1)
in the pursuit of##2##4##(1993-2#1)(2008-12#1)
in the putamen##2##3##(2008-7#2)
in the putative##3##3##(1992-6#1)(1997-9#1)(2008-10#1)
in the pyridine##2##3##(1992-1#1)(2008-10#1)
in the quality and##2##4##(2008-11#2)
in the quality control of##4##5##(1994-1#1)(2008-10#2)(2010-4#1)
in the quality control##5##4##(1994-1#1)(2008-10#3)(2010-4#1)
in the quality of the##3##5##(1996-3#1)(2008-3#1)(2011-2#1)
in the quality of##11##4##(1996-2#2)(1996-3#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#2)(2012-3#1)
in the quality##20##3##(1994-1#1)(1995-2#1)(1996-2#2)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#3)(2012-3#1)
in the quantification of##5##4##(2008-10#4)(2013-1#1)
in the quantitative##4##3##(2008-10#2)(2008-4#1)(2013-1#1)
in the quantity of##2##4##(1992-12#1)(2008-10#1)
in the rAAV-antisense 6A8 cDNA-transduced SKW6 cells##2##7##(2008-8#2)
in the rAAV-antisense 6A8 cDNA-transduced SKW6##3##6##(2008-8#3)
in the rabbit##4##3##(1992-6#1)(1992-9#1)(2008-5#1)(2013-1#1)
in the radial##3##3##(1990-11#1)(2008-10#1)(2009-7#1)
in the radiologic##2##3##(1996-1#1)(1997-8#1)
in the radiological##3##3##(1993-3#1)(1997-8#1)(2011-2#1)
in the rainbow trout##3##4##(2008-5#1)(2008-6#2)
in the random##2##3##(2008-9#1)(2013-8#1)
in the range 0##63##4##(1990-2#1)(1993-8#1)(2008-10#60)(2008-3#1)
in the range 1##11##4##(2008-10#11)
in the range 2##6##4##(2008-10#6)
in the range 3##3##4##(2008-10#3)
in the range 4##4##4##(2008-10#4)
in the range 5##3##4##(2008-10#3)
in the range 6##4##4##(2008-10#4)
in the range 99##2##4##(2008-10#2)
in the range between 0##3##5##(2008-10#3)
in the range between 1##2##5##(2008-10#2)
in the range between##6##4##(2008-10#6)
in the range comprised between##2##5##(2008-10#2)
in the range from 0##6##5##(2008-10#5)(2008-3#1)
in the range from 1##2##5##(1990-2#1)(2008-10#1)
in the range from 91 to##2##6##(2008-10#2)
in the range from##20##4##(1990-2#1)(2008-10#17)(2008-3#2)
in the range of 0##61##5##(2008-10#60)(2011-2#1)
in the range of 1##17##5##(2008-10#16)(2008-3#1)
in the range of 10(-4)##2##5##(2008-10#2)
in the range of 1x10(-7) to##2##6##(2008-10#2)
in the range of 2##9##5##(2008-10#9)
in the range of 3##5##5##(2008-10#5)
in the range of 4##5##5##(2008-10#4)(2013-1#1)
in the range of 5##8##5##(2008-10#8)
in the range of 7##3##5##(2008-10#3)
in the range of 9##2##5##(2008-10#2)
in the range of 95-105%##2##5##(2008-10#2)
in the range of 99##3##5##(2008-10#3)
in the range of pH##4##5##(2008-10#4)
in the range of##220##4##(1990-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-10#199)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#3)(2011-7#1)(2013-1#1)
in the range pH##2##4##(2008-10#2)
in the range##433##3##(1990-11#1)(1990-2#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-10#399)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#2)(2010-10#1)(2010-4#1)(2011-2#3)(2011-7#1)(2013-1#1)
in the ranges of 1##3##5##(2008-10#3)
in the ranges of 2##2##5##(2008-10#2)
in the ranges of##9##4##(2008-10#9)
in the ranges##20##3##(2007-12#1)(2008-10#19)
in the raphe nuclei##5##4##(2008-7#5)
in the raphe##6##3##(2008-7#5)(2012-3#1)
in the rapid##3##3##(1991-2#1)(2008-10#1)(2013-1#1)
in the rapidly growing##2##4##(1990-5#1)(1991-6#1)
in the rat and##3##4##(1992-6#1)(2008-11#1)(2008-4#1)
in the rat brain by##2##5##(1996-12#1)(2008-10#1)
in the rat brain##11##4##(1993-3#3)(1993-8#1)(1994-11#1)(1996-12#5)(2008-10#1)
in the rat but##2##4##(1992-12#1)(2008-8#1)
in the rat hippocampus##3##4##(1990-5#2)(1996-12#1)
in the rat kidney##3##4##(1994-5#2)(1995-12#1)
in the rat kindling model##2##5##(1994-2#2)
in the rat knee joint##2##5##(1992-6#2)
in the rat liver##2##4##(2008-10#1)(2009-8#1)
in the rat salivary gland##2##5##(1995-11#2)
in the rat##118##3##(1990-12#1)(1990-3#1)(1990-5#5)(1991-1#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-12#3)(1992-6#8)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#6)(1993-6#2)(1993-8#2)(1994-11#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#5)(1995-11#4)(1995-12#7)(1995-2#1)(1995-8#2)(1995-9#1)(1996-12#10)(1996-2#6)(1996-5#2)(1997-2#2)(1997-7#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
in the rate and extent of##2##6##(2008-10#2)
in the rate of##21##4##(1990-5#1)(1994-5#2)(1995-6#1)(2008-10#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-3#1)(2013-1#2)
in the rate##24##3##(1990-5#1)(1994-5#2)(1995-6#1)(2008-10#7)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#3)(2012-3#1)(2013-1#2)
in the rates of primary and secondary infection##2##8##(2008-10#2)
in the rates of##12##4##(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#2)(2008-10#4)(2008-11#1)(2010-3#1)(2013-1#1)
in the rates##14##3##(1990-8#1)(1992-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#2)(2008-10#4)(2008-11#1)(2010-3#1)(2013-1#1)
in the ratio 1##2##4##(2008-10#2)
in the ratio of##7##4##(1994-3#1)(2008-10#4)(2008-6#1)(2011-1#1)
in the ratio##14##3##(1994-3#1)(2008-10#11)(2008-6#1)(2011-1#1)
in the rats##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
in the raw beef patties with 15% flaxseed flour##2##9##(2010-4#2)
in the raw##3##3##(1992-5#1)(2010-4#2)
in the reaction mechanism##3##4##(1995-6#1)(2008-10#2)
in the reaction medium##6##4##(1996-5#1)(2008-10#5)
in the reaction mixture##3##4##(1994-5#1)(2008-10#2)
in the reaction system##2##4##(2008-10#2)
in the reaction##32##3##(1991-9#1)(1994-5#1)(1995-6#1)(1996-5#1)(2008-10#22)(2008-11#1)(2008-8#1)(2008-9#2)(2013-1#2)
in the reactor##2##3##(2008-7#2)
in the reagent##5##3##(2008-10#5)
in the real samples##3##4##(2008-10#3)
in the real world##2##4##(2008-10#1)(2009-12#1)
in the real##8##3##(2008-10#5)(2008-3#1)(2009-12#1)(2012-3#1)
in the rear of##2##4##(2008-10#2)
in the rear##3##3##(1996-12#1)(2008-10#2)
in the recent past##2##4##(2008-7#1)(2012-5#1)
in the recent##7##3##(1993-2#1)(1997-4#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-5#1)
in the recently##2##3##(2008-8#1)(2011-2#1)
in the receptacle area##3##4##(2008-10#3)
in the reception##2##3##(1996-1#1)(2008-11#1)
in the receptor##3##3##(2006-6#1)(2008-5#1)(2008-8#1)
in the receptor-mediated##2##3##(1996-2#1)(1997-1#1)
in the recipient##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)
in the recognition of##3##4##(1995-2#1)(2009-1#1)(2009-3#1)
in the recognition##4##3##(1994-3#1)(1995-2#1)(2009-1#1)(2009-3#1)
in the recombination##2##3##(1995-8#1)(2013-1#1)
in the reconstituted##3##3##(1991-5#1)(1992-8#1)(2008-9#1)
in the reconstruction of##3##4##(1990-5#1)(2009-11#1)(2012-3#1)
in the recording of##2##4##(1994-12#1)(2008-3#1)
in the recovery of##4##4##(1993-3#1)(1995-8#1)(2008-10#1)(2008-11#1)
in the recovery room##3##4##(2008-7#1)(2010-7#2)
in the recovery##8##3##(1993-3#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-7#2)
in the recruitment of##2##4##(2009-6#1)(2013-1#1)
in the red##4##3##(1997-6#1)(2008-10#1)(2008-3#2)
in the redox##3##3##(2008-10#3)
in the reduced##2##3##(2008-10#2)
in the reducing##2##3##(1992-12#1)(2008-10#1)
in the reduction of##9##4##(1991-1#1)(1992-1#1)(1996-12#1)(2008-10#2)(2008-2#1)(2009-3#1)(2009-7#1)(2011-1#1)
in the reduction##14##3##(1991-1#1)(1992-1#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2009-12#1)(2009-3#1)(2009-7#1)(2011-1#1)
in the reference##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
in the reform##2##3##(1994-12#1)(1997-2#1)
in the regenerating##2##3##(1993-12#1)(2008-9#1)
in the region Middle East and North Africa##2##8##(1997-8#2)
in the region of the##3##5##(2007-12#1)(2008-10#1)(2013-1#1)
in the region of##12##4##(1996-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2013-1#1)
in the region##37##3##(1991-5#1)(1991-6#1)(1993-12#1)(1993-9#1)(1996-11#1)(1997-5#1)(1997-8#2)(2007-12#1)(2008-10#20)(2008-11#1)(2008-12#3)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the regional##2##3##(2008-5#1)(2010-6#1)
in the regions of the##2##5##(1990-12#1)(2008-8#1)
in the regions of##3##4##(1990-12#1)(2008-12#1)(2008-8#1)
in the regions##6##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)(2013-8#1)
in the regulation of Ca2+##3##5##(1992-9#1)(1995-11#1)(1995-6#1)
in the regulation of cardiac##2##5##(1992-6#1)(2010-12#1)
in the regulation of cellular##2##5##(1991-5#1)(2008-9#1)
in the regulation of energy##3##5##(2008-4#1)(2008-7#1)(2009-8#1)
in the regulation of gene expression##3##6##(1991-6#1)(2008-7#1)(2013-1#1)
in the regulation of muscle tone##3##6##(1995-2#3)
in the regulation of neuronal##2##5##(1995-11#1)(2010-8#1)
in the regulation of respiration##3##5##(2008-7#3)
in the regulation of the##11##5##(1992-11#1)(1993-12#1)(1993-6#2)(1995-12#1)(1995-8#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
in the regulation of##84##4##(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#5)(1992-9#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-11#3)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#4)(1996-3#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#1)(2009-8#4)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#1)
in the regulation##85##3##(1990-5#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#5)(1992-9#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-11#3)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#4)(1996-3#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#1)(2009-8#4)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#1)
in the regulatory##7##3##(1995-3#1)(1995-8#1)(1997-1#1)(2008-4#1)(2010-10#1)(2011-2#2)
in the rehabilitation of##2##4##(1992-12#1)(2012-3#1)
in the rehabilitation##4##3##(1992-12#1)(2008-10#1)(2010-10#1)(2012-3#1)
in the reinforcing##2##3##(1993-6#1)(1994-2#1)
in the related##2##3##(2008-10#2)
in the relationship between##7##4##(1991-3#1)(2008-10#3)(2008-12#1)(2009-7#1)(2010-1#1)
in the relationship##9##3##(1991-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2009-7#1)(2010-1#1)
in the relative##11##3##(1990-3#2)(1991-2#1)(1992-6#1)(1994-11#1)(1994-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)
in the release of the##2##5##(1995-11#1)(2009-8#1)
in the release of##8##4##(1995-11#1)(1996-2#1)(1997-2#2)(2008-11#2)(2009-8#1)(2011-2#1)
in the remaining##12##3##(1991-3#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-4#1)(2013-1#1)
in the remnant solution##2##4##(1991-1#2)
in the removal of##2##4##(1997-7#1)(2008-12#1)
in the renal##5##3##(1992-3#1)(1997-1#1)(2008-10#1)(2011-2#2)
in the repair of##2##4##(1992-5#1)(2008-11#1)
in the replication##2##3##(2008-10#1)(2008-11#1)
in the reported##2##3##(2010-1#1)(2011-2#1)
in the representation##2##3##(2008-11#1)(2009-10#1)
in the reproducibility##2##3##(2008-10#2)
in the reproductive##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
in the research of human##2##5##(2008-9#1)(2010-12#1)
in the research on##2##4##(2008-10#1)(2008-5#1)
in the research##9##3##(2008-10#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#1)(2013-8#1)
in the resident##2##3##(1995-6#1)(2013-1#1)
in the residential construction industry##2##5##(1991-12#2)
in the residential##3##3##(1991-12#2)(1996-3#1)
in the residual##2##3##(2008-10#1)(2013-1#1)
in the resin phase##2##4##(2008-10#2)
in the resin was##2##4##(2008-10#2)
in the resin##4##3##(2008-10#4)
in the resistance of##3##4##(2008-10#1)(2008-9#2)
in the resistance to##2##4##(1993-8#1)(2008-10#1)
in the resistance##7##3##(1993-8#1)(2008-10#3)(2008-9#2)(2012-3#1)
in the resistant cactus##3##4##(2008-10#3)
in the resistant check##2##4##(2008-10#2)
in the resistant cultivar##3##4##(2008-10#2)(2011-10#1)
in the resistant cultivars##6##4##(2008-10#6)
in the resistant genotype##2##4##(2008-10#2)
in the resistant##30##3##(1990-5#1)(2008-10#28)(2011-10#1)
in the resonance##2##3##(2008-10#1)(2008-3#1)
in the respect of##2##4##(2008-10#2)
in the respective##6##3##(1992-10#1)(1993-12#1)(1995-6#1)(2008-10#2)(2010-12#1)
in the respiratory chain##2##4##(1994-11#1)(1995-2#1)
in the respiratory tract##5##4##(1992-3#1)(1992-9#1)(1996-1#2)(2008-11#1)
in the respiratory##10##3##(1991-2#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-2#1)(1996-1#2)(2008-10#1)(2008-11#1)(2008-7#1)
in the response of the##2##5##(1994-8#1)(2008-10#1)
in the response of##8##4##(1992-6#1)(1994-8#1)(1996-12#1)(2008-10#3)(2010-1#1)(2012-7#1)
in the response to inflammation and injury##2##7##(1990-5#2)
in the response to the##2##5##(1997-2#1)(2008-10#1)
in the response to##9##4##(1990-5#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#4)
in the response##20##3##(1990-5#2)(1990-6#1)(1992-6#1)(1994-8#1)(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#9)(2010-1#1)(2012-7#1)
in the rest of the##3##5##(1991-8#2)(2011-2#1)
in the rest of##4##4##(1991-8#2)(1992-9#1)(2011-2#1)
in the rest##5##3##(1991-8#2)(1992-9#1)(2008-10#1)(2011-2#1)
in the resting##4##3##(1994-3#1)(2011-2#1)(2013-8#2)
in the resulting##6##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-3#1)
in the results##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)
in the retention##3##3##(1995-11#1)(2008-10#2)
in the retina of##3##4##(1991-10#1)(2010-1#2)
in the retina##15##3##(1991-10#1)(2008-1#1)(2008-5#6)(2008-7#1)(2010-1#4)(2011-7#1)(2012-3#1)
in the retinol deficient group##2##5##(1994-8#2)
in the retinol deficient##3##4##(1994-8#3)
in the retrieval##2##3##(2008-3#2)
in the retroperitoneum##2##3##(2009-1#1)(2009-9#1)
in the reverse##2##3##(1996-12#1)(2008-10#1)
in the reversed-phase##3##3##(2008-10#3)
in the review##2##3##(2012-2#1)(2012-3#1)
in the revised##3##3##(1992-2#1)(1995-12#1)(2011-2#1)
in the revision##2##3##(2008-10#1)(2013-1#1)
in the rhesus##2##3##(1991-1#1)(1995-11#1)
in the rhizosphere and##3##4##(2008-10#3)
in the rhizosphere of cantaloupe plants##2##6##(2008-10#2)
in the rhizosphere of##7##4##(2008-10#7)
in the rhizosphere##18##3##(2008-10#15)(2008-12#2)(2009-8#1)
in the rhizospheres of two##2##5##(2008-10#2)
in the rhizospheres of##3##4##(2008-10#3)
in the rice genome##5##4##(1996-8#2)(2008-9#1)(2009-10#2)
in the rice##7##3##(1996-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#2)
in the right cerebellar hemisphere##2##5##(2008-7#1)(2012-3#1)
in the right eye and##2##5##(2011-2#1)(2013-1#1)
in the right eye##3##4##(2011-2#1)(2013-1#2)
in the right lobe of##2##5##(2008-12#1)(2012-2#1)
in the right lobe##3##4##(2008-11#1)(2008-12#1)(2012-2#1)
in the right way##2##4##(1993-12#1)(2009-6#1)
in the right##33##3##(1993-12#1)(1994-8#3)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
in the ring##2##3##(2011-1#1)(2011-2#1)
in the risk of##4##4##(1991-8#1)(2008-10#1)(2010-6#1)(2013-8#1)
in the risk##9##3##(1990-6#1)(1991-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2012-2#1)(2013-8#1)
in the river water##4##4##(2008-10#4)
in the river##5##3##(2008-10#5)
in the rodent and nonrodent test species used for drug safety assessments##2##12##(2010-11#2)
in the rodent and##3##4##(1995-9#1)(2010-11#2)
in the rodent##7##3##(1995-12#1)(1995-9#2)(1997-2#1)(2008-11#1)(2010-11#2)
in the role of the##3##5##(1991-1#1)(2008-10#1)(2012-3#1)
in the role of##5##4##(1991-1#1)(1994-12#1)(2008-10#1)(2012-3#2)
in the role##6##3##(1990-12#1)(1991-1#1)(1994-12#1)(2008-10#1)(2012-3#2)
in the room temperature ionic liquid##2##6##(2008-10#2)
in the root##7##3##(2008-10#5)(2008-9#1)(2009-8#1)
in the roots of##3##4##(2008-10#2)(2008-12#1)
in the roots##12##3##(2008-10#8)(2008-12#3)(2012-5#1)
in the rotation##3##3##(2008-10#2)(2010-12#1)
in the routine analysis##2##4##(2008-10#1)(2008-11#1)
in the routine##6##3##(2008-10#3)(2008-11#1)(2008-12#1)(2010-6#1)
in the rural##2##3##(1994-1#1)(2009-7#1)
in the sacral##2##3##(2008-7#2)
in the safe##2##3##(1991-1#1)(1996-9#1)
in the safety of##2##4##(1996-9#1)(2013-1#1)
in the sagittal plane##2##4##(2008-12#1)(2010-9#1)
in the sagittal##4##3##(1995-5#1)(2008-12#1)(2010-9#1)(2013-1#1)
in the saline##2##3##(1991-6#1)(2008-10#1)
in the salivary glands of##3##5##(2008-10#3)
in the salivary glands##5##4##(2008-10#5)
in the salivary##7##3##(2008-10#7)
in the same age group##2##5##(1990-6#1)(2012-12#1)
in the same age##3##4##(1990-6#1)(2008-1#1)(2012-12#1)
in the same cell##2##4##(2008-10#1)(2008-9#1)
in the same clade as##2##5##(2008-10#1)(2008-6#1)
in the same clade##3##4##(2008-10#2)(2008-6#1)
in the same conditions##3##4##(2008-10#3)
in the same direction##3##4##(1992-4#1)(2008-8#2)
in the same family##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
in the same fields##2##4##(2008-10#2)
in the same group##2##4##(2008-10#2)
in the same individual##2##4##(2008-8#1)(2012-3#1)
in the same manner##5##4##(1997-6#1)(2008-10#3)(2009-6#1)
in the same order of##2##5##(2008-11#1)(2008-9#1)
in the same order##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
in the same patient##4##4##(1994-12#1)(2010-12#1)(2013-1#1)(2013-8#1)
in the same population##2##4##(2008-10#1)(2012-12#1)
in the same position as##2##5##(1990-2#1)(2010-3#1)
in the same position##3##4##(1990-2#1)(2008-11#1)(2010-3#1)
in the same range##2##4##(1990-11#1)(2010-8#1)
in the same region##3##4##(1991-3#1)(2008-10#2)
in the same sample##4##4##(2008-10#4)
in the same school##2##4##(1991-12#1)(2010-1#1)
in the same time##2##4##(1991-2#1)(2008-10#1)
in the same way as samples##2##6##(2008-10#2)
in the same way as##6##5##(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#3)
in the same way that the##2##6##(1994-1#1)(2008-10#1)
in the same way that##4##5##(1994-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
in the same way##14##4##(1994-1#1)(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)
in the same##165##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-4#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#67)(2008-11#10)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in the sample and##5##4##(2008-10#5)
in the sample by##2##4##(2008-10#2)
in the sample chamber##2##4##(2008-10#1)(2008-9#1)
in the sample is##5##4##(2008-10#4)(2008-3#1)
in the sample solution was##2##5##(2008-10#2)
in the sample solution##12##4##(2008-10#12)
in the sample to##3##4##(2008-10#3)
in the sample using##3##4##(2008-10#3)
in the sample was##2##4##(2008-10#2)
in the sample were##2##4##(2008-10#2)
in the sample zone##3##4##(2008-10#3)
in the sample##72##3##(1990-5#1)(2007-11#1)(2008-10#63)(2008-3#2)(2008-4#3)(2008-9#1)(2010-11#1)
in the samples analyzed##2##4##(2008-10#2)
in the samples for##2##4##(2008-10#2)
in the samples was##2##4##(2008-10#2)
in the samples were in agreement with those obtained##2##9##(2008-10#2)
in the samples were in agreement with##3##7##(2008-10#3)
in the samples were##4##4##(2008-10#4)
in the samples##28##3##(2008-10#24)(2008-4#1)(2009-8#1)(2010-5#1)(2012-2#1)
in the sampling##4##3##(2008-10#3)(2008-8#1)
in the sand##2##3##(1991-12#1)(2008-10#1)
in the scale##2##3##(2008-10#1)(2008-11#1)
in the scattered##2##3##(2008-3#2)
in the scattering##2##3##(2008-3#2)
in the school setting##2##4##(1997-2#1)(2008-11#1)
in the school##5##3##(1991-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
in the schools in##2##4##(1991-12#2)
in the schools##3##3##(1991-1#1)(1991-12#2)
in the sciatic nerve##2##4##(1990-5#1)(1996-2#1)
in the scientific literature##6##4##(1993-12#1)(1997-2#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
in the scientific##9##3##(1993-12#1)(1997-2#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
in the screening of##2##4##(2008-10#1)(2011-2#1)
in the scrotal##2##3##(1994-8#1)(2008-10#1)
in the scrotum##2##3##(2012-3#1)(2013-1#1)
in the sea pansy##2##4##(2008-7#2)
in the sea water samples##2##5##(2008-10#2)
in the sea##5##3##(2008-10#2)(2008-7#2)(2008-8#1)
in the search for new##2##5##(1997-7#1)(2010-7#1)
in the search for the##2##5##(2008-10#1)(2008-5#1)
in the search for##15##4##(1991-12#1)(1992-12#1)(1994-12#1)(1995-6#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-5#3)(2009-11#1)(2010-7#1)(2011-3#1)(2012-3#1)
in the season##7##3##(2008-10#4)(2008-8#2)(2012-6#1)
in the second and third##3##5##(1993-12#1)(2008-10#1)(2013-1#1)
in the second case##2##4##(2010-12#1)(2011-1#1)
in the second day##2##4##(2008-12#1)(2012-3#1)
in the second group##3##4##(1991-5#1)(2007-8#1)(2008-10#1)
in the second half of##2##5##(2008-11#1)(2011-2#1)
in the second half##3##4##(2008-11#1)(2009-8#1)(2011-2#1)
in the second step of##2##5##(2008-10#1)(2008-6#1)
in the second trimester##3##4##(1991-6#1)(1993-3#1)(1994-3#1)
in the second week##2##4##(1992-3#2)
in the second##54##3##(1990-11#1)(1990-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-6#1)(2007-8#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
in the secondary##3##3##(2008-10#2)(2008-9#1)
in the secretion of##3##4##(1995-6#1)(1997-7#1)(2007-12#1)
in the secretion##4##3##(1995-6#1)(1997-7#1)(2007-12#1)(2008-7#1)
in the secretory##2##3##(2008-11#1)(2008-7#1)
in the sediment##3##3##(2008-10#3)
in the sediments of##2##4##(2008-10#2)
in the sediments##3##3##(2008-10#3)
in the seed coat##2##4##(2008-10#2)
in the seed##8##3##(2007-12#1)(2008-10#6)(2013-8#1)
in the segments##2##3##(1995-12#1)(2008-8#1)
in the selected ion monitoring##3##5##(2008-10#3)
in the selected##7##3##(1994-5#1)(2008-10#5)(2010-11#1)
in the selection and##2##4##(2008-4#1)(2010-4#1)
in the selection of##6##4##(1997-2#1)(2008-5#1)(2008-7#1)(2009-11#2)(2010-11#1)
in the selection##8##3##(1997-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2010-11#1)(2010-4#1)
in the selective##3##3##(2008-10#2)(2008-11#1)
in the selectivity##2##3##(2008-10#2)
in the seminiferous epithelium during##2##5##(2012-2#2)
in the seminiferous epithelium of##2##5##(2012-2#2)
in the seminiferous epithelium##9##4##(2009-10#4)(2012-2#5)
in the seminiferous tubules##2##4##(1995-6#1)(2009-10#1)
in the seminiferous##11##3##(1995-6#1)(2009-10#5)(2012-2#5)
in the senescent##2##3##(2013-7#2)
in the sense of##2##4##(2008-11#1)(2008-7#1)
in the sense that it##2##5##(2008-11#1)(2010-3#1)
in the sense that##6##4##(1995-12#1)(2008-11#1)(2008-8#1)(2010-3#2)(2011-2#1)
in the sense##9##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#2)(2011-2#1)
in the sensing##2##3##(2008-10#1)(2008-3#1)
in the sensitive##2##3##(2008-10#1)(2008-9#1)
in the sensitivity of the##3##5##(2008-10#2)(2008-11#1)
in the sensitivity of##4##4##(1997-3#1)(2008-10#2)(2008-11#1)
in the sensitivity##11##3##(1995-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2012-3#1)
in the sensor##2##3##(2008-10#2)
in the separated fractions##3##4##(2008-10#3)
in the separation and preconcentration of##3##6##(2008-10#3)
in the separation and##4##4##(2008-10#4)
in the separation of##5##4##(1993-8#1)(2008-10#4)
in the separation##12##3##(1993-8#1)(2008-10#11)
in the sequence of##2##4##(2008-10#2)
in the sequence##6##3##(1993-8#1)(1997-7#1)(2008-10#4)
in the sera from##3##4##(1994-3#2)(2013-8#1)
in the sera of patients with##2##6##(1990-12#1)(1993-2#1)
in the sera of##5##4##(1990-12#1)(1993-1#1)(1993-2#1)(1994-3#2)
in the sera##10##3##(1990-12#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#4)(2013-8#1)
in the series##6##3##(1990-2#1)(2008-4#3)(2008-8#1)(2010-11#1)
in the serum and##2##4##(1997-8#2)
in the serum of##6##4##(1990-2#1)(1992-9#1)(1993-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
in the serum##16##3##(1990-2#1)(1991-12#2)(1992-9#1)(1993-2#2)(1995-2#1)(1997-8#2)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#1)
in the serum-supplemented medium##3##4##(2008-11#3)
in the service of##2##4##(2008-11#1)(2010-6#1)
in the service##3##3##(2008-11#1)(2010-6#1)(2012-3#1)
in the set of##2##4##(2008-8#2)
in the set##4##3##(1990-11#2)(2008-8#2)
in the setting of a##2##5##(2008-4#1)(2010-10#1)
in the setting of##17##4##(1997-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the setting##18##3##(1994-12#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the settlement##2##3##(1990-12#1)(1996-5#1)
in the seventh##2##3##(2011-2#1)(2013-8#1)
in the sex##2##3##(2008-4#1)(2008-8#1)
in the shape of##3##4##(2008-10#1)(2008-3#1)(2009-7#1)
in the shape##5##3##(1995-9#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-7#1)
in the share of##3##4##(1991-2#1)(1992-12#1)(1995-3#1)
in the sheep##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
in the shell##2##3##(1995-2#1)(2008-12#1)
in the shock-probe burying test##2##5##(1993-3#2)
in the shock-probe##3##3##(1993-3#2)(1994-2#1)
in the short or##2##4##(1992-5#1)(2008-5#1)
in the short##5##3##(1990-9#1)(1992-5#1)(2008-5#1)(2010-1#1)(2012-2#1)
in the short-term##5##3##(1995-11#2)(2008-12#1)(2008-7#1)(2011-2#1)
in the side##2##3##(2008-10#1)(2010-6#1)
in the signal to##2##4##(1991-3#1)(2008-10#1)
in the signal transduction##5##4##(1990-12#1)(1993-8#1)(1994-3#1)(1997-7#1)(2008-8#1)
in the signal##9##3##(1990-12#1)(1991-3#1)(1993-8#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#2)
in the signaling pathway of##2##5##(1994-11#1)(2008-11#1)
in the signaling pathways##2##4##(2008-10#1)(2008-11#1)
in the signaling##4##3##(1994-11#1)(2008-10#1)(2008-11#2)
in the silkworm head##2##4##(1995-11#2)
in the silkworm##3##3##(1995-11#3)
in the simple##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
in the simulated##2##3##(2008-10#1)(2008-11#1)
in the simultaneous##3##3##(2008-10#2)(2008-8#1)
in the single##8##3##(1996-5#1)(2008-10#3)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the sinus gland##3##4##(2008-5#1)(2008-6#2)
in the sixth##2##3##(1993-8#1)(2010-9#1)
in the size of the##5##5##(1995-11#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)
in the size of##9##4##(1994-3#2)(1995-11#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
in the size range of##2##5##(1995-3#1)(2008-7#1)
in the size range##5##4##(1995-3#1)(2008-7#4)
in the size##15##3##(1991-12#1)(1994-3#2)(1995-11#1)(1995-3#1)(2008-10#1)(2008-7#4)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
in the skeletally immature patient##2##5##(2013-1#2)
in the skin and##2##4##(1992-6#2)
in the skin##11##3##(1991-6#1)(1992-6#2)(1995-11#1)(2008-10#2)(2008-5#4)(2011-2#1)
in the skull##3##3##(2008-7#1)(2012-12#2)
in the slope##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
in the slot##2##3##(1996-2#1)(2007-8#1)
in the slow##4##3##(1992-2#1)(1995-2#1)(2008-9#1)(2009-12#1)
in the small intestine##7##4##(2009-8#1)(2011-2#1)(2013-1#5)
in the small##13##3##(1990-11#1)(1996-12#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#5)(2013-8#2)
in the smallest##2##3##(1996-2#1)(2009-7#1)
in the smooth muscle##2##4##(1993-8#1)(1997-3#1)
in the social sciences##3##4##(1996-6#1)(2008-12#1)(2012-2#1)
in the social##8##3##(1991-3#1)(1995-12#1)(1996-6#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
in the sodium##2##3##(1994-3#2)
in the soft tissue##2##4##(2007-8#1)(2008-12#1)
in the soft##4##3##(1990-5#1)(2007-8#1)(2008-12#2)
in the soil and##3##4##(2008-10#3)
in the soil extracts##2##4##(2008-10#2)
in the soil microflora##2##4##(2008-10#2)
in the soil was##2##4##(2008-10#1)(2010-3#1)
in the soil##31##3##(1995-3#1)(2008-10#25)(2008-11#3)(2008-7#1)(2010-3#1)
in the soils##3##3##(2008-10#3)
in the solar##3##3##(2008-3#3)
in the sole##2##3##(1997-5#1)(2010-5#1)
in the solid phase##5##4##(2008-10#5)
in the solid sample##2##4##(2008-10#2)
in the solid##14##3##(2008-10#13)(2008-11#1)
in the soluble##2##3##(2008-10#2)
in the solution of##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
in the solution phase##2##4##(2008-10#2)
in the solution was##3##4##(2008-10#3)
in the solution##26##3##(1994-5#1)(2008-10#20)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-7#1)
in the solutions##4##3##(2008-10#4)
in the solvent##2##3##(2008-10#1)(2013-8#1)
in the sorption of all the seven metal ions are reported##2##11##(2008-10#2)
in the sorption of all the##3##6##(2008-10#3)
in the sorption of##7##4##(2008-10#7)
in the sorption##11##3##(2008-10#11)
in the sorting of##2##4##(2008-9#1)(2011-2#1)
in the source##2##3##(1996-2#1)(2008-10#1)
in the sources##2##3##(1991-2#1)(2008-10#1)
in the south##4##3##(2008-10#2)(2008-6#1)(2013-8#1)
in the south-central and##2##4##(2008-10#2)
in the south-central##3##3##(2008-10#3)
in the southeastern United States##6##5##(1993-1#1)(2008-10#4)(2008-5#1)
in the southeastern##9##3##(1993-1#1)(1996-12#1)(2008-10#5)(2008-12#1)(2008-5#1)
in the southern part of##2##5##(2008-8#1)(2010-8#1)
in the southern##8##3##(1990-6#1)(1996-8#2)(2008-10#1)(2008-8#1)(2010-8#2)(2012-3#1)
in the southwestern United States##2##5##(1990-8#2)
in the space##4##3##(1997-6#2)(2008-10#1)(2008-8#1)
in the spatial##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
in the speciation of##3##4##(2008-10#3)
in the speciation##4##3##(2008-10#3)(2008-9#1)
in the species##5##3##(2008-10#4)(2012-3#1)
in the specific growth##2##4##(2008-11#1)(2008-7#1)
in the specific##9##3##(1991-9#1)(1992-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)
in the spectra##2##3##(1994-11#1)(2008-10#1)
in the spectral range from##2##5##(2008-10#1)(2008-3#1)
in the spectral range of##2##5##(2008-10#2)
in the spectral range##4##4##(2008-10#3)(2008-3#1)
in the spectral region##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
in the spectral##10##3##(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#1)
in the spectrophotometric determination of##4##5##(2008-10#4)
in the spectrophotometric##6##3##(2008-10#6)
in the spent##2##3##(1995-6#1)(2008-11#1)
in the sperm##2##3##(2008-8#1)(2009-8#1)
in the spermatheca##2##3##(2008-6#1)(2008-8#1)
in the spermosphere##2##3##(2008-10#2)
in the spike##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
in the spiked##2##3##(2008-10#2)
in the spinal cord##10##4##(1990-5#1)(1991-5#1)(1995-12#1)(1996-12#2)(1997-3#1)(2008-12#1)(2009-11#1)(2011-1#1)(2012-3#1)
in the spinal##13##3##(1990-5#1)(1991-5#1)(1995-12#1)(1996-12#2)(1997-3#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the spleen and##2##4##(2008-10#2)
in the spleen##8##3##(1993-3#1)(1994-2#1)(1995-12#1)(2008-10#3)(2008-5#1)(2010-5#1)
in the sponges was##2##4##(1994-3#2)
in the spore##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
in the spring and##3##4##(2008-10#2)(2013-1#1)
in the spring of 1993##2##5##(2008-10#2)
in the spring of##7##4##(1996-2#1)(2008-10#3)(2008-11#1)(2011-9#1)(2012-3#1)
in the spring##11##3##(1996-2#1)(2008-10#6)(2008-11#1)(2011-9#1)(2012-3#1)(2013-1#1)
in the squid##2##3##(2008-7#1)(2013-8#1)
in the stability of the##2##5##(1997-1#1)(2008-10#1)
in the stability of##3##4##(1997-1#1)(2008-10#2)
in the stabilization##3##3##(1991-6#1)(2008-12#2)
in the stage##2##3##(2008-1#1)(2013-8#1)
in the standard##9##3##(1991-8#1)(2008-10#6)(2008-11#1)(2013-1#1)
in the standardization##3##3##(2006-6#1)(2008-10#2)
in the starch##2##3##(1995-6#1)(2008-10#1)
in the starting material##2##4##(2008-10#2)
in the state of oral tolerance##2##6##(2008-11#2)
in the state of##5##4##(2008-1#1)(2008-10#2)(2008-11#2)
in the state##10##3##(1991-8#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#3)
in the stationary phase##2##4##(2008-7#2)
in the statistical##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
in the steady-state level of##2##5##(1992-1#1)(1997-1#1)
in the steady-state##3##3##(1992-1#1)(1997-1#1)(2008-10#1)
in the stem##3##3##(2008-10#2)(2008-9#1)
in the sterile anther##2##4##(2008-8#2)
in the sterile##3##3##(2008-12#1)(2008-8#2)
in the steroid##3##3##(1991-12#1)(1991-5#2)
in the still##2##3##(1996-11#1)(2009-7#1)
in the stimulation of##2##4##(1997-2#1)(1997-8#1)
in the stimulation##3##3##(1993-3#1)(1997-2#1)(1997-8#1)
in the stimulatory##2##3##(2008-11#2)
in the stomach and##3##4##(1997-1#1)(2008-6#1)(2011-2#1)
in the stomach##10##3##(1993-6#1)(1997-1#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2011-2#2)(2013-1#1)
in the stools##2##3##(1991-6#1)(2009-1#1)
in the storage##2##3##(2008-3#1)(2008-7#1)
in the strategic planning process##2##5##(1994-2#1)(1996-1#1)
in the stratum corneum##4##4##(2008-10#1)(2008-5#3)
in the stream of life##3##5##(2010-10#3)
in the strength of##2##4##(1993-1#1)(2008-9#1)
in the strength##3##3##(1993-1#1)(2008-9#1)(2009-3#1)
in the stress response to DNA-damaging agents##2##7##(1995-8#2)
in the stress##3##3##(1995-8#2)(2008-9#1)
in the striatum and the nucleus accumbens##2##7##(1996-12#2)
in the striatum of##2##4##(2008-10#1)(2009-8#1)
in the striatum##13##3##(1991-4#1)(1994-2#2)(1996-12#4)(1997-2#2)(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)
in the structural##4##3##(1995-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
in the structure and function of##4##6##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
in the structure of the##5##5##(1990-5#1)(1993-8#1)(2008-10#1)(2008-5#2)
in the structure of##8##4##(1990-5#1)(1992-9#1)(1993-8#1)(2008-10#2)(2008-12#1)(2008-5#2)
in the structure##18##3##(1990-5#1)(1992-9#1)(1993-8#1)(1996-12#2)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)
in the structures of##2##4##(1994-8#1)(2008-8#1)
in the students'##2##3##(2008-11#2)
in the studied##8##3##(2008-10#8)
in the studies of##2##4##(2008-10#2)
in the studies##9##3##(1992-3#1)(1993-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
in the study and the##2##5##(1991-12#1)(1993-12#1)
in the study and##6##4##(1991-12#1)(1992-12#1)(1993-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
in the study group##2##4##(2011-1#1)(2013-1#1)
in the study of the##8##5##(1991-5#1)(1991-9#1)(2008-10#3)(2008-11#1)(2011-10#1)(2013-1#1)
in the study of##29##4##(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1996-3#3)(2008-10#8)(2008-11#4)(2008-8#1)(2010-1#1)(2011-10#1)(2011-2#1)(2011-3#3)(2012-2#1)(2012-3#1)(2013-1#1)
in the study population##2##4##(2008-11#1)(2008-7#1)
in the study sites##2##4##(2008-12#1)(2012-12#1)
in the study were##4##4##(1996-1#1)(2008-10#2)(2008-11#1)
in the study##119##3##(1990-11#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#2)(1996-3#3)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#12)(2008-12#5)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#9)(2011-3#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#12)(2013-7#1)
in the style##2##3##(2008-10#2)
in the subacute##2##3##(2008-8#1)(2011-2#1)
in the subarachnoid space##3##4##(2008-7#3)
in the subarachnoid##4##3##(1995-11#1)(2008-7#3)
in the subcapsular area##2##4##(2012-2#1)(2012-3#1)
in the subcutaneous##2##3##(2008-11#1)(2011-2#1)
in the subjective##3##3##(1992-12#1)(2008-5#2)
in the subjects with##2##4##(2008-5#1)(2008-7#1)
in the subjects##4##3##(1994-12#1)(2008-5#1)(2008-7#2)
in the submicrometer##2##3##(2008-10#2)
in the subphase##2##3##(1997-2#2)
in the subsequent##2##3##(2008-7#2)
in the substantia nigra and the##2##6##(2008-7#2)
in the substantia nigra and##3##5##(2008-7#3)
in the substantia nigra##10##4##(1990-5#1)(1995-2#3)(1995-8#1)(2008-7#4)(2012-2#1)
in the substrate##7##3##(1990-5#1)(1992-3#1)(1994-5#1)(2008-10#3)(2008-5#1)
in the subumbilical incision##2##4##(2011-2#2)
in the subunit##2##3##(1990-5#1)(2008-9#1)
in the success of##3##4##(2008-10#1)(2008-11#2)
in the successful implementation of##2##5##(1992-1#1)(2008-7#1)
in the successful##7##3##(1992-1#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
in the successive##2##3##(2008-10#1)(2008-11#1)
in the suicidal##2##3##(2010-6#2)
in the sulfate##2##3##(2008-10#2)
in the summer of##2##4##(2008-10#1)(2008-8#1)
in the summer##6##3##(1995-1#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-8#2)
in the superficial layers of##2##5##(2008-11#1)(2008-5#1)
in the superficial layers##4##4##(2008-11#2)(2008-5#2)
in the superficial##7##3##(1994-2#1)(1996-12#1)(2008-11#2)(2008-5#2)(2011-2#1)
in the superior temporal sulcus##2##5##(2008-11#1)(2009-10#1)
in the superior##3##3##(2008-11#1)(2009-10#1)(2012-8#1)
in the supernatant and##2##4##(2008-11#2)
in the supernatant of##2##4##(2008-11#1)(2008-9#1)
in the supernatant was##2##4##(2008-10#2)
in the supernatant##12##3##(2008-10#3)(2008-11#7)(2008-9#1)(2009-8#1)
in the supernatants of##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
in the supine position##2##4##(2011-2#1)(2012-3#1)
in the supply of##2##4##(1996-3#1)(2008-10#1)
in the support protocol##2##4##(2008-4#2)
in the support##4##3##(1994-3#1)(2008-10#1)(2008-4#2)
in the suppression of antibody production by in vitro immunized##2##10##(2008-11#2)
in the suppression of##9##4##(1990-12#1)(2008-10#5)(2008-11#2)(2010-1#1)
in the suppression##10##3##(1990-12#1)(2008-10#5)(2008-11#3)(2010-1#1)
in the supraclavicular##2##3##(2008-7#2)
in the surface##5##3##(1997-1#1)(1997-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
in the surgical management of##4##5##(1994-12#1)(2011-2#2)(2013-1#1)
in the surgical treatment of##2##5##(1990-3#1)(1991-3#1)
in the surgical treatment##3##4##(1990-3#1)(1990-5#1)(1991-3#1)
in the surgical##12##3##(1990-3#1)(1990-5#1)(1991-3#1)(1994-12#1)(2008-9#1)(2009-12#1)(2011-2#4)(2013-1#2)
in the surrounding space##2##4##(2008-8#2)
in the surrounding##9##3##(1990-11#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#3)
in the surroundings of##2##4##(1995-2#1)(2009-7#1)
in the survey##3##3##(1994-12#1)(2008-5#1)(2010-10#1)
in the survival of##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
in the survival##5##3##(2008-10#3)(2008-11#1)(2008-12#1)
in the surviving##2##3##(1992-3#1)(1994-3#1)
in the susceptibility to##2##4##(2008-10#1)(2011-2#1)
in the susceptibility##4##3##(1997-8#1)(2008-10#2)(2011-2#1)
in the susceptible cultivar##4##4##(2008-10#4)
in the susceptible cv##2##4##(2008-10#2)
in the susceptible than in the resistant cultivars##2##8##(2008-10#2)
in the susceptible##22##3##(1994-9#1)(1996-12#1)(2008-10#19)(2011-10#1)
in the suspension culture##4##4##(2008-11#4)
in the suspension##6##3##(1990-12#1)(2008-11#5)
in the symptomatic##2##3##(2011-2#1)(2012-2#1)
in the synaptic##2##3##(1997-2#1)(2013-8#1)
in the synthesis and##5##4##(1995-11#1)(2008-10#1)(2011-2#2)(2013-7#1)
in the synthesis of the##2##5##(1990-5#1)(1992-12#1)
in the synthesis of##13##4##(1990-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-8#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#1)
in the synthesis##20##3##(1990-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
in the synthetic##3##3##(1993-8#1)(2008-10#2)
in the system for##2##4##(2008-10#2)
in the system of##2##4##(1990-5#1)(2008-10#1)
in the system##20##3##(1990-5#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
in the table##2##3##(2008-10#1)(2008-6#1)
in the target##10##3##(1990-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2011-2#2)
in the targeting##2##3##(2008-9#1)(2009-7#1)
in the telomeric region##2##4##(1995-2#1)(2010-8#1)
in the temperate##2##3##(2008-10#1)(2008-8#1)
in the temperature range##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
in the temperature##7##3##(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)
in the temporal cortex##3##4##(1993-6#1)(1996-12#1)(2008-9#1)
in the temporal region##2##4##(2008-9#2)
in the temporal##8##3##(1993-6#1)(1996-12#1)(2008-7#1)(2008-9#5)
in the terminal##4##3##(1993-6#1)(1997-1#1)(2008-9#1)(2010-12#1)
in the ternary##2##3##(1994-5#1)(2008-10#1)
in the territory of the##2##5##(1992-2#1)(1996-3#1)
in the test sample##2##4##(2008-10#2)
in the test##10##3##(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2010-7#1)
in the tested##4##3##(2008-10#1)(2008-11#2)(2008-12#1)
in the testes##3##3##(2009-10#3)
in the testing##2##3##(2008-10#1)(2010-2#1)
in the testis was##2##4##(1992-12#1)(2008-9#1)
in the testis##20##3##(1992-12#3)(1993-12#1)(1995-6#1)(1995-8#1)(2008-7#2)(2008-9#1)(2009-10#3)(2010-5#1)(2011-2#1)(2012-2#6)
in the text##2##3##(2008-10#1)(2009-11#1)
in the thalamic##2##3##(1997-2#2)
in the thalamus##2##3##(2008-7#1)(2012-3#1)
in the theoretical##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
in the therapeutic milieu##2##4##(1993-2#1)(2010-5#1)
in the therapeutic##3##3##(1993-2#1)(1996-11#1)(2010-5#1)
in the therapy of##5##4##(1991-3#1)(1995-2#1)(1997-1#1)(2008-7#1)(2011-3#1)
in the third trimester##4##4##(1990-9#1)(1993-12#1)(1993-3#1)(2011-2#1)
in the third world##2##4##(1990-12#1)(2008-10#1)
in the third##19##3##(1990-12#1)(1990-9#1)(1991-8#1)(1993-12#2)(1993-3#1)(1993-8#2)(1997-8#1)(2008-10#4)(2008-11#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in the thoracic region##2##4##(1996-3#1)(2008-11#1)
in the thoracolumbar##3##3##(1997-6#1)(2008-8#2)
in the three castes##2##4##(2008-8#2)
in the three groups##3##4##(1994-12#1)(2008-10#1)(2010-4#1)
in the three regions##2##4##(2013-1#2)
in the three##26##3##(1991-6#1)(1992-4#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)
in the three-dimensional##3##3##(2008-10#1)(2008-9#1)(2009-3#1)
in the through-thickness direction##2##4##(2009-7#2)
in the thymus and##3##4##(1993-3#2)(2008-10#1)
in the thymus##10##3##(1993-3#2)(1997-7#1)(1997-9#1)(2008-10#4)(2008-5#2)
in the thyroid##3##3##(1990-2#2)(2008-9#1)
in the thyroids of##2##4##(2008-7#2)
in the time##4##3##(2008-2#1)(2010-8#1)(2011-2#2)
in the timing of##7##4##(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)(2012-6#1)
in the tissue##3##3##(1990-5#1)(2008-9#1)(2009-8#1)
in the tissues of##2##4##(1993-12#1)(2008-12#1)
in the tissues##7##3##(1991-5#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
in the titration##2##3##(2008-10#2)
in the topsoil were##2##4##(2008-10#2)
in the total amount of energy##2##6##(2008-8#2)
in the total amount of##4##5##(1996-12#2)(2008-8#2)
in the total biomass##2##4##(2008-7#2)
in the total##22##3##(1990-12#1)(1992-12#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-6#1)(2009-8#1)
in the town of Cabar##2##5##(2011-2#2)
in the trachea and##2##4##(1993-8#1)(2008-9#1)
in the trachea##4##3##(1993-8#1)(1997-1#1)(2008-5#1)(2008-9#1)
in the traditional##4##3##(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
in the training of medical graduates##2##6##(1992-1#1)(2009-10#1)
in the training of medical##3##5##(1992-1#1)(1994-6#1)(2009-10#1)
in the training of residents##2##5##(1993-3#1)(1996-9#1)
in the training of##5##4##(1992-1#1)(1993-3#1)(1994-6#1)(1996-9#1)(2009-10#1)
in the training##8##3##(1992-1#1)(1993-3#1)(1994-6#1)(1996-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-6#1)
in the transcription##2##3##(1991-9#1)(1995-11#1)
in the transcriptional activator##2##4##(2012-3#2)
in the transcriptional regulation of##2##5##(1996-12#1)(2008-11#1)
in the transcriptional regulation##3##4##(1992-12#1)(1996-12#1)(2008-11#1)
in the transcriptional##6##3##(1992-12#1)(1996-12#2)(2008-11#1)(2012-3#2)
in the transduction of##2##4##(1990-12#1)(1994-11#1)
in the transduction##3##3##(1990-12#1)(1994-11#2)
in the transformants##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
in the transformation of##3##4##(1990-5#1)(1992-8#1)(1993-2#1)
in the transformation##4##3##(1990-5#1)(1992-8#1)(1993-2#1)(2008-3#1)
in the transgenic##5##3##(1992-8#1)(1995-2#1)(2008-10#1)(2008-9#1)(2010-5#1)
in the transition state##2##4##(1991-9#1)(2009-5#1)
in the transition to##4##4##(1991-12#1)(2008-11#2)(2013-1#1)
in the transition##6##3##(1991-12#1)(1991-9#1)(2008-11#2)(2009-5#1)(2013-1#1)
in the translocation of##5##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
in the transmission of##4##4##(2008-10#2)(2010-1#2)
in the transmission##9##3##(2007-12#1)(2008-10#5)(2008-3#1)(2010-1#2)
in the transplanted kidney##2##4##(1992-2#2)
in the transport##2##3##(2012-2#1)(2012-8#1)
in the treated mice##2##4##(2008-9#2)
in the treated##10##3##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2012-3#1)
in the treatment and prevention of##2##6##(2008-10#1)(2008-7#1)
in the treatment and##7##4##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-6#2)
in the treatment arm##2##4##(2008-5#1)(2010-12#1)
in the treatment group##2##4##(2008-10#1)(2011-2#1)
in the treatment of a##2##5##(1994-2#1)(2013-8#1)
in the treatment of acute##5##5##(1990-5#1)(1991-3#1)(1992-3#1)(2007-8#1)(2011-2#1)
in the treatment of advanced colorectal cancer##2##7##(1990-12#2)
in the treatment of advanced##3##5##(1990-12#3)
in the treatment of affective disorders##2##6##(1991-11#1)(1996-12#1)
in the treatment of alcoholism##2##5##(1994-5#1)(1995-11#1)
in the treatment of an##4##5##(2008-10#1)(2010-11#1)(2011-3#1)(2012-3#1)
in the treatment of asthma##2##5##(1997-1#1)(1997-5#1)
in the treatment of breast cancer##3##6##(1993-11#2)(1996-11#1)
in the treatment of breast##4##5##(1993-11#2)(1993-6#1)(1996-11#1)
in the treatment of cancer##2##5##(2008-5#1)(2008-7#1)
in the treatment of cervical##3##5##(1991-1#1)(1994-12#1)(1996-3#1)
in the treatment of children##2##5##(2008-4#1)(2011-2#1)
in the treatment of chronic##4##5##(1993-5#1)(2008-11#1)(2008-9#1)(2010-11#1)
in the treatment of hypertension##2##5##(1990-6#1)(1995-11#1)
in the treatment of ischemic##2##5##(2010-6#1)(2013-1#1)
in the treatment of malignant pleural##3##6##(1991-6#1)(1992-12#2)
in the treatment of malignant##7##5##(1991-2#1)(1991-6#1)(1992-12#2)(1993-9#1)(1997-5#1)(2011-2#1)
in the treatment of many##2##5##(2008-9#1)(2011-3#1)
in the treatment of metastatic##2##5##(1990-2#1)(2012-3#1)
in the treatment of mucormycosis##2##5##(2011-2#2)
in the treatment of osteomyelitis##2##5##(2010-6#2)
in the treatment of pancreatic##2##5##(1990-9#1)(1993-6#1)
in the treatment of patients with##3##6##(1991-6#1)(1996-11#1)(2011-2#1)
in the treatment of psoriasis##2##5##(2007-11#1)(2008-6#1)
in the treatment of schizophrenia and schizoaffective##2##7##(2008-8#2)
in the treatment of severe##2##5##(1990-8#1)(2013-1#1)
in the treatment of stage##2##5##(1994-8#1)(2009-10#1)
in the treatment of such##2##5##(1990-9#1)(2013-1#1)
in the treatment of systemic##2##5##(1997-2#1)(2008-11#1)
in the treatment of the##2##5##(2007-8#1)(2008-10#1)
in the treatment of this##2##5##(1991-9#1)(2009-7#1)
in the treatment of##181##4##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#4)(1991-6#2)(1991-8#4)(1991-9#1)(1992-12#4)(1992-3#2)(1993-11#3)(1993-5#1)(1993-6#3)(1993-9#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#3)(1995-12#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-3#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-1#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-6#3)(2010-7#1)(2011-2#19)(2011-3#5)(2012-2#2)(2012-3#6)(2013-1#13)(2013-8#6)
in the treatment##194##3##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#4)(1991-6#2)(1991-8#4)(1991-9#1)(1992-12#4)(1992-3#2)(1993-11#3)(1993-5#1)(1993-6#3)(1993-9#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#3)(1995-12#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-3#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#3)(2010-6#5)(2010-7#1)(2011-2#20)(2011-3#5)(2012-2#2)(2012-3#6)(2013-1#14)(2013-8#6)
in the treatments that##2##4##(2008-10#2)
in the tree##5##3##(2008-10#4)(2011-2#1)
in the trellis##2##3##(2008-10#1)(2008-3#1)
in the trial##4##3##(1990-2#1)(1997-7#1)(2008-7#1)(2011-2#1)
in the trigeminal##4##3##(1996-2#1)(1997-2#2)(2008-9#1)
in the triradiate lumen##3##4##(2008-10#3)
in the tropical##4##3##(1990-8#1)(2008-10#3)
in the tropics##5##3##(1995-12#1)(2008-10#2)(2010-7#1)(2011-2#1)
in the troposphere and lower stratosphere##2##6##(2008-3#2)
in the troposphere##3##3##(2008-2#1)(2008-3#2)
in the trunk##2##3##(2008-10#1)(2008-5#1)
in the trypsin-like##2##3##(2008-5#2)
in the tube##4##3##(2008-10#3)(2008-8#1)
in the tumor cells##2##4##(1993-8#1)(1994-5#1)
in the tumor was##2##4##(1990-5#1)(1993-11#1)
in the tumor##8##3##(1990-5#1)(1993-11#2)(1993-8#1)(1994-5#2)(2011-2#1)(2013-1#1)
in the two cell lines##3##5##(2008-11#1)(2008-7#1)(2011-2#1)
in the two groups were##3##5##(2009-11#1)(2009-12#1)(2013-8#1)
in the two groups##13##4##(1990-5#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-1#1)(2009-11#1)(2009-12#2)(2011-1#1)(2012-2#2)(2013-8#1)
in the two species##4##4##(1996-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
in the two##62##3##(1990-5#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-9#2)(1993-1#1)(1993-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#3)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#3)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-8#1)
in the two-phase systems##4##4##(2008-10#4)
in the two-phase##5##3##(2008-10#5)
in the tympanic membrane##2##4##(1991-3#2)
in the type of##5##4##(1993-12#1)(1997-1#1)(2008-10#2)(2010-5#1)
in the tyrosine##2##3##(2008-8#1)(2013-1#1)
in the ulnar##2##3##(2008-9#2)
in the ultraendurance runners##3##4##(2013-8#3)
in the ultrasonic nebulizer##3##4##(1991-1#3)
in the ultrasonic##4##3##(1991-1#3)(2007-12#1)
in the ultrasonographic##2##3##(1990-9#1)(1993-12#1)
in the ultrastructure##2##3##(2008-10#1)(2008-5#1)
in the ultraviolet##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
in the umbilical cord##3##4##(1997-3#1)(2009-8#2)
in the undergraduate curriculum of##3##5##(2011-2#3)
in the undergraduate##5##3##(1991-1#1)(2008-12#1)(2011-2#3)
in the underlying##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
in the understanding and##2##4##(2008-11#1)(2011-2#1)
in the understanding of the##6##5##(1991-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
in the understanding of##8##4##(1991-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-1#1)(2009-3#1)(2012-2#1)
in the understanding##12##3##(1991-2#1)(2008-10#1)(2008-11#3)(2008-6#1)(2009-1#1)(2009-3#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
in the understory of##2##4##(2008-8#1)(2008-9#1)
in the understory##4##3##(2008-8#1)(2008-9#3)
in the unfolding##2##3##(2008-4#1)(2008-9#1)
in the unit##2##3##(2008-10#1)(2010-8#1)
in the universe##4##3##(2008-12#2)(2010-3#1)(2010-9#1)
in the university##2##3##(2008-11#1)(2008-12#1)
in the untreated##6##3##(1992-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#2)
in the upper explosive limit range##2##6##(2008-10#2)
in the upper layer##2##4##(2008-10#2)
in the upper part of the##2##6##(1991-9#1)(2008-5#1)
in the upper##32##3##(1991-9#2)(1993-2#1)(1993-9#1)(1994-5#1)(1995-6#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#2)
in the uptake and##2##4##(2008-11#1)(2008-9#1)
in the uptake##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
in the urban area of Puerto Carreño##3##7##(2012-12#3)
in the urban area of##5##5##(2008-11#1)(2009-10#1)(2012-12#3)
in the urban area##6##4##(2008-11#1)(2009-10#1)(2012-12#3)(2012-3#1)
in the urban##9##3##(1990-2#1)(2008-11#1)(2008-3#2)(2009-10#1)(2012-12#3)(2012-3#1)
in the urinary bladder##2##4##(2012-12#1)(2012-2#1)
in the urinary excretion of##4##5##(1991-12#1)(1994-5#3)
in the urinary##7##3##(1991-12#1)(1992-9#1)(1994-5#3)(2012-12#1)(2012-2#1)
in the urine and##2##4##(2008-12#1)(2012-2#1)
in the urine##13##3##(1990-2#1)(1994-8#2)(1997-2#1)(2008-10#6)(2008-12#1)(2012-2#1)(2013-8#1)
in the use of medical devices##2##6##(2008-11#2)
in the use of medical##3##5##(2008-11#2)(2008-4#1)
in the use of the##5##5##(1993-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-6#1)
in the use of##43##4##(1991-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#3)(1994-3#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#2)(2010-12#1)(2010-6#1)(2012-2#1)
in the use##44##3##(1991-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#3)(1994-3#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#2)(2010-12#1)(2010-6#1)(2012-2#1)(2013-8#1)
in the uterine##2##3##(1990-6#1)(2012-3#1)
in the uterus##2##3##(2012-2#1)(2012-3#1)
in the utilization of##2##4##(1996-6#1)(2011-2#1)
in the vaccinated##2##3##(1995-5#1)(2008-11#1)
in the valley##2##3##(2008-10#2)
in the value of##4##4##(2008-10#1)(2008-12#1)(2009-8#1)(2010-4#1)
in the value##5##3##(2008-10#1)(2008-12#1)(2009-8#1)(2010-4#1)(2012-2#1)
in the values of##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
in the variability of##2##4##(1990-11#1)(2008-11#1)
in the various cerebral subdivisions##2##5##(1997-2#2)
in the various systems##2##4##(2008-10#1)(2008-9#1)
in the various##8##3##(1995-3#1)(1996-12#1)(1997-2#2)(2008-10#3)(2008-9#1)
in the vascular tissues##3##4##(2008-10#3)
in the vascular##6##3##(2008-10#5)(2008-7#1)
in the vast majority of##3##5##(1997-1#1)(2008-11#1)(2008-12#1)
in the vector nematode Xiphinema americanum##2##6##(2008-10#2)
in the vector##7##3##(2008-10#7)
in the vegetative##2##3##(2008-8#1)(2009-12#1)
in the venom##2##3##(1993-6#1)(2008-7#1)
in the ventral##4##3##(1993-6#1)(1996-12#2)(2012-3#1)
in the ventricular zone##2##4##(1996-2#1)(2008-11#1)
in the ventricular##3##3##(1995-12#1)(1996-2#1)(2008-11#1)
in the ventrobasal complex##2##4##(1994-2#2)
in the ventrolateral##2##3##(1994-2#2)
in the ventromedial##3##3##(1994-2#2)(2008-11#1)
in the vertebral##2##3##(1993-3#1)(2013-1#1)
in the vertebrate##3##3##(1990-5#1)(2008-4#1)(2008-7#1)
in the vertical##4##3##(1991-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
in the very##4##3##(1993-12#1)(1997-2#1)(2009-7#1)(2011-3#1)
in the vicinity of a##2##5##(2008-10#1)(2008-11#1)
in the vicinity of the##12##5##(1990-11#1)(1990-2#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-7#1)(2009-12#1)(2009-7#1)
in the vicinity of##23##4##(1990-11#1)(1990-2#1)(1990-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-7#1)
in the vicinity##24##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-11#2)(1996-2#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-7#1)
in the vineyard##2##3##(2008-10#2)
in the viral##6##3##(1994-11#1)(1995-2#1)(2008-10#4)
in the virus##2##3##(1990-2#1)(2008-10#1)
in the visible and the near-infrared##2##6##(2008-3#2)
in the visible and##4##4##(2008-3#4)
in the visible region##6##4##(2008-10#5)(2008-3#1)
in the visible spectrum##2##4##(2008-10#1)(2008-3#1)
in the visible##17##3##(2008-10#9)(2008-2#1)(2008-3#6)(2009-12#1)
in the visual and olfactory systems##2##6##(2008-7#1)(2009-10#1)
in the visual cortex##4##4##(1990-8#2)(1996-2#1)(2008-11#1)
in the visual field and optic nerve##2##7##(2011-2#2)
in the visual field##3##4##(2008-9#1)(2011-2#2)
in the visual##13##3##(1990-8#2)(1996-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#3)(2012-2#1)(2013-7#1)
in the voltammetric##2##3##(2008-10#2)
in the volume##4##3##(1990-2#1)(1990-5#1)(2008-11#1)(2008-6#1)
in the volumetric##3##3##(2008-10#2)(2008-11#1)
in the volunteer##2##3##(1991-2#1)(1994-3#1)
in the wall appositions##2##4##(2008-10#2)
in the wall##4##3##(2008-10#2)(2008-7#1)(2009-7#1)
in the walls of##2##4##(2008-10#2)
in the warmer##2##3##(2008-10#2)
in the wastewater##2##3##(2008-10#2)
in the water samples##2##4##(2008-10#2)
in the water##15##3##(1991-5#2)(1997-2#1)(2008-10#9)(2008-2#2)(2008-5#1)
in the way of##4##4##(1997-8#1)(2008-11#1)(2008-12#1)(2010-5#1)
in the way that##4##4##(1997-5#1)(2008-11#2)(2008-4#1)
in the way##13##3##(1991-3#1)(1997-5#1)(1997-8#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-7#1)
in the weakly acidic medium##2##5##(2008-10#2)
in the weights##2##3##(1992-12#1)(1993-1#1)
in the west of##2##4##(1996-11#1)(2012-12#1)
in the west##3##3##(1996-11#1)(2008-10#1)(2012-12#1)
in the western United States##2##5##(2008-10#1)(2013-1#1)
in the western##7##3##(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2013-1#1)
in the wheat rhizosphere##3##4##(2008-10#3)
in the wheat##6##3##(2008-10#5)(2008-11#1)
in the white##5##3##(2008-10#2)(2008-5#1)(2010-12#1)(2010-5#1)
in the whole##10##3##(2008-10#6)(2008-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
in the wide pH range of##2##6##(2008-10#2)
in the wide##4##3##(2008-10#4)
in the wild and##2##4##(2010-5#1)(2012-3#1)
in the wild type##2##4##(2008-8#1)(2009-6#1)
in the wild##9##3##(2008-10#2)(2008-8#2)(2009-6#1)(2010-4#2)(2010-5#1)(2012-3#1)
in the wild-type strain##2##4##(2008-10#1)(2009-6#1)
in the wild-type##5##3##(2008-10#1)(2008-8#3)(2009-6#1)
in the winter##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
in the work##6##3##(1991-12#2)(1995-9#1)(1997-2#1)(2008-9#1)(2011-3#1)
in the working of##2##4##(2008-10#2)
in the working range##2##4##(2008-10#2)
in the working##6##3##(2008-10#6)
in the workplace##18##3##(1991-12#2)(1992-2#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-6#1)(2008-9#1)(2012-12#1)(2012-3#1)
in the world in##2##4##(2008-11#1)(2011-2#1)
in the world of managed##2##5##(1996-1#1)(1996-3#1)
in the world of##4##4##(1993-1#1)(1996-1#1)(1996-3#1)(1997-2#1)
in the world##29##3##(1993-1#1)(1994-9#3)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
in the worst##2##3##(1993-3#1)(2008-3#1)
in the wound##3##3##(2008-11#2)(2010-12#1)
in the wv/wv mice##2##4##(1996-12#2)
in the xylem and##2##4##(2008-10#1)(2008-11#1)
in the xylem##5##3##(2007-12#1)(2008-10#3)(2008-11#1)
in the year##11##3##(1990-12#1)(1993-2#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-5#2)(2010-5#1)(2011-2#2)(2013-8#1)
in the years ahead##2##4##(1992-2#1)(1996-9#1)
in the years to come##4##5##(1994-6#1)(1996-3#1)(2008-11#1)(2010-6#1)
in the years##10##3##(1992-2#1)(1994-6#1)(1996-3#1)(1996-9#2)(1997-8#1)(2008-11#1)(2008-12#1)(2010-6#1)(2013-1#1)
in the yeast cell##2##4##(1994-11#1)(2008-8#1)
in the yeast genome##2##4##(1993-9#1)(2008-11#1)
in the yeast##9##3##(1990-5#1)(1993-9#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the young adult##2##4##(1991-11#1)(1995-3#1)
in the young##7##3##(1991-11#2)(1995-3#1)(2008-7#2)(2008-9#1)(2013-7#1)
in the younger##4##3##(1991-1#1)(1992-8#1)(2008-7#1)(2010-8#1)
in the zone of host sympatry##2##6##(2008-10#2)
in the zone of##4##4##(2008-10#4)
in the zone##6##3##(1996-2#1)(2008-10#5)
in the##19930##2##(1990-10#6)(1990-11#67)(1990-12#67)(1990-2#55)(1990-3#47)(1990-5#145)(1990-6#54)(1990-7#3)(1990-8#53)(1990-9#48)(1991-1#55)(1991-10#14)(1991-11#40)(1991-12#104)(1991-2#85)(1991-3#85)(1991-4#2)(1991-5#80)(1991-6#64)(1991-7#10)(1991-8#35)(1991-9#35)(1992-1#37)(1992-10#16)(1992-11#13)(1992-12#91)(1992-2#58)(1992-3#103)(1992-4#14)(1992-5#18)(1992-6#84)(1992-7#1)(1992-8#25)(1992-9#59)(1993-1#49)(1993-11#44)(1993-12#110)(1993-2#68)(1993-3#122)(1993-5#8)(1993-6#93)(1993-8#106)(1993-9#21)(1994-1#32)(1994-11#75)(1994-12#97)(1994-2#114)(1994-3#82)(1994-5#114)(1994-6#29)(1994-8#99)(1994-9#29)(1995-1#24)(1995-10#2)(1995-11#106)(1995-12#128)(1995-2#131)(1995-3#51)(1995-5#49)(1995-6#110)(1995-8#89)(1995-9#25)(1996-1#46)(1996-11#49)(1996-12#234)(1996-2#126)(1996-3#85)(1996-5#53)(1996-6#49)(1996-8#19)(1996-9#35)(1997-1#88)(1997-2#151)(1997-3#139)(1997-4#28)(1997-5#35)(1997-6#46)(1997-7#81)(1997-8#102)(1997-9#14)(2006-5#4)(2006-6#14)(2007-11#22)(2007-12#124)(2007-8#19)(2007-9#1)(2008-1#90)(2008-10#5991)(2008-11#1292)(2008-12#401)(2008-2#84)(2008-3#351)(2008-4#136)(2008-5#437)(2008-6#116)(2008-7#632)(2008-8#460)(2008-9#474)(2009-1#32)(2009-10#124)(2009-11#36)(2009-12#79)(2009-2#6)(2009-3#49)(2009-4#21)(2009-5#37)(2009-6#55)(2009-7#90)(2009-8#133)(2009-9#33)(2010-1#72)(2010-10#77)(2010-11#76)(2010-12#124)(2010-2#9)(2010-3#35)(2010-4#69)(2010-5#80)(2010-6#73)(2010-7#69)(2010-8#92)(2010-9#28)(2011-1#109)(2011-10#10)(2011-2#804)(2011-3#54)(2011-4#1)(2011-7#19)(2011-9#1)(2012-12#148)(2012-2#329)(2012-3#299)(2012-4#2)(2012-5#9)(2012-6#9)(2012-7#7)(2012-8#4)(2012-9#3)(2013-1#568)(2013-3#2)(2013-7#52)(2013-8#293)
in theabsence of##2##3##(2008-11#2)
in their BAL##2##3##(2008-10#2)
in their abilities to##4##4##(1996-12#1)(1996-2#1)(2008-9#1)(2009-12#1)
in their ability to transmit##2##5##(2008-10#2)
in their ability to##21##4##(1991-2#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
in their apical cytoplasm##2##4##(2007-12#2)
in their association with##2##4##(1996-12#2)
in their basal##2##3##(2007-12#1)(2013-1#1)
in their binding##2##3##(1995-11#1)(1997-6#1)
in their capacity to protect##2##5##(2008-10#1)(2008-5#1)
in their care##3##3##(2008-11#1)(2010-10#1)(2013-8#1)
in their children##2##3##(2010-9#2)
in their choice of##2##4##(1993-6#1)(2008-9#1)
in their clinical##2##3##(1996-6#1)(2008-12#1)
in their communities##2##3##(1995-3#1)(2013-1#1)
in their countries##2##3##(2008-11#1)(2013-1#1)
in their decision making##2##4##(1996-2#1)(2010-7#1)
in their determination##2##3##(2008-10#2)
in their diet##2##3##(2008-7#1)(2010-1#1)
in their drinking water for##2##5##(2008-10#2)
in their effects on##8##4##(1990-5#1)(1993-6#1)(2008-12#1)(2008-8#2)(2008-9#2)(2012-3#1)
in their efforts to##3##4##(1995-3#1)(1996-3#2)
in their environment and##2##4##(2008-7#1)(2010-10#1)
in their environment##3##3##(2008-7#1)(2010-10#1)(2011-2#1)
in their etiology##2##3##(1997-8#1)(2011-2#1)
in their first##4##3##(1990-3#1)(1992-1#2)(2008-9#1)
in their flowers##2##3##(2008-8#1)(2011-10#1)
in their growth##2##3##(2008-10#1)(2009-10#1)
in their home##2##3##(1990-12#1)(2008-11#1)
in their homes##3##3##(2008-9#1)(2012-2#2)
in their introduced##2##3##(2008-8#2)
in their learning##2##3##(2008-11#1)(2008-12#1)
in their level of##3##4##(1994-2#1)(2008-10#1)(2010-5#1)
in their levels of##2##4##(1996-12#1)(2008-10#1)
in their life##2##3##(2008-9#1)(2010-8#1)
in their lifetime##2##3##(1990-6#1)(2009-5#1)
in their living##2##3##(2011-2#2)
in their metabolic##2##3##(1993-1#1)(2008-11#1)
in their mixture using##2##4##(2008-10#2)
in their mixture##3##3##(2008-10#3)
in their mixtures##3##3##(2008-10#3)
in their native##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
in their nontransgenic littermates##3##4##(1992-8#3)
in their organizations##2##3##(1996-3#2)
in their own homes following total hip replacement##2##8##(2010-10#2)
in their own homes##4##4##(1991-8#2)(2010-10#2)
in their own right##3##4##(1992-2#1)(2010-10#1)(2010-7#1)
in their own##19##3##(1991-8#2)(1992-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#3)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
in their patients##3##3##(2008-1#1)(2008-11#1)(2009-9#1)
in their patterns of##2##4##(2008-8#1)(2009-6#1)
in their performance##2##3##(1991-2#1)(2008-10#1)
in their personal##2##3##(1993-1#1)(2009-5#1)
in their pharmaceutical formulations##2##4##(2008-10#2)
in their pharmaceutical preparations##2##4##(2008-10#2)
in their pharmaceutical##5##3##(2008-10#5)
in their practice##3##3##(2008-11#2)(2010-8#1)
in their promoter regions##2##4##(1994-11#1)(2008-8#1)
in their promoter##3##3##(1994-11#1)(1995-2#1)(2008-8#1)
in their purified forms as well as in the crude saps of infected##2##13##(2008-10#2)
in their reactions##2##3##(2008-10#2)
in their relationships##2##3##(1994-12#1)(2008-11#1)
in their relative##5##3##(1992-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
in their reports##2##3##(2008-11#1)(2010-10#1)
in their resistance to##2##4##(2008-10#2)
in their respective##5##3##(1992-12#1)(1996-12#1)(2008-10#1)(2010-8#1)(2011-4#1)
in their response to##2##4##(2008-10#1)(2012-3#1)
in their responses to##3##4##(1995-11#1)(2008-10#1)(2010-8#1)
in their saprophytic##2##3##(2008-10#2)
in their sensitivity to##4##4##(2008-10#3)(2008-11#1)
in their social##2##3##(2008-11#2)
in their susceptibility to##2##4##(1994-5#1)(2008-8#1)
in their toxicity##2##3##(2008-10#2)
in their use of##2##4##(1990-9#1)(2008-11#1)
in their workplace##2##3##(1991-2#1)(2008-7#1)
in their##440##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-9#1)(1991-2#5)(1991-3#3)(1991-8#2)(1992-1#3)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#5)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#4)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#8)(1996-2#2)(1996-3#7)(1996-6#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(1997-9#2)(2007-12#7)(2008-1#3)(2008-10#93)(2008-11#34)(2008-12#14)(2008-2#1)(2008-4#2)(2008-5#13)(2008-6#1)(2008-7#10)(2008-8#22)(2008-9#17)(2009-10#4)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#7)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#8)(2010-9#4)(2011-1#2)(2011-10#2)(2011-2#17)(2011-4#1)(2012-12#1)(2012-2#8)(2012-3#10)(2013-1#14)(2013-8#6)
in them##8##2##(1993-8#1)(1995-10#1)(1996-11#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
in themselves##3##2##(1991-6#1)(2008-7#1)(2013-1#1)
in theory##4##2##(2008-3#1)(2008-7#1)(2010-7#1)(2012-2#1)
in thepresence of##3##3##(2008-11#3)
in thepresence##4##2##(2008-11#3)(2013-8#1)
in therapeutic doses##2##3##(1991-11#1)(2008-8#1)
in therapeutic##10##2##(1990-2#1)(1991-11#1)(1992-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
in therapeutically applied peat##2##4##(2008-10#2)
in therapy in##2##3##(1996-11#1)(2009-9#1)
in therapy of orthopaedic infections##2##5##(2007-11#2)
in therapy of##6##3##(1994-5#1)(2007-11#2)(2008-1#1)(2011-2#1)(2011-3#1)
in therapy##11##2##(1994-5#1)(1996-11#1)(2007-11#2)(2008-1#1)(2008-12#1)(2009-9#1)(2011-2#2)(2011-3#1)(2013-8#1)
in thermal##4##2##(1994-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
in these and other##2##4##(1995-12#1)(2008-6#1)
in these and##3##3##(1995-12#1)(2008-6#1)(2009-8#1)
in these animals##4##3##(1994-2#1)(1996-12#1)(1996-2#1)(2008-5#1)
in these areas##8##3##(1994-1#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
in these case##2##3##(2008-11#1)(2008-12#1)
in these cases##3##3##(1993-6#1)(2008-8#1)(2011-2#1)
in these categories##2##3##(1991-2#1)(2012-3#1)
in these cells was##2##4##(1994-6#1)(1995-8#1)
in these cells##27##3##(1990-2#1)(1991-6#1)(1994-11#1)(1994-3#2)(1994-6#3)(1995-2#3)(1995-6#2)(1995-8#3)(1996-12#1)(2008-10#1)(2008-11#5)(2008-6#1)(2008-7#2)(2009-8#1)
in these circumstances##2##3##(2011-1#1)(2012-12#1)
in these compounds##2##3##(1994-11#2)
in these conditions##3##3##(2008-10#2)(2008-11#1)
in these countries##3##3##(1996-9#1)(2008-10#1)(2009-3#1)
in these courses##3##3##(1994-12#1)(2013-1#2)
in these cultures##2##3##(1995-12#1)(2008-11#1)
in these diseases##2##3##(2008-10#1)(2009-1#1)
in these eight##2##3##(2008-7#1)(2011-3#1)
in these environments can##2##4##(2008-8#1)(2008-9#1)
in these environments##4##3##(1996-12#1)(2008-8#1)(2008-9#2)
in these experiments##9##3##(1994-3#1)(2008-10#8)
in these facial pain patients##2##5##(1993-1#2)
in these fields##2##3##(2008-1#1)(2010-7#1)
in these fractions##2##3##(1997-2#1)(2008-10#1)
in these genes##3##3##(2009-8#2)(2011-2#1)
in these highly##2##3##(2008-5#1)(2011-2#1)
in these hospitals##2##3##(1993-12#1)(2012-2#1)
in these materials##2##3##(2008-10#1)(2008-3#1)
in these matrices##2##3##(2008-10#2)
in these media##2##3##(2008-12#2)
in these mice##3##3##(1994-3#1)(2008-10#1)(2009-6#1)
in these models##2##3##(2008-10#1)(2008-9#1)
in these new##2##3##(2008-11#1)(2010-1#1)
in these organs##2##3##(1993-8#1)(1996-12#1)
in these pathways##2##3##(2009-1#1)(2011-3#1)
in these patients and##2##4##(2009-9#1)(2011-2#1)
in these patients was##2##4##(2008-5#1)(2008-7#1)
in these patients were##2##4##(1990-9#1)(2013-1#1)
in these patients##35##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-12#2)(1993-2#1)(1995-2#1)(1996-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#3)(2009-12#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#3)
in these plants##3##3##(2008-10#3)
in these procedures are##2##4##(2008-10#1)(2008-4#1)
in these processes##7##3##(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-10#1)(2013-1#1)
in these products##2##3##(2008-10#1)(2008-5#1)
in these programs##2##3##(1993-1#1)(1996-12#1)
in these regions##4##3##(1991-10#1)(2008-10#2)(2008-8#1)
in these same##2##3##(2008-10#1)(2008-11#1)
in these samples were##2##4##(2008-10#2)
in these samples##6##3##(1994-11#1)(2008-10#5)
in these settings##3##3##(1996-12#1)(2010-12#1)(2012-2#1)
in these societies##2##3##(2008-10#1)(2009-12#1)
in these solutions##2##3##(2008-10#2)
in these solvents##4##3##(2008-10#4)
in these species##4##3##(2008-10#2)(2008-7#1)(2010-12#1)
in these strains##2##3##(2008-10#1)(2012-3#1)
in these studies have##2##4##(1991-2#1)(2008-9#1)
in these studies##9##3##(1990-11#1)(1991-2#1)(1992-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)(2013-8#1)
in these subjects##2##3##(2008-10#1)(2008-6#1)
in these systems##3##3##(2008-8#1)(2008-9#1)(2009-10#1)
in these three##6##3##(1993-2#1)(2008-10#2)(2008-11#2)(2008-8#1)
in these tissues##2##3##(2008-10#1)(2012-2#1)
in these trials##2##3##(2012-2#1)(2013-1#1)
in these two cases##2##4##(2009-10#1)(2010-2#1)
in these two systems##2##4##(2008-11#1)(2009-9#1)
in these two##16##3##(1992-10#1)(1996-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
in these years##2##3##(1992-5#1)(2010-1#1)
in these##396##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#2)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#1)(1993-1#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#7)(1996-2#3)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#5)(2008-10#98)(2008-11#29)(2008-12#10)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#11)(2008-6#3)(2008-7#11)(2008-8#13)(2008-9#7)(2009-1#2)(2009-10#3)(2009-12#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#2)(2010-6#1)(2010-7#4)(2010-9#1)(2011-1#5)(2011-2#12)(2011-3#2)(2012-12#3)(2012-2#9)(2012-3#8)(2013-1#14)(2013-8#4)
in theta synchrony between the PFC and HC##2##8##(2013-8#2)
in theta##3##2##(2008-11#1)(2013-8#2)
in thickness##3##2##(2008-10#2)(2008-11#1)
in thin films##7##3##(2008-10#3)(2008-3#3)(2011-2#1)
in thin sections##2##3##(2008-10#1)(2008-9#1)
in thin##15##2##(1990-8#1)(1997-3#1)(2008-10#5)(2008-3#3)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
in thinking##2##2##(2008-11#1)(2008-12#1)
in third##2##2##(2012-3#1)(2013-1#1)
in thirty##2##2##(1991-12#1)(2009-4#1)
in this activity##2##3##(1996-3#1)(2008-7#1)
in this age group##7##4##(1991-8#1)(1995-12#1)(1997-1#4)(2008-8#1)
in this age##9##3##(1991-8#1)(1995-12#1)(1997-1#4)(2008-5#1)(2008-8#1)(2012-3#1)
in this agroecosystem##2##3##(2008-10#2)
in this analysis##5##3##(2008-10#2)(2008-3#1)(2010-11#1)(2010-12#1)
in this and##2##3##(2008-9#1)(2013-1#1)
in this animal model##2##4##(1992-12#1)(2011-2#1)
in this application##2##3##(2008-10#1)(2010-6#1)
in this area and##2##4##(2008-11#1)(2008-12#1)
in this area are##2##4##(2008-10#1)(2012-12#1)
in this area by##2##4##(2010-10#1)(2013-8#1)
in this area in##3##4##(1993-8#1)(1995-2#1)(2008-2#1)
in this area is##2##4##(1994-1#1)(2008-10#1)
in this area of research##3##5##(1997-8#1)(2008-2#1)(2010-7#1)
in this area of##7##4##(1997-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2010-7#1)
in this area will be##2##5##(1992-9#1)(2011-9#1)
in this area##66##3##(1990-11#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#9)(2008-12#5)(2008-2#4)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#2)(2010-11#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#3)(2011-9#1)(2012-12#2)(2013-1#2)(2013-8#2)
in this article are##4##4##(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)
in this article include##2##4##(1996-2#1)(2010-7#1)
in this article is##4##4##(1992-1#1)(1996-2#1)(2008-12#1)(2010-7#1)
in this article##58##3##(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1992-1#4)(1992-2#2)(1993-1#1)(1994-2#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#4)(1997-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#2)(2010-7#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
in this case report##2##4##(2008-12#1)(2012-3#1)
in this case study##3##4##(1994-1#2)(2012-12#1)
in this case the##2##4##(1995-2#1)(2013-8#1)
in this case was##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
in this case##29##3##(1992-3#1)(1994-1#2)(1995-2#1)(1996-5#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#3)(2009-3#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in this case)##3##3##(2008-10#2)(2010-11#1)
in this cell line##2##4##(2008-11#2)
in this chapter##4##3##(2008-4#1)(2008-9#2)(2013-1#1)
in this clinical setting##2##4##(2010-7#1)(2012-2#1)
in this clinical##3##3##(1990-3#1)(2010-7#1)(2012-2#1)
in this complex##3##3##(1995-2#1)(2008-10#2)
in this concentration range##2##4##(1992-3#1)(2008-10#1)
in this condition##4##3##(1991-3#1)(2008-11#1)(2011-1#1)(2011-2#1)
in this context##8##3##(1994-3#1)(2008-10#2)(2009-8#2)(2010-8#1)(2011-2#1)(2013-8#1)
in this contribution##2##3##(2008-10#2)
in this country##15##3##(1992-5#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-11#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-6#1)(2012-12#1)
in this crop##2##3##(2010-10#2)
in this cross##2##3##(2008-10#2)
in this disease##7##3##(1990-12#1)(1991-12#1)(1992-5#1)(1996-3#1)(2008-5#1)(2011-2#2)
in this disorder##3##3##(1992-3#1)(2008-7#1)(2009-10#1)
in this environment##2##3##(2008-8#2)
in this exciting##2##3##(2008-11#1)(2008-7#1)
in this experiment##5##3##(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
in this family of##2##4##(2008-6#1)(2009-9#1)
in this family##9##3##(1993-12#1)(1994-12#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-1#1)(2012-2#1)(2013-1#1)
in this field are##3##4##(2008-11#1)(2011-1#1)(2013-1#1)
in this field for##2##4##(2008-11#1)(2008-12#1)
in this field is##3##4##(1992-9#1)(1997-7#1)(2010-12#1)
in this field##28##3##(1992-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-7#1)(2013-1#1)(2013-8#2)
in this fragment##2##3##(2008-10#1)(2008-12#1)
in this fungus##4##3##(2008-10#4)
in this gene##4##3##(1994-11#1)(1996-2#1)(1997-7#1)(2013-1#1)
in this group had a##3##5##(2008-11#1)(2009-3#2)
in this group had##4##4##(2008-11#1)(2009-3#2)(2012-3#1)
in this group of patients##3##5##(1990-2#1)(1992-2#1)(2011-3#1)
in this group of##5##4##(1990-2#1)(1991-2#1)(1992-2#1)(2008-5#1)(2011-3#1)
in this group##30##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-2#1)(1992-2#1)(1995-11#2)(1995-12#1)(1996-11#2)(2008-10#4)(2008-11#2)(2008-5#3)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)
in this important field##2##4##(2008-11#1)(2013-1#1)
in this important##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
in this industry##2##3##(2008-11#2)
in this investigation##6##3##(2007-8#1)(2008-10#4)(2008-11#1)
in this issue of##5##4##(1994-12#1)(1997-2#1)(1997-3#2)(2013-1#1)
in this issue##10##3##(1994-12#1)(1995-1#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-3#2)(2010-5#1)(2013-1#1)(2013-8#1)
in this kind of##3##4##(2008-10#3)
in this laboratory##2##3##(1994-8#1)(2008-10#1)
in this large##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
in this latter##3##3##(2008-10#2)(2008-7#1)
in this location##2##3##(1996-9#1)(2008-10#1)
in this manner##5##3##(1991-3#1)(2008-10#1)(2009-9#1)(2010-11#1)(2011-1#1)
in this material##2##3##(2008-10#1)(2011-2#1)
in this method was##2##4##(2008-10#2)
in this method##8##3##(2008-10#6)(2008-11#2)
in this model##9##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-9#1)(2013-7#1)
in this mouse model##2##4##(2011-2#1)(2012-12#1)
in this new##6##3##(1993-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2012-2#1)
in this order##2##3##(1997-8#1)(2008-10#1)
in this organism##4##3##(1993-2#1)(2008-10#1)(2009-9#1)(2010-4#1)
in this paper are##3##4##(1992-9#1)(1997-2#1)(2008-12#1)
in this paper for the##2##5##(2008-10#2)
in this paper in##2##4##(1990-2#1)(2008-11#1)
in this paper is##6##4##(1994-1#1)(2008-10#2)(2009-11#1)(2012-2#1)(2013-8#1)
in this paper the##2##4##(1995-1#1)(2009-8#1)
in this paper to##2##4##(1995-12#1)(2008-10#1)
in this paper was##2##4##(2008-10#2)
in this paper we##2##4##(2011-2#1)(2013-1#1)
in this paper##109##3##(1990-11#1)(1990-2#1)(1991-12#1)(1992-1#1)(1992-9#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#66)(2008-11#6)(2008-12#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
in this particular##2##3##(1993-1#1)(1996-2#1)
in this pathogen##2##3##(2008-10#2)
in this pathology##3##3##(1991-11#1)(1993-6#1)(2011-2#1)
in this pathosystem##3##3##(2008-10#3)
in this patient group##2##4##(1996-3#1)(2008-7#1)
in this patient population##7##4##(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in this patient##17##3##(1993-1#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
in this period##5##3##(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)
in this phenomenon##2##3##(2012-2#1)(2013-8#1)
in this population##18##3##(1993-8#1)(1995-11#2)(2008-10#3)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-2#1)(2012-3#2)(2013-1#4)
in this procedure##2##3##(2008-10#1)(2008-11#1)
in this process has##2##4##(1995-8#1)(2008-1#1)
in this process is##2##4##(1994-6#1)(2010-3#1)
in this process##18##3##(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#2)
in this professional paper##2##4##(1997-1#2)
in this prospective##2##3##(2008-10#1)(2012-12#1)
in this range##2##3##(1996-12#1)(2008-11#1)
in this rare##2##3##(1991-6#1)(2010-11#1)
in this regard##8##3##(1997-7#1)(2008-11#3)(2009-11#1)(2010-5#1)(2010-9#1)(2011-2#1)
in this region are##2##4##(2008-7#1)(2012-2#1)
in this region during##2##4##(1992-10#1)(2008-10#1)
in this region has##2##4##(1994-8#1)(2012-12#1)
in this region in##2##4##(1996-1#1)(2008-10#1)
in this region##31##3##(1992-10#1)(1993-12#2)(1994-2#1)(1994-5#3)(1994-8#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#3)(2010-7#1)(2012-12#1)(2012-2#1)
in this regulatory##2##3##(2008-11#1)(2011-1#1)
in this report##11##3##(1993-3#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
in this research##6##3##(1997-3#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-4#1)(2012-2#1)
in this respect##3##3##(1994-9#1)(1995-5#1)(1997-8#1)
in this retrospective study##2##4##(2011-1#1)(2012-3#1)
in this retrospective##3##3##(2011-1#2)(2012-3#1)
in this review are##2##4##(2008-10#1)(2008-11#1)
in this review##19##3##(1995-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
in this same##2##3##(2008-10#1)(2008-8#1)
in this sample##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
in this sequence##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
in this series##9##3##(1992-2#1)(1995-11#1)(2008-5#2)(2008-6#1)(2009-3#1)(2009-9#1)(2012-2#1)(2012-3#1)
in this setting##12##3##(1992-11#1)(1995-2#1)(1997-2#1)(2008-11#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in this short##2##3##(1993-12#1)(2008-7#1)
in this single##2##3##(1996-12#1)(2013-1#1)
in this situation##2##3##(2008-11#1)(2008-7#1)
in this small##2##3##(2010-5#1)(2012-3#1)
in this species and##2##4##(2007-12#1)(2008-10#1)
in this species is##2##4##(2008-8#1)(2009-8#1)
in this species##21##3##(1990-11#1)(1992-10#1)(1994-8#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-8#2)
in this specific##2##3##(2008-10#1)(2012-5#1)
in this stage##2##3##(2007-12#1)(2013-1#1)
in this strain is##2##4##(2008-10#2)
in this strain##3##3##(2008-10#3)
in this study allowed##2##4##(2010-4#1)(2012-3#1)
in this study and##3##4##(2008-10#2)(2009-2#1)
in this study are##3##4##(2008-10#2)(2008-5#1)
in this study consisted of##2##5##(2008-11#1)(2011-2#1)
in this study could be##2##5##(2008-10#1)(2013-1#1)
in this study could##3##4##(2008-10#2)(2013-1#1)
in this study had##2##4##(1992-2#1)(2013-8#1)
in this study have##4##4##(2008-10#2)(2009-8#1)(2011-2#1)
in this study include##2##4##(2008-8#2)
in this study is##6##4##(2008-10#2)(2008-5#2)(2009-11#1)(2012-12#1)
in this study may be useful##2##6##(1996-2#1)(2008-10#1)
in this study may##3##4##(1996-2#1)(2008-10#1)(2010-12#1)
in this study revealed that##2##5##(2008-10#2)
in this study should be##2##5##(1996-8#1)(2008-10#1)
in this study should##3##4##(1996-8#1)(2008-10#2)
in this study showed##2##4##(2008-12#1)(2013-8#1)
in this study that##3##4##(2008-10#1)(2008-9#1)(2010-6#1)
in this study to##7##4##(1990-2#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-12#1)(2011-2#1)
in this study was that##2##5##(2011-1#1)(2013-1#1)
in this study was##7##4##(1993-12#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
in this study we##2##4##(2008-11#1)(2013-1#1)
in this study were##9##4##(1997-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-2#1)(2011-2#1)(2013-1#1)
in this study will##3##4##(2008-10#1)(2010-1#1)(2010-11#1)
in this study##206##3##(1990-2#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-12#2)(1996-2#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#4)(2006-6#1)(2008-10#81)(2008-11#7)(2008-12#8)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#9)(2013-1#15)(2013-8#4)
in this system are##2##4##(2008-10#1)(2008-8#1)
in this system##16##3##(1995-2#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2012-3#1)
in this technique##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
in this tissue##2##3##(1993-3#1)(2013-1#1)
in this type of patients##2##5##(2011-2#1)(2013-1#1)
in this type of##8##4##(2008-10#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#3)(2013-1#1)
in this unit are##7##4##(2008-4#3)(2008-9#2)(2010-7#1)(2012-3#1)
in this unit cover##2##4##(2008-9#2)
in this unit describe##3##4##(2008-4#1)(2008-9#2)
in this unit for##2##4##(2008-4#2)
in this unit is##7##4##(2008-4#5)(2008-9#1)(2010-8#1)
in this unit##49##3##(2008-2#1)(2008-4#30)(2008-9#15)(2010-7#1)(2010-8#1)(2012-3#1)
in this volume##2##3##(1992-6#1)(2008-11#1)
in this way##22##3##(1991-5#1)(1992-2#1)(1993-12#2)(1994-6#1)(1994-9#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)
in this work are##2##4##(2008-10#1)(2011-2#1)
in this work for the##3##5##(2008-10#3)
in this work for##4##4##(2008-10#4)
in this work was##3##4##(2008-10#3)
in this work we##2##4##(2008-10#1)(2008-11#1)
in this work##50##3##(1993-8#1)(1994-8#1)(2008-10#42)(2008-11#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)
in this##1314##2##(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#9)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#7)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#7)(1992-3#6)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#7)(1993-11#2)(1993-12#9)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#5)(1994-1#5)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#3)(1995-11#7)(1995-12#8)(1995-2#11)(1995-3#5)(1995-5#5)(1995-6#2)(1995-8#1)(1996-1#4)(1996-11#3)(1996-12#10)(1996-2#12)(1996-3#7)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#11)(1997-2#12)(1997-3#12)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#11)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#359)(2008-11#90)(2008-12#40)(2008-2#9)(2008-3#7)(2008-4#35)(2008-5#27)(2008-6#7)(2008-7#39)(2008-8#29)(2008-9#39)(2009-10#8)(2009-11#4)(2009-12#5)(2009-2#3)(2009-3#6)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#16)(2009-9#5)(2010-1#3)(2010-10#8)(2010-11#8)(2010-12#11)(2010-2#3)(2010-3#4)(2010-4#7)(2010-5#6)(2010-6#6)(2010-7#13)(2010-8#11)(2010-9#2)(2011-1#12)(2011-2#46)(2011-3#4)(2011-7#1)(2011-9#1)(2012-12#10)(2012-2#20)(2012-3#30)(2012-5#1)(2013-1#50)(2013-2#1)(2013-7#2)(2013-8#24)
in thoracic##3##2##(1990-2#1)(2012-12#1)(2012-3#1)
in those cases##2##3##(2007-8#1)(2008-5#1)
in those cells##2##3##(1997-3#1)(2008-10#1)
in those irrigated with fresh water (EC =##2##8##(2008-10#2)
in those of##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
in those patients##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
in those presenting##2##3##(2008-12#1)(2011-2#1)
in those receiving##2##3##(1994-12#1)(2011-2#1)
in those treated with##2##4##(1993-2#1)(2012-12#1)
in those treated##3##3##(1993-2#1)(2012-12#1)(2013-1#1)
in those who had##5##4##(2012-3#2)(2013-1#3)
in those who received##2##4##(1990-6#1)(2008-11#1)
in those who were##2##4##(2011-2#1)(2013-1#1)
in those who##14##3##(1990-6#1)(1991-12#1)(1991-3#1)(2008-11#1)(2011-2#1)(2012-3#3)(2013-1#6)
in those whose##2##3##(1995-5#1)(2008-7#1)
in those with##15##3##(1990-2#1)(1991-2#1)(1992-12#1)(1993-1#1)(1997-8#1)(2009-6#1)(2010-10#1)(2010-12#2)(2011-2#4)(2012-3#1)(2013-8#1)
in those without##4##3##(1990-8#1)(1991-12#1)(1996-12#1)(2010-4#1)
in those##82##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#2)(1994-12#1)(1995-12#2)(1995-5#1)(1996-12#2)(1997-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#2)(2011-2#10)(2012-12#1)(2012-3#5)(2013-1#9)(2013-8#3)
in three areas##2##3##(1993-12#1)(2008-9#1)
in three batches##2##3##(2008-11#1)(2013-1#1)
in three cases of##2##4##(1997-8#1)(2013-1#1)
in three cases##9##3##(1995-11#1)(1997-3#3)(1997-8#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
in three commercial##2##3##(2008-10#2)
in three consecutive##2##3##(2008-5#1)(2012-3#1)
in three different media##2##4##(2008-11#2)
in three different##21##3##(1995-6#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-7#1)(2010-12#1)(2013-8#2)
in three distinct##2##3##(2008-10#2)
in three groups##4##3##(2008-10#2)(2011-1#1)(2012-2#1)
in three main##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-9#1)
in three models##2##3##(2008-5#1)(2008-8#1)
in three of four##3##4##(2008-10#2)(2011-2#1)
in three of the four##2##5##(1994-12#1)(2008-9#1)
in three of the##5##4##(1994-12#1)(1996-12#1)(2008-10#2)(2008-9#1)
in three of##9##3##(1994-12#1)(1996-12#1)(2008-10#5)(2008-9#1)(2011-2#1)
in three patients##8##3##(1990-8#1)(1996-6#1)(1996-9#1)(2008-5#1)(2008-7#2)(2010-11#1)(2011-2#1)
in three phases##2##3##(1991-2#1)(2009-7#1)
in three steps##2##3##(2008-10#2)
in three types of##2##4##(1996-2#1)(2008-10#1)
in three types##3##3##(1996-2#1)(2008-10#2)
in three##177##2##(1990-6#1)(1990-8#1)(1991-2#2)(1991-7#1)(1992-2#1)(1992-6#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-6#2)(1996-9#2)(1997-2#1)(1997-3#5)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#70)(2008-11#9)(2008-12#3)(2008-3#3)(2008-5#5)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2012-7#1)(2012-9#1)(2013-1#4)(2013-8#6)
in three-dimensional##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
in thrombogenesis##2##2##(2006-6#1)(2013-1#1)
in thylakoid##2##2##(2009-10#2)
in thymocyte##3##2##(2008-10#3)
in thymocytes##3##2##(1995-8#1)(1997-7#1)(2008-10#1)
in thymus##4##2##(1995-12#1)(2008-10#1)(2008-5#2)
in thyroid pathology##2##3##(2013-1#2)
in thyroid##7##2##(2008-7#1)(2013-1#6)
in ticks##3##2##(2008-10#1)(2008-12#1)(2010-10#1)
in tight junction disruption##2##4##(2011-2#2)
in tight##3##2##(2011-10#1)(2011-2#2)
in tilled fields##2##3##(2008-10#2)
in tilled##5##2##(2008-10#5)
in time and space##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
in time and##5##3##(2008-10#1)(2008-11#2)(2013-1#2)
in time for##3##3##(2009-6#1)(2012-12#1)(2013-8#1)
in time in##2##3##(2008-10#1)(2008-11#1)
in time of##2##3##(1992-12#1)(2008-10#1)
in time to##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
in time##46##2##(1990-2#1)(1992-12#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-6#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
in time-dependent##3##2##(1994-5#1)(2008-11#1)(2008-3#1)
in timing##2##2##(2008-10#1)(2008-11#1)
in tissue culture##7##3##(1993-11#2)(1997-1#1)(2008-11#3)(2011-2#1)
in tissue engineering and regenerative medicine##2##6##(2009-7#1)(2012-5#1)
in tissue engineering##9##3##(2008-11#3)(2009-7#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-5#1)
in tissue extracts##4##3##(1990-11#1)(2008-10#2)(2008-11#1)
in tissue injury##2##3##(1990-2#2)
in tissue scaffold fabrication##2##4##(2010-9#2)
in tissue sections##2##3##(2008-4#2)
in tissue specimens##2##3##(2011-2#2)
in tissue##53##2##(1990-11#1)(1990-2#2)(1992-9#1)(1993-1#1)(1993-11#3)(1994-2#1)(1996-12#1)(1997-1#1)(2008-10#6)(2008-11#10)(2008-3#3)(2008-4#3)(2008-5#2)(2008-9#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-9#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#1)
in tissue-like phantoms##2##3##(2010-12#2)
in tissue-like##3##2##(2010-12#3)
in tissues and##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
in tissues of##2##3##(1992-3#1)(2008-12#1)
in tissues##21##2##(1990-11#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-12#1)(1995-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
in titanium bearing minerals by potentiometric titration using##2##8##(2008-10#2)
in titanium##4##2##(2008-10#4)
in titrations##2##2##(1991-11#1)(2008-10#1)
in titrimetric##2##2##(2008-10#2)
in tits##2##2##(2008-5#2)
in to the##2##3##(2008-10#1)(2008-12#1)
in to##9##2##(2008-10#4)(2008-12#3)(2010-8#1)(2013-1#1)
in tobacco and##3##3##(1993-11#1)(2008-10#2)
in tobacco##23##2##(1993-11#1)(1997-1#1)(2008-10#16)(2008-11#1)(2008-8#1)(2009-10#1)(2009-7#1)(2012-2#1)
in today's competitive##2##3##(1991-2#1)(1994-12#1)
in today's health care environment##2##5##(1991-12#1)(1991-3#1)
in today's health care##4##4##(1991-12#1)(1991-3#1)(1997-3#1)(2008-11#1)
in today's##17##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1994-12#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
in tolerance##5##2##(1996-12#1)(2008-10#3)(2008-12#1)
in tolerant rats##3##3##(1996-2#3)
in tolerant##5##2##(1996-2#3)(2008-10#2)
in toluene as an extractant##2##5##(2008-10#2)
in toluene##10##2##(2008-10#10)
in tomato and##2##3##(2008-10#2)
in tomato fruits##3##3##(2008-10#1)(2011-2#2)
in tomato in##2##3##(2008-10#2)
in tomato leaves##2##3##(2008-10#2)
in tomato plants##8##3##(2008-10#8)
in tomato roots##4##3##(2008-10#4)
in tomato##43##2##(1993-12#1)(2008-10#39)(2011-2#3)
in toothpastes##3##2##(2008-5#3)
in total RNA##2##3##(2008-10#1)(2008-11#1)
in total cell##2##3##(2008-5#1)(2008-7#1)
in total cholesterol##2##3##(1994-3#1)(2008-3#1)
in total competition intensity or##2##5##(2008-9#2)
in total hip##2##3##(2009-4#1)(2012-2#1)
in total parenteral nutrition (TPN)##2##5##(1992-9#1)(2008-10#1)
in total##47##2##(1990-6#1)(1990-8#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
in total)##3##2##(1992-12#1)(2008-10#2)
in touch##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
in trace amounts in##2##4##(2008-10#1)(2008-11#1)
in trace amounts##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
in trace quantities can be##2##5##(2008-10#2)
in trace##7##2##(2008-10#5)(2008-11#1)(2008-5#1)
in traditional Chinese##4##3##(1997-2#1)(2008-10#3)
in traditional##10##2##(1994-2#1)(1997-2#2)(1997-7#1)(2008-10#3)(2008-9#1)(2010-6#1)(2013-1#1)
in traffic accidents##2##3##(1990-9#1)(2010-11#1)
in traffic##4##2##(1990-9#1)(2010-11#2)(2010-3#1)
in training and education##2##4##(1997-6#1)(2008-11#1)
in training##4##2##(1997-3#1)(1997-6#1)(2008-11#1)(2011-2#1)
in traits##2##2##(2008-9#1)(2012-3#1)
in trans##6##2##(1991-12#1)(1993-12#1)(1994-5#1)(1995-6#2)(2008-10#1)
in transcription of the##2##4##(1996-12#1)(2010-10#1)
in transcription##4##2##(1993-12#1)(1996-12#1)(2009-6#1)(2010-10#1)
in transcriptional enhancement and##2##4##(1995-6#2)
in transcriptional regulation of##2##4##(2008-8#1)(2011-2#1)
in transcriptional regulation##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
in transcriptional##8##2##(1995-6#3)(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
in transcriptionally active##3##3##(1990-7#2)(2011-1#1)
in transfected cells##8##3##(1990-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-11#1)(2010-5#1)
in transfected##13##2##(1990-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1997-4#1)(2008-11#2)(2010-5#1)
in transfection##3##2##(1995-6#1)(2008-11#2)
in transfer##2##2##(1993-1#1)(2008-10#1)
in transferring##2##2##(1997-8#1)(2008-8#1)
in transformed cells##3##3##(1995-2#1)(2009-9#1)(2010-3#1)
in transformed##6##2##(1993-6#1)(1995-2#1)(2009-7#1)(2009-9#1)(2010-3#2)
in transformer-2##2##2##(2007-12#2)
in transforming##2##2##(2008-10#1)(2008-9#1)
in transfusion##4##2##(2008-10#3)(2011-2#1)
in transgene##3##2##(1995-2#1)(2008-8#1)(2011-1#1)
in transgenic Nicotiana##2##3##(2008-10#2)
in transgenic Petunia hybrida##2##4##(2008-9#2)
in transgenic animals##3##3##(1993-12#1)(1995-6#1)(2008-11#1)
in transgenic lines##3##3##(2008-10#2)(2008-9#1)
in transgenic maize plants and##2##5##(2008-8#2)
in transgenic mice##12##3##(1992-8#2)(1995-2#3)(1995-6#1)(1996-12#1)(1997-7#1)(2008-4#1)(2008-9#3)
in transgenic plants##10##3##(2008-10#7)(2008-8#2)(2011-2#1)
in transgenic potato##2##3##(2008-8#2)
in transgenic tobacco plants##4##4##(2008-10#2)(2008-8#1)(2011-10#1)
in transgenic tobacco##5##3##(2008-10#2)(2008-8#1)(2011-10#2)
in transgenic##54##2##(1992-8#2)(1993-12#2)(1995-2#3)(1995-6#3)(1996-12#1)(1997-7#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#8)(2008-9#11)(2009-10#1)(2010-7#1)(2011-10#2)(2011-2#1)
in transient expression assays##2##4##(1993-8#2)
in transient expression##3##3##(1993-8#2)(2008-11#1)
in transient##12##2##(1991-3#1)(1992-8#2)(1993-6#1)(1993-8#2)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#2)
in transit through##2##3##(1995-12#1)(2008-7#1)
in transit##3##2##(1995-12#1)(2008-7#1)(2012-2#1)
in transition##3##2##(2008-1#1)(2008-3#1)(2008-6#1)
in translating##3##2##(1996-2#1)(2008-1#1)(2008-11#1)
in translation##3##2##(1995-6#1)(2008-10#1)(2010-1#1)
in transmission by##3##3##(2008-10#3)
in transmission##8##2##(2008-10#7)(2008-9#1)
in transparent##2##2##(1997-6#1)(2008-3#1)
in transplanted##2##2##(2008-9#1)(2013-7#1)
in transport##3##2##(1995-8#1)(2008-10#1)(2011-1#1)
in transposa and##2##3##(2008-10#2)
in transposition frequency##3##3##(2012-3#3)
in transposition##6##2##(2009-10#1)(2012-3#5)
in transradial##2##2##(2011-2#2)
in transverse##2##2##(2009-3#1)(2009-7#1)
in trauma##2##2##(2009-4#1)(2012-2#1)
in traumatic brain injury##2##4##(2008-7#2)
in traumatic##3##2##(2008-7#2)(2012-2#1)
in travelers##3##2##(2011-2#3)
in treated animals##3##3##(2006-6#1)(2011-2#2)
in treated##15##2##(1992-9#1)(1995-8#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-9#1)(2011-2#2)(2012-3#1)
in treating patients with##2##4##(1991-8#1)(2009-8#1)
in treating patients##4##3##(1991-8#1)(2008-10#1)(2009-8#1)(2012-3#1)
in treating severe##2##3##(1991-3#1)(2011-2#1)
in treating##24##2##(1991-3#1)(1991-8#1)(1991-9#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-8#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#2)
in treatment (5)##2##3##(2013-1#2)
in treatment and##3##3##(1991-1#1)(1993-3#1)(2013-1#1)
in treatment for severe depression##2##5##(2013-8#2)
in treatment for severe##3##4##(2013-8#3)
in treatment for##6##3##(2008-7#1)(2013-8#5)
in treatment of patients with##2##5##(2008-11#1)(2010-4#1)
in treatment of##19##3##(1990-6#1)(1991-9#1)(1995-11#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2009-1#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
in treatment strategies##3##3##(2010-11#2)(2013-8#1)
in treatment##50##2##(1990-6#1)(1991-1#3)(1991-11#1)(1991-3#1)(1991-9#1)(1993-3#1)(1995-11#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-9#1)(2010-11#3)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#7)(2013-8#6)
in treatments (1)##2##3##(2013-1#2)
in treatments of##2##3##(2008-10#1)(2009-11#1)
in treatments with##6##3##(2008-10#6)
in treatments##14##2##(2008-10#9)(2008-5#1)(2009-11#1)(2013-1#3)
in tree##2##2##(2008-10#2)
in trees##7##2##(2008-10#3)(2008-8#2)(2008-9#1)(2012-8#1)
in trials##2##2##(2008-11#1)(2013-1#1)
in triggering##5##2##(1995-11#1)(2008-10#1)(2008-9#1)(2011-2#2)
in triglycerides##4##2##(1991-12#1)(2008-3#1)(2010-4#2)
in trimeric PEC##2##3##(2008-8#2)
in triploid crucian carp##2##4##(2010-5#2)
in tropical Asia##4##3##(2008-10#4)
in tropical and subtropical##2##4##(2008-10#2)
in tropical and##3##3##(1994-9#1)(2008-10#2)
in tropical##18##2##(1992-11#2)(1994-9#1)(2008-10#9)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)
in trying to##3##3##(1995-3#1)(1997-2#1)(2008-12#1)
in tsetse##2##2##(2010-4#2)
in tuber##2##2##(2008-10#2)
in tuberculosis##4##2##(1996-3#2)(2010-5#1)(2010-8#1)
in tumor cells##13##3##(1992-2#1)(1994-5#2)(2008-11#6)(2008-9#2)(2009-3#1)(2010-1#1)
in tumor growth and##2##4##(2009-3#1)(2013-8#1)
in tumor growth##5##3##(1994-6#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#1)
in tumor immunotherapy trials##2##4##(2009-3#1)(2011-2#1)
in tumor progression and##2##4##(2009-3#2)
in tumor##38##2##(1990-8#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(2008-10#1)(2008-11#6)(2008-8#1)(2008-9#5)(2009-11#2)(2009-12#1)(2009-3#5)(2010-1#1)(2010-7#1)(2011-2#4)(2013-1#1)(2013-8#2)
in tumorigenesis##5##2##(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)
in tumors with##2##3##(2009-8#1)(2011-2#1)
in tumors##10##2##(1990-11#1)(1993-11#1)(2008-9#2)(2009-4#1)(2009-8#1)(2011-2#3)(2012-2#1)
in tumour##3##2##(1992-9#1)(1997-3#1)(2011-2#1)
in tunnels##2##2##(2009-10#2)
in turbid media##2##3##(1994-2#1)(2008-3#1)
in turbidity##3##2##(2008-10#2)(2009-9#1)
in turbot##2##2##(2010-5#1)(2010-8#1)
in turbulent flows##2##3##(2008-3#1)(2008-9#1)
in turbulent##4##2##(2008-3#1)(2008-9#3)
in turkey##2##2##(2007-8#1)(2008-5#1)
in turn affects##2##3##(2008-8#1)(2010-11#1)
in turn are related to##2##5##(2008-10#1)(2008-8#1)
in turn are##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
in turn has##3##3##(1996-6#1)(2008-11#1)(2010-4#1)
in turn lead to##4##4##(2008-10#1)(2008-5#1)(2010-5#1)(2013-1#1)
in turn leads to##2##4##(2008-5#1)(2010-12#1)
in turn results in##2##4##(2008-10#1)(2008-5#1)
in turn will##3##3##(1996-3#1)(1997-2#1)(2008-12#1)
in turn##98##2##(1990-2#1)(1990-8#1)(1992-11#1)(1993-12#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(2008-1#1)(2008-10#17)(2008-11#9)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#2)
in twelve##3##2##(1993-2#1)(1995-2#1)(2008-8#1)
in twenty##3##2##(1993-3#1)(1997-3#1)(2008-10#1)
in twin gestations##2##3##(2012-3#2)
in twin##3##2##(2012-2#1)(2012-3#2)
in two (10%)##4##3##(1996-9#3)(2008-5#1)
in two Canadian##3##3##(2008-10#2)(2008-12#1)
in two Italian provenances##2##4##(2012-5#2)
in two and##2##3##(2008-10#1)(2008-5#1)
in two areas##5##3##(1994-2#1)(2008-10#1)(2013-1#3)
in two cases and##3##4##(2007-12#1)(2008-7#2)
in two cases##12##3##(1993-2#1)(1997-8#2)(2007-12#1)(2008-5#1)(2008-7#6)(2011-2#1)
in two children##3##3##(2008-10#1)(2008-9#1)(2009-3#1)
in two different##18##3##(1992-11#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2009-8#1)(2012-12#1)
in two dimensions##5##3##(2008-1#1)(2008-3#2)(2008-8#1)(2012-3#1)
in two distinct##2##3##(2008-10#1)(2008-5#1)
in two experiments##2##3##(2008-10#1)(2008-6#1)
in two families##2##3##(1991-12#2)
in two field experiments##2##4##(2008-10#2)
in two field##5##3##(2008-10#5)
in two forms##4##3##(1991-5#1)(1993-8#1)(2008-10#1)(2009-9#1)
in two groups of##2##4##(2008-12#1)(2008-5#1)
in two groups##7##3##(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#3)
in two hospitals in##2##4##(2008-11#1)(2012-12#1)
in two in##2##3##(1992-12#1)(1996-6#1)
in two key##3##3##(2008-3#1)(2008-8#1)(2012-2#1)
in two locations in##2##4##(2008-10#2)
in two locations##6##3##(2008-10#5)(2012-12#1)
in two maize cultivars##2##4##(2008-12#2)
in two of the four##3##5##(2008-10#2)(2008-5#1)
in two of the##7##4##(2008-10#3)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
in two of three##3##4##(2008-10#3)
in two of##10##3##(2008-10#6)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
in two or##2##3##(1996-12#1)(2008-9#1)
in two patients with##5##4##(1990-9#1)(1991-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
in two patients##15##3##(1990-9#1)(1991-3#1)(1993-1#1)(1993-2#1)(1995-12#1)(1996-9#1)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
in two populations##2##3##(2012-2#1)(2013-8#1)
in two rat strains##2##4##(1993-12#1)(2008-11#1)
in two regions##3##3##(1992-9#1)(1996-2#1)(2008-7#1)
in two seasons##2##3##(2008-10#2)
in two separate##5##3##(1991-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)
in two siblings with##2##4##(2008-7#1)(2009-3#1)
in two species of##2##4##(2007-12#1)(2008-9#1)
in two species##3##3##(1995-5#1)(2007-12#1)(2008-9#1)
in two stages##3##3##(2008-11#2)(2010-8#1)
in two states##2##3##(1991-3#2)
in two steps##5##3##(1993-9#1)(2008-10#3)(2010-10#1)
in two strains of##2##4##(2008-10#1)(2008-11#1)
in two subgroups##2##3##(2008-10#1)(2013-1#1)
in two to##2##3##(2008-10#1)(2010-8#1)
in two ways##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
in two years##3##3##(1996-3#1)(1997-8#1)(2013-1#1)
in two##320##2##(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#4)(1991-5#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-8#1)(1993-9#2)(1994-2#2)(1994-9#1)(1995-12#1)(1995-5#2)(1995-8#1)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#4)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#3)(2007-12#7)(2008-1#3)(2008-10#89)(2008-11#23)(2008-12#13)(2008-2#1)(2008-3#3)(2008-5#15)(2008-6#1)(2008-7#15)(2008-8#7)(2008-9#10)(2009-1#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#4)(2011-2#11)(2012-12#3)(2012-2#4)(2012-3#4)(2012-5#3)(2013-1#9)(2013-7#1)(2013-8#3)
in two-component##2##2##(2008-10#2)
in two-dimensional space##3##3##(2008-11#3)
in two-dimensional##8##2##(2008-11#4)(2008-3#1)(2011-2#2)(2012-4#1)
in two-phase##2##2##(2008-10#1)(2010-4#1)
in type 1 and type 2 diabetic patients##2##8##(1993-2#2)
in type 1 diabetes##2##4##(1991-12#1)(2010-11#1)
in type 1 diabetic patients##2##5##(2010-12#1)(2012-4#1)
in type 1##7##3##(1991-12#1)(1993-2#3)(2010-11#1)(2010-12#1)(2012-4#1)
in type 2 diabetes patients##2##5##(2008-11#1)(2011-2#1)
in type 2 diabetes##7##4##(2008-1#2)(2008-11#1)(2010-10#1)(2011-2#2)(2012-5#1)
in type 2##10##3##(2008-1#2)(2008-11#1)(2010-10#1)(2011-2#4)(2012-3#1)(2012-5#1)
in type I##2##3##(1995-12#1)(2008-11#1)
in type II##3##3##(1991-7#1)(1995-11#1)(2011-2#1)
in type##27##2##(1991-12#1)(1991-7#1)(1993-2#3)(1995-11#1)(1995-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2011-2#5)(2012-3#1)(2012-4#1)(2012-5#1)
in type-2##2##2##(1994-6#1)(2012-2#1)
in typical##5##2##(1993-3#1)(2008-10#2)(2008-5#1)(2009-10#1)
in ulcer##2##2##(1993-2#1)(2013-1#1)
in ulcerative colitis##2##3##(1992-9#1)(1995-10#1)
in ulcerative rectocolitis##2##3##(1990-3#1)(1992-3#1)
in ulcerative##5##2##(1990-3#1)(1990-6#1)(1992-3#1)(1992-9#1)(1995-10#1)
in ultrathin polymer##2##3##(2008-10#2)
in ultrathin##5##2##(2008-10#5)
in ultraviolet region##3##3##(2008-10#3)
in umbilical cord##2##3##(2009-8#1)(2011-1#1)
in unaffected##2##2##(1997-8#1)(2011-2#1)
in unanesthetized##2##2##(1997-2#1)(2008-4#1)
in unbuffered##2##2##(2008-10#1)(2009-12#1)
in under##2##2##(2008-10#2)
in undergraduate nursing##3##3##(2008-11#1)(2008-12#2)
in undergraduate##5##2##(2008-11#1)(2008-12#2)(2010-9#1)(2012-2#1)
in underground##3##2##(2008-10#3)
in underserved communities##2##3##(2012-2#2)
in understanding mechanisms of change in##2##6##(2012-2#2)
in understanding mechanisms of##3##4##(2008-8#1)(2012-2#2)
in understanding of the##2##4##(2008-12#1)(2008-7#1)
in understanding of##3##3##(2008-12#2)(2008-7#1)
in understanding the molecular basis of##2##6##(2008-11#1)(2008-9#1)
in understanding the molecular##3##4##(2008-11#2)(2008-9#1)
in understanding the role of##3##5##(1991-3#1)(2008-10#1)(2012-2#1)
in understanding the role##4##4##(1991-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
in understanding the##26##3##(1991-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#1)
in understanding##50##2##(1991-3#1)(1996-12#1)(1997-3#1)(1997-8#3)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-2#7)(2013-1#2)(2013-8#1)
in underwriting##3##2##(1992-3#1)(1993-12#2)
in undiluted human plasma by spectrofluorimetry##2##6##(2008-10#2)
in undiluted##4##2##(2008-10#4)
in unexpected##2##2##(2008-10#1)(2009-1#1)
in unexposed##2##2##(1992-6#1)(2008-10#1)
in unfertilized human oocytes and##2##5##(1994-11#2)
in unfertilized##4##2##(1993-6#1)(1994-11#3)
in unhealthy##2##2##(2008-11#1)(2010-6#1)
in uninfected cells or cells infected with##2##7##(1993-6#2)
in uninfected insect##2##3##(2008-11#1)(2008-7#1)
in uninfected##8##2##(1990-12#1)(1993-6#2)(2008-10#3)(2008-11#1)(2008-7#1)
in unique##4##2##(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)
in unit##2##2##(2008-10#1)(2008-11#1)
in unknown samples##2##3##(2008-10#2)
in unpolluted##2##2##(2008-10#2)
in unprotected##5##2##(1996-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
in unraveling the##2##3##(1995-12#1)(1997-3#1)
in unresolved##2##2##(2008-10#1)(2010-3#1)
in unsaturation##3##2##(2008-10#3)
in unselected consecutive patients with thyroid nodules##2##7##(2012-3#2)
in unstable resonators##2##3##(2008-3#2)
in untreated control plots##2##4##(2008-10#2)
in untreated control##3##3##(2008-10#3)
in untreated soil##2##3##(2008-10#2)
in untreated soils##2##3##(2008-10#2)
in untreated##16##2##(1996-12#1)(2008-10#12)(2008-12#1)(2008-9#1)(2010-11#1)
in unusual##3##2##(1994-5#1)(2009-1#1)(2012-2#1)
in unvaccinated rural dogs##2##4##(2008-12#2)
in up to##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
in upland##2##2##(2008-10#2)
in upper##11##2##(2008-10#6)(2008-9#2)(2010-1#1)(2010-9#1)(2012-3#1)
in uranium##3##2##(2008-10#3)
in urban and rural areas##2##5##(1991-3#1)(1994-2#1)
in urban and rural##4##4##(1991-3#1)(1994-2#1)(2008-10#1)(2012-3#1)
in urban areas and##2##4##(1994-2#1)(2008-5#1)
in urban areas##7##3##(1994-2#1)(1995-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-1#1)
in urban atmospheres##3##3##(2008-10#1)(2008-11#2)
in urban hospitals has##2##4##(1992-12#2)
in urban##37##2##(1991-3#1)(1992-12#3)(1994-2#2)(1995-1#1)(1996-3#1)(2008-10#6)(2008-11#7)(2008-3#2)(2008-5#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#4)
in urea##2##2##(2008-10#2)
in uremic serum##3##3##(2008-10#3)
in uremic##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
in ureteral##2##2##(1997-4#1)(2008-10#1)
in urinary tract infection##2##4##(1996-12#1)(2011-2#1)
in urinary tract##4##3##(1993-11#1)(1996-12#1)(1997-2#1)(2011-2#1)
in urinary##12##2##(1991-12#2)(1993-11#1)(1996-12#3)(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
in urine after##2##3##(2008-10#2)
in urine and serum##7##4##(1990-2#1)(1995-8#1)(2008-10#5)
in urine and##15##3##(1990-2#1)(1995-8#1)(2008-10#13)
in urine at##2##3##(2008-10#2)
in urine by flow injection hydride generation##2##7##(2008-10#2)
in urine by##11##3##(2008-10#11)
in urine cytology##2##3##(2012-2#1)(2013-8#1)
in urine has been##2##4##(2008-10#2)
in urine is##3##3##(1990-2#1)(2008-10#2)
in urine may##2##3##(1990-2#1)(2010-5#1)
in urine of patients##2##4##(1997-2#1)(2008-10#1)
in urine of##4##3##(1993-12#1)(1997-2#1)(2008-10#2)
in urine sample##2##3##(2008-10#2)
in urine samples and##2##4##(2008-10#2)
in urine samples from##3##4##(2008-10#3)
in urine samples##23##3##(2008-10#23)
in urine using##4##3##(2008-10#4)
in urine was developed##2##4##(2008-10#2)
in urine was##7##3##(2008-10#7)
in urine were determined##2##4##(2008-10#2)
in urine were##4##3##(2008-10#4)
in urine with##2##3##(2008-10#2)
in urine##127##2##(1990-12#2)(1990-2#5)(1993-12#1)(1994-12#1)(1995-8#1)(1997-2#1)(2008-10#111)(2008-12#1)(2009-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
in use and##2##3##(1992-9#1)(2008-12#1)
in use for##3##3##(2008-10#2)(2012-2#1)
in use of##4##3##(1991-2#1)(1994-2#1)(2008-3#1)(2008-9#1)
in use##24##2##(1991-2#1)(1992-9#1)(1994-2#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in used rockwool##2##3##(2008-10#2)
in used##7##2##(2008-10#6)(2011-2#1)
in users##3##2##(2013-8#3)
in using the##2##3##(2008-10#1)(2009-8#1)
in using##12##2##(1996-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
in utero and##2##3##(2009-8#1)(2012-3#1)
in utero exposure to##2##4##(2008-8#1)(2011-1#1)
in utero##12##2##(1991-1#1)(1994-8#2)(2008-10#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#2)
in utilization##4##2##(1991-3#1)(1993-1#1)(2008-11#1)(2011-2#1)
in vaccine trials##2##3##(1994-9#1)(1995-5#1)
in vaccine##7##2##(1994-9#1)(1995-5#4)(2007-11#1)(2008-11#1)
in vacuo##2##2##(2008-3#1)(2008-4#1)
in vacuum##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
in values##3##2##(2008-10#1)(2009-6#1)(2011-2#1)
in variable##5##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-1#1)(2011-2#1)
in variety##2##2##(2010-8#1)(2011-2#1)
in various animal##2##3##(2008-4#1)(2011-1#1)
in various areas of##2##4##(2008-9#2)
in various aspects of##2##4##(2011-2#1)(2012-3#1)
in various biological##2##3##(1994-8#1)(1997-2#1)
in various buffer##2##3##(2008-10#2)
in various chemical##2##3##(1992-4#1)(2008-10#1)
in various combinations with##2##4##(1993-11#1)(2008-10#1)
in various concentrations of##2##4##(2008-10#1)(2008-12#1)
in various countries##3##3##(1994-5#1)(2011-2#1)(2012-2#1)
in various crops##3##3##(2008-10#3)
in various environmental##3##3##(2008-10#3)
in various forms of##2##4##(1994-12#1)(2013-7#1)
in various host##2##3##(2008-10#1)(2011-2#1)
in various human tissues##3##4##(1995-6#1)(2008-8#2)
in various human##5##3##(1990-5#1)(1995-6#1)(2008-10#1)(2008-8#2)
in various inflammatory##3##3##(1990-2#1)(2008-5#1)(2012-3#1)
in various organisms##2##3##(1995-2#1)(2009-8#1)
in various organs and##2##4##(2008-9#1)(2012-3#1)
in various organs##5##3##(1990-12#1)(1996-12#1)(2008-9#1)(2012-12#1)(2012-3#1)
in various parts of the##2##5##(2008-11#1)(2011-2#1)
in various pathological conditions##2##4##(1992-2#1)(2012-2#1)
in various pathological##3##3##(1992-2#1)(2009-3#1)(2012-2#1)
in various pharmaceutical preparations##3##4##(2008-10#3)
in various plant species##2##4##(2008-10#2)
in various plant##4##3##(1995-6#1)(2008-10#3)
in various proportions##2##3##(2007-12#1)(2008-10#1)
in various real samples##2##4##(2008-10#2)
in various saline media##2##4##(2008-10#2)
in various samples after adsorption of its##2##7##(2008-10#2)
in various samples##5##3##(2008-10#5)
in various signaling pathways##2##4##(2009-8#1)(2012-2#1)
in various stages of##4##4##(1997-8#1)(2008-3#1)(2008-8#1)(2012-3#1)
in various standard alloys and##2##5##(2008-10#2)
in various standard##3##3##(2008-10#3)
in various tissues##8##3##(1992-12#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#1)(2012-2#1)
in various types of##6##4##(1992-8#1)(1993-3#1)(2008-10#1)(2008-11#1)(2011-2#2)
in various ways##3##3##(2008-11#1)(2008-7#1)(2012-3#1)
in various##173##2##(1990-12#1)(1990-2#2)(1990-5#2)(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-8#3)(2006-6#1)(2007-12#1)(2008-10#61)(2008-11#8)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#12)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#11)(2012-3#6)(2013-1#1)(2013-7#1)
in varying degrees##3##3##(1993-1#1)(1993-11#1)(1994-12#1)
in varying##4##2##(1993-1#1)(1993-11#1)(1994-12#1)(2008-4#1)
in vascular smooth muscle cells and fibroblasts##2##7##(1990-2#2)
in vascular smooth muscle cells from##2##6##(1990-2#1)(1995-11#1)
in vascular smooth muscle cells##5##5##(1990-2#3)(1994-11#1)(1995-11#1)
in vascular##21##2##(1990-2#3)(1990-9#1)(1991-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-3#2)(2012-4#1)(2013-8#1)
in vector##3##2##(2008-10#3)
in vegetable oils by##2##4##(2008-10#2)
in vegetable##7##2##(2008-10#7)
in vegetables by##2##3##(2008-10#2)
in vegetables is##2##3##(2008-10#2)
in vegetables##10##2##(2008-10#10)
in vegetative compatibility##2##3##(2008-10#2)
in vegetative##5##2##(2008-10#3)(2012-8#1)(2013-8#1)
in venous##6##2##(1996-3#2)(2008-7#1)(2009-7#1)(2009-8#1)(2013-1#1)
in ventilation##2##2##(1992-12#1)(1996-2#1)
in ventilator##2##2##(2010-7#1)(2011-2#1)
in ventral##4##2##(1993-6#1)(1994-12#1)(2008-6#2)
in vertebral##3##2##(1992-6#1)(2007-8#1)(2008-11#1)
in vertebrate evolution##2##3##(2008-8#1)(2011-2#1)
in vertebrate skeletal muscle##2##4##(1993-9#1)(2008-6#1)
in vertebrate##10##2##(1990-8#1)(1992-12#1)(1993-9#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
in vertebrates##9##2##(1993-2#1)(1995-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-4#1)(2012-3#1)
in very acid##2##3##(2008-10#2)
in very good agreement with the##2##6##(2008-9#1)(2011-2#1)
in very low##5##3##(1995-8#2)(1997-4#1)(2008-10#1)(2008-8#1)
in very old age##3##4##(2008-7#3)
in very small##2##3##(2008-10#1)(2008-9#1)
in very young##2##3##(2008-11#1)(2008-9#1)
in very##26##2##(1995-8#2)(1997-4#1)(1997-5#1)(2008-10#9)(2008-11#1)(2008-7#4)(2008-8#2)(2008-9#3)(2010-12#1)(2011-2#2)
in vesicle transport and##2##4##(1993-9#1)(2008-11#1)
in vesicle##5##2##(1993-9#1)(1997-1#1)(2008-11#2)(2009-8#1)
in vesicles##2##2##(1991-5#1)(2008-10#1)
in vesicular##2##2##(1995-2#1)(2009-7#1)
in vessel##2##2##(2009-8#1)(2010-9#1)
in vessels##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
in veterinary practice##2##3##(1996-11#1)(1996-8#1)
in veterinary##8##2##(1990-9#1)(1996-11#1)(1996-8#1)(1997-7#2)(2008-10#1)(2010-1#1)(2012-3#1)
in viability##5##2##(2008-10#1)(2008-11#2)(2009-4#1)(2012-3#1)
in viable cell number##3##4##(2008-11#3)
in viable##5##2##(2008-10#1)(2008-11#3)(2008-7#1)
in view of its##2##4##(1990-12#1)(2008-11#1)
in view of realizing the amperometric ion-selective electrode##2##8##(2008-10#2)
in view of the##15##4##(1992-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1997-3#1)(2008-10#7)(2008-7#1)(2009-8#1)(2013-1#1)
in view of##26##3##(1990-12#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1997-3#1)(2008-10#11)(2008-11#4)(2008-7#2)(2009-8#1)(2012-2#1)(2013-1#1)
in view##30##2##(1990-12#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1997-3#1)(2008-10#14)(2008-11#4)(2008-7#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
in vinegar##3##2##(2008-10#3)
in vineyards##4##2##(2008-10#4)
in violent##2##2##(1994-12#1)(2008-12#1)
in viral##6##2##(1994-11#1)(1997-3#1)(2008-10#2)(2011-2#1)(2011-3#1)
in virtual##2##2##(2009-3#1)(2012-3#1)
in virtually all##3##3##(1992-3#1)(1996-12#1)(2008-10#1)
in virtually##4##2##(1992-3#1)(1996-12#2)(2008-10#1)
in virulence and##5##3##(2008-10#5)
in virulence of##3##3##(2008-10#3)
in virulence##22##2##(1995-2#1)(2008-10#21)
in virus##7##2##(2008-10#4)(2008-11#2)(2013-1#1)
in visibly##2##2##(2008-10#2)
in vision##2##2##(2008-8#1)(2013-7#1)
in visual acuity##2##3##(2008-7#1)(2011-2#1)
in visual cortex##3##3##(2008-8#2)(2008-9#1)
in visual##13##2##(1996-2#1)(1997-4#1)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#3)(2012-3#1)
in vital capacity##2##3##(2012-2#1)(2012-3#1)
in vital##3##2##(1996-1#1)(2012-2#1)(2012-3#1)
in vitamin##7##2##(1990-11#1)(1994-5#1)(2008-10#4)(2011-1#1)
in vitiligo was##2##3##(2013-1#2)
in vitro AAA##2##3##(2009-7#2)
in vitro DNA##2##3##(1996-2#1)(2008-9#1)
in vitro RNA##3##3##(2008-10#1)(2008-7#2)
in vitro activation##2##3##(2008-9#2)
in vitro activities##2##3##(2011-3#1)(2012-2#1)
in vitro activity##5##3##(1993-1#2)(1997-1#1)(2008-11#1)(2011-2#1)
in vitro after##2##3##(2008-10#1)(2008-11#1)
in vitro agar##2##3##(1995-2#1)(2008-10#1)
in vitro allergy reaction evaluation system using##2##7##(2008-11#2)
in vitro allergy reaction evaluation system##3##6##(2008-11#3)
in vitro and ex vivo effects of##2##7##(2008-10#1)(2008-11#1)
in vitro and ex vivo##5##5##(2008-10#1)(2008-11#4)
in vitro and in planta##4##5##(2008-10#3)(2009-12#1)
in vitro and in situ##3##5##(1996-12#1)(2008-10#2)
in vitro and in the rhizosphere##2##6##(2008-10#2)
in vitro and in the##4##5##(2008-10#2)(2008-11#2)
in vitro and in vivo activities##2##6##(1990-2#1)(1992-6#1)
in vitro and in vivo assays##2##6##(2008-10#2)
in vitro and in vivo by##2##6##(2008-10#1)(2008-11#1)
in vitro and in vivo determinations##2##6##(2008-5#2)
in vitro and in vivo evidence supporting##2##7##(2008-5#1)(2011-2#1)
in vitro and in vivo studies##2##6##(1996-12#1)(2011-2#1)
in vitro and in vivo study##3##6##(1993-1#2)(2013-1#1)
in vitro and in vivo##61##5##(1990-2#1)(1991-2#1)(1992-6#1)(1993-1#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#2)(2010-11#2)(2011-1#1)(2011-2#3)(2013-1#5)(2013-8#1)
in vitro and in##77##4##(1990-2#1)(1991-2#1)(1992-6#1)(1993-1#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#7)(2008-4#1)(2008-5#9)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#3)(2010-11#3)(2011-1#1)(2011-2#3)(2013-1#5)(2013-8#1)
in vitro and on the##2##5##(2008-10#1)(2008-5#1)
in vitro and on##5##4##(2008-10#3)(2008-5#2)
in vitro and that##2##4##(1994-5#1)(2008-10#1)
in vitro and##120##3##(1990-2#1)(1990-5#2)(1991-2#1)(1992-6#3)(1993-1#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#4)(1996-2#1)(1996-8#1)(1997-8#1)(2006-6#3)(2008-1#1)(2008-10#28)(2008-11#13)(2008-4#2)(2008-5#12)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#3)(2009-4#2)(2010-11#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#7)(2013-8#1)
in vitro antibody production##2##4##(2008-4#2)
in vitro antifungal activity##2##4##(2008-10#1)(2008-5#1)
in vitro antifungal##3##3##(2008-10#1)(2008-5#2)
in vitro antimicrobial activity of the##2##6##(2008-11#1)(2012-3#1)
in vitro antimicrobial##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
in vitro antioxidant activity and##2##5##(2008-10#1)(2008-5#1)
in vitro approaches##2##3##(2008-11#1)(2008-5#1)
in vitro are##2##3##(1997-6#2)
in vitro as well as##2##5##(1992-9#1)(2009-5#1)
in vitro as##4##3##(1992-9#1)(1995-2#1)(2008-3#1)(2009-5#1)
in vitro assay##5##3##(1994-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
in vitro assays##12##3##(1995-2#1)(2008-10#7)(2008-4#1)(2008-9#1)(2010-4#1)(2013-1#1)
in vitro assessment##2##3##(2008-11#1)(2008-5#1)
in vitro based on the##2##5##(1997-6#1)(2013-8#1)
in vitro between##2##3##(2008-10#1)(2008-9#1)
in vitro binding assay##2##4##(1995-6#1)(2008-9#1)
in vitro binding##5##3##(1995-6#1)(2008-10#1)(2008-9#1)(2010-5#2)
in vitro biological activity##3##4##(1993-8#1)(2008-8#2)
in vitro both##2##3##(1992-12#1)(1995-12#1)
in vitro by using##2##4##(1991-3#1)(1997-7#1)
in vitro by##20##3##(1990-11#1)(1991-3#1)(1991-9#2)(1992-12#1)(1993-8#2)(1994-8#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2011-3#1)
in vitro cell##2##3##(2008-11#1)(2008-9#1)
in vitro cellular##2##3##(1990-3#1)(2008-11#1)
in vitro coculture system##2##4##(2008-11#2)
in vitro comparison##2##3##(2008-5#1)(2009-4#1)
in vitro conditions##3##3##(1993-2#1)(2008-11#1)(2008-5#1)
in vitro crosses##2##3##(2008-10#2)
in vitro culture##5##3##(2006-6#1)(2008-11#2)(2009-6#1)(2013-1#1)
in vitro cultured##3##3##(2008-10#1)(2008-11#2)
in vitro data##2##3##(1991-12#1)(2009-6#1)
in vitro development of##3##4##(1996-2#1)(2008-11#2)
in vitro development##5##3##(1996-2#2)(2008-11#2)(2009-12#1)
in vitro differentiation of##4##4##(1995-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
in vitro differentiation##5##3##(1995-6#1)(2008-11#1)(2008-8#1)(2008-9#2)
in vitro dissolution##2##3##(2012-2#2)
in vitro effects##2##3##(1997-1#1)(2008-10#1)
in vitro efficacy##2##3##(2008-5#2)
in vitro embryos##2##3##(2009-12#2)
in vitro evaluation of##2##4##(2008-11#1)(2008-9#1)
in vitro experimental##3##3##(2008-5#2)(2012-3#1)
in vitro experiments##6##3##(1993-12#1)(1994-5#1)(2008-10#3)(2008-5#1)
in vitro exposure of##2##4##(2013-1#2)
in vitro fertilization##9##3##(1993-1#1)(1994-9#1)(1995-6#1)(1996-9#1)(1997-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
in vitro for the##2##4##(1997-3#1)(2008-10#1)
in vitro for##10##3##(1991-2#1)(1993-8#1)(1995-11#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#2)
in vitro from##6##3##(1994-11#1)(2008-11#3)(2009-12#1)(2011-2#1)
in vitro growth of##2##4##(1993-8#1)(2008-10#1)
in vitro growth##4##3##(1993-8#1)(2008-10#3)
in vitro human##2##3##(2008-4#1)(2008-7#1)
in vitro immunization method##2##4##(2008-11#2)
in vitro immunization##11##3##(2008-11#11)
in vitro immunized PBMC##2##4##(2008-11#2)
in vitro immunized##4##3##(2008-11#4)
in vitro in the##2##4##(2008-5#1)(2012-2#1)
in vitro in##16##3##(1991-2#1)(1992-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-2#2)
in vitro infection of##2##4##(1996-12#1)(2008-9#1)
in vitro inhibition##2##3##(2008-10#1)(2009-12#1)
in vitro invasion##3##3##(2008-11#2)(2008-8#1)
in vitro is##2##3##(2008-2#1)(2008-8#1)
in vitro matured##2##3##(2008-11#1)(2013-1#1)
in vitro metabolism of NNK##2##5##(1990-6#1)(1993-11#1)
in vitro method##2##3##(1994-12#1)(2008-5#1)
in vitro methods are##2##4##(2008-10#1)(2008-4#1)
in vitro methods were##2##4##(2008-10#1)(2008-5#1)
in vitro methods##10##3##(1995-11#1)(2008-10#5)(2008-4#1)(2008-5#3)
in vitro micronucleus assay##2##4##(2011-1#2)
in vitro model for##2##4##(2008-11#2)
in vitro model of reconstructed##2##5##(2008-5#2)
in vitro model of##4##4##(2008-10#2)(2008-5#2)
in vitro model##23##3##(1994-8#1)(1995-8#1)(1995-9#1)(1997-6#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#7)
in vitro models##8##3##(1992-12#1)(2008-11#1)(2008-5#4)(2008-7#2)
in vitro mycelial growth##2##4##(2008-10#2)
in vitro of##5##3##(1994-5#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#1)
in vitro on##7##3##(1990-5#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
in vitro or in vivo##2##5##(1992-6#1)(2008-11#1)
in vitro or in##3##4##(1992-6#1)(1997-7#1)(2008-11#1)
in vitro permeation##2##3##(2008-10#1)(2008-5#1)
in vitro phosphorylation of the##2##5##(1995-6#1)(1997-2#1)
in vitro phosphorylation of##4##4##(1995-6#1)(1997-2#3)
in vitro phosphorylation##6##3##(1993-8#1)(1995-6#1)(1997-2#4)
in vitro procedure##2##3##(2008-10#1)(2008-11#1)
in vitro production of##3##4##(1994-8#1)(2008-11#2)
in vitro proliferation of##2##4##(2008-11#2)
in vitro proliferation##3##3##(2008-11#3)
in vitro protein##2##3##(1995-11#1)(2011-2#1)
in vitro reconstitution##2##3##(2008-4#1)(2009-9#1)
in vitro refolding of##2##4##(1995-8#1)(2009-3#1)
in vitro resistance to##2##4##(2008-5#1)(2011-2#1)
in vitro selection using##2##4##(2008-4#2)
in vitro selection##10##3##(1990-8#1)(1997-6#1)(2008-11#1)(2008-4#5)(2010-5#1)(2013-8#1)
in vitro studies of##2##4##(2008-10#1)(2008-11#1)
in vitro studies##17##3##(1992-9#1)(1994-8#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-5#1)(2009-1#1)(2009-12#1)(2013-1#1)
in vitro study##11##3##(1994-6#1)(2008-11#1)(2011-2#2)(2013-1#6)(2013-8#1)
in vitro susceptibility##2##3##(2008-5#1)(2011-2#1)
in vitro system to##4##4##(1993-3#1)(1994-6#1)(2008-11#1)(2013-8#1)
in vitro system##17##3##(1990-2#1)(1990-5#1)(1993-3#1)(1994-6#1)(1995-11#3)(1996-12#2)(2008-10#2)(2008-11#4)(2008-8#1)(2013-8#1)
in vitro systems for##2##4##(2008-10#1)(2008-11#1)
in vitro systems##7##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-12#1)(2009-3#1)
in vitro techniques##2##3##(1997-7#1)(2008-5#1)
in vitro test systems##2##4##(1991-12#1)(2008-10#1)
in vitro test##4##3##(1991-12#1)(2008-10#1)(2008-5#2)
in vitro tested##2##3##(1991-3#1)(2008-10#1)
in vitro testing##4##3##(1994-2#1)(2008-5#1)(2008-8#1)(2009-7#1)
in vitro tests##4##3##(2008-10#2)(2008-5#1)(2009-7#1)
in vitro to##7##3##(1990-8#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
in vitro transcription of##2##4##(1990-12#1)(2008-9#1)
in vitro transcription##9##3##(1990-12#1)(1990-5#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
in vitro transcripts of##3##4##(2008-10#3)
in vitro transcripts##8##3##(2008-10#7)(2008-9#1)
in vitro translation of##3##4##(1995-2#1)(1995-6#1)(1997-3#1)
in vitro translation##8##3##(1995-2#1)(1995-6#1)(1997-3#2)(2008-1#2)(2008-10#2)
in vitro transport##2##3##(2008-11#1)(2008-4#1)
in vitro treatment##2##3##(1990-2#1)(2009-8#1)
in vitro using a##2##4##(1991-10#1)(2008-5#1)
in vitro using##7##3##(1990-11#1)(1991-10#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
in vitro was studied##2##4##(2010-3#1)(2011-3#1)
in vitro was##3##3##(1997-1#1)(2010-3#1)(2011-3#1)
in vitro were investigated##2##4##(1993-3#1)(2008-8#1)
in vitro were reduced##2##4##(2008-10#1)(2008-9#1)
in vitro were##7##3##(1993-3#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#2)
in vitro when##2##3##(1996-12#1)(1996-2#1)
in vitro with NF-kappa B##2##5##(1995-12#2)
in vitro with a##3##4##(1995-2#1)(1996-3#1)(2008-10#1)
in vitro with an##2##4##(1994-8#1)(2008-10#1)
in vitro with##15##3##(1991-2#1)(1993-8#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-3#1)
in vitro##1060##2##(1990-11#7)(1990-12#6)(1990-2#4)(1990-3#4)(1990-5#7)(1990-6#4)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#8)(1991-2#8)(1991-3#4)(1991-5#3)(1991-8#1)(1991-9#2)(1992-12#8)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#7)(1992-8#3)(1992-9#5)(1993-1#7)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#18)(1993-9#3)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#10)(1994-6#2)(1994-8#19)(1994-9#1)(1995-11#15)(1995-12#12)(1995-2#17)(1995-3#2)(1995-6#15)(1995-8#7)(1995-9#3)(1996-12#12)(1996-2#14)(1996-3#1)(1996-5#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#9)(1997-4#6)(1997-6#8)(1997-7#12)(1997-8#6)(2006-6#7)(2008-1#9)(2008-10#185)(2008-11#142)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#24)(2008-5#83)(2008-6#2)(2008-7#22)(2008-8#23)(2008-9#40)(2009-1#1)(2009-10#4)(2009-12#20)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#6)(2009-7#6)(2009-8#5)(2009-9#1)(2010-1#3)(2010-11#8)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#3)(2010-8#1)(2011-1#5)(2011-2#24)(2011-3#8)(2012-2#18)(2012-3#4)(2012-5#1)(2013-1#38)(2013-8#7)
in vitro)##2##2##(2008-10#1)(2008-11#1)
in vitro]##3##2##(2011-3#1)(2012-3#1)(2013-1#1)
in vivo SPF values##3##4##(2008-5#3)
in vivo activity##5##3##(1992-6#1)(1993-1#1)(2008-7#3)
in vivo after##3##3##(1991-8#1)(2008-5#1)(2008-9#1)
in vivo analysis##2##3##(2008-10#1)(2009-12#1)
in vivo and in vitro studies##3##6##(1994-8#1)(1995-9#1)(2009-1#1)
in vivo and in vitro##39##5##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-5#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#3)(2011-2#1)
in vivo and in##40##4##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-5#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#3)(2011-2#1)
in vivo and the##2##4##(2008-10#2)
in vivo and their##2##4##(2008-7#1)(2013-1#1)
in vivo and##56##3##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-8#4)(1995-11#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(2006-6#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#3)(2011-2#1)(2013-1#1)
in vivo are##2##3##(2008-11#1)(2008-7#1)
in vivo assay##2##3##(2008-4#1)(2008-5#1)
in vivo assays are##2##4##(2008-10#2)
in vivo assays##7##3##(2008-10#6)(2011-2#1)
in vivo at##2##3##(1993-9#1)(1995-6#1)
in vivo behavior##2##3##(1990-8#2)
in vivo by##7##3##(1994-8#1)(1995-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#1)
in vivo conditions##3##3##(2008-5#1)(2009-3#1)(2010-6#1)
in vivo cytokine capture assay##2##5##(2008-4#2)
in vivo cytokine production##3##4##(2008-4#3)
in vivo cytokine secretion##2##4##(2008-4#2)
in vivo cytokine##7##3##(2008-4#7)
in vivo delivery##2##3##(1995-2#1)(2008-8#1)
in vivo detection##2##3##(1994-8#1)(2008-10#1)
in vivo determination of##2##4##(2008-10#2)
in vivo efficacy##2##3##(2008-10#1)(2012-2#1)
in vivo evidence that##3##4##(1994-11#1)(2008-10#1)(2008-11#1)
in vivo evidence##6##3##(1992-10#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
in vivo experiments##4##3##(1993-8#1)(1994-5#1)(2008-5#2)
in vivo for##7##3##(1991-2#1)(1993-12#1)(1995-11#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-7#1)
in vivo function of##4##4##(1996-2#1)(2008-11#1)(2008-9#1)(2012-2#1)
in vivo half-lives##2##3##(2008-4#1)(2013-1#1)
in vivo have##2##3##(1995-9#1)(2010-11#1)
in vivo human##2##3##(2008-5#1)(2013-1#1)
in vivo in mice##2##4##(1990-6#2)
in vivo in##10##3##(1990-6#2)(1992-10#1)(1996-2#1)(1997-7#2)(1997-8#1)(2006-6#1)(2008-10#1)(2010-12#1)
in vivo is not##2##4##(1997-7#1)(2008-7#1)
in vivo is##9##3##(1992-10#1)(1994-11#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)
in vivo kinetics of the##2##5##(1992-12#1)(2010-6#1)
in vivo methods##4##3##(2008-10#3)(2008-5#1)
in vivo microdialysis##4##3##(1994-8#1)(1997-2#1)(2008-10#2)
in vivo models##2##3##(2011-1#1)(2013-1#1)
in vivo monitoring of diffusible##2##5##(2008-10#2)
in vivo on##2##3##(1990-2#1)(2008-5#1)
in vivo or in vitro##3##5##(1995-2#1)(1996-12#1)(2008-11#1)
in vivo or in##4##4##(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#1)
in vivo or##5##3##(1992-11#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#1)
in vivo recombination##2##3##(2008-11#2)
in vivo studies of##2##4##(1996-12#1)(2010-7#1)
in vivo studies##9##3##(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2010-7#1)(2011-2#1)
in vivo study##7##3##(1990-5#1)(1993-1#2)(2008-5#2)(2010-5#1)(2013-1#1)
in vivo system##4##3##(1995-2#1)(1996-12#2)(2008-11#1)
in vivo testing##2##3##(2008-10#1)(2008-5#1)
in vivo tests##4##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)
in vivo the##3##3##(1994-11#1)(2006-6#1)(2008-5#1)
in vivo to##5##3##(1990-5#1)(1995-2#1)(1996-12#1)(2008-11#1)(2011-2#1)
in vivo transfection##2##3##(1995-2#2)
in vivo treatment##2##3##(1997-1#1)(2009-9#1)
in vivo using##7##3##(1993-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(2010-6#1)(2012-2#1)(2013-1#1)
in vivo was##2##3##(1995-12#1)(2008-9#1)
in vivo were##2##3##(2008-9#1)(2010-8#1)
in vivo with##5##3##(1992-9#1)(1993-9#1)(1995-11#1)(1995-6#1)(2008-8#1)
in vivo##563##2##(1990-11#6)(1990-2#2)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#5)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#3)(1992-12#6)(1992-6#7)(1992-8#1)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#10)(1993-9#4)(1994-11#8)(1994-2#3)(1994-3#3)(1994-5#8)(1994-6#1)(1994-8#8)(1995-10#1)(1995-11#14)(1995-12#7)(1995-2#18)(1995-3#1)(1995-6#9)(1995-9#3)(1996-12#10)(1996-2#9)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#6)(1997-8#4)(2006-6#7)(2007-11#1)(2008-1#3)(2008-10#58)(2008-11#50)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#18)(2008-5#54)(2008-6#1)(2008-7#24)(2008-8#6)(2008-9#23)(2009-1#1)(2009-10#1)(2009-12#13)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#3)(2010-1#5)(2010-11#7)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#17)(2011-3#1)(2011-7#2)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#18)(2013-8#3)
in vocational##2##2##(2008-11#1)(2010-1#1)
in vol##13##2##(2008-11#3)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
in voltammetric##4##2##(2008-10#4)
in voltammetry##3##2##(2008-10#3)
in volume##6##2##(1992-12#1)(2008-2#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
in volumetric##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
in volunteer administration##2##3##(1992-1#1)(1994-3#1)
in volunteer##6##2##(1992-1#1)(1994-3#1)(1996-3#2)(2008-10#2)
in walking##4##2##(2007-12#1)(2008-7#3)
in wall thickness##2##3##(2009-1#1)(2011-2#1)
in walls of##2##3##(2008-10#2)
in warm##2##2##(2008-10#2)
in warmer locations##2##3##(2008-10#2)
in washing powder##2##3##(2008-10#2)
in washing##3##2##(2008-10#3)
in waste water and##3##4##(2008-10#3)
in waste water##8##3##(2008-10#8)
in waste waters##2##3##(2008-10#2)
in waste##12##2##(2008-10#12)
in waste-water##3##2##(2008-10#3)
in wastewater by##2##3##(2008-10#2)
in wastewater effluents##2##3##(2008-10#2)
in wastewater from an##2##4##(2008-10#2)
in wastewater from##4##3##(2008-10#4)
in wastewater samples##5##3##(2008-10#5)
in wastewater treatment##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
in wastewater with##2##3##(2008-10#2)
in wastewater##28##2##(2008-10#26)(2008-7#1)(2009-4#1)
in wastewaters##3##2##(2008-10#3)
in water (w) were determined potentiometrically at 25 degrees C##2##10##(2008-10#2)
in water after preconcentration##2##4##(2008-10#2)
in water after##5##3##(2008-10#5)
in water analysis##4##3##(2008-10#4)
in water and air by##2##5##(2008-10#2)
in water and air##5##4##(2008-10#4)(2008-3#1)
in water and biological samples by graphite furnace atomic##2##9##(2008-10#2)
in water and fruit juice##3##5##(2008-10#3)
in water and in##6##4##(1992-12#1)(2008-10#3)(2008-3#1)(2011-2#1)
in water and sediment##2##4##(2008-10#2)
in water and sewage samples##2##5##(2008-10#2)
in water and the##2##4##(2008-10#2)
in water and vegetable samples##2##5##(2008-10#2)
in water and##44##3##(1992-12#1)(2008-10#39)(2008-3#3)(2011-2#1)
in water are##2##3##(2008-10#2)
in water as##4##3##(1991-6#1)(2008-10#3)
in water at##3##3##(1992-9#1)(2008-10#2)
in water by ICP-AES##3##4##(2008-10#3)
in water by##14##3##(2008-10#14)
in water can be##2##4##(2008-10#2)
in water containing##2##3##(2008-10#2)
in water for the##2##4##(2008-10#2)
in water has been developed##2##5##(2008-10#2)
in water has been##4##4##(2008-10#4)
in water is##3##3##(2008-10#3)
in water of##3##3##(2008-10#3)
in water or in##2##4##(2008-10#2)
in water samples after cloud point extraction##2##7##(2008-10#2)
in water samples after##4##4##(2008-10#4)
in water samples and##4##4##(2008-10#4)
in water samples by flame##2##5##(2008-10#2)
in water samples by using a##2##6##(2008-10#2)
in water samples by using##3##5##(2008-10#3)
in water samples by##16##4##(2008-10#16)
in water samples digested##2##4##(2008-10#2)
in water samples in##2##4##(2008-10#2)
in water samples is described##3##5##(2008-10#3)
in water samples is##7##4##(2008-10#7)
in water samples on##2##4##(2008-10#2)
in water samples using##6##4##(2008-10#6)
in water samples was developed##3##5##(2008-10#3)
in water samples was performed##2##5##(2008-10#2)
in water samples was##8##4##(2008-10#8)
in water samples were##2##4##(2008-10#2)
in water samples with a##4##5##(2008-10#4)
in water samples with satisfactory results##4##6##(2008-10#4)
in water samples with##8##4##(2008-10#8)
in water samples##122##3##(2008-10#121)(2012-2#1)
in water solution##5##3##(1991-5#1)(1995-2#1)(2008-10#2)(2008-3#1)
in water solutions##3##3##(2008-10#3)
in water striders##2##3##(2008-9#1)(2012-3#1)
in water using##6##3##(2008-10#5)(2008-3#1)
in water was##4##3##(2008-10#3)(2012-2#1)
in water were##5##3##(2008-10#5)
in water with##6##3##(2008-10#5)(2008-5#1)
in water without##2##3##(2008-10#2)
in water##353##2##(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#313)(2008-11#2)(2008-3#7)(2008-5#5)(2008-9#4)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#2)(2013-1#1)
in water-organic solvent mixtures##2##4##(2008-10#2)
in water-soluble organic##2##3##(2008-10#2)
in water-soluble##3##2##(2008-10#3)
in watermelon##2##2##(2008-10#2)
in waters after##2##3##(2008-10#2)
in waters and##3##3##(2008-10#3)
in waters by##7##3##(2008-10#7)
in waters of the Okavango Delta##2##6##(2008-10#2)
in waters using a##2##4##(2008-10#2)
in waters using##4##3##(2008-10#4)
in waters with##3##3##(2008-10#2)(2010-8#1)
in waters##32##2##(2008-10#31)(2010-8#1)
in wavelength##4##2##(2008-10#1)(2008-3#3)
in ways that are##2##4##(1995-5#1)(2012-2#1)
in ways that cannot be##2##5##(2013-1#2)
in ways that##10##3##(1995-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#3)
in ways##11##2##(1995-5#1)(2008-10#1)(2008-12#2)(2008-9#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#3)
in weak##5##2##(2008-10#5)
in weaned##2##2##(1996-12#2)
in weed habitats##2##3##(2008-10#2)
in weed hosts##2##3##(2008-10#2)
in weed##4##2##(2008-10#4)
in weeds##2##2##(2008-10#2)
in weight management##2##3##(2008-10#1)(2012-2#1)
in weight##11##2##(1990-11#1)(1991-2#3)(1992-12#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
in west##3##2##(2008-10#2)(2009-6#1)
in western Canada##2##3##(1994-3#1)(2008-10#1)
in western North America##2##4##(2008-10#2)
in western countries##2##3##(1990-3#1)(1992-9#1)
in western white pine (Pinus monticola)##3##6##(2008-10#3)
in western white pine##4##4##(2008-10#4)
in western##25##2##(1990-3#1)(1992-9#1)(1994-3#1)(1996-11#1)(1996-8#1)(2008-10#17)(2008-11#1)(2008-5#1)(2013-1#1)
in what is##4##3##(1997-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
in what##9##2##(1994-3#1)(1997-1#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)
in wheat (Triticum aestivum L##2##5##(2008-11#1)(2008-12#1)
in wheat and##3##3##(2008-10#3)
in wheat breeding programs##2##4##(2008-10#2)
in wheat flour by electrothermal atomic absorption spectrometry##2##8##(2008-10#2)
in wheat flour##7##3##(2008-10#7)
in wheat##44##2##(2008-10#37)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#1)(2011-10#1)
in which HIV##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
in which I##3##3##(1995-2#1)(2008-11#1)(2013-8#1)
in which a chemical##3##4##(2008-5#3)
in which a product##2##4##(1991-9#1)(2008-5#1)
in which a radical serves as a hydrogen bond##2##9##(2010-7#2)
in which a subject##2##4##(2010-8#1)(2012-3#1)
in which a##50##3##(1990-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1993-12#1)(1993-3#1)(1997-3#1)(2008-10#8)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-6#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
in which all the##2##4##(2008-10#1)(2008-11#1)
in which all##8##3##(2008-10#3)(2008-11#1)(2008-8#2)(2010-2#1)(2010-5#1)
in which an##16##3##(1990-8#1)(1991-12#1)(1993-12#1)(1996-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#2)(2011-8#1)(2013-1#1)
in which both the##3##4##(1995-6#1)(2008-10#2)
in which both##11##3##(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#5)(2008-8#1)(2011-2#1)(2012-2#1)
in which case##3##3##(1991-6#1)(2008-10#2)
in which changes##2##3##(1994-3#1)(2008-11#1)
in which chloride##2##3##(1994-5#1)(2008-10#1)
in which data##2##3##(2009-11#1)(2012-12#1)
in which different##4##3##(1997-7#1)(2008-8#2)(2011-2#1)
in which direct##2##3##(1994-5#1)(2008-10#1)
in which disease##2##3##(2008-10#1)(2008-9#1)
in which each##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)
in which either##2##3##(2008-8#2)
in which experimental##2##3##(2008-3#1)(2008-7#1)
in which females##2##3##(2008-8#2)
in which four##3##3##(1991-2#1)(1991-7#1)(2008-7#1)
in which human##2##3##(2008-4#1)(2008-5#1)
in which in-line##2##3##(2008-10#2)
in which individuals##2##3##(2008-9#1)(2009-8#1)
in which insurers##2##3##(1994-12#1)(1995-6#1)
in which it##4##3##(2008-11#1)(2008-4#2)(2012-3#1)
in which medicine##2##3##(2008-12#1)(2013-8#1)
in which molecular##3##3##(1994-5#1)(2008-10#1)(2012-12#1)
in which more than##3##4##(2008-10#1)(2011-2#1)(2011-3#1)
in which more##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)
in which no##2##3##(2008-10#2)
in which one##5##3##(1991-9#1)(1996-3#1)(2008-10#2)(2008-4#1)
in which only a##2##4##(2008-10#1)(2008-3#1)
in which only##3##3##(2008-10#2)(2008-3#1)
in which participants##4##3##(2008-11#1)(2008-4#1)(2008-6#1)(2009-10#1)
in which patients##2##3##(2008-11#1)(2012-3#1)
in which random##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
in which residues##2##3##(1994-5#1)(2008-10#1)
in which respondents##2##3##(2009-12#1)(2012-2#1)
in which root tissue included the soluble components##2##8##(2008-10#2)
in which several##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
in which significant##2##3##(2008-10#1)(2010-12#1)
in which some##2##3##(2008-8#1)(2009-10#1)
in which strong##2##3##(2008-10#1)(2008-8#1)
in which students##3##3##(1996-1#1)(2008-11#2)
in which the alternative##2##4##(1995-12#1)(2009-8#1)
in which the analyte##2##4##(2008-10#2)
in which the animals##2##4##(1994-3#1)(2008-8#1)
in which the enzyme##2##4##(1993-8#1)(2008-10#1)
in which the first##2##4##(2008-10#1)(2013-1#1)
in which the host##3##4##(2008-11#1)(2008-8#2)
in which the level of##3##5##(1990-12#1)(1996-3#1)(2008-10#1)
in which the maximum##2##4##(1993-8#1)(2008-10#1)
in which the microscopic##2##4##(2008-11#1)(2008-5#1)
in which the nuclear envelope##2##5##(2011-2#2)
in which the objective is##2##5##(2008-10#2)
in which the only##2##4##(1994-12#1)(2008-10#1)
in which the pathogen##2##4##(2008-10#2)
in which the patient##2##4##(1991-1#1)(2011-2#1)
in which the presence##2##4##(2008-5#1)(2008-8#1)
in which the research##2##4##(1992-1#2)
in which the sample##3##4##(1992-12#1)(2008-10#2)
in which the second##2##4##(1995-6#1)(2009-4#1)
in which the three##2##4##(2008-10#2)
in which the two##2##4##(2008-9#1)(2013-1#1)
in which the##235##3##(1990-12#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#3)(1991-9#3)(1992-1#4)(1992-10#2)(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#64)(2008-11#15)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#12)(2008-9#5)(2009-1#1)(2009-10#3)(2009-4#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#2)(2010-6#1)(2010-7#5)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#3)
in which their##2##3##(2008-8#1)(2011-2#1)
in which there is##5##4##(1990-3#1)(1997-3#1)(2008-8#1)(2009-8#1)(2012-12#1)
in which there##6##3##(1990-3#1)(1997-3#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)
in which these##4##3##(1990-6#1)(1993-2#1)(2008-2#1)(2010-5#1)
in which they were##5##4##(1994-3#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)
in which they will##2##4##(1996-3#2)
in which they##23##3##(1991-12#1)(1993-1#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#3)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-11#1)(2011-2#2)(2012-2#1)
in which this##3##3##(1996-8#1)(2008-10#2)
in which three##2##3##(2008-11#1)(2013-1#1)
in which to study the##3##5##(1994-8#1)(1995-2#1)(1997-3#1)
in which to study##4##4##(1994-8#1)(1995-2#1)(1997-3#1)(2008-4#1)
in which to##9##3##(1994-8#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2009-8#1)(2012-2#1)(2012-3#2)
in which two or more##2##5##(2008-10#1)(2010-12#1)
in which two##9##3##(1992-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)
in which we##10##3##(1995-9#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#2)(2010-9#1)(2012-2#1)(2012-3#1)
in which wheat##2##3##(2008-10#2)
in which##815##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#4)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#7)(1992-1#4)(1992-10#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#6)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#5)(1994-5#8)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#6)(1995-5#1)(1995-6#10)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#6)(1996-3#10)(1996-5#7)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#6)(2006-6#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-1#6)(2008-10#189)(2008-11#53)(2008-12#8)(2008-2#3)(2008-3#20)(2008-4#17)(2008-5#19)(2008-6#5)(2008-7#23)(2008-8#53)(2008-9#23)(2009-1#1)(2009-10#12)(2009-11#2)(2009-12#3)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#7)(2010-1#4)(2010-10#12)(2010-11#3)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#12)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#36)(2011-3#1)(2011-8#1)(2012-12#6)(2012-2#11)(2012-3#13)(2012-7#1)(2013-1#19)(2013-7#2)(2013-8#9)
in white and##2##3##(2008-10#2)
in white matter##2##3##(2008-6#1)(2010-12#1)
in white wine##4##3##(2008-10#4)
in white wines##2##3##(2008-10#2)
in white##12##2##(1991-3#1)(2008-10#8)(2008-6#1)(2010-12#1)(2013-8#1)
in whiteflies##4##2##(2008-10#4)
in whitefly##2##2##(2008-10#2)
in whole blood from##2##4##(2008-10#2)
in whole blood killing##2##4##(1996-12#2)
in whole blood samples##2##4##(2008-10#2)
in whole blood##23##3##(1991-2#1)(1993-2#1)(1996-12#2)(2006-6#4)(2008-10#13)(2008-9#1)(2013-1#1)
in whole##38##2##(1991-2#1)(1991-3#1)(1993-2#1)(1996-12#2)(2006-6#4)(2008-10#21)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#3)(2010-7#1)(2013-1#1)
in whom a benign##2##4##(1990-3#1)(1991-2#1)
in whom a##6##3##(1990-3#1)(1991-2#1)(1993-2#1)(2008-1#1)(2008-7#1)(2013-1#1)
in whom it##4##3##(1990-3#1)(1991-11#1)(2008-1#1)(2010-7#1)
in whom the##9##3##(1990-12#1)(1991-11#1)(1992-3#1)(2008-10#2)(2011-2#2)(2012-12#1)(2013-1#1)
in whom##45##2##(1990-12#1)(1990-3#3)(1991-11#4)(1991-2#3)(1992-3#1)(1993-2#1)(1994-12#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#5)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-2#4)(2012-12#1)(2013-1#7)
in wide range##2##3##(2008-10#1)(2012-3#1)
in wide##3##2##(2008-10#2)(2012-3#1)
in widely##2##2##(1995-2#1)(2007-12#1)
in widespread##3##2##(1991-12#1)(1994-9#1)(2008-10#1)
in wild and##2##3##(1990-3#1)(2008-8#1)
in wild type (WT)##2##4##(2008-8#1)(2013-8#1)
in wild type##6##3##(2008-8#3)(2008-9#1)(2009-8#1)(2013-8#1)
in wild##19##2##(1990-3#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#8)(2008-9#1)(2009-8#1)(2013-1#1)(2013-8#1)
in wild-type##7##2##(1990-5#1)(1995-9#1)(2008-10#2)(2008-9#1)(2009-8#1)(2012-3#1)
in wilt symptom##2##3##(2008-10#2)
in wilt##3##2##(2008-10#3)
in wind tunnel##2##3##(2008-10#1)(2009-6#1)
in wind##5##2##(2008-10#3)(2008-3#1)(2009-6#1)
in wine and cider##2##4##(2008-10#2)
in wine and##3##3##(2008-10#3)
in wine samples##5##3##(2008-10#5)
in wine using##2##3##(2008-10#2)
in wine##19##2##(2008-10#18)(2012-3#1)
in wines by##2##3##(2008-10#2)
in wines##11##2##(2008-10#11)
in winter wheat##5##3##(2008-10#5)
in winter##16##2##(2008-10#11)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)
in witches'-broom##2##2##(2008-10#2)
in women aged##2##3##(1994-2#1)(1994-9#1)
in women and##5##3##(1996-1#1)(2008-12#1)(2009-10#1)(2009-5#1)(2013-1#1)
in women in##4##3##(2008-1#1)(2008-5#1)(2012-3#1)(2013-1#1)
in women of reproductive age##2##5##(2011-1#2)
in women of##3##3##(1990-2#1)(2011-1#2)
in women over##2##3##(1990-8#1)(2012-3#1)
in women who##4##3##(1994-3#1)(1997-1#1)(2008-10#1)(2008-3#1)
in women with PCOS##3##4##(2008-4#2)(2010-11#1)
in women with breast cancer and##2##6##(1990-12#1)(2008-7#1)
in women with breast cancer##3##5##(1990-12#1)(2008-7#1)(2013-1#1)
in women with early breast cancer treated##2##7##(2011-2#2)
in women with gestational diabetes mellitus##2##6##(1992-12#2)
in women with low obstetric risk##2##6##(2013-1#2)
in women with##34##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1992-12#2)(1992-3#2)(1994-3#1)(1996-6#1)(1996-8#1)(2007-7#1)(2008-11#3)(2008-4#2)(2008-7#1)(2010-11#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#5)
in women##107##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#2)(1991-1#2)(1991-8#5)(1992-1#1)(1992-12#2)(1992-3#2)(1992-9#1)(1993-1#1)(1994-2#1)(1994-3#2)(1994-9#3)(1995-2#1)(1995-9#1)(1996-1#1)(1996-6#1)(1996-8#2)(1997-1#3)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#2)(2009-10#4)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-2#1)(2012-3#9)(2013-1#10)(2013-3#1)(2013-8#1)
in women's health##2##3##(1996-9#1)(2008-11#1)
in women's##7##2##(1996-9#1)(2008-1#1)(2008-11#4)(2011-2#1)
in women)##3##2##(1991-6#2)(2008-11#1)
in women]##2##2##(2008-12#1)(2012-3#1)
in wood##3##2##(2008-10#2)(2008-8#1)
in woody plants##2##3##(2008-10#1)(2009-8#1)
in woody##4##2##(2008-10#3)(2009-8#1)
in wool##3##2##(2008-10#3)
in work##4##2##(1994-6#1)(1997-1#1)(2008-7#1)(2012-12#1)
in workers exposed to##2##4##(2011-2#1)(2013-1#1)
in workers##9##2##(2008-8#5)(2011-2#2)(2013-1#2)
in working memory##2##3##(1994-3#1)(2013-8#1)
in working with##2##3##(1992-3#1)(1995-12#1)
in working##10##2##(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-5#2)(2011-2#1)(2013-8#1)
in workplace##3##2##(2008-10#2)(2008-9#1)
in world##2##2##(2008-10#1)(2010-8#1)
in worldwide##3##2##(2008-10#2)(2010-12#1)
in wounded##2##2##(2008-10#2)
in wounds##3##2##(2008-10#3)
in writing##4##2##(1995-12#1)(2008-12#2)(2009-9#1)
in xenograft models##3##3##(2009-4#1)(2011-2#1)(2012-2#1)
in xylem and phloem##2##4##(2012-8#2)
in xylem##6##2##(2009-8#1)(2012-5#1)(2012-8#4)
in xylene is used for the extractive separation of##2##9##(2008-10#2)
in xylene is used for##3##5##(2008-10#3)
in xylene##10##2##(2008-10#10)
in yaks##3##2##(2011-2#3)
in years##5##2##(2007-11#1)(2008-10#3)(2008-9#1)
in yeast and mammalian cells##2##5##(1997-3#2)
in yeast and##3##3##(1997-3#2)(2008-9#1)
in yeast are##2##3##(1996-3#1)(2008-7#1)
in yeast by##3##3##(1993-8#1)(1995-6#1)(2008-10#1)
in yeast cell##2##3##(2008-10#1)(2008-9#1)
in yeast cells##6##3##(1993-8#1)(1994-12#1)(2008-10#1)(2008-9#3)
in yeast is##2##3##(1993-9#1)(2008-8#1)
in yeast##49##2##(1990-12#1)(1992-10#1)(1993-2#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#3)(1997-7#3)(2008-10#8)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#2)(2012-2#1)(2012-3#2)
in yellow##2##2##(2008-10#1)(2008-12#1)
in yield and quality##2##4##(2008-10#2)
in yield##14##2##(2008-10#12)(2009-7#1)(2011-10#1)
in yields of##2##3##(1990-9#1)(1996-5#1)
in yields##6##2##(1990-9#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-11#1)(2012-12#1)
in yoghurt##2##2##(2008-10#2)
in yolk sac##2##3##(1993-12#1)(2008-9#1)
in young adults with##2##4##(1990-3#1)(2008-8#1)
in young adults##7##3##(1990-3#1)(1991-11#1)(1995-3#2)(2007-11#1)(2008-8#1)(2012-3#1)
in young and adult##3##4##(2008-7#1)(2012-3#2)
in young and by##2##4##(1990-3#1)(2008-7#1)
in young and middle-aged##2##4##(2008-7#2)
in young and old rats##2##5##(2008-7#2)
in young and older adults##2##5##(2008-11#1)(2009-10#1)
in young and##11##3##(1990-3#1)(2008-11#1)(2008-7#6)(2009-10#1)(2012-3#2)
in young animals##3##3##(2008-7#2)(2011-2#1)
in young athletes##7##3##(2010-1#3)(2012-3#4)
in young but##2##3##(1990-3#2)
in young children##9##3##(1997-1#2)(2008-1#2)(2008-4#1)(2010-6#2)(2012-2#1)(2013-8#1)
in young cirrhotics vs##4##4##(2012-3#4)
in young leaves##2##3##(2008-10#2)
in young male##3##3##(1990-6#1)(1996-8#1)(2008-7#1)
in young men##2##3##(2013-1#1)(2013-8#1)
in young patients with##4##4##(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
in young patients##6##3##(1990-3#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
in young rats##4##3##(1990-3#1)(2008-7#2)(2013-7#1)
in young subjects##2##3##(1993-1#1)(2008-7#1)
in young##97##2##(1990-3#8)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1993-1#1)(1993-12#2)(1994-11#1)(1995-3#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-9#1)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#13)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-1#3)(2010-6#2)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#15)(2013-1#5)(2013-7#2)(2013-8#3)
in younger age##2##3##(2012-3#1)(2013-1#1)
in younger dogs##2##3##(2012-3#2)
in younger patients##2##3##(2008-9#1)(2013-1#1)
in younger women##2##3##(1994-3#1)(2010-9#1)
in younger##17##2##(1994-12#1)(1994-3#1)(1997-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#2)
in your##13##2##(1993-1#3)(1994-3#2)(1995-3#1)(1996-1#1)(2008-11#2)(2009-1#1)(2011-2#2)(2012-3#1)
in youth##8##2##(2008-11#1)(2008-12#1)(2010-5#1)(2012-2#3)(2013-1#2)
in zebrafish##2##2##(1993-12#1)(2008-11#1)
in zinc##6##2##(1990-8#1)(1993-5#1)(2008-10#3)(2013-7#1)
in zones##2##2##(2008-10#1)(2011-2#1)
in zooplankton##2##2##(2008-8#1)(2010-8#1)
in zucchini squash##2##3##(2008-10#2)
in##83871##1##(1990-10#19)(1990-11#260)(1990-12#284)(1990-2#263)(1990-3#220)(1990-4#5)(1990-5#379)(1990-6#230)(1990-7#20)(1990-8#224)(1990-9#179)(1991-1#199)(1991-10#45)(1991-11#173)(1991-12#418)(1991-2#370)(1991-3#327)(1991-4#7)(1991-5#261)(1991-6#270)(1991-7#42)(1991-8#177)(1991-9#137)(1992-1#160)(1992-10#56)(1992-11#79)(1992-12#368)(1992-2#250)(1992-3#351)(1992-4#39)(1992-5#107)(1992-6#267)(1992-7#17)(1992-8#143)(1992-9#234)(1993-1#250)(1993-11#172)(1993-12#460)(1993-2#307)(1993-3#376)(1993-5#47)(1993-6#331)(1993-8#405)(1993-9#128)(1994-1#143)(1994-11#356)(1994-12#441)(1994-2#394)(1994-3#388)(1994-5#346)(1994-6#186)(1994-8#411)(1994-9#144)(1995-1#110)(1995-10#18)(1995-11#381)(1995-12#558)(1995-2#568)(1995-3#219)(1995-5#196)(1995-6#387)(1995-8#347)(1995-9#95)(1996-1#192)(1996-10#5)(1996-11#209)(1996-12#730)(1996-2#534)(1996-3#397)(1996-5#189)(1996-6#210)(1996-8#89)(1996-9#114)(1997-1#371)(1997-2#464)(1997-3#545)(1997-4#120)(1997-5#119)(1997-6#183)(1997-7#337)(1997-8#507)(1997-9#39)(2006-5#7)(2006-6#92)(2007-11#146)(2007-12#418)(2007-7#4)(2007-8#78)(2007-9#3)(2008-1#484)(2008-10#24740)(2008-11#5679)(2008-12#1797)(2008-2#298)(2008-3#1203)(2008-4#631)(2008-5#1763)(2008-6#371)(2008-7#2320)(2008-8#2188)(2008-9#2263)(2009-1#122)(2009-10#483)(2009-11#149)(2009-12#316)(2009-2#21)(2009-3#208)(2009-4#121)(2009-5#163)(2009-6#281)(2009-7#342)(2009-8#675)(2009-9#167)(2010-1#344)(2010-10#385)(2010-11#390)(2010-12#520)(2010-2#72)(2010-3#149)(2010-4#291)(2010-5#306)(2010-6#282)(2010-7#383)(2010-8#398)(2010-9#153)(2011-1#469)(2011-10#52)(2011-2#3541)(2011-3#218)(2011-4#8)(2011-5#1)(2011-7#54)(2011-8#6)(2011-9#10)(2012-12#621)(2012-2#1630)(2012-3#1669)(2012-4#23)(2012-5#54)(2012-6#17)(2012-7#42)(2012-8#33)(2012-9#18)(2013-1#2560)(2013-2#2)(2013-3#9)(2013-7#161)(2013-8#1369)
in&quot##2##1##(1997-3#1)(2008-10#1)
in- and##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
in-atomizer trapping for##2##3##(2008-10#2)
in-cell&quot##2##1##(2010-4#2)
in-center hemodialysis patients##2##3##(1996-2#2)
in-center##3##1##(1991-12#1)(1996-2#2)
in-depth case studies of##2##4##(1991-12#1)(2008-11#1)
in-depth exploration##2##2##(2009-7#1)(2013-8#1)
in-depth information##2##2##(1992-2#1)(1994-3#1)
in-depth interview##2##2##(2009-4#1)(2011-2#1)
in-depth interviews##3##2##(1997-3#1)(2013-1#2)
in-depth##18##1##(1991-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#2)
in-fiber##2##1##(2007-11#1)(2008-3#1)
in-field##2##1##(2008-10#2)
in-flight##5##1##(1990-11#1)(1991-2#1)(1996-12#1)(2008-3#2)
in-frame##2##1##(1993-12#1)(1995-8#1)
in-gel##2##1##(2008-10#1)(2008-9#1)
in-home care##3##2##(1995-3#3)
in-home hospital care##2##3##(1991-2#2)
in-home respite##2##2##(1992-3#2)
in-home##9##1##(1991-2#2)(1992-3#2)(1995-3#3)(2010-6#1)(2011-2#1)
in-hospital##7##1##(1991-12#2)(1992-6#1)(1996-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in-house resources##2##2##(2008-10#2)
in-house##22##1##(1992-2#2)(1993-2#1)(1994-1#2)(2008-10#14)(2010-3#1)(2011-2#1)(2012-12#1)
in-line complexation##3##2##(2008-10#3)
in-line dilution##2##2##(2008-10#2)
in-line gas-diffusion##2##2##(2008-10#2)
in-line preconcentration/separation##3##2##(2008-10#3)
in-line reaction column##2##3##(2008-10#2)
in-line with##2##2##(2008-1#1)(2008-10#1)
in-line##37##1##(2007-12#2)(2008-1#1)(2008-10#34)
in-patient##7##1##(1991-11#1)(1991-3#1)(1995-11#2)(2008-11#1)(2008-3#2)
in-patients##4##1##(1990-6#1)(1992-9#1)(2008-11#1)(2008-3#1)
in-person##3##1##(1994-2#1)(1997-1#1)(2008-12#1)
in-phase and opposed-phase spoiled GRE imaging##2##6##(1997-8#2)
in-phase and opposed-phase##5##3##(1997-8#5)
in-phase images##2##2##(1997-8#2)
in-phase imaging##2##2##(1997-8#2)
in-phase##13##1##(1997-8#12)(2009-3#1)
in-place ACBM##2##2##(1991-12#2)
in-place##3##1##(1991-12#3)
in-plane Young's relaxation modulus##2##4##(2009-7#2)
in-plane##4##1##(2008-10#1)(2009-7#3)
in-process##2##1##(2008-10#1)(2012-2#1)
in-row rotary cultivator##3##3##(2008-10#3)
in-service##3##1##(1992-2#1)(2010-11#1)(2012-12#1)
in-situ hybridization (FISH)##2##3##(2009-10#1)(2012-3#1)
in-situ monitoring of##3##3##(2008-10#3)
in-situ sampling##2##2##(2008-10#2)
in-situ##23##1##(2008-10#18)(2008-11#2)(2009-10#1)(2012-3#1)(2013-8#1)
in-stent restenosis##2##2##(2008-12#2)
in-stent##4##1##(2008-12#2)(2011-2#2)
in-tube SPME##3##2##(2008-10#3)
in-tube solid phase microextraction##2##4##(2008-10#2)
in-tube solid-phase microextraction##2##3##(2008-10#2)
in-tube##7##1##(2008-10#7)
in-use stocks##2##2##(2012-2#2)
in-use##4##1##(2008-5#2)(2012-2#2)
in-valve-mini-column##3##1##(2008-10#3)
in-vitro##9##1##(1992-3#1)(1993-8#1)(2008-10#1)(2008-9#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-3#1)
in-vivo##7##1##(2008-10#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-5#2)
inE##6##1##(2008-8#3)(2008-9#3)
inEscherichia coli##2##2##(2008-11#1)(2008-8#1)
inH##2##1##(2008-8#2)
inMycobacterium##2##1##(2008-11#2)
inNocardia andRhodococcus##3##2##(2008-11#3)
inS##2##1##(2008-8#2)
ina##5##1##(2008-11#4)(2008-7#1)
inability to##20##2##(1992-12#1)(1994-12#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
inability##27##1##(1992-12#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)
inaccessibility##2##1##(2008-7#1)(2009-12#1)
inaccessible for##2##2##(1993-3#1)(2008-7#1)
inaccessible to##4##2##(1990-5#1)(1997-4#1)(2008-11#1)(2009-10#1)
inaccessible##9##1##(1990-2#1)(1990-5#1)(1993-3#1)(1997-4#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-3#1)
inaccuracy##3##1##(2008-10#3)
inaccurate##6##1##(2008-10#2)(2008-11#2)(2008-8#1)(2013-1#1)
inactions##2##1##(2013-8#2)
inactivate the antibiotics##2##3##(2008-10#2)
inactivate the##3##2##(1995-2#1)(2008-10#2)
inactivate##14##1##(1993-8#1)(1995-2#1)(1996-2#1)(2008-10#8)(2012-2#3)
inactivated by##6##2##(1991-5#1)(1992-12#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-9#1)
inactivated enzyme##2##2##(1992-9#1)(2008-5#1)
inactivated in##3##2##(1990-12#1)(1992-9#1)(2008-10#1)
inactivated poliovirus##2##2##(1995-5#2)
inactivated the##2##2##(1993-3#1)(2008-10#1)
inactivated vaccine##4##2##(1996-12#1)(2008-5#2)(2013-8#1)
inactivated with##2##2##(1992-12#1)(1992-9#1)
inactivated##43##1##(1990-12#1)(1991-5#1)(1992-12#3)(1992-9#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-5#3)(1996-12#3)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
inactivates the##3##2##(1992-3#1)(1996-2#1)(2008-10#1)
inactivates##4##1##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)
inactivating##2##1##(1992-3#1)(2008-7#1)
inactivation and##3##2##(1993-6#1)(2008-7#1)(2011-3#1)
inactivation by heat##2##3##(1991-5#1)(2007-12#1)
inactivation by the##2##3##(1995-11#1)(2011-2#1)
inactivation by##6##2##(1991-5#1)(1991-9#1)(1992-12#1)(1995-11#1)(2007-12#1)(2011-2#1)
inactivation is##3##2##(1992-12#1)(1992-3#1)(2011-2#1)
inactivation occurred##2##2##(1990-2#1)(1994-11#1)
inactivation of the enzyme##2##4##(1991-5#1)(2011-2#1)
inactivation of the p53 function##2##5##(1994-12#2)
inactivation of the receptor##2##4##(1995-8#2)
inactivation of the##12##3##(1990-12#1)(1991-5#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-8#2)(2008-10#2)(2011-2#2)
inactivation of these##2##3##(1990-2#1)(2012-2#1)
inactivation of##49##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-5#2)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-2#1)(1995-6#2)(1995-8#3)(1996-2#1)(2007-12#1)(2008-10#6)(2008-11#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#3)(2011-3#2)(2012-2#5)(2013-1#1)
inactivation with##2##2##(2008-10#1)(2011-3#1)
inactivation##94##1##(1990-12#1)(1990-2#3)(1990-5#1)(1991-5#3)(1991-9#1)(1992-12#3)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#3)(1994-11#5)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#2)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#4)(1996-2#1)(2007-12#4)(2008-10#11)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#7)(2011-3#5)(2012-2#6)(2013-1#2)
inactivator of##2##2##(1994-5#1)(1997-1#1)
inactive GDP-bound##2##2##(1995-2#1)(1995-6#1)
inactive analogues##3##2##(1991-5#1)(2008-8#2)
inactive and active##2##3##(2008-10#1)(2012-3#1)
inactive and##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
inactive as##2##2##(1991-5#1)(1993-12#1)
inactive intermediate##2##2##(1994-12#1)(2008-9#1)
inactive mutant##2##2##(1995-12#1)(1995-6#1)
inactive precursors##2##2##(2008-11#1)(2013-1#1)
inactive protein##2##2##(1991-10#1)(2010-6#1)
inactive##78##1##(1990-3#2)(1991-10#1)(1991-5#2)(1991-6#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#5)(1995-11#4)(1995-12#1)(1995-2#2)(1995-6#3)(1996-5#3)(1997-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-8#3)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
inactivity##5##1##(1993-6#1)(1997-2#1)(2008-11#1)(2008-8#1)(2013-1#1)
inadequacies##3##1##(1996-6#1)(1997-3#1)(2013-1#1)
inadequacy of##4##2##(1995-11#1)(2009-5#1)(2012-3#1)(2013-1#1)
inadequacy##7##1##(1995-11#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
inadequate and that##4##3##(1994-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
inadequate and##8##2##(1994-3#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
inadequate care##3##2##(1992-2#1)(1993-3#1)(2008-10#1)
inadequate for their##2##3##(2008-10#1)(2008-7#1)
inadequate for##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
inadequate in##2##2##(2008-10#1)(2011-2#1)
inadequate nutritional intake##2##3##(2010-9#2)
inadequate samples##2##2##(1992-12#2)
inadequate to##4##2##(1993-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
inadequate treatment##4##2##(1993-9#1)(1996-11#1)(2013-1#2)
inadequate##72##1##(1990-12#1)(1991-12#1)(1992-12#4)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#2)(2010-3#1)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
inadequately prepared##3##2##(2008-11#2)(2011-1#1)
inadequately##10##1##(1993-3#1)(1995-2#1)(1997-8#1)(2008-11#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)
inadvertent##7##1##(1992-3#2)(2008-10#1)(2008-11#2)(2012-3#1)(2013-8#1)
inadvertently##2##1##(1997-8#1)(2011-2#1)
inaequalis and##4##2##(2008-10#4)
inaequalis populations##2##2##(2008-10#2)
inaequalis was##4##2##(2008-10#4)
inaequalis were##2##2##(2008-10#2)
inaequalis##54##1##(2008-10#54)
inanimate matter##2##2##(1997-6#1)(2008-12#1)
inanimate##6##1##(1991-2#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-9#1)(2012-2#1)
inaperisone (4 mg/kg i##3##4##(1992-3#3)
inaperisone##9##1##(1992-3#9)
inappropriate and##2##2##(1994-3#1)(1996-1#1)
inappropriate in##3##2##(1992-2#1)(1996-5#1)(2008-10#1)
inappropriate##37##1##(1990-5#1)(1990-8#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
inappropriately##5##1##(1994-3#1)(1995-8#1)(2008-5#1)(2008-7#1)(2008-9#1)
inattention##4##1##(1997-6#1)(2008-2#1)(2008-8#2)
inborn##3##1##(1992-9#1)(2012-2#1)(2012-3#1)
inboth##2##1##(2008-11#2)
inbred Oh516##2##2##(2008-10#2)
inbred backcross lines##2##3##(2008-10#2)
inbred backcross##3##2##(2008-10#3)
inbred line##9##2##(2008-10#7)(2008-8#2)
inbred lines derived from the cross##2##6##(2008-10#1)(2012-3#1)
inbred lines derived from##3##4##(2008-10#2)(2012-3#1)
inbred lines of##3##3##(2008-10#2)(2012-3#1)
inbred lines##24##2##(2008-10#16)(2008-8#2)(2012-3#6)
inbred mice##3##2##(1993-12#1)(1994-5#1)(1994-8#1)
inbred strains##4##2##(1994-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
inbred##74##1##(1993-12#1)(1994-5#1)(1994-8#3)(2008-10#46)(2008-11#2)(2008-12#1)(2008-8#5)(2009-10#2)(2012-3#13)
inbreds##15##1##(2008-10#13)(2008-9#1)(2012-3#1)
inbreeding as##2##2##(2012-3#2)
inbreeding avoidance##6##2##(2008-9#6)
inbreeding depression in##2##3##(2008-9#2)
inbreeding depression##15##2##(2008-8#10)(2008-9#5)
inbreeding##35##1##(2008-12#2)(2008-8#11)(2008-9#16)(2012-3#6)
incapable of##9##2##(1992-8#1)(1993-12#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-6#2)(2008-10#2)
incapacitating##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
incapacitation##3##1##(1996-12#3)
incapacity for Fas-mediated apoptosis##2##4##(1997-8#2)
incapacity##5##1##(1994-12#1)(1997-8#2)(2009-4#2)
incarcerated juveniles##2##2##(2008-11#2)
incarcerated women with substance use disorder##2##6##(2009-11#2)
incarcerated##6##1##(2008-11#3)(2009-11#2)(2013-1#1)
incarceration of inguinal hernia##2##4##(2008-12#2)
incarceration of##6##2##(2008-11#1)(2008-12#3)(2011-2#2)
incarceration##9##1##(2008-11#1)(2008-12#3)(2009-11#1)(2010-6#1)(2011-2#3)
incarnata##4##1##(2008-10#4)
incentive for##3##2##(1992-1#2)(1996-2#1)
incentive to##2##2##(1994-3#1)(2008-10#1)
incentive##18##1##(1991-12#2)(1992-1#2)(1992-3#3)(1993-6#2)(1994-3#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-1#1)(2008-10#2)(2012-3#1)(2013-8#1)
incentive&quot##2##1##(2008-8#2)
incentives and##3##2##(1991-2#1)(1997-1#1)(2011-2#1)
incentives are##2##2##(1996-12#1)(1997-2#1)
incentives for##6##2##(1991-12#1)(1993-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2010-5#1)
incentives in##3##2##(1993-12#1)(1994-1#1)(1996-12#1)
incentives that##2##2##(1997-1#2)
incentives to##4##2##(1994-2#1)(1995-2#1)(1997-2#1)(2008-6#1)
incentives##34##1##(1991-12#3)(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-3#3)(1994-1#1)(1994-2#2)(1995-2#1)(1996-12#4)(1996-3#2)(1997-1#3)(1997-2#4)(2008-11#1)(2008-6#1)(2010-5#2)(2011-2#2)
inception##8##1##(1995-12#1)(1996-3#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)(2011-2#1)
incessant##2##1##(2010-1#1)(2013-1#1)
incest avoidance##2##2##(2008-9#2)
incest##5##1##(1996-5#2)(2008-9#3)
incidence among##7##2##(1996-11#1)(2008-10#5)(2008-11#1)
incidence and mortality##4##3##(1992-12#1)(1994-9#1)(2009-5#1)(2011-2#1)
incidence and prevalence of##4##4##(1992-2#1)(1996-11#1)(2008-10#1)(2008-12#1)
incidence and prevalence##6##3##(1992-2#2)(1996-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
incidence and severity increased with##2##5##(2008-10#2)
incidence and severity of Fusarium ear rot and##2##8##(2008-10#2)
incidence and severity of##8##4##(2008-10#7)(2012-3#1)
incidence and severity were##5##4##(2008-10#5)
incidence and severity##36##3##(2008-10#35)(2012-3#1)
incidence and sources of##2##4##(2008-11#1)(2011-2#1)
incidence and the##2##3##(2008-1#1)(2008-10#1)
incidence and##80##2##(1991-11#1)(1992-12#1)(1992-2#2)(1993-11#1)(1994-9#3)(1996-11#1)(2008-1#1)(2008-10#53)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
incidence angle##3##2##(2008-10#2)(2008-2#1)
incidence are##2##2##(2008-10#2)
incidence at the group scale and##2##6##(2008-10#2)
incidence at the scale of the individual tree##2##8##(2008-10#2)
incidence at the##12##3##(2008-10#12)
incidence at##21##2##(1996-12#1)(2008-10#20)
incidence between the##2##3##(2008-10#2)
incidence between##4##2##(2008-10#4)
incidence by##4##2##(2008-10#4)
incidence can be##2##3##(1994-9#1)(2008-10#1)
incidence can##3##2##(1994-9#1)(2008-10#2)
incidence data were##2##3##(1991-3#1)(2008-10#1)
incidence data##13##2##(1991-3#2)(1994-9#2)(2008-10#9)
incidence density##2##2##(2008-11#2)
incidence during##2##2##(1996-11#1)(2008-10#1)
incidence from##4##2##(2008-10#3)(2009-8#1)
incidence had##2##2##(1994-9#1)(2008-10#1)
incidence has been##2##3##(1990-11#1)(1995-2#1)
incidence has##3##2##(1990-11#1)(1995-2#1)(1996-11#1)
incidence in the population##2##4##(1993-2#1)(2011-2#1)
incidence in the##15##3##(1991-6#1)(1992-9#2)(1993-2#1)(1997-3#1)(2008-10#7)(2008-7#1)(2011-2#1)(2013-1#1)
incidence in women##2##3##(1994-9#2)
incidence in##48##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-9#3)(1993-2#1)(1994-9#2)(1996-3#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#3)(2012-12#3)(2012-3#3)(2013-1#1)
incidence increased##4##2##(2008-10#3)(2008-7#1)
incidence is##14##2##(1991-12#1)(1991-3#1)(2008-10#4)(2008-7#4)(2011-2#1)(2012-3#1)(2013-1#2)
incidence may##3##2##(2008-10#2)(2008-5#1)
incidence of 0##2##3##(2012-2#1)(2013-1#1)
incidence of AWR##2##3##(2008-10#2)
incidence of CBS in##2##4##(2011-2#2)
incidence of CSF##3##3##(2011-2#1)(2012-3#2)
incidence of EPS##2##3##(2011-2#2)
incidence of TBE in Thurgau##2##5##(1996-11#2)
incidence of access site##2##4##(2011-2#2)
incidence of acute complications in children with diabetes##2##8##(1994-6#2)
incidence of acute##5##3##(1994-6#2)(1996-6#1)(2012-12#1)(2013-8#1)
incidence of adenocarcinoma##2##3##(2008-1#2)
incidence of aggression##2##3##(2008-7#1)(2012-3#1)
incidence of blossom##2##3##(2008-10#2)
incidence of both##3##3##(2008-10#2)(2008-12#1)
incidence of breast##4##3##(1994-12#1)(2008-7#1)(2013-7#2)
incidence of brown stem rot##4##5##(2008-10#4)
incidence of cancer##5##3##(1994-5#1)(2008-4#1)(2008-7#2)(2011-1#1)
incidence of certain##2##3##(1992-9#1)(1994-5#1)
incidence of clinical mastitis##2##4##(1992-2#1)(1996-8#1)
incidence of complications##5##3##(1991-8#1)(1993-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
incidence of congenital##4##3##(1990-9#2)(2008-7#1)(2011-1#1)
incidence of diffuse malignant mesothelioma##2##5##(1991-12#2)
incidence of disease##4##3##(2008-10#4)
incidence of errorless trials##2##4##(1992-12#2)
incidence of fire blight##5##4##(2008-10#5)
incidence of flower infection##3##4##(2008-10#3)
incidence of fruit brown rot##2##5##(2008-10#2)
incidence of fruit##4##3##(2008-10#4)
incidence of hepatomas##2##3##(1990-6#2)
incidence of infection by##2##4##(2008-10#2)
incidence of infection in##2##4##(2008-10#2)
incidence of infection##7##3##(2008-10#6)(2011-2#1)
incidence of isolation##3##3##(2008-10#3)
incidence of latent infection (ILI) of##2##6##(2008-10#2)
incidence of latent infection (ILI)##3##5##(2008-10#3)
incidence of latent infection##4##4##(2008-10#4)
incidence of lateral##2##3##(2008-8#1)(2013-1#1)
incidence of lettuce drop##2##4##(2008-10#2)
incidence of malaria##2##3##(2012-12#2)
incidence of malignant melanoma##2##4##(2011-2#2)
incidence of malignant##4##3##(1995-2#1)(2010-12#1)(2011-2#2)
incidence of melanoma##4##3##(2011-2#4)
incidence of mortality##2##3##(2008-7#1)(2012-3#1)
incidence of oesophageal and gastric##2##5##(2008-11#2)
incidence of pathological##2##3##(1990-11#1)(1993-3#1)
incidence of prostate cancer##3##4##(2008-6#1)(2010-1#1)(2010-12#1)
incidence of renal tumors##2##4##(1994-5#2)
incidence of renal##3##3##(1994-5#2)(2011-2#1)
incidence of serious##3##3##(1995-5#1)(2008-8#1)(2011-2#1)
incidence of side-effects##3##3##(2008-5#1)(2011-2#2)
incidence of spontaneous##2##3##(1990-8#1)(2008-7#1)
incidence of strawberry##3##3##(2008-10#3)
incidence of sudden infant death syndrome##3##6##(1991-11#2)(1991-9#1)
incidence of surgical##3##3##(2008-9#1)(2012-3#2)
incidence of the disease in the##2##6##(1994-9#1)(2008-10#1)
incidence of the disease in##4##5##(1992-9#1)(1994-9#1)(2008-10#2)
incidence of the disease##7##4##(1992-9#1)(1994-9#1)(1997-6#1)(2008-10#3)(2011-2#1)
incidence of the##15##3##(1992-9#1)(1993-8#1)(1994-9#1)(1997-6#1)(2008-10#6)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
incidence of this complication##3##4##(1991-3#1)(2013-1#2)
incidence of this##6##3##(1990-6#1)(1991-3#1)(2008-11#1)(2010-5#1)(2013-1#2)
incidence of tuberculosis##2##3##(1996-3#1)(2013-1#1)
incidence of varicocele##3##3##(1990-3#3)
incidence of vascular##2##3##(2011-2#1)(2013-1#1)
incidence of##429##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#7)(1990-5#1)(1990-6#7)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#5)(1991-9#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-9#4)(1993-11#2)(1993-12#2)(1993-3#2)(1993-8#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-9#2)(1995-12#3)(1995-2#1)(1995-5#2)(1996-1#1)(1996-11#4)(1996-3#3)(1996-6#3)(1996-8#1)(1997-1#1)(1997-3#3)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#3)(2008-1#5)(2008-10#112)(2008-11#12)(2008-12#7)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#18)(2008-8#10)(2008-9#13)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#45)(2012-12#3)(2012-2#4)(2012-3#15)(2013-1#29)(2013-7#4)(2013-8#4)
incidence on fruit in the tree##2##6##(2008-10#2)
incidence on white fir##3##4##(2008-10#3)
incidence on##8##2##(1995-12#1)(2008-10#7)
incidence or##3##2##(1994-2#1)(2008-10#2)
incidence over##2##2##(1994-9#1)(2008-10#1)
incidence ranged from##2##3##(2008-10#2)
incidence ranging from 0##2##4##(2008-10#1)(2011-2#1)
incidence ranging from##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
incidence rate was##2##3##(1996-8#1)(2011-2#1)
incidence rate##12##2##(1993-2#1)(1994-12#3)(1996-3#1)(1996-8#2)(2008-11#2)(2011-2#2)(2012-3#1)
incidence rates##5##2##(1991-2#1)(1992-2#1)(1994-12#1)(1996-3#1)(2012-3#1)
incidence relationships##2##2##(2008-10#2)
incidence relative to##2##3##(2008-10#2)
incidence remained##2##2##(2008-10#2)
incidence to##5##2##(1990-3#1)(2008-10#4)
incidence values##4##2##(2008-10#4)
incidence was 0##2##3##(2008-10#2)
incidence was higher##2##3##(2008-10#2)
incidence was low in##2##4##(2008-10#2)
incidence was low##3##3##(2008-10#3)
incidence was not##5##3##(2008-10#5)
incidence was observed##2##3##(1990-6#1)(1996-8#1)
incidence was positively correlated with##3##5##(2008-10#3)
incidence was reduced by##2##4##(2008-10#2)
incidence was significantly##2##3##(1992-5#1)(2008-10#1)
incidence was##42##2##(1990-3#2)(1990-6#1)(1991-8#1)(1992-5#1)(1996-11#1)(1996-8#1)(2008-10#35)
incidence were##3##2##(2008-10#3)
incidence will##3##2##(1992-2#1)(1992-9#1)(1995-2#1)
incidence with##3##2##(1990-11#1)(2008-10#1)(2012-12#1)
incidence##906##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#11)(1990-5#1)(1990-6#8)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#6)(1991-12#6)(1991-2#5)(1991-3#9)(1991-5#1)(1991-6#2)(1991-8#6)(1991-9#1)(1992-12#6)(1992-2#8)(1992-3#2)(1992-5#1)(1992-9#10)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#3)(1993-8#3)(1994-12#8)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#2)(1994-9#14)(1995-12#5)(1995-2#3)(1995-5#2)(1996-1#1)(1996-11#10)(1996-12#1)(1996-3#9)(1996-6#3)(1996-8#4)(1997-1#3)(1997-3#7)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#2)(2007-12#3)(2008-1#7)(2008-10#411)(2008-11#23)(2008-12#8)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#28)(2008-8#11)(2008-9#17)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#61)(2011-3#2)(2012-12#8)(2012-2#4)(2012-3#25)(2013-1#40)(2013-7#4)(2013-8#4)
incidence) were##2##2##(2008-10#2)
incidence)##6##1##(2008-10#4)(2010-3#1)(2012-12#1)
incidence-density##2##1##(2008-10#2)
incidences and/or severities of cytoplasmic vacuolization of the hepatocyte##2##9##(2008-9#2)
incidences and/or severities of##3##4##(2008-9#3)
incidences and/or##4##2##(2008-9#4)
incidences of epidermal##2##3##(2008-9#2)
incidences of infection##2##3##(2008-10#2)
incidences of neoplasms##3##3##(1995-11#1)(2008-9#2)
incidences of squamous cell##2##4##(2008-9#2)
incidences of thyroid gland##2##4##(2008-9#2)
incidences of##23##2##(1995-11#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#15)(2011-2#1)(2012-3#1)
incidences##37##1##(1991-6#1)(1992-5#1)(1995-11#1)(1997-7#1)(2008-10#7)(2008-8#1)(2008-9#21)(2011-2#3)(2012-3#1)
incident beam##5##2##(2008-2#2)(2008-3#3)
incident cases of##2##3##(1992-12#1)(1992-9#1)
incident cases##5##2##(1991-2#1)(1992-12#1)(1992-9#1)(1994-9#1)(1997-3#1)
incident laser beam##3##3##(2008-2#1)(2008-3#2)
incident laser##5##2##(2008-11#1)(2008-2#1)(2008-3#3)
incident light##6##2##(2008-10#2)(2008-3#4)
incident on##2##2##(2008-10#1)(2008-3#1)
incident power##2##2##(2007-12#1)(2008-3#1)
incident radiation##2##2##(2008-3#2)
incident reports and nurse's and patient's perspectives##2##7##(2010-10#2)
incident technique##2##2##(2010-10#2)
incident upon the##2##3##(2008-3#2)
incident upon##3##2##(2008-2#1)(2008-3#2)
incident wavelength##5##2##(2008-2#3)(2008-3#1)(2013-8#1)
incident##80##1##(1991-2#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-9#2)(1996-12#1)(1997-1#1)(1997-3#3)(2007-12#2)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#26)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-10#6)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
incidental findings##3##2##(1990-9#2)(2008-10#1)
incidental##18##1##(1990-9#2)(1991-3#1)(1992-5#1)(1992-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#4)
incidentally detected##3##2##(2008-7#1)(2013-1#2)
incidentally during##4##2##(1997-3#1)(2008-11#1)(2009-1#1)(2011-2#1)
incidentally##15##1##(1997-3#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
incidents and##3##2##(2009-10#1)(2010-11#1)(2013-1#1)
incidents in##2##2##(2008-11#2)
incidents involving TB##3##3##(2010-5#3)
incidents involving##5##2##(1992-12#1)(2010-1#1)(2010-5#3)
incidents is##2##2##(2008-11#2)
incidents occur in##2##3##(1991-12#1)(1993-12#1)
incidents of##4##2##(1991-6#1)(1993-2#1)(1994-2#1)(2008-10#1)
incidents##36##1##(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(2008-10#3)(2008-11#9)(2008-12#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#4)(2012-2#1)(2012-3#2)(2013-1#1)
incineration##3##1##(2008-10#3)
incinerator##3##1##(2008-10#2)(2008-3#1)
incipient speciation##2##2##(2008-9#1)(2012-3#1)
incipient##5##1##(1994-2#1)(2008-10#2)(2008-9#1)(2012-3#1)
incised##3##1##(2008-10#2)(2008-12#1)
incision and drainage##3##3##(2008-12#1)(2009-6#2)
incision and##6##2##(2008-10#1)(2008-12#2)(2009-6#2)(2012-3#1)
incision at the##2##3##(1991-12#1)(2013-1#1)
incision below the left clavicle##2##5##(2012-12#2)
incision in the##2##3##(2011-2#1)(2012-12#1)
incision in##3##2##(1992-2#1)(2011-2#1)(2012-12#1)
incision was##2##2##(1992-2#1)(2008-12#1)
incision with##2##2##(1990-2#1)(2009-8#1)
incision##30##1##(1990-2#1)(1991-12#1)(1992-2#2)(1992-3#1)(2008-10#2)(2008-12#4)(2008-9#2)(2009-6#2)(2009-8#1)(2010-3#1)(2011-2#5)(2012-12#5)(2012-3#2)(2013-1#1)
incisional wound site pain##2##4##(2012-12#2)
incisional##6##1##(1994-2#1)(1997-6#1)(2010-11#1)(2010-8#1)(2012-12#2)
incisions##6##1##(1992-1#1)(1992-2#2)(2008-10#1)(2011-2#2)
incisor teeth##3##2##(1996-3#3)
incisor##8##1##(1990-3#3)(1996-3#3)(2008-8#1)(2013-1#1)
incisors##7##1##(2013-1#7)
incited by##5##2##(2008-10#5)
incited significantly##2##2##(2008-10#2)
incited the##2##2##(2008-10#2)
incited##11##1##(2008-10#11)
inciting##3##1##(2008-10#3)
incl##2##1##(1995-5#2)
inclination and##2##2##(2008-11#1)(2008-12#1)
inclination##8##1##(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)
inclined to##3##2##(2008-6#1)(2010-6#1)(2013-1#1)
inclined##13##1##(2008-11#1)(2008-12#1)(2008-3#6)(2008-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
include (a)##2##2##(1994-1#1)(2012-2#1)
include a##40##2##(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#2)(2009-7#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
include adequate##2##2##(2008-1#1)(2010-7#1)
include alcohol and##2##3##(1990-2#1)(2008-1#1)
include all##3##2##(1991-11#1)(1993-12#1)(2011-2#1)
include also##2##2##(1995-5#1)(2008-7#1)
include an##12##2##(1991-12#1)(1995-1#1)(1996-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-12#1)(2010-10#1)
include any##2##2##(2008-10#1)(2008-11#1)
include both##8##2##(1994-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-8#1)
include cell##2##2##(2011-2#1)(2012-3#1)
include changes in##2##3##(1993-1#1)(2009-7#1)
include data##2##2##(1996-2#1)(2008-1#1)
include decreased##2##2##(2008-1#1)(2008-11#1)
include effects of##2##3##(2008-9#1)(2010-10#1)
include enhanced##3##2##(1992-2#1)(1996-1#1)(2010-7#1)
include evaluation##2##2##(1997-1#1)(2010-12#1)
include examining##2##2##(1996-2#1)(2008-9#1)
include four##2##2##(2008-12#1)(2012-3#1)
include genes##2##2##(2008-10#1)(2008-6#1)
include genetic##2##2##(1993-9#1)(2008-8#1)
include greater##3##2##(2007-11#1)(2008-12#1)(2012-3#1)
include having##2##2##(2008-11#1)(2012-2#1)
include improved##3##2##(1992-12#1)(2008-10#1)(2008-6#1)
include increased##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
include infection##2##2##(2008-10#2)
include its##2##2##(2010-7#1)(2011-7#1)
include lower##2##2##(1993-1#1)(2012-2#1)
include maintaining##2##2##(1997-2#1)(1997-3#1)
include more##2##2##(1993-12#1)(1994-2#1)
include muscular##2##2##(2011-2#2)
include nonsteroidal anti-inflammatory drugs##2##4##(2010-1#1)(2012-3#1)
include patients##2##2##(1996-3#1)(2011-2#1)
include primary##2##2##(2012-3#2)
include problems with##2##3##(1992-3#1)(2008-11#1)
include proper##2##2##(2008-8#1)(2013-1#1)
include studies##3##2##(2008-11#1)(2008-4#1)(2010-2#1)
include the concept of##2##4##(1990-3#1)(2008-10#1)
include the design and##2##4##(2008-10#1)(2010-11#1)
include the effect of##2##4##(2008-10#1)(2008-3#1)
include the effects of##3##4##(2008-10#1)(2008-9#1)(2010-6#1)
include the following##7##3##(1993-8#1)(2008-11#2)(2011-2#2)(2012-3#1)(2013-8#1)
include the importance of##2##4##(1995-12#1)(2010-4#1)
include the use of##2##4##(2008-10#1)(2009-6#1)
include the##87##2##(1990-3#1)(1992-12#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2007-12#2)(2008-10#17)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-6#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#1)
include their##2##2##(2008-11#1)(2010-10#1)
include those with##2##3##(2010-11#1)(2010-6#1)
include those##7##2##(1997-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)
include three##3##2##(1993-2#1)(2010-12#1)(2012-2#1)
include two##3##2##(1990-8#1)(2008-10#1)(2008-12#1)
include working##2##2##(2008-11#1)(2013-1#1)
include##593##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-3#3)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#6)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#4)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#8)(1996-3#9)(1996-5#1)(1996-6#2)(1997-1#7)(1997-2#4)(1997-3#8)(1997-5#1)(1997-7#2)(1997-8#2)(2006-5#1)(2007-11#3)(2007-12#6)(2008-1#8)(2008-10#94)(2008-11#49)(2008-12#12)(2008-2#4)(2008-3#6)(2008-4#12)(2008-5#6)(2008-6#8)(2008-7#16)(2008-8#15)(2008-9#23)(2009-11#3)(2009-12#7)(2009-3#1)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#8)(2010-11#6)(2010-12#7)(2010-2#2)(2010-4#3)(2010-5#3)(2010-6#7)(2010-7#13)(2010-8#5)(2011-2#39)(2011-3#2)(2011-4#1)(2011-7#2)(2012-12#1)(2012-2#17)(2012-3#23)(2013-1#23)(2013-7#1)(2013-8#6)
included &quot##2##2##(1992-2#1)(2011-2#1)
included 1##4##2##(1991-6#1)(1994-3#1)(2008-10#1)(2008-7#1)
included 10##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
included 14##3##2##(1990-2#1)(2009-11#1)(2011-2#1)
included 15##2##2##(1997-8#1)(2009-8#1)
included 2##2##2##(1997-4#1)(2008-7#1)
included 20##2##2##(1991-2#1)(2009-8#1)
included 40 patients##3##3##(2011-2#2)(2012-3#1)
included 50 patients##3##3##(2011-2#3)
included a##28##2##(1991-1#1)(1991-12#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
included abdominal##2##2##(1992-2#1)(2008-11#1)
included about##2##2##(1991-8#1)(1992-12#1)
included age##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
included all##2##2##(2008-10#1)(2010-2#1)
included an##6##2##(1993-1#1)(1993-2#1)(2008-10#3)(2013-1#1)
included and##4##2##(1990-3#1)(2008-10#3)
included are##2##2##(2008-10#1)(2008-11#1)
included as a##3##3##(2008-10#1)(2008-11#1)(2010-1#1)
included as an##3##3##(2008-10#2)(2008-12#1)
included as##8##2##(1996-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-1#1)(2010-11#1)
included at##3##2##(2008-4#1)(2008-8#1)(2012-3#1)
included because##2##2##(1990-9#1)(2008-10#1)
included both##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2012-3#1)
included data##2##2##(2008-11#1)(2011-2#1)
included family planning services##2##4##(1994-8#2)
included five##2##2##(2008-10#1)(2011-2#1)
included for##12##2##(1994-12#1)(1997-2#1)(2008-10#1)(2008-4#7)(2008-9#1)(2013-1#1)
included four##4##2##(1996-9#1)(2008-10#1)(2008-3#1)(2013-1#1)
included headache##2##2##(2008-12#1)(2012-3#1)
included in a##8##3##(1997-5#1)(1997-7#1)(2008-10#2)(2008-11#2)(2011-2#1)(2011-7#1)
included in any##2##3##(1995-12#1)(2008-11#1)
included in beta-cyclodextrin in##2##4##(2008-10#2)
included in many##2##3##(2008-10#1)(2008-11#1)
included in our##2##3##(1991-6#1)(2008-10#1)
included in the calibration##2##4##(2008-10#2)
included in the differential diagnosis of##4##6##(1997-7#1)(2008-5#1)(2013-1#1)(2013-8#1)
included in the differential diagnosis##5##5##(1997-7#1)(2008-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
included in the formal##2##4##(2008-10#2)
included in the model##5##4##(1996-3#1)(2008-10#2)(2008-7#2)
included in the revised##2##4##(1995-12#1)(2011-2#1)
included in the same##2##4##(2008-10#1)(2008-6#1)
included in the study##21##4##(1990-11#1)(1990-9#1)(1992-9#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#2)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
included in the##78##3##(1990-11#1)(1990-9#1)(1992-3#1)(1992-9#1)(1995-12#1)(1995-5#2)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2008-10#20)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
included in this study##16##4##(1994-3#1)(2008-10#6)(2008-9#1)(2010-7#1)(2010-8#1)(2012-3#4)(2013-1#2)
included in this##24##3##(1994-3#1)(2008-10#7)(2008-4#1)(2008-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#4)(2013-1#3)
included in##142##2##(1990-11#1)(1990-9#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-3#2)(1996-6#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2008-10#40)(2008-11#14)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#8)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#2)
included into the##3##3##(2008-10#2)(2008-12#1)
included isolates from##3##3##(2008-10#3)
included isolates of##3##3##(2008-10#3)
included isolates originating from##2##4##(2008-10#2)
included isolates##10##2##(2008-10#10)
included linear##2##2##(2008-10#2)
included nausea/vomiting##2##2##(1990-12#1)(1991-6#1)
included only##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
included patient##2##2##(1997-8#1)(2011-2#1)
included patients##2##2##(2012-2#1)(2013-1#1)
included questions##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
included representatives of##2##3##(2008-10#1)(2008-6#1)
included several##2##2##(2008-10#2)
included six##2##2##(2008-11#1)(2008-9#1)
included some##2##2##(2008-10#2)
included strains##2##2##(2008-10#2)
included studies##4##2##(2008-10#2)(2011-2#2)
included the amount of##2##4##(2008-10#2)
included the following##2##3##(2008-7#1)(2013-1#1)
included the introduction of##2##4##(2008-10#1)(2009-7#1)
included the use of##2##4##(2008-11#1)(2013-1#1)
included the##36##2##(1991-10#1)(1991-2#1)(1993-6#1)(1997-3#1)(2006-6#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-7#3)(2008-9#1)(2009-7#1)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
included those##3##2##(2008-9#1)(2011-2#2)
included three##3##2##(2008-10#2)(2008-11#1)
included to##5##2##(2008-12#2)(2008-4#3)
included two main##2##3##(1992-9#1)(2008-10#1)
included two##7##2##(1992-9#1)(1993-2#1)(2008-10#4)(2008-8#1)
included weight##2##2##(2008-11#1)(2008-12#1)
included were##2##2##(2008-10#1)(2009-8#1)
included within##3##2##(1992-9#1)(2008-10#1)(2013-8#1)
included##713##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#4)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#6)(1991-8#3)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#4)(1992-3#2)(1992-6#1)(1992-9#4)(1993-1#2)(1993-11#4)(1993-12#2)(1993-2#3)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#7)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#7)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#6)(2006-6#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#167)(2008-11#50)(2008-12#29)(2008-2#1)(2008-3#14)(2008-4#30)(2008-5#8)(2008-6#4)(2008-7#17)(2008-8#6)(2008-9#24)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#8)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#7)(2011-2#54)(2011-3#1)(2011-7#1)(2012-12#8)(2012-2#10)(2012-3#20)(2012-5#1)(2013-1#47)(2013-7#2)(2013-8#11)
included)##2##1##(1995-12#1)(2011-3#1)
includes a comparison of##2##4##(1992-2#1)(2008-3#1)
includes a discussion##2##3##(1996-3#1)(2008-4#1)
includes a review of the##2##5##(2007-11#1)(2013-1#1)
includes a##33##2##(1990-8#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-2#1)(1996-1#1)(1996-3#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-1#2)
includes alleviation of##2##3##(2009-7#1)(2011-2#1)
includes also##2##2##(2008-10#1)(2011-2#1)
includes an##9##2##(1991-6#1)(1992-1#1)(1992-2#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-3#1)
includes at least two##2##4##(2008-10#1)(2009-3#1)
includes at least##3##3##(1991-6#1)(2008-10#1)(2009-3#1)
includes both##6##2##(1990-8#1)(1994-12#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-3#1)
includes modules##2##2##(2011-2#1)(2012-3#1)
includes nurses##2##2##(1991-2#1)(1994-12#1)
includes replacement of##2##3##(2008-10#1)(2013-1#1)
includes results for##2##3##(1994-3#1)(2008-3#1)
includes results##3##2##(1991-1#1)(1994-3#1)(2008-3#1)
includes several##4##2##(1992-9#1)(2010-1#1)(2010-9#1)(2011-3#1)
includes some##3##2##(1990-5#1)(2008-9#1)(2010-10#1)
includes the analysis of##2##4##(2008-11#1)(2011-2#1)
includes the association of##2##4##(2008-10#2)
includes the effect of##3##4##(2008-10#1)(2008-3#2)
includes the entire##2##3##(1995-6#1)(1997-6#1)
includes the following##2##3##(2008-2#1)(2013-1#1)
includes the##47##2##(1990-8#1)(1991-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
includes three##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
includes two##3##2##(1993-2#1)(2007-11#1)(2008-10#1)
includes##265##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#3)(1992-1#2)(1992-12#4)(1992-2#2)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#3)(1995-6#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#54)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#14)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#21)(2011-3#3)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#2)
including (i)##2##2##(2008-10#1)(2010-4#1)
including 1##4##2##(2008-10#2)(2008-8#1)(2009-8#1)
including 11##2##2##(2008-10#1)(2008-12#1)
including 13##2##2##(2009-7#1)(2011-2#1)
including 16##2##2##(2008-1#1)(2011-2#1)
including 2##2##2##(1991-8#1)(2008-10#1)
including 23##2##2##(2008-10#2)
including 2D##2##2##(2008-6#1)(2011-2#1)
including 4##5##2##(1994-12#1)(1996-6#1)(2008-10#1)(2010-2#1)(2013-8#1)
including 5##2##2##(1991-11#1)(2008-10#1)
including B##2##2##(1997-2#1)(2008-10#1)
including Bacillus subtilis##2##3##(2008-10#1)(2011-2#1)
including CT##2##2##(2008-12#2)
including D##2##2##(2008-10#2)
including DNA##2##2##(2008-11#1)(2012-2#1)
including Pakistan##2##2##(2012-2#1)(2013-8#1)
including The National Institute for Nursing Research and Sigma Theta Tau International##2##12##(2013-1#2)
including a comparison##2##3##(2008-10#2)
including a history of##2##4##(1996-11#1)(2012-3#1)
including a large number##2##4##(1991-3#1)(2008-10#1)
including a large##5##3##(1991-3#1)(2008-1#1)(2008-10#2)(2012-3#1)
including a review of the##3##5##(2008-4#1)(2010-6#1)(2012-2#1)
including a variety of##2##4##(1996-5#1)(1997-7#1)
including a##56##2##(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
including absorption##2##2##(2008-12#1)(2008-2#1)
including acute##2##2##(2011-2#2)
including alkali##5##2##(2008-10#5)
including all##9##2##(2008-10#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
including also##2##2##(2009-10#1)(2011-2#1)
including alteration##2##2##(2008-10#1)(2008-9#1)
including amino acids##2##3##(2008-10#2)
including an##18##2##(1992-2#1)(1992-6#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-5#1)(2010-8#2)(2011-2#1)(2012-12#1)
including anorexia##2##2##(1997-7#1)(2010-6#1)
including antioxidant and##2##3##(2008-10#1)(2012-2#1)
including antioxidant##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
including any##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
including asthma##2##2##(2008-11#1)(2009-1#1)
including at least one##2##4##(2008-10#1)(2013-1#1)
including at##4##2##(2008-10#2)(2013-1#2)
including bacterial##3##2##(2008-4#2)(2008-9#1)
including biochemical##2##2##(2008-11#1)(2008-4#1)
including blood##3##2##(1995-2#1)(2008-9#1)(2010-6#1)
including bone marrow##3##3##(2008-11#2)(2008-9#1)
including bone##4##2##(2008-11#2)(2008-9#1)(2012-3#1)
including both##12##2##(1992-12#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
including bovine##2##2##(2008-7#1)(2008-9#1)
including calcium##2##2##(2008-10#1)(2011-1#1)
including cancer and##2##3##(2008-8#1)(2012-2#1)
including cancer##4##2##(2008-7#1)(2008-8#1)(2009-4#1)(2012-2#1)
including cancers##2##2##(2008-10#1)(2008-4#1)
including capillary##2##2##(2008-10#2)
including cell cycle##2##3##(2008-9#1)(2010-10#1)
including cell##10##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-6#1)(2013-1#1)(2013-8#1)
including changes in##2##3##(2011-1#1)(2011-2#1)
including changing##2##2##(2007-12#1)(2010-8#1)
including chemical##2##2##(1990-8#1)(2008-10#1)
including clinical chemistry##2##3##(1994-12#2)
including clinical##4##2##(1994-12#3)(2013-8#1)
including cognitive##2##2##(2007-12#1)(2012-2#1)
including concentration##2##2##(2008-10#2)
including consideration of##2##3##(1991-2#1)(2013-8#1)
including control##2##2##(2011-2#1)(2013-1#1)
including critical##2##2##(2008-11#1)(2008-8#1)
including cyclophosphamide##2##2##(1990-12#1)(2008-10#1)
including death##3##2##(1997-1#1)(2008-11#1)(2012-12#1)
including decreased##2##2##(1995-2#1)(2008-6#1)
including diabetes##3##2##(2008-5#1)(2008-6#1)(2009-6#1)
including diabetic nephropathy##2##3##(2011-2#2)
including diabetic##3##2##(2010-10#1)(2011-2#2)
including direct##2##2##(1995-5#1)(2012-3#1)
including dopamine##2##2##(2008-7#1)(2009-8#1)
including eight##2##2##(1992-11#1)(2008-9#1)
including experimental##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
including familial##2##2##(2012-3#2)
including flavonoids##2##2##(2008-10#1)(2009-8#1)
including four##4##2##(1997-7#1)(2008-10#2)(2008-3#1)
including gender##2##2##(2009-10#1)(2009-4#1)
including genetic##3##2##(1997-5#1)(2008-10#1)(2008-4#1)
including glucose and##2##3##(2008-10#1)(2008-11#1)
including glucose##3##2##(2008-10#1)(2008-11#2)
including growth##4##2##(1994-5#1)(2008-9#1)(2011-2#1)(2013-7#1)
including hardware##2##2##(2010-9#2)
including heart##3##2##(2008-10#1)(2010-12#1)(2010-7#1)
including heat##3##2##(2008-10#1)(2011-2#2)
including high##2##2##(2008-10#1)(2008-12#1)
including higher##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
including histone##2##2##(2011-2#1)(2011-9#1)
including host resistance##2##3##(2008-10#2)
including host##3##2##(2008-10#2)(2010-10#1)
including human##4##2##(1997-6#1)(2009-3#1)(2010-1#1)(2011-2#1)
including humans##3##2##(2008-8#1)(2008-9#1)(2010-4#1)
including hypertension##3##2##(2010-5#1)(2013-1#1)(2013-8#1)
including immunomodulatory##2##2##(2008-10#1)(2008-5#1)
including in##3##2##(2008-12#1)(2008-7#1)(2010-10#1)
including increased##2##2##(2008-10#1)(2008-12#1)
including individual##2##2##(1991-2#1)(1994-1#1)
including infections##2##2##(2012-12#1)(2012-3#1)
including information##2##2##(2010-12#1)(2012-2#1)
including initiation##2##2##(2013-1#1)(2013-7#1)
including inoculum##2##2##(2008-10#1)(2008-5#1)
including its##7##2##(1995-6#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-6#1)(2010-7#1)
including labeling##2##2##(2008-4#1)(2008-9#1)
including left##3##2##(1997-8#1)(2008-11#1)(2013-1#1)
including less##3##2##(1995-12#1)(2011-7#1)(2012-2#1)
including limited##2##2##(2008-12#1)(2013-1#1)
including long##2##2##(2008-10#1)(2008-12#1)
including luminol##2##2##(2008-10#2)
including many##3##2##(1996-2#1)(2008-10#1)(2009-10#1)
including matrix##3##2##(2008-10#3)
including mechanical##2##2##(2008-5#1)(2010-5#1)
including model##2##2##(2008-7#1)(2008-9#1)
including multiple##3##2##(1995-5#1)(2008-7#1)(2011-2#1)
including myoglobin##2##2##(2008-10#2)
including nitrogen##2##2##(2008-10#2)
including not only##2##3##(1995-2#1)(2012-2#1)
including nucleic##2##2##(2008-9#1)(2011-2#1)
including one with##2##3##(1990-3#1)(1995-11#1)
including one##10##2##(1990-3#1)(1993-12#1)(1995-11#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-3#1)(2012-12#1)
including our own##2##3##(2008-7#2)
including our##3##2##(2008-7#3)
including ours##2##2##(2008-4#1)(2011-2#1)
including pH##8##2##(2008-10#7)(2011-2#1)
including phosphorylation of##2##3##(1993-8#1)(2009-6#1)
including premature##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
including procedures##2##2##(2008-10#1)(2008-9#1)
including professional##2##2##(1994-3#1)(2010-11#1)
including proliferation##3##2##(1993-8#1)(2009-8#1)(2010-7#1)
including prospective##2##2##(1997-4#1)(2009-3#1)
including protein##2##2##(2008-7#1)(2011-2#1)
including reagent##3##2##(2008-10#3)
including recombination##2##2##(2008-10#1)(2008-8#1)
including reduced##2##2##(2010-7#1)(2012-3#1)
including relative##2##2##(2008-10#1)(2011-2#1)
including renal##2##2##(1997-8#1)(2008-7#1)
including resistant##2##2##(2008-10#1)(2013-8#1)
including response##2##2##(2008-10#1)(2008-9#1)
including sample##3##2##(2008-10#3)
including sampling and washing##4##4##(2008-10#4)
including sampling##5##2##(2008-10#4)(2009-4#1)
including searching##2##2##(2008-12#1)(2008-9#1)
including seven##2##2##(2008-10#2)
including several##2##2##(2008-10#1)(2012-3#1)
including six##2##2##(2008-10#1)(2008-9#1)
including smoking##2##2##(1993-6#1)(2012-12#1)
including social##2##2##(2008-1#1)(2012-2#1)
including some##5##2##(2008-10#4)(2011-2#1)
including stability##2##2##(2008-10#1)(2013-8#1)
including stem cell##2##3##(2010-11#1)(2011-2#1)
including stigma##2##2##(2008-1#1)(2009-5#1)
including survival##2##2##(2008-10#1)(2008-5#1)
including testing##2##2##(2008-11#1)(2013-8#1)
including that of##2##3##(1994-8#1)(2008-10#1)
including that##4##2##(1994-8#1)(2008-10#1)(2008-6#1)(2010-10#1)
including the biosynthesis##2##3##(2008-10#1)(2009-7#1)
including the brain##2##3##(2010-5#1)(2012-2#1)
including the development of##3##4##(2008-11#1)(2009-1#1)(2010-12#1)
including the genes##2##3##(2008-10#1)(2008-8#1)
including the maximum##2##3##(2008-10#1)(2008-12#1)
including the nucleus##2##3##(1990-9#1)(1994-2#1)
including the potential##2##3##(1991-12#1)(2008-11#1)
including the presence of##4##4##(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
including the prevention of##2##4##(2008-1#1)(2008-10#1)
including the previously##2##3##(1991-6#1)(1996-6#1)
including the recently##3##3##(2008-10#3)
including the recording##2##3##(2008-3#1)(2010-7#1)
including the role of##2##4##(2008-11#1)(2010-12#1)
including the time needed##2##4##(1997-2#1)(2008-10#1)
including the type of##2##4##(1991-3#1)(2008-7#1)
including the type##4##3##(1991-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
including the use of##3##4##(2008-10#3)
including the##241##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#4)(1997-8#1)(1997-9#1)(2008-1#4)(2008-10#56)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#14)(2011-3#1)(2012-2#6)(2012-3#5)(2013-1#6)(2013-8#5)
including their purification##2##3##(2008-4#2)
including their##12##2##(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
including these##2##2##(2008-11#1)(2011-2#1)
including those from##2##3##(1992-8#1)(2008-10#1)
including those of##4##3##(1993-2#1)(1995-2#1)(2008-11#2)
including those with##2##3##(1994-8#1)(2010-11#1)
including those##19##2##(1991-6#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-9#2)(2010-1#2)(2010-11#1)(2010-5#1)(2011-2#1)
including three##4##2##(1990-5#1)(1995-8#1)(2008-10#1)(2010-4#1)
including thyroid##2##2##(2011-2#1)(2013-1#1)
including total##2##2##(1991-12#1)(2010-11#1)
including transcription##2##2##(1995-2#1)(2011-2#1)
including two##8##2##(1993-3#1)(1993-6#1)(2008-10#5)(2010-1#1)
including various##2##2##(2008-10#1)(2009-8#1)
including vinblastine##2##2##(1991-6#1)(2008-5#1)
including visual##2##2##(2008-9#1)(2013-1#1)
including voltage and phase compensation##3##5##(2013-8#3)
including wall##2##2##(2008-10#1)(2010-9#1)
including weeds##3##2##(2008-10#3)
including what##2##2##(2008-11#1)(2012-2#1)
including##1625##1##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#7)(1993-2#6)(1993-3#7)(1993-6#5)(1993-8#5)(1993-9#2)(1994-1#5)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#7)(1994-5#2)(1994-8#4)(1995-1#2)(1995-11#3)(1995-12#9)(1995-2#13)(1995-3#2)(1995-5#6)(1995-6#5)(1995-8#4)(1995-9#1)(1996-1#5)(1996-11#4)(1996-12#7)(1996-2#9)(1996-3#3)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#10)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#6)(1997-9#1)(2007-11#1)(2007-12#7)(2007-9#2)(2008-1#15)(2008-10#381)(2008-11#109)(2008-12#37)(2008-2#7)(2008-3#20)(2008-4#43)(2008-5#40)(2008-6#16)(2008-7#59)(2008-8#37)(2008-9#55)(2009-1#2)(2009-10#10)(2009-11#4)(2009-12#8)(2009-2#1)(2009-3#6)(2009-4#7)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#20)(2009-9#9)(2010-1#12)(2010-10#10)(2010-11#8)(2010-12#17)(2010-2#1)(2010-3#2)(2010-4#9)(2010-5#14)(2010-6#13)(2010-7#13)(2010-8#8)(2010-9#8)(2011-1#14)(2011-2#97)(2011-3#8)(2011-7#2)(2011-8#1)(2011-9#1)(2012-12#13)(2012-2#45)(2012-3#54)(2012-7#1)(2013-1#59)(2013-7#5)(2013-8#40)
inclusion and exclusion criteria##4##4##(2011-2#1)(2012-12#1)(2013-1#2)
inclusion and##5##2##(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
inclusion bodies in##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
inclusion bodies##14##2##(1995-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#2)(2013-8#1)
inclusion complex between##4##3##(2008-10#4)
inclusion complex modified carbon paste electrode##2##6##(2008-10#2)
inclusion complex of##4##3##(2008-10#4)
inclusion complex with##3##3##(2008-10#3)
inclusion complex##27##2##(2008-10#25)(2012-2#1)(2012-3#1)
inclusion complexation of##2##3##(2008-10#2)
inclusion complexation##3##2##(2008-10#3)
inclusion complexes with##2##3##(2008-10#2)
inclusion complexes##7##2##(2008-10#7)
inclusion constant##5##2##(2008-10#5)
inclusion criteria of##2##3##(2008-10#1)(2012-2#1)
inclusion criteria were##5##3##(1996-11#1)(2010-10#1)(2012-3#2)(2013-1#1)
inclusion criteria##17##2##(1996-11#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)
inclusion formation##3##2##(2008-10#3)
inclusion in the##4##3##(2008-10#1)(2008-11#1)(2009-10#1)(2013-1#1)
inclusion in##8##2##(1996-1#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#1)
inclusion of a##3##3##(2008-10#2)(2008-8#1)
inclusion of additional##2##3##(1992-2#1)(2008-9#1)
inclusion of##46##2##(1990-8#1)(1991-10#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-5#2)(1997-8#2)(2008-10#13)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
inclusion production##3##2##(2008-10#3)
inclusion proteins##2##2##(2008-10#2)
inclusion rate##4##2##(1994-9#4)
inclusion##182##1##(1990-8#1)(1991-10#1)(1992-2#2)(1992-9#1)(1993-3#1)(1994-3#1)(1994-9#5)(1995-12#4)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-8#2)(2008-1#1)(2008-10#89)(2008-11#9)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#12)(2013-8#1)
inclusions are##2##2##(2008-7#2)
inclusions from##2##2##(2008-10#2)
inclusions in##9##2##(1992-9#1)(1993-12#1)(2008-10#6)(2008-7#1)
inclusions of##2##2##(2008-10#1)(2008-7#1)
inclusions to##2##2##(1993-6#1)(2008-10#1)
inclusions were##2##2##(1994-9#1)(2008-10#1)
inclusions##47##1##(1990-2#1)(1990-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-9#1)(2007-12#3)(2008-10#28)(2008-2#1)(2008-3#4)(2008-7#4)(2013-1#1)
inclusive fitness##4##2##(2008-8#4)
inclusive of the##3##3##(2008-11#1)(2013-1#2)
inclusive of##5##2##(1996-12#1)(2008-11#1)(2013-1#3)
inclusive##15##1##(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#4)(2012-2#1)(2012-3#1)(2013-1#3)
inclusive-fitness model##2##2##(2008-8#2)
incognita and##2##2##(2008-10#2)
incognita##19##1##(2008-10#19)
incognita-infested##2##1##(2008-10#2)
incoherent feed-forward##3##2##(2008-11#3)
incoherent reflection model for##2##4##(2008-3#2)
incoherent reflection model##3##3##(2008-3#3)
incoherent##21##1##(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#14)
incoherent-to-coherent conversion##4##2##(2008-2#2)(2008-3#2)
incoherent-to-coherent##5##1##(2008-2#3)(2008-3#2)
incoherently##2##1##(2007-12#1)(2008-3#1)
income and##4##2##(1993-1#1)(1993-3#1)(2009-5#1)(2010-10#1)
income effects on##2##3##(1992-3#2)
income gamble##2##2##(2011-2#2)
income levels##2##2##(2009-7#1)(2011-2#1)
income##53##1##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-3#4)(1994-1#2)(1994-12#2)(1994-2#2)(1994-6#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-1#2)(2008-11#4)(2008-12#5)(2009-5#3)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)
income-to-needs##4##1##(2008-12#4)
income/education##2##1##(2011-2#2)
incomes##8##1##(1994-1#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-11#3)(2011-2#1)
incoming##7##1##(2008-10#3)(2008-11#1)(2008-3#1)(2010-7#1)(2011-1#1)
incompatibility with##3##2##(2008-10#3)
incompatibility##22##1##(2008-10#13)(2008-11#1)(2008-8#4)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
incompatible interaction##2##2##(2008-10#2)
incompatible with the##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
incompatible with##10##2##(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#2)(2013-8#1)
incompatible##29##1##(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#4)(2013-1#2)(2013-8#1)
incompetence##4##1##(1992-12#1)(1995-5#1)(1996-11#1)(1997-7#1)
incomplete Freund's adjuvant##3##3##(1995-12#3)
incomplete and##5##2##(1990-6#1)(1993-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
incomplete data##3##2##(1990-9#1)(2008-11#1)(2013-8#1)
incomplete dominance##2##2##(2008-10#2)
incomplete in##2##2##(1993-6#1)(2008-10#1)
incomplete lineage sorting##2##3##(2012-3#2)
incomplete recovery##2##2##(2008-10#1)(2008-7#1)
incomplete replication##2##2##(1990-5#2)
incomplete resection##2##2##(1992-12#1)(2013-1#1)
incomplete sampling##2##2##(2008-10#1)(2008-8#1)
incomplete understanding of##2##3##(2012-2#1)(2012-3#1)
incomplete##86##1##(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#6)(2013-1#3)(2013-8#2)
incompletely dominant##5##2##(2008-10#4)(2012-3#1)
incompletely obliterated##2##2##(2008-7#2)
incompletely occluded##5##2##(1996-9#1)(2013-1#4)
incompletely##22##1##(1990-11#1)(1990-5#1)(1990-8#1)(1996-9#1)(2008-10#6)(2008-7#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)
inconclusive and##3##2##(1993-8#1)(1995-6#1)(2008-5#1)
inconclusive for a relationship between##3##5##(2013-8#3)
inconclusive for##7##2##(2008-11#1)(2013-8#6)
inconclusive##29##1##(1991-12#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-6#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#7)
incongruence between the##2##3##(2008-10#1)(2012-3#1)
incongruent with##2##2##(2010-7#1)(2013-8#1)
incongruent##6##1##(2008-10#2)(2008-9#1)(2010-7#1)(2013-8#2)
inconsistencies in the##3##3##(2008-10#1)(2013-1#2)
inconsistencies in##5##2##(2008-10#1)(2008-12#1)(2013-1#3)
inconsistencies##8##1##(1993-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#3)
inconsistency##8##1##(2008-10#1)(2008-11#3)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)
inconsistent findings##4##2##(2009-10#1)(2012-12#2)(2013-1#1)
inconsistent with a##2##3##(2008-10#1)(2013-1#1)
inconsistent with the##7##3##(1994-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-12#1)(2012-3#1)
inconsistent with##13##2##(1994-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
inconsistent##39##1##(1994-1#1)(1996-3#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-8#1)(2012-12#3)(2012-3#2)(2013-1#6)(2013-8#1)
inconspicuous##3##1##(2008-10#1)(2008-11#1)(2009-6#1)
incontinence and##2##2##(1992-8#1)(1996-11#1)
incontinence in##5##2##(1997-5#1)(2008-10#3)(2010-6#1)
incontinence##17##1##(1992-8#1)(1994-3#2)(1996-11#1)(1996-2#1)(1997-5#1)(2008-10#6)(2009-3#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
incontinent##2##1##(2008-10#1)(2008-7#1)
inconvenience##5##1##(1994-3#1)(2008-10#1)(2008-11#3)
inconvenient and##2##2##(2008-10#1)(2010-8#1)
inconvenient to##2##2##(1991-3#1)(1997-4#1)
inconvenient##5##1##(1991-3#1)(1997-4#1)(2008-10#1)(2010-8#1)(2012-12#1)
incoordination##8##1##(1992-12#1)(1997-2#7)
incorporate a##6##2##(1994-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2013-1#1)
incorporate both##2##2##(1992-3#1)(2013-1#1)
incorporate the##4##2##(1993-3#1)(2008-11#1)(2008-4#1)(2008-9#1)
incorporate##54##1##(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#7)(2008-4#1)(2008-6#2)(2008-8#4)(2008-9#4)(2009-11#1)(2010-1#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#5)
incorporated at the##3##3##(1996-5#1)(2008-11#2)
incorporated at##5##2##(1996-5#1)(2008-10#2)(2008-11#2)
incorporated by##2##2##(2008-10#1)(2008-11#1)
incorporated in a##2##3##(2008-10#2)
incorporated in the##7##3##(1996-2#1)(2008-10#4)(2008-12#1)(2008-5#1)
incorporated in##28##2##(1990-5#1)(1991-12#1)(1996-12#1)(1996-2#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#3)(2010-3#1)(2012-3#1)
incorporated into a##13##3##(1994-11#1)(1995-2#1)(2008-10#8)(2008-5#1)(2009-12#1)(2010-12#1)
incorporated into it##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
incorporated into the model##2##4##(1992-12#1)(2008-3#1)
incorporated into the##28##3##(1992-12#1)(1993-1#1)(1994-3#1)(2007-12#1)(2008-10#5)(2008-12#2)(2008-3#6)(2008-4#2)(2008-5#2)(2008-8#3)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
incorporated into##79##2##(1991-5#2)(1992-12#1)(1993-1#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#22)(2008-11#4)(2008-12#3)(2008-3#7)(2008-4#3)(2008-5#6)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-10#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
incorporated the##3##2##(2008-10#1)(2008-9#1)(2010-1#1)
incorporated to##6##2##(2008-10#1)(2009-8#1)(2009-9#1)(2012-12#1)(2013-1#2)
incorporated with##3##2##(2008-10#2)(2008-11#1)
incorporated within##2##2##(1994-9#1)(2008-10#1)
incorporated##163##1##(1990-5#3)(1991-12#3)(1991-5#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#57)(2008-11#17)(2008-12#4)(2008-3#7)(2008-4#3)(2008-5#10)(2008-8#6)(2008-9#5)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-10#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
incorporates a##5##2##(1995-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
incorporates the##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
incorporates##30##1##(1991-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
incorporating a##11##2##(1990-5#1)(1994-12#1)(1995-11#1)(2008-10#4)(2010-7#2)(2012-3#2)
incorporating an##7##2##(2008-10#6)(2009-6#1)
incorporating both##5##2##(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
incorporating genetics into##2##3##(2008-12#2)
incorporating such##2##2##(1996-6#1)(2008-10#1)
incorporating the##15##2##(1993-12#1)(1994-12#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
incorporating this##2##2##(2008-10#1)(2008-8#1)
incorporating two##2##2##(2008-10#2)
incorporating##100##1##(1990-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#3)(1995-11#1)(1995-12#1)(1996-6#2)(1996-9#1)(1997-2#2)(2008-1#1)(2008-10#44)(2008-11#7)(2008-12#4)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-7#3)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#2)
incorporation and##2##2##(1991-6#1)(2008-10#1)
incorporation by##2##2##(1993-11#1)(1997-1#1)
incorporation in a##2##3##(2008-10#1)(2009-3#1)
incorporation in##8##2##(1992-9#1)(1993-11#1)(1995-12#1)(2008-10#3)(2009-3#2)
incorporation into DNA##5##3##(1994-11#1)(1994-3#1)(1994-5#2)(2010-11#1)
incorporation into serine##2##3##(1997-1#2)
incorporation into the##3##3##(1996-6#1)(2008-10#2)
incorporation into##27##2##(1991-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#3)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)
incorporation occurred in##2##3##(1994-3#1)(2009-10#1)
incorporation of 3[H]-leucine into##2##4##(1994-8#2)
incorporation of D-alanine into LTA##2##5##(1995-6#2)
incorporation of [3H]thymidine##5##3##(1995-12#1)(1995-2#3)(1997-1#1)
incorporation of a##4##3##(1993-1#1)(1995-3#1)(2008-10#2)
incorporation of an##3##3##(1993-8#1)(2008-10#2)
incorporation of radiolabeled##2##3##(1995-11#1)(2008-10#1)
incorporation of the##4##3##(1991-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
incorporation of these##3##3##(1997-2#1)(2008-10#1)(2010-4#1)
incorporation of##78##2##(1990-5#1)(1991-5#1)(1992-1#1)(1992-10#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#20)(2008-11#8)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
incorporation on the##2##3##(1993-8#1)(1995-11#1)
incorporation on##3##2##(1992-3#1)(1993-8#1)(1995-11#1)
incorporation procedure##2##2##(1995-8#1)(2008-10#1)
incorporation was##7##2##(1990-2#1)(1993-12#2)(1996-12#1)(2008-10#2)(2008-11#1)
incorporation##166##1##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#3)(1992-1#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#5)(1993-6#1)(1993-8#7)(1994-11#3)(1994-3#4)(1994-5#3)(1994-8#4)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#6)(1997-2#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#21)(2008-3#2)(2008-4#5)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-8#2)
incorrect total dose##2##3##(2011-2#2)
incorrect##19##1##(1990-6#1)(1991-6#1)(1991-9#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-3#1)
incorrectly##7##1##(1990-11#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-1#1)(2010-4#1)(2012-3#1)
increase (p&lt##3##2##(2008-11#1)(2013-1#2)
increase above##4##2##(1995-12#1)(1995-2#1)(2008-10#1)(2011-2#1)
increase access##2##2##(1994-2#1)(1997-1#1)
increase after light initiation##2##4##(2008-10#2)
increase after the initial##2##4##(2008-10#2)
increase after##9##2##(1995-12#1)(2008-10#5)(2010-12#1)(2011-2#1)(2013-1#1)
increase and decrease##2##3##(1996-12#1)(2008-10#1)
increase and the##2##3##(2010-6#1)(2012-2#1)
increase and##11##2##(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-6#1)(2012-2#2)(2012-3#1)
increase as a function of##3##5##(1991-2#1)(2008-8#2)
increase as a##4##3##(1991-2#1)(2008-12#1)(2008-8#2)
increase as##9##2##(1991-2#1)(1994-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#2)(2010-12#1)
increase at pH##2##3##(2008-10#1)(2008-5#1)
increase at the##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
increase at##13##2##(1992-7#2)(1992-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)(2010-5#1)(2013-1#1)
increase between##2##2##(1995-5#1)(2011-2#1)
increase both##4##2##(1993-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
increase by the##3##3##(1993-6#1)(1997-6#1)(2008-2#1)
increase by##9##2##(1991-1#1)(1993-6#1)(1994-1#1)(1997-6#1)(2008-11#2)(2008-2#1)(2008-5#1)(2013-1#1)
increase cardiovascular##2##2##(2008-1#1)(2012-12#1)
increase cell##2##2##(2008-11#2)
increase compared to controls##2##4##(2008-10#1)(2011-2#1)
increase compared to##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
increase dramatically##3##2##(1994-2#1)(1995-3#1)(2008-9#1)
increase during##6##2##(1995-6#1)(1995-9#1)(2008-10#2)(2008-7#1)(2009-7#1)
increase efficiency of##2##3##(1996-1#1)(2008-3#1)
increase efficiency##4##2##(1996-1#1)(2008-11#1)(2008-12#1)(2008-3#1)
increase exercise##2##2##(2013-1#1)(2013-8#1)
increase expression##2##2##(1994-11#1)(2008-8#1)
increase for##6##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)
increase from##6##2##(1997-6#1)(2008-10#3)(2009-10#1)(2013-1#1)
increase funding for##2##3##(1994-1#1)(2008-10#1)
increase health-span##2##2##(2008-11#2)
increase if##2##2##(2008-10#2)
increase in CMV##2##3##(2008-10#2)
increase in DNA content##2##4##(2008-11#2)
increase in DNA##3##3##(2008-11#3)
increase in IL-2SA expression##2##4##(2008-11#2)
increase in IOP was obtained##2##5##(2013-1#2)
increase in IOP##3##3##(2013-1#3)
increase in IRS-I tyrosine phosphorylation##2##5##(1997-1#2)
increase in IRS-I##3##3##(1997-1#3)
increase in LDH##2##3##(1997-7#1)(2008-11#1)
increase in LDL metabolism##2##4##(1993-6#2)
increase in LDL##3##3##(1993-6#2)(1994-11#1)
increase in MnSOD##2##3##(1995-6#2)
increase in Pythium spp##2##4##(2008-10#2)
increase in [Ca2+]i##6##3##(1992-6#2)(1994-11#1)(1994-3#1)(1997-1#2)
increase in [cAMP]i##2##3##(1991-3#2)
increase in a##2##3##(2008-9#1)(2012-2#1)
increase in absorbance##3##3##(2008-10#3)
increase in acetylcholine levels##2##4##(1994-8#2)
increase in all##2##3##(2008-10#1)(2012-2#1)
increase in apoptosis##3##3##(1997-7#1)(2008-7#2)
increase in average##2##3##(1992-12#1)(2008-12#1)
increase in basal##3##3##(1993-8#1)(1995-11#1)(1995-6#1)
increase in blood flow velocity##2##5##(1996-3#2)
increase in blood flow##3##4##(1996-3#2)(2008-12#1)
increase in blood##4##3##(1996-3#2)(2008-10#1)(2008-12#1)
increase in body weight##2##4##(2008-7#1)(2013-1#1)
increase in body##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
increase in both##3##3##(1993-8#1)(1997-1#1)(2006-6#1)
increase in cell##7##3##(1995-11#1)(1995-2#1)(1996-2#1)(2008-11#1)(2011-1#2)(2013-8#1)
increase in chickpea##2##3##(2008-10#2)
increase in chitinase and beta-1##2##5##(2008-10#2)
increase in chitinase##3##3##(2008-10#3)
increase in collagen##2##3##(2008-5#1)(2009-8#1)
increase in core temperature##2##4##(1992-3#2)
increase in coverage##2##3##(1994-3#1)(2008-11#1)
increase in cytosolic##5##3##(1992-4#1)(1995-11#2)(2008-10#1)(2008-7#1)
increase in disease severity##2##4##(2008-10#2)
increase in disease##5##3##(2008-10#5)
increase in dopamine##2##3##(1994-2#1)(2009-8#1)
increase in effluent##2##3##(2008-12#1)(2008-7#1)
increase in electrolyte leakage##3##4##(2008-10#3)
increase in electrolyte loss##2##4##(2008-10#2)
increase in electrolyte##5##3##(2008-10#5)
increase in expression##2##3##(1993-8#1)(1996-12#1)
increase in extracellular##2##3##(1994-2#1)(1994-8#1)
increase in fluctuation##2##3##(1996-3#2)
increase in fluorescence intensity and##2##5##(2008-10#2)
increase in fluorescence intensity##3##4##(2008-10#3)
increase in fluorescence##5##3##(2008-10#5)
increase in flux##2##3##(1991-3#1)(1995-6#1)
increase in frequency of##2##4##(2008-10#2)
increase in frequency##3##3##(1992-3#1)(2008-10#2)
increase in growth rate##2##4##(2008-11#1)(2008-12#1)
increase in hospital##2##3##(1997-5#1)(2013-8#1)
increase in incidence##2##3##(1990-11#1)(2010-8#1)
increase in inflammatory##2##3##(1997-1#1)(2008-3#1)
increase in informational entropy##2##4##(1993-12#2)
increase in insulin##2##3##(2008-4#1)(2011-1#1)
increase in intracellular##7##3##(1991-5#1)(1995-11#1)(1995-8#2)(2008-11#1)(2008-7#1)(2012-2#1)
increase in lactate##2##3##(1994-2#1)(1995-12#1)
increase in mRNA##2##3##(1994-11#1)(2008-11#1)
increase in maternal##2##3##(2008-8#1)(2012-3#1)
increase in maximum##2##3##(1994-3#1)(2011-2#1)
increase in mean##2##3##(1990-9#1)(2011-2#1)
increase in mortality##6##3##(1991-3#1)(2008-8#1)(2008-9#2)(2013-8#2)
increase in number in##2##4##(2008-8#1)(2012-3#1)
increase in number##4##3##(2008-8#1)(2012-2#1)(2012-3#2)
increase in perfusion##2##3##(1993-3#2)
increase in physical activity##2##4##(2010-1#1)(2012-12#1)
increase in plant growth##2##4##(2013-8#2)
increase in plasma##4##3##(1996-12#1)(2008-10#1)(2008-6#1)(2010-10#1)
increase in prevalence##2##3##(2013-1#1)(2013-8#1)
increase in protein kinase##2##4##(1994-5#1)(2010-12#1)
increase in protein##4##3##(1993-6#1)(1994-5#1)(2008-7#1)(2010-12#1)
increase in reported##2##3##(1991-9#1)(1992-2#1)
increase in rice##2##3##(2008-10#1)(2013-8#1)
increase in risk##3##3##(2008-7#2)(2011-2#1)
increase in sensitivity##6##3##(1991-6#1)(2008-10#4)(2008-3#1)
increase in serum##5##3##(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)
increase in size and##2##4##(2007-12#2)
increase in size##6##3##(1993-12#1)(2007-12#3)(2008-5#1)(2013-1#1)
increase in specific##4##3##(1993-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
increase in superoxide##2##3##(1994-11#1)(2012-2#1)
increase in temperature##3##3##(1997-2#2)(2012-6#1)
increase in the activity of##5##5##(1994-5#1)(1995-2#1)(1997-1#1)(2008-11#2)
increase in the amount of the##2##6##(1992-6#1)(2009-8#1)
increase in the amount of##8##5##(1992-6#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#2)
increase in the concentration of the##2##6##(1995-3#1)(2008-10#1)
increase in the concentration of##5##5##(1993-3#1)(1995-3#1)(2008-10#2)(2012-2#1)
increase in the concentration##6##4##(1993-3#1)(1995-3#1)(2008-10#2)(2011-2#1)(2012-2#1)
increase in the expression of##3##5##(1994-8#1)(2008-10#1)(2012-3#1)
increase in the fluorescence intensity##2##5##(1995-6#1)(2008-10#1)
increase in the fluorescence##3##4##(1995-6#1)(2008-10#2)
increase in the incidence of##9##5##(1994-3#1)(1996-6#2)(2008-1#1)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-7#1)
increase in the level of##3##5##(1997-7#1)(2009-8#2)
increase in the levels of##4##5##(1994-2#1)(2008-10#2)(2008-12#1)
increase in the mRNA##2##4##(2008-11#1)(2010-1#1)
increase in the mean##4##4##(1990-9#1)(1993-1#1)(2008-11#1)(2008-9#1)
increase in the number of people##2##6##(1992-2#1)(2008-6#1)
increase in the number of##21##5##(1992-2#1)(1994-12#1)(1994-3#1)(1997-2#2)(1997-6#2)(2008-10#7)(2008-5#1)(2008-6#2)(2010-11#1)(2011-2#2)(2012-3#1)
increase in the number##24##4##(1992-2#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-2#3)(1997-6#2)(2008-10#7)(2008-5#1)(2008-6#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-3#1)
increase in the odds of##2##5##(2013-1#2)
increase in the order##2##4##(2008-10#2)
increase in the peak##2##4##(2008-10#1)(2008-11#1)
increase in the population of##2##5##(2008-8#1)(2011-2#1)
increase in the proportion of APP##2##6##(1996-12#2)
increase in the proportion of##5##5##(1991-12#1)(1996-12#2)(2007-12#1)(2008-12#1)
increase in the rate of [3H]dTTP incorporation into DNA##2##9##(1994-5#2)
increase in the rate of##4##5##(1990-5#1)(1994-5#2)(1995-6#1)
increase in the sensitivity of the##2##6##(2008-10#2)
increase in the sensitivity##3##4##(1995-2#1)(2008-10#2)
increase in the total##4##4##(1994-5#1)(1997-1#1)(2008-10#2)
increase in the##237##3##(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#4)(1995-3#3)(1995-6#3)(1996-12#2)(1996-6#3)(1997-1#5)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#49)(2008-11#22)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#7)(2009-3#1)(2009-7#2)(2009-8#7)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-8#2)(2011-1#5)(2011-2#11)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#3)
increase in total##5##3##(1992-11#1)(1994-3#1)(2008-11#1)(2008-12#1)(2008-9#1)
increase in virus##2##3##(2008-10#1)(2008-11#1)
increase in volumetric##2##3##(2008-11#1)(2008-7#1)
increase in water##3##3##(1994-8#1)(2008-5#2)
increase in weight##2##3##(1991-2#2)
increase in yield##3##3##(2008-10#3)
increase in##850##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#3)(1990-5#6)(1990-6#4)(1990-7#3)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#8)(1991-2#3)(1991-3#9)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#7)(1992-4#1)(1992-6#11)(1992-7#1)(1992-8#4)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#8)(1993-6#6)(1993-8#5)(1994-11#5)(1994-12#3)(1994-2#7)(1994-3#12)(1994-5#8)(1994-6#2)(1994-8#10)(1995-1#3)(1995-11#10)(1995-12#3)(1995-2#8)(1995-3#4)(1995-5#1)(1995-6#9)(1995-8#5)(1996-1#1)(1996-12#17)(1996-2#6)(1996-3#9)(1996-6#3)(1997-1#15)(1997-2#9)(1997-3#6)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#4)(2006-6#1)(2007-11#2)(2007-12#9)(2007-8#1)(2008-1#3)(2008-10#145)(2008-11#74)(2008-12#23)(2008-2#2)(2008-3#18)(2008-4#1)(2008-5#18)(2008-6#7)(2008-7#27)(2008-8#18)(2008-9#19)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#3)(2009-8#14)(2010-1#4)(2010-10#4)(2010-11#1)(2010-12#7)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#13)(2011-10#1)(2011-2#29)(2011-3#1)(2012-12#3)(2012-2#21)(2012-3#11)(2012-6#2)(2012-9#3)(2013-1#28)(2013-7#4)(2013-8#19)
increase is##13##2##(1991-3#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
increase its##5##2##(1994-3#2)(2008-10#1)(2008-11#1)(2008-7#1)
increase methane production##2##3##(2013-1#2)
increase microbial##2##2##(2008-10#1)(2010-4#1)
increase of NGFI-B mRNA##2##4##(1996-12#2)
increase of NPC##2##3##(2011-2#2)
increase of activity of##2##4##(2013-1#2)
increase of activity##3##3##(2008-11#1)(2013-1#2)
increase of both free and membrane-bound ribosomes##2##7##(2008-7#2)
increase of both##4##3##(1993-12#1)(2008-10#1)(2008-7#2)
increase of cytosolic##2##3##(1996-2#1)(2008-11#1)
increase of efficiency##2##3##(2008-10#1)(2008-8#1)
increase of final monoclonalantibody##2##4##(2008-11#2)
increase of fluorescence##3##3##(2008-10#3)
increase of intracellular##3##3##(1995-8#1)(2008-11#1)(2008-8#1)
increase of its##5##3##(1993-3#1)(2008-10#3)(2012-3#1)
increase of osmotic pressure from 300 mOsmol kg-1 to 366 mOsmol##2##11##(2008-11#2)
increase of osmotic pressure##6##4##(2008-11#6)
increase of serum##3##3##(1990-12#1)(2009-8#1)(2010-12#1)
increase of specific##2##3##(2008-11#1)(2008-7#1)
increase of surface potential##2##4##(2008-10#2)
increase of the cell##2##4##(1995-9#1)(2008-11#1)
increase of the signal##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
increase of the specific##2##4##(2008-11#1)(2008-7#1)
increase of the##43##3##(1993-8#1)(1995-9#1)(1997-5#1)(2008-10#15)(2008-11#10)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-3#1)
increase of##229##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#4)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-8#5)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#1)(1997-1#2)(1997-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#50)(2008-11#30)(2008-12#7)(2008-3#4)(2008-5#11)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#3)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-10#1)(2011-2#7)(2011-3#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#2)
increase on##3##2##(1997-8#1)(2008-10#1)(2009-11#1)
increase or decrease##5##3##(1990-9#1)(1996-2#1)(2008-10#1)(2008-3#2)
increase or##6##2##(1990-9#1)(1996-2#1)(2008-10#1)(2008-3#2)(2009-10#1)
increase our understanding of the##2##5##(2008-10#1)(2011-2#1)
increase our understanding of##6##4##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
increase our understanding##7##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
increase our##8##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
increase over##2##2##(2008-10#1)(2008-11#1)
increase paralleled##2##2##(1992-2#1)(2008-10#1)
increase product##2##2##(2008-10#1)(2008-5#1)
increase productivity##3##2##(1991-3#1)(1993-3#1)(2008-11#1)
increase public awareness of##2##4##(1994-1#1)(2008-10#1)
increase risk##3##2##(2009-12#2)(2012-12#1)
increase seen in##2##3##(1996-2#1)(2008-9#1)
increase sensitivity and selectivity##2##4##(2008-10#2)
increase sensitivity and##3##3##(2008-10#3)
increase sensitivity##6##2##(2008-10#6)
increase significantly in##2##3##(1994-1#1)(2008-10#1)
increase significantly the##2##3##(2008-3#1)(2013-1#1)
increase significantly##9##2##(1994-1#1)(2008-10#4)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
increase surface##2##2##(2009-7#1)(2013-1#1)
increase the amount of##2##4##(1997-3#1)(2013-8#1)
increase the binding of##2##4##(1993-6#1)(1995-2#1)
increase the binding##3##3##(1991-12#1)(1993-6#1)(1995-2#1)
increase the efficiency##2##3##(2008-3#1)(2008-7#1)
increase the frequency##2##3##(2008-10#1)(2008-11#1)
increase the incidence and severity of##2##6##(2008-10#1)(2012-3#1)
increase the incidence of##2##4##(2008-10#1)(2013-8#1)
increase the incidence##4##3##(2008-10#2)(2012-3#1)(2013-8#1)
increase the level of##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
increase the likelihood of##7##4##(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)
increase the likelihood##8##3##(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-12#1)
increase the longevity of##2##4##(2008-10#1)(2008-11#1)
increase the number of##4##4##(1993-11#1)(2008-10#1)(2008-8#2)
increase the probability of##5##4##(1991-12#1)(2008-3#1)(2008-7#3)
increase the probability##6##3##(1991-12#1)(2008-11#1)(2008-3#1)(2008-7#3)
increase the proportion of##2##4##(1994-2#1)(2008-11#1)
increase the quality##2##3##(2011-2#1)(2011-7#1)
increase the range of##2##4##(1994-5#1)(2012-3#1)
increase the risk of cancer##2##5##(2008-7#1)(2013-1#1)
increase the risk of##9##4##(1990-11#1)(1996-6#1)(2008-11#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
increase the risk##10##3##(1990-11#1)(1996-6#1)(2008-11#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
increase the safety##2##3##(2011-2#1)(2013-1#1)
increase the sensitivity of the##4##5##(2008-10#3)(2008-9#1)
increase the sensitivity of##6##4##(1997-3#1)(2008-10#3)(2008-9#1)(2011-2#1)
increase the sensitivity##12##3##(1997-3#1)(2008-10#9)(2008-9#1)(2011-2#1)
increase the size of the##2##5##(2008-3#1)(2008-5#1)
increase the solubility of##2##4##(2008-10#2)
increase the stability of the##2##5##(2008-10#1)(2011-2#1)
increase the##174##2##(1990-11#2)(1990-12#1)(1991-12#3)(1991-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#2)(1994-5#2)(1994-8#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-5#1)(2008-1#2)(2008-10#34)(2008-11#19)(2008-12#1)(2008-3#9)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#4)
increase their##12##2##(1990-12#1)(1992-12#1)(1993-11#1)(1993-2#1)(1996-3#1)(2008-11#2)(2008-9#1)(2010-1#1)(2011-7#1)(2012-3#1)(2013-1#1)
increase this##2##2##(1991-12#1)(2008-10#1)
increase to##8##2##(1990-12#1)(1991-5#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)
increase understanding of##2##3##(2008-12#1)(2013-8#1)
increase understanding##3##2##(2008-12#2)(2013-8#1)
increase urinary##2##2##(1991-12#2)
increase was detected##2##3##(2008-5#1)(2013-1#1)
increase was found in##2##4##(1992-12#1)(2008-7#1)
increase was not statistically significant##2##5##(2008-12#1)(2012-2#1)
increase was not##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
increase was observed in##2##4##(1996-2#1)(2008-12#1)
increase was observed##5##3##(1995-11#1)(1995-8#1)(1996-2#1)(2008-12#1)(2013-1#1)
increase was##33##2##(1990-11#1)(1990-8#1)(1991-8#1)(1992-12#2)(1992-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
increase when##2##2##(2008-10#1)(2008-9#1)
increase with age##2##3##(1997-7#1)(2010-8#1)
increase with increasing age##2##4##(1996-6#1)(2008-8#1)
increase with increasing##7##3##(1996-6#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)
increase with the##7##3##(1997-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)
increase with##33##2##(1991-2#1)(1993-12#1)(1995-2#1)(1996-2#2)(1996-6#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#5)(2010-11#1)(2010-8#1)(2013-1#1)
increase yields##2##2##(2008-11#2)
increase##1829##1##(1990-10#3)(1990-11#5)(1990-12#12)(1990-2#4)(1990-5#7)(1990-6#7)(1990-7#3)(1990-8#5)(1990-9#4)(1991-1#3)(1991-11#3)(1991-12#19)(1991-2#10)(1991-3#15)(1991-5#6)(1991-6#6)(1991-8#7)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#10)(1992-2#6)(1992-3#9)(1992-4#1)(1992-6#14)(1992-7#3)(1992-8#6)(1992-9#1)(1993-1#4)(1993-11#3)(1993-12#9)(1993-2#7)(1993-3#14)(1993-6#11)(1993-8#14)(1993-9#1)(1994-1#6)(1994-11#8)(1994-12#4)(1994-2#14)(1994-3#16)(1994-5#11)(1994-6#4)(1994-8#17)(1994-9#1)(1995-1#4)(1995-11#12)(1995-12#7)(1995-2#14)(1995-3#7)(1995-5#9)(1995-6#12)(1995-8#13)(1995-9#3)(1996-1#6)(1996-11#5)(1996-12#29)(1996-2#24)(1996-3#14)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#23)(1997-2#11)(1997-3#12)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#8)(1997-8#6)(2006-6#1)(2007-11#2)(2007-12#18)(2007-8#2)(2008-1#12)(2008-10#343)(2008-11#168)(2008-12#40)(2008-2#3)(2008-3#43)(2008-4#4)(2008-5#48)(2008-6#10)(2008-7#60)(2008-8#65)(2008-9#47)(2009-1#2)(2009-10#8)(2009-11#6)(2009-12#6)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#6)(2009-7#9)(2009-8#23)(2009-9#1)(2010-1#5)(2010-10#9)(2010-11#7)(2010-12#13)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#4)(2010-7#6)(2010-8#7)(2010-9#1)(2011-1#16)(2011-10#2)(2011-2#61)(2011-3#5)(2011-7#2)(2012-12#10)(2012-2#43)(2012-3#26)(2012-5#2)(2012-6#2)(2012-9#3)(2013-1#72)(2013-7#4)(2013-8#30)
increase) and##2##2##(1995-5#1)(2013-1#1)
increase) in the left eye (both significant at P &lt##2##9##(2013-1#2)
increase)##6##1##(1995-5#2)(2008-10#1)(2013-1#3)
increased (P &lt##3##3##(1992-12#1)(2011-3#2)
increased (P&lt##3##2##(2008-5#1)(2009-10#1)(2013-1#1)
increased (by##2##2##(2008-11#1)(2008-12#1)
increased (p &lt##2##3##(2008-12#1)(2013-8#1)
increased (p##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
increased 1 year after transplantation##2##5##(2011-2#2)
increased 1##3##2##(1990-5#1)(2011-2#2)
increased 3##2##2##(2011-2#1)(2011-3#1)
increased 3-fold in##2##3##(1990-12#1)(1995-6#1)
increased BDNF##2##2##(1997-2#1)(2012-2#1)
increased DNA synthesis##2##3##(1990-11#2)
increased DNA##3##2##(1990-11#2)(2013-1#1)
increased GSH##2##2##(2008-10#1)(2010-5#1)
increased MnSOD##2##2##(1995-6#2)
increased NGF##2##2##(1996-12#1)(1996-2#1)
increased P##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
increased ability to##3##3##(1995-2#1)(2010-2#1)(2011-1#1)
increased about##4##2##(1990-5#1)(1995-2#1)(1995-8#1)(2008-10#1)
increased according to the##2##4##(2008-10#2)
increased according to##3##3##(2008-10#2)(2008-12#1)
increased accumulation of##2##3##(1995-2#1)(2008-9#1)
increased activation in##2##3##(2008-11#2)
increased activation of the##2##4##(1993-6#1)(1996-6#1)
increased activation of##3##3##(1993-6#1)(1996-12#1)(1996-6#1)
increased activation##5##2##(1993-6#1)(1996-12#1)(1996-6#1)(2008-11#2)
increased activity of##2##3##(1992-5#1)(2008-7#1)
increased activity##4##2##(1992-5#1)(1995-2#1)(2008-11#1)(2008-7#1)
increased affinity for##5##3##(1990-2#1)(1991-12#1)(1992-6#1)(1995-2#1)(1995-6#1)
increased affinity##6##2##(1990-2#1)(1991-12#1)(1992-6#1)(1995-2#1)(1995-6#2)
increased after the##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
increased after##15##2##(1991-12#1)(1991-6#1)(1993-6#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-6#3)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
increased again##4##2##(1997-3#1)(2008-10#3)
increased aggressiveness##5##2##(2008-10#5)
increased alcohol##3##2##(2008-1#1)(2010-7#1)(2010-9#1)
increased allocation of##2##3##(2008-9#2)
increased allocation##3##2##(2008-8#1)(2008-9#2)
increased amounts of##3##3##(1991-5#1)(1993-3#1)(2012-2#1)
increased amounts##4##2##(1991-5#2)(1993-3#1)(2012-2#1)
increased and that##2##3##(1996-12#1)(2008-11#1)
increased and the##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
increased and their##2##3##(1996-6#1)(2008-5#1)
increased and##19##2##(1993-1#1)(1994-11#1)(1994-8#2)(1996-12#1)(1996-6#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
increased anxiety##2##2##(1996-2#2)
increased apoptosis##2##2##(2012-4#1)(2013-1#1)
increased approximately##3##2##(1995-8#1)(2008-10#1)(2008-11#1)
increased as a saturation-type curve with##2##6##(2008-10#2)
increased as a##3##3##(2008-10#3)
increased as the##12##3##(1997-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-3#1)
increased as##27##2##(1991-5#1)(1992-2#1)(1993-12#1)(1997-8#1)(2008-10#12)(2008-11#5)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-3#1)
increased at a higher rate##2##5##(2008-10#1)(2008-11#1)
increased at a##3##3##(2008-10#1)(2008-11#2)
increased at an average annual rate of##2##7##(1993-1#1)(1993-3#1)
increased at an##3##3##(1993-1#1)(1993-3#1)(2008-5#1)
increased at the##4##3##(1993-8#1)(2008-10#1)(2008-9#1)(2013-7#1)
increased at##20##2##(1991-2#1)(1993-1#2)(1993-3#1)(1993-8#1)(1994-5#1)(1995-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-9#2)(2013-1#1)(2013-7#1)
increased attention##6##2##(1992-1#1)(1994-3#2)(2008-10#1)(2008-11#1)(2010-5#1)
increased availability of##2##3##(2008-8#1)(2010-7#1)
increased availability##3##2##(2008-8#1)(2010-7#1)(2012-3#1)
increased awareness of##3##3##(1997-1#1)(2008-12#1)(2009-5#1)
increased awareness##4##2##(1994-1#1)(1997-1#1)(2008-12#1)(2009-5#1)
increased bacterial##2##2##(2008-10#1)(2009-8#1)
increased basal##2##2##(1997-1#2)
increased baseline risk##2##3##(2008-11#2)
increased between##3##2##(1996-12#1)(2008-10#2)
increased binding##5##2##(1993-1#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-7#1)
increased blood loss##2##3##(2011-2#1)(2012-12#1)
increased blood##7##2##(1992-6#1)(1994-5#1)(2008-11#1)(2011-2#1)(2012-12#2)(2013-8#1)
increased body mass index and##2##5##(2008-11#1)(2011-2#1)
increased body weight##2##3##(2008-10#1)(2013-1#1)
increased body##5##2##(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
increased bone##2##2##(2008-11#1)(2008-7#1)
increased both the##2##3##(1997-1#1)(2008-10#1)
increased both##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2012-2#1)
increased bronchial##2##2##(1992-5#1)(2010-5#1)
increased by 0##2##3##(1993-1#1)(1995-12#1)
increased by 1##2##3##(1991-5#1)(2008-10#1)
increased by 16##2##3##(2008-10#1)(2013-8#1)
increased by 18%##3##3##(1996-2#1)(2008-11#1)(2011-2#1)
increased by 25%##2##3##(2008-11#1)(2013-1#1)
increased by MHT##2##3##(2011-2#2)
increased by a factor of 30##2##6##(1993-9#1)(1995-3#1)
increased by a factor of##5##5##(1992-3#1)(1993-9#1)(1995-3#1)(2008-10#2)
increased by an##2##3##(1995-3#1)(1997-4#1)
increased by interferon-gamma##2##3##(1997-1#2)
increased by more than##2##4##(1996-2#1)(2008-7#1)
increased by the##3##3##(2008-10#2)(2013-1#1)
increased by up to##3##4##(1996-2#1)(2008-11#2)
increased by##101##2##(1990-3#1)(1991-3#3)(1991-5#1)(1991-8#3)(1991-9#1)(1992-2#1)(1992-3#4)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#2)(1995-12#2)(1995-3#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#4)(1997-1#5)(1997-4#1)(1997-6#1)(1997-8#2)(2008-10#18)(2008-11#13)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#3)(2010-10#1)(2011-2#7)(2012-12#1)(2012-6#1)(2013-1#4)(2013-8#6)
increased cAMP##3##2##(1995-8#3)
increased cancer latency and##2##4##(2008-7#2)
increased cancer##4##2##(1997-1#1)(2008-7#2)(2011-3#1)
increased capacity##2##2##(2008-10#1)(2008-9#1)
increased cardiac output##2##3##(2008-12#1)(2010-10#1)
increased cardiovascular risk and##2##4##(2008-6#1)(2009-10#1)
increased cardiovascular risk##3##3##(2008-6#1)(2009-10#1)(2012-3#1)
increased cardiovascular##4##2##(2008-1#1)(2008-6#1)(2009-10#1)(2012-3#1)
increased cell##8##2##(1992-8#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-6#1)(2012-5#1)
increased cellular##2##2##(1991-3#1)(2008-7#1)
increased cerebral##2##2##(2008-5#1)(2013-8#1)
increased chitinase and beta-1##2##4##(2008-10#2)
increased clinical##2##2##(1991-12#1)(2012-12#1)
increased cobalamin production##2##3##(2011-1#2)
increased cognitive##2##2##(2012-2#2)
increased collagen##3##2##(1994-12#1)(2008-11#1)(2012-3#1)
increased compared to##2##3##(1992-12#1)(1995-12#1)
increased compared##3##2##(1992-12#1)(1995-12#1)(2008-10#1)
increased competition##2##2##(1991-3#1)(1996-1#1)
increased concentration of##2##3##(2008-11#1)(2008-7#1)
increased concentrations of##2##3##(2008-10#1)(2008-11#1)
increased concordance##2##2##(1995-12#1)(2012-3#1)
increased conidial##2##2##(2008-10#2)
increased costs##2##2##(2010-7#1)(2012-3#1)
increased cyclic##2##2##(1994-2#1)(1995-8#1)
increased daily efficiency##3##3##(2010-8#3)
increased daily##5##2##(1991-12#1)(1997-1#1)(2010-8#3)
increased demand for##2##3##(1996-2#1)(1997-3#1)
increased demand##3##2##(1990-6#1)(1996-2#1)(1997-3#1)
increased demands##2##2##(1996-2#1)(2008-10#1)
increased density of##2##3##(2008-11#1)(2012-5#1)
increased density##3##2##(2008-11#1)(2008-7#1)(2012-5#1)
increased discussion##2##2##(2008-11#1)(2013-8#1)
increased disease severity##5##3##(2008-10#5)
increased disease##6##2##(2008-10#6)
increased dramatically##7##2##(1995-12#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)
increased due to##4##3##(2008-10#3)(2008-5#1)
increased during the first##2##4##(1991-12#1)(2008-10#1)
increased during the fruit development##2##5##(2008-9#2)
increased during the##16##3##(1991-12#2)(1992-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-2#1)(2013-1#1)
increased during##32##2##(1991-12#3)(1991-5#1)(1992-12#3)(1993-6#1)(1995-5#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
increased earlier##2##2##(1994-8#1)(1996-3#1)
increased efficiency##2##2##(1996-3#1)(2008-11#1)
increased emergence by##2##3##(2008-10#2)
increased enzyme##2##2##(2008-10#1)(2008-7#1)
increased epsilon 4 allele frequency##2##5##(1995-12#2)
increased even after##2##3##(2008-11#1)(2008-6#1)
increased exponentially##4##2##(2008-10#3)(2009-8#1)
increased exposure of##2##3##(1993-1#1)(2011-2#1)
increased exposure##3##2##(1993-1#1)(2008-9#1)(2011-2#1)
increased expression of the##3##4##(1991-3#1)(1995-2#1)(2008-11#1)
increased expression of##15##3##(1991-3#1)(1992-3#1)(1992-7#1)(1995-2#2)(1997-2#1)(1997-7#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-3#1)
increased expression##17##2##(1991-3#1)(1992-3#1)(1992-7#1)(1995-2#2)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#3)(2012-3#1)
increased first##2##2##(2008-11#1)(2008-8#1)
increased fitness##2##2##(2008-10#1)(2011-2#1)
increased flexion angle##2##3##(2011-2#1)(2013-1#1)
increased following##4##2##(1992-5#1)(2008-10#1)(2008-11#2)
increased food intake##3##3##(2009-12#3)
increased for##4##2##(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
increased formation of##4##3##(2007-11#1)(2008-10#3)
increased frequencies of##2##3##(2008-9#1)(2009-10#1)
increased frequency of##9##3##(1991-3#1)(1991-5#1)(1991-9#1)(1992-9#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-5#1)
increased from &lt##3##3##(1995-6#1)(2008-10#2)
increased from 0 to 1##2##5##(2008-10#2)
increased from 0 to##4##4##(2008-10#4)
increased from 0##13##3##(1991-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2010-10#1)(2010-4#1)
increased from 0% in##2##4##(1995-1#1)(2013-8#1)
increased from 0%##3##3##(1995-1#1)(2013-1#1)(2013-8#1)
increased from 1##5##3##(1993-8#1)(2008-10#1)(2008-3#1)(2009-11#1)(2013-1#1)
increased from 12 to##2##4##(2008-10#2)
increased from 23##2##3##(1995-3#1)(2008-10#1)
increased from 3##2##3##(1994-3#1)(2008-11#1)
increased from day##2##3##(2011-2#1)(2012-3#1)
increased from the##3##3##(2008-9#1)(2010-5#1)(2012-12#1)
increased from##68##2##(1990-12#1)(1991-11#1)(1991-2#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#1)(1997-4#1)(1997-6#1)(2008-10#26)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
increased fungus##2##2##(2008-10#2)
increased further##3##2##(2008-10#1)(2008-11#2)
increased ghrelin##2##2##(2012-3#1)(2013-8#1)
increased gradually##7##2##(2008-10#3)(2008-8#1)(2011-1#1)(2013-8#2)
increased greatly##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
increased growth##4##2##(1992-8#2)(2008-10#2)
increased hair loss##3##3##(2008-5#2)(2012-3#1)
increased health##3##2##(1996-1#1)(2008-10#1)(2009-6#1)
increased healthcare##2##2##(2010-12#1)(2013-1#1)
increased hepatic long-chain acyl-CoA##2##4##(1994-8#2)
increased hepatic##4##2##(1993-12#1)(1994-8#2)(2008-6#1)
increased hospital##2##2##(1993-1#1)(2012-3#1)
increased host##2##2##(2008-10#1)(2008-9#1)
increased hydration##2##2##(2008-10#1)(2008-5#1)
increased if##2##2##(1996-3#1)(2008-10#1)
increased immediately##2##2##(2008-9#1)(2013-8#1)
increased in 400 and 800 mg/L##3##6##(2008-9#3)
increased in 400##4##3##(2008-9#4)
increased in 500 mg/kg males##2##5##(2008-9#2)
increased in a##4##3##(1992-6#1)(2008-11#1)(2008-6#1)(2008-9#1)
increased in all##8##3##(1990-5#1)(1995-11#1)(2008-7#2)(2008-9#2)(2009-3#1)(2013-1#1)
increased in both##6##3##(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)
increased in frequency##4##3##(2008-10#3)(2008-7#1)
increased in number##2##3##(2008-11#1)(2011-2#1)
increased in patients with##2##4##(1995-12#1)(2011-1#1)
increased in patients##4##3##(1995-12#1)(1997-8#1)(2008-7#1)(2011-1#1)
increased in proportion to##2##4##(2008-11#1)(2008-7#1)
increased in recent years##2##4##(1993-1#1)(2008-10#1)
increased in response to##2##4##(1990-5#1)(2008-10#1)
increased in size##4##3##(1992-12#1)(1993-12#1)(2008-10#1)(2008-11#1)
increased in the final##2##4##(2011-7#1)(2013-1#1)
increased in the first##2##4##(2008-10#1)(2013-1#1)
increased in the following order##2##5##(2008-10#2)
increased in the past##2##4##(1993-3#1)(2012-2#1)
increased in the presence of the##2##6##(1997-1#1)(2008-10#1)
increased in the presence of##8##5##(1990-5#1)(1993-3#1)(1993-6#1)(1994-5#1)(1997-1#1)(2008-10#3)
increased in the##56##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#17)(2008-11#5)(2008-12#2)(2008-7#1)(2008-9#2)(2011-7#1)(2012-2#1)(2012-6#1)(2013-1#5)
increased in vitro##3##3##(1991-12#1)(1997-2#1)(2008-10#1)
increased in##192##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-3#2)(1996-11#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#40)(2008-11#20)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#21)(2009-3#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-6#1)(2012-8#1)(2013-1#7)(2013-8#2)
increased incidence in##3##3##(2008-9#2)(2012-3#1)
increased incidence of##11##3##(1990-11#1)(1994-5#2)(1996-3#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#2)(2013-7#1)
increased incidence##14##2##(1990-11#1)(1994-5#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-7#1)
increased incidences of##6##3##(2008-9#6)
increased incidences##8##2##(2008-9#8)
increased incubation time##2##3##(1993-8#1)(2008-10#1)
increased inflammation##2##2##(2008-3#1)(2011-2#1)
increased insulin secretion##2##3##(2010-11#2)
increased insulin##4##2##(1995-6#1)(2010-11#2)(2011-2#1)
increased intake##2##2##(2008-4#1)(2008-6#1)
increased intracellular levels of##2##4##(1997-2#2)
increased intracellular##6##2##(1993-8#1)(1997-2#2)(1997-8#1)(2008-10#1)(2008-11#1)
increased intracranial pressure##7##3##(1997-3#1)(2008-1#1)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#1)
increased knowledge of##3##3##(1994-1#1)(2008-9#2)
increased knowledge##5##2##(1994-1#1)(2008-8#1)(2008-9#2)(2010-10#1)
increased largely##2##2##(2008-10#2)
increased left##2##2##(2008-1#1)(2011-2#1)
increased length of##2##3##(2008-6#1)(2013-1#1)
increased level of##2##3##(1995-11#1)(2013-1#1)
increased levels of the##2##4##(1992-9#1)(2008-10#1)
increased levels of transaminases##2##4##(1992-5#1)(2012-12#1)
increased levels of##17##3##(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
increased life##3##2##(1992-9#1)(2008-8#1)(2012-12#1)
increased likelihood of##8##3##(1995-12#1)(1995-2#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
increased likelihood##9##2##(1992-1#1)(1995-12#1)(1995-2#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
increased linearly as##2##3##(2008-10#1)(2008-11#1)
increased linearly with the##3##4##(2008-10#2)(2008-11#1)
increased linearly with##8##3##(2008-10#6)(2008-11#1)(2008-8#1)
increased linearly##14##2##(2008-10#10)(2008-11#3)(2008-8#1)
increased liver##3##2##(1995-11#1)(2012-3#2)
increased markedly##3##2##(1992-3#1)(2008-10#2)
increased maternal##2##2##(2009-7#1)(2013-1#1)
increased melanin##3##2##(2008-5#1)(2010-6#1)(2011-2#1)
increased membrane##4##2##(1995-8#1)(1997-1#1)(2008-7#1)(2008-9#1)
increased metabolic activity##2##3##(1992-3#2)
increased metabolic load##4##3##(2008-11#4)
increased metabolic##9##2##(1992-3#2)(1994-8#1)(1996-3#1)(2008-11#4)(2010-12#1)
increased metabolism##2##2##(1993-12#1)(2012-3#1)
increased morbidity and mortality##2##4##(2012-3#2)
increased morbidity##4##2##(2010-12#1)(2012-3#2)(2013-1#1)
increased more than##2##3##(1996-3#1)(2008-8#1)
increased more##5##2##(1996-3#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)
increased mortality and##2##3##(2008-10#1)(2008-11#1)
increased mortality##11##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-8#1)
increased much##2##2##(2008-10#1)(2008-11#1)
increased muscle tone##2##3##(1995-2#1)(2008-12#1)
increased muscle##3##2##(1995-2#1)(2008-12#1)(2010-6#1)
increased nearly##2##2##(2008-7#1)(2013-8#1)
increased need to##2##3##(1995-3#1)(1996-9#1)
increased number of##9##3##(1990-12#1)(1991-12#1)(1991-3#1)(1994-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)
increased odds##4##2##(2011-2#1)(2012-3#2)(2013-1#1)
increased on##7##2##(1993-12#1)(1994-5#2)(1996-2#1)(2008-10#3)
increased only##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-4#1)
increased or decreased##5##3##(1991-9#1)(2008-10#3)(2012-2#1)
increased or##7##2##(1991-9#1)(1997-1#1)(2008-10#4)(2012-2#1)
increased our understanding of the##2##5##(2009-4#1)(2013-1#1)
increased our##3##2##(2008-11#1)(2009-4#1)(2013-1#1)
increased over a##3##3##(1994-1#1)(2008-10#1)(2008-8#1)
increased over the past##2##4##(2010-6#1)(2011-2#1)
increased over the##5##3##(1997-7#1)(2008-10#2)(2010-6#1)(2011-2#1)
increased over time in##2##4##(2012-2#2)
increased over time##4##3##(1990-12#1)(2009-7#1)(2012-2#2)
increased over##17##2##(1990-12#1)(1994-1#1)(1994-11#1)(1997-7#1)(2008-10#4)(2008-8#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#4)
increased patient##2##2##(2008-10#1)(2010-8#1)
increased personal##2##2##(2010-6#1)(2011-2#1)
increased phosphorylation of##2##3##(2009-6#1)(2012-2#1)
increased physical activity##2##3##(2012-12#1)(2012-2#1)
increased physical##3##2##(2008-6#1)(2012-12#1)(2012-2#1)
increased plant growth and##2##4##(2008-10#2)
increased plant growth##3##3##(2008-10#2)(2008-8#1)
increased plant##8##2##(2008-10#5)(2008-8#3)
increased plasma##4##2##(1994-12#1)(1997-2#1)(2008-5#1)(2008-6#1)
increased plasticity##4##2##(2008-8#4)
increased potency##4##2##(1991-1#2)(1994-5#1)(2009-8#1)
increased prescription##2##2##(2008-11#2)
increased prevalence of##4##3##(1996-11#1)(2008-7#1)(2008-8#1)(2012-5#1)
increased prevalence##5##2##(1996-11#1)(2008-7#2)(2008-8#1)(2012-5#1)
increased production of##6##3##(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)
increased production##7##2##(1994-5#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)
increased productivity##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
increased progressively##4##2##(2008-10#2)(2010-6#1)(2013-8#1)
increased proliferation##3##2##(1993-8#1)(2008-11#1)(2008-5#1)
increased proportionally##2##2##(1991-12#1)(1995-12#1)
increased protein##2##2##(2008-10#1)(2008-7#1)
increased proteinuria##2##2##(1994-5#1)(1996-6#1)
increased pulmonary blood flow##2##4##(1996-3#1)(2010-10#1)
increased pulmonary vascular resistance##2##4##(1990-11#1)(2010-10#1)
increased pulmonary##4##2##(1990-11#1)(1996-3#1)(2010-10#2)
increased rapidly in##2##3##(1997-3#1)(2011-7#1)
increased rapidly with##2##3##(2008-10#1)(2008-7#1)
increased rapidly##8##2##(1996-3#1)(1997-3#1)(2008-10#4)(2008-7#1)(2011-7#1)
increased rate of##7##3##(1990-2#1)(1991-7#1)(1994-3#1)(1994-8#1)(1995-6#1)(2008-10#2)
increased rate##9##2##(1990-2#1)(1991-7#1)(1994-3#1)(1994-8#1)(1995-6#1)(2008-10#3)(2011-2#1)
increased rates of infection##2##4##(2008-10#1)(2013-1#1)
increased rates of##3##3##(1996-12#1)(2008-10#1)(2013-1#1)
increased recently##2##2##(1993-3#1)(1994-1#1)
increased remarkably in##2##3##(1994-11#1)(2008-8#1)
increased resistance to FHB##2##4##(2011-10#2)
increased resistance to##7##3##(2008-10#4)(2008-7#1)(2011-10#2)
increased resistance##8##2##(2008-10#5)(2008-7#1)(2011-10#2)
increased response to##2##3##(1990-11#1)(1995-5#1)
increased response##3##2##(1990-11#1)(1995-5#1)(2008-11#1)
increased risk for complications##2##4##(1990-11#1)(2011-2#1)
increased risk for##26##3##(1990-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#6)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
increased risk of CP##2##4##(2011-2#2)
increased risk of SBI##2##4##(2006-5#2)
increased risk of death##2##4##(2008-11#1)(2011-2#1)
increased risk of developing##8##4##(1990-11#1)(1990-12#1)(1990-9#1)(1994-9#1)(2011-2#2)(2012-3#2)
increased risk of disease##2##4##(2008-10#2)
increased risk of mortality##2##4##(2008-9#1)(2011-2#1)
increased risk of##57##3##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-8#1)(1993-11#1)(1994-3#1)(1994-9#2)(1996-6#1)(2006-5#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-12#2)(2010-6#1)(2011-2#10)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
increased risk##89##2##(1990-11#2)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#2)(1996-11#2)(1996-6#1)(2006-5#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#12)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-7#1)(2010-10#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
increased risks##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
increased root##4##2##(2008-10#3)(2009-8#1)
increased scintigraphic activity##2##3##(2011-2#2)
increased secretion##4##2##(2008-11#2)(2008-6#1)(2009-5#1)
increased seedling emergence##2##3##(2008-10#2)
increased sensitivity of##4##3##(1991-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
increased sensitivity##9##2##(1991-1#1)(2008-10#3)(2008-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
increased serum levels of##2##4##(1990-9#1)(2011-2#1)
increased serum##4##2##(1990-9#1)(2008-7#1)(2011-2#1)(2012-3#1)
increased service##2##2##(1991-12#1)(1994-12#1)
increased severity of##3##3##(1997-6#1)(2008-10#1)(2012-3#1)
increased sharply##2##2##(2008-10#1)(2008-12#1)
increased signal##3##2##(2008-3#1)(2009-3#1)(2010-3#1)
increased significantly after treatment##2##4##(2011-1#2)
increased significantly after##3##3##(1991-3#1)(2011-1#2)
increased significantly and the##2##4##(2008-8#1)(2008-9#1)
increased significantly at##2##3##(2008-5#1)(2011-2#1)
increased significantly by##2##3##(2008-3#1)(2011-2#1)
increased significantly during the##2##4##(2008-10#1)(2008-9#1)
increased significantly during##6##3##(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
increased significantly from##5##3##(2008-10#1)(2008-12#2)(2009-2#1)(2013-1#1)
increased significantly in the##2##4##(2008-10#1)(2012-2#1)
increased significantly in##7##3##(1993-8#1)(2008-10#4)(2009-3#1)(2012-2#1)
increased significantly with##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
increased significantly##46##2##(1990-12#1)(1991-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-12#1)(1996-2#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
increased since##3##2##(1997-8#1)(2013-8#2)
increased size##2##2##(1996-3#1)(2008-8#1)
increased skin##3##2##(1997-3#1)(2008-5#2)
increased slowly##2##2##(2008-10#1)(2008-11#1)
increased soil##2##2##(2008-10#2)
increased spatial##2##2##(2008-10#1)(2008-8#1)
increased specific activity##2##3##(2008-8#1)(2008-9#1)
increased specific##8##2##(1995-12#1)(2008-11#4)(2008-8#1)(2008-9#1)(2013-1#1)
increased spontaneous##2##2##(2008-8#1)(2010-8#1)
increased stability of E6 and E7 mRNAs##2##7##(1995-2#2)
increased stability of##3##3##(1995-2#2)(2008-4#1)
increased stability##6##2##(1994-8#1)(1995-2#2)(2008-10#1)(2008-4#1)(2008-9#1)
increased steadily##2##2##(1994-12#1)(2008-10#1)
increased steady-state##2##2##(1992-10#1)(1995-2#1)
increased substantially##3##2##(1994-6#2)(1997-8#1)
increased substrate##2##2##(2008-7#2)
increased success##2##2##(2008-9#1)(2012-2#1)
increased surface##2##2##(1994-5#1)(2008-5#1)
increased survival##5##2##(1990-5#1)(1994-12#1)(2008-11#1)(2011-2#2)
increased susceptibility of##2##3##(2008-10#2)
increased susceptibility to##6##3##(2008-10#5)(2012-3#1)
increased susceptibility##9##2##(2008-10#8)(2012-3#1)
increased synthesis of##2##3##(1992-8#1)(2012-7#1)
increased temperature and##2##3##(2008-9#1)(2012-6#1)
increased temperature##3##2##(2008-10#1)(2008-9#1)(2012-6#1)
increased the MIMS response of all##2##6##(2008-10#2)
increased the apparent viscosity of##2##5##(2008-5#2)
increased the apparent##3##3##(2008-10#1)(2008-5#2)
increased the binding##2##3##(1993-6#1)(1997-3#1)
increased the complexity of##2##4##(1993-3#1)(2008-7#1)
increased the duration of the##2##5##(1997-2#2)
increased the expression of##6##4##(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-9#1)(2011-2#1)
increased the extent##2##3##(1996-2#1)(2008-5#1)
increased the fluorescence##3##3##(2008-10#2)(2008-11#1)
increased the frequency of##3##4##(1993-3#1)(1995-9#1)(2008-8#1)
increased the incidence of##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
increased the intensity of##2##4##(2008-5#2)
increased the intracellular##2##3##(1994-6#1)(2008-11#1)
increased the levels of##3##4##(1995-8#1)(2008-10#1)(2012-3#1)
increased the likelihood of##4##4##(1991-12#1)(2009-6#2)(2011-2#1)
increased the mortality##2##3##(2008-10#1)(2008-7#1)
increased the number of##6##4##(1993-6#1)(1994-8#1)(2008-10#2)(2008-6#2)
increased the percentage of##3##4##(1991-11#1)(1996-3#1)(2012-4#1)
increased the probability of##3##4##(1995-2#1)(2008-7#1)(2009-6#1)
increased the production of##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
increased the production##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
increased the rate of##2##4##(1995-6#1)(2010-11#1)
increased the sensitivity##2##3##(1997-4#1)(2008-10#1)
increased the stability##2##3##(2008-10#2)
increased the time##2##3##(2008-10#1)(2011-2#1)
increased the total##2##3##(1990-8#1)(1991-3#1)
increased the##176##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-2#1)(1993-3#4)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#4)(1994-5#2)(1994-6#2)(1994-8#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#4)(1995-9#1)(1996-12#4)(1996-2#6)(1996-3#1)(1997-2#4)(1997-3#2)(1997-4#2)(2007-11#1)(2008-10#41)(2008-11#17)(2008-12#3)(2008-3#1)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-6#3)(2009-7#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#7)
increased their##9##2##(1997-3#1)(2008-10#3)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
increased through##4##2##(1995-12#1)(2008-10#2)(2013-1#1)
increased throughout the##2##3##(2008-10#2)
increased thymidine incorporation##2##3##(1994-3#2)
increased tissue##2##2##(2008-10#2)
increased to 13##2##3##(1992-12#1)(2008-7#1)
increased to 15##2##3##(1990-6#1)(2011-1#1)
increased to 6##2##3##(2008-10#2)
increased to a maximum##2##4##(1993-3#1)(2008-11#1)
increased to a##3##3##(1993-3#1)(1996-12#1)(2008-11#1)
increased to approximately##4##3##(2008-10#2)(2008-11#2)
increased to include##2##3##(1993-12#1)(2010-10#1)
increased to##50##2##(1990-6#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-2#2)(2008-7#4)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#3)
increased tolerance##2##2##(2008-10#1)(2008-8#1)
increased total##5##2##(1991-3#1)(2008-10#1)(2008-12#2)(2012-3#1)
increased twofold and##2##3##(2008-10#2)
increased twofold##6##2##(2008-10#2)(2008-11#3)(2008-8#1)
increased understanding of the##3##4##(2008-10#1)(2008-5#1)(2009-11#1)
increased understanding of##6##3##(1995-5#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)
increased understanding##7##2##(1995-5#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)
increased until##4##2##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)
increased up to##7##3##(1997-3#1)(1997-8#1)(2008-10#3)(2011-2#1)(2013-1#1)
increased upon##2##2##(1993-9#1)(1995-6#1)
increased uptake##2##2##(1994-5#2)
increased urinary##3##2##(1991-12#1)(2008-5#1)(2012-3#1)
increased use of##10##3##(1991-11#1)(1991-12#1)(1991-3#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-7#1)(2013-1#1)
increased using an##2##3##(2008-10#1)(2013-8#1)
increased using##4##2##(2008-10#2)(2013-1#1)(2013-8#1)
increased vascular permeability##4##3##(1992-6#1)(1994-8#1)(2008-1#1)(2012-12#1)
increased vascular##5##2##(1992-6#1)(1994-8#1)(2008-1#1)(2012-12#1)(2013-8#1)
increased viability and##2##3##(2008-11#2)
increased waist circumference##2##3##(2008-11#2)
increased weight##2##2##(2011-2#2)
increased wetness##3##2##(2008-10#3)
increased when the##3##3##(1992-12#1)(2008-10#1)(2008-11#1)
increased when##12##2##(1992-12#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#1)
increased whereas##2##2##(1994-8#1)(1995-12#1)
increased while##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
increased with age##5##3##(1993-2#1)(2008-7#3)(2013-3#1)
increased with aging##2##3##(2008-7#2)
increased with an increase in##2##5##(2008-10#1)(2008-6#1)
increased with an##3##3##(2008-10#2)(2008-6#1)
increased with colony size##2##4##(2008-9#2)
increased with each##2##3##(2008-10#1)(2011-2#1)
increased with enrichment##2##3##(2008-8#2)
increased with higher##4##3##(2008-10#2)(2008-7#1)(2010-11#1)
increased with increased##3##3##(2008-10#3)
increased with increasing leaf wetness##2##5##(2008-10#2)
increased with increasing temperature##2##4##(1990-9#1)(2008-11#1)
increased with increasing the number of##2##6##(2008-10#2)
increased with increasing the##3##4##(2008-10#3)
increased with increasing##28##3##(1990-12#1)(1990-9#1)(1992-5#1)(1994-11#1)(1996-12#1)(1997-1#1)(2008-10#14)(2008-11#4)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
increased with mean##2##3##(2008-10#1)(2008-9#1)
increased with the increase in the##2##6##(2008-11#1)(2012-2#1)
increased with the increase##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
increased with the##16##3##(1990-8#1)(1990-9#1)(1994-11#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#1)(2012-2#1)
increased with time##6##3##(1991-1#1)(1991-8#1)(2008-10#4)
increased with##105##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#42)(2008-11#7)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#4)(2009-7#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-5#1)(2013-1#1)(2013-3#1)
increased within##2##2##(2008-10#1)(2013-8#1)
increased yield##2##2##(2008-10#2)
increased##2488##1##(1990-11#9)(1990-12#9)(1990-2#6)(1990-3#3)(1990-5#13)(1990-6#3)(1990-8#3)(1990-9#5)(1991-1#5)(1991-10#1)(1991-11#4)(1991-12#26)(1991-2#7)(1991-3#14)(1991-5#12)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#7)(1992-1#4)(1992-10#1)(1992-12#13)(1992-2#6)(1992-3#12)(1992-4#2)(1992-5#5)(1992-6#9)(1992-7#1)(1992-8#9)(1992-9#5)(1993-1#14)(1993-11#3)(1993-12#14)(1993-2#6)(1993-3#21)(1993-6#8)(1993-8#13)(1993-9#4)(1994-1#7)(1994-11#22)(1994-12#8)(1994-2#6)(1994-3#15)(1994-5#17)(1994-6#6)(1994-8#24)(1994-9#4)(1995-1#2)(1995-11#8)(1995-12#25)(1995-2#20)(1995-3#9)(1995-5#3)(1995-6#15)(1995-8#17)(1995-9#1)(1996-1#3)(1996-11#5)(1996-12#23)(1996-2#31)(1996-3#15)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#23)(1997-2#24)(1997-3#20)(1997-4#4)(1997-6#4)(1997-7#9)(1997-8#12)(2006-5#2)(2006-6#1)(2007-11#5)(2007-12#4)(2007-8#3)(2008-1#9)(2008-10#541)(2008-11#247)(2008-12#47)(2008-2#2)(2008-3#9)(2008-4#8)(2008-5#46)(2008-6#23)(2008-7#94)(2008-8#80)(2008-9#105)(2009-1#2)(2009-10#9)(2009-11#4)(2009-12#7)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#10)(2009-7#13)(2009-8#11)(2009-9#6)(2010-1#4)(2010-10#16)(2010-11#10)(2010-12#12)(2010-2#4)(2010-3#1)(2010-4#14)(2010-5#8)(2010-6#10)(2010-7#6)(2010-8#10)(2010-9#5)(2011-1#16)(2011-10#3)(2011-2#134)(2011-3#12)(2011-7#2)(2012-12#17)(2012-2#32)(2012-3#48)(2012-4#6)(2012-5#6)(2012-6#3)(2012-7#2)(2012-8#1)(2013-1#90)(2013-3#1)(2013-7#4)(2013-8#36)
increasein the##2##2##(2008-11#2)
increasein##3##1##(2008-11#3)
increases after the##3##3##(2008-5#2)(2008-8#1)
increases after##5##2##(2008-5#3)(2008-7#1)(2008-8#1)
increases and decreases in brain size in##2##7##(2012-3#2)
increases and decreases in##3##4##(2008-11#1)(2012-3#2)
increases and may##2##3##(1990-3#1)(2008-9#1)
increases and the##2##3##(2008-10#2)
increases and##13##2##(1990-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-3#1)(2012-3#2)
increases approximately##2##2##(1995-2#1)(1995-9#1)
increases as the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
increases as##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
increases at##5##2##(2007-11#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)
increases by##3##2##(1991-5#1)(2009-11#1)(2011-3#1)
increases cell viability##2##3##(2009-12#2)
increases crop##2##2##(2008-10#2)
increases during##3##2##(1997-7#1)(2008-12#1)(2008-3#1)
increases expected##2##2##(1991-2#1)(2008-8#1)
increases for##2##2##(2008-1#1)(2010-1#1)
increases from##7##2##(1991-11#1)(1992-2#1)(1994-8#1)(2008-10#3)(2008-11#1)
increases gradually##2##2##(1990-12#1)(2008-12#1)
increases in HIV##2##3##(1990-6#1)(1996-9#1)
increases in [Ca2+]i##3##3##(1994-3#1)(1995-11#2)
increases in both##5##3##(1994-8#1)(1995-1#1)(1997-1#1)(1997-4#1)(2012-12#1)
increases in frequency##2##3##(2008-10#1)(2010-4#1)
increases in hepatic##4##3##(1994-8#3)(2008-10#1)
increases in homicide rates##2##4##(2008-12#2)
increases in intracellular calcium##2##4##(1991-3#1)(1995-12#1)
increases in intracellular##7##3##(1991-3#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(2006-6#1)(2008-4#1)
increases in metabolic rate##3##4##(2008-3#1)(2010-4#2)
increases in muscle tone were##2##5##(1995-2#2)
increases in muscle##3##3##(1995-2#2)(2008-3#1)
increases in the order##2##4##(2008-10#1)(2009-9#1)
increases in the urinary excretion of protein##3##7##(1994-5#3)
increases in the##34##3##(1991-2#1)(1991-5#2)(1992-2#1)(1994-5#3)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2013-1#1)
increases in##168##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#3)(1992-2#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#7)(1995-1#1)(1995-11#6)(1995-12#2)(1995-2#3)(1996-12#8)(1996-2#4)(1996-3#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#1)(2006-6#1)(2008-10#27)(2008-11#5)(2008-12#7)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#3)(2009-5#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#7)
increases intracellular##2##2##(1996-2#1)(2008-9#1)
increases its##2##2##(1993-8#1)(2008-10#1)
increases linearly with##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
increases metabolic##2##2##(1995-6#1)(2013-8#1)
increases more##2##2##(2008-10#1)(2011-2#1)
increases mortality##3##2##(2011-2#2)(2012-12#1)
increases of its##2##3##(1995-2#1)(1996-12#1)
increases of the##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
increases of##17##2##(1990-10#1)(1990-12#1)(1991-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-8#1)
increases on##3##2##(1991-3#1)(1995-8#1)(2008-7#1)
increases or##2##2##(1991-2#1)(2012-3#1)
increases relative to the##2##4##(2008-8#2)
increases resistance to##2##3##(2008-10#1)(2011-10#1)
increases significantly in the##2##4##(2008-8#1)(2008-9#1)
increases significantly##3##2##(1991-9#1)(2008-8#1)(2008-9#1)
increases slightly with##2##3##(2007-12#1)(2008-2#1)
increases slightly##3##2##(2007-12#1)(2008-12#1)(2008-2#1)
increases the Vmax of##2##4##(1993-6#1)(1994-5#1)
increases the activity of##2##4##(1991-5#1)(2008-11#1)
increases the binding of##2##4##(1990-6#1)(1995-11#1)
increases the chance of##2##4##(2008-9#1)(2010-8#1)
increases the expression of##2##4##(1993-3#1)(2012-12#1)
increases the likelihood of##3##4##(2008-7#1)(2008-8#1)(2009-7#1)
increases the number of cells##2##5##(1997-1#1)(2008-9#1)
increases the number of##5##4##(1994-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
increases the probability##2##3##(2008-8#1)(2008-9#1)
increases the production##2##3##(1993-2#1)(2008-11#1)
increases the risk of##10##4##(1992-6#1)(1996-3#1)(1997-1#1)(2008-11#2)(2008-8#2)(2013-1#3)
increases the risk##11##3##(1992-6#1)(1994-2#1)(1996-3#1)(1997-1#1)(2008-11#2)(2008-8#2)(2013-1#3)
increases the sample##2##3##(2008-10#1)(2010-8#1)
increases the sensitivity by##2##4##(2008-10#2)
increases the sensitivity of##5##4##(1994-1#1)(1995-3#1)(2008-10#1)(2008-4#1)(2009-4#1)
increases the sensitivity##8##3##(1994-1#1)(1995-3#1)(2008-10#4)(2008-4#1)(2009-4#1)
increases the##96##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#4)(1995-11#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#2)(2008-10#17)(2008-11#8)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#5)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
increases their##2##2##(1993-8#1)(1995-8#1)
increases to the##3##3##(1990-5#1)(1993-12#1)(2008-8#1)
increases to##8##2##(1990-5#1)(1993-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#2)
increases until maturity and##2##4##(2008-5#2)
increases were observed##2##3##(2008-10#1)(2012-12#1)
increases were##5##2##(1993-8#1)(1994-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
increases when the##2##3##(2008-10#1)(2011-2#1)
increases when##3##2##(1995-6#1)(2008-10#1)(2011-2#1)
increases while##2##2##(1993-8#1)(2009-8#1)
increases with age##8##3##(2008-5#2)(2008-7#1)(2011-2#3)(2012-3#1)(2013-7#1)
increases with decreasing##2##3##(2008-10#1)(2008-9#1)
increases with increasing pH##2##4##(1990-5#1)(2008-10#1)
increases with increasing##9##3##(1990-5#1)(1991-11#1)(1997-2#1)(2008-10#3)(2008-9#1)(2009-7#2)
increases with the size of the##2##6##(2008-1#1)(2009-8#1)
increases with the##12##3##(1993-8#2)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-5#1)(2009-8#1)
increases with##47##2##(1990-5#1)(1990-6#1)(1991-11#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#6)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
increases##591##1##(1990-10#3)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#5)(1991-5#6)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-6#4)(1992-8#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#8)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#6)(1994-3#5)(1994-5#8)(1994-6#1)(1994-8#9)(1995-1#1)(1995-11#10)(1995-12#8)(1995-2#9)(1995-3#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-12#13)(1996-2#12)(1996-3#4)(1996-9#1)(1997-1#7)(1997-2#5)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#98)(2008-11#34)(2008-12#12)(2008-2#2)(2008-3#14)(2008-4#3)(2008-5#16)(2008-6#3)(2008-7#12)(2008-8#45)(2008-9#27)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#2)(2010-8#3)(2011-10#2)(2011-2#23)(2011-3#3)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#13)(2013-7#1)(2013-8#12)
increasing IPC##2##2##(2010-1#2)
increasing RVUs##3##2##(2013-1#3)
increasing activity##2##2##(2008-10#1)(2008-11#1)
increasing age##16##2##(1990-11#1)(1990-2#1)(1994-6#1)(1996-6#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2012-3#2)
increasing aggregation##3##2##(2008-10#3)
increasing altitude##3##2##(2009-5#3)
increasing among##2##2##(2008-12#1)(2012-2#1)
increasing amount of##2##3##(2008-10#1)(2011-2#1)
increasing amounts of##5##3##(1991-5#2)(2008-10#2)(2008-7#1)
increasing and##3##2##(1995-12#1)(1996-1#1)(2008-11#1)
increasing as the##2##3##(1991-2#1)(2013-1#1)
increasing attention as##2##3##(2008-8#1)(2010-7#1)
increasing attention##11##2##(1991-12#1)(1992-12#1)(1994-2#1)(2008-10#2)(2008-8#2)(2010-7#1)(2010-9#1)(2013-8#2)
increasing awareness##2##2##(2011-1#1)(2011-2#1)
increasing by##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
increasing cell##2##2##(2008-11#1)(2009-8#1)
increasing competition##2##2##(1994-2#1)(2008-7#1)
increasing complexity##2##2##(2008-11#1)(2011-2#1)
increasing concentrations for##2##3##(2011-3#1)(2013-1#1)
increasing concentrations of##10##3##(1990-11#1)(1994-8#1)(2008-10#3)(2008-11#4)(2011-2#1)
increasing concentrations##15##2##(1990-11#1)(1990-12#1)(1994-8#1)(2008-10#5)(2008-11#4)(2011-2#1)(2011-3#1)(2013-1#1)
increasing concern##4##2##(1996-3#1)(2008-10#1)(2010-8#1)(2012-12#1)
increasing consumption of##2##3##(2008-10#1)(2011-2#1)
increasing content of##2##3##(1997-2#1)(2008-8#1)
increasing costs##3##2##(1991-9#1)(2008-7#1)(2013-8#1)
increasing crosslinking##2##2##(2008-10#1)(2010-6#1)
increasing delay##2##2##(2013-8#2)
increasing demand for##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)
increasing demand##7##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-7#1)
increasing demands##3##2##(2008-11#1)(2013-1#2)
increasing distances##2##2##(2008-10#1)(2008-8#1)
increasing dosage of carbachol##2##4##(1994-8#2)
increasing dose##4##2##(2008-10#1)(2008-7#2)(2009-7#1)
increasing doses##5##2##(1991-6#1)(1997-4#1)(2008-7#2)(2011-2#1)
increasing evidence that##6##3##(2008-11#1)(2008-6#1)(2008-7#3)(2009-8#1)
increasing evidence##8##2##(2008-11#1)(2008-6#1)(2008-7#4)(2009-8#1)(2013-1#1)
increasing exercise##2##2##(2010-10#1)(2013-8#1)
increasing frequency and severity##2##4##(1991-12#1)(1995-5#1)
increasing frequency##4##2##(1991-12#1)(1995-5#1)(2008-10#1)(2008-7#1)
increasing importance of##2##3##(1991-12#1)(2008-10#1)
increasing importance##4##2##(1991-12#1)(1995-2#1)(2008-10#1)(2008-5#1)
increasing in##16##2##(1994-2#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#5)(2012-12#1)(2013-1#1)
increasing incidence in##2##3##(1991-6#1)(2011-2#1)
increasing incidence of##5##3##(1996-6#1)(1997-6#1)(2011-2#3)
increasing incidence##8##2##(1991-6#1)(1992-9#1)(1996-6#1)(1997-6#1)(2011-2#4)
increasing initial##2##2##(2008-11#1)(2008-8#1)
increasing inoculum densities##2##3##(2008-10#2)
increasing inoculum##3##2##(2008-10#3)
increasing interest in the potential##2##5##(2010-7#1)(2012-2#1)
increasing interest in the##6##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2012-2#1)
increasing interest in##12##3##(1991-2#1)(1992-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)
increasing interest##18##2##(1991-2#1)(1992-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#1)
increasing ionic strength##3##3##(1991-9#2)(1997-6#1)
increasing its##2##2##(2008-11#1)(2008-7#1)
increasing knowledge##2##2##(2008-5#1)(2012-12#1)
increasing larval##3##2##(2008-9#1)(2009-10#2)
increasing length of##2##3##(1992-6#1)(2008-8#1)
increasing level of##2##3##(2008-12#1)(2008-8#1)
increasing levels of##6##3##(1993-8#1)(2008-10#2)(2008-11#2)(2008-4#1)
increasing light##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
increasing markedly##2##2##(2008-10#1)(2010-10#1)
increasing morbidity##2##2##(1993-9#1)(2012-12#1)
increasing number of##20##3##(1991-6#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-3#2)(1994-5#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#2)(2011-2#1)
increasing numbers of##8##3##(1990-11#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
increasing numbers##9##2##(1990-11#1)(1993-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2013-1#1)
increasing of the##4##3##(1992-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
increasing of##8##2##(1992-5#1)(2008-10#1)(2008-12#1)(2008-8#3)(2008-9#2)
increasing order of##2##3##(2008-10#1)(2008-5#1)
increasing our##2##2##(2008-10#1)(2013-8#1)
increasing patient##2##2##(1996-3#1)(2008-8#1)
increasing population density##2##3##(2008-9#1)(2011-2#1)
increasing population##5##2##(1991-3#1)(2008-11#1)(2008-9#2)(2011-2#1)
increasing pressure on##2##3##(1992-6#1)(2008-5#1)
increasing pressure##6##2##(1992-6#1)(1993-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)
increasing prevalence of##8##3##(1991-12#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-3#2)
increasing productivity##2##2##(1991-2#1)(2008-9#1)
increasing proportion of the##3##4##(2008-10#2)(2008-9#1)
increasing proportion of##4##3##(1990-3#1)(2008-10#2)(2008-9#1)
increasing public##2##2##(1992-1#1)(2008-10#1)
increasing quadrat size##2##3##(2008-10#1)(2008-8#1)
increasing rapidly##4##2##(1992-11#1)(1997-7#1)(2008-10#2)
increasing sample##2##2##(2008-10#2)
increasing seed##2##2##(2008-10#1)(2013-8#1)
increasing size##2##2##(2008-11#1)(2008-8#1)
increasing speed##3##2##(1994-8#2)(2008-9#1)
increasing temperature##17##2##(1990-9#1)(1993-8#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#1)(2008-9#1)(2009-7#2)
increasing temperatures##4##2##(2008-10#3)(2012-8#1)
increasing the Km##2##3##(1990-5#1)(1994-5#1)
increasing the amount of##2##4##(1997-2#1)(2008-10#1)
increasing the concentration of##7##4##(1993-6#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-9#2)
increasing the efficiency of##2##4##(1991-2#1)(2012-2#1)
increasing the frequency of##2##4##(2008-10#1)(2008-8#1)
increasing the likelihood##2##3##(1995-1#1)(2010-2#1)
increasing the number of##9##4##(1997-2#1)(2008-10#4)(2008-7#1)(2008-8#2)(2012-12#1)
increasing the proportion of##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
increasing the ratio of##2##4##(2008-10#2)
increasing the risk of##3##4##(2008-9#2)(2013-1#1)
increasing the risk##4##3##(1997-3#1)(2008-9#2)(2013-1#1)
increasing the sample##2##3##(2008-10#2)
increasing the##132##2##(1990-2#1)(1990-5#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#40)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#11)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#8)
increasing their##6##2##(1991-5#1)(1992-1#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
increasing time##7##2##(1990-12#1)(1991-12#1)(2008-10#2)(2008-9#1)(2010-11#1)(2011-2#1)
increasing to##4##2##(1994-9#1)(1995-12#1)(2008-10#1)(2012-12#1)
increasing trend in##2##3##(1997-7#1)(2011-2#1)
increasing trend##5##2##(1997-7#1)(2008-12#1)(2009-4#1)(2009-6#1)(2011-2#1)
increasing use of##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
increasing use##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)
increasing variety of##2##3##(2011-2#1)(2013-8#1)
increasing with##4##2##(1991-5#1)(2008-12#1)(2008-8#1)(2011-2#1)
increasing##823##1##(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#6)(1991-2#8)(1991-3#6)(1991-5#5)(1991-6#3)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#5)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#8)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#4)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#11)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#4)(2006-6#1)(2007-12#6)(2008-10#208)(2008-11#54)(2008-12#23)(2008-2#3)(2008-3#13)(2008-4#6)(2008-5#14)(2008-6#4)(2008-7#31)(2008-8#45)(2008-9#31)(2009-10#5)(2009-11#2)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#8)(2009-8#4)(2010-1#4)(2010-10#7)(2010-11#3)(2010-12#10)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#8)(2010-8#6)(2010-9#2)(2011-1#3)(2011-10#1)(2011-2#40)(2011-3#3)(2011-4#1)(2011-7#1)(2012-12#7)(2012-2#10)(2012-3#9)(2012-4#2)(2012-6#1)(2012-8#1)(2013-1#26)(2013-7#2)(2013-8#17)
increasingly adopted##3##2##(1990-12#1)(2010-2#1)(2011-2#1)
increasingly apparent##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
increasingly becoming##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
increasingly being##5##2##(1990-11#1)(1995-2#1)(2008-11#2)(2012-2#1)
increasingly clear that##2##3##(1995-2#1)(2010-1#1)
increasingly competitive##4##2##(1994-12#2)(2008-10#1)(2008-11#1)
increasingly complex##3##2##(2008-11#1)(2010-10#2)
increasingly difficult##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
increasingly focused on##2##3##(1996-2#1)(2012-2#1)
increasingly important##15##2##(1995-1#2)(2006-6#1)(2008-10#3)(2008-11#3)(2010-10#1)(2010-12#2)(2011-2#1)(2011-7#1)(2012-3#1)
increasingly involved in##2##3##(1995-3#1)(2011-2#1)
increasingly popular and##2##3##(1995-2#1)(2008-11#1)
increasingly popular##7##2##(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
increasingly prevalent##2##2##(2008-3#1)(2009-6#1)
increasingly recognized as##3##3##(2008-10#1)(2008-7#1)(2009-3#1)
increasingly recognized##8##2##(2008-10#1)(2008-7#2)(2009-3#1)(2009-7#1)(2009-9#1)(2012-3#1)(2013-1#1)
increasingly sophisticated##3##2##(2008-11#2)(2008-9#1)
increasingly stringent##2##2##(1995-2#1)(2008-10#1)
increasingly used for##3##3##(1993-11#1)(2008-2#1)(2012-2#1)
increasingly used in##2##3##(2008-10#1)(2012-3#1)
increasingly used##6##2##(1992-3#1)(1993-11#1)(2008-10#1)(2008-2#1)(2012-2#1)(2012-3#1)
increasingly useful##2##2##(2008-10#2)
increasingly younger##2##2##(1997-2#1)(2008-9#1)
increasingly##137##1##(1990-11#1)(1990-12#1)(1991-3#2)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#6)(1995-3#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-2#3)(1997-5#2)(1997-8#1)(2006-6#2)(2008-1#2)(2008-10#18)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#6)(2011-7#1)(2012-2#5)(2012-3#6)(2013-1#4)(2013-8#2)
increment in##6##2##(1990-5#1)(2008-10#1)(2010-10#2)(2010-11#1)(2013-8#1)
increment of##8##2##(1996-2#1)(2008-10#5)(2008-5#1)(2008-9#1)
increment##25##1##(1990-5#1)(1996-2#1)(2008-10#12)(2008-5#1)(2008-9#4)(2010-10#2)(2010-11#1)(2011-2#2)(2013-8#1)
incremental cycling##3##2##(2011-2#3)
incremental increase in##3##3##(1992-3#1)(2008-8#1)(2011-2#1)
incremental value##2##2##(2008-11#1)(2010-12#1)
incremental##22##1##(1991-12#2)(1992-3#1)(1992-9#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#4)
incrementally##2##1##(1994-3#1)(2008-10#1)
increments##8##1##(1992-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2011-2#2)
incubated as##2##2##(1994-5#1)(2008-10#1)
incubated at 15##2##3##(2008-10#2)
incubated at 25 degrees C##3##5##(2008-10#2)(2008-5#1)
incubated at 37 degrees C for##2##6##(1992-6#1)(1994-8#1)
incubated at 37 degrees C##7##5##(1992-6#1)(1994-3#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#2)
incubated at 5##2##3##(2008-10#2)
incubated at different##2##3##(2008-10#2)
incubated at##28##2##(1992-6#1)(1994-3#1)(1994-8#1)(1997-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)
incubated for 24 h##2##4##(2008-11#1)(2008-12#1)
incubated for 48 h##2##4##(1990-11#1)(2008-10#1)
incubated for##12##2##(1990-11#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
incubated in a##4##3##(1995-11#1)(2008-10#2)(2008-8#1)
incubated in soil##2##3##(2008-10#2)
incubated in the presence of##2##5##(1991-3#1)(2008-11#1)
incubated in the##6##3##(1991-3#1)(2008-10#3)(2008-11#1)(2008-8#1)
incubated in vitro##5##3##(1991-2#1)(2008-10#3)(2008-6#1)
incubated in##36##2##(1991-2#1)(1991-3#1)(1993-8#2)(1994-5#1)(1995-11#1)(1995-8#1)(2008-10#19)(2008-11#6)(2008-6#1)(2008-8#2)(2013-1#1)
incubated on a##2##3##(2010-3#2)
incubated on##5##2##(2008-10#2)(2008-8#1)(2010-3#2)
incubated under controlled##2##3##(2008-10#2)
incubated under##6##2##(2008-10#3)(2008-11#3)
incubated with a##3##3##(1991-12#1)(1995-2#1)(1997-7#1)
incubated with bacterial components##2##4##(1996-12#2)
incubated with cells##2##3##(1997-7#2)
incubated with glucose##2##3##(2008-7#2)
incubated with the##6##3##(1990-12#3)(1993-8#1)(2008-11#2)
incubated with##51##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#2)(1991-5#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1996-12#4)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#5)(2010-11#1)(2010-3#1)
incubated##152##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#5)(1994-11#2)(1994-3#2)(1994-5#3)(1994-8#4)(1995-11#3)(1995-2#1)(1995-8#2)(1996-12#4)(1997-1#2)(1997-2#1)(1997-7#3)(1997-8#1)(2008-10#55)(2008-11#19)(2008-12#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#1)(2010-11#1)(2010-3#5)(2012-3#1)(2013-1#2)
incubates##2##1##(2011-3#2)
incubating the##2##2##(2008-11#2)
incubating them at##2##3##(2008-10#2)
incubating them##3##2##(2008-10#3)
incubating##13##1##(1990-11#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)
incubation at##8##2##(1992-3#1)(1994-8#1)(1997-8#1)(2008-10#4)(2008-11#1)
incubation conditions##3##2##(2008-10#2)(2008-7#1)
incubation distribution##5##2##(1992-9#5)
incubation for##5##2##(1990-11#1)(1996-2#1)(2008-10#1)(2010-6#1)(2012-12#1)
incubation in the dark##2##4##(2008-10#2)
incubation in the##4##3##(1990-12#1)(2008-10#2)(2008-11#1)
incubation in##6##2##(1990-12#1)(2008-10#3)(2008-11#1)(2008-9#1)
incubation medium##8##2##(1990-11#1)(1990-5#1)(1991-5#1)(1995-11#3)(1996-2#2)
incubation mixture##2##2##(1991-8#1)(1994-5#1)
incubation of the##8##3##(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2012-2#1)
incubation of##33##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1993-3#2)(1993-6#1)(1994-8#2)(1995-11#2)(1995-3#1)(1995-8#1)(1997-2#1)(2006-6#1)(2008-10#3)(2008-11#5)(2008-5#2)(2008-7#1)(2008-9#1)(2012-2#1)
incubation on##3##2##(2008-10#2)(2008-5#1)
incubation period and##2##3##(2008-10#2)
incubation period length##2##3##(2008-10#2)
incubation period of##2##3##(1991-12#1)(2008-10#1)
incubation period was##3##3##(1996-8#1)(2008-10#2)
incubation period##22##2##(1991-12#1)(1991-5#1)(1996-8#1)(2008-10#17)(2008-11#1)(2011-2#1)
incubation revealed##2##2##(2008-10#1)(2008-5#1)
incubation solution##2##2##(2008-10#2)
incubation temperature and batch##2##4##(2011-2#2)
incubation temperature and##6##3##(2008-10#1)(2008-12#1)(2011-2#4)
incubation temperature at##2##3##(2008-10#1)(2008-11#1)
incubation temperature of 37 degrees C##2##6##(2008-10#2)
incubation temperature of##3##3##(2008-10#2)(2011-2#1)
incubation temperature##21##2##(1996-12#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#6)
incubation temperatures##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
incubation time and the##2##4##(1991-5#1)(2008-10#1)
incubation time and##5##3##(1991-5#1)(2008-10#3)(2008-11#1)
incubation time of##4##3##(1996-2#2)(2008-10#1)(2008-9#1)
incubation time##28##2##(1990-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1996-2#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#3)(2008-9#2)(2010-5#1)(2011-3#1)
incubation times##4##2##(1990-12#1)(2008-10#3)
incubation was##2##2##(1997-7#1)(2008-10#1)
incubation with the##4##3##(1990-12#1)(1993-8#1)(1994-3#1)(2008-11#1)
incubation with##31##2##(1990-12#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#2)(1993-8#1)(1994-3#3)(1994-8#2)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#2)(1997-8#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-8#1)(2010-11#1)
incubation##258##1##(1990-11#4)(1990-12#9)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#4)(1991-8#1)(1992-12#3)(1992-3#2)(1992-9#5)(1993-3#2)(1993-6#3)(1993-8#3)(1994-11#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#6)(1995-11#5)(1995-2#2)(1995-3#3)(1995-8#2)(1996-12#2)(1996-2#8)(1996-8#1)(1997-1#4)(1997-2#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-10#84)(2008-11#25)(2008-12#4)(2008-4#1)(2008-5#16)(2008-7#4)(2008-8#5)(2008-9#7)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#1)
incubations of##2##2##(1990-12#1)(1994-8#1)
incubations##4##1##(1990-12#1)(1993-12#1)(1994-8#2)
incubator##7##1##(2008-10#1)(2008-11#4)(2008-5#1)(2013-1#1)
incubators##2##1##(2008-10#1)(2008-12#1)
incur##4##1##(1993-1#1)(1993-12#1)(2012-12#1)(2013-1#1)
incurred by the##2##3##(1991-3#1)(1993-12#1)
incurred by##8##2##(1991-3#1)(1993-12#1)(1995-1#1)(1995-12#1)(1997-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
incurred during##2##2##(2010-8#2)
incurred##15##1##(1991-12#1)(1991-3#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#3)(2011-2#1)(2013-8#1)
incursions##2##1##(1991-3#1)(2008-8#1)
indeed a##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
indeed able to##2##3##(1997-7#1)(2008-5#1)
indeed have##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
indeed the##2##2##(1994-3#1)(2010-6#1)
indeed##45##1##(1990-5#1)(1991-6#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#3)(2010-11#2)(2010-2#1)(2010-6#1)(2012-3#2)(2013-8#1)
indefinite##5##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-3#1)
indefinitely##2##1##(2008-10#1)(2008-11#1)
indel##2##1##(2008-10#1)(2012-3#1)
indels##2##1##(2010-3#1)(2013-8#1)
indemnity##2##1##(1991-12#1)(1991-3#1)
indeno(1##2##1##(2008-10#2)
indent##2##1##(2009-7#1)(2010-10#1)
indentation was performed##2##3##(2012-2#2)
indentation##6##1##(2008-10#1)(2009-7#3)(2012-2#2)
indentations##3##1##(1997-2#1)(2008-7#2)
indentified##2##1##(1995-3#1)(2011-2#1)
indents##2##1##(2009-7#1)(2010-10#1)
independence and##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
independence between##2##2##(1996-2#1)(1996-5#1)
independence of the##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
independence of##7##2##(1993-8#1)(2008-10#4)(2011-2#1)(2012-3#1)
independence structure of##2##3##(2011-2#2)
independence##33##1##(1991-2#1)(1992-3#1)(1993-1#1)(1993-8#1)(1996-2#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-10#6)(2008-11#3)(2010-1#2)(2010-10#2)(2011-2#8)(2012-2#1)(2012-3#2)(2013-8#1)
independence)##2##1##(1995-5#1)(2008-10#1)
independent analyses of##4##3##(1995-5#1)(2008-10#3)
independent analyses##5##2##(1995-5#1)(2008-10#4)
independent analysis by##2##3##(2008-10#2)
independent analysis##4##2##(2008-10#4)
independent analytical##3##2##(2008-10#3)
independent and##9##2##(1995-5#1)(1995-9#1)(2008-10#4)(2008-7#1)(2011-3#1)(2013-1#1)
independent association##2##2##(2010-4#1)(2010-5#1)
independent breeding##2##2##(2008-8#2)
independent cardiovascular risk factor##2##4##(1996-8#1)(2008-11#1)
independent clones##2##2##(1997-3#1)(2008-11#1)
independent coding##3##2##(1990-5#1)(2008-11#1)(2011-1#1)
independent cohort of##3##3##(2011-2#2)(2012-3#1)
independent community dwelling older adults##3##5##(2008-12#3)
independent component analysis (ICA)##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
independent component analysis and##2##4##(2008-11#1)(2009-11#1)
independent component analysis##6##3##(2008-10#2)(2008-11#2)(2009-11#1)(2010-8#1)
independent component##7##2##(2008-10#3)(2008-11#2)(2009-11#1)(2010-8#1)
independent components##3##2##(2008-10#1)(2008-11#2)
independent contractor##2##2##(1993-1#2)
independent contrasts##5##2##(2008-8#3)(2008-9#2)
independent data sets##3##3##(1995-9#1)(2008-10#1)(2008-8#1)
independent data##5##2##(1995-9#1)(2008-10#3)(2008-8#1)
independent determinations##4##2##(2008-10#3)(2010-11#1)
independent effects##2##2##(2008-7#1)(2008-9#1)
independent from its##2##3##(1996-5#1)(2009-8#1)
independent from the##2##3##(1990-2#1)(2012-12#1)
independent from##5##2##(1990-2#1)(1996-5#1)(2009-8#1)(2012-12#1)(2012-3#1)
independent genes##2##2##(2008-10#1)(2008-11#1)
independent groups##2##2##(2008-7#1)(2010-6#1)
independent in##2##2##(1994-8#1)(2011-2#1)
independent information##2##2##(2008-9#1)(2009-10#1)
independent introductions##2##2##(2008-8#2)
independent manner##2##2##(2008-11#1)(2009-3#1)
independent markers##2##2##(2008-10#2)
independent measurements##2##2##(2008-10#1)(2008-2#1)
independent mechanism##2##2##(1994-3#1)(1995-6#1)
independent mechanisms##2##2##(1991-1#1)(2012-3#1)
independent of Ca2+##2##3##(1994-11#1)(1996-2#1)
independent of all##2##3##(1995-3#1)(2008-3#1)
independent of any##3##3##(1993-11#1)(1993-3#1)(2008-3#1)
independent of each other##2##4##(2008-10#1)(2008-8#1)
independent of its##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
independent of lesion density##2##4##(2008-10#2)
independent of maternal##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
independent of pH##6##3##(1991-5#1)(2008-10#5)
independent of the above##2##4##(1995-11#1)(2008-10#1)
independent of the clinical##2##4##(1995-12#1)(2008-6#1)
independent of the number of##2##5##(2008-10#1)(2008-8#1)
independent of the presence of##2##5##(2008-10#1)(2008-11#1)
independent of the presence##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
independent of the type of##2##5##(1997-2#1)(2008-10#1)
independent of the##63##3##(1990-11#1)(1990-5#1)(1993-6#1)(1993-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1997-2#2)(2007-11#1)(2008-10#20)(2008-11#7)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2009-10#1)(2009-8#1)(2011-2#1)(2011-7#1)(2013-8#3)
independent of their##2##3##(1992-9#1)(2009-8#1)
independent of##162##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#5)(2007-11#1)(2008-10#50)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#10)(2009-10#1)(2009-8#3)(2010-10#1)(2010-5#2)(2011-2#8)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
independent on the##4##3##(2008-10#3)(2008-9#1)
independent on##5##2##(1990-12#1)(2008-10#3)(2008-9#1)
independent or##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
independent organization##2##2##(1997-3#1)(2007-12#1)
independent pathways##2##2##(1994-11#2)
independent patterns are simulated by randomly##2##6##(2008-10#2)
independent performance##2##2##(2008-7#2)
independent practice association##2##3##(1993-12#1)(1993-2#1)
independent practice##3##2##(1992-2#1)(1993-12#1)(1993-2#1)
independent predictors of##4##3##(2008-7#1)(2011-2#1)(2012-3#2)
independent prognostic##2##2##(1993-11#1)(2012-3#1)
independent reproduction##2##2##(2008-8#2)
independent resistance##2##2##(2008-10#2)
independent reviewers##6##2##(1997-8#1)(2012-12#4)(2013-1#1)
independent risk factor for##5##4##(1993-2#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
independent risk factor##8##3##(1993-2#1)(1994-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
independent risk factors##2##3##(2008-7#1)(2011-2#1)
independent risk##12##2##(1993-2#1)(1994-12#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
independent samples##2##2##(2008-10#1)(2008-12#1)
independent set of standards##2##4##(2008-10#2)
independent set of##3##3##(2008-10#2)(2012-3#1)
independent studies##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
independent transgenic##2##2##(2008-10#1)(2008-8#1)
independent validation##2##2##(2008-10#1)(2009-4#1)
independent variable##6##2##(2008-10#2)(2008-11#4)
independent variables##11##2##(1992-1#1)(1994-12#1)(1995-9#1)(2008-10#5)(2008-11#1)(2010-6#1)(2011-2#1)
independent walking##3##2##(1993-12#3)
independent##499##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-9#2)(1993-1#5)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#7)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#5)(1994-12#8)(1994-3#5)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#7)(1995-9#3)(1996-1#2)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#147)(2008-11#30)(2008-12#8)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#23)(2008-8#32)(2008-9#12)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#5)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#18)(2011-3#2)(2011-7#1)(2012-12#6)(2012-2#3)(2012-3#13)(2012-9#1)(2013-1#9)(2013-8#6)
independent)##2##1##(2008-11#1)(2009-8#1)
independently and##2##2##(1992-9#1)(1993-3#1)
independently associated with an increased odds ratio of VTE complication##2##10##(2012-3#2)
independently associated with poor##2##4##(2008-7#2)
independently associated with##12##3##(2008-7#2)(2008-8#1)(2010-6#1)(2012-3#2)(2013-1#6)
independently but##2##2##(2008-10#1)(2009-10#1)
independently by two##2##3##(2010-2#1)(2013-1#1)
independently by##6##2##(2008-10#2)(2009-9#1)(2010-2#1)(2013-1#2)
independently determined##2##2##(1995-12#1)(2008-10#1)
independently evolved##2##2##(2008-10#1)(2011-2#1)
independently from the##3##3##(1992-1#1)(2008-10#1)(2008-9#1)
independently from##5##2##(1992-1#1)(2008-10#2)(2008-5#1)(2008-9#1)
independently in##4##2##(2008-10#4)
independently into##2##2##(1997-7#1)(2008-10#1)
independently of the##10##3##(1992-2#1)(1992-9#1)(1993-2#1)(1997-3#1)(2006-6#1)(2008-10#2)(2008-11#2)(2012-2#1)
independently of##30##2##(1990-11#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#2)(1994-3#1)(1997-3#1)(2006-6#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-9#4)(2009-9#1)(2010-7#1)(2012-2#3)
independently prepared##2##2##(2008-10#2)
independently regulated##2##2##(1992-6#1)(1993-5#1)
independently reviewed##2##2##(2011-2#1)(2012-12#1)
independently varying##2##2##(2008-10#1)(2008-11#1)
independently with##3##2##(1995-11#1)(2008-10#1)(2013-8#1)
independently##130##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#34)(2008-11#10)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#11)(2013-8#2)
indeterminate##6##1##(1994-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
index &gt##2##2##(2012-3#1)(2013-8#1)
index (GI)##2##2##(2008-1#2)
index (PI)##2##2##(1996-1#1)(1996-6#1)
index (RI)##5##2##(1991-7#1)(1996-6#1)(2008-10#2)(2013-8#1)
index (SI)##3##2##(2008-5#1)(2011-2#2)
index (t##2##2##(2008-10#2)
index and a##2##3##(2010-8#1)(2012-3#1)
index and its related taxonomic traits were##2##7##(2008-8#2)
index and its related taxonomic traits##3##6##(2008-8#3)
index and its##4##3##(2007-11#1)(2008-8#3)
index and the##3##3##(2008-1#2)(2008-3#1)
index and##31##2##(2007-11#4)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#3)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-8#1)
index as##2##2##(1993-12#1)(2013-1#1)
index based on##2##3##(1995-2#1)(2008-10#1)
index can be##2##3##(2008-3#1)(2008-6#1)
index can##3##2##(1992-12#1)(2008-3#1)(2008-6#1)
index case##2##2##(2008-7#1)(2009-8#1)
index cases##2##2##(1992-9#1)(1993-1#1)
index changes##2##2##(2008-10#1)(2008-3#1)
index decreased##2##2##(2008-10#1)(2013-8#1)
index finger##3##2##(1996-2#1)(2008-12#1)(2008-9#1)
index for##9##2##(1990-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(2008-10#3)(2008-11#2)
index in##7##2##(2008-10#1)(2008-12#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
index is a##2##3##(1995-2#1)(2008-3#1)
index is##10##2##(1993-11#1)(1995-2#1)(2007-12#1)(2008-3#3)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)
index modulation and##2##3##(2008-3#2)
index modulation##3##2##(2007-12#1)(2008-3#2)
index of air##3##3##(2008-2#2)(2008-3#1)
index of association##4##3##(2008-10#4)
index of dispersion (D)##3##4##(2008-10#3)
index of dispersion##9##3##(2008-10#9)
index of non-elasticity##2##3##(2008-5#2)
index of patchiness##2##3##(2008-10#2)
index of refraction that##2##4##(2008-3#2)
index of refraction##11##3##(1991-9#1)(2008-2#1)(2008-3#9)
index of suspicion##8##3##(2008-11#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#3)(2013-8#1)
index of the##6##3##(1994-2#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-6#1)
index of##97##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-9#1)(1992-6#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-3#1)(2007-12#1)(2008-10#29)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#17)(2008-5#4)(2008-6#3)(2008-9#1)(2009-1#1)(2010-1#1)(2010-11#2)(2010-7#2)(2010-8#2)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
index on##2##2##(2010-8#1)(2011-1#1)
index or##2##2##(2008-8#1)(2011-2#1)
index pain##3##2##(2008-7#3)
index to##3##2##(2008-10#1)(2008-11#1)(2012-7#1)
index values##4##2##(1992-2#2)(2008-10#1)(2008-12#1)
index was calculated##4##3##(1991-2#1)(1992-3#2)(2012-3#1)
index was used to##2##4##(2008-10#2)
index was##21##2##(1991-2#1)(1992-3#2)(1992-6#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-7#1)(2009-3#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
index were##3##2##(1991-6#1)(2008-8#1)(2012-2#1)
index with##2##2##(2008-3#1)(2012-2#1)
index##476##1##(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-6#5)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#7)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#2)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#2)(1995-2#2)(1996-1#2)(1996-2#1)(1996-3#5)(1996-6#2)(1997-1#1)(2007-11#4)(2007-12#4)(2008-1#5)(2008-10#104)(2008-11#39)(2008-12#20)(2008-2#9)(2008-3#40)(2008-4#3)(2008-5#12)(2008-6#5)(2008-7#15)(2008-8#13)(2008-9#6)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#6)(2010-6#2)(2010-7#3)(2010-8#5)(2011-1#7)(2011-2#24)(2011-3#3)(2012-12#4)(2012-2#9)(2012-3#13)(2012-7#1)(2013-1#15)(2013-8#15)
index)##8##1##(1993-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
index]##2##1##(1996-3#1)(2012-3#1)
indexed by the##2##3##(1991-12#1)(2008-8#1)
indexed in the##2##3##(2011-4#1)(2012-3#1)
indexed in##3##2##(2011-4#1)(2012-3#1)(2013-8#1)
indexed##11##1##(1991-12#1)(1994-3#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-4#1)(2012-3#1)(2013-8#1)
indexes are##3##2##(1992-1#1)(2010-11#1)(2011-2#1)
indexes of##5##2##(2008-10#2)(2010-4#1)(2011-2#1)(2011-3#1)
indexes was##2##2##(2008-10#1)(2010-11#1)
indexes were##3##2##(2011-2#1)(2011-3#2)
indexes##34##1##(1991-12#1)(1992-1#2)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#4)(2008-10#8)(2008-3#1)(2009-10#1)(2010-11#3)(2010-3#1)(2010-4#1)(2011-2#4)(2011-3#3)(2012-3#2)
indexing hosts##2##2##(2008-10#2)
indexing##8##1##(1993-1#1)(2008-10#5)(2008-6#1)(2010-5#1)
indica and T##3##3##(2008-10#3)
indica and japonica##3##3##(2008-10#2)(2008-8#1)
indica and##8##2##(2008-10#7)(2008-8#1)
indica cv##2##2##(1995-6#1)(2008-9#1)
indica is##3##2##(2008-10#3)
indica on germination and seedling growth of##2##7##(2008-12#2)
indica on##3##2##(2008-10#1)(2008-12#2)
indica rice##2##2##(2008-9#2)
indica were##2##2##(2008-10#2)
indica##49##1##(1995-6#1)(2008-10#36)(2008-12#4)(2008-8#1)(2008-9#7)
indica) and##2##2##(2008-8#1)(2008-9#1)
indica)##4##1##(2008-10#2)(2008-8#1)(2008-9#1)
indicate a high prevalence of##2##5##(2008-12#1)(2012-2#1)
indicate a high##3##3##(1991-11#1)(2008-12#1)(2012-2#1)
indicate a need for##2##4##(1996-6#2)
indicate a strong##2##3##(2008-10#1)(2008-11#1)
indicate a##38##2##(1991-11#1)(1991-6#1)(1992-2#1)(1992-5#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-8#2)
indicate an##8##2##(1990-8#1)(1993-1#1)(1994-12#1)(1995-9#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
indicate different##2##2##(2012-3#1)(2013-1#1)
indicate excellent selectivity for##3##4##(2008-10#3)
indicate good selectivity for##2##4##(2008-10#2)
indicate good##4##2##(1991-3#1)(2008-10#3)
indicate how##2##2##(2009-7#1)(2011-2#1)
indicate no##2##2##(2008-10#2)
indicate that (i) the##2##4##(1994-8#1)(2008-10#1)
indicate that (i)##3##3##(1994-5#1)(1994-8#1)(2008-10#1)
indicate that a high percentage##2##5##(1991-12#1)(2008-10#1)
indicate that a single##2##4##(1993-8#1)(2008-10#1)
indicate that a##14##3##(1990-6#1)(1991-12#1)(1993-8#1)(1994-5#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
indicate that all##3##3##(2008-10#3)
indicate that an##3##3##(1992-8#1)(1995-2#1)(2008-11#1)
indicate that at least##2##4##(1994-11#1)(2008-10#1)
indicate that at##4##3##(1994-11#1)(1995-8#1)(2008-10#2)
indicate that both##15##3##(1991-12#1)(1991-5#1)(1995-11#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
indicate that children who##2##4##(1995-1#1)(2011-1#1)
indicate that children##3##3##(1995-1#1)(1996-12#1)(2011-1#1)
indicate that different##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
indicate that during##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
indicate that early##2##3##(2008-10#1)(2008-12#1)
indicate that establishment##2##3##(2008-10#1)(2008-7#1)
indicate that in the##3##4##(1997-1#1)(2008-10#1)(2008-5#1)
indicate that in##9##3##(1995-2#1)(1997-1#2)(1997-2#1)(2008-10#4)(2008-5#1)
indicate that increased##4##3##(1994-8#1)(2012-6#1)(2013-1#1)(2013-8#1)
indicate that it is##3##4##(1992-12#1)(2008-10#2)
indicate that it may be##2##5##(2008-10#1)(2009-4#1)
indicate that it##7##3##(1992-12#1)(2008-10#4)(2008-3#1)(2009-4#1)
indicate that many##2##3##(2008-10#2)
indicate that most of##2##4##(2008-10#1)(2008-5#1)
indicate that most patients##2##4##(1990-11#1)(2013-1#1)
indicate that most##5##3##(1990-11#1)(2008-10#2)(2008-5#1)(2013-1#1)
indicate that oncogenes##2##3##(1997-7#1)(2008-11#1)
indicate that other##2##3##(2008-10#1)(2008-4#1)
indicate that oxidative##2##3##(1992-12#1)(1994-2#1)
indicate that previous##2##3##(1997-3#1)(2010-5#1)
indicate that prolonged##2##3##(2008-8#1)(2013-1#1)
indicate that regulation of##3##4##(1997-1#1)(2008-7#2)
indicate that sensitivity to##2##4##(2008-10#1)(2008-11#1)
indicate that several##2##3##(1993-12#1)(2011-2#1)
indicate that some##2##3##(1995-12#1)(2008-10#1)
indicate that species##2##3##(1990-6#1)(2008-8#1)
indicate that the activation of##2##5##(1997-2#1)(2006-6#1)
indicate that the conditions##2##4##(2008-10#1)(2008-8#1)
indicate that the derivative##2##4##(2008-10#2)
indicate that the effect of##2##5##(1995-8#1)(1996-2#1)
indicate that the effects##2##4##(1996-3#1)(2008-11#1)
indicate that the increase in##2##5##(1995-6#1)(2008-10#1)
indicate that the interaction##2##4##(2008-10#2)
indicate that the main##3##4##(2008-10#1)(2008-11#2)
indicate that the method##2##4##(2008-10#2)
indicate that the presence of##2##5##(2008-10#1)(2008-12#1)
indicate that the procedure can eliminate##2##6##(2008-10#2)
indicate that the procedure##3##4##(2008-10#2)(2011-2#1)
indicate that the proposed##3##4##(2007-12#1)(2008-11#1)(2012-3#1)
indicate that the two##2##4##(1990-11#1)(2012-2#1)
indicate that the##182##3##(1990-11#3)(1990-12#1)(1990-8#3)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#6)(1995-8#1)(1996-2#6)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#3)(2008-10#54)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#6)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#1)(2009-7#4)(2010-11#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
indicate that there is a##4##5##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
indicate that there is##8##4##(1990-2#1)(1992-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)
indicate that there##10##3##(1990-2#1)(1992-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-5#1)(2013-1#1)
indicate that these individuals often have pulmonary asbestos##2##8##(1991-12#2)
indicate that these two##2##4##(1992-12#1)(2008-10#1)
indicate that these##12##3##(1991-12#2)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-12#1)(2008-10#3)(2012-2#1)
indicate that they##3##3##(2008-10#2)(2008-12#1)
indicate that this##11##3##(1991-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-3#2)
indicate that##714##2##(1990-11#4)(1990-12#5)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#9)(1991-2#1)(1991-3#2)(1991-5#7)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#5)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#6)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#5)(1993-6#7)(1993-8#9)(1993-9#3)(1994-11#7)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#10)(1994-6#3)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#8)(1995-2#10)(1995-6#10)(1995-8#8)(1996-1#3)(1996-12#11)(1996-2#13)(1996-3#3)(1996-6#3)(1997-1#10)(1997-2#4)(1997-3#3)(1997-6#1)(1997-7#6)(1997-8#4)(2006-6#1)(2007-12#3)(2008-1#3)(2008-10#188)(2008-11#41)(2008-12#12)(2008-2#2)(2008-3#13)(2008-4#3)(2008-5#16)(2008-6#2)(2008-7#25)(2008-8#26)(2008-9#14)(2009-10#4)(2009-12#4)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#7)(2009-8#4)(2010-1#4)(2010-10#4)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#17)(2012-12#6)(2012-2#13)(2012-3#5)(2012-5#1)(2012-6#1)(2013-1#19)(2013-8#8)
indicate the effectiveness of##2##4##(2008-7#1)(2012-2#1)
indicate the existence of an##2##5##(1990-5#1)(1997-6#1)
indicate the existence of##4##4##(1990-5#1)(1997-6#1)(2008-10#1)(2008-7#1)
indicate the involvement of##2##4##(2008-12#1)(2008-8#1)
indicate the need for##2##4##(1994-3#1)(2008-12#1)
indicate the need##3##3##(1994-3#1)(2008-12#1)(2010-9#1)
indicate the presence of a##2##5##(1993-3#1)(2008-10#1)
indicate the presence of two##2##5##(2008-10#1)(2008-7#1)
indicate the presence of##6##4##(1993-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
indicate the usefulness of##2##4##(2008-11#1)(2013-1#1)
indicate the##51##2##(1990-10#1)(1990-5#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-6#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#5)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
indicate there##2##2##(2008-10#1)(2009-7#1)
indicate two##2##2##(2008-10#1)(2008-11#1)
indicate##890##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#1)(1990-5#3)(1990-6#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#1)(1991-3#3)(1991-5#7)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#6)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#6)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#7)(1993-2#3)(1993-3#6)(1993-6#7)(1993-8#9)(1993-9#3)(1994-11#9)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#10)(1994-6#3)(1994-8#9)(1994-9#2)(1995-1#1)(1995-11#7)(1995-12#8)(1995-2#11)(1995-6#11)(1995-8#8)(1995-9#1)(1996-1#3)(1996-12#13)(1996-2#14)(1996-3#3)(1996-5#1)(1996-6#5)(1996-9#1)(1997-1#10)(1997-2#4)(1997-3#3)(1997-6#3)(1997-7#8)(1997-8#5)(2006-6#1)(2007-12#3)(2007-8#1)(2008-1#5)(2008-10#234)(2008-11#59)(2008-12#21)(2008-2#2)(2008-3#14)(2008-4#4)(2008-5#21)(2008-6#2)(2008-7#31)(2008-8#31)(2008-9#18)(2009-10#5)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#10)(2009-8#6)(2010-1#4)(2010-10#4)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#21)(2012-12#7)(2012-2#16)(2012-3#7)(2012-5#3)(2012-6#1)(2013-1#26)(2013-8#11)
indicated TMSG-1##2##2##(2008-9#2)
indicated a high##5##3##(1992-2#1)(1996-12#1)(2008-10#2)(2011-1#1)
indicated a linear##2##3##(2008-10#2)
indicated a need for##2##4##(2008-10#1)(2011-1#1)
indicated a need##3##3##(2008-10#1)(2011-1#2)
indicated a positive relationship between##2##5##(1995-3#1)(1996-12#1)
indicated a strong##3##3##(1994-6#1)(2008-10#2)
indicated a##47##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-6#1)(1995-3#1)(1996-12#3)(2008-10#22)(2008-11#4)(2008-12#2)(2009-8#1)(2010-4#2)(2011-1#3)(2013-1#1)
indicated above##2##2##(2008-10#2)
indicated aggregated patterns of disease incidence data##2##7##(2008-10#2)
indicated an##6##2##(1993-12#1)(1994-11#1)(1996-12#1)(2008-10#2)(2009-9#1)
indicated and##2##2##(1996-11#1)(1997-6#1)
indicated as the most##2##4##(2008-10#1)(2010-3#1)
indicated as##3##2##(2008-10#1)(2008-2#1)(2010-3#1)
indicated at##2##2##(1997-4#1)(2008-10#1)
indicated by a##4##3##(1995-8#1)(2008-10#1)(2008-8#1)(2012-7#1)
indicated by some##2##3##(1995-5#1)(2013-1#1)
indicated by the##14##3##(1991-2#1)(1997-8#1)(2008-10#7)(2008-3#2)(2008-8#1)(2008-9#1)(2013-1#1)
indicated by##48##2##(1990-5#1)(1991-2#1)(1992-2#1)(1993-3#2)(1993-8#1)(1994-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-8#1)(2008-10#20)(2008-11#3)(2008-3#2)(2008-8#3)(2008-9#1)(2011-2#2)(2012-2#2)(2012-7#1)(2012-9#1)(2013-1#2)
indicated enhanced##2##2##(2008-10#1)(2008-11#1)
indicated for the##3##3##(2010-10#1)(2010-11#1)(2011-2#1)
indicated for##15##2##(1996-11#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2011-2#5)
indicated high##3##2##(1995-11#1)(2008-10#2)
indicated higher##3##2##(2010-10#1)(2011-2#2)
indicated in the##4##3##(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
indicated in##14##2##(1995-11#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
indicated levels of##2##3##(2008-9#1)(2010-12#1)
indicated no significant##2##3##(2008-10#1)(2008-5#1)
indicated no##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
indicated or##2##2##(2008-10#1)(2008-5#1)
indicated promising results##2##3##(2008-10#1)(2008-5#1)
indicated significant##7##2##(2007-11#1)(2008-10#3)(2010-8#1)(2011-2#1)(2013-8#1)
indicated some##3##2##(1991-12#1)(2008-10#2)
indicated specific##2##2##(2008-10#1)(2008-5#1)
indicated that (1)##2##3##(1993-12#1)(1994-8#1)
indicated that a high level of##2##6##(2008-10#1)(2008-11#1)
indicated that a single##4##4##(2008-10#4)
indicated that a##18##3##(1990-11#1)(1993-12#1)(1993-3#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)
indicated that all##2##3##(2008-10#1)(2012-12#1)
indicated that although##2##3##(1997-8#1)(2008-11#1)
indicated that an##2##3##(2008-10#2)
indicated that both the##2##4##(2008-10#1)(2008-11#1)
indicated that both##5##3##(1991-6#1)(1992-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
indicated that cell##3##3##(1997-9#1)(2008-11#1)(2008-9#1)
indicated that chromosome##2##3##(2008-10#2)
indicated that disease incidence was##2##5##(2008-10#2)
indicated that disease##4##3##(2008-10#4)
indicated that during##2##3##(1995-9#1)(2008-10#1)
indicated that each##2##3##(2008-10#2)
indicated that in##4##3##(2008-10#3)(2008-9#1)
indicated that it is##3##4##(1996-12#1)(2008-10#2)
indicated that it##5##3##(1992-8#1)(1996-12#1)(2008-10#3)
indicated that metabolism##2##3##(1994-5#1)(2008-8#1)
indicated that most of the##2##5##(2008-10#1)(2008-7#1)
indicated that most of these##2##5##(2011-3#1)(2012-3#1)
indicated that most of##4##4##(2008-10#1)(2008-7#1)(2011-3#1)(2012-3#1)
indicated that most##6##3##(1995-12#1)(2008-10#1)(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
indicated that multiple##2##3##(2008-10#1)(2010-8#1)
indicated that only the##2##4##(2008-10#1)(2008-4#1)
indicated that only##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
indicated that patients with##2##4##(1991-5#1)(2008-6#1)
indicated that resistance to##2##4##(2008-10#2)
indicated that resistance##3##3##(2008-10#3)
indicated that sanA is##2##4##(2008-9#2)
indicated that some##2##3##(2008-10#1)(2008-12#1)
indicated that the addition of##2##5##(2008-10#1)(2008-11#1)
indicated that the differential##2##4##(1993-12#1)(2008-10#1)
indicated that the expression of##3##5##(1991-9#1)(2008-8#1)(2008-9#1)
indicated that the gene##2##4##(2008-10#2)
indicated that the major##2##4##(2010-8#1)(2011-3#1)
indicated that the majority##2##4##(2008-10#1)(2008-9#1)
indicated that the method##2##4##(2008-10#1)(2013-8#1)
indicated that the modified##2##4##(2008-10#1)(2008-8#1)
indicated that the presence of##2##5##(2008-10#2)
indicated that the resistance##4##4##(2008-10#4)
indicated that the translocation##2##4##(1996-6#1)(2008-8#1)
indicated that the two##3##4##(1990-2#1)(2008-10#1)(2008-9#1)
indicated that the virus##3##4##(2008-10#3)
indicated that the##198##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-9#2)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-8#2)(2008-10#93)(2008-11#10)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#16)(2008-9#12)(2009-1#1)(2009-6#1)(2009-7#2)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
indicated that their##2##3##(1995-8#1)(2008-11#1)
indicated that there was a##5##5##(2008-10#4)(2008-11#1)
indicated that there was##6##4##(2008-10#4)(2008-11#2)
indicated that there were##2##4##(2008-9#1)(2012-12#1)
indicated that there##10##3##(2008-10#4)(2008-11#3)(2008-8#1)(2008-9#1)(2012-12#1)
indicated that these##6##3##(2008-10#2)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
indicated that they##6##3##(1992-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-5#1)
indicated that this##12##3##(1994-5#1)(2008-10#6)(2008-5#2)(2008-8#3)
indicated that tolerance##2##3##(1992-3#1)(2008-10#1)
indicated that under##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
indicated that##557##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#5)(1994-11#2)(1994-3#2)(1994-5#3)(1994-8#5)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#5)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#4)(1997-9#1)(2008-10#240)(2008-11#29)(2008-12#13)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#39)(2008-9#38)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#2)(2010-10#1)(2010-12#3)(2010-4#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-2#9)(2011-3#7)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#6)(2013-8#8)
indicated the existence of##2##4##(1997-7#1)(2008-10#1)
indicated the occurrence of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
indicated the oxidation of##2##4##(2008-10#2)
indicated the presence of several##2##5##(2008-10#1)(2008-12#1)
indicated the presence of two classes of##2##7##(1994-3#1)(1994-8#1)
indicated the presence of two##5##5##(1993-8#1)(1994-3#1)(1994-8#1)(2008-10#1)(2010-2#1)
indicated the presence of##13##4##(1990-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-2#1)
indicated the##45##2##(1990-11#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#22)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
indicated to##3##2##(2008-10#1)(2013-1#2)
indicated two##2##2##(2008-10#1)(2008-9#1)
indicated##881##1##(1990-11#5)(1990-12#2)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#8)(1993-6#4)(1993-8#7)(1994-1#1)(1994-11#4)(1994-2#2)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#6)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#7)(1995-8#8)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#8)(1996-2#4)(1996-3#3)(1996-5#3)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#6)(1997-9#1)(2007-11#1)(2008-10#360)(2008-11#47)(2008-12#22)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#19)(2008-6#4)(2008-7#9)(2008-8#43)(2008-9#47)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#7)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#25)(2011-3#7)(2012-12#3)(2012-2#11)(2012-3#6)(2012-7#1)(2012-9#2)(2013-1#16)(2013-8#12)
indicates a##14##2##(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
indicates significant##2##2##(1994-5#1)(2008-10#1)
indicates that a##2##3##(1994-2#1)(2008-12#1)
indicates that although##2##3##(1993-12#1)(2008-11#1)
indicates that both methods##2##4##(2008-10#2)
indicates that either##2##3##(1995-6#1)(2008-10#1)
indicates that it is##2##4##(1993-12#1)(2008-10#1)
indicates that it##3##3##(1993-12#2)(2008-10#1)
indicates that many##3##3##(2008-10#1)(2008-8#2)
indicates that other##2##3##(2008-1#1)(2008-10#1)
indicates that the RNA is##2##5##(1997-7#2)
indicates that the method##2##4##(2008-10#2)
indicates that the reaction##2##4##(1996-5#1)(2008-10#1)
indicates that the##72##3##(1990-5#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-2#3)(1993-8#1)(1993-9#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#2)(2011-3#1)(2013-1#1)
indicates that there is##3##4##(1993-12#1)(2008-5#1)(2009-7#1)
indicates that there##4##3##(1993-12#1)(2008-11#1)(2008-5#1)(2009-7#1)
indicates that these##2##3##(2008-5#1)(2008-7#1)
indicates that they are##2##4##(1996-6#1)(2008-7#1)
indicates that they##4##3##(1996-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
indicates that this##2##3##(1995-6#1)(2008-11#1)
indicates that##239##2##(1990-2#3)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#4)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#6)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(2006-6#1)(2008-1#1)(2008-10#52)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#11)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
indicates the importance of##2##4##(2008-11#1)(2008-9#1)
indicates the potential cross-linking site##2##5##(2008-11#2)
indicates the presence##2##3##(1992-1#1)(1995-2#1)
indicates the significance of##2##4##(2009-7#1)(2011-1#1)
indicates the##26##2##(1990-2#1)(1992-1#1)(1992-10#1)(1993-6#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
indicates##314##1##(1990-2#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-6#6)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-5#2)(1996-6#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#2)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#72)(2008-11#21)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#14)(2008-6#2)(2008-7#13)(2008-8#11)(2008-9#12)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
indicating a better accessibility of the chelating sites##2##8##(2008-10#2)
indicating a better##3##3##(2008-10#2)(2008-6#1)
indicating a loss of##2##4##(2008-5#1)(2013-1#1)
indicating a role of##2##4##(1997-1#1)(2009-8#1)
indicating a role##3##3##(1997-1#1)(2008-10#1)(2009-8#1)
indicating a weakening##2##3##(2008-10#2)
indicating a##54##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-8#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#18)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-5#1)(2013-1#3)(2013-8#2)
indicating an increase in##2##4##(2008-10#2)
indicating an##10##2##(1991-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#2)
indicating both##2##2##(2008-11#1)(2012-3#1)
indicating frequent##2##2##(2008-10#2)
indicating good##2##2##(2008-10#1)(2008-11#1)
indicating heterogeneity of##2##3##(1992-3#1)(2008-10#1)
indicating high##2##2##(1993-8#1)(2008-8#1)
indicating its##6##2##(1994-3#1)(2008-10#3)(2008-11#1)(2013-1#1)
indicating limited##2##2##(2008-10#2)
indicating low##2##2##(2008-10#2)
indicating moderate##2##2##(2008-10#1)(2008-5#1)
indicating no##3##2##(1990-5#1)(2008-10#1)(2008-12#1)
indicating partial##2##2##(1994-12#1)(1995-6#1)
indicating significant##2##2##(1996-9#1)(2008-11#1)
indicating strong##2##2##(2008-5#1)(2008-8#1)
indicating that a##4##3##(1995-12#1)(2008-10#2)(2008-7#1)
indicating that it is a##2##5##(2008-10#1)(2013-1#1)
indicating that it was##2##4##(1990-5#1)(1995-12#1)
indicating that it##6##3##(1990-5#1)(1995-12#1)(2008-10#2)(2013-1#2)
indicating that its##2##3##(2008-10#2)
indicating that longicomin##2##3##(2008-8#2)
indicating that other##2##3##(2008-10#1)(2013-1#1)
indicating that resistance##2##3##(2008-10#2)
indicating that suppression was due to##2##6##(2008-10#2)
indicating that the electrode renewal gives a good reproducible##2##9##(2008-10#2)
indicating that the expression of##3##5##(1996-12#1)(2008-9#2)
indicating that the latter is##2##5##(1995-8#1)(2008-10#1)
indicating that the normal##2##4##(2008-12#1)(2008-9#1)
indicating that the resistance##2##4##(2008-10#2)
indicating that the sites are of the##2##7##(1994-5#2)
indicating that the two##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
indicating that the##87##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#3)(1994-8#2)(1995-11#1)(1995-2#2)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-10#37)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
indicating that there was##2##4##(2008-10#1)(2008-11#1)
indicating that there##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
indicating that these two##2##4##(1993-12#1)(2008-11#1)
indicating that these##12##3##(1992-4#1)(1993-12#1)(1995-2#1)(2008-10#3)(2008-11#4)(2008-7#1)(2010-5#1)
indicating that they were##3##4##(1991-5#1)(2008-10#1)(2008-5#1)
indicating that they##4##3##(1991-5#1)(2008-10#1)(2008-5#1)(2008-8#1)
indicating that this##13##3##(1993-6#1)(1993-8#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2009-4#1)(2013-1#1)
indicating that##269##2##(1990-11#1)(1990-5#3)(1990-8#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-5#4)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-6#3)(1995-8#3)(1995-9#1)(1996-12#5)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#111)(2008-11#22)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#8)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-5#2)(2010-8#2)(2011-2#5)(2011-3#1)(2012-3#1)(2012-5#1)(2013-1#7)(2013-8#1)
indicating the absence of##2##4##(2008-10#1)(2008-8#1)
indicating the existence of##2##4##(1991-5#1)(2008-10#1)
indicating the functional##2##3##(1995-2#1)(2011-3#1)
indicating the importance of##4##4##(1994-8#1)(1995-11#1)(2009-5#1)(2012-3#1)
indicating the involvement of the ER##3##6##(2008-11#3)
indicating the involvement of##7##4##(1991-3#1)(1991-5#1)(1994-5#1)(2008-11#3)(2011-2#1)
indicating the potential##2##3##(2008-8#1)(2009-7#1)
indicating the presence of a single##2##6##(2008-10#2)
indicating the presence of##7##4##(1994-8#1)(1995-6#1)(2008-10#3)(2008-3#1)(2009-8#1)
indicating the##57##2##(1991-3#1)(1991-5#2)(1992-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#2)(2008-10#18)(2008-11#5)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)
indicating their##5##2##(1992-12#1)(1997-3#1)(2008-10#2)(2008-11#1)
indicating##504##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#4)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#5)(1992-3#2)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#6)(1993-9#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#7)(1994-6#2)(1994-8#6)(1995-11#4)(1995-12#4)(1995-2#5)(1995-6#6)(1995-8#5)(1995-9#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#3)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#205)(2008-11#44)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#11)(2008-6#5)(2008-7#8)(2008-8#13)(2008-9#10)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#6)(2011-2#14)(2011-3#2)(2012-2#4)(2012-3#4)(2012-5#3)(2013-1#11)(2013-8#3)
indication and##2##2##(1997-5#1)(2008-10#1)
indication for##16##2##(1990-2#1)(1991-11#1)(1991-9#1)(1993-6#1)(1993-8#1)(1996-11#1)(1997-4#1)(1997-5#1)(2008-11#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#4)
indication is##4##2##(1996-3#1)(1997-5#1)(2011-2#1)(2012-12#1)
indication of the##9##3##(1990-5#1)(1992-11#1)(2008-11#3)(2008-3#1)(2008-4#1)(2009-5#1)(2012-2#1)
indication of##25##2##(1990-5#2)(1992-11#1)(1992-3#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#1)(2012-2#2)
indication that the##4##3##(2008-10#4)
indication that##10##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)
indication was##2##2##(1997-8#1)(2011-2#1)
indication##72##1##(1990-2#1)(1990-5#2)(1991-11#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-6#1)(1993-8#1)(1996-11#2)(1996-3#1)(1997-4#1)(1997-5#3)(1997-8#2)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#5)
indications and results of##3##4##(1990-9#1)(2008-10#2)
indications and##13##2##(1990-9#1)(1993-11#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
indications are##3##2##(1993-8#1)(2011-2#1)(2011-3#1)
indications for delivery and##2##4##(1996-11#2)
indications for imaging##2##3##(1990-11#2)
indications for surgery##3##3##(1990-3#1)(1990-9#1)(2008-7#1)
indications for the use of cortical allograft##2##7##(2011-2#2)
indications for the use of##4##5##(1990-9#2)(2011-2#2)
indications for the##6##3##(1990-9#2)(1991-3#1)(2010-6#1)(2011-2#2)
indications for which##2##3##(1992-5#1)(1997-6#1)
indications for##42##2##(1990-11#2)(1990-3#2)(1990-9#3)(1991-3#1)(1992-3#2)(1992-5#1)(1994-6#2)(1996-11#2)(1997-6#1)(2008-11#2)(2008-12#1)(2008-7#5)(2009-10#1)(2009-8#1)(2010-12#2)(2010-6#1)(2011-10#2)(2011-2#4)(2011-7#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
indications in##6##2##(1990-3#1)(1993-2#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-9#1)
indications of the##2##3##(2008-3#1)(2011-2#1)
indications of##10##2##(1991-2#1)(1991-6#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#2)(2011-2#1)(2013-1#1)
indications pertaining to##2##3##(2010-12#2)
indications that it##2##3##(2008-10#1)(2008-8#1)
indications that this##2##3##(1990-12#1)(2006-6#1)
indications that##7##2##(1990-12#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
indications to##3##2##(1991-3#1)(1993-3#1)(2012-3#1)
indications were found for##2##4##(1997-1#1)(2008-10#1)
indications were##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
indications##128##1##(1990-11#2)(1990-12#1)(1990-3#4)(1990-9#8)(1991-2#1)(1991-3#2)(1991-6#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-5#1)(1996-11#3)(1996-3#3)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(2006-6#1)(2007-11#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#3)(2010-12#8)(2010-6#3)(2011-10#2)(2011-2#13)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#2)
indicative literature values##2##3##(2008-10#2)
indicative of a##5##3##(1991-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2013-1#1)
indicative of an##2##3##(1994-3#1)(1997-3#1)
indicative of greater##2##3##(2008-11#1)(2009-11#1)
indicative of severe##2##3##(2010-10#1)(2012-12#1)
indicative of the degree of##2##5##(2008-5#1)(2008-8#1)
indicative of the##7##3##(1991-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
indicative of##48##2##(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1993-1#1)(1993-8#1)(1994-3#1)(1994-5#1)(1997-2#2)(1997-3#3)(2007-12#1)(2008-10#8)(2008-11#5)(2008-12#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-12#2)(2012-5#1)(2013-1#2)
indicative values##2##2##(2008-10#2)
indicative##57##1##(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1993-1#1)(1993-8#1)(1994-3#1)(1994-5#1)(1997-2#2)(1997-3#3)(2007-12#1)(2008-10#13)(2008-11#7)(2008-12#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2012-12#2)(2012-5#1)(2013-1#2)
indicator and##3##2##(2008-10#2)(2008-5#1)
indicator dye##2##2##(2008-10#2)
indicator electrode for the##4##4##(2008-10#4)
indicator electrode for##6##3##(2008-10#6)
indicator electrode in potentiometric titration of##10##6##(2008-10#10)
indicator electrode in potentiometric titrations##2##5##(2008-10#2)
indicator electrode in potentiometric##12##4##(2008-10#12)
indicator electrode in##18##3##(2008-10#18)
indicator electrode##34##2##(2008-10#34)
indicator electrodes##2##2##(2008-10#2)
indicator for the##5##3##(2008-10#2)(2008-11#2)(2008-7#1)
indicator for##15##2##(1992-3#1)(1995-2#2)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#1)(2013-1#2)
indicator in##3##2##(1994-12#1)(2008-10#2)
indicator is##2##2##(2008-10#1)(2013-1#1)
indicator latex##4##2##(1990-12#4)
indicator of a##3##3##(2008-10#2)(2013-7#1)
indicator of the quality of##2##5##(2008-12#1)(2010-12#1)
indicator of the##11##3##(1990-9#1)(1993-12#1)(2008-10#6)(2008-12#1)(2010-12#1)(2013-7#1)
indicator of##46##2##(1990-9#1)(1991-12#2)(1991-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1997-2#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-7#3)
indicator plants##3##2##(1997-3#1)(2008-10#2)
indicator reaction##9##2##(2008-10#9)
indicator strain##4##2##(2008-10#4)
indicator to the##2##3##(2010-11#1)(2013-1#1)
indicator to##3##2##(2008-10#1)(2010-11#1)(2013-1#1)
indicator trait##5##2##(2008-9#5)
indicator##215##1##(1990-12#5)(1990-2#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1997-2#2)(1997-3#2)(1997-8#1)(2006-6#1)(2008-10#126)(2008-11#7)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#1)(2012-12#2)(2012-2#4)(2012-4#1)(2013-1#8)(2013-7#3)
indicator&quot##2##1##(2008-9#2)
indicators and##9##2##(1990-8#1)(1997-1#1)(1997-3#1)(2008-11#4)(2011-1#1)(2012-4#1)
indicators are##2##2##(2008-11#1)(2013-1#1)
indicators for the##5##3##(1993-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-7#1)
indicators for##14##2##(1991-8#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#4)
indicators have##2##2##(2008-11#2)
indicators in the##3##3##(1994-2#1)(2009-10#1)(2010-12#1)
indicators in##8##2##(1994-2#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-12#2)(2013-1#1)
indicators of quality##2##3##(1996-2#2)
indicators of the##3##3##(1992-2#1)(2008-10#1)(2011-1#1)
indicators of##32##2##(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2009-8#1)(2010-11#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
indicators show##2##2##(1994-9#1)(2010-6#1)
indicators such as##2##3##(2008-9#1)(2010-6#1)
indicators that can##2##3##(2008-9#1)(2013-1#1)
indicators that##3##2##(1993-11#1)(2008-9#1)(2013-1#1)
indicators to##7##2##(1994-2#2)(1995-3#1)(1997-1#1)(2008-11#3)
indicators were##4##2##(1991-5#1)(1996-2#1)(2008-10#1)(2012-4#1)
indicators##166##1##(1990-8#1)(1991-1#3)(1991-12#2)(1991-2#2)(1991-5#5)(1991-8#1)(1992-12#1)(1992-2#3)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#7)(1994-9#1)(1995-12#4)(1995-3#1)(1995-5#1)(1996-2#10)(1996-3#3)(1997-1#3)(1997-2#2)(1997-3#8)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#23)(2008-12#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#3)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#1)(2012-4#3)(2013-1#12)(2013-8#1)
indicators'##2##1##(1991-5#2)
indices and the##2##3##(2008-2#1)(2012-2#1)
indices and##9##2##(1995-3#1)(2008-10#2)(2008-2#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
indices are##3##2##(2008-3#1)(2009-8#1)(2011-2#1)
indices by##2##2##(2008-10#2)
indices for the##4##3##(2008-10#4)
indices for##9##2##(2008-10#7)(2009-10#1)(2010-8#1)
indices in the##3##3##(2008-10#2)(2011-2#1)
indices in##7##2##(1995-3#1)(2008-10#4)(2008-12#1)(2011-2#1)
indices may##3##2##(1996-3#1)(2009-8#2)
indices of AUD severity##2##4##(2013-8#2)
indices of kidney in##2##4##(2008-12#2)
indices of lipid peroxidation##2##4##(1992-3#2)
indices of reproductive skew##2##4##(2008-8#2)
indices of the##4##3##(1995-3#1)(1997-6#1)(2008-2#1)(2012-2#1)
indices of##36##2##(1992-3#2)(1992-9#2)(1994-3#1)(1995-3#2)(1996-12#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#3)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
indices such as##2##3##(2008-10#1)(2009-8#1)
indices were##5##2##(2008-10#3)(2009-3#1)(2012-4#1)
indices##136##1##(1990-2#1)(1991-8#1)(1992-3#2)(1992-9#2)(1993-12#3)(1994-3#1)(1995-2#3)(1995-3#4)(1996-12#1)(1996-3#1)(1997-6#1)(2008-1#2)(2008-10#41)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#4)(2009-8#4)(2010-7#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#8)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#3)
indictment##2##1##(1991-6#1)(1996-5#1)
indicum##3##1##(2008-10#3)
indifferent to the##2##3##(1994-3#1)(2008-10#1)
indifferent to##4##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-8#1)
indifferent##7##1##(1991-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)
indigenous and introduced##2##3##(2008-10#1)(2008-8#1)
indigenous bacterial epiphytes and##2##4##(2008-10#2)
indigenous bacterial epiphytes##3##3##(2008-10#3)
indigenous bacterial##4##2##(2008-10#4)
indigenous peoples##2##2##(2008-1#1)(2013-1#1)
indigenous pollens##2##2##(2013-1#2)
indigenous populations##2##2##(2008-1#1)(2013-1#1)
indigenous##50##1##(1997-7#1)(2008-1#4)(2008-10#19)(2008-11#3)(2008-8#2)(2008-9#2)(2009-6#2)(2010-1#1)(2012-12#4)(2013-1#10)(2013-8#2)
indigenously developed paclitaxel-eluting##2##3##(2008-11#2)
indigent care##2##2##(1992-3#1)(2008-11#1)
indigent patients##2##2##(1996-3#1)(2008-11#1)
indigent population##2##2##(1992-2#1)(1996-3#1)
indigent##10##1##(1992-2#2)(1992-3#1)(1996-3#4)(2008-11#3)
indigo carmine##6##2##(1993-8#1)(2008-10#5)
indigo##8##1##(1993-8#1)(2008-10#7)
indirect ELISA##4##2##(1994-8#1)(2008-10#2)(2008-11#1)
indirect benefit##3##2##(1994-2#1)(2008-8#2)
indirect competitive immunoassay##3##3##(2008-10#3)
indirect competitive##6##2##(2008-10#6)
indirect detection##4##2##(2008-10#4)
indirect determination of the##2##4##(2008-10#2)
indirect determination of##9##3##(2008-10#9)
indirect double-antibody sandwich##2##3##(2008-10#2)
indirect effect##4##2##(1994-8#1)(2008-8#2)(2011-2#1)
indirect effects of predation##2##4##(2008-8#1)(2008-9#1)
indirect effects of##5##3##(1997-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
indirect effects on##2##3##(2008-7#1)(2008-8#1)
indirect effects##15##2##(1997-1#1)(2008-11#1)(2008-7#2)(2008-8#5)(2008-9#4)(2012-2#2)
indirect enzyme immunoassay##2##3##(1996-12#2)
indirect enzyme-linked immunosorbent assay##3##4##(2008-10#3)
indirect enzyme-linked immunosorbent##4##3##(2008-10#4)
indirect evidence##2##2##(1992-12#1)(2007-12#1)
indirect genetic effects##5##3##(2008-8#4)(2012-3#1)
indirect genetic##6##2##(2008-8#4)(2008-9#1)(2012-3#1)
indirect immunofluorescence using a##2##4##(2008-10#1)(2008-9#1)
indirect immunofluorescence##5##2##(1990-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
indirect immunofluorescent##4##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-8#1)
indirect method##5##2##(1993-11#1)(1993-3#1)(2008-10#1)(2008-11#2)
indirect methods##7##2##(1993-2#1)(1997-4#1)(1997-5#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-3#1)
indirect photoacoustic spectroscopy##2##3##(2008-3#2)
indirect photometric detection##2##3##(1997-2#1)(2008-10#1)
indirect photometric##4##2##(1997-2#1)(2008-10#3)
indirect potentiometric##2##2##(2008-10#2)
indirect spectrophotometric method##5##3##(2008-10#5)
indirect spectrophotometric##6##2##(2008-10#6)
indirect tensammetric##2##2##(2008-10#2)
indirect##190##1##(1990-12#3)(1991-12#4)(1991-2#1)(1991-6#1)(1992-12#3)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-8#2)(1996-12#2)(1996-2#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#72)(2008-11#9)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#17)(2008-9#16)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-2#5)(2012-2#3)(2012-3#3)(2013-8#2)
indirect&quot##2##1##(1994-1#1)(1997-1#1)
indirectly affect##2##2##(1996-1#1)(2012-2#1)
indirectly affects##2##2##(2008-11#1)(2008-9#1)
indirectly by a##2##3##(2008-10#1)(2008-9#1)
indirectly by##9##2##(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-6#1)
indirectly determined##2##2##(2008-10#2)
indirectly standardized##2##2##(1995-2#2)
indirectly through##3##2##(1994-8#1)(2008-11#1)(2012-3#1)
indirectly with##3##2##(2008-4#2)(2008-9#1)
indirectly##64##1##(1992-3#2)(1992-6#1)(1992-9#1)(1994-8#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-2#2)(1997-3#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#1)(2010-11#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#3)(2012-6#1)
indiscriminate##4##1##(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
indispensable for##8##2##(1996-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
indispensable##23##1##(1990-3#1)(1991-5#2)(1994-2#2)(1996-2#2)(1997-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
indistinguishable from that of native##2##5##(1992-8#1)(1995-2#1)
indistinguishable from that of##4##4##(1992-3#1)(1992-8#1)(1995-2#1)(2008-12#1)
indistinguishable from that##5##3##(1992-3#1)(1992-8#1)(1995-12#1)(1995-2#1)(2008-12#1)
indistinguishable from the##5##3##(1991-12#1)(1993-8#1)(2008-10#2)(2008-7#1)
indistinguishable from those##2##3##(2008-7#1)(2013-8#1)
indistinguishable from wild-type##2##3##(1993-12#1)(2008-10#1)
indistinguishable from##26##2##(1990-12#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-8#1)(1995-12#1)(1995-2#2)(2008-10#9)(2008-12#1)(2008-7#4)(2012-2#1)(2013-8#1)
indistinguishable##38##1##(1990-12#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-8#1)(1995-12#1)(1995-2#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
indium (III) and thallium (III)##2##5##(2008-10#2)
indium (III)##3##2##(2008-10#3)
indium and thallium with##2##4##(2008-10#2)
indium and thallium##4##3##(2008-10#4)
indium and##6##2##(2008-10#6)
indium in##5##2##(2008-10#5)
indium oxide##2##2##(2008-10#2)
indium tin oxide (ITO) coated glass##2##6##(2008-10#2)
indium tin oxide (ITO)##3##4##(2008-10#2)(2008-12#1)
indium tin oxide##5##3##(2008-10#2)(2008-12#2)(2009-12#1)
indium tin##6##2##(1995-3#1)(2008-10#2)(2008-12#2)(2009-12#1)
indium##33##1##(1993-11#1)(1995-3#1)(2008-10#28)(2008-12#2)(2009-12#1)
individual Tom40 molecules##2##3##(2012-2#2)
individual YACs were##2##3##(1997-2#2)
individual amino acid##2##3##(1993-8#1)(1997-9#1)
individual anatomical##2##2##(1991-2#1)(2008-11#1)
individual and focus group interviews##2##5##(2008-11#1)(2008-12#1)
individual and group##3##3##(2008-8#1)(2009-11#1)(2013-1#1)
individual and##15##2##(1991-1#1)(1994-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
individual attitudes##2##2##(1994-12#1)(2010-10#1)
individual based##3##2##(1997-6#2)(2008-7#1)
individual calibration##2##2##(2008-10#2)
individual case##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)
individual cell##4##2##(1995-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
individual cells##9##2##(2008-1#1)(2008-11#5)(2008-2#1)(2008-5#1)(2009-9#1)
individual change##3##2##(2008-12#3)
individual characteristics##2##2##(1992-3#1)(2011-2#1)
individual chemical##3##2##(1995-6#1)(2008-10#1)(2008-4#1)
individual clinical##2##2##(1994-12#1)(1996-2#1)
individual components in##2##3##(2008-10#2)
individual components of the##3##4##(2008-10#3)
individual components of##8##3##(1992-9#1)(2008-10#3)(2008-12#1)(2008-8#3)
individual components##14##2##(1992-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2009-12#1)
individual compounds##5##2##(2008-10#4)(2009-8#1)
individual countries##4##2##(1990-12#3)(1994-9#1)
individual data##2##2##(2008-10#1)(2011-2#1)
individual departments##2##2##(1994-3#1)(1996-3#1)
individual differences in the requirement for IL-2 and IL-4##2##9##(2008-11#2)
individual differences in the##5##4##(1993-6#1)(2008-11#3)(2008-2#1)
individual differences in##7##3##(1993-6#1)(2008-11#5)(2008-2#1)
individual differences##11##2##(1992-7#1)(1993-6#1)(2008-11#5)(2008-2#1)(2008-7#1)(2008-8#1)(2013-8#1)
individual diseases##2##2##(2008-10#2)
individual element##2##2##(2008-10#2)
individual factors##2##2##(2008-11#1)(2010-10#1)
individual features of##2##3##(2008-1#1)(2008-11#1)
individual features##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
individual females##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
individual fields##2##2##(2008-10#2)
individual fitness##4##2##(2008-8#2)(2008-9#2)
individual genes##5##2##(1997-6#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)
individual group##2##2##(2008-9#1)(2009-5#1)
individual growth##2##2##(2008-8#2)
individual has##3##2##(1994-12#1)(1996-3#1)(2008-11#1)
individual health care##2##3##(1994-1#1)(1995-12#1)
individual health##4##2##(1994-1#1)(1995-12#1)(1996-6#1)(2010-8#1)
individual identity##2##2##(2008-8#2)
individual immune responses##2##3##(2008-11#2)
individual information##2##2##(1997-3#1)(2011-7#1)
individual interviews##2##2##(2008-11#2)
individual ionic currents##2##3##(2008-11#2)
individual ionic##3##2##(2008-11#3)
individual is##2##2##(1995-9#1)(2008-10#1)
individual isolates##6##2##(2008-10#5)(2011-2#1)
individual larvae##2##2##(2008-11#2)
individual learning##2##2##(2008-11#2)
individual lesions##2##2##(2008-10#2)
individual level##4##2##(2008-12#1)(2008-8#2)(2011-9#1)
individual loci##2##2##(2008-10#2)
individual management##2##2##(1991-2#1)(2008-4#1)
individual members##2##2##(1997-7#1)(2008-8#1)
individual metal##3##2##(1990-5#1)(2008-10#2)
individual needs##2##2##(1992-1#1)(2010-1#1)
individual nodules##2##2##(2008-5#2)
individual or##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
individual patient##11##2##(1990-9#1)(1993-12#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
individual patients with##2##3##(2010-12#1)(2013-1#1)
individual patients##12##2##(1997-4#1)(1997-5#1)(2008-11#2)(2008-2#1)(2010-12#1)(2011-3#1)(2012-5#1)(2013-1#4)
individual plant was##2##3##(2008-10#1)(2008-9#1)
individual plant##4##2##(2008-10#2)(2008-9#1)(2009-8#1)
individual plants in##3##3##(2008-10#2)(2008-9#1)
individual plants##7##2##(2008-10#6)(2008-9#1)
individual populations##2##2##(2008-10#2)
individual proteins##2##2##(2008-10#1)(2011-2#1)
individual reaction##2##2##(1990-5#1)(2008-10#1)
individual recovery values##2##3##(2008-10#2)
individual risk##5##2##(2008-9#1)(2010-11#1)(2013-8#3)
individual sample##3##2##(2008-10#2)(2008-9#1)
individual scaling##2##2##(1995-9#2)
individual seed##2##2##(2008-10#1)(2008-8#1)
individual sensors##2##2##(2008-10#2)
individual separation of##4##3##(2008-10#4)
individual species##11##2##(2008-10#8)(2008-8#1)(2009-8#1)(2012-3#1)
individual spores##3##2##(2011-2#3)
individual strains##3##2##(2008-10#3)
individual students##2##2##(2008-12#2)
individual supported employment program for##2##5##(1993-3#2)
individual test##2##2##(1991-12#1)(2008-9#1)
individual therapy##2##2##(1990-12#1)(2012-2#1)
individual to the##2##3##(2008-7#1)(2013-1#1)
individual to##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
individual trabeculae##2##2##(2009-7#2)
individual treatment##3##2##(2009-11#1)(2009-3#1)(2013-1#1)
individual tree##5##2##(2008-10#5)
individual trees##4##2##(2008-10#4)
individual tumour##2##2##(2008-11#1)(2011-2#1)
individual users##2##2##(1996-2#1)(2008-7#1)
individual variables##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
individual variation in##2##3##(2008-8#1)(2012-3#1)
individual variation##3##2##(2007-12#1)(2008-8#1)(2012-3#1)
individual was##2##2##(1996-12#1)(2010-5#1)
individual who##2##2##(1997-3#1)(2012-3#1)
individual with a##3##3##(1994-1#1)(2011-1#2)
individual with##6##2##(1994-1#1)(2008-10#1)(2009-10#1)(2011-1#2)(2013-1#1)
individual##763##1##(1990-12#4)(1990-5#3)(1990-9#2)(1991-1#4)(1991-12#5)(1991-2#7)(1991-5#2)(1991-6#2)(1992-1#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#4)(1994-1#3)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#3)(1994-9#2)(1995-12#5)(1995-2#3)(1995-5#5)(1995-6#4)(1995-8#2)(1995-9#5)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#6)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#8)(1997-8#1)(1997-9#2)(2006-6#1)(2007-12#8)(2008-1#8)(2008-10#201)(2008-11#66)(2008-12#19)(2008-2#5)(2008-3#7)(2008-4#8)(2008-5#12)(2008-6#4)(2008-7#25)(2008-8#42)(2008-9#32)(2009-10#4)(2009-11#3)(2009-12#5)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#7)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#6)(2010-8#8)(2011-1#6)(2011-2#21)(2011-3#3)(2011-7#1)(2011-9#1)(2012-12#3)(2012-2#18)(2012-3#17)(2012-5#1)(2013-1#22)(2013-8#13)
individual's genetic##3##2##(2008-4#1)(2010-4#1)(2012-3#1)
individual's##21##1##(1994-2#1)(1994-3#1)(1995-2#1)(1997-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#2)(2009-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
individual- and community-level indicators##2##4##(2009-6#2)
individual-based model##6##2##(2008-8#3)(2008-9#3)
individual-based models##2##2##(2008-9#2)
individual-based##21##1##(2008-10#1)(2008-8#7)(2008-9#12)(2011-2#1)
individual-level##4##1##(1994-9#1)(2008-8#2)(2010-7#1)
individualisation##2##1##(2008-11#1)(2008-6#1)
individualise##2##1##(2008-6#1)(2008-8#1)
individualised##3##1##(1995-5#1)(2011-3#2)
individuality##4##1##(1995-12#1)(1996-2#1)(2009-10#1)(2010-7#1)
individualization##2##1##(2008-11#1)(2008-12#1)
individualize their##2##2##(1995-1#1)(2010-10#1)
individualize##3##1##(1995-1#1)(1997-4#1)(2010-10#1)
individualized to##2##2##(2009-2#1)(2011-2#1)
individualized##22##1##(1991-3#1)(1995-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
individually and as a##2##4##(2008-10#1)(2009-8#1)
individually and in combination##2##4##(2008-10#2)
individually and in##3##3##(1996-12#1)(2008-10#2)
individually and with##2##3##(2008-10#1)(2008-7#1)
individually and##11##2##(1996-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-8#1)(2010-7#1)(2010-9#1)
individually in their##2##3##(2008-10#1)(2008-12#1)
individually in##5##2##(2008-10#3)(2008-12#1)(2012-2#1)
individually into##2##2##(2008-10#1)(2008-7#1)
individually on##3##2##(2008-10#2)(2008-8#1)
individually or in##2##3##(1990-9#1)(1996-1#1)
individually or##3##2##(1990-9#1)(1996-1#1)(2008-9#1)
individually tailored##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
individually##82##1##(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#3)(1997-8#1)(1997-9#1)(2008-10#28)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-8#1)(2010-1#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
individuals (p##2##2##(2009-6#1)(2011-2#1)
individuals above##2##2##(1994-9#1)(2008-11#1)
individuals already##2##2##(2012-12#1)(2013-8#1)
individuals among##2##2##(2008-5#1)(2008-9#1)
individuals and in##2##3##(2012-2#2)
individuals and the##2##3##(1995-3#1)(2008-8#1)
individuals and##39##2##(1990-2#1)(1991-9#1)(1993-12#1)(1993-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-8#5)(2008-9#1)(2009-12#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
individuals are more likely to##2##5##(2008-8#2)
individuals are##15##2##(1994-2#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-8#4)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
individuals as##2##2##(2010-2#1)(2010-8#1)
individuals at risk for##4##4##(1991-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
individuals at risk##5##3##(1991-1#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
individuals at the##3##3##(2008-10#2)(2009-7#1)
individuals at##9##2##(1991-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
individuals before##2##2##(1994-12#1)(2013-7#1)
individuals by##5##2##(1991-6#1)(1995-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
individuals displayed##2##2##(1997-3#1)(2008-7#1)
individuals do##2##2##(1992-3#1)(1995-9#1)
individuals during##2##2##(2008-11#1)(2010-8#1)
individuals examined##2##2##(1997-3#1)(1997-7#1)
individuals for##3##2##(1996-3#1)(2008-10#1)(2012-3#1)
individuals from the##4##3##(1997-7#1)(2008-12#2)(2011-2#1)
individuals from##13##2##(1994-1#1)(1997-7#1)(2008-10#1)(2008-12#7)(2011-2#2)(2013-1#1)
individuals had##3##2##(1996-11#1)(2008-12#2)
individuals have##11##2##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
individuals in the##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
individuals in##19##2##(1990-3#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-9#1)(1994-12#1)(1995-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2013-8#1)
individuals interact##2##2##(2008-9#2)
individuals is##8##2##(1995-5#1)(1995-9#1)(2008-11#3)(2008-12#1)(2008-9#1)(2011-2#1)
individuals may##7##2##(1992-11#1)(1996-12#1)(2008-12#1)(2008-8#1)(2009-6#2)(2010-6#1)
individuals move##2##2##(2008-8#2)
individuals of European##2##3##(2008-8#1)(2012-2#1)
individuals of M##2##3##(2008-10#1)(2008-11#1)
individuals of different##2##3##(2008-10#1)(2011-2#1)
individuals of species##3##3##(2008-8#2)(2008-9#1)
individuals of the same##2##4##(1991-11#1)(2012-12#1)
individuals of the##3##3##(1991-11#1)(2008-8#1)(2012-12#1)
individuals of##22##2##(1991-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#7)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#1)
individuals often##3##2##(1991-12#2)(2008-10#1)
individuals older than 65 years of age##3##7##(2011-2#3)
individuals on##2##2##(2008-9#1)(2009-7#1)
individuals over##2##2##(1991-12#1)(2008-9#1)
individuals prefer##2##2##(1997-3#1)(2011-2#1)
individuals recruited from##2##3##(2008-12#1)(2008-7#1)
individuals showed##2##2##(1993-1#1)(2013-8#1)
individuals showing##2##2##(2010-4#1)(2013-1#1)
individuals than##4##2##(2008-10#1)(2008-8#3)
individuals that##5##2##(2008-10#1)(2008-12#1)(2008-8#2)(2009-10#1)
individuals to develop##2##3##(1993-3#1)(2008-7#1)
individuals to learn##2##3##(1996-5#1)(2008-4#1)
individuals to##15##2##(1991-12#1)(1993-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
individuals using##2##2##(1995-12#1)(2008-8#1)
individuals was##2##2##(2008-9#1)(2009-10#1)
individuals were observed in##2##4##(2008-10#1)(2010-5#1)
individuals were observed##3##3##(2008-10#1)(2010-5#1)(2010-8#1)
individuals were##15##2##(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#2)(2010-6#1)(2010-8#1)(2013-1#1)
individuals who are##6##3##(1991-12#1)(1992-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2009-6#1)
individuals who do##2##3##(1996-5#1)(2012-3#1)
individuals who were##3##3##(1992-3#1)(2008-12#1)(2012-3#1)
individuals who##20##2##(1991-12#1)(1992-2#1)(1992-3#1)(1995-12#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-11#3)(2008-12#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
individuals will##4##2##(1992-6#1)(2008-5#1)(2009-10#2)
individuals with chronic##3##3##(1993-3#1)(1997-1#1)(2010-2#1)
individuals with co-occurring substance abuse and mental health disorders##3##9##(2013-8#3)
individuals with co-occurring substance##4##4##(2013-8#4)
individuals with diabetes##3##3##(2013-1#3)
individuals with early repolarization syndrome##2##5##(2012-3#2)
individuals with lesbian and gay parents##2##6##(2012-2#2)
individuals with no##2##3##(1994-3#1)(2010-12#1)
individuals with predisposing##2##3##(2007-12#1)(2011-2#1)
individuals with the##6##3##(1997-3#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
individuals with##80##2##(1992-1#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-3#2)(1994-12#4)(1994-2#2)(1994-3#1)(1997-1#1)(1997-3#5)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#8)
individuals within a population##2##4##(2008-10#2)
individuals within a##3##3##(2008-10#2)(2011-1#1)
individuals within each##2##3##(2008-10#1)(2012-3#1)
individuals within the##2##3##(2008-8#1)(2009-5#1)
individuals within##10##2##(2008-10#3)(2008-8#3)(2009-5#1)(2011-1#1)(2012-3#1)(2012-7#1)
individuals without##4##2##(1997-3#1)(2010-10#1)(2010-9#1)(2011-2#1)
individuals##586##1##(1990-12#1)(1990-2#3)(1990-3#2)(1991-1#1)(1991-11#3)(1991-12#8)(1991-2#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-6#1)(1992-9#3)(1993-1#2)(1993-12#3)(1993-3#4)(1994-1#2)(1994-12#6)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#2)(1997-1#2)(1997-2#3)(1997-3#14)(1997-6#1)(1997-7#4)(1997-8#3)(2007-11#1)(2007-12#5)(2008-1#6)(2008-10#50)(2008-11#37)(2008-12#32)(2008-3#2)(2008-4#3)(2008-5#13)(2008-6#3)(2008-7#13)(2008-8#60)(2008-9#32)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#6)(2009-7#5)(2009-8#3)(2009-9#3)(2010-1#5)(2010-10#3)(2010-11#6)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#3)(2010-8#12)(2010-9#3)(2011-1#3)(2011-2#41)(2011-8#3)(2012-12#5)(2012-2#14)(2012-3#16)(2012-7#1)(2013-1#22)(2013-7#1)(2013-8#23)
individuals'##13##1##(1995-6#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#3)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
individuals/m(2))##2##1##(2013-8#2)
individuating##2##1##(2008-11#2)
individuation##2##1##(2008-11#1)(2013-1#1)
indocyanine green##3##2##(1992-2#1)(2013-1#2)
indocyanine##5##1##(1992-2#1)(2010-4#2)(2013-1#2)
indole##7##1##(1993-6#1)(1994-8#1)(2008-10#3)(2008-12#1)(2008-8#1)
indole-3-acetamide##2##1##(2008-10#2)
indole-3-acetic acid (IAA)##6##3##(2008-10#4)(2008-11#1)(2008-12#1)
indole-3-acetic##8##1##(2008-10#6)(2008-11#1)(2008-12#1)
indole-3-butyric acid (IBA)##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
indoleamine 2##2##2##(2008-11#2)
indolecarboxylic acids and their regulation effects on##2##7##(2008-10#2)
indolence##2##1##(2008-12#2)
indolent##7##1##(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
indolequinoline and quinolone alkaloids in coptis-evodia herb couple and the Chinese herbal preparations by##2##14##(2008-10#2)
indoles##2##1##(1995-12#1)(2010-3#1)
indolicidin##3##1##(1992-8#3)
indomethacin and##3##2##(1990-11#1)(2008-10#2)
indomethacin inhibited##2##2##(1991-5#1)(1996-2#1)
indomethacin##27##1##(1990-11#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-6#1)(1994-8#3)(1995-6#1)(1996-2#1)(1997-1#3)(2008-10#7)(2008-11#5)(2012-2#1)
indomethacin-induced enterocolitis##2##2##(2012-2#2)
indoor air pollution##2##3##(1991-3#1)(1994-9#1)
indoor air##8##2##(1991-3#1)(1993-2#1)(1994-9#2)(2008-10#3)(2010-5#1)
indoor and outdoor aeromicological##2##4##(2010-5#2)
indoor and outdoor air##6##4##(2008-10#6)
indoor and outdoor##15##3##(2008-10#11)(2008-11#1)(2010-5#3)
indoor pollution##3##2##(2008-10#3)
indoor sources##2##2##(2008-11#2)
indoor##40##1##(1991-3#3)(1993-2#2)(1994-9#3)(2008-10#19)(2008-11#4)(2008-3#1)(2010-5#5)(2013-1#3)
indoors and##4##2##(2008-10#1)(2010-5#1)(2012-12#2)
indoors##11##1##(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#2)(2012-12#3)
indophenol blue##3##2##(2008-10#3)
indophenol##4##1##(2008-10#4)
induce a##26##2##(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#3)
induce activation##2##2##(1994-2#1)(1997-3#1)
induce aggregation##2##2##(1990-5#2)
induce an##6##2##(1993-3#1)(1995-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
induce and##2##2##(2008-4#1)(2008-8#1)
induce antibody##3##2##(1995-5#1)(2008-11#2)
induce apoptosis in##3##3##(1993-8#1)(2008-8#2)
induce apoptosis of##3##3##(2008-8#1)(2008-9#1)(2009-3#1)
induce apoptosis when used as##2##5##(2009-12#2)
induce apoptosis##12##2##(1993-8#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#1)(2009-12#3)(2009-3#1)
induce both##4##2##(1995-5#1)(2008-10#2)(2013-8#1)
induce cell##6##2##(2008-11#2)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
induce changes in the##2##4##(2008-8#1)(2012-2#1)
induce changes##3##2##(2008-5#1)(2008-8#1)(2012-2#1)
induce different##3##2##(1995-12#1)(2008-11#1)(2012-3#1)
induce differentiation of##2##3##(2008-11#2)
induce differentiation##3##2##(1997-3#1)(2008-11#2)
induce expression of##3##3##(1995-12#1)(2008-11#1)(2009-4#1)
induce formation of##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
induce growth##2##2##(1997-7#1)(2008-10#1)
induce in##2##2##(1994-6#1)(2008-10#1)
induce oxidative stress and chronic inflammation##2##6##(2012-5#2)
induce oxidative##3##2##(1995-6#1)(2012-5#2)
induce plant##2##2##(2008-10#1)(2011-10#1)
induce potent##2##2##(1995-5#2)
induce proliferation of##2##3##(1993-3#1)(1997-3#1)
induce proliferation##3##2##(1993-3#1)(1997-3#1)(2008-4#1)
induce pulmonary##2##2##(1993-6#1)(2013-8#1)
induce rapid phospholipid flip-flop##2##4##(1994-5#2)
induce resistance##6##2##(2008-10#6)
induce severe##2##2##(1993-11#1)(2008-10#1)
induce similar##4##2##(1995-5#1)(2008-10#2)(2013-8#1)
induce strong##2##2##(2008-11#1)(2008-8#1)
induce substantial##2##2##(1997-1#1)(2008-10#1)
induce systemic T cell##2##4##(2008-11#2)
induce systemic resistance in plants##3##5##(2008-10#3)
induce systemic resistance in##8##4##(2008-10#8)
induce systemic resistance to##2##4##(2008-10#1)(2013-8#1)
induce systemic resistance##11##3##(2008-10#10)(2013-8#1)
induce systemic##14##2##(2008-10#11)(2008-11#2)(2013-8#1)
induce the expression of##3##4##(1996-12#1)(2008-7#1)(2008-8#1)
induce the production of##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
induce the##30##2##(1990-5#1)(1992-12#1)(1993-8#1)(1994-11#2)(1994-5#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#2)(2009-7#2)(2010-7#1)
induce these##2##2##(2008-10#2)
induce translocation of##2##3##(1993-8#1)(2008-11#1)
induce tumors in##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
induce##352##1##(1990-5#3)(1990-9#1)(1991-2#1)(1991-5#5)(1992-12#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#5)(1993-3#2)(1993-6#3)(1993-8#4)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#10)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-5#6)(1995-6#1)(1995-8#3)(1995-9#3)(1996-12#2)(1996-2#5)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#4)(2006-6#2)(2007-11#2)(2008-10#89)(2008-11#36)(2008-12#6)(2008-3#4)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#20)(2008-9#9)(2009-10#2)(2009-12#5)(2009-3#3)(2009-4#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-7#3)(2011-10#1)(2011-2#19)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#2)(2013-1#7)(2013-8#7)
induced DNA##3##2##(1993-12#1)(1994-11#1)(1995-6#1)
induced IFN-gamma production##2##3##(2008-11#2)
induced MhNPR1 expression in##2##4##(2011-10#2)
induced a decrease in##2##4##(2008-10#2)
induced a dose-dependent increase in##4##5##(1993-3#1)(1994-11#1)(2008-10#1)(2008-5#1)
induced a dose-dependent##5##3##(1993-3#1)(1994-11#1)(2008-10#1)(2008-5#1)(2010-11#1)
induced a local##2##3##(2008-10#2)
induced a significant##3##3##(1993-3#1)(2011-2#1)(2013-1#1)
induced a##51##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-11#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#2)(1997-4#1)(2008-10#13)(2008-11#4)(2008-5#4)(2010-11#1)(2011-2#2)(2013-1#2)
induced abortions##5##2##(2008-11#1)(2013-1#4)
induced activity was##2##3##(1992-8#1)(1995-8#1)
induced after##3##2##(1995-11#1)(1997-7#1)(2008-10#1)
induced alterations in##2##3##(1991-6#1)(2008-11#1)
induced an increase in##2##4##(1993-8#1)(2008-10#1)
induced an increase of the##2##5##(2008-10#1)(2008-11#1)
induced an increase of##4##4##(2008-10#1)(2008-11#1)(2008-8#2)
induced an increase##7##3##(1993-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#2)
induced an##15##2##(1991-12#1)(1993-6#1)(1993-8#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#2)(2009-6#1)(2011-2#1)
induced and constitutive plant resistance##2##5##(2008-8#2)
induced and constitutive##3##3##(2008-8#3)
induced and maintained with##2##4##(1996-6#1)(2010-7#1)
induced and##9##2##(1994-6#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-8#3)(2009-8#1)(2010-7#1)
induced apoptosis in##3##3##(2008-11#1)(2011-2#2)
induced apoptosis of##2##3##(2008-8#1)(2011-2#1)
induced apoptosis##9##2##(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#3)
induced at the##2##3##(1992-12#1)(2008-10#1)
induced at##5##2##(1992-12#1)(1992-9#1)(1993-6#1)(2008-10#2)
induced bone resorption##2##3##(1993-6#1)(2008-12#1)
induced bone##3##2##(1993-6#1)(2008-12#2)
induced both local and systemic##2##5##(2008-10#2)
induced both##5##2##(1993-8#1)(2008-10#4)
induced breakdown spectrometry##2##3##(2008-10#2)
induced breakdown spectroscopy##2##3##(2008-10#2)
induced breakdown##4##2##(2008-10#4)
induced by Ach##2##3##(2011-2#2)
induced by H##2##3##(1997-1#1)(2008-12#1)
induced by IL-2##2##3##(2008-8#2)
induced by IPTG##2##3##(1994-8#1)(2013-1#1)
induced by LPS and IFN-gamma/LPS##2##5##(2008-8#2)
induced by LPS##3##3##(2008-8#3)
induced by M##2##3##(2008-10#2)
induced by NGF##2##3##(2008-11#2)
induced by PMA##2##3##(1994-8#1)(1995-6#1)
induced by a##14##3##(1993-3#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-5#1)
induced by acute##2##3##(1991-9#1)(1994-2#1)
induced by an##4##3##(1993-2#1)(2008-2#1)(2010-4#1)(2013-1#1)
induced by anticancer##2##3##(2008-11#2)
induced by arachidonic acid##2##4##(1990-12#1)(1994-11#1)
induced by binding of 3##2##5##(1993-8#2)
induced by bradykinin##2##3##(1997-1#2)
induced by central##2##3##(1992-6#1)(2010-12#1)
induced by chemotherapy##2##3##(2008-8#1)(2010-12#1)
induced by chronic EtOH##2##4##(2008-10#2)
induced by combined##2##3##(2011-2#2)
induced by compost##2##3##(2008-10#2)
induced by doxorubicin##3##3##(1991-6#1)(2011-2#2)
induced by electric fields in biological##2##6##(1997-6#2)
induced by environmental##2##3##(2009-4#1)(2009-8#1)
induced by exposing##2##3##(2011-10#1)(2013-1#1)
induced by fMLP##2##3##(1995-6#1)(1996-2#1)
induced by fungal##2##3##(2008-10#2)
induced by growth##2##3##(1991-9#1)(2010-10#1)
induced by harringtonine##2##3##(2008-8#2)
induced by high##2##3##(2008-10#1)(2008-7#1)
induced by infection with##2##4##(1996-11#1)(2011-2#1)
induced by injection of##2##4##(2008-8#1)(2008-9#1)
induced by intracellular##2##3##(1991-2#1)(2008-7#1)
induced by ligand binding##2##4##(1993-8#1)(1995-2#1)
induced by low##2##3##(1991-5#1)(2008-7#1)
induced by lower##2##3##(1990-9#1)(2008-8#1)
induced by nerve growth factor##2##5##(1996-12#1)(2008-11#1)
induced by phenylephrine##2##3##(1991-6#2)
induced by stress##2##3##(2008-10#1)(2010-4#1)
induced by subcutaneous injection##2##4##(2008-11#1)(2013-1#1)
induced by subcutaneous##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
induced by the addition of##2##5##(2008-11#1)(2008-4#1)
induced by the presence##2##4##(2008-11#1)(2012-12#1)
induced by the##31##3##(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#2)(1996-5#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-8#1)
induced by these agents##2##4##(2008-10#1)(2008-11#1)
induced by these##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2011-3#1)
induced by treatment of##2##4##(1994-11#1)(2008-10#1)
induced by treatment##3##3##(1994-11#1)(2008-10#1)(2009-7#1)
induced by vaccination##2##3##(1995-2#1)(1995-9#1)
induced by various##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
induced by##397##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#4)(1990-6#3)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#7)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#4)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#8)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#4)(1994-8#11)(1994-9#1)(1995-11#6)(1995-12#9)(1995-2#4)(1995-3#1)(1995-6#4)(1995-8#4)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#1)(1996-5#4)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#3)(1997-7#3)(1997-8#4)(2007-12#3)(2008-10#59)(2008-11#34)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#9)(2008-8#23)(2008-9#11)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2010-10#2)(2010-12#6)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-10#3)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#3)
induced c-fos##2##2##(1997-2#1)(1997-3#1)
induced cardiac##2##2##(1994-11#1)(2011-2#1)
induced cell apoptosis##2##3##(2008-9#2)
induced cell death##5##3##(2008-11#1)(2008-9#1)(2009-12#3)
induced cell##9##2##(1994-9#1)(2008-11#1)(2008-9#3)(2009-12#3)(2012-2#1)
induced changes in##4##3##(1997-2#1)(2008-11#1)(2008-9#1)(2012-5#1)
induced changes##5##2##(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-5#1)
induced chromosome##2##2##(2008-11#2)
induced colon##2##2##(1990-6#2)
induced conditions##2##2##(2008-11#1)(2011-1#1)
induced conformational change of G(o)alpha##2##5##(2008-9#2)
induced conformational##3##2##(1992-6#1)(2008-9#2)
induced convection##2##2##(1992-8#1)(2008-10#1)
induced damage##2##2##(2012-3#1)(2013-8#1)
induced differentiation in##2##3##(1990-6#1)(2008-11#1)
induced disease##2##2##(2008-10#2)
induced during##5##2##(1994-12#1)(1994-2#1)(2008-10#1)(2008-11#2)
induced either by##2##3##(1997-1#1)(2007-12#1)
induced either##3##2##(1997-1#1)(2007-12#1)(2012-6#1)
induced eosinophilic##2##2##(2008-11#1)(2010-11#1)
induced expression of##4##3##(1997-7#1)(1997-9#1)(2008-10#2)
induced fluorescence detection##4##3##(1997-2#1)(2008-10#3)
induced fluorescence##17##2##(1997-2#1)(2008-10#16)
induced following##2##2##(1991-7#1)(2008-10#1)
induced for##2##2##(2008-8#1)(2008-9#1)
induced from##5##2##(1990-5#1)(2008-12#1)(2008-8#2)(2013-1#1)
induced growth##2##2##(2011-2#1)(2013-8#1)
induced in a##4##3##(1993-8#1)(2008-10#2)(2012-2#1)
induced in mice##3##3##(1995-12#1)(1996-12#1)(2008-10#1)
induced in rats##2##3##(2008-4#1)(2011-3#1)
induced in the##17##3##(1990-2#1)(1991-5#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
induced in tomato roots##2##4##(2008-10#2)
induced in vitro##2##3##(1997-3#1)(2008-11#1)
induced in##55##2##(1990-2#1)(1990-3#1)(1991-5#1)(1991-7#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-12#5)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-7#2)(2009-8#2)(2010-5#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
induced increases in##2##3##(1991-3#2)
induced inflammation##2##2##(2012-2#1)(2013-8#1)
induced injury##2##2##(1995-11#1)(2008-9#1)
induced learning##2##2##(1991-7#1)(2010-1#1)
induced lesions##2##2##(2008-1#1)(2008-10#1)
induced local resistance by##2##4##(2008-10#2)
induced local##3##2##(2008-10#3)
induced lower##2##2##(2008-10#1)(2008-8#1)
induced more##2##2##(2008-10#1)(2012-4#1)
induced murine##2##2##(1993-3#1)(2010-8#1)
induced necrotic lesions##2##3##(2008-10#2)
induced on the##2##3##(2008-10#1)(2008-5#1)
induced on##5##2##(2008-10#3)(2008-12#1)(2008-5#1)
induced only##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
induced ossicle##2##2##(2008-12#2)
induced pH change##2##3##(2009-12#2)
induced plasma##4##2##(2008-10#4)
induced pluripotent stem cells##2##4##(2010-10#1)(2012-5#1)
induced pluripotent##3##2##(2010-10#1)(2012-5#2)
induced pneumonitis##2##2##(2010-12#2)
induced rapid##4##2##(1990-12#1)(2008-10#1)(2009-8#1)(2010-6#1)
induced reproduction in##2##3##(2008-7#2)
induced resistance against##2##3##(2008-10#2)
induced resistance and##3##3##(2008-10#3)
induced resistance in##3##3##(2008-10#3)
induced resistance is##5##3##(2008-10#5)
induced resistance to##2##3##(2008-10#2)
induced resistance##30##2##(2008-10#25)(2008-8#4)(2009-6#1)
induced resistant##2##2##(2008-10#1)(2008-11#1)
induced responses##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
induced revenue##2##2##(1991-3#2)
induced significant##5##2##(1997-2#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#1)
induced similar##2##2##(2008-10#1)(2008-11#1)
induced strong##2##2##(2012-2#2)
induced symptoms##4##2##(2008-10#4)
induced systemic resistance (ISR)##5##4##(2008-10#5)
induced systemic resistance and##2##4##(2008-10#1)(2013-8#1)
induced systemic resistance##12##3##(2008-10#11)(2013-8#1)
induced systemic##14##2##(2008-10#13)(2013-8#1)
induced the expression of##4##4##(1990-12#1)(2008-10#2)(2011-10#1)
induced the growth of lactic acid bacteria##2##7##(2008-11#2)
induced the growth##3##3##(2008-11#3)
induced the production of unusual cytoplasmic ribbon-like inclusions##2##8##(2008-10#2)
induced the production of##3##4##(2008-10#3)
induced the##28##2##(1990-12#1)(1991-5#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(2008-10#11)(2008-11#5)(2008-8#1)(2008-9#1)(2011-10#1)(2011-2#2)(2011-3#1)
induced through##2##2##(2008-11#2)
induced to differentiate##3##3##(1993-3#1)(2008-11#2)
induced to undergo apoptosis##2##4##(1995-2#1)(2008-9#1)
induced to##14##2##(1991-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#1)
induced with##15##2##(1995-12#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
induced##1139##1##(1990-11#2)(1990-12#7)(1990-2#4)(1990-3#3)(1990-5#8)(1990-6#7)(1990-7#1)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#5)(1991-3#9)(1991-5#14)(1991-6#8)(1991-7#6)(1991-8#2)(1991-9#3)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#6)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#8)(1993-6#8)(1993-8#10)(1993-9#2)(1994-11#13)(1994-12#4)(1994-2#5)(1994-3#8)(1994-5#4)(1994-6#8)(1994-8#19)(1994-9#2)(1995-11#13)(1995-12#16)(1995-2#6)(1995-3#1)(1995-6#7)(1995-8#9)(1995-9#3)(1996-11#2)(1996-12#13)(1996-2#14)(1996-3#3)(1996-5#7)(1996-6#2)(1997-1#5)(1997-2#9)(1997-3#3)(1997-4#7)(1997-6#4)(1997-7#9)(1997-8#4)(1997-9#1)(2006-6#1)(2007-12#7)(2008-1#4)(2008-10#285)(2008-11#99)(2008-12#19)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#26)(2008-6#3)(2008-7#21)(2008-8#59)(2008-9#33)(2009-10#5)(2009-11#1)(2009-12#6)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#6)(2009-8#12)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#11)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#2)(2011-10#7)(2011-2#40)(2011-3#3)(2012-12#3)(2012-2#22)(2012-3#10)(2012-4#1)(2012-5#4)(2012-6#2)(2013-1#26)(2013-7#3)(2013-8#16)
inducer and##2##2##(2008-10#1)(2012-3#1)
inducer of##11##2##(1990-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
inducer##24##1##(1990-5#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#2)(1995-2#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
inducers include##2##2##(2008-10#2)
inducers of##5##2##(1994-11#1)(2008-10#4)
inducers##13##1##(1992-6#1)(1994-11#1)(2008-10#9)(2009-9#1)(2010-10#1)
induces a significant##2##3##(2008-5#1)(2011-2#1)
induces a similar##2##3##(1991-5#1)(2008-10#1)
induces a##32##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-5#3)(1994-8#1)(1996-2#2)(1997-4#2)(2008-10#8)(2008-3#1)(2008-5#2)(2008-7#2)(2011-2#2)(2011-3#1)(2013-8#1)
induces an##4##2##(1992-6#1)(1994-8#1)(1997-2#1)(2009-8#1)
induces apoptosis in##2##3##(2011-2#1)(2012-2#1)
induces apoptosis##6##2##(2008-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
induces differentiation##2##2##(1993-11#1)(1993-3#1)
induces ferritin##2##2##(1990-5#2)
induces generation of superoxide anion##2##5##(1993-6#2)
induces mainly##2##2##(2008-5#1)(2008-7#1)
induces obesity and##2##3##(2010-6#1)(2010-7#1)
induces protein##2##2##(2009-7#1)(2010-1#1)
induces resistance##3##2##(2008-10#2)(2009-6#1)
induces significant##2##2##(1996-12#1)(2008-10#1)
induces strong##2##2##(1994-11#1)(1995-2#1)
induces systemic resistance in##2##4##(2008-10#2)
induces systemic##4##2##(2008-10#4)
induces the formation of##2##4##(2008-10#1)(2008-9#1)
induces the##16##2##(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#6)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#2)(2013-1#1)
induces tolerance##2##2##(2012-3#1)(2013-1#1)
induces##167##1##(1990-12#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-5#5)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#3)(1994-1#1)(1994-11#3)(1994-2#1)(1994-5#4)(1994-8#4)(1995-10#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#4)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#2)(2008-10#26)(2008-11#17)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#3)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#3)(2011-10#1)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#3)
inducibility of the##2##3##(1990-3#1)(1993-6#1)
inducibility of##5##2##(1990-3#1)(1993-6#1)(1995-11#1)(2008-11#1)(2009-10#1)
inducibility##10##1##(1990-3#2)(1990-5#1)(1993-6#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)
inducible HSP70##2##2##(1994-8#2)
inducible NOS##2##2##(1994-11#1)(2009-10#1)
inducible by##5##2##(1990-5#1)(1992-6#2)(1993-9#1)(1995-2#1)
inducible expression of##2##3##(1993-12#1)(1993-9#1)
inducible expression##5##2##(1993-12#1)(1993-8#1)(1993-9#2)(1997-8#1)
inducible nitric oxide synthase (iNOS)##5##5##(1996-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
inducible nitric oxide synthase##7##4##(1996-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
inducible nitric oxide##8##3##(1996-12#2)(1996-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
inducible promoter##2##2##(1993-9#1)(2008-10#1)
inducible transcription##2##2##(1995-6#1)(1996-12#1)
inducible##52##1##(1990-5#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#4)(1996-2#2)(1997-7#2)(1997-8#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
inducing a##13##2##(1990-12#1)(1990-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
inducing and##2##2##(2008-10#1)(2012-12#1)
inducing apoptosis of##2##3##(2008-11#1)(2008-9#1)
inducing apoptosis##5##2##(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#1)
inducing cell##2##2##(2008-11#1)(2011-2#1)
inducing expression of##2##3##(1997-3#1)(2012-2#1)
inducing expression##3##2##(1997-3#1)(2008-9#1)(2012-2#1)
inducing resistance##2##2##(2008-10#2)
inducing signal##2##2##(1996-2#1)(2008-10#1)
inducing systemic resistance##2##3##(2008-10#2)
inducing the##9##2##(1993-11#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
inducing them to##2##3##(2008-7#1)(2009-7#1)
inducing##99##1##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#28)(2008-11#6)(2008-12#1)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#5)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
inducted##3##1##(2008-11#1)(2008-9#1)(2011-2#1)
induction and##13##2##(1995-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)
induction are##2##2##(1991-5#1)(2008-11#1)
induction by##15##2##(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#3)(2008-8#2)(2010-5#1)
induction can##2##2##(1997-2#1)(2008-11#1)
induction chemotherapy##10##2##(1990-6#4)(2008-10#6)
induction from##2##2##(1990-12#1)(2008-10#1)
induction in the##2##3##(1996-12#1)(2008-10#1)
induction in##17##2##(1990-3#1)(1995-12#1)(1996-12#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-9#2)(2009-8#1)
induction is##6##2##(1991-12#1)(1991-5#1)(1993-8#1)(1994-11#1)(2008-10#1)(2012-2#1)
induction medium in##2##3##(2008-11#2)
induction medium##6##2##(2008-11#6)
induction of HB-EGF##2##3##(1997-1#2)
induction of IFN-gamma production##2##4##(2008-4#2)
induction of L-FABP##2##3##(1994-8#2)
induction of LTP##5##3##(1995-12#2)(1995-2#1)(2008-7#2)
induction of a##3##3##(2008-10#3)
induction of acrosome reaction in##2##5##(2013-1#2)
induction of alpha Amy3##2##4##(1994-11#2)
induction of an##2##3##(1997-7#1)(2008-10#1)
induction of anaesthesia##4##3##(2010-7#1)(2011-2#3)
induction of anti-inflammatory##2##3##(2008-12#1)(2012-2#1)
induction of apoptosis##12##3##(1993-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#3)(2009-12#1)(2011-2#1)
induction of cell##2##3##(2008-8#1)(2012-2#1)
induction of chitinase##2##3##(2008-10#2)
induction of cytoglobin##2##3##(2010-11#2)
induction of defense##2##3##(2008-10#2)
induction of differentiation##2##3##(1994-11#1)(2008-11#1)
induction of either##3##3##(1991-12#1)(1995-2#1)(1995-5#1)
induction of ferritin H##2##4##(1990-5#2)
induction of hepatic microsomal##2##4##(1993-12#2)
induction of hepatic##3##3##(1993-12#3)
induction of host##2##3##(2008-10#2)
induction of human##2##3##(2008-11#1)(2008-8#1)
induction of labor##2##3##(2008-11#2)
induction of long-term potentiation in the##2##6##(1995-12#1)(2008-7#1)
induction of long-term potentiation##4##4##(1995-12#2)(2008-7#2)
induction of long-term##5##3##(1995-12#2)(2008-7#2)(2011-2#1)
induction of multiple##2##3##(2008-10#1)(2012-2#1)
induction of other##2##3##(1992-10#1)(2013-1#1)
induction of oxidative stress##2##4##(2008-10#2)
induction of proliferation##3##3##(1991-3#2)(2013-1#1)
induction of resistance##3##3##(2008-10#3)
induction of several##2##3##(2008-10#1)(2011-1#1)
induction of systemic resistance in##2##5##(2008-10#2)
induction of systemic resistance##6##4##(2008-10#6)
induction of systemic##7##3##(2008-10#7)
induction of the##15##3##(1991-9#1)(1992-8#2)(1993-9#1)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#3)(2008-5#1)(2009-8#1)(2011-1#1)(2013-1#1)
induction of these##2##3##(1994-6#1)(2008-10#1)
induction of this##2##3##(1996-2#1)(1997-2#1)
induction of##243##2##(1990-12#2)(1990-5#2)(1991-12#2)(1991-3#3)(1991-5#5)(1991-9#2)(1992-10#2)(1992-12#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#6)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#8)(1995-2#3)(1995-5#3)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-7#4)(1997-8#1)(2008-10#61)(2008-11#25)(2008-12#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#5)(2009-12#1)(2009-6#1)(2009-8#4)(2010-11#2)(2010-3#1)(2010-7#2)(2011-1#3)(2011-2#14)(2012-2#10)(2012-3#2)(2013-1#8)(2013-8#1)
induction on##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
induction period##4##2##(2008-10#4)
induction phase##3##2##(2008-10#3)
induction profile##2##2##(1996-12#2)
induction showed##2##2##(2008-8#1)(2012-2#1)
induction therapy##3##2##(2008-1#1)(2008-10#2)
induction using##3##2##(1996-11#1)(2008-12#1)(2008-4#1)
induction was achieved##2##3##(1995-8#1)(2008-12#1)
induction was also##2##3##(1996-12#1)(2009-10#1)
induction was not##2##3##(1995-2#1)(2008-10#1)
induction was##13##2##(1990-5#2)(1993-8#1)(1995-2#1)(1995-8#1)(1996-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)
induction were##2##2##(1995-2#1)(1996-12#1)
induction with##6##2##(1995-11#1)(1995-12#2)(2007-7#1)(2008-8#1)(2011-3#1)
induction##440##1##(1990-12#3)(1990-3#3)(1990-5#5)(1990-6#4)(1991-1#1)(1991-12#3)(1991-3#3)(1991-5#9)(1991-9#2)(1992-10#2)(1992-12#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#6)(1994-11#8)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#13)(1995-2#8)(1995-5#3)(1995-6#4)(1995-8#5)(1996-11#1)(1996-12#9)(1996-2#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-7#5)(1997-8#7)(2007-7#2)(2008-1#1)(2008-10#101)(2008-11#57)(2008-12#13)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#17)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#6)(2010-1#2)(2010-11#3)(2010-3#1)(2010-5#1)(2010-7#4)(2011-1#3)(2011-2#19)(2011-3#1)(2012-2#13)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
inductions of##2##2##(1993-8#2)
inductions##4##1##(1993-8#2)(2008-11#2)
inductive qualitative##2##2##(2010-10#1)(2013-1#1)
inductive##12##1##(1992-8#1)(1993-5#1)(1994-12#1)(1995-5#1)(2008-10#2)(2008-11#3)(2010-10#1)(2011-1#1)(2013-1#1)
inductively coulped plasma mass spectrometry##2##5##(2008-10#2)
inductively coupled argon##2##3##(2008-10#2)
inductively coupled mass spectrometry##2##4##(2008-10#2)
inductively coupled mass##3##3##(2008-10#3)
inductively coupled plasma (ICP)##2##4##(1992-3#1)(2008-10#1)
inductively coupled plasma atomic emission spectrometer (ICP-AES)##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectrometry (ICP-AES) and inductively coupled plasma mass spectrometry (ICP-MS)##2##14##(2008-10#2)
inductively coupled plasma atomic emission spectrometry (ICP-AES)##11##7##(2008-10#11)
inductively coupled plasma atomic emission spectrometry and##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectrometry determination of##2##8##(2008-10#2)
inductively coupled plasma atomic emission spectrometry##44##6##(1992-3#1)(2008-10#43)
inductively coupled plasma atomic emission spectroscopy technique##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectroscopy##4##6##(2008-10#4)
inductively coupled plasma atomic emission##56##5##(1992-3#1)(2008-10#55)
inductively coupled plasma atomic##58##4##(1992-3#1)(2008-10#57)
inductively coupled plasma emission##2##4##(2008-10#2)
inductively coupled plasma mass spectrometer (ICP-MS)##2##6##(2008-10#2)
inductively coupled plasma mass spectrometer##3##5##(2008-10#3)
inductively coupled plasma mass spectrometry (ICP-MS) using##2##7##(2008-10#2)
inductively coupled plasma mass spectrometry (ICP-MS)##22##6##(2008-10#22)
inductively coupled plasma mass spectrometry (ICPMS)##3##6##(2008-10#2)(2010-11#1)
inductively coupled plasma mass spectrometry for the##2##7##(2008-10#2)
inductively coupled plasma mass spectrometry for##4##6##(2008-10#4)
inductively coupled plasma mass spectrometry##61##5##(2008-10#58)(2010-11#3)
inductively coupled plasma mass##66##4##(2008-10#63)(2010-11#3)
inductively coupled plasma optical emission spectrometry (ICP-OES)##7##7##(2008-10#7)
inductively coupled plasma optical emission spectrometry##16##6##(2008-10#16)
inductively coupled plasma optical emission##17##5##(2008-10#16)(2011-2#1)
inductively coupled plasma spectrometry of platinum group metals##2##8##(2008-10#2)
inductively coupled plasma spectrometry##3##4##(2008-10#3)
inductively coupled plasma##160##3##(1992-3#2)(2008-10#154)(2010-11#3)(2011-2#1)
inductively coupled plasma-atomic emission spectrometry (ICP-AES)##6##6##(2008-10#6)
inductively coupled plasma-atomic emission spectrometry##14##5##(2008-10#14)
inductively coupled plasma-atomic emission##18##4##(2008-10#18)
inductively coupled plasma-mass spectrometer##2##4##(2008-10#2)
inductively coupled plasma-mass spectrometry (ICP-MS)##6##5##(2008-10#6)
inductively coupled plasma-mass spectrometry##12##4##(2008-10#12)
inductively coupled plasma-mass##15##3##(2008-10#15)
inductively coupled plasma-optical emission spectrometry##3##5##(2008-10#3)
inductively coupled plasma-optical emission spectroscopy##2##5##(2008-10#2)
inductively coupled plasma-optical emission##6##4##(2008-10#6)
inductively coupled plasma-time of flight-mass spectrometry##2##6##(2008-10#2)
inductively coupled##207##2##(1992-3#2)(2008-10#201)(2010-11#3)(2011-2#1)
inductively##211##1##(1992-3#2)(2008-10#205)(2010-11#3)(2011-2#1)
induration##2##1##(1990-6#1)(1997-2#1)
industrial CTW##2##2##(2008-12#2)
industrial and##10##2##(1993-3#1)(1995-2#1)(2008-10#5)(2008-11#2)(2008-7#1)
industrial application##3##2##(1991-5#1)(2008-5#1)(2012-2#1)
industrial applications##10##2##(2008-10#3)(2008-11#3)(2008-9#1)(2011-2#1)(2012-2#2)
industrial area##2##2##(2008-10#1)(2012-3#1)
industrial effluent##3##2##(2008-10#3)
industrial effluents##4##2##(2008-10#4)
industrial environments##2##2##(2008-10#1)(2008-3#1)
industrial microbiology was##2##3##(2011-2#2)
industrial process##4##2##(2008-10#3)(2011-2#1)
industrial processes##2##2##(2008-10#1)(2011-2#1)
industrial production of##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
industrial production##4##2##(1992-11#1)(2008-11#1)(2011-2#1)(2012-2#1)
industrial products in clinical application##2##5##(2012-3#2)
industrial products##4##2##(2011-2#2)(2012-3#2)
industrial sample##2##2##(2008-10#2)
industrial samples##4##2##(2008-10#4)
industrial scale##5##2##(2008-11#2)(2008-5#2)(2008-7#1)
industrial sectors##2##2##(2008-11#1)(2008-5#1)
industrial sludge##3##2##(2008-10#1)(2008-11#2)
industrial strain##2##2##(1996-6#1)(2013-1#1)
industrial waste water samples##2##4##(2008-10#2)
industrial waste water##4##3##(2008-10#4)
industrial waste waters##4##3##(2008-10#4)
industrial waste##9##2##(2008-10#9)
industrial wastewater samples##2##3##(2008-10#2)
industrial wastewaters##2##2##(2008-10#1)(2008-7#1)
industrial water##2##2##(2008-10#2)
industrial##174##1##(1991-5#1)(1991-6#1)(1992-11#1)(1993-3#4)(1994-3#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#2)(2007-11#1)(2008-10#78)(2008-11#21)(2008-12#3)(2008-3#6)(2008-5#5)(2008-6#1)(2008-7#6)(2008-9#2)(2009-10#1)(2010-6#1)(2011-1#2)(2011-2#17)(2012-2#4)(2012-3#7)(2013-1#3)(2013-8#1)
industrialised##2##1##(2008-11#1)(2010-11#1)
industrialized countries##7##2##(1990-6#1)(1991-2#1)(1993-2#1)(1994-12#1)(1995-2#1)(2008-1#1)(2012-2#1)
industrialized nations##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
industrialized societies##4##2##(2008-10#1)(2009-12#1)(2010-7#1)(2013-1#1)
industrialized##21##1##(1990-6#1)(1991-2#1)(1993-2#2)(1994-12#1)(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#5)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
industrially important##4##2##(2008-11#3)(2008-12#1)
industrially##8##1##(1993-12#1)(2008-11#5)(2008-12#1)(2008-7#1)
industries and##3##2##(1997-7#1)(2009-12#1)(2013-8#1)
industries are##3##2##(1995-1#1)(2009-8#2)
industries##45##1##(1991-1#1)(1991-12#3)(1991-3#1)(1993-12#1)(1994-3#2)(1995-1#2)(1995-2#1)(1996-5#1)(1997-7#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
industry and health##2##3##(1991-3#1)(1993-12#1)
industry and that##2##3##(2008-11#1)(2010-7#1)
industry and the##2##3##(1991-1#1)(2009-12#1)
industry and##16##2##(1991-1#2)(1991-3#2)(1993-12#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-12#1)(2010-7#1)(2011-2#3)
industry are##3##2##(2008-10#1)(2008-11#2)
industry for##3##2##(1994-12#1)(1995-1#1)(2008-7#1)
industry has been##2##3##(2008-11#1)(2008-5#1)
industry has led##2##3##(2008-11#2)
industry has##9##2##(1995-5#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)
industry have##3##2##(1992-3#1)(2008-10#1)(2008-5#1)
industry in the##3##3##(2008-10#2)(2010-12#1)
industry in##11##2##(1991-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-12#1)(2013-8#1)
industry is##9##2##(1990-3#1)(1991-2#1)(2008-10#3)(2008-11#3)(2008-5#1)
industry marketing##2##2##(1996-1#1)(2009-7#1)
industry practices##2##2##(2008-10#2)
industry regarding the##2##3##(1996-2#1)(2010-11#1)
industry since##2##2##(1993-3#1)(1994-12#1)
industry to##7##2##(1996-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-4#1)
industry uses##2##2##(1996-1#1)(2008-9#1)
industry was##2##2##(1997-3#1)(2008-11#1)
industry##218##1##(1990-3#1)(1991-1#2)(1991-12#5)(1991-2#1)(1991-3#6)(1991-6#1)(1992-12#1)(1992-3#3)(1993-1#1)(1993-12#6)(1993-3#1)(1994-12#3)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#5)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#44)(2008-11#32)(2008-12#5)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#3)(2009-4#3)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-7#6)(2010-9#1)(2011-2#9)(2012-2#2)(2013-1#1)(2013-8#5)
industry-supported##2##1##(1991-1#1)(2009-4#1)
industry]##3##1##(1990-3#1)(2011-3#2)
indwelling catheter##2##2##(1993-2#1)(2008-10#1)
indwelling catheters##3##2##(2008-1#3)
indwelling electrodes##5##2##(2012-2#5)
indwelling##16##1##(1990-11#1)(1993-2#1)(1997-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#7)
ineffective against the##2##3##(2008-10#1)(2011-2#1)
ineffective against##7##2##(1994-6#1)(2008-10#4)(2011-2#1)(2012-3#1)
ineffective as##2##2##(2008-11#1)(2011-10#1)
ineffective in##7##2##(1994-2#1)(1997-1#1)(2008-10#4)(2010-6#1)
ineffective##43##1##(1990-5#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1996-2#1)(1997-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
ineffectiveness##2##1##(1996-2#1)(2013-1#1)
inefficiency of the##2##3##(1996-8#1)(2008-3#1)
inefficiency of##3##2##(1996-8#1)(2008-3#2)
inefficiency to##2##2##(1997-2#1)(2008-2#1)
inefficiency##8##1##(1992-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-2#1)(2008-3#2)(2013-8#1)
inefficient##16##1##(1990-11#1)(1992-2#1)(1992-3#1)(1994-11#1)(1997-5#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#2)
inelastic scattering##2##2##(2008-2#1)(2008-3#1)
inelastic##7##1##(1995-3#1)(2008-2#3)(2008-3#3)
inequalities in##4##2##(2008-11#1)(2009-10#1)(2010-11#2)
inequalities##9##1##(2008-1#2)(2008-11#4)(2009-10#1)(2010-11#2)
inequality in##2##2##(2008-8#1)(2011-2#1)
inequality with##2##2##(2011-2#1)(2013-1#1)
inequality##17##1##(2007-12#1)(2008-11#1)(2008-8#2)(2009-6#1)(2011-2#6)(2013-1#6)
inequities in##2##2##(2009-6#2)
inequities##3##1##(2009-6#3)
inequity##2##1##(1997-5#1)(2008-1#1)
inert gas##2##2##(2008-10#2)
inert gases##2##2##(1992-3#1)(1997-1#1)
inert support##2##2##(2008-10#2)
inert##26##1##(1992-3#1)(1994-3#1)(1997-1#1)(2007-12#1)(2008-10#16)(2008-5#1)(2008-8#1)(2009-10#1)(2012-2#2)(2013-1#1)
inertial confinement fusion##4##3##(1991-9#1)(2008-3#3)
inertial force##2##2##(2008-10#2)
inertial##9##1##(1991-9#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#3)(2010-8#1)
inescapable stress##2##2##(2008-11#2)
inescapable##4##1##(2008-11#3)(2008-5#1)
inevitable##10##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
inevitably##9##1##(1991-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-5#1)
inexorable##2##1##(1993-3#1)(2010-10#1)
inexorably##2##1##(2008-7#1)(2009-9#1)
inexpensive alternative to##2##3##(2008-10#1)(2012-2#1)
inexpensive and##11##2##(2008-10#10)(2008-7#1)
inexpensive materials##2##2##(2008-10#2)
inexpensive method##2##2##(2008-10#2)
inexpensive spectrophotometric method##2##3##(2008-10#2)
inexpensive##67##1##(1991-6#1)(1994-11#1)(1996-1#1)(2007-12#1)(2008-10#48)(2008-11#3)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-9#1)(2012-2#1)(2012-3#1)
inexpensively##4##1##(1993-2#1)(1996-11#1)(2008-12#1)(2008-2#1)
inexperienced##5##1##(1992-2#1)(2008-8#1)(2008-9#1)(2012-2#2)
inextricably linked##2##2##(2008-10#1)(2008-11#1)
inf1##2##1##(2008-10#2)
infancy and early childhood##2##4##(2010-5#1)(2013-8#1)
infancy and early##3##3##(2010-5#1)(2013-8#2)
infancy and##10##2##(1996-9#1)(2008-10#1)(2008-11#2)(2009-9#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#2)
infancy or##2##2##(2011-1#1)(2011-2#1)
infancy##39##1##(1991-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-9#2)(1997-7#1)(2008-10#5)(2008-11#5)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
infant abductions##2##2##(1993-2#1)(1995-12#1)
infant and maternal##3##3##(1992-2#1)(1993-3#1)(2009-11#1)
infant and##5##2##(1992-2#1)(1993-3#1)(1994-3#1)(2008-11#1)(2009-11#1)
infant at##2##2##(2008-11#1)(2011-2#1)
infant behavior##3##2##(1990-12#2)(1994-3#1)
infant by##2##2##(2009-12#1)(2013-1#1)
infant death##16##2##(1990-11#1)(1991-11#6)(1991-9#4)(1993-12#2)(1996-9#1)(2008-11#1)(2009-8#1)
infant death]##2##2##(1990-11#1)(1991-9#1)
infant deaths##2##2##(2008-1#1)(2010-9#1)
infant feeding in the context of HIV##2##7##(2012-2#2)
infant feeding##3##2##(2012-2#3)
infant formulas##5##2##(2008-10#5)
infant health##7##2##(1993-3#2)(1994-3#3)(2008-10#1)(2010-12#1)
infant massage##4##2##(2008-10#4)
infant mental##2##2##(1991-2#1)(2009-9#1)
infant mortality and##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
infant mortality in the##3##4##(1990-11#2)(1997-6#1)
infant mortality##12##2##(1990-11#3)(1993-2#4)(1995-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2012-3#1)
infant nutrition##4##2##(1991-6#3)(2012-2#1)
infant oral##3##2##(2008-11#1)(2011-2#2)
infant presented with##2##3##(2008-10#1)(2011-2#1)
infant stimuli##2##2##(2009-9#2)
infant vaccines##2##2##(1995-5#2)
infant was##5##2##(1991-11#1)(2008-10#1)(2008-12#1)(2010-10#1)(2011-1#1)
infant who was##2##3##(2008-12#1)(2012-3#1)
infant who##6##2##(1991-2#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-3#1)
infant with a##2##3##(2012-2#1)(2013-1#1)
infant with##12##2##(1994-6#1)(1995-6#1)(1997-3#2)(2010-6#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
infant##182##1##(1990-11#6)(1990-12#5)(1991-1#1)(1991-11#8)(1991-12#1)(1991-2#3)(1991-6#3)(1991-9#5)(1992-2#3)(1993-12#6)(1993-2#6)(1993-3#4)(1994-3#8)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#3)(1996-12#2)(1996-9#1)(1997-3#3)(1997-6#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-1#2)(2008-10#24)(2008-11#15)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#2)(2009-8#1)(2009-9#3)(2010-10#4)(2010-11#2)(2010-12#1)(2010-6#2)(2010-9#2)(2011-1#3)(2011-2#10)(2012-2#12)(2012-3#5)(2013-1#3)
infant's cue##2##2##(1990-12#2)
infant's##8##1##(1990-12#3)(1993-3#2)(2007-11#1)(2008-1#1)(2009-11#1)
infantile Crohn's disease##2##3##(2010-12#2)
infantile autism##2##2##(1991-2#2)
infantile cerebral palsy##3##3##(2009-4#3)
infantile form of Pompe disease##2##5##(2012-12#2)
infantile spasms##2##2##(1990-9#1)(2011-2#1)
infantile type##2##2##(1996-9#1)(2012-3#1)
infantile##25##1##(1990-9#2)(1991-2#2)(1994-8#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-4#3)(2010-12#3)(2011-2#2)(2012-12#3)(2012-3#1)
infants and children who received##2##5##(2008-11#2)
infants and children who##3##4##(1992-1#1)(2008-11#2)
infants and children##9##3##(1991-12#1)(1992-1#1)(1992-3#1)(1995-6#1)(2008-10#1)(2008-11#3)(2011-2#1)
infants and families##3##3##(1991-12#3)
infants and toddlers##7##3##(1992-12#2)(2012-2#5)
infants and young children##3##4##(1997-1#2)(2008-11#1)
infants and##31##2##(1990-3#1)(1991-12#4)(1992-1#1)(1992-12#2)(1992-3#2)(1995-3#1)(1995-6#1)(1997-1#3)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2011-1#1)(2011-2#2)(2012-2#5)
infants are##11##2##(1990-11#1)(1991-6#1)(1995-5#1)(1996-11#1)(1997-6#1)(2007-11#2)(2008-11#3)(2012-2#1)
infants at##6##2##(1991-6#1)(1994-1#1)(1994-6#1)(2010-10#1)(2011-2#1)(2012-12#1)
infants born##3##2##(1991-12#1)(2007-12#1)(2008-11#1)
infants by##3##2##(1995-12#1)(2009-11#2)
infants for##2##2##(1995-5#1)(2008-10#1)
infants in the##2##3##(1993-12#1)(2008-11#1)
infants in##8##2##(1990-11#1)(1993-12#1)(1995-12#1)(2008-11#2)(2010-4#1)(2011-2#1)(2012-2#1)
infants is##3##2##(2008-11#2)(2012-12#1)
infants of##5##2##(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(2008-11#1)
infants older than##2##3##(1994-6#2)
infants should be##2##3##(1990-11#1)(1994-6#1)
infants should##3##2##(1990-11#1)(1994-6#1)(1994-9#1)
infants the##2##2##(1991-6#1)(1993-12#1)
infants under##2##2##(1993-12#1)(1995-12#1)
infants was##2##2##(2010-4#1)(2012-12#1)
infants were##13##2##(1991-11#4)(1991-2#1)(1992-3#1)(1993-12#1)(1994-6#3)(2010-4#1)(2010-5#1)(2012-2#1)
infants who had##2##3##(1991-11#1)(1991-3#1)
infants who were##2##3##(1995-5#1)(2012-12#1)
infants who##7##2##(1991-11#1)(1991-3#1)(1995-5#2)(2011-1#1)(2012-12#2)
infants whose mothers did not have pre-eclampsia##2##7##(2011-2#2)
infants whose mothers##4##3##(2011-2#4)
infants whose##5##2##(1991-2#1)(2011-2#4)
infants with CHD##2##3##(2010-9#2)
infants with bronchopulmonary dysplasia##2##4##(2010-5#2)
infants with severe##2##3##(1994-6#1)(1996-3#1)
infants with very low##2##4##(1994-6#1)(1995-5#1)
infants with##27##2##(1990-11#1)(1990-9#1)(1991-12#1)(1993-3#2)(1994-6#3)(1995-5#1)(1996-3#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-5#3)(2010-9#3)(2011-1#1)(2011-2#1)(2012-3#1)
infants##256##1##(1990-11#7)(1990-3#2)(1990-9#2)(1991-1#1)(1991-11#7)(1991-12#6)(1991-2#7)(1991-3#2)(1991-6#3)(1991-9#2)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#3)(1993-12#11)(1993-2#1)(1993-3#3)(1994-1#1)(1994-3#7)(1994-6#20)(1994-9#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#7)(1995-6#1)(1995-8#4)(1996-11#1)(1996-2#2)(1996-3#3)(1996-8#1)(1997-1#3)(1997-6#1)(1997-8#1)(2006-5#2)(2007-11#14)(2007-12#2)(2008-1#3)(2008-10#12)(2008-11#29)(2008-7#1)(2008-9#2)(2009-11#3)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-4#3)(2010-5#5)(2010-6#3)(2010-9#3)(2011-1#6)(2011-2#12)(2012-12#10)(2012-2#12)(2012-3#2)(2013-8#1)
infants'##5##1##(1991-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-9#1)
infants]##5##1##(1990-11#2)(1994-6#2)(1996-11#1)
infarct angioplasty##2##2##(2008-11#2)
infarct volume##3##2##(2008-7#3)
infarct##19##1##(1990-3#2)(1996-11#1)(1997-2#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-7#4)(2011-2#7)
infarcted cerebral volume##2##3##(1996-6#2)
infarction and##15##2##(1993-2#1)(1995-12#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)
infarction as##2##2##(1993-12#1)(2011-2#1)
infarction due to##2##3##(2011-2#1)(2013-8#1)
infarction during pregnancy##2##3##(1991-3#2)
infarction during##3##2##(1991-3#2)(1995-12#1)
infarction in a##2##3##(2007-8#1)(2008-11#1)
infarction in the##5##3##(1991-3#1)(1994-12#1)(1996-3#1)(2008-12#1)(2008-3#1)
infarction in##16##2##(1990-3#1)(1991-3#2)(1991-6#1)(1994-12#2)(1996-3#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2013-1#1)
infarction is##3##2##(1991-6#1)(1997-5#2)
infarction or##3##2##(1992-9#1)(2009-6#1)(2013-7#1)
infarction with##5##2##(1990-9#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-8#1)
infarction##155##1##(1990-12#1)(1990-3#4)(1990-9#5)(1991-3#6)(1991-6#6)(1992-12#2)(1992-3#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1994-12#3)(1995-12#4)(1995-2#2)(1995-8#2)(1996-2#3)(1996-3#1)(1996-8#1)(1996-9#2)(1997-5#10)(2007-8#3)(2008-10#5)(2008-11#9)(2008-12#4)(2008-3#14)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-6#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#6)
infarction]##6##1##(1990-12#1)(1994-6#1)(1995-5#1)(2008-10#1)(2013-8#2)
infarctions is##2##2##(2009-5#1)(2012-3#1)
infarctions##6##1##(1991-3#1)(1996-11#1)(1996-9#1)(2009-5#1)(2012-3#2)
infarcts and##4##2##(2008-8#1)(2010-12#1)(2011-2#2)
infarcts##8##1##(1996-2#1)(2008-8#1)(2010-12#1)(2011-2#4)(2012-3#1)
infect a##4##2##(2008-10#4)
infect and cause##2##3##(2008-10#2)
infect and##5##2##(2008-10#4)(2008-4#1)
infect different##3##2##(2008-10#3)
infect leaf##2##2##(2008-10#2)
infect plants##2##2##(1997-3#1)(2008-10#1)
infect rice##3##2##(2008-10#3)
infect susceptible##2##2##(2008-10#2)
infect the##5##2##(2008-10#4)(2008-8#1)
infect tobacco##2##2##(2008-10#2)
infect##80##1##(1990-5#1)(1997-1#1)(1997-3#1)(2006-5#1)(2008-10#63)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#3)(2013-1#1)(2013-8#2)
infectants##5##1##(1997-7#5)
infected A##2##2##(2008-10#2)
infected N##2##2##(2008-10#2)
infected Nicotiana benthamiana##3##3##(1995-2#1)(2008-10#2)
infected Sf-9##2##2##(2008-11#2)
infected and non-infected##2##3##(2008-11#1)(2008-9#1)
infected and uninfected##3##3##(1994-9#1)(2008-10#2)
infected and##18##2##(1994-9#1)(1995-12#2)(2008-10#11)(2008-11#2)(2008-9#1)(2011-3#1)
infected animals##3##2##(2008-5#1)(2012-12#2)
infected at##6##2##(2008-10#4)(2008-11#2)
infected barley leaves##3##3##(2008-10#3)
infected barley##5##2##(2008-10#5)
infected bay laurel leaves##2##4##(2008-10#2)
infected but##2##2##(2008-10#1)(2013-1#1)
infected by P##3##3##(2008-10#3)
infected by both##2##3##(2008-10#2)
infected by subgroup##2##3##(2008-10#2)
infected by the same##2##4##(2008-10#2)
infected by the##7##3##(1996-11#1)(2008-10#5)(2008-5#1)
infected by##50##2##(1991-11#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-3#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2012-3#5)(2013-8#2)
infected cattle##2##2##(1996-12#2)
infected cell cultures##3##3##(2008-11#3)
infected cell##4##2##(2008-10#1)(2008-11#3)
infected cells to##2##3##(1997-3#1)(2008-10#1)
infected cells were##2##3##(1997-3#1)(2009-8#1)
infected cells##27##2##(1990-7#1)(1997-1#2)(1997-3#3)(2008-10#6)(2008-11#7)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
infected chickpea##2##2##(2008-10#2)
infected citrus##2##2##(2008-10#2)
infected cultures##2##2##(2008-11#2)
infected during##4##2##(2008-10#3)(2008-5#1)
infected epidermal cyst and gout##2##5##(2009-10#2)
infected female##3##2##(2008-10#2)(2012-3#1)
infected females##2##2##(2012-3#2)
infected fruit##8##2##(2008-10#8)
infected host##3##2##(2008-10#2)(2008-6#1)
infected hosts##2##2##(2013-8#2)
infected in##3##2##(1996-11#1)(1996-5#1)(2008-10#1)
infected individuals##6##2##(1990-2#1)(2008-11#3)(2008-12#1)(2010-12#1)
infected insect cells##2##3##(1993-6#1)(1993-8#1)
infected leaf##4##2##(2008-10#4)
infected leaves and##2##3##(2008-10#2)
infected leaves##13##2##(2008-10#13)
infected maize##2##2##(2008-10#2)
infected male and##2##3##(2008-10#2)
infected mammalian##2##2##(2008-11#1)(2011-2#1)
infected mice##4##2##(1996-12#1)(2008-4#1)(2012-12#1)(2012-2#1)
infected mouse##3##2##(1995-9#2)(2008-4#1)
infected or##2##2##(1993-8#1)(2008-5#1)
infected partners##2##2##(2011-2#2)
infected patients##5##2##(1990-2#1)(2008-11#2)(2010-5#1)(2013-8#1)
infected persons##4##2##(1997-1#1)(2009-11#1)(2013-8#2)
infected plant material##3##3##(2008-10#3)
infected plant tissue##3##3##(2008-10#3)
infected plant##13##2##(2008-10#13)
infected plants and##2##3##(2008-10#1)(2012-2#1)
infected plants in##3##3##(2008-10#3)
infected plants to##2##3##(2008-10#2)
infected plants was##2##3##(2008-10#2)
infected plants were##5##3##(2008-10#5)
infected plants##39##2##(2008-10#38)(2012-2#1)
infected pollen##3##2##(2008-10#3)
infected potato plants##2##3##(2008-10#2)
infected potato tubers##2##3##(2008-10#2)
infected potato##7##2##(2008-10#7)
infected psylla##2##2##(2008-10#2)
infected resistant##2##2##(2008-10#2)
infected root tissue##2##3##(2008-10#2)
infected roots in##2##3##(2008-10#2)
infected roots##8##2##(2008-10#8)
infected samples##3##2##(2008-10#2)(2008-9#1)
infected seed of##3##3##(2008-10#3)
infected seed##8##2##(2008-10#8)
infected seeds##3##2##(2008-10#3)
infected source plants at##2##4##(2008-10#2)
infected source plants##3##3##(2008-10#3)
infected soybean##3##2##(2008-10#3)
infected spikelets##4##2##(2008-10#4)
infected stands##3##2##(2008-10#3)
infected subdural hematoma##3##3##(2008-7#3)
infected the##4##2##(2008-10#4)
infected ticks##2##2##(1996-11#1)(2008-10#1)
infected tissue##10##2##(2008-10#7)(2008-9#1)(2011-2#2)
infected tissues##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
infected to##2##2##(2008-10#1)(2008-9#1)
infected tobacco##3##2##(2008-10#3)
infected tomato plants##3##3##(2008-10#3)
infected tomato##4##2##(2008-10#4)
infected trees##12##2##(2008-10#12)
infected trees)##2##2##(2008-10#2)
infected tubers##3##2##(2008-10#3)
infected via##2##2##(2008-10#2)
infected vines as##2##3##(2008-10#2)
infected vines##5##2##(2008-10#5)
infected was##3##2##(2008-10#3)
infected wild##2##2##(2008-10#2)
infected with C##3##3##(2008-10#3)
infected with CMV##2##3##(2008-10#2)
infected with F##6##3##(2008-10#4)(2008-12#1)(2011-10#1)
infected with HBV##2##3##(2013-1#2)
infected with HIV##8##3##(1993-1#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-6#2)(2008-10#1)(2011-2#1)
infected with R##5##3##(2008-10#4)(2009-6#1)
infected with S##2##3##(1996-8#1)(2008-10#1)
infected with Xanthomonas##2##3##(2008-10#2)
infected with a recombinant baculovirus##3##5##(1993-8#1)(2008-10#1)(2008-7#1)
infected with a recombinant##4##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
infected with a##13##3##(1993-8#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-7#1)(2011-2#1)
infected with both viruses##2##4##(2008-10#2)
infected with both##3##3##(2008-10#3)
infected with either##2##3##(2008-10#1)(2008-7#1)
infected with human immunodeficiency virus##2##5##(2008-11#1)(2011-2#1)
infected with human##3##3##(2008-11#2)(2011-2#1)
infected with mixtures##2##3##(2008-10#2)
infected with only##2##3##(2008-10#2)
infected with recombinant##3##3##(1995-2#1)(1997-8#1)(2008-11#1)
infected with the apple proliferation phytoplasma##2##6##(2008-10#2)
infected with the recombinant##2##4##(2008-11#1)(2011-3#1)
infected with the virus##2##4##(2008-10#2)
infected with the##22##3##(1993-6#1)(1994-11#1)(1994-5#1)(2008-10#14)(2008-11#1)(2008-9#1)(2009-7#1)(2011-3#1)(2012-3#1)
infected with wild-type##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
infected with##171##2##(1993-1#1)(1993-2#1)(1993-6#6)(1993-8#2)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#5)(1996-8#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2008-10#97)(2008-11#10)(2008-12#3)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2011-10#1)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
infected women##3##2##(1990-6#2)(1994-9#1)
infected wounds##4##2##(1991-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
infected##741##1##(1990-12#1)(1990-2#3)(1990-6#2)(1990-7#1)(1990-9#3)(1991-11#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#7)(1993-8#5)(1994-11#1)(1994-5#1)(1994-9#3)(1995-12#4)(1995-2#3)(1995-6#1)(1995-9#6)(1996-11#5)(1996-12#12)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#7)(1997-5#2)(1997-6#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#466)(2008-11#44)(2008-12#8)(2008-4#4)(2008-5#20)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#13)(2009-10#3)(2009-11#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#2)(2010-12#2)(2010-5#1)(2011-10#1)(2011-2#19)(2011-3#9)(2012-12#5)(2012-2#3)(2012-3#13)(2013-1#9)(2013-8#8)
infected)##4##1##(2008-10#3)(2008-11#1)
infecting species##3##2##(2008-10#3)
infecting the##2##2##(2008-10#2)
infecting tomato in##2##3##(2008-10#2)
infecting tomato##3##2##(2008-10#3)
infecting##40##1##(1991-11#1)(1995-2#1)(1996-12#1)(2008-10#32)(2008-4#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-3#1)
infection (8)##2##2##(1997-5#1)(2007-11#1)
infection (i##2##2##(2008-5#1)(2013-8#1)
infection acquired##2##2##(1990-9#1)(2009-8#1)
infection after##2##2##(2008-8#1)(2008-9#1)
infection also##2##2##(1991-6#1)(2011-2#1)
infection among##8##2##(1990-2#1)(1990-3#1)(2008-10#1)(2009-5#1)(2011-2#3)(2013-1#1)
infection and colonization by##2##4##(2008-10#2)
infection and colonization of##2##4##(2008-10#2)
infection and colonization##4##3##(2008-10#4)
infection and disease##2##3##(2008-10#1)(2011-2#1)
infection and high##2##3##(2008-11#2)
infection and nodule##2##3##(2011-2#2)
infection and precancerous lesions##4##4##(2011-3#4)
infection and reproduction##2##3##(2008-10#1)(2008-8#1)
infection and sporulation##2##3##(2008-10#2)
infection and subsequent##2##3##(2008-10#2)
infection and the##7##3##(2008-10#3)(2010-12#1)(2011-2#1)(2011-3#1)(2013-8#1)
infection and to##2##3##(2008-6#1)(2009-8#1)
infection and##110##2##(1990-9#1)(1991-8#1)(1993-12#1)(1994-5#1)(1996-11#2)(1997-1#2)(2007-11#1)(2007-12#1)(2008-10#47)(2008-11#7)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#7)(2012-12#2)(2013-1#7)(2013-8#2)
infection are##11##2##(1995-12#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-10#1)(2012-3#1)(2013-1#2)
infection as##4##2##(1991-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
infection at the##3##3##(2008-11#2)(2009-8#1)
infection at##11##2##(2008-10#6)(2008-11#2)(2009-8#1)(2010-5#1)(2012-2#1)
infection based on##2##3##(2008-10#2)
infection because##2##2##(2008-10#1)(2012-12#1)
infection between##2##2##(2008-10#2)
infection by A##2##3##(2008-10#2)
infection by Botrytis cinerea was##2##5##(2008-10#2)
infection by F##2##3##(2008-10#2)
infection by Fusarium##2##3##(2008-10#2)
infection by M##7##3##(1990-12#1)(2008-10#6)
infection by P##3##3##(2008-10#3)
infection by Pythium##2##3##(2008-10#2)
infection by Rhizoctonia##2##3##(2008-10#2)
infection by Stagonospora nodorum##2##4##(2008-10#2)
infection by a##3##3##(2008-10#2)(2009-10#1)
infection by ascospores##2##3##(2008-10#2)
infection by the pathogen##2##4##(2008-10#2)
infection by the##6##3##(1996-8#1)(2008-10#5)
infection by this pathogen##2##4##(2008-10#1)(2009-8#1)
infection by##88##2##(1990-12#1)(1995-2#1)(1996-8#1)(2008-10#73)(2008-12#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
infection can be##3##3##(1990-9#1)(1997-1#1)(2007-12#1)
infection can cause##2##3##(1992-5#1)(2013-1#1)
infection can##9##2##(1990-9#1)(1992-5#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-8#1)(2013-1#2)
infection caused by Pseudomonas syringae pv##2##6##(2008-10#2)
infection caused by##8##3##(1990-3#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-12#1)
infection caused##9##2##(1990-3#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-5#1)(2010-12#1)
infection compared to##2##3##(2011-10#1)(2011-2#1)
infection control link##3##3##(2008-11#3)
infection control strategies##2##3##(2010-11#1)(2011-2#1)
infection control was##2##3##(2007-11#2)
infection control##18##2##(1995-6#1)(2007-11#2)(2008-10#3)(2008-11#6)(2008-12#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-3#1)
infection could##5##2##(1990-3#1)(1997-6#1)(2008-10#3)
infection court##5##2##(2008-10#5)
infection courts##5##2##(2008-10#5)
infection cushions##2##2##(2008-10#2)
infection cycle##4##2##(2008-10#3)(2008-7#1)
infection cycles##2##2##(2008-10#2)
infection decreased##2##2##(2008-10#1)(2008-11#1)
infection density##3##2##(2008-10#2)(2008-11#1)
infection due to##3##3##(2008-12#1)(2010-12#1)(2013-1#1)
infection during the##4##3##(1996-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
infection during##8##2##(1990-9#2)(1996-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
infection dynamics##3##2##(2008-8#1)(2009-6#2)
infection early##2##2##(2008-10#1)(2011-2#1)
infection efficiency and##2##3##(2008-10#2)
infection efficiency as##2##3##(2008-10#2)
infection efficiency of##2##3##(2008-10#2)
infection efficiency##18##2##(2008-10#17)(2011-3#1)
infection events##2##2##(2008-10#2)
infection for the##5##3##(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)
infection for##11##2##(1995-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2013-1#2)
infection found##2##2##(2008-10#1)(2012-3#1)
infection frequency##7##2##(2008-10#6)(2008-8#1)
infection from##9##2##(1995-12#1)(1996-11#1)(2008-10#4)(2008-12#1)(2011-2#1)(2012-2#1)
infection has##7##2##(1996-11#1)(1997-3#1)(2010-12#2)(2010-6#1)(2012-3#1)(2013-8#1)
infection have##3##2##(2009-8#3)
infection hypha##2##2##(2008-10#2)
infection hyphae##8##2##(2008-10#7)(2012-2#1)
infection in a##12##3##(1990-3#1)(1991-3#1)(1993-11#1)(1993-5#1)(1994-6#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
infection in an infant##2##4##(1995-6#1)(2008-10#1)
infection in an##5##3##(1992-12#1)(1995-6#1)(2008-10#1)(2009-6#1)(2010-12#1)
infection in both##3##3##(2008-10#2)(2012-2#1)
infection in children##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
infection in commercial##2##3##(1990-3#1)(2008-10#1)
infection in kernels of maize##2##5##(2008-10#2)
infection in kernels##3##3##(2008-10#3)
infection in mice##2##3##(1996-12#1)(2013-1#1)
infection in patients with##2##4##(2008-5#1)(2010-8#1)
infection in patients##3##3##(2008-5#1)(2010-8#1)(2011-2#1)
infection in potato##2##3##(2008-10#1)(2009-6#1)
infection in pregnancy##3##3##(2008-11#1)(2009-8#1)(2012-3#1)
infection in pregnant women##2##4##(1994-6#1)(2007-12#1)
infection in the chicken##2##4##(2008-5#2)
infection in the##14##3##(1993-11#1)(1994-3#1)(1996-11#1)(2008-10#3)(2008-5#2)(2008-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
infection in two##2##3##(1995-8#1)(2008-10#1)
infection in which##2##3##(2011-2#2)
infection in##140##2##(1990-3#3)(1991-1#2)(1991-11#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-11#3)(1993-5#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#2)(1996-3#2)(1996-6#1)(1996-8#2)(1997-5#2)(2007-12#1)(2008-1#1)(2008-10#45)(2008-11#2)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#2)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#14)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#4)
infection incidence to##2##3##(1990-3#1)(2008-10#1)
infection incidence was##2##3##(1990-3#1)(2008-10#1)
infection incidence##6##2##(1990-3#2)(2008-10#4)
infection increased##3##2##(2008-10#2)(2011-3#1)
infection intensities and##2##3##(1994-9#2)
infection intensities##3##2##(1994-9#3)
infection is a##2##3##(2008-2#1)(2011-3#1)
infection is the most common##2##5##(2008-11#2)
infection is the most##3##4##(2008-11#2)(2008-8#1)
infection is the##8##3##(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-12#1)(2012-3#1)
infection is##30##2##(1990-6#2)(1990-9#2)(1991-3#1)(1996-6#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-8#1)(2010-12#1)(2011-2#2)(2011-3#2)(2012-3#2)(2013-1#1)
infection level##4##2##(2008-10#4)
infection level)##2##2##(2008-10#2)
infection levels##3##2##(2008-10#2)(2010-8#1)
infection management##3##2##(2011-2#3)
infection may be##2##3##(2008-10#2)
infection may##3##2##(2008-10#3)
infection might##2##2##(2009-6#1)(2009-8#1)
infection model##4##2##(2008-10#3)(2013-8#1)
infection models##2##2##(2008-10#1)(2012-2#1)
infection occurs##2##2##(2008-10#2)
infection of Arabidopsis thaliana##2##4##(2008-10#2)
infection of a##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
infection of apple##2##3##(2008-10#2)
infection of maize##3##3##(2008-10#3)
infection of susceptible##4##3##(2008-10#4)
infection of the central nervous system##5##6##(2007-12#1)(2008-7#2)(2010-12#1)(2011-2#1)
infection of the host##2##4##(2008-10#2)
infection of the upper##2##4##(1996-6#1)(2008-10#1)
infection of the##21##3##(1996-6#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#2)(2010-10#2)(2010-12#1)(2011-2#3)(2011-3#1)
infection of this##2##3##(2008-10#1)(2012-12#1)
infection of tobacco with##3##4##(2008-10#2)(2012-2#1)
infection of tobacco##6##3##(2008-10#5)(2012-2#1)
infection of##103##2##(1990-9#1)(1996-12#2)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#56)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#5)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2011-10#1)(2011-2#6)(2011-3#2)(2012-12#3)(2012-2#1)(2013-8#1)
infection often##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
infection on the##6##3##(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-8#1)
infection on##23##2##(1992-9#2)(1995-9#1)(1997-1#1)(1997-3#1)(2006-5#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-8#1)(2013-8#1)
infection or##10##2##(1992-2#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
infection peg##2##2##(2008-10#2)
infection period##2##2##(2008-10#2)
infection periods##5##2##(2008-10#5)
infection phase##3##2##(2008-10#2)(2008-11#1)
infection process and the##3##4##(2008-10#1)(2010-10#2)
infection process and##4##3##(2008-10#2)(2010-10#2)
infection process##14##2##(2008-10#6)(2010-10#6)(2011-10#2)
infection rate was##3##3##(1991-9#1)(2008-10#2)
infection rate##14##2##(1991-9#1)(1996-12#1)(1996-8#1)(2008-10#10)(2012-2#1)
infection rates##9##2##(2008-10#6)(2009-5#1)(2010-12#1)(2011-3#1)
infection reported##2##2##(2007-12#1)(2008-10#1)
infection resulted in##2##3##(2008-10#2)
infection severity##2##2##(2008-10#2)
infection should be##2##3##(2008-10#1)(2008-7#1)
infection showed##2##2##(1992-12#1)(1996-8#1)
infection significantly increased##2##3##(2008-10#2)
infection site##5##2##(2008-10#5)
infection sites and##2##3##(2008-10#2)
infection sites##5##2##(2008-10#5)
infection status##2##2##(2010-12#1)(2011-2#1)
infection structure##4##2##(2008-10#4)
infection structures##4##2##(2008-10#4)
infection than##2##2##(2008-10#2)
infection that can##2##3##(2008-9#1)(2012-3#1)
infection that##5##2##(2008-10#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
infection through##5##2##(2008-10#3)(2009-6#1)(2011-2#1)
infection times for ascospores##2##4##(2008-10#2)
infection times##5##2##(2008-10#5)
infection to occur##3##3##(2008-10#3)
infection to##13##2##(1993-12#1)(1993-3#1)(1996-6#1)(2008-10#6)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
infection transmission##2##2##(2008-8#1)(2011-3#1)
infection type##9##2##(2008-10#9)
infection types##3##2##(2008-10#3)
infection under##2##2##(2008-10#2)
infection until##2##2##(2008-10#1)(2011-2#1)
infection using##2##2##(2008-10#1)(2011-2#1)
infection vesicles and primary hyphae##2##5##(2008-10#2)
infection vesicles##5##2##(2008-10#5)
infection was associated with##3##4##(2008-10#3)
infection was confirmed by##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
infection was diagnosed##2##3##(1996-12#1)(1997-5#1)
infection was due to##2##4##(1996-11#1)(2008-10#1)
infection was found to be##3##5##(2011-2#1)(2012-3#2)
infection was found##4##3##(1996-12#1)(2011-2#1)(2012-3#2)
infection was identified##2##3##(2008-10#2)
infection was not##2##3##(2008-10#2)
infection was strongly##2##3##(2008-10#2)
infection was the##2##3##(2008-10#1)(2008-5#1)
infection was##53##2##(1990-6#1)(1991-9#1)(1994-5#1)(1996-11#1)(1996-12#3)(1997-5#1)(2008-10#30)(2008-11#1)(2008-5#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#4)(2012-3#3)(2013-1#1)
infection were detected##2##3##(2008-10#1)(2008-5#1)
infection were not##2##3##(2008-10#2)
infection were observed##2##3##(2008-10#2)
infection were##23##2##(2008-10#15)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
infection when##6##2##(2008-10#4)(2010-5#1)(2013-8#1)
infection with T##3##3##(2008-5#1)(2009-6#1)(2011-2#1)
infection with a##5##3##(2008-10#3)(2011-2#1)(2013-7#1)
infection with an##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
infection with chronic hepatitis B##2##5##(2009-8#2)
infection with the##4##3##(1996-12#1)(1996-6#1)(2009-6#1)(2010-5#1)
infection with##63##2##(1995-5#1)(1996-11#1)(1996-12#5)(1996-6#2)(1997-1#2)(2007-12#1)(2008-10#19)(2008-11#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#3)(2009-8#2)(2010-5#1)(2010-6#1)(2011-10#1)(2011-2#6)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
infection within##5##2##(2007-11#1)(2008-10#4)
infection would##2##2##(1995-12#1)(2008-5#1)
infection##1609##1##(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#9)(1990-6#6)(1990-8#2)(1990-9#8)(1991-1#3)(1991-11#1)(1991-3#4)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#1)(1992-9#6)(1993-11#3)(1993-12#3)(1993-3#5)(1993-5#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#4)(1994-9#5)(1995-1#3)(1995-12#7)(1995-2#4)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#3)(1996-11#14)(1996-12#16)(1996-2#1)(1996-3#4)(1996-5#3)(1996-6#6)(1996-8#5)(1996-9#2)(1997-1#15)(1997-3#9)(1997-4#1)(1997-5#8)(1997-6#1)(1997-7#2)(1997-8#1)(2006-5#1)(2007-11#8)(2007-12#15)(2008-1#5)(2008-10#716)(2008-11#62)(2008-12#23)(2008-2#15)(2008-4#4)(2008-5#39)(2008-6#1)(2008-7#31)(2008-8#22)(2008-9#34)(2009-10#4)(2009-11#1)(2009-12#4)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#15)(2009-7#1)(2009-8#26)(2010-10#13)(2010-11#6)(2010-12#23)(2010-3#1)(2010-5#5)(2010-6#12)(2010-7#2)(2010-8#5)(2011-1#3)(2011-10#9)(2011-2#109)(2011-3#24)(2012-12#23)(2012-2#15)(2012-3#24)(2013-1#53)(2013-7#1)(2013-8#31)
infection) and##4##2##(2008-10#3)(2011-3#1)
infection)##10##1##(1996-11#1)(2008-10#6)(2011-3#2)(2013-8#1)
infection-inhibiting factor##2##2##(2008-10#2)
infection-related##3##1##(2008-10#1)(2008-7#1)(2009-8#1)
infection-type##2##1##(2008-10#2)
infection]##12##1##(1990-12#1)(1990-2#1)(1990-6#1)(1992-2#1)(1993-2#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-5#1)(2011-2#1)
infectionin##2##1##(2008-11#1)(2010-12#1)
infections among##4##2##(2008-10#1)(2008-12#1)(2013-8#2)
infections and the##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
infections and##22##2##(1990-3#1)(1992-2#1)(1996-11#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
infections are not##4##3##(1995-2#1)(1996-12#1)(2011-2#2)
infections are the##2##3##(2011-2#1)(2011-3#1)
infections are##18##2##(1992-6#1)(1995-2#1)(1996-12#1)(1996-9#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#8)(2011-3#2)(2012-12#1)
infections as##2##2##(1990-5#1)(2013-8#1)
infections associated with##3##3##(2010-5#1)(2011-2#1)(2013-1#1)
infections at##2##2##(1993-6#1)(2008-10#1)
infections by##4##2##(1990-6#1)(2008-10#3)
infections can be##4##3##(2008-10#2)(2012-12#1)(2012-3#1)
infections can##5##2##(2008-10#2)(2008-5#1)(2012-12#1)(2012-3#1)
infections caused by##11##3##(1994-9#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
infections caused##12##2##(1994-9#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)
infections could##2##2##(2008-10#2)
infections due to##4##3##(1990-6#1)(2008-12#1)(2008-5#1)(2011-2#1)
infections has been##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
infections have been##4##3##(1993-2#1)(2008-10#2)(2013-1#1)
infections have increased##2##3##(1997-6#1)(2008-10#1)
infections have##10##2##(1990-11#1)(1993-2#1)(1997-6#2)(2008-10#3)(2008-9#1)(2013-1#1)(2013-8#1)
infections in a##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
infections in both##2##3##(2008-10#2)
infections in children##4##3##(2007-12#1)(2008-11#1)(2009-5#1)(2012-12#1)
infections in humans##6##3##(1996-12#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#1)
infections in patients##3##3##(1990-9#1)(2008-10#1)(2009-3#1)
infections in the##8##3##(1993-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-6#1)(2011-2#1)
infections in##70##2##(1990-3#2)(1990-9#1)(1991-8#1)(1993-11#1)(1993-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-5#4)(2008-7#3)(2008-9#1)(2009-3#2)(2009-5#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
infections is discussed##2##3##(2008-10#1)(2011-2#1)
infections is##6##2##(1993-3#1)(2007-11#1)(2008-10#3)(2011-2#1)
infections lead to##2##3##(2008-10#1)(2013-1#1)
infections like##2##2##(2009-12#1)(2012-2#1)
infections make##2##2##(1997-4#1)(2008-10#1)
infections may also##2##3##(2008-10#1)(2011-2#1)
infections may##6##2##(2008-10#2)(2008-7#1)(2011-2#2)(2013-8#1)
infections occur##3##2##(2008-10#2)(2008-8#1)
infections occurred##2##2##(1992-9#1)(2008-10#1)
infections of plant##2##3##(2008-10#1)(2008-9#1)
infections of the upper##2##4##(1991-6#1)(2008-10#1)
infections of the##9##3##(1991-6#1)(1995-5#1)(1995-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
infections of##28##2##(1991-6#1)(1991-8#1)(1995-5#1)(1995-9#1)(1996-12#1)(2008-10#14)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#2)(2011-2#1)(2013-8#1)
infections on##3##2##(2008-10#3)
infections or##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
infections reported in##2##3##(2007-12#1)(2011-3#1)
infections such as##2##3##(2008-11#1)(2011-2#1)
infections that##4##2##(1997-3#1)(2008-10#1)(2009-6#1)(2011-2#1)
infections was##3##2##(2008-10#2)(2012-3#1)
infections were detected##4##3##(2008-10#4)
infections were observed##2##3##(2008-10#2)
infections were##16##2##(1991-8#1)(1993-2#1)(1996-12#1)(2008-10#12)(2013-8#1)
infections with a##2##3##(1992-5#1)(2008-10#1)
infections with the##2##3##(1996-12#1)(2008-10#1)
infections with##14##2##(1990-6#3)(1992-5#1)(1996-11#2)(1996-12#2)(1997-3#1)(2007-11#1)(2008-10#2)(2010-6#1)(2013-8#1)
infections within##3##2##(2008-10#3)
infections worldwide##2##2##(2008-10#1)(2012-2#1)
infections##482##1##(1990-11#1)(1990-12#2)(1990-3#4)(1990-5#1)(1990-6#6)(1990-9#2)(1991-11#1)(1991-6#2)(1991-8#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#4)(1993-3#1)(1993-6#1)(1994-5#3)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#4)(1995-9#1)(1996-1#1)(1996-11#6)(1996-12#11)(1996-3#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#8)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#1)(2007-11#4)(2007-12#4)(2007-8#4)(2008-1#2)(2008-10#139)(2008-11#12)(2008-12#9)(2008-5#15)(2008-7#8)(2008-8#6)(2008-9#9)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#2)(2011-1#2)(2011-2#51)(2011-3#7)(2012-12#10)(2012-2#14)(2012-3#17)(2013-1#26)(2013-7#2)(2013-8#18)
infections)##2##1##(2008-10#1)(2008-5#1)
infections]##7##1##(1990-12#1)(1990-2#1)(1993-11#1)(1995-11#1)(1997-5#1)(2011-2#1)(2011-3#1)
infectious HIV##3##2##(1997-3#1)(2008-4#1)(2012-12#1)
infectious agent##4##2##(1995-2#1)(1995-5#1)(2011-2#1)(2013-8#1)
infectious agents##11##2##(1997-6#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
infectious and##2##2##(1997-8#1)(2012-2#1)
infectious bovine##2##2##(2008-11#1)(2013-8#1)
infectious bronchitis virus (IBV)##4##4##(2008-5#4)
infectious bronchitis virus in##2##4##(2008-5#2)
infectious bronchitis virus##10##3##(1996-11#1)(2008-5#9)
infectious bronchitis##13##2##(1996-11#1)(2008-5#11)(2013-8#1)
infectious bursal disease virus##4##4##(2008-5#4)
infectious clone##5##2##(2008-10#3)(2008-9#2)
infectious clones of##3##3##(2008-10#2)(2008-9#1)
infectious complications##6##2##(1991-12#2)(1997-8#1)(2008-7#1)(2011-2#1)(2011-3#1)
infectious coryza##2##2##(2008-5#2)
infectious disease in##3##3##(1991-3#1)(2008-11#1)(2008-7#1)
infectious disease outbreaks##2##3##(2010-2#1)(2010-5#1)
infectious disease to##2##3##(1997-3#1)(2010-6#1)
infectious disease##17##2##(1990-12#1)(1991-3#1)(1991-8#1)(1994-9#1)(1995-5#1)(1997-3#1)(2008-11#4)(2008-7#2)(2010-2#1)(2010-5#1)(2010-6#2)(2011-2#1)
infectious diseases and##4##3##(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
infectious diseases in children##2##4##(1997-8#2)
infectious diseases of##2##3##(1997-8#1)(2008-11#1)
infectious diseases##31##2##(1994-6#2)(1996-1#1)(1996-11#1)(1997-3#2)(1997-8#3)(2008-10#8)(2008-11#1)(2008-8#1)(2009-6#2)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
infectious endocarditis]##2##2##(1997-2#1)(1997-8#1)
infectious exacerbations##2##2##(2008-7#2)
infectious in vitro transcripts##3##4##(2008-10#3)
infectious in##8##2##(1997-3#3)(2008-10#5)
infectious laryngotracheitis##2##2##(1992-2#1)(2013-8#1)
infectious mononucleosis##5##2##(1992-2#1)(2008-5#2)(2008-9#1)(2011-2#1)
infectious odontostomatitis##2##2##(1990-2#2)
infectious on##4##2##(1997-3#1)(2008-10#2)(2008-9#1)
infectious or##2##2##(1996-11#1)(2008-10#1)
infectious process##3##2##(2010-6#1)(2011-2#2)
infectious to##2##2##(1997-3#2)
infectious transcripts##3##2##(2008-10#3)
infectious units/cell##4##2##(2008-11#4)
infectious virus titers##2##3##(2008-11#2)
infectious virus##3##2##(2007-12#1)(2008-11#2)
infectious yellows virus##4##3##(2008-10#4)
infectious##213##1##(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-11#4)(1997-2#1)(1997-3#11)(1997-6#1)(1997-7#1)(1997-8#6)(2007-12#1)(2008-10#57)(2008-11#13)(2008-4#2)(2008-5#21)(2008-7#7)(2008-8#8)(2008-9#10)(2009-1#1)(2009-6#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#5)(2010-8#1)(2011-2#14)(2011-3#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#5)
infectiousness##2##1##(1990-8#1)(2010-5#1)
infective agent##2##2##(1997-1#1)(2009-8#1)
infective dose##5##2##(2009-6#4)(2011-2#1)
infective endocarditis (IE)##2##3##(2006-6#1)(2011-2#1)
infective endocarditis##5##2##(2006-6#2)(2011-2#3)
infective endocarditis?##2##2##(2011-2#2)
infective insects##4##2##(2008-10#4)
infective##30##1##(1997-1#1)(2006-6#2)(2008-10#10)(2009-6#4)(2009-8#1)(2011-2#9)(2012-12#1)(2012-3#1)(2013-1#1)
infectivity of the##2##3##(2008-10#2)
infectivity of##8##2##(1991-5#1)(2008-10#6)(2011-3#1)
infectivity##20##1##(1991-5#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)
infectoria##5##1##(2008-10#5)
infects the##3##2##(2008-10#1)(2013-8#2)
infects##11##1##(2008-10#8)(2012-12#1)(2013-8#2)
infer that##5##2##(1991-5#1)(1992-2#1)(1994-8#1)(2008-10#1)(2008-5#1)
infer the##6##2##(2008-11#1)(2008-12#1)(2008-3#3)(2008-8#1)
infer##28##1##(1991-5#1)(1992-2#1)(1993-12#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-3#1)(2012-3#1)(2012-7#1)(2012-9#1)(2013-1#2)(2013-8#1)
inference for##2##2##(2008-9#1)(2011-2#1)
inference from##2##2##(2008-6#1)(2012-3#1)
inference in##2##2##(2008-9#1)(2009-7#1)
inference is##2##2##(2008-10#1)(2010-5#1)
inference of##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
inference##25##1##(2008-10#8)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-3#3)
inferences about mutation##2##3##(2008-12#2)
inferences about##5##2##(1993-1#1)(2008-12#2)(2008-8#1)(2010-5#1)
inferences##20##1##(1991-12#2)(1993-1#1)(2008-10#1)(2008-11#9)(2008-12#2)(2008-8#1)(2010-5#1)(2012-3#1)(2012-5#1)(2012-7#1)
inferential##3##1##(2008-8#1)(2011-2#1)(2012-3#1)
inferior cerebellar artery##3##3##(2008-7#3)
inferior competitor##8##2##(2008-8#8)
inferior competitors##5##2##(2008-8#5)
inferior frontal##3##2##(1995-2#1)(1995-5#1)(2008-11#1)
inferior hip joint mobilization)##2##4##(2008-12#2)
inferior hip joint##3##3##(2008-12#3)
inferior parietal lobule##2##3##(2008-11#2)
inferior to that of##2##4##(1990-11#1)(2008-7#1)
inferior to that##3##3##(1990-11#1)(2008-11#1)(2008-7#1)
inferior to the##2##3##(2008-11#1)(2013-1#1)
inferior to##6##2##(1990-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2013-1#1)
inferior vena cava (IVC) in##2##5##(2011-2#1)(2013-1#1)
inferior vena cava##10##3##(1992-9#2)(2008-11#3)(2011-2#3)(2013-1#2)
inferior vena##11##2##(1992-9#2)(2008-11#3)(2009-5#1)(2011-2#3)(2013-1#2)
inferior##66##1##(1990-11#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-9#2)(1994-3#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-11#8)(2008-12#5)(2008-6#1)(2008-7#4)(2008-8#16)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#7)(2013-1#7)
inferolateral##2##1##(2008-11#1)(2012-3#1)
inferotemporal##4##1##(1993-6#1)(1997-2#3)
inferred a##2##2##(1995-12#1)(2013-1#1)
inferred based on##2##3##(2008-10#2)
inferred from a##2##3##(2008-10#1)(2008-8#1)
inferred from the##7##3##(1990-5#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
inferred from##18##2##(1990-5#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-10#1)(2010-3#1)(2013-8#1)
inferred phylogeny##2##2##(2008-10#1)(2009-10#1)
inferred that the##2##3##(1995-6#1)(2010-6#1)
inferred that##11##2##(1990-9#1)(1992-6#1)(1993-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2010-6#1)
inferred##50##1##(1990-5#1)(1990-9#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-5#1)(2008-10#12)(2008-11#4)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2010-10#2)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
inferring##7##1##(1995-3#1)(2008-11#1)(2008-4#3)(2008-7#1)(2010-10#1)
infers that##2##2##(2008-8#1)(2012-3#1)
infers##3##1##(2008-8#1)(2012-3#2)
infertile men##2##2##(2008-12#2)
infertile patients with PCR##2##4##(2008-12#2)
infertile patients##5##2##(2008-12#4)(2011-1#1)
infertile##14##1##(1992-1#1)(2008-10#1)(2008-12#10)(2011-1#2)
infertility and##5##2##(1992-1#1)(2008-10#1)(2009-10#1)(2010-11#1)(2010-3#1)
infertility in##3##2##(2008-12#1)(2008-4#1)(2010-11#1)
infertility patients with severe##2##4##(1991-3#2)
infertility patients with##3##3##(1991-12#1)(1991-3#2)
infertility patients##4##2##(1991-12#1)(1991-3#3)
infertility treatment##2##2##(2008-12#1)(2012-3#1)
infertility were##2##2##(1991-12#1)(1991-2#1)
infertility##35##1##(1990-3#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#3)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-9#1)(2008-10#1)(2008-12#4)(2008-4#1)(2009-10#1)(2009-8#1)(2010-11#3)(2010-3#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
infest##3##1##(2008-10#2)(2011-2#1)
infestans and##2##2##(2008-10#2)
infestans can##2##2##(2008-10#2)
infestans collected from##3##3##(2008-10#3)
infestans from potato##2##3##(2008-10#2)
infestans from##6##2##(2008-10#6)
infestans in the Toluca Valley##3##5##(2008-10#3)
infestans in the Toluca##4##4##(2008-10#4)
infestans in the##8##3##(2008-10#8)
infestans in##18##2##(2008-10#17)(2009-6#1)
infestans infection##2##2##(2008-8#1)(2009-6#1)
infestans isolates##3##2##(2008-10#3)
infestans on##4##2##(2008-10#4)
infestans population##3##2##(2008-10#3)
infestans populations from##2##3##(2008-10#2)
infestans populations##7##2##(2008-10#7)
infestans sensu lato in Ecuador##2##5##(2008-10#2)
infestans sensu lato in##3##4##(2008-10#3)
infestans sensu lato##5##3##(2008-10#5)
infestans sporangia##2##2##(2008-10#2)
infestans to##8##2##(2008-10#8)
infestans were##8##2##(2008-10#8)
infestans##138##1##(2008-10#132)(2008-8#2)(2009-6#4)
infestation and##3##2##(1996-12#2)(2008-10#1)
infestation by##8##2##(2008-10#7)(2011-2#1)
infestation foci##3##2##(2008-10#3)
infestation for##3##2##(2008-10#1)(2011-2#2)
infestation in the##2##3##(1996-12#1)(2008-10#1)
infestation in##6##2##(1996-12#2)(2008-10#3)(2011-2#1)
infestation of##5##2##(1996-6#1)(2008-10#1)(2010-10#2)(2011-2#1)
infestation was##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
infestation with##9##2##(1996-12#1)(2008-10#6)(2008-12#1)(2011-2#1)
infestation##61##1##(1996-12#10)(1996-6#1)(2008-10#35)(2008-12#3)(2010-10#2)(2011-2#6)(2012-12#2)(2012-3#1)(2013-8#1)
infestations by##3##2##(2008-10#3)
infestations##9##1##(1996-12#3)(2008-10#5)(2013-8#1)
infested animals##2##2##(2008-12#2)
infested areas##3##2##(2008-10#3)
infested by##3##2##(2008-10#2)(2013-8#1)
infested herd was treated with##2##5##(1996-12#2)
infested seed and##2##3##(2008-10#2)
infested seed##3##2##(2008-10#3)
infested soil##9##2##(2008-10#9)
infested the##2##2##(1996-12#1)(2008-10#1)
infested with H##2##3##(2008-10#2)
infested with P##5##3##(2008-10#5)
infested with R##2##3##(2008-10#2)
infested with T##3##3##(2008-10#3)
infested with either##2##3##(1996-12#1)(2008-10#1)
infested with one##2##3##(1996-12#2)
infested with ten##2##3##(1996-12#2)
infested with the pathogen##2##4##(2008-10#2)
infested with the##3##3##(2008-10#3)
infested with##41##2##(1996-12#6)(2008-10#35)
infested##97##1##(1996-12#15)(2008-10#77)(2008-12#2)(2011-2#2)(2013-8#1)
infesting##4##1##(2008-10#3)(2013-8#1)
infiltrate in##3##2##(1991-2#1)(2008-9#1)(2009-8#1)
infiltrate into##2##2##(2008-10#1)(2013-1#1)
infiltrate##16##1##(1990-12#1)(1990-6#1)(1991-2#1)(1995-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#2)(2010-12#1)(2013-1#2)
infiltrated into##3##2##(2008-10#3)
infiltrated with##6##2##(2008-10#5)(2009-7#1)
infiltrated##12##1##(1990-2#1)(2008-10#8)(2008-7#1)(2009-1#1)(2009-7#1)
infiltrates and##3##2##(2008-5#1)(2010-12#1)(2013-1#1)
infiltrates was##2##2##(2013-1#2)
infiltrates with##2##2##(2009-8#1)(2010-11#1)
infiltrates##20##1##(1990-9#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#4)(2010-11#1)(2010-12#1)(2013-1#7)
infiltrating M/Ms##2##2##(1991-2#2)
infiltrating T##2##2##(1995-12#1)(2010-3#1)
infiltrating inflammatory cells##4##3##(2012-3#4)
infiltrating the##2##2##(2008-10#1)(2013-7#1)
infiltrating##15##1##(1990-12#1)(1991-2#2)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-7#1)
infiltration after partial wound closure##2##5##(2008-7#2)
infiltration and##7##2##(1990-9#1)(1991-3#1)(1995-12#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
infiltration by##2##2##(2008-7#1)(2012-3#1)
infiltration in the##2##3##(2008-10#1)(2010-1#1)
infiltration in##5##2##(2008-10#1)(2008-5#1)(2010-1#2)(2011-2#1)
infiltration into the##2##3##(2008-10#1)(2013-1#1)
infiltration of PMNLs and MPhi##3##5##(2010-1#3)
infiltration of PMNLs and##4##4##(2010-1#4)
infiltration of the##6##3##(1990-3#1)(1995-12#1)(1996-9#1)(2009-8#1)(2010-12#1)(2011-2#1)
infiltration of##28##2##(1990-3#1)(1991-3#2)(1994-5#1)(1995-12#1)(1996-9#1)(2008-10#5)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-1#5)(2010-12#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-7#1)
infiltration or##2##2##(2011-2#1)(2013-1#1)
infiltration prior to wound closure##2##5##(2008-7#2)
infiltration were##2##2##(1995-2#1)(2008-7#1)
infiltration with##4##2##(2008-10#2)(2008-7#2)
infiltration##74##1##(1990-3#1)(1990-9#1)(1991-3#3)(1991-9#1)(1994-5#1)(1995-12#2)(1995-2#1)(1996-9#3)(2007-11#1)(2008-1#1)(2008-10#15)(2008-5#2)(2008-7#10)(2009-5#1)(2009-8#1)(2010-1#7)(2010-12#1)(2010-6#3)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)
infiltrative##6##1##(1991-12#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
infinite##16##1##(1993-8#1)(1994-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)
infinity##3##1##(2007-12#1)(2008-11#1)(2008-12#1)
infirm##2##1##(1991-11#1)(2013-8#1)
infl ovules##2##2##(2008-8#2)
inflamed##9##1##(1993-2#1)(1995-11#3)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#2)
inflammaging##2##1##(2010-1#2)
inflammation and a##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
inflammation and associated##2##3##(1993-9#1)(2008-10#1)
inflammation and proteolysis##2##3##(2013-1#2)
inflammation and rheumatoid arthritis##2##4##(2008-5#2)
inflammation and the##2##3##(2011-2#1)(2013-1#1)
inflammation and##37##2##(1990-5#2)(1992-6#1)(1993-9#1)(1994-11#1)(1996-3#1)(1997-2#2)(2008-10#3)(2008-5#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#5)
inflammation are##2##2##(2011-2#1)(2013-8#1)
inflammation in the##3##3##(1992-6#1)(2008-11#1)(2011-2#1)
inflammation in##13##2##(1992-6#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#1)(2011-2#4)(2012-2#1)
inflammation induced##2##2##(2009-10#1)(2012-3#1)
inflammation is##5##2##(2009-10#1)(2010-1#2)(2011-2#1)(2013-1#1)
inflammation of the##3##3##(2008-12#1)(2008-4#1)(2009-1#1)
inflammation of##6##2##(1997-1#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-1#1)
inflammation or##2##2##(2009-11#1)(2013-8#1)
inflammation##170##1##(1990-2#2)(1990-3#3)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-5#1)(1992-6#3)(1993-11#1)(1993-2#4)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-3#1)(1997-1#2)(1997-2#5)(1997-8#3)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#5)(2008-5#9)(2008-7#3)(2008-9#4)(2009-1#3)(2009-10#6)(2009-11#1)(2009-8#2)(2010-1#5)(2010-10#2)(2010-12#3)(2010-5#4)(2010-9#1)(2011-1#3)(2011-2#20)(2011-7#1)(2012-12#7)(2012-2#9)(2012-3#5)(2012-5#2)(2013-1#8)(2013-8#10)
inflammation)##2##1##(2008-6#1)(2010-12#1)
inflammation-associated##2##1##(1991-12#1)(2009-8#1)
inflammatory DSP##3##2##(2010-6#3)
inflammatory and immune##2##3##(1997-8#1)(2008-11#1)
inflammatory and infectious##2##3##(2012-2#2)
inflammatory and##13##2##(1991-3#1)(1991-8#1)(1997-8#2)(2008-11#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2010-11#1)(2012-2#2)(2013-8#1)
inflammatory bowel disease (IBD)##3##4##(2008-11#1)(2010-12#1)(2011-2#1)
inflammatory bowel disease##22##3##(1992-6#2)(1994-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-12#8)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
inflammatory bowel diseases##2##3##(2010-12#1)(2012-2#1)
inflammatory bowel##26##2##(1992-6#2)(1994-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-12#9)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
inflammatory cascade##2##2##(2007-11#1)(2009-12#1)
inflammatory cell infiltrates##3##3##(2013-1#3)
inflammatory cell##5##2##(1991-5#1)(2011-2#1)(2013-1#3)
inflammatory cells in##2##3##(1997-1#1)(1997-8#1)
inflammatory cells##17##2##(1992-5#1)(1997-1#4)(1997-8#1)(2008-10#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-3#6)(2013-8#1)
inflammatory complications##2##2##(1996-3#1)(2013-1#1)
inflammatory condition##3##2##(1990-12#1)(2009-7#1)(2012-12#1)
inflammatory conditions##9##2##(1993-3#1)(1995-11#1)(2008-11#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
inflammatory cytokine##2##2##(2007-11#1)(2008-7#1)
inflammatory cytokines in##2##3##(1996-12#1)(2008-10#1)
inflammatory cytokines##10##2##(1994-11#1)(1996-12#1)(1996-2#2)(1997-1#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
inflammatory demyelinating polyneuropathy##3##3##(2008-7#2)(2012-3#1)
inflammatory demyelinating##5##2##(1995-12#1)(2008-2#1)(2008-7#2)(2012-3#1)
inflammatory disease##4##2##(1994-3#1)(1996-2#1)(2012-2#1)(2013-1#1)
inflammatory diseases (IMID)##4##3##(2011-2#4)
inflammatory diseases of##2##3##(2012-3#1)(2013-1#1)
inflammatory diseases such as atherosclerosis##2##5##(2008-10#1)(2012-12#1)
inflammatory diseases such as##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
inflammatory diseases##26##2##(1991-2#1)(1992-12#1)(2008-10#3)(2008-11#1)(2009-6#1)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
inflammatory disorder of the##3##4##(2008-9#1)(2012-3#1)(2013-1#1)
inflammatory disorder##4##2##(2008-9#1)(2012-3#2)(2013-1#1)
inflammatory disorders##4##2##(2008-5#1)(2008-9#1)(2010-12#1)(2012-3#1)
inflammatory infiltrate##2##2##(2008-10#1)(2008-5#1)
inflammatory infiltrates##3##2##(2008-7#1)(2009-8#1)(2013-1#1)
inflammatory joint##3##2##(1993-2#2)(2012-2#1)
inflammatory lesions in the##2##4##(1995-12#1)(2008-12#1)
inflammatory lesions in##3##3##(1995-12#1)(2008-12#1)(2008-4#1)
inflammatory lesions##4##2##(1995-12#1)(2008-11#1)(2008-12#1)(2008-4#1)
inflammatory markers##5##2##(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
inflammatory mediators and##3##3##(2008-12#1)(2010-1#1)(2013-1#1)
inflammatory mediators##9##2##(2008-12#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
inflammatory myopathy##2##2##(2008-7#1)(2013-1#1)
inflammatory process and##2##3##(2008-4#1)(2010-12#1)
inflammatory process in##2##3##(1993-1#1)(2008-1#1)
inflammatory process of##2##3##(1997-8#1)(2010-6#1)
inflammatory process##14##2##(1992-6#3)(1993-1#2)(1997-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2013-1#1)
inflammatory processes are##2##3##(2011-2#2)
inflammatory processes##10##2##(1993-2#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
inflammatory pseudotumor##2##2##(2009-3#1)(2010-12#1)
inflammatory pseudotumour##2##2##(2008-7#1)(2013-1#1)
inflammatory reaction and##2##3##(1992-3#1)(2013-1#1)
inflammatory reaction##6##2##(1992-3#1)(1997-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
inflammatory renal disease##3##3##(2013-8#3)
inflammatory response in##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
inflammatory response to##2##3##(1994-5#1)(2008-12#1)
inflammatory response##26##2##(1994-5#2)(1994-6#1)(1995-12#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#2)(2011-2#1)(2012-3#4)(2013-1#2)
inflammatory responses and##2##3##(1995-2#1)(2011-2#1)
inflammatory responses in##3##3##(2008-10#3)
inflammatory responses that##2##3##(2008-10#2)
inflammatory responses##15##2##(1995-2#1)(2008-10#6)(2008-3#3)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
inflammatory signs##2##2##(2008-7#1)(2011-2#1)
inflammatory state##3##2##(1994-5#1)(1997-8#2)
inflammatory syndrome##5##2##(2008-10#1)(2009-7#1)(2009-8#1)(2010-5#2)
inflammatory tissue##5##2##(1990-2#2)(1994-5#1)(2009-5#1)(2011-2#1)
inflammatory vaginitis##2##2##(2011-2#2)
inflammatory##326##1##(1990-12#1)(1990-2#2)(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#6)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#5)(1992-9#1)(1993-1#2)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#4)(1994-6#2)(1995-11#1)(1995-12#4)(1995-2#2)(1996-12#1)(1996-2#3)(1996-3#4)(1997-1#7)(1997-3#2)(1997-5#1)(1997-8#9)(2007-11#2)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#9)(2008-7#15)(2008-8#3)(2008-9#6)(2009-1#2)(2009-10#5)(2009-12#3)(2009-3#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#8)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#15)(2010-5#4)(2010-6#5)(2010-7#1)(2011-1#3)(2011-2#34)(2011-7#1)(2012-12#4)(2012-2#12)(2012-3#22)(2013-1#28)(2013-7#1)(2013-8#6)
inflate the##2##2##(2008-10#1)(2009-4#1)
inflate##3##1##(2008-10#1)(2009-4#1)(2010-5#1)
inflated##3##1##(1997-6#1)(2012-2#1)(2013-8#1)
inflation and##3##2##(1991-2#1)(2008-10#1)(2008-7#1)
inflation in##2##2##(1992-2#1)(1996-2#1)
inflation of##2##2##(1997-3#1)(2008-7#1)
inflation##13##1##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-3#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-7#2)
inflected##2##1##(1996-2#1)(2009-10#1)
inflection point of the##2##4##(2008-10#1)(2008-8#1)
inflection point##5##2##(2008-10#4)(2008-8#1)
inflection##10##1##(2008-10#7)(2008-8#2)(2009-8#1)
inflectional##2##1##(2008-10#1)(2013-1#1)
inflections##2##1##(2008-10#1)(2009-8#1)
inflicted on##2##2##(2008-8#2)
inflicted##4##1##(1995-9#1)(2008-8#2)(2013-8#1)
infliximab in##2##2##(2010-12#2)
infliximab therapy in##2##3##(2010-12#2)
infliximab therapy##5##2##(2010-12#4)(2012-3#1)
infliximab##20##1##(2008-7#1)(2010-12#12)(2011-2#2)(2012-3#5)
inflorescence##10##1##(2008-10#5)(2008-11#1)(2008-9#2)(2009-10#1)(2009-5#1)
inflorescences were##2##2##(2008-10#1)(2008-8#1)
inflorescences##7##1##(2008-10#2)(2008-8#4)(2011-10#1)
inflow and outflow##2##3##(1995-12#1)(1997-3#1)
inflow##6##1##(1991-11#1)(1995-12#1)(1997-3#1)(2008-7#1)(2008-9#2)
influence a##3##2##(1994-3#2)(2008-11#1)
influence and##5##2##(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
influence both##3##2##(1994-12#1)(2008-10#1)(2010-8#1)
influence by##2##2##(2010-11#1)(2012-3#1)
influence cell##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
influence disease##3##2##(2008-10#2)(2009-8#1)
influence during##2##2##(2008-7#1)(2013-1#1)
influence each##2##2##(2011-2#1)(2012-2#1)
influence exerted##3##2##(2008-10#3)
influence from##3##2##(2008-10#1)(2012-2#2)
influence gene##2##2##(2008-10#1)(2013-1#1)
influence health##2##2##(1990-12#1)(1996-3#1)
influence how##3##2##(1997-1#1)(2008-12#1)(2010-2#1)
influence in discriminating##2##3##(2008-10#2)
influence in##10##2##(1990-3#1)(1993-9#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-5#2)
influence is##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
influence later alcohol use and##2##5##(2008-12#2)
influence levels##2##2##(1995-12#1)(2008-6#1)
influence negative##2##2##(1995-1#1)(2010-10#1)
influence of American##2##3##(1993-2#1)(2011-2#1)
influence of KCl##2##3##(1990-5#1)(2008-12#1)
influence of a cream containing 20% glycerin##2##7##(2008-5#2)
influence of a##12##3##(1990-12#1)(1990-6#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-1#1)(2012-3#1)
influence of age on##5##4##(1995-8#1)(2008-8#2)(2008-9#2)
influence of age##10##3##(1994-8#1)(1995-8#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-9#1)(2012-2#1)
influence of alpha-ketoglutarate##2##3##(2007-8#2)
influence of body##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
influence of both##2##3##(2008-10#1)(2012-2#1)
influence of childhood community##2##4##(2010-7#2)
influence of complex##2##3##(2008-10#2)
influence of diabetes on the relationship between N-terminal pro-B-type natriuretic peptide##2##11##(2011-2#2)
influence of diabetes on the##3##5##(2008-1#1)(2011-2#2)
influence of dietary##3##3##(1991-6#2)(2008-11#1)
influence of different parameters##3##4##(2008-10#3)
influence of different##15##3##(1996-12#1)(2008-10#9)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
influence of dispersal##2##3##(2008-9#2)
influence of each##2##3##(2008-5#1)(2008-8#1)
influence of ethanol##2##3##(2008-10#2)
influence of experimental##2##3##(2008-10#1)(2011-2#1)
influence of flow rates of##3##5##(2008-10#3)
influence of food##2##3##(1997-1#1)(2008-9#1)
influence of foreign##4##3##(2008-10#4)
influence of high##2##3##(1993-11#1)(2011-2#1)
influence of inoculum##3##3##(2008-10#3)
influence of media##2##3##(2008-11#2)
influence of mixing##2##3##(1997-2#1)(2008-8#1)
influence of moisture in##2##4##(2008-10#2)
influence of moisture##4##3##(2008-10#4)
influence of nutrition##2##3##(1996-8#1)(2013-1#1)
influence of other##2##3##(2008-10#2)
influence of pH##5##3##(2008-10#5)
influence of sample matrix##2##4##(2008-10#2)
influence of sample##3##3##(2008-10#3)
influence of several##10##3##(2008-10#9)(2008-11#1)
influence of temperature on the##2##5##(2008-10#2)
influence of temperature on##3##4##(2008-10#3)
influence of temperature##5##3##(2008-10#4)(2008-3#1)
influence of the formation of##2##5##(2008-10#2)
influence of the mesocortical DA system##2##6##(1996-5#2)
influence of the type and##2##5##(2008-10#2)
influence of the##75##3##(1990-2#1)(1994-11#1)(1995-11#1)(1996-3#1)(1996-5#2)(2008-10#38)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#3)(2010-4#1)(2011-2#4)(2012-9#1)
influence of these##6##3##(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
influence of this##2##3##(1996-11#1)(2006-6#1)
influence of tumor##2##3##(1993-9#1)(2009-3#1)
influence of two##2##3##(2008-10#1)(2008-5#1)
influence of ultraviolet##2##3##(2008-5#1)(2011-2#1)
influence of various##7##3##(2008-10#7)
influence of##464##2##(1990-12#1)(1990-2#3)(1990-5#3)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#191)(2008-11#33)(2008-12#5)(2008-2#4)(2008-3#16)(2008-5#19)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#16)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#3)(2009-6#2)(2009-7#7)(2009-8#4)(2010-1#4)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-9#4)(2011-2#25)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#3)(2012-6#2)(2012-9#2)(2013-1#6)(2013-8#7)
influence on a##2##3##(2008-10#2)
influence on analytical##2##3##(2008-10#2)
influence on development of##2##4##(2011-2#2)
influence on heart rate##2##4##(2010-5#2)
influence on sensitivity##2##3##(2008-10#2)
influence on survival##4##3##(1990-12#1)(1995-2#2)(2008-10#1)
influence on the degree of##2##5##(2008-10#2)
influence on the reaction##2##4##(1994-5#1)(1996-5#1)
influence on the selectivity##2##4##(2008-10#2)
influence on the##58##3##(1990-2#1)(1990-6#1)(1991-1#1)(1991-6#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-8#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2009-1#1)(2010-4#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-8#1)(2013-1#1)(2013-8#2)
influence on their##3##3##(2008-11#2)(2013-8#1)
influence on this##3##3##(1995-2#1)(2008-11#2)
influence on##131##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-8#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#4)(1995-5#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#34)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-9#1)(2011-2#10)(2011-3#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#4)
influence over the##3##3##(1993-8#1)(2009-8#1)(2013-1#1)
influence over##4##2##(1993-8#1)(2008-11#1)(2009-8#1)(2013-1#1)
influence return##2##2##(1993-1#2)
influence strongly##2##2##(2008-10#1)(2008-5#1)
influence survival##2##2##(1991-2#1)(2012-3#1)
influence that##5##2##(1995-2#1)(2008-10#2)(2008-2#1)(2008-9#1)
influence the distribution of##4##4##(1997-1#2)(2008-10#1)(2008-9#1)
influence the evolution of##2##4##(2008-9#1)(2010-4#1)
influence the final##2##3##(1995-11#1)(2008-10#1)
influence the frequency of##2##4##(1993-11#1)(1994-8#1)
influence the growth##2##3##(2008-10#1)(2009-8#1)
influence the magnitude of##2##4##(2008-10#1)(2008-8#1)
influence the mating behaviors##2##4##(2008-6#2)
influence the outcome of##5##4##(2008-12#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
influence the outcome##6##3##(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
influence the peak##2##3##(2008-10#1)(2013-8#1)
influence the performance of##2##4##(2008-10#1)(2013-1#1)
influence the quality of##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
influence the relative##2##3##(1995-2#1)(2012-6#1)
influence the results##3##3##(2008-10#2)(2010-6#1)
influence the sensitivity of##2##4##(2008-11#2)
influence the sexual##2##3##(1990-9#1)(2008-7#1)
influence the success of##2##4##(2008-10#1)(2008-11#1)
influence the success##3##3##(2008-10#2)(2008-11#1)
influence the##132##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-9#2)(1996-1#2)(1996-12#1)(1997-1#4)(1997-2#2)(1997-3#1)(2006-6#1)(2008-10#27)(2008-11#8)(2008-12#4)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#6)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#5)(2013-8#2)
influence their##9##2##(1997-1#1)(2008-11#2)(2008-8#3)(2010-9#1)(2012-3#1)(2013-8#1)
influence them##2##2##(2008-9#1)(2012-2#1)
influence these##3##2##(1995-8#1)(2008-10#1)(2010-9#1)
influence this##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
influence was##5##2##(2008-10#2)(2008-5#2)(2013-8#1)
influence whether##2##2##(1993-12#1)(2008-3#1)
influence##973##1##(1990-12#4)(1990-2#5)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#5)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#4)(1992-9#5)(1993-1#2)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#6)(1994-3#7)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#8)(1995-2#8)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#4)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#3)(1996-5#3)(1996-8#1)(1997-1#9)(1997-2#7)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#3)(2006-6#3)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#295)(2008-11#69)(2008-12#18)(2008-2#8)(2008-3#23)(2008-4#2)(2008-5#38)(2008-6#5)(2008-7#23)(2008-8#35)(2008-9#29)(2009-1#2)(2009-10#4)(2009-11#1)(2009-3#6)(2009-5#3)(2009-6#3)(2009-7#8)(2009-8#10)(2009-9#2)(2010-1#11)(2010-10#4)(2010-11#4)(2010-2#2)(2010-4#8)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#8)(2011-1#3)(2011-2#47)(2011-3#4)(2012-12#2)(2012-2#22)(2012-3#13)(2012-6#3)(2012-8#1)(2012-9#2)(2013-1#29)(2013-7#1)(2013-8#20)
influenced and##2##2##(1992-12#1)(2008-9#1)
influenced by a number of##2##5##(2008-5#1)(2008-7#1)
influenced by a##4##3##(2008-5#1)(2008-7#1)(2011-2#2)
influenced by both##2##3##(1992-12#1)(1996-2#1)
influenced by crop rotation##2##4##(2008-10#2)
influenced by environmental##2##3##(2008-10#1)(2011-2#1)
influenced by factors such as##2##5##(1995-3#1)(2012-12#1)
influenced by many##3##3##(2008-12#1)(2011-1#1)(2012-3#1)
influenced by multiple##2##3##(2008-10#2)
influenced by the amount of##2##5##(1996-12#1)(2008-10#1)
influenced by the presence of##3##5##(1993-8#1)(2008-10#1)(2008-9#1)
influenced by the type of the##2##6##(2008-10#1)(2008-5#1)
influenced by the type of##4##5##(1995-11#1)(2008-10#2)(2008-5#1)
influenced by the##55##3##(1990-11#2)(1991-9#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-5#2)(1995-11#1)(1996-12#3)(1996-6#1)(1997-7#1)(2008-10#17)(2008-11#5)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-6#2)(2010-10#1)(2010-8#1)(2011-2#3)
influenced by their##2##3##(2011-3#1)(2012-2#1)
influenced by various factors##3##4##(2008-11#1)(2008-2#1)(2012-2#1)
influenced by##153##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#2)(1991-3#2)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-6#2)(1993-8#2)(1994-2#1)(1994-5#2)(1995-11#1)(1995-2#3)(1995-3#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#39)(2008-11#18)(2008-12#3)(2008-2#1)(2008-5#5)(2008-7#3)(2008-8#10)(2008-9#7)(2009-5#1)(2009-6#3)(2009-8#2)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
influenced disease##2##2##(2008-10#2)
influenced hemodynamic less##2##3##(2012-3#2)
influenced how##2##2##(2008-12#1)(2010-1#1)
influenced male behaviors##2##3##(2008-6#2)
influenced outcomes##2##2##(2011-1#2)
influenced the extent##2##3##(2008-10#1)(2008-11#1)
influenced the subsequent##2##3##(1993-6#1)(2008-9#1)
influenced the##32##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-6#2)(1994-2#1)(1995-11#1)(1995-5#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#1)
influenced##237##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#4)(1993-8#2)(1994-2#2)(1994-5#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#59)(2008-11#22)(2008-12#7)(2008-2#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#11)(2008-9#14)(2009-3#1)(2009-5#2)(2009-6#4)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#12)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#4)(2013-8#2)
influences in the##2##3##(1995-2#1)(2012-12#1)
influences in##5##2##(1995-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-12#1)
influences of age##2##3##(2013-8#2)
influences of childhood community adversity##2##5##(2010-7#2)
influences of different##3##3##(2008-10#2)(2011-2#1)
influences of the##6##3##(1992-2#1)(2008-10#4)(2008-2#1)
influences of##32##2##(1992-2#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-9#2)(2009-5#1)(2009-7#2)(2010-11#1)(2010-7#2)(2011-2#1)(2013-8#2)
influences on growth##2##3##(2007-11#1)(2010-6#1)
influences on the##6##3##(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)
influences on young adult achievement##2##5##(2010-7#2)
influences on##33##2##(1991-5#1)(1994-5#1)(1995-2#1)(1996-2#3)(1997-3#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#5)(2008-9#1)(2009-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#2)(2013-1#2)
influences perception of##2##3##(2008-11#2)
influences such##2##2##(2008-11#1)(2012-3#1)
influences the development of##2##4##(2009-5#1)(2011-2#1)
influences the##25##2##(1993-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-9#1)(2011-2#2)(2013-1#3)
influences their##2##2##(2008-12#1)(2008-8#1)
influences upon##2##2##(1993-12#1)(2008-11#1)
influences##158##1##(1990-12#2)(1990-8#2)(1991-5#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#4)(1997-3#3)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#17)(2008-12#5)(2008-2#2)(2008-4#2)(2008-6#2)(2008-7#6)(2008-8#12)(2008-9#5)(2009-10#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#8)(2013-8#3)
influencing cell##2##2##(2008-9#1)(2009-8#1)
influencing factor##2##2##(2008-10#1)(2008-9#1)
influencing factors##4##2##(2008-10#1)(2008-11#2)(2008-9#1)
influencing the decision##2##3##(2012-3#2)
influencing the determination of##3##4##(2008-10#3)
influencing the development of##2##4##(1995-11#1)(2008-10#1)
influencing the##47##2##(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-11#2)(1995-3#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-11#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-3#2)
influencing their##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
influencing these##2##2##(1996-2#1)(2008-4#1)
influencing##109##1##(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-10#33)(2008-11#7)(2008-12#4)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#7)(2008-9#5)(2009-11#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)
influent##10##1##(2008-10#8)(2008-11#1)(2008-7#1)
influential and##2##2##(1992-3#1)(2008-8#1)
influential data##2##2##(2008-10#2)
influential factors##2##2##(2008-10#1)(2010-10#1)
influential in##3##2##(1992-12#1)(2008-10#1)(2013-8#1)
influential parameters##2##2##(2008-10#2)
influential points##2##2##(2008-10#2)
influential##27##1##(1992-12#1)(1992-3#1)(1993-12#1)(1995-3#1)(1996-1#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-10#2)(2011-2#1)(2013-8#3)
influenza A and B##2##4##(2011-2#2)
influenza A and##3##3##(2011-2#2)(2012-2#1)
influenza A##19##2##(1992-6#2)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
influenza A(H3N2) viruses##3##3##(2013-8#3)
influenza A(H3N2)##5##2##(1994-9#1)(2013-8#4)
influenza A/H1##2##2##(2011-2#2)
influenza A/H1N1 and A/H3N2##3##4##(2011-2#3)
influenza B viruses##2##3##(1994-9#2)
influenza B##6##2##(1992-6#2)(1994-9#2)(2011-2#2)
influenza activity##4##2##(1992-6#2)(1994-9#2)
influenza circulation seasons##2##3##(2012-12#2)
influenza disease##3##2##(2012-3#2)(2013-1#1)
influenza hemagglutinin##2##2##(1992-9#1)(2012-2#1)
influenza in the##2##3##(2011-9#1)(2013-1#1)
influenza in##5##2##(2010-5#1)(2011-9#1)(2012-3#2)(2013-1#1)
influenza infection##2##2##(2013-1#2)
influenza season##3##2##(1992-6#2)(2011-2#1)
influenza testing##3##2##(2011-2#3)
influenza vaccination coverage##2##3##(2011-2#2)
influenza vaccination##8##2##(2008-7#1)(2011-2#6)(2012-3#1)
influenza vaccinations##3##2##(2012-3#3)
influenza vaccine##5##2##(1991-8#1)(1992-6#2)(2012-3#1)(2013-8#1)
influenza virus##20##2##(1990-5#2)(1992-6#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#3)
influenza viruses from##3##3##(2008-9#1)(2011-2#2)
influenza viruses##14##2##(1992-6#1)(2008-9#1)(2011-2#5)(2011-3#1)(2013-8#6)
influenza##142##1##(1990-5#2)(1991-8#1)(1992-6#15)(1992-9#1)(1994-9#7)(1995-5#1)(1996-6#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-6#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-2#37)(2011-3#3)(2011-9#2)(2012-12#5)(2012-2#4)(2012-3#13)(2013-1#8)(2013-8#21)
influenza-associated mortality was##2##3##(1992-6#2)
influenza-like illness##3##2##(2011-2#2)(2011-9#1)
influenza-like##5##1##(1990-2#1)(1996-8#1)(2011-2#2)(2011-9#1)
influenzae type b conjugate vaccines##2##5##(2007-11#1)(2008-10#1)
influenzae type b##13##3##(1990-12#2)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#1)
influenzae type##16##2##(1990-12#2)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)
influenzae##29##1##(1990-12#2)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#7)(1997-3#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#5)(2011-2#4)
influx and efflux##5##3##(1990-2#1)(1994-8#4)
influx and##8##2##(1990-2#1)(1994-8#5)(2008-12#1)(2010-5#1)
influx by##3##2##(1991-1#1)(1992-8#1)(1994-11#1)
influx in##4##2##(1991-1#1)(1994-5#1)(1994-8#1)(1996-2#1)
influx into##3##2##(1991-5#2)(2010-8#1)
influx of Ca2+##4##3##(1990-5#2)(1994-2#1)(1995-11#1)
influx of T-lymphocytes##2##3##(1996-12#2)
influx of##15##2##(1990-5#2)(1991-1#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-12#3)(1997-8#1)(2008-10#2)(2008-5#1)(2010-3#1)
influx stimulating##2##2##(1992-12#2)
influx##46##1##(1990-2#2)(1990-5#2)(1991-1#3)(1991-5#2)(1992-12#3)(1992-8#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#9)(1994-9#1)(1995-11#1)(1996-12#3)(1996-2#2)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
infolding system##4##2##(2008-7#4)
inform and##3##2##(1994-1#1)(2009-4#1)(2012-3#1)
inform clinical##3##2##(2008-12#1)(2010-7#1)(2011-10#1)
inform current##2##2##(2010-2#1)(2010-8#1)
inform future##2##2##(2011-3#1)(2013-1#1)
inform on the##2##3##(2008-10#1)(2009-8#1)
inform policymakers##2##2##(1994-1#1)(2009-4#1)
inform the##8##2##(1992-1#1)(2008-11#2)(2009-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
inform##52##1##(1992-1#2)(1994-1#2)(1995-12#1)(1996-1#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#7)(2008-12#4)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
informal caregivers##2##2##(1992-1#2)
informal interviews##2##2##(2008-11#1)(2010-8#1)
informal support##2##2##(1996-3#1)(2009-5#1)
informal##21##1##(1992-1#3)(1992-12#2)(1992-3#1)(1994-1#1)(1996-1#1)(1996-3#2)(2008-11#3)(2008-12#1)(2009-5#3)(2009-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
informally##2##1##(1995-9#1)(2008-12#1)
informants##8##1##(1994-1#1)(1996-3#1)(2008-1#1)(2011-2#3)(2013-1#2)
informatics##5##1##(1992-12#1)(1994-12#2)(1996-3#1)(2008-10#1)
information about HIV##2##3##(1996-5#1)(2009-5#1)
information about a##2##3##(2007-12#1)(2010-7#1)
information about different##2##3##(2010-8#1)(2011-3#1)
information about his HIV status##2##5##(1996-5#2)
information about how the##2##4##(1992-12#1)(2008-10#1)
information about how##4##3##(1992-12#1)(1996-5#1)(2008-10#1)(2011-2#1)
information about patients##2##3##(1990-3#1)(1997-1#1)
information about sexual##2##3##(1996-11#1)(2008-7#1)
information about the nature of##2##5##(2010-8#1)(2012-2#1)
information about the nature##3##4##(2010-8#1)(2011-2#1)(2012-2#1)
information about the sensory##2##4##(2008-10#1)(2009-8#1)
information about the##66##3##(1990-11#1)(1990-2#1)(1991-1#2)(1991-2#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2007-12#2)(2008-10#15)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#7)(2012-2#3)(2012-3#2)(2013-8#1)
information about their##7##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#2)(2013-1#1)(2013-8#1)
information about these##2##3##(2008-9#1)(2011-2#1)
information about##143##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#3)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-11#3)(1996-2#2)(1996-3#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#19)(2008-11#10)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2009-8#2)(2010-10#4)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#10)(2011-3#2)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#2)
information accessible##3##2##(1995-12#1)(1996-1#1)(1997-2#1)
information among##2##2##(1996-12#1)(2008-10#1)
information and is##2##3##(2008-11#2)
information and knowledge##2##3##(1993-2#1)(2008-7#1)
information and the##2##3##(1995-3#1)(2008-9#1)
information and to##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
information and##61##2##(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-1#5)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
information are available##3##3##(1997-6#1)(1997-8#1)(2009-12#1)
information are##9##2##(1997-3#2)(1997-6#1)(1997-8#1)(2008-12#1)(2008-8#2)(2009-12#1)(2010-8#1)
information as##4##2##(1994-2#1)(1996-1#1)(1997-6#1)(2008-11#1)
information at##2##2##(2008-10#1)(2012-2#1)
information available in##2##3##(2011-2#1)(2013-1#1)
information available on the##2##4##(2008-10#1)(2008-4#1)
information available to##3##3##(1997-3#1)(2008-11#1)(2009-5#1)
information available##8##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-5#1)(2011-2#1)(2013-1#1)
information being##2##2##(1993-12#1)(1996-2#1)
information between##5##2##(1996-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
information by##3##2##(1993-1#1)(1996-11#1)(2008-11#1)
information can also be##2##4##(2008-6#1)(2012-3#1)
information can be obtained##3##4##(1992-5#1)(2008-9#1)(2013-1#1)
information can be used##2##4##(2010-4#1)(2013-1#1)
information can be##12##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#3)(2010-1#1)(2010-4#1)(2013-1#2)
information can##17##2##(1992-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#4)(2010-1#1)(2010-4#1)(2012-3#1)(2013-1#2)
information collected##4##2##(2008-10#1)(2008-11#1)(2012-3#2)
information concerning the##4##3##(1994-12#1)(1994-5#1)(2008-10#1)(2008-6#1)
information concerning their##2##3##(1995-12#1)(1997-6#1)
information concerning##14##2##(1990-8#1)(1991-2#3)(1994-12#1)(1994-5#1)(1995-12#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
information contained in##2##3##(2008-10#1)(2008-7#1)
information content of##2##3##(1997-6#1)(2008-10#1)
information content##3##2##(1997-6#1)(2008-10#1)(2010-10#1)
information could##2##2##(2008-10#1)(2009-11#1)
information demands##2##2##(1997-3#1)(2008-10#1)
information do##2##2##(2008-11#1)(2010-11#1)
information during##2##2##(2008-4#1)(2010-4#1)
information exchange##4##2##(1992-2#2)(1995-12#1)(1996-2#1)
information exists regarding##2##3##(2011-2#1)(2012-5#1)
information exists##3##2##(2008-11#1)(2011-2#1)(2012-5#1)
information facilitates##3##2##(1997-3#1)(2008-11#1)(2008-9#1)
information for further##2##3##(2008-10#1)(2013-1#1)
information for other##2##3##(2008-11#2)
information for the##12##3##(1997-8#1)(2006-6#1)(2008-10#3)(2008-11#3)(2008-9#1)(2010-5#1)(2011-7#1)(2013-8#1)
information for##51##2##(1990-11#1)(1990-12#1)(1990-6#1)(1992-5#1)(1994-8#1)(1996-11#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#13)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#5)(2010-5#1)(2010-8#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
information found in the##2##4##(1991-2#1)(2011-3#1)
information found on##2##3##(2011-1#2)
information found##4##2##(1991-2#1)(2011-1#2)(2011-3#1)
information from a cDNA##2##4##(1997-7#1)(2011-2#1)
information from a##5##3##(1995-1#1)(1997-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
information from complex##2##3##(2008-10#2)
information from the##14##3##(1991-12#1)(1991-2#1)(1997-7#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#2)
information from##41##2##(1991-12#1)(1991-2#1)(1992-3#1)(1994-2#1)(1995-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
information given##2##2##(1993-6#1)(2008-11#1)
information gleaned from##2##3##(1996-3#1)(2009-9#1)
information has been##6##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2013-1#1)
information in a##3##3##(1991-11#1)(1993-6#1)(1994-2#1)
information in predicting##2##3##(2009-8#1)(2013-1#1)
information in the##14##3##(1992-2#1)(1993-3#1)(1996-2#1)(1997-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#1)
information in##42##2##(1991-11#1)(1992-2#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2009-10#3)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#4)(2011-3#1)(2013-1#4)(2013-8#1)
information infrastructure##5##2##(1994-12#1)(1997-3#3)(2010-8#1)
information into account##2##3##(2008-3#1)(2009-10#1)
information into##7##2##(1990-5#2)(1993-12#1)(1997-2#1)(2008-11#1)(2008-3#1)(2009-10#1)
information is available concerning the##3##5##(2008-10#2)(2008-12#1)
information is available on the##4##5##(2008-10#3)(2012-3#1)
information is available on##6##4##(1993-1#1)(2008-10#3)(2008-6#1)(2012-3#1)
information is available##13##3##(1993-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
information is not##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
information is presented##2##3##(2008-1#1)(2010-11#1)
information is provided##3##3##(2008-10#1)(2008-4#2)
information is required##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
information is to##2##3##(1992-3#1)(2008-4#1)
information is##52##2##(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-10#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#5)(2013-8#1)
information management environment##2##3##(1995-2#2)
information management in##2##3##(1995-2#1)(2010-8#1)
information management##11##2##(1993-1#1)(1994-2#1)(1995-1#1)(1995-2#4)(1996-3#1)(2007-12#1)(2008-10#1)(2010-8#1)
information may##7##2##(1992-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
information necessary##3##2##(1993-2#1)(1994-1#2)
information needed to##3##3##(1994-3#1)(2008-10#1)(2008-9#1)
information needed##4##2##(1994-3#1)(2008-10#1)(2008-6#1)(2008-9#1)
information needs in##2##3##(1997-3#2)
information needs of##5##3##(1991-12#1)(1994-12#1)(1997-3#3)
information needs##13##2##(1991-12#1)(1994-12#1)(1996-3#1)(1997-3#9)(2010-8#1)
information networks##4##2##(1993-2#1)(1996-1#2)(2010-8#1)
information not##2##2##(2008-10#2)
information obtainable##2##2##(2008-7#1)(2012-2#1)
information obtained from a##2##4##(2008-10#1)(2008-12#1)
information obtained from##9##3##(1991-3#1)(2008-10#5)(2008-12#1)(2012-12#1)(2013-1#1)
information obtained##14##2##(1991-3#1)(1994-2#1)(1997-3#1)(2008-10#6)(2008-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
information of both##2##3##(1994-8#1)(2008-10#1)
information of the##7##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)
information of##28##2##(1994-3#1)(1994-8#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#2)(2010-6#1)(2011-2#5)(2013-8#1)
information on a##3##3##(1991-1#1)(1995-6#1)(2013-1#1)
information on heart function##2##4##(2013-1#2)
information on platelet-leukocyte conjugate formation in whole blood and on factors that##2##12##(2006-6#2)
information on smoking##2##3##(1991-12#1)(1992-6#1)
information on the Internet##4##4##(1996-2#1)(2008-11#3)
information on the actual##2##4##(1993-12#1)(2008-11#1)
information on the causes of##2##5##(2008-10#2)
information on the effects of##2##5##(2008-10#2)
information on the health care context##2##6##(1997-3#2)
information on the health##3##4##(1991-3#1)(1997-3#2)
information on the number of##2##5##(2008-10#1)(2008-3#1)
information on the number##5##4##(1994-6#2)(2008-10#1)(2008-3#2)
information on the##86##3##(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-10#25)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2011-2#4)(2012-2#3)(2013-1#5)(2013-8#1)
information on their##5##3##(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
information on this##2##3##(1993-3#1)(2008-7#1)
information on using##2##3##(2008-12#1)(2008-9#1)
information on##178##2##(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1994-2#3)(1994-3#3)(1994-6#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#5)(1997-7#2)(1997-8#1)(2006-6#2)(2007-12#2)(2008-1#1)(2008-10#34)(2008-11#14)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#6)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#13)(2013-8#1)
information or##4##2##(2008-11#1)(2008-9#1)(2010-3#1)(2012-3#1)
information over a##2##3##(2008-10#1)(2008-11#1)
information processing##15##2##(1996-2#2)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
information provided by a##2##4##(1993-2#1)(2008-11#1)
information provided by the##3##4##(1992-12#1)(2008-10#1)(2010-8#1)
information provided by##8##3##(1992-12#1)(1993-2#1)(2008-10#2)(2008-11#1)(2010-6#1)(2010-8#2)
information provided##10##2##(1992-12#1)(1993-2#1)(2008-10#2)(2008-11#3)(2010-6#1)(2010-8#2)
information provides##2##2##(1994-2#1)(2008-6#1)
information regarding the##12##3##(1990-6#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#2)
information regarding##18##2##(1990-6#1)(1993-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
information related to the##2##4##(1995-12#1)(2008-5#1)
information related to##6##3##(1995-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
information relative to the##2##4##(2008-10#1)(2008-5#1)
information relevant to the##2##4##(2008-3#1)(2009-6#1)
information relevant to##4##3##(1995-8#1)(2008-3#1)(2008-7#1)(2009-6#1)
information required##3##2##(2008-11#2)(2009-10#1)
information resource##5##2##(1997-2#1)(2008-4#3)(2008-9#1)
information resources for##2##3##(1996-2#1)(1997-2#1)
information resources##4##2##(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#1)
information retrieval##7##2##(1992-1#2)(1994-8#2)(2008-11#1)(2008-9#1)(2010-12#1)
information search and retrieval skills##2##5##(2008-11#2)
information search##3##2##(1997-3#1)(2008-11#2)
information security##2##2##(2010-8#2)
information services##2##2##(1991-2#1)(1993-1#1)
information sharing##3##2##(1995-2#1)(2008-11#1)(2011-9#1)
information should be useful##2##4##(2008-10#2)
information should##3##2##(2008-10#3)
information sources##5##2##(1991-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(2012-12#1)
information such as##3##3##(2008-4#1)(2011-2#1)(2011-3#1)
information superhighway##4##2##(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)
information system for##3##3##(1995-12#1)(1996-3#1)(2010-8#1)
information system is##2##3##(1992-3#1)(1994-2#1)
information system##21##2##(1991-1#1)(1992-3#2)(1993-2#1)(1994-2#2)(1995-12#2)(1996-12#1)(1996-3#3)(1997-3#1)(2008-10#2)(2010-8#3)(2012-3#2)(2013-1#1)
information systems and##5##3##(1993-1#1)(1993-3#1)(1995-1#1)(1996-3#1)(2008-10#1)
information systems for##2##3##(1994-2#1)(2011-2#1)
information systems into##2##3##(1997-3#2)
information systems that##3##3##(1993-2#1)(1995-12#1)(1996-3#1)
information systems will##2##3##(1995-12#1)(1997-3#1)
information systems##46##2##(1993-1#1)(1993-2#6)(1993-3#2)(1994-2#1)(1995-1#3)(1995-12#2)(1995-2#1)(1996-2#2)(1996-3#4)(1997-1#1)(1997-3#9)(2008-10#8)(2008-7#1)(2010-8#2)(2011-2#2)(2012-3#1)
information technologies##3##2##(2010-8#1)(2013-1#2)
information technology and##2##3##(2008-11#2)
information technology in##5##3##(1993-2#1)(2008-10#2)(2010-8#1)(2013-1#1)
information technology to##3##3##(1995-3#1)(2008-11#2)
information technology##24##2##(1993-2#2)(1994-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(2008-10#2)(2008-11#6)(2010-8#1)(2011-1#2)(2012-2#2)(2013-1#2)
information that can be##4##4##(1996-1#1)(1996-12#1)(2008-10#1)(2008-12#1)
information that is available##3##4##(1992-9#1)(2008-9#1)(2013-8#1)
information that is##5##3##(1992-9#1)(2008-3#2)(2008-9#1)(2013-8#1)
information that will##2##3##(1997-3#1)(2010-10#1)
information that##24##2##(1992-9#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2012-2#1)(2013-8#1)
information they##3##2##(2008-11#1)(2008-9#1)(2010-5#1)
information to be##4##3##(2008-11#1)(2009-11#1)(2011-10#1)(2011-2#1)
information to consumers##2##3##(1996-2#1)(1997-3#1)
information to develop##2##3##(1993-12#1)(2008-7#1)
information to enhance##2##3##(1996-2#1)(2008-10#1)
information to guide##2##3##(1993-2#1)(1996-2#1)
information to rural physiotherapists##2##4##(1993-2#2)
information to the##8##3##(1990-2#1)(2008-10#3)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#1)
information to##45##2##(1990-2#3)(1991-2#2)(1993-12#2)(1993-2#4)(1995-1#1)(1996-2#3)(1996-6#2)(1997-3#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
information transmission##2##2##(2011-2#2)
information used##2##2##(1997-3#1)(2008-10#1)
information using##2##2##(2010-3#1)(2011-3#1)
information was available##2##3##(2008-10#1)(2008-7#1)
information was collected from##2##4##(1994-1#1)(2008-8#1)
information was collected##3##3##(1994-1#1)(2008-8#1)(2011-9#1)
information was obtained##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
information was used##2##3##(1992-2#1)(2008-11#1)
information was##23##2##(1990-3#2)(1991-12#1)(1992-1#1)(1992-2#1)(1994-1#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-9#1)(2013-1#1)
information were also##2##3##(1997-3#1)(2011-2#1)
information were##6##2##(1992-2#1)(1993-2#1)(1997-3#1)(2008-11#1)(2011-2#2)
information which##2##2##(1997-6#1)(2008-12#1)
information will be##3##3##(1993-2#1)(2008-12#1)(2012-2#1)
information will##6##2##(1993-2#1)(1994-11#1)(1994-2#1)(2008-12#1)(2010-5#1)(2012-2#1)
information with##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
information would##2##2##(1994-5#1)(2008-11#1)
information##1435##1##(1990-11#2)(1990-12#1)(1990-2#8)(1990-3#3)(1990-5#3)(1990-6#2)(1990-8#5)(1991-1#6)(1991-11#2)(1991-12#11)(1991-2#12)(1991-3#4)(1991-5#2)(1991-6#2)(1991-8#2)(1992-1#5)(1992-11#1)(1992-12#3)(1992-2#16)(1992-3#5)(1992-5#3)(1992-6#2)(1992-9#4)(1993-1#10)(1993-12#15)(1993-2#25)(1993-3#10)(1993-6#4)(1994-1#5)(1994-11#1)(1994-12#13)(1994-2#22)(1994-3#8)(1994-5#2)(1994-6#3)(1994-8#8)(1994-9#2)(1995-1#10)(1995-10#1)(1995-11#5)(1995-12#17)(1995-2#14)(1995-3#4)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#22)(1996-11#11)(1996-12#4)(1996-2#25)(1996-3#25)(1996-5#5)(1996-6#7)(1996-8#2)(1997-1#7)(1997-2#8)(1997-3#63)(1997-4#1)(1997-5#2)(1997-6#9)(1997-7#7)(1997-8#7)(2006-6#3)(2007-11#1)(2007-12#11)(2007-9#1)(2008-1#11)(2008-10#189)(2008-11#139)(2008-12#23)(2008-2#6)(2008-3#34)(2008-4#46)(2008-5#14)(2008-6#18)(2008-7#30)(2008-8#9)(2008-9#48)(2009-10#8)(2009-11#2)(2009-12#9)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#9)(2010-11#8)(2010-12#4)(2010-3#3)(2010-4#4)(2010-5#9)(2010-6#3)(2010-7#5)(2010-8#34)(2010-9#2)(2011-1#16)(2011-10#1)(2011-2#54)(2011-3#8)(2011-7#1)(2011-9#2)(2012-12#15)(2012-2#34)(2012-3#21)(2012-5#1)(2013-1#59)(2013-8#16)
information)##3##1##(1995-12#1)(2010-1#1)(2012-2#1)
information-limiting##2##1##(1995-1#2)
information-seeking##4##1##(1995-1#3)(1995-2#1)
information-theoretic approach##2##2##(2008-7#1)(2010-10#1)
information-theoretic criteria##2##2##(2008-7#2)
information-theoretic##5##1##(2008-7#3)(2010-10#1)(2012-2#1)
information?##2##1##(2009-5#1)(2013-8#1)
informational entropy##3##2##(1993-12#3)
informational##10##1##(1993-12#3)(1995-1#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#2)
informations##6##1##(1990-5#1)(1997-4#1)(1997-8#1)(2008-10#1)(2013-1#2)
informative about##2##2##(2008-7#1)(2013-1#1)
informative and##2##2##(2008-11#1)(2008-6#1)
informative genes##2##2##(2008-10#2)
informative to##2##2##(2008-10#1)(2010-12#1)
informative##33##1##(1990-6#1)(1991-2#1)(1992-3#1)(1994-9#1)(1997-3#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-1#1)(2010-12#2)(2011-3#2)(2013-1#1)
informed about the##5##3##(1995-12#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-9#1)
informed about##7##2##(1995-1#1)(1995-12#1)(1997-6#2)(2008-10#1)(2008-9#1)(2009-9#1)
informed by a##2##3##(2008-12#1)(2008-6#1)
informed by the##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
informed by##7##2##(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2012-3#1)
informed choices##2##2##(1997-3#1)(2008-11#1)
informed consent##21##2##(1993-2#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-9#1)(1997-6#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#3)(2010-11#3)(2010-7#1)(2011-2#2)(2012-3#1)
informed decisions##3##2##(1991-2#1)(1993-12#1)(2013-1#1)
informed his##2##2##(1995-6#1)(2008-12#1)
informed purchasing##2##2##(1991-2#1)(2008-11#1)
informed the##2##2##(1990-2#1)(2008-11#1)
informed##69##1##(1990-2#1)(1991-2#2)(1992-2#1)(1993-12#1)(1993-2#3)(1994-2#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-6#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#3)(2008-10#5)(2008-11#5)(2008-12#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#3)(2009-9#1)(2010-11#3)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
informing##2##1##(1990-2#1)(2010-2#1)
informs about the##2##3##(1997-6#1)(2011-3#1)
informs##4##1##(1993-2#1)(1997-6#1)(2008-11#1)(2011-3#1)
infra-red##7##1##(1991-2#2)(2008-10#4)(2013-1#1)
infra-umbilical##2##1##(1990-2#1)(2008-12#1)
infrabony##2##1##(2009-5#1)(2010-5#1)
inframammary fold##2##2##(2013-1#2)
inframammary##3##1##(2011-2#1)(2013-1#2)
infraorbital sinuses##2##2##(2008-5#2)
infrared (ATR-FTIR)##2##2##(2008-10#2)
infrared (FT-IR)##2##2##(2008-10#2)
infrared (FTIR)##13##2##(2008-10#10)(2008-3#1)(2008-5#1)(2008-8#1)
infrared (IR) spectra##2##3##(2008-10#2)
infrared (IR) spectroscopy##2##3##(2008-10#1)(2008-5#1)
infrared (IR)##7##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
infrared (NIR) spectroscopy##2##3##(2008-10#2)
infrared (NIR)##4##2##(2008-10#3)(2010-1#1)
infrared Fourier transform##4##3##(2008-10#4)
infrared Fourier##5##2##(2008-10#5)
infrared absorption##3##2##(2008-10#2)(2008-3#1)
infrared and##4##2##(2008-10#3)(2011-2#1)
infrared determination of##3##3##(2008-10#3)
infrared drying##2##2##(2008-10#2)
infrared evolved gas##3##3##(2008-10#3)
infrared microspectroscopy##2##2##(2008-5#2)
infrared radiation spectra##2##3##(2008-3#2)
infrared radiation##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
infrared radiometer for measuring the air-sea temperature difference##2##8##(2008-3#2)
infrared region of the spectrum##2##5##(2008-10#2)
infrared region##4##2##(2008-10#4)
infrared spectra of##2##3##(2008-10#2)
infrared spectra##8##2##(2008-10#8)
infrared spectral radiance from water##2##5##(2008-3#2)
infrared spectral##4##2##(2008-3#4)
infrared spectrometer##6##2##(2008-10#3)(2008-3#3)
infrared spectrometry (FT-IR)##3##3##(1997-2#1)(2008-10#2)
infrared spectrometry and##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
infrared spectrometry##17##2##(1997-2#2)(2008-10#14)(2008-5#1)
infrared spectroscopic##4##2##(2008-10#3)(2008-3#1)
infrared spectroscopy (ATR-FTIR)##3##3##(2008-10#2)(2008-5#1)
infrared spectroscopy (NIRS)##2##3##(2008-10#2)
infrared spectroscopy and multivariate##2##4##(2008-10#2)
infrared spectroscopy and##6##3##(2008-10#5)(2012-2#1)
infrared spectroscopy is##2##3##(2008-10#2)
infrared spectroscopy to##2##3##(1994-11#1)(2008-10#1)
infrared spectroscopy##42##2##(1994-11#2)(2008-10#36)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#1)
infrared spectrum##3##2##(2008-10#3)
infrared thermograph technique##2##3##(2008-3#2)
infrared##216##1##(1991-1#1)(1993-1#1)(1994-11#2)(1997-2#2)(2008-10#144)(2008-2#3)(2008-3#37)(2008-5#8)(2008-7#3)(2008-8#3)(2009-10#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
infrarenal##3##1##(2008-10#1)(2009-8#1)(2011-2#1)
infrastructure and##5##2##(1995-12#1)(1996-1#1)(2008-11#1)(2010-8#2)
infrastructure for data-based cancer control planning and##2##7##(1997-1#2)
infrastructure for##4##2##(1996-3#1)(1997-1#3)
infrastructure that##2##2##(1996-3#1)(2008-11#1)
infrastructure##36##1##(1991-6#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-12#3)(1995-2#1)(1996-1#1)(1996-3#2)(1997-1#4)(1997-3#5)(2008-10#1)(2008-11#5)(2008-5#1)(2010-12#1)(2010-8#6)(2011-2#1)(2012-2#1)
infratemporal fossa##3##2##(2011-2#1)(2012-3#2)
infrequent and##2##2##(1995-6#1)(2011-2#1)
infrequent cause of##2##3##(1991-3#1)(2012-3#1)
infrequent disease##2##2##(1990-12#1)(2011-2#1)
infrequent in##2##2##(1990-2#1)(2008-10#1)
infrequent##19##1##(1990-12#1)(1990-2#1)(1991-3#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#2)
infrequently encountered##2##2##(2011-2#1)(2012-2#1)
infrequently reported##2##2##(2008-1#1)(2010-6#1)
infrequently##12##1##(1994-8#2)(1996-9#1)(2007-11#1)(2008-1#1)(2008-11#2)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#1)
infundibulum##2##1##(2008-12#2)
infuse##2##1##(1997-3#1)(2010-8#1)
infused##6##1##(1997-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)
infusion and##3##2##(1990-12#1)(1995-12#1)(2008-7#1)
infusion in##4##2##(1990-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
infusion increased##2##2##(1994-3#1)(2008-5#1)
infusion of CCK##2##3##(1993-6#2)
infusion of amino##2##3##(2010-7#2)
infusion of##25##2##(1990-12#1)(1990-8#1)(1993-3#3)(1993-6#4)(1994-11#1)(1994-12#1)(1995-12#2)(1996-11#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-6#2)(2010-11#1)(2010-7#2)(2011-2#2)(2012-3#1)
infusion on##3##2##(1995-12#1)(2012-12#1)(2013-8#1)
infusion only##2##2##(1991-6#1)(2008-5#1)
infusion pump##2##2##(2008-1#1)(2011-2#1)
infusion pumps##7##2##(2010-9#2)(2011-1#1)(2011-2#4)
infusion rate##3##2##(1993-1#1)(1994-12#1)(2008-11#1)
infusion therapy##2##2##(1995-2#1)(2012-3#1)
infusion with##2##2##(2010-7#1)(2011-2#1)
infusion##88##1##(1990-10#1)(1990-12#4)(1990-3#1)(1990-8#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-6#4)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#4)(1995-2#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2010-11#2)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#10)(2012-12#3)(2012-2#3)(2012-3#5)(2013-8#3)
infusions of β-lactam##2##3##(2013-1#2)
infusions of##8##2##(1993-6#2)(1995-11#1)(1997-1#1)(2012-12#2)(2013-1#2)
infusions##20##1##(1990-10#1)(1990-5#1)(1992-7#1)(1993-6#2)(1994-2#4)(1995-11#1)(1997-1#1)(2008-10#2)(2008-7#1)(2012-12#4)(2013-1#2)
ing##3##1##(2008-11#3)
ingenious##3##1##(2008-9#2)(2012-2#1)
ingentis##3##1##(2007-12#3)
ingest##3##1##(1995-12#1)(2008-1#1)(2008-10#1)
ingested SLCV##2##2##(2008-10#2)
ingested amounts##2##2##(2008-11#1)(2012-2#1)
ingested by##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
ingested##15##1##(2008-10#3)(2008-11#2)(2008-7#2)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#4)
ingesting##4##1##(1991-11#1)(2008-10#1)(2008-12#1)(2010-6#1)
ingestion and##3##2##(1994-11#1)(2008-6#1)(2010-1#1)
ingestion of a##2##3##(2009-6#1)(2011-2#1)
ingestion of the##4##3##(1992-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
ingestion of##19##2##(1992-2#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-6#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
ingestion on##2##2##(2012-2#1)(2013-1#1)
ingestion was##2##2##(2008-10#1)(2010-11#1)
ingestion##41##1##(1992-2#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#4)(2007-12#3)(2008-10#8)(2008-6#1)(2008-7#2)(2009-6#1)(2010-1#2)(2010-11#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-8#1)
ingredient in##3##2##(2008-5#1)(2008-8#1)(2010-4#1)
ingredient is##2##2##(2008-5#2)
ingredient of##4##2##(1991-6#1)(1994-8#1)(1997-3#1)(2008-10#1)
ingredient to##3##2##(2008-5#2)(2011-2#1)
ingredient within##3##2##(2008-10#1)(2008-5#2)
ingredient##42##1##(1991-1#1)(1991-6#1)(1994-8#1)(1995-1#2)(1997-3#1)(2008-10#4)(2008-11#2)(2008-5#24)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#3)
ingredient)##2##1##(2008-5#2)
ingredients and##5##2##(2008-10#2)(2008-5#2)(2011-2#1)
ingredients are##4##2##(2008-5#2)(2009-7#1)(2012-12#1)
ingredients for##6##2##(2008-5#4)(2010-7#2)
ingredients from##3##2##(2008-5#2)(2009-12#1)
ingredients in##8##2##(2008-10#6)(2010-9#2)
ingredients that##2##2##(2008-10#1)(2011-2#1)
ingredients were##2##2##(2008-10#1)(2008-5#1)
ingredients##66##1##(1990-3#1)(1994-3#1)(2008-10#12)(2008-11#2)(2008-5#28)(2009-12#2)(2009-7#3)(2010-4#1)(2010-7#4)(2010-9#3)(2011-2#5)(2012-12#1)(2012-2#3)
ingredients'##3##1##(2008-5#3)
ingress in##2##2##(2008-10#2)
ingress into the##2##3##(2008-10#2)
ingress of##2##2##(1996-2#1)(2008-10#1)
ingress##13##1##(1996-2#1)(2008-10#11)(2008-9#1)
ingression##2##1##(2008-10#2)
ingroup and outgroup##2##3##(2008-11#2)
ingrowth##4##1##(2008-10#2)(2009-3#1)(2009-7#1)
ingrowths##2##1##(2007-12#1)(2011-2#1)
inguinal area##2##2##(2008-5#1)(2009-9#1)
inguinal hernia with incarceration of urinary bladder diverticulum in a##2##10##(2011-2#2)
inguinal hernia##10##2##(1992-5#1)(1996-3#1)(2008-10#2)(2008-12#3)(2011-2#2)(2012-12#1)
inguinal##29##1##(1992-5#2)(1994-12#1)(1996-3#1)(2008-10#6)(2008-12#4)(2008-5#1)(2008-7#2)(2009-2#1)(2009-9#3)(2010-11#1)(2011-2#4)(2012-12#2)(2012-4#1)
inguinoscrotal hernia##2##2##(2008-12#2)
inguinoscrotal##3##1##(1992-5#1)(2008-12#2)
inhabitants of##3##2##(1991-3#1)(2011-2#2)
inhabitants were##2##2##(2008-7#1)(2013-1#1)
inhabitants##16##1##(1990-12#1)(1991-3#1)(1991-6#1)(1994-11#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#4)(2012-12#1)(2013-1#1)
inhabitants)##2##1##(1991-2#1)(2011-2#1)
inhabited##2##1##(2008-12#1)(2008-8#1)
inhabiting a##2##2##(2008-10#1)(2008-8#1)
inhabiting the same##2##3##(2008-10#2)
inhabiting##9##1##(2008-10#3)(2008-8#3)(2010-8#1)(2011-2#2)
inhalation and##3##2##(1996-2#1)(2008-5#1)(2012-3#1)
inhalation challenge##2##2##(2008-10#2)
inhalation in##2##2##(1993-2#1)(1996-2#1)
inhalation is##2##2##(1996-3#1)(2013-8#1)
inhalation method##2##2##(1995-5#1)(2008-7#1)
inhalation of##7##2##(1994-6#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-10#2)(2012-3#1)
inhalation products##2##2##(1997-2#2)
inhalation technique##2##2##(1992-3#1)(1997-1#1)
inhalation##51##1##(1990-3#1)(1991-1#1)(1992-12#1)(1992-3#3)(1993-2#2)(1994-2#3)(1994-6#1)(1995-5#1)(1996-1#3)(1996-2#3)(1996-3#4)(1997-1#5)(1997-2#5)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
inhalational##5##1##(1991-6#1)(2010-7#1)(2012-3#3)
inhalative##2##1##(1992-6#1)(2013-8#1)
inhale##3##1##(1992-3#2)(1996-1#1)
inhaled aerosols to##2##3##(1994-12#1)(1997-2#1)
inhaled aerosols##4##2##(1994-12#1)(1997-2#1)(2013-1#2)
inhaled and intranasal corticosteroids##3##4##(2007-11#3)
inhaled and##4##2##(2007-11#3)(2008-11#1)
inhaled corticosteroid##2##2##(1996-1#1)(2008-11#1)
inhaled corticosteroids##9##2##(2007-11#4)(2008-11#4)(2011-2#1)
inhaled drugs##3##2##(1997-1#2)(2010-10#1)
inhaled nitric oxide##3##3##(1997-1#1)(2008-12#2)
inhaled or##2##2##(2007-11#1)(2010-5#1)
inhaled tritiated##2##2##(1993-8#2)
inhaled##64##1##(1990-5#2)(1991-12#2)(1992-3#4)(1993-8#4)(1994-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#8)(1997-2#1)(2007-11#9)(2008-10#2)(2008-11#8)(2008-12#2)(2008-5#1)(2010-10#2)(2010-2#1)(2010-5#2)(2011-2#1)(2013-1#3)(2013-8#2)
inhaler (MDI)##8##2##(1992-3#2)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#2)
inhaler is##2##2##(1994-2#1)(1996-2#1)
inhaler with a spacer##2##4##(2007-11#1)(2008-8#1)
inhaler##33##1##(1992-3#2)(1993-2#3)(1994-2#4)(1996-1#2)(1996-2#9)(1997-1#3)(1997-2#4)(2007-11#2)(2008-8#2)(2010-11#1)(2010-6#1)
inhalers (MDIs)##9##2##(1992-3#2)(1996-1#5)(1996-2#1)(1997-1#1)
inhalers have##2##2##(1992-3#2)
inhalers##34##1##(1992-2#5)(1992-3#12)(1996-1#10)(1996-2#5)(1997-1#1)(2011-2#1)
inherent heterogeneity##2##2##(2008-10#2)
inherent immune##2##2##(2010-1#1)(2012-3#1)
inherent in the use of##2##5##(2008-10#1)(2010-12#1)
inherent in the##7##3##(1991-1#1)(1991-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-12#1)
inherent in this##2##3##(1992-3#1)(2008-10#1)
inherent in##21##2##(1990-8#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-3#1)(1995-3#2)(2008-10#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
inherent incentives##2##2##(1991-12#1)(1991-2#1)
inherent limitations of##2##3##(2008-10#1)(2008-7#1)
inherent optical properties##2##3##(2008-2#1)(2008-3#1)
inherent optical##3##2##(2008-2#2)(2008-3#1)
inherent problems that##2##3##(2008-10#1)(2008-12#1)
inherent problems##4##2##(2008-10#1)(2008-12#2)(2009-9#1)
inherent resistance to##2##3##(2008-10#2)
inherent stability##2##2##(2008-10#1)(2008-9#1)
inherent to the##4##3##(1996-11#1)(2008-10#2)(2009-6#1)
inherent to##10##2##(1992-3#1)(1996-11#1)(2008-10#5)(2008-11#1)(2009-5#1)(2009-6#1)
inherent##96##1##(1990-2#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-11#2)(1995-3#2)(1996-11#2)(2008-1#1)(2008-10#26)(2008-11#9)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
inherently faster##2##2##(2008-10#1)(2008-3#1)
inherently##17##1##(1994-11#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2010-7#1)(2013-1#1)
inherit dominance##2##2##(2008-8#2)
inherit##5##1##(2008-8#5)
inheritance has##2##2##(2008-7#2)
inheritance of EBS is linked to##2##6##(1991-12#2)
inheritance of resistance to leprosis##2##5##(2008-10#2)
inheritance of resistance to##9##4##(2008-10#8)(2012-3#1)
inheritance of resistance##13##3##(2008-10#12)(2012-3#1)
inheritance of the##4##3##(1994-11#1)(2008-10#1)(2008-12#1)(2013-8#1)
inheritance of##40##2##(1991-12#2)(1993-6#1)(1994-11#1)(1994-9#1)(1996-12#1)(2008-10#24)(2008-12#2)(2008-4#1)(2008-8#4)(2010-4#1)(2012-3#1)(2013-8#1)
inheritance pattern##2##2##(2008-7#1)(2012-3#1)
inheritance##65##1##(1991-12#2)(1993-6#1)(1994-11#1)(1994-9#2)(1996-12#1)(1997-3#1)(2008-10#31)(2008-11#1)(2008-12#4)(2008-4#1)(2008-7#4)(2008-8#7)(2008-9#1)(2010-4#1)(2011-2#2)(2012-3#4)(2013-8#1)
inherited and##3##2##(2008-9#2)(2012-12#1)
inherited ataxias##2##2##(2008-7#2)
inherited by##2##2##(1994-11#1)(2009-8#1)
inherited diseases##4##2##(1995-12#1)(2008-11#1)(2010-12#1)(2011-2#1)
inherited disorders##2##2##(1991-11#1)(1994-9#1)
inherited from P##3##3##(2008-10#3)
inherited from the##2##3##(2008-10#1)(2011-2#1)
inherited from##8##2##(2008-10#4)(2009-6#1)(2010-9#1)(2011-2#2)
inherited in a##2##3##(2008-7#1)(2011-2#1)
inherited metabolic diseases##2##3##(1990-8#1)(2010-12#1)
inherited metabolic##4##2##(1990-8#1)(2008-10#1)(2010-12#1)(2010-6#1)
inherited##57##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#1)(1993-1#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-3#2)(1997-7#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#6)(2012-12#2)(2012-3#3)(2013-8#1)
inhibin subunits##3##2##(2008-8#3)
inhibin##6##1##(1992-6#1)(2008-8#5)
inhibit DNA##2##2##(1997-3#1)(2008-9#1)
inhibit a##2##2##(2008-10#1)(2008-11#1)
inhibit both##2##2##(2008-1#1)(2008-9#1)
inhibit cell growth##3##3##(1994-8#1)(2008-11#2)
inhibit cell##4##2##(1994-3#1)(1994-8#1)(2008-11#2)
inhibit cyclooxygenase##2##2##(2008-5#1)(2012-2#1)
inhibit growth of##5##3##(1993-1#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
inhibit growth##7##2##(1993-1#1)(1995-2#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)
inhibit in vitro##2##3##(1997-3#1)(2008-10#1)
inhibit insulin##2##2##(1994-8#1)(1997-1#1)
inhibit its##2##2##(2011-2#1)(2011-3#1)
inhibit pepsinogen secretion##3##3##(1995-8#3)
inhibit platelet aggregation##2##3##(1993-8#1)(2006-6#1)
inhibit some##2##2##(1995-2#1)(2011-3#1)
inhibit the activity of the##2##5##(1995-11#1)(2009-6#1)
inhibit the activity of##3##4##(1995-11#1)(2008-1#1)(2009-6#1)
inhibit the cell##2##3##(2008-11#1)(2008-8#1)
inhibit the enzyme##2##3##(1996-2#1)(2008-11#1)
inhibit the expression of##5##4##(1995-11#1)(2008-9#2)(2010-1#1)(2013-1#1)
inhibit the formation of##3##4##(1994-5#1)(1996-3#1)(2008-8#1)
inhibit the growth of##9##4##(2008-10#6)(2008-8#1)(2008-9#1)(2011-2#1)
inhibit the pathogen##2##3##(2008-10#2)
inhibit the synthesis of##2##4##(1993-8#1)(2008-10#1)
inhibit the##71##2##(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-8#3)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#5)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#2)(2006-6#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-3#1)(2008-8#7)(2008-9#4)(2009-6#2)(2010-1#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
inhibit their##2##2##(2008-11#1)(2010-5#1)
inhibit this##3##2##(1995-11#1)(2008-11#1)(2009-12#1)
inhibit thrombin##3##2##(1994-5#3)
inhibit transcription of##2##3##(2008-7#1)(2010-4#1)
inhibit transcription##3##2##(2008-7#1)(2008-9#1)(2010-4#1)
inhibit tumor growth##5##3##(1993-11#1)(1994-6#1)(2008-8#2)(2008-9#1)
inhibit tumor##6##2##(1993-11#1)(1994-6#1)(2008-11#1)(2008-8#2)(2008-9#1)
inhibit##226##1##(1990-4#1)(1990-8#2)(1990-9#1)(1991-3#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#6)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#6)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#2)(1994-8#9)(1995-11#9)(1995-2#4)(1995-6#2)(1995-8#7)(1995-9#1)(1996-12#2)(1996-2#6)(1996-3#1)(1997-1#5)(1997-3#3)(1997-4#2)(2006-6#3)(2008-1#2)(2008-10#28)(2008-11#17)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#14)(2008-9#13)(2009-10#1)(2009-12#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-2#6)(2011-3#4)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
inhibited ET-1-induced##2##2##(1993-8#2)
inhibited HIV-1 strain##2##3##(2011-3#2)
inhibited HL-60##2##2##(1995-3#2)
inhibited O2-##2##2##(1994-8#1)(1996-2#1)
inhibited U937##2##2##(1995-3#1)(2012-2#1)
inhibited after##3##2##(2008-10#3)
inhibited almost##2##2##(1990-5#1)(1992-4#1)
inhibited and##7##2##(1990-2#1)(1994-5#1)(1995-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
inhibited appressorium formation##2##3##(2008-10#2)
inhibited at##4##2##(2008-10#2)(2008-7#1)(2009-3#1)
inhibited both##6##2##(1992-6#1)(1993-3#1)(1996-2#1)(2006-6#1)(2008-11#1)(2011-3#1)
inhibited by OxLDL##2##3##(1995-2#2)
inhibited by RA##2##3##(2008-11#2)
inhibited by a##4##3##(1995-2#1)(1996-2#1)(2008-5#1)(2008-8#1)
inhibited by an##2##3##(1990-5#1)(1991-2#1)
inhibited by approximately##2##3##(1993-3#1)(1993-8#1)
inhibited by both##3##3##(1990-2#1)(1993-6#1)(1994-5#1)
inhibited by dexamethasone##2##3##(1993-3#1)(1997-1#1)
inhibited by indomethacin##3##3##(1990-11#1)(1991-3#1)(1997-1#1)
inhibited by other##3##3##(1990-8#1)(1994-6#1)(1994-8#1)
inhibited by phorbol##2##3##(1991-5#1)(1994-11#1)
inhibited by the addition of 20##2##6##(2008-8#1)(2012-2#1)
inhibited by the addition of##4##5##(1993-8#1)(1994-3#1)(2008-8#1)(2012-2#1)
inhibited by the##14##3##(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-2#1)(2013-1#1)
inhibited by wortmannin##2##3##(1994-11#1)(1995-8#1)
inhibited by##147##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-5#4)(1990-8#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1992-3#8)(1993-3#4)(1993-6#3)(1993-8#6)(1994-11#5)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#9)(1995-11#1)(1995-2#6)(1995-6#2)(1995-8#4)(1996-12#4)(1996-2#3)(1997-1#4)(1997-2#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-10#17)(2008-11#15)(2008-5#2)(2008-8#7)(2008-9#1)(2009-3#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
inhibited cell growth##4##3##(1994-11#1)(2008-11#2)(2013-1#1)
inhibited cell proliferation##2##3##(2009-9#1)(2011-2#1)
inhibited cell##10##2##(1993-8#1)(1994-11#1)(2008-11#3)(2008-12#1)(2009-9#1)(2011-2#2)(2013-1#1)
inhibited compared with##2##3##(2008-8#2)
inhibited enzyme##2##2##(1995-6#1)(2008-10#1)
inhibited expression of##3##3##(2008-8#2)(2012-2#1)
inhibited for##2##2##(2008-5#1)(2011-2#1)
inhibited from##3##2##(1994-11#2)(2012-3#1)
inhibited fungal##2##2##(2008-10#2)
inhibited germination of##3##3##(2008-10#3)
inhibited glisoxepide##2##2##(1992-3#2)
inhibited growth in##2##3##(1990-6#1)(1993-11#1)
inhibited growth of##3##3##(1994-8#1)(2008-10#2)
inhibited growth##9##2##(1990-6#1)(1993-11#1)(1994-8#1)(2008-10#3)(2008-11#2)(2011-2#1)
inhibited high KCl-stimulated##2##3##(1996-2#2)
inhibited high##4##2##(1995-11#1)(1996-2#3)
inhibited in a##2##3##(1992-6#1)(2012-2#1)
inhibited in the presence of##3##5##(1994-11#1)(2008-10#1)(2008-11#1)
inhibited in the##4##3##(1994-11#1)(1994-2#1)(2008-10#1)(2008-11#1)
inhibited in vitro##2##3##(1993-8#1)(1995-6#1)
inhibited in##17##2##(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
inhibited its##3##2##(1990-5#1)(1994-5#1)(2008-10#1)
inhibited markedly by##2##3##(1995-8#1)(2008-8#1)
inhibited nematode##3##2##(2008-10#3)
inhibited only##2##2##(1997-4#1)(2008-10#1)
inhibited peaks##2##2##(2008-10#2)
inhibited platelet aggregation##2##3##(1992-4#1)(2008-5#1)
inhibited proliferation and##2##3##(2008-11#1)(2011-2#1)
inhibited proliferation##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
inhibited secretion##3##2##(1995-11#1)(2008-11#2)
inhibited spore germination##2##3##(2008-10#2)
inhibited telomerase##2##2##(2008-11#2)
inhibited the activity of##2##4##(1997-6#1)(2011-2#1)
inhibited the binding of##4##4##(1990-11#1)(1991-6#1)(1995-11#1)(1995-2#1)
inhibited the binding##5##3##(1990-11#1)(1991-6#1)(1995-11#1)(1995-2#2)
inhibited the development of##2##4##(2008-11#1)(2012-3#1)
inhibited the enzyme by##2##4##(1994-11#1)(1995-6#1)
inhibited the enzyme##3##3##(1990-9#1)(1994-11#1)(1995-6#1)
inhibited the formation of##4##4##(1993-11#1)(2006-6#1)(2008-10#1)(2009-8#1)
inhibited the growth of human##2##5##(2008-11#1)(2010-6#1)
inhibited the growth of the##2##5##(1992-8#1)(2008-10#1)
inhibited the growth of##9##4##(1990-11#1)(1992-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)
inhibited the growth##10##3##(1990-11#1)(1992-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)
inhibited the increase##2##3##(1993-12#1)(1996-2#1)
inhibited the invasion##2##3##(2008-11#2)
inhibited the production of##3##4##(1994-8#1)(2008-10#2)
inhibited the proliferation##2##3##(2008-11#1)(2013-8#1)
inhibited the responses##2##3##(1990-7#1)(1991-6#1)
inhibited the tumor##2##3##(1994-12#1)(2008-9#1)
inhibited the##105##2##(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#4)(1995-2#3)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#4)(1996-5#1)(1997-1#3)(1997-4#3)(1997-6#2)(1997-8#1)(2006-6#1)(2008-10#15)(2008-11#11)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#5)(2009-8#2)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
inhibited this##2##2##(2008-10#1)(2008-5#1)
inhibited tumor growth##2##3##(1990-11#1)(2010-1#1)
inhibited with the##2##3##(2008-8#1)(2009-10#1)
inhibited with##3##2##(2008-12#1)(2008-8#1)(2009-10#1)
inhibited##558##1##(1990-10#1)(1990-11#8)(1990-12#1)(1990-2#7)(1990-3#1)(1990-5#10)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#10)(1991-6#3)(1991-9#2)(1992-1#1)(1992-3#13)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#3)(1993-12#3)(1993-3#5)(1993-6#6)(1993-8#15)(1994-11#17)(1994-12#1)(1994-2#3)(1994-3#8)(1994-5#10)(1994-6#3)(1994-8#23)(1995-11#14)(1995-12#1)(1995-2#17)(1995-3#4)(1995-6#14)(1995-8#11)(1996-12#7)(1996-2#13)(1996-5#1)(1997-1#10)(1997-2#4)(1997-4#9)(1997-6#3)(1997-7#1)(1997-8#2)(2006-6#4)(2008-10#88)(2008-11#52)(2008-12#6)(2008-5#14)(2008-7#11)(2008-8#24)(2008-9#11)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#15)(2011-3#6)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#5)(2013-8#2)
inhibiting [3H]imipramine binding##2##3##(1990-5#2)
inhibiting activity##3##2##(1997-3#1)(2008-11#2)
inhibiting bud##2##2##(2012-4#2)
inhibiting effect##4##2##(1991-12#1)(2008-10#2)(2008-8#1)
inhibiting effects of##2##3##(2008-10#1)(2008-8#1)
inhibiting the growth of Rhizoctonia solani##2##6##(2008-10#2)
inhibiting the growth of##3##4##(2008-10#3)
inhibiting the growth##4##3##(2008-10#3)(2008-11#1)
inhibiting the##23##2##(1992-3#3)(1995-2#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2010-1#1)(2011-3#1)(2012-3#1)(2013-8#1)
inhibiting tumor##2##2##(2009-3#1)(2013-8#1)
inhibiting##85##1##(1990-2#1)(1990-5#2)(1991-12#2)(1992-3#4)(1992-8#1)(1994-11#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#14)(2008-11#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#3)(2012-4#2)(2013-1#1)(2013-7#1)(2013-8#2)
inhibition (which results in##2##4##(2008-11#2)
inhibition action of##2##3##(2008-10#2)
inhibition activity##3##2##(1994-5#1)(2008-10#1)(2009-6#1)
inhibition against##2##2##(2008-5#1)(2010-11#1)
inhibition and##15##2##(1990-4#1)(1991-11#1)(1993-3#2)(1994-6#1)(1994-8#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-7#1)
inhibition assays##2##2##(2009-12#1)(2011-2#1)
inhibition at##2##2##(2008-11#1)(2008-5#1)
inhibition by##39##2##(1990-11#2)(1990-5#2)(1991-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-11#1)(1995-8#3)(1997-1#1)(2008-10#2)(2008-11#6)(2008-5#1)(2008-7#2)(2008-9#5)(2009-9#1)(2011-2#2)(2013-7#1)(2013-8#1)
inhibition effect of##4##3##(2008-10#3)(2008-11#1)
inhibition effect##8##2##(2008-10#7)(2008-11#1)
inhibition effects in##2##3##(1995-6#1)(2008-11#1)
inhibition effects were##2##3##(2008-10#1)(2008-11#1)
inhibition effects##7##2##(1995-6#1)(2008-10#2)(2008-11#4)
inhibition factor##5##2##(1991-12#4)(2008-10#1)
inhibition grouping##2##2##(2008-10#2)
inhibition has##2##2##(2008-10#1)(2008-5#1)
inhibition in the rat visual cortex##2##6##(2011-2#2)
inhibition in the##7##3##(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
inhibition in##18##2##(1993-11#1)(1993-3#1)(1993-8#2)(1994-8#2)(1995-2#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2011-2#2)(2013-8#1)
inhibition is##5##2##(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
inhibition may##3##2##(1997-2#1)(2008-7#1)(2008-8#1)
inhibition measurements##2##2##(1992-12#1)(2008-10#1)
inhibition method##4##2##(2008-10#4)
inhibition occurred when##3##3##(1994-8#1)(2008-10#2)
inhibition occurred##5##2##(1993-3#1)(1994-8#1)(2008-10#3)
inhibition of AH109A invasion##2##4##(2008-11#2)
inhibition of Ca2+ influx##2##4##(1991-1#2)
inhibition of DNA synthesis##2##4##(1991-2#1)(2009-3#1)
inhibition of DNA##5##3##(1990-2#1)(1991-2#1)(1993-8#1)(1997-3#1)(2009-3#1)
inhibition of DSB repair##2##4##(2011-2#1)(2013-1#1)
inhibition of ENOX2##2##3##(2009-9#2)
inhibition of HIV-1##2##3##(1992-12#1)(1996-5#1)
inhibition of ICSS produced by the##2##6##(1996-2#2)
inhibition of TNF-alpha##2##3##(2008-10#1)(2008-11#1)
inhibition of [3H]D-aspartate transport##3##4##(1995-11#3)
inhibition of aggregation##2##3##(2008-8#2)
inhibition of bacterial growth##2##4##(1997-8#1)(2008-5#1)
inhibition of both##2##3##(1992-12#1)(2008-10#1)
inhibition of cell cycle progression##2##5##(1997-7#1)(2012-3#1)
inhibition of cell growth##4##4##(1995-2#1)(2008-11#3)
inhibition of cell proliferation##3##4##(1992-3#1)(1995-2#1)(2008-11#1)
inhibition of cell##10##3##(1991-9#1)(1992-3#1)(1995-2#2)(1997-7#1)(2008-11#4)(2012-3#1)
inhibition of cellular##3##3##(1991-5#1)(1994-3#1)(2008-1#1)
inhibition of cholate uptake##2##4##(1992-3#2)
inhibition of elastase##2##3##(2008-5#2)
inhibition of estrogen stimulated##2##4##(2008-11#2)
inhibition of ethanol absorption in the##2##6##(2008-11#2)
inhibition of fungal growth##2##4##(2008-10#2)
inhibition of fungal##3##3##(2008-10#3)
inhibition of gastric##2##3##(1997-4#1)(2008-11#1)
inhibition of gene expression##2##4##(1992-12#1)(2008-11#1)
inhibition of glucose##2##3##(2008-10#1)(2008-11#1)
inhibition of growth##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
inhibition of human##5##3##(1993-8#2)(1994-8#1)(1995-2#1)(2010-6#1)
inhibition of intracellular##2##3##(1990-8#1)(1994-3#1)
inhibition of phagocytosis##3##3##(1994-6#3)
inhibition of platelet##2##3##(2008-5#1)(2008-7#1)
inhibition of prostanoid synthesis##2##4##(1994-3#2)
inhibition of protein kinase C##2##5##(1994-8#1)(2008-8#1)
inhibition of protein synthesis##2##4##(1991-2#1)(1994-11#1)
inhibition of protein##7##3##(1991-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-8#2)(2008-8#1)
inhibition of rat##2##3##(1994-11#1)(1994-8#1)
inhibition of sphingosine kinase##2##4##(2009-9#2)
inhibition of the activation of##2##5##(1996-2#1)(2008-10#1)
inhibition of the enzyme##5##4##(1990-5#1)(1990-8#2)(1993-6#1)(2008-10#1)
inhibition of the tail-flick##2##4##(1992-3#2)
inhibition of the##40##3##(1990-5#1)(1990-8#3)(1991-5#1)(1992-3#4)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-6#1)(2008-10#8)(2008-11#2)(2008-9#1)(2009-12#2)(2010-12#1)(2011-1#1)(2011-3#1)(2013-1#1)
inhibition of this pathway##2##4##(2009-12#1)(2011-2#1)
inhibition of this##3##3##(2008-5#1)(2009-12#1)(2011-2#1)
inhibition of tumor##2##3##(1993-1#1)(2008-11#1)
inhibition of tyrosinase##2##3##(2008-10#1)(2008-5#1)
inhibition of ubiquitin-proteasome pathway##5##4##(2008-9#5)
inhibition of viral##3##3##(2008-10#2)(2008-8#1)
inhibition of##323##2##(1990-11#1)(1990-2#1)(1990-5#8)(1990-8#6)(1991-1#3)(1991-2#2)(1991-3#1)(1991-5#6)(1991-9#2)(1992-12#4)(1992-3#7)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#7)(1993-9#1)(1994-11#8)(1994-12#1)(1994-2#1)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#10)(1995-11#11)(1995-12#2)(1995-2#7)(1995-6#3)(1995-8#4)(1996-12#2)(1996-2#5)(1996-5#1)(1996-6#2)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#4)(1997-7#2)(1997-8#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-10#46)(2008-11#34)(2008-12#1)(2008-4#2)(2008-5#11)(2008-7#8)(2008-8#10)(2008-9#10)(2009-12#3)(2009-3#1)(2009-8#1)(2009-9#5)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#1)
inhibition on##10##2##(1994-3#3)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)
inhibition produced by##3##3##(2008-10#2)(2008-8#1)
inhibition produced through extinction##2##4##(2008-5#2)
inhibition produced##5##2##(2008-10#2)(2008-5#2)(2008-8#1)
inhibition rates of##2##3##(1991-3#1)(2008-8#1)
inhibition signal##2##2##(1995-2#1)(2008-11#1)
inhibition studies##2##2##(1991-9#1)(2008-11#1)
inhibition test##3##2##(1991-12#1)(2008-11#2)
inhibition to##2##2##(1992-8#1)(2008-11#1)
inhibition was competitive##2##3##(1992-3#1)(2008-11#1)
inhibition was observed at##2##4##(1994-11#1)(2008-10#1)
inhibition was observed##4##3##(1994-11#1)(1996-12#1)(1996-2#1)(2008-10#1)
inhibition was related##2##3##(2008-10#1)(2008-11#1)
inhibition was relieved##2##3##(1991-12#1)(1991-5#1)
inhibition was##25##2##(1991-12#1)(1991-5#1)(1992-3#2)(1993-3#1)(1994-11#3)(1994-8#3)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2010-1#1)(2012-7#1)(2013-1#1)
inhibition were##2##2##(1994-8#1)(2008-5#1)
inhibition with##3##2##(1992-9#1)(2008-10#1)(2008-5#1)
inhibition zones##4##2##(2008-10#1)(2012-2#3)
inhibition##645##1##(1990-11#6)(1990-2#2)(1990-4#1)(1990-5#10)(1990-7#1)(1990-8#6)(1991-1#3)(1991-11#1)(1991-12#12)(1991-2#2)(1991-3#2)(1991-5#8)(1991-9#4)(1992-12#8)(1992-3#12)(1992-4#1)(1992-6#4)(1992-8#7)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#9)(1993-6#5)(1993-8#11)(1993-9#1)(1994-11#14)(1994-12#1)(1994-2#2)(1994-3#9)(1994-5#4)(1994-6#5)(1994-8#26)(1995-11#15)(1995-12#2)(1995-2#12)(1995-6#5)(1995-8#12)(1996-12#5)(1996-2#7)(1996-5#1)(1996-6#2)(1997-1#7)(1997-2#6)(1997-3#4)(1997-4#4)(1997-7#4)(1997-8#1)(2006-6#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#110)(2008-11#67)(2008-12#2)(2008-4#7)(2008-5#27)(2008-6#2)(2008-7#21)(2008-8#18)(2008-9#19)(2009-11#1)(2009-12#4)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#6)(2010-1#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#22)(2011-3#4)(2012-12#1)(2012-2#11)(2012-3#2)(2012-7#2)(2013-1#14)(2013-7#1)(2013-8#5)
inhibition)##7##1##(1992-12#1)(2008-10#3)(2008-11#3)
inhibitions##2##1##(1996-2#1)(2008-11#1)
inhibitor (TIMP)##2##2##(1990-8#1)(1992-6#1)
inhibitor H-7##2##2##(1994-11#1)(1997-2#1)
inhibitor PD98059##2##2##(2011-2#1)(2013-1#1)
inhibitor and the##2##3##(1991-3#1)(2009-7#1)
inhibitor and##14##2##(1990-3#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-8#2)(2008-1#1)(2008-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#2)
inhibitor as##2##2##(2009-6#1)(2012-2#1)
inhibitor for##3##2##(2008-10#1)(2009-12#1)(2010-11#1)
inhibitor from##2##2##(1994-3#1)(1995-3#1)
inhibitor has##2##2##(2008-5#1)(2008-7#1)
inhibitor in##6##2##(1992-6#1)(1992-9#1)(1994-8#1)(2006-6#1)(2011-2#1)(2012-2#1)
inhibitor is not##2##3##(1991-3#1)(2008-10#1)
inhibitor of DNA methylation##2##4##(2013-8#2)
inhibitor of DNA##3##3##(2008-11#1)(2013-8#2)
inhibitor of NO synthase##2##4##(1997-2#1)(2008-7#1)
inhibitor of both##3##3##(1994-8#1)(2008-11#2)
inhibitor of cytochrome##2##3##(1995-8#1)(2008-10#1)
inhibitor of deoxyhypusine synthase##2##4##(1997-1#2)
inhibitor of human##3##3##(1994-11#1)(1995-2#1)(2008-10#1)
inhibitor of myosin-based activities in plant##2##6##(2008-11#2)
inhibitor of protein kinase A##2##5##(1993-8#1)(1996-12#1)
inhibitor of protein kinase C (PKC)##2##6##(1996-12#1)(1997-7#1)
inhibitor of protein kinase C##6##5##(1993-8#1)(1994-6#2)(1996-12#1)(1997-7#1)(2008-11#1)
inhibitor of protein kinase##8##4##(1993-8#2)(1994-6#2)(1996-12#2)(1997-7#1)(2008-11#1)
inhibitor of protein##13##3##(1992-8#1)(1993-8#2)(1994-11#2)(1994-6#2)(1996-12#2)(1997-7#1)(2008-11#1)(2008-8#2)
inhibitor of the##11##3##(1990-2#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-11#1)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2013-1#1)
inhibitor of von Willebrand##2##4##(1994-11#2)
inhibitor of##125##2##(1990-2#1)(1990-5#2)(1990-8#4)(1991-12#1)(1992-12#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#5)(1994-11#7)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#4)(1995-11#1)(1995-2#4)(1995-6#2)(1995-8#6)(1996-12#2)(1996-2#2)(1997-1#3)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#5)(2008-11#16)(2008-5#7)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-6#1)(2011-2#5)(2011-3#2)(2013-1#4)(2013-8#3)
inhibitor that##3##2##(1995-2#1)(2008-7#1)(2008-8#1)
inhibitor therapy##3##2##(2010-12#1)(2010-2#1)(2013-1#1)
inhibitor to##2##2##(1991-3#1)(2012-2#1)
inhibitor treatment##2##2##(2012-12#1)(2013-1#1)
inhibitor use##2##2##(2013-1#2)
inhibitor was##6##2##(1990-5#1)(1991-3#1)(1996-3#1)(2008-12#1)(2008-8#1)(2012-3#1)
inhibitor with##3##2##(1990-12#1)(2008-11#2)
inhibitor##417##1##(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#7)(1990-8#7)(1991-12#5)(1991-3#6)(1991-5#5)(1992-1#1)(1992-10#2)(1992-12#7)(1992-3#1)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#3)(1993-2#1)(1993-3#6)(1993-6#3)(1993-8#15)(1994-11#19)(1994-2#1)(1994-3#6)(1994-5#6)(1994-6#7)(1994-8#9)(1995-11#4)(1995-2#8)(1995-3#1)(1995-6#6)(1995-8#9)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#4)(1996-6#1)(1997-1#6)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#2)(2006-6#3)(2008-1#1)(2008-10#33)(2008-11#37)(2008-12#4)(2008-4#6)(2008-5#16)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#7)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#12)(2011-3#5)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#24)(2013-8#5)
inhibitor) and##2##2##(2011-2#1)(2012-3#1)
inhibitor) treatment##2##2##(1996-2#1)(2008-11#1)
inhibitor)##15##1##(1993-8#1)(1996-2#1)(2008-11#3)(2008-7#2)(2008-9#2)(2011-2#3)(2011-3#2)(2012-3#1)
inhibitor-1##7##1##(1995-8#2)(1997-1#1)(2009-8#2)(2011-2#2)
inhibitors (AIs) are##2##3##(2011-1#1)(2013-8#1)
inhibitors (SSRIs)##5##2##(2008-11#1)(2008-6#1)(2012-3#2)(2013-1#1)
inhibitors against the##2##3##(2012-2#1)(2012-3#1)
inhibitors against##5##2##(2008-11#1)(2010-1#1)(2012-2#2)(2012-3#1)
inhibitors and the##3##3##(2008-5#1)(2009-8#1)(2013-1#1)
inhibitors and##26##2##(1997-7#1)(1997-8#3)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#4)(2011-3#1)(2013-1#5)
inhibitors are##10##2##(2008-1#2)(2008-11#2)(2008-4#1)(2011-2#1)(2011-3#2)(2013-1#2)
inhibitors at the##2##3##(1991-5#1)(1994-8#1)
inhibitors but##2##2##(1991-2#1)(2008-10#1)
inhibitors can##3##2##(1994-11#1)(1994-3#1)(2011-3#1)
inhibitors did not##2##3##(2008-10#1)(2013-1#1)
inhibitors for the treatment of##2##5##(2008-1#1)(2008-5#1)
inhibitors for the##5##3##(1996-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)
inhibitors for##8##2##(1994-12#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)
inhibitors has been##2##3##(2008-5#1)(2012-3#1)
inhibitors have##5##2##(2006-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
inhibitors in the##5##3##(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
inhibitors in##15##2##(1994-9#1)(1995-11#1)(1996-12#1)(2008-1#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
inhibitors is##3##2##(2008-4#1)(2011-3#1)(2013-1#1)
inhibitors may##3##2##(2010-10#1)(2012-2#2)
inhibitors of HIV-1##2##3##(1991-9#1)(2013-1#1)
inhibitors of cyclooxygenase-2 possess little potential for decreasing in vitro phagocytosis by rat macrophages or canine neutrophils##2##17##(2008-10#2)
inhibitors of human##4##3##(1991-5#1)(1994-8#1)(2008-10#1)(2013-1#1)
inhibitors of protein##3##3##(1993-8#1)(2008-11#1)(2009-9#1)
inhibitors of the##11##3##(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-6#1)
inhibitors of##71##2##(1990-8#1)(1991-5#2)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#3)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(2006-6#1)(2008-10#9)(2008-11#5)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#5)
inhibitors on##6##2##(1994-11#1)(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)
inhibitors or angiotensin II receptor blockers##2##6##(1996-6#1)(2008-11#1)
inhibitors or##3##2##(1993-6#1)(1996-6#1)(2008-11#1)
inhibitors such as##4##3##(1991-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
inhibitors targeting##2##2##(2008-5#1)(2011-3#1)
inhibitors that##2##2##(2006-6#1)(2009-10#1)
inhibitors to##2##2##(1992-6#1)(2011-1#1)
inhibitors was##2##2##(1990-8#1)(2008-11#1)
inhibitors were##3##2##(1992-10#1)(2008-10#1)(2012-2#1)
inhibitors with##2##2##(1991-3#1)(2013-1#1)
inhibitors##360##1##(1990-10#2)(1990-11#4)(1990-2#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-5#11)(1991-8#1)(1991-9#3)(1992-10#3)(1992-12#1)(1992-6#5)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#6)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#7)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-5#1)(1996-6#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#3)(2006-6#6)(2007-7#1)(2008-1#11)(2008-10#36)(2008-11#27)(2008-12#1)(2008-4#4)(2008-5#13)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#10)(2009-10#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#4)(2010-12#3)(2010-5#3)(2010-7#5)(2011-1#8)(2011-2#27)(2011-3#17)(2012-12#1)(2012-2#9)(2012-3#13)(2013-1#26)(2013-8#3)
inhibitors)##3##1##(1993-3#1)(2008-10#1)(2008-4#1)
inhibitors]##3##1##(2011-3#3)
inhibitory action of##4##3##(1990-11#2)(1994-8#1)(2008-10#1)
inhibitory action##7##2##(1990-11#2)(1994-8#2)(2008-10#2)(2013-7#1)
inhibitory activities on##2##3##(2011-3#2)
inhibitory activities##9##2##(1990-10#1)(1992-6#3)(2011-3#5)
inhibitory activity against##7##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-10#1)(2012-2#1)
inhibitory activity of##7##3##(1994-11#2)(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
inhibitory activity were##2##3##(1994-3#2)
inhibitory activity##32##2##(1990-5#4)(1991-12#1)(1992-12#1)(1994-11#2)(1994-3#4)(1996-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-3#2)(2012-2#3)(2012-3#1)
inhibitory and##4##2##(1997-3#1)(2008-11#1)(2013-1#2)
inhibitory avoidance training##2##3##(1997-2#2)
inhibitory avoidance##3##2##(1997-2#3)
inhibitory compounds##5##2##(2008-10#4)(2011-2#1)
inhibitory concentration (MIC)##6##3##(2008-5#2)(2008-7#1)(2009-6#1)(2012-3#1)(2013-8#1)
inhibitory concentration##13##2##(1995-11#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
inhibitory concentrations (MIC)##2##3##(2008-5#1)(2010-2#1)
inhibitory concentrations (MICs) of##2##4##(2008-10#1)(2008-5#1)
inhibitory concentrations (MICs)##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
inhibitory concentrations##8##2##(2008-10#1)(2008-5#3)(2010-2#1)(2011-2#2)(2012-3#1)
inhibitory connections##2##2##(1996-2#1)(2008-11#1)
inhibitory control##2##2##(2013-8#2)
inhibitory effect of RC-160##2##4##(1995-2#2)
inhibitory effect of captopril on##2##5##(2008-10#2)
inhibitory effect of##39##3##(1990-11#1)(1991-6#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-2#2)(1997-4#2)(2008-10#10)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-8#1)
inhibitory effect on the##9##4##(1992-5#1)(1993-6#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2012-2#1)
inhibitory effect on##26##3##(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1996-2#1)(1997-4#2)(2008-10#7)(2008-11#3)(2008-5#2)(2010-4#1)(2012-2#1)
inhibitory effect was##4##3##(1990-11#1)(1995-6#1)(2008-10#1)(2008-9#1)
inhibitory effect##78##2##(1990-11#2)(1991-6#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#4)(1995-11#3)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#2)(1996-5#1)(1997-4#4)(2008-10#18)(2008-11#9)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
inhibitory effects of some dipeptides##2##5##(2008-10#2)
inhibitory effects of the##2##4##(2008-11#1)(2008-5#1)
inhibitory effects of##23##3##(1990-11#1)(1990-6#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-11#2)(1997-3#2)(2008-10#4)(2008-11#3)(2008-5#3)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
inhibitory effects on##11##3##(1991-5#1)(1993-1#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-11#2)(2011-2#1)(2013-1#1)
inhibitory effects##42##2##(1990-11#1)(1990-6#1)(1991-5#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-8#2)(1995-11#4)(1996-2#1)(1997-3#2)(2008-10#8)(2008-11#8)(2008-5#3)(2008-7#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
inhibitory elements##2##2##(2008-11#2)
inhibitory factor (LIF)##4##3##(1991-12#1)(1995-11#1)(1996-2#1)(2008-11#1)
inhibitory factor##14##2##(1991-12#1)(1995-11#1)(1996-2#8)(2008-11#1)(2008-8#1)(2010-4#1)(2010-6#1)
inhibitory interneurons##2##2##(1994-2#1)(2008-7#1)
inhibitory mechanisms##2##2##(1993-8#1)(2009-7#1)
inhibitory neurotransmitters##2##2##(1996-12#1)(1997-2#1)
inhibitory peptide##4##2##(1997-1#1)(2008-11#2)(2009-10#1)
inhibitory receptors##2##2##(2008-9#1)(2010-5#1)
inhibitory regulation of acid invertase##2##5##(2008-9#2)
inhibitory regulation##3##2##(1995-11#1)(2008-9#2)
inhibitory role##2##2##(2009-6#1)(2013-1#1)
inhibitory signals##2##2##(1995-11#1)(2008-8#1)
inhibitory spectrum##2##2##(2008-11#2)
inhibitory substances##3##2##(2008-11#3)
inhibitory synapses##2##2##(2009-8#2)
inhibitory than the##3##3##(1997-1#1)(2008-10#2)
inhibitory than##6##2##(1997-1#1)(2008-10#4)(2008-11#1)
inhibitory to a##2##3##(2008-10#1)(2008-11#1)
inhibitory to##12##2##(1997-1#1)(2008-10#9)(2008-11#2)
inhibitory##333##1##(1990-10#1)(1990-11#5)(1990-12#1)(1990-5#5)(1990-6#1)(1991-12#2)(1991-5#4)(1991-6#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#6)(1994-5#2)(1994-8#9)(1995-11#12)(1995-2#4)(1995-6#4)(1995-8#1)(1996-12#2)(1996-2#14)(1996-5#1)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#7)(2006-6#1)(2008-10#58)(2008-11#44)(2008-12#2)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#5)(2009-10#3)(2009-12#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#9)(2011-3#8)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#4)
inhibitory)##2##1##(1994-8#1)(2008-4#1)
inhibits cell##2##2##(1993-8#1)(1994-8#1)
inhibits it##3##2##(2008-8#3)
inhibits its##2##2##(1994-11#1)(2010-10#1)
inhibits myelination##2##2##(2008-5#1)(2008-7#1)
inhibits platelet aggregation##2##3##(1990-12#1)(2006-6#1)
inhibits proliferation of##3##3##(1993-11#1)(1995-12#1)(2013-7#1)
inhibits protein##2##2##(1991-5#1)(2011-3#1)
inhibits the formation of##2##4##(1992-5#1)(2011-2#1)
inhibits the growth of##4##4##(1997-1#1)(1997-7#1)(2008-10#1)(2008-8#1)
inhibits the proliferation of##3##4##(1996-2#1)(1997-1#1)(2010-1#1)
inhibits the##41##2##(1990-12#1)(1991-1#1)(1991-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#2)(1996-2#2)(1997-1#3)(1997-7#2)(2006-6#1)(2008-10#3)(2008-11#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-1#1)(2011-2#1)(2011-3#1)(2013-1#2)
inhibits their##2##2##(1993-8#1)(2011-2#1)
inhibits this##2##2##(1993-11#1)(2008-10#1)
inhibits translation##2##2##(1997-6#1)(2008-10#1)
inhibits tumor##2##2##(2008-11#1)(2012-2#1)
inhibits##142##1##(1990-12#3)(1990-8#1)(1991-1#2)(1991-5#2)(1991-6#2)(1992-3#5)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#6)(1994-11#2)(1994-5#2)(1994-8#5)(1995-11#5)(1995-12#2)(1995-2#1)(1995-6#3)(1995-8#1)(1996-2#4)(1996-5#1)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(2006-6#2)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-7#2)(2009-8#4)(2010-1#4)(2010-10#1)(2011-2#6)(2011-3#3)(2012-2#3)(2013-1#2)(2013-7#1)
inhomogeneities of##2##2##(2008-3#2)
inhomogeneities##13##1##(2008-2#1)(2008-3#10)(2008-8#1)(2009-7#1)
inhomogeneity##6##1##(1991-5#1)(2008-3#5)
inhomogeneous##14##1##(1990-9#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#3)(2009-8#1)(2011-2#1)(2012-3#1)
initial SCr level of##2##4##(2008-1#2)
initial acquisition and##2##3##(1991-2#1)(2008-5#1)
initial acquisition##3##2##(1991-2#1)(1993-3#1)(2008-5#1)
initial activity##2##2##(2008-10#1)(2012-2#1)
initial aggregation##2##2##(2008-10#2)
initial and final##2##3##(1996-9#1)(2008-8#1)
initial and terminal##3##3##(1993-11#2)(2010-8#1)
initial and##9##2##(1993-11#2)(1996-9#1)(2008-10#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
initial appearance##2##2##(2008-10#1)(2011-2#1)
initial assessment and##2##3##(2008-7#1)(2011-2#1)
initial assessment##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
initial attempt##2##2##(1995-5#1)(2009-8#1)
initial cell##7##2##(2008-10#2)(2008-11#5)
initial clinical##5##2##(1997-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
initial colonization##2##2##(2008-10#2)
initial complexes##2##2##(1995-6#1)(2008-10#1)
initial concentration of the##3##4##(1995-11#1)(2008-10#2)
initial concentration of##8##3##(1995-11#1)(2008-10#5)(2008-7#1)(2011-2#1)
initial concentration##11##2##(1995-11#1)(2008-10#7)(2008-7#2)(2011-2#1)
initial condition##2##2##(2008-10#1)(2013-8#1)
initial conditions and quadrat size##2##5##(2008-10#2)
initial conditions and##4##3##(2008-10#4)
initial conditions##13##2##(2008-10#7)(2008-11#2)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
initial contact##2##2##(1995-11#1)(2008-10#1)
initial decrease in##3##3##(1996-11#1)(2008-11#1)(2008-5#1)
initial decrease##6##2##(1996-11#1)(2008-10#2)(2008-11#2)(2008-5#1)
initial diagnosis of a##3##4##(2008-7#1)(2010-6#1)(2011-2#1)
initial diagnosis of##4##3##(1991-7#1)(2008-7#1)(2010-6#1)(2011-2#1)
initial diagnosis was##2##3##(1996-3#1)(2008-11#1)
initial diagnosis##10##2##(1991-7#2)(1996-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#2)(2013-8#1)
initial disease##3##2##(2008-10#3)
initial dose##3##2##(1994-12#1)(2008-11#1)(2010-6#1)
initial down-regulation##2##2##(1996-12#1)(1997-7#1)
initial drug##3##2##(1992-1#1)(1993-12#1)(1995-3#1)
initial energetic level##2##3##(2008-8#2)
initial enzyme##2##2##(2011-1#1)(2013-1#1)
initial epidemic conditions##3##3##(2008-10#3)
initial evaluation##3##2##(1992-1#1)(2008-11#2)
initial experience##7##2##(1992-2#1)(2010-6#1)(2011-2#3)(2012-12#2)
initial exposure to##3##3##(1991-6#1)(2008-10#2)
initial exposure##4##2##(1991-6#1)(2008-10#2)(2011-2#1)
initial formation of a##2##4##(1993-8#1)(2011-2#1)
initial glucose concentration##2##3##(2008-5#1)(2008-7#1)
initial glucose##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
initial headspace or dissolved O(2)##2##5##(2011-2#2)
initial headspace##4##2##(2011-2#4)
initial hydrolysis##2##2##(2008-10#2)
initial immune##2##2##(2007-12#1)(2011-2#1)
initial implementation##2##2##(1995-2#1)(1996-12#1)
initial increase##2##2##(1990-5#1)(2008-10#1)
initial infection##8##2##(2008-10#8)
initial inocula##4##2##(2008-10#4)
initial inoculum and##2##3##(2008-10#2)
initial inoculum##9##2##(2008-10#9)
initial interviews##2##2##(2008-6#1)(2013-1#1)
initial isolates##3##2##(2008-10#3)
initial lesion##2##2##(2008-10#1)(2010-6#1)
initial level of anxiety that##2##5##(2009-7#2)
initial level##3##2##(2008-8#1)(2009-7#2)
initial levels of##3##3##(1993-8#1)(2008-11#1)(2011-2#1)
initial levels##5##2##(1993-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
initial location##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
initial management##4##2##(1995-11#1)(2008-8#1)(2008-9#1)(2010-9#1)
initial manifestation##2##2##(1991-3#1)(1993-2#1)
initial model##3##2##(2008-4#1)(2008-8#2)
initial mortality rate##2##3##(2008-9#2)
initial mortality##4##2##(1995-3#1)(2008-9#3)
initial operation##6##2##(2008-10#1)(2011-2#4)(2012-3#1)
initial particle##2##2##(1996-1#1)(1996-12#1)
initial performance##3##2##(2008-10#3)
initial period of##2##3##(2008-8#2)
initial period##3##2##(2008-8#2)(2011-2#1)
initial phase##7##2##(1994-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-3#1)(2013-8#1)
initial population##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
initial postspawning##2##2##(2010-8#2)
initial presentation and##2##3##(1991-2#1)(2012-3#1)
initial presentation of##2##3##(2008-11#1)(2012-12#1)
initial presentation##6##2##(1991-2#1)(2008-11#1)(2009-3#2)(2012-12#1)(2012-3#1)
initial rate of the##4##4##(2008-10#4)
initial rate of##7##3##(1994-5#1)(2008-10#6)
initial rate##18##2##(1994-5#1)(2008-10#17)
initial rates of##2##3##(1990-2#1)(1994-5#1)
initial reaction rates##3##3##(2008-7#3)
initial reaction##4##2##(2008-7#3)(2013-1#1)
initial reduction in dimensionality is##2##5##(2010-7#2)
initial reduction in##3##3##(2009-11#1)(2010-7#2)
initial reduction##4##2##(2009-11#1)(2010-7#2)(2011-2#1)
initial response##2##2##(1997-7#1)(2008-10#1)
initial results##4##2##(1996-8#1)(2008-10#2)(2008-11#1)
initial screening##7##2##(1995-12#1)(2008-10#5)(2013-1#1)
initial sensitivity after##2##3##(2008-10#2)
initial set##2##2##(2008-11#1)(2008-12#1)
initial slope##2##2##(2008-10#2)
initial solution##3##2##(2008-10#3)
initial spatial##2##2##(2008-10#1)(2009-8#1)
initial spore##2##2##(2008-10#2)
initial stage of##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
initial stages of##8##3##(2007-12#2)(2008-1#2)(2008-10#2)(2008-8#1)(2009-8#1)
initial stages##10##2##(1991-12#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-8#1)(2009-8#1)(2010-12#1)
initial step##4##2##(1992-12#1)(2008-1#1)(2008-10#1)(2010-4#1)
initial studies suggest##2##3##(1995-11#1)(2008-11#1)
initial studies##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
initial study##3##2##(1994-3#2)(2008-6#1)
initial symptoms##4##2##(1991-6#1)(2008-10#2)(2008-7#1)
initial training##2##2##(2008-11#1)(2008-5#1)
initial treatment##4##2##(1992-3#1)(1993-6#1)(2010-5#1)(2013-1#1)
initial value##3##2##(1990-3#2)(1993-6#1)
initial vectors##2##2##(2008-10#2)
initial##629##1##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-9#2)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#2)(1991-7#2)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#2)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#4)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#5)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#2)(1995-2#3)(1995-3#6)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#7)(2008-10#191)(2008-11#45)(2008-12#7)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#26)(2008-8#23)(2008-9#15)(2009-1#3)(2009-11#1)(2009-12#3)(2009-3#3)(2009-6#4)(2009-7#4)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#39)(2011-3#2)(2012-12#9)(2012-2#9)(2012-3#8)(2013-1#22)(2013-8#13)
initial-rate potentiometric##2##2##(2008-10#2)
initial-rate##3##1##(2008-10#3)
initialized##4##1##(1997-2#1)(2008-10#2)(2012-3#1)
initially a##2##2##(2008-10#1)(2009-1#1)
initially and##2##2##(2010-1#1)(2013-1#1)
initially as##2##2##(1995-8#1)(2011-1#1)
initially by##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
initially classified##3##2##(2008-10#1)(2008-12#2)
initially considered##2##2##(2008-10#1)(2013-1#1)
initially followed by##2##3##(2008-11#1)(2008-5#1)
initially formed##3##2##(1996-5#2)(2008-10#1)
initially fumigated##2##2##(2008-10#2)
initially identified##4##2##(2008-12#1)(2009-10#1)(2011-2#1)(2012-3#1)
initially in excess over##2##4##(1991-5#2)
initially in the##2##3##(2008-10#1)(2008-12#1)
initially in##7##2##(1991-5#2)(1995-12#1)(2007-11#1)(2008-10#2)(2008-12#1)
initially increased##3##2##(2008-10#2)(2008-8#1)
initially infested with##2##3##(1996-12#1)(2008-10#1)
initially not##2##2##(1990-6#1)(1997-3#1)
initially on the##2##3##(2008-10#2)
initially on##3##2##(2008-10#2)(2013-1#1)
initially presented##2##2##(2008-10#1)(2009-7#1)
initially respond to##2##3##(1996-9#1)(2010-7#1)
initially set##2##2##(1996-2#1)(2009-10#1)
initially showed##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2010-6#1)
initially tested##3##2##(1992-8#1)(1994-8#1)(2008-10#1)
initially the##2##2##(2008-12#1)(2012-3#1)
initially treated with##5##3##(1991-3#1)(2008-7#2)(2013-8#2)
initially treated##7##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-7#2)(2013-8#2)
initially were S(T)R(V)##2##3##(2008-10#2)
initially with##4##2##(1992-12#1)(1996-12#1)(2008-10#2)
initially##186##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-12#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#2)(1995-12#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#56)(2008-11#9)(2008-12#11)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#3)(2009-3#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#2)
initials##3##1##(2008-10#2)(2008-8#1)
initiate a##8##2##(1992-12#3)(1992-9#1)(1993-8#1)(2008-10#1)(2009-9#1)(2012-2#1)
initiate its##2##2##(1996-2#1)(2013-7#1)
initiate the##11##2##(1990-7#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)
initiate##58##1##(1990-5#1)(1990-7#1)(1991-6#1)(1992-12#3)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-2#3)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
initiated a study of##3##4##(1993-3#1)(1993-9#1)(1995-11#1)
initiated a##12##2##(1991-2#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(1995-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
initiated an##3##2##(1991-8#1)(1995-2#1)(1997-6#1)
initiated and the##2##3##(2008-8#1)(2013-8#1)
initiated and##4##2##(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
initiated at the##3##3##(1990-5#1)(1991-3#1)(2008-10#1)
initiated at##6##2##(1990-5#1)(1991-3#2)(2008-10#1)(2010-12#1)(2011-2#1)
initiated by a##3##3##(1995-8#1)(2008-10#1)(2012-3#1)
initiated by the##3##3##(2008-10#1)(2008-11#1)(2011-9#1)
initiated by##22##2##(1990-5#1)(1992-4#1)(1992-9#1)(1995-2#1)(1995-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
initiated from##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
initiated in the##3##3##(1994-2#1)(2008-5#1)(2012-3#1)
initiated in##11##2##(1991-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(2008-1#1)(2008-12#1)(2008-5#2)(2010-10#1)(2011-2#1)(2012-3#1)
initiated injury##2##2##(1995-11#2)
initiated on##7##2##(1994-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#3)
initiated studies##2##2##(1993-12#1)(2008-10#1)
initiated the##4##2##(1992-2#1)(1995-12#1)(2008-7#1)(2010-7#1)
initiated to##11##2##(1997-4#1)(2008-10#4)(2008-11#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)
initiated with##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
initiated##141##1##(1990-5#2)(1991-2#2)(1991-3#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-3#3)(1993-9#1)(1994-1#1)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-8#1)(1995-9#1)(1997-4#1)(1997-6#2)(2008-1#2)(2008-10#31)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#12)(2011-9#1)(2012-2#6)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#1)
initiates DNA##2##2##(1997-6#1)(2012-3#1)
initiates a##3##2##(1990-12#1)(1996-5#1)(2010-5#1)
initiates the##3##2##(1994-2#1)(2007-11#1)(2008-10#1)
initiates##11##1##(1990-12#1)(1994-2#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)(2012-3#1)
initiating a##4##2##(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
initiating and##3##2##(1994-8#1)(1995-3#1)(2010-7#1)
initiating epidemics##2##2##(2008-10#2)
initiating events##2##2##(2008-10#1)(2009-10#1)
initiating or##2##2##(2008-7#1)(2011-2#1)
initiating the##4##2##(1994-11#1)(2008-11#1)(2008-8#1)(2011-2#1)
initiating##42##1##(1992-12#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#3)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
initiation among##2##2##(2013-1#2)
initiation and elongation##2##3##(1994-8#1)(2008-8#1)
initiation and growth##2##3##(2008-8#1)(2011-2#1)
initiation and progression##2##3##(2008-10#1)(2011-2#1)
initiation and the##2##3##(2008-11#1)(2008-8#1)
initiation and##25##2##(1991-6#2)(1993-3#2)(1994-8#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#4)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)
initiation and/or advice&quot##2##3##(2011-2#2)
initiation at##2##2##(1995-2#1)(2008-10#1)
initiation codon##3##2##(1994-11#1)(1996-8#1)(1997-6#1)
initiation codons##4##2##(1996-8#4)
initiation factor##4##2##(1993-12#1)(1994-3#1)(1997-1#1)(2010-12#1)
initiation factors##2##2##(1994-3#1)(2010-4#1)
initiation in##6##2##(1995-6#1)(1997-3#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
initiation into drug use##2##4##(2013-8#2)
initiation of HAART##3##3##(2009-7#1)(2010-5#1)(2011-2#1)
initiation of PD+HD therapy##3##4##(2011-2#3)
initiation of a##3##3##(1994-5#1)(2008-6#1)(2012-2#1)
initiation of an##2##3##(1991-1#1)(1997-8#1)
initiation of disease##3##3##(2008-10#3)
initiation of the reaction##3##4##(2008-10#3)
initiation of the##9##3##(1991-11#1)(2008-10#7)(2010-8#1)
initiation of therapy##4##3##(1996-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
initiation of treatment##4##3##(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
initiation of##81##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1996-11#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-7#2)(2009-8#2)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#13)(2012-2#1)(2013-1#4)
initiation site##6##2##(1995-2#1)(1997-2#3)(1997-6#1)(1997-7#1)
initiation sites were##5##3##(1993-3#1)(1996-8#1)(1997-6#3)
initiation sites##20##2##(1993-3#1)(1996-8#5)(1997-2#5)(1997-6#9)
initiation were##2##2##(1991-12#1)(1997-3#1)
initiation##220##1##(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-6#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-11#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#4)(1995-6#5)(1996-11#1)(1996-8#10)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#1)(1997-6#11)(1997-7#4)(1997-8#2)(2008-1#1)(2008-10#30)(2008-11#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#7)(2008-8#14)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#21)(2012-2#2)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#7)
initiative and##2##2##(1991-12#1)(2008-11#1)
initiative are discussed##2##3##(2009-3#1)(2013-1#1)
initiative are##3##2##(1995-3#1)(2009-3#1)(2013-1#1)
initiative at##2##2##(1995-3#1)(2008-11#1)
initiative for##3##2##(1995-1#1)(1997-1#1)(2008-10#1)
initiative in the##2##3##(1997-8#1)(2008-6#1)
initiative in which##2##3##(1995-6#1)(1996-12#1)
initiative in##6##2##(1995-6#1)(1996-11#1)(1996-12#1)(1997-8#1)(2008-6#1)(2013-1#1)
initiative is the##3##3##(1991-12#1)(2013-1#2)
initiative is##9##2##(1991-12#1)(1994-3#1)(2008-1#1)(2013-1#5)(2013-8#1)
initiative of the##4##3##(1995-3#2)(2008-10#1)(2010-11#1)
initiative of##5##2##(1995-3#2)(2008-10#1)(2010-1#1)(2010-11#1)
initiative that##2##2##(1993-3#1)(1996-1#1)
initiative to##8##2##(1994-12#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
initiative##102##1##(1990-12#1)(1991-12#4)(1992-2#1)(1993-3#1)(1994-12#3)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#5)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-1#3)(2008-10#5)(2008-11#9)(2008-12#5)(2008-6#1)(2008-7#1)(2009-3#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#1)(2011-2#2)(2011-8#1)(2011-9#1)(2012-2#2)(2013-1#26)(2013-8#2)
initiative's##2##1##(2013-1#2)
initiatives and##3##2##(1996-1#1)(1996-3#1)(2011-2#1)
initiatives are##2##2##(1993-12#1)(1996-1#1)
initiatives as##2##2##(1994-12#1)(1997-1#1)
initiatives have##4##2##(1994-1#1)(1996-12#1)(1997-2#1)(2011-2#1)
initiatives in##9##2##(1993-2#1)(1995-12#1)(1997-1#3)(1997-2#2)(2008-11#1)(2009-3#1)
initiatives is##2##2##(1992-1#1)(2013-1#1)
initiatives of##2##2##(1995-2#1)(2008-10#1)
initiatives such as##3##3##(1995-12#1)(1997-2#1)(2012-2#1)
initiatives to##4##2##(1992-2#1)(2008-11#1)(2008-7#1)(2009-5#1)
initiatives##77##1##(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#2)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#7)(1997-1#4)(1997-2#5)(1997-3#2)(2008-10#2)(2008-11#7)(2008-12#3)(2008-7#1)(2009-3#1)(2009-5#2)(2010-8#4)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
initiator of##3##2##(1994-11#1)(2008-10#1)(2009-8#1)
initiator or a##2##3##(1995-9#2)
initiator protein##2##2##(1997-6#2)
initiator##18##1##(1990-5#1)(1990-8#1)(1991-8#1)(1994-11#1)(1995-9#2)(1997-6#2)(2008-10#4)(2008-12#3)(2008-5#1)(2008-8#1)(2009-8#1)
inject effector proteins into##2##4##(2011-2#1)(2013-8#1)
inject##4##1##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
injectable##14##1##(1991-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)(2009-7#2)(2012-2#3)(2013-1#3)
injected CCK-8##2##2##(1994-2#2)
injected MTEC1 cells##2##3##(2008-8#2)
injected and##3##2##(2008-10#1)(2008-3#1)(2009-4#1)
injected animals##5##2##(2008-5#5)
injected as a##2##3##(2008-10#1)(2011-2#1)
injected as##3##2##(2008-10#2)(2011-2#1)
injected at##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
injected by##4##2##(1997-3#1)(2008-10#3)
injected directly into a##2##4##(2008-10#2)
injected directly into the##3##4##(2008-10#3)
injected directly into##6##3##(2008-10#6)
injected i##5##2##(1994-11#1)(1997-4#2)(2010-1#2)
injected in the##2##3##(2008-10#2)
injected in##8##2##(2008-10#7)(2011-1#1)
injected into a carrier stream of##3##6##(2008-10#3)
injected into a carrier stream##4##5##(2008-10#4)
injected into a carrier##6##4##(2008-10#6)
injected into a##25##3##(1993-8#1)(1994-2#1)(2008-10#22)(2008-2#1)
injected into an##3##3##(2008-10#3)
injected into rats##2##3##(1991-9#1)(2008-10#1)
injected into the carrier##3##4##(2008-10#3)
injected into the flow line##2##5##(2008-10#2)
injected into the##38##3##(1993-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#2)
injected into##81##2##(1991-9#1)(1993-6#1)(1993-8#1)(1994-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#52)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
injected intraperitoneally##3##2##(2008-11#2)(2010-5#1)
injected intratumorally##2##2##(1993-11#2)
injected intravenously##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
injected on##2##2##(1990-12#1)(2008-10#1)
injected onto the##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
injected onto##6##2##(1992-3#1)(2008-10#4)(2008-11#1)
injected sample##6##2##(2008-10#6)
injected subcutaneously with##2##3##(1995-11#1)(2012-3#1)
injected subcutaneously##3##2##(1995-11#1)(2008-8#1)(2012-3#1)
injected the##2##2##(2008-10#1)(2010-1#1)
injected to the##2##3##(2008-10#2)
injected to##5##2##(2008-10#5)
injected volume##4##2##(2008-10#4)
injected with 0##2##3##(1994-5#1)(2008-12#1)
injected with a##4##3##(1993-3#1)(1995-12#1)(2008-10#1)(2010-1#1)
injected with the##4##3##(1993-3#1)(1993-8#1)(1994-5#1)(2008-4#1)
injected with##34##2##(1990-7#2)(1993-11#1)(1993-3#2)(1993-8#2)(1994-5#4)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#6)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
injected##263##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#3)(1991-9#1)(1992-3#2)(1993-11#6)(1993-3#4)(1993-6#2)(1993-8#5)(1994-11#1)(1994-2#3)(1994-5#4)(1994-8#1)(1995-11#1)(1995-12#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-8#2)(2007-12#1)(2008-10#130)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#10)(2008-9#5)(2009-10#1)(2009-4#1)(2010-1#5)(2010-10#1)(2010-11#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#3)(2012-3#4)(2013-1#7)
injecting the sample into##2##4##(2008-10#2)
injecting the##7##2##(1993-6#1)(1995-2#1)(2008-10#3)(2008-11#1)(2010-8#1)
injecting##34##1##(1993-6#1)(1994-8#3)(1994-9#1)(1995-2#2)(1997-8#1)(2008-10#18)(2008-11#2)(2008-9#2)(2010-8#2)(2011-2#2)
injection (FI) system##15##3##(2008-10#15)
injection (FI) was##3##3##(2008-10#3)
injection (FI)##57##2##(2008-10#57)
injection amperometric##3##2##(2008-10#3)
injection analysis (BIA)##4##3##(2008-10#4)
injection analysis (SIA)##28##3##(2008-10#28)
injection analysis and##8##3##(2008-10#8)
injection analysis for the determination of##3##6##(2008-10#3)
injection analysis for##8##3##(2008-10#7)(2008-11#1)
injection analysis is##3##3##(2008-10#3)
injection analysis method for the determination of##2##7##(2008-10#2)
injection analysis method##3##3##(2008-10#3)
injection analysis of trace##2##4##(2008-10#2)
injection analysis of##25##3##(2008-10#25)
injection analysis system for##3##4##(2008-10#3)
injection analysis system with##2##4##(2008-10#2)
injection analysis system##15##3##(2008-10#15)
injection analysis technique##3##3##(2008-10#3)
injection analysis using##4##3##(2008-10#4)
injection analysis with##18##3##(2008-10#18)
injection analysis##229##2##(2008-10#226)(2008-11#2)(2008-9#1)
injection and sexual##2##3##(2013-8#2)
injection and##28##2##(1990-5#1)(1993-11#1)(1995-3#1)(1997-4#1)(2008-10#17)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
injection approach##7##2##(2008-10#6)(2010-5#1)
injection assay##2##2##(2008-10#2)
injection at a##3##3##(2008-10#2)(2012-2#1)
injection at##7##2##(1994-5#1)(2008-10#2)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
injection catalytic spectrophotometric##3##3##(2008-10#3)
injection catalytic##4##2##(2008-10#4)
injection chemiluminescence##12##2##(2008-10#12)
injection chromatographic##3##2##(2008-10#3)
injection determination of cobalt##2##4##(2008-10#2)
injection determination of##22##3##(2008-10#22)
injection determination##25##2##(2008-10#25)
injection drug use initiation##2##4##(2013-1#2)
injection drug users##3##3##(1996-3#1)(2013-8#2)
injection drug##5##2##(1996-3#1)(2013-1#2)(2013-8#2)
injection electrogenerated##2##2##(2008-10#2)
injection experiments##3##2##(1996-12#1)(2008-10#2)
injection fluorimetric determination##2##3##(2008-10#2)
injection fluorimetric##3##2##(2008-10#3)
injection for##6##2##(1991-3#1)(2008-10#2)(2008-9#1)(2011-2#2)
injection from##2##2##(2008-10#1)(2011-2#1)
injection hydride generation atomic absorption spectrometry##2##6##(2008-10#2)
injection hydride generation atomic absorption##3##5##(2008-10#3)
injection hydride generation atomic fluorescence spectrometry##2##6##(2008-10#2)
injection hydride generation atomic##5##4##(2008-10#5)
injection hydride generation##10##3##(2008-10#10)
injection in a##2##3##(2008-10#1)(2012-3#1)
injection in children##2##3##(2008-10#1)(2011-2#1)
injection in the##4##3##(1991-6#1)(1993-1#1)(1997-3#1)(2008-9#1)
injection in##18##2##(1991-6#2)(1992-6#1)(1993-1#1)(1993-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#2)
injection inductively coupled plasma mass##2##5##(2008-10#2)
injection inductively coupled plasma##4##4##(2008-10#4)
injection initiation##4##2##(2013-1#4)
injection into a##3##3##(2008-10#3)
injection into the##9##3##(1994-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)(2010-8#1)
injection into##16##2##(1991-12#1)(1994-12#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-6#1)(2010-8#1)
injection is##7##2##(2008-10#5)(2011-2#2)
injection lab-on-valve##5##2##(2008-10#5)
injection liquid-liquid extraction##2##3##(2008-10#2)
injection loop##2##2##(2008-10#2)
injection manifold##7##2##(2008-10#7)
injection may##2##2##(2008-10#2)
injection method for the determination of##2##6##(2008-10#2)
injection method for the##7##4##(2008-10#7)
injection method for##9##3##(2008-10#9)
injection method has been developed for the##2##7##(2008-10#2)
injection method has been##3##4##(2008-10#3)
injection method is##6##3##(2008-10#5)(2011-2#1)
injection method##32##2##(1992-2#1)(2008-10#30)(2011-2#1)
injection modalities##3##2##(2008-10#3)
injection mode##6##2##(2008-10#6)
injection of 10##2##3##(1990-2#1)(1994-12#1)
injection of 50 mg##2##4##(2008-10#2)
injection of 500##2##3##(1995-12#1)(2008-10#1)
injection of CCK-8##2##3##(1994-2#2)
injection of PGE2 at##3##4##(1997-2#3)
injection of a##11##3##(1990-6#1)(1992-12#1)(1993-1#1)(2008-10#6)(2008-12#1)(2013-8#1)
injection of beta-AP(1-40) into NBM##2##5##(2008-8#2)
injection of beta-AP(1-40)##3##3##(2008-8#3)
injection of botulinum toxin##2##4##(2008-10#1)(2012-3#1)
injection of corticosteroids##3##3##(1997-5#2)(2011-2#1)
injection of fluorescein##5##3##(2008-12#5)
injection of idazoxan##2##3##(1997-4#2)
injection of lipopolysaccharide##2##3##(1996-12#1)(1997-2#1)
injection of morphine##2##3##(1996-2#1)(1997-2#1)
injection of plasmid DNA##3##4##(1997-8#2)(2008-4#1)
injection of samples##2##3##(2008-10#2)
injection of segments of##2##4##(2008-10#2)
injection of substance P##2##4##(1994-8#2)
injection of the##13##3##(1990-11#1)(1992-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-4#2)(2009-8#1)
injection of##177##2##(1990-11#1)(1990-2#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-12#2)(1992-12#3)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-8#3)(1994-12#1)(1994-2#7)(1994-5#7)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-3#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#10)(1997-3#1)(1997-4#5)(1997-5#2)(1997-8#5)(2008-10#34)(2008-11#4)(2008-12#7)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#11)(2008-9#9)(2009-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#3)(2011-2#9)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
injection on the##2##3##(2010-12#1)(2013-8#1)
injection on##4##2##(1993-11#1)(2008-10#1)(2010-12#1)(2013-8#1)
injection on-line dilution##2##3##(2008-10#2)
injection on-line solid phase##2##4##(2008-10#2)
injection on-line##12##2##(2008-10#12)
injection or##4##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
injection port##5##2##(2008-10#5)
injection potentiometric##4##2##(2008-10#4)
injection potentiometry by a##2##4##(2008-10#2)
injection potentiometry##9##2##(2008-10#9)
injection procedure##6##2##(2008-10#5)(2011-2#1)
injection rate##2##2##(2008-10#2)
injection sample was##2##3##(2008-10#2)
injection samples##4##2##(2008-10#4)
injection site reactions##2##3##(1996-8#1)(2008-8#1)
injection site##11##2##(1990-6#1)(1994-5#1)(1996-12#1)(1996-8#1)(1997-3#2)(2008-12#1)(2008-8#2)(2011-2#2)
injection sites##5##2##(1993-1#1)(2008-11#1)(2008-8#2)(2010-4#1)
injection spectrofluorimetry##2##2##(2008-10#2)
injection spectrophotometric assay of##2##4##(2008-10#2)
injection spectrophotometric determination of ritodrine hydrochloride##2##6##(2008-10#2)
injection spectrophotometric determination of trace amounts of##2##7##(2008-10#2)
injection spectrophotometric determination of trace##3##5##(2008-10#3)
injection spectrophotometric determination of##19##4##(2008-10#19)
injection spectrophotometric method for the determination of##4##7##(2008-10#4)
injection spectrophotometric method for the##6##5##(2008-10#6)
injection spectrophotometric method for##8##4##(2008-10#8)
injection spectrophotometric method##10##3##(2008-10#10)
injection spectrophotometric procedure##2##3##(2008-10#2)
injection spectrophotometric##35##2##(2008-10#35)
injection spectrophotometry##4##2##(2008-10#4)
injection system and##9##3##(2008-10#9)
injection system for the determination of##5##6##(2008-10#5)
injection system for the spectrophotometric determination of##2##7##(2008-10#2)
injection system for the##10##4##(2008-10#10)
injection system for##22##3##(2008-10#22)
injection system is##9##3##(2008-10#9)
injection system was##4##3##(2008-10#4)
injection system with in-line##2##4##(2008-10#2)
injection system with##17##3##(2008-10#17)
injection system##98##2##(2008-10#98)
injection systems##6##2##(2008-10#6)
injection technique for##4##3##(2008-10#4)
injection technique##14##2##(2008-10#13)(2009-4#1)
injection techniques##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
injection therapy with##2##3##(2013-1#2)
injection therapy##4##2##(1994-6#1)(2010-12#1)(2013-1#2)
injection throughput##3##2##(2008-10#3)
injection time##4##2##(2008-10#4)
injection titration##6##2##(2008-10#6)
injection to##4##2##(2008-10#1)(2008-8#1)(2011-2#2)
injection using##3##2##(2008-10#2)(2011-2#1)
injection valve and##2##3##(2008-10#2)
injection valve##8##2##(2008-10#8)
injection volume of##10##3##(2008-10#10)
injection volume##19##2##(2008-10#19)
injection volumes of##2##3##(2008-10#2)
injection volumes##3##2##(2008-10#3)
injection was##10##2##(1994-5#1)(2008-10#4)(2008-8#1)(2011-2#4)
injection were##2##2##(2008-10#1)(2011-2#1)
injection wetting film extraction##2##4##(2008-10#2)
injection wetting film##3##3##(2008-10#3)
injection with##16##2##(2008-10#13)(2008-11#1)(2008-8#1)(2008-9#1)
injection##1313##1##(1990-11#1)(1990-2#1)(1990-5#4)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#6)(1991-3#2)(1991-6#3)(1991-8#1)(1992-12#5)(1992-2#1)(1992-6#3)(1992-8#1)(1993-1#6)(1993-11#7)(1993-3#1)(1993-8#3)(1994-12#2)(1994-2#9)(1994-5#19)(1994-6#2)(1994-8#6)(1994-9#2)(1995-11#1)(1995-12#8)(1995-2#1)(1995-3#2)(1995-5#3)(1996-12#7)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#14)(1997-3#4)(1997-4#6)(1997-5#5)(1997-8#6)(2007-12#1)(2008-1#4)(2008-10#932)(2008-11#16)(2008-12#11)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#22)(2008-9#20)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#1)(2011-2#45)(2011-3#5)(2012-12#1)(2012-2#5)(2012-3#9)(2013-1#20)(2013-7#1)(2013-8#18)
injection)##5##1##(2008-10#4)(2008-3#1)
injection-chemiluminescence##2##1##(2008-10#2)
injection-hydride##6##1##(2008-10#6)
injection-locked##2##1##(2008-3#2)
injection-site##2##1##(2008-11#2)
injections (0##2##2##(1993-6#1)(1994-8#1)
injections and##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
injections at##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
injections given##2##2##(1993-6#1)(1994-8#1)
injections h(-1) can be##2##4##(2008-10#2)
injections h(-1)##4##2##(2008-10#4)
injections in the##4##3##(1996-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
injections in##8##2##(1994-5#1)(1994-8#1)(1996-3#1)(1997-5#1)(2008-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
injections into##3##2##(1990-9#1)(1996-5#1)(2008-11#1)
injections of 1##2##3##(1990-11#1)(2008-10#1)
injections of 10##3##3##(2008-10#3)
injections of Bevacizumab##2##3##(2011-2#2)
injections of a##8##3##(1994-8#1)(2008-10#5)(2013-1#2)
injections of cis-flupenthixol##2##3##(1993-6#2)
injections of the##3##3##(1993-6#1)(1996-5#1)(1997-2#1)
injections of##59##2##(1990-11#1)(1990-12#2)(1991-12#1)(1993-11#1)(1993-6#3)(1994-5#1)(1994-8#3)(1995-2#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1997-2#3)(2008-10#21)(2008-12#1)(2008-4#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
injections per h##4##3##(2008-10#4)
injections per hour##3##3##(2008-10#3)
injections per##8##2##(2008-10#8)
injections was##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
injections were##4##2##(1993-1#1)(2011-2#3)
injections##146##1##(1990-11#1)(1990-12#2)(1990-9#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-6#6)(1994-5#2)(1994-6#1)(1994-8#10)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#2)(1997-2#3)(1997-5#1)(2008-10#56)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#4)(2010-1#1)(2010-4#1)(2011-2#20)(2011-3#1)(2012-12#1)(2012-3#2)(2012-4#1)(2013-1#4)(2013-8#4)
injections)##6##1##(1994-5#1)(2008-10#3)(2013-1#2)
injectisome##3##1##(2013-8#3)
injectisomes##4##1##(2013-8#4)
injector and##7##2##(2008-10#7)
injector##18##1##(2008-10#17)(2011-2#1)
injectors##2##1##(2011-2#2)
injunction against enforcement of##2##4##(1997-6#1)(1997-7#1)
injunction##4##1##(1995-6#2)(1997-6#1)(1997-7#1)
injunctive relief##2##2##(1995-12#2)
injunctive##3##1##(1995-12#2)(2012-12#1)
injure##4##1##(1995-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
injured by##6##2##(1992-1#1)(1995-3#1)(2008-1#1)(2008-8#1)(2011-2#2)
injured cells##3##2##(2008-10#2)(2009-6#1)
injured nerve##2##2##(1997-3#1)(2008-9#1)
injured peripheral nerves##2##3##(2011-2#2)
injured test nerve##2##3##(1997-3#2)
injured##56##1##(1990-6#2)(1990-9#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-6#1)(1992-9#1)(1994-12#2)(1995-1#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#5)(2010-1#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
injuries after blunt##2##3##(1990-9#2)
injuries and##11##2##(1991-6#1)(1993-3#2)(1996-6#1)(2008-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
injuries are##7##2##(1990-9#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#2)
injuries at work##2##3##(2008-11#2)
injuries can##3##2##(1994-3#2)(2008-8#1)
injuries during##2##2##(1990-6#1)(1996-2#1)
injuries from##2##2##(1991-3#1)(1992-2#1)
injuries have been##2##3##(2011-2#1)(2013-1#1)
injuries in children##4##3##(2008-10#1)(2008-11#1)(2013-1#2)
injuries in the##5##3##(1994-8#1)(2009-7#1)(2013-1#3)
injuries in##20##2##(1990-6#1)(1991-12#1)(1994-12#1)(1994-8#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2009-7#1)(2013-1#9)
injuries involving the##2##3##(2010-1#1)(2013-1#1)
injuries is##4##2##(1990-6#1)(1990-9#1)(2008-8#1)(2010-1#1)
injuries of the##2##3##(2008-9#1)(2012-2#1)
injuries of##3##2##(1991-6#1)(2008-9#1)(2012-2#1)
injuries that##2##2##(2009-7#1)(2011-2#1)
injuries to the##5##3##(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#2)
injuries to##8##2##(1990-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#3)
injuries were identified##2##3##(2010-1#1)(2012-12#1)
injuries were##6##2##(1990-2#2)(1990-6#1)(2010-1#1)(2012-12#1)(2013-1#1)
injuries##170##1##(1990-2#4)(1990-3#1)(1990-6#14)(1990-9#8)(1991-12#2)(1991-3#4)(1991-6#4)(1992-2#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#4)(1994-12#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#6)(2008-11#10)(2008-12#2)(2008-5#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#2)(2009-6#2)(2009-7#2)(2010-1#6)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#13)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#31)(2013-8#4)
injuries)##2##1##(2008-4#1)(2010-9#1)
injuries]##7##1##(1990-2#2)(1990-6#1)(1991-6#1)(1992-6#1)(1993-2#1)(1996-8#1)
injurious##4##1##(1993-12#1)(1996-9#1)(2008-7#1)(2012-3#1)
injury after##3##2##(1995-11#1)(2008-7#1)(2012-3#1)
injury among##3##2##(1991-8#1)(2008-8#1)(2012-12#1)
injury and disease##2##3##(1997-3#1)(2008-1#1)
injury and ill-health and the##2##5##(2008-11#2)
injury and ill-health in##3##4##(2008-11#3)
injury and ill-health##5##3##(2008-11#5)
injury and in the##3##4##(1995-2#1)(1997-8#1)(2013-8#1)
injury and in##4##3##(1995-2#1)(1997-8#1)(2013-1#1)(2013-8#1)
injury and small animals##2##4##(2011-2#2)
injury and the##3##3##(2008-7#1)(2010-1#2)
injury and##42##2##(1992-9#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#7)(2008-7#2)(2008-8#1)(2009-7#1)(2010-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-9#1)(2013-1#4)(2013-8#1)
injury are##3##2##(2008-12#1)(2010-11#1)(2011-7#1)
injury as a##5##3##(1994-3#2)(2008-11#1)(2008-7#1)(2011-2#1)
injury as##7##2##(1994-3#2)(1995-11#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
injury associated with##2##3##(2008-7#1)(2013-8#1)
injury at##2##2##(1991-11#1)(2013-1#1)
injury by##4##2##(1995-11#1)(1997-8#1)(2008-11#1)(2013-1#1)
injury can##2##2##(2011-2#1)(2013-1#1)
injury caused by##2##3##(2008-7#1)(2013-8#1)
injury caused##3##2##(2008-7#2)(2013-8#1)
injury due to##3##3##(2010-7#1)(2011-2#1)(2012-3#1)
injury during##3##2##(2008-12#1)(2008-8#1)(2010-5#1)
injury following##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
injury from##3##2##(1995-11#2)(2008-10#1)
injury has##2##2##(1992-6#1)(1994-12#1)
injury in a##2##3##(2012-2#1)(2013-1#1)
injury in rats##2##3##(2008-7#1)(2009-8#1)
injury in the##4##3##(1995-11#1)(1996-12#1)(2011-2#1)(2012-3#1)
injury in##24##2##(1995-11#2)(1996-12#1)(1996-6#1)(2008-11#1)(2008-7#2)(2009-6#3)(2009-8#1)(2010-10#1)(2010-12#3)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)
injury induced by##2##3##(2008-9#1)(2010-12#1)
injury is not##2##3##(1995-11#1)(2008-11#1)
injury is##14##2##(1990-12#1)(1992-9#1)(1995-11#2)(1997-8#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
injury level##2##2##(2008-8#1)(2013-1#1)
injury may be associated with##2##5##(2011-2#2)
injury may be##4##3##(2008-12#1)(2008-7#1)(2011-2#2)
injury may##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)
injury mechanisms##4##2##(1990-6#1)(2010-1#3)
injury occurred##3##2##(1991-12#1)(1993-12#1)(2013-1#1)
injury of##3##2##(2012-2#2)(2013-1#1)
injury on##4##2##(1991-12#1)(2008-9#3)
injury rate##4##2##(1997-2#1)(2008-11#3)
injury rehabilitation##2##2##(1992-3#1)(1994-12#1)
injury severity##2##2##(2010-1#1)(2011-2#1)
injury that##4##2##(1995-12#1)(2013-1#2)(2013-8#1)
injury to the##11##3##(1990-9#1)(1995-12#2)(2008-7#1)(2008-9#2)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#2)
injury to##20##2##(1990-9#1)(1992-6#1)(1995-12#2)(2008-12#1)(2008-7#1)(2008-9#3)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
injury using##2##2##(1990-7#1)(2008-8#1)
injury was not##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
injury was observed##2##3##(1992-12#1)(1995-2#1)
injury was##12##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1992-12#1)(1995-2#1)(1996-11#1)(2008-10#2)(2008-7#2)(2012-2#1)
injury who##2##2##(2008-7#1)(2013-8#1)
injury with a##2##3##(1996-6#1)(2012-2#1)
injury with the##2##3##(1992-6#1)(2009-11#1)
injury with##10##2##(1991-6#1)(1992-6#1)(1995-11#1)(1996-6#1)(2008-9#1)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
injury##439##1##(1990-12#4)(1990-2#2)(1990-5#3)(1990-6#3)(1990-7#2)(1990-9#2)(1991-11#3)(1991-12#7)(1991-6#1)(1991-8#1)(1992-12#3)(1992-3#1)(1992-6#3)(1992-9#6)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#3)(1994-6#2)(1995-1#3)(1995-10#1)(1995-11#14)(1995-12#5)(1995-2#2)(1995-5#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#3)(1997-1#2)(1997-2#7)(1997-3#4)(1997-7#1)(1997-8#3)(2007-12#1)(2007-8#1)(2008-1#6)(2008-10#16)(2008-11#20)(2008-12#11)(2008-4#3)(2008-7#37)(2008-8#12)(2008-9#21)(2009-1#2)(2009-10#2)(2009-11#2)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#16)(2010-10#2)(2010-11#1)(2010-12#7)(2010-5#6)(2010-6#1)(2010-7#6)(2010-8#1)(2010-9#3)(2011-10#1)(2011-2#27)(2011-7#3)(2012-12#6)(2012-2#15)(2012-3#28)(2012-9#1)(2013-1#45)(2013-7#1)(2013-8#13)
injury-related##2##1##(1997-3#1)(2009-9#1)
ink##10##1##(2008-10#8)(2008-5#1)(2013-8#1)
inkpads##2##1##(2008-10#2)
inks##11##1##(2008-10#10)(2008-5#1)
inland cultivated sites##2##3##(2008-10#2)
inland##6##1##(2008-10#2)(2008-3#4)
inlet and##2##2##(1990-3#1)(2008-10#1)
inlet##14##1##(1990-3#1)(2008-10#11)(2008-11#1)(2008-5#1)
inlet)##2##1##(2008-11#2)
inmates##3##1##(1992-2#2)(2012-3#1)
innate and adaptive immune responses##2##5##(2010-10#1)(2013-8#1)
innate and adaptive##4##3##(2008-6#1)(2010-1#1)(2010-10#1)(2013-8#1)
innate and##6##2##(2008-6#1)(2010-1#1)(2010-10#1)(2013-7#1)(2013-8#2)
innate antiviral##2##2##(2013-1#2)
innate immune response to##2##4##(2010-1#1)(2013-7#1)
innate immune response##4##3##(2010-1#2)(2013-7#1)(2013-8#1)
innate immune responses##2##3##(2008-10#1)(2008-4#1)
innate immune##13##2##(2008-10#4)(2008-4#1)(2010-1#3)(2012-3#3)(2013-7#1)(2013-8#1)
innate immunity##7##2##(2008-10#2)(2009-3#1)(2009-8#2)(2012-3#2)
innate mechanisms##2##2##(2008-5#1)(2013-1#1)
innate##42##1##(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#3)(2010-1#5)(2010-10#1)(2010-8#2)(2011-10#1)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#3)
inner and outer##3##3##(1991-10#1)(2011-2#1)(2013-8#1)
inner cell mass##4##3##(2008-5#1)(2008-9#2)(2013-8#1)
inner cell##5##2##(2008-10#1)(2008-5#1)(2008-9#2)(2013-8#1)
inner city##6##2##(1991-1#1)(1996-8#1)(2008-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
inner contacts##3##2##(2008-10#3)
inner core##7##2##(1995-3#4)(2008-10#1)(2008-8#2)
inner cortex and stele tissues##3##5##(2008-10#3)
inner diameter of##3##3##(2007-12#2)(2012-2#1)
inner diameter##8##2##(1994-2#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
inner ear malformations##2##3##(2011-1#2)
inner ear##9##2##(1994-9#2)(2008-9#2)(2009-9#1)(2011-1#3)(2011-2#1)
inner layer##4##2##(2008-10#2)(2008-12#2)
inner membrane##10##2##(1990-2#2)(1991-10#1)(1992-7#2)(1994-5#1)(1997-8#1)(2009-6#1)(2011-2#1)(2013-8#1)
inner nuclear membrane##3##3##(2008-9#1)(2011-2#2)
inner nuclear##4##2##(1991-10#1)(2008-9#1)(2011-2#2)
inner preputial##2##2##(2008-10#2)
inner shell capsid##2##3##(2008-8#2)
inner shell##3##2##(2008-8#3)
inner structure##2##2##(1995-8#1)(2007-12#1)
inner surface##4##2##(2008-10#2)(2008-11#2)
inner wall of##4##3##(2008-10#4)
inner wall##7##2##(1997-2#1)(2008-10#5)(2008-9#1)
inner##136##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-10#4)(1991-5#4)(1992-7#2)(1994-2#1)(1994-5#3)(1994-9#2)(1995-3#4)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(2007-12#3)(2008-10#45)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#4)(2008-8#5)(2008-9#8)(2009-6#2)(2009-9#1)(2010-9#1)(2011-1#3)(2011-2#9)(2012-2#2)(2013-1#1)(2013-8#5)
inner-city minority##2##2##(2011-1#2)
inner-city##3##1##(1991-1#1)(2011-1#2)
innervate##2##1##(1994-2#1)(2013-1#1)
innervated by the##6##3##(1997-3#2)(2007-12#1)(2008-12#1)(2008-9#1)(2011-2#1)
innervated by##11##2##(1994-9#1)(1996-2#1)(1997-3#3)(2007-12#3)(2008-12#1)(2008-9#1)(2011-2#1)
innervated##13##1##(1991-12#1)(1994-9#1)(1996-2#1)(1997-3#3)(1997-4#1)(2007-12#3)(2008-12#1)(2008-9#1)(2011-2#1)
innervating the##3##2##(1992-12#1)(1997-2#1)(2007-12#1)
innervating##5##1##(1992-12#1)(1997-2#1)(2007-12#3)
innervation and##2##2##(1992-6#1)(2012-2#1)
innervation of NXIIts##2##3##(2008-8#2)
innervation of the guinea pig extraocular muscles##2##7##(1997-3#2)
innervation of the##5##3##(1992-6#2)(1996-5#1)(1997-3#2)
innervation of##11##2##(1992-6#3)(1993-5#1)(1995-12#1)(1996-5#1)(1997-3#2)(2008-8#2)(2013-8#1)
innervation pattern of##2##3##(2007-12#1)(2013-1#1)
innervation##29##1##(1992-6#4)(1993-5#1)(1994-12#1)(1995-12#1)(1996-5#2)(1997-3#2)(2007-12#5)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
innervations##2##1##(2008-7#1)(2012-3#1)
innocent##2##1##(1997-1#1)(2009-9#1)
innocuous##8##1##(1991-12#2)(1996-12#2)(2008-10#2)(2008-11#1)(2011-2#1)
innovated##2##1##(2012-3#1)(2013-1#1)
innovation and##3##2##(1994-12#1)(2008-11#1)(2013-8#1)
innovation in##4##2##(1995-1#2)(2008-8#1)(2010-5#1)
innovation of##2##2##(2011-2#1)(2012-3#1)
innovation that##2##2##(2008-11#1)(2008-12#1)
innovation##31##1##(1993-12#1)(1994-12#2)(1994-2#1)(1995-1#5)(1996-2#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-4#2)(2008-8#1)(2010-3#1)(2010-5#4)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
innovations and##2##2##(2013-8#2)
innovations have##2##2##(1992-2#1)(1995-1#1)
innovations in##6##2##(2008-11#1)(2008-8#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-8#1)
innovations that##3##2##(2010-8#1)(2011-2#1)(2013-1#1)
innovations##23##1##(1992-2#1)(1992-3#1)(1995-1#2)(1997-2#1)(2008-11#2)(2008-12#1)(2008-8#2)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
innovative and##5##2##(1997-2#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
innovative approach to##2##3##(2008-10#1)(2011-2#1)
innovative approach##5##2##(1992-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
innovative approaches to##3##3##(1996-3#1)(2008-4#1)(2012-2#1)
innovative method##2##2##(1991-2#1)(2008-4#1)
innovative project##2##2##(2008-12#2)
innovative responses##2##2##(1994-2#1)(2012-2#1)
innovative revenue generation##2##3##(1991-12#2)
innovative way##2##2##(1992-5#1)(2009-8#1)
innovative##75##1##(1991-12#2)(1991-2#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#11)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-3#2)(2009-8#1)(2010-11#4)(2010-12#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
inocula of##2##2##(2008-10#2)
inocula to##2##2##(2008-10#2)
inocula##23##1##(2008-10#21)(2008-5#1)(2008-7#1)
inoculant##4##1##(2008-10#3)(2011-2#1)
inoculants##3##1##(2008-10#3)
inoculate plants##2##2##(2008-10#2)
inoculate##9##1##(2008-10#8)(2008-11#1)
inoculated 10##2##2##(2008-10#2)
inoculated 4##2##2##(2008-10#2)
inoculated after##3##2##(2008-10#3)
inoculated and uninoculated##3##3##(2008-10#3)
inoculated and##12##2##(2008-10#11)(2011-10#1)
inoculated artificially with##2##3##(2008-10#2)
inoculated at 2 million##2##4##(2008-11#2)
inoculated at bloom##2##3##(2008-10#2)
inoculated at the##5##3##(2008-10#5)
inoculated at##21##2##(2008-10#18)(2008-11#3)
inoculated by##5##2##(2008-10#5)
inoculated controls##2##2##(2008-10#2)
inoculated fruit were##2##3##(2008-10#2)
inoculated in the greenhouse##2##4##(2008-10#2)
inoculated in the##3##3##(2008-10#3)
inoculated in##8##2##(2008-10#6)(2008-5#2)
inoculated into the##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
inoculated into##6##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
inoculated isolates##6##2##(2008-10#6)
inoculated leaf##8##2##(2008-10#8)
inoculated leaves and##3##3##(2008-10#2)(2008-5#1)
inoculated leaves were##2##3##(2008-10#2)
inoculated leaves##19##2##(2008-10#16)(2008-5#1)(2008-8#2)
inoculated on the##3##3##(2008-10#3)
inoculated on##7##2##(2008-10#7)
inoculated one##2##2##(2008-10#2)
inoculated onto a##3##3##(2008-10#3)
inoculated onto##9##2##(2008-10#7)(2008-8#1)(2012-2#1)
inoculated or##2##2##(2008-10#2)
inoculated plant##2##2##(2008-10#2)
inoculated plants to##2##3##(2008-10#2)
inoculated plants##14##2##(2008-10#13)(2008-5#1)
inoculated plots##4##2##(2008-10#4)
inoculated seedlings##3##2##(2008-10#3)
inoculated separately##2##2##(2008-10#2)
inoculated to##5##2##(2008-10#5)
inoculated trees##4##2##(2008-10#4)
inoculated with 1##2##3##(2008-10#2)
inoculated with A##2##3##(2008-10#2)
inoculated with B##2##3##(2008-10#2)
inoculated with C##2##3##(2008-10#1)(2013-1#1)
inoculated with E##2##3##(2008-10#2)
inoculated with Fusarium##2##3##(2008-10#2)
inoculated with GINV##2##3##(2008-10#2)
inoculated with M##3##3##(2008-10#3)
inoculated with P##6##3##(2008-10#6)
inoculated with R##3##3##(2008-10#3)
inoculated with Trichoderma hamatum 382##2##5##(2008-10#2)
inoculated with a##13##3##(2008-10#11)(2008-12#1)(2011-2#1)
inoculated with an##3##3##(2008-10#3)
inoculated with conidia of##3##4##(2008-10#3)
inoculated with conidial suspensions##3##4##(2008-10#3)
inoculated with either##4##3##(2008-10#4)
inoculated with in vitro transcripts##2##5##(2008-10#2)
inoculated with isolates of morphotype A##2##6##(2008-10#2)
inoculated with isolates of##3##4##(2008-10#3)
inoculated with isolates##4##3##(2008-10#4)
inoculated with one of##2##4##(2008-10#2)
inoculated with one##3##3##(2008-10#3)
inoculated with race##2##3##(2008-10#2)
inoculated with the nematode##2##4##(2008-10#2)
inoculated with the pathogen##2##4##(2008-10#2)
inoculated with the##21##3##(1995-12#1)(2008-10#16)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)
inoculated with two##3##3##(2008-10#3)
inoculated with wild-type isolates##2##4##(2008-10#2)
inoculated with##153##2##(1995-12#1)(2008-10#135)(2008-11#1)(2008-12#5)(2008-5#5)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
inoculated within##2##2##(2008-10#2)
inoculated##409##1##(1990-8#1)(1991-12#1)(1993-8#1)(1995-12#1)(2008-10#357)(2008-11#6)(2008-12#7)(2008-5#17)(2008-7#2)(2008-8#4)(2008-9#1)(2009-6#2)(2010-4#2)(2011-10#2)(2011-2#2)(2012-2#2)(2013-1#1)
inoculating detached##2##2##(2008-10#2)
inoculating the##2##2##(2008-10#2)
inoculating##14##1##(2008-10#12)(2008-8#1)(2008-9#1)
inoculation access period##3##3##(2008-10#3)
inoculation access##4##2##(2008-10#4)
inoculation and##14##2##(2008-10#14)
inoculation at##2##2##(2008-10#2)
inoculation by##5##2##(1997-3#1)(2008-10#4)
inoculation developed##2##2##(2008-10#2)
inoculation did not##2##3##(2008-10#2)
inoculation experiments in##3##3##(2008-10#3)
inoculation experiments##4##2##(2008-10#4)
inoculation in##11##2##(2008-10#10)(2012-3#1)
inoculation method##3##2##(2008-10#3)
inoculation methods##10##2##(2008-10#10)
inoculation of leaves##4##3##(2008-10#4)
inoculation of plants##2##3##(2008-10#2)
inoculation of the##8##3##(2008-10#7)(2008-5#1)
inoculation of##47##2##(1997-3#1)(2008-10#39)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#2)
inoculation on the##2##3##(2008-10#2)
inoculation on##9##2##(2008-10#9)
inoculation onto##2##2##(2008-10#2)
inoculation or##3##2##(2008-10#3)
inoculation period##4##2##(2008-10#4)
inoculation resulted in##2##3##(2008-10#1)(2008-11#1)
inoculation sites##2##2##(2008-10#2)
inoculation studies##3##2##(2008-10#3)
inoculation technique##4##2##(2008-10#4)
inoculation tests##4##2##(2008-10#4)
inoculation time##4##2##(2008-5#4)
inoculation times##2##2##(2008-10#1)(2008-5#1)
inoculation to##9##2##(2008-10#8)(2008-11#1)
inoculation was##9##2##(2008-10#9)
inoculation were##5##2##(2008-10#4)(2008-5#1)
inoculation with B##3##3##(2008-10#3)
inoculation with C##2##3##(2008-10#2)
inoculation with a##2##3##(2008-10#2)
inoculation with nonpathogenic spores##2##4##(2008-10#2)
inoculation with the pathogen##7##4##(2008-10#7)
inoculation with the##11##3##(1991-3#1)(2008-10#10)
inoculation with##46##2##(1991-3#1)(2008-10#44)(2011-2#1)
inoculation zones and##2##3##(2008-10#2)
inoculation##424##1##(1991-3#1)(1993-8#2)(1994-5#1)(1995-2#1)(1997-2#1)(1997-3#2)(2008-10#383)(2008-11#7)(2008-12#2)(2008-5#9)(2008-8#5)(2008-9#5)(2011-2#1)(2012-12#3)(2012-3#1)
inoculation) will detect##2##3##(2008-10#2)
inoculation)##10##1##(2008-10#10)
inoculations demonstrated that##3##3##(2008-10#3)
inoculations of##7##2##(2008-10#7)
inoculations per##2##2##(2008-10#2)
inoculations were##2##2##(2008-10#2)
inoculations with##6##2##(2008-10#5)(2008-5#1)
inoculations##35##1##(2008-10#34)(2008-5#1)
inoculative##2##1##(2008-10#2)
inoculum and weather variables##2##4##(2008-10#2)
inoculum and weather##3##3##(2008-10#3)
inoculum and##14##2##(2008-10#14)
inoculum at##2##2##(2008-10#1)(2008-11#1)
inoculum availability##3##2##(2008-10#3)
inoculum concentration##7##2##(2008-10#7)
inoculum concentrations were##2##3##(2008-10#2)
inoculum concentrations##5##2##(2008-10#5)
inoculum consisted of##2##3##(2008-10#2)
inoculum densities of the pathogen##2##5##(2008-10#2)
inoculum densities##9##2##(2008-10#9)
inoculum density and##2##3##(2008-10#2)
inoculum density treatments##2##3##(2008-10#2)
inoculum density was low##2##4##(2008-10#2)
inoculum density was##3##3##(2008-10#3)
inoculum density##31##2##(2008-10#31)
inoculum dispersal##3##2##(2008-10#3)
inoculum during the period##2##4##(2008-10#2)
inoculum during the##3##3##(2008-10#3)
inoculum for infection##2##3##(2008-10#2)
inoculum for the##3##3##(2008-10#3)
inoculum for##14##2##(2008-10#14)
inoculum from##8##2##(2008-10#7)(2008-5#1)
inoculum in the##4##3##(2008-10#4)
inoculum in##13##2##(2008-10#13)
inoculum is##7##2##(2008-10#5)(2008-7#2)
inoculum level##3##2##(2008-10#3)
inoculum levels of##2##3##(2008-10#2)
inoculum levels##9##2##(2008-10#9)
inoculum moved##2##2##(2008-10#2)
inoculum movement to roots##3##4##(2008-10#3)
inoculum of P##3##3##(2008-10#3)
inoculum of##11##2##(2008-10#11)
inoculum on##4##2##(2008-10#4)
inoculum only##2##2##(2008-10#2)
inoculum or##4##2##(2008-10#4)
inoculum potential##3##2##(2008-10#3)
inoculum pressure##4##2##(2008-10#4)
inoculum produced##2##2##(2008-10#2)
inoculum size##2##2##(2008-11#1)(2008-5#1)
inoculum source and##2##3##(2008-10#2)
inoculum source for##3##3##(2008-10#3)
inoculum source##12##2##(2008-10#12)
inoculum sources of##2##3##(2008-10#2)
inoculum sources##12##2##(2008-10#12)
inoculum to##5##2##(2008-10#5)
inoculum virulent to##2##3##(2008-10#2)
inoculum was used##2##3##(2008-10#1)(2013-8#1)
inoculum was##12##2##(2008-10#11)(2013-8#1)
inoculum##306##1##(1991-11#1)(2008-10#288)(2008-11#8)(2008-5#4)(2008-7#3)(2013-8#2)
inoculum)##2##1##(2008-10#2)
inoperable##11##1##(1991-2#1)(1993-2#1)(1993-6#3)(1996-3#1)(1997-5#1)(2008-12#1)(2008-7#1)(2009-10#1)(2013-1#1)
inordinately##2##1##(2008-12#1)(2012-3#1)
inorganic As##3##2##(2008-10#3)
inorganic Se##4##2##(2008-10#4)
inorganic and methyl mercury##3##4##(2008-10#3)
inorganic and organic anions##2##4##(2008-10#2)
inorganic and organic ligands##2##4##(2008-10#2)
inorganic and organic mercury##3##4##(2008-10#3)
inorganic and organic##16##3##(2008-10#13)(2008-12#1)(2008-6#1)(2011-2#1)
inorganic and##25##2##(2008-10#21)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#1)
inorganic anions in##4##3##(2008-10#4)
inorganic anions##16##2##(2008-10#16)
inorganic antimony##2##2##(2008-10#2)
inorganic arsenic in water##3##4##(2008-10#3)
inorganic arsenic in##6##3##(2008-10#6)
inorganic arsenic is##2##3##(2008-10#2)
inorganic arsenic species##5##3##(2008-10#5)
inorganic arsenic##30##2##(1995-11#1)(2008-10#29)
inorganic beryllium species##2##3##(2008-10#2)
inorganic beryllium##3##2##(2008-10#3)
inorganic carbon##3##2##(2008-10#3)
inorganic cations##7##2##(2008-10#7)
inorganic contaminants in##3##3##(2008-10#1)(2008-11#2)
inorganic filler weight##2##3##(2011-2#2)
inorganic forms of phosphorus##2##4##(2008-10#2)
inorganic ions and##2##3##(2008-10#2)
inorganic ions in##2##3##(2008-10#1)(2008-11#1)
inorganic ions##10##2##(2008-10#9)(2008-11#1)
inorganic iron##4##2##(2008-10#4)
inorganic lead##2##2##(1995-11#1)(2008-10#1)
inorganic mercury##15##2##(2008-10#15)
inorganic metal##2##2##(2008-10#2)
inorganic or##2##2##(2008-10#2)
inorganic oxyanions of As and Se##2##6##(2008-10#2)
inorganic oxyanions of As##3##4##(2008-10#3)
inorganic phosphate##4##2##(1991-5#1)(2008-10#2)(2010-8#1)
inorganic phosphates##7##2##(1990-5#1)(2008-10#6)
inorganic phosphorus in##2##3##(2008-10#2)
inorganic phosphorus##4##2##(1994-2#2)(2008-10#2)
inorganic pigments##2##2##(2008-10#2)
inorganic redox partners##2##3##(1990-5#2)
inorganic redox##3##2##(1990-5#2)(2008-10#1)
inorganic salt##4##2##(2008-10#4)
inorganic salts##10##2##(1990-5#1)(1991-9#1)(1994-5#1)(2008-10#4)(2008-11#3)
inorganic selenium species##4##3##(2008-10#4)
inorganic selenium##10##2##(2008-10#9)(2010-11#1)
inorganic species##8##2##(2008-10#8)
inorganic sulfur##2##2##(2008-10#2)
inorganic support##2##2##(2008-10#2)
inorganic##260##1##(1990-5#4)(1991-5#1)(1991-9#1)(1994-2#2)(1994-5#1)(1995-11#3)(1995-3#1)(2008-10#218)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2013-1#1)
inorganic/organic##2##1##(2008-10#2)
inorganics##2##1##(2008-10#2)
inosinate##2##1##(1990-10#1)(1994-8#1)
inosine 5'-monophosphate dehydrogenase##3##3##(1994-11#3)
inosine for guanosine##2##3##(1992-3#2)
inosine##19##1##(1991-7#1)(1992-3#2)(1994-11#3)(1994-8#1)(1997-2#1)(2008-10#8)(2011-2#1)(2013-1#2)
inositol 1##13##2##(1990-8#1)(1991-6#1)(1993-8#4)(1995-11#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-8#2)(2009-7#1)
inositol derivatives##5##2##(2008-11#5)
inositol hexaphosphate##2##2##(1990-8#2)
inositol lipid cycle##2##3##(1993-8#2)
inositol phosphate production##2##3##(1997-1#2)
inositol phosphate##5##2##(1995-11#1)(1997-1#3)(1997-7#1)
inositol phosphates##6##2##(1991-5#1)(1993-6#5)
inositol tetrakisphosphate##3##2##(1993-6#1)(1997-1#2)
inositol triphosphate##2##2##(1995-11#1)(2008-11#1)
inositol trisphosphate production in##3##4##(1991-12#1)(1993-3#2)
inositol trisphosphate production##4##3##(1990-8#1)(1991-12#1)(1993-3#2)
inositol trisphosphate was##2##3##(1990-8#2)
inositol trisphosphate##14##2##(1990-8#5)(1991-12#2)(1993-3#3)(1993-6#3)(1995-2#1)
inositol##67##1##(1990-8#8)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1993-3#3)(1993-6#9)(1993-8#8)(1994-11#1)(1995-11#3)(1995-2#3)(1996-12#1)(1997-1#10)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#6)(2008-8#5)(2009-7#1)(2012-2#1)
inositol(1##4##1##(1994-11#4)
inositol-1##2##1##(1993-1#1)(2011-1#1)
inotropic support##4##2##(2010-5#1)(2012-3#1)(2013-1#2)
inotropic##5##1##(1996-3#1)(2010-5#1)(2012-3#1)(2013-1#2)
inpatient and outpatient##8##3##(1992-12#2)(1993-12#1)(1995-2#1)(1996-3#3)(2013-1#1)
inpatient and##10##2##(1992-12#2)(1993-12#1)(1995-2#1)(1996-3#4)(1997-1#1)(2013-1#1)
inpatient beds##3##2##(1992-12#1)(1997-2#1)(2009-6#1)
inpatient care in##2##3##(1991-1#1)(1992-2#1)
inpatient care##14##2##(1991-1#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#3)(1993-1#1)(1993-12#2)(1993-3#1)(1995-2#2)
inpatient case##3##2##(1994-12#1)(1995-2#1)(2008-12#1)
inpatient cost##2##2##(1992-12#2)
inpatient hospital services##2##3##(1992-1#1)(1994-3#1)
inpatient hospital##6##2##(1991-3#1)(1992-1#1)(1992-2#1)(1994-3#1)(1995-2#1)(1997-2#1)
inpatient hospitalization##2##2##(1992-1#1)(1997-3#1)
inpatient or##2##2##(1991-2#1)(1994-2#1)
inpatient physician##2##2##(1993-12#2)
inpatient population##2##2##(1991-2#1)(1995-2#1)
inpatient psychiatric treatment##4##3##(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)
inpatient psychiatric##7##2##(1991-2#3)(1992-2#1)(1992-3#2)(1993-1#1)
inpatient ratesetting##2##2##(1993-12#2)
inpatient services##6##2##(1991-2#1)(1991-3#1)(1992-2#1)(1994-12#1)(1996-3#1)(2008-11#1)
inpatient treatment of##3##3##(1991-2#1)(1992-3#2)
inpatient treatment with##2##3##(1992-3#1)(1993-2#1)
inpatient treatment##10##2##(1991-2#1)(1992-1#1)(1992-3#5)(1993-2#2)(2008-4#1)
inpatient unit##3##2##(1992-3#1)(1993-2#1)(2010-2#1)
inpatient##107##1##(1991-1#6)(1991-12#1)(1991-2#8)(1991-3#5)(1992-1#6)(1992-12#5)(1992-2#7)(1992-3#8)(1993-1#5)(1993-12#7)(1993-2#6)(1993-3#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#7)(1996-2#1)(1996-3#5)(1997-1#1)(1997-2#3)(1997-3#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-1#2)
inpatients and outpatients##3##3##(2011-2#3)
inpatients and##5##2##(2008-11#1)(2011-2#4)
inpatients were##2##2##(2011-2#1)(2013-1#1)
inpatients with##3##2##(2008-11#2)(2013-8#1)
inpatients##23##1##(1990-2#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(2008-11#4)(2008-7#1)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#3)(2013-8#1)
inplace##2##1##(1991-12#1)(2008-11#1)
input and the##4##3##(1992-9#1)(2008-3#3)
input and##8##2##(1990-5#1)(1992-9#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-10#1)
input by##2##2##(2008-10#1)(2008-11#1)
input data##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
input for the##2##3##(2008-10#1)(2012-12#1)
input for##5##2##(1994-8#1)(2008-10#2)(2008-3#1)(2012-12#1)
input from##7##2##(1997-3#1)(2008-11#2)(2008-3#1)(2011-8#1)(2012-2#2)
input in##5##2##(1991-2#4)(2008-11#1)
input into##3##2##(1994-8#1)(1996-8#1)(2008-4#1)
input is##5##2##(1991-2#2)(1997-3#1)(2008-8#1)(2009-12#1)
input of##5##2##(1993-2#1)(2008-10#1)(2009-11#1)(2011-2#1)(2011-3#1)
input or##2##2##(1997-3#1)(2008-3#1)
input parameters##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#1)
input pathways##2##2##(2008-11#2)
input price##6##2##(1992-1#2)(1992-12#1)(1992-2#1)(1993-1#2)
input prices##3##2##(1992-1#1)(1992-2#2)
input signal##2##2##(2008-11#2)
input than##2##2##(1996-2#1)(2008-11#1)
input to the##4##3##(1991-2#2)(2008-11#1)(2013-8#1)
input to##8##2##(1991-2#2)(1994-12#1)(1995-1#1)(2008-11#1)(2008-9#1)(2010-3#1)(2013-8#1)
input variables to##2##3##(2008-10#1)(2013-8#1)
input variables were##3##3##(2008-10#3)
input variables##11##2##(1992-2#1)(2008-10#9)(2013-8#1)
input##167##1##(1990-5#3)(1990-7#1)(1991-2#8)(1991-3#1)(1991-6#1)(1992-1#3)(1992-12#2)(1992-2#4)(1992-6#1)(1992-9#2)(1993-1#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#6)(2007-11#2)(2007-12#2)(2008-10#25)(2008-11#21)(2008-12#1)(2008-2#7)(2008-3#25)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)(2011-3#1)(2011-8#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
input-output##4##1##(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
inputs and outputs##2##3##(1992-2#2)
inputs and##9##2##(1992-2#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2013-8#1)
inputs are##4##2##(1992-1#1)(1992-2#1)(2008-10#1)(2008-9#1)
inputs between##2##2##(2008-8#2)
inputs from##7##2##(1994-2#2)(2008-9#1)(2009-12#1)(2010-9#1)(2012-2#1)(2013-8#1)
inputs on the##3##3##(1992-2#1)(1997-7#1)(2008-9#1)
inputs on##4##2##(1992-2#1)(1997-7#1)(2008-9#2)
inputs to the##3##3##(1993-6#1)(1996-5#1)(2013-8#1)
inputs to##9##2##(1993-6#1)(1996-2#1)(1996-5#1)(2008-7#1)(2009-10#2)(2010-10#1)(2012-2#1)(2013-8#1)
inputs##69##1##(1992-1#1)(1992-2#6)(1993-6#1)(1994-2#2)(1995-2#1)(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#6)(2008-11#8)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#11)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#6)(2013-1#2)(2013-8#5)
inquired about##2##2##(2011-2#1)(2012-12#1)
inquired##3##1##(2011-2#1)(2012-12#1)(2012-2#1)
inquiries##2##1##(2008-7#1)(2013-1#1)
inquiry and##3##2##(1993-2#2)(2008-12#1)
inquiry into the##2##3##(2009-5#1)(2011-2#1)
inquiry##21##1##(1990-6#1)(1991-8#4)(1992-12#1)(1993-2#3)(1993-3#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#1)(2013-8#1)
inquisitiveness##2##1##(1993-12#1)(2008-11#1)
insane##2##1##(1994-1#1)(2011-2#1)
inscriptions##2##1##(2009-9#1)(2010-5#1)
insect abundances##6##2##(2008-8#6)
insect and##3##2##(2008-10#1)(2008-8#1)(2009-6#1)
insect cell culture##3##3##(2008-11#3)
insect cell cultures at the##2##5##(2008-7#2)
insect cell cultures##5##3##(2008-11#2)(2008-7#3)
insect cell growth##2##3##(2008-11#2)
insect cell line##8##3##(2008-11#5)(2008-7#3)
insect cell lines##9##3##(1997-8#1)(2008-11#4)(2008-7#1)(2008-9#1)(2013-8#2)
insect cell##33##2##(1993-6#1)(1997-8#1)(2008-11#21)(2008-7#7)(2008-9#1)(2013-8#2)
insect cells and##2##3##(2008-11#2)
insect cells infected with a recombinant baculovirus##2##7##(1993-8#1)(2008-7#1)
insect cells infected with a##3##5##(1993-8#1)(2008-11#1)(2008-7#1)
insect cells infected with##4##4##(1993-6#1)(1993-8#1)(2008-11#1)(2008-7#1)
insect cells with a##2##4##(1993-6#1)(2008-11#1)
insect cells with##4##3##(1993-6#1)(2008-11#2)(2008-7#1)
insect cells##32##2##(1992-10#1)(1992-3#1)(1993-6#6)(1993-8#4)(2008-10#1)(2008-11#13)(2008-7#5)(2011-2#1)
insect communities##3##2##(2008-8#2)(2008-9#1)
insect feeding medium##3##3##(2008-10#3)
insect feeding##7##2##(2008-10#3)(2009-8#4)
insect glycoproteins##2##2##(2008-10#2)
insect herbivory##3##2##(2008-8#2)(2009-8#1)
insect larvae##4##2##(2008-7#3)(2011-2#1)
insect orders##4##2##(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
insect pest of##2##3##(2008-10#1)(2013-8#1)
insect pest##5##2##(2008-10#3)(2009-8#1)(2013-8#1)
insect pests##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
insect populations##3##2##(2008-9#3)
insect proteins##2##2##(2008-10#2)
insect species richness##2##3##(2008-8#1)(2008-9#1)
insect species##8##2##(2007-12#2)(2008-10#2)(2008-8#2)(2008-9#1)(2009-8#1)
insect transmission##2##2##(2008-10#2)
insect vector##4##2##(2008-10#4)
insect vectors have##2##3##(2008-10#2)
insect vectors##7##2##(2008-10#7)
insect##200##1##(1992-10#1)(1992-3#1)(1992-6#1)(1993-6#7)(1993-8#4)(1995-11#1)(1995-6#3)(1997-8#1)(2007-12#9)(2008-10#47)(2008-11#41)(2008-5#2)(2008-6#1)(2008-7#19)(2008-8#23)(2008-9#14)(2009-6#1)(2009-8#8)(2010-1#2)(2010-4#2)(2011-10#1)(2011-2#3)(2012-2#4)(2013-8#4)
insect's head##2##2##(2008-10#2)
insect's##4##1##(2008-10#4)
insect-borne##2##1##(2008-10#1)(2010-8#1)
insecticidal activity##2##2##(2008-11#2)
insecticidal crystal##2##2##(1993-12#1)(1995-6#1)
insecticidal##7##1##(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-8#1)
insecticide##13##1##(1993-8#1)(1996-12#1)(1997-7#2)(2008-10#4)(2008-11#2)(2008-9#2)(2012-12#1)
insecticides and their analogs##2##4##(2008-10#2)
insecticides and##3##2##(2008-10#2)(2012-12#1)
insecticides in##2##2##(2008-10#1)(2010-5#1)
insecticides##25##1##(1997-7#1)(2008-10#15)(2008-11#3)(2010-1#1)(2010-5#1)(2012-12#4)
insects and##8##2##(1995-11#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-8#2)
insects have been##2##3##(2010-1#2)
insects in##2##2##(2007-12#1)(2008-10#1)
insects is##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
insects of the##2##3##(2007-12#1)(2010-1#1)
insects of##5##2##(2007-12#1)(2008-10#2)(2010-1#2)
insects or##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
insects that##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
insects was##2##2##(2008-10#2)
insects were##3##2##(2008-10#3)
insects with##3##2##(2007-12#1)(2008-8#1)(2010-4#1)
insects##103##1##(1992-6#2)(1995-11#1)(1996-11#1)(2007-12#9)(2008-10#36)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#3)(2008-8#13)(2008-9#13)(2009-10#1)(2009-8#8)(2010-1#6)(2010-4#2)(2012-2#2)(2012-3#1)
insects' bodies##2##2##(2008-10#2)
insecurity and##2##2##(2009-10#1)(2011-2#1)
insecurity##6##1##(1994-12#1)(2009-10#4)(2011-2#1)
inseminated##3##1##(2008-8#1)(2013-1#2)
insemination##7##1##(1996-9#2)(2007-12#1)(2008-6#1)(2012-3#2)(2013-1#1)
insensitive genotypes##2##2##(2008-10#2)
insensitive isolates##3##2##(2008-10#3)
insensitive mutants##2##2##(2008-10#2)
insensitive to the toxin##3##4##(2008-10#3)
insensitive to the##16##3##(1995-11#1)(2006-6#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-9#2)(2009-8#1)(2010-10#1)
insensitive to##44##2##(1991-5#1)(1993-8#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-8#2)(1997-9#1)(2006-6#1)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)
insensitive##69##1##(1990-12#2)(1990-2#1)(1991-12#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-11#3)(1995-2#1)(1995-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-9#1)(2006-6#1)(2008-10#32)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)(2012-5#1)
insensitivity in the##4##3##(2008-10#4)
insensitivity in##6##2##(2008-10#6)
insensitivity may##2##2##(2008-10#2)
insensitivity to Ptr ToxA##2##4##(2008-10#2)
insensitivity to the##2##3##(2008-10#1)(2009-8#1)
insensitivity to##13##2##(1992-8#1)(2007-12#1)(2008-10#8)(2009-8#2)(2010-7#1)
insensitivity was##2##2##(2008-10#2)
insensitivity##39##1##(1991-5#1)(1992-8#1)(2007-12#1)(2008-10#30)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-7#1)
insert DNA##4##2##(1997-2#1)(2008-4#2)(2008-8#1)
insert and##2##2##(1996-12#1)(2008-8#1)
insert in the##2##3##(1996-12#1)(2013-8#1)
insert in##6##2##(1993-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
insert sizes##2##2##(1997-2#2)
insert##36##1##(1990-7#1)(1990-8#1)(1992-3#1)(1992-6#2)(1993-9#1)(1995-2#1)(1996-12#3)(1996-2#1)(1997-2#4)(1997-6#1)(2008-10#4)(2008-11#4)(2008-4#3)(2008-8#5)(2010-7#1)(2013-1#2)(2013-8#1)
inserted DNA fragment##2##3##(2008-11#1)(2008-8#1)
inserted DNA##3##2##(2008-11#2)(2008-8#1)
inserted as##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)
inserted at the##2##3##(1993-2#1)(1996-12#1)
inserted by##2##2##(1996-3#1)(2008-11#1)
inserted downstream of the##2##4##(1994-6#1)(2008-8#1)
inserted downstream##3##2##(1990-8#1)(1994-6#1)(2008-8#1)
inserted flapless with##2##3##(2013-1#2)
inserted in a##2##3##(2011-2#1)(2013-8#1)
inserted in the##5##3##(1997-8#1)(2008-10#4)
inserted in##13##2##(1991-6#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#4)(2011-2#1)(2011-7#1)(2013-1#2)(2013-8#1)
inserted into a##7##3##(1995-2#1)(2008-10#3)(2008-11#2)(2008-7#1)
inserted into the chromosome##2##4##(1991-5#1)(1993-9#1)
inserted into the##26##3##(1990-2#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-9#2)(1994-8#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#4)(2008-9#2)(2010-5#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-1#1)
inserted into##43##2##(1990-2#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-9#2)(1994-8#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-6#2)(2008-10#7)(2008-11#5)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#3)(2010-5#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-1#2)
inserted percutaneously##2##2##(2008-10#1)(2012-3#1)
inserted under##2##2##(1991-12#1)(2008-9#1)
inserted with a##3##3##(2008-10#1)(2013-1#2)
inserted with##8##2##(1993-8#1)(2008-10#2)(2009-10#1)(2013-1#4)
inserted##116##1##(1990-2#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#4)(1997-8#6)(2008-10#23)(2008-11#11)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#5)(2009-10#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#12)(2013-8#1)
inserting a##2##2##(2008-10#2)
inserting##8##1##(1993-12#1)(1995-8#1)(2008-10#4)(2008-8#1)(2011-2#1)
insertion and##4##2##(2008-10#2)(2008-11#1)(2010-7#1)
insertion at the##2##3##(2008-12#1)(2010-6#1)
insertion at##3##2##(2008-12#1)(2008-8#1)(2010-6#1)
insertion attempts##2##2##(1992-12#1)(2012-2#1)
insertion for##2##2##(2008-12#1)(2013-8#1)
insertion has##2##2##(2008-12#1)(2009-7#1)
insertion in##5##2##(1993-6#1)(1996-6#1)(2008-11#1)(2010-6#1)(2012-3#1)
insertion into the##4##3##(1991-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
insertion into##7##2##(1991-6#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
insertion is##4##2##(2008-8#1)(2010-12#2)(2010-9#1)
insertion loss##3##2##(2008-3#2)(2009-5#1)
insertion method##2##2##(2010-12#1)(2010-6#1)
insertion occurred##2##2##(1995-9#1)(2008-10#1)
insertion of CTrach and ETT##2##5##(2010-7#2)
insertion of a##13##3##(1991-10#1)(1991-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-9#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
insertion of foreign genes##2##4##(2008-11#1)(2008-8#1)
insertion of implantable cardioverter-defibrillators##2##4##(2008-12#2)
insertion of the##9##3##(1992-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#3)(2013-1#1)
insertion of##44##2##(1990-5#1)(1991-10#2)(1991-12#1)(1992-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#1)(1995-11#1)(1995-5#1)(1995-9#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-3#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
insertion or deletion##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
insertion sites##4##2##(2008-10#2)(2008-11#1)(2009-3#1)
insertion success##2##2##(2012-2#2)
insertion torque##3##2##(2013-1#3)
insertion was##6##2##(2008-12#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#2)
insertion##162##1##(1990-5#1)(1991-10#3)(1991-12#1)(1991-6#1)(1992-12#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#2)(1994-12#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-9#3)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#3)(1997-7#2)(1997-8#2)(2008-10#22)(2008-11#8)(2008-12#6)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#13)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#6)(2010-12#3)(2010-4#1)(2010-6#4)(2010-7#7)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#13)(2013-8#4)
insertion/deletion##2##1##(2008-10#1)(2010-5#1)
insertional Achilles tendinosis##2##3##(2010-3#2)
insertional mutagenesis##8##2##(2008-10#7)(2008-9#1)
insertional##16##1##(1993-12#1)(1993-9#1)(1995-2#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-9#1)(2010-3#2)
insertions and##2##2##(2009-10#1)(2012-3#1)
insertions of##2##2##(1997-2#1)(1997-3#1)
insertions were##3##2##(1997-3#1)(2008-10#1)(2012-3#1)
insertions##18##1##(1990-8#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-10#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)
inserts of##2##2##(2008-10#1)(2008-8#1)
inserts##15##1##(1991-5#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-8#5)
inside a##15##2##(2008-10#6)(2008-11#2)(2008-3#4)(2008-7#1)(2009-10#1)(2013-8#1)
inside an##2##2##(2008-2#1)(2012-3#1)
inside and outside the##3##4##(1997-2#1)(2008-2#1)(2011-2#1)
inside and##5##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
inside microparticles##2##2##(2008-3#2)
inside of a##2##3##(2008-2#1)(2008-8#1)
inside of the##4##3##(2008-10#2)(2008-11#1)(2009-8#1)
inside of##9##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)
inside or outside of##2##4##(2008-8#1)(2012-12#1)
inside or outside##3##3##(1995-8#1)(2008-8#1)(2012-12#1)
inside plant##2##2##(2008-10#2)
inside surface of the##2##4##(2008-10#2)
inside the cells##2##3##(1993-8#1)(2008-9#1)
inside the tree canopy##2##4##(2008-10#2)
inside the##68##2##(1991-5#2)(1992-12#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-9#1)(1997-6#1)(1997-8#2)(2007-12#4)(2007-9#1)(2008-10#23)(2008-11#5)(2008-12#2)(2008-3#7)(2008-5#2)(2008-7#3)(2008-9#3)(2009-10#1)(2009-7#1)(2010-12#2)(2010-4#1)(2012-2#1)(2013-8#2)
inside##147##1##(1991-5#2)(1992-12#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#2)(1997-2#1)(1997-6#1)(1997-8#2)(2007-12#4)(2007-9#1)(2008-10#53)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#15)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
inside-out membrane vesicles##3##3##(1997-8#3)
inside-out##4##1##(1997-8#3)(2012-2#1)
insidious##2##1##(2011-2#1)(2013-1#1)
insight and##4##2##(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
insight can be##2##3##(2008-11#2)
insight in the##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
insight in##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2013-8#1)
insight into how##8##3##(1997-7#1)(2008-11#3)(2008-6#1)(2009-7#1)(2010-12#1)(2013-1#1)
insight into the current state##2##5##(2008-10#1)(2012-2#1)
insight into the mechanism of##4##5##(2008-10#2)(2008-11#1)(2013-1#1)
insight into the mechanism##7##4##(1990-5#1)(2008-10#3)(2008-11#1)(2009-5#1)(2013-1#1)
insight into the mechanisms of##2##5##(2008-11#1)(2008-4#1)
insight into the mechanisms##3##4##(2008-11#1)(2008-4#1)(2008-9#1)
insight into the potential##3##4##(2009-8#1)(2012-2#1)(2013-1#1)
insight into the role of##3##5##(1991-10#1)(1992-6#1)(2008-11#1)
insight into the unique##3##4##(1993-12#1)(2010-6#1)(2011-2#1)
insight into the##62##3##(1990-5#1)(1991-10#1)(1992-1#1)(1992-6#1)(1993-12#2)(1993-2#1)(1994-1#1)(1996-2#1)(1997-2#1)(1997-9#2)(2008-10#15)(2008-11#8)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#3)
insight into their##4##3##(2008-10#1)(2008-8#1)(2009-9#1)(2012-3#1)
insight into this##3##3##(1993-8#1)(1995-5#1)(2010-12#1)
insight into##108##2##(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-9#2)(2008-10#21)(2008-11#15)(2008-3#1)(2008-4#2)(2008-6#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#1)
insight on the##4##3##(1993-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
insight on##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
insight to##2##2##(1990-2#1)(2012-2#1)
insight##143##1##(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-9#2)(2008-10#25)(2008-11#21)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#6)(2013-8#5)
insights about the##2##3##(1992-2#1)(2011-2#1)
insights about##5##2##(1992-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
insights and##3##2##(1992-3#1)(2010-10#1)(2011-2#1)
insights are##2##2##(1992-3#1)(2009-3#1)
insights can be##2##3##(1993-12#1)(1996-1#1)
insights from##4##2##(2009-8#1)(2011-2#1)(2013-1#2)
insights in##8##2##(2008-10#2)(2008-11#2)(2011-2#3)(2012-2#1)
insights into the complex##2##4##(2008-10#1)(2012-3#1)
insights into the evolution of##5##5##(1993-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)
insights into the mechanisms##2##4##(2008-11#1)(2008-7#1)
insights into the molecular##3##4##(1992-9#1)(2008-11#1)(2012-2#1)
insights into the pathogenesis of##2##5##(2008-7#1)(2010-12#1)
insights into the role##2##4##(2012-12#1)(2013-8#1)
insights into the##61##3##(1992-9#1)(1993-2#1)(1994-2#1)(1997-8#1)(2008-10#7)(2008-11#7)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#2)
insights into##95##2##(1991-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#13)(2008-11#8)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#4)(2010-10#1)(2010-11#4)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#2)
insights may##2##2##(2012-3#1)(2013-1#1)
insights of##2##2##(2008-11#1)(2010-1#1)
insights on the##2##3##(2008-10#1)(2008-11#1)
insights on##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
insights provided by##2##3##(2008-6#1)(2013-8#1)
insights that can be##2##4##(2008-9#1)(2013-8#1)
insights that##4##2##(2008-2#1)(2008-9#1)(2009-10#1)(2013-8#1)
insights to##2##2##(2008-12#1)(2013-1#1)
insights##146##1##(1991-3#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#17)(2008-11#14)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#5)(2010-10#2)(2010-11#4)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#14)(2012-12#1)(2012-2#10)(2012-3#5)(2013-1#14)(2013-8#4)
insignificant bias##2##2##(2008-10#2)
insignificant in##2##2##(2008-10#2)
insignificant##28##1##(1990-2#1)(1992-3#1)(1993-6#1)(1993-9#1)(1995-12#1)(1996-3#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
insignificantly##2##1##(1993-11#1)(2008-7#1)
insipidus##11##1##(1994-11#2)(1997-8#2)(2008-4#2)(2008-7#1)(2011-1#3)(2012-3#1)
insist on a##2##3##(2008-11#2)
insist on##3##2##(1995-12#1)(2008-11#2)
insist##5##1##(1995-12#1)(2008-11#2)(2009-5#1)(2012-3#1)
insisting##4##1##(2008-4#3)(2013-8#1)
insists##2##1##(1992-2#1)(1992-3#1)
insofar as they##2##3##(1996-2#1)(2008-5#1)
insofar as##3##2##(1996-2#1)(2008-5#1)(2012-3#1)
insolubility##5##1##(2008-10#4)(2008-4#1)
insoluble A beta##3##3##(1994-11#3)
insoluble Cr(VI)##3##2##(2008-10#3)
insoluble amyloid deposits##2##3##(1994-11#2)
insoluble cell fraction##2##3##(1990-5#2)
insoluble complexes##2##2##(2008-10#2)
insoluble compounds##3##2##(2008-10#3)
insoluble in water##2##3##(2008-11#1)(2012-2#1)
insoluble in##6##2##(1996-1#1)(2008-10#3)(2008-11#1)(2012-2#1)
insoluble lignin##2##2##(2008-6#2)
insoluble##55##1##(1990-5#2)(1990-8#1)(1993-8#1)(1994-11#8)(1996-1#2)(2008-10#23)(2008-11#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2011-2#2)(2012-2#1)
insolubles##3##1##(2008-10#3)
insomnia##10##1##(1994-6#2)(1997-4#1)(2010-7#2)(2013-1#4)(2013-8#1)
insonation##3##1##(2008-10#2)(2008-8#1)
inspect##3##1##(1997-5#1)(2008-6#1)(2011-1#1)
inspected##3##1##(2008-10#1)(2011-2#1)(2013-8#1)
inspecting##2##1##(2008-10#1)(2009-3#1)
inspection and##3##2##(2008-10#2)(2011-2#1)
inspection of the##4##3##(1994-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
inspection of##11##2##(1992-9#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2009-8#1)(2010-7#1)
inspection##25##1##(1992-2#1)(1992-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(2008-10#7)(2008-11#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
inspections##3##1##(1993-2#1)(1996-3#1)(1996-5#1)
inspiration##6##1##(1996-2#1)(2008-12#1)(2009-11#1)(2011-2#1)(2012-3#2)
inspiratory and expiratory##2##3##(1996-2#1)(1996-3#1)
inspiratory flow rate##2##3##(1997-2#1)(2012-2#1)
inspiratory flow##8##2##(1992-3#2)(1995-3#4)(1997-2#1)(2012-2#1)
inspiratory##20##1##(1992-3#2)(1994-2#1)(1995-3#5)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#1)(2011-2#3)(2012-2#2)
inspired by##2##2##(2008-12#1)(2012-3#1)
inspired the##2##2##(2008-12#1)(2009-5#1)
inspired##8##1##(1992-2#1)(2008-12#2)(2008-8#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-8#1)
instabilities in##2##2##(2008-11#1)(2008-3#1)
instabilities##9##1##(2007-12#2)(2008-11#2)(2008-2#1)(2008-3#1)(2013-1#3)
instability analysis##3##2##(2008-10#2)(2013-8#1)
instability and##11##2##(1993-11#1)(1995-6#1)(2008-11#1)(2008-12#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
instability during##2##2##(2008-10#1)(2013-1#1)
instability in##6##2##(1992-8#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
instability of a##2##3##(2008-3#1)(2013-1#1)
instability of the##6##3##(1990-5#1)(1992-12#1)(2008-9#2)(2011-7#1)(2012-3#1)
instability of##13##2##(1990-5#1)(1992-12#1)(1992-2#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
instability or##2##2##(2008-12#1)(2013-1#1)
instability that##4##2##(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
instability##99##1##(1990-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-2#2)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#9)(2009-1#1)(2009-5#1)(2011-10#1)(2011-2#13)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#14)(2012-9#1)(2013-1#18)(2013-8#1)
instability)##2##1##(1993-12#1)(2008-9#1)
instable##4##1##(1990-11#2)(2008-10#1)(2013-8#1)
install##2##1##(1996-1#1)(2008-9#1)
installation of##7##2##(1994-3#1)(1997-1#1)(2008-10#4)(2009-10#1)
installation##14##1##(1994-3#3)(1997-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
installations##5##1##(1991-3#2)(2008-10#2)(2009-10#1)
installed at the##2##3##(2008-3#2)
installed in##2##2##(2008-10#1)(2013-1#1)
installed with##2##2##(2008-10#1)(2010-4#1)
installed##12##1##(1991-12#1)(2008-10#2)(2008-3#3)(2008-7#1)(2010-4#1)(2011-1#1)(2013-1#3)
installing dust control devices##3##4##(2009-12#3)
installing##5##1##(1994-1#2)(2009-12#3)
instance of a##4##3##(1993-11#1)(1993-6#1)(2008-11#1)(2008-12#1)
instance of##8##2##(1993-11#1)(1993-6#2)(1996-12#1)(2008-11#2)(2008-12#1)(2008-8#1)
instance the##2##2##(2008-10#2)
instance##40##1##(1993-11#1)(1993-6#2)(1996-12#1)(1997-7#3)(1997-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
instances due to##2##3##(1997-3#1)(2012-3#1)
instances for##2##2##(2008-12#2)
instances in the##2##3##(2008-10#1)(2013-8#1)
instances of##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
instances the##2##2##(1995-5#1)(1997-5#1)
instances where##3##2##(1993-2#1)(2008-4#1)(2008-8#1)
instances##54##1##(1990-11#1)(1991-12#4)(1991-6#2)(1992-1#1)(1992-5#1)(1993-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
instant and lasting relief of dentin hypersensitivity##2##7##(2011-2#2)
instant and lasting relief of##3##5##(2011-2#3)
instant and lasting##4##3##(2011-2#4)
instant powders##2##2##(2008-10#2)
instant##11##1##(2008-10#3)(2008-11#1)(2008-5#2)(2011-2#5)
instantaneous##15##1##(1990-11#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-9#1)(2010-8#2)(2012-2#1)(2013-1#1)
instantaneously##4##1##(2008-10#3)(2012-2#1)
instantly##5##1##(1992-3#1)(2008-10#4)
instar larvae of##2##3##(1997-8#1)(2010-10#1)
instar larvae##9##2##(1992-6#4)(1995-11#1)(1997-8#1)(2008-12#1)(2010-10#1)(2013-8#1)
instar##15##1##(1992-6#6)(1995-11#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-10#1)(2013-8#1)
instars##3##1##(2007-12#1)(2008-10#1)(2008-7#1)
instationary batch##2##2##(2008-11#2)
instead a##2##2##(1992-12#1)(2012-3#1)
instead of &quot##2##3##(2008-10#1)(2008-12#1)
instead of 60##2##3##(2008-10#2)
instead of a##2##3##(1997-8#1)(2008-10#1)
instead of an##3##3##(1993-8#1)(1994-2#1)(1995-8#1)
instead of being##2##3##(1991-6#1)(2013-8#1)
instead of on##2##3##(1990-11#1)(2008-10#1)
instead of the usual##2##4##(1994-2#1)(2007-12#1)
instead of the##13##3##(1990-11#1)(1992-12#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)
instead of##84##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-10#30)(2008-11#6)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#3)(2011-3#2)(2012-12#2)(2012-3#1)(2012-7#1)(2013-8#1)
instead##118##1##(1990-11#2)(1990-12#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#38)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#9)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#2)(2012-12#2)(2012-3#2)(2012-7#1)(2013-8#1)
instillation in##2##2##(2008-11#1)(2012-3#1)
instillation of the##3##3##(1993-11#1)(2008-10#1)(2008-4#1)
instillation of##10##2##(1990-11#1)(1993-11#1)(1994-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#2)
instillation##24##1##(1990-11#1)(1993-11#1)(1994-12#1)(1995-12#3)(1997-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-2#5)(2012-3#1)
instilled mice at 8 weeks##2##5##(2008-10#2)
instilled mice##4##2##(2008-10#4)
instilled##12##1##(1993-11#1)(1995-3#1)(2008-10#9)(2010-10#1)
institute##8##1##(1993-9#1)(1994-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2010-9#1)
instituted a##2##2##(1997-2#2)
instituted##10##1##(1991-1#1)(1991-12#2)(1996-11#1)(1996-5#1)(1997-2#2)(2008-12#1)(2008-6#1)(2008-7#1)
institutes and##2##2##(2008-11#1)(2010-10#1)
institutes##4##1##(2008-11#1)(2010-10#1)(2013-1#2)
institution and##4##2##(1996-3#1)(2008-11#1)(2008-12#1)(2013-1#1)
institution for the##2##3##(1992-12#1)(2008-12#1)
institution for##3##2##(1991-6#1)(1992-12#1)(2008-12#1)
institution in##3##2##(1991-3#1)(2011-3#1)(2012-2#1)
institution of##5##2##(1996-12#1)(1997-2#2)(2008-1#1)(2011-2#1)
institution with##5##2##(1990-6#1)(2008-12#1)(2008-8#2)(2013-1#1)
institution##65##1##(1990-6#1)(1990-9#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-2#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-2#2)(2008-1#1)(2008-11#5)(2008-12#4)(2008-3#1)(2008-8#4)(2008-9#1)(2009-4#4)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#12)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
institution's##6##1##(1990-11#1)(1996-2#2)(2008-8#2)(2013-1#1)
institutional and##2##2##(1991-6#1)(2009-11#1)
institutional care##5##2##(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(2008-12#1)
institutional commitment##2##2##(1996-3#1)(2009-3#1)
institutional experience##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
institutional review##2##2##(1993-2#1)(1995-1#1)
institutional support##2##2##(1991-2#1)(2013-8#1)
institutional##42##1##(1991-1#4)(1991-2#2)(1991-6#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#2)(1995-1#1)(1995-3#3)(1996-2#1)(1996-3#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2010-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
institutionalised##11##1##(2008-10#3)(2008-7#2)(2011-2#6)
institutionalization of##3##2##(1996-2#1)(2010-1#2)
institutionalization##6##1##(1996-2#1)(1997-3#1)(2008-5#1)(2008-7#1)(2010-1#2)
institutionalized elderly home residents##2##4##(2008-1#2)
institutionalized elderly##4##2##(2008-1#3)(2008-7#1)
institutionalized##11##1##(1991-6#1)(1994-12#2)(1997-3#2)(1997-8#1)(2008-1#3)(2008-7#2)
institutions and sex ratios in India##2##6##(2011-2#2)
institutions and##15##2##(1990-6#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-12#3)(2011-2#2)(2012-12#1)(2013-8#1)
institutions are##3##2##(1994-12#1)(2010-10#1)(2010-12#1)
institutions as##3##2##(1993-1#1)(1995-1#1)(2008-11#1)
institutions for##3##2##(1990-6#1)(2008-12#1)(2012-12#1)
institutions have##2##2##(1997-1#1)(2012-2#1)
institutions in##6##2##(1991-6#1)(1995-3#1)(1996-1#1)(2010-12#1)(2013-8#2)
institutions such as##2##3##(1991-3#1)(2012-12#1)
institutions that##4##2##(1993-12#1)(1995-12#1)(2008-12#1)(2012-12#1)
institutions to##4##2##(1993-12#1)(1994-12#1)(1997-1#1)(2008-10#1)
institutions were##3##2##(1993-12#1)(2009-8#1)(2012-3#1)
institutions##103##1##(1990-6#3)(1990-8#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#4)(1993-12#8)(1993-2#2)(1993-3#1)(1994-1#2)(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#4)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#6)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-8#1)(2010-10#1)(2010-12#3)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#4)
instructed that##3##2##(2008-11#3)
instructed to##7##2##(1991-2#1)(2008-7#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
instructed##12##1##(1991-2#1)(2008-11#3)(2008-7#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
instruction and##4##2##(1993-1#1)(2008-12#2)(2013-1#1)
instruction as##2##2##(2011-2#2)
instruction in##3##2##(1993-12#2)(2013-1#1)
instruction on##4##2##(1996-11#1)(2013-1#3)
instruction##45##1##(1991-12#5)(1993-1#2)(1993-12#2)(1993-8#1)(1994-3#1)(1994-6#1)(1996-11#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#8)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#9)(2013-8#2)
instructional method##2##2##(1996-1#2)
instructional technique in##2##3##(1993-1#1)(2011-2#1)
instructional##12##1##(1993-1#1)(1996-1#2)(2008-12#3)(2011-2#4)(2013-1#1)(2013-8#1)
instructions and##5##2##(2009-11#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
instructions for##6##2##(2008-10#1)(2008-4#4)(2012-12#1)
instructions in##2##2##(1994-1#1)(2011-2#1)
instructions on##6##2##(1990-2#2)(1991-2#1)(1992-12#1)(2008-4#1)(2013-1#1)
instructions to##5##2##(1994-3#1)(1995-12#1)(2008-11#2)(2009-4#1)
instructions##33##1##(1990-2#2)(1991-2#1)(1992-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#5)(2008-4#5)(2009-11#1)(2009-4#1)(2009-7#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#1)
instructive##4##1##(1997-6#1)(2008-10#1)(2009-12#1)(2010-11#1)
instructors who normally teach##2##4##(2011-2#2)
instructors##6##1##(1993-1#1)(2008-10#1)(2008-12#1)(2011-2#3)
instrument and##5##2##(1996-3#1)(2008-10#2)(2008-3#2)
instrument are##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
instrument calibration##2##2##(2008-10#2)
instrument can##3##2##(2008-3#1)(2011-2#2)
instrument design and##2##3##(2008-10#1)(2008-3#1)
instrument design##4##2##(2008-10#2)(2008-3#2)
instrument detection##2##2##(2008-10#2)
instrument for the##2##3##(2008-10#1)(2008-12#1)
instrument for use in##2##4##(1992-3#1)(2010-11#1)
instrument for##19##2##(1991-12#1)(1992-3#1)(1994-3#1)(1995-2#1)(2008-10#5)(2008-11#2)(2008-12#2)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
instrument has##3##2##(2008-2#1)(2008-5#1)(2012-12#1)
instrument is##14##2##(2008-10#7)(2008-3#4)(2008-9#1)(2010-12#1)(2012-12#1)
instrument measures##2##2##(1993-2#1)(2008-3#1)
instrument or##2##2##(1991-3#1)(1996-2#1)
instrument outputs##2##2##(2008-3#2)
instrument parameters##2##2##(2008-3#1)(2008-9#1)
instrument performance##2##2##(2008-3#1)(2008-4#1)
instrument sensitivity##2##2##(2008-10#1)(2008-9#1)
instrument that##6##2##(1992-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-10#1)
instrument to measure##5##3##(1993-3#1)(1997-1#1)(2008-3#1)(2008-7#1)(2010-11#1)
instrument to##12##2##(1993-3#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)
instrument was developed##2##3##(1996-1#1)(2009-12#1)
instrument was evaluated##2##3##(1993-3#1)(1997-2#1)
instrument was##12##2##(1993-1#1)(1993-3#1)(1996-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2009-12#1)(2010-10#1)(2012-12#1)
instrument were##2##2##(2008-10#1)(2008-11#1)
instrument with##4##2##(1990-11#1)(1993-2#1)(2008-10#1)(2010-6#1)
instrument within primary health care for##2##6##(2010-10#2)
instrument##221##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#2)(1993-3#3)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#4)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#79)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#34)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#11)(2009-12#8)(2010-10#7)(2010-11#4)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#9)(2013-8#3)
instrumental analysis##4##2##(2008-10#3)(2008-5#1)
instrumental and chemical variables##2##4##(2008-10#2)
instrumental and##8##2##(2008-10#6)(2008-5#2)
instrumental approaches##3##2##(2008-10#3)
instrumental assessments##2##2##(2008-5#2)
instrumental conditions##3##2##(2008-10#3)
instrumental detection##3##2##(2008-10#3)
instrumental factors##3##2##(2008-10#3)
instrumental for the##3##3##(1993-11#1)(2009-8#1)(2011-2#1)
instrumental in the##2##3##(2008-10#1)(2008-4#1)
instrumental in##9##2##(1995-1#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-8#1)(2013-7#1)
instrumental limit of detection##2##4##(2008-10#2)
instrumental line shape##2##3##(2008-3#2)
instrumental methods##4##2##(2008-10#2)(2008-5#2)
instrumental neutron activation analysis##2##4##(2008-10#2)
instrumental operation##2##2##(2008-10#1)(2008-4#1)
instrumental parameter##2##2##(2008-10#2)
instrumental parameters such as##2##4##(2008-10#2)
instrumental parameters were##4##3##(2008-10#4)
instrumental parameters##9##2##(2008-10#9)
instrumental requirements##2##2##(2008-10#1)(2009-12#1)
instrumental technique##2##2##(2008-10#2)
instrumental tests##3##2##(1991-6#2)(2008-5#1)
instrumental to##2##2##(2009-8#1)(2012-2#1)
instrumental variables##6##2##(2008-10#6)
instrumental##124##1##(1990-3#1)(1990-6#1)(1991-3#3)(1991-6#2)(1992-5#1)(1993-11#1)(1995-1#1)(1996-3#1)(1996-5#1)(2008-10#71)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#12)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
instrumentation and fusion##2##3##(2012-12#1)(2012-3#1)
instrumentation and##14##2##(2008-10#6)(2008-3#1)(2008-8#3)(2010-11#1)(2012-12#1)(2012-3#2)
instrumentation are##2##2##(2008-10#2)
instrumentation for the##3##3##(2008-10#2)(2008-11#1)
instrumentation for##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
instrumentation has##2##2##(2008-10#2)
instrumentation hyphenation##2##2##(2008-10#2)
instrumentation system##2##2##(2008-10#2)
instrumentation to##3##2##(2008-8#2)(2012-2#1)
instrumentation used##2##2##(2008-10#1)(2008-8#1)
instrumentation with##2##2##(2008-10#2)
instrumentation##68##1##(1997-6#1)(2008-10#39)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#11)(2008-9#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
instrumented fusions##2##2##(2012-3#2)
instrumented##7##1##(1994-3#1)(2008-11#1)(2012-3#3)(2013-1#2)
instruments and##11##2##(1993-12#1)(1993-3#1)(1996-2#1)(2008-10#3)(2010-9#1)(2013-1#4)
instruments are##5##2##(2008-11#2)(2008-3#1)(2008-4#1)(2009-12#1)
instruments as well as##2##4##(1992-3#1)(2008-9#1)
instruments developed##2##2##(2008-10#2)
instruments for##8##2##(2008-10#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
instruments had##3##2##(2008-10#1)(2013-1#2)
instruments have been##3##3##(2008-10#1)(2010-1#1)(2010-10#1)
instruments have##4##2##(1991-3#1)(2008-10#1)(2010-1#1)(2010-10#1)
instruments in##4##2##(2010-1#1)(2012-2#1)(2013-1#2)
instruments is##2##2##(2008-3#1)(2011-2#1)
instruments may##3##2##(2011-2#1)(2013-1#2)
instruments that##3##2##(2008-10#1)(2010-4#1)(2010-9#1)
instruments used##5##2##(2008-10#2)(2008-11#1)(2013-1#2)
instruments was##2##2##(2008-9#2)
instruments were##9##2##(1990-2#1)(1992-2#1)(2008-10#3)(2013-1#4)
instruments will##2##2##(2008-10#1)(2008-3#1)
instruments##143##1##(1990-2#1)(1990-8#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#12)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#18)(2009-12#2)(2010-1#4)(2010-10#1)(2010-11#2)(2010-4#2)(2010-7#1)(2010-9#3)(2011-2#6)(2011-7#2)(2012-12#1)(2012-2#5)(2013-1#27)(2013-8#1)
insufficiency and##6##2##(1996-11#1)(1996-3#1)(2008-5#1)(2010-12#1)(2011-3#1)(2012-3#1)
insufficiency in##3##2##(1995-8#1)(1997-5#1)(2011-2#1)
insufficiency of##2##2##(1997-2#1)(2013-1#1)
insufficiency##55##1##(1990-12#2)(1990-2#2)(1991-3#1)(1991-6#2)(1993-3#3)(1994-3#2)(1995-8#1)(1996-11#3)(1996-3#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-7#2)(2011-2#4)(2011-3#3)(2012-2#4)(2012-3#4)(2013-1#11)
insufficiency]##2##1##(1991-6#1)(1995-2#1)
insufficient and##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
insufficient control##2##2##(2008-10#1)(2010-5#1)
insufficient data##2##2##(2008-10#1)(2011-2#1)
insufficient evidence to##3##3##(2011-2#1)(2013-1#2)
insufficient for##2##2##(2008-10#1)(2008-9#1)
insufficient in##2##2##(2011-1#1)(2012-2#1)
insufficient intake of calcium##2##4##(1997-8#2)
insufficient time##2##2##(1990-2#1)(2011-1#1)
insufficient to explain the##2##4##(2008-11#1)(2012-2#1)
insufficient to explain##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
insufficient to##12##2##(1995-5#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-8#2)(2011-2#2)(2012-2#1)(2012-3#1)
insufficient##68##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#10)(2008-11#6)(2008-8#2)(2008-9#2)(2009-10#2)(2009-7#1)(2010-1#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
insufficiently##3##1##(1997-2#1)(2008-10#1)(2011-2#1)
insufflation gas##3##2##(1992-12#3)
insufflation##9##1##(1992-12#3)(2012-12#1)(2012-3#4)(2013-1#1)
insula was##2##2##(2008-11#2)
insula##7##1##(1995-8#1)(2008-11#6)
insulated##2##1##(2008-10#1)(2011-1#1)
insulating##9##1##(2008-10#3)(2009-5#2)(2012-2#2)(2013-8#2)
insulation workers##3##2##(1991-12#3)
insulation##6##1##(1991-12#3)(1992-3#1)(2008-10#2)
insulator##2##1##(2008-10#1)(2013-8#1)
insulators##2##1##(2008-10#1)(2008-7#1)
insulin (group##2##2##(2012-4#2)
insulin action##4##2##(1991-7#1)(1993-8#1)(1994-8#1)(2008-10#1)
insulin aerosol##2##2##(1996-3#2)
insulin and IGF-1 receptors##3##4##(1994-11#3)
insulin and IGF-1##7##3##(1994-11#5)(1996-2#1)(2008-9#1)
insulin and glucagon##3##3##(1994-11#1)(2008-11#1)(2008-3#1)
insulin and its##2##3##(2008-9#2)
insulin and leptin levels as compared to##2##7##(2013-1#2)
insulin and##35##2##(1994-11#6)(1994-6#1)(1994-8#1)(1996-11#1)(1996-12#2)(1996-2#3)(2008-10#1)(2008-11#5)(2008-3#2)(2008-7#1)(2008-9#4)(2010-10#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#3)
insulin as##2##2##(2008-12#1)(2009-9#1)
insulin autoantibodies (IAA)##2##3##(1994-12#2)
insulin autoimmune syndrome##2##3##(1997-8#2)
insulin binding and##2##3##(1993-8#1)(1997-1#1)
insulin binding##6##2##(1993-8#1)(1995-11#2)(1997-1#3)
insulin concentration##4##2##(2008-8#1)(2010-10#2)(2012-2#1)
insulin concentrations##4##2##(1994-11#1)(2010-10#1)(2010-8#2)
insulin dependent diabetes mellitus##2##4##(1992-5#1)(2008-11#1)
insulin dependent diabetes##3##3##(1992-5#1)(2008-11#2)
insulin dosing##2##2##(2008-1#2)
insulin gene##2##2##(2008-11#1)(2008-4#1)
insulin genes##2##2##(1993-3#2)
insulin growth##2##2##(2008-11#1)(2013-1#1)
insulin in response to##2##4##(1992-6#1)(2010-11#1)
insulin independence##2##2##(2010-10#2)
insulin infusion##2##2##(2008-1#1)(2012-3#1)
insulin injections##2##2##(1994-6#1)(2008-11#1)
insulin level##3##2##(1994-12#2)(2011-1#1)
insulin levels in##3##3##(1991-7#1)(2010-8#1)(2011-1#1)
insulin levels##7##2##(1991-7#2)(1994-8#1)(2010-8#1)(2011-1#1)(2013-1#2)
insulin may##2##2##(1994-11#1)(1994-12#1)
insulin on##3##2##(1991-7#1)(1996-2#1)(1997-2#1)
insulin production##2##2##(1996-11#1)(2008-11#1)
insulin receptor gene##4##3##(1994-12#4)
insulin receptor phosphorylation by##2##4##(1995-6#2)
insulin receptor##24##2##(1992-10#2)(1993-8#3)(1994-11#1)(1994-12#5)(1995-6#5)(1995-8#1)(1997-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-12#1)
insulin receptors and##2##3##(1994-12#1)(2008-12#1)
insulin receptors##10##2##(1993-8#5)(1994-12#1)(1995-6#2)(2008-12#1)(2008-5#1)
insulin reduction##2##2##(2009-9#2)
insulin regulation of##2##3##(1995-6#1)(1996-2#1)
insulin release in##2##3##(1995-8#1)(2010-11#1)
insulin release##7##2##(1994-11#1)(1995-8#3)(2008-1#1)(2008-11#1)(2010-11#1)
insulin resistance (HOMA-IR)##3##3##(2011-1#2)(2013-8#1)
insulin resistance (IR)##3##3##(2010-4#1)(2013-1#1)(2013-8#1)
insulin resistance and##15##3##(1994-11#2)(2008-4#3)(2008-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#3)(2012-3#1)(2013-8#1)
insulin resistance in the##2##4##(2011-1#2)
insulin resistance in##10##3##(2008-1#3)(2008-3#1)(2008-9#2)(2011-1#2)(2012-5#1)(2013-1#1)
insulin resistance index##2##3##(2012-3#1)(2013-1#1)
insulin resistance is##2##3##(1994-12#1)(2008-7#1)
insulin resistance with##2##3##(1994-12#1)(2010-7#1)
insulin resistance##72##2##(1994-11#2)(1994-12#2)(2008-1#6)(2008-3#2)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#4)(2010-10#3)(2010-11#3)(2010-12#4)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#15)(2011-2#1)(2012-3#2)(2012-5#3)(2013-1#3)(2013-7#1)(2013-8#4)
insulin resistant##3##2##(2008-10#1)(2008-3#1)(2012-5#1)
insulin response was##2##3##(1994-12#1)(1995-8#1)
insulin response##3##2##(1994-12#1)(1995-8#1)(2010-10#1)
insulin responses##2##2##(1995-8#1)(2010-10#1)
insulin secreting##2##2##(1997-1#1)(2008-11#1)
insulin secretion and##5##3##(1991-7#1)(1994-8#1)(2008-1#1)(2010-10#1)(2010-11#1)
insulin secretion from isolated mouse islets##2##6##(1994-8#2)
insulin secretion in glucose-free medium##2##5##(1995-8#2)
insulin secretion in##9##3##(1994-12#1)(1995-8#6)(2010-11#1)(2013-1#1)
insulin secretion is##2##3##(1994-12#1)(1994-8#1)
insulin secretion##35##2##(1991-7#3)(1994-11#1)(1994-12#3)(1994-8#5)(1995-8#9)(1997-4#1)(2008-1#1)(2008-11#5)(2010-10#1)(2010-11#5)(2013-1#1)
insulin secretory function##3##3##(2010-10#3)
insulin sensitivity and##3##3##(1993-2#1)(2010-10#2)
insulin sensitivity##22##2##(1992-6#1)(1993-2#2)(1994-12#4)(1997-1#2)(2008-1#3)(2008-11#1)(2008-4#1)(2008-9#1)(2010-10#3)(2010-4#1)(2012-2#1)(2012-3#2)
insulin signaling pathway##6##3##(2008-11#2)(2010-12#4)
insulin signaling##8##2##(2008-11#2)(2010-12#5)(2012-2#1)
insulin stimulation of##4##3##(1992-10#1)(1994-11#3)
insulin stimulation##6##2##(1992-10#2)(1994-11#3)(2008-11#1)
insulin therapy has##2##3##(2010-12#2)
insulin therapy##8##2##(1997-4#3)(2010-12#3)(2012-5#2)
insulin to##5##2##(1992-6#1)(1997-4#1)(2008-1#1)(2008-9#1)(2012-2#1)
insulin treatment##3##2##(1993-8#1)(2011-1#1)(2011-2#1)
insulin was##5##2##(1996-3#2)(2008-11#1)(2008-7#1)(2008-9#1)
insulin were##4##2##(1991-2#1)(2008-7#1)(2010-8#1)(2012-2#1)
insulin##469##1##(1990-12#4)(1991-1#1)(1991-2#2)(1991-7#8)(1992-10#6)(1992-5#1)(1992-6#4)(1993-2#2)(1993-3#2)(1993-8#15)(1994-11#24)(1994-12#24)(1994-6#2)(1994-8#9)(1995-11#4)(1995-2#1)(1995-6#9)(1995-8#18)(1996-11#10)(1996-12#2)(1996-2#9)(1996-3#6)(1997-1#8)(1997-2#1)(1997-4#11)(1997-8#3)(2008-1#22)(2008-10#6)(2008-11#34)(2008-12#5)(2008-3#10)(2008-4#12)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#23)(2009-9#10)(2010-10#23)(2010-11#20)(2010-12#14)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#20)(2011-2#2)(2012-2#9)(2012-3#7)(2012-4#2)(2012-5#8)(2013-1#13)(2013-7#3)(2013-8#6)
insulin)##4##1##(1996-11#1)(1997-2#1)(2008-1#1)(2008-11#1)
insulin-degrading##2##1##(1995-6#1)(1997-1#1)
insulin-dependent diabetes mellitus (IDDM)##2##4##(1995-3#1)(2011-2#1)
insulin-dependent diabetes mellitus##5##3##(1995-3#1)(1995-9#1)(1997-3#1)(1997-8#1)(2011-2#1)
insulin-dependent diabetes##10##2##(1990-5#1)(1992-6#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-9#1)(1997-3#1)(1997-8#1)(2011-2#1)(2013-1#1)
insulin-dependent##13##1##(1990-5#1)(1992-6#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1997-3#1)(1997-8#1)(2011-2#1)(2013-1#3)
insulin-independent##2##1##(1995-6#2)
insulin-induced##5##1##(1995-2#1)(1995-8#3)(2012-2#1)
insulin-like effect##2##2##(2008-11#2)
insulin-like growth factor (IGF-I)##2##4##(1995-11#1)(2008-8#1)
insulin-like growth factor 1##5##4##(2008-4#1)(2008-9#3)(2010-10#1)
insulin-like growth factor##15##3##(1991-7#2)(1992-4#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2010-10#1)(2010-4#1)(2012-12#1)
insulin-like growth factor-1 (IGF-1)##2##4##(1990-12#1)(2011-1#1)
insulin-like growth factor-I (IGF-I)##5##4##(1991-12#1)(1995-12#1)(1997-1#1)(2008-11#2)
insulin-like growth factor-I receptor##2##4##(2008-8#2)
insulin-like growth factor-I##9##3##(1991-12#1)(1994-6#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-11#2)(2008-8#2)
insulin-like growth factors##2##3##(2010-5#2)
insulin-like growth##28##2##(1990-12#1)(1991-12#1)(1991-7#2)(1992-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#4)(2010-10#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-12#1)
insulin-like##34##1##(1990-12#1)(1991-12#1)(1991-7#2)(1992-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#4)(2010-10#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-3#1)
insulin-mimetic##2##1##(2008-11#2)
insulin-producing##3##1##(2010-11#3)
insulin-receptor##2##1##(1995-11#1)(1997-1#1)
insulin-related processes##2##2##(1995-11#2)
insulin-related##3##1##(1995-11#2)(1995-8#1)
insulin-responsive##3##1##(1994-11#2)(2008-11#1)
insulin-secreting cells##3##2##(2008-11#3)
insulin-secreting##5##1##(1997-1#2)(2008-11#3)
insulin-stimulated glucose##2##2##(2008-3#1)(2008-9#1)
insulin-stimulated##9##1##(1992-10#1)(1992-6#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)
insulinemia##2##1##(2008-10#1)(2008-4#1)
insulinoma##6##1##(1995-8#1)(1997-5#1)(2008-11#3)(2008-2#1)
insulins##4##1##(1990-12#2)(1997-4#1)(2008-1#1)
insulitis and##2##2##(2010-11#2)
insult##16##1##(1990-5#2)(1992-9#1)(1994-2#2)(1996-12#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#2)
insults##12##1##(1994-2#2)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2011-2#3)(2013-1#1)
insurable##2##1##(1995-1#2)
insurance and health##2##3##(1995-2#1)(2011-2#1)
insurance and the##2##3##(1992-12#1)(1994-1#1)
insurance and##8##2##(1992-12#1)(1992-3#1)(1994-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2011-2#1)
insurance applicants##4##2##(1995-1#4)
insurance carriers##3##2##(1994-2#1)(1996-5#1)(2012-2#1)
insurance companies##3##2##(1996-1#1)(1996-3#1)(2012-12#1)
insurance coverage among disabled Medicare enrollees##2##6##(1992-2#2)
insurance coverage and##3##3##(1992-2#1)(1993-3#1)(2010-4#1)
insurance coverage are##2##3##(1991-12#1)(2011-2#1)
insurance coverage for##2##3##(1995-12#2)
insurance coverage were##2##3##(1994-3#1)(2009-5#1)
insurance coverage##23##2##(1991-12#2)(1991-2#1)(1992-2#3)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#2)(1995-12#3)(2008-11#3)(2009-5#1)(2010-4#1)(2011-2#2)(2012-3#1)
insurance for##7##2##(1991-1#1)(1991-2#2)(1992-2#1)(1992-3#1)(1995-3#1)(2011-2#1)
insurance in the##2##3##(1992-3#1)(1995-2#1)
insurance in##7##2##(1992-12#1)(1992-3#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-11#1)(2012-12#1)
insurance industry##5##2##(1992-3#1)(1993-1#1)(1995-1#1)(1995-12#1)(1997-3#1)
insurance information##2##2##(1991-2#1)(1991-3#1)
insurance market##2##2##(1997-2#1)(1997-3#1)
insurance medicine##2##2##(1995-1#1)(1996-2#1)
insurance plan##2##2##(1991-2#1)(1992-2#1)
insurance policies##2##2##(1993-3#1)(1996-3#1)
insurance policy##3##2##(1993-12#2)(1993-3#1)
insurance programs##3##2##(1993-1#1)(1995-3#1)(2010-5#1)
insurance risk##2##2##(1991-12#1)(1994-12#1)
insurance scheme##2##2##(1995-11#1)(2013-8#1)
insurance status##5##2##(1992-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(2012-3#1)
insurance##190##1##(1991-1#2)(1991-12#7)(1991-2#12)(1991-3#5)(1992-1#5)(1992-12#5)(1992-2#7)(1992-3#6)(1993-1#3)(1993-12#4)(1993-2#1)(1993-3#6)(1994-1#7)(1994-12#2)(1994-2#13)(1994-3#2)(1994-8#1)(1995-1#11)(1995-11#1)(1995-12#8)(1995-2#3)(1995-3#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#9)(1996-5#3)(1997-1#2)(1997-2#5)(1997-3#5)(1997-8#1)(2008-1#2)(2008-11#11)(2008-7#4)(2009-5#1)(2010-4#1)(2010-5#5)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
insurance-based##2##1##(1993-2#1)(2008-8#1)
insure that##2##2##(1993-2#1)(2008-8#1)
insure##9##1##(1991-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
insured##14##1##(1991-12#2)(1992-2#2)(1994-12#1)(1994-2#2)(1997-3#4)(2008-11#1)(2011-2#1)(2012-2#1)
insurer##2##1##(1995-12#1)(2008-7#1)
insurers##19##1##(1991-1#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-11#1)(2010-8#1)(2012-12#1)
intact and triton-treated##2##3##(1994-11#2)
intact and##11##2##(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(2008-11#2)(2010-12#1)(2011-2#1)(2012-12#1)
intact cell##2##2##(1994-11#1)(2008-9#1)
intact cells##14##2##(1990-11#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
intact foliage##3##2##(2008-10#3)
intact in##2##2##(2008-10#1)(2008-5#1)
intact male##3##2##(1994-2#2)(2008-11#1)
intact males##2##2##(1993-8#1)(1995-2#1)
intact membrane##2##2##(1997-8#1)(2008-9#1)
intact muscle##2##2##(1997-2#1)(2008-9#1)
intact myelinated##2##2##(1997-3#2)
intact on##2##2##(2008-10#1)(2012-12#1)
intact or##2##2##(1993-8#1)(2008-10#1)
intact organisms##2##2##(1993-12#2)
intact plants##10##2##(1997-3#1)(2008-10#3)(2008-11#6)
intact salivary gland##2##3##(2007-11#1)(2008-11#1)
intact tissues##3##2##(1994-8#1)(2008-10#2)
intact type VI collagen microfibrils##3##5##(1993-3#3)
intact type VI collagen##5##4##(1993-3#5)
intact##204##1##(1990-11#1)(1990-2#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-3#5)(1993-6#2)(1993-8#4)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#7)(1995-12#1)(1995-2#4)(1995-6#4)(1995-8#1)(1996-12#3)(1996-2#7)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#3)(1997-3#4)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#40)(2008-11#16)(2008-12#2)(2008-4#7)(2008-5#8)(2008-7#7)(2008-8#6)(2008-9#11)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
intake and##12##2##(1992-12#1)(1992-9#1)(1993-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-8#1)(2013-8#3)
intake as##4##2##(1996-2#1)(1997-8#2)(2010-1#1)
intake can##3##2##(1997-8#1)(2008-11#2)
intake compared##2##2##(2008-5#1)(2010-6#1)
intake during##2##2##(1994-12#1)(2008-9#1)
intake from##2##2##(2008-10#1)(2010-1#1)
intake in##10##2##(1990-8#1)(1994-12#2)(2008-10#1)(2009-8#1)(2010-5#1)(2010-9#2)(2013-8#2)
intake is##5##2##(1991-6#1)(1997-4#1)(2010-1#1)(2012-2#2)
intake may##3##2##(2008-4#1)(2009-12#2)
intake of energy##2##3##(1994-12#1)(2013-1#1)
intake of the##7##3##(1991-2#1)(1993-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
intake of##55##2##(1991-11#2)(1991-2#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-6#4)(2011-2#4)(2012-12#2)(2012-3#4)(2013-1#6)
intake on##2##2##(1991-11#1)(2013-1#1)
intake to##2##2##(2008-4#1)(2009-11#1)
intake was##10##2##(1991-2#2)(1993-8#1)(1994-12#1)(2008-9#1)(2010-8#1)(2013-1#2)(2013-8#2)
intake were##2##2##(2008-4#1)(2013-8#1)
intake##186##1##(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#4)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-8#3)(1994-12#6)(1994-2#2)(1994-3#2)(1995-12#1)(1996-2#5)(1996-8#1)(1997-4#6)(1997-8#5)(2007-11#1)(2008-1#2)(2008-10#15)(2008-11#10)(2008-12#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#3)(2009-12#3)(2009-5#1)(2009-8#4)(2009-9#2)(2010-1#5)(2010-4#2)(2010-5#1)(2010-6#8)(2010-8#1)(2010-9#3)(2011-2#10)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#13)(2013-8#20)
intakes of##6##2##(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
intakes were##3##2##(2010-6#1)(2013-1#2)
intakes##17##1##(2008-10#1)(2008-5#1)(2010-1#1)(2010-6#5)(2011-2#2)(2012-2#2)(2013-1#5)
integerrima and##2##2##(2008-10#2)
integerrima##4##1##(2008-10#4)
integral equation is solved##2##4##(2008-2#1)(2008-3#1)
integral equation is##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
integral equation of the##3##4##(2008-10#1)(2008-2#1)(2009-10#1)
integral equation##9##2##(2008-10#1)(2008-2#2)(2008-3#1)(2009-10#4)(2012-3#1)
integral equations##4##2##(2008-10#1)(2009-7#1)(2012-3#2)
integral is##2##2##(2008-3#2)
integral membrane proteins##3##3##(1991-2#1)(1995-8#1)(2008-8#1)
integral membrane##9##2##(1991-10#1)(1991-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#2)(2011-2#1)
integral of [Ca2+]i##2##3##(1994-6#2)
integral of##3##2##(1994-6#2)(2008-7#1)
integral part of the##6##4##(1991-2#1)(1992-6#1)(1995-11#1)(1997-4#1)(2008-10#1)(2012-2#1)
integral part of##17##3##(1991-2#1)(1992-1#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)
integral part##18##2##(1991-2#1)(1992-1#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)
integral photography##2##2##(2008-3#2)
integral to the##2##3##(2012-3#1)(2013-1#1)
integral to##8##2##(1992-12#1)(1995-12#1)(2008-11#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-1#2)
integral##88##1##(1991-10#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#2)(1994-12#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-4#1)(2008-10#10)(2008-11#5)(2008-2#4)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#5)(2009-5#1)(2009-7#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#3)
integrals is##3##2##(2008-2#1)(2008-3#2)
integrals##6##1##(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#3)
integrase inhibitors##2##2##(2011-2#1)(2011-3#1)
integrase is##2##2##(1992-6#2)
integrase##19##1##(1992-6#3)(1996-6#1)(1997-3#5)(2011-2#1)(2011-3#8)(2012-2#1)
integrate and##4##2##(1994-12#1)(1995-1#1)(1997-3#1)(2008-11#1)
integrate as a single copy##2##5##(1995-5#1)(2008-10#1)
integrate into##2##2##(2008-10#1)(2012-2#1)
integrate multiple##2##2##(2009-8#1)(2011-3#1)
integrate shade and hormone##2##4##(2009-8#2)
integrate the##10##2##(1992-1#1)(1993-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-3#2)(2013-1#1)
integrate their##2##2##(2008-11#1)(2008-12#1)
integrate these##2##2##(2010-1#1)(2012-12#1)
integrate##53##1##(1991-6#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-3#2)(2008-10#5)(2008-11#6)(2008-12#6)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)
integrate-and-fire##2##1##(2008-11#2)
integrated absorbance##4##2##(2008-10#4)
integrated and##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2013-8#1)
integrated approach to##8##3##(1993-12#2)(1996-2#1)(2008-10#2)(2008-11#2)(2008-12#1)
integrated approach##12##2##(1993-12#2)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#1)
integrated at a single##2##4##(2008-10#1)(2008-11#1)
integrated at##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
integrated chemometric approach##3##3##(2008-10#3)
integrated circuit##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
integrated circuits##3##2##(2008-11#1)(2008-3#2)
integrated control of##2##3##(1997-7#1)(2008-10#1)
integrated control##3##2##(1997-7#2)(2008-10#1)
integrated delivery network##2##3##(1997-1#1)(2008-11#1)
integrated delivery system##6##3##(1996-1#3)(1996-3#2)(1997-3#1)
integrated delivery systems##4##3##(1996-1#2)(1996-3#2)
integrated delivery##13##2##(1996-1#6)(1996-3#4)(1997-1#1)(1997-3#1)(2008-11#1)
integrated devices##2##2##(2008-7#2)
integrated disease management##2##3##(2008-10#2)
integrated gas-liquid##2##2##(2008-10#2)
integrated health and##2##3##(1991-3#1)(2008-11#1)
integrated health care delivery##3##4##(1996-1#3)
integrated health care systems##3##4##(1997-1#3)
integrated health care##9##3##(1994-1#1)(1995-2#1)(1996-1#3)(1997-1#3)(1997-3#1)
integrated health##14##2##(1991-3#1)(1994-1#1)(1994-2#1)(1995-2#1)(1996-1#3)(1996-3#1)(1997-1#3)(1997-3#1)(2008-11#1)(2012-2#1)
integrated in a##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
integrated in the undergraduate curriculum of##2##6##(2011-2#2)
integrated in the##6##3##(1995-6#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#2)
integrated in##18##2##(1995-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
integrated information systems##2##3##(1995-12#1)(1996-3#1)
integrated information##3##2##(1995-12#2)(1996-3#1)
integrated intensity##2##2##(2008-2#1)(2008-3#1)
integrated into a##2##3##(1994-12#1)(1996-8#1)
integrated into the##7##3##(1995-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-9#2)(2013-1#1)
integrated into##18##2##(1993-6#1)(1994-12#2)(1995-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
integrated microchip##2##2##(2008-10#2)
integrated on a##3##3##(2008-10#3)
integrated on-line to##2##3##(2008-10#2)
integrated optical displacement sensor based on triangulation and optical beam deflection##2##11##(2008-2#2)
integrated optical##9##2##(2008-10#3)(2008-2#3)(2008-3#3)
integrated optics##2##2##(2008-10#1)(2008-3#1)
integrated over the##2##3##(2008-10#2)
integrated pest management (IPM)##3##4##(2008-10#3)
integrated pest management systems##2##4##(2008-10#2)
integrated pest management##13##3##(1997-7#1)(2008-10#9)(2008-9#1)(2013-8#2)
integrated pest##14##2##(1997-7#1)(2008-10#10)(2008-9#1)(2013-8#2)
integrated photoelasticity##4##2##(2008-3#4)
integrated platform of a##2##4##(2008-10#2)
integrated platform of##4##3##(2008-10#4)
integrated platform##5##2##(2008-10#5)
integrated public health information##3##4##(1995-12#2)(1996-3#1)
integrated public##4##2##(1995-12#2)(1996-3#1)(2008-6#1)
integrated system of##2##3##(1997-1#1)(2008-10#1)
integrated system##5##2##(1995-12#1)(1997-1#1)(1997-3#1)(2008-10#2)
integrated systems##5##2##(1996-3#1)(1997-3#2)(2008-10#1)(2009-12#1)
integrated the expression##2##3##(2008-11#2)
integrated the##3##2##(2008-11#2)(2008-3#1)
integrated to##6##2##(1995-12#1)(2008-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)
integrated treatment intervention##2##3##(2012-3#2)
integrated treatment##10##2##(2008-6#1)(2012-3#9)
integrated use of##4##3##(1997-7#1)(2008-10#1)(2011-2#2)
integrated with a##2##3##(1994-1#1)(2008-11#1)
integrated with##11##2##(1994-1#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)
integrated##316##1##(1990-5#1)(1990-9#2)(1991-3#1)(1992-12#1)(1992-3#2)(1993-12#2)(1993-6#2)(1994-1#2)(1994-12#4)(1994-2#2)(1995-12#6)(1995-2#4)(1995-3#1)(1995-6#1)(1996-1#9)(1996-2#1)(1996-3#13)(1996-8#1)(1997-1#5)(1997-2#2)(1997-3#7)(1997-7#8)(1997-8#3)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#91)(2008-11#24)(2008-12#9)(2008-2#6)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#8)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#8)(2012-3#16)(2013-1#3)(2013-8#6)
integrates the##2##2##(2010-8#2)
integrates these##3##2##(2008-11#1)(2010-6#1)(2012-2#1)
integrates##25##1##(1992-12#1)(1993-3#1)(1994-2#2)(1995-12#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-4#1)(2009-10#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-2#3)
integrating a##2##2##(2008-10#1)(2008-11#1)
integrating health##2##2##(1994-1#1)(1997-3#1)
integrating multiple##2##2##(2008-10#1)(2010-7#1)
integrating surveillance##2##2##(1997-3#2)
integrating the##9##2##(1993-1#1)(1996-3#1)(2008-3#1)(2008-6#2)(2009-11#1)(2011-2#2)(2012-3#1)
integrating these##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
integrating this##3##2##(1991-12#1)(2008-10#1)(2012-2#1)
integrating##53##1##(1990-2#1)(1991-1#1)(1991-12#1)(1992-1#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-3#4)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#4)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
integration activity##2##2##(1992-6#2)
integration and##14##2##(1991-3#1)(1997-1#2)(2008-10#2)(2008-11#4)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2012-2#1)
integration events##3##2##(2008-10#2)(2008-11#1)
integration has a##2##3##(2008-9#1)(2009-8#1)
integration has##3##2##(2008-9#1)(2009-8#2)
integration in the##2##3##(2008-10#1)(2008-3#1)
integration in##6##2##(1991-3#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-11#1)(2011-1#1)
integration is##2##2##(2008-10#1)(2008-9#1)
integration loci##2##2##(2008-11#2)
integration of chemical##3##3##(2008-10#3)
integration of different##2##3##(1994-12#1)(2013-1#1)
integration of services##2##3##(1991-2#1)(1997-1#1)
integration of the##18##3##(1993-6#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)
integration of theory to practice##2##5##(2008-11#2)
integration of##86##2##(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#3)(1994-12#1)(1994-2#1)(1995-1#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#14)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#2)(2011-9#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
integration process##4##2##(1997-1#4)
integration site##2##2##(2008-11#1)(2013-7#1)
integration sites##5##2##(1997-3#1)(2008-10#2)(2011-1#1)(2012-12#1)
integration time)##2##2##(2008-10#2)
integration times##3##2##(2008-10#1)(2008-3#2)
integration was##2##2##(2009-8#1)(2012-3#1)
integration with other##2##3##(1997-7#1)(2008-10#1)
integration with##6##2##(1991-2#1)(1997-7#2)(2008-10#1)(2008-12#1)(2009-7#1)
integration##205##1##(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-6#3)(1993-12#1)(1993-2#2)(1993-6#4)(1994-12#1)(1994-2#2)(1995-1#3)(1995-12#1)(1995-2#2)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#2)(1997-1#7)(1997-2#2)(1997-3#3)(1997-7#4)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#39)(2008-11#25)(2008-12#3)(2008-2#1)(2008-3#16)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#2)(2009-6#2)(2009-7#1)(2009-8#12)(2010-10#2)(2010-11#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#2)(2011-3#1)(2011-7#1)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#1)
integrations##3##1##(1997-7#1)(2008-3#1)(2011-1#1)
integrative literature##2##2##(2009-12#1)(2012-3#1)
integrative medicine##5##2##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
integrative review##4##2##(2010-10#2)(2012-3#1)(2013-8#1)
integrative##33##1##(1991-2#1)(1994-2#3)(1994-3#1)(1996-1#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-2#4)(2012-3#2)(2013-8#4)
integrator##5##1##(1996-1#1)(2009-8#1)(2011-2#3)
integrators##2##1##(1993-1#1)(2008-11#1)
integrin alpha(v)beta(3) and##3##3##(2010-6#3)
integrin alpha(v)beta(3)##5##2##(2010-6#5)
integrin and##2##2##(1991-5#1)(2010-6#1)
integrin cluster##3##2##(2010-10#3)
integrin clusters in a population of##2##6##(2010-10#2)
integrin clusters in##3##3##(2010-10#3)
integrin clusters##5##2##(2010-10#5)
integrin receptor##2##2##(1995-6#2)
integrin receptors##2##2##(1995-6#1)(2006-6#1)
integrin signalling##3##2##(2010-10#3)
integrin α(v) β(3)##3##3##(2010-12#3)
integrin##46##1##(1991-5#1)(1992-2#2)(1994-5#1)(1995-6#3)(1997-2#1)(2006-6#3)(2008-11#3)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#4)(2010-10#12)(2010-12#3)(2010-6#8)
integrin-mediated##2##1##(2010-1#1)(2010-6#1)
integrins are##2##2##(2006-6#1)(2008-7#1)
integrins##8##1##(1995-2#2)(2006-6#1)(2008-7#1)(2009-1#2)(2009-3#1)(2011-1#1)
integrity and##5##2##(1996-2#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
integrity as well as##2##4##(2008-7#1)(2008-9#1)
integrity as##3##2##(2008-7#1)(2008-9#2)
integrity is##2##2##(2008-10#1)(2009-12#1)
integrity of the##20##3##(1990-2#1)(1990-5#1)(1992-3#1)(1994-5#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#4)(2011-2#2)(2012-12#1)
integrity of this##2##3##(1995-2#1)(2008-10#1)
integrity of##39##2##(1990-2#1)(1990-5#2)(1991-2#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
integrity plays a key role in##2##6##(2011-2#1)(2012-2#1)
integrity testing##3##2##(2008-9#1)(2012-2#2)
integrity##100##1##(1990-12#1)(1990-2#1)(1990-5#2)(1991-2#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-7#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-7#5)(2008-9#6)(2009-10#3)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#5)
integument##3##1##(1991-2#1)(2012-2#1)(2012-3#1)
integumentary##4##1##(2007-12#3)(2011-2#1)
intein##5##1##(2009-7#2)(2011-2#1)(2011-3#2)
intellectual disability##2##2##(2012-2#1)(2013-1#1)
intellectual##16##1##(1993-3#2)(1996-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-10#2)(2010-5#1)(2011-2#3)(2012-2#2)(2013-1#1)
intellectuals##3##1##(2010-1#2)(2011-2#1)
intelligence and##4##2##(2008-11#1)(2010-1#2)(2012-3#1)
intelligence of##2##2##(1990-9#1)(2013-1#1)
intelligence##26##1##(1990-9#1)(1997-3#5)(2007-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-8#1)(2010-1#5)(2010-3#1)(2010-8#2)(2012-3#3)(2013-1#2)
intelligent##9##1##(1991-2#1)(1992-2#1)(2008-10#4)(2009-11#1)(2010-3#1)(2010-5#1)
intelligentsia in the##2##3##(2008-12#2)
intelligentsia in##3##2##(2008-12#3)
intelligentsia##8##1##(2008-12#8)
intelligibility##4##1##(2008-9#4)
intend to##11##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)
intend##12##1##(1995-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-8#1)
intended as##4##2##(1991-2#1)(1992-12#1)(1994-6#1)(2012-2#1)
intended for##11##2##(2008-10#3)(2008-3#2)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
intended meaning of##2##3##(2008-11#2)
intended meaning##3##2##(2008-11#2)(2012-3#1)
intended to be##2##3##(2008-4#1)(2013-8#1)
intended to provide##2##3##(2008-11#1)(2008-5#1)
intended to reduce##2##3##(1992-12#1)(1996-1#1)
intended to##24##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#1)(1992-1#1)(1992-12#1)(1996-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
intended use##2##2##(2010-6#1)(2011-2#1)
intended##59##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#2)(1993-3#1)(1994-6#1)(1996-1#2)(2008-10#8)(2008-11#6)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#4)(2013-8#2)
intends to##4##2##(2008-11#1)(2008-12#1)(2009-10#1)(2012-3#1)
intenpecies##3##1##(2008-9#3)
intense and##2##2##(2008-10#2)
intense but##2##2##(2008-10#2)
intense debate##2##2##(1997-1#1)(2010-12#1)
intense in##5##2##(1993-11#1)(1996-12#1)(2008-10#1)(2008-9#1)(2012-7#1)
intense pulsed##2##2##(2010-6#2)
intense when the##2##3##(1994-5#1)(2008-11#1)
intense##91##1##(1990-6#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-7#1)(2008-10#32)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2012-7#2)(2013-1#2)(2013-8#2)
intensely expressed##2##2##(1990-11#1)(2012-3#1)
intensely pumped Nd##2##3##(2008-3#2)
intensely pumped##3##2##(2008-3#3)
intensely stained##2##2##(1997-2#1)(2008-7#1)
intensely##19##1##(1990-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-2#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#1)(2010-10#1)(2012-2#1)(2012-3#1)
intensification of##4##2##(1994-8#1)(2008-10#2)(2010-12#1)
intensification time##2##2##(2008-10#2)
intensification##8##1##(1993-9#1)(1994-8#1)(2008-10#4)(2010-11#1)(2010-12#1)
intensified charge-coupled device##2##3##(2008-10#2)
intensified in the##2##3##(2008-10#1)(2013-1#1)
intensified##20##1##(1991-3#1)(1994-2#1)(1996-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2013-1#1)
intensifying##6##1##(2007-8#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-2#1)
intensities and potentials##2##3##(2008-10#2)
intensities and##5##2##(1994-9#2)(2008-10#3)
intensities are##3##2##(2008-10#1)(2008-3#2)
intensities by##2##2##(1994-9#1)(2008-9#1)
intensities could be##2##3##(2008-10#1)(2008-11#1)
intensities for##2##2##(2008-10#2)
intensities from a##3##3##(2008-10#3)
intensities in the##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
intensities of the##10##3##(2008-10#7)(2008-3#1)(2008-8#1)(2012-3#1)
intensities of##24##2##(1992-3#3)(1993-8#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-8#2)(2012-3#1)
intensities on##3##2##(2008-7#2)(2009-11#1)
intensities ranging from 0##2##4##(2008-10#1)(2008-11#1)
intensities that##2##2##(2008-10#1)(2008-3#1)
intensities the##2##2##(2008-3#2)
intensities were##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
intensities with##2##2##(2008-10#1)(2008-3#1)
intensities##83##1##(1992-3#4)(1993-8#1)(1994-9#3)(1996-2#1)(2006-6#1)(2008-10#39)(2008-11#3)(2008-2#1)(2008-3#15)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2011-2#2)(2012-3#1)(2013-8#2)
intensity and a##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
intensity and duration of##2##4##(1994-2#1)(2009-3#1)
intensity and duration##3##3##(1994-2#1)(2008-10#1)(2009-3#1)
intensity and frequency##2##3##(1990-8#1)(2013-1#1)
intensity and the concentration of##2##5##(2008-10#2)
intensity and the##16##3##(2007-12#1)(2008-10#9)(2008-12#1)(2008-3#1)(2010-11#3)(2010-4#1)
intensity and unpleasantness##3##3##(2008-10#3)
intensity and##59##2##(1990-8#1)(1991-11#1)(1992-3#1)(1994-2#1)(1994-8#2)(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#2)(2009-4#1)(2010-11#3)(2010-4#1)(2011-1#1)(2011-2#3)(2012-8#1)(2013-1#4)
intensity are##3##2##(2008-10#1)(2008-3#2)
intensity as##2##2##(2008-10#1)(2009-5#1)
intensity at the##3##3##(2008-10#2)(2008-3#1)
intensity at##12##2##(2008-10#8)(2008-3#2)(2009-11#2)
intensity by##3##2##(2008-10#1)(2008-3#2)
intensity change##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
intensity changes in##2##3##(2008-10#1)(2008-3#1)
intensity changes##5##2##(1996-2#1)(2008-10#3)(2008-3#1)
intensity distribution of##2##3##(2008-10#1)(2008-3#1)
intensity distribution##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
intensity distributions##7##2##(2008-2#1)(2008-3#5)(2010-12#1)
intensity during##3##2##(1994-12#1)(2013-8#2)
intensity enhancement##2##2##(2008-10#1)(2008-3#1)
intensity for##4##2##(2008-10#4)
intensity from##8##2##(2008-10#5)(2008-3#1)(2008-5#1)(2013-8#1)
intensity has##3##2##(2008-3#1)(2008-9#2)
intensity heat-evoked tail-flick response##2##4##(1992-3#2)
intensity in a##2##3##(2008-10#1)(2010-1#1)
intensity in all##2##3##(2009-10#1)(2009-3#1)
intensity in the range of##2##5##(2008-10#2)
intensity in the##7##3##(1991-11#2)(1991-5#1)(2008-10#3)(2009-3#1)
intensity in##16##2##(1991-11#2)(1991-5#1)(1992-12#1)(1992-9#1)(2008-10#4)(2008-3#1)(2009-10#1)(2009-3#2)(2010-1#1)(2013-8#2)
intensity increase##2##2##(2007-12#1)(2009-11#1)
intensity increased##5##2##(1994-8#1)(2008-10#1)(2008-6#1)(2008-9#2)
intensity inside##4##2##(2008-3#3)(2008-7#1)
intensity is a linear function of##2##6##(2008-10#2)
intensity is proportional to the concentration of##3##7##(2008-10#2)(2008-12#1)
intensity is proportional to##4##4##(2008-10#3)(2008-12#1)
intensity is##21##2##(2008-10#18)(2008-12#1)(2008-7#2)
intensity noise##2##2##(2008-3#2)
intensity of a##4##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
intensity of aggregation##2##3##(1990-5#1)(2008-10#1)
intensity of care provided##2##4##(1992-1#2)
intensity of care##3##3##(1992-1#3)
intensity of fluorescence##4##3##(2008-10#3)(2008-11#1)
intensity of reflectance##4##3##(2008-10#4)
intensity of sexual selection on##2##5##(2008-8#2)
intensity of sexual selection##5##4##(2008-8#3)(2008-9#2)
intensity of sexual##6##3##(2008-8#3)(2008-9#3)
intensity of stimulation##3##3##(1997-3#1)(2008-7#2)
intensity of symptoms##2##3##(2008-10#1)(2013-1#1)
intensity of the complex##2##4##(2008-10#2)
intensity of the##49##3##(1990-12#1)(1993-3#2)(1995-11#1)(1995-6#1)(1997-8#1)(2008-10#34)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-7#1)
intensity of these##2##3##(2008-10#2)
intensity of##169##2##(1990-12#1)(1990-5#2)(1991-2#3)(1992-1#4)(1992-3#2)(1993-1#1)(1993-3#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-1#1)(1997-2#3)(1997-3#2)(1997-8#1)(2007-11#1)(2008-10#80)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#8)(2009-10#1)(2009-7#1)(2010-11#2)(2010-4#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-8#3)
intensity on the##2##3##(2008-3#1)(2009-10#1)
intensity on##15##2##(1991-11#2)(1997-8#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-10#1)(2009-11#2)(2011-2#1)(2012-2#1)
intensity or##3##2##(2008-10#1)(2008-9#2)
intensity patterns##2##2##(2008-3#2)
intensity produced by##2##3##(2008-10#1)(2008-4#1)
intensity produced##4##2##(2008-10#3)(2008-4#1)
intensity profile pump beam##2##4##(2008-3#2)
intensity profile##6##2##(2008-2#1)(2008-3#5)
intensity profiles##3##2##(2008-3#2)(2008-5#1)
intensity progression##2##2##(2010-1#2)
intensity ratio of##3##3##(2008-10#1)(2008-3#2)
intensity ratio##10##2##(2008-10#6)(2008-2#1)(2008-3#3)
intensity showed##2##2##(2008-10#2)
intensity significantly affected##2##3##(1992-2#1)(2008-10#1)
intensity that##5##2##(2008-10#1)(2008-7#2)(2008-9#1)(2013-8#1)
intensity to##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
intensity values##2##2##(2008-10#2)
intensity was found##2##3##(2008-10#1)(2008-2#1)
intensity was linear over a nitrite concentration of##2##8##(2008-10#2)
intensity was linear over a##3##5##(2008-10#3)
intensity was linear with the##3##5##(2008-10#3)
intensity was linear with##6##4##(2008-10#6)
intensity was linear##13##3##(2008-10#13)
intensity was measured at##2##4##(2008-10#2)
intensity was measured##4##3##(2008-10#4)
intensity was proportional to the##2##5##(2008-10#1)(2008-3#1)
intensity was##42##2##(1991-12#1)(1992-1#1)(1996-2#1)(2008-10#33)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-7#1)
intensity were investigated##2##3##(2008-10#2)
intensity were##7##2##(1992-12#1)(2008-10#4)(2008-5#1)(2008-9#1)
intensity when##3##2##(1992-12#1)(2008-10#1)(2013-8#1)
intensity with the##3##3##(1992-12#1)(2008-10#1)(2008-6#1)
intensity with##6##2##(1992-12#1)(2008-10#3)(2008-3#1)(2008-6#1)
intensity within##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
intensity##653##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#7)(1991-12#1)(1991-2#4)(1991-5#3)(1991-6#1)(1992-1#5)(1992-12#7)(1992-2#2)(1992-3#5)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#5)(1995-10#1)(1995-11#1)(1995-12#5)(1995-6#1)(1995-8#2)(1996-1#1)(1996-2#2)(1996-5#3)(1997-2#3)(1997-3#2)(1997-8#5)(2007-11#7)(2007-12#6)(2008-10#282)(2008-11#14)(2008-12#8)(2008-2#8)(2008-3#73)(2008-4#3)(2008-5#9)(2008-6#10)(2008-7#20)(2008-8#13)(2008-9#24)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#4)(2009-3#7)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#6)(2010-10#1)(2010-11#5)(2010-12#4)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#12)(2012-12#2)(2012-2#7)(2012-3#1)(2012-8#1)(2013-1#11)(2013-8#11)
intensity)##2##1##(2008-3#1)(2010-11#1)
intensity-modulated##2##1##(2007-11#1)(2011-2#1)
intensive and##5##2##(2008-10#2)(2008-11#1)(2013-1#2)
intensive care for##2##3##(1997-3#1)(2013-8#1)
intensive care medicine##2##3##(1997-1#1)(1997-2#1)
intensive care nursery experience##2##4##(1995-1#2)
intensive care patients##4##3##(1990-2#3)(2008-7#1)
intensive care unit (ICU)##3##4##(1992-2#1)(2011-2#1)(2012-3#1)
intensive care unit for##2##4##(1991-11#1)(2010-12#1)
intensive care unit of##2##4##(2010-8#1)(2013-1#1)
intensive care unit##28##3##(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-2#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-5#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
intensive care unit]##2##3##(1990-6#1)(1991-3#1)
intensive care units##13##3##(1991-2#1)(1994-3#2)(2008-10#1)(2008-11#3)(2010-12#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
intensive care##74##2##(1990-11#1)(1990-2#3)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1992-2#1)(1993-3#1)(1994-3#2)(1995-1#3)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#14)(2008-5#2)(2008-7#1)(2009-1#1)(2009-5#2)(2010-10#1)(2010-12#2)(2010-7#2)(2010-8#3)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
intensive efforts##2##2##(2008-10#1)(2011-2#1)
intensive investigation##2##2##(2011-3#1)(2013-8#1)
intensive research##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
intensive studies##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
intensive training in##2##3##(1993-3#1)(2008-12#1)
intensive treatment for##3##3##(2012-2#3)
intensive treatment with##2##3##(1994-12#1)(2013-1#1)
intensive treatment##7##2##(1994-12#1)(1996-11#1)(2012-2#3)(2013-1#2)
intensive use of##2##3##(2008-10#2)
intensive##170##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1992-1#1)(1992-2#1)(1992-3#3)(1992-5#1)(1993-3#2)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#3)(1995-2#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-11#1)(2008-1#1)(2008-10#30)(2008-11#18)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#3)(2010-10#1)(2010-12#4)(2010-7#2)(2010-8#3)(2011-2#14)(2011-3#1)(2012-12#1)(2012-2#8)(2012-3#8)(2013-1#10)(2013-7#1)(2013-8#4)
intensively sampled##2##2##(2008-10#2)
intensively studied##4##2##(2008-10#1)(2008-9#1)(2011-2#2)
intensively##19##1##(1996-2#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#2)
intent of the##4##3##(1994-2#1)(1997-1#1)(2009-4#1)(2011-2#1)
intent of##7##2##(1994-1#1)(1994-2#1)(1997-1#1)(2008-12#1)(2009-4#1)(2010-5#1)(2011-2#1)
intent to complain##2##3##(1993-12#2)
intent to use condoms##3##4##(2008-4#3)
intent to##8##2##(1993-12#2)(1996-3#1)(2008-4#4)(2010-12#1)
intent##26##1##(1992-12#1)(1993-12#2)(1994-1#1)(1994-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-4#5)(2008-6#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#3)
intention and##3##2##(2009-6#1)(2012-3#1)(2013-1#1)
intention of##4##2##(1995-3#1)(1997-4#1)(2008-10#1)(2009-9#1)
intention to##5##2##(2009-5#1)(2011-1#3)(2013-8#1)
intention##16##1##(1994-3#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-1#3)(2012-3#1)(2013-1#1)(2013-8#1)
intentional and automatic retrieval##2##4##(2009-10#2)
intentional and##3##2##(2009-10#2)(2013-1#1)
intentional inferences##2##2##(2008-11#2)
intentional##25##1##(1992-3#1)(1997-2#1)(2008-10#3)(2008-11#7)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
intentionally##6##1##(1995-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)
intentions and##3##2##(1991-3#1)(2008-11#1)(2009-12#1)
intentions to##2##2##(1991-3#1)(2009-10#1)
intentions##16##1##(1990-11#1)(1991-3#2)(1995-3#1)(2008-11#1)(2009-10#2)(2009-12#8)(2011-1#1)
inter atrial septum##4##3##(2012-3#4)
inter##11##1##(2008-10#4)(2008-11#1)(2008-12#1)(2012-3#4)(2013-1#1)
inter- and intracellular##2##3##(2008-10#2)
inter- and intraspecific##2##3##(2008-8#2)
inter- and##11##2##(2008-10#7)(2008-8#2)(2011-2#1)(2012-2#1)
inter-##13##1##(1991-2#1)(2008-10#8)(2008-8#2)(2011-2#1)(2012-2#1)
inter-assay##6##1##(1990-11#1)(1996-12#1)(2008-10#3)(2011-3#1)
inter-day##12##1##(2008-10#11)(2011-3#1)
inter-disciplinary##2##1##(2008-11#1)(2009-7#1)
inter-individual##4##1##(2010-4#1)(2010-7#1)(2013-8#2)
inter-item correlation##2##2##(2013-1#2)
inter-laboratory comparison##2##2##(2008-10#2)
inter-laboratory##11##1##(2008-10#11)
inter-professional education##4##2##(2008-11#2)(2008-12#2)
inter-professional learning##2##2##(2008-11#2)
inter-professional##9##1##(2008-11#5)(2008-12#3)(2010-10#1)
inter-rater reliability of the##2##4##(2008-11#1)(2008-9#1)
inter-rater reliability##7##2##(2008-10#1)(2008-11#1)(2008-9#3)(2010-10#2)
inter-rater##8##1##(2008-10#2)(2008-11#1)(2008-9#3)(2010-10#2)
inter-relationships##3##1##(1990-9#1)(1991-2#1)(1992-9#1)
inter-simple sequence repeats##2##3##(2008-10#2)
inter-simple sequence##3##2##(2008-10#3)
inter-spawning##3##1##(2010-8#3)
inter-species differences##3##2##(2008-10#1)(2011-3#2)
inter-species##4##1##(2008-10#1)(2008-11#1)(2011-3#2)
inter-strain hybrids##2##2##(2008-12#2)
interact at##2##2##(2008-10#1)(2009-7#1)
interact differently##2##2##(2009-12#1)(2013-8#1)
interact directly or indirectly with##2##5##(2008-4#1)(2008-9#1)
interact directly with the##4##4##(1995-6#2)(1996-2#2)
interact directly with##5##3##(1993-8#1)(1995-6#2)(1996-2#2)
interact directly##7##2##(1993-8#1)(1995-6#2)(1996-2#2)(2008-4#1)(2008-9#1)
interact in a complex manner##2##5##(2007-11#1)(2008-11#1)
interact in a##4##3##(1992-10#1)(1993-8#1)(2007-11#1)(2008-11#1)
interact in vitro##2##3##(1995-12#1)(1995-2#1)
interact in##11##2##(1992-10#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-8#2)(2008-9#1)
interact strongly with##2##3##(1994-5#1)(2009-10#1)
interact strongly##3##2##(1994-5#1)(2008-10#1)(2009-10#1)
interact to affect sexual trait##2##5##(2012-3#2)
interact to##5##2##(1995-2#1)(2010-1#1)(2012-3#3)
interact with a##6##3##(1991-9#1)(1993-8#1)(1995-2#1)(2008-4#1)(2009-3#1)(2012-2#1)
interact with each other##4##4##(1994-12#1)(1995-2#2)(2008-10#1)
interact with other##2##3##(2008-12#1)(2011-2#1)
interact with the active site##2##5##(2008-8#2)
interact with the##20##3##(1990-2#1)(1991-5#1)(1994-5#2)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2012-3#2)
interact with##88##2##(1990-2#2)(1991-5#1)(1991-9#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1995-11#1)(1995-2#6)(1995-5#1)(1995-6#3)(1995-9#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
interact##141##1##(1990-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#6)(1995-11#2)(1995-12#1)(1995-2#9)(1995-5#1)(1995-6#5)(1995-9#1)(1996-2#4)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#9)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#8)(2013-1#2)(2013-8#4)
interacted significantly with##2##3##(1996-6#1)(2008-10#1)
interacted with the##3##3##(1994-5#1)(1995-8#1)(2008-5#1)
interacted with##12##2##(1991-5#1)(1994-5#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2010-10#1)(2011-2#2)
interacted##20##1##(1991-5#1)(1991-6#1)(1994-5#2)(1995-8#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#3)
interacting loci##2##2##(2008-8#1)(2011-2#1)
interacting molecules##2##2##(2008-11#1)(2010-12#1)
interacting phenotypes##5##2##(2008-8#5)
interacting protein##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
interacting proteins##7##2##(2008-1#1)(2008-4#1)(2008-9#3)(2009-8#1)(2011-2#1)
interacting with the##6##3##(1990-4#1)(1990-5#1)(1994-11#1)(1995-5#1)(2008-10#1)(2013-1#1)
interacting with##29##2##(1990-4#1)(1990-5#1)(1991-3#1)(1994-11#3)(1994-8#1)(1995-5#1)(1996-2#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#2)(2008-8#3)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#2)
interacting##81##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-3#1)(1993-12#1)(1994-11#3)(1994-8#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-6#3)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#11)(2008-9#7)(2009-12#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
interaction (i##2##2##(1997-2#1)(2008-9#1)
interaction among##7##2##(2008-10#1)(2008-11#2)(2008-12#3)(2010-6#1)
interaction and the##2##3##(2008-4#1)(2009-12#1)
interaction and##22##2##(1992-12#1)(1995-2#2)(1996-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-6#1)(2012-3#2)
interaction are##5##2##(1991-3#1)(2008-10#2)(2009-11#1)(2009-12#1)
interaction assays##2##2##(2009-10#2)
interaction between ADAM22 and 14-3-3beta##2##5##(2008-9#2)
interaction between P##2##3##(2008-10#2)
interaction between RIPs and rRNA##2##5##(2008-8#2)
interaction between RIPs and##3##4##(2008-8#3)
interaction between a##4##3##(1997-1#1)(2008-10#3)
interaction between intestinal epithelial cells##2##5##(2008-11#2)
interaction between the analyte and##2##5##(2008-10#1)(2010-7#1)
interaction between the two##9##4##(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-3#1)
interaction between the##41##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-3#1)(1994-5#1)(1996-2#1)(1996-5#2)(1997-2#1)(2008-10#16)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-10#1)(2012-3#2)
interaction between these##2##3##(2008-11#1)(2008-7#1)
interaction between two##5##3##(1990-11#1)(2008-10#2)(2008-8#2)
interaction between##183##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-2#2)(1991-5#2)(1992-1#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-11#1)(1994-5#3)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#3)(1997-1#1)(1997-2#1)(2006-6#2)(2008-1#1)(2008-10#73)(2008-11#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#18)(2008-9#10)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#3)(2013-8#2)
interaction by##5##2##(1990-12#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
interaction can be##2##3##(1994-3#1)(2008-8#1)
interaction chromatography##8##2##(1991-5#1)(2008-10#7)
interaction data##2##2##(2008-4#1)(2010-10#1)
interaction effects of##3##3##(2008-10#2)(2008-4#1)
interaction effects##7##2##(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)
interaction energy##3##2##(2008-10#3)
interaction for##3##2##(2008-10#2)(2008-12#1)
interaction had##2##2##(2008-10#2)
interaction has also been##2##4##(2008-10#1)(2013-8#1)
interaction has##3##2##(2008-10#1)(2011-10#1)(2013-8#1)
interaction in the##6##3##(1991-7#1)(1995-11#1)(1996-5#1)(2008-10#3)
interaction in##24##2##(1990-12#3)(1990-5#1)(1991-7#1)(1993-1#1)(1995-11#1)(1996-5#1)(2008-10#8)(2008-9#1)(2009-3#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-7#2)(2013-8#1)
interaction information##2##2##(2008-4#1)(2011-3#1)
interaction is negligible##2##3##(2008-10#1)(2010-5#1)
interaction is##12##2##(1994-12#1)(1994-5#1)(2008-10#7)(2010-5#1)(2010-7#1)(2011-2#1)
interaction maps##2##2##(2011-2#1)(2012-2#1)
interaction mating##2##2##(2008-9#2)
interaction model##2##2##(2008-10#1)(2012-2#1)
interaction networks##6##2##(2008-4#2)(2011-2#2)(2012-2#1)(2012-3#1)
interaction of guanidine hydrochloride with##2##5##(1993-3#2)
interaction of histone with nucleic acids##2##6##(2008-10#2)
interaction of protein##4##3##(1990-12#1)(1994-5#2)(2008-10#1)
interaction of the##20##3##(1990-2#1)(1992-12#1)(1994-5#1)(1995-2#1)(1996-5#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-2#1)
interaction of two##4##3##(2008-10#3)(2008-8#1)
interaction of vitamin##2##3##(1992-9#1)(1993-12#1)
interaction of##169##2##(1990-12#1)(1990-2#3)(1991-1#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#4)(1994-11#1)(1994-12#1)(1994-5#5)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#3)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#80)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#8)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#5)(2012-2#3)(2012-8#1)
interaction on the##3##3##(1994-2#1)(2008-10#2)
interaction on##8##2##(1994-2#1)(2008-10#7)
interaction parameters for the##2##4##(2008-10#2)
interaction parameters##3##2##(2008-10#3)
interaction partners##2##2##(2008-8#2)
interaction pathways##3##2##(2008-11#2)(2008-9#1)
interaction patterns##2##2##(2012-3#2)
interaction phenotypes##2##2##(2008-10#2)
interaction rates##2##2##(2008-8#1)(2008-9#1)
interaction site##2##2##(2010-7#1)(2012-3#1)
interaction sites##3##2##(2008-10#2)(2008-8#1)
interaction studies##2##2##(2008-4#1)(2012-2#1)
interaction that##5##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)
interaction to##2##2##(2008-10#1)(2013-8#1)
interaction trap##2##2##(2008-9#2)
interaction was found between##2##4##(2008-10#1)(2009-7#1)
interaction was found##3##3##(1993-6#1)(2008-10#1)(2009-7#1)
interaction was significant##2##3##(2008-10#2)
interaction was##23##2##(1990-12#1)(1993-1#1)(1993-6#1)(1995-2#1)(2008-10#15)(2008-9#2)(2009-7#1)(2012-2#1)
interaction were##2##2##(2008-10#2)
interaction with DNA##2##3##(2008-10#2)
interaction with a##5##3##(1993-6#1)(1993-8#1)(1994-11#1)(2010-4#1)(2013-8#1)
interaction with beta-CD##2##3##(2008-10#2)
interaction with other##3##3##(1995-2#1)(1997-8#1)(2013-1#1)
interaction with the estrogen receptor##2##5##(2008-11#2)
interaction with the host##2##4##(2008-10#1)(2011-2#1)
interaction with the##25##3##(1990-4#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-2#4)(1997-1#2)(1997-2#1)(2008-10#7)(2008-11#3)(2011-2#3)(2013-1#1)
interaction with their##2##3##(2008-7#1)(2010-10#1)
interaction with##123##2##(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#3)(1995-11#2)(1995-2#2)(1995-6#4)(1995-8#2)(1996-2#4)(1997-1#3)(1997-2#3)(1997-4#1)(1997-8#1)(2008-10#41)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#2)(2010-10#1)(2010-4#2)(2011-2#8)(2012-2#1)(2013-1#4)(2013-8#1)
interaction##864##1##(1990-11#2)(1990-12#11)(1990-2#7)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-2#2)(1991-3#1)(1991-5#7)(1991-6#4)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#5)(1993-1#3)(1993-11#1)(1993-12#1)(1993-3#4)(1993-6#5)(1993-8#11)(1993-9#1)(1994-11#6)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#13)(1994-6#2)(1994-8#1)(1995-11#10)(1995-12#3)(1995-2#16)(1995-5#2)(1995-6#10)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#7)(1996-5#6)(1997-1#4)(1997-2#7)(1997-3#3)(1997-4#1)(1997-8#3)(2006-6#3)(2008-1#1)(2008-10#350)(2008-11#33)(2008-12#7)(2008-2#4)(2008-3#8)(2008-4#14)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#35)(2008-9#41)(2009-10#5)(2009-11#3)(2009-12#2)(2009-3#2)(2009-6#3)(2009-7#11)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#2)(2011-10#3)(2011-2#34)(2011-3#4)(2012-12#1)(2012-2#14)(2012-3#12)(2012-4#1)(2012-8#1)(2013-1#10)(2013-7#2)(2013-8#12)
interaction)##2##1##(2008-10#2)
interactional patterns##3##2##(2008-6#2)(2010-10#1)
interactional##5##1##(1992-1#1)(2008-6#2)(2010-10#1)(2013-8#1)
interactions also were##2##3##(2008-10#2)
interactions also##3##2##(2008-10#3)
interactions among the##2##3##(2008-10#1)(2008-8#1)
interactions among##16##2##(1993-1#1)(2008-10#10)(2008-4#1)(2008-8#3)(2010-5#1)
interactions and on##2##3##(1991-10#1)(2008-10#1)
interactions and the##5##3##(1993-8#1)(2008-10#2)(2008-5#1)(2010-8#1)
interactions and##32##2##(1991-10#1)(1993-8#1)(1995-1#1)(1995-2#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2011-3#1)
interactions are described##2##3##(2008-10#1)(2008-4#1)
interactions are not##2##3##(1991-8#1)(2008-10#1)
interactions are##22##2##(1991-8#1)(1992-3#1)(1993-3#1)(1994-5#4)(2008-10#5)(2008-11#3)(2008-4#1)(2008-9#2)(2009-10#1)(2010-10#1)(2012-2#1)(2012-3#1)
interactions as##2##2##(2008-10#1)(2012-3#1)
interactions at the cell surface##2##5##(2008-4#2)
interactions at the##4##3##(1996-12#1)(2008-11#1)(2008-4#2)
interactions at##7##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-10#1)(2010-7#1)
interactions because##2##2##(1996-12#1)(2010-10#1)
interactions between an##2##3##(2007-12#1)(2008-10#1)
interactions between genes##3##3##(2012-3#2)(2013-7#1)
interactions between plants and##2##4##(2008-8#1)(2009-8#1)
interactions between the host and##2##5##(2008-10#2)
interactions between the two##4##4##(1993-6#1)(1997-2#1)(2008-10#2)
interactions between the##30##3##(1991-2#1)(1993-6#2)(1993-9#1)(1997-2#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
interactions between these##2##3##(2008-10#1)(2013-8#1)
interactions between##142##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-8#3)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#48)(2008-11#7)(2008-12#2)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#9)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#7)(2012-4#3)(2013-1#2)(2013-7#1)(2013-8#4)
interactions by##4##2##(2008-10#2)(2008-4#1)(2013-1#1)
interactions can be##6##3##(2008-4#1)(2008-8#2)(2009-10#1)(2010-11#1)(2011-2#1)
interactions can##10##2##(1990-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#3)(2009-10#1)(2010-11#1)(2011-2#1)
interactions caused from##2##3##(2008-10#2)
interactions caused##3##2##(1992-3#1)(2008-10#2)
interactions did not##2##3##(2008-10#1)(2008-8#1)
interactions due to##2##3##(2008-5#1)(2012-6#1)
interactions for the##2##3##(1997-2#1)(2008-7#1)
interactions for##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
interactions has been##2##3##(1992-9#1)(2008-9#1)
interactions has##4##2##(1992-9#1)(2008-9#1)(2009-11#1)(2010-8#1)
interactions have recently been developed##2##5##(2008-4#1)(2013-1#1)
interactions have##6##2##(1997-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-3#1)(2013-1#1)
interactions in a##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
interactions in immediate##2##3##(2010-11#2)
interactions in the##8##3##(1991-3#1)(1991-6#1)(1993-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-10#1)
interactions in##48##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-7#2)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#2)
interactions into##2##2##(2008-10#1)(2013-8#1)
interactions involved in##2##3##(2009-3#1)(2012-2#1)
interactions involving##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
interactions is##8##2##(1992-8#1)(1994-9#1)(1995-12#1)(2008-10#2)(2008-4#2)(2011-2#1)
interactions may be##2##3##(2008-11#1)(2008-9#1)
interactions may##7##2##(1990-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#2)(2013-1#1)
interactions might##2##2##(2008-10#1)(2008-7#1)
interactions must##3##2##(1993-8#1)(2008-10#1)(2008-9#1)
interactions occur between##2##3##(2008-10#2)
interactions occur##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
interactions occurring##2##2##(2008-10#1)(2009-11#1)
interactions of ATP and ADP with rubisco activase##2##8##(1991-9#2)
interactions of ATP##3##3##(1991-9#2)(2008-8#1)
interactions of C5a##2##3##(2008-10#2)
interactions of porcine##2##3##(2013-1#2)
interactions of quantitative trait loci##2##5##(2008-10#2)
interactions of quantitative trait##3##4##(2008-10#3)
interactions of the##14##3##(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#3)(1994-5#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-4#1)
interactions of this##2##3##(2008-10#1)(2008-5#1)
interactions of##55##2##(1990-11#1)(1991-9#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-8#4)(1994-5#1)(1997-2#1)(2008-10#21)(2008-11#1)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#4)(2009-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#2)
interactions often##2##2##(2008-10#2)
interactions on##10##2##(1993-6#1)(1995-11#1)(2008-10#4)(2008-8#3)(2010-3#1)
interactions or##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
interactions play a significant role in##2##6##(2008-4#1)(2010-1#1)
interactions play a##3##3##(2008-4#1)(2009-7#1)(2010-1#1)
interactions play##4##2##(1993-9#1)(2008-4#1)(2009-7#1)(2010-1#1)
interactions should be##2##3##(2008-10#1)(2008-11#1)
interactions such as##2##3##(2008-4#1)(2008-6#1)
interactions that occur##2##3##(1996-3#1)(2009-7#1)
interactions that they##2##3##(2008-8#1)(2008-9#1)
interactions that##13##2##(1991-6#1)(1992-9#1)(1996-3#1)(2008-10#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
interactions to##6##2##(2008-10#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-3#1)
interactions using##5##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
interactions were observed##2##3##(2008-10#1)(2013-1#1)
interactions were##12##2##(2008-10#8)(2008-11#1)(2013-1#2)(2013-8#1)
interactions with host##2##3##(2006-6#1)(2008-10#1)
interactions with other##2##3##(1990-2#1)(2013-1#1)
interactions with the##9##3##(1994-5#1)(1995-6#1)(2008-10#4)(2008-4#1)(2010-5#1)(2011-7#1)
interactions with three##2##3##(1993-6#1)(2008-9#1)
interactions with##58##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#3)(2006-6#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#5)(2009-12#2)(2010-5#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
interactions within the##3##3##(1991-5#1)(1992-4#1)(1993-6#1)
interactions within##6##2##(1991-5#1)(1992-4#1)(1992-9#1)(1993-6#1)(2008-7#1)(2012-3#1)
interactions##776##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#5)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-3#9)(1992-4#4)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#8)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#6)(1993-8#9)(1993-9#3)(1994-12#1)(1994-3#1)(1994-5#12)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-6#3)(1995-8#3)(1996-12#5)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#10)(1997-3#3)(1997-7#3)(2006-6#2)(2007-12#3)(2008-1#2)(2008-10#234)(2008-11#33)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#42)(2008-5#19)(2008-6#3)(2008-7#12)(2008-8#62)(2008-9#48)(2009-10#4)(2009-11#2)(2009-12#5)(2009-3#4)(2009-5#1)(2009-6#3)(2009-7#7)(2009-8#9)(2009-9#5)(2010-1#2)(2010-10#7)(2010-11#5)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-10#1)(2011-2#16)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#16)(2012-3#18)(2012-4#4)(2012-6#1)(2013-1#16)(2013-7#2)(2013-8#13)
interactions)##4##1##(1990-5#1)(1993-12#1)(2008-10#1)(2011-2#1)
interactions?##3##1##(1991-9#1)(2008-11#2)
interactive effects of##3##3##(2008-10#1)(2012-3#2)
interactive effects##6##2##(2008-10#1)(2012-3#4)(2013-8#1)
interactive learning##2##2##(2008-11#1)(2012-3#1)
interactive multimedia##3##2##(2008-11#3)
interactive strategy##4##2##(2008-12#4)
interactive##45##1##(1994-1#1)(1995-2#2)(2008-10#3)(2008-11#7)(2008-12#6)(2008-6#5)(2008-9#2)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#6)(2013-1#1)(2013-8#3)
interactively##3##1##(2008-11#1)(2008-6#2)
interactome##3##1##(2013-1#3)
interactors##2##1##(2008-8#1)(2009-10#1)
interacts in##2##2##(1995-12#1)(2012-2#1)
interacts specifically##2##2##(1993-12#1)(1993-8#1)
interacts with other##2##3##(1993-8#1)(2013-8#1)
interacts with the##13##3##(1994-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)(2011-3#1)(2012-3#1)
interacts with##45##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1993-11#1)(1993-8#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-2#3)(1997-3#1)(1997-4#1)(2008-10#6)(2008-11#3)(2008-8#3)(2008-9#5)(2009-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
interacts##53##1##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#3)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1997-2#3)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-8#3)(2008-9#6)(2009-12#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
interampatte##3##1##(2010-10#3)
interampatteness##2##1##(2010-10#2)
interannual##2##1##(2010-8#1)(2012-2#1)
interbody fusion##5##2##(2008-7#2)(2011-2#3)
interbreeding##3##1##(2008-10#2)(2008-8#1)
interbulbar##2##1##(1993-3#2)
intercalary##3##1##(2007-12#2)(2012-9#1)
intercalate into##2##2##(1991-6#1)(1994-5#1)
intercalate##5##1##(1991-6#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-6#1)
intercalated in double helix DNA##2##5##(2008-10#2)
intercalated into##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
intercalated##13##1##(1994-5#2)(2008-10#7)(2008-6#1)(2010-4#3)
intercalates into##2##2##(2008-10#2)
intercalating agents##2##2##(2008-11#1)(2008-4#1)
intercalation and##2##2##(1994-5#1)(2008-10#1)
intercalation compounds##2##2##(2010-4#2)
intercalation of##5##2##(1993-8#2)(2008-10#2)(2009-6#1)
intercalation##13##1##(1993-8#3)(1994-5#3)(2008-10#4)(2009-6#1)(2010-4#2)
intercalibration##2##1##(2008-10#1)(2008-3#1)
intercanine distance##2##2##(2012-3#2)
intercellular adhesion molecule##2##3##(1995-2#2)
intercellular adhesion molecule-1 (ICAM-1)##2##4##(2009-10#1)(2010-1#1)
intercellular adhesion##5##2##(1995-2#2)(2009-10#2)(2010-1#1)
intercellular communication##5##2##(1994-11#2)(2008-11#1)(2008-9#1)(2013-8#1)
intercellular hyphae##2##2##(2008-10#2)
intercellular lipids##2##2##(2008-5#2)
intercellular space##4##2##(2008-10#2)(2008-5#1)(2009-7#1)
intercellular spaces of the##4##4##(2008-10#4)
intercellular spaces of##6##3##(2008-10#6)
intercellular spaces##11##2##(2008-10#11)
intercellular##44##1##(1990-12#1)(1994-11#2)(1994-5#1)(1995-2#2)(2008-10#20)(2008-11#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#4)(2009-7#1)(2010-1#1)(2013-8#1)
intercellularly and##2##2##(2008-10#1)(2008-8#1)
intercept of the##3##3##(2008-10#3)
intercept of##6##2##(2008-10#5)(2009-8#1)
intercept were significantly##2##3##(2008-10#2)
intercept were##4##2##(2008-10#4)
intercept##26##1##(1997-8#1)(2008-10#24)(2009-8#1)
intercepted##3##1##(1996-5#2)(2008-11#1)
interception##4##1##(2008-10#4)
intercepts##2##1##(2008-10#1)(2008-9#1)
interchain disulfide##2##2##(1990-5#1)(1993-6#1)
interchain immonium ions##2##3##(2008-10#2)
interchain##6##1##(1990-5#2)(1993-6#1)(2008-10#2)(2008-11#1)
interchange##7##1##(1993-3#1)(1994-11#1)(1997-1#1)(2008-10#1)(2009-9#3)
interchangeability of##2##2##(1990-2#1)(2013-1#1)
interchangeability##4##1##(1990-2#1)(2013-1#3)
interchanged##2##1##(2013-1#2)
interchip free-space##2##2##(2008-3#2)
intercomparison##3##1##(2008-10#2)(2008-11#1)
interconnect system##2##2##(2008-3#2)
interconnect##3##1##(2008-3#2)(2009-5#1)
interconnected cylindrical##2##2##(2008-10#2)
interconnected##9##1##(1991-10#1)(1994-5#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#2)
interconnecting##3##1##(1997-6#1)(2008-1#1)(2008-5#1)
interconnection##5##1##(1995-3#1)(2008-3#4)
interconnections##4##1##(2008-11#2)(2008-3#2)
intercontinental migration of##2##3##(2008-10#2)
intercontinental##3##1##(2008-10#2)(2012-3#1)
interconversion between the##4##3##(2008-10#4)
interconversion of##3##2##(1990-9#1)(1992-10#1)(2008-10#1)
interconversion##11##1##(1990-9#1)(1992-10#1)(1997-1#3)(2008-10#6)
intercorrelated##2##1##(1996-12#1)(2008-10#1)
intercostal veins##3##2##(2011-2#3)
intercostal##11##1##(1990-2#2)(1997-1#1)(2008-10#4)(2011-2#4)
intercourse among##2##2##(1990-9#1)(2012-2#1)
intercourse with a##2##3##(2008-12#2)
intercourse with##5##2##(2008-12#4)(2012-2#1)
intercourse##20##1##(1990-9#6)(1996-6#1)(2008-12#6)(2008-7#1)(2009-12#1)(2009-5#1)(2010-7#1)(2012-12#1)(2012-2#2)
intercross##3##1##(2008-8#1)(2010-4#1)(2012-3#1)
intercrossed and##2##2##(2008-10#2)
interday precision##2##2##(2008-10#2)
interday##4##1##(2008-10#4)
interdependence and##2##2##(1994-12#1)(2009-8#1)
interdependence##8##1##(1994-12#1)(2009-8#6)(2011-2#1)
interdependencies##2##1##(2008-11#1)(2010-1#1)
interdependent##4##1##(2009-10#1)(2009-8#2)(2013-1#1)
interdiffused quantum wells##2##3##(2008-2#2)
interdiffused quantum##3##2##(2008-2#3)
interdiffusion##3##1##(2008-2#3)
interdigitated array##3##2##(2008-10#3)
interdigitated electrodes##3##2##(2008-10#3)
interdigitated gel phase##2##3##(1993-8#2)
interdigitated microelectrode array##2##3##(2008-10#2)
interdigitated##14##1##(1992-4#1)(1993-8#4)(2008-10#9)
interdisciplinary approach in##3##3##(1995-5#1)(1997-8#1)(2008-4#1)
interdisciplinary approach##6##2##(1992-2#1)(1995-5#1)(1997-8#1)(2008-4#1)(2011-2#1)(2013-1#1)
interdisciplinary assessment##4##2##(1995-1#2)(2013-1#2)
interdisciplinary collaboration##2##2##(1992-12#1)(1996-1#1)
interdisciplinary community service-learning##2##3##(2008-1#2)
interdisciplinary connections##2##2##(2011-2#2)
interdisciplinary group of##2##3##(1992-1#1)(2010-10#1)
interdisciplinary palliative care team##2##4##(2009-9#2)
interdisciplinary research##2##2##(1993-2#1)(2011-2#1)
interdisciplinary team of##2##3##(1994-12#1)(1995-5#1)
interdisciplinary team##4##2##(1994-12#2)(1995-5#1)(2010-10#1)
interdisciplinary##48##1##(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-12#2)(1995-1#2)(1995-11#1)(1995-5#4)(1996-1#3)(1996-2#1)(1997-2#1)(1997-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
interdomain linker##2##2##(2009-7#1)(2013-8#1)
interdomain##3##1##(1993-2#1)(2009-7#1)(2013-8#1)
interest and research##2##3##(2009-1#1)(2010-6#1)
interest and##17##2##(1991-3#2)(1993-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2009-1#1)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)
interest are presented##2##3##(2008-10#1)(2008-12#1)
interest are##7##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2013-8#1)
interest as it##2##3##(2011-2#2)
interest as##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#2)
interest at##2##2##(1996-3#1)(2008-10#1)
interest because it is##3##4##(2011-2#3)
interest because it##7##3##(1990-8#1)(1996-6#1)(2008-10#1)(2011-2#4)
interest because of its isolated##2##5##(2011-2#2)
interest because of its##5##4##(2011-2#5)
interest because of the##5##4##(1990-12#1)(1997-3#1)(2008-3#1)(2011-2#2)
interest because of##13##3##(1990-12#1)(1993-1#1)(1997-3#1)(2008-3#1)(2011-2#9)
interest because they##2##3##(1996-12#1)(2008-10#1)
interest because##23##2##(1990-12#1)(1990-8#1)(1993-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-3#1)(2011-2#14)
interest for a##2##3##(2008-11#1)(2010-7#1)
interest for the##7##3##(2008-10#3)(2008-3#1)(2008-9#1)(2009-12#1)(2013-8#1)
interest for##30##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-9#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#5)(2008-9#3)(2009-12#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-8#1)
interest groups##4##2##(1992-2#1)(1995-3#1)(1996-3#1)(2012-2#1)
interest had##2##2##(1995-12#1)(2011-2#1)
interest has##4##2##(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#1)
interest in a##4##3##(1992-12#1)(1992-9#1)(2008-5#1)(2008-9#1)
interest in clinical##2##3##(2011-3#1)(2013-1#1)
interest in colorectal##2##3##(1991-3#1)(2013-1#1)
interest in developing##5##3##(1994-12#1)(2008-5#1)(2009-7#1)(2010-10#1)(2011-3#1)
interest in research##2##3##(1994-3#1)(2013-1#1)
interest in the development of##3##5##(2008-10#1)(2008-11#1)(2009-7#1)
interest in the effects of##2##5##(1995-2#1)(2008-7#1)
interest in the potential##3##4##(1992-9#1)(2010-7#1)(2012-2#1)
interest in the use of##3##5##(1995-5#1)(2008-3#1)(2008-7#1)
interest in the##37##3##(1990-2#1)(1990-5#1)(1992-9#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-9#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
interest in their##2##3##(2008-10#1)(2012-2#1)
interest in these##2##3##(2008-11#1)(2010-1#1)
interest in this##5##3##(1995-3#1)(2008-10#1)(2008-11#1)(2013-8#2)
interest in understanding the##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
interest in using##2##3##(1996-2#1)(2008-9#1)
interest in##119##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#4)(1996-9#3)(1997-3#1)(1997-7#3)(2008-10#19)(2008-11#11)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-12#2)(2009-6#2)(2009-7#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#4)
interest include##2##2##(1990-2#1)(2010-7#1)
interest is in##2##3##(1992-9#1)(2010-2#1)
interest is the##4##3##(1994-9#1)(2008-5#1)(2008-9#2)
interest is##18##2##(1992-9#1)(1994-9#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#2)(2010-2#1)(2010-5#1)(2012-2#1)
interest of a##2##3##(2008-5#1)(2009-7#1)
interest of our##2##3##(2008-6#1)(2013-1#1)
interest of##14##2##(1994-1#2)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
interest or##2##2##(2008-7#2)
interest over##2##2##(2008-9#2)
interest regarding##3##2##(2010-12#1)(2011-3#2)
interest since##2##2##(1991-12#1)(2008-10#1)
interest to the##2##3##(2008-10#2)
interest to##20##2##(1990-2#1)(1993-11#1)(1993-12#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
interest was the##2##3##(1993-12#1)(1996-12#1)
interest was##5##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-8#1)(2010-7#1)
interest when##2##2##(2008-10#1)(2013-7#1)
interest with##2##2##(1995-3#1)(2008-10#1)
interest##436##1##(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-1#3)(1993-11#1)(1993-12#3)(1993-3#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#2)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-6#4)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#4)(2006-6#1)(2008-1#1)(2008-10#72)(2008-11#38)(2008-12#9)(2008-2#2)(2008-3#9)(2008-4#18)(2008-5#6)(2008-6#3)(2008-7#16)(2008-8#9)(2008-9#20)(2009-1#2)(2009-12#4)(2009-4#2)(2009-6#2)(2009-7#4)(2009-8#3)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-5#4)(2010-6#2)(2010-7#4)(2010-9#3)(2011-1#27)(2011-2#31)(2011-3#5)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#9)
interested in developing their##2##4##(2008-11#1)(2008-12#1)
interested in developing##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
interested in investigating##2##3##(1992-2#1)(2008-11#1)
interested in the##3##3##(1995-5#2)(2008-1#1)
interested in##25##2##(1991-3#1)(1992-2#1)(1992-3#2)(1994-12#1)(1994-2#1)(1995-5#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-9#1)(2010-10#2)(2010-2#1)(2011-2#2)(2011-9#1)(2013-8#1)
interested##34##1##(1991-3#1)(1992-2#1)(1992-3#2)(1993-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-9#1)(2010-1#1)(2010-10#2)(2010-2#1)(2011-2#2)(2011-9#1)(2013-1#2)(2013-8#1)
interesting and novel##2##3##(2008-8#1)(2010-12#1)
interesting and##5##2##(1994-6#1)(1996-9#1)(2008-8#1)(2010-12#1)(2013-1#1)
interesting case of bladder##2##4##(2008-10#2)
interesting case of##5##3##(2008-10#2)(2010-6#1)(2012-2#1)(2013-1#1)
interesting case##8##2##(2008-10#2)(2009-8#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#2)
interesting clinical##2##2##(1992-5#1)(2010-11#1)
interesting correlation##2##2##(2008-10#1)(2010-8#1)
interesting elements##3##2##(2008-10#3)
interesting features##2##2##(1996-2#1)(2011-2#1)
interesting finding is##2##3##(2008-10#1)(2008-2#1)
interesting for the##2##3##(2008-10#1)(2008-3#1)
interesting for##4##2##(1993-8#1)(2008-10#1)(2008-3#1)(2011-7#1)
interesting in##2##2##(2008-10#1)(2008-11#1)
interesting inhibitory effect##2##3##(2008-10#1)(2012-2#1)
interesting results##2##2##(1997-8#1)(2008-10#1)
interesting since##2##2##(2008-3#1)(2010-11#1)
interesting targets for##2##3##(2008-10#1)(2013-8#1)
interesting that the##2##3##(2008-11#1)(2008-9#1)
interesting that##6##2##(1992-12#1)(2008-11#3)(2008-12#1)(2008-9#1)
interesting##115##1##(1990-5#1)(1990-8#1)(1991-6#2)(1992-12#1)(1992-5#2)(1993-8#2)(1994-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#29)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-11#5)(2010-12#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#4)
interestingly##3##1##(2008-11#2)(2010-11#1)
interests and##6##2##(1991-2#1)(1992-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-2#1)
interests in##3##2##(2008-11#1)(2009-6#1)(2013-1#1)
interests of the##6##3##(1991-12#1)(1997-1#1)(2008-8#1)(2010-9#2)(2012-12#1)
interests of##12##2##(1991-12#1)(1995-2#3)(1997-1#1)(1997-3#2)(2008-8#1)(2010-9#2)(2012-12#1)(2013-1#1)
interests##45##1##(1990-6#2)(1991-12#1)(1991-2#2)(1991-6#2)(1992-1#2)(1992-2#1)(1992-3#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#3)(2009-6#1)(2010-1#1)(2010-2#1)(2010-9#2)(2012-12#1)(2012-2#1)(2013-1#3)
interface and##8##2##(1993-9#1)(1994-5#1)(2008-10#5)(2008-9#1)
interface applications##2##2##(2008-10#2)
interface as##3##2##(1993-8#1)(2010-8#1)(2013-1#1)
interface between##15##2##(1996-2#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-10#1)
interface can be used##2##4##(2008-10#1)(2008-4#1)
interface concept##2##2##(2008-10#2)
interface could##2##2##(2008-10#2)
interface for##5##2##(2008-10#4)(2010-8#1)
interface has been##2##3##(2008-10#2)
interface has##3##2##(2008-10#2)(2013-1#1)
interface in order to##2##4##(2008-10#1)(2010-8#1)
interface in##8##2##(1990-12#1)(1991-5#2)(1992-3#1)(2008-10#2)(2008-8#1)(2010-8#1)
interface is##3##2##(2008-10#1)(2008-3#2)
interface of the##7##3##(1991-12#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-8#1)
interface of##18##2##(1991-12#1)(1997-2#1)(2008-10#10)(2008-3#2)(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#1)
interface that##2##2##(2010-10#1)(2013-8#1)
interface to##5##2##(2008-10#3)(2008-7#1)(2010-10#1)
interface was##9##2##(1994-5#1)(2008-10#6)(2008-5#1)(2010-8#1)
interface where##2##2##(2008-10#2)
interface with##4##2##(2008-10#2)(2010-10#1)(2013-1#1)
interface##177##1##(1990-11#1)(1990-12#2)(1991-12#1)(1991-3#4)(1991-5#2)(1992-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-5#3)(1995-2#1)(1995-3#1)(1996-2#2)(1997-2#2)(2008-10#89)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#8)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-9#3)(2010-10#4)(2010-8#8)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#2)
interfaced to a##2##3##(1997-2#1)(2008-10#1)
interfaced to##4##2##(1997-2#2)(2008-10#2)
interfaced with##2##2##(2008-1#1)(2008-10#1)
interfaced##8##1##(1997-2#2)(2008-1#1)(2008-10#5)
interfaces and##2##2##(2008-10#2)
interfaces in##3##2##(1990-8#1)(2008-10#1)(2009-7#1)
interfaces##21##1##(1990-8#1)(1991-5#1)(1992-11#1)(1997-2#1)(2008-10#12)(2008-11#1)(2009-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
interfacial area##2##2##(2008-10#1)(2008-7#1)
interfacial pressure detector##2##3##(2008-10#2)
interfacial pressure##6##2##(2008-10#6)
interfacial region##2##2##(2008-7#2)
interfacial tension##3##2##(1997-1#1)(2008-10#1)(2010-4#1)
interfacial transport##3##2##(1991-5#2)(2008-10#1)
interfacial##44##1##(1990-8#2)(1991-3#1)(1991-5#3)(1993-6#1)(1993-8#1)(1997-1#1)(2008-10#23)(2008-5#1)(2008-7#4)(2009-11#2)(2009-3#1)(2010-4#2)(2012-2#2)
interfacing of a##4##3##(2008-10#4)
interfacing of##6##2##(1997-2#1)(2008-10#5)
interfacing##11##1##(1994-6#1)(1997-2#1)(2008-10#8)(2009-10#1)
interferants##3##1##(2008-10#3)
interfere and##2##2##(2008-10#2)
interfere in the##9##3##(2008-10#9)
interfere in##12##2##(2008-10#12)
interfere the##6##2##(2008-10#6)
interfere with fungal growth##2##4##(2008-10#1)(2010-7#1)
interfere with other##3##3##(2008-10#3)
interfere with platelet aggregation##2##4##(1991-12#1)(2008-5#1)
interfere with the determination of##5##5##(2008-10#5)
interfere with the determination##9##4##(2008-10#9)
interfere with the##36##3##(1990-12#1)(1990-5#1)(1993-3#1)(1997-2#1)(2008-10#22)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-3#1)
interfere with##89##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-5#1)(1993-3#2)(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#39)(2008-11#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
interfere##130##1##(1990-12#1)(1990-5#2)(1991-12#1)(1991-5#1)(1993-3#2)(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#79)(2008-11#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
interfered by##2##2##(2008-10#2)
interfered with its##2##3##(2008-10#1)(2013-1#1)
interfered with the##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
interfered with##12##2##(1990-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1996-6#1)(2008-10#2)(2008-11#2)(2010-5#1)(2013-1#2)
interfered##16##1##(1990-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1996-6#1)(2008-10#6)(2008-11#2)(2010-5#1)(2013-1#2)
interference and##11##2##(1995-8#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#2)(2013-1#1)
interference are##2##2##(2007-11#1)(2008-10#1)
interference between##3##2##(2007-11#1)(2008-8#1)(2013-8#1)
interference by##18##2##(1990-2#1)(2008-10#16)(2008-2#1)
interference can be##3##3##(2008-10#2)(2008-8#1)
interference caused by the##2##4##(2008-10#2)
interference caused by##11##3##(2008-10#10)(2008-5#1)
interference device##3##2##(2008-7#2)(2013-8#1)
interference due to##3##3##(2008-10#3)
interference effect of several##2##4##(2008-10#2)
interference effect of##4##3##(2008-10#4)
interference effect on the##4##4##(2008-10#4)
interference effect##10##2##(2007-12#1)(2008-10#9)
interference effects of the##2##4##(2008-10#1)(2008-2#1)
interference effects of##5##3##(2008-10#4)(2008-2#1)
interference effects##8##2##(2008-10#5)(2008-2#2)(2008-3#1)
interference filters##4##2##(2008-2#1)(2008-3#3)
interference for##2##2##(2008-10#1)(2008-2#1)
interference free##3##2##(2008-10#3)
interference fringe##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
interference from dissolved##2##3##(2008-10#2)
interference from excipients##3##3##(2008-10#3)
interference from many##3##3##(2008-10#3)
interference from other##5##3##(2008-10#4)(2008-3#1)
interference from oxidizable species##2##4##(2008-10#2)
interference from several common##2##4##(2008-10#2)
interference from silicate##2##3##(2008-10#2)
interference from some##3##3##(2008-10#3)
interference from surfactants##2##3##(2008-10#2)
interference from the##3##3##(2008-10#3)
interference from water-vapor lines##2##4##(2008-3#2)
interference from##60##2##(1990-2#1)(1995-2#1)(2008-10#54)(2008-3#3)(2011-2#1)
interference hyperspectral image##2##3##(2013-8#2)
interference in the determination of##5##5##(2008-10#5)
interference in the##11##3##(1990-12#1)(1997-7#1)(2008-10#8)(2010-5#1)
interference in##19##2##(1990-12#1)(1992-11#2)(1993-2#2)(1997-7#1)(2008-10#11)(2009-9#1)(2010-5#1)
interference is caused by##2##4##(2007-12#1)(2008-3#1)
interference is##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
interference method##6##2##(2008-10#5)(2008-3#1)
interference of Cu on##2##4##(2008-10#2)
interference of a large number of##3##6##(2008-10#3)
interference of a##7##3##(2008-10#7)
interference of almost all##2##4##(2008-10#2)
interference of organic##2##3##(2008-10#2)
interference of other##3##3##(2008-10#3)
interference of the##11##3##(2008-10#8)(2008-5#1)(2008-7#1)(2013-1#1)
interference of##73##2##(1990-12#1)(2007-12#2)(2008-10#60)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#2)
interference on the##4##3##(2008-10#4)
interference on##8##2##(1994-6#1)(2008-10#7)
interference pattern##4##2##(2007-12#1)(2008-3#3)
interference problems##3##2##(2008-10#2)(2009-12#1)
interference screw##2##2##(2009-10#2)
interference studies##2##2##(2008-10#2)
interference study of##2##3##(2008-10#2)
interference study##6##2##(2008-10#6)
interference system##2##2##(2013-8#2)
interference that##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
interference to##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
interference was found##4##3##(2008-10#4)
interference was observed for##2##4##(2008-10#2)
interference was observed##10##3##(2008-10#9)(2008-3#1)
interference was##22##2##(1991-12#1)(2008-10#19)(2008-3#1)(2013-1#1)
interference were##2##2##(2008-10#1)(2008-3#1)
interference with the##5##3##(1997-1#1)(2008-10#1)(2008-11#1)(2013-7#1)(2013-8#1)
interference with##9##2##(1997-1#1)(2008-10#2)(2008-11#3)(2012-12#1)(2013-7#1)(2013-8#1)
interference##415##1##(1990-12#2)(1990-2#2)(1991-12#1)(1992-11#2)(1993-2#4)(1994-6#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-7#1)(2007-11#3)(2007-12#6)(2008-10#286)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#32)(2008-4#2)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-8#1)(2009-9#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#13)
interferences and has been successfully applied to the determination of##2##10##(2008-10#2)
interferences and##12##2##(2008-10#12)
interferences are caused by##2##4##(2008-10#2)
interferences are##9##2##(2008-10#9)
interferences as##2##2##(1991-7#1)(2008-10#1)
interferences between##2##2##(2008-10#2)
interferences by##2##2##(2008-10#2)
interferences can be##3##3##(2008-10#1)(2008-11#2)
interferences can##4##2##(2008-10#2)(2008-11#2)
interferences caused by alkali and alkaline earth##2##7##(2008-10#2)
interferences caused by the##4##4##(2008-10#4)
interferences caused by##10##3##(2008-10#10)
interferences due to##3##3##(2008-10#3)
interferences from common##2##3##(2008-10#2)
interferences from surface-active compounds##2##4##(2008-10#2)
interferences from the##3##3##(2008-10#3)
interferences from##21##2##(2008-10#21)
interferences in the determination of##2##5##(2008-10#2)
interferences in the##5##3##(2008-10#5)
interferences in##11##2##(2008-10#11)
interferences may##2##2##(2008-10#2)
interferences of other##2##3##(2008-10#1)(2008-2#1)
interferences of the##3##3##(2008-10#3)
interferences of##21##2##(1990-2#1)(2008-10#19)(2008-2#1)
interferences on percent recovery of##3##5##(2008-10#3)
interferences on the##6##3##(2008-10#6)
interferences on##11##2##(2008-10#11)
interferences was##5##2##(2008-10#5)
interferences were investigated##3##3##(2008-10#3)
interferences were observed##4##3##(2008-10#4)
interferences were##11##2##(2008-10#11)
interferences with##2##2##(2008-10#2)
interferences##183##1##(1990-2#1)(1991-7#1)(1993-1#1)(2008-10#175)(2008-11#2)(2008-2#2)(2012-12#1)
interferent in##3##2##(2008-10#3)
interferent ions##2##2##(2008-10#2)
interferent##14##1##(2008-10#14)
interferential##2##1##(2008-10#1)(2010-1#1)
interferents are##2##2##(2008-10#2)
interferents in##3##2##(2008-10#3)
interferents such as##2##3##(2008-10#2)
interferents were##2##2##(2008-10#2)
interferents##31##1##(2008-10#31)
interferes in the##3##3##(2008-10#3)
interferes with the##7##3##(1994-11#1)(2006-6#2)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
interferes with##17##2##(1990-5#1)(1994-11#1)(1994-5#1)(1997-6#1)(2006-6#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2013-1#1)(2013-7#1)
interferes##24##1##(1990-5#1)(1994-11#1)(1994-5#1)(1997-6#1)(2006-6#2)(2007-12#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-7#1)(2013-1#1)(2013-7#1)
interfering RNA##2##2##(2010-5#1)(2011-2#1)
interfering anions##2##2##(2008-10#2)
interfering cations##7##2##(2008-10#7)
interfering compounds##8##2##(2008-10#8)
interfering effect##6##2##(2008-10#6)
interfering effects of##4##3##(2008-10#4)
interfering effects##8##2##(2008-10#8)
interfering elements in##2##3##(2008-10#2)
interfering elements##5##2##(2008-10#5)
interfering ions and##2##3##(2008-10#2)
interfering ions are##2##3##(2008-10#2)
interfering ions on the recovery of the analytes##3##8##(2008-10#3)
interfering ions on the recovery of the##5##7##(2008-10#5)
interfering ions on the##9##4##(2008-10#9)
interfering ions on##10##3##(2008-10#10)
interfering ions was##4##3##(2008-10#4)
interfering ions were##3##3##(2008-10#3)
interfering ions##36##2##(2008-10#36)
interfering metal ions##2##3##(2008-10#2)
interfering peaks##6##2##(1997-2#6)
interfering species for##2##3##(2008-10#2)
interfering species##8##2##(2008-10#7)(2008-3#1)
interfering substances##5##2##(2008-10#5)
interfering with the generation of##2##5##(2010-7#1)(2011-2#1)
interfering with the##3##3##(2010-7#1)(2011-2#2)
interfering with##10##2##(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#3)
interfering##128##1##(1995-3#1)(1997-2#7)(2006-6#1)(2008-10#105)(2008-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#1)(2013-1#1)
interferogram##5##1##(2008-3#2)(2013-8#3)
interferograms##4##1##(2008-3#4)
interferometer and##3##2##(2008-3#3)
interferometer for##7##2##(2007-11#2)(2007-12#1)(2008-3#4)
interferometer is##2##2##(2007-11#1)(2007-12#1)
interferometer was##2##2##(2007-11#1)(2013-8#1)
interferometer with a##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
interferometer with##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2013-8#1)
interferometer##46##1##(2007-11#8)(2007-12#6)(2008-10#1)(2008-2#4)(2008-3#23)(2010-4#1)(2013-8#3)
interferometric##11##1##(2007-12#2)(2008-10#1)(2008-3#7)(2008-5#1)
interferometry with##3##2##(2008-3#2)(2008-5#1)
interferometry##23##1##(1992-8#1)(1994-11#2)(2007-12#2)(2008-3#16)(2008-5#1)(2009-7#1)
interferon (IFN)##2##2##(1993-2#1)(2009-8#1)
interferon (IFN)-gamma##5##2##(1994-8#1)(1996-12#2)(2008-10#1)(2008-11#1)
interferon alpha##6##2##(1997-1#3)(1997-5#1)(2009-10#1)(2010-4#1)
interferon and ribavirin##3##3##(2011-2#2)(2013-7#1)
interferon and##5##2##(2008-10#1)(2008-7#1)(2011-2#2)(2013-7#1)
interferon gamma##3##2##(1995-12#1)(2008-11#2)
interferon has been##2##3##(1991-6#1)(1997-1#1)
interferon has##3##2##(1991-6#1)(1997-1#2)
interferon regulatory factor-1##2##3##(1994-11#1)(2012-3#1)
interferon regulatory##4##2##(1994-11#1)(2012-3#2)(2013-1#1)
interferon##53##1##(1990-5#1)(1990-6#2)(1991-6#3)(1991-8#2)(1992-2#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-8#2)(1997-1#6)(1997-5#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
interferon-alpha (IFN-alpha)##2##2##(1994-3#1)(2009-5#1)
interferon-alpha##6##1##(1990-5#1)(1993-2#1)(1994-3#1)(1997-5#1)(2007-11#1)(2009-5#1)
interferon-alpha-2a##3##1##(1990-2#2)(2010-6#1)
interferon-based therapy for##2##3##(2009-7#1)(2011-2#1)
interferon-based therapy##3##2##(2009-7#2)(2011-2#1)
interferon-beta##11##1##(1990-5#1)(2008-11#10)
interferon-gamma (IFN-gamma)##3##2##(2008-11#2)(2008-7#1)
interferon-gamma##16##1##(1994-8#1)(1996-2#1)(1997-1#3)(2008-10#1)(2008-11#7)(2008-4#1)(2008-7#2)
interferons and##3##2##(1993-2#1)(1996-2#1)(1997-1#1)
interferons##9##1##(1990-5#1)(1993-2#1)(1995-12#2)(1996-2#1)(1997-1#4)
interfertile##2##1##(2008-10#2)
interfertility##3##1##(2008-8#3)
interfood##3##1##(2008-5#3)
interfragmentary contact area##2##3##(2013-1#2)
interfragmentary contact surface##2##3##(2013-1#2)
interfragmentary contact##4##2##(2013-1#4)
intergeneric##2##1##(2008-10#1)(2008-5#1)
intergenic region of##2##3##(2008-10#1)(2008-8#1)
intergenic region separating##2##3##(1994-11#1)(2008-10#1)
intergenic region##12##2##(1994-11#1)(1996-6#2)(2008-10#5)(2008-8#1)(2008-9#2)(2011-2#1)
intergenic regions##5##2##(1993-2#1)(1996-3#1)(2008-10#1)(2008-4#1)(2012-3#1)
intergenic sequences##3##2##(1996-6#1)(2008-10#1)(2011-2#1)
intergenic spacer (IGS) region of the nuclear ribosomal RNA gene##2##10##(2008-10#2)
intergenic spacer (IGS) region of##3##5##(2008-10#3)
intergenic spacer (IGS)##6##3##(2008-10#6)
intergenic spacer region##4##3##(2008-10#3)(2011-2#1)
intergenic spacer##16##2##(2008-10#15)(2011-2#1)
intergenic##40##1##(1993-2#1)(1994-11#1)(1996-3#1)(1996-6#3)(2008-10#26)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#3)(2012-3#1)
intergroup##3##1##(2008-10#1)(2009-5#1)(2013-8#1)
interhyoid muscle in##2##3##(2011-2#2)
interhyoid muscle##7##2##(2011-2#7)
interhyoid##8##1##(2011-2#8)
interictal and preseizure##2##3##(2013-8#2)
interictal##3##1##(2010-8#1)(2013-8#2)
interim##16##1##(1992-12#1)(1992-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#5)
interindividual differences in##2##3##(1993-12#1)(2008-11#1)
interindividual differences##3##2##(1993-12#1)(1995-11#1)(2008-11#1)
interindividual variability in 24-h urinary excretion of##2##7##(1995-11#2)
interindividual variability of##2##3##(1995-11#1)(2008-10#1)
interindividual variability##4##2##(1995-11#3)(2008-10#1)
interindividual variation in##4##3##(1996-8#1)(2008-12#1)(2008-8#1)(2010-10#1)
interindividual##12##1##(1993-12#1)(1995-11#4)(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)
interior##21##1##(1992-3#1)(1994-11#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2009-10#1)(2010-10#1)(2013-1#1)
interketosidic linkages##2##2##(1994-11#2)
interlaboratory comparison##2##2##(2008-10#1)(2008-4#1)
interlaboratory study##5##2##(2008-10#5)
interlaboratory##14##1##(2008-10#12)(2008-4#1)(2008-5#1)
interlayer##3##1##(1991-5#1)(1991-9#1)(2008-10#1)
interlesion gaps##2##2##(2010-6#2)
interleukin (IL)-6##2##2##(2008-11#1)(2011-2#1)
interleukin 1##4##2##(1990-2#1)(1990-7#1)(1995-2#1)(1996-2#1)
interleukin 2##5##2##(1990-12#1)(2008-11#3)(2008-4#1)
interleukin 3##3##2##(1991-5#1)(1992-3#1)(1994-5#1)
interleukin 6##4##2##(2008-11#2)(2011-1#1)(2011-2#1)
interleukin 7 (IL-7)##3##3##(1995-2#1)(2008-11#2)
interleukin 7##6##2##(1995-2#2)(2008-11#3)(2008-9#1)
interleukin 8 (IL-8)##2##3##(1994-5#1)(2009-10#1)
interleukin 8##3##2##(1994-5#2)(2009-10#1)
interleukin 9##2##2##(2008-4#2)
interleukin##41##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#2)(1993-2#1)(1993-8#1)(1994-5#3)(1995-2#3)(1996-12#2)(1996-2#1)(2007-11#1)(2008-11#11)(2008-12#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-10#2)(2011-1#1)(2011-2#2)
interleukin-1 alpha##4##2##(1992-6#1)(1993-8#1)(1994-6#1)(1994-8#1)
interleukin-1 and##2##2##(1994-6#1)(2008-7#1)
interleukin-1 beta mutant##2##3##(1993-8#2)
interleukin-1 beta##7##2##(1990-10#3)(1993-8#2)(1995-12#1)(1996-12#1)
interleukin-1##22##1##(1990-10#4)(1990-12#1)(1992-6#1)(1993-8#3)(1994-11#1)(1994-6#5)(1994-8#1)(1995-12#1)(1995-6#2)(1996-12#1)(2008-5#1)(2008-7#1)
interleukin-12 (IL-12)##2##2##(2008-11#2)
interleukin-13##2##1##(2008-4#2)
interleukin-1beta##7##1##(1997-1#6)(2008-10#1)
interleukin-2 (IL-2) and##2##3##(2008-11#1)(2008-5#1)
interleukin-2 (IL-2)##7##2##(1991-6#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)
interleukin-2 and LAK##2##3##(1991-8#1)(1994-6#1)
interleukin-2 and##5##2##(1991-8#1)(1992-12#2)(1994-6#1)(2008-11#1)
interleukin-2##28##1##(1990-12#1)(1990-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(2008-11#4)(2008-5#1)(2008-7#3)(2008-8#1)
interleukin-3 receptor alpha##2##3##(1993-12#2)
interleukin-3 receptor##3##2##(1993-12#2)(1994-11#1)
interleukin-4##6##1##(1997-1#5)(2008-11#1)
interleukin-6 (IL-6) and##2##3##(1990-5#1)(2008-11#1)
interleukin-6 (IL-6)##8##2##(1990-5#1)(1994-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
interleukin-6 and##4##2##(1994-6#1)(2008-4#1)(2008-8#1)(2011-2#1)
interleukin-6 in##3##2##(1990-5#1)(2008-5#1)(2011-2#1)
interleukin-6##27##1##(1990-5#2)(1994-3#1)(1994-6#4)(1995-12#3)(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2011-2#3)(2012-3#2)
interleukin-8 (IL-8)##2##2##(1994-11#1)(2013-1#1)
interleukin-8##4##1##(1994-11#1)(2008-10#1)(2009-3#1)(2013-1#1)
interleukins##4##1##(1990-9#2)(1996-10#1)(1996-12#1)
interline transfer CCD##3##3##(2008-3#3)
interlobular septa##2##2##(2010-10#1)(2012-12#1)
interlocking detachable##2##2##(1997-3#2)
interlocking##9##1##(1997-3#2)(2010-2#1)(2011-2#1)(2013-1#5)
intermaxillipedal process##2##2##(2008-5#2)
intermedia##5##1##(2007-12#2)(2013-1#3)
intermediary conducting polymer layer##2##4##(2008-10#2)
intermediary oxidised sulphur##2##3##(2008-10#2)
intermediary selfing##2##2##(2008-8#2)
intermediary##11##1##(1991-11#1)(1995-12#1)(1996-3#1)(2008-10#4)(2008-8#3)(2013-1#1)
intermediate and##9##2##(1990-9#1)(1992-3#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-7#3)(2008-9#1)
intermediate between##4##2##(2008-10#3)(2009-8#1)
intermediate care facilities##2##3##(1991-2#1)(1992-2#1)
intermediate care##3##2##(1991-1#1)(1991-2#1)(1992-2#1)
intermediate density##2##2##(1995-6#1)(2008-11#1)
intermediate doses##2##2##(2013-1#2)
intermediate filament##3##2##(1991-12#1)(1997-2#1)(2011-2#1)
intermediate filaments in##3##3##(2008-8#1)(2009-10#2)
intermediate filaments##11##2##(1992-9#1)(2008-8#5)(2009-10#4)(2009-8#1)
intermediate for 'Florunner'##2##3##(2008-10#2)
intermediate for##4##2##(1997-8#1)(2008-10#3)
intermediate frequencies##2##2##(2008-10#1)(2012-3#1)
intermediate hosts##3##2##(2011-2#2)(2013-8#1)
intermediate in the synthesis of##3##5##(1992-12#1)(1994-3#1)(2011-1#1)
intermediate in the##5##3##(1992-12#1)(1994-3#1)(2008-5#1)(2009-7#1)(2011-1#1)
intermediate in##10##2##(1992-12#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)
intermediate is##2##2##(1990-5#1)(2009-8#1)
intermediate layer between the##2##4##(1993-12#1)(2008-10#1)
intermediate leaves##2##2##(2008-10#2)
intermediate level of##2##3##(2008-10#1)(2008-8#1)
intermediate level##3##2##(2008-10#2)(2008-8#1)
intermediate levels of##9##3##(2008-3#1)(2008-8#5)(2008-9#2)(2012-3#1)
intermediate of##2##2##(1996-5#1)(2008-11#1)
intermediate products##4##2##(2008-11#1)(2008-3#3)
intermediate rates##2##2##(1993-9#1)(2009-7#1)
intermediate sensitivity##2##2##(2008-10#2)
intermediate step##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
intermediate to high CBS concentrations##2##5##(1993-8#2)
intermediate to high##3##3##(1993-8#2)(2011-2#1)
intermediate to those of the##3##5##(1993-2#1)(2013-8#2)
intermediate to those of##4##4##(1993-2#1)(2008-12#1)(2013-8#2)
intermediate to##7##2##(1993-2#1)(1993-8#2)(2008-12#1)(2011-2#1)(2013-8#2)
intermediate values##2##2##(2008-10#1)(2008-8#1)
intermediate##214##1##(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#5)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#3)(1994-8#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#5)(1997-2#1)(1997-8#2)(2008-10#45)(2008-11#10)(2008-12#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#21)(2008-9#13)(2009-10#4)(2009-7#2)(2009-8#6)(2010-10#4)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#3)(2013-8#5)
intermediate-like properties##2##2##(1993-8#2)
intermediate-term##2##1##(1992-1#2)
intermediately##2##1##(2008-10#1)(2011-2#1)
intermediates and##3##2##(1991-5#1)(1991-6#1)(1996-5#1)
intermediates by##2##2##(1991-9#1)(1994-9#1)
intermediates in oxidative hair dyes##2##5##(2008-10#2)
intermediates in the##3##3##(2008-10#2)(2008-5#1)
intermediates in##9##2##(1996-5#2)(1997-1#1)(1997-4#1)(2008-10#4)(2008-5#1)
intermediates of##2##2##(1990-5#1)(2008-10#1)
intermediates##52##1##(1990-5#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-9#3)(1996-5#6)(1996-6#2)(1997-1#3)(1997-4#3)(1997-6#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#2)(2012-2#1)
intermediates)##3##1##(2008-10#1)(2008-7#1)(2012-3#1)
intermedium in##2##2##(2008-8#1)(2008-9#1)
intermedium was##2##2##(2008-8#1)(2008-9#1)
intermedium##12##1##(2008-10#3)(2008-8#4)(2008-9#5)
intermedium-derived resistance##2##2##(2008-10#2)
intermembrane space##2##2##(1993-2#1)(2009-6#1)
intermembrane##3##1##(1993-2#1)(2009-6#1)(2013-8#1)
intermetatarsal##2##1##(2012-2#2)
intermittent agitation##2##2##(2008-11#2)
intermittent claudication##4##2##(1995-2#3)(2008-8#1)
intermittent clean##2##2##(2008-7#2)
intermittent exercise##4##2##(2013-8#4)
intermittent fever##2##2##(2011-2#1)(2012-2#1)
intermittent flow##2##2##(2011-2#2)
intermittent high glucose##2##3##(2012-4#2)
intermittent ozone theraphy in##2##4##(2007-8#2)
intermittent ozone##3##2##(2007-8#3)
intermittent##48##1##(1990-3#1)(1991-2#1)(1993-2#1)(1994-2#1)(1995-2#3)(1995-8#1)(1996-2#1)(1997-7#1)(2007-8#3)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#5)(2012-2#1)(2012-4#2)(2013-8#5)
intermittently##6##1##(1991-12#1)(1995-9#2)(2008-11#2)(2008-5#1)
intermolecular hydrogen bonding##3##3##(1993-8#1)(2008-10#1)(2008-5#1)
intermolecular interactions##6##2##(1992-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
intermolecular##25##1##(1991-5#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-8#2)(1996-5#1)(1997-7#1)(2008-10#10)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-7#1)(2013-8#1)
intermoult##2##1##(1995-8#2)
internal amplification control##2##3##(2008-10#2)
internal and external imagery##2##4##(1992-12#2)
internal and external##14##3##(1992-12#2)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#2)(2009-8#1)(2012-2#2)(2012-3#1)
internal and##15##2##(1992-12#2)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#2)(2009-8#1)(2012-2#2)(2012-3#1)
internal as well as external##2##5##(2008-10#1)(2008-12#1)
internal buffer##2##2##(2008-10#2)
internal calcium##2##2##(1994-11#2)
internal calibration##2##2##(2008-10#2)
internal carotid arteries##2##3##(2008-7#2)
internal carotid artery (ICA)##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
internal carotid artery dissection##3##4##(2011-2#3)
internal carotid artery stenosis##2##4##(2008-7#1)(2013-1#1)
internal carotid artery##22##3##(1997-3#1)(2008-7#7)(2010-3#1)(2011-2#6)(2012-3#4)(2013-1#2)(2013-8#1)
internal carotid occlusion##2##3##(1996-6#1)(2008-7#1)
internal carotid##32##2##(1996-6#1)(1996-9#2)(1997-3#1)(2008-7#11)(2010-3#1)(2011-2#6)(2011-3#3)(2012-3#4)(2013-1#2)(2013-8#1)
internal coding exons##2##3##(2008-9#2)
internal compartment##2##2##(2008-7#2)
internal consistency##10##2##(2008-7#1)(2009-11#1)(2009-12#2)(2010-11#1)(2010-7#1)(2013-1#4)
internal contact##3##2##(2008-10#3)
internal contradictions##2##2##(2008-12#1)(2008-8#1)
internal control##4##2##(2008-10#4)
internal deletions##3##2##(1993-9#1)(1995-6#1)(2011-2#1)
internal diameter of##3##3##(2008-10#2)(2013-1#1)
internal diameter##5##2##(2008-10#4)(2013-1#1)
internal field intensity##2##3##(2008-3#2)
internal field##3##2##(2008-2#1)(2008-3#2)
internal fixation and##2##3##(2010-5#1)(2012-2#1)
internal fixation of##3##3##(2008-12#1)(2010-12#1)(2013-1#1)
internal fixation techniques##2##3##(2008-12#1)(2010-12#1)
internal fixation##10##2##(2008-12#2)(2008-8#1)(2009-4#1)(2010-12#3)(2010-5#1)(2012-2#1)(2013-1#1)
internal flow##3##2##(2008-5#3)
internal furnace gas##3##3##(2008-10#3)
internal iliac artery##2##3##(2008-12#2)
internal imagery##5##2##(1992-12#5)
internal jugular and subclavian vein rupture##2##6##(2008-12#2)
internal jugular vein##3##3##(1992-12#2)(2011-2#1)
internal jugular##6##2##(1992-12#3)(2008-12#2)(2011-2#1)
internal light##2##2##(2008-10#1)(2008-3#1)
internal mammary artery##3##3##(1993-8#2)(2011-2#1)
internal mammary##5##2##(1993-8#2)(1994-12#1)(2011-2#1)(2013-1#1)
internal medicine and##2##3##(1994-12#1)(2009-12#1)
internal medicine##5##2##(1993-6#1)(1994-12#1)(2009-12#1)(2011-2#1)(2012-3#1)
internal membranes##5##2##(1990-5#5)
internal milieu##2##2##(1990-2#1)(2013-8#1)
internal necrosis than##2##3##(2008-10#2)
internal necrosis##4##2##(2008-10#4)
internal organ##2##2##(2008-10#1)(2008-5#1)
internal organs##6##2##(2007-12#1)(2008-5#1)(2010-7#1)(2012-3#3)
internal population sizes##2##3##(2008-10#2)
internal positions##2##2##(1995-12#1)(2008-4#1)
internal postural##2##2##(2013-1#2)
internal reference##3##2##(2008-10#3)
internal reflection##4##2##(2008-10#3)(2008-3#1)
internal ribosomal entry##2##3##(1993-6#1)(2008-11#1)
internal ribosome entry site (IRES)##2##5##(1997-8#1)(2008-10#1)
internal root##2##2##(2008-10#1)(2013-1#1)
internal sequence of##2##3##(2008-10#2)
internal sequence##4##2##(1995-8#1)(2008-10#2)(2012-3#1)
internal site##2##2##(1995-5#1)(2008-4#1)
internal solution##2##2##(2008-10#2)
internal spermatic##2##2##(1990-9#2)
internal standard (IS)##5##3##(2008-10#5)
internal standard and##5##3##(2008-10#4)(2011-3#1)
internal standard for the##3##4##(2008-10#2)(2008-12#1)
internal standard for##4##3##(2008-10#3)(2008-12#1)
internal standard method##6##3##(1993-3#1)(2008-10#5)
internal standard to##5##3##(2008-10#5)
internal standard was used##2##4##(1992-12#1)(2008-10#1)
internal standard was##4##3##(1992-12#1)(2008-10#3)
internal standard were##2##3##(2008-10#2)
internal standard##79##2##(1992-12#1)(1993-3#2)(1993-6#1)(1995-12#1)(1997-2#1)(2008-10#64)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-3#1)
internal standard)##2##2##(2008-10#2)
internal standardization for##2##3##(2008-10#2)
internal standardization##6##2##(2008-10#6)
internal standards and##2##3##(2008-10#2)
internal standards##8##2##(1997-2#1)(2008-10#7)
internal structure of##3##3##(1991-2#1)(2009-12#1)(2011-2#1)
internal structure##5##2##(1991-2#1)(2008-6#1)(2009-12#1)(2011-2#1)(2013-8#1)
internal structures##3##2##(1994-11#1)(1995-6#1)(2008-12#1)
internal to##2##2##(1996-3#1)(2008-10#1)
internal transcribed spacer (ITS) 2##2##5##(2008-10#2)
internal transcribed spacer (ITS) of##2##5##(2008-10#2)
internal transcribed spacer (ITS) region of the ribosomal##2##8##(2008-10#2)
internal transcribed spacer (ITS) region of the##3##7##(2008-10#3)
internal transcribed spacer (ITS) region of##7##6##(2008-10#7)
internal transcribed spacer (ITS) region##15##5##(2008-10#15)
internal transcribed spacer (ITS) regions of##4##6##(2008-10#4)
internal transcribed spacer (ITS) regions##7##5##(2008-10#7)
internal transcribed spacer (ITS) sequence data##2##6##(2008-10#2)
internal transcribed spacer (ITS) sequence##4##5##(2008-10#4)
internal transcribed spacer (ITS) sequences##2##5##(2008-10#1)(2008-9#1)
internal transcribed spacer (ITS)##36##4##(2008-10#35)(2008-9#1)
internal transcribed spacer 1 (ITS1) region##2##6##(2008-10#2)
internal transcribed spacer 1##6##4##(2008-10#6)
internal transcribed spacer region and##2##5##(2008-10#2)
internal transcribed spacer region##13##4##(2008-10#12)(2008-9#1)
internal transcribed spacer regions of##2##5##(2008-10#2)
internal transcribed spacer regions##3##4##(2008-10#3)
internal transcribed spacer##70##3##(2008-10#67)(2008-12#1)(2008-9#2)
internal transcribed spacers##3##3##(2008-10#2)(2008-8#1)
internal transcribed##74##2##(2008-10#70)(2008-12#1)(2008-8#1)(2008-9#2)
internal validity of##2##3##(1991-1#1)(1995-12#1)
internal validity##4##2##(1991-1#1)(1995-12#1)(2008-11#1)(2010-10#1)
internal vertebral venous plexus##4##4##(2011-2#4)
internal volume##2##2##(2008-10#2)
internal wall##2##2##(2007-11#1)(2008-10#1)
internal##530##1##(1990-2#1)(1990-3#5)(1990-5#5)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#1)(1992-12#11)(1992-3#2)(1992-9#1)(1993-12#3)(1993-3#4)(1993-5#2)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#2)(1994-3#5)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#227)(2008-11#11)(2008-12#17)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#17)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#4)(2009-4#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#26)(2011-3#4)(2012-2#5)(2012-3#17)(2013-1#18)(2013-8#5)
internalization of angiotensin II##2##4##(1994-8#2)
internalization of##9##2##(1994-8#2)(1997-1#2)(2008-11#3)(2008-5#1)(2011-2#1)
internalization process##2##2##(1994-8#1)(1995-11#1)
internalization##26##1##(1994-8#5)(1995-11#2)(1995-2#1)(1995-6#2)(1996-2#1)(1997-1#3)(2008-11#4)(2008-5#1)(2008-9#2)(2009-10#1)(2009-6#1)(2011-2#2)(2011-3#1)
internalize and##2##2##(1991-12#1)(1995-8#1)
internalize##4##1##(1991-12#1)(1992-12#1)(1995-6#1)(1995-8#1)
internalized by##2##2##(1994-8#1)(1995-8#1)
internalized into##2##2##(1995-6#1)(1997-7#1)
internalized##12##1##(1991-12#2)(1992-5#1)(1994-8#4)(1995-6#2)(1995-8#1)(1997-7#1)(2011-2#1)
internalizing and externalizing##3##3##(1995-2#1)(2008-12#1)(2013-1#1)
internalizing or externalizing behavior##2##4##(2008-12#2)
internalizing##9##1##(1995-2#2)(2008-12#3)(2008-9#1)(2009-7#2)(2013-1#1)
internally coherent##3##2##(2008-3#1)(2013-8#2)
internally deleted##2##2##(1991-5#1)(2008-10#1)
internally generated##2##2##(1994-8#1)(2013-1#1)
internally infested##2##2##(2008-10#2)
internally transcribed spacer##2##3##(2008-10#2)
internally with##2##2##(2008-10#2)
internally##23##1##(1990-11#1)(1991-12#1)(1991-5#1)(1994-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#2)(2013-8#2)
international aid##2##2##(1997-7#1)(2008-10#1)
international and##4##2##(1997-7#1)(2008-12#1)(2012-3#1)(2013-1#1)
international collaborative##2##2##(2011-2#1)(2012-3#1)
international comparison##3##2##(1990-6#1)(1993-2#2)
international comparisons##2##2##(1993-2#1)(2009-7#1)
international conference##4##2##(1994-8#1)(1995-9#1)(2008-10#1)(2008-12#1)
international databases##2##2##(2011-4#1)(2012-12#1)
international differential groups##2##3##(2008-10#2)
international experts##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
international group##2##2##(2009-12#1)(2011-10#1)
international guidelines##4##2##(1997-7#1)(2009-1#1)(2011-2#1)(2012-3#1)
international health care##2##3##(1996-2#1)(2008-12#1)
international health##4##2##(1996-2#1)(2008-11#1)(2008-12#1)(2009-6#1)
international infant mortality##2##3##(1993-2#2)
international journals##3##2##(1993-6#1)(1994-12#1)(1997-3#1)
international level##4##2##(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
international literature##7##2##(1991-11#1)(1997-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2011-3#1)
international medical##2##2##(1991-8#1)(2010-2#1)
international migration##2##2##(2011-2#2)
international project##3##2##(1991-9#1)(1995-12#1)(1997-7#1)
international regulatory##2##2##(2008-10#1)(2008-11#1)
international security##2##2##(1992-12#2)
international standard##2##2##(1993-2#1)(2008-10#1)
international standards##5##2##(1996-8#1)(2008-1#1)(2008-12#1)(2009-7#1)(2013-8#1)
international survey##3##2##(1997-8#1)(2008-10#1)(2011-10#1)
international validation of##2##3##(2008-10#1)(2008-11#1)
international validation##3##2##(2008-10#2)(2008-11#1)
international workshop##2##2##(1993-1#1)(2012-2#1)
international##184##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#3)(1992-12#2)(1993-1#2)(1993-2#7)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#2)(2006-6#1)(2007-12#2)(2008-1#5)(2008-10#36)(2008-11#22)(2008-12#8)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#4)(2011-10#2)(2011-2#8)(2011-3#1)(2011-4#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#4)
internationalisation of the nursing curriculum##2##5##(2008-12#2)
internationalisation##4##1##(2008-11#2)(2008-12#2)
internationalism and##2##2##(1992-5#1)(2010-1#1)
internationalism##3##1##(1992-5#2)(2010-1#1)
internationally##17##1##(1990-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-12#5)(2010-5#1)(2010-7#1)(2012-2#1)
internet obesity prevention programs##2##4##(2013-1#2)
internet##12##1##(2007-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
internet-based##4##1##(2008-10#2)(2008-11#1)(2010-5#1)
interneuronal##2##1##(1990-5#1)(2009-9#1)
interneurons and##3##2##(1997-3#3)
interneurons are##4##2##(1990-5#1)(2008-7#1)(2012-2#2)
interneurons##26##1##(1990-5#3)(1994-2#1)(1997-3#7)(2007-12#2)(2008-11#2)(2008-7#2)(2009-8#1)(2012-2#6)(2013-8#2)
internists##3##1##(1993-12#1)(1995-11#1)(2008-1#1)
internode##3##1##(2008-10#1)(2008-8#1)(2012-5#1)
internodes in all##2##3##(2011-2#2)
internodes##10##1##(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#4)
internship##4##1##(1994-12#2)(1996-1#1)(2011-2#1)
internucleosomal DNA fragmentation##3##3##(1993-3#1)(1993-8#1)(1995-12#1)
internucleosomal DNA##4##2##(1993-3#1)(1993-8#1)(1995-12#1)(1995-8#1)
interobserver reproducibility##3##2##(1997-8#3)
interobserver variability in##2##3##(2009-11#2)
interobserver variability##5##2##(1991-12#1)(2009-11#2)(2009-2#2)
interobserver##9##1##(1991-12#1)(1997-8#4)(2009-11#2)(2009-2#2)
interosseous##3##1##(2008-9#2)(2012-3#1)
interparental conflict##6##2##(2010-1#6)
interpartner conflict##5##2##(2009-9#5)
interpersonal (e##2##2##(2008-12#1)(2009-4#1)
interpersonal and##2##2##(2008-11#1)(2008-9#1)
interpersonal communication and##2##3##(2008-11#1)(2009-3#1)
interpersonal communication##4##2##(2008-11#1)(2008-12#1)(2009-3#2)
interpersonal difficulties##2##2##(2008-11#2)
interpersonal problems##2##2##(2010-7#1)(2011-2#1)
interpersonal relations##2##2##(1990-12#1)(2010-10#1)
interpersonal relationship##2##2##(2008-4#1)(2012-3#1)
interpersonal relationships##2##2##(2012-12#1)(2012-3#1)
interpersonal skills##3##2##(1996-2#1)(2008-11#2)
interpersonal##35##1##(1990-12#1)(1991-3#1)(1992-3#1)(1995-3#1)(1996-2#1)(2008-1#2)(2008-11#7)(2008-12#4)(2008-4#2)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#5)
interphalangeal motion##2##2##(2008-9#2)
interphalangeal##6##1##(2008-9#3)(2010-11#1)(2011-2#1)(2012-3#1)
interphase FISH##2##2##(1997-3#2)
interphase cells##4##2##(1990-3#1)(1992-6#2)(2011-2#1)
interphase nuclei##4##2##(1990-3#1)(2008-4#2)(2008-9#1)
interphase##18##1##(1990-3#4)(1992-6#2)(1997-3#3)(2008-4#2)(2008-9#3)(2009-8#1)(2011-2#3)
interplay between the##2##3##(2008-10#1)(2009-9#1)
interplay between##17##2##(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#3)(2009-9#1)(2011-2#2)(2012-2#1)(2013-7#1)
interplay in##3##2##(1995-8#1)(2008-8#1)(2012-3#1)
interplay of##5##2##(1990-11#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-7#1)
interplay##27##1##(1990-11#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#3)(2009-9#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#2)
interploidy crosses##2##2##(2009-12#2)
interpolated total number of##2##4##(2008-10#2)
interpolated##5##1##(2008-10#4)(2008-8#1)
interpolation of the##2##3##(2008-5#1)(2008-9#1)
interpolation of##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
interpolation##8##1##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)
interposed between##2##2##(2007-12#1)(2011-2#1)
interposition arthroplasty##3##2##(2010-11#1)(2011-2#2)
interposition##8##1##(2008-9#2)(2009-10#1)(2010-11#1)(2011-2#3)(2011-3#1)
interpower power cords##2##3##(2011-2#2)
interpractice variation in repeat prescribing##3##5##(2008-11#3)
interpractice variation##4##2##(2008-11#4)
interpret and##2##2##(2008-10#1)(2008-11#1)
interpret the##11##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#4)(2010-8#1)(2012-2#1)(2012-3#1)
interpret##33##1##(1991-11#1)(1991-3#1)(1993-2#1)(1993-8#1)(1995-3#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)
interpretable##6##1##(1991-3#1)(1992-12#1)(2008-10#1)(2008-7#1)(2010-6#1)(2013-1#1)
interpretation and limitations##2##3##(2008-10#1)(2009-11#1)
interpretation and##8##2##(1993-12#1)(1993-3#1)(2008-10#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
interpretation in##5##2##(1991-1#1)(1992-12#1)(1997-8#1)(2007-12#1)(2008-10#1)
interpretation is##2##2##(1997-7#1)(2013-1#1)
interpretation of both##2##3##(2008-10#1)(2008-3#1)
interpretation of data##2##3##(2008-7#1)(2011-2#1)
interpretation of laboratory##2##3##(1994-12#1)(2008-10#1)
interpretation of postmortem carboxyhemoglobin##2##4##(1996-12#2)
interpretation of results##4##3##(1995-3#1)(1996-12#1)(2008-10#1)(2009-8#1)
interpretation of the MS/MS spectrum##2##5##(2008-4#1)(2008-8#1)
interpretation of the data##2##4##(1995-11#1)(2008-5#1)
interpretation of the results is##2##5##(1991-12#1)(2008-4#1)
interpretation of the results##4##4##(1991-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
interpretation of the##36##3##(1991-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1996-11#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2011-2#1)(2011-3#1)
interpretation of##92##2##(1991-12#3)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#3)(1997-8#2)(2007-11#1)(2008-10#23)(2008-11#6)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2011-2#2)(2011-3#2)(2012-2#3)(2013-1#2)
interpretation##148##1##(1990-6#1)(1991-1#1)(1991-12#4)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#3)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#30)(2008-11#8)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#3)
interpretations and##2##2##(1994-3#1)(2008-11#1)
interpretations of the##3##3##(2008-10#2)(2008-11#1)
interpretations of##9##2##(1991-11#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2012-3#1)
interpretations##17##1##(1991-11#1)(1991-12#1)(1994-3#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-8#2)(2009-8#1)(2012-3#2)
interpretative##2##1##(1991-12#1)(2010-10#1)
interpreted and##3##2##(1996-11#1)(2008-10#1)(2010-1#1)
interpreted as a##3##3##(1993-8#1)(2008-10#1)(2012-7#1)
interpreted as being##2##3##(2008-10#1)(2008-3#1)
interpreted as evidence that##2##4##(1991-5#1)(1993-9#1)
interpreted as evidence##4##3##(1991-5#1)(1993-9#1)(1994-5#1)(1996-2#1)
interpreted as indicating that##2##4##(2007-12#1)(2008-5#1)
interpreted as##27##2##(1991-2#1)(1991-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-1#1)(2013-8#1)
interpreted by the##3##3##(1993-8#1)(1997-6#1)(2008-10#1)
interpreted by##6##2##(1993-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
interpreted in terms of the##2##5##(2008-10#2)
interpreted in terms of##8##4##(1994-5#1)(2008-10#6)(2008-3#1)
interpreted in the##2##3##(1991-6#1)(2012-3#1)
interpreted in##12##2##(1991-6#1)(1994-5#1)(1997-3#1)(2008-10#6)(2008-3#1)(2008-8#1)(2012-3#1)
interpreted on the basis of##2##5##(1994-5#1)(2008-5#1)
interpreted to be##4##3##(1992-12#1)(1996-2#1)(2008-10#2)
interpreted to indicate##2##3##(2008-10#1)(2009-10#1)
interpreted to mean##3##3##(1996-5#1)(2008-10#2)
interpreted to##10##2##(1992-12#1)(1996-2#1)(1996-5#1)(2008-10#5)(2008-3#1)(2009-10#1)
interpreted with caution##4##3##(1994-12#1)(1997-1#1)(2011-1#1)(2011-2#1)
interpreted with##6##2##(1994-12#1)(1997-1#1)(2007-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
interpreted##87##1##(1990-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-5#3)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#2)(1997-3#2)(1997-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#5)(2008-5#7)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#1)
interpreter##2##1##(2008-11#1)(2010-8#1)
interpreters##5##1##(1991-12#1)(2010-8#1)(2013-8#3)
interpreting research##3##2##(2010-5#1)(2013-1#2)
interpreting results##2##2##(2008-4#1)(2012-3#1)
interpreting the##10##2##(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-3#1)
interpreting##31##1##(1993-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#3)(2013-1#3)
interpretive##4##1##(2008-10#1)(2008-12#1)(2010-10#1)(2010-9#1)
interprofessional education##11##2##(2008-11#6)(2008-12#3)(2012-2#1)(2013-1#1)
interprofessional learning##2##2##(2008-11#1)(2008-12#1)
interprofessional workers##2##2##(2008-11#2)
interprofessional##25##1##(2008-11#13)(2008-12#7)(2012-12#1)(2012-2#2)(2013-1#2)
interquartile range 1##2##3##(2013-1#2)
interrelated##12##1##(1992-12#1)(1997-1#1)(2008-11#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-8#2)(2011-2#1)(2011-3#1)(2013-1#2)
interrelation between##2##2##(1993-2#1)(2008-11#1)
interrelation##3##1##(1993-2#1)(2008-11#1)(2008-9#1)
interrelationship##4##1##(1995-2#1)(1996-1#1)(2008-10#1)(2013-1#1)
interrelationships among##4##2##(2008-10#2)(2008-12#1)(2008-8#1)
interrelationships between##2##2##(2008-10#1)(2013-1#1)
interrelationships##8##1##(1994-8#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2013-1#1)
interrogate the##2##2##(2008-11#1)(2011-2#1)
interrogate##4##1##(2008-10#2)(2008-11#1)(2011-2#1)
interrogated##5##1##(2008-10#3)(2009-12#1)(2012-3#1)
interrogating##3##1##(2008-2#1)(2008-3#1)(2009-12#1)
interrogation of##2##2##(2007-12#1)(2009-9#1)
interrogation##10##1##(2007-12#1)(2008-10#1)(2009-9#1)(2010-8#1)(2011-2#6)
interrupted amperometry##2##2##(2008-10#2)
interrupted by a##3##3##(1990-8#1)(1995-2#1)(2008-10#1)
interrupted by three##2##3##(1993-6#1)(1997-4#1)
interrupted by two introns##2##4##(1993-6#1)(1995-9#1)
interrupted by##15##2##(1990-12#1)(1990-8#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#2)(1995-2#1)(1995-6#1)(1995-9#1)(1997-4#2)(1997-7#1)(2008-10#1)
interrupted stitch is##2##3##(1991-2#2)
interrupted stitch##3##2##(1991-2#3)
interrupted##30##1##(1990-12#1)(1990-8#1)(1991-2#4)(1991-8#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-3#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1997-4#2)(1997-7#1)(2008-10#7)(2012-12#1)
interrupter technique##2##2##(2008-1#2)
interrupter##3##1##(1995-3#1)(2008-1#2)
interrupting##3##1##(1993-12#1)(2008-4#1)(2011-2#1)
interruption and##2##2##(1994-6#1)(2008-10#1)
interruption of hemodialysis##2##3##(2013-1#2)
interruption of the moist##2##4##(2008-10#2)
interruption of the##9##3##(1990-5#1)(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2012-12#1)
interruption of##16##2##(1990-5#1)(1991-3#1)(1993-3#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2012-12#1)(2012-2#1)(2013-1#2)
interruption##23##1##(1990-2#1)(1990-5#1)(1991-3#1)(1993-3#1)(1994-6#1)(1995-2#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-7#2)(2009-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
interruptions and##2##2##(1993-12#1)(2008-10#1)
interruptions of##4##2##(2008-10#1)(2008-3#1)(2010-8#2)
interruptions##8##1##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#2)(2011-2#1)
interscapular brown adipose tissue##2##4##(2011-2#2)
intersect##2##1##(2008-7#1)(2013-1#1)
intersection of##3##2##(2008-11#1)(2008-3#1)(2010-10#1)
intersection##7##1##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-10#1)(2013-1#1)
intersections##3##1##(2008-10#1)(2008-5#1)(2008-6#1)
intersex##6##1##(1991-6#1)(2008-10#4)(2013-8#1)
intersexual##2##1##(2008-9#1)(2010-5#1)
interspecies##8##1##(1992-6#1)(1993-8#1)(2008-5#1)(2009-6#1)(2013-1#2)(2013-8#2)
interspecific competition and##2##3##(2008-8#2)
interspecific competition##10##2##(2008-8#9)(2008-9#1)
interspecific crosses and##2##3##(2008-10#2)
interspecific crosses##8##2##(2008-10#8)
interspecific hybrid##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
interspecific hybridization events##2##3##(2008-10#2)
interspecific hybridization in##2##3##(2008-10#2)
interspecific hybridization was##3##3##(2008-10#1)(2008-9#2)
interspecific hybridization##9##2##(2008-10#5)(2008-9#4)
interspecific hybrids##8##2##(2007-12#1)(2008-10#4)(2008-8#1)(2008-9#2)
interspecific interactions##3##2##(2008-8#2)(2008-9#1)
interspecific level##2##2##(2008-6#1)(2012-3#1)
interspecific transmission of dsRNA##2##4##(2008-10#2)
interspecific##61##1##(1993-12#1)(2007-12#1)(2008-10#28)(2008-6#1)(2008-7#1)(2008-8#15)(2008-9#9)(2011-2#1)(2012-3#3)(2013-8#1)
interspersed##4##1##(1996-12#1)(2008-10#1)(2008-11#1)(2010-5#1)
interspinous ratio and##2##3##(2012-12#2)
interspinous ratio##4##2##(2012-12#4)
interspinous##5##1##(2012-12#5)
interstate##5##1##(1995-12#2)(1997-3#3)
intersterility group##2##2##(2008-10#2)
intersterility##4##1##(2008-10#2)(2010-10#2)
interstimulus interval##2##2##(2008-9#2)
interstitial and##2##2##(2008-9#1)(2013-8#1)
interstitial brachytherapy##2##2##(1991-8#1)(1994-2#1)
interstitial cells##2##2##(2008-8#1)(2012-12#1)
interstitial changes##3##2##(1991-12#1)(1993-2#2)
interstitial deletion of##2##3##(1996-12#1)(1997-3#1)
interstitial deletion##3##2##(1996-12#2)(1997-3#1)
interstitial hernia##3##2##(2012-12#3)
interstitial lung disease##8##3##(1997-3#1)(1997-8#1)(2011-2#1)(2012-12#3)(2012-2#2)
interstitial lung##9##2##(1991-12#1)(1997-3#1)(1997-8#1)(2011-2#1)(2012-12#3)(2012-2#2)
interstitial nephritis##2##2##(2008-5#1)(2011-2#1)
interstitial pneumonia##2##2##(2011-2#2)
interstitial##49##1##(1991-12#3)(1991-8#1)(1992-1#1)(1993-2#3)(1994-2#1)(1996-12#4)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2011-2#5)(2012-12#10)(2012-2#3)(2013-1#1)(2013-8#2)
interstrand##2##1##(2008-11#2)
intersubject variability##3##2##(2008-11#3)
intersubunit##2##1##(1991-10#1)(1995-6#1)
intertidal##3##1##(2008-10#1)(2008-9#2)
intertrochanteric femoral##2##2##(2010-11#1)(2011-2#1)
intertrochanteric fractures##4##2##(2009-3#1)(2013-1#3)
intertrochanteric##9##1##(2009-3#4)(2010-11#1)(2011-2#1)(2013-1#3)
intertwined##2##1##(2008-12#2)
interval (CI)##6##2##(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)(2012-3#1)
interval 6##2##2##(1993-12#2)
interval and circadian timing##2##4##(2009-7#2)
interval and##4##2##(2008-10#1)(2009-7#3)
interval between 0##4##3##(2008-10#4)
interval between the##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
interval between##15##2##(1992-9#1)(1994-9#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#3)(2010-5#1)(2011-2#1)
interval censored##3##2##(1992-9#2)(1995-12#1)
interval compared with##2##3##(1996-3#1)(2012-12#1)
interval estimates of##2##3##(1994-9#1)(2011-2#1)
interval estimates##4##2##(1994-9#2)(2008-11#1)(2011-2#1)
interval for##8##2##(1991-2#1)(1996-3#5)(2008-10#2)
interval from the##2##3##(2008-3#1)(2013-1#1)
interval from##6##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#2)
interval in the##2##3##(1995-6#1)(2013-8#1)
interval in##5##2##(1991-8#1)(1995-6#1)(2010-11#1)(2012-12#1)(2013-8#1)
interval mapping was##2##3##(2008-10#2)
interval mapping##12##2##(2008-10#10)(2008-12#1)(2012-3#1)
interval of 16##2##3##(2011-2#2)
interval of the##4##3##(2008-10#2)(2008-5#2)
interval of##25##2##(1991-2#1)(1991-6#1)(1991-7#1)(1993-11#1)(1994-3#2)(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#5)(2008-5#3)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-8#1)
interval or##2##2##(2013-1#1)(2013-8#1)
interval the##2##2##(2008-10#2)
interval to##2##2##(2008-10#1)(2010-12#1)
interval was 0##2##3##(2008-10#2)
interval was##11##2##(1991-6#1)(1991-8#1)(1992-3#1)(1993-6#1)(1996-12#1)(2008-10#4)(2008-5#1)(2010-8#1)
interval##213##1##(1990-6#1)(1991-1#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#5)(1992-12#1)(1992-3#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-6#2)(1994-11#3)(1994-3#4)(1994-9#4)(1995-1#2)(1995-12#2)(1995-6#2)(1995-9#1)(1996-12#2)(1996-3#7)(1996-8#1)(1997-3#2)(1997-4#1)(1997-9#1)(2008-10#57)(2008-11#4)(2008-12#7)(2008-3#5)(2008-5#7)(2008-7#6)(2008-8#1)(2008-9#9)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#2)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#12)(2013-8#4)
intervals 1##2##2##(2008-10#1)(2013-8#1)
intervals across the DEJ##2##4##(2010-10#2)
intervals after##4##2##(2008-10#3)(2008-5#1)
intervals and##8##2##(1992-2#1)(1992-3#1)(2008-10#5)(2010-7#1)
intervals are##3##2##(2008-10#3)
intervals between##5##2##(1992-11#1)(2008-10#2)(2008-5#1)(2010-8#1)
intervals during##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
intervals for the##3##3##(2008-10#2)(2008-5#1)
intervals for##9##2##(1991-9#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2013-1#1)
intervals from##3##2##(2008-10#2)(2013-1#1)
intervals of 2##3##3##(2008-10#2)(2008-5#1)
intervals of the##6##3##(2008-10#4)(2008-9#2)
intervals of##24##2##(1992-9#1)(1994-2#1)(1997-2#1)(2008-10#16)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)
intervals were##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
intervals with the##2##3##(2008-10#2)
intervals with##4##2##(2008-10#4)
intervals##150##1##(1990-2#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-5#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#68)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#7)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
intervals)##3##1##(2008-10#2)(2013-1#1)
intervene in the##2##3##(1995-6#1)(2013-1#1)
intervene in##4##2##(1995-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
intervene##11##1##(1995-6#1)(2006-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2013-1#1)
intervened and control##3##3##(2012-3#1)(2013-1#2)
intervened##8##1##(2012-3#2)(2013-1#5)(2013-8#1)
intervenes##2##1##(1997-7#1)(2011-1#1)
intervening##12##1##(1990-3#1)(1994-1#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
intervention among##2##2##(2012-2#1)(2012-3#1)
intervention and the##4##3##(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)
intervention and##19##2##(1991-12#1)(1991-6#1)(1993-3#1)(1996-11#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2013-1#1)
intervention approaches##2##2##(2010-12#1)(2012-2#1)
intervention are##7##2##(2008-11#3)(2008-12#2)(2012-2#1)(2013-1#1)
intervention as well as##2##4##(1991-8#1)(2013-1#1)
intervention as##3##2##(1991-8#1)(2011-1#1)(2013-1#1)
intervention at##2##2##(1997-2#1)(2011-2#1)
intervention based on##2##3##(2008-7#1)(2011-2#1)
intervention by##2##2##(2008-10#1)(2012-2#1)
intervention can##4##2##(1993-12#1)(2008-11#1)(2012-3#1)(2013-8#1)
intervention conditions##2##2##(2012-2#2)
intervention design##2##2##(1994-1#2)
intervention designed to improve##2##4##(2008-8#1)(2010-10#1)
intervention designed to##3##3##(1992-2#1)(2008-8#1)(2010-10#1)
intervention followed by##3##3##(2008-7#1)(2011-1#2)
intervention for the##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
intervention for##30##2##(1990-12#1)(1992-1#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-6#2)(2008-8#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
intervention from##2##2##(2008-10#1)(2011-2#1)
intervention group and##2##3##(2008-12#1)(2010-4#1)
intervention group showed##2##3##(2008-12#1)(2008-8#1)
intervention group##9##2##(2008-12#4)(2008-8#1)(2010-4#3)(2013-1#1)
intervention implementation##2##2##(1997-1#1)(2012-2#1)
intervention in a##2##3##(2008-8#1)(2013-1#1)
intervention in primary care##2##4##(2008-11#1)(2008-12#1)
intervention in the##6##3##(1994-1#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-11#2)
intervention in##31##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#2)(1994-1#1)(1994-6#2)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-7#1)(2008-8#2)(2010-10#3)(2010-7#1)(2013-1#3)(2013-8#1)
intervention is##9##2##(1991-3#1)(1993-1#1)(1994-1#2)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
intervention must##2##2##(1992-12#1)(2012-3#1)
intervention of##7##2##(1997-7#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-9#1)(2012-2#1)(2012-3#1)
intervention on the##2##3##(2012-3#1)(2013-1#1)
intervention on##8##2##(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#3)
intervention or##5##2##(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
intervention period##4##2##(1991-12#1)(2012-12#2)(2013-1#1)
intervention program for##2##3##(1991-12#1)(2008-11#1)
intervention program participation and##2##4##(2008-12#2)
intervention program##12##2##(1991-12#1)(1991-2#1)(1994-3#1)(2008-11#2)(2008-12#4)(2010-10#1)(2012-12#2)
intervention programs##7##2##(1992-12#1)(2008-11#2)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
intervention research##3##2##(2008-2#1)(2011-2#1)(2012-2#1)
intervention services##6##2##(1992-1#1)(1994-1#4)(2010-12#1)
intervention strategies##6##2##(1993-3#1)(1997-2#1)(2008-12#1)(2009-11#1)(2010-7#1)(2011-3#1)
intervention studies##4##2##(1992-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
intervention study was##2##3##(2008-11#1)(2012-2#1)
intervention study##7##2##(1991-8#1)(2008-11#1)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#2)
intervention they focused on##2##4##(2013-1#2)
intervention to prevent##2##3##(1995-12#1)(2010-4#1)
intervention to the##2##3##(2008-12#1)(2013-8#1)
intervention to##14##2##(1994-3#1)(1995-12#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-10#1)(2010-4#3)(2013-1#3)(2013-8#1)
intervention trial##3##2##(1995-9#1)(2009-12#1)(2010-12#1)
intervention vs##3##2##(2008-11#1)(2012-3#2)
intervention was delivered##2##3##(2008-4#1)(2008-8#1)
intervention was##8##2##(2008-4#1)(2008-8#2)(2013-1#4)(2013-8#1)
intervention were more likely to##2##5##(2013-1#2)
intervention were##5##2##(2008-12#2)(2011-1#1)(2013-1#2)
intervention with##7##2##(1992-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
intervention zones was##2##3##(2008-12#2)
intervention zones##3##2##(2008-12#3)
intervention##447##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-6#2)(1991-8#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#11)(1994-3#5)(1994-6#2)(1995-1#5)(1995-12#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#11)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-1#2)(2008-10#12)(2008-11#34)(2008-12#40)(2008-2#2)(2008-3#1)(2008-4#11)(2008-5#1)(2008-6#4)(2008-7#8)(2008-8#16)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#17)(2010-11#1)(2010-12#7)(2010-4#10)(2010-5#1)(2010-7#9)(2010-9#4)(2011-1#11)(2011-2#34)(2011-3#2)(2011-9#1)(2012-12#8)(2012-2#20)(2012-3#10)(2013-1#59)(2013-8#10)
intervention)##4##1##(2010-8#1)(2011-1#1)(2013-1#2)
intervention]##2##1##(1992-3#1)(1996-3#1)
interventional cardiologists##2##2##(1993-12#1)(2008-11#1)
interventional cardiology##2##2##(2008-11#1)(2013-8#1)
interventional procedure##2##2##(2011-2#1)(2012-12#1)
interventional procedures##6##2##(2009-12#1)(2010-12#1)(2011-2#4)
interventional radiology##7##2##(1993-3#2)(2012-2#5)
interventional techniques##2##2##(2011-2#1)(2012-12#1)
interventional##34##1##(1993-12#1)(1993-3#2)(1995-11#1)(1997-3#1)(1997-6#1)(2008-11#4)(2009-12#1)(2009-8#1)(2010-12#2)(2011-2#7)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
interventionists##2##1##(2011-2#2)
interventions and appropriate##2##3##(2008-11#1)(2010-10#1)
interventions and##16##2##(1993-12#1)(1994-3#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)
interventions are##10##2##(1993-12#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-6#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#1)
interventions by##2##2##(1993-3#1)(2012-2#1)
interventions can ensue##2##3##(2008-12#2)
interventions can##5##2##(2008-12#2)(2008-2#1)(2008-8#2)
interventions carried out##2##3##(2008-10#2)
interventions designed to##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
interventions designed##4##2##(2008-4#1)(2012-2#1)(2013-1#2)
interventions focused on##2##3##(2011-2#1)(2012-2#1)
interventions focused##3##2##(2011-2#1)(2012-2#2)
interventions for smoking cessation##2##4##(2013-1#2)
interventions for the##2##3##(2011-2#1)(2013-1#1)
interventions for##27##2##(1994-3#1)(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#5)(2013-1#8)
interventions has##2##2##(2009-7#1)(2012-2#1)
interventions have##5##2##(2008-11#1)(2008-12#1)(2008-4#1)(2010-11#1)(2011-2#1)
interventions in a##2##3##(2008-7#1)(2012-2#1)
interventions in low##2##3##(2008-10#1)(2012-2#1)
interventions in the##6##3##(1993-3#1)(2008-2#1)(2010-5#1)(2011-2#2)(2012-2#1)
interventions in##23##2##(1993-3#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#5)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#2)
interventions included##2##2##(1997-8#1)(2013-1#1)
interventions is##2##2##(2011-2#1)(2013-1#1)
interventions may##2##2##(2008-12#1)(2008-4#1)
interventions of##3##2##(2012-3#1)(2013-1#2)
interventions on the##2##3##(1992-9#1)(2013-1#1)
interventions on##4##2##(1992-9#1)(2008-12#1)(2009-4#1)(2013-1#1)
interventions such as##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
interventions targeting##2##2##(2007-12#1)(2013-1#1)
interventions that are##2##3##(2012-3#1)(2013-1#1)
interventions that can##2##3##(2008-11#1)(2013-1#1)
interventions that promote##2##3##(1992-12#1)(2009-6#1)
interventions that##15##2##(1991-3#1)(1992-12#1)(2008-11#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#7)
interventions to collect##2##3##(2013-1#2)
interventions to improve##2##3##(1996-12#1)(2008-11#1)
interventions to reduce##2##3##(2008-10#1)(2010-1#1)
interventions to##19##2##(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
interventions was##2##2##(1995-3#1)(2012-2#1)
interventions were##4##2##(2012-2#2)(2012-3#1)(2013-1#1)
interventions which are##2##3##(2008-7#1)(2013-1#1)
interventions which##5##2##(1994-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
interventions with##5##2##(1992-3#1)(2008-11#2)(2009-5#1)(2013-1#1)
interventions##300##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-3#2)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#14)(2008-11#31)(2008-12#11)(2008-2#3)(2008-4#6)(2008-6#9)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#6)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#7)(2010-11#2)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#30)(2012-12#1)(2012-2#40)(2012-3#6)(2013-1#51)(2013-7#2)(2013-8#3)
interventions?##3##1##(2011-2#1)(2013-1#2)
interventricular##2##1##(1996-11#1)(2008-10#1)
intervertebral disc##6##2##(2008-7#1)(2009-12#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
intervertebral foramen##5##2##(2008-7#1)(2011-2#1)(2013-8#3)
intervertebral##18##1##(1996-8#1)(1996-9#1)(2007-8#5)(2008-7#2)(2009-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
interview and##2##2##(2010-8#1)(2011-2#1)
interview data and##2##3##(2013-1#2)
interview data##4##2##(2008-11#1)(2013-1#3)
interview in##2##2##(2008-7#1)(2013-8#1)
interview is##3##2##(2010-6#1)(2010-8#1)(2011-2#1)
interview questions##2##2##(2008-11#1)(2011-8#1)
interview study##4##2##(1997-4#1)(2013-1#1)(2013-8#2)
interview to##2##2##(2008-11#1)(2012-12#1)
interview transcripts##4##2##(1993-3#1)(2008-12#1)(2009-5#1)(2013-1#1)
interview was##3##2##(1990-12#1)(2012-3#2)
interview with Peter##2##3##(1994-1#1)(2010-5#1)
interview with Richard##2##3##(1996-8#1)(2009-8#1)
interview with##11##2##(1992-2#1)(1994-1#1)(1996-8#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
interview##86##1##(1990-11#1)(1990-12#3)(1990-6#1)(1991-6#1)(1992-2#2)(1993-12#2)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-8#2)(1997-1#1)(1997-4#1)(2008-1#2)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-2#6)(2011-8#1)(2012-12#2)(2012-3#5)(2013-1#7)(2013-8#5)
interviewed using the##3##3##(1992-2#1)(2008-7#1)(2013-1#1)
interviewed using##9##2##(1992-2#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
interviewed##52##1##(1990-12#2)(1990-8#2)(1991-6#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1995-1#3)(1995-2#1)(1996-6#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
interviewees##4##1##(1990-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
interviewing##6##1##(1992-2#1)(1997-1#2)(2008-11#1)(2008-12#1)(2013-1#1)
interviews among##2##2##(2008-11#1)(2009-12#1)
interviews and##3##2##(2010-1#1)(2010-10#2)
interviews conducted##2##2##(2008-11#1)(2013-8#1)
interviews of key##2##3##(1991-1#1)(2013-1#1)
interviews of##3##2##(1991-1#1)(2009-12#1)(2013-1#1)
interviews to##3##2##(2008-6#1)(2013-1#2)
interviews was##3##2##(2008-11#2)(2012-3#1)
interviews were conducted with##6##4##(1995-1#1)(1997-3#1)(2008-12#2)(2010-4#1)(2013-1#1)
interviews were conducted##9##3##(1995-1#1)(1997-3#1)(2008-11#2)(2008-12#2)(2010-4#1)(2013-1#2)
interviews were performed##3##3##(2010-10#1)(2010-6#1)(2013-1#1)
interviews were undertaken with##2##4##(2008-9#1)(2010-10#1)
interviews were used to collect data##4##6##(2008-11#2)(2012-3#2)
interviews were used##5##3##(2008-11#3)(2012-3#2)
interviews were##31##2##(1995-1#1)(1997-3#1)(2008-1#1)(2008-11#7)(2008-12#4)(2008-9#1)(2010-10#3)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#5)
interviews with 24##2##3##(1997-3#1)(2011-2#1)
interviews with a##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
interviews with key##2##3##(1996-3#1)(2008-12#1)
interviews with men##2##3##(2008-11#2)
interviews with##33##2##(1992-5#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#2)(1997-4#1)(2008-11#3)(2008-12#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
interviews##127##1##(1991-1#1)(1991-6#1)(1992-5#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(2008-1#4)(2008-11#23)(2008-12#11)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#3)(2009-8#1)(2010-1#1)(2010-10#12)(2010-11#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#6)(2013-1#23)(2013-8#4)
intestinal Caco-2 cells##3##3##(2008-11#3)
intestinal I/R##3##2##(2010-5#3)
intestinal absorption of##2##3##(1994-8#1)(2008-11#1)
intestinal absorption##4##2##(1991-8#1)(1994-8#1)(2008-10#1)(2008-11#1)
intestinal bacteria##10##2##(2008-11#6)(2008-8#1)(2010-10#1)(2010-11#1)(2012-2#1)
intestinal bacterial##2##2##(2008-11#2)
intestinal cell##3##2##(1994-6#1)(2008-11#2)
intestinal content of##2##3##(2011-2#2)
intestinal digestion for##2##3##(2008-10#2)
intestinal digestion##3##2##(2008-10#3)
intestinal epithelial Caco-2 cells##2##4##(2008-11#2)
intestinal epithelial Caco-2##3##3##(2008-11#3)
intestinal epithelial cell monolayers##2##4##(2008-11#2)
intestinal epithelial cell##3##3##(2008-11#2)(2011-2#1)
intestinal epithelial cells##8##3##(1990-2#1)(2008-11#6)(2008-6#1)
intestinal epithelial##17##2##(1990-2#1)(2008-10#1)(2008-11#12)(2008-6#1)(2009-8#1)(2011-2#1)
intestinal fluid##2##2##(1996-6#1)(2008-11#1)
intestinal immune##4##2##(2008-11#2)(2009-12#1)(2012-2#1)
intestinal intraepithelial lymphocytes##2##3##(1996-12#1)(2008-11#1)
intestinal ischemia##2##2##(2009-8#1)(2013-1#1)
intestinal lymphoid patches##2##3##(1992-12#2)
intestinal manifestation of UC##2##4##(2011-2#2)
intestinal metaplasia##3##2##(1997-1#3)
intestinal microbiota##3##2##(2010-10#1)(2010-5#1)(2011-2#1)
intestinal microflora##2##2##(2008-11#2)
intestinal mucin##8##2##(1990-8#2)(1991-12#5)(2008-7#1)
intestinal mucosa and##2##3##(1990-3#1)(1996-6#1)
intestinal mucosa##8##2##(1990-2#1)(1990-3#2)(1992-12#1)(1996-3#1)(1996-6#1)(2009-8#1)(2011-2#1)
intestinal obstruction##10##2##(1990-5#1)(1992-5#1)(2008-12#3)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
intestinal occlusion##3##2##(1990-3#1)(1990-5#1)(2010-1#1)
intestinal parasites##3##2##(1996-12#1)(2008-10#1)(2013-1#1)
intestinal pathogens##2##2##(1995-2#1)(2011-2#1)
intestinal peptide##5##2##(1994-11#1)(1994-3#3)(1994-8#1)
intestinal perforations##3##2##(2011-2#3)
intestinal polyps are##2##3##(2009-12#2)
intestinal protein##2##2##(1994-11#1)(2011-2#1)
intestinal resection##3##2##(1992-5#1)(1995-12#1)(2013-1#1)
intestinal segments##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
intestinal type##6##2##(1990-2#6)
intestinal##213##1##(1990-2#11)(1990-3#5)(1990-5#3)(1990-6#1)(1990-8#3)(1991-12#6)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#3)(1992-5#2)(1992-6#2)(1992-9#1)(1994-11#3)(1994-3#3)(1994-6#1)(1994-8#11)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-3#1)(1996-6#3)(1997-1#4)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#11)(2008-11#36)(2008-12#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#3)(2009-8#5)(2010-1#2)(2010-10#2)(2010-11#1)(2010-5#5)(2011-1#2)(2011-2#22)(2011-3#4)(2012-12#3)(2012-2#7)(2012-3#7)(2013-1#9)(2013-8#1)
intestinal-type##4##1##(1990-6#1)(1997-1#1)(2013-1#1)(2013-8#1)
intestinalis and##2##2##(2010-12#1)(2012-2#1)
intestinalis is##2##2##(2012-2#2)
intestinalis##8##1##(2008-11#1)(2010-12#1)(2012-2#6)
intestine and the##3##3##(1995-2#1)(2008-5#1)(2010-12#1)
intestine and##14##2##(1991-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-5#3)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
intestine in##2##2##(1990-11#2)
intestine is##3##2##(1991-6#1)(1992-6#1)(2009-1#1)
intestine of##4##2##(1995-9#1)(2008-12#1)(2011-3#1)(2013-1#1)
intestine##81##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#3)(1991-6#1)(1992-5#3)(1992-6#1)(1993-2#1)(1993-3#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#2)(1997-7#1)(1997-9#1)(2008-10#4)(2008-11#8)(2008-12#4)(2008-5#7)(2008-8#1)(2009-1#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#8)
intestine)##2##1##(2008-12#1)(2009-8#1)
intestine]##3##1##(1990-11#1)(1990-3#1)(1992-5#1)
intestines##3##1##(2008-10#1)(2009-6#1)(2013-1#1)
inthe##10##1##(2008-11#7)(2009-8#3)
intima##3##1##(1997-8#2)(2007-12#1)
intima-media thickness and##3##3##(2008-11#2)(2009-1#1)
intima-media thickness in##2##3##(2008-11#1)(2010-10#1)
intima-media thickness##9##2##(2008-11#5)(2008-7#1)(2009-1#1)(2010-10#1)(2013-8#1)
intimal hyperplasia##6##2##(2006-6#5)(2011-3#1)
intimal##14##1##(1995-8#1)(1997-8#3)(2006-6#5)(2010-4#2)(2011-2#2)(2011-3#1)
intimate and##2##2##(2008-11#1)(2009-10#1)
intimate contact##2##2##(2008-10#1)(2012-3#1)
intimate partner violence (IPV)##2##4##(2008-12#1)(2010-11#1)
intimate partner violence##7##3##(2008-12#1)(2008-6#1)(2010-11#1)(2012-12#4)
intimate partner##8##2##(2008-12#1)(2008-6#1)(2010-11#1)(2012-12#4)(2012-2#1)
intimate relationships##2##2##(2012-2#2)
intimate##27##1##(1992-2#1)(1996-2#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-11#1)(2012-12#4)(2012-2#5)(2012-3#1)
intimately linked to##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
intimately linked##4##2##(2008-11#1)(2008-2#1)(2011-2#1)(2012-3#1)
intimately##8##1##(1993-8#1)(1996-2#1)(2008-11#2)(2008-2#1)(2010-10#1)(2011-2#1)(2012-3#1)
into 1##7##2##(2008-10#6)(2008-12#1)
into 10##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
into 100##2##2##(2008-10#1)(2011-3#1)
into 11##2##2##(2008-10#2)
into 2 groups##3##3##(1990-2#1)(2010-4#1)(2012-3#1)
into 3 groups##4##3##(2008-10#1)(2012-4#1)(2013-1#2)
into 3##6##2##(2008-10#2)(2012-3#1)(2012-4#1)(2013-1#2)
into 4##6##2##(1996-5#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)
into 4M5NC##2##2##(2008-10#2)
into 6 groups##2##3##(1996-6#1)(2013-1#1)
into 6##3##2##(1996-6#1)(2008-10#1)(2013-1#1)
into 7##2##2##(2008-6#1)(2011-2#1)
into A beta##2##3##(1995-12#1)(1996-2#1)
into A##3##2##(1995-12#1)(1996-2#1)(2008-9#1)
into Andean and##2##3##(2008-10#2)
into B##4##2##(1997-1#3)(2008-10#1)
into CER vesicles##2##3##(2008-5#2)
into CHO cells##3##3##(1990-8#1)(2008-11#2)
into DNA##12##2##(1991-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-12#1)(2008-4#1)(2008-9#1)(2010-11#1)(2012-2#1)
into Drosophila##2##2##(2008-8#1)(2008-9#1)
into ES cells##2##3##(1997-8#1)(2008-9#1)
into Escherichia coli##3##3##(1991-9#1)(1993-9#1)(1994-8#1)
into HeLa cells##3##3##(1993-3#1)(2008-9#2)
into HepG2 cells##2##3##(1994-6#1)(2008-8#1)
into ICP##2##2##(2008-10#2)
into NBM##3##2##(2008-8#3)
into OLs##2##2##(2008-7#2)
into RNA##2##2##(2008-10#1)(2008-9#1)
into ROS##2##2##(1993-3#1)(2009-8#1)
into S phase##3##3##(1992-10#2)(1993-8#1)
into S##4##2##(1992-10#2)(1993-8#1)(1994-3#1)
into SF-CO(2)##3##2##(2008-10#3)
into Tf##3##2##(2010-11#3)
into a Raman##2##3##(2007-12#1)(2008-10#1)
into a baculovirus##2##3##(1993-6#1)(2008-11#1)
into a carrier stream of##4##5##(2008-10#4)
into a carrier stream to be stacked inside a holding coil and flow reversed through a reaction coil##2##18##(2008-10#2)
into a carrier stream##7##4##(2008-10#7)
into a carrier##9##3##(2008-10#9)
into a cell##2##3##(2008-11#1)(2008-9#1)
into a coherent##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
into a common clade##2##4##(2008-10#2)
into a common##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
into a distinct actin network##2##5##(2008-11#1)(2008-9#1)
into a donor stream of##2##5##(2008-10#2)
into a flow injection system##2##5##(2008-10#2)
into a flow injection##3##4##(2008-10#3)
into a flow##6##3##(2008-10#6)
into a flow-through##2##3##(2008-10#2)
into a flowing##3##3##(2008-10#2)(2008-9#1)
into a gas chromatograph##2##4##(2008-10#2)
into a gas##3##3##(2008-10#3)
into a given##2##3##(1991-1#1)(2008-10#1)
into a home-made##2##3##(2008-10#2)
into a hot##2##3##(2008-10#2)
into a large##3##3##(1995-5#1)(2008-10#2)
into a local##2##3##(2008-10#1)(2008-8#1)
into a more##3##3##(1991-5#1)(2008-11#1)(2010-1#1)
into a new##2##3##(2008-5#1)(2008-8#1)
into a nursing##2##3##(1995-2#1)(2008-11#1)
into a plasticized poly(vinyl chloride)##2##5##(2008-10#2)
into a product##2##3##(2008-10#1)(2008-5#1)
into a series of##4##4##(2008-10#4)
into a single##11##3##(1993-8#1)(1995-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)
into a small##7##3##(1990-5#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-7#1)
into a solution of##2##4##(2008-10#1)(2008-2#1)
into a stream of##3##4##(2008-10#3)
into a system of##2##4##(1995-2#1)(2008-7#1)
into a training set##2##4##(1995-9#1)(2008-10#1)
into a variety of cell types##3##6##(2008-11#2)(2008-9#1)
into a variety of cell##4##5##(1991-6#1)(2008-11#2)(2008-9#1)
into a variety of##6##4##(1991-6#1)(2008-11#2)(2008-9#1)(2009-12#1)(2013-1#1)
into a##325##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#2)(1995-12#4)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-12#8)(2008-1#2)(2008-10#143)(2008-11#22)(2008-12#4)(2008-2#5)(2008-3#4)(2008-5#8)(2008-6#2)(2008-7#13)(2008-8#7)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#6)
into account all##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
into account both##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
into account different##2##3##(2008-10#1)(2008-8#1)
into account is##2##3##(1994-3#1)(2013-8#1)
into account the differences in the##2##6##(1997-2#1)(2008-3#1)
into account the sensitivity##2##4##(2008-10#2)
into account the##41##3##(1990-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-5#2)(1996-1#1)(1997-2#1)(2008-10#14)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2011-2#2)(2011-3#1)(2012-3#1)
into account this##2##3##(2008-11#1)(2011-2#1)
into account to##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
into account when##4##3##(2008-10#1)(2011-2#1)(2013-8#2)
into account##128##2##(1990-11#1)(1990-6#1)(1990-9#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#40)(2008-11#10)(2008-2#1)(2008-3#13)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#7)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
into active##2##2##(1993-8#1)(2012-3#1)
into adipocytes##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-4#1)
into adulthood##4##2##(2008-2#2)(2008-4#1)(2010-10#1)
into all##2##2##(2008-11#2)
into an OAH##2##3##(2008-7#2)
into an acidic carrier stream and##2##6##(2008-10#2)
into an aqueous##2##3##(2008-10#2)
into an array of##2##4##(2008-3#1)(2009-8#1)
into an array##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
into an integrated##2##3##(1997-3#1)(2008-11#1)
into an intensively fluorescent compound##2##5##(2008-10#2)
into an osteoblastic tendency##2##4##(2008-11#2)
into an##61##2##(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1997-3#2)(1997-8#2)(2008-10#27)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-5#2)(2010-6#1)(2010-9#1)(2012-2#1)
into and##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
into any##6##2##(1997-3#1)(1997-4#1)(2008-4#3)(2008-9#1)
into appropriate##2##2##(1991-3#1)(2008-9#1)
into aqueous##2##2##(2008-10#2)
into areas##2##2##(2008-9#1)(2010-4#1)
into astrocytes##5##2##(2008-11#5)
into at least##5##3##(1993-9#1)(1995-11#1)(2008-10#3)
into barley cultivars##2##3##(2008-10#2)
into barley##3##2##(2008-10#3)
into benzene##4##2##(2008-10#4)
into bile by##2##3##(2008-11#2)
into bile##4##2##(2008-11#4)
into blood##2##2##(2010-11#1)(2012-3#1)
into bone marrow##2##3##(1994-5#1)(2010-8#1)
into both the##3##3##(2010-1#1)(2012-2#1)(2012-3#1)
into both##5##2##(1995-6#1)(2008-11#1)(2010-1#1)(2012-2#1)(2012-3#1)
into cell##3##2##(1991-5#1)(2008-11#1)(2010-6#1)
into cells##14##2##(1990-5#2)(1993-3#1)(1993-8#1)(1997-7#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-9#1)(2013-1#1)
into cellular protein was measured as an##2##7##(2008-11#2)
into cellular##3##2##(2008-11#2)(2008-9#1)
into central##2##2##(1997-4#1)(2008-11#1)
into chloroform by##2##3##(2008-10#2)
into chloroform##12##2##(2008-10#12)
into chromium##2##2##(2008-10#2)
into classes##2##2##(2008-10#1)(2013-1#1)
into clinical practice##7##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-5#1)(2012-12#1)(2012-3#1)
into clinical##9##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
into close proximity##2##3##(1994-5#2)
into close##3##2##(1994-5#2)(2008-4#1)
into commercial##4##2##(2008-10#4)
into consideration the##4##3##(1995-9#1)(2008-10#2)(2008-11#1)
into consideration##16##2##(1991-11#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
into contact with##7##3##(1995-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-5#2)(2010-1#1)
into contiguous##2##2##(2008-10#1)(2008-3#1)
into control##2##2##(2008-12#1)(2012-2#1)
into coordinated##2##2##(2009-9#1)(2012-12#1)
into cortical##2##2##(2008-10#1)(2008-11#1)
into cosmetic##3##2##(2008-5#3)
into courses##2##2##(1996-1#1)(2008-12#1)
into deeper##2##2##(1993-11#1)(2008-10#1)
into developing##2##2##(2008-10#1)(2013-1#1)
into dichloromethane##3##2##(2008-10#3)
into different groups##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
into different##13##2##(1996-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#2)
into dimers##2##2##(2008-8#1)(2008-9#1)
into disaccharides##2##2##(2008-7#2)
into discrete##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
into disease##2##2##(2008-10#2)
into distinct groups##3##3##(2008-10#2)(2008-9#1)
into distinct##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2012-2#1)
into each of##2##3##(1997-6#1)(2008-1#1)
into each##4##2##(1994-12#1)(1997-6#1)(2008-1#1)(2008-10#1)
into either##5##2##(2008-10#4)(2008-3#1)
into embryos##2##2##(1993-3#1)(2008-4#1)
into enucleated rabbit##2##3##(2008-9#2)
into ethyl acetate##2##3##(2008-10#2)
into existing##3##2##(1996-3#1)(2008-10#2)
into fewer##2##2##(1993-12#1)(2008-10#1)
into filaments##2##2##(2008-8#2)
into five groups##7##3##(1990-12#1)(2008-10#1)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)
into five##23##2##(1990-12#1)(1995-12#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)
into focus##2##2##(2011-2#1)(2013-1#1)
into force##2##2##(2008-11#1)(2010-5#1)
into four categories##3##3##(1997-8#1)(2009-12#1)(2011-2#1)
into four distinct##2##3##(2008-10#2)
into four groups based on their##2##6##(2008-9#1)(2011-2#1)
into four groups depending on the##2##6##(2008-7#1)(2010-1#1)
into four groups##14##3##(1991-2#1)(1992-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#3)
into four phylogenetic##2##3##(2008-10#2)
into four sections##2##3##(2008-10#1)(2012-2#1)
into four##38##2##(1991-2#1)(1992-1#1)(1992-4#1)(1997-2#1)(1997-8#1)(2008-10#12)(2008-11#3)(2008-5#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#3)
into fractions##3##2##(2008-10#3)
into free##2##2##(2008-10#2)
into functional##3##2##(1997-7#1)(2008-7#1)(2008-8#1)
into functionally##3##2##(1994-3#1)(2007-12#1)(2008-11#1)
into gaseous##3##2##(2008-10#3)
into general##2##2##(1991-6#1)(1997-3#1)
into genetic##3##2##(2008-10#3)
into geographic##2##2##(2008-10#1)(2011-2#1)
into global##2##2##(2008-3#1)(2009-6#1)
into groups##3##2##(1993-2#1)(2009-7#1)(2013-8#1)
into health care##4##3##(1991-2#1)(1997-1#1)(1997-5#1)(2008-12#1)
into health##5##2##(1991-2#1)(1997-1#1)(1997-5#1)(2008-12#1)(2013-8#1)
into healthy##3##2##(2008-10#2)(2008-9#1)
into hepatic cells##2##3##(1994-5#1)(2008-8#1)
into hepatocyte-like cells##2##3##(2008-9#2)
into hepatocytes##2##2##(1992-3#1)(2012-2#1)
into hepatoma##2##2##(1995-2#1)(2008-8#1)
into her##2##2##(2008-12#1)(2011-2#1)
into higher##2##2##(2008-10#1)(2010-5#1)
into his##2##2##(2008-12#1)(2010-12#1)
into host##2##2##(2011-2#2)
into how##9##2##(1997-7#1)(2008-11#4)(2008-6#1)(2009-7#1)(2010-12#1)(2013-1#1)
into human skin from##2##4##(2008-5#2)
into human skin##4##3##(2008-5#4)
into human##13##2##(1993-8#1)(1997-7#1)(2008-11#2)(2008-12#1)(2008-5#5)(2008-8#3)
into hydrated##2##2##(1992-6#1)(2008-10#1)
into immature##2##2##(1992-12#2)
into improved##2##2##(2008-10#2)
into injured##3##2##(2010-6#1)(2011-2#1)(2012-3#1)
into inpatient##3##2##(1992-12#1)(1995-12#1)(1997-2#1)
into intestinal##2##2##(2008-10#1)(2008-11#1)
into irradiated##2##2##(2008-8#1)(2013-1#1)
into isobutyl methyl ketone (IBMK)##2##5##(2008-10#2)
into it##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
into its##12##2##(1991-7#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-7#1)(2011-2#1)
into large##5##2##(1992-6#1)(2008-10#3)(2008-11#1)
into late##3##2##(2008-11#1)(2009-5#1)(2010-1#1)
into law##7##2##(1991-12#2)(1991-3#1)(1993-1#1)(1994-3#1)(1996-5#2)
into lethally irradiated##2##3##(2010-11#1)(2011-2#1)
into life##2##2##(1991-2#1)(2013-1#1)
into lipid##2##2##(2008-10#1)(2008-7#1)
into liposomes##6##2##(1995-2#2)(1997-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
into local##2##2##(1991-12#1)(2013-1#1)
into low##2##2##(2008-12#1)(2013-8#1)
into maize##2##2##(2008-8#2)
into mammalian cells##2##3##(2008-4#1)(2008-8#1)
into mammalian##3##2##(1994-11#1)(2008-4#1)(2008-8#1)
into mammary##2##2##(2008-8#2)
into many##2##2##(2008-7#1)(2011-2#1)
into mature##3##2##(1990-5#1)(2008-11#1)(2008-5#1)
into medical education in the##2##5##(2008-12#2)
into medical##8##2##(1991-1#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-12#2)(2009-11#1)(2010-1#1)
into membrane##2##2##(1993-3#1)(2008-10#1)
into methyl isobutyl ketone (MIBK)##2##5##(2008-10#2)
into methyl##3##2##(2008-10#3)
into mice##2##2##(2008-4#1)(2013-1#1)
into mitochondria##3##2##(1990-2#2)(2012-2#1)
into more##3##2##(2008-4#1)(2008-5#1)(2010-9#1)
into mouse##6##2##(1994-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-10#1)
into multinucleated##3##2##(2008-11#3)
into multiple##4##2##(1993-2#1)(2008-11#1)(2010-6#1)(2013-8#1)
into muscle##5##2##(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#1)
into myotubes##2##2##(1993-3#1)(2008-11#1)
into nascent##2##2##(1995-8#1)(2008-9#1)
into natural##2##2##(2008-8#1)(2011-1#1)
into networks##2##2##(2008-8#1)(2009-9#1)
into neuronal and##2##3##(1993-8#1)(2008-11#1)
into neurons##4##2##(1994-11#1)(1995-12#1)(2008-7#2)
into new##3##2##(2008-9#1)(2010-4#1)(2013-1#1)
into nine##2##2##(1993-9#1)(2009-10#1)
into normal##6##2##(1990-2#1)(2008-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)
into nuclei##2##2##(2008-8#2)
into one of these##2##4##(1993-8#1)(2008-11#1)
into one of##6##3##(1992-7#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
into one##15##2##(1992-7#1)(1993-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
into organic solvent##2##3##(2008-10#2)
into organic##3##2##(2008-10#3)
into osteoblasts##3##2##(2008-11#2)(2008-9#1)
into other##2##2##(2008-11#1)(2010-8#1)
into our##7##2##(2008-10#1)(2008-11#2)(2008-8#4)
into particular##2##2##(2008-10#1)(2012-2#1)
into patient care##3##3##(1993-3#1)(1997-3#1)(2008-12#1)
into patient##4##2##(1990-12#1)(1993-3#1)(1997-3#1)(2008-12#1)
into perspective the##2##3##(1990-11#1)(2008-3#1)
into plant cells##2##3##(2008-9#1)(2009-8#1)
into plant##4##2##(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
into plasma##3##2##(1994-12#1)(2008-10#2)
into plasmid##2##2##(2008-8#1)(2008-9#1)
into plasticized##3##2##(2008-10#3)
into plots##2##2##(2008-10#2)
into polyaniline-polyacrylonitrile composite matrix##2##4##(2008-10#2)
into possible##3##2##(2008-10#1)(2008-8#1)(2009-4#1)
into practice##13##2##(1996-2#1)(1997-4#1)(1997-7#1)(2008-11#5)(2008-12#1)(2009-11#1)(2010-10#2)(2013-1#1)
into primary rat##4##3##(1993-2#1)(2008-9#3)
into primary##5##2##(1993-2#2)(2008-9#3)
into protein##2##2##(1990-5#1)(2008-4#1)
into proteins##2##2##(2008-4#1)(2008-8#1)
into proteoliposomes##2##2##(1995-8#2)
into pure DPPC liposomes##3##4##(2008-10#3)
into pure##4##2##(2008-10#4)
into quality##2##2##(1993-3#1)(1993-6#1)
into question the##2##3##(1995-5#1)(2008-10#1)
into question##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
into rabbits##2##2##(1990-2#1)(2008-10#1)
into rat##5##2##(1992-3#1)(1993-8#1)(1995-12#1)(1995-2#1)(2008-10#1)
into rats##4##2##(1991-9#1)(1993-8#1)(1995-2#1)(2008-10#1)
into remission##2##2##(1991-9#1)(2010-10#1)
into risk##2##2##(2011-2#2)
into routine oncological care##2##4##(2012-3#2)
into routine##4##2##(1997-6#1)(2008-10#1)(2012-3#2)
into secondary##2##2##(1997-6#1)(2008-10#1)
into serine##3##2##(1997-1#3)
into seven lineages##2##3##(2008-10#2)
into seven##4##2##(1997-2#1)(2008-10#3)
into several##7##2##(1991-5#1)(1992-6#1)(1993-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)
into six##13##2##(1990-12#1)(1991-12#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-8#1)
into small##5##2##(2008-10#3)(2008-4#1)(2008-7#1)
into smaller##2##2##(2008-10#1)(2010-10#1)
into soil##2##2##(2008-10#2)
into solution##4##2##(2008-10#3)(2011-2#1)
into specific##2##2##(1995-12#1)(2008-11#1)
into spontaneously##2##2##(1994-11#1)(1994-5#1)
into standard##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
into subgroups##2##2##(2008-10#1)(2013-8#1)
into subtypes##2##2##(2008-9#1)(2012-3#1)
into such##4##2##(1994-1#1)(2008-11#1)(2010-11#1)(2010-7#1)
into supercritical carbon dioxide##2##4##(2008-10#2)
into supercritical##3##2##(2008-10#3)
into syngeneic mice##2##3##(1990-8#1)(2008-4#1)
into syngeneic##3##2##(1990-8#1)(2008-4#2)
into synthetic saliva##2##3##(2008-10#2)
into synthetic##3##2##(2008-10#3)
into taiwanin##2##2##(1996-5#2)
into that##2##2##(2008-11#1)(2008-5#1)
into the 21st century##5##4##(1991-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#1)
into the Caco-2 cell monolayers##2##5##(2008-11#2)
into the DNA##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
into the ER##2##3##(1991-2#2)
into the GC##2##3##(2008-10#2)
into the HPLC system##2##4##(2008-10#2)
into the L(2) phase region##2##5##(2008-5#2)
into the Medicare##2##3##(1992-2#1)(1994-12#1)
into the NTS##3##3##(1997-2#3)
into the United States##2##4##(2008-10#2)
into the abdominal##3##3##(1995-3#1)(1997-8#1)(2011-2#1)
into the air##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
into the analysis##2##3##(2008-10#1)(2013-8#1)
into the anterior##3##3##(1994-8#1)(1995-2#1)(1997-2#1)
into the appropriate##2##3##(1992-9#1)(2008-12#1)
into the aqueous##2##3##(1991-5#1)(2008-10#1)
into the atmosphere##4##3##(1995-3#1)(2008-10#1)(2008-11#2)
into the atomizer##3##3##(2008-10#3)
into the basal##3##3##(1994-11#1)(2008-10#1)(2009-10#1)
into the biology of##2##4##(2008-4#1)(2008-5#1)
into the biology##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
into the bladder##5##3##(1992-12#1)(1992-3#1)(2008-10#1)(2012-12#1)(2013-1#1)
into the blood##4##3##(1991-12#1)(2008-11#1)(2008-7#1)(2009-9#1)
into the brain##6##3##(1994-5#1)(1994-8#1)(2008-6#1)(2009-8#3)
into the bulk##2##3##(2008-10#2)
into the carrier stream##3##4##(2008-10#3)
into the carrier##4##3##(2008-10#4)
into the causes##2##3##(2008-10#1)(2009-3#1)
into the cavity##3##3##(1997-8#1)(2008-10#1)(2008-3#1)
into the cell##6##3##(1991-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-9#1)
into the cells##2##3##(2008-11#1)(2011-3#1)
into the center of##2##4##(1991-2#1)(2008-11#1)
into the central##2##3##(2008-11#1)(2008-6#1)
into the chromatographic system##2##4##(2008-10#1)(2010-11#1)
into the chromatographic##3##3##(2008-10#2)(2010-11#1)
into the chromosome of##2##4##(1993-9#1)(2008-10#1)
into the chromosome##3##3##(1991-5#1)(1993-9#1)(2008-10#1)
into the circulation##3##3##(2006-6#1)(2008-10#1)(2013-8#1)
into the clinical##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
into the coding region of##2##5##(1997-3#1)(1997-7#1)
into the conduits of##2##4##(2008-10#2)
into the culture media##2##4##(1992-8#1)(2008-11#1)
into the culture medium##6##4##(1993-12#1)(1993-3#1)(1993-6#1)(1996-2#1)(1997-1#1)(2008-11#1)
into the culture supernatant##2##4##(2008-11#2)
into the culture##13##3##(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1996-2#1)(1997-1#1)(2008-11#5)(2008-7#1)
into the cytoplasm of##3##4##(1994-11#1)(1995-5#1)(2008-10#1)
into the cytoplasm##5##3##(1994-11#1)(1994-6#1)(1995-5#1)(2008-10#1)(2008-11#1)
into the cytosol##3##3##(1990-5#1)(1994-5#1)(2011-2#1)
into the decision making process##2##5##(1996-6#2)
into the degree##2##3##(2008-12#1)(2011-2#1)
into the design##2##3##(1996-6#1)(2008-8#1)
into the detrusor##3##3##(2008-10#3)
into the developing##3##3##(2007-12#2)(2010-12#1)
into the development of##5##4##(1997-7#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-2#1)
into the diversity##2##3##(2008-10#1)(2011-1#1)
into the duodenal##2##3##(1991-6#1)(2008-12#1)
into the dynamics of##2##4##(1994-3#1)(2008-11#1)
into the effect of##2##4##(2008-7#1)(2008-8#1)
into the effluent##2##3##(2008-10#1)(2008-11#1)
into the ejaculatory duct##2##4##(2008-7#2)
into the embryo sac##3##4##(2009-8#3)
into the embryo##4##3##(1994-12#1)(2009-8#3)
into the emulsion##2##3##(2008-10#2)
into the endoplasmic reticulum##4##4##(1991-10#1)(1991-2#2)(1996-3#1)
into the environment##5##3##(1991-12#1)(1992-1#1)(2008-10#3)
into the etiology of##2##4##(2008-7#1)(2010-6#1)
into the evolutionary##2##3##(1997-9#1)(2008-9#1)
into the expression##3##3##(1994-5#2)(2008-3#1)
into the extracellular##2##3##(1994-11#1)(2012-3#1)
into the flame of an atomic##2##6##(2008-10#2)
into the flame##8##3##(2008-10#8)
into the flow line##3##4##(2008-10#3)
into the flow system##2##4##(2008-10#2)
into the flow##9##3##(2008-10#8)(2008-9#1)
into the follicular##2##3##(2008-5#1)(2012-3#1)
into the following##3##3##(2008-6#1)(2010-6#1)(2011-3#1)
into the food##2##3##(2008-5#1)(2009-8#1)
into the frontal##3##3##(2011-2#3)
into the functional##2##3##(2009-1#1)(2009-7#1)
into the furnace##2##3##(2008-10#2)
into the future##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
into the gaseous##3##3##(2008-10#3)
into the graphite tube and##2##5##(2008-10#2)
into the graphite tube##8##4##(2008-10#8)
into the graphite##10##3##(2008-10#10)
into the gut##2##3##(1990-5#1)(2007-12#1)
into the hepatic##2##3##(1995-11#1)(1997-8#1)
into the host cell##2##4##(2008-11#1)(2008-9#1)
into the host cytoplasm##2##4##(1996-12#2)
into the host##7##3##(1995-2#1)(1996-12#2)(2008-11#1)(2008-8#2)(2008-9#1)
into the human##3##3##(1995-2#1)(1997-7#1)(2008-9#1)
into the importance of##2##4##(1996-12#1)(1997-9#1)
into the insect##2##3##(1993-6#1)(2008-10#1)
into the intercellular spaces of the##2##6##(2008-10#2)
into the intestinal lumen##2##4##(2011-2#2)
into the joint##2##3##(1996-9#1)(2008-5#1)
into the lateral##2##3##(1991-12#1)(1997-2#1)
into the left##5##3##(1997-3#1)(1997-6#1)(2008-10#1)(2009-4#1)(2012-3#1)
into the lesioned spinal cord##2##5##(2008-7#2)
into the lipid##2##3##(1994-5#1)(2008-10#1)
into the local##2##3##(1997-8#1)(2008-8#1)
into the lumen of the##3##5##(1997-1#1)(2008-7#1)(2011-2#1)
into the lumen##5##3##(1991-12#1)(1997-1#1)(2008-7#1)(2011-2#2)
into the lung##3##3##(1994-12#1)(2008-10#2)
into the mainstream##2##3##(1994-3#1)(1994-8#1)
into the mechanism of##5##4##(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
into the mechanism##8##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
into the mechanisms of##4##4##(2008-11#2)(2008-4#1)(2009-8#1)
into the mechanisms##6##3##(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)
into the medial##2##3##(1994-2#1)(1996-2#1)
into the medical##2##3##(2008-11#1)(2010-12#1)
into the medium was##2##4##(1993-6#1)(1995-2#1)
into the medium##16##3##(1990-2#1)(1990-5#1)(1991-5#2)(1992-3#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-4#1)(2013-7#1)
into the membrane##5##3##(1991-10#2)(1994-5#1)(2008-10#1)(2009-5#1)
into the middle phase##2##4##(2008-10#2)
into the middle##3##3##(2008-10#2)(2008-7#1)
into the model##3##3##(1992-12#1)(2008-3#1)(2008-9#1)
into the molecular##4##3##(1992-9#1)(2008-11#1)(2011-1#1)(2012-2#1)
into the mouse##2##3##(1995-12#1)(2008-10#1)
into the mutant conformation##2##4##(1991-5#2)
into the mycobacterial##2##3##(1995-5#2)
into the nature##2##3##(2008-10#1)(2012-3#1)
into the nebulizer##2##3##(2008-10#2)
into the nebulizer-burner system##2##4##(2008-10#2)
into the needle##2##3##(2008-10#2)
into the next##2##3##(2008-3#1)(2008-4#1)
into the novel##2##3##(2008-10#1)(2011-2#1)
into the nucleus##12##3##(1993-6#1)(1994-11#1)(1996-12#2)(1997-2#2)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)
into the nursing curriculum##2##4##(2008-11#1)(2008-12#1)
into the oil##2##3##(2008-10#1)(2008-5#1)
into the optical##3##3##(2008-3#3)
into the organic phase##6##4##(1994-8#1)(2008-10#4)(2008-7#1)
into the organic##7##3##(1994-8#1)(2008-10#5)(2008-7#1)
into the pathogenesis of MVD##2##5##(2010-12#2)
into the pathogenesis of##4##4##(2008-7#1)(2010-12#3)
into the patient's##3##3##(1995-3#1)(2008-11#1)(2012-2#1)
into the peritoneal cavity##3##4##(2008-12#2)(2011-2#1)
into the phage##2##3##(1991-6#1)(1995-2#1)
into the phenomenon##2##3##(2008-9#1)(2009-5#1)
into the phloem##2##3##(2008-10#2)
into the plasma for##2##4##(2008-10#2)
into the plasma##5##3##(2008-10#5)
into the plasmid##3##3##(1992-3#1)(2008-10#1)(2008-8#1)
into the polymer##3##3##(2008-10#3)
into the polymeric matrix##2##4##(2008-10#1)(2010-4#1)
into the polypyrrole##2##3##(2008-10#2)
into the population##2##3##(2008-10#1)(2013-1#1)
into the pores of##2##4##(2008-10#1)(2008-11#1)
into the posterior fossa##2##4##(1996-9#1)(2011-2#1)
into the potential##5##3##(1994-2#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-1#1)
into the proposed##2##3##(2008-10#1)(2009-10#1)
into the pulmonary circulation##2##4##(1992-3#1)(1994-8#1)
into the pulmonary##3##3##(1992-3#1)(1994-8#1)(2010-5#1)
into the reaction##3##3##(2008-10#1)(2009-8#1)(2010-4#1)
into the right atrium##5##4##(2008-11#1)(2013-1#2)(2013-2#2)
into the right##8##3##(1995-12#1)(1996-9#1)(1997-1#1)(2008-11#1)(2013-1#2)(2013-2#2)
into the role of##4##4##(1991-10#1)(1992-6#1)(2008-11#1)(2013-8#1)
into the role##5##3##(1991-10#1)(1992-6#1)(2008-11#1)(2012-12#1)(2013-8#1)
into the roles of##2##4##(2010-12#1)(2011-2#1)
into the same##8##3##(1997-7#1)(2008-1#1)(2008-10#3)(2010-1#1)(2010-5#1)(2013-8#1)
into the sample##2##3##(2008-10#2)
into the sea##2##3##(2008-11#1)(2008-8#1)
into the sensor##2##3##(2008-10#2)
into the sequence##2##3##(2008-10#1)(2008-4#1)
into the skin##4##3##(2008-10#1)(2008-5#3)
into the small##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
into the soil##6##3##(2008-10#4)(2008-11#1)(2008-7#1)
into the soils##2##3##(2008-10#2)
into the solution##3##3##(2008-10#3)
into the source##3##3##(2008-10#2)(2008-11#1)
into the sphenoid sinus##2##4##(2011-2#2)
into the structural##3##3##(2008-4#1)(2008-8#2)
into the structure##2##3##(2008-10#1)(2008-9#1)
into the study##3##3##(2008-4#1)(2009-6#1)(2011-1#1)
into the subadventitial layer of the##2##6##(2011-2#2)
into the surfactant-rich phase##3##4##(2008-10#1)(2008-7#2)
into the sweat glands##2##4##(2008-5#2)
into the synovial##2##3##(1993-2#1)(2008-5#1)
into the system##9##3##(2008-10#7)(2010-6#2)
into the target##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
into the three##2##3##(1997-6#1)(2009-10#1)
into the tumor##2##3##(2013-1#2)
into the upper phase##4##4##(2008-10#4)
into the upper##7##3##(1994-9#1)(2008-10#6)
into the vas##2##3##(1994-8#2)
into the vascular##2##3##(1997-1#1)(2008-10#1)
into the vector##4##3##(1991-6#1)(2008-11#1)(2008-8#1)(2010-5#1)
into the world of##2##4##(1994-2#1)(2010-8#1)
into the##1066##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#7)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#10)(1991-2#6)(1991-3#1)(1991-5#7)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#4)(1992-2#1)(1992-3#6)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#3)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#9)(1993-8#2)(1993-9#3)(1994-1#3)(1994-11#7)(1994-12#6)(1994-2#7)(1994-3#5)(1994-5#7)(1994-6#1)(1994-8#9)(1994-9#3)(1995-11#2)(1995-12#3)(1995-2#8)(1995-3#4)(1995-5#5)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#10)(1996-2#8)(1996-3#2)(1996-5#3)(1996-6#4)(1996-9#6)(1997-1#9)(1997-2#18)(1997-3#11)(1997-6#3)(1997-7#7)(1997-8#12)(1997-9#2)(2006-6#1)(2007-12#7)(2008-1#2)(2008-10#332)(2008-11#76)(2008-12#14)(2008-2#4)(2008-3#19)(2008-4#14)(2008-5#27)(2008-6#8)(2008-7#32)(2008-8#26)(2008-9#25)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#5)(2009-8#17)(2009-9#3)(2010-1#3)(2010-11#6)(2010-12#7)(2010-4#5)(2010-5#7)(2010-6#10)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#5)(2011-10#1)(2011-2#38)(2011-3#2)(2011-7#1)(2012-12#3)(2012-2#17)(2012-3#14)(2012-4#1)(2013-1#22)(2013-2#2)(2013-7#1)(2013-8#6)
into their##24##2##(1990-5#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#3)(2008-8#2)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
into these##7##2##(1993-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-11#1)
into this area##2##3##(1995-2#1)(2008-11#1)
into this##15##2##(1993-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
into those##4##2##(1997-3#1)(2008-10#1)(2009-12#1)(2010-12#1)
into three categories##5##3##(2008-10#1)(2008-6#1)(2010-12#2)(2011-2#1)
into three different##4##3##(1997-8#1)(2008-10#2)(2013-1#1)
into three distinct groups##2##4##(2008-10#1)(2011-2#1)
into three distinct##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
into three groups##14##3##(1996-6#1)(1996-9#1)(1997-6#1)(2008-10#5)(2008-9#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
into three major##3##3##(2008-6#1)(2009-7#1)(2012-3#1)
into three##65##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#2)
into thyroid##2##2##(1994-11#1)(2013-1#1)
into tissue##4##2##(1993-12#1)(2008-11#1)(2011-2#1)(2011-3#1)
into tissues##3##2##(1991-5#1)(2008-10#1)(2008-11#1)
into tobacco##2##2##(2008-10#1)(2008-7#1)
into toluene##2##2##(2008-10#2)
into total##2##2##(1994-8#2)
into treatment##2##2##(2008-9#1)(2011-1#1)
into tumors##2##2##(1994-5#2)
into two categories##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
into two distinct groups##4##4##(2008-10#4)
into two distinct##9##3##(1995-12#1)(2008-10#7)(2008-5#1)
into two groups by##2##4##(1995-12#1)(2008-10#1)
into two groups that##3##4##(2008-10#2)(2013-1#1)
into two groups##38##3##(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-2#1)(1995-12#2)(1995-3#1)(1996-6#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
into two main##2##3##(2008-10#1)(2011-2#1)
into two major groups##2##4##(2008-10#2)
into two major##6##3##(1993-6#1)(2008-10#4)(2008-11#1)
into two phases##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
into two sections##2##3##(2008-10#1)(2008-4#1)
into two separate##2##3##(1993-6#1)(1996-2#1)
into two subfamilies##2##3##(2008-8#2)
into two subgroups##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
into two subpopulations##2##3##(2008-10#1)(2008-11#1)
into two types##2##3##(1997-2#1)(2008-10#1)
into two##112##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-6#2)(1995-12#3)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#45)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
into types##2##2##(1997-8#1)(2008-7#1)
into underlying##2##2##(1991-3#1)(1991-5#1)
into uninoculated leaves##3##3##(2008-10#3)
into unlabelled cells##2##3##(1991-5#2)
into urine##2##2##(1990-12#1)(2008-10#1)
into various diluents##3##3##(2008-10#3)
into various organic solvents##3##4##(2008-10#3)
into various types##2##3##(2008-11#1)(2013-1#1)
into various##16##2##(1991-12#1)(1993-2#1)(1994-5#1)(2008-10#7)(2008-11#1)(2008-9#3)(2013-1#2)
into vector##2##2##(1995-12#1)(2008-9#1)
into very##3##2##(1990-11#1)(1991-5#1)(2008-11#1)
into water##3##2##(2008-10#3)
into wheat ceramides##2##3##(2008-5#2)
into wheat##6##2##(2008-10#1)(2008-5#2)(2008-8#2)(2011-10#1)
into whether##2##2##(2008-8#1)(2011-1#1)
into which the##3##3##(1993-8#1)(2008-10#1)(2008-5#1)
into which##8##2##(1993-8#1)(1995-3#1)(2008-10#4)(2008-5#1)(2010-12#1)
into wild-type##2##2##(2008-10#1)(2013-1#1)
into xylene##4##2##(2008-10#4)
into yeast##3##2##(2008-4#2)(2008-8#1)
into zeolites##2##2##(2008-10#2)
into##3464##1##(1990-11#6)(1990-12#6)(1990-2#7)(1990-3#2)(1990-5#24)(1990-6#1)(1990-7#1)(1990-8#10)(1990-9#6)(1991-1#4)(1991-10#6)(1991-11#2)(1991-12#20)(1991-2#15)(1991-3#7)(1991-5#25)(1991-6#9)(1991-7#2)(1991-8#2)(1991-9#7)(1992-1#5)(1992-10#2)(1992-11#2)(1992-12#17)(1992-2#1)(1992-3#11)(1992-4#2)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#8)(1993-1#8)(1993-11#3)(1993-12#21)(1993-2#12)(1993-3#13)(1993-6#19)(1993-8#18)(1993-9#7)(1994-1#10)(1994-11#18)(1994-12#21)(1994-2#9)(1994-3#20)(1994-5#26)(1994-6#6)(1994-8#16)(1994-9#4)(1995-1#2)(1995-11#5)(1995-12#27)(1995-2#23)(1995-3#9)(1995-5#13)(1995-6#10)(1995-8#7)(1995-9#4)(1996-1#4)(1996-12#15)(1996-2#23)(1996-3#9)(1996-5#14)(1996-6#10)(1996-8#4)(1996-9#7)(1997-1#23)(1997-2#32)(1997-3#26)(1997-4#3)(1997-5#1)(1997-6#12)(1997-7#17)(1997-8#25)(1997-9#2)(2006-6#1)(2007-11#1)(2007-12#27)(2007-8#2)(2008-1#8)(2008-10#1061)(2008-11#289)(2008-12#57)(2008-2#16)(2008-3#54)(2008-4#58)(2008-5#93)(2008-6#30)(2008-7#92)(2008-8#138)(2008-9#116)(2009-1#2)(2009-10#18)(2009-11#4)(2009-12#11)(2009-3#6)(2009-4#6)(2009-5#8)(2009-6#6)(2009-7#18)(2009-8#34)(2009-9#7)(2010-1#14)(2010-10#13)(2010-11#19)(2010-12#19)(2010-2#2)(2010-3#6)(2010-4#14)(2010-5#16)(2010-6#19)(2010-7#10)(2010-8#12)(2010-9#7)(2011-1#16)(2011-10#2)(2011-2#110)(2011-3#13)(2011-7#2)(2012-12#10)(2012-2#51)(2012-3#38)(2012-4#3)(2012-5#1)(2013-1#90)(2013-2#2)(2013-7#1)(2013-8#32)
intolerable##2##1##(1996-3#1)(2008-10#1)
intolerance##11##1##(1994-3#1)(2008-1#2)(2008-12#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
intolerant to##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
intolerant##4##1##(2008-5#1)(2012-3#2)(2013-1#1)
intoxicated by##2##2##(1990-9#1)(1991-11#1)
intoxicated##7##1##(1990-9#1)(1991-11#1)(1997-2#1)(2008-10#1)(2009-8#2)(2010-1#1)
intoxication in mice##3##3##(1990-5#3)
intoxication in##6##2##(1990-5#3)(1992-7#1)(2012-3#1)(2013-8#1)
intoxication with##2##2##(1995-11#1)(2013-1#1)
intoxication##26##1##(1990-5#4)(1991-11#3)(1992-7#1)(1995-11#3)(2008-10#4)(2009-12#3)(2009-8#2)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
intoxications##2##1##(1990-3#1)(2013-8#1)
intra abdominal##2##2##(2008-11#2)
intra and##2##2##(2008-10#1)(2013-1#1)
intra##7##1##(2007-8#1)(2008-10#1)(2008-11#2)(2010-7#1)(2012-2#1)(2013-1#1)
intra- and extracellular##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
intra- and extracranially##2##3##(2008-7#1)(2011-2#1)
intra- and inter-assay##3##3##(2008-10#2)(2011-3#1)
intra- and inter-day##3##3##(2008-10#2)(2011-3#1)
intra- and inter-laboratory##2##3##(2008-10#2)
intra- and intermolecular##2##3##(1997-7#1)(2008-10#1)
intra- and interobserver reproducibility##2##4##(1997-8#2)
intra- and interspecies##2##3##(1992-6#1)(2009-6#1)
intra- and##30##2##(1992-12#1)(1992-6#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#2)(2011-3#2)(2012-2#1)(2013-8#3)
intra-##33##1##(1992-12#1)(1992-6#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-8#3)
intra-Golgi##4##1##(1997-1#2)(2008-11#1)(2009-7#1)
intra-abdominal abscesses in##2##3##(2013-8#2)
intra-abdominal abscesses##3##2##(2013-8#3)
intra-abdominal pressure##2##2##(1996-11#1)(2011-2#1)
intra-abdominal testis##2##2##(1997-3#1)(2008-10#1)
intra-abdominal##10##1##(1996-11#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#2)(2013-8#3)
intra-accumbens infusions of D-amphetamine##2##4##(1993-6#2)
intra-accumbens##3##1##(1993-6#3)
intra-aneurysmal##3##1##(1997-3#2)(1997-6#1)
intra-aortic##3##1##(2009-2#1)(2013-1#2)
intra-arterial##7##1##(1994-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-3#1)(2008-6#1)(2008-8#1)
intra-articular effusion##2##2##(2011-2#2)
intra-articular injections of a hyaluronic acid preparation##2##7##(2013-1#2)
intra-articular injections of##3##3##(2013-1#3)
intra-articular injections##4##2##(2013-1#4)
intra-articular##17##1##(1996-9#1)(1997-5#1)(2008-11#1)(2009-1#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#7)(2013-8#1)
intra-assay##4##1##(1996-12#1)(2008-10#3)
intra-axial##2##1##(2011-2#1)(2012-3#1)
intra-class##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
intra-day and inter-day##2##3##(2008-10#2)
intra-day and##3##2##(2008-10#3)
intra-day##6##1##(2008-10#6)
intra-epithelial##3##1##(1993-8#3)
intra-hepatic and##2##2##(2008-10#1)(2008-11#1)
intra-individual##2##1##(2008-10#1)(2008-5#1)
intra-laboratory##4##1##(2008-10#2)(2013-1#2)
intra-operative##5##1##(2008-9#2)(2009-12#1)(2012-12#1)(2013-1#1)
intra-operatively##4##1##(2008-9#3)(2013-1#1)
intra-peritoneal##3##1##(2008-12#2)(2008-6#1)
intra-professional education##2##2##(2008-12#2)
intra-species biodiversity of spore-forming bacteria##2##5##(2011-2#2)
intra-species##5##1##(1997-7#1)(2008-11#1)(2008-7#1)(2011-2#2)
intra-specific##2##1##(2008-10#1)(2011-2#1)
intra-uterine##2##1##(1996-9#1)(2009-6#1)
intraabdominal##8##1##(1990-2#2)(1990-9#1)(1991-3#2)(1994-5#1)(2008-12#1)(2013-8#1)
intraaortic axial##2##2##(2008-8#2)
intraaortic##4##1##(2008-3#1)(2008-8#3)
intraarterial thrombolysis##3##2##(1996-6#3)
intraarterial##6##1##(1993-8#1)(1994-11#1)(1994-3#1)(1996-6#3)
intraarticular injection of corticosteroids##2##4##(1997-5#2)
intraarticular injection##3##2##(1997-5#3)
intraarticular##4##1##(1997-5#3)(2008-12#1)
intracanal##2##1##(2012-3#2)
intracardiac##2##1##(2008-11#1)(2008-5#1)
intracarpal pathology##3##2##(2008-9#3)
intracaval##2##1##(1991-6#1)(2011-2#1)
intracavitary##2##1##(2008-12#1)(2010-12#1)
intracavity polarization##2##2##(2008-2#1)(2008-3#1)
intracavity##26##1##(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#16)
intracellular ATP##3##2##(2008-11#3)
intracellular Ca(2+) concentration##2##3##(2008-11#1)(2012-2#1)
intracellular Ca(2+) signals##2##3##(2008-8#1)(2009-8#1)
intracellular Ca(2+)##14##2##(2006-6#3)(2008-11#3)(2008-8#4)(2009-10#1)(2009-8#2)(2012-2#1)
intracellular Ca2+ chelator##2##3##(1994-3#1)(1996-2#1)
intracellular Ca2+ concentrations##2##3##(1995-8#1)(1996-2#1)
intracellular Ca2+ levels##3##3##(1994-5#1)(1995-12#1)(1996-2#1)
intracellular Ca2+##24##2##(1990-2#1)(1990-8#2)(1991-5#1)(1991-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-8#2)(1996-2#4)(1996-5#1)(2008-9#1)
intracellular H(2)O(2)##2##2##(2008-11#2)
intracellular RNA from##2##3##(1997-3#2)
intracellular RNA##3##2##(1997-3#3)
intracellular ROS level##2##3##(2008-11#2)
intracellular ROS##6##2##(2008-11#5)(2012-2#1)
intracellular ZDV##2##2##(2008-7#2)
intracellular accumulation of##7##3##(1990-8#1)(1994-11#1)(1995-6#1)(1997-1#1)(2008-11#2)(2013-1#1)
intracellular accumulation##9##2##(1990-8#1)(1994-11#1)(1995-6#1)(1997-1#1)(2008-11#4)(2013-1#1)
intracellular amino acid pool##2##4##(1990-12#2)
intracellular amino acid##4##3##(1990-12#4)
intracellular amino##5##2##(1990-12#5)
intracellular and##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
intracellular antibody##2##2##(2008-11#1)(2008-8#1)
intracellular antigen##3##2##(1990-5#1)(2008-9#2)
intracellular antigens##4##2##(1990-12#2)(2008-4#1)(2008-9#1)
intracellular cAMP levels##3##3##(1995-8#1)(2008-10#2)
intracellular cAMP##7##2##(1994-11#1)(1995-11#1)(1995-8#2)(2008-10#2)(2008-11#1)
intracellular cGMP##3##2##(1995-8#3)
intracellular calcium and##3##3##(1990-2#2)(1997-8#1)
intracellular calcium concentration##4##3##(1995-2#1)(1995-8#2)(2008-8#1)
intracellular calcium##24##2##(1990-2#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-8#3)(1996-2#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)
intracellular cholesterol##2##2##(1990-8#1)(1994-3#1)
intracellular concentration sites##2##3##(1990-5#2)
intracellular concentration##4##2##(1990-5#2)(2008-7#1)(2013-1#1)
intracellular cyclic AMP##4##3##(1995-11#3)(2008-10#1)
intracellular domain##4##2##(1993-8#3)(2008-8#1)
intracellular drug distribution##2##3##(2008-11#2)
intracellular expression of##2##3##(2008-10#1)(2008-8#1)
intracellular free Ca2+ concentration##2##4##(1995-8#2)
intracellular free Ca2+##3##3##(1995-8#2)(2008-9#1)
intracellular free##5##2##(1994-6#1)(1995-8#2)(2008-7#1)(2008-9#1)
intracellular hyphae##2##2##(2008-10#2)
intracellular immunoglobulin##3##2##(2008-11#2)(2008-9#1)
intracellular immunoglobulins##2##2##(2008-11#2)
intracellular ionized calcium##2##3##(2008-4#1)(2008-9#1)
intracellular ions##4##2##(1991-11#1)(2008-9#1)(2010-4#2)
intracellular levels of##5##3##(1990-8#1)(1993-8#1)(1997-2#2)(2008-4#1)
intracellular lipid##2##2##(1996-2#1)(2012-2#1)
intracellular localization of##2##3##(1993-2#1)(1993-8#1)
intracellular localization##5##2##(1993-2#1)(1993-8#1)(1995-2#1)(2011-2#1)(2013-1#1)
intracellular metabolic##2##2##(2008-11#2)
intracellular molecules##2##2##(2008-4#1)(2010-7#1)
intracellular nucleotide##5##2##(2008-11#5)
intracellular organelles##3##2##(2008-9#2)(2012-2#1)
intracellular oxidative stress##2##3##(2008-11#1)(2008-9#1)
intracellular oxygen##2##2##(2010-11#2)
intracellular pH (pHi)##2##3##(2010-8#2)
intracellular pH measurements in##2##4##(2008-10#1)(2010-8#1)
intracellular pH##14##2##(1990-2#1)(1993-8#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-9#3)(2010-8#4)
intracellular partner(s)##2##2##(1996-2#2)
intracellular pathogen##4##2##(1995-2#1)(2009-8#2)(2011-2#1)
intracellular pathogens##4##2##(1995-2#1)(1995-5#1)(2009-8#1)(2012-3#1)
intracellular phosphoepitopes##2##2##(2008-9#2)
intracellular processing##4##2##(1990-8#1)(1993-8#3)
intracellular protein delivery##2##3##(2008-11#2)
intracellular protein##5##2##(2008-11#5)
intracellular reactive oxygen species (ROS)##4##5##(2008-11#1)(2008-9#1)(2009-8#1)(2012-2#1)
intracellular receptors##2##2##(2011-2#1)(2013-1#1)
intracellular recordings##2##2##(1994-2#1)(2008-11#1)
intracellular second messengers##2##3##(1995-8#1)(2008-7#1)
intracellular signal transduction##3##3##(1995-11#1)(2008-8#1)(2009-12#1)
intracellular signaling molecules##2##3##(1994-12#1)(2009-8#1)
intracellular signaling pathways##7##3##(1996-12#1)(2008-11#2)(2008-7#1)(2009-12#2)(2012-2#1)
intracellular signaling##12##2##(1994-12#1)(1995-11#1)(1996-12#1)(2008-11#2)(2008-7#2)(2009-12#2)(2009-8#1)(2012-2#2)
intracellular signalling##3##2##(1994-11#1)(1996-2#1)(2009-1#1)
intracellular signals##2##2##(1994-6#1)(2008-9#1)
intracellular sodium##4##2##(1994-3#4)
intracellular stores##4##2##(1992-3#1)(1994-11#1)(1994-8#1)(1996-12#1)
intracellular trafficking and##2##3##(1994-8#1)(2008-11#1)
intracellular trafficking##4##2##(1993-6#1)(1994-8#1)(1995-5#1)(2008-11#1)
intracellular transport of##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
intracellular transport##7##2##(1992-5#1)(1995-6#1)(1997-1#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
intracellular##432##1##(1990-12#8)(1990-2#6)(1990-5#4)(1990-8#10)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1992-12#2)(1992-3#1)(1992-5#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#11)(1994-11#10)(1994-12#1)(1994-2#5)(1994-3#10)(1994-5#1)(1994-6#7)(1994-8#5)(1995-11#9)(1995-12#2)(1995-2#5)(1995-5#5)(1995-6#2)(1995-8#19)(1996-12#6)(1996-2#13)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#2)(1997-3#3)(1997-8#1)(2006-6#3)(2007-12#3)(2008-1#1)(2008-10#28)(2008-11#77)(2008-12#1)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#26)(2008-8#15)(2008-9#27)(2009-1#1)(2009-10#1)(2009-12#3)(2009-6#6)(2009-8#9)(2009-9#2)(2010-11#2)(2010-12#1)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#6)(2012-2#9)(2012-3#1)(2013-1#11)(2013-8#3)
intracellularly and##2##2##(2013-1#1)(2013-8#1)
intracellularly applied##2##2##(1992-8#2)
intracellularly in the##2##3##(1993-6#1)(1994-11#1)
intracellularly in##3##2##(1993-6#1)(1994-11#1)(2008-10#1)
intracellularly##16##1##(1990-8#1)(1992-12#1)(1992-8#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
intracerebellar##5##1##(1997-2#5)
intracerebral haemorrhage##7##2##(2008-7#4)(2008-8#3)
intracerebral hematoma##3##2##(2008-12#3)
intracerebral hemorrhage##7##2##(2007-9#1)(2008-7#1)(2009-11#1)(2012-12#1)(2012-3#2)(2013-8#1)
intracerebral lesions##2##2##(2008-7#2)
intracerebral##26##1##(1992-12#1)(1993-6#1)(1994-8#1)(1996-6#1)(2007-9#1)(2008-12#4)(2008-7#8)(2008-8#4)(2009-11#1)(2012-12#1)(2012-3#2)(2013-8#1)
intracerebroventricular (i##3##2##(1994-2#1)(1996-12#1)(1996-2#1)
intracerebroventricular injection of##3##3##(1995-12#1)(1997-2#1)(2008-8#1)
intracerebroventricular##9##1##(1992-3#2)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-8#1)
intracerebroventricularly (i##5##2##(1992-3#2)(1996-2#1)(1997-4#2)
intracerebroventricularly##6##1##(1991-9#1)(1992-3#2)(1996-2#1)(1997-4#2)
intrachain disulfide bonds##3##3##(1990-5#3)
intrachain##4##1##(1990-5#4)
intrachromosomal insertion##2##2##(2012-3#2)
intrachromosomal##3##1##(1993-12#1)(2012-3#2)
intraclass correlation##4##2##(2008-10#3)(2008-12#1)
intracochlear##3##1##(2008-9#3)
intracranial and##3##2##(2008-7#1)(2011-2#2)
intracranial aneurysm##2##2##(2008-7#1)(2011-2#1)
intracranial aneurysms##8##2##(1995-11#1)(1997-3#1)(2008-7#3)(2009-7#1)(2009-9#1)(2011-2#1)
intracranial arterial##2##2##(1997-6#2)
intracranial arteries##2##2##(2012-3#1)(2013-8#1)
intracranial arteriovenous##2##2##(1991-2#2)
intracranial haemorrhage and need##2##4##(1992-6#2)
intracranial haemorrhage and##3##3##(1992-6#3)
intracranial haemorrhage##8##2##(1992-6#4)(2008-7#2)(2011-2#2)
intracranial hypertension##11##2##(1995-11#1)(2008-7#5)(2009-5#1)(2010-5#2)(2011-2#2)
intracranial hypotension##3##2##(2008-7#3)
intracranial metastases##2##2##(1997-4#2)
intracranial pressure (ICP)##6##3##(1993-1#1)(2008-12#1)(2008-7#2)(2010-5#1)(2011-2#1)
intracranial pressure and##3##3##(1993-1#1)(2011-2#2)
intracranial pressure##14##2##(1993-1#2)(1997-3#1)(2008-1#1)(2008-12#2)(2008-7#3)(2010-5#1)(2011-2#3)(2013-1#1)
intracranial saccular aneurysms##2##3##(1995-11#1)(2010-9#1)
intracranial self-stimulation (ICSS)##2##3##(1991-2#1)(1996-2#1)
intracranial self-stimulation##3##2##(1991-2#2)(1996-2#1)
intracranial tumor##3##2##(2011-2#2)(2012-2#1)
intracranial tumour##2##2##(2008-7#2)
intracranial##103##1##(1991-2#4)(1991-6#1)(1992-6#4)(1993-1#2)(1993-9#1)(1994-8#2)(1995-11#4)(1996-2#1)(1996-6#1)(1997-3#4)(1997-4#2)(1997-6#2)(2007-9#1)(2008-1#2)(2008-12#2)(2008-7#27)(2008-8#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#18)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#5)
intracranialis##2##1##(1990-12#2)
intractable epilepsy##2##2##(2008-7#1)(2009-9#1)
intractable facial pain##2##3##(1993-1#2)
intractable##16##1##(1993-1#2)(1994-3#1)(1997-5#1)(2008-10#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
intracystic papillary carcinoma##2##3##(1992-2#1)(2011-2#1)
intracystic##5##1##(1992-2#1)(1993-1#1)(2008-12#1)(2011-2#2)
intracytoplasmic sperm injection##3##3##(2009-5#1)(2012-3#2)
intracytoplasmic##9##1##(1991-8#1)(1994-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-3#2)
intraday and##2##2##(2008-10#2)
intradermal injection of##2##3##(1995-12#1)(2008-9#1)
intradermal injection##5##2##(1992-12#1)(1992-6#1)(1995-12#1)(2008-9#1)(2012-2#1)
intradermal reaction##2##2##(1990-6#1)(1993-3#1)
intradermal##11##1##(1990-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-12#1)(1995-5#1)(2008-5#2)(2008-9#1)(2012-12#1)(2012-2#1)
intradermally##3##1##(1990-6#1)(1995-11#1)(2008-12#1)
intradiscal aspiration of##2##3##(2012-2#2)
intradiscal injections of##2##3##(1996-3#2)
intradiscal##4##1##(1996-3#2)(2012-2#2)
intraductal papilloma##3##2##(1991-2#3)
intraductal pathology##2##2##(1990-11#2)
intraductal##7##1##(1990-11#2)(1991-2#3)(1994-12#1)(2012-2#1)
intradural spinal surgery##2##3##(2012-3#2)
intradural spinal##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
intradural spine surgery##3##3##(2012-3#3)
intradural##14##1##(2008-12#1)(2008-7#3)(2009-5#1)(2011-2#4)(2012-3#5)
intraepithelial lesions##3##2##(1994-1#1)(1994-12#1)(2008-11#1)
intraepithelial neoplasia and##2##3##(1991-2#1)(2013-1#1)
intraepithelial neoplasia##15##2##(1991-2#4)(1994-12#2)(1994-2#1)(2011-2#4)(2012-3#1)(2013-1#3)
intraepithelial##23##1##(1991-2#4)(1994-1#1)(1994-12#3)(1994-2#1)(1996-12#1)(2008-11#3)(2010-3#1)(2011-2#4)(2012-3#1)(2013-1#4)
intrafloral integration##3##2##(2009-8#3)
intragastric pH##2##2##(1993-12#2)
intragastric##7##1##(1993-12#4)(1996-12#2)(1997-4#1)
intragastrically##2##1##(1996-2#1)(2008-11#1)
intragenic##4##1##(1990-5#1)(1993-12#1)(1997-3#1)(2011-2#1)
intraguild predation##3##2##(2008-8#3)
intragyral##4##1##(1994-8#4)
intrahepatic biliary lithiasis##2##3##(1990-3#2)
intrahepatic or##2##2##(1997-8#1)(2012-2#1)
intrahepatic portal##2##2##(2009-8#2)
intrahepatic##11##1##(1990-3#2)(1991-12#1)(1997-8#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
intrahost##2##1##(2012-2#1)(2013-8#1)
intraindividual##2##1##(2011-2#1)(2013-1#1)
intraluminal thrombus##2##2##(2008-7#2)
intraluminal tonometry##2##2##(2012-3#2)
intraluminal##10##1##(1992-6#1)(1996-6#1)(2008-7#2)(2009-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
intramammary infections##3##2##(1990-6#3)
intramedullary AVM##3##2##(1997-6#2)(2008-7#1)
intramedullary fixation##2##2##(2013-1#2)
intramedullary nail##7##2##(2009-3#1)(2011-2#2)(2013-1#4)
intramedullary##20##1##(1997-6#2)(2008-7#2)(2008-8#2)(2009-3#2)(2011-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
intramitochondrial##2##1##(1991-12#1)(1994-8#1)
intramolecular base pairing##2##3##(1991-5#1)(2008-4#1)
intramolecular charge-transfer character##2##3##(2008-10#2)
intramolecular hydrogen##2##2##(1992-12#1)(1993-3#1)
intramolecular lactonization##2##2##(2010-7#2)
intramolecular##32##1##(1991-5#2)(1992-12#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#1)(1995-2#1)(1995-8#1)(1996-5#7)(2008-10#9)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#2)
intramural fibroids##2##2##(1994-2#2)
intramural spread##2##2##(1991-12#2)
intramural##9##1##(1990-3#1)(1990-9#1)(1991-12#2)(1994-2#2)(2008-10#1)(2012-2#1)(2013-1#1)
intramuscular haemangioma##2##2##(2010-5#2)
intramuscular injection of##9##3##(1997-8#3)(2008-4#1)(2008-8#3)(2011-2#1)(2012-3#1)
intramuscular injection##11##2##(1991-3#1)(1997-8#3)(2008-4#1)(2008-8#4)(2011-2#1)(2012-3#1)
intramuscular##28##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#1)(1995-8#1)(1997-8#3)(2008-1#1)(2008-4#1)(2008-8#7)(2010-4#3)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
intramuscularly##4##1##(1990-2#1)(1990-6#1)(2008-5#1)(2008-9#1)
intranasal corticosteroid##2##2##(2007-11#1)(2012-12#1)
intranasal corticosteroids on##2##3##(2007-11#1)(2012-12#1)
intranasal corticosteroids##6##2##(2007-11#5)(2012-12#1)
intranasal instillation##2##2##(2008-10#2)
intranasal##21##1##(1995-2#1)(1995-9#1)(2007-11#8)(2008-10#7)(2011-2#1)(2012-12#2)(2013-1#1)
intranasally##5##1##(1995-2#2)(2008-10#1)(2008-5#2)
intranuclear binding##4##2##(1994-11#4)
intranuclear coccidian parasite##2##3##(2013-1#2)
intranuclear##9##1##(1990-5#1)(1994-11#4)(1995-6#1)(2008-5#1)(2013-1#2)
intraobserver##2##1##(1997-8#2)
intraocular foreign##2##2##(2009-12#2)
intraocular infections##2##2##(2008-12#2)
intraocular lens implantation##5##3##(2010-9#1)(2011-2#3)(2013-1#1)
intraocular lens##9##2##(1991-2#1)(2010-9#1)(2011-2#6)(2013-1#1)
intraocular lenses##2##2##(1991-2#1)(2011-2#1)
intraocular pressure (IOP)##4##3##(2011-2#3)(2013-1#1)
intraocular pressure##8##2##(1990-11#1)(1993-1#1)(2010-10#1)(2011-2#3)(2013-1#2)
intraocular##27##1##(1990-11#1)(1991-2#2)(1993-1#1)(2008-12#2)(2008-3#2)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#10)(2013-1#3)
intraoperative MEP mapping##2##3##(2010-7#2)
intraoperative analgesic##2##2##(2010-7#2)
intraoperative assessment of##2##3##(1992-9#1)(2013-1#1)
intraoperative bleeding##3##2##(1994-3#1)(2008-7#1)(2011-2#1)
intraoperative blood loss##4##3##(1994-3#3)(1996-1#1)
intraoperative blood##5##2##(1994-3#3)(1996-1#1)(2011-2#1)
intraoperative complications##4##2##(1993-12#1)(1996-3#1)(2008-9#1)(2012-3#1)
intraoperative imaging of##2##3##(2011-7#2)
intraoperative imaging##3##2##(2011-7#2)(2013-1#1)
intraoperative monitoring of##2##3##(2008-10#1)(2012-3#1)
intraoperative monitoring##3##2##(2008-10#1)(2012-3#2)
intraoperative periprosthetic femoral##2##3##(2013-1#2)
intraoperative##78##1##(1990-3#1)(1991-3#1)(1991-6#1)(1992-2#2)(1992-4#1)(1992-9#2)(1993-1#2)(1993-12#1)(1994-3#4)(1996-1#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#8)(2011-2#7)(2011-3#1)(2011-7#4)(2012-12#4)(2012-3#5)(2013-1#6)(2013-8#1)
intraoperatively and##2##2##(1994-1#1)(2013-8#1)
intraoperatively##7##1##(1991-3#1)(1993-1#1)(1994-1#1)(1994-3#1)(2010-7#1)(2012-3#1)(2013-8#1)
intraoral##5##1##(1990-6#1)(1993-1#1)(2013-1#3)
intraorbital hematoma##3##2##(2011-2#3)
intraorbital##4##1##(2011-2#3)(2012-3#1)
intraosseous##5##1##(2008-9#1)(2010-3#4)
intraparenchymal##6##1##(1991-6#1)(2008-12#1)(2008-7#2)(2012-3#2)
intraparenchymatous##2##1##(1996-6#1)(1996-9#1)
intrapartum##3##1##(1994-3#2)(2013-1#1)
intraperitoneal (i##7##2##(1994-5#1)(1994-8#1)(1996-12#1)(1996-2#3)(2008-10#1)
intraperitoneal Ringer's lactate instillation##2##4##(1995-12#2)
intraperitoneal accumulation of leukocytes##2##4##(2008-12#2)
intraperitoneal accumulation of##3##3##(2008-12#3)
intraperitoneal chemotherapy##2##2##(1994-6#1)(2010-12#1)
intraperitoneal injection of##7##3##(1992-12#1)(1994-5#1)(1997-2#1)(2010-7#1)(2011-2#2)(2011-3#1)
intraperitoneal injection##9##2##(1991-12#1)(1992-12#1)(1994-5#1)(1997-2#1)(2010-7#1)(2011-2#2)(2011-3#2)
intraperitoneal##33##1##(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-12#2)(1996-12#1)(1996-2#3)(1997-2#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#3)(2011-3#2)(2012-2#1)
intraperitoneally (i##3##2##(1992-12#1)(2010-1#1)(2010-5#1)
intraperitoneally administered##2##2##(2008-11#1)(2013-1#1)
intraperitoneally in##2##2##(2008-12#1)(2011-2#1)
intraperitoneally injected##2##2##(1993-8#1)(1994-5#1)
intraperitoneally##17##1##(1990-5#1)(1992-12#1)(1993-8#3)(1994-5#1)(2008-11#4)(2008-12#2)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
intraplatelet magnesium concentrations##2##3##(2008-7#2)
intrapopulation##2##1##(2008-10#1)(2008-8#1)
intrapulmonary##2##1##(1996-3#1)(1997-1#1)
intraradices in##2##2##(2008-10#2)
intraradices##4##1##(2008-10#4)
intrarenal neuroblastoma##3##2##(2008-10#3)
intrarenal##4##1##(2008-10#3)(2011-2#1)
intraspecific competition##4##2##(2008-8#4)
intraspecific crosses##2##2##(2008-10#2)
intraspecific variability##2##2##(2008-10#2)
intraspecific variation in##3##3##(2008-10#1)(2012-2#2)
intraspecific variation##5##2##(2008-10#2)(2008-8#1)(2012-2#2)
intraspecific##28##1##(2008-10#15)(2008-8#8)(2008-9#1)(2012-2#2)(2012-3#2)
intraspinal##4##1##(1997-3#1)(2008-7#1)(2010-5#2)
intratesticular##2##1##(2007-8#1)(2011-5#1)
intrathecal TCA##2##2##(2010-12#2)
intrathecal baclofen##4##2##(2011-2#4)
intrathecal injection of fluorescein##4##4##(2008-12#4)
intrathecal##15##1##(2008-12#4)(2010-12#3)(2011-2#7)(2012-3#1)
intrathecally##7##1##(1992-3#2)(1995-12#2)(2011-2#3)
intrathoracic##4##1##(1991-3#1)(2008-11#1)(2010-12#1)(2013-1#1)
intratracheal##2##1##(1996-3#1)(2008-9#1)
intratumor heterogeneity##2##2##(2013-1#2)
intratumor##3##1##(2013-1#3)
intratumoral drug##2##2##(1995-10#1)(2013-1#1)
intratumoral##5##1##(1993-11#1)(1994-5#1)(1995-10#1)(2013-1#2)
intrauterine fetal##3##2##(1992-5#1)(2008-11#1)(2010-8#1)
intrauterine growth restriction##2##3##(2008-11#2)
intrauterine growth retardation and low birth weight##2##7##(2013-1#2)
intrauterine growth retardation##3##3##(2010-3#1)(2013-1#2)
intrauterine growth##5##2##(2008-11#2)(2010-3#1)(2013-1#2)
intrauterine pregnancy##2##2##(1994-12#2)
intrauterine##34##1##(1990-11#1)(1991-2#2)(1991-6#1)(1992-5#1)(1993-12#2)(1994-12#3)(1994-3#1)(1996-1#1)(1996-11#1)(1996-3#2)(2008-11#3)(2009-11#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#6)
intravaginal##2##1##(1994-3#1)(1995-8#1)
intravascular bone marrow##2##3##(2010-8#2)
intravascular catheters##2##2##(1991-3#1)(1994-5#1)
intravascular treatment##2##2##(1996-6#1)(2008-7#1)
intravascular ultrasound catheter##2##3##(2008-11#2)
intravascular ultrasound##4##2##(2008-11#3)(2008-6#1)
intravascular##28##1##(1991-3#1)(1993-2#1)(1994-5#2)(1995-11#1)(1996-3#1)(1996-6#2)(1997-6#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-3#1)(2013-1#1)
intravenous (IV)##2##2##(1993-1#1)(2012-12#1)
intravenous administration of##6##3##(1991-2#1)(1995-11#1)(2008-10#1)(2008-7#2)(2012-12#1)
intravenous administration##11##2##(1991-2#1)(1991-6#1)(1995-11#1)(1996-11#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-12#1)
intravenous and oral##3##3##(2010-12#1)(2012-12#2)
intravenous and##4##2##(2010-12#1)(2010-7#1)(2012-12#2)
intravenous antibiotic##2##2##(1997-7#1)(2012-12#1)
intravenous antibiotics##2##2##(2008-10#1)(2013-1#1)
intravenous catheter##2##2##(1993-6#1)(2012-2#1)
intravenous cocaine##3##2##(1991-1#2)(1993-6#1)
intravenous drug abuse##2##3##(2008-5#1)(2009-7#1)
intravenous drug abusers (IVDAs)##2##4##(1991-1#2)
intravenous drug use##2##3##(1996-11#1)(2013-1#1)
intravenous drug users##6##3##(1991-1#1)(1992-9#3)(1997-6#1)(2013-8#1)
intravenous drug##18##2##(1990-6#1)(1991-1#3)(1992-9#3)(1996-11#1)(1997-6#1)(2008-12#1)(2008-5#2)(2009-6#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
intravenous fluid##2##2##(1991-6#1)(2012-3#1)
intravenous glucose##2##2##(1994-12#1)(2010-10#1)
intravenous immunoglobulin##5##2##(2010-8#2)(2011-2#1)(2012-3#2)
intravenous immunoglobulins##2##2##(2012-3#2)
intravenous infusion of##2##3##(1990-8#1)(2008-11#1)
intravenous infusion##4##2##(1990-8#1)(2008-11#1)(2010-11#1)(2012-3#1)
intravenous infusions##2##2##(1990-10#1)(2012-12#1)
intravenous injection of##4##3##(1992-12#1)(1994-5#1)(2013-1#1)(2013-8#1)
intravenous injection##7##2##(1992-12#1)(1993-11#2)(1994-5#1)(2009-12#1)(2013-1#1)(2013-8#1)
intravenous midazolam##3##2##(1993-1#3)
intravenous self-administration##3##2##(1993-6#3)
intravenous treatment with##2##3##(2008-10#1)(2008-9#1)
intravenous treatment##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
intravenous urography##2##2##(2011-2#2)
intravenous##128##1##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#5)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-9#3)(1993-1#6)(1993-11#2)(1993-6#6)(1993-8#2)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-5#1)(1996-11#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-6#1)(2010-7#4)(2010-8#2)(2011-2#7)(2012-12#7)(2012-2#5)(2012-3#9)(2013-1#5)(2013-8#3)
intravenously at##2##2##(1991-6#1)(2008-11#1)
intravenously##22##1##(1991-6#1)(1993-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-6#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-7#1)(2010-7#2)(2010-8#1)(2011-2#4)(2013-1#1)
intraventricular asynchrony##2##2##(2008-10#2)
intraventricular haemorrhage (IVH)##2##3##(2008-7#2)
intraventricular haemorrhage##4##2##(2008-7#4)
intraventricular hemorrhage##2##2##(2012-3#2)
intraventricular injection of##2##3##(1991-12#1)(2008-7#1)
intraventricular injection##4##2##(1991-12#3)(2008-7#1)
intraventricular##19##1##(1991-12#4)(1991-8#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-7#6)(2011-2#1)(2012-3#3)
intraventricularly##2##1##(1991-12#1)(1995-12#1)
intravesical part##2##2##(1997-4#1)(2008-10#1)
intravesical ureter##4##2##(1997-4#3)(2008-10#1)
intravesical##11##1##(1993-11#2)(1997-4#4)(2008-10#4)(2011-2#1)
intravesically##2##1##(1993-11#2)
intravital##3##1##(2011-2#1)(2012-2#2)
intravitreal injections of##2##3##(2011-2#1)(2012-3#1)
intravitreal##8##1##(2010-9#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#3)
intricate##6##1##(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)
intrigue##2##1##(2008-11#2)
intriguing##12##1##(1992-2#1)(1994-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)
intrinsic activity##5##2##(1990-5#1)(1991-2#1)(1994-8#1)(1995-11#1)(2012-2#1)
intrinsic and extrinsic work values##2##5##(2010-10#2)
intrinsic and extrinsic work##3##4##(1996-1#1)(2010-10#2)
intrinsic and extrinsic##8##3##(1996-1#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-10#2)(2011-2#1)(2013-1#1)
intrinsic and##9##2##(1996-1#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-10#2)(2011-2#1)(2013-1#1)
intrinsic apoptosis##3##2##(2011-2#3)
intrinsic apoptotic pathway##2##3##(2009-12#1)(2011-2#1)
intrinsic complexation constants##3##3##(2008-10#3)
intrinsic complexation##4##2##(2008-10#4)
intrinsic constants##2##2##(2008-10#2)
intrinsic defects##2##2##(1997-8#1)(2008-1#1)
intrinsic effects##2##2##(1994-2#1)(1996-2#1)
intrinsic factors##2##2##(2008-11#1)(2011-2#1)
intrinsic feature of##2##3##(2008-11#1)(2008-7#1)
intrinsic feature##3##2##(2008-11#2)(2008-7#1)
intrinsic feedback##2##2##(2009-12#1)(2010-11#1)
intrinsic fluorescence of the##4##4##(1990-5#1)(2008-10#2)(2008-8#1)
intrinsic fluorescence of tryptophan##2##4##(1992-6#1)(2008-8#1)
intrinsic fluorescence of##9##3##(1990-5#1)(1992-6#1)(1995-6#1)(2008-10#4)(2008-8#2)
intrinsic fluorescence##13##2##(1990-5#1)(1992-6#2)(1995-6#2)(2008-10#4)(2008-3#2)(2008-8#2)
intrinsic link##2##2##(2008-8#2)
intrinsic mechanisms to##2##3##(2008-11#1)(2009-10#1)
intrinsic motivation##3##2##(2008-11#3)
intrinsic noise##2##2##(2008-10#1)(2008-11#1)
intrinsic sensitivity##2##2##(2008-10#1)(2008-3#1)
intrinsic to the##2##3##(2010-12#1)(2011-2#1)
intrinsic to##3##2##(1996-2#1)(2010-12#1)(2011-2#1)
intrinsic upregulation of##2##3##(1992-8#2)
intrinsic value for math and English##3##6##(2009-7#3)
intrinsic viscosity of poly(ethylene terephthalate)##2##5##(2008-10#2)
intrinsic viscosity of##3##3##(2008-10#3)
intrinsic##154##1##(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#36)(2008-11#12)(2008-2#1)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#10)(2008-9#1)(2009-10#2)(2009-12#3)(2009-3#2)(2009-5#2)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#11)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
intrinsically##15##1##(1992-1#1)(1993-12#1)(1994-8#1)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-8#1)
introduce a new##4##3##(2008-3#1)(2009-8#1)(2013-8#2)
introduce a##16##2##(1991-11#1)(1993-2#1)(1997-8#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#2)
introduce an##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
introduce and##2##2##(2008-2#1)(2010-3#1)
introduce the##11##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-1#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
introduce##65##1##(1991-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-9#1)(1996-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-8#3)(2010-10#2)(2010-11#2)(2010-3#2)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
introduced 2##3##2##(2008-10#3)
introduced H##2##2##(2008-10#2)
introduced a##7##2##(1991-12#1)(1995-2#2)(2008-10#1)(2008-11#2)(2010-6#1)
introduced an##3##2##(1992-1#1)(1994-6#1)(2008-8#1)
introduced and##13##2##(1990-8#1)(1992-9#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#1)(2010-9#1)(2011-7#1)(2012-3#1)
introduced antagonists##2##2##(2008-10#2)
introduced as a##8##3##(2008-10#3)(2008-3#2)(2008-5#1)(2009-10#1)(2012-2#1)
introduced as an##3##3##(1997-8#1)(2008-10#1)(2008-3#1)
introduced as##16##2##(1997-8#1)(2008-10#7)(2008-12#1)(2008-3#3)(2008-5#1)(2009-10#1)(2012-2#1)(2013-8#1)
introduced at the##3##3##(1992-5#1)(2010-9#1)(2011-2#1)
introduced at##5##2##(1992-5#1)(2008-10#1)(2008-12#1)(2010-9#1)(2011-2#1)
introduced by the##6##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
introduced by##20##2##(1995-3#1)(1996-2#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-5#1)(2012-3#1)(2013-1#1)
introduced directly into the##3##4##(2008-10#3)
introduced during##2##2##(2008-11#1)(2011-3#1)
introduced for##10##2##(1990-5#1)(1991-9#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-12#2)
introduced in a##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2012-12#1)
introduced in order to##2##4##(2008-11#2)
introduced in the##15##3##(1990-5#1)(1995-2#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#1)(2013-8#2)
introduced in this##4##3##(2008-10#3)(2008-12#1)
introduced in##38##2##(1990-5#1)(1991-2#1)(1991-9#1)(1993-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-8#2)
introduced into a##9##3##(1993-12#1)(2008-10#6)(2008-2#1)(2008-9#1)
introduced into the flame##3##4##(2008-10#3)
introduced into the flow##4##4##(2008-10#4)
introduced into the graphite##3##4##(2008-10#3)
introduced into the source##2##4##(2008-10#2)
introduced into the system##2##4##(2008-10#2)
introduced into the##46##3##(1993-1#1)(1994-9#1)(1996-1#1)(1997-3#2)(1997-6#2)(2008-10#29)(2008-11#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#2)(2011-1#1)
introduced into##91##2##(1990-12#1)(1990-8#1)(1993-1#1)(1993-12#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-3#2)(1997-6#4)(1997-7#1)(1997-8#1)(2008-10#48)(2008-11#7)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-8#2)(2011-1#1)
introduced isolate of##3##3##(2008-10#3)
introduced on the##2##3##(1990-3#1)(2008-10#1)
introduced over##2##2##(2008-10#2)
introduced pathogens##2##2##(2008-10#2)
introduced population##2##2##(2008-10#1)(2012-3#1)
introduced the##7##2##(1993-11#1)(1993-3#1)(1996-12#1)(1996-3#1)(2008-11#3)
introduced through a##2##3##(1990-2#1)(1992-1#1)
introduced through##4##2##(1990-2#1)(1992-1#1)(2008-10#2)
introduced to facilitate##2##3##(2008-9#1)(2010-5#1)
introduced to the##5##3##(1994-1#1)(1997-8#1)(2008-10#2)(2008-9#1)
introduced to##26##2##(1990-11#1)(1991-3#1)(1992-1#1)(1993-1#1)(1994-1#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#1)
introduced using a##2##3##(2008-10#2)
introduced via##2##2##(2008-10#1)(2008-4#1)
introduced which##2##2##(2008-11#1)(2013-1#1)
introduced##384##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#2)(1992-1#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#2)(1994-1#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#5)(2007-11#1)(2008-10#150)(2008-11#32)(2008-12#7)(2008-2#3)(2008-3#17)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#25)(2008-9#10)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-5#2)(2010-6#2)(2010-9#2)(2011-1#1)(2011-2#8)(2011-3#2)(2011-7#1)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#5)
introduces a new##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)
introduces a##11##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-5#1)(2013-1#1)
introduces and##2##2##(2008-10#1)(2010-7#1)
introduces the possibility##2##3##(2008-10#1)(2012-2#1)
introduces the##10##2##(1991-2#1)(1995-9#1)(2008-10#1)(2009-7#1)(2012-12#1)(2012-2#2)(2012-3#3)
introduces two##2##2##(2008-5#1)(2013-8#1)
introduces##35##1##(1991-2#1)(1994-12#1)(1995-9#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
introducing a new##3##3##(1993-1#1)(2008-10#1)(2008-3#1)
introducing a##13##2##(1992-6#1)(1993-1#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2010-10#1)(2011-2#1)(2012-2#1)
introducing feedback##2##2##(2010-10#2)
introducing new##2##2##(2009-11#1)(2011-3#1)
introducing the##6##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2011-2#1)
introducing them##2##2##(1997-1#1)(2008-10#1)
introducing##57##1##(1992-6#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-8#1)(1997-1#2)(1997-6#1)(1997-7#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#3)(2008-9#1)(2009-11#2)(2010-1#2)(2010-10#3)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
introduction and development of##2##4##(2008-11#1)(2008-12#1)
introduction and spread of##2##4##(1990-3#1)(2008-10#1)
introduction and##8##2##(1990-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2012-2#1)
introduction effort was##2##3##(2008-8#2)
introduction in##6##2##(2008-10#4)(2008-7#1)(2010-12#1)
introduction into the##4##3##(1991-11#1)(2008-10#3)
introduction into##6##2##(1991-11#1)(2008-10#4)(2008-8#1)
introduction of 2##2##3##(2008-10#2)
introduction of a medical##2##4##(2008-6#1)(2011-2#1)
introduction of a##19##3##(1992-12#1)(1993-3#1)(1994-8#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
introduction of an##5##3##(2008-10#2)(2008-11#2)(2008-12#1)
introduction of drug-eluting stents##3##4##(2008-11#2)(2011-2#1)
introduction of new##6##3##(1990-2#1)(1991-3#1)(1993-1#1)(1995-5#1)(2008-10#1)(2008-3#1)
introduction of the pathogen into##2##5##(2008-10#2)
introduction of the pathogen##3##4##(2008-10#3)
introduction of the##36##3##(1991-9#1)(1992-3#1)(1994-6#2)(1997-5#2)(1997-6#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
introduction of these##2##3##(1993-12#1)(2008-11#1)
introduction of this##2##3##(2008-10#1)(2012-8#1)
introduction of##166##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#43)(2008-11#23)(2008-12#9)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#7)
introduction success##2##2##(2008-8#2)
introduction systems##2##2##(2008-10#1)(2010-7#1)
introduction techniques##5##2##(2008-10#3)(2008-11#2)
introduction to the feature issue##2##5##(2008-3#2)
introduction to the##8##3##(1992-3#1)(1997-2#1)(2008-10#3)(2008-3#2)(2012-2#1)
introduction to##26##2##(1991-3#1)(1992-3#1)(1993-3#2)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#3)(2008-7#1)(2009-9#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#2)
introduction within##2##2##(1995-6#1)(2008-11#1)
introduction##273##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-9#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-11#2)(2008-1#3)(2008-10#100)(2008-11#30)(2008-12#12)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#9)
introductions of the same species##2##5##(2008-8#2)
introductions of##8##2##(2008-10#6)(2008-8#2)
introductions##14##1##(2008-10#7)(2008-8#7)
introductory part##2##2##(2008-10#2)
introductory##8##1##(1992-1#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)
introgressed from##3##2##(2008-10#3)
introgressed into##4##2##(2008-10#4)
introgressed##9##1##(2008-10#8)(2012-3#1)
introgression##8##1##(2008-10#2)(2008-8#5)(2012-3#1)
intron 3##3##2##(1995-6#1)(2010-4#1)(2011-1#1)
intron alleles##2##2##(2008-10#2)
intron and genome##2##3##(2008-8#2)
intron and##5##2##(2008-10#1)(2008-12#1)(2008-8#2)(2011-1#1)
intron in the##3##3##(1993-8#1)(1997-8#1)(2008-10#1)
intron of the##8##3##(1991-2#1)(1991-6#1)(1992-10#1)(1993-8#1)(1995-6#1)(2008-10#1)(2012-3#2)
intron of##14##2##(1991-2#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-8#1)(1995-6#1)(2008-10#3)(2012-3#2)
intron sequences##2##2##(1993-12#1)(2008-11#1)
intron size##4##2##(2008-8#4)
intron##61##1##(1991-2#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-6#1)(1993-1#1)(1993-12#4)(1993-2#7)(1993-6#1)(1993-8#3)(1994-11#1)(1995-6#2)(1997-8#2)(2008-10#11)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#8)(2008-9#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#3)
intron-containing##4##1##(1993-6#1)(2008-10#1)(2013-8#2)
intron-exon structure##2##2##(1993-12#1)(1993-6#1)
intron-exon##3##1##(1993-12#1)(1993-6#1)(1995-8#1)
intron/exon##4##1##(1993-8#1)(1996-2#1)(2008-11#1)(2008-4#1)
intronic##7##1##(1993-12#3)(1993-2#1)(1996-2#1)(2011-1#1)(2012-3#1)
intronless genes##3##2##(1993-2#1)(1993-8#1)(2008-9#1)
intronless##8##1##(1992-6#1)(1993-2#2)(1993-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-5#1)
introns and encodes a protein of##2##6##(1993-6#1)(1996-6#1)
introns and##9##2##(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-9#1)(1996-6#1)(2008-4#1)(2008-6#1)
introns are embedded molecular switches regulated by##2##7##(2013-8#2)
introns in the##2##3##(2008-10#1)(2010-5#1)
introns in##4##2##(2008-10#1)(2008-8#1)(2010-5#1)(2013-8#1)
introns of##2##2##(1993-6#1)(2008-11#1)
introns were##2##2##(2010-5#2)
introns##52##1##(1990-12#1)(1991-9#1)(1993-12#2)(1993-2#6)(1993-6#4)(1993-8#3)(1994-11#3)(1994-12#1)(1995-6#2)(1995-9#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#4)
introspection##3##1##(1993-2#1)(2009-4#1)(2012-3#1)
intrusion##8##1##(2008-10#1)(2008-11#1)(2010-2#3)(2012-3#2)(2013-1#1)
intrusive##6##1##(2008-10#2)(2008-4#1)(2009-11#1)(2009-12#1)(2010-8#1)
intubated##4##1##(1996-3#1)(2008-11#1)(2010-7#2)
intubation and##2##2##(1991-11#1)(2010-7#1)
intubation##15##1##(1991-11#1)(1993-6#4)(1996-6#1)(2008-11#3)(2010-7#6)
intuitions##3##1##(2008-11#1)(2012-2#2)
intuitive##13##1##(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
intuitively##3##1##(2008-6#1)(2008-8#1)(2008-9#1)
intussusception##3##1##(2009-2#1)(2011-2#1)(2013-1#1)
inulin##4##1##(1992-1#1)(2008-10#3)
invade and##2##2##(2008-9#1)(2011-2#1)
invade the seed##2##3##(2008-10#2)
invade the##7##2##(2008-10#6)(2011-2#1)
invade##21##1##(2008-10#10)(2008-5#1)(2008-9#4)(2011-2#3)(2012-2#2)(2013-8#1)
invaded by the##2##3##(2008-10#2)
invaded by##4##2##(1990-3#1)(2008-10#2)(2008-8#1)
invaded the##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
invaded##21##1##(1990-3#1)(1992-1#1)(1995-6#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-8#4)(2011-2#1)(2013-8#1)
invaders##3##1##(2008-11#2)(2008-8#1)
invades the##2##2##(2008-10#1)(2013-1#1)
invades##4##1##(2008-10#2)(2008-8#1)(2013-1#1)
invading hyphae##5##2##(2008-10#5)
invading the##4##2##(1993-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
invading##24##1##(1990-2#1)(1990-5#1)(1993-8#1)(2008-10#12)(2008-4#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
invadopodia##2##1##(2011-2#2)
invadopodia/podosomes##2##1##(2011-2#2)
invaginated##2##1##(2008-10#2)
invagination##6##1##(1990-3#2)(2007-12#1)(2008-10#1)(2011-2#2)
invaginations of the##3##3##(1995-2#1)(2007-12#1)(2008-7#1)
invaginations##5##1##(1995-2#1)(2007-12#3)(2008-7#1)
invalid##5##1##(1995-2#1)(1997-1#1)(2008-3#1)(2013-1#2)
invalidate##3##1##(1995-6#1)(2010-4#1)(2011-2#1)
invaluable in##2##2##(2008-7#1)(2012-2#1)
invaluable information##2##2##(2008-10#1)(2012-3#1)
invaluable to##2##2##(1995-1#1)(1995-12#1)
invaluable tools##2##2##(2008-11#2)
invaluable##20##1##(1992-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#4)(2012-2#1)(2012-3#1)
invariably##12##1##(1995-12#1)(1995-8#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
invariance##4##1##(1991-9#1)(1994-2#1)(1995-2#1)(2009-11#1)
invariant NK T cell clones##2##5##(2008-4#2)
invariant NK T##3##3##(2008-4#3)
invariant and##3##2##(2008-3#1)(2012-2#2)
invariant item##2##2##(2012-2#2)
invariant representations##2##2##(2009-10#2)
invariant under the##2##3##(1996-3#1)(2013-8#1)
invariant under##3##2##(1996-3#1)(2008-6#1)(2013-8#1)
invariant##28##1##(1990-12#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-9#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2009-10#3)(2009-8#1)(2010-4#1)(2012-2#5)(2013-8#1)
invasion and angiogenesis##3##3##(2008-11#3)
invasion and metastasis##5##3##(2008-5#1)(2008-8#1)(2011-2#3)
invasion and metastatic##2##3##(1990-11#1)(2013-1#1)
invasion and spread of##3##4##(1990-11#1)(2008-10#1)(2010-3#1)
invasion and spread##4##3##(1990-11#1)(2008-10#1)(2008-5#1)(2010-3#1)
invasion and subsequent##2##3##(2008-10#1)(2008-8#1)
invasion and##32##2##(1990-11#3)(1990-9#1)(1992-2#1)(2008-10#6)(2008-11#7)(2008-5#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#2)
invasion assay##4##2##(2008-11#2)(2013-8#2)
invasion by##7##2##(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#1)
invasion in##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
invasion into##2##2##(2008-11#1)(2011-2#1)
invasion is##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
invasion of AH109A cells across##2##5##(2008-11#2)
invasion of AH109A cells##6##4##(2008-11#6)
invasion of AH109A##7##3##(2008-11#7)
invasion of a rat ascites hepatoma cell line of AH109A##2##10##(2008-11#2)
invasion of a rat ascites hepatoma cell line##3##8##(2008-11#3)
invasion of a##7##3##(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
invasion of cancer cells##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
invasion of hepatoma cells in culture##3##6##(2008-11#3)
invasion of hepatoma cells##4##4##(2008-11#4)
invasion of hepatoma##5##3##(2008-11#4)(2013-8#1)
invasion of privacy##2##3##(1995-12#1)(1996-5#1)
invasion of rat ascites hepatoma##2##5##(2008-11#2)
invasion of the##13##3##(1991-6#1)(2008-10#6)(2008-11#2)(2008-7#1)(2011-2#2)(2013-8#1)
invasion of##51##2##(1991-6#1)(1995-12#1)(1996-5#1)(2008-10#10)(2008-11#20)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#5)
invasion site##2##2##(2008-10#1)(2009-8#1)
invasion to##2##2##(2008-8#1)(2010-10#1)
invasion##184##1##(1990-11#3)(1990-9#2)(1991-6#1)(1992-2#1)(1995-12#1)(1996-5#1)(2008-10#37)(2008-11#50)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#10)(2008-9#8)(2009-12#3)(2009-3#1)(2009-8#1)(2010-10#1)(2010-3#4)(2010-6#2)(2011-1#2)(2011-2#21)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#17)
invasions##5##1##(2008-10#1)(2008-8#3)(2010-3#1)
invasive activity##5##2##(2008-11#5)
invasive and metastatic##2##3##(2008-11#1)(2012-2#1)
invasive and noninvasive species##2##4##(2008-8#2)
invasive and noninvasive##3##3##(2008-8#3)
invasive and##11##2##(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#3)(2010-12#1)(2012-2#1)
invasive approach##7##2##(2008-12#1)(2010-11#1)(2011-2#4)(2013-1#1)
invasive approaches##6##2##(2008-10#1)(2011-2#1)(2013-1#4)
invasive bladder cancer##3##3##(2013-8#3)
invasive bladder tumours##3##3##(1991-6#2)(1991-9#1)
invasive bladder##6##2##(1991-6#2)(1991-9#1)(2013-8#3)
invasive breast##3##2##(1993-11#1)(2013-1#2)
invasive cancer##4##2##(1991-2#1)(1995-2#1)(1997-8#1)(2011-2#1)
invasive capacity##3##2##(2008-11#2)(2008-9#1)
invasive carcinoma##4##2##(1990-6#2)(1994-1#1)(1994-2#1)
invasive carcinomas##3##2##(1994-12#1)(1997-8#2)
invasive cervical cancer##3##3##(1990-12#1)(2011-3#1)(2012-3#1)
invasive cervical##5##2##(1990-12#1)(2011-3#1)(2012-3#1)(2013-1#2)
invasive disease##2##2##(1994-2#1)(2008-11#1)
invasive ductal##3##2##(1994-12#2)(2011-2#1)
invasive growth and##2##3##(1990-11#1)(2008-11#1)
invasive growth of##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
invasive growth##9##2##(1990-11#1)(1994-11#1)(2008-10#1)(2008-11#5)(2013-1#1)
invasive infections in##2##3##(1996-12#1)(2007-12#1)
invasive infections##3##2##(1993-6#1)(1996-12#1)(2007-12#1)
invasive lobular##2##2##(1994-12#1)(2011-2#1)
invasive malignancy##2##2##(1997-1#1)(2009-12#1)
invasive management##2##2##(1996-3#1)(2010-11#1)
invasive meningococcal disease##2##3##(2013-1#2)
invasive methods for##2##3##(1995-8#1)(2013-1#1)
invasive methods##4##2##(1995-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
invasive or##2##2##(1994-2#1)(2011-3#1)
invasive procedures in##4##3##(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
invasive procedures##11##2##(2008-10#3)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
invasive pulmonary aspergillosis##2##3##(2008-5#1)(2013-1#1)
invasive species##2##2##(2008-10#1)(2008-8#1)
invasive surgery##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
invasive surgical##4##2##(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
invasive technique##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
invasive test##3##2##(2012-3#1)(2013-1#2)
invasive than##3##2##(1997-3#1)(2008-4#1)(2011-2#1)
invasive therapy##2##2##(1997-2#1)(2009-12#1)
invasive treatment for##2##3##(1997-3#1)(2013-1#1)
invasive tumors up to 10 mm in size##2##8##(1990-2#2)
invasive##200##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-9#1)(1991-2#2)(1991-6#2)(1991-9#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#6)(2007-12#2)(2008-10#13)(2008-11#23)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-12#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-5#1)(2010-6#2)(2010-8#2)(2011-2#23)(2011-3#2)(2012-12#7)(2012-2#6)(2012-3#10)(2013-1#28)(2013-8#7)
invasively##2##1##(2008-12#1)(2011-2#1)
invasiveness of the##2##3##(1990-6#1)(2011-2#1)
invasiveness of##4##2##(1990-6#1)(1991-2#1)(1995-6#1)(2011-2#1)
invasiveness##14##1##(1990-6#1)(1991-2#1)(1995-6#1)(1997-3#2)(2008-11#2)(2008-12#1)(2008-8#2)(2011-2#3)(2013-1#1)
invention##2##1##(2009-1#1)(2010-12#1)
inventory and##3##2##(1996-2#1)(2011-2#1)(2013-8#1)
inventory of the##2##3##(1997-3#1)(2013-1#1)
inventory of##4##2##(1996-12#1)(1997-3#1)(2012-2#1)(2013-1#1)
inventory##21##1##(1991-9#1)(1992-1#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-7#3)(2009-3#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
inverse Monte Carlo method##2##4##(2008-3#2)
inverse Monte Carlo##3##3##(2008-3#3)
inverse PCR with highly overlapped primers##3##6##(1997-2#3)
inverse agonists##3##2##(1995-11#1)(2008-11#1)(2009-8#1)
inverse correlation##6##2##(1992-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)
inverse distance##2##2##(2008-10#1)(2009-7#1)
inverse growth associated##5##3##(2008-11#5)
inverse growth##6##2##(2008-11#6)
inverse least-squares##2##2##(2008-10#2)
inverse problems##2##2##(2008-3#2)
inverse procedure is##2##3##(2008-3#2)
inverse procedure##3##2##(2008-3#3)
inverse relation##2##2##(1991-5#1)(2008-8#1)
inverse relationship with the##2##4##(1993-2#1)(2008-7#1)
inverse relationship with##3##3##(1993-2#1)(2008-3#1)(2008-7#1)
inverse relationship##10##2##(1991-5#1)(1993-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2013-7#1)(2013-8#3)
inverse sampling##6##2##(1995-9#3)(1996-3#3)
inverse technique is##2##3##(2008-3#2)
inverse technique##3##2##(2008-3#3)
inverse transform##2##2##(2008-3#1)(2013-8#1)
inverse##78##1##(1990-8#1)(1991-5#2)(1992-2#1)(1993-2#1)(1995-11#1)(1995-9#3)(1996-3#3)(1997-2#3)(2008-10#13)(2008-11#9)(2008-2#1)(2008-3#16)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#3)(2009-8#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#4)
inversely associated##2##2##(1991-3#1)(2008-10#1)
inversely correlated with the##3##4##(1990-2#1)(1997-4#1)(2011-2#1)
inversely correlated with##9##3##(1990-2#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#1)
inversely correlated##10##2##(1990-2#1)(1991-12#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#1)
inversely proportional to the##4##4##(1990-9#1)(1993-6#1)(2008-10#1)(2012-3#1)
inversely proportional to##8##3##(1990-9#1)(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#2)(2008-9#1)(2012-3#1)
inversely related to ration##2##4##(2010-8#2)
inversely related to the degree of heterogeneity##2##7##(2008-10#2)
inversely related to the##6##4##(1990-8#1)(1995-12#1)(2008-10#2)(2008-9#2)
inversely related to##11##3##(1990-8#1)(1994-6#1)(1995-12#1)(2008-10#2)(2008-9#4)(2010-8#2)
inversely related##12##2##(1990-8#1)(1994-6#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-9#4)(2010-8#2)
inversely with the##3##3##(2008-10#1)(2008-9#1)(2009-7#1)
inversely with##7##2##(1995-11#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-7#1)
inversely##43##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#8)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
inversion algorithm##3##2##(2008-2#1)(2008-3#2)
inversion and##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
inversion in##3##2##(1993-1#1)(2008-7#1)(2011-2#1)
inversion model##2##2##(2008-3#2)
inversion of configuration at##2##4##(1996-5#2)
inversion of the##2##3##(2008-3#1)(2010-4#1)
inversion of##14##2##(1994-8#1)(1996-5#2)(1997-2#1)(2008-11#1)(2008-2#3)(2008-3#5)(2010-4#1)
inversion recovery##2##2##(2011-2#2)
inversion results##2##2##(2008-3#1)(2008-7#1)
inversion##61##1##(1992-7#1)(1993-1#1)(1994-8#3)(1996-5#2)(1997-2#1)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#30)(2008-7#4)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#6)
inversions in##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
inversions##10##1##(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#2)
inversus##5##1##(2009-8#5)
invertase from##2##2##(1997-2#2)
invertase##21##1##(1996-3#1)(1997-2#3)(2008-10#7)(2008-9#10)
invertebrate LDH##2##2##(1994-11#2)
invertebrate hosts##2##2##(2008-9#2)
invertebrate lectins##2##2##(1990-5#2)
invertebrate##24##1##(1990-5#3)(1992-12#1)(1994-11#3)(1995-12#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#2)(2009-8#1)(2010-7#1)(2013-1#1)
invertebrates have##2##2##(2008-10#1)(2008-9#1)
invertebrates was##2##2##(2008-11#1)(2013-1#1)
invertebrates##13##1##(1990-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
inverted U-shaped##2##2##(2008-5#2)
inverted and##3##2##(2008-11#3)
inverted exclamation##2##2##(2008-10#2)
inverted repeat##6##2##(1993-12#1)(2008-10#2)(2008-8#2)(2011-1#1)
inverted repeats##2##2##(1993-12#1)(1996-6#1)
inverted##33##1##(1990-2#1)(1993-1#1)(1993-12#2)(1995-8#1)(1996-6#1)(1997-2#1)(1997-9#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-5#2)(2008-8#3)(2009-11#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#2)
invest in##3##2##(1993-12#1)(2008-8#1)(2008-9#1)
invest##5##1##(1992-8#1)(1993-12#1)(2008-8#2)(2008-9#1)
invested in##2##2##(2008-10#1)(2008-9#1)
invested##5##1##(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2013-1#1)
investigate a##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
investigate cellular##2##2##(2008-1#1)(2008-11#1)
investigate effect of##2##3##(2008-12#1)(2008-9#1)
investigate factors##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
investigate further##4##2##(1995-6#1)(1996-2#1)(2008-5#1)(2012-2#1)
investigate genetic##2##2##(1997-8#1)(2008-10#1)
investigate how##12##2##(1994-12#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-8#5)(2008-9#1)(2010-12#1)(2011-2#1)
investigate its##5##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
investigate mechanisms of##2##3##(2008-11#1)(2008-8#1)
investigate potential##2##2##(1994-12#1)(1994-5#1)
investigate quantitatively the##2##3##(1995-5#1)(2008-10#1)
investigate the applicability of##2##4##(1995-9#1)(2008-10#1)
investigate the contribution of##2##4##(1995-8#1)(2009-6#1)
investigate the correlation between##2##4##(2008-5#1)(2013-8#1)
investigate the effect of##20##4##(2008-10#4)(2008-12#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
investigate the effects of##15##4##(1992-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
investigate the effects##17##3##(1992-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-2#1)
investigate the efficacy of##3##4##(2008-9#1)(2009-8#1)(2013-1#1)
investigate the feasibility of the##2##5##(2008-2#1)(2008-3#1)
investigate the feasibility of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
investigate the influence of##12##4##(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2011-2#3)
investigate the interaction between##2##4##(1993-6#1)(2008-10#1)
investigate the mechanism of##6##4##(1994-8#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)
investigate the mechanism##8##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
investigate the molecular##4##3##(1996-12#1)(1996-2#1)(1997-7#1)(2008-9#1)
investigate the possibility##4##3##(1994-8#1)(2008-11#2)(2012-3#1)
investigate the possible##3##3##(1994-5#1)(2008-5#1)(2012-2#1)
investigate the potential##3##3##(1995-2#1)(2011-2#1)(2012-3#1)
investigate the relationship between the##8##5##(1991-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)
investigate the relationship between##17##4##(1991-2#1)(1993-8#1)(1994-3#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#2)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
investigate the relationship of##3##4##(1990-8#1)(2008-10#1)(2008-9#1)
investigate the relationship##21##3##(1990-8#1)(1991-2#1)(1993-8#1)(1994-3#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-7#2)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
investigate the robustness##2##3##(1995-11#1)(2008-11#1)
investigate the role of##16##4##(1993-2#1)(1993-6#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-7#1)(2011-10#1)(2011-2#3)
investigate the role##17##3##(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-7#1)(2011-10#1)(2011-2#3)
investigate the vertical##2##3##(2008-11#2)
investigate the##284##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#55)(2008-11#20)(2008-12#8)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#13)(2008-9#17)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#6)(2009-8#2)(2009-9#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#16)(2011-3#4)(2012-12#2)(2012-2#7)(2012-3#12)(2013-1#9)(2013-8#6)
investigate theoretically##3##2##(2008-3#2)(2008-8#1)
investigate these##2##2##(2008-6#1)(2013-1#1)
investigate this hypothesis##2##3##(2008-10#1)(2008-11#1)
investigate this mechanism##2##3##(1990-12#1)(2010-3#1)
investigate this##10##2##(1990-12#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#3)(2010-3#1)(2013-8#1)
investigate what##2##2##(2008-10#2)
investigate whether a##2##3##(2008-11#1)(2008-5#1)
investigate whether##24##2##(1990-5#1)(1992-12#1)(1995-6#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-8#4)(2008-9#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
investigate##465##1##(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#2)(1993-6#3)(1993-8#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#5)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#85)(2008-11#48)(2008-12#13)(2008-2#3)(2008-3#16)(2008-4#2)(2008-5#17)(2008-6#6)(2008-7#12)(2008-8#27)(2008-9#23)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#4)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#25)(2011-3#4)(2012-12#2)(2012-2#11)(2012-3#20)(2012-5#1)(2013-1#15)(2013-8#9)
investigated a##2##2##(1996-12#1)(2008-11#1)
investigated and a##2##3##(2008-10#1)(2009-3#1)
investigated and are##2##3##(1995-11#1)(2008-10#1)
investigated and compared##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
investigated and discussed##2##3##(2008-10#2)
investigated and found to##2##4##(2008-10#2)
investigated and found##3##3##(2008-10#3)
investigated and optimized##4##3##(2008-10#4)
investigated and the##14##3##(2008-10#13)(2008-3#1)
investigated and used to##2##4##(2008-10#1)(2011-2#1)
investigated and used##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
investigated and##57##2##(1995-11#1)(2008-10#40)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-1#2)
investigated as a function of##2##5##(2008-10#1)(2008-3#1)
investigated as a##12##3##(2008-10#6)(2008-3#3)(2008-7#1)(2010-1#1)(2010-7#1)
investigated as potential##2##3##(2008-10#2)
investigated as selective##2##3##(2008-10#2)
investigated as well##3##3##(2008-10#3)
investigated as##39##2##(2008-10#25)(2008-11#2)(2008-12#2)(2008-3#3)(2008-7#2)(2009-9#1)(2010-1#1)(2010-7#1)(2012-2#1)(2012-5#1)
investigated at 25 degrees C##2##5##(2008-10#2)
investigated at different##2##3##(2008-10#2)
investigated at pH##2##3##(2008-10#2)
investigated at##16##2##(1995-3#1)(2008-10#14)(2008-11#1)
investigated both##3##2##(1995-6#1)(2008-10#2)
investigated by a##7##3##(1991-6#1)(1992-5#1)(1992-9#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-7#1)
investigated by analysis of the##2##5##(2008-10#1)(2008-2#1)
investigated by conducting##2##3##(2008-10#1)(2008-11#1)
investigated by cyclic voltammetry (CV)##2##5##(2008-10#2)
investigated by cyclic voltammetry and##2##5##(2008-10#2)
investigated by cyclic voltammetry##5##4##(2008-10#5)
investigated by cyclic##8##3##(2008-10#8)
investigated by electron microscopy##2##4##(2007-12#1)(2008-10#1)
investigated by in vivo##2##4##(1994-2#1)(2008-8#1)
investigated by means of a##3##5##(1990-8#1)(2008-3#1)(2008-9#1)
investigated by means of##11##4##(1990-8#1)(2008-10#6)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
investigated by measuring the##4##4##(2008-10#3)(2008-5#1)
investigated by measuring##6##3##(1991-9#1)(2008-10#3)(2008-11#1)(2008-5#1)
investigated by potentiometry##2##3##(2008-10#2)
investigated by the##3##3##(2008-10#1)(2008-11#2)
investigated by transmission electron microscopy and##2##6##(2008-10#1)(2009-11#1)
investigated by transmission electron microscopy##3##5##(2008-10#2)(2009-11#1)
investigated by using a##3##4##(2008-10#2)(2008-7#1)
investigated by using the##3##4##(2008-10#3)
investigated by using##16##3##(1991-9#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)
investigated by##142##2##(1990-11#2)(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-6#1)(2007-12#2)(2008-10#77)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#1)(2009-7#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
investigated compounds with##2##3##(2008-10#2)
investigated compounds##7##2##(2008-10#7)
investigated drugs##6##2##(2008-10#5)(2008-11#1)
investigated during the##2##3##(2008-10#2)
investigated during##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
investigated employing##2##2##(2008-10#2)
investigated experimentally and theoretically##2##4##(2008-10#1)(2008-3#1)
investigated experimentally and##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
investigated experimentally##7##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)
investigated for a##3##3##(2008-10#2)(2010-12#1)
investigated for optimum##2##3##(2008-10#2)
investigated for the determination of##2##5##(2008-10#2)
investigated for the##12##3##(1993-8#1)(2008-10#9)(2011-2#1)(2012-3#1)
investigated for their##4##3##(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)
investigated for various##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
investigated for##51##2##(1993-8#1)(1994-11#1)(1997-7#1)(2006-6#1)(2008-10#29)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
investigated from##6##2##(1994-6#1)(2008-10#2)(2008-11#2)(2008-5#1)
investigated further##5##2##(2008-10#2)(2009-12#1)(2010-12#1)(2011-2#1)
investigated here##3##2##(2008-10#2)(2008-12#1)
investigated how the##2##3##(2007-11#1)(2009-8#1)
investigated how##7##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-8#1)(2011-2#1)
investigated in a series of##4##5##(1991-8#1)(2008-10#3)
investigated in a##20##3##(1991-8#1)(1993-3#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-1#1)
investigated in aqueous##4##3##(2008-10#3)(2008-3#1)
investigated in both##2##3##(2008-10#1)(2008-3#1)
investigated in controlled##2##3##(2008-10#2)
investigated in detail##28##3##(1994-5#1)(2008-10#26)(2011-2#1)
investigated in four##2##3##(2008-10#1)(2011-1#1)
investigated in human##4##3##(1991-5#1)(1993-8#1)(1994-8#1)(2011-3#1)
investigated in normal and##2##4##(1994-8#1)(2010-11#1)
investigated in normal##3##3##(1994-8#1)(2008-10#1)(2010-11#1)
investigated in order to optimize##2##5##(2008-10#2)
investigated in order to##6##4##(2008-10#5)(2008-11#1)
investigated in order##7##3##(2008-10#5)(2008-11#2)
investigated in terms of##8##4##(1994-8#1)(1996-2#1)(2008-10#4)(2008-3#1)(2010-6#1)
investigated in the adult male cricket##2##6##(2008-5#2)
investigated in the concentration##2##4##(2008-10#2)
investigated in the present##3##4##(1992-12#1)(2008-11#1)(2009-10#1)
investigated in the##21##3##(1990-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)
investigated in this paper##2##4##(2008-10#2)
investigated in this study##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
investigated in this work##3##4##(1993-8#1)(2008-10#1)(2011-2#1)
investigated in this##9##3##(1993-8#1)(2008-10#5)(2008-12#1)(2008-8#1)(2011-2#1)
investigated in various##2##3##(2008-11#1)(2008-8#1)
investigated in vitro##5##3##(1990-11#1)(1996-12#1)(1997-4#1)(2006-6#1)(2008-10#1)
investigated in vivo##4##3##(1990-11#1)(1990-5#1)(1996-12#1)(2008-5#1)
investigated in##211##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#6)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-8#1)(2006-6#1)(2008-10#94)(2008-11#9)(2008-12#2)(2008-3#5)(2008-5#4)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#3)(2012-4#2)(2013-1#1)(2013-8#1)
investigated its##6##2##(1992-3#1)(1993-8#1)(2008-10#1)(2008-7#2)(2013-1#1)
investigated methods##2##2##(2008-10#1)(2012-3#1)
investigated on the##3##3##(2008-10#3)
investigated on##10##2##(1991-2#1)(2008-10#6)(2008-9#1)(2010-7#1)(2013-1#1)
investigated over the##3##3##(2008-10#2)(2008-3#1)
investigated over##5##2##(2008-10#4)(2008-3#1)
investigated parameters##2##2##(2008-10#1)(2008-3#1)
investigated samples##3##2##(2008-10#3)
investigated several##2##2##(1997-8#1)(2012-12#1)
investigated species##2##2##(2007-12#1)(2012-3#1)
investigated spectrophotometrically##3##2##(2008-10#3)
investigated systematically##2##2##(2008-10#1)(2010-4#1)
investigated that##2##2##(2008-2#1)(2011-2#1)
investigated the ability of##2##4##(2008-10#1)(2008-8#1)
investigated the association##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
investigated the binding##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
investigated the effect of the##2##5##(1994-11#1)(2011-2#1)
investigated the effect of##22##4##(1992-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
investigated the effects of##13##4##(1991-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-11#1)(2010-4#1)
investigated the effects##14##3##(1991-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-11#1)(2010-4#1)
investigated the efficacy of##4##4##(2007-8#1)(2008-10#1)(2011-2#2)
investigated the expression of##4##4##(1996-12#1)(2008-11#1)(2008-7#1)(2013-1#1)
investigated the expression##8##3##(1996-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
investigated the feasibility of##4##4##(1996-2#1)(2008-11#1)(2008-5#1)(2013-1#1)
investigated the functional##2##3##(2011-2#2)
investigated the impact##2##3##(1993-6#1)(2008-9#1)
investigated the influence of dietary##2##5##(1991-6#1)(2008-11#1)
investigated the influence of##7##4##(1991-6#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-7#1)
investigated the influence##8##3##(1991-6#1)(1994-11#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-7#1)
investigated the mechanism of##2##4##(2008-11#1)(2008-2#1)
investigated the mechanism##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
investigated the neural##3##3##(1995-12#1)(2008-8#1)(2013-8#1)
investigated the possible##4##3##(1994-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
investigated the potential##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
investigated the presence of##2##4##(2008-12#1)(2013-1#1)
investigated the regulation##3##3##(1996-12#1)(2008-11#1)(2010-11#1)
investigated the relationship between tyrosine phosphorylation and##2##7##(1994-6#1)(1996-12#1)
investigated the relationship between##5##4##(1994-6#1)(1996-12#1)(2008-10#2)(2010-10#1)
investigated the relationship of##2##4##(1996-12#1)(2008-5#1)
investigated the relationship##7##3##(1994-6#1)(1996-12#2)(2008-10#2)(2008-5#1)(2010-10#1)
investigated the relationships##2##3##(1996-2#1)(2008-8#1)
investigated the response##3##3##(1995-12#1)(1995-2#1)(2009-8#1)
investigated the risk##2##3##(2008-11#2)
investigated the role of the##2##5##(1995-12#1)(2008-12#1)
investigated the role of##9##4##(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-6#1)
investigated the temporal##2##3##(1997-2#1)(2008-3#1)
investigated the use of##5##4##(1997-3#1)(2008-10#3)(2008-12#1)
investigated the##208##2##(1990-3#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#5)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#5)(1996-3#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-8#3)(2007-8#1)(2008-10#33)(2008-11#25)(2008-12#6)(2008-2#1)(2008-3#6)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#8)(2008-9#6)(2009-12#1)(2009-7#3)(2009-8#5)(2010-10#1)(2010-11#4)(2010-3#1)(2010-4#3)(2010-6#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#11)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#3)
investigated these##2##2##(2008-11#1)(2011-2#1)
investigated this##5##2##(1990-11#1)(1996-12#1)(2008-4#1)(2008-8#1)(2009-10#1)
investigated through a##2##3##(2008-10#2)
investigated through the##2##3##(2008-7#1)(2011-2#1)
investigated through##7##2##(2008-10#3)(2008-7#1)(2009-7#1)(2011-2#1)(2013-8#1)
investigated to determine the##3##4##(2008-10#2)(2013-1#1)
investigated to determine##4##3##(2008-10#2)(2009-11#1)(2013-1#1)
investigated to develop##2##3##(2008-10#1)(2009-11#1)
investigated to find##4##3##(2008-10#4)
investigated to improve the##2##4##(2008-10#2)
investigated to##31##2##(1991-12#1)(1996-5#1)(2008-10#21)(2008-11#2)(2008-3#2)(2008-8#1)(2009-11#2)(2013-1#1)
investigated under##7##2##(1996-6#1)(2008-10#4)(2008-11#1)(2013-8#1)
investigated using a##8##3##(1993-12#1)(2008-10#5)(2008-9#1)(2010-4#1)
investigated using an##2##3##(1991-5#1)(1993-6#1)
investigated using cyclic voltammetry##2##4##(2008-10#2)
investigated using human##2##3##(1993-3#1)(2011-2#1)
investigated using the##6##3##(2008-10#3)(2008-11#1)(2008-5#2)
investigated using##56##2##(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1997-1#1)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-8#1)
investigated was##2##2##(1990-9#1)(1996-12#1)
investigated were##5##2##(1991-1#1)(2008-10#2)(2008-3#1)(2010-6#1)
investigated whether the##6##3##(1994-2#1)(1994-3#1)(1995-8#1)(2008-6#1)(2009-11#1)(2010-12#1)
investigated whether this##2##3##(1994-8#1)(2008-10#1)
investigated whether##33##2##(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#2)(2012-2#2)(2012-3#1)
investigated which##2##2##(2008-10#1)(2008-8#1)
investigated with a##4##3##(1991-2#1)(1997-3#1)(2008-10#1)(2008-5#1)
investigated with an##3##3##(2008-10#2)(2008-3#1)
investigated with regard to##3##4##(2008-10#3)
investigated with respect to##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
investigated with the##7##3##(1996-5#1)(2008-10#6)
investigated with##38##2##(1990-5#1)(1991-2#1)(1995-11#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-3#1)
investigated##1692##1##(1990-11#7)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#7)(1993-6#5)(1993-8#14)(1994-11#10)(1994-12#1)(1994-2#5)(1994-3#6)(1994-5#6)(1994-6#8)(1994-8#9)(1995-11#11)(1995-12#9)(1995-2#7)(1995-3#3)(1995-6#2)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#14)(1996-2#18)(1996-3#1)(1996-5#4)(1996-6#1)(1997-1#6)(1997-2#9)(1997-3#8)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2006-6#4)(2007-11#1)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#847)(2008-11#112)(2008-12#30)(2008-2#12)(2008-3#45)(2008-4#5)(2008-5#38)(2008-6#7)(2008-7#38)(2008-8#38)(2008-9#24)(2009-10#6)(2009-11#4)(2009-12#5)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#13)(2009-8#14)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#9)(2010-12#3)(2010-3#1)(2010-4#10)(2010-5#2)(2010-6#7)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#8)(2011-10#2)(2011-2#43)(2011-3#3)(2012-12#4)(2012-2#15)(2012-3#19)(2012-4#2)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#21)(2013-8#15)
investigates a##2##2##(2008-10#1)(2008-8#1)
investigates the effect of##4##4##(1991-2#1)(1996-12#1)(2008-11#1)(2011-2#1)
investigates the effects of##3##4##(1991-12#1)(2008-8#1)(2013-8#1)
investigates the relationship between##2##4##(2008-8#1)(2008-9#1)
investigates the relationship of##2##4##(1994-2#1)(2008-7#1)
investigates the relationship##4##3##(1994-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
investigates the##25##2##(1991-12#1)(1991-2#1)(1992-2#1)(1994-2#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
investigates whether##2##2##(1997-4#1)(2013-1#1)
investigates##36##1##(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2010-8#1)(2011-2#4)(2013-1#3)(2013-8#2)
investigating mechanisms of##2##3##(1996-5#1)(2008-11#1)
investigating the effect of##3##4##(2008-10#2)(2008-5#1)
investigating the effects of##2##4##(1997-2#1)(2010-7#1)
investigating the efficacy of##2##4##(2008-10#1)(2009-12#1)
investigating the influence of##2##4##(2008-10#1)(2011-2#1)
investigating the mechanism of##2##4##(1993-8#1)(2008-11#1)
investigating the##31##2##(1991-2#1)(1993-8#1)(1997-2#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
investigating##72##1##(1991-2#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-9#1)(1996-5#1)(1997-2#1)(2008-1#2)(2008-10#12)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#3)
investigation about##2##2##(2008-10#1)(2008-11#1)
investigation aimed##2##2##(2008-2#1)(2013-8#1)
investigation also##2##2##(1996-12#1)(1997-6#1)
investigation and##17##2##(1990-2#1)(1992-12#1)(1993-11#1)(2006-6#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-6#1)(2013-8#2)
investigation at##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
investigation for##5##2##(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
investigation in the##4##3##(1992-1#1)(1993-12#1)(2009-6#1)(2013-1#1)
investigation in##13##2##(1991-3#2)(1992-1#1)(1993-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-9#1)(2012-2#2)(2013-1#1)
investigation include##2##2##(1992-9#1)(2008-3#1)
investigation included a##2##3##(2008-10#1)(2011-2#1)
investigation included##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
investigation into a seated unloading movement strategy for the lumbar spine##2##11##(2010-3#2)
investigation into the##8##3##(1996-12#1)(2008-10#5)(2008-9#2)
investigation into##11##2##(1996-12#1)(2008-10#5)(2008-7#1)(2008-9#2)(2010-3#2)
investigation is necessary##2##3##(1991-8#1)(2010-10#1)
investigation is##6##2##(1991-8#1)(2008-3#1)(2009-6#1)(2010-10#1)(2011-2#2)
investigation it was##2##3##(1990-6#1)(2008-10#1)
investigation of a##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
investigation of all##2##3##(1992-12#1)(2012-2#1)
investigation of biological##2##3##(1992-5#1)(2013-1#1)
investigation of different##2##3##(2008-10#1)(2008-8#1)
investigation of its##2##3##(1990-11#1)(2008-10#1)
investigation of large##2##3##(2008-11#1)(2008-7#1)
investigation of other##2##3##(1995-12#1)(2008-10#1)
investigation of specific##2##3##(2011-2#2)
investigation of the behavior of a##2##6##(2008-10#1)(2008-9#1)
investigation of the effect of##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
investigation of the interaction##2##4##(2008-10#2)
investigation of the##52##3##(1995-11#1)(1995-12#1)(1995-9#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#3)
investigation of these##3##3##(1997-8#1)(2008-5#1)(2008-9#1)
investigation of this##3##3##(2008-10#2)(2011-2#1)
investigation of##166##2##(1990-11#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-9#1)(1996-6#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#63)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-12#2)(2011-1#2)(2011-2#9)(2012-2#4)(2013-1#5)(2013-8#5)
investigation on the##4##3##(2008-7#1)(2008-8#1)(2011-3#2)
investigation on##12##2##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)(2011-3#3)
investigation period##2##2##(2008-10#1)(2012-2#1)
investigation revealed##2##2##(1993-8#1)(2010-2#1)
investigation showed##3##2##(2007-11#1)(2008-10#2)
investigation shows##3##2##(1994-2#1)(1995-2#1)(2007-12#1)
investigation that##2##2##(2008-11#1)(2008-4#1)
investigation times of the 3-month animals##2##6##(1994-3#2)
investigation times##3##2##(1994-3#3)
investigation to determine##2##3##(2008-11#1)(2013-1#1)
investigation to##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
investigation was conducted##2##3##(1990-3#1)(2008-12#1)
investigation was to determine##2##4##(2008-10#1)(2013-8#1)
investigation was to##8##3##(2006-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#1)(2013-8#1)
investigation was undertaken to##3##4##(1993-2#1)(1995-12#1)(2008-10#1)
investigation was undertaken##4##3##(1990-12#1)(1993-2#1)(1995-12#1)(2008-10#1)
investigation was##20##2##(1990-12#1)(1990-3#1)(1993-2#1)(1995-12#1)(2006-6#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
investigation##438##1##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#7)(1996-12#3)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#5)(2006-6#2)(2007-11#3)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#110)(2008-11#30)(2008-12#11)(2008-2#4)(2008-3#17)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#6)(2008-9#17)(2009-10#3)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#20)(2011-3#4)(2011-9#1)(2012-12#1)(2012-2#11)(2012-3#2)(2012-7#1)(2013-1#15)(2013-7#1)(2013-8#14)
investigational agents##2##2##(2008-12#1)(2011-3#1)
investigational##6##1##(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2011-3#1)
investigations and##6##2##(2008-10#2)(2008-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
investigations are expected to##2##4##(1993-11#1)(2012-12#1)
investigations are needed##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
investigations are##9##2##(1993-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
investigations by##2##2##(1997-6#1)(2008-11#1)
investigations failed to##2##3##(2008-11#1)(2008-7#1)
investigations have shown that##2##4##(1992-3#1)(2008-10#1)
investigations have shown##3##3##(1992-3#1)(2008-10#2)
investigations have##7##2##(1992-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
investigations in the##2##3##(1995-9#1)(2012-2#1)
investigations in this area##2##4##(2008-2#1)(2013-1#1)
investigations in this##3##3##(2008-2#1)(2008-8#1)(2013-1#1)
investigations in##12##2##(1992-5#1)(1993-12#1)(1993-2#1)(1995-9#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
investigations into the##3##3##(2008-10#1)(2010-12#1)(2010-6#1)
investigations into##7##2##(2008-10#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)
investigations is##2##2##(1996-1#1)(2012-2#1)
investigations it is##2##3##(2008-6#1)(2011-1#1)
investigations of citrus samples##2##4##(2008-10#2)
investigations of new##2##3##(2007-8#1)(2008-11#1)
investigations of the##8##3##(1991-5#1)(1994-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
investigations of this##2##3##(1995-11#1)(2008-10#1)
investigations of##40##2##(1991-5#1)(1992-1#1)(1992-5#1)(1993-1#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#5)(2011-2#1)(2012-3#1)(2013-1#1)
investigations on the##3##3##(1997-6#1)(2008-10#1)(2008-7#1)
investigations on##6##2##(1993-1#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-7#1)
investigations performed##2##2##(1991-8#1)(1997-8#1)
investigations revealed a##3##3##(1990-12#1)(1991-11#1)(2008-10#1)
investigations revealed that##3##3##(2008-10#3)
investigations revealed##8##2##(1990-12#1)(1991-11#1)(2008-10#5)(2010-11#1)
investigations show##3##2##(1990-11#1)(2010-10#1)(2010-5#1)
investigations to##3##2##(2008-10#2)(2012-12#1)
investigations using##3##2##(1991-6#1)(2008-10#1)(2008-11#1)
investigations were performed##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
investigations were##11##2##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2009-7#1)(2010-6#1)(2011-2#2)
investigations with##4##2##(2008-10#2)(2008-5#1)(2012-12#1)
investigations##218##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#2)(2007-12#1)(2007-8#2)(2008-10#56)(2008-11#15)(2008-12#7)(2008-2#3)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#11)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#3)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#5)(2013-7#2)(2013-8#2)
investigator in##2##2##(1992-1#1)(2013-1#1)
investigator to##2##2##(2010-11#1)(2010-7#1)
investigator##16##1##(1992-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#2)(2010-11#2)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
investigator's##2##1##(1992-12#1)(2008-9#1)
investigators and##3##2##(2008-4#1)(2009-4#1)(2012-12#1)
investigators have attempted to##2##4##(2012-12#1)(2012-3#1)
investigators have##8##2##(1991-12#1)(1995-2#1)(1997-1#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
investigators of##2##2##(1996-12#1)(2008-4#1)
investigators or##2##2##(1993-12#1)(2008-10#1)
investigators that##2##2##(1994-8#1)(2008-4#1)
investigators to study##2##3##(2008-11#1)(2010-6#1)
investigators to##12##2##(1994-2#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#2)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)
investigators who##2##2##(2008-2#1)(2008-4#1)
investigators##58##1##(1990-3#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#9)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#3)(2010-11#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)
investigators'##2##1##(2009-4#1)(2011-2#1)
investing in##3##2##(1992-1#1)(1997-6#1)(2008-8#1)
investing##4##1##(1992-1#1)(1997-6#1)(2008-10#1)(2008-8#1)
investment and##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
investment by##3##2##(2008-8#3)
investment from##2##2##(2008-8#2)
investment in sexual##3##3##(2012-3#3)
investment in the##3##3##(2008-10#1)(2008-8#1)(2009-11#1)
investment in workers##5##3##(2008-8#5)
investment in##23##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-8#10)(2009-11#1)(2012-3#6)(2013-1#1)
investment is##3##2##(2008-8#2)(2008-9#1)
investment of the##3##3##(1994-12#1)(1994-3#2)
investment of##5##2##(1992-12#1)(1994-12#1)(1994-3#2)(2008-9#1)
investment per##3##2##(2008-9#2)(2010-8#1)
investment that##2##2##(2008-9#2)
investment##77##1##(1992-12#1)(1993-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1995-12#2)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#30)(2008-9#16)(2009-11#1)(2010-8#2)(2012-3#8)(2013-1#1)(2013-8#1)
investments can##2##2##(1994-2#1)(2008-8#1)
investments in##5##2##(1993-2#1)(1994-2#1)(1997-6#1)(2008-8#1)(2008-9#1)
investments may##2##2##(1992-2#1)(2008-8#1)
investments##25##1##(1991-9#1)(1992-2#1)(1993-2#2)(1994-12#1)(1994-2#3)(1995-12#2)(1996-1#1)(1997-6#2)(2008-11#1)(2008-8#8)(2008-9#1)(2009-10#1)(2012-2#1)
investors##2##1##(1993-1#1)(2008-5#1)
invests##2##1##(1994-1#1)(2012-2#1)
invisible##8##1##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#1)
invitation##3##1##(1992-3#1)(2008-11#2)
invitations##2##1##(2011-1#1)(2012-3#1)
invited to participate in##2##4##(2008-11#1)(2012-12#1)
invited to participate##4##3##(2008-11#2)(2011-1#1)(2012-12#1)
invited to##14##2##(1991-6#1)(1992-5#1)(2008-10#2)(2008-11#4)(2010-6#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
invited##26##1##(1990-2#1)(1991-6#2)(1992-5#1)(1993-11#1)(1995-12#1)(1996-11#1)(1997-8#1)(2008-10#4)(2008-11#5)(2008-12#1)(2009-6#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
invitro##2##1##(2008-11#2)
invivo##2##1##(2008-11#1)(2008-8#1)
invoke an##2##2##(2008-3#1)(2008-8#1)
invoke##4##1##(1997-7#1)(2008-11#1)(2008-3#1)(2008-8#1)
invoked by##2##2##(2008-9#1)(2011-9#1)
invoked##4##1##(2008-10#1)(2008-9#1)(2009-11#1)(2011-9#1)
invoking##2##1##(1992-12#1)(2008-10#1)
involucrin antigenicity##2##2##(2008-5#2)
involuntary bladder contractions##2##3##(2008-7#2)
involuntary##9##1##(1993-12#1)(1993-6#1)(1995-2#1)(1996-9#1)(2008-7#3)(2009-11#1)(2011-1#1)
involuted##2##1##(1991-11#2)
involution was##2##2##(1993-12#1)(2008-10#1)
involution##13##1##(1990-12#2)(1993-12#2)(2008-10#2)(2008-7#1)(2011-2#2)(2013-7#4)
involve a variety of##2##4##(1992-9#1)(2008-10#1)
involve a##11##2##(1992-9#2)(1993-8#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-12#1)(2009-7#1)
involve an##5##2##(1991-5#1)(1992-8#1)(2008-11#1)(2008-12#1)(2013-8#1)
involve any##2##2##(1995-8#1)(2013-8#1)
involve changes in the##3##4##(2008-10#1)(2008-9#2)
involve community##2##2##(1991-2#1)(2010-8#1)
involve de novo##2##3##(1990-5#1)(2008-11#1)
involve high##2##2##(1992-2#1)(2008-10#1)
involve in##2##2##(2008-11#1)(2008-12#1)
involve multiple##2##2##(2008-1#1)(2010-9#1)
involve the##27##2##(1990-12#1)(1991-3#1)(1991-6#1)(1994-2#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
involve##141##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#23)(2008-11#8)(2008-12#7)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#5)
involved a##8##2##(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#1)
involved an##4##2##(1993-1#1)(2008-10#1)(2008-8#1)(2012-4#1)
involved and the##4##3##(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
involved and##17##2##(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
involved are not##2##3##(2008-10#1)(2008-4#1)
involved are the##2##3##(2008-7#1)(2013-1#1)
involved are##7##2##(2008-10#2)(2008-4#2)(2008-7#1)(2010-5#1)(2013-1#1)
involved by the##2##3##(2008-7#2)
involved by##6##2##(1990-3#1)(2008-1#1)(2008-7#2)(2009-7#1)(2012-3#1)
involved during##2##2##(2008-10#2)
involved for##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
involved have##3##2##(1995-2#1)(2008-7#1)(2011-1#1)
involved in Ca2+##2##3##(1990-2#1)(1995-11#1)
involved in DNA-DNA interactions##2##4##(1995-12#2)
involved in RNA splicing##4##4##(1995-6#3)(2008-9#1)
involved in a large##2##4##(2008-10#1)(2008-4#1)
involved in a nosocomial cluster of##2##6##(2010-11#2)
involved in a##21##3##(1991-9#1)(1993-3#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#2)(2011-2#1)(2011-3#1)(2012-3#1)
involved in acetylcholine##2##3##(2008-8#2)
involved in an##3##3##(1993-3#1)(1996-8#1)(2008-10#1)
involved in apoptosis##2##3##(2008-10#1)(2008-11#1)
involved in assessing##2##3##(1994-1#1)(1995-3#1)
involved in at least##2##4##(1995-8#1)(2008-11#1)
involved in binding to the##2##5##(1995-6#2)
involved in binding to##3##4##(1993-3#1)(1995-6#2)
involved in binding##6##3##(1993-3#1)(1994-5#1)(1995-6#2)(1996-12#1)(2008-9#1)
involved in both##5##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-8#1)
involved in cell growth and##2##5##(2008-10#1)(2013-7#1)
involved in cell wall##2##4##(2008-10#1)(2012-2#1)
involved in cell##11##3##(1992-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-7#1)
involved in cellular##4##3##(2008-10#1)(2008-11#1)(2010-7#1)(2012-3#1)
involved in controlling the##2##4##(2008-8#2)
involved in controlling##4##3##(1994-11#1)(1997-8#1)(2008-8#2)
involved in depression##2##3##(2008-4#1)(2013-8#1)
involved in determining the##4##4##(1990-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
involved in determining##5##3##(1990-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
involved in differentiation##2##3##(2008-8#1)(2013-7#1)
involved in disease resistance##2##4##(2008-10#2)
involved in disease##3##3##(1997-5#1)(2008-10#2)
involved in early##4##3##(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
involved in ethanol##2##3##(2008-11#1)(2012-3#1)
involved in gene##2##3##(1993-12#1)(2009-7#1)
involved in generating##4##3##(1995-2#1)(2008-11#2)(2008-9#1)
involved in glucose##2##3##(2008-11#1)(2013-7#1)
involved in host##2##3##(1992-12#1)(2008-10#1)
involved in human##5##3##(1994-11#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-9#1)
involved in inflammatory##2##3##(1997-3#1)(2008-4#1)
involved in initiating##2##3##(1994-11#1)(1995-3#1)
involved in its##4##3##(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
involved in learning##2##3##(2008-11#1)(2008-7#1)
involved in lipid##2##3##(1996-3#1)(2008-10#1)
involved in long##2##3##(2008-10#1)(2008-7#1)
involved in maintaining the##2##4##(1995-6#1)(1995-9#1)
involved in maintaining##3##3##(1995-6#1)(1995-9#1)(2008-1#1)
involved in many important##2##4##(2008-10#1)(2008-8#1)
involved in many##8##3##(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-8#2)
involved in mediating the##3##4##(1996-12#1)(2006-6#1)(2008-9#1)
involved in modulating##2##3##(1994-6#1)(2009-10#1)
involved in oral##2##3##(2008-11#1)(2013-1#1)
involved in other##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
involved in pathogenicity of##2##4##(2008-10#2)
involved in pathogenicity##3##3##(2008-10#3)
involved in plant##3##3##(2008-10#1)(2009-8#1)(2012-2#1)
involved in post-translational##2##3##(1992-8#1)(2013-1#1)
involved in protein##3##3##(1995-2#1)(1996-2#1)(2011-2#1)
involved in receptor-mediated##2##3##(1993-9#1)(2008-4#1)
involved in regulating the##2##4##(2008-10#1)(2008-8#1)
involved in regulating##4##3##(2008-10#1)(2008-8#2)(2010-1#1)
involved in resistance to##2##4##(1994-8#1)(2008-10#1)
involved in resistance##3##3##(1994-8#1)(2008-10#2)
involved in ribosome##2##3##(2011-2#2)
involved in starch##2##3##(2008-10#1)(2008-9#1)
involved in such a##2##4##(2008-10#1)(2008-11#1)
involved in such##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
involved in suppression of##2##4##(2008-10#2)
involved in synaptic##2##3##(1997-7#1)(2008-7#1)
involved in the activation##3##4##(1992-6#1)(1993-6#1)(1994-2#1)
involved in the biosynthesis of##5##5##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#2)
involved in the catabolism of##2##5##(1994-8#1)(2008-11#1)
involved in the cell cycle##2##5##(2008-11#1)(2011-2#1)
involved in the cell##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
involved in the control of##2##5##(2008-9#1)(2009-8#1)
involved in the defense response of western white pine##2##9##(2008-10#2)
involved in the development of##7##5##(1992-3#1)(1997-8#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-3#2)
involved in the development##8##4##(1992-3#1)(1997-8#1)(2008-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#2)
involved in the enzymatic##2##4##(2008-10#1)(2009-5#1)
involved in the epidemic##2##4##(2008-10#2)
involved in the etiology of##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
involved in the formation of##3##5##(2008-10#1)(2008-9#1)(2010-11#1)
involved in the formation##6##4##(2008-10#4)(2008-9#1)(2010-11#1)
involved in the host##3##4##(2008-10#1)(2010-10#2)
involved in the induction of ascospore germination##2##7##(2008-10#2)
involved in the induction of##4##5##(2008-10#3)(2008-7#1)
involved in the induction##5##4##(2008-10#4)(2008-7#1)
involved in the interaction##2##4##(2008-10#2)
involved in the invasion of##2##5##(2008-11#1)(2012-2#1)
involved in the maintenance of a##2##6##(2010-12#1)(2013-1#1)
involved in the maintenance of##5##5##(2008-5#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)
involved in the maintenance##6##4##(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2013-1#1)
involved in the mechanism of##2##5##(1993-8#1)(2011-2#1)
involved in the mechanism##3##4##(1993-8#1)(2008-8#1)(2011-2#1)
involved in the mediation of##2##5##(1997-1#1)(2008-4#1)
involved in the modulation of##2##5##(1997-3#1)(2008-7#1)
involved in the observed##2##4##(2008-10#1)(2008-9#1)
involved in the oxidative##3##4##(1990-2#2)(2008-10#1)
involved in the pathogenesis of the##2##6##(1995-5#1)(2008-7#1)
involved in the pathogenesis of##13##5##(1993-12#1)(1994-11#1)(1995-5#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
involved in the pathophysiology##2##4##(2008-7#2)
involved in the process of##3##5##(1996-12#1)(2008-10#1)(2008-8#1)
involved in the process##4##4##(1996-12#1)(1997-2#1)(2008-10#1)(2008-8#1)
involved in the regulation of muscle tone##2##7##(1995-2#2)
involved in the regulation of the##5##6##(1993-12#1)(1993-6#2)(1995-12#1)(2010-12#1)
involved in the regulation of##25##5##(1992-6#1)(1993-12#1)(1993-6#2)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#3)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-12#2)(2013-1#1)
involved in the resistance of##2##5##(2008-9#2)
involved in the resistance##3##4##(1993-8#1)(2008-9#2)
involved in the suppression of##3##5##(2008-10#3)
involved in the synthesis and##2##5##(2008-10#1)(2011-2#1)
involved in the synthesis##3##4##(2008-10#2)(2011-2#1)
involved in the##290##3##(1990-2#3)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#3)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#3)(1993-8#4)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#3)(1995-11#2)(1995-12#2)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#4)(1996-2#6)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-7#1)(1997-8#4)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#66)(2008-11#18)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#20)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#5)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-3#1)(2010-5#2)(2010-6#1)(2011-2#11)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#7)(2013-8#6)
involved in their##2##3##(2008-11#2)
involved in these reactions##2##4##(2008-10#1)(2008-4#1)
involved in these##11##3##(1992-3#1)(1993-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-4#2)(2010-12#1)(2011-1#1)
involved in this process##7##4##(1993-1#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-5#1)
involved in this##20##3##(1991-3#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
involved in vesicle##2##3##(1993-9#1)(1997-1#1)
involved in##780##2##(1990-2#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#1)(1991-7#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#5)(1992-6#4)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#5)(1993-6#6)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#9)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#8)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#8)(1995-2#12)(1995-3#4)(1995-5#2)(1995-6#12)(1995-8#6)(1995-9#2)(1996-12#8)(1996-2#13)(1996-3#5)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#7)(1997-2#7)(1997-3#4)(1997-5#1)(1997-7#8)(1997-8#7)(1997-9#1)(2006-6#4)(2007-12#5)(2008-1#4)(2008-10#147)(2008-11#64)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#13)(2008-5#11)(2008-6#6)(2008-7#23)(2008-8#24)(2008-9#44)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#3)(2009-3#3)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#11)(2009-9#2)(2010-1#4)(2010-10#5)(2010-11#9)(2010-12#10)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-9#1)(2011-1#6)(2011-2#34)(2011-3#2)(2012-12#2)(2012-2#21)(2012-3#18)(2012-5#1)(2013-1#18)(2013-7#3)(2013-8#17)
involved may##2##2##(1997-1#1)(2008-6#1)
involved more##2##2##(1990-5#1)(2008-11#1)
involved most##2##2##(2008-7#1)(2013-1#1)
involved on the##2##3##(2008-10#2)
involved the##20##2##(1990-6#1)(1990-9#1)(1995-12#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-7#2)(2009-8#1)(2010-6#1)(2011-2#2)(2013-1#1)
involved was##2##2##(2008-10#2)
involved were##3##2##(1997-8#1)(2008-12#1)(2010-1#1)
involved will##3##2##(1997-8#1)(2008-10#1)(2009-5#1)
involved with a##3##3##(1996-9#1)(2009-3#1)(2013-1#1)
involved with##17##2##(1990-11#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2011-3#1)(2013-1#3)
involved##1072##1##(1990-11#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-12#4)(1992-3#6)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#6)(1993-6#6)(1993-8#6)(1993-9#3)(1994-1#3)(1994-11#10)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#4)(1994-8#11)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#13)(1995-2#14)(1995-3#4)(1995-5#4)(1995-6#14)(1995-8#7)(1995-9#2)(1996-1#2)(1996-12#9)(1996-2#13)(1996-3#7)(1996-5#2)(1996-6#2)(1996-8#3)(1996-9#4)(1997-1#8)(1997-2#10)(1997-3#5)(1997-5#2)(1997-7#9)(1997-8#9)(1997-9#1)(2006-6#5)(2007-12#6)(2008-1#9)(2008-10#220)(2008-11#88)(2008-12#13)(2008-2#1)(2008-3#5)(2008-4#20)(2008-5#16)(2008-6#7)(2008-7#37)(2008-8#31)(2008-9#51)(2009-1#2)(2009-10#9)(2009-11#1)(2009-12#3)(2009-3#4)(2009-5#4)(2009-6#3)(2009-7#7)(2009-8#13)(2009-9#4)(2010-1#7)(2010-10#6)(2010-11#11)(2010-12#12)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#5)(2010-7#5)(2010-9#1)(2011-1#9)(2011-2#47)(2011-3#3)(2012-12#3)(2012-2#23)(2012-3#21)(2012-4#2)(2012-5#1)(2012-7#1)(2013-1#33)(2013-7#5)(2013-8#23)
involvement and##13##2##(1997-3#1)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2009-9#1)(2010-7#1)(2012-2#2)(2013-1#1)
involvement are often##2##3##(1996-2#1)(1997-8#1)
involvement are##5##2##(1996-2#1)(1997-3#2)(1997-8#1)(2008-12#1)
involvement by##7##2##(1990-6#1)(1990-8#1)(2008-1#1)(2009-9#1)(2012-3#2)(2013-8#1)
involvement during##2##2##(2010-12#1)(2013-1#1)
involvement for##2##2##(1994-2#1)(2008-11#1)
involvement has been##2##3##(2008-12#1)(2013-1#1)
involvement in a##2##3##(1992-2#1)(2010-10#1)
involvement in cellular##2##3##(2011-2#2)
involvement in nonprescription medicine purchase decisions##2##6##(1995-2#2)
involvement in the##10##3##(1990-6#1)(1991-1#1)(1994-11#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
involvement in##54##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-8#1)(1992-2#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#8)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
involvement is##8##2##(1992-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-7#2)(2011-2#1)(2012-2#1)
involvement may be##2##3##(2008-7#1)(2011-2#1)
involvement may##3##2##(2008-7#2)(2011-2#1)
involvement occurred##3##2##(1997-8#2)(2013-1#1)
involvement of a##6##3##(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(2008-11#2)
involvement of an##4##3##(1991-10#1)(1993-12#1)(1995-2#1)(1997-3#1)
involvement of beta3 integrin in##2##5##(2009-9#2)
involvement of both##2##3##(1995-8#1)(2008-11#1)
involvement of myosin##2##3##(1992-6#1)(2008-11#1)
involvement of phospholipase A(2) and cyclooxygenase in##2##7##(2008-11#2)
involvement of phospholipase##3##3##(2008-11#3)
involvement of protein##2##3##(1997-1#1)(2008-11#1)
involvement of service users in##2##5##(2008-12#2)
involvement of the##27##3##(1990-6#2)(1992-3#1)(1993-3#1)(1993-6#1)(1994-5#2)(1995-11#1)(1996-12#1)(1997-8#3)(2007-12#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
involvement of these##5##3##(1990-12#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-11#1)
involvement of transition metals##2##4##(2008-5#1)(2011-1#1)
involvement of##163##2##(1990-12#1)(1990-5#1)(1990-6#3)(1991-10#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#3)(1993-12#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#5)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-8#2)(1996-12#3)(1996-6#1)(1997-1#3)(1997-2#6)(1997-3#1)(1997-7#1)(1997-8#4)(2006-6#2)(2007-12#1)(2007-8#1)(2008-10#17)(2008-11#28)(2008-12#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#2)
involvement policies##2##2##(2008-7#2)
involvement requires##2##2##(2008-6#1)(2013-1#1)
involvement was seen##2##3##(2012-3#2)
involvement was##7##2##(1990-12#1)(1990-2#1)(1991-6#1)(2008-11#1)(2012-2#1)(2012-3#2)
involvement were##2##2##(1997-8#1)(2013-8#1)
involvement with##5##2##(1996-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2013-1#1)
involvement##367##1##(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#7)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#3)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#5)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#8)(1995-3#7)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#9)(1997-5#1)(1997-7#1)(1997-8#15)(2006-6#2)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#22)(2008-11#39)(2008-12#17)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#19)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#2)(2009-5#2)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#5)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#25)(2012-12#3)(2012-2#7)(2012-3#12)(2013-1#21)(2013-7#1)(2013-8#7)
involvements##2##1##(2007-8#1)(2012-2#1)
involves a combination of##2##4##(2008-10#1)(2011-3#1)
involves a reactive##2##3##(1992-12#1)(2013-1#1)
involves a sequence of##2##4##(2008-10#1)(2011-2#1)
involves a series of##2##4##(1995-8#1)(1996-5#1)
involves a site that is##2##5##(1994-5#2)
involves a##40##2##(1990-12#1)(1990-2#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-8#1)(1996-5#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
involves an##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
involves both##2##2##(2008-10#1)(2008-7#1)
involves dry heating to 60 degrees C and higher##2##9##(2008-10#2)
involves four##2##2##(1997-8#1)(2008-10#1)
involves gene mutation that causes the##2##6##(2008-10#2)
involves laboratory##2##2##(2008-10#1)(2008-7#1)
involves many##2##2##(1992-2#1)(2013-8#1)
involves measurements##2##2##(2008-11#1)(2008-3#1)
involves multiple##2##2##(1992-12#1)(2012-2#1)
involves one##2##2##(1994-5#1)(2011-2#1)
involves patients##2##2##(2008-5#1)(2012-3#1)
involves sample##2##2##(2008-10#2)
involves specific##2##2##(1992-6#1)(2012-2#1)
involves the conversion of##2##4##(1991-5#1)(2009-11#1)
involves the development of##2##4##(2008-5#1)(2010-11#1)
involves the extraction of##2##4##(2008-10#1)(2008-11#1)
involves the formation of a##2##5##(1993-6#1)(2008-9#1)
involves the immobilization of##2##4##(2008-10#1)(2009-3#1)
involves the induction##2##3##(2008-11#1)(2011-1#1)
involves the injection of##2##4##(2008-10#2)
involves the use of a##3##5##(2008-10#2)(2013-1#1)
involves the use of##9##4##(1991-3#1)(2008-10#6)(2008-11#1)(2013-1#1)
involves the##69##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-3#1)(1991-5#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#26)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#3)
involves three##2##2##(1993-12#1)(2008-10#1)
involves two steps##2##3##(2008-10#2)
involves two##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
involves##248##1##(1990-12#3)(1990-2#2)(1990-5#2)(1991-3#1)(1991-5#3)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#3)(1994-5#4)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-8#2)(1995-9#1)(1996-5#4)(1996-9#1)(1997-1#2)(1997-2#3)(1997-8#2)(2008-1#1)(2008-10#74)(2008-11#12)(2008-12#4)(2008-3#5)(2008-4#6)(2008-5#9)(2008-7#5)(2008-8#5)(2008-9#7)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#10)(2011-3#3)(2011-8#1)(2012-12#1)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#9)(2013-8#3)
involving 58##2##2##(1992-4#1)(2008-10#1)
involving a##16##2##(1992-9#1)(1994-5#1)(1994-6#1)(1995-8#1)(2008-10#6)(2008-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#2)
involving all##4##2##(1996-2#1)(1997-7#1)(2008-10#1)(2013-1#1)
involving amino##2##2##(1997-6#1)(2008-10#1)
involving an##4##2##(1992-2#1)(2008-10#2)(2008-12#1)
involving both the##2##3##(2008-10#1)(2013-8#1)
involving both##6##2##(2008-10#3)(2008-5#1)(2009-7#1)(2013-8#1)
involving choline##2##2##(2008-10#1)(2008-11#1)
involving different##3##2##(2008-10#1)(2012-3#2)
involving major##3##2##(1994-9#1)(2008-10#1)(2008-7#1)
involving more##2##2##(2008-3#1)(2008-6#1)
involving multiple##2##2##(2008-9#1)(2009-10#1)
involving only##2##2##(2008-10#2)
involving patients in##2##3##(2008-11#1)(2008-12#1)
involving patients##3##2##(2008-11#1)(2008-12#1)(2012-3#1)
involving protein##2##2##(1994-11#1)(2008-11#1)
involving radiation##2##2##(2008-7#1)(2013-1#1)
involving small numbers of##2##4##(2010-4#1)(2012-2#1)
involving the anterior part of the annulus##2##7##(1996-6#2)
involving the carina##2##3##(2010-7#2)
involving the celiac axis##2##4##(2008-12#2)
involving the celiac##3##3##(2008-12#3)
involving the endometrium##2##3##(2011-2#2)
involving the face##3##3##(2013-1#3)
involving the head##2##3##(1994-6#1)(2008-6#1)
involving the left##2##3##(2008-11#1)(2008-7#1)
involving the middle##2##3##(1996-9#1)(2013-1#1)
involving the proximal##3##3##(1997-3#1)(2008-11#1)(2010-12#1)
involving the same##2##3##(2008-10#2)
involving the skull##3##3##(2008-1#1)(2010-12#2)
involving the use of a##2##5##(2008-10#1)(2008-11#1)
involving the use of##9##4##(2008-10#6)(2008-11#1)(2008-12#1)(2010-6#1)
involving the##108##2##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1996-5#1)(1996-6#2)(1996-9#6)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2007-12#2)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#8)(2012-2#1)(2012-3#2)(2013-1#7)
involving two##6##2##(2007-12#1)(2008-10#3)(2008-11#1)(2009-8#1)
involving zinc##2##2##(2008-10#2)
involving##365##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#3)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#99)(2008-11#20)(2008-12#14)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#6)(2009-10#5)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#19)(2012-2#5)(2012-3#8)(2012-7#1)(2013-1#19)(2013-8#5)
invulnerability and optimism bias##2##4##(2010-7#2)
invulnerability and##3##2##(2010-7#3)
invulnerability##10##1##(2010-7#10)
invulnerable##3##1##(2008-8#3)
inward K(+)##5##2##(2008-8#5)
inward current##4##2##(1993-3#1)(1995-11#2)(2008-8#1)
inward currents##6##2##(1993-8#1)(1995-11#4)(2008-8#1)
inward rectified##2##2##(2008-8#2)
inward##22##1##(1993-3#2)(1993-8#1)(1995-11#6)(1996-2#1)(1997-2#1)(2008-7#1)(2008-8#9)(2009-1#1)
inward-rectifying K+##2##2##(1994-12#2)
inward-rectifying##3##1##(1994-12#3)
in vitro scratch##2##2##(2013-8#2)
in vitro##4##1##(2012-3#1)(2013-1#1)(2013-8#2)
iodate and iodide in table salts##2##6##(2008-10#2)
iodate and iodide in table##3##5##(2008-10#3)
iodate and iodide##4##3##(2008-10#4)
iodate and##6##2##(2008-10#6)
iodate by##2##2##(2008-10#2)
iodate in##6##2##(2008-10#6)
iodate was##2##2##(2008-10#2)
iodate with a##2##3##(2008-10#2)
iodate with##4##2##(2008-10#4)
iodate##33##1##(2008-10#33)
iodate-bromate##4##1##(2008-10#4)
iodide and nitrite##2##3##(2008-10#2)
iodide and##10##2##(2008-10#10)
iodide at##2##2##(2008-10#2)
iodide by##4##2##(2008-10#4)
iodide concentration##2##2##(2008-10#2)
iodide contents in##2##3##(1990-2#1)(2008-10#1)
iodide during##2##2##(2008-10#1)(2008-11#1)
iodide in acidic##3##3##(2008-10#3)
iodide in the presence of##2##5##(2008-10#2)
iodide in the##3##3##(2008-10#3)
iodide in##15##2##(2008-10#15)
iodide ion in a photographic developing solution was##2##8##(2008-10#2)
iodide ion in a photographic developing solution##5##7##(2008-10#5)
iodide ion in##7##3##(2008-10#7)
iodide ion##13##2##(2008-10#13)
iodide ion-selective electrode detector##2##4##(2008-10#2)
iodide ion-selective electrode##3##3##(2008-10#3)
iodide ions##2##2##(2008-10#2)
iodide is##3##2##(2008-10#3)
iodide to##4##2##(2008-10#3)(2008-11#1)
iodide was##3##2##(2008-10#2)(2008-11#1)
iodide were##3##2##(2008-10#3)
iodide with##2##2##(2008-10#2)
iodide##115##1##(1990-2#1)(1994-2#1)(1994-5#1)(2008-10#100)(2008-11#4)(2008-4#1)(2008-9#3)(2009-6#1)(2010-4#1)(2011-1#2)
iodide)##4##1##(1990-12#2)(2008-10#1)(2008-5#1)
iodide-selective##3##1##(2008-10#3)
iodides##2##1##(2008-10#2)
iodimetric##4##1##(2008-10#4)
iodinated##7##1##(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
iodine and##7##2##(1997-8#1)(2008-10#6)
iodine as##2##2##(2008-10#2)
iodine in##5##2##(1997-8#2)(2008-10#2)(2012-3#1)
iodine is determined##2##3##(2008-10#2)
iodine is##3##2##(2008-10#3)
iodine lines##2##2##(2008-3#2)
iodine solution##3##2##(2008-10#3)
iodine to##2##2##(2008-10#2)
iodine was##2##2##(2008-10#1)(2012-12#1)
iodine##84##1##(1990-3#1)(1990-8#1)(1992-2#2)(1997-8#9)(2008-10#56)(2008-3#4)(2008-8#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#1)
iodine-125-labeled GNRs##2##2##(2012-12#2)
iodized##2##1##(1997-8#1)(2008-10#1)
iodoacetamide##2##1##(1994-11#1)(2008-5#1)
iodometric determination of##3##3##(2008-10#3)
iodometric titration##4##2##(2008-10#4)
iodometric##9##1##(2008-10#9)
iodometry##3##1##(2008-10#2)(2008-5#1)
iodophor##2##1##(1990-6#1)(1992-2#1)
iodothyronine deiodinase##3##2##(1995-12#2)(2011-1#1)
iodotyrosines and iodothyronines##3##3##(2008-10#3)
iodotyrosines##4##1##(1995-12#1)(2008-10#3)
ion activity##2##2##(2008-10#2)
ion adsorption##4##2##(2008-10#4)
ion against##2##2##(2008-10#2)
ion amperometry at##2##3##(2008-10#2)
ion and is##2##3##(1992-12#1)(1992-6#1)
ion and##30##2##(1992-12#1)(1992-6#2)(1993-8#1)(1995-6#1)(2007-12#2)(2008-10#22)(2009-8#1)
ion are described##2##3##(2008-10#2)
ion as a##2##3##(2008-10#2)
ion as##4##2##(2008-10#3)(2012-2#1)
ion associate formation##2##3##(2008-10#2)
ion associate of##2##3##(2008-10#2)
ion associate##14##2##(2008-10#14)
ion associates are##2##3##(2008-10#2)
ion associates of##5##3##(2008-10#5)
ion associates with##2##3##(2008-10#2)
ion associates##14##2##(2008-10#14)
ion association complex [Fe(bipy)(3)](2+)[(FinBr(4))(2)](2-)##2##4##(2008-10#2)
ion association complex##5##3##(2008-10#5)
ion association constants##3##3##(2008-10#3)
ion association reagent and##2##4##(2008-10#2)
ion association##20##2##(2008-10#20)
ion at##4##2##(2008-10#4)
ion based on##4##3##(2008-10#4)
ion beam##3##2##(2008-10#2)(2008-3#1)
ion binding##6##2##(1992-3#1)(1997-2#1)(2008-10#4)
ion by##7##2##(2008-10#7)
ion can##4##2##(2008-10#3)(2008-8#1)
ion capturing##2##2##(2008-10#2)
ion carrier##3##2##(2008-10#3)
ion carriers in##2##3##(2008-10#2)
ion chamber##3##2##(2009-11#3)
ion channel##17##2##(1992-6#2)(1994-8#5)(1995-12#1)(1995-8#2)(2008-11#2)(2009-8#1)(2010-8#1)(2011-3#1)(2012-3#2)
ion channels##8##2##(1993-9#1)(1995-2#2)(1997-7#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
ion chelation##2##2##(1993-8#1)(2008-10#1)
ion chemistry##4##2##(2008-10#4)
ion chromatograph##3##2##(2008-10#3)
ion chromatographic analyses##2##3##(2008-10#1)(2010-4#1)
ion chromatographic##7##2##(2008-10#6)(2010-4#1)
ion chromatography (IC) with##5##4##(2008-10#5)
ion chromatography (IC)##10##3##(2008-10#10)
ion chromatography and##3##3##(2008-10#3)
ion chromatography for##3##3##(2008-10#3)
ion chromatography with##2##3##(2008-10#2)
ion chromatography##38##2##(2008-10#38)
ion complexation by##3##3##(2008-10#3)
ion complexation##5##2##(2008-10#5)
ion complexes##2##2##(2008-10#2)
ion concentration in the##2##4##(2008-10#2)
ion concentration in##3##3##(2008-10#3)
ion concentration range##3##3##(2008-10#3)
ion concentration##16##2##(2008-10#16)
ion concentrations in##2##3##(2008-10#2)
ion concentrations##5##2##(2008-10#4)(2010-11#1)
ion current##2##2##(2008-10#2)
ion determination##5##2##(2008-10#5)
ion due to the##2##4##(2008-10#2)
ion exchange and##7##3##(1993-9#1)(2008-10#6)
ion exchange chromatography on##2##4##(2008-4#1)(2009-9#1)
ion exchange chromatography##5##3##(1994-8#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)
ion exchange column##2##3##(2008-10#2)
ion exchange columns##3##3##(1991-5#1)(2008-10#2)
ion exchange membranes##2##3##(2008-10#1)(2013-1#1)
ion exchange resin##10##3##(2008-10#10)
ion exchange resins##5##3##(2008-10#5)
ion exchange selectivity##3##3##(2008-10#3)
ion exchange##65##2##(1990-8#1)(1991-5#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-2#1)(2008-10#54)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
ion exchanger and##2##3##(2008-10#2)
ion exchanger##18##2##(2008-10#18)
ion exchangers and##2##3##(1997-2#1)(2008-10#1)
ion exchangers##7##2##(1990-5#1)(1997-2#1)(2008-10#5)
ion fluxes##3##2##(1992-6#1)(2008-10#2)
ion for##2##2##(2008-10#2)
ion formation##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
ion formed##3##2##(2008-10#3)
ion forms a##2##3##(2008-10#2)
ion from aqueous solutions##2##4##(2008-10#2)
ion from aqueous##3##3##(2008-10#3)
ion from##4##2##(2008-10#4)
ion has been##4##3##(2008-10#4)
ion has##5##2##(1993-8#1)(2008-10#4)
ion imprinted polymer (IIP) particles##2##5##(2008-10#2)
ion in a##20##3##(1993-5#1)(1993-8#1)(2008-10#17)(2008-11#1)
ion in aqueous media##2##4##(2008-10#2)
ion in aqueous samples##3##4##(2008-10#3)
ion in aqueous solution##2##4##(2008-10#2)
ion in aqueous##8##3##(2008-10#8)
ion in basic##2##3##(2008-10#2)
ion in comparison to##2##4##(2008-10#2)
ion in comparison with some##2##5##(2008-10#2)
ion in comparison with##3##4##(2008-10#3)
ion in comparison##5##3##(2008-10#5)
ion in natural waters##2##4##(2008-10#2)
ion in natural##3##3##(2008-10#3)
ion in solution##2##3##(2008-10#2)
ion in the sample##2##4##(2008-10#2)
ion in the##14##3##(1995-6#1)(1997-2#1)(2008-10#12)
ion in water##4##3##(2008-10#4)
ion in##79##2##(1992-9#1)(1993-5#1)(1993-8#1)(1995-6#1)(1997-2#1)(2008-10#73)(2008-11#1)
ion interactions##2##2##(2008-10#2)
ion is described##2##3##(2008-10#2)
ion is increased##2##3##(2008-10#2)
ion is observed##2##3##(2008-10#2)
ion is##18##2##(1995-6#1)(2008-10#17)
ion mass spectrometry##9##3##(2008-10#6)(2008-2#1)(2008-5#1)(2012-12#1)
ion mass##10##2##(2008-10#7)(2008-2#1)(2008-5#1)(2012-12#1)
ion measurements##2##2##(2008-10#2)
ion mobility spectra of##3##4##(2008-10#3)
ion mobility spectrometer##7##3##(2008-10#7)
ion mobility spectrometry (IMS) was##2##5##(2008-10#1)(2010-9#1)
ion mobility spectrometry (IMS)##8##4##(2008-10#7)(2010-9#1)
ion mobility spectrometry##23##3##(2008-10#22)(2010-9#1)
ion mobility##37##2##(2008-10#36)(2010-9#1)
ion monitoring (SIM)##6##3##(2008-10#6)
ion monitoring mode##7##3##(2008-10#6)(2008-11#1)
ion monitoring##18##2##(2008-10#17)(2008-11#1)
ion on a##2##3##(2008-10#2)
ion on the##3##3##(1990-5#1)(2008-10#2)
ion on##6##2##(1990-5#1)(2008-10#4)(2012-7#1)
ion over a wide concentration range##3##6##(2008-10#3)
ion over a wide variety of other##2##7##(2008-10#2)
ion over a wide variety of##4##6##(2008-10#4)
ion over a wide##8##4##(2008-10#8)
ion over a##9##3##(2008-10#9)
ion over alkali##4##3##(2008-10#4)
ion over other##2##3##(2008-10#2)
ion over the concentration range of##2##6##(2008-10#2)
ion over the concentration range##3##5##(2008-10#3)
ion over wide concentration##2##4##(2008-10#2)
ion over##21##2##(2008-10#21)
ion pair as an electroactive material##2##6##(2008-10#2)
ion pair as an##3##4##(2008-10#3)
ion pair formation##2##3##(2008-10#2)
ion pair formed##2##3##(2008-10#2)
ion pair in##2##3##(2008-10#2)
ion pair of##5##3##(2008-10#5)
ion pair with##2##3##(2008-10#2)
ion pair##23##2##(1995-6#1)(2008-10#22)
ion pairing reversed phase and cation exchange##2##7##(2008-10#2)
ion pairing##4##2##(2008-10#3)(2008-11#1)
ion pairs with##2##3##(2008-10#2)
ion pairs##8##2##(2008-10#8)
ion peaks##2##2##(1990-12#1)(2008-10#1)
ion per##2##2##(2008-10#2)
ion permeability of##2##3##(2008-10#1)(2008-8#1)
ion permeability##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
ion release##2##2##(2008-5#2)
ion released by##2##3##(2008-10#2)
ion selective PVC membrane electrode##2##5##(2008-10#2)
ion selective PVC membrane##3##4##(2008-10#3)
ion selective electrode based on##3##5##(2008-10#3)
ion selective electrode##16##3##(2008-10#15)(2008-5#1)
ion selective electrodes##13##3##(2008-10#12)(2008-6#1)
ion selective##37##2##(2008-10#35)(2008-5#1)(2008-6#1)
ion selectivity and thermodynamic properties##2##5##(1991-5#2)
ion selectivity and##3##3##(1991-5#2)(2008-10#1)
ion selectivity##6##2##(1991-5#2)(2008-10#4)
ion sensing##3##2##(2008-10#3)
ion sensitive##3##2##(2008-10#3)
ion sensor based on##2##4##(2008-10#2)
ion sensor##3##2##(2008-10#3)
ion sensors##3##2##(2008-10#3)
ion solution##5##2##(2008-10#5)
ion sorption##5##2##(2008-10#5)
ion species##2##2##(2008-10#2)
ion to the##3##3##(2008-10#3)
ion to##9##2##(1997-4#1)(2008-10#8)
ion transfer##2##2##(2008-10#2)
ion transport in the##2##4##(2008-12#2)
ion transport##8##2##(1992-6#1)(1997-1#2)(1997-6#1)(2008-10#1)(2008-12#2)(2010-7#1)
ion trap mass spectrometer##3##4##(2008-10#3)
ion trap mass spectrometry##4##4##(2008-10#1)(2008-8#2)(2010-11#1)
ion trap mass##8##3##(2008-10#5)(2008-8#2)(2010-11#1)
ion trap##14##2##(2008-10#8)(2008-11#1)(2008-8#2)(2010-11#1)(2010-7#2)
ion using##4##2##(2008-10#4)
ion was found to be##3##5##(2008-10#3)
ion was##11##2##(2008-10#11)
ion were##4##2##(2008-10#4)
ion with a##4##3##(2008-10#4)
ion with##11##2##(2008-10#11)
ion##994##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-3#1)(1991-5#3)(1992-12#1)(1992-3#1)(1992-6#6)(1992-9#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#6)(1993-9#2)(1994-11#1)(1994-5#1)(1994-8#9)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#8)(1995-8#3)(1996-5#1)(1997-1#3)(1997-2#9)(1997-4#1)(1997-6#2)(1997-7#1)(2007-12#3)(2008-10#842)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-11#3)(2009-3#1)(2009-8#6)(2009-9#1)(2010-11#3)(2010-4#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#4)(2012-12#1)(2012-2#1)(2012-3#4)(2012-7#2)(2013-1#1)(2013-8#1)
ion)##3##1##(2008-10#3)
ion-associate of##2##2##(2008-10#2)
ion-associate##5##1##(2008-10#5)
ion-associated complexes##2##2##(2008-10#2)
ion-association complex##4##2##(2008-10#4)
ion-association complexes##2##2##(2008-10#2)
ion-association##8##1##(2008-10#8)
ion-channel sensor based on self-assembled monolayer of thioctic acid##2##9##(2008-10#2)
ion-channel##3##1##(2008-10#3)
ion-chromatographic##3##1##(2008-10#3)
ion-chromatography with##2##2##(2008-10#2)
ion-chromatography##5##1##(2008-10#5)
ion-cycle##3##1##(2008-8#3)
ion-exchange HPLC method##2##3##(1997-2#1)(2008-10#1)
ion-exchange adsorption##2##2##(2008-10#1)(2008-7#1)
ion-exchange and potentiometric selectivity##2##4##(2008-10#2)
ion-exchange and##4##2##(1993-8#1)(2008-10#3)
ion-exchange chromatography and##3##3##(1993-8#1)(1997-1#1)(1997-2#1)
ion-exchange chromatography##9##2##(1991-9#1)(1993-8#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-8#1)
ion-exchange membranes##2##2##(2008-7#2)
ion-exchange or##3##2##(2008-10#2)(2008-6#1)
ion-exchange resin##2##2##(2008-10#2)
ion-exchange resins modified with##2##4##(2008-10#2)
ion-exchange resins##3##2##(2008-10#3)
ion-exchange##46##1##(1991-9#1)(1993-8#2)(1997-1#1)(1997-2#5)(2008-10#30)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#2)
ion-exchanger##11##1##(2008-10#11)
ion-exclusion##3##1##(2008-10#3)
ion-molecule##2##1##(2008-10#2)
ion-pair HPLC##2##2##(2008-10#2)
ion-pair chromatography##2##2##(2008-10#2)
ion-pair complex as selective##2##4##(2008-10#2)
ion-pair complex##7##2##(2008-10#7)
ion-pair extraction##7##2##(2008-10#7)
ion-pair formation between##2##3##(2008-10#2)
ion-pair formation##10##2##(2008-10#10)
ion-pair formed##3##2##(2008-10#3)
ion-pair liquid chromatography##3##3##(2008-10#3)
ion-pair liquid##5##2##(2008-10#5)
ion-pair of##2##2##(2008-10#2)
ion-pair reversed phase chromatographic system##2##5##(2008-10#2)
ion-pair reversed phase chromatography##3##4##(2008-10#3)
ion-pair reversed phase high performance liquid chromatography##2##7##(2008-10#2)
ion-pair reversed phase high performance liquid##3##6##(2008-10#3)
ion-pair reversed phase##8##3##(2008-10#8)
ion-pair reversed-phase##4##2##(2008-10#4)
ion-pair##67##1##(2008-10#67)
ion-pairing reagent##4##2##(2008-10#4)
ion-pairing reversed phase##2##3##(2008-10#1)(2010-11#1)
ion-pairing##13##1##(2008-10#11)(2008-11#1)(2010-11#1)
ion-pairs with the##2##3##(2008-10#2)
ion-pairs##6##1##(2008-10#6)
ion-selective PVC membrane electrode based on##2##6##(2008-10#2)
ion-selective PVC membrane sensor based on##3##6##(2008-10#3)
ion-selective PVC membrane##6##3##(2008-10#6)
ion-selective electrode (ISE) based on##2##5##(2008-10#2)
ion-selective electrode (ISE) can be calibrated in##2##7##(2008-10#2)
ion-selective electrode (ISE)##12##3##(2008-10#12)
ion-selective electrode based on##5##4##(2008-10#5)
ion-selective electrode detector##5##3##(2008-10#5)
ion-selective electrode for the determination of##3##6##(2008-10#3)
ion-selective electrode for##4##3##(2008-10#4)
ion-selective electrode has been##2##4##(2008-10#2)
ion-selective electrode in##2##3##(2008-10#2)
ion-selective electrode##55##2##(2008-10#55)
ion-selective electrodes (ISEs) can be##2##5##(2008-10#2)
ion-selective electrodes (ISEs) is##3##4##(2008-10#3)
ion-selective electrodes (ISEs)##8##3##(2008-10#8)
ion-selective electrodes based on##4##4##(2008-10#4)
ion-selective electrodes for##2##3##(2008-10#2)
ion-selective electrodes##30##2##(2008-10#30)
ion-selective membrane electrodes based on##2##5##(2008-10#2)
ion-selective membrane electrodes##3##3##(2008-10#3)
ion-selective membrane##5##2##(2008-10#5)
ion-selective piezoelectric##2##2##(2008-10#2)
ion-selective poly(vinyl chloride)##2##3##(2008-10#2)
ion-selective polymeric membrane electrode##2##4##(2008-10#2)
ion-selective polymeric membrane sensor based on##2##6##(2008-10#2)
ion-selective polymeric membrane##4##3##(2008-10#4)
ion-selective##114##1##(2008-10#114)
ion-sensitive field-effect##2##2##(1995-8#1)(2008-10#1)
ion-sensitive membrane##2##2##(2008-10#2)
ion-sensitive##5##1##(1995-8#1)(2008-10#4)
ion-spray mass spectrometry##4##3##(1994-5#3)(2008-10#1)
ion-transporting filaments##2##2##(2008-7#2)
ion-transporting##4##1##(2008-7#4)
ionic additive##2##2##(2008-10#2)
ionic concentration##3##2##(1996-12#1)(2008-10#2)
ionic currents##5##2##(2008-11#4)(2013-1#1)
ionic dyes##2##2##(2008-10#2)
ionic dyskinesia##2##2##(2008-7#2)
ionic interaction##2##2##(1991-5#1)(2012-3#1)
ionic liquid##11##2##(2008-10#11)
ionic liquids (ILs)##3##3##(2008-10#2)(2010-7#1)
ionic liquids as##2##3##(2008-10#2)
ionic liquids##6##2##(1995-3#1)(2008-10#4)(2010-7#1)
ionic media##3##2##(2008-10#3)
ionic medium of##2##3##(2008-10#2)
ionic medium##9##2##(2008-10#9)
ionic radii##3##2##(2008-10#3)
ionic species of##2##3##(2008-10#2)
ionic species##5##2##(2008-10#5)
ionic strength 0##2##3##(2008-10#2)
ionic strength adjustment buffer##2##4##(2008-10#2)
ionic strength and pH of##2##5##(2008-10#2)
ionic strength and pH on their chromatographic behavior was investigated##2##10##(2008-10#2)
ionic strength and pH##4##4##(2008-10#4)
ionic strength and##14##3##(1993-3#1)(1997-2#1)(2008-10#11)(2013-1#1)
ionic strength in##2##3##(1997-6#1)(2008-10#1)
ionic strength of 0##5##4##(1995-2#1)(2008-10#4)
ionic strength of the##4##4##(1997-2#1)(2008-10#3)
ionic strength of##12##3##(1995-2#1)(1997-2#1)(2008-10#10)
ionic strength on the##2##4##(2008-10#2)
ionic strength on##3##3##(2008-10#3)
ionic strength was##4##3##(1997-2#2)(2008-10#1)(2008-7#1)
ionic strength were##3##3##(2008-10#3)
ionic strength##102##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-9#2)(1992-4#1)(1993-3#1)(1994-5#4)(1995-2#1)(1997-2#5)(1997-6#1)(2008-10#79)(2008-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
ionic strength) and##2##3##(2008-10#2)
ionic strength)##3##2##(1992-3#1)(2008-10#2)
ionic strengths in NaClO(4)##2##4##(2008-10#2)
ionic strengths in##3##3##(2008-10#3)
ionic strengths of##2##3##(1995-2#1)(2008-10#1)
ionic strengths##13##2##(1994-5#1)(1995-2#1)(2008-10#10)(2008-7#1)
ionic##222##1##(1990-11#2)(1990-2#1)(1990-5#2)(1991-5#3)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-5#6)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#6)(1997-6#1)(2008-10#162)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#7)(2009-5#1)(2010-4#1)(2010-7#7)(2011-2#1)(2012-3#1)(2013-1#2)
ionisation constant of ketoprofen##2##4##(2008-10#2)
ionisation constant of##3##3##(2008-10#3)
ionisation mass spectrometry##3##3##(2008-10#3)
ionisation of a##2##3##(2008-10#2)
ionisation of##5##2##(2008-10#5)
ionisation##20##1##(2008-10#19)(2008-11#1)
ionizable##5##1##(1993-8#1)(2008-10#3)(2008-5#1)
ionization (ESI)##3##2##(2008-10#3)
ionization constants were##2##3##(2008-10#2)
ionization constants##6##2##(2008-10#5)(2008-9#1)
ionization detector (FID)##3##3##(2008-10#3)
ionization detector##7##2##(2008-10#6)(2008-11#1)
ionization mass spectrometry##12##3##(1990-12#2)(2008-10#9)(2010-6#1)
ionization mass##15##2##(1990-12#2)(2008-10#12)(2010-6#1)
ionization methods##2##2##(2010-7#2)
ionization of##7##2##(1992-11#1)(1994-5#1)(2008-10#5)
ionization process##2##2##(2008-10#1)(2008-3#1)
ionization source##7##2##(2008-10#6)(2011-3#1)
ionization tandem mass spectrometry##3##4##(2008-10#3)
ionization technique##2##2##(2008-10#1)(2008-11#1)
ionization##105##1##(1990-12#2)(1992-11#1)(1994-5#1)(2007-12#2)(2008-10#75)(2008-11#2)(2008-3#8)(2008-9#1)(2009-6#1)(2010-11#2)(2010-6#1)(2010-7#5)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
ionization-mass spectrometry##4##2##(2008-10#2)(2008-5#1)(2011-1#1)
ionized calcium##5##2##(1990-2#2)(1990-8#1)(2008-4#1)(2008-9#1)
ionized##18##1##(1990-2#2)(1990-8#1)(1991-5#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
ionizing radiation and##2##3##(2008-7#2)
ionizing radiation or##2##3##(1995-8#1)(2008-9#1)
ionizing radiation##21##2##(1995-12#2)(1995-6#1)(1995-8#2)(1997-7#1)(1997-8#2)(2008-7#6)(2008-9#4)(2012-2#1)(2013-1#2)
ionizing radiation-induced##2##2##(1995-12#1)(2013-1#1)
ionizing##28##1##(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#2)(1997-3#1)(1997-7#2)(1997-8#2)(2008-11#1)(2008-7#7)(2008-9#4)(2012-2#1)(2013-1#3)
ionome##2##1##(2009-8#2)
ionomer liner##2##2##(1990-2#2)
ionomer##10##1##(1990-2#3)(2008-10#3)(2010-4#2)(2013-1#2)
ionomycin##16##1##(1990-8#1)(1993-3#1)(1994-11#1)(1994-3#2)(1995-11#1)(1995-2#2)(1995-8#4)(1997-1#1)(2008-11#2)(2008-9#1)
ionophore A23187##4##2##(1991-5#1)(1994-11#1)(2008-10#1)(2008-8#1)
ionophore and##6##2##(1994-3#1)(2008-10#5)
ionophore for##9##2##(2008-10#9)
ionophore in##7##2##(2008-10#7)
ionophore showed##2##2##(2008-10#2)
ionophore to##2##2##(2008-10#2)
ionophore was##7##2##(2008-10#7)
ionophore##89##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1994-11#1)(1994-3#3)(1995-11#3)(1995-2#1)(1997-1#1)(2006-6#1)(2008-10#71)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
ionophore)##2##1##(2008-10#2)
ionophore-based ISEs##2##2##(2008-10#2)
ionophore-based##4##1##(2008-10#4)
ionophore-immobilized##2##1##(2008-10#2)
ionophores and##3##2##(2008-10#3)
ionophores are##2##2##(2008-10#2)
ionophores containing dithiocarbamoyl##2##3##(2008-10#2)
ionophores containing##4##2##(2008-10#4)
ionophores have been##2##3##(2008-10#2)
ionophores in##6##2##(2008-10#6)
ionophores to##2##2##(2008-10#2)
ionophores were##3##2##(2008-10#3)
ionophores##41##1##(1995-2#1)(2008-10#40)
ionotropic glutamate receptors##3##3##(1995-11#3)
ionotropic##6##1##(1995-11#3)(2008-7#2)(2013-1#1)
ions (detection at##2##3##(2008-10#2)
ions (e##3##2##(2008-10#3)
ions Cu(II)##3##2##(2008-10#3)
ions across##2##2##(2008-10#1)(2012-2#1)
ions and a##2##3##(2008-10#2)
ions and common##2##3##(2008-10#2)
ions and could be used##5##5##(2008-10#5)
ions and organic compounds##2##4##(2008-10#2)
ions and other##3##3##(2008-10#3)
ions and the##4##3##(2008-10#4)
ions and##61##2##(2008-10#58)(2008-5#1)(2009-8#2)
ions are adsorbed##3##3##(2008-10#3)
ions are described##2##3##(2008-10#2)
ions are determined##2##3##(2008-10#2)
ions are reported##6##3##(2008-10#6)
ions are then stripped from the disk##2##7##(2008-10#2)
ions are tolerated##2##3##(2008-10#2)
ions are##49##2##(1993-8#1)(1995-6#1)(1995-8#1)(1997-7#2)(2008-10#44)
ions arising from##2##3##(1991-11#1)(2008-10#1)
ions as well as##2##4##(2007-12#1)(2008-10#1)
ions as##9##2##(2007-12#1)(2008-10#7)(2012-2#1)
ions at pH 10##2##4##(2008-10#2)
ions at pH##4##3##(2008-10#4)
ions at the##2##3##(2008-10#1)(2008-8#1)
ions at##13##2##(2008-10#12)(2008-8#1)
ions based on##5##3##(2008-10#5)
ions by atomic absorption##2##4##(2008-10#2)
ions by##26##2##(2008-10#24)(2008-9#1)(2013-1#1)
ions can be quantitatively##3##4##(2008-10#3)
ions can be##9##3##(2008-10#9)
ions commonly##3##2##(2008-10#3)
ions could be##4##3##(2008-10#4)
ions could##6##2##(1994-6#1)(2008-10#5)
ions detected##2##2##(2008-10#2)
ions determination##4##2##(2008-10#4)
ions did not interfere with the##2##6##(2008-10#2)
ions did not##3##3##(2008-10#2)(2008-11#1)
ions do not interfere with the determination##2##7##(2008-10#2)
ions do not##5##3##(2008-10#5)
ions except##2##2##(2008-10#2)
ions extraction and the EN 12341 standard##2##7##(2008-10#2)
ions extraction and##3##3##(2008-10#3)
ions extraction##4##2##(2008-10#4)
ions for##6##2##(2008-10#6)
ions formed##3##2##(2008-10#3)
ions from aqueous solutions##5##4##(2008-10#5)
ions from aqueous##7##3##(2008-10#7)
ions from solution samples##3##4##(2008-10#3)
ions from synthetic##2##3##(2008-10#2)
ions from the##6##3##(1990-12#1)(1994-6#1)(1995-11#1)(2008-10#3)
ions from water##4##3##(2008-10#4)
ions from##38##2##(1990-12#1)(1994-6#1)(1995-11#1)(2008-10#35)
ions has been investigated in##2##5##(2008-10#2)
ions has been investigated##4##4##(2008-10#4)
ions has been##7##3##(2008-10#7)
ions has##8##2##(2008-10#8)
ions have been investigated##4##4##(2008-10#4)
ions have been##10##3##(2008-10#10)
ions have##14##2##(2008-10#14)
ions in a##3##3##(2008-10#3)
ions in airborne##3##3##(2008-10#3)
ions in aqueous solution##4##4##(2008-10#4)
ions in aqueous##7##3##(2008-10#7)
ions in concentrations##2##3##(2008-10#2)
ions in its##2##3##(1995-8#1)(2008-10#1)
ions in natural waters##2##4##(2008-10#2)
ions in natural##3##3##(2008-10#3)
ions in real##3##3##(2008-10#3)
ions in river and##3##4##(2008-10#3)
ions in synthetic samples##2##4##(2008-10#2)
ions in the aqueous##2##4##(2008-10#2)
ions in the concentration range##4##5##(2008-10#4)
ions in the presence of##4##5##(2008-10#4)
ions in the presence##5##4##(2008-10#5)
ions in the solution##2##4##(2008-10#2)
ions in the##36##3##(1993-8#1)(2008-10#32)(2008-11#1)(2011-1#1)(2013-7#1)
ions in water samples##3##4##(2008-10#3)
ions in water were##2##4##(2008-10#2)
ions in water##6##3##(2008-10#6)
ions in##120##2##(1992-4#1)(1992-9#1)(1993-8#1)(1995-8#1)(1997-7#1)(2008-10#105)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-4#2)(2011-1#1)(2013-7#1)
ions increased##3##2##(1991-5#1)(2008-10#1)(2013-7#1)
ions into##2##2##(2008-11#1)(2009-8#1)
ions is##15##2##(2008-10#13)(2008-3#1)(2010-7#1)
ions may##2##2##(2008-10#2)
ions of the##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
ions of##14##2##(1990-12#1)(1995-6#1)(2008-10#11)(2008-7#1)
ions on a##3##3##(2008-10#3)
ions on the determination of##13##5##(2008-10#13)
ions on the extraction##2##4##(2008-10#2)
ions on the sorption##2##4##(2008-10#2)
ions on the##38##3##(2008-10#38)
ions on##53##2##(2008-10#51)(2010-11#2)
ions onto a column##2##4##(2008-10#2)
ions onto a##3##3##(2008-10#3)
ions onto the##2##3##(2008-10#2)
ions onto##11##2##(2008-10#11)
ions or##5##2##(2008-10#5)
ions over a large number of##2##6##(2008-10#2)
ions over a wide concentration range##6##6##(2008-10#6)
ions over a##9##3##(2008-10#9)
ions over the concentration range##2##5##(2008-10#2)
ions over##14##2##(2008-10#14)
ions produced in##2##3##(2008-10#2)
ions released##2##2##(1997-8#1)(2008-10#1)
ions should##2##2##(2008-10#2)
ions showed that##2##3##(2008-10#2)
ions studied##5##2##(2008-10#5)
ions such as Cu(II)##3##4##(2008-10#3)
ions such as##13##3##(2008-10#12)(2010-7#1)
ions than##2##2##(2008-10#2)
ions that do not##2##4##(2008-10#2)
ions that##4##2##(2008-10#4)
ions through a bulk liquid membrane##2##6##(2008-10#2)
ions through a##4##3##(2008-10#4)
ions through##7##2##(2008-10#6)(2011-2#1)
ions to form##2##3##(1990-2#1)(2008-10#1)
ions to the##2##3##(1994-11#1)(2008-10#1)
ions to##8##2##(1990-2#1)(1994-11#2)(2008-10#5)
ions using a##2##3##(2008-10#2)
ions using##7##2##(2008-10#7)
ions was also carried out##2##5##(2008-10#2)
ions was also##4##3##(2008-10#4)
ions was investigated in##2##4##(2008-10#1)(2008-3#1)
ions was prepared by using##2##5##(2008-10#2)
ions was studied##5##3##(2008-10#5)
ions was##36##2##(2008-10#34)(2008-3#1)(2011-2#1)
ions were also investigated##3##4##(2008-10#3)
ions were also##5##3##(2008-10#4)(2009-8#1)
ions were described##2##3##(2008-10#2)
ions were determined by##3##4##(2008-10#3)
ions were determined##6##3##(2008-10#6)
ions were exchanged for the single-charged##2##6##(2008-10#2)
ions were investigated##3##3##(2008-10#3)
ions were obtained##2##3##(2008-10#2)
ions were quantitatively retained on the##2##6##(2008-10#2)
ions were removed##2##3##(2008-10#2)
ions were sorbed in the minicolumn##2##6##(2008-10#2)
ions were studied##6##3##(2008-10#6)
ions were##70##2##(2008-10#63)(2008-3#2)(2008-5#1)(2009-8#1)(2011-2#3)
ions which##2##2##(2008-10#2)
ions with EDTA##3##3##(2008-10#3)
ions with a##4##3##(2008-10#4)
ions with the##4##3##(2008-10#4)
ions with##34##2##(2008-10#34)
ions##1104##1##(1990-12#2)(1990-2#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-3#3)(1992-4#1)(1992-9#3)(1993-5#1)(1993-6#1)(1993-8#4)(1994-11#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-6#4)(1995-8#3)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#1)(2007-12#3)(2008-10#991)(2008-11#9)(2008-12#1)(2008-3#10)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#6)(2009-8#7)(2010-11#4)(2010-4#2)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#1)(2013-7#3)
iontophoresis##3##1##(2008-5#1)(2011-2#2)
iowae##4##1##(2008-5#4)
ipomoeae##4##1##(2008-10#4)
iprodione was##2##2##(2008-10#2)
iprodione##14##1##(2008-10#14)
iprodione-tolerant##2##1##(2008-10#2)
ipsilateral SHM##2##2##(2011-2#2)
ipsilateral areas##2##2##(2008-5#2)
ipsilateral breast##2##2##(1991-2#1)(1994-12#1)
ipsilateral hippocampus##2##2##(1996-12#2)
ipsilateral to the lesion##3##4##(1993-3#1)(1996-2#1)(1997-3#1)
ipsilateral to the##4##3##(1990-9#1)(1993-3#1)(1996-2#1)(1997-3#1)
ipsilateral##40##1##(1990-9#1)(1991-2#2)(1993-3#5)(1994-12#2)(1996-12#5)(1996-2#1)(1996-5#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-12#2)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#2)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
iralukast##2##1##(2008-5#2)
iran##15##1##(2012-2#7)(2013-1#8)
iridium in##3##2##(2008-10#3)
iridium oxide##4##2##(2008-10#4)
iridium##21##1##(1991-8#1)(2008-10#20)
iridophores are##3##2##(2008-5#3)
iridophores##7##1##(2008-5#7)
iris and macular##2##3##(2011-2#2)
iris and##4##2##(1996-2#1)(2008-9#1)(2011-2#2)
iris phenotypes##2##2##(2008-8#2)
iris yellow spot virus (IYSV)##2##5##(2008-10#2)
iris yellow spot virus##3##4##(2008-10#3)
iris##17##1##(1996-2#1)(2008-10#6)(2008-5#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#4)
iron (Fe(III))##2##2##(2008-5#2)
iron (Fe)##2##2##(1996-2#1)(2008-10#1)
iron (II)##5##2##(2008-10#4)(2009-9#1)
iron (III)##3##2##(2008-10#3)
iron acquisition##2##2##(2008-5#1)(2011-2#1)
iron and aluminum##2##3##(2008-10#2)
iron and chromium##4##3##(2008-10#4)
iron and copper were##2##4##(2008-10#2)
iron and copper##3##3##(2008-10#3)
iron and lead in lubricating oils##2##6##(2008-10#2)
iron and lead##3##3##(2008-10#3)
iron and manganese in##2##4##(2008-10#2)
iron and manganese##6##3##(2008-10#6)
iron and vanadium by H-point standard addition method##2##8##(2008-10#2)
iron and vanadium##5##3##(2008-10#5)
iron and zinc by##2##4##(2008-10#2)
iron and zinc##9##3##(2008-10#8)(2013-8#1)
iron and##63##2##(1992-3#1)(1994-5#1)(1996-2#1)(2008-10#51)(2008-8#1)(2011-2#4)(2012-2#1)(2013-7#1)(2013-8#2)
iron are discussed##2##3##(2008-10#2)
iron are##3##2##(1995-3#1)(2008-10#2)
iron as Fe(II) in##2##4##(2008-10#2)
iron as##4##2##(2008-10#4)
iron by##9##2##(2008-10#9)
iron chalcogenide glass ion-selective electrode##2##5##(2008-10#2)
iron chalcogenide glass##3##3##(2008-10#3)
iron chalcogenide##5##2##(2008-10#5)
iron chelator##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
iron chelators##2##2##(2008-11#1)(2013-8#1)
iron compounds##2##2##(2011-2#2)
iron concentration of##4##3##(1996-2#3)(2008-10#1)
iron concentration##8##2##(1996-12#1)(1996-2#3)(2008-10#3)(2011-2#1)
iron concentrations##2##2##(2008-10#2)
iron content in##3##3##(2008-10#2)(2012-2#1)
iron content##7##2##(1992-3#1)(2008-10#5)(2012-2#1)
iron could##3##2##(1996-2#2)(2008-1#1)
iron deficiency##7##2##(1990-11#1)(1991-6#1)(1995-6#1)(1997-7#1)(2008-1#3)
iron determination in##2##3##(2008-10#2)
iron determination##9##2##(2008-10#9)
iron dissolution##2##2##(2008-10#2)
iron from##7##2##(2008-10#4)(2008-5#3)
iron has been##2##3##(2008-10#1)(2013-8#1)
iron homeostasis##3##2##(1990-5#1)(2013-8#2)
iron hydroxide phase##2##3##(2008-10#2)
iron hydroxide precipitates##2##3##(2008-10#2)
iron hydroxide##8##2##(2008-10#8)
iron hydroxides##2##2##(2008-10#2)
iron in beer##3##3##(2008-10#3)
iron in natural waters##2##4##(2008-10#2)
iron in natural##3##3##(2008-10#3)
iron in tap##3##3##(2008-10#3)
iron in the##8##3##(1993-2#1)(2008-10#7)
iron in water samples##4##4##(2008-10#4)
iron in##48##2##(1993-2#2)(1996-8#1)(1997-8#1)(2008-10#43)(2012-2#1)
iron ions##6##2##(1993-8#4)(2008-10#2)
iron is##9##2##(1992-8#2)(2008-10#5)(2008-11#2)
iron levels##2##2##(2008-10#2)
iron limitation##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
iron matrix##2##2##(2008-10#2)
iron metabolism in##2##3##(1993-11#1)(2013-8#1)
iron metabolism##5##2##(1993-11#2)(2013-8#3)
iron on the##3##3##(1994-5#2)(2008-10#1)
iron on##4##2##(1994-5#2)(2008-10#2)
iron or manganese##2##3##(2008-10#2)
iron overload##5##2##(1995-8#3)(2009-8#1)(2012-2#1)
iron oxide##10##2##(2008-10#4)(2008-11#1)(2012-12#2)(2012-2#2)(2013-1#1)
iron phosphide##3##2##(2008-11#3)
iron phthalocyanine##2##2##(2008-10#2)
iron production process##2##3##(2008-10#2)
iron production##3##2##(2008-10#3)
iron reduction##2##2##(2008-10#1)(2009-8#1)
iron saccharate##2##2##(2008-1#2)
iron samples##3##2##(2008-10#2)(2008-11#1)
iron speciation##3##2##(2008-10#3)
iron species##2##2##(2008-10#2)
iron stores##2##2##(2008-1#1)(2008-5#1)
iron supplementation##4##2##(2008-1#4)
iron transport##4##2##(1993-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
iron uptake system##3##3##(1996-8#1)(1997-7#1)(2011-2#1)
iron uptake##5##2##(1996-2#1)(1996-8#1)(1997-7#2)(2011-2#1)
iron was##5##2##(1992-8#2)(2008-10#2)(2013-8#1)
iron were##5##2##(2008-10#5)
iron##463##1##(1990-11#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-6#3)(1991-9#1)(1992-3#2)(1992-8#8)(1993-11#6)(1993-2#3)(1993-8#6)(1994-5#8)(1995-3#1)(1995-6#1)(1995-8#3)(1996-12#4)(1996-2#10)(1996-8#2)(1997-7#5)(1997-8#1)(2008-1#19)(2008-10#283)(2008-11#15)(2008-5#11)(2008-7#1)(2008-8#2)(2009-8#5)(2009-9#5)(2010-11#1)(2011-2#12)(2012-12#4)(2012-2#15)(2013-1#3)(2013-7#3)(2013-8#15)
iron(II) and##4##2##(2008-10#4)
iron(II) in##4##2##(2008-10#4)
iron(II) phthalocyanine##2##2##(2008-10#2)
iron(II) with##2##2##(2008-10#2)
iron(II)##32##1##(2008-10#31)(2012-12#1)
iron(II)/iron(III)##3##1##(2008-10#3)
iron(III) and##20##2##(2008-10#20)
iron(III) at the##2##3##(2008-10#2)
iron(III) by##3##2##(2008-10#3)
iron(III) in the##3##3##(2008-10#3)
iron(III) in##5##2##(2008-10#5)
iron(III) oxide##3##2##(2008-10#3)
iron(III) solution##2##2##(2008-10#2)
iron(III) using##2##2##(2008-10#2)
iron(III) was##2##2##(2008-10#2)
iron(III) were##2##2##(2008-10#2)
iron(III) with##2##2##(2008-10#2)
iron(III)##84##1##(2008-10#84)
iron)##3##1##(2008-10#3)
iron-containing##2##1##(1996-12#2)
iron-deficiency anaemia##2##2##(1994-6#2)
iron-deficiency##3##1##(1993-5#1)(1994-6#2)
iron-poor##2##1##(1996-12#2)
iron-rich##3##1##(1996-12#1)(2008-10#2)
iron-sulfur##2##1##(1991-5#1)(2008-11#1)
ironic remark##2##2##(2008-11#2)
ironic##4##1##(1994-9#1)(2008-11#3)
irradiance and the##2##3##(2008-3#1)(2008-8#1)
irradiance and##8##2##(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2013-1#1)
irradiance are##2##2##(2008-2#1)(2008-3#1)
irradiance measurements##3##2##(2008-2#1)(2008-3#2)
irradiance##40##1##(1993-3#1)(2008-10#1)(2008-2#14)(2008-3#16)(2008-5#1)(2008-7#4)(2008-8#1)(2009-8#1)(2013-1#1)
irradiances##3##1##(2008-3#3)
irradiated at##4##2##(1991-2#1)(2008-10#2)(2010-1#1)
irradiated by a##3##3##(2008-11#2)(2008-3#1)
irradiated by##10##2##(2008-10#4)(2008-11#3)(2008-3#1)(2008-9#1)(2011-2#1)
irradiated cells##7##2##(1995-6#1)(2011-2#6)
irradiated for##2##2##(1997-3#1)(2013-1#1)
irradiated samples##2##2##(2008-10#2)
irradiated with UV light##2##4##(2008-11#2)
irradiated with UV##3##3##(2008-11#2)(2008-9#1)
irradiated with##13##2##(1993-9#1)(1994-8#1)(1996-6#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2009-7#1)(2012-3#1)(2013-1#1)
irradiated##80##1##(1991-2#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-8#1)(2008-10#20)(2008-11#7)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#6)(2009-7#4)(2010-1#1)(2010-11#1)(2011-2#11)(2012-3#1)(2013-1#4)
irradiating##2##1##(2008-5#1)(2008-9#1)
irradiation and##6##2##(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)
irradiation as well as##2##4##(2010-11#1)(2013-1#1)
irradiation at the same##2##4##(2008-8#1)(2012-2#1)
irradiation at the##3##3##(2008-8#1)(2011-2#1)(2012-2#1)
irradiation at##8##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-2#1)(2012-2#1)
irradiation by##4##2##(1994-11#1)(2008-10#2)(2008-3#1)
irradiation dose##4##2##(2008-10#3)(2008-5#1)
irradiation for##5##2##(1993-9#2)(1994-8#1)(2008-7#1)(2013-1#1)
irradiation from the##2##3##(2008-11#1)(2008-8#1)
irradiation from##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
irradiation had##3##2##(2008-10#2)(2008-8#1)
irradiation in##4##2##(1994-12#1)(1995-6#1)(2008-10#1)(2009-2#1)
irradiation induced##2##2##(2008-8#2)
irradiation is##5##2##(1990-9#1)(1995-6#1)(2008-10#2)(2012-2#1)
irradiation of cefazolin sodium##2##4##(2008-10#2)
irradiation of the##3##3##(1992-12#1)(2008-9#1)(2010-4#1)
irradiation of##14##2##(1990-5#1)(1991-8#1)(1992-12#1)(1993-9#1)(1994-11#1)(1996-3#1)(2008-10#3)(2008-8#1)(2008-9#2)(2010-4#1)(2012-2#1)
irradiation on##2##2##(2009-3#1)(2012-2#1)
irradiation power and##3##3##(2008-10#3)
irradiation power##4##2##(2008-10#4)
irradiation prior to##2##3##(2008-10#1)(2009-7#1)
irradiation time of##3##3##(2008-10#3)
irradiation time##15##2##(2008-10#12)(2008-8#1)(2009-3#1)(2011-2#1)
irradiation times##5##2##(2008-10#4)(2008-7#1)
irradiation to##6##2##(2008-10#4)(2008-7#1)(2009-7#1)
irradiation using##2##2##(1993-9#1)(2012-2#1)
irradiation was used##2##3##(2008-10#2)
irradiation was##11##2##(1990-8#1)(1994-11#1)(1994-12#1)(1995-6#2)(1995-8#3)(2008-10#3)
irradiation were##3##2##(2008-10#2)(2008-9#1)
irradiation with##12##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)
irradiation##215##1##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-4#1)(1992-6#1)(1993-8#1)(1993-9#7)(1994-11#4)(1994-12#3)(1994-8#1)(1995-11#1)(1995-6#9)(1995-8#4)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#3)(2007-12#1)(2008-10#84)(2008-11#12)(2008-3#9)(2008-5#6)(2008-7#8)(2008-8#10)(2008-9#7)(2009-11#1)(2009-2#3)(2009-3#3)(2009-7#4)(2009-8#1)(2010-10#3)(2010-11#1)(2010-4#1)(2011-2#4)(2012-2#6)(2012-3#1)(2013-1#3)
irradiation-hydride##2##1##(2008-10#2)
irradiations##2##1##(2013-1#2)
irrational beliefs##5##2##(2010-5#5)
irrational##7##1##(2008-11#1)(2010-5#6)
irreducible##4##1##(2008-10#1)(2009-8#1)(2011-2#2)
irregular##26##1##(1991-2#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#5)(2013-1#4)
irregulare group I##2##3##(2008-10#2)
irregulare group IV##2##3##(2008-10#2)
irregulare group##4##2##(2008-10#4)
irregulare sensu stricto##2##3##(2008-10#2)
irregulare sensu##3##2##(2008-10#3)
irregulare##18##1##(2008-10#16)(2010-10#2)
irregularities and##2##2##(2008-10#1)(2008-4#1)
irregularities##3##1##(2008-10#1)(2008-4#1)(2011-3#1)
irregularity##5##1##(2008-11#1)(2008-9#1)(2011-2#2)(2013-8#1)
irregularly shaped##5##2##(2008-10#4)(2008-5#1)
irregularly##8##1##(2008-10#6)(2008-5#1)(2011-2#1)
irrelevant to the##2##3##(1992-5#1)(2008-11#1)
irrelevant to##3##2##(1992-5#1)(2008-11#2)
irrelevant##14##1##(1990-12#1)(1991-2#1)(1992-5#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
irreproducible##2##1##(2008-10#2)
irresistible##2##1##(1991-3#2)
irrespective of its##2##3##(2008-10#1)(2013-1#1)
irrespective of site##2##3##(2008-7#1)(2013-1#1)
irrespective of the fungal inoculum density##4##6##(2008-10#4)
irrespective of the##23##3##(1995-9#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-9#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
irrespective of their##4##3##(1994-1#1)(1996-12#1)(2008-10#1)(2012-4#1)
irrespective of whether it was##2##5##(2008-10#1)(2008-11#1)
irrespective of whether##4##3##(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)
irrespective of##58##2##(1990-9#1)(1992-6#1)(1993-11#1)(1994-1#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-12#3)(2008-10#19)(2008-11#10)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-4#1)(2013-1#3)
irreversible and##7##2##(1991-5#1)(1995-9#1)(2008-10#5)
irreversible binding of##3##3##(1991-3#1)(2006-6#1)(2011-2#1)
irreversible changes##2##2##(2008-10#1)(2010-1#1)
irreversible cyclic voltammograms and##2##4##(2008-10#2)
irreversible cyclic voltammograms##3##3##(2008-10#3)
irreversible damage##2##2##(2008-11#1)(2008-5#1)
irreversible inhibitor of##2##3##(1990-2#1)(1992-3#1)
irreversible oxidation##3##2##(2008-10#3)
irreversible vegetation##3##2##(2008-8#3)
irreversible##73##1##(1990-12#1)(1990-2#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-3#1)(1997-7#1)(2006-6#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
irreversibly##11##1##(1991-2#1)(1991-4#3)(1991-5#1)(1996-5#1)(2008-10#5)
irrigants to##2##2##(2012-3#1)(2013-1#1)
irrigants##6##1##(2012-3#1)(2013-1#5)
irrigated with saline water##3##4##(2008-10#3)
irrigated with saline##4##3##(2008-10#3)(2013-1#1)
irrigated with##8##2##(2008-10#6)(2013-1#2)
irrigated##13##1##(2008-10#11)(2013-1#2)
irrigation and##7##2##(2008-10#7)
irrigation method##2##2##(2008-10#2)
irrigation methods##6##2##(2008-10#6)
irrigation of##2##2##(2012-3#1)(2013-8#1)
irrigation regime##3##2##(2008-10#3)
irrigation season##3##2##(2008-10#3)
irrigation systems##6##2##(2008-10#6)
irrigation than under##3##3##(2008-10#3)
irrigation water in##2##3##(2008-10#2)
irrigation water##17##2##(2008-10#17)
irrigation were##3##2##(2008-10#2)(2013-8#1)
irrigation with##4##2##(2008-10#3)(2012-3#1)
irrigation##97##1##(2008-10#92)(2012-3#3)(2013-8#2)
irrigation)##4##1##(2008-10#3)(2012-9#1)
irritability##7##1##(1993-2#1)(2008-11#1)(2009-5#1)(2009-7#2)(2011-1#1)(2013-8#1)
irritable bowel syndrome##4##3##(1995-10#1)(2010-12#1)(2013-1#2)
irritable bowel##5##2##(1995-10#1)(2010-12#1)(2013-1#3)
irritable##6##1##(1995-10#1)(2008-4#1)(2010-12#1)(2013-1#3)
irritancy and##2##2##(2008-10#1)(2008-5#1)
irritancy##3##1##(2008-10#1)(2008-5#2)
irritant capacity of##2##3##(2008-5#2)
irritant capacity##4##2##(2008-5#4)
irritant dermatitis##2##2##(2008-5#2)
irritant gas##2##2##(1996-12#2)
irritant##12##1##(1992-3#1)(1996-12#2)(2008-5#9)
irritants##3##1##(1994-3#1)(2008-5#2)
irritated##3##1##(2008-5#3)
irritating##2##1##(2008-5#2)
irritation and##2##2##(2008-10#1)(2011-3#1)
irritation is##2##2##(2008-11#1)(2008-5#1)
irritation or##2##2##(2008-10#2)
irritation potential of##5##3##(2008-5#5)
irritation potential##7##2##(2008-5#7)
irritation##36##1##(1992-6#1)(1993-6#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-5#23)(2009-11#1)(2011-3#3)
is &gt##6##2##(1993-8#1)(2008-1#1)(2008-10#3)(2013-1#1)
is &lt##7##2##(2008-10#6)(2013-1#1)
is &quot##9##2##(1990-11#1)(1991-3#1)(1994-2#1)(1995-1#1)(1995-3#1)(2008-11#2)(2009-10#1)(2009-7#1)
is (6##2##2##(2008-10#2)
is (MY(2-))##2##2##(2008-10#2)
is -0##2##2##(2008-10#2)
is -1##2##2##(2008-10#2)
is 0##125##2##(1991-3#1)(1992-4#2)(1993-8#2)(1994-5#2)(1995-2#1)(1996-5#1)(2008-10#101)(2008-11#2)(2008-9#2)(2009-5#1)(2011-3#3)(2013-1#1)(2013-8#6)
is 1##64##2##(1991-9#1)(1992-3#1)(1992-9#1)(2008-10#51)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#2)(2013-8#2)
is 10##8##2##(2008-10#6)(2008-11#1)(2008-7#1)
is 100##2##2##(2008-10#2)
is 100% identical to the##2##5##(1995-9#2)
is 100%##3##2##(1990-9#1)(1995-9#2)
is 1000##2##2##(2008-10#1)(2010-1#1)
is 11##3##2##(1993-3#1)(1994-1#1)(2008-11#1)
is 12##5##2##(1994-6#1)(2008-1#1)(2008-10#3)
is 15 s##2##3##(2008-10#2)
is 15##5##2##(1994-2#1)(2007-12#1)(2008-10#3)
is 2 ng ml(-1)##2##4##(2008-10#2)
is 2 orders of magnitude##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
is 2##52##2##(1992-3#1)(1992-4#2)(1993-8#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#39)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
is 2-6##2##2##(2008-10#2)
is 20##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
is 21##2##2##(1990-7#1)(2008-11#1)
is 29##2##2##(1994-3#1)(1995-6#1)
is 3##26##2##(1992-12#1)(1996-5#1)(2007-12#1)(2008-10#21)(2008-8#2)
is 30##3##2##(2008-10#3)
is 35##2##2##(2008-10#1)(2008-11#1)
is 38##2##2##(1995-6#1)(2008-10#1)
is 4##18##2##(1993-2#1)(1994-12#1)(2008-10#12)(2008-7#2)(2008-9#1)(2010-5#1)
is 40##3##2##(1991-12#1)(2008-3#1)(2011-2#1)
is 5##23##2##(1993-8#1)(1994-9#1)(2008-10#17)(2008-5#1)(2010-5#1)(2012-2#1)(2012-3#1)
is 5%##2##2##(1996-11#1)(2011-2#1)
is 50##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
is 6##11##2##(1996-3#1)(1997-9#1)(2008-10#8)(2011-2#1)
is 7##7##2##(1991-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
is 78##3##2##(2007-12#1)(2011-3#1)(2012-12#1)
is 8##8##2##(1990-5#1)(2008-10#6)(2008-8#1)
is 80##3##2##(2008-10#2)(2008-8#1)
is 9##6##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-7#1)
is 92%##2##2##(2008-10#1)(2008-9#1)
is A##3##2##(2008-10#2)(2008-8#1)
is Ca(2+)-dependent##2##2##(1995-11#1)(2008-8#1)
is Pseudomonas syringae##2##3##(2008-10#1)(2009-8#1)
is a 1##2##3##(1997-3#1)(2008-5#1)
is a Gram-positive##3##3##(2011-2#3)
is a T-cell##2##3##(1995-1#1)(1995-12#1)
is a bacterial##2##3##(2008-12#1)(2013-8#1)
is a barrier to##2##4##(1994-3#1)(1996-3#1)
is a barrier##4##3##(1994-3#1)(1996-3#1)(2011-2#2)
is a basic##4##3##(1993-3#1)(1995-1#1)(2008-4#2)
is a benign##4##3##(1990-12#1)(1991-11#1)(2012-12#1)(2013-8#1)
is a better predictor##2##4##(1991-2#1)(2012-3#1)
is a better##5##3##(1991-2#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-8#1)
is a bibliographic##3##3##(1991-12#1)(2012-3#2)
is a bifunctional##3##3##(1990-8#1)(2008-10#2)
is a bioactive##2##3##(2008-10#1)(2009-3#1)
is a biochemical marker for##2##5##(1990-8#1)(2007-12#1)
is a biochemical##3##3##(1990-8#1)(1993-8#1)(2007-12#1)
is a biocontrol agent of##2##5##(2008-10#2)
is a biocontrol agent##3##4##(2008-10#3)
is a broad##2##3##(2008-12#1)(2010-8#1)
is a by-product of##2##4##(2008-10#1)(2008-8#1)
is a candidate for##4##4##(1995-12#1)(1996-2#1)(2008-10#2)
is a candidate##6##3##(1992-6#1)(1995-12#2)(1996-2#1)(2008-10#2)
is a case##7##3##(2008-1#2)(2008-12#2)(2009-1#1)(2011-2#1)(2012-3#1)
is a causative##2##3##(2008-12#1)(2008-7#1)
is a cause of##2##4##(1994-8#1)(2008-10#1)
is a cause##4##3##(1994-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
is a cell##2##3##(1992-12#1)(2008-11#1)
is a cellular##2##3##(1997-2#1)(2008-8#1)
is a central theme in##2##5##(2008-11#1)(2009-7#1)
is a central##7##3##(2008-1#1)(2008-11#2)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#1)
is a challenge##2##3##(2013-1#2)
is a challenging task##4##4##(2008-10#1)(2008-5#1)(2009-12#1)(2012-12#1)
is a challenging##7##3##(2008-10#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-12#1)
is a characteristic##4##3##(1996-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
is a cheap##2##3##(1993-3#1)(2008-10#1)
is a chemical##2##3##(2008-11#1)(2010-9#1)
is a chronic inflammatory##3##4##(1997-8#1)(2012-3#1)(2013-1#1)
is a chronic##18##3##(1990-3#1)(1995-12#1)(1997-8#4)(2008-5#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
is a classic##2##3##(2008-10#1)(2010-7#1)
is a classical##2##3##(2008-10#1)(2011-2#1)
is a clear##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
is a clinical condition##2##4##(2008-8#1)(2011-2#1)
is a clinical syndrome##2##4##(2008-10#1)(2012-3#1)
is a clinical##14##3##(1991-1#1)(1991-6#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#4)(2012-3#3)
is a close relationship between##2##5##(2008-8#1)(2011-2#1)
is a collection of##4##4##(1994-12#1)(1996-2#1)(2008-9#1)(2010-8#1)
is a combination of##4##4##(1997-4#1)(2008-3#2)(2010-11#1)
is a common and essential##2##5##(2008-2#1)(2012-2#1)
is a common and##5##4##(2008-10#1)(2008-2#1)(2008-9#2)(2012-2#1)
is a common cause of morbidity##2##6##(2009-8#1)(2011-2#1)
is a common cause of##4##5##(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
is a common component of##2##5##(2011-2#1)(2012-2#1)
is a common disease in##2##5##(2008-10#1)(2012-2#1)
is a common disorder##3##4##(1995-2#1)(1997-8#1)(2008-9#1)
is a common feature of##3##5##(1993-12#1)(2008-5#1)(2009-5#1)
is a common finding in##2##5##(1996-6#1)(2008-7#1)
is a common occurrence##3##4##(2008-11#1)(2010-7#1)(2011-2#1)
is a common problem in##4##5##(1993-2#1)(2008-5#1)(2008-6#1)(2008-9#1)
is a common problem##5##4##(1993-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)
is a common theme##2##4##(2008-5#1)(2009-8#1)
is a common##72##3##(1990-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#4)(2009-12#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#7)(2013-1#5)(2013-8#3)
is a commonly used##2##4##(2012-12#1)(2012-2#1)
is a commonly##4##3##(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
is a complex and##2##4##(1997-3#1)(2008-10#1)
is a complex disease##2##4##(2008-1#1)(2008-7#1)
is a complex of##3##4##(1992-9#1)(2008-10#2)
is a complex process and##2##5##(2008-10#1)(2008-7#1)
is a complex process in which##3##6##(2008-5#1)(2008-8#1)(2011-2#1)
is a complex process##5##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
is a complex##25##3##(1991-12#1)(1992-9#1)(1994-1#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
is a complicated process##2##4##(2008-7#1)(2012-2#1)
is a component of the##5##5##(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-7#1)
is a component of##10##4##(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#1)
is a component##12##3##(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2013-1#1)
is a composite##2##3##(2008-10#1)(2013-1#1)
is a concept that##2##4##(2008-10#1)(2008-11#1)
is a concept##4##3##(2008-10#1)(2008-11#1)(2010-10#1)(2010-8#1)
is a concern##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
is a condition in which##3##5##(2010-1#1)(2010-12#1)(2010-5#1)
is a condition##8##3##(1997-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a consensus##2##3##(1993-12#1)(2011-2#1)
is a consequence of##5##4##(1991-3#1)(2008-10#2)(2010-6#1)(2011-2#1)
is a considerable##7##3##(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-3#1)
is a constant##5##3##(2008-10#3)(2008-11#1)(2008-9#1)
is a continued##2##3##(2008-9#1)(2010-12#1)
is a continuous##2##3##(1997-2#1)(2011-2#1)
is a contributory factor##2##4##(2008-11#1)(2008-12#1)
is a convenient##2##3##(2008-1#1)(2008-9#1)
is a core##2##3##(2008-11#1)(2012-3#1)
is a critical component##2##4##(2008-10#1)(2008-7#1)
is a critical factor in##2##5##(1993-1#1)(2008-10#1)
is a critical factor##3##4##(1993-1#1)(2008-10#1)(2008-8#1)
is a critical step##2##4##(2008-10#1)(2008-11#1)
is a critical##19##3##(1993-1#1)(1994-2#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
is a crucial factor for##2##5##(2009-10#1)(2012-3#1)
is a crucial part of##2##5##(2008-10#1)(2008-12#1)
is a crucial##6##3##(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-3#1)
is a cumulative process##2##4##(2008-10#1)(2011-2#1)
is a cumulative##3##3##(2008-10#2)(2011-2#1)
is a cytokine that##2##4##(1995-6#1)(2009-7#1)
is a cytokine##3##3##(1994-11#1)(1995-6#1)(2009-7#1)
is a decrease in##4##4##(1990-11#1)(2008-10#1)(2011-2#2)
is a demanding##2##3##(1991-2#1)(2008-9#1)
is a description of##2##4##(1992-1#1)(2008-9#1)
is a descriptive##3##3##(2008-11#1)(2010-9#1)(2013-1#1)
is a desirable goal##2##4##(1997-2#1)(2010-12#1)
is a desirable##3##3##(1992-1#1)(1997-2#1)(2010-12#1)
is a destructive disease of##4##5##(2008-10#4)
is a destructive disease##5##4##(2008-10#5)
is a destructive##6##3##(2008-10#5)(2013-8#1)
is a devastating complication##2##4##(2008-8#1)(2011-2#1)
is a devastating disease##2##4##(2008-10#1)(2012-2#1)
is a devastating##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
is a diagnostic##4##3##(1991-6#1)(1996-11#1)(2008-10#1)(2008-4#1)
is a different##2##3##(2008-10#1)(2008-8#1)
is a difficult problem##3##4##(2008-10#2)(2010-6#1)
is a difficult task##3##4##(1990-9#1)(2008-5#1)(2008-7#1)
is a difficult##7##3##(1990-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)
is a direct##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
is a discussion of##4##4##(1991-2#1)(2008-9#3)
is a discussion##5##3##(1991-2#1)(2008-12#1)(2008-9#3)
is a disease of##4##4##(1991-6#1)(2008-10#2)(2011-2#1)
is a disease##10##3##(1991-6#1)(1992-9#1)(2008-10#4)(2008-11#1)(2008-7#2)(2011-2#1)
is a disorder##2##3##(2008-1#1)(2008-7#1)
is a distinct member##2##4##(2008-10#2)
is a distinct possibility##2##4##(1991-3#1)(2008-10#1)
is a distinct##10##3##(1990-12#1)(1991-3#1)(2008-10#5)(2008-7#1)(2011-2#1)(2012-2#1)
is a doctor##2##3##(1994-1#1)(2013-1#1)
is a dopamine##2##3##(2008-10#1)(2008-7#1)
is a double##2##3##(2008-1#1)(2008-3#1)
is a drug##2##3##(2008-10#2)
is a family of##2##4##(2008-8#1)(2009-10#1)
is a family##3##3##(2008-8#1)(2009-10#1)(2013-1#1)
is a fast and##2##4##(2008-10#1)(2008-9#1)
is a fast##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
is a feasible##3##3##(2008-10#1)(2008-8#1)(2010-6#1)
is a first step toward##2##5##(1997-7#1)(2010-12#1)
is a first step##3##4##(1997-2#1)(1997-7#1)(2010-12#1)
is a first##5##3##(1994-2#1)(1997-2#1)(1997-7#1)(2010-12#1)(2013-1#1)
is a flexible##2##3##(1996-12#1)(2008-9#1)
is a focus of##2##4##(1991-1#1)(2009-3#1)
is a form of##3##4##(1994-3#1)(2008-10#2)
is a frequent complication in##2##5##(2008-5#1)(2012-3#1)
is a frequent complication of##2##5##(2008-1#1)(2009-9#1)
is a frequent complication##4##4##(2008-1#1)(2008-5#1)(2009-9#1)(2012-3#1)
is a frequent##11##3##(1995-10#1)(2008-1#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
is a frequently##2##3##(2011-2#1)(2013-8#1)
is a function of charges involved in the formation reaction##3##10##(2008-10#3)
is a function of the density of##2##7##(2008-10#2)
is a function of the##10##5##(1994-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)
is a function of##19##4##(1994-12#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2012-2#1)
is a fundamental component of##2##5##(2008-10#1)(2008-11#1)
is a fundamental component##3##4##(2008-10#1)(2008-11#2)
is a fundamental##11##3##(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-11#1)
is a fungal##2##3##(2008-5#1)(2011-2#1)
is a general feature of##3##5##(1997-3#1)(1997-7#1)(2011-1#1)
is a general##11##3##(1992-12#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
is a generalized##2##3##(2008-4#1)(2008-9#1)
is a generally##2##3##(2008-5#1)(2008-9#1)
is a genetic##3##3##(2008-2#1)(2009-4#1)(2010-7#1)
is a genetically##4##3##(2008-11#2)(2009-3#1)(2013-1#1)
is a global##4##3##(2008-1#1)(2008-8#1)(2012-12#1)(2013-8#1)
is a glycoprotein and##3##4##(1991-9#1)(1993-11#1)(1994-8#1)
is a glycosylated##2##3##(1992-10#1)(1993-6#1)
is a good alternative to traditional##2##6##(1994-9#1)(2010-4#1)
is a good alternative##3##4##(1994-9#1)(2010-4#1)(2013-1#1)
is a good candidate for##3##5##(1992-6#1)(1993-9#1)(1996-12#1)
is a good candidate##5##4##(1992-6#1)(1993-9#1)(1996-12#1)(2010-5#1)(2013-8#1)
is a good indicator of##2##5##(2008-10#1)(2008-12#1)
is a good##28##3##(1990-3#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-9#1)(1995-9#1)(1996-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
is a great##6##3##(1994-9#1)(1996-6#1)(2008-10#2)(2008-12#1)(2011-2#1)
is a group of##2##4##(2008-10#1)(2012-3#1)
is a growing##13##3##(1994-3#1)(1996-1#1)(2008-11#2)(2008-12#2)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
is a hallmark##4##3##(1991-2#1)(2008-11#1)(2009-8#1)(2013-8#1)
is a heterogeneous##5##3##(1995-2#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
is a high priority##2##4##(1994-2#1)(2008-1#1)
is a high##11##3##(1994-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2012-2#1)
is a higher##4##3##(1996-3#1)(2008-10#1)(2009-1#1)(2011-2#1)
is a highly conserved and##2##5##(1994-11#1)(1997-4#1)
is a highly conserved##4##4##(1994-11#1)(1994-2#1)(1997-4#1)(2009-7#1)
is a highly effective##2##4##(2011-2#1)(2012-3#1)
is a highly sensitive##2##4##(2008-10#1)(2010-5#1)
is a highly##24##3##(1993-8#1)(1994-11#1)(1994-2#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-3#2)
is a homologue of##2##4##(1995-2#1)(1997-7#1)
is a host##2##3##(2008-10#2)
is a huge##2##3##(1995-12#1)(2012-12#1)
is a human##2##3##(1995-2#1)(2009-7#1)
is a key determinant##2##4##(2008-10#1)(2008-11#1)
is a key enzyme in##2##5##(1990-2#1)(2008-9#1)
is a key enzyme##4##4##(1990-2#1)(1993-6#1)(2008-11#1)(2008-9#1)
is a key factor in the##3##6##(2008-10#1)(2013-1#1)(2013-8#1)
is a key factor in##7##5##(1996-1#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
is a key factor##9##4##(1996-1#1)(2008-1#1)(2008-10#3)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
is a key process##2##4##(2008-10#1)(2010-8#1)
is a key regulator of##2##5##(2008-11#1)(2012-2#1)
is a key regulatory component##2##5##(1993-12#1)(2008-10#1)
is a key step in##2##5##(2008-11#1)(2011-2#1)
is a key##46##3##(1990-2#1)(1991-2#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1996-1#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
is a known complication of##3##5##(2008-12#1)(2012-2#1)(2013-1#1)
is a known##8##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a lack of data##2##5##(2008-11#1)(2010-10#1)
is a lack of##12##4##(1994-6#1)(1995-2#1)(2008-11#6)(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#1)
is a large##6##3##(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#3)
is a leading cause of blindness##2##6##(2008-1#1)(2010-10#1)
is a leading cause of death##2##6##(2008-10#1)(2011-2#1)
is a leading cause of##9##5##(1993-3#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-7#1)(2011-2#3)(2013-1#1)
is a leading risk factor for##2##6##(2011-2#1)(2012-3#1)
is a leading##12##3##(1993-3#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#1)
is a learning##2##3##(2009-5#1)(2011-2#1)
is a lethal##2##3##(1993-3#1)(2010-7#1)
is a life-threatening complication of##2##5##(2010-10#1)(2011-2#1)
is a life-threatening complication##3##4##(2010-10#1)(2011-2#1)(2011-3#1)
is a life-threatening disease##2##4##(2008-11#1)(2011-2#1)
is a life-threatening##7##3##(1993-2#1)(2008-11#1)(2010-10#1)(2011-2#3)(2011-3#1)
is a ligand for##2##4##(1990-5#1)(2008-9#1)
is a ligand##3##3##(1990-5#1)(1992-3#1)(2008-9#1)
is a linear function of##3##5##(2008-10#2)(2008-8#1)
is a linear##5##3##(2008-10#4)(2008-8#1)
is a little##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
is a long process##3##4##(1996-2#1)(2008-11#1)(2008-8#1)
is a long##5##3##(1996-2#1)(2006-6#1)(2008-11#1)(2008-8#1)(2009-8#1)
is a main source of##2##5##(2008-12#1)(2013-1#1)
is a main##3##3##(2008-12#1)(2008-9#1)(2013-1#1)
is a major cause of morbidity and mortality in##2##9##(2008-12#1)(2009-12#1)
is a major cause of morbidity##3##6##(2008-12#1)(2008-2#1)(2009-12#1)
is a major cause of##7##5##(2008-1#1)(2008-12#1)(2008-2#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
is a major cause##8##4##(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
is a major component in##2##5##(1992-6#1)(2008-12#1)
is a major component of the##4##6##(1990-9#1)(1995-12#1)(1997-2#1)(2008-11#1)
is a major component of##7##5##(1990-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
is a major component##10##4##(1990-9#1)(1992-6#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
is a major concern in##2##5##(2008-10#1)(2012-3#1)
is a major concern##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
is a major contributor to##2##5##(2008-1#1)(2011-9#1)
is a major disease of##2##5##(2008-10#2)
is a major disease##5##4##(2008-10#5)
is a major environmental##2##4##(2009-3#1)(2011-2#1)
is a major factor##3##4##(1994-5#1)(1996-3#1)(2008-8#1)
is a major health problem in##2##6##(2010-8#1)(2013-1#1)
is a major mechanism##2##4##(2008-11#1)(2008-4#1)
is a major problem in##2##5##(1991-9#1)(2008-10#1)
is a major public health concern##2##6##(2008-11#1)(2013-1#1)
is a major public health##4##5##(2008-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
is a major site of##2##5##(1994-11#1)(2008-1#1)
is a major##81##3##(1990-11#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-1#3)(2008-10#19)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)
is a marked##3##3##(1992-3#1)(1997-7#1)(2008-9#1)
is a matter of##2##4##(2008-7#1)(2009-5#1)
is a matter##3##3##(2008-1#1)(2008-7#1)(2009-5#1)
is a measure of the##2##5##(2008-10#2)
is a measure of##5##4##(2008-10#3)(2008-11#1)(2009-3#1)
is a measure##7##3##(2008-10#4)(2008-11#1)(2009-3#1)(2009-6#1)
is a mediator of##2##4##(1995-2#1)(2008-11#1)
is a medical##3##3##(1996-5#1)(2010-12#1)(2012-3#1)
is a member of a family of##2##7##(1992-3#1)(1995-8#1)
is a member of a##5##5##(1992-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(2008-11#1)
is a member of the##9##5##(1993-3#1)(1996-12#2)(1997-7#2)(2008-10#2)(2011-2#2)
is a member of##15##4##(1992-3#1)(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#3)(1997-7#2)(2008-10#3)(2008-11#1)(2011-2#2)
is a metabolically##2##3##(2008-10#2)
is a method of##4##4##(1995-3#1)(1997-6#1)(2010-6#1)(2011-2#1)
is a mixture of##3##4##(1992-11#1)(1996-12#1)(2008-10#1)
is a model for##3##4##(1990-5#1)(1995-12#1)(2010-8#1)
is a model of##2##4##(2008-9#1)(2011-2#1)
is a model system for##2##5##(2008-10#1)(2012-3#1)
is a model system##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
is a model##11##3##(1990-5#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)
is a modification of the##3##5##(2008-10#1)(2008-11#1)(2012-2#1)
is a more efficient##2##4##(1990-11#1)(2008-10#1)
is a more important##2##4##(2008-12#1)(2008-9#1)
is a more potent##2##4##(1991-5#1)(1993-8#1)
is a more##18##3##(1990-11#1)(1991-5#1)(1992-3#1)(1993-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2013-1#1)
is a much##4##3##(1993-3#1)(1996-12#1)(2008-10#2)
is a multi-step process##2##4##(2008-11#1)(2008-7#1)
is a multidisciplinary##2##3##(2010-5#1)(2011-2#1)
is a multidomain##2##3##(1994-5#1)(2009-6#1)
is a multifunctional##4##3##(1995-8#1)(2007-12#1)(2008-5#1)(2010-5#1)
is a multisystem##3##3##(1997-8#1)(2008-9#1)(2012-3#1)
is a must##3##3##(1995-11#1)(2008-7#1)(2010-8#1)
is a narrow##2##3##(2008-10#1)(2008-11#1)
is a natural##8##3##(1993-3#1)(2008-1#1)(2008-10#3)(2008-6#1)(2011-2#1)(2013-1#1)
is a naturally occurring##2##4##(2008-5#1)(2008-7#1)
is a necessary step for##2##5##(1994-1#1)(2012-2#1)
is a necessary##7##3##(1994-1#1)(1997-1#1)(2008-11#1)(2008-8#2)(2010-4#1)(2012-2#1)
is a necessity##2##3##(2008-11#1)(2011-3#1)
is a necrotrophic##2##3##(2008-10#2)
is a need for a##2##5##(1997-6#1)(2011-2#1)
is a need for development of##2##6##(2009-8#1)(2011-1#1)
is a need for##21##4##(1993-12#1)(1995-2#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
is a need to develop##4##5##(2008-10#1)(2008-5#1)(2012-2#2)
is a need to improve##2##5##(2010-5#1)(2011-2#1)
is a need to increase##2##5##(2008-1#1)(2012-3#1)
is a need to##23##4##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
is a need##45##3##(1993-12#1)(1995-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
is a negative##2##3##(2009-6#1)(2012-2#1)
is a neurological##3##3##(2008-11#1)(2008-7#1)(2010-8#1)
is a neuropeptide##2##3##(1996-2#1)(2008-5#1)
is a neutral##2##3##(1994-8#1)(2008-9#1)
is a new and##2##4##(2008-6#1)(2012-3#1)
is a new class of##2##5##(1991-9#1)(2008-10#1)
is a new member of the genus##2##7##(2008-10#2)
is a new member of the##3##6##(2008-10#2)(2009-3#1)
is a new species in the genus##2##7##(2008-10#2)
is a new technique##3##4##(1991-9#1)(2008-1#1)(2012-2#1)
is a new therapeutic##2##4##(1993-11#1)(2013-8#1)
is a new##38##3##(1990-8#1)(1991-9#2)(1993-11#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-3#1)(2010-8#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a newly discovered##2##4##(1992-8#1)(2007-11#1)
is a newly##4##3##(1992-8#1)(2007-11#1)(2008-10#2)
is a non-contact##2##3##(2009-7#1)(2013-1#1)
is a noninvasive##4##3##(1993-1#1)(1993-11#1)(2010-9#1)(2011-2#1)
is a normal component of##2##5##(2008-10#1)(2008-11#1)
is a normal##5##3##(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)
is a novel apoptosis-inducing gene##2##5##(2008-8#1)(2008-9#1)
is a novel gene##2##4##(2008-10#1)(2008-9#1)
is a novel member of the##2##6##(2008-10#1)(2013-1#1)
is a novel technique##2##4##(2009-6#1)(2012-2#1)
is a novel##31##3##(1991-5#1)(1993-1#1)(1995-6#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#2)
is a nuclear##3##3##(1996-2#1)(2008-1#1)(2008-11#1)
is a one##2##3##(1995-10#1)(1997-5#1)
is a parasitic##2##3##(2008-10#1)(2010-11#1)
is a part of the##14##5##(2008-10#1)(2010-6#1)(2010-8#1)(2011-2#11)
is a part of##15##4##(2008-10#2)(2010-6#1)(2010-8#1)(2011-2#11)
is a partial##2##3##(1995-11#1)(2008-4#1)
is a particularly##4##3##(2008-4#2)(2008-5#1)(2011-2#1)
is a paucity of##5##4##(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a pervasive##2##3##(2008-12#1)(2009-8#1)
is a phenomenon##2##3##(2008-11#1)(2013-7#1)
is a phospholipid##2##3##(1992-11#1)(2008-11#1)
is a pivotal##2##3##(1994-1#1)(2011-2#1)
is a plant##3##3##(1993-8#1)(2008-10#1)(2008-12#1)
is a plasma##2##3##(1995-2#1)(2009-10#1)
is a pleiotropic##2##3##(2008-4#1)(2008-9#1)
is a polygenic##2##3##(2010-5#1)(2012-3#1)
is a polypeptide##2##3##(1996-2#1)(2008-8#1)
is a porous##2##3##(2008-10#1)(2012-2#1)
is a positive##3##3##(1993-12#1)(2008-11#1)(2008-8#1)
is a possibility##4##3##(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
is a possible##7##3##(1992-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)(2013-1#2)
is a potent inducer of##4##5##(1992-8#1)(1993-3#1)(2008-11#1)(2011-2#1)
is a potent inhibitor of##5##5##(1992-12#1)(1994-11#1)(1997-1#1)(1997-4#2)
is a potent##30##3##(1990-2#1)(1990-6#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-3#2)(1993-8#2)(1994-11#3)(1994-2#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
is a potential cause of##2##5##(1997-6#1)(2008-7#1)
is a potential inducer of##2##5##(1992-3#1)(2008-10#1)
is a potential##18##3##(1992-3#1)(1993-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-4#1)(2012-2#3)(2012-3#1)(2013-1#1)
is a potentially fatal##2##4##(2009-11#1)(2011-2#1)
is a potentially serious##2##4##(2010-8#1)(2011-2#1)
is a potentially##12##3##(2008-10#1)(2008-11#2)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
is a powerful predictor##2##4##(2008-12#1)(2012-2#1)
is a powerful technique for##2##5##(1993-3#1)(2008-2#1)
is a powerful technique to##2##5##(2008-10#2)
is a powerful technique##4##4##(1993-3#1)(2008-10#2)(2008-2#1)
is a powerful tool for the##2##6##(2008-10#1)(2008-4#1)
is a powerful tool for##7##5##(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#1)
is a powerful tool to##2##5##(2008-11#1)(2008-4#1)
is a powerful tool##9##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)
is a powerful##19##3##(1993-3#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#1)(2009-8#1)(2012-2#1)
is a practical##6##3##(1991-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)
is a predictor of##2##4##(2008-12#1)(2011-2#1)
is a predictor##3##3##(2008-12#1)(2010-10#1)(2011-2#1)
is a prerequisite for##7##4##(1990-2#1)(1991-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2012-2#1)
is a prevalent##2##3##(2008-12#1)(2013-1#1)
is a previously undescribed##2##4##(2008-10#2)
is a previously##3##3##(2008-10#3)
is a primary##6##3##(1991-2#1)(1995-8#1)(2008-10#3)(2008-11#1)
is a priority##2##3##(2008-10#1)(2013-1#1)
is a problem in##2##4##(2008-10#1)(2008-11#1)
is a problem##8##3##(1996-5#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#1)
is a procedure in which a##2##6##(2008-5#1)(2012-3#1)
is a procedure##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
is a process that##2##4##(2011-2#2)
is a process##7##3##(1995-2#1)(1996-1#1)(2008-9#1)(2010-5#1)(2011-2#3)
is a program##2##3##(2008-4#2)
is a progressive##8##3##(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2013-7#1)
is a project##2##3##(2010-8#1)(2013-1#1)
is a prominent##4##3##(1994-11#1)(1996-12#1)(2009-10#1)(2011-2#1)
is a promising approach for##2##5##(2008-10#1)(2012-2#1)
is a promising approach##3##4##(2008-10#2)(2012-2#1)
is a promising cancer##2##4##(2008-11#1)(2012-2#1)
is a promising method for##2##5##(2008-10#2)
is a promising method##3##4##(1991-9#1)(2008-10#2)
is a promising technique for##2##5##(1991-9#1)(2008-10#1)
is a promising tool for##2##5##(2008-10#2)
is a promising##24##3##(1991-9#2)(1997-3#1)(2008-10#10)(2008-11#4)(2008-6#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)
is a prospective##4##3##(1995-2#1)(1996-6#1)(2008-10#1)(2008-8#1)
is a protective##2##3##(1996-12#1)(2011-2#1)
is a protein kinase##2##4##(1993-12#1)(2009-7#1)
is a protein of##2##4##(1994-11#1)(2008-8#1)
is a protein##6##3##(1993-12#1)(1994-11#1)(1995-6#1)(2008-8#1)(2009-7#2)
is a pseudogene##2##3##(1993-12#1)(1993-2#1)
is a public health problem##2##5##(2012-12#1)(2013-1#1)
is a public health##3##4##(2010-7#1)(2012-12#1)(2013-1#1)
is a public##4##3##(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#1)
is a putative##4##3##(1994-11#1)(2008-10#1)(2012-3#2)
is a qualitative and##2##4##(2012-3#1)(2013-1#1)
is a qualitative##3##3##(2012-3#2)(2013-1#1)
is a rapid and##2##4##(1991-12#1)(2011-2#1)
is a rapid##5##3##(1991-12#1)(1993-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
is a rapidly expanding##2##4##(2008-5#1)(2008-9#1)
is a rapidly##6##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-10#1)
is a rare and##3##4##(1993-6#1)(2011-2#1)(2013-1#1)
is a rare autosomal recessive##3##5##(1997-8#1)(2011-1#2)
is a rare autosomal##4##4##(1997-8#1)(2011-1#3)
is a rare benign##3##4##(2008-10#1)(2009-1#1)(2010-6#1)
is a rare but potentially life-threatening##2##6##(2008-8#1)(2013-8#1)
is a rare but##8##4##(1992-12#1)(1996-12#1)(2008-11#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
is a rare case of##2##5##(1990-5#1)(2012-2#1)
is a rare complication of##8##5##(2009-1#1)(2010-8#1)(2011-2#5)(2012-12#1)
is a rare complication##10##4##(2008-12#1)(2009-1#1)(2009-11#1)(2010-8#1)(2011-2#5)(2012-12#1)
is a rare condition that##2##5##(2009-1#1)(2013-1#1)
is a rare condition##8##4##(1990-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-5#1)(2013-1#3)
is a rare congenital anomaly##4##5##(1991-8#1)(2008-11#1)(2010-11#1)(2010-5#1)
is a rare congenital malformation##2##5##(2008-11#2)
is a rare congenital##7##4##(1991-8#1)(2008-10#1)(2008-11#3)(2010-11#1)(2010-5#1)
is a rare disease##11##4##(1992-12#1)(1993-6#2)(1996-3#1)(1997-5#1)(2008-12#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
is a rare disorder characterized by##2##6##(2010-1#1)(2010-7#1)
is a rare disorder##3##4##(2010-1#1)(2010-7#1)(2011-2#1)
is a rare entity with##2##5##(2008-10#1)(2010-12#1)
is a rare entity##7##4##(2008-10#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)
is a rare event##4##4##(2008-10#2)(2009-9#1)(2011-2#1)
is a rare form##2##4##(1994-5#1)(2011-2#1)
is a rare neoplasm##2##4##(2008-7#1)(2010-3#1)
is a rare phenomenon##2##4##(2008-10#1)(2011-2#1)
is a rare primary##2##4##(1993-3#1)(2010-6#1)
is a rare subtype of##3##5##(2008-12#1)(2009-12#1)(2012-3#1)
is a rare tumor##2##4##(2013-1#2)
is a rare variant of##3##5##(2008-12#1)(2009-10#1)(2013-1#1)
is a rare##131##3##(1990-12#2)(1990-5#2)(1991-11#1)(1991-8#1)(1992-12#2)(1993-3#1)(1993-6#3)(1994-5#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-8#3)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#4)(2008-12#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#20)(2012-12#5)(2012-2#3)(2012-3#6)(2013-1#17)(2013-7#1)(2013-8#2)
is a readily##2##3##(1995-2#1)(2013-1#1)
is a reasonable##4##3##(1991-1#1)(1991-9#1)(2008-10#1)(2009-10#1)
is a recently identified##2##4##(1997-1#1)(2009-10#1)
is a recently##5##3##(1997-1#1)(2008-10#2)(2009-10#1)(2013-1#1)
is a recognized##2##3##(2009-7#1)(2012-3#1)
is a relatively common##3##4##(2009-6#1)(2011-2#2)
is a relatively frequent##2##4##(1991-12#1)(2010-5#1)
is a relatively new technique##2##5##(2008-10#1)(2010-3#1)
is a relatively new##7##4##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-2#1)
is a relatively rare##2##4##(2012-2#1)(2013-1#1)
is a relatively uncommon##2##4##(2008-1#1)(2013-1#1)
is a relatively##28##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1994-12#1)(1994-6#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
is a reliable and valid measure of##2##7##(2010-9#1)(2013-1#1)
is a reliable and valid##3##5##(2010-10#1)(2010-9#1)(2013-1#1)
is a reliable and##5##4##(1992-12#1)(2008-12#1)(2010-10#1)(2010-9#1)(2013-1#1)
is a reliable##9##3##(1992-12#1)(2008-12#1)(2008-5#1)(2010-10#2)(2010-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
is a report of##2##4##(1991-12#1)(2008-10#1)
is a report##5##3##(1990-9#1)(1991-12#1)(1993-2#1)(2008-10#2)
is a representative of the##2##5##(2011-2#2)
is a representative of##3##4##(2011-2#3)
is a representative##4##3##(2010-8#1)(2011-2#3)
is a result of the##4##5##(1993-8#1)(1996-11#1)(2008-10#2)
is a result of##10##4##(1991-12#1)(1993-8#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)
is a retrospective##8##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#1)
is a review of the##4##5##(1991-1#1)(2008-11#2)(2008-12#1)
is a review of##5##4##(1991-1#1)(2008-11#2)(2008-12#1)(2008-7#1)
is a rich source of##2##5##(2008-5#1)(2008-9#1)
is a risk factor for##8##5##(1996-6#1)(2008-10#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#2)
is a risk##12##3##(1996-6#1)(1997-3#1)(2008-10#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-5#1)(2011-2#2)(2013-8#1)
is a routine##2##3##(2008-10#1)(2013-1#1)
is a safe and effective##4##5##(1993-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
is a safe and##8##4##(1993-1#1)(1993-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
is a safe##11##3##(1993-1#1)(1993-12#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
is a scientific##2##3##(2008-7#1)(2010-7#1)
is a selective##6##3##(1993-12#1)(2008-10#3)(2008-11#1)(2008-12#1)
is a sensitive##4##3##(1995-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
is a serious and##2##4##(2012-3#1)(2013-8#1)
is a serious complication##2##4##(2011-2#1)(2013-1#1)
is a serious disease of##7##5##(2008-10#7)
is a serious disease##9##4##(2008-10#8)(2011-2#1)
is a serious fungal disease##2##5##(2008-10#2)
is a serious fungal##3##4##(2008-10#3)
is a serious problem##5##4##(2008-10#3)(2008-11#1)(2008-7#1)
is a serious##33##3##(1991-6#1)(2008-10#19)(2008-11#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
is a set of##6##4##(1991-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)
is a severe disease##3##4##(2008-10#3)
is a severe##4##3##(2008-10#3)(2011-2#1)
is a sharp##2##3##(1995-6#1)(2010-12#1)
is a shift##2##3##(1996-2#1)(2010-12#1)
is a signal##2##3##(1994-12#1)(2008-5#1)
is a significant change in##2##5##(2008-11#1)(2008-3#1)
is a significant risk factor for##4##6##(1997-3#1)(2011-2#1)(2012-5#1)(2013-1#1)
is a significant time##2##4##(2008-9#1)(2010-5#1)
is a significant##25##3##(1994-2#1)(1994-3#1)(1997-1#1)(1997-3#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#2)(2012-5#1)(2013-1#1)
is a simple and##4##4##(2008-10#2)(2008-6#1)(2008-7#1)
is a simple##13##3##(1993-2#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#1)
is a simpler##2##3##(2008-10#2)
is a single##2##3##(2008-10#1)(2009-10#1)
is a single-copy gene##2##4##(1993-12#1)(1996-6#1)
is a site##2##3##(1995-11#1)(2012-2#1)
is a small##8##3##(1991-7#1)(1992-3#1)(1994-5#1)(2008-10#3)(2008-11#1)(2011-2#1)
is a socially##2##3##(1995-11#1)(2010-7#1)
is a soil-inhabiting##2##3##(2008-10#1)(2011-2#1)
is a soilborne pathogen##2##4##(2008-10#2)
is a soilborne##4##3##(2008-10#4)
is a solid##2##3##(2008-11#1)(2010-9#1)
is a source of##4##4##(2008-7#1)(2013-1#2)(2013-8#1)
is a special case##2##4##(2008-3#1)(2008-8#1)
is a special##3##3##(2008-3#1)(2008-8#1)(2012-3#1)
is a specific##12##3##(1990-2#1)(1995-11#1)(1997-2#1)(2008-11#4)(2008-7#1)(2010-6#1)(2012-2#2)(2013-1#1)
is a standard##4##3##(2008-11#2)(2008-9#1)(2011-2#1)
is a statistical##3##3##(2008-9#1)(2011-3#1)(2012-3#1)
is a step##2##3##(1995-2#1)(2012-2#1)
is a strong##15##3##(1991-9#1)(1993-2#1)(1994-11#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)
is a subjective##3##3##(2008-10#1)(2010-6#1)(2012-2#1)
is a substantial##3##3##(1997-7#1)(2010-1#1)(2013-8#1)
is a substrate for##4##4##(1991-5#1)(1992-7#2)(2009-3#1)
is a suitable alternative##2##4##(1996-1#1)(2008-3#1)
is a suitable method for##2##5##(2008-10#2)
is a suitable method##3##4##(2008-10#3)
is a suitable tool for studying##2##6##(1993-6#1)(2008-8#1)
is a suitable##13##3##(1993-6#1)(1995-2#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
is a summary of the##2##5##(1991-3#1)(2009-10#1)
is a superior##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
is a syndrome##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
is a system##2##3##(1993-3#1)(2008-11#1)
is a systemic disease##4##4##(1997-8#1)(2008-8#1)(2011-2#1)(2013-8#1)
is a systemic##7##3##(1997-8#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
is a target##2##3##(2008-11#1)(2011-1#1)
is a technique that##2##4##(2008-10#1)(2008-3#1)
is a technique used##2##4##(2008-7#1)(2012-2#1)
is a technique##7##3##(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
is a therapeutic##2##3##(2010-12#1)(2013-1#1)
is a thin##2##3##(2008-5#1)(2008-8#1)
is a time##3##3##(1990-3#1)(1993-12#2)
is a tool to##2##4##(2008-10#1)(2008-12#1)
is a transcriptional activator##2##4##(1997-3#1)(2008-9#1)
is a transcriptional##3##3##(1997-3#1)(2008-9#1)(2013-1#1)
is a transient##2##3##(2012-3#1)(2013-1#1)
is a transmembrane##3##3##(1993-12#2)(1996-12#1)
is a treatment option##2##4##(2012-3#1)(2013-1#1)
is a tumor##2##3##(1995-6#1)(2012-3#1)
is a two-stage##2##3##(1991-12#1)(2008-10#1)
is a type of##2##4##(2008-9#1)(2011-1#1)
is a type##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
is a typical##6##3##(1990-3#1)(2008-10#3)(2008-8#1)(2011-2#1)
is a ubiquitous##4##3##(1992-10#1)(1993-9#1)(2013-1#1)(2013-8#1)
is a unique feature##2##4##(2008-10#1)(2008-7#1)
is a unique##17##3##(1991-3#1)(1993-8#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
is a useful strategy for##2##5##(2008-10#1)(2010-10#1)
is a useful technique for##2##5##(2008-9#1)(2013-8#1)
is a useful technique##3##4##(2008-9#1)(2010-7#1)(2013-8#1)
is a useful tool for##3##5##(1995-11#1)(2008-10#1)(2008-5#1)
is a useful tool to##3##5##(2008-10#1)(2008-11#1)(2011-2#1)
is a useful tool##6##4##(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
is a useful##37##3##(1990-12#1)(1992-3#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-8#1)
is a valid alternative to##2##5##(1990-2#1)(1992-5#1)
is a valid alternative##4##4##(1990-2#1)(1992-5#1)(2008-10#1)(2008-7#1)
is a valid treatment for##2##5##(2011-3#1)(2013-1#1)
is a valid##8##3##(1990-2#1)(1992-5#1)(2008-10#1)(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
is a valuable tool for##4##5##(2008-3#1)(2008-6#1)(2008-9#2)
is a valuable tool##5##4##(2008-3#1)(2008-6#1)(2008-9#2)(2010-11#1)
is a valuable##12##3##(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-3#1)
is a variant of##2##4##(1992-2#1)(2010-7#1)
is a vascular disease##2##4##(2008-10#2)
is a vascular##7##3##(1997-3#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#1)
is a vertex shared with the##2##6##(2008-6#2)
is a very common##3##4##(2008-11#1)(2012-2#1)(2013-1#1)
is a very complex process that##2##6##(2011-2#1)(2013-1#1)
is a very complex process##3##5##(1992-9#1)(2011-2#1)(2013-1#1)
is a very complex##4##4##(1992-9#1)(2008-5#1)(2011-2#1)(2013-1#1)
is a very good##2##4##(2008-10#2)
is a very important##7##4##(1991-2#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a very rare##10##4##(1992-2#1)(1997-5#1)(1997-8#1)(2008-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
is a very sensitive##2##4##(2008-10#1)(2012-3#1)
is a very serious##3##4##(1995-3#1)(2012-12#1)(2012-3#1)
is a very useful##4##4##(1991-2#1)(1997-8#1)(2008-10#1)(2008-11#1)
is a very##52##3##(1991-2#2)(1992-12#1)(1992-2#1)(1992-9#2)(1995-3#1)(1995-5#1)(1996-3#1)(1997-5#1)(1997-8#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
is a viable option##2##4##(2008-10#1)(2009-10#1)
is a viable treatment##2##4##(2008-8#1)(2012-12#1)
is a viable##10##3##(2008-10#5)(2008-8#1)(2009-10#1)(2010-11#1)(2012-12#1)(2013-1#1)
is a viral disease##2##4##(2008-10#2)
is a viral##4##3##(1992-9#1)(1996-11#1)(2008-10#2)
is a vital##2##3##(2009-7#1)(2011-2#1)
is a way of##2##4##(2008-5#2)
is a way to##2##4##(2008-11#1)(2010-11#1)
is a way##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)
is a weak##3##3##(2008-11#1)(2009-5#1)(2010-3#1)
is a well established##2##4##(2008-11#1)(2012-12#1)
is a well known##4##4##(1993-11#1)(2008-11#1)(2008-4#1)(2010-11#1)
is a well##8##3##(1993-11#1)(1996-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)(2012-12#1)
is a well-established##2##3##(2008-3#1)(2008-9#1)
is a well-known##7##3##(1991-3#1)(2008-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
is a well-recognized##2##3##(2010-7#1)(2012-3#1)
is a wide##3##3##(1997-6#1)(2008-12#1)(2008-5#1)
is a widely used##7##4##(1995-8#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
is a widely##8##3##(1995-8#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a widespread disease##2##4##(2008-10#2)
is a widespread##6##3##(2008-10#5)(2011-2#1)
is a##2691##2##(1990-11#5)(1990-12#7)(1990-2#7)(1990-3#4)(1990-5#5)(1990-6#3)(1990-8#6)(1990-9#3)(1991-1#7)(1991-11#4)(1991-12#14)(1991-2#14)(1991-3#5)(1991-5#6)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#9)(1992-1#3)(1992-10#4)(1992-11#3)(1992-12#11)(1992-2#5)(1992-3#11)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#3)(1992-8#2)(1992-9#5)(1993-1#6)(1993-11#4)(1993-12#24)(1993-2#10)(1993-3#20)(1993-6#10)(1993-8#12)(1993-9#5)(1994-1#7)(1994-11#17)(1994-12#10)(1994-2#12)(1994-3#9)(1994-5#9)(1994-6#3)(1994-8#9)(1994-9#4)(1995-1#6)(1995-10#2)(1995-11#8)(1995-12#12)(1995-2#23)(1995-3#4)(1995-5#3)(1995-6#12)(1995-8#9)(1995-9#2)(1996-1#7)(1996-11#5)(1996-12#21)(1996-2#15)(1996-3#11)(1996-5#3)(1996-6#8)(1996-8#2)(1996-9#3)(1997-1#11)(1997-2#9)(1997-3#13)(1997-4#7)(1997-5#6)(1997-6#9)(1997-7#17)(1997-8#21)(2006-6#4)(2007-11#1)(2007-12#11)(2007-8#4)(2007-9#1)(2008-1#33)(2008-10#470)(2008-11#183)(2008-12#62)(2008-2#8)(2008-3#42)(2008-4#43)(2008-5#65)(2008-6#22)(2008-7#73)(2008-8#72)(2008-9#91)(2009-1#8)(2009-10#22)(2009-11#8)(2009-12#12)(2009-3#10)(2009-4#4)(2009-5#8)(2009-6#11)(2009-7#18)(2009-8#25)(2009-9#11)(2010-1#12)(2010-10#19)(2010-11#22)(2010-12#23)(2010-2#1)(2010-3#6)(2010-4#6)(2010-5#24)(2010-6#20)(2010-7#21)(2010-8#26)(2010-9#7)(2011-1#15)(2011-2#194)(2011-3#9)(2011-7#1)(2011-8#1)(2011-9#1)(2012-12#27)(2012-2#78)(2012-3#85)(2012-5#1)(2013-1#134)(2013-7#5)(2013-8#46)
is able to generate##2##4##(1994-3#1)(2008-6#1)
is able to induce##3##4##(2008-10#1)(2008-9#1)(2009-12#1)
is able to interact##2##4##(1994-5#1)(2009-8#1)
is able to recognize##2##4##(1995-8#1)(2009-8#1)
is able to reproduce##3##4##(1995-8#1)(2008-8#1)(2009-5#1)
is able to rescue the##2##5##(1993-9#1)(2008-11#1)
is able to##64##3##(1993-9#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-8#3)(1997-8#1)(2008-10#17)(2008-11#5)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-12#1)(2009-5#1)(2009-8#4)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#3)
is abnormal##2##2##(1990-6#1)(2010-6#1)
is about 0##3##3##(1993-8#1)(2008-10#2)
is about 1##7##3##(1992-5#1)(1992-8#1)(1993-8#1)(2008-10#3)(2008-8#1)
is about 10##4##3##(2008-10#4)
is about 2 months##2##4##(2008-10#2)
is about 2##3##3##(2008-10#3)
is about 90%##2##3##(1991-2#1)(2008-10#1)
is about the##2##3##(1994-5#1)(2013-8#1)
is about##56##2##(1990-11#3)(1991-2#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-8#2)(1994-5#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#31)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
is above##3##2##(1990-9#1)(2008-3#1)(2008-8#1)
is absent in other##2##4##(2008-10#1)(2008-3#1)
is absent in the##2##4##(1993-2#1)(2008-8#1)
is absent in##5##3##(1993-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
is absent##8##2##(1993-2#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-8#1)(2013-8#1)
is absorbed by##2##3##(2008-3#1)(2010-12#1)
is absorbed##5##2##(2008-10#2)(2008-3#1)(2010-12#1)(2012-2#1)
is abundant and##2##3##(1995-2#1)(2008-9#1)
is abundant##3##2##(1995-2#2)(2008-9#1)
is accelerated##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
is acceptable##8##2##(1990-9#1)(1991-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
is accepted##4##2##(2008-10#1)(2008-11#3)
is accessed##2##2##(2008-12#1)(2009-5#1)
is accessible and##2##3##(1993-11#1)(2008-7#1)
is accessible##4##2##(1993-11#1)(2008-12#1)(2008-7#1)(2010-8#1)
is accompanied by a##7##4##(1997-7#1)(2008-10#2)(2009-8#1)(2011-2#3)
is accompanied by an increase in##2##6##(2008-3#1)(2010-5#1)
is accompanied by an##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-5#1)
is accompanied by changes in##2##5##(1993-8#1)(1995-3#1)
is accompanied by increased##2##4##(1992-12#1)(1994-3#1)
is accompanied by the##3##4##(2008-10#1)(2009-8#1)(2012-3#1)
is accompanied by##32##3##(1992-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#2)(2009-8#6)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)
is accomplished by a##2##4##(2008-10#1)(2008-9#1)
is accomplished by##7##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)
is accomplished with##3##3##(2007-11#1)(2008-10#2)
is accomplished##17##2##(1994-2#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#3)(2008-9#1)(2010-4#1)
is accounted for by##2##4##(2008-1#1)(2008-10#1)
is accounted for##4##3##(2008-1#1)(2008-10#2)(2008-3#1)
is accumulated in the##2##4##(2008-12#1)(2008-7#1)
is accumulated##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
is accumulating##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
is accurate and##5##3##(2008-10#4)(2010-3#1)
is accurate##8##2##(1997-2#1)(2008-10#5)(2008-8#1)(2010-3#1)
is achievable##2##2##(1994-2#1)(2008-11#1)
is achieved and##2##3##(2008-11#1)(2008-9#1)
is achieved at##3##3##(2008-10#2)(2008-9#1)
is achieved by means of##4##5##(1991-12#1)(2008-10#2)(2008-12#1)
is achieved by the##3##4##(1992-1#1)(2008-10#2)
is achieved by##28##3##(1991-12#1)(1992-1#1)(1994-5#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
is achieved for##3##3##(2008-10#2)(2013-1#1)
is achieved from##2##3##(2008-10#1)(2010-7#1)
is achieved in##2##3##(2008-11#1)(2008-8#1)
is achieved over the##2##4##(1990-2#1)(2013-8#1)
is achieved through the##2##4##(1994-9#1)(2008-9#1)
is achieved through##4##3##(1994-9#1)(2007-12#1)(2008-9#1)(2010-4#1)
is achieved using##2##3##(2008-10#1)(2008-11#1)
is achieved with the##2##4##(2008-10#1)(2008-3#1)
is achieved with##7##3##(2008-10#3)(2008-3#3)(2012-2#1)
is achieved##77##2##(1990-2#1)(1991-12#1)(1992-1#1)(1994-5#1)(1994-8#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#35)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#8)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
is acknowledged##5##2##(1992-1#1)(2008-11#2)(2008-12#1)(2012-3#1)
is acquired in##2##3##(1997-1#1)(2008-10#1)
is acquired##6##2##(1990-9#1)(1997-1#1)(2008-10#2)(2008-3#1)(2009-3#1)
is acquiring Cantonese##2##3##(2008-9#2)
is activated by##12##3##(1990-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-5#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)
is activated in##4##3##(1991-9#1)(1992-12#1)(2008-11#1)(2013-1#1)
is activated when##2##3##(1995-8#1)(2008-10#1)
is activated##25##2##(1990-2#1)(1991-3#1)(1991-9#2)(1992-12#2)(1992-6#1)(1993-11#1)(1994-5#1)(1995-8#1)(1996-12#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-3#1)(2013-1#1)
is active against##2##3##(1990-8#1)(2008-10#1)
is active in##4##3##(1992-12#1)(1994-2#1)(2011-2#1)(2012-3#1)
is active##14##2##(1990-12#1)(1990-8#2)(1991-5#1)(1992-12#1)(1994-2#1)(1997-9#1)(2008-10#2)(2008-11#1)(2011-2#1)(2011-4#1)(2012-3#1)(2013-8#1)
is actively##4##2##(1990-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
is actual##2##2##(1995-9#1)(2012-3#1)
is actually##6##2##(1992-5#1)(2008-10#3)(2008-5#1)(2013-8#1)
is adapted to##3##3##(2007-12#1)(2009-10#1)(2013-8#1)
is added to the solution##2##5##(2008-10#2)
is added to the##6##4##(1991-3#1)(1992-12#1)(2008-10#4)
is added to##10##3##(1991-3#1)(1992-12#1)(1995-2#1)(2008-10#6)(2008-11#1)
is added##19##2##(1991-3#1)(1992-11#1)(1992-12#1)(1995-2#1)(2008-10#11)(2008-11#2)(2008-8#1)(2010-12#1)
is additive##2##2##(1990-2#1)(1991-5#1)
is addressed in##2##3##(2010-9#1)(2012-2#1)
is addressed##11##2##(1992-2#1)(1992-3#1)(2008-10#5)(2008-2#1)(2010-5#1)(2010-9#1)(2012-2#1)
is adequate for the##2##4##(2008-10#2)
is adequate for##6##3##(1991-6#1)(2008-10#4)(2008-9#1)
is adequate match of the screw diameter up with the pedicle diameter##2##12##(2007-11#2)
is adequate##12##2##(1991-6#2)(2007-11#2)(2008-10#7)(2008-9#1)
is adjusted##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
is administered in##2##3##(2008-10#2)
is administered##5##2##(1993-6#1)(2008-10#3)(2010-11#1)
is adopted##3##2##(2008-10#2)(2009-7#1)
is adsorbed##5##2##(1994-5#1)(2008-10#4)
is advanced##3##2##(1990-3#1)(1994-8#1)(2008-11#1)
is advantageous as it##2##4##(2008-2#1)(2008-7#1)
is advantageous for##2##3##(1995-12#1)(2008-2#1)
is advantageous in##2##3##(2009-10#1)(2010-9#1)
is advantageous##10##2##(1995-12#1)(1997-6#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-9#1)
is advisable##7##2##(1990-9#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
is advised##2##2##(1996-11#1)(2008-7#1)
is advocated##5##2##(1990-9#1)(1993-2#1)(1997-7#1)(1997-8#1)(2008-10#1)
is affected and##2##3##(2008-11#1)(2010-7#1)
is affected by a##2##4##(2008-11#1)(2008-9#1)
is affected by the##9##4##(1991-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)
is affected by##24##3##(1990-9#1)(1991-12#1)(1995-5#1)(1996-12#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
is affected##38##2##(1990-9#1)(1991-12#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-10#9)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
is again##3##2##(1992-6#1)(2006-6#1)(2009-11#1)
is aimed at##6##3##(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-12#1)(2012-2#1)
is aimed##7##2##(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-12#1)(2011-3#1)(2012-2#1)
is alive##4##2##(1990-2#1)(1990-9#1)(1991-6#1)(2010-9#1)
is all the more##3##4##(1991-3#1)(1992-3#1)(2008-10#1)
is all##5##2##(1991-3#1)(1992-3#1)(1996-1#1)(2008-10#1)(2011-2#1)
is allowed to##3##3##(2008-10#2)(2008-8#1)
is allowed##4##2##(2008-10#3)(2008-8#1)
is almost always##2##3##(2008-11#1)(2010-6#1)
is almost complete in##2##4##(2008-10#2)
is almost identical to the##2##5##(1995-9#1)(2009-8#1)
is almost the same as##2##5##(1995-12#1)(2008-2#1)
is almost##22##2##(1991-2#1)(1995-12#1)(1995-9#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-6#1)(2012-3#1)
is already a##2##3##(2008-10#1)(2010-7#1)
is already##15##2##(1990-12#1)(1992-11#1)(1993-1#1)(1994-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
is also a major##2##4##(2008-10#2)
is also a##27##3##(1990-11#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-6#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-3#1)
is also an important##2##4##(2008-5#1)(2008-8#1)
is also an increase in the##2##6##(2007-12#1)(2011-2#1)
is also an##7##3##(1996-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
is also applicable to##5##4##(2008-10#1)(2008-11#2)(2008-4#2)
is also applicable##6##3##(2008-10#2)(2008-11#2)(2008-4#2)
is also associated with increased##2##5##(1996-12#1)(2013-1#1)
is also associated with##7##4##(1991-12#1)(1996-12#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
is also associated##8##3##(1991-12#1)(1996-12#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
is also capable of##2##4##(2008-10#2)
is also capable##3##3##(2008-10#2)(2011-2#1)
is also carried##2##3##(2008-10#2)
is also common##2##3##(1997-1#1)(1997-8#1)
is also confirmed by##2##4##(1997-4#1)(2008-10#1)
is also considered##2##3##(2008-10#1)(2008-8#1)
is also consistent with the##2##5##(2008-5#1)(2008-8#1)
is also consistent with##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
is also demonstrated in##2##4##(2008-10#2)
is also demonstrated##3##3##(2007-12#1)(2008-10#2)
is also described##9##3##(1992-1#1)(2008-10#6)(2010-11#1)(2013-1#1)
is also detected in the##2##5##(1996-12#1)(2008-10#1)
is also detected##3##3##(1996-12#1)(1997-2#1)(2008-10#1)
is also determined##3##3##(1992-9#1)(2008-10#2)
is also discussed##25##3##(1991-2#1)(1991-8#1)(2008-10#14)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#1)
is also essential for##2##4##(1995-6#1)(2008-7#1)
is also essential##4##3##(1995-6#1)(1997-1#1)(2008-7#1)(2010-7#1)
is also evaluated##3##3##(1990-9#1)(2008-10#1)(2008-11#1)
is also given##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
is also highly##4##3##(1990-2#1)(1995-2#1)(2009-10#1)(2011-2#1)
is also implicated in##2##4##(1994-9#1)(2008-10#1)
is also important for##4##4##(1994-5#1)(1995-6#1)(2008-10#1)(2008-9#1)
is also important to##3##4##(1993-6#1)(2008-10#1)(2008-7#1)
is also important##12##3##(1992-3#1)(1993-6#1)(1994-5#1)(1995-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)
is also included##8##3##(1997-3#1)(2008-4#6)(2008-9#1)
is also increasing##3##3##(1995-11#1)(2008-8#1)(2013-1#1)
is also induced by##2##4##(1997-7#1)(2008-11#1)
is also investigated and##2##4##(2008-10#1)(2008-12#1)
is also investigated##8##3##(2008-10#4)(2008-12#1)(2008-3#2)(2010-4#1)
is also involved in##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
is also known##3##3##(1990-5#1)(2008-7#1)(2010-6#1)
is also made##2##3##(2008-10#1)(2008-5#1)
is also necessary for##2##4##(2008-9#1)(2009-8#1)
is also not##2##3##(2008-3#1)(2013-1#1)
is also of##5##3##(1990-2#1)(1993-11#1)(2008-9#1)(2011-2#2)
is also possible to##5##4##(1997-4#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-6#1)
is also possible##7##3##(1997-4#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)
is also present##2##3##(1997-7#1)(2008-10#1)
is also presented##21##3##(1993-6#1)(1995-6#1)(1997-2#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)
is also proposed##5##3##(1994-2#1)(2008-10#2)(2008-3#2)
is also provided##10##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-9#2)
is also regulated##2##3##(1993-11#1)(2008-9#1)
is also reported##6##3##(1991-5#1)(1992-9#1)(2008-10#4)
is also required for##3##4##(1995-2#1)(2008-10#1)(2013-7#1)
is also required##5##3##(1994-12#1)(1995-2#1)(2008-10#1)(2008-6#1)(2013-7#1)
is also responsible for##4##4##(1990-8#1)(1996-1#1)(2008-10#1)(2010-5#1)
is also seen in##2##4##(2009-12#1)(2009-9#1)
is also shown to##2##4##(1995-2#1)(2008-10#1)
is also shown##7##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-7#1)
is also significantly##2##3##(1990-8#1)(1993-3#1)
is also stressed##2##3##(2008-10#1)(2008-4#1)
is also studied##2##3##(2008-10#2)
is also suggested##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
is also suitable for##3##4##(2008-10#3)
is also supported by##3##4##(1994-12#1)(2008-1#1)(2008-10#1)
is also the first##2##4##(2008-10#1)(2009-1#1)
is also the major##2##4##(1995-6#1)(2012-2#1)
is also the##10##3##(1995-6#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#2)(2012-2#1)
is also under##2##3##(2008-10#1)(2008-11#1)
is also used as an##3##5##(2008-11#1)(2008-3#1)(2008-9#1)
is also used##8##3##(1992-5#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
is also useful##3##3##(1992-3#1)(1997-1#1)(2008-1#1)
is also very##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
is also well##2##3##(1990-3#1)(2008-3#1)
is also##409##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#3)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#6)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#3)(2008-1#4)(2008-10#106)(2008-11#17)(2008-12#9)(2008-2#4)(2008-3#19)(2008-4#21)(2008-5#10)(2008-6#5)(2008-7#5)(2008-8#16)(2008-9#17)(2009-1#2)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#17)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#2)
is altered and##2##3##(1994-9#1)(2008-8#1)
is altered in##3##3##(1992-6#1)(1994-8#1)(2008-7#1)
is altered##8##2##(1992-6#1)(1994-8#1)(1994-9#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-7#1)(2013-8#1)
is always a##2##3##(1991-3#1)(2008-6#1)
is always##20##2##(1991-3#1)(1994-2#1)(1995-1#1)(1995-9#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-12#1)(2011-2#1)
is amenable to##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
is among the most##2##4##(2008-5#1)(2010-7#1)
is among the##8##3##(1992-12#1)(2008-10#1)(2008-5#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-3#1)
is among##10##2##(1992-12#1)(2008-10#2)(2008-5#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-3#1)
is ample evidence##2##3##(1991-5#1)(2008-7#1)
is amplified by##2##3##(1997-1#1)(2008-3#1)
is amplified##5##2##(1990-6#1)(1997-1#1)(2008-3#1)(2009-7#1)(2011-2#1)
is an X-linked##3##3##(2009-8#1)(2011-2#1)(2012-2#1)
is an abnormal##3##3##(2010-5#1)(2013-1#2)
is an absolute##3##3##(2008-10#3)
is an abundant##2##3##(1995-2#1)(2010-4#1)
is an acceptable##2##3##(1996-12#1)(2008-11#1)
is an accepted##2##3##(2008-12#1)(2013-8#1)
is an accurate##2##3##(2008-2#1)(2010-1#1)
is an active##10##3##(1991-11#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
is an acute##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
is an adaptation of##2##4##(2012-2#1)(2013-1#1)
is an adaptive##2##3##(2012-2#1)(2013-1#1)
is an additional##2##3##(1993-3#1)(2008-10#1)
is an aerobic##2##3##(2011-2#2)
is an age-related##2##3##(2008-7#2)
is an aggressive##2##3##(2008-10#2)
is an alkaline##2##3##(2008-10#1)(2008-11#1)
is an allele of##2##4##(1995-9#1)(1997-4#1)
is an alternative to##5##4##(1994-9#1)(2008-10#2)(2008-4#1)(2013-1#1)
is an alternative##9##3##(1994-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#2)
is an ancient##2##3##(2009-8#2)
is an apparent##3##3##(1991-12#1)(2008-7#1)(2010-1#1)
is an appealing##2##3##(2008-10#1)(2008-8#1)
is an appropriate##2##3##(2008-10#1)(2008-3#1)
is an area of##2##4##(2008-10#1)(2008-11#1)
is an area that##2##4##(2008-11#1)(2008-5#1)
is an area##5##3##(2008-10#2)(2008-11#2)(2008-5#1)
is an attractive alternative##2##4##(1997-8#1)(2012-2#1)
is an attractive technique##3##4##(2008-10#3)
is an attractive##9##3##(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-10#1)(2012-2#1)
is an autoimmune disease##2##4##(2008-1#1)(2010-12#1)
is an autoimmune##4##3##(2008-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
is an autosomal dominant disorder##4##5##(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
is an autosomal dominant##10##4##(1993-12#1)(1997-3#1)(2008-12#1)(2008-4#1)(2010-6#2)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
is an autosomal recessive disorder##2##5##(2008-7#1)(2011-1#1)
is an autosomal recessive##6##4##(1990-8#1)(1995-6#1)(2008-4#2)(2008-7#1)(2011-1#1)
is an autosomal##16##3##(1990-8#1)(1993-12#1)(1995-6#1)(1997-3#1)(2008-12#1)(2008-4#3)(2008-7#1)(2010-6#2)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
is an easily##4##3##(1994-12#1)(2008-10#1)(2009-9#1)(2013-1#1)
is an easy##2##3##(2008-9#1)(2010-3#1)
is an economical and##2##4##(2008-10#2)
is an economical##3##3##(2008-10#2)(2011-1#1)
is an economically important##2##4##(2008-10#2)
is an effective alternative##2##4##(2010-8#1)(2013-8#1)
is an effective and##4##4##(1990-12#1)(1991-12#1)(2008-11#1)(2010-8#1)
is an effective means of##2##5##(2008-10#2)
is an effective method of##2##5##(2008-12#1)(2011-2#1)
is an effective method to##2##5##(2008-10#1)(2013-1#1)
is an effective method##5##4##(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
is an effective strategy for##3##5##(2008-5#1)(2010-7#1)(2013-1#1)
is an effective strategy##4##4##(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
is an effective tool##3##4##(1994-3#1)(1996-3#1)(2008-11#1)
is an effective way to##2##5##(2008-11#1)(2012-3#1)
is an effective##32##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-9#1)(1994-3#1)(1996-3#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
is an efficient approach##2##4##(2010-12#1)(2010-5#1)
is an efficient method to##2##5##(1997-8#1)(2011-2#1)
is an efficient##8##3##(1995-2#1)(1996-12#1)(1997-8#1)(2008-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
is an emerging pathogen##2##4##(2011-2#1)(2013-1#1)
is an emerging##7##3##(2008-10#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
is an endangered##2##3##(2008-11#1)(2008-8#1)
is an endemic##2##3##(2012-2#1)(2013-1#1)
is an endogenous##2##3##(1996-2#1)(2008-7#1)
is an endonuclease##2##3##(1994-8#1)(1995-6#1)
is an enormous##3##3##(1997-5#1)(2008-10#1)(2010-7#1)
is an environmentally##2##3##(2008-10#2)
is an enzyme##2##3##(2008-11#1)(2010-12#1)
is an essential component of the##2##6##(1997-3#1)(2012-2#1)
is an essential component of##6##5##(1994-12#1)(1997-3#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
is an essential component##8##4##(1994-12#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-8#1)
is an essential enzyme for##3##5##(2009-6#1)(2009-7#1)(2011-3#1)
is an essential micronutrient##3##4##(1993-11#1)(2012-2#2)
is an essential step to##2##5##(1995-6#1)(2008-10#1)
is an essential step##3##4##(1995-6#1)(2008-10#1)(2011-2#1)
is an essential trace element##2##5##(2008-10#1)(2012-2#1)
is an essential##35##3##(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#5)(2013-1#2)(2013-8#3)
is an established##9##3##(1991-1#1)(2008-11#2)(2008-12#1)(2008-9#2)(2011-2#2)(2011-3#1)
is an evaluation##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
is an evolving##2##3##(1991-12#1)(1996-6#1)
is an example of##2##4##(1993-12#1)(2008-10#1)
is an excellent tool for##2##5##(2008-10#2)
is an excellent##8##3##(1991-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2010-6#1)(2013-1#1)
is an exciting##2##3##(1992-9#1)(2012-12#1)
is an extension of the##3##5##(2008-3#1)(2008-6#1)(2010-5#1)
is an extension of##7##4##(1991-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-5#1)(2013-8#1)
is an extremely rare and##2##5##(2008-10#1)(2013-1#1)
is an extremely rare condition##2##5##(2008-10#2)
is an extremely rare##11##4##(2008-10#4)(2008-12#3)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
is an extremely##16##3##(2008-10#8)(2008-11#1)(2008-12#3)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
is an ideal##7##3##(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)
is an imbalance between##2##4##(1993-2#1)(2008-7#1)
is an important addition to the##2##6##(2008-11#1)(2008-9#1)
is an important and##3##4##(1993-1#1)(2008-8#1)(2011-7#1)
is an important aspect of##3##5##(2008-10#2)(2012-2#1)
is an important aspect##4##4##(2007-12#1)(2008-10#2)(2012-2#1)
is an important cause of##4##5##(2008-12#1)(2008-8#1)(2011-2#2)
is an important component in the##2##6##(2008-4#2)
is an important component of the##2##6##(1996-2#1)(2008-10#1)
is an important component of##3##5##(1996-2#1)(2008-10#2)
is an important component##5##4##(1996-2#1)(2008-10#2)(2008-4#2)
is an important consideration##3##4##(1993-1#1)(2010-11#1)(2013-1#1)
is an important contributor to##2##5##(2008-10#1)(2008-7#1)
is an important determinant of the##4##6##(1992-2#1)(1993-3#1)(1996-3#1)(1997-8#1)
is an important determinant of##9##5##(1992-2#1)(1993-3#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
is an important disease of barley in many production areas##2##10##(2008-10#2)
is an important disease of barley in many##3##8##(2008-10#3)
is an important disease of##6##5##(2008-10#6)
is an important disease##8##4##(2008-10#7)(2008-11#1)
is an important factor in the##2##6##(2008-3#1)(2012-2#1)
is an important factor in##3##5##(2008-11#1)(2008-3#1)(2012-2#1)
is an important factor##7##4##(1992-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-2#1)(2013-1#1)
is an important feature of the##3##6##(1992-4#1)(2009-4#1)(2013-1#1)
is an important feature of##4##5##(1992-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
is an important feature##5##4##(1992-4#1)(2009-4#1)(2011-2#2)(2013-1#1)
is an important human pathogen##2##5##(2008-7#1)(2008-9#1)
is an important independent##2##4##(2008-11#1)(2008-8#1)
is an important issue##2##4##(2008-3#1)(2008-9#1)
is an important means of##2##5##(1993-1#1)(2008-10#1)
is an important mechanism of##3##5##(2008-10#1)(2008-5#1)(2008-9#1)
is an important part of the##2##6##(1996-6#1)(2011-2#1)
is an important part of##4##5##(1996-6#1)(2008-4#1)(2011-2#2)
is an important phenomenon in##2##5##(2008-9#1)(2012-3#1)
is an important public health##3##5##(1991-6#1)(2010-3#1)(2011-2#1)
is an important regulator of##2##5##(1995-2#1)(1997-4#1)
is an important step##2##4##(2009-7#1)(2012-3#1)
is an important structural##2##4##(2008-9#1)(2009-7#1)
is an important tool for##4##5##(2008-4#1)(2009-8#1)(2012-2#1)(2013-8#1)
is an important tool in the##2##6##(1992-2#1)(2010-12#1)
is an important tool##9##4##(1992-2#1)(1997-3#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is an important##157##3##(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1993-1#3)(1993-3#2)(1994-2#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#36)(2008-11#13)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#9)(2009-4#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#3)(2011-1#2)(2011-2#10)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#6)(2013-8#4)
is an inappropriate##2##3##(2008-10#1)(2008-5#1)
is an increase##3##3##(1992-3#1)(2008-11#1)(2010-12#1)
is an increased risk of##2##5##(2009-12#1)(2011-2#1)
is an increased##3##3##(1994-5#1)(2009-12#1)(2011-2#1)
is an increasing##10##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)
is an increasingly popular##3##4##(2008-10#1)(2008-11#2)
is an independent risk##2##4##(2008-7#1)(2008-8#1)
is an independent##3##3##(1993-11#1)(2008-7#1)(2008-8#1)
is an indication of the##2##5##(2008-3#1)(2009-5#1)
is an indication##3##3##(2008-3#1)(2009-5#1)(2010-3#1)
is an indicator of##2##4##(2008-10#2)
is an indicator##3##3##(2008-10#2)(2008-12#1)
is an indispensable##3##3##(1991-5#2)(2008-10#1)
is an infrequent##2##3##(2011-2#2)
is an infrequently##3##3##(1996-9#1)(2008-1#1)(2012-2#1)
is an inherited##3##3##(1990-5#1)(1997-3#1)(2010-6#1)
is an inhibitor of the##2##5##(2008-7#1)(2009-8#1)
is an initial##4##3##(1994-1#1)(2009-11#1)(2009-8#1)(2010-4#1)
is an innovative##4##3##(1991-2#1)(2008-10#1)(2009-12#1)(2010-7#1)
is an integral part of##5##5##(1994-6#1)(1997-3#1)(2008-11#1)(2008-7#1)(2012-2#1)
is an integral##9##3##(1991-2#1)(1994-6#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#2)(2013-1#1)
is an interdisciplinary##2##3##(1996-1#1)(2013-1#1)
is an interesting##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
is an international##3##3##(1996-1#1)(2008-10#1)(2013-1#1)
is an intracellular##7##3##(1996-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
is an intrinsic##3##3##(1993-3#1)(2008-10#1)(2008-5#1)
is an obligate##4##3##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
is an obligately##2##3##(2008-10#1)(2011-2#1)
is an obligatory##2##3##(1996-5#1)(2013-1#1)
is an observational##2##3##(1996-3#1)(2012-3#1)
is an ongoing challenge for##2##5##(2008-7#1)(2011-2#1)
is an open##2##3##(2008-8#1)(2009-12#1)
is an opportunity##2##3##(2008-12#2)
is an option##2##3##(1994-12#1)(2011-2#1)
is an oral##2##3##(1995-6#1)(2013-1#1)
is an organelle##2##3##(2011-2#2)
is an original##2##3##(2008-8#1)(2011-2#1)
is an uncommon but well##2##5##(2008-10#1)(2008-7#1)
is an uncommon but##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
is an uncommon cause of##3##5##(2008-12#1)(2008-7#1)(2012-3#1)
is an uncommon cause##4##4##(2008-12#1)(2008-7#1)(2009-8#1)(2012-3#1)
is an uncommon complication##2##4##(2008-7#1)(2011-2#1)
is an uncommon condition##2##4##(2008-7#1)(2011-2#1)
is an uncommon malignancy##2##4##(1992-3#1)(2013-8#1)
is an uncommon type of##2##5##(2011-3#1)(2013-1#1)
is an uncommon##28##3##(1991-6#1)(1992-3#1)(2008-10#1)(2008-12#2)(2008-7#5)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#4)(2013-1#2)(2013-8#1)
is an unusual##9##3##(1991-8#1)(1994-6#1)(1997-6#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)
is an update of an##2##5##(1994-3#1)(2012-2#1)
is an update of##3##4##(1994-3#1)(2012-2#2)
is an##778##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-5#5)(1991-6#2)(1991-8#1)(1992-1#3)(1992-10#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-1#5)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#8)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#7)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#9)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#4)(2007-12#3)(2008-1#6)(2008-10#143)(2008-11#59)(2008-12#27)(2008-2#4)(2008-3#14)(2008-4#15)(2008-5#17)(2008-6#2)(2008-7#34)(2008-8#18)(2008-9#24)(2009-10#4)(2009-11#1)(2009-12#5)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#7)(2009-8#12)(2009-9#4)(2010-1#7)(2010-10#5)(2010-11#4)(2010-12#7)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#11)(2010-7#6)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#49)(2011-3#4)(2011-7#3)(2011-8#1)(2012-12#5)(2012-2#32)(2012-3#18)(2012-9#1)(2013-1#39)(2013-7#2)(2013-8#17)
is analogous to that##2##4##(1991-5#2)
is analogous to##5##3##(1991-5#2)(2008-12#1)(2008-3#1)(2010-7#1)
is analysed##10##2##(1993-6#1)(1996-11#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-5#1)
is analyzed and##2##3##(2008-4#1)(2013-8#1)
is analyzed in the##2##4##(2008-3#2)
is analyzed in##3##3##(1995-1#1)(2008-3#2)
is analyzed using##2##3##(2008-10#1)(2009-11#1)
is analyzed##22##2##(1995-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-8#3)(2008-9#2)(2009-11#1)(2013-1#1)(2013-8#1)
is another factor##2##3##(1991-5#1)(2008-5#1)
is another important##2##3##(2008-1#1)(2008-11#1)
is another key##2##3##(2008-11#1)(2012-2#1)
is another##15##2##(1991-5#1)(1994-5#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
is anticipated##7##2##(1991-2#1)(1995-12#1)(1996-9#1)(1997-7#1)(2008-12#1)(2011-7#1)(2013-7#1)
is any##2##2##(1996-12#1)(2012-3#1)
is apparent that##5##3##(1995-12#1)(2006-6#1)(2008-10#2)(2011-1#1)
is apparent##8##2##(1990-5#1)(1994-9#1)(1995-12#1)(2006-6#1)(2008-10#2)(2008-11#1)(2011-1#1)
is apparently not##2##3##(1991-8#1)(2008-10#1)
is apparently##7##2##(1990-2#1)(1990-5#1)(1991-8#1)(1995-2#1)(2008-10#2)(2009-5#1)
is applicable for##4##3##(1996-3#1)(2008-10#3)
is applicable in##2##3##(2008-10#1)(2010-5#1)
is applicable to all##2##4##(1996-6#1)(2008-10#1)
is applicable to the##10##4##(2008-10#9)(2011-1#1)
is applicable to##24##3##(1994-3#1)(1996-6#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-1#1)
is applicable##34##2##(1994-3#1)(1996-3#1)(1996-6#1)(2008-10#21)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)
is applied and##3##3##(2008-10#1)(2008-12#1)(2010-7#1)
is applied during##2##3##(2008-11#1)(2012-2#1)
is applied for the determination of##2##6##(2008-10#2)
is applied for the##3##4##(2008-10#3)
is applied for##8##3##(2008-10#7)(2008-3#1)
is applied on the##2##4##(2008-10#1)(2010-8#1)
is applied to a##4##4##(2008-10#1)(2008-3#1)(2010-10#1)(2013-8#1)
is applied to determine the##2##5##(2008-10#2)
is applied to determine##3##4##(2008-10#3)
is applied to the analysis of##3##6##(2008-10#3)
is applied to the determination of##8##6##(2008-10#8)
is applied to the##22##4##(2008-10#18)(2008-3#3)(2008-8#1)
is applied to two##2##4##(2008-10#1)(2008-7#1)
is applied to##52##3##(1995-5#1)(2007-12#1)(2008-10#32)(2008-11#2)(2008-3#8)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-8#1)
is applied##88##2##(1995-5#1)(2007-12#1)(2008-10#54)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#10)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#3)(2013-8#2)
is appraised##2##2##(2008-10#1)(2011-2#1)
is approaching##2##2##(2008-1#1)(2009-6#1)
is appropriate and##2##3##(2011-2#1)(2013-8#1)
is appropriate for##6##3##(2008-10#2)(2008-12#1)(2008-4#1)(2010-12#1)(2012-3#1)
is appropriate in##2##3##(2008-10#1)(2010-6#1)
is appropriate to##5##3##(1997-1#1)(2008-10#3)(2009-12#1)
is appropriate##17##2##(1991-1#1)(1997-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
is approximated by##2##3##(1992-2#1)(2008-3#1)
is approximately 0##2##3##(2008-3#1)(2012-3#1)
is approximately 1##3##3##(2008-10#2)(2008-3#1)
is approximately 10##2##3##(1997-6#1)(2008-3#1)
is approximately 3%##2##3##(2008-10#2)
is approximately 30 percent##2##4##(2010-12#1)(2013-1#1)
is approximately 40##2##3##(1994-2#1)(2008-3#1)
is approximately 40%##2##3##(2008-4#1)(2008-7#1)
is approximately proportional to the##2##5##(2008-10#1)(2008-3#1)
is approximately twice##2##3##(1993-1#1)(2008-3#1)
is approximately##46##2##(1991-11#2)(1991-3#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-2#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-7#3)(2009-9#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#1)
is arbitrarily##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
is arguably the##2##3##(2010-5#1)(2013-1#1)
is argued that##12##3##(1991-3#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2013-1#2)
is argued##14##2##(1991-3#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2013-1#2)
is around 0##2##3##(2008-10#1)(2008-11#1)
is around 1##2##3##(2008-10#1)(2009-11#1)
is around 3%##2##3##(2008-10#2)
is around 5% for the analytes##2##6##(2008-10#2)
is around##13##2##(2008-10#9)(2008-11#1)(2008-12#1)(2009-11#1)(2013-1#1)
is arrested##2##2##(1993-6#1)(2008-8#1)
is as effective as##2##4##(1994-3#1)(1995-9#1)
is as effective##3##3##(1994-3#2)(1995-9#1)
is as expected##2##3##(2010-11#1)(2013-1#1)
is as follows##2##3##(1990-2#1)(1995-8#1)
is as high as##3##4##(1997-2#1)(2008-10#1)(2010-8#1)
is as low as##7##4##(2008-10#5)(2008-9#1)(2011-3#1)
is as much##3##3##(2008-1#1)(2008-3#1)(2009-4#1)
is as sensitive as##2##4##(1992-3#1)(2008-10#1)
is as true##2##3##(1993-2#1)(2013-7#1)
is as##37##2##(1990-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-8#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
is ascribed to##2##3##(1997-2#1)(2008-10#1)
is assayed##2##2##(2008-10#2)
is assembled by##3##3##(2008-10#3)
is assembled##4##2##(2008-10#3)(2008-8#1)
is assessed as##3##3##(2008-10#1)(2013-8#2)
is assessed by##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
is assessed using##2##3##(2008-10#1)(2008-8#1)
is assessed with##2##3##(2008-3#1)(2012-2#1)
is assessed##18##2##(1996-2#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-8#2)(2009-10#1)(2012-2#2)(2013-8#2)
is assigned##4##2##(1994-12#1)(2008-8#1)(2010-5#1)(2012-2#1)
is assisted##2##2##(2008-2#1)(2011-3#1)
is associated to##4##3##(2008-10#2)(2008-9#1)(2009-10#1)
is associated with a decrease in##2##6##(1996-2#1)(2008-7#1)
is associated with a high##2##5##(2010-11#1)(2013-8#1)
is associated with a reduction##2##5##(2009-7#1)(2012-2#1)
is associated with a variety of##2##6##(2008-10#1)(2012-3#1)
is associated with a##28##4##(1990-8#1)(1991-12#1)(1991-2#1)(1993-8#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-7#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
is associated with an increase in##2##6##(2008-9#1)(2009-8#1)
is associated with an increase##3##5##(1990-8#1)(2008-9#1)(2009-8#1)
is associated with an increased incidence of##2##7##(2008-10#1)(2013-7#1)
is associated with an increased risk for##2##7##(2011-1#1)(2013-1#1)
is associated with an increased risk of##3##7##(1992-8#1)(2011-2#1)(2013-1#1)
is associated with an increased risk##5##6##(1992-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
is associated with an increased##9##5##(1992-8#1)(1995-12#1)(2008-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
is associated with an##17##4##(1990-5#1)(1990-8#1)(1992-8#1)(1993-8#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
is associated with better##2##4##(2008-5#1)(2009-11#1)
is associated with both##2##4##(2010-4#1)(2012-2#1)
is associated with cellular proliferation##2##5##(1994-11#1)(1994-3#1)
is associated with decreased##3##4##(2008-7#1)(2009-1#1)(2010-10#1)
is associated with high morbidity and mortality##2##7##(2009-7#1)(2013-1#1)
is associated with high##3##4##(2009-10#1)(2009-7#1)(2013-1#1)
is associated with higher##6##4##(1993-6#1)(1995-12#1)(1996-6#1)(2008-11#1)(2009-12#1)(2013-1#1)
is associated with improved##2##4##(2008-12#1)(2008-7#1)
is associated with increased risk of##3##6##(2008-11#1)(2011-2#1)(2013-1#1)
is associated with increased risk##5##5##(1993-12#2)(2008-11#1)(2011-2#1)(2013-1#1)
is associated with increased##14##4##(1991-12#1)(1993-12#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#2)
is associated with less##2##4##(2013-1#2)
is associated with loss of the##2##6##(1997-3#1)(2008-10#1)
is associated with loss of##3##5##(1997-3#1)(2008-10#1)(2011-2#1)
is associated with poor outcomes##2##5##(2009-1#1)(2013-8#1)
is associated with poor##3##4##(2008-5#1)(2009-1#1)(2013-8#1)
is associated with reduced##3##4##(2008-12#1)(2010-1#2)
is associated with reductions in##2##5##(2012-2#1)(2013-1#1)
is associated with several##2##4##(2011-2#1)(2012-2#1)
is associated with significant##3##4##(1995-1#1)(2008-7#1)(2012-3#1)
is associated with some##2##4##(1994-3#1)(2008-7#1)
is associated with specific##4##4##(1990-6#1)(2010-12#1)(2011-2#2)
is associated with the development of##3##6##(2008-10#1)(2008-7#1)(2010-12#1)
is associated with the development##4##5##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
is associated with the metabolic syndrome and##2##7##(2010-4#2)
is associated with the risk of##2##6##(2008-11#1)(2010-12#1)
is associated with the##30##4##(1990-7#1)(1991-10#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1997-7#1)(2006-6#2)(2008-10#6)(2008-11#2)(2008-7#1)(2010-12#3)(2010-4#2)(2011-2#4)(2013-1#2)(2013-8#1)
is associated with##213##3##(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#3)(1993-8#3)(1994-11#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-6#2)(1997-1#4)(1997-3#2)(1997-5#1)(1997-7#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#1)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#8)(2010-4#3)(2010-6#3)(2011-1#2)(2011-2#22)(2012-2#8)(2012-3#6)(2012-5#1)(2013-1#20)(2013-7#1)(2013-8#6)
is associated##221##2##(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#3)(1993-8#3)(1994-11#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-6#2)(1997-1#4)(1997-3#2)(1997-5#1)(1997-7#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#9)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#2)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#8)(2010-4#3)(2010-6#3)(2011-1#2)(2011-2#22)(2012-2#8)(2012-3#6)(2012-5#1)(2013-1#20)(2013-7#1)(2013-8#6)
is assumed that the##2##4##(1993-3#1)(2009-8#1)
is assumed that##6##3##(1993-3#1)(2008-10#3)(2009-8#1)(2012-2#1)
is assumed to be a##2##5##(1991-12#1)(2008-11#1)
is assumed to be##4##4##(1991-12#1)(2008-11#1)(2008-12#1)(2008-9#1)
is assumed to##7##3##(1991-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
is assumed##19##2##(1991-12#1)(1993-3#1)(1994-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
is asymmetric##2##2##(1997-3#1)(2008-2#1)
is at a wavelength##2##4##(2008-3#2)
is at a##3##3##(1996-3#1)(2008-3#2)
is at best##2##3##(2009-10#1)(2013-8#1)
is at its lowest level##2##5##(1993-2#1)(1996-8#1)
is at its##4##3##(1993-2#1)(1996-8#1)(2008-12#1)(2010-5#1)
is at least 3 months##2##5##(2008-10#2)
is at least in part mediated by##2##7##(1991-5#1)(2011-2#1)
is at least in part##3##5##(1991-5#1)(2008-11#1)(2011-2#1)
is at least##10##3##(1991-2#1)(1991-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-2#1)
is at once##2##3##(2008-7#2)
is at the same time##2##5##(2009-10#1)(2013-1#1)
is at the##18##3##(1990-11#2)(1991-12#1)(1991-2#1)(1992-8#1)(1994-11#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-11#3)(2009-10#1)(2009-7#1)(2013-1#1)
is at##63##2##(1990-11#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-5#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(2007-12#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
is attached to an##2##4##(2008-12#1)(2008-4#1)
is attached to the##2##4##(2008-10#1)(2008-7#1)
is attached to##7##3##(1990-12#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)
is attached##9##2##(1990-12#1)(1994-8#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)
is attained##2##2##(2008-10#1)(2008-5#1)
is attempted by##2##3##(2008-10#1)(2008-7#1)
is attempted##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
is attenuated by##2##3##(2008-11#1)(2012-2#1)
is attenuated in##2##3##(1996-2#1)(1996-5#1)
is attenuated##5##2##(1996-2#1)(1996-5#1)(2008-11#1)(2010-12#1)(2012-2#1)
is attributable to the##2##4##(2008-10#1)(2008-5#1)
is attributable to##6##3##(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
is attributed to an##2##4##(1994-5#1)(2008-10#1)
is attributed to differential##2##4##(2008-10#1)(2008-2#1)
is attributed to the##8##4##(1990-5#1)(1992-3#1)(2008-10#3)(2008-9#2)(2012-2#1)
is attributed to##18##3##(1990-5#1)(1992-3#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2012-2#1)
is attributed##19##2##(1990-5#1)(1992-3#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-4#1)(2012-2#1)
is augmented by##2##3##(1993-3#1)(2008-6#1)
is automatic##2##2##(2008-10#1)(2008-9#1)
is automatically##4##2##(1995-12#1)(2008-10#2)(2008-3#1)
is autosomal dominant##2##3##(1997-3#2)
is available for further##2##4##(2008-9#1)(2010-1#1)
is available for##6##3##(2008-10#2)(2008-9#1)(2009-12#1)(2010-1#1)(2012-2#1)
is available from##3##3##(2008-8#1)(2012-12#2)
is available in##4##3##(1990-6#2)(1992-9#1)(2009-7#1)
is available on the##6##4##(2007-12#1)(2008-10#3)(2008-6#1)(2012-3#1)
is available on##10##3##(1993-1#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-6#2)(2012-12#1)(2012-3#1)
is available to the##2##4##(1992-5#1)(2008-2#1)
is available to##15##3##(1992-5#1)(2008-11#1)(2008-2#1)(2010-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
is available##66##2##(1990-6#2)(1991-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-12#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#1)(2008-6#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#1)
is averaged##2##2##(2008-3#2)
is avirulent##3##2##(2008-10#3)
is avoided##2##2##(2008-10#1)(2008-2#1)
is balanced##2##2##(1995-9#1)(2013-1#1)
is based in the##3##4##(2008-10#1)(2009-7#2)
is based in##5##3##(2008-10#2)(2009-7#2)(2013-8#1)
is based mainly on##2##4##(2008-3#1)(2011-2#1)
is based on a##48##4##(1990-12#1)(1990-6#1)(1991-2#1)(1992-2#1)(1997-2#2)(2007-11#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is based on an##9##4##(1993-12#1)(1996-12#1)(2008-10#5)(2008-3#1)(2010-1#1)
is based on clinical##2##4##(2008-5#1)(2008-8#1)
is based on data##2##4##(1991-12#1)(1996-12#1)
is based on its catalytic effect on the oxidation##3##9##(2008-10#3)
is based on its catalytic effect on the##4##8##(2008-10#4)
is based on its##7##4##(2008-10#7)
is based on personal##2##4##(1996-2#1)(2010-5#1)
is based on recent##2##4##(1996-1#1)(2008-11#1)
is based on solid phase##2##5##(2008-10#2)
is based on that##2##4##(2008-10#1)(2011-2#1)
is based on the CL reaction##3##6##(2008-10#3)
is based on the ability of IL-9 to stimulate the proliferation of the##2##13##(2008-4#2)
is based on the ability of##3##6##(1995-5#1)(2008-4#2)
is based on the ability##4##5##(1995-5#1)(2008-4#2)(2008-6#1)
is based on the accumulation of##2##6##(2008-10#2)
is based on the application of##3##6##(2008-10#2)(2008-11#1)
is based on the assumption that##2##6##(2008-10#1)(2008-11#1)
is based on the assumption##3##5##(2008-10#2)(2008-11#1)
is based on the author's##2##5##(1991-1#1)(2008-12#1)
is based on the catalytic effect of manganese (II) on the oxidation of##2##13##(2008-10#2)
is based on the catalytic effect of##11##7##(2008-10#11)
is based on the catalytic##12##5##(2008-10#12)
is based on the changes in##2##6##(2008-10#2)
is based on the chemical sorption of##2##7##(2008-10#2)
is based on the chemical##3##5##(2008-10#3)
is based on the combination of##2##6##(2008-10#2)
is based on the combined##2##5##(2008-10#2)
is based on the complex##3##5##(2008-10#2)(2008-3#1)
is based on the complexation##3##5##(2008-10#3)
is based on the coupling##2##5##(2008-10#2)
is based on the development of##3##6##(2008-10#2)(2008-5#1)
is based on the differential##2##5##(2008-9#1)(2010-7#1)
is based on the efficient##2##5##(2008-10#1)(2008-2#1)
is based on the employment of##2##6##(2008-10#2)
is based on the enhancement of##2##6##(2008-10#2)
is based on the expression##2##5##(2008-10#1)(2008-9#1)
is based on the fact that##5##6##(1993-9#1)(2008-10#4)
is based on the fluorescence quenching of##2##7##(2008-10#2)
is based on the fluorescence##4##5##(2008-10#4)
is based on the following##2##5##(2008-10#2)
is based on the formation of a##5##7##(2008-10#5)
is based on the formation of##13##6##(2008-10#13)
is based on the inhibition effect of##3##7##(2008-10#3)
is based on the injection of##2##6##(2008-10#2)
is based on the injection##3##5##(2008-10#3)
is based on the measurement of the##4##7##(2008-10#4)
is based on the measurement of##6##6##(2008-10#6)
is based on the on-line##4##5##(2008-10#4)
is based on the oxidation of##7##6##(2008-10#7)
is based on the oxidation reaction of##2##7##(2008-10#2)
is based on the oxidation##9##5##(2008-10#9)
is based on the premise that##2##6##(2008-9#1)(2013-1#1)
is based on the presence##2##5##(1990-5#1)(2008-10#1)
is based on the reaction between##10##6##(2008-10#10)
is based on the reaction of##10##6##(2008-10#10)
is based on the reaction##21##5##(2008-10#21)
is based on the separation and##2##6##(2008-10#2)
is based on the separation##3##5##(2008-10#3)
is based on the simultaneous##3##5##(2008-10#1)(2008-3#1)(2008-9#1)
is based on the solid-phase extraction of##2##7##(2008-10#2)
is based on the sorption of##4##6##(2008-10#4)
is based on the use of##8##6##(1990-12#2)(2008-10#4)(2008-11#1)(2008-3#1)
is based on the utilization of##2##6##(2008-10#2)
is based on the well-known##2##5##(2008-10#1)(2008-2#1)
is based on the##305##4##(1990-12#3)(1990-5#1)(1991-1#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#245)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#6)(2010-10#1)(2010-7#1)(2011-2#2)(2011-3#2)(2012-2#1)(2013-1#2)(2013-8#2)
is based on their##3##4##(2008-10#2)(2008-11#1)
is based on three##2##4##(2008-10#1)(2008-11#1)
is based on two##2##4##(1991-6#1)(2008-3#1)
is based on##508##3##(1990-12#4)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-2#3)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-11#2)(2008-10#338)(2008-11#17)(2008-12#3)(2008-2#4)(2008-3#25)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#11)(2009-11#1)(2009-8#1)(2010-1#3)(2010-10#3)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2011-3#2)(2012-2#4)(2013-1#9)(2013-8#4)
is based upon the##7##4##(1990-12#1)(1996-3#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)
is based upon##14##3##(1990-12#1)(1991-3#2)(1991-5#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
is based##535##2##(1990-12#5)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-2#3)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#2)(2007-11#2)(2008-10#344)(2008-11#19)(2008-12#3)(2008-2#4)(2008-3#26)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#2)(2008-8#6)(2008-9#12)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-10#3)(2010-11#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#7)(2011-3#2)(2012-2#4)(2012-3#2)(2013-1#9)(2013-8#5)
is becoming a##3##3##(2008-10#2)(2008-7#1)
is becoming an important topic##2##5##(2008-10#1)(2008-12#1)
is becoming an important##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
is becoming an increasingly common##2##5##(2013-1#2)
is becoming an increasingly important##2##5##(2006-6#1)(2010-10#1)
is becoming an increasingly##4##4##(2006-6#1)(2010-10#1)(2013-1#2)
is becoming an##8##3##(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#2)
is becoming increasingly##2##3##(2011-2#2)
is becoming more##4##3##(1992-9#1)(1995-2#1)(2010-7#1)(2011-2#1)
is becoming##24##2##(1990-2#1)(1992-9#1)(1995-2#1)(1995-5#1)(1996-3#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-7#1)(2011-2#4)(2013-1#2)
is beginning to emerge##2##4##(1995-9#1)(2011-2#1)
is beginning to shift##2##4##(2008-11#1)(2008-5#1)
is beginning to##7##3##(1995-1#1)(1995-9#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#1)
is being applied to##2##4##(2008-10#1)(2010-4#1)
is being developed##4##3##(1995-12#1)(1997-5#2)(2010-4#1)
is being employed##2##3##(2008-10#1)(2008-4#1)
is being increasingly recognized##2##4##(2009-3#1)(2009-9#1)
is being increasingly##6##3##(1993-11#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-2#2)
is being tested##3##3##(1997-6#1)(2008-5#2)
is being used in the##2##5##(2008-11#1)(2011-2#1)
is being used in##3##4##(2008-11#2)(2011-2#1)
is being used to##6##4##(2008-10#2)(2008-11#2)(2008-3#1)(2010-10#1)
is being used##15##3##(2008-10#4)(2008-11#6)(2008-3#1)(2010-10#1)(2011-2#2)(2013-1#1)
is being##72##2##(1990-9#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#3)(1994-1#1)(1994-11#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#4)
is believed that##8##3##(1991-3#1)(1994-8#1)(1995-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
is believed to be a##5##5##(1994-11#1)(1994-5#1)(2008-11#1)(2008-9#1)(2011-2#1)
is believed to be involved in the##2##7##(2010-3#1)(2013-8#1)
is believed to be the##2##5##(1992-9#1)(2008-3#1)
is believed to be##13##4##(1992-9#1)(1994-11#2)(1994-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
is believed to play an important role in##2##8##(1995-12#1)(2010-12#1)
is believed to play##4##4##(1995-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
is believed to represent##2##4##(2008-10#1)(2011-2#1)
is believed to result from##2##5##(1995-11#1)(2008-10#1)
is believed to##30##3##(1992-4#1)(1992-9#1)(1994-11#2)(1994-5#1)(1995-11#2)(1995-12#2)(1996-1#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2013-1#1)(2013-8#1)
is believed##38##2##(1991-3#1)(1992-4#1)(1992-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1996-1#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#5)(2013-1#1)(2013-8#1)
is below the threshold##2##4##(2008-10#2)
is below the##4##3##(2007-12#1)(2008-10#2)(2013-1#1)
is below##10##2##(1993-9#1)(2007-12#1)(2008-10#5)(2008-8#1)(2009-11#1)(2013-1#1)
is beneficial for the##2##4##(1993-3#1)(2012-2#1)
is beneficial for##4##3##(1993-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
is beneficial to##5##3##(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)
is beneficial##13##2##(1993-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
is best described##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
is best known##2##3##(2008-10#1)(2008-12#1)
is best suited##2##3##(1993-12#1)(2008-10#1)
is best##16##2##(1993-12#1)(1994-3#1)(1996-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)
is better than the##2##4##(2012-3#1)(2013-8#1)
is better than##9##3##(1993-3#1)(2008-10#6)(2012-3#1)(2013-8#1)
is better##20##2##(1990-9#1)(1993-3#1)(2008-10#7)(2008-2#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#3)(2012-6#1)(2013-1#1)(2013-8#2)
is between 0##2##3##(2008-10#2)
is between 1 and 20##2##5##(2008-10#1)(2008-11#1)
is between the##2##3##(2007-12#1)(2008-8#1)
is between##14##2##(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-8#1)(2009-4#1)(2013-8#1)
is beyond doubt##2##3##(2011-2#1)(2013-1#1)
is beyond the##2##3##(2008-11#1)(2008-9#1)
is beyond##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
is biologically active##3##3##(1993-6#1)(2008-10#2)
is biologically##4##2##(1993-6#1)(2008-10#3)
is blended##2##2##(2008-12#1)(2012-3#1)
is blocked by the##2##4##(2008-11#1)(2010-7#1)
is blocked by##7##3##(1993-6#1)(1994-2#1)(1995-8#1)(2008-11#1)(2008-7#1)(2010-7#1)(2013-8#1)
is blocked##8##2##(1993-6#1)(1994-2#1)(1995-6#1)(1995-8#1)(2008-11#1)(2008-7#1)(2010-7#1)(2013-8#1)
is born##2##2##(1993-12#1)(1995-12#1)
is both necessary and sufficient for##3##6##(1991-2#2)(2009-10#1)
is both##22##2##(1991-2#2)(1991-3#1)(1992-3#1)(1995-1#1)(1996-1#2)(1996-2#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
is bound by##3##3##(1991-5#1)(1992-10#1)(1995-2#1)
is bound to the##2##4##(1991-5#1)(2008-4#1)
is bound to##4##3##(1991-5#1)(1994-8#1)(1996-2#1)(2008-4#1)
is bound##10##2##(1991-5#2)(1992-10#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-4#1)(2009-3#1)
is briefly described##2##3##(2008-11#2)
is briefly##4##2##(1997-8#1)(2008-10#1)(2008-11#2)
is broad##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
is broken##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
is brought##2##2##(2008-10#1)(2008-4#1)
is built around##2##3##(1997-3#1)(2012-3#1)
is built##8##2##(1997-3#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-3#2)
is by far the##2##4##(1993-1#1)(2010-12#1)
is by no means##3##4##(1995-1#1)(2008-9#1)(2009-3#1)
is by##11##2##(1991-2#1)(1992-3#1)(1993-1#1)(1995-1#1)(1997-1#1)(2008-10#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-7#1)
is ca##2##2##(2008-10#2)
is calcium##2##2##(1993-8#1)(2010-12#1)
is calculated and compared with##2##5##(2008-3#2)
is calculated and##3##3##(2008-10#1)(2008-3#2)
is calculated as the##2##4##(2008-10#2)
is calculated as##3##3##(2008-10#3)
is calculated by##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
is calculated from the difference##2##5##(2008-10#2)
is calculated from the##7##4##(2008-10#4)(2008-3#2)(2008-9#1)
is calculated from##10##3##(2008-10#7)(2008-3#2)(2008-9#1)
is calculated to be##4##4##(1990-6#1)(2008-10#2)(2008-2#1)
is calculated##32##2##(1990-6#1)(2007-12#2)(2008-10#15)(2008-2#2)(2008-3#8)(2008-8#1)(2008-9#1)(2009-5#2)
is called the##2##3##(2008-10#1)(2012-3#1)
is called##14##2##(1991-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-1#1)(2009-10#1)(2010-6#2)(2011-2#2)(2012-3#1)
is capable of binding##3##4##(2008-10#1)(2008-9#1)(2009-8#1)
is capable of detecting##4##4##(1995-3#1)(2008-10#2)(2008-9#1)
is capable of direct##2##4##(1995-2#1)(2011-2#1)
is capable of directly##2##4##(2007-12#1)(2008-10#1)
is capable of generating##2##4##(2008-10#1)(2008-3#1)
is capable of identifying##2##4##(2008-10#1)(2009-12#1)
is capable of inducing##4##4##(1991-12#1)(1994-11#1)(1995-12#1)(2008-10#1)
is capable of mediating the electron transfer to##2##8##(2008-10#2)
is capable of##61##3##(1990-2#1)(1990-5#1)(1991-12#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#3)(2008-3#6)(2008-4#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-8#1)(2010-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
is capable##62##2##(1990-2#1)(1990-5#1)(1991-12#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#4)(2008-3#6)(2008-4#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-8#1)(2010-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
is carefully controlled##2##3##(2008-10#1)(2008-5#1)
is carefully##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
is carried out by a##2##5##(2008-10#1)(2008-4#1)
is carried out by complexation with##2##6##(2008-10#2)
is carried out by##7##4##(2008-10#5)(2008-4#1)(2008-5#1)
is carried out in a closed##2##6##(2008-10#2)
is carried out in a##4##5##(2008-10#4)
is carried out in an on-line system##2##7##(2008-10#2)
is carried out in the##2##5##(2008-10#2)
is carried out in##9##4##(2008-10#8)(2008-7#1)
is carried out on##3##4##(2008-10#3)
is carried out through##2##4##(2008-4#1)(2012-12#1)
is carried out using##5##4##(2008-10#3)(2008-7#1)(2013-8#1)
is carried out with##3##4##(1990-5#1)(1993-2#1)(2008-10#1)
is carried out##47##3##(1990-5#1)(1991-11#1)(1993-2#1)(1994-2#1)(1996-5#1)(2008-10#31)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
is carried##50##2##(1990-5#1)(1991-11#1)(1993-2#1)(1994-2#1)(1995-5#1)(1996-5#1)(2008-10#32)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
is catalyzed by a##2##4##(1990-10#1)(2012-2#1)
is catalyzed by##3##3##(1990-10#1)(2008-10#1)(2012-2#1)
is catalyzed##4##2##(1990-10#1)(2008-10#1)(2008-11#1)(2012-2#1)
is caused by Phytophthora##2##4##(2008-10#2)
is caused by a##9##4##(1997-3#1)(2008-10#5)(2008-12#1)(2011-2#1)(2012-12#1)
is caused by at least##2##5##(2008-10#1)(2008-6#1)
is caused by mutations in##2##5##(2013-1#1)(2013-8#1)
is caused by mutations##3##4##(1995-2#1)(2013-1#1)(2013-8#1)
is caused by the##12##4##(1993-3#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2010-4#1)(2013-8#1)
is caused by their##2##4##(2008-11#1)(2008-8#1)
is caused by##61##3##(1990-9#1)(1991-6#1)(1993-3#1)(1995-2#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
is caused largely by##2##4##(2008-10#1)(2008-8#1)
is caused primarily by##2##4##(2008-10#1)(2011-1#1)
is caused##68##2##(1990-9#1)(1991-6#2)(1993-3#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-1#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
is causing##2##2##(2008-10#1)(2013-8#1)
is central to the##4##4##(1997-1#1)(2008-1#1)(2008-8#1)(2008-9#1)
is central to##9##3##(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
is certainly##2##2##(2008-8#1)(2010-11#1)
is challenged by##2##3##(2008-11#1)(2008-5#1)
is challenged##4##2##(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
is challenging and##2##3##(2008-11#1)(2010-12#1)
is challenging because of##2##4##(2011-1#1)(2013-1#1)
is challenging##7##2##(2008-11#1)(2010-12#1)(2011-1#1)(2013-1#3)(2013-8#1)
is changed##4##2##(1997-3#1)(2008-7#1)(2008-8#2)
is changing##4##2##(1992-9#1)(1994-2#1)(1997-3#1)(2008-11#1)
is characterised by measuring the##2##5##(1994-12#1)(2008-10#1)
is characterised by the##2##4##(1993-3#1)(2007-8#1)
is characterised by##10##3##(1993-3#1)(1994-12#1)(1996-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2010-10#1)(2013-7#1)
is characterised##13##2##(1991-2#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-12#1)(2010-10#1)(2013-7#1)
is characteristic of##11##3##(1990-5#1)(1991-2#1)(1991-5#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-8#1)
is characteristic##13##2##(1990-5#1)(1991-2#1)(1991-5#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-6#1)(2009-8#2)
is characterized as##3##3##(1997-3#1)(2008-10#1)(2008-12#1)
is characterized by a##15##4##(1991-7#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
is characterized by an##6##4##(1994-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
is characterized by cortical##2##4##(2008-7#2)
is characterized by inflammatory##2##4##(2008-4#1)(2010-12#1)
is characterized by its##4##4##(2008-10#3)(2013-1#1)
is characterized by loss of##2##5##(1996-3#1)(1997-1#1)
is characterized by the presence of##2##6##(2010-6#2)
is characterized by the##12##4##(1995-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-6#4)(2011-2#2)
is characterized by##91##3##(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#2)(1992-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#2)(2008-10#16)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#7)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
is characterized##97##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#2)(1992-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#18)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#7)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
is cheap and##2##3##(2008-10#2)
is cheap##5##2##(1990-2#1)(2008-10#3)(2011-2#1)
is checked##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
is chosen##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
is claimed##2##2##(1997-4#1)(2008-5#1)
is classically##2##2##(2008-7#1)(2012-2#1)
is classified according to the##2##5##(1997-8#1)(2013-1#1)
is classified as##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
is classified into##3##3##(1997-8#1)(2008-12#1)(2012-2#1)
is classified##10##2##(1995-3#1)(1997-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is clear that the##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
is clear that##17##3##(1995-11#1)(1995-5#1)(1996-3#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-9#2)(2009-8#1)(2011-2#2)
is clear##30##2##(1995-11#1)(1995-5#1)(1996-3#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-8#1)
is cleared##2##2##(1994-5#1)(1997-1#1)
is clearly demonstrated##3##3##(2008-10#1)(2008-11#2)
is clearly not##2##3##(1996-12#1)(2008-10#1)
is clearly##18##2##(1992-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)
is cleaved##5##2##(1995-2#1)(2008-4#1)(2009-6#1)(2009-7#1)(2010-3#1)
is clinically##9##2##(1992-2#1)(2008-10#1)(2008-7#3)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
is cloned and##2##3##(1997-7#1)(2008-8#1)
is cloned##4##2##(1995-8#1)(1997-7#1)(2008-8#1)(2008-9#1)
is close to the##4##4##(1994-5#1)(1995-11#1)(2008-10#1)(2008-3#1)
is close to##10##3##(1994-5#1)(1995-11#1)(2008-10#5)(2008-3#1)(2011-2#1)(2013-8#1)
is closely associated with the##3##5##(1993-8#1)(2012-2#2)
is closely associated with##6##4##(1993-8#1)(2008-8#2)(2008-9#1)(2012-2#2)
is closely linked to##3##4##(2008-10#2)(2012-5#1)
is closely linked##4##3##(2008-10#2)(2008-11#1)(2012-5#1)
is closely related to the##2##5##(1991-7#1)(2008-3#1)
is closely related to##14##4##(1991-7#1)(1994-12#1)(1996-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)
is closely related##16##3##(1991-7#1)(1994-12#1)(1996-12#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)
is closely similar to##2##4##(1994-5#1)(2008-6#1)
is closely##31##2##(1991-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-5#1)(2009-7#1)(2011-3#1)(2012-2#2)(2012-5#1)
is coated with a##2##4##(2008-10#2)
is coated with##3##3##(2008-10#2)(2012-2#1)
is collected and##2##3##(2008-10#1)(2008-8#1)
is collected in a##3##4##(2008-10#3)
is collected in##4##3##(2008-10#4)
is collected##11##2##(2008-10#8)(2008-3#1)(2008-8#1)(2008-9#1)
is combined with##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
is combined##5##2##(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#1)
is commercially available##3##3##(2008-10#2)(2008-4#1)
is commercially##4##2##(2008-10#2)(2008-4#1)(2010-4#1)
is common and##2##3##(2008-10#1)(2008-6#1)
is common in the##4##4##(2008-11#1)(2010-7#1)(2012-3#2)
is common in##14##3##(2006-5#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-7#1)(2012-2#1)(2012-3#4)(2013-1#1)
is common to##2##3##(1991-5#1)(1996-1#1)
is common##28##2##(1991-5#1)(1996-1#1)(1996-11#1)(2006-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#6)(2013-1#1)
is commonly employed for##2##4##(2008-10#2)
is commonly found in##3##4##(2008-10#2)(2009-8#1)
is commonly found##5##3##(2008-10#2)(2008-12#1)(2009-8#1)(2013-8#1)
is commonly performed##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
is commonly used as a##2##5##(1992-11#1)(2008-10#1)
is commonly used for##3##4##(2008-10#3)
is commonly used in##2##4##(2011-2#1)(2013-1#1)
is commonly used to##2##4##(2008-4#1)(2008-8#1)
is commonly used##10##3##(1992-11#1)(2008-10#4)(2008-4#1)(2008-8#1)(2011-2#2)(2013-1#1)
is commonly##38##2##(1991-4#1)(1992-11#1)(1996-3#1)(2008-10#12)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
is commonplace##2##2##(2008-11#1)(2008-12#1)
is compact##3##2##(1993-8#1)(2008-10#1)(2008-3#1)
is comparable to that in##2##5##(2008-10#1)(2010-3#1)
is comparable to that##4##4##(1995-11#1)(1996-5#1)(2008-10#1)(2010-3#1)
is comparable to the##4##4##(2008-10#2)(2008-3#1)(2012-2#1)
is comparable to##12##3##(1995-11#1)(1996-5#1)(2008-10#5)(2008-3#2)(2010-3#2)(2012-2#1)
is comparable with that of the##3##6##(2007-12#1)(2008-10#1)(2008-3#1)
is comparable with that of##4##5##(2007-12#1)(2008-10#1)(2008-3#2)
is comparable with##8##3##(1990-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)
is comparable##24##2##(1990-2#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#5)(2008-5#1)(2010-3#2)(2012-2#1)(2013-1#1)
is comparatively##2##2##(1992-9#1)(2008-9#1)
is compared to that##3##4##(1994-2#1)(2008-6#1)(2010-8#1)
is compared to the##3##4##(1993-12#1)(2008-10#1)(2008-7#1)
is compared to##12##3##(1993-12#1)(1994-2#1)(1997-2#1)(2008-10#4)(2008-6#1)(2008-7#2)(2010-8#1)(2012-2#1)
is compared with a##2##4##(1995-11#1)(2007-12#1)
is compared with the##2##4##(1993-2#1)(2008-10#1)
is compared with##14##3##(1991-3#1)(1992-5#1)(1993-2#1)(1995-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)
is compared##30##2##(1991-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(1997-2#1)(2007-12#2)(2008-10#9)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2010-8#2)(2012-2#1)
is compatible with all##2##4##(2008-10#1)(2008-9#1)
is compatible with##10##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-2#1)(2011-7#1)(2013-1#1)
is compelling##2##2##(2008-7#1)(2011-2#1)
is compensated##2##2##(2008-3#1)(2013-1#1)
is competitive with##2##3##(1994-5#1)(1996-5#1)
is competitive##3##2##(1994-5#1)(1996-5#1)(2008-10#1)
is completed##9##2##(1994-3#1)(2008-10#5)(2008-12#1)(2008-8#1)(2009-8#1)
is completely blocked##2##3##(1997-7#1)(2008-9#1)
is completely buried##2##3##(1994-5#1)(2012-2#1)
is completely eluted##2##3##(2008-10#2)
is completely##19##2##(1993-12#1)(1993-9#1)(1994-5#1)(1997-7#2)(2007-12#1)(2008-10#6)(2008-4#2)(2008-9#1)(2009-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
is complex and##9##3##(1992-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-9#1)(2011-2#1)
is complex##19##2##(1991-12#1)(1991-3#1)(1992-12#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-12#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
is complexed##2##2##(2008-10#2)
is complicated by the##2##4##(2008-11#1)(2008-8#1)
is complicated by##12##3##(1990-12#1)(1994-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#3)(2008-9#1)(2013-1#1)(2013-8#1)
is complicated##17##2##(1990-12#1)(1994-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
is composed of a##5##4##(1992-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
is composed of an##2##4##(2008-10#1)(2011-2#1)
is composed of four##2##4##(1993-6#1)(2008-5#1)
is composed of the##2##4##(1990-5#1)(2008-6#1)
is composed of three##4##4##(2008-8#1)(2009-7#1)(2010-8#2)
is composed of two##4##4##(1994-5#1)(1995-2#1)(1996-2#1)(2008-8#1)
is composed of##41##3##(1990-11#1)(1990-5#1)(1990-8#1)(1992-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-7#1)(2010-11#1)(2010-8#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
is composed##43##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-7#1)(2010-11#1)(2010-8#3)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
is compounded##2##2##(2008-10#1)(2010-7#1)
is comprised of a##2##4##(1990-12#1)(2011-2#1)
is comprised of##7##3##(1990-12#1)(1990-8#1)(2008-10#2)(2008-6#1)(2011-2#1)(2013-8#1)
is compromised in##2##3##(2009-8#1)(2012-2#1)
is compromised##6##2##(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#2)(2012-2#1)
is computed##2##2##(2008-10#1)(2008-3#1)
is conceivable that##4##3##(1995-6#1)(2008-10#1)(2008-7#1)(2009-10#1)
is concentrated##4##2##(1992-6#1)(2008-10#1)(2008-9#1)(2010-10#1)
is concerned with the##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
is concerned with##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
is concerned##9##2##(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#2)
is concluded that the##17##4##(1991-2#1)(1991-6#1)(1992-12#1)(1993-8#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
is concluded that this##2##4##(2008-5#1)(2009-7#1)
is concluded that##75##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-3#2)(1997-2#3)(1997-3#1)(1997-8#4)(1997-9#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-7#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
is concluded##84##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#3)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-3#2)(1997-2#3)(1997-3#1)(1997-8#4)(1997-9#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-7#2)(2010-10#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
is conditioned by##2##3##(2008-10#2)
is conditioned##3##2##(2008-10#3)
is conducive to##2##3##(1993-2#1)(2011-2#1)
is conducted by##4##3##(1993-3#1)(1997-2#1)(2008-10#1)(2012-2#1)
is conducted in##2##3##(1994-12#1)(2008-10#1)
is conducted##11##2##(1993-3#1)(1994-12#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
is conducting##2##2##(2008-5#2)
is conferred by the##2##4##(2008-10#2)
is conferred by##3##3##(2008-10#3)
is conferred##4##2##(1995-5#1)(2008-10#3)
is configured##2##2##(1991-5#1)(2008-10#1)
is confined to##2##3##(1997-3#1)(2008-7#1)
is confirmed by the##3##4##(2008-10#2)(2008-11#1)
is confirmed by##11##3##(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2010-12#1)(2012-12#1)
is confirmed##19##2##(1990-3#1)(1990-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#2)
is confronted with the##2##4##(1992-1#1)(1993-11#1)
is connected to the##3##4##(2008-8#1)(2008-9#1)(2012-2#1)
is connected##4##2##(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
is conservative##2##2##(1992-9#1)(2008-8#1)
is conserved among##2##3##(1993-9#1)(2008-10#1)
is conserved between##2##3##(1995-2#1)(2012-3#1)
is conserved in all##2##4##(1993-9#1)(1995-2#1)
is conserved in##4##3##(1993-9#1)(1995-2#1)(1995-6#1)(2008-8#1)
is conserved##11##2##(1992-6#1)(1993-9#2)(1995-2#2)(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
is considerable evidence that##3##4##(2008-5#1)(2008-9#1)(2009-10#1)
is considerable variation##2##3##(2013-1#2)
is considerable##18##2##(1992-9#1)(1994-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2012-2#1)(2013-1#3)
is considerably more##2##3##(1992-12#1)(2012-3#1)
is considerably##10##2##(1991-12#1)(1991-8#1)(1992-12#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-3#1)
is considered a##14##3##(1992-12#1)(1993-2#1)(1993-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-10#2)(2011-2#1)(2012-2#2)(2013-8#1)
is considered an##5##3##(2008-10#3)(2012-2#1)(2013-7#1)
is considered and##3##3##(2008-10#2)(2008-11#1)
is considered as an##4##4##(1992-9#1)(2008-10#1)(2008-11#1)(2010-8#1)
is considered as the##2##4##(2007-8#1)(2008-10#1)
is considered as##9##3##(1992-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2010-8#1)
is considered in##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2012-3#1)
is considered that the##3##4##(2008-10#2)(2008-6#1)
is considered that##7##3##(2008-10#3)(2008-6#1)(2008-9#2)(2009-7#1)
is considered the##4##3##(1997-1#1)(2008-10#3)
is considered to be a##5##5##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
is considered to be one of the##2##7##(2008-8#1)(2013-8#1)
is considered to be the##2##5##(2011-2#1)(2013-7#1)
is considered to be##19##4##(1992-9#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
is considered to have##3##4##(1993-2#1)(1996-9#1)(2008-5#1)
is considered to##31##3##(1992-9#1)(1993-2#1)(1994-11#2)(1996-12#1)(1996-9#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
is considered##109##2##(1990-3#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-11#1)(1993-2#2)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#22)(2008-11#8)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#3)(2009-6#2)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#6)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#9)
is consistent with a role for##2##6##(1993-12#1)(1996-12#1)
is consistent with a##10##4##(1991-3#1)(1991-9#1)(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-8#1)
is consistent with current##2##4##(2008-10#1)(2008-3#1)
is consistent with experimental##2##4##(2008-12#1)(2010-10#1)
is consistent with previous##2##4##(2008-7#1)(2008-9#1)
is consistent with that of##2##5##(2008-10#2)
is consistent with that##3##4##(1994-2#1)(2008-10#2)
is consistent with the hypothesis that##3##6##(1993-6#1)(2008-10#1)(2008-6#1)
is consistent with the hypothesis##4##5##(1993-6#1)(2008-10#2)(2008-6#1)
is consistent with the observation that##2##6##(2008-10#2)
is consistent with the##24##4##(1991-10#1)(1993-3#1)(1993-6#1)(1995-6#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#2)(2013-1#2)
is consistent with##62##3##(1991-10#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-2#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#3)(2013-1#3)
is consistent##67##2##(1991-10#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#3)(1994-2#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#4)(2013-1#3)
is consistently better##2##3##(2008-10#1)(2012-3#1)
is consistently higher##2##3##(2008-11#1)(2012-3#1)
is consistently##6##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#2)
is constant##6##2##(2008-10#3)(2008-12#1)(2008-9#2)
is constituted by##5##3##(2008-10#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
is constituted##6##2##(2008-10#1)(2008-9#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
is constitutively expressed##2##3##(1995-6#1)(2008-8#1)
is constitutively##3##2##(1995-6#1)(2008-8#1)(2011-2#1)
is constrained##2##2##(2008-8#1)(2008-9#1)
is constructed and##2##3##(2008-10#1)(2008-3#1)
is constructed by##2##3##(2008-10#1)(2008-6#1)
is constructed for##3##3##(1995-9#1)(2007-12#1)(2008-11#1)
is constructed from a##2##4##(2008-10#2)
is constructed from##4##3##(2008-10#2)(2008-3#1)(2010-8#1)
is constructed##15##2##(1995-9#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-6#1)(2009-2#1)(2010-8#1)(2011-2#1)
is consumed in the##2##4##(2008-10#1)(2008-7#1)
is consumed##5##2##(1994-3#1)(2008-10#3)(2008-7#1)
is contained within a##2##4##(1995-2#1)(2009-10#1)
is contained within contig##2##4##(1994-11#2)
is contained within##5##3##(1994-11#2)(1995-2#1)(1995-6#1)(2009-10#1)
is contained##6##2##(1992-12#1)(1994-11#2)(1995-2#1)(1995-6#1)(2009-10#1)
is contentious##3##2##(2008-11#1)(2008-8#1)(2010-10#1)
is continuing##3##2##(1994-9#1)(2008-6#1)(2011-2#1)
is continuous##4##2##(1991-9#1)(1994-1#1)(2008-10#1)(2009-8#1)
is continuously circulated##2##3##(2008-10#2)
is continuously##12##2##(1991-3#1)(2008-10#7)(2008-2#1)(2008-6#1)(2010-11#1)(2010-12#1)
is contraindicated##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
is controlled at##3##3##(1991-6#1)(1997-1#1)(2008-11#1)
is controlled by a microcomputer##2##5##(2008-10#2)
is controlled by a single recessive gene##2##7##(2008-10#1)(2008-9#1)
is controlled by a single recessive##3##6##(2008-10#2)(2008-9#1)
is controlled by a single##5##5##(2008-10#4)(2008-9#1)
is controlled by a##12##4##(1994-12#1)(1995-2#2)(2008-10#8)(2008-9#1)
is controlled by the##5##4##(1990-11#1)(1994-2#1)(2008-4#1)(2009-12#1)(2011-2#1)
is controlled by two##2##4##(2008-10#1)(2010-4#1)
is controlled by##31##3##(1990-11#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#3)(1995-5#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
is controlled via##2##3##(2008-12#1)(2012-2#1)
is controlled##42##2##(1990-11#2)(1991-6#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#3)(1995-5#1)(1997-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
is controversial and##2##3##(2011-2#1)(2013-1#1)
is controversial##11##2##(1993-3#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-1#1)(2011-2#2)(2013-1#4)
is convenient and##2##3##(2008-10#1)(2012-2#1)
is convenient##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
is conventionally##2##2##(2008-10#1)(2008-9#1)
is converted into##3##3##(2008-10#2)(2011-2#1)
is converted to a##3##4##(1992-8#2)(2008-10#1)
is converted to##9##3##(1992-8#2)(2008-10#5)(2011-1#1)(2012-2#1)
is converted##16##2##(1992-8#2)(2008-10#9)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
is correct##2##2##(2008-9#1)(2009-8#1)
is correctly##2##2##(2008-3#1)(2008-8#1)
is correlated to the##2##4##(2008-10#2)
is correlated with a##2##4##(1997-7#1)(2008-8#1)
is correlated with the##4##4##(1997-8#1)(2007-12#1)(2008-11#1)(2012-2#1)
is correlated with##16##3##(1994-8#1)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is correlated##19##2##(1994-8#1)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-8#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is corroborated by##2##3##(2007-12#1)(2008-3#1)
is cosmetically##2##2##(2008-5#2)
is cost-effective##2##2##(2008-8#1)(2012-3#1)
is costly##2##2##(2008-8#2)
is counterbalanced by##3##3##(1992-12#1)(1995-12#1)(2007-11#1)
is coupled to##5##3##(1993-8#1)(2008-10#2)(2008-11#1)(2009-10#1)
is coupled with the##2##4##(2008-10#2)
is coupled with##4##3##(2008-10#4)
is coupled##13##2##(1993-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2009-10#1)
is covered by##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
is covered with a##2##4##(2008-10#1)(2008-12#1)
is covered with##3##3##(2008-10#1)(2008-12#2)
is covered##7##2##(2008-10#2)(2008-11#1)(2008-12#2)(2011-2#2)
is created and##3##3##(1994-3#1)(1995-3#1)(2011-2#1)
is created that##2##3##(1994-5#1)(2008-3#1)
is created via##2##3##(2008-10#1)(2013-1#1)
is created##11##2##(1994-3#1)(1994-5#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#2)
is critical for its##2##4##(1995-2#1)(2008-9#1)
is critical for the##6##4##(2008-10#3)(2009-8#1)(2012-2#1)(2013-1#1)
is critical for##32##3##(1991-12#1)(1992-12#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-9#3)(2009-8#3)(2010-10#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#2)(2013-8#1)
is critical in##5##3##(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
is critical to effective##2##4##(1995-5#1)(2013-1#1)
is critical to the success of##2##6##(1994-12#1)(2011-2#1)
is critical to the##5##4##(1994-12#1)(1996-12#1)(2008-11#1)(2011-2#2)
is critical to##19##3##(1993-3#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#1)
is critical##73##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2008-10#12)(2008-11#7)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-7#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-4#1)(2013-1#4)(2013-8#2)
is critically important##2##3##(2008-7#1)(2010-7#1)
is critically##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)
is crucial for obtaining##2##4##(1995-2#1)(2008-4#1)
is crucial for the##5##4##(1994-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-11#1)
is crucial for##19##3##(1991-2#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#2)(2010-7#1)(2011-2#1)(2013-1#1)
is crucial in the##2##4##(2007-12#1)(2011-2#1)
is crucial in##6##3##(2007-12#1)(2008-10#1)(2010-10#1)(2011-2#2)(2012-2#1)
is crucial that##4##3##(1995-5#1)(2008-10#1)(2010-9#1)(2013-1#1)
is crucial to provide##2##4##(1991-12#1)(2010-11#1)
is crucial to the##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
is crucial to understand##2##4##(2008-9#1)(2012-2#1)
is crucial to##12##3##(1991-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#2)
is crucial##48##2##(1991-12#1)(1991-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-7#1)(2010-9#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
is cured##2##2##(1994-9#2)
is currently available##2##3##(1994-2#1)(1994-3#1)
is currently being used##2##4##(2008-10#1)(2010-6#1)
is currently being##9##3##(1992-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-3#1)(2010-6#1)(2013-1#1)
is currently in##3##3##(2008-3#1)(2009-4#1)(2011-2#1)
is currently not##4##3##(1992-12#1)(2008-1#1)(2011-2#1)(2011-3#1)
is currently occurring##2##3##(2008-10#1)(2008-7#1)
is currently regarded as a##2##5##(1996-2#1)(2011-2#1)
is currently the most widely used##2##6##(1991-3#1)(1996-1#1)
is currently the most##4##4##(1991-3#1)(1996-1#2)(2008-10#1)
is currently the##6##3##(1991-3#1)(1996-1#2)(2008-10#1)(2011-2#1)(2013-1#1)
is currently under evaluation##2##4##(2011-3#1)(2013-1#1)
is currently under##4##3##(2008-11#1)(2010-3#1)(2011-3#1)(2013-1#1)
is currently used for##2##4##(2010-11#1)(2010-7#1)
is currently used##4##3##(2008-10#2)(2010-11#1)(2010-7#1)
is currently##66##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#3)(1996-2#2)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#10)(2011-3#2)(2012-3#2)(2013-1#4)
is dangerous##2##2##(1994-6#1)(2008-11#1)
is dead##2##2##(2007-12#1)(2008-8#1)
is dealing with##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
is dealing##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
is dealt with##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
is debatable##2##2##(2008-10#1)(2012-2#1)
is debate##2##2##(2008-11#1)(2009-10#1)
is debated##3##2##(1993-3#1)(2008-11#1)(2008-8#1)
is decreased by##3##3##(1992-1#1)(2008-10#1)(2009-9#1)
is decreased to##2##3##(2008-10#1)(2008-9#1)
is decreased##11##2##(1992-1#1)(1996-2#1)(2008-10#5)(2008-9#2)(2009-9#1)(2012-2#1)
is dedicated to##2##3##(2008-10#1)(2009-9#1)
is dedicated##3##2##(2008-1#1)(2008-10#1)(2009-9#1)
is deduced from##2##3##(2008-11#1)(2008-3#1)
is deduced##5##2##(1993-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
is deficient in##3##3##(2008-10#2)(2009-8#1)
is deficient##4##2##(2008-10#2)(2008-11#1)(2009-8#1)
is defined as a situation in which##2##7##(2008-11#1)(2008-5#1)
is defined as a##6##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)
is defined as an##2##4##(2008-7#1)(2011-2#1)
is defined as the##7##4##(1991-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
is defined as##21##3##(1991-11#1)(1992-2#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#2)(2012-3#1)
is defined by the##2##4##(2008-10#1)(2008-9#1)
is defined by##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
is defined in##3##3##(1993-3#1)(1997-3#1)(1997-6#1)
is defined##33##2##(1991-11#1)(1992-2#1)(1993-3#1)(1997-3#1)(1997-6#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#1)
is delayed##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
is delivered##5##2##(1993-3#1)(1997-2#1)(1997-3#1)(2008-12#1)(2009-8#1)
is demonstrated and##2##3##(2008-10#1)(2008-9#1)
is demonstrated by application to##2##5##(2008-10#1)(2008-3#1)
is demonstrated by applying it to##2##6##(2008-10#2)
is demonstrated by the##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
is demonstrated by##21##3##(1995-2#2)(2007-11#2)(2008-10#13)(2008-3#2)(2008-5#1)(2012-3#1)
is demonstrated for the first time##3##6##(2007-11#1)(2008-10#2)
is demonstrated for the##4##4##(2007-11#1)(2008-10#3)
is demonstrated for##8##3##(1997-2#1)(2007-11#1)(2008-10#5)(2008-3#1)
is demonstrated in the present##2##5##(2008-10#1)(2008-11#1)
is demonstrated in the##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
is demonstrated in this##2##4##(1995-3#1)(2013-1#1)
is demonstrated in##8##3##(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2013-1#2)
is demonstrated over##2##3##(2008-10#2)
is demonstrated that the##4##4##(2008-10#2)(2008-3#1)(2013-1#1)
is demonstrated that##15##3##(1993-8#1)(2007-12#1)(2008-10#5)(2008-3#6)(2013-1#2)
is demonstrated to be a##2##5##(2008-10#1)(2008-6#1)
is demonstrated to be##4##4##(1992-1#1)(2008-10#2)(2008-6#1)
is demonstrated to promote the electrochemical##2##6##(2008-10#2)
is demonstrated to##8##3##(1992-1#1)(2008-10#6)(2008-6#1)
is demonstrated using##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
is demonstrated with the##2##4##(2008-10#2)
is demonstrated with##5##3##(2008-10#2)(2008-3#2)(2010-12#1)
is demonstrated##114##2##(1992-1#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-2#2)(1995-3#1)(1996-5#1)(1997-2#2)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#56)(2008-11#2)(2008-2#3)(2008-3#21)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
is dependent on both##2##4##(1995-3#1)(1995-5#1)
is dependent on pH##2##4##(2008-10#2)
is dependent on the concentration of##2##6##(2008-10#2)
is dependent on the##22##4##(1990-2#1)(1996-5#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
is dependent on##50##3##(1990-11#1)(1990-2#1)(1991-5#2)(1992-10#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
is dependent upon the##6##4##(1990-3#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
is dependent upon##13##3##(1990-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)
is dependent##65##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-5#2)(1992-10#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
is depleted##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
is deposited as##2##3##(2008-10#2)
is deposited##3##2##(2008-10#3)
is deprotonated##2##2##(1992-3#1)(2008-10#1)
is derived by use of##2##5##(2008-3#2)
is derived from a##3##4##(2008-10#2)(2008-4#1)
is derived from the##6##4##(1995-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-3#1)
is derived from##15##3##(1991-11#1)(1993-2#1)(1995-2#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#1)(2012-3#1)(2013-1#1)
is derived to##2##3##(2008-3#1)(2013-1#1)
is derived##28##2##(1991-11#1)(1993-2#1)(1995-2#1)(1995-9#1)(2007-11#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#1)(2012-3#1)(2013-1#2)
is described and evaluated##2##4##(2008-10#2)
is described and the##2##4##(1995-9#1)(2008-12#1)
is described and##12##3##(1990-9#1)(1995-9#1)(1996-2#2)(1996-5#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-3#1)
is described as a##3##4##(1991-3#1)(2008-10#1)(2011-2#1)
is described as well as##2##5##(2008-10#2)
is described as well##3##4##(2008-10#2)(2008-3#1)
is described as##10##3##(1991-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
is described based on the##3##5##(2008-10#3)
is described based on##5##4##(2008-10#5)
is described by means of##2##5##(2008-3#1)(2008-6#1)
is described by##7##3##(1994-5#1)(2008-10#4)(2008-3#1)(2008-6#1)
is described for detecting##2##4##(1990-12#1)(2008-10#1)
is described for the determination of hydrazine##2##7##(2008-10#2)
is described for the determination of trace##5##7##(2008-10#5)
is described for the determination of##46##6##(2008-10#46)
is described for the first time##2##6##(2008-10#2)
is described for the identification of##2##6##(2008-10#2)
is described for the selective##2##5##(2008-10#2)
is described for the sequential determination of##2##7##(2008-10#2)
is described for the simultaneous determination of##3##7##(2008-10#3)
is described for the##67##4##(2008-10#66)(2008-2#1)
is described for##90##3##(1990-12#1)(1992-8#1)(2008-10#77)(2008-11#3)(2008-2#1)(2008-4#5)(2008-9#1)(2013-1#1)
is described here##2##3##(1991-6#1)(2010-6#1)
is described herein##2##3##(2008-10#1)(2008-11#1)
is described in a##5##4##(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)
is described in detail##4##4##(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
is described in the second##2##5##(1997-6#1)(2010-11#1)
is described in the##4##4##(1997-6#1)(2008-10#1)(2008-4#1)(2010-11#1)
is described in this paper##5##5##(1996-12#1)(2008-10#4)
is described in this unit##4##5##(2008-2#1)(2008-4#3)
is described in this##14##4##(1996-12#1)(2008-10#8)(2008-2#1)(2008-4#3)(2013-1#1)
is described in which##2##4##(1994-5#1)(2008-10#1)
is described in##32##3##(1991-2#1)(1994-12#1)(1994-5#1)(1996-12#1)(1997-6#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-4#5)(2008-9#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-1#1)
is described of##2##3##(1991-3#1)(2009-10#1)
is described that is##2##4##(2008-10#2)
is described that##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
is described where a##2##4##(2008-10#2)
is described which allows##2##4##(1992-9#1)(2011-2#1)
is described which is##2##4##(1990-2#1)(2008-10#1)
is described which##9##3##(1990-2#1)(1991-2#1)(1992-9#1)(1993-2#1)(2008-10#3)(2010-11#1)(2011-2#1)
is described with##5##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
is described##527##2##(1990-11#1)(1990-12#5)(1990-2#2)(1990-6#1)(1990-9#3)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#3)(1995-12#8)(1995-2#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#5)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#332)(2008-11#14)(2008-12#6)(2008-2#7)(2008-3#23)(2008-4#21)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#2)(2009-7#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
is designated as##6##3##(2008-10#3)(2008-8#1)(2008-9#2)
is designated##12##2##(2008-10#6)(2008-8#2)(2008-9#3)(2012-2#1)
is designed and##2##3##(2008-10#1)(2008-6#1)
is designed for##4##3##(1991-1#1)(2008-1#1)(2008-2#1)(2008-9#1)
is designed to##17##3##(1991-12#2)(1992-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#3)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
is designed##28##2##(1991-1#1)(1991-12#2)(1992-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-6#1)(2008-9#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
is desirable and##2##3##(1995-2#1)(1996-6#1)
is desirable to##3##3##(2008-9#1)(2012-2#1)(2012-3#1)
is desirable##9##2##(1995-2#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-9#2)(2010-7#1)(2012-2#1)(2012-3#1)
is desired##3##2##(1995-5#1)(2008-4#1)(2008-7#1)
is destabilized by##2##3##(2008-7#1)(2013-8#1)
is detectable in##3##3##(1994-3#1)(1995-12#1)(2008-10#1)
is detectable##6##2##(1994-11#1)(1994-3#1)(1995-12#1)(2008-10#2)(2012-3#1)
is detected at##5##3##(1996-12#1)(2008-10#3)(2009-5#1)
is detected by##9##3##(2008-10#5)(2008-3#1)(2008-9#3)
is detected in the##2##4##(1994-11#1)(2008-10#1)
is detected in##8##3##(1994-11#1)(1996-12#2)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#2)
is detected on glassy carbon electrode##2##6##(2008-10#2)
is detected using a##2##4##(2008-10#2)
is detected using##3##3##(2008-10#2)(2008-9#1)
is detected with##2##3##(1993-2#1)(2008-10#1)
is detected##48##2##(1992-12#1)(1993-2#1)(1994-11#1)(1996-12#3)(2007-11#1)(2007-12#1)(2008-10#28)(2008-3#1)(2008-4#1)(2008-9#5)(2009-5#1)(2011-2#2)(2013-1#2)
is detection##2##2##(1992-1#1)(2008-3#1)
is determined after##2##3##(2008-10#2)
is determined as##2##3##(2008-10#1)(2008-2#1)
is determined at pH##2##4##(2008-10#2)
is determined by a##2##4##(2008-10#1)(2008-7#1)
is determined by differential pulse polarography##2##6##(2008-10#2)
is determined by measuring the##2##5##(2008-10#1)(2008-4#1)
is determined by the##21##4##(1990-8#1)(1993-6#1)(1994-8#1)(1996-3#1)(2008-10#10)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-8#1)(2012-3#1)
is determined by##51##3##(1990-8#2)(1993-6#1)(1994-8#3)(1996-3#1)(2008-10#25)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#2)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
is determined directly##2##3##(2008-10#2)
is determined from the##2##4##(2008-10#2)
is determined in##5##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
is determined on##2##3##(2008-10#1)(2009-3#1)
is determined primarily by##2##4##(2008-8#2)
is determined that##2##3##(2008-3#2)
is determined to be##2##4##(2008-3#1)(2009-11#1)
is determined using##4##3##(2008-10#3)(2008-8#1)
is determined##94##2##(1990-8#2)(1991-2#1)(1991-5#1)(1993-6#1)(1994-8#3)(1996-3#1)(2008-1#1)(2008-10#48)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is determining##2##2##(2008-7#1)(2008-8#1)
is developed and##2##3##(2008-10#1)(2008-3#1)
is developed by##3##3##(2008-10#3)
is developed for determination of##3##5##(2008-10#3)
is developed for the determination of##4##6##(2008-10#4)
is developed for the##10##4##(2008-10#9)(2009-5#1)
is developed for##24##3##(1993-12#1)(1994-9#1)(2008-10#19)(2008-3#1)(2008-9#1)(2009-5#1)
is developed in order to##2##5##(2008-10#2)
is developed in the##2##4##(2008-10#1)(2012-3#1)
is developed in this paper##3##5##(2008-10#3)
is developed in##8##3##(2008-10#6)(2008-3#1)(2012-3#1)
is developed that##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
is developed to##5##3##(2008-10#1)(2008-3#2)(2010-7#1)(2013-8#1)
is developed##86##2##(1993-12#1)(1994-12#1)(1994-9#1)(1996-6#1)(2008-10#55)(2008-12#1)(2008-3#13)(2008-6#1)(2008-9#2)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
is developing##4##2##(2008-11#1)(2008-5#3)
is developmentally##2##2##(1994-11#1)(1997-3#1)
is devoid of##3##3##(1991-12#1)(1995-8#1)(1997-1#1)
is devoted to##4##3##(1995-5#1)(2008-10#2)(2012-3#1)
is devoted##5##2##(1991-12#1)(1995-5#1)(2008-10#2)(2012-3#1)
is diagnosed of##2##3##(2009-8#1)(2013-1#1)
is diagnosed##10##2##(1990-6#1)(1992-12#1)(1994-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#2)(2009-9#1)(2013-1#1)
is different for##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
is different from all the##2##5##(1993-12#1)(2008-10#1)
is different from all##4##4##(1993-12#1)(2008-10#2)(2008-2#1)
is different from that in##3##5##(1993-8#1)(2008-8#1)(2013-1#1)
is different from that##6##4##(1993-2#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
is different from the##4##4##(1991-1#1)(1995-10#1)(2010-8#2)
is different from##19##3##(1991-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-10#1)(1995-12#1)(1996-5#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#2)(2013-1#1)
is different in##2##3##(2008-11#1)(2009-7#1)
is different##37##2##(1991-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-10#1)(1995-12#1)(1996-5#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
is difficult and##3##3##(2008-7#1)(2010-7#1)(2013-1#1)
is difficult because of##2##4##(2010-12#1)(2012-12#1)
is difficult because##8##3##(2008-10#1)(2008-3#1)(2008-9#1)(2009-1#1)(2010-12#1)(2012-12#1)(2012-3#2)
is difficult to achieve##3##4##(2008-9#1)(2010-12#1)(2011-2#1)
is difficult to determine##2##4##(1995-12#1)(2008-2#1)
is difficult to diagnose##3##4##(2009-12#1)(2010-3#1)(2013-8#1)
is difficult to predict##2##4##(2008-5#1)(2011-2#1)
is difficult to treat##2##4##(2008-7#1)(2011-2#1)
is difficult to##39##3##(1991-12#1)(1991-2#1)(1994-6#1)(1995-12#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#2)
is difficult##65##2##(1991-12#1)(1991-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-2#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#8)(2012-12#2)(2012-3#3)(2012-9#1)(2013-1#4)(2013-8#2)
is digested and##2##3##(1990-12#1)(2008-10#1)
is digested##3##2##(1990-12#1)(1993-8#1)(2008-10#1)
is diluted##3##2##(2008-10#2)(2008-5#1)
is diminished##3##2##(1992-9#1)(1997-8#1)(2008-8#1)
is directed to##4##3##(1991-6#1)(2006-6#1)(2008-10#1)(2008-11#1)
is directed toward##2##3##(2011-2#1)(2011-7#1)
is directed towards the##2##4##(2008-6#2)
is directed##16##2##(1990-11#2)(1991-6#1)(1994-5#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
is directly applicable##2##3##(2008-10#1)(2008-11#1)
is directly correlated with##3##4##(1993-11#1)(2008-2#1)(2010-7#1)
is directly coupled with##2##4##(2008-10#2)
is directly implicated in##2##4##(1990-8#1)(2011-2#1)
is directly linked to##2##4##(2008-5#1)(2011-2#1)
is directly performed on the##2##5##(2008-10#2)
is directly proportional to the concentration of##3##7##(2008-10#3)
is directly proportional to the##4##5##(2008-10#4)
is directly proportional to##5##4##(2008-10#4)(2008-11#1)
is directly related to the##7##5##(2008-10#5)(2008-3#1)(2008-5#1)
is directly related to##14##4##(1994-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-9#2)(2013-1#1)(2013-8#1)
is directly##52##2##(1990-8#1)(1993-11#1)(1993-8#1)(1994-12#1)(1997-2#1)(2008-10#26)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
is disagreement##2##2##(1996-11#1)(1997-7#1)
is discharged##2##2##(2008-10#1)(2008-11#1)
is discouraged##4##2##(1997-5#1)(2008-10#2)(2008-8#1)
is discovered##5##2##(2008-8#1)(2008-9#1)(2009-11#1)(2013-1#2)
is discussed along with##2##4##(2008-10#1)(2008-5#1)
is discussed and the##2##4##(1996-2#1)(2008-7#1)
is discussed and##5##3##(1996-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-9#1)
is discussed as a##3##4##(1995-3#1)(2008-10#1)(2009-6#1)
is discussed as##6##3##(1990-5#1)(1995-3#1)(2008-10#1)(2009-6#1)(2010-10#1)(2011-2#1)
is discussed in detail##2##4##(2008-10#2)
is discussed in light of##2##5##(2008-3#1)(2011-2#1)
is discussed in relation to the##3##6##(2008-10#2)(2008-11#1)
is discussed in relation to##6##5##(2008-10#4)(2008-11#2)
is discussed in the context of##5##6##(2008-10#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-1#1)
is discussed in the light of the##2##7##(1993-3#1)(1997-7#1)
is discussed in the light of##3##6##(1993-3#1)(1997-7#1)(2008-10#1)
is discussed in the##10##4##(1993-3#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-1#1)
is discussed in this article##2##5##(2010-2#1)(2013-1#1)
is discussed in this paper##3##5##(1997-3#1)(2008-10#1)(2008-12#1)
is discussed in this##6##4##(1997-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2010-2#1)(2013-1#1)
is discussed in##31##3##(1993-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-1#1)
is discussed with##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
is discussed##209##2##(1990-12#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(2008-1#2)(2008-10#77)(2008-11#14)(2008-12#7)(2008-2#3)(2008-3#11)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#7)(2012-3#1)(2012-4#1)(2013-1#5)(2013-8#2)
is dispensable for##4##3##(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)
is dispersed##3##2##(1997-2#1)(2008-10#2)
is disrupted by##3##3##(1993-2#1)(1994-11#1)(1996-5#1)
is disrupted##4##2##(1993-2#1)(1994-11#1)(1996-5#1)(1997-4#1)
is dissociated##2##2##(2008-10#1)(2010-7#1)
is dissolved in##5##3##(2008-10#5)
is dissolved with##2##3##(2008-10#2)
is dissolved##8##2##(2008-10#7)(2008-4#1)
is distinct from other##2##4##(2008-10#2)
is distinct from that##2##4##(1995-12#1)(2008-10#1)
is distinct from##14##3##(1991-5#1)(1993-11#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-9#1)(2010-12#2)
is distributed##9##2##(1994-9#1)(2008-10#3)(2008-6#1)(2009-8#1)(2010-6#1)(2011-2#2)
is disturbed##3##2##(1994-8#2)(2008-11#1)
is diverse##2##2##(2008-10#1)(2011-2#1)
is divided into the##2##4##(2008-10#1)(2010-6#1)
is divided into three##2##4##(2008-10#1)(2008-3#1)
is divided into two phases##2##5##(2008-4#1)(2008-5#1)
is divided into two##3##4##(2008-4#2)(2008-5#1)
is divided into##10##3##(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-6#1)
is divided##11##2##(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)
is documented##4##2##(1990-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
is doing well##3##3##(2008-8#1)(2013-1#1)(2013-7#1)
is dominant and##2##3##(2008-10#1)(2009-8#1)
is dominant##6##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)
is dominated by the##2##4##(2008-11#1)(2008-3#1)
is dominated by##6##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)
is done by##3##3##(2008-10#2)(2011-2#1)
is done on a##2##4##(1990-6#1)(2012-2#1)
is done on##3##3##(1990-6#1)(2010-7#1)(2012-2#1)
is done##15##2##(1990-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(2008-1#1)(2008-10#5)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
is down##4##2##(1994-9#1)(2008-10#2)(2008-9#1)
is downregulated##2##2##(2008-7#1)(2011-2#1)
is dramatically enhanced by##2##4##(2008-10#1)(2008-11#1)
is dramatically##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
is drawn##6##2##(1991-1#1)(1994-3#1)(1995-11#1)(2008-10#2)(2008-5#1)
is driven by the##4##4##(1993-9#1)(2008-10#1)(2008-9#1)(2011-1#1)
is driven by##14##3##(1993-12#1)(1993-9#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-9#3)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
is driven to##2##3##(2008-10#2)
is driven##18##2##(1993-12#1)(1993-9#1)(1994-6#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
is due in part to the##2##6##(2007-12#1)(2008-10#1)
is due in part to##3##5##(2007-12#1)(2008-10#2)
is due in##4##3##(2007-12#1)(2008-10#2)(2008-6#1)
is due only to##2##4##(1997-2#1)(2012-3#1)
is due to a##10##4##(1990-5#1)(2008-10#6)(2009-10#1)(2010-1#1)(2012-2#1)
is due to an##6##4##(1997-3#1)(1997-7#1)(2008-10#4)
is due to different##2##4##(2008-2#1)(2012-3#1)
is due to its##3##4##(1991-6#1)(1992-9#1)(1995-2#1)
is due to mutations in##2##5##(2008-11#2)
is due to the fact that##2##6##(2008-10#1)(2008-3#1)
is due to the formation##2##5##(2008-11#1)(2008-3#1)
is due to the presence of##2##6##(1992-3#1)(1997-6#1)
is due to the temperature##2##5##(2008-3#2)
is due to the##26##4##(1990-5#1)(1992-3#1)(1994-9#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#1)(2012-3#1)
is due to##90##3##(1990-5#4)(1990-6#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-2#3)(2008-3#16)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2010-1#1)(2010-11#1)(2010-4#1)(2012-2#2)(2012-3#3)(2012-7#1)
is due##103##2##(1990-5#4)(1990-6#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#24)(2008-11#4)(2008-2#4)(2008-3#16)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2010-1#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-7#1)
is dynamically##2##2##(1995-2#1)(2008-6#1)
is early##3##2##(1992-12#1)(1995-12#1)(2008-11#1)
is easier to##8##3##(2008-10#4)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#1)
is easier##11##2##(1990-11#1)(1991-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2013-1#1)
is easily##17##2##(1996-1#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
is easy for##2##3##(2008-10#1)(2008-5#1)
is easy to perform##2##4##(2008-10#1)(2012-2#1)
is easy to use##3##4##(1991-11#1)(2008-10#1)(2008-11#1)
is easy to##16##3##(1991-11#1)(1994-12#1)(2008-10#5)(2008-11#3)(2008-3#1)(2010-8#1)(2011-2#2)(2012-2#2)
is easy##21##2##(1991-11#1)(1994-12#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#3)(2012-2#2)
is effective against##2##3##(2008-10#2)
is effective and safe in##2##5##(2008-1#1)(2010-12#1)
is effective and##5##3##(1994-8#1)(1997-2#1)(2008-1#1)(2008-11#1)(2010-12#1)
is effective as a##2##4##(2008-11#1)(2012-2#1)
is effective as##3##3##(1990-2#1)(2008-11#1)(2012-2#1)
is effective for the##2##4##(2008-11#1)(2008-8#1)
is effective for##7##3##(1996-1#1)(2008-10#2)(2008-11#2)(2008-8#2)
is effective in reducing##2##4##(2008-10#1)(2011-2#1)
is effective in the##2##4##(2008-10#1)(2009-12#1)
is effective in##16##3##(1993-6#1)(1995-2#1)(2008-10#4)(2008-11#3)(2008-7#1)(2009-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
is effective##40##2##(1990-2#1)(1992-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
is effectively a##2##3##(2008-9#2)
is effectively##4##2##(2008-7#1)(2008-8#1)(2008-9#2)
is efficacious in##2##3##(1991-3#1)(1992-1#1)
is efficacious##4##2##(1991-3#1)(1992-1#1)(2008-7#1)(2013-1#1)
is efficient and##2##3##(2008-4#1)(2012-3#1)
is efficient for##2##3##(2008-5#1)(2008-7#1)
is efficient##6##2##(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
is efficiently##2##2##(1995-5#1)(2008-10#1)
is either incomplete or##2##4##(2010-8#1)(2012-2#1)
is either##8##2##(1991-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)(2010-8#1)(2012-2#1)
is elaborated##4##2##(1990-2#1)(2008-10#2)(2008-12#1)
is elevated in##2##3##(1991-7#1)(2008-12#1)
is elevated##5##2##(1991-7#1)(1995-6#1)(2008-12#1)(2008-8#1)(2009-9#1)
is eliminated by the addition of EDTA##2##7##(2008-10#2)
is eliminated by the addition of##3##6##(2008-10#3)
is eliminated by##7##3##(1991-5#1)(2008-10#5)(2012-2#1)
is eliminated##8##2##(1991-5#1)(1995-2#1)(2008-10#5)(2012-2#1)
is eluted by##2##3##(2008-10#2)
is eluted with 0##2##4##(2008-10#2)
is eluted with##7##3##(2008-10#6)(2008-5#1)
is eluted##10##2##(2008-10#9)(2008-5#1)
is embedded within##2##3##(2011-2#1)(2013-1#1)
is embedded##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
is emerging as a##4##4##(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
is emerging as an##2##4##(1992-1#1)(2011-2#1)
is emerging as##6##3##(1992-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#2)
is emerging evidence##3##3##(1994-5#1)(2008-4#1)(2009-6#1)
is emerging##11##2##(1992-1#1)(1994-5#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#3)
is emphasised##6##2##(1996-6#1)(2007-11#1)(2008-11#3)(2008-7#1)
is emphasized##12##2##(1991-11#1)(1991-12#1)(1991-3#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)
is employed in##3##3##(2008-10#2)(2008-3#1)
is employed to##6##3##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#3)
is employed##19##2##(1990-8#1)(1994-12#1)(1994-2#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)
is encoded by a##3##4##(1993-6#1)(1995-6#1)(2008-8#1)
is encoded by the##4##4##(1993-2#1)(1994-6#1)(1995-6#1)(2008-3#1)
is encoded by two##2##4##(1993-9#1)(1997-7#1)
is encoded by##12##3##(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#2)(1997-7#2)(2008-3#1)(2008-8#1)
is encoded##15##2##(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#2)(1997-7#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)
is encountered on the skin##2##5##(2008-5#2)
is encountered##3##2##(1995-5#1)(2008-5#2)
is encouraged##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
is encouraging##2##2##(2008-11#1)(2012-3#1)
is endemic in##3##3##(1991-11#1)(2011-2#1)(2012-3#1)
is endemic##7##2##(1991-11#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-3#1)
is enforced by##4##3##(2008-3#1)(2008-8#1)(2011-2#2)
is enhanced by the##3##4##(1996-3#1)(2008-10#1)(2009-8#1)
is enhanced by##12##3##(1991-5#1)(1994-8#1)(1996-3#2)(2006-6#1)(2008-10#2)(2009-10#1)(2009-8#1)(2012-2#2)(2012-3#1)
is enhanced during##2##3##(2008-11#1)(2008-7#1)
is enhanced in the##2##4##(2008-10#1)(2009-8#1)
is enhanced in##4##3##(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)
is enhanced when##3##3##(1994-1#1)(2008-10#2)
is enhanced##28##2##(1991-5#1)(1994-1#1)(1994-8#2)(1996-3#2)(2006-6#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
is enough##3##2##(2008-10#2)(2008-5#1)
is enriched in##2##3##(1990-7#1)(2013-1#1)
is entirely consistent with##2##4##(1990-11#1)(1993-12#1)
is entirely##4##2##(1990-11#1)(1993-12#1)(1996-6#1)(1997-7#1)
is envisaged##3##2##(2008-10#2)(2008-9#1)
is envisioned##2##2##(2008-10#1)(2008-9#1)
is enzootic in##2##3##(2008-10#1)(2011-2#1)
is enzymatically##2##2##(2008-10#2)
is equal or##2##3##(1992-1#1)(2008-1#1)
is equal to the##4##4##(2008-10#1)(2008-3#3)
is equal to##8##3##(2007-11#1)(2008-10#4)(2008-3#3)
is equal##14##2##(1992-1#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-8#1)(2008-9#1)(2009-10#1)
is equally##2##2##(2009-3#1)(2010-2#1)
is equipped with##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
is equivalent to the##4##4##(1991-3#1)(1993-8#1)(2008-2#1)(2008-3#1)
is equivalent to##10##3##(1991-3#1)(1991-8#1)(1993-8#1)(2008-10#5)(2008-2#1)(2008-3#1)
is equivalent##11##2##(1991-3#1)(1991-8#1)(1993-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)
is equivocal##2##2##(2008-1#1)(2008-9#1)
is especially difficult##2##3##(2008-10#1)(2012-2#1)
is especially important in##2##4##(2008-9#1)(2011-2#1)
is especially important##4##3##(1994-3#1)(2008-9#1)(2010-1#1)(2011-2#1)
is especially prone to##2##4##(2008-10#1)(2008-8#1)
is especially relevant in##2##4##(1996-5#1)(2013-1#1)
is especially true##5##3##(1990-12#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-3#1)
is especially useful for the##2##5##(2008-10#1)(2008-5#1)
is especially useful##3##3##(1995-11#1)(2008-10#1)(2008-5#1)
is especially##28##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-3#1)(1994-3#1)(1995-11#1)(1996-5#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)
is essential before##2##3##(1994-12#1)(2008-7#1)
is essential for control of##2##5##(2008-10#1)(2008-9#1)
is essential for normal##2##4##(2009-10#1)(2011-2#1)
is essential for successful##2##4##(1992-6#1)(2011-2#1)
is essential for the development of##4##6##(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
is essential for the##19##4##(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
is essential for understanding##2##4##(2008-10#1)(2012-2#1)
is essential for##77##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-6#2)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-10#2)(2009-8#3)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-2#4)(2012-3#2)(2013-1#3)
is essential if##2##3##(1993-12#1)(2013-1#1)
is essential in the##4##4##(1994-12#1)(2008-10#1)(2008-12#1)(2010-10#1)
is essential in##10##3##(1993-3#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-10#1)(2010-8#1)(2010-9#1)
is essential that##5##3##(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2013-8#1)
is essential to determine##2##4##(2008-11#1)(2010-12#1)
is essential to ensure##4##4##(2008-11#2)(2008-12#2)
is essential to the##3##4##(2008-12#1)(2010-5#1)(2013-1#1)
is essential to##35##3##(1991-2#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#4)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-12#1)(2012-3#3)(2013-1#2)
is essential##155##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-5#3)(1991-6#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-6#1)(1994-9#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#20)(2008-11#12)(2008-12#6)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#8)(2008-9#5)(2009-10#2)(2009-11#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#14)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#7)(2013-8#1)
is essentially a##2##3##(2008-4#1)(2010-5#1)
is essentially##11##2##(1991-2#1)(1992-8#1)(1993-3#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-5#1)
is established as##2##3##(2008-10#2)
is established between##4##3##(1990-9#1)(2008-10#2)(2013-1#1)
is established by##4##3##(1991-11#1)(1993-3#1)(2008-11#1)(2008-7#1)
is established in the##2##4##(2008-10#1)(2009-1#1)
is established in##5##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)
is established with the##2##4##(2008-10#1)(2012-2#1)
is established with##3##3##(2008-10#2)(2012-2#1)
is established##34##2##(1990-12#1)(1990-9#1)(1991-11#1)(1993-3#1)(1994-1#1)(1996-6#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#4)
is estimated at##2##3##(2012-12#1)(2012-2#1)
is estimated by##4##3##(1995-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
is estimated that approximately##2##4##(2012-12#1)(2013-1#1)
is estimated that##11##3##(1990-2#1)(1991-6#1)(2008-10#1)(2008-11#2)(2009-12#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
is estimated to be##6##4##(1996-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)
is estimated to range from##2##5##(2012-2#1)(2013-1#1)
is estimated to##12##3##(1996-3#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
is estimated##33##2##(1990-2#1)(1991-6#1)(1995-9#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#2)
is evaluated and##2##3##(2008-10#1)(2011-2#1)
is evaluated by##5##3##(1994-9#1)(2008-10#3)(2008-11#1)
is evaluated for##4##3##(2008-10#2)(2008-3#1)(2008-6#1)
is evaluated in terms of##2##5##(2008-9#1)(2009-7#1)
is evaluated in##4##3##(2008-10#1)(2008-6#1)(2008-9#1)(2009-7#1)
is evaluated using##3##3##(2008-10#2)(2008-6#1)
is evaluated with##2##3##(2008-10#2)
is evaluated##31##2##(1994-9#1)(1997-2#1)(2008-10#16)(2008-11#2)(2008-3#2)(2008-6#3)(2008-8#2)(2008-9#2)(2009-7#1)(2011-2#1)
is even more##5##3##(1995-11#1)(1995-2#1)(2008-10#1)(2013-1#2)
is even rarer##4##3##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
is even##15##2##(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
is ever##3##2##(1992-1#1)(2008-8#1)(2012-12#1)
is evidence for##2##3##(2008-10#1)(2012-3#1)
is evidence of##7##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2012-12#1)(2012-3#1)
is evidence that high##2##4##(2010-1#1)(2010-9#1)
is evidence that the##2##4##(1992-7#1)(2010-1#1)
is evidence that##15##3##(1991-12#1)(1992-7#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-1#2)(2010-11#1)(2010-9#1)(2011-2#1)
is evidence##29##2##(1991-12#1)(1992-7#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
is evidenced##2##2##(1997-4#1)(2011-2#1)
is evident in##3##3##(2012-12#1)(2013-1#2)
is evident that the##4##4##(1993-1#1)(1997-8#1)(2008-9#1)(2011-3#1)
is evident that##12##3##(1992-1#1)(1993-1#1)(1993-12#1)(1997-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)
is evident##19##2##(1992-1#1)(1993-1#1)(1993-12#1)(1997-8#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
is evolutionarily stable##2##3##(2008-9#2)
is evolutionarily##5##2##(1994-11#1)(1995-6#1)(2008-8#1)(2008-9#2)
is evolving##2##2##(1991-2#1)(2010-12#1)
is exactly what##2##3##(2008-9#1)(2009-10#1)
is examined and##3##3##(1990-3#1)(2008-10#2)
is examined by##2##3##(2008-10#1)(2008-3#1)
is examined for its##2##4##(2008-11#1)(2008-3#1)
is examined for the##2##4##(2008-3#2)
is examined for##6##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#3)
is examined from##2##3##(1992-3#1)(1993-3#1)
is examined in relation to the##2##6##(2008-10#1)(2009-8#1)
is examined in##7##3##(1991-3#1)(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-8#1)
is examined##40##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1997-6#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-3#9)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-2#1)
is exceedingly rare in##2##4##(2009-1#1)(2013-1#1)
is exceedingly rare##6##3##(2008-11#1)(2009-1#1)(2010-1#1)(2012-3#1)(2013-1#2)
is excellent##10##2##(1992-12#1)(1996-9#2)(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
is excised##2##2##(1993-12#1)(2008-4#1)
is excited at##2##3##(2008-10#2)
is excited##5##2##(1992-12#1)(2008-10#3)(2008-3#1)
is exclusively expressed in##2##4##(2008-8#1)(2012-2#1)
is excreted##3##2##(2008-10#2)(2012-2#1)
is exemplified by##3##3##(2008-8#2)(2011-2#1)
is exemplified##6##2##(2008-10#1)(2008-3#1)(2008-8#3)(2011-2#1)
is exerted##2##2##(2008-11#1)(2009-8#1)
is exhibited##2##2##(1994-5#1)(1995-6#1)
is expanded to##2##3##(2008-3#2)
is expanding##2##2##(1991-2#1)(2008-12#1)
is expected in##4##3##(1993-1#1)(2008-11#2)(2008-5#1)
is expected that it##2##4##(2008-10#1)(2008-11#1)
is expected that##10##3##(1991-1#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-12#1)(2012-3#1)
is expected to be a##4##5##(1992-12#1)(2008-11#2)(2010-6#1)
is expected to be##9##4##(1992-12#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#1)
is expected to have a##3##5##(2008-11#1)(2008-3#1)(2011-2#1)
is expected to have##4##4##(2008-11#1)(2008-3#2)(2011-2#1)
is expected to improve##2##4##(1997-6#1)(2008-10#1)
is expected to increase##3##4##(1991-12#1)(2008-9#1)(2012-3#1)
is expected to##42##3##(1991-1#2)(1991-12#1)(1992-12#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#6)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2010-10#1)(2010-6#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)
is expected##63##2##(1991-1#3)(1991-12#1)(1992-12#1)(1993-1#1)(1995-8#1)(1996-5#2)(1997-6#2)(1997-8#1)(2008-10#10)(2008-11#13)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2010-10#1)(2010-12#1)(2010-6#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#3)
is expensive and##2##3##(2012-3#1)(2013-1#1)
is expensive##3##2##(1993-3#1)(2012-3#1)(2013-1#1)
is experienced##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
is experimentally demonstrated##2##3##(1997-6#1)(2008-3#1)
is experimentally verified##3##3##(2008-10#2)(2008-3#1)
is experimentally##9##2##(1997-6#1)(2007-12#1)(2008-10#3)(2008-3#4)
is explained by the##4##4##(1993-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
is explained by##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2013-1#1)
is explained##17##2##(1993-12#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-3#1)(2009-5#1)(2013-1#1)
is explicitly##3##2##(2008-11#1)(2008-9#2)
is exploited in##2##3##(2008-10#2)
is explored and##3##3##(1994-2#1)(2008-11#1)(2009-10#1)
is explored##10##2##(1992-9#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-9#1)(2013-1#1)
is exposed to the##3##4##(1994-5#1)(2008-10#1)(2008-11#1)
is exposed to##8##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-9#1)
is exposed##9##2##(1990-5#1)(1994-5#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-9#1)
is expressed as a##4##4##(1993-2#1)(1996-6#1)(2008-10#1)(2008-3#1)
is expressed as##6##3##(1993-2#1)(1996-6#1)(2008-10#2)(2008-3#1)(2012-2#1)
is expressed at##5##3##(1993-2#1)(1995-2#1)(1996-12#1)(1997-7#1)(2009-10#1)
is expressed by a##2##4##(2008-10#1)(2008-5#1)
is expressed by##6##3##(1995-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-8#1)
is expressed in a##2##4##(1993-3#1)(2008-5#1)
is expressed in all##2##4##(1993-6#1)(1996-12#1)
is expressed in the##4##4##(1993-12#1)(1997-2#1)(1997-7#1)(2013-1#1)
is expressed in##22##3##(1992-3#1)(1992-6#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
is expressed on##2##3##(1993-12#1)(2012-2#1)
is expressed specifically in the##2##5##(1993-12#1)(1995-2#1)
is expressed specifically in##4##4##(1993-12#1)(1993-8#1)(1995-2#1)(2008-8#1)
is expressed ubiquitously##2##3##(1995-6#1)(1997-7#1)
is expressed##59##2##(1991-5#1)(1992-3#1)(1992-6#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-7#5)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#4)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2012-2#3)(2013-1#3)
is extended to the##2##4##(2008-2#1)(2008-8#1)
is extended to##6##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
is extended with##2##3##(1997-8#1)(2009-12#1)
is extended##13##2##(1997-8#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)
is extensive##2##2##(1993-12#1)(2011-2#1)
is extensively##4##2##(1992-4#1)(2008-9#1)(2010-11#1)(2011-2#1)
is extracted by##2##3##(2007-12#1)(2008-10#1)
is extracted with##3##3##(2008-10#3)
is extracted##19##2##(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#1)
is extremely common##2##3##(2008-11#1)(2008-5#1)
is extremely effective##2##3##(2008-11#1)(2011-3#1)
is extremely important##3##3##(1995-9#2)(2007-12#1)
is extremely rare and##2##4##(2008-12#1)(2013-1#1)
is extremely rare in##3##4##(2008-8#1)(2010-12#1)(2012-12#1)
is extremely rare##13##3##(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
is extremely sensitive##3##3##(1994-8#1)(2008-5#1)(2009-5#1)
is extremely useful for##2##4##(2008-10#1)(2008-4#1)
is extremely variable##2##3##(1991-2#1)(2013-1#1)
is extremely##39##2##(1991-2#1)(1994-11#1)(1994-8#1)(1995-9#2)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
is fabricated by##2##3##(1994-2#1)(2008-10#1)
is fabricated##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
is faced with##2##3##(1995-5#1)(2008-11#1)
is facilitated by the##2##4##(2008-10#1)(2013-8#1)
is facilitated by##5##3##(1990-2#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
is facilitated##7##2##(1990-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2012-3#1)(2013-8#1)
is fairly##2##2##(2008-10#2)
is far from##3##3##(1994-12#1)(2008-10#1)(2013-8#1)
is far##8##2##(1991-3#1)(1994-12#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-8#1)(2013-8#1)
is fast and##4##3##(1996-12#1)(2008-10#2)(2010-4#1)
is fast##12##2##(1996-12#1)(2008-10#9)(2009-3#1)(2010-4#1)
is faster and##3##3##(2008-10#2)(2008-11#1)
is faster##6##2##(2008-10#4)(2008-11#1)(2008-9#1)
is favorable##2##2##(2008-10#1)(2013-1#1)
is favored##6##2##(2008-8#4)(2008-9#2)
is favourable##2##2##(1991-8#1)(2007-11#1)
is favoured##4##2##(2008-11#1)(2012-3#1)(2012-7#1)(2013-1#1)
is feasible and##4##3##(2008-10#2)(2011-2#1)(2012-12#1)
is feasible in##2##3##(1991-2#1)(2008-1#1)
is feasible with##2##3##(1997-6#1)(2012-3#1)
is feasible##28##2##(1991-2#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
is filled with##3##3##(2007-12#2)(2008-10#1)
is filled##4##2##(2007-12#2)(2008-10#2)
is financed and##2##3##(1997-2#1)(1997-5#1)
is financed##3##2##(1996-2#1)(1997-2#1)(1997-5#1)
is finished##2##2##(2008-10#2)
is firmly##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
is first##17##2##(1995-11#2)(1997-7#1)(2007-12#1)(2008-10#10)(2008-8#1)(2012-2#1)(2013-1#1)
is fixed##7##2##(1992-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
is flexible and##2##3##(1992-2#1)(2008-10#1)
is flexible##4##2##(1992-2#1)(2008-10#2)(2008-5#1)
is focused on the##5##4##(1992-5#1)(1992-6#1)(1994-5#1)(2007-12#1)(2008-3#1)
is focused on##14##3##(1991-3#1)(1992-5#1)(1992-6#1)(1994-5#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-10#1)(2011-2#3)(2012-2#1)
is focused##17##2##(1991-3#1)(1992-5#1)(1992-6#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#3)(2012-2#1)
is focussed on##3##3##(2008-10#1)(2010-9#2)
is followed by a discussion of##3##6##(2008-10#1)(2008-4#1)(2009-12#1)
is followed by a##6##4##(1990-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)
is followed by the##2##4##(2008-10#1)(2008-11#1)
is followed by##17##3##(1990-5#1)(1992-12#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2012-2#1)(2012-3#1)
is followed in the##3##4##(2008-10#2)(2009-11#1)
is followed##21##2##(1990-5#1)(1992-12#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-12#1)(2012-2#1)(2012-3#1)
is for a##2##3##(1993-12#2)
is for the##2##3##(1994-12#1)(2008-10#1)
is for##14##2##(1993-12#2)(1994-1#1)(1994-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2013-1#1)
is forcing##2##2##(1992-1#1)(1993-2#1)
is formed at##2##3##(2008-10#1)(2009-7#1)
is formed between##3##3##(2008-10#2)(2008-4#1)
is formed by an##2##4##(2008-10#1)(2011-2#1)
is formed by the##3##4##(1992-4#1)(2008-10#1)(2008-3#1)
is formed by##10##3##(1992-4#1)(2008-10#4)(2008-3#2)(2010-8#1)(2011-2#2)
is formed in##3##3##(1994-5#1)(2008-10#2)
is formed on the##2##4##(2008-12#1)(2008-5#1)
is formed##35##2##(1992-4#1)(1993-12#1)(1994-5#1)(2008-10#19)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#2)(2010-8#1)(2011-2#2)(2013-8#1)
is formulated##3##2##(1995-12#1)(2008-2#1)(2013-8#1)
is found among##2##3##(2012-2#1)(2013-1#1)
is found as##3##3##(1996-6#2)(2008-10#1)
is found for##3##3##(1997-1#1)(2008-2#1)(2009-4#1)
is found in a##2##4##(1993-9#1)(2012-2#1)
is found in the##6##4##(1990-6#1)(2008-10#1)(2008-9#2)(2009-8#1)(2010-8#1)
is found in##21##3##(1990-11#1)(1990-3#1)(1990-6#1)(1993-9#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-9#3)(2009-6#1)(2009-8#3)(2010-8#2)(2012-2#1)
is found not##2##3##(2008-10#2)
is found that the##8##4##(1990-8#1)(2008-10#3)(2008-3#2)(2009-7#1)(2010-3#1)
is found that##25##3##(1990-3#1)(1990-8#1)(1994-9#1)(1996-5#1)(2008-10#11)(2008-3#5)(2008-5#1)(2008-8#2)(2009-7#1)(2010-3#1)
is found to be 2##2##5##(2008-10#2)
is found to be a##3##5##(1991-5#1)(2008-10#2)
is found to be better than##2##6##(2008-10#2)
is found to be linear##3##5##(2008-10#3)
is found to be the##3##5##(1996-5#1)(2008-10#2)
is found to be##33##4##(1991-5#1)(1996-2#1)(1996-5#2)(2007-11#1)(2008-10#22)(2008-11#1)(2008-2#2)(2008-3#1)(2010-11#1)(2012-3#1)
is found to##46##3##(1991-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(2007-11#1)(2008-10#25)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#1)(2009-7#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
is found##117##2##(1990-11#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-5#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#4)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#45)(2008-11#3)(2008-2#5)(2008-3#9)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-3#1)(2010-8#3)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#4)
is fraught with##2##3##(2008-11#1)(2008-9#1)
is free from matrix##2##4##(2008-10#2)
is free from the interference of##2##6##(2008-10#2)
is free from##13##3##(1991-12#1)(2008-10#9)(2008-11#2)(2011-2#1)
is free of##3##3##(1991-8#1)(2008-10#1)(2008-3#1)
is free##17##2##(1991-12#1)(1991-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2011-2#1)(2012-3#1)
is freely##2##2##(2008-10#1)(2009-2#1)
is frequent##2##2##(2008-10#1)(2013-8#1)
is frequently an##2##3##(2008-10#1)(2008-5#1)
is frequently associated with##2##4##(2008-7#1)(2010-8#1)
is frequently compromised by##2##4##(2008-11#1)(2009-12#1)
is frequently due to##2##4##(1993-11#1)(2008-5#1)
is frequently observed in##2##4##(2008-10#1)(2013-1#1)
is frequently observed##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
is frequently performed##2##3##(1990-9#1)(2008-7#1)
is frequently recognized##2##3##(2008-11#1)(2008-5#1)
is frequently seen in##2##4##(1994-11#1)(2008-11#1)
is frequently used in##2##4##(2008-11#2)
is frequently##40##2##(1990-9#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1997-4#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#1)(2009-12#2)(2009-4#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
is from 0##2##3##(2008-10#2)
is from the##2##3##(2008-11#1)(2008-8#1)
is from##16##2##(1993-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2013-1#1)
is fully reversible##3##3##(2008-10#3)
is fully##11##2##(1991-2#1)(2007-11#1)(2008-10#8)(2008-9#1)
is functional in##2##3##(1996-3#2)
is functional##6##2##(1992-10#1)(1993-9#1)(1996-3#2)(2008-10#1)(2012-3#1)
is functionally active##2##3##(1992-12#1)(1996-12#1)
is functionally##9##2##(1991-2#1)(1992-12#1)(1996-12#1)(1996-2#1)(2008-11#2)(2009-5#1)(2009-8#1)(2011-2#1)
is fundamental for##4##3##(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
is fundamental to##3##3##(1994-12#1)(2008-10#1)(2010-5#1)
is fundamental##8##2##(1994-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-2#1)
is funded##2##2##(1994-3#1)(2012-12#1)
is further supported by the##2##5##(2008-8#1)(2009-9#1)
is further##25##2##(1993-8#1)(1994-5#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2013-1#3)(2013-8#1)
is fused##3##2##(2008-10#2)(2008-6#1)
is gaining momentum in##2##4##(1994-2#1)(2008-7#1)
is gaining popularity##2##3##(2008-12#1)(2010-7#1)
is gaining##7##2##(1994-2#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)
is general##4##2##(2008-11#1)(2008-4#2)(2008-8#1)
is generalized to##3##3##(1992-9#1)(2008-3#2)
is generally a##3##3##(1991-6#1)(2008-11#1)(2013-1#1)
is generally accepted as##2##4##(1994-12#1)(2008-9#1)
is generally accepted that##5##4##(2008-10#1)(2008-11#2)(2012-3#2)
is generally accepted##8##3##(1990-12#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-3#2)
is generally assumed that##2##4##(1994-11#1)(2013-8#1)
is generally believed that##2##4##(2010-7#1)(2011-10#1)
is generally considered##4##3##(1996-3#1)(2010-1#1)(2011-2#1)(2012-7#1)
is generally more##3##3##(1995-5#1)(1997-2#1)(2008-11#1)
is generally not##3##3##(1996-5#1)(2008-10#2)
is generally observed##3##3##(2008-5#1)(2008-7#1)(2009-10#1)
is generally regarded as##2##4##(2008-10#2)
is generally smaller##2##3##(2008-10#1)(2008-4#1)
is generally thought##2##3##(1997-2#1)(2008-11#1)
is generally##74##2##(1990-12#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-11#1)(2008-10#15)(2008-11#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-7#2)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#3)(2013-8#1)
is generated by a##2##4##(1994-6#1)(2008-3#1)
is generated by the##2##4##(1995-6#2)
is generated by##10##3##(1993-6#1)(1994-6#1)(1995-6#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#2)
is generated in##4##3##(1995-2#1)(2008-10#2)(2008-2#1)
is generated##23##2##(1993-6#1)(1994-6#1)(1995-2#1)(1995-6#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#2)(2010-7#1)(2013-1#1)
is genetic##2##2##(2008-10#2)
is genetically determined##4##3##(1990-2#1)(2008-12#1)(2008-7#1)(2012-3#1)
is genetically##13##2##(1990-2#2)(1996-2#1)(2008-10#5)(2008-12#2)(2008-7#1)(2008-9#1)(2012-3#1)
is given and##2##3##(2008-10#2)
is given as##5##3##(1992-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-4#1)
is given by the##3##4##(2008-10#1)(2008-3#1)(2010-10#1)
is given by##4##3##(2008-10#1)(2008-3#2)(2010-10#1)
is given for the##4##4##(2008-3#2)(2008-5#1)(2008-9#1)
is given for##6##3##(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2013-8#1)
is given in##2##3##(2008-10#1)(2008-4#1)
is given on the##2##4##(2008-10#1)(2008-2#1)
is given on##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
is given that##2##3##(2007-11#1)(2008-3#1)
is given to the##7##4##(1991-6#1)(1992-3#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-6#1)
is given to##16##3##(1991-6#1)(1992-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-6#1)(2012-2#1)
is given##67##2##(1991-3#2)(1991-6#1)(1992-12#1)(1992-3#2)(1992-4#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#5)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#2)(2008-6#1)(2008-9#3)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
is globally##2##2##(2008-7#1)(2013-8#1)
is going to##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
is going##5##2##(1991-2#1)(1996-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
is good agreement##2##3##(2008-10#2)
is good evidence##2##3##(2008-7#1)(2010-12#1)
is good##16##2##(1991-6#1)(1992-3#1)(1996-8#1)(1996-9#1)(2008-10#4)(2008-3#1)(2008-7#5)(2010-12#1)(2013-1#1)
is governed by a##2##4##(2008-10#2)
is governed by the##5##4##(2008-10#4)(2008-7#1)
is governed by##10##3##(1992-3#1)(2008-10#7)(2008-4#1)(2008-7#1)
is gradually##2##2##(2008-10#1)(2012-3#1)
is great interest in##2##4##(2008-11#1)(2009-7#1)
is great##8##2##(1994-12#1)(1997-6#1)(1997-8#1)(2008-11#4)(2009-7#1)
is greater for##2##3##(1996-12#1)(2008-9#1)
is greater in the##2##4##(2008-10#1)(2013-1#1)
is greater in##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
is greater than##12##3##(1991-3#1)(1992-9#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-2#1)(2013-8#1)
is greater with##2##3##(2012-3#1)(2013-1#1)
is greater##25##2##(1990-11#1)(1991-3#1)(1992-9#2)(1995-12#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
is greatest##3##2##(1990-12#1)(1990-9#1)(2008-7#1)
is greatly enhanced##4##3##(2008-10#4)
is greatly increased##2##3##(2008-10#2)
is greatly##12##2##(1992-9#1)(1993-12#1)(1993-9#1)(2008-10#8)(2008-11#1)
is growing interest##4##3##(1997-7#1)(2010-1#1)(2010-12#1)(2011-3#1)
is growing##21##2##(1991-3#1)(1996-1#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#2)(2009-8#1)(2010-1#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
is grown##3##2##(2008-10#3)
is hampered by the lack of##2##6##(2008-5#1)(2013-1#1)
is hampered by##4##3##(1990-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
is hampered##5##2##(1990-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
is handled##2##2##(1995-11#1)(1996-12#1)
is hard to##2##3##(2008-12#1)(2008-9#1)
is hardly##5##2##(2008-10#1)(2008-2#1)(2008-7#2)(2013-8#1)
is harmful##2##2##(2008-10#1)(2009-11#1)
is heated##3##2##(2008-10#3)
is heavily concentrated in##2##4##(1994-3#1)(2012-2#1)
is heavily##5##2##(1994-3#1)(1994-5#1)(2008-3#1)(2008-7#1)(2012-2#1)
is held##2##2##(2008-10#1)(2012-3#1)
is helpful in##3##3##(1991-2#1)(2010-1#1)(2010-12#1)
is helpful##4##2##(1991-2#1)(2008-7#1)(2010-1#1)(2010-12#1)
is here described##2##3##(2008-10#2)
is here##7##2##(1997-3#1)(2008-10#6)
is herein##2##2##(1993-6#1)(2008-10#1)
is heterogeneous##5##2##(1992-11#1)(1996-2#1)(2008-10#1)(2008-12#1)(2013-8#1)
is heterothallic and##2##3##(2008-10#2)
is high in patients with##2##5##(1994-9#1)(1995-10#1)
is high in##3##3##(1994-9#1)(1995-10#1)(2008-8#1)
is high##33##2##(1991-2#1)(1992-11#1)(1994-9#2)(1995-10#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-8#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
is higher among##2##3##(1996-6#1)(2008-9#1)
is higher and##2##3##(2008-10#1)(2011-2#1)
is higher in the##2##4##(2008-10#2)
is higher in##5##3##(1994-3#1)(2008-10#3)(2008-7#1)
is higher than in##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
is higher than other##2##4##(2008-10#1)(2010-7#1)
is higher than that of##3##5##(2008-8#1)(2008-9#1)(2011-2#1)
is higher than that##7##4##(2008-10#2)(2008-8#2)(2008-9#2)(2011-2#1)
is higher than the##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
is higher than##22##3##(1994-3#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
is higher when the##2##4##(1991-3#1)(2009-5#1)
is higher##41##2##(1991-3#1)(1994-3#2)(1995-12#1)(1996-5#1)(1996-6#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
is highest in##2##3##(1990-9#1)(2012-3#1)
is highlighted as an##2##4##(2008-10#2)
is highlighted by the##2##4##(2009-4#1)(2013-1#1)
is highlighted by##3##3##(2008-3#1)(2009-4#1)(2013-1#1)
is highlighted through##2##3##(1996-5#1)(2008-7#1)
is highlighted##19##2##(1993-12#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
is highly conserved and##2##4##(2011-2#1)(2013-8#1)
is highly conserved##10##3##(1993-12#1)(1993-6#1)(1994-11#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
is highly correlated##2##3##(2008-9#1)(2010-10#1)
is highly dependent on the##3##5##(1997-1#1)(2008-5#1)(2008-9#1)
is highly desirable##4##3##(2008-11#2)(2008-7#1)(2011-2#1)
is highly effective##2##3##(2008-10#1)(2008-3#1)
is highly expressed in the##3##5##(1993-8#1)(1995-8#1)(2008-11#1)
is highly expressed in##7##4##(1993-8#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
is highly expressed##9##3##(1993-3#1)(1993-8#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-9#1)(2008-11#1)(2008-9#1)(2011-2#1)
is highly homologous to##4##4##(1993-12#1)(1993-6#1)(1994-11#1)(2008-10#1)
is highly increased##2##3##(1993-8#1)(1995-12#1)
is highly influenced by the##2##5##(2008-10#2)
is highly polymorphic##2##3##(2008-12#1)(2008-9#1)
is highly prevalent in##5##4##(2008-9#1)(2010-7#1)(2012-3#2)(2013-1#1)
is highly prevalent##6##3##(2008-9#1)(2010-7#1)(2012-3#3)(2013-1#1)
is highly recommended to##2##4##(2008-9#1)(2009-2#1)
is highly recommended##5##3##(2008-9#1)(2009-2#1)(2011-2#2)(2013-8#1)
is highly resistant to##2##4##(2008-10#2)
is highly selective and##3##4##(2008-10#3)
is highly selective for##2##4##(2008-10#2)
is highly selective to##4##4##(2008-10#4)
is highly selective##10##3##(2008-10#10)
is highly sensitive to both##2##5##(1992-4#1)(2009-7#1)
is highly sensitive to##3##4##(1992-4#1)(2008-3#1)(2009-7#1)
is highly sensitive##6##3##(1992-4#1)(2008-10#3)(2008-3#1)(2009-7#1)
is highly significant##2##3##(2012-3#1)(2013-1#1)
is highly specific##2##3##(1990-12#1)(2008-12#1)
is highly stimulated by##2##4##(1993-3#1)(2009-8#1)
is highly susceptible to##3##4##(2008-10#3)
is highly susceptible##4##3##(2008-10#4)
is highly variable##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
is highly##113##2##(1990-12#2)(1990-3#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-9#1)(2008-10#33)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#8)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#3)(2013-8#3)
is hindered by##2##3##(2008-10#1)(2012-2#1)
is homogenous##2##2##(2008-10#1)(2010-10#1)
is homologous to mammalian##2##4##(1996-6#1)(2008-11#1)
is homologous to the##2##4##(1996-3#1)(2008-9#1)
is homologous to##8##3##(1990-2#1)(1992-8#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-11#1)(2008-9#1)
is homologous##10##2##(1990-2#1)(1992-8#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
is hoped that the##8##4##(1991-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2013-1#2)
is hoped that##20##3##(1991-1#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)
is hoped##21##2##(1991-1#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)
is host##2##2##(2008-10#2)
is how to##6##3##(1991-1#1)(1997-2#1)(2007-12#1)(2008-11#2)(2008-6#1)
is how##13##2##(1991-1#1)(1997-2#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)
is however##4##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
is hybridized##2##2##(2008-10#2)
is hydrolyzed##2##2##(1990-8#1)(2008-10#1)
is hypothesised##3##2##(2006-6#1)(2009-4#1)(2011-2#1)
is hypothesized that this##4##4##(1995-11#1)(2008-10#1)(2009-1#1)(2009-8#1)
is hypothesized that##12##3##(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-1#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)
is hypothesized to be##3##4##(1995-3#1)(2008-9#1)(2010-11#1)
is hypothesized to##4##3##(1995-3#1)(2008-9#1)(2010-11#1)(2011-1#1)
is hypothesized##17##2##(1995-11#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#1)
is ideally suited to##2##4##(1990-9#1)(2008-9#1)
is ideally##3##2##(1990-9#1)(2008-10#1)(2008-9#1)
is identical to that##2##4##(1991-11#1)(2008-10#1)
is identical to the##5##4##(1992-3#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#1)
is identical to those##2##4##(1996-12#1)(2008-10#1)
is identical to##15##3##(1990-5#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(2008-10#4)(2008-11#1)
is identical##16##2##(1990-5#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-3#1)
is identified as##2##3##(1991-5#1)(1993-1#1)
is identified by##2##3##(1993-3#1)(2011-3#1)
is identified in##2##3##(2007-12#1)(2012-3#1)
is identified##16##2##(1991-12#1)(1991-5#1)(1993-1#1)(1993-3#1)(1995-1#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-1#1)(2009-10#1)(2011-3#1)(2012-3#1)
is illustrated by a number of practically relevant applications##2##9##(2008-10#2)
is illustrated by a##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
is illustrated by the##4##4##(2008-10#3)(2008-3#1)
is illustrated by two case studies##2##6##(2008-10#2)
is illustrated by##15##3##(2008-10#9)(2008-11#2)(2008-3#2)(2008-9#1)(2013-1#1)
is illustrated for##2##3##(2008-10#1)(2010-5#1)
is illustrated in##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
is illustrated through##2##3##(2009-4#1)(2010-6#1)
is illustrated using##3##3##(1992-9#1)(2009-7#1)(2013-8#1)
is illustrated with##6##3##(1990-12#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)
is illustrated##40##2##(1990-12#1)(1992-9#1)(1995-12#1)(2008-10#18)(2008-11#4)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-6#1)(2013-1#2)(2013-8#1)
is immediately##2##2##(2008-10#1)(2008-11#1)
is immersed in##2##3##(2008-10#2)
is immobile##2##2##(1991-5#1)(2008-10#1)
is immobilized on a##4##4##(2008-10#3)(2008-4#1)
is immobilized on the##3##4##(2008-10#3)
is immobilized on##8##3##(2008-10#7)(2008-4#1)
is immobilized##11##2##(2008-10#9)(2008-4#2)
is impaired by##2##3##(1992-1#1)(1993-6#1)
is impaired in##2##3##(1994-11#1)(2008-8#1)
is impaired##10##2##(1992-1#1)(1993-6#1)(1994-11#1)(1995-8#1)(2008-11#1)(2008-8#1)(2010-7#2)(2012-3#1)(2013-1#1)
is imperative for##2##3##(2009-11#1)(2010-11#1)
is imperative that##5##3##(1992-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2011-1#1)
is imperative to##4##3##(1997-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is imperative##14##2##(1992-1#2)(1997-2#1)(2008-11#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is implemented in the##3##4##(1995-2#1)(2008-10#1)(2012-3#1)
is implemented in##4##3##(1995-2#1)(2008-10#2)(2012-3#1)
is implemented##6##2##(1995-2#1)(2008-10#3)(2008-3#1)(2012-3#1)
is implicated as##2##3##(2008-11#1)(2013-1#1)
is implicated in the##4##4##(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
is implicated in##6##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2013-1#2)
is implicated##9##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2013-1#3)
is important because it##3##4##(1993-3#1)(2008-11#1)(2008-7#1)
is important because the##3##4##(2008-1#1)(2008-10#1)(2010-8#1)
is important because##8##3##(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)
is important both##2##3##(2008-10#2)
is important for clinicians to##2##5##(2011-2#1)(2012-3#1)
is important for control##2##4##(1996-12#1)(2012-2#1)
is important for medical##3##4##(1993-1#1)(2008-10#1)(2013-1#1)
is important for social##2##4##(2008-11#1)(2008-8#1)
is important for the long-term##2##5##(2008-10#1)(2010-2#1)
is important for the##12##4##(1990-2#1)(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
is important for understanding the##3##5##(1995-2#1)(2008-10#2)
is important for##58##3##(1990-2#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-1#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-9#2)(1996-12#2)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-2#1)(2010-7#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#6)
is important from##2##3##(2008-10#1)(2008-3#1)
is important in assessing##2##4##(2008-10#1)(2010-12#1)
is important in predicting##2##4##(2008-12#1)(2012-3#1)
is important in the##3##4##(2011-2#3)
is important in##22##3##(1993-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
is important since it can be##2##6##(1992-2#1)(2013-8#1)
is important since##4##3##(1992-2#1)(1993-2#1)(2012-2#1)(2013-8#1)
is important that the##3##4##(2008-12#1)(2008-7#1)(2010-8#1)
is important that##15##3##(1991-1#1)(1992-1#1)(1992-6#1)(1995-2#2)(1996-12#1)(1997-8#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-1#1)(2010-8#1)(2013-1#1)
is important to assess##2##4##(2008-10#1)(2013-1#1)
is important to avoid##3##4##(1997-5#1)(2008-7#1)(2012-2#1)
is important to determine whether##2##5##(2008-4#1)(2008-8#1)
is important to determine##4##4##(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
is important to ensure##2##4##(1993-6#1)(2010-10#1)
is important to evaluate##3##4##(2008-1#1)(2008-9#1)(2012-2#1)
is important to have##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
is important to remember that##2##5##(1991-11#1)(2013-1#1)
is important to understand the##5##5##(1994-3#2)(2008-10#1)(2008-5#1)(2012-2#1)
is important to understand##9##4##(1994-3#2)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
is important to##79##3##(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-2#2)(1994-3#2)(1995-2#1)(1997-1#1)(1997-5#2)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#2)(2010-10#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#7)(2012-2#8)(2012-3#1)(2013-1#8)(2013-8#1)
is important##212##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1995-2#4)(1995-9#2)(1996-12#3)(1996-5#1)(1996-8#2)(1997-1#2)(1997-5#2)(1997-8#2)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#25)(2008-11#9)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-7#7)(2008-8#7)(2008-9#5)(2009-1#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#5)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#16)(2012-2#12)(2012-3#4)(2013-1#20)(2013-8#4)
is impossible##5##2##(1990-11#1)(1994-6#1)(2008-10#2)(2008-11#1)
is impractical##2##2##(2008-11#1)(2011-2#1)
is impregnated with##3##3##(2008-10#3)
is improved by##2##3##(2008-10#2)
is improved##6##2##(2008-10#3)(2008-3#2)(2012-3#1)
is in a##8##3##(2008-10#1)(2009-1#1)(2009-5#1)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
is in accord with the##2##5##(1991-9#1)(2008-9#1)
is in accord with##3##4##(1991-9#1)(2008-10#1)(2008-9#1)
is in accordance with the##3##5##(1996-11#1)(2008-10#1)(2011-2#1)
is in agreement with the##3##5##(2008-10#2)(2008-7#1)
is in agreement with##8##4##(1993-6#1)(2008-10#5)(2008-12#1)(2008-7#1)
is in contact with##2##4##(1994-5#1)(2008-10#1)
is in contrast to the##3##5##(1994-11#1)(2008-10#1)(2008-11#1)
is in contrast to##7##4##(1992-10#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-8#1)
is in contrast with the##3##5##(1992-12#1)(2008-10#2)
is in contrast with##4##4##(1992-12#1)(2008-10#2)(2010-3#1)
is in contrast##11##3##(1992-10#1)(1992-12#1)(1994-11#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-3#1)
is in direct##2##3##(1990-6#1)(2008-10#1)
is in fact##4##3##(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)
is in good agreement with the##5##6##(1995-11#1)(2008-10#3)(2008-3#1)
is in good agreement with##7##5##(1995-11#1)(2008-10#3)(2008-3#2)(2008-8#1)
is in its infancy##2##4##(1997-7#1)(2012-2#1)
is in its##3##3##(1997-7#1)(2011-2#1)(2012-2#1)
is in nuclear-transferred embryos supported by the transgenic F(4)##2##9##(2008-8#2)
is in part due to##2##5##(2008-10#1)(2008-11#1)
is in part##5##3##(1995-2#1)(1996-6#1)(2008-10#2)(2008-11#1)
is in phase II trials##2##5##(2008-5#2)
is in phase II##3##4##(2008-5#3)
is in phase III##2##4##(2008-5#2)
is in phase##6##3##(2008-5#6)
is in progress##5##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
is in proportion to the concentration of proteins##2##8##(2008-10#2)
is in proportion to the concentration of##4##7##(2008-10#4)
is in the range 1##2##5##(2008-10#2)
is in the range of##2##5##(2008-10#1)(2008-2#1)
is in the range##12##4##(1993-9#1)(2008-10#9)(2008-2#1)(2008-3#1)
is in the##34##3##(1990-5#1)(1991-2#1)(1993-9#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
is in this##2##3##(2008-10#1)(2009-11#1)
is in##160##2##(1990-11#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#3)(1995-11#2)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#49)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#2)(2009-1#1)(2009-11#1)(2009-5#3)(2009-9#1)(2010-10#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#1)(2011-2#6)(2011-3#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)
is inactivated by##3##3##(1992-12#1)(1993-6#1)(2008-4#1)
is inactivated##7##2##(1990-12#1)(1992-12#3)(1993-6#1)(2008-4#2)
is inadequate and that##2##4##(2011-2#1)(2012-2#1)
is inadequate and##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
is inadequate##5##2##(1993-12#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
is inappropriate##2##2##(1995-9#1)(2008-10#1)
is incapable of##3##3##(1993-12#1)(1995-6#1)(1997-6#1)
is included for##5##3##(2008-4#4)(2008-9#1)
is included in the##2##4##(2008-3#1)(2008-4#1)
is included in##4##3##(2008-11#2)(2008-3#1)(2008-4#1)
is included to##2##3##(2008-4#2)
is included##24##2##(1992-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#10)(2008-5#1)(2008-9#1)(2009-9#1)
is incomplete##4##2##(1993-6#1)(2010-4#1)(2012-3#1)(2013-1#1)
is inconsistent with##2##3##(2008-12#1)(2008-8#1)
is inconsistent##4##2##(2008-12#1)(2008-8#1)(2013-1#2)
is inconvenient##2##2##(1991-3#1)(2008-10#1)
is incorporated into the##2##4##(2008-4#1)(2013-8#1)
is incorporated into##3##3##(2008-4#2)(2013-8#1)
is incorporated##7##2##(1993-6#1)(1996-5#1)(2008-11#1)(2008-4#2)(2010-3#1)(2013-8#1)
is increased as##2##3##(1993-12#1)(2008-3#1)
is increased by##4##3##(1993-8#1)(1993-9#1)(1996-2#1)(2008-12#1)
is increased during##2##3##(2008-10#1)(2008-8#1)
is increased in the##2##4##(1992-3#1)(1997-2#1)
is increased in##9##3##(1992-3#1)(1993-11#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)
is increased significantly##2##3##(1990-12#1)(2008-5#1)
is increased through##2##3##(1995-12#1)(2008-10#1)
is increased##41##2##(1990-12#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#2)
is increasing evidence that##5##4##(2008-11#1)(2008-6#1)(2008-7#3)
is increasing evidence##6##3##(2008-11#1)(2008-6#1)(2008-7#4)
is increasing in##6##3##(1997-3#1)(1997-6#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
is increasing interest in the##2##5##(2008-11#1)(2010-7#1)
is increasing interest in##3##4##(2008-11#1)(2010-10#1)(2010-7#1)
is increasing rapidly##3##3##(1992-11#1)(1997-7#1)(2008-10#1)
is increasing worldwide##2##3##(2010-10#1)(2010-12#1)
is increasing##58##2##(1991-12#1)(1991-2#1)(1991-3#2)(1992-11#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2010-10#5)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#4)(2011-4#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
is increasingly becoming an##2##4##(2008-10#1)(2008-11#1)
is increasingly being##2##3##(2008-11#2)
is increasingly recognized##2##3##(2008-7#1)(2012-3#1)
is increasingly##15##2##(1991-3#1)(1992-3#1)(1992-6#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-9#2)(2010-1#1)(2012-3#1)(2013-8#1)
is incubated with##2##3##(2008-10#1)(2008-7#1)
is incubated##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
is indeed a##2##3##(2008-10#1)(2008-8#1)
is indeed##12##2##(1994-3#1)(1994-5#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-8#3)(2008-9#1)(2010-11#1)
is independent of pH in the range of##2##8##(2008-10#2)
is independent of pH##3##4##(2008-10#3)
is independent of the orientation of the##2##7##(2007-11#1)(2008-3#1)
is independent of the##12##4##(1995-11#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)
is independent of##37##3##(1992-10#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#2)(2007-11#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#5)(2008-8#3)(2009-10#1)(2011-2#1)(2013-8#1)
is independent##38##2##(1992-10#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#2)(2007-11#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#5)(2008-8#3)(2009-10#1)(2011-2#2)(2013-8#1)
is independently associated with a##2##5##(2008-8#1)(2013-1#1)
is independently associated with##3##4##(2008-8#1)(2013-1#2)
is indexed in##2##3##(2011-4#1)(2013-8#1)
is indexed##3##2##(2008-11#1)(2011-4#1)(2013-8#1)
is indicated by##4##3##(1993-3#1)(1993-8#1)(2008-9#1)(2011-2#1)
is indicated for##5##3##(1996-11#1)(2008-9#1)(2011-2#3)
is indicated in patients with##2##5##(2008-10#1)(2008-3#1)
is indicated in##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
is indicated that##2##3##(2008-10#1)(2013-8#1)
is indicated##25##2##(1993-3#1)(1993-8#1)(1996-11#1)(1997-3#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-12#1)(2010-3#1)(2011-2#6)(2012-2#1)(2013-8#2)
is indicative of a##2##4##(1991-3#1)(2008-11#1)
is indicative of##4##3##(1991-3#1)(2008-11#2)(2008-3#1)
is indispensable for the##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
is indispensable for##6##3##(1996-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
is indispensable##7##2##(1990-3#1)(1996-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
is induced by##17##3##(1990-11#2)(1990-5#1)(1991-9#1)(1992-7#1)(1993-9#1)(1995-12#2)(2008-10#2)(2008-11#3)(2008-6#1)(2010-3#1)(2010-4#1)(2011-2#1)
is induced in##2##3##(2008-4#1)(2011-10#1)
is induced##24##2##(1990-11#2)(1990-5#1)(1991-9#1)(1992-7#1)(1993-9#1)(1995-12#2)(1997-7#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-6#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-10#1)(2011-2#1)(2012-3#1)
is inducible##2##2##(1995-12#1)(1995-2#1)
is inevitable##2##2##(2008-10#1)(2008-11#1)
is inexpensive##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
is infectious##2##2##(2008-10#1)(2008-9#1)
is influenced by the##10##4##(1990-11#1)(1996-6#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#1)
is influenced by##29##3##(1990-11#1)(1991-3#1)(1993-8#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#2)(2009-8#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
is influenced##31##2##(1990-11#1)(1991-3#1)(1993-8#1)(1996-6#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#2)(2009-8#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
is infrequent##2##2##(1997-8#1)(2008-10#1)
is infrequently##3##2##(2010-1#1)(2011-2#2)
is inherent in##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
is inherently##8##2##(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#1)(2010-7#1)
is inherited from P##2##4##(2008-10#2)
is inherited##3##2##(2008-10#2)(2012-12#1)
is inhibited by the##2##4##(1995-2#1)(2012-2#1)
is inhibited by##15##3##(1990-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#2)(1995-2#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2012-2#1)
is inhibited in##3##3##(1994-11#1)(2008-10#2)
is inhibited##23##2##(1990-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-2#2)(1997-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
is initially##8##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-1#1)(2009-7#1)(2012-2#1)
is initiated before##2##3##(2008-10#1)(2008-7#1)
is initiated by##5##3##(1995-2#1)(1995-8#1)(2008-10#2)(2013-1#1)
is initiated##16##2##(1991-3#1)(1994-1#1)(1994-6#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
is injected into a carrier stream of##2##7##(2008-10#2)
is injected into a carrier##3##5##(2008-10#3)
is injected into a##7##4##(2008-10#6)(2008-2#1)
is injected into the##6##4##(2007-12#1)(2008-10#5)
is injected into##14##3##(2007-12#1)(2008-10#12)(2008-2#1)
is injected##17##2##(1997-1#1)(2007-12#1)(2008-10#14)(2008-2#1)
is innervated by the##2##4##(2007-12#1)(2011-2#1)
is innervated by##3##3##(2007-12#2)(2011-2#1)
is insensitive to the##4##4##(1995-11#1)(2008-10#1)(2008-2#1)(2009-8#1)
is insensitive to##6##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-8#1)
is inserted into the##2##4##(2008-3#1)(2008-8#1)
is inserted into##3##3##(2008-3#1)(2008-8#2)
is inserted##10##2##(1991-12#2)(1993-2#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-8#2)
is insignificant##2##2##(2008-10#2)
is instrumental in##2##3##(2009-8#1)(2013-7#1)
is instrumental##3##2##(2009-8#2)(2013-7#1)
is insufficient to##4##3##(1995-5#1)(2008-11#1)(2012-2#1)(2012-3#1)
is insufficient##8##2##(1995-12#1)(1995-5#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)(2012-3#1)
is integral to##2##3##(2009-5#1)(2013-1#1)
is integral##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
is intended as an##2##4##(1992-12#1)(1994-6#1)
is intended as##3##3##(1991-2#1)(1992-12#1)(1994-6#1)
is intended for##3##3##(2008-10#2)(2008-3#1)
is intended to##6##3##(1990-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2010-8#1)
is intended##12##2##(1990-12#1)(1991-2#1)(1992-12#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2010-8#1)
is intercalated##2##2##(1994-5#1)(2008-10#1)
is intercepted by the adjacent keto group to produce an##2##10##(1996-5#2)
is interesting##6##2##(1992-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)
is intermediate between##2##3##(2008-10#2)
is intermediate##4##2##(1990-6#1)(2008-10#3)
is interpreted as evidence for##2##5##(1994-5#1)(1996-2#1)
is interpreted as##4##3##(1994-5#1)(1995-1#1)(1996-2#1)(1996-3#1)
is interpreted##5##2##(1994-5#1)(1995-1#1)(1996-2#1)(1996-3#1)(2009-10#1)
is interrupted by##3##3##(1990-12#1)(1993-6#2)
is interrupted##4##2##(1990-12#1)(1993-6#2)(2008-10#1)
is intimately##2##2##(2008-11#1)(2011-2#1)
is intriguing##2##2##(1996-2#1)(2008-8#1)
is intrinsically##3##2##(1994-8#1)(2008-3#1)(2009-6#1)
is introduced as##3##3##(2008-3#3)
is introduced based on the##2##5##(2008-10#1)(2008-3#1)
is introduced in this paper##2##5##(2008-10#2)
is introduced in this##3##4##(2008-10#3)
is introduced in##4##3##(2008-10#4)
is introduced into a##2##4##(2008-10#1)(2008-2#1)
is introduced into the##2##4##(1993-1#1)(2008-10#1)
is introduced into##5##3##(1993-1#1)(2008-10#2)(2008-11#1)(2008-2#1)
is introduced that##2##3##(2008-3#2)
is introduced through the##2##4##(2008-10#2)
is introduced to##3##3##(1992-1#1)(2008-2#1)(2010-11#1)
is introduced##46##2##(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#1)(1996-6#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#10)(2008-4#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is invariant under##2##3##(1996-3#1)(2008-6#1)
is inversely proportional to##3##4##(1997-2#1)(2008-9#1)(2012-3#1)
is inversely related to the##3##5##(2008-10#1)(2008-9#2)
is inversely related to##4##4##(1994-6#1)(2008-10#1)(2008-9#2)
is inversely##8##2##(1991-3#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-9#3)(2012-3#1)
is investigated and##3##3##(2008-10#2)(2008-6#1)
is investigated as a##2##4##(2008-3#2)
is investigated by##3##3##(2008-10#1)(2008-2#1)(2009-7#1)
is investigated for##2##3##(2008-10#1)(2008-11#1)
is investigated in##3##3##(2008-3#1)(2008-8#1)(2011-1#1)
is investigated to##2##3##(2008-10#1)(2008-3#1)
is investigated##32##2##(1995-12#1)(1996-5#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-6#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)
is invisible##2##2##(2008-10#1)(2008-3#1)
is involved in a variety of##2##6##(1997-1#1)(2008-5#1)
is involved in a##5##4##(1991-9#1)(1997-1#1)(2008-11#1)(2008-5#1)(2009-8#1)
is involved in cell##2##4##(1994-9#1)(2009-7#1)
is involved in many##4##4##(2008-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
is involved in the activation of##2##6##(1992-6#1)(1994-2#1)
is involved in the early##2##5##(2010-1#1)(2010-12#1)
is involved in the regulation of##6##6##(1994-5#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
is involved in the##40##4##(1990-8#1)(1991-3#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-2#2)(1997-1#1)(2008-10#4)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#2)
is involved in this process##2##5##(1994-11#1)(1995-12#1)
is involved in this##3##4##(1991-3#1)(1994-11#1)(1995-12#1)
is involved in##96##3##(1990-2#1)(1990-8#1)(1991-11#1)(1991-3#3)(1991-9#2)(1992-6#2)(1993-11#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-2#3)(1997-1#2)(1997-3#1)(1997-7#2)(2008-10#8)(2008-11#7)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#5)
is involved with##2##3##(2009-3#1)(2013-1#1)
is involved##107##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-9#2)(1992-6#2)(1993-11#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-2#3)(1997-1#2)(1997-3#1)(1997-7#2)(2008-10#11)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#5)
is irreversible and##2##3##(2008-10#2)
is isolated from##2##3##(2008-8#2)
is isolated##3##2##(1994-8#1)(2008-8#2)
is it like##2##3##(2008-8#1)(2008-9#1)
is it##22##2##(1991-12#1)(1991-2#1)(1991-3#2)(1992-2#1)(1994-1#1)(1994-12#1)(1995-3#1)(1995-5#2)(1996-10#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)
is it?##2##2##(1993-9#1)(2008-2#1)
is its##17##2##(1994-2#1)(1994-3#2)(1994-8#1)(2007-12#1)(2008-10#6)(2008-3#3)(2008-4#1)(2009-5#1)(2009-8#1)
is itself##3##2##(1996-3#1)(2008-10#1)(2009-1#1)
is just##5##2##(1995-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-8#1)
is justified in##2##3##(2012-3#1)(2013-1#1)
is justified##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
is kept##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2013-8#1)
is key to##3##3##(2008-7#1)(2008-9#1)(2010-11#1)
is key##5##2##(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-1#1)
is known about how to##2##5##(1997-1#1)(2010-11#1)
is known about how##6##4##(1997-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)
is known about its##3##4##(2008-7#1)(2013-8#2)
is known about the diversity##2##5##(2008-10#1)(2009-8#1)
is known about the effect of##2##6##(2008-12#1)(2012-2#1)
is known about the mechanisms##2##5##(2008-11#1)(2013-1#1)
is known about the##41##4##(1990-5#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#2)
is known about##64##3##(1990-5#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#4)
is known as a##4##4##(1992-3#1)(2008-5#2)(2010-7#1)
is known as##6##3##(1992-3#1)(1994-6#1)(2008-4#1)(2008-5#2)(2010-7#1)
is known for its##4##4##(2008-10#2)(2009-9#1)(2011-2#1)
is known for##6##3##(2008-10#2)(2009-9#1)(2010-12#1)(2011-2#2)
is known in the##3##4##(1996-11#2)(2009-3#1)
is known in##5##3##(1996-11#2)(2008-12#1)(2008-5#1)(2009-3#1)
is known of##6##3##(1992-10#1)(1993-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
is known on##2##3##(2008-8#1)(2013-1#1)
is known since##2##3##(2008-10#1)(2008-5#1)
is known that the##2##4##(1990-6#1)(2008-7#1)
is known that##8##3##(1990-6#1)(1991-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)
is known to affect the##2##5##(2008-10#1)(2012-3#1)
is known to affect##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
is known to alter##2##4##(1992-12#1)(2008-7#1)
is known to be a##7##5##(1994-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-2#1)(2013-1#1)
is known to be associated with##2##6##(2008-11#1)(2011-2#1)
is known to be involved in##2##6##(2009-8#1)(2010-11#1)
is known to be responsible for##2##6##(1997-8#1)(2011-1#1)
is known to be##23##4##(1992-11#1)(1994-11#1)(1996-2#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
is known to depend on##2##5##(2008-10#1)(2008-8#1)
is known to enhance##2##4##(2008-10#1)(2008-11#1)
is known to exert its##2##5##(2012-2#2)
is known to form##2##4##(2008-10#1)(2010-11#1)
is known to have##3##4##(2008-1#1)(2009-9#1)(2011-2#1)
is known to increase##2##4##(2008-1#1)(2012-12#1)
is known to induce##4##4##(1995-6#1)(1996-12#1)(2008-10#1)(2008-5#1)
is known to occur in##2##5##(2008-6#1)(2009-8#1)
is known to occur##3##4##(2008-5#1)(2008-6#1)(2009-8#1)
is known to play a role in##2##7##(1996-2#1)(2012-2#1)
is known to play a##4##5##(1993-8#1)(1996-2#1)(2008-11#1)(2012-2#1)
is known to play an important role in##2##8##(1996-12#1)(2011-2#1)
is known to play##6##4##(1993-8#1)(1996-12#1)(1996-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
is known to produce##2##4##(1995-12#1)(2008-10#1)
is known to reduce##2##4##(2008-5#1)(2011-2#1)
is known to regulate##2##4##(2008-8#1)(2010-11#1)
is known to##76##3##(1991-3#1)(1992-11#1)(1992-12#2)(1993-8#2)(1994-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#3)(1997-2#1)(1997-8#2)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#8)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#3)(2009-9#1)(2010-11#3)(2010-3#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)
is known##198##2##(1990-5#2)(1990-6#1)(1991-3#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-6#1)(1996-11#2)(1996-12#2)(1996-2#3)(1997-1#1)(1997-2#2)(1997-8#2)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#28)(2008-11#16)(2008-12#4)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#5)(2009-9#2)(2010-1#2)(2010-11#5)(2010-12#1)(2010-3#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#2)(2013-1#7)(2013-8#4)
is known)##2##2##(2008-3#2)
is laborious and##2##3##(2008-10#1)(2008-11#1)
is lack of##3##3##(2008-5#1)(2010-12#1)(2011-10#1)
is lacking in##3##3##(1995-11#1)(2008-1#1)(2008-8#1)
is lacking##17##2##(1993-12#1)(1995-11#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-2#2)
is laid on the importance of##2##6##(1990-3#2)
is laid on the##3##4##(1990-3#2)(2008-2#1)
is laid on##4##3##(1990-3#3)(2008-2#1)
is large relative to the##2##5##(2008-8#1)(2011-2#1)
is large##9##2##(1991-3#1)(1993-11#1)(1994-2#1)(2008-3#2)(2008-8#2)(2011-2#2)
is largely composed of##2##4##(2010-5#1)(2011-2#1)
is largely due to the##2##5##(2012-2#1)(2013-7#1)
is largely not##2##3##(1997-3#1)(2012-3#1)
is largely responsible for##2##4##(1996-3#1)(2012-2#1)
is largely unknown##4##3##(2008-10#1)(2008-11#1)(2013-8#2)
is largely##36##2##(1990-5#1)(1991-2#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-5#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
is larger for##2##3##(2007-11#1)(2008-10#1)
is larger in##2##3##(2008-8#1)(2012-3#1)
is larger than that of##2##5##(2008-3#1)(2008-7#1)
is larger than the##2##4##(2008-10#1)(2008-3#1)
is larger than##7##3##(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)
is larger##13##2##(2007-11#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#3)(2009-7#1)(2012-3#1)
is later##4##2##(1995-6#1)(1995-9#1)(2008-8#1)(2011-1#1)
is leading to the##2##4##(2008-11#1)(2013-8#1)
is leading to##4##3##(1993-6#1)(2008-11#1)(2012-12#1)(2013-8#1)
is leading##5##2##(1993-6#1)(1996-5#1)(2008-11#1)(2012-12#1)(2013-8#1)
is led into##2##3##(2008-10#2)
is left untreated##2##3##(2008-9#1)(2012-2#1)
is left##4##2##(2008-8#2)(2008-9#1)(2012-2#1)
is less affected by##2##4##(2008-10#1)(2008-11#1)
is less clear##3##3##(1991-12#1)(2011-2#1)(2013-1#1)
is less important##2##3##(2008-8#1)(2010-6#1)
is less invasive and##2##4##(2008-7#2)
is less invasive##3##3##(2008-7#2)(2011-2#1)
is less likely to##2##4##(2008-8#2)
is less likely##3##3##(2008-1#1)(2008-8#2)
is less risky##2##3##(1990-2#1)(2013-1#1)
is less sensitive to##5##4##(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
is less sensitive##7##3##(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)
is less than 0##2##4##(2008-10#2)
is less than 3##2##4##(2008-10#2)
is less than that##2##4##(2008-10#1)(2008-9#1)
is less than the##4##4##(2008-3#2)(2008-9#1)(2013-1#1)
is less than##36##3##(1991-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#19)(2008-11#1)(2008-3#4)(2008-7#1)(2008-9#2)(2012-2#1)(2013-1#2)(2013-8#2)
is less well understood##3##4##(1995-8#1)(2011-2#1)(2013-1#1)
is less well##4##3##(1995-8#1)(2011-2#2)(2013-1#1)
is less##88##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-6#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2010-1#1)(2010-12#1)(2010-6#3)(2010-7#1)(2011-2#9)(2012-2#1)(2013-1#6)(2013-8#4)
is liberated##3##2##(1993-8#1)(2008-10#2)
is likely not##2##3##(2008-10#1)(2008-9#1)
is likely that the##5##4##(1995-12#1)(1997-1#1)(2008-8#1)(2012-3#1)(2013-1#1)
is likely that this##5##4##(1992-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-8#1)
is likely that##27##3##(1992-12#2)(1994-2#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#2)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-8#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
is likely the##5##3##(1993-8#1)(2008-10#3)(2010-7#1)
is likely to be a##2##5##(1997-6#1)(2008-8#1)
is likely to be an##2##5##(1990-2#1)(2011-2#1)
is likely to be involved##2##5##(1991-7#1)(2008-10#1)
is likely to be more##2##5##(2008-10#1)(2008-9#1)
is likely to be##31##4##(1990-12#1)(1990-2#1)(1991-7#1)(1993-2#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-5#1)(2011-2#3)(2012-2#1)
is likely to have##3##4##(1991-12#1)(2008-10#1)(2013-1#1)
is likely to influence the##2##5##(1996-12#1)(2008-10#1)
is likely to influence##3##4##(1996-12#1)(2008-10#1)(2008-7#1)
is likely to play##2##4##(1997-7#1)(2008-9#1)
is likely to##59##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-2#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
is likely##112##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-12#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-9#1)(1997-1#3)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#19)(2008-11#7)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
is limited and##5##3##(1996-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)
is limited at##2##3##(2008-10#1)(2008-8#1)
is limited by a##2##4##(1997-2#1)(2008-12#1)
is limited by its##2##4##(1994-9#1)(2012-2#1)
is limited by the##5##4##(1991-3#1)(1997-1#1)(2012-3#2)(2013-1#1)
is limited by##13##3##(1991-3#1)(1994-9#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2012-2#1)(2012-3#2)(2013-1#1)
is limited in##3##3##(2008-9#1)(2011-2#2)
is limited to the##3##4##(1997-3#1)(2008-10#1)(2012-3#1)
is limited to##10##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
is limited##62##2##(1991-3#1)(1992-1#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
is linear from##4##3##(2008-10#4)
is linear in the concentration range##3##6##(2008-10#3)
is linear in the range 0##3##6##(2008-10#3)
is linear in the range of 0##4##7##(2008-10#4)
is linear in the range of##8##6##(2008-10#8)
is linear in the range##12##5##(2008-10#12)
is linear in the##15##4##(2008-10#15)
is linear in##17##3##(2008-10#16)(2008-2#1)
is linear over 0##2##4##(2008-10#2)
is linear over the concentration range##6##6##(2008-10#6)
is linear over the range of##2##6##(2008-10#2)
is linear over the range##4##5##(2008-10#4)
is linear over the##11##4##(2008-10#11)
is linear over##17##3##(2008-10#17)
is linear up to##7##4##(2008-10#7)
is linear with the concentration of##3##6##(2008-10#3)
is linear with the concentration##4##5##(2008-10#4)
is linear with the##5##4##(2008-10#5)
is linear with##9##3##(2008-10#9)
is linear##62##2##(2008-10#58)(2008-2#1)(2008-3#1)(2008-8#2)
is linearly proportional to the##2##5##(2008-10#2)
is linearly##7##2##(1997-2#1)(2008-10#6)
is linked to the##8##4##(1991-12#1)(1994-6#1)(1996-3#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
is linked to##15##3##(1991-12#2)(1994-6#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#2)
is linked with##2##3##(2008-10#2)
is linked##18##2##(1990-2#1)(1991-12#2)(1994-6#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#2)
is listed as##2##3##(2011-2#2)
is little affected by##3##4##(2008-10#3)
is little evidence##4##3##(1993-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
is little or no##2##4##(1993-8#1)(2008-8#1)
is little##25##2##(1992-2#1)(1993-3#1)(1993-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#3)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
is localized in the##2##4##(1991-9#1)(1997-8#1)
is localized to the Golgi##2##5##(1995-2#1)(2009-8#1)
is localized to the##3##4##(1995-2#1)(1995-8#1)(2009-8#1)
is localized to##4##3##(1995-2#1)(1995-8#1)(2009-8#2)
is localized##8##2##(1991-5#1)(1991-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-8#1)(2009-8#2)
is locally##2##2##(1997-7#1)(2011-2#1)
is located at the##3##4##(1995-12#1)(2008-7#1)(2009-12#1)
is located at##5##3##(1990-7#1)(1995-12#1)(2008-10#1)(2008-7#1)(2009-12#1)
is located between##2##3##(2008-8#1)(2012-12#1)
is located in the central##2##5##(2008-8#1)(2008-9#1)
is located in the##10##4##(1995-2#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
is located in##12##3##(1994-5#1)(1995-2#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2013-8#1)
is located near the##3##4##(1997-9#1)(2008-10#1)(2008-8#1)
is located on chromosome##2##4##(2008-8#1)(2008-9#1)
is located on the##5##4##(1993-9#1)(2008-10#1)(2008-5#2)(2008-8#1)
is located on##7##3##(1993-9#1)(2008-10#1)(2008-5#2)(2008-8#2)(2008-9#1)
is located upstream##2##3##(1993-6#1)(1995-6#1)
is located within a##2##4##(1992-4#1)(1995-6#1)
is located within##5##3##(1992-4#1)(1993-8#1)(1994-2#1)(1995-6#1)(2008-10#1)
is located##55##2##(1990-7#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-6#1)(1997-7#1)(1997-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
is long##2##2##(2008-10#1)(2008-9#1)
is longer##2##2##(2008-10#2)
is lost after##2##3##(2008-10#1)(2010-11#1)
is lost##7##2##(2008-10#2)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
is low and##4##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
is low but##2##3##(1996-8#1)(1997-5#1)
is low compared##2##3##(2008-8#1)(2012-3#1)
is low in##3##3##(1993-2#1)(2007-11#1)(2008-9#1)
is low or##4##3##(1994-3#1)(2008-10#2)(2008-9#1)
is low##40##2##(1990-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-2#1)(1994-1#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#3)(2009-1#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
is lower than that of##4##5##(1994-5#1)(2007-12#1)(2008-10#1)(2011-3#1)
is lower than the##2##4##(2008-11#1)(2008-12#1)
is lower than##10##3##(1994-5#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-12#1)(2011-3#1)
is lower##15##2##(1990-11#1)(1994-5#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
is m(o)=2##2##2##(2008-10#2)
is made between the##2##4##(2008-10#1)(2008-11#1)
is made between##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
is made by##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
is made from##2##3##(2008-11#1)(2008-3#1)
is made in##2##3##(1991-12#1)(2008-10#1)
is made of the##5##4##(1992-1#1)(2008-10#2)(2008-3#1)(2012-3#1)
is made of##9##3##(1992-1#1)(1993-8#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-7#1)(2012-3#1)
is made on the##2##4##(1991-3#1)(2008-2#1)
is made on##4##3##(1991-3#1)(2008-2#1)(2008-3#1)(2012-3#1)
is made possible by##2##4##(2008-3#1)(2012-2#1)
is made that##2##3##(1995-5#1)(2009-10#1)
is made to develop##2##4##(1991-3#1)(2008-10#1)
is made to react with##2##5##(2008-10#2)
is made to##10##3##(1991-3#1)(1996-6#1)(1996-9#1)(2008-10#5)(2008-4#1)(2013-1#1)
is made up of##6##4##(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
is made with the##2##4##(2008-5#1)(2010-7#1)
is made with##3##3##(2008-5#1)(2008-7#1)(2010-7#1)
is made##64##2##(1990-3#1)(1991-12#1)(1991-3#3)(1992-1#1)(1992-9#2)(1993-8#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#3)
is mainly based on##2##4##(1996-11#1)(2008-10#1)
is mainly due to the##4##5##(1992-1#1)(2008-5#1)(2009-12#1)(2009-7#1)
is mainly due to##7##4##(1992-1#1)(1994-5#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-7#1)(2012-3#1)
is mainly mediated by##3##4##(2008-11#1)(2008-9#1)(2009-10#1)
is mainly reflected##2##3##(2008-12#1)(2013-1#1)
is mainly##38##2##(1992-1#1)(1992-11#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-11#1)(1997-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
is maintained by##4##3##(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)
is maintained for##3##3##(1995-2#1)(2008-11#1)(2011-3#1)
is maintained in the concentration range##4##6##(2008-10#4)
is maintained in##6##3##(1995-6#1)(2008-10#4)(2010-12#1)
is maintained##26##2##(1994-2#1)(1995-2#1)(1995-6#1)(1996-9#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
is major concern##2##3##(2008-7#1)(2012-2#1)
is making##2##2##(1996-2#1)(1997-7#1)
is managed by##2##3##(2007-12#1)(2008-10#1)
is managed##4##2##(1992-12#1)(2007-12#1)(2008-10#2)
is mandatory if##2##3##(1990-9#1)(2008-10#1)
is mandatory to##2##3##(1997-6#1)(2011-2#1)
is mandatory##12##2##(1990-9#1)(1996-11#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
is manifested by a##2##4##(2008-10#1)(2008-11#1)
is manifested by##6##3##(1990-5#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
is manipulated##2##2##(2008-10#1)(2012-3#1)
is marked by##4##3##(1995-6#1)(1997-2#1)(2008-7#1)(2009-5#1)
is markedly inhibited##2##3##(1992-1#1)(1994-2#1)
is markedly##5##2##(1991-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(1996-3#1)
is maximal##3##2##(1991-5#1)(2011-3#1)(2013-8#1)
is maximized##3##2##(2008-10#1)(2008-8#2)
is maximum##2##2##(2008-10#1)(2012-3#1)
is meant##3##2##(1994-9#1)(1996-2#1)(2008-12#1)
is measurable##2##2##(2008-10#1)(2008-12#1)
is measured as##2##3##(1993-3#1)(2008-4#1)
is measured at##22##3##(2008-10#21)(2008-3#1)
is measured by a##2##4##(2008-10#1)(2008-9#1)
is measured by an##2##4##(1991-2#1)(2008-10#1)
is measured by the##2##4##(2008-10#1)(2008-9#1)
is measured by##11##3##(1991-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)
is measured in##4##3##(1992-3#1)(2008-10#3)
is measured spectrophotometrically at##2##4##(2008-10#2)
is measured##57##2##(1991-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(2008-10#41)(2008-11#1)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#3)(2009-11#1)(2013-1#1)
is mediated at least##2##4##(1992-6#1)(2008-9#1)
is mediated by a cis-acting##2##5##(1994-12#1)(1995-6#1)
is mediated by a##12##4##(1992-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-6#2)(1996-2#1)(1997-9#1)(2008-10#2)(2008-11#1)(2009-8#1)
is mediated by an##4##4##(1993-3#1)(1995-11#1)(1995-8#1)(2008-5#1)
is mediated by both##3##4##(1994-8#1)(2008-10#1)(2008-6#1)
is mediated by the##7##4##(1994-12#1)(1995-2#1)(1997-4#1)(2008-10#2)(2009-8#1)(2012-2#1)
is mediated by##44##3##(1990-5#1)(1992-3#1)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#3)(1997-2#2)(1997-4#1)(1997-7#1)(1997-9#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#2)(2009-9#1)(2012-2#1)(2012-3#1)
is mediated through the##2##4##(1996-2#1)(2012-3#1)
is mediated through##3##3##(1996-2#2)(2012-3#1)
is mediated via##2##3##(1993-6#1)(2008-8#1)
is mediated##53##2##(1990-5#1)(1992-3#1)(1992-6#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#5)(1997-2#2)(1997-4#1)(1997-7#1)(1997-9#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2009-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
is mentioned##2##2##(1992-6#1)(2008-10#1)
is merged with a##2##4##(2008-10#2)
is merged with##3##3##(2008-10#3)
is met##2##2##(2012-2#1)(2012-3#1)
is metabolized##4##2##(1990-11#1)(1997-6#1)(2008-10#1)(2010-11#1)
is mild##2##2##(2008-9#1)(2011-2#1)
is minimal##7##2##(1992-5#1)(1996-9#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
is minimized by##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
is minimized##7##2##(2008-10#3)(2008-11#1)(2008-3#2)(2011-2#1)
is misleading##2##2##(2008-10#1)(2008-11#1)
is missing##5##2##(1995-11#1)(1995-12#1)(2007-12#1)(2013-1#1)(2013-8#1)
is mixed with##3##3##(1995-3#1)(2008-10#2)
is mixed##6##2##(1995-3#1)(2008-10#4)(2008-11#1)
is modeled as a##3##4##(2008-10#2)(2008-8#1)
is modeled##5##2##(2008-10#3)(2008-3#1)(2008-8#1)
is modified by##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
is modified##7##2##(1994-3#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)
is modulated by phosphorylation##2##4##(1994-11#1)(1996-2#1)
is modulated by##10##3##(1993-11#1)(1994-11#1)(1995-9#1)(1996-2#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#1)
is modulated##16##2##(1992-10#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)(2013-8#1)
is monitored at##8##3##(2008-10#8)
is monitored by##4##3##(2008-10#4)
is monitored spectrophotometrically at##3##4##(2008-10#3)
is monitored spectrophotometrically##6##3##(2008-10#6)
is monitored##28##2##(2008-10#26)(2008-3#1)(2008-5#1)
is more accurate than##2##4##(2008-10#1)(2012-3#1)
is more appropriate##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
is more closely related##3##4##(2008-9#3)
is more common and##2##4##(2011-2#1)(2012-2#1)
is more common in##2##4##(2008-12#1)(2010-8#1)
is more common##5##3##(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
is more commonly##2##3##(2008-7#1)(2009-1#1)
is more complex##3##3##(1994-2#1)(2008-10#2)
is more complicated##2##3##(1992-8#1)(2008-8#1)
is more difficult to##4##4##(2008-11#1)(2008-8#1)(2010-6#2)
is more difficult##7##3##(1992-1#1)(1992-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#2)
is more effective for##2##4##(2008-10#1)(2008-4#1)
is more effective##7##3##(1991-9#1)(1995-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#1)
is more efficient in##2##4##(2008-3#1)(2012-2#1)
is more efficient##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
is more likely to be##3##5##(2010-3#1)(2013-1#2)
is more likely to occur##2##5##(1990-6#1)(1996-11#1)
is more likely to##6##4##(1990-6#1)(1996-11#1)(2010-10#1)(2010-3#1)(2013-1#2)
is more likely##9##3##(1990-6#1)(1993-8#1)(1996-11#1)(2008-8#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#2)
is more often##2##3##(2011-2#1)(2013-1#1)
is more open to##2##4##(1994-1#1)(2013-1#1)
is more precise and accurate##2##5##(2008-10#2)
is more prevalent##3##3##(1991-6#1)(1993-3#1)(2008-5#1)
is more pronounced in the##2##5##(1995-12#1)(2010-12#1)
is more pronounced##3##3##(1995-12#1)(2008-10#1)(2010-12#1)
is more reliable##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
is more sensitive than the##2##5##(2008-7#1)(2008-8#1)
is more sensitive than##7##4##(1991-8#1)(1996-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)
is more sensitive to##6##4##(1991-5#1)(1992-12#1)(1992-8#1)(2008-10#1)(2008-6#1)(2008-9#1)
is more sensitive##15##3##(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
is more stable than##2##4##(2008-10#2)
is more stable##3##3##(2008-10#2)(2008-5#1)
is more suitable for##3##4##(2008-10#1)(2010-4#2)
is more than twice##2##4##(2008-10#1)(2008-9#1)
is more than##12##3##(1990-6#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)
is more useful for##2##4##(2008-3#1)(2009-8#1)
is more useful##4##3##(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
is more##161##2##(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(2007-12#3)(2007-8#1)(2008-10#33)(2008-11#5)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#10)(2008-9#10)(2009-1#1)(2009-10#2)(2009-8#3)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-2#10)(2012-2#3)(2012-3#3)(2012-7#1)(2012-9#1)(2013-1#9)
is morphologically##2##2##(2008-5#1)(2010-3#1)
is most closely related to PFBV##2##6##(2008-10#2)
is most closely##3##3##(1993-2#1)(2008-10#2)
is most common in##2##4##(2008-10#1)(2008-5#1)
is most common##5##3##(1992-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2010-8#1)
is most commonly##5##3##(2010-12#1)(2011-2#1)(2013-1#3)
is most effective when##2##4##(1994-1#1)(2008-9#1)
is most effective##3##3##(1994-1#1)(2008-7#1)(2008-9#1)
is most important for##2##4##(1994-6#1)(2008-10#1)
is most important##4##3##(1994-3#1)(1994-6#1)(2008-10#1)(2011-2#1)
is most likely a##3##4##(1995-11#1)(2008-4#1)(2009-8#1)
is most likely the##2##4##(2008-10#1)(2008-11#1)
is most likely to occur##2##5##(2008-10#1)(2008-8#1)
is most likely to##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
is most likely##16##3##(1991-12#1)(1995-11#1)(1996-11#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
is most often seen##2##4##(1992-5#1)(2008-10#1)
is most often##7##3##(1992-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-5#1)
is most probably##3##3##(1995-8#1)(2006-6#1)(2008-3#1)
is most similar to##2##4##(2008-10#2)
is most##69##2##(1990-12#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
is mostly based on##2##4##(2010-7#1)(2011-2#1)
is mostly due to##2##4##(2008-10#1)(2009-12#1)
is mostly found in the##2##5##(2008-12#1)(2011-2#1)
is mostly##19##2##(1996-11#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-7#1)(2011-2#3)(2013-1#2)
is much better than that##2##5##(2008-10#2)
is much better##3##3##(2008-10#2)(2008-11#1)
is much faster##6##3##(2007-12#1)(2008-10#2)(2008-3#1)(2010-6#1)(2012-3#1)
is much greater than that##2##5##(2008-10#1)(2008-8#1)
is much greater##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
is much higher in##2##4##(2008-10#1)(2008-9#1)
is much higher than that of##3##6##(2008-10#2)(2008-8#1)
is much higher than##8##4##(1994-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
is much higher##11##3##(1994-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
is much larger##2##3##(2008-10#1)(2008-3#1)
is much less##6##3##(1993-2#1)(1996-11#1)(1996-2#1)(1997-4#1)(2011-2#1)(2012-3#1)
is much lower than##2##4##(2008-10#1)(2008-5#1)
is much lower##4##3##(1997-7#1)(2008-10#1)(2008-5#1)(2012-12#1)
is much more rapid##2##4##(2008-10#1)(2008-7#1)
is much more##13##3##(1994-1#1)(1994-5#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
is much rarer##2##3##(2009-1#1)(2010-12#1)
is much shorter##2##3##(2008-10#1)(2010-10#1)
is much##63##2##(1992-9#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-12#1)(2008-10#20)(2008-11#5)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#2)
is multi-factorial##2##2##(2011-2#1)(2012-2#1)
is multifactorial##5##2##(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#2)
is multimodal##2##2##(2012-2#1)(2012-3#1)
is multiple##2##2##(2009-8#1)(2012-3#1)
is multiplied##2##2##(2012-2#2)
is myotonic dystrophy##2##3##(2013-1#2)
is named##2##2##(2008-10#1)(2008-8#1)
is narrow##2##2##(1995-1#1)(2008-10#1)
is native to the##2##4##(2008-10#1)(2008-11#1)
is naturally##3##2##(1992-6#1)(1995-8#1)(2008-10#1)
is near the##2##3##(1992-3#1)(2013-8#1)
is near##4##2##(1992-3#1)(2008-11#1)(2008-8#1)(2013-8#1)
is nearly##6##2##(1991-3#1)(1994-12#1)(2008-10#1)(2008-3#2)(2008-6#1)
is necessary and##2##3##(1995-2#1)(1997-3#1)
is necessary as##2##3##(2008-10#1)(2008-2#1)
is necessary for effective##2##4##(2008-11#1)(2010-7#1)
is necessary for environmental##2##4##(2008-10#2)
is necessary for the##8##4##(1993-3#1)(1994-11#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-7#1)
is necessary for##38##3##(1990-9#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-7#3)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is necessary in order to##5##5##(1992-5#1)(2008-10#2)(2008-11#1)(2009-3#1)
is necessary in##8##3##(1992-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-3#1)
is necessary to carry out##2##5##(2008-11#1)(2013-1#1)
is necessary to determine##2##4##(1991-8#1)(2009-8#1)
is necessary to develop##2##4##(2008-10#1)(2012-2#1)
is necessary to examine the##2##5##(1996-12#1)(2008-3#1)
is necessary to examine##3##4##(1996-12#1)(2008-11#1)(2008-3#1)
is necessary to extend##2##4##(2011-2#1)(2012-3#1)
is necessary to identify##3##4##(1995-5#1)(2008-10#1)(2013-8#1)
is necessary to maintain##4##4##(1990-2#1)(1991-1#1)(1996-12#1)(2008-7#1)
is necessary to minimise##2##4##(2010-3#1)(2012-2#1)
is necessary to obtain quantitative recoveries for##2##7##(2008-10#2)
is necessary to obtain##3##4##(2008-10#2)(2013-8#1)
is necessary to overcome the##2##5##(1995-5#1)(2008-3#1)
is necessary to perform a##2##5##(2009-3#1)(2013-8#1)
is necessary to reduce##2##4##(2008-4#1)(2013-1#1)
is necessary to##75##3##(1990-2#1)(1991-1#3)(1991-6#1)(1991-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#2)(1995-5#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#9)(2008-11#9)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#4)
is needed and##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
is needed before##2##3##(1993-3#1)(2010-10#1)
is needed for the##2##4##(2008-10#2)
is needed for##10##3##(1995-2#1)(2008-10#5)(2010-5#1)(2011-2#2)(2012-2#1)
is needed from##2##3##(1997-1#1)(2010-11#1)
is needed in order to##3##5##(2008-10#1)(2009-3#1)(2013-1#1)
is needed in##7##3##(1995-5#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-3#1)(2013-1#1)
is needed on##3##3##(1993-1#1)(2008-11#1)(2012-2#1)
is needed to address the##3##5##(1993-1#1)(1994-12#1)(2008-11#1)
is needed to assess##2##4##(2008-11#1)(2010-10#1)
is needed to confirm these##2##5##(2009-7#1)(2011-2#1)
is needed to confirm##3##4##(2009-7#1)(2011-2#2)
is needed to determine if##2##5##(1994-12#1)(2008-10#1)
is needed to determine##6##4##(1994-12#1)(2008-10#3)(2008-11#1)(2008-12#1)
is needed to ensure##2##4##(2013-1#2)
is needed to identify##2##4##(1992-11#1)(2010-10#1)
is needed to uncover the##2##5##(2008-8#1)(2008-9#1)
is needed to understand##2##4##(2012-3#1)(2013-1#1)
is needed to verify##2##4##(2008-10#1)(2008-9#1)
is needed to##40##3##(1992-11#1)(1993-1#1)(1994-12#2)(1995-6#1)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#3)
is needed##118##2##(1990-3#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#3)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#3)(1997-2#1)(1997-8#1)(2008-1#4)(2008-10#25)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#7)(2012-2#4)(2012-3#1)(2013-1#7)
is negative##4##2##(1995-11#2)(2008-10#1)(2011-2#1)
is negatively controlled by##2##4##(1990-11#1)(2011-1#1)
is negatively correlated with the##3##5##(2008-10#1)(2008-8#2)
is negatively correlated with##5##4##(2008-10#1)(2008-8#3)(2012-3#1)
is negatively related##2##3##(2008-5#1)(2012-3#1)
is negatively##10##2##(1990-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-8#3)(2011-1#1)(2012-3#2)
is negligible in##2##3##(1990-12#1)(2008-10#1)
is negligible##12##2##(1990-12#1)(1991-3#1)(2008-10#7)(2008-3#1)(2010-5#1)(2010-7#1)
is neither##9##2##(1990-5#1)(1991-3#1)(1993-8#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-9#2)(2013-1#1)
is neutralized##2##2##(1996-12#1)(2008-5#1)
is never an##2##3##(2008-10#1)(2008-6#1)
is never##3##2##(1992-9#1)(2008-10#1)(2008-6#1)
is new in##2##3##(2009-5#1)(2009-8#1)
is new##3##2##(2008-11#1)(2009-5#1)(2009-8#1)
is no convincing evidence##2##4##(1992-2#1)(1995-11#1)
is no evidence of##4##4##(1990-2#1)(2009-7#1)(2012-2#1)(2013-1#1)
is no evidence that##4##4##(1993-3#1)(2008-10#2)(2012-12#1)
is no evidence##13##3##(1990-2#1)(1992-2#1)(1993-3#1)(1995-11#1)(2008-10#3)(2008-11#1)(2009-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is no interference##2##3##(2008-10#2)
is no longer considered##3##4##(1991-2#1)(2008-10#1)(2008-11#1)
is no longer stable##2##4##(2008-8#1)(2008-9#1)
is no longer##13##3##(1991-2#1)(1994-1#1)(1994-3#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
is no more##2##3##(1996-11#1)(1996-12#1)
is no need to##2##4##(1994-1#1)(2008-10#1)
is no need##3##3##(1994-1#1)(2008-10#2)
is no significant difference in##2##5##(1996-6#1)(2008-10#1)
is no significant difference##4##4##(1996-6#1)(2008-10#2)(2008-9#1)
is no significant##6##3##(1990-2#1)(1996-6#1)(2008-10#2)(2008-9#1)(2009-5#1)
is no simple##2##3##(2008-8#1)(2008-9#1)
is no specific treatment for##2##5##(1994-9#1)(2013-1#1)
is no specific treatment##3##4##(1994-9#1)(2011-2#1)(2013-1#1)
is no universal##2##3##(1996-6#1)(2013-1#1)
is no##154##2##(1990-2#3)(1990-6#1)(1991-2#2)(1992-12#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#2)(2008-1#3)(2008-10#26)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#7)(2009-12#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#13)(2013-8#2)
is non-specific##3##2##(1990-5#1)(2008-10#1)(2008-9#1)
is non-toxic##2##2##(2008-10#1)(2012-2#1)
is nonlinear##2##2##(1990-8#1)(2008-8#1)
is normal##6##2##(1990-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-8#1)(2009-7#1)
is normalized##2##2##(1994-8#1)(1996-2#1)
is normally expressed in##3##4##(1997-7#1)(1997-8#1)(2008-11#1)
is normally expressed##6##3##(1994-11#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-12#1)
is normally not##2##3##(1993-1#1)(2008-10#1)
is normally##17##2##(1990-5#1)(1992-3#1)(1993-1#1)(1994-11#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-8#1)
is not a decisive factor##2##5##(2013-1#2)
is not a genetic##2##4##(2008-11#2)
is not a good##2##4##(2008-9#1)(2011-2#1)
is not a limiting factor##2##5##(2008-1#1)(2008-10#1)
is not a##52##3##(1990-5#2)(1991-1#1)(1991-5#1)(1992-12#1)(1993-12#4)(1994-12#1)(1995-11#2)(1995-6#4)(1996-3#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#4)(2008-3#2)(2008-9#3)(2010-9#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#4)
is not able to##2##4##(2008-10#1)(2008-8#1)
is not adequate##2##3##(1993-3#1)(1997-8#1)
is not affected by the##5##5##(1997-8#1)(2008-10#3)(2008-9#1)
is not affected by##6##4##(1997-8#1)(2008-10#4)(2008-9#1)
is not affected##9##3##(1995-6#1)(1997-8#1)(2008-10#4)(2008-8#1)(2008-9#2)
is not always easy##3##4##(1991-3#1)(2008-11#1)(2010-9#1)
is not always##15##3##(1991-2#1)(1991-3#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-3#1)(2009-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-8#1)
is not an uncommon##2##4##(2008-1#1)(2008-8#1)
is not an##12##3##(1990-5#1)(1996-11#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-3#1)(2012-12#1)
is not applicable to##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
is not applicable##5##3##(1995-3#1)(2008-10#2)(2008-3#1)(2008-9#1)
is not applied to##2##4##(2008-10#1)(2010-5#1)
is not appropriate##4##3##(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#1)
is not as##10##3##(1990-12#1)(1996-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-7#2)
is not associated with##9##4##(1991-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
is not available##4##3##(1993-2#1)(2008-10#2)(2008-9#1)
is not based##2##3##(1996-6#1)(2008-11#1)
is not caused by##3##4##(1996-5#1)(2011-2#1)(2012-2#1)
is not changed by##2##4##(2008-10#1)(2008-11#1)
is not changed##3##3##(2008-10#2)(2008-11#1)
is not clear whether##7##4##(2008-10#3)(2008-11#3)(2008-8#1)
is not clear##19##3##(1993-12#1)(2008-10#4)(2008-11#5)(2008-5#2)(2008-8#1)(2009-8#1)(2009-9#1)(2013-1#4)
is not clearly##2##3##(2010-5#1)(2011-1#1)
is not complete##4##3##(1995-9#1)(2008-10#2)(2008-4#1)
is not completely understood##2##4##(2008-3#1)(2008-7#1)
is not completely##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
is not considered##4##3##(1997-1#1)(1997-8#1)(2008-10#1)(2013-1#1)
is not consistent##2##3##(1996-5#1)(2013-8#1)
is not controlled by##4##4##(1994-2#1)(2008-10#2)(2011-2#1)
is not controlled##5##3##(1994-2#1)(2008-10#2)(2011-2#1)(2012-2#1)
is not coupled##2##3##(1992-6#1)(1995-11#1)
is not degraded by##2##4##(1992-3#1)(1993-6#1)
is not dependent on##6##4##(1994-8#1)(1995-11#1)(1996-12#1)(2006-6#1)(2008-10#2)
is not dependent##7##3##(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(2006-6#1)(2008-10#2)
is not detected##3##3##(1990-8#1)(1996-12#1)(2012-12#1)
is not determined##2##3##(1991-12#1)(1995-11#1)
is not disrupted##2##3##(1994-12#1)(2008-10#1)
is not due to a##2##5##(2008-10#1)(2008-4#1)
is not due to the##2##5##(2008-6#1)(2013-1#1)
is not due to##10##4##(1993-6#1)(1994-2#1)(1995-8#2)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#1)
is not easily##2##3##(2008-10#1)(2008-12#1)
is not easy to##2##4##(1994-1#1)(2008-10#1)
is not easy##4##3##(1994-1#1)(1996-3#1)(2008-10#1)(2011-7#1)
is not entirely##2##3##(2009-10#1)(2011-2#1)
is not essential for the##2##5##(1993-12#1)(2008-10#1)
is not essential for##7##4##(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-2#1)(2008-10#2)
is not exactly##2##3##(2008-10#1)(2010-5#1)
is not expressed##2##3##(1995-6#1)(2013-1#1)
is not feasible##2##3##(1995-11#1)(2013-1#1)
is not frequent##2##3##(2008-10#1)(2012-6#1)
is not fully understood##6##4##(2008-11#1)(2008-4#1)(2008-6#1)(2012-3#2)(2013-8#1)
is not fully##9##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-3#2)(2013-8#1)
is not important##3##3##(2008-10#1)(2008-8#2)
is not in the##3##4##(1994-12#1)(1997-8#1)(2008-10#1)
is not in##4##3##(1990-5#1)(1994-12#1)(1997-8#1)(2008-10#1)
is not induced by##2##4##(1993-8#1)(1996-12#1)
is not induced##3##3##(1993-8#1)(1996-12#1)(2008-11#1)
is not inhibited by##2##4##(1993-8#1)(2008-11#1)
is not involved in##3##4##(1993-3#1)(1995-8#1)(2008-10#1)
is not involved##5##3##(1993-3#1)(1995-8#1)(1996-9#1)(2008-10#1)(2008-11#1)
is not just a##2##4##(2008-7#1)(2012-12#1)
is not just##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
is not justified##3##3##(1992-2#1)(1992-6#1)(2008-10#1)
is not known if##2##4##(2008-10#1)(2008-5#1)
is not known##30##3##(1990-11#1)(1990-5#1)(1992-10#1)(1993-9#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-7#2)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#6)(2012-2#3)(2012-3#1)
is not limited to##5##4##(2008-10#1)(2008-2#2)(2011-2#1)(2013-1#1)
is not limited##6##3##(2008-10#1)(2008-2#3)(2011-2#1)(2013-1#1)
is not linked to##2##4##(1995-2#1)(2008-10#1)
is not mediated by##4##4##(1994-3#1)(1994-8#1)(1996-12#1)(2009-7#1)
is not mediated##6##3##(1994-3#1)(1994-8#2)(1996-12#1)(2008-5#1)(2009-7#1)
is not necessarily the##3##4##(1996-3#1)(1997-5#1)(2008-10#1)
is not necessarily##7##3##(1996-3#1)(1997-5#1)(2008-10#3)(2008-8#1)(2012-2#1)
is not necessary for##2##4##(1994-2#1)(2011-2#1)
is not necessary to##4##4##(1997-6#1)(2008-10#2)(2008-11#1)
is not necessary##11##3##(1990-2#1)(1990-9#1)(1994-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2011-1#1)(2011-2#1)
is not observed##3##3##(1994-5#1)(1996-2#1)(2008-10#1)
is not on##2##3##(1997-1#1)(2010-12#1)
is not only to##3##4##(2008-4#1)(2010-3#1)(2011-2#1)
is not only##20##3##(1991-12#1)(1995-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#3)
is not oriented##2##3##(2008-10#1)(2008-8#1)
is not possible to##5##4##(1996-11#1)(2008-10#2)(2011-2#1)(2012-12#1)
is not possible with##2##4##(2008-6#1)(2011-2#1)
is not possible##15##3##(1996-11#1)(1997-3#1)(2008-10#5)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#4)(2012-12#1)
is not present in the##2##5##(2008-10#1)(2012-3#1)
is not present##3##3##(1993-12#1)(2008-10#1)(2012-3#1)
is not quite##2##3##(1991-6#1)(2008-9#1)
is not readily##3##3##(1995-12#1)(2008-2#1)(2009-8#1)
is not recommended##7##3##(2008-2#1)(2010-2#1)(2011-2#4)(2013-1#1)
is not reflected##2##3##(2008-11#1)(2009-7#1)
is not related to the##3##5##(1991-12#1)(1994-6#1)(1995-8#1)
is not related to##9##4##(1990-8#1)(1991-12#1)(1992-12#1)(1994-6#1)(1995-8#1)(1997-8#1)(2011-2#2)(2013-1#1)
is not required for the##2##5##(1991-5#1)(1995-6#1)
is not required for##4##4##(1991-5#1)(1993-12#1)(1993-6#1)(1995-6#1)
is not required to##2##4##(1995-2#1)(2008-10#1)
is not required##13##3##(1991-5#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#6)(2009-5#1)
is not responsible for##2##4##(1994-8#1)(1995-2#1)
is not restricted to##4##4##(1991-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
is not retained##2##3##(2008-10#2)
is not satisfactory##2##3##(1991-6#1)(2012-2#1)
is not sensitive to the##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
is not sensitive to##6##4##(1991-6#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
is not sensitive##7##3##(1991-6#1)(1992-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
is not significant##3##3##(1996-8#1)(2008-10#1)(2009-8#1)
is not significantly affected by##2##5##(1993-3#1)(1995-8#1)
is not significantly different##3##4##(1990-6#1)(2008-10#1)(2008-11#1)
is not significantly##8##3##(1990-6#1)(1992-3#1)(1993-3#1)(1995-8#1)(2008-10#1)(2008-11#2)(2010-10#1)
is not so##3##3##(1991-6#1)(2008-10#1)(2008-7#1)
is not specific for##2##4##(1993-8#1)(1994-11#1)
is not standardized##2##3##(2008-11#1)(2011-2#1)
is not straightforward##2##3##(1990-12#1)(2008-10#1)
is not strictly##3##3##(1995-9#1)(2008-11#1)(2010-5#1)
is not subject to##3##4##(1995-12#1)(2008-11#1)(2012-3#1)
is not sufficient to##3##4##(1996-12#1)(2008-5#1)(2009-8#1)
is not sufficient##9##3##(1996-12#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
is not suitable for##2##4##(2008-10#2)
is not suitable##3##3##(2008-10#3)
is not surprising because##2##4##(2008-5#1)(2010-1#1)
is not surprising that##2##4##(2008-5#1)(2011-2#1)
is not surprising##5##3##(2008-4#1)(2008-5#2)(2010-1#1)(2011-2#1)
is not the case for##2##5##(2008-10#1)(2008-11#1)
is not the case##4##4##(1991-6#1)(2008-10#1)(2008-11#1)(2010-3#1)
is not the only##4##4##(2008-10#1)(2008-6#1)(2008-7#1)(2013-8#1)
is not the same##2##4##(2008-10#2)
is not the##27##3##(1991-1#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#3)(2013-8#1)
is not to##4##3##(1994-1#1)(2008-7#1)(2010-7#1)(2011-2#1)
is not too great##2##4##(2008-8#2)
is not too##3##3##(2008-8#3)
is not transmitted##2##3##(2008-10#2)
is not true##2##3##(1992-9#1)(2008-10#1)
is not uncommon##2##3##(2009-11#1)(2012-3#1)
is not understood##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
is not uniform##3##3##(2008-10#2)(2009-4#1)
is not used here##2##4##(2008-10#2)
is not useful##2##3##(2008-7#1)(2008-9#1)
is not very##3##3##(1994-8#1)(2008-10#2)
is not well described##2##4##(2008-9#1)(2009-11#1)
is not well documented##2##4##(2008-10#1)(2012-3#1)
is not well established##2##4##(1996-11#1)(2009-10#1)
is not well known##2##4##(2010-11#1)(2011-2#1)
is not well understood##10##4##(1993-9#1)(1996-6#1)(2008-10#3)(2008-7#1)(2009-11#1)(2010-10#1)(2010-11#1)(2013-1#1)
is not well##19##3##(1993-9#1)(1996-11#1)(1996-6#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2010-10#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
is not widely##3##3##(2008-10#1)(2010-6#1)(2013-1#1)
is not without its##3##4##(2008-12#2)(2010-11#1)
is not without##5##3##(1996-1#1)(2008-12#2)(2010-10#1)(2010-11#1)
is not yet fully##3##4##(1991-2#1)(1997-8#1)(2009-7#1)
is not yet understood##2##4##(1991-11#1)(2013-1#1)
is not yet##19##3##(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-8#1)(1994-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
is not##730##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#7)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#4)(1991-5#4)(1991-6#6)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#11)(1993-2#1)(1993-3#4)(1993-6#3)(1993-8#5)(1993-9#3)(1994-1#4)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#7)(1995-1#1)(1995-11#7)(1995-12#6)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#11)(1995-8#5)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#9)(1996-2#3)(1996-3#4)(1996-5#4)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#5)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#7)(2006-6#1)(2007-11#4)(2007-12#4)(2008-1#5)(2008-10#143)(2008-11#53)(2008-12#11)(2008-2#6)(2008-3#16)(2008-4#8)(2008-5#16)(2008-6#4)(2008-7#21)(2008-8#17)(2008-9#19)(2009-10#6)(2009-11#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#7)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#43)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#12)(2012-3#16)(2012-6#1)(2013-1#24)(2013-8#6)
is notably##2##2##(2008-8#1)(2013-8#1)
is noted in##2##3##(1997-1#1)(2008-3#1)
is noted##3##2##(1997-1#1)(2008-3#1)(2012-2#1)
is noteworthy that##8##3##(1992-12#1)(1993-2#1)(1995-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)
is noteworthy##10##2##(1992-12#1)(1993-2#1)(1995-8#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-12#1)(2012-2#1)
is nothing##2##2##(2008-10#1)(2008-3#1)
is notoriously difficult to##3##4##(2008-8#1)(2008-9#1)(2010-12#1)
is notoriously difficult##4##3##(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
is novel and##2##3##(2008-10#2)
is novel##7##2##(2008-10#3)(2008-11#2)(2008-9#1)(2012-2#1)
is now a##6##3##(1997-1#1)(2008-10#3)(2010-12#1)(2012-3#1)
is now accepted as a##2##5##(1990-9#1)(1996-11#1)
is now accepted that##2##4##(2007-12#1)(2008-5#1)
is now accepted##4##3##(1990-9#1)(1996-11#1)(2007-12#1)(2008-5#1)
is now applied to##2##4##(2008-10#1)(2008-12#1)
is now available##6##3##(1992-12#1)(1995-5#1)(2008-10#2)(2008-4#1)(2011-2#1)
is now becoming##3##3##(1993-11#1)(2008-7#1)(2009-3#1)
is now being used to##3##5##(1990-11#1)(1994-5#1)(2008-7#1)
is now being used##5##4##(1990-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-7#1)
is now being##6##3##(1990-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
is now clear that##4##4##(2008-7#1)(2010-12#1)(2011-2#2)
is now considered a##3##4##(2008-1#1)(2009-5#1)(2011-3#1)
is now considered##5##3##(2008-1#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-3#1)
is now established##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
is now in##2##3##(1997-2#1)(1997-8#1)
is now known that##3##4##(2009-4#1)(2011-2#1)(2013-1#1)
is now known to be##2##5##(2008-6#1)(2010-7#1)
is now known##6##3##(2008-10#1)(2008-6#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
is now possible to##4##4##(1990-12#1)(1993-8#1)(2008-10#1)(2012-2#1)
is now possible##5##3##(1990-12#1)(1993-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
is now recognised##3##3##(2008-11#1)(2008-12#1)(2010-12#1)
is now recognized as##2##4##(2008-12#1)(2008-5#1)
is now recognized to##2##4##(2008-7#2)
is now recognized##4##3##(2008-12#1)(2008-5#1)(2008-7#2)
is now recommended##2##3##(2011-2#1)(2013-1#1)
is now strong evidence that##2##5##(1990-2#1)(2008-8#1)
is now the##6##3##(1992-12#1)(1992-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
is now used##2##3##(1993-1#1)(2008-10#1)
is now well established##2##4##(1996-2#1)(1997-1#1)
is now well understood##2##4##(2008-9#1)(2013-1#1)
is now well##5##3##(1996-2#1)(1997-1#1)(2008-5#1)(2008-9#1)(2013-1#1)
is now widely accepted##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
is now##117##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-5#2)(1993-1#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#7)(2010-7#1)(2011-2#9)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#1)
is nowadays##4##2##(1993-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
is obeyed in the##9##4##(2008-10#9)
is obeyed in##11##3##(2008-10#11)
is obeyed over the range##3##5##(2008-10#3)
is obeyed over the##7##4##(2008-10#7)
is obeyed##24##2##(2008-10#24)
is obscure##4##2##(1993-3#1)(2008-9#1)(2010-12#1)(2010-8#1)
is observable##2##2##(2008-10#1)(2008-11#1)
is observed and##2##3##(2008-10#2)
is observed at##2##3##(2008-10#2)
is observed between##2##3##(1992-4#1)(2008-5#1)
is observed by##2##3##(2008-10#1)(2008-4#1)
is observed for##8##3##(1996-5#1)(2008-10#7)
is observed in many##2##4##(2008-10#1)(2013-8#1)
is observed in the range##2##5##(2008-10#2)
is observed in the##9##4##(1990-5#1)(1990-8#1)(1993-8#1)(1994-5#1)(1996-5#1)(2008-10#4)
is observed in##23##3##(1990-5#1)(1990-8#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-5#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
is observed on the##2##4##(2008-10#1)(2008-12#1)
is observed on##3##3##(2008-10#2)(2008-12#1)
is observed only##3##3##(1993-8#1)(2008-10#1)(2013-8#1)
is observed when##2##3##(2008-10#1)(2008-9#1)
is observed with##4##3##(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
is observed##86##2##(1990-5#2)(1990-8#1)(1991-5#3)(1992-4#1)(1993-2#1)(1993-8#2)(1994-5#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#43)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
is obtained at##2##3##(2008-10#2)
is obtained between##2##3##(2008-10#2)
is obtained by the##2##4##(2008-3#1)(2008-5#1)
is obtained by using##2##4##(2008-10#2)
is obtained by##13##3##(1990-9#1)(2008-10#6)(2008-3#3)(2008-5#1)(2010-11#1)(2010-8#1)
is obtained for the##2##4##(2008-10#1)(2008-3#1)
is obtained for##4##3##(2008-10#2)(2008-3#2)
is obtained from the##3##4##(2008-10#2)(2008-3#1)
is obtained from##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
is obtained on##2##3##(2008-10#1)(2008-8#1)
is obtained over the##2##4##(2008-10#2)
is obtained under##3##3##(2008-10#3)
is obtained up to##2##4##(2008-10#2)
is obtained when the##2##4##(2008-10#2)
is obtained within##2##3##(2008-10#2)
is obtained##70##2##(1990-12#1)(1990-9#1)(1996-3#1)(1996-9#1)(2007-12#1)(2008-10#47)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#1)(2008-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)
is obviously lower than##2##4##(2008-10#2)
is obviously##6##2##(1992-3#1)(2008-10#3)(2008-11#1)(2010-5#1)
is occurring##5##2##(2008-10#2)(2008-11#2)(2008-8#1)
is of 1##2##3##(2008-10#2)
is of a##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
is of concern##4##3##(1994-2#1)(2008-12#2)(2011-2#1)
is of considerable importance##2##4##(2008-11#1)(2008-7#1)
is of considerable##5##3##(2008-10#2)(2008-11#1)(2008-7#2)
is of critical importance##2##4##(1991-1#1)(2008-10#1)
is of fundamental importance to##2##5##(2008-10#1)(2010-7#1)
is of fundamental##3##3##(1995-12#1)(2008-10#1)(2010-7#1)
is of general##3##3##(2007-11#1)(2008-11#2)
is of great importance in##2##5##(1997-1#1)(2008-10#1)
is of great importance##10##4##(1990-11#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-7#1)(2013-1#1)
is of great interest for##2##5##(2008-11#1)(2012-2#1)
is of great interest##4##4##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
is of great##19##3##(1990-11#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
is of growing##2##3##(2008-11#1)(2008-8#1)
is of importance for##2##4##(2008-11#1)(2008-9#1)
is of importance in the##2##5##(1997-8#1)(2008-5#1)
is of importance##6##3##(1992-6#1)(1994-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
is of interest because it is##2##6##(2011-2#2)
is of interest because it##4##5##(1990-8#1)(2011-2#3)
is of interest for##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
is of interest##10##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#5)
is of large interest because of##2##6##(2011-2#2)
is of major importance in##2##5##(2008-5#1)(2011-2#1)
is of major importance##4##4##(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
is of major##6##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
is of no##2##3##(2008-10#1)(2008-7#1)
is of paramount importance##2##4##(1994-12#1)(2008-10#1)
is of particular concern in##3##5##(2008-10#1)(2008-3#1)(2012-3#1)
is of particular concern##5##4##(1991-3#1)(2008-10#2)(2008-3#1)(2012-3#1)
is of particular interest because##2##5##(1990-12#1)(2008-10#1)
is of particular interest##3##4##(1990-12#1)(1997-1#1)(2008-10#1)
is of particular##11##3##(1990-12#1)(1991-3#1)(1992-8#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
is of phylogenetic interest because of its##2##7##(2011-2#2)
is of phylogenetic interest because of##3##6##(2011-2#3)
is of phylogenetic interest because##4##5##(2011-2#4)
is of practical##3##3##(2008-10#2)(2013-1#1)
is of prime importance for the##2##6##(2008-9#2)
is of prime importance##3##4##(2008-10#1)(2008-9#2)
is of significant##2##3##(1994-9#1)(2008-10#1)
is of special interest because of its##2##7##(2011-2#2)
is of special interest##4##4##(2011-2#4)
is of the##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2013-7#1)
is of utmost importance##5##4##(1991-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
is of utmost##6##3##(1991-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
is of vital##2##3##(2008-10#1)(2008-5#1)
is of##151##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-1#1)(1991-3#2)(1991-6#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#37)(2008-11#16)(2008-12#5)(2008-3#2)(2008-5#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#25)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)
is offered##8##2##(1993-12#1)(1994-12#1)(1995-11#1)(2008-12#2)(2010-1#1)(2010-5#1)(2013-1#1)
is offering##2##2##(1992-2#1)(2008-5#1)
is often a##8##3##(1993-11#1)(1995-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
is often accompanied##2##3##(2008-5#1)(2008-9#1)
is often associated with##13##4##(1993-11#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-7#1)(2012-12#2)(2013-1#1)
is often asymptomatic##2##3##(2010-7#1)(2013-1#1)
is often based on##3##4##(1990-6#1)(2010-5#1)(2012-2#1)
is often complicated by##2##4##(2009-7#1)(2012-12#1)
is often delayed##2##3##(1997-8#1)(2009-8#1)
is often desirable##2##3##(2008-3#1)(2008-9#1)
is often diagnosed##2##3##(1993-3#1)(1997-8#1)
is often difficult to##2##4##(2008-10#1)(2010-5#1)
is often difficult##5##3##(1993-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)
is often downregulated in##2##4##(2011-2#1)(2013-1#1)
is often found##2##3##(2008-10#1)(2008-7#1)
is often hampered by the##2##5##(1990-12#1)(2011-3#1)
is often hampered by##3##4##(1990-12#1)(1992-9#1)(2011-3#1)
is often limited##2##3##(2008-10#1)(2008-8#1)
is often linked##2##3##(1996-6#1)(2009-7#1)
is often necessary in##2##4##(2008-10#2)
is often necessary to##2##4##(2008-9#1)(2011-2#1)
is often necessary##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
is often not##3##3##(1994-3#1)(2008-11#2)
is often poor##2##3##(2008-11#1)(2010-1#1)
is often seen##2##3##(2008-11#1)(2010-7#1)
is often suggested##2##3##(1997-3#1)(2011-2#1)
is often the case##2##4##(2008-4#1)(2011-2#1)
is often the first##2##4##(1993-2#1)(2011-2#1)
is often the##5##3##(1993-2#1)(2008-3#1)(2008-4#1)(2011-2#2)
is often used as a##2##5##(1996-3#1)(2013-1#1)
is often used as##3##4##(1996-3#1)(2010-12#1)(2013-1#1)
is often used in##3##4##(2008-10#1)(2008-7#1)(2009-7#1)
is often used to##4##4##(1993-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
is often used##10##3##(1993-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-1#2)
is often##151##2##(1990-12#1)(1990-6#1)(1991-12#1)(1992-2#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#3)(2008-10#14)(2008-11#11)(2008-12#4)(2008-3#6)(2008-4#5)(2008-5#5)(2008-7#6)(2008-8#3)(2008-9#6)(2009-12#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#12)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#10)(2013-8#3)
is on a##2##3##(2008-10#2)
is on an##2##3##(2008-10#1)(2008-12#1)
is on the increase##2##4##(1995-11#1)(2008-1#1)
is on the##16##3##(1992-12#1)(1994-2#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
is on##36##2##(1991-2#1)(1992-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-3#2)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
is once again##2##3##(2008-6#1)(2010-1#1)
is one in which the##2##5##(2009-7#1)(2012-12#1)
is one of a##2##4##(1995-12#1)(2008-11#1)
is one of several##6##4##(1994-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-2#1)
is one of the best##2##5##(1991-6#1)(2008-12#1)
is one of the common##2##5##(2008-10#1)(2013-1#1)
is one of the factors##2##5##(2008-10#1)(2008-7#1)
is one of the first##2##5##(1996-12#1)(2012-3#1)
is one of the fundamental##3##5##(1995-8#1)(2008-8#1)(2013-8#1)
is one of the important##4##5##(1992-12#1)(1993-3#1)(2008-9#1)(2009-8#1)
is one of the key##2##5##(2008-8#1)(2008-9#1)
is one of the leading causes of##4##7##(2007-12#1)(2010-8#1)(2011-2#2)
is one of the main##7##5##(1991-6#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-6#1)
is one of the major causes of##3##7##(2008-11#2)(2009-12#1)
is one of the major##18##5##(1995-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
is one of the most aggressive##2##6##(2008-1#1)(2011-3#1)
is one of the most common and##2##7##(2008-11#1)(2008-3#1)
is one of the most common##17##6##(1990-8#1)(1990-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#4)
is one of the most destructive diseases of##2##8##(2008-10#2)
is one of the most destructive##3##6##(2008-10#3)
is one of the most devastating##2##6##(1997-7#1)(2008-10#1)
is one of the most important and##2##7##(2010-10#1)(2010-7#1)
is one of the most important diseases of wheat##2##9##(2008-10#1)(2011-10#1)
is one of the most important diseases of##4##8##(2008-10#3)(2011-10#1)
is one of the most important##18##6##(1993-6#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-10#1)(2011-2#2)(2013-7#1)(2013-8#1)
is one of the most intensely studied##2##7##(1995-5#1)(2010-10#1)
is one of the most rapidly##2##6##(2008-12#1)(2011-10#1)
is one of the most sensitive##2##6##(2008-10#1)(2008-7#1)
is one of the most serious##2##6##(1991-3#1)(2008-10#1)
is one of the most widely distributed##2##7##(2008-10#2)
is one of the most widely used##2##7##(2008-10#1)(2012-2#1)
is one of the most widely##6##6##(2008-10#4)(2008-11#1)(2012-2#1)
is one of the most##75##5##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-5#1)(1996-11#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#2)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
is one of the parameters##2##5##(2008-10#1)(2008-3#1)
is one of the primary##2##5##(1993-1#1)(2008-10#1)
is one of the rare##2##5##(2010-5#1)(2012-12#1)
is one of the simplest##2##5##(2008-10#2)
is one of the##162##4##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-12#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#44)(2008-11#10)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-10#2)(2011-2#9)(2011-3#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
is one of##179##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-12#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-12#3)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#45)(2008-11#14)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-10#2)(2011-2#10)(2011-3#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#2)
is one that##2##3##(2008-11#1)(2008-3#1)
is one##209##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-12#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-12#5)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#45)(2008-11#17)(2008-12#9)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#4)(2011-1#2)(2011-10#2)(2011-2#10)(2011-3#2)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#2)
is ongoing##3##2##(2011-2#2)(2012-3#1)
is only a##4##3##(1994-12#1)(1994-6#1)(2008-11#1)(2013-1#1)
is only observed##2##3##(1993-6#2)
is only one##6##3##(1993-8#1)(1997-4#1)(2008-3#1)(2010-11#1)(2013-1#1)(2013-8#1)
is only partially##2##3##(1991-3#1)(1991-8#1)
is only possible##3##3##(1994-12#1)(1996-6#1)(2008-10#1)
is only the beginning##2##4##(1996-1#1)(2008-11#1)
is only the second##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
is only the##8##3##(1996-1#1)(2008-10#2)(2008-11#1)(2011-2#3)(2012-3#1)
is only weakly##2##3##(1990-8#1)(2008-3#1)
is only##64##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-12#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#3)(1994-6#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-4#1)(1997-9#1)(2008-10#10)(2008-11#7)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-7#1)(2011-2#7)(2012-3#1)(2013-1#3)(2013-8#2)
is open to##5##3##(1995-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
is operated##2##2##(1992-1#1)(1994-12#1)
is operating##2##2##(2009-5#2)
is opposite##2##2##(2008-10#1)(2008-8#1)
is optically##2##2##(2007-12#2)
is optimized by##2##3##(2008-10#2)
is optimized for##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
is optimized##8##2##(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
is optimum##2##2##(1993-3#1)(2008-10#1)
is organized in##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
is organized into##2##3##(2008-10#1)(2011-2#1)
is organized##9##2##(1991-2#1)(1997-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#2)
is oriented##5##2##(1990-2#1)(1994-12#1)(1995-2#1)(2008-6#1)(2008-8#1)
is otherwise##3##2##(2007-12#1)(2008-8#1)(2008-9#1)
is our##4##2##(1994-6#1)(1997-3#1)(2007-9#1)(2011-2#1)
is outlined as##2##3##(2008-10#1)(2011-2#1)
is outlined##9##2##(1990-9#1)(1992-1#2)(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
is over##6##2##(1996-2#1)(2008-10#4)(2008-5#1)
is over-expressed in##2##3##(2009-3#1)(2012-2#1)
is overcome by##3##3##(2008-10#3)
is overexpressed in##3##3##(1992-9#1)(2008-11#2)
is oxidised##3##2##(2008-10#3)
is oxidized by the##2##4##(2008-10#2)
is oxidized to iodine##2##4##(2008-10#2)
is oxidized to sulfate and##2##5##(2008-10#2)
is oxidized to##7##3##(2008-10#7)
is oxidized##13##2##(1994-5#1)(2008-10#12)
is paid to##10##3##(1990-6#1)(1992-3#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2011-3#1)
is paid##11##2##(1990-6#1)(1992-3#1)(1995-11#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2011-3#1)
is parameterized##2##2##(2008-10#1)(2008-6#1)
is part of a##6##4##(1990-7#1)(1992-1#1)(1994-1#1)(1997-7#1)(2008-10#1)(2012-12#1)
is part of the Genomic Encyclopedia of Bacteria and Archaea project##18##11##(2011-2#18)
is part of the##30##4##(1990-10#1)(1995-12#2)(1996-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#20)(2012-2#2)(2012-3#1)
is part of##38##3##(1990-10#1)(1990-7#1)(1992-1#1)(1994-1#1)(1995-12#2)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#21)(2012-12#1)(2012-2#2)(2012-3#1)
is partial##2##2##(2008-10#2)
is partially due to##2##4##(1991-12#1)(2010-5#1)
is partially##8##2##(1991-11#1)(1991-12#1)(1995-8#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-5#1)
is particularly efficient##2##3##(2008-2#1)(2008-4#1)
is particularly important because##2##4##(1993-11#1)(2010-4#1)
is particularly important for##3##4##(1997-7#1)(2008-9#1)(2012-2#1)
is particularly important in##2##4##(1992-5#1)(2011-2#1)
is particularly important##8##3##(1992-5#1)(1993-11#1)(1997-7#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
is particularly suitable for##3##4##(2008-10#1)(2008-9#1)(2010-12#1)
is particularly suited##2##3##(1991-9#1)(2008-9#1)
is particularly useful for##3##4##(1997-1#1)(2008-11#1)(2008-12#1)
is particularly useful in##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)
is particularly useful##9##3##(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2010-6#1)
is particularly well##3##3##(1997-6#1)(2008-10#1)(2012-3#1)
is particularly##52##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-3#1)(1995-3#1)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-9#4)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)
is partitioned##2##2##(2008-10#1)(2008-8#1)
is partly dependent on##3##4##(2008-11#1)(2010-5#1)(2013-8#1)
is partly due to the##2##5##(1997-7#1)(2008-10#1)
is partly due to##4##4##(1997-7#1)(2008-10#1)(2008-3#1)(2013-8#1)
is partly##13##2##(1991-2#1)(1992-12#1)(1996-2#1)(1997-7#2)(2008-10#1)(2008-11#3)(2008-3#1)(2010-5#1)(2013-8#2)
is passed through the##2##4##(2008-10#2)
is passed##4##2##(2008-10#4)
is pathogenic to##2##3##(2008-10#1)(2010-3#1)
is pathogenic##3##2##(2008-10#2)(2010-3#1)
is perceived as high##2##4##(2008-8#1)(2010-3#1)
is perceived as##3##3##(2008-11#1)(2008-8#1)(2010-3#1)
is perceived to be##2##4##(1993-3#1)(2009-4#1)
is perceived##6##2##(1993-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-3#1)
is perfectly##2##2##(2008-10#1)(2008-9#1)
is performed at a##2##4##(2008-10#2)
is performed by a##3##4##(2008-10#3)
is performed by the##5##4##(2008-10#2)(2008-3#2)(2009-12#1)
is performed by##19##3##(1991-2#1)(1991-3#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-11#1)
is performed in a##4##4##(2008-10#4)
is performed in##9##3##(2008-10#6)(2008-3#1)(2008-9#1)(2013-1#1)
is performed on a##2##4##(2008-10#1)(2008-9#1)
is performed on the##2##4##(1997-2#1)(2008-10#1)
is performed on##8##3##(1997-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
is performed to##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
is performed using##4##3##(2008-10#2)(2008-9#1)(2012-2#1)
is performed with##2##3##(2008-10#1)(2008-3#1)
is performed##62##2##(1991-2#1)(1991-3#1)(1994-6#1)(1996-3#2)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
is perhaps##3##2##(1992-3#1)(2008-9#2)
is phosphorylated at##2##3##(2008-7#1)(2010-12#1)
is phosphorylated by##2##3##(1993-8#1)(2008-11#1)
is phosphorylated##5##2##(1993-8#1)(1995-6#1)(2008-11#1)(2008-7#1)(2010-12#1)
is physically##3##2##(2008-4#1)(2009-8#1)(2010-7#1)
is pivotal##2##2##(1995-2#1)(2013-7#1)
is placed at##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
is placed on##12##3##(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)
is placed##19##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#2)(2013-1#1)
is plagued##2##2##(1995-5#1)(2008-3#1)
is planned##3##2##(1994-12#1)(1997-8#1)(2008-7#1)
is plausible that##4##3##(2008-11#1)(2009-6#1)(2009-7#1)(2009-8#1)
is plausible##5##2##(2008-10#1)(2008-11#1)(2009-6#1)(2009-7#1)(2009-8#1)
is played by##2##3##(1996-2#1)(2008-10#1)
is plotted##2##2##(1997-6#1)(2008-11#1)
is poor##11##2##(1996-9#1)(2008-10#4)(2008-12#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
is poorly understood##19##3##(1996-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
is poorly##28##2##(1991-3#1)(1996-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-8#1)
is portable##3##2##(2008-10#2)(2008-9#1)
is positioned at the##2##4##(1995-8#1)(2008-10#1)
is positioned##5##2##(1991-12#1)(1995-8#1)(1997-7#1)(2008-10#2)
is positive for##2##3##(1990-6#1)(2008-10#1)
is positive##6##2##(1990-6#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
is positively correlated with##2##4##(1991-7#1)(2012-3#1)
is positively related to##3##4##(1991-12#1)(2010-2#1)(2012-3#1)
is positively related##4##3##(1991-12#1)(2010-12#1)(2010-2#1)(2012-3#1)
is positively##8##2##(1991-12#1)(1991-7#1)(1993-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-3#2)
is possible and the##2##4##(2008-10#1)(2008-11#1)
is possible and##6##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
is possible by##5##3##(2008-10#3)(2008-3#1)(2013-8#1)
is possible for##3##3##(1995-5#1)(2008-11#1)(2008-3#1)
is possible if##5##3##(2008-10#1)(2008-11#1)(2008-8#3)
is possible in the##3##4##(2008-10#2)(2013-1#1)
is possible in##6##3##(1991-11#1)(2008-10#4)(2013-1#1)
is possible only if##2##4##(2008-10#1)(2008-8#1)
is possible only##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
is possible that low##2##4##(2008-7#1)(2012-2#1)
is possible that the##6##4##(1994-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
is possible that##29##3##(1992-2#1)(1993-2#1)(1994-5#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
is possible to detect##3##4##(2008-10#2)(2008-4#1)
is possible to extract##4##4##(2008-10#1)(2008-11#1)(2008-3#2)
is possible to produce##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
is possible to##79##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-8#1)(2008-10#29)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#4)(2009-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
is possible with##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-9#1)
is possible##163##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-11#2)(1991-3#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#53)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#4)(2008-5#4)(2008-7#7)(2008-8#6)(2008-9#6)(2009-1#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
is possibly a##3##3##(1994-8#1)(1996-12#1)(2007-12#1)
is possibly##9##2##(1990-11#1)(1994-11#1)(1994-8#1)(1995-9#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
is postulated that##3##3##(1995-8#1)(2008-11#1)(2010-10#1)
is postulated to##3##3##(1994-3#1)(2008-10#1)(2008-2#1)
is postulated##8##2##(1994-3#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)
is potentially##14##2##(1990-11#1)(1992-12#1)(1992-6#1)(1995-11#1)(1996-1#1)(1997-5#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
is potentiated by##3##3##(1994-12#1)(1994-6#1)(2008-5#1)
is potentiated##4##2##(1994-12#1)(1994-6#1)(1996-2#1)(2008-5#1)
is practically##2##2##(2008-10#2)
is practiced##3##2##(1995-1#1)(2008-11#1)(2012-3#1)
is preceded by##3##3##(1994-2#1)(1995-8#1)(2012-3#1)
is preceded##5##2##(1994-2#1)(1995-8#1)(2008-11#1)(2009-6#1)(2012-3#1)
is precise and##2##3##(1992-12#1)(2008-10#1)
is preconcentrated##4##2##(2008-10#4)
is predicted to be##5##4##(1993-12#1)(2008-10#1)(2008-8#2)(2008-9#1)
is predicted to encode a##2##5##(1996-6#1)(2008-10#1)
is predicted to##13##3##(1993-12#1)(1994-12#1)(1996-6#1)(2008-10#3)(2008-8#2)(2008-9#3)(2013-8#2)
is predicted##17##2##(1993-12#1)(1994-12#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-8#5)(2008-9#3)(2013-8#2)
is predictive of increased liver enzymes and##2##7##(2012-3#2)
is predictive of##3##3##(1996-6#1)(2012-3#2)
is predictive##4##2##(1996-6#1)(2012-3#2)(2013-8#1)
is predominantly expressed in the##2##5##(1995-8#1)(1997-2#1)
is predominantly expressed in##4##4##(1995-8#2)(1997-2#1)(2009-8#1)
is predominantly##8##2##(1995-8#2)(1996-12#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-3#1)
is preferable to##7##3##(1990-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-3#1)(2013-1#1)
is preferable##11##2##(1990-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)
is preferred for##2##3##(2008-1#1)(2008-10#1)
is preferred##6##2##(1990-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-10#1)(2013-8#1)
is prepared by##6##3##(2008-10#6)
is prepared##12##2##(2008-10#11)(2008-4#1)
is prerequisite for##2##3##(1994-3#1)(2011-2#1)
is present and##2##3##(2009-6#1)(2011-2#1)
is present as a single copy##2##6##(1993-2#1)(1997-4#1)
is present as##3##3##(1993-2#1)(1997-4#1)(2008-10#1)
is present at##6##3##(1992-8#1)(1993-3#1)(1994-5#1)(1995-2#1)(2008-10#2)
is present in different##2##4##(2008-9#1)(2013-1#1)
is present in high##2##4##(1992-6#1)(2008-10#1)
is present in most##2##4##(1992-12#1)(2010-6#1)
is present in the sample##2##5##(2008-10#2)
is present in the##17##4##(1993-6#2)(1994-5#2)(1997-7#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-6#1)(2009-8#1)(2012-7#1)
is present in this##2##4##(1995-2#2)
is present in##50##3##(1990-2#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-5#2)(1995-2#2)(1997-7#1)(2008-10#13)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
is present on##2##3##(1997-7#1)(2008-10#1)
is present throughout##2##3##(1994-2#1)(2008-10#1)
is present to##2##3##(1994-5#1)(2008-10#1)
is present##82##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-2#1)(1994-5#4)(1994-9#1)(1995-2#3)(1997-1#1)(1997-4#1)(1997-7#2)(2008-10#22)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#6)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#2)
is presented and compared##2##4##(1993-6#1)(2008-10#1)
is presented and the##3##4##(1990-12#1)(2008-10#1)(2011-7#1)
is presented and##17##3##(1990-12#1)(1990-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-3#1)(2011-7#1)(2013-8#1)
is presented as a##13##4##(1993-1#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-8#1)(2012-2#1)
is presented as an##2##4##(2008-10#1)(2009-8#1)
is presented as##20##3##(1993-1#1)(1996-5#1)(2008-10#6)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#1)
is presented by##2##3##(2008-10#1)(2008-3#1)
is presented for determination of##2##5##(2008-10#2)
is presented for the analysis of polycyclic aromatic hydrocarbons##2##9##(2008-10#2)
is presented for the determination of##6##6##(2008-10#6)
is presented for the##16##4##(1993-12#1)(2008-10#14)(2008-3#1)
is presented for##29##3##(1993-12#1)(2008-10#21)(2008-11#1)(2008-3#3)(2008-4#1)(2010-8#1)(2013-1#1)
is presented from##2##3##(2008-1#1)(2008-10#1)
is presented here##9##3##(1994-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
is presented in detail##2##4##(2008-10#1)(2008-9#1)
is presented in the##4##4##(2008-4#1)(2008-8#1)(2010-10#2)
is presented in this paper##9##5##(2008-10#8)(2009-7#1)
is presented in this work##3##5##(2008-10#3)
is presented in this##14##4##(2008-10#12)(2008-4#1)(2009-7#1)
is presented in which the##2##5##(2008-10#1)(2008-3#1)
is presented in which##6##4##(1990-2#1)(1991-2#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
is presented in##29##3##(1990-2#1)(1991-2#1)(1996-2#1)(1997-2#1)(2008-10#15)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#2)
is presented of a##2##4##(1993-2#1)(2008-10#1)
is presented of##5##3##(1990-8#1)(1992-2#1)(1993-2#1)(1997-5#1)(2008-10#1)
is presented on the##4##4##(1992-1#1)(2008-1#1)(2008-10#2)
is presented on##5##3##(1992-1#1)(2008-1#1)(2008-10#2)(2008-11#1)
is presented that is##2##4##(1997-1#1)(2008-3#1)
is presented that##13##3##(1990-2#1)(1992-12#1)(1993-1#1)(1995-1#1)(1997-1#1)(2008-10#3)(2008-3#5)
is presented to show##4##4##(1996-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
is presented to##15##3##(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2010-8#1)(2013-1#1)
is presented together with##2##4##(2008-10#1)(2008-3#1)
is presented which##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
is presented with##3##3##(2008-10#3)
is presented##392##2##(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#2)(1995-9#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#2)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#3)(2007-12#3)(2008-1#3)(2008-10#173)(2008-11#19)(2008-12#2)(2008-2#6)(2008-3#44)(2008-4#8)(2008-5#5)(2008-7#14)(2008-8#4)(2008-9#4)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-8#3)(2010-9#1)(2011-2#7)(2011-3#1)(2011-7#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#4)
is presently##7##2##(2008-11#2)(2008-7#1)(2010-12#1)(2010-6#1)(2011-3#1)(2013-7#1)
is preserved##4##2##(2008-10#2)(2008-7#1)(2009-12#1)
is presumably##6##2##(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-9#1)(2012-3#1)
is presumed that##3##3##(1995-8#1)(2008-10#1)(2011-2#1)
is presumed to##4##3##(1993-6#1)(1994-5#1)(2008-10#1)(2008-8#1)
is presumed##8##2##(1993-6#1)(1994-5#1)(1995-8#1)(2008-10#2)(2008-8#1)(2009-6#1)(2011-2#1)
is prevalent##3##2##(2008-10#2)(2012-3#1)
is primarily a##3##3##(1992-3#1)(1997-2#1)(2012-12#1)
is primarily based on##2##4##(2010-11#1)(2011-2#1)
is primarily driven by##2##4##(2008-10#1)(2012-2#1)
is primarily due to##2##4##(2012-12#1)(2013-1#1)
is primarily responsible for the##2##5##(2008-11#1)(2008-5#1)
is primarily##26##2##(1992-10#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
is principally##2##2##(2008-10#1)(2008-11#1)
is probable that##3##3##(1995-8#1)(2007-12#1)(2008-12#1)
is probable##5##2##(1995-8#1)(1996-11#1)(2007-12#1)(2008-12#1)(2012-12#1)
is probably a major##2##4##(2008-10#1)(2012-12#1)
is probably a##3##3##(1995-11#1)(2008-10#1)(2012-12#1)
is probably an##3##3##(1994-2#1)(2008-10#1)(2011-2#1)
is probably due to a##2##5##(1991-11#1)(1992-6#1)
is probably due to##3##4##(1991-11#1)(1992-6#1)(2008-10#1)
is probably mediated by##2##4##(1996-2#1)(1997-2#1)
is probably much##2##3##(1991-12#1)(2008-10#1)
is probably not##4##3##(1992-12#1)(1994-5#1)(2008-10#2)
is probably one of the##2##5##(2008-7#1)(2008-9#1)
is probably related to##3##4##(1996-2#1)(1997-2#1)(2011-1#1)
is probably responsible for##2##4##(1997-1#1)(2008-10#1)
is probably the most##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
is probably the reason for the##2##6##(2008-5#1)(2009-8#1)
is probably the##10##3##(1991-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)
is probably##48##2##(1990-11#1)(1991-11#1)(1991-12#3)(1992-12#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-2#2)(1997-1#2)(1997-2#2)(2008-10#13)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)
is problematic in##2##3##(2008-10#1)(2011-2#1)
is problematic##4##2##(1992-12#1)(2008-10#1)(2011-2#2)
is processed in the##2##4##(2008-12#1)(2013-8#1)
is processed in##3##3##(2008-11#1)(2008-12#1)(2013-8#1)
is produced and##2##3##(1993-3#1)(2008-10#1)
is produced as##2##3##(2008-5#1)(2009-5#1)
is produced at##2##3##(2008-10#1)(2008-5#1)
is produced by a##2##4##(2008-10#1)(2008-8#1)
is produced by the##3##4##(2008-10#2)(2009-12#1)
is produced by##13##3##(1994-11#1)(1995-3#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#1)(2009-12#1)
is produced in##12##3##(1990-8#1)(1992-7#1)(1994-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)(2009-7#1)
is produced when##2##3##(2008-10#1)(2008-2#1)
is produced##44##2##(1990-8#1)(1992-7#1)(1993-3#1)(1994-11#3)(1995-3#1)(1996-12#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-2#1)
is producing##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
is projected##3##2##(1994-9#1)(2008-3#2)
is promising to##2##3##(1992-12#1)(2013-1#1)
is promising##6##2##(1992-12#1)(2008-10#2)(2012-2#1)(2013-1#1)(2013-8#1)
is promoted by##2##3##(1993-3#1)(2008-10#1)
is prone to##3##3##(1995-9#1)(2008-10#1)(2008-4#1)
is properly##3##2##(1993-12#1)(1994-12#1)(2008-3#1)
is proportional to the CL intensity##2##6##(2008-10#2)
is proportional to the concentration of##10##6##(2008-10#9)(2008-12#1)
is proportional to the square root of##2##7##(2007-12#1)(2008-3#1)
is proportional to the##23##4##(1996-3#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)
is proportional to##33##3##(1996-3#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#2)
is proportional##34##2##(1996-3#1)(2007-12#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#2)
is proposed and a##2##4##(2008-10#2)
is proposed and applied to##2##5##(2008-10#2)
is proposed and##15##3##(1997-2#1)(2008-10#8)(2008-3#6)
is proposed as a##7##4##(1990-5#1)(1993-12#1)(1995-1#1)(2008-10#3)(2008-11#1)
is proposed as an##4##4##(1991-5#1)(2008-10#2)(2013-7#1)
is proposed as##13##3##(1990-5#1)(1991-5#1)(1993-12#1)(1995-1#1)(2008-10#5)(2008-11#2)(2013-1#1)(2013-7#1)
is proposed based on the##2##5##(2008-10#2)
is proposed based on##4##4##(2008-10#3)(2008-11#1)
is proposed for determining##3##4##(2008-10#2)(2008-11#1)
is proposed for estimating##2##4##(2008-3#1)(2010-11#1)
is proposed for simultaneous determination of##3##6##(2008-10#3)
is proposed for spectrophotometric determination of##2##6##(2008-10#2)
is proposed for spectrophotometric##3##4##(2008-10#3)
is proposed for the determination of thiamine##2##7##(2008-10#2)
is proposed for the determination of trace amounts of##3##9##(2008-10#3)
is proposed for the determination of trace##4##7##(2008-10#4)
is proposed for the determination of##29##6##(2008-10#29)
is proposed for the extraction of##2##6##(2008-10#2)
is proposed for the extraction##4##5##(2008-10#4)
is proposed for the resolution of##2##6##(2008-10#2)
is proposed for the simultaneous determination of##6##7##(2008-10#6)
is proposed for the simultaneous##7##5##(2008-10#7)
is proposed for the spectrophotometric determination of##4##7##(2008-10#4)
is proposed for the##71##4##(1995-6#1)(1996-2#1)(2008-10#66)(2008-11#1)(2008-9#1)(2012-12#1)
is proposed for##99##3##(1990-5#1)(1995-6#1)(1996-2#1)(2008-10#89)(2008-11#2)(2008-3#2)(2008-9#1)(2010-11#1)(2012-12#1)
is proposed here##2##3##(2008-10#1)(2008-3#1)
is proposed in the##3##4##(2008-10#1)(2010-5#1)(2013-8#1)
is proposed in this paper##5##5##(2008-10#4)(2008-6#1)
is proposed in this##7##4##(2008-10#5)(2008-6#1)(2008-7#1)
is proposed in which##2##4##(1991-5#1)(1991-9#1)
is proposed in##12##3##(1991-5#1)(1991-9#1)(2008-10#6)(2008-6#1)(2008-7#1)(2010-5#1)(2013-8#1)
is proposed that the##8##4##(2008-1#1)(2008-10#3)(2009-6#1)(2010-10#1)(2013-8#2)
is proposed that this##2##4##(2008-10#1)(2012-12#1)
is proposed that##26##3##(1991-2#1)(1995-5#1)(1996-12#1)(2006-6#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#2)
is proposed to account for##2##5##(1996-5#1)(2008-9#1)
is proposed to be##4##4##(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
is proposed to involve the Fe((III))Pc/Fe((II))Pc redox process##2##8##(2008-10#2)
is proposed to occur##2##4##(1994-8#1)(2008-10#1)
is proposed to select##2##4##(2008-10#2)
is proposed to##25##3##(1994-8#2)(1996-5#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
is proposed using##4##3##(2008-10#3)(2010-8#1)
is proposed when##2##3##(1991-2#1)(2008-10#1)
is proposed whereby##2##3##(1994-2#1)(2011-2#1)
is proposed##371##2##(1990-5#2)(1991-1#1)(1991-2#3)(1991-5#2)(1991-9#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#274)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#19)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#5)(2009-6#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#7)
is protective##2##2##(1995-5#1)(2008-5#1)
is proved to be##4##4##(2008-10#2)(2008-8#1)(2009-7#1)
is proved to##5##3##(2008-10#2)(2008-2#1)(2008-8#1)(2009-7#1)
is proved##7##2##(2008-10#3)(2008-2#1)(2008-8#1)(2009-7#1)(2011-2#1)
is proven to be##2##4##(2008-11#1)(2013-8#1)
is proven##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
is provided by a##2##4##(1997-6#1)(2008-10#1)
is provided by the##2##4##(2008-10#1)(2008-11#1)
is provided by##9##3##(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2010-5#1)(2010-7#1)(2011-2#1)
is provided for##7##3##(2008-4#4)(2008-7#1)(2010-3#1)(2013-8#1)
is provided in this study##3##5##(2008-10#3)
is provided in this##4##4##(2008-10#3)(2008-11#1)
is provided in##5##3##(2008-10#3)(2008-11#1)(2012-3#1)
is provided to##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
is provided with##2##3##(1992-1#1)(1996-1#1)
is provided##63##2##(1992-1#2)(1992-2#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#11)(2008-5#1)(2008-7#3)(2008-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#4)(2013-8#2)
is providing##4##2##(1996-3#1)(1997-3#1)(2008-1#1)(2008-5#1)
is published##2##2##(2008-11#1)(2010-8#1)
is pumped##7##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)
is qualitatively different##2##3##(2008-12#1)(2008-9#1)
is qualitatively##4##2##(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
is quantified by##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
is quantified##5##2##(1992-9#1)(2008-10#2)(2008-2#1)(2008-9#1)
is quantitated##2##2##(2008-10#2)
is quantitative##5##2##(2008-10#5)
is quantitatively adsorbed on##2##4##(2008-10#2)
is quantitatively described by##2##4##(1990-5#1)(2009-11#1)
is quantitatively retained on##3##4##(2008-10#3)
is quantitatively retained##4##3##(2008-10#4)
is quantitatively##11##2##(1990-5#2)(2008-1#1)(2008-10#7)(2009-11#1)
is questionable##6##2##(1991-2#1)(1991-6#1)(1995-2#1)(2008-10#2)(2012-3#1)
is questioned by##2##3##(1992-9#2)
is questioned##5##2##(1992-3#1)(1992-9#2)(2008-10#1)(2008-9#1)
is quick and##2##3##(2008-10#1)(2008-11#1)
is quick##6##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)
is quicker and##2##3##(2008-10#2)
is quicker##3##2##(1996-1#1)(2008-10#2)
is quickly##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
is quite common in##3##4##(1995-3#1)(2008-10#1)(2008-8#1)
is quite common##4##3##(1995-3#1)(2008-10#2)(2008-8#1)
is quite different from##2##4##(1996-2#1)(2008-9#1)
is quite different##4##3##(1994-12#1)(1996-2#1)(2008-7#1)(2008-9#1)
is quite difficult##3##3##(2008-10#1)(2008-9#1)(2009-1#1)
is quite low##3##3##(1996-2#1)(2008-12#1)(2012-3#1)
is quite variable##2##3##(1997-3#1)(2008-10#1)
is quite##33##2##(1990-9#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-3#1)(2008-10#11)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2010-6#1)(2012-3#1)(2013-1#1)
is radical##2##2##(2008-7#1)(2011-2#1)
is raised##2##2##(2008-11#1)(2010-8#1)
is rapid and simple##4##4##(2008-10#3)(2008-11#1)
is rapid and##9##3##(1994-3#1)(2008-10#7)(2008-11#1)
is rapid with##2##3##(2008-10#2)
is rapid##31##2##(1994-11#1)(1994-3#1)(2008-10#22)(2008-11#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-3#1)(2010-6#1)
is rapidly induced##2##3##(1996-12#1)(2008-1#1)
is rapidly phosphorylated on##2##4##(1991-5#1)(1995-8#1)
is rapidly##14##2##(1991-5#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-5#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-12#1)(2011-3#1)(2012-2#1)
is rare and is##2##4##(2010-12#1)(2011-2#1)
is rare and##12##3##(1991-6#1)(1997-1#1)(2007-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)
is rare but##3##3##(2008-12#1)(2010-12#1)(2011-2#1)
is rare in the##3##4##(2008-10#1)(2008-9#1)(2010-5#1)
is rare in##7##3##(2007-12#1)(2008-10#2)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
is rare##52##2##(1990-11#1)(1991-6#2)(1995-10#1)(1995-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#7)(2013-1#4)(2013-8#2)
is rarely associated with##2##4##(1995-1#1)(2012-12#1)
is rarely encountered in##2##4##(2010-10#1)(2011-2#1)
is rarely seen in##2##4##(2011-2#1)(2013-8#1)
is rarely seen##4##3##(2008-11#2)(2011-2#1)(2013-8#1)
is rarely##24##2##(1990-6#1)(1995-1#1)(1996-11#1)(1996-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-10#2)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#2)(2013-8#1)
is rate limiting##2##3##(1993-9#1)(2008-10#1)
is rate##3##2##(1993-9#1)(2008-10#1)(2009-8#1)
is rather limited##2##3##(2008-12#1)(2008-2#1)
is rather##14##2##(1990-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-10#1)(2011-2#1)(2013-1#2)
is reached at##2##3##(2008-10#1)(2008-11#1)
is reached##8##2##(1993-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2010-12#1)
is reacted with##3##3##(2008-10#3)
is read##4##2##(1990-12#1)(2008-10#3)
is readily##12##2##(1991-5#1)(1992-8#1)(2008-10#5)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
is realized by##2##3##(2008-10#1)(2008-2#1)
is realized##5##2##(2008-10#3)(2008-2#1)(2008-5#1)
is really##4##2##(2008-10#3)(2008-9#1)
is reasonable to assume that##2##5##(1991-6#2)
is reasonable to##4##3##(1991-6#2)(2010-4#1)(2012-3#1)
is reasonable##5##2##(1991-6#2)(1997-3#1)(2010-4#1)(2012-3#1)
is receiving##3##2##(1995-1#1)(2010-5#1)(2013-1#1)
is recognised as a major##2##5##(2008-11#1)(2012-2#1)
is recognised##5##2##(2008-11#2)(2012-12#1)(2012-2#1)(2013-7#1)
is recognized as the##2##4##(2008-10#1)(2009-10#1)
is recognized as##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
is recognized by##4##3##(1995-6#2)(2008-11#2)
is recognized##12##2##(1995-11#1)(1995-6#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)
is recommended as a##2##4##(2008-10#1)(2013-1#1)
is recommended as an##2##4##(1991-3#1)(2008-10#1)
is recommended as##6##3##(1991-3#1)(2008-10#4)(2013-1#1)
is recommended for all##3##4##(2008-12#1)(2009-12#1)(2011-2#1)
is recommended for##13##3##(1990-12#1)(1992-6#1)(1993-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
is recommended in##6##3##(1990-2#1)(1990-3#1)(1997-4#1)(2008-10#1)(2011-2#1)(2013-1#1)
is recommended that this##2##4##(2008-10#1)(2008-11#1)
is recommended that##11##3##(1991-3#2)(1997-8#1)(2008-10#3)(2008-11#1)(2010-8#1)(2012-12#1)(2012-2#2)
is recommended to##6##3##(1992-11#1)(2008-10#4)(2008-11#1)
is recommended##74##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-1#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#2)(1997-7#1)(1997-8#3)(2008-10#21)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
is recorded by##2##3##(2007-12#1)(2008-10#1)
is recorded##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
is recovered##2##2##(2008-2#1)(2010-7#1)
is reduced and##2##3##(2008-10#2)
is reduced but##2##3##(2008-10#1)(2012-2#1)
is reduced by a factor of##2##6##(2007-12#1)(2008-10#1)
is reduced by##8##3##(2007-12#1)(2008-10#5)(2008-8#1)(2013-8#1)
is reduced from##2##3##(1993-8#1)(2008-10#1)
is reduced if##3##3##(2008-10#3)
is reduced in##7##3##(1991-2#1)(1993-9#1)(1994-5#2)(2008-1#1)(2008-10#1)(2008-12#1)
is reduced or##2##3##(2007-11#1)(2008-6#1)
is reduced to Fe(II)##2##4##(2008-10#2)
is reduced to the##4##4##(2008-10#3)(2009-10#1)
is reduced to##13##3##(2008-10#9)(2008-3#2)(2008-7#1)(2009-10#1)
is reduced when##2##3##(1993-3#1)(2008-10#1)
is reduced##58##2##(1991-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#2)(1995-2#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
is referred to as##4##4##(2008-10#1)(2008-11#1)(2009-10#1)(2010-4#1)
is referred to##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-4#1)
is referred##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-3#1)
is refined##2##2##(1992-2#1)(2008-10#1)
is reflected in the##3##4##(2007-11#1)(2008-11#1)(2008-8#1)
is reflected in##6##3##(1996-12#1)(2007-11#1)(2008-11#2)(2008-8#1)(2009-11#1)
is reflected##9##2##(1995-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-11#1)
is refractory to##2##3##(2008-9#1)(2012-3#1)
is regarded as a##3##4##(1996-3#1)(2008-3#1)(2013-1#1)
is regarded as an##2##4##(2008-11#1)(2009-12#1)
is regarded as the##3##4##(1994-3#1)(2008-10#2)
is regarded as##12##3##(1991-6#1)(1993-2#1)(1994-3#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2013-1#1)
is regularly##2##2##(1993-11#1)(2011-2#1)
is regulated at##3##3##(2009-6#1)(2009-8#1)(2013-1#1)
is regulated by a complex##2##5##(2010-8#1)(2012-2#1)
is regulated by a##4##4##(1990-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
is regulated by both##2##4##(1993-12#1)(2008-11#1)
is regulated by the##6##4##(1993-6#1)(1994-12#2)(2008-6#1)(2008-8#1)(2013-1#1)
is regulated by##29##3##(1990-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#5)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#3)
is regulated in response to##2##5##(2009-8#1)(2011-1#1)
is regulated in##8##3##(1993-8#1)(1994-11#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-4#1)(2011-1#1)
is regulated##54##2##(1990-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#3)(1994-8#2)(1995-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#7)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#4)
is reinforced by##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
is reinforced##5##2##(1996-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)
is related to a##2##4##(2008-10#2)
is related to financial##2##4##(2010-10#2)
is related to the level##2##5##(2008-11#1)(2008-5#1)
is related to the specific energy dissipation rate##2##8##(2008-7#2)
is related to the##36##4##(1991-12#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-8#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
is related to their##2##4##(2008-8#1)(2013-7#1)
is related to##76##3##(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-8#2)(1994-5#2)(1994-6#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-2#1)(2008-10#19)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
is related with##2##3##(2008-10#1)(2011-2#1)
is related##81##2##(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#3)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-2#1)(2008-10#20)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
is relatively easy to##2##4##(1991-3#1)(2012-12#1)
is relatively easy##3##3##(1991-3#1)(1997-3#1)(2012-12#1)
is relatively high##2##3##(2008-3#1)(2008-8#1)
is relatively less##3##3##(1990-12#1)(2008-8#2)
is relatively low##2##3##(1994-2#1)(2010-4#1)
is relatively new##2##3##(2008-10#1)(2010-11#1)
is relatively rare##3##3##(2010-5#1)(2012-3#1)(2013-1#1)
is relatively uncommon##2##3##(2013-1#2)
is relatively##38##2##(1990-12#1)(1991-12#1)(1991-3#1)(1994-11#1)(1994-2#1)(1997-1#1)(1997-3#1)(2008-10#13)(2008-3#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
is released during the##2##4##(1990-5#1)(1992-6#1)
is released from##5##3##(1990-2#1)(1992-6#2)(1995-2#1)(2008-10#1)
is released##16##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-6#3)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-4#1)
is relevant to the##2##4##(2008-10#1)(2008-7#1)
is relevant to##7##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
is relevant##8##2##(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)
is reliable and##2##3##(2008-10#1)(2010-11#1)
is reliable for##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
is reliable##6##2##(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)
is relieved##2##2##(1990-9#2)
is remarkable##7##2##(1991-11#1)(1991-6#1)(1997-6#1)(2008-12#1)(2008-8#3)
is remarkably##3##2##(2008-1#1)(2008-10#1)(2008-9#1)
is reminiscent of the##2##4##(1993-3#1)(2009-6#1)
is reminiscent of##3##3##(1993-3#1)(1993-8#1)(2009-6#1)
is removed by precipitation##2##4##(2008-10#2)
is removed from the##2##4##(2008-5#1)(2011-2#1)
is removed to##2##3##(1997-7#1)(2008-10#1)
is removed##11##2##(1997-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)
is rendered##2##2##(1991-2#1)(2012-2#1)
is repeatable##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
is repeated##2##2##(1992-3#1)(1994-9#1)
is replaced by##4##3##(2008-10#2)(2008-11#1)(2009-1#1)
is replaced with##3##3##(1994-5#1)(2008-10#2)
is replaced##8##2##(1994-5#1)(2008-10#4)(2008-11#2)(2009-1#1)
is reported as##3##3##(1991-8#1)(2008-10#2)
is reported for the determination of##3##6##(2008-10#3)
is reported for the first time##4##6##(2008-10#3)(2008-3#1)
is reported for the simultaneous##2##5##(2008-10#2)
is reported for the##13##4##(2008-10#12)(2008-3#1)
is reported for##15##3##(2008-10#13)(2008-3#1)(2010-11#1)
is reported here##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
is reported if the##2##4##(1997-5#1)(2008-10#1)
is reported in this##3##4##(2008-10#3)
is reported in which##2##4##(1995-3#1)(2008-10#1)
is reported in##8##3##(1990-6#1)(1992-9#1)(1995-3#1)(2008-10#4)(2008-9#1)
is reported that##4##3##(1994-5#1)(2008-12#1)(2008-2#1)(2011-2#1)
is reported to be##4##4##(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#1)
is reported to have##4##4##(1991-5#1)(2008-10#1)(2010-11#1)(2013-1#1)
is reported to##13##3##(1991-5#1)(1992-3#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-11#1)(2013-1#2)
is reported with##3##3##(1997-8#1)(2008-10#1)(2011-1#1)
is reported##187##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#3)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#97)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#8)(2008-5#4)(2008-7#11)(2008-9#4)(2009-12#3)(2009-4#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#3)
is represented by a##3##4##(1990-12#1)(2008-10#1)(2008-11#1)
is represented by the##3##4##(2009-1#1)(2011-2#2)
is represented by##8##3##(1990-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2011-2#2)(2013-1#1)
is represented##10##2##(1990-12#1)(1992-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-9#1)(2011-2#2)(2013-1#1)
is reproducible and##3##3##(1997-2#1)(2008-10#2)
is reproducible##9##2##(1997-2#1)(1997-8#1)(2008-10#7)
is reproducibly##2##2##(1997-2#1)(2008-10#1)
is required and##2##3##(1994-12#1)(2008-10#1)
is required because##2##3##(1995-2#1)(2008-10#1)
is required before##2##3##(1992-3#1)(2008-11#1)
is required for accurate##2##4##(2008-10#2)
is required for expression of##2##5##(2008-5#1)(2010-3#1)
is required for insulin##2##4##(1994-11#1)(1995-6#1)
is required for its##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
is required for normal##3##4##(2008-9#1)(2012-2#1)(2012-3#1)
is required for pollen fertility##2##5##(2009-10#2)
is required for the##19##4##(1991-6#1)(1992-10#1)(1993-12#2)(1993-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-8#2)(2008-10#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-3#2)(2013-1#1)
is required for##83##3##(1991-12#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-12#4)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#2)(1996-2#2)(1996-3#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-7#3)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-9#5)(2009-10#3)(2009-6#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
is required in order to##3##5##(1994-12#1)(2010-11#1)(2010-6#1)
is required in the##3##4##(2008-10#2)(2008-11#1)
is required in this##2##4##(1992-11#1)(2008-10#1)
is required in##10##3##(1992-11#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-11#1)(2010-4#1)(2010-6#1)
is required on the##2##4##(2008-12#1)(2010-11#1)
is required to achieve##3##4##(1996-2#1)(2008-10#1)(2010-12#1)
is required to clarify##2##4##(2008-7#1)(2011-2#1)
is required to ensure that##2##5##(2008-3#1)(2008-5#1)
is required to improve##2##4##(2008-10#1)(2011-2#1)
is required to obtain##2##4##(1992-12#1)(2011-2#1)
is required to prevent##2##4##(2009-1#1)(2010-1#1)
is required to##35##3##(1990-9#1)(1991-2#1)(1992-12#1)(1994-1#1)(1995-10#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-8#1)(2011-2#3)(2013-8#1)
is required##182##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-12#4)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-6#2)(1996-2#3)(1996-3#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-7#4)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#28)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#4)(2008-9#7)(2009-1#1)(2009-10#5)(2009-6#3)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#14)(2012-2#4)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#4)
is required]##2##2##(1990-2#1)(1997-4#1)
is reserved for##2##3##(1992-5#1)(2011-2#1)
is resistance to##2##3##(2008-4#1)(2011-3#1)
is resistant to##9##3##(1993-2#1)(1994-11#1)(1994-8#1)(2008-10#5)(2011-2#1)
is resolved##3##2##(1995-3#1)(2008-11#1)(2008-3#1)
is responsible for D-alanine##2##4##(1995-6#2)
is responsible for a##3##4##(1996-2#1)(2008-9#1)(2012-2#1)
is responsible for considerable##2##4##(2007-12#1)(2008-10#1)
is responsible for significant##2##4##(2008-10#1)(2013-1#1)
is responsible for the##22##4##(1991-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1996-2#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#2)
is responsible for this##2##4##(1991-5#1)(1994-5#1)
is responsible for widespread##2##4##(2008-10#2)
is responsible for##58##3##(1991-11#2)(1991-5#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#2)(1996-2#2)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#2)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#3)
is responsible##59##2##(1991-11#2)(1991-5#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#2)(1996-2#2)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#2)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#3)
is restricted to the##5##4##(1990-5#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#1)
is restricted to##15##3##(1990-5#2)(1992-1#1)(1994-2#1)(1995-2#1)(1995-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#1)
is restricted##17##2##(1990-5#2)(1992-1#1)(1994-2#1)(1995-2#1)(1995-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-3#1)
is retained on a##2##4##(2008-10#2)
is retained##10##2##(1992-9#1)(2008-10#7)(2010-3#1)(2011-2#1)
is reused##2##2##(2008-10#2)
is revealed##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
is reverse biased##2##3##(2008-10#2)
is reversible and##2##3##(2008-10#2)
is reversible##6##2##(1997-1#1)(1997-7#1)(2008-10#3)(2013-7#1)
is reviewed to##2##3##(1991-3#1)(1993-1#1)
is reviewed with##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
is reviewed##47##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-8#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2010-9#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#1)
is rich in##5##3##(1993-12#1)(2008-10#2)(2008-3#1)(2009-1#1)
is right##2##2##(1992-9#1)(1996-3#1)
is rising##4##2##(1991-12#1)(1991-6#1)(2011-1#1)(2012-2#1)
is robust and##2##3##(2008-10#1)(2012-3#1)
is robust##6##2##(2008-10#2)(2008-4#1)(2008-8#2)(2012-3#1)
is robustly##2##2##(2008-11#1)(2013-1#1)
is routinely used to##2##4##(2008-11#1)(2008-9#1)
is routinely##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
is rugged##2##2##(1997-2#1)(2008-10#1)
is safe and effective when##2##5##(1996-12#1)(2010-12#1)
is safe and effective##3##4##(1996-12#1)(2009-3#1)(2010-12#1)
is safe and##8##3##(1994-3#1)(1996-12#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-12#1)(2013-1#1)
is safe##13##2##(1994-3#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
is safer to use##2##4##(2012-3#2)
is satisfactory##8##2##(1995-2#1)(1995-5#1)(1996-11#1)(2008-10#4)(2012-2#1)
is saturable and##2##3##(1990-11#1)(1995-2#1)
is scanned##3##2##(2008-10#1)(2008-3#2)
is scheduled##2##2##(2011-4#1)(2012-2#1)
is secondary to##3##3##(1994-8#1)(1995-8#1)(1997-2#1)
is secondary##5##2##(1994-8#1)(1995-8#1)(1997-2#1)(2008-11#1)(2008-7#1)
is secreted##6##2##(1992-12#1)(1997-6#1)(2008-12#2)(2008-4#1)(2008-5#1)
is seemingly##2##2##(1992-6#1)(2008-7#1)
is seen as a##6##4##(1993-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2013-1#1)
is seen as##8##3##(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2013-1#2)
is seen for##2##3##(2008-10#1)(2009-9#1)
is seen in the##2##4##(1996-9#1)(2012-3#1)
is seen in##3##3##(1996-9#1)(2008-7#1)(2012-3#1)
is seen most commonly after##2##5##(2008-11#1)(2011-2#1)
is seen that##2##3##(2008-10#2)
is seen to##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
is seen##27##2##(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-8#1)(1996-1#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
is seldom##4##2##(1990-9#1)(1992-5#1)(2010-7#1)(2013-1#1)
is selected as its##2##4##(2008-10#1)(2011-2#1)
is selected as##3##3##(2008-10#2)(2011-2#1)
is selected##8##2##(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
is selective for##3##3##(1992-12#1)(2008-10#2)
is selective##7##2##(1992-12#1)(2008-10#5)(2012-3#1)
is selectively detected by AFS in a Ar/H(2) miniaturized flame after sodium borohydride reduction to##2##15##(2008-10#2)
is selectively##10##2##(1997-7#1)(2008-10#8)(2008-8#1)
is sensitive and##4##3##(2008-10#3)(2008-3#1)
is sensitive to its##2##4##(1997-2#1)(2008-4#1)
is sensitive to protein##2##4##(1991-2#1)(1993-12#1)
is sensitive to the##6##4##(1994-5#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-5#1)
is sensitive to##27##3##(1990-12#1)(1990-8#1)(1991-2#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2010-5#1)(2012-3#1)
is sensitive##46##2##(1990-12#1)(1990-8#1)(1991-2#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2010-5#1)(2011-3#1)(2012-3#1)
is separated by##2##3##(2008-10#2)
is separated from the liquid phase using a##2##8##(2008-10#2)
is separated from the liquid##3##5##(2008-10#3)
is separated from the solution##2##5##(2008-10#2)
is separated from the##6##4##(2008-10#6)
is separated from##8##3##(2008-10#8)
is separated##12##2##(2008-10#12)
is sequestered by##2##3##(1990-2#1)(1997-6#1)
is sequestered##3##2##(1990-2#1)(1992-6#1)(1997-6#1)
is set at##2##3##(1996-12#1)(2008-10#1)
is set to##2##3##(2008-9#2)
is set up##3##3##(2007-11#1)(2008-10#2)
is set##9##2##(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-9#2)
is several##2##2##(2008-11#1)(2011-2#1)
is severe##2##2##(1995-12#1)(2008-10#1)
is severely##3##2##(1990-11#1)(1995-6#1)(1996-2#1)
is sexually transmitted##3##3##(2011-2#3)
is sexually##4##2##(1993-8#1)(2011-2#3)
is shared by##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
is shared##4##2##(1997-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
is shifted to more##2##4##(2008-10#2)
is shifted to##3##3##(1994-5#1)(2008-10#2)
is shifted toward##2##3##(2008-10#1)(2008-9#1)
is shifted##7##2##(1994-5#1)(2008-10#4)(2008-3#1)(2008-9#1)
is short##2##2##(2008-11#1)(2012-3#1)
is shorter##2##2##(2008-6#1)(2008-7#1)
is showing##2##2##(2009-4#1)(2010-6#1)
is shown by##4##3##(1991-5#1)(1994-8#1)(2008-10#2)
is shown here##4##3##(1992-3#1)(2008-10#2)(2008-3#1)
is shown how the##3##4##(2008-6#2)(2008-8#1)
is shown that a##6##4##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)
is shown that an##2##4##(2008-10#1)(2008-3#1)
is shown that in##3##4##(2008-10#3)
is shown that spectral##2##4##(2008-10#1)(2008-2#1)
is shown that the##31##4##(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#9)(2008-6#2)(2009-9#1)(2010-12#1)(2010-3#1)
is shown that these##3##4##(2008-10#2)(2008-2#1)
is shown that##95##3##(1990-5#1)(1991-3#1)(1994-5#2)(1995-2#1)(1997-2#1)(2007-12#2)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#25)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#2)(2009-9#1)(2010-12#3)(2010-3#1)(2011-1#1)(2012-2#1)
is shown the##2##3##(2008-10#1)(2013-1#1)
is shown to be a##4##5##(1992-6#1)(2008-3#1)(2009-10#1)(2010-7#1)
is shown to be##20##4##(1992-1#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-9#1)(1997-4#1)(2008-10#6)(2008-3#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
is shown to increase the##2##5##(2010-10#1)(2012-3#1)
is shown to reduce##2##4##(1994-9#1)(2008-3#1)
is shown to result##2##4##(1994-5#1)(1995-2#1)
is shown to##37##3##(1990-2#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1997-4#1)(2008-10#11)(2008-3#2)(2008-8#2)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is shown with##2##3##(2008-3#1)(2008-8#1)
is shown##163##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1997-2#2)(1997-4#1)(2007-12#3)(2008-10#57)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#30)(2008-5#1)(2008-6#4)(2008-8#8)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
is significant in##2##3##(2008-11#1)(2008-9#1)
is significant##14##2##(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#1)
is significantly better##3##3##(1991-8#1)(2008-2#1)(2013-8#1)
is significantly correlated with the##2##5##(1993-3#1)(2010-2#1)
is significantly correlated with##3##4##(1992-12#1)(1993-3#1)(2010-2#1)
is significantly decreased in##2##4##(1993-3#1)(2007-11#1)
is significantly decreased##3##3##(1993-3#1)(1994-8#1)(2007-11#1)
is significantly different##2##3##(1993-8#1)(2008-10#1)
is significantly enhanced##2##3##(1994-8#1)(2008-8#1)
is significantly greater than##2##4##(1993-3#1)(1996-3#1)
is significantly greater##3##3##(1993-3#1)(1996-3#1)(2013-1#1)
is significantly high##2##3##(2008-10#1)(2010-8#1)
is significantly higher for##2##4##(2008-10#1)(2008-9#1)
is significantly higher in##2##4##(2008-10#1)(2008-8#1)
is significantly higher##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
is significantly increased##2##3##(1992-12#1)(2008-11#1)
is significantly less##2##3##(1992-6#1)(2008-10#1)
is significantly reduced##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
is significantly##46##2##(1991-11#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-6#1)(1993-3#3)(1993-8#1)(1994-8#2)(1996-3#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
is similar for##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
is similar in the##2##4##(1991-11#1)(1992-2#1)
is similar in##7##3##(1991-11#1)(1992-2#1)(1992-4#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#1)
is similar to other##2##4##(1990-11#1)(1990-7#1)
is similar to that observed##2##5##(2009-5#1)(2013-1#1)
is similar to that of##10##5##(1991-9#1)(1992-12#1)(1993-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-7#1)
is similar to that seen in##3##6##(1994-5#1)(2008-10#1)(2012-3#1)
is similar to that##23##4##(1990-2#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#2)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
is similar to the##11##4##(1992-3#1)(1993-2#1)(1993-6#1)(1995-6#1)(2008-10#4)(2008-3#1)(2008-7#1)(2012-3#1)
is similar to what##2##4##(1995-12#1)(2008-11#1)
is similar to##45##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#1)(2010-11#1)(2010-7#1)(2012-3#2)(2013-1#2)
is similar##61##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-5#1)(2010-11#1)(2010-7#1)(2012-3#2)(2013-1#2)
is similarly##2##2##(1991-5#1)(1995-8#1)
is simple and consists of##2##5##(2008-2#1)(2008-6#1)
is simple and inexpensive##2##4##(2007-12#1)(2008-10#1)
is simple and##18##3##(1996-2#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-6#1)(2010-5#1)
is simple to perform and##2##5##(1990-2#1)(2009-10#1)
is simple to perform##3##4##(1990-2#1)(1993-6#1)(2009-10#1)
is simple to prepare and##2##5##(2008-10#2)
is simple to##8##3##(1990-2#1)(1993-6#1)(1997-2#1)(2008-10#4)(2009-10#1)
is simple##61##2##(1990-12#2)(1990-2#1)(1991-9#1)(1993-6#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#39)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-5#2)(2012-2#1)(2013-1#1)
is simpler than##2##3##(2008-11#1)(2009-8#1)
is simpler##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
is simplified by##2##3##(1997-6#1)(2008-10#1)
is simplified##4##2##(1997-6#1)(2008-10#2)(2008-3#1)
is simply##2##2##(1995-1#1)(1996-11#1)
is simulated##2##2##(2008-10#1)(2012-2#1)
is simultaneously##4##2##(1995-3#1)(2008-10#1)(2008-3#1)(2009-6#1)
is single##2##2##(2008-3#1)(2013-8#1)
is situated in the##2##4##(1993-8#1)(2010-6#1)
is situated##4##2##(1993-8#1)(2007-11#1)(2010-6#1)(2011-2#1)
is slightly greater##2##3##(2008-10#1)(2009-4#1)
is slightly higher##2##3##(1993-6#1)(2013-1#1)
is slightly##11##2##(1993-6#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-11#2)(2009-4#1)(2009-7#1)(2012-3#1)(2013-1#1)
is slow##5##2##(1994-2#1)(1994-5#1)(2008-10#1)(2008-8#1)(2009-3#1)
is small compared with##2##4##(1995-3#1)(2008-3#1)
is small compared##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
is small enough to##2##4##(2008-10#1)(2008-3#1)
is small##17##2##(1991-9#1)(1994-2#1)(1995-3#1)(1995-9#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
is smaller than##8##3##(1995-6#1)(1996-6#1)(2008-10#4)(2008-2#1)(2013-1#1)
is smaller##9##2##(1995-6#1)(1996-6#1)(2008-10#4)(2008-2#1)(2011-2#1)(2013-1#1)
is so expensive##2##3##(2008-11#1)(2010-8#1)
is so far inconclusive##2##4##(1991-12#1)(2012-12#1)
is so far##3##3##(1991-12#1)(2012-12#1)(2013-1#1)
is so##15##2##(1991-12#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-6#2)(2010-8#1)(2012-12#1)(2013-1#1)
is social##2##2##(1995-12#1)(2010-3#1)
is solved##7##2##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#1)
is some evidence of##2##4##(1991-1#1)(2011-2#1)
is some evidence##4##3##(1991-1#1)(1996-6#1)(2008-5#1)(2011-2#1)
is some##11##2##(1990-8#1)(1991-1#1)(1996-6#1)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
is sometime##2##2##(1990-3#1)(2013-1#1)
is sometimes##7##2##(1991-11#1)(1993-9#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-8#1)(2012-2#1)
is somewhat##5##2##(1994-5#1)(2008-10#1)(2008-11#2)(2012-2#1)
is sorbed onto##2##3##(2008-10#2)
is sparse##4##2##(1993-12#1)(2008-12#1)(2012-12#1)(2013-1#1)
is spatially and temporally regulated##2##5##(1994-2#1)(2011-2#1)
is spatially##6##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
is specialized for processing##2##4##(2008-11#2)
is specialized for##3##3##(2008-11#3)
is specialized##4##2##(2008-11#4)
is specially##2##2##(2008-10#2)
is specific for the##4##4##(1995-2#1)(2008-10#1)(2011-1#1)(2013-8#1)
is specific for##10##3##(1990-11#1)(1990-5#1)(1993-6#1)(1995-2#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-1#1)(2013-8#1)
is specific to##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
is specific##17##2##(1990-11#1)(1990-5#1)(1991-8#1)(1993-6#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
is specifically##8##2##(1990-8#1)(1993-12#2)(1994-2#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
is specified by##2##3##(1994-12#1)(1995-6#1)
is spectrophotometrically determined##2##3##(2008-10#2)
is spectroscopically##2##2##(1992-8#1)(1994-5#1)
is speculated that##4##3##(1992-3#1)(1995-11#1)(1996-2#1)(2008-10#1)
is speculated##5##2##(1992-3#1)(1995-11#1)(1996-2#1)(2008-10#2)
is split into two##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
is split into##4##3##(1996-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
is split##6##2##(1996-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-4#1)
is spread##2##2##(2008-10#2)
is spreading##2##2##(2008-10#1)(2012-3#1)
is stabilized by##7##3##(1990-5#1)(1991-3#1)(1992-10#1)(1995-6#2)(2008-8#1)(2011-2#1)
is stabilized##10##2##(1990-5#1)(1991-3#1)(1992-10#1)(1992-12#1)(1994-9#1)(1995-6#2)(2008-8#1)(2011-2#2)
is stable and##2##3##(2008-12#1)(2011-2#1)
is stable for at least##3##5##(2008-10#2)(2008-8#1)
is stable for more than##2##5##(2008-10#2)
is stable for##10##3##(2008-10#9)(2008-8#1)
is stable##23##2##(1991-5#1)(1992-12#1)(1994-9#1)(2008-10#15)(2008-12#1)(2008-8#2)(2011-2#1)(2013-8#1)
is stained with##2##3##(1990-12#1)(2008-4#1)
is stained##3##2##(1990-12#1)(2008-4#1)(2008-7#1)
is started##2##2##(2009-7#1)(2011-2#1)
is statistically significant##4##3##(1991-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
is statistically##7##2##(1991-1#1)(2008-10#1)(2008-11#2)(2008-9#2)(2011-2#1)
is steadily##2##2##(2011-2#2)
is steady##2##2##(2008-8#1)(2013-8#1)
is still a significant##2##4##(2009-5#1)(2010-12#1)
is still a##19##3##(1996-11#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
is still an underestimated##2##4##(1992-9#1)(2012-2#1)
is still an##3##3##(1992-9#1)(2008-5#1)(2012-2#1)
is still clearly##2##3##(2008-10#1)(2008-11#1)
is still controversial##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
is still in its infancy##2##5##(1995-5#1)(2008-10#1)
is still in##4##3##(1995-5#1)(2008-10#1)(2009-3#1)(2010-7#1)
is still lacking##3##3##(1997-8#1)(2010-1#1)(2012-3#1)
is still limited##2##3##(2008-11#1)(2011-2#1)
is still needed##2##3##(2008-10#1)(2010-12#1)
is still not clear##3##4##(2008-11#1)(2009-8#1)(2013-7#1)
is still not fully understood##4##5##(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)
is still not##14##3##(1993-6#1)(1994-11#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
is still of##2##3##(2011-2#1)(2011-3#1)
is still poorly understood##3##4##(1991-11#1)(2008-8#1)(2012-3#1)
is still possible##2##3##(1996-1#1)(2008-10#1)
is still present in the##2##5##(1995-2#1)(2008-10#1)
is still questionable##2##3##(2008-10#1)(2008-8#1)
is still required to##2##4##(2009-10#1)(2011-2#1)
is still required##4##3##(1997-1#1)(2009-10#1)(2011-2#2)
is still significant##2##3##(2008-8#1)(2009-8#1)
is still the##5##3##(1990-5#1)(1997-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
is still uncertain##2##3##(2013-1#2)
is still unclear##8##3##(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
is still under##2##3##(1992-5#1)(2008-10#1)
is still unknown##12##3##(1991-3#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#2)(2009-6#1)(2012-3#1)(2013-8#1)
is still valid##3##3##(2008-3#1)(2008-9#2)
is still very low in the nature##2##7##(2008-10#2)
is still very##3##3##(1994-2#1)(2008-10#2)
is still##167##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-11#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#6)(2006-6#1)(2007-11#1)(2008-10#22)(2008-11#15)(2008-12#6)(2008-3#2)(2008-5#3)(2008-7#6)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#12)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#3)
is stimulated by a##2##4##(1995-8#1)(2008-5#1)
is stimulated by##12##3##(1990-12#1)(1990-5#1)(1992-12#2)(1992-6#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-5#1)(2012-2#1)
is stimulated##13##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-12#2)(1992-6#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-5#1)(2012-2#1)
is stopped##2##2##(2007-11#1)(2008-10#1)
is stored##4##2##(1997-6#1)(2008-11#1)(2008-7#2)
is straightforward##2##2##(1992-9#1)(1995-9#1)
is strain-specific##3##2##(2008-10#3)
is strengthened##2##2##(2008-11#1)(2013-8#1)
is stressed##10##2##(1990-5#1)(1990-9#1)(1991-6#1)(1995-1#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2012-2#1)
is strictly dependent on the##2##5##(1990-9#1)(2008-10#1)
is strictly##7##2##(1990-9#1)(2008-10#2)(2011-1#1)(2011-2#2)(2012-2#1)
is strikingly similar to the##2##5##(1994-12#1)(2008-5#1)
is strikingly##5##2##(1993-2#1)(1994-12#1)(2008-12#1)(2008-5#1)(2013-8#1)
is stripped from##2##3##(2008-10#2)
is strong evidence that##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
is strong evidence##5##3##(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
is strong##16##2##(1993-11#1)(1995-11#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#3)(2008-8#3)(2009-8#1)(2012-2#1)(2013-1#1)
is stronger##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
is strongly associated with##4##4##(1996-1#1)(1997-8#1)(2011-2#1)(2011-7#1)
is strongly dependent on the##7##5##(1995-8#1)(2008-10#2)(2008-3#2)(2009-5#1)(2011-2#1)
is strongly dependent on##8##4##(1995-8#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-5#1)(2011-2#1)
is strongly dependent##9##3##(1995-8#1)(2008-10#3)(2008-3#2)(2008-8#1)(2009-5#1)(2011-2#1)
is strongly influenced by##2##4##(2008-10#1)(2008-11#1)
is strongly recommended##3##3##(2008-11#1)(2008-7#2)
is strongly related to the##2##5##(2008-10#2)
is strongly related to##3##4##(2008-10#2)(2013-8#1)
is strongly##35##2##(1991-2#1)(1991-7#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#4)(2009-5#1)(2010-5#1)(2011-2#2)(2011-7#1)(2012-12#1)(2013-8#1)
is structurally##4##2##(1995-6#1)(2007-12#1)(2008-11#1)(2008-8#1)
is structured##3##2##(1991-1#1)(2010-5#1)(2012-3#1)
is studied and##6##3##(2008-10#5)(2009-11#1)
is studied by the batch equilibrium technique and##2##8##(2008-10#2)
is studied by##9##3##(2008-10#7)(2008-2#1)(2008-3#1)
is studied in detail##2##4##(1992-3#1)(2008-11#1)
is studied using##2##3##(2008-10#1)(2008-12#1)
is studied with##2##3##(2008-3#1)(2008-8#1)
is studied##38##2##(1992-3#1)(1994-8#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2009-11#1)(2013-8#1)
is subject to##7##3##(1992-12#1)(1993-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-1#1)
is subjected to##4##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
is subsequently eluted with##2##4##(2008-10#2)
is subsequently##13##2##(1993-9#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2012-2#1)
is substantial##5##2##(1992-12#1)(1994-3#1)(2008-11#1)(2008-7#1)(2012-2#1)
is substantially##6##2##(1990-12#1)(1991-5#1)(1993-3#1)(1997-3#1)(2008-8#1)(2010-5#1)
is substituted##2##2##(1993-12#1)(2011-2#1)
is successful##6##2##(2008-10#3)(2008-5#1)(2012-2#1)(2013-8#1)
is successfully applied to the determination of##4##7##(2008-10#4)
is successfully applied to the##6##5##(2008-10#5)(2008-5#1)
is successfully applied to##12##4##(2008-10#11)(2008-5#1)
is successfully applied##15##3##(2008-10#14)(2008-5#1)
is successfully used for the##2##5##(2008-10#1)(2008-5#1)
is successfully used##3##3##(1990-9#1)(2008-10#1)(2008-5#1)
is successfully##20##2##(1990-9#1)(2008-10#17)(2008-5#2)
is such that##2##3##(1997-3#1)(2008-10#1)
is such##4##2##(1993-11#1)(1993-3#1)(1997-3#1)(2008-10#1)
is sufficient for the##2##4##(1995-2#1)(2008-10#1)
is sufficient for##7##3##(1990-11#1)(1993-9#1)(1995-2#1)(2007-12#1)(2008-10#2)(2013-1#1)
is sufficient to explain the##2##5##(2008-11#2)
is sufficient to##18##3##(1993-12#1)(1994-11#2)(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-7#1)
is sufficient##28##2##(1990-11#1)(1991-12#1)(1993-12#1)(1993-9#1)(1994-11#2)(1995-2#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#1)(2013-1#1)
is sufficiently large##2##3##(2008-8#2)
is sufficiently##10##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#3)(2010-4#1)(2013-1#1)
is suggested as a##6##4##(2008-10#6)
is suggested as##7##3##(2008-10#7)
is suggested by the##2##4##(1997-5#1)(2009-9#1)
is suggested by##5##3##(1997-5#1)(2009-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
is suggested for the##3##4##(2008-10#2)(2008-11#1)
is suggested for##5##3##(2008-10#4)(2008-11#1)
is suggested that the##23##4##(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#2)(1993-6#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-11#3)(2008-12#1)(2008-8#3)(2008-9#2)(2010-1#1)(2011-2#1)
is suggested that there may##2##5##(1996-12#1)(2008-8#1)
is suggested that there##3##4##(1996-12#1)(2008-10#1)(2008-8#1)
is suggested that this##7##4##(1990-2#1)(1997-7#1)(2008-10#2)(2008-12#2)(2008-8#1)
is suggested that##78##3##(1990-2#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#3)(1992-3#2)(1992-5#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#3)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-6#1)(2008-10#9)(2008-11#11)(2008-12#4)(2008-7#3)(2008-8#9)(2008-9#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#4)
is suggested to be##7##4##(1990-11#1)(1993-1#1)(2008-10#4)(2008-11#1)
is suggested to##12##3##(1990-11#1)(1993-1#1)(1994-11#1)(2008-10#4)(2008-11#3)(2011-2#1)(2013-1#1)
is suggested##124##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#4)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#3)(1996-6#1)(1997-2#2)(1997-5#2)(1997-7#2)(1997-8#2)(2006-6#1)(2007-11#1)(2008-10#31)(2008-11#17)(2008-12#4)(2008-5#2)(2008-7#3)(2008-8#9)(2008-9#3)(2009-12#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#1)
is suggestive of##4##3##(1994-5#1)(1995-2#1)(1995-3#1)(2008-10#1)
is suitable as##2##3##(2008-10#1)(2011-2#1)
is suitable for application##2##4##(2008-10#2)
is suitable for clinical##2##4##(2008-10#1)(2008-4#1)
is suitable for routine analysis##2##5##(2008-10#2)
is suitable for routine##3##4##(2008-10#2)(2008-5#1)
is suitable for the determination of##5##6##(2008-10#5)
is suitable for the simultaneous##3##5##(2008-10#3)
is suitable for the##15##4##(2008-10#12)(2010-12#1)(2010-8#1)(2013-1#1)
is suitable for use##3##4##(1996-12#1)(2008-10#2)
is suitable for##59##3##(1991-2#1)(1993-2#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-10#39)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2010-12#1)(2010-8#2)(2012-3#1)(2013-1#1)
is suitable##66##2##(1991-2#1)(1993-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(2007-11#1)(2008-10#42)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#2)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
is suited for##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
is summarised##3##2##(2008-11#1)(2011-2#1)(2011-3#1)
is summarized##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-8#2)
is superior in##2##3##(2011-2#1)(2013-8#1)
is superior or##2##3##(1993-12#1)(2008-10#1)
is superior over##2##3##(2008-10#2)
is superior to other##2##4##(2008-10#1)(2010-6#1)
is superior to the##4##4##(2008-10#2)(2008-11#1)(2010-12#1)
is superior to##19##3##(1990-12#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-6#1)(2012-2#1)
is superior##26##2##(1990-12#1)(1993-12#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
is supplemented by##2##3##(1990-5#1)(1996-11#1)
is supplemented##3##2##(1990-5#1)(1996-11#1)(2008-10#1)
is supported by a##3##4##(2008-5#1)(2008-9#1)(2013-1#1)
is supported by the##6##4##(1993-12#1)(1996-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
is supported by##13##3##(1991-12#1)(1993-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
is supported##17##2##(1991-12#1)(1993-12#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
is supposed##2##2##(2008-10#1)(2012-2#1)
is suppressed and##2##3##(2008-9#1)(2012-3#1)
is suppressed by##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
is suppressed in##2##3##(2008-7#1)(2008-8#1)
is suppressed##13##2##(1990-11#1)(1993-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#2)
is surgical##3##2##(1992-9#1)(1993-3#1)(2008-10#1)
is surgically##2##2##(2008-10#1)(2008-5#1)
is surprisingly##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
is surrounded by an##2##4##(2007-12#1)(2008-7#1)
is surrounded by##4##3##(1993-9#1)(2007-12#1)(2008-7#2)
is surveyed##2##2##(1991-12#1)(1995-2#1)
is susceptible to##6##3##(2008-10#6)
is susceptible##9##2##(2008-10#8)(2011-2#1)
is suspended in##2##3##(2008-11#1)(2008-5#1)
is suspended##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
is sustained##2##2##(1992-2#1)(2011-2#1)
is symmetrical##2##2##(1991-5#1)(2010-3#1)
is symptom##2##2##(2011-2#1)(2012-12#1)
is synthesized and##3##3##(1992-6#1)(2008-10#1)(2008-4#1)
is synthesized by##4##3##(1995-12#1)(1995-2#1)(1997-1#1)(2009-10#1)
is synthesized from##2##3##(2008-4#1)(2012-2#1)
is synthesized in the##3##4##(1993-12#1)(1994-11#1)(2008-10#1)
is synthesized in##5##3##(1993-12#1)(1994-11#1)(1995-6#1)(2008-10#1)(2009-7#1)
is synthesized simply and rapidly from##2##6##(2008-10#2)
is synthesized##19##2##(1990-5#1)(1992-6#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#5)(2008-4#3)(2009-10#1)(2009-7#1)(2012-2#1)
is taken as an##2##4##(2007-11#1)(2008-10#1)
is taken as##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
is taken into account##7##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
is taken into##9##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
is taken to##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
is taken up by##2##4##(1990-2#1)(1995-6#1)
is taken##26##2##(1990-2#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-2#1)(2012-3#1)
is taking place##2##3##(1993-6#1)(2011-2#1)
is taking##6##2##(1993-6#1)(1996-1#1)(1997-6#1)(2008-11#1)(2008-7#1)(2011-2#1)
is tantamount to the##2##4##(1992-2#1)(2012-3#1)
is targeted to##2##3##(1995-11#1)(2008-1#1)
is targeted##5##2##(1995-11#1)(2008-1#2)(2008-12#1)(2009-4#1)
is taxonomically##2##2##(2011-2#1)(2012-3#1)
is technically##8##2##(1990-5#1)(1994-9#1)(1997-5#1)(2008-10#1)(2008-12#1)(2009-8#1)(2012-3#1)(2013-1#1)
is temperature##3##2##(1994-8#1)(2008-10#2)
is temporarily##2##2##(1991-2#1)(2008-9#1)
is termed##5##2##(1995-2#2)(2008-10#1)(2008-5#1)(2010-7#1)
is tested in##3##3##(2008-10#2)(2008-9#1)
is tested on##3##3##(2009-8#1)(2012-2#1)(2013-8#1)
is tested##14##2##(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
is that a##3##3##(2010-4#1)(2011-2#1)(2012-3#1)
is that in##5##3##(1990-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
is that it is##4##4##(1994-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
is that it##13##3##(1994-9#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-1#1)
is that no##2##3##(2008-10#1)(2008-11#1)
is that of the##3##4##(1995-2#1)(2013-1#1)(2013-8#1)
is that of##10##3##(1992-3#1)(1993-1#1)(1994-12#1)(1995-2#2)(2008-11#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
is that people with##2##4##(1996-1#1)(2008-12#1)
is that sexual##2##3##(1993-9#1)(2008-10#1)
is that such##2##3##(2010-5#1)(2013-8#1)
is that the##47##3##(1991-3#1)(1993-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
is that there##2##3##(2007-11#1)(2008-4#1)
is that these##3##3##(2006-6#1)(2008-5#1)(2008-7#1)
is that they usually##2##4##(2011-2#2)
is that they##5##3##(1991-2#2)(2011-2#3)
is that this##3##3##(2008-11#1)(2013-8#2)
is that which##2##3##(2008-8#1)(2008-9#1)
is that##169##2##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#9)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#2)(2012-3#5)(2013-1#5)(2013-8#6)
is the &quot##2##3##(1996-6#1)(2008-9#1)
is the ability of##2##4##(1997-6#1)(2009-1#1)
is the ability to##3##4##(1994-3#1)(2008-10#1)(2008-11#1)
is the ability##5##3##(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2009-1#1)
is the absence of the##2##5##(1991-9#1)(2008-10#1)
is the absence of##4##4##(1990-5#1)(1991-9#1)(2008-10#2)
is the analogous parent molecule##2##5##(2010-7#2)
is the appearance of##2##4##(1991-3#1)(2008-3#1)
is the application of##2##4##(2008-10#1)(2008-9#1)
is the area##2##3##(1992-9#1)(1995-1#1)
is the association##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
is the basic##2##3##(2008-10#1)(2008-11#1)
is the basis for a##3##5##(2008-10#1)(2008-7#1)(2008-9#1)
is the basis for the##4##5##(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
is the basis for##8##4##(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2012-2#1)
is the basis of this##2##5##(2008-10#1)(2011-2#1)
is the basis of##3##4##(2008-10#2)(2011-2#1)
is the basis##12##3##(1997-6#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
is the beginning of##2##4##(1991-12#1)(2008-12#1)
is the best way##2##4##(2008-9#1)(2010-12#1)
is the best##18##3##(1991-3#1)(1991-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
is the beta value for##2##5##(2008-10#2)
is the case for##4##4##(1991-6#1)(1994-5#1)(2008-10#1)(2013-1#1)
is the case in##4##4##(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
is the case of##4##4##(1997-2#1)(2008-10#2)(2012-3#1)
is the case with##2##4##(2008-5#1)(2013-7#1)
is the case##22##3##(1991-6#1)(1994-5#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
is the catalytic##3##3##(2008-11#1)(2008-4#2)
is the causal agent of a##2##6##(2008-10#2)
is the causal agent of##11##5##(2008-10#11)
is the causative agent of##3##5##(2011-2#2)(2013-1#1)
is the cause of##4##4##(1996-12#1)(2008-10#2)(2008-12#1)
is the cause##5##3##(1996-12#1)(2008-10#2)(2008-12#1)(2013-7#1)
is the center##2##3##(2008-7#1)(2008-8#1)
is the central##3##3##(1995-12#1)(2008-10#1)(2008-9#1)
is the chief##2##3##(1993-11#1)(2008-10#1)
is the combination of##2##4##(2008-4#1)(2009-1#1)
is the commonest primary##2##4##(2008-1#1)(2010-11#1)
is the commonest##7##3##(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-3#1)
is the concentration##2##3##(2008-10#1)(2012-2#1)
is the construction##2##3##(2008-10#1)(2011-2#1)
is the contribution of##3##4##(2008-11#1)(2008-12#1)(2013-1#1)
is the critical##2##3##(1994-2#1)(2008-8#1)
is the current##4##3##(1991-2#1)(2012-2#1)(2013-1#2)
is the determination of##2##4##(2008-10#1)(2011-2#1)
is the development of##4##4##(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
is the development##5##3##(2008-10#2)(2009-8#1)(2011-2#1)(2013-1#1)
is the distance between the##2##5##(2008-3#2)
is the dominant##4##3##(2008-10#3)(2008-7#1)
is the driving##2##3##(1993-1#1)(1994-8#1)
is the effect of##2##4##(2008-12#1)(2008-8#1)
is the effect##4##3##(1993-3#1)(2008-12#1)(2008-7#1)(2008-8#1)
is the effectiveness of multilevel##2##5##(2012-12#2)
is the environment##2##3##(2007-12#1)(2008-8#1)
is the essential##3##3##(1996-12#1)(1997-3#1)(2008-6#1)
is the establishment of a##2##5##(1991-12#1)(2008-10#1)
is the evolutionarily##2##3##(2011-2#2)
is the extent to which##2##5##(2008-11#1)(2009-9#1)
is the fact that##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
is the failure to##2##4##(2008-11#1)(2012-2#1)
is the field##2##3##(1991-1#1)(1996-2#1)
is the fifth##3##3##(1997-3#1)(2009-1#1)(2013-1#1)
is the first application of##2##5##(2008-10#1)(2008-3#1)
is the first attempt##2##4##(2008-11#1)(2010-2#1)
is the first case of##4##5##(1997-8#1)(2008-5#1)(2010-3#1)(2012-3#1)
is the first case##5##4##(1997-8#1)(2008-5#1)(2010-3#1)(2012-3#2)
is the first comprehensive##2##4##(2008-10#1)(2013-1#1)
is the first demonstration of##4##5##(2008-10#3)(2008-8#1)
is the first demonstration##5##4##(2008-10#4)(2008-8#1)
is the first described##2##4##(1994-3#1)(2008-10#1)
is the first description of the##2##6##(2008-10#1)(2009-7#1)
is the first description of##4##5##(1997-5#1)(2008-10#2)(2009-7#1)
is the first documented##2##4##(2008-12#1)(2008-9#1)
is the first example of a##3##6##(1991-2#1)(1996-3#1)(2012-3#1)
is the first example of##4##5##(1991-2#1)(1996-3#1)(2011-2#1)(2012-3#1)
is the first instance of##2##5##(2008-11#1)(2008-12#1)
is the first line of##3##5##(1993-12#1)(2008-7#1)(2013-1#1)
is the first of##2##4##(1994-5#1)(2008-9#1)
is the first report confirming the##2##6##(2011-2#2)
is the first report describing##4##5##(1994-12#1)(2008-10#2)(2008-11#1)
is the first report of a##10##6##(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
is the first report of successful treatment of##2##8##(1991-4#1)(2008-10#1)
is the first report of the effects of##2##8##(2008-11#1)(2013-1#1)
is the first report of the##8##6##(1997-2#1)(2008-10#5)(2008-11#1)(2013-1#1)
is the first report of##42##5##(1991-4#1)(1992-10#1)(1992-3#1)(1997-2#1)(1997-7#1)(2008-10#22)(2008-11#4)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
is the first report on the##12##6##(2008-10#9)(2008-12#1)(2008-9#2)
is the first report on##19##5##(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-6#1)(2011-2#2)
is the first report to show##2##6##(1990-5#1)(2009-12#1)
is the first report##82##4##(1990-5#1)(1991-4#1)(1992-10#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#37)(2008-11#9)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#4)(2009-12#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
is the first reported case of##9##6##(2008-10#1)(2008-7#2)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
is the first reported##13##4##(1992-8#1)(2008-10#3)(2008-7#2)(2008-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
is the first step in##4##5##(1994-3#1)(2008-10#1)(2010-9#1)(2011-2#1)
is the first step to##2##5##(1992-12#1)(2011-2#1)
is the first step##10##4##(1992-12#1)(1994-3#2)(2008-10#1)(2008-6#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
is the first study##7##4##(2008-10#5)(2008-8#1)(2011-2#1)
is the first time that##6##5##(1991-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
is the first time to##2##5##(2008-9#2)
is the first time##14##4##(1991-11#1)(1991-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-9#3)(2011-2#1)(2012-2#1)
is the first to##7##4##(1993-1#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-3#1)
is the first##230##3##(1990-5#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#73)(2008-11#17)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#12)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#31)(2011-3#1)(2012-2#3)(2012-3#7)(2013-1#8)(2013-3#1)(2013-8#2)
is the first-line treatment##2##4##(2010-12#1)(2013-8#1)
is the first-line##4##3##(2010-12#3)(2013-8#1)
is the focal point of##2##5##(1992-3#1)(2008-10#1)
is the focus of this##2##5##(2008-12#1)(2010-6#1)
is the focus of##3##4##(2008-12#1)(2010-6#1)(2010-7#1)
is the following##2##3##(1993-8#1)(2008-8#1)
is the formation of##2##4##(1997-1#1)(2008-11#1)
is the foundation##2##3##(2008-10#1)(2008-5#1)
is the fourth##2##3##(2008-6#1)(2011-2#1)
is the function of the##2##5##(2008-10#2)
is the functional##2##3##(2008-9#1)(2009-10#1)
is the generation##2##3##(2008-10#1)(2008-8#1)
is the gold standard for##2##5##(2008-11#1)(2013-8#1)
is the gold standard##4##4##(1996-6#1)(2008-11#1)(2011-3#1)(2013-8#1)
is the highest##4##3##(1990-3#1)(2008-10#1)(2008-12#1)(2012-12#1)
is the human##2##3##(1997-7#1)(2008-5#1)
is the identification of##2##4##(2010-12#1)(2010-4#1)
is the imaging##2##3##(2012-12#1)(2012-2#1)
is the impact##2##3##(1994-3#2)
is the importance of##2##4##(2008-11#2)
is the initial##2##3##(2011-1#1)(2011-2#1)
is the key factor in##2##5##(2008-10#1)(2008-3#1)
is the key factor##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
is the key to##4##4##(1992-2#1)(1995-12#1)(2008-10#1)(2009-8#1)
is the key##16##3##(1992-2#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)
is the lack of##5##4##(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#2)
is the largest##5##3##(1991-5#1)(2008-3#1)(2009-10#1)(2011-1#1)(2013-1#1)
is the leading cause of death##2##6##(1990-6#1)(2012-2#1)
is the leading cause of##6##5##(1990-6#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
is the leading##7##3##(1990-6#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
is the light source##2##4##(2008-10#1)(2008-3#1)
is the log10##2##3##(2008-10#2)
is the low##2##3##(1996-3#1)(2008-10#1)
is the main cause of##2##5##(2010-12#1)(2012-2#1)
is the main mechanism##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
is the main species##3##4##(2008-10#3)
is the main##24##3##(1994-11#1)(1995-3#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
is the mainstay of treatment##2##5##(2010-12#1)(2013-1#1)
is the mainstay of##4##4##(1997-1#1)(2008-10#1)(2010-12#1)(2013-1#1)
is the mainstay##5##3##(1997-1#1)(2008-10#2)(2010-12#1)(2013-1#1)
is the major##24##3##(1990-12#1)(1992-11#1)(1992-9#1)(1993-6#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
is the major)##2##3##(2008-11#2)
is the maximum##3##3##(2008-10#2)(2008-7#1)
is the means by which##2##5##(1996-1#1)(2008-10#1)
is the mechanism##2##3##(2008-10#1)(2008-8#1)
is the method of choice for##4##6##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
is the method of choice##5##5##(1992-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
is the method of##7##4##(1990-11#1)(1992-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
is the method##8##3##(1990-11#1)(1992-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
is the mole fraction of##2##5##(2008-10#2)
is the more##4##3##(2008-10#2)(2009-10#1)(2009-8#1)
is the most abundant##3##4##(2008-10#2)(2011-2#1)
is the most active##2##4##(1992-2#1)(2008-11#1)
is the most apparent##2##4##(1995-1#1)(2008-5#1)
is the most appropriate way to##2##6##(2008-10#2)
is the most appropriate##5##4##(1993-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
is the most common and##4##5##(2008-7#1)(2010-5#1)(2013-1#2)
is the most common cause of##7##6##(1993-9#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
is the most common chronic##2##5##(2008-9#1)(2011-1#1)
is the most common method##2##5##(2008-4#1)(2012-2#1)
is the most common neoplasm##2##5##(2010-6#1)(2012-3#1)
is the most common type of##3##6##(2010-6#1)(2011-2#1)(2013-1#1)
is the most common##49##4##(1991-12#1)(1993-1#1)(1993-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#1)
is the most commonly##5##4##(2008-10#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-7#1)
is the most critical##2##4##(2008-10#1)(2008-3#1)
is the most destructive##2##4##(2008-10#1)(2013-8#1)
is the most effective means to control##2##7##(2008-10#2)
is the most effective##9##4##(1991-3#1)(1997-2#1)(2008-10#5)(2008-7#1)(2012-2#1)
is the most frequent##6##4##(1990-3#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#2)
is the most important##8##4##(1995-2#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
is the most likely##2##4##(1994-2#1)(2008-10#1)
is the most prevalent##2##4##(2008-5#1)(2013-8#1)
is the most probable##3##4##(1991-12#1)(1994-5#1)(2013-1#1)
is the most sensitive method##2##5##(2008-10#1)(2010-12#1)
is the most sensitive##3##4##(2008-10#1)(2010-12#1)(2010-6#1)
is the most serious##4##4##(1991-11#1)(2008-10#2)(2012-2#1)
is the most suitable##3##4##(2008-10#2)(2013-1#1)
is the most widely used##3##5##(2008-3#1)(2008-4#1)(2011-1#1)
is the most widely##5##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
is the most widespread##2##4##(2008-10#1)(2011-2#1)
is the most##161##3##(1990-3#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-5#2)(2010-6#4)(2010-7#1)(2011-1#2)(2011-2#13)(2012-12#1)(2012-2#12)(2012-3#3)(2013-1#14)(2013-8#5)
is the natural##2##3##(2008-10#2)
is the need for##4##4##(1992-1#1)(1995-11#1)(1996-2#1)(2008-11#1)
is the need to##3##4##(1991-1#1)(2008-10#1)(2008-11#1)
is the need##8##3##(1991-1#1)(1992-1#1)(1993-3#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-11#2)
is the notion of##2##4##(2008-12#1)(2009-3#1)
is the number of##4##4##(1993-12#1)(2008-8#2)(2009-3#1)
is the number##5##3##(1993-12#1)(2008-8#2)(2009-3#1)(2012-2#1)
is the only known##2##4##(1997-1#1)(2008-10#1)
is the only one##2##4##(2008-6#1)(2011-2#1)
is the only way##4##4##(1994-9#1)(1997-5#1)(2010-6#1)(2010-7#1)
is the only##35##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#4)(2013-1#1)
is the outcome##3##3##(1990-12#1)(1994-1#2)
is the percentage of##2##4##(1993-12#1)(2013-1#1)
is the possibility of##2##4##(2008-10#1)(2008-9#1)
is the potential for the##2##5##(1997-6#1)(2008-10#1)
is the potential of##2##4##(2008-11#1)(2009-12#1)
is the potential##6##3##(1997-6#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-4#1)
is the precise##2##3##(2009-4#1)(2011-2#1)
is the predominant##3##3##(2008-10#2)(2008-11#1)
is the preferred##5##3##(1996-3#1)(1996-5#1)(2008-4#1)(2008-9#1)(2010-7#1)
is the presence of##5##4##(1993-2#1)(1993-9#1)(2008-11#1)(2008-5#1)(2012-3#1)
is the primary##13##3##(1991-3#1)(1992-3#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
is the principal##3##3##(1993-11#1)(2008-10#1)(2009-8#1)
is the process of##3##4##(2008-10#1)(2008-9#2)
is the process##5##3##(2008-10#1)(2008-4#1)(2008-9#2)(2013-8#1)
is the product of##2##4##(2008-10#1)(2008-7#1)
is the product##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
is the production of##2##4##(1992-10#1)(2008-3#1)
is the quality##2##3##(1996-2#1)(2008-7#1)
is the rate-limiting enzyme in##2##5##(1991-9#1)(1994-11#1)
is the rate-limiting##4##3##(1991-9#2)(1994-11#1)(2008-1#1)
is the reason##2##3##(2010-6#1)(2011-2#1)
is the recognition##2##3##(1991-6#1)(1995-6#1)
is the reduced##2##3##(1990-2#1)(2008-7#1)
is the relative##2##3##(2008-10#2)
is the relatively##2##3##(2008-10#1)(2008-11#1)
is the responsibility of the##2##5##(1995-9#1)(2012-12#1)
is the responsibility of##3##4##(1995-9#1)(2008-11#1)(2012-12#1)
is the result of a##2##5##(2008-8#1)(2010-12#1)
is the result of the##3##5##(1994-5#1)(2008-3#1)(2008-8#1)
is the result of##12##4##(1994-1#1)(1994-5#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-8#2)(2010-12#1)(2013-7#1)
is the reverse##2##3##(2008-9#1)(2010-7#1)
is the role of the##3##5##(1995-12#1)(2007-12#1)(2008-11#1)
is the role of##7##4##(1993-11#2)(1995-12#1)(2007-12#1)(2008-11#2)(2012-2#1)
is the same as that##4##5##(1993-8#1)(2008-10#1)(2008-8#1)(2010-1#1)
is the same as the##4##5##(1991-5#1)(2008-10#3)
is the same as##9##4##(1991-5#1)(1993-8#1)(2008-10#4)(2008-8#1)(2009-8#1)(2010-1#1)
is the same for all##2##5##(1994-5#1)(2008-8#1)
is the same for##3##4##(1994-5#1)(2008-8#1)(2009-6#1)
is the same in##2##4##(1993-6#1)(2008-9#1)
is the same virus##2##4##(2008-10#1)(2008-8#1)
is the same##27##3##(1991-5#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-6#1)(1997-1#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)
is the second case of##2##5##(2007-8#1)(2013-1#1)
is the second completed genome sequence of##5##7##(2011-2#5)
is the second leading cause of cancer-related##2##7##(2008-1#1)(2011-2#1)
is the second leading cause of##3##6##(2008-1#1)(2011-2#1)(2013-1#1)
is the second leading##4##4##(2008-1#1)(2009-5#1)(2011-2#1)(2013-1#1)
is the second most common##3##5##(2008-11#1)(2010-11#1)(2010-8#1)
is the second most##4##4##(2008-11#1)(2010-11#1)(2010-8#1)(2013-1#1)
is the second reported case of##2##6##(2008-10#1)(2008-7#1)
is the second##29##3##(1995-6#1)(1995-9#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#7)(2013-1#3)(2013-8#1)
is the shape of the##2##5##(1997-3#1)(2008-3#1)
is the simultaneous##2##3##(2008-12#1)(2009-10#1)
is the single most##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
is the site of##2##4##(2007-12#1)(2008-11#1)
is the site##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
is the smallest##3##3##(2008-10#2)(2008-9#1)
is the sole##4##3##(1992-5#1)(2008-10#2)(2011-2#1)
is the source of##3##4##(2010-5#1)(2011-2#1)(2013-7#1)
is the stability of##2##4##(1995-1#1)(2008-10#1)
is the standard##2##3##(2008-10#1)(2010-7#1)
is the standardized##2##3##(2008-8#2)
is the strength of##2##4##(2008-8#1)(2013-8#1)
is the study of the##2##5##(2008-10#2)
is the study of##4##4##(2008-10#3)(2013-8#1)
is the subject of ongoing##2##5##(2008-7#1)(2009-8#1)
is the subject of the present##2##6##(1993-6#1)(2011-1#1)
is the subject of##6##4##(1993-6#1)(1996-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)
is the target##2##3##(2008-3#1)(2008-9#1)
is the third most##3##4##(2008-8#1)(2012-2#1)(2013-8#1)
is the third##7##3##(1993-12#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
is the total##2##3##(1991-3#1)(1994-5#1)
is the treatment of choice for##5##6##(1991-9#1)(2008-8#1)(2011-2#1)(2013-1#2)
is the treatment of choice in##3##6##(1990-9#1)(1992-12#1)(2009-4#1)
is the treatment of choice##10##5##(1990-9#1)(1991-9#1)(1992-12#1)(2007-8#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#2)
is the type species of the genus##17##7##(2011-2#17)
is the type species of the##19##6##(2011-2#19)
is the type##22##3##(2011-2#22)
is the use of##9##4##(1994-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2012-2#1)
is the value##2##3##(1997-8#1)(2008-10#1)
is the wavelength##2##3##(2008-10#1)(2008-3#1)
is the wild-type##2##3##(1990-10#1)(1991-9#1)
is the world's##2##3##(1995-2#1)(2008-12#1)
is the##1408##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#4)(1990-5#7)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#11)(1991-4#1)(1991-5#4)(1991-6#3)(1991-8#2)(1991-9#6)(1992-1#4)(1992-10#3)(1992-11#1)(1992-12#6)(1992-2#5)(1992-3#8)(1992-5#3)(1992-8#3)(1992-9#6)(1993-1#3)(1993-11#6)(1993-12#7)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#7)(1993-9#6)(1994-1#5)(1994-11#5)(1994-12#8)(1994-2#3)(1994-3#9)(1994-5#9)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#4)(1995-12#7)(1995-2#11)(1995-3#3)(1995-5#2)(1995-6#7)(1995-8#2)(1995-9#3)(1996-1#4)(1996-11#1)(1996-12#8)(1996-2#7)(1996-3#9)(1996-5#5)(1996-6#6)(1996-8#2)(1997-1#10)(1997-2#6)(1997-3#9)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#8)(2007-11#1)(2007-12#7)(2007-8#4)(2008-1#10)(2008-10#305)(2008-11#92)(2008-12#27)(2008-2#7)(2008-3#35)(2008-4#17)(2008-5#30)(2008-6#6)(2008-7#34)(2008-8#45)(2008-9#45)(2009-1#6)(2009-10#11)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#12)(2009-9#1)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#22)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#6)(2010-6#12)(2010-7#10)(2010-8#4)(2010-9#4)(2011-1#11)(2011-10#1)(2011-2#120)(2011-3#6)(2012-12#9)(2012-2#38)(2012-3#26)(2012-5#1)(2013-1#53)(2013-3#1)(2013-7#4)(2013-8#22)
is their##9##2##(1994-5#1)(1995-11#1)(2008-10#3)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)
is then added to##2##4##(2008-8#2)
is then applied to the##2##5##(2008-3#1)(2008-4#1)
is then determined##3##3##(2008-10#2)(2008-11#1)
is then eluted##2##3##(2008-10#2)
is then merged with##2##4##(2008-10#2)
is then monitored##2##3##(2008-10#2)
is then used to##4##4##(1992-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
is then used##5##3##(1992-12#1)(1997-7#1)(2008-6#1)(2008-7#1)(2008-8#1)
is then##57##2##(1990-12#1)(1990-5#2)(1991-12#2)(1992-12#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#27)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2012-2#1)
is theoretically##3##2##(2008-3#2)(2011-1#1)
is therapeutic##2##2##(1994-12#1)(1994-3#1)
is there a need##2##4##(1991-3#1)(2009-4#1)
is there a##11##3##(1991-3#1)(1993-9#1)(1994-3#1)(1995-3#1)(1997-3#1)(2008-11#4)(2008-12#1)(2009-4#1)
is there##17##2##(1990-11#1)(1991-1#1)(1991-2#1)(1991-3#2)(1993-9#1)(1994-3#1)(1995-3#1)(1997-3#1)(2008-11#5)(2008-12#1)(2009-4#1)(2011-2#1)
is therefore a##9##3##(1993-11#1)(1993-2#1)(2008-10#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
is therefore an##2##3##(1994-3#1)(2009-8#1)
is therefore necessary##2##3##(1990-3#1)(2012-3#1)
is therefore not##2##3##(1997-7#1)(2008-1#1)
is therefore possible##2##3##(2008-10#1)(2013-8#1)
is therefore##61##2##(1990-12#1)(1990-3#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#4)(2009-1#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
is thick##2##2##(2008-7#2)
is this##4##2##(1995-1#1)(2008-10#1)(2008-11#1)(2009-8#1)
is thought that##5##3##(1990-3#1)(1996-11#1)(2008-11#1)(2008-2#1)(2010-6#1)
is thought to be an##2##5##(2011-2#1)(2012-12#1)
is thought to be generated##2##5##(1991-5#1)(1995-2#1)
is thought to be important##2##5##(2008-7#1)(2008-8#1)
is thought to be the##3##5##(1990-11#1)(1994-9#1)(2008-11#1)
is thought to be##22##4##(1990-11#1)(1991-2#1)(1991-5#1)(1994-11#1)(1994-9#2)(1995-2#1)(2006-6#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
is thought to occur##2##4##(1994-3#1)(2008-11#1)
is thought to play a##2##5##(1993-3#1)(2011-2#1)
is thought to represent##2##4##(2008-11#1)(2013-1#1)
is thought to##43##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-2#2)(1997-1#1)(2006-6#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
is thought##49##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-2#2)(1996-11#1)(1997-1#1)(2006-6#1)(2008-10#3)(2008-11#6)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
is threatened##3##2##(1993-12#1)(1997-3#1)(2008-10#1)
is three-fold##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
is through the##3##3##(1994-1#1)(2009-12#1)(2011-2#1)
is through##7##2##(1994-1#1)(1994-12#2)(2007-12#1)(2009-12#1)(2011-2#1)(2013-1#1)
is thus a##5##3##(1996-6#1)(1997-3#1)(2008-8#1)(2010-12#1)(2012-12#1)
is thus avoided##3##3##(2008-10#3)
is thus likely##2##3##(1994-12#1)(2008-8#1)
is thus##27##2##(1992-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-8#1)
is tied to##2##3##(1996-5#1)(2011-2#1)
is tightly correlated with##2##4##(2012-2#1)(2013-1#1)
is tightly linked to##2##4##(2008-10#1)(2013-8#1)
is tightly regulated by##2##4##(2008-9#1)(2013-1#1)
is tightly regulated##3##3##(2008-9#1)(2012-2#1)(2013-1#1)
is tightly##10##2##(2007-8#1)(2008-10#2)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
is tilted##2##2##(2008-2#1)(2008-3#1)
is time consuming##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
is time dependent and##2##4##(2008-10#1)(2008-7#1)
is time##9##2##(1993-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
is time-consuming and##2##3##(1995-2#1)(2008-10#1)
is time-consuming##3##2##(1993-9#1)(1995-2#1)(2008-10#1)
is timely##2##2##(2008-11#2)
is tissue dependent##2##3##(1994-8#1)(2008-10#1)
is to a large##2##4##(2008-9#1)(2011-2#1)
is to achieve a##2##4##(1994-8#1)(2008-7#1)
is to achieve##3##3##(1994-8#1)(2008-7#1)(2012-2#1)
is to aid the##2##4##(2008-9#2)
is to allow the##2##4##(1995-12#1)(2012-3#1)
is to analyze##6##3##(2008-8#1)(2009-10#1)(2009-5#1)(2011-7#1)(2013-1#2)
is to apply##2##3##(2008-11#1)(2008-8#1)
is to assess the##10##4##(1994-12#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#2)(2013-8#1)
is to assess##12##3##(1994-12#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
is to avoid##2##3##(1997-2#1)(2011-2#1)
is to be a##2##4##(2012-3#1)(2013-8#1)
is to be avoided##2##4##(2013-1#1)(2013-8#1)
is to be considered##2##4##(2008-7#1)(2008-8#1)
is to be used##4##4##(1996-12#1)(2008-3#1)(2008-4#2)
is to be##27##3##(1990-8#2)(1991-11#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1994-8#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
is to become##2##3##(2010-11#1)(2013-8#1)
is to calculate the##2##4##(2008-10#1)(2008-7#1)
is to compare the##2##4##(2008-11#1)(2013-1#1)
is to compare##7##3##(2008-10#2)(2008-11#1)(2012-3#2)(2013-1#2)
is to control the##2##4##(1997-2#1)(2008-11#1)
is to critically##2##3##(2008-2#1)(2013-1#1)
is to define##2##3##(2008-11#1)(2008-7#1)
is to demonstrate the##3##4##(2008-11#2)(2013-1#1)
is to demonstrate##4##3##(2008-11#2)(2008-6#1)(2013-1#1)
is to derive##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
is to describe a##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
is to describe the##13##4##(1992-1#1)(1993-1#1)(1994-1#1)(2008-11#2)(2008-12#1)(2008-5#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)
is to describe##24##3##(1992-1#1)(1992-2#1)(1993-1#1)(1994-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#3)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)
is to design##3##3##(2008-10#3)
is to determine the##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
is to determine whether##2##4##(2011-2#1)(2013-1#1)
is to determine##9##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
is to develop a##2##4##(1991-12#1)(2013-8#1)
is to develop and##2##4##(2008-10#1)(2010-7#1)
is to develop##8##3##(1991-12#1)(1993-2#1)(1997-1#1)(2008-10#2)(2010-7#1)(2010-8#1)(2013-8#1)
is to discover##2##3##(2008-11#1)(2012-3#1)
is to discuss the##7##4##(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
is to discuss##11##3##(1996-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
is to do##2##3##(2008-9#1)(2013-8#1)
is to elucidate the##2##4##(2008-11#1)(2008-9#1)
is to enable##2##3##(2008-10#1)(2008-11#1)
is to ensure that##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
is to ensure##5##3##(1994-1#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)
is to evaluate the##7##4##(2008-10#2)(2008-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
is to evaluate whether##2##4##(2011-2#1)(2013-1#1)
is to evaluate##13##3##(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#3)
is to examine the##3##4##(1991-2#1)(2008-10#1)(2011-2#1)
is to examine##8##3##(1991-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
is to expand##2##3##(2008-3#1)(2012-2#1)
is to explore the##4##4##(2008-10#2)(2008-11#1)(2011-3#1)
is to facilitate the growth and development of##2##8##(1994-1#1)(1996-3#1)
is to familiarize##2##3##(2008-8#1)(2011-2#1)
is to find##3##3##(2008-5#1)(2009-3#1)(2009-6#1)
is to focus##3##3##(1994-1#1)(1996-3#1)(2012-2#1)
is to highlight the##4##4##(2006-6#1)(2008-1#1)(2010-5#1)(2012-12#1)
is to identify the##5##4##(1996-3#1)(2008-12#1)(2010-12#1)(2013-1#2)
is to identify##12##3##(1996-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-10#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
is to illustrate the##4##4##(2012-2#3)(2013-1#1)
is to improve survival##2##4##(1994-6#1)(2012-3#1)
is to improve the##3##4##(2008-11#1)(2010-5#1)(2013-1#1)
is to improve##8##3##(1991-12#1)(1994-6#1)(1996-2#1)(2008-11#2)(2010-5#1)(2012-3#1)(2013-1#1)
is to increase the##2##4##(2008-7#1)(2011-2#1)
is to increase##4##3##(1996-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
is to inform##2##3##(1992-1#1)(2012-3#1)
is to investigate the effect of##2##6##(2008-10#1)(2011-3#1)
is to investigate the##6##4##(2008-10#2)(2008-5#1)(2010-12#1)(2011-3#2)
is to investigate##14##3##(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-3#2)(2012-3#1)
is to make##2##3##(1991-12#1)(1994-9#1)
is to meet##3##3##(1992-1#1)(1994-2#1)(2008-11#1)
is to offer##2##3##(1993-2#1)(2010-7#1)
is to play a##2##4##(1992-3#1)(2008-7#1)
is to present a case of a##2##7##(2012-12#2)
is to present a case of##3##6##(2011-2#1)(2012-12#2)
is to present a##7##4##(1993-12#1)(2008-3#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
is to present the##4##4##(1997-3#1)(2008-3#1)(2013-1#2)
is to present##19##3##(1993-12#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-3#2)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#3)
is to produce##2##3##(2008-11#1)(2013-1#1)
is to promote the##2##4##(2008-10#1)(2008-11#1)
is to protect##2##3##(1995-3#1)(2008-11#1)
is to provide a general##2##5##(1997-3#1)(2008-6#1)
is to provide a##13##4##(1996-2#2)(1996-3#1)(1997-3#1)(2008-11#2)(2008-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
is to provide an overview of##3##6##(1995-3#1)(2008-9#1)(2010-12#1)
is to provide an overview##4##5##(1995-3#1)(2008-11#1)(2008-9#1)(2010-12#1)
is to provide an##6##4##(1994-2#1)(1995-3#1)(1997-8#1)(2008-11#1)(2008-9#1)(2010-12#1)
is to provide the##3##4##(2008-7#1)(2009-5#1)(2010-9#1)
is to provide##32##3##(1992-3#1)(1994-2#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-8#3)
is to publish peer-reviewed##3##4##(2010-12#3)
is to reduce##4##3##(2008-10#1)(2008-7#1)(2009-6#1)(2009-9#1)
is to relate the##2##4##(2008-5#1)(2012-2#1)
is to report on a##2##5##(2008-11#1)(2013-1#1)
is to report on##3##4##(2008-11#2)(2013-1#1)
is to report the##2##4##(2012-3#1)(2013-1#1)
is to report##7##3##(2008-11#3)(2009-10#1)(2012-3#1)(2013-1#2)
is to result##2##3##(1991-3#1)(2008-9#1)
is to review recent##2##4##(2008-10#1)(2010-12#1)
is to review the##7##4##(1994-3#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
is to review##12##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
is to show that##4##4##(1994-2#1)(2008-10#1)(2013-1#2)
is to show the##2##4##(2008-10#1)(2009-9#1)
is to show##8##3##(1994-2#1)(2008-10#2)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
is to suggest a##2##4##(2007-12#1)(2008-11#1)
is to suggest##3##3##(2007-12#1)(2008-11#1)(2008-6#1)
is to summarize the##2##4##(2009-4#1)(2010-1#1)
is to summarize##4##3##(2008-10#1)(2008-4#1)(2009-4#1)(2010-1#1)
is to the##2##3##(1990-12#1)(2008-11#1)
is to treat##2##3##(1992-5#1)(2008-10#1)
is to use the##2##4##(1994-3#1)(2008-4#1)
is to use these##2##4##(1994-2#1)(2008-10#1)
is to use##7##3##(1994-2#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-2#1)
is to##481##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#1)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#3)(1993-6#1)(1994-1#5)(1994-12#4)(1994-2#6)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#7)(1996-3#5)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#2)(2006-6#1)(2007-12#3)(2008-1#2)(2008-10#50)(2008-11#49)(2008-12#9)(2008-2#4)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#7)(2008-7#15)(2008-8#12)(2008-9#14)(2009-10#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#8)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#3)(2011-2#26)(2011-3#9)(2011-7#1)(2012-12#6)(2012-2#22)(2012-3#21)(2013-1#29)(2013-8#13)
is too expensive##2##3##(1996-5#1)(1997-6#1)
is too high##2##3##(2008-3#1)(2008-8#1)
is too large##2##3##(1993-12#1)(2008-3#1)
is too late##2##3##(1996-8#1)(2008-11#1)
is too low##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
is too##23##2##(1993-12#1)(1996-5#1)(1996-8#1)(1997-6#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
is totally##2##2##(2008-10#1)(2008-3#1)
is toxic to##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
is toxic##5##2##(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
is traditionally##3##2##(1991-11#1)(1994-12#1)(2012-3#1)
is transcribed into##2##3##(1993-2#1)(2008-11#1)
is transcribed##9##2##(1993-12#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-6#1)(2008-11#2)(2008-8#2)
is transferred to the##2##4##(2008-10#1)(2013-1#1)
is transferred to##4##3##(1994-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
is transferred##8##2##(1994-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
is transformed into##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
is translated##2##2##(2008-3#1)(2008-7#1)
is translocated##2##2##(1992-6#1)(1993-8#1)
is transmitted by the##4##4##(2008-10#4)
is transmitted##10##2##(1997-6#1)(2007-12#1)(2008-10#7)(2012-2#1)
is transported into##3##3##(1993-8#2)(2012-2#1)
is transported##6##2##(1993-8#2)(2008-10#2)(2009-8#1)(2012-2#1)
is trapped in the##2##4##(2008-10#2)
is trapped in##4##3##(2008-10#3)(2008-11#1)
is treated with##6##3##(2008-10#5)(2009-7#1)
is treated##11##2##(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#2)(2009-7#1)
is triggered by##5##3##(1995-11#1)(1996-2#1)(1997-3#1)(2008-7#1)(2012-3#1)
is triggered##8##2##(1995-11#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-3#1)
is true##4##2##(1996-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
is truly##3##2##(1995-5#1)(2008-7#1)(2009-7#1)
is truncated##2##2##(1996-12#1)(2008-3#1)
is tunable##2##2##(2008-2#1)(2008-3#1)
is tuned##2##2##(2007-12#1)(2008-9#1)
is typical for##2##3##(2008-12#1)(2013-1#1)
is typical of##6##3##(1991-3#1)(1993-8#1)(1996-1#1)(2007-12#1)(2008-12#1)(2010-10#1)
is typical##8##2##(1991-3#1)(1993-8#1)(1996-1#1)(2007-12#1)(2008-12#2)(2010-10#1)(2013-1#1)
is typically low##2##3##(2008-11#1)(2008-8#1)
is typically observed in young women##2##6##(2013-1#2)
is typically##18##2##(1994-3#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-8#3)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
is ubiquitous in##2##3##(2008-9#1)(2009-3#1)
is ubiquitously expressed##2##3##(1997-7#1)(2011-2#1)
is ubiquitously##3##2##(1997-7#1)(2011-2#1)(2013-8#1)
is unable to##6##3##(1990-11#1)(1995-5#1)(1997-6#1)(2008-10#1)(2010-10#1)(2011-1#1)
is unaffected by##3##3##(1996-2#1)(2008-10#1)(2009-9#1)
is unavailable##2##2##(2012-12#1)(2013-1#1)
is uncertain##9##2##(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-8#1)(2010-6#1)(2012-2#1)
is unchanged##2##2##(2009-2#1)(2009-6#1)
is unclear whether the##3##4##(2008-8#2)(2012-3#1)
is unclear whether this##2##4##(1996-1#1)(2008-11#1)
is unclear whether##8##3##(1996-1#1)(2008-11#1)(2008-8#2)(2009-10#1)(2012-3#1)(2013-1#2)
is unclear##29##2##(1993-12#1)(1996-1#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
is uncommon in##4##3##(1996-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
is uncommon##13##2##(1990-8#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#3)(2013-8#1)
is under development by##3##4##(2008-5#3)
is under development##5##3##(2008-10#1)(2008-5#3)(2009-9#1)
is under the control of##4##5##(1993-6#1)(1997-1#1)(2008-10#1)(2008-7#1)
is under the##5##3##(1993-6#1)(1997-1#1)(2008-10#1)(2008-7#1)(2012-12#1)
is under##23##2##(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-6#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-5#4)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
is undergoing##4##2##(1994-8#1)(1996-5#1)(2008-10#1)(2008-11#1)
is underlined##2##2##(1991-6#1)(2008-10#1)
is underpinned by##2##3##(2008-10#1)(2008-12#1)
is understood##2##2##(2008-11#1)(2012-3#1)
is undertaken##4##2##(1991-3#1)(1996-2#1)(2008-10#2)
is underway##3##2##(1994-1#1)(1994-5#1)(2010-12#1)
is undetectable in##2##3##(2013-1#2)
is undetectable##3##2##(2008-8#1)(2013-1#2)
is undoubtedly##2##2##(2010-1#1)(2010-12#1)
is unfit##2##2##(2008-11#1)(2013-8#1)
is unhelpful##2##2##(1997-8#1)(2009-11#1)
is uniform##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
is unimodal##2##2##(2008-8#1)(2012-2#1)
is unique among##5##3##(1992-10#1)(1995-8#1)(2010-3#1)(2010-7#1)(2012-3#1)
is unique in that it can##2##6##(1995-9#1)(2013-8#1)
is unique in that it##3##5##(1993-6#1)(1995-9#1)(2013-8#1)
is unique in that##4##4##(1993-6#1)(1995-9#1)(2008-10#1)(2013-8#1)
is unique to the##3##4##(2009-10#1)(2009-8#1)(2011-2#1)
is unique to##6##3##(1992-6#1)(1995-6#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
is unique##25##2##(1990-5#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-1#1)(1995-6#1)(1995-8#1)(1995-9#1)(2008-10#4)(2009-10#1)(2009-8#1)(2010-3#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
is uniquely##6##2##(1990-5#1)(1994-8#1)(1996-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
is unknown at##2##3##(1992-9#1)(2008-11#1)
is unknown but##3##3##(1990-12#1)(1990-3#1)(2013-8#1)
is unknown##59##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-3#2)(2008-1#1)(2008-10#8)(2008-11#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
is unlikely that##8##3##(1993-9#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-5#2)
is unlikely to be a##2##5##(2009-7#1)(2010-1#1)
is unlikely to be##9##4##(1992-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2013-8#1)
is unlikely to##16##3##(1992-6#1)(1993-9#1)(1994-5#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-1#1)(2013-8#1)
is unlikely##31##2##(1990-11#1)(1991-12#1)(1992-6#1)(1993-9#2)(1994-5#1)(1995-12#1)(1995-5#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-7#1)(2010-1#1)(2011-3#1)(2013-8#1)
is unnecessary##2##2##(2008-10#2)
is unrelated to##4##3##(1991-3#1)(2008-7#1)(2009-12#1)(2010-12#1)
is unreliable##2##2##(1994-12#1)(2008-9#1)
is unstable##4##2##(1994-11#1)(2008-10#2)(2008-2#1)
is unsuitable for##2##3##(2008-10#1)(2008-7#1)
is unsuitable##3##2##(2008-10#2)(2008-7#1)
is unusual##7##2##(1995-12#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)
is unusually##2##2##(1991-5#1)(2008-1#1)
is up to##5##3##(2008-10#4)(2008-5#1)
is up-regulated in##2##3##(2008-10#1)(2011-2#1)
is up-regulated##4##2##(1995-8#1)(1997-7#1)(2008-10#1)(2011-2#1)
is upregulated by##2##3##(1997-7#1)(2009-8#1)
is upregulated in##2##3##(2010-12#1)(2013-1#1)
is upregulated##5##2##(1997-7#1)(2009-8#2)(2010-12#1)(2013-1#1)
is urgent##3##2##(1994-12#1)(1997-4#1)(2012-3#1)
is urgently needed##2##3##(1995-2#1)(2011-2#1)
is used as a novel ionophore in plasticized##2##8##(2008-10#2)
is used as a novel##3##5##(2008-10#3)
is used as a##21##4##(1991-6#1)(1993-3#1)(1996-6#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-9#1)(2009-7#1)
is used as an##7##4##(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
is used as the##9##4##(2008-10#7)(2008-2#1)(2008-8#1)
is used as##58##3##(1991-6#1)(1993-3#1)(1996-6#1)(2007-12#1)(2008-10#38)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)
is used at##2##3##(2008-10#1)(2010-1#1)
is used because##2##3##(1997-2#1)(2008-5#1)
is used by##3##3##(1990-12#1)(1996-1#1)(2012-3#1)
is used extensively##2##3##(2008-6#1)(2010-5#1)
is used for direct##2##4##(2008-10#1)(2008-4#1)
is used for the determination of##3##6##(2008-10#3)
is used for the##15##4##(2008-10#13)(2008-11#2)
is used for##52##3##(1993-2#1)(1997-6#1)(2008-10#36)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-9#1)(2010-6#1)(2010-7#1)(2011-1#1)
is used in a##5##4##(1994-5#1)(1997-3#1)(2008-10#3)
is used in conjunction with##3##5##(2008-11#1)(2008-3#1)(2008-7#1)
is used in the treatment of Parkinson's disease##2##8##(1992-3#1)(2008-10#1)
is used in the##13##4##(1992-3#1)(1992-6#1)(1995-12#1)(1996-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-6#1)(2010-8#1)(2013-1#1)
is used in##35##3##(1992-12#1)(1992-3#1)(1992-6#1)(1994-5#1)(1995-12#1)(1996-9#2)(1997-3#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
is used instead of##2##4##(2008-10#1)(2011-2#1)
is used more##2##3##(2008-4#1)(2009-12#1)
is used on##2##3##(2008-10#2)
is used that##2##3##(2008-2#1)(2008-3#1)
is used throughout##3##3##(2008-10#2)(2011-2#1)
is used to analyze##2##4##(2008-3#1)(2009-10#1)
is used to calculate the##4##5##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
is used to calculate##5##4##(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)
is used to characterize##2##4##(1995-12#1)(2007-11#1)
is used to compare##2##4##(2008-2#1)(2008-8#1)
is used to compute##2##4##(2008-3#1)(2008-6#1)
is used to control##2##4##(2008-10#1)(2008-9#1)
is used to describe the##2##5##(2008-11#1)(2008-3#1)
is used to describe##4##4##(1990-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
is used to detect##4##4##(2008-10#2)(2008-4#1)(2008-9#1)
is used to determine the##3##5##(2008-2#2)(2008-4#1)
is used to determine##7##4##(1993-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-11#1)
is used to estimate the##3##5##(2008-10#1)(2008-3#1)(2010-6#1)
is used to explain the##2##5##(2008-10#1)(2008-3#1)
is used to identify the##2##5##(2008-9#1)(2010-4#1)
is used to identify##3##4##(1997-3#1)(2008-9#1)(2010-4#1)
is used to implement##2##4##(2008-10#1)(2008-3#1)
is used to improve##2##4##(2008-11#1)(2013-1#1)
is used to investigate the##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
is used to measure the##2##5##(2008-10#1)(2008-4#1)
is used to measure##5##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)
is used to prevent##2##4##(2008-10#1)(2013-1#1)
is used to produce##2##4##(2008-10#1)(2008-3#1)
is used to quantify##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
is used to sample##3##4##(2008-10#3)
is used to study##2##4##(2008-3#1)(2010-7#1)
is used to treat##2##4##(1991-9#1)(2012-3#1)
is used to##124##3##(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#38)(2008-11#10)(2008-12#1)(2008-2#10)(2008-3#21)(2008-4#5)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#8)(2009-10#1)(2009-7#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
is used with##3##3##(2008-10#1)(2008-3#2)
is used##342##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#3)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-6#2)(2007-11#4)(2007-12#2)(2008-10#151)(2008-11#24)(2008-12#3)(2008-2#13)(2008-3#37)(2008-4#9)(2008-5#6)(2008-6#5)(2008-7#1)(2008-8#3)(2008-9#12)(2009-10#2)(2009-12#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
is useful as a##3##4##(1995-8#1)(2008-10#1)(2010-12#1)
is useful for the##4##4##(1996-6#1)(2008-10#2)(2008-11#1)
is useful for##23##3##(1990-12#1)(1994-9#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
is useful in the diagnosis##2##5##(2008-12#1)(2011-2#1)
is useful in the##3##4##(1991-11#1)(2008-12#1)(2011-2#1)
is useful in##12##3##(1991-11#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
is useful to##7##3##(1990-12#1)(1996-6#1)(2008-10#1)(2008-11#3)(2013-1#1)
is useful##52##2##(1990-12#2)(1991-11#1)(1991-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-6#3)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2010-12#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
is useless in##2##3##(1991-6#1)(2011-2#1)
is useless##3##2##(1991-6#1)(1992-2#1)(2011-2#1)
is using##3##2##(2008-9#1)(2009-10#1)(2009-3#1)
is usually a##2##3##(1990-9#1)(1991-4#1)
is usually associated with##4##4##(2008-1#1)(2009-8#1)(2013-1#1)(2013-8#1)
is usually assumed##2##3##(1992-3#1)(2008-9#1)
is usually considered a##2##4##(2008-10#1)(2009-7#1)
is usually considered##3##3##(2008-10#1)(2008-4#1)(2009-7#1)
is usually diagnosed##2##3##(2008-10#1)(2011-2#1)
is usually found##2##3##(1991-6#1)(2013-8#1)
is usually made##3##3##(2008-6#1)(2012-2#1)(2012-3#1)
is usually normal##2##3##(2010-12#1)(2013-1#1)
is usually not##3##3##(1990-12#1)(2008-2#1)(2013-1#1)
is usually performed##2##3##(1990-9#1)(2008-10#1)
is usually required##2##3##(1995-5#1)(2008-10#1)
is usually secondary##2##3##(2008-10#1)(2013-8#1)
is usually seen in adults##2##5##(2008-10#1)(2011-2#1)
is usually seen##4##3##(1997-5#1)(2008-10#1)(2009-11#1)(2011-2#1)
is usually##92##2##(1990-12#2)(1990-9#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-3#1)(1997-4#2)(1997-5#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#2)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#4)
is utilized for##2##3##(2008-10#2)
is utilized to##4##3##(2008-10#2)(2008-3#2)
is utilized##9##2##(2008-10#6)(2008-3#2)(2008-7#1)
is valid and##2##3##(2008-3#1)(2010-10#1)
is valid for the##2##4##(2008-10#2)
is valid for##4##3##(1995-3#1)(2008-10#3)
is valid only##3##3##(2008-3#3)
is valid##12##2##(1995-3#1)(1996-2#1)(2008-10#4)(2008-3#4)(2008-9#1)(2010-10#1)
is validated by comparison##2##4##(2008-3#2)
is validated by##6##3##(2008-10#3)(2008-3#2)(2008-5#1)
is validated##8##2##(2008-10#5)(2008-3#2)(2008-5#1)
is valuable to##2##3##(2008-9#2)
is valuable##7##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2012-2#1)
is variable##7##2##(1991-6#1)(1995-3#1)(2008-1#1)(2009-8#1)(2011-2#2)(2013-1#1)
is varied##5##2##(1997-2#1)(2007-12#1)(2008-10#2)(2008-9#1)
is varying##2##2##(1990-9#1)(2007-11#1)
is vascular##2##2##(2011-2#1)(2013-8#1)
is verified by##5##3##(1994-2#1)(2008-10#1)(2008-3#2)(2008-8#1)
is verified##12##2##(1994-2#1)(2008-10#4)(2008-12#1)(2008-3#4)(2008-8#1)(2009-4#1)
is very attractive##2##3##(2008-1#1)(2008-10#1)
is very challenging##2##3##(1992-3#1)(2010-7#1)
is very common##4##3##(1991-6#1)(1996-11#1)(2008-1#1)(2008-11#1)
is very convenient##2##3##(2008-10#2)
is very difficult to##9##4##(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-6#1)(2013-1#1)(2013-8#1)
is very essential##2##3##(2008-10#1)(2010-11#1)
is very high in##2##4##(1992-5#1)(2011-1#1)
is very high##4##3##(1992-5#1)(1993-6#1)(2007-11#1)(2011-1#1)
is very important for##9##4##(1992-12#1)(1996-11#1)(2008-11#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
is very important in##2##4##(2008-10#2)
is very important to investigate the##3##6##(2008-10#2)(2008-11#1)
is very important to##8##4##(1991-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
is very important##21##3##(1991-6#1)(1992-12#1)(1996-11#1)(2008-10#5)(2008-11#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is very large##2##3##(2008-11#1)(2008-9#1)
is very likely##3##3##(1992-8#1)(2008-1#1)(2008-5#1)
is very limited and##2##4##(2008-10#2)
is very limited##3##3##(1993-1#1)(2008-10#2)
is very little##5##3##(2008-7#2)(2008-8#1)(2009-8#1)(2010-7#1)
is very low##4##3##(1996-6#1)(2008-3#1)(2008-5#1)(2008-9#1)
is very much##2##3##(2008-1#1)(2009-3#1)
is very rare and##3##4##(2010-6#1)(2012-3#1)(2013-1#1)
is very rare##18##3##(1991-3#1)(2008-10#1)(2008-7#4)(2008-8#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
is very selective##2##3##(2008-10#2)
is very sensitive##7##3##(2008-1#1)(2008-10#3)(2008-11#1)(2010-3#1)(2011-2#1)
is very similar to that of##3##6##(1993-2#1)(1993-8#1)(2008-8#1)
is very similar to that##5##5##(1993-2#1)(1993-8#1)(1994-5#2)(2008-8#1)
is very similar to##8##4##(1992-12#1)(1993-2#1)(1993-8#2)(1994-5#2)(2008-10#1)(2008-8#1)
is very similar##11##3##(1992-12#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-5#2)(2008-10#2)(2008-11#1)(2008-8#1)
is very simple and##2##4##(2008-10#2)
is very simple##8##3##(2008-10#8)
is very strong##2##3##(2008-10#2)
is very unusual##2##3##(1991-6#1)(1997-8#1)
is very useful for##3##4##(2008-10#2)(2010-8#1)
is very useful in##2##4##(2012-2#2)
is very useful##5##3##(2008-10#2)(2010-8#1)(2012-2#2)
is very weak##3##3##(2008-10#1)(2008-7#2)
is very##157##2##(1990-2#1)(1991-3#1)(1991-6#4)(1992-12#4)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-5#2)(1995-11#1)(1995-8#1)(1996-11#2)(1996-6#1)(1997-2#2)(1997-8#1)(2007-11#1)(2008-1#6)(2008-10#45)(2008-11#10)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#4)(2008-9#5)(2009-3#1)(2009-8#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#4)
is via##5##2##(1992-3#1)(2008-11#2)(2010-1#1)(2011-2#1)
is viewed as a##2##4##(1992-3#1)(2012-3#1)
is viewed as##3##3##(1992-3#1)(2008-11#1)(2012-3#1)
is viewed##5##2##(1992-3#1)(2008-11#2)(2008-2#1)(2012-3#1)
is virtually absent in##2##4##(1990-2#1)(2008-10#1)
is virtually##7##2##(1990-2#1)(1993-8#1)(1995-12#1)(2008-10#4)
is virulent on##2##3##(2008-10#2)
is virulent to##2##3##(2008-10#2)
is virulent##4##2##(2008-10#4)
is vital for##5##3##(1994-3#1)(2008-9#1)(2009-9#1)(2010-10#1)(2012-5#1)
is vital that##2##3##(1997-1#1)(2012-2#1)
is vital to the##3##4##(2008-10#1)(2010-4#1)(2013-8#1)
is vital to##6##3##(2008-10#1)(2008-11#2)(2010-4#1)(2013-8#2)
is vital##18##2##(1992-12#1)(1994-3#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-1#1)(2012-2#1)(2012-5#1)(2013-8#2)
is vulnerable to##3##3##(2008-8#1)(2012-3#1)(2013-1#1)
is warranted and##2##3##(1991-12#1)(2008-11#1)
is warranted for##2##3##(2011-2#1)(2012-2#1)
is warranted to##3##3##(2008-7#1)(2009-4#1)(2013-1#1)
is warranted##22##2##(1990-12#1)(1991-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#4)(2009-4#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#3)(2013-1#5)
is washed##3##2##(2008-10#1)(2008-8#2)
is weak##6##2##(1992-6#1)(2008-10#1)(2008-9#2)(2009-8#1)(2011-2#1)
is weaker##4##2##(1994-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
is weakly##4##2##(2008-5#2)(2010-12#1)(2013-7#1)
is well accepted##3##3##(1991-6#1)(2008-10#2)
is well conserved in##2##4##(1996-12#1)(2008-7#1)
is well described by##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
is well described##6##3##(1992-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
is well documented##7##3##(2008-10#1)(2008-11#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-2#1)
is well established##11##3##(1991-12#1)(1992-6#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
is well known in the##2##5##(2008-12#1)(2009-10#1)
is well known that##14##4##(1993-3#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
is well known to##2##4##(2008-7#1)(2009-8#1)
is well known##23##3##(1993-3#1)(1995-5#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
is well recognized##2##3##(1990-9#1)(2011-2#1)
is well suited for##5##4##(1995-2#1)(2008-10#3)(2008-11#1)
is well suited to##3##4##(1997-8#1)(2008-10#1)(2008-6#1)
is well suited##8##3##(1995-2#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-6#1)
is well tolerated and##2##4##(2008-10#1)(2013-1#1)
is well tolerated##7##3##(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
is well##87##2##(1990-9#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#16)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
is well-documented##2##2##(1997-3#2)
is well-known##4##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
is what##4##2##(1993-11#1)(1994-2#1)(2008-9#1)(2010-8#1)
is when the##2##3##(1991-3#1)(2008-3#1)
is when##4##2##(1991-3#1)(2008-3#1)(2008-8#1)(2010-4#1)
is whether the##3##3##(1997-2#1)(2009-10#1)(2009-5#1)
is whether##8##2##(1991-1#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-11#1)(2009-10#1)(2009-5#1)(2011-2#1)
is why the##2##3##(2008-10#1)(2011-2#1)
is why##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
is wide##2##2##(1997-5#1)(2008-10#1)
is widely accepted##5##3##(1991-3#1)(1994-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
is widely distributed in##2##4##(1993-11#1)(2008-10#1)
is widely recognized##3##3##(2008-12#1)(2008-3#1)(2012-2#1)
is widely used as a model##2##6##(2008-9#1)(2009-9#1)
is widely used as a##4##5##(2008-10#1)(2008-9#1)(2009-9#1)(2011-2#1)
is widely used as##5##4##(1996-8#1)(2008-10#1)(2008-9#1)(2009-9#1)(2011-2#1)
is widely used for##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
is widely used in Japan##2##5##(2008-10#1)(2010-6#1)
is widely used in##11##4##(1990-6#1)(1996-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-12#1)(2010-6#1)(2010-7#1)
is widely used##24##3##(1990-6#1)(1994-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#2)
is widely utilized##2##3##(2008-10#1)(2008-9#1)
is widely##50##2##(1990-6#1)(1991-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
is wider##2##2##(2008-10#1)(2008-8#1)
is widespread##7##2##(1992-3#1)(1995-8#1)(2008-10#3)(2008-7#1)(2013-1#1)
is with##3##2##(1996-11#1)(2008-12#1)(2008-3#1)
is within the##5##3##(1991-9#1)(1995-2#1)(2008-10#2)(2008-11#1)
is within##8##2##(1991-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-12#1)
is without##3##2##(1996-3#1)(1997-6#1)(2008-11#1)
is working with##2##3##(1994-9#1)(2010-9#1)
is working##6##2##(1994-9#1)(1996-2#1)(1997-3#1)(2008-5#1)(2010-9#1)(2012-2#1)
is worse than##2##3##(1995-8#1)(2008-11#1)
is worse##3##2##(1995-8#1)(2008-11#2)
is worth##2##2##(1997-3#1)(2008-10#1)
is written##4##2##(2008-1#1)(2008-3#1)(2008-9#1)(2010-8#1)
is yet to be##4##4##(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
is yet##7##2##(1990-2#1)(1996-2#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is your diagnosis?##4##3##(1992-6#1)(1993-11#1)(1994-5#1)(2007-12#1)
is your##7##2##(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1996-12#1)(2007-12#1)(2012-3#1)
is zero##3##2##(2008-10#2)(2008-8#1)
is ~0##3##2##(2007-12#1)(2008-3#2)
is ~2##2##2##(2007-12#1)(2008-3#1)
is##27232##1##(1990-10#3)(1990-11#62)(1990-12#95)(1990-2#75)(1990-3#38)(1990-5#91)(1990-6#48)(1990-7#10)(1990-8#53)(1990-9#58)(1991-1#47)(1991-10#5)(1991-11#45)(1991-12#118)(1991-2#114)(1991-3#126)(1991-4#3)(1991-5#81)(1991-6#84)(1991-7#11)(1991-8#27)(1991-9#51)(1992-1#63)(1992-10#23)(1992-11#18)(1992-12#128)(1992-2#57)(1992-3#108)(1992-4#20)(1992-5#36)(1992-6#68)(1992-7#9)(1992-8#29)(1992-9#84)(1993-1#55)(1993-11#55)(1993-12#143)(1993-2#88)(1993-3#133)(1993-6#94)(1993-8#120)(1993-9#59)(1994-1#61)(1994-11#104)(1994-12#141)(1994-2#97)(1994-3#98)(1994-5#148)(1994-6#43)(1994-8#86)(1994-9#62)(1995-1#37)(1995-10#6)(1995-11#76)(1995-12#132)(1995-2#197)(1995-3#48)(1995-5#71)(1995-6#126)(1995-8#83)(1995-9#47)(1996-1#64)(1996-10#1)(1996-11#56)(1996-12#140)(1996-2#145)(1996-3#109)(1996-5#84)(1996-6#78)(1996-8#27)(1996-9#33)(1997-1#125)(1997-2#128)(1997-3#123)(1997-4#46)(1997-5#48)(1997-6#75)(1997-7#116)(1997-8#140)(1997-9#9)(2006-5#2)(2006-6#24)(2007-11#73)(2007-12#189)(2007-8#21)(2007-9#3)(2008-1#169)(2008-10#7551)(2008-11#1654)(2008-12#460)(2008-2#249)(2008-3#1016)(2008-4#381)(2008-5#547)(2008-6#181)(2008-7#703)(2008-8#809)(2008-9#820)(2009-1#56)(2009-10#147)(2009-11#51)(2009-12#99)(2009-2#5)(2009-3#61)(2009-4#42)(2009-5#69)(2009-6#77)(2009-7#119)(2009-8#256)(2009-9#63)(2010-1#91)(2010-10#144)(2010-11#141)(2010-12#210)(2010-2#22)(2010-3#73)(2010-4#78)(2010-5#118)(2010-6#130)(2010-7#160)(2010-8#139)(2010-9#42)(2011-1#116)(2011-10#8)(2011-2#1281)(2011-3#89)(2011-4#5)(2011-7#16)(2011-8#2)(2011-9#1)(2012-12#169)(2012-2#568)(2012-3#511)(2012-4#2)(2012-5#5)(2012-6#2)(2012-7#6)(2012-9#4)(2013-1#893)(2013-3#1)(2013-7#45)(2013-8#418)
is/is not##6##2##(2011-2#6)
ischaemia after##2##2##(2008-10#1)(2008-7#1)
ischaemia and##5##2##(1991-2#1)(1992-5#1)(1996-2#1)(2008-7#1)(2011-2#1)
ischaemia by##2##2##(2008-7#1)(2011-2#1)
ischaemia in##5##2##(1990-9#1)(2008-7#2)(2009-11#1)(2011-2#1)
ischaemia##34##1##(1990-3#1)(1990-9#2)(1991-2#1)(1992-5#1)(1995-11#2)(1996-2#1)(1996-6#1)(2008-10#2)(2008-3#2)(2008-7#16)(2009-11#1)(2011-2#3)(2012-2#1)
ischaemia-reperfusion##3##1##(2008-7#3)
ischaemic cardiomyopathy##3##2##(2008-10#3)
ischaemic heart disease##6##3##(1990-6#1)(1995-12#2)(2008-5#1)(2009-10#1)(2012-2#1)
ischaemic stroke and##2##3##(2008-8#1)(2009-11#1)
ischaemic stroke##7##2##(2008-7#2)(2008-8#4)(2009-11#1)
ischaemic##31##1##(1990-6#1)(1991-11#1)(1995-12#2)(1996-8#1)(2008-10#7)(2008-5#1)(2008-7#6)(2008-8#7)(2009-10#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
ischemia (i##2##2##(1994-2#1)(1996-11#1)
ischemia and##4##2##(2008-10#1)(2009-5#1)(2010-1#1)(2012-3#1)
ischemia in the##2##3##(1996-12#1)(1997-2#1)
ischemia in##3##2##(1992-5#1)(1996-12#1)(1997-2#1)
ischemia is##3##2##(1996-12#1)(2008-11#1)(2011-2#1)
ischemia on##2##2##(1990-5#1)(2008-12#1)
ischemia##66##1##(1990-5#4)(1991-3#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-6#2)(1994-2#10)(1994-3#1)(1996-11#1)(1996-12#7)(1997-2#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-1#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
ischemia)##3##1##(1990-3#1)(1994-2#1)(1996-12#1)
ischemia-reperfusion##4##1##(1996-12#2)(1997-4#1)(2012-3#1)
ischemia/reperfusion injury in##4##3##(2008-7#1)(2010-12#3)
ischemia/reperfusion injury##6##2##(2008-7#1)(2010-1#1)(2010-12#3)(2010-5#1)
ischemia/reperfusion of##2##2##(2010-12#2)
ischemia/reperfusion##9##1##(2008-7#1)(2010-1#1)(2010-12#5)(2010-5#2)
ischemic attack##2##2##(1991-3#1)(2013-8#1)
ischemic brain##2##2##(1994-2#1)(2011-2#1)
ischemic cardiomyopathy##2##2##(2008-7#1)(2010-6#1)
ischemic cerebral##2##2##(1990-3#1)(1996-12#1)
ischemic colitis##5##2##(2013-1#5)
ischemic heart disease (IHD) have been studied##2##7##(2012-3#2)
ischemic heart disease (IHD)##3##4##(2008-3#1)(2012-3#2)
ischemic heart disease and##2##4##(1992-9#1)(2008-10#1)
ischemic heart disease##16##3##(1992-9#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-12#2)(2010-4#1)(2010-6#2)(2012-3#4)
ischemic heart##17##2##(1992-9#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-12#2)(2010-4#1)(2010-6#2)(2012-3#5)
ischemic injury##2##2##(1997-2#1)(2013-1#1)
ischemic insult##2##2##(1990-5#1)(1996-12#1)
ischemic insults##3##2##(2008-7#2)(2011-2#1)
ischemic myocardium##3##2##(2008-10#3)
ischemic preconditioning##2##2##(2008-10#1)(2010-12#1)
ischemic stress##2##2##(1996-12#1)(2008-10#1)
ischemic stroke and##2##3##(2008-10#1)(2009-11#1)
ischemic stroke secondary to##2##4##(2009-6#1)(2013-8#1)
ischemic stroke##24##2##(2008-10#1)(2008-8#1)(2008-9#4)(2009-11#5)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#7)(2012-3#1)(2013-1#1)(2013-8#1)
ischemic##104##1##(1990-3#2)(1990-5#1)(1991-3#3)(1992-5#1)(1992-9#2)(1993-6#3)(1994-2#1)(1995-5#1)(1996-12#5)(1997-2#4)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#5)(2009-6#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-6#4)(2011-2#7)(2011-3#1)(2012-12#7)(2012-3#7)(2013-1#8)(2013-8#4)
ischiorectal##2##1##(1997-8#1)(2012-3#1)
ischium##2##1##(2013-1#2)
ishikariensis##6##1##(2008-10#6)
island countries##3##2##(2008-1#3)
island films##2##2##(2008-10#2)
island of Rab##2##3##(2011-2#2)
island of##5##2##(1995-6#1)(2008-10#2)(2011-2#2)
island##30##1##(1991-6#4)(1992-1#1)(1994-11#1)(1995-6#1)(1996-6#2)(2008-1#4)(2008-10#8)(2008-11#1)(2008-8#3)(2011-1#1)(2011-2#2)(2013-8#2)
islands and##2##2##(1990-6#1)(2008-1#1)
islands in the##2##3##(1992-11#1)(2008-10#1)
islands in##3##2##(1992-11#1)(1996-6#1)(2008-10#1)
islands of##3##2##(1995-3#1)(2011-2#1)(2013-8#1)
islands were##3##2##(1996-6#1)(2008-10#2)
islands##36##1##(1990-5#2)(1990-6#1)(1992-11#1)(1993-5#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-6#2)(2008-1#3)(2008-10#6)(2008-8#7)(2008-9#6)(2011-2#1)(2013-8#1)
islet amyloid##3##2##(1992-6#2)(1993-8#1)
islet cell surface antibodies (ICSA)##2##5##(1994-12#2)
islet cell tumours##4##3##(2008-1#1)(2008-2#3)
islet cell##8##2##(1994-12#2)(1996-2#1)(2008-1#1)(2008-2#3)(2010-11#1)
islet cells##3##2##(2008-1#1)(2010-11#2)
islet dysfunction##2##2##(1991-7#2)
islet engraftment in##2##3##(2010-11#2)
islet isolation procedure is##2##4##(2008-11#2)
islet isolation##10##2##(2008-11#6)(2010-10#2)(2010-11#1)(2010-12#1)
islet survival and function##2##4##(2010-11#2)
islet transplantation##11##2##(2008-11#1)(2010-10#3)(2010-11#4)(2010-12#3)
islet yield##3##2##(2008-11#3)
islet##77##1##(1991-7#5)(1992-6#5)(1993-8#1)(1994-12#2)(1995-8#7)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#10)(2008-2#3)(2009-8#1)(2010-10#6)(2010-11#28)(2010-12#5)
islets and in##2##3##(1995-8#2)
islets and β-cells##2##3##(2010-11#2)
islets and##9##2##(1995-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#3)
islets in##2##2##(2008-10#1)(2008-5#1)
islets of Langerhans##6##3##(1994-8#1)(1995-8#2)(2009-8#1)(2010-11#1)(2010-12#1)
islets of the organ were##2##5##(2008-5#2)
islets of##8##2##(1994-8#1)(1995-8#2)(2008-5#2)(2009-8#1)(2010-11#1)(2010-12#1)
islets pretreated##2##2##(1995-8#2)
islets to##3##2##(1995-2#1)(2008-11#1)(2010-11#1)
islets was##2##2##(1995-8#1)(2008-5#1)
islets were##2##2##(1995-8#1)(2010-11#1)
islets with##2##2##(2008-10#1)(2010-11#1)
islets##61##1##(1994-8#2)(1995-2#1)(1995-8#22)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#8)(2009-8#2)(2010-10#1)(2010-11#13)(2010-12#3)
isn't##4##1##(1992-11#1)(1993-1#1)(1993-3#1)(1995-12#1)
iso-butylamine##3##1##(2008-10#3)
iso-chronous##2##1##(2008-5#2)
iso-osmotically##2##1##(1997-1#2)
isoamyl##2##1##(2008-10#1)(2008-7#1)
isobaric ropivacain##2##2##(2012-3#2)
isobaric##8##1##(2008-10#1)(2012-12#2)(2012-3#5)
isobutyl methyl ketone (IBMK)##6##4##(2008-10#6)
isobutyl methyl ketone##7##3##(2008-10#7)
isobutyl methyl##8##2##(2008-10#7)(2008-11#1)
isobutyl##17##1##(2008-10#16)(2008-11#1)
isocaine##3##1##(2008-10#3)
isocaloric##2##1##(2008-3#1)(2010-6#1)
isocenter position##3##2##(2009-2#3)
isocitrate dehydrogenase##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#2)(2013-1#1)
isocitrate##13##1##(2008-10#7)(2008-11#2)(2008-7#1)(2010-12#2)(2013-1#1)
isocortex##3##1##(1994-8#3)
isocoumarin derivatives##2##2##(2012-2#2)
isocoumarin##5##1##(1991-3#3)(2012-2#2)
isocratic HPLC##2##2##(2008-10#2)
isocratic elution with##4##3##(2008-10#4)
isocratic elution##7##2##(1997-2#1)(2008-10#5)(2009-8#1)
isocratic mode##4##2##(2008-10#3)(2010-11#1)
isocratic reversed-phase##2##2##(2008-10#2)
isocratic##29##1##(1997-2#1)(2008-10#25)(2008-5#1)(2009-8#1)(2010-11#1)
isocyanate##5##1##(2008-10#2)(2008-11#2)(2008-5#1)
isocyanuric##3##1##(2008-10#3)
isodose##2##1##(2008-11#1)(2009-11#1)
isoelectric focusing##9##2##(1992-3#1)(2008-10#2)(2008-11#3)(2008-4#2)(2010-7#1)
isoelectric point (pI)##2##3##(1995-12#1)(2008-4#1)
isoelectric point of the##2##4##(2008-11#1)(2008-8#1)
isoelectric point of##5##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
isoelectric point##12##2##(1993-3#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
isoelectric points##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2009-9#1)
isoelectric precipitation##2##2##(2008-7#2)
isoelectric##30##1##(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-4#3)(2008-7#3)(2008-8#1)(2009-9#1)(2010-7#1)
isoenzyme of##2##2##(1993-2#1)(2013-1#1)
isoenzyme##4##1##(1993-2#1)(1994-8#1)(2008-11#1)(2013-1#1)
isoenzymes##7##1##(1990-2#1)(1994-8#2)(2008-5#2)(2008-7#1)(2010-11#1)
isoeugenol##2##1##(2008-5#2)
isoflavone daidzein##2##2##(2008-10#2)
isoflavone glucoside##3##2##(2008-11#3)
isoflavone##8##1##(2008-10#2)(2008-11#5)(2012-2#1)
isoflavones##9##1##(2008-10#4)(2010-1#1)(2010-3#4)
isoflavonoids##2##1##(2011-1#2)
isoflurane##6##1##(1991-6#1)(2010-7#2)(2012-3#3)
isoform content##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
isoform is##2##2##(1995-2#1)(2008-10#1)
isoform of PKA##2##3##(1994-8#2)
isoform of protein##2##3##(1993-12#1)(1993-6#1)
isoform of the##2##3##(1995-11#1)(1996-12#1)
isoform of##11##2##(1992-12#1)(1993-12#1)(1993-6#1)(1994-8#2)(1995-11#2)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#1)
isoform patterns##2##2##(1992-3#1)(2008-10#1)
isoform usage##2##2##(2012-3#2)
isoform was##5##2##(1995-8#1)(2008-10#4)
isoform which##2##2##(1992-3#1)(1995-8#1)
isoform##56##1##(1992-12#1)(1992-3#5)(1993-12#1)(1993-6#1)(1994-8#3)(1995-11#3)(1995-2#1)(1995-8#3)(1996-12#2)(1996-2#2)(1996-6#1)(2008-10#12)(2008-11#6)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-9#1)(2010-7#3)(2011-2#2)(2012-3#2)(2013-8#1)
isoforms and##4##2##(1993-3#1)(2008-10#2)(2013-8#1)
isoforms are##2##2##(2009-10#1)(2013-7#1)
isoforms during##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
isoforms from##4##2##(1993-12#1)(2008-10#3)
isoforms have##3##2##(1990-12#1)(1995-2#1)(2008-10#1)
isoforms in rat##2##3##(1992-12#1)(2008-10#1)
isoforms in##6##2##(1992-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
isoforms of SNAP-25##2##3##(1995-2#2)
isoforms of mouse liver cytosol##2##5##(2008-10#2)
isoforms of porcine aromatase##2##4##(1995-8#2)
isoforms of the##3##3##(1994-8#1)(1996-12#1)(2010-7#1)
isoforms of##24##2##(1992-3#1)(1993-12#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-2#4)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-9#1)(2010-7#1)
isoforms were##3##2##(1995-8#1)(2008-10#2)
isoforms with##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
isoforms##85##1##(1990-12#1)(1992-12#1)(1992-3#4)(1993-12#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-6#4)(1994-8#1)(1995-2#7)(1995-6#1)(1995-8#5)(1996-12#2)(1996-2#1)(1997-1#2)(2008-10#23)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#4)(2009-9#3)(2010-12#1)(2010-7#2)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#3)
isofraxidin and##5##2##(2008-10#5)
isogenic##7##1##(1993-8#1)(1996-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-6#1)
isoindole##2##1##(2008-10#2)
isolable##2##1##(2008-10#1)(2010-5#1)
isolate (pathogenic on##8##3##(2008-10#8)
isolate 10343##3##2##(2008-5#3)
isolate 78-62##3##2##(2008-10#3)
isolate Bangalore##2##2##(2008-10#2)
isolate C##3##2##(2008-10#2)(2008-5#1)
isolate EN-4##3##2##(2008-10#3)
isolate ND90Pr##3##2##(2008-10#3)
isolate Sh12B of S##2##4##(2008-10#2)
isolate Sh12B of##3##3##(2008-10#3)
isolate ZJ1##2##2##(2008-9#2)
isolate a##3##2##(1991-5#1)(2008-10#1)(2008-11#1)
isolate after##2##2##(2008-10#2)
isolate and##13##2##(1990-2#1)(1993-8#1)(1997-2#1)(2008-10#8)(2008-5#1)(2011-2#1)
isolate as##3##2##(2008-10#2)(2009-6#1)
isolate collected from##3##3##(2008-10#2)(2008-12#1)
isolate each##2##2##(2008-10#2)
isolate from the##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
isolate from##23##2##(2008-10#17)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-2#1)
isolate gene##2##2##(1993-9#1)(1996-2#1)
isolate had a##3##3##(2008-10#3)
isolate had##4##2##(2008-10#4)
isolate in##8##2##(2008-10#8)
isolate induced##3##2##(2008-10#3)
isolate is##6##2##(2008-10#6)
isolate of F##3##3##(2008-10#3)
isolate of P##2##3##(2008-10#2)
isolate of R##2##3##(2008-10#2)
isolate of Rhizoctonia solani##3##4##(2008-10#3)
isolate of T##2##3##(2008-10#2)
isolate of each##2##3##(2008-10#2)
isolate of the fungus##2##4##(2008-10#2)
isolate of the##9##3##(2008-10#8)(2011-2#1)
isolate of##49##2##(2008-10#43)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#2)
isolate on##3##2##(2008-10#2)(2011-2#1)
isolate revealed##2##2##(2008-10#2)
isolate showed##2##2##(1997-8#1)(2011-2#1)
isolate tested##2##2##(2008-10#2)
isolate that##2##2##(2008-10#1)(2011-2#1)
isolate the##9##2##(1992-6#1)(1997-2#2)(2008-10#3)(2008-4#1)(2008-8#1)(2012-2#1)
isolate to##3##2##(2008-10#3)
isolate used##2##2##(2008-10#2)
isolate was composed##2##3##(2008-10#2)
isolate was identified##2##3##(2012-2#2)
isolate was##19##2##(2008-10#15)(2008-8#1)(2011-2#1)(2012-2#2)
isolate were determined##2##3##(2008-10#2)
isolate were inoculated on S##2##5##(2008-10#2)
isolate were inoculated##3##3##(2008-10#3)
isolate were##7##2##(2008-10#7)
isolate##393##1##(1990-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-2#4)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#306)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#7)(2009-10#1)(2009-12#1)(2009-6#2)(2010-6#1)(2011-2#13)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
isolate)##5##1##(2008-10#5)
isolate-plant##2##1##(2008-10#2)
isolate-specific##6##1##(2008-10#6)
isolated HS##2##2##(2008-10#2)
isolated a cDNA##2##3##(1993-12#1)(1995-12#1)
isolated a##16##2##(1991-2#1)(1993-12#2)(1993-2#1)(1993-6#2)(1995-12#1)(1995-2#1)(1995-6#2)(1997-4#1)(2008-10#1)(2008-11#3)(2008-5#1)
isolated after##6##2##(1990-2#1)(1993-12#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-5#1)
isolated an##2##2##(2008-11#2)
isolated and characterised##3##3##(1993-2#1)(2008-11#2)
isolated and characterized as##2##4##(1991-5#1)(2008-11#1)
isolated and characterized from##2##4##(2008-11#1)(2008-8#1)
isolated and characterized##14##3##(1991-2#1)(1991-5#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-5#1)(2013-8#1)
isolated and cultured in##2##4##(1995-8#1)(2008-4#1)
isolated and identified##2##3##(2008-10#1)(2008-11#1)
isolated and purified from##3##4##(2008-10#2)(2008-12#1)
isolated and purified##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
isolated and sequenced##9##3##(1991-5#1)(1991-6#2)(1992-4#1)(1993-2#1)(1993-3#1)(1995-11#1)(1997-1#1)(2008-10#1)
isolated and##50##2##(1990-8#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-4#1)(1992-6#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-4#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#2)(2013-8#1)
isolated as a##2##3##(1990-2#1)(2011-2#1)
isolated as##4##2##(1990-2#1)(1990-9#1)(2008-11#1)(2011-2#1)
isolated at a##2##3##(2008-10#1)(2008-5#1)
isolated at##8##2##(2008-10#5)(2008-12#1)(2008-5#1)(2009-3#1)
isolated atrial flutter##2##3##(2010-11#2)
isolated but##2##2##(2008-12#1)(2008-5#1)
isolated by density gradient centrifugation##2##5##(1994-8#1)(2008-9#1)
isolated by semi-preparative##2##3##(1990-8#1)(2008-10#1)
isolated by##31##2##(1990-8#1)(1993-3#1)(1993-8#1)(1994-8#2)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#9)(2008-11#4)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)
isolated cDNA clones##2##3##(1993-6#1)(1995-2#1)
isolated cells and##2##3##(1995-11#1)(2008-11#1)
isolated cells##6##2##(1995-11#2)(2008-11#3)(2008-8#1)
isolated chicken##2##2##(1990-2#1)(2008-12#1)
isolated compounds were##2##3##(2008-11#2)
isolated coronary##2##2##(1994-11#1)(2012-3#1)
isolated directly from##3##3##(2008-11#1)(2008-5#2)
isolated during the period##2##4##(2008-5#1)(2008-7#1)
isolated during the##4##3##(2008-10#1)(2008-5#2)(2008-7#1)
isolated during##5##2##(2008-10#2)(2008-5#2)(2008-7#1)
isolated elements##2##2##(2008-10#1)(2013-1#1)
isolated ferric low-spin siroheme-CN is##2##5##(1993-8#2)
isolated for the first time##2##5##(2008-5#1)(2013-1#1)
isolated for##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
isolated four##3##2##(1991-5#1)(1995-8#1)(1997-8#1)
isolated frequently##2##2##(2008-10#1)(2008-5#1)
isolated from 18##2##3##(2008-11#1)(2008-5#1)
isolated from 2##2##3##(1997-9#1)(2008-10#1)
isolated from EBs##2##3##(2008-11#2)
isolated from M##2##3##(2008-10#1)(2011-10#1)
isolated from Phyllomedusa##2##3##(1993-3#1)(1994-5#1)
isolated from a genomic library of##2##6##(1990-5#1)(2008-10#1)
isolated from a genomic library##3##5##(1990-5#1)(1993-6#1)(2008-10#1)
isolated from a human##6##4##(1993-8#1)(1994-11#2)(2008-11#1)(2008-8#1)(2008-9#1)
isolated from a lambda##2##4##(1993-2#1)(2008-11#1)
isolated from a rat##2##4##(1992-10#1)(1996-12#1)
isolated from a##44##3##(1990-5#1)(1992-10#1)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#10)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#2)(2010-6#1)(2011-2#3)(2012-2#2)
isolated from an##7##3##(1990-11#1)(1990-5#1)(1993-9#1)(1994-11#1)(1997-7#1)(2011-2#2)
isolated from blighted##2##3##(2008-10#2)
isolated from clinical specimens##2##4##(2008-12#1)(2008-7#1)
isolated from clinical##4##3##(2008-12#1)(2008-7#1)(2013-8#2)
isolated from different##4##3##(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
isolated from diseased##6##3##(2008-10#6)
isolated from each##2##3##(2008-10#1)(2008-9#1)
isolated from fasted animals##2##4##(1994-8#2)
isolated from fasted##3##3##(1994-8#2)(1995-6#1)
isolated from field##2##3##(2008-10#2)
isolated from healthy##4##3##(2008-10#2)(2008-12#2)
isolated from human feces##2##4##(2008-11#1)(2012-2#1)
isolated from human##14##3##(1991-5#2)(1992-3#1)(1992-6#1)(1996-12#1)(1997-1#1)(2008-11#3)(2008-8#2)(2011-2#2)(2012-2#1)
isolated from infected##4##3##(1991-3#1)(2008-10#3)
isolated from lettuce##2##3##(2008-10#2)
isolated from onion##3##3##(2008-10#3)
isolated from other##4##3##(2008-10#4)
isolated from patients##4##3##(1994-5#1)(2008-5#1)(2012-2#2)
isolated from plant##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
isolated from rainbow trout##2##4##(1994-5#1)(1997-9#1)
isolated from rat##3##3##(1992-6#1)(1995-11#1)(2008-11#1)
isolated from rats##2##3##(1997-1#1)(2008-11#1)
isolated from roots##2##3##(2008-10#2)
isolated from six##2##3##(1995-12#1)(2008-10#1)
isolated from soil##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
isolated from soybean##4##3##(2008-10#4)
isolated from strawberry##3##3##(2008-10#3)
isolated from sweet orange##2##4##(2008-10#2)
isolated from symptomatic##3##3##(2008-10#3)
isolated from symptomless##2##3##(2008-10#2)
isolated from systemically infected##2##4##(2008-10#2)
isolated from the cells##2##4##(1994-3#1)(2008-11#1)
isolated from the leaves of##2##5##(2010-2#1)(2011-3#1)
isolated from the reaction##2##4##(1996-5#1)(2008-8#1)
isolated from the roots##2##4##(2008-10#1)(2008-11#1)
isolated from the same orchard##2##5##(2008-10#2)
isolated from the same##3##4##(1991-9#1)(2008-10#2)
isolated from the skin of##2##5##(1994-11#1)(1994-5#1)
isolated from the soil##2##4##(2008-10#2)
isolated from the##75##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#3)(1992-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-5#1)(2008-10#20)(2008-11#8)(2008-12#1)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
isolated from these##6##3##(2008-10#4)(2008-2#1)(2008-9#1)
isolated from this##4##3##(1990-8#1)(1995-6#1)(2008-10#1)(2011-3#1)
isolated from tobacco##4##3##(2008-10#3)(2008-8#1)
isolated from tomato##2##3##(2008-10#2)
isolated from two##3##3##(1990-8#1)(2008-8#1)(2011-2#1)
isolated from various##2##3##(2008-9#1)(2009-6#1)
isolated from##442##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#3)(1990-6#1)(1990-8#4)(1991-12#3)(1991-3#1)(1991-5#3)(1991-6#2)(1991-9#5)(1992-10#1)(1992-3#1)(1992-6#4)(1992-7#1)(1993-12#5)(1993-2#3)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#3)(1994-11#9)(1994-12#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#2)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-12#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-6#1)(1997-7#4)(1997-8#4)(1997-9#2)(2008-10#171)(2008-11#22)(2008-12#9)(2008-2#1)(2008-5#18)(2008-6#2)(2008-7#3)(2008-8#18)(2008-9#15)(2009-5#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-10#1)(2011-2#27)(2011-3#4)(2012-2#16)(2012-3#2)(2013-1#3)(2013-8#6)
isolated genomic##2##2##(1991-7#1)(1993-6#1)
isolated hepatocytes##4##2##(1993-3#1)(1994-8#1)(1995-11#1)(1996-2#1)
isolated human##5##2##(1991-12#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
isolated hydronephrosis##3##2##(2008-10#3)
isolated in Guangzhou##2##3##(2013-8#2)
isolated in a##2##3##(2008-10#1)(2012-2#1)
isolated in peninsular Malaysia##2##4##(2008-12#2)
isolated in the##5##3##(1990-2#1)(1992-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
isolated in##30##2##(1990-2#1)(1991-11#1)(1992-6#1)(2008-10#11)(2008-12#4)(2008-5#5)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
isolated lymphocytes##2##2##(1990-12#1)(2008-11#1)
isolated membrane##2##2##(1993-8#1)(2008-11#1)
isolated mitochondria##4##2##(1991-3#2)(1995-11#1)(2008-5#1)
isolated more##2##2##(1997-3#1)(2008-10#1)
isolated natural product Amavadin##2##4##(2008-10#2)
isolated neonatal##2##2##(1992-3#1)(2008-10#1)
isolated nerve terminals##2##3##(1995-11#1)(1997-7#1)
isolated or##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
isolated organic matter was##2##4##(2008-10#2)
isolated over##2##2##(1996-12#1)(2008-10#1)
isolated pancreatic##3##2##(1994-11#1)(2010-1#1)(2013-1#1)
isolated patches##3##2##(2008-9#3)
isolated perfused rat liver##2##4##(1993-3#1)(2008-11#1)
isolated phylogenetic##2##2##(2011-2#2)
isolated pituitary##2##2##(2013-1#2)
isolated populations##7##2##(2008-11#1)(2008-8#2)(2008-9#4)
isolated power earthing during##2##4##(2012-3#2)
isolated previously##2##2##(1991-12#1)(2012-3#1)
isolated protoplasts##2##2##(1994-11#1)(1997-3#1)
isolated pulmonary##2##2##(2008-11#2)
isolated rat hepatocytes##5##3##(1992-3#2)(1993-3#1)(1996-2#2)
isolated rat liver##2##3##(1990-2#1)(1995-8#1)
isolated rat##17##2##(1990-2#1)(1991-2#2)(1992-3#3)(1993-3#1)(1993-6#1)(1994-3#1)(1995-8#2)(1996-2#3)(1997-1#2)(2010-12#1)
isolated retroperitoneal##2##2##(1994-6#2)
isolated right##2##2##(2008-10#1)(2011-2#1)
isolated rural##2##2##(1993-12#1)(1996-3#1)
isolated strain##5##2##(1994-12#1)(2008-10#2)(2011-2#2)
isolated strains##3##2##(1991-3#2)(2008-5#1)
isolated the##2##2##(1993-8#1)(2008-10#1)
isolated to##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
isolated under##2##2##(1994-5#1)(2008-10#1)
isolated using##6##2##(1991-6#1)(1993-8#1)(1995-12#2)(1997-7#1)(2008-8#1)
isolated were##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
isolated yields##3##2##(2008-12#1)(2010-7#2)
isolated zygotes##2##2##(2009-12#2)
isolated##1013##1##(1990-11#5)(1990-12#2)(1990-2#10)(1990-5#7)(1990-6#1)(1990-8#8)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#5)(1991-5#6)(1991-6#5)(1991-7#1)(1991-9#6)(1992-10#2)(1992-11#1)(1992-3#6)(1992-4#1)(1992-6#9)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#11)(1993-2#9)(1993-3#10)(1993-6#14)(1993-8#17)(1993-9#5)(1994-11#17)(1994-12#4)(1994-3#2)(1994-5#10)(1994-6#3)(1994-8#13)(1994-9#1)(1995-11#12)(1995-12#6)(1995-2#9)(1995-3#4)(1995-6#7)(1995-8#6)(1995-9#2)(1996-12#6)(1996-2#5)(1996-3#3)(1996-5#3)(1996-6#3)(1996-8#1)(1997-1#6)(1997-2#3)(1997-3#6)(1997-4#2)(1997-6#1)(1997-7#8)(1997-8#9)(1997-9#2)(2007-8#3)(2008-1#1)(2008-10#270)(2008-11#70)(2008-12#26)(2008-2#2)(2008-4#5)(2008-5#48)(2008-6#3)(2008-7#11)(2008-8#42)(2008-9#36)(2009-10#2)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#5)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#2)(2010-9#2)(2011-1#6)(2011-10#1)(2011-2#48)(2011-3#5)(2012-12#1)(2012-2#25)(2012-3#14)(2013-1#26)(2013-8#21)
isolates (besides##2##2##(2008-10#2)
isolates (n =##3##3##(2008-10#3)
isolates Pti2##2##2##(2008-10#2)
isolates after##2##2##(2008-10#2)
isolates all were##2##3##(2008-10#2)
isolates all##3##2##(2008-10#2)(2008-8#1)
isolates also were tested for##2##5##(2008-10#2)
isolates also were##6##3##(2008-10#6)
isolates also##9##2##(2008-10#9)
isolates among##2##2##(2008-10#2)
isolates analyzed##4##2##(2008-10#4)
isolates and also##2##3##(2008-10#1)(2008-7#1)
isolates and isolates from##2##4##(2008-10#2)
isolates and isolates##3##3##(2008-10#3)
isolates and the##6##3##(2008-10#6)
isolates and were not##2##4##(2008-10#2)
isolates and##51##2##(2008-10#47)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
isolates appeared##2##2##(2008-10#2)
isolates are##10##2##(2008-10#10)
isolates as C##4##3##(2008-10#4)
isolates as##13##2##(2008-10#12)(2008-11#1)
isolates associated with##2##3##(2008-10#2)
isolates at##2##2##(2008-10#2)
isolates averaged##2##2##(2008-10#2)
isolates based on##5##3##(2008-10#5)
isolates being##2##2##(2008-10#2)
isolates belonged to the same##2##5##(2008-10#1)(2008-12#1)
isolates belonged to##9##3##(2008-10#7)(2008-12#1)(2008-9#1)
isolates belonging to NA-VCG2 and NA-VCG5##2##6##(2008-10#2)
isolates belonging to race##2##4##(2008-10#2)
isolates belonging to the##5##4##(2008-10#4)(2010-6#1)
isolates belonging to##16##3##(1996-12#1)(2008-10#14)(2010-6#1)
isolates between##3##2##(2008-10#3)
isolates but also##2##3##(2008-10#2)
isolates but##4##2##(2008-10#4)
isolates by##3##2##(1995-12#1)(2008-10#2)
isolates came from##2##3##(2008-10#2)
isolates can be##2##3##(2008-10#2)
isolates can##3##2##(2008-10#2)(2011-2#1)
isolates capable of causing##2##4##(2008-10#2)
isolates caused##4##2##(2008-10#4)
isolates causing##3##2##(2008-10#3)
isolates classified##3##2##(2008-10#3)
isolates clustered into##2##3##(2008-10#2)
isolates clustered together##3##3##(2008-10#3)
isolates clustered##9##2##(2008-10#9)
isolates collected during##4##3##(2008-10#4)
isolates collected from durum wheat##2##5##(2008-10#2)
isolates collected from one##2##4##(2008-10#2)
isolates collected from potato##3##4##(2008-10#3)
isolates collected from the##2##4##(2008-10#2)
isolates collected from##28##3##(2008-10#28)
isolates collected in##9##3##(2008-10#9)
isolates collected##44##2##(2008-10#44)
isolates common to##2##3##(2008-10#2)
isolates compared##2##2##(2008-10#2)
isolates confirmed##2##2##(2008-10#2)
isolates contained##4##2##(2008-10#4)
isolates could be##8##3##(2008-10#7)(2008-5#1)
isolates could not be##2##4##(2008-10#2)
isolates could##10##2##(2008-10#9)(2008-5#1)
isolates demonstrated##2##2##(2008-10#2)
isolates derived from the same##2##5##(2008-10#2)
isolates derived from the##3##4##(2008-10#3)
isolates derived from##7##3##(2008-10#7)
isolates did not produce##2##4##(2008-10#2)
isolates did not##8##3##(2008-10#8)
isolates differed##3##2##(2008-10#3)
isolates displayed##2##2##(2008-10#2)
isolates do not##2##3##(2008-10#2)
isolates each##2##2##(2008-10#2)
isolates evaluated##2##2##(2008-10#2)
isolates examined##4##2##(2008-10#3)(2008-5#1)
isolates exhibited##2##2##(2008-10#2)
isolates for##10##2##(2008-10#9)(2008-7#1)
isolates formed a##2##3##(2008-10#2)
isolates formed##6##2##(2008-10#6)
isolates from 15##2##3##(2008-10#2)
isolates from 2003##2##3##(2008-10#2)
isolates from Africa and##2##4##(2008-10#2)
isolates from Africa##5##3##(2008-10#5)
isolates from California were##2##4##(2008-10#2)
isolates from California##4##3##(2008-10#4)
isolates from Dermacentor marginatus##2##4##(1995-12#2)
isolates from Ethiopia##3##3##(2008-10#3)
isolates from Europe##3##3##(2008-10#3)
isolates from Israel##4##3##(2008-10#4)
isolates from Japan belonged to lineage##2##6##(2008-10#2)
isolates from MIN##2##3##(2008-10#2)
isolates from Malus##2##3##(2008-10#2)
isolates from North America##2##4##(2008-10#2)
isolates from North##3##3##(2008-10#3)
isolates from Ontario##2##3##(2008-10#2)
isolates from South America and##2##5##(2008-10#2)
isolates from Spain##2##3##(2008-10#2)
isolates from a##8##3##(2008-10#7)(2011-2#1)
isolates from almond##4##3##(2008-10#4)
isolates from artichoke##4##3##(2008-10#4)
isolates from bell pepper##2##4##(2008-10#2)
isolates from cacao##2##3##(2008-10#2)
isolates from coffee##3##3##(2008-10#3)
isolates from common wheat##2##4##(2008-10#2)
isolates from cotton##2##3##(2008-10#2)
isolates from cruciferous##2##3##(2008-10#2)
isolates from different geographical##2##4##(2008-10#1)(2011-2#1)
isolates from different##10##3##(2008-10#9)(2011-2#1)
isolates from durum wheat##4##4##(2008-10#4)
isolates from each host##2##4##(2008-10#2)
isolates from each##7##3##(2008-10#7)
isolates from forage legumes##2##4##(2008-10#2)
isolates from four different##2##4##(2008-10#2)
isolates from grass pea##2##4##(2011-2#2)
isolates from native##2##3##(2008-10#2)
isolates from ornamental asparagus##2##4##(2008-10#2)
isolates from other hosts##3##4##(2008-10#3)
isolates from other##6##3##(2008-10#6)
isolates from prg##2##3##(2008-10#2)
isolates from rice and##2##4##(2008-10#2)
isolates from seven field populations##2##5##(2008-10#2)
isolates from soybean##2##3##(2008-10#2)
isolates from strawberry##2##3##(2008-10#2)
isolates from the United States and##2##6##(2008-10#2)
isolates from the United States were##2##6##(2008-10#2)
isolates from the United States##10##5##(2008-10#10)
isolates from the wild##2##4##(2008-10#2)
isolates from the##29##3##(1992-5#1)(2008-10#26)(2008-5#2)
isolates from three##2##3##(2008-10#2)
isolates from tomato##3##3##(2008-10#3)
isolates from various hosts and##2##5##(2008-10#2)
isolates from various##3##3##(2008-10#3)
isolates from wheat##3##3##(2008-10#3)
isolates from wild##2##3##(2008-10#2)
isolates from##248##2##(1992-5#1)(1995-12#2)(1996-8#1)(2008-10#229)(2008-5#5)(2008-9#1)(2011-2#7)(2013-1#1)(2013-8#1)
isolates grouped##4##2##(2008-10#4)
isolates had a##2##3##(1997-8#1)(2008-10#1)
isolates had the##2##3##(2008-10#2)
isolates had##13##2##(1997-8#1)(2008-10#11)(2008-5#1)
isolates harboured##2##2##(2011-2#2)
isolates has been##2##3##(2008-10#2)
isolates has##3##2##(1996-12#1)(2008-10#2)
isolates have a##2##3##(2008-10#2)
isolates have also been##2##4##(1995-5#1)(2008-10#1)
isolates have##6##2##(1995-5#1)(2008-10#4)(2008-12#1)
isolates having##2##2##(2008-10#2)
isolates identical##3##2##(2008-10#3)
isolates identified as##3##3##(2008-10#3)
isolates identified##4##2##(2008-10#4)
isolates in RG##2##3##(2008-10#2)
isolates in VCG##6##3##(2008-10#6)
isolates in each##2##3##(2008-10#2)
isolates in lineages##3##3##(2008-10#3)
isolates in the collection##2##4##(2008-10#1)(2008-5#1)
isolates in the inoculated plots##2##5##(2008-10#2)
isolates in the same AG##2##5##(2008-10#2)
isolates in the##13##3##(2008-10#12)(2008-5#1)
isolates in these##2##3##(2008-10#2)
isolates in##43##2##(2008-10#41)(2008-5#1)(2012-3#1)
isolates included##3##2##(2008-10#3)
isolates increased##2##2##(2008-10#2)
isolates induced##2##2##(2008-10#2)
isolates infected##2##2##(2008-10#2)
isolates into four##2##3##(2008-10#2)
isolates into three##2##3##(2008-10#2)
isolates into##13##2##(2008-10#12)(2008-5#1)
isolates is##2##2##(2008-10#2)
isolates may be##4##3##(2008-10#3)(2008-5#1)
isolates may##7##2##(2008-10#6)(2008-5#1)
isolates obtained from the##2##4##(2008-10#1)(2011-2#1)
isolates obtained from##10##3##(2008-10#8)(2011-2#2)
isolates obtained in##2##3##(2008-10#2)
isolates obtained##14##2##(2008-10#11)(2008-5#1)(2011-2#2)
isolates of A##10##3##(1996-12#1)(2008-10#8)(2013-1#1)
isolates of AG-12##3##3##(2008-10#3)
isolates of AG-13 were##2##4##(2008-10#2)
isolates of AG-13##4##3##(2008-10#4)
isolates of ARF18##3##3##(2008-10#3)
isolates of Alternaria alternata##2##4##(2008-10#2)
isolates of Aphanomyces euteiches##2##4##(2008-10#2)
isolates of B##5##3##(2008-10#5)
isolates of Bipolaris##2##3##(2008-10#2)
isolates of C##27##3##(2008-10#24)(2008-5#2)(2013-1#1)
isolates of Cercospora kikuchii##2##4##(2008-10#2)
isolates of Colletotrichum##2##3##(2008-10#2)
isolates of D##2##3##(2008-10#2)
isolates of Escherichia coli##2##4##(1996-12#1)(2012-3#1)
isolates of F##24##3##(2008-10#24)
isolates of Fusarium oxysporum f##3##5##(2008-10#3)
isolates of Fusarium oxysporum##5##4##(2008-10#5)
isolates of Fusarium spp##2##4##(2008-10#2)
isolates of Fusarium##10##3##(2008-10#10)
isolates of G##10##3##(2008-10#10)
isolates of L##4##3##(2008-10#3)(2008-5#1)
isolates of M##8##3##(2008-10#8)
isolates of Mycosphaerella graminicola##3##4##(2008-10#3)
isolates of P##25##3##(2008-10#25)
isolates of Phytophthora infestans collected from##2##6##(2008-10#2)
isolates of Phytophthora infestans##6##4##(2008-10#6)
isolates of Phytophthora##9##3##(2008-10#9)
isolates of Puccinia triticina##2##4##(2008-10#2)
isolates of Puccinia##4##3##(2008-10#4)
isolates of Pyricularia##2##3##(2008-10#2)
isolates of Pythium##2##3##(2008-10#2)
isolates of R##8##3##(2008-10#8)
isolates of S##5##3##(2008-10#3)(2011-2#1)(2012-3#1)
isolates of SYSV##2##3##(2008-10#2)
isolates of Sclerotinia##2##3##(2008-10#2)
isolates of T##7##3##(2008-10#7)
isolates of US-8##2##3##(2008-10#2)
isolates of Ustilago##2##3##(2008-10#2)
isolates of V##12##3##(2008-10#12)
isolates of Verticillium spp##2##4##(2008-10#2)
isolates of Verticillium##5##3##(2008-10#5)
isolates of Xanthomonas##2##3##(2008-10#1)(2008-9#1)
isolates of a##5##3##(2008-10#4)(2008-9#1)
isolates of all##2##3##(2008-10#2)
isolates of both##4##3##(2008-10#3)(2012-2#1)
isolates of different##3##3##(2008-10#2)(2008-5#1)
isolates of each of##2##4##(2008-10#2)
isolates of each##4##3##(2008-10#4)
isolates of either##3##3##(2008-10#3)
isolates of group##2##3##(2008-10#2)
isolates of morphotype A##5##4##(2008-10#5)
isolates of nonpathogenic Fusarium##2##4##(2008-10#2)
isolates of nonpathogenic##4##3##(2008-10#4)
isolates of other##3##3##(2008-10#3)
isolates of potato##2##3##(2008-10#2)
isolates of race 1##2##4##(2008-10#2)
isolates of race##3##3##(2008-10#3)
isolates of races##3##3##(2008-10#3)
isolates of the A##2##4##(2008-10#2)
isolates of the most##2##4##(2008-10#2)
isolates of the other##2##4##(2008-10#2)
isolates of the pathogen##3##4##(2008-10#3)
isolates of the same##4##4##(2008-10#4)
isolates of the##34##3##(1995-12#1)(2008-10#32)(2013-8#1)
isolates of this##2##3##(2008-10#1)(2008-5#1)
isolates of three##2##3##(2008-10#2)
isolates of##384##2##(1995-12#1)(1995-2#1)(1996-12#4)(1997-8#1)(2008-10#343)(2008-12#3)(2008-5#11)(2008-7#2)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#2)
isolates on the##2##3##(2008-10#2)
isolates on##10##2##(2008-10#9)(2008-5#1)
isolates or##5##2##(2008-10#5)
isolates originated from##4##3##(2008-10#4)
isolates originating from##5##3##(2008-10#5)
isolates parasitized##3##2##(2008-10#3)
isolates pathogenic to##3##3##(2008-10#3)
isolates possessing##2##2##(2008-10#2)
isolates produced a##2##3##(2008-10#2)
isolates produced##15##2##(2008-10#15)
isolates proved##2##2##(2008-5#1)(2008-7#1)
isolates reacting##2##2##(2008-10#2)
isolates recovered from the##2##4##(2008-10#2)
isolates recovered from##9##3##(2008-10#9)
isolates recovered##12##2##(2008-10#12)
isolates recovered)##3##2##(2008-10#3)
isolates referred to##2##3##(2008-10#2)
isolates represent##3##2##(2008-10#3)
isolates representative of##2##3##(2008-10#2)
isolates representing the##2##3##(2008-10#2)
isolates representing##10##2##(2008-10#10)
isolates resistant to##3##3##(2008-10#3)
isolates revealed a##2##3##(2008-10#2)
isolates revealed that the##3##4##(2008-10#2)(2011-2#1)
isolates revealed that##5##3##(2008-10#4)(2011-2#1)
isolates revealed##10##2##(2008-10#9)(2011-2#1)
isolates sampled from different##3##4##(2008-10#3)
isolates sampled from##9##3##(2008-10#9)
isolates sampled##13##2##(2008-10#13)
isolates showed a##4##3##(2008-10#3)(2010-4#1)
isolates showed greater##2##3##(2008-10#2)
isolates showed##12##2##(2008-10#8)(2008-5#2)(2010-4#1)(2012-3#1)
isolates showing##3##2##(2008-10#3)
isolates studied##5##2##(2008-10#5)
isolates tested in this study##2##5##(2008-10#1)(2008-12#1)
isolates tested in##5##3##(2008-10#4)(2008-12#1)
isolates tested were##4##3##(1992-6#1)(2008-10#3)
isolates tested##24##2##(1992-6#1)(2008-10#22)(2008-12#1)
isolates than##5##2##(2008-10#5)
isolates that can##2##3##(2008-10#2)
isolates that did not belong to any of the##2##9##(2008-10#2)
isolates that express the##2##4##(2008-10#2)
isolates that had##2##3##(2008-10#2)
isolates that were identified as##2##5##(2008-10#1)(2013-8#1)
isolates that were##8##3##(2008-10#7)(2013-8#1)
isolates that##32##2##(2008-10#30)(2011-1#1)(2013-8#1)
isolates to their##2##3##(2008-10#2)
isolates to##13##2##(2008-10#13)
isolates used in this study##2##5##(1997-8#1)(2008-12#1)
isolates used##3##2##(1997-8#1)(2008-10#1)(2008-12#1)
isolates using##5##2##(1995-12#1)(2008-10#3)(2008-12#1)
isolates was assessed##2##3##(2008-10#2)
isolates was confirmed by##2##4##(2008-10#2)
isolates was determined by##2##4##(2008-10#1)(2012-3#1)
isolates was determined##4##3##(2008-10#3)(2012-3#1)
isolates was examined##2##3##(2008-10#1)(2008-5#1)
isolates was studied##2##3##(2008-10#2)
isolates was tested##2##3##(2008-10#2)
isolates was##36##2##(2008-10#33)(2008-5#2)(2012-3#1)
isolates were able to##6##4##(2008-10#4)(2011-2#2)
isolates were also##3##3##(2008-10#2)(2008-5#1)
isolates were amplified##2##3##(2008-10#1)(2013-8#1)
isolates were analyzed for##2##4##(2008-10#2)
isolates were analyzed##3##3##(2008-10#3)
isolates were characterized by##5##4##(2008-10#5)
isolates were characterized##7##3##(2008-10#7)
isolates were classified into##2##4##(2008-10#2)
isolates were collected from##2##4##(2008-10#2)
isolates were collected##4##3##(2008-10#4)
isolates were determined##7##3##(2008-10#6)(2008-9#1)
isolates were distinct##2##3##(2008-10#2)
isolates were distinguished##2##3##(2008-10#2)
isolates were divided into two groups##2##6##(2008-10#2)
isolates were divided into two##3##5##(2008-10#3)
isolates were divided into##4##4##(2008-10#4)
isolates were evaluated on##2##4##(2008-10#2)
isolates were evaluated##4##3##(2008-10#4)
isolates were examined##4##3##(2008-10#3)(2012-2#1)
isolates were found in##2##4##(2008-10#2)
isolates were found##5##3##(2008-10#4)(2008-5#1)
isolates were from##2##3##(2008-10#2)
isolates were grouped##2##3##(2008-10#2)
isolates were identified as T##2##5##(2008-10#2)
isolates were identified as##8##4##(2008-10#7)(2008-5#1)
isolates were identified by##2##4##(2008-10#1)(2013-8#1)
isolates were identified##12##3##(2008-10#10)(2008-5#1)(2013-8#1)
isolates were inoculated##4##3##(2008-10#4)
isolates were more closely related to##2##6##(2008-10#2)
isolates were more##4##3##(2008-10#4)
isolates were nonpathogenic on##2##4##(2008-10#2)
isolates were nonpathogenic##5##3##(2008-10#5)
isolates were not significantly more pathogenic on##2##7##(2008-10#2)
isolates were not##4##3##(2008-10#4)
isolates were obtained##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
isolates were pathogenic on##5##4##(2008-10#5)
isolates were pathogenic to##2##4##(2008-10#2)
isolates were pathogenic##7##3##(2008-10#7)
isolates were recovered from##4##4##(2008-10#4)
isolates were recovered##7##3##(2008-10#6)(2012-2#1)
isolates were represented by##2##4##(2008-10#2)
isolates were resistant to both##2##5##(2008-10#2)
isolates were resistant to##8##4##(2008-10#2)(2008-5#2)(2011-2#1)(2012-3#1)(2013-8#2)
isolates were resistant##10##3##(2008-10#3)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
isolates were sampled from##2##4##(2008-10#2)
isolates were sampled##3##3##(2008-10#3)
isolates were screened for##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
isolates were screened##4##3##(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)
isolates were selected from##2##4##(2008-10#1)(2013-8#1)
isolates were selected##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
isolates were similar##2##3##(1997-8#1)(2011-2#1)
isolates were subjected to##3##4##(2008-10#2)(2008-12#1)
isolates were tested for pathogenicity on##2##6##(2008-10#2)
isolates were tested##5##3##(2008-10#5)
isolates were the##4##3##(2008-10#4)
isolates were used##2##3##(2008-10#2)
isolates were vegetatively self-incompatible##2##4##(2008-10#2)
isolates were vegetatively##3##3##(2008-10#3)
isolates were very##2##3##(2008-10#2)
isolates were##208##2##(1996-12#1)(1997-8#1)(2008-10#168)(2008-12#2)(2008-5#13)(2008-7#3)(2008-9#2)(2009-6#1)(2011-2#8)(2012-2#3)(2012-3#1)(2013-8#5)
isolates with##15##2##(2008-10#15)
isolates within a##5##3##(2008-10#5)
isolates within each##2##3##(2008-10#2)
isolates within the species C##2##5##(2008-10#2)
isolates within the##4##3##(2008-10#4)
isolates within##18##2##(2008-10#18)
isolates would##2##2##(2008-10#1)(2008-5#1)
isolates##2060##1##(1991-3#3)(1992-5#1)(1992-6#1)(1993-12#1)(1995-12#5)(1995-2#1)(1995-5#1)(1996-12#8)(1996-8#1)(1997-3#1)(1997-8#7)(2008-1#1)(2008-10#1844)(2008-11#1)(2008-12#13)(2008-4#1)(2008-5#65)(2008-7#9)(2008-8#2)(2008-9#8)(2009-6#3)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#38)(2012-2#13)(2012-3#9)(2013-1#5)(2013-8#11)
isolates) and##3##2##(2008-10#3)
isolates) showed##2##2##(2008-10#2)
isolates) were##2##2##(2008-10#2)
isolates)##28##1##(2008-10#27)(2008-5#1)
isolating and##2##2##(2008-10#1)(2008-4#1)
isolating barriers##2##2##(2008-10#1)(2012-3#1)
isolating the##5##2##(1996-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
isolating##30##1##(1993-8#1)(1994-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-4#4)(2008-5#1)(2008-9#4)(2011-2#1)(2012-3#2)
isolation and a##2##3##(2008-10#1)(2011-2#1)
isolation and characterization##2##3##(1993-12#1)(2008-11#1)
isolation and identification of##2##4##(2008-11#1)(2012-2#1)
isolation and preconcentration of##2##4##(2008-10#2)
isolation and purification of##3##4##(2008-10#2)(2008-11#1)
isolation and purification##7##3##(2008-10#5)(2008-11#1)(2011-3#1)
isolation and##44##2##(1990-5#1)(1991-6#1)(1993-12#2)(1994-11#1)(1994-12#1)(1996-2#1)(1997-7#1)(2008-10#17)(2008-11#6)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#2)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#1)
isolation between populations##2##3##(2008-10#1)(2008-9#1)
isolation between species##2##3##(2008-8#1)(2008-9#1)
isolation between the##2##3##(2008-8#1)(2008-9#1)
isolation between##7##2##(2008-10#1)(2008-8#2)(2008-9#3)(2012-3#1)
isolation but##2##2##(2009-5#1)(2011-2#1)
isolation by distance (IBD)##2##4##(2008-9#1)(2013-1#1)
isolation by distance##6##3##(2008-10#1)(2008-9#2)(2012-3#1)(2013-1#2)
isolation by##7##2##(2008-10#1)(2008-11#1)(2008-9#2)(2012-3#1)(2013-1#2)
isolation calling response##2##3##(2008-4#2)
isolation for##2##2##(2008-10#2)
isolation from interfering##2##3##(2008-3#2)
isolation from##11##2##(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-9#1)(2012-2#1)
isolation in##5##2##(1991-2#1)(1993-5#1)(2008-10#1)(2008-8#1)(2011-2#1)
isolation is##6##2##(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)
isolation may##2##2##(2008-10#1)(2008-12#1)
isolation methods##3##2##(2008-10#2)(2010-10#1)
isolation of Cryptococcus neoformans##2##4##(2008-5#2)
isolation of Helicobacter pylori##2##4##(2008-12#2)
isolation of P##3##3##(2008-10#3)
isolation of a##10##3##(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-6#2)(2008-11#2)(2008-8#1)
isolation of highly##2##3##(2008-10#2)
isolation of human##2##3##(2008-9#2)
isolation of influenza##2##3##(1994-9#1)(2008-9#1)
isolation of other##2##3##(2008-11#1)(2008-8#1)
isolation of proteins##2##3##(1990-5#1)(2008-9#1)
isolation of the analyte##2##4##(2008-10#1)(2009-8#1)
isolation of the compounds##2##4##(2008-10#1)(2008-12#1)
isolation of the##13##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-8#1)(2011-2#1)
isolation of these##2##3##(2008-11#1)(2008-4#1)
isolation of this##2##3##(1991-2#1)(2008-5#1)
isolation of two##2##3##(2008-10#1)(2008-4#1)
isolation of##108##2##(1990-3#1)(1990-5#1)(1991-2#1)(1992-3#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#3)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#26)(2008-11#13)(2008-12#8)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#6)(2008-8#3)(2008-9#9)(2009-12#2)(2009-8#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-8#1)
isolation on##3##2##(2008-11#1)(2008-8#2)
isolation or##4##2##(1994-6#1)(2010-5#1)(2011-2#2)
isolation procedure is##3##3##(1994-5#1)(2008-11#2)
isolation procedure##4##2##(1994-5#1)(2008-11#3)
isolation procedures##2##2##(2008-11#1)(2008-9#1)
isolation rate of Campylobacter##2##4##(2008-10#2)
isolation rate of##3##3##(2008-10#2)(2008-12#1)
isolation rate##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
isolation to##2##2##(2008-7#1)(2008-9#1)
isolation was performed##2##3##(2008-11#1)(2013-8#1)
isolation was##4##2##(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
isolation##305##1##(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#2)(1991-6#1)(1992-3#1)(1993-12#2)(1993-5#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#73)(2008-11#47)(2008-12#12)(2008-2#4)(2008-3#7)(2008-4#15)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#21)(2008-9#29)(2009-10#1)(2009-12#4)(2009-5#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#12)(2011-3#1)(2011-7#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#4)
isolations and##2##2##(2008-10#1)(2012-2#1)
isolations of##2##2##(2008-10#1)(2009-12#1)
isolations##8##1##(1992-6#1)(2008-10#5)(2009-12#1)(2012-2#1)
isolator##6##1##(2008-3#4)(2012-2#2)
isolegs##3##1##(2008-8#3)
isoleucine##12##1##(1990-12#1)(1993-12#1)(1994-3#1)(2008-10#7)(2008-11#1)(2010-6#1)
isolines of##2##2##(2008-10#2)
isolines##8##1##(2008-10#8)
isomenthone##2##1##(2008-10#2)
isomer of##3##2##(1993-1#1)(2008-10#1)(2008-9#1)
isomer##16##1##(1991-5#4)(1993-1#1)(1993-6#1)(1994-5#1)(1996-5#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)
isomerase activity##2##2##(1990-9#1)(1993-6#1)
isomerase and##6##2##(2008-10#5)(2010-10#1)
isomerase gene##2##2##(1997-8#1)(2012-3#1)
isomerase##24##1##(1990-9#1)(1993-6#6)(1995-3#1)(1997-6#2)(1997-8#1)(2008-10#8)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
isomeric end-labeled -SH deoxyoligonucleotides on##2##5##(2008-10#2)
isomeric ethyl##2##2##(2008-10#2)
isomeric glycosylfructoses##2##2##(1992-12#2)
isomeric##18##1##(1992-12#3)(1994-5#2)(1996-5#3)(2008-10#10)
isomerisation effects on##2##3##(2008-10#2)
isomerization##4##1##(1991-5#1)(1991-9#1)(2008-10#1)(2009-9#1)
isomerized to##2##2##(1995-6#1)(2011-1#1)
isomers and##3##2##(1993-6#1)(1995-6#1)(2008-8#1)
isomers by high-performance##2##3##(2008-10#2)
isomers by##5##2##(1991-5#1)(2008-10#4)
isomers in##2##2##(2008-10#1)(2008-9#1)
isomers of the##2##3##(1992-9#1)(2008-10#1)
isomers of##10##2##(1990-9#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-6#1)(2008-10#5)
isomers on##2##2##(2008-10#2)
isomers##36##1##(1990-11#1)(1990-9#2)(1991-5#4)(1992-9#2)(1993-6#2)(1994-5#1)(1994-6#1)(1995-6#2)(2008-10#17)(2008-8#1)(2008-9#2)(2011-10#1)
isometric shoulder flexion with##2##4##(2010-9#2)
isometric shoulder flexion##4##3##(2010-9#4)
isometric##19##1##(1994-3#1)(2008-10#5)(2008-12#1)(2008-8#1)(2010-7#1)(2010-9#4)(2012-2#1)(2013-1#3)(2013-8#2)
isometrically##3##1##(2007-12#1)(2008-8#1)(2011-2#1)
isomorphy was##2##2##(2008-8#2)
isomorphy##9##1##(2008-8#9)
isoniazid (INH)##2##2##(2008-1#1)(2008-10#1)
isoniazid and iproniazid phosphate##2##4##(2008-11#2)
isoniazid and##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
isoniazid in pharmaceutical preparations##2##4##(2008-10#2)
isoniazid in##3##2##(2008-10#3)
isoniazid##24##1##(2008-1#1)(2008-10#19)(2008-11#3)(2011-2#1)
isoniazide##2##1##(1990-6#1)(2008-10#1)
isooctane##2##1##(2008-10#2)
isopenicillin N##5##2##(2011-1#5)
isopentenyl##2##1##(2008-8#1)(2010-10#1)
isopeptidase activity##2##2##(1994-11#2)
isoprenaline and forskolin##2##3##(1997-2#2)
isoprenaline and##3##2##(1997-2#2)(2008-10#1)
isoprenaline##5##1##(1997-2#4)(2008-10#1)
isoprenoid metabolism##2##2##(1990-12#2)
isoprenoid##5##1##(1990-12#3)(2008-10#1)(2008-5#1)
isopropanol was##2##2##(2008-11#1)(2008-5#1)
isopropanol##16##1##(1991-5#6)(1997-8#1)(2008-10#5)(2008-11#2)(2008-5#2)
isopropyl alcohol##2##2##(2008-10#2)
isopropyl##6##1##(1991-12#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
isoproterenol##9##1##(1990-3#1)(2008-10#4)(2008-11#1)(2010-8#1)(2011-2#2)
isoproterenol-stimulated##2##1##(1994-8#2)
isoproturon and diuron##2##3##(2008-10#2)
isoproturon and##4##2##(2008-10#4)
isoproturon##6##1##(2008-10#6)
isoquinoline alkaloid##2##2##(2008-11#2)
isoquinoline##4##1##(1996-2#1)(2008-11#3)
isosbestic##3##1##(2008-10#3)
isosporosis##5##1##(1996-12#5)
isosteric heat of##2##3##(2010-4#2)
isosteric heat##3##2##(2010-4#3)
isosteric##4##1##(2010-4#4)
isosurface##2##1##(2008-6#2)
isosurfaces##2##1##(2008-6#2)
isotachophoresis (cITP)##2##2##(2008-10#2)
isotachophoresis##11##1##(2008-10#11)
isotherm approach##4##2##(2008-10#4)
isotherm behaviour##2##2##(2008-10#2)
isotherm model##2##2##(2008-10#2)
isotherm of##2##2##(1994-5#1)(2008-10#1)
isotherm##24##1##(1991-3#1)(1994-5#1)(1997-2#1)(2008-10#21)
isothermal adsorption behaviour##2##3##(1997-2#2)
isothermal adsorption##3##2##(1997-2#3)
isothermal amplification (LAMP)##2##3##(2009-6#2)
isothermal amplification reactions##2##3##(1997-6#2)
isothermal amplification##4##2##(1997-6#2)(2009-6#2)
isothermal titration calorimetry##2##3##(1994-5#1)(1997-2#1)
isothermal##19##1##(1994-5#1)(1997-2#6)(1997-6#2)(2008-10#4)(2008-2#1)(2008-3#1)(2009-6#2)(2009-7#1)(2011-2#1)
isotherms and##4##2##(2008-10#2)(2009-11#1)(2010-4#1)
isotherms are##2##2##(2008-10#2)
isotherms of##5##2##(1993-8#1)(1994-5#1)(2008-10#2)(2010-4#1)
isotherms show##2##2##(1994-5#2)
isotherms were##2##2##(2008-10#2)
isotherms##31##1##(1990-8#1)(1993-8#1)(1994-5#4)(2008-10#19)(2009-11#1)(2010-4#4)(2011-2#1)
isothiocyanate (FITC)##2##2##(2008-10#2)
isothiocyanate and##3##2##(2008-10#3)
isothiocyanate##18##1##(1990-12#1)(2008-10#14)(2008-4#2)(2008-5#1)
isothiocyanates against##2##2##(2008-10#2)
isothiocyanates##4##1##(2008-10#4)
isotonic##9##1##(1994-8#1)(1995-3#1)(2008-10#5)(2008-12#1)(2013-7#1)
isotope analysis of##2##3##(2008-10#1)(2012-9#1)
isotope analysis##3##2##(2008-10#2)(2012-9#1)
isotope dilution (ID)##2##3##(2008-10#2)
isotope dilution mass spectrometry (IDMS)##2##5##(2008-10#2)
isotope dilution method##4##3##(2008-10#4)
isotope dilution##20##2##(1990-11#1)(1991-5#1)(2008-10#18)
isotope effect on##2##3##(1991-3#1)(1993-8#1)
isotope effect##8##2##(1991-3#2)(1993-8#3)(1995-6#1)(1996-5#1)(2009-6#1)
isotope effects were##2##3##(1991-9#1)(2008-10#1)
isotope effects##4##2##(1991-9#2)(1995-6#1)(2008-10#1)
isotope exchange##3##2##(1991-9#2)(1995-6#1)
isotope in the##2##3##(1992-12#1)(2008-10#1)
isotope injection##2##2##(1994-5#2)
isotope pair##2##2##(2008-10#2)
isotope ratio analysis##2##3##(2008-10#2)
isotope ratio##10##2##(2008-10#10)
isotope ratios in##3##3##(2008-10#3)
isotope ratios##9##2##(2008-10#9)
isotope selection effects##2##3##(1991-3#2)
isotope tracers##2##2##(1993-8#1)(2008-6#1)
isotope##87##1##(1990-11#1)(1990-5#1)(1991-3#4)(1991-5#1)(1991-9#4)(1992-12#2)(1993-8#4)(1994-2#1)(1994-5#2)(1995-6#3)(1996-5#1)(2008-10#52)(2008-3#2)(2008-4#1)(2008-6#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-9#1)
isotope-dilution##3##1##(2008-10#3)
isotopes in##4##2##(2008-10#4)
isotopes were##3##2##(2008-10#3)
isotopes##16##1##(2008-10#12)(2010-6#1)(2010-8#3)
isotopic abundance##2##2##(1990-12#1)(2011-2#1)
isotopic analysis##5##2##(2008-10#5)
isotopic composition of##2##3##(2008-10#2)
isotopic composition##3##2##(2008-10#3)
isotopic dilution##2##2##(2008-10#2)
isotopic reference materials##2##3##(2008-10#2)
isotopic##26##1##(1990-12#1)(1994-5#1)(2008-10#18)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)
isotopically labeled##2##2##(1994-11#1)(2008-10#1)
isotopically##3##1##(1994-11#1)(2008-10#1)(2008-11#1)
isotopomer distribution##3##2##(2008-7#3)
isotopomer distributions##2##2##(2008-7#2)
isotopomer model##2##2##(2008-7#2)
isotopomer##13##1##(1997-1#1)(2008-7#12)
isotropic scaling##3##2##(2008-3#3)
isotropic scattering##4##2##(2008-2#1)(2008-3#3)
isotropic##21##1##(2008-10#1)(2008-2#2)(2008-3#16)(2008-6#1)(2013-1#1)
isotype of##3##2##(1990-12#2)(1993-6#1)
isotype##7##1##(1990-12#3)(1993-6#1)(1995-5#1)(1996-12#1)(2008-8#1)
isotypes##2##1##(1996-2#1)(2008-11#1)
isozyme banding##2##2##(2008-10#2)
isozyme electrophoresis##2##2##(2008-10#1)(2008-8#1)
isozyme in##3##2##(1992-11#1)(1993-12#1)(1997-2#1)
isozyme patterns##3##2##(2008-10#2)(2008-11#1)
isozyme was##2##2##(2008-10#1)(2008-11#1)
isozyme##35##1##(1990-8#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-6#4)(1994-11#1)(1994-5#1)(1997-2#3)(2008-10#13)(2008-11#2)(2008-8#1)(2008-9#1)(2009-3#1)(2012-5#1)
isozymes in##3##2##(1993-6#1)(1993-8#1)(2008-10#1)
isozymes was##2##2##(1997-2#1)(2008-10#1)
isozymes##23##1##(1990-12#1)(1992-10#2)(1993-6#1)(1993-8#1)(1994-11#3)(1995-2#1)(1996-6#1)(1997-2#2)(2008-10#9)(2008-11#1)(2012-2#1)
israelensis##2##1##(1993-12#2)
issue 1 of 2010##2##4##(2011-2#2)
issue a##2##2##(2008-10#1)(2008-11#1)
issue and##5##2##(1991-3#1)(1992-1#1)(1994-1#1)(2012-2#2)
issue dedicated to##3##3##(1993-6#1)(2008-7#1)(2012-3#1)
issue for the##2##3##(2008-10#1)(2009-12#1)
issue for##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-9#1)
issue in the##5##3##(1996-5#1)(1996-9#1)(2008-10#1)(2008-8#1)(2009-9#1)
issue in##19##2##(1996-5#1)(1996-9#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-7#1)(2011-2#2)(2013-1#1)
issue is##7##2##(1991-2#1)(1992-1#1)(2008-10#1)(2008-8#2)(2009-5#1)(2013-8#1)
issue of Radiology Management##4##4##(1991-2#1)(1995-1#1)(1995-2#1)(1996-1#1)
issue of the Health Care Financing Review##3##7##(1994-12#1)(1996-2#1)(1997-3#1)
issue of the Journal of Pediatric Urology##3##7##(2008-10#3)
issue of the Journal of##5##5##(2008-10#3)(2008-3#1)(2009-8#1)
issue of the##16##3##(1993-12#1)(1994-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)
issue of whether##2##3##(1992-2#1)(1994-1#1)
issue of##67##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#3)(2009-10#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
issue on##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
issue the##2##2##(1991-2#1)(1991-3#1)
issue with##3##2##(1993-12#1)(2008-7#1)(2012-3#1)
issue##205##1##(1990-11#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-6#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#4)(1993-12#2)(1993-2#2)(1993-6#1)(1994-1#5)(1994-12#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#4)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#16)(2008-11#29)(2008-12#7)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#3)(2009-12#2)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#9)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#10)(2013-8#5)
issue]##2##1##(1991-11#1)(1997-4#1)
issued a##4##2##(1995-12#1)(1997-6#1)(2008-5#1)(2013-8#1)
issued by the##3##3##(1996-3#1)(2008-9#1)(2011-2#1)
issued from##2##2##(2008-10#2)
issued recommendations##2##2##(2008-5#1)(2011-2#1)
issued##24##1##(1991-2#1)(1991-6#1)(1992-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#2)(2010-7#2)(2011-2#3)(2013-1#1)(2013-8#2)
issues about##2##2##(2009-10#1)(2011-2#1)
issues affecting##2##2##(2008-11#1)(2008-12#1)
issues and challenges##3##3##(1996-1#1)(2008-5#1)(2010-8#1)
issues and evidence##2##3##(1992-1#1)(1994-3#1)
issues and in##2##3##(1995-3#1)(2008-10#1)
issues and options##2##3##(1997-1#2)
issues and the##3##3##(2008-11#1)(2008-9#1)(2010-12#1)
issues and##41##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#2)(1997-1#2)(1997-2#3)(2008-1#1)(2008-10#1)(2008-11#7)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)
issues are discussed and##2##4##(1991-3#1)(1997-1#1)
issues are discussed##4##3##(1991-3#1)(1997-1#1)(2008-11#1)(2008-3#1)
issues are##14##2##(1991-3#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-9#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2010-12#1)
issues arising from the##2##4##(2008-11#1)(2010-5#1)
issues arising from##3##3##(2008-11#1)(2010-5#1)(2012-2#1)
issues arising##5##2##(1991-12#1)(1995-2#1)(2008-11#1)(2010-5#1)(2012-2#1)
issues around##3##2##(2008-11#1)(2009-8#1)(2012-12#1)
issues as well as##2##4##(2008-6#1)(2012-2#1)
issues as##4##2##(1995-3#1)(1997-2#1)(2008-6#1)(2012-2#1)
issues associated with studies##2##4##(2008-12#1)(2008-8#1)
issues associated with the##3##4##(2008-10#1)(2008-11#2)
issues associated with##12##3##(1991-1#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-8#1)
issues by##2##2##(2009-12#1)(2012-2#1)
issues concerned with##2##3##(1995-2#1)(2008-11#1)
issues concerned##3##2##(1995-2#1)(2008-11#2)
issues concerning##5##2##(1992-2#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-8#1)
issues connected##2##2##(1990-6#1)(1994-6#1)
issues facing##2##2##(2008-11#1)(2010-11#1)
issues for the 21st century##2##5##(2007-12#1)(2008-12#1)
issues for the##5##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)
issues for##20##2##(1991-1#1)(1993-1#3)(1993-3#1)(1995-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2010-8#1)(2012-2#1)
issues from##2##2##(1994-2#1)(2008-11#1)
issues have##2##2##(1991-2#1)(2008-10#1)
issues identified##2##2##(1991-1#1)(2009-4#1)
issues in a##2##3##(1995-12#1)(2012-2#1)
issues in long-term care##2##4##(1991-1#1)(2009-4#1)
issues in nursing##3##3##(2008-11#3)
issues in the##15##3##(1991-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
issues in##58##2##(1991-1#3)(1991-12#1)(1992-3#1)(1992-9#1)(1993-1#3)(1993-2#2)(1993-3#1)(1994-2#1)(1995-12#3)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#7)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#2)(2008-9#3)(2009-4#2)(2010-11#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)
issues include##4##2##(1992-3#1)(2008-6#1)(2010-11#1)(2010-7#1)
issues including##2##2##(2008-11#1)(2010-5#1)
issues involved in##5##3##(1991-12#1)(1993-2#1)(2008-2#1)(2009-9#1)(2010-7#1)
issues involved##7##2##(1991-12#1)(1993-2#1)(2008-2#1)(2008-9#1)(2009-9#1)(2010-7#2)
issues is##4##2##(1991-1#1)(2007-12#1)(2009-8#1)(2011-1#1)
issues limit the##2##3##(1992-9#1)(2008-10#1)
issues may##3##2##(1991-3#1)(1997-2#1)(2010-11#1)
issues of the##5##3##(1992-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
issues of##36##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#2)(1993-2#2)(1994-8#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#1)(2009-5#1)(2010-1#2)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
issues pertaining to##2##3##(2008-4#1)(2010-4#1)
issues regarding the use of##2##5##(1992-9#1)(2009-11#1)
issues regarding the##5##3##(1992-9#1)(1996-6#1)(1997-2#1)(2008-1#1)(2009-11#1)
issues regarding##8##2##(1992-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-10#1)
issues related to multiple##2##4##(2008-11#2)
issues related to the##4##4##(1994-2#1)(2008-10#2)(2013-1#1)
issues related to##20##3##(1991-2#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-2#2)(2013-1#2)
issues relating to##7##3##(1993-3#1)(1995-5#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
issues relevant to##2##3##(1992-12#1)(2013-1#1)
issues such as the##2##4##(2008-12#1)(2008-7#1)
issues such as##9##3##(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-6#1)
issues surrounding##6##2##(1991-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-8#1)
issues that arose##2##3##(1997-1#1)(2008-12#1)
issues that must be considered##2##5##(1997-2#1)(2008-4#1)
issues that must be##3##4##(1995-2#1)(1997-2#1)(2008-4#1)
issues that need to be addressed##4##6##(1994-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
issues that need to be##5##5##(1994-2#1)(2008-11#2)(2008-9#1)(2011-2#1)
issues that##26##2##(1991-1#1)(1991-3#1)(1994-2#1)(1995-2#1)(1997-1#2)(1997-2#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-4#3)(2008-6#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
issues to be addressed before##2##5##(2010-10#1)(2011-2#1)
issues to be addressed in##2##5##(1994-12#1)(1997-2#1)
issues to be addressed##4##4##(1994-12#1)(1997-2#1)(2010-10#1)(2011-2#1)
issues to be considered when##2##5##(1993-2#2)
issues to be##6##3##(1993-2#2)(1994-12#1)(1997-2#1)(2010-10#1)(2011-2#1)
issues to##7##2##(1993-2#2)(1994-12#1)(1997-2#1)(2010-10#1)(2010-6#1)(2011-2#1)
issues were##4##2##(2008-10#1)(2008-9#1)(2010-1#1)(2012-3#1)
issues when##2##2##(1997-2#1)(2010-8#1)
issues which##4##2##(1995-1#1)(2008-1#1)(2008-11#2)
issues with##7##2##(1997-2#1)(2008-10#1)(2008-11#2)(2010-4#1)(2010-5#1)(2012-2#1)
issues within the##3##3##(1991-12#1)(1995-1#1)(1996-2#1)
issues within##4##2##(1991-12#1)(1995-1#1)(1996-2#1)(2008-3#1)
issues##515##1##(1990-2#1)(1990-6#2)(1991-1#11)(1991-12#7)(1991-2#8)(1991-3#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#6)(1992-3#4)(1992-9#6)(1993-1#7)(1993-12#3)(1993-2#10)(1993-3#6)(1993-9#1)(1994-12#3)(1994-2#7)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#6)(1995-12#4)(1995-2#5)(1995-3#6)(1995-5#8)(1995-6#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#10)(1996-3#4)(1996-6#2)(1996-8#2)(1997-1#8)(1997-2#17)(1997-3#7)(1997-4#2)(2007-12#5)(2008-1#7)(2008-10#31)(2008-11#82)(2008-12#24)(2008-2#2)(2008-3#6)(2008-4#9)(2008-5#6)(2008-6#10)(2008-7#5)(2008-8#3)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#5)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#7)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#5)(2011-1#4)(2011-2#13)(2012-12#4)(2012-2#12)(2012-3#8)(2013-1#14)(2013-8#8)
issues)##2##1##(1993-12#1)(2008-9#1)
isthmus##6##1##(2008-12#1)(2013-1#5)
it &quot##2##2##(1994-1#1)(2009-5#1)
it a useful##2##3##(2008-10#2)
it a very##2##3##(2008-10#2)
it a##22##2##(1990-3#1)(1991-3#1)(1993-11#1)(1994-11#1)(1994-9#1)(1996-9#1)(2008-10#9)(2008-5#1)(2008-7#2)(2012-12#1)(2012-3#2)(2013-1#1)
it abolished the##2##3##(1990-3#1)(1991-6#1)
it achieved##2##2##(1991-12#1)(2008-10#1)
it affects##4##2##(1993-3#1)(1997-8#1)(2008-11#1)(2008-7#1)
it against##4##2##(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
it allowed##3##2##(1992-12#1)(2008-10#1)(2008-12#1)
it allows for##2##3##(1994-12#1)(2011-2#1)
it allows##11##2##(1994-12#1)(1997-3#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
it also has##2##3##(1992-9#1)(2009-6#1)
it also highlights the##2##4##(2007-12#1)(2011-2#1)
it also performs##2##3##(1995-6#1)(2008-3#1)
it also showed a##3##4##(2008-10#1)(2008-9#1)(2011-3#1)
it also##32##2##(1990-11#1)(1990-8#1)(1992-9#1)(1993-2#1)(1995-11#1)(1995-6#1)(1997-1#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
it an attractive##2##3##(2012-3#1)(2013-1#1)
it an ideal##5##3##(2008-10#1)(2008-11#1)(2010-6#1)(2012-2#2)
it an important##5##3##(1994-12#1)(1995-12#1)(2008-1#1)(2012-2#2)
it an##14##2##(1991-12#1)(1994-12#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-6#1)(2012-2#4)(2012-3#1)(2013-1#1)
it and the##4##3##(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
it and##10##2##(1994-1#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
it appeared that the##4##4##(1993-8#1)(2008-10#2)(2011-2#1)
it appeared that##5##3##(1993-8#1)(1995-9#1)(2008-10#2)(2011-2#1)
it appeared##6##2##(1993-8#1)(1995-9#1)(2008-10#2)(2008-11#1)(2011-2#1)
it appears that the##10##4##(1992-6#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2010-5#1)(2013-1#1)
it appears that##27##3##(1992-2#1)(1992-6#2)(1994-12#1)(1996-1#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
it appears to be##2##4##(1991-12#1)(1993-2#1)
it appears to##3##3##(1991-12#1)(1993-2#1)(2009-7#1)
it appears##30##2##(1991-12#1)(1992-2#1)(1992-6#2)(1993-2#1)(1994-12#1)(1996-1#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
it are##6##2##(1993-3#1)(1994-1#1)(1995-5#1)(1997-2#1)(2008-4#1)(2008-7#1)
it as a##15##3##(1991-12#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
it as an##2##3##(2008-11#1)(2008-12#1)
it as##22##2##(1991-12#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
it associated with##2##3##(1994-8#1)(2011-2#1)
it at the##2##3##(1995-2#1)(2011-2#1)
it at##5##2##(1995-2#1)(2008-2#1)(2008-8#1)(2010-1#1)(2011-2#1)
it be of##2##3##(2008-9#1)(2009-6#1)
it be##7##2##(1991-11#1)(1991-8#1)(1997-8#1)(2008-10#1)(2008-9#2)(2009-6#1)
it became apparent##2##3##(1993-1#1)(1994-2#1)
it became clear that##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
it became evident that##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
it became##12##2##(1993-1#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2011-2#2)(2011-3#1)
it becomes##8##2##(1993-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#1)
it being##4##2##(1996-3#1)(2008-10#3)
it binds to##2##3##(1994-3#1)(2008-10#1)
it by##10##2##(1993-1#1)(1994-12#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#1)
it can also be##6##4##(1991-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-10#1)
it can also##10##3##(1991-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
it can be concluded that the##2##6##(2008-10#2)
it can be concluded that##11##5##(1997-6#1)(2008-10#5)(2008-12#1)(2012-2#3)(2012-9#1)
it can be concluded##12##4##(1994-12#1)(1997-6#1)(2008-10#5)(2008-12#1)(2012-2#3)(2012-9#1)
it can be difficult##2##4##(2008-10#1)(2012-2#1)
it can be easily##2##4##(2008-10#1)(2008-11#1)
it can be employed as a stability indicating one##2##9##(2008-10#2)
it can be stated that##2##5##(1992-11#1)(2009-8#1)
it can be suggested that##2##5##(1994-11#1)(2010-4#1)
it can be used as a##3##6##(2008-10#1)(2008-11#1)(2012-2#1)
it can be used as##5##5##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
it can be used for##2##5##(2008-10#2)
it can be used##8##4##(2008-10#3)(2008-11#2)(2008-3#1)(2012-2#1)(2013-1#1)
it can be##77##3##(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#5)(2012-3#2)(2012-9#1)(2013-1#5)(2013-8#1)
it can cause##5##3##(1992-2#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
it can easily be##2##4##(2007-12#1)(2008-3#1)
it can##119##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#3)(1992-3#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#29)(2008-11#7)(2008-12#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#3)(2012-9#1)(2013-1#8)(2013-8#4)
it cannot be considered##2##4##(1992-2#1)(2007-12#1)
it cannot be##7##3##(1992-2#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
it cannot##9##2##(1992-2#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#2)(2011-2#1)
it carried##2##2##(1993-2#1)(2008-11#1)
it caused##4##2##(2008-10#3)(2008-7#1)
it causes a##2##3##(2008-10#1)(2008-5#1)
it causes##9##2##(2008-10#3)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
it challenging##2##2##(2008-12#1)(2013-1#1)
it clear that##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
it clearly##2##2##(2008-10#1)(2008-11#1)
it comes to##5##3##(1991-3#1)(1994-12#1)(1996-3#1)(1996-9#1)(1997-6#1)
it comes##7##2##(1991-3#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2008-10#1)
it compared##2##2##(2008-10#1)(2009-8#1)
it contained##4##2##(1991-9#1)(1995-12#1)(2008-10#1)(2008-11#1)
it contains##5##2##(1993-12#1)(1994-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
it could be a##3##4##(2009-5#1)(2010-7#1)(2013-1#1)
it could be concluded that the##2##6##(2008-10#1)(2008-5#1)
it could be used##2##4##(2008-10#1)(2008-9#1)
it could be useful##2##4##(2008-10#1)(2008-11#1)
it could be##27##3##(1992-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-3#1)(2013-1#1)(2013-8#1)
it could not##3##3##(2008-10#1)(2008-7#2)
it could##43##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-3#1)(1993-11#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
it creates##3##2##(1994-8#1)(1996-3#1)(2012-3#1)
it decreased from 2##2##4##(2008-7#2)
it decreased with increasing##2##4##(2008-10#1)(2008-11#1)
it decreased##7##2##(1996-12#1)(2008-10#2)(2008-11#2)(2008-7#2)
it demonstrates##2##2##(2008-1#1)(2013-1#1)
it depends on you!)##2##4##(2009-3#2)
it depends##3##2##(2008-3#1)(2009-3#2)
it describes##3##2##(1994-2#1)(2008-4#1)(2010-1#1)
it develops##2##2##(2008-11#1)(2008-3#1)
it did in##2##3##(2008-12#1)(2008-8#1)
it did not improve##2##4##(1996-12#1)(2008-10#1)
it did not induce##2##4##(1992-8#1)(1993-8#1)
it did not promote##2##4##(2008-11#2)
it did not##19##3##(1991-12#1)(1992-8#1)(1993-8#1)(1996-12#1)(2008-10#6)(2008-11#3)(2008-7#1)(2009-6#1)(2010-1#1)(2011-2#2)(2013-8#1)
it did##26##2##(1991-12#1)(1992-8#1)(1993-8#1)(1996-12#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
it difficult for##4##3##(2008-8#1)(2009-8#1)(2010-12#1)(2013-8#1)
it difficult to##11##3##(1992-12#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
it difficult##15##2##(1992-12#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
it directly##2##2##(1994-11#1)(2008-10#1)
it disappeared##2##2##(1991-11#1)(1996-2#1)
it displays##2##2##(2008-10#1)(2011-2#1)
it do##2##2##(2012-12#2)
it does in##2##3##(1991-2#1)(2010-10#1)
it does not require##2##4##(2008-10#1)(2009-7#1)
it does not##21##3##(1992-1#1)(1993-6#1)(1994-3#1)(1994-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2012-12#1)(2013-1#1)
it does##32##2##(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-1#1)
it during##4##2##(2008-11#1)(2008-5#1)(2008-7#2)
it easier to##4##3##(1992-12#1)(1992-8#1)(2008-10#1)(2011-2#1)
it easier##5##2##(1992-12#1)(1992-8#1)(1997-7#1)(2008-10#1)(2011-2#1)
it effectively##2##2##(2008-11#2)
it either##2##2##(1993-1#1)(1996-3#1)
it emerges##2##2##(1990-9#1)(2008-12#1)
it enables##3##2##(2008-10#1)(2008-11#2)
it encodes a##2##3##(1990-12#1)(2009-10#1)
it encodes##4##2##(1990-12#1)(1994-8#1)(1995-2#1)(2009-10#1)
it exhibits##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
it exists##5##2##(1991-12#1)(1993-3#1)(1994-1#1)(2008-11#1)(2008-3#1)
it extends the LR parsing algorithm by using a##2##9##(2011-3#2)
it extends##4##2##(1993-6#1)(2008-4#1)(2011-3#2)
it focuses on##2##3##(2008-12#1)(2010-1#1)
it focuses##3##2##(1994-1#1)(2008-12#1)(2010-1#1)
it follows that##2##3##(2008-10#1)(2010-1#1)
it for##8##2##(1993-12#1)(1994-3#1)(1997-3#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
it from the other##2##4##(1992-5#1)(2008-10#1)
it from##10##2##(1992-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-12#1)(2012-3#1)
it functions in the##2##4##(1993-12#1)(1996-3#1)
it functions in##3##3##(1993-12#1)(1996-3#1)(2008-10#1)
it generally##2##2##(1992-9#1)(2008-10#1)
it generates##2##2##(1990-5#1)(2008-10#1)
it had a##6##3##(1995-12#1)(1997-8#1)(2008-7#3)(2008-8#1)
it had no effect on##3##5##(1995-6#1)(1996-12#1)(2008-10#1)
it had no effect##4##4##(1993-12#1)(1995-6#1)(1996-12#1)(2008-10#1)
it had##20##2##(1993-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
it harder to##2##3##(1996-5#1)(2009-8#1)
it harder##3##2##(1996-5#2)(2009-8#1)
it has a high##2##4##(1992-8#1)(2010-3#1)
it has a##8##3##(1992-8#1)(1993-2#1)(1995-6#1)(2008-10#2)(2008-8#1)(2010-3#1)(2013-1#1)
it has also been##2##4##(1994-2#2)
it has also##3##3##(1994-2#2)(2011-3#1)
it has an##5##3##(1990-12#1)(1993-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
it has become apparent that##2##5##(1997-8#1)(2008-11#1)
it has become clear that##3##5##(2008-10#1)(2009-3#1)(2010-12#1)
it has become evident that##2##5##(2011-2#1)(2012-2#1)
it has become increasingly##3##4##(1995-2#1)(2008-9#1)(2010-12#1)
it has become##13##3##(1995-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-3#1)(2010-12#3)(2011-2#1)(2012-2#1)
it has been applied##3##4##(1990-9#1)(2008-10#2)
it has been associated with##2##5##(2008-10#1)(2009-3#1)
it has been concluded that##2##5##(2008-10#2)
it has been demonstrated that##6##5##(1991-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
it has been demonstrated##7##4##(1990-9#1)(1991-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
it has been difficult to##3##5##(2008-4#1)(2008-8#1)(2013-8#1)
it has been established that##2##5##(1990-8#1)(2008-12#1)
it has been found that the##2##6##(2008-10#2)
it has been found that##7##5##(2008-10#5)(2008-9#1)(2009-11#1)
it has been hypothesized that##2##5##(2008-8#1)(2009-12#1)
it has been known##2##4##(2012-2#1)(2013-1#1)
it has been necessary to##2##5##(2008-10#1)(2008-4#1)
it has been necessary##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
it has been observed that##5##5##(1991-2#1)(2008-10#3)(2010-1#1)
it has been observed##6##4##(1991-2#1)(2008-10#4)(2010-1#1)
it has been possible to##5##5##(1993-8#1)(1996-8#1)(2008-10#2)(2008-3#1)
it has been possible##6##4##(1993-8#1)(1996-8#1)(2008-10#2)(2008-3#1)(2010-6#1)
it has been postulated that##2##5##(2008-7#1)(2013-1#1)
it has been proposed that the##2##6##(1994-3#1)(1995-2#1)
it has been proposed that##4##5##(1994-3#1)(1995-2#1)(2008-7#1)(2008-8#1)
it has been proved##2##4##(1992-5#1)(2008-10#1)
it has been reported that##2##5##(2008-7#1)(2013-8#1)
it has been reported##4##4##(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
it has been revealed that##3##5##(1991-9#1)(2008-1#1)(2008-9#1)
it has been shown that the##4##6##(1990-11#1)(2008-10#2)(2013-8#1)
it has been shown that##8##5##(1990-11#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
it has been shown to##2##5##(2008-11#1)(2013-1#1)
it has been shown##11##4##(1990-11#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-1#2)(2013-8#1)
it has been suggested that##11##5##(1990-8#1)(1992-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-2#1)(2013-1#1)
it has been used to##2##5##(1993-2#1)(2008-10#1)
it has been used##3##4##(1993-2#1)(2008-10#2)
it has been##105##3##(1990-11#1)(1990-8#2)(1990-9#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-1#2)(2008-10#30)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#5)
it has long been recognized that##2##6##(2008-5#1)(2010-1#1)
it has long##3##3##(2008-4#1)(2008-5#1)(2010-1#1)
it has no##4##3##(1997-7#1)(2008-10#1)(2008-7#1)(2010-6#1)
it has not been##3##4##(1995-6#1)(2008-10#1)(2008-5#1)
it has not##6##3##(1992-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)
it has potential##2##3##(2008-10#2)
it has recently##2##3##(2008-4#1)(2010-12#1)
it has the advantage of##3##5##(2008-10#2)(2008-11#1)
it has the##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2013-8#1)
it has##198##2##(1990-11#1)(1990-12#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#3)(2008-10#52)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#5)(2012-3#3)(2013-1#9)(2013-8#6)
it have a##2##3##(1997-7#1)(2008-2#1)
it have##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
it helps##3##2##(1990-6#1)(2008-11#1)(2010-3#1)
it highly##2##2##(1996-12#1)(2008-11#1)
it if they##2##3##(1994-2#1)(2008-7#1)
it important##2##2##(1996-11#1)(2011-7#1)
it impossible to##4##3##(2009-8#1)(2012-12#1)(2012-3#2)
it improves##5##2##(2008-4#2)(2008-7#1)(2010-7#1)(2011-2#1)
it in a##4##3##(1993-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
it in the##7##3##(1993-6#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
it in##24##2##(1992-1#1)(1993-6#2)(1994-9#1)(1995-11#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
it inaccessible##2##2##(1993-3#1)(2008-11#1)
it includes##2##2##(2010-7#1)(2011-2#1)
it increased##8##2##(1990-5#2)(1994-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
it increases the##2##3##(2008-10#1)(2008-8#1)
it increases##5##2##(1996-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-12#1)
it indicates that##2##3##(2008-10#2)
it inhibited the##2##3##(2008-11#2)
it inhibited##4##2##(1994-11#1)(1997-4#1)(2008-11#2)
it inhibits the##2##3##(1994-8#1)(2008-5#1)
it inhibits##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
it into a##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
it into the##3##3##(1994-9#1)(1995-12#1)(2008-2#1)
it into##9##2##(1994-9#1)(1995-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-8#1)
it involves##3##2##(1994-6#1)(2009-7#1)(2013-1#1)
it is a major##2##4##(1992-6#1)(2013-1#1)
it is a very##4##4##(1992-12#1)(1995-3#1)(2008-10#2)
it is a##42##3##(1992-12#1)(1992-6#1)(1993-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)
it is able to##2##4##(2008-11#1)(2011-2#1)
it is accompanied by##2##4##(1995-3#1)(2008-12#1)
it is achieved##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
it is advisable to##2##4##(2008-12#1)(2013-1#1)
it is also a##2##4##(2010-7#1)(2012-12#1)
it is also important##2##4##(2008-10#2)
it is also possible to##3##5##(1997-6#1)(2008-10#1)(2008-4#1)
it is also the##2##4##(2009-1#1)(2012-2#1)
it is also##23##3##(1990-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-9#3)(2009-1#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
it is always##2##3##(1994-2#1)(2008-5#1)
it is an##12##3##(1991-2#1)(1994-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
it is applied to##3##4##(1995-5#1)(2008-10#1)(2012-2#1)
it is applied##4##3##(1995-5#1)(2008-10#2)(2012-2#1)
it is appropriate to##2##4##(2008-10#2)
it is appropriate##3##3##(2008-10#3)
it is argued that##2##4##(1995-11#1)(2008-7#1)
it is assessed##2##3##(2008-11#1)(2012-2#1)
it is associated with##6##4##(1990-5#1)(1993-6#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
it is assumed that##3##4##(1993-3#1)(2008-10#2)
it is at##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
it is becoming##2##3##(2008-10#1)(2011-2#1)
it is being used as##2##5##(2008-11#2)
it is being##4##3##(2008-11#2)(2010-4#1)(2013-1#1)
it is believed that##3##4##(1994-8#1)(1995-1#1)(2008-11#1)
it is believed##4##3##(1994-8#1)(1995-1#1)(1997-8#1)(2008-11#1)
it is beneficial to##2##4##(2008-11#1)(2008-7#1)
it is called##2##3##(1991-1#1)(2009-10#1)
it is clear that the##2##5##(2008-10#1)(2008-12#1)
it is clear that##8##4##(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
it is concluded that the##4##5##(1995-6#1)(2008-10#1)(2008-11#1)(2009-7#1)
it is concluded that##10##4##(1995-6#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-7#1)
it is concluded##11##3##(1990-3#1)(1995-6#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-7#1)
it is confirmed that##2##4##(2008-2#1)(2008-8#1)
it is considered a##2##4##(2008-10#1)(2012-2#1)
it is considered that##3##4##(2008-10#1)(2008-9#2)
it is considered##6##3##(1994-8#1)(2008-10#2)(2008-9#2)(2012-2#1)
it is critical that##2##4##(2010-11#1)(2013-1#1)
it is critical to##2##4##(2008-11#1)(2008-2#1)
it is critical##4##3##(2008-11#1)(2008-2#1)(2010-11#1)(2013-1#1)
it is crucial to##2##4##(1991-12#1)(2012-2#1)
it is crucial##3##3##(1991-12#1)(2008-10#1)(2012-2#1)
it is demonstrated that the##3##5##(2008-10#1)(2008-3#1)(2013-1#1)
it is demonstrated that##4##4##(2008-10#1)(2008-3#2)(2013-1#1)
it is demonstrated##5##3##(2008-10#1)(2008-11#1)(2008-3#2)(2013-1#1)
it is desirable to##2##4##(2008-9#1)(2012-3#1)
it is desirable##3##3##(2008-9#2)(2012-3#1)
it is difficult to diagnose##2##5##(2009-12#1)(2013-8#1)
it is difficult to distinguish##2##5##(2012-9#1)(2013-8#1)
it is difficult to##16##4##(1994-6#1)(1995-12#1)(2008-10#2)(2008-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-9#1)(2013-8#2)
it is difficult##17##3##(1994-6#1)(1995-12#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-9#1)(2013-8#2)
it is easier and##2##4##(1991-3#1)(2008-12#1)
it is easier to##2##4##(2008-10#1)(2013-1#1)
it is easier##4##3##(1991-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
it is easily##2##3##(2008-10#1)(2008-4#1)
it is easy to carry and store the##2##8##(2008-10#2)
it is easy to see##2##5##(1994-12#1)(2011-2#1)
it is easy to##4##4##(1994-12#1)(2008-10#2)(2011-2#1)
it is easy##5##3##(1994-12#1)(2008-10#3)(2011-2#1)
it is effective##2##3##(1997-2#1)(2008-11#1)
it is enhanced##2##3##(2008-7#1)(2008-9#1)
it is especially##3##3##(1991-8#1)(1994-3#1)(2013-1#1)
it is essential that##4##4##(2008-7#1)(2009-11#1)(2010-12#1)(2013-8#1)
it is essential to##7##4##(1991-6#1)(1994-9#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#2)
it is essential##12##3##(1991-6#1)(1994-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
it is estimated that##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
it is estimated##5##3##(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
it is evident that the##3##5##(1993-1#1)(1997-8#1)(2008-9#1)
it is evident that##5##4##(1993-1#1)(1997-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
it is expected that##2##4##(2008-10#1)(2010-12#1)
it is feasible that##2##4##(2008-11#1)(2009-7#1)
it is feasible to##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
it is feasible##5##3##(2008-10#1)(2008-11#2)(2009-7#1)(2011-1#1)
it is found in##2##4##(1990-3#1)(2012-2#1)
it is found that##4##4##(2008-10#3)(2009-7#1)
it is found##6##3##(1990-3#1)(2008-10#3)(2009-7#1)(2012-2#1)
it is generally accepted that##3##5##(2008-10#1)(2008-11#1)(2012-3#1)
it is generally##10##3##(1994-11#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2010-7#1)(2012-3#1)(2012-7#1)
it is highly desirable to##2##5##(2008-11#1)(2011-2#1)
it is highly##4##3##(1992-3#1)(2008-11#2)(2011-2#1)
it is hoped that##2##4##(2008-10#1)(2008-4#1)
it is hoped##3##3##(1993-3#1)(2008-10#1)(2008-4#1)
it is hypothesized that this##2##5##(1995-11#1)(2009-1#1)
it is hypothesized that##5##4##(1995-11#1)(2008-7#2)(2009-1#1)(2009-12#1)
it is hypothesized##6##3##(1995-11#1)(2008-7#2)(2009-1#1)(2009-12#1)(2010-11#1)
it is imperative that##4##4##(2008-11#1)(2008-8#1)(2009-4#1)(2011-1#1)
it is imperative to##2##4##(2012-12#1)(2013-1#1)
it is imperative##7##3##(2008-11#1)(2008-8#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
it is important for##5##4##(1993-1#1)(2008-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
it is important that##4##4##(1992-6#1)(1995-2#1)(2008-11#1)(2010-8#1)
it is important to consider##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
it is important to determine##2##5##(2008-4#1)(2012-2#1)
it is important to establish##3##5##(1993-1#1)(2008-10#2)
it is important to evaluate##2##5##(2008-1#1)(2008-9#1)
it is important to have##2##5##(2008-10#1)(2008-9#1)
it is important to immediately##2##5##(2010-6#1)(2011-2#1)
it is important to know the##2##6##(2008-10#1)(2010-5#1)
it is important to know##4##5##(1997-5#1)(2008-10#1)(2008-4#1)(2010-5#1)
it is important to perform##2##5##(2008-7#1)(2012-3#1)
it is important to recognize the##2##6##(2011-2#1)(2013-1#1)
it is important to understand the statistical sample of groups from which these norms are drawn##2##16##(1994-3#2)
it is important to understand the##3##6##(1994-3#2)(2012-2#1)
it is important to understand##5##5##(1994-3#2)(2008-10#1)(2011-2#1)(2012-2#1)
it is important to##43##4##(1992-9#1)(1993-1#1)(1994-2#1)(1994-3#2)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#6)
it is important##53##3##(1992-6#1)(1992-9#1)(1993-1#2)(1994-2#1)(1994-3#2)(1995-2#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#8)
it is impossible##2##3##(1994-6#1)(2008-10#1)
it is in##7##3##(1990-5#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#2)
it is involved in##2##4##(1995-2#1)(1996-12#1)
it is involved##3##3##(1995-2#1)(1996-12#1)(2013-7#1)
it is known that##3##4##(1990-6#1)(2008-10#1)(2008-7#1)
it is known to be##2##5##(2010-3#1)(2011-2#1)
it is known to##3##4##(2008-5#1)(2010-3#1)(2011-2#1)
it is known##8##3##(1990-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)
it is lacking##2##3##(1995-11#1)(2009-7#1)
it is large##2##3##(1994-2#1)(2011-2#1)
it is less invasive##2##4##(2008-7#1)(2011-2#1)
it is likely that the##4##5##(1995-12#1)(1997-1#1)(2008-8#1)(2012-3#1)
it is likely that this##4##5##(1992-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
it is likely that##22##4##(1992-12#2)(1994-2#1)(1995-12#1)(1997-1#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-8#1)(2010-1#1)(2012-2#1)(2012-3#1)
it is likely to##2##4##(2008-10#1)(2012-2#1)
it is likely##24##3##(1992-12#2)(1994-2#1)(1995-12#1)(1997-1#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-8#1)(2010-1#1)(2012-2#2)(2012-3#1)
it is made##2##3##(2008-3#1)(2009-7#1)
it is mixed##2##3##(2008-10#2)
it is more difficult to##2##5##(2008-11#1)(2010-6#1)
it is more##9##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-6#1)
it is much faster##2##4##(2008-10#1)(2008-3#1)
it is much##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
it is necessary for##2##4##(2008-11#1)(2010-7#1)
it is necessary to examine##2##5##(1996-12#1)(2008-11#1)
it is necessary to have##2##5##(1991-1#1)(2008-11#1)
it is necessary to identify##2##5##(1995-5#1)(2008-10#1)
it is necessary to understand##5##5##(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
it is necessary to##37##4##(1991-1#2)(1991-6#1)(1993-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
it is necessary##41##3##(1991-1#2)(1991-6#1)(1993-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#6)(2008-11#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-7#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
it is needed##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
it is no##2##3##(2008-10#1)(2012-2#1)
it is not a##3##4##(1994-12#1)(1995-6#1)(2010-9#1)
it is not always##3##4##(2007-11#1)(2008-10#1)(2009-3#1)
it is not clear whether##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
it is not clear##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
it is not known##2##4##(2008-10#1)(2012-3#1)
it is not necessary to##3##5##(1997-6#1)(2008-10#1)(2008-11#1)
it is not possible to##4##5##(2008-10#2)(2011-2#1)(2012-12#1)
it is not widely used##2##5##(2010-6#1)(2013-1#1)
it is not yet##2##4##(1990-2#1)(2010-8#1)
it is not##43##3##(1990-2#1)(1991-1#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
it is noteworthy that##4##4##(1993-2#1)(2008-7#1)(2010-10#1)(2012-2#1)
it is now clear that##2##5##(2010-12#1)(2011-2#1)
it is now possible to##2##5##(1990-12#1)(1993-8#1)
it is now widely accepted that##2##6##(2011-2#1)(2012-3#1)
it is now##13##3##(1990-12#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
it is of##6##3##(2008-10#3)(2008-11#1)(2013-1#1)(2013-7#1)
it is often##8##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#2)
it is one of the most##3##6##(1994-12#1)(2008-11#1)(2010-10#1)
it is one of the##5##5##(1994-12#1)(2008-10#1)(2008-11#2)(2010-10#1)
it is only present##2##4##(1996-12#1)(2008-10#1)
it is only##5##3##(1994-12#2)(1996-12#1)(2008-10#1)(2008-11#1)
it is plausible that##3##4##(2008-11#1)(2009-6#1)(2009-8#1)
it is plausible##4##3##(2008-10#1)(2008-11#1)(2009-6#1)(2009-8#1)
it is possible that the##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
it is possible that they##2##5##(1994-5#1)(2008-11#1)
it is possible that this##2##5##(1995-5#1)(1997-1#1)
it is possible that##17##4##(1992-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
it is possible to construct##2##5##(2008-3#1)(2008-9#1)
it is possible to detect##2##5##(2008-10#1)(2008-4#1)
it is possible to determine the##3##6##(2008-10#1)(2008-4#1)(2008-9#1)
it is possible to determine##6##5##(2008-10#4)(2008-4#1)(2008-9#1)
it is possible to extract the##2##6##(2008-3#2)
it is possible to measure##2##5##(1990-12#1)(2009-12#1)
it is possible to obtain a model adjusted to the concentration values of the mixtures used in the calibration##2##19##(2008-10#2)
it is possible to perform quantitative##2##6##(2008-10#2)
it is possible to perform##4##5##(2008-10#3)(2008-7#1)
it is possible to produce##2##5##(2008-10#1)(2008-11#1)
it is possible to##72##4##(1990-12#1)(1990-5#1)(1991-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-8#1)(2008-10#27)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#4)(2009-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
it is possible##91##3##(1990-12#1)(1990-5#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-3#2)(1997-1#1)(1997-8#1)(2008-10#30)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-3#2)(2013-1#2)
it is preferable to##2##4##(1990-6#1)(2011-3#1)
it is premature##2##3##(2009-9#1)(2013-1#1)
it is produced##2##3##(1992-7#1)(2008-11#1)
it is proposed that the##3##5##(2008-10#2)(2013-8#1)
it is proposed that##7##4##(2008-10#3)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
it is proposed##8##3##(2008-10#3)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
it is quite likely that##2##5##(1997-1#1)(2008-4#1)
it is quite##3##3##(1997-1#1)(2008-10#1)(2008-4#1)
it is rare##2##3##(2008-11#1)(2008-12#1)
it is rarely seen##2##4##(2008-11#1)(2013-8#1)
it is rarely##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
it is rather##2##3##(2008-10#1)(2008-11#1)
it is reasonable to##3##4##(1991-6#1)(2010-4#1)(2012-3#1)
it is recommended that##8##4##(1991-3#1)(1997-8#1)(2008-10#3)(2010-8#1)(2012-12#1)(2012-2#1)
it is recommended to##2##4##(2008-10#1)(2008-11#1)
it is recommended##10##3##(1991-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
it is reported##2##3##(2008-12#1)(2011-2#1)
it is responsible for the##4##5##(1994-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
it is seen##3##3##(1997-3#1)(2008-1#1)(2008-10#1)
it is shown how the##2##5##(2008-6#2)
it is shown that a##2##5##(2008-8#1)(2010-12#1)
it is shown that the##7##5##(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-9#1)(2010-3#1)
it is shown that##26##4##(1990-5#1)(1994-5#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#1)
it is shown##30##3##(1990-5#1)(1994-5#1)(1995-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#3)(2008-8#2)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#1)
it is significantly##2##3##(1992-12#1)(1992-6#1)
it is speculated that##2##4##(1992-3#1)(1996-2#1)
it is still unclear whether##2##5##(2013-8#2)
it is still unclear##3##4##(2013-1#1)(2013-8#2)
it is still##13##3##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#3)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#3)
it is strictly##2##3##(2008-10#1)(2011-2#1)
it is strongly##2##3##(2008-11#1)(2012-12#1)
it is suggested that the##9##5##(1991-2#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-11#3)(2008-8#1)(2008-9#1)
it is suggested that this##3##5##(2008-10#1)(2008-12#1)(2008-8#1)
it is suggested that##28##4##(1991-12#2)(1991-2#1)(1992-3#1)(1992-5#1)(1994-8#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-7#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#4)(2008-9#1)(2013-1#1)
it is suggested##29##3##(1991-12#2)(1991-2#1)(1992-3#1)(1992-5#1)(1994-8#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-7#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#4)(2008-9#1)(2013-1#1)
it is suitable for##3##4##(2008-10#3)
it is suitable##4##3##(2008-10#3)(2010-12#1)
it is the case##3##4##(2008-10#2)(2008-5#1)
it is the first time##2##5##(2008-10#2)
it is the first##3##4##(2008-10#3)
it is the same##2##4##(1996-6#1)(2008-8#1)
it is the##26##3##(1991-10#1)(1991-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2012-12#1)
it is thought that##2##4##(1996-11#1)(2008-2#1)
it is to##6##3##(1990-12#1)(1993-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
it is too early to##2##5##(2008-1#1)(2008-5#1)
it is too##4##3##(1993-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
it is unclear how##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
it is unclear if##2##4##(2012-12#1)(2013-1#1)
it is unclear whether the##2##5##(2008-8#2)
it is unclear whether##6##4##(1996-1#1)(2008-8#2)(2009-10#1)(2013-1#2)
it is unclear##13##3##(1996-1#1)(2008-10#2)(2008-8#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
it is unknown whether##3##4##(2008-11#2)(2008-7#1)
it is unlikely that##7##4##(1993-9#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-5#1)
it is used##5##3##(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#2)
it is useful to##2##4##(2008-10#1)(2013-1#1)
it is useful##4##3##(2008-10#2)(2010-12#1)(2013-1#1)
it is usually##5##3##(1991-2#1)(1995-5#1)(1997-3#1)(2008-10#2)
it is very difficult to##3##5##(2008-11#1)(2008-5#1)(2010-6#1)
it is very important to investigate the##2##7##(2008-10#1)(2008-11#1)
it is very important to##4##5##(2008-10#2)(2008-11#1)(2008-8#1)
it is very important##5##4##(2008-10#2)(2008-11#2)(2008-8#1)
it is very##10##3##(1993-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-8#1)(2010-6#1)
it is vital for##3##4##(2008-9#1)(2009-9#1)(2010-10#1)
it is vital##4##3##(1997-1#1)(2008-9#1)(2009-9#1)(2010-10#1)
it is well known that##2##5##(2008-10#1)(2011-2#1)
it is well suited##2##4##(2008-11#1)(2008-6#1)
it is well##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)
it is well-known that##2##4##(2008-10#1)(2008-11#1)
it is##1057##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#3)(1990-5#6)(1990-6#2)(1990-9#3)(1991-1#4)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#7)(1991-6#4)(1991-8#1)(1992-1#1)(1992-12#7)(1992-2#1)(1992-3#8)(1992-5#2)(1992-6#3)(1992-7#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#3)(1994-1#3)(1994-11#2)(1994-12#11)(1994-2#6)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#6)(1995-12#5)(1995-2#5)(1995-3#3)(1995-5#8)(1995-6#5)(1995-8#2)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#9)(1996-2#2)(1996-3#5)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#7)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#6)(1997-9#1)(2007-11#3)(2007-12#6)(2008-1#6)(2008-10#243)(2008-11#101)(2008-12#22)(2008-2#15)(2008-3#26)(2008-4#17)(2008-5#18)(2008-6#10)(2008-7#35)(2008-8#25)(2008-9#30)(2009-1#3)(2009-10#7)(2009-11#3)(2009-12#6)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#7)(2009-9#5)(2010-1#3)(2010-10#4)(2010-11#11)(2010-12#9)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#7)(2010-7#5)(2010-8#7)(2010-9#2)(2011-1#4)(2011-2#56)(2011-3#3)(2012-12#11)(2012-2#23)(2012-3#16)(2012-7#1)(2012-9#1)(2013-1#39)(2013-7#2)(2013-8#17)
it just a##3##3##(2008-10#1)(2008-11#2)
it lacks adequate##2##3##(2012-2#1)(2013-1#1)
it lacks##3##2##(2010-4#1)(2012-2#1)(2013-1#1)
it leads to##3##3##(1994-6#1)(1997-7#1)(2012-3#1)
it led##2##2##(1995-2#1)(2008-10#1)
it makes the##2##3##(1995-12#1)(2008-10#1)
it makes##4##2##(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)
it may act as##3##4##(1990-2#1)(2008-7#1)(2008-8#1)
it may also be##3##4##(2008-10#1)(2008-8#2)
it may also##7##3##(2008-10#1)(2008-8#3)(2008-9#1)(2009-10#1)(2013-8#1)
it may be a##6##4##(1993-2#1)(1994-11#1)(2008-10#3)(2010-7#1)
it may be associated with the##2##6##(2008-7#1)(2009-9#1)
it may be associated with##3##5##(2008-7#1)(2009-9#1)(2013-1#1)
it may be desirable to##2##5##(2008-11#1)(2008-4#1)
it may be difficult to##2##5##(1992-2#1)(2013-1#1)
it may be necessary to##2##5##(2008-11#1)(2008-4#1)
it may be possible to use##2##6##(2008-3#1)(2008-5#1)
it may be possible to##9##5##(1993-12#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)
it may be possible##10##4##(1993-12#1)(1994-6#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)
it may be that##2##4##(2008-10#1)(2008-7#1)
it may be useful to##2##5##(1992-2#1)(2008-10#1)
it may be##45##3##(1992-2#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-5#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#1)(2013-1#2)
it may cause##2##3##(2008-7#2)
it may have##5##3##(1995-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#1)
it may not##3##3##(1990-2#2)(1992-10#1)
it may play a##3##4##(1991-5#1)(1995-6#1)(2008-10#1)
it may play an important role in##2##7##(2008-10#1)(2010-5#1)
it may play##5##3##(1991-5#1)(1995-6#1)(2008-10#2)(2010-5#1)
it may represent a##2##4##(2008-10#1)(2011-2#1)
it may represent##3##3##(2008-10#1)(2011-2#2)
it may##107##2##(1990-2#3)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#1)(1997-1#2)(1997-6#1)(2007-11#2)(2008-10#20)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#3)
it means that##2##3##(2008-7#1)(2010-7#1)
it means##7##2##(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-1#2)
it mediates##4##2##(1993-12#1)(1997-2#1)(2008-5#1)(2012-2#1)
it might be##9##3##(1995-6#1)(1996-6#1)(1997-8#1)(2008-10#3)(2012-12#1)(2012-2#2)
it might##14##2##(1990-3#1)(1995-6#1)(1996-6#1)(1997-8#1)(2008-10#3)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#4)
it must be##4##3##(1995-5#1)(1996-1#1)(2008-10#1)(2008-7#1)
it must##8##2##(1991-1#1)(1991-3#1)(1993-2#2)(1995-5#1)(1996-1#1)(2008-10#1)(2008-7#1)
it necessary to##4##3##(1991-3#1)(2008-10#2)(2010-5#1)
it necessary##6##2##(1991-1#1)(1991-3#1)(1992-2#1)(2008-10#2)(2010-5#1)
it now##2##2##(2009-5#1)(2012-2#1)
it occurred##2##2##(1993-3#1)(2008-10#1)
it occurs in##2##3##(2010-11#1)(2012-12#1)
it occurs##5##2##(1992-12#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-8#1)
it offers a##2##3##(2008-10#1)(2013-8#1)
it offers##4##2##(1996-1#1)(2008-10#1)(2012-2#1)(2013-8#1)
it often##4##2##(2008-11#1)(2009-3#1)(2012-2#1)(2012-3#1)
it on the##3##3##(1995-5#1)(1997-6#1)(2008-9#1)
it on##6##2##(1995-5#1)(1997-6#1)(2008-10#1)(2008-9#2)(2011-2#1)
it one of the most common##2##6##(1991-2#1)(1997-7#1)
it opens a##2##3##(2008-10#1)(2012-2#1)
it out##3##2##(1997-1#1)(2008-10#1)(2012-12#1)
it passes through##2##3##(2008-10#1)(2008-3#1)
it permits##2##2##(1997-8#1)(2008-10#1)
it possesses a##2##3##(1993-12#1)(2009-8#1)
it possesses##4##2##(1993-12#1)(1995-2#1)(1995-9#1)(2009-8#1)
it possible for##4##3##(1992-3#1)(2008-10#1)(2008-9#1)(2010-12#1)
it possible to carry out##2##5##(1993-11#1)(1997-6#1)
it possible to characterize the##2##5##(2008-10#1)(2008-6#1)
it possible to compare the##2##5##(1994-6#1)(2008-10#1)
it possible to identify##4##4##(2008-10#1)(2008-11#2)(2008-4#1)
it possible to obtain##5##4##(2008-10#3)(2008-3#1)(2010-7#1)
it possible to select##2##4##(1997-2#1)(2008-10#1)
it possible to##52##3##(1991-6#1)(1992-5#1)(1993-11#1)(1994-6#2)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-10#20)(2008-11#4)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
it possible##56##2##(1991-6#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-6#2)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-10#21)(2008-11#4)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
it potentially##2##2##(2008-10#1)(2008-5#1)
it potentiated##2##2##(1990-5#1)(2008-8#1)
it presents in##2##3##(2009-1#1)(2013-1#1)
it presents##4##2##(2008-10#1)(2009-1#1)(2010-6#1)(2013-1#1)
it prevents##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
it produced a##2##3##(1992-12#1)(2008-9#1)
it produced##4##2##(1990-8#1)(1992-12#1)(2008-11#1)(2008-9#1)
it promotes##3##2##(2008-11#1)(2013-1#2)
it proved##2##2##(2008-10#1)(2011-2#1)
it provided##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
it provides a##4##3##(2008-10#1)(2008-9#1)(2009-3#1)(2009-8#1)
it provides an overview of##2##5##(1994-2#1)(2010-6#1)
it provides the same##2##4##(2008-10#1)(2009-8#1)
it provides the##3##3##(2008-10#1)(2009-8#1)(2010-10#1)
it provides##17##2##(1994-2#1)(2008-10#7)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-6#1)(2013-1#2)
it raises##3##2##(1993-2#1)(1995-2#1)(2008-11#1)
it rapidly##2##2##(2008-10#1)(2008-3#1)
it reached##3##2##(2008-11#1)(2010-1#1)(2011-2#1)
it reaches##2##2##(2008-11#1)(2009-10#1)
it ready for the next##2##5##(2008-10#2)
it receives##2##2##(2009-12#1)(2010-5#1)
it reduced##2##2##(2008-10#2)
it reduces the##2##3##(2010-8#1)(2011-2#1)
it reduces##3##2##(2010-8#1)(2011-2#1)(2012-2#1)
it remained##2##2##(1990-5#1)(2008-10#1)
it remains a##3##3##(2008-12#1)(2008-6#1)(2011-2#1)
it remains controversial##2##3##(1994-12#1)(1997-7#1)
it remains largely unknown how##2##5##(2011-2#1)(2012-3#1)
it remains to be shown##2##5##(2008-10#1)(2013-8#1)
it remains to be##4##4##(2008-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
it remains unclear how##2##4##(2008-8#1)(2009-5#1)
it remains unclear##6##3##(2008-8#1)(2009-5#1)(2009-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
it remains##26##2##(1990-12#1)(1991-12#1)(1994-12#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#2)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
it removes##2##2##(1990-3#1)(2012-3#1)
it represented##3##2##(1991-2#1)(2008-10#2)
it represents a##2##3##(2008-10#2)
it represents##5##2##(2008-10#2)(2008-7#1)(2010-6#1)(2011-2#1)
it requires##12##2##(1991-3#1)(1993-1#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
it revealed a##2##3##(1991-11#1)(2011-2#1)
it revealed##3##2##(1991-11#1)(2008-5#1)(2011-2#1)
it right##4##2##(1991-2#1)(1993-1#1)(1994-12#1)(2013-8#1)
it safe in##2##3##(1997-2#1)(2008-11#1)
it safe to##2##3##(2008-11#1)(2011-2#1)
it safe##6##2##(1997-2#1)(2008-11#3)(2011-2#2)
it seemed##4##2##(1990-2#1)(1993-8#1)(2008-10#1)(2008-8#1)
it seems reasonable to##3##4##(1990-9#1)(2008-10#1)(2008-12#1)
it seems that the##6##4##(1990-12#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
it seems that##15##3##(1990-12#3)(1993-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
it seems to be##2##4##(2008-11#1)(2013-1#1)
it seems to##3##3##(2008-11#1)(2013-1#2)
it seems##26##2##(1990-12#3)(1990-9#1)(1991-12#1)(1993-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#3)
it serves as a##4##4##(1994-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
it serves as##6##3##(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#2)(2011-2#1)
it serves to##2##3##(1990-5#1)(2008-9#1)
it serves##8##2##(1990-5#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)
it shares##3##2##(1994-12#1)(1996-6#1)(2008-9#1)
it should be combined with##2##5##(2008-10#1)(2011-2#1)
it should be noted that##2##5##(2008-10#1)(2008-11#1)
it should be possible to##6##5##(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#1)
it should be taken##2##4##(2008-10#1)(2013-1#1)
it should be very useful for##2##6##(1997-8#1)(2008-10#1)
it should be##39##3##(1991-2#1)(1992-12#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
it should not be##2##4##(1994-2#1)(1996-6#1)
it should##44##2##(1991-2#1)(1992-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
it showed a##2##3##(2008-11#1)(2008-5#1)
it showed no##2##3##(1997-7#1)(2008-10#1)
it showed significant##2##3##(2008-10#1)(2013-1#1)
it showed that##2##3##(2008-10#1)(2013-8#1)
it showed##11##2##(1994-12#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#1)(2013-8#1)
it shows##8##2##(1990-12#1)(2008-10#4)(2008-3#1)(2008-8#1)(2011-1#1)
it significantly potentiated##2##3##(1996-2#2)
it significantly##3##2##(1996-2#2)(2010-7#1)
it still##3##2##(1996-10#1)(2010-6#1)(2013-1#1)
it strongly##2##2##(2008-8#2)
it suggests that##4##3##(1990-2#1)(2008-10#1)(2008-8#2)
it suggests##6##2##(1990-2#1)(2008-10#1)(2008-8#2)(2008-9#1)(2013-1#1)
it suitable for##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
it takes for##2##3##(2008-3#1)(2012-3#1)
it takes to##3##3##(1993-12#1)(1993-3#1)(2012-3#1)
it takes##8##2##(1991-3#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#2)
it the##7##2##(1992-1#1)(1992-6#1)(1995-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
it through##4##2##(2008-10#3)(2008-12#1)
it thus##2##2##(1990-9#1)(2008-7#1)
it to a##5##3##(1995-5#1)(1996-1#1)(2008-10#2)(2008-9#1)
it to be a##2##4##(2008-10#1)(2012-2#1)
it to be##17##3##(1990-2#1)(1991-2#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
it to differ from##2##4##(2008-10#2)
it to the##12##3##(1990-8#1)(1995-2#1)(1997-1#2)(1997-3#1)(2008-10#4)(2012-2#1)(2013-1#2)
it to##74##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
it truly##2##2##(1991-3#1)(2008-3#1)
it turns##2##2##(2011-1#1)(2013-8#1)
it useful##2##2##(2007-12#1)(2008-11#1)
it values##2##2##(1997-3#1)(2010-3#1)
it was 0##5##3##(2008-10#5)
it was a##4##3##(1990-5#1)(1995-6#1)(2008-10#2)
it was also found that##2##5##(2008-11#1)(2008-5#1)
it was also##9##3##(1990-5#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#2)
it was an##3##3##(1992-9#1)(2008-10#1)(2012-12#1)
it was applied to the determination of these##2##8##(2008-10#2)
it was applied to the determination of##3##7##(2008-10#3)
it was applied to the##8##5##(2008-10#7)(2010-4#1)
it was applied to##10##4##(2008-10#8)(2010-4#1)(2011-2#1)
it was applied##12##3##(2008-10#10)(2010-4#1)(2011-2#1)
it was associated with##3##4##(1994-12#1)(2008-5#1)(2010-7#1)
it was associated##4##3##(1994-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
it was assumed that##3##4##(2008-10#1)(2008-6#2)
it was capable of##2##4##(1995-2#1)(2013-1#1)
it was caused by##2##4##(2008-10#1)(2010-1#1)
it was compared##2##3##(2008-10#1)(2012-2#1)
it was composed##2##3##(1990-6#1)(2007-12#1)
it was concluded that the##5##5##(1991-5#1)(1991-9#1)(1993-11#1)(2008-10#1)(2008-5#1)
it was concluded that##15##4##(1991-12#1)(1991-5#1)(1991-9#2)(1993-11#1)(2008-10#7)(2008-12#1)(2008-5#1)(2011-2#1)
it was confirmed that##2##4##(1995-12#1)(2008-8#1)
it was decided that##2##4##(2008-11#1)(2011-4#1)
it was demonstrated that the##3##5##(2008-10#1)(2008-6#1)(2008-8#1)
it was demonstrated that##8##4##(2008-10#4)(2008-6#1)(2008-8#3)
it was demonstrated##12##3##(1991-5#1)(1994-2#1)(2008-10#5)(2008-6#1)(2008-8#3)(2009-8#1)
it was dependent on##2##4##(1992-2#1)(2012-2#1)
it was detected in##2##4##(2008-10#1)(2008-8#1)
it was difficult to##2##4##(1990-2#1)(2008-10#1)
it was discovered that##2##4##(1997-1#1)(2008-10#1)
it was first introduced##2##4##(1991-3#1)(2008-10#1)
it was first##4##3##(1991-3#1)(1992-2#1)(2008-10#2)
it was found in##2##4##(1994-11#1)(2008-10#1)
it was found that As(2)O(3)##2##5##(2008-8#2)
it was found that the##20##5##(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)
it was found that they##2##5##(2008-10#1)(2010-1#1)
it was found that##53##4##(1990-12#1)(1991-11#1)(1991-6#1)(1992-3#1)(1995-11#1)(2007-11#1)(2008-10#24)(2008-11#5)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#6)(2009-11#1)(2010-1#1)(2010-5#3)(2011-2#1)
it was found to be##4##5##(2008-10#3)(2008-11#1)
it was found to##5##4##(1992-6#1)(2008-10#3)(2008-11#1)
it was found##63##3##(1990-12#1)(1991-11#1)(1991-6#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-11#1)(2007-11#1)(2008-10#28)(2008-11#7)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#6)(2009-11#1)(2010-1#1)(2010-5#3)(2011-2#2)(2013-1#1)
it was helpful##2##3##(1994-3#1)(2008-12#1)
it was highest in##2##4##(1990-8#1)(2008-12#1)
it was hypothesized that##5##4##(1992-2#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-8#1)
it was in##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
it was incubated##2##3##(2008-7#1)(2013-1#1)
it was indicated##2##3##(2008-10#1)(2008-8#1)
it was inhibited##2##3##(2008-11#1)(2012-3#1)
it was introduced into##2##4##(2008-10#2)
it was introduced##3##3##(2008-10#2)(2010-12#1)
it was more##4##3##(1991-8#1)(1993-8#1)(2008-11#1)(2011-2#1)
it was most##3##3##(2008-10#2)(2008-9#1)
it was necessary to remove##2##5##(2008-10#2)
it was necessary to##5##4##(1990-2#1)(2008-10#3)(2008-5#1)
it was not affected by##2##5##(1990-6#1)(1993-2#1)
it was not in##2##4##(2008-10#1)(2011-2#1)
it was not possible to##2##5##(2008-10#2)
it was not present##2##4##(2008-10#1)(2008-11#1)
it was not##21##3##(1990-6#1)(1991-3#1)(1993-2#1)(1995-12#1)(2008-10#9)(2008-11#4)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
it was observed that the##7##5##(1993-9#1)(2008-10#3)(2009-6#1)(2011-1#1)(2012-12#1)
it was observed that##15##4##(1993-9#1)(1994-8#1)(2008-10#7)(2008-2#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
it was observed##16##3##(1993-9#1)(1994-8#1)(2008-10#7)(2008-2#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
it was one##2##3##(1992-9#1)(1997-6#1)
it was only##2##3##(1994-12#1)(2008-10#1)
it was possible to estimate the##2##6##(2008-10#2)
it was possible to estimate##3##5##(1991-3#1)(2008-10#2)
it was possible to obtain a##2##6##(2008-10#2)
it was possible to obtain an##2##6##(2008-10#2)
it was possible to obtain##5##5##(2008-10#5)
it was possible to##38##4##(1990-6#1)(1991-3#2)(1992-9#1)(1993-8#1)(2008-10#23)(2008-11#4)(2008-7#4)(2008-9#1)(2013-1#1)
it was possible##40##3##(1990-6#1)(1991-3#2)(1992-9#1)(1993-8#1)(2008-10#24)(2008-11#4)(2008-7#4)(2008-9#2)(2013-1#1)
it was previously##2##3##(2008-10#1)(2012-3#1)
it was proved that##2##4##(2008-10#2)
it was recently##2##3##(2008-10#1)(2010-7#1)
it was revealed that##3##4##(1993-12#1)(2008-10#2)
it was reversed##3##3##(1994-2#1)(1997-7#1)(2008-10#1)
it was seen that##2##4##(2008-10#1)(2011-2#1)
it was shown that the##6##5##(1992-9#1)(1994-11#1)(2008-10#3)(2008-11#1)
it was shown that##21##4##(1992-9#1)(1993-2#1)(1994-11#2)(1996-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#2)(2008-8#2)(2011-1#1)(2012-2#1)(2013-8#2)
it was shown##22##3##(1992-9#1)(1993-2#1)(1994-11#2)(1996-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2011-1#1)(2012-2#1)(2013-8#2)
it was significantly##4##3##(2008-10#2)(2010-11#1)(2010-4#1)
it was successfully applied to the##2##6##(2008-10#2)
it was successfully applied to##3##5##(2008-10#3)
it was successfully applied##4##4##(2008-10#4)
it was suggested that the##3##5##(1993-3#1)(1993-8#1)(1995-11#1)
it was suggested that##5##4##(1993-3#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
it was suggested##6##3##(1993-3#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-12#1)
it was the##5##3##(1990-6#1)(1994-11#1)(1997-6#1)(2008-10#2)
it was too##2##3##(1991-3#1)(1995-12#1)
it was unclear whether##2##4##(2010-3#1)(2012-2#1)
it was used to##3##4##(1992-12#1)(2008-10#2)
it was used##6##3##(1990-6#1)(1992-12#1)(2008-1#1)(2008-10#2)(2009-5#1)
it was##490##2##(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#6)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#8)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#6)(1992-3#1)(1992-5#1)(1992-6#4)(1992-9#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-6#2)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#203)(2008-11#36)(2008-12#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#11)(2008-8#21)(2008-9#8)(2009-11#2)(2009-12#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-7#4)(2011-1#2)(2011-2#14)(2011-3#1)(2011-4#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#4)
it wasn't##2##2##(1997-3#1)(2012-2#1)
it were##4##2##(1995-12#1)(1995-3#1)(2008-10#2)
it will be a##3##4##(1996-3#1)(2008-10#1)(2008-5#1)
it will be an##2##4##(1996-1#1)(2008-11#1)
it will be more##2##4##(2008-12#1)(2008-8#1)
it will be possible##3##4##(1992-9#1)(2008-8#1)(2009-8#1)
it will be useful for##2##5##(1996-12#1)(2008-10#1)
it will be##23##3##(1991-7#1)(1992-3#1)(1992-9#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#4)(2009-8#1)(2011-2#1)
it will provide##2##3##(2008-11#1)(2009-12#1)
it will##35##2##(1990-11#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
it with a##5##3##(1996-1#1)(2008-10#2)(2008-4#1)(2010-8#1)
it with other##2##3##(2008-11#1)(2008-5#1)
it with the##6##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
it with##28##2##(1990-2#1)(1992-12#1)(1996-1#1)(1996-11#1)(1996-8#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
it work##2##2##(1993-11#1)(2011-3#1)
it works##3##2##(2008-10#1)(2008-4#2)
it would appear that##2##4##(1991-11#1)(2011-2#1)
it would appear##3##3##(1991-11#1)(2008-11#1)(2011-2#1)
it would be necessary to##2##5##(2008-12#1)(2008-8#1)
it would be possible to##3##5##(1996-3#1)(2008-10#1)(2011-3#1)
it would be##20##3##(1990-11#1)(1991-12#1)(1993-3#1)(1994-1#2)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
it would seem##3##3##(2008-11#2)(2009-1#1)
it would##35##2##(1990-11#2)(1990-5#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-3#1)(1994-1#2)(1996-1#1)(1996-3#1)(1996-9#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#2)
it yields##2##2##(2008-3#1)(2008-7#1)
it##3650##1##(1990-11#7)(1990-12#13)(1990-2#13)(1990-3#9)(1990-5#17)(1990-6#11)(1990-8#6)(1990-9#8)(1991-1#9)(1991-10#1)(1991-11#5)(1991-12#19)(1991-2#10)(1991-3#30)(1991-5#7)(1991-6#9)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#21)(1992-2#22)(1992-3#17)(1992-4#1)(1992-5#8)(1992-6#11)(1992-7#1)(1992-8#3)(1992-9#8)(1993-1#9)(1993-11#12)(1993-12#15)(1993-2#14)(1993-3#20)(1993-6#17)(1993-8#16)(1993-9#7)(1994-1#13)(1994-11#11)(1994-12#31)(1994-2#19)(1994-3#13)(1994-5#7)(1994-6#10)(1994-8#14)(1994-9#8)(1995-1#4)(1995-11#12)(1995-12#22)(1995-2#24)(1995-3#7)(1995-5#25)(1995-6#21)(1995-8#3)(1995-9#7)(1996-1#13)(1996-10#1)(1996-11#6)(1996-12#25)(1996-2#12)(1996-3#21)(1996-5#8)(1996-6#12)(1996-8#5)(1996-9#4)(1997-1#21)(1997-2#17)(1997-3#16)(1997-4#7)(1997-5#5)(1997-6#13)(1997-7#18)(1997-8#16)(1997-9#1)(2006-6#2)(2007-11#7)(2007-12#16)(2007-8#3)(2008-1#24)(2008-10#871)(2008-11#293)(2008-12#76)(2008-2#21)(2008-3#68)(2008-4#49)(2008-5#74)(2008-6#27)(2008-7#115)(2008-8#120)(2008-9#99)(2009-1#10)(2009-10#25)(2009-11#8)(2009-12#17)(2009-3#10)(2009-4#4)(2009-5#12)(2009-6#13)(2009-7#14)(2009-8#31)(2009-9#6)(2010-1#19)(2010-10#15)(2010-11#21)(2010-12#21)(2010-2#4)(2010-3#12)(2010-4#7)(2010-5#18)(2010-6#23)(2010-7#24)(2010-8#22)(2010-9#4)(2011-1#15)(2011-2#162)(2011-3#12)(2011-4#1)(2011-7#2)(2012-12#38)(2012-2#87)(2012-3#66)(2012-7#1)(2012-9#3)(2013-1#123)(2013-7#5)(2013-8#63)
it&quot##2##1##(2008-11#1)(2008-5#1)
it's##17##1##(1990-5#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-9#2)(2010-12#1)(2012-12#1)(2012-3#3)(2013-8#1)
it)##2##1##(1992-9#1)(1993-6#1)
it?##7##1##(1991-12#1)(1993-9#1)(1997-6#1)(2008-2#1)(2010-10#1)(2012-2#1)(2012-3#1)
it?]##4##1##(1990-6#1)(1991-3#1)(1991-6#1)(1996-2#1)
italiae##3##1##(2008-10#3)
italian##5##1##(2008-10#1)(2013-1#4)
italicum was##2##2##(2008-10#2)
italicum##4##1##(2008-10#4)
itching##6##1##(2008-5#4)(2012-12#2)
item and##4##2##(2008-11#1)(2012-2#2)(2013-1#1)
item hierarchy##2##2##(2012-2#2)
item in the set##2##4##(1990-11#2)
item is##2##2##(2012-2#2)
item length##2##2##(2012-2#2)
item quality##2##2##(2012-2#2)
item##41##1##(1990-11#2)(1993-2#1)(1993-6#1)(2008-11#2)(2008-12#3)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-2#21)(2012-3#2)(2013-1#2)
item-writing flaws##5##2##(2008-12#5)
item-writing guidelines##2##2##(2008-12#2)
item-writing##8##1##(2008-12#8)
items and##4##2##(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
items encoded in##2##3##(2008-9#2)
items for##2##2##(1993-12#1)(2008-12#1)
items in the##2##3##(2010-1#1)(2012-2#1)
items in##6##2##(2008-11#1)(2010-1#1)(2010-8#1)(2012-2#3)
items long##2##2##(2012-2#2)
items of the##3##3##(2008-10#2)(2010-10#1)
items of##4##2##(1991-2#1)(2008-10#2)(2010-10#1)
items showed##2##2##(2008-6#1)(2010-10#1)
items that##2##2##(2008-7#1)(2009-4#1)
items to##2##2##(2008-10#1)(2012-2#1)
items was##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
items were##9##2##(1991-2#2)(2008-12#2)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
items with##5##2##(2008-11#1)(2010-11#1)(2010-2#2)(2012-2#1)
items##94##1##(1990-11#1)(1991-12#1)(1991-2#3)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#3)(1993-3#2)(1996-3#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#9)(2008-12#5)(2008-6#1)(2008-7#4)(2008-9#3)(2009-11#2)(2009-12#3)(2009-4#1)(2010-1#3)(2010-10#2)(2010-11#3)(2010-2#2)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#21)(2012-3#2)(2013-1#2)(2013-8#1)
items)##5##1##(1990-12#1)(1990-8#1)(2008-11#1)(2008-6#1)(2008-7#1)
iterated prisoner's dilemma##2##3##(2008-8#2)
iterated##3##1##(2008-10#1)(2008-8#2)
iteration##5##1##(2008-10#2)(2008-3#2)(2011-8#1)
iterations##3##1##(2008-11#1)(2008-2#1)(2008-4#1)
iterative Fourier transform algorithm##2##4##(2008-3#2)
iterative approach##2##2##(2008-11#1)(2008-3#1)
iterative computer##2##2##(2008-10#2)
iterative method for##2##3##(2008-10#1)(2010-3#1)
iterative method##3##2##(2008-10#2)(2010-3#1)
iterative search##2##2##(2008-10#2)
iterative target transformation factor analysis##2##5##(2008-10#2)
iterative##38##1##(1992-9#1)(2007-11#1)(2008-10#13)(2008-11#4)(2008-2#4)(2008-3#7)(2008-6#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-8#1)(2013-1#3)
iteratively##4##1##(2008-10#3)(2011-2#1)
itraconazole and##2##2##(2008-5#2)
itraconazole##7##1##(2008-5#6)(2013-8#1)
its &quot##3##2##(1990-9#1)(1994-1#1)(2008-11#1)
its 1##11##2##(2008-10#5)(2011-2#6)
its 3##9##2##(2008-9#1)(2011-2#8)
its 5' flanking##3##3##(1990-8#1)(1993-6#1)(2011-10#1)
its 5'##5##2##(1990-8#1)(1993-6#1)(1997-8#1)(2008-8#1)(2011-10#1)
its A##3##2##(1993-11#2)(2008-3#1)
its C-terminal##2##2##(1991-5#1)(1993-12#1)
its DNA##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
its ability to detect##2##4##(1991-3#1)(1997-7#1)
its ability to extract##2##4##(2008-10#2)
its ability to grow##2##4##(2008-10#1)(2011-2#1)
its ability to induce##5##4##(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)
its ability to##56##3##(1991-3#1)(1991-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#2)(1995-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#21)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-3#1)(2013-1#1)
its ability##57##2##(1991-3#1)(1991-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#2)(1995-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#21)(2008-11#5)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-3#1)(2013-1#1)
its absence##5##2##(1991-12#1)(1993-8#1)(2008-10#2)(2013-8#1)
its absorbance##2##2##(2008-10#2)
its accelerated##2##2##(1995-1#1)(1997-8#1)
its accumulation was##2##3##(2008-10#2)
its accumulation##4##2##(1995-6#1)(2008-10#3)
its accuracy was##3##3##(2008-10#3)
its accuracy##5##2##(2008-10#5)
its acetylated##2##2##(2008-10#2)
its action##5##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
its activation##2##2##(2008-5#1)(2009-8#1)
its active##5##2##(1993-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
its activities##2##2##(2009-6#1)(2011-2#1)
its activity is##2##3##(1992-8#1)(2008-5#1)
its activity##16##2##(1991-5#1)(1992-8#1)(1993-6#1)(1995-6#2)(1997-1#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
its acute##3##2##(1994-5#1)(2008-9#1)(2010-12#1)
its adequate##2##2##(1991-2#2)
its administration##3##2##(2007-8#1)(2008-10#2)
its adoption##3##2##(1994-12#1)(2008-3#2)
its adsorption##3##2##(2008-10#2)(2013-1#1)
its advantages##5##2##(2008-10#4)(2008-9#1)
its affinity for##2##3##(1992-6#1)(1995-11#1)
its affinity##5##2##(1992-6#1)(1993-8#1)(1995-11#1)(2008-11#1)(2008-5#1)
its aggregation##2##2##(1990-12#1)(1991-2#1)
its aims and##2##3##(1993-11#1)(2010-1#1)
its aims##3##2##(1993-11#1)(1993-6#1)(2010-1#1)
its alpha##2##2##(1990-12#1)(1991-7#1)
its amino acid sequence##2##4##(2008-10#2)
its amino acid##3##3##(2008-10#3)
its amino##5##2##(1990-7#1)(2008-10#4)
its analogs##3##2##(1990-5#1)(2008-11#1)(2009-7#1)
its analogue##4##2##(2008-11#2)(2010-3#2)
its analytical##9##2##(2008-10#8)(2010-7#1)
its anatomical##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
its anti-inflammatory##2##2##(2008-5#1)(2011-2#1)
its anti-tumor##2##2##(2008-11#1)(2008-9#1)
its antibody##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
its antigen##2##2##(2008-11#1)(2009-3#1)
its antioxidant##3##2##(2008-10#2)(2012-3#1)
its appearance##2##2##(2008-10#2)
its applicability for the##2##4##(2008-10#2)
its applicability for##4##3##(1992-12#1)(2008-10#2)(2008-3#1)
its applicability in##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
its applicability to##2##3##(2008-10#1)(2008-3#1)
its applicability##11##2##(1992-12#1)(2008-10#6)(2008-3#2)(2010-12#1)(2012-3#1)
its application as an##2##4##(1997-6#1)(2008-10#1)
its application as##5##3##(1997-6#1)(2008-10#4)
its application for the##5##4##(2008-10#4)(2008-11#1)
its application for##13##3##(2008-10#11)(2008-11#1)(2008-7#1)
its application in a##2##4##(2008-10#1)(2008-11#1)
its application in the##4##4##(1993-2#1)(2008-10#3)
its application in##20##3##(1993-2#1)(1995-3#1)(2008-10#15)(2008-11#1)(2011-2#1)(2013-8#1)
its application to the##11##4##(2008-10#10)(2012-2#1)
its application to##38##3##(1990-5#1)(2008-10#29)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#2)
its application##92##2##(1990-5#1)(1992-2#1)(1993-2#1)(1995-3#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#67)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-8#1)
its approach to##2##3##(1997-1#1)(2008-10#1)
its approach##3##2##(1997-1#1)(2008-10#1)(2013-1#1)
its appropriate##2##2##(2008-10#1)(2012-2#1)
its aqueous##2##2##(2008-10#2)
its associated##14##2##(1994-3#1)(2008-10#6)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
its associates and impact on work load in institutional long-term care##2##11##(2008-7#2)
its association with the##4##4##(1992-3#1)(1994-12#1)(1997-5#1)(2009-8#1)
its association with##18##3##(1992-3#1)(1994-12#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
its assumptions##2##2##(2008-3#1)(2008-9#1)
its attachment to##3##3##(1992-9#1)(1995-2#1)(2008-10#1)
its autophosphorylation##2##2##(1995-2#1)(1995-8#1)
its availability##3##2##(1991-3#1)(1997-1#1)(2012-3#1)
its base##2##2##(2008-12#1)(2013-1#1)
its basis##2##2##(1994-2#1)(1995-3#1)
its beginning##2##2##(2008-10#1)(2009-8#1)
its behavior##3##2##(1993-8#1)(2008-8#1)(2009-5#1)
its behaviour##2##2##(2008-5#1)(2013-1#1)
its being##2##2##(1991-7#1)(2013-8#1)
its beneficiaries##2##2##(1995-2#1)(1997-3#1)
its binding site##4##3##(1992-3#1)(1996-3#1)(2008-10#1)(2008-8#1)
its binding to##4##3##(2008-3#1)(2008-7#1)(2008-8#2)
its binding##12##2##(1990-2#1)(1992-3#1)(1995-11#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#4)
its biocompatibility##2##2##(2008-10#1)(2008-12#1)
its biological activity##3##3##(1995-12#1)(2008-8#2)
its biological##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)
its boards##2##2##(2012-2#2)
its branches and##2##3##(1997-8#2)
its branches##5##2##(1997-8#5)
its breakdown##3##2##(2008-10#3)
its broad##4##2##(1997-6#1)(2008-11#1)(2010-11#1)(2011-1#1)
its cDNA was##2##3##(1990-8#1)(2008-9#1)
its cDNA##6##2##(1990-8#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
its capability to##3##3##(1993-12#1)(2010-3#1)(2012-2#1)
its capacity to##5##3##(1994-8#1)(2008-10#3)(2013-1#1)
its capacity##6##2##(1994-8#1)(2008-10#3)(2008-11#1)(2013-1#1)
its catalytic action on the oxidation of##2##7##(2008-10#2)
its catalytic action on##3##4##(2008-10#3)
its catalytic activity##4##3##(1993-8#1)(1996-2#1)(2008-10#2)
its catalytic effect on the##10##5##(2008-10#10)
its catalytic effect on##11##4##(2008-10#11)
its catalytic function##2##3##(1990-5#1)(1996-2#1)
its catalytic##21##2##(1990-5#1)(1993-8#1)(1996-2#2)(2008-10#17)
its cell##5##2##(1990-5#1)(1990-8#1)(2007-12#1)(2008-11#1)(2011-2#1)
its cells##3##2##(2007-12#1)(2008-8#1)(2011-2#1)
its cellular##2##2##(2008-11#2)
its central nervous system##2##4##(2008-10#1)(2010-1#1)
its central##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
its changes##2##2##(2008-10#1)(2008-6#1)
its characteristic##3##2##(2010-6#1)(2012-12#1)(2013-1#1)
its characteristics##4##2##(1993-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
its chemical##6##2##(2008-10#4)(2008-7#1)(2011-2#1)
its chronic##4##2##(1992-12#1)(1996-12#1)(2008-12#1)(2010-12#1)
its clinical features and##2##4##(2010-1#1)(2013-8#1)
its clinical##15##2##(2008-10#2)(2008-11#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-8#2)
its close##2##2##(2007-12#1)(2008-10#1)
its comparison##2##2##(2008-10#1)(2013-1#1)
its complementary##2##2##(1991-5#1)(1996-2#1)
its complete##3##2##(1995-6#1)(2008-9#1)(2011-2#1)
its complex with##3##3##(2008-10#3)
its complex##8##2##(2008-10#6)(2012-3#1)(2013-1#1)
its complexation with##2##3##(2008-10#2)
its complexes##3##2##(2008-10#3)
its complexity##2##2##(2013-1#1)(2013-8#1)
its complications##5##2##(1990-11#1)(2008-1#1)(2008-7#1)(2010-10#1)(2013-1#1)
its components##10##2##(1990-11#1)(1991-2#1)(1997-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)
its comprehensive##2##2##(1997-2#1)(2013-1#1)
its concentration in##2##3##(2008-10#1)(2008-11#1)
its concentration was##4##3##(1991-5#1)(2008-10#3)
its concentration##19##2##(1991-5#1)(2008-10#15)(2008-11#2)(2009-9#1)
its conclusion##4##2##(1992-2#2)(1994-9#1)(2008-5#1)
its configuration##2##2##(1995-3#1)(2008-10#1)
its conformational##2##2##(1992-6#1)(2009-5#1)
its connections with the##2##4##(1993-6#1)(2013-8#1)
its connections with##3##3##(1993-6#1)(2011-2#1)(2013-8#1)
its connections##6##2##(1993-6#2)(2011-2#3)(2013-8#1)
its considerable##2##2##(1994-1#1)(2011-2#1)
its constituent##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
its content was determined by##3##5##(2008-10#3)
its content##7##2##(1990-3#1)(2008-10#3)(2008-11#1)(2008-5#2)
its context##2##2##(2008-9#1)(2013-1#1)
its continuous##2##2##(2008-10#1)(2009-12#1)
its contribution to the##2##4##(2008-3#1)(2008-7#1)
its control##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
its controlled object##2##3##(2009-5#2)
its conversion into##3##3##(1991-7#1)(2008-10#1)(2008-11#1)
its conversion##4##2##(1991-7#1)(2008-10#2)(2008-11#1)
its correct diagnosis##2##3##(2012-12#1)(2012-3#1)
its correct##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
its correlation with serum##2##4##(2009-5#1)(2011-2#1)
its correlation with##3##3##(2008-10#1)(2009-5#1)(2011-2#1)
its correlation##4##2##(2008-10#2)(2009-5#1)(2011-2#1)
its corresponding##6##2##(1994-8#1)(2008-10#3)(2008-5#1)(2008-6#1)
its critical##6##2##(2008-11#1)(2008-5#2)(2009-10#1)(2010-11#1)(2013-1#1)
its current##5##2##(1992-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-1#1)
its cytoplasm##2##2##(2008-8#1)(2011-2#1)
its daily##2##2##(1991-2#1)(2013-1#1)
its decrease##2##2##(2008-10#1)(2011-2#1)
its degradation product were##2##4##(2008-10#2)
its degradation product##5##3##(2008-10#4)(2008-5#1)
its degradation products##4##3##(2008-10#4)
its degradation##10##2##(1995-8#1)(2008-10#8)(2008-5#1)
its degree of##3##3##(1990-6#1)(1991-5#1)(1992-6#1)
its degree##4##2##(1990-6#1)(1991-5#1)(1992-6#1)(2008-11#1)
its derivative##3##2##(2008-10#2)(2008-5#1)
its derivatives##30##2##(1990-6#1)(1993-11#2)(1993-8#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#12)(2008-11#2)(2008-5#2)(2008-8#2)(2008-9#3)(2013-1#1)
its detection##12##2##(2008-10#9)(2011-2#1)(2013-1#2)
its determination at##3##3##(2008-10#3)
its determination by flame atomic##3##5##(2008-10#3)
its determination by the##2##4##(2008-10#1)(2008-11#1)
its determination by##12##3##(2008-10#11)(2008-11#1)
its determination in##9##3##(2008-10#9)
its determination##30##2##(1997-2#2)(2008-10#27)(2008-11#1)
its development##11##2##(2006-6#1)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#1)(2012-3#2)(2013-1#1)
its diagnosis##4##2##(2008-12#1)(2009-9#1)(2011-2#1)(2012-3#1)
its diagnostic##2##2##(2008-7#1)(2011-2#1)
its different##3##2##(2009-10#1)(2013-8#2)
its diffusion##2##2##(2008-10#1)(2008-11#1)
its direct##3##2##(2008-8#2)(2012-12#1)
its direction##4##2##(1991-2#2)(2008-11#1)(2008-9#1)
its disorders##2##2##(1995-5#1)(2008-6#1)
its dissociation##3##2##(1995-11#1)(2008-10#2)
its distal##3##2##(1997-5#1)(2008-7#1)(2011-2#1)
its distribution##4##2##(2008-10#2)(2008-12#1)(2011-2#1)
its downstream##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
its dynamic##2##2##(2008-5#1)(2009-10#1)
its earlier##2##2##(1993-3#1)(2010-9#1)
its earliest##2##2##(1996-3#1)(2010-10#1)
its early diagnosis and##2##4##(1993-11#1)(2008-12#1)
its early diagnosis##3##3##(1993-11#1)(2008-12#1)(2010-8#1)
its early##6##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)
its ease of##2##3##(2008-10#1)(2008-11#1)
its economic##2##2##(1992-1#1)(2008-10#1)
its effect of##2##3##(2011-3#2)
its effect on the binding of##2##6##(1995-11#2)
its effect on the##11##4##(1992-12#1)(1993-8#1)(1994-3#1)(1995-11#3)(2008-10#4)(2008-11#1)
its effect on##36##3##(1992-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-11#4)(1995-12#1)(1995-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-4#2)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
its effect##47##2##(1992-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-4#2)(2011-2#2)(2011-3#2)(2012-3#3)(2013-1#2)(2013-8#1)
its effectiveness in##4##3##(1993-1#1)(2008-10#1)(2008-11#1)(2012-3#1)
its effectiveness##8##2##(1991-3#1)(1993-1#1)(2008-10#2)(2008-11#2)(2009-4#1)(2012-3#1)
its effects on##15##3##(1993-3#1)(1994-5#1)(1995-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
its effects##22##2##(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
its efficacy and safety##2##4##(2008-5#1)(2008-6#1)
its efficacy for##2##3##(2008-11#1)(2009-10#1)
its efficacy in##2##3##(2008-10#1)(2010-12#1)
its efficacy##9##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)
its efficiency##2##2##(1991-12#1)(2008-3#1)
its electrochemical behavior and##2##4##(2008-10#2)
its electrochemical##5##2##(2008-10#5)
its electrostatic interaction with##2##4##(2008-10#2)
its elimination##3##2##(1994-9#1)(1997-7#1)(2007-11#1)
its emphasis on##2##3##(1997-1#1)(2008-8#1)
its empirical##2##2##(1992-12#2)
its end##2##2##(1996-2#1)(2008-9#1)
its enhancing effect on the##5##5##(2008-10#5)
its entire##3##2##(1996-6#1)(2008-10#1)(2008-2#1)
its environment##5##2##(1990-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#1)
its environmental##6##2##(2008-10#3)(2008-11#1)(2011-2#1)(2012-3#1)
its equilibrium##2##2##(2008-10#2)
its equivalent##2##2##(1991-8#1)(1997-6#1)
its eradication##2##2##(2008-11#1)(2011-2#1)
its essential##2##2##(2011-2#1)(2012-3#1)
its ethyl##3##2##(1991-6#1)(2008-10#2)
its etiology##3##2##(1992-3#1)(2008-10#1)(2010-6#1)
its evaluation##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
its evolution##10##2##(1991-8#1)(1992-9#1)(2008-10#4)(2008-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
its evolutionary##2##2##(2008-9#1)(2009-6#1)
its exact##3##2##(1996-3#1)(2009-7#1)(2013-8#1)
its existence##2##2##(1992-2#1)(2011-2#1)
its experience##3##2##(1995-5#1)(1996-12#1)(2008-5#1)
its experimental##2##2##(2008-11#1)(2008-3#1)
its export##2##2##(2008-10#1)(2008-12#1)
its exposure to##2##3##(2008-10#1)(2008-11#1)
its expression in##6##3##(1996-12#1)(1997-2#2)(1997-7#1)(2008-8#2)
its expression is##6##3##(1992-12#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
its expression level##2##3##(1996-6#1)(2010-12#1)
its expression##25##2##(1992-12#1)(1993-12#1)(1993-3#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-2#2)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#5)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
its extensive##2##2##(2009-6#1)(2013-1#1)
its extracellular##3##2##(1991-6#1)(1993-6#2)
its extraction##3##2##(2008-10#2)(2008-12#1)
its extreme##3##2##(1996-12#1)(2008-10#1)(2011-1#1)
its failure##3##2##(1990-11#1)(1990-6#1)(2009-7#1)
its family##2##2##(1995-5#1)(1996-12#1)
its favorable##2##2##(2008-10#1)(2010-11#1)
its feasibility for##2##3##(2008-10#1)(2008-5#1)
its feasibility##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
its final##2##2##(2008-10#2)
its findings##2##2##(1995-5#1)(2008-11#1)
its first year##2##3##(1991-1#1)(1995-1#1)
its first##16##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-12#1)(1995-1#1)(1997-2#1)(2008-10#6)(2008-5#1)(2009-8#1)(2011-2#2)
its fluorescence intensity##2##3##(2008-10#2)
its fluorescence##5##2##(1990-12#1)(2008-10#4)
its focus##2##2##(2008-7#1)(2010-10#1)
its formation##4##2##(1990-7#1)(2008-10#1)(2009-8#1)(2011-2#1)
its former glory##2##3##(2008-5#1)(2010-8#1)
its four##4##2##(1995-3#1)(2008-10#2)(2013-1#1)
its free##2##2##(1997-7#1)(2008-5#1)
its frequency##2##2##(2008-10#1)(2008-7#1)
its full##3##2##(1992-8#1)(2008-10#1)(2008-11#1)
its function in##5##3##(1993-3#1)(2008-8#2)(2008-9#1)(2009-8#1)
its function##13##2##(1992-9#1)(1993-3#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
its functional##8##2##(1995-12#1)(1996-2#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#2)(2013-1#1)
its functions are##2##3##(1995-12#1)(2011-2#1)
its functions##5##2##(1995-12#1)(2008-6#1)(2008-9#1)(2011-2#2)
its fundamental##2##2##(1993-2#1)(2008-3#1)
its future##3##2##(1996-3#1)(2010-8#1)(2012-3#1)
its gene##5##2##(1991-7#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)
its genetic##5##2##(2008-10#2)(2008-9#1)(2009-8#1)(2011-2#1)
its genetically##2##2##(2009-5#1)(2011-1#1)
its genome##6##2##(2008-10#2)(2011-2#3)(2012-3#1)
its genomic##3##2##(1997-7#1)(2008-10#1)(2008-4#1)
its geographic##2##2##(2008-10#2)
its goals##3##2##(1994-3#1)(1994-9#1)(1995-12#1)
its good##3##2##(1992-12#1)(2008-10#1)(2009-1#1)
its great##2##2##(1995-6#1)(1996-1#1)
its growth##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
its health##5##2##(1992-12#1)(1995-12#1)(2008-10#2)(2012-2#1)
its high sensitivity##2##3##(2008-10#2)
its high##24##2##(1991-2#1)(1992-6#1)(1993-3#1)(1997-4#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)
its higher##5##2##(2007-8#1)(2008-10#2)(2008-5#2)
its highest##2##2##(2008-10#1)(2008-5#1)
its highly##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2009-7#1)
its history##3##2##(1990-3#1)(2008-11#1)(2008-8#1)
its host plant##3##3##(2009-8#3)
its host##19##2##(1997-1#1)(2008-10#10)(2008-9#1)(2009-8#3)(2011-1#1)(2011-2#2)(2013-8#1)
its hosts##2##2##(2008-10#1)(2008-8#1)
its human counterpart##3##3##(1997-7#2)(2011-1#1)
its human##4##2##(1997-7#2)(2008-10#1)(2011-1#1)
its humectancy##2##2##(2008-5#2)
its hydrolysis##2##2##(2008-10#2)
its hydrophobic##2##2##(2008-10#1)(2008-11#1)
its image##3##2##(1994-12#1)(1994-3#2)
its immune system##2##3##(1995-12#1)(2012-2#1)
its immunogenicity##2##2##(2008-11#1)(2013-8#1)
its impact on the##6##4##(1996-1#1)(2008-11#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
its impact on##23##3##(1994-3#1)(1996-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
its impact##25##2##(1994-1#1)(1994-3#1)(1996-1#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
its implementation in##3##3##(1995-3#1)(1995-5#1)(2008-3#1)
its implementation##9##2##(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(2008-3#2)(2012-2#1)(2012-3#2)
its implication##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)
its implications on##2##3##(1992-12#1)(2011-2#1)
its implications##13##2##(1992-12#1)(1992-9#1)(1993-5#1)(1993-8#1)(1995-2#1)(2008-1#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
its importance in##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
its importance##6##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
its important derivatives##2##3##(2008-10#2)
its improvement##2##2##(2008-11#1)(2011-2#1)
its in vivo##2##3##(1992-6#1)(2008-10#1)
its in##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
its inactivation##2##2##(1995-6#1)(2007-12#1)
its inception##4##2##(1996-3#2)(2008-12#1)(2008-9#1)
its incidence##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
its inclusion##3##2##(1995-12#2)(2009-10#1)
its increased##2##2##(1995-2#1)(2008-10#1)
its increasing##2##2##(1991-6#1)(2007-12#1)
its induction##2##2##(1993-6#1)(2008-10#1)
its influence on the##5##4##(1991-6#1)(1994-5#1)(2008-11#1)(2008-2#1)(2008-7#1)
its influence on##11##3##(1991-6#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2013-8#1)
its influence##12##2##(1991-6#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
its inherent##2##2##(2008-12#1)(2008-4#1)
its inhibition effect on the##2##5##(2008-10#2)
its inhibition##9##2##(1992-9#1)(1993-8#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#2)
its inhibitory effect on the##3##5##(1993-6#1)(2008-10#2)
its inhibitory effect on##5##4##(1993-6#1)(2008-10#3)(2008-5#1)
its inhibitory##6##2##(1993-6#1)(2008-10#3)(2008-5#1)(2013-1#1)
its initial##12##2##(1991-12#1)(1992-2#1)(1993-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-2#2)
its insect##2##2##(2008-8#1)(2008-9#1)
its insensitivity to##2##3##(2007-12#1)(2010-7#1)
its intensity and##2##3##(1994-8#1)(2011-2#1)
its intensity##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
its interaction with##14##3##(1994-11#1)(1997-1#1)(1997-2#1)(2008-10#9)(2009-10#1)(2010-4#1)
its interaction##15##2##(1994-11#1)(1997-1#1)(1997-2#1)(2008-10#9)(2008-8#1)(2009-10#1)(2010-4#1)
its interactions with##2##3##(1997-2#1)(2008-9#1)
its interactions##3##2##(1997-2#2)(2008-9#1)
its interference##4##2##(1997-1#1)(2008-10#2)(2008-3#1)
its internal##2##2##(2008-12#1)(2009-10#1)
its intracellular##3##2##(1996-2#1)(2008-11#1)(2009-8#1)
its introduction##2##2##(2008-10#1)(2012-2#1)
its involvement in##2##3##(1996-12#1)(1996-2#1)
its involvement##4##2##(1996-12#1)(1996-2#2)(2011-2#1)
its ion pair##3##3##(1995-6#1)(2008-10#2)
its ionic##2##2##(2008-10#1)(2010-7#1)
its ionization##2##2##(2008-10#2)
its isoelectric##2##2##(2008-7#2)
its isolated##6##2##(1993-8#1)(1994-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
its isolation from##2##3##(2008-1#1)(2008-3#1)
its isolation##3##2##(2008-1#1)(2008-3#1)(2009-12#1)
its isotope##2##2##(2008-10#2)
its keto acid##3##3##(2008-11#3)
its key role in##2##4##(2008-9#1)(2013-1#1)
its key##4##2##(1993-3#1)(2008-6#1)(2008-9#1)(2013-1#1)
its kinase##2##2##(1995-6#1)(2013-8#1)
its known##4##2##(1991-12#1)(2008-10#1)(2010-12#1)(2012-2#1)
its lack of##3##3##(1992-5#1)(2009-8#1)(2013-1#1)
its large size##2##3##(2008-6#1)(2013-7#1)
its large##4##2##(2008-6#1)(2011-1#1)(2012-2#1)(2013-7#1)
its leadership role##2##3##(2008-11#1)(2008-12#1)
its length##3##2##(1990-5#1)(2008-3#1)(2013-1#1)
its level##2##2##(1992-6#1)(2008-10#1)
its life cycle##4##3##(2008-10#1)(2009-3#1)(2009-8#1)(2012-2#1)
its ligand##4##2##(1994-12#1)(1995-2#1)(2008-8#1)(2011-2#1)
its likely##2##2##(2008-10#1)(2008-5#1)
its limitations##8##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2011-2#1)
its localization##2##2##(2008-9#1)(2012-2#1)
its location##3##2##(1990-8#1)(2013-1#2)
its long##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2010-7#1)
its long-term##4##2##(2008-10#1)(2008-11#2)(2008-9#1)
its low cost##2##3##(1993-3#1)(2009-1#1)
its low##9##2##(1993-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-1#1)
its lower##2##2##(2008-10#2)
its mRNA level##3##3##(1994-11#1)(2008-9#1)(2013-1#1)
its mRNA##8##2##(1994-11#2)(1995-12#1)(1995-2#1)(2008-8#1)(2008-9#2)(2013-1#1)
its main branches##2##3##(1997-8#2)
its main metabolites##2##3##(1995-11#1)(2008-10#1)
its main##21##2##(1995-11#1)(1997-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2009-1#1)(2010-1#1)(2012-2#1)(2012-3#1)
its major metabolites##2##3##(2008-10#1)(2011-3#1)
its major##10##2##(1997-8#1)(2008-10#6)(2008-11#1)(2011-3#1)(2013-8#1)
its malignant##2##2##(2010-11#1)(2013-1#1)
its mammalian##2##2##(1990-5#1)(2011-2#1)
its managed care##2##3##(1993-2#1)(1994-12#1)
its management and##2##3##(1991-2#1)(2013-1#1)
its management##14##2##(1991-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#3)
its manufacture##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
its many##3##2##(1992-3#1)(2008-5#1)(2008-7#1)
its maximal##2##2##(1992-12#1)(1993-8#1)
its maximum##9##2##(2008-10#7)(2008-12#1)(2008-7#1)
its meaning##2##2##(2008-11#1)(2010-10#1)
its measurement##2##2##(2010-5#1)(2012-2#1)
its mechanism is##2##3##(2008-8#1)(2013-8#1)
its mechanism of action##8##4##(1992-3#1)(1995-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-3#1)
its mechanism of##9##3##(1992-3#1)(1995-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#2)(2011-3#1)
its mechanism##15##2##(1992-3#1)(1995-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-12#1)(2011-3#1)(2013-8#2)
its mechanisms##3##2##(2010-12#1)(2011-2#1)(2011-3#1)
its medical##2##2##(1993-2#1)(1995-2#1)
its members##3##2##(2011-2#2)(2012-12#1)
its metabolic##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
its metabolite##11##2##(1993-12#1)(1995-11#1)(2008-10#8)(2009-6#1)
its metabolites##20##2##(1993-3#1)(1995-8#1)(2008-10#11)(2008-11#5)(2008-7#1)(2011-3#1)
its metal##3##2##(2008-10#3)
its mobility##2##2##(2008-10#2)
its mode of##2##3##(1992-10#1)(2008-8#1)
its modulation##4##2##(1990-3#3)(1993-2#1)
its modulatory##2##2##(2008-7#1)(2009-12#1)
its molecular mechanism##2##3##(2008-10#1)(2008-8#1)
its molecular structure##3##3##(1991-2#1)(2008-10#2)
its molecular##12##2##(1991-2#1)(1992-6#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#2)
its more##4##2##(1990-2#1)(1991-12#1)(2008-11#1)(2009-8#1)
its morphological##2##2##(2008-5#1)(2012-12#1)
its most##4##2##(1990-5#1)(1993-12#1)(1994-12#1)(2010-5#1)
its mouth##2##2##(2008-5#2)
its movement##3##2##(1990-2#1)(2008-10#1)(2013-8#1)
its mutant##3##2##(2008-8#2)(2008-9#1)
its native state##3##3##(2008-10#3)
its native##7##2##(2008-10#4)(2008-7#1)(2008-9#1)(2010-6#1)
its natural##9##2##(1993-6#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)
its normal##2##2##(1990-5#1)(2008-10#1)
its novel##2##2##(2008-10#1)(2011-2#1)
its nuclear##4##2##(1990-5#1)(1994-11#1)(2008-8#1)(2011-2#1)
its obligation to##2##3##(1995-12#1)(1995-6#1)
its occurrence and##2##3##(2008-10#1)(2008-7#1)
its occurrence##4##2##(2008-10#1)(2008-7#2)(2009-8#1)
its on-line##2##2##(2008-10#2)
its onset##2##2##(1991-6#1)(1997-7#1)
its operation##3##2##(2007-12#1)(2008-11#1)(2010-12#1)
its organizational structure##2##3##(1994-2#1)(1996-1#1)
its origin##5##2##(1991-12#1)(2008-8#1)(2010-7#1)(2013-1#2)
its original value##2##3##(2008-5#1)(2008-8#1)
its original##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
its outcome##2##2##(2008-9#1)(2012-3#1)
its own expression##2##3##(1990-5#1)(2010-10#1)
its own promoter##3##3##(1995-2#2)(2008-10#1)
its own##51##2##(1990-12#1)(1990-5#2)(1991-5#2)(1991-9#2)(1992-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1996-1#1)(1996-12#1)(1996-2#2)(1997-7#2)(2008-10#6)(2008-11#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#3)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)
its oxidation products##3##3##(2008-10#2)(2008-11#1)
its oxidation##10##2##(2008-10#7)(2008-11#1)(2008-5#1)(2011-1#1)
its parameters##2##2##(2008-10#1)(2008-8#1)
its parent##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
its participation in##2##3##(2011-2#1)(2013-8#1)
its pathogenesis##7##2##(1991-3#1)(1992-5#1)(1997-4#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)
its pathogenicity##2##2##(2008-10#1)(2011-2#1)
its pathophysiology and##2##3##(2010-6#1)(2012-3#1)
its pathophysiology##3##2##(1996-11#1)(2010-6#1)(2012-3#1)
its peak current##2##3##(2008-10#2)
its peak##4##2##(1991-5#1)(1995-6#1)(2008-10#2)
its performance with##2##3##(1994-9#1)(2008-5#1)
its performance##11##2##(1994-9#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#1)
its permeation##2##2##(2008-10#1)(2008-5#1)
its pharmaceutical formulation##5##3##(2008-10#5)
its pharmaceutical formulations (tablets and injections)##2##6##(2008-10#2)
its pharmaceutical formulations##3##3##(2008-10#3)
its pharmaceutical##10##2##(2008-10#10)
its phosphorylated##3##2##(2008-4#1)(2008-7#2)
its phosphorylation##2##2##(1995-2#1)(2008-11#1)
its phylogenetic##2##2##(2007-12#1)(2011-2#1)
its physical and##2##3##(2008-5#1)(2013-1#1)
its physical##3##2##(2008-5#1)(2010-12#1)(2013-1#1)
its physiological##7##2##(1994-3#1)(1995-11#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-5#1)
its portability and##2##3##(2008-10#2)
its possible use##2##3##(2008-10#1)(2013-1#1)
its possible##17##2##(1991-3#1)(1994-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
its potency##2##2##(1995-11#1)(2008-10#1)
its potential application as constructed wetland media##2##7##(2013-1#2)
its potential application##3##3##(2011-2#1)(2013-1#2)
its potential as a##2##4##(2010-12#1)(2011-2#1)
its potential for##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
its potential impact in##2##4##(2008-11#1)(2008-3#1)
its potential importance##2##3##(1997-8#1)(2010-7#1)
its potential role in##2##4##(2008-11#1)(2008-5#1)
its potential therapeutic##2##3##(1993-8#1)(2013-1#1)
its potential to##8##3##(2008-10#4)(2008-11#1)(2008-5#1)(2012-2#1)(2012-6#1)
its potential use##2##3##(1995-5#1)(2008-10#1)
its potential usefulness##2##3##(1990-2#1)(2008-10#1)
its potential##41##2##(1990-2#1)(1991-12#1)(1993-8#1)(1995-5#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#11)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#4)
its practical##3##2##(2008-10#1)(2008-4#1)(2010-9#1)
its precise##2##2##(2008-9#1)(2012-2#1)
its precision##2##2##(2008-10#1)(2008-7#1)
its preconcentration##4##2##(2008-10#4)
its predictions##4##2##(2008-10#1)(2008-11#1)(2008-8#2)
its preliminary##3##2##(1991-6#1)(2008-8#1)(2012-3#1)
its presence in the##2##4##(1995-11#1)(2008-10#1)
its presence in##4##3##(1995-11#1)(2008-10#3)
its presence##8##2##(1994-11#1)(1994-8#1)(1995-11#1)(2008-10#4)(2009-9#1)
its presentation in##2##3##(1991-11#1)(2009-8#1)
its presentation##4##2##(1991-11#1)(2009-8#1)(2011-2#1)(2013-7#1)
its prevalence and##3##3##(2008-6#1)(2011-2#1)(2013-8#1)
its prevalence##5##2##(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
its prevention##5##2##(1997-2#1)(2009-5#1)(2012-12#2)(2013-7#1)
its primary##2##2##(1990-5#1)(1994-11#1)
its principal##2##2##(2008-10#1)(2008-9#1)
its product##3##2##(1995-2#1)(2008-4#1)(2011-2#1)
its prognosis and##2##3##(1990-3#1)(2013-1#1)
its prognostic##2##2##(1994-8#1)(2009-11#1)
its promoter##2##2##(2012-3#1)(2013-1#1)
its proper##2##2##(2008-10#1)(2008-11#1)
its properties##7##2##(1991-12#1)(1997-7#1)(2008-10#3)(2008-5#1)(2010-1#1)
its protective##4##2##(1992-6#1)(2008-5#1)(2011-2#1)(2013-1#1)
its proteolytic##2##2##(2008-8#1)(2013-8#1)
its protonated##2##2##(2008-10#2)
its purified##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
its purity##2##2##(2008-8#1)(2012-2#1)
its putative role##2##3##(1990-5#1)(2008-10#1)
its putative##5##2##(1990-5#1)(1997-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
its quality##2##2##(2008-10#2)
its quantitative##2##2##(2008-10#2)
its quantity##2##2##(1991-11#1)(2011-2#1)
its rapid##3##2##(2008-10#2)(2008-9#1)
its rarity##6##2##(2008-10#1)(2008-12#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)
its reaction with##12##3##(2008-10#12)
its reactivity##3##2##(1990-12#1)(1996-2#1)(2010-7#1)
its real##2##2##(1996-1#1)(2011-1#1)
its recent##3##2##(1992-1#1)(1996-2#1)(2008-6#1)
its receptor in##4##3##(1991-7#1)(1995-11#1)(2008-11#1)(2013-7#1)
its receptor##29##2##(1991-12#1)(1991-7#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-6#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-6#1)(2013-7#1)
its receptors##7##2##(1992-4#1)(2008-8#3)(2011-1#1)(2011-2#2)
its recognition##2##2##(1994-3#1)(2008-1#1)
its recombinant##3##2##(1994-8#1)(2008-8#1)(2008-9#1)
its redox##2##2##(2008-10#2)
its reducing##2##2##(2008-10#2)
its reduction##3##2##(2008-10#2)(2011-2#1)
its regulation by##2##3##(1990-5#1)(2008-4#1)
its regulation##6##2##(1990-5#1)(1994-11#1)(2006-6#1)(2008-4#1)(2010-11#1)(2011-1#1)
its regulatory##4##2##(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
its relation to##14##3##(1990-2#1)(1991-12#1)(1992-3#1)(1993-5#1)(1994-12#1)(1996-6#1)(1997-6#1)(2008-12#2)(2008-7#1)(2012-3#1)(2013-8#3)
its relationship to##11##3##(1992-12#1)(1993-12#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-1#1)(2009-11#1)(2012-2#1)(2013-1#1)
its relationship with the##4##4##(1995-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
its relationship with##11##3##(1991-12#1)(1995-12#1)(2008-10#3)(2008-7#1)(2012-12#2)(2013-1#3)
its relationship##22##2##(1991-12#1)(1992-12#1)(1993-12#1)(1995-12#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-1#1)(2009-11#1)(2012-12#2)(2012-2#1)(2013-1#4)
its relative##4##2##(2008-10#2)(2008-4#1)(2012-3#1)
its relatively high##2##3##(1997-2#1)(2009-5#1)
its relatively low##2##3##(2008-10#1)(2009-1#1)
its relatively##4##2##(1997-2#1)(2008-10#1)(2009-1#1)(2009-5#1)
its relevance to the##2##4##(2008-9#1)(2012-3#1)
its relevance to##6##3##(2008-12#1)(2008-7#1)(2008-9#2)(2012-2#1)(2012-3#1)
its reliability##6##2##(2008-10#4)(2008-11#2)
its requirements##2##2##(1991-1#1)(2008-10#1)
its research##2##2##(2009-3#1)(2010-7#1)
its resistance to##3##3##(1994-8#1)(2008-3#1)(2013-8#1)
its resistance##5##2##(1994-8#1)(2008-10#2)(2008-3#1)(2013-8#1)
its resonance##2##2##(2008-10#1)(2013-8#1)
its respective##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
its response to the##2##4##(1997-2#1)(2009-8#1)
its response to##4##3##(1997-2#1)(2008-7#1)(2009-12#1)(2009-8#1)
its response##6##2##(1997-2#1)(2008-10#2)(2008-7#1)(2009-12#1)(2009-8#1)
its results##5##2##(1992-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-6#1)
its robustness##3##2##(2008-10#2)(2008-3#1)
its role as a##4##4##(2008-10#2)(2009-6#1)(2011-2#1)
its role in the##9##4##(1995-2#1)(1997-6#1)(2008-12#1)(2008-8#2)(2011-7#1)(2012-2#1)(2013-1#2)
its role in##37##3##(1991-12#1)(1991-5#1)(1994-11#1)(1994-3#1)(1995-2#2)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-2#3)(2013-1#3)(2013-8#1)
its role##45##2##(1991-12#1)(1991-5#1)(1994-11#1)(1994-3#1)(1995-2#2)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-2#3)(2013-1#3)(2013-8#1)
its safety and##2##3##(2008-10#1)(2008-8#1)
its safety##6##2##(1990-12#1)(2008-10#2)(2008-8#1)(2012-2#1)(2012-3#1)
its secondary structure similar to its native state in##2##9##(2008-10#2)
its selectivity##2##2##(2008-10#2)
its sensitivity is##2##3##(1990-9#1)(2009-5#1)
its sensitivity to##4##3##(1995-11#1)(2008-10#2)(2008-3#1)
its sensitivity was##3##3##(1992-6#1)(1996-2#1)(2008-11#1)
its sensitivity##11##2##(1990-9#1)(1992-6#1)(1995-11#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-5#1)
its separation from##2##3##(1990-3#1)(2008-10#1)
its separation##3##2##(1990-3#1)(2008-10#2)
its sequence##3##2##(1997-7#1)(2008-10#2)
its severity##2##2##(2011-2#1)(2012-3#1)
its short##2##2##(2008-10#2)
its side-effects##3##2##(2008-11#3)
its signal##3##2##(2008-10#1)(2008-3#1)(2010-6#1)
its similarity to##2##3##(2008-10#1)(2008-5#1)
its simplicity##5##2##(2008-10#2)(2008-11#2)(2010-7#1)
its single##2##2##(1994-5#1)(2008-10#1)
its sister##2##2##(2008-10#1)(2008-8#1)
its size##2##2##(1996-6#1)(2008-10#1)
its social##2##2##(2008-11#1)(2008-8#1)
its solubility in##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
its soluble##2##2##(2008-10#2)
its solution##3##2##(2008-10#2)(2009-7#1)
its sorption onto##2##3##(2008-10#2)
its sorption##3##2##(2008-10#3)
its speciation##2##2##(2008-10#2)
its specific activity##2##3##(1992-12#1)(1993-8#1)
its specific##16##2##(1990-2#1)(1990-5#1)(1992-12#1)(1993-8#1)(1994-1#1)(1995-11#1)(1995-5#1)(1996-3#1)(2008-10#3)(2008-11#2)(2010-7#1)(2011-2#1)(2013-7#1)
its specificity for##3##3##(1992-9#1)(1995-6#1)(2008-10#1)
its specificity##5##2##(1991-12#1)(1992-9#1)(1995-6#1)(2008-10#1)(2011-2#1)
its spectrophotometric determination##2##3##(2008-10#2)
its speed##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
its stability##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
its staff##2##2##(1994-12#1)(1997-2#1)
its statistical##2##2##(1995-12#1)(2008-11#1)
its stimulating##2##2##(1995-11#1)(2012-3#1)
its strategic##4##2##(1994-11#1)(1994-2#1)(1994-3#1)(1995-3#1)
its strength is##2##3##(2008-10#1)(2008-9#1)
its strength##3##2##(1990-5#1)(2008-10#1)(2008-9#1)
its strong##4##2##(1996-12#1)(1996-3#1)(2008-9#1)(2010-11#1)
its structural and##2##3##(2008-7#1)(2009-10#1)
its structural##5##2##(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2012-2#1)
its structure and##2##3##(1993-8#1)(1994-11#1)
its structure##12##2##(1993-8#1)(1994-11#1)(1994-3#2)(1997-7#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)
its subsequent##9##2##(1994-11#2)(1994-6#1)(1997-6#1)(2008-10#4)(2008-4#1)
its substrate specificity##2##3##(1995-2#1)(1995-6#1)
its substrate##7##2##(1993-6#1)(1993-8#1)(1995-2#1)(1995-6#1)(2008-7#1)(2009-7#2)
its success is##3##3##(1994-2#1)(1994-3#1)(1994-9#1)
its success##8##2##(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-1#1)(2008-11#2)
its suitability for##4##3##(1995-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
its suitability##6##2##(1995-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-7#1)
its supportive##2##2##(1996-1#1)(2008-11#1)
its suppression by##5##3##(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-9#1)
its suppression##6##2##(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-9#1)
its surface##10##2##(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2013-1#1)
its surrounding##3##2##(2008-4#1)(2009-12#1)(2011-2#1)
its survival##2##2##(2008-10#2)
its sustainability##2##2##(2008-12#1)(2012-2#1)
its synaptic##3##2##(2008-11#1)(2008-4#2)
its systemic##2##2##(2008-10#1)(2008-8#1)
its target##4##2##(1993-3#1)(1994-3#1)(1997-7#1)(2011-2#1)
its theoretical##3##2##(1997-3#1)(2008-10#2)
its therapeutic##4##2##(1994-8#1)(2008-1#1)(2008-11#1)(2008-7#1)
its thickness##2##2##(2007-11#1)(2008-5#1)
its three##2##2##(1996-6#1)(2007-12#1)
its threshold##2##2##(2009-5#1)(2010-7#1)
its tolerance##2##2##(1996-3#1)(2008-10#1)
its total##4##2##(2008-10#3)(2008-5#1)
its trace##2##2##(2008-10#2)
its transcription##3##2##(2010-5#1)(2011-1#1)(2012-2#1)
its transcriptional##3##2##(1994-11#1)(2008-8#1)(2008-9#1)
its transmission##4##2##(1992-2#1)(2008-10#1)(2008-9#1)(2010-1#1)
its transport##2##2##(1994-11#1)(2008-3#1)
its treatment with##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
its treatment##11##2##(1991-2#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
its two##4##2##(1991-2#1)(1994-5#1)(2008-10#2)
its type species##2##3##(2011-2#2)
its type##3##2##(2008-10#1)(2011-2#2)
its typical##2##2##(1991-6#1)(2011-3#1)
its unique##5##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#2)
its unusual##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
its upper##2##2##(2008-11#1)(2008-5#1)
its usage##2##2##(2008-10#1)(2008-11#1)
its use and##2##3##(2010-5#1)(2013-8#1)
its use as a##4##4##(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
its use as##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
its use for the##2##4##(2008-10#1)(2010-8#1)
its use for##9##3##(1990-3#1)(2008-10#6)(2008-11#1)(2010-8#1)
its use in the##9##4##(1997-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2011-2#1)(2013-8#1)
its use in##19##3##(1994-11#1)(1996-3#1)(1997-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
its use is##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2010-2#1)
its use under##2##3##(1992-3#1)(2008-6#1)
its use with##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
its use##63##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#1)(1995-11#1)(1996-3#1)(1997-5#1)(2008-1#2)(2008-10#17)(2008-11#9)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-7#1)(2013-8#4)
its usefulness##6##2##(1996-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
its utility in##2##3##(2008-10#1)(2008-11#1)
its utility##6##2##(1995-3#1)(2008-10#2)(2008-11#2)(2012-3#1)
its utilization##2##2##(2008-10#2)
its value##3##2##(1991-12#1)(1994-12#1)(2009-8#1)
its variant##3##2##(1990-8#1)(2008-8#2)
its variants##2##2##(1991-8#1)(2008-9#1)
its various##6##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)
its vector##5##2##(2008-10#5)
its very nature##2##3##(2007-12#1)(2010-12#1)
its very##5##2##(2007-12#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-2#1)
its virulence##5##2##(1993-3#1)(2008-10#2)(2008-9#1)(2011-2#1)
its volatile##2##2##(2008-10#1)(2011-10#1)
its way##4##2##(1994-3#1)(1996-1#1)(2008-11#1)(2008-12#1)
its weight##2##2##(1993-3#2)
its whitefly vector##2##3##(2008-10#2)
its wide##5##2##(2008-10#1)(2009-1#2)(2009-12#1)(2011-2#1)
its widespread##4##2##(1997-5#1)(2008-10#2)(2008-9#1)
its withdrawal##3##2##(1996-12#2)(2011-2#1)
its work##2##2##(1995-6#1)(1997-3#1)
its yeast##2##2##(1995-2#1)(2008-5#1)
its zinc-finger domain##2##3##(1995-2#2)
its##3841##1##(1990-10#3)(1990-11#8)(1990-12#10)(1990-2#11)(1990-3#10)(1990-5#27)(1990-6#5)(1990-7#3)(1990-8#9)(1990-9#7)(1991-1#7)(1991-11#3)(1991-12#18)(1991-2#22)(1991-3#12)(1991-5#16)(1991-6#12)(1991-7#5)(1991-8#4)(1991-9#3)(1992-1#6)(1992-10#2)(1992-12#20)(1992-2#14)(1992-3#12)(1992-4#1)(1992-5#4)(1992-6#11)(1992-8#3)(1992-9#10)(1993-1#6)(1993-11#10)(1993-12#13)(1993-2#13)(1993-3#21)(1993-5#2)(1993-6#17)(1993-8#28)(1994-1#5)(1994-11#27)(1994-12#16)(1994-2#8)(1994-3#26)(1994-5#16)(1994-6#5)(1994-8#19)(1994-9#8)(1995-1#4)(1995-10#1)(1995-11#26)(1995-12#25)(1995-2#33)(1995-3#9)(1995-5#12)(1995-6#32)(1995-8#16)(1995-9#1)(1996-1#15)(1996-11#1)(1996-12#18)(1996-2#26)(1996-3#16)(1996-5#7)(1996-6#9)(1996-8#4)(1996-9#2)(1997-1#16)(1997-2#27)(1997-3#13)(1997-4#6)(1997-5#5)(1997-6#7)(1997-7#28)(1997-8#14)(1997-9#1)(2006-6#2)(2007-11#6)(2007-12#21)(2007-8#6)(2008-1#18)(2008-10#1084)(2008-11#262)(2008-12#68)(2008-2#9)(2008-3#67)(2008-4#25)(2008-5#107)(2008-6#20)(2008-7#82)(2008-8#138)(2008-9#108)(2009-1#13)(2009-10#32)(2009-11#4)(2009-12#13)(2009-2#1)(2009-3#13)(2009-4#5)(2009-5#14)(2009-6#10)(2009-7#15)(2009-8#46)(2009-9#11)(2010-1#8)(2010-10#9)(2010-11#13)(2010-12#27)(2010-2#5)(2010-3#10)(2010-4#8)(2010-5#11)(2010-6#16)(2010-7#20)(2010-8#11)(2010-9#8)(2011-1#22)(2011-10#4)(2011-2#209)(2011-3#17)(2011-4#1)(2011-7#6)(2012-12#26)(2012-2#74)(2012-3#60)(2012-6#3)(2012-7#1)(2013-1#113)(2013-7#11)(2013-8#56)
its'##2##1##(2008-11#2)
itself and its##2##3##(2008-5#1)(2008-9#1)
itself and the##5##3##(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)
itself and##13##2##(1994-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)
itself as a##3##3##(2008-11#1)(2010-8#1)(2012-2#1)
itself as the##2##3##(1995-3#1)(2011-4#1)
itself as##6##2##(1995-3#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-4#1)(2012-2#1)
itself but##2##2##(1992-6#1)(1994-11#1)
itself can also##2##3##(2009-12#1)(2013-8#1)
itself from##2##2##(2008-10#2)
itself had no##3##3##(1996-2#2)(2008-10#1)
itself in##7##2##(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#3)(2013-1#1)
itself is the##2##3##(2008-4#1)(2013-7#1)
itself is##14##2##(1993-1#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-1#1)(2010-10#1)(2013-1#1)(2013-7#1)
itself or##5##2##(1991-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-9#1)
itself plays##2##2##(2008-5#2)
itself to##7##2##(1995-3#1)(1996-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2012-3#1)
itself was##5##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
itself##145##1##(1990-11#2)(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-7#1)(2008-1#1)(2008-10#23)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-4#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
ituC##2##1##(2008-10#2)
iv##4##1##(1990-2#1)(1990-8#1)(1991-3#1)(2008-10#1)
iv)##2##1##(2008-11#1)(2009-9#1)
j##9##1##(1997-4#6)(2008-10#1)(2008-8#1)(2010-6#1)
j)(pot) value##2##2##(2008-10#2)
j)(pot) values##2##2##(2008-10#2)
j)(pot)##4##1##(2008-10#4)
jaapii##7##1##(2008-10#7)
jaceae##6##1##(2008-10#6)
jade##2##1##(2013-8#2)
jadeite##2##1##(2013-8#2)
jaggedness##3##1##(2008-3#3)
jail##2##1##(1992-2#1)(1996-5#1)
jannaschii##2##1##(2008-7#2)
janvier##2##1##(2013-1#2)
japonica rice##3##2##(1996-8#1)(2008-10#2)
japonica##21##1##(1994-11#1)(1996-8#1)(2008-10#9)(2008-5#5)(2008-8#1)(2008-9#1)(2009-10#2)(2013-8#1)
japonica)##4##1##(2008-6#2)(2008-8#1)(2009-10#1)
japonicum##5##1##(2008-10#3)(2008-8#2)
japonicus and##2##2##(2008-12#1)(2011-2#1)
japonicus##10##1##(2008-12#3)(2008-5#2)(2008-6#2)(2009-8#1)(2011-2#1)(2013-8#1)
jar##2##1##(2008-10#1)(2013-1#1)
jargon##3##1##(1992-3#2)(2008-8#1)
jasmonate (MeJA) treatment##2##3##(2008-10#1)(2011-10#1)
jasmonate (MeJA)##3##2##(2008-10#1)(2011-10#2)
jasmonate and##2##2##(2008-10#1)(2011-10#1)
jasmonate##14##1##(2008-10#10)(2008-9#1)(2011-10#3)
jasmonic acid (JA)##3##3##(2009-8#2)(2011-10#1)
jasmonic acid production##3##3##(2008-5#3)
jasmonic acid##13##2##(2008-10#5)(2008-5#3)(2009-8#3)(2011-10#1)(2012-2#1)
jasmonic##16##1##(2008-10#7)(2008-5#3)(2009-6#1)(2009-8#3)(2011-10#1)(2012-2#1)
jatropha oil##2##2##(2009-3#2)
jatropha##4##1##(2009-3#4)
jaundice secondary to##2##3##(1991-3#1)(1992-9#1)
jaundice##18##1##(1990-8#2)(1990-9#1)(1991-3#2)(1992-9#4)(1994-6#1)(2008-11#1)(2008-12#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
jaundiced##2##1##(1991-8#1)(2013-1#1)
javanica##14##1##(2008-10#14)
jaw that##2##2##(2010-3#1)(2011-2#1)
jaw##23##1##(1990-9#3)(1993-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#2)(2013-1#7)
jaw-closer##2##1##(1997-2#2)
jaws##11##1##(1991-3#1)(2008-1#3)(2009-10#1)(2012-12#3)(2013-1#3)
jealousy##4##1##(2008-12#3)(2010-11#1)
jejunal fluid##2##2##(1991-12#2)
jejunal##10##1##(1990-5#1)(1990-9#1)(1991-12#3)(1991-9#1)(2007-12#1)(2008-5#1)(2013-1#2)
jejuni chromosomal DNA##2##3##(1993-9#2)
jejuni##14##1##(1990-3#3)(1993-9#5)(2008-10#2)(2010-12#1)(2011-1#3)
jejunum##12##1##(1990-5#2)(1990-9#1)(1991-12#1)(1991-5#4)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
jelly coat##3##2##(1994-11#1)(2008-8#2)
jelly coats in##2##3##(2008-8#2)
jelly coats##5##2##(2008-8#5)
jelly##12##1##(1994-11#1)(2008-10#2)(2008-8#8)(2011-2#1)
jellyfish##6##1##(1996-6#1)(2008-10#2)(2012-3#3)
jeopardize##6##1##(1994-1#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-9#1)(2013-1#1)
jeopardy##2##1##(1995-6#1)(2008-11#1)
jet and##2##2##(1991-1#1)(2008-3#1)
jet nebulizer##8##2##(1991-1#3)(1993-2#1)(1994-12#2)(1996-3#2)
jet nebulizers##7##2##(1992-3#1)(1993-2#1)(1994-12#1)(1995-3#4)
jet##39##1##(1991-1#4)(1992-11#1)(1992-3#1)(1993-2#2)(1994-12#3)(1995-3#5)(1996-12#1)(1996-3#2)(2008-10#8)(2008-11#2)(2008-3#7)(2010-7#1)(2011-2#1)(2013-1#1)
jewellery industry##2##2##(2008-10#2)
jewellery##3##1##(2008-10#3)
jigsaw##2##1##(1995-8#1)(2008-12#1)
jiroveci infection##2##2##(2010-12#2)
jiroveci##3##1##(2010-12#3)
jitter and##2##2##(2007-11#1)(2012-3#1)
jitter in##2##2##(2008-3#1)(2009-8#1)
jitter##13##1##(2007-11#1)(2008-3#10)(2009-8#1)(2012-3#1)
jitteriness##2##1##(2011-1#2)
job at##3##2##(1990-2#1)(1991-2#1)(2008-8#1)
job burnout##2##2##(1996-2#2)
job content and##2##3##(1991-3#1)(1995-2#1)
job content##3##2##(1991-3#2)(1995-2#1)
job descriptions##2##2##(1994-1#1)(1997-2#1)
job in##4##2##(1993-1#1)(1993-2#2)(1995-6#1)
job insecurity in##2##3##(2009-10#2)
job insecurity##4##2##(2009-10#4)
job of##5##2##(1994-3#1)(1995-2#1)(1996-1#1)(2011-2#1)(2012-12#1)
job outlook in brief##3##4##(1991-1#1)(1993-1#1)(1997-1#1)
job satisfaction among nurses##2##4##(2008-11#1)(2008-7#1)
job satisfaction among##3##3##(1992-1#1)(2008-11#1)(2008-7#1)
job satisfaction and##4##3##(1991-2#1)(2008-11#1)(2010-10#1)(2013-1#1)
job satisfaction of##4##3##(1991-2#1)(1992-3#1)(1994-5#1)(2010-11#1)
job satisfaction##27##2##(1991-2#5)(1992-1#1)(1992-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(2008-11#6)(2008-12#2)(2008-7#1)(2008-9#1)(2010-10#2)(2010-11#3)(2013-1#2)
job security##2##2##(2008-9#1)(2009-10#1)
job strain in##3##3##(2008-10#3)
job strain##5##2##(2008-10#5)
job turnover and regional attrition##3##5##(1994-3#3)
job##100##1##(1990-12#2)(1990-2#2)(1991-1#1)(1991-11#2)(1991-2#11)(1991-3#4)(1992-1#2)(1992-3#1)(1993-1#2)(1993-2#4)(1993-3#3)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-5#1)(1995-1#1)(1995-2#3)(1995-6#2)(1996-1#2)(1996-2#4)(1997-1#3)(1997-2#1)(2008-10#5)(2008-11#7)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#6)(2010-10#2)(2010-11#5)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
jobs at##2##2##(1992-8#1)(2008-11#1)
jobs##20##1##(1990-2#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-1#3)(1994-3#4)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(2008-11#1)(2008-9#1)(2010-3#1)
jock##2##1##(2010-7#2)
jogging##10##1##(1991-8#10)
join##9##1##(1994-2#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)
joined by##5##2##(1992-6#1)(2008-11#1)(2008-4#1)(2008-8#2)
joined the##5##2##(1990-7#1)(1991-11#1)(1997-4#1)(2008-10#1)(2011-2#1)
joined to##4##2##(1997-1#1)(2008-10#1)(2008-4#1)(2010-5#1)
joined with##3##2##(1991-1#1)(2008-12#1)(2008-6#1)
joined##22##1##(1990-7#1)(1991-1#1)(1991-11#2)(1992-6#1)(1994-9#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-2#1)
joining a##2##2##(1996-3#1)(2008-9#1)
joining activity##2##2##(1993-2#1)(1997-3#1)
joining of##3##2##(1997-7#3)
joining the##3##2##(1992-6#1)(2008-10#1)(2008-7#1)
joining##24##1##(1991-6#2)(1992-6#1)(1993-2#2)(1993-6#1)(1996-3#1)(1997-3#4)(1997-7#5)(1997-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)
joins##3##1##(2008-4#1)(2008-8#1)(2013-1#1)
joint (TMJ)##2##2##(2011-2#1)(2012-3#1)
joint after##2##2##(1995-10#1)(2010-5#1)
joint and##3##2##(1997-6#1)(2008-12#1)(2009-7#1)
joint angles##2##2##(2008-12#1)(2011-2#1)
joint arthritis##3##2##(2008-9#1)(2009-10#1)(2010-11#1)
joint destruction##4##2##(2009-1#1)(2011-2#2)(2012-3#1)
joint disease##2##2##(2011-2#1)(2012-2#1)
joint diseases##2##2##(1993-2#1)(2010-11#1)
joint dysfunction##2##2##(2010-1#2)
joint effect of##2##3##(2008-10#1)(2008-9#1)
joint effect##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
joint had an increased##2##4##(2011-2#2)
joint in##4##2##(1996-9#1)(2011-2#2)(2013-1#1)
joint initiative between##2##3##(2008-11#2)
joint is the##2##3##(2008-9#1)(2011-1#1)
joint is##4##2##(1997-6#1)(2008-9#1)(2010-3#1)(2011-1#1)
joint manipulation##5##2##(2008-12#5)
joint meeting##2##2##(2008-5#1)(2009-11#1)
joint moment##2##2##(2011-2#2)
joint moments##3##2##(2011-2#3)
joint of the little finger##3##5##(2008-9#3)
joint of the##4##3##(2008-9#4)
joint of##5##2##(2008-9#4)(2012-3#1)
joint osteoarthritis##3##2##(2008-9#3)
joint pain and##2##3##(2012-2#1)(2012-3#1)
joint pain##3##2##(2008-1#1)(2012-2#1)(2012-3#1)
joint polymorphism##2##2##(2008-9#2)
joint position##2##2##(1993-1#1)(2012-3#1)
joint prostheses##3##2##(2009-7#3)
joint replacement##5##2##(2007-8#1)(2008-10#1)(2008-8#1)(2009-3#1)(2012-3#1)
joint transform##2##2##(2008-3#2)
joint use of##2##3##(2008-10#2)
joint venture##5##2##(1992-8#1)(1994-1#1)(1994-3#2)(2008-5#1)
joint ventures have a##2##4##(2008-11#2)
joint ventures##11##2##(1991-1#1)(1993-1#2)(2008-11#8)
joint was##3##2##(2010-3#2)(2012-2#1)
joint##216##1##(1990-6#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-1#4)(1993-2#3)(1993-5#1)(1994-1#1)(1994-3#3)(1994-8#1)(1995-10#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-4#1)(1997-6#3)(1997-8#3)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#14)(2008-12#13)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#2)(2009-7#8)(2010-1#5)(2010-10#2)(2010-11#5)(2010-3#6)(2010-5#5)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#27)(2012-12#3)(2012-2#8)(2012-3#15)(2013-1#9)(2013-8#2)
joint-space narrowing in##2##3##(2011-2#2)
joint-space narrowing##3##2##(2011-2#3)
joint-space widening in##2##3##(2011-2#2)
joint-space widening##3##2##(2011-2#3)
joint-space##6##1##(2011-2#6)
jointed##2##1##(2007-12#1)(2008-8#1)
jointly by##3##2##(1991-3#1)(2008-10#2)
jointly##13##1##(1991-3#1)(1991-5#1)(1992-1#1)(1992-5#1)(2008-10#2)(2008-11#4)(2008-3#1)(2010-1#1)(2010-7#1)
joints and##2##2##(2008-12#1)(2012-3#1)
joints in##4##2##(1997-7#1)(2011-2#3)
joints is##2##2##(2011-2#1)(2013-1#1)
joints of##2##2##(1997-5#1)(2012-3#1)
joints##38##1##(1991-11#1)(1991-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-9#2)(1997-5#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#2)
joints)##3##1##(2009-3#2)(2012-3#1)
jordani##4##1##(2010-8#4)
joules##2##1##(1992-12#1)(1993-1#1)
journal articles on strategic management in nonprofit organizations##2##8##(1993-12#2)
journal articles##4##2##(1993-12#2)(1994-3#1)(1996-2#1)
journal clubs##2##2##(2008-12#2)
journal is##3##2##(1991-2#1)(1992-2#1)(1994-6#1)
journal of##3##2##(2008-9#1)(2010-12#1)(2013-1#1)
journal##37##1##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#2)(1994-12#1)(1994-3#2)(1994-6#3)(1995-1#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-9#1)(2008-11#1)(2008-12#5)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#5)
journal's##2##1##(1993-12#1)(2009-4#1)
journalists##2##1##(1994-3#1)(2008-12#1)
journals and##5##2##(1997-3#1)(2008-10#1)(2010-1#1)(2010-8#1)(2012-2#1)
journals for##2##2##(1991-12#1)(1994-6#1)
journals in##4##2##(1991-12#1)(1994-6#1)(2012-12#1)(2013-1#1)
journals were##2##2##(2010-11#1)(2013-1#1)
journals##41##1##(1991-12#5)(1991-2#1)(1993-12#2)(1993-6#1)(1994-12#2)(1994-6#2)(1997-3#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-8#1)
journey from a##2##3##(2008-11#1)(2011-2#1)
journey from##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
journey into##2##2##(1994-2#1)(2008-10#1)
journey of##3##2##(2008-12#1)(2010-12#1)(2013-8#1)
journey to##2##2##(2008-11#1)(2008-9#1)
journey##27##1##(1992-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#4)(2008-9#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#3)
jp/arabi/##2##1##(1997-6#1)(1997-8#1)
jpg&quot##2##1##(2013-8#2)
judge the##2##2##(1997-6#1)(2008-10#1)
judge##25##1##(1991-9#1)(1994-12#1)(1995-12#5)(1995-6#2)(1996-2#1)(1996-5#4)(1997-6#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)
judged by the##4##3##(1993-8#1)(2008-11#2)(2013-1#1)
judged by##14##2##(1990-10#1)(1990-5#1)(1991-12#1)(1993-8#1)(1995-11#1)(1997-2#3)(1997-7#1)(2008-11#2)(2008-5#1)(2008-9#1)(2013-1#1)
judged their##2##2##(1990-6#1)(2008-10#1)
judged to be##8##3##(1992-12#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)
judged to##10##2##(1992-12#1)(1996-12#1)(1996-8#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)
judged##37##1##(1990-10#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-2#3)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#4)(2008-5#4)(2008-9#2)(2010-7#1)(2011-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
judgement in##2##2##(1994-12#1)(2013-8#1)
judgement of##2##2##(1996-6#1)(2008-2#1)
judgement##12##1##(1990-12#1)(1994-12#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#2)
judgements of##2##2##(2008-9#1)(2013-8#1)
judgements##5##1##(2008-12#1)(2008-9#2)(2010-11#1)(2013-8#1)
judges##3##1##(1997-8#1)(2008-9#2)
judging from##2##2##(1996-6#1)(2008-5#1)
judging the##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
judging##9##1##(1992-12#1)(1996-2#1)(1996-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#1)
judgment and##3##2##(1993-12#1)(1993-2#1)(2008-1#1)
judgment for##2##2##(2008-11#1)(2008-6#1)
judgment##16##1##(1992-3#1)(1993-12#1)(1993-2#1)(1995-12#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-6#1)(2010-3#1)(2010-8#1)(2013-8#1)
judgmental##2##1##(1993-1#1)(2008-11#1)
judgments about the self relative to##2##6##(2008-11#2)
judgments about the##3##3##(2008-11#2)(2012-3#1)
judgments about##6##2##(2008-11#5)(2012-3#1)
judgments of##4##2##(1992-3#1)(1993-12#1)(2008-1#1)(2008-12#1)
judgments##18##1##(1992-3#1)(1993-12#2)(2008-1#1)(2008-11#9)(2008-12#1)(2008-6#1)(2011-2#2)(2012-3#1)
judicial##7##1##(1993-12#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-12#1)(2013-8#1)
judicious use of##3##3##(2009-3#1)(2013-1#2)
judicious##5##1##(2008-10#1)(2009-3#1)(2010-1#1)(2013-1#2)
jugular and subclavian##3##3##(2008-12#3)
jugular foramen##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
jugular vein##5##2##(1992-12#2)(1996-6#1)(2011-2#1)(2012-3#1)
jugular##18##1##(1992-12#3)(1996-6#1)(1996-9#1)(2008-12#3)(2008-7#1)(2011-2#6)(2012-3#3)
juice and##8##2##(1993-2#4)(2008-10#3)(2009-7#1)
juice as##2##2##(2008-10#2)
juice by##3##2##(2008-10#3)
juice of##4##2##(2008-10#3)(2009-7#1)
juice sac##7##2##(2008-10#7)
juice samples were##3##3##(2008-10#3)
juice samples##7##2##(2008-10#7)
juice were##2##2##(2008-10#2)
juice##82##1##(1993-2#4)(1993-6#2)(2008-10#60)(2008-7#3)(2009-7#3)(2010-5#5)(2011-2#1)(2012-2#3)(2012-3#1)
juice)##3##1##(2008-10#3)
juices and tea infusions##2##4##(2008-10#2)
juices and##10##2##(2008-10#9)(2009-8#1)
juices by##3##2##(2008-10#3)
juices##28##1##(2008-10#27)(2009-8#1)
jujube fruit##4##2##(2008-10#4)
jujube##5##1##(2008-10#5)
juliflora##2##1##(2013-1#2)
jump attempts##2##2##(2009-1#2)
jump height##4##2##(2009-1#4)
jump muscle##2##2##(2008-9#2)
jump output##2##2##(2008-9#2)
jump process##2##2##(2011-2#1)(2013-8#1)
jump protocol##2##2##(2009-1#2)
jump##27##1##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-8#1)(2008-9#5)(2009-1#11)(2011-2#1)(2012-2#1)(2013-8#1)
jumping behaviour in morphine-dependent mice##3##5##(1996-2#3)
jumping behaviour##4##2##(1996-2#4)
jumping##7##1##(1990-6#1)(1996-2#5)(2008-8#1)
jumps##9##1##(2008-10#2)(2009-1#3)(2009-6#1)(2011-2#1)(2012-2#2)
jun##2##1##(1992-12#1)(1994-6#1)
junD mRNA was##2##3##(1996-12#2)
junD mRNA##3##2##(1996-12#3)
junD##8##1##(1996-12#8)
juncea and B##3##3##(2008-10#3)
juncea and##4##2##(2008-10#3)(2011-1#1)
juncea cv##2##2##(2008-10#2)
juncea recombinant line##2##3##(2008-10#2)
juncea recombinant##3##2##(2008-10#3)
juncea seed meal##3##3##(2008-10#3)
juncea##24##1##(2008-10#23)(2011-1#1)
juncea)##4##1##(2008-10#2)(2011-1#2)
juncos##3##1##(2008-8#3)
junction (DEJ)##2##2##(2008-5#1)(2010-10#1)
junction and##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
junction arteriovenous fistulas##2##3##(2008-7#2)
junction between##3##2##(1993-8#1)(2007-12#1)(2012-3#1)
junction obstruction unmasked after correction of vesicoureteral reflux using endoscopic treatment with Deflux##2##13##(2008-10#2)
junction obstruction##8##2##(2008-10#7)(2009-9#1)
junction of the##6##3##(1996-12#2)(1997-8#1)(2007-12#2)(2010-8#1)
junction of##11##2##(1990-5#1)(1993-8#1)(1993-9#1)(1996-12#3)(1997-8#1)(2007-12#3)(2010-8#1)
junction potential##5##2##(1997-4#2)(2008-10#3)
junction regulation##2##2##(2009-10#2)
junction restructuring##3##2##(2009-10#3)
junction sequences##2##2##(1992-6#1)(1993-6#1)
junction was used##2##3##(2008-10#2)
junction was##3##2##(1992-5#1)(2008-10#2)
junction##120##1##(1990-5#1)(1991-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-3#4)(1996-12#4)(1997-3#1)(1997-4#2)(1997-8#1)(2007-12#4)(2008-10#23)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#5)(2008-9#2)(2009-10#14)(2009-8#1)(2009-9#2)(2010-10#2)(2010-8#1)(2011-2#9)(2012-2#9)(2012-3#7)(2013-1#5)(2013-8#1)
junction)##2##1##(2008-11#1)(2012-2#1)
junctional diversity##2##2##(1997-9#2)
junctional##13##1##(1990-2#1)(1994-11#2)(1995-6#2)(1996-12#2)(1997-9#2)(2008-11#2)(2009-10#1)(2013-1#1)
junctions and##6##2##(1994-3#1)(1995-8#1)(2008-11#2)(2009-10#2)
junctions are##4##2##(1996-12#1)(2008-7#1)(2009-10#2)
junctions between##3##2##(2009-10#1)(2012-2#2)
junctions can be##2##3##(2008-7#2)
junctions have##2##2##(2008-7#2)
junctions in the##2##3##(1997-9#1)(2009-10#1)
junctions in##4##2##(1996-12#1)(1997-9#1)(2008-4#1)(2009-10#1)
junctions inManduca sextamidgut epithelium##2##4##(2008-7#2)
junctions is##2##2##(1997-7#1)(2008-7#1)
junctions with##2##2##(2008-7#1)(2009-10#1)
junctions##69##1##(1993-6#5)(1994-11#1)(1994-3#2)(1994-9#1)(1995-8#1)(1996-12#2)(1997-7#2)(1997-9#4)(2008-10#2)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#20)(2009-10#15)(2011-2#3)(2012-2#5)
juncture##2##1##(2010-8#1)(2011-2#1)
june##3##1##(1996-3#1)(2008-11#1)(2012-2#1)
junior faculty##6##2##(2009-4#6)
junior##12##1##(1990-3#1)(1991-2#1)(1993-1#1)(2009-4#7)(2011-2#2)
junk bond##3##2##(1992-11#3)
junk##6##1##(1992-11#5)(2013-1#1)
jurisdictional##2##1##(2008-12#1)(2011-9#1)
jurisdictions##8##1##(1994-1#1)(1995-1#1)(1995-12#2)(1996-3#1)(2008-12#2)(2011-9#1)
jury##7##1##(1995-12#2)(1995-6#3)(1996-5#2)
jury's##3##1##(1991-12#1)(1995-12#1)(1995-6#1)
just a few##3##3##(1992-9#1)(2008-7#1)(2011-2#1)
just a##14##2##(1992-9#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
just about##2##2##(2008-11#2)
just above##2##2##(2008-3#2)
just after##2##2##(2008-10#1)(2011-2#1)
just an##2##2##(1997-2#1)(2008-10#1)
just another##3##2##(1995-2#1)(1996-12#1)(2008-11#1)
just as likely to##2##4##(1994-12#1)(2013-1#1)
just as##10##2##(1992-3#1)(1994-12#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
just at##2##2##(2008-10#1)(2009-8#1)
just before the##3##3##(1992-2#1)(2008-10#1)(2010-4#1)
just before they##2##3##(1992-12#1)(2008-10#1)
just before##10##2##(1992-12#1)(1992-2#1)(1993-3#1)(2008-10#4)(2008-11#2)(2010-4#1)
just beginning to##3##3##(1994-2#1)(2009-8#2)
just below the##2##3##(2008-10#2)
just can't##2##2##(1995-2#1)(1997-6#1)
just detectable in##2##3##(1994-11#2)
just five##2##2##(2008-10#1)(2010-9#1)
just how##2##2##(1997-4#1)(2008-11#1)
just like the##2##3##(2008-11#1)(2009-4#1)
just one enzyme##2##3##(2008-10#1)(2008-7#1)
just one##8##2##(2008-10#4)(2008-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
just over##3##2##(1992-6#1)(1992-9#1)(2013-8#1)
just prior to##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
just the##14##2##(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#1)(2011-2#1)
just under##3##2##(1992-6#2)(2010-11#1)
just upstream from the##2##4##(1997-2#1)(1997-7#1)
just##147##1##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#4)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#30)(2008-11#17)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#4)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
just?##2##1##(1992-2#1)(1996-12#1)
justice in##2##2##(1994-2#1)(2009-11#1)
justice system##6##2##(1996-1#2)(2008-11#4)
justice##23##1##(1991-12#1)(1992-2#1)(1994-1#1)(1994-2#2)(1996-1#4)(1996-5#1)(1997-1#1)(2008-11#7)(2008-6#3)(2009-11#1)(2010-11#1)
justifiable##5##1##(1991-9#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
justification for the##2##3##(2008-11#1)(2009-6#1)
justification for##6##2##(1995-6#1)(2008-11#2)(2008-12#1)(2009-6#1)(2013-1#1)
justification##13##1##(1992-3#1)(1994-3#1)(1995-5#1)(1995-6#1)(2008-11#3)(2008-12#1)(2009-6#1)(2012-2#2)(2013-1#2)
justified by the##2##3##(1992-2#1)(1993-12#1)
justified in##4##2##(1994-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
justified on##2##2##(1997-4#1)(2008-7#1)
justified##17##1##(1990-6#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
justifies##4##1##(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)
justify a##3##2##(1990-12#1)(1990-9#1)(1997-8#1)
justify the##6##2##(1991-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
justify their##2##2##(1997-1#1)(2008-5#1)
justify##18##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1995-5#2)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2011-2#1)
justifying the##4##2##(1996-2#1)(2008-10#2)(2008-12#1)
justifying##7##1##(1996-2#1)(2008-10#3)(2008-12#1)(2009-1#1)(2012-3#1)
juvenile age##3##2##(1994-8#3)
juvenile and adult##2##3##(2012-2#2)
juvenile court##2##2##(1997-6#1)(2011-2#1)
juvenile growth##4##2##(2008-11#3)(2008-9#1)
juvenile hormone (JH)##3##3##(1992-6#1)(1995-11#1)(2012-2#1)
juvenile hormone##6##2##(1992-6#1)(1995-11#1)(2008-8#2)(2008-9#1)(2012-2#1)
juvenile idiopathic arthritis##2##3##(2012-3#2)
juvenile peptide hormone in lepidopteran insects##2##6##(1992-6#2)
juvenile polyps##3##2##(2009-12#1)(2011-2#2)
juvenile stage and##2##3##(2007-12#1)(2008-6#1)
juvenile stage##3##2##(2007-12#1)(2008-12#1)(2008-6#1)
juvenile survival##6##2##(2008-11#2)(2008-8#4)
juvenile tick##2##2##(2008-8#2)
juvenile viability##3##2##(2008-8#3)
juvenile##94##1##(1990-12#2)(1992-6#4)(1993-11#2)(1993-5#1)(1994-11#1)(1994-8#5)(1995-11#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#8)(2008-12#4)(2008-6#1)(2008-7#2)(2008-8#17)(2008-9#3)(2009-12#2)(2010-12#1)(2010-8#13)(2011-2#5)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#1)
juvenile-onset##2##1##(1997-8#1)(2013-1#1)
juveniles and young adults##2##4##(2007-12#2)
juveniles and young##3##3##(2007-12#2)(2008-10#1)
juveniles and##6##2##(2007-12#2)(2008-10#2)(2008-9#1)(2012-3#1)
juveniles from##2##2##(2008-10#2)
juveniles in##3##2##(2008-10#2)(2008-9#1)
juveniles of the##3##3##(2008-10#3)
juveniles of##5##2##(2008-10#4)(2008-8#1)
juveniles were##2##2##(2008-10#1)(2010-8#1)
juveniles##45##1##(1994-8#1)(2007-12#5)(2008-10#22)(2008-11#3)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#6)(2010-8#3)(2012-3#1)
k is##3##2##(1992-9#1)(2008-10#1)(2008-5#1)
k populations##2##2##(1996-3#2)
k was##2##2##(2008-10#2)
k##23##1##(1992-9#5)(1996-3#2)(2008-10#9)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-2#1)
k(ROH)##2##1##(2009-8#2)
k(ROH)/k(s)##3##1##(2009-8#3)
k(a)##2##1##(2008-10#1)(2008-12#1)
k(d) was 0##2##3##(2008-10#2)
k(d) was##3##2##(2008-10#3)
k(exp)##3##1##(2008-10#3)
k(inact)/Ki##2##1##(1993-8#2)
k)##5##1##(2008-10#5)
k)fluoranthene##2##1##(2008-10#2)
kD domain##2##2##(2010-5#2)
kD protein##2##2##(1993-3#1)(2008-11#1)
kD substrate##2##2##(1993-3#2)
kD##12##1##(1992-12#2)(1993-3#3)(1993-8#1)(2008-11#4)(2010-5#2)
kDa (SR##2##2##(1995-6#2)
kDa and an##2##3##(1990-5#1)(2008-10#1)
kDa and was##2##3##(2008-10#1)(2013-1#1)
kDa and##16##2##(1990-5#2)(1991-12#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(2008-10#6)(2008-5#1)(2010-12#1)(2013-1#1)
kDa as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##2##9##(2008-10#2)
kDa band##3##2##(1996-12#1)(2008-11#1)(2008-7#1)
kDa consisting of##2##3##(1995-6#1)(1997-4#1)
kDa for##2##2##(1993-6#1)(1995-8#1)
kDa from##2##2##(1995-6#1)(2008-10#1)
kDa heat shock protein##3##4##(1996-12#2)(1997-4#1)
kDa in size##3##3##(2008-11#3)
kDa in##13##2##(1990-12#1)(1993-12#1)(1993-8#1)(1994-11#1)(1996-12#1)(1997-7#1)(2008-10#4)(2008-11#3)
kDa isoform##2##2##(1996-12#1)(2008-11#1)
kDa on SDS-polyacrylamide##2##3##(1994-5#1)(2008-11#1)
kDa polypeptide##4##2##(1991-9#2)(1993-8#1)(1994-11#1)
kDa protein in##2##3##(1991-9#1)(1995-11#1)
kDa protein was##2##3##(1995-8#1)(2011-2#1)
kDa protein which##3##3##(1990-7#1)(1997-1#1)(1997-8#1)
kDa protein with##2##3##(1996-12#1)(1996-2#1)
kDa protein##21##2##(1990-11#1)(1990-7#1)(1991-9#2)(1992-8#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-7#4)(2011-2#1)
kDa proteins##2##2##(1993-8#1)(1996-12#1)
kDa species that was##2##4##(1992-10#2)
kDa subunit of##3##3##(1991-12#1)(2008-6#1)(2009-7#1)
kDa subunit##6##2##(1990-5#1)(1991-12#1)(1994-11#1)(2008-6#1)(2009-7#1)(2011-2#1)
kDa that##3##2##(1992-10#1)(2008-10#1)(2011-2#1)
kDa was observed##2##3##(2008-10#2)
kDa was shown to##2##4##(1996-2#1)(2008-10#1)
kDa was##8##2##(1993-8#1)(1996-2#1)(2008-10#4)(2008-11#1)(2013-1#1)
kDa were##3##2##(1995-12#1)(2008-10#1)(2008-12#1)
kDa which##5##2##(1990-5#2)(1993-8#1)(1995-12#1)(1995-2#1)
kDa with an##2##3##(2008-10#2)
kDa##279##1##(1990-11#5)(1990-12#6)(1990-5#11)(1990-7#2)(1991-12#4)(1991-9#4)(1992-10#6)(1992-3#1)(1992-6#5)(1992-8#2)(1993-1#3)(1993-12#4)(1993-2#2)(1993-6#4)(1993-8#9)(1994-11#8)(1994-5#2)(1994-6#1)(1994-8#4)(1995-11#5)(1995-12#11)(1995-2#4)(1995-6#13)(1995-8#4)(1995-9#1)(1996-12#15)(1996-2#4)(1996-3#2)(1996-6#3)(1997-1#2)(1997-2#11)(1997-4#2)(1997-7#4)(1997-8#1)(2007-12#1)(2008-10#48)(2008-11#15)(2008-12#5)(2008-5#9)(2008-6#3)(2008-7#6)(2009-6#1)(2009-7#7)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#7)(2012-2#7)(2013-1#2)
kDa) and##8##2##(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(2008-10#2)(2008-11#1)(2009-9#1)
kDa) have##2##2##(1994-5#1)(2008-10#1)
kDa) in##2##2##(1994-11#1)(2012-2#1)
kDa) was##3##2##(1991-10#1)(2008-10#1)(2008-11#1)
kDa) were##2##2##(1991-9#1)(2010-11#1)
kDa)##44##1##(1990-5#3)(1990-7#1)(1991-10#1)(1991-9#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-5#2)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#1)(2009-9#1)(2010-11#1)(2011-2#3)(2012-2#3)
kGy##5##1##(2008-10#2)(2009-7#3)
kHz and##2##2##(2008-3#1)(2010-9#1)
kHz##18##1##(1990-12#1)(1994-8#3)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#9)(2010-9#1)
kHz)##3##1##(1993-8#1)(2008-10#1)(2008-2#1)
kII =##2##2##(1990-5#2)
kII##3##1##(1990-5#3)
kJ mol(-1) at 298 K##2##5##(2008-10#2)
kJ mol(-1) by##2##3##(2008-10#2)
kJ mol(-1) n(-1) and##2##4##(2008-10#2)
kJ mol(-1) n(-1)##4##3##(2008-10#4)
kJ mol(-1)##17##2##(2008-10#16)(2008-5#1)
kJ mol(-1)n(-1)##2##2##(2008-10#2)
kJ mol-1##5##2##(1992-10#4)(1994-11#1)
kJ##33##1##(1992-10#4)(1994-11#1)(2008-10#19)(2008-5#2)(2008-8#2)(2008-9#2)(2013-8#3)
kJ/mol at##2##2##(1992-3#2)
kJ/mol for the##2##3##(1993-8#2)
kJ/mol##6##1##(1992-3#3)(1993-8#3)
kJmol(-1)##3##1##(2008-10#3)
kPa for##2##2##(2008-10#2)
kPa to##2##2##(2008-10#1)(2009-7#1)
kPa##17##1##(2008-10#13)(2008-7#1)(2009-5#1)(2009-7#2)
kV##13##1##(1997-8#2)(2008-10#10)(2008-3#1)
kV) &gt##5##2##(1997-8#5)
kV)##7##1##(1997-8#7)
kW and##2##2##(2008-3#2)
kW##3##1##(2008-3#3)
kW/cm(2)##2##1##(2008-3#2)
kaempferol##2##1##(2008-10#1)(2008-5#1)
kainate receptors##2##2##(1995-11#2)
kainate##7##1##(1994-2#2)(1995-11#4)(1995-2#1)
kainate-induced seizures##3##2##(1994-2#3)
kainic acid##2##2##(1993-6#1)(2008-4#1)
kanamycin resistance##5##2##(2008-10#4)(2008-7#1)
kanamycin##8##1##(1997-8#1)(2008-10#6)(2008-7#1)
kappa =##4##2##(1990-5#2)(1997-8#2)
kappa B activity##3##3##(1994-6#3)
kappa B##13##2##(1993-9#2)(1994-6#4)(1995-2#6)(2013-1#1)
kappa concordance##2##2##(2009-8#2)
kappa light chain constant region##2##5##(1997-8#2)
kappa light chain restriction##2##4##(2009-8#2)
kappa light chain##4##3##(1997-8#2)(2009-8#2)
kappa s##2##2##(1990-5#2)
kappa##48##1##(1990-5#9)(1991-7#2)(1992-10#1)(1992-8#1)(1993-2#1)(1993-9#2)(1994-6#4)(1995-2#6)(1995-6#2)(1996-12#1)(1997-8#5)(2007-11#1)(2008-10#3)(2008-11#1)(2009-8#4)(2010-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
kappa(t)##2##1##(2008-10#2)
kappa-opioid and NMDA receptors##2##4##(1997-2#2)
kappa-opioid and NMDA##3##3##(1997-2#3)
kappa-opioid##11##1##(1995-11#5)(1997-2#6)
karyopherin beta##2##2##(1995-2#2)
karyopherin##3##1##(1995-2#3)
karyosome capsule##3##2##(2008-7#3)
karyosome##12##1##(2007-12#3)(2008-7#9)
karyotype in##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
karyotype of##4##2##(2008-10#1)(2008-12#3)
karyotype variation##2##2##(2008-12#2)
karyotype##14##1##(1997-3#1)(2008-10#2)(2008-11#3)(2008-12#7)(2013-8#1)
karyotypes and##3##2##(2008-12#3)
karyotypes of the##2##3##(1990-5#1)(2008-12#1)
karyotypes of##6##2##(1990-5#1)(2008-12#5)
karyotypes with##2##2##(2008-10#1)(2010-11#1)
karyotypes##19##1##(1990-5#2)(2008-10#1)(2008-12#12)(2010-1#2)(2010-11#1)(2012-3#1)
karyotypic abnormalities##3##2##(1990-5#1)(2008-8#2)
karyotypic complexity##2##2##(2012-3#2)
karyotypic##8##1##(1990-5#1)(2008-8#2)(2012-3#5)
karyotyping##3##1##(1996-6#1)(2008-10#1)(2010-8#1)
kava on a##2##3##(2008-1#2)
kava on##3##2##(2008-1#3)
kava##9##1##(2008-1#9)
kava-drinking##2##1##(2008-1#2)
kazusa##2##1##(1997-6#1)(1997-8#1)
kb DNA fragment was determined and##2##6##(1997-8#1)(2008-8#1)
kb DNA fragment was##3##4##(1997-8#1)(2008-8#2)
kb DNA fragment##7##3##(1992-3#1)(1996-3#1)(1997-8#1)(2008-8#3)(2008-9#1)
kb DNA##9##2##(1992-3#1)(1996-3#1)(1997-8#2)(2008-8#4)(2008-9#1)
kb and 5##2##3##(1997-8#1)(2008-8#1)
kb and##15##2##(1991-6#1)(1993-12#1)(1994-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#2)(2008-11#1)(2008-8#4)(2012-3#1)
kb cDNA##2##2##(1990-2#1)(1996-2#1)
kb downstream from##3##3##(1993-2#2)(1997-8#1)
kb from##2##2##(1995-9#1)(1996-6#1)
kb in length and##2##4##(1993-2#1)(2008-8#1)
kb in length##5##3##(1993-2#2)(1997-2#1)(2008-8#2)
kb in size##4##3##(1994-11#1)(2008-10#3)
kb in the##5##3##(1990-2#1)(1997-7#1)(2008-11#2)(2012-3#1)
kb in##18##2##(1990-2#2)(1993-2#2)(1994-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-8#4)(2012-3#1)
kb long and##2##3##(1993-2#1)(1993-6#1)
kb long##3##2##(1993-2#1)(1993-6#1)(1997-7#1)
kb mRNA##5##2##(1993-8#1)(1995-12#1)(1996-12#1)(1997-2#2)
kb of DNA##2##3##(1993-12#1)(2012-3#1)
kb of genomic DNA##2##4##(1993-2#1)(1997-7#1)
kb of the genome##2##4##(2008-10#2)
kb of the##6##3##(1993-2#1)(1997-8#1)(2008-10#3)(2008-8#1)
kb of##16##2##(1991-6#1)(1993-12#1)(1993-2#2)(1996-12#2)(1997-7#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-8#2)(2012-3#1)
kb on the##5##3##(1993-12#2)(1993-6#2)(1996-6#1)
kb on##7##2##(1993-12#2)(1993-6#2)(1996-3#1)(1996-6#1)(1997-7#1)
kb region at Xq28##2##4##(2008-12#2)
kb region##8##2##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#3)
kb segment from##2##3##(1995-9#1)(1996-6#1)
kb segment of##2##3##(1995-9#1)(2008-11#1)
kb segment##5##2##(1995-9#2)(1996-6#2)(2008-11#1)
kb transcript##3##2##(1993-8#1)(1997-2#1)(2008-8#1)
kb were##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
kb##168##1##(1990-2#4)(1991-6#2)(1991-9#1)(1992-3#1)(1993-12#6)(1993-2#8)(1993-3#6)(1993-6#3)(1993-8#2)(1994-11#3)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#5)(1996-12#4)(1996-2#2)(1996-3#5)(1996-6#9)(1996-8#1)(1997-2#12)(1997-3#2)(1997-6#1)(1997-7#6)(1997-8#7)(1997-9#1)(2007-12#1)(2008-10#21)(2008-11#10)(2008-12#4)(2008-8#23)(2008-9#5)(2011-2#1)(2012-3#7)
kb) and##3##2##(1995-6#1)(2008-10#1)(2008-6#1)
kb) for##2##2##(1995-12#1)(1995-6#1)
kb) was##4##2##(1993-12#1)(1993-8#1)(2008-11#1)(2008-5#1)
kb)##19##1##(1993-12#1)(1993-8#1)(1994-11#3)(1995-12#1)(1995-5#1)(1995-6#2)(1997-2#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)
kbp##5##1##(1996-12#1)(2008-10#1)(2008-11#3)
kbp)##2##1##(2008-10#2)
kcal/d energy##2##2##(2013-1#2)
kcal/mol is##2##2##(1992-3#1)(2008-11#1)
kcal/mol##14##1##(1992-3#2)(1993-8#5)(1994-5#2)(2008-11#5)
kcal/mol) in the##2##3##(1993-8#2)
kcal/mol)##6##1##(1993-8#5)(1996-5#1)
kcal/mole##2##1##(1991-5#2)
kcat values##3##2##(1991-5#1)(1994-5#1)(1995-6#1)
kcat##10##1##(1991-5#1)(1993-9#1)(1994-5#5)(1995-6#2)(1995-8#1)
kcat/Km##4##1##(1993-8#2)(1994-5#2)
kd##3##1##(1993-12#2)(1996-12#1)
keV)##3##1##(2008-3#2)(2010-3#1)
keep his##2##2##(1993-11#1)(2008-10#1)
keep in mind that##4##4##(1992-3#1)(2009-12#1)(2012-12#1)(2013-1#1)
keep in mind the##2##4##(1995-3#1)(2009-1#1)
keep in mind##6##3##(1992-3#1)(1995-3#1)(2009-1#1)(2009-12#1)(2012-12#1)(2013-1#1)
keep in touch##2##3##(2008-11#1)(2008-9#1)
keep in##9##2##(1990-9#1)(1992-3#1)(1995-3#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-12#1)(2012-12#1)(2013-1#1)
keep the patient##2##3##(1992-1#1)(1994-5#1)
keep the##10##2##(1992-1#1)(1992-3#1)(1994-3#3)(1994-5#1)(1997-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
keep them##3##2##(1993-6#1)(1994-3#1)(2010-4#1)
keep your##3##2##(1993-2#1)(1994-1#1)(2008-10#1)
keep##53##1##(1990-3#1)(1990-9#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#5)(1994-5#1)(1995-1#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
keeping in view the##2##4##(2008-10#2)
keeping in##3##2##(2008-10#2)(2013-1#1)
keeping pace##2##2##(1991-2#1)(2008-11#1)
keeping paediatric patients motivated during the cochlear implant rehabilitative process##2##10##(2008-9#2)
keeping tabs on an endangered species##2##6##(1991-5#2)
keeping the##11##2##(1992-9#1)(2008-10#4)(2008-5#4)(2009-8#1)(2012-2#1)
keeping up##2##2##(1997-2#1)(2009-5#1)
keeping with expectations##2##3##(2008-10#1)(2008-8#1)
keeping with the##5##3##(1994-1#1)(1995-1#1)(2008-12#1)(2009-8#1)(2010-4#1)
keeping with##12##2##(1990-6#1)(1994-1#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)
keeping##50##1##(1990-6#1)(1991-2#2)(1991-5#2)(1992-12#1)(1992-9#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
keeps##6##1##(1994-2#1)(2008-10#3)(2008-8#2)
kefyr 2Y305##2##2##(2013-1#2)
kelp and##2##2##(2008-10#2)
kelp##3##1##(2008-10#3)
kelvin##2##1##(1994-9#1)(1995-6#1)
kept at a##2##3##(1992-1#1)(2008-3#1)
kept at##8##2##(1992-1#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-3#1)
kept constant at##2##3##(2008-10#2)
kept constant##4##2##(1997-6#1)(2008-10#2)(2008-3#1)
kept for##4##2##(2008-10#1)(2008-11#1)(2009-1#1)(2010-8#1)
kept in a##4##3##(1996-12#1)(2008-10#2)(2008-5#1)
kept in the##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
kept in##25##2##(1996-12#2)(2008-10#10)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
kept on##2##2##(2011-2#1)(2013-8#1)
kept the##3##2##(2008-8#1)(2010-1#1)(2010-4#1)
kept under##5##2##(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#1)
kept wet##2##2##(2008-10#2)
kept##79##1##(1992-1#1)(1994-12#1)(1995-12#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#3)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
keratan##2##1##(1993-2#2)
keratin 1##3##2##(1996-2#1)(2011-2#2)
keratin 14##3##2##(1991-12#2)(1996-2#1)
keratin 8##3##2##(2012-3#3)
keratin gene##2##2##(1991-12#1)(2008-9#1)
keratin genes##2##2##(1996-2#1)(2011-2#1)
keratin intermediate##5##2##(1991-12#1)(2008-8#4)
keratin##33##1##(1991-12#5)(1996-2#5)(2008-11#2)(2008-5#4)(2008-8#5)(2008-9#1)(2009-10#1)(2011-2#7)(2012-3#3)
keratin-like proteins##2##2##(2008-8#2)
keratinization##2##1##(2008-5#1)(2010-6#1)
keratinized tissue##2##2##(2008-5#1)(2013-1#1)
keratinocyte cells##3##2##(2008-11#1)(2012-3#2)
keratinocyte differentiation##5##2##(1994-3#2)(2008-11#2)(2008-5#1)
keratinocyte##21##1##(1991-12#1)(1992-3#1)(1994-11#1)(1994-3#3)(1996-2#1)(2008-11#7)(2008-5#3)(2008-7#1)(2008-9#1)(2012-3#2)
keratinocytes and melanocytes##2##3##(2008-5#2)
keratinocytes and##4##2##(2008-5#3)(2009-3#1)
keratinocytes in##2##2##(1997-1#1)(2012-2#1)
keratinocytes only##2##2##(2008-11#1)(2008-5#1)
keratinocytes were##2##2##(1995-11#1)(2008-5#1)
keratinocytes##40##1##(1993-11#1)(1994-3#2)(1995-11#1)(1996-2#3)(1997-1#3)(2008-11#7)(2008-12#4)(2008-5#10)(2009-3#1)(2010-6#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
keratins and##3##2##(2008-5#2)(2008-8#1)
keratins##13##1##(2008-11#1)(2008-5#7)(2008-8#2)(2011-2#3)
keratitis after##2##2##(2013-1#2)
keratitis##11##1##(2010-10#2)(2011-2#7)(2013-1#2)
keratoconjunctivitis in yaks##2##3##(2011-2#2)
keratoconjunctivitis in##4##2##(2008-9#1)(2011-2#2)(2012-3#1)
keratoconjunctivitis##10##1##(2008-9#1)(2011-2#6)(2012-3#2)(2013-8#1)
keratoconus##3##1##(2011-2#2)(2012-3#1)
keratocysts##2##1##(1997-3#1)(2013-1#1)
keratopathy##2##1##(2011-2#1)(2012-3#1)
keratoplasty (PK)##2##2##(2011-2#2)
keratoplasty##7##1##(2010-10#2)(2011-2#4)(2013-1#1)
keratosis actinica##3##2##(2011-2#3)
keratosis##10##1##(2007-8#3)(2011-2#6)(2012-12#1)
kernel blight##2##2##(2008-10#2)
kernel infection by##2##3##(2008-10#2)
kernel infection##6##2##(2008-10#6)
kernel partial least-squares##2##3##(2008-10#2)
kernel proteins##2##2##(2008-10#2)
kernel were##2##2##(2008-10#2)
kernel##31##1##(2008-10#30)(2011-3#1)
kernels and a##2##3##(2008-10#1)(2012-3#1)
kernels and##4##2##(2008-10#3)(2012-3#1)
kernels of##5##2##(2008-10#4)(2010-4#1)
kernels with wounded##2##3##(2008-10#2)
kernels with##3##2##(2008-10#3)
kernels##44##1##(1991-9#1)(2008-10#35)(2008-12#1)(2010-4#1)(2012-3#5)(2013-8#1)
kerosene##13##1##(2008-10#10)(2008-11#3)
ketals##4##1##(1993-8#1)(1996-5#1)(2008-5#2)
ketamine hydrochloride and##2##3##(2013-1#2)
ketamine hydrochloride##3##2##(2013-1#3)
ketamine##9##1##(1992-12#1)(2012-3#2)(2013-1#6)
ketimine##4##1##(1990-8#4)
keto acid##5##2##(2008-10#2)(2008-11#3)
keto##9##1##(1990-9#1)(1996-5#2)(2008-10#2)(2008-11#4)
ketoacidosis##7##1##(1994-6#2)(2009-8#1)(2011-1#4)
ketoconazole was##2##2##(2008-11#1)(2008-5#1)
ketoconazole##11##1##(1991-5#1)(2008-11#4)(2008-5#5)(2012-3#1)
ketogenic##2##1##(2008-3#2)
ketone (MIBK)##3##2##(2008-10#3)
ketone and##7##2##(2008-10#7)
ketone group##2##2##(1997-1#2)
ketone##44##1##(1994-5#1)(1995-11#1)(1996-5#3)(1997-1#5)(2008-10#33)(2008-11#1)
ketones and##4##2##(1996-5#2)(2008-12#1)(2011-2#1)
ketones are##2##2##(2008-10#1)(2012-3#1)
ketones from##2##2##(2010-7#1)(2012-3#1)
ketones##19##1##(1996-5#5)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#3)(2011-2#1)(2011-3#1)(2012-3#3)
ketoprofen##10##1##(2008-10#6)(2012-3#4)
ketotifen##3##1##(2010-6#3)
key activities##2##2##(2008-11#1)(2013-1#1)
key amino acids##2##3##(2009-8#1)(2011-2#1)
key amino##3##2##(2008-8#1)(2009-8#1)(2011-2#1)
key areas##4##2##(1991-2#1)(2008-1#1)(2008-11#1)(2008-12#1)
key aspects##3##2##(1995-2#1)(2008-6#1)(2010-10#1)
key assumptions##2##2##(2008-8#1)(2012-3#1)
key business##3##2##(1993-1#1)(1993-12#1)(1993-3#1)
key characteristics of the##2##4##(2010-12#1)(2013-1#1)
key characteristics of##4##3##(1994-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
key charged##2##2##(1995-6#2)
key component of##2##3##(2008-10#2)
key component##6##2##(2008-10#2)(2008-11#3)(2013-8#1)
key components in##2##3##(2008-10#2)
key components of##7##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#1)
key components##11##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)
key determinant of##2##3##(2008-11#1)(2009-8#1)
key determinant##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
key determinants##2##2##(2008-4#1)(2012-2#1)
key developmental##2##2##(2009-8#2)
key domains##2##2##(2008-11#1)(2009-11#1)
key element in##2##3##(2008-7#1)(2009-10#1)
key element##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
key elements in##2##3##(2008-10#1)(2011-1#1)
key elements of the##3##4##(1994-1#1)(2008-11#1)(2008-9#1)
key elements to##2##3##(1993-12#1)(2010-8#1)
key elements##8##2##(1993-12#1)(1994-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-8#1)(2011-1#1)
key enzyme for##3##3##(1997-1#1)(2008-11#1)(2008-8#1)
key enzyme of##4##3##(1992-8#1)(1993-6#1)(2008-10#1)(2009-8#1)
key enzyme##13##2##(1990-2#1)(1992-3#1)(1992-8#1)(1993-6#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-8#1)
key enzymes in the##2##4##(2008-10#1)(2011-2#1)
key enzymes in##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
key enzymes involved in the##2##5##(2008-9#1)(2012-5#1)
key enzymes involved in##3##4##(2008-11#1)(2008-9#1)(2012-5#1)
key enzymes##8##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-5#1)
key events##2##2##(2009-10#2)
key factor for##3##3##(2008-10#1)(2008-9#1)(2009-7#1)
key factor in##13##3##(1994-5#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
key factor that##2##3##(2008-3#1)(2012-2#1)
key factor##21##2##(1994-5#1)(1996-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
key factors in##3##3##(2008-1#1)(2008-10#1)(2012-3#1)
key factors##10##2##(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
key feature of the##3##4##(1996-12#1)(2008-10#2)
key feature of##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
key features of##4##3##(1997-6#1)(2008-8#1)(2011-2#2)
key features##8##2##(1997-6#1)(2008-11#1)(2008-8#1)(2009-12#1)(2011-2#3)(2012-3#1)
key findings##2##2##(1991-12#1)(2008-11#1)
key for##3##2##(2008-11#1)(2010-8#1)(2013-8#1)
key functional##2##2##(1993-6#1)(2012-3#1)
key functions of##2##3##(1997-1#1)(2013-1#1)
key hospital##2##2##(1993-3#1)(1994-3#1)
key in##2##2##(2008-10#1)(2013-1#1)
key informant interviews##2##3##(2013-1#2)
key informants##4##2##(1996-3#1)(2008-1#1)(2013-1#2)
key intermediates##2##2##(2008-10#1)(2008-5#1)
key is##3##2##(1993-2#1)(2010-3#1)(2011-2#1)
key issue##5##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)
key issues and##2##3##(1997-2#1)(2010-8#1)
key issues that##2##3##(2008-11#1)(2012-2#1)
key issues##10##2##(1992-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#2)(2010-4#1)(2010-8#1)(2012-2#1)
key mechanism##3##2##(2008-10#2)(2012-2#1)
key mediators##2##2##(2008-11#1)(2009-10#1)
key messages##4##2##(2010-4#2)(2010-8#2)
key molecules##2##2##(2009-8#1)(2013-8#1)
key nutrient components##2##3##(2008-7#2)
key odour-active compounds##2##3##(2008-10#2)
key parameters##5##2##(1992-3#1)(1992-9#1)(2008-11#2)(2013-8#1)
key player in##3##3##(1994-12#1)(1996-2#1)(2011-2#1)
key players in the##2##4##(1997-2#1)(2011-1#1)
key players in##4##3##(1997-2#1)(2011-1#1)(2013-7#2)
key players##5##2##(1997-2#1)(2011-1#1)(2013-1#1)(2013-7#2)
key points##2##2##(2008-12#1)(2010-10#1)
key problems##2##2##(1995-12#1)(2010-5#1)
key process in##2##3##(2008-10#1)(2010-8#1)
key process##5##2##(1993-12#1)(2008-10#2)(2010-11#1)(2010-8#1)
key processes##2##2##(2009-4#1)(2010-8#1)
key question##2##2##(2008-11#1)(2012-12#1)
key questions that##2##3##(1995-1#1)(2010-12#1)
key questions##3##2##(1995-1#1)(2008-11#1)(2010-12#1)
key raw material##2##3##(2008-10#2)
key regulator of##4##3##(1994-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
key regulators of##4##3##(2008-11#1)(2010-4#1)(2012-2#2)
key regulatory##6##2##(1993-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)
key research##2##2##(2010-10#1)(2011-2#1)
key results##2##2##(2007-12#1)(2009-8#1)
key role in##40##3##(1991-5#1)(1991-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#4)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
key role of##6##3##(1991-7#1)(2008-9#1)(2009-8#1)(2013-1#3)
key role##51##2##(1991-5#1)(1991-7#1)(1991-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-5#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-3#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#4)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)
key roles in the##2##4##(2008-1#1)(2010-12#1)
key roles in##8##3##(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
key roles##11##2##(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-1#1)
key signal##2##2##(2008-11#1)(2009-8#1)
key signaling##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
key stakeholders##3##2##(1991-1#1)(1991-3#1)(1992-1#1)
key step for##2##3##(2008-11#1)(2012-3#1)
key step in the##3##4##(1990-5#1)(1992-3#1)(2008-10#1)
key step in this##2##4##(1992-8#1)(2008-11#1)
key step in##8##3##(1990-5#1)(1992-3#1)(1992-8#1)(1994-11#1)(2008-10#1)(2008-11#2)(2011-2#1)
key step##13##2##(1990-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-11#1)(1996-5#1)(2008-10#2)(2008-11#3)(2011-2#1)(2012-3#1)
key strategies##2##2##(2008-10#1)(2012-3#1)
key string##5##2##(2008-7#5)
key strings##3##2##(2008-7#3)
key studies##2##2##(2008-10#1)(2008-7#1)
key success factors##2##3##(1994-2#1)(2010-8#1)
key success##3##2##(1994-2#1)(1996-1#1)(2010-8#1)
key themes##4##2##(2008-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
key to a##2##3##(1991-1#1)(2011-2#1)
key to the##9##3##(1991-1#1)(1992-2#1)(1994-12#1)(1994-2#1)(1997-1#1)(2008-7#2)(2010-10#1)(2011-9#1)
key to##41##2##(1991-1#2)(1992-2#1)(1992-3#1)(1992-8#1)(1994-12#3)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#4)(2011-3#1)(2011-9#1)(2013-1#1)(2013-8#1)
key topics##2##2##(1992-5#1)(2012-12#1)
key words##5##2##(2008-1#2)(2008-11#1)(2012-2#1)(2013-1#1)
key##561##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#3)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#7)(1994-2#8)(1994-3#8)(1994-5#1)(1994-8#3)(1995-1#2)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#3)(1995-6#3)(1996-1#3)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#3)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-1#10)(2008-10#56)(2008-11#52)(2008-12#12)(2008-3#9)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#17)(2008-8#21)(2008-9#15)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#7)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#20)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#10)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#9)(2011-1#8)(2011-10#1)(2011-2#28)(2011-3#3)(2011-9#1)(2012-12#12)(2012-2#23)(2012-3#12)(2012-5#1)(2013-1#29)(2013-7#4)(2013-8#11)
keyhole limpet hemocyanin (KLH)##3##4##(2008-10#2)(2008-9#1)
keyhole limpet##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
keypeck)##2##1##(2008-5#2)
keys to##4##2##(1991-12#1)(1995-1#1)(1996-1#1)(2008-10#1)
keyword and##2##2##(2010-12#2)
keyword search##2##2##(2010-12#1)(2011-2#1)
keyword##6##1##(1991-12#1)(2010-12#4)(2011-2#1)
keywords##4##1##(2008-10#2)(2010-6#1)(2013-1#1)
kg N ha(-1) from##2##4##(2008-12#2)
kg N ha(-1)##3##3##(2008-12#3)
kg N##4##2##(1996-12#1)(2008-12#3)
kg fresh##2##2##(2008-10#2)
kg ha(-1)##3##2##(2008-12#3)
kg ha(-1))##2##2##(2008-12#2)
kg in##4##2##(1994-3#1)(2012-2#1)(2012-3#2)
kg of soil##2##3##(2008-10#2)
kg of##5##2##(2008-10#3)(2008-11#2)
kg##43##1##(1991-3#1)(1994-3#1)(1996-12#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#11)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#3)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#4)
kg(-1) and##5##2##(2008-10#2)(2010-7#2)(2011-3#1)
kg(-1) body weight##2##3##(2010-11#1)(2012-3#1)
kg(-1) body##3##2##(2008-12#1)(2010-11#1)(2012-3#1)
kg(-1) bw##4##2##(2008-10#3)(2010-5#1)
kg(-1) i##4##2##(2008-12#4)
kg(-1) in##2##2##(2008-10#1)(2008-3#1)
kg(-1) of##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
kg(-1) was##2##2##(2008-11#1)(2008-5#1)
kg(-1) were##4##2##(2008-10#3)(2008-11#1)
kg(-1)##82##1##(2008-10#38)(2008-11#7)(2008-12#13)(2008-3#4)(2008-5#2)(2008-8#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#7)(2010-8#2)(2011-3#2)(2012-3#2)
kg(-1)) and##6##2##(2008-10#2)(2008-12#3)(2010-7#1)
kg(-1)) in##2##2##(2008-10#1)(2008-12#1)
kg(-1)) were##2##2##(2008-10#2)
kg(-1))##33##1##(1997-4#1)(2008-10#22)(2008-12#8)(2010-7#1)(2011-3#1)
kg)##6##1##(1996-12#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-1#1)
kg- 1##3##2##(2008-11#3)
kg-##4##1##(2008-11#4)
kg-1 animal##2##2##(1994-8#2)
kg-1##19##1##(1994-8#2)(1997-2#2)(2008-11#14)(2008-9#1)
kg/ha##9##1##(2008-10#5)(2011-1#4)
kg/ha)##2##1##(2008-10#2)
kg/m(2)##4##1##(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)
kg/m(2))##3##1##(2010-8#1)(2012-12#2)
kg/m2##5##1##(2011-2#5)
kg/m2)##2##1##(1994-12#1)(2013-1#1)
kickoff conference##2##2##(2012-2#2)
kid was born##2##3##(2008-9#2)
kidnapping##2##1##(1992-2#1)(1993-12#1)
kidney 293##2##2##(2008-11#2)
kidney and in##2##3##(1994-5#1)(2008-10#1)
kidney and intestine##2##3##(2008-11#2)
kidney and liver##4##3##(1991-5#2)(1994-5#1)(2008-6#1)
kidney and##34##2##(1990-11#1)(1991-5#3)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#2)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#6)(2013-1#4)(2013-7#1)
kidney but##3##2##(1990-3#1)(2008-11#1)(2011-2#1)
kidney cDNA library##3##3##(1993-6#1)(1997-7#1)(2010-5#1)
kidney cancer##3##2##(1991-8#1)(2008-11#1)(2011-2#1)
kidney cells and##2##3##(1991-3#1)(2013-8#1)
kidney cells##4##2##(1991-3#3)(2013-8#1)
kidney cortex##4##2##(1994-8#3)(2010-4#1)
kidney cytosols##2##2##(1990-11#2)
kidney disease (CKD) is##2##4##(2009-1#1)(2012-2#1)
kidney disease (CKD)##5##3##(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
kidney disease and##2##3##(2008-11#1)(2011-2#1)
kidney disease are##2##3##(2009-12#1)(2013-1#1)
kidney disease in##3##3##(2009-6#2)(2012-2#1)
kidney disease##30##2##(1997-1#2)(2008-10#1)(2008-11#1)(2009-1#2)(2009-12#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-4#3)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#3)
kidney failure##5##2##(1996-6#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
kidney fibroblasts##2##2##(2008-11#1)(2008-5#1)
kidney from##2##2##(1990-3#1)(2008-11#1)
kidney function##7##2##(1991-3#1)(1993-2#1)(1994-5#1)(1994-9#1)(2009-3#1)(2010-12#1)(2012-2#1)
kidney glucagon##2##2##(1995-11#2)
kidney in##8##2##(1997-8#1)(2008-10#1)(2008-12#2)(2011-2#1)(2012-12#2)(2013-1#1)
kidney injury##6##2##(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#3)
kidney is##7##2##(1994-5#1)(2008-10#3)(2010-10#1)(2011-2#2)
kidney of##3##2##(2008-5#2)(2009-6#1)
kidney on##2##2##(2008-10#1)(2011-2#1)
kidney soluble extract##2##3##(1990-2#2)
kidney soluble##3##2##(1990-2#3)
kidney stones##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
kidney tissue##2##2##(2010-4#2)
kidney to##3##2##(1995-11#1)(2010-1#1)(2011-2#1)
kidney transplant patients##3##3##(1994-5#3)
kidney transplant##9##2##(1994-5#3)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#2)(2012-3#1)
kidney transplantation##7##2##(1995-12#3)(2011-2#1)(2012-12#2)(2013-1#1)
kidney tumors were##2##3##(1994-5#2)
kidney tumors##4##2##(1992-12#1)(1994-5#2)(2011-2#1)
kidney was##4##2##(1990-2#1)(1991-12#1)(2008-10#1)(2011-2#1)
kidney weights were significantly##2##4##(2008-9#2)
kidney weights were##3##3##(2008-9#3)
kidney weights##4##2##(2008-9#4)
kidney were##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
kidney which##2##2##(1990-9#1)(2011-2#1)
kidney while##2##2##(1990-3#1)(1994-5#1)
kidney with##2##2##(1992-6#1)(2013-1#1)
kidney##340##1##(1990-11#6)(1990-12#5)(1990-2#7)(1990-3#6)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#5)(1991-5#4)(1991-8#4)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#2)(1993-12#5)(1993-2#4)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#6)(1994-5#15)(1994-8#4)(1994-9#1)(1995-11#6)(1995-12#7)(1995-2#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-6#2)(1997-1#3)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-1#3)(2008-10#38)(2008-11#23)(2008-12#6)(2008-5#8)(2008-6#1)(2008-8#3)(2008-9#8)(2009-1#2)(2009-12#1)(2009-3#4)(2009-5#1)(2009-6#7)(2009-8#2)(2010-1#1)(2010-10#3)(2010-12#6)(2010-4#8)(2010-5#3)(2010-6#1)(2011-2#37)(2011-3#1)(2012-12#11)(2012-2#12)(2012-3#7)(2013-1#18)(2013-7#1)(2013-8#7)
kidney&quot##2##1##(2008-1#2)
kidneys and##5##2##(1990-11#1)(1992-12#1)(1993-8#1)(1994-12#1)(1997-1#1)
kidneys of rats##2##3##(1994-5#1)(2009-6#1)
kidneys of streptozotocin-induced diabetic rats##2##5##(2011-3#2)
kidneys of streptozotocin-induced diabetic##3##4##(2011-3#3)
kidneys of##9##2##(1994-5#3)(1997-1#1)(2008-5#1)(2009-6#1)(2011-3#3)
kidneys were##4##2##(2008-12#1)(2008-5#1)(2009-6#1)(2012-3#1)
kidneys with##3##2##(1996-6#2)(2008-10#1)
kidneys##48##1##(1990-11#1)(1991-6#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-5#6)(1995-11#1)(1995-12#1)(1996-3#2)(1996-6#2)(1997-1#2)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#5)(2009-6#2)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)
kids##3##1##(1996-12#1)(2008-4#1)(2008-9#1)
kikuchii was##2##2##(2008-10#2)
kikuchii##5##1##(2008-10#5)
kill the##4##2##(1996-9#1)(2008-10#2)(2011-2#1)
kill##31##1##(1995-2#3)(1996-9#1)(1997-5#1)(2008-10#8)(2008-11#5)(2008-7#5)(2008-8#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
killed after##2##2##(2008-10#1)(2008-11#1)
killed all##2##2##(1994-2#1)(1996-12#1)
killed at##3##2##(1992-6#1)(2008-7#1)(2008-8#1)
killed by tobacco##2##3##(1992-6#2)
killed by##7##2##(1992-6#2)(2008-10#3)(2012-2#1)(2012-3#1)
killed root##2##2##(2008-10#2)
killed##31##1##(1990-12#2)(1990-3#2)(1992-6#3)(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#3)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
killer (NK) cells##5##3##(1995-2#1)(2008-4#1)(2010-1#1)(2012-3#1)(2013-1#1)
killer (NK)##10##2##(1995-2#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#3)
killer cell activity##5##3##(1993-3#1)(2007-11#1)(2008-10#3)
killer cell##12##2##(1993-3#1)(2007-11#1)(2008-10#6)(2008-4#2)(2008-9#1)(2012-3#1)
killer cells##15##2##(1990-12#3)(1991-8#1)(1993-3#2)(1995-2#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#3)
killer toxins##4##2##(1993-12#3)(2008-10#1)
killer##53##1##(1990-12#3)(1991-8#1)(1992-2#1)(1993-12#5)(1993-3#3)(1994-6#1)(1995-2#2)(1996-12#2)(2007-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-1#1)(2012-3#2)(2013-1#6)(2013-7#1)
killifish##2##1##(2008-8#1)(2012-3#1)
killing activity##2##2##(2008-11#1)(2012-12#1)
killing and##2##2##(2008-7#1)(2008-9#1)
killing by##3##2##(1995-8#1)(2008-8#1)(2012-2#1)
killing of##5##2##(1993-8#3)(2008-4#1)(2008-8#1)
killing spectra##2##2##(1993-12#2)
killing##45##1##(1991-5#2)(1993-12#3)(1993-8#4)(1994-1#1)(1994-3#1)(1995-2#1)(1995-8#4)(1996-12#2)(2008-10#3)(2008-11#5)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
kills##4##1##(1996-9#2)(2008-9#1)(2011-2#1)
kilobase##4##1##(1990-8#1)(1997-9#1)(2008-12#1)(2008-8#1)
kilobases (kb)##2##2##(2008-10#1)(2011-2#1)
kilobases##8##1##(1991-12#1)(1994-11#1)(1994-9#1)(1995-6#1)(1997-9#2)(2008-10#1)(2011-2#1)
kilogram of body weight##2##4##(2011-3#2)
kilogram of##3##2##(2008-12#1)(2011-3#2)
kilogram##5##1##(1996-12#1)(1997-8#1)(2008-12#1)(2011-3#2)
kilometers##5##1##(1991-8#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-9#1)
kin groups##2##2##(2010-8#2)
kin recognition##4##2##(2008-8#4)
kin selection and##2##3##(2008-8#1)(2010-4#1)
kin selection##5##2##(2008-8#3)(2010-4#2)
kin##17##1##(1993-6#1)(2008-5#1)(2008-8#9)(2009-10#2)(2010-4#2)(2010-8#2)
kin-discrimination mechanisms##2##2##(2008-8#2)
kinase (PK)##5##2##(1993-2#2)(1993-9#1)(1997-6#1)(2008-7#1)
kinase A pathway##2##3##(1995-12#1)(1997-1#1)
kinase A##21##2##(1993-8#4)(1994-8#3)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
kinase B##3##2##(2008-3#2)(2010-12#1)
kinase C (PKC)##25##3##(1990-5#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2013-8#1)
kinase C activity##7##3##(1990-5#1)(1990-8#2)(1993-8#2)(2008-11#1)(2008-3#1)
kinase C##137##2##(1990-12#2)(1990-5#12)(1990-8#6)(1991-5#2)(1991-7#1)(1992-12#2)(1992-8#6)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#8)(1994-11#9)(1994-3#1)(1994-5#9)(1994-6#2)(1994-8#3)(1995-11#4)(1995-12#1)(1995-2#5)(1995-6#3)(1995-8#4)(1996-12#1)(1996-6#2)(1997-1#5)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#20)(2008-3#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-12#2)(2013-8#1)
kinase II (CaM kinase II)##2##5##(1990-5#1)(1993-6#1)
kinase II (CaMK##2##3##(1995-8#1)(1996-12#1)
kinase II (CaMKII)##3##3##(2008-8#1)(2009-7#1)(2012-2#1)
kinase II immunoreactivity in##2##4##(1990-5#2)
kinase II of##2##3##(1990-5#1)(2008-8#1)
kinase II with calmodulin##2##4##(1993-6#2)
kinase II##44##2##(1990-12#3)(1990-5#6)(1993-6#12)(1993-8#3)(1994-11#1)(1995-2#4)(1995-8#2)(1996-12#2)(1996-2#3)(1997-7#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-7#1)(2012-2#1)
kinase activation and##2##3##(1997-1#1)(2009-6#1)
kinase activation##14##2##(1992-8#1)(1994-11#2)(1995-6#1)(1995-8#7)(1997-1#1)(2009-6#1)(2009-8#1)
kinase activities##2##2##(1993-8#1)(1997-2#1)
kinase activity by##2##3##(1993-8#1)(2011-2#1)
kinase activity in a##2##4##(1992-7#1)(1992-8#1)
kinase activity in##7##3##(1992-7#1)(1992-8#2)(1993-8#1)(1995-12#2)(2008-6#1)
kinase activity of##2##3##(1993-8#1)(2009-7#1)
kinase activity was##4##3##(1992-9#1)(1997-1#1)(1997-3#1)(2008-6#1)
kinase activity##36##2##(1990-12#3)(1992-7#3)(1992-8#4)(1992-9#1)(1993-8#4)(1995-12#4)(1995-6#2)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-4#1)(2008-6#2)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#2)(2013-8#1)
kinase and##18##2##(1990-8#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-6#1)(1996-2#3)(2008-10#2)(2008-7#2)(2009-6#1)(2012-3#1)(2013-1#3)
kinase are##2##2##(1993-6#1)(1995-11#1)
kinase assay##2##2##(1993-6#1)(2010-4#1)
kinase by##3##2##(1990-8#1)(1993-8#1)(1995-8#1)
kinase cascade##2##2##(1997-1#1)(2009-8#1)
kinase catalytic##2##2##(1994-11#1)(2013-1#1)
kinase domain in complex with imatinib##2##6##(2009-7#2)
kinase domain##8##2##(1995-2#1)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#2)(2012-2#1)
kinase encoded by##2##3##(2008-10#1)(2011-2#1)
kinase family##2##2##(1997-8#1)(2013-1#1)
kinase for##2##2##(1992-6#1)(1996-12#1)
kinase from##4##2##(1990-2#1)(1990-5#3)
kinase gene in##2##3##(2007-11#1)(2012-2#1)
kinase gene##5##2##(1997-8#1)(2007-11#1)(2008-10#1)(2012-2#2)
kinase in a##2##3##(1993-8#1)(1995-2#1)
kinase in the##4##3##(1992-9#1)(1993-8#1)(1995-8#1)(2010-10#1)
kinase in##12##2##(1990-2#1)(1992-9#1)(1993-8#4)(1995-2#1)(1995-8#2)(1996-2#1)(2010-10#1)(2013-1#1)
kinase inhibitor##19##2##(1990-12#3)(1992-6#1)(1993-3#1)(1994-6#1)(1995-2#2)(1996-12#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-11#2)(2012-2#1)(2012-3#1)
kinase inhibitors##16##2##(1990-8#2)(1994-11#2)(1997-2#1)(2008-11#1)(2008-5#1)(2009-7#3)(2010-5#3)(2011-2#1)(2011-3#1)(2013-1#1)
kinase is a##2##3##(1992-8#1)(1996-2#1)
kinase is##4##2##(1992-8#2)(1995-8#1)(1996-2#1)
kinase may be##2##3##(1994-11#1)(1996-2#1)
kinase or##2##2##(1995-2#1)(1996-2#1)
kinase receptors##4##2##(1995-2#2)(2009-8#1)(2012-3#1)
kinase showed##2##2##(1990-10#1)(1995-12#1)
kinase signal##2##2##(1996-2#1)(2008-11#1)
kinase signaling##5##2##(1996-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
kinase that##4##2##(1995-8#1)(1997-7#1)(2008-8#1)(2009-7#1)
kinase was##5##2##(1990-5#1)(1992-7#1)(1992-9#1)(1994-8#1)(2008-6#1)
kinase with##4##2##(1990-8#2)(1993-6#1)(1995-6#1)
kinase##609##1##(1990-10#2)(1990-11#1)(1990-12#13)(1990-2#3)(1990-5#29)(1990-8#16)(1991-3#1)(1991-5#2)(1991-7#1)(1992-12#2)(1992-3#2)(1992-6#5)(1992-7#9)(1992-8#15)(1992-9#8)(1993-12#3)(1993-2#4)(1993-3#7)(1993-6#25)(1993-8#45)(1993-9#1)(1994-11#21)(1994-12#2)(1994-3#3)(1994-5#11)(1994-6#7)(1994-8#11)(1995-11#6)(1995-12#10)(1995-2#27)(1995-6#12)(1995-8#26)(1996-12#9)(1996-2#26)(1996-6#2)(1997-1#11)(1997-2#9)(1997-3#2)(1997-6#1)(1997-7#5)(1997-8#4)(2007-11#1)(2008-10#14)(2008-11#27)(2008-3#7)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#13)(2008-8#16)(2008-9#8)(2009-10#4)(2009-11#1)(2009-5#1)(2009-6#4)(2009-7#11)(2009-8#17)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#7)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#20)(2011-3#1)(2012-2#8)(2012-3#10)(2013-1#11)(2013-7#1)(2013-8#5)
kinase) family##2##2##(1996-2#2)
kinase)##6##1##(1995-8#1)(1996-2#2)(1997-2#1)(2010-10#1)(2012-3#1)
kinase-##2##1##(1997-6#1)(2008-10#1)
kinase-dependent##2##1##(1995-2#1)(2009-7#1)
kinase-mediated phosphoryltransfer##2##2##(2008-7#2)
kinase-mediated##3##1##(1996-12#1)(2008-7#2)
kinase-negative##4##1##(1996-2#1)(1997-7#3)
kinases and they##2##3##(1997-2#1)(2008-4#1)
kinases and##6##2##(1990-8#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-4#1)(2011-2#1)
kinases are##3##2##(1995-6#1)(1996-2#2)
kinases in##5##2##(1996-2#1)(1997-1#1)(1997-7#1)(2008-11#1)(2012-3#1)
kinases that are##2##3##(1995-2#1)(2010-8#1)
kinases that may regulate##2##4##(1993-3#1)(2012-2#1)
kinases that##7##2##(1993-2#1)(1993-3#1)(1995-2#2)(2010-8#1)(2012-2#1)(2013-1#1)
kinases to##3##2##(1993-3#1)(1996-2#1)(2009-8#1)
kinases##90##1##(1990-8#3)(1993-2#2)(1993-3#2)(1993-8#5)(1994-11#6)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#8)(1995-6#8)(1995-8#1)(1996-2#11)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#2)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#1)
kind of effect##2##3##(1993-3#1)(2008-11#1)
kind of memory##2##3##(2009-10#2)
kind of samples##3##3##(2008-10#3)
kind of treatment##3##3##(1993-3#1)(2008-12#1)(2013-8#1)
kind of##92##2##(1990-6#2)(1990-8#1)(1990-9#2)(1991-3#1)(1991-6#1)(1993-1#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-10#29)(2008-11#5)(2008-12#5)(2008-3#3)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#2)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#2)(2013-8#1)
kind was##2##2##(2008-10#2)
kind##113##1##(1990-6#2)(1990-8#1)(1990-9#2)(1991-3#1)(1991-6#1)(1993-1#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#34)(2008-11#8)(2008-12#6)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#3)(2012-3#2)(2013-8#1)
kindergarten##7##1##(2008-11#1)(2008-12#4)(2011-2#1)(2013-1#1)
kindergartens##3##1##(2011-2#3)
kindled animals##2##2##(1996-12#2)
kindled rats##3##2##(1990-5#2)(1992-12#1)
kindled seizures##3##2##(1990-5#1)(1992-12#1)(1994-2#1)
kindled##13##1##(1990-5#4)(1992-12#3)(1994-2#1)(1996-12#5)
kindling epileptogenesis##2##2##(1996-12#1)(2013-8#1)
kindling##10##1##(1990-5#1)(1992-12#2)(1994-2#4)(1996-12#2)(2013-8#1)
kindreds##6##1##(1993-3#1)(1995-8#1)(1997-7#3)(2008-7#1)
kinds and concentrations of##2##4##(2008-12#1)(2008-8#1)
kinds of commercially available##2##4##(1993-3#1)(2008-10#1)
kinds of oncogenes##2##3##(2008-11#2)
kinds of##101##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-6#2)(1997-2#1)(1997-3#1)(2008-10#41)(2008-11#12)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#7)(2008-9#3)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#2)
kinds##106##1##(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-6#2)(1997-2#1)(1997-3#1)(2008-10#41)(2008-11#12)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#8)(2008-9#5)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#2)
kinematic focusing##4##2##(2008-10#4)
kinematic plan##2##2##(2008-11#2)
kinematic##14##1##(1993-3#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
kinematics as well##2##3##(2008-12#1)(2011-2#1)
kinematics during##2##2##(2008-12#1)(2013-1#1)
kinematics of the##3##3##(2011-2#3)
kinematics of##5##2##(2011-2#5)
kinematics##21##1##(2008-12#5)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#10)(2013-1#2)
kinesin##2##1##(2009-10#1)(2012-2#1)
kinesio##2##1##(2013-1#2)
kinetic analysis of##8##3##(1990-2#1)(1995-6#1)(2008-10#5)(2008-5#1)
kinetic analysis##13##2##(1990-2#1)(1993-3#1)(1994-8#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)
kinetic and equilibrium##3##3##(2008-10#3)
kinetic and thermodynamic##4##3##(1990-9#1)(1991-6#1)(2008-10#2)
kinetic and##12##2##(1990-9#1)(1991-6#1)(1993-8#2)(2008-10#6)(2008-11#1)(2008-8#1)
kinetic approach##2##2##(2008-10#1)(2008-5#1)
kinetic behavior##4##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-7#1)
kinetic constants for##3##3##(1993-8#1)(1994-8#1)(2008-10#1)
kinetic constants of##2##3##(1996-2#1)(2008-10#1)
kinetic constants##11##2##(1991-3#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-2#1)(2008-10#3)(2008-7#2)(2011-1#1)
kinetic curve of##2##3##(2008-10#2)
kinetic data##10##2##(2008-10#8)(2008-4#1)(2013-1#1)
kinetic determination of##11##3##(2008-10#11)
kinetic effect of##2##3##(2008-10#1)(2008-8#1)
kinetic effect##3##2##(2008-10#2)(2008-8#1)
kinetic effects##2##2##(1995-12#1)(2008-11#1)
kinetic energy##7##2##(2008-10#7)
kinetic equations and##2##3##(2008-10#2)
kinetic fluorimetric method##2##3##(2008-10#2)
kinetic information##2##2##(2008-10#2)
kinetic isotope effect##5##3##(1991-3#1)(1993-8#1)(1995-6#1)(1996-5#1)(2009-6#1)
kinetic isotope effects##2##3##(1991-9#2)
kinetic isotope##7##2##(1991-3#1)(1991-9#2)(1993-8#1)(1995-6#1)(1996-5#1)(2009-6#1)
kinetic measurements##3##2##(2008-10#3)
kinetic mechanism for the##2##4##(1995-6#1)(2008-10#1)
kinetic mechanism of##2##3##(1990-11#1)(1991-9#1)
kinetic mechanism##6##2##(1990-11#1)(1991-9#1)(1995-6#2)(2008-10#1)(2008-3#1)
kinetic method for the determination of##2##6##(2008-10#2)
kinetic method for the##3##4##(2008-10#3)
kinetic method for##4##3##(2008-10#4)
kinetic method is##2##3##(2008-10#2)
kinetic method was##2##3##(2008-10#2)
kinetic method##15##2##(2008-10#15)
kinetic methods##3##2##(2008-10#3)
kinetic model for##2##3##(1994-5#1)(1996-2#1)
kinetic model##6##2##(1994-5#1)(1996-2#1)(2008-11#2)(2008-7#1)(2009-11#1)
kinetic models##5##2##(2008-10#2)(2010-4#1)(2010-7#1)(2011-2#1)
kinetic of##5##2##(2008-10#5)
kinetic parameters for the##3##4##(1990-9#1)(1994-5#1)(2008-7#1)
kinetic parameters for##5##3##(1990-9#1)(1993-8#1)(1994-5#1)(2008-7#1)(2011-3#1)
kinetic parameters in the##2##4##(1994-8#1)(2008-10#1)
kinetic parameters in##4##3##(1994-8#1)(1995-12#2)(2008-10#1)
kinetic parameters involved in##2##4##(1995-12#1)(2008-10#1)
kinetic parameters of##3##3##(1990-5#1)(2008-10#1)(2008-4#1)
kinetic parameters##27##2##(1990-5#1)(1990-9#1)(1991-9#2)(1993-8#1)(1994-5#2)(1994-8#1)(1995-12#4)(1995-8#1)(1997-6#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-3#1)
kinetic profiles##3##2##(2008-10#3)
kinetic properties of##3##3##(1993-12#1)(1995-3#1)(1997-2#1)
kinetic properties##6##2##(1993-12#1)(1993-8#1)(1994-2#1)(1995-3#1)(1997-2#2)
kinetic rate##3##2##(2008-4#1)(2012-2#2)
kinetic rates##2##2##(2010-10#2)
kinetic reaction##2##2##(2008-10#2)
kinetic resistance##2##2##(2008-11#2)
kinetic resolution##2##2##(1992-11#1)(2011-1#1)
kinetic spectrophotometric determination of##6##4##(2008-10#6)
kinetic spectrophotometric method for##2##4##(2008-10#2)
kinetic spectrophotometric method##5##3##(2008-10#5)
kinetic spectrophotometric##13##2##(2008-10#13)
kinetic studies of##4##3##(1993-8#1)(1994-5#1)(2008-11#2)
kinetic studies show that##2##4##(1995-6#1)(2008-10#1)
kinetic studies##12##2##(1993-8#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-10#4)(2008-11#3)
kinetic study of the reduction##2##5##(2008-10#1)(2008-8#1)
kinetic study of##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
kinetic study using##2##3##(2008-10#2)
kinetic study##9##2##(2008-10#5)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
kinetic surface##2##2##(2008-10#2)
kinetic theory##3##2##(1990-5#2)(2008-3#1)
kinetic##277##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-9#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#6)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#9)(1994-2#1)(1994-5#5)(1994-8#3)(1995-12#6)(1995-2#2)(1995-3#1)(1995-6#9)(1995-8#1)(1996-12#1)(1996-2#3)(1996-5#2)(1997-2#2)(1997-6#1)(2008-10#151)(2008-11#12)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#1)(2009-6#1)(2010-10#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#3)(2013-1#1)(2013-8#2)
kinetic-catalytic##2##1##(2008-10#2)
kinetic-fluorimetric methods##2##2##(2008-10#2)
kinetic-fluorimetric##3##1##(2008-10#3)
kinetic-spectrophotometric determination of levodopa##2##4##(2008-10#2)
kinetic-spectrophotometric determination of##5##3##(2008-10#5)
kinetic-spectrophotometric method is##2##3##(2008-10#2)
kinetic-spectrophotometric method##3##2##(2008-10#3)
kinetic-spectrophotometric##10##1##(2008-10#10)
kinetically##15##1##(1990-2#1)(1991-9#1)(1992-3#1)(2008-10#7)(2008-4#1)(2008-7#3)(2010-4#1)
kinetically-hindered surface##2##2##(2008-10#2)
kinetically-hindered##3##1##(2008-10#3)
kinetics and mass transfer##2##4##(2008-10#1)(2010-4#1)
kinetics and the##3##3##(2008-10#3)
kinetics and thermodynamics of biomachining pure copper##2##7##(2008-8#2)
kinetics and thermodynamics of##4##4##(1993-3#1)(2008-10#1)(2008-8#2)
kinetics and##22##2##(1993-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
kinetics at##2##2##(2008-10#1)(2013-8#1)
kinetics between##2##2##(2007-11#1)(2009-10#1)
kinetics by##3##2##(1997-2#1)(2008-11#1)(2011-2#1)
kinetics can##2##2##(2008-10#1)(2008-7#1)
kinetics for##2##2##(2008-10#1)(2011-2#1)
kinetics in both##2##3##(2008-10#1)(2012-2#1)
kinetics in the##6##3##(1990-2#1)(1994-8#1)(2008-10#2)(2008-6#1)(2013-8#1)
kinetics in##15##2##(1990-2#1)(1990-5#1)(1993-11#1)(1994-8#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
kinetics is##3##2##(2008-10#2)(2008-11#1)
kinetics of impurity removal##2##4##(2008-7#2)
kinetics of induction##2##3##(1995-2#1)(2008-10#1)
kinetics of the reaction##4##4##(2008-10#4)
kinetics of the two##2##4##(2008-10#1)(2010-4#1)
kinetics of the##27##3##(1992-12#1)(1995-9#1)(2008-10#16)(2008-2#1)(2008-5#2)(2008-7#2)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)
kinetics of this reaction##2##4##(2008-10#2)
kinetics of this##3##3##(2008-10#3)
kinetics of##108##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#4)(1992-12#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-12#3)(1995-2#4)(1995-8#2)(1995-9#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-6#1)(2008-10#39)(2008-11#11)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
kinetics or##2##2##(2009-12#1)(2011-1#1)
kinetics to wild-type##2##3##(2013-1#2)
kinetics to##4##2##(2008-11#1)(2008-7#1)(2013-1#2)
kinetics was##4##2##(2008-10#3)(2008-7#1)
kinetics were##5##2##(1995-12#1)(2008-10#2)(2008-11#2)
kinetics with a##2##3##(1994-5#1)(2008-10#1)
kinetics with##4##2##(1991-5#1)(1994-5#1)(2008-10#2)
kinetics##241##1##(1990-12#1)(1990-2#2)(1990-5#5)(1990-8#5)(1991-5#1)(1992-12#1)(1992-3#2)(1992-4#2)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#3)(1994-8#3)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-2#3)(1997-2#2)(1997-4#1)(1997-6#2)(2006-6#1)(2007-11#1)(2008-10#82)(2008-11#29)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#6)
kinetin at 0##2##3##(2008-10#2)
kinetin##3##1##(2008-10#2)(2013-1#1)
kingdom##10##1##(1996-12#1)(2008-10#2)(2009-12#1)(2009-8#4)(2011-2#1)(2013-8#1)
kingdoms##4##1##(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
kink##5##1##(1993-5#1)(1994-5#2)(2008-9#2)
kinking of the##2##3##(2008-9#1)(2011-2#1)
kinking##4##1##(2008-9#1)(2011-2#2)(2013-1#1)
kinship##10##1##(1997-6#1)(2008-12#4)(2010-8#2)(2011-2#3)
kissing##3##1##(2008-11#1)(2011-2#2)
kisspeptins##2##1##(2009-6#2)
kit for##2##2##(1996-5#1)(2008-10#1)
kit##38##1##(1996-2#1)(1996-5#7)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#5)(2008-5#2)(2008-7#1)(2008-8#2)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-8#1)
kitchen##5##1##(2007-12#1)(2008-12#1)(2011-2#1)(2013-1#2)
kits and##2##2##(1997-7#1)(2008-10#1)
kits are##2##2##(2008-10#1)(2008-5#1)
kits which##2##2##(2011-2#1)(2012-2#1)
kits##19##1##(1994-1#1)(1996-5#2)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2011-2#1)(2011-3#1)(2012-2#2)
klaroid##4##1##(2008-9#4)
klarsicht##2##1##(2008-9#2)
km but do discriminate against foreign songs##2##7##(2008-8#2)
km from##3##2##(1996-11#1)(2008-10#1)(2008-3#1)
km in##3##2##(2008-10#2)(2008-2#1)
km of##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
km with##2##2##(2008-2#2)
km##40##1##(1990-11#1)(1996-11#1)(2007-12#3)(2008-10#10)(2008-12#1)(2008-2#5)(2008-3#9)(2008-7#1)(2008-8#6)(2008-9#1)(2010-8#1)(2013-1#1)
km(2)##2##1##(2008-10#2)
km)##6##1##(2008-10#3)(2008-3#1)(2010-6#1)(2013-1#1)
knee OA##4##2##(1992-3#2)(2013-1#2)
knee and ankle##2##3##(2009-4#1)(2011-2#1)
knee and##7##2##(1996-9#1)(2009-11#1)(2009-4#2)(2011-2#1)(2013-1#2)
knee arthroplasty##15##2##(1994-3#2)(2008-8#2)(2009-3#4)(2012-12#1)(2013-1#6)
knee evaluation scoring systems##2##4##(2013-1#2)
knee evaluation##6##2##(2013-1#6)
knee extension AROM##3##3##(2008-12#3)
knee extension##6##2##(2008-12#5)(2011-2#1)
knee flexion angle##2##3##(2013-1#2)
knee flexion##6##2##(2009-3#1)(2011-2#2)(2013-1#3)
knee joint##11##2##(1992-6#2)(1994-8#1)(1997-8#1)(2007-8#2)(2009-7#1)(2011-2#1)(2013-1#3)
knee joints##3##2##(1991-6#1)(1994-8#1)(2012-12#1)
knee osteoarthritis##5##2##(1992-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
knee pain##5##2##(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
knee replacement##10##2##(1990-6#1)(1993-12#1)(1994-12#1)(1995-2#1)(2007-8#1)(2008-8#1)(2009-3#1)(2012-12#2)(2013-1#1)
knee score##2##2##(2009-3#2)
knee was##8##2##(1997-8#6)(2008-8#1)(2013-1#1)
knee##157##1##(1990-6#1)(1991-6#2)(1992-3#3)(1992-6#2)(1993-12#1)(1993-3#2)(1994-12#1)(1994-3#2)(1994-8#2)(1995-2#1)(1995-5#1)(1996-9#1)(1997-8#11)(2007-8#4)(2008-11#2)(2008-12#12)(2008-8#12)(2009-11#1)(2009-3#8)(2009-4#2)(2009-7#2)(2010-3#1)(2011-2#16)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#52)(2013-7#1)
knees and##3##2##(2008-8#2)(2009-3#1)
knees in##2##2##(2013-1#2)
knees were##3##2##(2009-3#2)(2011-2#1)
knees##21##1##(1992-3#1)(2008-12#1)(2008-5#1)(2008-8#3)(2009-3#4)(2011-2#1)(2012-2#1)(2013-1#9)
knew about##2##2##(1990-2#1)(2013-1#1)
knew that##2##2##(1996-6#1)(2009-10#1)
knew##9##1##(1990-2#1)(1990-6#1)(1996-6#2)(2008-11#2)(2009-10#1)(2012-3#1)(2013-1#1)
knife##9##1##(1994-12#3)(1996-3#1)(1997-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
knitted##2##1##(2008-10#1)(2008-7#1)
knives##3##1##(1991-3#1)(2008-10#2)
knobs##2##1##(2008-10#1)(2009-10#1)
knock down##2##2##(2010-12#1)(2011-1#1)
knock##3##1##(2008-9#1)(2010-12#1)(2011-1#1)
knock-down##6##1##(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
knockdown of##3##2##(2012-12#2)(2013-1#1)
knockdown##9##1##(2009-10#4)(2012-12#3)(2012-2#1)(2013-1#1)
knockout mice show##2##3##(2008-12#1)(2008-4#1)
knockout mice##10##2##(1994-12#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)
knockout##23##1##(1994-12#1)(1995-2#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#7)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
knockout&quot##2##1##(1995-2#1)(2008-4#1)
knot tying##2##2##(1995-1#2)
knot##6##1##(1995-1#4)(2008-10#1)(2012-2#1)
knots##3##1##(1993-5#1)(1995-1#2)
knotted and serpentine reactors##2##4##(2008-10#2)
knotted and##4##2##(2008-10#4)
knotted reactor preconcentration systems##2##4##(2008-10#2)
knotted reactor##6##2##(2008-10#6)
knotted##14##1##(2008-10#14)
know about the##2##3##(1992-3#1)(2012-2#1)
know about##9##2##(1990-2#1)(1991-12#1)(1992-3#1)(1994-2#2)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
know and##2##2##(2009-5#1)(2009-7#1)
know how##5##2##(1991-3#1)(1993-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
know if the##2##3##(1993-3#1)(2008-10#1)
know if##6##2##(1991-3#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
know little about##2##3##(2008-10#2)
know of##2##2##(1996-11#1)(2008-9#1)
know that they##2##3##(1993-3#1)(1995-9#1)
know that##8##2##(1991-12#1)(1992-3#1)(1993-3#1)(1995-9#1)(1997-1#1)(1997-5#1)(2008-1#1)(2008-12#1)
know the##24##2##(1994-2#1)(1995-5#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
know their##2##2##(1992-12#1)(1996-11#1)
know to##2##2##(1991-12#1)(2009-6#1)
know what a healthy human looks##2##6##(1991-2#2)
know what##8##2##(1991-2#2)(1994-12#1)(1996-11#1)(2008-11#2)(2008-4#1)(2013-8#1)
know where we are##2##4##(2013-1#2)
know whether they##2##3##(1995-1#1)(2012-3#1)
know whether##6##2##(1995-1#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)
know##109##1##(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#2)(1992-12#1)(1992-3#2)(1993-1#1)(1993-3#2)(1994-12#1)(1994-2#4)(1995-1#1)(1995-5#1)(1995-9#1)(1996-11#4)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#17)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#6)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
know-how##2##1##(2008-11#2)
knowing in practice##3##3##(2008-12#3)
knowing in##4##2##(2008-11#1)(2008-12#3)
knowing the##4##2##(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
knowing##13##1##(2008-1#1)(2008-11#3)(2008-12#5)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
knowledge about patients' rights##4##4##(2013-8#4)
knowledge about the effects of##3##5##(2008-11#1)(2009-10#1)(2012-2#1)
knowledge about the##20##3##(1991-6#2)(1993-11#1)(1993-12#1)(1996-11#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-1#1)(2010-11#1)(2012-2#2)
knowledge about this##2##3##(2008-11#1)(2011-3#1)
knowledge about##57##2##(1991-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#7)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
knowledge acquisition and##2##3##(2008-12#1)(2008-9#1)
knowledge acquisition##4##2##(2008-11#2)(2008-12#1)(2008-9#1)
knowledge among##3##2##(1993-2#1)(1997-5#1)(2009-12#1)
knowledge and attitudes toward testicular cancer##2##6##(2009-5#2)
knowledge and attitudes##6##3##(1991-2#1)(2009-5#2)(2010-3#2)(2013-1#1)
knowledge and cultural beliefs about the etiology and management of orofacial clefts##2##12##(2009-10#2)
knowledge and experience##3##3##(2008-11#3)
knowledge and practices##3##3##(2010-1#1)(2010-9#1)(2012-12#1)
knowledge and skills in##3##4##(2008-11#1)(2008-7#1)(2009-6#1)
knowledge and skills##6##3##(1991-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)
knowledge and to##2##3##(2011-2#1)(2012-3#1)
knowledge and understanding of the##2##5##(2008-10#1)(2009-7#1)
knowledge and understanding of##5##4##(1997-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-2#1)
knowledge and understanding##6##3##(1997-8#1)(2008-10#1)(2008-11#2)(2009-7#1)(2012-2#1)
knowledge and##66##2##(1990-6#1)(1991-1#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#12)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)
knowledge are##2##2##(1996-2#1)(2008-12#1)
knowledge as well as##2##4##(1994-12#1)(2009-6#1)
knowledge base and##2##3##(2008-11#1)(2013-1#1)
knowledge base##5##2##(1992-9#1)(2008-10#2)(2008-11#1)(2013-1#1)
knowledge can be used##2##4##(2008-3#1)(2009-12#1)
knowledge concerning the##2##3##(2008-5#1)(2011-3#1)
knowledge development in##2##3##(2008-11#1)(2010-10#1)
knowledge development##6##2##(2008-11#4)(2010-10#1)(2010-9#1)
knowledge diffusion##2##2##(2010-12#2)
knowledge for##5##2##(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
knowledge from the##3##3##(1994-6#1)(1996-3#1)(2008-11#1)
knowledge from##8##2##(1994-6#1)(1996-3#1)(1997-5#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)
knowledge gained##4##2##(2008-11#2)(2008-9#1)(2011-8#1)
knowledge gaps##3##2##(2013-1#3)
knowledge has been##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
knowledge has##4##2##(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
knowledge in the##4##3##(2008-11#1)(2013-1#2)(2013-8#1)
knowledge in##18##2##(1990-6#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-6#1)(2013-1#3)(2013-8#1)
knowledge is##4##2##(1993-1#1)(2008-12#1)(2009-8#1)(2010-5#1)
knowledge of biological##2##3##(2008-10#2)
knowledge of cellular##2##3##(1992-2#1)(2008-11#1)
knowledge of child development##2##4##(1995-1#1)(2011-1#1)
knowledge of how##2##3##(2012-2#1)(2013-1#1)
knowledge of its##4##3##(1996-9#1)(2008-8#2)(2010-12#1)
knowledge of osteoporosis##3##3##(1996-6#3)
knowledge of the guidelines##2##4##(1990-6#1)(2012-12#1)
knowledge of the mechanisms##2##4##(1992-9#1)(2008-7#1)
knowledge of the molecular##2##4##(2011-2#1)(2013-1#1)
knowledge of the natural##2##4##(1990-12#1)(1997-3#1)
knowledge of the various##3##4##(1993-11#1)(1997-4#1)(2012-2#1)
knowledge of the##68##3##(1990-12#1)(1990-6#1)(1991-12#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-6#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-3#2)(1997-4#2)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
knowledge of their##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
knowledge of these##3##3##(1996-12#1)(2013-1#2)
knowledge of ways in which##2##5##(2008-10#2)
knowledge of##176##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#2)(1994-8#1)(1995-1#3)(1995-5#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#3)(1997-7#1)(2008-1#1)(2008-10#35)(2008-11#18)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#15)(2013-8#2)
knowledge on how##4##3##(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
knowledge on the##13##3##(1990-8#1)(1991-3#1)(1993-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-4#1)(2011-7#1)(2012-3#2)(2013-1#1)
knowledge on##26##2##(1990-8#1)(1991-2#1)(1991-3#1)(1993-1#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#3)(2013-1#1)
knowledge or##2##2##(2012-12#1)(2012-2#1)
knowledge regarding the##5##3##(2008-11#2)(2008-12#1)(2012-12#1)(2012-3#1)
knowledge regarding##9##2##(2008-10#2)(2008-11#2)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
knowledge related to the##2##4##(1997-1#1)(2009-5#1)
knowledge related to##5##3##(1997-1#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
knowledge scores were##2##3##(1996-9#2)
knowledge such as##2##3##(2010-8#1)(2011-2#1)
knowledge systems##2##2##(2009-12#1)(2009-6#1)
knowledge that##10##2##(1990-11#1)(1993-12#1)(2008-10#1)(2008-11#2)(2012-2#3)(2012-3#1)(2013-8#1)
knowledge this##10##2##(1997-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
knowledge to##6##2##(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#3)
knowledge translation##3##2##(2008-12#1)(2010-10#2)
knowledge was measured##2##3##(1991-2#1)(2013-8#1)
knowledge was##5##2##(1991-2#1)(1994-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
knowledge with##2##2##(2010-10#1)(2012-12#1)
knowledge##713##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#4)(1990-8#3)(1991-1#1)(1991-12#1)(1991-2#9)(1991-3#2)(1991-6#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#7)(1993-2#3)(1993-3#2)(1993-6#1)(1994-1#6)(1994-12#3)(1994-2#1)(1994-6#3)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#6)(1996-6#3)(1996-9#3)(1997-1#4)(1997-3#7)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#5)(2007-11#3)(2007-12#5)(2008-1#5)(2008-10#82)(2008-11#93)(2008-12#30)(2008-2#7)(2008-3#20)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#17)(2008-8#10)(2008-9#17)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#6)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#8)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#8)(2010-10#14)(2010-11#4)(2010-12#7)(2010-3#6)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#6)(2011-1#16)(2011-2#28)(2011-3#3)(2011-7#2)(2011-8#1)(2012-12#11)(2012-2#29)(2012-3#24)(2013-1#54)(2013-7#3)(2013-8#15)
knowledgeable about the##3##3##(1991-1#1)(2008-12#1)(2013-1#1)
knowledgeable in the##2##3##(1992-3#1)(1993-1#1)
knowledgeable##6##1##(1991-1#1)(1992-3#1)(1993-1#1)(2008-12#1)(2013-1#2)
knowlesi malaria##2##2##(2012-12#2)
knowlesi##5##1##(2012-12#5)
known a priori##2##3##(2010-1#1)(2012-3#1)
known a##3##2##(2008-12#1)(2010-1#1)(2012-3#1)
known about effects##2##3##(2010-8#2)
known about the##43##3##(1990-5#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-8#2)
known about##68##2##(1990-5#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#4)
known amino acid##2##3##(1993-6#1)(2012-2#1)
known amount of##4##3##(2008-10#3)(2008-12#1)
known amounts of##9##3##(1993-6#1)(2008-10#7)(2008-5#1)
known and unknown##2##3##(1995-9#1)(2008-10#1)
known and##16##2##(1990-2#1)(1991-1#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
known as &quot##7##3##(2008-10#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
known as a##8##3##(1992-3#2)(2008-10#1)(2008-5#2)(2009-12#1)(2010-6#1)(2010-7#1)
known as an##4##3##(1993-3#1)(2008-11#2)(2008-8#1)
known as the##16##3##(1994-1#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-9#1)(2009-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
known as##131##2##(1990-11#1)(1990-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-1#2)(1996-2#5)(1996-9#1)(1997-5#1)(2007-12#1)(2008-10#26)(2008-11#8)(2008-12#1)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#7)(2009-12#3)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#3)(2010-7#2)(2011-2#10)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#5)(2013-7#1)
known bacterial##3##2##(1996-12#1)(2008-10#2)
known binding##2##2##(2008-11#1)(2008-9#1)
known but##2##2##(2008-7#1)(2012-2#1)
known cause of##4##3##(2008-4#2)(2010-12#1)(2012-12#1)
known cellular##2##2##(1997-1#1)(2012-3#1)
known chronic venous disorders##2##4##(2010-7#2)
known complications##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
known concentration##3##2##(2008-10#3)
known concentrations##5##2##(2008-10#4)(2008-3#1)
known disease##2##2##(2008-10#1)(2013-1#1)
known excess of##2##3##(2008-10#2)
known factors##2##2##(2009-12#1)(2013-1#1)
known for its##5##3##(2008-10#2)(2009-9#1)(2011-2#2)
known for their##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2012-5#1)
known for##21##2##(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#4)(2012-2#2)(2012-5#1)
known from previous##2##3##(1992-10#1)(2008-3#1)
known from the##2##3##(1991-2#1)(2008-10#1)
known from##8##2##(1991-2#1)(1992-10#1)(1997-4#2)(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)
known function##2##2##(2008-10#1)(2008-7#1)
known genes and##3##3##(1995-12#1)(1995-6#1)(1996-6#1)
known genes##20##2##(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#3)(1997-2#1)(1997-6#1)(1997-8#3)(2008-10#1)(2008-9#1)
known genetic##3##2##(1997-3#1)(2008-10#2)
known history of hypertension and taking##2##6##(2008-7#2)
known history##4##2##(2008-10#1)(2008-7#3)
known how##2##2##(1997-7#1)(2010-11#1)
known in the##8##3##(1996-11#2)(2008-12#2)(2008-2#1)(2009-10#1)(2009-3#1)(2013-1#1)
known in##15##2##(1991-12#1)(1995-2#1)(1996-11#2)(2008-12#3)(2008-2#1)(2008-5#2)(2009-10#1)(2009-3#1)(2012-12#2)(2013-1#1)
known mammalian##2##2##(2008-4#1)(2008-8#1)
known markers##2##2##(2008-9#1)(2011-2#1)
known mechanisms##3##2##(1994-8#1)(2008-7#1)(2008-9#1)
known medical##2##2##(1997-8#1)(2010-6#1)
known meiotic##2##2##(2008-9#1)(2012-3#1)
known members of the##3##4##(1991-5#1)(1993-9#1)(1995-6#1)
known molecular##2##2##(1997-3#1)(2008-5#1)
known of the##3##3##(2008-5#1)(2008-8#2)
known of##7##2##(1992-10#1)(1993-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)
known only##2##2##(2008-10#2)
known or if##2##3##(2008-2#2)
known or predicted##3##3##(1994-9#1)(1997-6#1)(1997-8#1)
known or##10##2##(1994-9#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2013-1#1)
known primary##2##2##(2008-10#1)(2012-2#1)
known protein##4##2##(1992-4#1)(2008-10#1)(2008-9#1)(2011-2#1)
known proteins##6##2##(1995-12#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-7#1)(2013-8#1)
known races##2##2##(2008-10#2)
known risk factors##2##3##(1990-8#1)(1997-5#1)
known risk##3##2##(1990-8#1)(1997-5#2)
known sequence##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
known since##3##2##(2008-10#2)(2008-5#1)
known sources##2##2##(1991-5#1)(2008-11#1)
known strains##2##2##(2008-10#1)(2008-12#1)
known that an##2##3##(2008-2#1)(2009-12#1)
known that both##2##3##(2008-11#1)(2011-2#1)
known that the##6##3##(1990-6#1)(1993-3#1)(1997-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
known that##32##2##(1990-6#1)(1991-3#1)(1991-6#1)(1993-3#1)(1997-2#2)(1997-5#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#3)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
known three-dimensional structure##2##3##(1992-1#1)(1993-6#1)
known to affect the##3##4##(2008-1#1)(2008-10#1)(2012-3#1)
known to affect##6##3##(1994-3#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
known to be a good##2##5##(1994-11#1)(2008-7#1)
known to be a##13##4##(1994-11#1)(1994-5#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-7#1)(2010-3#1)(2010-7#1)(2012-2#2)(2013-1#1)
known to be associated with##3##5##(2008-11#1)(2010-10#1)(2011-2#1)
known to be expressed##2##4##(1992-11#1)(2011-1#1)
known to be exquisitely sensitive to##2##6##(2008-7#1)(2012-2#1)
known to be important##2##4##(1995-6#1)(2008-3#1)
known to be involved in DNA##2##6##(1993-12#1)(1993-2#1)
known to be involved in##7##5##(1993-12#1)(1993-2#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-11#1)
known to be related to##2##5##(1993-11#1)(2008-10#1)
known to be##72##3##(1990-9#1)(1991-12#2)(1992-11#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#3)(1997-8#3)(2008-1#2)(2008-10#11)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#3)(2012-6#1)(2013-1#2)
known to cause##4##3##(1991-12#1)(1993-8#1)(1996-3#1)(2008-11#1)
known to confer##2##3##(2008-10#2)
known to contain a##2##4##(2008-10#1)(2008-11#1)
known to contain##6##3##(1997-3#1)(2008-10#3)(2008-11#1)(2013-1#1)
known to control##2##3##(2008-10#1)(2009-8#1)
known to enhance##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
known to extend##2##3##(2008-10#1)(2008-11#1)
known to form complexes with##2##5##(2008-10#1)(2010-11#1)
known to form##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)
known to have a##2##4##(1994-11#1)(2008-1#1)
known to have##11##3##(1990-2#1)(1992-3#1)(1994-11#1)(2007-12#1)(2008-1#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
known to improve##2##3##(1996-2#1)(2008-11#1)
known to increase##3##3##(2008-1#1)(2012-12#1)(2012-2#1)
known to induce##8##3##(1995-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-7#1)
known to infect##3##3##(2008-10#2)(2012-2#1)
known to influence##2##3##(2008-8#1)(2009-6#1)
known to inhibit##2##3##(1993-1#1)(1997-3#1)
known to modulate##3##3##(1995-9#1)(2008-11#1)(2008-5#1)
known to occur in##4##4##(1990-11#1)(2008-6#1)(2008-7#1)(2009-8#1)
known to occur##6##3##(1990-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
known to play a role in##3##6##(1996-2#1)(2012-2#1)(2012-7#1)
known to play a##5##4##(1993-8#1)(1996-2#1)(2008-11#1)(2012-2#1)(2012-7#1)
known to play an important role in the##2##8##(1994-2#1)(1996-12#1)
known to play an important role in##4##7##(1994-2#1)(1996-12#1)(2011-2#2)
known to play##9##3##(1993-8#1)(1994-2#1)(1996-12#1)(1996-2#1)(2008-11#1)(2011-2#2)(2012-2#1)(2012-7#1)
known to possess##2##3##(2008-11#1)(2009-2#1)
known to produce##6##3##(1995-12#1)(2008-10#2)(2008-3#1)(2008-7#2)
known to promote##3##3##(1992-6#1)(1995-8#1)(2008-10#1)
known to protect##2##3##(2010-7#1)(2013-1#1)
known to regulate##5##3##(1995-2#1)(2008-8#1)(2010-11#1)(2012-2#2)
known to result in##2##4##(1995-2#1)(2008-10#1)
known to stimulate##2##3##(1990-5#1)(1995-8#1)
known to the##3##3##(2007-9#1)(2008-10#1)(2011-2#1)
known to##229##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-9#1)(1991-12#3)(1991-3#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#5)(1995-6#2)(1995-8#4)(1995-9#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-8#3)(2007-12#2)(2007-9#1)(2008-1#5)(2008-10#42)(2008-11#25)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#8)(2009-9#1)(2010-10#1)(2010-11#3)(2010-3#2)(2010-6#1)(2010-7#3)(2011-1#3)(2011-2#10)(2012-12#3)(2012-2#14)(2012-3#2)(2012-6#1)(2012-7#1)(2013-1#5)
known today##2##2##(1991-6#1)(2008-10#1)
known vertebrate##2##2##(1997-9#1)(2010-5#1)
known##1032##1##(1990-11#5)(1990-12#2)(1990-2#2)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#1)(1991-3#2)(1991-5#8)(1991-6#4)(1991-8#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#5)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#8)(1993-8#5)(1993-9#4)(1994-1#1)(1994-11#7)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#6)(1994-6#1)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#10)(1995-2#13)(1995-5#6)(1995-6#9)(1995-8#7)(1995-9#6)(1996-1#3)(1996-11#4)(1996-12#10)(1996-2#11)(1996-3#4)(1996-5#1)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#8)(1997-3#5)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#6)(1997-8#12)(1997-9#2)(2006-6#1)(2007-12#5)(2007-9#1)(2008-1#11)(2008-10#218)(2008-11#69)(2008-12#22)(2008-2#12)(2008-3#16)(2008-4#11)(2008-5#35)(2008-6#4)(2008-7#35)(2008-8#14)(2008-9#29)(2009-10#2)(2009-11#1)(2009-12#7)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#15)(2009-9#4)(2010-1#3)(2010-10#2)(2010-11#8)(2010-12#8)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#1)(2010-6#6)(2010-7#10)(2010-8#4)(2010-9#1)(2011-1#9)(2011-2#51)(2011-3#4)(2012-12#10)(2012-2#47)(2012-3#18)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#33)(2013-7#1)(2013-8#13)
known&quot##2##1##(2008-10#2)
knows about##2##2##(1990-11#1)(1991-3#1)
knows that##2##2##(1995-1#1)(2012-3#1)
knows##5##1##(1990-11#1)(1991-3#1)(1995-1#1)(2008-10#1)(2012-3#1)
knuckles##2##1##(2008-5#2)
kojic acid##4##2##(2008-5#4)
kolleri##3##1##(2008-10#3)
koningii were##2##2##(2008-10#1)(2008-5#1)
koningii##8##1##(2008-10#7)(2008-5#1)
korean##5##1##(2010-1#3)(2010-6#1)(2012-3#1)
kow##3##1##(1991-5#3)
kraft pulp##2##2##(2008-11#1)(2008-6#1)
kriging##5##1##(2008-10#4)(2008-11#1)
kringle 1##2##2##(1995-6#1)(2008-8#1)
kringle 4##2##2##(1993-8#2)
kringle##9##1##(1993-8#6)(1995-6#1)(2008-8#2)
kringles##2##1##(1993-8#1)(2008-8#1)
krusei and##2##2##(2008-5#2)
krusei##5##1##(2008-5#5)
ku (1##2##2##(2008-8#2)
ku protein##3##2##(2008-8#2)(2008-9#1)
ku##29##1##(2008-8#14)(2008-9#15)
kuwanon##2##1##(2011-3#2)
kwo##3##1##(1991-5#3)
kyphosis from##2##2##(2008-8#2)
kyphosis##3##1##(2008-8#3)
kyste##3##1##(2011-2#2)(2013-1#1)
l min(-1)##9##2##(2008-10#9)
l mol(-1) cm(-1) and 0##2##5##(2008-10#2)
l mol(-1) cm(-1) and 2##2##5##(2008-10#2)
l mol(-1) cm(-1) and detection limit 0##2##7##(2008-10#2)
l mol(-1) cm(-1) and the##2##5##(2008-10#2)
l mol(-1) cm(-1) and##11##4##(2008-10#11)
l mol(-1) cm(-1) at 612 nm##2##6##(2008-10#2)
l mol(-1) cm(-1) at 660 nm##2##6##(2008-10#2)
l mol(-1) cm(-1) at##10##4##(2008-10#10)
l mol(-1) cm(-1) for##2##4##(2008-10#2)
l mol(-1) cm(-1)##43##3##(2008-10#43)
l mol(-1) cm(-1))##2##3##(2008-10#2)
l mol(-1)##53##2##(2008-10#53)
l mol(-1)cm(-1)##2##2##(2008-10#2)
l sample at##2##3##(2008-10#2)
l scale##3##2##(2008-11#3)
l stirred##3##2##(2008-11#3)
l##115##1##(1991-12#1)(1991-5#6)(2007-12#1)(2008-10#79)(2008-11#20)(2008-4#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-6#1)
l'hydatidose##2##1##(2011-2#2)
l'âge##3##1##(2008-11#1)(2011-2#2)
l(+)##2##1##(2008-10#1)(2008-5#1)
l(-1) (3sigma)##3##2##(2008-10#3)
l(-1) (S/N=3)##4##2##(2008-10#4)
l(-1) (as##3##2##(2008-10#3)
l(-1) Co(II)##2##2##(2008-10#2)
l(-1) Cr(VI)##6##2##(2008-10#6)
l(-1) Fe##2##2##(2008-10#2)
l(-1) Ni##2##2##(2008-10#2)
l(-1) Pb(II)##2##2##(2008-10#2)
l(-1) S(2-)##3##2##(2008-10#3)
l(-1) Se##2##2##(2008-10#2)
l(-1) V##2##2##(2008-10#2)
l(-1) acetic acid##2##3##(2008-10#2)
l(-1) and 1##2##3##(2008-10#2)
l(-1) and 2##3##3##(2008-10#3)
l(-1) and 3##2##3##(2008-10#2)
l(-1) and a##8##3##(2008-10#8)
l(-1) and detection##2##3##(2008-10#2)
l(-1) and the detection limit##4##5##(2008-10#4)
l(-1) and the detection##5##4##(2008-10#5)
l(-1) and the relative standard deviation##4##6##(2008-10#4)
l(-1) and the relative standard##5##5##(2008-10#5)
l(-1) and the##19##3##(2008-10#19)
l(-1) and##55##2##(2008-10#55)
l(-1) ascorbic acid was 2##2##5##(2008-10#2)
l(-1) ascorbic acid##4##3##(2008-10#4)
l(-1) at a##2##3##(2008-10#2)
l(-1) at pH##3##3##(2008-10#3)
l(-1) at##7##2##(2008-10#7)
l(-1) bromide##2##2##(2008-10#2)
l(-1) chromium(VI)##2##2##(2008-10#2)
l(-1) concentration range##4##3##(2008-10#4)
l(-1) concentration##8##2##(2008-10#8)
l(-1) concentrations##2##2##(2008-10#2)
l(-1) detection limit##3##3##(2008-10#3)
l(-1) detection##4##2##(2008-10#4)
l(-1) for 5##2##3##(2008-10#2)
l(-1) for Cd##4##3##(2008-10#4)
l(-1) for Cd(II)##2##3##(2008-10#2)
l(-1) for a##3##3##(2008-10#3)
l(-1) for cadmium##3##3##(2008-10#3)
l(-1) for copper and 0##2##5##(2008-10#2)
l(-1) for copper and##3##4##(2008-10#3)
l(-1) for copper##4##3##(2008-10#4)
l(-1) for iron##2##3##(2008-10#2)
l(-1) for the##9##3##(2008-10#9)
l(-1) for##106##2##(2008-10#106)
l(-1) fructose solution##2##3##(2008-10#2)
l(-1) glucose##2##2##(2008-10#1)(2008-11#1)
l(-1) hydrogen peroxide##3##3##(2008-10#3)
l(-1) in the##4##3##(2008-10#4)
l(-1) in##14##2##(2008-10#14)
l(-1) lead##2##2##(2008-10#2)
l(-1) level##15##2##(2008-10#15)
l(-1) level)##7##2##(2008-10#7)
l(-1) levels in##2##3##(2008-10#2)
l(-1) levels of##3##3##(2008-10#3)
l(-1) levels##10##2##(2008-10#10)
l(-1) of BPA##2##3##(2008-10#2)
l(-1) of Mo##2##3##(2008-10#2)
l(-1) of Trolox##2##3##(2008-10#2)
l(-1) of##58##2##(2008-10#56)(2008-11#2)
l(-1) or##3##2##(2008-10#3)
l(-1) range##5##2##(2008-10#5)
l(-1) sample is##2##3##(2008-10#2)
l(-1) sodium##6##2##(2008-10#6)
l(-1) tetrabutylammonium##3##2##(2008-10#3)
l(-1) to nmol l(-1)##2##4##(2008-10#2)
l(-1) to##5##2##(2008-10#4)(2008-11#1)
l(-1) using##4##2##(2008-10#4)
l(-1) was achieved##3##3##(2008-10#3)
l(-1) was obtained##7##3##(2008-10#7)
l(-1) was##15##2##(2008-10#15)
l(-1) were##5##2##(2008-10#5)
l(-1) with a detection limit of 0##4##7##(2008-10#4)
l(-1) with a detection limit of##14##6##(2008-10#14)
l(-1) with a relative standard deviation##2##6##(2008-10#2)
l(-1) with a##23##3##(2008-10#23)
l(-1) with an##4##3##(2008-10#4)
l(-1) with the detection limit of##3##6##(2008-10#3)
l(-1) with the detection limit##4##5##(2008-10#4)
l(-1) with the detection##5##4##(2008-10#5)
l(-1) with the##9##3##(2008-10#9)
l(-1) with##38##2##(2008-10#38)
l(-1) zinc##2##2##(2008-10#2)
l(-1)##961##1##(2008-10#949)(2008-11#12)
l(-1)) and good##2##3##(2008-10#2)
l(-1)) and##11##2##(2008-10#11)
l(-1)) of##4##2##(2008-10#1)(2008-11#3)
l(-1)) was##7##2##(2008-10#7)
l(-1)) were##3##2##(2008-10#3)
l(-1))##74##1##(2008-10#70)(2008-11#4)
l(-3)##3##1##(2008-10#3)
l)##4##1##(2008-10#1)(2008-11#3)
l- and##3##2##(2008-10#3)
l-1##4##1##(2008-11#4)
l-2-haloacid dehalogenases##2##2##(2011-1#2)
l-ascorbate##3##1##(2008-10#3)
l-ascorbic acid and##2##3##(2008-10#2)
l-ascorbic acid concentration##2##3##(2008-10#2)
l-ascorbic acid in pharmaceutical formulations##2##5##(2008-10#2)
l-ascorbic acid in##4##3##(2008-10#4)
l-ascorbic acid##26##2##(2008-10#25)(2008-5#1)
l-carnosine##5##1##(2011-1#5)
l-cysteine (0##2##2##(2008-10#2)
l-cysteine and glutathione##8##3##(2008-10#8)
l-cysteine and##16##2##(2008-10#15)(2011-1#1)
l-cysteine self-assembled monolayers modified gold electrode##2##6##(2008-10#2)
l-cysteine##39##1##(2008-10#38)(2011-1#1)
l-cystine and##2##2##(2008-10#2)
l-cystine##7##1##(2008-10#7)
l-dansyl amino acids##2##3##(2008-10#2)
l-dopa and/or##2##2##(2008-7#2)
l-dopa##11##1##(2008-10#8)(2008-7#3)
l-glutamate##7##1##(2008-10#7)
l-his##2##1##(2008-10#2)
l-lactate and pyruvate##3##3##(2008-10#3)
l-lactate##7##1##(2008-10#7)
l-lysine##5##1##(2008-10#3)(2008-5#1)(2012-5#1)
l-malic acid with##3##3##(2008-10#3)
l-malic acid##4##2##(2008-10#4)
l-phenylalanine##5##1##(2008-10#5)
l-serine##2##1##(2008-10#2)
l-thyroxine (l-T(4))##2##2##(2008-10#2)
l-tyrosine and its##2##3##(2008-10#2)
l-tyrosine##7##1##(2008-10#7)
l/day##2##1##(1990-11#2)
l/min##9##1##(1993-2#1)(1995-3#1)(2010-6#1)(2011-2#6)
la Caféine##3##2##(2013-1#3)
la chirurgie##2##2##(2011-2#2)
la consommation##2##2##(2013-1#2)
la femme##3##2##(2013-1#3)
la grande citerne##2##3##(2013-1#2)
la grossesse##6##2##(2011-2#1)(2013-1#5)
la guérison##2##2##(2013-1#2)
la littérature##3##2##(2011-2#1)(2013-1#2)
la mise en place d'un##3##5##(2011-2#1)(2013-1#2)
la survenue##2##2##(2013-1#2)
la##75##1##(1990-6#1)(1993-12#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#5)(2011-2#11)(2011-3#3)(2013-1#46)
lab and##2##2##(2008-10#1)(2009-5#1)
lab on##2##2##(2008-10#2)
lab##26##1##(1992-1#1)(1994-8#1)(1994-9#1)(1996-3#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
lab-on-valve##9##1##(2008-10#9)
label distribution in##2##3##(2008-7#2)
label in the##2##3##(1991-3#1)(2008-10#1)
label to##3##2##(2008-11#1)(2008-12#1)(2009-8#1)
label with##3##2##(2008-7#2)(2010-12#1)
label##48##1##(1990-12#2)(1991-3#1)(1991-5#1)(1992-3#1)(1993-8#1)(1997-4#1)(2007-12#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#5)(2009-8#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-1#4)
label-free capacitive immunosensor##2##3##(2008-10#2)
label-free##8##1##(2008-10#6)(2009-3#1)(2010-11#1)
labeled DNA##2##2##(2008-10#1)(2008-4#1)
labeled RGD-BBN##2##2##(2010-6#2)
labeled SUVs##2##2##(2008-10#2)
labeled and##2##2##(1990-12#1)(2008-10#1)
labeled antibody##2##2##(2008-10#2)
labeled as##2##2##(2008-1#1)(2011-2#1)
labeled at the##2##3##(2008-4#1)(2009-6#1)
labeled axons##3##2##(1997-3#2)(2008-11#1)
labeled by a##2##3##(2008-10#2)
labeled by##11##2##(1994-11#1)(1995-6#1)(2008-10#4)(2008-9#3)(2010-12#2)
labeled in##2##2##(1995-6#1)(1997-3#1)
labeled polypeptides##3##2##(1994-11#2)(1994-5#1)
labeled rate (7##2##3##(2008-10#2)
labeled rate##5##2##(2008-10#5)
labeled the surface of##2##4##(2008-10#2)
labeled the##3##2##(1993-1#1)(2008-10#2)
labeled with a##2##3##(1997-2#1)(2008-10#1)
labeled with acrylodan at its##2##5##(1994-5#2)
labeled with both##2##3##(1991-3#1)(2008-12#1)
labeled with horseradish peroxidase (HRP)##2##5##(2008-10#1)(2012-2#1)
labeled with horseradish peroxidase##3##4##(2008-10#2)(2012-2#1)
labeled with##37##2##(1991-3#1)(1993-8#1)(1994-11#3)(1994-2#1)(1994-5#3)(1995-12#1)(1996-2#1)(1997-2#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2012-2#1)
labeled##174##1##(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-1#3)(1993-11#1)(1993-8#1)(1994-11#7)(1994-2#3)(1994-5#5)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-6#2)(1996-12#2)(1996-2#1)(1997-1#8)(1997-2#4)(1997-3#5)(1997-6#1)(2008-1#2)(2008-10#66)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#8)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#9)(2009-6#1)(2009-8#1)(2010-12#2)(2010-6#4)(2011-2#2)(2012-2#1)
labeling and##11##2##(1993-8#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#3)(2013-1#1)(2013-8#1)
labeling at##2##2##(1997-3#1)(2008-7#1)
labeling experiments##2##2##(2008-10#1)(2008-9#1)
labeling for##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
labeling in the##2##3##(1997-3#1)(2008-7#1)
labeling in##9##2##(1995-11#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-9#1)
labeling medical images##2##3##(2013-1#2)
labeling of chitin##2##3##(2008-10#2)
labeling of histidine##3##3##(2008-10#3)
labeling of the##4##3##(2008-10#4)
labeling of##34##2##(1991-12#1)(1991-9#1)(1993-8#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#16)(2008-4#8)(2008-7#1)(2009-10#1)(2010-7#1)(2013-7#1)
labeling pattern##6##2##(2008-10#3)(2008-7#3)
labeling patterns##2##2##(2008-10#1)(2008-7#1)
labeling using##2##2##(2008-4#1)(2011-2#1)
labeling was##7##2##(1990-9#1)(1991-12#3)(1994-5#1)(1997-2#1)(2008-10#1)
labeling with a##2##3##(1994-8#1)(2008-9#1)
labeling with the##2##3##(2008-10#1)(2008-7#1)
labeling with##7##2##(1990-5#1)(1991-12#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#2)
labeling##164##1##(1990-5#1)(1990-9#1)(1991-12#7)(1991-9#2)(1992-4#1)(1993-2#2)(1993-8#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#3)(1995-12#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#2)(2007-12#2)(2008-1#1)(2008-10#46)(2008-11#4)(2008-12#1)(2008-4#16)(2008-5#1)(2008-7#12)(2008-8#8)(2008-9#18)(2009-1#1)(2009-10#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
labelled HRP##2##2##(2008-10#2)
labelled antibodies##3##2##(2008-10#3)
labelled cells##2##2##(1990-12#1)(2008-11#1)
labelled to##2##2##(1990-11#1)(1991-5#1)
labelled with horseradish peroxidase##2##4##(1997-3#1)(2008-10#1)
labelled with##11##2##(1990-11#1)(1990-12#1)(1992-9#1)(1993-2#1)(1997-3#3)(2008-10#3)(2008-11#1)
labelled##58##1##(1990-11#2)(1990-12#5)(1990-5#1)(1991-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-1#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2008-10#14)(2008-11#7)(2008-8#1)(2011-2#2)(2013-8#1)
labelling of##3##2##(1990-11#1)(2009-8#2)
labelling##12##1##(1990-11#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2009-8#2)
labels and##2##2##(1992-3#1)(2012-3#1)
labels in##3##2##(1995-1#1)(2008-10#1)(2008-12#1)
labels of infant health##2##4##(1994-3#2)
labels used##3##2##(1997-4#1)(2008-10#2)
labels##32##1##(1992-12#1)(1992-3#2)(1993-6#1)(1993-8#4)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-12#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2012-2#1)(2012-3#1)
labial gland of##2##3##(2007-12#2)
labial##5##1##(2007-12#3)(2012-3#1)(2013-1#1)
labile species##2##2##(2008-10#2)
labile##18##1##(1997-1#1)(2008-10#13)(2008-7#1)(2008-9#1)(2010-4#1)(2010-9#1)
lability of the##2##3##(1994-11#1)(2008-10#1)
lability of##5##2##(1992-9#1)(1994-11#1)(1995-6#1)(2008-10#2)
lability##7##1##(1992-9#1)(1994-11#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-8#1)
labium##2##1##(2007-12#2)
labor and employment issues##2##4##(1993-12#2)
labor and##5##2##(1992-2#1)(1993-12#2)(2008-11#1)(2008-9#1)
labor as##2##2##(1990-2#1)(1994-3#1)
labor force##5##2##(1991-1#2)(1997-2#1)(1997-6#1)(2009-10#1)
labor in##7##2##(2008-12#1)(2008-8#3)(2012-3#3)
labor intensive and##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
labor intensive##7##2##(1990-5#1)(2008-10#2)(2008-11#2)(2012-3#1)(2013-1#1)
labor market areas##5##3##(1992-12#5)
labor market##12##2##(1991-1#1)(1992-12#5)(1992-2#1)(1994-12#1)(1994-3#2)(2011-2#1)(2012-3#1)
labor seniority##2##2##(2011-2#2)
labor to##2##2##(1994-3#2)
labor##79##1##(1990-2#1)(1990-5#1)(1991-1#3)(1992-12#5)(1992-2#3)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#9)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-8#7)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#10)(2012-12#1)(2012-3#8)(2013-1#3)
labor-intensive##3##1##(2008-11#1)(2008-4#1)(2011-7#1)
laboratorial##2##1##(2008-10#1)(2008-5#1)
laboratories and##3##2##(2008-11#1)(2008-12#1)(2009-4#1)
laboratories are##5##2##(1994-12#1)(2008-10#2)(2011-2#2)
laboratories as##2##2##(1994-1#1)(2008-10#1)
laboratories by##2##2##(1994-6#1)(2008-10#1)
laboratories for##2##2##(1994-12#1)(2008-10#1)
laboratories from##4##2##(2008-10#3)(2008-5#1)
laboratories have##2##2##(1994-9#1)(2008-10#1)
laboratories in##5##2##(1993-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)
laboratories involved in##2##3##(2008-10#1)(2008-12#1)
laboratories is##3##2##(1994-12#1)(2008-10#2)
laboratories of##2##2##(2008-11#1)(2011-1#1)
laboratories revealed that##3##3##(2008-10#2)(2008-6#1)
laboratories to##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)(2013-8#1)
laboratories took part in##2##4##(2008-10#2)
laboratories with##2##2##(2008-10#1)(2008-8#1)
laboratories##118##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-6#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-5#2)(2008-10#51)(2008-11#10)(2008-12#6)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
laboratory analysis##6##2##(2008-10#4)(2012-2#1)(2013-1#1)
laboratory and clinical##4##3##(2008-10#1)(2008-12#1)(2009-7#1)(2013-1#1)
laboratory and field##2##3##(2008-10#2)
laboratory and##29##2##(1991-3#1)(1993-1#1)(1994-12#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-10#1)(2012-12#1)(2013-1#2)
laboratory animals##6##2##(1993-6#1)(2008-10#3)(2008-4#1)(2011-3#1)
laboratory are##2##2##(2008-10#1)(2011-2#1)
laboratory as##2##2##(2008-10#1)(2011-2#1)
laboratory assays##2##2##(1997-6#1)(2008-10#1)
laboratory at the##2##3##(2011-2#1)(2013-1#1)
laboratory automation##5##2##(2008-10#5)
laboratory conditions and##2##3##(1992-3#1)(2008-10#1)
laboratory conditions with##3##3##(2008-10#1)(2008-9#1)(2011-10#1)
laboratory conditions##17##2##(1992-3#1)(1993-6#1)(1996-12#1)(2008-10#10)(2008-12#1)(2008-9#1)(2010-4#1)(2011-10#1)
laboratory constructed##2##2##(2008-10#2)
laboratory culture##2##2##(2008-11#1)(2008-12#1)
laboratory data##5##2##(1991-3#1)(1997-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
laboratory diagnosis of##2##3##(2008-10#1)(2013-8#1)
laboratory diagnostic##2##2##(1994-12#1)(2013-8#1)
laboratory diagnostics##3##2##(1994-12#2)(2013-8#1)
laboratory examination##2##2##(1997-8#2)
laboratory experiment##2##2##(2008-7#1)(2010-3#1)
laboratory experiments with##2##3##(2008-10#1)(2008-11#1)
laboratory experiments##9##2##(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)
laboratory findings##4##2##(1990-9#1)(1994-12#1)(2010-6#1)(2011-2#1)
laboratory for##7##2##(1996-1#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-8#1)
laboratory glassware##2##2##(2008-10#2)
laboratory has shown that##2##4##(1994-8#1)(2008-10#1)
laboratory has##5##2##(1992-6#1)(1994-8#1)(2008-10#1)(2008-5#1)(2009-3#1)
laboratory in##4##2##(2008-10#3)(2008-11#1)
laboratory information##2##2##(2008-10#1)(2013-1#1)
laboratory investigations and##2##3##(2008-12#1)(2012-3#1)
laboratory investigations##10##2##(1990-3#1)(1994-6#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
laboratory maintenance of##2##3##(2008-9#2)
laboratory measurements##2##2##(2008-10#1)(2008-3#1)
laboratory medicine##6##2##(1994-12#6)
laboratory method##2##2##(2008-10#1)(2008-7#1)
laboratory mice##2##2##(2008-12#1)(2008-8#1)
laboratory mixer##3##2##(2008-5#3)
laboratory of the##4##3##(2008-10#3)(2011-2#1)
laboratory of##6##2##(2008-10#4)(2010-6#1)(2011-2#1)
laboratory or##9##2##(1994-12#1)(1995-9#1)(2007-11#1)(2008-10#3)(2008-9#1)(2011-2#1)(2012-3#1)
laboratory parameters##6##2##(1996-1#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
laboratory physicians##2##2##(1994-12#2)
laboratory population was##2##3##(2008-10#2)
laboratory population##7##2##(2008-10#7)
laboratory populations of##2##3##(2008-8#1)(2008-9#1)
laboratory prepared##3##2##(2008-10#3)
laboratory rats##2##2##(1992-1#1)(1992-12#1)
laboratory reference##2##2##(2008-10#1)(2008-3#1)
laboratory research##2##2##(2008-10#1)(2011-7#1)
laboratory results##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
laboratory rodents##2##2##(2008-4#2)
laboratory samples##2##2##(2008-10#1)(2011-2#1)
laboratory scale##2##2##(1997-2#1)(2008-10#1)
laboratory sciences##3##2##(1994-12#3)
laboratory scientists##2##2##(1994-12#1)(2008-6#1)
laboratory service##3##2##(1993-2#2)(2008-6#1)
laboratory services##2##2##(1993-2#1)(2008-12#1)
laboratory settings##2##2##(1994-3#1)(2008-5#1)
laboratory setup are##2##3##(2008-3#1)(2008-9#1)
laboratory showed that##3##3##(1991-3#1)(1993-1#1)(2009-8#1)
laboratory strain##6##2##(1996-12#1)(2011-2#3)(2012-3#2)
laboratory strains of##3##3##(1996-6#1)(2012-3#2)
laboratory strains##5##2##(1996-6#1)(2012-3#4)
laboratory studies##10##2##(2006-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2010-8#1)
laboratory technologists and##2##3##(1994-12#1)(2008-12#1)
laboratory test##2##2##(1994-6#1)(1997-4#1)
laboratory testing##5##2##(1994-12#1)(1996-6#1)(2008-10#2)(2011-2#1)
laboratory tests and##2##3##(1996-2#1)(2009-4#1)
laboratory tests##15##2##(1991-2#1)(1992-12#1)(1994-12#1)(1994-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-3#1)
laboratory to##8##2##(2008-10#4)(2008-11#1)(2008-5#2)(2011-2#1)
laboratory using##7##2##(1990-11#1)(1990-2#1)(2008-10#4)(2012-2#1)
laboratory was##2##2##(2008-10#1)(2010-6#1)
laboratory were##3##2##(1993-1#1)(2008-10#2)
laboratory with the different##2##4##(2008-10#2)
laboratory with##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
laboratory yeast strains##2##3##(1996-6#2)
laboratory##512##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#3)(1992-1#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#5)(1993-2#5)(1993-6#2)(1994-1#3)(1994-12#36)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-6#5)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#5)(1997-6#2)(1997-8#4)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#170)(2008-11#19)(2008-12#17)(2008-2#3)(2008-3#6)(2008-4#10)(2008-5#18)(2008-6#4)(2008-7#13)(2008-8#9)(2008-9#18)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#7)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#31)(2011-3#2)(2011-7#1)(2012-12#5)(2012-2#7)(2012-3#9)(2013-1#10)(2013-8#5)
laboratory&quot##2##1##(2008-1#1)(2008-10#1)
laboratory-based survey of Campylobacter infections in##2##6##(2008-10#2)
laboratory-based##5##1##(2008-10#2)(2008-3#1)(2008-6#1)(2009-11#1)
laboratory-made##9##1##(2008-10#8)(2008-5#1)
laboratory-prepared test##2##2##(2008-10#2)
laboratory-prepared##3##1##(2008-10#3)
laborers##8##1##(1997-6#2)(2009-10#1)(2009-12#5)
laborious and time-consuming##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
laborious and##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)
laborious##13##1##(2008-10#9)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#1)
labour and##4##2##(1994-3#1)(2007-12#1)(2008-11#2)
labour##22##1##(1990-11#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#7)(1996-11#1)(2007-12#1)(2008-11#6)(2008-7#1)(2011-2#1)(2013-8#1)
labour-intensive##2##1##(1993-9#1)(2008-10#1)
labral##2##1##(2007-12#1)(2008-8#1)
labrusca##3##1##(2008-10#3)
labruscana 'Concord'##3##2##(2008-10#3)
labruscana##5##1##(2008-10#5)
labs##5##1##(2008-10#4)(2008-11#1)
labyrinth##3##1##(1991-2#2)(2009-8#1)
labyrinthine##3##1##(1991-2#1)(2008-12#1)(2008-9#1)
lac##6##1##(1990-5#1)(1994-12#1)(1995-2#1)(2008-10#2)(2009-8#1)
lacZ expression##3##2##(1993-12#1)(1995-6#1)(1997-8#1)
lacZ fusion##3##2##(1993-9#2)(2008-10#1)
lacZ fusions##2##2##(1993-12#1)(1997-7#1)
lacZ gene##7##2##(1993-12#2)(1997-8#1)(2008-11#4)
lacZ reporter gene##4##3##(1993-12#1)(1993-9#1)(2008-8#1)(2009-12#1)
lacZ##34##1##(1990-5#1)(1993-12#12)(1993-9#3)(1995-12#1)(1995-6#1)(1996-3#2)(1997-7#3)(1997-8#3)(2008-10#1)(2008-11#4)(2008-8#1)(2009-12#2)
lacZ-based vectors##2##2##(1993-12#2)
lacZ-based##3##1##(1993-12#3)
laccase activity##5##2##(2008-10#5)
laccase and##4##2##(2008-10#2)(2008-5#2)
laccase from##3##2##(2008-10#2)(2008-6#1)
laccase##29##1##(2008-10#22)(2008-5#2)(2008-6#2)(2011-1#2)(2013-1#1)
laccase-catalysed polymerization of natural phenols##2##5##(2011-1#2)
laceration##3##1##(1991-3#1)(2010-1#1)(2012-2#1)
lacerations##5##1##(1990-2#1)(1995-9#1)(2007-11#1)(2010-1#1)(2012-2#1)
lack a##5##2##(1997-7#1)(2008-10#2)(2008-8#1)(2009-8#1)
lack any##3##2##(2008-5#1)(2008-7#2)
lack functional##2##2##(1996-2#1)(1997-7#1)
lack of a##26##3##(1991-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)
lack of additional##2##3##(2008-12#1)(2011-2#1)
lack of adequate##5##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)(2011-3#1)
lack of an##8##3##(1993-12#1)(1995-2#1)(2008-7#1)(2010-12#1)(2011-10#1)(2011-2#1)(2013-1#2)
lack of appropriate##2##3##(2008-10#1)(2008-9#1)
lack of association##2##3##(2008-10#1)(2011-2#1)
lack of attention##3##3##(1994-2#1)(2008-12#1)(2012-2#1)
lack of awareness of##2##4##(2008-10#1)(2011-2#1)
lack of clarity##2##3##(2008-12#2)
lack of confidence##2##3##(2008-10#1)(2008-12#1)
lack of consensus on##2##4##(2008-5#1)(2012-12#1)
lack of consensus##6##3##(1995-5#1)(2008-5#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
lack of control##3##3##(1992-3#1)(2009-7#1)(2013-1#1)
lack of correlation between##3##4##(1991-12#1)(2008-10#2)
lack of correlation##5##3##(1991-12#1)(2008-10#4)
lack of data##3##3##(2008-11#2)(2010-10#1)
lack of desquamation##2##3##(2008-5#2)
lack of discussion##2##3##(2008-11#1)(2008-8#1)
lack of education##2##3##(2010-8#1)(2013-8#1)
lack of effective##2##3##(2008-11#1)(2008-9#1)
lack of efficacy##2##3##(2008-7#1)(2011-2#1)
lack of efficient##2##3##(2008-10#1)(2008-12#1)
lack of evidence##6##3##(1995-2#1)(2008-11#2)(2008-12#1)(2011-10#1)(2011-2#1)
lack of expression of##2##4##(2008-9#1)(2009-8#1)
lack of family##2##3##(1994-1#1)(2008-7#1)
lack of information in##2##4##(1992-2#2)
lack of information##5##3##(1992-2#2)(1993-3#1)(2008-6#1)(2012-2#1)
lack of interest##2##3##(2008-5#1)(2013-1#1)
lack of knowledge about##2##4##(1996-11#1)(2008-5#1)
lack of knowledge and##2##4##(2008-11#1)(2009-6#1)
lack of knowledge to help patients to quit (OR = 0##2##9##(2011-2#2)
lack of knowledge##10##3##(1996-11#1)(1997-1#1)(2008-11#3)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#2)
lack of natural##2##3##(2008-10#2)
lack of resistance##2##3##(2008-12#1)(2009-8#1)
lack of resources and##3##4##(1997-3#1)(2008-1#1)(2010-12#1)
lack of response##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
lack of selectivity##2##3##(1997-1#1)(2008-5#1)
lack of sensitivity and##2##4##(2008-4#1)(2011-2#1)
lack of sensitivity##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
lack of significant##3##3##(2008-10#2)(2013-1#1)
lack of social##2##3##(1992-1#1)(2013-1#1)
lack of spatial##3##3##(1995-11#1)(2008-10#2)
lack of standardization of##2##4##(2008-10#1)(2012-2#1)
lack of sufficient##2##3##(2008-11#1)(2012-2#1)
lack of the##4##3##(1997-6#1)(2010-12#1)(2010-5#1)(2011-2#1)
lack of typical##4##3##(2007-12#1)(2008-5#1)(2009-8#1)(2013-8#1)
lack of##362##2##(1990-12#1)(1990-2#2)(1991-10#1)(1991-12#4)(1991-2#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-2#3)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-11#4)(1995-12#2)(1995-2#5)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#2)(2008-1#5)(2008-10#73)(2008-11#36)(2008-12#16)(2008-3#2)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#9)(2009-10#3)(2009-11#2)(2009-12#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#7)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#3)(2010-8#4)(2011-10#2)(2011-2#27)(2011-3#1)(2012-12#3)(2012-2#11)(2012-3#6)(2013-1#20)(2013-8#8)
lack specific##2##2##(1990-2#1)(2008-7#1)
lack the##11##2##(1994-1#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-8#1)(2009-10#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lack##417##1##(1990-12#1)(1990-2#3)(1990-6#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-2#3)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-11#4)(1995-12#5)(1995-2#5)(1995-5#1)(1995-6#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#3)(2008-1#6)(2008-10#78)(2008-11#36)(2008-12#16)(2008-3#2)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#16)(2008-8#6)(2008-9#9)(2009-10#6)(2009-11#2)(2009-12#3)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#3)(2010-8#4)(2011-10#2)(2011-2#29)(2011-3#1)(2012-12#3)(2012-2#13)(2012-3#8)(2013-1#22)(2013-8#12)
lacked a##6##2##(1990-7#1)(1993-3#1)(1995-6#1)(1997-7#1)(2008-10#2)
lacked the##7##2##(1990-5#1)(1991-8#1)(2008-10#4)(2008-8#1)
lacked##37##1##(1990-5#2)(1990-7#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-9#2)(1994-3#1)(1995-6#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2012-12#1)
lacking Gla##2##2##(1991-12#2)
lacking a C3 ketone##2##4##(1997-1#2)
lacking a##5##2##(1993-6#1)(1997-1#2)(2010-8#1)(2012-3#1)
lacking both##4##2##(1992-10#1)(1993-12#1)(1997-3#1)(2013-1#1)
lacking for##2##2##(2010-12#1)(2011-2#1)
lacking in##8##2##(1995-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-8#1)
lacking phytoene synthase##2##3##(2009-10#2)
lacking the##7##2##(1993-12#1)(1993-8#1)(1996-5#1)(2008-10#2)(2009-8#1)(2011-2#1)
lacking this##2##2##(1992-6#1)(2008-10#1)
lacking##117##1##(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-6#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#2)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-6#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#6)(2012-3#4)(2013-1#5)
lacks an##2##2##(1992-12#1)(1992-6#1)
lacks sensitivity for##2##3##(2008-10#1)(2008-6#1)
lacks the C-terminal##2##3##(2008-8#1)(2010-5#1)
lacks the##17##2##(1991-5#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#2)(2010-5#1)(2011-2#1)(2012-3#1)
lacks##42##1##(1990-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lacquer film were##2##3##(2008-10#2)
lacquer film##9##2##(2008-10#9)
lacquer films were##2##3##(2008-10#2)
lacquer films##7##2##(2008-10#7)
lacquer##22##1##(2008-10#21)(2008-5#1)
lacrimal gland##3##2##(2013-8#3)
lacrimal glands##2##2##(2011-2#2)
lacrimal##8##1##(1995-9#1)(2007-11#1)(2011-2#2)(2013-8#4)
lactalbumin hydrolysate and yeast##2##4##(2008-11#2)
lactalbumin hydrolysate##3##2##(2008-11#3)
lactase activity of##2##3##(1991-12#2)
lactase activity##3##2##(1991-12#3)
lactase##9##1##(1991-12#6)(1992-9#1)(2013-1#2)
lactate accumulation##5##2##(2008-10#2)(2008-11#3)
lactate and ammonia##2##3##(2008-11#1)(2008-7#1)
lactate and##9##2##(1995-8#1)(2008-10#2)(2008-11#3)(2008-7#2)(2012-3#1)
lactate concentration##4##2##(2008-10#2)(2013-8#2)
lactate dehydrogenase (LDH)##6##3##(1994-2#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-11#2)
lactate dehydrogenase activity##5##3##(2008-11#2)(2008-7#1)(2012-2#2)
lactate dehydrogenase##22##2##(1992-11#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#3)(2008-10#2)(2008-11#7)(2008-7#2)(2008-9#1)(2010-12#1)(2012-2#2)
lactate dehydrogenase-B processed pseudogene##2##4##(1990-8#2)
lactate dehydrogenase-B##4##2##(1990-8#4)
lactate flux was##2##3##(1991-5#2)
lactate from glucose##2##3##(2008-11#2)
lactate oxidase##2##2##(2008-10#2)
lactate production##6##2##(1992-9#1)(2008-11#5)
lactate transport##2##2##(1991-5#2)
lactate was##3##2##(1994-8#1)(2008-11#2)
lactate##102##1##(1990-8#4)(1991-3#1)(1991-5#6)(1992-11#1)(1992-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#3)(1995-12#6)(1995-8#1)(1997-1#1)(2008-10#21)(2008-11#27)(2008-7#8)(2008-9#1)(2009-1#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
lactate/pyruvate##4##1##(1995-8#4)
lactatedehydrogenase activity##2##2##(2008-11#2)
lactating camels##2##2##(2011-2#2)
lactating mothers##3##2##(2008-10#1)(2011-2#2)
lactating rats##4##2##(1990-11#4)
lactating##11##1##(1990-11#4)(1990-6#1)(1992-12#1)(2008-10#1)(2011-2#4)
lactation##11##1##(1991-11#1)(1996-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-9#1)
lactic acid and##2##3##(2008-10#2)
lactic acid bacteria and##2##4##(2008-11#1)(2013-1#1)
lactic acid bacteria##9##3##(2008-10#1)(2008-11#6)(2013-1#2)
lactic acid in##6##3##(2008-10#5)(2013-8#1)
lactic acid production##2##3##(2008-7#2)
lactic acid##27##2##(1990-3#1)(2008-10#10)(2008-11#6)(2008-5#2)(2008-7#3)(2008-8#1)(2013-1#3)(2013-8#1)
lactic acidosis##4##2##(1990-3#2)(1991-11#1)(2008-8#1)
lactic and##2##2##(2008-10#1)(2008-5#1)
lactic dehydrogenase##2##2##(1990-5#1)(2008-5#1)
lactic##42##1##(1990-3#3)(1990-5#1)(1991-11#1)(2008-10#16)(2008-11#6)(2008-5#6)(2008-7#3)(2008-8#2)(2013-1#3)(2013-8#1)
lacticin 3147##4##2##(2011-1#4)
lactis bv##2##2##(2008-6#2)
lactis##8##1##(1991-5#2)(1993-2#1)(2008-10#1)(2008-6#4)
lactobacilli##4##1##(1991-3#2)(2012-2#2)
lactobacillus##3##1##(2008-12#1)(2012-2#2)
lactofen##7##1##(2008-10#7)
lactoferrin gene expression levels##2##4##(2008-10#2)
lactoferrin gene##3##2##(2008-10#3)
lactoferrin##14##1##(1996-12#8)(2008-10#6)
lactone form##2##2##(2008-10#2)
lactone quorum-sensing signals##2##3##(2008-9#2)
lactone##11##1##(1991-6#1)(1995-2#3)(1996-5#1)(2008-10#2)(2008-9#2)(2009-6#2)
lactones (AHLs)##2##2##(2008-10#1)(2008-9#1)
lactones##8##1##(1996-5#3)(2008-10#2)(2008-9#3)
lactose and##3##2##(1990-2#1)(2008-10#1)(2008-11#1)
lactose##20##1##(1990-2#3)(1996-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2013-1#2)(2013-7#1)
lactucae on Lettuce##2##3##(2008-10#2)
lactucae on##3##2##(2008-10#3)
lactucae sporangia##3##2##(2008-10#3)
lactucae##18##1##(2008-10#18)
lactulose administration##2##2##(1996-6#2)
lactulose##7##1##(1990-2#3)(1992-12#1)(1996-6#3)
lacunar infarction##2##2##(2008-7#1)(2009-10#1)
lacunar syndrome##5##2##(2009-10#5)
lacunar##8##1##(2008-7#1)(2009-10#6)(2009-11#1)
ladder##12##1##(1994-12#2)(1997-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#1)
ladders##2##1##(1994-3#1)(1995-6#1)
laden##2##1##(2008-8#2)
lady who presented with a history of##2##7##(2008-12#1)(2012-2#1)
lady who presented with##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
lady who##4##2##(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
lady##10##1##(1992-12#2)(2008-12#2)(2010-10#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
laevis PARP##3##2##(1993-12#3)
laevis development##2##2##(1993-6#1)(2008-6#1)
laevis egg extracts##2##3##(1993-2#1)(2008-9#1)
laevis egg##5##2##(1993-2#2)(1993-6#1)(2008-9#2)
laevis eggs##2##2##(1993-2#1)(1993-6#1)
laevis gamma-cry##3##2##(1993-6#3)
laevis##49##1##(1992-3#1)(1993-12#5)(1993-2#3)(1993-5#1)(1993-6#14)(1994-8#2)(1995-12#2)(1996-2#2)(1997-2#1)(1997-3#1)(1997-7#4)(2008-10#1)(2008-11#2)(2008-6#2)(2008-7#1)(2008-9#3)(2011-2#3)(2013-8#1)
laevis)##3##1##(1996-6#2)(2008-10#1)
lag behind##4##2##(1995-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
lag between##2##2##(2008-7#1)(2008-8#1)
lag distances##3##2##(2008-10#3)
lag in##2##2##(2008-7#1)(2010-1#1)
lag period##5##2##(2008-10#4)(2008-7#1)
lag phase and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
lag phase##14##2##(2008-11#1)(2008-5#4)(2008-7#2)(2011-2#6)(2012-2#1)
lag phases##3##2##(2008-11#1)(2008-5#2)
lag phenomenon##2##2##(2008-7#2)
lag time##7##2##(1990-8#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-1#1)
lag times from##2##3##(2008-5#1)(2011-2#1)
lag times of##2##3##(2008-5#2)
lag times##5##2##(2008-5#4)(2011-2#1)
lag##63##1##(1990-8#1)(1994-8#1)(1995-5#1)(1997-3#1)(2008-10#13)(2008-11#6)(2008-5#10)(2008-7#8)(2008-8#2)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#14)(2012-2#2)(2013-1#1)
lag-2##4##1##(1994-12#4)
lag-phase duration##2##2##(2008-11#2)
lagenophorae##3##1##(2008-10#3)
lager beers##2##2##(2008-10#2)
lagged##2##1##(2008-10#1)(2013-1#1)
lagging##2##1##(1993-11#1)(2008-10#1)
lagging-strand##5##1##(1992-3#5)
lagoon##3##1##(2008-10#1)(2010-8#1)(2012-2#1)
lags##3##1##(2008-11#1)(2008-8#2)
lagunculariae##2##1##(2010-3#2)
laid down in the##2##4##(1997-5#1)(2008-11#1)
laid down in##3##3##(1991-11#1)(1997-5#1)(2008-11#1)
laid down##7##2##(1991-11#1)(1997-5#1)(2008-10#4)(2008-11#1)
laid in##2##2##(2008-12#1)(2008-8#1)
laid on##6##2##(1990-3#4)(2008-10#1)(2008-2#1)
laid##18##1##(1990-3#4)(1991-11#1)(1995-2#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
lake and##6##2##(2008-10#4)(2008-8#1)(2011-2#1)
lake area##2##2##(2010-6#2)
lake fish assemblage##2##3##(2010-8#2)
lake sediment samples##3##3##(2008-10#3)
lake sediment##4##2##(2008-10#4)
lake water and##2##3##(2008-10#2)
lake water sample##2##3##(2008-10#2)
lake water samples##4##3##(2008-10#4)
lake water##13##2##(2008-10#13)
lake##40##1##(1990-11#1)(1996-8#1)(2008-10#28)(2008-11#1)(2008-8#1)(2010-6#2)(2010-8#2)(2011-2#1)(2012-3#1)(2013-8#2)
lakes and##2##2##(1996-9#1)(2010-6#1)
lakes##9##1##(1996-9#2)(2008-8#1)(2010-6#5)(2013-8#1)
lamb##8##1##(1991-12#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-4#2)
lambda =##2##2##(2008-3#2)
lambda DNA##4##2##(1994-11#2)(1995-2#1)(2008-11#1)
lambda EMBL4##2##2##(1991-6#1)(1993-2#1)
lambda and##3##2##(1992-6#1)(1994-11#1)(2008-8#1)
lambda gt 11 cDNA library##2##5##(2008-11#1)(2008-8#1)
lambda gt11 cDNA library##2##4##(1990-8#1)(1993-6#1)
lambda has##2##2##(1992-6#1)(1994-11#1)
lambda in##2##2##(1994-11#2)
lambda is a##2##3##(1992-6#1)(2008-8#1)
lambda is reduced to 0##2##5##(2008-3#2)
lambda is##8##2##(1992-6#1)(2008-2#1)(2008-3#3)(2008-8#3)
lambda light chain disease##2##4##(1992-2#2)
lambda light chain##4##3##(1992-2#2)(2008-11#1)(2009-3#1)
lambda light##5##2##(1992-2#2)(2008-11#2)(2009-3#1)
lambda phage DNA##2##3##(1990-12#1)(1995-8#1)
lambda plasmid DNA replication##3##4##(1994-11#3)
lambda plasmid replication##2##3##(1994-11#2)
lambda plasmid##5##2##(1994-11#5)
lambda##74##1##(1990-12#1)(1990-8#1)(1991-6#1)(1992-2#2)(1992-4#2)(1992-6#8)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#14)(1994-5#2)(1995-2#4)(1995-6#1)(1995-8#1)(1996-6#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#1)(2008-8#6)(2008-9#2)(2009-3#1)
lambda(-4##2##1##(2008-2#2)
lambda(SFS)(max)##2##1##(2008-10#2)
lambda(em)##4##1##(2008-10#4)
lambda(max)##14##1##(2008-10#12)(2008-5#1)(2008-9#1)
lambda-DNA##4##1##(2008-8#4)
lambda-DNA/HindIII##2##1##(2008-10#2)
lambda=0##2##1##(2007-11#1)(2009-7#1)
lambdaN gene expression##3##3##(2008-8#1)(2008-9#2)
lambdaN gene##13##2##(2008-8#10)(2008-9#3)
lambdaN##15##1##(2008-8#11)(2008-9#4)
lambs from##2##2##(1991-8#1)(2010-4#1)
lambs that had been infested with##2##6##(1996-12#2)
lambs that had##3##3##(1996-12#3)
lambs were infested with##2##4##(1996-12#2)
lambs were##5##2##(1991-8#1)(1996-12#4)
lambs##25##1##(1990-6#1)(1991-8#3)(1996-12#15)(2008-10#1)(2008-9#2)(2010-4#3)
lamella##5##1##(2008-10#1)(2008-7#3)(2010-6#1)
lamellae in##3##2##(2008-7#3)
lamellae of##2##2##(2008-7#2)
lamellae##20##1##(1994-5#1)(2008-10#3)(2008-5#1)(2008-7#15)
lamellar lipid##2##2##(2008-5#2)
lamellar silk scaffolds##3##3##(2012-2#3)
lamellar structure##2##2##(2008-5#2)
lamellar##24##1##(1994-5#3)(1995-8#1)(2008-5#9)(2008-7#1)(2009-7#1)(2012-2#8)(2013-1#1)
lamellipodia##3##1##(2008-6#1)(2012-2#2)
lameness##5##1##(1990-9#1)(1994-9#1)(2012-3#1)(2013-8#2)
lamin A tail##5##3##(2011-2#5)
lamin A##9##2##(2011-2#9)
lamin B##2##2##(2008-8#1)(2011-2#1)
lamin B1##2##2##(2011-2#2)
lamin C2##5##2##(2011-2#5)
lamin##22##1##(2008-8#2)(2011-2#20)
lamina II##2##2##(1997-3#2)
lamina and##2##2##(2007-12#1)(2011-2#1)
lamina is##2##2##(2008-7#1)(2008-8#1)
lamina of##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
lamina propria of##2##3##(2008-11#1)(2009-1#1)
lamina propria##7##2##(1997-1#1)(2008-11#4)(2008-4#1)(2009-1#1)
lamina##37##1##(1996-6#1)(1997-1#1)(1997-3#5)(2007-12#3)(2008-10#3)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#5)(2009-1#1)(2009-10#1)(2011-2#2)
laminae I and II of the dorsal horn##2##8##(1995-12#2)
laminae I and II##3##4##(1995-12#3)
laminae##9##1##(1995-12#3)(1997-3#6)
laminar counterflow##3##2##(2008-2#1)(2008-3#2)
laminar distribution##2##2##(1997-2#2)
laminar flow##2##2##(2008-10#1)(2008-11#1)
laminar flows##6##2##(2008-10#3)(2008-9#3)
laminar##25##1##(1992-9#1)(1997-2#3)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#3)(2010-9#1)
laminarin##2##1##(2008-10#2)
laminarinase was##2##2##(2008-10#2)
laminarinase##7##1##(2008-10#7)
laminated##2##1##(2008-10#1)(2008-11#1)
laminectomy##8##1##(1991-11#1)(1991-9#1)(1992-12#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
laminin 332 γ2 chain##2##4##(2013-8#2)
laminin 332##12##2##(2013-8#12)
laminin and##2##2##(2008-10#1)(2008-11#1)
laminin chain variants##2##3##(2008-11#2)
laminin fragments##3##2##(1997-1#3)
laminin##31##1##(1992-6#2)(1996-12#1)(1997-1#4)(2008-10#2)(2008-11#5)(2008-9#1)(2012-5#3)(2013-8#13)
laminin-5##3##1##(2008-11#1)(2008-5#2)
laminin-enriched extract##2##2##(1997-3#2)
laminins##3##1##(2008-11#3)
laminitis##3##1##(1997-5#3)
laminotomy##3##1##(2008-7#2)(2011-2#1)
lamins (gene)##2##2##(2008-8#2)
lamins are##2##2##(2008-8#1)(2011-2#1)
lamins in##2##2##(2011-2#2)
lamins##18##1##(2008-8#4)(2011-2#14)
lamivudine##4##1##(2009-8#4)
lamotrigine##2##1##(2008-8#1)(2010-2#1)
lamp is##2##2##(2008-10#2)
lamp of##2##2##(2008-10#1)(2008-11#1)
lamp##21##1##(2008-10#15)(2008-11#2)(2008-3#2)(2008-9#1)(2013-1#1)
lamprey##9##1##(1993-3#3)(1994-11#1)(1997-3#5)
lamps##5##1##(2008-10#4)(2008-11#1)
land and##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
land mine detection##2##3##(2008-10#2)
land mine##3##2##(2008-10#3)
land mines##5##2##(2008-10#5)
land plants##4##2##(2009-6#4)
land use##2##2##(2008-10#1)(2009-7#1)
land##31##1##(1992-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#4)(2009-7#1)(2010-7#1)(2011-2#2)
land-race##2##1##(2008-10#2)
landfill leachates##3##2##(2008-10#3)
landfill##6##1##(2008-10#6)
landing on##2##2##(2008-10#1)(2012-12#1)
landing##8##1##(1997-2#1)(2008-10#1)(2011-2#5)(2012-12#1)
landlords##2##1##(1996-5#2)
landmark##11##1##(1990-11#1)(1994-2#1)(1995-12#1)(2008-11#3)(2008-9#1)(2009-10#1)(2009-7#1)(2013-1#2)
landmarks and##3##2##(2009-5#1)(2010-6#1)(2012-12#1)
landmarks for##2##2##(1993-2#1)(2012-12#1)
landmarks##10##1##(1993-2#1)(1997-2#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-6#1)(2010-7#1)(2012-12#2)
landrace##2##1##(2008-10#2)
landraces##8##1##(2008-10#8)
landscape genetic##2##2##(2013-1#2)
landscape genetics##2##2##(2013-1#2)
landscape of the##2##3##(2008-10#2)
landscape of##8##2##(1993-2#1)(1994-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)
landscape structure##3##2##(2008-8#1)(2013-1#2)
landscape##34##1##(1993-2#1)(1994-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#8)(2008-9#1)(2009-5#1)(2012-9#1)(2013-1#9)
landscapes to##2##2##(1995-3#1)(2008-8#1)
landscapes##23##1##(1995-3#4)(1997-2#1)(2008-3#1)(2008-8#12)(2008-9#4)(2013-1#1)
lane##2##1##(1996-2#1)(2009-12#1)
langerhans cell histiocytosis##2##3##(2009-5#1)(2012-3#1)
language and vocal skills of a set of monozygous twin girls##2##11##(2008-9#2)
language and##15##2##(2008-1#1)(2008-11#2)(2008-12#2)(2008-9#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
language comprehension processes in##2##4##(2012-3#2)
language delay##3##2##(2008-11#1)(2008-9#2)
language development in##2##3##(2008-9#2)
language development##9##2##(2008-11#2)(2008-9#4)(2009-8#1)(2011-1#1)(2012-2#1)
language disorders##2##2##(2008-11#1)(2008-7#1)
language for##4##2##(1992-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
language impairment (SLI)##2##3##(2008-11#1)(2009-8#1)
language impairment##4##2##(2008-11#2)(2009-8#2)
language in##3##2##(1991-2#1)(1996-5#1)(2013-1#1)
language is##2##2##(2011-2#1)(2013-8#1)
language of##8##2##(1995-1#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
language processing##4##2##(2008-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
language production of children##2##4##(2011-1#2)
language production##3##2##(1996-2#1)(2011-1#2)
language proficiency##2##2##(2008-12#1)(2012-12#1)
language skills##4##2##(2008-9#4)
language spoken##2##2##(1995-12#1)(2013-1#1)
language to the##2##3##(2008-10#2)
language to##3##2##(2008-10#2)(2011-2#1)
language used##2##2##(2008-11#1)(2013-1#1)
language##145##1##(1991-2#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#3)(1996-5#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#19)(2008-12#7)(2008-2#6)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#15)(2009-10#1)(2009-12#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-5#5)(2010-9#1)(2011-1#12)(2011-2#13)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#11)(2013-8#8)
language)##2##1##(2008-1#1)(2009-9#1)
language?##3##1##(1992-2#1)(1997-7#1)(2012-2#1)
languages and##2##2##(2008-10#1)(2013-8#1)
languages##7##1##(1993-11#1)(1994-12#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-3#1)(2013-8#1)
lanosterol 14 alpha-demethylase (P-450(14)DM)##2##4##(1992-3#2)
lanosterol 14 alpha-demethylase##4##3##(1992-3#2)(2008-5#2)
lanosterol 14##6##2##(1991-5#2)(1992-3#2)(2008-5#2)
lanosterol and##2##2##(1992-3#2)
lanosterol##8##1##(1991-5#2)(1992-3#4)(2008-5#2)
lansoprazole##13##1##(2008-11#8)(2012-2#5)
lanthanide ions##4##2##(2008-10#4)
lanthanide metal ions was in the order##2##7##(2008-10#2)
lanthanide metal ions##5##3##(2008-10#5)
lanthanide metal##6##2##(2008-10#5)(2008-4#1)
lanthanide##26##1##(1997-2#1)(2008-10#24)(2008-4#1)
lanthanide(III) ions##2##2##(2008-10#2)
lanthanide(III)##3##1##(2008-10#3)
lanthanides and##2##2##(2008-10#2)
lanthanides are##2##2##(2008-10#2)
lanthanides from##3##2##(2008-10#3)
lanthanides in##3##2##(2008-10#3)
lanthanides##32##1##(2008-10#32)
lanthanoid series##2##2##(2008-10#2)
lanthanoids(III)##4##1##(2008-10#4)
lanthanum and##2##2##(2008-10#2)
lanthanum chloride##2##2##(2008-10#2)
lanthanum from##2##2##(2008-10#1)(2008-7#1)
lanthanum metal##2##2##(2008-10#2)
lanthanum##27##1##(1997-2#2)(2007-12#1)(2008-10#21)(2008-7#1)(2008-9#1)(2012-2#1)
lanthanum(III)##3##1##(2008-10#3)
lap belt was##2##3##(2013-1#2)
lap##3##1##(2011-2#1)(2013-1#2)
laparoscope is##2##2##(1991-12#2)
laparoscope##6##1##(1991-12#2)(1992-1#1)(1992-12#2)(1996-3#1)
laparoscopic adhesiolysis##3##2##(1991-3#3)
laparoscopic adjustable gastric banding##3##4##(2012-12#3)
laparoscopic adrenalectomy##2##2##(2012-12#2)
laparoscopic appendectomy was performed##2##4##(2011-2#2)
laparoscopic appendectomy##3##2##(1992-2#1)(2011-2#2)
laparoscopic approach##2##2##(1994-2#1)(1996-1#1)
laparoscopic cholecystectomy##12##2##(2008-12#4)(2008-8#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#2)
laparoscopic fundoplication##2##2##(2008-12#2)
laparoscopic hysterectomy##8##2##(1993-3#2)(1996-1#3)(1996-2#1)(2010-3#1)(2013-1#1)
laparoscopic management##2##2##(2008-10#2)
laparoscopic myomectomy##4##2##(1993-12#1)(1993-3#1)(1994-2#1)(2011-1#1)
laparoscopic orchidopexy##2##2##(2008-10#2)
laparoscopic presacral neurectomy##3##3##(1994-3#3)
laparoscopic procedures##3##2##(1993-3#1)(2008-10#1)(2009-12#1)
laparoscopic sterilization##3##2##(1995-1#2)(1996-3#1)
laparoscopic surgery for##3##3##(1996-8#1)(2013-1#2)
laparoscopic surgery##19##2##(1991-3#1)(1993-12#2)(1995-1#1)(1996-8#1)(2008-10#2)(2008-12#2)(2009-8#1)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#5)
laparoscopic suturing##2##2##(1995-1#1)(2008-10#1)
laparoscopic techniques##3##2##(1994-3#1)(1995-1#1)(2008-10#1)
laparoscopic tubal##2##2##(1993-12#1)(1993-3#1)
laparoscopic##125##1##(1991-3#4)(1992-2#2)(1992-3#1)(1993-12#7)(1993-2#1)(1993-3#6)(1994-2#4)(1994-3#4)(1995-1#9)(1995-3#1)(1996-1#4)(1996-2#1)(1996-3#1)(1996-8#1)(2008-10#12)(2008-12#10)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#8)(2012-12#18)(2012-3#5)(2013-1#9)
laparoscopically assisted vaginal hysterectomies##2##4##(1993-12#1)(1995-1#1)
laparoscopically assisted vaginal hysterectomy##7##4##(1993-12#4)(1994-2#3)
laparoscopically assisted vaginal radical hysterectomy##2##5##(1994-2#2)
laparoscopically assisted vaginal##11##3##(1993-12#5)(1994-2#5)(1995-1#1)
laparoscopically##19##1##(1992-3#1)(1993-12#5)(1994-2#5)(1994-3#2)(1995-1#1)(2008-10#1)(2011-2#3)(2013-1#1)
laparoscopies##2##1##(1991-12#1)(1992-2#1)
laparoscopy and the##2##3##(1993-12#1)(1993-6#1)
laparoscopy and##8##2##(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1996-3#1)(2009-8#1)(2012-12#1)
laparoscopy for adnexal##2##3##(1996-3#2)
laparoscopy for treatment of pelvic##3##5##(1992-1#1)(1992-3#1)(1995-2#1)
laparoscopy for##8##2##(1992-1#1)(1992-3#1)(1994-3#1)(1995-2#2)(1996-3#2)(2008-10#1)
laparoscopy has##4##2##(1991-12#1)(1993-12#1)(1993-3#1)(1995-2#1)
laparoscopy in the##2##3##(1991-12#1)(1996-1#1)
laparoscopy in##6##2##(1991-12#2)(1991-3#1)(1993-12#1)(1994-3#1)(1996-1#1)
laparoscopy is##2##2##(1995-2#1)(1996-3#1)
laparoscopy to##2##2##(1993-12#1)(1995-2#1)
laparoscopy was used##2##3##(1991-3#1)(1992-1#1)
laparoscopy was##3##2##(1991-3#1)(1992-1#1)(2008-10#1)
laparoscopy##73##1##(1991-12#5)(1991-2#1)(1991-3#7)(1992-1#2)(1992-12#1)(1992-3#4)(1993-1#1)(1993-12#7)(1993-2#1)(1993-3#5)(1993-6#1)(1994-12#1)(1994-3#3)(1995-1#1)(1995-2#10)(1995-3#6)(1996-1#5)(1996-2#1)(1996-3#6)(2008-10#2)(2009-8#1)(2012-12#1)(2013-1#1)
laparoscopy-assisted##3##1##(1993-2#1)(2013-1#2)
laparotomy (group##2##2##(1991-3#1)(1996-3#1)
laparotomy and##5##2##(1994-3#2)(1996-1#2)(2013-1#1)
laparotomy for##6##2##(1991-2#1)(1996-3#3)(2008-12#1)(2011-2#1)
laparotomy in the management of ovarian masses##2##7##(1996-1#2)
laparotomy in the##3##3##(1991-3#1)(1996-1#2)
laparotomy in##4##2##(1991-3#1)(1993-6#1)(1996-1#2)
laparotomy is##3##2##(1990-2#1)(1992-5#1)(2011-2#1)
laparotomy should be##2##3##(1990-2#1)(2008-12#1)
laparotomy was performed##2##3##(1990-2#1)(1992-3#1)
laparotomy was##4##2##(1990-2#2)(1992-3#1)(2013-8#1)
laparotomy##50##1##(1990-2#6)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-2#2)(1994-3#4)(1995-3#1)(1996-1#7)(1996-3#6)(2008-10#1)(2008-12#4)(2009-8#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
laponite##2##1##(2008-10#2)
laponite-clay-nanoparticles##2##1##(2008-10#2)
lapse rates##2##2##(1993-3#1)(2012-6#1)
lapse##5##1##(1993-3#1)(2008-10#2)(2012-6#1)(2013-8#1)
lapsed##2##1##(1996-5#1)(2012-3#1)
larch##3##1##(2008-10#3)
large (&gt##2##2##(1996-12#1)(2008-8#1)
large (n =##2##3##(1990-5#1)(2009-9#1)
large AVMs##2##2##(2008-7#2)
large B cell##2##3##(2013-1#2)
large B-cell lymphoma##5##3##(2008-5#1)(2009-8#3)(2013-8#1)
large B-cell##8##2##(2008-5#1)(2009-8#6)(2013-8#1)
large DNA##3##2##(2008-10#1)(2008-11#2)
large T-antigen##2##2##(1997-7#1)(2008-11#1)
large academic##3##2##(1995-3#1)(2008-11#1)(2011-2#1)
large aggregates##2##2##(2007-12#1)(2008-11#1)
large alternating magnetic##2##3##(2012-2#2)
large amount of data##3##4##(1995-5#1)(2008-10#1)(2010-8#1)
large amount of the##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
large amount of##25##3##(1995-5#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
large amount##27##2##(1995-5#1)(2007-12#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
large amounts of hIL-6##2##4##(2008-11#2)
large amounts of sample##2##4##(2008-10#2)
large amounts of the##2##4##(1994-5#1)(2010-10#1)
large amounts of##49##3##(1990-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#22)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#3)
large amounts##53##2##(1990-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#22)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
large amplitude##4##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
large and giant middle cerebral artery aneurysms##2##7##(2011-2#2)
large and high-flow cerebral arteriovenous##2##5##(2008-7#2)
large and high-flow##3##3##(2008-7#3)
large and small vessel vasculitis in Japan##2##7##(1997-8#2)
large and small##5##3##(1995-12#1)(1997-8#2)(2008-3#1)(2010-11#1)
large and##31##2##(1995-12#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-8#2)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#5)(2012-2#1)
large animal##4##2##(2008-11#1)(2008-4#2)(2012-12#1)
large areas of##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
large areas##6##2##(1990-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
large as##6##2##(1992-3#1)(1993-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
large blood##3##2##(2011-2#3)
large body of evidence##3##4##(1992-3#1)(2008-10#1)(2009-3#1)
large body of##10##3##(1992-3#1)(1992-5#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-2#2)
large body##11##2##(1992-3#1)(1992-5#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2012-2#2)
large bubble##3##2##(2008-11#3)
large cell neuroendocrine##2##3##(2013-1#2)
large cell##8##2##(1991-9#1)(2008-11#2)(2009-8#1)(2012-3#1)(2013-1#3)
large changes in the##2##4##(2008-10#1)(2008-7#1)
large chromosomal##2##2##(2008-10#1)(2011-2#1)
large class##2##2##(2008-11#1)(2013-8#1)
large clinical trial##2##3##(1995-9#1)(2013-1#1)
large clinical##4##2##(1995-12#1)(1995-9#1)(2013-1#2)
large cluster##2##2##(1996-12#1)(2008-10#1)
large clusters##2##2##(2008-10#1)(2013-1#1)
large cohort of##3##3##(2009-8#1)(2011-2#2)
large cohort##4##2##(2009-8#1)(2011-2#3)
large community-based##2##2##(2009-8#1)(2009-9#1)
large complex refractive##4##3##(2008-3#4)
large complex##5##2##(2008-3#4)(2012-2#1)
large concentrations of##4##3##(2008-10#4)
large conductance Ca(2+)-activated K+ channels in##2##6##(1994-11#2)
large contribution##2##2##(2008-10#1)(2009-4#1)
large cystic##3##2##(1990-6#1)(2008-7#1)(2011-2#1)
large cysts##2##2##(1991-2#1)(1995-12#1)
large delta##2##2##(1994-11#2)
large differences between##2##3##(1994-5#1)(1995-12#1)
large differences in the##2##4##(2008-11#1)(2013-8#1)
large differences in##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
large differences##10##2##(1992-12#1)(1994-5#2)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
large dispersion##2##2##(2008-10#1)(2008-5#1)
large distances##2##2##(2007-12#1)(2008-11#1)
large doses of##2##3##(1990-9#1)(1992-3#1)
large doses##3##2##(1990-9#1)(1991-8#1)(1992-3#1)
large droplets##2##2##(1994-12#1)(2008-3#1)
large dsRNA (L-dsRNA)##2##3##(2008-10#2)
large dynamic##2##2##(2008-10#1)(2008-3#1)
large effect##3##2##(2009-9#1)(2011-2#1)(2012-3#1)
large effects on##2##3##(2008-10#1)(2008-8#1)
large effects##3##2##(1994-9#1)(2008-10#1)(2008-8#1)
large enough to##5##3##(1992-6#1)(2008-11#1)(2008-3#2)(2011-2#1)
large enough##6##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)
large errors##2##2##(2008-10#1)(2008-11#1)
large excess of##6##3##(1991-11#1)(1995-2#1)(2008-10#4)
large excess##8##2##(1991-11#1)(1995-2#1)(2008-10#6)
large extent##8##2##(1991-8#1)(1996-6#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
large extracellular##3##2##(1993-6#1)(2007-12#1)(2009-8#1)
large field##3##2##(2010-10#1)(2010-12#1)(2012-2#1)
large flow range##2##3##(2008-10#2)
large fraction of##3##3##(2008-10#2)(2008-7#1)
large granular##2##2##(2008-7#1)(2010-1#1)
large granules##2##2##(2008-5#2)
large group of##7##3##(2008-10#2)(2008-12#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
large group##11##2##(2008-10#3)(2008-12#3)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
large groups##2##2##(1993-12#1)(1994-9#1)
large health##2##2##(1991-7#1)(2010-8#1)
large host##2##2##(2008-10#1)(2008-8#1)
large in##2##2##(1990-11#1)(2008-7#1)
large increases in##3##3##(1990-6#1)(1990-7#1)(2008-10#1)
large insert DNA into##2##4##(2008-4#2)
large insert##3##2##(2008-4#3)
large interest##3##2##(2011-2#3)
large intergenic region##2##3##(2008-9#2)
large intestinal##3##2##(2009-8#1)(2011-2#2)
large intestine##10##2##(1990-11#1)(1991-5#1)(1991-6#1)(1992-5#1)(1995-10#1)(2008-12#1)(2009-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
large intra- and inter-individual variations in serum T##2##8##(2013-8#2)
large intracranial##2##2##(1995-11#1)(2011-2#1)
large linear##3##2##(2008-10#3)
large literature##2##2##(2008-11#1)(2009-11#1)
large loop excision of the##2##5##(1994-2#1)(2012-3#1)
large majority of the##2##4##(2008-3#1)(2013-8#1)
large majority of##6##3##(1991-9#1)(2008-10#2)(2008-3#1)(2010-8#1)(2013-8#1)
large majority##7##2##(1991-9#1)(2008-10#2)(2008-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
large mass##4##2##(1991-2#1)(2008-11#2)(2011-2#1)
large metropolitan areas##2##3##(1991-2#1)(1994-1#1)
large metropolitan##3##2##(1991-2#1)(1994-1#1)(2008-11#1)
large molecular##3##2##(1990-5#1)(1994-8#2)
large molecules##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
large monophyletic##2##2##(2008-10#1)(2013-8#1)
large mothers produce large##2##4##(2008-8#2)
large mothers##3##2##(2008-8#3)
large necrotic areas##2##3##(2008-10#1)(2010-12#1)
large nonspherical##2##2##(2008-3#2)
large number of cations##4##4##(2008-10#4)
large number of different##6##4##(1994-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
large number of samples##9##4##(2008-10#5)(2008-11#2)(2008-9#1)(2010-11#1)
large number of##111##3##(1990-12#1)(1990-6#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-9#1)(2007-12#1)(2008-10#39)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
large number##113##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-9#1)(2007-12#1)(2008-10#40)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
large numbers of T cells##2##5##(2008-4#1)(2011-2#1)
large numbers of cells##2##4##(2008-11#2)
large numbers of children##2##4##(1996-12#1)(2009-6#1)
large numbers of samples##3##4##(2008-10#2)(2008-9#1)
large numbers of##36##3##(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#5)(2009-10#1)(2009-6#1)(2011-2#2)
large numbers##37##2##(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#5)(2009-10#1)(2009-6#1)(2011-2#2)
large oil##2##2##(2009-10#2)
large open reading##3##3##(2008-10#3)
large optical##2##2##(2008-3#1)(2013-8#1)
large part##8##2##(1993-2#2)(1995-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
large particles##7##2##(2008-10#5)(2008-2#1)(2008-3#1)
large patches##2##2##(2008-9#2)
large plasmid##2##2##(2008-10#1)(2012-3#1)
large plasmids##2##2##(2012-3#2)
large population size##2##3##(2008-10#1)(2008-9#1)
large population##9##2##(1994-8#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
large populations of##2##3##(1997-6#1)(2008-10#1)
large populations##8##2##(1996-2#1)(1997-6#2)(2008-10#3)(2009-12#1)(2009-7#1)
large positive##2##2##(1992-3#1)(2012-2#1)
large proportion of the##6##4##(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)(2013-8#1)
large proportion of##14##3##(1990-3#1)(1992-12#2)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
large protein##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
large proteins##6##2##(1994-8#1)(1997-2#5)
large public##2##2##(2008-10#1)(2009-9#1)
large quantities in##2##3##(2008-10#2)
large quantities of##19##3##(1993-6#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-11#5)(2008-5#1)(2008-9#2)(2009-7#1)(2013-1#1)
large quantities##26##2##(1993-6#1)(1996-5#1)(1997-1#2)(1997-3#1)(2008-10#9)(2008-11#7)(2008-5#1)(2008-9#2)(2009-7#1)(2013-1#1)
large randomized##3##2##(2008-10#1)(2009-5#1)(2010-10#1)
large range of##9##3##(1991-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2010-1#1)
large receptive fields##2##3##(2007-12#1)(2008-11#1)
large relative to the strength of##2##6##(2008-8#2)
large relative to the##3##4##(2008-8#2)(2011-2#1)
large release of##2##3##(1994-2#1)(2008-9#1)
large response##2##2##(2008-10#2)
large restriction fragments##2##3##(1992-6#2)
large sample theory##2##3##(1995-9#1)(1996-3#1)
large sample##13##2##(1995-9#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-8#1)(2012-2#2)
large scale application##2##3##(2008-11#1)(2008-7#1)
large scale cell##2##3##(2008-11#2)
large scale of##2##3##(2008-11#1)(2011-3#1)
large scale production##3##3##(2008-11#2)(2011-2#1)
large scale sampling studies##2##4##(2008-10#2)
large scale##39##2##(1994-6#1)(2008-10#10)(2008-11#16)(2008-12#1)(2008-7#3)(2009-12#1)(2010-10#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
large scales##2##2##(2008-8#1)(2009-8#1)
large sequence sets##2##3##(2008-4#2)
large series of samples##2##4##(2008-10#2)
large series of##5##3##(2008-10#3)(2008-5#1)(2008-7#1)
large series##8##2##(2008-10#4)(2008-5#1)(2008-7#2)(2009-8#1)
large set of##6##3##(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-3#1)(2013-8#1)
large size##7##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-3#1)(2013-7#1)
large sizes##2##2##(2008-8#1)(2013-8#1)
large skeletal defects##2##3##(2010-6#2)
large soft tissue##2##3##(2009-3#1)(2010-6#1)
large spectral##3##2##(2007-11#1)(2008-3#2)
large studies##3##2##(2008-7#1)(2010-1#1)(2010-12#1)
large subunit ribosomal##2##3##(1991-6#1)(2010-4#1)
large subunit##7##2##(1991-6#1)(1993-8#1)(1995-12#1)(2008-10#2)(2010-4#1)(2013-8#1)
large surface area##4##3##(2008-10#1)(2008-11#1)(2009-12#1)(2010-7#1)
large teaching##2##2##(1991-3#1)(1996-2#1)
large tumor##2##2##(1995-2#1)(2013-1#1)
large uncertainties in the##2##4##(2008-3#2)
large unilamellar vesicles##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
large urban##4##2##(1992-1#1)(1992-12#2)(1995-5#1)
large vacuoles##2##2##(2008-11#1)(2008-12#1)
large variability in##2##3##(2010-10#1)(2011-2#1)
large variability##7##2##(1997-3#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)(2012-2#1)
large variety of applications##2##4##(2008-3#1)(2008-9#1)
large variety of##7##3##(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#1)
large vessels##4##2##(1997-8#1)(2008-11#1)(2010-9#1)(2011-2#1)
large volume of aqueous##3##4##(2008-10#3)
large volume of literature##2##4##(2008-10#1)(2013-8#1)
large volume of##11##3##(1995-3#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-8#1)(2013-8#1)
large volume water##2##3##(2008-10#2)
large volume##18##2##(1995-3#1)(2008-10#13)(2008-11#1)(2008-8#1)(2010-8#1)(2013-8#1)
large volumes of##8##3##(2008-10#6)(2009-7#1)(2012-2#1)
large volumes##9##2##(2008-10#6)(2009-7#2)(2012-2#1)
large white##3##2##(2008-12#2)(2010-1#1)
large##1316##1##(1990-11#6)(1990-12#3)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#7)(1991-5#4)(1991-6#7)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#3)(1992-3#8)(1992-5#5)(1992-6#6)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#3)(1993-6#4)(1993-8#2)(1994-1#3)(1994-11#8)(1994-12#4)(1994-2#11)(1994-3#3)(1994-5#6)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#12)(1995-2#5)(1995-3#3)(1995-5#6)(1995-6#4)(1995-8#3)(1995-9#2)(1996-11#1)(1996-12#9)(1996-2#8)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#7)(1997-4#1)(1997-6#4)(1997-7#3)(1997-8#4)(1997-9#1)(2007-11#2)(2007-12#14)(2007-8#1)(2008-1#3)(2008-10#314)(2008-11#116)(2008-12#22)(2008-2#11)(2008-3#52)(2008-4#16)(2008-5#22)(2008-6#11)(2008-7#49)(2008-8#50)(2008-9#42)(2009-1#2)(2009-10#9)(2009-11#5)(2009-12#9)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#9)(2009-8#26)(2009-9#4)(2010-1#4)(2010-10#10)(2010-11#6)(2010-12#7)(2010-4#5)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#6)(2011-2#64)(2011-3#1)(2012-12#4)(2012-2#29)(2012-3#29)(2012-9#1)(2013-1#42)(2013-7#1)(2013-8#18)
large-aperture##2##1##(2008-2#1)(2008-3#1)
large-area##3##1##(2008-11#1)(2009-11#2)
large-caliber##2##1##(2011-3#1)(2013-1#1)
large-core##3##1##(2008-3#3)
large-scale analysis of##2##3##(2010-1#1)(2010-4#1)
large-scale clinical##2##2##(2008-11#1)(2010-5#1)
large-scale epidemiological studies##2##3##(2008-10#1)(2008-8#1)
large-scale epidemiological##3##2##(1991-8#1)(2008-10#1)(2008-8#1)
large-scale expression data##2##3##(2008-4#2)
large-scale expression##3##2##(1995-12#1)(2008-4#2)
large-scale fermentation##3##2##(1990-5#1)(2008-11#2)
large-scale gene expression##3##3##(2008-4#2)(2008-8#1)
large-scale mammalian cell##2##3##(2008-11#2)
large-scale phylogenetic##2##2##(2008-10#1)(2011-2#1)
large-scale population##2##2##(2008-1#1)(2008-10#1)
large-scale preparation##2##2##(1995-12#1)(2008-9#1)
large-scale production of##3##3##(1992-11#1)(2008-11#2)
large-scale production##6##2##(1992-11#1)(2008-11#4)(2011-2#1)
large-scale screening##2##2##(2008-9#2)
large-scale studies##3##2##(2008-11#1)(2011-2#1)(2011-8#1)
large-scale##101##1##(1990-3#1)(1990-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-12#2)(1995-6#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-1#2)(2008-10#13)(2008-11#23)(2008-12#2)(2008-3#1)(2008-4#8)(2008-7#2)(2008-8#4)(2008-9#3)(2009-6#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-2#4)(2011-8#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
large-volume##9##1##(1996-2#1)(2008-10#6)(2008-7#1)(2009-8#1)
largely absent##2##2##(2009-4#1)(2009-7#1)
largely based##3##2##(2008-12#2)(2008-7#1)
largely be##3##2##(1996-3#1)(2012-2#1)(2013-8#1)
largely because of the##2##4##(1995-5#1)(2008-8#1)
largely because of##3##3##(1995-5#1)(2008-7#1)(2008-8#1)
largely because##4##2##(1995-5#1)(1997-3#1)(2008-7#1)(2008-8#1)
largely been##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-4#1)
largely by the##2##3##(2008-10#1)(2008-6#1)
largely by##5##2##(2008-10#2)(2008-6#1)(2008-8#1)(2010-4#1)
largely dependent on the##2##4##(1990-8#1)(2011-2#1)
largely dependent##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
largely depends on##2##3##(2008-10#1)(2008-5#1)
largely directed##2##2##(1997-7#1)(2010-12#1)
largely due to the##4##4##(2008-11#1)(2012-2#2)(2013-7#1)
largely due to##6##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#2)(2013-7#1)
largely due##7##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2012-2#2)(2013-7#1)
largely excluded##2##2##(2008-10#1)(2011-2#1)
largely focused on##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
largely ignored##5##2##(1997-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
largely informal##2##2##(1992-1#1)(2008-11#1)
largely insensitive to##2##3##(1997-9#1)(2008-3#1)
largely on the##2##3##(2008-5#1)(2013-8#1)
largely on##7##2##(1990-5#1)(1993-2#1)(2008-11#1)(2008-5#1)(2008-7#2)(2013-8#1)
largely overlooked##2##2##(2008-8#1)(2011-2#1)
largely responsible for the##3##4##(1995-8#1)(1996-3#1)(2008-10#1)
largely responsible for##5##3##(1995-8#1)(1996-3#1)(1997-7#1)(2008-10#1)(2012-2#1)
largely restricted to##3##3##(1994-3#1)(1997-3#1)(2012-2#1)
largely similar##2##2##(2008-12#1)(2010-10#1)
largely superseded##2##2##(1990-11#1)(2011-2#1)
largely through##3##2##(1992-1#1)(2008-10#1)(2009-10#1)
largely uncharacterized##2##2##(2008-9#1)(2012-2#1)
largely unexplored##3##2##(1992-12#1)(2008-8#1)(2008-9#1)
largely unknown##18##2##(1994-2#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
largely unrecognized##2##2##(2008-5#1)(2010-6#1)
largely##207##1##(1990-11#2)(1990-5#2)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#1)(1997-3#4)(1997-7#2)(1997-8#1)(1997-9#1)(2007-12#3)(2008-1#2)(2008-10#27)(2008-11#11)(2008-12#6)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#11)(2008-9#9)(2009-1#1)(2009-10#2)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-4#4)(2010-5#1)(2010-6#2)(2011-2#12)(2011-3#1)(2012-2#10)(2012-3#4)(2012-4#1)(2013-1#4)(2013-7#1)(2013-8#8)
larger (p = 0##2##4##(1993-11#1)(1996-2#1)
larger amount of##3##3##(1992-3#1)(2008-10#2)
larger amounts of##6##3##(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-3#1)
larger and more##3##3##(1996-2#1)(2008-8#1)(2012-3#1)
larger and##4##2##(1996-2#1)(2008-11#1)(2008-8#1)(2012-3#1)
larger area##2##2##(1991-6#1)(2008-11#1)
larger as##2##2##(2008-10#1)(2008-11#1)
larger by##2##2##(1996-1#1)(2008-3#1)
larger colonies##2##2##(2008-9#2)
larger context of##2##3##(1997-1#1)(2010-7#1)
larger doses##2##2##(1992-3#1)(2012-2#1)
larger females##2##2##(2008-8#2)
larger for##5##2##(1997-2#1)(2007-11#1)(2008-10#2)(2010-9#1)
larger group##3##2##(1995-2#1)(2008-5#1)(2008-8#1)
larger groups##4##2##(2008-8#4)
larger in size##2##3##(1996-2#1)(2008-10#1)
larger in##11##2##(1991-6#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-8#3)(2012-3#2)(2013-8#1)
larger individuals##2##2##(2008-9#1)(2010-8#1)
larger lesions##4##2##(2008-10#4)
larger number of##8##3##(1992-2#1)(1992-9#1)(1997-2#1)(2008-10#4)(2008-11#1)
larger numbers##3##2##(1995-12#1)(2008-10#1)(2012-2#1)
larger population##2##2##(1995-12#1)(2008-10#1)
larger research##2##2##(1992-1#1)(1997-1#1)
larger sample of##2##3##(2008-11#1)(2010-7#1)
larger sample size##2##3##(2008-10#1)(2012-3#1)
larger sample##7##2##(2008-10#2)(2008-11#1)(2008-12#2)(2010-7#1)(2012-3#1)
larger scale##4##2##(1992-5#1)(1994-3#1)(2008-11#1)(2009-8#1)
larger series##2##2##(2008-10#1)(2010-12#1)
larger size##4##2##(2008-10#1)(2008-8#1)(2009-10#1)(2012-3#1)
larger sizes##2##2##(2008-10#1)(2010-8#1)
larger studies##2##2##(2008-11#1)(2009-4#1)
larger study##8##2##(2008-11#3)(2008-12#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-7#1)
larger surface##3##2##(1994-9#1)(1996-12#1)(2008-7#1)
larger than 0##3##3##(2008-10#1)(2009-12#1)(2009-7#1)
larger than 1##3##3##(1997-1#1)(2008-10#2)
larger than 100##3##3##(1996-3#1)(2008-10#1)(2009-7#1)
larger than 50 kDa##2##4##(1997-2#1)(2008-10#1)
larger than 50##3##3##(1997-2#1)(1997-3#1)(2008-10#1)
larger than that in##2##4##(1997-7#1)(2008-10#1)
larger than that of the##8##5##(1995-11#1)(1997-1#1)(2008-11#1)(2008-3#2)(2008-9#2)(2013-8#1)
larger than that of##13##4##(1995-11#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-2#1)(2013-8#1)
larger than that##21##3##(1995-11#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-3#5)(2008-7#1)(2008-9#3)(2009-2#1)(2013-8#1)
larger than the##12##3##(1995-3#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2010-9#1)
larger than those##7##3##(1991-5#1)(2008-10#3)(2008-8#1)(2009-7#1)(2011-2#1)
larger than##78##2##(1991-5#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-9#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#9)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#5)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
larger the##5##2##(2008-10#2)(2008-3#3)
larger value of##4##3##(2008-10#3)(2008-7#1)
larger vesicles##2##2##(1995-6#2)
larger volume##2##2##(2008-10#1)(2008-5#1)
larger volumes of sample##2##4##(2008-10#2)
larger volumes of##3##3##(2008-10#2)(2008-9#1)
larger##375##1##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#4)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#5)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#95)(2008-11#25)(2008-12#5)(2008-2#2)(2008-3#20)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#14)(2008-8#30)(2008-9#15)(2009-10#4)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#5)(2009-8#3)(2010-10#3)(2010-11#2)(2010-12#3)(2010-5#1)(2010-7#6)(2010-8#3)(2010-9#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#10)(2012-5#2)(2013-1#4)(2013-8#6)
largest difference##2##2##(1993-8#1)(1996-6#1)
largest group##2##2##(1995-12#1)(2011-2#1)
largest share of##2##3##(2008-10#1)(2010-12#1)
largest subunit##2##2##(1997-7#2)
largest##115##1##(1990-11#1)(1990-8#2)(1991-2#2)(1991-5#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#32)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-5#1)(2013-1#3)(2013-8#2)
larici-populina strain 93CV1##2##3##(2008-10#2)
larici-populina strain 93ID6##2##3##(2008-10#2)
larici-populina strain##5##2##(2008-10#5)
larici-populina##20##1##(2008-10#20)
laromustine##3##1##(2010-11#3)
larva##12##1##(1992-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)
larvae and adult mites##3##4##(2007-12#3)
larvae and adults##3##3##(1997-7#1)(1997-8#1)(2008-12#1)
larvae and##15##2##(1993-12#2)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)
larvae are##4##2##(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
larvae as##3##2##(2008-7#1)(2009-6#1)(2012-2#1)
larvae have##2##2##(1995-12#1)(2008-8#1)
larvae in##4##2##(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#1)
larvae increased##2##2##(2008-6#1)(2008-7#1)
larvae of M##3##3##(2008-11#2)(2013-1#1)
larvae of the##7##3##(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
larvae of##21##2##(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-4#1)(2010-8#3)(2011-2#1)(2013-1#1)(2013-8#1)
larvae sired by males of the##2##6##(2010-8#2)
larvae to##2##2##(2008-8#1)(2010-8#1)
larvae was##4##2##(2008-7#3)(2011-2#1)
larvae were##9##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-8#2)(2013-8#1)
larvae##149##1##(1992-6#4)(1993-12#3)(1993-9#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#4)(1997-9#1)(2007-12#4)(2008-10#10)(2008-11#8)(2008-12#16)(2008-5#6)(2008-6#5)(2008-7#20)(2008-8#12)(2008-9#4)(2009-10#1)(2009-6#5)(2010-10#3)(2010-4#2)(2010-8#19)(2011-2#6)(2012-2#1)(2013-1#3)(2013-8#5)
larvae)##2##1##(2008-11#1)(2008-7#1)
larval density##3##2##(2008-9#1)(2009-10#2)
larval fishes##2##2##(2010-8#2)
larval food resources##2##3##(2008-8#1)(2008-9#1)
larval form from##2##3##(2011-2#2)
larval growth##2##2##(2008-7#1)(2010-8#1)
larval instars##2##2##(2008-10#1)(2008-7#1)
larval stage##4##2##(2008-8#3)(2013-1#1)
larval stages##2##2##(1990-3#1)(2009-10#1)
larval supply##2##2##(2008-9#2)
larval thrips##2##2##(2008-10#2)
larval##74##1##(1990-3#1)(1992-6#3)(1996-12#4)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-6#3)(2008-7#2)(2008-8#13)(2008-9#11)(2009-10#3)(2009-6#2)(2009-8#1)(2010-8#9)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
laryngeal cancer##3##2##(1992-9#2)(2011-2#1)
laryngeal carcinoma cells##2##3##(2011-2#2)
laryngeal carcinoma##7##2##(1997-8#2)(2011-2#5)
laryngeal involvement##2##2##(1990-6#2)
laryngeal mucosa##3##2##(2008-11#1)(2012-3#2)
laryngeal tumors##2##2##(1990-9#1)(1997-8#1)
laryngeal##29##1##(1990-6#3)(1990-9#1)(1991-12#1)(1992-9#2)(1997-8#5)(2008-11#1)(2010-12#1)(2011-2#8)(2012-12#1)(2012-3#5)(2013-1#1)
laryngectomy##3##1##(2011-1#2)(2012-3#1)
laryngopharyngitis and tonsillitis caused by Streptococcus##2##6##(2011-2#2)
laryngopharyngitis##4##1##(2011-2#4)
larynx##15##1##(1990-8#1)(1993-9#2)(1994-2#1)(2008-11#2)(2010-7#6)(2011-2#1)(2013-1#1)(2013-8#1)
lasB##3##1##(1995-2#3)
lasB-lacZ##3##1##(1995-2#3)
lasR##8##1##(1995-2#8)
lasalocid##3##1##(2008-10#3)
lascivious##2##1##(1995-12#1)(2009-10#1)
laser Doppler velocimeter##2##3##(2008-3#2)
laser Doppler wind sensor##3##4##(2008-3#3)
laser Doppler##8##2##(1994-11#1)(2008-3#5)(2008-5#2)
laser ablation ICP-MS##2##3##(2008-10#2)
laser ablation for##2##3##(2008-10#1)(2008-3#1)
laser ablation inductively coupled plasma mass spectrometry##2##7##(2008-10#1)(2010-11#1)
laser ablation inductively coupled plasma time of flight mass spectrometry (LA-ICP-TOF-MS)##2##11##(2008-10#2)
laser ablation inductively coupled plasma##4##5##(2008-10#3)(2010-11#1)
laser ablation##19##2##(1991-2#1)(1994-12#1)(1996-1#1)(2008-10#11)(2008-3#4)(2010-11#1)
laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS)##2##6##(2008-10#2)
laser absorption spectroscopy##2##3##(2008-3#2)
laser absorption##6##2##(2008-3#6)
laser absorption-scattering technique##2##3##(2008-3#2)
laser and the##6##3##(1991-2#1)(2008-10#2)(2008-3#3)
laser and##16##2##(1991-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#6)
laser angioplasty##2##2##(1991-3#2)
laser are##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
laser array##3##2##(2008-2#2)(2008-3#1)
laser as a##3##3##(2008-10#1)(2008-3#2)
laser as an##3##3##(1991-1#1)(2008-10#2)
laser as##8##2##(1991-1#1)(2008-10#3)(2008-3#4)
laser at 1064 nm##2##4##(2008-10#1)(2008-2#1)
laser at 157 nm##2##4##(2008-3#2)
laser at##13##2##(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#6)
laser beam and##2##3##(2008-3#2)
laser beam by use of##2##5##(2008-3#2)
laser beam is##2##3##(2008-3#2)
laser beam passes through##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
laser beam that##2##3##(2008-2#1)(2008-3#1)
laser beam was##2##3##(2008-3#2)
laser beam with##2##3##(2008-3#1)(2009-5#1)
laser beam##49##2##(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#8)(2008-3#28)(2008-9#1)(2009-12#1)(2009-5#3)(2012-2#1)
laser beams are##2##3##(2008-3#2)
laser beams is##2##3##(2008-2#1)(2008-3#1)
laser beams##8##2##(2008-2#2)(2008-3#6)
laser by##5##2##(2008-3#5)
laser can be used to##2##5##(1992-1#2)
laser can be##5##3##(1992-1#2)(2008-2#1)(2008-3#2)
laser can##6##2##(1992-1#2)(2008-2#1)(2008-3#2)(2012-3#1)
laser cavities##2##2##(2008-2#1)(2008-3#1)
laser cavity##6##2##(2008-2#1)(2008-3#5)
laser coagulation##2##2##(1991-9#2)
laser confocal scanning microscopy##2##4##(2008-10#1)(2008-7#1)
laser confocal##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
laser coupled to an##2##4##(2008-10#1)(2008-3#1)
laser crystal##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
laser desorption##2##2##(2008-10#2)
laser desorption/ionization (MALDI)##3##3##(2008-11#1)(2008-4#1)(2010-7#1)
laser desorption/ionization time of flight mass spectrometry##3##7##(2008-10#1)(2008-11#2)
laser desorption/ionization time-of-flight mass spectrometry##3##5##(2008-10#2)(2011-2#1)
laser desorption/ionization time-of-flight##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
laser desorption/ionization##11##2##(2008-10#4)(2008-11#4)(2008-4#1)(2010-7#1)(2011-2#1)
laser diffraction##2##2##(1995-3#1)(2008-3#1)
laser diode and##2##3##(2008-3#2)
laser diode pulses##2##3##(2008-2#2)
laser diode with##2##3##(2008-3#2)
laser diode##19##2##(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#10)
laser diodes##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
laser emission##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
laser emitting##2##2##(2008-10#1)(2008-9#1)
laser energy at##2##3##(2008-10#1)(2008-3#1)
laser energy##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
laser excision of##2##3##(1991-2#2)
laser excision##3##2##(1991-2#2)(1996-1#1)
laser excisional conization##2##3##(1991-1#2)
laser excisional##3##2##(1991-1#3)
laser excitation##4##2##(2008-10#3)(2008-3#1)
laser excited##2##2##(2008-2#1)(2008-3#1)
laser fiber##3##2##(1992-1#1)(1994-2#1)(1995-2#1)
laser fields##2##2##(2008-3#2)
laser for##11##2##(1992-1#1)(1992-3#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
laser frequency##8##2##(2008-2#1)(2008-3#7)
laser from##2##2##(1991-12#1)(2008-2#1)
laser gain##2##2##(2008-3#2)
laser has been##5##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#2)
laser has##6##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-3#1)
laser have been studied##2##4##(2008-2#1)(2008-3#1)
laser heating##2##2##(2008-3#2)
laser in a##3##3##(2008-2#1)(2008-3#2)
laser in the##5##3##(1996-1#1)(2008-2#2)(2008-3#1)(2013-1#1)
laser in##18##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-6#2)(1994-12#1)(1996-1#1)(2008-2#3)(2008-3#3)(2009-4#1)(2012-3#1)(2013-1#1)
laser induced breakdown##2##3##(2008-10#2)
laser induced fluorescence detection##2##4##(1997-2#1)(2008-10#1)
laser induced fluorescence##6##3##(1997-2#1)(2008-10#5)
laser induced##10##2##(1997-2#1)(2008-10#9)
laser induced-breakdown spectroscopy##2##3##(2008-10#2)
laser intensities##2##2##(2008-3#2)
laser intensity##7##2##(2008-3#7)
laser into the##3##3##(2008-2#1)(2008-3#2)
laser into##4##2##(2008-2#1)(2008-3#3)
laser irradiance##3##2##(1993-3#1)(2008-2#1)(2008-3#1)
laser irradiation at##2##3##(2008-10#1)(2012-2#1)
laser irradiation##8##2##(1996-5#1)(2008-10#2)(2008-3#2)(2012-2#3)
laser is proposed##2##3##(2008-3#2)
laser is##14##2##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#6)(2012-3#1)
laser laparoscopic adhesiolysis##2##3##(1991-3#2)
laser laparoscopy for treatment of pelvic endometriosis##2##7##(1992-1#1)(1995-2#1)
laser laparoscopy##9##2##(1991-3#1)(1992-1#2)(1992-3#1)(1995-2#5)
laser light scattering##3##3##(2008-10#1)(2008-3#2)
laser light source##2##3##(2008-2#1)(2008-3#1)
laser light##27##2##(1994-3#1)(2007-12#3)(2008-10#3)(2008-2#3)(2008-3#12)(2008-7#1)(2012-2#4)
laser light-scattering##2##2##(1993-2#1)(2008-3#1)
laser line##5##2##(2008-3#5)
laser linewidth##3##2##(2008-2#1)(2008-3#2)
laser machine##2##2##(2008-10#2)
laser microdissection##2##2##(2008-12#2)
laser mode##2##2##(2007-12#1)(2008-3#1)
laser of##3##2##(1993-1#1)(2008-10#1)(2008-3#1)
laser on##2##2##(2008-3#2)
laser operating at##5##3##(2008-10#2)(2008-3#3)
laser operating in the##2##4##(2008-10#1)(2008-3#1)
laser operating near##2##3##(2008-3#2)
laser operating##10##2##(2008-10#3)(2008-2#1)(2008-3#6)
laser operation##5##2##(2007-12#2)(2008-3#3)
laser optical feedback imaging##2##4##(2008-3#2)
laser oscillator##4##2##(2007-11#2)(2008-3#2)
laser oscillators##2##2##(2008-3#2)
laser output##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser particle##3##2##(2008-3#3)
laser photocoagulation##3##2##(1993-6#3)
laser power is##3##3##(1992-12#1)(2008-2#1)(2008-3#1)
laser power##13##2##(1992-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)
laser provides##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
laser pulse##4##2##(1995-6#1)(2007-11#1)(2008-10#2)
laser pulses with a##2##4##(2008-2#1)(2008-3#1)
laser pulses##16##2##(1992-8#1)(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#8)
laser pumped by a##2##4##(2007-12#1)(2008-2#1)
laser pumped by##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser pumped##4##2##(1993-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
laser pumping##3##2##(2007-11#1)(2008-3#2)
laser radar cross##2##3##(2008-3#2)
laser radar has been##2##4##(2008-3#2)
laser radar##11##2##(2008-3#11)
laser radiation at##2##3##(2008-10#2)
laser radiation is##2##3##(2008-2#2)
laser radiation that##2##3##(2008-2#1)(2008-3#1)
laser radiation##12##2##(2008-10#2)(2008-2#6)(2008-3#4)
laser ranging##3##2##(2008-3#3)
laser rate equation##2##3##(2008-3#2)
laser resonator##6##2##(2008-2#5)(2008-3#1)
laser resonators##4##2##(2008-2#1)(2008-3#3)
laser rod##2##2##(2008-3#2)
laser safety##4##2##(1993-3#4)
laser scanned##2##2##(2008-10#2)
laser scanning confocal microscopy##3##4##(2008-11#2)(2008-7#1)
laser scanning cytometry##2##3##(2008-9#2)
laser scanning microscopy (CLSM)##2##4##(2008-9#1)(2010-8#1)
laser scanning microscopy##11##3##(2008-10#2)(2008-11#2)(2008-8#3)(2008-9#3)(2010-8#1)
laser scanning##21##2##(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#4)(2008-9#8)(2010-8#1)(2011-2#1)
laser shots##2##2##(2008-3#2)
laser source##14##2##(2008-10#1)(2008-3#10)(2008-9#3)
laser sources##5##2##(1992-1#1)(2008-3#3)(2008-9#1)
laser surgery##5##2##(1992-1#2)(1992-2#2)(2012-12#1)
laser system for the##3##4##(2008-3#3)
laser system with##2##3##(2008-3#1)(2010-1#1)
laser system##14##2##(1992-11#1)(2008-10#1)(2008-3#7)(2008-7#1)(2010-1#4)
laser systems##2##2##(1991-1#1)(1991-3#1)
laser that is##3##3##(2007-12#1)(2008-3#2)
laser that##6##2##(2007-12#1)(2008-3#5)
laser therapy is##2##3##(1991-6#1)(1991-9#1)
laser therapy##7##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(2008-10#2)(2013-1#1)
laser to a##2##3##(2008-2#1)(2008-3#1)
laser to##8##2##(2008-2#2)(2008-3#6)
laser trabeculoplasty in##2##3##(1990-11#1)(2011-2#1)
laser trabeculoplasty##6##2##(1990-11#3)(2011-2#3)
laser trapping and##2##3##(2008-3#1)(2008-8#1)
laser treatment##6##2##(1990-11#1)(1993-6#1)(1996-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
laser users##2##2##(1993-3#2)
laser vaporization##3##2##(1991-2#2)(1992-3#1)
laser was used as##2##4##(1990-11#1)(2008-2#1)
laser was used##3##3##(1990-11#1)(2008-10#1)(2008-2#1)
laser was##15##2##(1990-11#1)(1992-12#2)(2008-10#1)(2008-2#4)(2008-3#3)(2012-2#1)(2012-3#3)
laser wavelength##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
laser wavelengths##5##2##(2008-3#5)
laser were##2##2##(1991-2#1)(2008-10#1)
laser with a wavelength##2##4##(2008-3#2)
laser with a##16##3##(1996-11#1)(2008-10#1)(2008-2#3)(2008-3#11)
laser with an##4##3##(2008-2#1)(2008-3#3)
laser with external##2##3##(2008-2#1)(2008-3#1)
laser with the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
laser with##32##2##(1991-2#1)(1996-11#1)(2008-10#2)(2008-2#9)(2008-3#18)(2012-2#1)
laser##929##1##(1990-11#5)(1990-12#1)(1990-5#2)(1991-1#5)(1991-12#2)(1991-2#12)(1991-3#11)(1991-6#3)(1991-9#4)(1992-1#16)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#13)(1992-8#1)(1993-1#4)(1993-12#1)(1993-2#1)(1993-3#8)(1993-5#2)(1993-6#7)(1993-8#1)(1994-11#1)(1994-12#8)(1994-2#2)(1994-3#2)(1995-2#9)(1995-3#1)(1995-6#1)(1996-1#6)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#10)(2007-12#27)(2008-10#105)(2008-11#12)(2008-12#2)(2008-2#126)(2008-3#408)(2008-4#2)(2008-5#3)(2008-7#9)(2008-8#7)(2008-9#18)(2009-12#1)(2009-4#1)(2009-5#6)(2009-7#2)(2010-1#4)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2011-7#2)(2012-12#1)(2012-2#11)(2012-3#10)(2013-1#3)(2013-8#2)
laser's##5##1##(2008-10#1)(2008-3#4)
laser-assisted##3##1##(2008-10#1)(2012-3#2)
laser-backlit##2##1##(2008-3#2)
laser-based##6##1##(1992-3#1)(2008-10#3)(2008-3#1)(2010-1#1)
laser-capture microdissection##3##2##(2009-8#1)(2010-1#1)(2011-2#1)
laser-diode side-pumped solid-state##2##3##(2008-3#2)
laser-diode##5##1##(2007-11#1)(2008-3#4)
laser-excited time-resolved Shpol'skii spectrometry##3##4##(2008-10#3)
laser-excited##4##1##(1994-2#1)(2008-10#3)
laser-induced air optical breakdown##2##4##(2008-2#2)
laser-induced damage threshold##2##3##(2008-3#2)
laser-induced damage##4##2##(2008-3#4)
laser-induced fluorescence (LIF)##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
laser-induced fluorescence detector##2##3##(2008-10#2)
laser-induced fluorescence##21##2##(2008-10#10)(2008-2#2)(2008-3#9)
laser-induced fluorimetry##2##2##(2008-10#2)
laser-induced plasma##2##2##(2008-10#2)
laser-induced thermal acoustics##4##3##(2008-3#4)
laser-induced##42##1##(2008-10#17)(2008-2#5)(2008-3#19)(2008-8#1)
laser-tissue interaction##2##2##(1993-1#1)(2008-7#1)
laser-tissue##3##1##(1992-12#1)(1993-1#1)(2008-7#1)
laserlike emission##2##2##(2008-3#2)
lasers and##2##2##(1992-12#1)(2008-3#1)
lasers are##5##2##(2008-3#5)
lasers as a##2##3##(2008-3#1)(2012-3#1)
lasers at##3##2##(2008-2#1)(2008-3#2)
lasers based on##2##3##(2008-3#2)
lasers by##3##2##(2008-3#3)
lasers for##8##2##(1991-3#2)(1993-3#1)(2008-3#5)
lasers have##2##2##(1992-12#1)(2008-7#1)
lasers in a##2##3##(2008-3#2)
lasers in##6##2##(1993-3#2)(2008-10#1)(2008-2#1)(2008-3#2)
lasers is presented##2##3##(2008-2#1)(2008-3#1)
lasers is##5##2##(2008-2#1)(2008-3#3)(2008-9#1)
lasers that##2##2##(2008-3#2)
lasers to##5##2##(2008-3#5)
lasers with##8##2##(2007-11#1)(2007-12#1)(2008-3#6)
lasers##108##1##(1991-3#5)(1992-12#2)(1993-3#4)(2007-11#3)(2007-12#7)(2008-10#2)(2008-2#4)(2008-3#72)(2008-7#3)(2008-9#3)(2010-8#1)(2012-3#1)(2013-8#1)
lasing##8##1##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#2)
last 20 years##5##3##(1994-3#1)(2008-10#2)(2009-10#1)(2011-3#1)
last 20##9##2##(1992-6#1)(1994-12#2)(1994-3#1)(2008-10#2)(2008-8#1)(2009-10#1)(2011-3#1)
last 30##7##2##(1995-6#1)(2008-10#2)(2009-6#1)(2010-8#1)(2011-2#2)
last 6 years##3##3##(1996-9#1)(1997-4#1)(2007-8#1)
last case of##2##3##(1991-8#1)(1994-9#1)
last case##5##2##(1991-8#2)(1994-9#2)(2008-7#1)
last century##4##2##(2008-10#1)(2008-2#1)(2011-3#1)(2013-1#1)
last evaluation##2##2##(2008-7#1)(2011-2#1)
last exposure##2##2##(2008-10#2)
last fights##2##2##(2008-9#2)
last follow-up##2##2##(1997-3#1)(2008-10#1)
last in##2##2##(2008-11#1)(2008-4#1)
last injection##2##2##(1994-5#1)(2008-8#1)
last instar larvae##2##3##(1992-6#2)
last month##3##2##(1996-12#2)(2008-10#1)
last resort##3##2##(1997-2#1)(2008-8#1)(2010-10#1)
last section##2##2##(1992-6#1)(2011-2#1)
last two decades have##2##4##(2009-8#1)(2010-11#1)
last two decades##16##3##(1994-3#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
last two steps of##3##4##(1993-2#1)(2010-2#1)(2011-1#1)
last two##29##2##(1990-8#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
last word##2##2##(1993-12#1)(2008-11#1)
last year##4##2##(1993-8#1)(1994-2#1)(1996-5#1)(2008-10#1)
last years##10##2##(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#4)(2011-3#1)
last##369##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#7)(1990-8#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#7)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#6)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#3)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#2)(1995-12#4)(1995-2#2)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#3)(1997-7#4)(1997-8#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#49)(2008-11#18)(2008-12#8)(2008-2#1)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#4)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#31)(2011-3#7)(2012-12#2)(2012-2#10)(2012-3#7)(2012-7#1)(2013-1#11)(2013-8#2)
lasted at least##2##3##(2008-10#1)(2008-8#1)
lasted for about##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
lasted for one year##2##4##(1993-2#1)(2008-10#1)
lasted for##14##2##(1990-5#1)(1991-6#2)(1993-2#1)(1993-3#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2013-1#1)
lasted more than##3##3##(1990-12#1)(2008-9#2)
lasted on##2##2##(2008-6#1)(2012-3#1)
lasted##35##1##(1990-12#1)(1990-5#2)(1991-6#3)(1991-8#2)(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2012-12#1)(2012-3#1)(2013-1#2)
lasting effect##2##2##(1993-2#1)(2008-12#1)
lasting effects##2##2##(2008-11#1)(2013-8#1)
lasting for##5##2##(1991-5#2)(1996-9#1)(2008-10#1)(2013-1#1)
lasting##39##1##(1990-9#1)(1991-3#1)(1991-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
lastly##4##1##(1990-8#1)(1993-6#1)(2008-10#1)(2011-10#1)
lasts &gt##2##2##(2008-10#1)(2008-7#1)
lasts##6##1##(1991-11#1)(1991-12#1)(2008-10#1)(2008-7#2)(2009-5#1)
lata##14##1##(2008-10#12)(2009-3#1)(2011-2#1)
late 1990s##3##2##(1990-11#1)(2008-10#2)
late March##3##2##(2008-10#3)
late S##2##2##(1996-3#1)(2008-11#1)
late adolescence##4##2##(2008-11#2)(2009-7#2)
late as##3##2##(1992-12#1)(2008-5#1)(2008-7#1)
late blight developed in##2##4##(2008-10#2)
late blight epidemics##2##3##(2008-10#2)
late blight in the##2##4##(2008-10#2)
late blight in##7##3##(2008-10#7)
late blight of potato and tomato##2##6##(2008-10#2)
late blight of potato##3##4##(2008-10#3)
late blight of##6##3##(2008-10#6)
late blight pathogen##5##3##(2008-10#5)
late blight resistance##2##3##(2008-10#2)
late blight severity##4##3##(2008-10#4)
late blight##56##2##(2008-10#54)(2008-8#1)(2009-6#1)
late colonizers##3##2##(2008-5#3)
late complication of##2##3##(2008-12#1)(2012-2#1)
late complication##3##2##(2008-1#1)(2008-12#1)(2012-2#1)
late complications##3##2##(1993-9#1)(1995-12#1)(2011-3#1)
late effects##3##2##(2010-11#3)
late embryogenesis abundant##2##3##(2008-10#2)
late embryonic##2##2##(1996-12#1)(2008-11#1)
late events##2##2##(1994-5#1)(2007-12#1)
late exponential growth##2##3##(2008-11#1)(2011-2#1)
late fall##2##2##(2008-10#1)(2008-7#1)
late family formation##2##3##(2011-2#2)
late flowering##3##2##(2008-10#3)
late for##2##2##(2013-1#2)
late gene expression##4##3##(1997-3#4)
late gene transcription##2##3##(1997-3#2)
late gene##6##2##(1997-3#6)
late in life##2##3##(2008-10#1)(2010-2#1)
late in the growing season##2##5##(2008-10#2)
late in the##7##3##(2008-10#5)(2008-11#1)(2008-8#1)
late in##18##2##(1991-5#1)(1994-3#1)(1995-12#1)(1995-9#1)(2008-10#9)(2008-11#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)
late onset##2##2##(1991-6#1)(2010-11#1)
late phase of##4##3##(1990-6#2)(1995-12#1)(1995-6#1)
late phase##8##2##(1990-6#2)(1993-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(2008-11#1)(2010-8#1)
late phases##3##2##(2008-9#1)(2010-12#2)
late presentation##5##2##(2008-1#1)(2013-1#4)
late preterm infant##3##3##(2008-11#1)(2010-11#2)
late preterm##7##2##(2008-11#3)(2010-11#2)(2012-2#2)
late promoter##3##2##(1995-6#1)(1997-3#1)(2008-11#1)
late restenosis##2##2##(2006-6#2)
late season##4##2##(2008-10#4)
late spring##4##2##(2008-10#4)
late stage of##7##3##(1991-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
late stage##9##2##(1991-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
late stages of the HIV-1 replication cycle##3##7##(2011-3#3)
late stages of##11##3##(1994-12#1)(2008-10#3)(2008-5#1)(2009-5#1)(2011-3#3)(2012-2#1)(2012-3#1)
late stages##15##2##(1994-12#1)(2008-10#4)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-3#4)(2012-2#1)(2012-3#1)
late summer##3##2##(2008-10#3)
late vitellogenic##2##2##(2008-6#1)(2010-5#1)
late yolk sacs##2##3##(2007-12#2)
late##339##1##(1990-11#1)(1990-3#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#8)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#11)(1997-4#1)(1997-8#5)(2006-6#3)(2007-12#4)(2008-1#3)(2008-10#119)(2008-11#20)(2008-12#9)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#6)(2010-10#1)(2010-11#6)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#5)(2012-2#8)(2012-3#3)(2012-6#1)(2012-7#1)(2013-1#13)(2013-8#3)
late-LTP##2##1##(2008-7#1)(2009-6#1)
late-arising mutation##2##2##(2008-9#2)
late-arising##5##1##(2008-9#5)
late-maturing##2##1##(2008-10#2)
late-onset Alzheimer's disease##2##3##(2008-10#1)(2008-7#1)
late-onset##8##1##(1990-5#2)(2008-10#2)(2008-7#1)(2009-8#3)
late-season##6##1##(2008-10#5)(2011-2#1)
late-stage##5##1##(1997-1#1)(2008-11#1)(2010-12#3)
late-term##2##1##(1991-12#2)
lately##3##1##(1997-6#1)(2008-11#1)(2008-8#1)
latencies in##2##2##(1996-2#1)(2008-7#1)
latencies of##2##2##(1996-2#1)(2008-11#1)
latencies##11##1##(1993-3#1)(1996-2#6)(1996-6#1)(2008-11#1)(2008-7#1)(2013-8#1)
latency and##4##2##(2008-7#2)(2008-8#1)(2009-12#1)
latency for##3##2##(1996-2#1)(2008-11#2)
latency in the##2##3##(2008-7#1)(2012-12#1)
latency in##6##2##(2008-10#2)(2008-7#3)(2012-12#1)
latency of##2##2##(1993-3#1)(2013-8#1)
latency period##2##2##(2008-7#1)(2011-2#1)
latency responses##3##2##(1996-5#3)
latency time##3##2##(1995-2#1)(2008-5#2)
latency to immobility##2##3##(2008-11#2)
latency##49##1##(1990-8#1)(1993-3#1)(1995-2#2)(1996-2#4)(1996-5#4)(1997-1#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#7)(2008-8#1)(2009-12#1)(2010-7#1)(2010-8#3)(2011-2#4)(2012-12#5)(2013-1#1)(2013-8#1)
latent B##2##2##(2008-10#2)
latent EBV infection##2##3##(2010-6#2)
latent S##3##2##(2008-10#3)
latent and##2##2##(2008-10#1)(2008-5#1)
latent factors explaining##2##3##(2008-10#2)
latent factors##4##2##(2008-10#4)
latent finger##2##2##(2012-2#2)
latent form##2##2##(1990-2#1)(2008-12#1)
latent infection at##2##3##(2008-10#2)
latent infection in##2##3##(2008-10#2)
latent infection was##3##3##(2008-10#3)
latent infection##25##2##(2008-10#25)
latent infections in the##2##4##(1993-11#1)(2008-10#1)
latent infections##7##2##(1993-11#1)(2008-10#6)
latent inhibition##2##2##(2008-5#2)
latent period (LP)##2##3##(2008-10#2)
latent period for##2##3##(2008-10#2)
latent period of##2##3##(2008-10#2)
latent period was recorded##2##4##(2008-10#2)
latent period was##5##3##(2008-10#5)
latent period##34##2##(2008-10#34)
latent periods##4##2##(2008-10#2)(2008-8#2)
latent precursor##2##2##(2011-2#2)
latent variable##6##2##(2008-10#1)(2008-12#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-2#1)
latent virus##5##2##(2008-10#2)(2008-9#3)
latent##136##1##(1990-2#1)(1991-3#1)(1993-11#1)(1993-2#1)(1995-6#1)(1995-8#2)(1997-3#1)(2007-12#1)(2008-10#92)(2008-12#2)(2008-5#4)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-6#3)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#2)
latent-class##2##1##(2010-1#2)
latently infected##6##2##(2008-10#5)(2012-12#1)
later and##4##2##(1994-2#1)(2008-10#2)(2008-7#1)
later by##2##2##(2008-10#1)(2008-8#1)
later confirmed by##2##3##(2008-11#1)(2011-2#1)
later developed##2##2##(1991-12#1)(2008-11#1)
later development##2##2##(1996-11#1)(2013-1#1)
later developmental stages##2##3##(1997-7#1)(2008-10#1)
later examination##2##2##(1996-12#1)(2013-1#1)
later for##3##2##(2008-5#1)(2009-6#1)(2013-1#1)
later in life##6##3##(1991-6#1)(2008-10#3)(2010-11#1)(2010-6#1)
later in the course of##2##5##(2008-7#1)(2008-9#1)
later in the course##3##4##(1996-11#1)(2008-7#1)(2008-9#1)
later in the##11##3##(1996-11#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-6#1)
later in##22##2##(1991-6#1)(1994-3#1)(1995-2#1)(1996-11#1)(1997-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2012-6#1)(2013-1#1)
later of##2##2##(1994-6#1)(2008-10#1)
later revealed##2##2##(2008-12#1)(2013-8#1)
later stage of##3##3##(2008-11#1)(2008-8#1)(2010-1#1)
later stage##6##2##(2008-11#3)(2008-8#1)(2010-1#2)
later stages of##6##3##(1990-5#1)(1991-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2013-8#1)
later stages##11##2##(1990-5#1)(1991-12#1)(1993-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
later steps##3##2##(1997-7#2)(2011-2#1)
later than##5##2##(1995-9#1)(1996-3#1)(2008-10#2)(2008-11#1)
later the##6##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
later time points##3##3##(1993-11#1)(2008-8#1)(2009-11#1)
later time##5##2##(1991-12#1)(1993-11#2)(2008-8#1)(2009-11#1)
later to determine##2##3##(1994-3#1)(2010-12#1)
later to##5##2##(1990-9#1)(1992-12#1)(1994-3#1)(2008-10#1)(2010-12#1)
later used##2##2##(2008-10#1)(2008-8#1)
later with a##2##3##(1997-8#1)(2008-10#1)
later##306##1##(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-6#4)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#2)(1993-1#4)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-8#3)(1995-9#2)(1996-11#2)(1996-12#4)(1996-3#2)(1996-6#1)(1996-9#2)(1997-3#1)(1997-5#3)(1997-7#4)(1997-8#1)(2007-8#1)(2008-1#4)(2008-10#54)(2008-11#23)(2008-12#10)(2008-2#1)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#15)(2008-8#10)(2008-9#6)(2009-1#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#15)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#8)(2012-6#1)(2013-1#15)(2013-8#10)
later-inoculated##2##1##(2008-10#2)
lateral and##7##2##(1993-9#2)(1997-3#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
lateral ankle sprain##2##3##(2012-3#1)(2013-1#1)
lateral bending##5##2##(2012-12#1)(2013-1#4)
lateral branches##2##2##(2008-10#1)(2012-3#1)
lateral cells##2##2##(2007-12#1)(2008-10#1)
lateral chest##3##2##(1997-8#3)
lateral diffusion##4##2##(1994-5#1)(2007-12#1)(2008-7#2)
lateral discoid meniscus##2##3##(2013-1#2)
lateral discoid##3##2##(2013-1#3)
lateral dispersal##2##2##(2008-10#2)
lateral epicondylalgia##3##2##(2008-12#3)
lateral eyes##3##2##(1993-3#3)
lateral film##3##2##(1997-8#3)
lateral flow##2##2##(2008-10#2)
lateral hypothalamic ICSS##2##3##(1991-2#2)
lateral hypothalamic##6##2##(1991-2#3)(1993-6#2)(1994-2#1)
lateral hypothalamus##9##2##(1991-12#1)(1993-6#4)(1996-2#2)(2009-10#2)
lateral lobes##2##2##(2007-12#2)
lateral mass screw fixation##2##4##(2012-12#2)
lateral mass##3##2##(2012-12#2)(2012-3#1)
lateral mobility##2##2##(2008-7#2)
lateral modes##4##2##(2008-3#4)
lateral or medial##2##3##(1993-11#1)(1997-2#1)
lateral or##3##2##(1993-11#1)(1993-12#1)(1997-2#1)
lateral periodontal cyst##2##3##(2013-1#2)
lateral recess##7##2##(2011-2#5)(2013-1#2)
lateral regions of the##2##4##(1991-10#1)(1996-12#1)
lateral regions of##3##3##(1990-9#1)(1991-10#1)(1996-12#1)
lateral regions##4##2##(1990-9#1)(1991-10#1)(1996-12#1)(2008-11#1)
lateral resolution##5##2##(2007-12#1)(2008-10#1)(2008-3#2)(2010-3#1)
lateral root##2##2##(2008-8#2)
lateral roots##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
lateral sclerosis (ALS)##3##3##(2008-4#1)(2008-7#1)(2009-9#1)
lateral sclerosis##11##2##(1993-9#1)(1996-5#1)(2008-4#2)(2008-7#1)(2009-7#1)(2009-9#2)(2010-7#1)(2013-1#2)
lateral sensillum styloconicum##3##3##(2008-8#3)
lateral sinus##2##2##(2008-7#1)(2010-5#1)
lateral skull base##4##3##(2011-2#4)
lateral temporal##2##2##(2008-11#1)(2011-2#1)
lateral to the##3##3##(1991-12#1)(2008-7#1)(2012-3#1)
lateral ventricle##5##2##(1991-12#1)(2008-7#4)
lateral ventricles##2##2##(1991-8#1)(1995-5#1)
lateral wall of the##4##4##(2007-11#1)(2007-12#1)(2011-2#1)(2013-1#1)
lateral wall of##5##3##(2007-11#1)(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
lateral wall##7##2##(2007-11#1)(2007-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
lateral walls##2##2##(1991-6#1)(2008-10#1)
lateral##245##1##(1990-12#1)(1990-3#3)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#5)(1993-6#9)(1993-9#3)(1994-2#3)(1994-5#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#8)(1997-6#1)(1997-8#8)(2007-11#1)(2007-12#15)(2008-10#13)(2008-11#6)(2008-12#7)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#18)(2008-8#9)(2008-9#4)(2009-1#3)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#16)(2012-12#5)(2012-2#2)(2012-3#10)(2013-1#28)
lateralis##12##1##(2008-10#5)(2008-6#2)(2010-4#4)(2011-2#1)
laterality##4##1##(1994-8#3)(2010-5#1)
lateralization of##4##2##(2012-2#3)(2013-8#1)
lateralization on the##2##3##(1994-8#1)(1997-2#1)
lateralization on##3##2##(1994-8#1)(1995-5#1)(1997-2#1)
lateralization##11##1##(1994-8#2)(1995-5#1)(1997-2#3)(2009-9#1)(2012-2#3)(2013-8#1)
lateralized##2##1##(1994-8#1)(2009-10#1)
laterally based thenar flap##2##4##(2008-9#2)
laterally##11##1##(1993-3#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#3)(2009-9#2)
latest IAHSS survey##2##3##(1994-12#1)(1995-12#1)
latest findings##2##2##(1990-3#1)(2009-10#1)
latest##40##1##(1990-3#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-11#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-7#2)(2013-8#2)
latex 1##2##2##(2008-10#2)
latex agglutination##2##2##(1990-12#1)(2008-5#1)
latex and##2##2##(1990-9#1)(2011-2#1)
latex films##3##2##(2008-10#3)
latex particle##2##2##(1990-12#1)(2008-10#1)
latex particles were##2##3##(1990-12#1)(2008-10#1)
latex particles##8##2##(1990-12#2)(2008-10#3)(2010-6#3)
latex##35##1##(1990-12#9)(1990-9#1)(1996-12#1)(2008-10#13)(2008-11#1)(2008-3#3)(2008-5#2)(2008-9#1)(2010-6#3)(2011-2#1)
latexes##2##1##(2008-10#2)
lather creaminess##2##2##(2008-5#2)
lather##4##1##(2008-10#1)(2008-5#3)
lathyroides and##3##2##(2008-10#3)
lathyroides##5##1##(2008-10#5)
lathyroides)##2##1##(2008-10#2)
latipes##6##1##(2007-12#1)(2008-11#1)(2008-6#2)(2009-7#2)
latissimus dorsi flap##2##3##(1992-9#1)(2008-7#1)
latissimus dorsi myocutaneous##2##3##(1990-9#1)(1994-12#1)
latissimus dorsi##10##2##(1990-9#2)(1992-9#1)(1994-12#1)(2008-10#1)(2008-7#2)(2012-12#1)(2013-1#2)
latitude and##2##2##(2008-10#1)(2011-2#1)
latitude##10##1##(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
latitudinal positions##2##2##(2008-10#2)
latitudinal variation in##2##3##(2008-9#2)
latitudinal##7##1##(2008-10#3)(2008-9#3)(2010-8#1)
latter approach##2##2##(2008-10#1)(2012-2#1)
latter are##8##2##(1996-5#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)
latter being the##2##3##(2008-12#1)(2012-2#1)
latter being##7##2##(1992-2#1)(2008-12#2)(2008-8#1)(2012-2#2)(2013-1#1)
latter case##16##2##(1990-2#1)(1991-2#1)(1991-8#1)(1993-9#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-8#1)
latter category##2##2##(1996-2#1)(2008-12#1)
latter conditions##2##2##(1996-2#1)(2008-10#1)
latter effect##3##2##(1995-2#1)(1997-4#1)(2008-5#1)
latter group is##2##3##(2008-7#1)(2011-1#1)
latter group##7##2##(1991-12#1)(1992-5#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)
latter includes##2##2##(1996-9#1)(2008-7#1)
latter is a##2##3##(1997-7#1)(2008-10#1)
latter is not##4##3##(1991-2#1)(1995-8#1)(2008-10#1)(2009-8#1)
latter is##23##2##(1990-11#2)(1990-3#1)(1991-2#1)(1991-3#1)(1991-5#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-7#1)(2008-8#1)(2009-8#2)(2010-6#1)(2011-2#1)(2012-2#1)
latter may be##3##3##(1996-6#1)(1997-8#1)(2008-7#1)
latter may##6##2##(1993-11#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-7#1)
latter method##5##2##(2008-10#3)(2008-7#1)(2011-2#1)
latter of which##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
latter part##4##2##(1994-2#1)(2008-12#1)(2008-5#1)(2011-2#1)
latter samples##2##2##(2008-10#1)(2013-1#1)
latter systems##2##2##(2008-10#1)(2013-1#1)
latter technique##4##2##(2006-6#1)(2008-10#2)(2008-3#1)
latter three##3##2##(2008-10#2)(2009-3#1)
latter two##9##2##(2008-10#5)(2008-8#1)(2009-7#1)(2010-5#1)(2013-1#1)
latter was##7##2##(1992-12#1)(1994-11#1)(1995-2#1)(2008-10#2)(2012-2#1)(2013-1#1)
latter##274##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#3)(1997-8#4)(2006-6#1)(2008-1#2)(2008-10#79)(2008-11#12)(2008-12#7)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-2#11)(2012-3#1)(2012-6#1)(2013-1#7)(2013-8#2)
lattice and##2##2##(1992-4#1)(1996-12#1)
lattice parameters##3##2##(2008-10#2)(2013-8#1)
lattice##20##1##(1991-9#1)(1992-4#1)(1993-2#1)(1993-5#1)(1994-2#1)(1996-12#2)(2007-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
lattice-like##2##1##(1996-12#1)(2011-2#1)
launch of##3##2##(2010-5#1)(2010-8#2)
launch##8##1##(1996-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)(2010-8#2)
launched a##3##2##(1991-6#1)(1993-3#1)(2012-12#1)
launched by the##2##3##(1993-6#1)(2008-3#1)
launched in##5##2##(2008-3#1)(2008-5#2)(2008-6#1)(2012-12#1)
launched pump power##4##3##(2008-2#2)(2008-3#2)
launched##22##1##(1990-6#1)(1991-6#1)(1993-3#1)(1993-6#1)(2007-12#1)(2008-2#2)(2008-3#6)(2008-5#4)(2008-6#1)(2008-9#1)(2012-12#2)(2012-2#1)
launches##2##1##(1993-5#1)(1997-6#1)
launching a new##2##3##(1990-11#1)(1995-12#1)
launching a##3##2##(1990-11#1)(1994-12#1)(1995-12#1)
launching of##2##2##(1991-12#1)(2008-3#1)
launching##13##1##(1990-11#1)(1991-12#1)(1994-12#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#6)
laurentii##8##1##(2008-10#6)(2008-5#2)
lauric acid##5##2##(1991-9#1)(2008-10#4)
lauryl ether##7##2##(2008-10#3)(2008-5#4)
lauryl##12##1##(1992-12#1)(2008-10#4)(2008-5#7)
laurylether sulphate##2##2##(2008-5#2)
lavage and##3##2##(1991-12#1)(1996-12#2)
lavage fluid##5##2##(1990-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-5#1)
lavage in##4##2##(1990-2#2)(2008-5#1)(2008-8#1)
lavage was performed##2##3##(1990-2#1)(1995-11#1)
lavage was##4##2##(1990-2#2)(1995-11#1)(2010-7#1)
lavage##29##1##(1990-2#8)(1991-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-12#5)(2008-12#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-7#4)(2011-2#1)(2013-8#1)
lavender and rose oil##2##4##(2008-10#2)
lavender and rose##3##3##(2008-10#3)
lavender##5##1##(2008-10#5)
law and the##3##3##(1997-8#1)(2011-2#1)(2013-1#1)
law and##12##2##(1992-12#1)(1994-1#1)(1994-5#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#3)
law enforcement##4##2##(2008-1#1)(2008-10#1)(2013-8#2)
law firm##2##2##(1995-12#2)
law for##5##2##(1995-12#1)(2008-10#2)(2008-3#2)
law in the##9##3##(1997-8#1)(2008-10#8)
law in##10##2##(1996-5#1)(1997-8#1)(2008-10#8)
law is##32##2##(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#28)(2008-3#1)
law model##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
law of##4##2##(1993-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
law the##2##2##(1994-3#1)(1995-12#1)
law to##4##2##(1996-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
law was developed##2##3##(2008-10#2)
law was##21##2##(1997-8#1)(2008-10#18)(2008-8#2)
law with##5##2##(2008-10#2)(2008-8#2)(2009-10#1)
law##198##1##(1990-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#4)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#4)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#8)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#7)(2007-11#1)(2008-1#2)(2008-10#86)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#6)(2009-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#6)
law)##2##1##(1994-5#1)(2008-10#1)
law-enforcement##2##1##(2010-1#2)
lawns##2##1##(2008-11#1)(2008-9#1)
laws and##3##2##(1993-3#1)(1996-2#1)(2012-3#1)
laws or##2##2##(2008-11#1)(2008-8#1)
laws were##2##2##(1997-1#1)(2008-10#1)
laws##35##1##(1990-2#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-3#1)(1992-8#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#2)(2008-8#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
lawsuit filed by##3##3##(1995-12#2)(1996-5#1)
lawsuit was##2##2##(1993-12#1)(1996-5#1)
lawsuit##11##1##(1992-3#1)(1993-12#1)(1995-12#4)(1996-5#4)(2008-11#1)
lawsuits##7##1##(1992-2#1)(1993-12#1)(1995-6#1)(2008-11#4)
lax##3##1##(1995-6#1)(1996-5#1)(2008-11#1)
laxa is##2##2##(2008-7#2)
laxa##9##1##(2008-10#5)(2008-5#1)(2008-7#3)
lay eggs##2##2##(2008-12#1)(2013-1#1)
lay in the##3##3##(1997-7#1)(2008-10#2)
lay the##4##2##(2008-12#1)(2008-4#1)(2012-12#1)(2013-8#1)
lay##23##1##(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
layer 4##2##2##(2008-11#2)
layer IV and##2##3##(1997-2#1)(1997-3#1)
layer IV##3##2##(1997-2#1)(1997-3#2)
layer after##2##2##(2008-3#1)(2013-8#1)
layer and the output layer##4##5##(2010-8#4)
layer and the##8##3##(1991-6#1)(2008-10#2)(2008-3#1)(2010-8#4)
layer and##18##2##(1991-6#2)(1993-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-5#1)(2010-8#5)(2011-2#1)(2013-1#1)
layer at the##3##3##(2008-10#3)
layer at##4##2##(2008-10#4)
layer between##3##2##(1993-12#1)(2008-10#2)
layer by##4##2##(2008-10#3)(2013-8#1)
layer cells##2##2##(2008-11#2)
layer for##2##2##(1995-3#1)(2008-3#1)
layer have been##2##3##(2008-10#1)(2010-4#1)
layer in a##2##3##(2008-10#1)(2008-12#1)
layer in the##7##3##(1991-5#5)(2009-5#1)(2011-2#1)
layer in##10##2##(1991-5#5)(2008-10#2)(2008-12#1)(2009-5#1)(2011-2#1)
layer is##8##2##(2008-10#5)(2008-3#1)(2008-6#1)(2013-8#1)
layer of Nafion(R)##2##3##(2008-10#2)
layer of compact osmiophilic material##2##5##(2008-10#2)
layer of medium electron density##2##5##(2008-12#2)
layer of sclerites##2##3##(2008-7#2)
layer of the skin##2##4##(2008-5#2)
layer of the##22##3##(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-12#4)(2008-5#3)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#3)(2013-8#1)
layer of##63##2##(1993-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#27)(2008-12#7)(2008-3#2)(2008-5#8)(2008-7#4)(2009-9#1)(2010-4#1)(2010-6#1)(2011-2#5)(2013-1#1)(2013-8#1)
layer on the surface of##2##5##(2008-10#2)
layer on the##7##3##(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)
layer on##13##2##(2008-10#7)(2008-12#1)(2008-5#3)(2008-6#1)(2009-5#1)
layer over the##2##3##(1996-1#1)(2012-12#1)
layer over##3##2##(1996-1#1)(2008-2#1)(2012-12#1)
layer that##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
layer thickness##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2009-5#1)
layer titration##3##2##(2008-10#3)
layer to the##2##3##(2008-10#1)(2008-7#1)
layer to##12##2##(2008-10#8)(2008-7#2)(2010-4#1)(2013-8#1)
layer was##15##2##(1990-12#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#2)(2013-8#1)
layer with##8##2##(1994-8#1)(2008-10#5)(2009-5#2)
layer##392##1##(1990-12#1)(1991-10#5)(1991-2#1)(1991-5#5)(1991-6#3)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#4)(1993-8#1)(1994-2#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#2)(2006-6#1)(2007-12#2)(2008-10#171)(2008-11#17)(2008-12#17)(2008-2#2)(2008-3#26)(2008-4#1)(2008-5#25)(2008-6#2)(2008-7#7)(2008-9#4)(2009-11#3)(2009-5#13)(2009-8#2)(2009-9#1)(2010-1#1)(2010-4#5)(2010-6#1)(2010-8#13)(2011-2#13)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#10)
layer-by-layer (LBL)##3##2##(2008-10#3)
layer-by-layer self-assembly##3##2##(2008-10#3)
layer-by-layer##12##1##(2008-10#11)(2010-9#1)
layered double##2##2##(2010-4#2)
layered manufacturing##2##2##(2009-7#2)
layered on the##2##3##(1997-1#1)(2008-9#1)
layered##19##1##(1993-2#1)(1994-9#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-7#3)(2010-4#2)
layers II to VI##2##4##(1994-2#2)
layers II##6##2##(1994-2#5)(1997-2#1)
layers and##13##2##(1995-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
layers by##2##2##(1990-11#1)(2008-10#1)
layers in the##4##3##(1991-5#1)(1992-9#1)(2008-10#1)(2008-3#1)
layers in##5##2##(1991-5#1)(1992-9#1)(2008-10#2)(2008-3#1)
layers is presented##2##3##(2008-10#1)(2008-3#1)
layers is##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
layers of a##2##3##(2008-10#1)(2008-3#1)
layers of iron(III) tetra-(N-methyl-4-pyridyl)-porphyrin##2##4##(2008-10#2)
layers of the epidermis##2##4##(1994-5#1)(2008-5#1)
layers of the skin##2##4##(2008-10#1)(2008-11#1)
layers of the stratum corneum##3##5##(2008-5#3)
layers of the##18##3##(1990-5#1)(1994-5#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
layers of##53##2##(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#16)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#5)(2008-7#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#4)(2012-12#1)(2013-1#1)
layers on the##2##3##(2008-10#2)
layers on##5##2##(2008-10#5)
layers only##2##2##(2008-5#1)(2012-2#1)
layers that##2##2##(2008-10#2)
layers the##2##2##(1992-9#1)(2008-10#1)
layers to##5##2##(2008-10#4)(2008-7#1)
layers were##11##2##(2008-10#7)(2008-12#2)(2008-3#1)(2008-9#1)
layers with##4##2##(2008-12#1)(2008-3#2)(2009-7#1)
layers##203##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-8#1)(1992-9#3)(1993-11#1)(1994-11#1)(1994-2#9)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1997-2#5)(1997-3#3)(1997-4#1)(2008-10#70)(2008-11#12)(2008-12#11)(2008-2#1)(2008-3#20)(2008-5#16)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#2)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
laying##6##1##(2007-12#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)
laymen##2##1##(2008-5#2)
layout##11##1##(1993-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-10#2)(2009-6#1)(2010-12#1)
layouts of##2##2##(2008-10#1)(2009-10#1)
lays out##2##2##(1997-3#1)(2012-3#1)
lays##6##1##(1995-12#1)(1997-3#1)(2008-11#1)(2008-9#1)(2010-8#1)(2012-3#1)
laziness were the##2##3##(1991-6#1)(1992-2#1)
le 3ème trimestre##2##3##(2013-1#2)
le arning##2##2##(2008-11#2)
le cas##5##2##(2011-2#1)(2013-1#4)
le plus souvent##3##3##(2011-2#2)(2013-1#1)
le pronostic##2##2##(2011-2#1)(2013-1#1)
le risque##2##2##(2013-1#2)
le syndrome de sevrage##2##4##(2013-1#2)
le##41##1##(2008-11#4)(2011-2#7)(2011-3#1)(2013-1#29)
leach from##4##2##(2008-10#4)
leachability##2##1##(2008-10#2)
leachable and total metals in##3##5##(2008-10#3)
leachable and total##4##3##(2008-10#4)
leachant##2##1##(2008-10#2)
leachates and##3##2##(2008-10#3)
leachates by##2##2##(2008-10#2)
leachates##14##1##(2008-10#14)
leached with##2##2##(2008-10#2)
leached##6##1##(2008-10#5)(2011-1#1)
leaching and##3##2##(2008-10#2)(2008-11#1)
leaching behaviour##2##2##(2008-10#2)
leaching method was##2##3##(2008-10#2)
leaching method##4##2##(2008-10#4)
leaching of the##2##3##(2008-10#2)
leaching of##10##2##(2008-10#10)
leaching procedures##2##2##(2008-10#2)
leaching process##2##2##(2008-10#2)
leaching solutions##2##2##(2008-10#2)
leaching with##3##2##(2008-10#3)
leaching##51##1##(2008-10#46)(2008-11#3)(2008-5#1)(2011-2#1)
lead (II) ions##2##3##(2008-10#2)
lead (II)##10##2##(2008-10#10)
lead (Pb)##4##2##(2008-10#4)
lead a##4##2##(1994-12#1)(1994-9#1)(2008-10#1)(2013-8#1)
lead an##2##2##(1997-1#1)(2009-6#1)
lead and cadmium##7##3##(2008-10#7)
lead and chromium(VI)##2##3##(2008-10#2)
lead and copper##6##3##(2008-10#6)
lead and mercury##5##3##(2008-10#3)(2009-12#1)(2013-1#1)
lead and nickel in##2##4##(2008-10#2)
lead and nickel##7##3##(2008-10#7)
lead and thallium##3##3##(2008-10#3)
lead and zinc in##2##4##(2008-10#2)
lead and zinc##6##3##(2008-10#6)
lead and##50##2##(1996-3#1)(1996-5#1)(2008-10#46)(2009-12#1)(2013-1#1)
lead are##2##2##(2008-10#2)
lead by##6##2##(2008-10#6)
lead can be##2##3##(2008-10#2)
lead coffin##2##2##(2008-10#2)
lead complex##3##2##(2008-10#3)
lead compound##3##2##(1992-12#1)(2008-11#1)(2011-3#1)
lead concentration in##2##3##(2008-10#2)
lead concentration of##3##3##(2008-10#3)
lead concentration##11##2##(1992-12#3)(2008-10#8)
lead content##4##2##(2008-10#4)
lead determination in##4##3##(2008-10#4)
lead determination was##2##3##(2008-10#2)
lead determination##12##2##(2008-10#12)
lead determined##2##2##(2008-10#2)
lead electrode##2##2##(2008-10#2)
lead free##3##2##(2009-5#3)
lead from water##3##3##(2011-2#3)
lead from##5##2##(1992-12#1)(2008-10#1)(2011-2#3)
lead in biological samples##2##4##(2008-10#2)
lead in biological##3##3##(2008-10#3)
lead in blood is##2##4##(2008-10#2)
lead in blood##3##3##(2008-10#3)
lead in drinking water##3##4##(2008-10#3)
lead in human##4##3##(2008-10#3)(2012-9#1)
lead in several samples##2##4##(2008-10#2)
lead in several##3##3##(2008-10#3)
lead in water samples##4##4##(2008-10#4)
lead in water##9##3##(2008-10#9)
lead in##88##2##(1992-12#2)(2008-10#85)(2012-9#1)
lead ion##5##2##(2008-10#5)
lead ions##4##2##(2008-10#4)
lead is##5##2##(2008-10#5)
lead level##3##2##(1992-12#1)(2008-10#2)
lead nitrate##2##2##(2008-11#2)
lead nurses##2##2##(2008-11#2)
lead optimization##2##2##(2008-10#1)(2010-11#1)
lead reacts with##3##3##(2008-10#3)
lead salts##5##2##(2008-10#5)
lead the##3##2##(1991-2#1)(2009-6#1)(2009-7#1)
lead time bias##2##3##(1990-8#1)(1992-2#1)
lead to a better understanding of##2##6##(2008-11#1)(2009-12#1)
lead to a better##4##4##(2008-11#1)(2009-12#1)(2011-2#2)
lead to a decrease in##2##5##(2008-10#2)
lead to a decrease##3##4##(2008-10#2)(2010-1#1)
lead to a more##2##4##(1990-3#1)(2008-10#1)
lead to a reduction##2##4##(2008-10#1)(2013-8#1)
lead to a significant##2##4##(2008-10#1)(2009-11#1)
lead to a##38##3##(1990-11#1)(1990-3#1)(1990-8#1)(1997-1#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-1#2)(2010-10#1)(2010-7#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
lead to advances in##2##4##(2008-11#1)(2013-8#1)
lead to adverse##2##3##(2008-11#2)
lead to altered##2##3##(2008-7#1)(2011-10#1)
lead to an improvement##2##4##(1990-2#1)(2008-2#1)
lead to an increase of##2##5##(2008-11#1)(2009-11#1)
lead to an increase##3##4##(2008-11#2)(2009-11#1)
lead to an##13##3##(1990-2#1)(1995-3#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2013-1#1)
lead to better##5##3##(1993-2#1)(2008-11#1)(2008-9#1)(2010-10#1)(2012-12#1)
lead to changes in##2##4##(1997-1#1)(2008-11#1)
lead to chronic##4##3##(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
lead to death##2##3##(1997-8#1)(2011-2#1)
lead to different##2##3##(2008-4#2)
lead to disease##2##3##(2008-10#1)(2008-7#1)
lead to enhanced AChE activity##2##5##(2008-11#2)
lead to enhanced##3##3##(2008-11#2)(2008-5#1)
lead to evolution##2##3##(2012-3#2)
lead to greater##5##3##(2008-10#2)(2009-7#1)(2011-2#2)
lead to higher##4##3##(1992-11#1)(1993-3#1)(2008-10#1)(2008-9#1)
lead to improved##4##3##(2008-10#1)(2008-3#1)(2011-10#1)(2011-2#1)
lead to increased##8##3##(1992-4#1)(1994-11#1)(2008-3#1)(2010-11#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
lead to large##2##3##(2008-10#1)(2010-6#1)
lead to loss of##2##4##(2008-9#1)(2012-3#1)
lead to loss##3##3##(2008-9#1)(2010-10#1)(2012-3#1)
lead to more effective##2##4##(1997-2#1)(2008-10#1)
lead to more##6##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#2)(2013-1#1)
lead to new##8##3##(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2012-2#2)(2013-8#1)
lead to optimal##2##3##(2008-8#1)(2013-8#1)
lead to serious##4##3##(1997-1#1)(2008-10#2)(2009-9#1)
lead to significant##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
lead to symptoms##3##3##(1992-1#1)(1997-3#1)(2013-1#1)
lead to the development of##5##5##(2008-1#1)(2008-10#2)(2011-2#1)(2012-3#1)
lead to the development##7##4##(2008-1#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)
lead to the expression of##3##5##(1996-12#1)(2008-5#1)(2009-8#1)
lead to the formation of##3##5##(2008-10#1)(2008-12#1)(2011-2#1)
lead to the formation##4##4##(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
lead to the identification of##3##5##(2008-10#1)(2008-11#1)(2009-4#1)
lead to the most##2##4##(2008-10#1)(2010-2#1)
lead to the preferential##2##4##(2008-11#2)
lead to the##60##3##(1991-6#1)(1992-2#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#9)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
lead to this##2##3##(2008-5#1)(2011-2#1)
lead to treatment failure##2##4##(2009-7#1)(2013-8#1)
lead to very##3##3##(1997-6#1)(2012-12#1)(2012-2#1)
lead to##358##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#57)(2008-11#37)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#17)(2008-6#1)(2008-7#14)(2008-8#14)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#4)(2010-9#2)(2011-1#1)(2011-10#2)(2011-2#33)(2011-3#1)(2012-12#9)(2012-2#10)(2012-3#11)(2013-1#12)(2013-7#1)(2013-8#12)
lead us to conclude##2##4##(2008-10#2)
lead us to##7##3##(1993-3#1)(1994-3#1)(2008-10#4)(2008-7#1)
lead us##8##2##(1993-3#1)(1994-3#1)(2008-10#4)(2008-7#1)(2012-3#1)
lead using##3##2##(2008-10#3)
lead was##8##2##(2008-10#7)(2011-2#1)
lead were##5##2##(2008-10#5)
lead white##2##2##(2008-10#2)
lead with##8##2##(2008-10#8)
lead##785##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#8)(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#412)(2008-11#44)(2008-12#6)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#18)(2008-6#1)(2008-7#15)(2008-8#15)(2008-9#15)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#5)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#6)(2010-10#5)(2010-11#4)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-10#2)(2011-2#37)(2011-3#2)(2012-12#9)(2012-2#10)(2012-3#12)(2012-9#1)(2013-1#15)(2013-7#1)(2013-8#13)
lead(II) and cadmium(II)##5##3##(2008-10#5)
lead(II) and##7##2##(2008-10#7)
lead(II) by##2##2##(2008-10#2)
lead(II) in natural water samples##2##5##(2008-10#2)
lead(II) in##7##2##(2008-10#7)
lead(II) ions##2##2##(2008-10#2)
lead(II)##52##1##(2008-10#52)
lead)##3##1##(2008-10#3)
leader RNA##2##2##(2008-8#2)
leader and trailer##2##3##(2008-8#2)
leader and##4##2##(2008-8#3)(2012-2#1)
leader in##3##2##(1994-1#1)(1995-1#1)(2008-11#1)
leader of the##3##3##(1991-10#1)(1992-5#1)(1996-1#1)
leader region of##3##3##(1991-9#1)(2008-9#2)
leader region##4##2##(1991-9#1)(2008-8#1)(2008-9#2)
leader sequence and a##2##4##(1991-10#1)(1993-6#1)
leader sequence and##3##3##(1991-10#1)(1993-6#2)
leader sequence of the##2##4##(1991-10#1)(2008-9#1)
leader sequence of##3##3##(1991-10#2)(2008-9#1)
leader sequence##10##2##(1991-10#4)(1993-6#3)(2008-10#1)(2008-7#1)(2008-9#1)
leader sequences##2##2##(1997-3#1)(2008-8#1)
leader##41##1##(1991-10#5)(1991-9#4)(1992-5#2)(1993-1#1)(1993-12#2)(1993-6#3)(1994-1#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#8)(2008-9#3)(2012-2#1)
leaders and##3##2##(1993-12#1)(1996-3#1)(2010-11#1)
leaders are##2##2##(1992-1#1)(1997-1#1)
leaders as##2##2##(1996-1#1)(2010-10#1)
leaders can##3##2##(1994-12#1)(1996-3#1)(1997-1#1)
leaders in##2##2##(1993-12#1)(1996-9#1)
leaders must##2##2##(1993-2#1)(1997-3#1)
leaders of the##2##3##(1994-1#1)(2012-2#1)
leaders of##3##2##(1994-1#1)(1994-2#1)(2012-2#1)
leaders should take##2##3##(1994-1#2)
leaders to##3##2##(1997-2#1)(2008-6#1)(2009-3#1)
leaders will be##2##3##(1993-12#2)
leaders will##3##2##(1993-12#2)(2008-1#1)
leaders##53##1##(1991-2#1)(1992-1#4)(1992-5#2)(1993-12#6)(1993-2#1)(1994-1#6)(1994-12#2)(1994-2#2)(1996-1#2)(1996-3#3)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(2008-1#1)(2008-11#2)(2008-6#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-8#2)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
leadership and management##2##3##(1996-3#1)(2008-11#1)
leadership and##8##2##(1991-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-11#3)(2008-6#1)
leadership can##2##2##(1994-1#1)(1994-2#1)
leadership development##3##2##(1995-12#1)(1996-1#1)(2008-12#1)
leadership in an##2##3##(1993-12#1)(1994-2#1)
leadership in the##5##3##(1994-2#2)(1996-3#1)(2008-12#1)(2008-6#1)
leadership in##10##2##(1992-1#1)(1993-12#1)(1994-2#3)(1996-3#3)(2008-12#1)(2008-6#1)
leadership is##2##2##(1991-2#1)(2009-5#1)
leadership qualities##2##2##(1990-12#1)(1993-12#1)
leadership style##4##2##(1992-2#4)
leadership##88##1##(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#5)(1992-5#2)(1993-12#7)(1993-3#1)(1994-1#8)(1994-12#2)(1994-2#5)(1994-3#3)(1995-1#2)(1995-12#1)(1996-1#6)(1996-3#7)(1997-1#3)(1997-2#2)(1997-3#2)(2008-10#1)(2008-11#6)(2008-12#5)(2008-6#4)(2009-5#1)(2010-1#1)(2010-10#2)(2010-8#1)(2013-1#3)
leading cause of death and##2##5##(1995-11#1)(2008-10#1)
leading cause of death in##3##5##(1995-2#1)(2010-10#1)(2012-2#1)
leading cause of death worldwide##2##5##(2011-2#1)(2013-8#1)
leading cause of death##10##4##(1990-6#1)(1995-11#1)(1995-2#1)(1997-1#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
leading cause of##28##3##(1990-6#1)(1993-3#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-1#3)(2008-10#1)(2008-12#1)(2010-10#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
leading causes of death##2##4##(2008-10#1)(2012-3#1)
leading causes of##8##3##(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-3#1)
leading edges stimulated an ETR under##3##6##(2011-2#3)
leading edges stimulated an ETR##4##5##(2011-2#4)
leading electrolyte##2##2##(2008-10#2)
leading experts##2##2##(2008-8#1)(2012-2#1)
leading risk factor##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
leading the##5##2##(1996-5#1)(1997-1#1)(2008-11#1)(2008-9#1)(2009-4#1)
leading to a better##2##4##(2008-10#1)(2008-11#1)
leading to a decrease##2##4##(2008-10#2)
leading to a##33##3##(1993-8#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-8#1)
leading to an increased##2##4##(1995-6#1)(1995-8#1)
leading to an##6##3##(1995-6#1)(1995-8#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-7#1)
leading to better##2##3##(2011-2#1)(2012-3#1)
leading to different levels of##2##5##(2008-10#1)(2008-11#1)
leading to different##4##3##(2008-10#2)(2008-11#2)
leading to functional selectivity in##2##5##(2009-12#2)
leading to greater##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
leading to higher##3##3##(2008-8#1)(2011-7#1)(2013-1#1)
leading to increased##8##3##(1995-12#1)(2010-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
leading to inhibition of##3##4##(1994-12#1)(2009-8#1)(2013-1#1)
leading to low##2##3##(2008-10#1)(2009-9#1)
leading to more##3##3##(2008-10#2)(2012-3#1)
leading to no##2##3##(1991-6#1)(2012-3#1)
leading to pulmonary##2##3##(2008-12#1)(2011-2#1)
leading to sustained##2##3##(2011-2#1)(2013-1#1)
leading to the development of##2##5##(1994-8#1)(2008-9#1)
leading to the formation of##2##5##(2008-10#1)(2008-11#1)
leading to the##49##3##(1990-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-6#2)(1996-5#1)(1996-9#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-8#2)
leading to their##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
leading to this##2##3##(2008-11#1)(2009-12#1)
leading to two##2##3##(2008-10#2)
leading to##264##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#1)(2008-1#2)(2008-10#51)(2008-11#27)(2008-12#7)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#3)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#17)(2011-7#1)(2012-12#4)(2012-2#8)(2012-3#13)(2012-5#1)(2013-1#13)(2013-7#2)(2013-8#6)
leading us to##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
leading##367##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#5)(1997-7#2)(2007-12#1)(2008-1#7)(2008-10#62)(2008-11#33)(2008-12#10)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#13)(2008-9#4)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#37)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#11)(2012-3#16)(2012-5#1)(2013-1#18)(2013-7#2)(2013-8#8)
leads and##3##2##(1993-1#1)(2008-12#1)(2009-10#1)
leads to a decrease in the##2##6##(1992-8#1)(2008-3#1)
leads to a decrease in##3##5##(1992-8#1)(2008-3#1)(2013-1#1)
leads to a decrease##4##4##(1992-8#1)(2008-3#1)(2008-7#1)(2013-1#1)
leads to a high##3##4##(2008-10#2)(2010-12#1)
leads to a higher##2##4##(2010-7#1)(2013-1#1)
leads to a large##2##4##(2008-10#1)(2008-3#1)
leads to a reduction in the##2##6##(1995-5#1)(2008-3#1)
leads to a reduction in##3##5##(1995-5#1)(2008-3#2)
leads to a##39##3##(1991-3#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-5#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2013-1#3)(2013-8#1)
leads to activation of##3##4##(1992-6#1)(1994-6#1)(2008-12#1)
leads to an improved anti-fouling ability against##2##7##(2008-10#2)
leads to an improved##3##4##(2008-10#2)(2008-5#1)
leads to an increase in the##2##6##(1990-5#1)(2009-8#1)
leads to an increase in##3##5##(1990-5#1)(2008-10#1)(2009-8#1)
leads to an increased##2##4##(1995-6#1)(1997-6#1)
leads to an##16##3##(1990-5#1)(1991-3#1)(1992-1#1)(1995-6#1)(1997-6#1)(2008-10#6)(2008-3#1)(2008-5#2)(2009-8#1)(2011-3#1)
leads to cell death##2##4##(2008-11#1)(2012-2#1)
leads to cell##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
leads to confusion##2##3##(1991-2#1)(2013-1#1)
leads to different##2##3##(2008-10#1)(2008-3#1)
leads to failure of##2##4##(2009-8#1)(2012-3#1)
leads to high##2##3##(2008-11#1)(2008-7#1)
leads to higher##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
leads to increased##9##3##(1995-2#2)(1996-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2013-1#1)
leads to reduced##2##3##(2008-5#1)(2008-8#1)
leads to reductions in##2##4##(1995-2#1)(2008-4#1)
leads to significant##3##3##(2009-12#1)(2011-3#1)(2013-1#1)
leads to the accumulation of##3##5##(1995-2#1)(2009-7#1)(2012-3#1)
leads to the activation of##3##5##(1993-12#1)(1994-6#1)(1995-6#1)
leads to the conclusion that##2##5##(1992-3#1)(2011-2#1)
leads to the formation of##4##5##(1996-5#1)(2008-10#3)
leads to the##29##3##(1990-5#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-2#2)(1995-6#2)(1996-5#2)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
leads to transient##2##3##(2008-7#1)(2011-1#1)
leads to tumor##2##3##(2011-2#1)(2013-1#1)
leads to very##3##3##(2008-10#1)(2008-4#2)
leads to##229##2##(1990-2#1)(1990-5#2)(1991-2#1)(1991-3#3)(1992-1#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-12#1)(1995-2#8)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#6)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#32)(2008-11#11)(2008-12#2)(2008-3#15)(2008-4#5)(2008-5#5)(2008-7#13)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#1)(2009-6#3)(2009-7#2)(2009-8#5)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#4)(2010-7#2)(2011-1#3)(2011-2#7)(2011-3#3)(2011-9#1)(2012-2#3)(2012-3#10)(2013-1#14)(2013-8#3)
leads us to##3##3##(1994-8#1)(2008-5#1)(2010-6#1)
leads##250##1##(1990-2#1)(1990-5#2)(1991-2#1)(1991-3#3)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-12#1)(1995-2#8)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#6)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#34)(2008-11#12)(2008-12#5)(2008-3#16)(2008-4#5)(2008-5#6)(2008-7#13)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#3)(2009-12#1)(2009-6#3)(2009-7#2)(2009-8#6)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#9)(2011-3#4)(2011-9#1)(2012-2#4)(2012-3#11)(2013-1#14)(2013-8#3)
leaf (or##2##2##(2008-10#2)
leaf N and NSC##3##4##(2012-5#3)
leaf age##8##2##(2008-10#8)
leaf and plant##2##3##(2008-10#2)
leaf and pod##2##3##(2008-10#1)(2013-8#1)
leaf and root##3##3##(2008-10#1)(2010-11#2)
leaf and shoot##2##3##(2008-10#2)
leaf and stem##3##3##(2008-10#3)
leaf and stripe rust##2##4##(2008-10#2)
leaf and##27##2##(1993-2#1)(2008-10#19)(2008-8#1)(2008-9#2)(2010-11#2)(2011-2#1)(2013-8#1)
leaf area covered by##2##4##(2008-10#2)
leaf area was##2##3##(2008-10#2)
leaf area##27##2##(2008-10#24)(2008-8#1)(2008-9#1)(2012-5#1)
leaf at##2##2##(2008-10#2)
leaf bases##2##2##(2008-10#2)
leaf blade##2##2##(2008-10#2)
leaf blades##3##2##(2008-10#3)
leaf blast lesions##2##3##(2008-10#2)
leaf blast##9##2##(2008-10#9)
leaf blight (caused by##2##4##(2008-10#2)
leaf blight and leaf spot##2##5##(2008-10#2)
leaf blight and##3##3##(2008-10#3)
leaf blight in##3##3##(2008-10#3)
leaf blight of carrot##2##4##(2008-10#2)
leaf blight of##4##3##(2008-10#4)
leaf blight on##2##3##(2008-10#2)
leaf blight symptoms##2##3##(2008-10#2)
leaf blight##31##2##(2008-10#31)
leaf blotch resistance##2##3##(2008-10#2)
leaf blotch##12##2##(2008-10#12)
leaf cell##2##2##(2008-10#2)
leaf chlorophyll##2##2##(2008-12#1)(2012-9#1)
leaf colonization in##3##3##(2008-10#3)
leaf colonization##7##2##(2008-10#7)
leaf crumple virus##2##3##(2008-10#2)
leaf crumple##3##2##(2008-10#3)
leaf curl Bangladesh virus##2##4##(2008-10#2)
leaf curl disease##3##3##(2008-10#3)
leaf curl symptoms in tomato plants##3##6##(2008-10#3)
leaf curl symptoms in tomato##4##5##(2008-10#4)
leaf curl symptoms in##5##4##(2008-10#5)
leaf curl symptoms##7##3##(2008-10#7)
leaf curl virus in##2##4##(2008-10#1)(2008-9#1)
leaf curl virus##28##3##(2008-10#26)(2008-9#2)
leaf curl##65##2##(2008-10#63)(2008-9#2)
leaf development##3##2##(2008-10#1)(2009-6#1)(2009-8#1)
leaf discs of##3##3##(2008-10#2)(2008-7#1)
leaf discs##4##2##(2008-10#2)(2008-7#1)(2013-8#1)
leaf disease##2##2##(2008-10#2)
leaf disk##2##2##(2008-10#2)
leaf disks colonized)##2##3##(2008-10#2)
leaf disks in##2##3##(2008-10#2)
leaf disks of##2##3##(2008-10#2)
leaf disks were##2##3##(2008-10#2)
leaf disks##18##2##(2008-10#18)
leaf drop##2##2##(2008-10#2)
leaf extract##3##2##(2008-10#3)
leaf extracts##9##2##(2008-10#8)(2010-3#1)
leaf hairs##3##2##(2008-10#3)
leaf has##2##2##(2008-9#1)(2009-6#1)
leaf in##3##2##(2008-10#3)
leaf infection by##2##3##(2008-10#2)
leaf infection##7##2##(2008-10#7)
leaf inoculation##2##2##(2008-10#2)
leaf lesions##7##2##(2008-10#7)
leaf level##2##2##(2008-10#2)
leaf litter##9##2##(2008-10#5)(2008-8#2)(2010-3#2)
leaf luteovirus##2##2##(2008-10#2)
leaf material##2##2##(2008-10#2)
leaf mesophyll##2##2##(2008-10#2)
leaf mold##6##2##(2008-12#6)
leaf nitrogen (N)##2##3##(2012-5#1)(2012-9#1)
leaf nitrogen content##2##3##(2008-10#2)
leaf nitrogen##6##2##(2008-10#3)(2012-5#2)(2012-9#1)
leaf of##4##2##(1994-8#1)(2008-10#1)(2008-8#2)
leaf or##2##2##(2008-10#1)(2008-9#1)
leaf pathogen##2##2##(2008-10#2)
leaf pathogens##2##2##(2008-10#1)(2010-3#1)
leaf petioles##2##2##(2008-10#2)
leaf phenolics##2##2##(2008-11#2)
leaf position##3##2##(2008-10#3)
leaf rot##2##2##(2008-10#2)
leaf rust and stripe rust##5##5##(2008-10#5)
leaf rust and##8##3##(2008-10#8)
leaf rust caused by Melampsora medusae##2##6##(2008-10#2)
leaf rust caused by##3##4##(2008-10#3)
leaf rust in##5##3##(2008-10#5)
leaf rust isolates##4##3##(2008-10#4)
leaf rust resistance gene##6##4##(2008-10#6)
leaf rust resistance genes##8##4##(2008-10#8)
leaf rust resistance##21##3##(2008-10#21)
leaf rust severity and##2##4##(2008-10#2)
leaf rust severity as##2##4##(2008-10#2)
leaf rust severity##5##3##(2008-10#5)
leaf rust than tan spot##2##5##(2008-10#2)
leaf rust uredospore production##2##4##(2008-10#2)
leaf rust##73##2##(2008-10#73)
leaf rust-susceptible##2##2##(2008-10#2)
leaf samples##10##2##(2008-10#8)(2008-12#2)
leaf scab and##2##3##(2008-10#2)
leaf scald##2##2##(2008-10#2)
leaf scale##3##2##(2008-10#3)
leaf scorch##2##2##(2008-10#2)
leaf segments incubated in##2##4##(2008-10#2)
leaf segments##6##2##(2008-10#6)
leaf shape##2##2##(2009-5#2)
leaf sheath##5##2##(2008-10#5)
leaf size##4##2##(2008-9#2)(2012-9#2)
leaf soil##2##2##(2008-11#2)
leaf spot (CLS)##2##3##(2008-10#1)(2012-3#1)
leaf spot (GLS)##3##3##(2008-10#3)
leaf spot development##5##3##(2008-10#5)
leaf spot disease##8##3##(2008-10#7)(2010-3#1)
leaf spot epidemics##5##3##(2008-10#5)
leaf spot in##3##3##(2008-10#3)
leaf spot incidence##2##3##(2008-10#2)
leaf spot is##4##3##(2008-10#4)
leaf spot isolates were##4##4##(2008-10#4)
leaf spot isolates##5##3##(2008-10#5)
leaf spot of perennial ryegrass##3##5##(2008-10#3)
leaf spot of##19##3##(2008-10#19)
leaf spot on##4##3##(2008-10#4)
leaf spot pathogen##2##3##(2008-10#2)
leaf spot severity in##2##4##(2008-10#2)
leaf spot severity##5##3##(2008-10#5)
leaf spot suppression##2##3##(2008-10#2)
leaf spot virus##7##3##(2008-10#7)
leaf spot was##2##3##(2008-10#2)
leaf spot##113##2##(2008-10#111)(2010-3#1)(2012-3#1)
leaf spot)##2##2##(2008-10#2)
leaf spots##9##2##(2008-10#8)(2010-3#1)
leaf spotting##2##2##(2008-10#2)
leaf streak##2##2##(2008-10#2)
leaf surface##10##2##(1994-11#1)(2008-10#9)
leaf surfaces and##3##3##(2008-10#3)
leaf surfaces of##2##3##(2008-10#2)
leaf surfaces##6##2##(2008-10#6)
leaf temperature##3##2##(2008-10#3)
leaf through##2##2##(2008-10#2)
leaf tissue at##2##3##(2008-10#1)(2013-8#1)
leaf tissue by##2##3##(2008-10#2)
leaf tissue of##3##3##(2008-10#3)
leaf tissue##26##2##(2008-10#23)(2008-8#1)(2013-8#2)
leaf tissues and##3##3##(2008-10#3)
leaf tissues was##2##3##(2008-10#2)
leaf tissues##20##2##(2008-10#18)(2008-8#2)
leaf to##2##2##(2008-10#2)
leaf veins##2##2##(2008-10#2)
leaf was##7##2##(2008-10#7)
leaf water##2##2##(2012-7#1)(2012-9#1)
leaf wetness duration and##2##4##(2008-10#2)
leaf wetness duration##13##3##(2008-10#13)
leaf wetness durations##3##3##(2008-10#3)
leaf wetness period##3##3##(2008-10#3)
leaf wetness required##2##3##(2008-10#2)
leaf wetness was##5##3##(2008-10#5)
leaf wetness##44##2##(2008-10#44)
leaf without##2##2##(2008-10#1)(2009-8#1)
leaf##846##1##(1993-2#1)(1994-11#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#738)(2008-11#8)(2008-12#14)(2008-5#1)(2008-7#1)(2008-8#19)(2008-9#13)(2009-5#2)(2009-6#4)(2009-8#3)(2010-11#2)(2010-3#8)(2011-10#2)(2011-2#1)(2012-3#1)(2012-5#7)(2012-6#1)(2012-7#2)(2012-9#8)(2013-8#6)
leaf-associated##4##1##(2008-10#4)
leaf-cutting ant##2##2##(2008-8#2)
leafhopper proteins##2##2##(2008-10#2)
leafhopper vector##3##2##(2008-10#3)
leafhopper##17##1##(2008-10#17)
leafhoppers and##2##2##(2008-10#2)
leafhoppers##14##1##(2008-10#14)
leaflet of##2##2##(1995-2#1)(2008-11#1)
leaflet or##2##2##(2008-10#2)
leaflet##26##1##(1995-2#1)(2008-10#22)(2008-11#3)
leaflets (7##2##2##(2008-10#2)
leaflets and##7##2##(2008-10#6)(2008-11#1)
leaflets in##2##2##(2008-10#2)
leaflets##28##1##(1996-1#1)(2008-10#26)(2008-11#1)
leafminer##3##1##(2008-10#3)
leafroll virus (PLRV)##2##3##(2008-10#2)
leafroll virus##4##2##(2008-10#4)
leafroll##5##1##(2008-10#5)
leafroll-associated##6##1##(2008-10#6)
leafworm##2##1##(2013-8#2)
leafy##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
leak and##4##2##(2008-7#2)(2011-2#2)
leak at##2##2##(1995-11#1)(2008-10#1)
leak out##2##2##(2007-12#1)(2008-9#1)
leak##27##1##(1991-8#1)(1995-11#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-7#6)(2008-9#2)(2011-2#8)(2012-3#2)
leakage and##3##2##(2008-10#3)
leakage current measurement##3##3##(2012-3#3)
leakage current##5##2##(2012-3#5)
leakage from##2##2##(1994-5#1)(2008-10#1)
leakage in##3##2##(1990-5#1)(2008-12#1)(2011-2#1)
leakage increased##2##2##(1994-5#1)(2008-12#1)
leakage of the##2##3##(1990-3#1)(2008-10#1)
leakage of##11##2##(1990-3#1)(1994-12#1)(1995-11#1)(1996-2#1)(2008-10#5)(2008-5#1)(2008-7#1)
leakage than##2##2##(2008-10#2)
leakage was##2##2##(1994-5#1)(2008-10#1)
leakage##52##1##(1990-3#1)(1990-5#1)(1991-3#2)(1994-12#1)(1994-5#3)(1995-11#2)(1996-2#1)(2008-10#20)(2008-12#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-3#7)
leakiness##2##1##(1994-8#1)(2011-2#1)
leaking##4##1##(1991-5#1)(2008-7#1)(2012-2#2)
leaks and##3##2##(1994-6#1)(2008-8#1)(2011-2#1)
leaks##13##1##(1994-6#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#5)(2012-3#2)
leaky waveguide##2##2##(2008-10#2)
leaky##5##1##(1990-5#2)(2008-10#3)
lean body##3##2##(2008-7#1)(2012-2#2)
lean rats##3##2##(1996-12#3)
lean subjects##2##2##(2008-3#2)
lean##29##1##(1994-11#1)(1996-12#7)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#2)(2008-9#1)(2012-2#6)(2012-3#1)(2013-8#3)
leap##4##1##(1996-1#1)(2010-4#3)
learn about##9##2##(1994-1#1)(1996-1#1)(1997-3#1)(2008-11#3)(2009-8#1)(2011-2#1)(2012-2#1)
learn anything from##2##3##(1992-5#1)(1993-12#1)
learn from each other##2##4##(1997-3#1)(2008-11#1)
learn from##9##2##(1991-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1997-3#1)(2008-11#2)(2008-4#1)(2010-1#1)
learn how to##4##3##(1991-3#1)(1994-1#1)(1995-9#2)
learn how##6##2##(1991-1#1)(1991-3#1)(1994-1#1)(1995-9#2)(2012-2#1)
learn more about the pathophysiology of##2##6##(2008-7#1)(2010-11#1)
learn more about the##3##4##(1993-11#1)(2008-7#1)(2010-11#1)
learn more about##4##3##(1993-11#1)(1997-3#1)(2008-7#1)(2010-11#1)
learn more##6##2##(1993-11#1)(1997-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
learn new##3##2##(1993-12#1)(1996-3#1)(2010-4#1)
learn that##2##2##(1992-12#1)(2008-11#1)
learn the##5##2##(1994-12#1)(2008-8#1)(2009-10#1)(2010-6#1)(2013-1#1)
learn to##11##2##(1990-11#1)(1991-2#1)(1993-12#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-8#2)(2012-2#1)
learn##81##1##(1990-11#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#3)(2008-11#14)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#5)(2013-1#3)(2013-8#2)
learned a##2##2##(2008-11#1)(2008-8#1)
learned about the##2##3##(2008-4#1)(2012-2#1)
learned about##7##2##(2008-3#1)(2008-4#1)(2008-8#2)(2010-10#1)(2011-3#1)(2012-2#1)
learned and##3##2##(1994-2#1)(2009-10#1)(2013-8#1)
learned by##4##2##(1993-12#1)(1994-1#1)(2008-12#2)
learned during##2##2##(2008-12#1)(2010-7#1)
learned from the##4##3##(1991-11#1)(1992-2#1)(1997-2#1)(2008-12#1)
learned from this##5##3##(1994-3#2)(2008-11#1)(2009-8#1)(2012-2#1)
learned from##17##2##(1991-11#1)(1992-2#1)(1993-5#1)(1994-3#2)(1997-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
learned in##4##2##(1991-2#1)(1995-12#1)(2008-8#1)(2010-12#1)
learned that##2##2##(1997-3#1)(2009-8#1)
learned the task at an older juvenile age##2##8##(1994-8#2)
learned the task at##3##4##(1994-8#3)
learned the##4##2##(1994-8#3)(2008-3#1)
learned to##3##2##(1993-6#1)(2008-6#2)
learned##76##1##(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-1#4)(1994-2#1)(1994-3#2)(1994-8#3)(1995-12#2)(1995-2#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#3)(2008-4#1)(2008-6#2)(2008-8#8)(2009-10#1)(2009-11#3)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-7#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#1)(2013-8#2)
learned&quot##2##1##(2011-2#2)
learned?##2##1##(2008-10#2)
learner to##2##2##(2008-11#1)(2008-12#1)
learner##3##1##(1994-2#1)(2008-11#1)(2008-12#1)
learners and##3##2##(1994-12#1)(2008-12#1)(2013-1#1)
learners in##4##2##(2008-11#3)(2011-2#1)
learners to##2##2##(2008-12#2)
learners##17##1##(1994-12#1)(2008-11#6)(2008-12#6)(2008-6#1)(2011-2#2)(2013-1#1)
learning (EBL)##2##2##(2008-12#2)
learning (PBL)##7##2##(2008-10#1)(2008-11#1)(2008-12#3)(2011-1#1)(2013-8#1)
learning ability of##2##3##(1990-5#1)(1994-3#1)
learning ability##5##2##(1990-5#1)(1994-3#1)(1995-8#3)
learning about##4##2##(2008-11#2)(2009-9#1)(2010-10#1)
learning activities##6##2##(1992-1#1)(2008-11#2)(2008-12#2)(2010-8#1)
learning and competence##2##3##(2008-11#2)
learning and memory ability##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
learning and memory and##2##4##(1993-12#1)(2011-2#1)
learning and memory are##2##4##(2008-5#1)(2012-2#1)
learning and memory in##7##4##(1993-3#1)(2008-10#1)(2008-9#1)(2009-8#3)(2011-2#1)
learning and memory##33##3##(1993-12#2)(1993-3#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#3)(2011-2#3)(2012-2#9)(2013-8#1)
learning and teaching strategy##2##4##(2008-11#2)
learning and teaching##3##3##(2008-11#3)
learning and the##2##3##(2008-11#2)
learning and##69##2##(1991-7#1)(1992-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1997-2#1)(2008-10#5)(2008-11#20)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#4)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#11)(2013-8#1)
learning approach to##4##3##(2008-11#2)(2008-12#1)(2013-1#1)
learning approach##8##2##(2008-11#3)(2008-12#2)(2010-12#1)(2011-1#1)(2013-1#1)
learning approaches##7##2##(2008-11#4)(2008-12#1)(2011-2#1)(2012-2#1)
learning are##2##2##(2008-11#1)(2008-12#1)
learning as##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
learning at##2##2##(2008-11#1)(2008-12#1)
learning by##4##2##(2008-11#2)(2008-12#1)(2012-2#1)
learning can be##4##3##(1997-2#1)(2008-11#2)(2012-2#1)
learning classifier##2##2##(2010-7#2)
learning community##3##2##(2008-11#1)(2008-12#2)
learning contract##4##2##(1992-1#1)(2008-11#3)
learning contracts as##2##3##(2008-11#2)
learning contracts##7##2##(2008-11#7)
learning curve for##2##3##(2008-11#1)(2011-2#1)
learning curve##5##2##(2008-11#1)(2011-2#3)(2012-2#1)
learning deficit##2##2##(1991-7#2)
learning deficits on this task##2##5##(1993-3#2)
learning deficits##6##2##(1993-12#1)(1993-3#4)(2012-2#1)
learning difficulties##8##2##(1997-3#1)(2008-11#6)(2011-1#1)
learning disabilities##12##2##(1995-1#1)(2008-11#2)(2008-12#2)(2011-1#6)(2012-3#1)
learning disability##5##2##(2008-11#5)
learning disturbance at 7 months##2##5##(1995-8#2)
learning during a##2##3##(2008-11#2)
learning during the##2##3##(1993-3#1)(2008-11#1)
learning during##7##2##(1993-3#1)(2008-11#5)(2011-1#1)
learning environment to##2##3##(2008-12#2)
learning environment##13##2##(2008-11#4)(2008-12#9)
learning environments##5##2##(2008-11#4)(2012-3#1)
learning experience##6##2##(2008-11#3)(2008-12#3)
learning experiences##7##2##(2008-11#6)(2008-12#1)
learning for students##2##3##(2008-11#2)
learning for##7##2##(2008-11#5)(2008-12#1)(2013-1#1)
learning from##6##2##(1992-12#1)(1992-2#1)(2008-11#2)(2008-5#1)(2013-8#1)
learning groups##3##2##(2008-11#3)
learning has##2##2##(2008-11#2)
learning how to##2##3##(1992-1#1)(2009-12#1)
learning in a##8##3##(2008-11#4)(2008-12#2)(2009-10#1)(2011-1#1)
learning in health##3##3##(1994-1#1)(1996-1#1)(2008-11#1)
learning in nurse education##3##4##(2008-11#2)(2008-12#1)
learning in practice settings##2##4##(2008-11#2)
learning in practice##9##3##(2008-11#8)(2008-12#1)
learning in the workplace##2##4##(2008-11#2)
learning in the##6##3##(1994-8#1)(2008-11#3)(2008-12#1)(2012-2#1)
learning in this##2##3##(2008-11#1)(2008-12#1)
learning in##45##2##(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-8#1)(1996-1#1)(2008-11#25)(2008-12#7)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#3)(2012-3#1)
learning into##2##2##(2008-11#1)(2008-12#1)
learning is a##2##3##(2010-10#1)(2011-2#1)
learning is##15##2##(1994-1#1)(1995-2#2)(2008-11#8)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)
learning items##2##2##(2008-11#2)
learning materials##4##2##(2008-11#2)(2008-12#2)
learning method##4##2##(2008-11#3)(2008-12#1)
learning methods##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
learning model##5##2##(1997-2#1)(2008-11#3)(2013-8#1)
learning needs##4##2##(1992-12#1)(2008-11#1)(2008-12#1)(2012-3#1)
learning of a##2##3##(2008-11#2)
learning of large networks##2##4##(2010-10#2)
learning of##18##2##(1993-6#1)(1994-1#1)(2008-11#8)(2008-12#2)(2008-4#1)(2008-8#1)(2010-10#2)(2010-6#1)(2011-1#1)
learning on##2##2##(2008-11#2)
learning opportunities##5##2##(2008-11#4)(2008-12#1)
learning or##2##2##(1992-12#1)(2013-8#1)
learning outcomes that##2##3##(2008-11#2)
learning outcomes##13##2##(2008-11#7)(2008-12#3)(2011-1#1)(2012-2#1)(2013-1#1)
learning paradigm##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
learning paradigms##2##2##(2008-7#2)
learning performance##3##2##(2008-7#1)(2008-8#2)
learning principles##2##2##(1992-1#1)(2008-12#1)
learning problem##2##2##(2010-7#2)
learning process##5##2##(1997-6#1)(2008-11#1)(2008-12#1)(2008-8#2)
learning rate eta##2##3##(2008-10#2)
learning rate##5##2##(2008-10#5)
learning resource##2##2##(2008-11#2)
learning resources use by nursing students##2##6##(2008-11#2)
learning resources##11##2##(1996-2#1)(2008-11#9)(2008-12#1)
learning rule##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
learning session##2##2##(1994-8#2)
learning skills##2##2##(2008-10#1)(2008-11#1)
learning strategies that##2##3##(2008-11#1)(2008-12#1)
learning strategies##5##2##(2008-11#3)(2008-12#2)
learning strategy##6##2##(2008-11#5)(2008-12#1)
learning system##3##2##(2008-7#1)(2009-5#1)(2010-12#1)
learning task in the##2##4##(1993-3#1)(2008-7#1)
learning tasks##2##2##(2008-5#1)(2013-8#1)
learning teams##2##2##(2008-11#2)
learning technology##3##2##(2008-11#1)(2008-12#2)
learning that##3##2##(1995-12#1)(1996-1#1)(2008-11#1)
learning the##3##2##(1994-8#1)(2008-11#2)
learning theories##2##2##(2008-11#1)(2008-12#1)
learning theory##3##2##(2008-12#1)(2008-4#1)(2013-8#1)
learning through##2##2##(1995-2#1)(2008-11#1)
learning to##8##2##(1991-9#1)(2008-11#3)(2008-12#2)(2012-3#1)(2013-8#1)
learning tool##4##2##(2008-11#2)(2008-12#2)
learning using##4##2##(1994-3#1)(2008-11#3)
learning with##2##2##(2008-11#2)
learning within##2##2##(1993-1#1)(2008-12#1)
learning##670##1##(1990-5#1)(1991-2#2)(1991-7#5)(1991-9#1)(1992-1#7)(1992-12#5)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#6)(1993-3#9)(1993-6#4)(1994-1#4)(1994-12#2)(1994-3#2)(1994-8#7)(1995-1#1)(1995-12#1)(1995-2#8)(1995-8#6)(1996-1#3)(1996-2#3)(1996-3#1)(1997-2#3)(1997-3#2)(1997-6#2)(1997-7#2)(2008-1#1)(2008-10#24)(2008-11#286)(2008-12#98)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#12)(2008-8#10)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#13)(2009-9#1)(2010-1#1)(2010-10#8)(2010-12#2)(2010-6#1)(2010-7#6)(2010-8#2)(2011-1#21)(2011-2#16)(2012-12#2)(2012-2#26)(2012-3#7)(2013-1#3)(2013-8#14)
learning)##2##1##(2008-12#1)(2008-7#1)
learning-based##4##1##(2008-8#3)(2010-12#1)
learning/memory##2##1##(1993-3#1)(2008-8#1)
learns##3##1##(2008-12#1)(2010-10#1)(2012-12#1)
learnt##4##1##(2008-12#2)(2008-8#1)(2013-1#1)
leasing##2##1##(1993-2#2)
least 12##4##2##(1995-2#1)(2008-10#3)
least 120##2##2##(2008-10#2)
least 15##4##2##(1990-12#1)(1994-3#1)(2008-11#1)(2008-9#1)
least 2##13##2##(1996-12#1)(2008-10#9)(2008-11#1)(2009-8#1)(2011-2#1)
least 30##5##2##(1991-6#1)(1995-2#1)(2008-2#1)(2011-2#2)
least 5##10##2##(1990-5#1)(1991-7#1)(1994-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
least affected by##2##3##(2008-10#2)
least affected##3##2##(2008-10#3)
least amount of##8##3##(2008-10#7)(2008-7#1)
least amount##9##2##(2008-10#7)(2008-7#2)
least at##4##2##(1991-3#1)(2008-11#1)(2008-12#1)(2013-8#1)
least eight##3##2##(2008-10#2)(2008-8#1)
least five##8##2##(1993-6#1)(2008-10#4)(2010-8#1)(2011-1#1)(2012-12#1)
least for##15##2##(1996-3#1)(2008-10#6)(2008-3#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
least four##10##2##(1993-2#1)(1993-9#1)(1995-6#2)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)
least in the##8##3##(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#3)
least in##49##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#4)(2008-5#3)(2008-8#3)(2010-4#1)(2011-2#5)(2012-2#5)
least likely to##2##3##(1992-2#1)(2008-10#1)
least median squares (LMS)##2##4##(2008-10#2)
least on##2##2##(2008-10#1)(2010-4#1)
least once per##2##3##(2008-10#1)(2008-7#1)
least once##8##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#1)
least one in##2##3##(2008-10#1)(2013-1#1)
least one of##8##3##(1993-2#1)(1994-11#1)(2008-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
least one##82##2##(1990-11#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-6#2)(1995-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2006-6#1)(2008-10#16)(2008-11#8)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
least partially##8##2##(1993-1#1)(1993-12#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-5#1)(2009-7#1)
least satisfied##2##2##(2008-10#1)(2009-11#1)
least some of the##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
least some of##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)
least some##20##2##(1990-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#2)
least square (PLS)##4##3##(2008-10#4)
least square analysis##2##3##(2008-10#1)(2008-8#1)
least square##16##2##(2008-10#13)(2008-8#2)(2013-1#1)
least squares (PLS)##30##3##(2008-10#29)(2009-10#1)
least squares estimate method##2##4##(2008-6#2)
least squares method##2##3##(2008-10#2)
least squares modeling##4##3##(2008-10#4)
least squares regression analysis##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
least squares regression and##3##4##(2008-10#3)
least squares regression to##2##4##(2008-10#2)
least squares regression was used##2##5##(2008-10#2)
least squares regression##23##3##(1993-12#1)(2008-10#20)(2008-11#2)
least squares##117##2##(1993-12#1)(1995-2#1)(2008-10#106)(2008-11#3)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-3#1)
least the##9##2##(1990-11#1)(1994-12#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#1)
least three distinct##4##3##(1994-5#1)(2008-10#1)(2008-5#1)(2009-8#1)
least three of these##2##4##(1993-6#1)(2011-2#1)
least three##32##2##(1991-2#2)(1993-6#1)(1994-5#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#1)(2011-2#3)(2012-3#1)
least two classes##2##3##(1995-11#1)(1995-8#1)
least two distinct##3##3##(1990-8#1)(2008-10#1)(2010-10#1)
least two of the##2##4##(2008-10#1)(2012-3#1)
least two of##4##3##(1997-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
least two other##2##3##(1996-5#1)(2008-10#1)
least two##57##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1992-10#2)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-10#17)(2008-11#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#2)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)
least up to##2##3##(2008-10#2)
least##811##1##(1990-11#2)(1990-12#4)(1990-5#4)(1990-6#4)(1990-8#4)(1990-9#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-11#1)(1992-2#3)(1992-3#4)(1992-6#2)(1993-1#2)(1993-12#4)(1993-2#4)(1993-3#4)(1993-6#5)(1993-8#8)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1995-11#2)(1995-12#5)(1995-2#9)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#4)(1995-9#1)(1996-1#2)(1996-12#6)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#3)(1997-1#3)(1997-2#3)(1997-3#6)(1997-6#3)(1997-7#3)(1997-8#5)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#344)(2008-11#47)(2008-12#8)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#17)(2008-6#10)(2008-7#21)(2008-8#19)(2008-9#13)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#4)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#3)(2010-4#3)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#6)(2011-2#29)(2012-12#9)(2012-2#13)(2012-3#10)(2012-4#1)(2012-5#1)(2013-1#26)(2013-8#5)
least)##2##1##(2008-10#2)
least-square##2##1##(2008-10#2)
least-squares and principal component regression##2##5##(2008-10#2)
least-squares and##3##2##(2008-10#3)
least-squares fit##4##2##(2008-2#1)(2008-3#3)
least-squares fitting##3##2##(2008-2#1)(2008-3#2)
least-squares method##6##2##(2008-10#3)(2008-3#3)
least-squares regression (PLS)##2##3##(2008-10#2)
least-squares regression##12##2##(2008-10#12)
least-squares technique##2##2##(2008-3#2)
least-squares##67##1##(1992-12#1)(1992-4#1)(1993-8#1)(2008-10#48)(2008-2#2)(2008-3#13)(2013-1#1)
leather and##2##2##(2008-10#1)(2012-2#1)
leather tanneries##3##2##(2009-12#3)
leather##13##1##(2008-10#9)(2009-12#3)(2012-2#1)
leave a##3##2##(1990-3#1)(1995-12#1)(2008-9#1)
leave it in##2##3##(1993-6#2)
leave the##7##2##(1991-2#1)(1992-3#1)(1995-6#1)(1996-1#1)(2008-8#2)(2008-9#1)
leave##28##1##(1990-3#1)(1991-2#1)(1991-3#1)(1992-3#2)(1993-6#2)(1994-5#1)(1995-12#2)(1995-6#1)(1996-1#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#5)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
leave-on##7##1##(2008-5#7)
leave-one-out##3##1##(2008-10#1)(2010-8#1)(2011-3#1)
leaves (NIST##2##2##(2008-10#2)
leaves (cv##2##2##(2008-10#2)
leaves (leaf##2##2##(2008-10#2)
leaves GBW##2##2##(2008-10#2)
leaves NIST##2##2##(2008-10#2)
leaves after##4##2##(2008-10#3)(2008-9#1)
leaves against##3##2##(2008-10#3)
leaves and berries##3##3##(2008-10#3)
leaves and coverslips were sprayed with##2##6##(2008-10#2)
leaves and coverslips##4##3##(2008-10#4)
leaves and flowers##2##3##(2008-10#1)(2008-5#1)
leaves and fruit##5##3##(2008-10#5)
leaves and roots of##2##4##(2008-10#1)(2008-12#1)
leaves and roots##8##3##(2008-10#5)(2008-12#2)(2009-8#1)
leaves and seed##2##3##(2008-10#2)
leaves and stems of##2##4##(2008-10#1)(2008-11#1)
leaves and stems##8##3##(2008-10#6)(2008-11#2)
leaves and subsequent##2##3##(2008-10#2)
leaves and the##4##3##(2008-10#3)(2008-9#1)
leaves and was##2##3##(2008-10#2)
leaves and##73##2##(2008-10#55)(2008-11#3)(2008-12#4)(2008-5#2)(2008-8#2)(2008-9#4)(2009-8#1)(2010-3#1)(2011-10#1)
leaves appeared to##2##3##(2008-10#2)
leaves appeared##3##2##(2008-10#3)
leaves aqueous extract##2##3##(2008-12#2)
leaves are##2##2##(2008-10#1)(2011-1#1)
leaves as##3##2##(2008-10#2)(2008-8#1)
leaves at##12##2##(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#1)(2013-8#1)
leaves but not##2##3##(2008-10#2)
leaves but##3##2##(2008-10#3)
leaves by##10##2##(1994-11#1)(2008-10#9)
leaves caused##2##2##(2008-10#2)
leaves collected##2##2##(2008-10#2)
leaves colonized by##2##3##(2008-10#2)
leaves compared with##4##3##(2008-10#4)
leaves contain##2##2##(2008-10#1)(2008-9#1)
leaves following##2##2##(2008-10#2)
leaves for the##2##3##(2008-10#2)
leaves for##6##2##(2008-10#6)
leaves from healthy##2##3##(2008-10#2)
leaves from##11##2##(2008-10#10)(2008-8#1)
leaves in the presence of##2##5##(2008-10#2)
leaves in the##4##3##(2008-10#4)
leaves in##16##2##(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#2)
leaves increased##3##2##(2008-10#3)
leaves incubated##2##2##(2008-10#2)
leaves infected with##2##3##(2008-10#2)
leaves infected##3##2##(2008-10#3)
leaves inoculated with##3##3##(2008-10#3)
leaves may be##2##3##(2008-10#2)
leaves may##3##2##(2008-10#3)
leaves of Morus alba##4##4##(2011-3#4)
leaves of the##6##3##(1992-2#1)(1995-2#1)(2008-10#4)
leaves of##55##2##(1992-2#1)(1995-2#1)(2008-10#37)(2008-11#2)(2008-12#3)(2008-8#1)(2010-2#1)(2011-3#4)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
leaves on the##2##3##(2008-10#2)
leaves on##6##2##(2008-10#5)(2008-12#1)
leaves or##10##2##(2008-10#8)(2009-8#1)(2011-10#1)
leaves per##3##2##(2008-10#2)(2008-12#1)
leaves pretreated with ASM##2##4##(2008-10#2)
leaves showed##3##2##(2008-10#3)
leaves showing##6##2##(2008-10#6)
leaves than##3##2##(2008-10#2)(2012-9#1)
leaves that were##2##3##(2008-10#2)
leaves that##5##2##(2008-10#4)(2008-12#1)
leaves to##4##2##(2008-10#4)
leaves treated with##3##3##(2008-10#3)
leaves under##5##2##(2008-10#3)(2008-8#1)(2013-8#1)
leaves using##3##2##(2008-10#3)
leaves was significantly##5##3##(2008-10#5)
leaves was studied##2##3##(2008-10#2)
leaves was##17##2##(2008-10#16)(2008-9#1)
leaves were added to##2##4##(2008-10#2)
leaves were significantly##2##3##(2008-10#1)(2012-9#1)
leaves were##25##2##(2008-10#22)(2008-9#1)(2012-2#1)(2012-9#1)
leaves when##3##2##(2008-10#3)
leaves which##2##2##(2008-10#2)
leaves with##11##2##(2008-10#11)
leaves within##2##2##(2008-10#2)
leaves##602##1##(1990-11#1)(1990-5#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-11#4)(1995-2#1)(1995-6#1)(2008-10#502)(2008-11#8)(2008-12#19)(2008-5#5)(2008-8#13)(2008-9#14)(2009-8#2)(2010-2#1)(2010-3#3)(2011-1#1)(2011-10#6)(2011-3#4)(2012-2#4)(2012-3#1)(2012-7#1)(2012-9#3)(2013-1#1)(2013-8#3)
leaves) and##2##2##(2008-10#2)
leaves)##7##1##(2008-10#7)
leaving a##2##2##(2011-2#2)
leaving behind##4##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)
leaving group at C-4 of the##2##6##(1993-8#2)
leaving group##9##2##(1993-8#8)(2008-11#1)
leaving the##15##2##(1991-5#1)(1993-1#1)(1994-12#1)(1997-6#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
leaving##50##1##(1991-11#1)(1991-12#1)(1991-5#1)(1993-1#1)(1993-8#8)(1994-12#2)(1994-5#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)
lecanii and##3##2##(2008-10#3)
lecanii strains##2##2##(2008-5#2)
lecanii##12##1##(2008-10#9)(2008-5#3)
lecithin cholesterol##2##2##(1993-6#1)(2013-1#1)
lecithin##12##1##(1990-3#1)(1991-12#1)(1993-6#1)(1993-8#2)(2008-10#4)(2008-11#2)(2013-1#1)
lectin (BRA-3)##2##2##(1993-6#2)
lectin and##4##2##(1993-8#2)(2008-10#2)
lectin from##2##2##(2008-10#2)
lectin of##4##2##(1990-5#2)(1991-7#1)(2008-10#1)
lectin was##2##2##(1990-5#2)
lectin##43##1##(1990-5#9)(1991-7#1)(1992-6#2)(1993-3#2)(1993-6#2)(1993-8#12)(1994-8#1)(1995-11#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-7#1)
lectins and##2##2##(1990-5#1)(1991-9#1)
lectins##23##1##(1990-5#10)(1991-9#1)(1993-3#1)(1993-8#1)(1994-11#2)(1995-11#6)(2008-11#1)(2008-9#1)
lecture##9##1##(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
lecturer and##2##2##(2008-11#2)
lecturer practitioner and joint##2##4##(2008-11#2)
lecturer practitioner##11##2##(2008-11#6)(2008-12#5)
lecturer practitioners##3##2##(2008-11#1)(2008-12#2)
lecturer preceptor##2##2##(2008-11#2)
lecturer##29##1##(2008-11#21)(2008-12#8)
lecturer's##4##1##(2008-11#4)
lecturers and##3##2##(2008-11#2)(2008-12#1)
lecturers are##2##2##(2008-11#2)
lecturers in the##2##3##(2008-10#2)
lecturers in##6##2##(2008-10#2)(2008-11#4)
lecturers were##2##2##(2008-10#2)
lecturers within##2##2##(2008-11#2)
lecturers##31##1##(2008-10#6)(2008-11#22)(2008-12#3)
lecturers'##3##1##(2008-11#3)
lectures##8##1##(1993-11#1)(1994-12#3)(1994-6#1)(2008-11#1)(2011-2#1)(2012-2#1)
led by the##2##3##(1994-12#1)(2008-10#1)
led by##5##2##(1994-12#1)(1996-1#1)(1996-11#1)(2008-10#2)
led in##2##2##(1995-5#1)(2011-3#1)
led researchers##3##2##(2008-11#2)(2011-2#1)
led the##9##2##(1994-1#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-1#1)
led to a dramatic##2##4##(1996-6#1)(1997-1#1)
led to a greater##2##4##(2009-11#1)(2012-2#1)
led to a loss of##2##5##(1992-12#1)(2008-11#1)
led to a new##3##4##(2008-5#1)(2008-7#1)(2012-2#1)
led to a reduction in##2##5##(1992-2#1)(2008-3#1)
led to a significant reduction in##2##6##(2009-4#1)(2011-10#1)
led to a significant reduction##3##5##(2008-10#1)(2009-4#1)(2011-10#1)
led to a significant##7##4##(2008-10#1)(2008-11#2)(2009-4#1)(2011-10#1)(2013-1#2)
led to a substantial##2##4##(1993-6#1)(2008-10#1)
led to a variety of##2##5##(2008-11#1)(2012-3#1)
led to a##71##3##(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1995-12#1)(1996-11#1)(1996-6#2)(1997-1#2)(1997-7#1)(2008-10#9)(2008-11#8)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-6#3)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
led to an increase in##4##5##(2008-10#1)(2008-11#1)(2008-12#1)(2011-3#1)
led to an increase of##2##5##(1991-6#1)(2008-11#1)
led to an increase##6##4##(1991-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-3#1)
led to an##15##3##(1990-12#1)(1991-6#1)(1991-8#1)(1992-2#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-6#1)(2011-3#1)(2013-1#1)
led to changes in the##2##5##(2008-10#1)(2009-12#1)
led to further##3##3##(1996-1#1)(1997-7#1)(2008-10#1)
led to improved##2##3##(1990-9#1)(2008-10#1)
led to increased##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
led to interest in##2##4##(1994-12#1)(2008-10#1)
led to its##2##3##(1997-5#1)(2008-10#1)
led to marked##3##3##(2008-10#1)(2009-3#1)(2012-2#1)
led to more##3##3##(2008-10#3)
led to reduced##2##3##(2008-5#1)(2008-9#1)
led to satisfactory##2##3##(2008-10#2)
led to significant increase##2##4##(2008-10#1)(2011-1#1)
led to significant##5##3##(2008-10#1)(2009-3#1)(2011-1#2)(2013-8#1)
led to specific##2##3##(1995-2#1)(2010-6#1)
led to the accumulation of##2##5##(2008-10#1)(2011-1#1)
led to the conclusion that the##3##6##(1992-9#1)(2008-10#1)(2008-3#1)
led to the development of a##2##6##(2008-4#1)(2011-2#1)
led to the development of the##2##6##(2008-3#2)
led to the development of##11##5##(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2011-2#1)
led to the discovery of the##3##6##(2008-11#1)(2011-3#1)(2013-8#1)
led to the discovery of##4##5##(1995-8#1)(2008-11#1)(2011-3#1)(2013-8#1)
led to the discovery##5##4##(1995-8#1)(2008-11#1)(2010-8#1)(2011-3#1)(2013-8#1)
led to the finding that##2##5##(1994-8#1)(2010-7#1)
led to the following##2##4##(2008-11#1)(2008-6#1)
led to the formation of##2##5##(1996-5#1)(2008-10#1)
led to the identification of two##3##6##(1991-9#1)(2008-11#1)(2011-2#1)
led to the identification of##5##5##(1991-9#1)(2008-11#2)(2008-7#1)(2011-2#1)
led to the identification##6##4##(1991-9#1)(2008-11#2)(2008-7#2)(2011-2#1)
led to the same results##2##5##(2008-10#1)(2012-2#1)
led to the suggestion that##3##5##(1991-10#1)(1992-6#1)(1997-4#1)
led to the total##2##4##(2008-10#1)(2008-11#1)
led to the##86##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#17)(2008-11#9)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#3)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#1)(2013-8#2)
led to##296##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#4)(1993-8#2)(1994-12#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#5)(1996-6#4)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2007-8#1)(2008-1#4)(2008-10#56)(2008-11#26)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#6)(2010-7#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#13)(2011-3#3)(2012-12#5)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#7)
led us to perform##2##4##(2008-10#1)(2011-2#1)
led us to propose##2##4##(1994-2#1)(2009-8#1)
led us to##14##3##(1990-2#1)(1994-2#1)(1994-8#2)(1995-3#1)(1996-2#1)(1996-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#3)(2012-3#1)
led##354##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#3)(1993-6#4)(1993-8#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#5)(1996-6#5)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#5)(2007-8#1)(2008-1#4)(2008-10#63)(2008-11#33)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#11)(2008-6#5)(2008-7#8)(2008-8#9)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#6)(2010-7#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#18)(2011-3#4)(2012-12#6)(2012-2#9)(2012-3#4)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#7)
leech##4##1##(1996-12#2)(1997-3#1)(2009-8#1)
leek leaves##3##2##(2008-10#3)
leek plants were##2##3##(2008-10#2)
leek plants##3##2##(2008-10#3)
leek##15##1##(2008-10#15)
lef##4##1##(1997-3#4)
lef-7##3##1##(1997-3#3)
leflunomide##2##1##(2012-3#1)(2013-1#1)
lefs##4##1##(1997-3#4)
left HM and##2##3##(2008-9#2)
left HM##4##2##(2008-9#4)
left L5##2##2##(2012-2#2)
left MeA##2##2##(1997-3#2)
left adrenal adenoma##2##3##(2011-2#2)
left adrenal##4##2##(1990-6#1)(2011-2#3)
left and right##10##3##(1991-2#1)(1992-12#1)(1997-8#1)(2007-12#1)(2008-11#1)(2010-12#2)(2011-2#3)
left and##11##2##(1991-2#1)(1992-12#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-11#1)(2010-12#2)(2011-2#3)
left anterior descending artery##3##4##(2008-11#3)
left anterior descending##4##3##(2008-11#3)(2013-1#1)
left anterior##6##2##(1993-12#1)(1996-2#1)(2008-11#3)(2013-1#1)
left atria##2##2##(2013-1#2)
left atrial appendage perforation##2##4##(2008-11#2)
left atrial appendage##3##3##(2008-11#2)(2010-12#1)
left atrial##7##2##(1997-8#1)(2008-11#3)(2008-12#1)(2009-6#1)(2010-12#1)
left behind##2##2##(2008-10#2)
left border##2##2##(2008-10#2)
left breast##6##2##(2008-10#2)(2011-2#1)(2012-3#2)(2013-1#1)
left buttock##2##2##(2012-12#1)(2013-8#1)
left by##2##2##(1995-8#1)(2008-8#1)
left cardiac sympathetic nerve##4##4##(2008-9#4)
left cardiac##5##2##(1993-3#1)(2008-9#4)
left cerebellum##2##2##(2008-11#2)
left cervical##3##2##(1991-3#1)(2012-3#1)(2013-8#1)
left coronary artery##4##3##(2010-5#1)(2013-2#2)(2013-8#1)
left end##3##2##(1996-6#1)(1997-7#1)(2010-7#1)
left eye##12##2##(2008-11#1)(2010-10#1)(2010-9#1)(2011-2#6)(2013-1#2)(2013-8#1)
left flank pain##2##3##(2011-2#1)(2013-1#1)
left flank##4##2##(2008-12#2)(2011-2#1)(2013-1#1)
left foot##4##2##(1996-11#1)(2010-3#2)(2013-1#1)
left for##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
left forearm##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
left frontal lobe##2##3##(1996-2#1)(2008-12#1)
left frontal##4##2##(1990-8#1)(1996-2#1)(2008-12#1)(2013-1#1)
left heart##2##2##(1997-1#1)(2010-6#1)
left hemiparesis##4##2##(1991-6#1)(2008-12#1)(2008-7#1)(2013-8#1)
left hemisphere##5##2##(1991-11#1)(1996-2#1)(2008-11#2)(2008-7#1)
left hip##2##2##(2012-12#1)(2013-1#1)
left iliac##3##2##(1997-3#1)(2008-12#1)(2010-6#1)
left in place##2##3##(1990-8#1)(1994-9#1)
left in##6##2##(1990-8#1)(1994-9#1)(1996-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
left inferior##3##2##(2008-11#2)(2009-8#1)
left internal##3##2##(2010-3#1)(2011-2#2)
left kidney and##4##3##(2011-2#1)(2013-1#3)
left kidney##9##2##(1990-6#1)(2011-2#3)(2013-1#5)
left lateral##8##2##(1990-3#1)(1992-9#1)(2008-11#1)(2008-7#2)(2012-3#1)(2013-1#2)
left lateralization of the pTC##2##5##(2012-2#2)
left lateralization of##3##3##(2012-2#3)
left lobe##2##2##(2008-1#1)(2012-12#1)
left lower extremity##2##3##(2009-1#1)(2012-2#1)
left lower lobe##4##3##(1991-3#1)(2007-8#1)(2008-1#2)
left lower##11##2##(1991-3#1)(2007-8#1)(2008-1#2)(2008-7#2)(2009-1#1)(2010-11#3)(2012-2#1)
left lung##4##2##(1991-9#1)(2010-7#1)(2013-1#2)
left lungs##2##2##(1996-3#1)(2008-10#1)
left main##6##2##(1990-9#2)(2008-11#2)(2010-2#1)(2011-2#1)
left median##2##2##(2010-8#2)
left middle cerebral artery##2##4##(2008-7#1)(2013-8#1)
left middle##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
left nephrectomy was##2##3##(2008-10#1)(2013-1#1)
left open##3##2##(1992-3#1)(2008-11#2)
left or right##2##3##(2008-8#1)(2009-10#1)
left ovarian##2##2##(1997-8#1)(2013-1#1)
left parietotemporal##3##2##(1995-2#2)(1997-3#1)
left pleural effusion##3##3##(1991-12#1)(1997-4#1)(2013-1#1)
left pleural space##2##3##(2008-11#1)(2012-3#1)
left pleural##7##2##(1990-5#2)(1991-12#1)(1997-4#1)(2008-11#1)(2012-3#1)(2013-1#1)
left posterior temporal##2##3##(2009-8#1)(2012-2#1)
left posterior##3##2##(1997-6#1)(2009-8#1)(2012-2#1)
left pulmonary artery##3##3##(2012-12#2)(2013-1#1)
left renal vein##4##3##(2010-11#4)
left renal##5##2##(2008-11#1)(2010-11#4)
left side of##9##3##(1991-3#1)(1993-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#2)(2012-12#1)(2012-3#1)
left side##15##2##(1990-3#1)(1991-3#1)(1993-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-9#1)(2012-12#1)(2012-3#1)
left sided##4##2##(1997-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
left subclavian artery##2##3##(2008-11#1)(2010-7#1)
left superior temporal gyrus##2##4##(1996-2#2)
left superior temporal##3##3##(1996-2#2)(2012-12#1)
left superior##4##2##(1996-2#2)(2011-2#1)(2012-12#1)
left temporal lobe##2##3##(1993-9#1)(2008-7#1)
left testis##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
left thalamus##2##2##(2008-7#2)
left the hospital in##2##4##(1993-6#1)(2008-12#1)
left the hospital##3##3##(1993-6#1)(2008-12#1)(2012-12#1)
left the##8##2##(1993-6#2)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
left thigh##2##2##(2013-1#1)(2013-8#1)
left thumb##4##2##(2010-6#4)
left to##4##2##(1996-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
left transverse sinus##2##3##(1996-6#2)
left undisturbed##2##2##(2008-10#1)(2008-8#1)
left untreated##7##2##(1992-2#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#3)
left ventricle in##2##3##(2013-1#2)
left ventricle##15##2##(1991-3#1)(1997-8#1)(2008-10#1)(2010-5#1)(2010-6#1)(2013-1#10)
left ventricular (LV)##2##3##(2011-2#1)(2012-2#1)
left ventricular apical ballooning##2##4##(2009-6#1)(2010-5#1)
left ventricular cavity and##2##4##(2008-11#1)(2012-2#1)
left ventricular contractile state##2##4##(2012-2#2)
left ventricular dimensions##3##3##(2008-12#3)
left ventricular dysfunction##6##3##(1992-12#1)(2008-12#1)(2008-3#1)(2009-1#1)(2010-5#1)(2010-6#1)
left ventricular ejection fraction was##2##5##(1997-5#1)(2008-12#1)
left ventricular ejection fraction##5##4##(1997-5#2)(2008-10#1)(2008-11#1)(2008-12#1)
left ventricular end-diastolic dimension##2##4##(2008-12#2)
left ventricular end-diastolic##3##3##(1997-8#1)(2008-12#2)
left ventricular failure##2##3##(1990-9#1)(1996-3#1)
left ventricular function##6##3##(1990-9#1)(2008-3#1)(2010-5#1)(2012-2#2)(2013-1#1)
left ventricular global##2##3##(2008-12#2)
left ventricular hypertrophy and##3##4##(2008-1#1)(2013-1#1)(2013-8#1)
left ventricular hypertrophy##7##3##(2008-1#1)(2008-12#2)(2009-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
left ventricular mass was##2##4##(2012-3#2)
left ventricular mass##6##3##(1997-8#1)(2011-2#1)(2012-12#1)(2012-3#3)
left ventricular myocardial performance index##3##5##(2008-12#3)
left ventricular remodeling in##2##4##(2012-12#1)(2013-8#1)
left ventricular structure and function##2##5##(2009-1#1)(2012-2#1)
left ventricular systolic dysfunction##2##4##(2010-11#1)(2013-1#1)
left ventricular systolic function following##2##5##(2008-11#1)(2010-6#1)
left ventricular systolic function##3##4##(2008-11#1)(2010-6#1)(2013-1#1)
left ventricular systolic##5##3##(2008-11#1)(2010-11#1)(2010-6#1)(2013-1#2)
left ventricular wall##2##3##(1993-12#1)(2012-2#1)
left ventricular##81##2##(1990-9#2)(1992-12#2)(1993-12#1)(1994-12#1)(1995-11#1)(1996-3#1)(1997-5#2)(1997-8#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#16)(2008-3#2)(2009-1#3)(2009-6#1)(2010-11#1)(2010-5#3)(2010-6#2)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#12)(2012-3#4)(2013-1#5)(2013-8#2)
left visual field##2##3##(1996-2#2)
left##537##1##(1990-3#4)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#4)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#6)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-9#4)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#4)(1996-11#1)(1996-2#11)(1996-3#7)(1996-5#1)(1996-6#9)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#11)(2007-12#2)(2007-8#1)(2008-1#4)(2008-10#33)(2008-11#35)(2008-12#29)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#23)(2008-8#6)(2008-9#13)(2009-1#6)(2009-10#8)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#10)(2010-12#6)(2010-2#2)(2010-3#7)(2010-5#5)(2010-6#12)(2010-7#5)(2010-8#4)(2010-9#2)(2011-2#43)(2011-3#1)(2012-12#15)(2012-2#22)(2012-3#21)(2013-1#61)(2013-2#2)(2013-7#1)(2013-8#15)
left-handed##2##1##(1992-6#1)(1995-6#1)
left-pawed##3##1##(1997-2#3)
left-side##2##1##(2008-10#1)(2010-3#1)
left-sided##13##1##(1997-7#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#2)(2011-2#5)
left-to-right##3##1##(1996-3#1)(2008-11#1)(2010-10#1)
left/right asymmetry in##2##3##(2010-4#2)
left/right asymmetry##4##2##(2010-4#4)
left/right##8##1##(1996-11#2)(2008-12#1)(2009-10#1)(2010-4#4)
leftward##5##1##(1990-5#1)(1994-8#1)(2008-5#1)(2009-10#2)
leg and##7##2##(1990-11#1)(1991-3#1)(1997-8#1)(2008-12#2)(2008-5#1)(2011-2#1)
leg exercises##2##2##(2013-8#2)
leg length##2##2##(1997-4#2)
leg muscles##3##2##(2013-8#3)
leg pain##8##2##(1991-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)
leg ulcers##7##2##(1990-6#1)(1997-3#2)(2008-1#1)(2013-1#3)
leg wash##2##2##(2008-5#2)
leg with##3##2##(2010-9#1)(2012-12#2)
leg##60##1##(1990-11#1)(1990-6#1)(1991-11#1)(1991-3#1)(1994-6#1)(1995-2#1)(1997-2#1)(1997-3#5)(1997-4#3)(1997-8#2)(2007-12#2)(2008-1#1)(2008-12#5)(2008-5#8)(2008-7#2)(2008-9#1)(2009-1#1)(2010-6#1)(2010-9#2)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#6)(2013-8#5)
legacy of##5##2##(1993-1#2)(1995-1#1)(2008-10#1)(2013-1#1)
legacy##11##1##(1992-12#2)(1992-3#2)(1993-1#2)(1995-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
legal abortions in##2##3##(1996-11#2)
legal abortions##3##2##(1996-11#3)
legal action##3##2##(2008-11#2)(2009-11#1)
legal and##4##2##(1997-7#1)(2008-1#1)(2008-11#1)(2012-12#1)
legal basis##2##2##(1995-12#1)(2013-8#1)
legal cases##5##2##(2008-11#5)
legal framework##3##2##(1994-1#1)(1996-3#1)(2008-10#1)
legal implications##2##2##(1997-2#1)(1997-5#1)
legal issues in##3##3##(1996-1#1)(2008-11#2)
legal issues##8##2##(1991-1#1)(1996-1#1)(1997-3#1)(2008-11#4)(2008-12#1)
legal requirements##2##2##(2008-10#1)(2008-5#1)
legal standards##2##2##(1991-12#1)(2008-12#1)
legal##92##1##(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#27)(2008-12#4)(2008-5#2)(2009-11#2)(2009-9#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
legality##2##1##(1992-12#1)(2013-1#1)
legally##5##1##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#2)
legend##2##1##(1992-11#1)(2011-2#1)
legislation and##6##2##(1994-1#1)(2008-11#3)(2008-12#1)(2011-2#1)
legislation did##2##2##(2008-11#1)(2013-8#1)
legislation has been##2##3##(1996-1#1)(2008-10#1)
legislation has##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
legislation in the##2##3##(1994-1#1)(2008-10#1)
legislation of##2##2##(1997-3#1)(2012-3#1)
legislation on##2##2##(1993-6#1)(2012-12#1)
legislation related to##2##3##(1997-1#1)(2008-11#1)
legislation that##3##2##(1991-2#1)(1994-1#1)(2009-7#1)
legislation would##2##2##(1993-1#1)(2008-11#1)
legislation##69##1##(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-1#1)(1993-1#1)(1993-5#1)(1993-6#2)(1994-1#8)(1994-3#1)(1994-8#1)(1995-12#3)(1996-1#1)(1996-3#3)(1996-5#2)(1996-8#1)(1997-1#2)(1997-3#4)(1997-8#1)(2008-10#7)(2008-11#11)(2008-12#1)(2009-7#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
legislation]##2##1##(1993-6#1)(1996-1#1)
legislative issues##2##2##(1992-2#2)
legislative##16##1##(1990-11#1)(1992-1#1)(1992-2#3)(1994-1#2)(1994-3#1)(1996-1#1)(1996-3#2)(2008-11#1)(2008-12#2)(2009-12#1)(2012-2#1)
legislatively mandated##2##2##(1997-3#2)
legislators##7##1##(1992-1#1)(1996-2#1)(2008-11#4)(2010-5#1)
legitimate##5##1##(1991-1#1)(1991-3#1)(1992-9#1)(2008-6#1)(2010-12#1)
legs of##2##2##(2007-12#1)(2008-7#1)
legs##25##1##(1993-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#2)(2008-5#7)(2008-7#1)(2008-9#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#2)
legume Stylosanthes at##2##3##(2008-10#2)
legume##16##1##(1993-8#1)(2008-10#11)(2009-8#1)(2010-10#2)(2013-8#1)
legumes##10##1##(2008-10#7)(2011-2#1)(2012-2#1)(2013-8#1)
leguminous##4##1##(2008-10#3)(2010-7#1)
leiden##2##1##(1997-6#1)(2013-8#1)
leiocephala##2##1##(2010-3#2)
leiomyoma of the ureter##3##4##(2013-7#3)
leiomyoma of the##5##3##(1992-5#1)(2012-2#1)(2013-7#3)
leiomyoma##15##1##(1992-12#2)(1992-5#1)(1992-9#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-7#3)
leiomyomas and##2##2##(1991-2#1)(1994-6#1)
leiomyomas are##2##2##(1991-2#2)
leiomyomas##8##1##(1991-2#6)(1994-6#1)(2012-12#1)
leiomyosarcoma##3##1##(1990-9#1)(2012-2#2)
leishmaniasis in##3##2##(2009-5#1)(2012-2#1)(2013-1#1)
leishmaniasis##11##1##(1990-6#1)(1991-11#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-2#2)(2013-1#3)
leishmaniosis##4##1##(2011-2#4)
leisure and##2##2##(2010-10#1)(2013-1#1)
leisure time##3##2##(1996-11#1)(2009-3#1)(2010-11#1)
leisure##7##1##(1996-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2012-12#2)(2013-1#1)
lemildipine##2##1##(2008-5#2)
lemma and palea##4##3##(2008-10#4)
lemma##12##1##(2008-10#8)(2008-8#2)(2008-9#2)
lemon and##2##2##(2008-10#1)(2011-2#1)
lemon juice##3##2##(2008-10#3)
lemon pectin##2##2##(2011-2#2)
lemon##19##1##(2008-10#11)(2010-8#2)(2011-2#6)
lend strong support##2##3##(1990-11#1)(1991-1#1)
lend support to the##2##4##(2009-7#1)(2010-1#1)
lend##6##1##(1990-11#1)(1991-1#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-1#1)
lends itself to##3##3##(2008-10#2)(2008-6#1)
lends support to##2##3##(1995-8#1)(2008-8#1)
lends##7##1##(1995-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
length (1##4##2##(2008-10#2)(2008-11#1)(2009-10#1)
length (e##2##2##(1997-6#1)(2008-6#1)
length after##2##2##(2008-5#1)(2010-5#1)
length and abdominal girth##2##4##(1996-8#2)
length and secondary##2##3##(2008-10#2)
length and sequence##2##3##(2008-10#1)(2008-4#1)
length and the##7##3##(1992-7#1)(1993-12#2)(2008-3#1)(2008-9#2)(2012-2#1)
length and width gradient##3##4##(2008-10#3)
length and width##5##3##(1993-12#1)(2008-10#4)
length and##65##2##(1990-5#1)(1991-11#1)(1992-7#1)(1993-12#3)(1993-2#2)(1994-12#1)(1996-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2008-10#18)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#7)(2009-7#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
length as##2##2##(1991-3#1)(2008-10#1)
length at##2##2##(2008-9#1)(2010-8#1)
length but##2##2##(2011-2#1)(2013-8#1)
length density##3##2##(2008-10#3)
length did not##2##3##(2008-10#1)(2010-8#1)
length during##2##2##(2008-10#1)(2009-1#1)
length for the##2##3##(1995-9#1)(2008-11#1)
length from##3##2##(2008-10#1)(2013-1#2)
length in a##3##3##(2008-11#2)(2008-12#1)
length in the##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
length in##12##2##(1996-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
length increased##2##2##(2008-10#2)
length is less than##2##4##(1997-8#1)(2008-11#1)
length is##12##2##(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
length mouse glycophorin##2##3##(1991-5#2)
length of 1##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
length of 2##2##3##(2008-10#1)(2008-3#1)
length of 25##2##3##(1997-8#1)(2008-10#1)
length of UV irradiation##2##4##(2008-10#2)
length of follow-up##3##3##(1994-9#1)(2012-3#1)(2013-1#1)
length of hospital stay##9##4##(1991-12#3)(1992-2#1)(1996-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
length of hospitalization##3##3##(1991-2#1)(1993-2#1)(2008-10#1)
length of stay (LOS)##5##4##(1991-12#1)(1993-12#3)(1994-3#1)
length of stay and##2##4##(2011-2#1)(2012-2#1)
length of stay for##3##4##(1992-2#1)(1993-12#1)(1993-2#1)
length of stay in hospital##2##5##(1992-5#1)(2013-1#1)
length of stay of##2##4##(1991-1#1)(1992-12#1)
length of stay##34##3##(1991-1#1)(1991-12#2)(1992-1#1)(1992-12#3)(1992-2#2)(1992-5#1)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#4)(1995-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
length of stays##4##3##(2010-8#4)
length of the inhibition period##2##5##(1991-12#2)
length of the##55##3##(1991-12#3)(1992-6#1)(1992-9#1)(1994-5#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#3)(2007-12#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
length of therapy##3##3##(2008-11#1)(2008-6#2)
length of time##5##3##(1995-12#1)(1996-12#1)(2008-8#1)(2009-10#1)(2011-3#1)
length of##204##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#9)(1991-2#1)(1992-1#1)(1992-12#3)(1992-2#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#4)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-8#4)(2007-12#4)(2008-10#35)(2008-11#6)(2008-2#2)(2008-3#7)(2008-5#2)(2008-6#8)(2008-7#6)(2008-8#9)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#3)
length on##2##2##(2008-3#1)(2008-6#1)
length polymorphism for##2##3##(1997-3#1)(2008-10#1)
length polymorphism##169##2##(1995-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#154)(2008-11#1)(2008-12#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
length scale##8##2##(2008-10#5)(2008-3#1)(2013-1#2)
length scales##2##2##(2008-10#1)(2008-2#1)
length that##2##2##(1996-12#1)(2008-3#1)
length variation##3##2##(2010-8#1)(2011-3#1)(2012-3#1)
length was measured in##2##4##(2008-10#1)(2008-7#1)
length was measured##3##3##(2008-10#1)(2008-7#1)(2010-1#1)
length was##12##2##(1993-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
length were##11##2##(1992-6#1)(1993-12#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-7#3)(2012-3#1)(2013-1#1)
length with the##3##3##(1993-8#1)(1996-6#1)(2008-7#1)
length with##5##2##(1993-8#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
length##778##1##(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#1)(1991-3#2)(1991-5#5)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#4)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#10)(1993-2#8)(1993-3#3)(1993-6#1)(1993-8#5)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#4)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#5)(1997-6#7)(1997-7#2)(1997-8#8)(1997-9#1)(2007-11#2)(2007-12#6)(2008-10#325)(2008-11#26)(2008-12#14)(2008-2#8)(2008-3#25)(2008-4#2)(2008-5#5)(2008-6#12)(2008-7#19)(2008-8#31)(2008-9#19)(2009-1#5)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#5)(2009-6#1)(2009-7#3)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#15)(2010-9#1)(2011-1#6)(2011-2#13)(2011-3#3)(2012-12#2)(2012-2#7)(2012-3#13)(2012-5#1)(2013-1#28)(2013-8#12)
length) were##3##2##(1990-2#1)(2008-10#1)(2008-11#1)
length)##12##1##(1990-2#1)(2008-10#8)(2008-11#1)(2008-9#1)(2010-12#1)
lengthen##2##1##(1990-12#1)(2012-3#1)
lengthened segments])##2##2##(2009-3#2)
lengthened the##2##2##(2008-11#1)(2008-5#1)
lengthened##6##1##(1991-2#1)(2008-11#1)(2008-5#2)(2009-3#2)
lengthening the##2##2##(2008-10#1)(2008-8#1)
lengthening##18##1##(1997-4#1)(2008-10#1)(2008-8#1)(2009-10#4)(2009-3#3)(2009-4#1)(2012-2#5)(2013-1#2)
lengths and##7##2##(1992-4#2)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)
lengths from##4##2##(1997-6#1)(2008-10#1)(2012-3#1)(2013-8#1)
lengths of pediatric patient stay##2##5##(1994-1#2)
lengths of stay##11##3##(1991-3#1)(1992-3#2)(1993-1#2)(1993-12#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-3#2)
lengths of the##3##3##(2008-10#3)
lengths of##26##2##(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#2)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1995-1#1)(1996-1#1)(1996-3#2)(2008-10#4)(2008-2#1)(2008-9#1)(2009-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
lengths on##2##2##(2008-10#2)
lengths were##6##2##(1995-6#1)(2008-10#2)(2008-2#1)(2009-3#2)
lengths when##2##2##(2008-10#1)(2008-3#1)
lengths##75##1##(1990-3#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-4#2)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#2)(1997-2#2)(1997-6#2)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-3#2)(2009-7#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#3)
lengthy process##2##2##(1990-12#1)(1992-2#1)
lengthy##11##1##(1990-12#1)(1992-12#2)(1992-2#1)(1994-8#2)(1996-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
lens and the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
lens and##9##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2010-8#1)
lens dose##2##2##(1993-9#2)
lens epithelial cells##2##3##(2012-2#2)
lens exchange with multifocal intraocular lens implantation##2##7##(2011-2#2)
lens exchange##3##2##(2011-2#3)
lens fibers##2##2##(2012-2#2)
lens of##2##2##(1993-3#1)(2008-10#1)
lens spectrometry (TLS)##3##3##(2008-10#3)
lens spectrometry##10##2##(2008-10#10)
lens##96##1##(1990-3#1)(1991-2#1)(1991-6#2)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#4)(2007-12#2)(2008-10#23)(2008-11#1)(2008-2#13)(2008-3#18)(2010-8#2)(2010-9#2)(2011-2#13)(2011-7#1)(2012-2#6)(2013-1#1)
lenses and##3##2##(1991-6#1)(2008-3#1)(2011-2#1)
lenses is##2##2##(2008-3#2)
lenses of##2##2##(1991-6#1)(2008-2#1)
lenses##20##1##(1991-2#1)(1991-6#2)(1991-9#1)(1993-11#3)(2008-10#2)(2008-2#2)(2008-3#4)(2008-7#1)(2011-2#4)
lensing##23##1##(2007-12#1)(2008-10#8)(2008-3#14)
lenslet##4##1##(2008-3#4)
lenticels##3##1##(2008-10#3)
lentiginous##2##1##(2010-6#1)(2012-3#1)
lentigo maligna melanoma##2##3##(2011-2#2)
lentigo maligna##3##2##(2011-2#3)
lentigo##8##1##(2011-2#8)
lentil and##2##2##(2008-10#2)
lentil lectin monomers##3##3##(1993-8#3)
lentil lectin##6##2##(1993-8#6)
lentil##17##1##(1993-8#6)(2008-10#11)
lentis##3##1##(2008-10#3)
leonurine##5##1##(2012-2#5)
lepidopteran##6##1##(1992-6#2)(2008-10#2)(2008-11#2)
lepidopterophagy##2##1##(2012-3#2)
lepidopterous and coleopteran pests##2##4##(2008-10#2)
leprae##2##1##(2011-2#2)
leprosis##6##1##(2008-10#6)
leprosy##3##1##(1990-5#1)(2011-2#1)(2012-2#1)
leptin and insulin resistance##2##4##(2013-1#1)(2013-8#1)
leptin and insulin##3##3##(2010-6#1)(2013-1#1)(2013-8#1)
leptin and##5##2##(2010-6#1)(2013-1#2)(2013-8#2)
leptin gene##3##2##(2008-10#3)
leptin in##4##2##(2008-4#1)(2008-9#1)(2012-3#2)
leptin levels##5##2##(2013-1#4)(2013-8#1)
leptin receptor##3##2##(2008-10#1)(2008-4#1)(2010-12#1)
leptin##38##1##(2008-10#6)(2008-4#7)(2008-9#3)(2010-12#1)(2010-6#1)(2010-7#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#7)
leptokurtic movement distributions##2##3##(2008-8#2)
leptokurtosis##3##1##(2008-8#3)
leptomeningeal venous disconnection##2##3##(2008-7#2)
leptomeningeal venous##4##2##(2008-7#4)
leptomeningeal##11##1##(2008-7#7)(2012-3#2)(2013-8#2)
leptospirosis##5##1##(1996-3#1)(2008-9#3)(2009-12#1)
les caractéristiques##2##2##(2013-1#2)
les complications##2##2##(2011-2#2)
les##29##1##(1990-6#1)(1996-3#1)(2008-11#4)(2008-5#2)(2009-10#1)(2011-2#6)(2013-1#14)
lesbian and bisexual college women##4##5##(2008-12#4)
lesbian and bisexual women##2##4##(2008-12#2)
lesbian and bisexual##7##3##(2008-12#7)
lesbian and gay adolescents##2##4##(1992-1#2)
lesbian and gay parents##4##4##(2012-2#4)
lesbian and gay##6##3##(1992-1#2)(2012-2#4)
lesbian and##14##2##(1992-1#2)(2008-12#8)(2012-2#4)
lesbian identity##2##2##(2008-12#2)
lesbian women##2##2##(2008-12#2)
lesbian##25##1##(1992-1#2)(1995-6#1)(2008-12#18)(2012-2#4)
lesbians are##2##2##(2008-12#2)
lesbians##6##1##(1996-5#1)(2008-12#5)
lesbians'##2##1##(2008-12#2)
lesion (1##2##2##(1997-6#1)(2008-12#1)
lesion after##2##2##(1997-8#1)(2011-2#1)
lesion and was##2##3##(1995-8#1)(2006-6#1)
lesion and##10##2##(1990-3#1)(1990-9#1)(1995-8#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-7#1)(2009-1#1)(2013-1#1)
lesion appearance##2##2##(2008-10#1)(2010-6#1)
lesion are##4##2##(2008-6#1)(2008-7#1)(2009-11#1)(2013-1#1)
lesion area##8##2##(2008-10#5)(2012-3#3)
lesion as##2##2##(2010-6#1)(2013-8#1)
lesion at##2##2##(2009-2#1)(2013-8#1)
lesion caused by##2##3##(1991-6#1)(2008-1#1)
lesion caused##3##2##(1991-6#1)(2008-1#1)(2008-10#1)
lesion conspicuity##5##2##(1997-8#5)
lesion density##11##2##(2008-10#11)
lesion detection and##2##3##(2008-1#1)(2010-12#1)
lesion detection##4##2##(1997-8#2)(2008-1#1)(2010-12#1)
lesion development##14##2##(1997-8#2)(2008-10#12)
lesion diameter##3##2##(1990-9#1)(2008-10#2)
lesion expansion and growth in planta##2##6##(2008-10#2)
lesion expansion##10##2##(2008-10#10)
lesion extension##6##2##(2008-10#5)(2012-3#1)
lesion for##2##2##(1991-5#1)(1994-12#1)
lesion formation##3##2##(1997-8#1)(2008-10#1)(2008-5#1)
lesion from##2##2##(2010-3#1)(2013-1#1)
lesion groups##2##2##(1993-3#2)
lesion growth rate of##2##4##(2008-8#2)
lesion had##3##2##(2008-10#1)(2010-6#1)(2012-3#1)
lesion has been##2##3##(1996-2#1)(2008-9#1)
lesion has##3##2##(1996-2#1)(2008-9#1)(2013-1#1)
lesion in the right##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
lesion in the##18##3##(1990-9#1)(1991-2#2)(1996-9#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
lesion in##25##2##(1990-9#1)(1991-2#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-11#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
lesion involving the##2##3##(2009-5#1)(2011-2#1)
lesion is##10##2##(1991-6#2)(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
lesion length was##2##3##(2008-10#2)
lesion length##9##2##(2008-10#9)
lesion lengths##2##2##(2008-10#2)
lesion may##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
lesion number##3##2##(2008-10#3)
lesion numbers##2##2##(2008-10#2)
lesion of nucleus robustus archistriatalis##2##5##(2008-8#2)
lesion of the nigrostriatal##2##4##(1994-8#1)(1996-12#1)
lesion of the##15##3##(1991-3#1)(1994-8#2)(1996-12#1)(1996-2#3)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
lesion of##24##2##(1990-8#1)(1991-2#1)(1991-3#1)(1994-8#2)(1996-12#1)(1996-2#3)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#5)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
lesion on the##4##3##(1996-3#1)(2008-10#1)(2010-6#1)(2012-12#1)
lesion on##8##2##(1994-8#1)(1996-3#1)(2008-10#1)(2010-6#1)(2012-12#2)(2013-1#2)
lesion or##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
lesion per##4##2##(2008-10#4)
lesion placement##2##2##(2008-7#1)(2010-6#1)
lesion resulted in##2##3##(1996-12#1)(2012-3#1)
lesion scores##6##2##(2008-5#6)
lesion should##2##2##(1996-3#1)(1997-8#1)
lesion size was##2##3##(2008-10#2)
lesion size##20##2##(1995-12#1)(2008-10#17)(2010-6#1)(2012-3#1)
lesion status##2##2##(2012-2#2)
lesion that##3##2##(2007-8#1)(2011-2#1)(2012-3#1)
lesion the##2##2##(1991-3#1)(1993-8#1)
lesion was a##2##3##(2010-6#1)(2013-1#1)
lesion was##24##2##(1990-8#1)(1995-11#1)(2008-10#3)(2008-8#1)(2009-11#1)(2010-12#1)(2010-6#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
lesion were##4##2##(1991-6#1)(1993-8#1)(1996-3#1)(2012-3#1)
lesion which##2##2##(2008-10#1)(2013-1#1)
lesion with##9##2##(1990-6#1)(1996-3#1)(1997-6#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
lesion##440##1##(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-2#4)(1991-3#3)(1991-5#1)(1991-6#5)(1991-7#1)(1992-12#2)(1992-2#3)(1993-1#2)(1993-3#8)(1993-6#1)(1993-8#3)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#4)(1995-11#4)(1995-12#3)(1995-8#2)(1996-12#4)(1996-2#7)(1996-3#6)(1996-9#4)(1997-2#3)(1997-3#1)(1997-6#3)(1997-7#2)(1997-8#26)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#122)(2008-11#8)(2008-12#6)(2008-2#2)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#16)(2008-8#8)(2008-9#4)(2009-1#2)(2009-11#4)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#6)(2010-3#2)(2010-5#1)(2010-6#11)(2010-7#1)(2011-2#30)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#18)(2013-1#27)(2013-8#9)
lesion-induced EEG changes##2##3##(1991-9#2)
lesion-induced deficits##2##2##(1991-2#1)(1997-2#1)
lesion-induced##8##1##(1991-12#1)(1991-2#1)(1991-9#2)(1993-3#2)(1996-12#1)(1997-2#1)
lesion-to-liver contrast##2##2##(1997-8#2)
lesion]##2##1##(1997-8#1)(2012-2#1)
lesioned animals##4##2##(1990-5#1)(1993-3#1)(1994-3#1)(2008-7#1)
lesioned monkeys##2##2##(1994-3#2)
lesioned pigeons##2##2##(1990-11#2)
lesioned rats##7##2##(1994-8#4)(1997-2#2)(2012-2#1)
lesioned##23##1##(1990-11#3)(1990-5#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#3)(1994-8#4)(1997-2#2)(2008-11#1)(2008-5#1)(2008-7#3)(2012-2#1)
lesioning the##2##2##(1993-6#1)(2008-7#1)
lesioning##4##1##(1993-6#1)(1994-8#1)(2008-7#2)
lesions after##2##2##(2010-7#1)(2012-3#1)
lesions and in##2##3##(2008-11#1)(2010-12#1)
lesions and##37##2##(1990-3#1)(1992-3#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1997-8#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#1)
lesions are##21##2##(1990-3#1)(1991-9#1)(1995-11#1)(1997-8#3)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#2)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)
lesions as##4##2##(1990-9#1)(2008-11#1)(2011-2#1)(2011-3#1)
lesions at the##2##3##(1992-6#1)(2008-12#1)
lesions at##6##2##(1992-6#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
lesions can##3##2##(1990-9#1)(2008-5#1)(2013-1#1)
lesions caused by##6##3##(1995-11#1)(2008-10#5)
lesions consisting of##2##3##(1990-5#1)(2008-10#1)
lesions consisting##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
lesions constitute##2##2##(2008-10#1)(2012-2#1)
lesions developed at##2##3##(2008-10#2)
lesions developed##4##2##(1997-8#1)(2008-10#3)
lesions diagnosed##2##2##(1991-2#1)(2013-1#1)
lesions due to##2##3##(2008-5#1)(2012-3#1)
lesions during the acute phase of##2##6##(2013-1#2)
lesions during##3##2##(2012-2#1)(2013-1#2)
lesions facilitated##2##2##(1993-6#1)(2009-10#1)
lesions from##2##2##(1991-8#1)(2008-10#1)
lesions had no effect on##3##5##(1990-5#1)(1993-6#1)(1994-2#1)
lesions had##5##2##(1990-5#1)(1993-6#1)(1994-2#1)(1997-8#1)(2012-3#1)
lesions have##3##2##(2008-12#1)(2008-7#2)
lesions in a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
lesions in female##2##3##(2008-9#1)(2013-8#1)
lesions in patients with##3##4##(1993-6#1)(1996-11#1)(2008-11#1)
lesions in patients##4##3##(1993-6#1)(1996-11#1)(2008-11#1)(2012-12#1)
lesions in the colon and##2##5##(2008-12#2)
lesions in the##37##3##(1991-3#1)(1992-12#1)(1993-9#1)(1995-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
lesions in this##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
lesions in##83##2##(1990-6#1)(1991-3#1)(1992-12#2)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-8#4)(2008-10#10)(2008-11#6)(2008-12#5)(2008-4#2)(2008-5#8)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-9#1)(2010-12#4)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
lesions increased##3##2##(1991-9#1)(2008-10#2)
lesions induced##2##2##(1990-5#1)(2008-10#1)
lesions involving the##2##3##(2008-7#1)(2012-3#1)
lesions involving##3##2##(1997-8#1)(2008-7#1)(2012-3#1)
lesions is##15##2##(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(2008-11#1)(2008-7#2)(2009-1#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
lesions may##3##2##(2008-10#1)(2008-7#1)(2010-6#1)
lesions occurred##2##2##(2011-2#1)(2012-3#1)
lesions of the LH##2##4##(2009-10#2)
lesions of the hippocampus##3##4##(1990-11#1)(1993-6#2)
lesions of the neostriatum##2##4##(1993-3#2)
lesions of the nucleus accumbens##3##5##(1993-6#1)(1994-3#1)(1996-5#1)
lesions of the nucleus##4##4##(1993-3#1)(1993-6#1)(1994-3#1)(1996-5#1)
lesions of the ventral##2##4##(1993-6#1)(1997-2#1)
lesions of the white matter##2##5##(1996-11#2)
lesions of the##44##3##(1990-11#1)(1990-3#2)(1990-5#1)(1993-3#4)(1993-6#9)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1996-11#2)(1996-5#3)(1997-2#1)(1997-3#1)(1997-8#2)(2008-7#2)(2008-8#1)(2009-10#2)(2012-2#2)(2012-3#3)
lesions of##70##2##(1990-11#2)(1990-3#2)(1990-5#1)(1991-2#1)(1993-3#4)(1993-6#10)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1996-11#2)(1996-5#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#4)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#2)(2009-11#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#2)
lesions often##2##2##(2008-10#2)
lesions on a##3##3##(1993-3#1)(2008-10#2)
lesions on the##14##3##(1991-9#1)(2008-10#8)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lesions on wounded##2##3##(2008-10#2)
lesions on##38##2##(1990-5#1)(1991-9#1)(1993-3#2)(2008-10#29)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lesions only##2##2##(2008-10#1)(2008-11#1)
lesions or##4##2##(1991-8#1)(1993-3#1)(1994-8#1)(2008-10#1)
lesions per cm(2))##2##3##(2008-10#2)
lesions per leaf for the##2##5##(2008-10#2)
lesions per leaf##3##3##(2008-10#3)
lesions per plant##2##3##(2008-10#2)
lesions per##9##2##(2008-10#9)
lesions produce##3##2##(1993-3#1)(2008-12#2)
lesions produced##3##2##(1993-3#1)(1993-6#1)(1994-8#1)
lesions should be##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
lesions showed##2##2##(1997-8#1)(2012-3#1)
lesions such as##3##3##(2010-12#1)(2011-2#1)(2012-3#1)
lesions tend to##2##3##(1997-8#1)(2008-7#1)
lesions than##3##2##(1991-2#1)(2008-10#2)
lesions that are##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
lesions that can be##2##4##(2008-9#1)(2012-2#1)
lesions that##13##2##(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)
lesions to the fruit##2##4##(2008-10#2)
lesions to the##3##3##(1993-8#1)(2008-10#2)
lesions to##7##2##(1993-8#1)(1997-4#1)(2008-10#3)(2012-3#1)(2013-8#1)
lesions treated with##2##3##(2008-10#1)(2008-5#1)
lesions using##2##2##(2008-2#1)(2009-12#1)
lesions was##8##2##(1990-6#1)(1993-3#1)(1993-8#1)(2008-10#2)(2008-5#1)(2010-6#1)(2013-1#1)
lesions were classified##2##3##(1990-12#1)(1993-8#1)
lesions were excised and##2##4##(2008-10#1)(2011-2#1)
lesions were located in##2##4##(1991-8#1)(2012-3#1)
lesions were observed##2##3##(2008-10#1)(2013-1#1)
lesions were repaired by##2##4##(2008-11#2)
lesions were##39##2##(1990-12#1)(1990-5#1)(1991-8#1)(1993-8#2)(1994-12#1)(2008-10#8)(2008-11#2)(2008-5#6)(2008-7#1)(2008-9#1)(2010-3#1)(2010-6#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
lesions which##3##2##(2008-7#1)(2010-12#1)(2011-2#1)
lesions who underwent##2##3##(2008-7#1)(2011-2#1)
lesions with##9##2##(1996-6#2)(1997-8#1)(2008-10#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
lesions within the##2##3##(2008-10#1)(2012-2#1)
lesions##758##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#4)(1990-5#8)(1990-6#4)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#9)(1991-3#3)(1991-6#5)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#16)(1993-6#24)(1993-8#7)(1993-9#1)(1994-1#9)(1994-11#5)(1994-12#11)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#6)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#29)(2007-11#1)(2007-8#3)(2008-1#3)(2008-10#155)(2008-11#23)(2008-12#15)(2008-2#2)(2008-4#3)(2008-5#41)(2008-6#2)(2008-7#33)(2008-8#4)(2008-9#11)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#3)(2009-5#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#23)(2010-3#2)(2010-6#14)(2010-7#2)(2010-9#3)(2011-1#1)(2011-2#58)(2011-3#7)(2011-7#1)(2012-12#4)(2012-2#29)(2012-3#37)(2013-1#25)(2013-7#1)(2013-8#10)
lesions)##9##1##(1991-2#1)(1994-12#2)(1994-6#1)(1997-2#1)(2008-10#3)(2011-2#1)
lesions]##3##1##(1990-9#1)(2008-11#1)(2012-3#1)
less about##2##2##(1995-11#1)(1996-6#1)
less abundant in##3##3##(1994-2#1)(1996-12#1)(2008-10#1)
less abundant##5##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
less accurate in##2##3##(2009-12#1)(2009-7#1)
less accurate##3##2##(2009-12#2)(2009-7#1)
less active in##3##3##(1995-11#1)(1996-2#1)(2011-2#1)
less active than##3##3##(1992-6#1)(1994-8#1)(1995-8#1)
less active##10##2##(1992-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-2#1)(2008-5#1)(2011-2#1)
less affected by##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-10#1)(2012-3#1)
less affected##9##2##(1991-5#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-10#1)(2012-3#1)(2013-1#1)
less affinity for##2##3##(1994-11#1)(2008-10#1)
less aggregated##2##2##(2008-10#2)
less aggressive##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2013-1#1)
less agreement with##4##3##(2013-1#4)
less agreement##5##2##(1995-1#1)(2013-1#4)
less amount of##2##3##(2008-10#1)(2008-12#1)
less amounts of##2##3##(1997-4#1)(2008-10#1)
less and##3##2##(1994-2#1)(1996-1#1)(2013-8#1)
less anxious##2##2##(1991-1#1)(2009-12#1)
less apparent##2##2##(2008-10#2)
less area##2##2##(1996-1#1)(2008-10#1)
less at##6##2##(1991-6#1)(1997-3#1)(2008-10#3)(2012-12#1)
less attention##2##2##(2008-9#1)(2009-4#1)
less attractive than ORE##2##4##(2008-10#2)
less attractive than##3##3##(2008-10#3)
less attractive to##2##3##(2008-10#2)
less attractive##7##2##(2008-10#5)(2013-8#2)
less black rot##2##3##(2008-10#2)
less blood##2##2##(2011-2#1)(2012-3#1)
less by##3##2##(1997-1#1)(2009-8#1)(2011-2#1)
less clear##9##2##(1991-12#1)(1992-2#1)(2008-10#2)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
less close##2##2##(2008-12#2)
less common allele##2##3##(1993-6#1)(1995-12#1)
less common in##2##3##(2009-1#1)(2010-6#1)
less common##6##2##(1993-6#1)(1995-12#1)(2009-1#1)(2009-12#1)(2010-6#1)(2011-2#1)
less commonly##5##2##(2008-11#1)(2011-2#3)(2012-3#1)
less complex##2##2##(1992-9#1)(1995-3#1)
less concerned##2##2##(1997-8#1)(2009-12#1)
less confusion and##3##3##(1997-3#1)(2013-1#2)
less consistent in##2##3##(2008-10#1)(2010-12#1)
less consistent##3##2##(1991-6#1)(2008-10#1)(2010-12#1)
less contaminated##2##2##(2008-11#2)
less differentiated##2##2##(2008-11#1)(2008-8#1)
less disease (P = 0##2##5##(2008-10#2)
less disease##10##2##(2008-10#10)
less diseased##2##2##(2008-10#2)
less educated##2##2##(1995-12#1)(2009-5#1)
less effective in##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
less effective than##4##3##(1990-8#1)(1995-11#1)(2008-10#2)
less effective##18##2##(1990-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
less effectively##2##2##(1996-2#1)(2008-11#1)
less efficient than the##2##4##(2008-11#1)(2008-9#1)
less efficient than##3##3##(1995-2#1)(2008-11#1)(2008-9#1)
less efficient##13##2##(1990-11#1)(1990-5#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2012-5#1)
less efficiently##2##2##(1991-7#1)(2008-10#1)
less emotional##2##2##(1994-1#1)(1995-1#1)
less evident##3##2##(1992-2#1)(1994-3#1)(2009-1#1)
less expensive than##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
less expensive##8##2##(1992-1#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
less extensive##5##2##(1992-5#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-6#1)
less favorably##2##2##(2008-10#1)(2008-7#1)
less flexion##2##2##(2008-9#2)
less for##4##2##(2008-10#3)(2008-9#1)
less frequent in##4##3##(1994-6#1)(2011-2#2)(2013-1#1)
less frequent than##2##3##(1996-11#1)(2008-6#1)
less frequent##13##2##(1993-6#1)(1994-6#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
less frequently in##2##3##(2008-4#1)(2011-2#1)
less frequently than##2##3##(2008-10#1)(2013-1#1)
less frequently##18##2##(1990-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-2#1)(2013-1#1)
less good##2##2##(1996-6#1)(2011-2#1)
less harmful##3##2##(1990-11#1)(2008-10#1)(2012-3#1)
less highly aligned##2##3##(2013-1#2)
less impaired##2##2##(1994-8#1)(2008-9#1)
less important than##2##3##(2008-11#1)(2010-6#1)
less important##10##2##(1990-5#1)(1991-2#2)(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)
less in the##6##3##(1994-11#1)(1995-3#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
less in##20##2##(1993-2#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(2008-10#8)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
less information##2##2##(2008-6#1)(2011-2#1)
less inhibitory than##2##3##(2008-10#2)
less inoculum##2##2##(2008-10#1)(2008-11#1)
less intense##4##2##(1996-3#1)(2008-10#1)(2008-3#2)
less intensive##2##2##(2008-10#2)
less intrusive##2##2##(2008-10#1)(2010-8#1)
less invasive and##4##3##(2008-10#1)(2008-7#2)(2010-12#1)
less invasive##8##2##(2008-10#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#2)
less is known about the##3##5##(1990-5#1)(1994-3#1)(2008-11#1)
less is known about##6##4##(1990-5#1)(1994-3#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
less is##9##2##(1990-5#1)(1993-12#2)(1994-3#1)(1996-9#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
less labor##2##2##(2008-11#2)
less laborious##3##2##(2008-10#3)
less likely than white##2##4##(1995-12#1)(1995-2#1)
less likely than##3##3##(1994-2#1)(1995-12#1)(1995-2#1)
less likely to be##4##4##(2008-4#1)(2008-8#1)(2009-5#1)(2010-11#1)
less likely to have##2##4##(1992-2#1)(1995-12#1)
less likely to provide##3##4##(1995-12#1)(2008-9#1)(2011-2#1)
less likely to receive##2##4##(1995-12#1)(2012-3#1)
less likely to##24##3##(1991-11#1)(1992-2#1)(1993-1#1)(1995-12#4)(1996-11#1)(1997-2#1)(2008-12#2)(2008-4#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-3#1)
less likely##28##2##(1991-11#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-12#5)(1995-2#1)(1996-11#1)(1997-2#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-3#1)
less marked##2##2##(1997-8#1)(2008-11#1)
less morbidity##2##2##(2008-10#1)(2008-7#1)
less obvious##2##2##(2008-10#1)(2008-2#1)
less of the##2##3##(2008-10#2)
less often##5##2##(1990-8#1)(2008-11#1)(2011-2#3)
less or##3##2##(2010-3#1)(2012-3#2)
less pain##2##2##(1992-2#1)(2008-3#1)
less pathogenic##2##2##(2008-10#2)
less polar environment##2##3##(1994-5#1)(2012-2#1)
less polar##3##2##(1990-2#1)(1994-5#1)(2012-2#1)
less positive potentials##2##3##(2008-10#2)
less positive values##3##3##(2008-10#3)
less positive##10##2##(2008-10#6)(2008-12#1)(2009-7#1)(2013-1#1)(2013-8#1)
less potent than##4##3##(1992-6#1)(1994-11#1)(1994-6#1)(1994-8#1)
less potent##6##2##(1992-1#1)(1992-6#1)(1994-11#2)(1994-6#1)(1994-8#1)
less precise##2##2##(2008-10#1)(2012-2#1)
less prevalent##3##2##(1993-1#1)(2011-2#1)(2012-3#1)
less prominent##2##2##(1995-2#1)(2011-2#1)
less pronounced than##3##3##(2006-6#1)(2008-10#1)(2008-7#1)
less pronounced##10##2##(1994-2#1)(2006-6#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-9#2)(2012-6#1)
less protection against##2##3##(1991-6#1)(2008-10#1)
less reliable##4##2##(2008-10#2)(2012-2#1)(2013-1#1)
less responsive to##2##3##(2008-1#1)(2008-9#1)
less risk of##2##3##(2008-10#1)(2013-8#1)
less risk##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
less robust##2##2##(2008-8#1)(2010-12#1)
less satisfactory##3##2##(2008-10#2)(2008-9#1)
less satisfied than##2##3##(1996-2#2)
less satisfied with##2##3##(1995-12#1)(2010-10#1)
less satisfied##5##2##(1992-3#1)(1995-12#1)(1996-2#2)(2010-10#1)
less sedentary behavior##2##3##(2013-1#2)
less segregated from##3##3##(2011-2#3)
less selective##2##2##(1996-2#1)(2008-10#1)
less sensitive than##3##3##(2008-10#1)(2010-6#1)(2010-7#1)
less sensitive to the##3##4##(2008-10#2)(2008-8#1)
less sensitive to##13##3##(1994-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)
less sensitive##22##2##(1994-8#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#2)
less severe in##3##3##(1994-5#1)(1997-2#1)(2008-10#1)
less severe than the##2##4##(2008-5#1)(2008-8#1)
less severe than##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
less severe##13##2##(1994-5#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#1)(2011-3#1)
less significant##3##2##(2008-10#2)(2013-1#1)
less similar##2##2##(2008-10#2)
less so##2##2##(1994-2#1)(2008-10#1)
less sophisticated##3##2##(1997-6#1)(2009-10#1)(2011-2#1)
less specific##3##2##(1991-2#1)(2008-10#2)
less stable##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
less stress and##2##3##(2013-1#2)
less stringent##3##2##(1995-6#1)(2008-12#1)(2010-11#1)
less strong##2##2##(2008-10#1)(2013-8#1)
less strongly##2##2##(2008-10#1)(2010-2#1)
less successful##4##2##(1991-2#1)(1993-2#1)(1994-2#1)(2008-10#1)
less suitable##2##2##(2008-10#1)(2011-2#1)
less suited for##2##3##(2008-10#1)(2012-12#1)
less susceptible to##4##3##(1993-12#1)(1994-6#1)(1996-12#1)(2008-10#1)
less susceptible##5##2##(1993-12#1)(1994-6#1)(1996-12#1)(2008-10#2)
less tense and elastic##2##4##(2008-5#2)
less than 0##91##3##(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#1)(1990-8#1)(1991-11#5)(1991-12#4)(1991-2#7)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#11)(1992-12#4)(1992-2#2)(1992-3#5)(1993-1#2)(1994-1#4)(1994-3#1)(1994-5#1)(1995-1#2)(2008-10#20)(2008-2#2)(2008-3#2)(2011-3#1)(2012-2#1)
less than 1 year##3##4##(1991-2#1)(1995-8#1)(2012-3#1)
less than 1##31##3##(1990-2#1)(1991-10#1)(1991-2#1)(1994-1#1)(1995-8#1)(2008-10#16)(2008-11#2)(2008-3#2)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#3)
less than 1% and##2##4##(2008-10#2)
less than 1% of##4##4##(1996-11#1)(2008-10#1)(2008-5#1)(2013-7#1)
less than 1%##14##3##(1992-2#1)(1996-11#1)(2008-10#9)(2008-5#1)(2008-8#1)(2013-7#1)
less than 10##12##3##(1990-12#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)
less than 10% of the##2##5##(2008-10#2)
less than 10% of##6##4##(1990-5#1)(2008-10#3)(2009-8#1)(2010-12#1)
less than 10%##14##3##(1990-5#1)(1995-12#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2009-8#1)(2010-12#1)
less than 100##4##3##(1990-5#1)(2008-10#2)(2008-5#1)
less than 11##2##3##(2008-10#2)
less than 12##3##3##(1993-12#1)(1996-3#1)(2008-10#1)
less than 14##2##3##(2008-10#1)(2013-8#1)
less than 2##19##3##(1990-9#1)(1991-8#1)(1995-2#1)(1997-4#1)(2008-10#12)(2008-11#1)(2013-1#2)
less than 2% of all##2##5##(2010-6#1)(2013-1#1)
less than 2% of##3##4##(2009-11#1)(2010-6#1)(2013-1#1)
less than 2%##11##3##(1996-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2009-11#1)(2010-6#1)(2013-1#1)
less than 20 min##2##4##(1994-3#1)(2008-10#1)
less than 20##9##3##(1990-12#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2008-9#1)
less than 20%##3##3##(1997-4#1)(1997-6#1)(2012-3#1)
less than 200##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
less than 24 hours post operatively from a tonsillectomy##2##8##(2013-1#2)
less than 25%##2##3##(1993-11#1)(2008-11#1)
less than 3##12##3##(1990-5#1)(2008-10#8)(2008-2#1)(2008-3#1)(2011-2#1)
less than 3%##3##3##(2008-10#2)(2013-8#1)
less than 3-kDa##2##3##(1990-5#2)
less than 30 s##3##4##(1990-5#1)(2008-10#2)
less than 30##6##3##(1990-5#1)(1993-1#1)(1994-12#1)(2008-10#2)(2011-3#1)
less than 4##7##3##(2008-10#7)
less than 4%##6##3##(1990-6#1)(2008-10#5)
less than 40##4##3##(1996-6#1)(1997-8#1)(2008-10#1)(2008-8#1)
less than 4min##2##3##(2008-10#2)
less than 5 min##3##4##(1993-3#1)(2008-10#2)
less than 5##8##3##(1993-3#1)(2008-10#3)(2010-11#1)(2011-2#1)(2012-3#2)
less than 5% for both##3##5##(2008-10#3)
less than 5% for##4##4##(2008-10#4)
less than 5% in##3##4##(1994-9#1)(2008-10#2)
less than 5% of the##2##5##(2008-10#1)(2008-5#1)
less than 5% of##6##4##(1991-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
less than 5%##27##3##(1991-12#1)(1994-9#1)(1995-6#1)(2008-10#17)(2008-5#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
less than 5%)##2##3##(2008-10#2)
less than 50##8##3##(1991-2#1)(1991-6#1)(1995-2#1)(2008-10#4)(2013-1#1)
less than 50% in##2##4##(1997-3#1)(2008-5#1)
less than 50% of##3##4##(1993-12#1)(1994-3#1)(2013-1#1)
less than 50%##9##3##(1993-12#1)(1994-3#1)(1997-3#1)(1997-7#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
less than 5min##2##3##(2008-10#2)
less than 6 months##2##4##(2008-11#1)(2013-1#1)
less than 6##6##3##(1992-6#1)(2008-10#3)(2008-11#1)(2013-1#1)
less than 60##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
less than 7##3##3##(1990-2#1)(1990-5#1)(1996-11#1)
less than 7%##2##3##(2008-10#1)(2008-2#1)
less than 75 years##2##4##(1991-2#1)(2008-5#1)
less than 75##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
less than 8 min##2##4##(2008-10#2)
less than 8##6##3##(1995-3#1)(2008-10#5)
less than 8% for##2##4##(2008-10#1)(2008-5#1)
less than 8%##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)
less than 90##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
less than a##3##3##(2008-11#2)(2012-3#1)
less than approximately##3##3##(2008-10#1)(2008-3#2)
less than did##2##3##(2008-10#2)
less than expected##2##3##(1995-11#1)(2008-10#1)
less than four##3##3##(1997-4#1)(2008-10#2)
less than half##2##3##(1995-6#1)(2008-10#1)
less than in the##2##4##(2008-10#2)
less than in##5##3##(1995-12#1)(2008-10#4)
less than one##8##3##(1990-12#1)(1991-6#1)(1992-9#1)(2008-10#3)(2012-3#1)(2013-8#1)
less than optimal##4##3##(1991-2#1)(1996-11#1)(1997-2#1)(2013-1#1)
less than or equal to##6##5##(1990-12#1)(1990-3#1)(1993-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
less than or##7##3##(1990-12#1)(1990-3#1)(1993-2#1)(1995-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
less than predicted##2##3##(2008-10#1)(2008-3#1)
less than seven##2##3##(1990-3#1)(1997-2#1)
less than that of the##2##5##(2007-12#1)(2008-5#1)
less than that of##4##4##(1997-4#1)(2007-12#1)(2008-5#1)(2008-9#1)
less than that with the##2##5##(2008-10#2)
less than that##9##3##(1994-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#3)
less than the mean of the components in##2##8##(2008-10#2)
less than the mean of the components##3##7##(2008-10#3)
less than the##18##3##(1992-2#1)(1996-12#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2013-1#1)
less than those of the control groups##4##7##(2008-9#4)
less than those of the##9##5##(1991-11#1)(2008-11#1)(2008-9#7)
less than those of##12##4##(1991-11#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-9#7)(2010-4#1)
less than those##14##3##(1991-11#1)(1991-3#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-9#7)(2010-4#1)
less than two years##2##4##(1996-3#1)(2012-12#1)
less than two##3##3##(1995-11#1)(1996-3#1)(2012-12#1)
less than##542##2##(1990-11#2)(1990-12#12)(1990-2#8)(1990-3#4)(1990-4#1)(1990-5#9)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#5)(1991-2#11)(1991-3#2)(1991-6#5)(1991-8#2)(1991-9#11)(1992-12#4)(1992-2#4)(1992-3#5)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-1#5)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#3)(1996-12#3)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#6)(1997-6#1)(1997-7#1)(1997-8#3)(2007-12#2)(2008-10#224)(2008-11#21)(2008-12#1)(2008-2#6)(2008-3#26)(2008-5#12)(2008-7#5)(2008-8#3)(2008-9#14)(2009-11#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#6)(2011-3#3)(2012-12#1)(2012-2#10)(2012-3#13)(2013-1#13)(2013-7#1)(2013-8#4)
less then##3##2##(2008-10#2)(2008-7#1)
less time consuming##2##3##(2008-10#2)
less time in##2##3##(1992-3#1)(2008-11#1)
less time##10##2##(1992-3#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-2#1)
less time-consuming##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
less to##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
less toxic than##3##3##(1994-5#2)(2008-10#1)
less toxic##7##2##(1991-8#1)(1994-5#2)(2008-10#3)(2011-2#1)
less variable##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
less virulent than##5##3##(2008-10#5)
less virulent##10##2##(2006-6#1)(2008-10#9)
less vulnerable to##2##3##(1996-11#1)(2009-8#1)
less well established##2##3##(2008-1#1)(2011-2#1)
less well than##2##3##(2008-10#1)(2008-11#1)
less well understood##4##3##(1995-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
less well##13##2##(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
less when##2##2##(2008-10#1)(2008-11#1)
less with a##2##3##(2008-10#2)
less with##3##2##(1992-9#1)(2008-10#2)
less##1414##1##(1990-11#5)(1990-12#15)(1990-2#11)(1990-3#5)(1990-4#1)(1990-5#13)(1990-6#1)(1990-8#4)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#7)(1991-12#9)(1991-2#15)(1991-3#3)(1991-5#1)(1991-6#9)(1991-7#1)(1991-8#3)(1991-9#11)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#10)(1992-3#8)(1992-5#1)(1992-6#4)(1992-9#4)(1993-1#9)(1993-11#3)(1993-12#8)(1993-2#9)(1993-3#2)(1993-6#3)(1993-8#2)(1994-1#6)(1994-11#6)(1994-12#5)(1994-2#14)(1994-3#6)(1994-5#8)(1994-6#3)(1994-8#6)(1994-9#1)(1995-1#5)(1995-11#8)(1995-12#17)(1995-2#7)(1995-3#5)(1995-5#3)(1995-6#4)(1995-8#6)(1995-9#1)(1996-1#4)(1996-11#8)(1996-12#6)(1996-2#12)(1996-3#6)(1996-5#3)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#6)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2006-6#2)(2007-12#3)(2008-1#6)(2008-10#457)(2008-11#62)(2008-12#17)(2008-2#9)(2008-3#39)(2008-4#7)(2008-5#28)(2008-6#3)(2008-7#23)(2008-8#27)(2008-9#42)(2009-1#2)(2009-10#7)(2009-11#7)(2009-12#8)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#7)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#7)(2010-7#7)(2010-8#6)(2010-9#3)(2011-1#3)(2011-10#1)(2011-2#65)(2011-3#4)(2011-7#1)(2012-12#5)(2012-2#28)(2012-3#28)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#54)(2013-7#1)(2013-8#17)
less-healthy##2##1##(2011-2#2)
less-thans##3##1##(2008-10#3)
lessen the##3##2##(1997-2#1)(1997-8#1)(2008-9#1)
lessen##4##1##(1997-2#1)(1997-8#1)(2008-9#1)(2009-9#1)
lessening##3##1##(1991-2#1)(2008-11#1)(2008-5#1)
lessens the##2##2##(2008-8#1)(2008-9#1)
lessens##3##1##(2008-8#1)(2008-9#1)(2010-12#1)
lesser amounts of the##2##4##(1995-6#1)(2008-11#1)
lesser amounts##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
lesser degree##12##2##(1991-12#1)(1993-8#1)(1994-6#1)(1994-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)
lesser extent in##3##3##(1997-2#1)(1997-9#1)(2008-11#1)
lesser extent to##2##3##(1990-11#1)(2011-2#1)
lesser extent##40##2##(1990-11#1)(1991-12#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-9#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)
lesser than##3##2##(2008-10#1)(2013-1#2)
lesser##75##1##(1990-10#1)(1990-11#1)(1991-12#2)(1991-8#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#3)(1995-8#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-9#1)(2008-10#21)(2008-11#5)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#3)
lesson##5##1##(1991-3#1)(1995-12#1)(2008-8#1)(2010-1#1)(2013-1#1)
lessons for##5##2##(1991-12#1)(1993-12#1)(1995-1#1)(1997-7#1)(2008-11#1)
lessons from the##7##3##(1993-2#1)(1994-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
lessons from##17##2##(1993-2#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2013-1#1)(2013-8#2)
lessons have been##2##3##(2008-10#1)(2008-12#1)
lessons have##3##2##(2008-10#2)(2008-12#1)
lessons in##2##2##(1992-2#1)(2008-10#1)
lessons learned and##2##3##(1994-2#1)(2009-10#1)
lessons learned for greater success##2##5##(1994-1#2)
lessons learned from a##2##4##(2008-8#1)(2010-8#1)
lessons learned from##6##3##(1994-3#2)(1997-2#1)(2008-8#1)(2010-8#1)(2013-1#1)
lessons learned in##2##3##(1995-12#1)(2008-8#1)
lessons learned##19##2##(1994-1#4)(1994-2#1)(1994-3#2)(1995-12#2)(1995-2#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-10#1)(2010-7#1)(2010-8#1)(2013-1#1)
lessons of##2##2##(1991-2#1)(1993-2#1)
lessons to be##2##3##(2008-12#2)
lessons to##3##2##(2008-12#2)(2013-1#1)
lessons we have learned##2##4##(2008-3#1)(2009-8#1)
lessons we##3##2##(2008-3#1)(2009-8#1)(2012-2#1)
lessons were learned##2##3##(1991-2#1)(1996-2#1)
lessons##69##1##(1991-12#1)(1991-2#3)(1992-2#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#6)(2008-3#3)(2008-6#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2012-2#1)(2013-1#4)(2013-8#2)
let the##4##2##(1994-1#1)(1995-6#1)(1997-8#1)(2008-6#1)
let##10##1##(1991-9#1)(1992-3#1)(1994-1#1)(1995-6#2)(1997-6#1)(1997-8#1)(2008-5#1)(2008-6#1)(2008-8#1)
let-7 in normal fimbrial epithelial cells of##2##7##(2012-12#2)
let-7##6##1##(2012-12#6)
lethal challenge##2##2##(1995-2#1)(2012-2#1)
lethal disease##2##2##(2011-2#1)(2013-1#1)
lethal dose##2##2##(1995-11#1)(2008-11#1)
lethal for##3##2##(1996-12#1)(2008-10#1)(2012-3#1)
lethal in##2##2##(1997-3#1)(2012-3#1)
lethal phenotype##3##2##(1995-2#1)(1997-3#1)(2008-12#1)
lethal photosensitization##2##2##(2012-2#2)
lethal to##3##2##(1993-12#1)(2008-10#2)
lethal##52##1##(1991-5#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#1)(1997-3#3)(1997-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#2)(2013-8#1)
lethality and##4##2##(1993-12#1)(1996-12#1)(1997-3#1)(2011-2#1)
lethality from##2##2##(1996-12#2)
lethality in##3##2##(1990-9#1)(1995-2#1)(2008-5#1)
lethality of##5##2##(1994-5#1)(1997-8#3)(2008-4#1)
lethality##26##1##(1990-9#1)(1993-12#2)(1994-5#2)(1995-2#1)(1996-12#7)(1997-3#1)(1997-8#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#1)
lethally irradiated mice##2##3##(2008-10#1)(2008-9#1)
lethally irradiated##4##2##(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
lethargy##5##1##(2008-11#1)(2008-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
lets##2##1##(2008-6#1)(2013-1#1)
letter and##2##2##(2008-11#1)(2008-12#1)
letter fluency##2##2##(1996-2#2)
letter to the##3##3##(2008-7#1)(2008-8#1)(2010-2#1)
letter##22##1##(1996-2#2)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-2#1)
letters and##6##2##(1990-9#1)(2008-10#1)(2010-5#1)(2013-1#2)(2013-8#1)
letters of##2##2##(1991-9#1)(2013-8#1)
letters or##2##2##(1990-8#1)(1997-3#1)
letters requesting##2##2##(1992-8#1)(2010-8#1)
letters##27##1##(1990-8#1)(1990-9#1)(1991-9#1)(1992-2#1)(1992-8#1)(1997-2#2)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2010-5#1)(2010-8#4)(2012-2#2)(2013-1#2)(2013-8#5)
letting##5##1##(1991-2#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-8#1)
lettuce (Lactuca sativa)##2##3##(2008-10#2)
lettuce and##11##2##(2008-10#10)(2008-11#1)
lettuce by##2##2##(2008-10#2)
lettuce cultivars##2##2##(2008-10#2)
lettuce downy mildew##4##3##(2008-10#4)
lettuce drop incidence##3##3##(2008-10#3)
lettuce drop##8##2##(2008-10#8)
lettuce in Ohio##2##3##(2008-10#2)
lettuce infected with##2##3##(2008-10#2)
lettuce infectious yellows virus##3##4##(2008-10#3)
lettuce is##3##2##(2008-10#2)(2008-11#1)
lettuce leaves##2##2##(2008-10#2)
lettuce plants##5##2##(2008-10#5)
lettuce seedlings##4##2##(2008-10#4)
lettuce to##3##2##(2008-10#2)(2013-8#1)
lettuce##94##1##(2008-10#89)(2008-11#4)(2013-8#1)
lettuce)##3##1##(2008-10#3)
leucine aminopeptidase##2##2##(1992-3#1)(2012-6#1)
leucine and##5##2##(1994-8#1)(2008-10#1)(2008-11#3)
leucine rich repeat##2##3##(2008-9#2)
leucine zipper##3##2##(1993-12#2)(1996-6#1)
leucine##26##1##(1991-12#1)(1992-3#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-6#1)(1997-7#1)(1997-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#2)(2008-9#2)(2010-6#1)(2012-6#1)
leucine-rich repeat##3##2##(2009-6#2)(2009-8#1)
leucine-rich##4##1##(1992-10#1)(2009-6#2)(2009-8#1)
leucinostatin A##2##2##(1994-3#2)
leucisculus##5##1##(2012-2#5)
leucite and apatite glass-ceramics##2##4##(2009-7#2)
leucite##3##1##(2009-7#3)
leuco Xylene cyanol FF##2##4##(2008-10#2)
leuco Xylene##3##2##(2008-10#3)
leuco crystal violet##2##3##(2008-10#2)
leuco##5##1##(2008-10#5)
leucocrystal violet##2##2##(2008-10#2)
leucocyte counts##2##2##(1990-10#1)(2008-10#1)
leucocyte##9##1##(1990-10#1)(1991-12#2)(1993-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)
leucocytes##5##1##(1991-11#4)(2008-10#1)
leucocytosis and##2##2##(1993-6#1)(2009-11#1)
leucocytosis##4##1##(1993-6#1)(1997-8#1)(2008-12#1)(2009-11#1)
leucovorin##2##1##(1990-2#1)(2008-10#1)
leucrose##2##1##(1992-12#2)
leucémie aiguë##6##2##(2013-1#6)
leucémies aiguës myéloblastiques##2##3##(2013-1#2)
leucémies aiguës##3##2##(2013-1#3)
leukaemia and##2##2##(2008-7#1)(2009-3#1)
leukaemia with##2##2##(1993-2#1)(2011-3#1)
leukaemia##30##1##(1993-2#1)(2006-6#2)(2008-11#3)(2008-12#6)(2008-7#2)(2009-12#1)(2009-3#4)(2010-11#2)(2011-2#5)(2011-3#2)(2013-1#2)
leukaemias##2##1##(2008-11#1)(2011-2#1)
leukaemic##2##1##(2010-11#1)(2013-7#1)
leukemia (ALL)##3##2##(1991-8#1)(2010-6#1)(2011-2#1)
leukemia (AML)##7##2##(2008-4#1)(2010-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
leukemia (CML)##4##2##(1990-2#1)(2009-7#1)(2010-11#1)(2011-2#1)
leukemia HL-60 cells##2##3##(2008-11#1)(2008-8#1)
leukemia and lymphoma##5##3##(1991-3#1)(1992-3#3)(2013-1#1)
leukemia and##12##2##(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#3)(1997-7#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
leukemia cell line##4##3##(1993-6#1)(2008-11#1)(2008-4#1)(2008-9#1)
leukemia cell lines A20##2##4##(2008-9#2)
leukemia cell lines##6##3##(1993-3#2)(2008-11#2)(2008-9#2)
leukemia cell##11##2##(1993-3#2)(1993-6#1)(2008-11#4)(2008-4#1)(2008-9#3)
leukemia cells##11##2##(1990-2#1)(1990-6#1)(1994-5#1)(1995-2#1)(2008-11#3)(2008-9#1)(2009-12#2)(2013-1#1)
leukemia in a##3##3##(1990-8#2)(2009-8#1)
leukemia in##5##2##(1990-8#2)(2008-11#1)(2008-9#1)(2009-8#1)
leukemia inhibitory factor (LIF)##3##4##(1991-12#1)(1995-11#1)(1996-2#1)
leukemia inhibitory factor##4##3##(1991-12#1)(1995-11#1)(1996-2#1)(2010-6#1)
leukemia mortality##2##2##(1991-3#2)
leukemia or##3##2##(1991-3#1)(2010-11#1)(2011-2#1)
leukemia patients##3##2##(1991-2#1)(2008-9#1)(2011-2#1)
leukemia presenting##2##2##(2008-11#1)(2011-2#1)
leukemia stem cells##2##3##(2011-2#2)
leukemia virus##10##2##(1990-8#1)(1995-2#1)(1997-8#1)(2008-11#5)(2011-2#1)(2012-3#1)
leukemia virus-transformed lamb##2##3##(1995-8#1)(2008-11#1)
leukemia virus-transformed##3##2##(1995-8#2)(2008-11#1)
leukemia was##4##2##(1991-2#1)(1991-3#1)(2008-11#1)(2012-3#1)
leukemia with##2##2##(1992-12#1)(2012-3#1)
leukemia##172##1##(1990-2#2)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#3)(1991-3#5)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#3)(1993-6#1)(1994-5#2)(1995-11#1)(1995-2#3)(1995-8#2)(1996-2#1)(1996-3#1)(1997-5#4)(1997-7#2)(1997-8#1)(2008-10#10)(2008-11#30)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#14)(2009-12#6)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-11#4)(2010-6#5)(2010-8#1)(2011-2#23)(2012-12#1)(2012-3#6)(2013-1#6)(2013-8#1)
leukemias##4##1##(1990-8#2)(1992-2#1)(2011-2#1)
leukemic cell line##2##3##(1990-5#1)(2008-11#1)
leukemic cell lines##3##3##(1990-2#1)(2008-11#1)(2008-9#1)
leukemic cell##6##2##(1990-2#1)(1990-5#1)(1993-12#1)(2008-11#2)(2008-9#1)
leukemic cells##15##2##(1991-2#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#2)(1995-2#1)(2008-11#2)(2008-9#3)(2010-6#1)(2011-2#1)
leukemic##27##1##(1990-2#1)(1990-5#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#3)(1995-2#1)(2008-11#4)(2008-9#5)(2009-12#1)(2010-6#2)(2011-2#2)(2013-1#2)
leukocyte 12-lipoxygenase##3##2##(1994-11#3)
leukocyte adherence##2##2##(1991-12#1)(1991-5#1)
leukocyte adhesion##4##2##(1995-2#2)(2008-11#1)(2012-12#1)
leukocyte counts##2##2##(1994-12#1)(2008-9#1)
leukocyte elastase (HLE)##3##3##(1992-12#1)(1993-8#1)(2008-5#1)
leukocyte elastase##4##2##(1992-12#1)(1993-8#1)(2008-5#2)
leukocyte subpopulations##2##2##(1995-12#2)
leukocyte subsets##2##2##(2008-9#1)(2009-6#1)
leukocyte transendothelial migration##2##3##(1995-2#2)
leukocyte##47##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-12#3)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1995-12#2)(1995-2#4)(1997-1#1)(2006-6#3)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#8)(2009-12#1)(2009-6#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
leukocyte-endothelium interaction##2##2##(1995-2#2)
leukocytes and##8##2##(1991-5#2)(1995-12#1)(2006-6#2)(2008-10#1)(2008-5#2)
leukocytes in##3##2##(1992-12#1)(1996-3#1)(2008-10#1)
leukocytes through endothelial##2##3##(2008-10#2)
leukocytes to##3##2##(1992-12#1)(1995-2#1)(2008-5#1)
leukocytes with##2##2##(1994-11#1)(2008-12#1)
leukocytes##61##1##(1990-3#1)(1991-2#1)(1991-5#3)(1992-12#4)(1992-6#3)(1993-6#2)(1994-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-6#2)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#6)(2008-5#5)(2008-9#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-8#2)(2013-1#5)
leukocytes)##2##1##(2008-10#1)(2013-8#1)
leukocytic chemotaxis##3##2##(2008-10#3)
leukocytic##4##1##(2008-10#4)
leukocytoclastic##2##1##(1997-4#1)(1997-8#1)
leukocytosis##5##1##(1990-9#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
leukodystrophy##4##1##(1997-3#2)(2008-11#2)
leukoencephalopathy##7##1##(1991-8#2)(1996-11#1)(2007-9#1)(2008-8#1)(2010-12#2)
leukopenia and##2##2##(2008-5#1)(2008-8#1)
leukopenia in##2##2##(1991-8#1)(1993-2#1)
leukopenia##8##1##(1990-12#1)(1991-6#2)(1991-8#1)(1993-2#1)(1994-8#1)(2008-5#1)(2008-8#1)
leukotriene B4##2##2##(1991-5#1)(1994-8#1)
leukotriene C4##2##2##(1992-3#1)(1993-6#1)
leukotriene D4 receptor##5##3##(1993-6#5)
leukotriene D4##6##2##(1993-6#6)
leukotriene receptor antagonists##2##3##(2008-1#1)(2012-12#1)
leukotriene receptor##4##2##(2008-1#2)(2012-12#2)
leukotriene##21##1##(1991-5#1)(1992-3#1)(1993-6#9)(1994-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-6#1)(2010-1#2)(2012-12#2)
leukotrienes##6##1##(1993-6#1)(1994-8#2)(2008-1#1)(2010-1#2)
leupeptin##2##1##(1995-6#1)(2008-10#1)
leur##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
levamisole and##2##2##(2008-1#2)
levamisole##10##1##(1991-8#1)(1996-6#1)(2008-1#7)(2013-1#1)
levator scapulae##2##2##(2010-9#2)
level (2##2##2##(1993-1#2)
level (4##2##2##(2013-1#1)(2013-8#1)
level (ICPC##2##2##(1994-6#2)
level (MCL)##2##2##(2008-10#1)(2008-9#1)
level (i##2##2##(2008-10#2)
level (p &lt##3##3##(1994-11#2)(2008-3#1)
level (p##4##2##(1994-11#2)(2008-3#1)(2011-2#1)
level C##2##2##(2008-10#2)
level III##5##2##(1994-12#2)(2008-10#2)(2008-11#1)
level about##2##2##(1997-3#1)(2008-10#1)
level above##2##2##(2008-11#1)(2012-3#1)
level after##7##2##(1994-5#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-6#1)
level and increased##2##3##(2008-10#2)
level and on##3##3##(2008-10#1)(2010-11#1)(2010-12#1)
level and the calibration curve was linear over the concentration range##2##11##(2008-10#2)
level and the##7##3##(1993-3#1)(1996-2#1)(1997-5#1)(2008-10#3)(2008-3#1)
level and type of##3##4##(1996-2#1)(2008-11#1)(2010-5#1)
level and with##2##3##(2008-10#1)(2008-12#1)
level and##80##2##(1990-12#3)(1991-1#1)(1991-3#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-5#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-3#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#8)(2012-2#2)(2013-1#3)
level are obtained##2##3##(2007-12#1)(2008-10#1)
level are##5##2##(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
level as low as 0##2##5##(2008-10#2)
level as the##4##3##(1991-11#1)(1991-12#1)(2008-10#1)(2008-5#1)
level as##14##2##(1991-11#1)(1991-12#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-2#1)
level at a##2##3##(2008-10#2)
level at the##3##3##(2008-9#2)(2013-1#1)
level at which##2##3##(2008-10#1)(2011-2#1)
level at##13##2##(1991-6#1)(1997-1#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-9#2)(2011-2#1)(2013-1#1)
level attained with##2##3##(1994-11#1)(2008-11#1)
level attained##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
level based on the##2##4##(2008-10#2)
level based on##3##3##(2008-10#3)
level below##5##2##(1991-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
level between the##2##3##(2008-10#2)
level between##5##2##(2008-10#4)(2013-1#1)
level but##2##2##(2008-8#1)(2008-9#1)
level by thermal lensing##2##4##(2008-10#2)
level by##16##2##(1994-3#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-4#2)(2011-2#2)(2013-1#1)
level can be##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2009-8#1)
level caused##2##2##(2008-10#1)(2008-12#1)
level data##2##2##(2011-9#2)
level decreased##3##2##(2008-11#1)(2008-7#1)(2011-1#1)
level decreases##2##2##(2008-10#1)(2008-9#1)
level detection##2##2##(2008-10#1)(2012-2#1)
level determination##5##2##(2008-10#4)(2009-8#1)
level did not##2##3##(2008-7#1)(2009-6#1)
level due to##4##3##(1996-12#1)(2008-10#1)(2011-10#1)(2012-12#1)
level during the##3##3##(1994-12#2)(2008-8#1)
level during##7##2##(1990-9#1)(1993-9#1)(1994-12#2)(2008-10#1)(2008-12#1)(2008-8#1)
level elimination##2##2##(2008-10#2)
level expression and##2##3##(1994-6#1)(2008-8#1)
level expression of##2##3##(1994-8#1)(2008-11#1)
level expression##5##2##(1994-6#1)(1994-8#1)(2008-11#1)(2008-8#2)
level for the##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
level for##21##2##(1993-9#1)(1996-12#1)(1996-8#1)(2008-10#10)(2008-3#1)(2008-8#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#3)
level from##5##2##(1990-2#1)(2008-10#2)(2008-8#1)(2012-2#1)
level had##3##2##(1990-2#1)(2008-10#2)
level have##2##2##(1997-7#1)(2008-10#1)
level higher than##2##3##(2008-10#1)(2011-2#1)
level in a##2##3##(2008-10#2)
level in the thymus##2##4##(1993-3#1)(2008-10#1)
level in the##27##3##(1990-3#1)(1993-3#2)(1996-12#1)(1996-2#4)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)
level in##74##2##(1990-3#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#4)(2007-12#1)(2008-10#16)(2008-11#6)(2008-12#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#2)(2013-7#1)
level including##2##2##(2008-11#1)(2008-7#1)
level increased##4##2##(1997-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
level is##17##2##(1993-11#1)(1996-1#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-8#2)(2011-2#1)
level lasted for 3 hours##2##5##(2008-8#2)
level observed##3##2##(1993-8#1)(1997-9#2)
level of 0##7##3##(2007-12#1)(2008-10#5)(2008-12#1)
level of 1##5##3##(2008-10#4)(2008-11#1)
level of 3##2##3##(2008-10#1)(2008-11#1)
level of 4##3##3##(1990-8#1)(2008-10#1)(2013-1#1)
level of 8##2##3##(1990-11#1)(2008-10#1)
level of ATP##2##3##(2008-11#1)(2008-8#1)
level of CAT##3##3##(1997-8#1)(2008-11#2)
level of DNA damage was##2##5##(1994-8#2)
level of PHS##2##3##(2012-3#2)
level of PVA addition##2##4##(2008-10#2)
level of PVA##3##3##(2008-10#3)
level of a##2##3##(1992-9#1)(1993-12#1)
level of about 0##2##4##(2008-10#1)(2009-5#1)
level of accuracy##6##3##(1993-5#1)(2008-10#4)(2008-3#1)
level of activity##4##3##(1994-2#2)(2008-10#1)(2010-10#1)
level of aggressiveness##2##3##(2008-10#2)
level of antibody production##2##4##(2008-11#2)
level of apoptosis##2##3##(2008-11#1)(2008-12#1)
level of approximately##2##3##(2008-11#1)(2008-3#1)
level of athleticism##2##3##(2009-7#2)
level of both##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
level of calcium##2##3##(1994-3#1)(2008-8#1)
level of care##8##3##(1991-1#1)(2008-10#1)(2010-10#1)(2012-12#4)(2013-8#1)
level of cell death##2##4##(2008-11#2)
level of cell##3##3##(2008-11#3)
level of colonization##2##3##(2008-10#1)(2008-11#1)
level of competence##2##3##(1991-6#1)(2007-12#1)
level of concern##2##3##(1993-3#1)(2008-10#1)
level of confidence in##2##4##(2008-10#2)
level of confidence##9##3##(2008-10#7)(2008-9#1)(2009-7#1)
level of consciousness##3##3##(1997-3#1)(2008-7#1)(2012-12#1)
level of conservation##2##3##(2008-11#1)(2008-9#1)
level of control##3##3##(2008-10#2)(2008-11#1)
level of detection (LOD)##2##4##(2008-10#2)
level of detection of##2##4##(2008-10#1)(2008-5#1)
level of detection##6##3##(1993-8#1)(2008-10#4)(2008-5#1)
level of disease incidence##2##4##(2008-10#2)
level of disease##10##3##(2008-10#9)(2008-7#1)
level of diversity##3##3##(2008-10#3)
level of education and the##2##5##(1991-2#1)(2013-1#1)
level of education##5##3##(1991-2#1)(1994-3#1)(2010-1#1)(2010-11#1)(2013-1#1)
level of environmental##2##3##(2008-10#1)(2008-8#1)
level of exposure##2##3##(1996-3#1)(2013-1#1)
level of expression of the##5##5##(2008-10#2)(2008-11#2)(2011-1#1)
level of expression##12##3##(1992-10#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
level of functioning##3##3##(1993-2#1)(1997-8#2)
level of gene##4##3##(1994-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
level of genetic differentiation among##2##5##(2008-10#2)
level of genetic differentiation##4##4##(2008-10#4)
level of genetic variation##2##4##(2008-10#2)
level of genetic##8##3##(2008-10#8)
level of genotype resistance##2##4##(2008-10#2)
level of health care##2##4##(1990-2#1)(1993-3#1)
level of health##3##3##(1990-2#1)(1993-3#1)(2008-10#1)
level of induction##3##3##(2008-10#2)(2008-11#1)
level of knowledge##6##3##(2008-11#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
level of latent infection##2##4##(2008-10#2)
level of light##2##3##(2008-10#2)
level of lipid peroxidation##2##4##(1991-5#1)(2009-8#1)
level of lipid##3##3##(1991-5#1)(2009-8#2)
level of mRNA##3##3##(1993-9#1)(1995-12#1)(2008-8#1)
level of neck##2##3##(2009-4#1)(2013-1#1)
level of noise##3##3##(2008-10#1)(2008-9#2)
level of parasite virulence##2##4##(2008-8#2)
level of physical activity##3##4##(2008-12#1)(2013-1#2)
level of polymorphism##2##3##(2008-10#1)(2008-12#1)
level of population##2##3##(2008-10#1)(2008-12#1)
level of processing##3##3##(2008-11#1)(2009-10#1)(2009-12#1)
level of protection##4##3##(1996-12#1)(2008-10#3)
level of quality##2##3##(2013-1#2)
level of recombinant human##2##4##(1993-6#1)(2008-7#1)
level of reporter gene expression##2##5##(1995-2#1)(2008-8#1)
level of reproductive effort##2##4##(2008-8#2)
level of resistance of##2##4##(2008-10#2)
level of resistance to Tomato##2##5##(2008-10#2)
level of resistance to WB on##2##6##(2008-10#2)
level of resistance to##6##4##(2008-10#6)
level of resistance was##3##4##(2008-10#3)
level of resistance##19##3##(2008-10#18)(2008-8#1)
level of resolution##2##3##(2008-10#1)(2008-7#1)
level of satisfaction with the##2##5##(2008-11#1)(2013-8#1)
level of selfishness##3##3##(2008-9#3)
level of sensitivity##2##3##(2008-4#1)(2008-9#1)
level of significance##3##3##(1992-2#1)(2010-6#1)(2010-9#1)
level of stress##3##3##(2008-11#3)
level of superoxide##2##3##(1993-6#1)(2008-10#1)
level of the##55##3##(1990-3#2)(1991-12#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-12#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2008-10#9)(2008-11#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
level of their##2##3##(2008-10#1)(2008-11#1)
level of this##2##3##(2008-10#2)
level of use##2##3##(1991-3#1)(1994-2#1)
level of virulence##3##3##(2008-10#3)
level of virus accumulation##2##4##(2008-10#2)
level of virus##3##3##(2008-10#3)
level of vitamin##2##3##(1990-8#1)(1993-12#1)
level of##770##2##(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#2)(1991-6#4)(1992-1#4)(1992-10#3)(1992-2#3)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#7)(1993-5#1)(1993-6#6)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#10)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#4)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#14)(1996-2#3)(1996-3#3)(1996-6#1)(1996-9#3)(1997-1#7)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#8)(2006-6#1)(2007-12#4)(2007-8#1)(2008-1#7)(2008-10#223)(2008-11#67)(2008-12#12)(2008-3#3)(2008-4#2)(2008-5#16)(2008-6#2)(2008-7#16)(2008-8#45)(2008-9#19)(2009-1#1)(2009-10#3)(2009-12#6)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#8)(2009-8#15)(2009-9#1)(2010-1#4)(2010-10#6)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#10)(2011-10#1)(2011-2#16)(2011-3#1)(2011-7#1)(2012-12#8)(2012-2#11)(2012-3#15)(2013-1#20)(2013-8#16)
level on##9##2##(1996-3#2)(2008-10#3)(2008-11#1)(2008-9#2)(2011-2#1)
level or##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
level reached##2##2##(2008-10#1)(2008-11#1)
level remained##2##2##(2011-1#1)(2012-5#1)
level required##2##2##(2008-8#1)(2010-7#1)
level revealed##2##2##(2008-10#1)(2008-11#1)
level set by##2##3##(2008-10#1)(2008-9#1)
level set##4##2##(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)
level sets##2##2##(2008-6#2)
level showed##2##2##(2008-12#1)(2011-1#1)
level significantly increased in##2##4##(2008-11#1)(2008-12#1)
level similar to##3##3##(2008-10#3)
level than##3##2##(1995-12#1)(2008-10#2)
level that##6##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-3#1)
level the##8##2##(1991-6#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
level to the##2##3##(1993-2#1)(2011-2#1)
level to##10##2##(1990-6#1)(1993-2#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-7#1)(2010-9#1)(2011-2#1)
level using a##2##3##(1997-2#1)(2008-10#1)
level using##4##2##(1997-2#1)(2008-10#2)(2008-11#1)
level was 3##4##3##(2008-10#3)(2010-3#1)
level was 4##2##3##(2008-10#2)
level was also##3##3##(1995-2#1)(2008-11#2)
level was below the##2##4##(1992-6#1)(2011-2#1)
level was determined by##2##4##(2008-10#1)(2008-7#1)
level was determined##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
level was found in##2##4##(1996-2#1)(2008-10#1)
level was found##4##3##(1996-2#1)(2008-10#2)(2008-11#1)
level was normal##2##3##(1991-6#1)(2008-7#1)
level was not##2##3##(1996-12#1)(1997-1#1)
level was observed##7##3##(2008-10#6)(2008-7#1)
level was significantly higher in the##2##6##(1993-1#1)(2011-2#1)
level was significantly##9##3##(1992-3#1)(1993-1#1)(1996-12#5)(2008-10#1)(2011-2#1)
level was##79##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#3)(1992-11#1)(1992-3#2)(1992-6#2)(1993-1#1)(1995-12#1)(1995-2#1)(1996-12#6)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#6)(2008-1#2)(2008-10#24)(2008-11#5)(2008-7#3)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#2)
level were all below##2##4##(2008-10#2)
level were below 10%##2##4##(2008-10#2)
level were obtained##2##3##(2008-10#2)
level were significantly##2##3##(1997-2#1)(2008-12#1)
level were##16##2##(1996-2#1)(1997-2#1)(2008-10#12)(2008-12#2)
level where##2##2##(2008-10#2)
level while##2##2##(2008-10#1)(2008-8#1)
level will##3##2##(1997-2#1)(2008-11#1)(2009-10#1)
level with the##2##3##(2008-10#2)
level with those##2##3##(1994-2#1)(2008-10#1)
level with##15##2##(1993-2#1)(1994-2#1)(1997-2#1)(2008-10#9)(2008-4#1)(2008-7#1)(2010-11#1)
level within##4##2##(1995-1#1)(1997-7#1)(2008-10#1)(2011-2#1)
level without##3##2##(1993-8#1)(2008-7#1)(2008-8#1)
level##1962##1##(1990-11#3)(1990-12#7)(1990-2#10)(1990-3#6)(1990-5#2)(1990-6#3)(1990-8#4)(1990-9#3)(1991-1#2)(1991-11#5)(1991-12#5)(1991-2#9)(1991-3#6)(1991-5#5)(1991-6#15)(1991-7#1)(1991-9#2)(1992-1#7)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#5)(1992-3#4)(1992-6#4)(1992-9#2)(1993-1#7)(1993-11#8)(1993-12#11)(1993-2#6)(1993-3#14)(1993-5#2)(1993-6#9)(1993-8#8)(1993-9#5)(1994-11#12)(1994-12#15)(1994-2#18)(1994-3#3)(1994-5#5)(1994-6#9)(1994-8#9)(1995-1#3)(1995-11#9)(1995-12#6)(1995-2#8)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#5)(1995-9#2)(1996-1#5)(1996-12#30)(1996-2#14)(1996-3#9)(1996-5#2)(1996-6#5)(1996-8#1)(1996-9#3)(1997-1#12)(1997-2#11)(1997-3#9)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#9)(1997-8#11)(1997-9#2)(2006-6#1)(2007-12#13)(2007-8#1)(2008-1#16)(2008-10#602)(2008-11#158)(2008-12#52)(2008-3#16)(2008-4#6)(2008-5#31)(2008-6#14)(2008-7#47)(2008-8#101)(2008-9#51)(2009-1#1)(2009-10#7)(2009-12#7)(2009-2#1)(2009-3#5)(2009-4#6)(2009-5#3)(2009-6#8)(2009-7#12)(2009-8#26)(2009-9#2)(2010-1#6)(2010-10#9)(2010-11#9)(2010-12#8)(2010-2#1)(2010-3#4)(2010-4#9)(2010-5#7)(2010-6#6)(2010-7#7)(2010-8#5)(2010-9#6)(2011-1#20)(2011-10#4)(2011-2#71)(2011-3#3)(2011-7#1)(2011-9#4)(2012-12#15)(2012-2#23)(2012-3#32)(2012-5#4)(2012-6#1)(2013-1#63)(2013-7#1)(2013-8#28)
level) and##6##2##(2008-10#6)
level) for##2##2##(2008-10#2)
level)##33##1##(1995-8#1)(1997-8#1)(2008-10#30)(2008-3#1)
level-set##5##1##(2008-6#5)
leveled##3##1##(1997-7#1)(2011-2#1)(2013-1#1)
leveling##3##1##(1995-12#1)(2012-3#2)
levels &gt##3##2##(2008-10#3)
levels &lt##2##2##(2008-10#2)
levels (0##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
levels (p&lt##2##2##(2008-12#1)(2011-2#1)
levels above the##2##3##(2008-6#1)(2009-6#1)
levels above##6##2##(1996-1#1)(2008-10#3)(2008-6#1)(2009-6#1)
levels after 24##2##3##(1991-12#1)(2009-8#1)
levels after the##2##3##(1991-2#1)(2008-10#1)
levels after##12##2##(1990-11#1)(1991-12#1)(1991-2#1)(1995-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#2)
levels along##2##2##(2008-10#1)(2010-7#1)
levels also were##3##3##(1993-2#1)(2008-10#1)(2012-3#1)
levels also##4##2##(1993-2#1)(1996-12#1)(2008-10#1)(2012-3#1)
levels among##5##2##(1995-12#1)(1996-12#1)(2008-1#1)(2008-11#1)(2009-11#1)
levels and activities of##2##4##(2008-10#1)(2008-5#1)
levels and changes in##2##4##(1991-2#2)
levels and higher##2##3##(1992-9#1)(2008-8#1)
levels and that##2##3##(1996-12#1)(1997-7#1)
levels and the##9##3##(1991-1#1)(1991-2#1)(1993-11#1)(2008-10#3)(2008-5#2)(2009-10#1)
levels and their##3##3##(2008-10#1)(2010-9#2)
levels and##103##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-12#3)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#19)(2008-11#9)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#3)(2012-4#2)(2013-1#5)
levels are also##2##3##(1991-12#1)(2013-1#1)
levels are increased in##2##4##(1994-11#1)(2011-1#1)
levels are increased##3##3##(1994-11#1)(1996-12#1)(2011-1#1)
levels are not##2##3##(1995-8#1)(2008-9#1)
levels are##31##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-5#2)(2013-1#2)(2013-8#1)
levels as a predictor##2##4##(2012-3#1)(2013-1#1)
levels as a##4##3##(2008-8#1)(2012-3#1)(2013-1#2)
levels as low as##3##4##(2008-10#2)(2008-3#1)
levels as the##2##3##(1993-3#1)(2011-2#1)
levels as well as the##2##5##(2008-7#1)(2009-6#1)
levels as well as##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)
levels as##22##2##(1993-11#1)(1993-3#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#3)(2012-3#1)(2013-1#4)
levels at the##3##3##(2008-10#1)(2008-11#1)(2010-9#1)
levels at##13##2##(1994-2#1)(1995-11#1)(1996-1#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-3#1)(2010-9#1)
levels being##2##2##(1995-12#1)(2008-5#1)
levels below##4##2##(1991-5#1)(2008-10#3)
levels between 4##3##3##(2008-10#1)(2012-3#2)
levels between##10##2##(1994-2#1)(2008-10#5)(2011-2#1)(2012-3#2)(2013-8#1)
levels but##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
levels by a##2##3##(2008-10#1)(2013-1#1)
levels by hydride##2##3##(2008-10#2)
levels by testosterone##2##3##(1995-12#2)
levels by##31##2##(1992-3#1)(1993-3#1)(1994-12#1)(1995-12#3)(1995-2#1)(1996-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2013-1#3)(2013-7#1)(2013-8#1)
levels can be##6##3##(1994-8#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-2#1)(2013-8#1)
levels can##13##2##(1991-3#1)(1992-9#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
levels clearly##2##2##(1994-6#1)(2008-10#1)
levels comparable to those##3##4##(1990-2#1)(1993-6#1)(2008-10#1)
levels comparable to##5##3##(1990-2#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-5#1)
levels compared to##3##3##(1993-12#1)(1993-2#1)(2013-1#1)
levels compared with##2##3##(2008-10#1)(2010-4#1)
levels compared##5##2##(1993-12#1)(1993-2#1)(2008-10#1)(2010-4#1)(2013-1#1)
levels correlate with##2##3##(2012-3#1)(2013-1#1)
levels correlated##3##2##(1995-8#2)(2012-5#1)
levels could be##2##3##(1996-12#1)(2012-2#1)
levels could##4##2##(1994-1#1)(1996-12#1)(2012-2#2)
levels declined##2##2##(1990-5#1)(2008-10#1)
levels decreased##7##2##(1990-3#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-12#1)
levels detected##2##2##(1995-11#1)(2008-11#1)
levels did not change##2##4##(1994-2#1)(2008-10#1)
levels did not differ between the##2##6##(2008-10#1)(2013-8#1)
levels did not##8##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
levels do##2##2##(1991-12#1)(1992-1#1)
levels during pregnancy##2##3##(1994-3#1)(2008-11#1)
levels during the##3##3##(1995-8#1)(2008-5#1)(2012-2#1)
levels during##14##2##(1993-6#1)(1994-2#1)(1994-3#1)(1995-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2012-2#4)
levels estimated##2##2##(2008-10#1)(2008-9#1)
levels fell##2##2##(1994-12#1)(2011-2#1)
levels for the##2##3##(2008-10#1)(2008-9#1)
levels for young##2##3##(1992-2#1)(2012-2#1)
levels for##20##2##(1991-1#1)(1992-2#1)(1994-1#1)(1994-12#1)(1996-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
levels found in##6##3##(1993-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
levels found##7##2##(1993-12#1)(1995-2#1)(1995-8#1)(2008-10#2)(2013-1#1)(2013-8#1)
levels from 3##3##3##(2008-10#3)
levels from the##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
levels from##13##2##(1992-12#1)(2008-10#9)(2008-4#1)(2008-5#1)(2011-2#1)
levels had##6##2##(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
levels has been##3##3##(1993-2#1)(2008-10#2)
levels have been reported##2##4##(2010-12#1)(2012-2#1)
levels have been##9##3##(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
levels have##11##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
levels higher than##2##3##(2008-10#1)(2008-7#1)
levels in F##2##3##(1995-8#1)(2008-10#1)
levels in a##9##3##(1993-3#1)(1996-2#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2011-2#1)
levels in an##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
levels in anxiety disorders##2##4##(2013-8#2)
levels in any##2##3##(1996-12#1)(2013-8#1)
levels in both sexes##2##4##(1991-6#1)(2010-8#1)
levels in both the##2##4##(2008-10#1)(2008-11#1)
levels in both##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2010-8#1)
levels in bovine##2##3##(1991-9#2)
levels in brain##2##3##(1994-11#1)(1997-2#1)
levels in children with##3##4##(2011-1#3)
levels in culture##2##3##(2008-10#2)
levels in diabetes##3##3##(1993-3#1)(2011-2#2)
levels in excess of##2##4##(2008-10#1)(2008-7#1)
levels in food##2##3##(2008-10#2)
levels in human##7##3##(1992-6#1)(1993-1#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-12#1)
levels in maternal serum##2##4##(1995-8#2)
levels in mice##3##3##(1992-8#2)(2010-11#1)
levels in most##2##3##(1993-2#1)(1995-2#1)
levels in natural waters##2##4##(2008-10#2)
levels in normal##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
levels in obese##2##3##(2013-1#1)(2013-8#1)
levels in patients with dysthymic##2##5##(2011-2#2)
levels in patients with high-risk##2##5##(2011-2#2)
levels in patients with##9##4##(1991-7#1)(1992-11#1)(1993-2#2)(1996-12#1)(2011-2#4)
levels in plasma##2##3##(1995-12#1)(2012-3#1)
levels in rats##2##3##(1990-2#1)(2008-11#1)
levels in serum##5##3##(1992-12#1)(1994-3#1)(1996-10#1)(2008-10#1)(2011-2#1)
levels in smokers##3##3##(1992-9#2)(1994-6#1)
levels in the blood##2##4##(2008-10#2)
levels in the normal##2##4##(1992-9#1)(2008-1#1)
levels in the spleen##2##4##(1994-2#1)(2008-10#1)
levels in the striatum##2##4##(1996-12#1)(2009-8#1)
levels in the##65##3##(1990-5#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-2#5)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#4)(1996-2#1)(1997-2#3)(1997-3#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#1)
levels in these##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
levels in vitro##2##3##(1993-6#1)(1997-7#1)
levels in##265##2##(1990-12#1)(1990-2#4)(1990-5#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#5)(1993-1#2)(1993-2#4)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-6#1)(1995-11#1)(1995-12#8)(1995-2#5)(1995-6#1)(1995-8#7)(1996-10#1)(1996-12#10)(1996-2#3)(1997-2#7)(1997-3#1)(1997-7#1)(2008-1#2)(2008-10#63)(2008-11#13)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#6)(2011-2#18)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#8)(2013-8#8)
levels increase##2##2##(1994-1#1)(2009-12#1)
levels increased during##2##3##(1993-6#1)(2008-10#1)
levels increased in##3##3##(1990-5#1)(2008-10#1)(2008-7#1)
levels increased##13##2##(1990-5#1)(1993-12#1)(1993-6#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-6#2)(2008-7#1)
levels inside##2##2##(2008-10#2)
levels into##2##2##(2008-8#1)(2012-5#1)
levels is##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
levels markedly##2##2##(1991-6#1)(2008-10#1)
levels may be##2##3##(1991-3#1)(2009-11#1)
levels may##5##2##(1991-3#1)(1995-12#1)(2008-10#1)(2009-11#1)(2013-1#1)
levels measured##3##2##(1992-9#1)(1995-12#1)(2012-5#1)
levels might##2##2##(2010-4#1)(2011-2#1)
levels near##6##2##(2008-10#6)
levels normally seen##2##3##(2008-10#2)
levels observed for the##2##4##(2008-10#1)(2011-1#1)
levels observed in##3##3##(1993-3#1)(2008-10#2)
levels observed##6##2##(1991-3#1)(1993-3#1)(2008-10#3)(2011-1#1)
levels obtained from##2##3##(1996-12#1)(2011-1#1)
levels obtained using##2##3##(2008-10#1)(2008-7#1)
levels obtained##7##2##(1994-3#1)(1996-12#2)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)
levels occurred when##2##3##(1992-10#1)(2008-10#1)
levels occurred##3##2##(1991-12#1)(1992-10#1)(2008-10#1)
levels of 0##6##3##(1994-5#1)(2008-10#4)(2012-2#1)
levels of 1##2##3##(2008-10#1)(2012-2#1)
levels of 10##2##3##(2008-10#1)(2008-6#1)
levels of 200##2##3##(2008-5#1)(2010-1#1)
levels of 5-FU incorporation##2##4##(1993-8#2)
levels of AA##2##3##(1992-12#1)(1993-3#1)
levels of ACTH and##2##4##(1996-12#1)(2011-2#1)
levels of APN mRNA##2##4##(1995-8#2)
levels of ATP##2##3##(1994-3#2)
levels of As(III) and As(V) in##2##6##(2008-10#2)
levels of CoQ10##2##3##(1993-3#2)
levels of D-dimer##2##3##(2010-3#1)(2011-2#1)
levels of DNA##3##3##(1993-11#1)(2008-10#1)(2011-2#1)
levels of F##4##3##(2008-10#4)
levels of GH and IGF-I##2##5##(2012-3#2)
levels of GH were##2##4##(2010-5#1)(2012-3#1)
levels of GH##4##3##(2010-5#1)(2012-3#3)
levels of ILI##2##3##(2008-10#2)
levels of TAT##2##3##(1991-3#1)(2010-3#1)
levels of TNF-alpha##2##3##(1995-12#2)
levels of TYLCV resistance##2##4##(2008-10#2)
levels of a##7##3##(2008-10#2)(2008-3#4)(2012-2#1)
levels of active##2##3##(1993-8#1)(1997-7#1)
levels of activity##2##3##(2008-10#1)(2010-12#1)
levels of alcohol##2##3##(1997-2#1)(2009-7#1)
levels of alkaline phosphatase (ALP)##2##5##(2008-11#1)(2013-1#1)
levels of alpha-bungarotoxin binding##2##4##(1996-12#2)
levels of amino acids##2##4##(2008-10#1)(2010-1#1)
levels of ammonia##3##3##(2008-3#2)(2008-9#1)
levels of angiogenic inhibitors##2##4##(2008-1#2)
levels of anxiety##3##3##(2008-11#3)
levels of arsenic##4##3##(1995-11#2)(2008-10#1)(2013-1#1)
levels of ascorbic acid##2##4##(2011-2#2)
levels of bFGF mRNA##2##4##(1995-12#2)
levels of binding##2##3##(1993-8#2)
levels of both enzymes##2##4##(1993-9#1)(2008-10#1)
levels of both the##2##4##(1997-7#1)(2012-3#1)
levels of both##7##3##(1993-9#1)(1997-1#1)(1997-7#1)(2008-10#2)(2012-3#2)
levels of brain alpha-bungarotoxin binding##2##5##(1996-12#2)
levels of brain function##2##4##(2008-11#1)(2008-7#1)
levels of brain##4##3##(1996-12#2)(2008-11#1)(2008-7#1)
levels of calcium##3##3##(1993-11#1)(2008-1#1)(2008-10#1)
levels of care##3##3##(1991-11#2)(1994-12#1)
levels of charity##2##3##(1996-2#2)
levels of circulating##2##3##(2008-7#1)(2011-2#1)
levels of cobalt##2##3##(2008-10#2)
levels of confidence##3##3##(2008-10#3)
levels of control##2##3##(2008-10#2)
levels of copper##3##3##(2008-10#2)(2010-5#1)
levels of corticosterone##3##3##(1997-2#2)(2008-8#1)
levels of cortisol##2##3##(1991-6#1)(2008-6#1)
levels of cross-protection##2##3##(2008-8#2)
levels of cyclic AMP##2##4##(1994-2#1)(1997-2#1)
levels of cytokine##2##3##(2008-4#1)(2009-3#1)
levels of depression##2##3##(1991-1#1)(2008-11#1)
levels of dietary fiber##3##4##(1993-11#3)
levels of dietary##4##3##(1990-3#1)(1993-11#3)
levels of differentiation among##2##4##(2008-10#2)
levels of disease severity##3##4##(2008-10#2)(2009-4#1)
levels of disease##13##3##(2008-10#12)(2009-4#1)
levels of dissolved##3##3##(2008-10#3)
levels of diversity##2##3##(2008-10#2)
levels of each##5##3##(1997-7#1)(2008-10#3)(2011-2#1)
levels of education and##2##4##(1993-3#1)(2008-1#1)
levels of education##5##3##(1993-3#1)(1994-3#1)(2008-1#1)(2009-11#1)(2011-2#1)
levels of either##2##3##(1992-10#1)(1997-7#1)
levels of endogenous##2##3##(2008-11#1)(2009-8#1)
levels of estrogen receptor##4##4##(2008-11#4)
levels of estrogen##6##3##(2008-11#6)
levels of ethnic##2##3##(2009-7#2)
levels of exposure##3##3##(1993-1#1)(2008-10#1)(2008-12#1)
levels of expression in##2##4##(1997-1#1)(1997-6#1)
levels of expression of the##2##5##(1995-8#1)(2008-11#1)
levels of expression of##3##4##(1995-8#1)(2008-11#1)(2010-1#1)
levels of expression##8##3##(1995-8#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-11#2)(2010-1#1)(2011-1#1)
levels of extracellular##4##3##(1993-6#1)(1994-2#1)(2008-10#2)
levels of family##2##3##(2010-10#1)(2013-1#1)
levels of fatty##2##3##(2008-5#1)(2008-6#1)
levels of field resistance##2##4##(2008-10#2)
levels of floral integration##3##4##(2009-8#3)
levels of gene diversity##2##4##(2008-10#1)(2012-5#1)
levels of gene expression##2##4##(2008-9#1)(2011-2#1)
levels of gene flow##2##4##(2008-10#2)
levels of gene##8##3##(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2012-5#1)
levels of genetic differentiation were##2##5##(2008-10#2)
levels of genetic differentiation##6##4##(2008-10#4)(2012-3#1)(2012-5#1)
levels of genetic diversity##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
levels of genetic##11##3##(2008-10#6)(2008-8#1)(2008-9#1)(2012-3#1)(2012-5#1)(2013-1#1)
levels of genotypic##4##3##(2008-10#4)
levels of glucose##4##3##(1990-5#1)(2008-12#2)(2011-2#1)
levels of government##2##3##(1996-3#2)
levels of health##2##3##(1991-2#1)(1995-12#1)
levels of immunostaining##2##3##(1995-12#2)
levels of inbreeding##2##3##(2008-9#1)(2012-3#1)
levels of infection##4##3##(1991-8#1)(2008-10#2)(2008-8#1)
levels of insensitivity##2##3##(2008-10#2)
levels of irrationality##2##3##(2010-5#2)
levels of latent infection##3##4##(2008-10#3)
levels of lipid##3##3##(1990-5#2)(1992-12#1)
levels of long-chain fatty acids##2##5##(2008-4#1)(2008-5#1)
levels of mRNA in##2##4##(1991-5#1)(2008-7#1)
levels of mRNA##4##3##(1991-5#1)(2008-7#2)(2009-12#1)
levels of mRNAs##2##3##(1995-2#1)(1997-2#1)
levels of maternal monitoring##2##4##(2009-7#2)
levels of maternal##3##3##(1990-9#1)(2009-7#2)
levels of mercury##2##3##(2008-10#2)
levels of moniliformin##2##3##(2008-10#1)(2008-5#1)
levels of noise##3##3##(2008-3#2)(2013-8#1)
levels of one##2##3##(2008-7#1)(2011-3#1)
levels of other##2##3##(1990-12#1)(1995-8#1)
levels of palladium##2##3##(2008-10#2)
levels of partial resistance##4##4##(2008-10#4)
levels of participation##2##3##(1995-2#2)
levels of pesticide##2##3##(2008-10#2)
levels of pesticides##2##3##(2008-10#2)
levels of phenolic##2##3##(2008-10#2)
levels of phosphate and##2##4##(2008-10#1)(2012-12#1)
levels of phosphate##3##3##(2008-10#2)(2012-12#1)
levels of plasma##3##3##(1995-2#1)(1997-8#1)(2008-10#1)
levels of practice##2##3##(2008-11#2)
levels of productivity##2##3##(2008-8#1)(2008-9#1)
levels of protein##3##3##(2008-1#1)(2008-11#2)
levels of pseudouridine and 1-methyladenosine##2##5##(1992-3#2)
levels of reactive##2##3##(2008-10#1)(2011-2#1)
levels of resistance to##5##4##(2008-10#5)
levels of resistance were##2##4##(2008-10#2)
levels of resistance##15##3##(2008-10#13)(2008-11#1)(2008-8#1)
levels of resource##3##3##(2008-8#3)
levels of risk##5##3##(1993-12#1)(1995-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
levels of satisfaction and##2##4##(1995-12#1)(2008-10#1)
levels of satisfaction##3##3##(1995-12#1)(2008-10#2)
levels of selection##3##3##(2008-8#3)
levels of selenite##2##3##(1993-12#2)
levels of sensitivity##2##3##(1993-3#1)(2008-10#1)
levels of serum##9##3##(1991-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(2008-9#1)(2009-12#1)(2010-1#1)(2012-3#1)(2013-8#1)
levels of several##2##3##(2008-10#1)(2010-1#1)
levels of specific##2##3##(1995-11#1)(2012-7#1)
levels of spontaneous##2##3##(1993-6#1)(2013-1#1)
levels of staff##3##3##(1994-1#2)(1995-1#1)
levels of stress##2##3##(2008-4#1)(2008-9#1)
levels of testosterone##3##3##(1990-2#2)(2008-3#1)
levels of the pro-inflammatory##2##4##(2008-10#2)
levels of the##56##3##(1990-12#2)(1990-5#2)(1991-6#1)(1992-12#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-3#3)(2013-3#1)(2013-8#1)
levels of these two##2##4##(2009-10#1)(2010-2#1)
levels of these##8##3##(1992-3#1)(2008-1#1)(2008-10#2)(2009-10#1)(2010-2#1)(2011-2#1)(2013-8#1)
levels of this##6##3##(1991-5#1)(1992-5#1)(2008-10#3)(2011-2#1)
levels of three##4##3##(1996-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
levels of thyroid hormone led to##2##6##(1995-2#2)
levels of thyroid hormones##2##4##(1995-8#1)(2012-2#1)
levels of thyroid##4##3##(1995-2#2)(1995-8#1)(2012-2#1)
levels of total##8##3##(1996-12#1)(2008-10#2)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
levels of transcripts of##2##4##(2008-10#1)(2008-8#1)
levels of transcripts##5##3##(1996-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
levels of tumor##2##3##(1990-2#1)(2011-2#1)
levels of urinary factor H##3##5##(2009-6#3)
levels of urinary##6##3##(1996-12#1)(2008-10#2)(2009-6#3)
levels of violence victimization##2##4##(2013-1#2)
levels of violence##3##3##(2013-1#3)
levels of viral##2##3##(1997-3#1)(2008-10#1)
levels of virulence##4##3##(2008-10#2)(2008-8#2)
levels of virus##2##3##(2008-10#1)(2008-5#1)
levels of vitamin##2##3##(1992-9#1)(2012-3#1)
levels of##1069##2##(1990-12#6)(1990-2#4)(1990-3#2)(1990-5#6)(1990-6#1)(1990-8#4)(1990-9#3)(1991-1#5)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#4)(1991-6#2)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#4)(1993-1#3)(1993-11#6)(1993-12#5)(1993-2#2)(1993-3#11)(1993-6#7)(1993-8#9)(1993-9#2)(1994-1#3)(1994-11#5)(1994-12#4)(1994-2#7)(1994-3#7)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#3)(1995-12#14)(1995-2#18)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#7)(1996-1#3)(1996-12#21)(1996-2#6)(1996-3#2)(1996-6#1)(1997-1#6)(1997-2#11)(1997-3#6)(1997-6#2)(1997-7#9)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#11)(2008-10#316)(2008-11#82)(2008-12#14)(2008-3#12)(2008-4#5)(2008-5#20)(2008-6#6)(2008-7#16)(2008-8#38)(2008-9#22)(2009-10#6)(2009-11#2)(2009-12#6)(2009-3#1)(2009-4#2)(2009-6#6)(2009-7#9)(2009-8#11)(2010-1#10)(2010-10#4)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#5)(2011-1#7)(2011-10#1)(2011-2#52)(2011-3#2)(2012-12#7)(2012-2#14)(2012-3#29)(2012-5#4)(2012-7#2)(2013-1#23)(2013-3#1)(2013-7#2)(2013-8#12)
levels on##6##2##(1993-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)
levels or##6##2##(1993-6#1)(1996-6#1)(2008-11#2)(2008-9#1)(2009-7#1)
levels ranged from##2##3##(2008-10#1)(2012-2#1)
levels ranged##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
levels ranging from##2##3##(1996-12#1)(2008-10#1)
levels remained unchanged##2##3##(1991-6#1)(1993-12#1)
levels remained##4##2##(1991-6#1)(1993-12#1)(2008-5#1)(2012-5#1)
levels required for##2##3##(1995-2#1)(2008-8#1)
levels resulted in##2##3##(2008-10#1)(2008-5#1)
levels resulting in##2##3##(2008-10#1)(2012-12#1)
levels seen in##2##3##(1994-5#1)(2008-7#1)
levels seen##3##2##(1994-5#1)(2008-7#1)(2013-8#1)
levels showed a##3##3##(1990-8#1)(1996-12#1)(2008-10#1)
levels similar to##2##3##(1993-3#1)(2008-10#1)
levels than those##3##3##(1991-11#1)(2008-11#1)(2011-1#1)
levels than##12##2##(1991-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
levels that are##2##3##(2008-11#1)(2010-6#1)
levels that##7##2##(2008-11#1)(2008-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
levels through##2##2##(2008-11#1)(2009-9#1)
levels to a##2##3##(1994-8#1)(2013-1#1)
levels to##16##2##(1994-2#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
levels under the##2##3##(2008-11#1)(2008-7#1)
levels under##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
levels up to##5##3##(1990-12#1)(1997-2#1)(2008-10#2)(2011-2#1)
levels using a##3##3##(2008-10#2)(2012-5#1)
levels using the##2##3##(2008-10#2)
levels using##11##2##(1997-2#1)(2008-10#9)(2012-5#1)
levels via##2##2##(2008-10#1)(2008-6#1)
levels was observed in##2##4##(1994-8#1)(1996-12#1)
levels was##11##2##(1994-3#1)(1994-8#1)(1996-12#3)(2008-10#3)(2008-12#1)(2008-7#1)(2012-2#1)
levels were also##6##3##(1990-3#1)(1991-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
levels were approximately##2##3##(2008-10#1)(2008-8#1)
levels were assessed##2##3##(2008-10#1)(2008-12#1)
levels were comparable##2##3##(2008-11#1)(2008-7#1)
levels were compared##3##3##(1996-12#1)(2008-7#1)(2012-2#1)
levels were decreased##2##3##(2009-6#1)(2013-1#1)
levels were detected##2##3##(2008-10#1)(2009-8#1)
levels were determined in##3##4##(1990-12#1)(1993-2#1)(2008-10#1)
levels were determined##6##3##(1990-12#1)(1993-2#1)(2008-10#2)(2011-1#1)(2011-2#1)
levels were elevated in##3##4##(1994-3#1)(1995-2#1)(2009-6#1)
levels were found##7##3##(1995-8#1)(2006-6#1)(2008-10#1)(2008-12#2)(2011-2#2)
levels were high##2##3##(1991-5#1)(1995-8#1)
levels were higher and##2##4##(2010-8#1)(2011-1#1)
levels were higher in##4##4##(1992-1#1)(2008-10#2)(2008-9#1)
levels were higher##7##3##(1992-1#1)(2008-10#2)(2008-9#1)(2010-8#1)(2011-1#2)
levels were highly##2##3##(1992-3#1)(2008-12#1)
levels were increased##4##3##(1996-12#1)(1997-8#1)(2008-10#1)(2009-8#1)
levels were lower##2##3##(1990-9#1)(2013-8#1)
levels were maintained##3##3##(2008-10#2)(2008-6#1)
levels were measured in##3##4##(1990-3#1)(2011-1#1)(2013-7#1)
levels were measured##8##3##(1990-3#1)(2008-10#1)(2011-1#2)(2012-3#1)(2012-4#1)(2013-7#1)(2013-8#1)
levels were negatively correlated##2##4##(2008-10#1)(2010-12#1)
levels were not significantly different##2##5##(1991-12#1)(1992-3#1)
levels were not significantly##4##4##(1990-8#1)(1991-12#1)(1992-3#1)(2012-12#1)
levels were not##5##3##(1990-8#1)(1991-12#1)(1992-3#1)(2010-8#1)(2012-12#1)
levels were observed##5##3##(1994-3#1)(1996-12#2)(2008-6#1)(2013-8#1)
levels were positively correlated with##2##5##(2010-12#1)(2011-2#1)
levels were positively correlated##3##4##(2008-7#1)(2010-12#1)(2011-2#1)
levels were reduced in##3##4##(1996-12#2)(2008-10#1)
levels were reduced##5##3##(1993-3#1)(1996-12#2)(2008-10#2)
levels were seen##2##3##(2008-11#1)(2008-5#1)
levels were significantly decreased##2##4##(2008-10#1)(2011-2#1)
levels were significantly higher in##3##5##(2011-2#1)(2012-3#1)(2013-1#1)
levels were significantly higher##4##4##(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
levels were significantly reduced in##2##5##(1996-12#1)(2013-1#1)
levels were significantly reduced##4##4##(1996-12#1)(2008-10#1)(2010-4#1)(2013-1#1)
levels were significantly##14##3##(1996-12#1)(2008-10#5)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
levels were similar between##2##4##(1994-11#1)(2012-5#1)
levels were similar##4##3##(1991-11#1)(1994-11#1)(1995-12#1)(2012-5#1)
levels were within normal range in 17 patients##2##8##(2008-7#2)
levels were within normal range in##3##6##(2008-7#3)
levels were within##4##3##(2008-7#3)(2011-1#1)
levels were##148##2##(1990-12#3)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#4)(1994-11#3)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-12#8)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#5)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-6#2)(2009-8#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#8)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#3)
levels when the##2##3##(1995-12#1)(2008-8#1)
levels when##6##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
levels which##4##2##(1991-3#1)(1993-9#1)(2008-10#1)(2011-2#1)
levels with##10##2##(1994-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
levels within the##3##3##(1997-1#1)(2008-12#1)(2009-4#1)
levels within##6##2##(1990-10#1)(1992-5#1)(1997-1#1)(1997-2#1)(2008-12#1)(2009-4#1)
levels worldwide##2##2##(1994-9#1)(2008-11#1)
levels##2624##1##(1990-10#2)(1990-11#1)(1990-12#13)(1990-2#11)(1990-3#5)(1990-5#14)(1990-6#2)(1990-8#6)(1990-9#8)(1991-1#8)(1991-11#6)(1991-12#12)(1991-2#8)(1991-3#10)(1991-5#9)(1991-6#11)(1991-7#4)(1991-8#4)(1991-9#3)(1992-1#6)(1992-10#6)(1992-11#3)(1992-12#11)(1992-2#6)(1992-3#10)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#10)(1992-9#14)(1993-1#6)(1993-11#9)(1993-12#14)(1993-2#12)(1993-3#25)(1993-6#18)(1993-8#13)(1993-9#6)(1994-1#9)(1994-11#14)(1994-12#11)(1994-2#22)(1994-3#23)(1994-5#8)(1994-6#3)(1994-8#11)(1994-9#3)(1995-1#1)(1995-11#9)(1995-12#39)(1995-2#33)(1995-3#4)(1995-5#3)(1995-6#9)(1995-8#27)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#73)(1996-2#14)(1996-3#2)(1996-6#4)(1997-1#14)(1997-2#27)(1997-3#11)(1997-6#4)(1997-7#16)(1997-8#5)(1997-9#1)(2006-6#3)(2007-11#1)(2007-12#2)(2008-1#15)(2008-10#721)(2008-11#176)(2008-12#39)(2008-2#1)(2008-3#33)(2008-4#17)(2008-5#54)(2008-6#24)(2008-7#70)(2008-8#62)(2008-9#56)(2009-10#12)(2009-11#4)(2009-12#11)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#12)(2009-7#16)(2009-8#23)(2009-9#4)(2010-1#15)(2010-10#8)(2010-11#10)(2010-12#14)(2010-2#3)(2010-3#4)(2010-4#10)(2010-5#11)(2010-6#5)(2010-7#10)(2010-8#13)(2010-9#3)(2011-1#39)(2011-10#1)(2011-2#119)(2011-3#3)(2012-12#16)(2012-2#44)(2012-3#54)(2012-4#6)(2012-5#17)(2012-7#2)(2013-1#78)(2013-3#2)(2013-7#5)(2013-8#44)
levels) and##2##2##(2008-9#1)(2009-8#1)
levels) in##2##2##(1995-1#1)(2008-12#1)
levels)##11##1##(1995-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-9#2)(2009-8#2)(2010-7#1)
levels]##2##1##(2010-3#1)(2012-3#1)
lever##9##1##(1993-6#5)(1995-5#1)(1997-1#1)(2011-2#1)(2013-8#1)
leverage the##2##2##(2009-6#1)(2012-3#1)
leverage##3##1##(2009-6#1)(2012-3#1)(2013-1#1)
leveraging the##2##2##(2011-9#1)(2013-1#1)
leveraging##4##1##(2008-9#1)(2011-9#1)(2013-1#2)
levers##3##1##(1993-6#1)(1995-2#2)
levodopa and##5##2##(2008-10#4)(2008-7#1)
levodopa treatment##2##2##(2008-7#2)
levodopa##29##1##(2008-10#7)(2008-7#17)(2010-12#5)
levodopa-induced motor complications##2##3##(2010-12#2)
levofloxacin##18##1##(2008-10#9)(2008-12#1)(2008-7#4)(2010-12#1)(2011-1#1)(2011-2#2)
levofloxacin-based##2##1##(2010-12#2)
levonorgestrel in##2##2##(2008-10#2)
levonorgestrel##7##1##(2008-10#5)(2011-2#2)
levorphanol-induced##2##1##(1996-2#2)
levothyroxin replacement therapy##2##3##(2008-7#2)
levéis of##3##2##(2013-8#3)
levéis##4##1##(2013-8#4)
lexical##12##1##(1991-2#6)(2008-11#1)(2008-9#3)(2010-1#1)(2013-8#1)
lexicon##2##1##(2008-10#1)(2012-12#1)
li ved##2##2##(2012-12#2)
li##3##1##(2012-12#2)(2012-2#1)
liabilities##5##1##(1992-3#1)(2008-10#1)(2008-11#2)(2009-7#1)
liability for the##4##3##(1993-12#1)(1995-1#1)(1995-6#1)(1996-2#1)
liability of##4##2##(1991-12#2)(1992-1#1)(1995-3#1)
liability to##3##2##(1993-2#1)(1995-3#1)(1997-3#1)
liability##35##1##(1991-1#4)(1991-12#5)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#2)(1994-1#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-3#2)(1995-6#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-3#1)(2008-4#1)(2008-6#1)
liable for##3##2##(1994-3#1)(1995-12#1)(1997-1#1)
liable to##3##2##(1990-2#1)(1997-8#1)(2008-12#1)
liable##6##1##(1990-2#1)(1994-3#1)(1995-12#1)(1997-1#1)(1997-8#1)(2008-12#1)
liaison##3##1##(1992-2#1)(1996-8#1)(2008-11#1)
liberal##2##1##(1997-8#1)(2011-2#1)
liberate##4##1##(1993-8#1)(2008-10#2)(2008-6#1)
liberated by##4##2##(2008-10#2)(2008-3#1)(2009-8#1)
liberated from the##3##3##(2008-10#3)
liberated from##5##2##(1993-8#1)(1997-2#1)(2008-10#3)
liberated into##2##2##(2008-10#2)
liberated iodine##2##2##(2008-10#2)
liberated##24##1##(1993-8#1)(1994-3#1)(1994-9#1)(1997-2#1)(2008-10#14)(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-3#1)(2013-1#1)
liberating##4##1##(1996-2#1)(2008-11#1)(2008-5#2)
liberation in##2##2##(1995-11#1)(2008-10#1)
liberation of free##2##3##(2007-8#1)(2008-10#1)
liberation of##7##2##(1995-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-7#1)
liberation##17##1##(1994-3#4)(1995-11#4)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-7#1)
liberty interest##2##2##(1995-12#1)(1996-9#1)
liberty##5##1##(1995-12#1)(1996-9#1)(2011-2#3)
libitum##9##1##(2008-10#2)(2008-11#2)(2008-7#1)(2013-1#1)(2013-8#3)
librarian##5##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-3#1)
librarians##7##1##(1991-2#2)(1991-3#1)(1992-12#3)(1994-3#1)
libraries and##2##2##(1995-2#1)(2010-10#1)
libraries are described##2##3##(1991-12#1)(2008-4#1)
libraries are##4##2##(1991-12#1)(1991-3#1)(2008-10#1)(2008-4#1)
libraries constructed from##2##3##(1997-6#1)(2008-9#1)
libraries constructed##3##2##(1997-2#1)(1997-6#1)(2008-9#1)
libraries for##2##2##(2008-4#1)(2012-2#1)
libraries from##2##2##(1995-2#1)(1997-6#1)
libraries of##6##2##(1992-1#1)(1995-6#1)(1997-2#2)(2008-10#1)(2010-4#1)
libraries that can##2##3##(1997-6#1)(2008-4#1)
libraries that##7##2##(1995-2#1)(1997-2#1)(1997-6#2)(2008-4#2)(2011-2#1)
libraries were##3##2##(1996-8#1)(1997-6#1)(2008-9#1)
libraries with##5##2##(1997-2#2)(1997-4#1)(2008-4#1)(2012-3#1)
libraries##74##1##(1991-12#2)(1991-2#1)(1991-3#3)(1992-1#1)(1993-1#4)(1993-12#1)(1993-2#1)(1995-2#4)(1995-6#3)(1996-12#1)(1996-8#2)(1997-2#7)(1997-4#1)(1997-6#6)(2008-1#2)(2008-10#5)(2008-11#2)(2008-4#14)(2008-9#3)(2010-10#1)(2010-4#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
library and obtained one cDNA clone##2##6##(2008-8#2)
library and sequenced##3##3##(1992-10#1)(1994-11#1)(1997-7#1)
library and##13##2##(1992-10#1)(1993-6#1)(1994-11#2)(1996-3#1)(1997-7#1)(1997-8#1)(2008-8#5)(2011-2#1)
library by screening with##2##4##(1993-2#2)
library by using##2##3##(1993-2#1)(2008-9#1)
library by##8##2##(1993-2#3)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
library constructed from the##2##4##(1995-2#1)(2012-2#1)
library constructed from##3##3##(1991-6#1)(1995-2#1)(2012-2#1)
library constructed##5##2##(1991-6#1)(1993-12#1)(1995-2#1)(1997-8#1)(2012-2#1)
library construction##2##2##(1996-2#1)(1997-7#1)
library from##4##2##(1993-3#1)(1993-6#1)(1994-5#1)(2008-8#1)
library of a##2##3##(2008-10#1)(2012-2#1)
library of the##4##3##(1994-11#1)(1995-12#1)(1997-6#1)(1997-8#1)
library of##29##2##(1990-5#2)(1991-9#3)(1993-2#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-6#1)(1997-8#2)(2008-10#6)(2008-8#4)(2008-9#1)(2011-1#1)(2012-2#1)
library on##2##2##(1995-2#1)(2008-10#1)
library research##2##2##(1992-12#2)
library screening and##3##3##(1991-9#1)(1993-12#1)(1996-2#1)
library screening##5##2##(1991-9#1)(1993-12#1)(1996-2#1)(2008-9#1)(2011-2#1)
library search##2##2##(2008-5#1)(2011-2#1)
library that##6##2##(1991-9#1)(1996-2#1)(2008-10#2)(2009-12#2)
library to##3##2##(1997-8#1)(2012-3#1)(2013-8#1)
library using##2##2##(1993-9#1)(2008-10#1)
library was constructed using##2##4##(2008-9#2)
library was constructed##7##3##(2008-8#2)(2008-9#4)(2010-5#1)
library was screened using the##2##5##(2008-8#2)
library was screened using##5##4##(1992-3#1)(1992-6#1)(2008-10#1)(2008-8#2)
library was screened with##2##4##(1990-8#1)(2008-8#1)
library was screened##10##3##(1990-8#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-8#3)(2008-9#1)
library was##24##2##(1990-8#1)(1992-3#1)(1992-6#1)(1994-11#2)(1995-2#1)(1996-12#1)(1997-6#2)(1997-7#1)(2008-10#1)(2008-8#7)(2008-9#5)(2010-5#1)
library with a##4##3##(1991-9#1)(2008-2#1)(2008-7#1)(2008-8#1)
library with##10##2##(1991-9#1)(1993-12#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#2)
library##205##1##(1990-11#1)(1990-5#3)(1990-8#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#6)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#3)(1993-2#5)(1993-3#3)(1993-6#6)(1993-8#2)(1993-9#1)(1994-11#9)(1994-5#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#6)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-6#6)(1997-7#5)(1997-8#7)(2008-10#23)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#29)(2008-9#15)(2009-12#3)(2010-10#1)(2010-4#1)(2010-5#2)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
library's##2##1##(1994-3#1)(2010-8#1)
lice and##2##2##(1996-12#1)(2008-12#1)
lice##10##1##(1996-12#4)(2008-12#1)(2011-2#5)
license##3##1##(1996-5#1)(2008-5#2)
licensed in##2##2##(1994-6#1)(2010-11#1)
licensed##19##1##(1991-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-3#1)(2008-1#1)(2008-11#3)(2008-5#1)(2010-11#2)(2011-2#3)(2012-2#1)
licensing##7##1##(1994-12#1)(1996-8#2)(2012-3#1)(2013-8#3)
licensure##6##1##(1991-1#1)(1994-2#1)(1995-2#1)(1995-5#1)(2011-2#1)(2012-2#1)
lichen planus (OLP) is a##2##5##(2009-6#1)(2013-1#1)
lichen planus and##4##3##(1991-2#1)(2009-6#2)(2013-1#1)
lichen planus##13##2##(1990-5#1)(1991-2#2)(2009-6#5)(2013-1#5)
lichen ruber planus##3##3##(2011-2#3)
lichen samples##4##2##(2008-10#4)
lichen species##2##2##(2008-10#2)
lichen##36##1##(1990-5#1)(1991-2#2)(2008-10#12)(2008-11#2)(2008-5#2)(2008-9#1)(2009-6#5)(2010-6#2)(2011-2#4)(2013-1#5)
licheniformis##6##1##(2008-10#2)(2008-8#2)(2011-2#2)
lichens and##3##2##(2008-10#3)
lichens##9##1##(2008-10#9)
lick##5##1##(2008-11#4)(2008-5#1)
licks##3##1##(2008-11#3)
licorice water extract##2##3##(2008-10#2)
licorice##6##1##(2008-10#5)(2009-12#1)
lid##4##1##(1994-3#1)(2010-10#1)(2010-11#2)
lidamycin##4##1##(2008-9#4)
lidar LEANDRE II##2##3##(2008-3#2)
lidar and##3##2##(2008-3#3)
lidar at 9##3##3##(2008-2#2)(2008-3#1)
lidar at##4##2##(2008-2#2)(2008-3#2)
lidar backscatter##2##2##(2008-3#2)
lidar beam##4##2##(2008-3#4)
lidar data##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
lidar for atmospheric##2##3##(2008-3#2)
lidar instruments##2##2##(2008-2#1)(2008-3#1)
lidar inversion##3##2##(2008-2#1)(2008-3#2)
lidar measurements in##2##3##(2008-2#1)(2008-3#1)
lidar measurements is##2##3##(2008-3#2)
lidar measurements##13##2##(2008-10#1)(2008-2#4)(2008-3#8)
lidar observations##3##2##(2008-3#3)
lidar ozone profiles##2##3##(2008-2#2)
lidar profiles##2##2##(2008-3#2)
lidar ratio##4##2##(2008-2#4)
lidar return signals##2##3##(2008-3#2)
lidar return##3##2##(2008-3#3)
lidar signals##2##2##(2008-2#1)(2008-3#1)
lidar system at##2##3##(2008-3#2)
lidar system##10##2##(2008-2#1)(2008-3#9)
lidar systems are##2##3##(2008-3#2)
lidar systems##6##2##(2008-3#6)
lidar with##5##2##(2008-2#2)(2008-3#3)
lidar##127##1##(2007-12#1)(2008-10#2)(2008-2#34)(2008-3#90)
lidars##7##1##(2007-12#1)(2008-3#6)
lidocaine and ofloxacin##3##3##(2008-10#3)
lidocaine and##4##2##(2008-10#4)
lidocaine gel applied##2##3##(1993-1#2)
lidocaine gel##3##2##(1993-1#3)
lidocaine hydrochloride##2##2##(2008-10#2)
lidocaine injection##2##2##(2008-9#2)
lidocaine with##2##2##(1993-1#1)(2008-9#1)
lidocaine##32##1##(1990-9#6)(1993-1#4)(1996-9#2)(2008-10#12)(2008-11#1)(2008-9#7)
lidoflazine##3##1##(1994-8#3)
lie at the##2##3##(2008-11#1)(2008-7#1)
lie at##4##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
lie in the##4##3##(2008-10#2)(2008-8#1)(2010-7#1)
lie in##8##2##(1993-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-7#1)(2011-2#2)
lie upstream of##2##3##(1996-2#1)(2008-10#1)
lie within the##2##3##(2008-10#2)
lie within##3##2##(1994-5#1)(2008-10#2)
lie##23##1##(1992-9#1)(1993-12#1)(1994-5#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#3)
lies at the##3##3##(1993-3#1)(2008-5#1)(2013-1#1)
lies between the##3##3##(1992-12#1)(2008-10#1)(2012-12#1)
lies between##6##2##(1992-12#1)(1995-9#1)(2008-10#2)(2008-2#1)(2012-12#1)
lies in its ability to##2##5##(2008-10#1)(2012-3#1)
lies in its##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
lies in the##10##3##(1990-11#1)(1991-5#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
lies in##17##2##(1990-11#1)(1991-5#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2010-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
lies within a##2##3##(1992-4#1)(2008-10#1)
lies within##6##2##(1992-4#1)(1992-6#1)(1992-9#1)(1997-2#1)(2008-10#2)
lies##44##1##(1990-11#2)(1990-6#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-5#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
life and death##8##3##(1992-1#3)(1993-11#2)(2008-4#1)(2009-10#1)(2011-9#1)
life and the##4##3##(1992-12#1)(1996-9#1)(2012-2#1)(2013-8#1)
life and##55##2##(1991-11#1)(1992-1#4)(1992-11#1)(1992-12#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-9#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#2)(2010-7#1)(2011-2#6)(2011-9#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
life are##3##2##(2008-1#1)(2008-9#1)(2011-2#1)
life as##5##2##(2008-10#1)(2010-10#3)(2010-12#1)
life but##3##2##(1991-2#1)(2008-8#1)(2011-2#1)
life changes##2##2##(2010-10#1)(2011-2#1)
life conditions##2##2##(2012-12#1)(2012-2#1)
life course approach##2##3##(2009-10#2)
life course transitions##3##3##(2011-2#3)
life course##10##2##(2009-10#3)(2010-1#1)(2010-7#1)(2011-2#4)(2013-1#1)
life courses##2##2##(2011-2#2)
life cycle and##5##3##(2008-10#1)(2008-12#1)(2010-1#2)(2012-3#1)
life cycle in##2##3##(2008-9#1)(2012-2#1)
life cycle of the##2##4##(2008-10#1)(2011-2#1)
life cycle of##10##3##(1994-11#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
life cycle stages##3##3##(2008-10#2)(2008-11#1)
life cycle##44##2##(1994-11#1)(1995-2#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-8#4)(2008-9#3)(2009-3#1)(2009-8#1)(2010-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
life cycles of##5##3##(2008-10#2)(2008-9#1)(2012-2#2)
life cycles##8##2##(2008-10#3)(2008-9#1)(2012-2#3)(2013-1#1)
life during##2##2##(2009-9#1)(2012-2#1)
life events##7##2##(2008-11#2)(2008-12#1)(2008-4#3)(2009-12#1)
life expectancies##2##2##(2008-8#1)(2011-2#1)
life expectancy and##2##3##(2008-4#1)(2012-12#1)
life expectancy in##2##3##(1993-1#1)(1997-6#1)
life expectancy of##2##3##(1993-9#1)(1997-6#1)
life expectancy##18##2##(1991-6#1)(1993-1#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-8#1)(1997-6#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)
life expectation##3##2##(1991-8#2)(1992-9#1)
life extension##3##2##(2008-7#3)
life for##9##2##(1991-6#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-12#2)(2012-3#1)
life has been##2##3##(2008-7#1)(2010-11#1)
life histories##14##2##(2008-10#1)(2008-8#8)(2008-9#3)(2009-6#1)(2010-8#1)
life history and behavior##2##4##(2008-8#2)
life history and##5##3##(2008-10#1)(2008-12#1)(2008-8#3)
life history of##5##3##(2008-11#2)(2008-8#2)(2009-10#1)
life history##33##2##(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#18)(2009-10#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-8#4)(2012-3#1)
life in a##3##3##(2008-11#1)(2009-8#1)(2013-1#1)
life in the##7##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#1)
life in##41##2##(1990-2#1)(1990-3#1)(1992-11#1)(1993-6#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-7#4)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#8)(2011-3#1)(2012-3#1)(2013-1#5)(2013-8#2)
life insurance##9##2##(1991-12#1)(1994-12#1)(1995-1#5)(1995-12#1)(1996-2#1)
life is##12##2##(1995-1#1)(1996-11#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-6#1)(2010-10#1)(2012-2#1)(2013-1#1)
life may##3##2##(2008-11#1)(2008-4#1)(2010-1#1)
life more##2##2##(2008-4#1)(2013-1#1)
life of the##12##3##(1993-11#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-3#1)(2012-3#1)
life of##43##2##(1990-12#1)(1993-11#1)(1993-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-7#4)(2008-9#3)(2009-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#2)
life on the##2##3##(2008-5#1)(2011-2#1)
life on##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
life or##3##2##(2008-4#1)(2008-7#1)(2008-8#1)
life phenomena##2##2##(2010-10#2)
life quality##4##2##(1997-4#1)(2008-1#1)(2008-4#1)(2010-7#1)
life satisfaction##7##2##(1997-1#1)(2008-12#1)(2008-7#1)(2009-5#3)(2013-1#1)
life saving##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
life science research##2##3##(2012-3#1)(2013-1#1)
life science##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
life sciences##7##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)
life situation##2##2##(1991-6#1)(2012-3#1)
life span and##2##3##(2008-11#1)(2008-8#1)
life span by##2##3##(1990-3#2)
life span in##3##3##(1996-6#1)(2008-7#1)(2010-8#1)
life span is##2##3##(1992-2#1)(2008-10#1)
life span of the##4##4##(1991-5#1)(1993-8#1)(2008-10#2)
life span of##12##3##(1991-5#1)(1993-8#3)(1995-6#1)(2008-10#2)(2008-7#3)(2008-9#1)(2010-4#1)
life span was##2##3##(1995-6#1)(2008-9#1)
life span##41##2##(1990-3#4)(1991-5#1)(1992-2#1)(1993-8#3)(1995-6#3)(1996-6#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#4)(2010-4#1)(2010-8#3)
life stages##5##2##(2008-8#1)(2010-8#3)(2012-12#1)
life stressors##2##2##(2008-2#1)(2008-4#1)
life style##6##2##(1992-11#1)(2008-11#1)(2008-7#2)(2009-8#1)(2010-1#1)
life styles##2##2##(1990-9#1)(1997-6#1)
life support##11##2##(1992-5#2)(1995-1#1)(1995-12#1)(2008-11#3)(2009-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
life sustaining treatment##2##3##(1990-11#1)(1991-2#1)
life table analysis##3##3##(1991-3#1)(1993-2#1)(2008-9#1)
life table##11##2##(1991-3#1)(1993-1#1)(1993-2#1)(1995-3#2)(2008-12#1)(2008-9#1)(2011-2#4)
life tables##2##2##(2008-12#1)(2011-2#1)
life that##4##2##(2008-7#3)(2011-2#1)
life threatening complication##3##3##(2008-12#1)(2011-2#2)
life threatening event##2##3##(2011-2#2)
life threatening##11##2##(2008-10#1)(2008-12#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)
life time##4##2##(1995-12#1)(2008-10#3)
life to##4##2##(1993-12#1)(1996-5#1)(2010-1#1)(2012-2#1)
life using the##2##3##(1990-5#1)(2013-1#1)
life using##3##2##(1990-5#1)(2008-11#1)(2013-1#1)
life was##3##2##(1995-12#1)(2008-9#1)(2009-9#1)
life years##2##2##(2009-8#1)(2012-12#1)
life##792##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#5)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#5)(1991-8#5)(1992-1#5)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#6)(1993-12#8)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-9#1)(1995-1#12)(1995-12#10)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#6)(1995-8#2)(1995-9#1)(1996-11#4)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#82)(2008-11#37)(2008-12#33)(2008-2#3)(2008-4#12)(2008-5#7)(2008-6#1)(2008-7#46)(2008-8#44)(2008-9#24)(2009-1#1)(2009-10#9)(2009-11#5)(2009-12#6)(2009-3#4)(2009-5#7)(2009-6#8)(2009-7#1)(2009-8#8)(2009-9#7)(2010-1#11)(2010-10#18)(2010-11#11)(2010-12#7)(2010-2#3)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#7)(2010-8#14)(2010-9#3)(2011-1#4)(2011-2#68)(2011-3#7)(2011-7#2)(2011-9#1)(2012-12#17)(2012-2#23)(2012-3#23)(2012-9#1)(2013-1#31)(2013-7#3)(2013-8#13)
life&quot##2##1##(2008-10#1)(2009-10#1)
life)##3##1##(1993-2#1)(2010-11#1)(2010-5#1)
life-course##3##1##(2008-12#1)(2012-3#2)
life-cycle##2##1##(2011-2#1)(2011-3#1)
life-extending and##2##2##(2008-11#1)(2008-7#1)
life-history evolution##2##2##(2008-8#1)(2008-9#1)
life-history patterns##3##2##(2008-8#3)
life-history strategies##3##2##(2008-8#3)
life-history theory and##2##3##(2008-8#2)
life-history theory##5##2##(2008-8#5)
life-history traits on the##2##4##(2008-8#2)
life-history traits##22##2##(2008-11#1)(2008-8#16)(2008-9#5)
life-history transitions##3##2##(2008-8#3)
life-history##61##1##(2007-12#1)(2008-11#1)(2008-8#44)(2008-9#11)(2010-8#3)(2012-3#1)
life-long learning##5##2##(2008-11#3)(2008-12#2)
life-long##12##1##(1996-6#1)(2008-11#4)(2008-12#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#2)
life-prolonging treatment preferences##2##3##(2009-11#2)
life-prolonging##5##1##(2008-7#1)(2009-11#4)
life-saving##3##1##(1994-3#1)(1995-12#1)(2008-1#1)
life-sciences##3##1##(1992-12#1)(2008-9#2)
life-span##6##1##(2008-10#1)(2008-11#3)(2008-8#1)(2009-12#1)
life-sustaining treatment##3##2##(1991-2#2)(2010-4#1)
life-sustaining##7##1##(1991-2#2)(1993-12#1)(1995-12#1)(2008-7#1)(2010-4#2)
life-threatening complication in patients##2##4##(2011-2#1)(2012-12#1)
life-threatening complication in##3##3##(2011-2#1)(2011-3#1)(2012-12#1)
life-threatening complication of##5##3##(2008-12#2)(2009-7#1)(2010-10#1)(2011-2#1)
life-threatening complication##8##2##(2008-12#2)(2009-7#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-12#1)
life-threatening condition##2##2##(2009-12#1)(2011-3#1)
life-threatening illness##2##2##(1995-12#1)(2008-11#1)
life-threatening infection##2##2##(2008-12#1)(2011-2#1)
life-threatening##45##1##(1991-2#1)(1993-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-11#5)(2008-12#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
life-time##3##1##(2008-10#3)
life?##3##1##(2008-11#1)(2010-3#1)(2013-7#1)
life]##3##1##(1994-5#1)(1994-8#1)(1997-2#1)
lifecycle##3##1##(2008-11#1)(2010-5#1)(2011-2#1)
lifelong non-smokers##2##2##(1996-3#2)
lifelong##9##1##(1990-11#1)(1994-12#1)(1996-3#2)(2007-11#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)
lifesaving##2##1##(1994-6#1)(2013-8#1)
lifespan##17##1##(1996-2#1)(1997-7#1)(2008-11#3)(2008-7#3)(2008-9#2)(2009-5#1)(2010-3#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-7#1)
lifestyle and risk##3##3##(2010-7#2)(2010-9#1)
lifestyle and##7##2##(1996-8#1)(2008-6#1)(2010-7#2)(2010-9#1)(2012-2#1)(2013-1#1)
lifestyle as##2##2##(2011-2#2)
lifestyle changes in##2##3##(2010-8#2)
lifestyle changes##9##2##(1994-12#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-6#1)(2010-8#2)(2012-3#1)
lifestyle factors##2##2##(2009-8#1)(2010-5#1)
lifestyle intervention##2##2##(2012-12#1)(2012-3#1)
lifestyle modification##2##2##(2008-12#1)(2008-8#1)
lifestyle of##2##2##(1990-9#1)(2010-1#1)
lifestyle practices##2##2##(2011-2#1)(2013-1#1)
lifestyle risk factors##2##3##(2011-2#1)(2013-1#1)
lifestyle that##2##2##(2009-5#1)(2010-12#1)
lifestyle##61##1##(1990-9#1)(1991-6#1)(1993-2#1)(1994-12#1)(1996-8#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)
lifestyle)##2##1##(1994-6#1)(2013-1#1)
lifestyle-related diseases in the Asia-Pacific region##2##6##(2008-10#2)
lifestyles and##2##2##(2007-12#1)(2011-2#1)
lifestyles##11##1##(1991-1#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-9#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-12#1)
lifetime and##6##2##(1991-5#1)(2008-10#2)(2008-3#1)(2010-9#1)(2011-2#1)
lifetime in##2##2##(2008-3#2)
lifetime is about##2##3##(2008-10#2)
lifetime is##5##2##(1994-9#1)(1995-3#1)(2008-10#3)
lifetime of the biosensor##2##4##(2008-10#2)
lifetime of the electrode##3##4##(2008-10#3)
lifetime of the sensor was##2##5##(2008-10#2)
lifetime of the sensor##5##4##(2008-10#5)
lifetime of the##19##3##(2008-10#19)
lifetime of tumor-bearing mice##2##4##(2008-9#2)
lifetime of##38##2##(1992-6#1)(1994-5#2)(2008-10#31)(2008-8#2)(2008-9#2)
lifetime reproductive success##5##3##(2008-8#2)(2008-9#3)
lifetime was##4##2##(2008-10#4)
lifetime were##2##2##(2008-10#1)(2008-7#1)
lifetime##113##1##(1990-12#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-5#2)(1994-9#1)(1995-3#2)(2008-10#61)(2008-12#2)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#9)(2008-9#6)(2009-10#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-9#2)(2011-2#4)(2012-12#2)
lifetimes of##3##2##(1996-2#1)(2008-10#1)(2009-12#1)
lifetimes##8##1##(1991-5#1)(1996-2#2)(2008-10#1)(2008-3#2)(2008-8#1)(2009-12#1)
lift and##2##2##(2010-1#1)(2010-5#1)
lift##9##1##(1994-2#1)(1997-3#1)(2008-11#3)(2008-5#1)(2010-1#1)(2010-5#2)
lifting##5##1##(1997-8#1)(2008-8#1)(2010-1#1)(2010-8#1)(2013-1#1)
lifts##2##1##(1996-5#1)(2010-9#1)
ligament reconstruction##10##2##(2008-11#3)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#4)
ligament tears and##2##3##(2009-3#1)(2012-3#1)
ligament##48##1##(1990-6#2)(1995-8#2)(1997-8#2)(2008-11#4)(2008-12#2)(2008-9#2)(2009-1#1)(2009-3#2)(2009-7#7)(2009-9#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#14)
ligamentous##5##1##(2009-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
ligaments are##2##2##(2008-10#1)(2008-9#1)
ligaments between the midgut and salivary glands##2##7##(2008-10#2)
ligaments or tendons##2##3##(2013-1#2)
ligaments##13##1##(2008-10#3)(2008-12#1)(2008-9#3)(2009-7#3)(2013-1#3)
ligand 1##2##2##(2008-10#1)(2012-3#1)
ligand and the##2##3##(1997-2#1)(2008-10#1)
ligand and##10##2##(1994-8#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-5#1)
ligand are##2##2##(2008-10#1)(2008-4#1)
ligand binding and##2##3##(1994-8#1)(2012-2#1)
ligand binding in##2##3##(1995-11#1)(1996-12#1)
ligand binding properties##2##3##(1990-8#1)(1993-8#1)
ligand binding to either the##2##5##(1994-5#2)
ligand binding to the##3##4##(1993-8#1)(1995-2#1)(1997-7#1)
ligand binding to##8##3##(1993-8#2)(1994-5#2)(1995-2#2)(1997-7#1)(2008-4#1)
ligand binding##34##2##(1990-8#3)(1991-12#1)(1993-6#1)(1993-8#4)(1994-5#3)(1994-8#2)(1995-11#3)(1995-2#4)(1995-6#2)(1996-12#2)(1997-7#1)(2006-6#1)(2008-4#5)(2008-8#1)(2012-2#1)
ligand complexes##2##2##(2008-10#2)
ligand concentration##6##2##(1997-2#1)(2008-10#5)
ligand densities##2##2##(1997-2#1)(2008-7#1)
ligand dissociation##2##2##(1990-8#1)(1992-6#1)
ligand exchange##3##2##(2008-10#3)
ligand expression##2##2##(2008-11#1)(2013-1#1)
ligand for the##3##3##(1996-2#1)(2008-9#1)(2010-1#1)
ligand for##10##2##(1990-5#1)(1992-12#1)(1996-12#2)(1996-2#1)(2008-10#2)(2008-9#1)(2010-1#1)(2010-11#1)
ligand have##2##2##(2008-10#2)
ligand in the##2##3##(2006-6#1)(2008-10#1)
ligand in##8##2##(1990-11#1)(2006-6#1)(2008-10#5)(2008-11#1)
ligand is##6##2##(1994-5#1)(1996-2#1)(2008-10#3)(2008-4#1)
ligand of the##2##3##(1995-8#1)(2012-2#1)
ligand of##7##2##(1994-5#2)(1995-8#1)(1997-7#1)(2008-10#1)(2008-9#1)(2012-2#1)
ligand signatures##2##2##(2010-11#2)
ligand structure##3##2##(2008-10#3)
ligand substitution kinetic##2##3##(2008-10#2)
ligand substitution##3##2##(2008-10#2)(2008-12#1)
ligand system##2##2##(2008-12#1)(2008-8#1)
ligand to the##2##3##(1991-9#1)(1992-3#1)
ligand to##4##2##(1991-9#1)(1992-3#1)(2008-10#2)
ligand was found to be##2##5##(2008-10#2)
ligand was##7##2##(1993-8#1)(1994-8#1)(2008-10#4)(2008-8#1)
ligand with##4##2##(2008-10#3)(2008-8#1)
ligand##270##1##(1990-11#1)(1990-5#2)(1990-8#6)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#7)(1994-11#1)(1994-12#3)(1994-5#8)(1994-8#4)(1995-11#4)(1995-12#1)(1995-2#9)(1995-6#3)(1995-8#1)(1996-12#6)(1996-2#3)(1997-1#2)(1997-2#5)(1997-7#2)(2006-6#2)(2008-10#125)(2008-11#6)(2008-12#4)(2008-4#8)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#6)(2009-10#2)(2009-3#2)(2009-8#1)(2010-1#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#4)
ligand) complexes##2##2##(1995-11#1)(2008-10#1)
ligand)##7##1##(1995-11#1)(2008-10#6)
ligand-binding assays##2##2##(2010-11#1)(2013-1#1)
ligand-binding domain of##5##3##(1991-12#2)(1992-9#1)(2008-8#2)
ligand-binding domain##7##2##(1991-12#2)(1992-9#1)(2008-8#4)
ligand-binding##14##1##(1991-12#2)(1992-9#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-8#4)(2010-11#1)(2010-7#1)(2013-1#1)
ligand-dependent transcription##2##2##(1995-2#2)
ligand-dependent##5##1##(1995-2#2)(2008-10#1)(2012-2#1)(2013-1#1)
ligand-induced##3##1##(1992-6#1)(1994-12#1)(2008-10#1)
ligand-receptor##3##1##(1991-3#1)(2008-4#1)(2008-9#1)
liganded##10##1##(1990-8#3)(1992-6#7)
ligands and##10##2##(1997-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
ligands are##7##2##(1995-11#1)(2008-10#4)(2008-5#1)(2012-2#1)
ligands by##2##2##(2008-4#1)(2008-9#1)
ligands for the##3##3##(2008-10#3)
ligands for##13##2##(1992-4#1)(1994-6#1)(1995-11#1)(2008-10#5)(2008-8#2)(2009-10#1)(2013-1#1)(2013-8#1)
ligands have been##2##3##(1991-12#1)(2012-2#1)
ligands have##5##2##(1991-12#1)(2008-10#1)(2010-11#1)(2012-2#2)
ligands in a##5##3##(2008-10#4)(2009-3#1)
ligands in the##2##3##(2008-10#1)(2010-11#1)
ligands in##15##2##(2008-10#10)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#1)(2013-1#1)
ligands including##3##2##(1995-11#1)(1995-6#1)(2009-8#1)
ligands may##2##2##(2008-10#1)(2009-6#1)
ligands of##5##2##(1993-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
ligands on##3##2##(1994-2#1)(1995-2#1)(2008-10#1)
ligands such as##2##3##(1991-7#1)(2008-4#1)
ligands that bind to##2##4##(2008-1#1)(2008-4#1)
ligands that##6##2##(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-3#1)
ligands to opioid receptors##2##4##(2009-7#2)
ligands to the diiron site##2##5##(1991-12#2)
ligands to the##3##3##(1991-12#2)(2008-10#1)
ligands to##10##2##(1991-12#2)(1997-2#2)(2008-10#3)(2008-7#1)(2009-7#2)
ligands was##3##2##(2008-10#2)(2008-9#1)
ligands were##9##2##(1995-11#2)(2008-10#5)(2008-7#1)(2010-11#1)
ligands with##6##2##(2008-10#1)(2008-8#1)(2012-2#4)
ligands##202##1##(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-7#1)(1992-4#1)(1993-3#1)(1993-8#4)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#9)(1995-2#2)(1995-6#3)(1996-2#3)(1997-1#1)(1997-2#3)(2008-1#1)(2008-10#93)(2008-11#1)(2008-4#11)(2008-5#4)(2008-7#5)(2008-8#6)(2008-9#5)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-11#3)(2012-12#2)(2012-2#12)(2012-3#2)(2013-1#5)(2013-8#1)
ligase IV##8##2##(1997-7#8)
ligase##22##1##(1993-2#1)(1995-6#1)(1997-7#11)(2008-4#1)(2009-10#3)(2011-1#1)(2011-3#3)(2012-2#1)
ligases##7##1##(1997-7#2)(2008-4#2)(2009-10#2)(2010-7#1)
ligate the##2##2##(1993-8#1)(2011-3#1)
ligate##3##1##(1993-8#1)(2008-8#1)(2011-3#1)
ligated His85 are##2##3##(2008-9#2)
ligated His85##3##2##(2008-9#3)
ligated to a##2##3##(1992-3#1)(2008-10#1)
ligated with##2##2##(1990-5#1)(1995-8#1)
ligated##18##1##(1990-5#1)(1990-8#2)(1991-11#3)(1992-3#1)(1993-12#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#4)(2013-8#1)
ligating##2##1##(2008-10#1)(2008-8#1)
ligation and##7##2##(1993-2#1)(2008-11#1)(2011-3#1)(2012-3#2)(2013-1#2)
ligation is##2##2##(1994-5#1)(2013-1#1)
ligation of##7##2##(1990-5#1)(1997-6#1)(2008-11#1)(2008-2#1)(2011-3#2)(2013-1#1)
ligation reactions##3##2##(2010-7#3)
ligation was##2##2##(2013-1#2)
ligation with##2##2##(1993-2#1)(2013-1#1)
ligation##50##1##(1990-5#2)(1990-8#1)(1993-12#1)(1993-2#2)(1994-1#5)(1994-5#1)(1995-1#3)(1995-11#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#2)(2010-7#5)(2011-3#3)(2012-3#3)(2013-1#10)(2013-8#1)
ligature##5##1##(1990-9#1)(1995-1#3)(2008-10#1)
light (109##2##2##(2012-2#2)
light absorption##6##2##(1994-5#1)(2008-10#1)(2008-3#4)
light activation##2##2##(2011-1#1)(2013-1#1)
light and dark##3##3##(2008-10#2)(2013-7#1)
light and electron microscopy##8##4##(1992-2#1)(1997-3#1)(2006-6#1)(2008-10#5)
light and electron##12##3##(1992-2#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-7#2)
light and heavy chains were##2##5##(1993-8#1)(2008-11#1)
light and heavy##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
light and scanning##2##3##(2008-10#1)(2008-9#1)
light and temperature##2##3##(2008-10#2)
light and transmission electron microscopy##2##5##(2008-10#1)(2008-7#1)
light and transmission electron##3##4##(2008-10#1)(2008-7#2)
light and##48##2##(1990-5#1)(1992-2#1)(1993-8#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-3#4)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#4)(2011-1#1)(2013-7#1)
light are##3##2##(2008-2#1)(2008-8#1)(2010-6#1)
light as##2##2##(1991-6#1)(2008-3#1)
light at 470 nm##2##4##(2008-10#1)(2008-11#1)
light at##9##2##(1991-12#1)(1991-2#2)(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)
light attenuation by##2##3##(2008-7#2)
light beam##4##2##(2008-3#4)
light brown to brown type##2##5##(2008-10#2)
light brown to brown##3##4##(2008-10#3)
light brown##5##2##(2008-10#5)
light by##8##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
light can be##4##3##(1990-5#1)(1991-9#1)(1997-6#1)(2008-2#1)
light chain disease##3##3##(1992-2#2)(2013-8#1)
light chain of##3##3##(1994-11#1)(1994-5#1)(2008-11#1)
light chain restriction##3##3##(2008-9#1)(2009-8#2)
light chain##42##2##(1990-5#1)(1992-2#2)(1992-6#2)(1993-8#4)(1993-9#3)(1994-11#7)(1994-5#1)(1996-12#1)(1997-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2011-2#2)(2012-2#1)(2013-8#4)
light chains are##3##3##(1993-9#3)
light chains in##2##3##(1993-9#2)
light chains of##3##3##(1990-12#1)(1994-5#2)
light chains##15##2##(1990-12#2)(1993-9#7)(1994-11#1)(1994-5#2)(1995-2#1)(2011-2#2)
light conditions##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
light could##2##2##(2008-3#1)(2008-9#1)
light delivery##3##2##(2008-3#1)(2008-7#2)
light detection cell is##2##4##(2008-10#2)
light detection cell##6##3##(2008-10#6)
light detector##3##2##(2008-10#3)
light diesel fuels##2##3##(2008-11#2)
light distribution##2##2##(2008-3#1)(2008-7#1)
light dose of 4##2##4##(2012-3#2)
light dose##5##2##(2012-2#2)(2012-3#3)
light doses##2##2##(2008-7#1)(2012-3#1)
light emission##13##2##(2008-10#11)(2010-7#1)(2011-1#1)
light emitted##2##2##(1992-1#1)(2008-10#1)
light emitting diode (LED)##5##4##(2008-10#4)(2008-11#1)
light emitting diode as##2##4##(2008-10#1)(2008-7#1)
light emitting diode##13##3##(1991-2#1)(2008-10#10)(2008-11#1)(2008-7#1)
light emitting diodes (LEDs)##2##4##(2008-10#2)
light emitting##16##2##(1991-2#1)(2008-10#13)(2008-11#1)(2008-7#1)
light field##2##2##(2008-3#2)
light fluctuations##3##2##(2007-12#1)(2008-8#2)
light for##6##2##(1991-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)
light from the##4##3##(1991-6#1)(2008-10#3)
light from##11##2##(1991-6#1)(2008-10#5)(2008-2#2)(2008-3#3)
light has##3##2##(1990-11#1)(2008-2#1)(2008-3#1)
light illumination##2##2##(2008-9#1)(2011-2#1)
light impairs sleep##2##3##(1994-8#2)
light in a##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
light in the##7##3##(2008-10#2)(2008-3#4)(2013-1#1)
light in##14##2##(2008-10#4)(2008-2#2)(2008-3#5)(2009-4#1)(2013-1#1)(2013-7#1)
light initiation and##2##3##(2008-10#2)
light initiation##9##2##(2008-10#9)
light intensities##2##2##(2008-3#1)(2008-8#1)
light intensity and##2##3##(2008-10#1)(2008-7#1)
light intensity##13##2##(2008-10#5)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#2)(2013-8#1)
light interaction with##2##3##(1994-3#1)(2008-10#1)
light interception##2##2##(2008-10#2)
light into##2##2##(2008-3#1)(2011-1#1)
light irradiation##5##2##(2008-10#1)(2009-11#1)(2009-3#2)(2009-8#1)
light is##8##2##(2008-10#1)(2008-3#5)(2008-5#1)(2011-2#1)
light leaf spot##4##3##(2008-10#4)
light levels##2##2##(2008-8#2)
light masks##2##2##(2013-1#2)
light microscope##9##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-9#1)(2011-2#1)(2012-3#1)
light microscopic##4##2##(2008-10#3)(2012-2#1)
light microscopy and##5##3##(2008-1#1)(2008-10#2)(2008-11#1)(2012-3#1)
light microscopy showed##2##3##(2007-12#1)(2008-10#1)
light microscopy##23##2##(1996-3#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-3#1)
light near the##2##3##(2008-3#2)
light of a##4##3##(1993-11#1)(1993-3#1)(2008-10#1)(2013-1#1)
light of other##2##3##(1994-2#1)(2008-11#1)
light of past##2##3##(2012-2#1)(2012-9#1)
light of recent##3##3##(1991-6#1)(2009-8#1)(2011-2#1)
light of the recent##2##4##(1994-2#1)(2008-11#1)
light of the results##2##4##(2008-11#1)(2010-7#1)
light of the##26##3##(1990-3#1)(1993-3#1)(1994-2#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-8#3)(2009-5#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
light of these##3##3##(1993-1#1)(2008-11#1)(2013-8#1)
light of##75##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#1)(1993-1#1)(1993-11#1)(1993-3#2)(1994-1#1)(1994-2#2)(1994-5#1)(1995-12#1)(1996-1#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#13)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#3)(2011-2#3)(2012-2#4)(2012-3#4)(2012-9#1)(2013-1#1)(2013-8#2)
light on the##18##3##(1992-9#1)(1994-1#1)(1997-2#1)(1997-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-2#4)(2013-1#1)
light on this problem##2##4##(1992-8#1)(2008-8#1)
light on this##3##3##(1992-8#1)(2008-8#1)(2012-2#1)
light on##36##2##(1991-9#1)(1992-8#1)(1992-9#1)(1994-1#1)(1994-12#1)(1997-1#1)(1997-2#1)(1997-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-2#6)(2012-3#1)(2013-1#1)
light or malate##2##3##(2008-10#2)
light or##4##2##(1997-3#1)(2008-10#3)
light perception##2##2##(2008-9#1)(2011-2#1)
light periods##2##2##(2008-10#2)
light production##2##2##(2007-12#1)(2008-10#1)
light propagation in##2##3##(2008-10#1)(2008-3#1)
light propagation within the##2##4##(2008-10#2)
light propagation##6##2##(2008-10#3)(2008-3#3)
light pulse##4##2##(1994-2#2)(2008-5#2)
light pulses##7##2##(2008-3#1)(2008-5#6)
light quantity##4##2##(2008-10#4)
light regime##3##2##(2008-11#3)
light scatter##2##2##(2006-6#1)(2008-9#1)
light scattering (RLS) technique##3##4##(2008-10#3)
light scattering (RLS)##7##3##(2008-10#7)
light scattering and##2##3##(2008-10#2)
light scattering by##5##3##(2008-3#5)
light scattering in laser particle sizing##2##6##(2008-3#2)
light scattering in##7##3##(1994-3#2)(2008-3#5)
light scattering intensity##3##3##(2008-10#3)
light scattering is##3##3##(2008-3#2)(2008-4#1)
light scattering of##5##3##(2008-10#5)
light scattering signals##2##3##(2008-10#2)
light scattering technique and its##2##5##(2008-10#2)
light scattering technique was##2##4##(2008-10#2)
light scattering technique##9##3##(2008-10#9)
light scattering techniques##2##3##(1992-3#1)(2011-2#1)
light scattering were##2##3##(2008-10#1)(2008-8#1)
light scattering##81##2##(1992-3#1)(1994-3#2)(2008-10#49)(2008-2#2)(2008-3#21)(2008-4#3)(2008-8#1)(2011-2#2)
light source (LED) and##2##4##(2008-10#2)
light source and a##3##4##(2008-10#3)
light source and##7##3##(2008-10#7)
light source for##2##3##(2008-3#1)(2010-12#1)
light source##31##2##(1993-3#1)(2007-12#2)(2008-10#18)(2008-2#1)(2008-3#5)(2008-5#1)(2010-12#1)(2011-7#1)(2012-3#1)
light sources##9##2##(2007-11#1)(2008-3#2)(2008-4#1)(2008-9#3)(2011-7#2)
light that##4##2##(2008-3#3)(2008-8#1)
light therapy##3##2##(2007-11#1)(2008-12#1)(2013-1#1)
light through a##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
light through##8##2##(2007-12#1)(2008-10#2)(2008-3#4)(2008-6#1)
light to##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)
light transmission##3##2##(2007-12#1)(2008-3#2)
light utilization efficiency of##3##4##(2013-8#3)
light utilization efficiency##4##3##(2013-8#4)
light was emitted##2##3##(2008-10#1)(2008-7#1)
light was used to##2##4##(2008-10#1)(2008-2#1)
light was##16##2##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-7#3)(2011-1#1)
light wavelengths##2##2##(2008-10#1)(2008-11#1)
light were##2##2##(2008-11#1)(2008-2#1)
light with a##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
light with##6##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
light##932##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#5)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#8)(1991-6#5)(1991-9#3)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#5)(1993-5#1)(1993-6#2)(1993-8#6)(1993-9#10)(1994-1#2)(1994-11#8)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#5)(1994-6#1)(1994-8#5)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#4)(1997-9#1)(2006-6#2)(2007-11#6)(2007-12#26)(2008-1#2)(2008-10#291)(2008-11#51)(2008-12#6)(2008-2#25)(2008-3#129)(2008-4#14)(2008-5#26)(2008-6#1)(2008-7#32)(2008-8#28)(2008-9#26)(2009-10#3)(2009-11#2)(2009-3#4)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#13)(2009-9#2)(2010-1#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#1)(2011-1#6)(2011-2#21)(2011-7#4)(2012-2#20)(2012-3#14)(2012-9#1)(2013-1#13)(2013-7#2)(2013-8#13)
light)##3##1##(2008-10#1)(2008-5#1)(2013-1#1)
light- and##2##2##(1997-2#1)(2008-11#1)
light-##3##1##(1997-2#1)(2008-10#1)(2008-11#1)
light-activated disinfection (LAD) in the treatment of peri-implantitis##2##8##(2013-1#2)
light-colored##3##1##(1995-2#1)(2008-10#2)
light-cured##4##1##(2013-1#4)
light-curing technique##2##2##(2013-1#2)
light-curing##4##1##(2013-1#4)
light-dark cycle##2##2##(2008-5#2)
light-dark cycles##2##2##(1990-5#1)(2008-5#1)
light-dark regimes##2##2##(2008-11#2)
light-dark##9##1##(1990-5#1)(1991-9#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-5#3)
light-dependent##2##1##(2008-11#1)(2009-8#1)
light-emitting diode (LED)##2##3##(2008-10#2)
light-emitting diode##5##2##(2008-10#4)(2013-1#1)
light-emitting##8##1##(1995-3#1)(2007-12#1)(2008-10#5)(2013-1#1)
light-exposed##2##1##(2009-9#2)
light-grown cocultures##2##2##(2008-10#2)
light-harvesting##3##1##(1995-2#1)(1996-2#1)(2012-6#1)
light-induced##9##1##(1994-2#3)(1995-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)
light-scattering data##4##2##(2008-3#4)
light-scattering measurements##3##2##(2008-3#3)
light-scattering technique with##2##3##(2008-10#2)
light-scattering technique##4##2##(2008-10#3)(2008-3#1)
light-scattering##25##1##(1993-2#1)(2008-10#11)(2008-3#13)
lightening##3##1##(2008-5#3)
lighter##6##1##(1990-5#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-6#2)
lighting conditions##2##2##(1991-2#2)
lighting##8##1##(1991-2#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)
lightly infested##2##2##(1996-12#2)
lightly##10##1##(1994-3#1)(1996-12#3)(1996-3#1)(1997-2#1)(2008-10#3)(2008-7#1)
lightness##2##1##(2008-5#1)(2009-10#1)
lights##6##1##(2008-10#3)(2011-2#3)
lightweight##4##1##(2008-10#2)(2008-3#1)(2012-2#1)
lignans##4##1##(2008-10#1)(2008-11#1)(2011-3#2)
lignification##2##1##(2008-10#2)
lignin biosynthesis##4##2##(2008-10#2)(2009-8#2)
lignin content##3##2##(2008-10#1)(2008-6#2)
lignin degradation##2##2##(2008-6#1)(2009-9#1)
lignin genes##2##2##(2008-10#2)
lignin in##2##2##(2008-6#2)
lignin peroxidase (LIP)##2##3##(1990-12#1)(2008-6#1)
lignin peroxidase##5##2##(1990-12#2)(2008-6#3)
lignin##39##1##(1990-12#2)(2008-10#11)(2008-11#3)(2008-6#11)(2009-8#7)(2009-9#1)(2011-1#2)(2013-8#2)
lignin-like compounds##2##2##(2008-10#2)
ligninolytic##5##1##(2008-10#1)(2008-5#2)(2009-9#1)(2011-1#1)
lignocellulose##2##1##(2011-1#1)(2011-2#1)
lignocellulosic hydrolysate##2##2##(2011-1#2)
lignocellulosic hydrolysates##2##2##(2011-1#2)
lignocellulosic##6##1##(2011-1#4)(2013-1#2)
like &quot##3##2##(1992-3#1)(1994-1#1)(2009-4#1)
like a##15##2##(1990-2#1)(1991-11#1)(1992-1#1)(1996-5#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-9#1)(2011-2#1)
like an##5##2##(1997-2#1)(2008-10#3)(2008-3#1)
like bone##2##2##(2009-7#1)(2011-2#1)
like cell##2##2##(2008-11#1)(2009-3#1)
like diabetes mellitus##2##3##(2008-11#1)(2013-1#1)
like flow##2##2##(1994-1#1)(2008-10#1)
like in##2##2##(2008-7#1)(2011-2#1)
like linear discriminant analysis##2##4##(2008-10#2)
like many##3##2##(1991-6#1)(2008-9#1)(2013-8#1)
like most##2##2##(2008-10#1)(2009-10#1)
like other##2##2##(1996-12#1)(2012-2#1)
like power##2##2##(2008-10#1)(2008-11#1)
like several other##2##3##(1995-6#1)(2008-9#1)
like that of the##3##4##(1994-2#1)(2008-10#1)(2011-2#1)
like that of##7##3##(1992-9#1)(1993-1#1)(1994-2#1)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)
like that##9##2##(1991-7#1)(1992-9#1)(1993-1#1)(1994-2#1)(2008-10#1)(2008-8#2)(2009-6#1)(2011-2#1)
like the##25##2##(1992-2#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
like this##3##2##(1994-12#1)(2008-6#1)(2008-7#1)
like those##2##2##(1992-12#1)(1995-12#1)
like time##2##2##(2008-10#2)
like to be##2##3##(1992-2#1)(2008-8#1)
like to see##4##3##(1992-3#3)(1997-4#1)
like to##15##2##(1990-2#1)(1991-2#1)(1992-2#1)(1992-3#3)(1996-6#1)(1997-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
like##323##1##(1990-11#1)(1990-2#3)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-8#2)(1994-1#2)(1994-12#1)(1994-2#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#1)(2007-8#1)(2008-10#86)(2008-11#35)(2008-12#8)(2008-3#4)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#3)(2010-3#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#18)(2011-3#2)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#8)
likelihood and##3##2##(1994-9#1)(2008-10#2)
likelihood based##3##2##(1996-3#3)
likelihood for##2##2##(1992-1#1)(2008-8#1)
likelihood methods##5##2##(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
likelihood of adverse##2##3##(2009-1#1)(2010-12#1)
likelihood of having##6##3##(1992-2#1)(1995-12#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
likelihood of smoking##2##3##(2010-11#2)
likelihood of##64##2##(1991-12#2)(1992-2#1)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#2)(1996-9#1)(1997-2#1)(1997-3#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-6#4)(2009-7#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
likelihood ratio =##2##3##(2008-12#2)
likelihood ratio test##2##3##(2008-10#1)(2008-11#1)
likelihood ratio##9##2##(2008-10#4)(2008-11#1)(2008-12#4)
likelihood that##9##2##(1997-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-2#1)
likelihood##123##1##(1991-12#2)(1992-1#1)(1992-2#2)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#2)(1996-3#4)(1996-9#1)(1997-2#1)(1997-3#3)(1997-8#1)(2008-10#19)(2008-11#5)(2008-12#7)(2008-4#4)(2008-6#3)(2008-7#3)(2008-8#13)(2008-9#6)(2009-1#1)(2009-10#1)(2009-6#4)(2009-7#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#5)(2013-8#1)
likelihoods##2##1##(1996-3#1)(2008-9#1)
likely a##9##2##(1995-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-8#1)
likely among the##2##3##(2008-1#1)(2009-8#1)
likely an##2##2##(1992-6#1)(2009-8#1)
likely as##3##2##(2008-10#1)(2008-11#2)
likely associated with##2##3##(1997-2#1)(2008-7#1)
likely be##4##2##(2008-10#3)(2008-8#1)
likely by##4##2##(1994-12#1)(2008-10#1)(2009-10#1)(2012-2#1)
likely candidates for##2##3##(1992-12#1)(2008-7#1)
likely candidates##3##2##(1992-12#1)(2008-7#2)
likely cause of her##2##4##(1991-12#1)(2008-7#1)
likely cause of##4##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
likely causes##2##2##(2012-2#1)(2013-1#1)
likely coding##3##2##(1995-12#3)
likely contribute to the##2##4##(2008-10#1)(2012-2#1)
likely correlated with the##2##4##(2008-8#1)(2009-8#1)
likely due to the##4##4##(2008-10#3)(2013-8#1)
likely due to##17##3##(1993-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-8#1)
likely explanation for##3##3##(1992-5#1)(2012-3#2)
likely explanation##5##2##(1992-5#1)(1997-1#1)(2008-10#1)(2012-3#2)
likely genes##3##2##(1995-12#2)(1997-6#1)
likely have##2##2##(2008-11#1)(2009-9#1)
likely in##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
likely involved in##3##3##(1992-8#1)(2009-10#1)(2009-8#1)
likely involved##6##2##(1992-8#1)(1995-8#1)(1997-2#1)(2008-10#1)(2009-10#1)(2009-8#1)
likely lead to##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
likely more##2##2##(2008-10#1)(2011-2#1)
likely not##5##2##(2008-10#3)(2008-9#1)(2013-8#1)
likely originated##2##2##(2008-10#2)
likely play a role in##2##5##(2008-10#1)(2011-10#1)
likely play##3##2##(2008-10#1)(2008-8#1)(2011-10#1)
likely possess##2##2##(2008-10#2)
likely reflects##2##2##(1994-5#1)(2009-6#1)
likely related to##3##3##(1997-2#1)(2008-7#1)(2011-2#1)
likely responsible for the##2##4##(2009-8#1)(2011-2#1)
likely result in##3##3##(1996-2#1)(2009-3#1)(2012-2#1)
likely result##4##2##(1996-2#1)(2009-3#1)(2012-2#2)
likely site##2##2##(1993-3#1)(2008-10#1)
likely than##11##2##(1993-1#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#1)(2008-12#2)(2008-4#1)(2010-10#1)(2012-3#1)(2013-1#1)
likely that at least##2##4##(2008-10#1)(2008-11#1)
likely that many##2##3##(1997-1#1)(2007-12#1)
likely that the##6##3##(1995-12#1)(1997-1#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-1#1)
likely that this##6##3##(1992-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-3#1)
likely that##40##2##(1991-2#1)(1992-12#2)(1993-8#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#3)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
likely the result of##3##4##(1995-12#1)(2008-10#2)
likely the##11##2##(1993-8#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-7#1)
likely to achieve##3##3##(1992-2#1)(1992-6#1)(2009-7#1)
likely to affect##2##3##(1997-3#1)(2008-8#1)
likely to be a##3##4##(1997-6#1)(2008-12#1)(2008-8#1)
likely to be affected by##2##5##(2009-8#1)(2010-10#1)
likely to be an underestimate##2##5##(2008-10#1)(2011-2#1)
likely to be an##3##4##(1990-2#1)(2008-10#1)(2011-2#1)
likely to be based on##2##5##(1994-12#1)(2008-10#1)
likely to be due to##2##5##(2008-11#2)
likely to be important##3##4##(1992-6#1)(1996-2#1)(2011-3#1)
likely to be involved##3##4##(1991-7#1)(2008-10#1)(2008-5#1)
likely to be more vulnerable to##2##6##(2007-12#1)(2008-10#1)
likely to be more##3##4##(2007-12#1)(2008-10#1)(2008-9#1)
likely to be successful in##2##5##(2008-8#1)(2010-3#1)
likely to be useful##2##4##(2012-2#2)
likely to be##96##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-12#3)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-6#1)(2007-12#1)(2008-10#15)(2008-11#9)(2008-12#4)(2008-4#2)(2008-5#1)(2008-8#7)(2008-9#5)(2009-5#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-2#5)(2013-1#6)
likely to become##3##3##(1993-12#1)(2008-10#1)(2009-7#1)
likely to benefit from this##3##5##(2008-12#1)(2011-2#1)(2013-8#1)
likely to benefit from##5##4##(1997-6#1)(2008-12#1)(2011-2#2)(2013-8#1)
likely to cause##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
likely to change##3##3##(2008-9#1)(2009-12#1)(2010-3#1)
likely to continue##3##3##(2008-11#1)(2009-5#1)(2012-12#1)
likely to develop an##2##4##(1997-1#1)(2013-8#1)
likely to develop##4##3##(1997-1#1)(2010-12#1)(2013-8#2)
likely to die##3##3##(1995-2#1)(2008-7#1)(2008-8#1)
likely to encounter##2##3##(1991-12#1)(2008-9#1)
likely to evolve##3##3##(2008-8#1)(2010-10#2)
likely to experience##4##3##(1996-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
likely to fall##2##3##(1990-2#1)(2008-8#1)
likely to have a##5##4##(1995-12#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-6#1)
likely to have been##2##4##(1992-2#1)(2008-10#1)
likely to have##27##3##(1991-12#1)(1992-2#3)(1993-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#3)(2013-1#3)
likely to increase##2##3##(2009-5#1)(2012-2#1)
likely to influence the##3##4##(1996-12#1)(1997-1#1)(2008-10#1)
likely to influence##5##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-5#1)
likely to intervene if they##2##5##(2008-12#2)
likely to occur in##5##4##(1990-6#1)(2008-10#1)(2008-8#3)
likely to occur##8##3##(1990-6#1)(1996-11#1)(2008-10#2)(2008-5#1)(2008-8#3)
likely to play a##4##4##(1992-12#1)(1992-6#1)(1997-7#1)(2008-10#1)
likely to play##5##3##(1992-12#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-9#1)
likely to produce##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
likely to provide the home modalities##2##6##(1995-12#2)
likely to provide##9##3##(1990-3#1)(1995-12#2)(2008-11#1)(2008-9#2)(2009-7#1)(2010-11#1)(2011-2#1)
likely to reach the##2##4##(1997-1#1)(2011-2#1)
likely to receive a##2##4##(1995-12#1)(2012-3#1)
likely to receive##6##3##(1995-12#1)(2008-9#1)(2009-5#1)(2012-3#2)(2013-1#1)
likely to remain##2##3##(2008-9#1)(2013-1#1)
likely to report##6##3##(1995-12#1)(1997-2#1)(2008-12#1)(2009-5#2)(2013-1#1)
likely to respond to##2##4##(1996-11#1)(2008-12#1)
likely to respond##3##3##(1996-11#1)(2008-12#1)(2012-3#1)
likely to result##2##3##(2008-10#1)(2010-10#1)
likely to seek medical attention##2##5##(2012-12#2)
likely to##308##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-6#1)(1991-7#1)(1992-12#2)(1992-2#5)(1992-3#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#3)(1994-3#1)(1995-12#8)(1995-2#5)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#6)(1997-2#4)(1997-3#2)(1997-6#2)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#31)(2008-11#19)(2008-12#13)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#29)(2008-9#18)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#9)(2009-6#2)(2009-7#4)(2009-8#3)(2010-10#4)(2010-11#5)(2010-12#1)(2010-3#2)(2010-5#2)(2011-2#16)(2011-3#1)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#17)(2013-8#4)
likely was##3##2##(2008-10#2)(2008-7#1)
likely will##2##2##(2008-10#2)
likely##619##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#1)(1991-11#4)(1991-12#9)(1991-2#4)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#5)(1992-2#5)(1992-3#1)(1992-5#1)(1992-6#5)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#3)(1994-12#5)(1994-2#4)(1994-3#1)(1994-5#4)(1995-1#1)(1995-11#1)(1995-12#19)(1995-2#8)(1995-3#1)(1995-5#4)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#4)(1996-12#2)(1996-2#7)(1996-3#4)(1996-5#1)(1996-9#2)(1997-1#10)(1997-2#7)(1997-3#4)(1997-6#4)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#5)(2008-1#6)(2008-10#103)(2008-11#32)(2008-12#18)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#18)(2008-8#49)(2008-9#25)(2009-10#6)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#9)(2009-6#4)(2009-7#4)(2009-8#13)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#5)(2010-12#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#28)(2011-3#1)(2012-12#5)(2012-2#20)(2012-3#11)(2012-6#1)(2012-7#1)(2013-1#23)(2013-8#9)
likeness##3##1##(2008-11#2)(2012-3#1)
likewise##6##1##(2008-10#4)(2009-8#1)(2011-2#1)
lilii##3##1##(2008-10#3)
lily##6##1##(2008-10#6)
lima bean##3##2##(2008-10#3)
lima##7##1##(2008-10#4)(2008-7#3)
limb and##4##2##(1995-8#1)(2008-7#1)(2009-3#1)(2011-2#1)
limb anomalies##2##2##(2008-10#2)
limb bud##7##2##(1993-12#4)(1995-8#3)
limb cartilages##2##2##(2008-11#2)
limb cellulitis##4##2##(1991-8#4)
limb deformity##4##2##(2009-3#4)
limb development##5##2##(1997-3#1)(2008-11#1)(2009-3#3)
limb during##3##2##(2013-1#1)(2013-8#2)
limb dystonia##2##2##(2008-7#2)
limb inequality treatment##2##3##(2013-1#2)
limb inequality##4##2##(2013-1#4)
limb length##2##2##(2010-5#2)
limb lengthening##3##2##(2012-2#2)(2013-1#1)
limb mesenchymal cells##3##3##(1994-11#3)
limb mesenchyme##5##2##(1995-8#1)(2008-11#4)
limb movement##3##2##(1994-8#1)(2012-3#2)
limb muscle dysfunction##2##3##(2013-8#2)
limb was##4##2##(2009-3#1)(2011-3#1)(2012-3#2)
limb##120##1##(1991-6#1)(1991-8#4)(1992-9#1)(1993-12#8)(1994-11#3)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#7)(1996-3#1)(1997-3#2)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#13)(2008-12#2)(2008-3#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#2)(2009-3#10)(2010-5#2)(2010-8#1)(2011-2#6)(2011-3#5)(2012-2#3)(2012-3#9)(2013-1#12)(2013-8#8)
limb-length discrepancy##3##2##(2009-3#3)
limbal##6##1##(2008-11#1)(2010-10#4)(2012-3#1)
limber##3##1##(1997-5#2)(2008-10#1)
limbic and cortical##3##3##(1991-10#3)
limbic and##4##2##(1991-10#4)
limbic regions##2##2##(1991-10#2)
limbic system is##2##3##(1992-12#2)
limbic system##10##2##(1992-12#10)
limbic##23##1##(1991-10#6)(1992-12#10)(1993-6#1)(1994-2#1)(1996-12#2)(2008-5#1)(2008-7#1)(2013-8#1)
limbs and##3##2##(1991-11#1)(2008-7#1)(2010-12#1)
limbs are##2##2##(1991-3#1)(2012-12#1)
limbs in##4##2##(1993-12#1)(1997-8#2)(2010-12#1)
limbs of##3##2##(1994-8#1)(1997-8#1)(2010-6#1)
limbs##33##1##(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1993-12#1)(1994-8#1)(1997-8#4)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-8#3)
limbs)##2##1##(1997-8#2)
limbus##3##1##(2008-11#2)(2010-10#1)
lime leaf##2##2##(2008-10#1)(2011-2#1)
lime##10##1##(2008-10#9)(2011-2#1)
limetta fruit peel##2##3##(2012-3#2)
limetta##3##1##(2012-3#3)
limit (0##7##2##(2008-10#7)
limit (3s) of##3##3##(2008-10#3)
limit (3s)##4##2##(2008-10#4)
limit (3sigma) was 0##4##4##(2008-10#4)
limit (3sigma) was##5##3##(2008-10#5)
limit (3sigma)##26##2##(2008-10#26)
limit (3sigma/S) of 0##2##4##(2008-10#2)
limit 0##10##2##(1992-11#1)(2008-10#9)
limit 2##2##2##(2008-10#2)
limit = 0##2##3##(2008-10#2)
limit accepted##2##2##(2008-10#1)(2008-12#1)
limit and##26##2##(2008-10#25)(2008-7#1)
limit are##3##2##(2007-11#1)(2008-10#2)
limit as##2##2##(2008-10#1)(2012-2#1)
limit at##2##2##(2008-10#1)(2008-3#1)
limit cycles##2##2##(1993-5#1)(1995-5#1)
limit for the##8##3##(2008-10#8)
limit for##44##2##(2008-10#42)(2008-12#1)(2008-3#1)
limit in the##2##3##(2008-3#1)(2008-7#1)
limit in##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
limit is 0##26##3##(2008-10#26)
limit is 2##7##3##(2008-10#7)
limit is down to##2##4##(2008-10#2)
limit is##75##2##(2008-10#75)
limit its##4##2##(1994-8#1)(1995-3#1)(2008-10#1)(2008-7#1)
limit levels##2##2##(2008-10#2)
limit of 0##107##3##(1992-11#1)(2007-12#1)(2008-10#101)(2008-11#3)(2010-4#1)
limit of 1##53##3##(2008-10#50)(2008-11#1)(2008-2#1)(2008-3#1)
limit of 2##21##3##(2008-10#21)
limit of 3##12##3##(2008-10#12)
limit of 4##16##3##(1991-5#1)(2008-10#15)
limit of 5##10##3##(2008-10#9)(2008-7#1)
limit of 96##2##3##(2008-10#2)
limit of ascorbic acid was##2##5##(2008-10#2)
limit of detection (3sigma) of##3##5##(2008-10#3)
limit of detection (3sigma) was 0##2##6##(2008-10#2)
limit of detection (3sigma) was##3##5##(2008-10#3)
limit of detection (3sigma)##9##4##(2008-10#9)
limit of detection (LOD) and##2##5##(2008-10#2)
limit of detection (LOD) for##5##5##(2008-10#5)
limit of detection (LOD) of 0##2##6##(2008-10#2)
limit of detection (LOD) of##9##5##(2008-10#9)
limit of detection (LOD) was##3##5##(2008-10#3)
limit of detection (LOD)##33##4##(2008-10#33)
limit of detection (S/N=3) was 0##3##6##(2008-10#3)
limit of detection 0##3##4##(2008-10#3)
limit of detection achieved##3##4##(2008-10#3)
limit of detection and limit of quantification##3##7##(2008-10#2)(2012-2#1)
limit of detection and relative standard deviations were found to be##3##11##(2008-10#3)
limit of detection and##12##4##(1997-2#1)(2008-10#10)(2012-2#1)
limit of detection for the##3##5##(2008-10#3)
limit of detection for##17##4##(2008-10#17)
limit of detection in##2##4##(2008-10#1)(2012-8#1)
limit of detection is 0##7##5##(2008-10#7)
limit of detection is 1##3##5##(2008-10#2)(2013-1#1)
limit of detection is 2##4##5##(2008-10#4)
limit of detection is##18##4##(2008-10#17)(2013-1#1)
limit of detection of 0##7##5##(2008-10#7)
limit of detection of 1##4##5##(2008-10#4)
limit of detection of 3##2##5##(2008-10#2)
limit of detection of the method was##4##7##(2008-10#4)
limit of detection of the method##5##6##(2008-10#5)
limit of detection of the proposed##6##6##(2008-10#6)
limit of detection of the##15##5##(2008-10#15)
limit of detection of##50##4##(2008-10#47)(2009-6#1)(2011-2#2)
limit of detection was 0##9##5##(2008-10#9)
limit of detection was 3##2##5##(2008-10#2)
limit of detection was as low as##2##7##(2008-10#2)
limit of detection was found to be##3##7##(2008-10#3)
limit of detection was##33##4##(1997-2#1)(2008-10#32)
limit of detection##240##3##(1997-2#2)(2008-10#229)(2009-6#1)(2009-8#2)(2011-2#2)(2012-2#2)(2012-8#1)(2013-1#1)
limit of determination##5##3##(2008-10#5)
limit of quantification (LOQ)##4##4##(2008-10#4)
limit of quantification of##3##4##(2008-10#2)(2008-5#1)
limit of quantification were##2##4##(2008-10#2)
limit of quantification##25##3##(2008-10#21)(2008-5#3)(2012-2#1)
limit of quantitation (LOQ)##5##4##(2008-10#5)
limit of quantitation of##3##4##(2008-10#2)(2012-12#1)
limit of quantitation##13##3##(2008-10#12)(2012-12#1)
limit of the proposed technique##2##5##(2008-10#2)
limit of the proposed##6##4##(2008-10#6)
limit of the##32##3##(1993-2#1)(2007-11#1)(2008-10#24)(2008-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-8#2)
limit of this##10##3##(1990-2#1)(1995-11#1)(2008-10#6)(2008-11#1)(2010-7#1)
limit of##693##2##(1990-2#1)(1991-5#2)(1992-11#1)(1993-2#1)(1995-11#1)(1995-3#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#642)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#3)
limit on##4##2##(1993-12#2)(2007-12#1)(2012-2#1)
limit the effectiveness of##2##4##(2008-10#1)(2008-9#1)
limit the spread of##3##4##(1990-6#2)(2011-2#1)
limit the##35##2##(1990-6#2)(1990-9#1)(1991-1#1)(1992-9#1)(1994-3#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
limit their use##2##3##(2009-12#1)(2011-2#1)
limit their##4##2##(1991-12#1)(2008-9#1)(2009-12#1)(2011-2#1)
limit to##6##2##(2008-10#2)(2008-9#2)(2010-7#1)(2010-8#1)
limit using##3##2##(2008-10#3)
limit value##2##2##(2008-10#1)(2008-11#1)
limit values##3##2##(1991-12#1)(2008-11#1)(2011-2#1)
limit was 0##29##3##(2008-10#29)
limit was 2##9##3##(2008-10#9)
limit was 3##5##3##(2008-10#5)
limit was 5##4##3##(2008-10#4)
limit was lower than##3##4##(2008-10#3)
limit was lower##4##3##(2008-10#4)
limit was##119##2##(1990-12#1)(2008-10#117)(2008-3#1)
limit were##7##2##(2008-10#7)
limit##1321##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-5#5)(1992-11#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#3)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-8#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#1165)(2008-11#15)(2008-12#6)(2008-2#5)(2008-3#17)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#8)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#5)
limit) and##3##2##(2008-10#2)(2008-2#1)
limit)##5##1##(2008-10#3)(2008-2#2)
limitation and##5##2##(2008-11#1)(2008-8#2)(2009-1#1)(2012-12#1)
limitation by##2##2##(2008-12#1)(2008-8#1)
limitation due to##2##3##(2008-8#1)(2011-2#1)
limitation for##6##2##(1993-12#1)(1996-5#1)(2008-10#1)(2008-7#2)(2012-2#1)
limitation in##4##2##(1997-1#1)(2008-7#2)(2012-2#1)
limitation is##4##2##(1993-12#1)(2009-1#1)(2012-2#1)(2013-1#1)
limitation of the##5##3##(1991-3#1)(2008-10#2)(2008-11#2)
limitation of##21##2##(1991-3#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-3#1)
limitation on##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
limitation to##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2013-8#1)
limitation##74##1##(1991-3#1)(1993-12#3)(1994-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-10#13)(2008-11#8)(2008-12#1)(2008-3#2)(2008-7#8)(2008-8#11)(2008-9#2)(2009-1#2)(2009-10#1)(2009-12#1)(2010-11#1)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
limitations and##20##2##(1993-11#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-8#1)(2011-2#4)(2013-1#1)
limitations are discussed##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
limitations are##5##2##(1997-1#1)(2008-10#2)(2008-3#1)(2008-9#1)
limitations associated with##3##3##(2008-10#2)(2013-8#1)
limitations due to##2##3##(2008-11#1)(2012-12#1)
limitations for##4##2##(1995-2#1)(2008-10#1)(2009-12#1)(2011-2#1)
limitations imposed by the##2##4##(2008-10#1)(2008-11#1)
limitations imposed by##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
limitations in activities##3##3##(1993-3#1)(2008-12#2)
limitations in the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
limitations in##15##2##(1993-3#1)(1995-10#1)(1995-2#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
limitations may##2##2##(2009-8#1)(2012-7#1)
limitations of conventional##2##3##(1996-3#1)(2008-11#1)
limitations of current##2##3##(2008-7#1)(2011-2#1)
limitations of the##19##3##(1992-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-9#1)(2009-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
limitations of these##4##3##(2008-11#1)(2008-2#1)(2011-2#1)(2012-3#1)
limitations of this study##4##4##(1993-1#1)(2008-8#1)(2013-1#2)
limitations of this##8##3##(1993-1#1)(2008-8#2)(2012-12#1)(2012-2#1)(2013-1#3)
limitations of##68##2##(1992-3#1)(1992-9#1)(1993-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#2)(2008-10#18)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
limitations on##4##2##(1993-3#1)(1996-5#1)(2008-3#1)(2009-8#1)
limitations that##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
limitations to the##2##3##(2008-11#2)
limitations to##6##2##(2008-11#2)(2008-7#1)(2009-8#2)(2012-3#1)
limitations with##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
limitations##211##1##(1991-1#1)(1992-3#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-9#1)(1995-10#1)(1995-2#3)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#4)(2008-10#36)(2008-11#22)(2008-12#6)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#2)(2009-5#3)(2009-8#9)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#15)(2011-3#1)(2011-7#3)(2012-12#2)(2012-2#6)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#12)(2013-8#3)
limited English##4##2##(2008-12#2)(2010-8#2)
limited ability to##3##3##(1992-10#1)(2011-2#1)(2012-3#1)
limited ability##4##2##(1992-10#1)(1995-12#1)(2011-2#1)(2012-3#1)
limited amounts of##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
limited and the##4##3##(1996-2#1)(2008-10#2)(2011-2#1)
limited and##18##2##(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
limited anterior##2##2##(2008-8#2)
limited availability##2##2##(1994-12#1)(2013-8#1)
limited because##2##2##(2008-7#1)(2010-6#1)
limited by a##5##3##(1997-2#1)(2008-10#1)(2008-12#2)(2009-7#1)
limited by diffusion##2##3##(1990-12#1)(2008-10#1)
limited by its##7##3##(1994-9#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
limited by the availability of##3##5##(2008-10#2)(2008-8#1)
limited by the number of##2##5##(2012-3#1)(2013-8#1)
limited by the##22##3##(1991-3#1)(1994-6#1)(1996-2#1)(1997-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
limited by##57##2##(1990-12#1)(1991-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#5)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
limited confirmation of##2##3##(1992-3#2)
limited data##2##2##(2008-11#1)(2012-12#1)
limited dispersal##4##2##(2008-9#1)(2013-1#3)
limited due to the##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
limited effect##4##2##(1990-6#1)(1994-12#1)(2008-1#1)(2008-6#1)
limited experience##2##2##(1990-2#1)(1996-2#1)
limited for##3##2##(2008-10#2)(2009-7#1)
limited gene flow##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
limited genetic diversity##2##3##(2008-10#2)
limited geographic##4##2##(1993-2#1)(2008-10#2)(2008-8#1)
limited health##2##2##(1995-2#1)(2010-9#1)
limited in scope##2##3##(1994-3#1)(2008-1#1)
limited in their##2##3##(2008-9#1)(2011-2#1)
limited in##15##2##(1994-3#1)(2008-1#1)(2008-10#3)(2008-8#1)(2008-9#2)(2011-2#4)(2012-2#1)(2012-7#1)(2013-8#1)
limited information##3##2##(1994-12#1)(2011-2#2)
limited linear##2##2##(2008-10#1)(2008-4#1)
limited memory##2##2##(2008-11#1)(2011-2#1)
limited number of##23##3##(1993-9#1)(1994-2#1)(1996-3#1)(1997-9#1)(2007-12#1)(2008-10#7)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
limited number##24##2##(1993-9#1)(1994-2#1)(1996-3#1)(1997-9#1)(2007-12#1)(2008-10#7)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
limited on##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
limited or no##2##3##(2008-11#1)(2008-5#1)
limited or##4##2##(1995-3#1)(2008-11#1)(2008-5#1)(2012-2#1)
limited oxygen##2##2##(2008-7#2)
limited period##3##2##(1993-3#1)(2008-6#1)(2008-8#1)
limited potential##2##2##(1997-3#1)(2013-1#1)
limited proteolysis##2##2##(1993-8#1)(2008-9#1)
limited published data##2##3##(2008-11#1)(2011-2#1)
limited resection##4##2##(1992-3#1)(1994-12#2)(2010-12#1)
limited resources##7##2##(1990-2#1)(1991-6#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
limited sequence##3##2##(1990-5#1)(2008-10#2)
limited set of##4##3##(2008-11#2)(2009-11#1)(2011-2#1)
limited spread of##2##3##(1996-11#1)(2013-1#1)
limited study##2##2##(1997-3#1)(2010-11#1)
limited supply##2##2##(1996-11#1)(2009-12#1)
limited survey##2##2##(2008-10#1)(2011-1#1)
limited the number of##2##4##(1995-2#1)(2008-7#1)
limited the##6##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
limited time##2##2##(2008-10#1)(2008-9#1)
limited to a small area##2##5##(1991-8#1)(2008-10#1)
limited to a##5##3##(1991-8#1)(1996-1#1)(2008-10#1)(2008-7#1)(2010-8#1)
limited to one##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
limited to the##15##3##(1997-3#1)(2008-10#7)(2008-5#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
limited to##70##2##(1991-6#1)(1991-8#1)(1991-9#1)(1993-3#1)(1994-6#1)(1995-11#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#21)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-4#1)(2010-11#1)(2010-8#2)(2011-2#5)(2011-7#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
limited use in##2##3##(1992-2#1)(2011-2#1)
limited use##5##2##(1992-2#1)(2008-10#3)(2011-2#1)
limited usefulness##2##2##(1991-3#1)(2008-10#1)
limited variation##2##2##(2008-10#1)(2012-3#1)
limited##539##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#6)(1992-4#1)(1992-6#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#4)(1997-1#4)(1997-2#3)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(1997-9#1)(2007-12#4)(2008-1#3)(2008-10#126)(2008-11#26)(2008-12#12)(2008-2#9)(2008-3#13)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#15)(2008-8#21)(2008-9#24)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-5#1)(2010-6#1)(2010-8#8)(2010-9#2)(2011-1#3)(2011-2#41)(2011-3#3)(2011-7#3)(2012-12#7)(2012-2#19)(2012-3#15)(2012-7#1)(2013-1#19)(2013-8#7)
limiting amino acid##2##3##(2011-2#1)(2012-2#1)
limiting dilution##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
limiting factor for##6##3##(2008-10#4)(2008-11#1)(2012-2#1)
limiting factor in##3##3##(1996-3#1)(2008-10#2)
limiting factor##14##2##(1996-3#1)(2008-1#1)(2008-10#7)(2008-11#3)(2012-2#1)(2013-1#1)
limiting for##2##2##(1993-8#1)(2009-10#1)
limiting resource##2##2##(2008-8#2)
limiting resources##2##2##(2008-8#1)(2008-9#1)
limiting step##5##2##(1994-11#2)(2008-10#1)(2008-11#1)(2008-5#1)
limiting the number of##2##4##(2008-8#2)
limiting the##17##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
limiting##106##1##(1990-5#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-6#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#8)(2009-10#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
limits (3sigma##3##2##(2008-10#3)
limits (3sigma) were 0##2##4##(2008-10#2)
limits (3sigma) were##4##3##(2008-10#4)
limits (3sigma)##11##2##(2008-10#11)
limits (DLs)##3##2##(2008-10#3)
limits (MDL)##2##2##(2008-10#2)
limits (ppb)##2##2##(2008-10#2)
limits 0##5##2##(2008-10#3)(2013-1#2)
limits 1##2##2##(1997-3#1)(2008-10#1)
limits achieved were##3##3##(2008-10#3)
limits achieved##7##2##(2008-10#7)
limits and applicability##2##3##(2008-10#1)(2008-2#1)
limits and relative standard deviation##2##5##(2008-10#2)
limits and##19##2##(1991-3#1)(2008-10#15)(2008-2#1)(2008-3#1)(2009-7#1)
limits are 0##7##3##(2008-10#7)
limits are 1##4##3##(2008-10#4)
limits are##27##2##(1995-9#3)(2007-12#1)(2008-10#21)(2008-3#1)(2009-7#1)
limits as##4##2##(2008-10#3)(2008-8#1)
limits for Cd(II)##2##3##(2008-10#2)
limits for the##6##3##(2008-10#6)
limits for##58##2##(1995-9#3)(1997-2#1)(2007-12#1)(2008-10#48)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
limits in the##5##3##(2008-10#5)
limits in##12##2##(1992-11#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-6#1)(2012-3#1)
limits its##2##2##(1993-8#1)(2008-10#1)
limits obtained were in the range##2##6##(2008-10#2)
limits obtained were##3##3##(2008-10#3)
limits obtained##8##2##(2008-10#8)
limits of 0##19##3##(2008-10#19)
limits of 1##4##3##(2008-10#4)
limits of 27 and##2##4##(2008-10#2)
limits of 27##3##3##(2008-10#3)
limits of 6##2##3##(2008-10#2)
limits of agreement##3##3##(2008-12#2)(2009-1#1)
limits of detection (3##2##4##(2008-10#2)
limits of detection (3sigma)##2##4##(2008-10#2)
limits of detection (LOD) and##3##5##(2008-10#3)
limits of detection (LOD) ranged##2##5##(2008-10#2)
limits of detection (LOD)##10##4##(2008-10#9)(2010-5#1)
limits of detection (LODs)##5##4##(2008-10#5)
limits of detection (signal-to-noise##2##4##(2008-10#1)(2008-3#1)
limits of detection and quantification of##2##6##(2008-10#2)
limits of detection and quantification##4##5##(2008-10#4)
limits of detection and quantitation##2##5##(2008-10#2)
limits of detection and##11##4##(2008-10#11)
limits of detection are##5##4##(2008-10#5)
limits of detection for##12##4##(2008-10#11)(2010-11#1)
limits of detection from 0##2##5##(2008-10#2)
limits of detection from##3##4##(2008-10#3)
limits of detection in the##4##5##(2008-10#4)
limits of detection in##6##4##(2008-10#6)
limits of detection of##8##4##(2008-10#8)
limits of detection was##2##4##(2008-10#2)
limits of detection were 0##3##5##(2008-10#3)
limits of detection were##16##4##(2008-10#16)
limits of detection##110##3##(2008-10#107)(2008-3#1)(2010-11#1)(2010-5#1)
limits of determination##2##3##(2008-10#2)
limits of quantification were##3##4##(2008-10#2)(2011-3#1)
limits of quantification##11##3##(2008-10#10)(2011-3#1)
limits of quantitation were##2##4##(2008-10#2)
limits of quantitation##4##3##(2008-10#4)
limits of the developed method##2##5##(2008-10#2)
limits of the proposed##3##4##(2008-10#3)
limits of the##25##3##(1993-2#1)(1994-5#1)(2008-10#19)(2008-12#1)(2008-7#1)(2010-8#1)(2012-2#1)
limits of this##3##3##(2008-10#3)
limits of##255##2##(1993-2#2)(1993-3#2)(1994-5#1)(1997-2#1)(2008-1#1)(2008-10#231)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-2#1)
limits on the##3##3##(1992-11#1)(1995-9#1)(2008-10#1)
limits on##9##2##(1990-3#1)(1992-11#1)(1994-2#1)(1995-3#1)(1995-9#2)(2007-11#1)(2008-10#2)
limits ranged from 0##3##4##(2008-10#3)
limits ranged from##4##3##(2008-10#4)
limits ranging from 0##4##4##(2008-10#4)
limits ranging from##7##3##(2008-10#7)
limits reached##2##2##(2008-10#2)
limits the ability of##2##4##(2008-8#1)(2010-1#1)
limits the##14##2##(1991-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#1)
limits to the##2##3##(2008-10#1)(2008-12#1)
limits to##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)
limits under##3##2##(1995-9#1)(2008-10#2)
limits using##3##2##(2008-10#3)
limits were 0##12##3##(2008-10#12)
limits were calculated##3##3##(2008-10#3)
limits were determined##3##3##(2008-10#3)
limits were found to be##7##5##(2008-10#7)
limits were##62##2##(2008-10#61)(2011-2#1)
limits when##2##2##(2008-10#1)(2008-9#1)
limits with##2##2##(2008-10#2)
limits##694##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-9#9)(1996-12#1)(1996-2#2)(1997-2#3)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#576)(2008-11#4)(2008-12#7)(2008-2#3)(2008-3#6)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#5)(2009-1#1)(2009-12#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
limits) of##2##2##(2008-10#1)(2008-8#1)
limnophilus##3##1##(2011-2#3)
limonene and##3##2##(2008-11#2)(2008-5#1)
limonene##13##1##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#8)
limosum exoenzyme##2##2##(1992-3#2)
limpet hemocyanin (KLH)##5##3##(2008-10#4)(2008-9#1)
limpet##7##1##(2008-10#5)(2008-9#1)(2012-2#1)
limpets##2##1##(2011-2#2)
lin-12 and##3##2##(1994-12#3)
lin-12##6##1##(1994-12#6)
linalool##7##1##(2008-10#7)
lindane##4##1##(2008-10#2)(2010-6#2)
lindemuthianum##9##1##(2008-10#9)
line 183-2##2##2##(2008-10#2)
line 19##2##2##(2008-10#2)
line 24-18-7 was##2##3##(2008-10#2)
line H960642 is a##2##4##(2008-8#2)
line OT364##2##2##(2008-10#2)
line SS767##2##2##(2008-10#2)
line and its##2##3##(2008-10#1)(2008-11#1)
line and the##2##3##(2008-10#1)(2008-3#1)
line and##20##2##(1996-3#1)(2008-10#4)(2008-11#8)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#2)
line are##3##2##(1995-2#1)(2008-6#1)(2008-9#1)
line as a##2##3##(2008-11#1)(2008-3#1)
line as##3##2##(1995-2#1)(2008-11#1)(2008-3#1)
line at##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
line between the##2##3##(1995-8#1)(2008-10#1)
line between##7##2##(1995-8#1)(1996-11#1)(1997-5#1)(2008-10#3)(2008-3#1)
line by##9##2##(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-9#1)
line containing##4##2##(2008-10#3)(2011-2#1)
line contains##2##2##(2008-10#1)(2008-11#1)
line cross-contamination##4##2##(2008-11#4)
line drawings##3##2##(1996-2#1)(2008-6#2)
line established from##2##3##(2008-10#1)(2008-11#1)
line exhibited##2##2##(2008-10#1)(2008-11#1)
line expressing##3##2##(2008-10#1)(2008-11#2)
line flow system##2##3##(2008-10#2)
line for##13##2##(1991-5#1)(1992-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-9#1)(2012-2#1)(2012-3#1)
line from##6##2##(1991-3#1)(1995-11#2)(2008-10#1)(2008-11#1)(2013-1#1)
line health##2##2##(1997-4#1)(2008-11#1)
line imaging##2##2##(2008-2#2)
line in pilot scale##2##4##(2008-11#2)
line in the##2##3##(1991-12#1)(2008-3#1)
line in vitro##2##3##(2008-11#1)(2008-9#1)
line in which##3##3##(1994-3#1)(2008-10#2)
line in##17##2##(1990-11#1)(1991-12#1)(1994-3#1)(1995-8#1)(2008-10#2)(2008-11#9)(2008-3#1)(2008-9#1)
line index##4##2##(2013-8#4)
line intensity ratio##3##3##(2008-10#3)
line is a##3##3##(1990-11#1)(1990-5#1)(1994-12#1)
line is##9##2##(1990-11#1)(1990-5#2)(1994-12#1)(1997-1#1)(2008-10#1)(2008-11#3)
line jitter of CCD images##2##5##(2008-3#2)
line jitter of##3##3##(2008-3#3)
line jitter##5##2##(2008-3#5)
line of defense against##3##4##(1993-12#1)(2007-12#1)(2008-11#1)
line of defense##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
line of descent##2##3##(1997-7#1)(2011-2#1)
line of the##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
line of##30##2##(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#8)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
line or##2##2##(1997-7#1)(2009-10#1)
line orientations##2##2##(2013-1#2)
line p53 mutations##4##3##(1990-12#3)(1994-12#1)
line pairs/mm##2##2##(2008-2#1)(2008-3#1)
line parameters##2##2##(2008-3#2)
line population##5##2##(2008-10#5)
line positions##2##2##(2008-3#2)
line profile##2##2##(2008-10#1)(2008-3#1)
line shape of##3##3##(2008-2#1)(2008-3#2)
line shape##7##2##(2008-2#1)(2008-3#6)
line shapes and##2##3##(2008-3#2)
line shapes to the experimental counterparts##2##6##(2008-2#1)(2008-3#1)
line shapes##6##2##(2008-2#1)(2008-3#5)
line showed##3##2##(2008-10#2)(2011-2#1)
line source##3##2##(2008-3#3)
line strength##5##2##(2008-3#5)
line tension##2##2##(1997-2#2)
line that##9##2##(1990-7#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
line therapy##4##2##(1990-2#1)(1997-7#1)(2008-5#1)(2008-8#1)
line through##3##2##(1994-3#2)(2008-11#1)
line to##8##2##(1990-6#1)(1994-8#1)(2008-10#1)(2008-11#3)(2009-12#1)(2011-2#1)
line was found to##2##4##(2008-2#1)(2008-3#1)
line was##25##2##(1994-5#2)(1995-8#1)(2008-10#6)(2008-11#11)(2008-2#1)(2008-3#2)(2011-2#1)(2012-12#1)
line were inoculated##2##3##(2008-10#2)
line were##10##2##(2008-10#4)(2008-11#3)(2008-3#1)(2012-12#1)(2012-2#1)
line with a##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
line with our##2##3##(1995-12#1)(1995-3#1)
line with the##11##3##(1990-12#1)(2008-10#5)(2008-11#1)(2009-11#2)(2010-11#1)(2012-2#1)
line with##37##2##(1990-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-8#3)(2008-9#2)(2009-11#2)(2010-11#1)(2012-2#2)(2012-3#1)
line##829##1##(1990-11#3)(1990-12#7)(1990-2#4)(1990-5#10)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-1#6)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#4)(1994-1#2)(1994-11#7)(1994-12#5)(1994-2#1)(1994-3#5)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#3)(1995-6#5)(1995-8#7)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#1)(1997-1#9)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-10#185)(2008-11#246)(2008-12#4)(2008-2#10)(2008-3#59)(2008-4#6)(2008-5#3)(2008-6#6)(2008-7#10)(2008-8#35)(2008-9#28)(2009-10#2)(2009-11#2)(2009-12#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#15)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#11)(2013-8#5)
line' by##2##2##(2008-10#2)
line'##3##1##(2008-10#3)
line) to##2##2##(1994-11#1)(2011-1#1)
line)##11##1##(1994-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#1)(2012-2#1)
line-by-line##3##1##(2008-3#3)
line-dependent##2##1##(1994-2#1)(2008-11#1)
line-of-sight##3##1##(2008-2#1)(2008-3#2)
line-shape##3##1##(1994-5#1)(2008-3#2)
lineage C##2##2##(2008-10#2)
lineage I was##2##3##(2008-10#2)
lineage I##4##2##(2008-10#4)
lineage II##2##2##(2008-10#2)
lineage III##2##2##(2008-10#2)
lineage from##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
lineage in##2##2##(1994-12#1)(2008-10#1)
lineage included isolates of C##2##5##(2008-10#2)
lineage leading to##2##3##(2010-4#1)(2012-3#1)
lineage of##5##2##(1995-2#1)(2007-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
lineage sorting##3##2##(2012-3#3)
lineage was##3##2##(2008-10#3)
lineage##98##1##(1991-11#1)(1992-12#1)(1994-12#1)(1995-2#2)(1995-6#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#51)(2008-11#7)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#5)(2009-8#2)(2010-11#1)(2010-4#1)(2011-2#8)(2012-2#2)(2012-3#5)(2013-1#2)
lineage-specific##4##1##(2008-9#2)(2009-10#1)(2011-2#1)
lineages A##2##2##(2008-10#2)
lineages and human evolution##2##4##(1996-5#2)
lineages and##4##2##(1995-6#1)(1996-5#2)(2008-10#1)
lineages are##2##2##(2008-10#1)(2008-4#1)
lineages each contained##2##3##(2008-10#2)
lineages in##4##2##(1995-12#1)(1995-2#1)(2008-10#1)(2013-8#1)
lineages of F##3##3##(2008-10#3)
lineages of the##2##3##(2008-10#2)
lineages of##10##2##(1995-2#1)(2008-10#7)(2008-8#2)
lineages or##3##2##(1995-6#1)(2008-10#1)(2011-2#1)
lineages that##8##2##(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-8#1)
lineages was##2##2##(1990-5#1)(2008-8#1)
lineages were found##2##3##(2008-10#2)
lineages were identified##5##3##(2008-10#5)
lineages were isolated from##2##4##(2008-10#2)
lineages were##11##2##(2008-10#11)
lineages within the##2##3##(2008-10#1)(2011-2#1)
lineages within##5##2##(2008-10#4)(2011-2#1)
lineages##121##1##(1990-5#3)(1993-6#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-6#2)(1996-5#2)(1997-7#1)(2007-12#1)(2008-10#69)(2008-11#5)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#11)(2008-9#3)(2009-12#1)(2009-8#2)(2010-6#1)(2011-2#2)(2012-3#4)(2013-8#3)
lineal##4##1##(1991-2#1)(2008-10#3)
linear DNA##2##2##(1990-5#1)(2008-10#1)
linear Raman##3##2##(2008-2#3)
linear absorption##4##2##(2008-3#3)(2008-8#1)
linear accelerator##4##2##(1990-12#1)(1992-12#1)(1993-9#1)(2009-11#1)
linear alkylbenzene sulfonates (LAS)##3##4##(2008-10#3)
linear alkylbenzene sulfonates##5##3##(2008-10#5)
linear analysis##5##2##(2008-10#4)(2011-2#1)
linear analytical##2##2##(2008-10#2)
linear and non-linear##2##3##(2008-10#1)(2008-11#1)
linear and nonlinear##2##3##(2007-12#1)(2008-10#1)
linear and quadratic discriminant##2##4##(1991-12#2)
linear and quadratic##4##3##(1991-12#3)(2008-8#1)
linear and##12##2##(1991-12#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)
linear area##2##2##(1991-11#1)(1996-1#1)
linear at##2##2##(2008-10#1)(2008-11#1)
linear between 0##2##3##(2008-10#2)
linear between##9##2##(2008-10#8)(2012-2#1)
linear calibration curve in the range##2##6##(2008-10#2)
linear calibration curve was##3##4##(2008-10#3)
linear calibration curve##12##3##(2008-10#12)
linear calibration curves##4##3##(2008-10#4)
linear calibration graph was obtained from##2##6##(2008-10#2)
linear calibration graph was obtained in the range##2##8##(2008-10#2)
linear calibration graph was obtained in the##3##7##(2008-10#3)
linear calibration graph was obtained over the##2##7##(2008-10#2)
linear calibration graph was obtained within 0##2##7##(2008-10#2)
linear calibration graph was obtained##12##5##(2008-10#12)
linear calibration graph##15##3##(2008-10#15)
linear calibration graphs were obtained over the##2##7##(2008-10#2)
linear calibration graphs were obtained##4##5##(2008-10#4)
linear calibration graphs were##7##4##(2008-10#7)
linear calibration graphs##9##3##(2008-10#9)
linear calibration range of##3##4##(2008-10#3)
linear calibration range was##5##4##(2008-10#5)
linear calibration range##13##3##(2008-10#13)
linear calibration ranges##3##3##(2008-10#3)
linear calibration##71##2##(2008-10#71)
linear combination of the##3##4##(2008-10#3)
linear combination of##4##3##(2008-10#3)(2010-2#1)
linear combinations of##2##3##(2008-10#1)(2012-3#1)
linear concentration range of##10##4##(2008-10#9)(2013-1#1)
linear concentration range was from##2##5##(2008-10#2)
linear concentration range was##3##4##(2008-10#3)
linear concentration range##16##3##(2008-10#15)(2013-1#1)
linear concentration ranges were##2##4##(2008-10#2)
linear concentration ranges##8##3##(2008-10#8)
linear concentration##24##2##(2008-10#23)(2013-1#1)
linear contrasts##2##2##(2008-10#2)
linear correlation between the##4##4##(2008-10#4)
linear correlation between##7##3##(1995-8#1)(2008-10#6)
linear correlation was found between##2##5##(1993-1#1)(1995-8#1)
linear correlation was found##3##4##(1993-1#1)(1995-8#1)(2008-10#1)
linear correlation was##4##3##(1993-1#1)(1995-8#1)(2008-10#2)
linear correlation with the##2##4##(2008-10#1)(2008-11#1)
linear correlation##20##2##(1993-1#1)(1995-8#2)(2008-10#16)(2008-11#1)
linear dependence between the##2##4##(2008-10#2)
linear dependence##5##2##(2008-10#5)
linear determination range##4##3##(2008-10#4)
linear determination##6##2##(2008-10#6)
linear dichroism##5##2##(1994-5#1)(2008-10#3)(2008-3#1)
linear discriminant analysis (LDA) and soft independent##2##7##(2008-10#2)
linear discriminant analysis (LDA) and##3##5##(2008-10#3)
linear discriminant analysis (LDA)##7##4##(2008-10#7)
linear discriminant analysis and artificial neural networks##2##7##(2008-10#2)
linear discriminant analysis and##3##4##(2008-10#3)
linear discriminant analysis##17##3##(2008-10#17)
linear discriminant##18##2##(2008-10#18)
linear dynamic range for##2##4##(2008-10#2)
linear dynamic range from##9##4##(2008-10#9)
linear dynamic range is##2##4##(2008-10#2)
linear dynamic range of##7##4##(2008-10#7)
linear dynamic range was##3##4##(2008-10#3)
linear dynamic range##37##3##(2008-10#37)
linear dynamic ranges of##5##4##(2008-10#5)
linear dynamic ranges##10##3##(2008-10#10)
linear dynamic##51##2##(2008-10#51)
linear epitope##2##2##(1995-12#1)(1995-2#1)
linear epitopes##3##2##(1995-12#1)(2008-10#1)(2008-8#1)
linear equation##3##2##(1990-5#1)(2008-10#2)
linear equations##3##2##(2008-10#2)(2008-7#1)
linear food##2##2##(2008-8#1)(2008-9#1)
linear for the##3##3##(2008-10#3)
linear for##7##2##(2008-10#7)
linear from 0##8##3##(1997-2#1)(2008-10#7)
linear from 1##3##3##(2008-10#3)
linear from 5##2##3##(2008-10#2)
linear from##22##2##(1997-2#1)(2008-10#21)
linear function of the##3##4##(2008-10#2)(2008-11#1)
linear function of##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
linear function##6##2##(2008-10#4)(2008-11#1)(2008-8#1)
linear gradient elution##3##3##(2008-10#3)
linear gradient##5##2##(2008-10#5)
linear growth##4##2##(1996-11#1)(2008-10#1)(2008-12#2)
linear homoscedastic assays##3##3##(1995-9#3)
linear in the concentration range 0##2##6##(2008-10#2)
linear in the concentration range from##3##6##(2008-10#3)
linear in the concentration range of 0##2##7##(2008-10#2)
linear in the concentration range of##5##6##(2008-10#5)
linear in the concentration range##13##5##(2008-10#13)
linear in the concentration##15##4##(2008-10#15)
linear in the range 0##9##5##(2008-10#9)
linear in the range from##2##5##(2008-10#2)
linear in the range of 0##7##6##(2008-10#7)
linear in the range of 1##3##6##(2008-10#3)
linear in the range of##27##5##(2008-10#27)
linear in the range##50##4##(2008-10#50)
linear in the##72##3##(2008-10#71)(2008-2#1)
linear in##76##2##(2008-10#74)(2008-2#2)
linear increase in##4##3##(2008-12#1)(2008-7#3)
linear increase##5##2##(2008-11#1)(2008-12#1)(2008-7#3)
linear isotherm##3##2##(2008-10#3)
linear matrix##2##2##(2008-2#2)
linear method##3##2##(2008-10#3)
linear mixed models##3##3##(2008-10#2)(2012-2#1)
linear mixed##4##2##(1990-11#1)(2008-10#2)(2012-2#1)
linear model##9##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-5#1)(2013-8#1)
linear modeling##3##2##(2008-10#1)(2008-12#1)(2009-7#1)
linear models were##2##3##(2008-10#1)(2013-1#1)
linear models##11##2##(2008-10#6)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
linear no-threshold (LNT)##2##3##(2008-7#1)(2013-1#1)
linear no-threshold##3##2##(2008-7#1)(2013-1#2)
linear or##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
linear over a range of##4##5##(2008-10#4)
linear over a##8##3##(2008-10#8)
linear over the concentration range 0##4##6##(2008-10#4)
linear over the concentration range from##3##6##(2008-10#3)
linear over the concentration range of##4##6##(2008-10#4)
linear over the concentration range##16##5##(2008-10#16)
linear over the range 0##8##5##(2008-10#8)
linear over the range of 0##2##6##(2008-10#2)
linear over the range of 2##3##6##(2008-10#3)
linear over the range of##9##5##(2008-10#9)
linear over the range##27##4##(2008-10#27)
linear over the##48##3##(2008-10#48)
linear over three orders of magnitude with##2##7##(2008-10#2)
linear over##65##2##(2008-10#65)
linear peptide##2##2##(2008-11#1)(2013-1#1)
linear polarization##2##2##(2008-3#2)
linear potential response in the concentration range of##2##8##(2008-10#2)
linear potential response##3##3##(2008-10#3)
linear potential##4##2##(2008-10#4)
linear programming##4##2##(2008-11#1)(2008-7#2)(2009-3#1)
linear range and detection limit##2##5##(2008-10#2)
linear range and slope##3##4##(2008-10#3)
linear range and##10##3##(2008-10#10)
linear range between 1##4##4##(2008-10#4)
linear range between##10##3##(2008-10#10)
linear range extended##2##3##(2008-10#2)
linear range for the determination of##3##6##(2008-10#3)
linear range for##7##3##(2008-10#7)
linear range from 0##3##4##(2008-10#3)
linear range from 1##3##4##(2008-10#3)
linear range from##10##3##(2008-10#10)
linear range is##6##3##(2008-10#6)
linear range of 0##5##4##(2008-10#5)
linear range of the calibration curve##3##6##(2008-10#3)
linear range of the determination##3##5##(2008-10#3)
linear range of the##19##4##(2008-10#18)(2008-11#1)
linear range of this##3##4##(2008-10#3)
linear range of##53##3##(1991-2#1)(2008-10#51)(2008-11#1)
linear range up to 100##2##5##(2008-10#2)
linear range up to##4##4##(2008-10#4)
linear range was from##3##4##(2008-10#3)
linear range was##10##3##(2008-10#10)
linear range##139##2##(1991-2#1)(2008-10#136)(2008-11#1)(2008-4#1)
linear ranges are##2##3##(2008-10#2)
linear ranges of##8##3##(2008-10#7)(2008-4#1)
linear ranges were##5##3##(2008-10#5)
linear ranges##19##2##(2008-10#18)(2008-4#1)
linear regression (MLR)##5##3##(2008-10#5)
linear regression analyses##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
linear regression analysis##11##3##(1993-12#1)(1993-2#1)(2008-10#7)(2008-3#1)(2011-1#1)
linear regression equation##7##3##(2008-10#6)(2008-7#1)
linear regression method##3##3##(2008-10#2)(2013-8#1)
linear regression methods##5##3##(2008-10#5)
linear regression model##3##3##(1995-9#2)(2008-10#1)
linear regression models##2##3##(2008-11#1)(2011-3#1)
linear regression of##3##3##(2008-10#3)
linear regression was used to##2##5##(2013-1#1)(2013-8#1)
linear regression was##5##3##(2008-10#3)(2013-1#1)(2013-8#1)
linear regression##69##2##(1993-12#1)(1993-2#1)(1995-9#4)(2008-10#49)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#3)
linear relation in the range##2##5##(2008-10#2)
linear relation##3##2##(2008-10#3)
linear relationship between peak##3##4##(2008-10#3)
linear relationship between the##21##4##(2008-10#18)(2008-11#1)(2010-4#1)(2011-2#1)
linear relationship between##36##3##(2008-10#31)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#1)
linear relationship in the##2##4##(2008-10#2)
linear relationship was found between##3##5##(1995-8#1)(2008-10#2)
linear relationship was found##4##4##(1995-8#1)(2008-10#3)
linear relationship was obtained between the##5##6##(2008-10#5)
linear relationship was obtained##6##4##(2008-10#6)
linear relationship was##16##3##(1995-8#1)(2008-10#15)
linear relationship with the concentration of##2##6##(2008-10#2)
linear relationship with the##6##4##(2008-10#6)
linear relationship with##9##3##(2008-10#9)
linear relationship##67##2##(1995-8#1)(2008-10#61)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#1)
linear relationships between the##2##4##(2008-10#2)
linear relationships between##4##3##(2008-10#4)
linear relationships##10##2##(2008-10#10)
linear response and##2##3##(2008-10#1)(2008-2#1)
linear response for##9##3##(2008-10#9)
linear response in##4##3##(2008-10#4)
linear response is observed##3##4##(2008-10#3)
linear response is##8##3##(2008-10#8)
linear response of##4##3##(2008-10#4)
linear response over##8##3##(2008-10#7)(2010-3#1)
linear response range between 50 and##2##6##(2008-10#2)
linear response range from##2##4##(2008-10#2)
linear response range of##5##4##(2008-10#5)
linear response range##16##3##(2008-10#16)
linear response to Cu(II)##2##4##(2008-10#2)
linear response to pH##2##4##(2008-10#2)
linear response to##12##3##(2008-10#12)
linear response towards Hg(II)##2##4##(2008-10#2)
linear response was obtained in the##2##6##(2008-10#2)
linear response was obtained##4##4##(2008-10#4)
linear response was##5##3##(2008-10#5)
linear response with##7##3##(2008-10#7)
linear response##88##2##(2008-10#86)(2008-2#1)(2010-3#1)
linear responses in the range##3##5##(2008-10#3)
linear responses##7##2##(2008-10#7)
linear scale up##3##3##(2008-7#3)
linear scan##4##2##(2008-10#4)
linear selection gradients##2##3##(2008-8#2)
linear selective to hydrogen ion in the##2##7##(2008-10#2)
linear sweep stripping voltammetry##2##4##(2008-10#2)
linear sweep stripping##4##3##(2008-10#4)
linear sweep voltammetric##2##3##(2008-10#2)
linear sweep voltammetry and##3##4##(2008-10#3)
linear sweep voltammetry at a##2##5##(2008-10#2)
linear sweep voltammetry##11##3##(2008-10#11)
linear sweep##26##2##(2008-10#26)
linear to its##2##3##(2008-10#2)
linear to the concentration of##2##5##(2008-10#2)
linear to the##4##3##(2008-10#4)
linear to##8##2##(2008-10#8)
linear transformation##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
linear transformations##3##2##(2008-6#1)(2010-1#2)
linear trend##2##2##(2008-10#1)(2008-8#1)
linear up to 0##3##4##(2008-10#3)
linear up to 20##2##4##(2008-10#2)
linear up to 50##3##4##(2008-10#3)
linear up to##23##3##(2008-10#23)
linear variation##3##2##(2008-10#2)(2011-2#1)
linear with a##8##3##(2008-10#8)
linear with the concentration of##4##5##(2008-10#4)
linear with the concentration##5##4##(2008-10#5)
linear with the##10##3##(2008-10#10)
linear with##24##2##(2008-10#24)
linear working range##4##3##(2008-10#4)
linear working##6##2##(2008-10#6)
linear##1184##1##(1990-11#1)(1990-12#1)(1990-5#4)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#3)(1995-2#2)(1995-8#3)(1995-9#7)(1996-1#1)(1996-11#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#972)(2008-11#19)(2008-12#5)(2008-2#12)(2008-3#20)(2008-4#3)(2008-6#5)(2008-7#18)(2008-8#16)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#3)(2011-1#1)(2011-2#10)(2011-3#1)(2012-2#5)(2012-3#2)(2013-1#11)(2013-8#8)
linearisation methods##2##2##(2008-10#2)
linearity (r(2)##2##2##(2008-10#1)(2009-8#1)
linearity and reproducibility##2##3##(2008-10#2)
linearity and##8##2##(2008-10#7)(2008-5#1)
linearity between the##2##3##(2008-10#1)(2008-12#1)
linearity between##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
linearity for##2##2##(2008-10#1)(2012-12#1)
linearity in the range of##3##5##(2008-10#3)
linearity in the range##6##4##(2008-10#6)
linearity in the##10##3##(2008-10#10)
linearity in##14##2##(2008-10#13)(2011-3#1)
linearity is##5##2##(2008-10#5)
linearity of determination for both##2##5##(2008-10#2)
linearity of response##2##3##(2008-10#1)(2010-3#1)
linearity of the calibration##3##4##(2008-10#3)
linearity of the##7##3##(1996-2#1)(2008-10#6)
linearity of this method##2##4##(2008-10#2)
linearity of##19##2##(1996-2#1)(2008-10#17)(2010-3#1)
linearity on##2##2##(2008-5#2)
linearity over the##2##3##(2008-10#2)
linearity range of##3##3##(2008-10#3)
linearity range##9##2##(2008-10#9)
linearity was in the##2##4##(2008-10#2)
linearity was##6##2##(2008-10#6)
linearity were##3##2##(2008-10#3)
linearity with a##2##3##(2008-10#2)
linearity with##3##2##(2008-10#2)(2009-9#1)
linearity##137##1##(1992-3#1)(1996-2#2)(1997-2#1)(2008-10#115)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2009-8#3)(2009-9#1)(2010-3#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-8#2)
linearization of##2##2##(1996-2#1)(2008-3#1)
linearization##6##1##(1996-2#1)(2008-2#2)(2008-3#2)(2008-9#1)
linearized##3##1##(1996-2#1)(2008-3#1)(2008-8#1)
linearly by##3##2##(2008-10#3)
linearly correlated##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
linearly decreased##2##2##(2008-10#2)
linearly dependent on the##3##4##(2008-10#3)
linearly dependent on##4##3##(2008-10#4)
linearly in the##3##3##(2008-10#3)
linearly in##4##2##(2008-10#4)
linearly increased##2##2##(2008-10#2)
linearly increases##2##2##(2008-5#1)(2009-5#1)
linearly on##7##2##(2008-10#6)(2008-8#1)
linearly polarized light##2##3##(2007-11#1)(2007-12#1)
linearly polarized##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
linearly proportional to the concentration of##5##6##(2008-10#5)
linearly proportional to the##8##4##(2008-10#8)
linearly proportional##9##2##(1995-3#1)(2008-10#8)
linearly related to the concentration of##3##6##(2008-10#3)
linearly related to the##8##4##(1994-11#1)(2008-10#7)
linearly related to##10##3##(1994-11#1)(2008-10#9)
linearly related##11##2##(1994-11#1)(2008-10#9)(2008-6#1)
linearly to##3##2##(2008-10#3)
linearly with age##2##3##(2008-5#1)(2008-7#1)
linearly with both##2##3##(1993-8#1)(2008-10#1)
linearly with dose##2##3##(1993-8#1)(2013-1#1)
linearly with increasing##4##3##(1991-11#2)(2008-10#1)(2009-7#1)
linearly with the concentration of##5##5##(2008-10#5)
linearly with the##11##3##(2008-10#8)(2008-11#2)(2008-9#1)
linearly with time##2##3##(2008-10#2)
linearly with##29##2##(1991-11#2)(1993-8#2)(2008-10#17)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
linearly##107##1##(1991-11#2)(1993-8#2)(1994-11#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#70)(2008-11#5)(2008-2#2)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#2)(2013-1#1)
lined by flattened##2##3##(1990-6#1)(2008-12#1)
lined by##9##2##(1990-6#2)(2007-12#1)(2008-12#2)(2010-6#2)(2011-2#1)(2013-1#1)
lined with##5##2##(2008-10#3)(2010-12#1)(2013-1#1)
lined##15##1##(1990-6#2)(1996-2#1)(2007-12#1)(2008-10#3)(2008-12#2)(2010-12#1)(2010-6#2)(2011-2#1)(2013-1#2)
liner##5##1##(1990-2#2)(2008-10#1)(2013-1#2)
liners and##2##2##(1990-2#1)(2008-10#1)
liners##5##1##(1990-2#2)(2008-10#1)(2010-9#1)(2013-1#1)
lines (NILs)##4##2##(2008-10#4)
lines (RILs) derived from##2##4##(2008-10#2)
lines (RILs) derived##3##3##(2008-10#3)
lines (RILs) from a##2##4##(2008-10#2)
lines (RILs) from##3##3##(2008-10#2)(2008-8#1)
lines (RILs)##10##2##(2008-10#8)(2008-8#1)(2012-3#1)
lines after##2##2##(2008-9#1)(2012-2#1)
lines and cultivars##2##3##(2008-10#2)
lines and##40##2##(1994-5#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-10#12)(2008-11#12)(2008-8#5)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
lines are##12##2##(1992-4#1)(1992-6#1)(1995-12#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-6#1)
lines as##4##2##(1993-12#1)(2008-11#3)
lines at##2##2##(2008-3#1)(2008-8#1)
lines because##2##2##(2008-10#1)(2008-5#1)
lines but not in##2##4##(1992-8#1)(2008-10#1)
lines but##3##2##(1992-8#1)(2008-10#2)
lines by##16##2##(1991-12#1)(1997-7#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-3#1)(2008-9#1)(2012-3#1)
lines can##4##2##(1990-5#1)(1997-7#1)(2008-10#1)(2008-11#1)
lines carrying the##4##3##(1995-2#1)(2008-10#3)
lines carrying##5##2##(1995-2#1)(2008-10#4)
lines compared with susceptible ones##2##5##(2008-10#2)
lines compared with##5##3##(2008-10#4)(2008-11#1)
lines containing##3##2##(2008-10#1)(2008-11#2)
lines could##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
lines cultured##2##2##(2008-11#1)(2008-9#1)
lines derived from the cross##5##5##(2008-10#4)(2012-3#1)
lines derived from the##6##4##(2008-10#4)(2008-11#1)(2012-3#1)
lines derived from##14##3##(1993-8#1)(1995-12#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-8#1)(2012-3#1)
lines developed##2##2##(2008-10#2)
lines differing in##2##3##(1995-12#1)(2008-10#1)
lines expressing CP under the control of##2##7##(2008-10#2)
lines expressing##5##2##(1992-12#1)(2008-10#4)
lines for sequential sampling##2##4##(2008-10#2)
lines for the##2##3##(2008-11#1)(2008-3#1)
lines for##13##2##(2008-10#7)(2008-11#3)(2008-3#2)(2012-2#1)
lines from the##6##3##(2008-10#5)(2008-9#1)
lines from##12##2##(1992-6#1)(1995-2#1)(2008-10#7)(2008-11#2)(2008-9#1)
lines grown##2##2##(2008-10#1)(2008-11#1)
lines had##3##2##(2008-11#1)(2008-8#1)(2009-10#1)
lines harboring##3##2##(2008-10#2)(2012-2#1)
lines has been##2##3##(2008-10#1)(2008-3#1)
lines has##6##2##(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)
lines have##10##2##(2008-10#2)(2008-11#8)
lines having##2##2##(1995-12#1)(2008-10#1)
lines in the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
lines in##22##2##(1990-11#1)(1994-5#1)(1995-3#1)(1995-6#1)(1997-1#2)(2008-10#2)(2008-11#5)(2008-3#3)(2008-4#1)(2008-8#3)(2011-3#1)(2013-8#1)
lines including a##2##3##(2008-10#1)(2008-11#1)
lines including##3##2##(2008-10#2)(2008-11#1)
lines indicated that##2##3##(1992-2#1)(2008-10#1)
lines intensity##2##2##(2008-9#2)
lines is##4##2##(1994-8#1)(2008-11#2)(2008-3#1)
lines may be##3##3##(1993-12#1)(2008-11#1)(2008-12#1)
lines may##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
lines of a##4##3##(2008-10#3)(2008-9#1)
lines of evidence indicate that##4##5##(2008-7#2)(2009-7#1)(2011-2#1)
lines of evidence suggest that##2##5##(2008-2#1)(2011-2#1)
lines of evidence##9##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-7#1)(2011-2#2)(2012-3#1)
lines of normal##2##3##(2008-10#1)(2008-11#1)
lines of the##11##3##(1995-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2012-3#1)
lines of##54##2##(1992-8#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(2008-10#20)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-3#4)(2013-1#1)
lines or##6##2##(1997-3#1)(2008-10#2)(2008-11#3)
lines possessing##2##2##(2008-10#2)
lines represent##2##2##(2008-11#2)
lines should be##3##3##(1995-12#1)(2008-10#2)
lines showed##5##2##(1992-8#1)(2008-10#2)(2008-11#1)(2009-8#1)
lines such as##3##3##(2008-11#3)
lines tested##2##2##(2008-10#1)(2008-4#1)
lines that are##5##3##(1992-7#1)(2008-10#1)(2008-11#2)(2008-3#1)
lines that had##2##3##(2008-10#1)(2012-3#1)
lines that##18##2##(1992-7#1)(1994-2#1)(1994-5#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#1)(2008-9#1)(2012-3#1)
lines the##2##2##(2009-12#1)(2013-1#1)
lines to identify##2##3##(1992-6#1)(2008-10#1)
lines to##11##2##(1992-1#1)(1992-6#1)(1993-8#1)(2008-10#4)(2008-11#3)(2008-9#1)
lines used##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
lines using##3##2##(2008-10#1)(2008-11#2)
lines was##10##2##(1990-12#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
lines were analyzed##2##3##(2008-10#1)(2008-9#1)
lines were evaluated##2##3##(2008-10#2)
lines were identified##3##3##(2008-10#3)
lines were inoculated##2##3##(2008-10#2)
lines were selected##3##3##(2008-10#2)(2008-8#1)
lines were tested##3##3##(2008-10#3)
lines were used to##2##4##(2008-11#1)(2010-10#1)
lines were##56##2##(1990-11#2)(1991-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#32)(2008-11#6)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2012-3#1)
lines which##4##2##(1993-12#1)(1993-6#1)(2008-11#2)
lines with the lowest##2##4##(2008-10#2)
lines with the##3##3##(2008-10#3)
lines with##26##2##(1992-2#1)(1993-3#1)(1995-6#1)(2008-10#15)(2008-11#3)(2008-3#1)(2008-8#3)(2012-2#1)
lines##834##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#4)(1990-8#1)(1991-12#4)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#4)(1992-4#4)(1992-6#5)(1992-7#1)(1992-8#10)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#6)(1993-6#8)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#3)(1994-8#4)(1995-12#12)(1995-2#6)(1995-3#2)(1995-6#7)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#3)(1997-1#3)(1997-3#2)(1997-7#9)(1997-8#4)(2008-10#265)(2008-11#215)(2008-12#6)(2008-2#5)(2008-3#20)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#43)(2008-9#37)(2009-10#6)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#5)(2010-1#3)(2010-10#2)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#17)(2011-3#3)(2012-12#1)(2012-2#11)(2012-3#19)(2013-1#7)(2013-8#3)
lineshape##2##1##(1994-11#1)(2008-10#1)
lineswhich##2##1##(2008-11#2)
linewidth and a##3##3##(2008-2#1)(2008-3#2)
linewidth and##4##2##(2008-2#1)(2008-3#3)
linewidth equation##2##2##(2008-3#2)
linewidth estimate##2##2##(2008-3#2)
linewidth of a##4##3##(2008-2#4)
linewidth of the##4##3##(2008-2#1)(2008-3#3)
linewidth of##12##2##(2008-2#5)(2008-3#7)
linewidth##28##1##(2007-12#1)(2008-2#8)(2008-3#19)
linezolid##7##1##(2008-10#4)(2010-6#1)(2011-2#2)
linger##2##1##(1992-12#1)(1995-1#1)
lingual##4##1##(1994-12#1)(2008-11#1)(2013-1#2)
linguale##3##1##(2011-2#3)
linguistic access##2##2##(2010-8#2)
linguistic and cultural##2##3##(2010-8#2)
linguistic and##5##2##(2010-5#1)(2010-8#2)(2013-8#2)
linguistic##17##1##(1997-2#1)(2008-11#1)(2010-5#5)(2010-8#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
lini##7##1##(2008-10#7)
lining and##2##2##(2008-11#1)(2013-1#1)
lining of the##5##3##(1991-12#1)(1992-1#1)(2007-12#1)(2008-10#2)
lining of##6##2##(1991-12#1)(1992-1#1)(2007-12#1)(2008-10#2)(2013-1#1)
lining the##4##2##(1993-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
lining##19##1##(1991-12#1)(1992-1#1)(1993-1#1)(1996-9#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-2#1)(2013-1#3)
linings##2##1##(1995-12#1)(2010-3#1)
link and##2##2##(2008-10#1)(2008-9#1)
link between the##9##3##(1990-11#1)(1994-8#1)(2008-11#2)(2008-3#1)(2008-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
link between these##2##3##(2008-10#1)(2012-2#1)
link between##53##2##(1990-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-7#3)(2009-8#2)(2010-1#3)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#2)
link in##2##2##(2009-11#1)(2009-8#1)
link lecturers##2##2##(2008-11#2)
link nurses##3##2##(2008-11#3)
link of##3##2##(2008-10#1)(2012-2#2)
link protein##2##2##(1991-5#1)(1992-12#1)
link the##5##2##(1994-12#1)(1997-1#1)(2008-10#1)(2008-8#1)(2010-9#1)
link them##3##2##(1993-2#1)(1996-3#1)(2008-6#1)
link to##4##2##(2008-10#2)(2008-11#1)(2009-4#1)
link was##2##2##(1993-9#1)(2013-1#1)
link with##2##2##(2008-5#1)(2008-8#1)
link##127##1##(1990-11#1)(1991-3#1)(1991-5#1)(1992-12#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#22)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#2)
link?##3##1##(1991-3#1)(1992-1#1)(1994-3#1)
linkage analyses##2##2##(2008-10#2)
linkage analysis##9##2##(1990-12#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#1)
linkage between the##5##3##(1993-12#1)(1997-9#1)(2008-10#1)(2008-12#1)(2008-4#1)
linkage between##15##2##(1992-3#1)(1993-12#1)(1994-12#1)(1997-9#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-8#2)(2008-9#1)(2010-11#1)
linkage disequilibrium (LD)##3##3##(2008-12#1)(2010-5#1)(2012-5#1)
linkage disequilibrium among##2##3##(2008-10#2)
linkage disequilibrium between##2##3##(2008-10#1)(2008-9#1)
linkage disequilibrium in##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
linkage disequilibrium##18##2##(1995-6#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-9#1)(2010-5#1)(2012-2#2)(2012-3#3)(2012-5#1)
linkage group##13##2##(2008-10#11)(2008-9#1)(2013-8#1)
linkage groups##13##2##(2008-10#9)(2008-12#1)(2013-8#3)
linkage in the##2##3##(1997-4#1)(2010-2#1)
linkage in##4##2##(1990-8#1)(1997-4#1)(2010-2#1)(2012-3#1)
linkage map is##2##3##(1994-9#1)(2013-8#1)
linkage map of##6##3##(1996-8#1)(2008-10#2)(2008-8#1)(2010-8#1)(2013-8#1)
linkage map with##2##3##(1994-9#1)(2008-8#1)
linkage map##37##2##(1994-9#2)(1995-6#1)(1996-12#5)(1996-6#2)(1996-8#2)(1997-2#1)(2008-10#10)(2008-8#3)(2008-9#1)(2009-10#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-8#6)
linkage mapping##4##2##(1995-6#1)(2008-10#2)(2008-9#1)
linkage maps##4##2##(1995-6#1)(2008-10#2)(2008-8#1)
linkage of male##2##3##(2008-8#1)(2012-3#1)
linkage of the##2##3##(2008-11#1)(2011-2#1)
linkage of##15##2##(1992-6#1)(1994-2#1)(2008-10#2)(2008-11#4)(2008-8#3)(2011-2#1)(2012-3#3)
linkage relationships##2##2##(2008-10#2)
linkage to the##2##3##(1992-10#1)(1997-7#1)
linkage to##5##2##(1992-10#1)(1997-3#1)(1997-7#1)(2008-10#2)
linkage was##3##2##(2008-10#3)
linkage with##3##2##(1991-2#1)(2008-10#1)(2008-7#1)
linkage##174##1##(1990-12#1)(1990-8#3)(1991-2#2)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-9#4)(1995-2#1)(1995-6#5)(1996-12#5)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#67)(2008-11#6)(2008-12#4)(2008-4#2)(2008-7#1)(2008-8#10)(2008-9#9)(2009-10#2)(2010-11#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#10)(2012-5#1)(2013-8#11)
linkages between##6##2##(1992-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(2008-10#2)
linkages were##2##2##(1990-8#1)(2008-10#1)
linkages##26##1##(1990-8#1)(1991-1#1)(1991-7#1)(1992-12#1)(1994-1#1)(1994-11#3)(1994-3#1)(1995-1#1)(1997-2#1)(2008-10#9)(2008-12#1)(2008-4#3)(2008-8#1)(2009-10#1)
linked at##2##2##(1995-6#1)(2008-10#1)
linked by a##2##3##(1990-2#1)(2008-7#1)
linked by##7##2##(1990-2#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
linked genes##4##2##(2008-10#4)
linked in coupling phase to##2##5##(2008-10#2)
linked in coupling phase##3##4##(2008-10#3)
linked in repulsion with the resistance##2##6##(2008-10#2)
linked in repulsion##3##3##(2008-10#3)
linked in##7##2##(2008-10#6)(2008-5#1)
linked markers##3##2##(2008-10#3)
linked on##2##2##(2008-10#1)(2008-4#1)
linked pairs##2##2##(1993-8#1)(2008-12#1)
linked resistance genes##2##3##(2008-10#2)
linked through##2##2##(2008-7#1)(2008-9#1)
linked to Co-4##2##3##(2008-10#2)
linked to Rcm##2##3##(2008-10#2)
linked to Rsp genes##3##4##(2008-10#3)
linked to Rsp2##2##3##(2008-10#2)
linked to a major##3##4##(2008-10#1)(2008-8#1)(2010-5#1)
linked to a##13##3##(1991-11#1)(1992-3#1)(1995-6#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-7#1)(2013-8#1)
linked to an##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
linked to both##2##3##(2012-12#1)(2012-3#1)
linked to clinical##2##3##(1992-12#1)(2011-2#1)
linked to each other##2##4##(2008-11#1)(2008-8#1)
linked to each##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
linked to increased##3##3##(1997-3#1)(2008-10#2)
linked to its##2##3##(1991-6#1)(2008-4#1)
linked to the avirulence gene##2##5##(2008-10#2)
linked to the coding domain of##2##6##(1994-5#2)
linked to the development of##3##5##(2008-11#1)(2009-5#1)(2012-5#1)
linked to the gene##2##4##(1991-12#1)(2011-2#1)
linked to the##63##3##(1991-1#2)(1991-12#2)(1993-12#1)(1993-8#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-3#2)(1997-2#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
linked to this##2##3##(2008-10#1)(2008-12#1)
linked to##222##2##(1991-1#2)(1991-11#1)(1991-12#4)(1991-3#1)(1991-6#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#3)(1994-11#2)(1994-2#1)(1994-5#3)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(2007-12#1)(2008-1#2)(2008-10#76)(2008-11#14)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#12)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#5)(2012-5#1)(2012-9#1)(2013-1#6)(2013-7#1)(2013-8#3)
linked with a##2##3##(1992-2#1)(2008-10#1)
linked with the##3##3##(2008-8#1)(2008-9#1)(2013-7#1)
linked with##25##2##(1992-2#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
linked##335##1##(1990-2#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-3#2)(1991-6#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#4)(1994-11#3)(1994-2#1)(1994-5#4)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-7#1)(1997-8#1)(2007-12#3)(2008-1#3)(2008-10#117)(2008-11#19)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#12)(2008-9#9)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#13)(2011-3#3)(2012-12#2)(2012-2#7)(2012-3#5)(2012-5#1)(2012-9#1)(2013-1#8)(2013-7#3)(2013-8#4)
linker and the resulting##2##4##(2008-10#2)
linker and the##3##3##(2008-10#2)(2013-8#1)
linker between the two##2##4##(2008-10#1)(2010-5#1)
linker of##2##2##(2009-6#1)(2011-2#1)
linker repeat##3##2##(2008-6#3)
linker##25##1##(1990-2#1)(1992-6#2)(1994-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-6#2)(2009-7#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
linkers##4##1##(2008-10#1)(2008-4#2)(2010-7#1)
linking clone##2##2##(1995-6#1)(1995-8#1)
linking equation##4##2##(2008-3#4)
linking the##7##2##(1993-2#1)(1996-5#1)(2008-10#1)(2008-8#1)(2009-7#2)(2013-1#1)
linking theory##2##2##(2008-11#2)
linking with##2##2##(1996-3#1)(2008-10#1)
linking##53##1##(1990-8#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
links and##2##2##(2008-11#1)(2011-3#1)
links between the##2##3##(2008-11#1)(2008-8#1)
links between##20##2##(1992-12#2)(1992-5#1)(1995-2#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
links the##4##2##(1992-5#1)(2008-6#1)(2008-8#1)(2010-4#1)
links to##4##2##(2008-8#1)(2010-3#1)(2011-2#2)
links with##4##2##(1991-6#1)(2008-11#1)(2009-10#1)(2011-2#1)
links##56##1##(1991-3#1)(1991-6#1)(1992-12#2)(1992-5#2)(1993-9#1)(1994-11#1)(1995-2#1)(1996-5#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#3)(2010-4#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
linoleate##3##1##(2008-10#3)
linoleic acid and##2##3##(2008-11#1)(2009-6#1)
linoleic acid##11##2##(2008-11#8)(2008-12#1)(2008-5#1)(2009-6#1)
linoleic acids##2##2##(1994-8#1)(2009-6#1)
linoleic##16##1##(1994-8#1)(2008-10#2)(2008-11#9)(2008-12#1)(2008-5#1)(2009-6#2)
linolenic##3##1##(2008-10#2)(2008-11#1)
linuron and neburon##2##3##(2008-10#2)
linuron##4##1##(2008-10#4)
lions##2##1##(1996-12#1)(2013-1#1)
lip and dental trauma##2##4##(2010-7#2)
lip and##10##2##(1993-12#1)(2008-10#1)(2010-7#2)(2011-2#2)(2012-3#1)(2013-1#3)
lip or##2##2##(1997-3#1)(2012-3#1)
lip##26##1##(1991-6#1)(1991-8#2)(1993-12#1)(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-7#2)(2011-2#4)(2012-3#3)(2013-1#6)
lipase (LPL)##5##2##(1991-12#1)(1992-3#1)(1994-11#1)(1995-6#1)(2008-11#1)
lipase GDSL##2##2##(2009-8#2)
lipase activity in##3##3##(2008-10#1)(2010-10#2)
lipase activity inhibitor##4##3##(2010-10#4)
lipase activity was##2##3##(2012-2#2)
lipase activity##18##2##(2008-10#5)(2008-7#1)(2010-10#8)(2012-2#4)
lipase and amylase##2##3##(2008-10#2)
lipase and##4##2##(1992-3#1)(2008-10#2)(2012-2#1)
lipase from Pseudomonas cepacia##2##4##(2008-7#2)
lipase from##4##2##(2008-7#2)(2011-1#1)(2012-2#1)
lipase was##3##2##(2008-7#2)(2011-2#1)
lipase##59##1##(1991-12#2)(1992-3#5)(1994-11#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#7)(2009-8#2)(2010-10#8)(2011-1#1)(2011-2#3)(2012-2#9)(2012-3#1)(2013-1#1)
lipase-acyltransferase from Candida parapsilosis##2##4##(1997-2#2)
lipase-catalyzed##2##1##(2008-10#1)(2008-7#1)
lipase-producing##2##1##(2012-2#2)
lipases##6##1##(1995-2#2)(1995-3#2)(2008-7#1)(2012-2#1)
lipid (MEL)##2##2##(2008-11#2)
lipid A##8##2##(1990-5#4)(1995-12#1)(2011-2#3)
lipid abnormalities##2##2##(1991-12#1)(1993-2#1)
lipid accumulation##4##2##(1996-2#1)(2008-10#1)(2010-12#1)(2011-2#1)
lipid analysis##2##2##(2008-10#1)(2008-4#1)
lipid and glucose levels in##2##5##(2008-10#2)
lipid and glucose levels##3##4##(2008-10#3)
lipid and glucose metabolism##2##4##(2008-1#1)(2008-3#1)
lipid and glucose##5##3##(2008-1#1)(2008-10#3)(2008-3#1)
lipid and lipoprotein metabolism and##2##5##(2008-11#1)(2008-6#1)
lipid and lipoprotein##4##3##(1992-2#1)(2008-11#1)(2008-6#1)(2012-2#1)
lipid and##16##2##(1991-9#1)(1992-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-6#2)(2008-9#2)(2009-8#1)(2012-2#1)
lipid barrier##4##2##(2008-5#4)
lipid bilayer##11##2##(1991-5#1)(1992-9#2)(1994-5#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-5#1)(2009-9#1)
lipid bilayers##6##2##(1990-5#1)(1993-3#1)(2008-10#3)(2008-5#1)
lipid binding##2##2##(1992-3#1)(2008-10#1)
lipid changes##2##2##(2008-4#2)
lipid classes##5##2##(1994-5#1)(2008-11#4)
lipid components##4##2##(1992-12#1)(1997-6#1)(2008-10#1)(2008-11#1)
lipid composition and phase##2##4##(1994-5#1)(2008-5#1)
lipid composition##7##2##(1994-3#1)(1994-5#1)(2008-10#1)(2008-5#4)
lipid content of##2##3##(2010-8#1)(2013-1#1)
lipid content##6##2##(1994-11#1)(2008-11#2)(2009-8#1)(2010-8#1)(2013-1#1)
lipid deposition##2##2##(2012-2#2)
lipid droplets##6##2##(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#1)
lipid extract of##3##3##(1990-2#1)(2008-10#2)
lipid extract##6##2##(1990-2#1)(1991-5#3)(2008-10#2)
lipid extracts##2##2##(2008-10#2)
lipid film##3##2##(2008-11#1)(2008-5#2)
lipid fluidity##3##2##(1991-5#1)(1995-8#2)
lipid formulations of amphotericin##2##4##(2011-2#2)
lipid fraction##2##2##(1990-2#1)(2008-11#1)
lipid fractions##2##2##(1996-8#1)(2008-11#1)
lipid globules##2##2##(2008-10#2)
lipid homeostasis##2##2##(2010-10#2)
lipid hydroperoxides##7##2##(2008-10#1)(2009-8#4)(2010-6#1)(2013-1#1)
lipid in##2##2##(2008-9#1)(2013-1#1)
lipid lamellae##2##2##(2008-10#1)(2008-5#1)
lipid levels##5##2##(1991-6#1)(1997-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
lipid lowering##7##2##(1992-7#1)(2008-11#2)(2008-4#2)(2009-12#1)(2009-6#1)
lipid matrix##2##2##(2008-5#2)
lipid membrane and##2##3##(1994-11#1)(2008-10#1)
lipid membrane##8##2##(1994-11#3)(1994-5#3)(2008-10#2)
lipid membranes##4##2##(2008-10#4)
lipid messenger##2##2##(2012-2#1)(2013-1#1)
lipid metabolism and##2##3##(1994-12#1)(2008-11#1)
lipid metabolism in##4##3##(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
lipid metabolism was##2##3##(2008-10#1)(2008-9#1)
lipid metabolism##20##2##(1992-11#1)(1992-3#1)(1994-12#2)(1996-3#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
lipid mixture##4##2##(1990-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
lipid mobilization in##2##3##(2008-6#1)(2009-10#1)
lipid mobilization##3##2##(2008-6#2)(2009-10#1)
lipid molecule##2##2##(1992-9#1)(1996-2#1)
lipid monolayer##3##2##(1990-5#1)(1991-5#2)
lipid monolayers##3##2##(1990-5#2)(2008-10#1)
lipid nanoparticles##2##2##(2008-5#2)
lipid of##2##2##(1991-12#1)(2008-9#1)
lipid organization##4##2##(1993-8#1)(1994-5#1)(2008-5#2)
lipid oxidative##2##2##(2009-8#2)
lipid packing##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
lipid peroxidation and##5##3##(1996-2#2)(2008-7#2)(2011-2#1)
lipid peroxidation by##2##3##(1993-2#1)(1994-8#1)
lipid peroxidation in##3##3##(1992-3#1)(2008-11#1)(2008-12#1)
lipid peroxidation products##4##3##(1994-11#1)(2009-8#3)
lipid peroxidation##47##2##(1991-5#3)(1992-3#2)(1993-2#3)(1993-8#2)(1994-11#1)(1994-5#2)(1994-8#2)(1996-2#7)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-8#5)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
lipid peroxides in##4##3##(1990-5#3)(2013-1#1)
lipid peroxides##5##2##(1990-5#4)(2013-1#1)
lipid phase##5##2##(1991-5#3)(1994-5#1)(2008-10#1)
lipid phases##5##2##(1992-9#2)(1994-5#1)(2008-5#2)
lipid profile of##2##3##(2008-10#1)(2011-2#1)
lipid profile##7##2##(2008-10#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
lipid profiles and##2##3##(2008-3#2)
lipid profiles##9##2##(1991-12#2)(2008-10#2)(2008-3#2)(2009-12#1)(2010-4#1)(2011-2#1)
lipid rafts##3##2##(2008-7#2)(2011-2#1)
lipid regulators##2##2##(2008-10#2)
lipid response to##2##3##(2012-2#2)
lipid rigidity##2##2##(1995-8#1)(2008-5#1)
lipid species##2##2##(2012-12#2)
lipid values##2##2##(2008-10#2)
lipid vesicles##6##2##(1997-6#1)(2008-10#1)(2008-11#4)
lipid##408##1##(1990-2#5)(1990-5#14)(1991-12#6)(1991-5#14)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-7#1)(1992-9#6)(1993-2#4)(1993-3#1)(1993-8#7)(1994-11#6)(1994-12#4)(1994-3#1)(1994-5#13)(1994-8#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-8#3)(1996-2#10)(1996-3#2)(1996-8#1)(1997-6#2)(1997-8#3)(2007-12#3)(2008-1#1)(2008-10#60)(2008-11#44)(2008-12#1)(2008-3#6)(2008-4#7)(2008-5#39)(2008-6#6)(2008-7#7)(2008-8#4)(2008-9#15)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#19)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#1)(2011-2#14)(2012-12#5)(2012-2#11)(2012-3#1)(2013-1#13)(2013-8#1)
lipid-A##2##1##(2008-11#2)
lipid-associated##2##1##(1993-1#1)(2009-6#1)
lipid-laden##2##1##(1996-2#1)(2013-1#1)
lipid-lowering##2##1##(2008-3#1)(2010-4#1)
lipid-mediated NGF cDNA transfection##2##4##(1996-12#2)
lipid-mediated NGF gene transfection##3##4##(1996-12#3)
lipid-mediated NGF##5##2##(1996-12#5)
lipid-mediated##6##1##(1996-12#6)
lipid-soluble##3##1##(1993-8#1)(2008-10#2)
lipid-stimulated kinase##5##2##(1992-9#5)
lipid-stimulated##6##1##(1992-9#6)
lipidic##4##1##(2007-12#1)(2007-8#1)(2008-10#1)(2012-2#1)
lipidosis of CF##3##3##(2012-3#3)
lipids and proteins in the##2##5##(2008-10#1)(2008-7#1)
lipids and proteins##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
lipids and##23##2##(1991-11#1)(1991-5#1)(1992-12#1)(1993-1#1)(1994-12#1)(1995-8#1)(1996-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
lipids are##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
lipids by##2##2##(1990-2#1)(2008-11#1)
lipids extracted from##2##3##(2008-10#1)(2008-5#1)
lipids in the##5##3##(1994-5#2)(1997-2#1)(2008-9#1)(2010-11#1)
lipids in##11##2##(1994-5#2)(1996-8#1)(1997-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2013-8#1)
lipids of##3##2##(2008-10#2)(2009-8#1)
lipids was##2##2##(1993-2#1)(2008-5#1)
lipids were##6##2##(1990-2#1)(1996-3#1)(2008-10#1)(2008-5#2)(2010-8#1)
lipids with a##2##3##(1995-2#1)(2008-10#1)
lipids with##7##2##(1995-2#2)(2008-10#1)(2012-12#2)(2013-1#1)(2013-8#1)
lipids##137##1##(1990-2#7)(1990-8#1)(1991-11#1)(1991-5#3)(1992-12#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-5#6)(1994-6#1)(1995-2#4)(1995-8#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-2#2)(1997-5#1)(2007-12#1)(2008-10#17)(2008-11#14)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#24)(2008-7#4)(2008-8#4)(2008-9#4)(2009-7#1)(2009-8#6)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#3)
lipids)##4##1##(2008-11#2)(2008-5#1)(2008-9#1)
lipoamide dehydrogenase##5##2##(1992-1#5)
lipoblastoma##2##1##(2010-11#1)(2012-2#1)
lipodystrophy##9##1##(1996-3#2)(2008-10#1)(2010-6#4)(2011-2#2)
lipofectin##4##1##(1991-5#3)(2008-11#1)
lipofection##3##1##(2008-11#1)(2008-4#2)
lipofuscin granules##2##2##(1995-3#1)(2008-7#1)
lipofuscin in##5##2##(1995-3#4)(2011-2#1)
lipofuscin##13##1##(1992-12#1)(1995-3#10)(2008-7#1)(2011-2#1)
lipogenesis##2##1##(1994-8#1)(2013-1#1)
lipoic acid##2##2##(2008-5#2)
lipoid##4##1##(2008-5#2)(2011-2#2)
lipolysis##7##1##(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(2008-3#2)(2008-6#1)
lipolytic activity##4##2##(2010-10#3)(2012-2#1)
lipolytic##10##1##(1991-12#1)(1995-6#1)(2008-5#2)(2008-6#1)(2010-10#3)(2010-4#1)(2012-2#1)
lipoma is##2##2##(1990-12#1)(2010-3#1)
lipoma of the##2##3##(1990-3#1)(2011-2#1)
lipoma was##2##2##(2010-3#1)(2013-1#1)
lipoma##15##1##(1990-12#4)(1990-3#1)(2008-10#3)(2010-3#4)(2011-2#1)(2013-1#2)
lipomas are##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
lipomas##10##1##(1990-12#1)(2008-10#1)(2010-3#3)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
lipomatosis of##2##2##(2011-2#2)
lipomatosis##3##1##(2011-2#2)(2012-2#1)
lipomatous##6##1##(2009-1#3)(2012-2#3)
lipomeningomyelocele##2##1##(2008-7#2)
lipomyelomeningocele##2##1##(2008-7#2)
lipopeptide##3##1##(1997-2#3)
lipophilic TTF-TCNQ##2##2##(2008-10#2)
lipophilic acrylate resin##3##3##(2008-10#3)
lipophilic agents##3##2##(1997-1#2)(2008-5#1)
lipophilic anions##4##2##(2008-10#4)
lipophilic cationic##3##2##(2008-10#3)
lipophilic compounds##3##2##(2008-10#1)(2008-5#2)
lipophilic drugs##3##2##(1997-1#2)(2008-11#1)
lipophilic salts and various foreign common ions are tested##2##9##(2008-10#2)
lipophilic##77##1##(1994-3#2)(1994-5#1)(1994-8#1)(1996-2#1)(1997-1#4)(2008-10#52)(2008-11#3)(2008-4#1)(2008-5#12)
lipophilicity of##3##2##(2008-10#3)
lipophilicity##7##1##(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)
lipoplexes##2##1##(2008-11#2)
lipopolyamine-condensed##2##1##(1995-2#2)
lipopolylysine##6##1##(1991-5#6)
lipopolysaccharide (LPS) in##2##3##(1994-8#1)(1997-1#1)
lipopolysaccharide (LPS)##8##2##(1994-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)
lipopolysaccharide could##2##2##(1996-12#2)
lipopolysaccharide of##3##2##(1990-5#1)(1996-12#1)(2008-5#1)
lipopolysaccharide##29##1##(1990-5#4)(1993-3#1)(1994-8#1)(1995-12#2)(1996-12#7)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
lipopolysaccharide-treated host cells##2##3##(1996-12#2)
lipopolysaccharide-treated##3##1##(1996-12#3)
lipopolysaccharides##4##1##(1995-12#1)(2008-11#2)(2012-2#1)
lipoprotein (HDL) cholesterol##2##3##(2008-3#1)(2008-6#1)
lipoprotein (HDL)##6##2##(1993-6#1)(1994-11#1)(2008-3#1)(2008-6#2)(2010-4#1)
lipoprotein (LDL) receptor plays a##2##5##(1993-3#1)(1995-6#1)
lipoprotein (LDL) receptor##6##3##(1993-3#1)(1995-6#1)(1995-8#2)(2008-6#2)
lipoprotein (LDL)##17##2##(1991-5#1)(1992-5#1)(1993-3#1)(1995-6#1)(1995-8#3)(1996-2#1)(2008-10#2)(2008-3#1)(2008-6#4)(2010-12#1)(2011-1#1)
lipoprotein (VLDL)##4##2##(1995-6#1)(2008-10#2)(2008-6#1)
lipoprotein (a)##3##2##(1991-12#1)(1992-11#1)(2011-2#1)
lipoprotein and##3##2##(2008-10#1)(2008-12#2)
lipoprotein cholesterol ratio##2##3##(2008-3#2)
lipoprotein cholesterol##5##2##(2008-3#2)(2010-7#1)(2013-1#2)
lipoprotein fractions##3##2##(2008-6#1)(2012-2#2)
lipoprotein levels##2##2##(1991-12#1)(2011-1#1)
lipoprotein lipase (LPL) in##2##4##(1995-6#1)(2008-11#1)
lipoprotein lipase (LPL)##4##3##(1991-12#1)(1994-11#1)(1995-6#1)(2008-11#1)
lipoprotein lipase##12##2##(1991-12#2)(1992-3#1)(1994-11#2)(1995-6#2)(1996-11#1)(2008-11#2)(2008-3#1)(2013-1#1)
lipoprotein lipases##2##2##(1995-2#2)
lipoprotein metabolism in the metabolic syndrome##2##6##(2008-6#2)
lipoprotein metabolism in##5##3##(1993-6#1)(1994-8#1)(2008-6#3)
lipoprotein metabolism is##2##3##(2008-6#2)
lipoprotein metabolism##10##2##(1993-6#1)(1994-8#1)(2008-11#1)(2008-6#7)
lipoprotein oxidation##2##2##(2008-5#1)(2008-8#1)
lipoprotein receptor##11##2##(1990-2#2)(1991-2#2)(1993-3#2)(1994-9#1)(1995-2#2)(1995-6#1)(2013-1#1)
lipoprotein subclass##3##2##(2008-3#3)
lipoprotein that##2##2##(2008-10#1)(2008-6#1)
lipoprotein##131##1##(1990-2#7)(1990-8#2)(1991-11#3)(1991-12#4)(1991-2#2)(1991-5#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-3#3)(1993-6#3)(1993-8#1)(1994-11#6)(1994-8#2)(1994-9#1)(1995-2#5)(1995-6#6)(1995-8#3)(1996-11#1)(1996-2#2)(2008-10#8)(2008-11#5)(2008-12#4)(2008-3#10)(2008-5#2)(2008-6#21)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-2#4)(2013-1#4)(2013-8#2)
lipoproteins (LDL)##5##2##(1991-5#1)(1992-9#1)(1993-6#1)(1993-8#1)(2008-10#1)
lipoproteins and##6##2##(1991-12#1)(1995-6#1)(2008-10#1)(2012-2#3)
lipoproteins are##3##2##(2008-5#3)
lipoproteins in##2##2##(1995-6#1)(2010-12#1)
lipoproteins on##2##2##(1995-8#1)(2008-6#1)
lipoproteins to##2##2##(1995-6#1)(2008-7#1)
lipoproteins##47##1##(1990-8#3)(1991-11#2)(1991-12#2)(1991-5#2)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-2#2)(1995-6#6)(1995-8#4)(1996-11#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#6)(2013-8#1)
lipoproteins]##2##1##(1991-11#1)(1992-11#1)
liposarcoma##6##1##(1990-5#1)(1990-9#2)(2009-9#1)(2013-1#2)
liposarcomas##2##1##(2012-2#2)
liposoluble##2##1##(1990-8#1)(2008-11#1)
liposomal antigen##2##2##(1995-5#2)
liposomal media##2##2##(2008-8#2)
liposomal nanovesicles for##3##3##(2008-10#3)
liposomal nanovesicles##6##2##(2008-10#6)
liposomal##21##1##(1990-2#1)(1995-5#4)(2008-10#11)(2008-5#1)(2008-8#3)(2013-1#1)
liposome chromatography##2##2##(2008-10#2)
liposome coated zirconia-magnesia##2##3##(2008-10#2)
liposome coated##4##2##(2008-10#4)
liposome uptake##3##2##(1993-8#3)
liposome##22##1##(1993-8#3)(1994-5#2)(2008-10#11)(2008-8#1)(2008-9#4)(2011-2#1)
liposome-based##3##1##(2008-10#2)(2008-11#1)
liposome-loaded##3##1##(1993-8#3)
liposome/DNA complexes##2##2##(1997-1#2)
liposomes and##8##2##(1994-5#1)(1997-1#2)(2008-10#3)(2008-8#1)(2012-2#1)
liposomes are##2##2##(2008-10#2)
liposomes as##3##2##(2008-10#3)
liposomes by##2##2##(1997-1#1)(2008-10#1)
liposomes containing##2##2##(1995-2#1)(2008-8#1)
liposomes does not##2##3##(2008-10#1)(2008-5#1)
liposomes for##2##2##(1994-5#2)
liposomes has been##2##3##(2008-10#2)
liposomes have been##2##3##(2008-10#1)(2008-8#1)
liposomes have##3##2##(2008-10#2)(2008-8#1)
liposomes in##5##2##(1990-2#2)(1993-11#1)(1993-8#1)(2008-10#1)
liposomes of##2##2##(1991-5#1)(1995-2#1)
liposomes sensitized by hypocrellin and its derivatives##2##7##(2008-8#2)
liposomes sensitized by##3##3##(2008-8#3)
liposomes to the##2##3##(2008-10#1)(2008-8#1)
liposomes using##2##2##(2008-10#1)(2013-8#1)
liposomes with##2##2##(2008-10#1)(2008-8#1)
liposomes##87##1##(1990-2#5)(1990-8#1)(1991-5#7)(1993-11#1)(1993-8#1)(1994-11#2)(1994-5#7)(1995-11#1)(1995-2#3)(1995-5#1)(1996-2#1)(1997-1#5)(2008-10#37)(2008-11#2)(2008-5#2)(2008-8#9)(2012-2#1)(2013-8#1)
lipospheres plain##2##2##(1993-1#2)
lipospheres##3##1##(1993-1#3)
lipoteichoic acid##3##2##(1995-6#2)(1996-12#1)
lipoxygenase activity##2##2##(2008-10#2)
lipoxygenase##9##1##(1992-8#1)(2008-10#2)(2008-11#3)(2008-6#1)(2009-10#1)(2011-10#1)
lipoxygenases##4##1##(2009-6#4)
lips and##2##2##(2011-2#1)(2012-2#1)
lips are##3##2##(2011-2#3)
lips##10##1##(2008-10#1)(2011-2#7)(2012-2#1)(2013-1#1)
lipstick was##2##2##(2008-5#2)
lipstick##11##1##(2008-5#11)
liquefied##2##1##(1996-1#1)(2009-10#1)
liquid and glass##2##3##(2010-8#1)(2012-2#1)
liquid and solid##4##3##(2008-10#3)(2008-9#1)
liquid and##9##2##(1995-3#1)(2008-10#4)(2008-9#2)(2010-8#1)(2012-2#1)
liquid as it##2##3##(2012-2#2)
liquid as##3##2##(2008-10#1)(2012-2#2)
liquid chromatograph (HPLC)##2##3##(2008-10#2)
liquid chromatograph##3##2##(2008-10#3)
liquid chromatographic (HPLC)##3##3##(2008-10#3)
liquid chromatographic (LC) method##3##4##(2008-10#3)
liquid chromatographic (LC)##4##3##(2008-10#4)
liquid chromatographic analysis of##2##4##(2008-10#2)
liquid chromatographic analysis##4##3##(1994-8#1)(2008-10#3)
liquid chromatographic assay##3##3##(1997-2#1)(2008-10#2)
liquid chromatographic determination of##10##4##(1993-2#1)(1997-2#1)(2008-10#8)
liquid chromatographic method for the determination of##2##7##(2008-10#2)
liquid chromatographic method for the##5##5##(2008-10#5)
liquid chromatographic method for##8##4##(1997-2#1)(2008-10#7)
liquid chromatographic method##14##3##(1997-2#3)(2008-10#10)(2012-2#1)
liquid chromatographic separation of##4##4##(2008-10#4)
liquid chromatographic separation##5##3##(2008-10#5)
liquid chromatographic##52##2##(1993-2#1)(1994-8#1)(1997-2#5)(2008-10#44)(2012-2#1)
liquid chromatography (HPLC) and##7##4##(2008-10#6)(2009-8#1)
liquid chromatography (HPLC) as##2##4##(2008-10#2)
liquid chromatography (HPLC) coupled with##2##5##(2008-10#2)
liquid chromatography (HPLC) coupled##3##4##(2008-10#3)
liquid chromatography (HPLC) for the determination of##2##7##(2008-10#2)
liquid chromatography (HPLC) is##2##4##(2008-10#1)(2008-4#1)
liquid chromatography (HPLC) method with##3##5##(2008-10#3)
liquid chromatography (HPLC) method##7##4##(2008-10#6)(2008-5#1)
liquid chromatography (HPLC) using##3##4##(2008-10#3)
liquid chromatography (HPLC) was##2##4##(2008-10#2)
liquid chromatography (HPLC) with a##5##5##(2008-10#5)
liquid chromatography (HPLC) with detection at##2##6##(2008-10#2)
liquid chromatography (HPLC) with electrochemical##2##5##(2008-10#2)
liquid chromatography (HPLC) with##14##4##(1997-2#1)(2008-10#13)
liquid chromatography (HPLC)##81##3##(1992-11#1)(1995-3#1)(1997-2#1)(2008-10#69)(2008-11#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-8#1)(2011-1#1)
liquid chromatography (LC) and##2##4##(2008-10#2)
liquid chromatography (LC) has##2##4##(2008-10#2)
liquid chromatography (LC) system##2##4##(2008-10#2)
liquid chromatography (LC)##14##3##(2008-10#14)
liquid chromatography (RP-HPLC) was##2##4##(2008-10#2)
liquid chromatography (RP-HPLC)##6##3##(2008-10#6)
liquid chromatography (RP-LC)##3##3##(2008-10#3)
liquid chromatography after##2##3##(1991-12#1)(2008-11#1)
liquid chromatography analysis##5##3##(2008-10#5)
liquid chromatography and solid-phase##2##4##(1992-11#1)(2008-10#1)
liquid chromatography and ultraviolet detection##2##5##(2008-10#2)
liquid chromatography and##17##3##(1992-11#1)(1992-6#1)(2008-1#1)(2008-10#13)(2011-1#1)
liquid chromatography coupled with##8##4##(1995-11#1)(2008-10#7)
liquid chromatography determination##2##3##(2008-10#2)
liquid chromatography electrospray##2##3##(2008-10#2)
liquid chromatography for the determination of##2##6##(2008-10#2)
liquid chromatography for the##6##4##(2008-10#6)
liquid chromatography in##4##3##(2008-10#3)(2010-11#1)
liquid chromatography method##6##3##(1997-2#1)(2008-10#4)(2008-5#1)
liquid chromatography of##6##3##(1997-3#1)(2008-10#5)
liquid chromatography on a##2##4##(2008-10#2)
liquid chromatography on##4##3##(1997-2#1)(2008-10#3)
liquid chromatography separation##3##3##(2008-10#2)(2008-9#1)
liquid chromatography using##5##3##(2008-10#5)
liquid chromatography with UV##2##4##(2008-10#2)
liquid chromatography with a##5##4##(2008-10#2)(2008-5#2)(2009-8#1)
liquid chromatography with fluorescence detection##9##5##(2008-10#9)
liquid chromatography with fluorescence##11##4##(1993-2#1)(2008-10#10)
liquid chromatography with##39##3##(1991-7#1)(1992-1#1)(1993-2#1)(1995-6#1)(1997-2#1)(2008-10#30)(2008-5#3)(2009-8#1)
liquid chromatography##307##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-6#3)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-2#7)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#251)(2008-11#2)(2008-4#1)(2008-5#10)(2008-8#2)(2008-9#2)(2009-8#4)(2010-11#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#1)
liquid chromatography-UV##2##2##(2008-10#2)
liquid chromatography-electrospray ionization mass spectrometry##2##5##(2008-10#2)
liquid chromatography-electrospray ionization##3##3##(2008-10#3)
liquid chromatography-electrospray mass spectrometry##3##4##(2008-10#3)
liquid chromatography-electrospray##9##2##(2008-10#7)(2008-8#2)
liquid chromatography-electrospray-ion trap mass spectrometry##2##5##(2008-10#2)
liquid chromatography-electrospray-mass spectrometry##3##3##(2008-10#3)
liquid chromatography-inductively coupled plasma mass spectrometry##4##6##(2008-10#4)
liquid chromatography-inductively coupled plasma##5##4##(2008-10#5)
liquid chromatography-inductively coupled##6##3##(2008-10#6)
liquid chromatography-mass spectrometry##6##3##(1990-5#1)(1997-2#1)(2008-10#4)
liquid chromatography-tandem mass spectrometry##3##4##(2008-10#3)
liquid chromatography/electrospray/mass spectrometry##4##3##(2008-10#4)
liquid chromatography/tandem mass spectrometry##2##4##(2010-7#2)
liquid chromatography/tandem##4##2##(2008-10#2)(2010-7#2)
liquid core microcapsules##4##3##(2008-11#4)
liquid core waveguide (LCW)##2##4##(2008-10#2)
liquid core waveguide##7##3##(2008-10#7)
liquid core##12##2##(2008-10#8)(2008-11#4)
liquid crystal##9##2##(2008-10#7)(2008-3#1)(2008-7#1)
liquid crystals (LCs)##2##3##(1995-6#1)(2008-10#1)
liquid crystals##14##2##(1995-6#3)(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#4)
liquid culture##9##2##(2008-10#6)(2008-11#1)(2008-9#1)(2013-1#1)
liquid donor##2##2##(2008-10#2)
liquid embolization##2##2##(2008-7#2)
liquid extraction##7##2##(2008-10#7)
liquid film##3##2##(2008-10#3)
liquid filtration membrane##3##3##(2012-3#3)
liquid flow##3##2##(2008-10#2)(2008-8#1)
liquid flows##2##2##(2008-10#2)
liquid formulation##2##2##(2008-10#1)(2008-3#1)
liquid from the##2##3##(2008-10#1)(2008-12#1)
liquid from##3##2##(2008-10#2)(2008-12#1)
liquid helium##2##2##(2008-10#1)(2008-7#1)
liquid ion##2##2##(2008-10#2)
liquid ionization##2##2##(2008-10#2)
liquid junction potential##3##3##(2008-10#3)
liquid junction potentials##2##3##(2008-10#2)
liquid junction##7##2##(2008-10#7)
liquid lubricants##2##2##(2010-4#2)
liquid media##9##2##(1990-8#1)(2008-10#6)(2008-8#2)
liquid medium and##2##3##(1990-6#1)(2008-5#1)
liquid medium##8##2##(1990-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)
liquid membrane (SLM) and##2##4##(2008-10#2)
liquid membrane (SLM) method for##2##5##(2008-10#2)
liquid membrane (SLM)##5##3##(2008-10#5)
liquid membrane and##4##3##(2008-10#4)
liquid membrane containing##6##3##(2008-10#6)
liquid membrane used##2##3##(2008-10#2)
liquid membrane using##3##3##(2008-10#3)
liquid membrane##40##2##(2008-10#40)
liquid membranes##7##2##(2008-10#7)
liquid nitrogen in##2##3##(1995-11#2)
liquid nitrogen was##3##3##(1995-11#1)(2008-10#1)(2008-7#1)
liquid nitrogen##16##2##(1995-11#4)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)
liquid of##2##2##(2008-10#1)(2008-12#1)
liquid particles##3##2##(1992-3#2)(2008-3#1)
liquid petroleum gas##2##3##(2008-10#2)
liquid phase##12##2##(2008-10#11)(2008-11#1)
liquid propanol was##2##3##(2008-3#2)
liquid propanol##3##2##(2008-3#3)
liquid sample##5##2##(2008-10#5)
liquid samples##5##2##(2008-10#4)(2008-9#1)
liquid sampling##3##2##(2008-10#3)
liquid scintillation counting##3##3##(2008-10#2)(2008-11#1)
liquid scintillation##5##2##(1992-3#1)(1994-5#1)(2008-10#2)(2008-11#1)
liquid soap##6##2##(2008-10#5)(2008-5#1)
liquid stationary phase##2##3##(2008-10#2)
liquid surface##2##2##(2008-3#2)
liquid through the##2##3##(2008-10#1)(2011-2#1)
liquid to air##2##3##(1995-3#2)
liquid to##3##2##(1995-3#2)(2008-10#1)
liquid volume##2##2##(1997-1#1)(2008-10#1)
liquid waveguide capillary cell##2##4##(2008-10#2)
liquid waveguide##3##2##(2008-10#3)
liquid##779##1##(1990-12#3)(1990-5#2)(1990-6#1)(1990-8#3)(1991-12#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-2#2)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#6)(1995-3#7)(1995-6#4)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#14)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#572)(2008-11#12)(2008-12#3)(2008-3#22)(2008-4#2)(2008-5#15)(2008-7#20)(2008-8#8)(2008-9#8)(2009-10#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-4#2)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#10)(2011-3#1)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#1)
liquid-based##2##1##(2008-10#1)(2013-8#1)
liquid-core waveguide (LCW)##2##3##(2008-10#2)
liquid-core waveguide##5##2##(2008-10#5)
liquid-core##8##1##(2008-10#8)
liquid-crystal display monitor##2##3##(2008-3#2)
liquid-crystal##9##1##(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)
liquid-like##3##1##(2012-2#3)
liquid-liquid extraction (LLE)##5##3##(2008-10#5)
liquid-liquid extraction and##6##3##(2008-10#6)
liquid-liquid extraction for##2##3##(2008-10#2)
liquid-liquid extraction method for the selective separation and preconcentration of##2##10##(2008-10#2)
liquid-liquid extraction method##6##3##(2008-10#6)
liquid-liquid extraction of##8##3##(2008-10#8)
liquid-liquid extraction procedure##4##3##(2008-10#4)
liquid-liquid extraction system##4##3##(2008-10#4)
liquid-liquid extraction technique for##2##4##(2008-10#2)
liquid-liquid extraction using##3##3##(1997-2#1)(2008-10#2)
liquid-liquid extraction with##4##3##(2008-10#3)(2011-3#1)
liquid-liquid extraction##70##2##(1997-2#1)(2008-10#68)(2011-3#1)
liquid-liquid extraction-gas##2##2##(2008-10#2)
liquid-liquid microextraction##2##2##(2008-10#2)
liquid-liquid mixer##2##2##(2008-7#2)
liquid-liquid##85##1##(1997-2#1)(2008-10#80)(2008-7#2)(2009-8#1)(2011-3#1)
liquid-phase CRDS##2##2##(2010-7#2)
liquid-phase microextraction coupled with##3##4##(2008-10#3)
liquid-phase microextraction##8##2##(2008-10#8)
liquid-phase##13##1##(2008-10#9)(2008-11#1)(2010-7#3)
liquid-polymeric##2##1##(2008-10#2)
liquid-solid##6##1##(2008-10#4)(2008-3#1)(2009-8#1)
liquid/liquid##3##1##(2008-10#3)
liquids and##3##2##(1995-3#2)(2008-11#1)
liquids are##2##2##(1995-3#1)(2008-11#1)
liquids as##3##2##(2008-10#3)
liquids in##2##2##(2008-11#1)(2010-7#1)
liquids obtained by thermal##2##4##(2008-10#2)
liquids or##2##2##(1994-2#1)(2008-10#1)
liquids##42##1##(1994-2#1)(1995-3#9)(2008-10#14)(2008-11#6)(2008-3#6)(2008-5#2)(2010-7#2)(2011-2#1)(2012-2#1)
liquor by near-infrared##2##3##(2008-10#2)
liquor##15##1##(1993-8#1)(2008-10#6)(2008-12#2)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#3)
liquors##4##1##(2008-10#4)
lisinopril##3##1##(2008-10#3)
list as##3##2##(1991-11#1)(1993-2#1)(2008-10#1)
list length##4##2##(1993-3#1)(2008-6#3)
list of differential diagnosis##2##4##(2008-2#1)(2012-12#1)
list of references##2##3##(2008-4#1)(2008-9#1)
list of the##2##3##(1993-8#1)(2008-10#1)
list of##48##2##(1990-9#1)(1991-3#2)(1991-8#1)(1992-2#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-3#3)(1997-4#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
list parameters##2##2##(1991-11#2)
list the##2##2##(1994-6#1)(2011-1#1)
list##92##1##(1990-9#1)(1991-11#10)(1991-12#3)(1991-3#3)(1991-8#1)(1992-2#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#3)(1997-4#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-6#3)(2008-7#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2011-3#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
list)##2##1##(2008-10#1)(2011-3#1)
list-length##3##1##(2008-6#3)
listed and##2##2##(1993-8#1)(2011-3#1)
listed in the##2##3##(2010-3#1)(2013-7#1)
listed in##4##2##(1991-3#1)(1996-1#1)(2010-3#1)(2013-7#1)
listed##24##1##(1991-3#1)(1991-8#1)(1992-1#1)(1993-8#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-7#1)
listen##3##1##(1990-12#1)(2009-8#1)(2013-8#1)
listened to##4##2##(1997-4#1)(2008-9#1)(2009-6#1)(2010-11#1)
listener perceptions##5##2##(2011-1#5)
listener##6##1##(2009-10#1)(2011-1#5)
listeners##3##1##(2009-10#1)(2011-1#2)
listening skills##2##2##(2008-9#1)(2012-2#1)
listening to##7##2##(1991-2#1)(1996-5#1)(1997-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
listening##15##1##(1991-2#1)(1992-2#1)(1996-5#1)(1997-1#1)(2008-11#1)(2008-9#6)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
listeriolysin O##6##2##(1996-12#6)
listeriosis##2##1##(1992-2#1)(2012-2#1)
listing##6##1##(1991-12#1)(1993-1#1)(1994-3#1)(1995-12#2)(2011-3#1)
listmode data files##2##3##(2008-9#2)
lists and##5##2##(1991-11#1)(1993-2#1)(1997-4#1)(2008-12#1)(2012-12#1)
lists are##2##2##(1993-2#1)(1996-8#1)
lists for##2##2##(1993-12#1)(2013-8#1)
lists of##10##2##(1993-3#1)(1997-8#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-12#3)(2013-8#2)
lists##45##1##(1991-11#8)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#7)(1993-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#3)(2011-3#1)(2012-12#4)(2012-3#2)(2013-8#4)
lists]##2##1##(1991-11#2)
liter per bucket##2##3##(2008-10#2)
liter##12##1##(1992-8#1)(2008-10#11)
liter(-1) DO##2##2##(2008-10#2)
liter(-1)##6##1##(2008-10#6)
liter)##3##1##(2008-10#3)
literacy and##2##2##(2008-11#1)(2010-9#1)
literacy in##4##2##(1996-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
literacy skills##6##2##(1992-12#1)(1996-1#1)(2008-12#1)(2010-9#1)(2011-2#2)
literacy##42##1##(1992-12#1)(1994-12#1)(1996-1#6)(2008-11#6)(2008-12#3)(2009-8#8)(2009-9#2)(2010-9#4)(2011-1#2)(2011-2#7)(2013-1#1)(2013-8#1)
literal three-dimensional imaging##2##3##(2008-2#2)
literal##5##1##(2008-11#1)(2008-2#3)(2008-7#1)
literally##3##1##(1991-3#1)(2009-10#1)(2012-2#1)
literate##2##1##(2009-9#2)
literature about the##3##3##(1990-8#1)(2008-10#1)(2013-1#1)
literature about##6##2##(1990-8#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
literature addressing##2##2##(1993-2#1)(2008-11#1)
literature and an##2##3##(1991-3#1)(2008-10#1)
literature and in##2##3##(2008-11#1)(2008-9#1)
literature and our##2##3##(2008-2#1)(2009-4#1)
literature and personal##2##3##(1993-3#1)(2007-8#1)
literature and research##3##3##(1997-2#1)(2013-1#2)
literature and the##2##3##(1996-2#1)(2011-2#1)
literature and##47##2##(1990-3#1)(1991-1#2)(1991-3#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-5#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)
literature are##5##2##(1992-12#1)(1994-6#1)(2008-11#1)(2008-7#1)(2010-2#1)
literature as a##4##3##(2008-5#1)(2008-9#1)(2009-7#1)(2013-1#1)
literature as well as the##2##5##(1992-1#1)(2011-3#1)
literature as well as##3##4##(1992-1#1)(1996-12#1)(2011-3#1)
literature as##9##2##(1992-1#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-3#1)(2012-2#1)(2013-1#1)
literature available on##2##3##(2008-11#1)(2010-11#1)
literature available##5##2##(2008-10#1)(2008-11#2)(2010-11#1)(2012-2#1)
literature base##2##2##(2011-2#1)(2012-2#1)
literature between##2##2##(1995-11#1)(2010-7#1)
literature concerning the##4##3##(1996-9#1)(2008-11#1)(2010-9#1)(2011-2#1)
literature concerning##9##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-9#2)(2011-2#1)(2013-8#1)
literature data on##3##3##(2008-10#2)(2011-2#1)
literature data##9##2##(1990-5#1)(2008-10#6)(2008-7#1)(2011-2#1)
literature describes##2##2##(2008-11#1)(2008-7#1)
literature does not##4##3##(1996-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
literature for the##4##3##(1992-12#1)(2008-10#2)(2008-11#1)
literature for##9##2##(1991-3#2)(1992-12#1)(2008-10#5)(2008-11#1)
literature from##7##2##(1996-2#1)(2008-10#2)(2008-8#1)(2010-10#1)(2010-9#1)(2012-3#1)
literature has been##2##3##(1991-3#1)(1996-3#1)
literature has##6##2##(1991-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2013-1#2)
literature have##2##2##(1992-1#1)(2008-8#1)
literature in order to##2##4##(2008-11#1)(2008-12#1)
literature in##11##2##(1991-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#3)
literature indicates that##3##3##(1993-1#1)(1993-11#1)(2009-7#1)
literature is available on##2##4##(1994-12#1)(2007-12#1)
literature is limited##3##3##(1996-12#1)(2008-11#1)(2008-12#1)
literature is presented##3##3##(2010-11#1)(2010-12#1)(2010-8#1)
literature is reviewed and##4##4##(1993-8#1)(2008-11#1)(2008-12#1)(2013-1#1)
literature is reviewed##11##3##(1990-9#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
literature is##34##2##(1990-9#1)(1991-3#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#2)(1995-9#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
literature of the##3##3##(1991-3#1)(2008-5#1)(2008-7#1)
literature of##13##2##(1991-3#1)(1993-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-3#2)
literature on how##2##3##(2010-9#1)(2012-2#1)
literature on nursing work##2##4##(2012-3#2)
literature on nursing##3##3##(2012-3#3)
literature on the subject##4##4##(1994-1#1)(1996-11#1)(2009-1#1)(2012-2#1)
literature on the topic##5##4##(2008-1#1)(2008-11#2)(2009-6#1)(2012-3#1)
literature on the##29##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-1#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
literature on this topic##3##4##(1993-6#1)(2008-11#1)(2012-2#1)
literature on this##7##3##(1990-2#1)(1993-6#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-2#1)
literature on##74##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#5)(2012-3#4)(2013-1#5)
literature regarding the##3##3##(2008-10#1)(2012-2#2)
literature regarding##10##2##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#5)(2013-1#1)
literature related to##4##3##(2008-11#1)(2008-12#1)(2009-1#1)(2012-2#1)
literature review and##5##3##(2008-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)
literature review is##2##3##(2008-11#1)(2012-2#1)
literature review of##8##3##(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-9#1)
literature review##69##2##(1991-1#1)(1991-6#1)(1993-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#10)(2008-12#8)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#7)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
literature review]##6##2##(1991-3#1)(1993-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
literature search was##3##3##(1996-12#1)(2011-2#2)
literature search##9##2##(1996-12#1)(1997-8#1)(2008-10#1)(2011-2#2)(2013-1#3)(2013-8#1)
literature shows that##7##3##(2008-10#1)(2008-5#1)(2010-1#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
literature since##3##2##(1990-8#1)(2008-10#1)(2013-8#1)
literature sources##3##2##(2009-2#1)(2013-1#2)
literature suggests that##6##3##(1995-3#1)(2008-11#3)(2012-12#1)(2013-1#1)
literature suggests##10##2##(1992-2#1)(1995-3#1)(2008-11#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
literature surrounding the##2##3##(2010-12#1)(2011-2#1)
literature surrounding##3##2##(2008-6#1)(2010-12#1)(2011-2#1)
literature survey##3##2##(2008-10#1)(2008-8#2)
literature that has##2##3##(2008-11#1)(2012-2#1)
literature that##14##2##(1991-6#1)(1994-1#1)(2008-1#1)(2008-11#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#2)
literature through##4##2##(1994-2#1)(2008-12#1)(2010-9#1)(2012-3#1)
literature to##11##2##(1994-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-3#2)(2013-8#1)
literature using##2##2##(1992-12#1)(2008-12#1)
literature values##9##2##(2008-10#8)(2008-7#1)
literature was undertaken to##2##4##(2008-7#1)(2012-12#1)
literature was undertaken##3##3##(2008-7#1)(2012-12#2)
literature was##6##2##(2008-7#1)(2011-2#2)(2012-12#2)(2012-2#1)
literature with##6##2##(1992-12#2)(2008-10#1)(2009-3#1)(2010-10#1)(2010-5#1)
literature would suggest that##2##4##(2008-11#2)
literature##832##1##(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#10)(1991-6#5)(1992-1#7)(1992-12#10)(1992-2#2)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#8)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#3)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#2)(1994-8#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#2)(1996-1#1)(1996-11#3)(1996-12#6)(1996-2#3)(1996-3#5)(1996-6#5)(1996-9#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#9)(2006-5#1)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#104)(2008-11#87)(2008-12#40)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#41)(2008-8#18)(2008-9#14)(2009-1#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#3)(2009-7#8)(2009-8#5)(2010-1#5)(2010-10#9)(2010-11#7)(2010-12#13)(2010-2#1)(2010-3#6)(2010-5#2)(2010-6#8)(2010-7#4)(2010-8#6)(2010-9#7)(2011-1#3)(2011-10#1)(2011-2#52)(2011-3#4)(2011-7#2)(2012-12#15)(2012-2#30)(2012-3#32)(2013-1#64)(2013-2#1)(2013-7#1)(2013-8#13)
literature]##8##1##(1990-5#1)(1992-5#1)(1992-9#1)(1993-6#1)(2009-5#1)(2012-3#2)(2013-1#1)
literatures##6##1##(1990-12#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
liters##2##1##(2008-10#1)(2008-11#1)
lithiasic##3##1##(1990-9#1)(1992-9#2)
lithiasis in##2##2##(1992-3#1)(1997-8#1)
lithiasis##10##1##(1990-3#3)(1990-5#1)(1991-11#2)(1991-3#1)(1992-3#2)(1997-8#1)
lithium and##5##2##(1996-12#1)(2008-10#2)(2008-7#2)
lithium bis(oxalato)borate##2##2##(2008-10#2)
lithium determination in##3##3##(2008-10#3)
lithium determination##5##2##(2008-10#5)
lithium ions content in##2##4##(2008-10#2)
lithium ions##5##2##(2008-10#5)
lithium tetracyanoethylenide (LiTCNE)##2##3##(2008-10#2)
lithium traces determination##2##3##(2008-10#2)
lithium traces##3##2##(2008-10#3)
lithium triborate##2##2##(2008-2#1)(2008-3#1)
lithium##61##1##(1996-12#3)(1996-5#5)(2007-12#1)(2008-10#35)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#3)(2011-2#1)
lithography and##2##2##(2008-3#2)
lithography##10##1##(2008-2#4)(2008-3#4)(2008-5#1)(2012-2#1)
lithotripsy in##2##2##(2008-10#2)
lithotripsy is##4##2##(1991-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
lithotripsy of##2##2##(1992-3#1)(2008-10#1)
lithotripsy##16##1##(1990-11#1)(1991-3#1)(1991-9#1)(1992-3#1)(2008-10#4)(2011-2#1)(2012-12#2)(2013-1#5)
litigation may##2##2##(1991-3#1)(1996-12#1)
litigation##7##1##(1991-3#1)(1992-2#1)(1992-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(2012-12#1)
litre##4##1##(2008-10#3)(2008-11#1)
litter and##2##2##(1990-3#1)(1994-8#1)
litter in##2##2##(2008-10#1)(2010-3#1)
litter sex-ratio effects on##2##4##(1994-8#2)
litter sex-ratio##4##2##(1994-8#4)
litter size##3##2##(2008-8#3)
litter##32##1##(1990-3#1)(1994-8#7)(2008-10#7)(2008-11#4)(2008-8#7)(2010-3#5)(2011-2#1)
litterbag##3##1##(2008-11#3)
littermates##7##1##(1992-8#3)(1995-2#1)(1996-12#1)(2008-4#1)(2009-8#1)
litters of##2##2##(1994-8#1)(2008-10#1)
litters##7##1##(1994-8#2)(2008-10#3)(2008-8#1)(2010-3#1)
little about##3##2##(2008-10#2)(2012-3#1)
little activity##2##2##(1991-5#1)(1994-8#1)
little affected by##5##3##(2008-10#5)
little affected##6##2##(2008-10#6)
little as 0##8##3##(1993-1#1)(2008-10#5)(2008-6#1)(2010-4#1)
little as##27##2##(1992-12#1)(1993-1#1)(1993-9#1)(1994-2#1)(2008-10#15)(2008-11#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
little attention being##2##3##(2008-7#1)(2011-2#1)
little attention has been paid to the##3##7##(2009-8#1)(2012-2#1)(2013-2#1)
little attention has been paid to##5##6##(2008-5#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-2#1)
little attention in the literature##2##5##(2008-11#1)(2008-3#1)
little attention in##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
little attention##23##2##(1994-2#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-1#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-2#1)
little by##2##2##(2008-10#1)(2012-2#1)
little change in the##2##4##(1991-1#1)(2008-8#1)
little change##5##2##(1991-1#1)(2008-10#1)(2008-8#2)(2011-3#1)
little control over##3##3##(1995-1#1)(2008-1#2)
little control##4##2##(1995-1#1)(2008-1#2)(2011-2#1)
little damage to##2##3##(2008-10#2)
little data##2##2##(2008-10#1)(2008-8#1)
little dependence on##2##3##(2008-10#1)(2010-10#1)
little difference in##4##3##(1992-3#1)(2008-11#1)(2008-5#1)(2013-8#1)
little difference##5##2##(1992-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
little differences in the##2##4##(2008-10#2)
little different##2##2##(2008-10#1)(2010-8#1)
little direct##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
little effect of##2##3##(2008-10#1)(2008-11#1)
little effect on the##8##4##(1994-6#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2011-2#1)
little effect on##17##3##(1993-1#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-5#1)(2011-2#1)(2012-5#1)
little effect##22##2##(1993-1#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#2)(2009-5#1)(2011-2#1)(2012-5#1)
little effort has been##2##4##(2008-10#1)(2008-9#1)
little empirical evidence##4##3##(2008-11#2)(2008-8#1)(2009-8#1)
little empirical##7##2##(1993-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-8#1)(2010-1#1)
little evidence for##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)
little evidence of the##2##4##(2008-5#1)(2012-3#1)
little evidence of##4##3##(1995-12#1)(2008-5#1)(2008-8#1)(2012-3#1)
little evidence that##2##3##(1993-3#1)(2009-7#1)
little evidence##14##2##(1993-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#2)(2010-11#1)(2011-2#1)(2012-3#1)
little fundamental##2##2##(1994-2#1)(2009-7#1)
little genetic##2##2##(2008-10#1)(2013-1#1)
little has been##3##3##(1991-2#1)(1994-2#1)(2010-3#1)
little has##4##2##(1991-2#1)(1994-2#1)(2008-11#1)(2010-3#1)
little if any##4##3##(1991-7#1)(1995-2#1)(2008-3#1)(2012-2#1)
little in the way of##2##5##(2008-11#1)(2008-12#1)
little in the##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
little increase in##2##3##(2008-5#1)(2008-7#1)
little influence on the##6##4##(1997-8#1)(2008-10#1)(2008-11#2)(2010-4#2)
little influence on##8##3##(1997-8#1)(2008-10#2)(2008-11#2)(2009-5#1)(2010-4#2)
little information is available##3##4##(2008-10#2)(2008-11#1)
little information##8##2##(2008-1#1)(2008-10#3)(2008-11#3)(2009-10#1)
little interference##2##2##(2008-10#2)
little investigated##2##2##(2008-8#1)(2009-6#1)
little is known about how##3##5##(2008-7#1)(2010-11#1)(2011-2#1)
little is known about its##2##5##(2008-7#1)(2013-8#1)
little is known about the potential##2##6##(2008-10#2)
little is known about the##21##5##(1994-5#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#2)
little is known about their##3##5##(2007-12#1)(2012-12#1)(2013-1#1)
little is known about##37##4##(1994-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
little is known of the##2##5##(2008-5#1)(2008-8#1)
little is known of##4##4##(1993-1#1)(2008-12#1)(2008-5#1)(2008-8#1)
little is known regarding the##2##5##(1993-6#1)(2011-1#1)
little is known regarding##4##4##(1993-6#1)(2008-10#1)(2008-11#1)(2011-1#1)
little is known##47##3##(1993-1#1)(1993-6#1)(1994-5#1)(1995-2#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
little is##49##2##(1993-1#1)(1993-6#1)(1994-5#1)(1995-2#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
little measurable##2##2##(1997-1#1)(2008-10#1)
little more##2##2##(2008-8#1)(2008-9#1)
little of the##2##3##(2010-8#1)(2012-2#1)
little of##4##2##(1994-3#1)(1996-11#1)(2010-8#1)(2012-2#1)
little or no dependence##2##4##(1993-8#2)
little or no effect on the determination of##2##8##(2008-10#2)
little or no effect on##3##5##(2008-10#3)
little or no impact on##2##5##(1991-6#1)(1995-5#1)
little or no##37##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-5#1)(1995-9#1)(1997-3#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-12#1)(2013-1#1)(2013-8#1)
little or##40##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-5#1)(1995-9#1)(1997-3#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
little progress##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
little research has been conducted to##2##6##(2008-11#1)(2008-12#1)
little research has been conducted##3##5##(2008-11#1)(2008-12#1)(2012-2#1)
little research has been##4##4##(2008-11#1)(2008-12#1)(2010-12#1)(2012-2#1)
little research has##6##3##(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2012-2#1)
little research##10##2##(1996-1#1)(2008-11#2)(2008-12#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-12#1)(2012-2#1)
little role in the##2##4##(2008-7#1)(2011-2#1)
little role in##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
little skate##2##2##(2008-11#1)(2010-8#1)
little success##2##2##(1996-3#1)(2010-1#1)
little support##2##2##(2010-12#1)(2011-2#1)
little to the##2##3##(1996-1#1)(2013-1#1)
little to##5##2##(1992-8#1)(1996-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
little value in##2##3##(1991-2#1)(1992-3#1)
little value##3##2##(1991-2#1)(1992-3#1)(2008-5#1)
little variability between##2##3##(2008-10#2)
little variation in##3##3##(1990-9#1)(2008-9#2)
little variation##5##2##(1990-9#1)(2008-10#2)(2008-9#2)
little work has##2##3##(1995-11#1)(2008-10#1)
little written about##2##3##(2008-11#1)(2008-12#1)
little##471##1##(1990-11#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#7)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#4)(1995-1#2)(1995-11#5)(1995-12#3)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-8#3)(2007-12#1)(2008-1#4)(2008-10#111)(2008-11#37)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#16)(2008-6#2)(2008-7#8)(2008-8#22)(2008-9#21)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#6)(2010-1#5)(2010-10#2)(2010-11#4)(2010-12#5)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#15)(2012-3#10)(2012-5#1)(2013-1#11)(2013-2#1)(2013-8#4)
littoralis##6##1##(2008-10#3)(2013-8#3)
live and fixed##2##3##(2008-10#1)(2008-9#1)
live and##5##2##(1996-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)
live as##3##2##(2008-8#1)(2010-10#1)(2011-2#1)
live attenuated##5##2##(1995-5#2)(2008-11#1)(2010-8#1)(2011-2#1)
live births##9##2##(1990-9#1)(1991-11#2)(1991-3#2)(2013-1#4)
live cell##4##2##(2008-11#3)(2009-10#1)
live cells and fixed##2##4##(2008-10#1)(2008-9#1)
live cells and##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)
live cells##12##2##(2008-10#3)(2008-11#4)(2008-9#3)(2009-6#2)
live in areas##2##3##(1997-2#1)(2009-8#1)
live in##13##2##(1992-5#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#3)(2012-12#1)
live infectious bronchitis virus##2##4##(2008-5#2)
live longer##2##2##(1991-2#1)(2010-4#1)
live mediums##2##2##(2008-5#2)
live or##2##2##(2008-10#1)(2009-8#1)
live up to##2##3##(1996-2#1)(2008-5#1)
live vaccine##3##2##(1995-5#1)(2008-11#1)(2013-8#1)
live vaccines in##2##3##(2008-11#1)(2013-1#1)
live virus vaccine##2##3##(1995-9#2)
live virus vaccines##2##3##(2008-11#1)(2011-2#1)
live virus##4##2##(1995-9#2)(2008-11#1)(2011-2#1)
live with their##2##3##(1992-1#1)(1995-9#1)
live with##6##2##(1991-2#1)(1992-1#1)(1994-2#1)(1995-9#1)(2008-6#1)(2008-8#1)
live##143##1##(1990-2#1)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#2)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-12#1)(1994-2#2)(1995-5#8)(1995-6#1)(1995-9#3)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#17)(2008-11#17)(2008-12#3)(2008-5#6)(2008-6#1)(2008-8#6)(2008-9#7)(2009-10#2)(2009-6#13)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-4#2)(2010-8#4)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
live/dead##3##1##(2008-4#2)(2009-6#1)
lived alone##2##2##(1993-3#1)(2008-7#1)
lived and worked in##2##4##(2008-12#1)(2013-1#1)
lived experience of myocardial##2##4##(2009-5#2)
lived experience of##8##3##(2008-1#1)(2008-11#2)(2009-5#4)(2009-9#1)
lived experience##11##2##(2008-1#1)(2008-11#3)(2008-12#1)(2009-5#4)(2009-9#2)
lived experiences of##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
lived experiences##5##2##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)
lived in##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
lived##31##1##(1993-3#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#4)(2009-9#3)(2010-10#2)(2012-3#1)(2013-1#2)
livedo##3##1##(2007-9#2)(2012-3#1)
liver (BAL)##2##2##(2010-12#1)(2012-2#1)
liver AGT activity##2##3##(1993-11#1)(2008-5#1)
liver DNA##2##2##(1991-8#1)(1993-12#1)
liver ID1 activity and ID1 mRNA levels##2##7##(1995-12#2)
liver ID1 activity##4##3##(1995-12#4)
liver ID1##6##2##(1995-12#6)
liver UDP-glucuronosyltransferase##6##2##(2008-11#6)
liver abscess##4##2##(1995-10#1)(2012-2#3)
liver after##2##2##(1993-12#1)(2008-11#1)
liver alpha-N-acetylgalactosaminidase##2##2##(1993-12#2)
liver also##2##2##(1994-12#1)(2013-7#1)
liver and brain##5##3##(1990-11#1)(1992-10#1)(1994-5#1)(2008-4#2)
liver and heart tissues##4##4##(2008-10#4)
liver and hepatomas##2##3##(1990-5#2)
liver and in the##2##4##(2009-8#1)(2013-1#1)
liver and in##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
liver and its##2##3##(1994-8#1)(1996-2#1)
liver and kidney##11##3##(1990-11#1)(1990-12#1)(1991-5#1)(1993-12#2)(1994-11#2)(2008-10#2)(2008-9#2)
liver and lungs##2##3##(2010-11#1)(2013-1#1)
liver and muscle##2##3##(1996-12#1)(2012-2#1)
liver and spleen##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
liver and the##2##3##(1995-9#1)(2008-11#1)
liver and##70##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#4)(1991-12#1)(1991-5#1)(1992-10#1)(1992-6#2)(1993-12#4)(1993-3#2)(1993-6#2)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-11#2)(2010-5#1)(2012-2#4)(2013-1#3)(2013-8#1)
liver and/or##2##2##(1994-5#1)(2011-2#1)
liver are##3##2##(1990-11#1)(1997-1#1)(2010-12#1)
liver associated##2##2##(2010-12#1)(2011-2#1)
liver biopsies##5##2##(1990-2#1)(1993-2#4)
liver biopsy##7##2##(1991-8#2)(2008-1#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)
liver but##2##2##(2012-2#1)(2013-1#1)
liver by the##2##3##(1993-12#1)(1994-8#1)
liver by##10##2##(1993-12#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-2#2)(2008-11#1)(2008-5#1)(2010-5#1)
liver cDNA##4##2##(1992-3#1)(1994-11#1)(2008-11#1)(2008-8#1)
liver cancer##8##2##(1990-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#3)
liver cell line##5##3##(1992-6#1)(1994-6#1)(2008-11#1)(2010-11#1)(2010-5#1)
liver cell##14##2##(1990-9#1)(1992-5#1)(1992-6#1)(1994-6#1)(1995-2#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2010-5#1)
liver cells by##3##3##(1995-6#2)(2008-8#1)
liver cells were##2##3##(1993-12#1)(1996-2#1)
liver cells##25##2##(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-6#3)(1996-2#2)(1997-1#2)(2008-10#1)(2008-11#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#3)(2010-5#1)(2011-2#1)
liver cirrhosis and##3##3##(1992-2#1)(2009-8#1)(2010-10#1)
liver cirrhosis##11##2##(1992-2#1)(1997-5#1)(2008-10#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-8#1)(2013-8#1)
liver cytosol##4##2##(1993-8#1)(2008-10#3)
liver cytosolic##2##2##(1990-11#1)(1995-2#1)
liver damage##4##2##(2009-8#3)(2011-2#1)
liver deposition and sparing##2##4##(2012-2#2)
liver deposition is##2##3##(2012-2#2)
liver deposition##4##2##(2012-2#4)
liver development and##2##3##(2011-2#1)(2013-1#1)
liver disease (CLD)##2##3##(2008-10#2)
liver disease in##2##3##(1991-8#1)(2010-10#1)
liver disease patients##2##3##(2008-10#1)(2009-8#1)
liver disease who##3##3##(2008-1#2)(2011-2#1)
liver disease##41##2##(1990-8#1)(1991-11#1)(1991-8#6)(1992-12#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#8)(2010-10#1)(2010-12#3)(2011-2#3)(2012-3#1)(2013-1#6)
liver diseases##7##2##(1995-10#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
liver drug##2##2##(2008-10#2)
liver enzyme##3##2##(1991-12#1)(1993-12#1)(1995-6#1)
liver enzymes and##3##3##(2008-11#1)(2012-3#2)
liver enzymes were##2##3##(2008-1#1)(2008-8#1)
liver enzymes##6##2##(2008-1#1)(2008-11#1)(2008-8#1)(2012-3#2)(2013-1#1)
liver extracts##2##2##(2008-10#1)(2008-11#1)
liver failure##5##2##(2008-11#2)(2010-12#1)(2013-1#2)
liver fatty##2##2##(1994-8#1)(2009-8#1)
liver fibrosis##9##2##(2011-2#2)(2013-1#5)(2013-8#2)
liver fluke##3##2##(2008-12#3)
liver following burn injury##2##4##(2008-8#2)
liver following##3##2##(2008-10#1)(2008-8#2)
liver for##2##2##(1993-6#1)(2012-2#1)
liver from the##2##3##(2008-11#2)
liver from##3##2##(1996-2#1)(2008-11#2)
liver function and##2##3##(1992-12#1)(2010-10#1)
liver function tests##3##3##(1991-8#1)(2006-6#1)(2007-12#1)
liver function##11##2##(1991-8#1)(1992-12#2)(1992-5#1)(2006-6#2)(2007-12#1)(2008-10#1)(2009-8#1)(2010-10#1)(2012-3#1)
liver glycogen##3##2##(1993-8#2)(2008-10#1)
liver haemangioma##2##2##(2013-1#2)
liver in a##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
liver in the##2##3##(1993-3#2)
liver in##11##2##(1990-11#1)(1991-12#1)(1992-2#1)(1993-3#2)(1995-2#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-5#1)(2012-3#1)
liver injury and##4##3##(1994-6#1)(2009-7#1)(2012-2#1)(2013-1#1)
liver injury by##2##3##(2008-11#1)(2013-1#1)
liver injury##15##2##(1994-6#2)(1996-11#2)(2008-11#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#4)
liver is##8##2##(1990-5#1)(1991-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-7#1)
liver lesion##3##2##(2008-1#1)(2012-3#2)
liver lesions##15##2##(1990-9#1)(2008-1#1)(2010-12#12)(2012-2#1)
liver may##2##2##(1990-2#1)(2010-5#1)
liver membranes##4##2##(1994-3#4)
liver metastases from##2##3##(1994-6#1)(2009-9#1)
liver metastases##14##2##(1992-12#1)(1994-12#3)(1994-6#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-3#2)(2013-1#3)
liver metastasis is##2##3##(2011-2#2)
liver metastasis##6##2##(2011-2#3)(2013-1#3)
liver microsomal##3##2##(1993-11#1)(1994-8#1)(2011-3#1)
liver microsomes by##2##3##(1991-5#1)(1994-8#1)
liver microsomes from##2##3##(1994-8#1)(2011-3#1)
liver microsomes of the three species##2##6##(2011-3#2)
liver microsomes of##3##3##(2011-3#3)
liver microsomes were##2##3##(2011-3#2)
liver microsomes##26##2##(1990-5#1)(1991-5#6)(1993-8#1)(1994-8#9)(2011-3#9)
liver mitochondria and##2##3##(1990-2#1)(2008-5#1)
liver mitochondria##9##2##(1990-2#1)(1991-5#1)(1994-11#1)(1994-8#3)(1995-11#1)(2008-5#2)
liver monoamine##2##2##(1994-8#2)
liver of the female##3##4##(1995-9#1)(2010-5#2)
liver of the##5##3##(1995-9#1)(2008-12#1)(2010-5#3)
liver of##14##2##(1990-3#2)(1991-8#1)(1995-8#1)(1995-9#1)(2008-12#1)(2008-5#2)(2010-11#2)(2010-5#3)(2013-1#1)
liver or##3##2##(1994-11#1)(1994-5#1)(2008-10#1)
liver parenchyma##4##2##(1995-6#1)(1996-2#1)(2011-2#1)(2012-2#1)
liver parenchymal cells##2##3##(1994-3#2)
liver parenchymal##3##2##(1994-3#2)(2012-3#1)
liver resection##7##2##(2011-2#5)(2012-12#1)(2012-3#1)
liver samples##5##2##(1991-5#2)(2008-10#2)(2008-8#1)
liver slice##2##2##(1995-11#1)(2008-6#1)
liver slices incubated in##2##4##(1995-11#1)(2008-6#1)
liver slices##4##2##(1994-5#1)(1995-11#2)(2008-6#1)
liver specific##3##2##(1994-11#1)(2008-11#2)
liver specimens##2##2##(2008-8#1)(2011-2#1)
liver support systems##6##3##(2008-11#5)(2010-12#1)
liver support##10##2##(2008-11#8)(2010-12#2)
liver that##2##2##(1993-12#1)(1995-2#1)
liver tissue##7##2##(1990-2#2)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
liver tissues##5##2##(2008-10#3)(2008-11#1)(2012-3#1)
liver to##5##2##(1995-8#1)(2008-11#1)(2008-5#1)(2010-11#1)(2013-8#1)
liver toxicity in rats##2##4##(1993-12#1)(2008-10#1)
liver toxicity##3##2##(1993-12#1)(2008-10#1)(2013-1#1)
liver transplant donor candidates##2##4##(2012-2#2)
liver transplant##4##2##(2008-6#1)(2012-2#2)(2012-3#1)
liver transplantation for##2##3##(1991-11#2)
liver transplantation##20##2##(1991-11#3)(1992-3#1)(1992-9#1)(1993-2#2)(1994-6#3)(1995-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
liver trauma##2##2##(1991-6#1)(2013-8#1)
liver tumors in##2##3##(2008-9#1)(2011-1#1)
liver tumors were##2##3##(2008-10#2)
liver tumors##6##2##(1990-6#1)(2008-10#2)(2008-9#1)(2011-1#1)(2013-1#1)
liver tumour##2##2##(2011-2#1)(2012-2#1)
liver tumours##2##2##(2008-11#1)(2013-1#1)
liver type 1 iodothyronine deiodinase##2##5##(1995-12#2)
liver using##5##2##(1997-7#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-7#1)
liver was also##2##3##(1993-12#1)(2009-8#1)
liver was##17##2##(1990-11#1)(1990-5#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1997-1#1)(2008-10#3)(2008-6#1)(2009-8#1)(2010-5#1)(2011-1#2)
liver weight##3##2##(1994-5#1)(2013-1#2)
liver weights were##2##3##(1995-11#1)(2008-9#1)
liver weights##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
liver were##5##2##(1994-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
liver which##2##2##(2008-12#2)
liver with##5##2##(1991-7#1)(1995-2#1)(2009-1#1)(2010-12#1)(2013-1#1)
liver##872##1##(1990-10#2)(1990-11#15)(1990-12#3)(1990-2#9)(1990-3#3)(1990-5#26)(1990-6#1)(1990-8#3)(1990-9#2)(1991-11#5)(1991-12#8)(1991-3#3)(1991-5#14)(1991-6#3)(1991-7#4)(1991-8#14)(1992-10#3)(1992-12#6)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#8)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#19)(1993-2#8)(1993-3#11)(1993-6#5)(1993-8#7)(1994-11#11)(1994-12#4)(1994-2#2)(1994-3#9)(1994-5#10)(1994-6#10)(1994-8#27)(1995-10#4)(1995-11#9)(1995-12#9)(1995-2#10)(1995-6#7)(1995-8#7)(1995-9#4)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#1)(1997-1#6)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#7)(1997-9#1)(2006-6#2)(2007-12#1)(2007-8#1)(2008-1#13)(2008-10#76)(2008-11#58)(2008-12#12)(2008-4#4)(2008-5#19)(2008-6#7)(2008-7#1)(2008-8#18)(2008-9#12)(2009-1#1)(2009-12#2)(2009-6#2)(2009-7#3)(2009-8#32)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#11)(2010-12#44)(2010-5#15)(2010-6#1)(2010-7#7)(2010-8#1)(2011-1#4)(2011-2#33)(2011-3#10)(2012-12#2)(2012-2#33)(2012-3#18)(2013-1#56)(2013-7#3)(2013-8#9)
liver) and##2##2##(2008-10#2)
liver)##6##1##(1996-2#2)(1997-8#1)(2007-12#1)(2008-10#2)
liver-only CRLM##2##2##(2013-1#2)
liver-specific functions##2##2##(2008-11#2)
liver-specific##5##1##(1995-2#1)(2008-11#2)(2011-2#2)
livers and##4##2##(1990-5#1)(1991-3#1)(2008-10#1)(2008-11#1)
livers by##2##2##(2008-10#2)
livers during##2##2##(1990-5#1)(2008-8#1)
livers of##5##2##(2008-10#2)(2008-5#2)(2012-2#1)
livers##29##1##(1990-5#3)(1991-12#1)(1991-3#5)(1991-5#1)(1996-2#3)(2008-10#6)(2008-11#2)(2008-5#2)(2008-8#2)(2012-2#1)(2013-1#3)
lives and##5##2##(2008-1#1)(2008-11#2)(2010-8#1)(2011-2#1)
lives as##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
lives in road##2##3##(2010-11#2)
lives in the##2##3##(1996-12#1)(2008-11#1)
lives in##6##2##(1995-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-11#2)
lives of##11##2##(1991-2#1)(1993-8#1)(1995-6#1)(2008-11#4)(2008-8#1)(2009-5#1)(2010-10#1)(2010-8#1)
lives##55##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-9#2)(1995-1#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#11)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
livestock and##5##2##(1994-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
livestock industries##3##2##(1997-7#2)(2011-2#1)
livestock production##5##2##(1997-7#1)(2011-2#4)
livestock##40##1##(1990-3#1)(1991-3#1)(1994-3#1)(1996-3#1)(1997-7#9)(2008-10#4)(2008-11#3)(2008-8#1)(2010-1#2)(2010-4#2)(2011-2#13)(2012-2#1)(2013-1#1)
liveweight##2##1##(1991-3#1)(1996-12#1)
livia##2##1##(2008-5#1)(2008-8#1)
living alone##2##2##(1993-12#1)(2008-7#1)
living and##10##2##(1991-12#1)(1995-2#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
living animals##2##2##(2008-10#2)
living area##2##2##(2011-2#2)
living arrangements##2##2##(1997-3#1)(2011-2#1)
living at home##2##3##(2007-12#1)(2008-7#1)
living bacterial cells##2##3##(2008-10#2)
living cancer patients##2##3##(1993-11#2)
living cell adhesion##2##3##(2008-11#2)
living cell##4##2##(2008-11#3)(2008-5#1)
living cells and##3##3##(2008-11#1)(2009-7#1)(2009-9#1)
living cells##24##2##(1992-5#2)(1995-11#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-8#3)(2008-9#4)(2009-7#3)(2009-9#1)(2013-1#2)(2013-8#1)
living conditions##3##2##(2008-11#1)(2009-6#1)(2009-8#1)
living donor##3##2##(2010-10#1)(2011-2#2)
living embryo sacs of Torenia fournieri##2##6##(2008-11#1)(2008-9#1)
living embryo##3##2##(2008-11#2)(2008-9#1)
living in a##7##3##(1992-1#1)(1995-12#1)(2008-5#1)(2008-8#1)(2010-9#3)
living in nursing##2##3##(2008-5#1)(2010-10#1)
living in the community##4##4##(2008-12#1)(2008-7#1)(2009-6#1)(2012-12#1)
living in the##13##3##(1990-3#1)(1996-6#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#3)(2012-12#1)
living in urban areas##2##4##(2008-10#1)(2011-1#1)
living in##51##2##(1990-2#1)(1990-3#1)(1992-1#1)(1992-6#1)(1993-1#1)(1994-2#2)(1995-12#1)(1996-6#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-9#3)(2011-1#1)(2011-2#9)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
living near##3##2##(1991-3#3)
living organism##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
living organisms##6##2##(1992-11#1)(2008-10#2)(2009-8#1)(2010-11#1)(2011-2#1)
living tissue##2##2##(1993-3#1)(2009-8#1)
living with AIDS##2##3##(1997-6#1)(2012-3#1)
living with COPD##3##3##(2010-10#3)
living with HIV##3##3##(1992-9#1)(1995-6#1)(2013-1#1)
living with HIV/AIDS##2##3##(2008-1#1)(2013-1#1)
living with a##2##3##(1994-2#1)(2008-2#1)
living with##20##2##(1992-3#1)(1992-9#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-10#5)(2012-3#1)(2013-1#3)
living yeast##3##2##(1996-6#2)(2008-4#1)
living##229##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#3)(1996-3#1)(1996-6#3)(1997-1#1)(1997-3#1)(1997-6#2)(2007-12#1)(2008-1#3)(2008-10#30)(2008-11#20)(2008-12#20)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#8)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-10#8)(2010-11#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#2)(2011-2#22)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#6)
lizard##11##1##(2008-10#2)(2008-7#3)(2008-8#3)(2011-2#3)
lizards##21##1##(1991-5#3)(2008-10#3)(2008-7#7)(2008-8#5)(2008-9#2)(2011-2#1)
lmol(-1)cm(-1) at##2##2##(2008-10#2)
lmol(-1)cm(-1)##4##1##(2008-10#4)
ln [X + 1] -##2##5##(2008-10#2)
ln##5##1##(2008-10#5)
load (GL)##2##2##(2008-1#1)(2008-3#1)
load and##10##2##(1994-6#2)(2008-11#1)(2008-12#1)(2010-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
load application##3##2##(2013-1#3)
load in##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)
load is##2##2##(1993-3#1)(2008-10#1)
load of##5##2##(2008-1#1)(2008-10#2)(2008-6#1)(2012-3#1)
load on##2##2##(1991-6#1)(1997-5#1)
load to##2##2##(2009-3#1)(2012-2#1)
load was##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
load##90##1##(1991-6#2)(1992-10#1)(1993-3#1)(1994-6#2)(1997-5#1)(2008-1#3)(2008-10#13)(2008-11#8)(2008-12#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#5)(2009-8#2)(2010-11#1)(2010-12#5)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#15)(2013-8#5)
load)##2##1##(2009-7#1)(2010-10#1)
load-bearing##4##1##(2009-7#3)(2010-4#1)
load-induced plastic strain##2##3##(2009-7#2)
loaded at##3##2##(2008-10#1)(2013-1#2)
loaded by##2##2##(2011-2#1)(2013-1#1)
loaded in##3##2##(2008-10#1)(2008-9#1)(2009-7#1)
loaded into##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
loaded on the##2##3##(2008-10#2)
loaded on##7##2##(2008-10#7)
loaded resin##4##2##(2008-10#4)
loaded silica gel was##2##4##(2008-10#2)
loaded silica gel##3##3##(2008-10#3)
loaded single implants##2##3##(2013-1#2)
loaded with 1##3##3##(2008-10#3)
loaded with 1-(2-pyridylazo)-2-naphthol (PAN)##2##4##(2008-10#2)
loaded with PAN##3##3##(2008-10#3)
loaded with a##2##3##(1994-2#1)(2008-10#1)
loaded with calmagite##3##3##(2008-10#3)
loaded with the##4##3##(1997-1#1)(2008-10#3)
loaded with##39##2##(1992-6#1)(1994-2#1)(1997-1#1)(2008-10#33)(2008-7#1)(2008-9#1)(2011-2#1)
loaded##100##1##(1990-5#1)(1991-5#1)(1992-6#1)(1994-2#1)(1997-1#1)(2008-10#64)(2008-11#1)(2008-7#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-9#4)(2011-2#2)(2011-7#1)(2012-3#3)(2013-1#13)
loading and elution##3##3##(2008-10#3)
loading and unloading of##2##4##(2008-10#2)
loading and unloading##3##3##(2008-10#3)
loading and##18##2##(1990-2#1)(2008-10#11)(2009-4#2)(2009-7#1)(2010-11#1)(2013-1#2)
loading at##2##2##(2008-10#1)(2011-2#1)
loading capacities of##2##3##(2008-10#2)
loading capacity for##2##3##(2008-10#1)(2013-1#1)
loading capacity of the##2##4##(2008-10#2)
loading capacity of##3##3##(2008-10#3)
loading capacity##6##2##(2008-10#5)(2013-1#1)
loading dose of##2##3##(2011-2#1)(2012-12#1)
loading dose##3##2##(2008-1#1)(2011-2#1)(2012-12#1)
loading flow rate##6##3##(2008-10#6)
loading flow rates##2##3##(2008-10#2)
loading flow##8##2##(2008-10#8)
loading group and##3##3##(2013-1#3)
loading group##5##2##(2013-1#5)
loading half time (t(1/2))##2##4##(2008-10#2)
loading half time##3##3##(2008-10#3)
loading in the##2##3##(2008-10#1)(2013-1#1)
loading in##3##2##(2008-10#1)(2010-11#1)(2013-1#1)
loading is##3##2##(2008-2#1)(2009-7#1)(2010-7#1)
loading of implants in##2##4##(2010-5#1)(2013-1#1)
loading of single##2##3##(2013-1#2)
loading of the##3##3##(2008-10#3)
loading of##17##2##(1997-7#1)(2008-10#9)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2013-1#3)
loading on the##3##3##(1994-6#1)(2009-8#1)(2011-2#1)
loading on##4##2##(1994-6#1)(2008-10#1)(2009-8#1)(2011-2#1)
loading plots##2##2##(2008-10#2)
loading sample volume##2##3##(2008-10#2)
loading the##3##2##(2008-10#3)
loading time of##4##3##(2008-10#4)
loading time##6##2##(2008-10#6)
loading was##2##2##(2011-2#1)(2013-1#1)
loading with##2##2##(2008-10#1)(2009-7#1)
loading##158##1##(1990-2#1)(1991-5#2)(1992-9#1)(1994-6#2)(1995-2#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#64)(2008-11#2)(2008-2#3)(2008-5#1)(2009-3#6)(2009-4#2)(2009-5#1)(2009-7#15)(2009-8#1)(2010-11#5)(2010-12#2)(2010-4#3)(2010-5#2)(2010-7#3)(2011-2#11)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#21)(2013-8#1)
loadings versus##2##2##(2008-10#2)
loadings were##2##2##(1997-2#1)(2008-10#1)
loadings##10##1##(1997-2#2)(2008-10#4)(2009-7#1)(2011-2#3)
loads and##2##2##(2012-2#1)(2013-1#1)
loads of##2##2##(2008-10#1)(2008-8#1)
loads with##2##2##(2008-10#1)(2009-8#1)
loads##19##1##(2007-8#1)(2008-10#5)(2008-8#1)(2009-1#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
loam amended with##2##3##(2008-10#2)
loam and##3##2##(2008-10#3)
loam field##3##2##(2008-10#3)
loam soil##6##2##(2008-10#5)(2011-1#1)
loam soils##2##2##(2008-10#2)
loam##24##1##(2008-10#23)(2011-1#1)
loamy sand##4##2##(2008-10#4)
loamy##6##1##(2008-10#5)(2008-11#1)
loan##3##1##(1991-3#1)(1995-2#2)
lobar ablation##3##2##(1997-8#3)
lobar##9##1##(1997-8#3)(2008-2#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
lobby##2##1##(2008-10#1)(2008-12#1)
lobbying##2##1##(1991-8#1)(1997-3#1)
lobe and##3##2##(1992-9#1)(2008-7#1)(2009-8#1)
lobe epilepsy##3##2##(2008-4#3)
lobe from##2##2##(2008-10#1)(2011-2#1)
lobe of the##6##3##(1993-6#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
lobe of##10##2##(1993-5#1)(1993-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
lobe shape variation##2##3##(2012-3#2)
lobe shape##4##2##(2012-3#4)
lobe was##2##2##(1991-9#1)(2008-5#1)
lobe##91##1##(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-9#5)(1993-5#2)(1993-6#1)(1993-9#1)(1996-2#2)(1996-6#1)(1997-3#3)(1997-6#1)(1997-8#2)(2007-12#8)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#3)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#6)(2009-1#1)(2009-8#4)(2010-11#2)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#9)(2013-1#1)(2013-8#1)
lobe)##2##1##(1993-9#1)(2008-7#1)
lobectomy and##2##2##(2008-11#1)(2011-2#1)
lobectomy##13##1##(1990-6#1)(1992-12#3)(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#4)(2012-12#2)
lobes and##2##2##(2008-7#1)(2009-8#1)
lobes of the##5##3##(1990-8#1)(2008-11#1)(2011-1#1)(2013-1#2)
lobes were##4##2##(2007-12#1)(2008-7#1)(2013-1#2)
lobes##25##1##(1990-8#1)(1994-3#1)(1997-3#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#4)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#4)
loblolly pine##4##2##(2008-10#4)
loblolly##6##1##(2008-10#6)
lobotomy##2##1##(1993-6#2)
lobster tissue##2##2##(2008-10#2)
lobster##8##1##(1990-2#3)(2007-12#2)(2008-10#3)
lobsters##2##1##(2007-12#2)
lobular carcinoma##4##2##(1992-5#1)(1994-12#2)(2013-1#1)
lobular##5##1##(1992-5#1)(1994-12#2)(2011-2#1)(2013-1#1)
lobule VII##4##2##(1994-2#4)
lobule##8##1##(1994-2#4)(1996-2#1)(2008-11#3)
lobules of##2##2##(2008-1#1)(2012-2#1)
local DPCM##2##2##(2013-8#2)
local accumulation of##3##3##(2008-10#2)(2008-8#1)
local accumulation##4##2##(2008-10#3)(2008-8#1)
local adaptation##7##2##(2008-8#3)(2008-9#1)(2012-7#3)
local adaptations##2##2##(2010-8#1)(2013-1#1)
local administration of##5##3##(1994-2#1)(1996-11#1)(2008-12#1)(2011-2#2)
local anaesthesia##5##2##(1991-9#1)(1994-2#1)(2008-12#1)(2013-1#2)
local and global##4##3##(2008-11#1)(2008-8#1)(2010-7#1)(2013-8#1)
local and imported##2##3##(2008-10#2)
local and regional scales##4##4##(2008-10#1)(2008-8#3)
local and regional##8##3##(1997-3#1)(2008-10#1)(2008-8#5)(2008-9#1)
local and state##2##3##(1996-1#1)(1997-2#1)
local and systemic side effects##2##5##(1992-3#1)(1995-5#1)
local and systemic##14##3##(1991-8#1)(1992-3#1)(1995-5#1)(2008-10#5)(2008-12#1)(2010-6#1)(2011-2#3)(2013-1#1)
local and##44##2##(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-12#5)(2008-5#2)(2008-8#7)(2008-9#1)(2009-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2011-9#1)(2013-1#1)(2013-8#2)
local and/or##2##2##(1994-2#1)(2012-3#1)
local anesthesia##13##2##(1990-5#1)(1992-12#5)(1993-1#5)(1995-3#1)(2013-1#1)
local anesthetic agent##2##3##(1993-1#1)(2012-3#1)
local anesthetic efficacy##2##3##(1993-1#2)
local anesthetic preparation##2##3##(1993-1#2)
local anesthetic##15##2##(1993-1#11)(1994-2#1)(1995-3#1)(2012-3#1)(2013-1#1)
local anesthetics##4##2##(1993-1#4)
local application of##3##3##(1990-5#1)(1997-3#2)
local application##4##2##(1990-5#1)(1993-11#1)(1997-3#2)
local area##7##2##(1991-2#1)(1996-12#1)(2008-10#4)(2012-3#1)
local areas##2##2##(2008-10#1)(2008-11#1)
local bacterial##3##2##(2008-10#2)(2008-12#1)
local bodies##2##2##(2012-3#2)
local cancer##2##2##(1991-2#1)(1996-2#1)
local circuit connections##2##3##(2008-11#2)
local circuit##5##2##(1996-12#1)(2008-11#3)(2013-8#1)
local clinical##2##2##(2008-7#2)
local coexistence of##2##3##(2008-8#2)
local coexistence##5##2##(2008-8#5)
local color##2##2##(2008-6#2)
local communities##3##2##(1996-2#1)(1996-3#1)(1997-8#1)
local community##6##2##(1994-1#2)(2008-8#1)(2009-6#1)(2013-1#2)
local competitive##2##2##(2008-8#2)
local conditions##2##2##(1993-11#1)(2008-10#1)
local control##5##2##(1993-9#1)(1996-10#1)(2008-2#1)(2008-7#1)(2008-9#1)
local cortical##2##2##(2008-11#2)
local councils##3##2##(1997-8#3)
local demes##2##2##(2008-10#1)(2008-9#1)
local density regulation##5##3##(2008-8#5)
local density##7##2##(2008-8#6)(2013-1#1)
local destructive##2##2##(1991-2#2)
local diversity##4##2##(2008-8#4)
local dynamics of##2##3##(2008-10#1)(2008-8#1)
local dynamics##5##2##(2008-10#2)(2008-8#1)(2008-9#2)
local economic structures##2##3##(2011-2#2)
local effect##2##2##(2008-10#2)
local environment and##2##3##(2008-12#1)(2008-8#1)
local environment##3##2##(2008-12#1)(2008-8#1)(2011-2#1)
local environmental conditions##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
local environmental factors##2##3##(2010-6#2)
local environmental##9##2##(2008-10#3)(2008-11#1)(2008-8#1)(2010-6#4)
local excision##7##2##(1990-2#1)(1994-12#1)(1997-7#1)(2008-9#2)(2009-12#2)
local external beam radiation therapy for symptomatic bone metastases##2##9##(2008-7#2)
local extinction probabilities and##2##4##(2008-8#2)
local extinction probabilities##3##3##(2008-8#3)
local extinction probability##3##3##(2008-8#3)
local extinction##10##2##(2008-3#1)(2008-8#8)(2008-9#1)
local failure##2##2##(1991-2#1)(2009-12#1)
local field potentials (LFP)##2##4##(2008-11#2)
local field##3##2##(1990-5#1)(2008-11#2)
local flap##3##2##(2008-7#1)(2008-9#2)
local genetic map##2##3##(2008-10#2)
local health department##3##3##(1995-12#1)(1997-2#1)(2011-9#1)
local health departments (LHDs)##2##4##(1996-2#2)
local health departments##11##3##(1995-12#1)(1996-1#2)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2011-9#1)
local health##20##2##(1991-6#1)(1994-3#2)(1995-12#2)(1996-1#3)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2011-9#2)
local hospital##4##2##(1990-11#1)(1993-6#1)(1996-3#1)(2011-2#1)
local immune##2##2##(1992-12#1)(2010-1#1)
local independence##2##2##(2011-2#1)(2012-2#1)
local infection##3##2##(2008-10#1)(2008-9#1)(2009-4#1)
local inflammation##6##2##(2009-10#1)(2010-10#1)(2010-12#1)(2013-1#2)(2013-8#1)
local injection##4##2##(1996-8#1)(2008-11#1)(2011-2#2)
local intensity##2##2##(2008-10#1)(2008-7#1)
local interaction##2##2##(2008-10#1)(2008-8#1)
local intraarterial thrombolysis##2##3##(1996-6#2)
local lesion##2##2##(2008-10#1)(2008-9#1)
local level##8##2##(1992-2#1)(1994-2#1)(1996-1#1)(1997-2#2)(2008-10#1)(2011-9#1)(2012-12#1)
local lymph node assay (LLNA)##2##5##(2008-10#1)(2008-5#1)
local lymph node assay##4##4##(2008-10#1)(2008-5#3)
local maxima##2##2##(2008-8#2)
local measures of##4##3##(2008-5#1)(2008-9#1)(2013-1#2)
local motions##2##2##(1995-3#1)(2010-4#1)
local newspapers##2##2##(1997-3#1)(2009-4#1)
local optimum##2##2##(2008-10#1)(2008-8#1)
local or regional##3##3##(1992-2#1)(2008-10#1)(2013-1#1)
local or systemic##3##3##(2008-1#1)(2008-9#2)
local or##11##2##(1990-6#1)(1992-2#1)(1997-1#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2013-1#1)
local pH##3##2##(2008-10#1)(2009-12#2)
local population growth##2##3##(2008-8#1)(2008-9#1)
local population##10##2##(2008-10#2)(2008-8#2)(2008-9#4)(2011-2#1)(2012-2#1)
local populations of##2##3##(2008-10#2)
local populations##11##2##(2008-10#7)(2008-8#2)(2008-9#1)(2010-1#1)
local prey##2##2##(2008-8#2)
local processes##3##2##(2008-9#3)
local public health performance##5##4##(1995-12#2)(1996-3#3)
local public health##14##3##(1995-12#5)(1996-1#2)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#1)
local reactions##3##2##(1990-9#1)(1996-8#1)(2011-2#1)
local recurrence and##4##3##(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
local recurrence##17##2##(1990-3#1)(1993-11#1)(1994-12#2)(1997-7#2)(2008-11#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-3#3)(2011-2#2)(2013-1#1)
local recurrences##6##2##(1990-6#4)(1991-9#2)
local relapse##2##2##(1991-2#1)(1994-6#1)
local relapses##4##2##(1990-3#2)(1991-6#1)(1994-6#1)
local scale##4##2##(2008-10#1)(2008-6#1)(2008-8#2)
local service##2##2##(1995-3#2)
local shear##2##2##(1990-8#1)(2006-6#1)
local songs##2##2##(2008-8#2)
local strain##2##2##(2008-10#1)(2009-11#1)
local students##3##2##(2008-11#3)
local study##2##2##(1990-6#1)(2008-10#1)
local symmetries in##2##3##(2010-8#2)
local symmetries##3##2##(2010-8#3)
local system##2##2##(2008-10#2)
local systems##2##2##(2011-9#2)
local tissue##3##2##(1993-1#1)(2008-5#1)(2008-6#1)
local toxicity##2##2##(1997-3#1)(2008-5#1)
local treatment##2##2##(1990-11#1)(2011-2#1)
local tumor##3##2##(2008-11#2)(2013-8#1)
local variations in##2##3##(1992-9#1)(2010-3#1)
local vascular##2##2##(2009-8#1)(2010-10#1)
local##708##1##(1990-11#6)(1990-2#3)(1990-3#4)(1990-5#5)(1990-6#6)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#6)(1991-3#3)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#3)(1992-12#11)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#21)(1993-11#7)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#9)(1994-3#3)(1994-6#3)(1994-8#1)(1995-12#8)(1995-2#3)(1995-3#6)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#10)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#9)(1996-3#11)(1996-6#6)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#10)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#6)(2006-6#1)(2007-12#2)(2008-1#5)(2008-10#102)(2008-11#38)(2008-12#20)(2008-2#2)(2008-3#15)(2008-4#2)(2008-5#10)(2008-6#5)(2008-7#16)(2008-8#73)(2008-9#36)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#8)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#1)(2010-8#6)(2010-9#1)(2011-2#24)(2011-3#2)(2011-9#8)(2012-12#3)(2012-2#7)(2012-3#9)(2012-7#4)(2013-1#29)(2013-8#11)
local-regional##2##1##(1992-12#2)
localisation of##3##2##(1991-3#1)(2008-11#1)(2011-1#1)
localisation##10##1##(1991-3#1)(2008-11#4)(2010-12#2)(2011-1#1)(2011-2#2)
localise##3##1##(2008-11#1)(2009-7#1)(2012-2#1)
localised on the##2##3##(1995-11#1)(1996-6#1)
localised pain##3##2##(1997-4#3)
localised##14##1##(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-4#3)(1997-8#1)(2008-11#2)(2010-10#1)(2012-2#2)
localities in##4##2##(2008-6#1)(2011-2#2)(2012-12#1)
localities##10##1##(1995-5#1)(2008-6#1)(2008-8#4)(2011-2#2)(2012-12#1)(2013-8#1)
locality##5##1##(1990-8#1)(2008-11#2)(2008-5#1)(2012-3#1)
localization and a##2##3##(1993-12#1)(1994-8#1)
localization and expression##2##3##(1996-6#1)(2012-3#1)
localization and function of##2##4##(2008-1#1)(2010-5#1)
localization and##14##2##(1991-3#1)(1993-12#1)(1994-8#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-5#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
localization in the##2##3##(1990-3#1)(1996-12#1)
localization in##6##2##(1990-3#1)(1993-6#1)(1996-12#2)(1996-6#1)(2008-9#1)
localization is##3##2##(1994-5#1)(2008-7#1)(2012-2#1)
localization of AID##2##3##(2011-2#2)
localization of a##6##3##(1991-10#1)(1995-12#1)(1996-2#1)(1997-1#1)(2007-12#2)
localization of basic fibroblast growth factor in##2##7##(1992-3#1)(1995-12#1)
localization of hair keratin homologs##2##5##(2011-2#2)
localization of the##7##3##(1994-5#1)(1996-2#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)
localization of these##3##3##(1993-3#1)(1996-6#1)(2008-10#1)
localization of##94##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-6#3)(1991-9#1)(1992-3#3)(1992-6#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#3)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-5#1)(2009-8#5)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#1)
localization or##2##2##(1997-8#1)(2008-10#1)
localization pattern of##2##3##(1990-3#1)(2008-11#1)
localization pattern##3##2##(1990-3#2)(2008-11#1)
localization patterns##2##2##(2008-11#1)(2009-8#1)
localization signal##7##2##(1994-11#4)(1995-2#1)(1997-7#1)(2011-2#1)
localization technique##2##2##(1993-11#1)(2008-10#1)
localization to the##3##3##(1990-12#1)(1996-12#1)(2008-9#1)
localization to##5##2##(1990-12#1)(1992-10#1)(1996-12#1)(2008-10#1)(2008-9#1)
localization was##3##2##(1996-6#1)(2012-2#1)(2013-1#1)
localization##182##1##(1990-12#1)(1990-3#4)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#3)(1991-9#1)(1992-10#1)(1992-3#3)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#4)(1995-6#3)(1996-12#7)(1996-2#3)(1996-6#5)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#10)(2009-5#1)(2009-8#6)(2010-11#1)(2010-3#1)(2010-5#4)(2010-7#1)(2010-8#1)(2011-2#14)(2012-2#14)(2012-3#2)(2013-1#4)
localizations##5##1##(1991-8#1)(1994-12#1)(1994-2#1)(2011-2#1)(2012-2#1)
localize the##10##2##(1990-11#1)(1991-6#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(2008-10#1)(2013-1#1)
localize##33##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-6#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-2#3)(1995-6#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-8#2)(2011-2#3)(2012-2#1)(2013-1#1)
localized and##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
localized approximation to speed up##2##5##(2008-3#2)
localized approximation to##3##3##(2008-3#3)
localized at the##2##3##(1991-5#1)(2008-10#1)
localized at##3##2##(1991-5#1)(2008-10#1)(2008-11#1)
localized both##2##2##(1996-12#1)(2008-11#1)
localized brain##2##2##(1991-2#1)(1996-2#1)
localized cell##2##2##(2008-10#2)
localized changes##2##2##(2008-10#1)(2008-9#1)
localized in different##2##3##(1995-6#1)(2008-10#1)
localized in the##12##3##(1990-5#1)(1991-9#1)(1992-6#1)(1995-2#1)(1997-8#1)(2008-10#3)(2008-5#1)(2010-2#1)(2012-3#1)(2013-1#1)
localized in##30##2##(1990-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#2)
localized inoculation##2##2##(2008-10#2)
localized inside##2##2##(2008-10#1)(2008-5#1)
localized mainly in##2##3##(2008-9#1)(2009-10#1)
localized necrosis##2##2##(2008-10#2)
localized on##5##2##(1991-5#1)(1995-6#1)(2008-5#2)(2011-2#1)
localized only in the##2##4##(2008-10#1)(2008-5#1)
localized only in##3##3##(2008-10#2)(2008-5#1)
localized prostate cancer##3##3##(2008-7#2)(2013-1#1)
localized prostate##4##2##(2008-7#2)(2011-2#1)(2013-1#1)
localized resistance##3##2##(2008-10#3)
localized scleroderma##6##2##(2011-2#6)
localized surface##2##2##(2008-10#1)(2012-2#1)
localized the##2##2##(1995-6#1)(2008-9#1)
localized to chromosome##2##3##(1996-3#1)(1997-7#1)
localized to the##17##3##(1991-11#1)(1992-10#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-8#1)(1997-1#1)(1997-7#2)(2008-10#1)(2008-11#1)(2009-8#1)
localized to##30##2##(1991-11#1)(1992-10#1)(1992-7#1)(1993-6#3)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#2)
localized within##4##2##(1994-11#1)(2008-10#2)(2009-10#1)
localized##180##1##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#6)(1995-5#1)(1995-6#6)(1995-8#1)(1996-12#5)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#1)(2008-10#42)(2008-11#5)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#8)(2009-10#3)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
localizes at the##2##3##(1991-5#1)(2008-8#1)
localizes##3##1##(1991-5#1)(2008-8#1)(2011-2#1)
localizing##8##1##(1995-6#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-8#1)(2009-9#1)
locally adapted##2##2##(2008-9#2)
locally adaptive##2##2##(2008-9#1)(2012-3#1)
locally advanced breast cancer with an inflammatory component##2##8##(1991-8#2)
locally advanced breast cancer##7##4##(1991-8#6)(1993-11#1)
locally advanced breast##8##3##(1991-8#6)(1993-11#1)(2013-8#1)
locally advanced disease##2##3##(1992-3#1)(1997-7#1)
locally advanced head and neck##3##5##(1990-6#2)(1993-9#1)
locally advanced stage III##2##4##(2008-10#2)
locally advanced vulvar##2##3##(1992-3#2)
locally advanced##29##2##(1990-12#1)(1990-6#4)(1991-8#6)(1992-3#4)(1993-11#1)(1993-9#1)(1994-6#1)(1995-10#1)(1997-7#1)(2008-10#5)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
locally aggressive##2##2##(2008-7#1)(2010-3#1)
locally and systemically##2##3##(2008-10#1)(2010-12#1)
locally and##5##2##(1991-6#1)(2008-10#1)(2008-6#1)(2010-12#1)(2013-1#1)
locally by##2##2##(1992-3#1)(2008-10#1)
locally in the##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
locally in##5##2##(2007-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
locally independent##2##2##(2011-2#2)
locally invasive##2##2##(1997-7#1)(1997-8#1)
locally on##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
locally produced##2##2##(2012-2#1)(2013-8#1)
locally##95##1##(1990-12#1)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#6)(1992-12#1)(1992-3#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-10#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#6)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
locate in the##2##3##(2008-7#1)(2008-8#1)
locate in##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
locate##18##1##(1990-11#2)(1992-3#1)(1994-9#1)(1995-12#3)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)
located a##2##2##(2008-2#1)(2008-3#1)
located almost##2##2##(1997-6#1)(2008-10#1)
located and##4##2##(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
located around the##2##3##(1995-8#1)(2011-2#1)
located as##3##2##(2008-10#2)(2009-8#1)
located at a##2##3##(1990-11#1)(2008-6#1)
located at both ends##2##4##(1995-6#1)(2008-8#1)
located at different##2##3##(2008-10#1)(2012-7#1)
located at nucleotide##2##3##(1990-7#1)(2008-10#1)
located at or near the##2##5##(2008-10#2)
located at the level of##2##5##(2008-7#1)(2012-2#1)
located at the upper side of the flow cell##2##9##(2008-10#2)
located at the##26##3##(1991-10#1)(1992-1#1)(1992-2#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-9#2)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
located at##57##2##(1990-11#1)(1990-7#1)(1991-10#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-9#2)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-8#3)
located below the##2##3##(2008-11#1)(2012-12#1)
located between the##7##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#2)(2012-12#2)
located between##13##2##(1992-8#1)(1993-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-3#2)(2010-6#1)(2012-12#2)(2012-2#1)
located close to the##3##4##(1994-12#1)(1996-6#1)(2011-2#1)
located from the##2##3##(1997-6#1)(2008-10#1)
located immediately##2##2##(1992-9#1)(2011-1#1)
located in a##6##3##(1994-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
located in its##2##3##(1995-6#1)(2008-7#1)
located in microbodies##2##3##(2011-1#2)
located in the cytoplasm##2##4##(1995-2#1)(2008-11#1)
located in the inner##2##4##(1990-11#1)(2008-11#1)
located in the middle of the##2##6##(1993-2#1)(2009-10#1)
located in the same##4##4##(2008-10#2)(2008-5#1)(2008-8#1)
located in the spheno-clival region##2##5##(2011-2#2)
located in the##80##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-9#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#10)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2013-1#2)(2013-8#3)
located in this##2##3##(1992-1#1)(2008-12#1)
located in##136##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-6#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#21)(2008-11#9)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#9)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#6)
located inside##2##2##(1995-9#1)(2008-10#1)
located mainly at the##2##4##(2008-10#1)(2008-5#1)
located mainly##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
located mostly##2##2##(2008-10#1)(2011-2#1)
located near the 3'##2##4##(2008-10#2)
located near the##7##3##(1997-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)
located near##13##2##(1997-9#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)(2013-8#1)
located nearby##2##2##(2008-10#2)
located on an##2##3##(2008-10#1)(2008-8#1)
located on chromosome##10##3##(1993-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)
located on the dorsal side##2##5##(2008-5#2)
located on the left arm of chromosome##4##7##(1993-9#1)(1995-9#1)(1996-3#1)(1996-6#1)
located on the left arm of##5##6##(1993-9#1)(1995-9#1)(1996-3#1)(1996-6#2)
located on the left##6##4##(1993-9#1)(1995-9#1)(1996-3#1)(1996-6#2)(2010-12#1)
located on the long arm of##2##6##(2008-10#2)
located on the plasma membrane of the##2##7##(2008-8#2)
located on the short arm of chromosome 1A##2##8##(2008-10#2)
located on the short arm of chromosome##3##7##(2008-10#2)(2012-3#1)
located on the##37##3##(1990-5#1)(1992-4#1)(1993-9#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#3)(1997-6#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#3)(2008-8#3)(2008-9#2)(2009-9#1)(2010-12#2)(2012-3#1)(2013-8#1)
located on##70##2##(1990-5#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#3)(1996-3#2)(1996-6#3)(1997-2#1)(1997-6#1)(1997-8#3)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#9)(2008-9#4)(2009-10#2)(2009-9#1)(2010-12#2)(2012-3#1)(2013-8#1)
located outside the radiotherapeutic target volume for four treatment situations##2##10##(1993-9#2)
located outside the##5##3##(1992-9#1)(1993-9#2)(2008-10#1)(2008-7#1)
located predominantly in##2##3##(1992-3#1)(2008-7#1)
located throughout the##2##3##(2008-12#1)(2013-1#1)
located upstream of##3##3##(1995-6#1)(1996-6#1)(2011-2#1)
located upstream##5##2##(1993-6#1)(1995-6#1)(1996-6#1)(2008-8#1)(2011-2#1)
located with##2##2##(2008-10#1)(2008-3#1)
located within a##3##3##(1992-4#1)(1995-6#1)(2008-12#1)
located within the##6##3##(1993-12#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
located within##14##2##(1992-4#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-3#1)(2012-3#1)
located##422##1##(1990-11#3)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-10#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#4)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#7)(1995-8#3)(1995-9#2)(1996-12#6)(1996-2#4)(1996-3#5)(1996-5#1)(1996-6#6)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#3)(1997-7#3)(1997-8#6)(1997-9#2)(2007-12#7)(2008-1#1)(2008-10#89)(2008-11#17)(2008-12#8)(2008-2#2)(2008-3#8)(2008-5#8)(2008-6#1)(2008-7#20)(2008-8#20)(2008-9#19)(2009-10#4)(2009-12#2)(2009-8#5)(2009-9#2)(2010-12#4)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#16)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#12)(2012-7#1)(2013-1#5)(2013-8#12)
locates##2##1##(1996-8#1)(2008-10#1)
locating and##2##2##(1993-12#1)(2008-11#1)
locating the##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
locating##12##1##(1990-5#1)(1993-12#1)(1993-9#1)(1995-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#2)
location and extent of##2##4##(1996-6#1)(2011-2#1)
location and size of the##2##5##(1993-6#1)(1995-11#1)
location and the##6##3##(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#3)
location and##39##2##(1993-6#1)(1995-11#1)(1995-5#1)(1996-1#3)(1996-6#1)(1997-8#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-2#2)(2013-1#3)
location as##3##2##(1991-12#1)(2008-11#1)(2009-5#1)
location distribution of the##2##4##(1991-6#2)
location factor##2##2##(1993-1#2)
location for##6##2##(1995-5#1)(1995-6#1)(2008-10#2)(2010-7#1)(2011-2#1)
location from##2##2##(2008-10#2)
location in the##7##3##(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#2)
location in which the arm##2##5##(1993-6#2)
location in##14##2##(1993-3#1)(1993-6#2)(1995-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#2)
location is##2##2##(1990-12#1)(1991-2#1)
location of a##3##3##(1994-3#1)(2008-4#1)(2008-8#1)
location of newly##2##3##(2008-1#1)(2008-10#1)
location of the AFC##2##4##(2011-2#2)
location of the fragrance##2##4##(2008-5#2)
location of the resistance##2##4##(2008-10#2)
location of the##35##3##(1991-2#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-8#1)(1997-9#1)(2006-6#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-5#3)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
location of these##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
location of this##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
location of##88##2##(1991-2#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(1997-9#2)(2006-6#1)(2008-1#1)(2008-10#24)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
location on##2##2##(2008-10#2)
location to##2##2##(1996-12#1)(2008-10#1)
location was##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
location where##3##2##(2008-10#2)(2008-12#1)
location within the##2##3##(2008-12#1)(2012-2#1)
location within##4##2##(2008-11#2)(2008-12#1)(2012-2#1)
location##275##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-6#4)(1992-12#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#2)(1993-3#1)(1993-6#3)(1994-1#3)(1994-11#1)(1994-2#1)(1994-3#4)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#3)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#65)(2008-11#24)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#18)(2012-12#5)(2012-2#10)(2012-3#4)(2013-1#16)(2013-8#3)
location-specific##2##1##(2008-10#1)(2013-1#1)
location-years##3##1##(2008-10#3)
locations across##3##2##(1995-2#1)(2008-10#2)
locations and years##2##3##(2008-10#2)
locations and##12##2##(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)
locations around##2##2##(2008-10#1)(2008-5#1)
locations as logic##2##3##(2008-3#2)
locations as##4##2##(1997-6#1)(2008-3#2)(2012-3#1)
locations by##2##2##(2008-10#1)(2009-5#1)
locations in Germany##2##3##(2008-10#2)
locations in Michigan##2##3##(2008-10#2)
locations in eastern North##2##4##(2008-10#2)
locations in eastern##3##3##(2008-10#3)
locations in the United States and##2##6##(2008-10#2)
locations in the United States##3##5##(2008-10#3)
locations in the##9##3##(1992-3#1)(1997-6#1)(2008-10#5)(2008-5#1)(2011-2#1)
locations in##39##2##(1991-7#1)(1992-3#1)(1997-6#1)(2008-10#33)(2008-5#1)(2011-2#1)(2012-2#1)
locations is##2##2##(1995-1#1)(2008-8#1)
locations of the##6##3##(2008-10#3)(2008-3#1)(2012-12#1)(2013-1#1)
locations of##23##2##(1990-9#1)(1994-5#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#2)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
locations on##5##2##(1993-6#2)(2008-10#2)(2009-7#1)
locations over##2##2##(2008-10#2)
locations ranged from 0##2##4##(2008-10#2)
locations sampled in##2##3##(2008-10#2)
locations sampled##4##2##(2008-10#4)
locations throughout the world##2##4##(2008-10#1)(2011-1#1)
locations throughout the##3##3##(2008-10#2)(2011-1#1)
locations throughout##5##2##(2008-10#3)(2008-8#1)(2011-1#1)
locations was##4##2##(2008-10#4)
locations were##11##2##(1990-8#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2013-8#2)
locations where##3##2##(2008-10#2)(2009-5#1)
locations with##3##2##(1993-6#1)(2008-10#2)
locations within the##2##3##(2008-10#2)
locations within##4##2##(2008-10#3)(2011-1#1)
locations worldwide##3##2##(2008-10#3)
locations##241##1##(1990-8#1)(1990-9#1)(1991-7#1)(1992-3#1)(1993-6#3)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#3)(1997-8#1)(2008-10#143)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#10)(2008-8#10)(2008-9#3)(2009-1#2)(2009-5#3)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#5)
loci A##2##2##(2008-10#2)
loci across the##2##3##(2008-10#1)(2012-3#1)
loci and the##2##3##(2008-10#2)
loci and##17##2##(1993-6#1)(1996-6#1)(2008-10#10)(2008-9#1)(2012-3#3)(2013-8#1)
loci are required##2##3##(1994-9#1)(2008-12#1)
loci are##7##2##(1994-9#1)(2008-10#1)(2008-12#2)(2009-10#1)(2011-2#1)(2012-3#1)
loci as##3##2##(1993-3#1)(2008-10#1)(2012-3#1)
loci between##2##2##(2008-10#1)(2008-12#1)
loci conditioning##2##2##(2008-10#2)
loci conferring##2##2##(2008-10#1)(2008-8#1)
loci detected by the same##2##5##(2008-9#2)
loci detected by##3##3##(2008-9#3)
loci determine##2##2##(2008-10#1)(2008-8#1)
loci for##6##2##(2008-10#5)(2009-10#1)
loci from##2##2##(2008-10#1)(2008-12#1)
loci in the##2##3##(2008-10#1)(2008-4#1)
loci in##15##2##(1996-6#1)(2008-10#5)(2008-12#2)(2008-4#1)(2008-9#3)(2011-2#1)(2012-3#2)
loci makes##2##2##(2008-8#2)
loci of the##4##3##(1995-5#1)(1996-8#1)(2008-12#2)
loci of##10##2##(1995-2#1)(1995-5#2)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#3)
loci on##2##2##(2008-10#2)
loci that have##2##3##(2011-2#1)(2012-3#1)
loci that##6##2##(1991-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#2)
loci to##5##2##(1995-6#1)(2008-10#3)(2008-9#1)
loci using##2##2##(2008-10#1)(2008-12#1)
loci was##9##2##(2008-10#6)(2008-9#1)(2011-2#1)(2012-3#1)
loci were detected##2##3##(2008-10#1)(2008-12#1)
loci were##23##2##(1997-9#1)(2008-10#13)(2008-12#3)(2008-8#1)(2008-9#1)(2010-7#1)(2013-8#3)
loci with##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
loci within the##2##3##(1990-9#1)(2008-12#1)
loci##291##1##(1990-9#1)(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-8#1)(1994-9#3)(1995-11#3)(1995-2#1)(1995-5#2)(1995-6#2)(1996-6#2)(1996-8#2)(1997-8#2)(1997-9#1)(2008-10#138)(2008-11#7)(2008-12#26)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#14)(2008-9#19)(2009-10#3)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-2#6)(2012-3#30)(2012-5#1)(2013-1#1)(2013-8#8)
loci&quot##3##1##(2008-10#2)(2008-7#1)
lock##5##1##(2008-11#1)(2008-2#3)(2008-3#1)
lock-in##6##1##(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#2)
locked in##2##2##(1995-8#1)(2012-2#1)
locked##9##1##(1995-8#1)(2008-11#1)(2008-3#4)(2008-5#1)(2009-9#1)(2012-2#1)
locking of the knee##2##4##(2008-11#2)
locking of##4##2##(2008-11#2)(2008-3#2)
locking plate##2##2##(2008-9#2)
locking plates##2##2##(2008-9#2)
locking##25##1##(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#10)(2008-8#2)(2008-9#4)(2012-3#1)
locks##2##1##(1996-5#1)(2008-11#1)
loco-regional##4##1##(1990-12#2)(1990-3#1)(2012-2#1)
locomotion consumed##2##2##(2008-9#2)
locomotion data##3##2##(2013-1#3)
locomotion in##2##2##(1993-3#1)(1993-6#1)
locomotion of rats with a##2##5##(1993-3#2)
locomotion##26##1##(1991-2#1)(1993-3#7)(1993-6#2)(1994-2#2)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#6)(2013-1#4)
locomotor activity and##3##3##(1993-6#1)(2008-7#1)(2013-1#1)
locomotor activity##12##2##(1990-9#1)(1993-6#3)(1994-8#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
locomotor behaviour##2##2##(1993-12#1)(1994-3#1)
locomotor response to novelty##3##4##(1993-6#3)
locomotor response to##5##3##(1993-6#5)
locomotor response##6##2##(1993-6#6)
locomotor##38##1##(1990-9#1)(1992-12#1)(1993-12#1)(1993-3#4)(1993-6#9)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-2#4)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2010-8#2)(2013-1#2)
locomotory##4##1##(1991-2#1)(1993-3#1)(2007-12#1)(2008-8#1)
locoregional control##2##2##(1994-12#1)(1996-10#1)
locoregional recurrence##2##2##(1993-11#1)(2009-2#1)
locoregional##9##1##(1993-11#3)(1994-12#1)(1996-10#1)(2009-2#1)(2011-3#2)(2012-2#1)
locum##2##1##(1992-8#1)(2012-12#1)
locus and##5##2##(1995-2#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
locus by##2##2##(1996-8#1)(2008-8#1)
locus coeruleus##6##2##(1994-2#1)(1996-12#1)(1996-5#2)(2008-7#2)
locus conditioning##2##2##(2008-10#2)
locus for##7##2##(1994-12#1)(2008-10#3)(2008-11#1)(2009-10#1)(2011-1#1)
locus from H 7998##2##4##(2008-10#2)
locus from##4##2##(1997-3#1)(2008-10#3)
locus had##2##2##(2008-10#1)(2008-12#1)
locus haplotypes##2##2##(2008-10#2)
locus has##2##2##(1997-7#1)(1997-9#1)
locus identified##2##2##(2008-10#2)
locus in the##3##3##(2008-10#2)(2008-11#1)
locus in##9##2##(2008-10#6)(2008-11#1)(2008-9#1)(2010-8#1)
locus is##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)
locus of control##4##3##(1996-2#4)
locus of the##3##3##(1991-6#1)(1996-8#1)(2010-8#1)
locus of##17##2##(1991-2#1)(1991-6#1)(1995-12#1)(1995-2#2)(1996-2#4)(1996-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-3#1)
locus on chromosome 14##2##4##(1996-2#1)(2011-2#1)
locus on chromosome##14##3##(1991-10#1)(1993-11#1)(1994-9#1)(1996-2#1)(1996-6#2)(1997-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#2)
locus on human chromosome##4##4##(1990-5#1)(1995-8#1)(2008-9#1)(2012-3#1)
locus on the##3##3##(1996-12#2)(2008-10#1)
locus on##23##2##(1990-5#1)(1991-10#1)(1993-11#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#2)(1997-2#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-3#1)
locus or##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
locus showed##2##2##(1996-2#1)(2008-10#1)
locus that##4##2##(2008-10#3)(2010-5#1)
locus to##3##2##(2008-10#3)
locus was designated as##2##4##(2008-10#2)
locus was mapped to##2##4##(2008-10#1)(2008-8#1)
locus was##12##2##(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-8#1)
locus were##6##2##(1997-3#1)(2008-10#2)(2009-10#2)(2009-8#1)
locus with##5##2##(1995-5#1)(2008-10#4)
locus##259##1##(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-12#2)(1995-2#6)(1995-5#2)(1995-6#4)(1995-8#2)(1996-12#8)(1996-2#8)(1996-5#3)(1996-6#4)(1996-8#4)(1997-2#2)(1997-3#8)(1997-7#3)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#102)(2008-11#4)(2008-12#7)(2008-2#4)(2008-5#1)(2008-7#3)(2008-8#15)(2008-9#14)(2009-10#8)(2009-8#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-3#7)(2013-1#1)(2013-8#3)
locus)##3##1##(1996-3#1)(2008-11#1)(2008-8#1)
locust ventral##2##2##(1994-2#2)
locust##10##1##(1994-2#3)(2007-12#7)
lodgepole pine##2##2##(2008-10#2)
lodging##3##1##(2008-10#2)(2011-2#1)
lofexidine##3##1##(2008-11#3)
loft##3##1##(1990-11#3)
log 4##2##2##(2008-10#1)(2008-5#1)
log CFU + 1 per g of soil##2##8##(2008-10#2)
log K##4##2##(1992-9#1)(2008-10#3)
log K(ex) was##2##3##(2008-10#2)
log K(ex)##6##2##(2008-10#6)
log S and J'##2##4##(2008-8#2)
log S and##3##3##(2008-8#3)
log S##4##2##(2008-8#4)
log beta (CaF##2##3##(2008-10#2)
log c##2##2##(2008-10#2)
log degrees##2##2##(2008-10#2)
log of the##2##3##(2008-10#2)
log of##5##2##(1995-8#1)(2008-10#3)(2008-8#1)
log ratios##2##2##(2008-10#2)
log units##2##2##(2008-10#2)
log##62##1##(1990-5#2)(1991-9#2)(1992-9#1)(1995-12#1)(1995-8#1)(2008-10#38)(2008-5#2)(2008-7#1)(2008-8#6)(2009-11#1)(2009-6#1)(2009-7#2)(2012-2#2)(2013-1#2)
log(10) TCID(50)/ml##2##2##(2008-11#2)
log(10) copies/mL##2##2##(2013-1#2)
log(10)##7##1##(2008-10#3)(2008-11#2)(2013-1#2)
log-likelihood ratio##2##2##(2008-10#2)
log-likelihood##5##1##(2008-10#2)(2008-3#1)(2010-5#2)
log-linear##4##1##(2008-10#2)(2008-8#1)(2013-1#1)
log-linearity##2##1##(2008-11#2)
log-log plots##3##2##(2008-10#3)
log-log transformation of incidence##2##4##(2008-10#2)
log-log##7##1##(2008-10#6)(2008-9#1)
log-normal distribution##2##2##(2008-10#1)(2008-3#1)
log-normal##5##1##(1992-2#2)(2008-10#1)(2008-3#2)
log-rank##3##1##(1993-2#1)(2011-2#1)(2012-3#1)
log-scale##3##1##(2012-2#3)
log-transformed##3##1##(2008-10#1)(2009-1#1)(2013-1#1)
log10##3##1##(2008-10#2)(2013-1#1)
logD(M) versus##2##2##(2008-10#2)
logK values##2##2##(2008-10#2)
logK##3##1##(2008-10#3)
logK(D##2##1##(2008-10#2)
logK(H*)##2##1##(2008-10#2)
logK(ex(10))##2##1##(2008-10#2)
logK(ex)##2##1##(2008-10#2)
logK(s)(ZrO(2)-MgO)##2##1##(2008-10#2)
logK=2##2##1##(2008-10#2)
logMAR lines##2##2##(2011-2#2)
logMAR##3##1##(2011-2#3)
logarithm of the initial concentration of##2##6##(2008-10#2)
logarithm of the##12##3##(2008-10#11)(2008-5#1)
logarithm of##28##2##(2008-10#24)(2008-5#1)(2008-8#1)(2009-7#2)
logarithm##29##1##(2008-10#25)(2008-5#1)(2008-8#1)(2009-7#2)
logarithmic distribution##2##2##(2008-10#2)
logarithmic extraction constant##2##3##(2008-10#2)
logarithmic harmonic filter can##2##4##(2008-3#2)
logarithmic harmonic##3##2##(2008-3#3)
logarithmic##19##1##(2008-10#8)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-2#1)
logarithms of##2##2##(2008-10#1)(2008-7#1)
logbeta##3##1##(2008-10#3)
logbeta(1##6##1##(2008-10#6)
logic and##2##2##(2008-12#1)(2008-8#1)
logic models from##2##3##(2009-11#2)
logic of##5##2##(2008-8#3)(2009-5#1)(2010-11#1)
logic##21##1##(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-8#4)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-2#2)(2013-1#1)
logical##18##1##(1991-5#1)(1991-9#1)(1992-2#1)(1993-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2013-1#1)(2013-8#2)
logically##3##1##(1994-8#1)(2008-10#1)(2010-12#1)
logistic analysis##2##2##(2008-10#1)(2013-1#1)
logistic and exponential models best described the##2##7##(2008-10#2)
logistic equations##3##2##(2008-11#3)
logistic function##2##2##(1992-9#1)(2008-10#1)
logistic growth##4##2##(2008-9#1)(2012-2#1)(2013-8#2)
logistic model was##2##3##(2008-10#1)(2008-11#1)
logistic model##8##2##(2008-10#6)(2008-11#1)(2012-2#1)
logistic regression analyses##3##3##(2010-11#1)(2011-2#1)(2013-1#1)
logistic regression analysis of##6##4##(2008-10#3)(2008-11#1)(2012-3#2)
logistic regression analysis showed that##2##5##(2008-11#2)
logistic regression analysis showed##3##4##(2008-11#2)(2008-3#1)
logistic regression analysis##21##3##(2008-10#5)(2008-11#6)(2008-3#1)(2008-7#1)(2010-7#1)(2012-2#2)(2012-3#3)(2013-8#2)
logistic regression model was##2##4##(2008-11#1)(2011-2#1)
logistic regression model##9##3##(2008-10#2)(2008-11#1)(2009-5#1)(2010-5#1)(2011-2#4)
logistic regression models##6##3##(2008-10#3)(2009-5#1)(2010-12#1)(2013-1#1)
logistic regression was used to estimate##2##6##(2008-8#1)(2011-2#1)
logistic regression was used##3##4##(1994-12#1)(2008-8#1)(2011-2#1)
logistic regression was##4##3##(1994-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
logistic regression were##2##3##(2013-1#1)(2013-8#1)
logistic regression with##2##3##(2011-2#1)(2013-8#1)
logistic regression##62##2##(1991-3#1)(1992-9#1)(1994-12#1)(2008-10#15)(2008-11#8)(2008-3#1)(2008-7#2)(2008-8#2)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#4)
logistic##97##1##(1991-12#2)(1991-3#1)(1992-9#3)(1994-12#1)(2008-10#31)(2008-11#12)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#7)
logistical##3##1##(1993-2#1)(2008-11#1)(2010-11#1)
logistics of##2##2##(1995-2#1)(2008-11#1)
logistics##4##1##(1993-2#1)(1995-2#1)(1995-5#1)(2008-11#1)
lognormal species abundance##2##3##(2008-8#2)
lognormal##4##1##(2008-8#4)
logs as##2##2##(2008-10#1)(2013-1#1)
logs##11##1##(1992-12#1)(2008-10#4)(2012-2#3)(2013-1#3)
logs)##2##1##(2013-1#2)
lomefloxacin##4##1##(2008-10#4)
loneliness##3##1##(2009-12#1)(2009-9#1)(2011-2#1)
long 5'-untranslated region##2##3##(1993-12#1)(1997-7#1)
long DNA##3##2##(2008-11#3)
long Homer##2##2##(2008-11#2)
long PCR products##2##3##(1996-6#2)
long ago##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
long alkyl chains##2##3##(2008-5#1)(2011-2#1)
long alkyl##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
long and##26##2##(1992-12#1)(1993-2#2)(1993-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
long arm of##14##3##(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-9#1)(2010-7#1)(2012-12#1)
long arm##17##2##(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#8)(2008-12#3)(2008-9#1)(2010-7#1)(2012-12#1)
long as a##2##3##(1996-6#1)(2012-3#1)
long as##29##2##(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-3#1)
long axis view) (p &lt##2##5##(2008-10#2)
long axis##5##2##(2008-10#3)(2009-10#1)(2009-11#1)
long been implicated in the##2##5##(2008-11#1)(2008-7#1)
long been implicated in##3##4##(2008-11#1)(2008-7#1)(2009-6#1)
long been known##3##3##(2008-9#1)(2010-7#1)(2012-2#1)
long been recognized##5##3##(2008-11#2)(2008-5#1)(2010-1#1)(2013-1#1)
long been thought to##2##4##(1996-12#1)(2010-12#1)
long been used##2##3##(2008-10#1)(2008-11#1)
long been##37##2##(1993-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#3)
long before the##3##3##(2008-10#2)(2009-12#1)
long before##4##2##(2008-10#2)(2009-12#1)(2013-8#1)
long bone fractures##2##3##(2009-3#1)(2013-1#1)
long bone##5##2##(2009-3#1)(2010-6#2)(2013-1#2)
long bones##6##2##(2007-8#1)(2008-11#1)(2008-12#1)(2009-1#1)(2010-6#1)(2011-2#1)
long calls##4##2##(2008-8#4)
long chain fatty acid##3##4##(1992-3#1)(1993-8#1)(2008-10#1)
long chain fatty acids##2##4##(2008-10#2)
long chain fatty##5##3##(1992-3#1)(1993-8#1)(2008-10#3)
long chain##13##2##(1992-3#1)(1992-8#1)(1993-8#2)(1995-6#3)(2008-10#3)(2008-7#1)(2009-6#1)(2012-2#1)
long daylengths##3##2##(2012-3#3)
long distance##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
long distances in##3##3##(2008-10#2)(2008-11#1)
long distances##11##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#1)
long duration of action##2##4##(1996-2#1)(2008-11#1)
long duration##6##2##(1991-2#1)(1996-2#1)(2008-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
long enough for##2##3##(2012-12#1)(2013-1#1)
long enough to##2##3##(1993-8#1)(2008-10#1)
long enough##5##2##(1993-8#1)(2008-10#2)(2012-12#1)(2013-1#1)
long exposure to##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
long fatty acid chain##2##4##(1993-8#2)
long fiber##3##2##(2007-12#1)(2008-3#2)
long for##2##2##(2008-11#1)(2008-9#1)
long glume awn##2##3##(2008-10#2)
long half life##2##3##(2008-10#1)(2008-9#1)
long held##2##2##(2008-10#1)(2008-11#1)
long history of##7##3##(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
long history##10##2##(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
long journey##2##2##(2012-2#2)
long lasting##8##2##(1990-9#1)(1993-2#1)(2008-10#3)(2008-7#1)(2010-9#1)(2012-2#1)
long latency responses##2##3##(1996-5#2)
long latency##3##2##(1995-2#1)(1996-5#2)
long life##3##2##(2008-10#2)(2008-9#1)
long lifetime##3##2##(2008-10#3)
long lived##2##2##(2008-10#1)(2008-9#1)
long open reading frame##2##4##(1990-5#1)(2008-9#1)
long operation##2##2##(2008-7#2)
long path length spectroelectrochemical##2##4##(2008-10#2)
long pathlength##5##2##(2008-10#5)
long period of##3##3##(2008-9#1)(2010-6#1)(2012-7#1)
long period##10##2##(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#1)(2012-7#1)
long periodicity##2##2##(1993-3#1)(2008-5#1)
long periods of##7##3##(1995-1#1)(2008-1#1)(2008-10#3)(2008-11#2)
long periods##10##2##(1995-1#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-5#1)
long pulse##2##2##(1991-2#2)
long pulses##2##2##(2008-2#1)(2008-3#1)
long run##7##2##(1996-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2009-12#1)(2010-4#1)(2013-8#1)
long shelf-life ultra-high temperature##2##4##(2013-1#2)
long span partially edentulous maxilla with##2##6##(2013-1#2)
long span partially edentulous##3##4##(2013-1#3)
long survival##3##2##(1991-8#1)(2008-7#2)
long survivors##2##2##(1991-12#2)
long term care insurance##2##4##(1993-3#2)
long term care##9##3##(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(2008-12#2)
long term effects of##2##4##(1990-5#1)(2008-11#1)
long term in##3##3##(2008-11#1)(2008-8#1)(2010-12#1)
long term prognosis is##2##4##(1996-9#1)(2010-7#1)
long term stability and##2##4##(2008-10#1)(2008-5#1)
long term stability##7##3##(2008-10#5)(2008-5#2)
long term survival##4##3##(2010-7#2)(2013-1#2)
long term treatment with##2##4##(1996-3#1)(2008-7#1)
long term##77##2##(1990-2#1)(1990-5#1)(1992-1#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#14)(2008-11#5)(2008-12#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2010-12#1)(2010-7#3)(2011-2#4)(2011-3#2)(2012-2#2)(2013-1#6)(2013-8#3)
long terminal repeat##11##3##(1992-12#1)(1993-8#2)(1994-12#1)(1994-5#1)(1995-6#2)(1997-8#1)(2008-5#1)(2008-9#1)(2012-3#1)
long terminal##14##2##(1992-12#1)(1993-8#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#2)(1997-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
long time series##2##3##(2008-8#1)(2008-9#1)
long time##19##2##(1990-5#1)(1991-11#1)(1993-8#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-7#1)
long treatment##2##2##(2008-12#1)(2010-11#1)
long tubular##2##2##(2007-12#1)(2008-11#1)
long wavelength##5##2##(2006-6#1)(2008-10#3)(2011-7#1)
long with a##2##3##(1993-3#1)(2008-7#1)
long##638##1##(1990-2#1)(1990-5#4)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#7)(1991-3#1)(1991-8#3)(1992-1#2)(1992-12#7)(1992-3#9)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#6)(1993-6#1)(1993-8#11)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-5#1)(1995-6#9)(1996-1#3)(1996-12#4)(1996-2#5)(1996-3#4)(1996-5#2)(1996-6#5)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#6)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#4)(2006-6#1)(2007-11#2)(2007-12#8)(2007-8#1)(2008-1#3)(2008-10#131)(2008-11#46)(2008-12#10)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#17)(2008-6#4)(2008-7#26)(2008-8#25)(2008-9#25)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#5)(2009-3#2)(2009-6#2)(2009-7#2)(2009-8#5)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#5)(2010-7#11)(2010-8#3)(2010-9#1)(2011-2#41)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#14)(2012-3#9)(2012-7#1)(2013-1#25)(2013-8#12)
long)##3##1##(2008-10#3)
long- and short-term##2##3##(2008-10#1)(2010-5#1)
long-##3##1##(2008-10#1)(2009-8#1)(2010-5#1)
long-acting##9##1##(1997-1#2)(1997-4#1)(2008-11#1)(2009-9#4)(2013-1#1)
long-chain acyl-CoA esters##3##3##(1994-8#3)
long-chain acyl-CoA##9##2##(1990-5#1)(1994-8#8)
long-chain fatty acids and##2##4##(2008-5#1)(2013-1#1)
long-chain fatty acids##6##3##(1990-5#1)(2008-4#1)(2008-5#3)(2013-1#1)
long-chain##28##1##(1990-5#2)(1991-5#2)(1993-3#1)(1994-8#10)(1995-2#1)(2008-10#5)(2008-4#1)(2008-5#4)(2010-3#1)(2013-1#1)
long-chained marine##2##2##(2013-1#2)
long-chained##3##1##(2008-10#1)(2013-1#2)
long-day flowering##2##2##(2009-8#2)
long-day##3##1##(2009-8#3)
long-distance dispersal##5##2##(2008-10#4)(2008-9#1)
long-distance movement of##3##3##(2008-10#3)
long-distance movement##6##2##(2008-10#6)
long-distance transport of G##2##4##(2008-10#2)
long-distance transport of##3##3##(2008-10#3)
long-distance transport##4##2##(2008-10#3)(2012-8#1)
long-distance##22##1##(1993-2#1)(2008-10#16)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-8#1)
long-duration or##2##2##(2010-1#2)
long-duration##4##1##(1991-2#2)(2010-1#2)
long-haul##2##1##(2007-12#1)(2008-3#1)
long-lasting effects##2##2##(1991-12#1)(1995-12#1)
long-lasting in vitro hematopoiesis##4##4##(2009-12#4)
long-lasting##17##1##(1991-12#1)(1991-2#2)(1992-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#2)(2009-12#4)(2010-1#1)
long-lived elderly person##2##3##(2012-3#2)
long-lived elderly##3##2##(2012-3#3)
long-lived##16##1##(1991-5#2)(1995-12#1)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#1)(2012-2#1)(2012-3#3)(2012-5#1)
long-period fiber gratings##3##3##(2007-12#2)(2008-3#1)
long-period fiber##4##2##(2007-12#2)(2008-3#2)
long-period grating##2##2##(2008-10#1)(2008-3#1)
long-period gratings##4##2##(2007-11#4)
long-period##11##1##(2007-11#4)(2007-12#2)(2008-10#1)(2008-3#4)
long-range interactions##2##2##(2012-2#2)
long-range restriction##2##2##(2008-4#2)
long-range##15##1##(1993-1#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#2)(2008-9#1)(2012-2#3)
long-standing Parkinson's disease##2##3##(2008-7#2)
long-standing##16##1##(1990-12#1)(1993-6#1)(1997-1#1)(2008-10#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
long-tailed tits Aegithalos caudatus##2##4##(2008-8#2)
long-term administration of propranolol in##2##5##(2009-8#2)
long-term administration of##3##3##(2008-10#1)(2009-8#2)
long-term and residential care##2##4##(1997-1#2)
long-term and##4##2##(1993-3#1)(1997-1#2)(2011-2#1)
long-term benefits of##2##3##(2008-12#1)(2012-2#1)
long-term benefits##5##2##(2008-12#3)(2010-12#1)(2012-2#1)
long-term care (LTC) programs##2##4##(1994-2#1)(1995-2#1)
long-term care (LTC)##9##3##(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1997-3#1)(2008-7#1)(2010-10#1)
long-term care administration##2##3##(1992-3#1)(1993-3#1)
long-term care administrators##2##3##(1992-3#1)(2009-4#1)
long-term care and##2##3##(2008-12#1)(2013-1#1)
long-term care facilities in##2##4##(1994-12#1)(1997-1#1)
long-term care facilities##7##3##(1991-1#1)(1991-3#1)(1993-3#1)(1994-12#1)(1997-1#2)(1997-2#1)
long-term care for the##2##4##(1991-2#1)(1993-3#1)
long-term care for##3##3##(1991-2#1)(1993-3#1)(1996-2#1)
long-term care policy##2##3##(1997-2#1)(2009-3#1)
long-term care research##2##3##(2009-4#2)
long-term care services##2##3##(1991-3#1)(1995-3#1)
long-term care settings##4##3##(1997-1#2)(2009-4#2)
long-term care were##2##3##(1991-3#1)(1992-3#1)
long-term care##75##2##(1991-1#2)(1991-2#1)(1991-3#4)(1992-3#5)(1993-12#2)(1993-2#2)(1993-3#5)(1994-12#3)(1994-2#4)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#5)(1996-12#1)(1996-2#2)(1997-1#10)(1997-2#5)(1997-3#3)(2008-12#1)(2008-7#4)(2009-3#4)(2009-4#5)(2010-10#2)(2013-1#1)
long-term clinical##5##2##(2010-11#1)(2012-3#2)(2013-1#1)(2013-8#1)
long-term cultivation##4##2##(2008-11#3)(2008-5#1)
long-term cultures##6##2##(2008-11#6)
long-term depression (LTD)##2##3##(1995-2#1)(2012-2#1)
long-term depression and##2##3##(1993-12#1)(1995-2#1)
long-term depression at##2##3##(1997-7#2)
long-term depression##8##2##(1993-12#1)(1995-2#2)(1997-7#3)(2012-2#2)
long-term disability##4##2##(1997-8#1)(2010-12#1)(2013-1#2)
long-term effect of##2##3##(1991-8#1)(2011-2#1)
long-term effectiveness##3##2##(1993-2#1)(2008-11#1)(2012-2#1)
long-term effects of##7##3##(1995-11#1)(1996-12#1)(2008-11#1)(2009-1#2)(2009-7#1)(2013-1#1)
long-term effects##10##2##(1995-11#1)(1996-12#1)(2008-11#3)(2009-1#2)(2009-7#1)(2010-11#1)(2013-1#1)
long-term efficacy##4##2##(1995-11#1)(2009-8#1)(2012-3#1)(2013-1#1)
long-term establishment of##2##3##(2008-11#2)
long-term exposure to##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
long-term follow up##3##3##(2008-10#1)(2010-5#1)(2013-8#1)
long-term follow-up of##2##3##(2008-4#1)(2011-1#1)
long-term follow-up studies##2##3##(1992-9#1)(2009-8#1)
long-term follow-up##22##2##(1991-2#1)(1992-2#1)(1992-9#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#2)
long-term function##2##2##(2008-9#1)(2013-1#1)
long-term glycemic##2##2##(2012-5#2)
long-term health care administrators##2##4##(1992-2#2)
long-term health care##3##3##(1992-2#2)(2013-1#1)
long-term health##5##2##(1992-2#2)(2008-7#1)(2013-1#2)
long-term hemodialysis##3##2##(2008-10#1)(2011-2#2)
long-term hospital##2##2##(2008-11#2)
long-term influences##2##2##(2010-7#2)
long-term maintenance of##7##3##(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#1)
long-term management##3##2##(2008-10#3)
long-term memory formation##2##3##(2009-6#1)(2009-8#1)
long-term memory##7##2##(2008-11#1)(2009-6#2)(2009-8#1)(2010-1#1)(2013-8#2)
long-term monitoring of##2##3##(1997-3#1)(2008-9#1)
long-term monitoring##6##2##(1997-3#1)(2008-11#1)(2008-3#2)(2008-9#2)
long-term morbidity##2##2##(2008-2#1)(2013-7#1)
long-term neurological##2##2##(2008-11#1)(2010-10#1)
long-term operation##2##2##(2008-10#1)(2008-7#1)
long-term or##2##2##(1993-3#1)(2012-12#1)
long-term outcome##6##2##(1992-12#1)(2008-11#3)(2010-11#1)(2013-1#1)
long-term outcomes##16##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#5)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
long-term persistence of##2##3##(2008-5#1)(2008-8#1)
long-term physical##2##2##(2009-6#1)(2013-8#1)
long-term potentiation (LTP) and##2##4##(1993-12#1)(1995-2#1)
long-term potentiation (LTP)##8##3##(1990-5#1)(1993-12#1)(1995-12#2)(1995-2#1)(2008-11#1)(2008-7#2)
long-term potentiation in##5##3##(1990-5#1)(1993-12#1)(1995-12#2)(2008-7#1)
long-term potentiation of##2##3##(1995-2#1)(2012-2#1)
long-term potentiation##20##2##(1990-5#2)(1993-12#2)(1995-12#4)(1995-2#2)(1997-2#1)(2008-11#1)(2008-7#6)(2012-2#1)(2013-8#1)
long-term preservation##2##2##(2008-10#2)
long-term prognosis of##2##3##(2011-3#1)(2011-7#1)
long-term prognosis##6##2##(1991-6#1)(1996-9#1)(2008-10#1)(2010-5#1)(2011-3#1)(2011-7#1)
long-term response of##2##3##(2008-10#1)(2008-8#1)
long-term results in##2##3##(1994-2#1)(2010-10#1)
long-term results##14##2##(1991-3#1)(1991-6#2)(1992-9#1)(1993-11#1)(1994-2#1)(2008-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
long-term risk##3##2##(2008-11#1)(2008-5#1)(2009-8#1)
long-term safety##4##2##(2011-1#1)(2012-12#3)
long-term stability and reproducibility with##3##5##(2008-10#3)
long-term stability and##6##3##(2008-10#5)(2008-3#1)
long-term stability of the##3##4##(2008-10#2)(2010-1#1)
long-term stability of##10##3##(2008-10#5)(2008-11#3)(2008-4#1)(2010-1#1)
long-term stability were##2##3##(2008-10#2)
long-term stability##30##2##(2008-10#24)(2008-11#3)(2008-3#1)(2008-4#1)(2010-1#1)
long-term stable##2##2##(2008-10#1)(2008-5#1)
long-term storage of the##2##4##(2008-10#2)
long-term storage##4##2##(2008-10#3)(2008-9#1)
long-term studies are needed##2##4##(1991-12#1)(2008-3#1)
long-term studies##5##2##(1991-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
long-term study of##3##3##(1991-2#1)(1992-9#1)(2008-5#1)
long-term survival is##2##3##(2011-3#2)
long-term survival##8##2##(1991-12#1)(1997-3#1)(2008-7#2)(2011-3#2)(2012-3#1)(2013-1#1)
long-term survivors##4##2##(1990-9#1)(1991-6#1)(1997-3#1)(2010-11#1)
long-term synaptic plasticity##2##3##(2008-7#1)(2011-2#1)
long-term therapy##2##2##(2009-8#1)(2011-2#1)
long-term treatment of##3##3##(1997-4#1)(2010-8#1)(2012-3#1)
long-term treatment with##3##3##(1992-11#1)(1995-8#1)(2010-5#1)
long-term treatment##10##2##(1992-11#2)(1995-8#1)(1997-4#1)(1997-5#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-3#2)
long-term use of these drugs##2##5##(2008-10#1)(2008-11#1)
long-term use of##5##3##(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
long-term use##11##2##(1997-2#1)(2008-10#3)(2008-11#3)(2010-3#1)(2011-2#1)(2013-1#2)
long-term##587##1##(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#6)(1991-6#5)(1991-8#2)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#6)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#4)(1993-3#7)(1994-1#3)(1994-12#5)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#6)(1995-12#5)(1995-2#10)(1995-3#5)(1995-5#1)(1995-8#2)(1996-1#2)(1996-12#3)(1996-2#4)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#13)(1997-2#7)(1997-3#8)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2008-1#5)(2008-10#70)(2008-11#63)(2008-12#7)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#27)(2008-8#12)(2008-9#11)(2009-1#3)(2009-10#1)(2009-12#2)(2009-3#6)(2009-4#5)(2009-6#4)(2009-7#2)(2009-8#12)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#6)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#26)(2011-3#5)(2011-7#1)(2012-12#12)(2012-2#12)(2012-3#18)(2012-5#2)(2012-7#1)(2013-1#27)(2013-7#2)(2013-8#13)
long-term-care services##2##2##(2008-5#2)
long-term-care##5##1##(1992-8#1)(1997-2#1)(2008-5#2)(2010-10#1)
long-time##4##1##(1994-5#1)(1997-6#1)(2008-10#2)
long-wave##3##1##(2008-11#1)(2008-3#1)(2008-8#1)
long-wavelength##6##1##(1993-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-7#1)
longer and more##2##3##(1991-1#1)(2008-10#1)
longer and##6##2##(1991-1#1)(1991-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
longer at##2##2##(2008-10#1)(2008-12#1)
longer cDNA##2##2##(1996-2#2)
longer duration in##2##3##(2008-5#1)(2012-3#1)
longer duration of action##2##4##(1991-5#1)(2008-11#1)
longer duration of##3##3##(1991-5#1)(2008-11#1)(2012-5#1)
longer duration##8##2##(1991-5#1)(2008-11#3)(2008-5#1)(2012-3#1)(2012-5#1)(2013-1#1)
longer exposition##2##2##(2011-2#1)(2013-1#1)
longer exposure##2##2##(2008-10#1)(2008-12#1)
longer follow-up##6##2##(1990-12#1)(1993-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
longer for##2##2##(1996-2#1)(2008-9#1)
longer hospital##2##2##(2011-2#1)(2012-3#1)
longer in the##6##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
longer in##10##2##(1991-5#1)(1996-1#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-2#1)
longer lasting##2##2##(1994-8#1)(2013-8#1)
longer latent period##3##3##(2008-10#3)
longer life##2##2##(1996-8#1)(2008-5#1)
longer period of##6##3##(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
longer period##8##2##(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
longer periods of##4##3##(1996-6#1)(2008-10#2)(2008-11#1)
longer survival##3##2##(1997-2#1)(1997-5#2)
longer term##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2010-1#1)
longer than 300##2##3##(1996-3#1)(2009-4#1)
longer than 4##2##3##(2008-10#1)(2012-12#1)
longer than that##2##3##(2008-11#1)(2008-8#1)
longer than the other##2##4##(1997-4#1)(2008-10#1)
longer than the##4##3##(1997-4#1)(2008-10#2)(2013-8#1)
longer than those##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
longer than##35##2##(1990-12#1)(1991-2#1)(1991-5#1)(1993-8#1)(1994-12#1)(1996-3#1)(1997-4#2)(2008-10#9)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
longer the##2##2##(2011-2#2)
longer time##7##2##(1991-3#1)(2008-10#2)(2008-12#1)(2008-5#2)(2013-8#1)
longer to##3##2##(1994-9#1)(2008-10#1)(2012-2#1)
longer when##2##2##(2008-10#1)(2008-9#1)
longer##266##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#5)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#5)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#3)(1997-9#1)(2006-6#1)(2007-8#3)(2008-1#1)(2008-10#56)(2008-11#22)(2008-12#5)(2008-3#9)(2008-4#2)(2008-5#11)(2008-7#5)(2008-8#9)(2008-9#6)(2009-10#3)(2009-4#1)(2009-5#1)(2009-8#4)(2010-1#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#13)(2011-3#3)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#8)(2012-5#2)(2013-1#6)(2013-8#4)
longer-term##7##1##(1992-5#1)(1996-1#1)(2008-1#1)(2008-11#3)(2008-12#1)
longest##17##1##(1990-8#1)(1991-5#1)(1993-12#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-11#1)(2011-2#2)(2012-3#1)
longevity and##8##2##(2008-10#1)(2008-11#2)(2008-7#5)
longevity in##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
longevity indices in##2##3##(2008-10#2)
longevity of the##2##3##(2008-10#1)(2008-11#1)
longevity of##7##2##(2008-10#3)(2008-11#2)(2008-7#1)(2013-1#1)
longevity##37##1##(1991-6#1)(1992-11#3)(1996-8#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-7#9)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)
longibrachiatum##5##1##(2008-10#5)
longicolla isolates##2##2##(2008-10#2)
longicolla was##2##2##(2008-10#2)
longicolla##19##1##(2008-10#19)
longicomin##6##1##(2008-8#6)
longicornis##2##1##(2008-8#2)
longifolia Jack##4##2##(2008-11#4)
longipalpis##2##1##(2007-12#2)
longissimus dorsi##2##2##(2008-9#1)(2013-1#1)
longitude##4##1##(1995-6#1)(2008-10#3)
longitudinal Zeeman-effect background correction##2##4##(2008-10#2)
longitudinal analysis##2##2##(1995-2#1)(2008-12#1)
longitudinal and##3##2##(1994-3#1)(2010-1#1)(2013-1#1)
longitudinal axis##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
longitudinal data##5##2##(2008-10#1)(2008-12#1)(2009-10#1)(2009-6#1)(2009-7#1)
longitudinal expansion##2##2##(2008-10#1)(2009-1#1)
longitudinal ligament##2##2##(2008-12#2)
longitudinal models##3##2##(2013-1#3)
longitudinal randomized##2##2##(2008-10#1)(2011-2#1)
longitudinal studies are##2##3##(2012-2#1)(2013-1#1)
longitudinal studies of the##2##4##(1992-12#1)(2009-8#1)
longitudinal studies##7##2##(1992-12#1)(1992-3#1)(1994-9#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
longitudinal study examines##2##3##(2009-7#1)(2013-1#1)
longitudinal study of##8##3##(1990-2#1)(2008-11#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)
longitudinal study##22##2##(1990-2#1)(1996-9#1)(2008-11#5)(2009-11#1)(2009-7#5)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
longitudinal##109##1##(1990-2#2)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#3)(1994-3#1)(1994-9#1)(1995-2#1)(1996-9#1)(1997-3#1)(2008-10#10)(2008-11#5)(2008-12#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#3)(2009-6#1)(2009-7#7)(2009-8#2)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#7)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#9)(2013-8#1)
longitudinally##11##1##(1992-3#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
longrun##2##1##(1992-12#1)(1993-3#1)
longstanding AS##4##2##(2012-3#4)
longstanding##11##1##(1990-11#1)(2008-12#1)(2012-2#1)(2012-3#5)(2012-4#2)(2013-1#1)
longterm##6##1##(1994-6#1)(1995-12#2)(1997-3#1)(2008-7#1)(2013-1#1)
longus colli muscle##2##3##(2010-12#2)
longus tendon##3##2##(2008-12#1)(2010-7#2)
longus##14##1##(1997-8#1)(2008-12#1)(2008-9#5)(2009-1#1)(2009-10#1)(2010-12#2)(2010-3#1)(2010-7#2)
lonicerae##2##1##(2013-8#2)
lonidamine##2##1##(1990-6#1)(1993-11#1)
look at the##12##3##(1991-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2010-10#1)(2011-2#1)
look at##33##2##(1991-1#2)(1991-3#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
look for##8##2##(1991-11#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)
look into the##2##3##(1991-12#1)(2008-8#1)
look into##4##2##(1991-12#1)(2008-10#2)(2008-8#1)
look like##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
look to##2##2##(2008-11#1)(2010-10#1)
look up##3##2##(1992-3#1)(2008-6#1)(2009-7#1)
look##68##1##(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#3)(1993-3#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#3)(2008-10#6)(2008-11#4)(2008-12#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#6)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
looked at the##2##3##(1995-6#1)(2008-7#1)
looked at##5##2##(1991-3#1)(1995-6#1)(2008-12#1)(2008-5#1)(2008-7#1)
looked for##3##2##(1990-3#1)(1996-1#1)(2011-2#1)
looked##14##1##(1990-3#1)(1991-1#1)(1991-3#1)(1995-6#1)(1996-1#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#2)(2011-2#1)
looking at##4##2##(2008-1#1)(2008-2#1)(2008-5#1)(2013-1#1)
looking beyond##2##2##(2008-7#1)(2012-2#1)
looking for##4##2##(2008-11#1)(2010-10#2)(2012-2#1)
looking to##2##2##(2008-5#1)(2010-8#1)
looking##19##1##(1994-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#2)(2010-8#1)(2012-2#2)(2013-1#2)
looks at some##2##3##(1991-1#1)(1994-2#1)
looks at the##6##3##(1992-12#1)(1993-12#1)(1995-2#1)(2008-11#1)(2008-5#1)(2013-7#1)
looks at##13##2##(1991-1#1)(1992-12#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-5#1)(2013-7#1)(2013-8#1)
looks like##3##2##(1991-2#1)(2008-8#1)(2009-9#1)
looks##21##1##(1991-1#1)(1991-2#2)(1992-12#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-6#1)(2009-9#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
loop (500mul)##2##2##(2008-10#2)
loop 39-52##3##2##(1992-4#3)
loop and##3##2##(1997-3#1)(2011-2#1)(2013-1#1)
loop between helices##2##3##(1995-2#2)
loop between the##2##3##(1992-4#1)(1995-8#1)
loop between##5##2##(1992-4#2)(1995-2#2)(1995-8#1)
loop conization##4##2##(1992-2#1)(1994-12#3)
loop connections##4##2##(2008-11#4)
loop excision of the transformation zone##2##6##(1994-2#2)
loop excision of the##3##4##(1994-2#2)(2012-3#1)
loop for##2##2##(1991-5#1)(2008-6#1)
loop formation##2##2##(1992-3#2)
loop in the##3##3##(1995-2#1)(2009-6#1)(2010-8#1)
loop involving the##2##3##(2008-11#1)(2011-1#1)
loop is##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
loop ligation##3##2##(1995-1#3)
loop ligature (Endoloop)##2##3##(1995-1#2)
loop ligature##3##2##(1995-1#3)
loop of the##2##3##(2008-10#2)
loop of##13##2##(1995-6#2)(2008-10#7)(2008-11#1)(2008-12#2)(2012-3#1)
loop region of##2##3##(1992-3#1)(1993-8#1)
loop region##4##2##(1991-12#1)(1992-3#1)(1993-8#1)(2008-4#1)
loop size##3##2##(1992-3#1)(1993-12#1)(2008-10#1)
loop was##3##2##(1997-9#1)(2008-10#1)(2012-3#1)
loop with##2##2##(2008-11#1)(2008-8#1)
loop##141##1##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-2#3)(1992-3#12)(1992-4#5)(1993-12#2)(1993-8#3)(1994-12#4)(1994-2#3)(1995-1#7)(1995-2#4)(1995-6#3)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-9#1)(2008-10#23)(2008-11#16)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#4)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#1)
loop)##3##1##(2008-10#3)
loop-closing base pair##2##3##(1992-3#2)
looped suture employing a knot-free running##2##6##(1992-2#2)
looped suture##3##2##(1992-2#3)
looped##4##1##(1992-2#3)(2007-12#1)
looping##4##1##(2011-2#3)(2012-2#1)
loops and##2##2##(1991-6#1)(2012-2#1)
loops of##2##2##(1992-3#1)(2008-12#1)
loops with##3##2##(1992-3#1)(1993-12#1)(2008-11#1)
loops##23##1##(1991-6#1)(1992-3#2)(1993-12#2)(1997-9#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-8#1)(2010-10#2)(2011-2#1)(2011-3#1)(2012-2#4)
loose body##4##2##(2013-1#4)
loose islets##4##2##(2008-5#4)
loose##20##1##(2008-5#7)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
loosely adherent##2##2##(2008-11#1)(2012-3#1)
loosely associated##3##2##(1993-8#1)(2011-2#1)(2012-3#1)
loosely##13##1##(1993-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#2)
loosening##5##1##(2007-11#1)(2009-4#2)(2013-1#2)
looser##3##1##(2008-11#1)(2008-8#1)(2008-9#1)
lophophores are##3##2##(2008-9#3)
lophophores##6##1##(2008-9#6)
lopinavir and ritonavir##3##3##(2011-3#3)
lopinavir##5##1##(2011-3#5)
loratadine##2##1##(2008-10#1)(2010-9#1)
lorazepam##4##1##(1990-6#1)(2008-10#3)
lordosis##2##1##(2008-11#2)
lors de##2##2##(2011-2#2)
lose all##2##2##(2008-10#1)(2008-8#1)
lose an##2##2##(1992-6#1)(2008-10#1)
lose the##4##2##(1990-3#1)(2008-10#3)
lose their ability to##2##4##(1991-12#1)(2012-2#1)
lose their##6##2##(1990-5#1)(1991-12#1)(1995-6#1)(1996-12#1)(2008-7#1)(2012-2#1)
lose##27##1##(1990-3#1)(1990-5#1)(1991-12#1)(1992-6#1)(1993-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-7#2)(2008-8#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
loses its##2##2##(2008-10#2)
loses##7##1##(1990-6#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-2#1)(2011-2#1)
losing their##2##2##(1991-11#1)(1996-11#1)
losing##11##1##(1991-11#1)(1992-5#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-10#1)
loss (0##2##2##(2008-2#1)(2008-3#1)
loss after##2##2##(2010-8#1)(2013-1#1)
loss and a##2##3##(2008-7#1)(2012-3#1)
loss and the##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
loss and##33##2##(1991-12#1)(1993-12#1)(1994-12#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#3)(2010-4#1)(2011-2#6)(2012-3#2)(2013-1#3)(2013-7#2)
loss as##3##2##(1994-3#1)(2008-10#1)(2010-12#1)
loss associated with##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
loss at the##2##3##(1996-2#1)(2008-10#1)
loss but##2##2##(2008-10#1)(2010-4#1)
loss caused by##2##3##(2008-10#2)
loss control##2##2##(1992-2#2)
loss did not##3##3##(2008-2#2)(2011-2#1)
loss due to autophagy##2##4##(2008-7#2)
loss due to##8##3##(1993-2#2)(2008-10#2)(2008-7#2)(2011-2#1)(2013-1#1)
loss during##4##2##(1993-1#1)(2008-10#1)(2011-2#2)
loss for##3##2##(2008-10#1)(2008-3#1)(2010-9#1)
loss from the##7##3##(1992-2#2)(2008-10#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#1)
loss from##17##2##(1992-12#1)(1992-2#2)(1993-1#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-10#1)(2010-11#3)(2012-2#1)(2013-1#1)
loss in patients with##2##4##(2008-7#1)(2011-2#1)
loss in the##5##3##(1991-6#1)(1997-5#1)(2008-10#2)(2008-7#1)
loss in##42##2##(1990-3#1)(1991-6#1)(1994-9#1)(1996-5#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
loss is correlated with##2##4##(2007-12#1)(2013-8#1)
loss is frequently##2##3##(1994-11#1)(2008-5#1)
loss is##19##2##(1991-9#1)(1994-11#2)(1994-3#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-8#2)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#1)
loss may##2##2##(2013-1#1)(2013-8#1)
loss of 2##2##3##(2008-3#1)(2008-9#1)
loss of Medicaid eligibility##2##4##(1992-2#2)
loss of NOL7##2##3##(2013-1#2)
loss of a##5##3##(1993-3#1)(1996-11#1)(2008-10#1)(2008-4#1)(2012-3#1)
loss of activity##4##3##(1992-12#1)(1995-2#1)(2008-10#1)(2008-5#1)
loss of alleles##2##3##(1994-12#1)(2008-10#1)
loss of avirulence##2##3##(2008-10#2)
loss of body##3##3##(1990-9#1)(2008-9#1)(2012-3#1)
loss of cell##2##3##(2008-11#1)(2013-1#1)
loss of concentration##2##3##(1991-8#1)(2013-8#1)
loss of consciousness##8##3##(1992-6#1)(2008-11#4)(2012-12#1)(2012-3#2)
loss of cortical MAP-2##2##4##(2008-7#2)
loss of cortical##3##3##(2008-7#2)(2012-2#1)
loss of dignity##2##3##(1990-6#1)(1991-8#1)
loss of efficacy##2##3##(2008-10#1)(2008-7#1)
loss of endogenous##2##3##(2008-11#1)(2010-11#1)
loss of function alleles of Uba1##2##6##(2008-9#2)
loss of function of the##2##5##(2011-2#1)(2011-3#1)
loss of function##10##3##(1990-12#1)(1994-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#2)(2011-2#1)(2011-3#1)(2012-2#1)
loss of healthy growing points##2##5##(2008-10#2)
loss of hearing##2##3##(1994-9#2)
loss of heterozygosity (LOH)##2##4##(2012-3#2)
loss of heterozygosity##3##3##(1993-11#1)(2012-3#2)
loss of less than##2##4##(2008-2#2)
loss of membrane##2##3##(2008-10#1)(2008-9#1)
loss of neurones in##2##4##(1995-12#2)
loss of one##2##3##(2008-10#1)(2008-9#1)
loss of residual renal function##2##5##(2011-2#2)
loss of sensitivity##5##3##(2008-10#5)
loss of some##2##3##(1991-12#1)(1995-3#1)
loss of specific##3##3##(1990-5#1)(2008-9#1)(2012-2#1)
loss of telomeric DNA and eventual##2##6##(1990-5#2)
loss of telomeric DNA##3##4##(1990-5#3)
loss of the##23##3##(1990-11#1)(1993-2#1)(1993-8#1)(1997-3#2)(2008-10#8)(2008-12#1)(2008-5#2)(2009-8#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
loss of tissue##2##3##(1992-12#1)(2013-1#1)
loss of viability##2##3##(1995-2#1)(2012-3#1)
loss of virulence##3##3##(2008-11#2)(2013-1#1)
loss of vision in##2##4##(1994-8#1)(2011-2#1)
loss of vision##4##3##(1994-8#1)(1994-9#1)(2008-7#1)(2011-2#1)
loss of weight##4##3##(1990-9#1)(1991-11#1)(1993-3#1)(2008-7#1)
loss of##320##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#6)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#5)(1997-1#3)(1997-3#4)(1997-7#4)(1997-8#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#70)(2008-11#20)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#9)(2008-7#10)(2008-8#8)(2008-9#9)(2009-3#3)(2009-5#1)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-2#18)(2011-3#1)(2012-12#3)(2012-2#7)(2012-3#12)(2013-1#20)(2013-7#3)(2013-8#6)
loss on##2##2##(2011-2#1)(2013-8#1)
loss or##11##2##(1994-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#1)
loss over##2##2##(2008-3#1)(2013-8#1)
loss per##4##2##(2008-10#2)(2008-3#2)
loss rate of##3##3##(2008-10#1)(2012-3#2)
loss rate##5##2##(2008-10#2)(2012-3#3)
loss results in##2##3##(2008-5#1)(2009-8#1)
loss than##2##2##(2009-8#1)(2011-2#1)
loss through##2##2##(1992-3#1)(2008-11#1)
loss to##4##2##(1996-12#1)(2008-10#1)(2010-4#1)(2012-3#1)
loss varies##2##2##(2008-10#1)(2013-8#1)
loss was not##2##3##(2008-10#2)
loss was significantly##3##3##(1996-3#1)(2008-4#1)(2011-2#1)
loss was##21##2##(1991-2#1)(1992-2#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#4)(2013-1#1)
loss were##4##2##(2008-5#1)(2011-2#2)(2012-3#1)
loss while the##2##3##(2008-1#1)(2008-10#1)
loss##727##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#6)(1990-6#1)(1990-9#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#6)(1992-2#9)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#5)(1994-12#4)(1994-2#3)(1994-3#7)(1994-5#2)(1994-8#4)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#3)(1996-5#7)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#4)(1997-5#2)(1997-7#4)(1997-8#4)(2007-11#4)(2007-12#5)(2007-8#2)(2008-1#7)(2008-10#137)(2008-11#34)(2008-12#11)(2008-2#9)(2008-3#29)(2008-4#6)(2008-5#32)(2008-6#3)(2008-7#22)(2008-8#17)(2008-9#23)(2009-10#1)(2009-12#1)(2009-3#3)(2009-5#3)(2009-8#8)(2009-9#3)(2010-10#3)(2010-11#9)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#58)(2011-3#1)(2012-12#4)(2012-2#14)(2012-3#29)(2013-1#40)(2013-7#6)(2013-8#20)
loss)##5##1##(1991-12#1)(1994-6#1)(2008-10#2)(2008-5#1)
loss-of-function##7##1##(1993-9#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
losses and in##2##3##(1992-12#1)(2009-10#1)
losses and##12##2##(1992-12#1)(2008-10#4)(2008-3#1)(2009-10#2)(2010-4#1)(2011-10#1)(2011-2#2)
losses are##2##2##(2008-2#1)(2008-3#1)
losses can##2##2##(1991-5#1)(2008-10#1)
losses caused by##2##3##(2008-10#2)
losses due to##5##3##(1997-5#1)(2008-10#3)(2008-8#1)
losses for##2##2##(2008-10#1)(2008-11#1)
losses from##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
losses in PPS 7##2##4##(1993-3#2)
losses in the##4##3##(1991-3#1)(1991-5#1)(2008-10#1)(2011-2#1)
losses in##19##2##(1991-3#1)(1991-5#1)(1993-3#2)(1996-3#1)(2008-10#9)(2008-3#2)(2008-7#1)(2009-10#1)(2011-2#1)
losses of##15##2##(1991-5#1)(1997-2#1)(2008-10#9)(2008-2#1)(2008-3#1)(2009-6#1)(2012-2#1)
losses to##5##2##(2008-10#2)(2008-8#2)(2011-2#1)
losses were##5##2##(1993-12#1)(2008-10#3)(2008-3#1)
losses worldwide##2##2##(2007-12#1)(2008-10#1)
losses##118##1##(1991-3#2)(1991-5#4)(1992-1#1)(1992-12#1)(1993-12#2)(1993-3#3)(1996-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#61)(2008-11#1)(2008-2#2)(2008-3#10)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#3)(2009-6#2)(2010-4#2)(2010-8#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
lost a##4##2##(1990-5#1)(1994-2#1)(2009-5#1)(2012-3#1)
lost about##2##2##(1991-5#1)(2009-6#1)
lost after##5##2##(2008-10#2)(2010-11#1)(2012-3#1)(2013-1#1)
lost chance of recovery##2##4##(1995-6#2)
lost during##2##2##(2008-11#1)(2009-10#1)
lost from##4##2##(1991-2#2)(2010-3#1)(2013-1#1)
lost in the##3##3##(2008-10#1)(2008-11#2)
lost in##9##2##(1991-9#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-9#1)(2010-5#1)
lost its##3##2##(1990-2#1)(2008-12#1)(2011-2#1)
lost motility##2##2##(2008-10#2)
lost some##2##2##(2007-12#1)(2010-8#1)
lost the ability to induce##2##5##(2008-10#2)
lost the ability to##6##4##(1994-12#1)(2008-10#2)(2008-8#1)(2008-9#2)
lost the##11##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#3)(2009-6#1)(2011-2#1)
lost their##6##2##(1991-11#1)(1994-2#2)(2008-10#1)(2009-6#1)(2013-1#1)
lost through##2##2##(1997-3#1)(2008-5#1)
lost to follow-up##3##3##(1996-3#1)(2008-11#1)(2013-1#1)
lost to the##4##3##(1991-2#1)(1993-12#1)(1996-1#1)(2008-5#1)
lost to##13##2##(1991-2#1)(1993-12#3)(1995-8#1)(1996-1#1)(1996-3#2)(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
lost upon##2##2##(1990-5#1)(1992-3#1)
lost vision##3##2##(2008-7#2)(2010-10#1)
lost weight##2##2##(1993-12#1)(2010-8#1)
lost when##2##2##(1992-6#1)(2008-6#1)
lost##137##1##(1990-2#2)(1990-3#1)(1990-5#3)(1990-9#1)(1991-11#1)(1991-2#4)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#4)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-9#1)(1995-12#3)(1995-2#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-3#2)(1997-3#2)(1997-6#2)(2007-12#3)(2008-10#20)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#8)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#6)(2011-3#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
lot of##17##2##(1990-6#1)(1994-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-9#2)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
lot##33##1##(1990-6#1)(1993-12#1)(1994-2#1)(1994-3#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-9#3)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
lotion was##3##2##(2008-10#2)(2008-5#1)
lotion##16##1##(2008-10#6)(2008-5#8)(2012-3#1)(2013-8#1)
lotion)##2##1##(2008-5#2)
lotions##12##1##(2008-10#3)(2008-5#9)
lots from##2##2##(1995-5#1)(2008-10#1)
lots of##3##2##(2008-11#2)(2010-7#1)
lots##21##1##(1995-5#4)(2008-10#12)(2008-11#3)(2010-7#1)(2012-2#1)
lottery##8##1##(2008-8#2)(2013-1#6)
loud##2##1##(1996-5#1)(2008-8#1)
loud-sound##2##1##(2008-8#2)
loudness##7##1##(1995-12#1)(2008-9#5)(2013-8#1)
louse##11##1##(1996-12#8)(2007-12#2)(2008-12#1)
love##9##1##(1994-9#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
loved ones##4##2##(2009-5#2)(2011-2#1)(2013-8#1)
low (&lt##5##2##(1996-8#1)(2008-10#1)(2008-3#2)(2010-8#1)
low (0##3##2##(1991-11#1)(2008-10#1)(2008-7#1)
low (2##2##2##(1996-12#1)(2013-8#1)
low (3##2##2##(1995-11#1)(2008-10#1)
low (alpha-)##3##2##(2008-10#3)
low (i##2##2##(2008-9#1)(2010-11#1)
low FRS##2##2##(2013-8#2)
low GC##2##2##(2012-2#2)
low H(2)O(2)##2##2##(2008-10#1)(2010-4#1)
low HDL cholesterol##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
low HIV##2##2##(2009-12#1)(2012-3#1)
low Km##2##2##(1993-6#1)(1994-8#1)
low LET radiation##7##3##(2008-7#7)
low Lp(a)##2##2##(1996-8#2)
low Mr##3##2##(1990-5#3)
low RH##3##2##(2008-10#3)
low Reynolds number##2##3##(2008-10#1)(2013-1#1)
low SES##4##2##(2011-1#4)
low TSPO expression levels##2##4##(2012-2#2)
low TSPO##3##2##(2012-2#3)
low UV detection##3##3##(1991-7#1)(2008-10#2)
low UV##4##2##(1991-7#1)(2008-10#2)(2008-5#1)
low absolute##2##2##(1994-11#1)(2012-2#1)
low abundance##3##2##(1997-2#1)(2008-4#1)(2013-8#1)
low acid##2##2##(1997-1#1)(2008-10#1)
low activity of##2##3##(1997-7#1)(1997-8#1)
low activity##6##2##(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-7#1)
low acute toxicity##2##3##(1996-1#1)(2008-5#1)
low affinity binding##2##3##(1993-1#1)(2009-12#1)
low affinity for##4##3##(1990-8#1)(1995-2#1)(1995-6#1)(2008-10#1)
low affinity##17##2##(1990-11#1)(1990-8#2)(1993-1#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#2)(1996-2#1)(2008-10#2)(2008-7#2)(2009-12#1)
low agitation##2##2##(2008-11#1)(2011-2#1)
low alloy steel##2##3##(2008-10#2)
low alloy##3##2##(2008-10#3)
low amino acid identities of##2##5##(2008-10#2)
low amino acid identities##3##4##(2008-10#3)
low among##2##2##(2008-10#1)(2008-11#1)
low amount of##4##3##(2008-10#3)(2008-11#1)
low amounts of##3##3##(2008-10#2)(2012-2#1)
low amounts##4##2##(1994-2#1)(2008-10#2)(2012-2#1)
low and high sulfur containing##2##5##(2008-10#2)
low and high##14##3##(1991-9#1)(1992-3#1)(1995-11#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)
low and middle-income countries##3##4##(2008-10#3)
low and the##2##3##(1996-2#1)(2008-10#1)
low and##36##2##(1991-9#1)(1992-3#1)(1993-9#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#4)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
low anterior resection##2##3##(1997-8#1)(2008-12#1)
low anterior##3##2##(1990-9#1)(1997-8#1)(2008-12#1)
low anxiety##3##2##(1995-1#1)(2009-7#2)
low as 10##2##3##(2008-10#1)(2008-7#1)
low as##71##2##(1992-3#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-12#1)(2008-10#53)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-3#1)(2012-2#2)
low at##4##2##(1997-6#1)(2008-10#2)(2008-5#1)
low availability##2##2##(2008-8#1)(2009-1#1)
low average similarity##2##3##(2008-10#2)
low average##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
low back and pelvis kinematics##3##5##(2008-12#3)
low back and pelvis##5##4##(2008-12#5)
low back and##6##3##(2008-12#5)(2012-3#1)
low back pain (LBP)##3##4##(2010-9#1)(2012-12#1)(2013-1#1)
low back pain and##3##4##(2008-12#1)(2010-1#1)(2012-2#1)
low back pain in patients with infantile cerebral palsy##2##9##(2009-4#2)
low back pain in##4##4##(2009-4#3)(2012-3#1)
low back pain##32##3##(1993-6#2)(1996-6#1)(1997-4#1)(2008-12#7)(2009-4#4)(2010-1#5)(2010-9#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
low back##45##2##(1993-6#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-12#16)(2009-4#4)(2010-1#5)(2010-9#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
low bioavailability##2##2##(2008-10#1)(2012-2#1)
low birth weight babies##3##4##(1991-12#1)(1994-3#1)(1995-12#1)
low birth weight infants##5##4##(1991-6#1)(1993-3#1)(1995-8#2)(2008-10#1)
low birth weight##23##3##(1991-12#3)(1991-6#1)(1992-2#1)(1993-3#2)(1994-3#1)(1995-12#2)(1995-8#2)(1996-11#1)(2008-10#1)(2008-11#4)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
low birth weights##2##3##(1994-6#2)
low birth##27##2##(1991-12#3)(1991-6#1)(1992-2#1)(1993-3#2)(1994-3#1)(1994-6#2)(1995-12#2)(1995-8#2)(1996-11#1)(2008-10#1)(2008-11#4)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#2)
low blood levels of##2##4##(1993-1#1)(2013-1#1)
low blood##3##2##(1993-1#1)(2010-4#1)(2013-1#1)
low body##3##2##(2008-7#1)(2009-5#1)(2011-2#1)
low but significant##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
low but statistically significant##4##4##(1996-8#2)(2008-10#1)(2009-3#1)
low but##10##2##(1996-8#2)(1997-5#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
low calcium##3##2##(1993-11#1)(1994-3#2)
low capillary##2##2##(2008-10#2)
low carbohydrate##3##2##(2008-3#3)
low cell##5##2##(1991-8#1)(1993-8#1)(2008-11#2)(2010-11#1)
low cognitive##2##2##(2008-12#1)(2010-7#1)
low compared to##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)
low compared with that of##2##5##(2008-10#1)(2010-4#1)
low compared with##7##3##(2008-10#2)(2008-11#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
low compared##12##2##(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#1)
low complication rate##4##3##(1993-12#1)(1993-6#1)(1997-6#1)(2013-1#1)
low complication rates##2##3##(2011-2#1)(2013-1#1)
low complication##6##2##(1993-12#1)(1993-6#1)(1997-6#1)(2011-2#1)(2013-1#2)
low concentration and##2##3##(1996-3#1)(2008-10#1)
low concentration in##3##3##(2008-10#3)
low concentration levels##5##3##(2008-10#5)
low concentration of##10##3##(1993-1#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-9#1)
low concentration##37##2##(1993-1#1)(1996-2#1)(1996-3#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-9#4)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
low concentrations (0##3##3##(2006-6#1)(2008-10#1)(2008-5#1)
low concentrations by##3##3##(2008-10#3)
low concentrations in##7##3##(1990-11#1)(1993-11#1)(2008-10#3)(2008-12#1)(2013-8#1)
low concentrations of the##4##4##(1991-5#1)(2008-10#1)(2008-5#2)
low concentrations of##23##3##(1991-12#1)(1991-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1994-8#1)(2008-10#9)(2008-11#2)(2008-5#3)(2008-7#1)
low concentrations##65##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#3)(1992-6#2)(1992-7#2)(1992-8#1)(1993-11#1)(1994-8#2)(1997-1#1)(1997-4#1)(2006-6#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2013-8#1)
low consumption##2##2##(2008-10#2)
low contamination##2##2##(2008-10#2)
low content##2##2##(2008-10#2)
low contents of##2##3##(2008-10#2)
low contents##4##2##(2008-10#4)
low contrast##2##2##(2008-3#1)(2010-8#1)
low copy number##3##3##(1991-7#1)(2008-10#1)(2008-12#1)
low copy##4##2##(1991-7#1)(2008-10#1)(2008-12#1)(2008-8#1)
low cortisol and androgen levels##2##5##(2011-1#2)
low cost and##4##3##(2008-10#4)
low cost of##4##3##(1992-5#1)(2008-10#3)
low cost##44##2##(1992-3#1)(1992-5#1)(1993-3#1)(1997-2#1)(2008-10#27)(2008-11#1)(2008-3#1)(2008-8#1)(2009-1#3)(2009-5#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
low costs##2##2##(1991-3#1)(2008-10#1)
low cytotoxicity##3##2##(2008-11#2)(2011-2#1)
low degree of differentiation##2##4##(2011-2#2)
low degree of##6##3##(1990-12#1)(1991-6#1)(1996-3#1)(2008-10#1)(2011-2#2)
low density lipoprotein (LDL) receptor##3##5##(1993-3#1)(1995-8#2)
low density lipoprotein (LDL)##7##4##(1991-5#1)(1992-5#1)(1993-3#1)(1995-8#3)(2010-12#1)
low density lipoprotein ligated cholesterol##2##5##(1991-11#2)
low density lipoprotein receptor##7##4##(1991-2#1)(1993-3#2)(1994-9#1)(1995-2#2)(1995-6#1)
low density lipoprotein##28##3##(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1992-5#1)(1993-3#3)(1993-6#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-6#2)(1995-8#3)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)
low density lipoproteins (LDL)##3##4##(1991-5#1)(1993-6#1)(2008-10#1)
low density lipoproteins##11##3##(1990-8#1)(1991-11#2)(1991-12#2)(1991-5#2)(1992-3#1)(1993-6#1)(1995-2#1)(2008-10#1)
low density##45##2##(1990-8#1)(1991-11#5)(1991-12#3)(1991-2#1)(1991-5#4)(1992-3#1)(1992-5#1)(1993-3#3)(1993-6#2)(1994-8#2)(1994-9#1)(1995-2#4)(1995-6#2)(1995-8#3)(1997-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-8#1)
low detection limit of 0##4##5##(2008-10#4)
low detection limit of##7##4##(2008-10#7)
low detection limit##22##3##(2008-10#22)
low detection limits##11##3##(2008-10#11)
low detection##35##2##(2008-10#35)
low dielectric constants (K(D##2##4##(2008-10#2)
low dielectric constants##4##3##(2008-10#4)
low dielectric##5##2##(2008-10#5)
low disease##6##2##(2008-10#6)
low diversity##3##2##(2008-10#2)(2008-9#1)
low dosage##2##2##(2008-11#1)(2010-12#1)
low dose exposures##3##3##(2008-7#3)
low dose of##5##3##(1995-8#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)
low dose radiation##5##3##(2008-7#4)(2013-1#1)
low dose##35##2##(1995-8#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-7#20)(2008-8#2)(2010-1#2)(2012-2#2)(2013-1#2)(2013-8#1)
low dose-rate##2##2##(1994-8#1)(2013-1#1)
low doses of DNA damaging agents##2##6##(2008-7#2)
low doses of ionizing radiation##2##5##(2008-7#1)(2013-1#1)
low doses of ionizing##3##4##(2008-7#2)(2013-1#1)
low doses of low LET radiation##2##6##(2008-7#2)
low doses of radiation##3##4##(2008-7#3)
low doses of##22##3##(1990-5#1)(1990-6#1)(1992-5#1)(1993-1#1)(2008-10#2)(2008-11#1)(2008-7#12)(2010-1#1)(2013-1#2)
low doses##29##2##(1990-5#1)(1990-6#1)(1992-5#1)(1993-1#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#16)(2008-8#1)(2010-1#1)(2013-1#2)
low during##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
low duty cycle##2##3##(2008-3#2)
low early##2##2##(1992-9#1)(2011-2#1)
low educational##2##2##(2013-1#1)(2013-8#1)
low efficiency##3##2##(1990-5#1)(2008-11#1)(2008-8#1)
low electrical resistance##2##3##(2008-10#1)(2008-9#1)
low electrical##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
low energy electronic##3##3##(2008-10#3)
low energy##7##2##(1993-5#1)(1995-11#1)(2008-10#4)(2008-11#1)
low enough to##2##3##(1995-8#1)(2008-9#1)
low enough##3##2##(1995-3#1)(1995-8#1)(2008-9#1)
low enzyme##3##2##(1993-3#1)(2011-2#2)
low exposure##2##2##(2008-10#1)(2008-11#1)
low exposures##2##2##(1991-12#1)(2013-8#1)
low expression##2##2##(1997-7#1)(2008-10#1)
low fat##3##2##(1993-11#1)(2008-4#1)(2010-4#1)
low fluorescence##4##2##(2008-10#4)
low food##3##2##(2010-8#2)(2012-3#1)
low for##5##2##(1991-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
low frequencies##5##2##(2008-10#4)(2008-9#1)
low frequency of##5##3##(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)
low frequency##18##2##(1990-11#1)(1992-3#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-3#2)
low friction##2##2##(2009-9#2)
low gene flow##2##3##(2008-10#2)
low genetic diversity##2##3##(2008-10#2)
low genetic structure##2##3##(2013-1#2)
low genetic##7##2##(2008-10#3)(2011-3#1)(2013-1#3)
low grade##7##2##(1991-9#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
low growth##2##2##(2008-11#1)(2008-5#1)
low health literacy##3##3##(2009-8#3)
low health##4##2##(2009-8#3)(2010-10#1)
low humidity sensing##2##3##(2008-10#2)
low humidity sensor##2##3##(2008-10#2)
low humidity##4##2##(2008-10#4)
low if##2##2##(2008-10#1)(2008-11#1)
low immunization levels##2##3##(1996-12#2)
low immunization##3##2##(1996-12#3)
low in all##3##3##(2008-10#2)(2013-1#1)
low in cells##2##3##(1994-8#1)(1997-1#1)
low in the##7##3##(1990-5#1)(1994-2#1)(1995-11#1)(2008-10#3)(2009-7#1)
low in##34##2##(1990-5#1)(1990-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-1#1)(2007-11#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
low incidence of oropharyngeal adverse events##2##6##(2008-8#2)
low incidence of##13##3##(1990-6#2)(1993-11#1)(1995-5#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#1)(2011-2#3)
low incidence##15##2##(1990-6#2)(1993-11#1)(1995-5#1)(1996-3#1)(1997-1#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#1)(2011-2#3)
low income##5##2##(1994-12#2)(1995-12#1)(2008-12#1)(2012-2#1)
low initial##4##2##(2008-10#2)(2008-9#1)(2009-7#1)
low inoculum density##2##3##(2008-10#2)
low inoculum##4##2##(2008-10#4)
low intensity microwaves##2##3##(2011-2#2)
low intensity##7##2##(1992-3#1)(1996-5#1)(2008-10#2)(2011-2#2)(2013-1#1)
low ionic strength##7##3##(1990-11#1)(1990-5#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
low ionic##8##2##(1990-11#1)(1990-5#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-7#2)(2011-2#1)
low is##2##2##(1994-1#1)(2008-10#1)
low level of##28##3##(1992-10#1)(1997-2#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-8#2)(2011-10#1)(2011-7#1)(2013-1#1)
low level##47##2##(1990-3#1)(1992-10#1)(1993-1#1)(1993-9#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#1)(2008-8#3)(2008-9#1)(2011-10#1)(2011-7#1)(2013-1#1)
low levels in##6##3##(1993-2#1)(2008-10#4)(2008-6#1)
low levels of antibody##3##4##(1991-3#2)(2008-11#1)
low levels of genetic differentiation##2##5##(2012-3#1)(2012-5#1)
low levels of genetic##4##4##(2008-8#1)(2008-9#1)(2012-3#1)(2012-5#1)
low levels of linkage disequilibrium##2##5##(2008-10#1)(2010-5#1)
low levels of the##2##4##(1990-5#1)(2008-10#1)
low levels of##64##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#2)(1992-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#2)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#17)(2008-11#7)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#1)
low levels##84##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#2)(1992-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#4)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#27)(2008-11#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#1)
low light##4##2##(2007-12#1)(2008-11#1)(2008-5#1)(2009-8#1)
low limit of detection##2##4##(2008-10#2)
low limit of determination##2##4##(2008-10#2)
low limit of##4##3##(2008-10#4)
low limits of detection##6##4##(2008-10#6)
low limits##7##2##(2008-10#7)
low load##2##2##(2009-7#1)(2013-1#1)
low loss##2##2##(2007-11#1)(2012-3#1)
low lumbar spine##2##3##(2008-8#1)(2010-1#1)
low lumbar##3##2##(1991-11#1)(2008-8#1)(2010-1#1)
low magnesium##2##2##(1993-8#1)(2008-6#1)
low maternal##2##2##(2009-10#2)
low mean##2##2##(2008-9#2)
low mechanical##2##2##(2009-7#1)(2012-2#1)
low melting point##2##3##(2008-10#1)(2009-11#1)
low micromolar##3##2##(1992-3#1)(1995-11#1)(2008-10#1)
low milk##2##2##(2010-12#2)
low mitochondrial##2##2##(1994-11#1)(2008-10#1)
low molecular mass##3##3##(1995-6#1)(2008-10#1)(2009-12#1)
low molecular weight (LMW)##2##4##(2008-10#2)
low molecular weight anions##2##4##(2008-10#2)
low molecular weight compound##2##4##(2009-4#2)
low molecular weight compounds##4##4##(2008-10#4)
low molecular weight heparin##3##4##(2013-1#3)
low molecular weight selenium compounds##2##5##(2010-11#2)
low molecular weight selenium species##2##5##(2010-11#2)
low molecular weight selenium##4##4##(2010-11#4)
low molecular weight##34##3##(1991-9#2)(1993-8#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-9#1)(2010-11#4)(2010-8#1)(2011-2#2)(2013-1#3)(2013-8#1)
low molecular##41##2##(1991-9#2)(1993-8#1)(1995-6#1)(2008-10#18)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-11#4)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
low monitors##2##2##(2008-4#2)
low morbidity rate##2##3##(1994-2#1)(2011-2#1)
low morbidity##3##2##(1994-2#1)(1995-1#1)(2011-2#1)
low mortality rate##2##3##(1995-12#1)(2008-4#1)
low mortality##3##2##(1995-12#1)(2008-4#1)(2008-5#1)
low mug l(-1)##3##3##(2008-10#3)
low mug##4##2##(2008-10#4)
low number of cells##2##4##(1993-6#1)(1995-9#1)
low number of##4##3##(1990-12#1)(1993-6#1)(1995-9#1)(2008-10#1)
low numbers of ascospores##2##4##(2008-10#2)
low numbers of##6##3##(1992-12#1)(2008-10#3)(2008-4#1)(2013-1#1)
low numbers##7##2##(1992-12#1)(2008-10#4)(2008-4#1)(2013-1#1)
low on##6##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#2)
low or even##2##3##(1994-3#2)
low or high##6##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-9#2)(2013-1#1)
low or##21##2##(1992-12#1)(1994-3#2)(1995-12#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-2#1)(2012-9#2)(2013-1#1)(2013-8#1)
low output##2##2##(1995-3#1)(2008-3#1)
low oxygen partial pressure##3##4##(2008-11#2)(2013-8#1)
low oxygen##5##2##(1996-12#1)(2008-10#1)(2008-11#2)(2013-8#1)
low pH and##4##3##(1994-8#3)(2008-10#1)
low pH##24##2##(1990-5#2)(1990-8#2)(1991-9#2)(1993-8#2)(1994-8#4)(2008-10#9)(2008-11#1)(2010-4#1)(2013-8#1)
low pathogenic##2##2##(1996-12#1)(2008-10#1)
low percentage of##2##3##(2008-10#1)(2008-5#1)
low percentage##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
low performance##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
low polarity##2##2##(2008-10#1)(2008-7#1)
low polydispersity (PDI##2##3##(2008-12#2)
low population density##2##3##(2008-8#1)(2008-9#1)
low population##6##2##(2008-10#2)(2008-8#3)(2008-9#1)
low potential##3##2##(2008-10#2)(2008-5#1)
low power##5##2##(2008-10#4)(2011-2#1)
low precision##2##2##(2008-10#2)
low pressure##10##2##(1996-3#2)(1996-9#1)(2008-10#6)(2008-7#1)
low productivity##4##2##(2008-11#2)(2008-9#2)
low protein##5##2##(1993-8#1)(1996-12#1)(2008-10#2)(2008-11#1)
low pump##3##2##(2008-3#3)
low pyrolysis##2##2##(2008-10#2)
low rainfall##2##2##(2008-10#1)(2008-8#1)
low rainfall)##2##2##(2008-10#2)
low rate of##11##3##(1991-9#1)(1993-6#1)(1994-1#1)(1996-11#1)(2008-10#3)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
low rate##12##2##(1991-9#1)(1993-6#1)(1994-1#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
low rates of##3##3##(2008-8#1)(2008-9#1)(2012-12#1)
low reaction strains##2##3##(2013-8#2)
low reagent consumption##3##3##(2008-10#3)
low reagent##5##2##(2008-10#5)
low receptor##2##2##(1991-2#1)(1995-2#1)
low recovery##2##2##(2008-10#2)
low relative humidity (RH)##2##4##(2008-10#2)
low relative humidity##3##3##(2008-10#3)
low relative##5##2##(2008-10#4)(2012-9#1)
low reproductive success in##2##4##(2008-9#1)(2012-3#1)
low reproductive success##3##3##(2008-9#1)(2012-3#2)
low residual##2##2##(2008-11#1)(2008-3#1)
low resistance##6##2##(2008-10#5)(2009-8#1)
low resolution##3##2##(2008-10#3)
low resource settings##2##3##(2011-2#2)
low resource##4##2##(2008-9#1)(2011-2#2)(2013-1#1)
low risk for##2##3##(2008-10#1)(2009-3#1)
low risk of latent infection##2##5##(2008-10#2)
low risk of##7##3##(1992-5#1)(2008-10#3)(2010-7#1)(2011-2#1)(2012-3#1)
low risk##15##2##(1992-5#1)(1993-1#1)(1994-3#1)(1995-1#1)(2008-10#4)(2008-11#1)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#2)
low salt##2##2##(2008-8#1)(2011-2#1)
low sample volume##3##3##(2008-10#3)
low sample##7##2##(2008-10#7)
low selectivity##3##2##(1995-11#1)(2008-10#2)
low selenium mushroom##2##3##(2008-10#2)
low sensitivity and##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
low sensitivity of##3##3##(1990-3#1)(2008-8#1)(2011-2#1)
low sensitivity to the##2##4##(2008-5#1)(2008-8#1)
low sensitivity to##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
low sensitivity##15##2##(1990-3#1)(1992-3#1)(1993-3#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#4)
low sequence##3##2##(1993-9#1)(2008-10#1)(2011-1#1)
low serum##9##2##(1991-12#1)(1993-3#1)(1995-3#1)(1995-5#1)(2008-11#4)(2010-6#1)
low severity##2##2##(2008-10#2)
low signal intensity in the##2##5##(1991-11#2)
low signal intensity##5##3##(1991-11#4)(2011-2#1)
low signal##6##2##(1991-11#4)(2008-10#1)(2011-2#1)
low similarity##3##2##(2008-12#1)(2008-9#2)
low socio-economic status##2##3##(2008-1#1)(2012-3#1)
low socioeconomic##4##2##(2008-1#2)(2012-2#1)(2013-1#1)
low soil moisture##2##3##(2008-10#1)(2012-7#1)
low soil##3##2##(2008-10#2)(2012-7#1)
low solubility##7##2##(1997-1#2)(2008-10#5)
low solvent consumption##2##3##(2008-10#2)
low spore##2##2##(2008-10#2)
low stability##3##2##(1993-8#1)(2008-10#2)
low standard##2##2##(2008-10#1)(2011-3#1)
low stress##2##2##(2008-7#1)(2008-8#1)
low surface##3##2##(1996-12#1)(1997-2#1)(2013-8#1)
low survival##2##2##(2008-9#2)
low susceptibility to the##2##4##(2008-3#1)(2008-5#1)
low susceptibility##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
low symptom##2##2##(2008-10#1)(2011-1#1)
low tar and nicotine cigarettes##2##5##(2009-7#2)
low targeting##2##2##(2008-11#2)
low temperature culture##3##3##(2008-11#3)
low temperature electrothermal vaporization##2##4##(2008-10#2)
low temperature microwave-assisted extraction method##2##5##(2008-10#2)
low temperature of##2##3##(2008-10#2)
low temperature##33##2##(1993-6#1)(1997-2#1)(2008-10#14)(2008-11#6)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-4#1)
low temperatures and##2##3##(1993-8#1)(2008-10#1)
low temperatures##15##2##(1993-8#2)(2008-10#9)(2008-3#2)(2008-8#1)(2009-7#1)
low to allow##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
low to medium##3##3##(2008-10#2)(2008-5#1)
low to moderate##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)
low to##17##2##(1995-2#1)(1996-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-2#1)
low toxicity##4##2##(2008-10#2)(2008-11#2)
low values for##2##3##(1992-12#1)(2008-10#1)
low values##7##2##(1992-12#1)(1992-9#1)(2008-10#4)(2008-5#1)
low variability##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
low virulence on##4##3##(2008-10#4)
low virulence##7##2##(2008-10#7)
low viscosity##4##2##(2008-10#1)(2008-8#2)(2009-7#1)
low vitamin B12 level##2##4##(1990-3#1)(2010-1#1)
low vitamin B12##3##3##(1990-3#2)(2010-1#1)
low volume##3##2##(1992-11#1)(2008-10#2)
low water contents##2##3##(2008-10#2)
low water##5##2##(2008-10#4)(2011-2#1)
low with an average##2##4##(2008-10#2)
low with##5##2##(1993-1#1)(2008-10#4)
low yield##2##2##(1995-8#1)(2008-10#1)
low yields##2##2##(1990-2#1)(1996-5#1)
low##2053##1##(1990-11#6)(1990-12#5)(1990-2#2)(1990-3#6)(1990-5#13)(1990-6#4)(1990-7#1)(1990-8#8)(1990-9#2)(1991-11#15)(1991-12#11)(1991-2#3)(1991-3#4)(1991-5#8)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#9)(1992-10#3)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#14)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#11)(1993-11#7)(1993-12#6)(1993-2#4)(1993-3#13)(1993-5#1)(1993-6#10)(1993-8#21)(1993-9#3)(1994-1#4)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#7)(1994-5#3)(1994-6#2)(1994-8#17)(1994-9#2)(1995-1#4)(1995-11#12)(1995-12#9)(1995-2#9)(1995-3#5)(1995-5#2)(1995-6#8)(1995-8#8)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#18)(1996-2#12)(1996-3#7)(1996-5#3)(1996-6#4)(1996-8#5)(1996-9#3)(1997-1#8)(1997-2#11)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#7)(1997-9#1)(2006-6#1)(2007-11#4)(2007-12#2)(2008-1#6)(2008-10#749)(2008-11#110)(2008-12#44)(2008-2#9)(2008-3#34)(2008-4#12)(2008-5#33)(2008-6#5)(2008-7#75)(2008-8#68)(2008-9#51)(2009-1#5)(2009-10#6)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#6)(2009-5#3)(2009-6#1)(2009-7#17)(2009-8#9)(2009-9#7)(2010-1#18)(2010-10#11)(2010-11#9)(2010-12#9)(2010-2#2)(2010-4#10)(2010-5#3)(2010-6#4)(2010-7#5)(2010-8#10)(2010-9#6)(2011-1#14)(2011-10#1)(2011-2#70)(2011-3#5)(2011-7#1)(2012-12#18)(2012-2#31)(2012-3#33)(2012-4#1)(2012-5#1)(2012-7#4)(2012-8#1)(2012-9#3)(2013-1#61)(2013-7#1)(2013-8#26)
low- and middle-income##3##3##(1993-3#1)(2010-11#1)(2011-2#1)
low- and##5##2##(1993-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
low- or##2##2##(1993-1#1)(2013-8#1)
low- to##2##2##(2008-10#1)(2008-9#1)
low-##9##1##(1993-1#1)(1993-3#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-8#2)
low-CHO diet was associated with##2##5##(2013-8#2)
low-CHO diet was##3##3##(2013-8#3)
low-CHO diet##6##2##(2013-8#6)
low-GL##2##1##(2008-3#2)
low-LET##2##1##(2008-7#2)
low-SI areas##2##2##(1997-8#2)
low-a(w)-tolerant cells##2##2##(2008-10#2)
low-affinity##10##1##(1990-8#1)(1993-8#1)(1994-3#1)(1994-5#2)(1996-12#2)(2008-11#1)(2008-4#2)
low-anterior resection of the rectum##2##5##(2012-12#2)
low-anterior resection##3##2##(2012-12#3)
low-birefringence fiber##2##2##(2008-3#2)
low-birefringence##3##1##(2008-3#3)
low-calorie##2##1##(1995-3#1)(2008-5#1)
low-carbohydrate##6##1##(2008-3#5)(2013-8#1)
low-coherence##4##1##(2008-3#4)
low-contrast objects##2##2##(1997-8#2)
low-copy probes##2##2##(2008-10#2)
low-copy##3##1##(1995-2#1)(2008-10#2)
low-copy-number##3##1##(1993-12#3)
low-cost alternative##2##2##(2008-10#1)(2008-9#1)
low-cost and##3##2##(2008-10#3)
low-cost##41##1##(1995-1#1)(1996-3#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#3)(2012-2#1)
low-density lipoprotein (LDL) and##2##4##(2008-10#1)(2008-6#1)
low-density lipoprotein (LDL) receptor##3##4##(1995-6#1)(2008-6#2)
low-density lipoprotein (LDL)##9##3##(1995-6#1)(1996-2#1)(2008-10#2)(2008-6#4)(2011-1#1)
low-density lipoprotein cholesterol##2##3##(2010-7#1)(2013-1#1)
low-density lipoprotein oxidative modification by##2##5##(1994-11#2)
low-density lipoprotein##22##2##(1993-8#1)(1994-11#2)(1995-6#1)(1996-2#2)(2008-10#3)(2008-12#2)(2008-3#1)(2008-6#4)(2010-7#1)(2011-1#2)(2013-1#2)(2013-8#1)
low-density lipoproteins (LDL)##2##3##(1992-9#1)(1993-8#1)
low-density lipoproteins##3##2##(1992-9#1)(1993-8#1)(2009-8#1)
low-density##27##1##(1992-9#1)(1993-8#2)(1994-11#2)(1995-6#1)(1996-2#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#4)(2009-8#1)(2010-7#1)(2011-1#2)(2013-1#3)(2013-8#1)
low-depositing ZnPTO shampoo##2##3##(2008-5#2)
low-dimensional spaces##2##2##(2008-10#1)(2009-5#1)
low-dimensional##4##1##(1995-9#1)(2008-10#1)(2008-6#1)(2009-5#1)
low-diversity##2##1##(2008-9#2)
low-dosage tablets##2##2##(2008-10#2)
low-dosage##3##1##(2008-10#3)
low-dose interleukin-2 and##2##3##(1992-12#2)
low-dose##21##1##(1990-6#2)(1992-12#3)(1992-6#1)(1993-1#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2010-10#1)(2010-11#1)(2011-2#1)(2013-8#3)
low-educated##2##1##(2009-9#2)
low-energy##4##1##(1993-8#2)(1994-5#2)
low-fat##4##1##(1992-9#1)(1995-9#1)(1997-1#1)(2012-2#1)
low-flow##2##1##(2008-10#1)(2012-2#1)
low-frequency vibration blur##2##3##(2008-3#2)
low-frequency vibration##3##2##(2008-3#3)
low-frequency##12##1##(1992-9#1)(2008-11#1)(2008-12#1)(2008-3#6)(2008-9#1)(2012-3#1)(2013-8#1)
low-glycemic##3##1##(2008-3#3)
low-grade astrocytomas##4##2##(1994-8#1)(2008-7#3)
low-grade non-Hodgkin's lymphomas##2##3##(1990-12#2)
low-grade##22##1##(1990-10#1)(1990-12#3)(1994-1#2)(1994-8#1)(1997-1#4)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
low-income adults##4##2##(2013-1#4)
low-income families##5##2##(1992-2#1)(2008-11#3)(2009-9#1)
low-income urban##2##2##(2009-7#1)(2013-1#1)
low-income##25##1##(1992-2#1)(1993-3#1)(1995-12#1)(1995-3#1)(1997-2#2)(2008-11#5)(2008-8#1)(2009-12#1)(2009-7#2)(2009-9#1)(2012-2#2)(2013-1#7)
low-intensity exercise##3##2##(2010-4#2)(2013-8#1)
low-intensity##6##1##(2008-10#1)(2008-7#1)(2010-4#2)(2012-3#1)(2013-8#1)
low-level exposures to##2##3##(2008-7#1)(2013-1#1)
low-level##16##1##(1993-8#2)(1995-5#1)(2008-10#4)(2008-2#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#3)
low-loss##2##1##(2007-12#1)(2008-3#1)
low-molecular weight##5##2##(1990-5#1)(1991-12#1)(2008-10#2)(2013-1#1)
low-molecular##7##1##(1990-5#2)(1991-12#1)(2008-10#3)(2013-1#1)
low-molecular-weight fraction##2##2##(2008-10#1)(2010-4#1)
low-molecular-weight metabolites##3##2##(2008-10#3)
low-molecular-weight proteins##2##2##(2010-3#2)
low-molecular-weight##15##1##(1990-5#2)(1994-5#1)(2008-10#7)(2008-11#1)(2010-3#2)(2010-4#1)(2013-1#1)
low-nitrogen##2##1##(2008-10#2)
low-noise##6##1##(2008-1#1)(2008-10#1)(2008-3#2)(2009-5#1)(2009-7#1)
low-nutrition diet##3##2##(2011-2#3)
low-pass filtering##2##2##(2008-3#2)
low-power laser##2##2##(2008-3#2)
low-power seed##2##2##(2008-2#1)(2008-3#1)
low-power##12##1##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#4)(2012-2#1)
low-predation environments##3##2##(2008-8#2)(2012-3#1)
low-predation##6##1##(2008-8#4)(2012-3#2)
low-pressure##5##1##(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)
low-quality##6##1##(2008-10#1)(2008-8#4)(2008-9#1)
low-rainfall##2##1##(2008-10#2)
low-resistance##2##1##(1996-2#1)(2008-2#1)
low-resolution##3##1##(2008-10#2)(2008-3#1)
low-risk##11##1##(1993-1#1)(1993-12#1)(1997-3#1)(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
low-serum##2##1##(2008-11#2)
low-shear##2##1##(2008-11#2)
low-spin cyanide-ligated bacterial hemoglobin from Vitreoscilla##2##6##(2008-9#2)
low-spin##7##1##(1993-8#3)(1994-5#1)(2008-10#1)(2008-9#2)
low-temperature##9##1##(2008-10#5)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)
low-threshold Ca2+##2##2##(1992-8#2)
low-utilizing##2##1##(2010-8#2)
low-voltage##2##1##(1992-12#1)(2008-8#1)
low-volume##4##1##(1997-8#1)(2008-10#3)
lower (0##2##2##(2008-10#1)(2013-8#1)
lower (P = 0##2##4##(2008-10#1)(2008-5#1)
lower (P =##3##3##(2008-10#1)(2008-5#1)(2009-1#1)
lower (p &lt##2##3##(2008-10#1)(2013-1#1)
lower (p##4##2##(1992-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
lower abdominal pain##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
lower abdominal##5##2##(1991-3#1)(2008-10#1)(2011-2#2)(2013-1#1)
lower absolute##2##2##(1994-6#1)(2008-9#1)
lower academic achievement##2##3##(2008-11#1)(2010-1#1)
lower activity##3##2##(1995-2#1)(1995-8#1)(2008-8#1)
lower affinity than##2##3##(1995-11#1)(1995-6#1)
lower affinity##5##2##(1990-11#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-7#1)
lower after##2##2##(1991-6#1)(2008-4#1)
lower amount of##2##3##(2007-12#1)(2008-10#1)
lower amounts of##2##3##(1997-2#1)(2008-10#1)
lower and higher##5##3##(1994-11#1)(2008-10#2)(2008-8#1)(2010-8#1)
lower and upper##4##3##(1997-8#1)(2012-2#2)(2013-1#1)
lower and##14##2##(1994-11#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
lower at##12##2##(1995-6#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
lower back pain##2##3##(2008-4#1)(2009-9#1)
lower back##5##2##(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
lower binding##2##2##(1992-10#1)(2008-7#1)
lower blood##2##2##(1993-2#1)(2013-8#1)
lower body##3##2##(2010-1#1)(2012-2#1)(2013-1#1)
lower bound##2##2##(1997-6#1)(2008-2#1)
lower cell##4##2##(2008-11#3)(2008-9#1)
lower circulating##2##2##(1992-9#2)
lower compared with##4##3##(2008-10#1)(2011-2#2)(2011-3#1)
lower compared##5##2##(2008-10#1)(2008-5#1)(2011-2#2)(2011-3#1)
lower complication##2##2##(1991-3#1)(2011-2#1)
lower concentration of##6##3##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
lower concentration than##2##3##(2008-10#1)(2008-11#1)
lower concentration##12##2##(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
lower concentrations and##2##3##(2008-10#2)
lower concentrations in##2##3##(2008-10#2)
lower concentrations of##5##3##(1993-12#1)(1994-2#1)(2008-10#3)
lower concentrations##18##2##(1993-12#1)(1994-2#1)(1997-2#1)(2008-10#12)(2008-8#1)(2013-1#1)(2013-8#1)
lower copy##2##2##(1993-9#1)(2008-10#1)
lower cost##4##2##(1997-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
lower costs and higher##2##4##(2008-11#1)(2011-2#1)
lower costs##7##2##(1996-1#1)(1996-3#1)(2008-11#3)(2011-2#2)
lower cranial nerve palsies##2##4##(2008-7#1)(2011-2#1)
lower cranial##3##2##(2008-7#1)(2011-2#2)
lower density in the##2##4##(2008-7#1)(2008-9#1)
lower detection limit and##2##4##(2008-10#2)
lower detection limit of##9##4##(2008-10#8)(2008-11#1)
lower detection limit##20##3##(1990-12#1)(2008-10#18)(2008-11#1)
lower detection limits##8##3##(2008-10#8)
lower detection##28##2##(1990-12#1)(2008-10#26)(2008-11#1)
lower developmental threshold##2##3##(2008-8#2)
lower disease incidence##2##3##(2008-10#2)
lower disease severity##2##3##(2008-10#2)
lower disease##4##2##(2008-10#4)
lower dosages of##2##3##(1992-12#1)(2008-10#1)
lower dose##5##2##(1994-5#1)(2008-1#1)(2008-10#2)(2008-9#1)
lower doses##6##2##(1990-11#1)(1990-9#1)(1991-10#1)(1997-2#1)(2008-7#1)(2011-1#1)
lower efficacy##2##2##(2008-10#1)(2008-5#1)
lower enhancement##2##2##(1997-8#1)(2008-4#1)
lower esophageal sphincter##3##3##(1992-6#1)(1992-9#1)(2011-2#1)
lower eukaryotes##5##2##(1995-2#1)(2008-11#2)(2008-7#1)(2012-2#1)
lower expression of##2##3##(2008-10#1)(2008-11#1)
lower expression##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
lower extremities##15##2##(1993-6#1)(1995-8#1)(1997-4#1)(1997-8#4)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#1)
lower extremity injuries##2##3##(2013-1#2)
lower extremity weakness##2##3##(2008-8#1)(2009-3#1)
lower extremity##25##2##(1991-12#1)(2008-12#3)(2008-8#2)(2008-9#1)(2009-1#2)(2009-3#1)(2010-7#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#6)
lower female##3##2##(1990-2#1)(1994-1#1)(2008-5#1)
lower flow##2##2##(2008-7#1)(2010-4#1)
lower flux##3##2##(2008-10#1)(2008-7#2)
lower following##2##2##(2010-8#1)(2012-12#1)
lower for patients##2##3##(1990-12#1)(2010-10#1)
lower for the##2##3##(2008-10#2)
lower for##25##2##(1990-12#2)(1993-11#1)(1995-1#2)(1995-2#1)(1997-2#1)(2008-10#14)(2008-12#1)(2010-10#1)(2011-2#1)(2011-7#1)
lower fraction of##4##3##(1991-11#2)(2008-7#2)
lower fraction##5##2##(1991-11#2)(1994-2#1)(2008-7#2)
lower frequency of##3##3##(1991-3#1)(2008-10#1)(2012-3#1)
lower frequency##4##2##(1991-3#1)(2008-10#2)(2012-3#1)
lower genital tract##7##3##(1992-3#2)(1994-1#1)(2011-2#4)
lower genotypic diversity##2##3##(2008-10#2)
lower growth rate##2##3##(2008-5#1)(2008-9#1)
lower immune##2##2##(2008-9#1)(2011-2#1)
lower in males##2##3##(1991-6#2)
lower in older##2##3##(1995-5#1)(2008-7#1)
lower in patients##3##3##(1993-1#1)(2012-3#1)(2013-1#1)
lower in the obese patients##2##5##(2011-1#1)(2011-2#1)
lower in the##24##3##(1991-11#1)(1993-8#1)(1994-2#2)(2008-10#6)(2008-7#3)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
lower in##78##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#3)(1992-3#1)(1993-1#1)(1993-8#1)(1994-2#3)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#29)(2008-11#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
lower incidence of##8##3##(1990-8#1)(1992-3#1)(2008-10#4)(2011-2#2)
lower incidence##9##2##(1990-8#1)(1992-3#1)(2008-10#5)(2011-2#2)
lower intensity##2##2##(2008-10#1)(2008-7#1)
lower leaf##2##2##(2008-10#1)(2012-9#1)
lower leaves##2##2##(2008-10#2)
lower left##3##2##(2011-2#1)(2013-1#2)
lower leg and##2##3##(1997-8#1)(2011-2#1)
lower leg##7##2##(1994-6#1)(1997-8#2)(2010-6#1)(2011-2#1)(2012-12#2)
lower legs##2##2##(1993-8#1)(1997-8#1)
lower level of##12##3##(1993-8#1)(1997-3#1)(2008-10#3)(2008-11#2)(2009-12#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
lower level##15##2##(1990-3#1)(1993-8#1)(1997-3#1)(2008-10#4)(2008-11#2)(2009-12#1)(2010-11#2)(2011-1#1)(2012-3#1)(2013-8#1)
lower levels in##2##3##(1992-10#1)(1995-2#1)
lower levels of##28##3##(1991-1#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-9#1)(2009-10#1)(2009-7#3)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
lower levels##34##2##(1991-1#1)(1992-10#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#3)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
lower life satisfaction##2##3##(2009-5#2)
lower limb inequality##3##3##(2013-1#3)
lower limb##9##2##(1995-2#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
lower limit of detection (LOD)##5##5##(2008-10#5)
lower limit of detection of##3##5##(2008-10#3)
lower limit of detection##12##4##(2008-10#12)
lower limit of quantitation was 0##2##6##(2008-10#2)
lower limit of quantitation was##3##5##(2008-10#3)
lower limit of quantitation##4##4##(2008-10#4)
lower limit of##19##3##(1991-5#1)(2008-10#17)(2008-2#1)
lower limit##22##2##(1991-5#1)(2008-10#19)(2008-2#1)(2008-3#1)
lower limits of detection and##2##5##(2008-10#2)
lower limits of detection##4##4##(2008-10#4)
lower limits of##7##3##(2008-10#5)(2008-7#1)(2011-3#1)
lower limits##8##2##(2008-10#5)(2008-11#1)(2008-7#1)(2011-3#1)
lower lip and##2##3##(1993-12#1)(2012-3#1)
lower lip##6##2##(1991-8#2)(1993-12#1)(2012-3#1)(2013-1#2)
lower lobe##5##2##(1991-3#1)(1997-3#1)(2007-8#1)(2008-1#2)
lower lung##2##2##(1991-2#1)(2012-12#1)
lower mean##3##2##(2008-7#1)(2008-9#2)
lower number of##5##3##(2008-10#1)(2010-12#1)(2012-3#1)(2012-5#1)(2013-1#1)
lower numbers of##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
lower odds of##2##3##(2010-7#1)(2011-2#1)
lower odds##3##2##(2010-7#1)(2011-2#1)(2012-3#1)
lower on the##3##3##(2008-5#1)(2010-8#2)
lower on##5##2##(2008-10#1)(2008-5#1)(2010-8#2)(2011-2#1)
lower or##2##2##(1995-5#1)(2008-10#1)
lower out-of-pocket medical expenditures and medical debt (including fewer bills sent to collection)##2##13##(2013-1#2)
lower pH##5##2##(1992-12#1)(2008-10#3)(2013-1#1)
lower part of the##2##4##(1996-12#1)(2008-10#1)
lower part of##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
lower parts##6##2##(2008-10#2)(2008-12#2)(2013-1#2)
lower performance in##2##3##(1991-2#1)(2009-10#1)
lower population densities##2##3##(2008-10#2)
lower population##5##2##(2008-10#3)(2008-8#2)
lower power##2##2##(1992-12#1)(2008-7#1)
lower productivity##2##2##(2008-11#2)
lower quality##3##2##(1994-2#1)(2008-9#1)(2010-9#1)
lower rate of##5##3##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
lower rates of##3##3##(2009-3#1)(2012-12#1)(2013-1#1)
lower rates##5##2##(2008-10#1)(2008-6#1)(2009-3#1)(2012-12#1)(2013-1#1)
lower respiratory tract##2##3##(1996-3#1)(2008-11#1)
lower respiratory##4##2##(1996-3#1)(2008-1#1)(2008-11#1)(2013-8#1)
lower risk of##2##3##(2008-1#1)(2008-12#1)
lower risk##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
lower scale##2##2##(2008-10#2)
lower scores##3##2##(2008-7#2)(2010-10#1)
lower sensitivity to##2##3##(1991-6#1)(2012-3#1)
lower sensitivity##3##2##(1991-6#1)(2008-10#1)(2012-3#1)
lower serum cholesterol##2##3##(1991-6#2)
lower serum magnesium##2##3##(2011-2#2)
lower serum##4##2##(1991-6#2)(2011-2#2)
lower small intestine##3##3##(2008-5#3)
lower stability of##2##3##(2008-10#2)
lower stability##3##2##(1992-10#1)(2008-10#2)
lower stem##2##2##(2008-10#2)
lower stems##3##2##(2008-10#3)
lower stratosphere##3##2##(2008-3#3)
lower survival rates##2##3##(2008-11#1)(2009-10#1)
lower survival##5##2##(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
lower susceptibility##2##2##(2008-10#1)(2008-5#1)
lower temperature##10##2##(1992-10#1)(1992-8#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#2)
lower temperatures and##2##3##(2008-10#2)
lower temperatures##7##2##(2008-10#5)(2008-9#2)
lower than 0##12##3##(2008-10#12)
lower than 1##3##3##(2008-10#3)
lower than 1%##4##3##(2008-10#4)
lower than 10##2##3##(1996-2#1)(2008-10#1)
lower than 10%##5##3##(2008-10#5)
lower than 2##2##3##(2008-10#2)
lower than 2%##3##3##(2008-10#3)
lower than 20%##2##3##(2008-10#2)
lower than 3##5##3##(1990-2#1)(2008-10#3)(2012-12#1)
lower than 4##4##3##(2008-10#4)
lower than 5%##2##3##(2008-10#2)
lower than 7##2##3##(1990-9#1)(2008-10#1)
lower than 90%##2##3##(2008-10#2)
lower than 98 fl##2##4##(1990-3#2)
lower than expected##2##3##(1995-1#1)(2009-8#1)
lower than for##3##3##(2008-10#3)
lower than in control##3##4##(2008-10#1)(2008-11#1)(2010-1#1)
lower than in controls##3##4##(1992-11#1)(2008-7#1)(2011-2#1)
lower than in the##5##4##(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#1)
lower than in those##3##4##(1997-3#1)(2011-2#2)
lower than in##24##3##(1990-11#1)(1990-5#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-2#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#4)
lower than normal##2##3##(1993-3#1)(2008-10#1)
lower than that for##3##4##(1992-3#1)(1993-8#1)(2008-11#1)
lower than that found in##2##5##(1990-6#1)(2008-10#1)
lower than that in the##2##5##(1995-8#1)(2008-11#1)
lower than that in##5##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
lower than that measured##2##4##(1996-2#1)(2008-10#1)
lower than that observed##2##4##(1995-8#1)(2008-11#1)
lower than that obtained##2##4##(2008-11#1)(2009-10#1)
lower than that of the bare##2##6##(2008-10#2)
lower than that of the##7##5##(1991-8#1)(2008-10#4)(2008-9#1)(2010-1#1)
lower than that of##23##4##(1991-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#2)(2010-1#1)(2011-2#1)(2011-3#1)
lower than that##46##3##(1990-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#2)(1996-2#2)(1997-8#1)(2007-12#1)(2008-10#14)(2008-11#7)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-1#1)(2011-2#2)(2011-3#1)(2013-1#1)
lower than the Km for the androgenic steroid##2##8##(1990-11#2)
lower than the corresponding##2##4##(2008-10#1)(2009-9#1)
lower than the mean##2##4##(2008-7#1)(2009-11#1)
lower than the##33##3##(1990-11#2)(1990-6#1)(1991-11#1)(1993-3#1)(1996-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-11#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
lower than those detected in##2##5##(1995-12#1)(2008-10#1)
lower than those in other##2##5##(2008-10#2)
lower than those in the##3##5##(2010-8#1)(2011-2#2)
lower than those in##8##4##(1995-8#1)(2008-10#2)(2008-12#1)(2010-7#1)(2010-8#1)(2011-2#2)
lower than those obtained##2##4##(2008-10#1)(2008-11#1)
lower than those of the##5##5##(1995-8#1)(2008-10#2)(2011-3#1)(2013-1#1)
lower than those of##11##4##(1990-6#1)(1995-8#1)(2008-10#4)(2008-11#3)(2011-3#1)(2013-1#1)
lower than those##33##3##(1990-6#1)(1995-12#1)(1995-8#2)(2008-10#13)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#2)
lower than##245##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-9#1)(1991-11#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#4)(1996-12#1)(1996-2#3)(1996-5#2)(1997-3#1)(1997-8#3)(2007-12#1)(2008-10#120)(2008-11#16)(2008-12#7)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#10)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
lower the##12##2##(1992-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
lower thoracic##2##2##(2008-12#1)(2013-3#1)
lower threshold##2##2##(2008-10#1)(2008-3#1)
lower to##2##2##(1997-2#1)(2008-10#1)
lower total##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#2)(2013-8#1)
lower toxicity##3##2##(1990-11#1)(2008-10#2)
lower trapezius##4##2##(2010-9#4)
lower urinary tract symptoms##2##4##(2008-10#1)(2013-1#1)
lower urinary tract##6##3##(2008-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
lower value##2##2##(1991-9#1)(2013-1#1)
lower values for##2##3##(2008-10#1)(2008-7#1)
lower values were##2##3##(2008-10#1)(2010-6#1)
lower values##11##2##(2008-10#3)(2008-7#2)(2010-4#1)(2010-6#1)(2011-2#3)(2012-3#1)
lower vertebrates##2##2##(2008-12#1)(2008-4#1)
lower vitamin D##2##3##(2012-2#1)(2012-3#1)
lower when##2##2##(1990-5#1)(2008-10#1)
lower with##4##2##(1996-8#1)(2008-10#1)(2011-2#2)
lower yeast##2##2##(2008-10#1)(2008-7#1)
lower yield##2##2##(2008-10#1)(2008-5#1)
lower##1303##1##(1990-11#7)(1990-12#6)(1990-2#2)(1990-3#4)(1990-5#2)(1990-6#5)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#8)(1991-12#3)(1991-2#2)(1991-3#7)(1991-5#1)(1991-6#8)(1991-8#4)(1991-9#2)(1992-10#5)(1992-11#3)(1992-12#6)(1992-3#7)(1992-6#3)(1992-8#1)(1992-9#6)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#7)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#8)(1994-5#2)(1994-6#3)(1994-8#3)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#3)(1995-5#3)(1995-6#5)(1995-8#8)(1996-1#1)(1996-12#5)(1996-2#10)(1996-3#8)(1996-5#7)(1996-6#1)(1996-8#1)(1997-1#4)(1997-2#9)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#14)(2007-12#2)(2007-8#3)(2008-1#7)(2008-10#434)(2008-11#72)(2008-12#26)(2008-2#3)(2008-3#11)(2008-4#5)(2008-5#21)(2008-6#3)(2008-7#55)(2008-8#31)(2008-9#37)(2009-1#4)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#4)(2009-5#5)(2009-6#1)(2009-7#10)(2009-8#4)(2009-9#3)(2010-1#6)(2010-10#2)(2010-11#8)(2010-12#5)(2010-4#6)(2010-5#2)(2010-6#7)(2010-7#6)(2010-8#8)(2010-9#6)(2011-1#7)(2011-2#78)(2011-3#6)(2011-7#1)(2012-12#17)(2012-2#25)(2012-3#24)(2012-5#3)(2012-7#2)(2012-9#1)(2013-1#61)(2013-3#1)(2013-7#1)(2013-8#19)
lower-income##2##1##(2012-3#2)
lower-order##3##1##(2011-2#3)
lowered blood##2##2##(2008-11#1)(2008-5#1)
lowered by##2##2##(1991-12#1)(1992-6#1)
lowered cell##2##2##(2009-12#1)(2009-6#1)
lowered cellular##2##2##(1994-11#1)(2008-10#1)
lowered in##2##2##(2008-10#1)(2010-5#1)
lowered the##15##2##(1992-12#3)(1992-3#1)(1995-2#1)(2008-10#7)(2008-11#2)(2011-2#1)
lowered##51##1##(1991-12#1)(1991-6#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#14)(2008-11#7)(2008-5#2)(2008-7#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
lowering diets##2##2##(2008-4#2)
lowering may##2##2##(2008-4#1)(2009-11#1)
lowering of the##5##3##(1997-5#1)(2008-10#3)(2010-11#1)
lowering of##16##2##(1991-12#1)(1997-5#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-8#1)(2010-11#1)(2010-2#1)
lowering the##10##2##(1993-1#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2010-4#1)
lowering##54##1##(1991-12#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-1#1)(1995-2#1)(1997-5#1)(2008-1#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2013-8#1)
lowers the##4##2##(1993-12#1)(1995-2#1)(2007-8#1)(2008-10#1)
lowers##8##1##(1990-12#1)(1993-12#1)(1993-5#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-11#1)
lowest average##2##2##(1990-2#1)(2012-12#1)
lowest capacity##2##2##(2008-10#1)(2013-1#1)
lowest concentration of##3##3##(2008-10#3)
lowest concentration##6##2##(1994-11#1)(2008-10#5)
lowest detected##3##2##(2008-10#2)(2009-5#1)
lowest detection limit##3##3##(2008-10#3)
lowest detection##5##2##(2008-10#5)
lowest fitness##2##2##(2008-10#2)
lowest for##3##2##(2008-10#2)(2008-9#1)
lowest in the##5##3##(1996-12#1)(2008-10#2)(2008-7#1)(2009-10#1)
lowest in##18##2##(1991-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-10#1)(2009-7#2)(2013-8#1)
lowest level of##3##3##(1996-12#1)(2008-10#1)(2012-3#1)
lowest level##10##2##(1993-2#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-8#1)(2012-3#1)(2013-1#2)
lowest limit of detection##3##4##(2008-10#3)
lowest on##3##2##(2008-10#2)(2008-5#1)
lowest possible cost##2##3##(1997-1#1)(2008-11#1)
lowest possible##3##2##(1997-1#1)(2008-11#1)(2008-6#1)
lowest scores##2##2##(2009-11#1)(2012-3#1)
lowest values##5##2##(2008-10#3)(2008-11#1)(2013-1#1)
lowest was##2##2##(2008-5#1)(2013-8#1)
lowest##175##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-6#4)(1993-2#1)(1993-8#2)(1994-11#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(2008-1#1)(2008-10#86)(2008-11#7)(2008-12#3)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#3)(2010-5#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#10)(2013-8#2)
lowest-order modes##3##2##(2008-3#3)
lowest-order##5##1##(2007-12#1)(2008-3#4)
lowland rice##2##2##(2008-10#2)
lowland##6##1##(2008-10#3)(2008-8#2)(2010-8#1)
loyalty of##2##2##(1994-12#1)(1996-1#1)
loyalty##4##1##(1994-12#2)(1995-2#1)(1996-1#1)
lpr##2##1##(1997-8#2)
lr34/yr18##2##1##(2008-10#2)
lts1##2##1##(2009-10#2)
lubricant##5##1##(2008-10#4)(2010-10#1)
lubricants by##2##2##(2008-10#1)(2010-4#1)
lubricants##7##1##(2008-10#2)(2008-7#1)(2010-4#4)
lubricating oil samples##3##3##(2008-10#3)
lubricating oil##7##2##(2008-10#7)
lubricating oils by##4##3##(2008-10#4)
lubricating oils##15##2##(2008-10#15)
lubricating##25##1##(1995-3#1)(2008-10#23)(2010-10#1)
lubrication and##2##2##(1994-9#1)(2010-10#1)
lubrication##4##1##(1994-9#1)(2008-10#1)(2010-10#2)
lubricin##6##1##(2010-10#6)
lucent##7##1##(2007-12#2)(2008-5#2)(2008-7#3)
lucidum##3##1##(2008-11#3)
luciferase activity was##2##3##(2008-11#2)
luciferase activity##3##2##(2008-11#3)
luciferase and##2##2##(1993-6#1)(2008-10#1)
luciferase assay##2##2##(2008-11#1)(2009-8#1)
luciferase gene##6##2##(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#3)
luciferase in##2##2##(2008-10#2)
luciferase reporter gene##2##3##(1995-6#1)(2008-9#1)
luciferase reporter##4##2##(1995-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
luciferase##40##1##(1993-6#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#2)(2008-10#11)(2008-11#14)(2008-8#3)(2008-9#2)(2009-8#1)(2011-2#2)(2012-2#1)
luciferin##3##1##(2008-10#3)
lucigenin by##2##2##(2008-10#2)
lucigenin##8##1##(2008-10#8)
lucky##2##1##(2012-2#1)(2012-3#1)
lumbago##3##1##(1991-11#1)(1991-12#1)(2008-7#1)
lumbar BMC##2##2##(1991-11#2)
lumbar CSF##2##2##(1993-1#2)
lumbar disc disease or##2##4##(2008-12#1)(2013-1#1)
lumbar disc herniation##5##3##(1997-3#1)(2008-12#3)(2013-1#1)
lumbar disc##8##2##(1997-3#1)(2008-12#4)(2012-12#1)(2013-1#2)
lumbar disk##2##2##(1990-9#1)(2009-3#1)
lumbar hernia##2##2##(2008-12#2)
lumbar hernias are##2##3##(2008-12#2)
lumbar hernias##3##2##(2008-12#2)(2010-8#1)
lumbar interbody fusion##3##3##(2011-2#3)
lumbar puncture##3##2##(1990-12#1)(2008-7#1)(2012-3#1)
lumbar scoliosis in the##2##4##(1997-4#1)(2008-8#1)
lumbar scoliosis##3##2##(1997-4#1)(2008-8#2)
lumbar spinal##5##2##(1990-5#2)(2008-7#2)(2012-12#1)
lumbar spine surgery##6##3##(2008-7#3)(2012-12#3)
lumbar spine##20##2##(1991-11#3)(2008-7#3)(2008-8#2)(2010-1#1)(2010-3#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
lumbar vein##4##2##(2011-2#4)
lumbar vertebrae##5##2##(1996-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
lumbar vertebral##2##2##(2008-7#1)(2011-2#1)
lumbar##104##1##(1990-12#1)(1990-3#1)(1990-5#3)(1990-9#1)(1991-11#6)(1993-1#2)(1996-3#2)(1996-6#3)(1997-3#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-12#8)(2008-7#9)(2008-8#6)(2009-3#1)(2010-1#2)(2010-3#4)(2010-6#1)(2010-8#1)(2011-2#17)(2012-12#11)(2012-2#2)(2012-3#4)(2013-1#12)(2013-8#3)
lumber##2##1##(2008-10#2)
lumbo-pelvic##3##1##(2009-9#2)(2012-3#1)
lumbo-sacral junction##2##2##(2008-12#2)
lumbo-sacral##4##1##(2008-12#4)
lumbosacral PVM##3##2##(2013-8#3)
lumbosacral##14##1##(2008-7#3)(2009-11#1)(2009-9#1)(2010-6#2)(2012-3#2)(2013-8#5)
lumen and##4##2##(2008-11#1)(2008-7#1)(2013-1#2)
lumen between##2##2##(2007-12#1)(2008-7#1)
lumen diameter##4##2##(1997-4#1)(2009-1#2)(2011-2#1)
lumen even##2##2##(2008-7#1)(2011-2#1)
lumen in##2##2##(1991-2#1)(2008-10#1)
lumen is##2##2##(2007-12#2)
lumen of the gland##2##4##(2007-12#2)
lumen of the##10##3##(1997-1#1)(1997-6#1)(2007-12#3)(2008-10#2)(2008-7#1)(2011-2#2)
lumen of##14##2##(1997-1#1)(1997-6#1)(2007-12#3)(2008-10#5)(2008-7#1)(2011-2#2)(2011-3#1)
lumen was##3##2##(2008-6#1)(2008-7#2)
lumen with##3##2##(1990-8#1)(2007-12#1)(2008-7#1)
lumen##78##1##(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1996-3#1)(1996-6#1)(1997-1#4)(1997-4#2)(1997-6#2)(1997-8#1)(2007-12#12)(2008-10#11)(2008-11#7)(2008-5#1)(2008-6#2)(2008-7#10)(2009-1#2)(2009-3#2)(2010-2#1)(2010-7#1)(2011-2#7)(2011-3#2)(2013-1#4)
lumina##2##1##(1990-6#1)(2008-7#1)
luminal endothelial##2##2##(1995-2#2)
luminal surface LDL concentration##3##4##(2008-9#3)
luminal surface##5##2##(2008-9#5)
luminal##18##1##(1991-12#1)(1993-6#1)(1995-2#3)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#6)(2009-12#1)(2010-12#2)(2011-2#1)
luminance and contrast##2##3##(2008-3#2)
luminance in a##2##3##(2008-3#2)
luminance in##3##2##(2008-3#3)
luminance levels##3##2##(2008-3#1)(2011-2#2)
luminance of##2##2##(2008-3#2)
luminance##17##1##(1996-2#4)(2008-3#9)(2008-8#1)(2011-2#3)
luminescence analysis was##2##3##(2008-10#2)
luminescence analysis##6##2##(2008-10#6)
luminescence and##3##2##(1995-3#1)(2008-10#2)
luminescence determination of oil products and phenols in natural water##2##10##(2008-10#2)
luminescence determination of##4##3##(2008-10#4)
luminescence for the##2##3##(2008-10#2)
luminescence intensity##3##2##(2008-10#3)
luminescence method##4##2##(2008-10#4)
luminescence of##4##2##(1995-3#1)(2008-10#1)(2008-3#2)
luminescence phenomenon##2##2##(2008-10#2)
luminescence quenching##2##2##(2008-10#2)
luminescence spectroscopy##3##2##(2008-10#3)
luminescence technique##2##2##(2008-10#2)
luminescence was##2##2##(2008-10#1)(2012-2#1)
luminescence##65##1##(1992-11#1)(1995-3#3)(2007-12#3)(2008-10#48)(2008-11#2)(2008-3#4)(2010-1#1)(2012-2#1)(2013-1#2)
luminescent CdTe quantum dots prepared in aqueous phase##2##8##(2008-10#2)
luminescent CdTe quantum dots##3##4##(2008-10#3)
luminescent assay##2##2##(2008-10#2)
luminescent reagents##2##2##(2008-10#2)
luminescent##29##1##(2007-12#1)(2008-10#22)(2008-11#4)(2008-5#1)(2012-2#1)
luminol and ferricyanide##3##3##(2008-10#3)
luminol and periodate##3##3##(2008-10#3)
luminol and##9##2##(2008-10#9)
luminol in##2##2##(2008-10#2)
luminol oxidation by##2##3##(2008-10#2)
luminol oxidation##3##2##(2008-10#3)
luminol solution##6##2##(2008-10#6)
luminol##54##1##(2008-10#54)
luminol-H(2)O(2)##4##1##(2008-10#4)
luminol-H(2)O(2)-Cr(3+) system##2##2##(2008-10#2)
luminol-KIO(4)-H(2)O(2) CL system##2##3##(2008-10#2)
luminol-KIO(4)-H(2)O(2) CL##3##2##(2008-10#3)
luminol-based chemiluminescence##2##2##(2008-10#2)
luminol-dimethylsulfoxide-OH(-) chemiluminescence##2##2##(2008-10#2)
luminol-hydrogen peroxide##2##2##(2008-10#2)
luminol-hydrogen##3##1##(2008-10#3)
luminometer##4##1##(2008-10#3)(2012-2#1)
luminosity-type horizontal cells##2##3##(2008-8#2)
lumped into##2##2##(2008-10#1)(2008-7#1)
lumped##5##1##(2007-12#1)(2008-10#1)(2008-7#2)(2013-1#1)
lumps##4##1##(1992-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
lunch and##2##2##(2012-12#1)(2013-8#1)
lunch##5##1##(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
lung adenocarcinoma##10##2##(2008-1#1)(2008-11#3)(2008-9#4)(2012-2#1)(2013-8#1)
lung and##16##2##(1991-2#2)(1993-2#1)(1994-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-5#1)(2010-10#1)(2010-3#1)(2010-7#2)(2011-3#1)(2013-1#1)(2013-8#1)
lung at the##2##3##(1995-8#1)(1997-1#1)
lung biopsy##3##2##(2008-5#1)(2010-11#1)(2012-12#1)
lung by##4##2##(1992-12#1)(1994-12#2)(1995-8#1)
lung cDNA library##5##3##(1991-5#2)(1993-3#1)(1994-11#1)(1997-2#1)
lung cancer and mesothelioma##2##4##(1991-12#2)
lung cancer and##6##3##(1991-12#3)(1992-6#1)(2008-7#1)(2009-7#1)
lung cancer cell line##3##4##(1997-2#1)(2008-8#1)(2013-1#1)
lung cancer cell lines##2##4##(2008-11#1)(2012-2#1)
lung cancer cell##5##3##(1997-2#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
lung cancer cells##3##3##(2008-11#1)(2008-5#1)(2009-12#1)
lung cancer in##7##3##(1990-8#1)(1991-2#1)(1994-12#1)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
lung cancer incidence in Connecticut##2##5##(1996-3#2)
lung cancer incidence##5##3##(1996-3#4)(2011-3#1)
lung cancer is##2##3##(2008-11#1)(2010-5#1)
lung cancer patients and##2##4##(2008-11#1)(2010-5#1)
lung cancer patients##4##3##(2008-11#2)(2010-2#1)(2010-5#1)
lung cancer risk in##2##4##(1991-2#1)(1996-3#1)
lung cancer risk##4##3##(1991-2#2)(1996-3#2)
lung cancer specific##2##3##(2008-11#2)
lung cancer specimens##3##3##(1993-8#3)
lung cancer tissues##2##3##(1991-12#2)
lung cancer were##3##3##(1990-12#1)(1992-12#1)(2008-11#1)
lung cancer##118##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#9)(1991-2#5)(1991-8#3)(1992-12#2)(1992-6#4)(1993-2#1)(1993-8#4)(1993-9#1)(1994-12#3)(1994-6#2)(1994-8#1)(1995-9#1)(1996-2#1)(1996-3#7)(1997-2#1)(2008-1#2)(2008-10#5)(2008-11#11)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#4)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#3)(2009-7#2)(2010-2#3)(2010-5#3)(2011-2#1)(2011-3#5)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#4)
lung cancer]##3##2##(1997-4#1)(2008-1#1)(2008-11#1)
lung cancers##5##2##(1993-8#1)(2008-1#1)(2009-1#1)(2009-11#1)(2012-2#1)
lung capacity##4##2##(1991-12#1)(1996-2#2)(2012-3#1)
lung carcinoma cell line##3##4##(1994-8#1)(1996-12#1)(1997-2#1)
lung carcinoma##16##2##(1991-9#1)(1994-12#1)(1994-8#2)(1996-12#2)(1997-2#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-11#2)(2008-9#2)(2013-1#1)
lung cavities##3##2##(2010-8#3)
lung cell##4##2##(1990-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
lung cells##3##2##(1990-6#1)(1995-8#2)
lung cysts##2##2##(2012-2#2)
lung defense responses##3##3##(2008-10#3)
lung deposition##3##2##(1997-1#2)(2008-11#1)
lung development and##3##3##(1994-3#1)(1995-8#1)(1996-2#1)
lung development in##2##3##(1994-3#1)(1995-8#1)
lung development##7##2##(1994-3#2)(1995-8#3)(1996-2#1)(2010-7#1)
lung disease and##3##3##(1997-2#1)(1997-3#1)(2008-10#1)
lung disease in##7##3##(1990-3#1)(1991-12#1)(1997-3#1)(1997-4#2)(2012-2#1)(2012-3#1)
lung disease##32##2##(1990-3#1)(1991-12#2)(1994-12#1)(1994-6#2)(1995-2#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#1)
lung diseases##7##2##(1994-12#1)(1994-6#1)(1995-2#1)(2009-1#1)(2011-3#2)(2012-2#1)
lung dose##3##2##(1993-9#1)(1995-12#1)(1997-1#1)
lung eosinophilia##2##2##(2008-10#2)
lung expansion##2##2##(2008-10#1)(2012-3#1)
lung fibroblasts##7##2##(1990-5#2)(1993-3#1)(1995-12#1)(1995-8#2)(2008-11#1)
lung fields##2##2##(1991-12#1)(2012-12#1)
lung function and##2##3##(1991-12#1)(2008-11#1)
lung function tests and##2##4##(1997-2#1)(2008-7#1)
lung function tests##3##3##(1991-12#1)(1997-2#1)(2008-7#1)
lung function##15##2##(1991-12#4)(1991-2#1)(1992-6#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-11#1)(2008-7#1)(2009-1#1)(2012-2#2)
lung functions##4##2##(2012-2#3)(2012-3#1)
lung grafts##4##2##(2008-5#1)(2011-3#3)
lung hypoplasia##3##2##(1994-3#1)(2013-1#2)
lung in##3##2##(2008-2#1)(2010-7#1)(2012-3#1)
lung infections##2##2##(1997-5#1)(2008-10#1)
lung inflammation##2##2##(1990-2#1)(2008-10#1)
lung injuries##4##2##(1994-6#1)(2010-9#1)(2011-2#2)
lung injury##7##2##(1994-3#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
lung is##4##2##(1990-6#1)(2008-5#1)(2008-7#1)(2010-5#1)
lung lavage##4##2##(2010-7#4)
lung lesions##5##2##(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#2)
lung metastases##4##2##(1990-8#1)(1994-12#2)(2008-5#1)
lung metastasis##2##2##(2008-11#1)(2013-1#1)
lung parenchyma##5##2##(1991-12#3)(1992-1#1)(2009-1#1)
lung primary##2##2##(1990-12#1)(2008-2#1)
lung tissue##8##2##(1991-12#3)(1996-3#1)(2008-10#1)(2008-12#1)(2009-9#1)(2013-8#1)
lung tissues##3##2##(1993-8#2)(2008-12#1)
lung transplant##4##2##(1992-3#1)(2011-3#3)
lung transplantation is##2##3##(2011-3#1)(2012-2#1)
lung transplantation remains the##2##4##(1997-5#1)(2010-10#1)
lung transplantation##22##2##(1993-2#1)(1994-3#3)(1997-5#1)(2010-10#2)(2011-2#2)(2011-3#9)(2012-2#4)
lung transplantations are##2##3##(2011-3#2)
lung transplantations##3##2##(2011-2#1)(2011-3#2)
lung tumor multiplicity##2##3##(1994-5#2)
lung tumor##3##2##(1991-12#1)(1994-5#2)
lung tumors##2##2##(2008-11#1)(2009-11#1)
lung volumes##4##2##(1991-12#1)(1992-6#2)(2008-1#1)
lung was##3##2##(1995-8#1)(2008-8#1)(2009-9#1)
lung##554##1##(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#3)(1990-8#4)(1991-12#36)(1991-2#8)(1991-5#2)(1991-8#4)(1991-9#3)(1992-1#1)(1992-12#7)(1992-2#3)(1992-3#4)(1992-6#7)(1993-2#4)(1993-3#2)(1993-8#10)(1993-9#3)(1994-1#1)(1994-11#4)(1994-12#13)(1994-2#3)(1994-3#8)(1994-5#5)(1994-6#6)(1994-8#8)(1995-11#1)(1995-12#3)(1995-2#5)(1995-8#12)(1995-9#1)(1996-12#3)(1996-2#11)(1996-3#10)(1997-1#11)(1997-2#12)(1997-3#4)(1997-4#4)(1997-5#3)(1997-8#3)(2007-12#2)(2007-8#1)(2008-1#12)(2008-10#32)(2008-11#33)(2008-12#6)(2008-2#6)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#11)(2008-9#8)(2009-1#6)(2009-11#5)(2009-12#1)(2009-4#4)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#7)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#13)(2010-8#5)(2010-9#1)(2011-2#17)(2011-3#31)(2012-12#6)(2012-2#25)(2012-3#10)(2013-1#22)(2013-8#9)
lung)##3##1##(1994-12#1)(1996-2#1)(2008-10#1)
lung-transplant recipients and##2##3##(2012-2#2)
lungs and brain##2##3##(2008-10#1)(2009-9#1)
lungs and other##2##3##(1994-5#1)(1996-3#1)
lungs and##13##2##(1991-12#1)(1992-3#1)(1994-5#1)(1995-2#1)(1996-3#2)(1997-1#1)(2008-10#1)(2008-5#2)(2009-9#1)(2010-12#1)(2011-2#1)
lungs are##3##2##(2008-5#1)(2010-11#1)(2011-3#1)
lungs may##2##2##(1994-6#1)(1995-3#1)
lungs of##9##2##(1991-12#1)(1993-8#1)(1994-11#1)(1997-1#1)(2008-10#2)(2008-7#1)(2013-1#2)
lungs were##5##2##(1996-3#2)(2008-10#3)
lungs with##2##2##(1992-12#1)(1997-1#1)
lungs##93##1##(1990-11#1)(1991-12#3)(1992-1#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-8#4)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#10)(1997-1#8)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#7)(2008-7#1)(2008-8#1)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-2#2)(2012-3#2)(2013-1#4)
lupane##6##1##(2008-11#6)
lupin anthracnose##2##2##(2008-10#2)
lupin##8##1##(2008-10#8)
lupins##3##1##(2008-10#3)
lupus and##2##2##(1992-5#1)(2008-8#1)
lupus erythematosus (SLE)##9##3##(1990-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
lupus erythematosus with##3##3##(1997-8#1)(2008-1#1)(2012-2#1)
lupus erythematosus##35##2##(1990-12#1)(1990-9#1)(1992-5#4)(1994-6#1)(1995-5#1)(1997-8#2)(2008-1#2)(2008-10#2)(2008-4#1)(2009-5#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)
lupus nephritis##2##2##(2008-1#1)(2013-1#1)
lupus##46##1##(1990-12#1)(1990-9#1)(1992-5#5)(1994-6#1)(1995-5#1)(1997-8#3)(2008-1#3)(2008-10#3)(2008-4#1)(2008-8#2)(2009-5#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#7)
lupus-prone##2##1##(1993-3#1)(2008-10#1)
lurk##2##1##(1993-6#1)(2012-2#1)
luteal and menstrual##2##3##(2012-2#2)
luteal phase##3##2##(1990-8#1)(2012-2#2)
luteal regression##2##2##(2008-9#2)
luteal##13##1##(1990-8#1)(1992-9#4)(1997-1#2)(2008-9#2)(2012-2#4)
luteinizing hormone (LH)##3##3##(2008-4#1)(2011-1#1)(2013-8#1)
luteinizing hormone and##2##3##(1991-3#1)(2008-4#1)
luteinizing hormone receptor##2##3##(1995-11#1)(2008-8#1)
luteinizing hormone##9##2##(1990-2#1)(1991-3#2)(1995-11#1)(2008-4#2)(2008-8#1)(2011-1#1)(2013-8#1)
luteinizing##12##1##(1990-2#1)(1991-3#2)(1993-1#2)(1995-11#1)(1995-8#1)(2008-4#2)(2008-8#1)(2011-1#1)(2013-8#1)
luteolin##9##1##(2008-10#3)(2008-11#4)(2010-6#2)
luteovirus isolates##2##2##(2008-10#2)
luteovirus##11##1##(2008-10#11)
luteoviruses##5##1##(2008-10#5)
luteum##6##1##(1992-9#1)(1995-12#1)(2008-9#2)(2010-3#2)
lutreola##2##1##(2008-6#2)
lutropin##6##1##(1991-3#2)(1992-10#1)(1993-6#1)(1996-2#2)
luxA##2##1##(2008-11#2)
luxB##2##1##(2008-11#2)
luxCDABE##2##1##(2011-1#2)
luxury##3##1##(1993-3#1)(2008-11#1)(2008-7#1)
lyase was##2##2##(2008-10#2)
lyase##19##1##(1996-6#1)(1997-7#1)(2008-10#15)(2008-4#2)
lyases##2##1##(2011-2#2)
lycopersici race##2##2##(2008-10#2)
lycopersici was##2##2##(2008-10#2)
lycopersici were##2##2##(2008-10#2)
lycopersici##25##1##(2008-10#25)
lying between##2##2##(2008-10#1)(2008-7#1)
lying in##2##2##(2012-2#1)(2013-1#1)
lying to##2##2##(2010-10#2)
lying##15##1##(1993-12#1)(1995-11#1)(2008-10#3)(2008-7#3)(2009-3#1)(2010-10#4)(2012-2#1)(2013-1#1)
lymph node assay##7##3##(2008-10#4)(2008-5#3)
lymph node biopsies##2##3##(2008-5#1)(2012-12#1)
lymph node biopsy##5##3##(1991-3#1)(2008-1#1)(2008-5#1)(2011-2#2)
lymph node detection##2##3##(2010-11#1)(2010-12#1)
lymph node involvement##4##3##(1990-6#1)(1994-12#1)(2011-2#2)
lymph node lymphocytes from##2##4##(2008-11#2)
lymph node metastases##10##3##(1990-6#1)(1994-12#1)(1997-3#2)(2008-9#2)(2011-2#1)(2012-3#2)(2013-8#1)
lymph node metastasis in##3##4##(2011-2#2)(2013-1#1)
lymph node metastasis##15##3##(1990-2#1)(1991-12#1)(1994-12#1)(2008-12#1)(2009-12#1)(2010-6#2)(2011-2#4)(2013-1#4)
lymph node or##2##3##(1990-6#1)(1990-9#1)
lymph node responses##2##3##(2008-10#2)
lymph node##70##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#4)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1993-2#1)(1994-12#3)(1995-1#2)(1996-9#1)(1997-3#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#6)(2008-9#2)(2009-12#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#10)(2012-12#4)(2012-3#2)(2013-1#5)(2013-8#2)
lymph nodes and##6##3##(1990-12#1)(1990-8#1)(1992-2#1)(2008-1#1)(2008-10#1)(2012-12#1)
lymph nodes in##2##3##(1990-12#2)
lymph nodes was##2##3##(1994-12#2)
lymph nodes were##3##3##(1993-2#1)(2010-6#1)(2011-2#1)
lymph nodes##44##2##(1990-12#3)(1990-3#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-2#2)(1994-12#4)(1996-12#1)(1996-3#1)(1997-8#3)(2008-1#2)(2008-10#5)(2008-11#2)(2008-5#2)(2009-1#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-12#4)(2012-3#3)(2013-8#1)
lymph nodes)##2##2##(1997-8#1)(2008-10#1)
lymph##121##1##(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-6#3)(1992-1#1)(1992-2#1)(1993-2#3)(1994-12#7)(1995-1#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#2)(1997-7#1)(1997-8#4)(2007-12#1)(2008-1#3)(2008-10#12)(2008-11#5)(2008-12#1)(2008-5#8)(2008-9#2)(2009-1#1)(2009-12#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-6#3)(2010-7#1)(2011-2#12)(2012-12#8)(2012-3#5)(2013-1#5)(2013-8#3)
lymphadenectomy##4##1##(1990-3#1)(1992-9#1)(1993-3#1)(2013-1#1)
lymphadenitis and##2##2##(2008-1#1)(2009-7#1)
lymphadenitis in##3##2##(2008-5#2)(2013-8#1)
lymphadenitis##14##1##(1991-3#2)(1991-4#3)(1997-5#1)(2007-12#1)(2008-1#3)(2008-5#2)(2009-7#1)(2013-8#1)
lymphadenopathy or##2##2##(2010-1#1)(2010-6#1)
lymphadenopathy##10##1##(1997-8#1)(2008-1#2)(2008-11#1)(2008-5#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
lymphangioma##3##1##(2008-10#1)(2013-1#2)
lymphatic endothelial cells##2##3##(1997-7#1)(2008-9#1)
lymphatic filariasis elimination##3##3##(2008-1#3)
lymphatic##28##1##(1990-3#2)(1990-5#1)(1990-9#1)(1996-11#1)(1996-3#1)(1997-7#2)(2008-1#3)(2008-11#3)(2008-5#1)(2008-9#4)(2009-10#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
lymphectomy##2##1##(1992-9#2)
lymphedematous arm##2##2##(1992-12#2)
lymphnode metastasis##2##2##(2010-11#2)
lymphoblastic leukemia##10##2##(2008-10#1)(2008-11#5)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#1)
lymphoblastic##21##1##(2008-10#1)(2008-11#5)(2008-12#5)(2008-5#1)(2008-7#3)(2008-9#1)(2010-11#2)(2010-6#1)(2011-2#2)
lymphoblastoid cell##2##2##(1996-12#1)(2008-11#1)
lymphoblastoid##6##1##(1994-3#2)(1996-12#1)(2008-11#1)(2008-5#2)
lymphoblasts##7##1##(1996-2#3)(2008-5#4)
lymphocyte activation##3##2##(2007-12#1)(2008-4#2)
lymphocyte and##2##2##(1997-4#1)(2013-1#1)
lymphocyte count##3##2##(1993-12#1)(2008-7#1)(2010-5#1)
lymphocyte cultures##2##2##(1995-12#1)(2008-11#1)
lymphocyte migration##4##2##(1990-12#1)(2008-4#3)
lymphocyte populations##3##2##(1995-12#1)(1995-8#1)(2013-7#1)
lymphocyte proliferation and##2##3##(1993-12#1)(1995-12#1)
lymphocyte proliferation assay##4##3##(1995-12#1)(2008-12#1)(2011-2#2)
lymphocyte proliferation##10##2##(1993-12#1)(1995-12#3)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#2)
lymphocyte subpopulation##2##2##(2008-4#1)(2013-1#1)
lymphocyte subpopulations##2##2##(1995-12#1)(2008-4#1)
lymphocyte subsets and##2##3##(1991-6#1)(2008-10#1)
lymphocyte subsets##6##2##(1991-6#3)(2008-10#1)(2008-11#1)(2008-9#1)
lymphocyte##75##1##(1990-12#3)(1991-6#4)(1992-12#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-8#1)(1995-12#8)(1995-2#1)(1995-3#1)(1995-8#2)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#9)(2008-12#2)(2008-4#9)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#7)(2011-3#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
lymphocytes and monocytes##3##3##(1990-5#2)(1992-12#1)
lymphocytes and other cells##2##4##(1990-9#1)(2008-4#1)
lymphocytes and##25##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1994-3#1)(1995-12#1)(1995-5#1)(1997-8#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#2)(2009-11#1)(2011-2#1)
lymphocytes are##2##2##(2008-4#1)(2011-2#1)
lymphocytes by##4##2##(1991-3#1)(1992-6#1)(1994-3#2)
lymphocytes could be##2##3##(1995-2#1)(2011-2#1)
lymphocytes exposed to##2##3##(1993-8#1)(2008-11#1)
lymphocytes for##3##2##(1994-5#1)(1995-12#1)(2008-11#1)
lymphocytes from patients##2##3##(2008-11#2)
lymphocytes from##13##2##(1990-8#1)(1991-2#1)(1994-6#1)(1996-10#1)(1997-3#1)(2008-11#5)(2008-4#1)(2008-7#1)(2011-2#1)
lymphocytes in the##4##3##(1990-12#1)(1995-8#2)(2010-6#1)
lymphocytes in vitro##2##3##(2008-11#1)(2008-9#1)
lymphocytes in##10##2##(1990-12#1)(1995-8#2)(1996-9#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#1)
lymphocytes incubated##2##2##(1993-8#1)(1996-12#1)
lymphocytes is##2##2##(1990-12#1)(2008-4#1)
lymphocytes of##7##2##(1993-1#2)(1995-8#2)(2008-4#1)(2008-7#1)(2012-3#1)
lymphocytes stimulated with##2##3##(2008-11#2)
lymphocytes to detect##2##3##(2008-10#1)(2008-4#1)
lymphocytes to##6##2##(1997-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#2)
lymphocytes was##3##2##(2008-10#2)(2008-12#1)
lymphocytes were T cells##2##4##(2008-11#1)(2008-9#1)
lymphocytes were##8##2##(1990-12#2)(2008-11#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-2#1)
lymphocytes with##3##2##(1992-8#1)(2008-2#1)(2008-4#1)
lymphocytes##200##1##(1990-12#8)(1990-3#2)(1990-5#3)(1990-8#6)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1992-12#2)(1992-6#3)(1992-8#2)(1993-1#2)(1993-8#6)(1994-12#1)(1994-3#12)(1994-5#2)(1994-6#1)(1995-12#8)(1995-2#2)(1995-5#3)(1995-8#7)(1996-10#1)(1996-12#2)(1996-9#1)(1997-3#2)(1997-5#2)(1997-8#3)(1997-9#1)(2008-1#1)(2008-10#4)(2008-11#33)(2008-12#2)(2008-2#4)(2008-4#14)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#16)(2009-11#1)(2009-12#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#10)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
lymphocytes)##2##1##(1992-6#1)(2013-8#1)
lymphocytic cellular##2##2##(2008-9#2)
lymphocytic infiltration of##2##3##(1995-12#1)(2008-7#1)
lymphocytic infiltration##3##2##(1995-12#1)(2007-11#1)(2008-7#1)
lymphocytic leukemia (CLL)##3##3##(2008-9#1)(2009-12#1)(2011-2#1)
lymphocytic leukemia##10##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-12#2)(2009-6#1)(2011-2#1)
lymphocytic##26##1##(1991-12#1)(1991-6#1)(1991-8#1)(1994-11#2)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-7#2)(2008-9#4)(2009-12#2)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
lymphocytoses##2##1##(2010-1#2)
lymphoepithelial lesions##2##2##(2009-8#2)
lymphohistiocytosis##2##1##(2011-2#1)(2012-12#1)
lymphoid cell##2##2##(1997-7#1)(2008-5#1)
lymphoid cells and##2##3##(2008-5#1)(2009-8#1)
lymphoid cells##6##2##(1995-12#2)(2008-5#3)(2009-8#1)
lymphoid follicles##2##2##(1997-1#1)(2009-8#1)
lymphoid infiltrate##2##2##(2009-8#2)
lymphoid infiltrates##3##2##(2009-8#3)
lymphoid leukemia##2##2##(1997-5#1)(2012-3#1)
lymphoid organs##5##2##(1990-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
lymphoid patches##4##2##(1992-12#4)
lymphoid progenitors##2##2##(2008-4#2)
lymphoid proliferation in##3##3##(2008-11#3)
lymphoid proliferation##4##2##(2008-11#4)
lymphoid tissue (MALT)##3##3##(1997-1#1)(2009-8#2)
lymphoid tissue##12##2##(1992-12#1)(1997-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#3)(2013-1#2)
lymphoid tissues##7##2##(1997-9#1)(2008-10#3)(2008-9#1)(2010-12#1)(2011-2#1)
lymphoid##59##1##(1990-12#1)(1992-12#5)(1995-12#2)(1997-1#2)(1997-5#2)(1997-7#1)(1997-9#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-4#4)(2008-5#5)(2008-7#2)(2008-9#3)(2009-3#1)(2009-5#1)(2009-8#10)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#3)
lymphokine activated killer##2##3##(1991-8#1)(2008-11#1)
lymphokine##4##1##(1991-8#1)(1992-2#1)(2008-11#1)(2008-4#1)
lymphokine-activated killer cells##2##3##(1993-3#2)
lymphokine-activated killer##3##2##(1993-3#3)
lymphoma (FL)##2##2##(2010-11#2)
lymphoma (NHL)##2##2##(2013-1#2)
lymphoma and##12##2##(1991-8#1)(1994-3#1)(1997-1#2)(2008-10#1)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
lymphoma by##2##2##(1992-3#1)(2012-2#1)
lymphoma can##2##2##(1997-1#2)
lymphoma cell##3##2##(1993-2#1)(1995-11#1)(2008-4#1)
lymphoma in a##3##3##(1991-6#1)(1993-6#1)(2009-1#1)
lymphoma in the##4##3##(2008-5#1)(2008-7#1)(2009-1#1)(2009-7#1)
lymphoma in##9##2##(1991-6#1)(1993-6#1)(1994-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-7#1)
lymphoma involving the##3##3##(2008-1#1)(2009-7#2)
lymphoma involving##4##2##(2008-1#1)(2009-7#2)(2009-8#1)
lymphoma is usually##2##3##(2009-8#1)(2013-8#1)
lymphoma is##8##2##(1991-6#1)(2008-1#1)(2008-10#1)(2009-8#3)(2013-8#2)
lymphoma lesions##3##2##(2008-5#3)
lymphoma of mucosa-associated lymphoid tissue (MALT)##2##6##(2009-8#2)
lymphoma of mucosa-associated lymphoid tissue##3##5##(2009-8#3)
lymphoma of the##11##3##(1991-2#3)(1993-6#1)(2008-1#2)(2009-1#1)(2009-8#1)(2013-1#2)(2013-8#1)
lymphoma of##17##2##(1991-12#1)(1991-2#3)(1993-6#1)(2008-1#2)(2009-1#1)(2009-5#1)(2009-8#4)(2013-1#3)(2013-8#1)
lymphoma presenting as phlegmonous gastritis##2##5##(2008-12#2)
lymphoma presenting##3##2##(2008-12#3)
lymphoma##157##1##(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#3)(1991-8#1)(1992-12#4)(1992-3#3)(1993-2#3)(1993-6#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-11#2)(1997-1#5)(1997-8#3)(2008-1#8)(2008-10#6)(2008-11#4)(2008-12#6)(2008-2#1)(2008-4#4)(2008-5#10)(2008-7#6)(2008-9#1)(2009-1#9)(2009-3#1)(2009-5#2)(2009-7#5)(2009-8#25)(2010-11#4)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#13)(2013-8#4)
lymphoma-like##2##1##(1990-6#2)
lymphomas and##2##2##(2008-9#1)(2013-1#1)
lymphomas are##3##2##(1997-1#2)(2009-8#1)
lymphomas##36##1##(1990-12#2)(1990-8#2)(1992-12#1)(1992-9#1)(1993-2#1)(1993-9#1)(1997-1#3)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-8#10)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
lymphomononuclear##2##1##(1994-3#2)
lymphoplasmacytic##2##1##(2008-5#1)(2009-8#1)
lymphopoiesis##4##1##(1994-3#2)(1997-9#1)(2008-4#1)
lymphoproliferation and##2##2##(2008-10#1)(2008-5#1)
lymphoproliferation##4##1##(2008-10#1)(2008-5#2)(2011-2#1)
lymphoproliferative disorder##2##2##(2008-5#1)(2009-8#1)
lymphoproliferative disorders##5##2##(2008-5#2)(2008-9#1)(2009-7#1)(2011-3#1)
lymphoproliferative responses##2##2##(1995-5#1)(2011-2#1)
lymphoproliferative##13##1##(1995-5#1)(1997-4#1)(2008-5#4)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
lymphoreticular##2##1##(1990-8#1)(1993-3#1)
lymphosarcoma##3##1##(1995-11#2)(2012-3#1)
lymphovascular emboli##2##2##(2011-2#2)
lymphovascular invasion##5##2##(2009-12#1)(2011-2#4)
lymphovascular##9##1##(2009-12#1)(2011-2#8)
lyophilised samples##2##2##(2008-10#2)
lyophilised##6##1##(2008-10#6)
lyophilization##4##1##(2008-10#1)(2008-5#2)(2009-7#1)
lyophilized cells##3##2##(1994-6#1)(2008-10#2)
lyophilized##11##1##(1994-6#1)(2008-10#6)(2008-5#2)(2008-7#2)
lysate of##2##2##(1997-1#1)(2008-11#1)
lysate was##6##2##(1994-11#2)(2008-11#3)(2010-11#1)
lysate##27##1##(1991-10#1)(1993-12#1)(1994-11#2)(1995-12#2)(1997-1#1)(2008-10#4)(2008-11#13)(2008-9#1)(2009-3#1)(2010-11#1)
lysates of##5##2##(1993-9#1)(1994-6#1)(1995-6#1)(1997-3#1)(2010-12#1)
lysates##21##1##(1990-5#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#2)(1997-3#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#6)(2010-12#1)(2011-2#1)
lyse##7##1##(1994-3#2)(1994-5#1)(1995-2#1)(2009-6#2)(2011-2#1)
lysed##9##1##(1990-2#1)(1992-11#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-2#1)
lyses##4##1##(1994-3#3)(2011-2#1)
lysimeter##4##1##(2008-10#4)
lysine (0##2##2##(1995-6#1)(2008-10#1)
lysine analogs##2##2##(1995-6#2)
lysine and guanine##2##3##(2008-10#2)
lysine and tryptophan##2##3##(2012-2#2)
lysine and##5##2##(2008-10#2)(2008-11#1)(2012-2#2)
lysine oxidase on##2##3##(2008-10#2)
lysine residue##2##2##(1996-2#1)(2008-10#1)
lysine residues are##2##3##(1995-6#2)
lysine residues in##2##3##(1995-6#1)(1997-7#1)
lysine residues##13##2##(1992-6#1)(1994-5#2)(1995-6#8)(1997-7#1)(2009-12#1)
lysine##46##1##(1990-5#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-6#11)(1996-2#1)(1997-7#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-9#1)(2009-12#1)(2012-2#3)(2013-8#1)
lysine(469 and 707)##2##3##(1996-2#2)
lysines in##2##2##(2008-11#2)
lysis and##3##2##(1994-3#1)(2008-10#1)(2008-4#1)
lysis by##4##2##(1992-2#2)(2008-10#1)(2008-9#1)
lysis is##2##2##(2008-8#1)(2013-1#1)
lysis of the##2##3##(1992-12#1)(1997-6#1)
lysis of##6##2##(1992-12#2)(1996-1#1)(1997-6#1)(2009-6#1)(2013-1#1)
lysis syndrome in##3##3##(2008-7#3)
lysis syndrome##6##2##(2008-7#6)
lysis was##2##2##(2008-10#2)
lysis##38##1##(1992-12#2)(1992-2#3)(1994-3#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-12#2)(2008-4#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-6#3)(2011-2#1)(2013-1#3)
lyso-PC##6##1##(2008-8#6)
lysogenic phage##2##2##(1996-12#1)(1996-6#1)
lysogenic##3##1##(1995-5#1)(1996-12#1)(1996-6#1)
lysophosphatidic##2##1##(1990-8#1)(2008-7#1)
lysosomal aspartyl protease##3##3##(1994-5#1)(1995-8#2)
lysosomal carboxypeptidase B and prolyl-carboxypeptidase##2##5##(2006-6#2)
lysosomal degradation##3##2##(1991-5#1)(1992-12#1)(1994-5#1)
lysosomal enzyme assay##2##3##(2010-8#2)
lysosomal enzyme##5##2##(1993-8#1)(1996-8#1)(1997-7#1)(2010-8#2)
lysosomal enzymes##4##2##(1991-12#1)(1995-6#2)(2012-3#1)
lysosomal function##2##2##(1992-12#2)
lysosomal glycosidase##2##2##(1992-10#2)
lysosomal protease##2##2##(1990-5#1)(1997-1#1)
lysosomal proteases##2##2##(1992-12#1)(1997-1#1)
lysosomal protective protein##2##3##(1994-11#2)
lysosomal proteins##2##2##(1995-6#2)
lysosomal storage disease##3##3##(1992-10#1)(2010-8#2)
lysosomal storage disorder##2##3##(1996-8#1)(2008-10#1)
lysosomal storage of sulfated glycosaminoglycans##2##5##(1993-12#2)
lysosomal storage of##3##3##(1993-12#3)
lysosomal storage##8##2##(1992-10#1)(1993-12#3)(1996-8#1)(2008-10#1)(2010-8#2)
lysosomal system##5##2##(1992-12#3)(2008-7#2)
lysosomal##58##1##(1990-5#1)(1991-12#4)(1991-5#1)(1991-7#2)(1992-10#4)(1992-12#8)(1993-12#5)(1993-8#4)(1994-11#2)(1994-5#4)(1995-6#4)(1995-8#2)(1996-8#2)(1997-1#2)(1997-7#1)(2006-6#2)(2008-10#1)(2008-7#3)(2009-8#1)(2010-8#4)(2012-3#1)
lysosome##3##1##(1992-12#2)(2008-11#1)
lysosomes and##2##2##(1992-12#2)
lysosomes##10##1##(1990-5#2)(1991-12#1)(1992-10#1)(1992-12#5)(2008-7#1)
lysozyme and##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
lysozyme was##2##2##(2008-10#2)
lysozyme##26##1##(1992-12#1)(1992-9#1)(1995-3#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-7#1)(2011-2#3)(2013-8#3)
lystate##2##1##(1990-11#2)
lysyl endopeptidase##3##2##(2008-11#3)
lysyl##5##1##(2006-6#1)(2008-11#3)(2008-5#1)
lytic activity##2##2##(2008-10#1)(2009-6#1)
lytic enzymes##2##2##(2008-10#2)
lytic##23##1##(1994-5#1)(1995-2#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
lésions##2##1##(2013-1#2)
m &lt##2##2##(2008-8#1)(2013-1#1)
m a##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
m above sea##2##3##(2008-3#1)(2008-8#1)
m above the ground##2##4##(2008-10#2)
m above##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
m and##3##2##(2008-10#2)(2008-3#1)
m from the##5##3##(2008-10#4)(2008-3#1)
m from##6##2##(2008-10#5)(2008-3#1)
m gamma-IFN and h gamma-IFN##2##5##(1994-5#2)
m gamma-IFN--transduced tumor cells##2##4##(1994-5#2)
m is##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
m of##3##2##(2008-10#3)
m s(-1)##6##2##(2008-10#1)(2008-11#3)(2010-8#2)
m s(-1))##3##2##(2008-10#3)
m s(-2)) was##2##3##(2010-8#2)
m wide##3##2##(2008-10#3)
m x##2##2##(2008-10#1)(2008-3#1)
m##172##1##(1990-2#1)(1990-8#1)(1990-9#5)(1991-6#2)(1992-12#1)(1994-5#4)(1996-12#4)(2007-12#3)(2008-10#80)(2008-11#8)(2008-2#1)(2008-3#18)(2008-5#6)(2008-8#7)(2008-9#2)(2009-7#1)(2010-4#4)(2010-6#2)(2010-8#6)(2011-2#4)(2013-1#5)(2013-8#7)
m(-1) sr(-1)##4##2##(2008-2#2)(2008-3#2)
m(-1)##10##1##(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#2)
m(-1)) was##2##2##(2008-10#1)(2010-8#1)
m(-1))##7##1##(2008-10#4)(2008-7#1)(2010-8#2)
m(-2)##13##1##(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)
m(-2))##4##1##(2008-10#2)(2008-7#2)
m(-3)##15##1##(2008-10#10)(2008-5#3)(2010-5#2)
m(-3))##3##1##(2008-10#1)(2009-7#2)
m(2) g(-1)##6##2##(2008-10#4)(2008-11#1)(2009-11#1)
m(2) in##3##2##(2008-10#3)
m(2)##20##1##(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)
m(2))##2##1##(2008-10#2)
m(3) Pa(-1) mol(-1) at the##2##5##(2008-10#2)
m(3) Pa(-1)##3##2##(2008-10#3)
m(3)##6##1##(2008-10#4)(2008-2#1)(2010-8#1)
m(o) of##6##2##(2008-10#6)
m(o) were##3##2##(2008-10#3)
m(o)##10##1##(2008-10#10)
m(o)=2##3##1##(2008-10#3)
m) the signal##2##3##(2008-3#2)
m)##18##1##(2008-10#9)(2008-11#1)(2008-3#6)(2009-8#1)(2012-4#1)
m-##2##1##(2008-10#2)
m-2 yr-1##2##2##(2008-9#2)
m-FISH##2##1##(2013-8#2)
m-Nis##4##1##(2011-3#4)
m-THF##2##1##(1997-1#2)
m-cresol##3##1##(1990-8#1)(2008-10#2)
m-dinitrobenzene##2##1##(2008-10#2)
m-nitroaniline##3##1##(2008-10#3)
m-xylene##2##1##(2008-10#2)
m/s and##2##2##(2008-3#1)(2010-9#1)
m/s##7##1##(2008-3#1)(2009-7#4)(2010-9#2)
m/s) and##2##2##(2008-3#2)
m/s)##4##1##(2008-3#3)(2011-2#1)
m/v NaBH(4)##2##2##(2008-10#2)
m/v for##2##2##(2008-10#2)
m/v##11##1##(2008-10#11)
m/z##14##1##(2008-10#10)(2008-11#1)(2011-3#3)
m0##2##1##(2008-9#2)
m1##2##1##(2008-10#1)(2008-11#1)
m2##6##1##(2008-11#1)(2011-2#5)
m3##2##1##(2012-3#2)
m6418##5##1##(2008-10#5)
mA M(-1))##2##2##(2008-10#2)
mA##9##1##(2008-10#8)(2008-12#1)
mAMSA##5##1##(1994-8#5)
mAb HUC2-13##2##2##(2008-11#2)
mAb and##2##2##(1996-12#1)(2008-10#1)
mAb enhanced##2##2##(1996-12#1)(2008-8#1)
mAb production##3##2##(2008-11#1)(2011-2#2)
mAb to the##2##3##(1994-5#2)
mAb##39##1##(1990-5#1)(1993-8#4)(1994-5#3)(1996-12#6)(2008-10#7)(2008-11#9)(2008-4#1)(2008-8#3)(2009-8#1)(2011-2#4)
mAbs are##2##2##(2008-8#2)
mAbs were##4##2##(1996-12#3)(2008-8#1)
mAbs##27##1##(1994-5#3)(1996-12#7)(2008-10#1)(2008-11#9)(2008-4#3)(2008-8#4)
mCMV##4##1##(2008-4#4)
mES cells##4##2##(2008-11#4)
mGluR1 mRNA##2##2##(1996-12#2)
mGluR1##3##1##(1996-12#3)
mGluR5 mRNA##2##2##(1996-12#2)
mGluR5##4##1##(1996-12#4)
mGluR7##4##1##(1995-12#4)
mGluR7-like immunoreactivity##2##2##(1995-12#2)
mGnRH (analog##3##2##(1994-8#3)
mGnRH##4##1##(1994-8#4)
mIFN-gamma##2##1##(2008-11#2)
mIU/mL##2##1##(2009-12#1)(2011-1#1)
mJ at##3##2##(2008-2#1)(2008-3#1)(2010-1#1)
mJ cm(-2) min(-1)##4##3##(2008-10#4)
mJ cm(-2)##5##2##(2008-10#5)
mJ##18##1##(2007-12#2)(2008-10#8)(2008-2#2)(2008-3#2)(2008-5#1)(2010-1#3)
mL and##2##2##(2011-2#1)(2012-3#1)
mL extraction reservoir##2##3##(2008-10#2)
mL min(-1)##2##2##(2008-5#2)
mL of##11##2##(1993-1#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#2)
mL x min(-1) x kg(-1)##2##5##(2011-3#2)
mL##34##1##(1993-1#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#3)(2011-3#3)(2012-3#2)(2013-1#2)
mL(-1) for lopinavir##2##3##(2011-3#2)
mL(-1) for##14##2##(2008-10#1)(2008-5#6)(2011-3#7)
mL(-1)##32##1##(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#12)(2009-6#2)(2010-5#2)(2011-2#1)(2011-3#9)
mL(-1))##3##1##(2008-11#1)(2011-3#1)(2012-2#1)
mL)##7##1##(1996-3#2)(2008-11#1)(2010-1#1)(2011-2#3)
mL/kg/min during##2##2##(2013-1#2)
mL/min##4##1##(2008-10#2)(2009-8#1)(2011-2#1)
mL·mm Hg(-1) × 10##2##4##(2013-8#2)
mL·mm Hg(-1) × 100##2##4##(2013-8#2)
mL·mm Hg(-1) ×##4##3##(2013-8#4)
mM (0##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
mM (R(2)=0##2##2##(2008-10#2)
mM (n =##2##3##(1990-12#1)(1994-3#1)
mM Ca2+##5##2##(1990-5#1)(1990-8#2)(1993-8#1)(1996-2#1)
mM DPPH was##2##3##(2008-10#2)
mM HCO3-)##2##2##(1995-8#2)
mM K+##4##2##(1994-2#2)(1997-1#1)(2008-11#1)
mM MgCl2##2##2##(1993-8#1)(1995-11#1)
mM NaCl##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
mM NaH(2)PO(4)##2##2##(2008-10#2)
mM Ni2+##2##2##(1994-2#2)
mM SDS##2##2##(2008-10#2)
mM Tris##2##2##(2008-10#2)
mM Tris-HCl buffer##2##3##(2008-10#2)
mM and a##4##3##(1994-6#1)(2008-10#3)
mM and##16##2##(1990-12#1)(1991-5#1)(1991-7#1)(1992-7#1)(1994-6#2)(2008-10#5)(2008-11#3)(2008-7#1)(2011-2#1)
mM at##2##2##(2008-10#1)(2008-7#1)
mM borate buffer (pH 9##2##5##(2008-10#2)
mM borate buffer (pH##3##4##(2008-10#3)
mM borate buffer##4##3##(2008-10#4)
mM borate##6##2##(2008-10#6)
mM borax##2##2##(2008-10#2)
mM calcium concentration##2##3##(1994-3#2)
mM calcium##5##2##(1994-3#4)(1995-8#1)
mM cholesterol##2##2##(2008-10#2)
mM did not##2##3##(1994-11#1)(1997-1#1)
mM erythritol##2##2##(1991-5#2)
mM ethanol##3##2##(1992-7#3)
mM for##6##2##(1991-5#1)(2008-10#1)(2008-11#3)(2008-7#1)
mM glucose##9##2##(1992-8#1)(1993-8#1)(1994-11#1)(1995-8#3)(1997-1#1)(2008-10#1)(2008-11#1)
mM glutamate##4##2##(1997-1#1)(2008-11#2)(2008-7#1)
mM in##2##2##(2008-10#1)(2008-11#1)
mM malonic##2##2##(2008-10#2)
mM of##2##2##(1994-11#1)(2008-10#1)
mM pNP/mg##2##2##(2008-11#2)
mM phosphate buffer (pH 7##2##5##(2008-10#2)
mM phosphate buffer (pH 7)##2##5##(2008-10#2)
mM phosphate buffer (pH##5##4##(2008-10#5)
mM phosphate buffer##8##3##(2008-10#8)
mM phosphate##9##2##(2008-10#9)
mM potassium##3##2##(2008-10#3)
mM sodium butyrate##2##3##(2008-11#2)
mM sodium dodecyl sulfate##2##4##(2008-10#2)
mM sodium dodecyl##3##3##(2008-10#3)
mM sodium dodecylsulfate (SDS)##2##4##(2008-10#2)
mM sodium dodecylsulfate##3##3##(2008-10#3)
mM sodium phosphate##3##3##(2008-10#2)(2009-8#1)
mM sodium sulphide##2##3##(2008-10#2)
mM sodium##17##2##(2008-10#14)(2008-11#2)(2009-8#1)
mM with a detection limit of##2##6##(2008-10#2)
mM with a##4##3##(2008-10#4)
mM with##5##2##(2008-10#5)
mM##291##1##(1990-12#3)(1990-2#1)(1990-5#2)(1990-8#5)(1991-12#1)(1991-3#1)(1991-5#4)(1991-7#1)(1992-3#1)(1992-4#1)(1992-7#5)(1992-8#2)(1993-3#1)(1993-6#1)(1993-8#6)(1994-11#3)(1994-2#4)(1994-3#7)(1994-5#6)(1994-6#2)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#12)(1996-2#1)(1997-1#10)(1997-2#5)(1997-8#1)(2008-10#144)(2008-11#33)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#7)(2009-6#1)(2009-8#1)(2011-2#8)
mM(-1)##5##1##(2008-10#5)
mM) and glutamine##2##3##(2008-11#2)
mM) and##11##2##(1990-5#1)(1995-11#1)(1995-8#2)(1996-2#1)(2008-10#4)(2008-11#2)
mM) in##3##2##(2008-11#3)
mM) induced##2##2##(1996-2#1)(2011-2#1)
mM) of##3##2##(1990-2#1)(1994-11#1)(2008-7#1)
mM) or##2##2##(1990-2#1)(1996-2#1)
mM) was##2##2##(2008-10#1)(2008-11#1)
mM)##68##1##(1990-2#4)(1990-5#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#5)(1995-6#1)(1995-8#6)(1996-2#6)(1997-1#2)(1997-2#3)(1997-4#1)(2008-10#13)(2008-11#11)(2008-7#2)(2009-6#1)(2011-2#3)
mM-1 min-1 for##2##3##(1997-2#2)
mM-1 min-1##4##2##(1997-2#4)
mM-1 s-1)##3##2##(1995-6#3)
mM-1##8##1##(1991-9#1)(1995-6#3)(1997-2#4)
mN/m##2##1##(1997-2#2)
mOsm kg(-1)##5##2##(2008-11#5)
mOsm kg- 1##2##3##(2008-11#2)
mOsm kg-##3##2##(2008-11#3)
mOsm kg-1##3##2##(2008-11#3)
mOsm##14##1##(2008-11#14)
mOsm/kg##3##1##(1994-12#1)(2008-11#2)
mOsmol kg-1##11##2##(2008-11#11)
mOsmol##13##1##(2008-11#13)
mOsmol·kg(-1)##2##1##(2013-8#2)
mPFC##6##1##(2008-11#6)
mPGES-1##8##1##(2012-2#8)
mPa##2##1##(2008-10#2)
mRNA abundance##2##2##(1995-2#1)(2008-2#1)
mRNA accumulation##2##2##(1994-11#1)(2009-8#1)
mRNA analysis##2##2##(2008-11#1)(2008-7#1)
mRNA and IL-1Ra mRNA##2##4##(1996-12#2)
mRNA and enzyme activity##2##4##(1995-2#1)(1996-12#1)
mRNA and infiltration of##3##4##(2010-1#3)
mRNA and protein by##2##4##(1993-8#1)(1995-12#1)
mRNA and protein expression##4##4##(2008-11#1)(2012-2#1)(2013-1#2)
mRNA and protein levels of##3##5##(2011-3#2)(2012-2#1)
mRNA and protein levels##6##4##(1993-6#1)(2008-9#1)(2011-3#2)(2012-2#1)(2013-8#1)
mRNA and protein was##2##4##(1991-5#1)(1995-6#1)
mRNA and protein were##4##4##(1993-3#1)(2010-11#1)(2012-2#1)(2013-1#1)
mRNA and protein##28##3##(1990-5#1)(1991-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#1)(1997-7#1)(2008-11#2)(2008-8#2)(2008-9#1)(2010-11#1)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
mRNA and serum##2##3##(2008-9#1)(2011-2#1)
mRNA and the##4##3##(2008-10#1)(2008-11#3)
mRNA and##65##2##(1990-5#1)(1991-5#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-12#2)(1995-2#3)(1995-6#2)(1996-12#3)(1996-2#2)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#4)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#3)(2009-12#1)(2010-1#3)(2010-11#1)(2011-2#2)(2011-3#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
mRNA are##4##2##(1993-8#1)(1995-12#1)(1996-12#1)(2012-2#1)
mRNA as##2##2##(1996-12#1)(2008-10#1)
mRNA at the anterior##2##4##(1994-12#2)
mRNA at##4##2##(1994-12#2)(1996-12#1)(1997-2#1)
mRNA but##2##2##(1995-12#1)(1995-2#1)
mRNA by##10##2##(1992-10#1)(1995-6#3)(1996-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
mRNA can##2##2##(1993-6#1)(2011-2#1)
mRNA coding for##4##3##(1992-1#1)(1992-12#1)(2006-6#1)(2008-11#1)
mRNA compared##3##2##(2008-11#3)
mRNA concentrations##2##2##(1990-5#1)(2008-11#1)
mRNA content of##2##3##(1993-8#1)(2011-2#1)
mRNA content##3##2##(1992-3#1)(1993-8#1)(2011-2#1)
mRNA could be detected in##2##5##(2008-10#1)(2008-8#1)
mRNA could be detected##3##4##(2008-10#2)(2008-8#1)
mRNA decreased##3##2##(1990-5#1)(2008-8#1)(2012-3#1)
mRNA differential display##4##3##(2008-8#2)(2008-9#2)
mRNA down-regulation##3##2##(1995-12#3)
mRNA during##2##2##(1990-5#1)(1994-12#1)
mRNA encoding##4##2##(1993-2#1)(1996-12#1)(2008-11#1)(2008-6#1)
mRNA expression and##6##3##(1994-11#1)(1995-2#1)(2008-6#1)(2009-8#1)(2010-1#2)
mRNA expression as##2##3##(1995-12#1)(2008-8#1)
mRNA expression by##3##3##(1995-12#1)(1996-2#1)(2010-1#1)
mRNA expression in the rat brain##2##6##(1996-12#2)
mRNA expression in the##9##4##(1996-12#3)(1997-2#1)(2008-11#3)(2008-6#1)(2010-12#1)
mRNA expression in##17##3##(1994-11#2)(1994-3#1)(1996-12#4)(1997-2#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-9#1)(2010-12#1)
mRNA expression levels##5##3##(1995-12#1)(2008-11#3)(2009-8#1)
mRNA expression of##9##3##(1996-12#2)(1996-2#1)(2010-5#1)(2011-2#1)(2011-3#2)(2013-1#1)(2013-8#1)
mRNA expression was increased in##2##5##(1994-11#1)(2008-8#1)
mRNA expression was##7##3##(1994-11#1)(1995-2#1)(1996-12#1)(2008-6#1)(2008-8#1)(2008-9#2)
mRNA expression which##2##3##(1996-12#1)(2008-5#1)
mRNA expression##75##2##(1994-11#5)(1994-3#1)(1995-12#3)(1995-2#2)(1996-12#14)(1996-2#6)(1997-2#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-5#2)(2008-6#4)(2008-8#7)(2008-9#4)(2009-8#2)(2010-1#3)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#2)(2013-8#1)
mRNA for the##8##3##(1992-8#1)(1995-8#1)(1996-12#6)
mRNA for##17##2##(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#6)(1997-2#1)(2008-11#1)(2008-4#1)
mRNA from##4##2##(1991-5#1)(1993-9#1)(1995-2#1)(2008-7#1)
mRNA in a rat focal cerebral ischemia-reperfusion model##2##8##(1996-12#2)
mRNA in both##2##3##(1994-5#1)(1996-12#1)
mRNA in normal and##2##4##(1995-12#1)(1995-8#1)
mRNA in normal##3##3##(1993-8#1)(1995-12#1)(1995-8#1)
mRNA in rat##3##3##(1995-8#1)(1996-12#1)(2012-2#1)
mRNA in response to##2##4##(1994-11#1)(2008-10#1)
mRNA in the cortex##2##4##(1994-2#2)
mRNA in the dorsal##2##4##(1994-2#1)(1997-2#1)
mRNA in the##27##3##(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#3)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#4)(1997-2#3)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
mRNA in these cells##2##4##(1994-6#1)(1995-6#1)
mRNA in total##2##3##(1996-12#1)(2008-8#1)
mRNA in##76##2##(1990-5#2)(1991-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#5)(1994-11#2)(1994-2#3)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#3)(1996-12#13)(1996-2#1)(1997-2#3)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
mRNA increased in the##2##4##(1996-12#1)(2008-11#1)
mRNA increased##4##2##(1995-8#1)(1996-12#1)(1996-2#1)(2008-11#1)
mRNA induction##3##2##(1990-12#1)(2008-11#2)
mRNA is expressed##2##3##(1996-12#1)(1997-7#1)
mRNA is highly##2##3##(1990-12#1)(1997-9#1)
mRNA is present in##4##4##(1992-6#1)(1993-6#1)(2008-12#1)(2008-9#1)
mRNA is##18##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#2)(1996-12#2)(1997-7#1)(1997-9#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
mRNA isolated from##2##3##(1991-6#1)(1997-8#1)
mRNA level (p &lt##2##4##(1994-11#2)
mRNA level and##2##3##(1993-8#1)(1995-6#1)
mRNA level in##5##3##(1994-11#1)(2008-11#3)(2010-5#1)
mRNA level of the##3##4##(1996-12#1)(2008-11#2)
mRNA level of##8##3##(1995-11#1)(1996-12#1)(2008-11#3)(2009-8#1)(2010-4#1)(2011-2#1)
mRNA level was significantly reduced in##3##6##(1996-12#3)
mRNA level was significantly reduced##4##5##(1996-12#4)
mRNA level was significantly##5##4##(1996-12#5)
mRNA level was##10##3##(1992-6#1)(1995-2#1)(1996-12#6)(1996-2#1)(2013-1#1)
mRNA level##45##2##(1990-12#1)(1991-5#1)(1992-6#1)(1993-8#2)(1994-11#3)(1995-11#2)(1995-2#2)(1995-6#1)(1996-12#10)(1996-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-11#8)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#1)
mRNA levels and##5##3##(1991-9#1)(1992-10#1)(1993-6#2)(1994-11#1)
mRNA levels are##2##3##(1994-11#1)(1997-1#1)
mRNA levels in the##9##4##(1994-11#1)(1995-12#1)(1996-12#4)(1997-2#1)(1997-3#1)(2008-6#1)
mRNA levels in##16##3##(1990-2#1)(1991-5#1)(1994-11#1)(1995-12#5)(1995-6#1)(1996-12#4)(1997-2#1)(1997-3#1)(2008-6#1)
mRNA levels of##4##3##(1992-9#1)(1994-11#1)(2010-1#1)(2011-2#1)
mRNA levels was##2##3##(1996-12#2)
mRNA levels were similar##2##4##(1994-11#1)(1995-12#1)
mRNA levels were##13##3##(1991-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-12#5)(2008-6#1)(2008-8#1)(2013-1#1)
mRNA levels##72##2##(1990-2#1)(1990-3#1)(1991-5#3)(1991-9#1)(1992-10#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#4)(1994-11#6)(1994-3#1)(1995-12#12)(1995-2#1)(1995-6#3)(1996-12#18)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#2)
mRNA may##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
mRNA of genes##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
mRNA of the##3##3##(1995-12#1)(1997-8#1)(2010-1#1)
mRNA of##18##2##(1990-8#2)(1992-9#1)(1993-2#1)(1993-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-3#1)
mRNA only##2##2##(1995-6#1)(2008-11#1)
mRNA or##2##2##(1996-12#1)(2008-9#1)
mRNA positive##2##2##(2008-10#1)(2008-8#1)
mRNA processing##2##2##(1995-2#1)(2012-2#1)
mRNA remained unchanged##2##3##(1996-12#2)
mRNA sequences##2##2##(1995-9#1)(2008-4#1)
mRNA showed##4##2##(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#1)
mRNA significantly decreased##2##3##(1997-2#1)(2013-1#1)
mRNA significantly##3##2##(1997-2#1)(2013-1#2)
mRNA species is directed by##2##5##(1990-11#2)
mRNA species##7##2##(1990-11#2)(1990-2#2)(1995-8#1)(1996-12#1)(2008-4#1)
mRNA stability##4##2##(1995-2#1)(2008-11#2)(2008-5#1)
mRNA target##2##2##(2011-2#2)
mRNA to the endoplasmic reticulum##2##5##(2008-11#2)
mRNA to##8##2##(1993-3#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-2#2)(2008-11#2)
mRNA transcript##3##2##(1997-2#1)(2008-8#1)(2008-9#1)
mRNA transcription cycle##2##3##(2013-1#2)
mRNA transcription##7##2##(1995-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#3)
mRNA transcripts##7##2##(1992-3#1)(1992-8#1)(1997-1#1)(1997-2#1)(2008-8#2)(2009-10#1)
mRNA transport##2##2##(1995-2#1)(2012-2#1)
mRNA using##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
mRNA was abundantly expressed in##2##5##(1994-11#2)
mRNA was detected in##2##4##(1994-11#1)(2008-6#1)
mRNA was detected##3##3##(1994-11#1)(1996-12#1)(2008-6#1)
mRNA was expressed in##2##4##(1997-2#1)(2008-6#1)
mRNA was expressed##4##3##(1991-5#1)(1997-2#1)(2008-11#1)(2008-6#1)
mRNA was induced in the##2##5##(1996-12#1)(2010-5#1)
mRNA was localized##2##3##(1995-12#1)(2008-9#1)
mRNA was not observed in##2##5##(1995-11#1)(1996-12#1)
mRNA was not##4##3##(1995-11#1)(1996-12#1)(1996-2#1)(2008-8#1)
mRNA was observed##3##3##(1990-3#1)(1996-12#1)(2008-8#1)
mRNA was seen in##2##4##(1996-12#2)
mRNA was##46##2##(1990-3#1)(1991-5#1)(1992-6#1)(1993-2#2)(1994-11#4)(1994-12#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#14)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-6#2)(2008-8#4)(2008-9#1)(2010-5#1)(2011-2#2)
mRNA were also##2##3##(1990-5#1)(2008-11#1)
mRNA were higher##2##3##(1992-9#1)(1993-3#1)
mRNA were measured in##2##4##(1990-3#1)(1994-11#1)
mRNA were##19##2##(1990-3#1)(1990-5#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1995-11#1)(1996-12#5)(1996-2#1)(2008-11#1)(2008-12#3)
mRNA which##2##2##(1990-11#1)(1997-2#1)
mRNA with##2##2##(1993-6#1)(2008-9#1)
mRNA##778##1##(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#3)(1990-5#8)(1990-8#5)(1991-5#10)(1991-6#2)(1991-9#2)(1992-1#2)(1992-10#3)(1992-12#1)(1992-3#5)(1992-4#2)(1992-6#7)(1992-8#3)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#8)(1993-3#11)(1993-5#1)(1993-6#16)(1993-8#18)(1993-9#1)(1994-11#27)(1994-12#9)(1994-2#6)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#6)(1995-11#9)(1995-12#34)(1995-2#21)(1995-3#1)(1995-6#16)(1995-8#9)(1995-9#1)(1996-12#126)(1996-2#19)(1996-6#2)(1997-1#7)(1997-2#21)(1997-3#3)(1997-6#2)(1997-7#6)(1997-8#7)(1997-9#1)(2006-6#2)(2008-1#1)(2008-10#29)(2008-11#55)(2008-12#7)(2008-2#1)(2008-4#10)(2008-5#9)(2008-6#17)(2008-7#8)(2008-8#41)(2008-9#31)(2009-10#1)(2009-12#2)(2009-8#4)(2009-9#1)(2010-1#10)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#6)(2010-7#1)(2011-2#16)(2011-3#4)(2012-2#15)(2012-3#14)(2013-1#19)(2013-8#3)
mRNA)##6##1##(1993-3#1)(1996-12#3)(2008-10#1)(2008-9#1)
mRNA-injected oocytes was##2##3##(1994-8#2)
mRNA-injected oocytes##3##2##(1994-8#3)
mRNA/protein##2##1##(2010-10#2)
mRNAs and##3##2##(1996-12#1)(1996-2#1)(2008-11#1)
mRNAs are##7##2##(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-12#2)(1996-2#1)
mRNAs for##6##2##(1995-2#1)(1996-12#2)(2008-8#3)
mRNAs from##3##2##(1993-6#1)(1996-12#1)(2008-8#1)
mRNAs in the##2##3##(1992-6#1)(2008-4#1)
mRNAs in##8##2##(1991-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-4#1)
mRNAs of##3##2##(1996-12#1)(1997-2#1)(2008-4#1)
mRNAs that##4##2##(1990-5#1)(1991-7#1)(1995-2#1)(2010-10#1)
mRNAs to##4##2##(1994-12#1)(1996-12#1)(2012-2#1)(2013-1#1)
mRNAs were expressed##2##3##(1996-2#1)(2008-11#1)
mRNAs were##11##2##(1991-5#1)(1993-9#2)(1996-12#3)(1996-2#2)(2008-11#2)(2013-1#1)
mRNAs##92##1##(1990-3#1)(1990-5#1)(1991-5#2)(1991-7#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#4)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-12#20)(1996-2#6)(1997-2#3)(2008-10#4)(2008-11#10)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#5)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#3)
mRT-PCR##3##1##(2008-10#3)
mSERT cDNA##2##2##(1996-12#2)
mSERT##5##1##(1996-12#5)
mSTI1##3##1##(1997-7#3)
mSv##2##1##(1997-8#1)(2011-2#1)
mT)##3##1##(2008-12#1)(2011-2#2)
mTBI##2##1##(2009-8#2)
mTERT##5##1##(2008-11#5)
mTOR inhibitor##2##2##(2013-1#2)
mTOR inhibitors##2##2##(2013-1#2)
mTOR kinase inhibitors##3##3##(2009-7#3)
mTOR##12##1##(2009-7#7)(2013-1#5)
mU l(-1)##2##2##(2008-10#2)
mU/l##2##1##(2008-10#2)
mV (versus SCE)##2##3##(2008-10#2)
mV (versus##3##2##(2008-10#3)
mV (vs##3##2##(2008-10#3)
mV M(-1) for##5##3##(2008-10#5)
mV M(-1)##6##2##(2008-10#6)
mV and pulse##2##3##(2008-10#2)
mV and##4##2##(2008-10#4)
mV at pH 6##2##4##(2008-10#2)
mV at##3##2##(2008-10#3)
mV decade(-1)##7##2##(2008-10#7)
mV decade(-1))##2##2##(2008-10#2)
mV in##3##2##(1996-6#1)(2008-10#1)(2008-8#1)
mV on##2##2##(2008-10#1)(2008-8#1)
mV pH(-1) at 20+/-0##2##4##(2008-10#2)
mV per concentration decade##6##4##(2008-10#6)
mV per concentration##7##3##(2008-10#7)
mV per decade and a##2##5##(2008-10#2)
mV per decade and##4##4##(2008-10#4)
mV per decade of activity##2##5##(2008-10#2)
mV per decade of##3##4##(2008-10#3)
mV per decade over the concentration range of##2##8##(2008-10#2)
mV per decade over the##3##5##(2008-10#3)
mV per decade##27##3##(2008-10#27)
mV per decade)##2##3##(2008-10#2)
mV per pH##2##3##(2008-10#2)
mV per##38##2##(2008-10#38)
mV s(-1) and##2##3##(2008-10#2)
mV s(-1)##10##2##(2008-10#10)
mV to the##2##3##(1997-7#2)
mV versus Ag/AgCl##5##3##(2008-10#5)
mV versus SCE##2##3##(2008-10#2)
mV versus##11##2##(2008-10#11)
mV vs##4##2##(2008-10#4)
mV##145##1##(1990-5#2)(1993-8#6)(1996-6#1)(1997-2#2)(1997-7#2)(2008-10#126)(2008-7#1)(2008-8#3)(2009-9#2)
mV)##9##1##(2008-10#9)
mV/10-fold change in selenite concentration##2##5##(2008-10#2)
mV/decade and a##3##3##(2008-10#3)
mV/decade of##2##2##(2008-10#2)
mV/decade##7##1##(2008-10#7)
mV/pH##2##1##(2008-10#2)
mVs(-1)##2##1##(2008-10#2)
mW and a##3##3##(2008-2#1)(2008-3#2)
mW and##5##2##(2008-2#1)(2008-3#4)
mW at##2##2##(2007-12#1)(2008-3#1)
mW for##2##2##(2007-11#1)(2008-3#1)
mW in the##3##3##(2008-3#3)
mW in##4##2##(2008-3#4)
mW of average##2##3##(2007-11#1)(2007-12#1)
mW of power at##2##4##(2008-2#1)(2008-3#1)
mW of power##3##3##(2008-2#2)(2008-3#1)
mW of##13##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#7)(2008-9#1)
mW##34##1##(2007-11#2)(2007-12#3)(2008-2#9)(2008-3#19)(2008-9#1)
mW/cm(2)##4##1##(2008-11#1)(2008-7#3)
mW/cm2##3##1##(1993-8#2)(2013-1#1)
mWard##2##1##(2010-8#2)
mabs##2##1##(2006-6#2)
macaque##7##1##(1993-6#2)(1994-2#1)(1997-2#1)(1997-3#1)(2009-10#1)(2013-8#1)
macaques with SIV-PBj14##2##3##(1997-3#2)
macaques with##4##2##(1991-2#2)(1997-3#2)
macaques##13##1##(1990-11#1)(1991-2#2)(1991-9#1)(1994-2#1)(1997-3#4)(2008-10#1)(2008-4#2)(2012-3#1)
macedonica and Ph##2##3##(2008-12#2)
macerated##4##1##(1995-9#1)(2008-10#2)(2008-11#1)
maceration and##2##2##(2008-10#2)
maceration##6##1##(2008-10#6)
machine is##2##2##(1997-6#1)(2011-3#1)
machine learning approaches##2##3##(2011-2#1)(2012-2#1)
machine learning##4##2##(2010-12#2)(2011-2#1)(2012-2#1)
machine readable##2##2##(2010-8#2)
machine##37##1##(1990-2#1)(1990-6#1)(1991-3#1)(1997-6#6)(2007-11#1)(2008-10#5)(2008-4#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#3)(2010-7#2)(2010-8#2)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#2)
machined##2##1##(2008-10#2)
machinery and##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
machinery in##2##2##(2008-8#1)(2009-6#1)
machinery is##6##2##(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#2)(2013-8#1)
machinery of##3##2##(1991-5#1)(1992-6#1)(2009-5#1)
machinery that##3##2##(1993-12#1)(2009-8#1)(2012-2#1)
machinery to##3##2##(1995-6#1)(2009-8#1)(2011-2#1)
machinery##46##1##(1991-5#2)(1992-6#1)(1993-12#1)(1994-12#2)(1995-6#1)(2008-10#2)(2008-11#9)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2011-2#4)(2012-2#2)(2013-1#4)(2013-8#1)
machines of##2##2##(2010-7#1)(2011-3#1)
machines was##2##2##(2008-12#1)(2009-12#1)
machines work##2##2##(2008-10#1)(2008-7#1)
machines##25##1##(1990-11#1)(1996-1#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#2)(2009-12#3)(2010-7#1)(2011-3#1)(2013-1#1)(2013-8#1)
machining##7##1##(1994-2#1)(2008-10#1)(2008-3#1)(2008-8#4)
machinists##3##1##(1991-12#3)
macro and##2##2##(2008-10#1)(2008-11#1)
macro##11##1##(1994-12#1)(2008-10#6)(2008-11#2)(2009-5#1)(2012-2#1)
macro- and micronutrients##2##3##(2008-10#1)(2012-2#1)
macro- and##5##2##(1997-1#1)(2008-10#1)(2008-12#1)(2010-3#1)(2012-2#1)
macro-##6##1##(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2012-2#1)
macro-gravimetric##2##1##(2008-10#2)
macroalbuminuric##3##1##(1992-9#3)
macroangiopathy##2##1##(1993-2#1)(2012-2#1)
macrocephaly##2##1##(1997-3#1)(2012-3#1)
macrochirus##3##1##(2010-8#3)
macroclada was##2##2##(2008-10#2)
macroclada##5##1##(2008-10#5)
macroconidia##3##1##(2008-10#2)(2008-5#1)
macrocrania##2##1##(1996-9#1)(2008-7#1)
macrocycle##12##1##(2008-10#12)
macrocycles##3##1##(2008-10#3)
macrocyclic compounds##2##2##(2008-10#2)
macrocyclic diamides##2##2##(2008-10#2)
macrocyclic ethers##3##2##(2008-10#3)
macrocyclic glycopeptide antibiotics-vancomycin and teicoplanin##2##5##(2008-10#2)
macrocyclic polyether##2##2##(2008-10#2)
macrocyclic##28##1##(2008-10#28)
macrodactyly##3##1##(2009-5#3)
macroecology##2##1##(2008-8#1)(2008-9#1)
macrofilled##2##1##(2011-2#2)
macrolide##3##1##(2008-10#1)(2008-3#1)(2010-12#1)
macromolecular chelator##2##2##(2008-10#2)
macromolecular##20##1##(1991-11#1)(1992-4#1)(1992-6#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-7#1)(2012-2#1)(2013-8#2)
macromolecule##5##1##(1990-8#1)(1991-11#1)(2008-1#1)(2008-10#1)(2008-4#1)
macromolecules and cytokines##2##3##(2012-3#2)
macromolecules and particles##2##3##(2008-10#2)
macromolecules and##6##2##(1997-6#1)(2008-10#2)(2008-7#1)(2012-3#2)
macromolecules##33##1##(1995-2#1)(1996-5#3)(1997-2#1)(1997-6#4)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#5)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#2)
macronucleus##2##1##(2008-9#1)(2012-3#1)
macronutrient composition##4##2##(2008-3#4)
macronutrient##8##1##(2008-10#1)(2008-3#6)(2011-2#1)
macronutrients##7##1##(1996-12#1)(2008-10#1)(2008-3#4)(2013-1#1)
macroorganisms##2##1##(2008-10#1)(2008-8#1)
macrophage activity was##2##3##(1992-12#2)
macrophage activity##3##2##(1992-12#2)(2008-11#1)
macrophage cell line##2##3##(1990-12#1)(2008-10#1)
macrophage depletion##2##2##(2008-12#2)
macrophage function##2##2##(1997-4#1)(2008-10#1)
macrophage recognition of##2##3##(1990-12#1)(1995-2#1)
macrophage##37##1##(1990-12#2)(1991-5#5)(1991-6#1)(1992-12#2)(1992-5#1)(1994-6#2)(1994-8#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-8#1)(2010-12#1)(2013-1#1)
macrophage-derived##2##1##(1991-12#1)(2010-6#1)
macrophage-like cells##3##2##(1994-11#1)(1996-12#2)
macrophages and T-cells##2##3##(2008-10#2)
macrophages and dendritic cells##2##4##(2008-6#1)(2009-12#1)
macrophages and osteoclasts##2##3##(1991-5#1)(2011-2#1)
macrophages and##16##2##(1990-6#1)(1991-5#1)(1994-5#1)(1994-8#1)(1995-6#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
macrophages are##4##2##(2008-10#2)(2008-9#2)
macrophages by##2##2##(2008-12#1)(2011-1#1)
macrophages in all##2##3##(1990-12#1)(1997-8#1)
macrophages in the##2##3##(1997-2#1)(2008-11#1)
macrophages in vivo##2##3##(1992-12#1)(2008-11#1)
macrophages in##9##2##(1990-12#1)(1992-12#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-12#1)
macrophages is##3##2##(1993-3#1)(1995-12#1)(2008-11#1)
macrophages may##3##2##(1994-5#1)(2008-11#1)(2008-8#1)
macrophages obtained from##3##3##(1997-4#1)(2008-12#1)(2013-1#1)
macrophages obtained##4##2##(1996-2#1)(1997-4#1)(2008-12#1)(2013-1#1)
macrophages or##4##2##(1990-6#1)(2008-10#2)(2009-6#1)
macrophages play##2##2##(2008-9#1)(2012-12#1)
macrophages to##4##2##(1990-2#1)(1995-2#1)(2007-11#1)(2008-8#1)
macrophages was##2##2##(1991-5#1)(1993-3#1)
macrophages were investigated##3##3##(1993-3#1)(2008-11#1)(2008-8#1)
macrophages were##6##2##(1990-12#1)(1993-3#1)(2008-11#1)(2008-8#2)(2010-10#1)
macrophages##155##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#3)(1991-5#9)(1991-6#1)(1992-10#1)(1992-12#3)(1992-5#1)(1993-3#6)(1993-6#1)(1993-8#2)(1994-5#3)(1994-6#3)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#8)(1995-3#2)(1995-5#3)(1995-6#3)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-4#2)(1997-8#2)(2007-11#1)(2008-10#22)(2008-11#11)(2008-12#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#9)(2008-9#4)(2009-12#1)(2009-6#3)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
macrophages]##2##1##(1992-5#1)(2008-12#1)
macrophyllum##2##1##(2008-10#2)
macropores##2##1##(2008-10#1)(2008-6#1)
macroporous resin##4##2##(2008-10#3)(2013-8#1)
macroporous support##2##2##(2008-10#2)
macroporous##17##1##(2008-10#11)(2008-11#4)(2010-7#1)(2013-8#1)
macrorelief##3##1##(2008-5#3)
macroscopic activity##2##2##(2008-11#2)
macroscopic and microscopic##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
macroscopic and##5##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)
macroscopic haematuria##4##2##(1995-5#4)
macroscopic scale##2##2##(1995-3#1)(2009-7#1)
macroscopic symptoms##2##2##(2008-10#2)
macroscopic##44##1##(1990-11#1)(1991-12#1)(1995-12#1)(1995-3#1)(1995-5#4)(2008-10#8)(2008-11#6)(2008-3#2)(2008-5#4)(2008-7#4)(2009-7#3)(2009-8#1)(2011-2#1)(2012-2#6)(2013-8#1)
macroscopically##6##1##(1996-3#1)(2008-10#2)(2008-11#1)(2010-12#1)(2013-1#1)
macrosomia##3##1##(1996-11#3)
macrovascular##4##1##(2008-1#3)(2013-1#1)
macula##3##1##(2010-8#1)(2011-2#2)
maculans avirulence##2##2##(2008-10#2)
maculans isolate PHW1245##2##3##(2008-10#2)
maculans isolates##6##2##(2008-10#6)
maculans##40##1##(2008-10#38)(2011-10#2)
macular degeneration (AMD)##7##3##(2011-2#5)(2011-7#1)(2013-1#1)
macular degeneration##22##2##(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#15)(2011-7#2)(2013-1#1)
macular degeneration?##2##2##(2011-2#2)
macular disease##3##2##(2013-1#2)(2013-8#1)
macular edema (DME)##2##3##(2008-1#1)(2011-7#1)
macular edema##5##2##(2008-1#1)(2011-7#2)(2013-1#2)
macular epiretinal membrane##2##3##(2011-2#2)
macular thickness##6##2##(2011-2#2)(2013-1#4)
macular##58##1##(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#30)(2011-7#4)(2013-1#16)(2013-8#1)
maculata##2##1##(2008-10#2)
maculatus##3##1##(2009-10#1)(2010-8#2)
macules##10##1##(2010-6#6)(2011-2#1)(2012-3#2)(2013-1#1)
maculicola KD4326##2##2##(2008-10#2)
maculicola##5##1##(2008-10#5)
maculopathy##4##1##(2010-9#1)(2011-2#2)(2013-1#1)
made a full recovery##2##4##(2012-12#1)(2013-8#1)
made a good##3##3##(1997-6#1)(2008-7#1)(2010-5#1)
made a significant contribution to##3##5##(2008-11#2)(2013-1#1)
made a significant##6##3##(1993-3#1)(2008-11#2)(2008-9#1)(2009-6#1)(2013-1#1)
made a##28##2##(1992-1#2)(1993-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-7#3)(2008-9#1)(2009-10#3)(2009-6#1)(2010-10#1)(2010-5#1)(2012-12#1)(2013-1#2)(2013-8#1)
made about##2##2##(1995-2#1)(2008-10#1)
made according to##2##3##(2008-10#1)(2013-1#1)
made according##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
made after##2##2##(1992-12#1)(1994-2#1)
made among##4##2##(2008-10#2)(2010-12#1)(2013-1#1)
made an uneventful recovery##2##4##(1994-2#1)(1997-3#1)
made an##7##2##(1993-11#1)(1994-2#1)(1997-3#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
made and the##2##3##(2008-10#1)(2010-9#1)
made and##11##2##(1992-9#1)(1994-5#1)(2008-10#4)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-7#1)
made as##2##2##(2012-3#1)(2013-8#1)
made at the##5##3##(1994-9#1)(1995-12#1)(2008-10#2)(2008-3#1)
made at##14##2##(1990-2#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-10#2)(2013-1#1)
made available for##2##3##(1993-1#1)(1995-5#1)
made available##7##2##(1993-1#1)(1994-2#1)(1995-5#1)(2008-1#1)(2008-7#1)(2013-1#2)
made based on##5##3##(1991-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
made before##3##2##(1997-5#1)(1997-8#1)(2009-1#1)
made between the##3##3##(2008-10#2)(2008-11#1)
made between##19##2##(1994-3#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#1)
made by clinical##2##3##(1992-5#1)(2008-10#1)
made by means of##3##4##(2008-10#1)(2008-5#1)(2010-8#1)
made by pressing##2##3##(2007-12#1)(2008-10#1)
made by the##10##3##(1990-11#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
made by using the##2##4##(2008-10#2)
made by using##4##3##(2008-10#4)
made by##64##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#3)(2008-9#3)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
made changes##2##2##(2008-11#1)(2008-9#1)
made contact##2##2##(1992-3#1)(2008-10#1)
made during the##4##3##(2008-10#2)(2008-8#1)(2012-12#1)
made during##7##2##(1994-11#1)(1996-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-12#1)
made for each##3##3##(2008-10#3)
made for the##2##3##(2008-10#1)(2008-3#1)
made for##28##2##(1991-1#1)(1992-12#1)(1992-3#1)(1994-12#1)(1996-3#1)(1997-5#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2011-2#1)
made from a##2##3##(2008-10#1)(2009-7#1)
made from the##6##3##(1991-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)
made from##36##2##(1991-5#1)(1991-6#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
made great##2##2##(2011-3#1)(2012-3#1)
made in a##5##3##(1991-2#1)(2008-10#2)(2008-3#1)(2008-9#1)
made in different##2##3##(1994-6#1)(2008-10#1)
made in order to##4##4##(2008-10#2)(2008-11#1)(2012-7#1)
made in the assessment##2##4##(2008-11#1)(2008-8#1)
made in the field of##3##5##(2009-6#2)(2010-10#1)
made in the laboratory##3##4##(1992-3#1)(2008-10#1)(2008-2#1)
made in the past few years##2##6##(2010-7#1)(2011-2#1)
made in the##28##3##(1990-9#1)(1992-3#1)(1995-12#1)(1995-3#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-7#1)(2011-2#2)
made in this study##2##4##(1996-12#1)(2008-10#1)
made in this##5##3##(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
made in understanding the##3##4##(2008-11#1)(2011-1#1)(2011-2#1)
made in understanding##5##3##(2008-11#1)(2011-1#1)(2011-2#2)(2012-2#1)
made in##93##2##(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-6#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-9#1)(2007-8#1)(2008-10#26)(2008-11#15)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#2)
made into##3##2##(2008-10#1)(2008-9#1)(2011-3#1)
made it possible for##3##4##(1992-3#1)(2008-10#1)(2010-12#1)
made it possible to detect##2##5##(1991-6#1)(1994-6#1)
made it possible to identify##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
made it possible to obtain##4##5##(2008-10#3)(2008-3#1)
made it possible to##20##4##(1991-6#1)(1994-6#1)(1995-5#1)(1995-8#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)
made it possible##23##3##(1991-6#1)(1992-3#1)(1994-6#1)(1995-5#1)(1995-8#1)(2008-10#8)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)
made it##30##2##(1991-6#1)(1992-3#1)(1993-3#1)(1994-6#2)(1995-5#1)(1995-8#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
made its##2##2##(2008-11#1)(2010-12#1)
made more##4##2##(1994-9#1)(2008-10#1)(2008-6#1)(2012-2#1)
made no##2##2##(1997-8#1)(2012-3#1)
made of Teflon AF-2400##2##4##(2008-10#2)
made of a##2##3##(2008-10#1)(2009-7#1)
made of the same##2##4##(2008-11#2)
made of the##19##3##(1991-1#1)(1991-3#2)(1992-1#1)(1992-6#2)(1994-1#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2011-2#1)(2012-3#1)
made of##52##2##(1991-1#1)(1991-3#2)(1992-1#1)(1992-6#2)(1993-8#1)(1994-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#19)(2008-11#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
made on a##3##3##(2008-2#1)(2008-3#1)(2011-3#1)
made on the basis of##4##5##(1992-12#1)(2008-10#2)(2008-8#1)
made on the##15##3##(1991-3#1)(1991-6#1)(1992-12#1)(1993-11#1)(1996-1#1)(1996-5#1)(2008-10#5)(2008-2#1)(2008-8#2)(2009-10#1)
made on##29##2##(1991-3#2)(1991-6#1)(1992-12#1)(1993-11#1)(1993-2#1)(1996-1#1)(1996-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2011-3#1)(2012-3#1)
made possible by the##2##4##(2008-10#1)(2011-2#1)
made possible by##9##3##(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
made possible the determination of##2##5##(2008-10#2)
made possible##11##2##(1994-3#1)(2008-10#3)(2008-12#1)(2008-3#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
made significant##2##2##(2008-12#1)(2008-8#1)
made that##6##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#1)
made the largest##2##3##(2008-8#1)(2010-6#1)
made the##19##2##(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-6#1)(1996-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
made their##2##2##(1997-3#1)(2010-10#1)
made them##2##2##(2008-10#1)(2011-3#1)
made these##2##2##(1994-5#1)(2011-2#1)
made through the##2##3##(1992-9#1)(2007-12#1)
made through##4##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-9#1)
made to correlate##2##3##(1992-12#1)(2008-10#1)
made to determine the##3##4##(1990-6#1)(2008-10#1)(2013-1#1)
made to develop a##3##4##(2008-10#2)(2008-9#1)
made to develop##5##3##(1991-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
made to find##5##3##(1992-12#1)(2008-5#1)(2009-5#1)(2010-4#1)(2012-2#1)
made to improve##4##3##(1991-1#1)(1994-5#1)(2008-10#1)(2008-11#1)
made to react with##3##4##(2008-10#3)
made to study##2##3##(2008-10#1)(2008-11#1)
made to the##7##3##(1991-12#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
made to understand##2##3##(2008-5#1)(2011-2#1)
made to##74##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1993-12#1)(1993-2#1)(1994-5#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2008-10#18)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-5#2)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#5)
made towards##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
made until##2##2##(2008-7#1)(2010-1#1)
made up by a##3##4##(2008-10#2)(2008-5#1)
made up by##4##3##(2008-10#2)(2008-5#2)
made up of a##3##4##(1996-2#1)(2008-12#1)(2008-9#1)
made up of##20##3##(1991-12#1)(1991-3#1)(1993-3#1)(1996-1#1)(1996-2#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)
made up the##2##3##(2008-11#1)(2010-9#1)
made up to##2##3##(2008-10#2)
made up##35##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1996-1#1)(1996-2#1)(2007-12#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-9#1)
made use of##2##3##(2009-8#1)(2011-2#1)
made using a##5##3##(1995-11#1)(2008-10#3)(2011-1#1)
made using##19##2##(1991-5#1)(1995-11#1)(2008-10#13)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#1)
made when##3##2##(1992-9#1)(2008-10#1)(2008-4#1)
made which##2##2##(2008-11#1)(2013-8#1)
made with a##2##3##(2008-10#2)
made with the##8##3##(1993-8#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-7#1)(2013-1#1)
made with##26##2##(1990-12#1)(1991-3#1)(1993-8#1)(1995-6#1)(2008-1#1)(2008-10#8)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#2)(2013-1#1)
made without##2##2##(1997-2#1)(2010-4#1)
made##880##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#4)(1991-12#6)(1991-2#3)(1991-3#11)(1991-5#2)(1991-6#4)(1991-9#1)(1992-1#3)(1992-12#8)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#2)(1992-9#6)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#5)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#8)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#3)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-5#4)(1997-6#3)(1997-7#2)(1997-8#6)(1997-9#1)(2007-12#5)(2007-8#2)(2008-1#4)(2008-10#265)(2008-11#64)(2008-12#16)(2008-2#8)(2008-3#31)(2008-4#6)(2008-5#18)(2008-6#5)(2008-7#28)(2008-8#16)(2008-9#25)(2009-1#1)(2009-10#6)(2009-12#3)(2009-3#2)(2009-5#4)(2009-6#4)(2009-7#9)(2009-8#6)(2010-1#2)(2010-10#6)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#6)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#30)(2011-3#4)(2012-12#12)(2012-2#17)(2012-3#21)(2012-7#1)(2013-1#26)(2013-7#1)(2013-8#8)
maenas##2##1##(1994-11#1)(2008-7#1)
magainin##2##1##(1995-11#2)
magic T##2##2##(2008-3#2)
magic angle spinning (CPMAS) NMR and diffuse reflectance infrared##2##9##(2008-10#2)
magic angle spinning##3##3##(2008-10#3)
magic angle##4##2##(2008-10#4)
magic##8##1##(1994-2#1)(2008-10#4)(2008-3#2)(2008-7#1)
magma##2##1##(2008-10#1)(2013-8#1)
magnesia##2##1##(2008-10#1)(2011-2#1)
magnesium and age##2##3##(2008-7#2)
magnesium and calcium binding##2##4##(2008-10#2)
magnesium and calcium##3##3##(2008-10#3)
magnesium and zinc in honey##2##5##(2008-10#2)
magnesium and zinc##3##3##(2008-10#3)
magnesium and##15##2##(1994-5#1)(2008-10#9)(2008-6#1)(2008-7#2)(2011-2#2)
magnesium ascorbyl phosphate##2##3##(2008-5#2)
magnesium concentration##5##2##(2008-7#4)(2011-2#1)
magnesium concentrations were##2##3##(2008-7#2)
magnesium concentrations##5##2##(1991-9#1)(2008-7#4)
magnesium hydroxide coprecipitation##2##3##(2008-10#2)
magnesium in the##2##3##(2008-10#2)
magnesium in##14##2##(1991-1#1)(2008-10#13)
magnesium indicators##3##2##(1991-5#3)
magnesium ions##7##2##(2008-10#6)(2008-4#1)
magnesium is##2##2##(2008-10#1)(2011-2#1)
magnesium nitrate##3##2##(1991-12#1)(2008-10#2)
magnesium over##2##2##(2008-10#2)
magnesium reabsorption##2##2##(1997-8#1)(2008-6#1)
magnesium salts##2##2##(2008-10#1)(2008-7#1)
magnesium selectivity##2##2##(2008-10#2)
magnesium stearate##2##2##(2008-10#2)
magnesium were##5##2##(2008-10#5)
magnesium with##3##2##(2008-10#2)(2011-2#1)
magnesium##149##1##(1990-9#4)(1991-1#1)(1991-12#1)(1991-5#4)(1991-9#1)(1992-6#1)(1993-8#2)(1994-5#4)(1996-6#1)(1997-3#1)(1997-8#3)(2008-10#80)(2008-4#2)(2008-5#3)(2008-6#7)(2008-7#19)(2008-8#1)(2011-2#10)(2012-2#2)(2013-1#1)(2013-7#1)
magnesium(II)##4##1##(2008-10#4)
magnet and##2##2##(2008-10#2)
magnet##18##1##(1990-12#2)(1994-9#1)(2008-10#7)(2008-8#2)(2008-9#1)(2009-5#3)(2012-2#1)(2012-3#1)
magnetic and##2##2##(1992-3#1)(2008-4#1)
magnetic bead##2##2##(1990-12#1)(2008-4#1)
magnetic beads and##2##3##(1995-6#1)(2008-10#1)
magnetic beads in##3##3##(2008-10#3)
magnetic beads were introduced##2##4##(2008-10#2)
magnetic beads##24##2##(1990-12#1)(1995-6#3)(1995-8#1)(2008-10#14)(2008-11#1)(2008-4#2)(2008-8#1)(2010-11#1)
magnetic field can##2##3##(2008-9#2)
magnetic field in the##2##4##(2008-10#1)(2008-8#1)
magnetic field in##3##3##(2008-10#1)(2008-8#2)
magnetic field is##4##3##(2008-8#2)(2008-9#1)(2010-9#1)
magnetic field on##3##3##(2008-10#1)(2008-8#2)
magnetic field##39##2##(1992-12#1)(1992-3#1)(1993-3#1)(1995-8#1)(1997-3#1)(2008-10#9)(2008-3#1)(2008-8#13)(2008-9#6)(2009-5#1)(2010-9#1)(2011-2#2)(2012-2#1)
magnetic fields##12##2##(1992-3#8)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
magnetic isolation##2##2##(2008-10#2)
magnetic motor evoked potentials##2##4##(1996-6#2)
magnetic nanoparticles##7##2##(2008-10#4)(2011-2#1)(2012-2#2)
magnetic resonance (MR) images is##2##5##(1995-5#1)(2010-8#1)
magnetic resonance (MR) imaging##3##4##(1996-2#1)(2011-2#2)
magnetic resonance (MR)##8##3##(1995-11#1)(1995-5#1)(1996-2#1)(2010-8#1)(2011-2#2)(2012-2#2)
magnetic resonance (NMR)##9##3##(1992-4#1)(1993-3#1)(1996-2#1)(2008-10#4)(2008-4#1)(2010-8#1)
magnetic resonance and##6##3##(1996-11#1)(1997-8#1)(2008-10#2)(2009-10#1)(2012-2#1)
magnetic resonance angiography (MRA)##2##4##(2008-12#1)(2008-7#1)
magnetic resonance angiography##4##3##(2008-12#2)(2008-7#1)(2009-8#1)
magnetic resonance for##2##3##(2009-10#2)
magnetic resonance image##2##3##(2008-7#2)
magnetic resonance images##4##3##(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
magnetic resonance imaging (MRI) findings##4##5##(1996-11#1)(2012-12#2)(2012-3#1)
magnetic resonance imaging (MRI) of the##3##6##(2008-7#1)(2010-12#1)(2012-2#1)
magnetic resonance imaging (MRI) scan##2##5##(2008-7#1)(2013-1#1)
magnetic resonance imaging (MRI) showed##2##5##(2013-1#1)(2013-8#1)
magnetic resonance imaging (MRI)##29##4##(1995-5#1)(1996-11#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-9#3)(2011-2#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
magnetic resonance imaging and##8##4##(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#3)
magnetic resonance imaging in the##2##5##(1990-12#1)(2010-12#1)
magnetic resonance imaging in##4##4##(1990-12#1)(2010-12#1)(2012-12#1)(2013-3#1)
magnetic resonance imaging is##4##4##(1990-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
magnetic resonance imaging of a##2##5##(2011-2#1)(2013-1#1)
magnetic resonance imaging of##6##4##(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
magnetic resonance imaging revealed##2##4##(2008-11#1)(2008-12#1)
magnetic resonance imaging showed##2##4##(2008-7#1)(2010-10#1)
magnetic resonance imaging study##2##4##(2008-11#1)(2011-2#1)
magnetic resonance imaging to##2##4##(1990-12#1)(2012-3#1)
magnetic resonance imaging was performed##2##5##(2011-2#1)(2012-12#1)
magnetic resonance imaging was used to##2##6##(1996-2#1)(2008-11#1)
magnetic resonance imaging was##5##4##(1996-2#1)(2008-11#1)(2011-2#2)(2012-12#1)
magnetic resonance imaging##123##3##(1990-12#3)(1992-12#1)(1992-3#4)(1994-3#1)(1995-5#3)(1996-11#1)(1996-2#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#11)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#3)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#7)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-2#16)(2012-12#6)(2012-2#12)(2012-3#5)(2013-1#4)(2013-3#2)(2013-7#1)(2013-8#2)
magnetic resonance measurements##2##3##(2008-11#1)(2010-8#1)
magnetic resonance spectroscopy and##2##4##(2008-11#1)(2008-7#1)
magnetic resonance spectroscopy##13##3##(1991-1#1)(1994-2#1)(1994-5#1)(2008-10#4)(2008-11#3)(2008-7#2)(2010-12#1)
magnetic resonance studies##2##3##(1991-6#1)(2008-10#1)
magnetic resonance techniques##2##3##(2008-10#1)(2008-4#1)
magnetic resonance##209##2##(1990-12#3)(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#8)(1992-4#1)(1993-3#1)(1993-5#1)(1994-2#2)(1994-3#3)(1994-5#1)(1995-11#1)(1995-5#5)(1996-11#3)(1996-2#4)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#15)(2008-11#16)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#17)(2008-8#3)(2008-9#2)(2009-1#2)(2009-10#5)(2009-11#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#8)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#24)(2012-12#6)(2012-2#15)(2012-3#5)(2013-1#5)(2013-3#2)(2013-7#1)(2013-8#2)
magnetic sector##2##2##(2008-10#2)
magnetic stimulation (TMS)##3##3##(2010-7#2)(2011-2#1)
magnetic stimulation##18##2##(2008-10#1)(2008-7#4)(2009-10#1)(2010-5#2)(2010-7#7)(2011-2#3)
magnetic susceptibility##3##2##(2008-10#1)(2009-7#1)(2012-2#1)
magnetic##363##1##(1990-12#6)(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#18)(1992-4#1)(1993-3#2)(1993-5#4)(1994-2#2)(1994-3#3)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#5)(1995-6#4)(1995-8#2)(1996-11#3)(1996-2#5)(1996-6#2)(1997-3#1)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#62)(2008-11#23)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#2)(2008-7#23)(2008-8#18)(2008-9#10)(2009-1#2)(2009-10#6)(2009-11#3)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#10)(2010-8#3)(2010-9#4)(2011-1#1)(2011-2#30)(2012-12#6)(2012-2#26)(2012-3#5)(2013-1#5)(2013-3#2)(2013-7#1)(2013-8#3)
magnetite particles were##2##3##(1992-12#2)
magnetite particles##3##2##(1992-12#3)
magnetite##6##1##(1992-12#3)(2008-10#3)
magnetization##6##1##(1992-12#3)(2008-10#1)(2008-7#1)(2010-9#1)
magneto-optic##4##1##(2008-3#4)
magneto-optical##2##1##(2008-3#2)
magnetometer##2##1##(1992-8#1)(2012-12#1)
magnification of##2##2##(2008-2#1)(2008-9#1)
magnification##5##1##(1993-3#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
magnified##2##1##(2008-10#1)(2008-9#1)
magnitude and direction of##2##4##(2010-5#1)(2010-8#1)
magnitude and direction##3##3##(2008-10#1)(2010-5#1)(2010-8#1)
magnitude and duration of##2##4##(1996-2#1)(2008-11#1)
magnitude and##20##2##(1995-5#1)(1996-2#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#2)
magnitude for##3##2##(1991-5#1)(2008-10#1)(2008-9#1)
magnitude in the##2##3##(1993-2#1)(2008-3#1)
magnitude in##5##2##(1993-2#1)(2008-10#1)(2008-3#2)(2010-8#1)
magnitude of K(ex)##3##3##(2008-10#3)
magnitude of the##45##3##(1990-12#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-3#1)(2007-11#2)(2008-10#18)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2011-2#2)(2013-8#1)
magnitude of underreporting##2##3##(1997-3#2)
magnitude of##100##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-8#2)(1991-12#2)(1991-8#1)(1992-12#3)(1992-2#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(2007-11#3)(2008-10#38)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#2)(2009-11#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
magnitude order##3##2##(2008-10#3)
magnitude relative to##3##3##(1994-5#1)(1996-3#1)(2008-10#1)
magnitude than those##2##3##(2008-10#2)
magnitude than##3##2##(2008-10#3)
magnitude was##2##2##(2008-10#2)
magnitude with##6##2##(1997-2#1)(2008-10#4)(2008-5#1)
magnitude##257##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-5#3)(1990-8#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#5)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(2007-11#5)(2007-12#1)(2008-10#114)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#15)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#13)(2008-9#5)(2009-10#1)(2009-11#2)(2009-2#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#1)(2013-8#6)
magnitudes and##2##2##(1991-12#1)(2008-3#1)
magnitudes of the##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2009-2#1)
magnitudes of##9##2##(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)
magnitudes##13##1##(1991-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2013-8#1)
magnocellular neurons##2##2##(2008-4#2)
magnocellular##3##1##(1996-2#1)(2008-4#2)
magnolol to##2##2##(2011-2#2)
magnolol##15##1##(2008-10#7)(2011-2#8)
magnum##7##1##(1996-9#2)(2008-12#2)(2008-7#2)(2011-2#1)
maidis##6##1##(2008-10#6)
mail survey##3##2##(1991-2#1)(2011-1#1)(2012-3#1)
mail##10##1##(1991-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2007-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
mailed##12##1##(1991-8#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1996-3#1)(1997-2#1)(2008-1#1)(2009-4#1)(2010-10#1)(2010-11#2)
mailing##3##1##(1997-2#1)(2011-2#1)(2012-2#1)
main acidic##3##2##(2006-6#2)(2008-10#1)
main active##2##2##(2008-5#2)
main activity##2##2##(2013-1#2)
main advantage of the##5##4##(2008-10#3)(2008-3#2)
main advantage of##12##3##(2008-10#6)(2008-3#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
main advantage##13##2##(2008-10#7)(2008-3#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
main advantages and##2##3##(2008-10#2)
main advantages of##8##3##(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
main advantages##12##2##(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
main aim is to##2##4##(2008-10#2)
main aim of##6##3##(1993-2#1)(2008-11#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
main aim##8##2##(1993-2#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
main analytical characteristics##2##3##(2008-10#2)
main analytical##3##2##(2008-10#3)
main and foreign##2##3##(2008-10#2)
main and secondary##2##3##(2008-10#1)(2011-1#1)
main and##6##2##(2008-10#4)(2008-5#1)(2011-1#1)
main areas##2##2##(2008-11#1)(2008-4#1)
main arteries##3##2##(1997-8#3)
main bronchus##2##2##(1990-12#1)(2010-2#1)
main categories##2##2##(2008-11#1)(2011-2#1)
main cause of##9##3##(1991-6#1)(1994-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#2)
main cause##12##2##(1991-6#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#2)
main causes of##5##3##(1990-9#1)(2008-1#2)(2008-8#1)(2010-11#1)
main causes##7##2##(1990-9#1)(2008-1#2)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)
main cell##2##2##(2007-12#1)(2009-10#1)
main chain##4##2##(1992-4#1)(2008-9#2)(2009-7#1)
main characteristics of##5##3##(1991-12#1)(1993-11#1)(2008-10#2)(2013-1#1)
main characteristics##7##2##(1991-12#1)(1993-11#1)(2008-10#3)(2011-2#1)(2013-1#1)
main clades##3##2##(2008-10#2)(2013-8#1)
main clinical##6##2##(1991-2#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
main component##5##2##(2008-10#3)(2008-8#1)(2011-1#1)
main components of the##2##4##(2008-1#1)(2008-5#1)
main components of##7##3##(1993-8#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)
main components were##2##3##(2008-11#1)(2013-1#1)
main components##12##2##(1990-11#1)(1993-8#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
main concern##2##2##(2008-10#1)(2009-10#1)
main contributions##2##2##(2008-10#1)(2011-3#1)
main data##2##2##(2009-4#2)
main degradation product##2##3##(2008-10#2)
main degradation products##3##3##(2008-10#3)
main degradation##5##2##(2008-10#5)
main drawback##2##2##(2008-11#1)(2008-3#1)
main driving force##2##3##(2008-10#1)(2008-11#1)
main effect##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
main effects and##2##3##(1996-2#1)(2008-10#1)
main effects of##3##3##(2008-10#3)
main effects##8##2##(1996-2#1)(2008-10#6)(2013-1#1)
main emphasis##2##2##(1991-9#1)(2008-12#1)
main factor##4##2##(1994-5#1)(1997-3#1)(2008-10#1)(2012-12#1)
main factors affecting the##2##4##(2008-10#2)
main factors that influence##2##4##(2008-10#2)
main factors that##3##3##(2008-10#3)
main factors##12##2##(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2012-3#1)
main features of the##3##4##(1990-3#1)(1992-1#1)(2008-10#1)
main features of##4##3##(1990-3#1)(1992-1#1)(2008-10#1)(2008-5#1)
main features##6##2##(1990-3#1)(1992-1#1)(1996-2#1)(2008-10#1)(2008-5#2)
main feeding##2##2##(2008-7#2)
main findings are##3##3##(2008-6#1)(2008-8#1)(2009-7#1)
main findings##6##2##(2008-11#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
main focus of##3##3##(1995-12#1)(2008-10#1)(2011-1#1)
main focus##8##2##(1995-12#1)(1997-4#1)(2008-10#1)(2008-11#3)(2011-1#1)(2012-6#1)
main food##2##2##(2008-10#1)(2008-12#1)
main function##2##2##(2008-7#2)
main functional##2##2##(2008-10#2)
main functions##2##2##(2007-12#1)(2008-11#1)
main goal of the##2##4##(1991-3#1)(2008-10#1)
main goal of##4##3##(1991-3#1)(1991-6#1)(2008-10#1)(2013-1#1)
main goal was to##2##4##(1992-1#1)(2008-11#1)
main goal##8##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
main goals##2##2##(2009-6#1)(2012-2#1)
main group elements##2##3##(2008-10#2)
main group##5##2##(1991-9#1)(2008-10#3)(2009-8#1)
main groups##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
main hypothesis##2##2##(1994-2#1)(1997-3#1)
main limitation of##3##3##(2008-11#2)(2009-10#1)
main limitation##4##2##(2008-11#2)(2009-1#1)(2009-10#1)
main manifestations##2##2##(2008-5#1)(2012-2#1)
main mechanism##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
main metabolite##8##2##(1990-11#1)(2008-10#7)
main metabolites##5##2##(1990-11#1)(1993-12#1)(1995-11#1)(2008-10#2)
main objective of this work##2##5##(2008-10#1)(2009-6#1)
main objective of this##3##4##(1992-12#1)(2008-10#1)(2009-6#1)
main objective of##6##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2012-2#1)
main objectives##5##2##(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
main optical##2##2##(2008-3#2)
main oxidation##2##2##(2008-10#2)
main pathways of##2##3##(1995-12#1)(2009-8#1)
main peak##4##2##(2008-10#3)(2012-2#1)
main peaks##2##2##(2008-10#2)
main phases##2##2##(2012-2#1)(2012-9#1)
main plots##5##2##(2008-10#4)(2008-12#1)
main principles of##2##3##(2008-11#1)(2008-3#1)
main problem##4##2##(1994-6#1)(1995-3#1)(2008-10#1)(2012-3#1)
main problems##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
main prognostic##3##2##(1994-6#1)(2011-2#2)
main protein##2##2##(2008-8#1)(2011-2#1)
main proximity##2##2##(2008-10#2)
main pulmonary artery##2##3##(1991-5#1)(2008-11#1)
main purpose is to##2##4##(2008-2#1)(2008-8#1)
main purpose of##3##3##(1997-3#1)(2008-5#1)(2008-8#1)
main purpose##5##2##(1997-3#1)(2008-2#1)(2008-5#1)(2008-8#2)
main purposes##2##2##(1991-2#1)(2013-8#1)
main questions##2##2##(1991-6#1)(2011-2#1)
main reason for##5##3##(1991-9#1)(1994-6#1)(2009-11#1)(2012-12#1)(2013-1#1)
main reason##6##2##(1990-6#1)(1991-9#1)(1994-6#1)(2009-11#1)(2012-12#1)(2013-1#1)
main reasons##3##2##(1996-1#1)(1996-6#1)(2008-10#1)
main result is that##2##4##(2008-9#1)(2010-1#1)
main result is##3##3##(2008-3#1)(2008-9#1)(2010-1#1)
main result##5##2##(2008-3#1)(2008-9#2)(2010-1#1)(2013-8#1)
main results##6##2##(1993-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)
main role##3##2##(1990-5#1)(1997-2#1)(2008-10#1)
main site-specific cancer mortalities##2##4##(2010-1#2)
main source of##6##3##(1993-1#1)(1995-1#1)(2008-10#2)(2008-12#1)(2013-1#1)
main source##7##2##(1993-1#1)(1994-12#1)(1995-1#1)(2008-10#2)(2008-12#1)(2013-1#1)
main stem##3##2##(1990-9#2)(2008-10#1)
main steps##2##2##(2008-10#1)(2011-2#1)
main strategies##2##2##(2008-11#1)(2009-12#1)
main target##3##2##(1990-5#1)(2008-11#2)
main themes emerged##2##3##(2008-11#1)(2010-10#1)
main themes##3##2##(2008-11#1)(2009-5#1)(2010-10#1)
main theoretical##2##2##(2008-12#1)(2008-3#1)
main topic##2##2##(2011-2#1)(2013-1#1)
main topics##2##2##(2008-10#2)
main trunk##2##2##(1994-1#1)(1996-3#1)
main types of##3##3##(2008-10#2)(2010-12#1)
main vector species##5##3##(2008-10#5)
main vector##6##2##(2008-10#5)(2008-11#1)
main##662##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#8)(1990-6#1)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#4)(1991-9#4)(1992-1#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-2#2)(1996-3#3)(1996-6#5)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#2)(1997-7#1)(1997-8#6)(2006-6#2)(2007-11#1)(2007-12#3)(2007-8#3)(2008-1#8)(2008-10#209)(2008-11#59)(2008-12#19)(2008-2#1)(2008-3#17)(2008-4#2)(2008-5#25)(2008-6#1)(2008-7#15)(2008-8#19)(2008-9#8)(2009-1#3)(2009-10#6)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#6)(2010-10#5)(2010-11#2)(2010-12#7)(2010-2#2)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#30)(2011-3#2)(2012-12#4)(2012-2#15)(2012-3#8)(2012-6#1)(2012-9#1)(2013-1#17)(2013-8#15)
main-chain##2##1##(1994-5#1)(2008-8#1)
mainland China##2##2##(2013-8#2)
mainland Mexico##2##2##(2008-8#1)(2008-9#1)
mainland##8##1##(2008-10#2)(2008-8#2)(2008-9#2)(2013-8#2)
mainly a##2##2##(1997-6#1)(2008-5#1)
mainly affects##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
mainly as a##4##3##(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)
mainly as##7##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-3#1)
mainly associated with the##2##4##(2008-10#2)
mainly associated with##4##3##(2008-10#2)(2008-5#1)(2011-3#1)
mainly at the level of##2##5##(1993-6#1)(2008-10#1)
mainly at the##5##3##(1993-6#1)(1997-3#1)(2008-10#2)(2008-5#1)
mainly at##7##2##(1991-5#1)(1993-6#1)(1997-3#1)(2008-10#3)(2008-5#1)
mainly attributed to##2##3##(2008-10#2)
mainly based on##6##3##(1996-11#1)(2008-10#3)(2008-7#2)
mainly because of the##2##4##(1996-6#1)(2008-3#1)
mainly because of##4##3##(1996-6#1)(2008-1#1)(2008-3#1)(2011-7#1)
mainly because the##2##3##(1992-9#1)(2011-2#1)
mainly because##9##2##(1992-9#1)(1996-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2011-7#1)
mainly by initial conditions##3##4##(2008-10#3)
mainly by mu##2##3##(2008-10#2)
mainly by the##3##3##(1992-1#1)(1992-5#1)(1994-8#1)
mainly by their##2##3##(1995-8#1)(2008-10#1)
mainly by##32##2##(1991-6#1)(1992-1#1)(1992-12#1)(1992-5#1)(1994-8#3)(1995-8#1)(1997-8#2)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2013-8#1)
mainly composed of##3##3##(2008-10#2)(2008-7#1)
mainly confined to##2##3##(1994-11#1)(2010-12#1)
mainly consisted of##3##3##(2008-10#2)(2008-11#1)
mainly consisting of##3##3##(1991-8#1)(1996-2#1)(2013-8#1)
mainly contains##2##2##(2008-10#1)(2010-6#1)
mainly depends on the##2##4##(2008-7#1)(2011-1#1)
mainly due to a##5##4##(1994-5#1)(2008-10#4)
mainly due to the##8##4##(1992-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-12#1)
mainly due to##21##3##(1991-2#1)(1992-1#1)(1994-5#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
mainly expressed##2##2##(1995-12#1)(2008-8#1)
mainly for##3##2##(1995-11#1)(2011-2#2)
mainly from the##4##3##(1997-6#1)(2008-10#2)(2012-12#1)
mainly from##11##2##(1994-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#6)(2012-12#1)
mainly in the form of##3##5##(2008-10#2)(2008-5#1)
mainly in the##23##3##(1990-3#1)(1990-9#1)(1991-5#1)(1993-1#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
mainly in their##2##3##(2008-5#1)(2010-2#1)
mainly in##58##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-5#1)(1993-1#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
mainly interested##2##2##(2011-2#1)(2013-1#1)
mainly involved##2##2##(1995-6#1)(2013-8#1)
mainly involving the##2##3##(1997-3#1)(1997-8#1)
mainly involving##3##2##(1997-3#1)(1997-8#2)
mainly located on the##2##4##(2008-9#2)
mainly neutropenia##2##2##(2008-10#2)
mainly observed in##3##3##(2008-10#2)(2013-1#1)
mainly observed##4##2##(2008-10#3)(2013-1#1)
mainly of three##2##3##(1992-12#1)(1994-5#1)
mainly of##15##2##(1992-12#1)(1994-5#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#2)(2010-8#1)
mainly on the##10##3##(1992-12#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-8#1)
mainly on##25##2##(1990-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1997-5#1)(2008-10#5)(2008-11#2)(2008-3#4)(2008-5#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
mainly owing to##2##3##(1992-5#1)(1996-11#1)
mainly present in##2##3##(1994-2#1)(2008-5#1)
mainly present##3##2##(1994-2#1)(2008-5#1)(2011-2#1)
mainly reflected##3##2##(2008-12#1)(2012-5#1)(2013-1#1)
mainly related to##5##3##(2008-10#1)(2008-11#2)(2008-5#1)(2010-7#1)
mainly responsible for##4##3##(2008-10#1)(2009-12#1)(2009-8#1)(2012-2#1)
mainly the retina##2##3##(2009-12#2)
mainly the##11##2##(1996-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-12#2)(2013-1#1)
mainly through the##2##3##(2008-12#1)(2008-5#1)
mainly through##4##2##(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
mainly to the##7##3##(1994-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
mainly to##23##2##(1991-3#1)(1993-2#1)(1994-12#1)(1994-8#1)(1996-11#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)
mainly trihalomethanes##2##2##(2008-10#2)
mainly used##2##2##(1991-5#1)(2013-1#1)
mainly when##2##2##(1992-5#1)(2008-10#1)
mainly with##3##2##(2008-10#1)(2008-7#2)
mainly##435##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#7)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#4)(1992-5#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#3)(1996-2#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#9)(2007-12#2)(2008-1#2)(2008-10#122)(2008-11#22)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#24)(2008-7#23)(2008-8#14)(2008-9#10)(2009-10#2)(2009-12#5)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#21)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#6)(2012-3#7)(2012-5#1)(2013-1#18)(2013-7#1)(2013-8#11)
mainstay of the##2##3##(2008-12#1)(2010-1#1)
mainstay of treatment in##3##4##(2008-11#1)(2010-6#1)(2013-1#1)
mainstay of treatment##7##3##(2008-11#1)(2008-12#1)(2010-12#2)(2010-6#1)(2013-1#2)
mainstay of##18##2##(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-5#1)(2010-1#1)(2010-12#4)(2010-6#1)(2011-2#1)(2013-1#2)
mainstay##20##1##(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2009-5#1)(2010-1#1)(2010-12#4)(2010-6#1)(2011-2#1)(2013-1#3)
mainstream##12##1##(1994-3#1)(1994-8#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#3)(2013-1#2)(2013-8#1)
maintain a large##2##3##(2008-4#1)(2008-8#1)
maintain a projection to the lumbar spinal cord##2##8##(1990-5#2)
maintain a##19##2##(1990-5#2)(1991-1#1)(1991-6#1)(1993-12#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
maintain abstinence##2##2##(2010-2#2)
maintain an##4##2##(1995-2#1)(2008-11#1)(2008-6#1)(2012-3#1)
maintain appropriate##2##2##(1997-7#1)(2008-9#1)
maintain clinical credibility##2##3##(2008-11#2)
maintain excessive##2##2##(1994-8#1)(2008-10#1)
maintain homeostasis##2##2##(2009-12#1)(2010-1#1)
maintain or increase##2##3##(1993-2#1)(1996-1#1)
maintain or##3##2##(1993-2#1)(1996-1#1)(2010-10#1)
maintain quality of##2##3##(2008-11#1)(2010-12#1)
maintain the##33##2##(1992-10#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
maintain their##4##2##(1990-5#1)(1997-6#1)(2008-10#1)(2009-6#1)
maintain##150##1##(1990-2#1)(1990-5#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2008-1#3)(2008-10#12)(2008-11#20)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#3)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
maintained a##9##2##(1994-8#2)(2008-10#2)(2008-11#1)(2010-11#1)(2010-5#1)(2012-3#2)
maintained after##3##2##(1991-2#1)(1994-1#1)(2008-10#1)
maintained and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
maintained as##4##2##(2008-4#2)(2008-6#1)(2009-7#1)
maintained at +0##2##3##(2008-10#2)
maintained at 30 degrees C##2##5##(2008-10#2)
maintained at the##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
maintained at##27##2##(1994-9#1)(1995-2#1)(1996-12#1)(2008-10#15)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
maintained between##3##2##(2008-10#3)
maintained by##16##2##(1990-2#1)(1990-8#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-7#1)
maintained constant##3##2##(2008-10#2)(2008-7#1)
maintained continuously##2##2##(2008-10#2)
maintained for 3##2##3##(1990-6#1)(2008-5#1)
maintained for##22##2##(1990-6#1)(1993-11#1)(1995-12#1)(1995-2#1)(2008-10#3)(2008-11#8)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2011-3#1)
maintained high##2##2##(2008-10#1)(2008-11#1)
maintained in a##5##3##(1991-12#1)(2008-10#1)(2008-9#1)(2011-2#2)
maintained in the laboratory##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
maintained in the##17##3##(1997-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#2)(2010-7#1)(2012-12#1)
maintained in##46##2##(1991-12#1)(1992-1#1)(1992-4#1)(1993-9#1)(1994-3#2)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
maintained on collagen##3##3##(1994-8#3)
maintained on the##2##3##(1991-12#1)(2008-3#1)
maintained on##14##2##(1991-12#1)(1994-8#5)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-8#1)
maintained or##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
maintained over the##2##3##(1991-2#1)(2008-5#1)
maintained over##3##2##(1991-2#1)(2008-5#1)(2008-7#1)
maintained the ability to##2##4##(1993-8#1)(2012-2#1)
maintained the features of simplicity##2##5##(2008-10#2)
maintained the##13##2##(1992-12#1)(1993-8#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
maintained their##8##2##(1990-11#1)(1994-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
maintained through##2##2##(2008-11#1)(2008-8#1)
maintained throughout##3##2##(2008-11#1)(2010-11#1)(2013-8#1)
maintained under##7##2##(1991-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)
maintained until##2##2##(2008-6#1)(2010-4#1)
maintained up to##2##3##(2008-10#1)(2008-8#1)
maintained when##2##2##(2008-11#1)(2008-8#1)
maintained with##7##2##(1996-6#1)(2008-10#1)(2008-3#1)(2010-7#3)(2011-2#1)
maintained##280##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#7)(1994-9#1)(1995-12#1)(1995-2#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#68)(2008-11#43)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#11)(2008-8#14)(2008-9#11)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#5)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#7)
maintaining a healthy##2##3##(2008-8#1)(2011-2#1)
maintaining a##13##2##(1992-3#1)(1993-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#2)(2012-6#1)
maintaining constant##2##2##(2008-7#1)(2008-9#1)
maintaining good##3##2##(2008-10#2)(2011-2#1)
maintaining or##2##2##(2008-11#1)(2010-11#1)
maintaining stability##2##2##(2008-11#1)(2011-2#1)
maintaining the cold chain##2##4##(1994-9#2)
maintaining the high##2##3##(2008-10#1)(2008-8#1)
maintaining the homeostasis of the##2##5##(2009-10#1)(2013-8#1)
maintaining the integrity of the##2##5##(1990-2#1)(2008-10#1)
maintaining the##28##2##(1990-2#1)(1990-6#1)(1992-1#1)(1994-12#1)(1994-9#2)(1995-6#2)(1995-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
maintaining their##3##2##(1991-11#1)(2008-10#1)(2010-10#1)
maintaining##140##1##(1990-2#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#2)(1994-11#1)(1994-12#2)(1994-9#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1997-2#2)(1997-3#2)(1997-5#1)(2008-1#1)(2008-10#20)(2008-11#19)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#9)(2008-9#6)(2009-10#3)(2009-11#1)(2009-8#2)(2010-1#1)(2010-10#4)(2010-11#4)(2010-4#1)(2010-7#4)(2010-9#2)(2011-2#11)(2011-9#1)(2012-2#4)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
maintains its##2##2##(2008-10#1)(2008-11#1)
maintains that##2##2##(1997-2#1)(2011-2#1)
maintains the##5##2##(1991-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)
maintains##20##1##(1991-6#1)(1992-2#1)(1993-12#1)(1993-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)
maintenance and differentiation##2##3##(2008-11#2)
maintenance and##9##2##(2008-11#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-3#1)(2013-8#1)
maintenance care of dental implants##2##5##(2013-1#2)
maintenance dose##2##2##(1991-8#1)(2012-12#1)
maintenance metabolism##2##2##(2008-7#2)
maintenance of LTP##3##3##(1997-2#2)(2008-7#1)
maintenance of Mycobacterium tuberculosis##2##4##(2008-9#2)
maintenance of a##8##3##(1990-3#1)(1992-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
maintenance of continuous##2##3##(2008-7#1)(2011-2#1)
maintenance of function and quality of##2##6##(2009-12#2)
maintenance of high##3##3##(1995-11#1)(2008-11#1)(2008-8#1)
maintenance of oral##2##3##(2008-11#1)(2008-5#1)
maintenance of pregnancy##2##3##(1995-12#1)(2012-3#1)
maintenance of sinus rhythm##2##4##(2008-7#1)(2010-12#1)
maintenance of sodium channel##2##4##(2008-7#2)
maintenance of telomere##2##3##(2008-11#1)(2013-1#1)
maintenance of telomeres and##2##4##(2008-11#1)(2011-2#1)
maintenance of the##15##3##(1990-8#1)(1991-2#2)(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#1)
maintenance of##133##2##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-7#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-9#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#2)(2008-10#7)(2008-11#20)(2008-12#1)(2008-4#4)(2008-5#4)(2008-7#10)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-9#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#1)
maintenance organization (S/HMO)##2##3##(1992-1#1)(1995-2#1)
maintenance organization and##2##3##(1992-2#1)(1993-12#1)
maintenance organization##28##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#5)(1994-3#4)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#1)(2008-11#1)
maintenance organizations##20##2##(1991-1#2)(1991-3#6)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-3#1)(1997-2#2)
maintenance phase##3##2##(1996-11#1)(1997-2#1)(2008-1#1)
maintenance program##5##2##(2008-10#2)(2010-10#3)
maintenance therapy##3##2##(2011-2#2)(2011-3#1)
maintenance treatment##6##2##(1996-3#3)(2008-11#1)(2008-6#1)(2010-12#1)
maintenance work##2##2##(1991-12#1)(2009-10#1)
maintenance workers##4##2##(1991-12#4)
maintenance##291##1##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#6)(1991-11#1)(1991-12#9)(1991-2#3)(1991-3#8)(1991-7#2)(1991-8#1)(1992-1#3)(1992-2#2)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#5)(1994-2#1)(1994-3#6)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#6)(1996-8#1)(1997-1#3)(1997-2#6)(1997-7#2)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#36)(2008-12#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#16)(2008-8#7)(2008-9#12)(2009-10#4)(2009-11#3)(2009-12#3)(2009-3#1)(2009-6#2)(2009-8#4)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#19)(2011-3#1)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#10)(2013-7#4)(2013-8#3)
mais##4##1##(2011-2#1)(2013-1#3)
maitake##2##1##(1995-9#1)(2008-10#1)
maize (Zea mays L##4##4##(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)
maize (Zea mays##5##3##(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2012-3#1)
maize (Zea mays)##3##3##(2008-10#2)(2012-2#1)
maize (Zea##8##2##(2008-10#3)(2008-12#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
maize AChE##3##2##(2009-8#3)
maize alcohol dehydrogenase##2##3##(1991-10#2)
maize also##2##2##(2008-10#2)
maize and##5##2##(1990-8#1)(2008-10#2)(2008-8#1)(2012-3#1)
maize cultivars##3##2##(2008-10#1)(2008-12#2)
maize dwarf mosaic##3##3##(2008-10#1)(2008-9#2)
maize ears##5##2##(2008-10#5)
maize embryo sacs##2##3##(2008-11#2)
maize genome##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
maize genotype##2##2##(2008-10#2)
maize genotypes##9##2##(2008-10#9)
maize grown in##2##3##(2008-10#1)(2008-12#1)
maize hybrid##2##2##(2008-10#2)
maize in##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
maize inbred##5##2##(2008-10#4)(2012-3#1)
maize inbreds##2##2##(2008-10#2)
maize kernel##2##2##(2008-10#2)
maize kernels##3##2##(2008-10#3)
maize leaves showing chlorotic streaks##2##5##(2008-10#2)
maize leaves showing##3##3##(2008-10#3)
maize leaves##10##2##(2008-10#10)
maize lines##3##2##(2008-10#3)
maize or##2##2##(2008-10#2)
maize plants##6##2##(2008-10#3)(2008-8#3)
maize residue##3##2##(2008-10#3)
maize seedlings##3##2##(2008-10#2)(2009-8#1)
maize stalks##2##2##(2008-10#2)
maize that##2##2##(2008-12#2)
maize to##2##2##(2008-10#1)(2012-2#1)
maize was##4##2##(1995-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
maize yield in##3##3##(2008-12#3)
maize yield##5##2##(2008-12#5)
maize##232##1##(1990-8#1)(1991-10#2)(1991-12#1)(1994-6#2)(1995-2#3)(1995-6#1)(2008-10#139)(2008-11#3)(2008-12#16)(2008-8#14)(2008-9#10)(2009-10#9)(2009-8#8)(2012-2#13)(2012-3#7)(2013-8#3)
maize-specific##2##1##(2008-8#2)
maize-type##3##1##(2008-10#3)
major AT loci##2##3##(1995-6#2)
major AT##3##2##(1995-6#3)
major NORs##6##2##(1993-12#6)
major QTL on##2##3##(2008-10#1)(2012-3#1)
major QTL##5##2##(2008-10#3)(2008-8#1)(2012-3#1)
major R##2##2##(2008-10#2)
major U##3##2##(1995-3#1)(2008-10#1)(2009-7#1)
major abdominal##4##2##(1993-12#2)(2009-12#2)
major achievements and future potential##2##5##(1993-12#2)
major advantage of this##2##4##(2007-12#1)(2008-10#1)
major advantage of##3##3##(2007-12#1)(2008-10#2)
major advantage##4##2##(2007-12#1)(2008-10#3)
major adverse cardiac events##3##4##(2008-11#2)(2010-12#1)
major adverse events##2##3##(2010-12#1)(2011-2#1)
major adverse##5##2##(2008-11#2)(2010-12#2)(2011-2#1)
major aim of##2##3##(2008-12#1)(2010-8#1)
major alkaloids##3##2##(2008-10#2)(2012-3#1)
major and minor complications##2##4##(1990-9#1)(2009-3#1)
major and minor##8##3##(1990-9#1)(2008-10#4)(2008-4#1)(2009-3#1)(2013-1#1)
major and##12##2##(1990-9#1)(1997-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2013-1#1)
major approach##2##2##(2008-11#1)(2008-9#1)
major approaches##2##2##(1994-9#1)(2008-10#1)
major areas of##4##3##(1993-3#1)(2008-10#1)(2009-10#1)(2013-8#1)
major aromatic##2##2##(2008-10#2)
major arsenic##3##2##(2008-10#3)
major ascospore showers##2##3##(2008-10#2)
major aspects of##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
major barriers to##2##3##(2008-11#2)
major branches##2##2##(1997-8#1)(2008-10#1)
major capsid##2##2##(2008-1#1)(2008-5#1)
major carbon##2##2##(2008-10#1)(2011-2#1)
major cardiovascular events##2##3##(2010-1#1)(2013-8#1)
major cardiovascular surgery##2##3##(2008-8#2)
major cardiovascular##4##2##(2008-8#2)(2010-1#1)(2013-8#1)
major categories##2##2##(2008-11#1)(2008-12#1)
major category of##2##3##(2008-11#2)
major cause of death##3##4##(2010-12#1)(2012-3#1)(2013-8#1)
major cause of##29##3##(1990-11#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1995-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
major cause##30##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1995-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
major causes of##5##3##(2008-10#1)(2008-11#2)(2009-12#1)(2011-1#1)
major causes##8##2##(1992-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2011-1#1)
major cell##2##2##(1994-11#1)(1995-6#1)
major cellular events##2##3##(2008-12#1)(2011-2#1)
major cellular##5##2##(1995-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
major challenge for the##3##4##(1991-1#1)(2008-7#1)(2010-5#1)
major challenge for##4##3##(1991-1#1)(2008-11#1)(2008-7#1)(2010-5#1)
major challenge##11##2##(1991-1#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-5#1)(2012-2#1)(2012-3#2)
major challenges##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
major change in##2##3##(2008-10#2)
major changes in##3##3##(1991-3#1)(1996-3#1)(2009-10#1)
major changes##5##2##(1991-3#1)(1995-1#1)(1996-3#1)(2007-8#1)(2009-10#1)
major characteristics##4##2##(1994-8#1)(2008-10#2)(2008-4#1)
major clades##2##2##(2008-10#1)(2013-8#1)
major classes of##3##3##(1995-11#2)(2008-11#1)
major classes##4##2##(1995-11#2)(2008-11#1)(2009-10#1)
major clinical##6##2##(1994-1#1)(2008-11#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-3#1)
major cluster##2##2##(2008-10#2)
major clusters##4##2##(2008-10#4)
major complications##13##2##(1990-3#1)(1991-2#1)(1992-5#1)(1994-2#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#1)(2011-2#4)
major component of the##8##4##(1990-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
major component of##17##3##(1990-9#1)(1992-6#1)(1993-8#1)(1994-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-4#1)
major component##26##2##(1990-7#1)(1990-9#1)(1992-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)
major components of the##2##4##(1996-1#1)(2011-2#1)
major components of##7##3##(1996-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2011-3#2)
major components##9##2##(1996-1#1)(2008-10#4)(2008-5#1)(2011-2#1)(2011-3#2)
major compound##2##2##(2008-10#2)
major concern in##4##3##(2008-10#2)(2008-8#1)(2012-3#1)
major concern##8##2##(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
major concerns##2##2##(2008-1#1)(2008-10#1)
major constituent of##3##3##(1990-8#1)(1992-12#1)(2012-2#1)
major constituents of##5##3##(2008-10#2)(2008-12#2)(2009-8#1)
major constituents##9##2##(1994-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2009-8#1)
major contribution to the##2##4##(2008-10#1)(2008-2#1)
major contribution to##3##3##(2008-10#2)(2008-2#1)
major criteria##3##2##(1997-8#2)(2011-2#1)
major crops##2##2##(2008-10#1)(2011-10#1)
major cytoskeletal##2##2##(2009-10#1)(2009-8#1)
major degradation product of##2##4##(2008-10#2)
major degradation product##3##3##(2008-10#3)
major degradation##5##2##(2008-10#5)
major depression##13##2##(1995-5#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-8#3)(2011-2#5)
major depressive disorder (MDD)##3##4##(2008-4#1)(2011-2#1)(2012-3#1)
major depressive disorder and##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
major depressive disorder were##2##4##(2011-2#2)
major depressive disorder##9##3##(2008-4#2)(2011-2#5)(2012-3#1)(2013-1#1)
major depressive##11##2##(2008-4#2)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#2)
major determinant of##4##3##(2008-10#3)(2008-11#1)
major determinant##5##2##(1994-11#1)(2008-10#3)(2008-11#1)
major determinants of##2##3##(1997-9#1)(2008-10#1)
major developments in##2##3##(2012-2#1)(2013-8#1)
major developments##3##2##(2012-2#2)(2013-8#1)
major difference##2##2##(2008-10#2)
major differences in the##2##4##(1997-2#1)(2008-10#1)
major differences in##4##3##(1997-1#1)(1997-2#1)(2008-10#1)(2010-6#1)
major differences##6##2##(1992-6#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-8#1)(2010-6#1)
major disease##8##2##(2008-10#7)(2008-7#1)
major drawbacks##2##2##(2008-11#1)(2011-2#1)
major economic##4##2##(1992-6#1)(1997-3#1)(2008-10#2)
major effect on##3##3##(2008-9#2)(2013-1#1)
major effect##6##2##(1990-5#1)(2008-10#2)(2008-9#2)(2013-1#1)
major effects on##2##3##(1994-12#1)(1995-12#1)
major effects##3##2##(1994-12#1)(1995-12#1)(2008-10#1)
major efforts##2##2##(1994-5#1)(2009-10#1)
major elements##5##2##(1995-6#1)(2008-10#3)(2008-6#1)
major emphasis##2##2##(1991-6#1)(2013-8#1)
major energy##2##2##(2008-11#1)(2008-7#1)
major environmental factor##2##3##(2008-12#1)(2011-2#1)
major environmental##4##2##(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#1)
major ethnic##2##2##(2009-10#2)
major extracellular proteins of##2##4##(1995-2#2)
major factor contributing to##2##4##(2008-7#1)(2008-9#1)
major factor in##5##3##(1992-1#1)(1996-3#1)(2008-10#3)
major factor##13##2##(1992-1#1)(1994-5#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
major factors##5##2##(2008-10#3)(2008-3#1)(2012-3#1)
major feature of##2##3##(1990-2#1)(2008-7#1)
major features##2##2##(1994-12#1)(2008-9#1)
major finding of##2##3##(2009-7#1)(2011-1#1)
major findings##2##2##(1995-9#1)(2011-1#1)
major focus has been##2##4##(1996-2#1)(2012-2#1)
major focus of research##2##4##(1997-1#1)(2008-9#1)
major focus of##5##3##(1997-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
major focus##9##2##(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
major food##2##2##(1994-3#1)(2011-2#1)
major force##2##2##(1991-1#1)(2008-10#1)
major form of##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
major form##5##2##(1992-6#1)(2008-10#2)(2008-11#1)(2008-4#1)
major fraction##2##2##(1994-2#1)(2008-10#1)
major function of##2##3##(1990-5#1)(1997-2#1)
major functions of##2##3##(2009-7#1)(2012-2#1)
major fungal##3##2##(2008-10#2)(2009-6#1)
major gastrointestinal##2##2##(2012-2#2)
major gene controls##2##3##(2008-10#2)
major gene for resistance to##3##5##(2008-10#3)
major gene for resistance##4##4##(2008-10#4)
major gene for##5##3##(2008-10#5)
major gene##24##2##(2008-10#18)(2008-8#5)(2013-8#1)
major genes##6##2##(2008-10#6)
major genetic changes##2##3##(2008-10#2)
major genetic##3##2##(2008-10#2)(2010-5#1)
major goal in the##2##4##(1991-6#1)(2008-11#1)
major goal##4##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
major groove##5##2##(1992-3#1)(1992-4#2)(1994-5#1)(1995-8#1)
major groups of##5##3##(1990-5#1)(1992-12#1)(2008-10#2)(2009-8#1)
major groups##10##2##(1990-5#1)(1992-12#1)(2008-10#6)(2009-8#2)
major health##8##2##(1997-1#1)(2008-9#1)(2009-6#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
major histocompatibility complex (MHC) class I##3##6##(1995-12#1)(1995-2#1)(2008-1#1)
major histocompatibility complex (MHC)##5##4##(1990-5#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-1#1)
major histocompatibility complex class I##2##5##(1997-9#1)(2008-4#1)
major histocompatibility complex class II##2##5##(2008-10#1)(2008-5#1)
major histocompatibility complex class##5##4##(1997-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
major histocompatibility complex##14##3##(1990-5#2)(1995-12#1)(1995-2#2)(1997-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
major histocompatibility##19##2##(1990-5#2)(1995-12#2)(1995-2#2)(1995-5#1)(1997-9#3)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
major impact##7##2##(1993-12#1)(1994-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-12#1)
major implications##3##2##(1991-1#1)(1992-2#1)(1996-12#1)
major impurity was##2##3##(2008-10#2)
major in##2##2##(1991-3#1)(1994-12#1)
major interest##2##2##(1996-12#1)(2010-7#1)
major ions##4##2##(2008-10#4)
major issues##3##2##(1996-12#1)(2008-10#1)(2013-8#1)
major life##2##2##(2008-2#1)(2008-4#1)
major limitation of##2##3##(2008-11#1)(2012-3#1)
major limitation##5##2##(1997-1#1)(2008-11#2)(2012-3#1)(2013-1#1)
major limiting factor##2##3##(2008-10#1)(2008-11#1)
major loci##3##2##(2008-10#2)(2010-4#1)
major locus##2##2##(2008-10#2)
major losses##2##2##(2008-10#2)
major mechanism of##2##3##(2008-4#1)(2008-8#1)
major mechanism##4##2##(2008-11#1)(2008-4#2)(2008-8#1)
major medication##2##2##(2008-12#2)
major metabolic##2##2##(1990-6#1)(2008-10#1)
major metabolites##6##2##(1993-12#1)(2008-10#3)(2008-11#1)(2011-3#1)
major metals##2##2##(2008-10#2)
major morbidity##2##2##(1994-12#1)(2008-7#1)
major mouse##2##2##(1991-5#1)(1997-7#1)
major muscle##4##2##(2011-2#3)(2012-3#1)
major myelin##2##2##(2009-6#2)
major nodes##2##2##(2010-5#2)
major objective##2##2##(2008-7#1)(2011-2#1)
major obstacle to##3##3##(1994-12#1)(2008-11#1)(2012-2#1)
major one##2##2##(2008-6#1)(2011-2#1)
major open reading##2##3##(1997-7#1)(2008-10#1)
major organic##2##2##(2008-10#2)
major organizational changes##2##3##(2009-10#2)
major organizational##3##2##(1994-2#1)(2009-10#2)
major parameters##2##2##(2008-10#1)(2008-12#1)
major part of the##8##4##(1994-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)(2013-1#1)
major part##11##2##(1993-9#1)(1994-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2011-2#1)(2013-1#1)
major pathogen of##3##3##(2008-10#3)
major pathways##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
major peaks##2##2##(1993-6#1)(2008-10#1)
major phylogenetic groups##2##3##(2008-10#2)
major phylogenetic##3##2##(2008-10#2)(2008-8#1)
major physiological##5##2##(1990-12#1)(1994-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
major polypeptide##2##2##(1993-1#2)
major practical##2##2##(2008-8#1)(2011-2#1)
major problem in the##2##4##(1991-9#1)(2011-2#1)
major problem in##5##3##(1991-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
major problem was##2##3##(1992-3#1)(2008-10#1)
major problem##12##2##(1991-9#1)(1992-3#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2010-10#1)(2011-2#1)
major problems##8##2##(1990-2#2)(1997-2#1)(2008-11#1)(2008-12#1)(2009-12#1)(2013-1#2)
major product##3##2##(1990-12#1)(1991-5#1)(1996-5#1)
major progress##2##2##(1994-8#1)(2013-8#1)
major protein component of the##2##5##(1997-8#1)(2008-5#1)
major protein component##4##3##(1997-8#1)(2008-10#2)(2008-5#1)
major protein##9##2##(1997-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)
major proteins##3##2##(2008-10#2)(2008-6#1)
major public health threat in##2##5##(2007-12#1)(2011-2#1)
major public health##8##3##(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
major quantitative trait locus for##3##5##(2008-10#3)
major quantitative trait locus##7##4##(2008-10#7)
major quantitative trait##8##3##(2008-10#8)
major reason for the##2##4##(2008-8#1)(2009-5#1)
major reason for##5##3##(2008-10#1)(2008-3#1)(2008-8#2)(2009-5#1)
major reason##6##2##(2008-10#1)(2008-3#1)(2008-8#2)(2009-5#1)(2013-1#1)
major reduction in##3##3##(1990-11#1)(1994-11#1)(2008-10#1)
major reduction##4##2##(1990-11#1)(1990-5#1)(1994-11#1)(2008-10#1)
major resistance gene##2##3##(2008-10#2)
major resistance genes##12##3##(2008-10#12)
major resistance##17##2##(2008-10#16)(2012-2#1)
major response##2##2##(2008-10#1)(2008-7#1)
major risk factors##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
major risk##6##2##(1990-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
major role in regulating##3##4##(1997-9#1)(2009-8#1)(2012-3#1)
major role in the##12##4##(1991-6#1)(1992-10#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-8#1)(2008-11#1)(2009-1#1)(2009-7#1)
major role in##32##3##(1991-6#1)(1992-10#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-8#1)(1997-9#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
major role of##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
major role##40##2##(1991-6#1)(1992-10#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-8#1)(1997-9#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
major route##3##2##(1997-1#2)(2010-1#1)
major scab resistance##2##3##(2008-10#2)
major side##2##2##(1990-6#2)
major site of##5##3##(1994-11#1)(1995-6#1)(1997-8#1)(2008-1#1)(2010-8#1)
major source of##9##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
major source##11##2##(1994-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-11#1)(2010-7#1)(2012-2#2)(2013-1#1)
major sources of##3##3##(1994-3#1)(2010-5#1)(2011-2#1)
major sources##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
major species##5##2##(2008-10#4)(2010-11#1)
major steps##3##2##(1996-1#1)(2008-9#1)(2009-6#1)
major structural##4##2##(1995-2#1)(1995-6#1)(2008-7#1)(2009-7#1)
major substrate##2##2##(2008-11#1)(2012-2#1)
major surgery##3##2##(2009-5#1)(2009-6#2)
major target##3##2##(2008-11#1)(2008-5#1)(2009-11#1)
major targets of##2##3##(2008-10#1)(2008-5#1)
major targets##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
major themes##5##2##(1991-2#1)(1994-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
major therapeutic##2##2##(1990-6#1)(2010-11#1)
major topic##2##2##(2008-11#1)(2008-3#1)
major tranquilliser##2##2##(2008-7#2)
major tranquillisers##2##2##(2008-7#2)
major trends##2##2##(1991-1#1)(2008-10#1)
major vascular##3##2##(1994-3#1)(1996-11#1)(2009-5#1)
major vessels##2##2##(2013-1#2)
major was##2##2##(1992-9#1)(2008-10#1)
major wheat##2##2##(2008-10#2)
major##1274##1##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#7)(1990-6#9)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#5)(1991-11#2)(1991-12#2)(1991-2#8)(1991-3#4)(1991-5#4)(1991-6#7)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#8)(1992-9#4)(1993-1#3)(1993-11#1)(1993-12#14)(1993-2#4)(1993-3#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#7)(1994-11#8)(1994-12#12)(1994-2#7)(1994-3#5)(1994-5#3)(1994-8#7)(1994-9#3)(1995-1#3)(1995-11#5)(1995-12#8)(1995-2#19)(1995-3#3)(1995-5#2)(1995-6#13)(1995-8#5)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#9)(1996-2#8)(1996-3#5)(1996-5#5)(1997-1#12)(1997-2#6)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#15)(1997-9#6)(2006-6#2)(2007-12#9)(2007-8#1)(2008-1#10)(2008-10#338)(2008-11#89)(2008-12#28)(2008-2#4)(2008-3#8)(2008-4#25)(2008-5#27)(2008-6#13)(2008-7#32)(2008-8#33)(2008-9#22)(2009-1#2)(2009-10#12)(2009-11#2)(2009-12#8)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#9)(2009-7#6)(2009-8#12)(2010-1#4)(2010-10#1)(2010-11#6)(2010-12#11)(2010-3#2)(2010-4#4)(2010-5#9)(2010-6#3)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#10)(2011-10#1)(2011-2#59)(2011-3#7)(2011-7#1)(2011-9#1)(2012-12#4)(2012-2#32)(2012-3#22)(2013-1#31)(2013-7#1)(2013-8#16)
major)##5##1##(2008-10#1)(2008-11#2)(2008-5#2)
majority (85%) of##2##3##(2008-1#1)(2008-7#1)
majority of cases are##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
majority of cases the##3##4##(1997-4#1)(2008-9#1)(2010-11#1)
majority of cases##18##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
majority of cells##4##3##(1993-8#1)(1994-2#1)(2008-11#1)(2008-9#1)
majority of children##3##3##(1996-12#1)(2008-11#1)(2009-9#1)
majority of conidia##2##3##(2008-10#2)
majority of isolates##5##3##(2008-10#4)(2008-5#1)
majority of new##2##3##(1991-9#1)(2013-8#1)
majority of parents##2##3##(1992-2#1)(2008-9#1)
majority of patients with##3##4##(1992-3#1)(1996-2#1)(2012-2#1)
majority of patients##14##3##(1992-3#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
majority of published studies##2##4##(2008-9#1)(2011-2#1)
majority of respondents##2##3##(2010-8#1)(2012-2#1)
majority of students##2##3##(1991-9#1)(2008-12#1)
majority of studies##2##3##(2012-2#2)
majority of the isolates were resistant##2##6##(2008-10#1)(2011-2#1)
majority of the respondents##2##4##(1996-3#1)(2008-12#1)
majority of the##60##3##(1991-12#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#3)(1997-9#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-8#1)
majority of them##5##3##(1995-2#1)(2008-10#2)(2011-1#1)(2012-3#1)
majority of these##7##3##(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
majority of women##3##3##(1996-6#1)(2011-2#1)(2012-3#1)
majority of##256##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#4)(2008-10#46)(2008-11#20)(2008-12#7)(2008-3#1)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#3)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#1)(2011-10#1)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#13)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#4)
majority reported##2##2##(1993-1#1)(2008-12#1)
majority were##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
majority##302##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#5)(1994-3#5)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#2)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#5)(2008-10#56)(2008-11#22)(2008-12#11)(2008-3#1)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#9)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#5)(2010-12#4)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#15)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#5)
majus##2##1##(2008-10#1)(2008-8#1)
make a decision##2##3##(2008-10#1)(2013-1#1)
make a diagnosis##4##3##(1997-8#1)(2009-11#1)(2012-2#1)(2013-8#1)
make a difference##4##3##(2008-11#2)(2010-7#1)(2011-2#1)
make a distinction##3##3##(2008-11#1)(2010-12#2)
make a greater##2##3##(1994-1#1)(2008-5#1)
make a number of##2##4##(2008-11#1)(2008-12#1)
make a significant contribution to##2##5##(1992-12#1)(1994-12#1)
make a significant contribution##3##4##(1992-12#1)(1994-12#1)(2013-8#1)
make a strong##2##3##(1994-9#1)(2008-6#1)
make a##51##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-9#1)(1997-3#1)(1997-8#2)(2008-10#5)(2008-11#7)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#3)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
make among##2##2##(1991-2#1)(1994-3#1)
make an##4##2##(1992-12#1)(2007-9#1)(2008-11#1)(2008-7#1)
make any##2##2##(1993-12#1)(2010-7#1)
make appropriate##4##2##(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
make better##2##2##(2008-3#1)(2008-9#1)
make certain##2##2##(1994-12#1)(2013-8#1)
make clear##2##2##(1996-3#1)(2012-12#1)
make comparisons##3##2##(1991-12#1)(1995-12#1)(2008-10#1)
make decisions about##2##3##(1994-9#1)(1997-3#1)
make decisions##7##2##(1992-2#1)(1993-1#1)(1994-9#1)(1997-3#1)(2010-8#1)(2010-9#1)(2011-8#1)
make different##2##2##(2007-12#1)(2011-2#1)
make it a good##2##4##(2008-10#2)
make it a##8##3##(1990-3#1)(1994-9#1)(1996-9#1)(2008-10#4)(2008-5#1)
make it clear that##2##4##(2011-2#1)(2012-3#1)
make it difficult to##2##4##(1995-3#1)(2013-1#1)
make it possible to##8##4##(1992-5#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
make it##46##2##(1990-3#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-8#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
make more##6##2##(1995-1#1)(1997-3#2)(2008-10#1)(2008-8#1)(2011-2#1)
make no##4##2##(1995-2#1)(1996-3#1)(2008-8#1)(2013-8#1)
make or##2##2##(1994-1#1)(1994-3#1)
make predictions##2##2##(2008-10#1)(2008-8#1)
make recommendations##3##2##(2008-10#1)(2009-11#1)(2009-3#1)
make responsible##2##2##(1996-2#1)(2010-8#1)
make sense##4##2##(1997-2#1)(1997-7#2)(2010-11#1)
make such##3##2##(1991-1#1)(2008-10#2)
make sure that##6##3##(1993-1#2)(1993-3#1)(1995-9#1)(2008-10#1)(2008-11#1)
make sure##8##2##(1993-1#2)(1993-3#1)(1995-6#1)(1995-9#1)(2008-10#2)(2008-11#1)
make the following##2##3##(1997-1#1)(2008-10#1)
make the most of##2##4##(1994-12#2)
make the most##3##3##(1994-12#2)(2012-2#1)
make the##37##2##(1991-5#1)(1994-1#1)(1994-12#2)(1994-8#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#2)
make their way##2##3##(2008-10#1)(2013-8#1)
make their##4##2##(1994-3#1)(1995-3#1)(2008-10#1)(2013-8#1)
make them attractive##2##3##(2008-10#1)(2011-2#1)
make them useful##2##3##(2008-10#1)(2010-7#1)
make them##17##2##(1991-1#1)(1996-5#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-9#1)(2010-7#2)(2011-2#2)(2012-2#1)
make these##4##2##(1993-9#1)(2008-11#1)(2009-7#1)(2013-1#1)
make this##11##2##(1991-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1994-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2009-1#1)(2011-2#1)
make those##2##2##(1995-12#1)(2012-3#1)
make up a##2##3##(2008-11#1)(2011-2#1)
make up the##7##3##(2008-10#2)(2008-5#2)(2008-8#1)(2010-5#1)(2011-2#1)
make up##12##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)
make use of##5##3##(1992-9#1)(1996-3#1)(1996-5#1)(2008-10#1)(2011-2#1)
make##394##1##(1990-2#1)(1990-3#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-9#2)(1994-1#6)(1994-12#5)(1994-2#2)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-12#7)(1995-2#5)(1995-3#3)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#5)(1996-5#5)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#10)(1997-4#1)(1997-7#2)(1997-8#4)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#48)(2008-11#26)(2008-12#9)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#17)(2008-9#16)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#7)(2010-9#1)(2011-2#21)(2011-3#1)(2011-7#1)(2011-8#1)(2012-12#5)(2012-2#11)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#12)
make-up of##2##2##(1997-8#1)(2013-8#1)
make-up only##2##2##(2008-5#2)
make-up##11##1##(1997-8#1)(2008-10#1)(2008-5#8)(2013-8#1)
makers and program planners seeking to promote##2##7##(2013-1#2)
makers and##9##2##(1992-12#1)(1993-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2010-10#1)(2013-1#2)
makers of##4##2##(1994-1#1)(1996-3#1)(1996-5#1)(2012-12#1)
makers##32##1##(1992-12#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#2)(2013-1#2)(2013-8#2)
makes a difference in##2##4##(1997-3#1)(2008-9#1)
makes a##13##2##(1991-2#1)(1993-1#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#2)(2013-8#1)
makes it a##2##3##(2008-10#1)(2012-3#1)
makes it an ideal##2##4##(2008-10#1)(2012-2#1)
makes it an important##2##4##(1995-12#1)(2012-2#1)
makes it an##6##3##(1995-12#1)(1997-2#1)(2008-10#1)(2012-2#2)(2012-3#1)
makes it difficult for##2##4##(2010-12#1)(2013-8#1)
makes it difficult to##3##4##(1992-12#1)(2008-11#1)(2008-7#1)
makes it difficult##5##3##(1992-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-8#1)
makes it harder##2##3##(1996-5#2)
makes it impossible to##2##4##(2009-8#1)(2012-3#1)
makes it necessary to##3##4##(2008-10#2)(2010-5#1)
makes it possible to determine##2##5##(2008-10#1)(2013-1#1)
makes it possible to##17##4##(1994-6#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
makes it possible##18##3##(1994-6#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-7#1)(2012-2#1)(2013-1#1)
makes it suitable for use##2##5##(2008-3#1)(2013-1#1)
makes it suitable for##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
makes it##55##2##(1991-2#1)(1992-12#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#2)
makes its##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
makes possible a##3##3##(2008-10#2)(2008-11#1)
makes possible##6##2##(2008-10#5)(2008-11#1)
makes risk adjustment##2##3##(1997-1#1)(2008-11#1)
makes sense to##2##3##(2008-11#1)(2008-9#1)
makes such##2##2##(1996-1#1)(2008-8#1)
makes the peak##2##3##(2008-10#2)
makes the system##3##3##(2008-10#2)(2008-11#1)
makes the##39##2##(1993-2#2)(1993-6#1)(1994-3#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-8#3)
makes them suitable for##2##4##(2008-10#1)(2008-11#1)
makes them##11##2##(2008-10#4)(2008-11#2)(2008-4#1)(2009-10#1)(2011-2#3)
makes this##6##2##(1990-6#1)(2008-10#3)(2008-4#1)(2008-9#1)
makes up a##3##3##(2008-9#1)(2009-4#1)(2010-8#1)
makes us##2##2##(2008-12#1)(2011-2#1)
makes use of a##2##4##(2008-3#1)(2008-9#1)
makes use of the##4##4##(2008-10#3)(2008-3#1)
makes use of##13##3##(1991-5#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)
makes use##14##2##(1991-5#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)
makes##227##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-1#3)(1996-11#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-5#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#58)(2008-11#14)(2008-12#4)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#11)(2008-9#12)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#9)
makeup of##2##2##(1995-5#1)(2008-9#1)
makeup##4##1##(1995-5#1)(2008-5#2)(2008-9#1)
making a direct##2##3##(2008-10#1)(2012-12#1)
making a##19##2##(1990-5#1)(1991-8#1)(1992-5#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
making an##3##2##(1992-5#1)(2008-6#1)(2012-12#1)
making and##8##2##(1992-3#1)(1993-3#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
making clinical##2##2##(2008-12#1)(2012-12#1)
making comparisons##4##2##(1994-3#2)(2009-8#1)(2013-1#1)
making decisions##3##2##(1993-12#1)(2009-10#1)(2012-2#1)
making full use of##2##4##(2010-6#1)(2012-3#1)
making inferences about##2##3##(1993-1#1)(2008-12#1)
making it a##3##3##(1994-11#1)(2008-10#1)(2008-7#1)
making it an ideal##2##4##(2008-11#1)(2012-2#1)
making it an important##2##4##(2008-1#1)(2012-2#1)
making it an##5##3##(2008-1#1)(2008-11#1)(2012-2#2)(2013-1#1)
making it difficult for##2##4##(2008-8#1)(2009-8#1)
making it difficult to##4##4##(2008-10#2)(2012-3#1)(2013-8#1)
making it difficult##6##3##(2008-10#2)(2008-8#1)(2009-8#1)(2012-3#1)(2013-8#1)
making it possible to##4##4##(1997-2#1)(2008-10#2)(2008-9#1)
making it##33##2##(1992-1#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
making new##2##2##(2008-9#1)(2012-2#1)
making of##5##2##(1991-1#1)(2008-7#1)(2009-11#1)(2012-12#1)(2013-1#1)
making possible the##2##3##(2008-10#2)
making such##2##2##(1995-2#1)(2008-11#1)
making sure that the process does not impede patient care##2##10##(2011-1#1)(2011-2#1)
making the diagnosis##2##3##(2011-2#2)
making the##26##2##(1992-1#1)(1994-1#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-1#2)(2011-2#4)(2012-2#1)(2013-8#1)
making them##8##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-12#2)
making these##2##2##(1994-3#1)(2008-11#1)
making this##3##2##(2008-4#1)(2008-9#1)(2013-8#1)
making trait##2##2##(2008-11#1)(2012-12#1)
making up##2##2##(2008-10#1)(2008-5#1)
making use of a##3##4##(1994-12#1)(2008-10#1)(2008-9#1)
making use of the##3##4##(2008-10#3)
making use of##10##3##(1990-2#1)(1994-12#1)(1996-6#1)(2008-10#6)(2008-9#1)
making##266##1##(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#3)(1991-11#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1993-1#1)(1993-12#3)(1993-3#2)(1993-6#1)(1994-1#6)(1994-11#1)(1994-12#2)(1994-3#6)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#1)(1996-5#1)(1996-6#4)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#47)(2008-11#21)(2008-12#9)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#12)(2009-10#3)(2009-11#2)(2009-3#2)(2009-5#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#8)(2012-2#7)(2012-3#5)(2012-6#1)(2013-1#6)(2013-8#3)
mal##2##1##(1992-2#1)(1997-3#1)
malabathricum##5##1##(2009-8#5)
malabsorption and maldigestion##3##3##(2011-2#3)
malabsorption and##5##2##(1993-12#1)(2010-12#1)(2011-2#3)
malabsorption##7##1##(1993-12#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
malachite green##6##2##(2008-10#3)(2010-5#3)
malachite##7##1##(2008-10#4)(2010-5#3)
malacostracan##2##1##(2007-12#2)
maladapted##2##1##(2008-8#2)
maladaptive##2##1##(2008-8#1)(2009-11#1)
maladie épileptique##2##2##(2013-1#2)
maladie##4##1##(2013-1#4)
maladjusted and##2##2##(2009-11#2)
maladjusted##3##1##(2008-12#1)(2009-11#2)
maladjustment##2##1##(1991-6#1)(2008-11#1)
malaise##4##1##(1991-4#1)(1992-12#1)(2012-3#1)(2013-1#1)
malaria and the##2##3##(2009-6#1)(2012-12#1)
malaria and##3##2##(2009-6#1)(2012-12#1)(2013-8#1)
malaria control##3##2##(2010-1#1)(2011-2#1)(2013-1#1)
malaria diagnosis and treatment in##2##5##(2012-12#2)
malaria diagnosis and treatment##3##4##(2012-12#3)
malaria diagnosis network##3##3##(2012-12#3)
malaria diagnosis##9##2##(2012-12#9)
malaria in Colombia##4##3##(2012-12#4)
malaria in the##3##3##(2012-12#3)
malaria in##17##2##(1990-3#1)(1995-12#1)(2010-1#1)(2012-12#14)
malaria incidence in Colombian##2##4##(2012-12#2)
malaria incidence##3##2##(2012-12#3)
malaria is not##2##3##(2012-12#2)
malaria is##6##2##(1997-4#1)(2008-11#2)(2012-12#3)
malaria parasite##5##2##(1993-2#2)(2012-2#2)(2013-8#1)
malaria patients##3##2##(1994-8#1)(2012-12#2)
malaria transmission##2##2##(2010-1#2)
malaria was##2##2##(2012-12#2)
malaria were##2##2##(2012-12#2)
malaria with##3##2##(1993-8#1)(2011-2#1)(2012-12#1)
malaria##128##1##(1990-12#1)(1990-3#1)(1991-5#1)(1992-2#1)(1992-6#3)(1993-2#2)(1993-8#4)(1994-8#1)(1995-12#3)(1995-5#2)(1997-4#2)(1997-7#1)(2008-11#3)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#15)(2010-5#1)(2011-2#5)(2012-12#63)(2012-2#4)(2012-3#6)(2013-1#1)(2013-8#5)
malariae##3##1##(2008-4#1)(2012-12#1)(2012-2#1)
malarial##3##1##(1993-2#1)(2012-3#1)(2013-1#1)
malate dehydrogenase##3##2##(2008-10#3)
malate##10##1##(1991-3#1)(2008-10#9)
malathion##10##1##(1994-5#2)(2008-10#7)(2013-1#1)
male CD-1 mice##2##3##(1990-6#2)
male EODs##2##2##(2009-8#2)
male Fischer (F344/NCr)##2##3##(1993-12#2)
male Fischer 344 rats##8##4##(1990-3#1)(1990-6#2)(1992-12#1)(1994-3#2)(1994-5#1)(2008-7#1)
male Fischer 344##9##3##(1990-3#1)(1990-6#2)(1992-12#1)(1994-3#3)(1994-5#1)(2008-7#1)
male Fischer F344 rats##2##4##(1990-3#2)
male Fischer##13##2##(1990-3#3)(1990-6#2)(1992-12#1)(1993-12#2)(1994-3#3)(1994-5#1)(2008-7#1)
male Sprague-Dawley rats##3##3##(1993-3#1)(1996-2#1)(2008-7#1)
male Wistar rats were##2##4##(2008-7#1)(2011-3#1)
male Wistar rats##5##3##(1995-12#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
male Wistar##7##2##(1995-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
male activity of female-search##2##4##(2008-6#2)
male adults##3##2##(1991-12#1)(1996-11#1)(2013-8#1)
male albino rats were##2##4##(2008-10#1)(2012-2#1)
male albino rats##3##3##(2008-10#1)(2012-2#2)
male albino##5##2##(2008-10#2)(2008-12#1)(2012-2#2)
male and female Tg##5##4##(2008-9#5)
male and female components##3##4##(2008-9#3)
male and female gametes##2##4##(1997-7#1)(2008-11#1)
male and female mice##3##4##(1995-11#1)(2008-9#2)
male and female plant##2##4##(2008-8#2)
male and female rats is##2##5##(2008-10#1)(2010-1#1)
male and female rats##7##4##(1994-2#1)(1995-8#1)(2008-10#1)(2008-11#3)(2010-1#1)
male and female subjects##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
male and female##64##3##(1990-5#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-8#2)(1997-7#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#3)(2008-8#8)(2008-9#12)(2010-1#1)(2010-4#2)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#3)
male and healthy female##2##4##(2008-10#2)
male and infected female##2##4##(2008-10#2)
male and##90##2##(1990-5#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-8#2)(1997-7#1)(2008-10#10)(2008-11#5)(2008-12#5)(2008-4#1)(2008-5#4)(2008-8#8)(2008-9#21)(2010-1#1)(2010-4#3)(2011-2#8)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#3)
male batterers##3##2##(2009-5#3)
male body size##2##3##(1995-2#1)(2008-8#1)
male breast cancer##7##3##(1990-12#1)(1990-2#2)(1997-7#2)(2011-2#2)
male breast##10##2##(1990-12#2)(1990-2#2)(1992-2#2)(1997-7#2)(2011-2#2)
male buffalo meat##3##3##(2010-4#3)
male cells##5##2##(1990-3#2)(2008-12#3)
male characters##3##2##(2008-8#2)(2008-9#1)
male child presented with##2##4##(2008-10#1)(2010-11#1)
male child with##2##3##(2012-12#1)(2012-3#1)
male child##5##2##(2008-10#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
male contraceptive##3##2##(1994-8#1)(1997-6#2)
male embryos##3##2##(1994-11#2)(2008-11#1)
male excess##2##2##(1991-6#1)(2008-11#1)
male female-search##3##2##(2008-6#3)
male fertility are##2##3##(2008-9#1)(2012-2#1)
male fertility in##2##3##(2008-9#1)(2012-2#1)
male fertility##13##2##(1991-11#1)(2008-8#2)(2008-9#3)(2009-10#3)(2012-2#4)
male fitness##7##2##(2008-8#3)(2008-9#4)
male folklore##2##2##(2009-10#2)
male function##2##2##(2008-9#2)
male gender and##2##3##(2008-10#1)(2013-8#1)
male gender##6##2##(2008-10#1)(2011-2#3)(2013-8#2)
male germ cells##5##3##(1994-11#2)(1997-3#1)(2012-2#2)
male heterogametic##2##2##(2008-8#2)
male indicator trait##2##3##(2008-9#2)
male infant with##2##3##(1997-3#1)(2010-6#1)
male infant##4##2##(1997-3#1)(2008-12#1)(2010-6#1)(2011-1#1)
male infertility##4##2##(2008-12#2)(2009-10#1)(2012-2#1)
male investment##2##2##(2008-8#2)
male is described##2##3##(2008-11#1)(2010-6#1)
male killing##5##2##(2008-8#3)(2008-9#1)(2012-3#1)
male meadow voles##2##3##(1994-3#1)(2008-9#1)
male mice##7##2##(1995-11#1)(2008-7#1)(2008-9#4)(2011-2#1)
male or female##10##3##(2008-7#2)(2008-9#8)
male parental care and female multiple mating##3##7##(2008-8#3)
male parental care##4##3##(2008-8#4)
male partners##2##2##(1993-9#1)(2010-11#1)
male patient who##2##3##(2009-11#1)(2009-4#1)
male patient with##5##3##(2008-10#1)(2010-10#1)(2011-2#1)(2013-1#2)
male patient##11##2##(2008-10#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#2)
male patients with##5##3##(1990-2#1)(1991-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
male patients##14##2##(1990-2#1)(1991-2#2)(1997-3#1)(1997-8#1)(2008-3#1)(2009-11#1)(2010-12#1)(2011-2#2)(2012-3#3)(2013-1#1)
male physicians who##3##3##(2011-2#3)
male physicians##4##2##(2011-2#4)
male population##3##2##(1993-11#1)(1995-11#1)(2011-2#1)
male predominance in##2##3##(1994-12#1)(2012-3#1)
male predominance##4##2##(1994-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
male presented to##2##3##(2010-5#1)(2013-1#1)
male presented with a##4##4##(2008-12#1)(2008-7#1)(2009-5#1)(2010-6#1)
male presented with##8##3##(2008-10#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-6#1)(2011-2#2)
male presented##10##2##(2008-10#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#1)
male presenting##2##2##(2013-1#1)(2013-8#1)
male rat##4##2##(1990-11#1)(1992-8#1)(1994-2#2)
male rats were treated##2##4##(1997-4#1)(2008-11#1)
male rats were##4##3##(1990-11#1)(1997-4#1)(2008-10#1)(2008-11#1)
male rats##38##2##(1990-11#3)(1990-3#1)(1991-10#1)(1992-1#1)(1992-12#2)(1992-8#1)(1994-2#4)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#7)(2008-7#5)(2013-1#1)
male reproductive##5##2##(1993-3#1)(2007-12#1)(2009-10#1)(2012-2#1)(2013-8#1)
male secondary sexual##2##3##(2007-12#1)(2008-9#1)
male sex##5##2##(1997-7#1)(2007-12#2)(2008-12#1)(2013-1#1)
male sexual and reproductive health in Colombia##2##7##(2012-12#2)
male sexual characters##2##3##(2012-3#2)
male sexual##7##2##(1994-2#1)(2012-12#3)(2012-3#3)
male sperm##2##2##(2008-9#1)(2011-2#1)
male sterile##2##2##(2008-10#1)(2008-8#1)
male sterility##4##2##(1993-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
male subjects##5##2##(1992-3#2)(2009-1#1)(2009-12#1)(2012-3#1)
male than##2##2##(1994-2#1)(2008-9#1)
male to female##4##3##(1993-9#1)(1997-7#1)(2008-7#1)(2011-2#1)
male to##6##2##(1993-9#1)(1997-7#1)(2008-7#1)(2008-8#2)(2011-2#1)
male trait##2##2##(2008-8#2)
male traits##3##2##(2008-8#3)
male versus female##2##3##(2008-8#2)
male was##3##2##(1997-6#1)(2008-8#1)(2013-1#1)
male who developed##2##3##(1990-3#1)(2010-6#1)
male who had##2##3##(2012-3#1)(2013-1#1)
male who presented with a##2##5##(2008-7#1)(2013-8#1)
male who presented##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
male who##7##2##(1990-3#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
male with a##6##3##(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
male with##20##2##(1990-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#3)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
male x##2##2##(2008-12#2)
male##667##1##(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#9)(1990-5#2)(1990-6#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#4)(1992-1#2)(1992-12#4)(1992-2#3)(1992-3#7)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-8#2)(1993-9#2)(1994-11#6)(1994-12#2)(1994-2#14)(1994-3#4)(1994-5#2)(1994-8#5)(1995-11#4)(1995-12#5)(1995-2#3)(1995-6#1)(1995-8#5)(1996-11#5)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#3)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#25)(2008-12#26)(2008-3#2)(2008-4#5)(2008-5#11)(2008-6#11)(2008-7#26)(2008-8#65)(2008-9#65)(2009-1#4)(2009-10#13)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#10)(2009-6#3)(2009-7#1)(2009-8#7)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#12)(2010-5#5)(2010-6#5)(2010-7#4)(2010-8#3)(2011-1#4)(2011-2#43)(2011-3#1)(2012-12#9)(2012-2#18)(2012-3#33)(2012-7#1)(2013-1#29)(2013-8#17)
male's##4##1##(2008-8#3)(2009-8#1)
male)##7##1##(1993-12#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
male-biased##4##1##(1994-8#1)(2008-8#3)
male-female##3##1##(1992-5#1)(2008-8#2)
male-killing##3##1##(2012-3#3)
male-male competition##2##2##(2008-8#2)
male-specific##4##1##(2007-12#1)(2012-3#3)
male-sterile##3##1##(2008-10#1)(2008-8#2)
male/female##3##1##(2008-5#1)(2011-2#1)(2011-3#1)
maleate##11##1##(1993-12#1)(1996-12#4)(1996-5#1)(2008-10#4)(2012-12#1)
maleic and phthalic acids##2##4##(2008-10#2)
maleic anhydride##3##2##(1994-8#1)(1995-11#1)(1996-5#1)
maleic##10##1##(1994-8#1)(1995-11#1)(1996-5#1)(2008-10#7)
maleimide##2##1##(1990-2#1)(2008-10#1)
males (mean##3##2##(2007-12#1)(2008-1#1)(2013-8#1)
males (the##2##2##(2008-8#2)
males aged##2##2##(1992-5#1)(1993-11#1)
males and 1##3##3##(1991-6#1)(1992-9#1)(1994-6#1)
males and 10 females##4##4##(2007-8#1)(2008-9#3)
males and 10##5##3##(1994-6#1)(2007-8#1)(2008-9#3)
males and 13##2##3##(1993-11#1)(2008-9#1)
males and 15 females##2##4##(1991-12#2)
males and 4##2##3##(2008-10#1)(2013-7#1)
males and 5##3##3##(1991-6#1)(1994-6#1)(2008-5#1)
males and 800##2##3##(2008-9#2)
males and females at##6##4##(2008-9#6)
males and females exposed to##4##5##(2008-9#4)
males and females in both studies##3##6##(2008-9#3)
males and females in##5##4##(2008-9#4)(2012-3#1)
males and females was##3##4##(1994-6#1)(2008-9#2)
males and females##43##3##(1990-3#1)(1990-8#1)(1991-2#1)(1994-6#1)(1996-2#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#24)(2009-5#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
males and oviparae##3##3##(2008-9#3)
males and##103##2##(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-6#4)(1992-9#2)(1993-11#1)(1994-12#1)(1994-6#5)(1995-10#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#7)(2008-9#38)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#2)
males are##6##2##(1997-3#1)(2008-12#1)(2008-8#3)(2009-5#1)
males at 39 weeks##2##4##(2008-9#2)
males at 43 weeks##4##4##(2008-9#4)
males at##8##2##(2008-9#8)
males but not##2##3##(1995-2#1)(2013-8#1)
males but##4##2##(1994-6#1)(1995-2#1)(2008-8#1)(2013-8#1)
males compared to females##2##4##(2008-5#1)(2008-8#1)
males did not##2##3##(2008-11#1)(2013-8#1)
males from a##2##3##(2008-12#1)(2008-8#1)
males from##5##2##(2008-1#1)(2008-12#2)(2008-8#1)(2012-3#1)
males had##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
males have##2##2##(2008-5#1)(2008-9#1)
males in a##2##3##(2009-1#1)(2013-1#1)
males in four age groups (4##2##6##(2008-7#2)
males in the##4##3##(2008-5#1)(2008-8#1)(2008-9#2)
males in##13##2##(1990-2#1)(1997-7#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
males increased##2##2##(2008-6#1)(2008-9#1)
males invest in##2##3##(2008-8#1)(2008-9#1)
males living##2##2##(2008-10#1)(2013-1#1)
males of the common shrew (Sorex##2##6##(2008-12#2)
males of the##4##3##(2008-12#2)(2010-8#2)
males of##11##2##(1997-3#1)(2008-12#2)(2008-8#4)(2010-8#2)(2011-2#1)(2013-8#1)
males older than##2##3##(1990-12#1)(2011-2#1)
males or##2##2##(2008-9#1)(2012-12#1)
males over the age of 50##2##6##(1994-12#2)
males than in##6##3##(1990-12#1)(1992-12#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-3#1)
males than##8##2##(1990-12#1)(1992-12#1)(2008-11#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-3#1)
males to##3##2##(2008-6#1)(2008-8#1)(2012-2#1)
males typically##2##2##(1996-12#1)(2009-8#1)
males was##8##2##(1993-8#2)(2008-10#1)(2008-9#1)(2011-2#2)(2012-3#2)
males were less##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
males were more##2##3##(1995-2#1)(2008-12#1)
males were##13##2##(1991-12#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#1)
males who##4##2##(1994-12#1)(2010-7#2)(2012-2#1)
males with a##3##3##(1992-5#1)(2008-10#1)(2008-9#1)
males with##10##2##(1992-5#1)(1993-2#1)(2008-10#1)(2008-8#3)(2008-9#3)(2012-2#1)
males##414##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-6#9)(1991-8#1)(1992-12#1)(1992-5#2)(1992-9#3)(1993-11#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#5)(1994-2#7)(1994-3#1)(1994-6#12)(1994-8#1)(1995-10#1)(1995-11#2)(1995-2#4)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-3#4)(1997-5#1)(1997-7#4)(2007-12#7)(2007-8#1)(2008-1#3)(2008-10#18)(2008-11#13)(2008-12#12)(2008-4#3)(2008-5#8)(2008-6#5)(2008-7#9)(2008-8#68)(2008-9#75)(2009-1#2)(2009-10#1)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#2)(2010-12#3)(2010-3#1)(2010-4#7)(2010-5#1)(2010-7#3)(2010-8#5)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#9)(2012-3#19)(2013-1#9)(2013-7#2)(2013-8#11)
males'##3##1##(2008-12#1)(2009-5#1)(2012-12#1)
males) aging from##2##3##(2011-2#2)
males) with##2##2##(2011-2#1)(2013-1#1)
males)##10##1##(1996-9#1)(1997-8#1)(2008-7#1)(2009-10#1)(2011-2#3)(2013-1#2)(2013-8#1)
malformation disease##4##2##(2008-10#4)
malformation has##2##2##(2008-10#2)
malformation in##4##2##(1992-5#1)(2008-11#1)(2008-7#1)(2010-10#1)
malformation of the##4##3##(2008-10#1)(2008-8#2)(2012-3#1)
malformation of##5##2##(2008-10#1)(2008-8#2)(2012-3#2)
malformation syndrome##2##2##(2008-10#2)
malformation was##2##2##(2008-11#1)(2008-7#1)
malformation with##3##2##(1996-6#1)(1997-3#1)(2012-2#1)
malformation##66##1##(1990-9#2)(1992-2#1)(1992-5#2)(1996-6#5)(1996-9#1)(1997-3#1)(2008-10#13)(2008-11#3)(2008-7#25)(2008-8#2)(2008-9#1)(2010-10#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)
malformations and##5##2##(1991-2#1)(2011-1#3)(2013-8#1)
malformations in a##2##3##(2011-2#1)(2012-3#1)
malformations in the##3##3##(2008-10#1)(2008-7#2)
malformations in##7##2##(2008-10#1)(2008-7#3)(2011-2#1)(2012-3#2)
malformations is##5##2##(1990-9#1)(1995-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
malformations of the brain##3##4##(1997-6#1)(2008-7#2)
malformations of the##6##3##(1997-6#1)(2008-10#1)(2008-7#4)
malformations should be##2##3##(1996-11#1)(2008-7#1)
malformations was##2##2##(1993-12#1)(2008-7#1)
malformations with##4##2##(2008-7#4)
malformations##96##1##(1990-9#1)(1991-2#1)(1991-6#1)(1993-12#3)(1994-6#1)(1995-11#2)(1995-12#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-6#3)(2008-10#7)(2008-11#3)(2008-7#34)(2008-8#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-2#3)(2012-3#11)(2013-1#3)(2013-8#1)
malformations]##3##1##(1991-2#1)(1992-3#1)(1993-5#1)
malfunction of##3##2##(1997-4#1)(2008-11#1)(2009-3#1)
malfunction##4##1##(1997-4#1)(2008-11#1)(2009-3#1)(2010-3#1)
mali'##3##1##(2008-10#3)
mali)##2##1##(2008-10#2)
malic acid##4##2##(1992-3#1)(2008-10#3)
malic and##2##2##(2008-10#2)
malic enzyme##2##2##(2008-10#1)(2013-1#1)
malic##14##1##(1992-3#1)(2008-10#11)(2008-5#1)(2013-1#1)
maligna melanoma##3##2##(2011-2#3)
maligna##5##1##(2011-2#5)
malignancies and##8##2##(1990-12#1)(1990-8#1)(2008-10#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
malignancies are##4##2##(1990-8#1)(2010-6#1)(2011-2#1)(2011-3#1)
malignancies during pregnancy##2##3##(2013-1#2)
malignancies have##2##2##(2008-1#1)(2011-2#1)
malignancies in##4##2##(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
malignancies is##3##2##(1991-3#1)(2010-11#1)(2012-2#1)
malignancies of the##3##3##(1993-6#1)(1994-1#1)(2011-2#1)
malignancies of##5##2##(1990-2#1)(1990-6#1)(1993-6#1)(1994-1#1)(2011-2#1)
malignancies such as##2##3##(1991-11#1)(2011-2#1)
malignancies that##2##2##(2013-1#1)(2013-7#1)
malignancies with##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
malignancies##86##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-5#1)(1995-10#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#8)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-11#5)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#1)
malignancy and the##3##3##(1991-3#1)(2008-7#1)(2012-3#1)
malignancy and##8##2##(1991-3#1)(1993-8#2)(1994-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
malignancy by##2##2##(1994-12#1)(2013-8#1)
malignancy in children##2##3##(2009-1#1)(2010-11#1)
malignancy in##7##2##(1997-2#1)(2008-11#2)(2009-1#1)(2010-11#1)(2010-7#1)(2013-8#1)
malignancy is##3##2##(1996-1#1)(2008-1#1)(2013-8#1)
malignancy was##4##2##(1990-2#2)(1991-8#1)(1997-2#1)
malignancy with##2##2##(1997-5#1)(2013-8#1)
malignancy##101##1##(1990-12#1)(1990-2#7)(1990-6#4)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-8#3)(1992-2#1)(1992-3#1)(1993-8#2)(1994-11#3)(1994-12#3)(1994-5#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#3)(2008-9#2)(2009-1#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#8)
malignant and##6##2##(1994-12#1)(1995-12#1)(2008-2#1)(2010-11#1)(2012-2#1)(2013-1#1)
malignant behavior##3##2##(1990-2#2)(1990-6#1)
malignant bone##3##2##(1994-5#1)(2011-2#2)
malignant brain##4##2##(1995-12#1)(1997-8#1)(2011-3#1)(2013-8#1)
malignant cell##2##2##(1994-3#1)(2011-2#1)
malignant cells of##2##3##(2011-2#1)(2013-1#1)
malignant cells##17##2##(1990-11#1)(1993-1#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
malignant change in##2##3##(2008-7#1)(2010-12#1)
malignant change##4##2##(1991-2#1)(2008-7#2)(2010-12#1)
malignant cystosarcoma phyllodes##2##3##(2011-3#2)
malignant disease##8##2##(1990-9#1)(1993-2#1)(1996-11#1)(1997-4#1)(2008-11#1)(2009-1#1)(2011-2#1)(2012-2#1)
malignant diseases##5##2##(1990-11#1)(1990-2#1)(1992-2#1)(1997-5#1)(2008-11#1)
malignant disorders##4##2##(1990-10#2)(2008-9#1)(2011-2#1)
malignant glioma##8##2##(1993-9#1)(1995-2#1)(1997-7#1)(2008-8#2)(2011-2#2)(2013-1#1)
malignant gliomas##2##2##(1993-9#1)(2008-5#1)
malignant human##2##2##(1990-12#1)(1994-8#1)
malignant in##2##2##(1992-5#1)(2011-1#1)
malignant lesions##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
malignant lymphoma##8##2##(2008-10#4)(2008-5#1)(2009-1#1)(2009-8#1)(2012-3#1)
malignant lymphomas##3##2##(1993-2#1)(1997-8#1)(2011-2#1)
malignant melanoma and##2##3##(2008-7#1)(2011-2#1)
malignant melanoma##22##2##(1990-6#1)(1991-6#3)(1996-6#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-6#2)(2011-2#9)(2012-3#1)(2013-1#1)
malignant mesenchymal##3##2##(2011-2#2)(2013-1#1)
malignant mesothelioma in##2##3##(1991-12#2)
malignant mesothelioma is##2##3##(1991-12#1)(2010-12#1)
malignant mesothelioma##16##2##(1991-12#10)(1991-2#3)(1995-2#1)(2010-1#1)(2010-12#1)
malignant mixed Müllerian##2##3##(2011-2#2)
malignant mixed##3##2##(2011-2#3)
malignant nature##2##2##(2010-11#1)(2012-3#1)
malignant neoplasms##4##2##(1990-3#1)(1991-8#1)(1994-6#1)(2008-11#1)
malignant pain##2##2##(2008-4#2)
malignant patients##2##2##(1990-2#1)(2010-11#1)
malignant pleural effusions##2##3##(1991-6#2)
malignant pleural mesothelioma##7##3##(1992-12#3)(1995-2#1)(1997-5#2)(2008-10#1)
malignant pleural##9##2##(1991-6#2)(1992-12#3)(1995-2#1)(1997-5#2)(2008-10#1)
malignant schwannoma##3##2##(1994-6#3)
malignant skin##2##2##(2011-2#2)
malignant supratentorial infarction##3##3##(2012-3#3)
malignant syndrome##5##2##(2009-11#4)(2012-3#1)
malignant transformation in##5##3##(1990-5#2)(2008-7#2)(2011-2#1)
malignant transformation##22##2##(1990-5#2)(1990-8#1)(1992-9#2)(1993-11#1)(2008-11#1)(2008-7#4)(2009-12#1)(2009-8#2)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#3)
malignant tumor##5##2##(1990-5#1)(1994-12#2)(2008-12#1)(2013-1#1)
malignant tumors##8##2##(1990-11#1)(1994-12#1)(2008-4#1)(2010-1#2)(2011-2#3)
malignant tumors]##3##2##(1993-2#1)(2011-1#1)(2013-1#1)
malignant tumour##3##2##(2008-9#3)
malignant tumours##7##2##(1990-12#1)(1997-2#1)(2008-7#1)(2011-3#2)(2012-2#2)
malignant ventricular##2##2##(1996-3#1)(2012-3#1)
malignant##293##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#7)(1990-3#1)(1990-5#4)(1990-6#3)(1990-8#3)(1990-9#1)(1991-12#10)(1991-2#4)(1991-3#1)(1991-6#5)(1991-8#2)(1991-9#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-2#3)(1993-6#3)(1993-8#2)(1993-9#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-12#2)(1995-2#4)(1995-3#2)(1996-1#1)(1996-11#2)(1996-3#1)(1996-6#2)(1997-2#3)(1997-4#2)(1997-5#5)(1997-7#2)(1997-8#3)(2008-1#1)(2008-10#6)(2008-11#11)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#5)(2008-7#10)(2008-8#2)(2008-9#4)(2009-1#4)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#4)(2010-1#5)(2010-11#4)(2010-12#7)(2010-3#2)(2010-6#4)(2011-1#2)(2011-2#38)(2011-3#7)(2012-12#3)(2012-2#10)(2012-3#11)(2013-1#16)(2013-7#1)(2013-8#4)
malignant&quot##2##1##(1997-2#2)
malleable##2##1##(2008-7#2)
malleole)##2##1##(2013-1#2)
malleolus##5##1##(2009-3#1)(2010-3#1)(2010-6#2)(2012-2#1)
malnourished and well-nourished##2##3##(2008-11#2)
malnourished males##2##2##(2008-11#2)
malnourished patients##2##2##(1990-3#1)(1992-9#1)
malnourished##10##1##(1990-3#1)(1992-9#2)(2008-11#6)(2010-6#1)
malnutrition and feeding##2##3##(2010-9#2)
malnutrition and##5##2##(1993-12#1)(2008-11#1)(2010-9#2)(2012-12#1)
malnutrition in Yemen##4##3##(2010-6#4)
malnutrition in children##3##3##(1996-3#1)(2012-2#1)(2013-1#1)
malnutrition in the community##2##4##(2012-12#2)
malnutrition in##12##2##(1990-9#1)(1993-9#1)(1996-3#1)(2010-6#5)(2012-12#2)(2012-2#1)(2013-1#1)
malnutrition may##2##2##(2008-12#1)(2012-2#1)
malnutrition##41##1##(1990-9#1)(1991-8#1)(1993-12#3)(1993-9#1)(1996-3#1)(2008-10#2)(2008-11#4)(2008-12#2)(2010-6#7)(2010-9#3)(2011-2#5)(2012-12#4)(2012-2#5)(2013-1#1)(2013-8#1)
malocclusion with##2##2##(2013-1#2)
malocclusion##8##1##(1995-9#1)(2008-9#1)(2012-3#1)(2013-1#5)
malodor##5##1##(2008-5#5)
malodour is##2##2##(2008-5#2)
malodour##7##1##(2008-10#2)(2008-5#4)(2013-7#1)
malonate##6##1##(2008-10#6)
malondialdehyde (MDA)##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)
malondialdehyde concentration##2##2##(2008-11#1)(2010-12#1)
malondialdehyde in##2##2##(1993-2#1)(2013-1#1)
malondialdehyde##21##1##(1993-2#2)(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#5)(2010-12#1)(2012-2#3)(2013-1#1)
malonic acid##7##2##(2008-10#7)
malonic##15##1##(2008-10#15)
malonyl-CoA##6##1##(1995-6#6)
malonyl-di-aldehyde##3##1##(1990-8#3)
malpractice and##2##2##(1991-12#1)(1992-2#1)
malpractice suit##2##2##(1995-12#2)
malpractice##25##1##(1991-12#8)(1992-2#1)(1993-12#3)(1993-2#1)(1995-1#1)(1995-12#2)(1995-5#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#2)(2008-7#1)(2012-3#1)
malrotation##4##1##(2011-2#1)(2012-3#3)
malt##2##1##(1990-3#1)(2009-5#1)
maltase##3##1##(2012-2#2)(2013-1#1)
malting##3##1##(2008-10#3)
maltodextrin##3##1##(2008-10#3)
maltol in beverages##4##3##(2008-10#4)
maltol was##2##2##(2008-10#2)
maltol##9##1##(2008-10#9)
maltosa was##3##2##(1993-12#1)(1996-3#2)
maltosa##8##1##(1991-9#3)(1993-12#2)(1996-3#3)
maltose##6##1##(1992-12#1)(1992-9#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-2#1)
maltose) and##2##2##(2010-11#2)
maltose-binding protein (MBP)##3##3##(1992-9#1)(1994-8#1)(1995-12#1)
maltotriitol##2##1##(1990-9#2)
maltotriose##3##1##(1992-12#3)
maltreatment##2##1##(1994-2#1)(2012-3#1)
malvacearum##6##1##(2008-10#6)
mammal##4##1##(1997-2#1)(2008-10#1)(2008-8#1)(2011-3#1)
mammalia##3##1##(2008-8#3)
mammalian RNA##2##2##(1995-6#1)(2012-2#1)
mammalian TRs##2##2##(1991-6#2)
mammalian and yeast##2##3##(2008-11#1)(2009-6#1)
mammalian and##3##2##(1997-1#1)(2008-11#1)(2009-6#1)
mammalian brain##5##2##(1995-6#1)(2008-11#3)(2008-9#1)
mammalian cell culture processes##2##4##(2008-11#2)
mammalian cell culture##9##3##(2008-11#8)(2008-7#1)
mammalian cell cultures##10##3##(2008-11#10)
mammalian cell lines growing in##2##5##(2008-11#2)
mammalian cell lines##11##3##(2008-11#9)(2008-8#1)(2013-8#1)
mammalian cell##43##2##(2008-11#34)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2012-2#1)(2013-8#1)
mammalian cells and embryos##2##4##(2008-4#2)
mammalian cells and##8##3##(2008-11#3)(2008-4#2)(2008-8#1)(2009-12#1)(2013-7#1)
mammalian cells by##4##3##(2008-11#2)(2010-10#1)(2011-2#1)
mammalian cells can##2##3##(2008-11#2)
mammalian cells for##2##3##(2008-11#2)
mammalian cells grown in serum-free suspension culture##2##7##(2008-11#2)
mammalian cells grown in##3##4##(1993-12#1)(2008-11#2)
mammalian cells grown##4##3##(1993-12#1)(2008-11#3)
mammalian cells have##2##3##(2008-11#1)(2008-9#1)
mammalian cells in a##3##4##(2008-11#2)(2008-7#1)
mammalian cells in vitro##2##4##(1994-3#1)(1994-5#1)
mammalian cells in##8##3##(1994-3#1)(1994-5#1)(2008-11#4)(2008-7#1)(2008-8#1)
mammalian cells is##2##3##(1990-5#1)(2008-11#1)
mammalian cells to##2##3##(2008-11#1)(2013-8#1)
mammalian cells##101##2##(1990-5#2)(1991-5#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-6#3)(1993-9#1)(1994-11#2)(1994-3#2)(1994-5#2)(1995-2#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-3#3)(1997-7#3)(2008-1#1)(2008-11#40)(2008-4#4)(2008-7#3)(2008-8#8)(2008-9#6)(2009-12#1)(2010-10#1)(2011-2#5)(2013-7#1)(2013-8#1)
mammalian central nervous system##4##4##(1990-5#1)(1993-12#1)(2008-11#1)(2012-2#1)
mammalian expression vectors##3##3##(2008-11#3)
mammalian expression##5##2##(1994-11#1)(2008-11#3)(2008-8#1)
mammalian genomes##6##2##(1991-6#1)(1995-2#1)(1996-8#1)(1997-6#1)(2008-11#1)(2008-7#1)
mammalian host##2##2##(2008-11#1)(2011-2#1)
mammalian hosts##2##2##(2008-8#1)(2011-2#1)
mammalian models##2##2##(2008-10#1)(2008-11#1)
mammalian neocortex##2##2##(1994-3#1)(2008-11#1)
mammalian nuclear extracts##2##3##(1995-2#2)
mammalian protein##2##2##(1995-8#1)(2008-11#1)
mammalian species##11##2##(1991-12#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
mammalian systems##6##2##(1994-5#1)(2008-10#1)(2008-11#3)(2008-8#1)
mammalian target of rapamycin (mTOR)##3##5##(2008-7#1)(2013-1#2)
mammalian telomere##2##2##(2008-11#2)
mammalian##316##1##(1990-12#2)(1990-5#6)(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#5)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#7)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#4)(1994-8#3)(1995-11#1)(1995-2#11)(1995-6#6)(1995-8#4)(1996-12#1)(1996-2#1)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#8)(2008-1#1)(2008-10#7)(2008-11#110)(2008-12#1)(2008-4#9)(2008-5#4)(2008-7#7)(2008-8#17)(2008-9#16)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#9)(2012-2#8)(2013-1#2)(2013-7#1)(2013-8#3)
mammalian-cell culture##2##2##(2008-11#2)
mammals and##9##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-4#1)
mammals are##4##2##(1992-12#1)(2008-8#2)(2012-2#1)
mammals is##8##2##(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
mammals##71##1##(1990-5#1)(1992-10#1)(1992-12#2)(1993-3#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-11#2)(1995-2#2)(1995-6#1)(1996-12#2)(1997-7#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#11)(2008-9#9)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#5)(2013-1#4)
mammals)##2##1##(2008-8#1)(2013-1#1)
mammary adenocarcinoma##2##2##(1990-8#1)(1992-2#1)
mammary artery##5##2##(1993-8#2)(2008-8#1)(2011-2#2)
mammary cancer##6##2##(1993-1#4)(1995-2#1)(2008-10#1)
mammary cells##5##2##(1993-11#1)(1995-11#3)(2012-12#1)
mammary epithelial cell##2##3##(1993-11#1)(1994-11#1)
mammary epithelial cells##9##3##(1993-11#4)(1995-9#2)(2008-11#1)(2008-8#1)(2008-9#1)
mammary epithelial##13##2##(1993-11#6)(1994-11#2)(1995-9#2)(2008-11#1)(2008-8#1)(2008-9#1)
mammary gland cells##2##3##(2008-9#2)
mammary gland##21##2##(1992-9#3)(1994-12#1)(1995-11#2)(1995-12#1)(1995-9#1)(2008-10#1)(2008-8#1)(2008-9#3)(2009-12#2)(2012-2#5)(2013-1#1)
mammary glands of pregnant and lactating rats##2##7##(1990-11#2)
mammary glands of##4##3##(1990-11#2)(1992-12#1)(2008-8#1)
mammary glands##7##2##(1990-11#2)(1992-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
mammary progenitor##2##2##(2009-12#2)
mammary secretions##5##2##(1991-11#5)
mammary tumor##8##2##(1990-11#1)(1993-1#2)(1993-11#1)(1994-11#2)(1994-12#1)(2013-7#1)
mammary tumorigenesis##2##2##(1995-9#2)
mammary tumors##6##2##(1992-9#2)(1993-1#1)(1993-11#1)(1995-9#1)(2013-7#1)
mammary tumour cell line##3##4##(2008-11#3)
mammary##106##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-8#1)(1991-11#5)(1992-12#1)(1992-2#1)(1992-9#7)(1993-1#8)(1993-11#10)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#3)(1995-11#6)(1995-12#2)(1995-2#1)(1995-9#14)(1997-7#1)(2008-10#2)(2008-11#5)(2008-8#4)(2008-9#4)(2009-12#4)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)
mammogram##2##1##(1997-1#1)(1997-8#1)
mammograms##5##1##(1997-1#1)(1997-2#1)(2009-12#2)(2010-8#1)
mammographic and##2##2##(1990-2#1)(1997-7#1)
mammographic screening##2##2##(1992-2#1)(1993-2#1)
mammographic##6##1##(1990-2#1)(1992-2#2)(1993-2#1)(1997-7#1)(2009-11#1)
mammography and##5##2##(1997-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
mammography for screening purposes##2##4##(1990-6#2)
mammography for##3##2##(1990-6#2)(2012-2#1)
mammography in##5##2##(1990-11#1)(1992-2#1)(1994-3#1)(1997-8#2)
mammography##37##1##(1990-11#1)(1990-12#1)(1990-6#5)(1991-2#1)(1991-3#3)(1991-8#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(1996-11#1)(1997-1#2)(1997-8#9)(2008-10#1)(2008-3#1)(2009-11#1)(2011-2#3)(2012-2#2)(2013-1#1)
man and##6##2##(1991-6#1)(1994-12#1)(2008-8#1)(2009-1#1)(2009-10#1)(2011-2#1)
man in##3##2##(1997-7#1)(2010-1#1)(2013-1#1)
man is presented##2##3##(1997-8#1)(2008-11#1)
man presented with a##6##4##(2008-7#1)(2010-6#3)(2011-2#1)(2013-1#1)
man presented with##14##3##(1997-3#1)(2008-11#1)(2008-7#3)(2009-11#1)(2010-1#1)(2010-6#3)(2011-2#2)(2013-1#2)
man presented##15##2##(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#3)(2009-11#1)(2010-1#1)(2010-6#3)(2011-2#2)(2013-1#2)
man presenting with##3##3##(2008-7#1)(2012-12#1)(2012-3#1)
man presenting##4##2##(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
man was admitted to our##2##5##(2008-12#2)
man was##5##2##(2008-12#3)(2008-7#1)(2009-1#1)
man who developed##3##3##(2008-7#2)(2009-8#1)
man who had##5##3##(1990-8#1)(2008-11#3)(2010-6#1)
man who presented with a##2##5##(2008-5#1)(2008-7#1)
man who presented with##6##4##(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
man who presented##8##3##(1991-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
man who##23##2##(1990-8#1)(1991-11#1)(1991-4#1)(1994-2#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
man with a##7##3##(1997-3#1)(1997-6#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
man with no##3##3##(2010-12#1)(2012-3#1)(2013-8#1)
man with##36##2##(1992-12#1)(1992-2#1)(1994-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-12#3)(2008-9#1)(2009-1#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#7)(2013-8#2)
man without##3##2##(1990-5#1)(2008-7#1)(2013-8#1)
man##165##1##(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#8)(2008-12#9)(2008-5#2)(2008-7#11)(2008-8#2)(2008-9#2)(2009-1#5)(2009-10#2)(2009-11#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#6)(2010-7#3)(2011-2#16)(2012-12#5)(2012-2#1)(2012-3#12)(2013-1#14)(2013-8#3)
man&quot##3##1##(1993-2#1)(2008-11#1)(2008-4#1)
man-made##6##1##(1991-6#1)(1997-8#1)(2008-11#3)(2012-2#1)
manage for##3##2##(1994-1#2)(2008-10#1)
manage health care##2##3##(1996-3#1)(1997-2#1)
manage it##2##2##(2008-7#1)(2010-11#1)
manage problems##2##2##(2008-7#1)(2012-3#1)
manage psychiatric##2##2##(2013-1#2)
manage the disease##2##3##(2008-8#1)(2013-7#1)
manage the##17##2##(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
manage their##9##2##(1991-12#2)(1994-1#2)(1997-2#1)(2010-9#2)(2013-1#1)(2013-8#1)
manage this problem##3##3##(1994-3#2)(2007-11#1)
manage this##7##2##(1994-3#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
manage##101##1##(1990-3#1)(1991-1#1)(1991-12#2)(1993-12#2)(1993-2#1)(1994-1#5)(1994-2#3)(1994-3#3)(1995-12#3)(1996-2#3)(1996-3#2)(1997-2#4)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#11)(2008-11#10)(2008-6#1)(2008-7#7)(2008-8#3)(2010-11#3)(2010-7#3)(2010-9#2)(2011-10#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
manageable##5##1##(1996-3#1)(2008-1#1)(2008-10#2)(2008-6#1)
managed Medicare##2##2##(1997-2#1)(2008-6#1)
managed according to##2##3##(1994-2#1)(2008-10#1)
managed and##2##2##(2009-10#1)(2010-6#1)
managed at##3##2##(2010-2#1)(2011-2#1)(2012-3#1)
managed by a##2##3##(1991-2#1)(2007-12#1)
managed by non-surgical therapy##2##4##(2008-10#2)
managed by the##2##3##(2008-10#1)(2012-3#1)
managed by##13##2##(1991-12#1)(1991-2#1)(1995-10#1)(1996-3#1)(2007-12#1)(2008-10#4)(2010-12#1)(2012-3#1)(2013-1#2)
managed care and health##2##4##(1995-2#1)(1997-3#1)
managed care and##8##3##(1995-2#1)(1996-1#2)(1997-1#1)(1997-2#2)(1997-3#1)(2008-11#1)
managed care are##2##3##(1997-3#1)(2008-11#1)
managed care can##2##3##(1996-1#1)(1997-1#1)
managed care concepts##2##3##(1997-2#1)(2008-12#1)
managed care environment##3##3##(1996-12#1)(1996-2#1)(1997-3#1)
managed care for##3##3##(1996-3#1)(1997-2#1)(2008-12#1)
managed care in##4##3##(1995-12#1)(1996-12#1)(1996-2#1)(1997-3#1)
managed care is##3##3##(1996-1#1)(1997-3#2)
managed care on the##2##4##(1992-3#1)(1995-12#1)
managed care on##4##3##(1991-3#1)(1992-3#1)(1995-12#1)(1997-1#1)
managed care organizations##10##3##(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-6#2)(2009-6#1)
managed care plan##2##3##(1997-2#2)
managed care plans for##3##4##(1995-12#2)(1997-2#1)
managed care plans in##2##4##(1995-12#1)(2008-11#1)
managed care plans##13##3##(1994-2#1)(1995-12#5)(1996-12#1)(1997-2#4)(1997-3#1)(2008-11#1)
managed care program##3##3##(1995-12#1)(1996-1#1)(1997-2#1)
managed care programs##7##3##(1991-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-11#1)
managed care setting##4##3##(1992-2#2)(1997-2#1)(2009-11#1)
managed care##144##2##(1991-12#1)(1991-3#6)(1992-2#3)(1992-3#2)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#5)(1994-3#3)(1995-1#2)(1995-12#13)(1995-2#7)(1995-3#1)(1996-1#7)(1996-12#10)(1996-2#9)(1996-3#5)(1997-1#7)(1997-2#29)(1997-3#13)(1997-6#1)(2008-11#6)(2008-12#4)(2008-6#3)(2009-11#1)(2009-6#1)
managed care's##2##2##(1994-2#1)(1997-7#1)
managed care?##2##2##(1991-3#1)(1996-1#1)
managed competition##4##2##(1994-1#1)(1997-2#3)
managed conservatively##6##2##(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
managed cross protection##2##3##(2008-10#2)
managed forests##2##2##(2008-10#1)(2012-9#1)
managed in##2##2##(1995-2#1)(2008-10#1)
managed mental health##3##3##(1991-3#3)
managed mental##4##2##(1991-3#4)
managed on##4##2##(1993-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
managed successfully##3##2##(1994-2#1)(2008-11#1)(2010-11#1)
managed through##3##2##(2008-10#2)(2008-11#1)
managed to##2##2##(1994-3#1)(2008-3#1)
managed using a##2##3##(2008-12#1)(2011-2#1)
managed using##3##2##(2008-12#1)(2008-3#1)(2011-2#1)
managed with a##2##3##(2008-8#1)(2011-3#1)
managed with endovascular##2##3##(2008-12#2)
managed with##11##2##(2008-12#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
managed##247##1##(1991-12#3)(1991-2#1)(1991-3#11)(1992-12#1)(1992-2#4)(1992-3#3)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#9)(1994-3#4)(1995-1#2)(1995-10#1)(1995-12#13)(1995-2#9)(1995-3#1)(1996-1#8)(1996-12#10)(1996-2#9)(1996-3#8)(1997-1#7)(1997-2#34)(1997-3#14)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#18)(2008-11#10)(2008-12#7)(2008-3#2)(2008-6#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2012-9#1)(2013-1#8)(2013-7#1)(2013-8#2)
managed-care initiatives##2##2##(1992-2#2)
managed-care plans##4##2##(1996-2#4)
managed-care quality##2##2##(1996-2#2)
managed-care##16##1##(1992-2#3)(1995-2#1)(1996-2#12)
management a##2##2##(2009-10#1)(2010-12#1)
management after##2##2##(2008-11#1)(2011-2#1)
management among##3##2##(2009-12#1)(2010-11#1)(2011-2#1)
management and immunosuppressive##2##3##(2010-7#1)(2011-3#1)
management and leadership##2##3##(1992-2#1)(1994-2#1)
management and planning tools##4##4##(1994-1#2)(1994-2#2)
management and policy##2##3##(1991-2#1)(1993-1#1)
management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary##2##19##(2008-11#2)
management and prognosis##2##3##(2008-10#1)(2012-2#1)
management and quality##2##3##(1995-1#1)(1995-2#1)
management and reconstruction##2##3##(2011-2#2)
management and research##2##3##(2008-10#1)(2010-8#1)
management and surveillance##2##3##(2009-12#1)(2011-2#1)
management and the##3##3##(1991-3#1)(1996-2#1)(2007-11#1)
management and##74##2##(1991-1#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#4)(1995-1#1)(1995-2#2)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#3)(2007-11#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-7#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#5)(2013-8#1)
management application##2##2##(1992-3#1)(1997-3#1)
management approach##7##2##(1994-1#1)(1996-1#1)(2008-10#1)(2008-12#2)(2008-8#1)(2013-1#1)
management are discussed##2##3##(2011-3#1)(2013-1#1)
management are##8##2##(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#1)
management as a##3##3##(1992-12#1)(1994-12#1)(1997-3#1)
management as##4##2##(1992-12#1)(1994-12#1)(1997-3#1)(2010-5#1)
management at##5##2##(1995-12#1)(2008-7#1)(2009-4#1)(2013-1#2)
management because##2##2##(2008-10#1)(2011-2#1)
management by##3##2##(1993-1#1)(1994-12#1)(2011-2#1)
management can be##2##3##(2008-10#1)(2008-12#1)
management can##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
management capability##2##2##(2008-11#2)
management challenges##2##2##(1996-3#1)(2013-8#1)
management competencies##2##2##(1992-1#1)(1996-3#1)
management concepts##2##2##(2008-11#1)(2008-8#1)
management decisions##7##2##(2008-10#5)(2010-10#1)(2010-5#1)
management development in##5##3##(1991-2#1)(1994-1#2)(1994-2#1)(1996-3#1)
management development programs##3##3##(1994-1#2)(1996-3#1)
management development##21##2##(1991-2#1)(1992-1#2)(1994-1#11)(1994-2#3)(1994-3#1)(1996-3#3)
management during##4##2##(2008-11#1)(2011-2#1)(2012-12#2)
management education##8##2##(1991-12#1)(1992-1#2)(1992-12#1)(1992-3#1)(1996-1#2)(2009-8#1)
management for##12##2##(1992-3#1)(1994-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
management guidelines##6##2##(1990-6#2)(2008-6#1)(2009-11#1)(2009-8#1)(2012-3#1)
management has##8##2##(1996-1#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
management in a##3##3##(1994-2#1)(1996-1#1)(2008-11#1)
management in health care##4##4##(1994-12#2)(1994-2#1)(1995-2#1)
management in health##5##3##(1994-12#2)(1994-2#1)(1995-2#1)(2010-7#1)
management in older adults##3##4##(2010-11#1)(2010-7#2)
management in patients with##2##4##(2008-1#1)(2011-2#1)
management in patients##4##3##(2008-1#1)(2011-2#1)(2012-3#2)
management in the##10##3##(1991-12#1)(1992-1#1)(1992-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-7#1)
management in##56##2##(1991-1#1)(1991-12#2)(1992-1#2)(1992-2#2)(1993-12#2)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2009-12#2)(2010-11#1)(2010-12#1)(2010-7#4)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)
management including##2##2##(2011-2#1)(2011-3#1)
management information##4##2##(1992-3#2)(1993-3#1)(1996-12#1)
management is based on##2##4##(2009-8#1)(2010-5#1)
management is that##2##3##(2008-10#1)(2012-3#1)
management is##23##2##(1992-1#1)(1992-12#1)(1993-1#1)(1994-1#1)(1996-2#1)(1996-8#1)(2008-10#6)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
management issues and##2##3##(2008-1#1)(2010-6#1)
management issues##5##2##(1994-2#1)(2008-1#1)(2008-11#1)(2010-6#2)
management literature##2##2##(1994-1#1)(2008-12#1)
management methods in##2##3##(1993-3#1)(1997-2#1)
management methods##5##2##(1993-3#1)(1997-2#1)(2008-10#3)
management model##2##2##(1994-3#1)(1997-3#1)
management models##2##2##(1994-12#1)(2008-12#1)
management must##2##2##(1994-8#1)(2008-11#1)
management need##2##2##(1994-12#1)(2008-10#1)
management of ACS##3##3##(2008-3#3)
management of Fusarium wilt##2##4##(2008-10#2)
management of Fusarium##3##3##(2008-10#3)
management of OP poisoning##2##4##(2013-1#2)
management of PCS##2##3##(2013-1#2)
management of Rh##2##3##(1996-3#2)
management of a patient with##3##5##(2008-12#2)(2011-2#1)
management of a patient##5##4##(2008-12#3)(2008-8#1)(2011-2#1)
management of a##22##3##(1991-12#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-6#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
management of acute coronary syndromes##2##5##(2008-3#2)
management of acute coronary##3##4##(2008-3#3)
management of acute##7##3##(1995-8#1)(2008-3#3)(2008-8#1)(2012-12#1)(2013-1#1)
management of advanced##2##3##(2012-3#1)(2013-1#1)
management of an##5##3##(1991-6#1)(1996-11#1)(1997-6#1)(2008-12#1)(2010-7#1)
management of apple replant disease##2##5##(2008-10#2)
management of bacterial##2##3##(2008-10#2)
management of breast cancer##2##4##(1990-11#1)(2010-8#1)
management of breast##5##3##(1990-11#1)(1994-12#2)(2010-8#1)(2012-2#1)
management of cardiac##2##3##(2008-10#1)(2008-11#1)
management of carinal resection and##2##5##(2010-7#2)
management of certain##2##3##(2008-2#1)(2009-12#1)
management of chemicals##2##3##(2008-11#2)
management of children with##3##4##(2008-10#2)(2008-11#1)
management of children##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
management of complex##2##3##(2008-12#1)(2013-1#1)
management of coronary##2##3##(2008-11#1)(2008-12#1)
management of daily and rapidly changing situations##2##7##(2008-11#2)
management of daily##3##3##(2008-11#3)
management of diabetic##2##3##(2008-9#1)(2011-7#1)
management of fever in##4##4##(1994-3#3)(2008-11#1)
management of fire blight##2##4##(2008-10#2)
management of foot melanoma##3##4##(2012-3#3)
management of foot##5##3##(2010-10#2)(2012-3#3)
management of gallbladder cancer##2##4##(2010-12#2)
management of genital##2##3##(2013-8#2)
management of implantable medical device##2##5##(2012-3#2)
management of interfering peaks##2##4##(1997-2#2)
management of intersex disorders##2##4##(2008-10#2)
management of intra-laboratory flows##2##4##(2013-1#2)
management of large##2##3##(1992-3#1)(2011-2#1)
management of locally advanced##3##4##(1990-6#1)(1993-9#1)(2008-10#1)
management of migraine##2##3##(2008-9#1)(2009-9#1)
management of patients with bipolar disorder##2##6##(2012-3#2)
management of patients with##24##4##(1990-8#1)(1995-11#1)(1996-11#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#4)(2012-2#3)(2012-3#3)(2013-1#2)
management of patients##26##3##(1990-8#1)(1995-11#1)(1996-11#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#2)
management of potato##2##3##(2008-10#2)
management of potential##2##3##(2009-4#1)(2010-12#1)
management of severe##4##3##(1991-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
management of sleep##2##3##(2008-11#1)(2008-7#1)
management of soilborne pests##2##4##(2008-10#2)
management of soilborne##4##3##(2008-10#4)
management of such complex##2##4##(2011-2#1)(2013-1#1)
management of such patients##2##4##(2009-10#1)(2012-2#1)
management of such##6##3##(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
management of symptomatic##2##3##(2008-8#1)(2012-3#1)
management of the breast##2##4##(1994-12#1)(2010-7#1)
management of the disease##3##4##(1997-8#1)(2008-10#2)
management of the##29##3##(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-12#1)(1997-8#2)(2008-1#1)(2008-10#9)(2008-12#2)(2008-9#1)(2009-12#1)(2010-7#1)(2011-3#2)(2012-2#2)(2013-1#3)
management of these cases##3##4##(2008-9#1)(2010-7#1)(2013-1#1)
management of these patients##5##4##(1991-2#1)(2008-8#1)(2011-2#2)(2013-1#1)
management of these##14##3##(1991-2#1)(1993-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
management of this disease##4##4##(1991-2#1)(2008-10#1)(2010-8#1)(2011-2#1)
management of this##10##3##(1991-2#1)(2008-10#2)(2008-12#2)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)
management of tubal##2##3##(1991-12#1)(1994-3#1)
management of tuberculous##2##3##(2008-7#1)(2011-2#1)
management of unacceptable##2##3##(2011-2#2)
management of uncontrolled hypertensives##2##4##(2008-10#2)
management of##490##2##(1990-11#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-9#4)(1994-12#4)(1994-2#1)(1994-3#5)(1995-11#3)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#3)(1996-11#4)(1996-2#2)(1996-3#5)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#7)(2008-10#64)(2008-11#27)(2008-12#22)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#18)(2008-8#6)(2008-9#11)(2009-1#2)(2009-10#5)(2009-11#2)(2009-12#10)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#20)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#12)(2010-8#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#41)(2011-3#5)(2011-7#5)(2012-12#7)(2012-2#11)(2012-3#22)(2013-1#37)(2013-8#7)
management on##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
management opportunities##2##2##(1994-12#1)(2012-3#1)
management options##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
management or##2##2##(1993-12#1)(1995-3#1)
management perspective##2##2##(1991-12#1)(1992-12#1)
management plan##3##2##(2008-4#1)(2008-9#1)(2009-8#1)
management plans##3##2##(2008-4#1)(2009-12#1)(2010-7#1)
management policies##3##2##(2008-12#1)(2012-3#1)(2013-1#1)
management positions##2##2##(1992-3#1)(1994-12#1)
management practice##3##2##(1996-3#1)(2008-10#2)
management practices that##2##3##(1993-1#1)(2008-10#1)
management practices##12##2##(1992-1#1)(1992-3#1)(1993-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-11#1)
management principles##4##2##(1996-1#1)(2008-12#1)(2008-8#1)(2013-8#1)
management process##3##2##(1991-2#1)(1994-1#1)(1994-2#1)
management program designed to##2##4##(1997-2#1)(2013-1#1)
management program for##2##3##(2013-1#1)(2013-8#1)
management program##13##2##(1991-2#1)(1992-1#1)(1993-2#1)(1995-12#1)(1997-2#3)(2008-10#2)(2008-11#1)(2013-1#2)(2013-8#1)
management programme##2##2##(1991-8#1)(2010-11#1)
management programs and##2##3##(2008-10#1)(2008-8#1)
management programs##16##2##(1992-3#1)(1994-3#1)(1996-1#2)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#1)
management remains##2##2##(1997-5#1)(2008-8#1)
management requires##3##2##(1994-3#1)(2010-12#1)(2011-2#1)
management response##2##2##(2008-11#1)(2011-2#1)
management service##2##2##(1992-12#1)(2013-1#1)
management should be##3##3##(1993-1#1)(2009-7#1)(2013-1#1)
management should##6##2##(1993-1#1)(2008-10#1)(2008-11#2)(2009-7#1)(2013-1#1)
management skills##7##2##(1991-12#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(2007-12#1)
management strategies and##2##3##(1996-1#1)(2008-12#1)
management strategies for##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
management strategies that##3##3##(2008-10#1)(2008-9#1)(2010-7#1)
management strategies##25##2##(1990-11#1)(1996-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
management strategy for##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
management strategy in##2##3##(1992-1#1)(2013-8#1)
management strategy##12##2##(1992-1#1)(2008-10#8)(2008-7#1)(2013-1#1)(2013-8#1)
management structure##2##2##(1995-1#1)(1996-3#1)
management support##2##2##(1997-2#1)(2008-6#1)
management system for##2##3##(1993-1#1)(1993-3#1)
management system##12##2##(1993-1#1)(1993-3#1)(1997-1#1)(2008-10#4)(2008-12#2)(2008-9#1)(2010-5#1)(2013-1#1)
management systems and##2##3##(1997-2#1)(2008-10#1)
management systems in##2##3##(1996-12#1)(2008-1#1)
management systems that##3##3##(2008-1#1)(2008-12#2)
management systems##13##2##(1995-1#1)(1996-12#1)(1997-2#2)(2008-1#2)(2008-10#4)(2008-12#2)(2008-9#1)
management tactics##2##2##(2008-10#2)
management techniques##4##2##(1991-12#1)(1991-3#1)(2009-12#1)(2010-7#1)
management that##3##2##(1992-12#1)(1993-3#1)(2008-10#1)
management through##3##2##(1994-12#1)(2008-11#1)(2013-1#1)
management to improve##3##3##(1993-3#1)(1994-1#1)(2009-9#1)
management to##9##2##(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-9#1)
management tool##4##2##(1993-3#1)(1994-12#1)(2008-10#1)(2008-11#1)
management tools##6##2##(1996-1#1)(2008-10#5)
management training##4##2##(1991-2#1)(1994-2#1)(1997-2#2)
management using##2##2##(1992-1#1)(1992-6#1)
management was##6##2##(2008-10#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
management were##4##2##(1990-8#1)(1992-1#1)(2010-7#1)(2012-3#1)
management which##2##2##(1994-3#1)(2011-2#1)
management with##10##2##(1993-3#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-7#2)(2012-12#1)(2013-1#1)
management##1495##1##(1990-11#3)(1990-12#4)(1990-2#1)(1990-6#4)(1990-8#2)(1990-9#2)(1991-1#4)(1991-12#18)(1991-2#14)(1991-3#15)(1991-6#1)(1991-8#3)(1992-1#20)(1992-12#14)(1992-2#17)(1992-3#15)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#13)(1993-11#2)(1993-12#16)(1993-2#7)(1993-3#16)(1993-9#5)(1994-1#39)(1994-12#26)(1994-2#28)(1994-3#26)(1994-6#2)(1994-8#1)(1995-1#10)(1995-10#1)(1995-11#6)(1995-12#10)(1995-2#8)(1995-3#7)(1995-8#1)(1996-1#19)(1996-11#4)(1996-12#4)(1996-2#15)(1996-3#17)(1996-6#1)(1996-8#2)(1997-1#6)(1997-2#26)(1997-3#16)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#5)(2006-5#2)(2007-11#2)(2007-12#3)(2008-1#19)(2008-10#222)(2008-11#83)(2008-12#47)(2008-2#5)(2008-3#14)(2008-4#7)(2008-5#5)(2008-6#4)(2008-7#44)(2008-8#21)(2008-9#20)(2009-1#4)(2009-10#6)(2009-11#5)(2009-12#21)(2009-2#1)(2009-3#3)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#12)(2009-9#4)(2010-1#4)(2010-10#6)(2010-11#15)(2010-12#26)(2010-2#2)(2010-4#1)(2010-5#11)(2010-6#14)(2010-7#27)(2010-8#14)(2010-9#8)(2011-1#5)(2011-10#1)(2011-2#99)(2011-3#11)(2011-7#7)(2012-12#14)(2012-2#24)(2012-3#46)(2013-1#85)(2013-8#17)
management'##2##1##(1997-5#1)(2010-10#1)
management's##2##1##(1993-2#1)(2008-11#1)
management?##2##1##(1993-2#1)(2008-11#1)
management]##4##1##(1991-6#1)(2009-1#1)(2009-5#1)(2010-6#1)
managements##3##1##(1994-3#1)(2013-1#2)
manager in##3##2##(1991-12#1)(1992-1#1)(1995-3#1)
manager with##3##2##(1990-12#1)(1994-2#1)(1996-12#1)
manager##16##1##(1990-12#2)(1991-1#1)(1991-12#2)(1992-1#1)(1993-1#1)(1994-2#1)(1995-3#1)(1996-12#1)(2008-12#1)(2012-3#5)
manager's perspective##3##2##(1993-12#1)(1997-1#1)(2008-10#1)
manager's role##3##2##(1995-1#1)(1996-1#1)(1997-2#1)
manager's##6##1##(1993-12#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-10#1)
managerial roles##2##2##(1994-1#1)(1994-3#1)
managerial stereotypes##4##2##(2012-3#4)
managerial##22##1##(1991-12#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#3)(1994-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-12#1)(2009-8#1)(2012-3#5)
managers and##13##2##(1991-3#2)(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#2)(1996-2#1)(1996-3#1)(1997-4#1)(2008-11#1)(2011-2#1)(2012-3#1)
managers are##4##2##(1990-12#2)(1991-2#1)(1993-2#1)
managers as##2##2##(1997-1#2)
managers can##3##2##(1991-3#1)(1992-2#1)(1996-3#1)
managers could##2##2##(1993-2#1)(1994-2#1)
managers for##3##2##(1992-1#1)(1997-1#1)(2011-1#1)
managers have##3##2##(1996-1#1)(1997-2#1)(2012-3#1)
managers in British Columbia##2##4##(1994-1#1)(1997-2#1)
managers in the##3##3##(1991-2#1)(1994-1#1)(1994-2#1)
managers in##12##2##(1991-2#2)(1993-2#1)(1994-1#2)(1994-2#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-4#1)(2010-8#1)(2012-3#1)
managers must##2##2##(1995-1#2)
managers of##7##2##(1990-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1997-2#1)(2013-8#1)
managers to##3##2##(1992-1#1)(1993-5#1)(2010-8#1)
managers who are##2##3##(1997-2#1)(2012-3#1)
managers who##3##2##(1997-2#1)(2008-10#1)(2012-3#1)
managers with##3##2##(1993-12#1)(1995-2#1)(2009-3#1)
managers##134##1##(1990-12#6)(1991-1#2)(1991-12#2)(1991-2#5)(1991-3#4)(1992-1#7)(1992-12#1)(1992-2#5)(1992-3#3)(1993-1#2)(1993-12#2)(1993-2#4)(1993-3#4)(1993-5#1)(1994-1#7)(1994-12#7)(1994-2#6)(1994-3#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#4)(1996-12#3)(1996-2#8)(1996-3#4)(1997-1#7)(1997-2#7)(1997-4#2)(2008-10#2)(2008-11#3)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#10)(2013-8#1)
managers'##5##1##(1991-2#2)(1991-3#1)(1992-1#2)
manages##3##1##(1992-12#2)(1994-1#1)
managing &quot##2##2##(1994-1#2)
managing aggressive##2##2##(2008-7#1)(2009-6#1)
managing children's##2##2##(2008-11#1)(2010-11#1)
managing the##7##2##(1995-1#1)(1997-8#1)(2008-10#2)(2008-12#1)(2009-10#1)(2013-1#1)
managing this##2##2##(2009-8#1)(2013-1#1)
managing##75##1##(1991-1#2)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-2#1)(1994-1#3)(1994-12#1)(1994-3#4)(1995-1#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-7#1)(1997-8#6)(2008-10#12)(2008-11#9)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
mancozeb##7##1##(2008-10#7)
mandarin##2##1##(2008-10#2)
mandate and##2##2##(1997-2#1)(2008-3#1)
mandate for##2##2##(1996-3#1)(2010-5#1)
mandate##17##1##(1994-1#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-5#1)(2010-8#2)(2011-2#3)
mandated by the##3##3##(1996-6#1)(1997-2#1)(2009-3#1)
mandated by##5##2##(1992-1#1)(1996-6#1)(1997-2#1)(1997-3#1)(2009-3#1)
mandated the##2##2##(1997-3#1)(2008-12#1)
mandated to##2##2##(2008-12#1)(2010-11#1)
mandated##17##1##(1991-1#1)(1991-3#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-3#3)(2008-12#2)(2009-3#1)(2010-11#1)(2013-1#1)
mandates to##2##2##(2011-9#1)(2013-1#1)
mandates##8##1##(1991-2#2)(1997-1#1)(2010-8#3)(2011-9#1)(2013-1#1)
mandatory HIV testing of##2##4##(1990-3#1)(1995-1#1)
mandatory in##4##2##(1990-2#1)(1992-9#1)(2010-12#1)(2012-12#1)
mandatory to perform##2##3##(2011-2#1)(2012-2#1)
mandatory to##7##2##(1997-6#1)(2008-12#1)(2010-12#1)(2011-2#3)(2012-2#1)
mandatory##40##1##(1990-2#1)(1990-3#2)(1990-9#1)(1992-9#1)(1994-12#2)(1995-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#7)(2008-12#2)(2008-7#3)(2009-10#1)(2009-11#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
mandible##21##1##(1993-12#2)(1996-3#1)(1997-3#1)(2008-7#6)(2010-6#2)(2011-7#1)(2012-3#1)(2013-1#7)
mandibles##3##1##(1995-9#1)(2009-3#1)(2010-5#1)
mandibular and maxillary##2##3##(2013-1#2)
mandibular bone##2##2##(2008-5#1)(2013-1#1)
mandibular canines and##2##3##(2012-3#2)
mandibular canines##3##2##(2012-3#3)
mandibular condylar chondrocytes##2##3##(1994-6#2)
mandibular molars##3##2##(2013-1#3)
mandibular overdentures##3##2##(2013-1#3)
mandibular##36##1##(1993-1#1)(1994-6#2)(1997-5#1)(2008-5#1)(2008-7#1)(2011-2#4)(2011-7#1)(2012-12#2)(2012-3#4)(2013-1#19)
maneuver##10##1##(2008-1#1)(2008-7#5)(2012-12#1)(2012-3#3)
maneuvers##7##1##(1997-2#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-3#1)(2011-7#1)
manganese (II)##7##2##(2008-10#5)(2008-7#2)
manganese and iron##2##3##(2008-10#2)
manganese and zinc in##4##4##(2008-10#4)
manganese and zinc##6##3##(2008-10#6)
manganese and##15##2##(1990-2#1)(2008-10#14)
manganese by##3##2##(2008-10#3)
manganese determination by##2##3##(2008-10#2)
manganese determination##3##2##(2008-10#3)
manganese dioxide##4##2##(2008-10#4)
manganese hexacyanoferrate##2##2##(2008-10#2)
manganese in grain##2##3##(2008-10#2)
manganese in##21##2##(2008-10#21)
manganese ion##2##2##(1993-8#1)(2008-10#1)
manganese oxide##5##2##(2008-10#5)
manganese peroxidase##6##2##(2008-5#2)(2008-6#2)(2008-7#2)
manganese phthalocyanine##2##2##(2008-10#2)
manganese superoxide dismutase##3##3##(1995-6#1)(1996-6#2)
manganese using##2##2##(2008-10#2)
manganese was##4##2##(2008-10#4)
manganese with##3##2##(2008-10#3)
manganese##139##1##(1990-2#2)(1990-8#1)(1993-8#2)(1995-6#1)(1996-6#2)(2008-10#119)(2008-5#2)(2008-6#2)(2008-7#4)(2009-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
manganese(II) in##3##2##(2008-10#3)
manganese(II)##22##1##(2008-10#22)
manganese(IV) oxide##3##2##(2008-10#3)
manganese(IV)##8##1##(2008-10#8)
mangiferae##4##1##(2008-10#4)
mango floral and vegetative##2##4##(2008-10#2)
mango isolates as C##2##4##(2008-10#2)
mango isolates##4##2##(2008-10#4)
mango malformation disease##2##3##(2008-10#2)
mango trees##3##2##(2008-10#3)
mango##22##1##(2008-10#22)
mangrove##4##1##(2008-10#1)(2008-11#1)(2008-7#2)
mania##7##1##(1995-5#2)(2008-7#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)
manic states##2##2##(2012-3#2)
manic##5##1##(1995-5#1)(2009-8#1)(2012-3#3)
manifest as##3##2##(2008-7#1)(2009-9#1)(2011-2#1)
manifest in##3##2##(2008-11#2)(2011-2#1)
manifest themselves##2##2##(2008-3#1)(2008-7#1)
manifest##26##1##(1993-2#2)(1994-11#1)(1994-12#1)(1995-5#1)(1997-4#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
manifestation in##3##2##(1993-2#1)(1997-8#1)(2013-8#1)
manifestation of a##2##3##(1990-12#1)(1996-11#1)
manifestation of disease and##2##4##(2008-10#1)(2013-1#1)
manifestation of infection##2##3##(1991-3#1)(2011-3#1)
manifestation of the##3##3##(1992-12#1)(1997-8#1)(2008-11#1)
manifestation of this##3##3##(1992-1#1)(2008-7#1)(2008-9#1)
manifestation of##42##2##(1990-12#1)(1991-3#2)(1992-1#1)(1992-12#1)(1996-11#2)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-6#2)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
manifestation##55##1##(1990-12#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-2#1)(1996-11#2)(1997-5#1)(1997-8#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-6#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#2)
manifestations and##3##2##(2008-5#1)(2008-7#1)(2010-12#1)
manifestations are##9##2##(2008-10#1)(2008-4#1)(2008-7#2)(2009-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
manifestations can##2##2##(1991-11#1)(2010-6#1)
manifestations in##4##2##(1995-5#1)(1997-3#1)(2011-8#1)(2013-8#1)
manifestations of a##2##3##(2012-12#1)(2013-1#1)
manifestations of systemic##2##3##(2012-3#2)
manifestations of the##2##3##(1995-3#1)(2008-6#1)
manifestations of this disease##2##4##(1997-8#1)(2008-7#1)
manifestations of this##4##3##(1991-11#1)(1997-8#1)(2008-7#2)
manifestations of##37##2##(1990-5#2)(1991-11#1)(1991-2#1)(1992-12#1)(1994-6#2)(1995-3#1)(1997-3#1)(1997-8#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)
manifestations to##2##2##(2009-7#1)(2011-2#1)
manifestations were##4##2##(1996-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
manifestations##107##1##(1990-12#1)(1990-5#2)(1991-11#3)(1991-2#1)(1991-3#2)(1992-12#1)(1993-11#1)(1994-6#2)(1995-1#1)(1995-3#1)(1995-5#2)(1996-11#1)(1997-3#3)(1997-4#1)(1997-8#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#11)(2009-12#3)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#4)(2010-6#1)(2010-9#1)(2011-2#8)(2011-8#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#12)(2013-8#3)
manifestations]##4##1##(1990-3#2)(1991-2#1)(1992-11#1)
manifested by a##7##3##(2008-10#2)(2008-11#1)(2009-8#3)(2012-2#1)
manifested by##15##2##(1990-5#1)(1992-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#3)(2012-2#1)(2013-1#1)
manifested in##2##2##(1996-3#1)(2010-4#1)
manifested##30##1##(1990-5#1)(1992-1#1)(1992-12#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#3)(2010-4#1)(2012-2#1)(2013-1#1)
manifesting as##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
manifesting##6##1##(2008-5#2)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
manifests as##3##2##(2007-12#1)(2009-12#1)(2010-6#1)
manifests##9##1##(1995-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
manifold and##6##2##(2008-10#6)
manifold for the##4##3##(2008-10#4)
manifold for##8##2##(2008-10#8)
manifold in##4##2##(2008-10#4)
manifold of##3##2##(2008-10#2)(2013-8#1)
manifold was used to##4##4##(2008-10#4)
manifold was##10##2##(2008-10#10)
manifold with##3##2##(2008-10#3)
manifold##79##1##(2008-10#73)(2008-11#3)(2009-10#1)(2013-8#2)
manifolds##5##1##(2008-10#5)
manihotis from##3##2##(2008-10#3)
manihotis strains##2##2##(2008-10#2)
manihotis##15##1##(2008-10#15)
manipulate the##7##2##(1993-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-7#1)(2013-8#1)
manipulate their##2##2##(2009-8#1)(2012-3#1)
manipulate##30##1##(1993-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-8#3)(2010-7#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-8#2)
manipulated and##2##2##(2008-11#1)(2012-3#1)
manipulated by##5##2##(1993-3#1)(1995-2#1)(2008-10#2)(2008-12#1)
manipulated in a##2##3##(2009-12#1)(2012-3#1)
manipulated in##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2012-3#1)
manipulated to##6##2##(1991-12#1)(2008-10#3)(2009-12#1)(2009-8#1)
manipulated##27##1##(1991-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-8#2)(2010-10#1)(2010-9#1)(2011-7#1)(2012-3#2)
manipulates##3##1##(1990-5#1)(2008-11#1)(2008-8#1)
manipulating the##9##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-1#1)(2013-1#1)
manipulating##23##1##(1994-3#1)(1997-2#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#2)
manipulation and##10##2##(1995-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#1)(2009-9#1)
manipulation are##2##2##(2008-11#1)(2008-3#1)
manipulation in the management of lateral epicondylalgia##2##7##(2008-12#2)
manipulation in##3##2##(2008-12#2)(2009-5#1)
manipulation is##2##2##(1995-5#1)(2008-10#1)
manipulation of the##8##3##(1993-1#1)(1996-2#1)(1996-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)
manipulation of these##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
manipulation of##33##2##(1991-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
manipulation techniques##3##2##(2008-12#1)(2009-12#2)
manipulation treatment##2##2##(2008-12#2)
manipulation with the##2##3##(1995-5#1)(2008-10#1)
manipulation with##3##2##(1995-5#1)(2008-10#1)(2009-5#1)
manipulation##100##1##(1991-3#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-5#3)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-7#1)(2008-10#12)(2008-11#9)(2008-12#22)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#3)
manipulation)##2##1##(2009-12#2)
manipulations of the##5##3##(2008-10#1)(2008-11#2)(2008-4#1)(2011-1#1)
manipulations of##12##2##(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
manipulations that##2##2##(2008-12#1)(2008-2#1)
manipulations##34##1##(1990-11#1)(1991-12#1)(1991-7#1)(1992-6#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#4)(2008-8#1)(2008-9#3)(2010-7#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#1)(2013-1#1)
manipulative therapy##6##2##(2008-12#4)(2013-1#2)
manipulative##8##1##(2008-12#5)(2013-1#3)
mannan (Candida##2##2##(2008-10#2)
mannan##3##1##(1991-5#1)(2008-10#2)
mannan-binding protein##2##2##(1993-3#2)
mannan-binding##3##1##(1991-5#1)(1993-3#2)
manned hydrogen-gas##2##2##(2008-11#2)
manned##3##1##(2008-11#2)(2009-12#1)
mannequin##2##1##(2008-11#1)(2013-8#1)
mannequins##2##1##(2008-11#1)(2013-8#1)
manner and##13##2##(1990-12#1)(1991-2#1)(1992-2#1)(1993-1#1)(1994-5#1)(1994-8#1)(1996-3#1)(2008-11#2)(2009-8#1)(2011-2#2)(2012-12#1)
manner as##5##2##(1994-11#1)(1997-2#1)(2008-10#2)(2008-9#1)
manner at##3##2##(1991-6#1)(1992-6#1)(2008-11#1)
manner by##10##2##(1990-5#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-6#1)
manner during##2##2##(1995-11#1)(2008-6#1)
manner for##4##2##(1996-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
manner in a##2##3##(1992-6#1)(1995-11#1)
manner in primary##2##3##(1993-8#1)(1995-8#1)
manner in which the##3##4##(1992-1#1)(1994-2#1)(1997-8#1)
manner in which##6##3##(1992-1#1)(1993-2#2)(1994-2#1)(1997-8#1)(2008-10#1)
manner in##20##2##(1990-5#1)(1991-10#2)(1992-1#1)(1992-6#1)(1993-2#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-6#1)(2012-2#1)
manner is##2##2##(2008-11#1)(2009-9#1)
manner of##10##2##(1995-11#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-4#1)
manner that##8##2##(1993-6#1)(1995-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#1)
manner the##2##2##(2008-10#1)(2009-3#1)
manner to the##4##3##(1997-2#1)(2008-11#2)(2012-3#1)
manner to##13##2##(1990-5#1)(1992-10#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-7#1)(2012-2#2)(2012-3#1)
manner when##2##2##(1993-8#1)(2008-5#1)
manner which##3##2##(1993-8#1)(1997-1#1)(2010-9#1)
manner with##3##2##(1994-3#1)(1995-11#1)(1995-12#1)
manner##338##1##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-6#3)(1993-8#6)(1993-9#1)(1994-11#10)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#10)(1995-12#5)(1995-2#2)(1995-5#1)(1995-8#8)(1996-12#4)(1996-2#6)(1996-3#1)(1996-6#1)(1997-1#5)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#4)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#57)(2008-11#47)(2008-12#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#10)(2009-10#2)(2009-12#3)(2009-3#3)(2009-4#2)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#11)(2012-3#8)(2012-7#1)(2013-1#4)(2013-8#3)
manners##8##1##(1994-3#2)(1997-3#1)(2008-10#3)(2008-9#1)(2011-2#1)
mannitol oxidase##3##2##(2008-7#3)
mannitol was##3##2##(1993-8#1)(2008-10#1)(2011-2#1)
mannitol##32##1##(1991-10#9)(1992-6#1)(1993-8#1)(1995-11#1)(2008-10#11)(2008-6#1)(2008-7#3)(2008-8#2)(2011-2#1)(2012-7#2)
mannose 6-phosphate##2##2##(1995-6#2)
mannose moiety##2##2##(2008-10#2)
mannose##24##1##(1991-9#1)(1992-12#1)(1994-5#1)(1994-8#2)(1995-6#4)(1996-6#3)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2012-3#1)
mannose-rich sugar##2##2##(2008-11#2)
mannose-rich##3##1##(2008-11#3)
mannosylerythritol##3##1##(2008-11#3)
manoeuvre##4##1##(1994-3#1)(2008-9#2)(2009-4#1)
manpower and##7##2##(1990-2#2)(1991-2#1)(1994-2#1)(1995-9#3)
manpower planning##3##2##(1991-2#2)(2012-2#1)
manpower##18##1##(1990-2#2)(1990-6#3)(1991-2#6)(1993-1#1)(1994-2#1)(1995-9#3)(2008-11#1)(2012-2#1)
mansoni##14##1##(1993-2#3)(1996-8#1)(1997-6#4)(2010-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
mantle cell lymphoma involving the appendix##2##6##(2009-7#2)
mantle cell lymphoma##7##3##(2009-1#1)(2009-7#5)(2009-8#1)
mantle##13##1##(1995-6#2)(1996-2#1)(2008-7#2)(2009-1#1)(2009-7#5)(2009-8#1)(2011-2#1)
manual and automated##3##3##(2008-10#3)
manual and##8##2##(2008-10#6)(2008-12#1)(2013-1#1)
manual flame atomic absorption##2##4##(2008-10#2)
manual for the##2##3##(1991-12#1)(2010-10#1)
manual interpretation of##2##3##(2008-4#1)(2008-8#1)
manual method##2##2##(1991-12#1)(2008-10#1)
manual methods based on##2##4##(2008-10#2)
manual methods##5##2##(1991-3#2)(1993-1#1)(2008-10#2)
manual muscle testing##2##3##(2008-12#1)(2008-9#1)
manual muscle##4##2##(2008-12#3)(2008-9#1)
manual operations##2##2##(2008-11#1)(2010-8#1)
manual procedure##2##2##(2008-10#2)
manual searches##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
manual shimming##2##2##(2012-3#2)
manual test##2##2##(2008-10#2)
manual therapy practitioners##2##3##(2008-12#2)
manual therapy##7##2##(2008-12#6)(2013-1#1)
manual titration##2##2##(2008-10#2)
manual treatment##2##2##(2009-3#1)(2010-9#1)
manual##102##1##(1990-5#1)(1991-12#2)(1991-3#3)(1993-1#1)(1993-12#1)(1994-12#2)(1995-2#1)(1995-3#1)(2008-10#40)(2008-11#6)(2008-12#11)(2008-4#6)(2008-7#1)(2008-8#1)(2008-9#6)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#3)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)
manually infested##2##2##(2008-10#2)
manually operated##2##2##(2008-10#2)
manually##14##1##(2008-10#7)(2008-12#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-3#1)
manufactory##3##1##(2008-10#3)
manufacture and##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
manufacture of##6##2##(1996-9#1)(2008-11#2)(2008-5#1)(2009-7#1)(2011-2#1)
manufacture to##2##2##(2008-3#2)
manufacture##32##1##(1995-3#1)(1996-9#1)(2008-10#11)(2008-11#5)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-9#2)(2011-2#2)(2012-2#1)
manufactured by##6##2##(1994-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#2)
manufactured in##2##2##(1995-5#1)(2008-10#1)
manufactured with##2##2##(2008-3#2)
manufactured##16##1##(1994-3#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#3)(2011-1#1)(2011-2#2)
manufacturer of##2##2##(2008-10#1)(2011-2#1)
manufacturer##15##1##(1994-3#2)(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#1)(2010-6#1)(2011-2#4)(2013-1#1)
manufacturer's##7##1##(1994-1#1)(1996-5#1)(2008-10#1)(2008-3#2)(2009-7#1)(2011-2#1)
manufacturers of##3##2##(1993-11#1)(2008-10#1)(2008-5#1)
manufacturers##29##1##(1991-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1995-1#1)(1996-5#2)(2008-10#11)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
manufacturers'##2##1##(1993-3#1)(2012-12#1)
manufacturing and##6##2##(2008-11#1)(2010-11#1)(2012-2#4)
manufacturing industries##3##2##(1995-1#1)(1995-2#1)(2008-10#1)
manufacturing procedures##2##2##(2008-10#1)(2008-7#1)
manufacturing process controls##2##3##(2008-11#2)
manufacturing process of##2##3##(2008-10#2)
manufacturing process##9##2##(1995-5#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-4#1)
manufacturing processes##3##2##(1995-5#1)(2008-11#2)
manufacturing techniques##2##2##(2008-10#1)(2008-11#1)
manufacturing technologies##2##2##(1992-3#1)(2008-11#1)
manufacturing using##2##2##(2008-10#1)(2009-7#1)
manufacturing##64##1##(1992-3#1)(1993-3#1)(1994-3#3)(1995-1#2)(1995-2#1)(1995-5#2)(1996-2#1)(2008-10#14)(2008-11#13)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#4)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-2#6)(2013-8#1)
manure compost##2##2##(2008-10#2)
manure composted for##2##3##(2008-10#2)
manure or##3##2##(2008-10#3)
manure##29##1##(2008-10#29)
manuscript is##2##2##(2011-2#1)(2012-2#1)
manuscript##26##1##(2008-10#5)(2008-11#2)(2008-5#1)(2009-1#1)(2009-4#1)(2010-1#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
manuscripts##3##1##(1992-12#1)(2008-10#2)
many Canadian hospitals are##2##4##(1991-12#1)(1994-12#1)
many Canadian##3##2##(1991-12#1)(1994-12#1)(2008-10#1)
many Gram-negative##2##2##(2008-9#1)(2011-2#1)
many States##2##2##(1994-3#1)(1995-1#1)
many advances in##2##3##(2008-5#1)(2013-8#1)
many advances##3##2##(1990-9#1)(2008-5#1)(2013-8#1)
many advantages over##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
many advantages##8##2##(1993-1#1)(1994-3#1)(1997-4#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-2#1)
many amino acids and metal ions##2##6##(2008-10#2)
many analytical##2##2##(2008-10#1)(2010-7#1)
many anatomical##2##2##(2008-10#1)(2011-2#1)
many animals##2##2##(2007-12#1)(2011-2#1)
many applications##4##2##(1993-3#1)(1996-3#1)(2008-3#1)(2010-8#1)
many approaches##2##2##(2010-12#1)(2010-8#1)
many are##3##2##(1991-2#1)(2011-2#1)(2012-12#1)
many areas of the##3##4##(1992-12#1)(2007-12#1)(2008-7#1)
many areas of##5##3##(1992-12#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-9#1)
many areas to##2##3##(1994-3#1)(2008-11#1)
many areas##9##2##(1992-12#1)(1994-3#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
many as##11##2##(1996-11#1)(1997-6#1)(2008-10#6)(2008-12#1)(2010-8#1)(2012-12#1)
many aspects of the##2##4##(2008-5#1)(2012-2#1)
many aspects of##15##3##(1991-12#1)(1992-2#1)(1996-6#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
many aspects##18##2##(1991-12#1)(1992-2#1)(1996-6#1)(2008-11#3)(2008-5#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
many attempts##2##2##(2008-5#1)(2010-12#1)
many authors##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
many behavioral##2##2##(2008-8#2)
many benefits##2##2##(1993-12#1)(2008-10#1)
many benign##2##2##(2010-11#1)(2013-1#1)
many biological##6##2##(2008-2#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)
many cancers##2##2##(2011-2#1)(2012-2#1)
many cases it##2##3##(1991-6#1)(2008-3#1)
many cases##24##2##(1990-9#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-6#1)(1994-2#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
many cations and anions##2##4##(2008-10#2)
many cations and##3##3##(2008-10#3)
many cell functions##2##3##(1995-8#1)(2011-2#1)
many cell##6##2##(1993-6#1)(1995-8#1)(2008-11#2)(2008-7#1)(2011-2#1)
many cells##2##2##(1997-7#1)(2008-1#1)
many cellular functions##3##3##(2009-4#1)(2011-2#1)(2012-3#1)
many cellular processes##3##3##(2008-4#1)(2013-1#2)
many cellular proteins##2##3##(2008-5#1)(2008-8#1)
many cellular##8##2##(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
many centers##2##2##(2008-1#1)(2012-3#1)
many challenges##7##2##(1992-1#1)(1995-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-7#1)(2012-12#1)
many changes##2##2##(2011-2#1)(2012-2#1)
many characteristics of##3##3##(1993-3#1)(2008-7#1)(2008-9#1)
many characteristics##4##2##(1993-3#1)(2008-7#1)(2008-9#2)
many children are being treated with##2##6##(1997-1#1)(2011-1#1)
many children are##4##3##(1994-2#1)(1997-1#1)(2009-10#1)(2011-1#1)
many children##7##2##(1994-12#1)(1994-2#1)(1997-1#1)(2008-11#2)(2009-10#1)(2011-1#1)
many chronic diseases##2##3##(2008-10#1)(2010-1#1)
many clinical##2##2##(1995-9#1)(2010-8#1)
many common anions##2##3##(2008-10#2)
many common##5##2##(1990-8#1)(2008-10#4)
many complex##2##2##(2008-10#1)(2008-9#1)
many components of##2##3##(1991-3#1)(2008-11#1)
many conditions##3##2##(1995-2#1)(2008-12#1)(2008-8#1)
many cosmetic##2##2##(2008-5#2)
many countries and##2##3##(1993-12#1)(2011-2#1)
many countries because##2##3##(2008-10#1)(2010-7#1)
many countries##17##2##(1990-12#1)(1991-6#2)(1993-12#1)(1995-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2010-7#1)(2011-2#2)
many data##3##2##(1990-6#1)(2008-12#1)(2009-10#1)
many decisions##2##2##(2008-10#1)(2010-12#1)
many details##2##2##(2008-9#1)(2010-10#1)
many differences##2##2##(1996-1#1)(2011-2#1)
many different cell types##3##4##(2008-2#1)(2008-9#2)
many different types of##2##4##(2008-3#1)(2008-4#1)
many different##23##2##(1997-6#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2011-1#1)(2011-3#1)(2013-8#1)
many difficulties##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
many disciplines##2##2##(2008-4#1)(2010-10#1)
many diseases##13##2##(2008-10#5)(2008-11#2)(2008-5#2)(2011-10#1)(2011-3#1)(2013-1#1)(2013-8#1)
many dissimilar##2##2##(1990-11#1)(2008-3#1)
many diverse##2##2##(2008-12#1)(2013-8#1)
many drugs##2##2##(2008-10#1)(2011-1#1)
many economically important##3##3##(2008-10#3)
many essential##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
many eukaryotic##3##2##(1995-2#1)(1996-2#1)(2009-10#1)
many examples of##2##3##(2009-12#1)(2011-2#1)
many examples##5##2##(1992-1#1)(2008-10#1)(2009-12#1)(2011-2#2)
many exciting##3##2##(2008-10#2)(2009-5#1)
many facets of##3##3##(1994-12#1)(2007-12#1)(2012-3#1)
many facets##4##2##(1994-12#1)(2007-12#1)(2009-11#1)(2012-3#1)
many factors including##2##3##(2008-5#1)(2009-11#1)
many factors that##2##3##(2007-8#1)(2009-1#1)
many factors##16##2##(1991-12#1)(1993-2#1)(1994-1#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-1#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
many features that##3##3##(1997-2#1)(2008-9#1)(2011-1#1)
many features##5##2##(1997-2#1)(1997-3#2)(2008-9#1)(2011-1#1)
many female##2##2##(2008-8#1)(2009-10#1)
many fields##5##2##(2008-10#3)(2008-7#1)(2008-9#1)
many forms##6##2##(1990-9#1)(1996-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
many fragments##2##2##(1995-2#1)(2008-10#1)
many genes and##2##3##(2012-3#1)(2013-8#1)
many genes##9##2##(1997-2#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#3)(2013-8#2)
many genetic##2##2##(2008-10#1)(2011-2#1)
many have##4##2##(1993-3#1)(2008-10#2)(2010-9#1)
many health care organizations##3##4##(1994-12#1)(1996-1#1)(2008-11#1)
many health care##7##3##(1994-12#1)(1995-12#1)(1996-1#2)(2008-11#2)(2010-12#1)
many health##8##2##(1994-12#1)(1995-12#1)(1996-1#2)(2008-11#3)(2010-12#1)
many horticultural##2##2##(2008-10#2)
many hospital##2##2##(1994-2#1)(2008-11#1)
many hospitals##2##2##(1991-9#1)(2008-11#1)
many human diseases##3##3##(2008-4#1)(2009-8#1)(2011-2#1)
many human##6##2##(2008-4#1)(2009-8#1)(2011-2#3)(2012-2#1)
many important physiological##2##3##(2008-8#2)
many important##8##2##(1995-2#1)(2008-10#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
many improvements have been##2##4##(1997-8#1)(2010-5#1)
many in##2##2##(2008-11#1)(2008-6#1)
many infectious##2##2##(2008-10#1)(2008-8#1)
many instances##7##2##(1992-5#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
many instruments had not been validated##2##6##(2013-1#2)
many investigators##2##2##(2008-11#1)(2008-4#1)
many issues##2##2##(1991-2#1)(2010-8#1)
many laboratories##2##2##(1990-5#1)(2012-2#1)
many laboratory##2##2##(1996-2#1)(2013-1#1)
many large##4##2##(1997-2#1)(2008-11#1)(2008-5#1)(2010-12#1)
many mammalian##2##2##(1992-12#1)(1994-8#1)
many managers##2##2##(1993-1#1)(1997-1#1)
many marine species##2##3##(2013-1#2)
many marine##3##2##(2008-8#1)(2013-1#2)
many medical schools##2##3##(2011-2#1)(2013-1#1)
many medical##6##2##(1996-3#1)(1996-9#1)(1997-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
many miRNAs##2##2##(2010-7#2)
many models##2##2##(2008-1#1)(2008-8#1)
many months##5##2##(1996-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
many more##14##2##(1990-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2012-2#1)
many neurons##2##2##(1996-12#1)(1997-2#1)
many new##4##2##(2008-10#1)(2009-6#1)(2011-3#1)(2012-2#1)
many nursing faculty##2##3##(2008-11#2)
many of its##4##3##(2008-5#1)(2008-6#1)(2009-8#2)
many of the current##2##4##(2008-10#1)(2008-6#1)
many of the issues involved##2##5##(1993-2#1)(2008-9#1)
many of the issues##4##4##(1993-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
many of the same##2##4##(2008-10#1)(2012-3#1)
many of the techniques##2##4##(2008-2#1)(2008-4#1)
many of the##60##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
many of their##2##3##(2008-12#1)(2009-3#1)
many of them##5##3##(1990-6#1)(1994-3#1)(2008-10#1)(2009-10#1)(2013-1#1)
many of these clinical##2##4##(2013-7#2)
many of these##23##3##(1994-12#1)(1994-2#1)(1994-6#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-9#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#1)(2013-7#2)
many of those##5##3##(1991-3#1)(1994-12#1)(2008-5#1)(2010-8#1)(2012-2#1)
many of us##2##3##(1994-2#2)
many of which are##3##4##(1996-2#1)(2008-10#1)(2008-4#1)
many of which can be##2##5##(2009-7#1)(2013-1#1)
many of which##11##3##(1995-12#1)(1996-2#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2013-1#1)
many of##116##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-2#3)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#19)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#10)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
many opportunities to##2##3##(1996-2#1)(2008-11#1)
many organic vapors investigated##2##4##(2008-10#2)
many organisms##5##2##(1997-7#1)(2008-10#1)(2008-8#2)(2008-9#1)
many organizations##2##2##(1994-2#1)(1996-1#1)
many other proteins##2##3##(2008-11#1)(2010-4#1)
many other##35##2##(1991-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#12)(2008-11#4)(2008-9#3)(2010-1#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)
many others##5##2##(1991-3#1)(1991-6#1)(2008-10#1)(2009-4#1)(2010-8#1)
many parts of the world##3##5##(2008-10#1)(2008-12#1)(2012-2#1)
many parts of the##4##4##(1990-6#1)(2008-10#1)(2008-12#1)(2012-2#1)
many parts of##5##3##(1990-6#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-8#1)
many patients and##2##3##(1994-3#1)(2008-11#1)
many patients with##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
many patients##20##2##(1992-2#1)(1994-12#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-10#1)(2010-12#2)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#3)
many people##4##2##(1995-1#1)(1997-4#1)(2008-12#1)(2008-7#1)
many persons##2##2##(1994-9#1)(2008-11#1)
many pharmaceutical##2##2##(2008-10#1)(2012-2#1)
many phenotypic##2##2##(2008-11#1)(2009-5#1)
many physiological processes##3##3##(2008-9#2)(2010-10#1)
many physiological##5##2##(2008-10#1)(2008-9#2)(2010-10#1)(2013-8#1)
many plant pathogens##2##3##(2008-10#2)
many plant##5##2##(2008-10#4)(2009-8#1)
many potential##6##2##(1995-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
many principles##2##2##(2008-12#2)
many problems##3##2##(2008-10#2)(2008-11#1)
many publications##3##2##(1992-3#1)(1997-8#1)(2008-11#1)
many quality##2##2##(1993-12#1)(2012-2#1)
many questions##4##2##(1990-2#1)(1990-9#1)(1997-5#1)(2009-4#1)
many real##3##2##(2008-10#2)(2008-7#1)
many recent##2##2##(1990-8#1)(2008-11#1)
many regions of the world##2##5##(2008-10#1)(2008-5#1)
many regions of the##3##4##(1995-2#1)(2008-10#1)(2008-5#1)
many regions##6##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-3#1)
many reported##3##2##(1997-3#1)(2008-10#1)(2008-9#1)
many reports##3##2##(1991-5#1)(2008-10#1)(2013-1#1)
many researchers##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
many researches##2##2##(2010-10#1)(2013-1#1)
many roles##3##2##(2008-11#1)(2009-8#1)(2010-10#1)
many samples to##2##3##(2008-10#1)(2008-4#1)
many samples##3##2##(2008-10#2)(2008-4#1)
many similarities##4##2##(1993-3#1)(2008-9#1)(2013-8#2)
many species are##2##3##(2008-8#1)(2013-1#1)
many species of##4##3##(1990-2#1)(1995-12#1)(2008-10#1)(2013-8#1)
many species##10##2##(1990-2#1)(1995-12#1)(2008-10#2)(2008-8#2)(2008-9#1)(2013-1#2)(2013-8#1)
many still##2##2##(1991-2#1)(2011-2#1)
many students##3##2##(2008-11#2)(2008-12#1)
many studies have##4##3##(1992-9#1)(2008-9#1)(2009-11#1)(2011-2#1)
many studies##10##2##(1992-3#1)(1992-9#1)(2008-8#1)(2008-9#2)(2009-11#1)(2011-2#1)(2012-2#2)(2013-8#1)
many taxa##2##2##(2008-5#1)(2012-2#1)
many theoretical##2##2##(2008-8#2)
many times##8##2##(1990-12#1)(1991-3#1)(2008-10#3)(2008-12#1)(2008-9#1)(2013-8#1)
many tissues##5##2##(1992-3#1)(1994-11#1)(1995-2#1)(2008-11#1)(2009-7#1)
many transcription##2##2##(2009-10#1)(2009-8#1)
many types of##8##3##(1992-2#1)(1994-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-1#1)(2010-1#1)
many ways##7##2##(1995-1#1)(1995-3#1)(1996-3#1)(1997-6#1)(2010-4#1)(2010-5#1)(2013-1#1)
many were##3##2##(1991-2#1)(2008-11#1)(2010-1#1)
many will##2##2##(2008-1#1)(2013-8#1)
many years of##2##3##(1994-5#1)(2008-9#1)
many years to##2##3##(1997-1#1)(2008-10#1)
many years##29##2##(1990-9#1)(1991-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1997-1#2)(1997-4#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-7#1)(2012-12#2)(2012-3#2)
many##1262##1##(1990-11#3)(1990-12#4)(1990-2#3)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#5)(1991-12#8)(1991-2#5)(1991-3#5)(1991-5#3)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#6)(1992-11#2)(1992-12#7)(1992-2#9)(1992-3#10)(1992-5#2)(1992-9#2)(1993-1#8)(1993-12#5)(1993-2#5)(1993-3#8)(1993-6#5)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#15)(1994-2#11)(1994-3#10)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#7)(1995-11#2)(1995-12#8)(1995-2#13)(1995-3#5)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#10)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#9)(1996-5#1)(1996-6#3)(1996-8#3)(1996-9#1)(1997-1#7)(1997-2#7)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#6)(2006-6#1)(2007-12#13)(2007-8#2)(2008-1#7)(2008-10#243)(2008-11#100)(2008-12#26)(2008-2#3)(2008-3#13)(2008-4#21)(2008-5#34)(2008-6#10)(2008-7#32)(2008-8#51)(2008-9#66)(2009-1#3)(2009-10#13)(2009-11#6)(2009-12#4)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#14)(2009-9#1)(2010-1#9)(2010-10#8)(2010-11#8)(2010-12#16)(2010-4#5)(2010-5#8)(2010-6#3)(2010-7#13)(2010-8#8)(2010-9#1)(2011-1#11)(2011-10#1)(2011-2#51)(2011-3#7)(2011-7#2)(2012-12#9)(2012-2#30)(2012-3#23)(2012-4#1)(2013-1#40)(2013-7#3)(2013-8#25)
map and the##2##3##(1997-6#1)(2008-11#1)
map and##8##2##(1992-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)
map based on##2##3##(2008-10#2)
map construction##2##2##(1997-8#1)(2013-8#1)
map contained##2##2##(2013-8#2)
map containing##2##2##(2008-10#2)
map for##2##2##(1992-2#1)(2008-11#1)
map has##3##2##(1994-9#1)(1996-3#1)(2008-10#1)
map in##2##2##(2006-6#1)(2008-11#1)
map is##4##2##(1994-9#1)(1996-6#1)(2008-8#1)(2013-8#1)
map location of##2##3##(2008-10#2)
map location##3##2##(2008-10#2)(2008-4#1)
map of chromosome 7A##2##4##(2008-10#2)
map of chromosome##4##3##(1997-6#1)(1997-8#1)(2008-10#2)
map of the##22##3##(1992-3#1)(1994-2#1)(1995-6#1)(1996-8#4)(1997-8#3)(2006-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2010-7#1)(2011-2#2)
map of this##2##3##(1993-6#1)(1995-2#1)
map of##45##2##(1992-10#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-2#2)(1995-2#2)(1995-6#2)(1996-12#2)(1996-3#1)(1996-8#4)(1997-6#1)(1997-8#4)(2006-6#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#2)(2010-7#1)(2010-8#1)(2011-2#3)(2013-8#1)
map on##2##2##(1993-11#1)(2008-7#1)
map position##5##2##(1995-8#1)(1995-9#1)(1996-6#1)(2008-10#1)(2008-11#1)
map positions 64% to 92% of the genome##2##8##(1995-8#2)
map positions##3##2##(1995-8#2)(2008-9#1)
map previously##2##2##(1996-2#1)(2008-10#1)
map the gene##3##3##(1995-2#1)(2008-10#2)
map the##14##2##(1995-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-4#1)
map to the same##2##4##(2008-3#1)(2012-3#1)
map to the##5##3##(1996-8#1)(1997-9#2)(2008-3#1)(2012-3#1)
map to##6##2##(1996-8#1)(1997-9#2)(2008-10#1)(2008-3#1)(2012-3#1)
map was constructed##2##3##(1996-12#1)(2008-10#1)
map was##3##2##(1996-12#1)(2008-10#1)(2012-3#1)
map were##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
map will##2##2##(1997-2#1)(1997-8#1)
map##208##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-9#6)(1995-2#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-12#9)(1996-2#2)(1996-3#3)(1996-6#4)(1996-8#6)(1997-2#2)(1997-6#2)(1997-8#12)(1997-9#3)(2006-6#2)(2007-12#1)(2008-10#56)(2008-11#13)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#6)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-3#6)(2013-1#1)(2013-8#10)
map-based cloning of this##2##4##(2008-10#1)(2012-3#1)
map-based cloning of##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
map-based cloning##6##2##(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#2)
map-based##8##1##(1996-12#1)(1996-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#2)
mapped DNA markers##2##3##(1996-12#1)(2012-3#1)
mapped DNA##3##2##(1996-12#2)(2012-3#1)
mapped a##2##2##(1994-12#1)(1996-6#1)
mapped and characterized quantitative trait loci (QTL)##2##7##(2008-10#2)
mapped and##4##2##(1995-8#1)(2008-10#2)(2008-11#1)
mapped at the##2##3##(2008-10#1)(2008-8#1)
mapped at##3##2##(2008-10#2)(2008-8#1)
mapped by##2##2##(2008-10#1)(2008-9#1)
mapped in the##4##3##(1995-6#1)(2008-8#2)(2008-9#1)
mapped in this##2##3##(2008-8#1)(2012-3#1)
mapped in##9##2##(1995-6#1)(2008-10#2)(2008-8#3)(2008-9#1)(2012-3#2)
mapped on chromosome##6##3##(1997-6#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)
mapped on the##6##3##(1996-8#1)(1997-2#1)(1997-8#1)(2008-8#2)(2013-8#1)
mapped on##14##2##(1995-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-8#2)(2008-10#1)(2008-8#3)(2008-9#1)(2009-10#1)(2013-8#1)
mapped onto##2##2##(1996-8#1)(2008-8#1)
mapped the distribution of##2##4##(2008-7#2)
mapped the##11##2##(1993-12#1)(1994-12#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)(2012-2#1)(2012-3#1)
mapped through##2##2##(2008-10#1)(2010-8#1)
mapped to a##4##3##(1993-12#1)(1994-11#1)(2008-10#2)
mapped to chromosome##5##3##(1996-6#1)(1997-7#1)(2008-8#2)(2012-3#1)
mapped to human chromosome##3##4##(1994-12#1)(1997-8#1)(2008-9#1)
mapped to the same linkage group##2##6##(2008-10#2)
mapped to the same##4##4##(2008-10#4)
mapped to the short arm of chromosome##3##7##(2008-10#3)
mapped to the##15##3##(1990-8#1)(1991-10#1)(1994-11#1)(1997-2#2)(2008-10#9)(2012-3#1)
mapped to##41##2##(1990-8#1)(1991-10#1)(1993-12#1)(1994-11#2)(1994-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#15)(2008-8#3)(2008-9#2)(2011-2#1)(2012-3#6)(2013-1#1)
mapped within a##2##3##(2008-10#1)(2012-3#1)
mapped within##4##2##(1990-5#1)(1993-12#1)(2008-10#1)(2012-3#1)
mapped##128##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1993-12#3)(1993-9#1)(1994-11#2)(1994-12#3)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#2)(1996-3#1)(1996-6#2)(1996-8#4)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#5)(2007-12#1)(2008-10#36)(2008-11#3)(2008-7#2)(2008-8#15)(2008-9#5)(2009-10#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#15)(2013-1#1)(2013-8#1)
mapping algorithm##2##2##(2008-3#1)(2013-1#1)
mapping analysis##2##2##(1997-9#1)(2008-10#1)
mapping and expression##2##3##(2008-8#1)(2012-3#1)
mapping and##19##2##(1991-5#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)
mapping by##3##2##(2008-10#2)(2008-2#1)
mapping for##3##2##(2008-10#2)(2010-1#1)
mapping in##5##2##(2008-3#1)(2010-7#1)(2010-8#1)(2012-3#2)
mapping is##2##2##(2008-12#1)(2010-7#1)
mapping method##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
mapping of a##7##3##(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-9#2)
mapping of phosphate##3##3##(2008-10#3)
mapping of rice chromosomes 8 and 9##2##7##(1996-12#2)
mapping of rice chromosomes##3##4##(1996-12#2)(1997-2#1)
mapping of the##18##3##(1990-8#1)(1992-9#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-9#1)(2008-10#7)(2008-11#1)(2009-10#1)(2010-7#2)(2013-1#1)
mapping of##63##2##(1990-8#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#3)(2008-10#21)(2008-11#3)(2008-2#1)(2008-8#4)(2008-9#3)(2009-10#2)(2009-5#3)(2010-7#2)(2011-2#1)(2012-3#1)(2013-1#5)
mapping population and##2##3##(2008-10#1)(2012-3#1)
mapping population of##5##3##(2008-10#5)
mapping population##16##2##(2008-10#14)(2008-8#1)(2012-3#1)
mapping populations##2##2##(2008-10#1)(2010-10#1)
mapping procedure##2##2##(2008-10#1)(2012-2#1)
mapping region##2##2##(2008-9#2)
mapping results##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
mapping studies##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
mapping to be##2##3##(1993-9#1)(1994-11#1)
mapping to##9##2##(1991-1#1)(1993-9#1)(1994-11#1)(1994-9#1)(1997-9#1)(2008-10#2)(2008-11#1)(2012-3#1)
mapping using##4##2##(2008-10#1)(2008-11#2)(2010-8#1)
mapping##235##1##(1990-8#1)(1991-1#1)(1991-5#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-6#4)(1997-8#2)(1997-9#5)(2008-10#73)(2008-11#10)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#7)(2008-6#1)(2008-7#2)(2008-8#16)(2008-9#10)(2009-10#7)(2009-5#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#6)(2010-8#3)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#13)(2013-1#14)(2013-8#3)
mappings to##2##2##(2010-10#1)(2013-1#1)
mappings##5##1##(1991-9#1)(2010-10#2)(2013-1#2)
maprotiline and imipramine##2##3##(2008-10#2)
maprotiline and##3##2##(2008-10#3)
maps and##3##2##(1994-9#1)(2008-10#1)(2011-2#1)
maps are##3##2##(1995-6#1)(2008-12#2)
maps for##6##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#2)
maps in##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
maps of the##4##3##(2008-10#1)(2008-3#2)(2011-3#1)
maps of##17##2##(1990-11#1)(1995-6#2)(1997-2#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#2)(2011-3#1)
maps to a##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
maps to##11##2##(1990-8#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#4)(2008-9#1)(2011-2#2)
maps were developed and##2##4##(2008-12#1)(2010-8#1)
maps were##5##2##(2008-12#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
maps with##2##2##(2008-10#1)(2011-3#1)
maps within the##2##3##(1997-3#1)(1997-9#1)
maps within##3##2##(1997-3#1)(1997-9#1)(2008-10#1)
maps##84##1##(1990-11#1)(1990-8#2)(1991-6#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-9#3)(1995-2#1)(1995-6#5)(1996-12#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-9#1)(2008-10#19)(2008-11#5)(2008-12#5)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2010-10#2)(2010-8#4)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
marae##2##1##(2008-1#2)
marajoara sensu stricto##2##3##(2012-12#2)
marajoara##3##1##(2012-12#3)
marble industry effluent##3##3##(2008-12#3)
marble##10##1##(2008-10#6)(2008-11#1)(2008-12#3)
marbles##3##1##(2008-10#3)
marcescens strains from##2##3##(2008-10#2)
marcescens strains##3##2##(2008-10#3)
marcescens##23##1##(1996-12#3)(2008-10#15)(2009-6#2)(2010-6#2)(2011-2#1)
march##4##1##(1991-3#1)(2007-8#1)(2008-11#1)(2008-8#1)
mares##2##1##(2008-10#1)(2013-1#1)
margin and##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
margin of 2 cm##2##4##(1990-9#1)(1991-12#1)
margin of a##2##3##(2008-10#1)(2008-3#1)
margin of the##2##3##(1993-12#1)(2007-12#1)
margin of##10##2##(1990-9#1)(1991-12#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
margin##31##1##(1990-9#1)(1991-12#2)(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
marginal bone##6##2##(2013-1#6)
marginal chlorosis##2##2##(2008-10#2)
marginal dose##2##2##(2008-7#2)
marginal probabilities##2##2##(2010-1#1)(2011-2#1)
marginal sinus##11##2##(1996-9#11)
marginal survival distribution##3##3##(1995-9#3)
marginal survival##4##2##(1995-9#4)
marginal zone B cell lymphoma of mucosa-associated lymphoid tissue##2##9##(2009-8#2)
marginal zone B cell lymphoma##3##5##(2009-8#3)
marginal zone lymphoma of##2##4##(2009-8#2)
marginal zone lymphoma##3##3##(2009-8#3)
marginal zone##9##2##(1997-1#1)(2009-5#1)(2009-8#7)
marginal##74##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-9#4)(1996-9#12)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#7)(2010-1#1)(2010-10#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#9)
marginalized##4##1##(1993-3#1)(2008-12#1)(2010-11#1)(2010-9#1)
marginally affected##2##2##(1995-6#1)(2008-10#1)
marginally more##3##2##(2008-10#3)
marginally significant##2##2##(1991-8#1)(2012-3#1)
marginally toxic##2##2##(1990-2#1)(1990-5#1)
marginally##21##1##(1990-2#1)(1990-5#1)(1991-8#1)(1994-3#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#2)
marginata and##2##2##(2010-3#2)
marginata##3##1##(2010-3#3)
margins and##3##2##(1997-7#1)(2008-10#1)(2009-10#1)
margins are##2##2##(1997-7#1)(2011-2#1)
margins of resection##2##3##(2008-9#2)
margins of the##2##3##(1996-9#1)(2008-9#1)
margins of##6##2##(1995-2#1)(1996-9#1)(2008-3#1)(2008-9#3)
margins to##2##2##(1992-12#1)(2008-9#1)
margins were##3##2##(1991-6#1)(1992-2#1)(1997-7#1)
margins##35##1##(1991-6#1)(1992-12#2)(1992-2#1)(1992-9#1)(1994-6#1)(1995-2#1)(1996-2#2)(1996-9#1)(1997-7#8)(1997-8#1)(2008-10#4)(2008-3#2)(2008-9#4)(2009-10#1)(2011-2#4)(2013-1#1)
marigold##3##1##(2008-10#3)
marijuana and##2##2##(1991-1#1)(2008-11#1)
marijuana smoking##2##2##(1991-1#1)(2013-8#1)
marijuana use##3##2##(2008-9#1)(2013-8#2)
marijuana##17##1##(1991-1#3)(1991-12#1)(1991-4#2)(1996-1#1)(2008-11#1)(2008-9#1)(2012-12#1)(2013-8#7)
marina##2##1##(2008-10#2)
marinades and marinated##2##3##(2010-4#2)
marinades##4##1##(2010-4#4)
marinas in Hong Kong##2##4##(2008-10#2)
marinated pork##4##2##(2010-4#4)
marinated products##2##2##(2010-4#2)
marinated##6##1##(2010-4#6)
marine algae##7##2##(2008-10#2)(2008-11#5)
marine brown alga Sargassum##3##4##(2008-11#1)(2008-12#2)
marine brown##4##2##(2008-11#2)(2008-12#2)
marine bulk liquid transport##2##4##(2008-11#2)
marine ecosystems##2##2##(2012-2#2)
marine environment##12##2##(2008-10#2)(2008-11#9)(2011-2#1)
marine fish##2##2##(2010-5#2)
marine habitat in##2##3##(2008-9#2)
marine habitat##4##2##(2008-9#3)(2009-2#1)
marine invertebrate##4##2##(2008-11#1)(2008-8#2)(2010-7#1)
marine n-3 PUFA and rectal cancer risk##2##7##(2010-6#2)
marine n-3##3##2##(2010-6#3)
marine natural products##2##3##(2009-2#1)(2010-7#1)
marine natural##3##2##(2009-2#1)(2010-7#2)
marine organisms##2##2##(2008-5#2)
marine sediment##8##2##(2008-10#8)
marine sediments##4##2##(2008-10#4)
marine species##4##2##(2013-1#4)
marine to freshwater##3##3##(2010-8#3)
marine toxins##2##2##(2008-11#1)(2011-2#1)
marine water##6##2##(2008-10#5)(2008-9#1)
marine waters##6##2##(2008-10#6)
marine##135##1##(1991-12#1)(1991-6#1)(2008-10#46)(2008-11#24)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#8)(2009-2#2)(2009-8#3)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#4)(2011-2#6)(2012-2#6)(2013-1#10)
marinum infection##3##2##(2008-9#3)
marital quality##2##2##(2011-2#2)
marital status and##2##3##(1990-6#1)(1991-6#1)
marital status##7##2##(1990-12#1)(1990-6#1)(1991-6#3)(1992-2#1)(2010-6#1)
marital##13##1##(1990-12#1)(1990-6#1)(1991-6#3)(1992-2#1)(2010-6#1)(2011-2#5)(2012-2#1)
maritima##4##1##(2008-7#2)(2011-1#2)
maritime##2##1##(2008-10#1)(2008-11#1)
maritimus)##2##1##(1996-12#2)
mark Trace Elements in##4##4##(2008-10#4)
mark Trace Elements##5##3##(2008-10#5)
mark cells##6##2##(2008-11#3)(2008-7#3)
mark for##2##2##(2008-10#1)(2011-2#1)
mark success##2##2##(2010-8#2)
mark the development of##2##4##(1996-1#1)(2012-5#1)
mark the##4##2##(1996-1#1)(2008-4#1)(2010-2#1)(2012-5#1)
mark##79##1##(1991-6#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-10#32)(2008-11#19)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#7)(2009-8#1)(2010-2#1)(2010-8#4)(2011-2#2)(2012-2#4)(2012-5#1)
mark)##4##1##(2008-10#2)(2008-11#1)(2008-7#1)
mark-recapture study##2##2##(2008-8#2)
marked and##2##2##(1994-12#1)(1994-5#1)
marked by a##3##3##(1996-12#1)(2008-8#1)(2013-8#1)
marked by##14##2##(1995-1#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2013-8#1)
marked change##2##2##(2008-11#1)(2011-2#1)
marked changes in##2##3##(1996-2#1)(2012-2#1)
marked changes##3##2##(1996-2#1)(2008-7#1)(2012-2#1)
marked decrease##8##2##(1993-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-7#1)(2012-3#1)(2013-8#1)
marked difference in the##4##4##(1990-8#1)(2008-10#2)(2008-11#1)
marked difference##5##2##(1990-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
marked differences##4##2##(1991-9#1)(1994-6#1)(2008-10#1)(2008-2#1)
marked effect on##2##3##(2008-10#1)(2008-5#1)
marked eosinophilia##2##2##(1991-12#2)
marked host cell##2##3##(2008-10#2)
marked improvement in##2##3##(2008-10#1)(2011-1#1)
marked improvement##5##2##(1990-12#1)(1996-11#1)(2008-10#1)(2011-1#1)(2013-8#1)
marked in the##2##3##(2008-11#1)(2009-10#1)
marked in##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
marked increase in the##2##4##(1990-5#1)(1991-11#1)
marked increase in##10##3##(1990-11#1)(1990-5#1)(1991-11#1)(1992-8#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(2010-12#1)(2013-1#1)
marked increase##11##2##(1990-11#1)(1990-5#1)(1991-11#1)(1992-8#1)(1994-8#1)(1996-12#2)(1997-3#1)(1997-7#1)(2010-12#1)(2013-1#1)
marked increases in##3##3##(1992-8#1)(1996-12#1)(2008-6#1)
marked induction##2##2##(1996-12#1)(2008-10#1)
marked inhibitory##2##2##(1990-5#1)(1993-11#1)
marked loss of##2##3##(1997-8#1)(2008-10#1)
marked redness##2##2##(2008-5#1)(2011-2#1)
marked reduction##9##2##(1992-3#1)(1993-8#1)(1996-12#1)(2007-12#1)(2008-10#2)(2010-10#1)(2012-2#1)(2013-1#1)
marked reductions in##3##3##(1995-2#1)(2008-10#1)(2009-3#1)
marked release of##2##3##(1992-6#1)(1995-8#1)
marked shift##2##2##(2007-12#1)(2008-10#1)
marked strains##3##2##(2008-10#3)
marked suppression##3##2##(2008-5#1)(2010-4#2)
marked with##4##2##(2008-10#3)(2010-8#1)
marked##196##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-6#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1995-1#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#7)(1996-2#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#3)(2008-10#40)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#4)(2010-11#1)(2010-12#2)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#4)
markedly accelerate##2##2##(2008-11#1)(2011-2#1)
markedly affected by##2##3##(1992-3#1)(2008-10#1)
markedly altered##3##2##(2008-10#3)
markedly and##2##2##(1992-3#1)(1994-2#1)
markedly decreased as##2##3##(2008-10#1)(2008-11#1)
markedly decreased in##2##3##(2008-10#1)(2008-12#1)
markedly decreased##7##2##(1991-2#1)(1991-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)
markedly different##2##2##(1996-12#1)(2008-10#1)
markedly elevated##2##2##(1992-12#1)(1993-8#1)
markedly enhanced##6##2##(1990-11#1)(1992-8#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#1)
markedly from##2##2##(2008-2#1)(2012-3#1)
markedly higher##3##2##(1993-2#1)(1995-12#1)(2010-7#1)
markedly improved##7##2##(1993-11#1)(1994-3#1)(2008-10#2)(2008-7#1)(2010-6#1)(2011-2#1)
markedly in their##3##3##(1993-6#1)(2008-11#1)(2012-3#1)
markedly in##7##2##(1990-12#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2012-3#1)
markedly increased the##2##3##(1992-8#1)(2008-10#1)
markedly increased##6##2##(1992-8#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-6#1)(2008-10#1)
markedly inhibited by##3##3##(1990-2#1)(1993-8#1)(1994-2#1)
markedly inhibited the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
markedly inhibited##11##2##(1990-11#1)(1990-2#1)(1992-1#1)(1993-8#1)(1994-11#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
markedly less##3##2##(1990-5#1)(1995-11#1)(2008-10#1)
markedly lower than those##2##4##(2008-10#1)(2008-11#1)
markedly lower than##4##3##(1993-3#1)(2008-10#1)(2008-11#2)
markedly more##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
markedly reduce the##2##3##(2008-12#1)(2008-8#1)
markedly reduce##3##2##(2008-12#1)(2008-8#2)
markedly reduced by##2##3##(1996-2#1)(1997-1#1)
markedly reduced the##2##3##(2008-10#1)(2008-7#1)
markedly reduced##12##2##(1991-5#1)(1992-1#1)(1993-8#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-7#1)(2013-1#1)
markedly suppressed##3##2##(1994-11#1)(1994-6#1)(2011-2#1)
markedly##146##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#3)(1992-8#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#5)(1994-11#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#7)(1995-11#2)(1995-12#3)(1995-2#2)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2008-10#27)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#6)(2008-9#3)(2010-1#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
marker D1S249 locus##2##3##(2008-9#2)
marker D21S246##2##2##(1995-8#2)
marker XGli1##2##2##(2008-10#2)
marker accounted for##2##3##(2008-10#2)
marker and the##3##3##(2008-10#1)(2008-11#2)
marker and##9##2##(1996-3#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-10#1)
marker data##6##2##(2008-1#2)(2008-10#4)
marker enzyme##2##2##(1990-5#1)(2008-7#1)
marker expression##4##2##(2008-10#2)(2010-8#1)(2012-5#1)
marker for a##2##3##(2008-4#1)(2011-2#1)
marker for the resistant##2##4##(2008-10#2)
marker for the##9##3##(1993-8#1)(1995-12#1)(1995-6#1)(1997-9#1)(2008-10#4)(2008-7#1)
marker for this##2##3##(1994-2#1)(2013-8#1)
marker for##52##2##(1990-5#1)(1990-8#2)(1990-9#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#4)(2013-8#2)
marker gene in##2##3##(2008-10#1)(2008-11#1)
marker gene##9##2##(1994-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)
marker genes##4##2##(2008-10#1)(2008-8#2)(2011-10#1)
marker in the##2##3##(1996-11#1)(2008-1#1)
marker in##8##2##(1990-8#1)(1995-11#1)(1996-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-2#1)
marker ion##2##2##(2008-10#2)
marker is##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
marker loci##4##2##(2008-10#3)(2008-8#1)
marker of cellular##2##3##(2008-10#1)(2011-2#1)
marker of early##2##3##(2011-2#2)
marker of inflammation##2##3##(2009-10#1)(2011-2#1)
marker of the##7##3##(1992-6#1)(1997-6#1)(2008-10#3)(2009-12#1)(2011-2#1)
marker of##46##2##(1990-2#1)(1990-7#1)(1991-3#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-3#1)(1997-6#1)(2008-10#8)(2008-11#4)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#8)(2011-7#1)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
marker stocks##2##2##(2008-10#2)
marker system was##3##3##(2008-10#3)
marker system##4##2##(2008-10#4)
marker that##3##2##(2008-10#2)(2009-9#1)
marker to select##2##3##(2008-10#1)(2008-11#1)
marker to##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
marker was##7##2##(2008-10#6)(2008-11#1)
marker##307##1##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-1#2)(1993-2#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#3)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-12#1)(2008-1#3)(2008-10#119)(2008-11#25)(2008-12#5)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-10#1)(2011-2#17)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#3)(2012-4#1)(2012-5#2)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#6)
marker-assisted breeding##3##2##(2008-10#3)
marker-assisted selection (MAS)##3##3##(2008-10#2)(2012-3#1)
marker-assisted selection in##3##3##(2008-10#3)
marker-assisted selection of##3##3##(2008-10#3)
marker-assisted selection##17##2##(2008-10#15)(2012-3#2)
marker-assisted##20##1##(2008-10#18)(2012-3#2)
marker-trait##2##1##(2008-10#2)
markers allowed##2##2##(1995-6#1)(2008-10#1)
markers also##2##2##(2008-10#2)
markers and the##6##3##(1994-9#1)(1997-9#1)(2008-10#3)(2009-3#1)
markers and vertebrae##2##3##(2013-1#2)
markers and##40##2##(1990-8#1)(1994-9#1)(1997-9#1)(2008-10#22)(2008-3#1)(2008-8#1)(2008-9#4)(2009-3#1)(2010-10#1)(2010-5#1)(2012-3#1)(2013-1#4)(2013-8#1)
markers are##5##2##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
markers associated with##6##3##(2008-10#4)(2008-7#1)(2011-2#1)
markers at##3##2##(1994-9#1)(2008-10#1)(2011-2#1)
markers can be used to##2##5##(2012-2#1)(2013-1#1)
markers can be##6##3##(1994-12#2)(2008-9#1)(2012-2#1)(2013-1#2)
markers can##9##2##(1994-12#2)(2008-12#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
markers closely linked to##2##4##(2008-10#2)
markers developed##2##2##(2008-10#2)
markers during##2##2##(2008-10#1)(2008-11#1)
markers flanking the##2##3##(2008-10#1)(2012-3#1)
markers for marker-assisted##2##3##(2008-10#2)
markers for the##8##3##(2008-10#5)(2008-11#2)(2013-1#1)
markers for this pathogen##2##4##(2008-10#2)
markers for##50##2##(1991-8#1)(1993-11#1)(1995-6#1)(1997-8#2)(2008-10#21)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#4)
markers from##3##2##(1996-12#2)(2008-10#1)
markers generally were##2##3##(2008-10#2)
markers have##3##2##(2010-10#1)(2012-2#1)(2013-1#1)
markers identified in##3##3##(2008-10#3)
markers identified##6##2##(2008-10#6)
markers in a##4##3##(1991-11#1)(1995-6#1)(2009-8#1)(2012-5#1)
markers in order to##2##4##(2008-10#2)
markers in the##7##3##(1996-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-8#1)(2010-5#1)
markers in##38##2##(1991-11#2)(1995-11#1)(1995-6#1)(1995-9#1)(1996-3#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
markers including##2##2##(2011-1#1)(2013-1#1)
markers linked to a##2##4##(2008-10#2)
markers linked to the##5##4##(1995-6#1)(2008-10#4)
markers linked to##21##3##(1995-6#1)(2008-10#19)(2008-8#1)
markers localized in##2##3##(1996-12#1)(2008-10#1)
markers localized##3##2##(1996-12#1)(2008-10#2)
markers located at 21 linkage groups##2##6##(2013-8#2)
markers located at##3##3##(1995-6#1)(2013-8#2)
markers may be##2##3##(2008-10#1)(2008-12#1)
markers may##5##2##(1997-7#1)(2008-10#2)(2008-12#1)(2013-8#1)
markers of inflammation##3##3##(1990-2#1)(2008-3#1)(2013-1#1)
markers of nutrition##2##3##(2011-2#2)
markers of the##3##3##(2008-11#1)(2010-5#1)(2013-8#1)
markers of##47##2##(1990-2#1)(1992-12#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#5)(2008-7#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#6)(2013-8#3)
markers on##4##2##(1996-12#2)(2008-10#1)(2013-8#1)
markers or##4##2##(1996-12#1)(2008-10#1)(2008-9#2)
markers over##2##2##(2008-10#1)(2008-11#1)
markers revealed a##2##3##(2008-10#1)(2012-3#1)
markers revealed##4##2##(2008-10#3)(2012-3#1)
markers segregated in##2##3##(2008-10#2)
markers showed significant##2##3##(2008-10#2)
markers showed##4##2##(2008-10#4)
markers spanning the##2##3##(2008-10#2)
markers such as##4##3##(1990-8#1)(2008-11#1)(2008-5#1)(2010-5#1)
markers that could be used to##2##6##(2008-10#1)(2008-7#1)
markers that were##4##3##(2008-10#4)
markers that##13##2##(1997-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#3)
markers tightly linked to the##2##5##(1995-6#1)(2008-10#1)
markers tightly linked to##4##4##(1995-6#1)(2008-10#3)
markers to identify##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
markers to study the##2##4##(2008-10#2)
markers to the##2##3##(1992-3#1)(2008-10#1)
markers to##19##2##(1992-3#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
markers used in##2##3##(2008-10#1)(2008-8#1)
markers used##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
markers was##9##2##(2008-10#6)(2008-9#1)(2009-2#1)(2013-8#1)
markers were converted into##2##4##(1995-6#1)(2008-10#1)
markers were determined##2##3##(1997-8#1)(2009-8#1)
markers were developed from##2##4##(1997-8#1)(2008-10#1)
markers were developed##5##3##(1997-8#1)(2008-10#3)(2008-8#1)
markers were identified##4##3##(2008-10#3)(2012-5#1)
markers were not##2##3##(2008-10#2)
markers were tested##3##3##(1996-8#1)(2008-10#1)(2008-12#1)
markers were used to identify##2##5##(2008-10#2)
markers were used to##8##4##(2008-10#8)
markers were used##9##3##(2008-10#9)
markers were##50##2##(1990-8#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-8#2)(1997-9#1)(2008-10#31)(2008-12#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-8#1)(2012-5#1)(2013-1#1)(2013-8#2)
markers when##2##2##(1993-2#1)(2013-7#1)
markers will be useful##2##4##(1991-5#1)(2008-10#1)
markers will##3##2##(1991-5#1)(2008-10#2)
markers with##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)
markers##605##1##(1990-2#1)(1990-8#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#8)(1995-9#1)(1996-12#13)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#2)(1997-2#4)(1997-3#1)(1997-7#4)(1997-8#11)(1997-9#2)(2008-1#1)(2008-10#279)(2008-11#22)(2008-12#15)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#10)(2008-9#26)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#3)(2009-8#5)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-5#6)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#21)(2011-3#5)(2012-12#1)(2012-2#6)(2012-3#13)(2012-5#6)(2013-1#31)(2013-7#1)(2013-8#25)
markers)##2##1##(2010-9#1)(2012-3#1)
market and##6##2##(1994-3#1)(1995-1#1)(1997-6#1)(2008-10#1)(2011-2#1)(2012-3#1)
market basket##2##2##(1992-1#2)
market concentration##2##2##(1996-3#2)
market for health services##2##4##(1991-3#1)(1994-1#1)
market for health##4##3##(1991-3#1)(1994-1#1)(1994-2#2)
market for##10##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-3#2)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)
market in##5##2##(1991-1#1)(1996-5#1)(1997-3#1)(2008-3#1)(2012-12#1)
market may##2##2##(2008-11#1)(2010-5#1)
market research##3##2##(1994-12#2)(1996-1#1)
market share##6##2##(1991-12#1)(1991-3#1)(1993-1#2)(1997-2#1)(2008-12#1)
market structure##2##2##(1992-3#1)(2013-1#1)
market to##2##2##(1994-2#1)(2008-6#1)
market value##2##2##(1991-2#1)(2008-10#1)
market##150##1##(1990-5#1)(1990-6#1)(1991-1#3)(1991-12#2)(1991-2#3)(1991-3#8)(1992-1#2)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#3)(1992-8#1)(1993-1#3)(1993-12#2)(1993-2#4)(1993-3#2)(1994-1#5)(1994-12#5)(1994-2#3)(1994-3#6)(1995-1#2)(1995-2#3)(1996-1#2)(1996-3#2)(1996-5#1)(1997-1#4)(1997-2#5)(1997-3#3)(1997-5#2)(1997-6#2)(2008-10#16)(2008-11#17)(2008-12#1)(2008-3#1)(2008-5#6)(2008-6#2)(2009-6#1)(2009-9#2)(2010-5#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
marketability##2##1##(2008-10#2)
marketable pods##2##2##(2008-12#2)
marketable##6##1##(1992-1#1)(2008-10#3)(2008-12#2)
marketed drugs##2##2##(2008-10#1)(2011-3#1)
marketed##15##1##(1991-2#1)(1993-1#2)(1995-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-12#1)(2011-3#1)(2012-2#1)
marketers##8##1##(1995-12#1)(1995-2#2)(1996-3#3)(1997-2#2)
marketing and sales##2##3##(2008-11#2)
marketing and##5##2##(1991-3#1)(1995-12#1)(1996-1#1)(2008-11#2)
marketing applications##3##2##(2010-6#1)(2012-2#2)
marketing implications for the##2##4##(1991-2#1)(1993-12#1)
marketing of a##2##3##(1992-9#1)(1996-5#1)
marketing of##6##2##(1992-9#1)(1993-2#1)(1996-3#1)(1996-5#1)(2008-11#2)
marketing plan##6##2##(1993-3#1)(1994-3#2)(1995-1#2)(2010-7#1)
marketing strategies##4##2##(1992-3#2)(2008-11#1)(2012-3#1)
marketing##58##1##(1991-1#1)(1991-2#2)(1991-3#3)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1994-12#5)(1994-3#3)(1994-8#1)(1995-1#4)(1995-12#1)(1996-1#3)(1996-12#1)(1996-3#2)(1996-5#2)(1997-3#2)(2008-1#1)(2008-10#1)(2008-11#6)(2008-5#1)(2009-7#1)(2010-6#1)(2010-7#1)(2012-2#2)(2012-3#2)
marketplace##15##1##(1992-3#1)(1993-3#1)(1994-1#2)(1994-12#1)(1995-1#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-6#1)(2011-2#2)
markets and##4##2##(1995-2#1)(1997-1#1)(2009-7#2)
markets by##2##2##(1996-1#1)(1996-3#1)
markets with##2##2##(2008-10#1)(2008-11#1)
markets##26##1##(1991-3#1)(1993-12#2)(1995-2#3)(1996-1#1)(1996-3#3)(1997-1#2)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2009-7#2)(2010-7#1)(2011-2#1)(2013-1#1)
marking of##2##2##(1996-6#1)(2010-8#1)
marking##17##1##(1990-2#1)(1994-5#2)(1996-3#1)(1996-6#1)(2008-11#5)(2008-2#1)(2010-8#5)(2013-1#1)
markings##10##1##(1997-3#1)(2008-8#1)(2008-9#7)(2013-1#1)
marks from##2##2##(2008-11#1)(2012-2#1)
marks on##2##2##(2009-12#1)(2012-2#1)
marks##18##1##(1996-3#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#2)(2009-12#4)(2009-8#1)(2012-2#2)(2013-8#2)
marneffei in the##2##3##(2011-2#2)
marneffei##5##1##(2011-2#5)
marriage and divorce##2##3##(2008-12#1)(2011-2#1)
marriage is##2##2##(2011-2#2)
marriage##19##1##(1993-2#1)(1996-3#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-6#1)(2010-4#1)(2011-2#5)
marriages##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
married and##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
married couples##2##2##(1996-9#1)(2011-2#1)
married or##4##2##(1994-6#2)(2008-6#2)
married##24##1##(1990-6#2)(1991-6#2)(1994-3#1)(1994-6#2)(1996-3#1)(1996-5#2)(1996-9#1)(2007-12#1)(2008-6#2)(2009-10#1)(2010-11#2)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
marrow and##7##2##(1991-6#1)(1992-2#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
marrow cells##22##2##(1990-3#2)(1990-6#1)(1992-8#1)(1993-12#1)(1994-5#1)(1997-8#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-11#3)(2010-6#1)(2010-8#1)
marrow examination##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
marrow failure##3##2##(2008-11#1)(2010-8#1)(2011-2#1)
marrow in##2##2##(2008-10#1)(2010-6#1)
marrow mononuclear cell##2##3##(2010-6#2)
marrow mononuclear##7##2##(2008-10#1)(2010-6#6)
marrow necrosis preceding infantile acute lymphoblastic leukaemia##2##7##(2008-12#2)
marrow necrosis##4##2##(2008-12#4)
marrow stem##2##2##(2010-6#1)(2010-8#1)
marrow stromal cell##6##3##(2008-10#1)(2008-11#3)(2008-8#2)
marrow stromal##7##2##(2008-10#1)(2008-11#4)(2008-8#2)
marrow transplantation has been##2##4##(2008-11#1)(2010-11#1)
marrow transplantation##15##2##(1993-2#1)(1994-5#3)(1997-5#1)(1997-7#1)(2008-11#3)(2010-11#3)(2010-6#1)(2013-7#1)(2013-8#1)
marrow##173##1##(1990-3#2)(1990-6#2)(1991-2#1)(1991-6#4)(1992-2#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#4)(1994-5#6)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2008-10#11)(2008-11#35)(2008-12#6)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#10)(2009-1#1)(2009-10#1)(2009-8#1)(2010-1#5)(2010-11#7)(2010-12#1)(2010-6#13)(2010-8#11)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
marrow-derived##7##1##(1992-10#1)(1997-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-6#1)
marsupial and placental mammals##2##4##(2008-9#2)
martensite phase##2##2##(2009-7#2)
martis##3##1##(2011-2#3)
marylandi##5##1##(2008-10#5)
mascaras were##3##2##(2008-5#3)
mascaras##7##1##(2008-5#7)
masculine and##2##2##(2012-3#2)
masculine##4##1##(2008-11#1)(2009-5#1)(2012-3#2)
masculinities##2##1##(2008-11#2)
masculinity##5##1##(2008-11#5)
mashed tomato##3##2##(2008-10#3)
mask and##2##2##(2008-2#1)(2013-8#1)
mask is##3##2##(2007-11#1)(2008-3#2)
mask that##2##2##(2013-1#2)
mask##29##1##(1995-6#1)(1997-1#1)(1997-3#3)(2007-11#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-8#1)(2010-3#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
masked by##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
masked##16##1##(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
masking action##2##2##(2008-10#2)
masking agent##12##2##(2008-10#12)
masking agents##10##2##(2008-10#10)
masking effect was##2##3##(2008-5#2)
masking effect##4##2##(2008-10#1)(2008-5#3)
masking effects##2##2##(2008-10#1)(2008-5#1)
masking of##2##2##(2008-10#2)
masking reagent##2##2##(2008-10#2)
masking some##2##2##(2008-10#2)
masking##52##1##(1994-2#1)(2008-10#38)(2008-11#1)(2008-5#6)(2009-10#2)(2011-2#1)(2012-2#3)
masks and##2##2##(1992-3#1)(1997-1#1)
masks the##2##2##(2009-3#1)(2012-3#1)
masks##14##1##(1992-3#1)(1996-3#1)(1997-1#1)(2008-2#1)(2008-3#6)(2009-3#1)(2012-3#1)(2013-1#2)
maspin is##3##2##(1995-6#3)
maspin##8##1##(1995-6#8)
mass % higher##2##3##(1993-2#2)
mass %##4##2##(1993-2#4)
mass accuracy##2##2##(2011-2#1)(2012-12#1)
mass action##3##2##(2008-10#1)(2008-11#2)
mass analysis##4##2##(2008-10#3)(2008-3#1)
mass analyzer##2##2##(2010-7#2)
mass and##26##2##(1992-9#1)(1994-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#4)(2010-10#1)(2010-11#2)(2010-3#1)(2011-2#2)(2012-12#2)(2013-1#2)
mass as##3##2##(1992-3#1)(2008-10#1)(2010-5#1)
mass at the##4##3##(2008-10#2)(2013-1#2)
mass at##6##2##(2008-10#2)(2010-6#1)(2013-1#3)
mass balance##6##2##(1995-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
mass balances for##2##3##(2008-5#1)(2008-7#1)
mass balances##4##2##(2008-11#1)(2008-5#1)(2008-7#2)
mass based##2##2##(2008-10#1)(2010-7#1)
mass bias##2##2##(2008-10#2)
mass bleaching##3##2##(2008-9#2)(2012-2#1)
mass by##2##2##(1996-3#1)(2008-6#1)
mass change##2##2##(2008-10#2)
mass changes##2##2##(1990-8#1)(2008-10#1)
mass closure of##2##3##(1992-1#1)(1992-2#1)
mass closure##3##2##(1992-1#2)(1992-2#1)
mass concentration##2##2##(2008-11#1)(2008-5#1)
mass data##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
mass detection##4##2##(1990-8#1)(2008-10#3)
mass disaster##5##2##(1995-11#5)
mass distribution##3##2##(1993-2#2)(1996-3#1)
mass distributions##2##2##(1992-2#1)(2010-7#1)
mass during##2##2##(2008-10#1)(2009-8#1)
mass effect and oedema was##2##5##(1996-6#2)
mass effect and oedema##3##4##(1996-6#3)
mass effect##5##2##(1996-6#3)(2011-2#1)(2012-3#1)
mass flow rate##2##3##(1996-3#2)
mass flow##4##2##(1996-3#3)(2008-10#1)
mass for##2##2##(1994-3#1)(2008-10#1)
mass fraction##2##2##(1995-3#1)(2012-5#1)
mass from##2##2##(1994-11#1)(2008-7#1)
mass has been##2##3##(1990-8#1)(2008-8#1)
mass has##3##2##(1990-8#1)(1993-8#1)(2008-8#1)
mass immunization##2##2##(1994-9#2)
mass in a##2##3##(1990-2#1)(1991-8#1)
mass in the head of the pancreas##2##7##(1991-3#1)(2013-1#1)
mass in the left##8##4##(2008-11#1)(2010-11#2)(2010-6#1)(2012-12#2)(2013-1#2)
mass in the right##2##4##(1994-8#1)(2009-5#1)
mass in the##29##3##(1991-11#1)(1991-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#3)(2009-1#1)(2009-5#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#5)(2013-8#2)
mass in##41##2##(1990-2#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-8#1)(1994-6#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-5#1)(2010-11#2)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#4)
mass increased##2##2##(1992-12#1)(2010-8#1)
mass index (BMI)##16##3##(1991-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
mass index##68##2##(1991-11#2)(1993-12#1)(1994-12#4)(2008-10#5)(2008-11#6)(2008-12#2)(2008-7#9)(2008-8#1)(2009-7#1)(2010-1#1)(2010-4#3)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#10)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
mass is##7##2##(1993-11#1)(1996-2#1)(2008-10#3)(2011-2#1)(2012-2#1)
mass lesion##5##2##(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
mass lesions##3##2##(1996-11#1)(2008-7#1)(2011-2#1)
mass loss##6##2##(2008-10#4)(2008-11#1)(2013-8#1)
mass may##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
mass measurement##2##2##(1990-8#1)(2010-7#1)
mass measurements##4##2##(1990-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
mass media##2##2##(1991-3#1)(1992-2#1)
mass median aerodynamic diameter (MMAD)##3##5##(1992-2#1)(1996-12#1)(1997-2#1)
mass median diameter##2##3##(1995-3#1)(1996-3#1)
mass median diameters (MMD)##2##4##(1993-2#1)(1995-3#1)
mass median##7##2##(1992-2#1)(1993-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#1)
mass mimicking##3##2##(2008-12#1)(2012-12#2)
mass of 1##2##3##(2008-10#2)
mass of 14##2##3##(1992-8#1)(2008-11#1)
mass of 35 kDa##3##4##(2008-10#3)
mass of 35##4##3##(2008-10#4)
mass of aerosol##2##3##(1992-3#1)(1996-3#1)
mass of drug##2##3##(1995-3#1)(1996-2#1)
mass of eggs##2##3##(2010-8#2)
mass of the gel##3##4##(2008-10#3)
mass of the induced##2##4##(2008-12#2)
mass of the##16##3##(1990-8#1)(1995-6#2)(2008-10#7)(2008-12#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
mass of##97##2##(1990-5#3)(1990-8#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#40)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#5)(2010-12#1)(2010-6#1)(2010-8#4)(2011-2#1)(2013-1#3)
mass on the##7##3##(1990-8#1)(1991-12#1)(2008-10#1)(2010-6#1)(2012-12#2)(2013-8#1)
mass on##9##2##(1990-8#1)(1991-12#1)(2008-10#2)(2010-6#1)(2012-12#3)(2013-8#1)
mass or##3##2##(1991-11#1)(2008-6#1)(2008-9#1)
mass output rates##3##3##(2008-10#3)
mass output##4##2##(2008-10#4)
mass per egg##2##3##(2010-8#2)
mass production of the##2##4##(2008-7#1)(2013-8#1)
mass production of##6##3##(2008-11#3)(2008-7#2)(2013-8#1)
mass production##16##2##(1992-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2013-8#1)
mass profile##2##2##(1993-8#2)
mass range##2##2##(2008-10#1)(2013-1#1)
mass ratio##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
mass spectra and##2##3##(2011-2#2)
mass spectra of the##3##4##(1991-5#1)(2008-10#2)
mass spectra of##5##3##(1991-5#1)(2008-10#4)
mass spectra##20##2##(1991-5#1)(2008-10#12)(2008-5#1)(2011-2#6)
mass spectral fragmentation##2##3##(2008-10#1)(2011-2#1)
mass spectral##9##2##(2008-10#1)(2008-11#1)(2011-2#7)
mass spectrometer for##3##3##(2008-10#2)(2010-6#1)
mass spectrometer##31##2##(1997-8#1)(2008-1#1)(2008-10#21)(2008-3#2)(2010-6#1)(2010-7#3)(2010-9#1)(2011-3#1)
mass spectrometers##5##2##(2008-1#1)(2008-10#1)(2010-7#2)(2011-2#1)
mass spectrometric analysis##2##3##(2008-10#1)(2008-11#1)
mass spectrometric and##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
mass spectrometric detection##11##3##(2008-10#11)
mass spectrometric detector##2##3##(2008-10#2)
mass spectrometric measurements##2##3##(2008-10#1)(2010-11#1)
mass spectrometric techniques##2##3##(2008-10#2)
mass spectrometric##33##2##(1993-8#1)(2008-10#26)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
mass spectrometry (ESI-MS)##3##3##(2008-10#3)
mass spectrometry (ICP-MS)##25##3##(2008-10#25)
mass spectrometry (LA-ICP-MS)##3##3##(2008-10#1)(2010-11#2)
mass spectrometry (LC-MS/MS)##2##3##(2008-10#2)
mass spectrometry (MALDI-TOF-MS)##2##3##(2008-10#2)
mass spectrometry (MS) and##2##4##(1997-2#1)(2008-10#1)
mass spectrometry (MS)##6##3##(1997-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-7#1)
mass spectrometry analysis is##2##4##(2008-10#1)(2010-6#1)
mass spectrometry analysis##3##3##(2008-10#2)(2010-6#1)
mass spectrometry and##13##3##(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-7#1)(2012-2#1)(2013-8#2)
mass spectrometry as a##3##4##(1997-2#1)(2008-10#2)
mass spectrometry detection##6##3##(2008-10#6)
mass spectrometry detector##2##3##(2008-10#2)
mass spectrometry for the##4##4##(2008-10#4)
mass spectrometry for##8##3##(2008-10#8)
mass spectrometry has been##2##4##(1990-12#1)(1997-2#1)
mass spectrometry in##5##3##(2008-10#3)(2010-7#2)
mass spectrometry is##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
mass spectrometry of##4##3##(1992-6#1)(2008-10#1)(2008-9#1)(2010-7#1)
mass spectrometry system##2##3##(1997-2#1)(2008-10#1)
mass spectrometry to##2##3##(2010-6#1)(2010-7#1)
mass spectrometry using##2##3##(2008-10#2)
mass spectrometry was applied to##2##5##(2008-10#1)(2011-3#1)
mass spectrometry was used to##2##5##(2008-10#2)
mass spectrometry was used##3##4##(2008-10#3)
mass spectrometry was##5##3##(2008-10#4)(2011-3#1)
mass spectrometry with##2##3##(2008-10#2)
mass spectrometry##269##2##(1990-12#2)(1990-8#2)(1991-5#1)(1992-6#1)(1993-8#1)(1994-5#3)(1995-3#1)(1996-12#1)(1997-2#7)(2008-1#1)(2008-10#193)(2008-11#9)(2008-2#2)(2008-4#3)(2008-5#3)(2008-8#5)(2008-9#2)(2010-11#4)(2010-6#3)(2010-7#12)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#4)
mass spectrometry-based electronic nose##2##4##(2008-10#2)
mass spectrometry-based##4##2##(2008-10#2)(2010-5#1)(2010-7#1)
mass spectroscopy##3##2##(2008-10#2)(2008-7#1)
mass spectrum##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
mass than##2##2##(2008-12#1)(2008-9#1)
mass that##2##2##(2008-9#1)(2011-2#1)
mass to the##2##3##(2008-10#1)(2013-1#1)
mass to##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
mass transfer and##2##3##(2008-10#1)(2008-11#1)
mass transfer coefficient##3##3##(2008-10#1)(2008-7#2)
mass transfer in##2##3##(2008-10#2)
mass transfer of##3##3##(1990-12#1)(2008-10#2)
mass transfer resistance##2##3##(2012-2#2)
mass transfer##16##2##(1990-12#1)(2008-10#8)(2008-11#1)(2008-7#2)(2010-4#1)(2012-2#3)
mass transport in the adsorbent bed##2##6##(2008-10#2)
mass transport phenomenon##2##3##(2008-9#2)
mass transport##6##2##(2008-10#3)(2008-9#2)(2010-7#1)
mass vaccination##3##2##(1994-9#1)(2010-8#1)(2011-2#1)
mass was found##3##3##(1997-8#1)(2011-2#1)(2013-8#1)
mass was##32##2##(1990-2#1)(1992-12#1)(1996-1#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-3#2)(2012-9#1)(2013-1#2)(2013-8#4)
mass were##4##2##(1997-2#1)(2008-10#1)(2008-8#1)(2012-9#1)
mass which##2##2##(2008-7#1)(2011-2#1)
mass with##8##2##(1990-6#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
mass without##2##2##(2008-7#1)(2012-3#1)
mass##1081##1##(1990-12#5)(1990-2#2)(1990-5#5)(1990-6#2)(1990-8#9)(1991-11#5)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#4)(1991-6#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-12#5)(1992-2#5)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#7)(1993-3#1)(1993-6#2)(1993-8#7)(1994-11#2)(1994-12#6)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#6)(1995-2#1)(1995-3#7)(1995-6#4)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#7)(1996-6#4)(1997-1#1)(1997-2#11)(1997-3#1)(1997-7#2)(1997-8#4)(2007-12#4)(2008-1#4)(2008-10#452)(2008-11#42)(2008-12#19)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#11)(2008-6#3)(2008-7#36)(2008-8#16)(2008-9#27)(2009-1#3)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#15)(2010-12#2)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#12)(2010-7#26)(2010-8#13)(2010-9#1)(2011-1#5)(2011-2#61)(2011-3#3)(2012-12#26)(2012-2#17)(2012-3#18)(2012-5#1)(2012-9#2)(2013-1#36)(2013-7#1)(2013-8#23)
mass)##9##1##(1990-5#2)(2008-10#3)(2010-8#2)(2011-2#1)(2012-2#1)
mass-balance data##2##2##(2008-10#2)
mass-balance##3##1##(2008-10#3)
mass-flow rate##2##2##(2008-3#2)
mass-flow##3##1##(2008-3#3)
mass-spectrometric##2##1##(2008-10#1)(2010-7#1)
massage for medically fragile infants##2##5##(2008-10#2)
massage for##3##2##(2008-10#2)(2013-1#1)
massage in the##2##3##(2009-3#1)(2010-7#1)
massage in##6##2##(2008-10#2)(2008-12#1)(2009-3#1)(2010-7#2)
massage on##4##2##(2008-12#1)(2009-3#1)(2010-12#1)(2010-7#1)
massage sessions##2##2##(2008-10#2)
massage therapists##4##2##(2008-10#1)(2008-12#3)
massage therapy##5##2##(2008-11#1)(2008-12#2)(2009-3#1)(2010-6#1)
massage twice##2##2##(2008-10#1)(2008-12#1)
massage##51##1##(1991-2#2)(2008-10#20)(2008-11#1)(2008-12#12)(2009-3#4)(2009-9#1)(2010-12#2)(2010-6#1)(2010-7#5)(2011-2#1)(2013-1#2)
massaged##8##1##(2008-12#4)(2009-3#4)
masses and##4##2##(1994-2#1)(2008-10#1)(2010-7#1)(2011-2#1)
masses associated with##2##3##(2011-2#1)(2013-1#1)
masses in the##2##3##(2011-2#1)(2012-3#1)
masses in##3##2##(2009-6#1)(2011-2#1)(2012-3#1)
masses of the##5##3##(1993-8#1)(2008-10#3)(2010-8#1)
masses of##19##2##(1990-12#1)(1990-5#1)(1993-8#3)(2007-12#1)(2008-10#10)(2008-4#1)(2008-8#1)(2010-8#1)
masses up to##2##3##(2008-10#2)
masses was##2##2##(1996-1#1)(2010-8#1)
masses were##3##2##(2008-5#1)(2010-8#2)
masses##83##1##(1990-12#3)(1990-5#1)(1991-2#3)(1992-1#1)(1993-3#1)(1993-8#3)(1994-2#1)(1996-1#5)(1996-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-1#1)(2009-6#1)(2010-7#3)(2010-8#5)(2011-2#9)(2012-2#1)(2012-3#1)(2013-1#6)
masseter muscle##6##2##(1996-2#1)(2008-10#1)(2010-6#1)(2010-9#1)(2013-1#2)
masseter were##2##2##(2010-6#1)(2013-1#1)
masseter##13##1##(1996-2#1)(2008-10#3)(2010-6#3)(2010-9#3)(2013-1#3)
massive accumulation of##2##3##(1994-11#1)(1995-12#1)
massive and##3##2##(2008-10#2)(2008-5#1)
massive loss of##2##3##(1996-5#1)(2011-2#1)
massive wavelength-division multiplexing##2##3##(2007-12#2)
massive##61##1##(1990-3#1)(1991-6#2)(1992-1#1)(1992-2#1)(1992-5#2)(1993-2#1)(1994-11#2)(1994-12#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-8#1)(2007-12#2)(2008-10#6)(2008-12#6)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
massively parallel##5##2##(1997-6#1)(2008-11#1)(2009-10#1)(2009-5#1)(2011-2#1)
massively##12##1##(1990-6#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#2)
mast cell activation##4##3##(1995-11#4)
mast cell##15##2##(1993-3#2)(1993-8#1)(1995-11#4)(2008-5#2)(2008-6#2)(2009-6#1)(2010-1#1)(2011-2#2)
mast cell/IgE##2##2##(2008-8#2)
mast cells##10##2##(1995-11#1)(2008-11#1)(2008-6#1)(2008-9#4)(2009-6#2)(2011-2#1)
mast seeding##4##2##(2008-8#4)
mast##34##1##(1993-3#2)(1993-8#1)(1995-11#5)(2008-11#1)(2008-5#2)(2008-6#3)(2008-8#6)(2008-9#5)(2009-6#4)(2010-1#1)(2010-8#1)(2011-2#3)
mast-cell activation##2##2##(2009-6#2)
mastectomies##8##1##(2011-2#7)(2013-1#1)
mastectomy and##4##2##(1990-12#1)(1992-12#1)(1993-11#1)(2012-3#1)
mastectomy for##2##2##(1994-12#1)(2011-2#1)
mastectomy was performed##2##3##(2008-10#1)(2012-3#1)
mastectomy##27##1##(1990-12#1)(1990-9#1)(1992-12#3)(1993-11#2)(1994-12#4)(1997-7#1)(2008-10#1)(2010-7#1)(2011-2#2)(2012-3#5)(2013-1#6)
master modulatory loci&quot##2##3##(2008-10#2)
master patient scheduling##2##3##(1996-2#2)
master##17##1##(1991-3#1)(1992-2#3)(1996-12#1)(1996-2#2)(1996-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
master-oscillator power-amplifier##2##2##(2007-12#1)(2008-3#1)
master-oscillator##3##1##(2007-12#1)(2008-3#2)
mastication##3##1##(2008-10#1)(2011-2#2)
masticatory forces##2##2##(2013-1#2)
masticatory muscle reflexes##4##3##(1996-2#4)
masticatory muscle##5##2##(1996-2#4)(2008-7#1)
masticatory system##4##2##(2008-7#1)(2010-9#2)(2012-12#1)
masticatory##15##1##(1990-9#1)(1991-3#1)(1996-2#4)(2008-7#2)(2010-9#3)(2011-2#1)(2012-12#1)(2013-1#2)
masting and##2##2##(2008-8#1)(2008-9#1)
masting##4##1##(2008-8#2)(2008-9#2)
mastitis##8##1##(1990-6#1)(1992-2#2)(1996-3#1)(1996-8#2)(1997-8#2)
mastocytes in##2##2##(1991-11#2)
mastocytes##7##1##(1991-11#7)
mastocytic nodules##2##2##(1991-11#2)
mastocytosis##12##1##(1991-11#5)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#3)
mastoid fascial flap##4##3##(2009-1#4)
mastoid process##6##2##(2008-7#5)(2008-9#1)
mastoid##20##1##(1990-12#1)(2008-7#8)(2008-9#5)(2009-1#4)(2011-2#1)(2013-7#1)
mastoidectomy and##2##2##(2008-9#2)
mastoidectomy to##2##2##(2008-7#2)
mastoidectomy##11##1##(2008-7#7)(2008-9#4)
mastoiditis##2##1##(2008-9#2)
mastoparan (Mast)##2##2##(2008-10#2)
mastoparan and##2##2##(1991-5#1)(2008-10#1)
mastoparan##12##1##(1991-5#2)(1994-11#5)(1997-1#2)(2008-10#3)
mastoparan-induced inhibition of##2##3##(1997-1#2)
mat properties##3##2##(2011-2#3)
mat##10##1##(1990-11#1)(2009-1#1)(2009-12#1)(2011-2#7)
mat1-2##3##1##(2008-10#3)
match between the##2##3##(1995-3#1)(2008-8#1)
match between##5##2##(1995-12#1)(1995-3#1)(2008-3#2)(2008-8#1)
match of the##3##3##(2007-11#2)(2008-9#1)
match the##20##2##(1991-3#1)(1992-9#1)(1994-2#1)(1995-6#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
match those determined for the##2##5##(1992-9#2)
match those of##2##3##(2009-7#2)
match those##4##2##(1992-9#2)(2009-7#2)
match to sample##3##3##(2008-11#1)(2013-8#2)
match to##6##2##(1996-6#1)(1996-8#1)(2008-11#1)(2008-3#1)(2013-8#2)
match with the##4##3##(1990-2#1)(2008-10#1)(2012-2#2)
match##62##1##(1990-2#1)(1991-3#1)(1992-9#3)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-7#1)(2007-11#3)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#8)
matched and##2##2##(2009-10#1)(2011-2#1)
matched by age##2##3##(1991-6#1)(2013-1#1)
matched by##4##2##(1991-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
matched control##2##2##(2009-10#1)(2012-2#1)
matched controls##8##2##(1991-11#1)(1994-12#1)(1996-12#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#1)
matched for age##5##3##(1995-1#1)(1996-3#2)(2008-7#1)(2013-1#1)
matched for available##2##3##(2010-8#2)
matched for##10##2##(1991-12#1)(1991-3#1)(1992-5#1)(1995-1#1)(1996-3#2)(2008-7#1)(2010-8#2)(2013-1#1)
matched its text field##2##4##(2010-8#2)
matched normal##3##2##(1995-5#1)(2008-7#1)(2010-12#1)
matched pairs##2##2##(1992-12#1)(1992-8#1)
matched potential method##2##3##(2008-10#2)
matched the##10##2##(1995-12#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#2)(2010-8#1)(2013-1#1)
matched to the##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
matched to##6##2##(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)
matched well##2##2##(2008-10#1)(2011-2#1)
matched with the##3##3##(2008-10#2)(2012-2#1)
matched with##10##2##(1993-1#1)(1995-2#1)(1997-2#1)(2008-10#4)(2008-3#1)(2012-12#1)(2012-2#1)
matched##111##1##(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-12#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-8#2)(1994-12#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#16)(2008-11#6)(2008-12#3)(2008-3#3)(2008-4#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#2)(2009-8#1)(2010-11#4)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#3)
matches in##3##2##(1995-11#1)(2008-10#2)
matches the##9##2##(1996-6#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
matches to##2##2##(2008-10#1)(2008-8#1)
matches##21##1##(1995-11#1)(1996-6#2)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#2)
matching for##4##2##(2007-11#1)(2008-3#1)(2012-2#1)(2012-3#1)
matching is##2##2##(2008-3#1)(2008-4#1)
matching layer was##2##3##(2009-5#2)
matching resistance genes in the differential hosts is proposed##2##9##(2008-10#2)
matching##42##1##(1991-6#1)(1993-3#1)(1993-9#1)(1995-1#1)(1996-2#2)(2007-11#1)(2007-12#1)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
mate and##2##2##(2008-8#1)(2008-9#1)
mate choice and##2##3##(2008-9#2)
mate choice in birds##2##4##(2008-8#2)
mate choice in##5##3##(2008-8#4)(2008-9#1)
mate choice##24##2##(2008-8#5)(2008-9#11)(2009-6#7)(2012-3#1)
mate preference##2##2##(2008-9#2)
mate preferences for##2##3##(2008-9#2)
mate preferences of##2##3##(2008-8#1)(2008-9#1)
mate preferences##5##2##(2008-8#1)(2008-9#4)
mate recognition system##4##3##(2008-8#1)(2008-9#3)
mate recognition systems##2##3##(2008-8#1)(2008-9#1)
mate recognition##9##2##(2008-8#3)(2008-9#6)
mate search strategies##2##3##(2008-8#2)
mate search##6##2##(2008-8#6)
mate searching is##2##3##(2008-8#2)
mate searching##3##2##(2008-8#3)
mate to##2##2##(2008-10#1)(2008-8#1)
mate##64##1##(1995-6#1)(2008-10#1)(2008-8#27)(2008-9#25)(2009-6#9)(2012-3#1)
mate-finding strategies##2##2##(1990-8#2)
mate-finding##3##1##(1990-8#3)
mate-locating##2##1##(2008-6#2)
mate-search efficiency##2##2##(2008-8#2)
mated and##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
mated to##2##2##(2008-10#1)(2008-5#1)
mated with##2##2##(2008-10#1)(2008-6#1)
mated##11##1##(1992-3#2)(2008-10#3)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)
material (GBW##4##2##(2008-10#4)
material and a##4##3##(1990-8#1)(2008-10#2)(2008-9#1)
material and its##4##3##(2008-10#3)(2010-10#1)
material and of##2##3##(2008-10#1)(2008-5#1)
material and the##4##3##(2007-12#1)(2008-10#3)
material and##49##2##(1990-8#1)(1995-11#1)(1997-6#1)(2007-12#1)(2008-10#30)(2008-11#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-11#1)(2011-3#1)
material are##2##2##(2008-3#1)(2008-5#1)
material as##2##2##(2008-10#1)(2009-7#1)
material at##2##2##(2008-10#2)
material because##2##2##(2008-3#1)(2013-1#1)
material by##6##2##(2008-10#6)
material collected##2##2##(2008-10#1)(2008-5#1)
material consisting of##2##3##(1990-11#1)(2008-10#1)
material containing##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2009-7#1)
material deposited##3##2##(1994-2#1)(1995-12#1)(2008-10#1)
material did not##2##3##(1990-2#1)(2008-12#1)
material exhibits##2##2##(2008-10#1)(2009-7#1)
material for an##2##3##(2008-10#1)(2011-2#1)
material for the##13##3##(1995-6#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
material for##51##2##(1990-12#1)(1995-6#1)(1997-3#1)(2008-10#24)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#3)(2009-7#2)(2011-2#5)(2012-2#1)(2013-1#2)
material found in##2##3##(2008-10#1)(2013-1#1)
material frequently##2##2##(2008-10#2)
material from the##5##3##(1997-8#1)(2008-11#1)(2008-3#1)(2008-5#2)
material from##17##2##(1991-9#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-6#1)(2013-8#1)
material has been##4##3##(1990-9#1)(2008-10#2)(2010-4#1)
material have been##2##3##(2008-10#1)(2008-3#1)
material have##4##2##(2008-10#2)(2008-3#1)(2009-7#1)
material identified##2##2##(2008-10#1)(2010-3#1)
material in a##4##3##(2008-10#3)(2009-12#1)
material in the cytoplasm##2##4##(1992-2#1)(2008-10#1)
material in the##9##3##(1992-2#1)(2008-10#5)(2010-2#1)(2010-6#1)(2010-7#1)
material in##21##2##(1990-9#2)(1992-2#1)(1995-12#1)(1995-8#1)(2008-10#10)(2008-5#2)(2009-12#1)(2010-2#1)(2010-6#1)(2010-7#1)
material includes##2##2##(2010-5#1)(2013-1#1)
material into##3##2##(1994-12#1)(2007-12#1)(2011-2#1)
material is described##2##3##(2008-10#2)
material is##20##2##(1990-3#1)(1991-12#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-8#1)(2009-10#1)(2010-11#1)
material model##3##2##(2009-7#3)
material of a##2##3##(2008-10#2)
material of##16##2##(1991-11#1)(1994-3#1)(1995-6#1)(2008-10#9)(2008-4#1)(2011-3#1)(2012-3#1)(2013-1#1)
material on##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
material or##3##2##(1996-12#2)(2009-3#1)
material parameters##4##2##(2008-3#2)(2009-7#1)(2013-1#1)
material properties##4##2##(2008-10#2)(2009-7#2)
material recovered##2##2##(2008-10#2)
material resembling##2##2##(1990-5#1)(2008-7#1)
material resources##3##2##(2008-11#1)(2008-9#1)(2010-11#1)
material systems##2##2##(2009-5#1)(2012-2#1)
material that is##2##3##(1993-1#1)(2008-10#1)
material that##9##2##(1993-1#1)(2008-10#6)(2008-7#1)(2009-7#1)
material to##7##2##(2007-12#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-11#1)
material used##2##2##(2008-7#1)(2012-3#1)
material was also##2##3##(2008-10#2)
material was found to##3##4##(2008-10#2)(2008-3#1)
material was processed##2##3##(1996-12#1)(2013-1#1)
material was##33##2##(1996-12#1)(1997-3#1)(2008-10#21)(2008-3#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
material were analyzed##2##3##(2008-10#2)
material were##7##2##(1990-5#1)(2008-10#3)(2011-2#3)
material which##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
material with a##3##3##(1994-6#1)(2008-10#1)(2009-7#1)
material with##13##2##(1994-6#1)(2008-10#7)(2008-3#1)(2009-7#2)(2010-6#1)(2011-2#1)
material within the##2##3##(1992-2#1)(2011-2#1)
material within##4##2##(1992-2#1)(2008-10#2)(2011-2#1)
material##670##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-8#3)(1990-9#3)(1991-11#1)(1991-12#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1993-1#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-6#2)(1995-8#1)(1996-12#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#3)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#353)(2008-11#38)(2008-12#4)(2008-2#2)(2008-3#25)(2008-4#2)(2008-5#21)(2008-7#18)(2008-8#2)(2008-9#16)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#23)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2011-1#3)(2011-2#22)(2011-3#2)(2012-12#1)(2012-2#13)(2012-3#8)(2013-1#16)(2013-7#1)(2013-8#2)
material's##4##1##(2008-10#1)(2008-3#2)(2010-10#1)
material)##3##1##(2008-10#3)
material]##5##1##(1995-2#1)(2010-10#4)
materially##2##1##(1996-2#1)(2008-11#1)
materials after##2##2##(2008-10#1)(2009-7#1)
materials and techniques##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
materials and the##5##3##(2008-10#4)(2012-3#1)
materials and##56##2##(1991-12#1)(1992-2#1)(1995-3#1)(2007-12#2)(2008-10#33)(2008-11#2)(2008-2#4)(2008-5#2)(2008-9#2)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
materials are discussed##3##3##(2008-10#3)
materials are##15##2##(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
materials as##4##2##(2008-10#2)(2010-9#1)(2012-2#1)
materials at##2##2##(2008-10#1)(2010-7#1)
materials by electrothermal atomic absorption spectrometry (ETAAS)##2##7##(2008-10#2)
materials by electrothermal atomic absorption spectrometry##3##6##(2008-10#3)
materials by using##3##3##(2008-10#3)
materials by##21##2##(1991-7#1)(1997-3#1)(2008-10#17)(2008-11#1)(2008-12#1)
materials can be##5##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-9#1)
materials containing##2##2##(1991-12#1)(2008-10#1)
materials during##2##2##(2007-12#1)(2008-10#1)
materials exhibited##2##2##(1995-3#1)(2009-5#1)
materials for the##5##3##(2008-10#4)(2008-11#1)
materials for##20##2##(1995-6#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#8)(2008-11#2)(2009-12#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#2)
materials from the##2##3##(2008-10#2)
materials from##6##2##(2008-10#4)(2008-11#1)(2008-5#1)
materials has been##3##3##(2008-10#3)
materials has##4##2##(2008-10#4)
materials have been##4##3##(2008-10#1)(2009-11#1)(2009-5#1)(2012-2#1)
materials have##5##2##(1997-3#1)(2008-10#1)(2009-11#1)(2009-5#1)(2012-2#1)
materials in the##4##3##(1990-9#1)(1991-12#1)(2008-10#1)(2009-7#1)
materials in##18##2##(1990-9#1)(1991-12#2)(2008-10#7)(2008-3#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#2)
materials include##2##2##(1997-3#1)(2009-7#1)
materials into##3##2##(2008-10#2)(2009-12#1)
materials is a##2##3##(2008-10#1)(2008-5#1)
materials is described##2##3##(2008-10#2)
materials is##8##2##(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)
materials of##21##2##(1992-1#2)(2008-10#16)(2008-11#2)(2008-8#1)
materials on the##2##3##(2008-10#2)
materials on##6##2##(2008-10#5)(2008-5#1)
materials presented##2##2##(2013-1#2)
materials ranged from##2##3##(2008-10#2)
materials released##2##2##(2008-5#2)
materials science##4##2##(2008-10#1)(2009-7#1)(2010-7#1)(2012-2#1)
materials selection##2##2##(2008-10#1)(2010-7#1)
materials should##2##2##(1994-3#1)(2011-2#1)
materials showed##2##2##(2008-10#1)(2013-1#1)
materials studied##2##2##(2008-10#2)
materials such as##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2010-6#1)
materials that are##2##3##(2008-10#1)(2008-11#1)
materials that have##2##3##(2008-2#1)(2010-10#1)
materials that##14##2##(1996-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
materials through##2##2##(1990-2#1)(2009-10#1)
materials to##5##2##(1997-3#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
materials under##2##2##(2008-10#1)(2012-2#1)
materials used for##3##3##(2008-10#2)(2013-1#1)
materials used in the##3##4##(2008-10#3)
materials used in##5##3##(2008-10#5)
materials used##12##2##(2008-10#8)(2008-9#1)(2012-3#2)(2013-1#1)
materials using##2##2##(2008-10#2)
materials was##6##2##(2008-10#2)(2008-5#1)(2009-3#1)(2009-7#1)(2013-1#1)
materials were analyzed##3##3##(2008-10#2)(2013-1#1)
materials were prepared by##2##4##(2009-7#1)(2010-4#1)
materials were##27##2##(1997-3#1)(2007-12#1)(2008-10#21)(2008-7#1)(2009-7#1)(2010-4#1)(2013-1#1)
materials which##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
materials will##2##2##(2008-10#1)(2008-3#1)
materials with satisfactory results##2##4##(2008-10#2)
materials with##17##2##(1996-12#2)(1997-3#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-7#1)(2011-3#1)
materials##629##1##(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-12#8)(1991-3#1)(1991-7#2)(1991-9#1)(1992-1#2)(1992-2#2)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#5)(1994-9#1)(1995-12#1)(1995-3#6)(1995-6#1)(1996-12#7)(1996-2#2)(1996-5#2)(1997-3#6)(1997-6#1)(2007-11#1)(2007-12#8)(2008-1#1)(2008-10#357)(2008-11#20)(2008-12#5)(2008-2#9)(2008-3#16)(2008-4#2)(2008-5#21)(2008-7#7)(2008-8#3)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#3)(2009-7#15)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#8)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#13)(2011-3#2)(2012-12#3)(2012-2#8)(2012-3#6)(2013-1#21)(2013-8#2)
materials'##2##1##(2008-10#1)(2010-7#1)
materials)##5##1##(2008-10#4)(2010-7#1)
materiel management##2##2##(1992-1#2)
maternal acculturation##6##2##(2009-7#6)
maternal age at##2##3##(2012-12#1)(2013-1#1)
maternal age##15##2##(1997-3#6)(2008-10#1)(2009-12#3)(2010-6#1)(2012-12#1)(2012-3#2)(2013-1#1)
maternal and child health##4##4##(1991-3#1)(1995-12#1)(1996-12#1)(1997-2#1)
maternal and neonatal##2##3##(2012-3#2)
maternal and paternal##2##3##(2008-12#1)(2008-9#1)
maternal and perinatal##2##3##(2013-1#1)(2013-8#1)
maternal and##15##2##(1991-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
maternal behavior##5##2##(1990-12#2)(2008-11#1)(2008-8#1)(2011-2#1)
maternal behaviors##3##2##(2008-8#1)(2009-11#2)
maternal blood##2##2##(1992-5#1)(1996-3#1)
maternal body##2##2##(2008-8#1)(2010-6#1)
maternal care##2##2##(2008-8#2)
maternal cocaine use##2##3##(1992-12#2)
maternal cocaine##3##2##(1992-12#2)(2010-11#1)
maternal control at T1##2##4##(2009-10#2)
maternal control at##3##3##(2009-10#3)
maternal deaths##2##2##(2008-11#2)
maternal diabetes##5##2##(1996-11#3)(2007-12#1)(2012-3#1)
maternal effects##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
maternal experience with##2##3##(2011-2#2)
maternal factors##2##2##(1993-3#1)(2008-11#1)
maternal fitness##2##2##(2008-9#2)
maternal health##2##2##(2012-2#1)(2013-8#1)
maternal infection##2##2##(1990-9#2)
maternal lines##4##2##(2008-10#4)
maternal mRNAs##2##2##(1993-6#2)
maternal morbidity##2##2##(1992-2#1)(2012-3#1)
maternal mortality##3##2##(1995-12#1)(2008-11#2)
maternal or paternal effects##2##4##(2008-9#1)(2011-2#1)
maternal or##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
maternal perception of##2##3##(1993-3#2)
maternal performance##3##2##(2008-8#3)
maternal responsivity##2##2##(2009-10#2)
maternal self-esteem##2##2##(1993-3#2)
maternal serum##6##2##(1990-9#1)(1992-9#1)(1995-8#4)
maternal size##2##2##(2008-8#2)
maternal smoking##2##2##(2008-1#1)(2010-6#1)
maternal toxicity##6##2##(2011-2#6)
maternal##183##1##(1990-12#2)(1990-9#3)(1991-12#1)(1991-3#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#5)(1993-6#4)(1994-11#2)(1994-3#3)(1995-12#2)(1995-2#1)(1995-8#4)(1996-11#4)(1996-12#1)(1996-3#2)(1997-2#1)(1997-3#6)(1997-7#3)(2007-12#2)(2008-1#2)(2008-10#12)(2008-11#8)(2008-12#4)(2008-4#1)(2008-7#1)(2008-8#12)(2008-9#6)(2009-10#5)(2009-11#4)(2009-12#4)(2009-7#10)(2009-9#2)(2010-11#4)(2010-5#1)(2010-6#7)(2010-8#6)(2011-1#1)(2011-2#13)(2012-12#2)(2012-2#2)(2012-3#13)(2013-1#7)(2013-8#2)
maternal-child health program##2##3##(1993-3#2)
maternal-child##3##1##(1993-3#2)(1997-4#1)
maternal-fetal##2##1##(1995-12#1)(2013-1#1)
maternally derived deletions##3##3##(1997-3#3)
maternally derived##5##2##(1991-3#1)(1997-3#4)
maternally inherited##4##2##(1993-1#1)(2008-9#1)(2012-3#1)(2013-8#1)
maternally transmitted##4##2##(1993-1#2)(2008-9#1)(2012-3#1)
maternally##13##1##(1991-3#1)(1993-1#3)(1997-3#4)(2008-9#2)(2012-3#2)(2013-8#1)
maternally-derived##2##1##(2008-5#2)
maternel##3##1##(2011-2#1)(2013-1#2)
maternities##2##1##(2009-10#1)(2012-3#1)
maternity care##2##2##(2013-1#1)(2013-8#1)
maternity patients##2##2##(2007-12#2)
maternity services##3##2##(1994-12#2)(2008-11#1)
maternity##13##1##(1994-12#2)(1994-6#1)(1996-11#1)(2007-12#2)(2008-11#1)(2008-9#2)(2011-2#1)(2013-1#2)(2013-8#1)
mates and##2##2##(2008-8#2)
mates##23##1##(1991-6#1)(1995-12#1)(2008-8#16)(2008-9#4)(2012-3#1)
math and##4##2##(2008-12#1)(2009-7#3)
math##5##1##(2008-12#1)(2009-7#3)(2012-2#1)
mathematic##2##1##(2008-12#2)
mathematical and##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
mathematical arguments##2##2##(2008-3#2)
mathematical model for##2##3##(2009-8#1)(2013-8#1)
mathematical model incorporating##2##3##(2008-10#1)(2008-9#1)
mathematical model is##4##3##(2008-10#1)(2008-5#1)(2008-7#2)
mathematical model of##10##3##(2008-10#3)(2008-11#1)(2008-7#3)(2008-9#1)(2013-8#2)
mathematical model to describe the##2##5##(1991-11#1)(1992-9#1)
mathematical model to##7##3##(1991-11#1)(1992-9#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-7#1)
mathematical model was developed##2##4##(2008-10#2)
mathematical model was##6##3##(2008-10#2)(2008-7#2)(2013-8#2)
mathematical model which##2##3##(2008-10#2)
mathematical model##47##2##(1991-11#1)(1992-2#1)(1992-9#1)(1997-1#1)(2008-10#15)(2008-11#4)(2008-5#2)(2008-7#10)(2008-9#3)(2009-8#1)(2011-3#3)(2013-8#5)
mathematical modeling##4##2##(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
mathematical modelling##2##2##(2008-6#1)(2013-8#1)
mathematical models are##2##3##(2008-7#1)(2013-8#1)
mathematical models of##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#2)
mathematical models##16##2##(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-10#2)(2013-8#3)
mathematical test##2##2##(2008-11#2)
mathematical treatment##3##2##(2008-10#3)
mathematical treatments##2##2##(2008-10#2)
mathematical##127##1##(1991-11#1)(1992-2#1)(1992-9#2)(1994-5#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#41)(2008-11#13)(2008-12#5)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#13)(2008-9#8)(2009-8#3)(2010-10#3)(2011-2#3)(2011-3#3)(2012-12#1)(2012-2#2)(2013-8#11)
mathematically##8##1##(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)
mathematicians and##2##2##(2009-6#1)(2013-8#1)
mathematicians##4##1##(1990-8#1)(2009-5#1)(2009-6#1)(2013-8#1)
mathematics##6##1##(2008-1#1)(2008-11#1)(2008-12#2)(2010-1#1)(2013-8#1)
mating advantage##2##2##(2008-8#2)
mating and##8##2##(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#1)(2013-1#1)
mating behavior##5##2##(2008-10#2)(2008-12#2)(2008-8#1)
mating but##2##2##(2008-10#1)(2008-9#1)
mating decisions##3##2##(2008-8#2)(2008-9#1)
mating in##3##2##(2008-10#1)(2008-8#2)
mating inhibition##2##2##(2008-10#2)
mating is##3##2##(2008-8#2)(2008-9#1)
mating or teliospore germination##2##4##(2008-10#2)
mating or##3##2##(2008-10#3)
mating pheromone##3##2##(1991-5#3)
mating preferences##3##2##(2008-8#1)(2009-6#2)
mating response##2##2##(1996-2#2)
mating strategies##2##2##(2008-8#2)
mating success##11##2##(2008-8#3)(2008-9#6)(2012-3#2)
mating system in##2##3##(2008-10#1)(2008-9#1)
mating system of##3##3##(2008-9#3)
mating system##8##2##(2008-10#1)(2008-8#1)(2008-9#5)(2009-6#1)
mating systems##3##2##(2008-8#1)(2012-2#2)
mating to##2##2##(2008-8#1)(2008-9#1)
mating type and##5##3##(2008-10#5)
mating type frequencies##2##3##(2008-10#2)
mating type isolate to produce oospores##2##6##(2008-10#2)
mating type isolates##2##3##(2008-10#2)
mating type locus##2##3##(2008-10#2)
mating type of the##2##4##(2008-10#2)
mating type of##3##3##(2008-10#3)
mating type were##4##3##(2008-10#4)
mating type##56##2##(2008-10#56)
mating types in##3##3##(2008-10#3)
mating types occurred##2##3##(2008-10#2)
mating types of##3##3##(2008-10#3)
mating types were found##2##4##(2008-10#2)
mating types were##4##3##(2008-10#4)
mating types##21##2##(2008-10#21)
mating with multiple##2##3##(2008-8#2)
mating with several males##2##4##(2008-8#2)
mating with##6##2##(2008-10#1)(2008-8#5)
mating##217##1##(1991-5#3)(1995-12#1)(1995-6#1)(1996-2#2)(2008-10#111)(2008-11#3)(2008-12#5)(2008-5#2)(2008-6#2)(2008-8#44)(2008-9#28)(2009-6#4)(2012-2#2)(2012-3#8)(2013-1#1)
mating-type##4##1##(2008-10#3)(2012-3#1)
matings between##3##2##(2008-10#2)(2008-9#1)
matings of##2##2##(1995-2#1)(2008-10#1)
matings##10##1##(1995-2#1)(2008-10#3)(2008-8#1)(2008-9#5)
matric potential##10##2##(2008-10#10)
matric potentials of -7 x 10(3)##2##6##(2008-10#2)
matric potentials##6##2##(2008-10#6)
matric##16##1##(2008-10#16)
matricellular protein that##2##3##(2008-1#2)
matrices (i##2##2##(2008-10#1)(2012-12#1)
matrices and##11##2##(2008-10#7)(2008-5#1)(2008-9#1)(2010-6#1)(2010-8#1)
matrices are##5##2##(2008-10#5)
matrices as##2##2##(2008-10#2)
matrices by##10##2##(2008-10#9)(2008-5#1)
matrices compared##2##2##(2008-10#2)
matrices containing##5##2##(1995-5#1)(2008-10#4)
matrices could##2##2##(2008-10#2)
matrices for##4##2##(2008-10#2)(2008-4#1)(2010-11#1)
matrices into##2##2##(2008-10#1)(2011-2#1)
matrices is##4##2##(1990-2#2)(2008-10#2)
matrices like##3##2##(2008-10#2)(2008-11#1)
matrices of##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
matrices on##2##2##(2008-10#2)
matrices such as##6##3##(2008-10#6)
matrices thus##2##2##(1995-12#1)(2008-10#1)
matrices using cyanex-923 extractant##2##4##(2008-10#2)
matrices using##5##2##(2008-10#5)
matrices was##7##2##(2008-10#4)(2008-5#1)(2008-7#1)(2010-5#1)
matrices were##10##2##(2008-10#7)(2008-3#1)(2008-7#2)
matrices with##7##2##(1997-2#1)(2008-10#3)(2008-11#2)(2012-2#1)
matrices without##2##2##(2008-10#2)
matrices##219##1##(1990-2#3)(1995-12#2)(1995-5#1)(1996-1#1)(1997-2#2)(2008-10#144)(2008-11#11)(2008-3#9)(2008-4#1)(2008-5#5)(2008-7#10)(2008-8#1)(2008-9#7)(2009-11#1)(2009-4#1)(2010-11#5)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#5)
matrices)##2##1##(2008-10#1)(2008-7#1)
matrigel##7##1##(1993-3#1)(2008-11#5)(2013-1#1)
matrigel-coated dishes##2##2##(2008-11#2)
matrine##8##1##(2008-10#8)
matrix (MA)##2##2##(2009-7#1)(2013-1#1)
matrix and a##2##3##(1996-12#1)(2008-10#1)
matrix and its##2##3##(2008-8#1)(2009-10#1)
matrix and the##6##3##(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)
matrix and##32##2##(1995-8#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#18)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-7#1)(2010-4#1)
matrix anions##2##2##(2008-10#2)
matrix are##4##2##(2008-3#3)(2008-8#1)
matrix as a##2##3##(2008-10#2)
matrix attachment region##2##3##(2008-8#2)
matrix attachment##3##2##(2008-8#3)
matrix by##5##2##(2008-10#5)
matrix can be##2##3##(2008-10#2)
matrix can##5##2##(2008-10#2)(2008-8#2)(2008-9#1)
matrix components##7##2##(2008-10#3)(2008-5#1)(2008-7#2)(2011-1#1)
matrix composition##2##2##(2008-10#2)
matrix considering##2##2##(2008-10#2)
matrix constituents##4##2##(2008-10#4)
matrix containing##2##2##(2008-10#2)
matrix degradation##3##2##(1993-3#1)(2012-2#2)
matrix deposition##2##2##(2009-12#1)(2009-7#1)
matrix effect observed##2##3##(2008-10#2)
matrix effect##18##2##(2008-10#13)(2010-11#5)
matrix effects and##2##3##(2008-10#2)
matrix effects are##5##3##(2008-10#5)
matrix effects for##4##3##(2008-10#4)
matrix effects in the##2##4##(2008-10#2)
matrix effects were##4##3##(1997-2#1)(2008-10#3)
matrix effects##31##2##(1997-2#2)(2008-10#29)
matrix elements are##2##3##(2008-3#1)(2010-7#1)
matrix elements for##2##3##(2008-3#1)(2010-7#1)
matrix elements of##4##3##(2008-3#2)(2010-7#2)
matrix elements##23##2##(2008-10#14)(2008-3#4)(2008-5#1)(2010-7#4)
matrix elimination##3##2##(2008-10#3)
matrix factorization##3##2##(2008-10#3)
matrix fluorescence##3##2##(2008-10#3)
matrix for the##5##3##(2008-10#4)(2008-11#1)
matrix for##15##2##(2008-10#10)(2008-11#1)(2008-3#2)(2008-5#1)(2009-12#1)
matrix formalism##2##2##(2008-2#1)(2008-3#1)
matrix has been##2##3##(2008-10#2)
matrix has##3##2##(2008-10#3)
matrix in its##2##3##(1997-1#1)(2008-8#1)
matrix in the form of##2##5##(1994-5#1)(2008-10#1)
matrix in the##4##3##(1994-5#1)(2008-10#3)
matrix in which##2##3##(2008-5#2)
matrix in##19##2##(1991-5#1)(1994-5#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-5#5)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)
matrix influence##3##2##(2008-10#3)
matrix interference and##2##3##(2008-10#2)
matrix interference effect on the##2##5##(2008-10#2)
matrix interference##15##2##(2008-10#14)(2009-8#1)
matrix interferences can be eliminated because of the different retention times of the derivatives##2##14##(2008-11#2)
matrix interferences in##3##3##(2008-10#3)
matrix interferences##17##2##(2008-10#15)(2008-11#2)
matrix inversion of##2##3##(2008-2#2)
matrix inversion##4##2##(2008-2#4)
matrix ionized calcium##2##3##(1990-2#2)
matrix is an##3##3##(2008-8#2)(2008-9#1)
matrix is##23##2##(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)
matrix isopotential synchronous##2##3##(2008-10#2)
matrix made of##2##3##(2008-10#1)(2008-5#1)
matrix management##3##2##(1994-3#1)(1995-1#1)(2012-2#1)
matrix matched##4##2##(2008-10#4)
matrix matching##4##2##(2008-10#4)
matrix materials##2##2##(2008-10#2)
matrix may##4##2##(1997-3#1)(2008-10#1)(2008-8#2)
matrix membrane sensors for##2##4##(2008-10#2)
matrix membrane sensors##3##3##(2008-10#3)
matrix membrane##5##2##(2008-10#5)
matrix metalloproteinase##4##2##(1997-2#1)(2008-9#1)(2009-3#1)(2011-2#1)
matrix metalloproteinase-1##2##2##(1994-3#2)
matrix metalloproteinase-2 (MMP-2)##2##3##(2008-9#1)(2009-3#1)
matrix metalloproteinase-2##3##2##(1997-2#1)(2008-9#1)(2009-3#1)
matrix metalloproteinases and##4##3##(2008-1#1)(2008-9#1)(2009-3#1)(2013-1#1)
matrix metalloproteinases##7##2##(1993-3#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-3#1)(2013-1#1)
matrix method##3##2##(1990-8#1)(2008-3#1)(2008-6#1)
matrix modification##4##2##(1991-12#2)(2008-10#2)
matrix modifiers##3##2##(2008-10#3)
matrix of the##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)
matrix of##21##2##(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#2)(2009-8#1)
matrix on the##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
matrix on##4##2##(1994-8#1)(2008-10#2)(2008-11#1)
matrix or##3##2##(2008-10#2)(2008-2#1)
matrix protein##3##2##(1990-2#1)(2008-7#1)(2013-1#1)
matrix proteins##7##2##(1994-12#1)(1995-9#1)(2008-11#3)(2008-5#1)(2009-12#1)
matrix quality can##2##3##(2008-8#2)
matrix quality##5##2##(2008-8#3)(2012-2#2)
matrix resulted in a##2##4##(2008-10#2)
matrix samples##3##2##(2008-10#3)
matrix separation##6##2##(2008-10#6)
matrix showed##2##2##(2008-10#2)
matrix solid phase dispersion##3##4##(2008-10#3)
matrix spiking and recovery analyses##4##5##(2008-10#4)
matrix that##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
matrix through##2##2##(2008-10#2)
matrix to the##2##3##(2008-10#2)
matrix to##5##2##(2008-10#3)(2009-7#1)(2012-12#1)
matrix using##2##2##(2008-10#2)
matrix was analyzed by##2##4##(2008-10#2)
matrix was developed##2##3##(2008-10#1)(2010-7#1)
matrix was nearly##2##3##(2008-10#2)
matrix was used for sensor##2##5##(2008-10#2)
matrix was used for##4##4##(2008-10#4)
matrix was used##6##3##(2008-10#6)
matrix was##38##2##(2008-10#30)(2008-11#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-7#1)
matrix were##7##2##(2008-10#7)
matrix with a##2##3##(2008-10#2)
matrix with##9##2##(2008-10#8)(2009-4#1)
matrix##747##1##(1990-2#6)(1990-4#1)(1990-5#5)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#3)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#4)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#438)(2008-11#30)(2008-12#2)(2008-2#8)(2008-3#25)(2008-4#5)(2008-5#30)(2008-6#1)(2008-7#14)(2008-8#31)(2008-9#15)(2009-10#4)(2009-12#5)(2009-3#6)(2009-4#4)(2009-7#9)(2009-8#2)(2010-11#6)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#6)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#13)(2012-3#4)(2012-4#1)(2013-1#5)(2013-8#3)
matrix)##5##1##(2008-10#2)(2008-5#1)(2008-8#2)
matrix-assisted laser desorption/ionization (MALDI)##2##4##(2008-11#1)(2010-7#1)
matrix-assisted laser desorption/ionization##6##3##(2008-10#1)(2008-11#4)(2010-7#1)
matrix-assisted laser##8##2##(2008-10#3)(2008-11#4)(2010-7#1)
matrix-assisted##9##1##(2008-10#3)(2008-11#5)(2010-7#1)
matrix-free standards##2##2##(1991-12#1)(2008-10#1)
matrix-matched##3##1##(2008-10#2)(2010-11#1)
matrix-matching procedure##2##2##(2008-10#2)
matrix-rich##4##1##(2010-12#2)(2010-4#2)
matrixes of##2##2##(2008-10#2)
matrixes##10##1##(2008-10#10)
mats were##2##2##(2011-2#2)
mats##9##1##(1990-11#2)(2008-10#1)(2011-2#6)
matter and the##2##3##(2010-7#1)(2013-8#1)
matter and##11##2##(1997-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-8#1)
matter are##4##2##(2008-10#2)(2008-3#2)
matter by##6##2##(2008-10#4)(2008-11#2)
matter collected on##3##3##(2008-10#3)
matter collected##5##2##(2008-10#5)
matter contents##2##2##(2008-10#2)
matter how##6##2##(1994-12#1)(2008-7#4)(2010-10#1)
matter if##2##2##(1997-1#1)(2008-10#1)
matter in the##2##3##(2008-10#1)(2008-12#1)
matter in##6##2##(2008-10#2)(2008-11#3)(2008-12#1)
matter is##7##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-8#1)
matter of fact##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
matter of the##2##3##(1995-11#1)(2008-10#1)
matter of##29##2##(1991-3#1)(1993-12#1)(1995-11#1)(1997-5#2)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2013-1#2)(2013-8#1)
matter on##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
matter or##2##2##(2007-12#1)(2008-3#1)
matter such as##2##3##(2008-10#1)(2010-12#1)
matter that##2##2##(2008-1#1)(2010-12#1)
matter to the##2##3##(2008-10#2)
matter to##6##2##(1995-12#1)(1997-6#1)(2008-10#3)(2008-11#1)
matter was##6##2##(2008-10#5)(2008-5#1)
matter were##3##2##(1996-11#1)(2008-10#2)
matter which##2##2##(2008-10#1)(2011-2#1)
matter with##5##2##(1992-5#1)(2008-10#2)(2008-11#1)(2008-7#1)
matter##234##1##(1991-3#1)(1991-9#1)(1992-5#2)(1993-12#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-5#2)(1996-1#1)(1996-11#2)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#2)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#112)(2008-11#23)(2008-12#5)(2008-2#1)(2008-3#7)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-7#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#5)(2013-8#8)
matter)##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
matter?##5##1##(2008-11#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
matters to##2##2##(1996-12#1)(2013-8#1)
matters##23##1##(1990-6#1)(1991-2#1)(1993-1#1)(1995-12#3)(1996-12#1)(1997-2#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-8#1)(2011-2#3)(2013-8#1)
maturase##2##1##(1995-6#2)
maturation and##23##2##(1990-8#1)(1991-7#1)(1992-12#1)(1996-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-3#1)(2011-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
maturation in the##2##3##(1993-12#1)(2008-8#1)
maturation in vitro##2##3##(2008-9#1)(2012-2#1)
maturation in##9##2##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#2)
maturation is##2##2##(2008-5#1)(2008-8#1)
maturation of CEs##4##3##(2008-5#4)
maturation of adipose tissue with##2##5##(2008-11#2)
maturation of the spinal##2##4##(1992-12#2)
maturation of the##10##3##(1992-12#3)(1995-11#1)(2008-10#1)(2008-5#2)(2011-2#2)(2012-2#1)
maturation of##33##2##(1992-12#3)(1995-11#1)(1995-6#1)(1995-8#1)(2008-10#5)(2008-11#4)(2008-5#7)(2008-8#1)(2009-6#2)(2010-11#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#2)
maturation##126##1##(1990-8#1)(1991-7#1)(1992-12#4)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-6#2)(2007-12#1)(2008-10#24)(2008-11#8)(2008-12#2)(2008-5#20)(2008-7#2)(2008-8#9)(2008-9#2)(2009-12#1)(2009-6#3)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#2)
mature CEs##2##2##(2008-5#2)
mature DC##2##2##(2008-11#2)
mature DCs##3##2##(2011-2#3)
mature adipocytes##7##2##(2008-11#2)(2010-6#1)(2011-2#2)(2012-4#1)(2013-1#1)
mature and##3##2##(1991-11#1)(1995-8#1)(1997-6#1)
mature apothecia##2##2##(2008-10#2)
mature ascospores##2##2##(2008-10#2)
mature berries##2##2##(2008-10#2)
mature blood##2##2##(2008-11#2)
mature cystic teratoma (dermoid##2##4##(2013-8#2)
mature cystic teratoma##4##3##(2013-8#4)
mature dendritic cells##2##3##(2011-2#2)
mature erythrocytes##2##2##(2008-9#2)
mature form of##3##3##(1990-11#1)(1993-2#1)(2008-4#1)
mature form##6##2##(1990-11#1)(1993-2#1)(1995-8#2)(1997-1#1)(2008-4#1)
mature fruit##6##2##(2008-10#6)
mature fruits##3##2##(2008-10#2)(2012-2#1)
mature hematopoietic cells##2##3##(2008-9#1)(2010-8#1)
mature into##3##2##(2008-11#1)(2008-4#1)(2009-8#1)
mature lamin A##2##3##(2011-2#2)
mature leaves##3##2##(2008-10#1)(2008-9#2)
mature male##2##2##(2008-5#1)(2012-3#1)
mature oocytes##2##2##(2008-5#1)(2012-3#1)
mature osteoclasts through the##2##4##(2008-11#2)
mature osteoclasts through##3##3##(2008-11#3)
mature osteoclasts##7##2##(2008-11#7)
mature peptide##2##2##(1992-8#1)(2008-8#1)
mature pollen##3##2##(2008-10#1)(2009-12#2)
mature protective protein was detected##2##5##(1994-11#2)
mature protective protein##3##3##(1994-11#3)
mature protein of##2##3##(1990-5#1)(2008-10#1)
mature protein##9##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-11#3)(2008-10#1)
mature pseudothecia##4##2##(2008-10#4)
mature sperm##2##2##(2007-12#2)
mature##209##1##(1990-11#1)(1990-12#4)(1990-5#3)(1991-10#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#3)(1993-6#1)(1993-8#2)(1994-11#6)(1994-12#2)(1994-2#1)(1994-8#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#5)(1995-8#4)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-10#50)(2008-11#24)(2008-12#2)(2008-4#3)(2008-5#8)(2008-7#5)(2008-8#4)(2008-9#11)(2009-10#1)(2009-12#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-8#3)(2011-2#12)(2011-3#3)(2012-2#3)(2012-3#6)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#5)
matured and##2##2##(2008-10#1)(2008-11#1)
matured in##2##2##(2008-5#1)(2008-9#1)
matured on##2##2##(2008-10#2)
matured oocytes##2##2##(2008-9#1)(2013-1#1)
matured rapidly##2##2##(2008-10#1)(2008-11#1)
matured##18##1##(1993-12#1)(1995-6#1)(2008-10#5)(2008-11#4)(2008-5#2)(2008-9#2)(2010-8#1)(2013-1#2)
maturing##9##1##(1993-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#2)
maturity and then##2##3##(1991-12#1)(2008-5#1)
maturity and##15##2##(1991-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#4)
maturity in##3##2##(2008-10#2)(2012-3#1)
maturity of##7##2##(1995-5#1)(2008-10#4)(2009-10#2)
maturity##58##1##(1991-12#1)(1993-2#1)(1994-3#1)(1995-5#1)(1997-2#1)(2007-8#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-5#4)(2008-8#5)(2008-9#10)(2009-10#2)(2010-8#2)(2012-2#2)(2012-3#1)
max##3##1##(1990-5#1)(1993-8#1)(2008-10#1)
max)##10##1##(2008-10#9)(2008-11#1)
maxilla##16##1##(1996-3#1)(2008-6#1)(2010-5#1)(2011-2#2)(2011-7#1)(2012-12#1)(2013-1#9)
maxillary canine##2##2##(2013-1#2)
maxillary canines##3##2##(2013-1#3)
maxillary premolars##2##2##(2013-1#2)
maxillary sensilla styloconica of##2##4##(2008-8#2)
maxillary sensilla styloconica##3##3##(2008-8#3)
maxillary sinus##8##2##(1993-1#1)(2008-11#1)(2008-5#1)(2011-7#1)(2013-1#4)
maxillary##39##1##(1990-12#1)(1990-3#1)(1991-2#1)(1993-1#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-8#3)(2010-1#1)(2011-2#1)(2011-7#2)(2012-12#1)(2013-1#23)
maxillofacial surgery##10##2##(1993-1#4)(2008-7#4)(2011-2#1)(2012-3#1)
maxillofacial##16##1##(1993-1#4)(2007-12#1)(2008-7#6)(2011-2#2)(2012-3#2)(2013-1#1)
maxillomandibular##2##1##(2009-3#1)(2009-5#1)
maxima and Achatina achatina##2##4##(2008-12#2)
maxima and##3##2##(2008-12#2)(2008-3#1)
maxima are##2##2##(1994-5#1)(2008-8#1)
maxima at 410 and##2##4##(2008-10#1)(2008-11#1)
maxima at##7##2##(2008-10#6)(2008-11#1)
maxima in the lag##2##4##(2008-11#2)
maxima in the##6##3##(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)
maxima in##8##2##(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)
maxima of the##3##3##(2008-10#2)(2010-8#1)
maxima of##4##2##(2008-10#3)(2010-8#1)
maxima ranging from##2##3##(2008-10#2)
maxima was##2##2##(2008-10#1)(2008-12#1)
maxima were##2##2##(2008-10#1)(2008-5#1)
maxima##45##1##(1994-5#1)(2008-10#21)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#3)(2010-8#3)
maximal activity##2##2##(1992-12#1)(1994-5#1)
maximal at##3##2##(1991-12#1)(2008-10#1)(2013-8#1)
maximal cell concentration##2##3##(2008-11#2)
maximal cell density##2##3##(2008-11#2)
maximal cell##6##2##(2008-11#6)
maximal concentration##2##2##(2008-12#1)(2010-12#1)
maximal detector response##2##3##(2008-10#2)
maximal effect##2##2##(1993-8#1)(1997-1#1)
maximal expiratory flow##3##3##(2008-1#1)(2008-7#1)(2009-1#1)
maximal expiratory##4##2##(1997-2#1)(2008-1#1)(2008-7#1)(2009-1#1)
maximal in the##2##3##(1990-10#1)(2008-9#1)
maximal in##3##2##(1990-10#1)(1997-1#1)(2008-9#1)
maximal level##5##2##(1991-9#1)(1994-11#1)(1997-7#1)(2008-10#1)(2008-9#1)
maximal levels##4##2##(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)
maximal occlusion##3##2##(2013-1#3)
maximal oxygen uptake##2##3##(2013-1#1)(2013-8#1)
maximal oxygen##3##2##(2013-1#1)(2013-8#2)
maximal pressure##2##2##(2008-8#1)(2013-1#1)
maximal recovery##2##2##(1994-12#2)
maximal surgical resection##2##3##(2011-3#1)(2013-1#1)
maximal total##2##2##(1994-8#1)(2008-10#1)
maximal voluntary contraction##4##3##(2010-6#1)(2010-9#1)(2013-8#2)
maximal##145##1##(1990-10#1)(1990-12#2)(1990-8#2)(1991-12#1)(1991-5#4)(1991-9#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#23)(2008-11#16)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-1#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#6)
maximally##9##1##(1990-5#1)(1991-2#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-2#1)
maximise the##4##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
maximise##9##1##(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-12#1)(2013-8#2)
maximization of##4##2##(2008-7#2)(2008-9#1)(2012-2#1)
maximization##7##1##(1994-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
maximize the beneficial##2##3##(2008-10#1)(2008-9#1)
maximize the number of##2##4##(2008-4#1)(2012-2#1)
maximize the##18##2##(1993-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#2)(2011-2#1)(2012-2#1)
maximize##43##1##(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#8)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#6)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)
maximized##10##1##(1996-2#1)(2008-10#2)(2008-11#3)(2008-8#2)(2008-9#1)(2013-1#1)
maximizes the##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
maximizes##10##1##(1996-1#1)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#3)(2012-2#1)
maximizing the##10##2##(1991-12#1)(2008-10#2)(2008-9#1)(2009-10#1)(2010-12#3)(2010-3#1)(2012-2#1)
maximizing treatment##2##2##(2008-11#1)(2010-12#1)
maximizing##18##1##(1991-12#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#4)(2010-3#2)(2012-2#1)
maximum 3 months##2##3##(1996-2#1)(2008-12#1)
maximum absorbance at##7##3##(2008-10#7)
maximum absorbance for##2##3##(2008-10#2)
maximum absorbance##13##2##(2008-10#13)
maximum absorption wavelength##6##3##(2008-10#5)(2008-3#1)
maximum absorption##13##2##(2008-10#11)(2008-3#1)(2013-1#1)
maximum acceptable##2##2##(2008-9#1)(2010-3#1)
maximum activity was##2##3##(1991-6#1)(2012-2#1)
maximum activity##4##2##(1991-6#1)(1994-8#1)(2010-3#1)(2012-2#1)
maximum amount of##6##3##(2008-10#2)(2008-12#1)(2008-7#2)(2009-7#1)
maximum amount##7##2##(2008-10#2)(2008-12#1)(2008-7#2)(2009-5#1)(2009-7#1)
maximum and minimum##5##3##(2008-10#4)(2008-8#1)
maximum and##7##2##(2008-10#6)(2008-8#1)
maximum around##2##2##(2008-10#2)
maximum at 285 nm##2##4##(2008-10#2)
maximum at 30##2##3##(1995-2#1)(2008-9#1)
maximum at 580 nm##2##4##(2008-10#1)(2008-8#1)
maximum at around pH##2##4##(2008-10#2)
maximum at##35##2##(1993-3#1)(1993-8#1)(1995-2#1)(2008-10#22)(2008-12#1)(2008-3#2)(2008-8#4)(2008-9#1)(2013-1#1)(2013-8#1)
maximum average of##4##3##(1996-12#4)
maximum average##9##2##(1996-12#5)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
maximum binding##5##2##(1995-8#2)(2008-10#3)
maximum cell density and##2##4##(2008-11#1)(2008-7#1)
maximum cell density##8##3##(1993-8#1)(2008-11#5)(2008-7#2)
maximum cell##11##2##(1993-8#1)(2008-11#8)(2008-7#2)
maximum colour##2##2##(2008-10#2)
maximum concentration of##3##3##(1993-8#1)(2008-11#1)(2012-2#1)
maximum concentration##5##2##(1993-8#1)(2008-10#1)(2008-11#2)(2012-2#1)
maximum concentrations##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
maximum conversion efficiency of##2##4##(2007-12#2)
maximum difference##3##2##(1996-2#1)(2008-11#2)
maximum disease severity##2##3##(2008-10#2)
maximum disease##3##2##(2008-10#3)
maximum effectiveness##2##2##(1994-3#1)(2013-1#1)
maximum emission wavelength##2##3##(2008-10#2)
maximum emission##3##2##(2008-10#3)
maximum excitation and emission wavelengths##5##5##(2008-10#5)
maximum excitation##6##2##(2008-10#6)
maximum expression of##2##3##(1990-5#1)(2008-11#1)
maximum fluorescence##2##2##(2008-10#2)
maximum fresh##2##2##(1996-12#1)(2009-6#1)
maximum growth rate of##2##4##(2008-11#1)(2008-8#1)
maximum growth rate##4##3##(2008-11#1)(2008-8#2)(2011-2#1)
maximum in##13##2##(1997-3#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2010-5#1)(2012-3#1)
maximum increase in##2##3##(1997-3#1)(2013-1#1)
maximum infection##2##2##(2008-10#2)
maximum is##4##2##(1994-5#1)(2008-10#2)(2008-8#1)
maximum length##2##2##(1997-8#1)(2008-11#1)
maximum level##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
maximum levels at##2##3##(1995-11#1)(2008-10#1)
maximum levels of##3##3##(1993-8#1)(1996-12#1)(2009-6#1)
maximum levels##7##2##(1993-8#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-6#1)
maximum likelihood method##3##3##(2008-10#2)(2012-3#1)
maximum likelihood##18##2##(1994-9#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#2)(2012-3#4)
maximum likelihood-based##2##2##(2008-10#1)(2008-6#1)
maximum loading##3##2##(2008-10#2)(2010-11#1)
maximum loads##2##2##(2010-10#1)(2013-1#1)
maximum number of##8##3##(2008-10#7)(2008-3#1)
maximum number##9##2##(2008-10#8)(2008-3#1)
maximum of 10##2##3##(1992-9#1)(1996-5#1)
maximum of 12##2##3##(2008-10#2)
maximum of 2##3##3##(2008-10#2)(2008-11#1)
maximum of the##4##3##(2008-10#4)
maximum of##31##2##(1990-3#1)(1990-5#2)(1991-6#1)(1992-9#1)(1994-5#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-7#1)(2008-8#2)(2009-9#1)
maximum on##2##2##(2008-10#1)(2008-9#1)
maximum output power##2##3##(2008-3#2)
maximum output##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
maximum oxygen uptake##5##3##(2008-7#2)(2013-8#3)
maximum parsimony##5##2##(2008-10#4)(2008-9#1)
maximum peak##2##2##(2008-10#2)
maximum per-plant yield loss##2##4##(2008-10#2)
maximum performance##3##2##(2008-10#1)(2008-9#2)
maximum permissible levels##2##3##(2008-10#2)
maximum permissible load weight##2##4##(2013-1#2)
maximum permissible load##3##3##(2013-1#3)
maximum permissible##7##2##(1993-3#1)(2008-10#3)(2013-1#3)
maximum population##2##2##(2008-10#1)(2011-2#1)
maximum possible##4##2##(2008-10#3)(2008-8#1)
maximum pressure##2##2##(1994-2#1)(2013-1#1)
maximum production##2##2##(2008-11#2)
maximum rate of##3##3##(1994-3#1)(2008-8#2)
maximum rate##5##2##(1994-3#1)(1995-6#1)(2008-10#1)(2008-8#2)
maximum recovery of##2##3##(1994-12#1)(2008-12#1)
maximum recovery##3##2##(1994-12#1)(2008-12#2)
maximum reduction##2##2##(1994-5#1)(2008-11#1)
maximum residue level##2##3##(2008-10#2)
maximum response##4##2##(2008-10#3)(2008-11#1)
maximum retention##2##2##(2008-10#2)
maximum scattering##2##2##(2008-10#2)
maximum sensitivity and##2##3##(2008-10#2)
maximum sensitivity##5##2##(2008-10#5)
maximum signal##2##2##(2008-10#2)
maximum sorption##3##2##(2008-10#3)
maximum specific growth rate##5##4##(2008-10#1)(2008-7#3)(2010-11#1)
maximum specific growth##6##3##(2008-10#1)(2008-7#4)(2010-11#1)
maximum specific##8##2##(2008-10#1)(2008-11#2)(2008-7#4)(2010-11#1)
maximum speed##2##2##(1994-8#1)(2009-5#1)
maximum stability##4##2##(2008-10#4)
maximum striga##7##2##(2008-10#7)
maximum substrate consumption##2##3##(2008-7#2)
maximum susceptibility##4##2##(2008-10#4)
maximum temperature and##2##3##(2008-10#1)(2008-3#1)
maximum temperature##9##2##(2008-10#6)(2008-3#1)(2012-3#1)(2013-8#1)
maximum to##2##2##(1994-5#1)(2008-10#1)
maximum tolerable##2##2##(2008-10#2)
maximum value at##2##3##(2008-10#1)(2010-1#1)
maximum value##8##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-1#1)
maximum values##3##2##(2008-10#2)(2010-5#1)
maximum velocity##2##2##(2008-7#1)(2010-8#1)
maximum voluntary contraction##2##3##(2010-6#2)
maximum was##4##2##(1991-3#1)(1995-2#1)(2008-10#1)(2008-7#1)
maximum wavelength of##2##3##(2008-10#2)
maximum yield of##2##3##(2008-11#1)(2008-12#1)
maximum##587##1##(1990-3#1)(1990-5#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#4)(1993-8#5)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#5)(1994-8#2)(1994-9#3)(1995-11#1)(1995-2#4)(1995-6#2)(1995-8#2)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#3)(1997-3#2)(1997-8#2)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#288)(2008-11#42)(2008-12#12)(2008-2#4)(2008-3#20)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#22)(2008-8#21)(2008-9#12)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#3)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#15)(2012-3#7)(2013-1#14)(2013-8#9)
maximum)##4##1##(2008-10#2)(2010-8#2)
maximum-likelihood##2##1##(2008-10#1)(2010-3#1)
maximums##2##1##(2008-10#2)
maximus##2##1##(1990-5#1)(2008-10#1)
may accelerate##2##2##(2008-12#1)(2008-7#1)
may account for the##7##4##(1990-12#1)(2008-10#3)(2008-8#1)(2010-1#1)(2012-3#1)
may account for##16##3##(1990-12#2)(1991-12#1)(1992-12#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#3)(2010-1#1)(2012-3#1)
may achieve##2##2##(1990-8#1)(2008-12#1)
may act as a##7##4##(1990-5#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
may act as an##2##4##(1990-2#1)(2008-11#1)
may act as##17##3##(1990-2#1)(1990-5#1)(1992-10#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-11#4)(2008-7#1)(2008-8#1)(2012-2#1)
may act##24##2##(1990-2#1)(1990-5#2)(1992-10#1)(1995-12#1)(1996-12#1)(1996-2#1)(2006-6#1)(2008-10#6)(2008-11#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
may activate##4##2##(1991-5#1)(2007-11#1)(2008-10#1)(2011-2#1)
may actually reduce##2##3##(2010-3#1)(2011-3#1)
may actually##6##2##(1991-9#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)(2011-3#1)
may adversely##3##2##(1997-2#1)(2008-4#1)(2010-4#1)
may affect the##14##3##(1993-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2010-11#1)(2012-3#2)
may affect their##2##3##(1997-3#1)(2012-2#1)
may affect##32##2##(1990-11#1)(1990-3#1)(1991-11#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
may aid in the##2##4##(2008-11#1)(2010-9#1)
may aid in##3##3##(2008-10#1)(2008-11#1)(2010-9#1)
may aid##4##2##(2008-10#1)(2008-11#1)(2010-9#1)(2011-7#1)
may all##3##2##(2008-10#2)(2009-10#1)
may alleviate##2##2##(2008-10#1)(2012-12#1)
may allow for a##2##4##(2008-8#1)(2008-9#1)
may allow one to##2##4##(1997-2#1)(2009-8#1)
may allow some##2##3##(1991-1#1)(2008-9#1)
may allow the##4##3##(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#1)
may allow us to##2##4##(2008-10#2)
may allow##23##2##(1991-1#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#1)(2013-8#1)
may already be##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
may already##4##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)
may also assist in##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
may also be a##4##4##(1994-2#1)(2008-11#1)(2008-8#2)
may also be applied##2##4##(2008-10#1)(2008-9#1)
may also be effective##2##4##(1997-1#1)(2008-7#1)
may also be influenced##2##4##(2008-10#1)(2008-8#1)
may also be present in##2##5##(2008-7#1)(2010-5#1)
may also be relevant##2##4##(2009-8#1)(2012-2#1)
may also be used to##2##5##(1996-2#1)(2008-9#1)
may also be used##3##4##(1996-2#1)(2008-10#1)(2008-9#1)
may also be useful##2##4##(2008-7#1)(2012-12#1)
may also be##34##3##(1994-2#1)(1994-5#1)(1996-2#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
may also cause##4##3##(2006-6#1)(2011-2#3)
may also contribute to##5##4##(1990-11#1)(1995-2#1)(2008-10#1)(2008-7#1)(2010-5#1)
may also have a##2##4##(2008-5#1)(2011-2#1)
may also have an important##2##5##(1995-6#1)(2012-3#1)
may also have an##3##4##(1995-6#1)(2008-10#1)(2012-3#1)
may also have therapeutic##2##4##(1994-2#1)(1997-1#1)
may also have##11##3##(1993-1#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-3#1)
may also involve##2##3##(1997-3#1)(2008-12#1)
may also occur through##2##4##(2008-10#2)
may also occur##5##3##(2008-10#2)(2008-8#2)(2009-12#1)
may also play a##2##4##(2009-1#1)(2011-2#1)
may also play##3##3##(1994-11#1)(2009-1#1)(2011-2#1)
may also present##2##3##(1994-9#1)(2008-10#1)
may also prevent##4##3##(1993-2#1)(2008-8#2)(2009-8#1)
may also provide##2##3##(2008-4#1)(2008-8#1)
may also reduce##2##3##(2008-9#1)(2013-1#1)
may also serve as a transformative model for emerging EMR/EHR requirements##4##11##(2010-8#4)
may also serve##6##3##(1990-11#1)(2008-11#1)(2010-8#4)
may also suffer##2##3##(2009-8#1)(2011-2#1)
may also##114##2##(1990-11#2)(1991-12#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-10#17)(2008-11#6)(2008-12#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#4)(2010-12#2)(2010-5#2)(2010-8#4)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
may alter the##8##3##(1994-12#1)(1994-6#1)(1997-7#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
may alter##13##2##(1991-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
may appear##5##2##(1991-7#1)(1992-5#1)(2008-10#1)(2008-11#1)(2010-8#1)
may apply##2##2##(1995-2#1)(2011-2#1)
may arise from the##2##4##(1991-8#1)(2009-8#1)
may arise from##7##3##(1991-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-12#1)
may arise in##2##3##(1994-3#1)(2008-7#1)
may arise##15##2##(1991-8#1)(1992-9#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
may arrest##2##2##(2008-9#1)(2009-9#1)
may assist in the diagnosis##2##5##(1991-12#1)(2011-2#1)
may assist in the##4##4##(1991-12#1)(2010-10#1)(2011-2#1)(2012-2#1)
may assist in##7##3##(1991-12#1)(2008-10#1)(2010-10#1)(2011-2#2)(2012-2#2)
may assist##11##2##(1991-12#1)(2008-10#1)(2010-10#2)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-8#1)
may at##4##2##(2008-11#2)(2008-8#1)(2011-2#1)
may attach##2##2##(2008-11#2)
may avoid##6##2##(1990-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-6#1)(2012-3#1)
may be a candidate##2##4##(2008-9#1)(2009-9#1)
may be a common##3##4##(1990-5#1)(1994-11#1)(1997-3#1)
may be a general##2##4##(2008-10#1)(2008-7#1)
may be a good##2##4##(2008-11#1)(2013-1#1)
may be a major##2##4##(1991-11#1)(1997-8#1)
may be a more##3##4##(1993-12#1)(2008-10#1)(2011-2#1)
may be a novel##2##4##(1997-1#1)(2013-1#1)
may be a possible##3##4##(1993-3#1)(2008-7#1)(2013-1#1)
may be a promising##2##4##(2008-10#2)
may be a reflection of##2##5##(2008-10#1)(2012-3#1)
may be a significant##2##4##(2008-10#1)(2011-2#1)
may be a simple##2##4##(1996-12#1)(2008-7#1)
may be a suitable alternative##2##5##(1996-1#1)(2008-10#1)
may be a useful##11##4##(1991-3#1)(1992-12#2)(1993-3#1)(1995-2#1)(2008-10#3)(2009-6#1)(2010-11#1)(2011-2#1)
may be a valuable tool##2##5##(1997-2#1)(2008-11#1)
may be a valuable##3##4##(1997-2#1)(2008-10#1)(2008-11#1)
may be a##96##3##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#3)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
may be able to##11##4##(1993-11#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2011-7#1)(2012-12#1)
may be achieved by##5##4##(1995-11#1)(2008-10#1)(2008-8#2)(2009-8#1)
may be achieved in##2##4##(1993-1#1)(2013-7#1)
may be achieved with the##2##5##(1995-3#1)(2008-3#1)
may be achieved with##3##4##(1995-3#1)(2008-3#1)(2008-7#1)
may be achieved##13##3##(1992-9#1)(1993-1#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)(2013-7#1)
may be acting as##3##4##(1990-11#1)(2012-2#2)
may be adapted##2##3##(2008-10#1)(2008-4#1)
may be administered##3##3##(1997-5#1)(2008-3#1)(2010-12#1)
may be adopted##2##3##(2008-6#1)(2013-8#1)
may be advantageous##2##3##(1997-7#1)(2008-10#1)
may be affected by a variety of##2##7##(1997-8#1)(2013-1#1)
may be affected by##5##4##(1994-3#1)(1997-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
may be affected##7##3##(1994-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
may be also##2##3##(2008-10#1)(2012-3#1)
may be an additional mechanism##2##5##(1992-12#1)(2013-1#1)
may be an additional##4##4##(1992-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
may be an alternative##4##4##(1997-7#1)(1997-8#1)(2008-10#1)(2013-1#1)
may be an effective means##2##5##(2008-10#1)(2012-2#1)
may be an effective##12##4##(1991-2#1)(2008-10#3)(2008-11#2)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
may be an efficient##2##4##(2008-9#1)(2010-8#1)
may be an important mechanism of##2##6##(2008-10#1)(2011-2#1)
may be an important mechanism##4##5##(2008-10#2)(2008-8#1)(2011-2#1)
may be an important##14##4##(1994-11#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-8#3)(2011-2#1)(2013-7#1)
may be an indirect##2##4##(1993-11#1)(1997-3#1)
may be an##55##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-8#3)(2008-9#3)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
may be analyzed in a##2##5##(1991-5#1)(2008-9#1)
may be analyzed in##3##4##(1991-5#1)(2008-4#1)(2008-9#1)
may be analyzed##4##3##(1991-5#1)(2008-4#1)(2008-9#1)(2013-8#1)
may be applicable to##3##4##(2006-6#1)(2008-11#1)(2010-2#1)
may be applicable##4##3##(2006-6#1)(2008-11#1)(2010-2#1)(2012-2#1)
may be applied for##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
may be applied in##2##4##(2008-7#1)(2011-2#1)
may be applied to##5##4##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
may be applied##13##3##(1993-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
may be appropriate for##2##4##(2008-10#1)(2013-1#1)
may be as##2##3##(1995-5#1)(2008-11#1)
may be ascribed##2##3##(2008-10#2)
may be associated with a##3##5##(1992-3#1)(2008-10#1)(2010-10#1)
may be associated with the##6##5##(1992-12#1)(1996-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2013-1#1)
may be associated with##27##4##(1992-12#1)(1992-3#2)(1993-3#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
may be associated##28##3##(1992-12#1)(1992-3#2)(1993-3#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-7#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
may be asymptomatic##3##3##(1991-4#1)(2008-12#1)(2013-1#1)
may be at increased risk for##2##6##(2008-11#1)(2011-2#1)
may be at least##3##4##(1997-7#1)(1997-8#2)
may be at##10##3##(1993-1#1)(1996-12#1)(1997-7#1)(1997-8#2)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#2)
may be attractive##2##3##(2009-7#1)(2013-1#1)
may be attributable to##3##4##(1993-12#1)(1994-2#1)(2008-11#1)
may be attributable##4##3##(1993-12#1)(1994-2#1)(1994-6#1)(2008-11#1)
may be attributed to its##2##5##(2008-12#1)(2012-3#1)
may be attributed to the reduction of##2##7##(2008-10#2)
may be attributed to the##7##5##(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)
may be attributed to their##2##5##(2008-10#1)(2008-11#1)
may be attributed to##14##4##(1996-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2012-3#2)
may be because##3##3##(1990-11#1)(2006-6#1)(2008-11#1)
may be beneficial for##4##4##(1995-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
may be beneficial in##3##4##(2011-2#2)(2012-2#1)
may be beneficial##10##3##(1995-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
may be better##4##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)
may be carried##2##3##(2008-10#2)
may be causally##2##3##(1992-9#1)(1994-6#1)
may be caused by a##2##5##(1994-12#1)(2008-10#1)
may be caused by##11##4##(1994-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)
may be clinically##2##3##(2010-10#1)(2010-12#1)
may be closely linked to##2##5##(2008-10#1)(2008-11#1)
may be closely##3##3##(2008-10#2)(2008-11#1)
may be collected##2##3##(2008-10#1)(2008-12#1)
may be common##2##3##(2008-1#1)(2008-10#1)
may be complicated by##3##4##(2008-9#1)(2010-10#1)(2011-2#1)
may be compromised##2##3##(2008-10#1)(2010-11#1)
may be confused with##2##4##(2008-9#1)(2011-2#1)
may be conserved##2##3##(2008-10#1)(2012-3#1)
may be considered a##10##4##(1991-6#1)(1993-6#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2011-2#1)
may be considered an##2##4##(1990-6#1)(2008-10#1)
may be considered as a first##2##6##(2007-12#1)(2009-10#1)
may be considered as##7##4##(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-8#1)(2011-2#1)
may be considered to be a##2##6##(2008-8#1)(2012-3#1)
may be considered to be##3##5##(2008-8#1)(2010-11#1)(2012-3#1)
may be considered to##4##4##(2008-11#1)(2008-8#1)(2010-11#1)(2012-3#1)
may be considered##29##3##(1990-6#1)(1991-6#1)(1992-2#1)(1993-6#1)(1994-3#1)(1995-12#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)
may be correlated with the##2##5##(1991-12#1)(2008-10#1)
may be correlated with##3##4##(1991-12#1)(2008-10#2)
may be correlated##5##3##(1991-12#1)(1993-3#1)(2008-10#3)
may be counteracted by##2##4##(1992-11#1)(1993-1#1)
may be critical for##3##4##(2008-10#1)(2008-8#1)(2012-7#1)
may be crucial##2##3##(1997-1#1)(2008-12#1)
may be defined as##2##4##(1993-6#1)(2008-1#1)
may be defined##3##3##(1993-6#1)(2008-1#1)(2011-2#1)
may be delayed##3##3##(1990-12#1)(1992-2#1)(2012-3#1)
may be demonstrated##2##3##(2008-10#1)(2008-5#1)
may be derived from##3##4##(1991-12#1)(2009-6#1)(2012-3#1)
may be derived##4##3##(1991-12#1)(2008-11#1)(2009-6#1)(2012-3#1)
may be desirable##3##3##(1993-1#1)(2008-11#1)(2008-4#1)
may be detected##3##3##(1990-12#1)(1997-5#1)(2008-4#1)
may be determined in a##2##5##(2008-10#2)
may be determined##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
may be different##5##3##(1996-12#1)(1996-2#1)(2008-12#1)(2008-8#1)(2012-2#1)
may be difficult to##5##4##(1991-2#1)(1992-2#1)(1992-3#1)(2008-11#1)(2013-1#1)
may be difficult##9##3##(1991-2#1)(1992-2#1)(1992-3#1)(1997-8#1)(2008-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
may be discovered##2##3##(2008-10#1)(2009-8#1)
may be distinct##2##3##(2006-6#1)(2008-10#1)
may be distinguished##2##3##(1997-1#1)(2008-5#1)
may be divided into##2##4##(2008-10#2)
may be due to the##9##5##(1993-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
may be due to##31##4##(1990-2#1)(1991-3#1)(1993-2#1)(1993-6#1)(1994-3#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
may be due##37##3##(1990-2#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-7#1)(2008-10#12)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
may be easily##2##3##(2008-10#2)
may be effective in##5##4##(2008-10#1)(2008-12#2)(2008-7#1)(2013-1#1)
may be effective##7##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
may be either##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2010-6#1)
may be employed##2##3##(1991-12#1)(2013-1#1)
may be encountered##5##3##(1996-9#1)(2008-11#1)(2011-1#1)(2012-2#2)
may be enhanced by##4##4##(1993-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
may be enhanced##5##3##(1993-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
may be equivalent##2##3##(2008-10#1)(2012-3#1)
may be especially##4##3##(2007-11#1)(2008-10#1)(2008-12#1)(2009-7#1)
may be evaluated##2##3##(2006-5#1)(2008-1#1)
may be expected to##3##4##(1992-12#1)(2008-7#1)(2012-3#1)
may be expected##7##3##(1991-3#1)(1992-12#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-7#1)(2012-3#1)
may be explained by the##3##5##(1990-5#1)(1992-12#1)(2010-5#1)
may be explained by##5##4##(1990-5#1)(1992-12#1)(2008-10#1)(2008-9#1)(2010-5#1)
may be explained##6##3##(1990-5#1)(1992-12#1)(2008-10#1)(2008-9#2)(2010-5#1)
may be exploited##2##3##(2009-6#1)(2013-1#1)
may be extremely##2##3##(1995-6#1)(2008-12#1)
may be found at##2##4##(2008-10#1)(2008-7#1)
may be found in##4##4##(1997-8#1)(2008-9#1)(2010-1#1)(2010-7#1)
may be found##8##3##(1990-5#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)
may be functionally##2##3##(2008-8#1)(2010-10#1)
may be genetically##2##3##(2008-10#2)
may be given##2##3##(1994-9#1)(2009-2#1)
may be helpful##3##3##(2009-11#1)(2011-2#1)(2013-8#1)
may be higher in##2##4##(1992-9#1)(2012-12#1)
may be identical to the##2##5##(1993-6#1)(1994-11#1)
may be identified##3##3##(1992-2#1)(2008-7#1)(2012-2#1)
may be implicated in the##2##5##(2008-8#1)(2008-9#1)
may be implicated in##3##4##(1991-3#1)(2008-8#1)(2008-9#1)
may be implicated##4##3##(1991-3#1)(1992-12#1)(2008-8#1)(2008-9#1)
may be important for##6##4##(1992-3#1)(1994-11#1)(1995-2#1)(1996-12#1)(2008-10#1)(2011-10#1)
may be important in the##2##5##(1992-6#1)(1993-8#1)
may be important in##13##4##(1992-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-12#1)(2008-10#5)(2012-2#1)
may be important##24##3##(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-7#1)(2008-9#1)(2009-6#1)(2011-10#1)(2012-2#1)
may be improved##2##3##(2010-8#1)(2013-1#1)
may be in##2##3##(2008-10#1)(2008-12#1)
may be increased in##2##4##(1993-3#1)(2008-10#1)
may be indicated##3##3##(2008-4#1)(2008-7#1)(2010-12#1)
may be induced by##2##4##(2008-10#1)(2008-8#1)
may be induced##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
may be influenced by##6##4##(1990-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2013-1#1)
may be influenced##7##3##(1990-3#1)(1990-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2013-1#1)
may be inhibitory##2##3##(2008-11#2)
may be initiated##2##3##(2008-10#1)(2009-11#1)
may be interesting##2##3##(1993-8#1)(2008-10#1)
may be involved in determining the##2##6##(1990-8#1)(1997-7#1)
may be involved in its##2##5##(2008-11#1)(2008-8#1)
may be involved in regulating##2##5##(2008-8#2)
may be involved in the development of##2##7##(1992-3#1)(2010-12#1)
may be involved in the regulation of##2##7##(2008-8#1)(2010-12#1)
may be involved in the##21##5##(1991-1#1)(1991-3#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-5#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2010-12#2)
may be involved in##50##4##(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#1)(1997-9#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#4)(2010-12#2)(2012-2#1)(2013-8#1)
may be involved##55##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#1)(1997-9#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#4)(2009-10#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
may be lacking in##2##4##(2008-10#2)
may be less##3##3##(1992-9#1)(1995-8#1)(2008-10#1)
may be limited##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
may be linked to the##2##5##(2008-7#1)(2012-2#1)
may be linked to##6##4##(1992-8#1)(1993-1#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
may be located##3##3##(1990-2#1)(2008-10#1)(2012-3#1)
may be long##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
may be lost##2##3##(1995-12#1)(2008-11#1)
may be made##3##3##(2010-7#1)(2012-2#1)(2013-1#1)
may be measured##2##3##(1990-12#1)(2008-10#1)
may be mediated by the##4##5##(2008-10#1)(2008-11#2)(2008-5#1)
may be mediated by##12##4##(1990-5#1)(1992-8#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
may be mediated through##2##4##(1991-1#1)(1995-12#1)
may be mediated##15##3##(1990-5#1)(1991-1#1)(1992-8#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
may be modified##3##3##(2008-10#1)(2008-5#1)(2010-10#1)
may be more appropriate##2##4##(2008-12#1)(2010-2#1)
may be more common in##2##5##(2008-7#1)(2008-8#1)
may be more important##2##4##(2010-1#1)(2013-1#1)
may be more suitable for##2##5##(2008-10#1)(2011-2#1)
may be more than##2##4##(2012-2#1)(2013-1#1)
may be more widespread than previously##2##6##(1996-3#1)(2008-10#1)
may be more##33##3##(1991-12#1)(1991-2#1)(1991-6#1)(1996-3#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#3)
may be necessary for##3##4##(1993-8#1)(2008-8#1)(2013-8#1)
may be necessary to##8##4##(1990-3#1)(1991-12#1)(1994-3#1)(2008-11#1)(2008-4#2)(2009-5#1)(2012-2#1)
may be necessary##12##3##(1990-3#1)(1991-12#1)(1993-8#1)(1994-3#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
may be needed to##2##4##(2008-8#1)(2009-8#1)
may be needed##9##3##(1990-11#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-1#1)
may be observed##4##3##(1997-8#1)(2008-11#1)(2009-11#1)(2012-12#1)
may be obtained##4##3##(1996-3#1)(2008-10#2)(2008-5#1)
may be of biological##2##4##(1990-5#1)(2011-2#1)
may be of importance##2##4##(1995-8#1)(2008-5#1)
may be of particular##3##4##(1993-12#2)(2013-8#1)
may be of potential use##2##5##(1993-12#1)(2010-4#1)
may be of use##2##4##(2008-11#2)
may be of value in##2##5##(2008-11#1)(2008-9#1)
may be of value##3##4##(2008-11#2)(2008-9#1)
may be of##24##3##(1990-2#1)(1990-5#1)(1993-12#3)(1994-8#1)(1995-8#2)(2008-10#3)(2008-11#5)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
may be one of the factors##4##6##(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
may be one of the mechanisms##2##6##(2008-10#1)(2009-12#1)
may be one of the##8##5##(1994-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2013-8#1)
may be one##11##3##(1993-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2013-8#1)
may be part of a##2##5##(1994-8#1)(2008-11#1)
may be part of an##3##5##(1992-2#1)(1992-4#1)(2008-10#1)
may be part of the##2##5##(1996-2#1)(2008-9#1)
may be part of##8##4##(1992-2#1)(1992-4#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
may be partially due to##2##5##(1994-11#1)(2008-10#1)
may be partially explained by##3##5##(1993-11#1)(2008-10#2)
may be partially##6##3##(1993-11#1)(1994-11#1)(1996-2#1)(2008-10#3)
may be particularly effective in##2##5##(2010-10#1)(2013-1#1)
may be particularly effective##3##4##(2008-10#1)(2010-10#1)(2013-1#1)
may be particularly useful##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
may be particularly##11##3##(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
may be performed in##2##4##(2008-4#1)(2011-2#1)
may be performed##8##3##(1990-12#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)
may be placed in##2##4##(1996-1#1)(2008-10#1)
may be placed##3##3##(1996-1#1)(1997-5#1)(2008-10#1)
may be possible by##3##4##(1996-12#1)(2008-3#1)(2009-7#1)
may be possible to##10##4##(1993-12#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)
may be possible##16##3##(1993-12#1)(1994-6#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2009-4#1)(2009-7#1)
may be potential##2##3##(1992-1#1)(2011-2#1)
may be predicted##2##3##(2008-10#1)(2008-11#1)
may be preferable##2##3##(2008-7#1)(2010-11#1)
may be present in##6##4##(2008-10#2)(2008-7#2)(2008-9#2)
may be present##14##3##(1991-12#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2011-2#1)
may be prevented by##2##4##(2013-1#2)
may be prevented##4##3##(2008-11#1)(2010-10#1)(2013-1#2)
may be produced by##3##4##(2008-7#1)(2008-8#1)(2009-10#1)
may be produced##5##3##(1990-11#1)(1994-3#1)(2008-7#1)(2008-8#1)(2009-10#1)
may be protective##2##3##(2009-7#1)(2013-1#1)
may be quite##2##3##(1993-3#1)(2008-10#1)
may be readily##2##3##(2008-10#1)(2008-11#1)
may be recommended##2##3##(1997-7#1)(2011-2#1)
may be reduced by##2##4##(1997-1#1)(2011-2#1)
may be reduced##7##3##(1993-8#1)(1997-1#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
may be regarded as a##2##5##(1991-3#1)(2008-10#1)
may be regarded as##3##4##(1991-3#1)(2008-10#2)
may be regulated by##3##4##(1993-12#1)(1995-11#1)(2009-6#1)
may be related to differences in##2##6##(2008-10#1)(2008-5#1)
may be related to the##13##5##(1992-6#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-8#1)
may be related to##34##4##(1990-5#1)(1990-8#1)(1991-6#1)(1992-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2010-1#3)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-8#1)
may be related##37##3##(1990-5#1)(1990-8#1)(1991-6#1)(1992-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2010-1#3)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-8#1)
may be relevant to##2##4##(2008-11#1)(2010-10#1)
may be required for##8##4##(1991-7#1)(1994-11#1)(1995-11#1)(1995-2#1)(2008-10#3)(2013-1#1)
may be required##12##3##(1991-7#1)(1994-11#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#3)(2010-11#1)(2012-3#1)(2013-1#2)
may be resistant to##2##4##(2008-10#1)(2009-9#1)
may be responsible for the##10##5##(1990-2#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-7#1)(2008-7#1)(2008-9#1)
may be responsible for this##2##5##(1996-6#1)(2013-1#1)
may be responsible for##25##4##(1990-2#1)(1990-8#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
may be responsible##27##3##(1990-2#1)(1990-8#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
may be retained##2##3##(1997-2#1)(2008-10#1)
may be safely##2##3##(1993-12#1)(2008-10#1)
may be selected##2##3##(2008-8#2)
may be significant##2##3##(2008-10#1)(2008-12#1)
may be similar##2##3##(2008-10#1)(2012-2#1)
may be simultaneously##2##3##(2008-10#1)(2009-10#1)
may be specific##2##3##(2009-10#1)(2010-6#1)
may be sufficient to achieve##2##5##(1994-5#1)(2008-10#1)
may be sufficient##4##3##(1991-2#1)(1994-5#1)(1997-8#1)(2008-10#1)
may be suitable for the##2##5##(2008-11#1)(2008-8#1)
may be suitable for##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
may be susceptible to failure in the healthcare setting##2##9##(2011-1#1)(2011-2#1)
may be synthesized##2##3##(1993-3#1)(2008-4#1)
may be targeted##2##3##(2009-8#1)(2012-3#1)
may be the basis##2##4##(2008-10#1)(2012-3#1)
may be the best##3##4##(2008-4#1)(2009-12#1)(2010-7#1)
may be the causal agent of one form of YLS##2##10##(2008-10#2)
may be the causal agent of##3##6##(2008-10#3)
may be the first##3##4##(1994-8#1)(1996-11#1)(2008-6#1)
may be the only option##2##5##(1992-3#1)(2008-9#1)
may be the reason for the##2##6##(2008-11#1)(2008-7#1)
may be the result of##8##5##(1991-12#1)(1993-12#1)(1996-2#1)(1997-1#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)
may be the result##9##4##(1991-12#1)(1991-3#1)(1993-12#1)(1996-2#1)(1997-1#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)
may be the##50##3##(1991-12#1)(1991-3#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2010-12#1)(2010-7#2)(2010-8#1)(2012-3#1)
may be to##4##3##(1992-6#1)(1997-7#1)(2008-10#1)(2008-12#1)
may be triggered by##2##4##(1997-6#1)(2012-3#1)
may be unique to##2##4##(1992-12#1)(2012-2#1)
may be used as a reference##2##6##(2008-10#1)(2008-12#1)
may be used as a##8##5##(1993-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
may be used as part of##2##6##(2008-10#1)(2010-5#1)
may be used as##18##4##(1990-11#1)(1993-11#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2010-6#1)(2012-3#1)(2013-1#1)
may be used for the##4##5##(1990-11#1)(2008-10#1)(2008-12#1)(2010-12#1)
may be used for##11##4##(1990-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2012-12#1)(2013-8#2)
may be used in##9##4##(1991-6#1)(1992-6#1)(1995-2#1)(2008-10#3)(2008-9#1)(2009-5#1)(2011-2#1)
may be used to##18##4##(1991-2#2)(1993-8#1)(1994-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-9#1)(2009-12#1)(2010-7#2)(2012-2#1)(2012-3#1)(2013-1#1)
may be used##60##3##(1990-11#2)(1991-2#2)(1991-6#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-10#13)(2008-11#6)(2008-12#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
may be useful as a##4##5##(1996-2#1)(2008-10#1)(2008-11#2)
may be useful as##7##4##(1996-2#1)(2008-10#3)(2008-11#2)(2011-2#1)
may be useful for evaluating##2##5##(2008-5#1)(2010-4#1)
may be useful for##16##4##(1990-8#1)(1994-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-2#2)(2012-2#1)
may be useful in defining##2##5##(2008-7#1)(2009-9#1)
may be useful in developing##2##5##(2008-10#1)(2013-8#1)
may be useful in preventing##2##5##(2008-11#1)(2013-7#1)
may be useful in screening##2##5##(2008-10#1)(2012-3#1)
may be useful in the##2##5##(2008-10#1)(2012-2#1)
may be useful in##18##4##(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
may be useful to##7##4##(1992-2#1)(1997-3#1)(2008-10#2)(2008-12#2)(2008-9#1)
may be useful##54##3##(1990-8#1)(1992-2#1)(1992-6#1)(1994-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(2008-10#18)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
may be utilized for the##2##5##(2008-10#2)
may be utilized##5##3##(2008-10#3)(2008-11#1)(2013-8#1)
may be very important for##2##5##(1990-12#1)(2010-7#1)
may be very important##3##4##(1990-12#1)(2008-7#1)(2010-7#1)
may be very##7##3##(1990-12#1)(1997-8#1)(2008-1#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)
may be vital to##2##4##(2008-11#1)(2008-8#1)
may be warranted in##2##4##(2008-10#1)(2008-7#1)
may be warranted##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
may be##1499##2##(1990-11#8)(1990-12#7)(1990-2#5)(1990-3#2)(1990-5#7)(1990-6#3)(1990-8#5)(1991-1#3)(1991-11#2)(1991-12#10)(1991-2#12)(1991-3#9)(1991-4#1)(1991-5#3)(1991-6#8)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#9)(1992-2#8)(1992-3#12)(1992-4#1)(1992-6#6)(1992-8#2)(1992-9#7)(1993-1#6)(1993-11#4)(1993-12#16)(1993-2#8)(1993-3#9)(1993-6#8)(1993-8#11)(1993-9#1)(1994-1#1)(1994-11#8)(1994-12#4)(1994-2#8)(1994-3#9)(1994-5#3)(1994-6#6)(1994-8#7)(1994-9#3)(1995-11#7)(1995-12#10)(1995-2#12)(1995-3#6)(1995-5#6)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#11)(1996-2#8)(1996-3#9)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#14)(1997-2#6)(1997-3#8)(1997-4#4)(1997-5#8)(1997-6#4)(1997-7#11)(1997-8#12)(1997-9#1)(2006-5#1)(2006-6#3)(2007-11#6)(2007-12#8)(2008-1#15)(2008-10#291)(2008-11#101)(2008-12#45)(2008-2#1)(2008-3#10)(2008-4#24)(2008-5#30)(2008-6#8)(2008-7#56)(2008-8#62)(2008-9#57)(2009-1#1)(2009-10#9)(2009-11#11)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#6)(2009-8#12)(2009-9#5)(2010-1#8)(2010-10#14)(2010-11#10)(2010-12#20)(2010-2#3)(2010-4#4)(2010-5#3)(2010-6#5)(2010-7#9)(2010-8#7)(2011-1#8)(2011-10#1)(2011-2#62)(2011-3#3)(2011-7#2)(2012-12#12)(2012-2#30)(2012-3#39)(2012-7#1)(2013-1#48)(2013-7#5)(2013-8#23)
may become a##2##3##(2008-10#1)(2012-12#1)
may become available##2##3##(2008-5#1)(2012-2#1)
may become more##2##3##(2008-6#1)(2010-6#1)
may become part of##2##4##(2008-10#1)(2009-11#1)
may become##20##2##(1991-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
may belong to a##2##4##(2008-10#2)
may belong to the##2##4##(1993-8#1)(2008-10#1)
may belong to##5##3##(1993-8#1)(2008-10#3)(2008-8#1)
may benefit from##11##3##(1994-6#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-7#1)
may benefit##17##2##(1994-6#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
may better##2##2##(2008-10#1)(2013-1#1)
may bind##2##2##(1994-5#1)(2008-8#1)
may block##2##2##(2008-8#1)(2009-8#1)
may bring about##2##3##(2008-10#1)(2011-2#1)
may bring##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
may carry a##2##3##(2008-10#1)(2008-8#1)
may cause a##3##3##(1994-12#1)(2008-7#1)(2011-2#1)
may cause multiple##2##3##(2008-3#1)(2011-1#1)
may cause mutations##2##3##(1993-8#1)(2013-1#1)
may cause the##2##3##(1995-11#1)(1995-8#1)
may cause##40##2##(1991-2#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-12#2)(1995-11#1)(1995-8#1)(1997-8#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
may change##4##2##(2008-10#3)(2008-9#1)
may coexist##4##2##(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)
may come##2##2##(1997-2#1)(2009-9#1)
may compensate for the##2##4##(1994-12#1)(1995-8#1)
may compensate for##3##3##(1994-12#1)(1995-8#1)(2008-10#1)
may compete with##2##3##(2008-10#1)(2009-3#1)
may compete##4##2##(2008-10#2)(2008-5#1)(2009-3#1)
may complicate the##2##3##(1997-4#1)(2009-7#1)
may complicate##3##2##(1997-4#1)(1997-8#1)(2009-7#1)
may compromise##8##2##(2008-10#2)(2008-11#2)(2009-9#1)(2013-1#2)(2013-8#1)
may confer##2##2##(1993-2#1)(2008-10#1)
may confound##2##2##(2008-9#1)(2010-4#1)
may constitute a##8##3##(1990-8#1)(1991-5#1)(1992-12#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)
may constitute an##2##3##(1992-8#1)(2013-8#1)
may constitute##13##2##(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-6#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2013-8#1)
may contain a##2##3##(1995-12#1)(2008-5#1)
may contain high##2##3##(2008-5#1)(2010-11#1)
may contain##21##2##(1990-5#1)(1993-8#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2010-11#1)(2010-8#1)
may continue to##3##3##(1995-3#1)(2008-10#1)(2013-1#1)
may continue##5##2##(1995-3#1)(2008-10#1)(2011-2#1)(2011-7#1)(2013-1#1)
may contribute to a##6##4##(1994-8#1)(2008-10#2)(2008-11#1)(2009-10#1)(2012-3#1)
may contribute to the##24##4##(1990-5#1)(1992-4#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-12#2)(2006-6#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
may contribute to##54##3##(1990-5#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-12#4)(1997-3#1)(2006-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-9#2)(2011-2#2)(2011-7#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
may contribute##57##2##(1990-5#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-12#4)(1997-3#1)(2006-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-9#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
may control##2##2##(1994-11#1)(2008-11#1)
may cooperate##2##2##(1995-8#1)(1997-3#1)
may correlate with##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
may correlate##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2013-1#1)
may correspond to##4##3##(1990-5#1)(1995-12#1)(1995-9#1)(2008-10#1)
may correspond##5##2##(1990-5#1)(1995-12#1)(1995-9#1)(2008-10#2)
may counteract##2##2##(1994-12#1)(1995-2#1)
may create##3##2##(1994-1#1)(1994-3#1)(2013-1#1)
may decrease the##2##3##(2007-11#1)(2011-2#1)
may decrease with increasing##2##4##(2008-8#1)(2012-3#1)
may decrease##10##2##(1994-2#1)(1997-7#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
may delay##4##2##(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
may demonstrate##3##2##(1995-12#1)(2008-10#1)(2009-9#1)
may depend on the##3##4##(1994-8#1)(2008-10#1)(2008-12#1)
may depend on##8##3##(1994-2#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-2#1)
may depend##10##2##(1991-12#1)(1994-2#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-2#1)
may derive##2##2##(2008-10#1)(2008-11#1)
may determine##3##2##(1997-8#1)(2008-8#1)(2013-1#1)
may develop##8##2##(1994-5#1)(1996-6#1)(1997-1#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
may differ from##5##3##(2008-7#1)(2010-6#1)(2011-2#3)
may differ in##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
may differ##14##2##(1995-12#1)(1996-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-6#1)(2011-2#3)(2013-1#1)
may directly##8##2##(1995-9#1)(2006-6#1)(2008-10#2)(2008-8#1)(2009-8#1)(2013-7#1)(2013-8#1)
may display##2##2##(1993-2#1)(2011-2#1)
may disturb the##2##3##(2008-10#2)
may dominate##2##2##(2008-10#1)(2008-8#1)
may drive##2##2##(2008-6#1)(2013-8#1)
may effectively##3##2##(2008-10#2)(2010-10#1)
may either##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
may eliminate the##2##3##(2008-10#2)
may eliminate##3##2##(2008-10#2)(2008-12#1)
may emerge##2##2##(2008-8#1)(2010-11#1)
may enable##6##2##(1993-1#1)(1997-1#1)(2008-10#3)(2011-2#1)
may encode##2##2##(2008-2#1)(2013-8#1)
may encounter##2##2##(2008-12#1)(2008-4#1)
may enhance the##6##3##(1994-8#1)(2008-10#1)(2008-11#1)(2011-7#1)(2013-1#2)
may enhance##13##2##(1994-8#1)(2008-10#3)(2008-11#2)(2008-8#2)(2009-6#1)(2011-7#1)(2013-1#2)(2013-8#1)
may even be##2##3##(2008-10#1)(2010-10#1)
may even##6##2##(1994-3#1)(1997-2#1)(2008-10#1)(2009-10#1)(2010-10#1)(2011-2#1)
may eventually##2##2##(1993-3#1)(2008-10#1)
may evolve##6##2##(1990-6#1)(2008-8#2)(2008-9#2)(2011-2#1)
may exert##6##2##(1993-8#1)(1994-11#1)(1995-11#1)(2008-11#1)(2011-2#1)(2012-2#1)
may exhibit##7##2##(2008-10#2)(2008-7#1)(2009-10#1)(2009-12#2)(2010-12#1)
may exist in the##3##4##(2008-11#2)(2008-9#1)
may exist##9##2##(1992-12#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2012-2#1)
may experience##5##2##(2008-10#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
may explain its##2##3##(1993-8#1)(2008-11#1)
may explain some##2##3##(1992-9#1)(2008-10#1)
may explain the##18##3##(1990-12#2)(1993-8#1)(1995-11#1)(1995-9#1)(1996-5#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-8#2)(2009-10#1)(2013-1#1)
may explain their##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
may explain this##2##3##(2008-10#1)(2009-8#1)
may explain why##5##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
may explain##39##2##(1990-11#1)(1990-12#2)(1992-9#1)(1993-8#4)(1994-8#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-5#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)(2013-8#1)
may extend##3##2##(1991-2#1)(2008-12#1)(2013-8#1)
may face##2##2##(1994-1#1)(2008-11#1)
may facilitate a##2##3##(2008-9#1)(2010-1#1)
may facilitate the##6##3##(1993-12#2)(1994-12#1)(1997-4#1)(2008-8#1)(2009-6#1)
may facilitate##14##2##(1993-12#2)(1994-12#1)(1997-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2013-8#1)
may fail to##5##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)
may favour##2##2##(2008-10#1)(2008-5#1)
may find##5##2##(1997-2#1)(2008-10#2)(2008-11#1)(2010-9#1)
may form##4##2##(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
may function as a##4##4##(1995-11#1)(1995-2#1)(1997-7#1)(2009-8#1)
may function as##7##3##(1992-9#1)(1995-11#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2009-8#1)
may function to##2##3##(1991-10#1)(2008-8#1)
may function##12##2##(1991-10#1)(1992-12#1)(1992-9#1)(1995-11#1)(1995-2#2)(1997-7#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#1)
may further##7##2##(1991-12#1)(1996-9#1)(2008-11#2)(2009-4#1)(2011-2#1)(2012-2#1)
may gain##2##2##(2012-2#1)(2012-3#1)
may generate##3##2##(2008-11#1)(2008-8#2)
may give rise to##2##4##(1991-3#1)(1994-3#1)
may give##7##2##(1991-3#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
may go##4##2##(1991-2#1)(1997-4#1)(2008-5#1)(2010-12#1)
may hamper the##2##3##(1995-3#1)(2008-5#1)
may harbor##2##2##(2008-9#1)(2012-3#1)
may have a higher risk of developing breast cancer##2##9##(2008-12#2)
may have a higher risk of##3##6##(2008-12#2)(2013-1#1)
may have a higher##4##4##(2008-12#2)(2011-2#1)(2013-1#1)
may have a more##2##4##(2008-10#1)(2008-9#1)
may have a potential##2##4##(2011-2#1)(2012-2#1)
may have a protective effect##2##5##(2008-10#1)(2008-12#1)
may have a role in the##2##6##(1996-2#1)(2008-10#1)
may have a role in##8##5##(1992-12#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
may have a role##9##4##(1992-12#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
may have a selective##2##4##(2008-8#2)
may have a significant impact on##2##6##(2008-5#1)(2011-2#1)
may have a##43##3##(1990-3#1)(1992-12#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-12#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
may have advantages##2##3##(2008-10#1)(2008-7#1)
may have an##8##3##(1991-7#1)(1995-3#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-10#1)(2012-3#1)
may have arisen##3##3##(2008-10#3)
may have been caused by##2##5##(1993-1#1)(2008-8#1)
may have been derived from##2##5##(1992-12#1)(2010-8#1)
may have been generated##2##4##(1993-6#1)(1995-9#1)
may have been involved in the##2##6##(1996-6#1)(2008-10#1)
may have been used##2##4##(2008-10#2)
may have been##26##3##(1990-11#1)(1990-6#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-6#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-8#1)
may have beneficial##2##3##(2009-10#1)(2009-3#1)
may have caused the##2##4##(1991-3#1)(2008-11#1)
may have caused##4##3##(1991-3#1)(1997-8#1)(2008-11#2)
may have certain##2##3##(2008-11#1)(2008-9#1)
may have clinical implications##2##4##(2008-4#1)(2010-1#1)
may have consequences for the##2##5##(1994-11#1)(2008-11#1)
may have consequences##3##3##(1994-11#1)(2008-10#1)(2008-11#1)
may have contributed to the##4##5##(1991-2#1)(1997-5#1)(2008-10#1)(2012-7#1)
may have contributed to##9##4##(1991-2#1)(1996-2#1)(1997-5#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-3#1)(2012-7#1)
may have evolved##4##3##(1997-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
may have for the##2##4##(2008-12#1)(2013-1#1)
may have generated##2##3##(2008-6#1)(2008-8#1)
may have great##2##3##(2008-9#1)(2010-7#1)
may have implications for the##3##5##(1995-6#1)(2013-1#1)(2013-7#1)
may have implications for##8##4##(1992-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#2)(2013-7#1)
may have important implications for##2##5##(2008-10#1)(2008-3#1)
may have important implications##4##4##(1994-11#1)(2008-10#1)(2008-3#1)(2010-11#1)
may have important##5##3##(1994-11#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-1#1)
may have in##2##3##(1993-2#1)(2010-1#1)
may have led to##2##4##(2008-1#1)(2008-8#1)
may have little##2##3##(1995-5#1)(2008-11#1)
may have lost##2##3##(1994-12#1)(2008-6#1)
may have more##2##3##(1993-2#1)(1996-2#1)
may have occurred##6##3##(2008-10#4)(2011-2#2)
may have on##7##3##(1992-1#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
may have only##3##3##(1991-3#1)(1997-3#1)(2013-8#1)
may have resulted from##3##4##(1994-12#1)(2008-10#1)(2010-3#1)
may have significant##2##3##(1996-12#1)(2011-1#1)
may have some##2##3##(1993-3#1)(2008-5#1)
may have therapeutic##2##3##(2012-2#1)(2013-8#1)
may have to##2##3##(1993-12#1)(1995-2#1)
may have##236##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-7#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#4)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#48)(2008-11#12)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#10)(2008-9#7)(2009-10#3)(2009-3#2)(2009-8#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#13)(2012-12#2)(2012-2#4)(2012-3#6)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#5)
may help clinicians##2##3##(1992-3#1)(2012-2#1)
may help explain##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
may help identify##3##3##(2009-10#1)(2010-10#1)(2011-2#1)
may help in the##2##4##(2008-5#1)(2011-2#1)
may help in##5##3##(2008-10#1)(2008-5#2)(2010-10#1)(2011-2#1)
may help prevent##2##3##(2008-11#1)(2013-1#1)
may help the##3##3##(1991-2#1)(2007-11#1)(2013-1#1)
may help these##2##3##(2008-11#1)(2008-9#1)
may help to overcome##2##4##(2008-10#1)(2008-5#1)
may help to##21##3##(1991-8#1)(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#1)
may help##57##2##(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-11#1)(1996-1#1)(1996-11#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#2)(2010-12#1)(2011-1#3)(2011-2#4)(2012-2#4)(2012-3#3)(2012-9#1)(2013-1#5)
may hold##2##2##(2008-8#1)(2012-3#1)
may however##2##2##(2008-12#1)(2013-1#1)
may identify##3##2##(1991-2#1)(1993-12#1)(2010-5#1)
may impact on##2##3##(2007-11#1)(2008-9#1)
may impact the##4##3##(2008-10#1)(2012-2#2)(2013-1#1)
may impact##8##2##(2007-11#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
may impair##2##2##(1995-11#1)(2011-2#1)
may imply##3##2##(1996-11#1)(2008-9#2)
may improve the##7##3##(1994-5#1)(1994-6#1)(1997-7#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-2#1)
may improve##21##2##(1993-12#1)(1994-5#1)(1994-6#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-12#2)(2010-12#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
may in fact##2##3##(1994-5#1)(2008-7#1)
may in part##2##3##(1994-11#1)(2011-2#1)
may in turn lead to##2##5##(2010-5#1)(2013-1#1)
may in##8##2##(1994-11#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
may include a##2##3##(2008-11#1)(2013-8#1)
may include the##3##3##(2008-8#2)(2010-4#1)
may include##12##2##(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-8#1)
may incorporate##2##2##(2008-11#1)(2008-12#1)
may increase the risk of##3##5##(1996-6#1)(2008-11#1)(2012-12#1)
may increase the##6##3##(1996-6#1)(2008-11#1)(2008-7#2)(2008-8#1)(2012-12#1)
may increase##19##2##(1994-2#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-6#1)(2012-12#2)(2013-1#4)
may indeed##2##2##(2008-9#1)(2009-8#1)
may indicate a##3##3##(1996-6#1)(2008-10#2)
may indicate that the##2##4##(1990-11#1)(2008-10#1)
may indicate that##11##3##(1990-11#1)(1991-5#1)(1992-8#1)(2008-10#5)(2008-4#1)(2008-8#1)(2010-5#1)
may indicate the##3##3##(2008-12#1)(2008-9#1)(2012-12#1)
may indicate##22##2##(1990-11#1)(1991-5#1)(1992-8#1)(1993-1#1)(1996-6#1)(2008-10#8)(2008-12#1)(2008-4#2)(2008-8#2)(2008-9#1)(2010-5#1)(2012-12#1)(2012-5#1)
may induce apoptosis##2##3##(2008-12#1)(2009-12#1)
may induce##14##2##(1992-5#1)(1993-11#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#2)
may infect##2##2##(2006-5#1)(2008-10#1)
may influence the##10##3##(1990-2#1)(1993-2#2)(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
may influence##23##2##(1990-2#1)(1993-2#2)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
may inform##2##2##(1994-1#1)(2008-12#1)
may inhibit##3##2##(1992-3#1)(1993-3#1)(1995-8#1)
may initiate##2##2##(1993-8#1)(2008-7#1)
may interact with##2##3##(1990-2#1)(1995-6#1)
may interact##5##2##(1990-2#1)(1995-6#1)(2008-8#1)(2009-12#1)(2012-3#1)
may interfere with the##2##4##(2008-10#1)(2008-5#1)
may interfere with##4##3##(1995-9#1)(2008-10#1)(2008-5#1)(2013-8#1)
may introduce##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
may involve a##2##3##(1993-8#1)(2008-10#1)
may involve the##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
may involve##15##2##(1990-5#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-8#1)(1994-6#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
may lack##2##2##(2008-7#1)(2011-2#1)
may largely##2##2##(2008-10#1)(2013-8#1)
may lead to a##4##4##(2008-11#1)(2010-7#1)(2012-12#1)(2012-2#1)
may lead to an##3##4##(1990-2#1)(2008-11#1)(2013-1#1)
may lead to increased##3##4##(1992-4#1)(1994-11#1)(2012-12#1)
may lead to misleading results##2##5##(1997-2#1)(2008-12#1)
may lead to new##2##4##(2008-5#1)(2012-2#1)
may lead to the##10##4##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#4)(2013-1#1)
may lead to##57##3##(1990-2#1)(1992-1#1)(1992-4#1)(1993-8#1)(1994-11#1)(1994-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
may lie##4##2##(1996-2#1)(2008-11#1)(2010-7#1)(2011-2#1)
may limit its##2##3##(1995-3#1)(2008-7#1)
may limit##5##2##(1994-3#1)(1995-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
may lose##2##2##(2008-10#1)(2008-7#1)
may make a##2##3##(2008-5#1)(2009-10#1)
may make##7##2##(1995-2#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-10#1)(2011-2#1)
may manifest as##2##3##(2008-7#1)(2011-2#1)
may mean##3##2##(1994-3#1)(2008-7#2)
may mediate##5##2##(1991-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)
may mimic the##2##3##(2010-7#1)(2013-1#1)
may mimic##8##2##(1991-6#1)(1996-8#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
may modulate##7##2##(1992-12#1)(1993-9#1)(1995-12#1)(1995-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
may need to be##2##4##(1994-2#1)(2008-10#1)
may need to##8##3##(1994-2#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#1)
may need##10##2##(1994-2#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
may not always##2##3##(1996-12#1)(2008-9#1)
may not be a##4##4##(1992-2#1)(2008-8#1)(2009-6#1)(2011-2#1)
may not be able to##2##5##(1994-2#1)(1996-2#1)
may not be as##2##4##(2013-1#2)
may not be associated with##2##5##(2006-6#1)(2013-1#1)
may not be available##2##4##(2008-10#1)(2008-12#1)
may not be essential for##2##5##(2008-10#1)(2011-2#1)
may not be evident in##2##5##(2011-2#2)
may not be involved##2##4##(2008-8#2)
may not be representative of##2##5##(2008-10#1)(2009-8#1)
may not be the##4##4##(2008-8#1)(2008-9#2)(2012-3#1)
may not be##68##3##(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(2006-6#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
may not have a##2##4##(1996-12#1)(2008-6#1)
may not have##4##3##(1993-12#1)(1996-12#1)(2008-10#1)(2008-6#1)
may not necessarily##2##3##(1996-9#1)(2008-6#1)
may not only##2##3##(1990-12#1)(2011-1#1)
may not represent##2##3##(1996-2#1)(2008-5#1)
may not translate##2##3##(2011-2#1)(2012-12#1)
may not##116##2##(1990-12#1)(1990-2#2)(1991-2#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-1#2)(1997-5#1)(2006-6#1)(2008-10#18)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
may now be##3##3##(1997-6#1)(2008-11#1)(2008-8#1)
may occasionally present##2##3##(1992-2#1)(2008-7#1)
may occasionally##3##2##(1992-2#1)(2008-7#1)(2011-2#1)
may occur after##2##3##(2008-11#1)(2013-8#1)
may occur as##2##3##(2010-5#1)(2012-3#1)
may occur by##2##3##(1995-6#1)(2007-8#1)
may occur during the##2##4##(2008-11#1)(2013-1#1)
may occur during##6##3##(1997-8#1)(2008-11#1)(2008-9#1)(2010-8#1)(2013-1#2)
may occur either##2##3##(2008-9#1)(2011-2#1)
may occur if##2##3##(2008-7#1)(2008-8#1)
may occur in the##3##4##(2007-12#1)(2010-4#1)(2011-1#1)
may occur in##15##3##(1990-11#1)(1990-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
may occur on##2##3##(2008-10#2)
may occur spontaneously##2##3##(2008-7#1)(2011-2#1)
may occur with##3##3##(1993-6#1)(2011-2#1)(2012-3#1)
may occur##56##2##(1990-11#1)(1990-8#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
may offer a##3##3##(1994-12#1)(2008-11#1)(2011-2#1)
may offer##11##2##(1993-12#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)
may often##2##2##(2008-2#1)(2009-10#1)
may only be##3##3##(2008-9#1)(2010-1#1)(2013-8#1)
may only##6##2##(2008-9#1)(2010-1#1)(2011-1#2)(2013-1#1)(2013-8#1)
may open##2##2##(2008-10#1)(2008-9#1)
may operate##4##2##(1990-2#1)(2008-10#2)(2008-9#1)
may or may not be##5##5##(2008-8#1)(2009-8#1)(2010-1#1)(2010-10#1)(2013-1#1)
may or may not##8##4##(1995-5#1)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
may originate from##3##3##(1990-8#1)(2008-10#1)(2008-7#1)
may originate##4##2##(1990-8#1)(1995-3#1)(2008-10#1)(2008-7#1)
may participate in##4##3##(1995-6#1)(1996-2#1)(2008-7#1)(2011-2#1)
may participate##5##2##(1995-12#1)(1995-6#1)(1996-2#1)(2008-7#1)(2011-2#1)
may partly explain##2##3##(2008-10#1)(2008-11#1)
may permit##2##2##(1991-12#1)(1993-12#1)
may persist for years##2##4##(1995-9#1)(2011-2#1)
may play a certain role in the##2##7##(2008-8#2)
may play a critical role in##4##6##(1991-6#1)(1993-6#1)(1995-2#1)(2010-12#1)
may play a crucial role in##2##6##(2008-7#1)(2008-9#1)
may play a pivotal role in##2##6##(1995-2#1)(1997-8#1)
may play a pivotal role##3##5##(1995-2#1)(1997-8#1)(2013-7#1)
may play a role in defense##2##6##(2008-10#2)
may play a role in the development of##2##8##(2009-1#1)(2011-10#1)
may play a role in the regulation of##2##8##(1990-5#1)(1992-12#1)
may play a role in the##19##6##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1992-12#1)(1992-6#1)(1994-1#1)(1994-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-1#1)(2009-4#1)(2011-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
may play a role in##36##5##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-5#1)(1992-12#1)(1992-6#2)(1994-1#1)(1994-11#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-10#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
may play a role##43##4##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#2)(1992-9#1)(1994-1#1)(1994-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
may play a##67##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#3)
may play an important role in the##7##7##(1991-12#1)(1995-12#1)(2008-8#2)(2008-9#2)(2010-5#1)
may play an important role in##17##6##(1991-12#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#2)
may play an important role##18##5##(1991-12#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#2)
may play an##19##3##(1991-12#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#2)
may play important roles in##3##5##(1995-11#1)(2008-9#1)(2013-1#1)
may play important##4##3##(1995-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
may play in##2##3##(2008-7#2)
may play some##2##3##(1993-8#1)(2008-7#1)
may play##101##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-3#2)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#8)(2009-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-10#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
may possess##2##2##(2008-10#1)(2008-3#1)
may potentially##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)
may precede##2##2##(2008-10#1)(2012-3#1)
may predict##3##2##(1997-7#1)(2011-2#1)(2012-3#1)
may predispose##4##2##(1993-2#1)(2008-1#1)(2008-7#1)(2009-12#1)
may present as##2##3##(2008-1#1)(2008-8#1)
may present with##6##3##(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
may present##12##2##(2008-1#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-1#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-1#1)
may prevent##11##2##(1990-12#1)(1991-3#1)(1992-9#1)(1997-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
may proceed##2##2##(2008-10#1)(2010-10#1)
may produce##7##2##(1991-3#1)(1994-2#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-3#1)
may promote##2##2##(2008-9#1)(2013-1#1)
may protect against##2##3##(2010-2#1)(2013-1#1)
may protect##5##2##(2009-8#1)(2010-2#1)(2013-1#1)(2013-7#2)
may prove to be more##2##5##(2008-9#1)(2009-3#1)
may prove to be the##2##5##(1996-3#1)(2008-8#1)
may prove to be##7##4##(1994-2#1)(1996-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-3#1)
may prove to##8##3##(1994-2#1)(1996-3#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-3#1)
may prove useful in##4##4##(1996-2#1)(1997-2#1)(2008-5#1)(2013-1#1)
may prove useful##5##3##(1996-2#1)(1997-2#1)(2008-5#1)(2012-2#1)(2013-1#1)
may prove##19##2##(1994-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
may provide a means##2##4##(1990-5#1)(1997-8#1)
may provide a more##2##4##(2009-8#1)(2013-1#1)
may provide a novel##4##4##(1991-5#1)(1994-11#1)(1994-3#1)(2008-10#1)
may provide a significant##2##4##(2008-10#1)(2012-2#1)
may provide a simple##2##4##(2008-10#1)(2012-3#1)
may provide a##34##3##(1990-5#1)(1991-5#1)(1992-10#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#2)(2013-8#1)
may provide an##12##3##(1992-12#1)(1995-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-4#1)(2012-3#1)
may provide better##2##3##(2008-8#1)(2010-1#1)
may provide incentives##2##3##(1994-2#1)(1997-2#1)
may provide insight into the mechanisms##2##6##(2008-4#1)(2008-9#1)
may provide insight into the##3##5##(2008-11#1)(2008-4#1)(2008-9#1)
may provide insight into##5##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
may provide insight##6##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
may provide new insights##2##4##(2008-10#1)(2009-4#1)
may provide new##3##3##(1991-5#1)(2008-10#1)(2009-4#1)
may provide novel##2##3##(2009-6#1)(2013-8#1)
may provide some##2##3##(2007-11#1)(2008-10#1)
may provide the most##2##4##(2008-11#1)(2011-2#1)
may provide the##9##3##(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
may provide##90##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#3)(1992-10#1)(1992-12#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#2)(2007-11#2)(2008-1#2)(2008-10#16)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#3)(2012-9#1)(2013-1#7)(2013-8#2)
may reach##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
may reduce the need##2##4##(2008-11#1)(2008-9#1)
may reduce the risk##2##4##(2008-7#2)
may reduce the##7##3##(1993-2#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#2)
may reduce##21##2##(1993-2#1)(1993-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-7#1)(2010-11#1)(2011-2#1)(2011-7#1)(2013-1#3)
may reflect a##2##3##(1996-12#1)(2010-5#1)
may reflect the##12##3##(1992-11#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#4)(2009-10#2)(2009-3#1)
may reflect##23##2##(1990-12#1)(1992-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#4)(2008-8#1)(2009-10#3)(2009-3#1)(2009-8#1)(2010-5#1)
may regulate the##2##3##(1994-11#1)(1995-2#1)
may regulate##9##2##(1991-5#1)(1992-3#1)(1993-3#1)(1994-11#2)(1995-2#2)(2012-2#2)
may relate to##6##3##(1990-5#1)(1994-11#1)(1997-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
may relate##8##2##(1990-5#1)(1994-11#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)
may rely on##2##3##(2006-6#1)(2008-10#1)
may remain##5##2##(2008-10#1)(2008-12#1)(2008-2#1)(2012-12#1)(2013-1#1)
may render##3##2##(1994-1#1)(2008-10#1)(2008-11#1)
may replace##2##2##(1990-11#1)(2012-3#1)
may represent a novel##2##4##(1991-9#1)(2013-8#1)
may represent a##19##3##(1990-5#1)(1991-9#1)(1992-1#1)(1994-11#1)(1995-12#1)(1997-7#1)(2008-10#6)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
may represent an##4##3##(1995-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
may represent the first##2##4##(1990-2#1)(1990-5#1)
may represent the##5##3##(1990-2#1)(1990-5#1)(1993-1#1)(2007-12#1)(2008-10#1)
may represent##43##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-9#1)(1992-1#1)(1993-1#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#2)
may require a##4##3##(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#1)
may require surgical##2##3##(1991-2#1)(2013-1#1)
may require##21##2##(1991-2#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#5)
may reside in##2##3##(1990-5#1)(2008-10#1)
may resolve##2##2##(1995-5#1)(2008-8#1)
may respond to##4##3##(1994-12#1)(2010-1#1)(2012-2#1)(2013-8#1)
may respond##5##2##(1994-12#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
may result from##10##3##(1994-11#1)(1995-8#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
may result in a##4##4##(1995-5#1)(2008-10#1)(2009-9#1)(2012-2#1)
may result in an increase in the number of##2##9##(1997-6#1)(2008-10#1)
may result in increased##2##4##(1997-2#1)(2009-6#1)
may result in reduced##2##4##(2008-10#1)(2008-5#1)
may result in significant##2##4##(1997-3#1)(2011-2#1)
may result in the##2##4##(2008-11#1)(2009-5#1)
may result in##43##3##(1991-4#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-8#2)
may result##53##2##(1991-4#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#9)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
may reveal##6##2##(2008-10#2)(2009-10#1)(2009-8#2)(2011-2#1)
may run##2##2##(1991-12#1)(2008-9#1)
may seem##2##2##(2008-8#1)(2008-9#1)
may selectively##2##2##(1996-2#1)(2009-3#1)
may serve as a useful##2##5##(1995-5#1)(2009-11#1)
may serve as a##17##4##(1992-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
may serve as an alternative to##2##6##(2008-10#1)(2012-3#1)
may serve as an##4##4##(2008-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
may serve as##27##3##(1992-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
may serve to##5##3##(1991-2#1)(1994-12#1)(1994-5#1)(2008-1#1)(2009-6#1)
may serve##33##2##(1991-2#1)(1992-12#2)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2009-11#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
may shape##2##2##(2010-9#1)(2012-3#1)
may share##3##2##(1995-2#1)(2008-10#1)(2010-7#1)
may shorten##3##2##(1991-1#1)(2008-12#1)(2012-3#1)
may show##6##2##(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)
may significantly influence##2##3##(2008-10#1)(2008-11#1)
may significantly##6##2##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)
may sometimes##3##2##(1993-11#1)(2008-8#1)(2011-2#1)
may soon##3##2##(1990-8#1)(2008-10#1)(2012-2#1)
may specify##2##2##(2008-10#2)
may stabilize##2##2##(2008-8#1)(2009-12#1)
may stain##2##2##(2008-11#1)(2008-7#1)
may still be##2##3##(1996-11#1)(2008-10#1)
may still##6##2##(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
may stimulate##2##2##(2008-11#1)(2013-1#1)
may suggest a##4##3##(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
may suggest that##3##3##(1990-3#1)(2008-10#1)(2013-8#1)
may suggest the##2##3##(1996-12#1)(2006-6#1)
may suggest##13##2##(1990-3#1)(1991-12#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-12#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
may support the##2##3##(1993-3#1)(1997-4#1)
may support##3##2##(1993-3#1)(1997-4#1)(1997-6#1)
may take on##2##3##(1993-12#1)(1996-3#1)
may take##7##2##(1991-12#1)(1993-12#1)(1993-2#1)(1996-3#1)(1996-8#1)(2008-10#1)(2010-12#1)
may target##2##2##(2009-6#1)(2011-2#1)
may then be##2##3##(2008-10#1)(2008-9#1)
may then##5##2##(2008-10#1)(2008-7#2)(2008-9#1)(2009-9#1)
may therefore be##8##3##(1990-10#1)(1990-11#1)(1991-6#1)(1993-2#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
may therefore have##2##3##(2008-11#1)(2011-2#1)
may therefore##15##2##(1990-10#1)(1990-11#1)(1991-6#1)(1993-11#1)(1993-2#1)(1995-2#1)(2006-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2011-2#1)
may thus be##4##3##(1994-11#1)(1995-3#1)(2008-10#1)(2011-2#1)
may thus##13##2##(1990-11#1)(1993-11#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
may ultimately##4##2##(1997-1#1)(2009-3#1)(2010-5#1)(2011-2#1)
may underlie the##3##3##(1994-8#1)(2008-8#1)(2012-12#1)
may underlie##6##2##(1990-8#1)(1994-8#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-12#1)
may use##2##2##(2008-1#1)(2013-1#1)
may utilize##2##2##(2008-11#2)
may vary from##4##3##(1997-2#1)(2009-12#1)(2010-12#1)(2013-1#1)
may vary with the##2##4##(1997-1#1)(2008-11#1)
may vary##13##2##(1991-10#1)(1992-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-6#1)(2013-1#1)
may want to##3##3##(1992-12#1)(2008-4#1)(2011-1#1)
may well be##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
may well##12##2##(1990-5#1)(1991-5#1)(1992-2#2)(1993-8#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-8#1)
may work##2##2##(2008-6#1)(2008-9#1)
may yield##2##2##(2008-7#1)(2009-8#1)
may##4037##1##(1990-10#1)(1990-11#23)(1990-12#17)(1990-2#14)(1990-3#6)(1990-5#21)(1990-6#6)(1990-8#12)(1991-1#7)(1991-10#2)(1991-11#6)(1991-12#21)(1991-2#26)(1991-3#17)(1991-4#2)(1991-5#18)(1991-6#11)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#5)(1992-10#4)(1992-11#2)(1992-12#28)(1992-2#15)(1992-3#16)(1992-4#3)(1992-5#3)(1992-6#13)(1992-8#5)(1992-9#16)(1993-1#16)(1993-11#11)(1993-12#29)(1993-2#21)(1993-3#19)(1993-6#15)(1993-8#29)(1993-9#7)(1994-1#8)(1994-11#28)(1994-12#21)(1994-2#26)(1994-3#24)(1994-5#16)(1994-6#13)(1994-8#18)(1994-9#6)(1995-11#15)(1995-12#34)(1995-2#37)(1995-3#16)(1995-5#16)(1995-6#17)(1995-8#15)(1995-9#10)(1996-1#3)(1996-11#6)(1996-12#30)(1996-2#27)(1996-3#18)(1996-5#4)(1996-6#8)(1996-8#3)(1996-9#5)(1997-1#31)(1997-2#21)(1997-3#19)(1997-4#11)(1997-5#12)(1997-6#10)(1997-7#18)(1997-8#27)(1997-9#4)(2006-5#2)(2006-6#12)(2007-11#18)(2007-12#19)(2007-8#1)(2008-1#34)(2008-10#659)(2008-11#264)(2008-12#99)(2008-2#7)(2008-3#22)(2008-4#45)(2008-5#93)(2008-6#26)(2008-7#145)(2008-8#200)(2008-9#154)(2009-1#5)(2009-10#34)(2009-11#19)(2009-12#19)(2009-2#1)(2009-3#12)(2009-4#9)(2009-5#6)(2009-6#17)(2009-7#19)(2009-8#52)(2009-9#14)(2010-1#22)(2010-10#35)(2010-11#25)(2010-12#45)(2010-2#6)(2010-3#3)(2010-4#13)(2010-5#19)(2010-6#13)(2010-7#19)(2010-8#22)(2010-9#10)(2011-1#32)(2011-10#2)(2011-2#212)(2011-3#7)(2011-7#7)(2012-12#39)(2012-2#93)(2012-3#94)(2012-5#1)(2012-7#3)(2012-9#2)(2013-1#159)(2013-7#12)(2013-8#82)
maybe##12##1##(1991-9#1)(2008-10#4)(2008-11#3)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
maydis sequence##2##2##(1996-6#2)
maydis##26##1##(1996-6#5)(2008-10#17)(2009-8#2)(2010-7#2)
mays L##11##2##(2008-10#3)(2008-12#3)(2008-9#1)(2009-8#1)(2012-3#3)
mays##19##1##(2008-10#7)(2008-11#1)(2008-12#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-3#4)
maze is##2##2##(1994-3#1)(2008-11#1)
maze##26##1##(1992-12#3)(1993-3#1)(1993-6#3)(1994-2#1)(1994-3#5)(1994-8#2)(1995-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2011-2#2)(2012-2#1)(2013-8#1)
mbila##5##1##(2008-10#5)
mblf##2##1##(2013-8#2)
mccEh252 and herbicolin O##2##4##(2008-10#2)
mcg kg(-1)##2##2##(2008-12#2)
mcg##3##1##(1995-8#1)(2008-12#2)
mdr1##2##1##(2008-11#2)
mdx##4##1##(1995-12#4)
me##7##1##(1996-12#1)(2008-11#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-2#2)
meadow voles mounted higher##2##4##(2008-9#2)
meadow voles##9##2##(1994-3#2)(1994-8#3)(2008-9#4)
meadow##11##1##(1994-3#3)(1994-8#3)(2008-8#1)(2008-9#4)
meal amendments##5##2##(2008-10#5)
meal and##2##2##(2008-10#1)(2008-8#1)
meal at##3##2##(1994-12#1)(2008-10#2)
meal was##2##2##(2008-10#2)
meal##58##1##(1992-9#1)(1994-12#4)(1995-11#1)(1996-12#1)(1997-4#1)(2008-10#43)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
meals and##3##2##(1995-6#1)(2013-1#2)
meals##21##1##(1994-6#1)(1995-6#1)(1997-2#1)(1997-4#3)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#2)(2010-10#1)(2010-8#1)(2013-1#4)
mealybug wilt of pineapple##3##4##(2008-10#3)
mealybug wilt-associated##2##2##(2008-10#2)
mealybug##14##1##(2008-10#14)
mealybug-transmitted##4##1##(2008-10#4)
mealybugs##5##1##(2008-10#5)
mean (SD) increase##2##3##(2008-3#1)(2013-1#1)
mean (SD)##3##2##(2008-3#1)(2013-1#2)
mean +/- S##3##3##(1994-3#1)(1997-1#1)(1997-3#1)
mean +/- SD##3##3##(1993-3#1)(2008-11#1)(2012-3#1)
mean +/-##9##2##(1990-5#1)(1991-12#1)(1993-3#1)(1994-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2012-3#1)(2013-1#1)
mean 1##2##2##(1993-2#1)(2008-7#1)
mean =##2##2##(1993-1#2)
mean ADC in the##2##4##(2009-11#2)
mean Breslow's thickness of the##2##5##(2011-2#2)
mean CBF##4##2##(2008-7#4)
mean DON##4##2##(2008-10#4)
mean IND##3##2##(2008-10#3)
mean LOS##2##2##(1994-3#2)
mean R##2##2##(2008-10#2)
mean SRIF level##2##3##(1997-2#2)
mean SRIF##3##2##(1997-2#3)
mean absolute##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
mean activity coefficients##2##3##(2008-10#2)
mean activity##3##2##(2008-10#2)(2008-8#1)
mean age 69##2##3##(2008-7#1)(2011-2#1)
mean age =##2##3##(2010-1#2)
mean age and##3##3##(1991-12#1)(1997-8#1)(2013-8#1)
mean age at##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
mean age of 50##2##4##(2007-8#1)(2009-8#1)
mean age of onset##3##4##(1996-2#1)(2007-8#1)(2008-7#1)
mean age of the patients was##8##6##(1991-8#1)(1993-2#1)(2008-1#2)(2008-11#1)(2010-6#1)(2011-3#1)(2012-3#1)
mean age of the##9##4##(1991-8#1)(1993-2#1)(2008-1#2)(2008-11#2)(2010-6#1)(2011-3#1)(2012-3#1)
mean age of##37##3##(1991-11#1)(1991-8#1)(1993-2#1)(1994-12#1)(1995-10#1)(1996-2#1)(1997-3#3)(2007-8#3)(2008-1#3)(2008-11#2)(2008-12#1)(2008-7#2)(2009-8#2)(2010-1#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
mean age was##11##3##(1990-3#1)(1991-3#1)(1997-8#1)(2008-12#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
mean age##87##2##(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-5#1)(1993-2#2)(1994-12#1)(1994-3#1)(1995-10#1)(1996-2#1)(1997-3#3)(1997-8#2)(2007-8#3)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#3)(2008-5#1)(2008-7#6)(2008-9#2)(2009-8#2)(2010-1#4)(2010-3#1)(2010-6#1)(2011-2#8)(2011-3#1)(2012-12#2)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#4)
mean amplitude##3##2##(2012-5#1)(2013-8#2)
mean analysis##3##2##(2008-10#3)
mean and the distribution of values of##2##7##(2013-1#2)
mean and the##3##3##(2008-3#1)(2013-1#2)
mean and##11##2##(1990-12#1)(1992-9#1)(2008-10#4)(2008-3#3)(2013-1#2)
mean arterial blood pressure##2##4##(2012-3#1)(2013-8#1)
mean arterial pressure##3##3##(1994-3#1)(2011-2#2)
mean arterial##5##2##(1994-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
mean body weights of##3##4##(2008-9#3)
mean body weights##4##3##(2008-9#4)
mean body##6##2##(2008-12#1)(2008-9#4)(2011-2#1)
mean cell hemoglobin##4##3##(2008-9#4)
mean cell##6##2##(2008-11#1)(2008-7#1)(2008-9#4)
mean centering of ratio kinetic profiles##2##6##(2008-10#2)
mean centering##4##2##(2008-10#4)
mean concentration of##3##3##(2008-12#1)(2008-8#1)(2012-3#1)
mean concentration##6##2##(1996-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
mean content##3##2##(2008-10#2)(2008-8#1)
mean cycle duration##3##3##(1990-9#3)
mean daily##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
mean degree##2##2##(2008-10#2)
mean diameter of the##2##4##(2008-11#1)(2008-7#1)
mean diameter of##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
mean difference in##2##3##(1992-9#1)(2008-10#1)
mean difference##3##2##(1992-9#1)(2008-10#2)
mean differences##4##2##(2008-10#1)(2008-12#2)(2012-2#1)
mean disease incidence##2##3##(2008-10#2)
mean disease##8##2##(2008-10#7)(2010-12#1)
mean dispersal##3##2##(2013-1#3)
mean dose##2##2##(2009-2#2)
mean duration of##11##3##(1994-8#1)(1996-3#1)(2008-1#3)(2008-10#1)(2008-7#3)(2010-3#1)(2012-2#1)
mean duration##12##2##(1994-8#1)(1996-3#1)(2008-1#3)(2008-10#1)(2008-7#4)(2010-3#1)(2012-2#1)
mean egg recovery rate##2##4##(1996-12#2)
mean field##2##2##(2008-11#1)(2009-8#1)
mean fitness in##2##3##(1997-7#2)
mean fitness##11##2##(1997-7#2)(2008-8#3)(2008-9#6)
mean follow-up of##9##3##(1990-6#1)(1994-12#1)(1994-2#1)(1996-6#1)(2008-10#1)(2009-10#1)(2009-3#2)(2013-1#1)
mean follow-up##14##2##(1990-6#2)(1994-12#1)(1994-2#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-3#2)(2011-2#2)(2013-1#1)
mean for the##2##3##(1991-11#1)(1994-3#1)
mean for##5##2##(1991-11#1)(1991-12#1)(1994-3#1)(2008-3#1)(2008-5#1)
mean free energy##3##3##(2008-10#3)
mean free##4##2##(2008-10#3)(2008-3#1)
mean height##3##2##(2008-1#1)(2009-1#1)(2011-1#1)
mean heritability for##2##3##(2008-10#2)
mean hospital##2##2##(1996-1#1)(2011-2#1)
mean hyphal diameter of##2##4##(2008-10#2)
mean hyphal##3##2##(2008-10#2)(2008-7#1)
mean in##2##2##(1995-8#1)(2008-3#1)
mean incidence as##2##3##(2008-10#2)
mean incidence##8##2##(1992-2#1)(2008-10#7)
mean increase in##2##3##(1991-2#1)(1992-12#1)
mean infarct volume was##2##4##(2008-7#2)
mean intensity of##2##3##(2008-6#1)(2012-2#1)
mean intensity##4##2##(2008-10#1)(2008-6#1)(2008-9#1)(2012-2#1)
mean interommatidial##2##2##(2007-12#2)
mean length of##7##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-1#1)(2012-2#1)(2012-3#1)
mean level change##2##3##(2008-12#2)
mean level of##6##3##(1993-11#1)(2008-10#3)(2008-12#1)(2008-8#1)
mean level##9##2##(1992-11#1)(1993-11#1)(2008-10#3)(2008-12#3)(2008-8#1)
mean levels##3##2##(1997-2#1)(2008-1#1)(2008-12#1)
mean local##2##2##(2008-8#2)
mean number of##12##3##(1990-6#1)(1991-6#1)(1992-6#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-9#1)(2010-9#1)(2013-1#1)
mean number##13##2##(1990-6#1)(1991-6#2)(1992-6#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-9#1)(2010-9#1)(2013-1#1)
mean of 0##2##3##(2008-10#1)(2008-8#1)
mean of 1##3##3##(1990-6#1)(2008-10#1)(2010-6#1)
mean of 4##4##3##(1995-8#1)(2008-1#1)(2009-4#1)(2010-6#1)
mean of all##2##3##(2008-10#1)(2011-2#1)
mean of the##10##3##(1994-3#1)(2008-10#6)(2008-12#1)(2008-8#1)(2012-2#1)
mean of##41##2##(1990-6#1)(1991-12#1)(1994-3#1)(1995-8#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-11#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-2#3)
mean particle##2##2##(2008-5#1)(2013-1#1)
mean path length##2##3##(2008-10#1)(2008-3#1)
mean percent recovery##2##3##(2008-10#2)
mean percent##5##2##(1990-9#1)(1996-3#1)(2008-10#3)
mean percentage of##3##3##(1994-1#1)(2008-10#2)
mean percentage##6##2##(1994-1#1)(2008-10#5)
mean plasma##2##2##(1992-6#1)(2011-2#1)
mean platelet volume##2##3##(2008-10#1)(2008-7#1)
mean proportion of diseased spikelets per spike)##2##7##(2008-10#2)
mean protection)##2##2##(1995-5#2)
mean radius##2##2##(2008-2#1)(2008-3#1)
mean recoveries of##2##3##(2008-10#2)
mean recoveries##5##2##(2008-10#5)
mean recovery of##4##3##(1990-11#1)(1993-3#1)(2008-10#2)
mean recovery##11##2##(1990-11#1)(1993-3#1)(2008-10#9)
mean relative error##4##3##(2008-10#4)
mean relative standard deviation##2##4##(2008-10#2)
mean relative##9##2##(2008-10#9)
mean risk score for##2##4##(1991-6#2)
mean sampling rate##2##3##(2008-10#2)
mean score for##4##3##(1990-2#2)(1991-2#2)
mean score##7##2##(1990-2#2)(1991-2#2)(2011-1#1)(2013-8#2)
mean scores of##4##3##(1992-1#1)(2008-10#1)(2008-7#2)
mean scores##7##2##(1992-1#1)(2008-1#1)(2008-10#2)(2008-7#3)
mean sellar volume##2##3##(2011-2#2)
mean sensitivity of the##2##4##(2008-10#1)(2011-2#1)
mean sensitivity of##3##3##(2008-10#2)(2011-2#1)
mean serum creatinine##2##3##(2008-1#2)
mean serum##6##2##(1991-12#1)(2008-1#3)(2008-3#1)(2011-2#1)
mean signal##2##2##(2008-10#1)(2009-11#1)
mean size of##3##3##(1995-3#1)(1997-2#1)(2012-3#1)
mean square error##9##3##(2008-10#8)(2011-2#1)
mean square##19##2##(1992-4#1)(1992-9#1)(1994-5#2)(2008-10#9)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#3)
mean squared error##3##3##(2008-10#2)(2008-7#1)
mean standard error##3##3##(2008-10#3)
mean standard##4##2##(2008-10#4)
mean surface area##2##3##(2011-2#2)
mean survival of##2##3##(1990-2#2)
mean survival##5##2##(1990-2#2)(1991-8#1)(2008-7#2)
mean systolic and diastolic blood##2##5##(2008-10#1)(2010-7#1)
mean systolic and##3##3##(2008-10#1)(2008-7#1)(2010-7#1)
mean systolic##4##2##(1991-6#1)(2008-10#1)(2008-7#1)(2010-7#1)
mean temperature##7##2##(2008-10#7)
mean that the##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)
mean that##6##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)
mean the##4##2##(1994-12#1)(1996-5#2)(2008-7#1)
mean time interval between implantation and##2##6##(2008-9#2)
mean time of##4##3##(2008-11#2)(2009-3#2)
mean time to##5##3##(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)
mean time##13##2##(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#3)(2009-3#2)(2010-3#1)(2011-2#1)(2013-1#1)
mean total##6##2##(1991-11#1)(1993-11#1)(1994-2#1)(2008-7#1)(2009-10#1)(2010-12#1)
mean value and##2##3##(1993-1#1)(2008-3#1)
mean value of##9##3##(2008-10#4)(2008-11#3)(2011-2#1)(2013-1#1)
mean value##20##2##(1993-1#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
mean values and##2##3##(2008-10#2)
mean values for##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
mean values of##7##3##(1993-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-1#1)
mean values were##2##3##(2008-10#1)(2012-3#1)
mean values##19##2##(1991-12#1)(1993-1#1)(1994-12#1)(2008-10#9)(2008-11#2)(2008-7#2)(2010-1#1)(2010-12#1)(2012-3#1)
mean weight of##2##3##(2008-1#1)(2008-12#1)
mean weight##3##2##(2008-1#1)(2008-12#1)(2013-8#1)
mean width##2##2##(2009-1#2)
mean yield##2##2##(2008-10#1)(2008-9#1)
mean##858##1##(1990-11#4)(1990-12#1)(1990-2#10)(1990-3#4)(1990-5#1)(1990-6#6)(1990-8#2)(1990-9#5)(1991-11#5)(1991-12#9)(1991-2#4)(1991-3#3)(1991-6#6)(1991-8#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#6)(1993-1#6)(1993-11#3)(1993-2#5)(1993-3#2)(1994-1#2)(1994-12#7)(1994-2#3)(1994-3#7)(1994-5#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#6)(2007-12#5)(2007-8#3)(2008-1#18)(2008-10#250)(2008-11#29)(2008-12#27)(2008-2#3)(2008-3#22)(2008-4#1)(2008-5#17)(2008-6#1)(2008-7#47)(2008-8#22)(2008-9#39)(2009-1#4)(2009-10#2)(2009-11#5)(2009-2#3)(2009-3#4)(2009-4#1)(2009-8#5)(2009-9#2)(2010-1#5)(2010-10#5)(2010-11#2)(2010-12#4)(2010-3#6)(2010-4#1)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#7)(2011-2#42)(2011-3#1)(2012-12#2)(2012-2#16)(2012-3#24)(2012-5#2)(2012-6#1)(2013-1#41)(2013-7#1)(2013-8#13)
mean-squared error##2##2##(2008-10#1)(2008-3#1)
meaning and origins##2##3##(2008-11#2)
meaning and##8##2##(1992-2#1)(2008-10#1)(2008-11#5)(2008-12#1)
meaning of a##4##3##(1995-2#1)(1996-9#1)(2008-11#1)(2011-3#1)
meaning of an##2##3##(2008-11#1)(2008-12#1)
meaning of the profession to##2##5##(2012-3#2)
meaning of the##3##3##(2008-10#1)(2012-3#2)
meaning of##26##2##(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2010-10#2)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)
meaning that##4##2##(2008-5#1)(2008-8#1)(2010-1#1)(2010-10#1)
meaning to##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)
meaning##60##1##(1992-2#2)(1993-1#1)(1993-2#2)(1994-1#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-9#1)(2008-1#2)(2008-10#4)(2008-11#12)(2008-12#5)(2008-5#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2011-2#2)(2011-3#1)(2012-3#4)(2013-1#5)
meaningful and##3##2##(2010-10#1)(2012-2#1)(2013-8#1)
meaningful health##2##2##(1994-2#1)(1996-1#1)
meaningful improvements in##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
meaningful improvements##4##2##(2008-12#2)(2008-7#1)(2012-3#1)
meaningful in##2##2##(2008-12#1)(2010-7#1)
meaningful##55##1##(1990-11#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-12#9)(2008-3#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#1)(2009-6#1)(2010-10#3)(2010-12#3)(2010-4#1)(2010-7#2)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-8#1)
meaningfully##5##1##(1991-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2010-9#1)
meaningless##2##1##(1994-8#1)(2008-10#1)
meanings of##3##2##(2008-11#1)(2008-8#2)
meanings##4##1##(2008-11#1)(2008-8#3)
means +/-##2##2##(1990-5#1)(2008-10#1)
means an##3##2##(1991-1#1)(1993-3#1)(1995-1#1)
means analysis##2##2##(2008-10#2)
means and the##2##3##(1993-8#1)(2008-10#1)
means and##8##2##(1993-8#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)
means by which the##3##4##(2008-10#2)(2008-9#1)
means by which this##2##4##(1996-1#1)(2010-1#1)
means by which##12##3##(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-9#2)(2010-1#1)
means for determining##2##3##(2008-10#1)(2008-7#1)
means for the##7##3##(1991-6#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-9#1)
means for##30##2##(1991-6#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-8#1)(2006-6#1)(2008-10#12)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2012-3#1)(2013-8#1)
means of a model##2##4##(2008-10#1)(2009-8#1)
means of a##66##3##(1990-2#1)(1990-8#1)(1991-12#2)(1991-3#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-10#37)(2008-11#3)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-7#1)
means of adjusting##2##3##(2008-11#1)(2010-12#1)
means of administering##2##3##(1994-9#1)(1995-5#1)
means of confirming##2##3##(1990-8#1)(2008-10#1)
means of control##2##3##(2008-10#1)(2008-5#1)
means of creating##2##3##(1994-3#1)(2008-3#1)
means of enhancing##2##3##(2013-1#1)(2013-8#1)
means of evaluating##2##3##(1994-2#1)(2008-9#1)
means of maintaining##2##3##(2008-8#1)(2008-9#1)
means of monitoring for##2##4##(2008-10#2)
means of monitoring##4##3##(2008-10#4)
means of obtaining##2##3##(1994-12#1)(2008-4#1)
means of preventing##3##3##(1996-3#1)(1997-3#1)(2008-10#1)
means of providing##3##3##(1992-3#1)(1993-1#1)(2008-4#1)
means of quantifying the concentration of##2##6##(2008-10#2)
means of quantifying the##3##4##(2008-10#2)(2011-2#1)
means of reducing##2##3##(1993-11#1)(2008-10#1)
means of removing##2##3##(2008-5#1)(2008-7#1)
means of the##51##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-5#1)(1992-6#1)(1994-5#1)(1997-6#1)(1997-8#1)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2011-2#2)
means of this##5##3##(1993-3#1)(2008-10#2)(2008-3#1)(2008-8#1)
means of two##3##3##(2008-10#1)(2008-11#2)
means of understanding##4##3##(1990-5#1)(2008-10#1)(2008-11#1)(2009-12#1)
means of##439##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-8#3)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#5)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#189)(2008-11#31)(2008-12#5)(2008-2#4)(2008-3#21)(2008-4#3)(2008-5#14)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#4)(2013-7#4)(2013-8#2)
means or##2##2##(1992-9#1)(2008-9#1)
means that a##2##3##(2008-10#1)(2008-11#1)
means that the##12##3##(1993-8#1)(1995-3#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)
means that we##2##3##(2008-8#1)(2013-7#1)
means that##32##2##(1990-11#1)(1990-6#1)(1991-6#1)(1992-5#1)(1993-8#1)(1995-3#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-8#1)(2010-1#1)(2010-7#1)(2012-2#1)(2013-7#1)
means the##3##2##(1990-12#1)(1996-3#1)(2008-10#1)
means to achieve the##2##4##(1990-11#1)(1995-1#1)
means to improve##2##3##(2008-10#1)(2010-11#1)
means to the##2##3##(1993-11#1)(2008-5#1)
means to##53##2##(1990-11#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-2#3)(2008-10#10)(2008-11#10)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#2)(2009-12#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-5#1)(2012-2#2)(2013-1#3)(2013-8#2)
means was##2##2##(2008-10#2)
means##652##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#4)(1990-6#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-6#2)(1991-8#3)(1992-12#3)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#4)(1993-2#3)(1993-3#6)(1993-6#3)(1993-8#3)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#7)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#7)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#2)(1997-6#2)(1997-8#3)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#244)(2008-11#64)(2008-12#9)(2008-2#5)(2008-3#22)(2008-4#4)(2008-5#17)(2008-6#2)(2008-7#13)(2008-8#16)(2008-9#19)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#4)(2009-3#2)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#4)(2010-10#4)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-2#12)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#9)(2012-3#2)(2012-7#1)(2013-1#10)(2013-7#5)(2013-8#5)
meant that the##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-3#1)
meant that##7##2##(2008-10#3)(2008-11#1)(2008-8#1)(2011-3#1)(2013-1#1)
meant to##5##2##(1993-1#1)(1996-12#1)(1996-2#1)(2008-9#1)(2010-10#1)
meant##17##1##(1993-1#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-3#1)(2013-1#1)
meanwhile##8##1##(1997-5#1)(2008-10#4)(2008-11#2)(2011-2#1)
measles (rubella)##2##2##(2012-12#2)
measles and German measles in Colombia##2##6##(2012-12#2)
measles and German measles##4##4##(2012-12#4)
measles and##7##2##(2008-8#1)(2012-12#6)
measles epidemics##4##2##(1995-5#2)(2008-9#2)
measles##28##1##(1991-8#1)(1995-3#1)(1995-5#3)(1996-1#1)(2008-12#2)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#14)
measles-specific##4##1##(2008-12#4)
measurable and##2##2##(1991-2#1)(1994-1#1)
measurable effect on spread##2##4##(2008-10#2)
measurable effect on##4##3##(1992-12#1)(1993-3#1)(2008-10#2)
measurable quantities##4##2##(2008-10#2)(2008-11#1)(2010-10#1)
measurable##46##1##(1990-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#2)(2011-2#1)(2013-8#1)
measurably##4##1##(1991-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
measure a##3##2##(1995-2#1)(2008-3#1)(2008-9#1)
measure analysis##2##2##(1991-2#1)(2012-12#1)
measure and##8##2##(1991-11#1)(2008-11#3)(2008-6#2)(2009-10#1)(2012-3#1)
measure blood pressure##2##3##(2008-1#1)(2012-3#1)
measure blood##4##2##(2008-1#1)(2008-10#2)(2012-3#1)
measure both the##2##3##(2007-12#1)(2013-1#1)
measure both##4##2##(2007-12#2)(2008-10#1)(2013-1#1)
measure cerebral blood flow and##2##5##(1994-2#1)(2012-3#1)
measure construction##2##2##(2013-1#2)
measure directly##2##2##(2008-2#1)(2012-2#1)
measure effects of##2##3##(2008-10#2)
measure for the##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
measure for##13##2##(1990-3#1)(1994-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#4)(2009-6#1)(2012-2#1)(2013-1#1)
measure human##2##2##(1992-9#1)(1993-6#1)
measure in vivo##2##3##(2008-4#1)(2008-5#1)
measure in##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
measure is##6##2##(1992-2#1)(1994-9#1)(2008-10#1)(2008-6#1)(2010-10#1)(2011-2#1)
measure number six##2##3##(2007-8#2)
measure number##3##2##(2007-8#3)
measure of its##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
measure of multilocus correlation##4##4##(2008-10#4)
measure of multilocus##5##3##(2008-10#5)
measure of output##2##3##(1993-3#1)(1994-12#1)
measure of quality##2##3##(2012-3#1)(2013-1#1)
measure of the extent of##2##5##(1993-2#1)(2008-10#1)
measure of the##26##3##(1993-12#1)(1993-2#1)(1994-12#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-3#1)
measure of##115##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#2)(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#4)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#27)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#8)(2012-3#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#7)(2013-8#2)
measure only##2##2##(1992-12#1)(2008-4#1)
measure selection/specification##2##2##(2013-1#2)
measure social##2##2##(1992-3#1)(2011-2#1)
measure that##4##2##(1995-2#1)(1996-5#1)(2008-7#1)(2011-2#1)
measure the amount of##2##4##(2008-11#1)(2008-9#1)
measure the extent of##3##4##(1994-5#1)(1997-6#1)(2008-10#1)
measure the impact of##4##4##(1992-12#1)(1995-2#1)(2008-9#1)(2013-1#1)
measure the relative##2##3##(2008-10#2)
measure the##89##2##(1990-12#1)(1991-2#1)(1992-12#2)(1992-3#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#19)(2008-11#5)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#7)(2009-12#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-7#3)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#2)(2013-7#1)
measure their##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
measure tissue##2##2##(2008-4#1)(2012-2#1)
measure to##4##2##(2008-10#2)(2008-12#1)(2008-6#1)
measure was the##4##3##(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
measure was##6##2##(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
measure with##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
measure without##2##2##(2008-10#1)(2011-2#1)
measure##488##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-5#1)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#4)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#3)(1995-2#5)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#4)(2007-8#3)(2008-1#3)(2008-10#98)(2008-11#27)(2008-12#7)(2008-2#4)(2008-3#26)(2008-4#13)(2008-5#13)(2008-6#13)(2008-7#8)(2008-8#5)(2008-9#22)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-1#3)(2010-10#6)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#7)(2010-8#2)(2010-9#2)(2011-2#23)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#22)(2012-3#8)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#24)(2013-7#2)(2013-8#5)
measure)##3##1##(2008-12#3)
measure?##3##1##(1993-1#1)(2008-8#1)(2011-2#1)
measured a##3##2##(1996-3#1)(2008-3#1)(2009-11#1)
measured absorbance##2##2##(2008-10#2)
measured across##2##2##(2008-12#1)(2009-11#1)
measured after the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
measured after##12##2##(1992-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2013-1#1)
measured against##3##2##(1992-6#1)(2008-10#2)
measured an##2##2##(2008-11#1)(2011-2#1)
measured and calculated##4##3##(2008-2#1)(2008-3#2)(2012-2#1)
measured and compared with##3##4##(2008-10#1)(2008-3#1)(2009-6#1)
measured and the##5##3##(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#1)
measured and used##2##3##(2008-11#1)(2011-2#1)
measured and##30##2##(1997-8#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#8)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
measured as a function of##5##5##(2008-10#2)(2008-3#3)
measured as a##7##3##(2008-10#3)(2008-3#3)(2012-3#1)
measured as an##5##3##(2008-10#2)(2008-11#2)(2008-4#1)
measured as number of##2##4##(2008-10#2)
measured as the##4##3##(1993-3#1)(2008-10#3)
measured as##33##2##(1993-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#16)(2008-11#4)(2008-3#3)(2008-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
measured at 420 nm##2##4##(2008-10#2)
measured at a##3##3##(2008-10#3)
measured at different##5##3##(1996-12#1)(2008-10#1)(2008-7#2)(2008-8#1)
measured at four##4##3##(2008-11#1)(2008-3#1)(2010-5#1)(2013-3#1)
measured at several##2##3##(2008-10#1)(2008-3#1)
measured at specific##2##3##(2008-10#2)
measured at the##9##3##(1991-6#1)(2008-10#4)(2010-12#1)(2010-7#1)(2012-4#1)(2013-7#1)
measured at two##2##3##(2008-2#1)(2008-9#1)
measured at##93##2##(1990-11#2)(1990-2#1)(1991-12#1)(1991-6#1)(1996-12#1)(2008-10#59)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-4#1)(2013-1#3)(2013-3#1)(2013-7#1)
measured based on the##2##4##(2008-10#1)(2013-8#1)
measured based on##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
measured before and after##3##4##(2008-3#1)(2008-5#1)(2011-1#1)
measured before##5##2##(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)
measured between##2##2##(2008-10#1)(2012-3#1)
measured by CAT##2##3##(1995-8#1)(2008-11#1)
measured by ELISA##4##3##(1990-12#1)(1997-2#1)(2008-10#1)(2008-8#1)
measured by Western##2##3##(2008-5#1)(2011-2#1)
measured by a##21##3##(1990-6#1)(1991-2#1)(1992-3#1)(1995-6#1)(2007-11#1)(2008-10#7)(2008-3#3)(2008-8#2)(2008-9#1)(2010-3#1)(2011-3#1)(2013-1#1)
measured by an##6##3##(1991-2#1)(1991-3#1)(1994-11#1)(1995-5#1)(2008-10#2)
measured by both##2##3##(2008-10#2)
measured by flame atomic absorption spectrometry##2##6##(2008-10#2)
measured by flow##2##3##(1993-2#1)(2008-11#1)
measured by gas##2##3##(2008-10#1)(2008-11#1)
measured by in situ##2##4##(1995-12#1)(1996-12#1)
measured by in##3##3##(1995-12#1)(1996-12#1)(1997-2#1)
measured by liquid scintillation counting##2##5##(2008-10#1)(2008-11#1)
measured by radioimmunoassay##2##3##(1992-9#1)(1994-5#1)
measured by selective##2##3##(1995-11#1)(2008-11#1)
measured by the number of##2##5##(1991-2#1)(2008-10#1)
measured by the##49##3##(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
measured by their##2##3##(1994-8#1)(2008-10#1)
measured by this##2##3##(2008-10#2)
measured by use of a##2##5##(2008-3#1)(2009-1#1)
measured by use of##3##4##(2008-3#2)(2009-1#1)
measured by using##5##3##(1995-8#1)(2008-10#3)(2008-5#1)
measured by##234##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#3)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#82)(2008-11#17)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-1#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#3)
measured concentration##2##2##(2008-10#2)
measured concentrations##6##2##(1996-12#1)(2008-10#5)
measured data##10##2##(2008-10#1)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2012-3#1)
measured directly by##2##3##(2008-10#1)(2008-11#1)
measured directly with##2##3##(2008-10#2)
measured directly##10##2##(2008-10#8)(2008-11#1)(2008-3#1)
measured during the##2##3##(1992-2#1)(2008-11#1)
measured during##6##2##(1992-2#1)(1993-1#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)
measured experimentally##2##2##(2008-10#1)(2008-3#1)
measured exposure##3##2##(1993-1#2)(2011-2#1)
measured fluorescence from##2##3##(2008-3#2)
measured fluorescence##4##2##(2008-3#4)
measured following##2##2##(2008-10#2)
measured for each##4##3##(1992-3#1)(2008-10#3)
measured for##21##2##(1991-5#1)(1992-3#1)(1992-6#1)(1994-5#1)(1996-5#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
measured from the##7##3##(1990-8#1)(1991-5#1)(1991-6#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)
measured from##12##2##(1990-8#1)(1991-5#1)(1991-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-2#1)
measured in 15##2##3##(1990-2#1)(2008-8#1)
measured in a##12##3##(1993-11#1)(1994-3#1)(1996-2#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
measured in aqueous##2##3##(2008-10#2)
measured in both##4##3##(1993-3#1)(1994-3#1)(2008-3#1)(2013-7#1)
measured in different##2##3##(1990-3#1)(2008-10#1)
measured in plasma##2##3##(1993-2#1)(2010-11#1)
measured in real time##2##4##(2008-10#1)(2008-3#1)
measured in situ##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
measured in terms of the##3##5##(1992-3#1)(1996-3#1)(2008-10#1)
measured in terms of##10##4##(1991-6#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
measured in the field##2##4##(2008-10#2)
measured in the presence of##3##5##(1990-5#1)(1991-12#1)(2008-10#1)
measured in the presence##4##4##(1990-5#1)(1991-12#1)(1993-3#1)(2008-10#1)
measured in the range##3##4##(2008-10#3)
measured in the##38##3##(1990-5#1)(1991-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-2#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2011-2#1)
measured in this study##2##4##(2008-10#1)(2008-7#1)
measured in vitro##6##3##(1990-6#1)(1991-2#1)(1993-9#1)(2008-10#2)(2008-9#1)
measured in##151##2##(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#4)(1994-3#3)(1994-8#1)(1995-11#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#49)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#10)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#4)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
measured mass##3##2##(1993-2#1)(2008-10#2)
measured on a##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
measured on##16##2##(1995-5#1)(2006-6#1)(2008-10#6)(2008-3#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
measured over a##5##3##(1991-9#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-5#1)
measured over the##3##3##(2008-10#2)(2008-3#1)
measured over##12##2##(1991-9#1)(1997-1#1)(2008-10#4)(2008-3#2)(2008-8#1)(2011-2#1)(2012-5#1)(2013-8#1)
measured parameters##4##2##(2008-3#2)(2009-8#1)(2011-2#1)
measured quantitatively##2##2##(2008-10#1)(2008-12#1)
measured radiances##2##2##(2008-3#2)
measured rate##2##2##(2008-10#1)(2008-11#1)
measured relative##2##2##(2008-10#1)(2008-3#1)
measured responses##3##2##(2008-10#2)(2008-11#1)
measured simultaneously##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#2)
measured spectra##2##2##(2008-10#1)(2008-3#1)
measured spectral##2##2##(2008-3#2)
measured spectrophotometrically##3##2##(2008-10#3)
measured the distribution of##2##4##(1992-2#1)(2008-11#1)
measured the effect of##3##4##(1991-2#1)(1995-1#1)(2008-12#1)
measured the##35##2##(1991-2#1)(1991-5#1)(1992-2#1)(1993-8#1)(1994-11#2)(1995-1#1)(1995-8#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
measured three##2##2##(1994-9#1)(2008-10#1)
measured through##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2011-2#1)(2013-8#1)
measured throughout##2##2##(2010-7#1)(2013-8#1)
measured to be##7##3##(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-7#1)
measured to determine##5##3##(2007-8#1)(2008-10#3)(2010-4#1)
measured to##22##2##(1992-1#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-4#1)
measured total##2##2##(1993-2#1)(1993-9#1)
measured under##3##2##(2008-10#2)(2008-8#1)
measured using a##9##3##(1993-2#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#1)
measured using the##8##3##(1990-11#1)(1991-2#1)(1993-2#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
measured using##41##2##(1990-11#1)(1990-5#1)(1991-2#1)(1993-2#3)(1993-8#1)(1994-2#2)(1994-3#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
measured via##3##2##(1997-3#1)(2008-10#1)(2008-12#1)
measured were##2##2##(1996-12#1)(2011-2#1)
measured when the##2##3##(2008-10#1)(2013-1#1)
measured when##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
measured with a##15##3##(2007-11#1)(2008-10#6)(2008-12#2)(2008-3#5)(2009-11#1)
measured with an##7##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)
measured with high##2##3##(2008-3#1)(2008-8#1)
measured with the##6##3##(1992-9#1)(2008-10#3)(2008-7#1)(2010-7#1)
measured with##63##2##(1990-12#3)(1992-9#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#24)(2008-11#2)(2008-12#5)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-10#1)(2010-7#1)(2013-1#1)(2013-3#1)
measured##1190##1##(1990-11#7)(1990-12#6)(1990-2#3)(1990-3#4)(1990-5#3)(1990-6#2)(1990-8#4)(1990-9#2)(1991-11#4)(1991-12#3)(1991-2#7)(1991-3#4)(1991-5#8)(1991-6#5)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#5)(1992-6#4)(1992-9#4)(1993-1#9)(1993-11#1)(1993-12#1)(1993-2#13)(1993-3#6)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#7)(1994-12#3)(1994-2#7)(1994-3#6)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#5)(1996-1#2)(1996-12#10)(1996-2#8)(1996-3#3)(1996-5#1)(1996-6#4)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#1)(1997-7#1)(1997-8#5)(2006-6#3)(2007-11#3)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#402)(2008-11#65)(2008-12#22)(2008-2#24)(2008-3#120)(2008-4#7)(2008-5#32)(2008-6#6)(2008-7#25)(2008-8#22)(2008-9#23)(2009-1#3)(2009-10#1)(2009-11#6)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#6)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#7)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#7)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#35)(2011-3#3)(2012-12#4)(2012-2#9)(2012-3#16)(2012-4#1)(2012-5#3)(2013-1#33)(2013-3#2)(2013-7#2)(2013-8#15)
measurement accuracy##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
measurement and analysis##2##3##(2008-1#1)(2008-11#1)
measurement and speciation of##2##4##(2008-10#2)
measurement and the##3##3##(1990-8#1)(2008-10#2)
measurement and##27##2##(1990-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-5#2)(2009-10#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
measurement are##3##2##(1992-9#1)(2008-10#1)(2010-6#1)
measurement as##2##2##(2008-10#1)(2010-5#1)
measurement at##3##2##(2008-10#2)(2013-1#1)
measurement based on##2##3##(2010-4#1)(2013-8#1)
measurement beam##2##2##(2008-3#2)
measurement by ICP-MS##3##3##(2008-10#3)
measurement by a##2##3##(2008-10#2)
measurement by flame##2##3##(2008-10#2)
measurement by##16##2##(2008-10#12)(2008-2#1)(2008-3#1)(2009-10#1)(2013-8#1)
measurement campaign##2##2##(2008-3#1)(2008-5#1)
measurement can be##3##3##(1997-6#1)(2008-11#1)(2008-4#1)
measurement can##4##2##(1997-6#1)(2008-11#1)(2008-4#1)(2012-2#1)
measurement cell##2##2##(2008-10#2)
measurement conditions##4##2##(2008-10#4)
measurement could be##2##3##(2008-10#2)
measurement could##3##2##(1997-2#1)(2008-10#2)
measurement cycles##2##2##(2008-10#1)(2008-5#1)
measurement data##5##2##(2008-10#2)(2008-11#3)
measurement equivalence##3##2##(2009-11#3)
measurement error and temporal variability of risk factors##2##8##(1992-9#2)
measurement error and temporal variability##3##5##(1992-9#3)
measurement error and##4##3##(1992-9#3)(2008-3#1)
measurement error was##2##3##(2008-12#1)(2008-3#1)
measurement error##12##2##(1992-9#3)(2008-12#2)(2008-3#6)(2009-12#1)
measurement errors in##2##3##(2008-11#1)(2008-3#1)
measurement errors##7##2##(2008-10#3)(2008-11#2)(2008-3#2)
measurement for##7##2##(2008-10#3)(2008-5#1)(2008-9#1)(2013-1#2)
measurement frequency of##4##3##(2008-10#4)
measurement frequency##5##2##(2008-10#5)
measurement has##2##2##(2008-10#1)(2012-2#1)
measurement in the##2##3##(2008-10#2)
measurement in##23##2##(1991-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-10#13)(2008-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
measurement instruments##7##2##(2008-10#1)(2013-1#6)
measurement is##18##2##(2008-10#9)(2008-3#8)(2011-2#1)
measurement itself##2##2##(2008-11#1)(2008-3#1)
measurement method##2##2##(2007-11#1)(2013-8#1)
measurement methods##4##2##(1992-9#1)(2008-10#2)(2009-7#1)
measurement noise##2##2##(2008-3#2)
measurement occasions##2##2##(2009-10#1)(2010-10#1)
measurement of 3##2##3##(1997-4#1)(2008-10#1)
measurement of DNA##2##3##(2008-9#2)
measurement of a##6##3##(2008-10#3)(2008-3#2)(2010-2#1)
measurement of acetate##2##3##(2008-10#2)
measurement of blood pressure##2##4##(1991-6#1)(2008-7#1)
measurement of chromium(VI)##2##3##(2008-10#2)
measurement of dissolved##3##3##(2008-10#2)(2008-11#1)
measurement of fluorescence##3##3##(2008-10#2)(2008-9#1)
measurement of hydrogen peroxide in industrial applications##2##7##(2008-10#2)
measurement of hydrogen##3##3##(2008-10#2)(2008-3#1)
measurement of mRNA##2##3##(2008-4#2)
measurement of natriuretic##2##3##(2009-5#2)
measurement of optical##2##3##(2008-10#1)(2008-3#1)
measurement of oropharyngeal clearance##3##4##(1996-2#3)
measurement of pH in##2##4##(2008-10#1)(2010-8#1)
measurement of pH##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
measurement of phenol##2##3##(2008-10#2)
measurement of reticulated platelets##2##4##(2006-6#2)
measurement of serum##2##3##(1996-6#1)(2010-1#1)
measurement of the absorbance of the##2##6##(2008-10#2)
measurement of the decrease in the##2##6##(2008-10#2)
measurement of the intensity##3##4##(2008-10#2)(2008-2#1)
measurement of the optical##2##4##(2008-3#2)
measurement of the value##2##4##(2008-10#1)(2008-3#1)
measurement of the##77##3##(1990-2#1)(1992-11#1)(1994-2#1)(1994-9#1)(2006-6#2)(2007-11#2)(2007-12#3)(2008-10#38)(2008-11#1)(2008-2#3)(2008-3#17)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
measurement of these##2##3##(2008-9#1)(2012-12#1)
measurement of total##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
measurement of trace##2##3##(2008-10#2)
measurement of##296##2##(1990-11#1)(1990-2#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#2)(1993-1#1)(1993-2#2)(1993-5#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(2006-6#4)(2007-11#5)(2007-12#4)(2008-10#120)(2008-11#9)(2008-12#3)(2008-2#6)(2008-3#40)(2008-4#13)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#12)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#4)(2010-1#1)(2010-11#3)(2010-2#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)
measurement precision##3##2##(2008-10#3)
measurement principles##2##2##(2008-11#1)(2010-7#1)
measurement procedure##2##2##(2008-10#2)
measurement properties##2##2##(2012-2#2)
measurement range##5##2##(2008-10#2)(2008-11#2)(2008-3#1)
measurement repeatability##3##2##(2008-10#3)
measurement reproducibility##4##2##(2008-10#2)(2010-9#1)(2011-7#1)
measurement results were##2##3##(2008-10#2)
measurement results##9##2##(2008-10#5)(2009-11#1)(2012-2#1)(2012-3#2)
measurement sensitivity##2##2##(2008-3#1)(2008-9#1)
measurement setup##2##2##(2008-2#1)(2008-3#1)
measurement system is##2##3##(2008-10#1)(2008-9#1)
measurement system##10##2##(1995-1#1)(2008-10#5)(2008-3#2)(2008-9#1)(2013-1#1)
measurement systems##7##2##(1994-3#4)(1997-2#2)(2013-1#1)
measurement technique##3##2##(2008-10#1)(2008-3#2)
measurement techniques##4##2##(1990-8#1)(2008-10#1)(2008-3#1)(2010-7#1)
measurement that uses##2##3##(2008-3#2)
measurement that##4##2##(2008-3#4)
measurement to##2##2##(1993-12#1)(2008-3#1)
measurement tool##2##2##(2008-11#1)(2012-2#1)
measurement tools##7##2##(1990-12#1)(1992-3#1)(2008-10#1)(2010-11#1)(2010-7#1)(2013-1#2)
measurement uncertainty##9##2##(2008-10#7)(2008-3#2)
measurement using a##2##3##(2008-10#1)(2010-4#1)
measurement using##6##2##(1995-2#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)
measurement volume##2##2##(2008-2#1)(2008-3#1)
measurement was carried out##2##4##(2008-5#1)(2009-11#1)
measurement was of##2##3##(2008-3#2)
measurement was##16##2##(1993-12#1)(1996-12#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)
measurement were##2##2##(2008-5#2)
measurement with the##3##3##(2008-10#1)(2008-3#2)
measurement with##6##2##(2008-10#3)(2008-3#3)
measurement##765##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#3)(1991-11#1)(1991-12#3)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-9#5)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#5)(1994-2#4)(1994-3#8)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-6#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(2006-6#4)(2007-11#7)(2007-12#4)(2008-1#2)(2008-10#335)(2008-11#28)(2008-12#7)(2008-2#11)(2008-3#106)(2008-4#15)(2008-5#22)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#6)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#9)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#11)(2011-7#1)(2012-12#2)(2012-2#18)(2012-3#8)(2013-1#24)(2013-8#3)
measurement)##2##1##(2008-10#1)(2010-7#1)
measurement-regeneration cycles##2##2##(2008-10#2)
measurements (n=5)##2##2##(2008-10#2)
measurements across##2##2##(1995-2#1)(2008-12#1)
measurements allowed##2##2##(2008-10#1)(2009-7#1)
measurements and a##2##3##(2008-10#1)(2008-3#1)
measurements and are##2##3##(2008-3#1)(2011-1#1)
measurements and the##9##3##(2008-10#4)(2008-3#2)(2008-5#1)(2008-9#1)(2013-1#1)
measurements and##45##2##(1993-12#1)(1995-8#1)(2008-10#21)(2008-11#3)(2008-3#12)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-2#1)(2013-1#1)
measurements are compared with##2##4##(2008-2#1)(2008-3#1)
measurements are compared##3##3##(2008-2#2)(2008-3#1)
measurements are made##3##3##(1991-6#1)(2008-10#1)(2008-4#1)
measurements are used##2##3##(2008-3#2)
measurements are##30##2##(1991-6#1)(1996-6#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-8#2)(2009-8#1)(2011-7#1)
measurements as a##2##3##(2008-10#1)(2008-9#1)
measurements as well as##3##4##(2008-10#3)
measurements as##5##2##(2008-10#4)(2008-9#1)
measurements at the##3##3##(2008-10#3)
measurements at##15##2##(2008-10#11)(2008-3#3)(2013-1#1)
measurements based on##5##3##(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)
measurements by linear Raman spectroscopy##2##5##(2008-2#2)
measurements by use of##2##4##(2008-2#1)(2008-3#1)
measurements by##15##2##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#8)
measurements can be incorporated into##2##5##(1995-2#1)(2010-11#1)
measurements can be##6##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-11#1)
measurements can##8##2##(1991-1#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-11#1)
measurements could be##3##3##(1990-2#1)(2008-11#1)(2008-5#1)
measurements demonstrated that##2##3##(1992-12#1)(2008-11#1)
measurements during##3##2##(2008-3#2)(2013-1#1)
measurements for a##2##3##(2008-10#1)(2009-7#1)
measurements for the##2##3##(2008-10#1)(2008-3#1)
measurements for which##2##3##(2008-3#2)
measurements for##19##2##(2008-10#10)(2008-2#1)(2008-3#5)(2009-7#1)(2013-1#2)
measurements from a##2##3##(2008-3#2)
measurements from##13##2##(2008-10#1)(2008-3#7)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#1)(2013-1#1)
measurements have been used to##2##5##(2008-10#1)(2008-3#1)
measurements have been##5##3##(2008-10#2)(2008-3#2)(2008-5#1)
measurements in 0##2##3##(2008-10#2)
measurements in a##7##3##(1993-3#1)(2008-10#1)(2008-2#3)(2008-3#2)
measurements in the NIR##2##4##(2008-10#2)
measurements in the##19##3##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#8)(2013-1#1)(2013-8#1)
measurements in##65##2##(1990-2#1)(1990-6#2)(1990-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-12#2)(2008-10#23)(2008-11#2)(2008-2#5)(2008-3#14)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
measurements including##2##2##(2008-12#1)(2008-3#1)
measurements indicate that##2##3##(1994-5#1)(2008-10#1)
measurements indicate##4##2##(1994-5#1)(2008-10#2)(2008-3#1)
measurements indicated that##2##3##(2008-10#1)(2011-2#1)
measurements is 1##2##3##(2008-10#2)
measurements is discussed##3##3##(2008-10#1)(2008-3#2)
measurements is presented##3##3##(2008-10#1)(2008-3#2)
measurements is##13##2##(2008-10#7)(2008-3#6)
measurements made##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
measurements not##2##2##(1990-11#1)(1992-10#1)
measurements of 0##4##3##(2008-10#4)
measurements of 1##2##3##(2008-10#2)
measurements of CO##2##3##(2008-3#2)
measurements of CO(2)##2##3##(2008-2#1)(2008-3#1)
measurements of a##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
measurements of an##2##3##(2008-2#1)(2008-3#1)
measurements of aromatic##2##3##(2008-10#1)(2008-11#1)
measurements of arsenic##2##3##(2008-10#2)
measurements of atmospheric##3##3##(2008-3#3)
measurements of drug##2##3##(1990-2#1)(2010-11#1)
measurements of environmental##2##3##(2011-2#1)(2012-3#1)
measurements of hydrogen##2##3##(2008-10#1)(2008-3#1)
measurements of low##2##3##(2008-10#1)(2008-3#1)
measurements of several##2##3##(2008-3#2)
measurements of solar##2##3##(2008-3#2)
measurements of the##26##3##(1991-11#1)(1992-10#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#10)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
measurements of these##4##3##(2008-10#3)(2008-3#1)
measurements of trace gases in##2##5##(2008-3#2)
measurements of trace metals##2##4##(2008-10#2)
measurements of trace##7##3##(2008-10#4)(2008-11#1)(2008-3#2)
measurements of tropospheric##2##3##(2008-11#1)(2008-3#1)
measurements of##204##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-5#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#2)(2007-12#2)(2008-10#71)(2008-11#10)(2008-12#1)(2008-2#11)(2008-3#50)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#4)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
measurements on DSKNPH in DMSO##2##5##(2008-10#2)
measurements on fac-Re(CO)(3)(dpknph)Cl in polar##2##5##(2008-10#2)
measurements on fac-Re(CO)(3)(dpknph)Cl##3##3##(2008-10#3)
measurements on the##3##3##(1996-3#1)(2008-10#1)(2008-3#1)
measurements on##22##2##(1994-9#1)(1996-3#2)(2008-10#12)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
measurements over the##2##3##(2008-2#1)(2008-3#1)
measurements over##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
measurements reveal##2##2##(2008-10#1)(2008-3#1)
measurements revealed that##2##3##(1994-5#1)(1995-6#1)
measurements revealed##4##2##(1994-5#1)(1995-6#1)(2008-10#1)(2008-2#1)
measurements show that##2##3##(1994-5#1)(2008-3#1)
measurements show##5##2##(1994-5#1)(2008-10#1)(2008-3#3)
measurements showed##3##2##(1996-6#1)(2008-10#2)
measurements taken by##2##3##(2008-2#1)(2010-7#1)
measurements taken over the angular range 0 &lt##2##8##(2008-3#2)
measurements taken with a##2##4##(2008-2#2)
measurements taken with##3##3##(2008-2#2)(2008-3#1)
measurements taken##8##2##(2008-2#3)(2008-3#3)(2010-7#1)(2013-1#1)
measurements that##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
measurements to characterize the##2##4##(2008-3#1)(2011-2#1)
measurements to quantify##3##3##(2008-10#2)(2008-5#1)
measurements to##19##2##(1990-11#1)(1992-10#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
measurements using a##3##3##(2008-10#2)(2008-11#1)
measurements using the##2##3##(2008-10#1)(2008-11#1)
measurements using##9##2##(2008-10#6)(2008-11#2)(2008-3#1)
measurements was evaluated##2##3##(2008-10#2)
measurements was less than##2##4##(2008-10#1)(2008-2#1)
measurements was##10##2##(2008-10#8)(2008-2#1)(2012-12#1)
measurements were carried out in##2##5##(2008-10#2)
measurements were carried out using##3##5##(2008-10#3)
measurements were carried out##8##4##(2008-10#8)
measurements were compared with##2##4##(2008-11#1)(2008-3#1)
measurements were compared##4##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
measurements were made using##2##4##(2008-10#2)
measurements were made##3##3##(2008-10#3)
measurements were not##2##3##(1990-11#1)(2008-7#1)
measurements were obtained from##2##4##(2008-10#1)(2008-11#1)
measurements were obtained##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
measurements were performed in solvents that absorb##2##7##(2008-3#2)
measurements were performed in##3##4##(2008-10#1)(2008-3#2)
measurements were performed##10##3##(2008-10#4)(2008-3#4)(2008-5#1)(2012-2#1)
measurements were##51##2##(1990-11#1)(1994-3#1)(2008-10#28)(2008-11#2)(2008-3#8)(2008-5#3)(2008-7#1)(2010-7#1)(2010-8#1)(2012-2#3)(2012-5#1)(2013-8#1)
measurements when##2##2##(2008-2#1)(2008-3#1)
measurements which##2##2##(1996-8#1)(2008-10#1)
measurements with a##4##3##(1997-6#1)(2008-10#2)(2008-3#1)
measurements with the##5##3##(1996-6#1)(2008-10#2)(2008-3#2)
measurements with##19##2##(1996-6#1)(1997-6#1)(2008-10#9)(2008-3#8)
measurements##918##1##(1990-11#4)(1990-2#3)(1990-6#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#4)(1992-12#2)(1992-8#1)(1992-9#5)(1993-1#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-5#4)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#6)(1996-8#3)(1997-1#2)(1997-6#1)(1997-8#4)(2007-11#1)(2007-12#11)(2008-10#391)(2008-11#38)(2008-12#5)(2008-2#42)(2008-3#199)(2008-4#3)(2008-5#22)(2008-6#3)(2008-7#7)(2008-8#11)(2008-9#16)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#6)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-4#1)(2010-7#5)(2010-8#6)(2010-9#1)(2011-1#1)(2011-2#14)(2011-7#1)(2012-12#4)(2012-2#9)(2012-3#2)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#3)
measurements)##3##1##(2008-10#3)
measurements]##3##1##(1990-9#1)(1991-11#1)(1994-9#1)
measures against##2##2##(1995-5#1)(1996-3#1)
measures aimed at##4##3##(1995-1#1)(2008-10#1)(2008-12#1)(2009-6#1)
measures and##23##2##(1991-6#1)(1993-9#1)(1994-5#1)(1996-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-6#1)(2010-1#2)(2010-8#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
measures are discussed##3##3##(1990-2#1)(2008-11#1)(2013-1#1)
measures are more##2##3##(2008-11#2)
measures are##22##2##(1990-2#1)(1992-9#1)(1995-2#1)(1995-9#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-6#2)(2011-2#1)(2013-1#1)
measures based on##3##3##(1993-2#1)(1997-3#1)(2011-2#1)
measures based##4##2##(1991-3#1)(1993-2#1)(1997-3#1)(2011-2#1)
measures by##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
measures designed##2##2##(2008-7#1)(2011-2#1)
measures for the prevention##2##4##(2008-9#1)(2009-10#1)
measures for the##5##3##(1993-12#1)(1995-5#1)(2008-10#1)(2008-9#1)(2009-10#1)
measures for##23##2##(1991-1#1)(1993-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
measures from##2##2##(2008-8#1)(2008-9#1)
measures have been##4##3##(1992-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
measures in order to##2##4##(1992-9#1)(2008-7#1)
measures in the##2##3##(1991-11#1)(1996-8#1)
measures in##13##2##(1991-1#1)(1991-11#1)(1992-2#1)(1992-9#2)(1994-8#1)(1996-8#1)(1997-4#1)(2008-7#1)(2010-12#1)(2013-1#3)
measures include##2##2##(1995-12#1)(2008-12#1)
measures included##5##2##(2008-12#1)(2008-3#1)(2011-2#2)(2012-2#1)
measures may##2##2##(2008-9#1)(2010-8#1)
measures of beta-cell function##2##4##(1994-12#2)
measures of body##2##3##(2008-7#1)(2012-2#1)
measures of both##2##3##(2008-11#1)(2011-2#1)
measures of durability are##2##4##(2008-10#2)
measures of durability##3##3##(2008-10#3)
measures of efficacy##2##3##(2008-6#1)(2011-2#1)
measures of executive control##2##4##(2013-8#2)
measures of health##2##3##(1995-2#1)(2011-2#1)
measures of obesity##2##3##(2009-7#2)
measures of perceptions##3##3##(2013-1#3)
measures of quality##2##3##(1992-2#1)(1997-3#1)
measures of responding##2##3##(2008-5#2)
measures of status##2##3##(2008-12#2)
measures of the##5##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
measures of uncertainty##2##3##(2009-7#1)(2010-10#1)
measures of##133##2##(1991-1#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-8#3)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#18)(2008-11#8)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#2)(2009-7#5)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#2)(2010-7#4)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#4)
measures on##2##2##(2009-6#1)(2010-2#1)
measures or##2##2##(1995-2#1)(2008-10#1)
measures related to##2##3##(1996-2#1)(2011-2#1)
measures relative##2##2##(2008-10#1)(2008-3#1)
measures represent##2##2##(1995-2#1)(2008-7#1)
measures should be##2##3##(2012-3#1)(2013-1#1)
measures such as##3##3##(1992-12#1)(2008-7#1)(2009-7#1)
measures taken so far##2##4##(2008-11#2)
measures taken##7##2##(1991-3#2)(1996-6#1)(2008-11#3)(2010-6#1)
measures than##2##2##(2008-9#1)(2013-1#1)
measures that are used##2##4##(1992-9#1)(2008-10#1)
measures that are##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
measures that may##2##3##(2007-11#1)(2009-9#1)
measures that##15##2##(1992-9#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)
measures the differential pressure as a function of time across the##2##11##(2008-10#2)
measures the##12##2##(1990-8#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)
measures to##24##2##(1990-2#1)(1994-3#1)(1996-1#1)(1996-6#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
measures used to##2##3##(2008-10#1)(2010-11#1)
measures used##4##2##(2008-10#1)(2008-12#1)(2010-11#1)(2012-2#1)
measures was##6##2##(1996-2#1)(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
measures were##22##2##(1994-3#1)(1995-12#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-11#1)(2011-2#4)(2013-1#4)
measures which##2##2##(2008-10#2)
measures will help in##2##4##(2009-12#2)
measures will##3##2##(2009-12#2)(2012-3#1)
measures with##6##2##(1990-2#1)(1995-9#1)(2008-3#1)(2010-10#1)(2010-11#1)(2013-1#1)
measures would##2##2##(1997-2#1)(2013-1#1)
measures##588##1##(1990-12#1)(1990-2#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#5)(1991-6#2)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-9#11)(1993-1#1)(1993-12#4)(1993-2#4)(1993-3#4)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#5)(1994-3#8)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-12#7)(1995-2#7)(1995-3#1)(1995-5#4)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#6)(1996-3#6)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#6)(1997-3#11)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#68)(2008-11#30)(2008-12#23)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#16)(2008-9#21)(2009-1#3)(2009-10#6)(2009-11#5)(2009-12#3)(2009-3#2)(2009-4#2)(2009-6#5)(2009-7#8)(2009-9#2)(2010-1#8)(2010-10#7)(2010-11#6)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#5)(2010-9#2)(2011-1#6)(2011-2#47)(2011-3#3)(2011-9#1)(2012-12#8)(2012-2#14)(2012-3#10)(2013-1#50)(2013-7#1)(2013-8#12)
measuring 1##2##2##(2008-10#1)(2008-11#1)
measuring and##5##2##(1992-1#1)(1996-2#3)(1997-1#1)
measuring cell and##3##3##(2008-10#3)
measuring cell##7##2##(2008-10#6)(2008-11#1)
measuring conditions##2##2##(2008-10#2)
measuring different##2##2##(2008-10#1)(2008-5#1)
measuring of##2##2##(1994-3#1)(2008-10#1)
measuring program##2##2##(2008-10#1)(2008-11#1)
measuring range and##2##3##(2008-10#2)
measuring range of the##4##4##(2008-10#3)(2008-11#1)
measuring range of##8##3##(2008-10#7)(2008-11#1)
measuring range was##3##3##(2008-10#3)
measuring range##18##2##(2008-10#17)(2008-11#1)
measuring system##3##2##(2008-10#2)(2008-3#1)
measuring the absorbance at##4##4##(2008-10#4)
measuring the absorbance##5##3##(2008-10#5)
measuring the activity of##2##4##(2008-8#1)(2011-2#1)
measuring the amount of##3##4##(2008-10#2)(2008-5#1)
measuring the change in##3##4##(2008-10#2)(2008-11#1)
measuring the change##4##3##(2008-10#3)(2008-11#1)
measuring the decrease in absorbance at##2##6##(2008-10#2)
measuring the decrease in absorbance of##4##6##(2008-10#4)
measuring the decrease in absorbance##6##5##(2008-10#6)
measuring the decrease in##9##4##(2008-10#9)
measuring the decrease of##3##4##(2008-10#3)
measuring the decrease##12##3##(2008-10#12)
measuring the impact of##2##4##(2008-9#2)
measuring the peak##3##3##(2008-10#3)
measuring the size of##2##4##(2008-10#1)(2008-7#1)
measuring the##135##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-3#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#78)(2008-11#8)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
measuring their##3##2##(1996-3#1)(2008-10#1)(2008-5#1)
measuring time##2##2##(2008-10#1)(2011-2#1)
measuring total##2##2##(1990-12#1)(2008-2#1)
measuring veiling glare##2##3##(2008-3#2)
measuring##352##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1991-12#1)(1991-3#2)(1991-5#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-6#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#158)(2008-11#18)(2008-12#2)(2008-2#3)(2008-3#22)(2008-4#10)(2008-5#10)(2008-7#6)(2008-8#9)(2008-9#10)(2009-12#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#11)(2012-3#2)(2013-1#6)(2013-8#1)
meat DNA##2##2##(2010-4#2)
meat and bone meal##4##4##(2008-10#4)
meat and meat products##3##4##(2008-10#1)(2010-4#1)(2012-12#1)
meat and##12##2##(2008-10#9)(2010-4#1)(2012-12#1)(2013-1#1)
meat colour##2##2##(2013-1#2)
meat for##2##2##(2010-4#2)
meat from the##2##3##(2010-4#2)
meat from yak and cattle using##2##6##(2010-4#2)
meat from##7##2##(2010-4#7)
meat has##2##2##(1997-2#1)(2008-10#1)
meat is##3##2##(2010-4#3)
meat mixtures##2##2##(2010-4#2)
meat products and vegetables##2##4##(2008-10#2)
meat products and##3##3##(2008-10#3)
meat products##17##2##(2008-10#9)(2010-4#5)(2011-2#2)(2012-12#1)
meat quality##4##2##(2008-8#1)(2013-1#3)
meat samples and##2##3##(2008-10#1)(2012-2#1)
meat samples##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
meat species##2##2##(2010-4#2)
meat with##3##2##(2008-10#2)(2010-4#1)
meat##120##1##(1990-8#1)(1997-2#2)(2007-12#1)(2008-10#50)(2008-8#1)(2010-4#49)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#7)
meatal##2##1##(2008-10#2)
meats##6##1##(1997-2#1)(2008-10#4)(2010-4#1)
meatus and##2##2##(1992-1#1)(1994-2#1)
meatus##4##1##(1992-1#2)(1994-2#1)(2010-11#1)
mebendazole and##4##2##(2008-10#4)
mebendazole in##2##2##(2008-10#2)
mebendazole##14##1##(1991-8#2)(2008-10#12)
mecA gene##4##2##(2008-10#3)(2011-2#1)
mecA##5##1##(2008-10#4)(2011-2#1)
mechanical and biological##2##3##(1990-9#1)(2012-2#1)
mechanical and chemical##4##3##(2008-10#1)(2008-5#1)(2009-7#1)(2013-8#1)
mechanical and##15##2##(1990-9#1)(1992-3#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
mechanical asynchrony##4##2##(2008-10#4)
mechanical behaviour of Ti-15 Mo-5 Zr-3 Al alloy##2##8##(2009-7#2)
mechanical behaviour of##5##3##(2009-7#5)
mechanical behaviour##6##2##(2009-7#6)
mechanical cell##2##2##(2008-11#1)(2010-9#1)
mechanical characterization##2##2##(2009-7#1)(2013-1#1)
mechanical circulatory support##2##3##(2010-6#2)
mechanical equilibrium##2##2##(2009-5#1)(2013-8#1)
mechanical force##3##2##(2008-10#2)(2008-7#1)
mechanical forces and##2##3##(2008-7#1)(2009-8#1)
mechanical forces##3##2##(2008-7#1)(2009-8#1)(2013-8#1)
mechanical function##3##2##(2008-11#1)(2009-7#2)
mechanical inoculation of##4##3##(2008-10#4)
mechanical inoculation##12##2##(2008-10#12)
mechanical mitral##2##2##(2009-5#1)(2013-1#1)
mechanical parameters of##2##3##(2008-11#1)(2008-5#1)
mechanical polishing##3##2##(2008-10#2)(2008-3#1)
mechanical properties and##4##3##(2009-7#2)(2012-2#1)(2013-1#1)
mechanical properties of human##2##4##(2008-5#2)
mechanical properties of the scaffolds##2##5##(2009-7#2)
mechanical properties of the##12##4##(2007-8#1)(2008-5#1)(2008-7#1)(2009-7#6)(2009-8#1)(2013-1#2)
mechanical properties of##31##3##(1996-3#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-7#13)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
mechanical properties##54##2##(1995-3#1)(1996-3#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-11#2)(2009-7#23)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#5)(2013-8#1)
mechanical shear##2##2##(2008-11#2)
mechanical stability of the##2##4##(2008-10#2)
mechanical stability of##3##3##(1991-12#1)(2008-10#2)
mechanical stability##6##2##(1991-12#1)(2008-10#4)(2008-11#1)
mechanical stimulation of##2##3##(1994-2#1)(2009-8#1)
mechanical stimulation##8##2##(1994-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-2#2)(2013-8#1)
mechanical stimuli##2##2##(1997-3#1)(2008-11#1)
mechanical strain-induced##3##2##(1995-2#3)
mechanical strength##2##2##(2009-7#2)
mechanical stress##4##2##(2008-12#1)(2008-5#1)(2009-8#2)
mechanical ventilation##11##2##(1990-12#1)(1991-11#1)(1991-6#1)(1994-1#1)(1994-6#1)(1995-2#2)(2008-11#1)(2009-7#1)(2010-5#1)(2012-12#1)
mechanical##253##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-3#2)(1992-9#3)(1993-3#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-2#7)(1995-3#1)(1995-8#1)(1996-3#2)(1997-2#2)(1997-3#2)(1997-8#1)(2007-12#2)(2007-8#5)(2008-10#46)(2008-11#11)(2008-12#6)(2008-3#5)(2008-4#3)(2008-5#10)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#42)(2009-8#10)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#10)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#14)(2013-8#7)
mechanically induced long-period fiber gratings##2##5##(2007-12#2)
mechanically induced##4##2##(1994-6#1)(2007-12#2)(2009-8#1)
mechanically inoculated##2##2##(2008-10#2)
mechanically stable##2##2##(2008-10#2)
mechanically transmissible##2##2##(2008-10#2)
mechanically ventilated##3##2##(1990-12#1)(1994-12#1)(2011-2#1)
mechanically##34##1##(1990-12#1)(1994-12#1)(1994-6#2)(1995-2#1)(1996-3#1)(2007-12#2)(2008-10#17)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2011-2#1)(2012-2#1)
mechanics and##2##2##(2008-10#1)(2008-5#1)
mechanics of##4##2##(1994-3#1)(2008-5#1)(2008-8#1)(2010-1#1)
mechanics##24##1##(1994-2#1)(1994-3#1)(1996-5#4)(2008-10#4)(2008-4#1)(2008-5#4)(2008-8#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-2#1)
mechanism about##2##2##(2008-10#1)(2008-8#1)
mechanism and a##2##3##(2011-1#1)(2013-8#1)
mechanism and show that##2##4##(1994-8#1)(2010-3#1)
mechanism and##21##2##(1994-8#1)(2008-10#8)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
mechanism are also discussed##2##4##(2008-10#2)
mechanism are##6##2##(1995-8#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-1#1)
mechanism at##3##2##(2008-10#3)
mechanism based on##2##3##(2008-10#2)
mechanism based##3##2##(2008-10#2)(2008-7#1)
mechanism behind##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
mechanism by which T##2##4##(1995-2#1)(2008-10#1)
mechanism by which the##4##4##(1990-8#1)(1993-2#1)(1994-8#1)(2013-1#1)
mechanism by which these##3##4##(1994-11#1)(1995-12#1)(2008-11#1)
mechanism by which##28##3##(1990-11#1)(1990-5#2)(1990-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-9#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#2)(2013-1#2)
mechanism by##32##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-9#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2013-1#2)
mechanism can promote diversity##2##4##(2008-8#2)
mechanism can##5##2##(2008-10#1)(2008-5#1)(2008-8#2)(2010-10#1)
mechanism for a##2##3##(1995-8#1)(2008-10#1)
mechanism for increasing the##2##4##(2008-10#1)(2009-5#1)
mechanism for its##2##3##(2008-10#1)(2013-8#1)
mechanism for particles##2##3##(2008-11#2)
mechanism for rapid##2##3##(1993-6#1)(2008-11#1)
mechanism for the formation of##3##5##(1991-5#1)(2008-10#2)
mechanism for the interaction of##3##5##(1993-8#1)(2008-10#2)
mechanism for the reaction##2##4##(2008-10#2)
mechanism for the reduction was suggested##2##6##(2008-10#2)
mechanism for the reduction##3##4##(2008-10#3)
mechanism for the##30##3##(1991-5#1)(1992-12#1)(1993-8#1)(1995-3#1)(1995-6#2)(2008-10#17)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)
mechanism for this##2##3##(2008-10#1)(2008-11#1)
mechanism for##100##2##(1991-3#1)(1991-5#2)(1991-9#2)(1992-12#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-3#1)(2008-1#1)(2008-10#31)(2008-11#11)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
mechanism has been##8##3##(1996-11#1)(1996-3#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-2#1)
mechanism has##10##2##(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-2#1)
mechanism how##2##2##(2008-8#1)(2011-2#1)
mechanism in the##3##3##(1990-5#1)(2008-10#1)(2009-11#1)
mechanism in this##2##3##(2008-3#1)(2008-7#1)
mechanism in which##3##3##(1994-5#2)(2008-8#1)
mechanism in##27##2##(1990-5#1)(1992-8#1)(1994-5#2)(1995-8#1)(2008-10#6)(2008-3#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#3)
mechanism involved##3##2##(1994-12#1)(2008-10#1)(2009-5#1)
mechanism involves##4##2##(2008-10#1)(2008-9#1)(2010-1#1)(2011-1#1)
mechanism involving the##2##3##(2008-10#1)(2011-2#1)
mechanism involving##5##2##(1991-12#1)(1992-6#1)(2008-10#2)(2011-2#1)
mechanism is also discussed##2##4##(2008-10#2)
mechanism is also investigated##2##4##(2008-10#1)(2008-12#1)
mechanism is also##5##3##(2008-10#4)(2008-12#1)
mechanism is discussed##3##3##(2008-10#2)(2011-2#1)
mechanism is proposed##4##3##(1996-5#1)(2008-10#3)
mechanism is still unknown##2##4##(2008-7#1)(2008-9#1)
mechanism is unknown##3##3##(1993-6#1)(2008-11#1)(2008-7#1)
mechanism is##46##2##(1990-11#1)(1991-3#1)(1991-5#1)(1993-6#1)(1994-8#2)(1996-11#1)(1996-5#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-10#2)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
mechanism may be##2##3##(2008-10#2)
mechanism may##4##2##(2008-10#3)(2011-2#1)
mechanism of 3##2##3##(2008-10#2)
mechanism of CL##3##3##(2008-10#3)
mechanism of Cr(VI)##2##3##(2008-10#1)(2011-2#1)
mechanism of JH delivery##2##4##(2012-2#2)
mechanism of action for##2##4##(2008-10#1)(2008-5#1)
mechanism of action of the##3##5##(2008-10#2)(2008-11#1)
mechanism of action of##16##4##(1991-5#1)(1994-11#1)(1997-2#2)(2008-10#4)(2008-11#5)(2010-4#1)(2011-2#1)(2013-7#1)
mechanism of action##47##3##(1991-5#1)(1992-3#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-8#1)(1997-2#2)(1997-4#1)(2007-11#1)(2008-10#9)(2008-11#7)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#2)(2010-11#1)(2010-4#1)(2011-2#4)(2011-3#1)(2013-7#1)
mechanism of activation of the##2##5##(1994-3#1)(2008-10#1)
mechanism of activation of##3##4##(1994-3#1)(1995-2#1)(2008-10#1)
mechanism of an##2##3##(2008-10#2)
mechanism of biocontrol##3##3##(2008-10#3)
mechanism of biological control of##2##5##(2008-10#2)
mechanism of biological control##4##4##(2008-10#4)
mechanism of catalysis##2##3##(2008-10#1)(2008-4#1)
mechanism of cell death##2##4##(2008-11#1)(2008-7#1)
mechanism of disease##2##3##(2008-10#1)(2008-12#1)
mechanism of drug##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
mechanism of enhanced##2##3##(2008-10#1)(2008-11#1)
mechanism of environmental##2##3##(2008-8#1)(2009-8#1)
mechanism of injury##4##3##(2008-11#1)(2010-1#2)(2012-3#1)
mechanism of interaction between##2##4##(1990-11#1)(1990-2#1)
mechanism of interaction##5##3##(1990-11#1)(1990-2#2)(2008-10#2)
mechanism of its##2##3##(2008-5#1)(2008-9#1)
mechanism of primary##3##3##(2008-10#2)(2008-8#1)
mechanism of resistance##4##3##(2008-10#4)
mechanism of steroid 5 alpha-reductase##2##5##(1990-11#2)
mechanism of steroid##3##3##(1990-11#2)(1996-2#1)
mechanism of the effect of##2##5##(1995-8#1)(2011-3#1)
mechanism of the formation##2##4##(2008-10#1)(2011-2#1)
mechanism of the##46##3##(1991-5#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#22)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-2#1)
mechanism of this effect##3##4##(1990-3#1)(1995-8#2)
mechanism of this reaction##3##4##(1994-8#1)(2008-10#1)(2009-10#1)
mechanism of this##20##3##(1990-3#1)(1991-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#2)(2008-10#4)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
mechanism of transcriptional regulation##2##4##(1992-8#1)(2008-9#1)
mechanism of transcriptional##3##3##(1992-8#1)(2008-4#1)(2008-9#1)
mechanism of##344##2##(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#2)(1991-3#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#5)(1995-8#5)(1996-2#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#127)(2008-11#22)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#13)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#3)(2009-7#3)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#16)(2011-3#6)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
mechanism on the##2##3##(2008-10#1)(2008-8#1)
mechanism on##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
mechanism other than##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
mechanism proposed##2##2##(1996-5#1)(1997-6#1)
mechanism regulating##3##2##(2008-4#1)(2008-9#1)(2010-11#1)
mechanism responsible for the##2##4##(2008-10#2)
mechanism responsible for##4##3##(2008-10#3)(2012-2#1)
mechanism that reduces##2##3##(2008-10#1)(2008-6#1)
mechanism that regulates##2##3##(2008-11#1)(2010-11#1)
mechanism that##23##2##(1991-9#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-6#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
mechanism through which##3##3##(2008-11#1)(2008-8#1)(2012-3#1)
mechanism to prevent##3##3##(1993-2#1)(1994-9#1)(2008-10#1)
mechanism to##18##2##(1993-2#1)(1994-9#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#3)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#2)
mechanism underlying its##2##3##(1990-3#1)(2010-2#1)
mechanism underlying the##7##3##(1996-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#1)
mechanism underlying##16##2##(1990-3#1)(1996-12#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
mechanism was also discussed##4##4##(2008-10#4)
mechanism was discussed##4##3##(2008-10#4)
mechanism was investigated##2##3##(2008-10#1)(2013-8#1)
mechanism was proposed##2##3##(2008-10#2)
mechanism was suggested to##2##4##(2008-10#2)
mechanism was##19##2##(2008-10#18)(2013-8#1)
mechanism whereby##5##2##(1990-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
mechanism which##6##2##(1996-12#1)(1996-5#3)(2008-11#1)(2008-7#1)
mechanism with a##2##3##(2008-10#1)(2012-2#1)
mechanism with the##2##3##(2008-10#2)
mechanism with##5##2##(2008-10#4)(2012-2#1)
mechanism##907##1##(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#5)(1990-8#3)(1991-12#1)(1991-3#5)(1991-5#6)(1991-9#5)(1992-1#3)(1992-12#5)(1992-3#3)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#7)(1993-8#7)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#7)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#11)(1995-3#2)(1995-5#1)(1995-6#11)(1995-8#13)(1995-9#1)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#6)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#287)(2008-11#48)(2008-12#5)(2008-2#7)(2008-3#19)(2008-4#6)(2008-5#18)(2008-6#8)(2008-7#26)(2008-8#47)(2008-9#28)(2009-10#7)(2009-11#2)(2009-12#4)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#21)(2009-9#3)(2010-1#5)(2010-10#6)(2010-11#7)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#5)(2011-10#1)(2011-2#42)(2011-3#6)(2012-12#6)(2012-2#21)(2012-3#12)(2013-1#15)(2013-7#1)(2013-8#15)
mechanism(s) that##2##2##(2009-10#1)(2012-2#1)
mechanism(s)##9##1##(1991-6#1)(1993-8#1)(2008-10#2)(2008-5#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
mechanism-based classification##3##2##(2008-12#2)(2008-7#1)
mechanism-based##9##1##(1991-3#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-9#1)(2009-8#2)
mechanism]##2##1##(1990-11#1)(2010-12#1)
mechanisms (e##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
mechanisms affect##2##2##(2011-2#1)(2012-12#1)
mechanisms allowing##2##2##(2008-10#1)(2008-8#1)
mechanisms and in##2##3##(1997-1#1)(2008-10#1)
mechanisms and kinetics of##2##4##(1994-5#1)(2008-10#1)
mechanisms and management##2##3##(1990-9#1)(2011-2#1)
mechanisms and molecular##2##3##(2009-8#1)(2011-3#1)
mechanisms and pathways##2##3##(2008-11#1)(2009-8#1)
mechanisms and that##2##3##(1993-6#1)(2010-5#1)
mechanisms and the##5##3##(1990-8#1)(2008-11#2)(2010-12#1)(2010-4#1)
mechanisms and to##2##3##(2008-11#1)(2012-3#1)
mechanisms and##35##2##(1990-8#1)(1990-9#1)(1993-6#1)(1994-5#1)(1995-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#6)(2008-2#1)(2008-9#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)
mechanisms appear to##2##3##(1995-8#1)(2008-10#1)
mechanisms are also##2##3##(1996-11#1)(2008-10#1)
mechanisms are discussed##2##3##(1990-8#1)(2010-3#1)
mechanisms are impaired##2##3##(1997-1#1)(2013-7#1)
mechanisms are not##2##3##(2008-10#1)(2011-2#1)
mechanisms are responsible for##2##4##(2008-10#2)
mechanisms are##29##2##(1990-8#1)(1996-11#1)(1997-1#1)(1997-5#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-7#1)(2013-8#1)
mechanisms as##3##2##(1997-8#1)(2008-11#2)
mechanisms associated with##2##3##(2008-10#1)(2012-12#1)
mechanisms at the##2##3##(1994-2#1)(2008-11#1)
mechanisms at##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
mechanisms behind these##2##3##(2008-11#1)(2008-5#1)
mechanisms behind##3##2##(2008-11#2)(2008-5#1)
mechanisms by which the##2##4##(2008-10#1)(2008-9#1)
mechanisms by which these##2##4##(1996-2#1)(2008-7#1)
mechanisms by which##39##3##(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-8#3)(2010-1#1)(2010-4#2)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#1)
mechanisms by##42##2##(1993-9#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-8#3)(2010-1#1)(2010-4#2)(2011-2#4)(2011-3#2)(2012-2#3)(2013-1#1)
mechanisms can be##3##3##(2008-10#2)(2009-5#1)
mechanisms can##7##2##(2008-10#2)(2008-11#2)(2008-8#1)(2009-5#1)(2011-3#1)
mechanisms controlling##2##2##(2008-7#1)(2012-2#1)
mechanisms could be##2##3##(2010-6#1)(2011-2#1)
mechanisms could##4##2##(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
mechanisms exist to##2##3##(2008-7#1)(2011-2#1)
mechanisms exist##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
mechanisms explaining##2##2##(2008-11#1)(2008-8#1)
mechanisms for control##2##3##(1995-11#1)(2008-10#1)
mechanisms for its##2##3##(1995-6#1)(2008-10#1)
mechanisms for the##10##3##(1991-5#1)(1992-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-12#1)(2010-7#1)(2011-2#1)
mechanisms for these##2##3##(2008-7#2)
mechanisms for this##2##3##(1990-2#1)(2008-10#1)
mechanisms for##47##2##(1990-2#1)(1991-5#1)(1992-6#2)(1992-8#1)(1994-1#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
mechanisms governing##6##2##(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
mechanisms has##2##2##(2007-8#1)(2011-2#1)
mechanisms have been proposed##2##4##(1996-11#1)(2011-2#1)
mechanisms have been##7##3##(1996-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)
mechanisms have to be##2##4##(2011-1#1)(2011-2#1)
mechanisms have##11##2##(1993-1#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
mechanisms in the##7##3##(1992-6#1)(1994-3#1)(1995-8#1)(2008-10#3)(2011-2#1)
mechanisms in##33##2##(1992-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
mechanisms indicate that##2##3##(1990-6#1)(2008-10#1)
mechanisms involve##2##2##(2009-7#1)(2013-1#1)
mechanisms involved in the##2##4##(1990-8#1)(2008-11#1)
mechanisms involved in##12##3##(1990-8#1)(1993-6#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#2)(2013-1#1)
mechanisms involved##19##2##(1990-8#1)(1993-6#1)(1995-11#1)(1995-2#2)(1997-3#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-9#2)(2010-10#1)(2011-2#1)(2013-1#1)
mechanisms involving##4##2##(2008-11#1)(2008-4#1)(2009-6#1)(2011-2#1)
mechanisms is##3##2##(1995-2#1)(1995-8#1)(2008-11#1)
mechanisms leading to##3##3##(1992-9#1)(1994-8#1)(1995-12#1)
mechanisms may be##2##3##(1990-2#1)(2008-4#1)
mechanisms may##8##2##(1990-11#1)(1990-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
mechanisms occur##2##2##(2008-9#1)(2010-1#1)
mechanisms of Japanese cedar##2##4##(2012-12#2)
mechanisms of a##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
mechanisms of action and##5##4##(1991-2#1)(1995-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
mechanisms of action of##8##4##(1995-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)
mechanisms of action##30##3##(1991-2#1)(1994-8#1)(1995-12#1)(1995-5#2)(1995-6#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
mechanisms of biological control##2##4##(2008-10#2)
mechanisms of cell##2##3##(2008-10#1)(2011-2#1)
mechanisms of cytotoxicity##2##3##(1995-8#1)(2008-11#1)
mechanisms of dispersal were possible##2##5##(2008-10#2)
mechanisms of dispersal were##3##4##(2008-10#3)
mechanisms of drug resistance##2##4##(2008-10#1)(2008-11#1)
mechanisms of early##2##3##(1997-7#1)(2008-11#1)
mechanisms of immune privilege##3##4##(2010-1#3)
mechanisms of immune##5##3##(2008-10#1)(2010-1#3)(2013-1#1)
mechanisms of its##2##3##(1996-2#1)(2008-10#1)
mechanisms of joint manipulation##2##4##(2008-12#2)
mechanisms of neural##2##3##(2008-10#1)(2008-8#1)
mechanisms of resistance to##2##4##(2008-11#2)
mechanisms of resistance##6##3##(2008-10#3)(2008-11#3)
mechanisms of the##18##3##(2007-12#1)(2008-10#8)(2008-11#3)(2008-7#2)(2009-8#2)(2010-12#1)(2012-12#1)
mechanisms of their##2##3##(2008-10#1)(2013-1#1)
mechanisms of these##5##3##(1994-8#1)(2008-10#2)(2008-7#1)(2008-9#1)
mechanisms of this##2##3##(2008-10#1)(2008-5#1)
mechanisms of toxicity##2##3##(1991-1#1)(2008-11#1)
mechanisms of##228##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-8#2)(1994-8#2)(1995-12#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#51)(2008-11#27)(2008-12#5)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#6)(2009-1#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#7)(2010-1#3)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-12#3)(2012-2#10)(2012-3#5)(2013-1#15)(2013-8#2)
mechanisms other than##4##3##(1996-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
mechanisms play##2##2##(2009-4#1)(2011-2#1)
mechanisms regulating the##2##3##(2008-10#1)(2011-2#1)
mechanisms regulating##6##2##(2008-10#1)(2008-11#1)(2008-6#1)(2011-10#1)(2011-2#1)(2013-1#1)
mechanisms relating to##2##3##(2008-11#1)(2008-7#1)
mechanisms remain unclear##2##3##(2008-11#1)(2008-9#1)
mechanisms remain##3##2##(1993-8#1)(2008-11#1)(2008-9#1)
mechanisms responsible for the##4##4##(1997-2#1)(1997-5#1)(2009-3#1)(2011-2#1)
mechanisms responsible for##12##3##(1995-11#1)(1995-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)
mechanisms resulting in##2##3##(2009-11#1)(2010-12#1)
mechanisms such as##8##3##(1992-9#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-12#1)
mechanisms that allow##2##3##(2010-11#1)(2013-1#1)
mechanisms that are##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
mechanisms that can##4##3##(1994-1#1)(1997-2#1)(2008-11#1)(2011-2#1)
mechanisms that contribute to##2##4##(2011-7#1)(2012-3#1)
mechanisms that control##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
mechanisms that involve##2##3##(2008-11#1)(2008-7#1)
mechanisms that may underlie##2##4##(2010-10#1)(2012-12#1)
mechanisms that may##3##3##(2008-8#1)(2010-10#1)(2012-12#1)
mechanisms that mediate##3##3##(1993-8#1)(1996-2#1)(2013-8#1)
mechanisms that might##2##3##(2012-3#1)(2013-1#1)
mechanisms that regulate##4##3##(1995-8#1)(2008-11#2)(2012-2#1)
mechanisms that underlie##3##3##(2008-11#1)(2008-9#1)(2010-4#1)
mechanisms that##50##2##(1990-2#1)(1990-9#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-8#1)(1996-2#2)(1997-2#1)(2008-10#5)(2008-11#6)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
mechanisms to the##2##3##(1995-2#1)(2008-10#1)
mechanisms to##17##2##(1995-2#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2011-10#1)(2011-2#1)(2012-2#2)
mechanisms underlying some##2##3##(1990-5#1)(2008-11#1)
mechanisms underlying the induction##2##4##(2008-11#1)(2008-7#1)
mechanisms underlying the##15##3##(1993-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
mechanisms underlying these##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
mechanisms underlying##42##2##(1990-5#1)(1993-8#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
mechanisms were##7##2##(1993-8#1)(2008-10#4)(2008-11#2)
mechanisms whereby##2##2##(1995-5#1)(2008-6#1)
mechanisms which##3##2##(1991-6#1)(2008-11#1)(2009-8#1)
mechanisms##872##1##(1990-11#3)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#6)(1995-2#8)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#5)(1996-11#3)(1996-12#4)(1996-2#9)(1996-3#2)(1996-5#2)(1996-6#2)(1997-1#6)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#4)(1997-8#5)(2006-6#2)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#158)(2008-11#95)(2008-12#8)(2008-2#3)(2008-3#5)(2008-4#14)(2008-5#18)(2008-6#8)(2008-7#36)(2008-8#33)(2008-9#30)(2009-1#3)(2009-10#5)(2009-11#3)(2009-12#5)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#9)(2009-8#25)(2009-9#3)(2010-1#9)(2010-10#6)(2010-11#4)(2010-12#7)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#7)(2011-10#3)(2011-2#57)(2011-3#7)(2011-7#1)(2011-9#1)(2012-12#7)(2012-2#39)(2012-3#23)(2012-7#1)(2013-1#30)(2013-7#4)(2013-8#11)
mechanisms)##2##1##(1993-8#1)(2009-8#1)
mechanisms]##2##1##(2010-12#1)(2013-8#1)
mechanistic basis##3##2##(1995-8#1)(2009-8#1)(2011-2#1)
mechanistic details##2##2##(2009-12#1)(2012-2#1)
mechanistic explanation for##3##3##(1997-2#1)(2008-8#1)(2011-2#1)
mechanistic information##2##2##(2008-10#1)(2009-8#1)
mechanistic insight##2##2##(2009-10#1)(2013-1#1)
mechanistic model##3##2##(2008-10#2)(2013-1#1)
mechanistic models##4##2##(2008-9#2)(2010-11#1)(2013-1#1)
mechanistic studies##3##2##(1994-5#1)(2008-10#2)
mechanistic##50##1##(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-8#1)(1997-2#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#2)(2009-4#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
mechanistically related##2##2##(1994-5#1)(2010-6#1)
mechanistically##5##1##(1994-5#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#1)
mechanotherapy##4##1##(2008-12#4)
mechanotransduction##2##1##(1995-8#1)(2007-12#1)
meclofenamic##4##1##(2008-10#4)
med##4##1##(1991-6#1)(1997-6#1)(1997-8#1)(2008-10#1)
medaka##16##1##(1992-6#1)(1997-9#1)(2008-11#7)(2008-6#1)(2008-8#2)(2009-7#4)
medfly##2##1##(2007-12#1)(2008-11#1)
media alone##3##2##(1995-12#3)
media amended with##3##3##(2008-10#3)
media and in##2##3##(2008-10#2)
media and is##2##3##(2008-10#1)(2008-3#1)
media and##28##2##(2008-10#14)(2008-11#8)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)
media are##5##2##(2008-10#4)(2008-11#1)
media as well##2##3##(1990-8#1)(2008-9#1)
media as##3##2##(1990-8#1)(2008-10#1)(2008-9#1)
media at different##2##3##(2008-10#1)(2013-1#1)
media at the##2##3##(1994-2#1)(2008-11#1)
media at##6##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#2)
media attention in##2##3##(1996-11#1)(2008-11#1)
media based on##2##3##(2008-10#1)(2008-11#1)
media by means of a##2##5##(2008-10#2)
media by##11##2##(2008-10#9)(2008-11#1)(2008-6#1)
media conditioned##2##2##(1991-5#1)(2013-1#1)
media containing different##2##3##(2008-10#2)
media containing the##2##3##(1997-7#1)(2013-8#1)
media containing##14##2##(1997-7#1)(2008-10#9)(2008-11#2)(2012-7#1)(2013-8#1)
media coverage##2##2##(1991-3#2)
media cultures##2##2##(2008-10#2)
media following##3##2##(2008-9#2)(2010-2#1)
media for isolation of##3##4##(2008-10#2)(2008-12#1)
media for mammalian cells##2##4##(2008-11#2)
media for mammalian##3##3##(2008-11#3)
media for the##3##3##(2008-12#1)(2012-3#1)(2013-1#1)
media for##18##2##(1992-3#1)(1995-12#1)(2008-10#5)(2008-11#4)(2008-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
media giving##2##2##(2008-10#2)
media has been##3##3##(2008-10#3)
media have been##4##3##(2008-10#3)(2008-7#1)
media have##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
media in##10##2##(1990-3#1)(1991-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)
media influences##2##2##(2009-5#1)(2009-7#1)
media into##3##2##(2008-10#2)(2008-11#1)
media is described##2##3##(2008-3#1)(2010-6#1)
media is##12##2##(1995-5#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-8#2)(2010-6#1)(2012-2#1)
media led to##2##3##(2008-11#1)(2012-5#1)
media may##2##2##(1991-5#1)(2010-5#1)
media noise##5##2##(2008-3#5)
media of the##2##3##(1993-8#1)(2008-11#1)
media of##9##2##(1991-5#2)(1993-8#1)(1994-11#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
media on the##6##3##(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#1)
media on##8##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-8#1)(2010-8#1)
media or##2##2##(2008-10#2)
media prior to##2##3##(2008-10#2)
media reports##3##2##(2008-11#1)(2010-7#1)(2013-8#1)
media resulted in##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
media such as##3##3##(2008-10#3)
media supplemented with##4##3##(2008-10#2)(2008-11#2)
media that##4##2##(1992-12#1)(2008-10#2)(2008-8#1)
media to##9##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#2)
media used##3##2##(2008-10#2)(2008-12#1)
media using##9##2##(1994-2#1)(2008-10#8)
media was investigated##2##3##(2008-10#1)(2008-8#1)
media was used##2##3##(2008-10#2)
media was##14##2##(1991-3#1)(2008-10#8)(2008-11#3)(2008-7#1)(2008-8#1)
media were tested##2##3##(2008-10#1)(2008-6#1)
media were##11##2##(1997-8#1)(2008-10#6)(2008-11#2)(2008-6#1)(2013-1#1)
media when##2##2##(2008-10#1)(2011-2#1)
media with##16##2##(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#2)(2008-9#1)(2012-2#2)
media without##2##2##(2008-11#2)
media##618##1##(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#6)(1991-5#4)(1991-9#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#4)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-2#4)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-3#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#4)(2008-10#282)(2008-11#99)(2008-12#26)(2008-2#1)(2008-3#30)(2008-5#3)(2008-6#3)(2008-7#15)(2008-8#15)(2008-9#11)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#5)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#4)(2011-2#4)(2011-7#1)(2012-2#11)(2012-3#2)(2012-4#2)(2012-5#2)(2012-7#1)(2013-1#13)(2013-8#2)
media'##2##1##(2008-11#1)(2008-5#1)
medial amygdala##2##2##(1997-3#2)
medial and lateral##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
medial antebrachial cutaneous nerve##3##4##(2008-9#3)
medial border of##2##3##(2010-3#1)(2013-1#1)
medial collateral ligament##2##3##(2012-2#2)
medial collateral##4##2##(2012-2#4)
medial forebrain bundle##3##3##(1991-2#1)(1992-12#1)(1996-2#1)
medial frontal##2##2##(1994-3#1)(2008-11#1)
medial gastrocnemius##3##2##(1996-2#1)(1997-2#1)(2013-8#1)
medial habenula##2##2##(1996-12#2)
medial layer##2##2##(2006-6#1)(2010-4#1)
medial lobe##2##2##(2007-12#2)
medial malleolus##4##2##(2009-3#1)(2010-3#1)(2010-6#2)
medial pectoral nerve##2##3##(2013-1#2)
medial precuneus##2##2##(2008-11#2)
medial prefrontal cortex (PFC)##2##4##(1997-2#1)(2013-8#1)
medial prefrontal cortex##12##3##(1993-6#1)(1994-8#1)(1996-2#2)(1997-2#2)(2008-11#5)(2013-8#1)
medial prefrontal##17##2##(1991-2#1)(1993-3#2)(1993-6#1)(1994-8#1)(1996-2#2)(1997-2#2)(2008-11#7)(2013-8#1)
medial preoptic area##2##3##(1992-12#1)(1994-2#1)
medial regions##2##2##(2008-11#2)
medial rostral prefrontal cortex##2##4##(2008-11#2)
medial sensillum styloconicum##2##3##(2008-8#2)
medial septal##2##2##(1996-12#1)(2013-8#1)
medial temporal lobe##3##3##(1991-10#2)(2013-8#1)
medial temporal structures##4##3##(2008-11#3)(2008-6#1)
medial temporal##7##2##(1991-10#2)(2008-11#3)(2008-6#1)(2013-8#1)
medial wall##3##2##(1997-8#1)(2008-7#1)(2008-9#1)
medial##133##1##(1990-3#1)(1990-8#1)(1990-9#3)(1991-10#2)(1991-12#2)(1991-2#3)(1992-12#2)(1992-3#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-2#5)(1996-9#1)(1997-2#3)(1997-3#7)(1997-8#1)(2006-6#1)(2007-12#6)(2008-11#19)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#5)(2009-1#1)(2009-2#2)(2009-3#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#5)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#10)(2013-8#5)
medial-frontal negativity##2##2##(2008-11#2)
medialis##3##1##(1994-8#2)(2008-6#1)
medially##5##1##(2008-9#2)(2009-1#1)(2009-9#1)(2011-2#1)
median SVV error for the PD group##2##7##(2013-1#2)
median aerodynamic diameter##4##3##(1992-2#1)(1996-12#1)(1996-2#1)(1997-2#1)
median age of##6##3##(1992-5#1)(1992-9#1)(1997-8#1)(2011-1#2)(2013-1#1)
median age was##3##3##(1990-9#1)(2012-2#1)(2013-1#1)
median age##14##2##(1990-9#2)(1992-5#1)(1992-9#1)(1997-5#1)(1997-8#3)(2007-8#1)(2011-1#2)(2012-2#1)(2013-1#2)
median and##3##2##(2011-3#1)(2012-3#1)(2013-1#1)
median cost##2##2##(1995-2#2)
median effective dose##2##3##(2008-10#2)
median eminence##2##2##(1995-12#1)(2008-9#1)
median follow-up of##7##3##(1990-12#2)(1990-6#1)(1992-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
median follow-up##13##2##(1990-12#2)(1990-6#1)(1990-8#1)(1992-12#1)(1992-5#2)(1993-11#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-12#1)
median inhibitory concentration of##2##4##(2008-11#2)
median motor latency##2##3##(2010-8#2)
median nerve##7##2##(2008-12#1)(2008-9#5)(2009-5#1)
median number of##5##3##(1994-8#1)(2008-12#1)(2010-12#1)(2011-2#2)
median of 0##2##3##(2008-8#1)(2013-1#1)
median of##13##2##(1997-2#1)(2008-10#3)(2008-7#2)(2008-8#2)(2010-12#1)(2012-2#1)(2013-1#3)
median sensory##2##2##(2010-8#2)
median survival index##3##3##(2008-10#3)
median survival of##3##3##(1992-9#1)(2010-12#1)(2012-3#1)
median survival time##3##3##(1990-9#2)(1994-8#1)
median survival was##6##3##(1990-12#1)(1991-6#1)(1992-12#1)(1993-6#1)(1997-5#1)(2008-10#1)
median survival##17##2##(1990-12#1)(1990-9#2)(1991-6#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1997-5#2)(2008-10#5)(2010-12#1)(2012-3#1)
median time to progression was##2##5##(1993-1#1)(2013-1#1)
median time to##3##3##(1993-1#1)(2012-3#1)(2013-1#1)
median time##5##2##(1993-1#1)(2007-8#1)(2012-3#1)(2013-1#2)
median value##4##2##(1993-11#1)(1994-6#1)(2011-2#2)
median##178##1##(1990-12#5)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#6)(1991-12#1)(1991-6#2)(1991-8#2)(1992-12#2)(1992-2#2)(1992-5#3)(1992-6#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#4)(1997-8#3)(2007-12#8)(2007-8#4)(2008-10#24)(2008-11#2)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-5#1)(2010-12#4)(2010-4#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#15)(2013-8#2)
mediastinal and##2##2##(1997-8#1)(2009-8#1)
mediastinal localisation##2##2##(2010-12#2)
mediastinal mass##2##2##(1991-8#1)(2012-3#1)
mediastinal paraganglioma with##2##3##(1997-8#2)
mediastinal paraganglioma##3##2##(1997-8#3)
mediastinal##26##1##(1990-12#1)(1990-2#1)(1991-8#1)(1997-8#5)(2008-1#1)(2008-7#1)(2009-8#4)(2010-12#4)(2010-7#1)(2011-2#1)(2012-3#3)(2013-1#3)
mediastinitis##6##1##(1991-3#1)(2008-12#2)(2013-1#3)
mediastinum##5##1##(1991-8#2)(2008-11#1)(2010-12#2)
mediate a##2##2##(2013-1#2)
mediate cell##2##2##(1993-8#1)(2011-1#1)
mediate efficient##2##2##(1991-5#1)(1994-5#1)
mediate induction by oleic acid##2##5##(1993-9#2)
mediate many##2##2##(1996-2#1)(2009-8#1)
mediate specific##2##2##(1994-2#1)(1996-12#1)
mediate the difference attributable to##2##5##(2008-12#2)
mediate the effect##2##3##(1996-2#1)(2008-4#1)
mediate the relationship between##2##4##(2009-10#1)(2010-11#1)
mediate the##34##2##(1990-7#1)(1990-8#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-8#2)(1996-2#1)(1997-7#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-8#3)(2010-10#1)(2010-11#1)(2012-2#1)
mediate their##2##2##(1994-12#1)(1994-6#1)
mediate##87##1##(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#2)(1991-6#1)(1991-9#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#4)(1996-12#2)(1996-2#3)(1997-4#1)(1997-7#2)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#2)(2009-7#1)(2009-8#6)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
mediated by Agrobacterium##2##3##(2008-8#1)(2011-2#1)
mediated by P-gp##2##3##(2011-3#2)
mediated by a##16##3##(1992-3#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#2)(1996-2#1)(1997-9#1)(2008-10#2)(2008-11#2)(2009-1#1)(2009-8#1)
mediated by an##5##3##(1993-3#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-5#1)
mediated by differences in##2##4##(2013-1#1)(2013-8#1)
mediated by different##3##3##(1996-12#1)(2008-9#1)(2012-12#1)
mediated by muscarinic receptors##2##4##(1996-12#1)(2008-10#1)
mediated by non-NMDA receptors##2##4##(1997-2#1)(2008-7#1)
mediated by prostaglandins##2##3##(1994-3#1)(1996-2#1)
mediated by recombinant##2##3##(2008-9#2)
mediated by several##2##3##(2008-5#1)(2012-3#1)
mediated by specific##3##3##(2008-12#1)(2009-9#1)(2011-2#1)
mediated by the##28##3##(1991-10#1)(1991-2#1)(1994-12#1)(1995-11#1)(1995-2#3)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#5)(2008-5#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-7#1)(2012-2#1)
mediated by these##2##3##(1991-5#1)(2008-10#1)
mediated by two##4##3##(1994-11#1)(1995-8#1)(2008-9#1)(2009-10#1)
mediated by type II AMPA receptors were##2##7##(1996-2#2)
mediated by type##5##3##(1994-2#1)(1996-2#4)
mediated by viral factors##2##4##(2008-11#2)
mediated by##169##2##(1990-12#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-5#2)(1992-3#1)(1992-8#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#3)(1996-2#12)(1996-3#1)(1997-1#1)(1997-2#5)(1997-4#2)(1997-5#1)(1997-7#1)(1997-9#1)(2008-10#22)(2008-11#17)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-7#2)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
mediated inflammatory##2##2##(2011-1#1)(2012-3#1)
mediated primarily##2##2##(2008-11#1)(2008-7#1)
mediated searching##4##2##(1991-3#4)
mediated the effects of##2##4##(2009-6#1)(2010-2#1)
mediated the effects##3##3##(2008-9#1)(2009-6#1)(2010-2#1)
mediated the relation between RC##2##5##(2008-12#2)
mediated the relation between##3##4##(2008-12#2)(2010-1#1)
mediated the##10##2##(2008-12#3)(2008-9#2)(2009-6#1)(2010-1#2)(2010-2#1)(2013-1#1)
mediated through the##5##3##(1990-11#1)(1995-12#1)(1996-2#2)(2012-3#1)
mediated through##13##2##(1990-11#1)(1991-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-2#3)(2008-10#1)(2009-8#1)(2012-3#1)(2013-8#1)
mediated transformation##2##2##(2008-8#2)
mediated via the##2##3##(1993-6#1)(2013-7#1)
mediated via##9##2##(1990-5#1)(1993-6#1)(1995-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-7#1)
mediated##266##1##(1990-11#1)(1990-12#1)(1990-5#3)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#5)(1991-5#4)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#4)(1994-8#6)(1995-11#3)(1995-12#4)(1995-2#6)(1995-5#1)(1995-6#3)(1995-8#3)(1996-12#3)(1996-2#15)(1996-3#1)(1997-1#2)(1997-2#5)(1997-4#2)(1997-5#1)(1997-7#3)(1997-9#1)(2008-1#1)(2008-10#31)(2008-11#24)(2008-12#6)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#11)(2009-1#1)(2009-10#3)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#3)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#5)(2013-7#2)(2013-8#5)
mediates a##3##2##(1993-12#1)(1995-2#1)(2008-7#1)
mediates active##2##2##(1997-7#1)(2008-10#1)
mediates the rate-limiting step of steroidogenesis##2##6##(2012-2#2)
mediates the relationship between executive function and social outcome##2##9##(2009-10#2)
mediates the##12##2##(1992-6#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-8#1)(1996-5#1)(2009-10#2)(2009-7#2)(2012-2#2)
mediates transcriptional activation##2##3##(1993-9#1)(1997-2#1)
mediates##55##1##(1990-5#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#2)(1993-9#3)(1994-12#1)(1994-9#1)(1995-10#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-7#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-7#2)(2012-2#4)(2013-1#2)(2013-8#2)
mediating influence##2##2##(1995-2#1)(2013-1#1)
mediating the##21##2##(1991-12#1)(1992-8#1)(1993-6#4)(1995-2#1)(1996-12#2)(1996-5#1)(1997-2#1)(2006-6#1)(2008-10#5)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
mediating this##4##2##(1993-12#1)(2008-5#1)(2008-9#1)(2009-10#1)
mediating##61##1##(1990-5#1)(1991-1#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#4)(1994-11#1)(1994-3#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#3)(2011-9#1)(2012-3#2)(2013-1#3)(2013-8#3)
mediation of##7##2##(1990-2#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-4#1)(2011-2#1)
mediation##9##1##(1990-2#1)(1992-8#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-11#2)(2008-4#1)(2011-2#1)
mediational##2##1##(2010-1#2)
mediator and##5##2##(2008-10#5)
mediator for##6##2##(2008-10#6)
mediator in##2##2##(2008-10#1)(2013-7#1)
mediator of the##3##3##(2008-11#1)(2010-1#1)(2013-8#1)
mediator of##22##2##(1992-6#1)(1994-11#1)(1995-11#1)(1995-2#2)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
mediator to##2##2##(2008-10#2)
mediator##75##1##(1992-6#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-2#2)(1996-2#2)(1997-7#1)(2008-10#48)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#2)(2009-8#1)(2010-1#3)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
mediator-free##4##1##(2008-10#4)
mediators and##7##2##(2008-1#1)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#2)(2013-1#1)
mediators have##3##2##(2008-10#2)(2009-10#1)
mediators of the effects of##2##5##(2008-4#1)(2012-2#1)
mediators of the##3##3##(2008-4#1)(2009-5#1)(2012-2#1)
mediators of##13##2##(1994-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#3)(2013-8#1)
mediators such as cytokines##2##4##(2011-2#2)
mediators such as##4##3##(2008-10#2)(2011-2#2)
mediators that##3##2##(1997-1#1)(2009-3#1)(2013-1#1)
mediators##56##1##(1990-9#2)(1991-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#5)(2013-1#3)(2013-8#1)
medica##3##1##(2008-10#1)(2011-2#2)
medicaginis##9##1##(2008-10#9)
medicaid##2##1##(2012-2#2)
medical abortion##5##2##(2009-1#1)(2011-2#4)
medical accelerator##2##2##(2009-11#2)
medical admissions##2##2##(1990-11#1)(1996-3#1)
medical advances##2##2##(2007-11#1)(2008-11#1)
medical advice##2##2##(1993-12#1)(1996-3#1)
medical and dental##2##3##(2008-11#1)(2013-1#1)
medical and endoscopic treatment##2##4##(1991-11#1)(1993-2#1)
medical and ethical##2##3##(1994-9#1)(2013-1#1)
medical and industrial##2##3##(2008-10#1)(2013-8#1)
medical and non-medical graduates##3##4##(1994-12#3)
medical and non-medical##4##3##(1994-12#3)(2008-12#1)
medical and nursing##2##3##(1993-3#1)(1996-6#1)
medical and pharmacy##2##3##(1994-12#1)(2009-6#1)
medical and social##4##3##(1993-11#1)(1996-3#1)(2010-11#1)(2012-3#1)
medical and surgical treatment##2##4##(2008-7#1)(2010-12#1)
medical and surgical##11##3##(1993-12#3)(1993-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)
medical and##57##2##(1990-6#1)(1991-11#1)(1991-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1994-12#7)(1994-5#1)(1994-9#1)(1995-1#2)(1996-3#1)(1996-6#2)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
medical applications##2##2##(1994-2#1)(2009-12#1)
medical attention##5##2##(1991-6#1)(1994-9#1)(2010-10#1)(2012-12#2)
medical audit##5##2##(1991-8#1)(1992-2#1)(1994-12#1)(2012-3#2)
medical biochemists##2##2##(1994-12#2)
medical cannabis##2##2##(2013-8#2)
medical care and##5##3##(1991-12#2)(1993-12#1)(1997-4#1)(2011-3#1)
medical care costs and##3##4##(2008-11#3)
medical care for##2##3##(1994-9#1)(1996-9#1)
medical care in##2##3##(1993-11#1)(2010-8#1)
medical care is##4##3##(1997-4#1)(1997-5#1)(2008-4#1)(2008-7#1)
medical care organizations##2##3##(1991-2#1)(1996-3#1)
medical care to##2##3##(1995-6#1)(1996-9#1)
medical care use##2##3##(2012-3#1)(2013-1#1)
medical care##62##2##(1991-12#6)(1991-2#1)(1991-3#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#4)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
medical center##9##2##(1991-12#1)(1991-3#1)(1992-2#1)(2007-9#1)(2008-3#1)(2010-12#1)(2011-2#3)
medical centers and##2##3##(1994-3#1)(2013-1#1)
medical centers to##2##3##(1991-12#1)(1996-1#1)
medical centers##12##2##(1991-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-3#3)(1996-1#3)(2011-2#1)(2013-1#1)
medical clinics##2##2##(1995-10#1)(2013-8#1)
medical colleges##3##2##(1992-1#1)(2010-11#1)(2012-3#1)
medical community##5##2##(1991-12#1)(1993-6#1)(2008-8#1)(2010-6#1)(2010-8#1)
medical complications##5##2##(2008-9#3)(2012-3#1)(2013-8#1)
medical condition##8##2##(1994-3#1)(1995-12#1)(1995-6#2)(1996-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
medical conditions and##3##3##(2008-10#1)(2008-8#1)(2009-1#1)
medical conditions##15##2##(1991-12#1)(1992-3#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-1#3)(2010-2#1)(2012-3#1)
medical consultation##2##2##(1991-6#1)(2013-8#1)
medical costs##5##2##(1991-12#1)(1994-12#1)(1997-1#1)(2008-11#1)(2008-7#1)
medical coverage##2##2##(1995-12#2)
medical data##2##2##(1993-3#1)(2008-6#1)
medical database##2##2##(2010-8#2)
medical debt repayment##2##3##(2008-11#2)
medical debt##4##2##(2008-11#2)(2013-1#2)
medical decision##2##2##(1993-6#1)(2011-2#1)
medical decision-making##6##2##(2008-4#2)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
medical decisions for##2##3##(1995-12#2)
medical decisions##4##2##(1994-6#1)(1995-12#2)(2012-2#1)
medical departments##2##2##(1993-6#1)(2012-2#1)
medical device##9##2##(1993-3#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-3#4)
medical devices is##2##3##(2010-6#2)
medical devices##13##2##(1992-3#1)(2008-11#5)(2010-6#3)(2011-2#2)(2012-3#2)
medical diagnoses##2##2##(2008-10#1)(2009-4#1)
medical diagnosis##2##2##(1990-12#1)(2013-8#1)
medical diagnostic##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
medical director##3##2##(1993-1#1)(1993-12#2)
medical directors##5##2##(1991-3#1)(1995-1#2)(1995-3#1)(1996-2#1)
medical disorders##4##2##(1997-8#1)(2008-8#1)(2010-2#1)(2012-2#1)
medical doctor##2##2##(1990-6#1)(1992-5#1)
medical doctors##9##2##(1996-6#2)(1997-8#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
medical education in Nigeria##2##4##(2009-10#2)
medical education in the United States##2##6##(1991-8#2)
medical education in the##4##4##(1991-8#2)(2008-12#2)
medical education in##8##3##(1991-8#2)(2008-11#1)(2008-12#2)(2008-8#1)(2009-10#2)
medical education##38##2##(1991-8#5)(1992-12#1)(1992-8#2)(1994-12#2)(1995-2#1)(1996-8#1)(1997-4#1)(2008-1#2)(2008-11#7)(2008-12#3)(2008-8#2)(2009-10#3)(2010-11#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
medical educators##2##2##(2009-10#1)(2009-12#1)
medical effectiveness##2##2##(1993-12#1)(1996-3#1)
medical emergencies##6##2##(1995-12#1)(2008-1#3)(2009-4#1)(2011-3#1)
medical emergency##3##2##(2010-12#1)(2010-8#1)(2011-2#1)
medical entomology in France##2##4##(2010-1#2)
medical entomology in##4##3##(2010-1#4)
medical entomology##13##2##(2010-1#13)
medical equipment##4##2##(1997-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
medical ethics##7##2##(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#4)
medical evaluation##3##2##(2008-5#1)(2011-2#2)
medical events##2##2##(1994-6#1)(2008-11#1)
medical evidence##3##2##(1990-2#1)(1995-12#1)(2008-11#1)
medical examinations##5##2##(1997-8#2)(2009-12#1)(2010-6#2)
medical expenditures##3##2##(1994-2#1)(2013-1#2)
medical expert##2##2##(1995-11#1)(2011-2#1)
medical factors such as types of##2##6##(1994-12#2)
medical factors##4##2##(1994-12#3)(2008-11#1)
medical faculties##2##2##(2008-10#1)(2013-1#1)
medical fields##2##2##(2008-11#1)(2011-2#1)
medical filters##3##2##(2011-2#3)
medical gas##3##2##(2011-2#3)
medical geographic##3##2##(2013-8#3)
medical graduates##7##2##(1991-8#1)(1992-1#1)(1994-12#2)(2009-10#1)(2012-2#1)(2013-8#1)
medical group administrators##2##3##(1991-1#1)(1993-1#1)
medical group##10##2##(1991-1#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-3#2)(1996-1#1)(1997-1#1)
medical groups##9##2##(1992-3#2)(1993-1#3)(1994-3#2)(2008-11#2)
medical history and##3##3##(2008-7#1)(2009-1#1)(2010-10#1)
medical history of##2##3##(2007-12#1)(2010-3#1)
medical history was##3##3##(2008-11#1)(2012-5#1)(2013-1#1)
medical history##17##2##(1993-2#1)(1995-5#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#1)
medical humanities##5##2##(1997-3#1)(2011-2#4)
medical illness##2##2##(2009-4#1)(2012-3#1)
medical images##6##2##(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#3)
medical imaging##3##2##(1996-1#1)(2009-10#1)(2010-6#1)
medical information##6##2##(1993-12#1)(1995-6#1)(2008-11#1)(2010-4#1)(2010-8#1)(2012-12#1)
medical intervention##2##2##(2008-8#1)(2010-10#1)
medical interventions##2##2##(1993-12#1)(2010-10#1)
medical journals##6##2##(1994-12#1)(1997-3#1)(2008-11#1)(2009-10#1)(2010-2#1)(2013-8#1)
medical knowledge##4##2##(1994-6#1)(1996-3#1)(2008-11#1)(2008-12#1)
medical laboratory##2##2##(2008-10#1)(2008-12#1)
medical literature##14##2##(1990-8#1)(1992-12#1)(1996-6#1)(2008-11#1)(2008-7#1)(2010-6#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
medical malpractice##7##2##(1991-12#3)(1993-12#1)(1997-1#1)(1997-8#1)(2012-3#1)
medical management of##3##3##(1991-2#1)(2012-2#1)(2013-8#1)
medical management##15##2##(1991-2#1)(1997-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#2)(2011-3#3)(2012-2#1)(2013-1#1)(2013-8#1)
medical manpower##6##2##(1990-6#3)(1991-2#3)
medical messages##2##2##(2010-8#2)
medical model##2##2##(1995-12#1)(2009-10#1)
medical office group##2##3##(1994-3#2)
medical office##4##2##(1994-3#2)(1996-1#1)(1997-3#1)
medical offices##2##2##(2008-10#1)(2009-6#1)
medical oncology##2##2##(2008-10#1)(2009-4#1)
medical or surgical##2##3##(1996-6#1)(2013-1#1)
medical organizations##2##2##(1993-12#1)(1996-3#1)
medical outcomes##3##2##(1992-4#2)(1995-2#1)
medical patients##2##2##(1993-2#1)(2010-12#1)
medical payments##2##2##(1991-12#2)
medical personnel and##2##3##(2010-1#1)(2013-1#1)
medical personnel##10##2##(1992-3#1)(1994-6#1)(2008-1#1)(2008-10#2)(2009-3#1)(2010-1#2)(2012-3#1)(2013-1#1)
medical polypropylene##2##2##(2012-3#2)
medical practice and##2##3##(1993-12#1)(1995-12#1)
medical practice in##2##3##(1995-12#1)(1996-3#1)
medical practice##18##2##(1992-12#1)(1993-1#1)(1993-12#2)(1994-1#1)(1995-12#2)(1996-1#1)(1996-3#2)(1997-3#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
medical practices and##2##3##(1997-3#1)(2008-12#1)
medical practices##10##2##(1993-12#3)(1996-3#1)(1997-3#1)(2008-12#1)(2008-4#2)(2008-7#1)(2012-2#1)
medical practitioners to##2##3##(2008-10#1)(2013-8#1)
medical practitioners##6##2##(2008-10#2)(2008-8#1)(2009-10#1)(2010-8#1)(2013-8#1)
medical problems##7##2##(1995-6#1)(1996-9#1)(2012-2#2)(2012-3#2)(2013-1#1)
medical procedure##3##2##(1995-2#2)(1997-7#1)
medical procedures and##2##3##(1992-2#1)(2008-11#1)
medical procedures##10##2##(1992-2#1)(1995-12#1)(1996-9#1)(2008-11#3)(2008-4#1)(2009-9#2)(2011-2#1)
medical products##2##2##(1994-3#1)(2008-11#1)
medical profession##6##2##(1991-2#1)(1995-11#1)(2008-12#3)(2012-2#1)
medical professionals##4##2##(1992-3#2)(1995-6#1)(1996-9#1)
medical provider##4##2##(2013-1#4)
medical providers##4##2##(2009-9#1)(2013-1#2)(2013-8#1)
medical purposes##3##2##(1996-9#1)(1997-6#2)
medical quality##2##2##(1993-8#1)(2010-8#1)
medical reasons##2##2##(2008-10#1)(2013-8#1)
medical record##8##2##(1992-3#1)(1994-6#2)(1996-2#1)(2008-11#1)(2009-10#1)(2010-8#2)
medical records and##5##3##(1994-3#2)(2009-8#1)(2013-1#1)(2013-8#1)
medical records in##3##3##(1993-11#1)(1994-6#2)
medical records of patients##3##4##(1992-3#1)(2008-7#1)(2012-12#1)
medical records of##7##3##(1990-2#1)(1992-3#1)(1996-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
medical records##38##2##(1990-2#1)(1991-7#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-12#3)(1994-3#4)(1994-6#2)(1995-12#1)(1996-2#1)(1996-3#3)(1997-3#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#1)
medical rehabilitation##2##2##(1993-6#1)(2013-1#1)
medical research##10##2##(1991-2#1)(1991-6#1)(1993-2#1)(1993-6#2)(1997-3#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-12#1)
medical research]##2##2##(1993-6#1)(1997-4#1)
medical resources##2##2##(1991-12#1)(2007-11#1)
medical school in##2##3##(2013-8#2)
medical school libraries##2##3##(1991-3#2)
medical school##12##2##(1991-3#2)(1992-8#1)(1994-12#1)(2008-3#2)(2009-3#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
medical schools and##2##3##(1991-8#1)(1997-3#1)
medical schools in##3##3##(1991-6#1)(2009-10#1)(2013-1#1)
medical schools of##2##3##(2011-2#1)(2013-7#1)
medical schools##24##2##(1991-2#3)(1991-6#1)(1991-8#1)(1993-1#1)(1993-11#2)(1994-12#2)(1997-2#1)(1997-3#1)(2008-10#2)(2008-12#1)(2009-10#1)(2009-6#1)(2011-2#4)(2013-1#2)(2013-7#1)
medical science##2##2##(1993-11#1)(2010-12#1)
medical service use##2##3##(1991-1#2)
medical service##10##2##(1991-1#2)(1995-12#1)(1996-3#2)(2008-3#5)
medical services##17##2##(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#2)(1994-2#1)(1994-3#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2012-3#1)(2013-1#1)
medical settings##5##2##(2009-5#1)(2009-6#3)(2011-2#1)
medical specialists in##2##3##(1991-12#1)(1996-1#1)
medical specialties and diagnostic groups##2##5##(1991-11#2)
medical specialties and##5##3##(1991-11#2)(1991-6#1)(1992-4#2)
medical specialties##8##2##(1991-11#2)(1991-6#2)(1992-4#2)(1996-1#1)(2011-2#1)
medical specialty##3##2##(1994-12#1)(2010-10#1)(2010-12#1)
medical staff leaders for##2##4##(1992-1#2)
medical staff leaders##3##3##(1992-1#3)
medical staff##28##2##(1991-1#1)(1991-12#3)(1991-3#1)(1992-1#4)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-3#2)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-2#2)(2012-2#2)
medical staffs##2##2##(1991-12#1)(1994-3#1)
medical student##2##2##(1994-3#1)(2010-8#1)
medical students and##2##3##(1991-6#1)(2013-8#1)
medical students at the##2##4##(2008-10#1)(2008-11#1)
medical students at##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
medical students in the##2##4##(2008-4#1)(2013-7#1)
medical students in##7##3##(2008-4#1)(2009-6#2)(2011-2#1)(2013-1#2)(2013-7#1)
medical students to##3##3##(1992-2#1)(2008-11#1)(2008-3#1)
medical students##37##2##(1991-6#2)(1992-12#1)(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#1)(2009-6#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#3)
medical subjects##2##2##(2009-4#2)
medical symptoms##3##2##(2008-11#2)(2009-9#1)
medical teaching##5##2##(1993-3#1)(1994-12#2)(1997-5#1)(2013-8#1)
medical technologies##3##2##(1997-1#1)(2010-8#1)(2012-2#1)
medical technologists at##2##3##(1994-12#1)(2010-6#1)
medical technologists##3##2##(1994-12#2)(2010-6#1)
medical technology##8##2##(1992-1#1)(1992-2#1)(1994-12#2)(1997-1#1)(2008-11#1)(2008-12#1)(2012-2#1)
medical tests##2##2##(2010-10#1)(2010-11#1)
medical textbooks##2##2##(1995-12#1)(2008-7#1)
medical therapy and##2##3##(1996-11#1)(2010-6#1)
medical therapy as##2##3##(2011-3#1)(2013-1#1)
medical therapy in##2##3##(2009-10#1)(2011-3#1)
medical therapy##18##2##(1990-11#2)(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-11#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-3#2)(2012-3#1)(2013-1#3)
medical training##6##2##(1994-12#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-11#1)(2012-2#1)
medical treatment and##3##3##(1991-6#1)(2011-2#2)
medical treatment is##3##3##(1990-12#1)(1997-5#1)(2008-7#1)
medical treatment of##3##3##(1994-2#1)(1995-2#1)(2008-10#1)
medical treatment##36##2##(1990-12#1)(1991-11#1)(1991-6#1)(1994-2#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-3#2)(1996-9#1)(1997-5#1)(1997-8#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-2#4)(2012-3#4)(2013-1#1)
medical university staff##2##3##(2008-12#2)
medical use of##2##3##(1991-6#1)(2013-1#1)
medical use##3##2##(1991-6#1)(2013-1#1)(2013-8#1)
medical##1214##1##(1990-11#5)(1990-12#5)(1990-2#2)(1990-6#5)(1990-8#1)(1991-1#8)(1991-11#5)(1991-12#26)(1991-2#18)(1991-3#10)(1991-6#13)(1991-7#1)(1991-8#10)(1991-9#2)(1992-1#9)(1992-12#7)(1992-2#9)(1992-3#15)(1992-4#4)(1992-5#3)(1992-6#1)(1992-8#3)(1993-1#11)(1993-11#10)(1993-12#27)(1993-2#9)(1993-3#13)(1993-6#11)(1993-8#2)(1994-1#5)(1994-12#43)(1994-2#9)(1994-3#25)(1994-5#2)(1994-6#12)(1994-8#1)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#4)(1995-12#21)(1995-2#13)(1995-3#6)(1995-5#2)(1995-6#8)(1995-8#4)(1996-1#12)(1996-11#2)(1996-2#10)(1996-3#19)(1996-5#2)(1996-6#11)(1996-8#2)(1996-9#7)(1997-1#10)(1997-2#8)(1997-3#14)(1997-4#5)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#19)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#2)(2008-1#11)(2008-10#28)(2008-11#81)(2008-12#23)(2008-3#12)(2008-4#9)(2008-5#3)(2008-6#6)(2008-7#18)(2008-8#14)(2008-9#8)(2009-1#3)(2009-10#15)(2009-11#9)(2009-12#6)(2009-3#4)(2009-4#7)(2009-5#1)(2009-6#10)(2009-7#3)(2009-8#4)(2009-9#4)(2010-1#23)(2010-10#9)(2010-11#7)(2010-12#11)(2010-2#7)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#16)(2010-7#3)(2010-8#22)(2010-9#1)(2011-1#1)(2011-2#74)(2011-3#9)(2012-12#15)(2012-2#32)(2012-3#48)(2012-5#1)(2013-1#55)(2013-7#4)(2013-8#43)
medical-scientific studies of humans##2##4##(1997-5#2)
medical-scientific##4##1##(1997-5#3)(2008-12#1)
medical-surgical##2##1##(2008-3#1)(2012-2#1)
medically compromised patients undergoing oral surgery##3##6##(1993-1#3)
medically compromised##4##2##(1993-1#3)(2008-1#1)
medically fragile##3##2##(1992-3#1)(2008-10#2)
medically important##3##2##(1993-2#1)(2010-1#1)(2013-8#1)
medically indicated services##2##3##(1993-1#2)
medically indicated##4##2##(1993-1#3)(1993-11#1)
medically indigent##2##2##(1992-2#2)
medically treated##2##2##(1994-12#1)(2011-2#1)
medically underserved##3##2##(1997-1#2)(2008-1#1)
medically unexplained##2##2##(2009-6#1)(2010-1#1)
medically##39##1##(1990-12#1)(1991-3#1)(1992-2#4)(1992-3#2)(1993-1#6)(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(1997-1#2)(1997-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
medicament##4##1##(1997-2#2)(2008-10#1)(2013-1#1)
medicaments##7##1##(1991-8#1)(1997-2#3)(2008-11#2)(2011-3#1)
medicated PD patients##2##3##(2008-7#2)
medicated##5##1##(1995-5#1)(2008-11#1)(2008-7#2)(2013-8#1)
medication administration##2##2##(2008-2#1)(2010-6#1)
medication after an AMI##2##4##(2009-6#2)
medication and medical##2##3##(2012-3#2)
medication and##8##2##(1995-1#1)(2008-11#2)(2008-7#2)(2008-8#1)(2012-3#2)
medication calculation##2##2##(2008-12#2)
medication chart written/updated##2##3##(2012-12#2)
medication chart##3##2##(2012-12#3)
medication compliance##2##2##(2013-8#2)
medication data##2##2##(2009-3#1)(2010-8#1)
medication errors were##2##3##(2011-1#2)
medication errors##7##2##(2011-1#7)
medication for##5##2##(2008-11#1)(2009-7#1)(2010-1#1)(2010-7#1)(2013-8#1)
medication in primary##2##3##(2008-11#1)(2011-1#1)
medication in the##2##3##(2008-1#1)(2008-8#1)
medication in##10##2##(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
medication is##4##2##(1994-9#1)(1996-6#1)(2008-4#1)(2010-7#1)
medication management##6##2##(2008-11#3)(2012-12#3)
medication safety##2##2##(2011-1#2)
medication score in favour of##2##5##(2011-2#2)
medication score##3##2##(2011-2#3)
medication side effects##2##3##(2009-7#1)(2009-9#1)
medication to##4##2##(2008-12#1)(2008-8#1)(2010-11#1)(2010-4#1)
medication use##4##2##(2008-5#1)(2009-3#1)(2010-4#1)(2013-1#1)
medication was##5##2##(1996-6#1)(2008-11#2)(2008-7#1)(2011-2#1)
medication with##2##2##(1990-2#1)(2008-7#1)
medication##165##1##(1990-2#1)(1990-3#1)(1991-2#2)(1992-3#2)(1993-11#4)(1993-2#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#2)(1996-11#1)(1996-3#1)(1996-6#3)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-11#3)(2008-1#1)(2008-11#22)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#8)(2008-8#5)(2009-3#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#7)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#14)(2011-2#7)(2012-12#8)(2012-3#3)(2013-1#3)(2013-8#7)
medications and##5##2##(1996-1#1)(2008-11#2)(2008-5#1)(2013-1#1)
medications can##2##2##(1997-1#1)(2010-1#1)
medications for##2##2##(2009-7#1)(2012-3#1)
medications in##3##2##(2008-8#1)(2009-12#1)(2012-3#1)
medications is##2##2##(1991-2#1)(2008-11#1)
medications may##2##2##(2008-11#1)(2011-2#1)
medications or##4##2##(2009-8#1)(2011-2#3)
medications that##2##2##(2008-7#1)(2010-12#1)
medications to##3##2##(1996-9#1)(2008-8#1)(2011-2#1)
medications used##4##2##(2008-10#1)(2008-11#3)
medications were##4##2##(2008-11#2)(2010-6#1)(2012-12#1)
medications##78##1##(1991-2#1)(1996-1#2)(1996-9#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#13)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#4)(2012-3#4)(2012-5#1)(2013-1#5)(2013-8#1)
medicinal herb##3##2##(1994-11#1)(2008-11#1)(2009-3#1)
medicinal herbs##2##2##(2008-10#1)(2008-9#1)
medicinal plant##8##2##(1991-6#1)(2008-10#3)(2008-11#3)(2008-12#1)
medicinal plants have##2##3##(2008-11#1)(2011-3#1)
medicinal plants##13##2##(2008-10#3)(2008-11#3)(2008-5#3)(2010-6#1)(2011-3#1)(2012-2#1)(2013-1#1)
medicinal preparation##4##2##(2008-10#4)
medicinal preparations##3##2##(2008-10#3)
medicinal use##2##2##(2008-12#1)(2013-8#1)
medicinal##46##1##(1991-6#1)(1994-11#1)(1996-11#1)(2008-10#17)(2008-11#9)(2008-12#2)(2008-5#3)(2008-9#2)(2009-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
medicine and health##2##3##(1996-6#1)(2010-1#1)
medicine and medical##2##3##(2008-11#1)(2011-3#1)
medicine and the##3##3##(2008-11#2)(2010-1#1)
medicine and##29##2##(1992-3#1)(1994-12#2)(1994-5#1)(1994-9#1)(1996-6#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-1#3)(2010-10#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
medicine are##3##2##(1997-5#1)(2008-11#1)(2013-1#1)
medicine as##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
medicine at the##3##3##(1992-3#1)(2010-1#1)(2010-6#1)
medicine at##4##2##(1992-3#1)(1993-11#1)(2010-1#1)(2010-6#1)
medicine for##3##2##(2008-10#2)(2013-1#1)
medicine has led to##2##4##(1992-5#1)(2013-8#1)
medicine has##5##2##(1991-8#1)(1992-5#1)(1996-3#1)(2013-8#2)
medicine in the##4##3##(1990-6#1)(2009-5#1)(2010-5#1)(2012-2#1)
medicine in##20##2##(1990-6#1)(1993-6#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
medicine is##12##2##(1993-11#1)(1994-12#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(2010-1#1)(2010-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
medicine of##4##2##(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
medicine practice##2##2##(2008-7#1)(2011-2#1)
medicine that is##2##3##(2011-2#1)(2013-8#1)
medicine that##4##2##(2008-7#1)(2011-2#1)(2013-8#2)
medicine to be applied##4##4##(2010-8#4)
medicine to##6##2##(1996-12#1)(2008-11#1)(2010-8#4)
medicine was##2##2##(2008-12#1)(2013-8#1)
medicine will##3##2##(2012-3#1)(2013-8#2)
medicine##327##1##(1990-11#1)(1990-6#2)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-7#1)(1993-11#7)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#5)(1994-1#1)(1994-11#1)(1994-12#9)(1994-3#4)(1994-5#1)(1994-6#4)(1994-9#2)(1995-1#2)(1995-2#4)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#6)(1997-5#4)(1997-7#1)(1997-8#2)(2008-1#3)(2008-10#31)(2008-11#30)(2008-12#12)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-4#2)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#1)(2010-1#8)(2010-10#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#18)(2011-3#4)(2012-12#1)(2012-2#11)(2012-3#8)(2012-5#2)(2013-1#14)(2013-7#1)(2013-8#22)
medicine)##4##1##(1997-2#1)(2008-1#1)(2010-10#2)
medicine?]##2##1##(1993-11#1)(1993-3#1)
medicine]##22##1##(1990-3#2)(1991-11#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1996-11#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#2)(2009-1#1)
medicines and##5##2##(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-3#1)
medicines are##4##2##(2008-11#1)(2011-1#3)
medicines classified in the cardiovascular therapeutic group##2##7##(2008-11#2)
medicines classified##3##2##(2008-11#3)
medicines in##5##2##(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)
medicines is##2##2##(2008-11#1)(2011-2#1)
medicines was significantly higher in##2##5##(2008-11#2)
medicines was significantly##3##3##(2008-11#3)
medicines##64##1##(1990-6#1)(1992-2#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#6)(2008-11#16)(2008-12#2)(2008-7#2)(2009-3#1)(2010-2#1)(2010-5#1)(2011-1#13)(2011-2#5)(2011-3#3)(2013-1#5)(2013-8#2)
medico-legal##2##1##(1997-8#1)(2008-7#1)
medieval##7##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-6#1)(2013-8#2)
medigap insurance##2##2##(1991-2#1)(1992-2#1)
medigap##8##1##(1991-2#2)(1992-2#4)(1997-3#2)
mediolateral##2##1##(1997-3#1)(2010-9#1)
meditation##2##1##(2008-10#2)
mediterranean##2##1##(1992-9#1)(2008-10#1)
medium (0 or##2##3##(2011-2#2)
medium (maximal##2##2##(1997-3#1)(2008-11#1)
medium (pH##7##2##(2008-10#7)
medium (with##2##2##(2008-10#2)
medium DRG neurons##2##3##(1996-12#2)
medium abolished##2##2##(1995-12#1)(2008-10#1)
medium absorption##2##2##(2008-3#2)
medium adjusted##2##2##(1996-12#1)(2008-10#1)
medium after##4##2##(1993-8#1)(2008-10#3)
medium allowed##5##2##(1993-12#1)(2008-10#3)(2011-2#1)
medium and can##2##3##(2008-11#2)
medium and in the##2##4##(2008-10#2)
medium and in##3##3##(2008-10#3)
medium and its##3##3##(2008-10#3)
medium and long-term##2##3##(2008-12#1)(2013-1#1)
medium and on##2##3##(2008-10#1)(2008-11#1)
medium and the resulting##2##4##(2008-10#2)
medium and the##10##3##(1995-3#1)(2008-10#5)(2008-11#3)(2011-2#1)
medium and then##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
medium and##77##2##(1990-6#1)(1992-12#1)(1993-8#2)(1993-9#1)(1994-3#1)(1995-3#1)(1996-2#2)(2008-1#1)(2008-10#36)(2008-11#18)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-12#1)(2011-2#2)(2011-3#1)(2012-4#1)(2013-1#2)
medium are##3##2##(2008-10#2)(2008-3#1)
medium as well as##2##4##(2008-11#1)(2008-3#1)
medium as##10##2##(1992-3#1)(1992-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)
medium at pH 7##2##4##(2008-10#2)
medium at pH##6##3##(2008-10#6)
medium at room temperature##3##4##(2008-10#3)
medium at the##2##3##(2008-11#1)(2008-3#1)
medium at##18##2##(2008-10#13)(2008-11#4)(2008-3#1)
medium based on##2##3##(2008-10#2)
medium by use of##2##4##(2007-11#1)(2008-3#1)
medium by##12##2##(1993-3#1)(1993-6#1)(1995-8#1)(2007-11#1)(2008-10#6)(2008-3#2)
medium can be##2##3##(2008-11#2)
medium change##2##2##(1996-2#1)(2008-11#1)
medium components##6##2##(2008-11#3)(2013-1#3)
medium composed of##3##3##(2008-10#3)
medium composition##7##2##(2008-11#7)
medium consisting of##3##3##(2008-11#2)(2008-12#1)
medium consumption and##2##3##(2008-11#2)
medium containing 0 (control)##2##4##(2008-12#1)(2013-1#1)
medium containing 0##4##3##(1992-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
medium containing 1%##2##3##(1997-1#1)(2008-8#1)
medium containing NAA##2##3##(2013-1#2)
medium containing##64##2##(1991-12#1)(1992-6#2)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#19)(2008-11#21)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#7)
medium could##2##2##(1992-12#1)(2008-10#1)
medium decreased##2##2##(2008-11#1)(2011-2#1)
medium during##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
medium exchange##4##2##(2008-10#1)(2008-11#3)
medium feed##2##2##(2008-11#1)(2008-7#1)
medium flow##2##2##(2008-10#1)(2008-11#1)
medium for the##6##3##(2008-10#3)(2008-11#3)
medium for##21##2##(2008-10#11)(2008-11#6)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
medium formed with##2##3##(2008-10#2)
medium formulation and##2##3##(2008-11#1)(2008-5#1)
medium formulation##8##2##(2008-11#7)(2008-5#1)
medium from##4##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
medium glucose concentration##2##3##(2008-11#2)
medium has been monitored##2##4##(2008-10#2)
medium has been##6##3##(2008-10#5)(2008-2#1)
medium has##7##2##(2008-10#5)(2008-11#1)(2008-2#1)
medium in a stirred tank bioreactor##2##6##(2008-11#2)
medium in a##3##3##(2008-11#3)
medium in the presence of##2##5##(1997-2#1)(2008-10#1)
medium in the range##3##4##(2008-10#3)
medium in the##13##3##(1992-8#1)(1997-2#1)(2008-10#6)(2008-11#4)(2011-2#1)
medium in##31##2##(1992-8#1)(1993-12#1)(1997-2#1)(1997-3#1)(2008-10#11)(2008-11#13)(2008-7#1)(2008-8#1)(2011-2#1)
medium increased##4##2##(2008-11#3)(2008-7#1)
medium inoculated with##2##3##(2008-10#1)(2008-7#1)
medium is described##2##3##(2008-10#1)(2008-4#1)
medium is proposed##2##3##(2008-10#2)
medium is##21##2##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#1)(2009-5#1)
medium level of##2##3##(2008-10#2)
medium of low##3##3##(1991-11#2)(2008-8#1)
medium of pH##3##3##(2008-10#3)
medium of the##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
medium of##29##2##(1991-11#2)(1991-5#1)(1995-12#1)(1995-6#1)(1997-1#2)(1997-2#1)(2008-10#15)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#2)
medium on##7##2##(2008-10#3)(2008-11#3)(2011-2#1)
medium optimization##3##2##(2008-11#3)
medium or from##2##3##(2008-10#2)
medium or in the presence of##2##6##(1996-2#1)(2008-10#1)
medium or in the##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
medium or##13##2##(1995-11#1)(1996-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2013-1#1)
medium osmotic potential##2##3##(2008-9#2)
medium performance##2##2##(2008-11#1)(2011-2#1)
medium perfusion rate##4##3##(2008-11#4)
medium perfusion##6##2##(2008-11#6)
medium prevented##2##2##(1991-10#1)(2008-11#1)
medium replacement##2##2##(2008-11#2)
medium showed that##2##3##(2008-10#2)
medium showed##6##2##(2008-10#2)(2008-11#3)(2008-12#1)
medium such as##2##3##(1996-5#1)(2008-3#1)
medium supplement##2##2##(2008-11#2)
medium supplemented with 1##2##4##(2008-11#1)(2008-12#1)
medium supplemented with glucose##3##4##(2008-11#3)
medium supplemented with##16##3##(2008-10#5)(2008-11#7)(2008-12#1)(2008-7#2)(2008-8#1)
medium term##4##2##(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
medium than##2##2##(2008-10#1)(2008-11#1)
medium that contained##2##3##(1993-12#1)(1997-4#1)
medium that##6##2##(1993-12#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-3#1)
medium to form a##5##4##(2008-10#5)
medium to form##8##3##(2008-10#8)
medium to support##2##3##(2008-11#2)
medium to##24##2##(1994-3#2)(2008-10#13)(2008-11#5)(2008-5#2)(2008-7#1)(2013-1#1)
medium type and serum##2##4##(2008-11#2)
medium under##2##2##(2008-10#1)(2008-3#1)
medium up to##4##3##(2008-10#3)(2008-11#1)
medium used to##3##3##(1997-3#1)(2008-10#2)
medium used was##2##3##(2008-11#1)(2008-5#1)
medium used##5##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
medium using##7##2##(1992-12#1)(2008-10#6)
medium volume##2##2##(1993-12#1)(2008-7#1)
medium was developed##2##3##(2008-10#1)(2008-11#1)
medium was evaluated##2##3##(2008-10#1)(2008-11#1)
medium was investigated##3##3##(2008-10#3)
medium was replenished##2##3##(2008-10#1)(2008-11#1)
medium was studied##2##3##(2008-10#2)
medium was taken##2##3##(2008-10#1)(2008-11#1)
medium was used to##2##4##(2008-10#1)(2008-7#1)
medium was##54##2##(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#2)(2008-10#21)(2008-11#20)(2008-12#1)(2008-5#1)(2008-7#3)(2011-2#1)
medium were higher than in##2##5##(2008-10#1)(2008-11#1)
medium were##13##2##(1996-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2011-2#1)
medium when##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
medium which##5##2##(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#2)
medium with a##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
medium with an##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
medium with or without##2##4##(1996-2#1)(2008-11#1)
medium with the##2##3##(2008-10#1)(2008-11#1)
medium with##35##2##(1996-2#1)(1996-6#1)(2008-10#9)(2008-11#10)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
medium without##8##2##(1992-6#1)(2008-10#3)(2008-11#4)
medium##1179##1##(1990-11#4)(1990-2#2)(1990-5#5)(1990-6#3)(1990-8#1)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#7)(1992-12#6)(1992-3#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#8)(1993-3#5)(1993-6#5)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#6)(1994-6#1)(1994-8#2)(1995-11#5)(1995-12#2)(1995-2#5)(1995-3#2)(1995-6#1)(1995-8#7)(1996-12#5)(1996-2#10)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#489)(2008-11#332)(2008-12#17)(2008-2#5)(2008-3#36)(2008-4#4)(2008-5#19)(2008-6#2)(2008-7#29)(2008-8#14)(2008-9#11)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#16)(2011-3#1)(2012-2#5)(2012-3#1)(2012-4#3)(2012-7#1)(2012-8#1)(2013-1#23)(2013-7#1)
medium) and##2##2##(2008-10#1)(2008-9#1)
medium)##9##1##(2008-10#3)(2008-11#3)(2008-9#2)(2009-10#1)
medium- and##5##2##(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
medium-##6##1##(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#2)
medium-chain##4##1##(1990-8#1)(1991-5#1)(1993-3#1)(2011-1#1)
medium-range order##2##2##(2012-2#2)
medium-sized and small##2##3##(1996-8#1)(2008-12#1)
medium-sized spiny neurons##2##3##(2013-8#2)
medium-sized##9##1##(1990-8#1)(1991-12#1)(1996-8#1)(1997-8#1)(2008-12#1)(2011-2#2)(2013-8#2)
medium-term##4##1##(2010-11#1)(2011-2#3)
mediumexchange##2##1##(2008-11#2)
mediums##7##1##(2008-10#5)(2008-5#2)
medoxomil##4##1##(2008-11#4)
medroxyprogesterone acetate (MPA)##2##3##(1993-1#2)
medroxyprogesterone acetate##7##2##(1993-1#4)(1997-7#1)(2008-10#1)(2011-2#1)
medroxyprogesterone##9##1##(1990-11#2)(1993-1#4)(1997-7#1)(2008-10#1)(2011-2#1)
medulla and##6##2##(1996-12#1)(1997-2#2)(2008-12#1)(2008-5#1)(2008-8#1)
medulla oblongata##2##2##(2008-6#2)
medulla##26##1##(1990-2#1)(1990-5#3)(1993-8#1)(1995-2#1)(1996-12#2)(1997-2#6)(2007-12#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#2)(2008-8#3)
medullary cancer##2##2##(1994-12#1)(1996-11#1)
medullary thyroid##4##2##(1992-6#3)(2013-1#1)
medullary type##2##2##(2008-8#2)
medullary##24##1##(1990-5#1)(1991-11#1)(1992-6#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#3)(1996-11#1)(1996-9#1)(2008-10#1)(2008-8#4)(2009-3#1)(2011-2#1)(2013-1#3)
medulloblastoma in the elderly##2##4##(2009-1#2)
medulloblastoma in the##4##3##(2008-7#1)(2009-1#3)
medulloblastoma in##7##2##(1997-3#1)(2008-7#2)(2009-1#4)
medulloblastoma##18##1##(1991-2#1)(1993-9#1)(1994-3#1)(1997-3#7)(2008-7#3)(2009-1#5)
medulloblastomas##7##1##(1991-2#5)(2008-7#1)(2009-1#1)
medusae f##4##2##(2008-10#4)
medusae##10##1##(2008-10#10)
meet a##2##2##(1991-1#1)(1995-12#1)
meet current##3##2##(1994-2#1)(2009-3#1)(2012-12#1)
meet the challenges of##2##4##(1994-2#1)(2008-11#1)
meet the challenges##3##3##(1994-12#1)(1994-2#1)(2008-11#1)
meet the demands##4##3##(1994-2#1)(1995-2#1)(2008-9#1)(2012-3#1)
meet the information needs of##2##5##(1991-12#1)(1994-12#1)
meet the needs of both##2##5##(2008-6#1)(2010-7#1)
meet the needs of the##3##5##(1994-2#1)(1997-1#1)(2010-7#1)
meet the needs of##16##4##(1991-1#1)(1991-3#1)(1993-1#1)(1994-1#2)(1994-2#2)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-7#2)
meet the needs##17##3##(1991-1#1)(1991-3#1)(1993-1#1)(1994-1#2)(1994-2#2)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-7#2)
meet the requirements of the##2##5##(1996-12#1)(2008-3#1)
meet the requirements of##4##4##(1996-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
meet the spiritual needs of##2##5##(2008-11#1)(2011-1#1)
meet the##70##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#2)(1993-1#1)(1993-12#1)(1994-1#3)(1994-12#3)(1994-2#4)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(2008-10#5)(2008-11#11)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-4#1)(2010-7#3)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#6)
meet these requirements##4##3##(1992-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
meet these##8##2##(1992-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
meet with##2##2##(2008-11#1)(2010-8#1)
meet your##3##2##(1992-1#1)(1992-12#1)(1995-2#1)
meet##128##1##(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#2)(1992-1#3)(1992-12#3)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#5)(1994-12#3)(1994-2#6)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#21)(2008-12#6)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#6)
meeting and##2##2##(2009-5#1)(2009-9#1)
meeting in##3##2##(2008-10#2)(2011-2#1)
meeting of the American Society##2##5##(1997-7#1)(2008-8#1)
meeting of the American##3##4##(1995-6#1)(1997-7#1)(2008-8#1)
meeting of the##8##3##(1995-6#1)(1997-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2011-2#2)
meeting of##10##2##(1995-6#1)(1996-3#1)(1997-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-5#1)(2011-2#2)
meeting on##3##2##(1992-3#1)(2008-11#1)(2010-4#1)
meeting the challenge##3##3##(1997-2#1)(2010-11#1)(2012-12#1)
meeting the needs of##2##4##(1995-1#1)(2008-11#1)
meeting the##15##2##(1993-1#1)(1994-2#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
meeting their##2##2##(1994-1#1)(1994-2#1)
meeting these##3##2##(1994-2#1)(2008-7#1)(2012-12#1)
meeting was to##2##3##(1994-9#1)(2008-5#1)
meeting was##4##2##(1994-9#1)(2008-5#3)
meeting with the##2##3##(1993-2#1)(2008-5#1)
meeting with##4##2##(1993-2#1)(2008-5#1)(2008-7#1)(2012-3#1)
meeting##143##1##(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#3)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-11#51)(2008-12#1)(2008-3#1)(2008-5#10)(2008-7#6)(2008-8#4)(2009-11#1)(2009-4#4)(2009-5#4)(2009-9#1)(2010-11#2)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
meetings and##4##2##(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
meetings in##3##2##(1996-11#1)(2008-5#1)(2011-2#1)
meetings##20##1##(1992-12#1)(1993-11#1)(1995-6#1)(1996-11#2)(1997-1#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
meets its##2##2##(1991-5#1)(1994-9#1)
meets the needs of##2##4##(1994-3#1)(2008-10#1)
meets the requirements for##2##4##(2008-10#1)(2013-1#1)
meets the requirements##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
meets the##11##2##(1993-3#1)(1994-3#1)(1997-3#1)(2008-10#4)(2011-2#1)(2013-1#2)(2013-8#1)
meets##23##1##(1991-5#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1997-3#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
mefenamic acid##5##2##(2008-10#1)(2012-2#4)
mefenamic##9##1##(2008-10#4)(2012-2#5)
mefenoxam insensitivity##2##2##(2008-10#2)
mefenoxam selection##2##2##(2008-10#2)
mefenoxam sensitivity##4##2##(2008-10#4)
mefenoxam##18##1##(2008-10#18)
mefloquine##2##1##(1993-8#2)
megabase##3##1##(1995-12#2)(2008-10#1)
megacolon and##2##2##(1994-12#2)
megacolon associated with##2##3##(1994-12#2)
megacolon##5##1##(1993-6#1)(1994-12#4)
megakaryoblastic leukemia##2##2##(2008-4#1)(2009-12#1)
megakaryoblastic##4##1##(2008-12#1)(2008-4#1)(2009-12#2)
megakaryocyte##3##1##(1995-11#2)(2008-7#1)
megalourethra##5##1##(2008-10#5)
megasperma##2##1##(2008-10#2)
megaterium##5##1##(2008-10#2)(2011-1#3)
megaureter##2##1##(2008-10#2)
megaureters##4##1##(2008-10#4)
megavoltage##2##1##(1992-3#1)(2008-11#1)
meibomiae##6##1##(2008-10#6)
meioses##2##1##(2008-12#2)
meiosis and differentiation##2##3##(2009-10#1)(2012-2#1)
meiosis and##5##2##(2008-9#1)(2009-10#1)(2012-2#3)
meiosis is##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
meiosis occurs##2##2##(2008-9#2)
meiosis stage##2##2##(2008-8#1)(2012-2#1)
meiosis##24##1##(1995-9#1)(2008-10#2)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2011-2#1)(2012-2#7)(2012-3#2)
meiosis-specific RecA-like##2##2##(1995-6#1)(1995-8#1)
meiosis-specific lamin C2##2##3##(2011-2#2)
meiosis-specific recA-like genes##2##3##(1995-8#2)
meiosis-specific##8##1##(1995-6#2)(1995-8#3)(2011-2#2)(2012-3#1)
meiotic maturation and##3##3##(2012-3#1)(2013-1#2)
meiotic maturation##6##2##(2012-3#1)(2013-1#5)
meiotic mutants##4##2##(2008-9#4)
meiotic pentavalents##2##2##(2008-12#2)
meiotic prophase##5##2##(2007-12#1)(2008-11#1)(2011-2#3)
meiotic recombination##4##2##(1995-6#1)(1997-7#1)(2008-9#1)(2012-3#1)
meiotic silencing##2##2##(2012-3#2)
meiotic##40##1##(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#5)(2008-7#3)(2008-9#8)(2009-10#1)(2011-2#5)(2012-2#1)(2012-3#5)(2013-1#5)
melamine based polymeric sequestering##2##4##(2008-10#2)
melamine##5##1##(2008-10#5)
melancholia and##3##2##(2008-12#3)
melancholia##8##1##(2008-12#4)(2008-6#1)(2010-6#3)
melancholic##2##1##(2008-11#1)(2010-7#1)
melanin biosynthesis is##2##3##(2008-10#1)(2008-9#1)
melanin pigment##2##2##(2010-6#2)
melanin production##3##2##(2008-10#2)(2008-5#1)
melanin##14##1##(2008-10#3)(2008-11#1)(2008-5#3)(2008-9#2)(2010-6#2)(2011-2#1)(2013-1#2)
melanin-concentrating hormone##2##2##(1993-5#1)(2008-7#1)
melanization of##2##2##(2008-10#2)
melanization##4##1##(2008-10#4)
melanized appressoria##4##2##(2008-10#4)
melanized##7##1##(2008-10#6)(2009-8#1)
melanocortin##2##1##(2008-4#1)(2008-9#1)
melanocyte cultures##2##2##(2008-5#2)
melanocyte##7##1##(1995-2#1)(2008-5#3)(2008-9#1)(2011-2#2)
melanocytes and##3##2##(1994-12#1)(1997-7#1)(2008-5#1)
melanocytes in##2##2##(2008-5#2)
melanocytes into##2##2##(2008-5#1)(2009-3#1)
melanocytes is not##2##3##(2008-9#1)(2011-2#1)
melanocytes with##2##2##(1995-2#1)(2008-9#1)
melanocytes##27##1##(1994-12#2)(1995-2#6)(1997-7#1)(2008-5#10)(2008-9#2)(2009-3#1)(2010-6#2)(2011-2#2)(2013-1#1)
melanocytic nevi##4##2##(2011-2#2)(2012-3#2)
melanocytic##6##1##(2008-7#2)(2011-2#2)(2012-3#2)
melanocytoma##3##1##(2008-7#3)
melanogaster age at slow rates##2##5##(2008-8#2)
melanogaster and##7##2##(1993-2#1)(2008-10#1)(2012-2#2)(2012-3#3)
melanogaster##58##1##(1993-12#2)(1993-2#6)(1993-6#2)(1993-9#1)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#1)(1997-7#6)(1997-8#4)(2007-12#1)(2008-10#1)(2008-11#4)(2008-7#2)(2008-8#5)(2008-9#7)(2009-7#2)(2010-1#1)(2012-2#2)(2012-3#6)
melanogenesis by##2##2##(2008-5#2)
melanogenesis of##2##2##(1995-2#1)(2008-11#1)
melanogenesis##16##1##(1995-2#1)(2008-11#2)(2008-5#13)
melanogenic proteins##2##2##(1995-2#2)
melanogenic##8##1##(1995-2#5)(2008-11#1)(2008-5#2)
melanoma and##7##2##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#3)(2013-1#1)
melanoma by##2##2##(1991-6#1)(2010-6#1)
melanoma cell differentiation##2##3##(2008-11#2)
melanoma cell line##3##3##(1997-9#1)(2008-11#1)(2008-8#1)
melanoma cell##9##2##(1992-2#2)(1997-9#1)(2008-11#3)(2008-8#1)(2009-10#2)
melanoma cells and##4##3##(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
melanoma cells to##4##3##(2009-3#1)(2009-4#2)(2012-3#1)
melanoma cells was##2##3##(2008-5#1)(2013-1#1)
melanoma cells were##3##3##(1994-5#1)(2009-10#1)(2013-1#1)
melanoma cells with##2##3##(2008-11#1)(2013-1#1)
melanoma cells##33##2##(1993-5#1)(1994-5#1)(1997-7#3)(2008-11#3)(2008-5#2)(2008-8#1)(2009-10#2)(2009-3#7)(2009-4#2)(2011-2#2)(2012-3#3)(2013-1#6)
melanoma growth##2##2##(2013-1#2)
melanoma in##8##2##(1994-12#1)(1994-8#1)(2010-6#1)(2011-2#4)(2013-8#1)
melanoma is a rare##2##4##(2011-2#2)
melanoma is##7##2##(2008-9#1)(2009-3#1)(2011-2#4)(2012-3#1)
melanoma metastasis##3##2##(2009-2#1)(2009-3#1)(2013-1#1)
melanoma of the##4##3##(1990-12#1)(2008-9#1)(2009-3#1)(2010-6#1)
melanoma patients in##2##3##(1994-5#1)(2011-2#1)
melanoma patients##3##2##(1994-5#1)(2011-2#1)(2012-12#1)
melanoma skin cancer cells##3##4##(2012-3#3)
melanoma skin cancer##4##3##(2012-3#4)
melanoma susceptibility##2##2##(1997-7#1)(2008-8#1)
melanoma tumor##2##2##(1994-5#1)(2012-3#1)
melanoma was##2##2##(2011-2#2)
melanoma##188##1##(1990-12#2)(1990-6#2)(1991-6#4)(1992-2#7)(1993-5#1)(1994-12#1)(1994-2#2)(1994-5#6)(1994-8#1)(1996-6#2)(1997-7#11)(1997-9#1)(2007-8#1)(2008-11#9)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#11)(2009-10#5)(2009-2#1)(2009-3#14)(2009-4#5)(2010-6#14)(2011-2#48)(2012-12#1)(2012-3#17)(2013-1#12)(2013-8#1)
melanomas##16##1##(1994-6#1)(1996-6#1)(2008-9#3)(2009-4#2)(2011-2#8)(2012-3#1)
melanophores##5##1##(2008-5#4)(2008-6#1)
melanopterus at Palmyra##2##3##(2010-8#2)
melanopterus##4##1##(2010-8#4)
melanosomes##3##1##(2008-8#3)
melanotropic##2##1##(1995-2#2)
melanotropins##3##1##(1993-5#1)(1995-2#2)
melatonin (MT)##2##2##(2008-11#2)
melatonin administration##2##2##(2008-12#2)
melatonin and its derivatives##3##4##(2008-10#3)
melatonin and its##4##3##(2008-10#4)
melatonin and##6##2##(1993-6#1)(2008-10#4)(2011-2#1)
melatonin binding##2##2##(1993-6#1)(1995-12#1)
melatonin in the##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
melatonin in##8##2##(1995-11#2)(1996-2#1)(2008-10#2)(2008-11#3)
melatonin levels##2##2##(1991-6#1)(1994-6#1)
melatonin on##4##2##(1990-5#1)(1996-2#1)(2008-12#1)(2010-12#1)
melatonin receptors##4##2##(1995-12#1)(1996-2#2)(2013-7#1)
melatonin synthesis##2##2##(2008-5#2)
melatonin tablets##2##2##(2008-10#2)
melatonin were##2##2##(1991-6#1)(2008-10#1)
melatonin##68##1##(1990-2#4)(1990-5#5)(1991-6#2)(1992-12#2)(1993-6#4)(1994-12#1)(1994-6#1)(1995-11#2)(1995-12#3)(1995-9#1)(1996-2#6)(2008-10#11)(2008-11#5)(2008-12#4)(2008-5#4)(2010-12#1)(2011-2#7)(2013-7#5)
melatonin-loaded sugar spheres containing 10%##2##5##(2008-11#2)
melatonin-loaded sugar spheres##3##3##(2008-11#3)
meleagridis and M##3##3##(2008-5#3)
meleagridis##4##1##(2008-5#4)
meliloti##5##1##(2008-11#1)(2008-8#2)(2008-9#2)
melittin and mastoparan##3##3##(1994-11#3)
melittin on##3##2##(2008-10#3)
melittin##11##1##(1994-11#4)(1994-5#2)(2008-10#5)
melittin-DPPC##2##1##(2008-10#2)
mellitus (DM)##6##2##(2011-1#1)(2011-3#2)(2012-2#1)(2012-5#1)(2013-8#1)
mellitus and##13##2##(1992-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
mellitus in##10##2##(1994-6#2)(1996-11#2)(2008-10#1)(2008-11#2)(2010-10#1)(2010-11#1)(2013-1#1)
mellitus is##6##2##(1992-8#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
mellitus was##4##2##(1992-12#1)(1994-6#1)(2008-1#1)(2008-10#1)
mellitus##137##1##(1990-2#1)(1991-12#1)(1991-7#2)(1992-12#5)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1994-11#2)(1994-12#4)(1994-6#4)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#5)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#1)(2008-1#6)(2008-10#9)(2008-11#14)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#9)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#5)(2011-2#6)(2011-3#4)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#2)(2013-1#15)(2013-8#4)
melo##3##1##(2008-10#3)
melody recognition and##2##3##(2008-9#2)
melody recognition##4##2##(2008-9#4)
melon (Cucumis melo)##2##3##(2008-10#2)
melon and##2##2##(2008-10#2)
melon crops##2##2##(2008-10#2)
melon plants##3##2##(2008-10#3)
melon was##2##2##(2008-10#2)
melon##24##1##(2008-10#24)
melonis and F##2##3##(2008-10#2)
melonis##12##1##(2008-10#12)
meloxicam##10##1##(2008-11#8)(2011-2#2)
melphalan##5##1##(1992-2#1)(2011-3#3)(2012-12#1)
melt inclusions in##3##3##(2008-10#3)
melt samples##2##2##(2008-10#2)
melt##15##1##(2008-10#13)(2008-11#2)
melting of##2##2##(1992-1#1)(2013-8#1)
melting or##2##2##(1991-2#1)(2010-9#1)
melting point##6##2##(1993-8#1)(2008-10#3)(2008-5#1)(2009-11#1)
melting temperature##3##2##(2008-11#1)(2009-3#1)(2011-1#1)
melting##28##1##(1991-2#1)(1992-1#1)(1992-3#1)(1993-8#2)(1995-3#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-7#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-8#2)
melts after dissolution of the sample in dilute nitric acid##2##10##(2008-10#2)
melts by flame atomic absorption spectrometry##2##6##(2008-10#2)
melts by##3##2##(2008-10#3)
melts##7##1##(2008-10#7)
member in##2##2##(2008-10#1)(2008-9#1)
member of a##10##3##(1992-3#1)(1993-2#2)(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
member of the family Potyviridae##3##5##(2008-10#3)
member of the family##23##4##(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#8)(2011-2#12)
member of the genus Potyvirus##5##5##(2008-10#5)
member of the genus##26##4##(2008-10#19)(2011-2#7)
member of the growing##2##4##(1993-3#1)(2008-10#1)
member of the heat shock##2##5##(1992-12#1)(1995-11#1)
member of the superfamily of##2##5##(1995-12#1)(2008-11#1)
member of the##101##3##(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-6#3)(1995-8#4)(1996-12#3)(1996-2#1)(1997-3#2)(1997-7#2)(2008-10#34)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#24)(2012-3#1)(2013-1#1)
member of##125##2##(1990-5#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-9#1)(1994-11#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-6#3)(1995-8#5)(1996-12#4)(1996-2#2)(1997-3#2)(1997-7#2)(2008-10#37)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#2)(2011-1#1)(2011-2#24)(2012-3#1)(2013-1#1)
member who is##2##3##(1992-3#1)(1993-2#1)
member with##2##2##(1992-3#1)(2010-4#1)
member##158##1##(1990-5#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#8)(1993-3#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-6#3)(1995-8#6)(1996-1#1)(1996-12#5)(1996-2#3)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2008-10#39)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-3#1)(2009-8#1)(2009-9#2)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#26)(2012-2#2)(2012-3#1)(2013-1#2)
members and chairs##5##3##(2009-4#5)
members and##12##2##(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-4#6)(2011-2#1)
members are##9##2##(1996-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
members belonging to##2##3##(1997-9#1)(2008-9#1)
members can##4##2##(1995-6#1)(1996-1#1)(1996-3#1)(2008-9#1)
members expressed##2##2##(1993-12#1)(2009-12#1)
members in the##2##3##(1991-2#1)(2008-10#1)
members in##13##2##(1990-5#1)(1991-2#2)(1992-2#1)(1995-1#1)(2008-10#1)(2008-6#1)(2008-9#3)(2010-10#1)(2010-4#1)(2012-3#1)
members may##2##2##(2008-11#1)(2009-4#1)
members of a family##2##4##(1995-8#1)(1997-8#1)
members of a tRNA(Gly)1 multigene family##2##6##(1997-7#2)
members of a##13##3##(1991-7#1)(1995-8#1)(1996-12#1)(1997-7#2)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
members of herding##2##3##(2009-8#2)
members of hereditary melanoma##2##4##(1997-7#2)
members of the Association##3##4##(1994-3#2)(2008-10#1)
members of the B##2##4##(2008-10#1)(2011-2#1)
members of the Bcl-2 family##4##5##(2008-11#2)(2011-2#2)
members of the Brn-3 subfamily of POU transcription factors##2##9##(1996-12#2)
members of the IL-6 subfamily##2##5##(1996-2#2)
members of the Xanthomonas avr/pth gene family##2##7##(2008-10#2)
members of the Xanthomonas##3##4##(2008-10#3)
members of the class##3##4##(1991-2#1)(2008-10#2)
members of the family Bunyaviridae##2##5##(2008-10#2)
members of the family Enterobacteriaceae##2##5##(2008-10#2)
members of the family Potyviridae##2##5##(2008-10#2)
members of the family##16##4##(1991-12#1)(1997-8#2)(2008-10#8)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
members of the gene family##2##5##(2008-10#2)
members of the genera##2##4##(2008-10#1)(2013-8#1)
members of the genus Trichovirus##2##5##(2008-10#2)
members of the genus##10##4##(2008-10#7)(2008-9#1)(2011-2#2)
members of the group##2##4##(2008-10#1)(2008-11#1)
members of the hsp70 family##2##5##(1995-6#2)
members of the same family##3##5##(1997-4#1)(2008-10#1)(2008-5#1)
members of the same species##2##5##(1995-2#1)(2012-2#1)
members of the same##6##4##(1995-2#1)(1997-4#1)(2008-10#2)(2008-5#1)(2012-2#1)
members of the yeast HSP70 multigene family##2##7##(1993-9#2)
members of the##136##3##(1990-3#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-9#3)(1994-1#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#4)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#5)(2008-1#1)(2008-10#41)(2008-11#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#5)
members of their##3##3##(1991-1#1)(1995-1#1)(2010-10#1)
members of these families##2##4##(1997-9#1)(2006-6#1)
members of this##5##3##(1995-6#1)(2008-10#3)(2009-5#1)
members of two##2##3##(1997-7#1)(2006-6#1)
members of##201##2##(1990-3#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-9#3)(1994-1#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#7)(1995-8#2)(1996-1#1)(1996-12#6)(1996-2#5)(1996-3#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#6)(1997-9#1)(2006-6#2)(2008-1#1)(2008-10#52)(2008-11#15)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#2)(2010-10#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#5)
members share relatively low degrees of 16S rRNA gene sequence similarity##2##11##(2011-2#2)
members share##3##2##(1992-7#1)(2011-2#2)
members that##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)
members to##5##2##(1996-2#1)(1996-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
members were##9##2##(1992-2#1)(1997-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
members who##5##2##(1995-2#1)(1996-5#1)(2008-12#2)(2010-11#1)
members##371##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#3)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#7)(1993-3#2)(1993-6#2)(1993-9#3)(1994-1#1)(1994-12#3)(1994-3#4)(1994-5#1)(1994-6#1)(1995-1#3)(1995-12#2)(1995-2#3)(1995-6#15)(1995-8#2)(1996-1#2)(1996-12#6)(1996-2#10)(1996-3#8)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#6)(1997-9#3)(2006-6#2)(2008-1#2)(2008-10#60)(2008-11#28)(2008-12#10)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#7)(2008-7#8)(2008-8#5)(2008-9#24)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#9)(2009-5#1)(2009-6#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#18)(2012-12#6)(2012-2#10)(2012-3#4)(2013-1#3)(2013-8#7)
members'##10##1##(1990-12#1)(1994-12#1)(1996-8#1)(2008-11#1)(2008-6#1)(2010-10#5)
membership and##3##2##(1996-2#1)(2007-12#1)(2008-11#1)
membership grade of##2##3##(2008-10#2)
membership in the##2##3##(1993-1#1)(2008-4#1)
membership was##2##2##(2008-10#1)(2010-8#1)
membership##25##1##(1991-1#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#1)(1994-3#3)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#2)(2010-10#1)(2010-8#1)
memberships##3##1##(2010-8#1)(2012-2#2)
membrane (or##2##2##(2009-7#2)
membrane and cytoplasmic##2##3##(1991-5#1)(2008-8#1)
membrane and the nucleus##2##4##(2008-11#2)
membrane and the underlying##2##4##(2009-10#1)(2009-5#1)
membrane and the##13##3##(1990-12#1)(1995-6#1)(2008-10#6)(2008-11#2)(2009-10#1)(2009-5#1)(2009-8#1)
membrane and to##2##3##(1994-11#1)(2008-10#1)
membrane and water solution##2##4##(2008-10#2)
membrane and##71##2##(1990-12#1)(1991-10#2)(1991-5#1)(1992-12#2)(1993-8#2)(1994-11#2)(1994-5#1)(1995-6#4)(1997-8#1)(2008-10#30)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-12#1)(2011-2#2)(2011-3#2)(2012-2#2)
membrane anion and cation-selective electrodes##2##5##(2008-10#2)
membrane antigen##8##2##(1991-12#1)(1992-2#1)(1994-8#3)(2008-7#1)(2008-9#1)(2011-2#1)
membrane are##5##2##(1990-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
membrane assembly of##2##3##(1991-10#1)(1995-6#1)
membrane assembly##4##2##(1991-10#1)(1995-6#2)(2008-7#1)
membrane at##4##2##(2008-10#2)(2008-8#1)(2009-10#1)
membrane based on the##2##4##(2008-10#2)
membrane based on##7##3##(2008-10#7)
membrane based##10##2##(2008-10#10)
membrane binding domain##3##3##(1995-6#3)
membrane binding##5##2##(1995-6#4)(2008-11#1)
membrane blebbing##2##2##(2008-10#1)(2010-2#1)
membrane bound##5##2##(1990-5#1)(1994-6#1)(1994-8#1)(2007-12#1)(2009-8#1)
membrane but##2##2##(1994-11#1)(2009-10#1)
membrane by##9##2##(1992-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-6#1)(2008-10#2)(2009-7#1)(2009-8#1)
membrane can be##4##3##(2008-10#4)
membrane can##6##2##(1995-6#1)(2008-10#5)
membrane cell and##4##3##(2008-10#4)
membrane cell##6##2##(2008-10#6)
membrane changes##2##2##(2008-7#1)(2008-9#1)
membrane coated##2##2##(1995-2#1)(2008-10#1)
membrane components in##2##3##(1992-11#2)
membrane components##6##2##(1992-11#2)(1995-12#2)(2008-10#1)(2008-11#1)
membrane composition and##3##3##(1991-5#1)(2008-10#2)
membrane composition##12##2##(1991-5#1)(2008-10#11)
membrane conductance##2##2##(1991-5#1)(2011-2#1)
membrane containing##12##2##(2008-10#11)(2008-9#1)
membrane damage##5##2##(1995-8#2)(2009-6#3)
membrane depolarization##2##2##(1992-3#1)(2010-11#1)
membrane desolvator##3##2##(2008-10#3)
membrane disk modified by a recently synthesized##2##7##(2008-10#2)
membrane disks modified by##9##4##(2008-10#9)
membrane disks modified with##6##4##(2008-10#6)
membrane disks modified##15##3##(2008-10#15)
membrane disks##16##2##(2008-10#16)
membrane domain##4##2##(1993-6#2)(1997-2#1)(2008-8#1)
membrane domains##3##2##(1993-6#1)(2008-11#1)(2009-7#1)
membrane due to##2##3##(2008-10#2)
membrane dynamics##3##2##(2008-11#1)(2011-2#2)
membrane electrode and##2##3##(2008-10#2)
membrane electrode based on a##2##5##(2008-10#2)
membrane electrode based on##15##4##(2008-10#15)
membrane electrode for##6##3##(2008-10#6)
membrane electrode sensitive to##2##4##(2008-10#2)
membrane electrode was##2##3##(2008-10#2)
membrane electrode##51##2##(2008-10#50)(2010-12#1)
membrane electrodes based on some recently synthesized##2##7##(2008-10#2)
membrane electrodes based on##12##4##(2008-10#12)
membrane electrodes for the##3##4##(2008-10#3)
membrane electrodes were##3##3##(2008-10#3)
membrane electrodes##43##2##(2008-10#43)
membrane electron transport##5##3##(2009-9#5)
membrane electron##7##2##(2009-9#7)
membrane enzyme##2##2##(1991-12#1)(1995-3#1)
membrane fatty acids##2##3##(2008-9#1)(2011-1#1)
membrane fatty##4##2##(2008-9#1)(2011-1#3)
membrane filter##6##2##(2008-10#6)
membrane filters##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
membrane filtration##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
membrane fluidity and##3##3##(1995-11#2)(2008-9#1)
membrane fluidity##7##2##(1991-5#1)(1995-11#2)(1996-12#1)(1997-1#1)(2008-9#2)
membrane folding##2##2##(2008-7#1)(2009-5#1)
membrane for##10##2##(2008-10#8)(2011-2#1)(2013-1#1)
membrane fraction##8##2##(1991-12#1)(1991-5#1)(1993-8#3)(1994-11#1)(2008-11#2)
membrane fractions of the##2##4##(1995-12#1)(2008-11#1)
membrane fractions##10##2##(1990-5#2)(1992-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(2008-11#2)
membrane from the##2##3##(1991-5#1)(2008-11#1)
membrane from##4##2##(1991-5#1)(2008-10#2)(2008-11#1)
membrane fusion##9##2##(2008-10#1)(2008-11#1)(2008-8#3)(2011-3#1)(2012-2#3)
membrane glycoproteins##2##2##(2008-10#1)(2008-11#1)
membrane has been studied##3##4##(2008-10#3)
membrane has been##8##3##(1990-12#1)(2008-10#6)(2008-11#1)
membrane has##10##2##(1990-12#1)(2008-10#8)(2008-11#1)
membrane having##4##2##(2008-10#4)
membrane hyperpolarization and relaxation##2##4##(1997-4#2)
membrane hyperpolarization##3##2##(1994-11#1)(1997-4#2)
membrane in a##3##3##(2008-10#1)(2010-10#1)(2012-2#1)
membrane in the presence##2##4##(1992-12#1)(2008-8#1)
membrane in the##4##3##(1992-12#1)(2008-10#2)(2008-8#1)
membrane in##15##2##(1992-12#1)(1994-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-10#1)(2012-2#1)
membrane incorporating##2##2##(2008-10#2)
membrane inlet mass spectrometric (MIMS)##2##5##(2008-10#2)
membrane inlet mass spectrometric##3##4##(2008-10#3)
membrane inlet mass##4##3##(2008-10#4)
membrane insertion##3##2##(1996-3#2)(2008-11#1)
membrane integrity##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
membrane interface##3##2##(2008-10#2)(2012-2#1)
membrane into an acceptor stream containing##2##6##(2008-10#2)
membrane into an acceptor stream##3##5##(2008-10#3)
membrane into##7##2##(2008-10#4)(2008-7#3)
membrane ion selective electrode##3##4##(2008-10#3)
membrane ion-selective electrodes##2##3##(2008-10#2)
membrane ion-selective##4##2##(2008-10#4)
membrane is described##3##3##(2008-10#3)
membrane is enhanced##2##3##(2008-10#1)(2008-11#1)
membrane is not##2##3##(1990-8#1)(2008-10#1)
membrane is used##2##3##(2008-10#2)
membrane is##17##2##(1990-8#1)(2008-10#13)(2008-11#1)(2009-10#1)(2012-2#1)
membrane layers##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
membrane lipid peroxidation##2##3##(2008-10#1)(2008-8#1)
membrane lipid##10##2##(1995-8#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#4)
membrane lipids##6##2##(1990-2#2)(1991-5#1)(2008-8#3)
membrane markers##3##2##(1995-11#1)(2013-1#2)
membrane material and##2##3##(2008-7#1)(2009-5#1)
membrane materials##2##2##(2008-10#2)
membrane matrix##5##2##(2008-10#3)(2010-4#1)(2012-2#1)
membrane method##3##2##(2008-10#3)
membrane might be derived from pre-karyote##2##6##(2009-6#2)
membrane might##3##2##(1997-8#1)(2009-6#2)
membrane of Escherichia coli was##2##5##(1991-5#1)(2008-10#1)
membrane of Escherichia coli##4##4##(1990-11#1)(1991-10#1)(1991-5#1)(2008-10#1)
membrane of a##3##3##(2008-10#1)(2013-1#2)
membrane of the sperm##2##4##(1994-8#1)(2008-8#1)
membrane of the##16##3##(1990-11#1)(1990-12#2)(1993-8#1)(1994-8#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#3)(2008-9#1)(2012-2#1)
membrane of##57##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#2)(1991-10#1)(1991-5#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-8#1)(1996-2#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-8#2)(2010-11#1)(2010-12#2)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
membrane on the electrode##2##4##(2008-10#2)
membrane on the##3##3##(2008-10#3)
membrane or##5##2##(1992-12#1)(2007-12#1)(2008-10#2)(2008-7#1)
membrane orientation##3##2##(1991-10#1)(1996-3#1)(2009-12#1)
membrane patches##2##2##(1994-11#1)(1997-6#1)
membrane performance##2##2##(2008-10#2)
membrane permeability##9##2##(1990-2#1)(1990-5#1)(1991-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
membrane permeation##2##2##(1991-5#2)
membrane perturbation##3##2##(1995-11#1)(1997-1#2)
membrane phase and##2##3##(2008-10#2)
membrane phase##5##2##(2008-10#5)
membrane phosphatidylserine##2##2##(1995-2#1)(2008-10#1)
membrane phospholipid##2##2##(1995-2#2)
membrane phospholipids##4##2##(1991-5#1)(1994-3#3)
membrane pore##3##2##(2008-11#1)(2008-7#2)
membrane potential and##4##3##(1994-11#1)(1997-1#2)(2008-8#1)
membrane potential##31##2##(1990-12#1)(1990-8#1)(1994-11#2)(1996-2#1)(1997-1#3)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#8)(2009-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
membrane potentials of##2##3##(2008-11#2)
membrane potentials were##2##3##(2008-11#2)
membrane potentials##6##2##(1994-11#1)(2008-11#5)
membrane potentiometric sensor for##3##4##(2008-10#3)
membrane potentiometric sensor##5##3##(2008-10#5)
membrane potentiometric##6##2##(2008-10#6)
membrane preconcentration##2##2##(2008-10#2)
membrane preparation##4##2##(1991-5#2)(1996-2#1)(2008-10#1)
membrane preparations##3##2##(1993-1#1)(1995-6#1)(2008-11#1)
membrane probe##2##2##(1991-5#2)
membrane properties##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
membrane protein in##2##3##(2008-11#1)(2011-2#1)
membrane protein of##7##3##(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-5#1)
membrane protein overexpression in bacteria##2##5##(2011-1#2)
membrane protein overexpression##3##3##(2011-1#3)
membrane protein##35##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1995-12#2)(1995-2#2)(1996-6#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-5#3)(2008-8#4)(2009-7#2)(2011-1#4)(2011-2#3)
membrane proteins and lipids##2##4##(2008-7#1)(2008-8#1)
membrane proteins and##5##3##(1993-8#1)(1995-12#1)(2008-7#1)(2008-8#2)
membrane proteins are##2##3##(2008-4#1)(2009-9#1)
membrane proteins by##3##3##(1993-8#1)(1995-12#1)(2008-11#1)
membrane proteins in##2##3##(2008-10#1)(2011-2#1)
membrane proteins of##3##3##(1995-12#2)(2008-5#1)
membrane proteins under##2##3##(2008-7#2)
membrane proteins with##3##3##(1990-5#1)(1994-11#1)(1995-8#1)
membrane proteins##43##2##(1990-5#3)(1991-2#2)(1992-11#1)(1992-12#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-5#1)(1995-12#5)(1995-2#1)(1995-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-9#1)(2011-1#4)(2011-2#1)(2013-7#1)
membrane receptor##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
membrane receptors that##2##3##(2008-10#1)(2008-7#1)
membrane receptors##6##2##(1991-5#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-7#1)
membrane recycling##4##2##(1997-1#3)(1997-7#1)
membrane redox##2##2##(2009-9#2)
membrane sampler##3##2##(2008-10#3)
membrane samples##3##2##(1994-5#2)(2008-11#1)
membrane sensor based on ethyl-2-benzoyl-2-phenylcarbamoyl acetate##2##6##(2008-10#2)
membrane sensor based on##6##4##(2008-10#6)
membrane sensor for##2##3##(2008-10#2)
membrane sensor##26##2##(2008-10#26)
membrane sensors based on##3##4##(2008-10#3)
membrane sensors for##5##3##(2008-10#5)
membrane sensors##13##2##(2008-10#13)
membrane separation##2##2##(2008-10#2)
membrane showed##2##2##(2008-10#2)
membrane structure##4##2##(1994-3#1)(1994-8#1)(2008-7#1)(2009-7#1)
membrane structures##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
membrane surface area##2##3##(2008-11#1)(2008-7#1)
membrane surface##8##2##(1991-12#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
membrane system##4##2##(1996-3#1)(2008-10#3)
membrane systems##2##2##(2008-10#2)
membrane than##2##2##(1990-5#1)(2008-10#1)
membrane that##5##2##(2008-10#4)(2008-7#1)
membrane thickness##2##2##(2008-10#1)(2009-5#1)
membrane through a##2##3##(1996-3#2)
membrane through##3##2##(1996-3#2)(2009-7#1)
membrane to##7##2##(1990-12#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-5#1)(2011-1#1)
membrane traffic##3##2##(2008-11#3)
membrane transplantation##2##2##(2011-2#2)
membrane transport in##2##3##(1996-2#1)(2008-4#1)
membrane transport of##3##3##(1996-2#2)(2008-10#1)
membrane transport##9##2##(1993-9#1)(1996-2#3)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)
membrane transporter##3##2##(1996-12#3)
membrane type##3##2##(2008-7#2)(2009-3#1)
membrane vesicles prepared from##2##4##(1997-8#1)(2008-11#1)
membrane vesicles##15##2##(1991-9#1)(1993-8#1)(1994-8#1)(1997-3#1)(1997-8#5)(2008-10#1)(2008-11#4)(2008-8#1)
membrane was##17##2##(1991-3#1)(1994-11#2)(2008-10#9)(2008-11#2)(2008-7#1)(2011-2#1)(2013-8#1)
membrane were##16##2##(1990-11#1)(1991-3#1)(1993-3#1)(1994-5#1)(1995-12#1)(2008-10#9)(2008-11#1)(2012-3#1)
membrane which##2##2##(1997-6#1)(2008-10#1)
membrane with a##4##3##(2008-10#4)
membrane with the##3##3##(1991-10#1)(2008-10#2)
membrane with##16##2##(1991-10#1)(1993-8#1)(2008-10#13)(2011-2#1)
membrane##1401##1##(1990-11#4)(1990-12#9)(1990-2#15)(1990-5#22)(1990-8#4)(1991-10#9)(1991-12#5)(1991-2#3)(1991-3#4)(1991-5#20)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#11)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#7)(1993-6#7)(1993-8#18)(1993-9#1)(1994-11#16)(1994-12#1)(1994-3#7)(1994-5#13)(1994-6#2)(1994-8#16)(1995-11#5)(1995-12#12)(1995-2#17)(1995-3#2)(1995-6#21)(1995-8#9)(1996-12#8)(1996-2#11)(1996-3#7)(1996-6#2)(1997-1#10)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#11)(2006-6#3)(2007-12#9)(2008-10#611)(2008-11#88)(2008-12#1)(2008-4#7)(2008-5#15)(2008-6#4)(2008-7#47)(2008-8#41)(2008-9#42)(2009-10#7)(2009-12#1)(2009-3#2)(2009-5#7)(2009-6#11)(2009-7#14)(2009-8#10)(2009-9#24)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#12)(2011-2#28)(2011-3#4)(2012-12#2)(2012-2#25)(2012-3#6)(2012-4#2)(2013-1#12)(2013-7#2)(2013-8#7)
membrane)##8##1##(1997-8#2)(2008-10#5)(2008-9#1)
membrane-anchored##3##1##(2008-11#1)(2008-7#1)(2011-2#1)
membrane-associated##9##1##(1990-8#2)(1991-10#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-6#1)(1997-3#1)
membrane-based electrodes can also be used##2##6##(2008-10#2)
membrane-based optical flow-through sensor##2##4##(2008-10#2)
membrane-based##9##1##(2008-10#9)
membrane-bound and##2##2##(1995-2#1)(2008-6#1)
membrane-bound##25##1##(1990-5#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-7#3)(2009-7#1)(2011-2#1)
membrane-compromised##2##1##(2008-9#2)
membrane-interacting##2##1##(1995-2#1)(2008-10#1)
membrane-spanning domains##3##2##(1995-2#1)(1995-8#1)(1997-7#1)
membrane-spanning##6##1##(1991-12#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-11#2)
membrane-type matrix##2##2##(1997-2#2)
membranes also##2##2##(2008-10#2)
membranes and a##2##3##(1995-6#1)(2008-7#1)
membranes and the##2##3##(2008-10#1)(2008-11#1)
membranes and##24##2##(1990-5#1)(1993-3#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-6#2)(1996-2#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#3)
membranes are##6##2##(1991-5#1)(2008-10#3)(2008-7#1)(2009-8#1)
membranes as a##2##3##(1993-1#1)(2008-10#1)
membranes as##4##2##(1990-5#1)(1992-6#1)(1993-1#1)(2008-10#1)
membranes based on##2##3##(2008-10#2)
membranes by##6##2##(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
membranes containing the##2##3##(2008-10#2)
membranes containing##13##2##(2008-10#13)
membranes during platelet stimulation with thrombin##2##6##(1992-6#2)
membranes during##3##2##(1992-6#2)(2012-2#1)
membranes for the##3##3##(2008-10#3)
membranes for##13##2##(1993-3#1)(2008-10#10)(2008-11#1)(2008-9#1)
membranes from MXT mammary cancer##2##5##(1993-1#2)
membranes from##14##2##(1993-1#3)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-4#1)
membranes has been##2##3##(1990-5#1)(2008-10#1)
membranes have been##2##3##(2008-10#1)(2012-2#1)
membranes have##4##2##(2008-10#2)(2009-6#1)(2012-2#1)
membranes in a concentration-dependent manner##2##5##(1991-6#1)(1993-6#1)
membranes in a##4##3##(1991-10#1)(1991-6#1)(1993-6#1)(2008-10#1)
membranes in order to gain##2##5##(2008-9#2)
membranes in the##4##3##(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#1)
membranes in##17##2##(1991-10#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#2)
membranes is##2##2##(2008-10#2)
membranes isolated from##3##3##(1992-7#1)(1994-3#1)(1997-1#1)
membranes isolated##4##2##(1992-7#1)(1994-3#1)(1997-1#1)(2008-4#1)
membranes leading to##2##3##(2008-10#1)(2008-11#1)
membranes obtained##2##2##(1990-8#1)(2008-10#1)
membranes of different##3##3##(2008-10#2)(2008-11#1)
membranes of rat##2##3##(1990-5#1)(1995-2#1)
membranes of the##3##3##(2008-10#2)(2008-7#1)
membranes of##23##2##(1990-5#2)(1992-12#1)(1993-1#1)(1994-11#1)(1995-2#1)(1996-9#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-7#1)(2010-10#1)
membranes or##4##2##(1992-9#1)(1994-5#2)(1995-11#1)
membranes plasticized with##2##3##(2008-10#2)
membranes prepared by##2##3##(2008-11#2)
membranes prepared from##3##3##(1991-5#1)(1995-11#1)(2008-11#1)
membranes prepared##6##2##(1991-5#1)(1995-11#1)(2008-11#4)
membranes showed##2##2##(1991-5#1)(2008-10#1)
membranes that are##2##3##(2008-11#1)(2009-8#1)
membranes that##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-7#1)
membranes the##2##2##(2008-10#2)
membranes to##3##2##(1991-5#1)(2008-11#1)(2009-8#1)
membranes using##4##2##(1993-6#1)(1995-11#1)(1996-2#1)(2008-10#1)
membranes was also##2##3##(1997-1#1)(1997-4#1)
membranes was##14##2##(1992-3#1)(1993-3#1)(1993-6#1)(1995-12#1)(1997-1#1)(1997-4#2)(1997-7#1)(2008-10#3)(2008-11#2)(2008-9#1)
membranes were examined##2##3##(1993-6#1)(2008-10#1)
membranes were investigated##2##3##(1991-5#1)(2008-7#1)
membranes were prepared by##2##4##(2008-10#2)
membranes were prepared##3##3##(1997-4#1)(2008-10#2)
membranes were tested##2##3##(2008-10#1)(2008-7#1)
membranes were##18##2##(1991-5#1)(1993-6#1)(1993-8#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-7#2)(2011-2#1)
membranes with EGF##2##3##(1993-3#2)
membranes with a##2##3##(1995-11#1)(2008-10#1)
membranes with the##2##3##(1992-7#1)(2008-7#1)
membranes with##19##2##(1992-12#1)(1992-3#1)(1992-7#2)(1993-3#3)(1993-6#1)(1994-3#2)(1995-11#2)(1995-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#1)
membranes without##2##2##(2008-10#1)(2011-2#1)
membranes##434##1##(1990-12#1)(1990-2#1)(1990-5#12)(1990-8#3)(1991-10#3)(1991-3#1)(1991-5#11)(1991-6#2)(1992-12#3)(1992-3#3)(1992-6#4)(1992-7#3)(1992-9#3)(1993-1#7)(1993-3#10)(1993-5#1)(1993-6#11)(1993-8#4)(1993-9#1)(1994-11#5)(1994-3#7)(1994-5#12)(1994-8#5)(1995-11#13)(1995-12#2)(1995-2#6)(1995-6#8)(1995-8#5)(1996-12#1)(1996-2#3)(1996-6#1)(1996-9#1)(1997-1#6)(1997-2#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#150)(2008-11#38)(2008-4#5)(2008-5#1)(2008-7#17)(2008-8#4)(2008-9#8)(2009-10#1)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-6#2)(2010-7#2)(2011-2#6)(2012-2#7)(2012-3#4)(2013-1#3)
membranes)##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
membranes]##2##1##(1996-9#1)(2011-1#1)
membranoproliferative glomerulonephritis##5##2##(2012-2#3)(2013-1#1)(2013-8#1)
membranoproliferative##6##1##(2012-2#3)(2013-1#1)(2013-8#2)
membranous glomerulopathy##2##2##(2008-1#1)(2013-8#1)
membranous lipodystrophy##3##2##(2010-6#3)
membranous##15##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-3#1)(2010-6#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
memo##3##1##(1995-6#1)(1996-5#1)(2008-8#1)
memorial lecture##2##2##(2008-9#1)(2009-5#1)
memorial##3##1##(2008-9#1)(2009-5#1)(2010-1#1)
memories##9##1##(1995-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-11#1)(2013-8#1)
memorize##4##1##(2008-6#4)
memorized color cues##2##3##(2008-6#2)
memory CD4+ and CD8+##2##4##(1995-12#2)
memory and swim speed##4##4##(2008-12#4)
memory and##11##2##(1991-10#1)(1993-12#1)(2008-11#1)(2008-12#4)(2008-6#1)(2009-8#1)(2011-2#1)(2013-8#1)
memory effect##5##2##(2008-10#2)(2008-7#2)(2009-7#1)
memory for the##2##3##(2008-11#2)
memory for##4##2##(2008-11#3)(2008-9#1)
memory formation is##2##3##(2009-6#1)(2009-8#1)
memory formation##11##2##(1994-8#2)(1997-2#1)(2008-7#2)(2009-6#2)(2009-8#4)
memory function##2##2##(1997-4#1)(2008-9#1)
memory group##3##2##(2008-12#3)
memory in the##6##3##(1991-2#1)(1993-3#1)(2008-11#1)(2009-8#1)(2012-2#2)
memory in##15##2##(1991-2#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#4)(2011-2#1)(2012-2#3)(2012-3#1)
memory is##4##2##(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
memory of colors##2##3##(2008-6#2)
memory of##7##2##(1991-12#1)(1992-5#1)(2008-10#1)(2008-6#3)(2009-11#1)
memory on the##2##3##(2011-2#2)
memory performance##7##2##(1994-8#1)(2008-12#4)(2008-7#1)(2012-3#1)
memory processes##3##2##(2008-11#1)(2009-10#2)
memory requirements##2##2##(2008-3#1)(2008-4#1)
memory self-efficacy##6##2##(2008-12#6)
memory system##6##2##(2008-3#5)(2008-6#1)
memory tasks##2##2##(1993-3#1)(2011-2#1)
memory that##2##2##(1993-3#1)(2008-6#1)
memory##224##1##(1991-10#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-12#2)(1993-3#9)(1994-3#1)(1994-8#6)(1995-12#3)(1995-5#3)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#10)(2008-11#19)(2008-12#25)(2008-2#1)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#7)(2008-7#21)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#7)(2009-11#1)(2009-6#4)(2009-7#4)(2009-8#13)(2009-9#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#16)(2012-3#6)(2013-1#2)(2013-8#11)
memory&quot##2##1##(2009-8#1)(2012-2#1)
memory)##6##1##(1993-3#2)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
men (n =##3##3##(2008-12#1)(2011-2#1)(2013-8#1)
men about##2##2##(1996-11#1)(2009-5#1)
men after a##2##3##(1996-1#1)(2012-3#1)
men aged 40-59##2##3##(2008-7#2)
men aged##12##2##(1990-6#1)(1991-6#2)(1997-5#1)(1997-8#1)(2008-7#4)(2009-10#1)(2009-5#2)
men and 8##2##3##(2011-2#1)(2013-1#1)
men and boys##2##3##(2009-10#1)(2013-8#1)
men and in##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
men and women with##2##4##(1995-3#1)(2010-10#1)
men and women##34##3##(1993-2#2)(1995-12#1)(1995-3#1)(1996-6#1)(1996-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-12#2)(2013-1#2)(2013-8#3)
men and##82##2##(1990-12#1)(1990-8#1)(1991-6#2)(1992-9#2)(1993-2#2)(1994-12#2)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-8#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-5#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#11)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#7)(2013-8#5)
men as##2##2##(1991-8#1)(2009-12#1)
men by##4##2##(2008-12#2)(2011-2#2)
men did##2##2##(1992-2#1)(2013-8#1)
men drank##2##2##(2008-1#2)
men free of##2##3##(1991-7#1)(2008-3#1)
men had##3##2##(1996-11#1)(1996-6#1)(2013-1#1)
men has##2##2##(2008-10#1)(2009-5#1)
men have##4##2##(1991-11#1)(1996-11#1)(2009-5#1)(2010-6#1)
men in Norway##2##3##(1995-2#1)(1996-11#1)
men in Okinawa##3##3##(2008-10#3)
men in the##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-10#1)(2011-2#1)
men in##24##2##(1990-2#1)(1990-6#1)(1995-2#1)(1996-11#2)(1997-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-5#5)(2010-10#1)(2011-2#2)(2013-8#1)
men increased##2##2##(1996-3#1)(2008-10#1)
men need##2##2##(1995-9#1)(2010-10#1)
men of the##2##3##(1991-8#1)(2008-3#1)
men of##5##2##(1991-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-5#1)
men presenting with##2##3##(2008-5#1)(2011-2#1)
men to##5##2##(2008-12#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-10#1)
men undergoing AS##3##3##(2010-10#3)
men undergoing active surveillance for prostate cancer##2##7##(2009-5#1)(2010-10#1)
men undergoing active surveillance##3##4##(2009-5#1)(2010-10#2)
men undergoing##6##2##(2009-5#1)(2010-10#5)
men were recruited##2##3##(2008-1#1)(2008-4#1)
men were##7##2##(1991-8#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)
men who had##4##3##(1996-11#1)(1996-6#1)(2009-5#1)(2010-10#1)
men who have sex with men (MSM)##3##7##(2009-5#2)(2011-2#1)
men who have sex with men##7##6##(1996-5#1)(2009-5#5)(2011-2#1)
men who have##9##3##(1996-5#1)(2009-5#6)(2010-10#1)(2011-2#1)
men who##17##2##(1996-11#1)(1996-5#1)(1996-6#1)(2008-3#1)(2009-5#8)(2010-10#2)(2010-7#1)(2011-2#2)
men with prostate cancer##5##4##(2008-7#1)(2009-5#4)
men with##17##2##(1990-11#1)(1991-7#3)(1992-3#1)(1997-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#4)(2009-9#1)(2013-1#2)(2013-8#1)
men without##2##2##(2009-5#2)
men##380##1##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-6#4)(1990-8#1)(1991-11#5)(1991-12#3)(1991-6#6)(1991-7#4)(1991-8#7)(1992-2#1)(1992-3#4)(1992-9#3)(1993-2#3)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#11)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#6)(2007-7#1)(2007-8#2)(2008-1#11)(2008-10#16)(2008-11#13)(2008-12#22)(2008-3#4)(2008-4#7)(2008-5#7)(2008-7#11)(2008-9#2)(2009-10#9)(2009-11#2)(2009-12#7)(2009-3#1)(2009-5#59)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#14)(2010-12#2)(2010-4#2)(2010-6#3)(2010-7#1)(2010-9#2)(2011-2#37)(2011-3#1)(2011-7#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#16)(2013-8#20)
men's health##2##2##(2009-5#2)
men's perceptions and##3##3##(2008-1#2)(2008-11#1)
men's perceptions##5##2##(2008-1#2)(2008-11#2)(2009-5#1)
men's##12##1##(2008-1#2)(2008-11#2)(2009-5#7)(2010-10#1)
men) with##2##2##(1996-1#1)(1996-6#1)
men)##8##1##(1991-6#1)(1996-1#1)(1996-6#1)(2007-8#1)(2008-1#1)(2010-6#1)(2011-2#1)(2013-8#1)
men]##4##1##(1990-3#1)(1991-8#1)(1993-3#1)(2009-10#1)
menace##2##1##(2013-1#1)(2013-8#1)
menadione##3##1##(1995-8#2)(2008-10#1)
menadione-catalyzed H(2)O(2) production assay is##2##5##(2008-11#2)
menadione-catalyzed H(2)O(2) production assay##3##4##(2008-11#3)
menadione-catalyzed H(2)O(2) production##4##3##(2008-11#4)
menadione-catalyzed##7##1##(2008-11#7)
menin##4##1##(2008-11#4)
meningeal melanocytoma##2##2##(2008-7#2)
meningeal##14##1##(1990-2#1)(1996-11#1)(1996-9#2)(2008-12#2)(2008-7#7)(2009-11#1)
meninges##3##1##(2008-7#1)(2008-8#1)(2012-3#1)
meningioma is##2##2##(2008-7#2)
meningioma of the##2##3##(2008-7#1)(2011-2#1)
meningioma##15##1##(2008-7#8)(2010-11#1)(2011-2#4)(2012-12#1)(2013-1#1)
meningiomas##7##1##(2008-7#4)(2011-2#3)
meningitic E##2##2##(2009-12#2)
meningitidis was##2##2##(2008-12#2)
meningitidis##19##1##(1993-12#3)(2006-5#1)(2008-12#8)(2009-7#1)(2010-12#1)(2010-8#1)(2013-1#4)
meningitis and##5##2##(1993-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
meningitis caused by##4##3##(2009-11#1)(2009-12#1)(2011-2#1)(2013-8#1)
meningitis from##2##2##(2008-9#1)(2013-7#1)
meningitis has##2##2##(1996-3#1)(2011-2#1)
meningitis in children##3##3##(2008-11#1)(2013-7#2)
meningitis in##8##2##(1993-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-7#3)
meningitis is a##2##3##(2010-12#1)(2011-2#1)
meningitis was##3##2##(2008-1#1)(2008-12#1)(2009-12#1)
meningitis who##2##2##(1996-3#1)(2008-10#1)
meningitis##66##1##(1990-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1995-8#1)(1996-3#3)(1997-5#2)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#2)(2008-7#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#4)(2009-6#1)(2010-12#4)(2011-2#14)(2012-3#1)(2013-7#7)(2013-8#1)
meningococcal##5##1##(2013-1#5)
meniscal##6##1##(1993-11#3)(2008-10#1)(2012-2#1)(2013-1#1)
meniscectomy##3##1##(2008-8#1)(2013-1#2)
menisci##2##1##(2013-1#2)
meniscus repair and anterior cruciate ligament reconstruction##3##7##(2013-1#3)
meniscus##10##1##(1990-9#1)(1993-11#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#5)
menopausal status##5##2##(1993-1#1)(1993-11#1)(1993-2#1)(1997-7#1)(2010-10#1)
menopausal transition##2##2##(2008-11#1)(2012-3#1)
menopausal women##2##2##(2008-11#1)(2009-5#1)
menopausal##13##1##(1993-1#1)(1993-11#1)(1993-2#1)(1997-7#1)(2007-7#2)(2008-11#2)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-3#1)
menopause duration##4##2##(2011-2#4)
menopause in women##2##3##(2008-12#1)(2010-12#1)
menopause##11##1##(1991-11#1)(1994-12#1)(1997-6#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#5)
menstrual cycle##8##2##(1990-12#1)(1995-11#1)(2008-4#1)(2012-2#3)(2012-3#2)
menstrual period##2##2##(2008-7#1)(2011-2#1)
menstrual##17##1##(1990-12#1)(1993-2#1)(1995-11#2)(2008-4#2)(2008-7#1)(2010-11#1)(2011-2#2)(2012-2#5)(2012-3#2)
menstruation##5##1##(1991-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
menstruum##2##1##(2011-2#2)
mensuration##3##1##(1995-5#2)(2008-10#1)
ment##2##1##(2008-11#2)
mental and physical health##2##4##(1996-9#1)(2009-5#1)
mental and physical##4##3##(1996-9#1)(2009-5#1)(2010-1#2)
mental and spiritual##2##3##(2008-12#2)
mental and##10##2##(1993-12#1)(1995-5#1)(1996-9#1)(2008-12#2)(2009-5#1)(2010-1#2)(2010-7#1)(2012-3#1)
mental development##3##2##(1991-2#1)(1994-3#1)(2008-8#1)
mental disability##2##2##(1990-6#1)(1995-12#1)
mental disorder##3##2##(1991-1#1)(2010-12#1)(2012-2#1)
mental disorders and##3##3##(2010-4#3)
mental disorders##9##2##(1991-2#1)(2008-11#1)(2009-10#1)(2010-4#5)(2010-5#1)
mental health and substance abuse##3##5##(1996-12#1)(1997-2#1)(2012-2#1)
mental health and##13##3##(1992-2#1)(1993-3#1)(1994-12#2)(1996-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
mental health as##2##3##(1995-2#1)(2010-2#1)
mental health care and##2##4##(1994-1#1)(2013-1#1)
mental health care is##2##4##(2008-11#1)(2013-1#1)
mental health care##11##3##(1991-3#1)(1994-1#1)(1994-3#1)(1996-12#2)(1997-3#1)(2008-11#1)(2012-3#1)(2013-1#3)
mental health consumers who##2##4##(1995-1#2)
mental health consumers##4##3##(1995-1#3)(2008-12#1)
mental health disorders among##2##4##(2008-11#2)
mental health disorders##7##3##(2008-11#3)(2013-8#4)
mental health in##3##3##(1996-1#1)(2012-12#1)(2013-1#1)
mental health is##2##3##(1992-1#1)(2009-10#1)
mental health issues##5##3##(2008-11#2)(2008-12#2)(2010-1#1)
mental health legislation##2##3##(1994-1#2)
mental health needs of##2##4##(2008-11#1)(2010-10#1)
mental health needs##4##3##(1997-2#1)(2008-11#2)(2010-10#1)
mental health nurses##11##3##(2008-11#3)(2008-12#3)(2009-6#2)(2010-5#3)
mental health nursing practice##2##4##(2008-11#2)
mental health nursing students##2##4##(2008-11#1)(2008-12#1)
mental health nursing##10##3##(2008-11#6)(2008-12#3)(2009-6#1)
mental health of##2##3##(2008-12#1)(2010-1#1)
mental health policy##2##3##(1992-1#2)
mental health problems in##3##4##(1992-2#1)(1993-1#1)(1997-5#1)
mental health problems##17##3##(1992-1#1)(1992-2#2)(1993-1#3)(1993-3#1)(1996-1#3)(1997-3#1)(1997-5#1)(2008-11#5)
mental health professionals##10##3##(1991-1#1)(1994-1#4)(2008-11#3)(2009-9#2)
mental health profiles##2##3##(1992-1#1)(2008-11#1)
mental health promotion##4##3##(2008-11#1)(2010-12#2)(2013-1#1)
mental health providers##2##3##(1996-3#2)
mental health risk##2##3##(2009-9#1)(2012-3#1)
mental health service delivery##3##4##(1992-1#1)(1992-3#1)(2008-11#1)
mental health service##9##3##(1991-3#1)(1992-1#1)(1992-3#1)(2008-11#3)(2008-12#2)(2013-1#1)
mental health services in##2##4##(1996-3#1)(2008-11#1)
mental health services##13##3##(1992-3#1)(1994-1#2)(1996-12#1)(1996-3#4)(1997-1#1)(2008-11#2)(2008-12#1)(2013-1#1)
mental health status##2##3##(2010-2#2)
mental health system##3##3##(1994-1#2)(1997-3#1)
mental health##232##2##(1991-1#1)(1991-3#4)(1992-1#10)(1992-2#5)(1992-3#4)(1993-1#5)(1993-2#1)(1993-3#2)(1994-1#16)(1994-12#2)(1994-3#1)(1995-1#4)(1995-2#3)(1996-1#7)(1996-12#4)(1996-3#6)(1997-1#1)(1997-2#5)(1997-3#8)(1997-4#1)(1997-5#2)(2008-10#1)(2008-11#41)(2008-12#26)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-5#3)(2009-6#4)(2009-9#4)(2010-1#2)(2010-10#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#16)(2013-8#7)
mental healthcare##5##2##(1991-3#1)(1992-1#1)(1992-2#2)(1993-2#1)
mental hospital##2##2##(1996-9#1)(2012-3#1)
mental illness and##2##3##(2009-10#1)(2012-3#1)
mental illness in##2##3##(1993-5#1)(2012-3#1)
mental illness##25##2##(1993-5#1)(1994-2#1)(1996-1#1)(2008-11#2)(2008-12#4)(2008-4#1)(2009-10#1)(2009-6#3)(2011-1#6)(2011-3#1)(2012-3#3)(2013-1#1)
mental illnesses##3##2##(1991-1#1)(1993-1#1)(2012-2#1)
mental impairments##2##2##(1991-3#1)(1997-2#1)
mental processes##3##2##(2013-8#3)
mental representations of sex-typed bodies##2##5##(2013-8#2)
mental representations of##5##3##(2013-8#5)
mental representations##7##2##(2012-2#1)(2013-8#6)
mental retardation and##2##3##(1993-3#1)(1995-2#1)
mental retardation or##2##3##(1993-3#1)(1997-3#1)
mental retardation##15##2##(1993-3#5)(1995-1#2)(1995-2#1)(1996-9#1)(1997-3#1)(1997-8#2)(2010-7#1)(2010-8#1)(2011-1#1)
mental rotation##3##2##(1996-2#2)(2008-11#1)
mental state##2##2##(1993-11#1)(2008-7#1)
mental states##3##2##(2008-11#1)(2008-7#2)
mental status##3##2##(2010-10#1)(2012-12#1)(2013-1#1)
mental time travel##3##3##(2013-8#3)
mental well-being and##3##3##(1991-8#2)(2010-7#1)
mental well-being##7##2##(1991-8#6)(2010-7#1)
mental work##3##2##(2010-6#1)(2012-2#2)
mental##388##1##(1990-6#1)(1991-1#3)(1991-12#1)(1991-2#2)(1991-3#6)(1991-8#8)(1992-1#11)(1992-2#7)(1992-3#4)(1993-1#6)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#7)(1993-5#1)(1994-1#16)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#7)(1995-12#1)(1995-2#5)(1995-5#3)(1996-1#8)(1996-12#4)(1996-2#2)(1996-3#6)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#9)(1997-4#2)(1997-5#2)(1997-8#2)(2008-10#2)(2008-11#48)(2008-12#32)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#6)(2009-11#2)(2009-3#2)(2009-5#4)(2009-6#8)(2009-8#1)(2009-9#4)(2010-1#4)(2010-10#2)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#8)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#9)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#10)(2012-3#19)(2013-1#19)(2013-8#23)
mentalizing##2##1##(2008-11#2)
mentally ill patients##2##3##(1992-3#1)(1996-9#1)
mentally ill##18##2##(1990-2#1)(1992-1#2)(1992-3#3)(1994-2#3)(1995-2#2)(1996-1#1)(1996-9#1)(1997-2#1)(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
mentally retarded patients##2##3##(1997-8#2)
mentally retarded##11##2##(1991-1#2)(1991-6#2)(1993-1#2)(1997-8#5)
mentally strenuous##2##2##(2013-1#2)
mentally##45##1##(1990-2#2)(1991-1#2)(1991-6#2)(1992-1#2)(1992-3#3)(1993-1#2)(1994-1#4)(1994-12#1)(1994-2#3)(1995-11#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-8#6)(2008-12#1)(2009-7#1)(2010-6#1)(2011-2#4)(2013-1#3)(2013-8#1)
menthol##3##1##(2008-10#2)(2008-11#1)
menthone##5##1##(2008-10#4)(2008-11#1)
menthyl acetate##2##2##(2008-10#2)
mention of##3##2##(2009-9#1)(2013-1#2)
mention the##2##2##(1995-2#1)(2011-2#1)
mention##11##1##(1990-3#1)(1992-1#1)(1995-2#1)(1996-8#1)(2009-10#1)(2009-9#1)(2011-2#3)(2013-1#2)
mentioned above##4##2##(1993-9#1)(2008-10#2)(2008-8#1)
mentioned in##3##2##(1992-6#1)(2008-11#1)(2008-7#1)
mentioned##69##1##(1990-9#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2010-6#2)(2011-1#2)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#1)
mentioning##3##1##(2008-10#1)(2010-7#1)(2011-2#1)
mentor and##2##2##(2008-11#1)(2008-7#1)
mentor in##2##2##(2008-11#2)
mentor is a##2##3##(1993-12#1)(2008-7#1)
mentor##24##1##(1993-12#1)(2008-11#10)(2008-12#2)(2008-7#10)(2008-9#1)
mentor's##2##1##(2008-7#2)
mentoring##5##1##(1997-2#1)(2008-11#1)(2008-9#3)
mentors to##2##2##(2008-11#2)
mentors##6##1##(2008-1#1)(2008-11#4)(2010-2#1)
mentorship##7##1##(1993-12#1)(2008-11#4)(2008-7#1)(2009-4#1)
menu mode##4##2##(1991-12#4)
menu##5##1##(1991-12#4)(2008-9#1)
menuing software##2##2##(1991-12#2)
menus##3##1##(1991-12#1)(2008-10#1)(2012-2#1)
menziesii)##2##1##(2008-10#2)
meperidine intrathecally##2##2##(2011-2#2)
meperidine##5##1##(1995-11#1)(2011-2#4)
meq of Cl(-) per##2##4##(2008-10#2)
meq##5##1##(2008-10#5)
mequitazine and##3##2##(2008-10#3)
mequitazine in human plasma##3##4##(2008-10#3)
mequitazine##7##1##(2008-10#7)
mer)##5##1##(2008-10#3)(2008-11#2)
mercaptans##5##1##(2008-10#3)(2008-6#2)
mercapto##6##1##(2008-10#5)(2008-8#1)
mercaptoacetic##2##1##(2008-10#2)
mercaptopicolinate##3##1##(1995-8#3)
merchant seamen##4##2##(1991-12#4)
merchant##6##1##(1991-12#5)(2008-11#1)
mercuric chloride##4##2##(1990-5#1)(2008-10#1)(2008-7#2)
mercuric##10##1##(1990-5#1)(2006-6#1)(2008-10#6)(2008-7#2)
mercury (Hg(2+)) and##2##3##(2008-10#2)
mercury (Hg)##2##2##(2006-6#1)(2008-10#1)
mercury (II) in##2##3##(2008-10#2)
mercury (II)##7##2##(2008-10#7)
mercury after##2##2##(2008-10#2)
mercury and##9##2##(1995-2#2)(2008-10#7)
mercury are##3##2##(1994-3#1)(2008-10#2)
mercury at##3##2##(2008-10#3)
mercury by solid##2##3##(2008-10#2)
mercury by##11##2##(2008-10#11)
mercury complex##2##2##(2008-10#2)
mercury compounds in water samples##2##5##(2008-10#2)
mercury containing##2##2##(2008-10#2)
mercury cycle##2##2##(2008-10#2)
mercury determination by##3##3##(2008-10#3)
mercury determination in##2##3##(2008-10#2)
mercury determination##8##2##(2008-10#8)
mercury determinations##2##2##(2008-10#2)
mercury drop electrode was##5##4##(2008-10#5)
mercury drop electrode##54##3##(2008-10#54)
mercury drop electrodes##2##3##(2008-10#2)
mercury drop##57##2##(2008-10#57)
mercury electrode and##6##3##(2008-10#6)
mercury electrode at##2##3##(2008-10#2)
mercury electrode##30##2##(1990-5#2)(2008-10#28)
mercury electrodes##4##2##(2008-10#4)
mercury extraction from##2##3##(2008-10#2)
mercury film electrode (MFE)##3##4##(2008-10#3)
mercury film electrode##9##3##(2008-10#9)
mercury film electrodes for the##2##5##(2008-10#2)
mercury film electrodes##8##3##(2008-10#8)
mercury film on##2##3##(2008-10#2)
mercury film##24##2##(2008-10#24)
mercury in biological samples##2##4##(2008-10#2)
mercury in biological##3##3##(2008-10#3)
mercury in environmental##2##3##(2008-10#2)
mercury in natural##2##3##(2008-10#2)
mercury in the##3##3##(2008-10#3)
mercury in##35##2##(2008-10#35)
mercury ions##13##2##(2008-10#13)
mercury is##5##2##(2008-10#5)
mercury lamp##2##2##(2008-10#2)
mercury prior to##2##3##(2008-10#2)
mercury ranging##2##2##(2008-10#2)
mercury species are##2##3##(2008-10#2)
mercury species##14##2##(2008-10#14)
mercury standard##2##2##(2008-10#2)
mercury surface##3##2##(1990-5#1)(2008-10#2)
mercury thin film electrodes##4##4##(2008-10#4)
mercury thiocyanate##2##2##(2008-10#2)
mercury vapour##3##2##(2008-10#3)
mercury was determined##2##3##(2008-10#2)
mercury was##6##2##(2008-10#6)
mercury were##3##2##(2008-10#3)
mercury##373##1##(1990-5#3)(1992-11#2)(1994-3#1)(1995-2#2)(1996-3#1)(2006-6#1)(2007-12#1)(2008-10#356)(2008-11#1)(2008-3#2)(2008-7#1)(2009-12#1)(2013-1#1)
mercury(II) and lead(II)##4##3##(2008-10#4)
mercury(II) and methylmercury##2##3##(2008-10#2)
mercury(II) and##7##2##(2008-10#7)
mercury(II) by##6##2##(2008-10#6)
mercury(II) in aqueous##2##3##(2008-10#2)
mercury(II) in##5##2##(2008-10#5)
mercury(II) ion-selective electrode##2##3##(2008-10#2)
mercury(II) ions##3##2##(2008-10#3)
mercury(II) was##2##2##(2008-10#2)
mercury(II) were also##2##3##(2008-10#2)
mercury(II)##46##1##(2008-10#46)
mercury)##2##1##(2008-10#2)
mercury-film##3##1##(2008-10#3)
mercury-free##2##1##(2008-10#2)
mercury-producing plant##2##2##(1996-3#2)
mercy##4##1##(1993-5#1)(2008-6#1)(2008-8#2)
mere##10##1##(1995-8#1)(2008-11#1)(2009-6#2)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
merely foreseen##2##2##(2012-2#2)
merely##18##1##(1990-5#1)(1990-8#2)(1994-12#2)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
merge with##2##2##(1996-1#1)(2009-9#1)
merge##8##1##(1992-8#1)(1993-12#1)(1996-1#2)(2007-12#1)(2008-10#1)(2008-4#1)(2009-9#1)
merged streams of##2##3##(2008-10#2)
merged with a##6##3##(2008-10#6)
merged with an##2##3##(2008-10#2)
merged with the origin of the##2##6##(2012-2#2)
merged with the##5##3##(2008-10#3)(2012-2#2)
merged with##20##2##(1993-3#1)(2008-10#16)(2011-2#1)(2012-2#2)
merged##27##1##(1993-3#1)(2008-10#22)(2011-2#2)(2012-2#2)
merger##12##1##(1991-9#1)(1992-8#1)(1993-12#2)(1993-5#2)(1995-3#1)(1996-3#2)(2008-11#2)(2012-2#1)
mergers##2##1##(1991-9#1)(2008-12#1)
merges with the##2##3##(2008-10#2)
merges with##4##2##(2008-10#4)
merges##7##1##(2008-10#4)(2009-10#1)(2013-1#1)(2013-8#1)
merging the##2##2##(1996-2#1)(2008-10#1)
merging with##2##2##(2008-1#1)(2008-11#1)
merging zones##4##2##(2008-10#4)
merging##17##1##(1991-1#1)(1991-3#1)(1995-2#2)(1996-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-10#1)(2013-1#1)
merging-zones##2##1##(2008-10#2)
meridian##10##1##(2008-9#9)(2011-2#1)
meridians##3##1##(2008-9#1)(2010-7#2)
meridionalis and D##3##3##(2008-10#3)
meridionalis but##2##2##(2008-10#2)
meridionalis##16##1##(2008-10#16)
meristem and the##2##3##(1997-8#1)(2009-8#1)
meristem##14##1##(1997-8#1)(2008-10#1)(2008-12#4)(2008-8#1)(2009-8#7)
meristems##4##1##(2008-8#1)(2008-9#1)(2009-8#2)
merit and##4##2##(2008-10#4)
merit as##3##2##(2008-10#2)(2013-8#1)
merit further##2##2##(2011-2#1)(2012-3#1)
merit of the method##2##4##(2008-10#2)
merit of the##8##3##(2008-10#8)
merit of##9##2##(2008-10#9)
merit##41##1##(1991-1#1)(1992-8#1)(1997-1#1)(2008-10#31)(2008-3#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
merits and demerits of##2##4##(2008-10#2)
merits and##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2013-1#1)
merits of these##2##3##(2008-3#1)(2010-12#1)
merits of this##2##3##(2008-10#1)(2008-4#1)
merits of##13##2##(1992-9#1)(1993-1#1)(1993-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2010-12#1)(2011-2#1)
merits##27##1##(1992-1#1)(1992-9#1)(1993-1#1)(1993-2#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
meropenem##2##1##(2008-7#2)
mersalyl##4##1##(1994-8#4)
mesalazine##3##1##(2010-11#3)
mesangial cells##11##2##(1992-6#2)(1993-8#3)(1995-11#2)(2008-1#1)(2011-2#3)
mesangial##14##1##(1992-6#2)(1993-8#3)(1995-11#2)(1996-6#1)(1997-8#1)(2008-1#1)(2011-2#4)
mesencephalic##8##1##(1990-9#1)(1994-2#1)(1996-2#3)(1997-2#1)(2008-7#2)
mesencephalon##2##1##(1996-12#1)(2008-7#1)
mesenchymal and epithelial##2##3##(1994-5#1)(2013-1#1)
mesenchymal cell##3##2##(1991-5#1)(1994-5#1)(2008-11#1)
mesenchymal cells inhibited from undergoing##2##5##(1994-11#2)
mesenchymal cells##8##2##(1994-11#4)(2008-11#2)(2008-6#1)(2011-2#1)
mesenchymal elements##2##2##(2011-2#1)(2012-3#1)
mesenchymal neoplasms##2##2##(2012-3#1)(2013-1#1)
mesenchymal progenitor cells##4##3##(2008-11#4)
mesenchymal stem cell population##2##4##(2008-11#2)
mesenchymal stem cell##6##3##(2008-11#3)(2010-10#1)(2011-2#1)(2012-5#1)
mesenchymal stem cells (MSCs) to##2##5##(2008-11#1)(2010-8#1)
mesenchymal stem cells (MSCs)##4##4##(2008-11#2)(2008-9#1)(2010-8#1)
mesenchymal stem cells##23##3##(2008-11#7)(2008-9#6)(2009-10#1)(2010-12#2)(2010-3#1)(2010-8#2)(2012-4#1)(2013-1#3)
mesenchymal stem##29##2##(2008-11#10)(2008-9#6)(2009-10#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#1)(2012-4#1)(2012-5#1)(2013-1#3)
mesenchymal tumor##3##2##(1994-5#1)(2010-6#1)(2013-1#1)
mesenchymal tumors##5##2##(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
mesenchymal##71##1##(1990-5#1)(1991-5#1)(1994-11#4)(1994-5#3)(2008-10#1)(2008-11#20)(2008-6#2)(2008-9#7)(2009-1#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#10)(2012-12#1)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#7)
mesenchyme##12##1##(1993-3#1)(1995-8#2)(2008-11#5)(2008-6#3)(2010-6#1)
mesenchymes##2##1##(2008-6#2)
mesendoblast##2##1##(2007-12#2)
mesenterial##2##1##(2012-3#2)
mesenteric arteries##3##2##(1992-3#2)(2008-11#1)
mesenteric artery dissection##2##3##(2013-1#2)
mesenteric artery##12##2##(1991-6#2)(1992-3#1)(2008-11#1)(2013-1#7)(2013-8#1)
mesenteric fibromatosis##2##2##(1994-5#2)
mesenteric ischemia##2##2##(2008-11#2)
mesenteric lymph node##2##3##(1993-2#1)(2008-5#1)
mesenteric lymph nodes##2##3##(1996-12#1)(2008-11#1)
mesenteric lymph##4##2##(1993-2#1)(1996-12#1)(2008-11#1)(2008-5#1)
mesenteric##35##1##(1991-6#2)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-2#1)(1994-5#3)(1996-12#1)(1997-8#1)(2008-11#5)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
mesenteritis##2##1##(1992-5#1)(2011-2#1)
mesenteron##5##1##(2008-7#5)
mesentery in##2##2##(1990-8#1)(2011-2#1)
mesentery##13##1##(1990-5#1)(1990-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
mesentery-derived mesothelial cells##2##3##(2008-11#2)
mesentery-derived##4##1##(2008-11#4)
mesh and##2##2##(2008-11#1)(2011-2#1)
mesh size##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
mesh##26##1##(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#4)(2009-7#1)(2010-11#1)(2010-6#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
mesh)##2##1##(2008-10#2)
meshes##4##1##(2009-7#4)
meshwork##3##1##(2007-12#1)(2008-7#2)
mesial##5##1##(1995-5#2)(2012-12#3)
meso##3##1##(1994-5#1)(2009-5#2)
meso-##2##1##(2008-10#1)(2010-7#1)
meso-2##3##1##(1992-12#3)
meso-fluidic##2##1##(2008-10#2)
meso-nitrogen##2##1##(2008-10#2)
meso-tetrakis##4##1##(2008-10#3)(2008-3#1)
mesocarp and##3##2##(2008-10#3)
mesocarp##6##1##(2008-10#6)
mesocosm period##2##2##(2010-8#2)
mesocosm##3##1##(2008-8#1)(2010-8#2)
mesocosms to##2##2##(2008-8#2)
mesocosms##5##1##(2008-8#3)(2010-8#2)
mesoderm##10##1##(1993-12#1)(1994-12#2)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-7#1)
mesodermal##2##1##(1993-12#1)(2013-1#1)
mesolimbic dopaminergic##2##2##(1995-2#1)(2009-8#1)
mesolimbic##5##1##(1991-1#1)(1993-6#1)(1995-2#1)(2009-7#1)(2009-8#1)
mesonephric duct##3##2##(2008-10#3)
mesonephric##4##1##(2008-10#4)
mesopause winds##2##2##(2008-3#2)
mesopause##4##1##(2008-3#4)
mesophilic##5##1##(2008-7#1)(2008-9#2)(2011-2#2)
mesophyll and##2##2##(2008-10#1)(2008-9#1)
mesophyll cells##6##2##(2008-10#5)(2012-2#1)
mesophyll protoplasts##2##2##(2008-9#2)
mesophyll##17##1##(2008-10#13)(2008-9#3)(2012-2#1)
mesopic##2##1##(2011-2#2)
mesoporous MCM-41##3##2##(2010-4#3)
mesoporous material##3##2##(2008-10#2)(2010-4#1)
mesoporous materials##3##2##(2008-10#3)
mesoporous silica##4##2##(2008-10#3)(2010-4#1)
mesoporous structure##2##2##(2008-10#1)(2009-11#1)
mesoporous##24##1##(2008-10#17)(2009-11#1)(2010-4#6)
mesoscale##4##1##(1992-11#1)(2008-10#2)(2008-3#1)
mesoscopic activity in##2##3##(2008-11#2)
mesoscopic##7##1##(2008-11#5)(2013-1#2)
mesostructured tin oxide##3##3##(2008-10#3)
mesothelial cells##5##2##(1991-12#1)(2008-11#3)(2011-2#1)
mesothelial-cell##4##1##(2008-11#4)
mesothelin##4##1##(2012-2#4)
mesothelioma among##2##2##(1991-12#1)(1995-2#1)
mesothelioma associated with chronic empyema with elevation of serum CYFRA19##2##10##(2010-1#2)
mesothelioma in school teachers##2##4##(1991-12#2)
mesothelioma in##7##2##(1991-12#5)(1995-2#1)(1997-5#1)
mesothelioma is a##2##3##(1991-12#1)(2010-12#1)
mesothelioma is##6##2##(1991-12#2)(1997-5#1)(2010-12#2)(2010-5#1)
mesothelioma tissues##3##2##(1991-12#3)
mesothelioma##56##1##(1991-12#32)(1991-2#3)(1992-12#3)(1995-12#1)(1995-2#3)(1997-5#5)(2008-10#1)(2010-1#2)(2010-12#4)(2010-5#2)
mesotheliomas##4##1##(1991-12#2)(1995-10#1)(2010-12#1)
mesotympanum##2##1##(2008-9#2)
mesquite pods##2##2##(2008-10#2)
mesquite##3##1##(2008-10#3)
message and##2##2##(1992-7#1)(2008-4#1)
message by##2##2##(1994-11#1)(1995-2#1)
message is##2##2##(1993-8#1)(2011-2#1)
message of##2##2##(1997-6#1)(1997-7#1)
message that##4##2##(2008-4#1)(2008-8#1)(2010-11#1)(2010-8#1)
message to##2##2##(2010-11#1)(2011-2#1)
message##47##1##(1991-3#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-6#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2008-11#3)(2008-4#5)(2008-6#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-11#3)(2010-4#1)(2010-8#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
messages encouraging physical activity##2##4##(2009-6#2)
messages for##2##2##(2008-10#1)(2010-8#1)
messages of the##2##3##(2008-10#1)(2010-4#1)
messages on##2##2##(2008-4#1)(2009-6#1)
messages to##2##2##(2008-4#1)(2010-8#1)
messages##30##1##(1990-8#1)(1992-2#1)(1994-11#1)(1996-1#1)(2008-10#2)(2008-11#4)(2008-4#3)(2009-6#6)(2010-11#3)(2010-2#1)(2010-4#2)(2010-8#5)
messenger RNA (mRNA)##2##3##(1994-8#1)(2013-1#1)
messenger RNA##11##2##(1991-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#2)(2013-1#1)
messenger and##2##2##(1995-11#1)(2008-8#1)
messenger in the thyroid##2##4##(1990-2#2)
messenger in the##3##3##(1990-2#2)(1995-8#1)
messenger in##4##2##(1990-2#2)(1993-6#1)(1995-8#1)
messenger##32##1##(1990-2#2)(1991-5#1)(1992-3#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#2)
messengers that##2##2##(1991-3#1)(2008-5#1)
messengers##15##1##(1991-3#2)(1992-8#1)(1993-6#1)(1993-9#1)(1995-8#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#2)(2013-1#1)
messengers'##3##1##(1994-6#1)(2008-5#2)
mesylate and##4##2##(2008-10#2)(2008-7#2)
mesylate##9##1##(1990-11#1)(2008-10#4)(2008-7#2)(2009-4#1)(2010-11#1)
met by##5##2##(1992-8#1)(2008-11#2)(2008-5#1)(2012-2#1)
met in##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-10#1)
met inclusion criteria##2##3##(2012-12#1)(2012-2#1)
met the criteria##4##3##(2011-2#1)(2012-2#2)(2013-1#1)
met the inclusion criteria##4##4##(2010-6#1)(2012-3#2)(2013-1#1)
met the##19##2##(2008-10#2)(2008-11#1)(2008-7#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
met to##2##2##(1995-12#1)(1997-3#1)
met with##2##2##(1995-12#1)(2009-10#1)
met##81##1##(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-2#2)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2008-10#4)(2008-11#8)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2010-1#1)(2010-10#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#8)(2013-8#2)
meta##3##1##(2008-10#2)(2011-2#1)
meta-analyses are##3##2##(1996-6#1)(2013-1#2)
meta-analyses in##3##2##(1993-12#1)(1996-6#1)(2013-1#1)
meta-analyses of##3##2##(1996-6#2)(2010-5#1)
meta-analyses that##2##2##(1993-12#1)(2010-2#1)
meta-analyses##21##1##(1991-3#1)(1993-12#3)(1996-6#6)(2008-11#1)(2010-11#1)(2010-2#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#4)
meta-analysis and##4##2##(1996-3#1)(1996-6#1)(2009-10#1)(2010-11#1)
meta-analysis evaluates the##2##3##(2009-9#1)(2010-11#1)
meta-analysis in##3##2##(1996-6#2)(2008-9#1)
meta-analysis of studies##2##3##(2008-4#1)(2013-8#1)
meta-analysis of the##6##3##(1997-7#1)(2008-10#3)(2009-10#1)(2013-1#1)
meta-analysis of##21##2##(1991-10#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-9#2)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
meta-analysis on##2##2##(2008-7#1)(2013-8#1)
meta-analysis suggests##2##2##(2008-8#1)(2011-2#1)
meta-analysis to##3##2##(2008-10#2)(2008-8#1)
meta-analysis was performed##2##3##(2008-10#1)(2011-2#1)
meta-analysis was##4##2##(1996-8#1)(2008-10#2)(2011-2#1)
meta-analysis##69##1##(1991-10#1)(1992-7#1)(1994-6#1)(1995-12#2)(1996-3#4)(1996-6#5)(1996-8#1)(1997-7#2)(2008-10#11)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#3)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
meta-analytic##7##1##(1996-6#3)(2008-11#2)(2008-4#1)(2013-8#1)
meta-awareness##2##1##(2013-8#2)
metabolic abnormalities##5##2##(2008-10#1)(2008-11#2)(2008-4#1)(2012-3#1)
metabolic acidosis##2##2##(1990-5#1)(2008-5#1)
metabolic activation##3##2##(1991-5#1)(2008-8#1)(2011-1#1)
metabolic activities##2##2##(2011-2#2)
metabolic activity in##3##3##(1991-10#1)(2008-11#1)(2011-1#1)
metabolic activity of the##3##4##(1990-11#1)(2008-10#2)
metabolic activity##13##2##(1990-11#1)(1991-10#1)(1992-3#2)(2008-10#2)(2008-11#5)(2008-9#1)(2011-1#1)
metabolic advantage##5##2##(2008-3#5)
metabolic and hormonal responses##2##4##(1994-12#2)
metabolic and hormonal##4##3##(1994-12#2)(2013-7#2)
metabolic and mitogenic##2##3##(2008-9#1)(2010-12#1)
metabolic and##17##2##(1994-12#2)(1994-5#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-7#2)
metabolic changes in##2##3##(2008-10#1)(2012-2#1)
metabolic changes##7##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-7#1)
metabolic complications##5##2##(1990-3#1)(1996-11#1)(2011-3#3)
metabolic control in##3##3##(1994-12#1)(1994-6#1)(2012-5#1)
metabolic control were##2##3##(1995-2#1)(2011-1#1)
metabolic control##13##2##(1994-12#3)(1994-6#1)(1995-2#2)(1996-11#2)(2011-1#1)(2011-2#1)(2012-4#2)(2012-5#1)
metabolic demand##2##2##(2010-12#1)(2010-7#1)
metabolic derangements##2##2##(2008-6#2)
metabolic differences between##2##3##(1995-5#1)(2008-10#1)
metabolic diseases##6##2##(1990-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)
metabolic disorder##4##2##(2008-11#1)(2010-6#1)(2011-2#1)(2012-3#1)
metabolic disorders##12##2##(1992-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
metabolic disturbances in##2##3##(2008-10#1)(2009-12#1)
metabolic disturbances##4##2##(2008-10#1)(2008-11#1)(2009-12#2)
metabolic dysfunction##2##2##(1992-12#1)(2012-2#1)
metabolic effects##4##2##(1993-1#1)(2008-5#1)(2009-7#1)(2010-4#1)
metabolic energy##2##2##(1994-8#1)(2008-11#1)
metabolic engineering##9##2##(2008-11#8)(2011-2#1)
metabolic enzymes##4##2##(1994-8#1)(2008-11#2)(2008-9#1)
metabolic fluxes##3##2##(2008-11#2)(2008-7#1)
metabolic footprint of aging##2##4##(2012-2#2)
metabolic functions and##2##3##(1992-5#1)(1992-9#1)
metabolic functions##10##2##(1990-11#1)(1992-5#1)(1992-9#1)(2008-10#2)(2008-11#5)
metabolic load##6##2##(2008-11#6)
metabolic models##2##2##(2008-7#2)
metabolic network##2##2##(2008-7#2)
metabolic networks##3##2##(2008-7#1)(2009-11#1)(2010-7#1)
metabolic parameters and##2##3##(2012-12#1)(2012-5#1)
metabolic parameters##5##2##(1994-12#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
metabolic pathway of##2##3##(2011-3#1)(2012-5#1)
metabolic pathway##9##2##(1990-6#1)(1993-2#1)(1994-8#1)(2008-11#2)(2008-8#1)(2010-7#1)(2011-3#1)(2012-5#1)
metabolic pathways and##2##3##(2008-10#1)(2012-2#1)
metabolic pathways##15##2##(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#1)
metabolic perturbations##2##2##(1991-12#1)(1991-2#1)
metabolic potential in##2##3##(1995-6#1)(2008-11#1)
metabolic potential##4##2##(1995-6#2)(2008-11#1)(2011-2#1)
metabolic processes and##2##3##(1997-1#1)(2008-10#1)
metabolic processes in##2##3##(2012-2#2)
metabolic processes##7##2##(1997-1#1)(2008-1#1)(2008-10#2)(2008-9#1)(2012-2#2)
metabolic products##2##2##(1990-11#1)(1994-9#1)
metabolic profile##2##2##(2010-4#1)(2013-1#1)
metabolic rate##10##2##(1991-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#2)(2013-8#1)
metabolic rates##3##2##(2008-11#2)(2010-4#1)
metabolic reactions##3##2##(1993-8#1)(2008-7#2)
metabolic requirements##2##2##(1996-3#1)(2008-1#1)
metabolic response##4##2##(2008-11#2)(2008-12#2)
metabolic responses##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#2)
metabolic side##2##2##(2008-8#2)
metabolic stress##3##2##(2010-9#1)(2011-1#1)(2012-12#1)
metabolic syndrome (MetS)##2##3##(2010-10#1)(2013-8#1)
metabolic syndrome (n =##2##4##(2008-11#1)(2008-3#1)
metabolic syndrome and cardiovascular risk##2##5##(2008-1#2)
metabolic syndrome and##8##3##(2008-1#2)(2008-3#2)(2008-7#1)(2010-4#2)(2013-8#1)
metabolic syndrome group##2##3##(2008-3#2)
metabolic syndrome has##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
metabolic syndrome in##9##3##(2008-10#2)(2008-3#4)(2009-9#1)(2012-2#1)(2012-3#1)
metabolic syndrome is##5##3##(2008-1#2)(2008-3#2)(2008-6#1)
metabolic syndrome was##2##3##(2008-11#1)(2010-4#1)
metabolic syndrome##87##2##(2008-1#16)(2008-10#5)(2008-11#8)(2008-3#23)(2008-6#7)(2008-7#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-4#4)(2010-5#3)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#2)
metabolic##434##1##(1990-11#4)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#6)(1994-2#4)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-9#1)(1996-11#6)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-6#1)(2007-8#1)(2008-1#19)(2008-10#31)(2008-11#78)(2008-12#2)(2008-3#37)(2008-4#2)(2008-5#5)(2008-6#11)(2008-7#29)(2008-8#10)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#12)(2011-3#6)(2012-12#2)(2012-2#12)(2012-3#8)(2012-4#2)(2012-5#4)(2013-1#13)(2013-7#4)(2013-8#8)
metabolically active##3##2##(1993-1#1)(2008-11#2)
metabolically labeled with##3##3##(1994-11#2)(2008-1#1)
metabolically##22##1##(1990-11#1)(1990-2#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-11#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#2)(2013-1#2)
metabolised mainly by##2##3##(1994-8#2)
metabolised##5##1##(1994-8#4)(1996-12#1)
metabolism after##2##2##(2008-10#1)(2008-7#1)
metabolism and are##2##3##(1992-10#1)(2008-10#1)
metabolism and body growth##2##4##(2013-1#2)
metabolism and its##4##3##(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)
metabolism and the##2##3##(2008-11#1)(2009-9#1)
metabolism and##50##2##(1992-10#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#5)
metabolism are##4##2##(1991-12#1)(1996-6#1)(2008-10#1)(2010-5#1)
metabolism as##3##2##(1992-3#1)(1994-11#1)(2008-11#1)
metabolism associated with##2##3##(2008-11#1)(2008-9#1)
metabolism by the##2##3##(2008-10#2)
metabolism by##12##2##(1990-11#1)(1995-6#1)(2008-10#3)(2008-11#5)(2008-7#1)(2010-11#1)
metabolism can be##2##3##(1990-9#1)(2012-2#1)
metabolism can##3##2##(1990-9#1)(2008-7#1)(2012-2#1)
metabolism during##2##2##(1991-12#1)(2011-2#1)
metabolism for##2##2##(1994-8#1)(2008-3#1)
metabolism from##2##2##(2008-11#1)(2011-2#1)
metabolism has##2##2##(1994-2#1)(2008-10#1)
metabolism in a##2##3##(1991-10#1)(2008-5#1)
metabolism in breast cancer##2##4##(1993-11#2)
metabolism in liver##2##3##(1990-11#1)(2011-3#1)
metabolism in patients with##2##4##(2009-10#1)(2011-2#1)
metabolism in the##11##3##(1990-9#1)(1991-12#1)(1992-12#1)(1992-6#1)(1995-9#1)(1997-2#1)(2008-3#3)(2008-6#2)
metabolism in these##3##3##(1992-10#1)(2008-6#1)(2008-7#1)
metabolism in##54##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-10#2)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-11#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#3)(1995-2#1)(1995-9#1)(1997-2#1)(2008-10#2)(2008-11#6)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#2)
metabolism is##15##2##(1992-10#1)(1992-11#1)(1992-6#2)(1994-11#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-6#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
metabolism may##2##2##(1994-11#1)(2013-7#1)
metabolism might##2##2##(2008-6#1)(2008-7#1)
metabolism of Corynebacterium glutamicum##2##4##(2008-7#2)
metabolism of NA in hypothalamus##2##5##(2008-8#2)
metabolism of NA##3##3##(2008-8#3)
metabolism of a##2##3##(2008-11#2)
metabolism of the##6##3##(1991-3#1)(1993-11#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
metabolism of##66##2##(1990-11#1)(1990-6#2)(1991-3#1)(1991-5#2)(1992-11#1)(1993-11#3)(1993-6#2)(1994-5#1)(1994-8#3)(2008-10#7)(2008-11#18)(2008-5#2)(2008-7#6)(2008-8#5)(2008-9#1)(2009-1#3)(2009-4#1)(2009-6#2)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#2)
metabolism or##3##2##(1990-11#1)(1992-9#1)(2012-2#1)
metabolism regulation##2##2##(2007-8#1)(2012-3#1)
metabolism that##2##2##(1993-6#1)(2009-10#1)
metabolism through##2##2##(1991-11#1)(2012-2#1)
metabolism to##5##2##(1993-9#1)(1994-11#1)(2008-11#2)(2009-8#1)
metabolism under##2##2##(2008-7#1)(2009-8#1)
metabolism was##9##2##(1993-6#2)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)
metabolism were investigated##2##3##(1996-6#1)(2011-3#1)
metabolism were##6##2##(1990-12#1)(1994-5#1)(1996-6#1)(2008-11#1)(2010-4#1)(2011-3#1)
metabolism without##2##2##(1994-5#2)
metabolism##436##1##(1990-11#4)(1990-12#4)(1990-5#1)(1990-6#2)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#5)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-10#5)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-9#1)(1993-1#1)(1993-11#8)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#10)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#7)(1994-8#12)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#3)(1996-3#1)(1996-6#2)(1997-1#4)(1997-2#2)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#74)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#9)(2008-7#36)(2008-8#9)(2008-9#10)(2009-1#4)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#20)(2011-3#3)(2012-12#1)(2012-2#12)(2012-3#5)(2012-7#2)(2012-9#1)(2013-1#18)(2013-7#1)(2013-8#7)
metabolism)##2##1##(1995-11#1)(2008-11#1)
metabolisms##2##1##(2008-9#1)(2011-1#1)
metabolite in human plasma with##2##5##(2008-10#2)
metabolite in human plasma##4##4##(2008-10#4)
metabolite in urine##2##3##(2008-10#2)
metabolite in##8##2##(1991-1#1)(2008-10#7)
metabolite of 3##2##3##(1992-3#1)(1994-5#1)
metabolite of MPTP##2##3##(1990-7#1)(2008-7#1)
metabolite of NO##2##3##(2008-10#1)(2008-7#1)
metabolite of##19##2##(1990-7#1)(1991-5#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-9#1)(1996-12#1)(2008-10#4)(2008-7#2)(2009-12#1)
metabolite pools##2##2##(2008-7#2)
metabolite produced by##2##3##(2008-10#2)
metabolite production##3##2##(2008-10#3)
metabolite profiles of##2##3##(2008-10#1)(2009-8#1)
metabolite profiles##3##2##(2008-10#1)(2009-8#2)
metabolite was##3##2##(1990-11#1)(1992-1#1)(2008-11#1)
metabolite which##2##2##(1990-11#1)(1990-8#1)
metabolite with strong antimicrobial##2##4##(2008-10#1)(2008-11#1)
metabolite with##3##2##(2008-10#2)(2008-11#1)
metabolite##109##1##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#2)(1991-5#5)(1992-1#3)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-9#2)(1996-12#2)(2008-10#48)(2008-11#5)(2008-5#1)(2008-7#9)(2008-8#2)(2009-12#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-5#2)
metabolites and the##2##3##(2008-10#1)(2008-11#1)
metabolites and##12##2##(2008-10#1)(2008-11#2)(2008-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-8#1)
metabolites are still present today and continue to contaminate soil and water##2##12##(2008-11#2)
metabolites are##7##2##(1992-1#1)(2008-10#2)(2008-11#3)(2010-11#1)
metabolites as##2##2##(2008-9#1)(2011-3#1)
metabolites by##6##2##(1993-8#1)(1995-11#2)(2008-10#2)(2008-11#1)
metabolites derived from##3##3##(1991-5#1)(2010-11#1)(2011-1#1)
metabolites formed by##2##3##(2010-11#1)(2011-1#1)
metabolites formed##5##2##(1990-11#1)(1991-5#1)(2010-11#2)(2011-1#1)
metabolites generated##2##2##(2011-1#1)(2011-3#1)
metabolites in radish##3##3##(2008-10#3)
metabolites in rat urine by##2##5##(2008-10#2)
metabolites in the rat brain##2##5##(1993-3#2)
metabolites in the##5##3##(1993-3#2)(2008-10#3)
metabolites in##26##2##(1991-5#1)(1993-3#2)(1994-8#2)(2008-10#14)(2008-11#3)(2008-7#1)(2008-9#2)(2011-3#1)
metabolites is##3##2##(2008-10#2)(2008-11#1)
metabolites may##2##2##(1995-9#1)(2008-9#1)
metabolites of trichloroethylene##2##3##(2008-10#2)
metabolites of##14##2##(1993-11#1)(1993-12#1)(1994-8#1)(2008-10#5)(2008-11#2)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
metabolites produced by the##2##4##(1993-6#1)(2008-10#1)
metabolites produced by##5##3##(1993-6#2)(2008-10#3)
metabolites produced##6##2##(1993-6#2)(1995-11#1)(2008-10#3)
metabolites that can##2##3##(2008-10#1)(2010-11#1)
metabolites that##6##2##(2008-10#3)(2010-11#1)(2011-1#1)(2013-8#1)
metabolites to##4##2##(1991-1#1)(1991-8#1)(1994-5#1)(2013-8#1)
metabolites using##3##2##(2008-10#3)
metabolites was##2##2##(1990-6#1)(2008-10#1)
metabolites were detected in##2##4##(2008-10#1)(2011-3#1)
metabolites were investigated##2##3##(1991-5#1)(2008-11#1)
metabolites were##19##2##(1990-11#1)(1991-5#1)(1992-6#1)(1994-3#1)(1995-11#2)(1997-3#1)(2008-10#7)(2008-11#2)(2008-7#1)(2011-3#2)
metabolites with##6##2##(1993-8#2)(1996-12#1)(2008-10#2)(2008-7#1)
metabolites##220##1##(1990-11#2)(1990-2#1)(1990-6#2)(1991-1#1)(1991-5#7)(1991-8#1)(1992-1#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#5)(1995-11#10)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#76)(2008-11#27)(2008-12#2)(2008-7#9)(2008-9#5)(2009-8#1)(2010-11#9)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#8)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
metabolize##10##1##(1997-4#1)(2008-10#3)(2008-5#1)(2009-9#1)(2011-1#2)(2012-2#1)(2012-3#1)
metabolized by##5##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
metabolized from pesticides##2##3##(2008-10#2)
metabolized in##3##2##(1992-12#1)(1996-12#1)(2011-2#1)
metabolized to##3##2##(1992-10#1)(2008-11#1)(2010-11#1)
metabolized##30##1##(1990-11#5)(1990-6#1)(1992-10#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#2)(2011-2#1)(2011-3#1)
metabolizers##2##1##(2008-10#2)
metabolizes##2##1##(1993-3#1)(2008-10#1)
metabolizing enzymes##4##2##(1990-11#1)(1993-11#1)(1994-8#1)(2010-12#1)
metabolizing##6##1##(1990-11#2)(1993-11#1)(1994-8#1)(2010-12#1)(2012-2#1)
metabolome##5##1##(2009-8#2)(2012-2#1)(2012-3#1)(2012-5#1)
metabolomics##7##1##(2011-2#1)(2012-2#1)(2012-3#5)
metabonomic##2##1##(2008-10#2)
metabotropic glutamate receptor##6##3##(1993-8#3)(1995-12#3)
metabotropic glutamate receptors (mGluRs)##2##4##(1995-12#2)
metabotropic glutamate receptors##4##3##(1995-12#2)(1996-12#2)
metabotropic glutamate##11##2##(1993-8#3)(1995-12#5)(1996-12#2)(2008-11#1)
metabotropic##12##1##(1993-8#3)(1995-12#6)(1996-12#2)(2008-11#1)
metacarpal##3##1##(1997-3#2)(2009-7#1)
metacarpophalangeal joint##2##2##(2008-9#2)
metacarpophalangeal##5##1##(2008-9#4)(2012-3#1)
metacentric##3##1##(2008-12#3)
metacercariae##2##1##(2008-12#1)(2009-8#1)
metachromatic##5##1##(1997-3#2)(2008-5#1)(2008-9#2)
metachronous##4##1##(1990-12#1)(1990-8#2)(2009-12#1)
metacognitive##3##1##(2008-11#2)(2008-12#1)
metagenome##3##1##(2011-1#3)
metagenomes##2##1##(2011-2#1)(2012-2#1)
metagenomic##2##1##(2011-2#1)(2012-2#1)
metagenomics##5##1##(2011-1#1)(2011-2#4)
metal affinity chromatography##2##3##(2009-3#1)(2011-2#1)
metal analysis##9##2##(2008-10#9)
metal and the##2##3##(2008-10#2)
metal and##8##2##(1994-6#1)(2008-10#6)(2010-11#1)
metal availability##2##2##(2008-10#2)
metal based##2##2##(2010-11#2)
metal binding capacity of##2##4##(2008-10#2)
metal binding##9##2##(2008-10#6)(2010-11#3)
metal by##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
metal cations and##2##3##(2008-10#2)
metal cations in##5##3##(2008-10#5)
metal cations such as##2##4##(2008-10#1)(2009-8#1)
metal cations##34##2##(2008-10#33)(2009-8#1)
metal chalcogenide##4##2##(2010-5#4)
metal chelate is##2##3##(2008-10#2)
metal chelate##8##2##(1995-8#1)(2008-10#7)
metal chelation##2##2##(2008-10#2)
metal complex##9##2##(2008-10#7)(2011-2#2)
metal complex+free##2##2##(2008-10#2)
metal complexes in##2##3##(2008-10#2)
metal complexes is##2##3##(2008-10#2)
metal complexes##21##2##(2008-10#19)(2010-7#2)
metal complexing##2##2##(2008-10#2)
metal concentration##4##2##(2008-10#4)
metal concentrations in##3##3##(2008-10#3)
metal concentrations were##2##3##(2008-10#2)
metal concentrations##10##2##(2008-10#10)
metal content of##2##3##(2008-10#2)
metal content was##2##3##(2008-10#2)
metal content##8##2##(2008-10#7)(2010-11#1)
metal contents in serum and hair samples##2##7##(2008-10#2)
metal contents in serum and hair##3##6##(2008-10#3)
metal contents##4##2##(2008-10#4)
metal coupons##3##2##(2013-8#3)
metal determination in##2##3##(2008-10#2)
metal determination##4##2##(1993-2#1)(2008-10#3)
metal dissolution##2##2##(2008-10#2)
metal elements##2##2##(2008-10#2)
metal enrichment##3##2##(2008-10#3)
metal exchange##3##2##(2008-10#3)
metal extraction##5##2##(2008-10#5)
metal film##4##2##(2007-12#3)(2008-10#1)
metal films##2##2##(1992-8#1)(2008-3#1)
metal fractions##3##2##(2008-10#3)
metal homeostasis##4##2##(2010-11#3)(2011-2#1)
metal humates##2##2##(2008-10#2)
metal in the##3##3##(2008-10#2)(2008-5#1)
metal in##8##2##(2008-10#6)(2008-5#1)(2010-11#1)
metal ion and##2##3##(2008-10#2)
metal ion binding##4##3##(1992-3#1)(2008-10#3)
metal ion concentration##3##3##(2008-10#3)
metal ion concentrations##4##3##(2008-10#3)(2010-11#1)
metal ion determination##3##3##(2008-10#3)
metal ion extraction##2##3##(2008-10#2)
metal ion in##3##3##(1995-6#1)(2008-10#2)
metal ion is##4##3##(1995-6#1)(2008-10#3)
metal ion recovery##3##3##(2008-10#3)
metal ion sorption##4##3##(2008-10#4)
metal ion uptake##2##3##(2008-10#2)
metal ion##85##2##(1992-3#1)(1994-11#1)(1995-6#3)(1997-2#3)(1997-4#1)(2008-10#73)(2008-4#1)(2010-11#2)
metal ions and anions##3##4##(2008-10#3)
metal ions and could be used in a pH range of 2##3##12##(2008-10#3)
metal ions and could be used in##4##7##(2008-10#4)
metal ions and the##3##4##(2008-10#3)
metal ions and their##2##4##(2008-10#2)
metal ions and##25##3##(2008-10#25)
metal ions are extracted into xylene as##2##7##(2008-10#2)
metal ions are extracted into##3##5##(2008-10#3)
metal ions are reported##4##4##(2008-10#4)
metal ions are##13##3##(1995-8#1)(1997-7#1)(2008-10#11)
metal ions at##4##3##(2008-10#4)
metal ions but##2##3##(2008-10#2)
metal ions by##6##3##(2008-10#6)
metal ions could be##3##4##(2008-10#3)
metal ions could##4##3##(1994-6#1)(2008-10#3)
metal ions determination in the##2##5##(2008-10#2)
metal ions do not##2##4##(2008-10#2)
metal ions from aqueous solutions##3##5##(2008-10#3)
metal ions from aqueous##4##4##(2008-10#4)
metal ions from##12##3##(1994-6#1)(2008-10#11)
metal ions has been##3##4##(2008-10#3)
metal ions have been##2##4##(2008-10#2)
metal ions have##4##3##(2008-10#4)
metal ions in aqueous solution##2##5##(2008-10#2)
metal ions in different##2##4##(2008-10#2)
metal ions in river and##2##5##(2008-10#2)
metal ions in several synthetic##2##5##(2008-10#2)
metal ions in the sorption of##2##6##(2008-10#2)
metal ions in the##8##4##(2008-10#8)
metal ions in water##3##4##(2008-10#3)
metal ions in##40##3##(1997-7#1)(2008-10#39)
metal ions increased##2##3##(1991-5#1)(2008-10#1)
metal ions is less than sorption capacity##2##7##(2008-10#2)
metal ions is##7##3##(2008-10#7)
metal ions on a##2##4##(2008-10#2)
metal ions on the##9##4##(2008-10#9)
metal ions on##13##3##(2008-10#12)(2010-11#1)
metal ions or##2##3##(2008-10#2)
metal ions studied##2##3##(2008-10#2)
metal ions such as Cu(II)##2##5##(2008-10#2)
metal ions such as##6##4##(2008-10#6)
metal ions through the##2##4##(2008-10#1)(2011-2#1)
metal ions was studied in##2##5##(2008-10#2)
metal ions was##11##3##(2008-10#11)
metal ions were recovered##2##4##(2008-10#2)
metal ions were studied##2##4##(2008-10#2)
metal ions were##20##3##(2008-10#20)
metal ions with the##2##4##(2008-10#2)
metal ions with##13##3##(2008-10#13)
metal ions##345##2##(1991-5#1)(1993-6#1)(1994-6#2)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#2)(2008-10#329)(2008-12#1)(2008-4#1)(2008-8#1)(2010-11#3)(2011-2#1)
metal ions/complexes##2##2##(2008-10#2)
metal is##7##2##(2008-10#5)(2008-12#1)(2009-12#1)
metal loading capacity##2##3##(2008-10#2)
metal loading##3##2##(2008-10#3)
metal may##2##2##(2008-10#1)(2012-12#1)
metal mobilization##2##2##(2008-10#2)
metal or##2##2##(2008-10#1)(2008-2#1)
metal oxides##4##2##(2008-10#4)
metal parts##2##2##(2008-10#1)(2008-3#1)
metal picrates (Li(+)##2##3##(2008-10#2)
metal picrates with##4##3##(2008-10#4)
metal picrates##11##2##(2008-10#11)
metal pollution##2##2##(1994-11#1)(2008-10#1)
metal preconcentration##3##2##(2008-10#3)
metal profile##2##2##(2008-10#2)
metal removal##4##2##(2008-12#1)(2008-7#2)(2008-8#1)
metal salts##2##2##(2008-10#1)(2008-7#1)
metal sorption##3##2##(2008-10#3)
metal speciation##2##2##(2008-10#2)
metal species and##2##3##(2008-10#2)
metal species in##2##3##(2008-10#2)
metal species##14##2##(2008-10#13)(2010-11#1)
metal stents##6##2##(1990-8#1)(2008-11#3)(2008-12#2)
metal surfaces##2##2##(2013-1#1)(2013-8#1)
metal to the##2##3##(2008-10#1)(2008-11#1)
metal to##4##2##(2008-10#3)(2008-11#1)
metal tolerance##2##2##(2011-2#2)
metal uptake##8##2##(2008-10#7)(2013-8#1)
metal vapor elution analysis##4##4##(2008-10#4)
metal vapors##2##2##(2008-10#2)
metal was##10##2##(2008-10#10)
metal waveguides##3##2##(2008-3#3)
metal##916##1##(1990-3#1)(1990-5#2)(1990-8#1)(1991-5#2)(1992-3#2)(1992-8#3)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1994-11#3)(1994-5#8)(1994-6#3)(1995-6#3)(1995-8#2)(1996-5#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#2)(2007-12#3)(2008-10#766)(2008-11#6)(2008-12#6)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#3)(2009-3#1)(2009-8#1)(2010-11#24)(2010-12#1)(2010-5#6)(2010-6#1)(2010-7#2)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#6)
metal&lt##2##1##(2008-10#2)
metal(II) hexafluoroantimonates(V)##2##2##(2008-10#2)
metal(II)##3##1##(2008-10#3)
metal-EDTA##2##1##(2008-10#2)
metal-HS species##2##2##(2008-10#2)
metal-HS##3##1##(2008-10#3)
metal-binding and metalloprotein analysis##2##4##(2008-10#2)
metal-binding sites##3##2##(2008-4#2)(2010-11#1)
metal-binding##10##1##(1995-3#1)(1996-2#1)(2008-10#4)(2008-4#3)(2010-11#1)
metal-containing proteins##2##2##(2010-11#2)
metal-dependent##2##1##(1994-6#1)(2010-3#1)
metal-doped##3##1##(2008-10#3)
metal-enhanced fluorescence##4##2##(2009-12#1)(2009-5#3)
metal-humate##2##1##(2008-10#2)
metal-ion transporter##2##2##(1997-7#2)
metal-ion##5##1##(1992-4#1)(1997-7#3)(2008-10#1)
metal-ligand complexes using the##2##4##(2008-10#2)
metal-ligand complexes##5##2##(2008-10#4)(2010-11#1)
metal-ligand model##2##2##(2008-10#2)
metal-ligand systems##2##2##(2008-10#2)
metal-ligand##10##1##(2008-10#9)(2010-11#1)
metal-organic##2##1##(2008-10#1)(2010-12#1)
metal-polymer##2##1##(2008-10#2)
metal-porphine##2##1##(2008-10#2)
metal-uptake##2##1##(2008-10#2)
metal/ligand##2##1##(2008-10#2)
metalaxyl insensitivity##2##2##(2008-10#2)
metalaxyl resistant isolates##2##3##(2008-10#2)
metalaxyl resistant##3##2##(2008-10#3)
metalaxyl sensitive##2##2##(2008-10#2)
metalaxyl sensitivity and##2##3##(2008-10#2)
metalaxyl sensitivity##6##2##(2008-10#6)
metalaxyl##35##1##(2008-10#35)
metalinguistic##2##1##(2012-3#2)
metallic alloy##3##2##(1991-9#1)(2008-10#1)(2008-7#1)
metallic alloys##2##2##(1995-3#1)(2008-10#1)
metallic cations##4##2##(1992-6#1)(2008-10#3)
metallic cobalt##2##2##(2008-10#2)
metallic content##3##2##(2008-10#3)
metallic elements in##3##3##(2008-10#3)
metallic elements##4##2##(2008-10#4)
metallic glasses##2##2##(1995-3#1)(2012-2#1)
metallic impurities##2##2##(2008-10#2)
metallic ions##5##2##(2008-10#5)
metallic iron##2##2##(1994-5#1)(2008-10#1)
metallic liquid##2##2##(2012-2#2)
metallic or##2##2##(1992-3#1)(2008-7#1)
metallic particles##2##2##(2008-10#2)
metallic potentiometric sensors##2##3##(2008-10#2)
metallic sensors##2##2##(2008-10#2)
metallic substrates##2##2##(2008-7#2)
metallic thin film##4##3##(2008-3#4)
metallic##78##1##(1991-9#1)(1992-3#1)(1992-6#1)(1994-5#1)(1995-3#2)(1996-5#1)(2007-12#1)(2008-10#45)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#3)
metallised##3##1##(2008-10#3)
metallized##3##1##(2008-10#2)(2008-2#1)
metallo-organic sorbent-iron##2##2##(2008-10#2)
metallochromic indicator##2##2##(2008-10#2)
metallochromic##3##1##(2008-10#3)
metalloenzyme##3##1##(1991-5#1)(1992-3#1)(1995-8#1)
metallofluorescent indicators##2##2##(2008-10#2)
metalloid##4##1##(2008-10#4)
metalloids and non-volatile ions in airborne particulate matter by a new two-step sequential leaching procedure Part##2##16##(2008-10#2)
metalloids##4##1##(2008-10#3)(2010-11#1)
metallomics##3##1##(2008-10#2)(2010-11#1)
metalloporphyrin##4##1##(2008-10#3)(2010-6#1)
metalloporphyrins##6##1##(2008-10#3)(2010-6#3)
metalloprotease##4##1##(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)
metalloproteases##4##1##(2006-6#1)(2008-4#2)(2008-7#1)
metalloprotein analysis##3##2##(2008-10#3)
metalloproteinase 2##2##2##(2010-1#2)
metalloproteinase in the##2##3##(1992-9#1)(2008-9#1)
metalloproteinase with##2##2##(1997-2#1)(2009-7#1)
metalloproteinase##15##1##(1990-8#2)(1992-6#2)(1992-9#1)(1997-2#1)(2008-1#1)(2008-5#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-1#2)(2011-2#1)
metalloproteinase-1##4##1##(1994-3#2)(2008-5#1)(2008-9#1)
metalloproteinase-2 (MMP-2)##3##2##(2008-11#1)(2008-9#1)(2009-3#1)
metalloproteinase-2##4##1##(1997-2#1)(2008-11#1)(2008-9#1)(2009-3#1)
metalloproteinases and their##3##3##(1992-6#1)(2008-1#1)(2008-9#1)
metalloproteinases and##5##2##(1992-6#1)(2008-1#1)(2008-9#1)(2009-3#1)(2013-1#1)
metalloproteinases##14##1##(1992-6#1)(1993-3#1)(1997-2#1)(2007-11#1)(2008-1#3)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
metalloproteins and##4##2##(2010-11#4)
metalloproteins in##2##2##(2010-11#2)
metalloproteins##12##1##(1994-3#1)(2008-10#3)(2010-11#8)
metalloproteomes##5##1##(2010-11#5)
metallothionein (MT) and##2##3##(1990-5#1)(2008-10#1)
metallothionein (MT) proteins##2##3##(2008-10#2)
metallothionein (MT)##10##2##(1990-5#1)(1993-12#1)(2008-10#8)
metallothionein and metallothionein-Ia mRNA in##2##5##(1990-5#2)
metallothionein and metallothionein-Ia mRNA##3##4##(1990-5#3)
metallothionein and##4##2##(1990-5#3)(1994-11#1)
metallothionein in##3##2##(2008-10#3)
metallothionein isoforms##4##2##(2008-10#4)
metallothionein promoter##2##2##(2008-11#2)
metallothionein turnover##3##2##(2008-10#3)
metallothionein##48##1##(1990-5#6)(1991-5#4)(1992-6#1)(1993-12#4)(1994-11#2)(2008-10#28)(2008-11#3)
metallothionein-Ia mRNA##4##2##(1990-5#4)
metallothioneins##12##1##(1990-5#1)(2008-10#10)(2011-2#1)
metallurgical samples##2##2##(2008-10#2)
metallurgical##4##1##(2008-10#4)
metals (Al##2##2##(2008-10#2)
metals (e##4##2##(2008-10#4)
metals (namely##2##2##(2008-10#2)
metals analysis in estuarine and seawater##2##6##(2008-10#2)
metals analysis##3##2##(2008-10#3)
metals and anions in##2##4##(2008-10#2)
metals and anions##5##3##(2008-10#5)
metals and for##2##3##(2008-10#2)
metals and metalloids##2##3##(2008-10#1)(2010-11#1)
metals and the##5##3##(1994-6#1)(2008-10#2)(2010-11#2)
metals and##29##2##(1994-6#1)(2008-10#24)(2010-11#3)(2012-3#1)
metals are##9##2##(2008-10#6)(2008-12#2)(2009-12#1)
metals as##2##2##(2008-11#1)(2008-7#1)
metals at##7##2##(2008-10#7)
metals by the chelating groups##2##5##(2008-10#2)
metals by the##5##3##(2008-10#5)
metals by##14##2##(2008-10#14)
metals can be##4##3##(2008-10#4)
metals could be##3##3##(2008-10#3)
metals determined##2##2##(2008-10#2)
metals did not##2##3##(2008-10#2)
metals for##2##2##(2008-10#2)
metals from aqueous##2##3##(2008-10#2)
metals from the##2##3##(2008-10#2)
metals from##11##2##(2008-10#11)
metals have been determined##2##4##(2008-10#2)
metals have been##3##3##(2008-10#3)
metals have##4##2##(2008-10#3)(2008-11#1)
metals in air particulate matters##2##5##(2008-10#2)
metals in alloys##2##3##(2008-10#2)
metals in aqueous##2##3##(2008-10#2)
metals in biological##2##3##(2008-10#1)(2010-11#1)
metals in complex##2##3##(2008-10#2)
metals in human##3##3##(2008-10#2)(2008-11#1)
metals in sediments##4##3##(2008-10#4)
metals in soil##2##3##(2008-10#2)
metals in soils and sediments##2##5##(2008-10#2)
metals in soils##3##3##(2008-10#3)
metals in solid samples##2##4##(2008-10#2)
metals in solution##3##3##(2008-10#3)
metals in the##7##3##(2008-10#5)(2011-1#1)(2011-2#1)
metals in urine##2##3##(2008-10#2)
metals in used lubricating oils by##2##6##(2008-10#2)
metals in used lubricating oils##3##5##(2008-10#3)
metals in used##4##3##(2008-10#4)
metals in waters and##2##4##(2008-10#2)
metals in##93##2##(1994-6#1)(2008-10#78)(2008-11#2)(2008-12#4)(2008-5#1)(2010-11#4)(2011-1#2)(2011-2#1)
metals ions##2##2##(2008-10#2)
metals is##4##2##(2008-10#3)(2008-12#1)
metals measured##2##2##(2008-10#2)
metals on##7##2##(1994-6#1)(2008-10#6)
metals or##2##2##(2008-10#2)
metals such as Pd(II) and Pt(IV)##2##6##(2008-10#2)
metals such as##7##3##(2008-10#6)(2008-12#1)
metals that##2##2##(2008-10#2)
metals to be determined##2##4##(2008-10#2)
metals to##4##2##(2008-10#3)(2011-2#1)
metals under study##3##3##(2008-10#3)
metals using##6##2##(2008-10#6)
metals was also##2##3##(2008-10#2)
metals was studied##2##3##(2008-10#2)
metals was##12##2##(2008-10#12)
metals were determined##3##3##(2008-10#3)
metals were investigated##3##3##(2008-10#3)
metals were##15##2##(2008-10#15)
metals with the##2##3##(2008-10#1)(2008-11#1)
metals with##9##2##(2008-10#8)(2008-11#1)
metals without##2##2##(2008-10#1)(2008-5#1)
metals##408##1##(1991-5#1)(1992-6#1)(1994-3#1)(1994-6#3)(1995-3#1)(2008-10#350)(2008-11#7)(2008-12#10)(2008-5#5)(2008-7#3)(2009-10#1)(2009-12#2)(2010-11#8)(2011-1#4)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
metals)##3##1##(2008-10#3)
metam sodium##2##2##(2008-10#2)
metam##4##1##(2008-10#4)
metamaterials##3##1##(2012-2#3)
metamere##2##1##(2007-12#2)
metameric spinal AVM##2##3##(2008-7#2)
metameric spinal##4##2##(2008-7#4)
metamorphic##2##1##(2012-2#1)(2012-3#1)
metamorphosis in##2##2##(2008-8#1)(2012-2#1)
metamorphosis##8##1##(1995-11#1)(1995-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
metanephrine##2##1##(2008-10#2)
metaphase I##2##2##(2009-12#1)(2013-1#1)
metaphase chromosome##2##2##(1990-3#1)(2008-9#1)
metaphase chromosomes##7##2##(1990-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
metaphase##19##1##(1990-3#2)(1993-12#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-9#3)(2009-12#1)(2011-2#2)(2013-1#2)
metaphases##2##1##(1990-5#1)(1992-12#1)
metaphor##3##1##(1991-3#1)(2009-10#1)(2012-2#1)
metaphorical##3##1##(2008-12#1)(2012-2#2)
metaphors##2##1##(2012-12#1)(2012-2#1)
metaphyseal fracture##2##2##(2013-1#2)
metaphyseal fractures##4##2##(2011-2#3)(2013-1#1)
metaphyseal##10##1##(2009-4#2)(2011-2#4)(2013-1#4)
metaphysis##4##1##(1991-11#1)(1993-8#1)(2009-1#1)(2012-2#1)
metaplasia##10##1##(1991-2#1)(1992-2#2)(1992-9#2)(1997-1#3)(2008-10#1)(2009-6#1)
metaplastic##3##1##(2008-11#1)(2012-3#2)
metapopulation dynamics##8##2##(2008-8#7)(2008-9#1)
metapopulation extinction time##2##3##(2008-8#2)
metapopulation is##3##2##(2008-8#1)(2008-9#2)
metapopulation model that##2##3##(2008-8#2)
metapopulation model##6##2##(2008-10#1)(2008-8#4)(2008-9#1)
metapopulation models##6##2##(2008-8#6)
metapopulation structure of##2##3##(2008-10#2)
metapopulation with##3##2##(2008-8#1)(2008-9#2)
metapopulation##60##1##(2008-10#6)(2008-8#38)(2008-9#16)
metapopulations by##2##2##(2008-10#1)(2008-8#1)
metapopulations##15##1##(2008-10#2)(2008-8#10)(2008-9#3)
metastable##6##1##(1992-8#1)(1995-3#1)(2008-10#2)(2010-4#1)(2012-2#1)
metastases after##2##2##(1997-4#1)(2012-3#1)
metastases and the##2##3##(1994-12#1)(1996-6#1)
metastases and##5##2##(1990-12#1)(1991-8#1)(1994-12#1)(1996-6#1)(2011-2#1)
metastases are##3##2##(1997-4#1)(2008-1#1)(2011-2#1)
metastases at##2##2##(1992-5#1)(2009-10#1)
metastases caused by prostate cancer##2##5##(2011-2#2)
metastases following##2##2##(1992-2#1)(1996-8#1)
metastases from internal malignancies are##2##5##(1990-8#1)(2010-6#1)
metastases from internal##3##3##(1990-8#1)(2010-11#1)(2010-6#1)
metastases from osteogenic sarcoma##2##4##(1992-12#2)
metastases from##16##2##(1990-12#1)(1990-8#3)(1992-12#5)(1994-6#1)(2008-10#1)(2009-9#1)(2010-11#2)(2010-6#2)
metastases had##2##2##(1990-6#1)(2008-9#1)
metastases in patients with##2##4##(1991-6#1)(2013-8#1)
metastases in##6##2##(1991-6#2)(1992-2#1)(1995-12#1)(2007-8#1)(2013-8#1)
metastases is##3##2##(1996-6#1)(1997-4#1)(2010-12#1)
metastases of##7##2##(1990-12#1)(1990-8#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-3#1)
metastases to the##4##3##(1997-4#1)(2008-1#1)(2008-11#1)(2013-8#1)
metastases to##6##2##(1990-8#1)(1997-4#1)(2008-1#1)(2008-11#2)(2013-8#1)
metastases treated with##2##3##(1997-4#1)(2008-7#1)
metastases was##2##2##(1990-6#1)(2008-8#1)
metastases were##2##2##(2011-2#1)(2013-8#1)
metastases##149##1##(1990-12#5)(1990-2#1)(1990-6#5)(1990-8#7)(1990-9#2)(1991-12#1)(1991-2#1)(1991-6#3)(1991-8#8)(1992-11#1)(1992-12#8)(1992-2#3)(1992-5#1)(1993-1#2)(1993-11#1)(1994-12#8)(1994-6#2)(1995-12#3)(1996-10#1)(1996-6#2)(1996-8#1)(1997-3#2)(1997-4#7)(1997-5#1)(1997-8#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-6#4)(2010-9#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-3#6)(2013-1#4)(2013-8#5)
metastases]##2##1##(1997-4#1)(2011-3#1)
metastasis (p##2##2##(1991-12#1)(1993-11#1)
metastasis and##10##2##(1993-3#1)(1994-12#2)(2008-11#1)(2009-4#1)(2010-3#1)(2012-3#3)(2013-1#1)
metastasis as a presenting feature of lung adenocarcinoma##2##8##(2008-9#2)
metastasis as a##4##3##(2008-9#2)(2011-2#1)(2013-7#1)
metastasis as##5##2##(2008-10#1)(2008-9#2)(2011-2#1)(2013-7#1)
metastasis by##3##2##(1994-12#1)(2013-1#2)
metastasis from##4##2##(1991-6#1)(2008-7#1)(2010-11#1)(2013-1#1)
metastasis in the##2##3##(1996-6#1)(2010-11#1)
metastasis in##19##2##(1992-12#1)(1993-8#1)(1994-12#2)(1996-6#2)(1997-8#1)(2007-8#1)(2008-5#1)(2009-5#1)(2010-11#1)(2011-2#4)(2013-1#4)
metastasis into the##2##3##(1994-12#2)
metastasis is##5##2##(2008-11#1)(2010-3#1)(2011-2#2)(2012-3#1)
metastasis model of##2##3##(1994-12#1)(2008-11#1)
metastasis model##3##2##(1994-12#2)(2008-11#1)
metastasis of ovarian cancer##2##4##(1990-12#1)(1991-6#1)
metastasis of the##2##3##(2008-1#1)(2013-1#1)
metastasis of##21##2##(1990-12#1)(1990-8#1)(1991-6#2)(1992-2#1)(1994-12#1)(1996-10#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#3)
metastasis revealing##2##2##(2007-8#2)
metastasis to the##3##3##(1992-2#1)(1997-8#1)(2010-6#1)
metastasis to##6##2##(1992-2#1)(1997-8#1)(2008-8#2)(2010-6#1)(2012-3#1)
metastasis was##3##2##(2008-10#1)(2008-12#1)(2011-3#1)
metastasis were##4##2##(1992-2#1)(1994-12#1)(1994-8#1)(2008-10#1)
metastasis without##2##2##(1990-2#1)(2013-1#1)
metastasis##165##1##(1990-12#4)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-6#3)(1992-12#1)(1992-2#3)(1992-5#3)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#16)(1994-8#1)(1995-9#1)(1996-10#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#2)(2007-8#5)(2008-1#4)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2010-11#3)(2010-3#6)(2010-6#5)(2010-7#1)(2011-2#19)(2011-3#1)(2012-2#1)(2012-3#7)(2013-1#21)(2013-7#1)(2013-8#1)
metastasis&quot##2##1##(1990-6#2)
metastasis-suppressing##2##1##(2011-2#1)(2013-1#1)
metastasis]##2##1##(1990-9#1)(2009-5#1)
metastasize to##2##2##(2010-6#1)(2012-3#1)
metastasize##5##1##(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
metastasized to the##4##3##(1994-5#1)(2010-6#1)(2012-3#1)(2013-8#1)
metastasized##8##1##(1993-11#1)(1994-5#1)(2008-11#1)(2010-6#1)(2012-3#1)(2013-7#1)(2013-8#2)
metastasizing leiomyoma##2##2##(2012-3#2)
metastasizing to##2##2##(2008-5#2)
metastasizing##4##1##(2008-5#2)(2012-3#2)
metastatic adenocarcinoma##4##2##(2010-11#1)(2010-7#2)(2013-1#1)
metastatic breast cancer##7##3##(1990-6#2)(1991-6#2)(1996-11#1)(2010-8#1)(2013-8#1)
metastatic breast##9##2##(1990-6#2)(1991-6#2)(1994-2#1)(1996-11#1)(2010-8#1)(2012-12#1)(2013-8#1)
metastatic colorectal cancer##4##3##(1990-12#1)(1990-2#2)(1992-12#1)
metastatic colorectal carcinoma##2##3##(1990-2#1)(1992-12#1)
metastatic colorectal##6##2##(1990-12#1)(1990-2#3)(1992-12#2)
metastatic disease to the##3##4##(1990-12#1)(2008-1#2)
metastatic disease##13##2##(1990-11#1)(1990-12#1)(1997-5#1)(2007-11#1)(2008-1#4)(2011-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
metastatic lesions##4##2##(1994-12#1)(2008-8#1)(2010-12#1)(2013-8#1)
metastatic lymph nodes##3##3##(1990-12#1)(1994-12#2)
metastatic malignant melanoma##2##3##(1991-6#1)(2009-3#1)
metastatic malignant##4##2##(1990-10#1)(1991-6#1)(2009-3#1)(2011-3#1)
metastatic melanoma cells##5##3##(1997-7#1)(2009-3#3)(2013-1#1)
metastatic melanoma##14##2##(1990-6#1)(1992-2#2)(1997-7#3)(2009-3#4)(2010-6#3)(2013-1#1)
metastatic phenotype##3##2##(1994-5#1)(2009-3#2)
metastatic potential##3##2##(1990-8#1)(2008-9#1)(2012-3#1)
metastatic potentials##2##2##(2008-11#1)(2008-9#1)
metastatic process##4##2##(1990-6#1)(1990-8#1)(2008-4#1)(2011-2#1)
metastatic progression##3##2##(2009-3#1)(2013-1#2)
metastatic prostate cancer is##2##4##(1992-2#1)(2013-8#1)
metastatic prostate cancer##3##3##(1992-2#1)(2008-11#1)(2013-8#1)
metastatic prostate cancers##3##3##(2011-2#3)
metastatic prostate##7##2##(1990-12#1)(1992-2#1)(2008-11#1)(2011-2#3)(2013-8#1)
metastatic prostatic cancer##2##3##(1991-7#2)
metastatic rate##2##2##(1997-1#1)(2012-3#1)
metastatic renal cell carcinoma##6##4##(1990-2#2)(1991-8#3)(1994-12#1)
metastatic renal cell##7##3##(1990-2#2)(1991-8#3)(1994-12#1)(2011-3#1)
metastatic solid##2##2##(1995-9#1)(2008-11#1)
metastatic spinal cord compression##2##4##(1991-9#1)(1993-9#1)
metastatic spread to##2##3##(1994-12#1)(1997-8#1)
metastatic spread##7##2##(1990-11#1)(1991-2#1)(1994-12#1)(1997-8#1)(2008-1#1)(2009-9#1)(2010-7#1)
metastatic to the##3##3##(1992-2#1)(1994-2#1)(2008-12#1)
metastatic tumors##4##2##(1994-2#1)(2010-7#2)(2011-2#1)
metastatic##148##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#8)(1990-3#1)(1990-6#5)(1990-8#3)(1991-2#1)(1991-3#1)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#1)(1992-12#3)(1992-2#5)(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#5)(1994-2#3)(1994-5#2)(1995-9#1)(1996-11#2)(1997-1#1)(1997-5#2)(1997-7#3)(1997-8#1)(2007-11#1)(2008-1#5)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#8)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#4)(2010-7#6)(2010-8#1)(2011-2#9)(2011-3#5)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#7)(2013-8#5)
metatarsal##17##1##(2008-12#4)(2010-11#2)(2010-3#4)(2011-2#2)(2012-12#1)(2012-2#4)
metatarsals##3##1##(2008-12#1)(2010-3#2)
metatarsophalangeal joint##3##2##(2010-5#3)
metatarsophalangeal##4##1##(2010-5#3)(2012-3#1)
metatarsus##3##1##(1991-8#1)(2012-2#2)
metavanadate##3##1##(2008-10#3)
metazoan##2##1##(2008-7#1)(2011-2#1)
metazoans##2##1##(2009-8#2)
meteorites##2##1##(2008-10#2)
meteorological conditions##3##2##(2008-11#2)(2008-2#1)
meteorological parameters##3##2##(2008-10#2)(2008-11#1)
meteorological##15##1##(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#1)(2009-7#2)
meter of##2##2##(1995-8#1)(2008-5#1)
meter##17##1##(1995-8#1)(2008-10#7)(2008-3#4)(2008-5#1)(2009-11#1)(2010-10#1)(2012-2#1)(2012-3#1)
metered dose inhaler (MDI) and##2##5##(1992-3#1)(1997-2#1)
metered dose inhaler (MDI)##6##4##(1992-3#2)(1996-1#1)(1996-2#1)(1997-2#2)
metered dose inhaler##7##3##(1992-3#2)(1996-1#1)(1996-2#1)(1997-2#2)(2007-11#1)
metered dose inhalers (MDIs) contain##2##5##(1996-1#2)
metered dose inhalers (MDIs)##7##4##(1992-3#1)(1996-1#5)(1997-1#1)
metered dose inhalers##17##3##(1992-2#3)(1992-3#5)(1996-1#8)(1997-1#1)
metered dose##26##2##(1992-2#3)(1992-3#8)(1995-12#1)(1996-1#9)(1996-2#1)(1997-1#1)(1997-2#2)(2007-11#1)
metered##28##1##(1991-12#1)(1992-2#3)(1992-3#8)(1995-12#1)(1996-1#9)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(2007-11#1)
metered-dose inhaler##4##2##(1996-2#1)(1997-1#1)(2008-8#2)
metered-dose inhalers##2##2##(1992-3#1)(1996-2#1)
metered-dose##6##1##(1992-3#1)(1996-2#2)(1997-1#1)(2008-8#2)
metering valve##3##2##(1992-3#1)(1996-1#2)
metering##4##1##(1992-3#1)(1996-1#3)
meters##11##1##(1990-11#1)(2008-10#2)(2008-3#3)(2008-5#4)(2012-3#1)
meters)##2##1##(1990-11#1)(2009-6#1)
metformin hydrochloride##2##2##(2012-2#2)
metformin treatment##2##2##(2011-2#2)
metformin##20##1##(1994-8#5)(1995-8#2)(2008-10#2)(2010-11#1)(2011-2#6)(2012-2#4)
meth + marijuana##2##3##(2013-8#2)
meth-only##2##1##(2013-8#2)
methacholine##3##1##(1996-1#1)(2012-3#2)
methacrylate##17##1##(1994-8#2)(2007-12#1)(2008-10#7)(2008-3#3)(2008-5#1)(2008-7#2)(2013-1#1)
methacrylate) (PMMA)##3##2##(2008-10#2)(2010-4#1)
methacrylate)##6##1##(2008-10#4)(2008-3#1)(2010-4#1)
methacrylic acid (MAA)##2##3##(2008-10#2)
methacrylic##3##1##(2008-10#3)
methacrylic-acrylic##2##1##(2008-10#2)
methadone maintenance treatment program##2##4##(1996-3#2)
methadone maintenance treatment##3##3##(1996-3#3)
methadone maintenance##7##2##(1991-1#2)(1996-3#3)(2008-10#2)
methadone patients##2##2##(1991-1#2)
methadone treatment##5##2##(1991-1#1)(1996-3#1)(2008-10#1)(2008-6#1)(2012-12#1)
methadone##21##1##(1991-1#6)(1996-3#4)(2008-10#3)(2008-6#4)(2008-7#1)(2009-7#1)(2012-12#2)
methadone-maintained##2##1##(1991-1#2)
metham sodium##3##2##(2008-10#3)
methamphetamine and##3##2##(2008-10#1)(2013-1#2)
methamphetamine users##2##2##(2011-2#1)(2013-1#1)
methamphetamine##19##1##(1991-1#3)(2008-10#4)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#7)(2013-8#2)
methane and##3##2##(2008-10#2)(2009-12#1)
methane concentration##2##2##(2008-2#1)(2008-3#1)
methane concentrations of##2##3##(2008-2#1)(2008-3#1)
methane conversion##3##2##(2008-10#3)
methane emissions from rice paddy fields##2##6##(2008-3#2)
methane in##2##2##(2008-10#1)(2008-3#1)
methane production from##3##3##(2013-1#3)
methane production##6##2##(2013-1#6)
methane##43##1##(1991-12#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#6)(2008-3#12)(2008-5#2)(2009-12#1)(2013-1#6)
methane-air flame##4##2##(2008-10#3)(2008-2#1)
methane-air premixed##2##2##(2008-3#2)
methane-air##7##1##(2008-10#3)(2008-2#1)(2008-3#3)
methanogen##4##1##(2008-7#4)
methanogenic culture##2##2##(2008-7#2)
methanogenic##3##1##(2008-7#3)
methanogens##2##1##(2008-7#2)
methanol and ethanol##5##3##(2008-10#5)
methanol and##16##2##(2008-10#15)(2008-5#1)
methanol as a##2##3##(2008-11#1)(2008-7#1)
methanol as mobile phase##2##4##(2008-10#1)(2012-2#1)
methanol as the##3##3##(2008-10#2)(2012-2#1)
methanol as##11##2##(2008-10#6)(2008-11#1)(2008-7#2)(2012-2#2)
methanol at##4##2##(1990-9#1)(2008-10#3)
methanol concentration in##3##3##(2008-7#3)
methanol concentration##6##2##(2008-10#1)(2008-7#5)
methanol content##4##2##(2008-10#4)
methanol extract of Aegle marmelos##4##5##(2012-2#4)
methanol extract of##8##3##(2008-11#1)(2012-2#5)(2012-3#1)(2013-8#1)
methanol extract##11##2##(2008-11#3)(2008-12#1)(2012-2#5)(2012-3#1)(2013-8#1)
methanol gave##2##2##(1996-5#2)
methanol in the presence of##2##5##(1995-9#1)(1996-5#1)
methanol in the##4##3##(1995-9#1)(1996-5#1)(2008-10#2)
methanol in##9##2##(1995-9#1)(1996-5#1)(2008-10#7)
methanol is##2##2##(2008-10#2)
methanol modifier##2##2##(2008-10#2)
methanol on##3##2##(2008-10#2)(2008-5#1)
methanol solution##3##2##(2008-10#3)
methanol to##2##2##(2008-10#1)(2008-7#1)
methanol was added to the surfactant-rich phase##2##7##(2008-10#2)
methanol was##5##2##(2008-10#5)
methanol were##2##2##(2008-10#2)
methanol##172##1##(1990-2#1)(1990-9#2)(1993-11#1)(1995-9#2)(1996-5#6)(1996-6#1)(1997-7#1)(2008-10#125)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#3)(2008-7#9)(2008-8#1)(2012-2#9)(2012-3#1)(2013-1#1)(2013-8#1)
methanol) and##2##2##(2008-10#2)
methanol)##7##1##(2008-10#5)(2008-5#1)(2013-8#1)
methanol-phosphate buffer##2##2##(2008-10#2)
methanol-water##11##1##(2008-10#11)
methanol/water##7##1##(2008-10#6)(2008-5#1)
methanolic solution of the##2##4##(2008-10#1)(2008-11#1)
methanolic solution##5##2##(2008-10#4)(2008-11#1)
methanolic solutions##2##2##(2008-10#2)
methanolic##13##1##(2008-10#10)(2008-11#2)(2008-12#1)
methemerythrin##2##1##(1992-8#2)
methemoglobin##4##1##(1990-8#1)(2008-11#2)(2010-4#1)
methicillin resistant##2##2##(2010-2#1)(2013-1#1)
methicillin##3##1##(2008-7#1)(2010-2#1)(2013-1#1)
methicillin-resistant Staphylococcus aureus (MRSA)##4##4##(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus##11##3##(2007-12#1)(2008-10#3)(2008-11#3)(2010-6#2)(2011-2#1)(2012-2#1)
methicillin-resistant strains##2##2##(1991-3#1)(2008-7#1)
methicillin-resistant##15##1##(1991-3#2)(2007-12#1)(2008-10#3)(2008-11#4)(2008-7#1)(2010-6#2)(2011-2#1)(2012-2#1)
methide radical##2##2##(2008-10#2)
methimazole##5##1##(2011-2#4)(2012-3#1)
methimazole-induced##2##1##(2011-2#1)(2012-3#1)
methionine adenosyltransferase##2##2##(1992-6#2)
methionine and##2##2##(2008-10#1)(2008-5#1)
methionine in##2##2##(1991-12#1)(2008-10#1)
methionine metabolism##2##2##(1993-9#1)(2009-8#1)
methionine sulphoximine##2##2##(2008-11#2)
methionine was##2##2##(1997-2#2)
methionine##28##1##(1990-5#1)(1991-12#1)(1992-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1997-2#2)(1997-7#1)(2008-10#10)(2008-11#3)(2008-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
methionyl##2##1##(1990-2#1)(2006-6#1)
methocarbamol##3##1##(2008-10#3)
method (GHPSAM)##2##2##(2008-10#2)
method (HPSAM) and##2##3##(2008-10#2)
method (HPSAM)##10##2##(2008-10#10)
method (flow##2##2##(2008-10#1)(2008-9#1)
method (the##2##2##(2008-10#2)
method 2)##2##2##(2008-10#2)
method A)##2##2##(2008-10#2)
method B)##3##2##(2008-10#3)
method CALUX##2##2##(2008-10#2)
method a##7##2##(2008-10#6)(2008-11#1)
method according to##4##3##(2008-10#4)
method accuracy##3##2##(2008-10#3)
method achieves the##2##3##(2008-10#1)(2011-2#1)
method after##5##2##(2008-10#4)(2011-2#1)
method agreed well with##2##4##(2008-10#2)
method agreed well##3##3##(2008-10#3)
method agreed with##3##3##(2008-10#3)
method agreed##8##2##(2008-10#8)
method allow##2##2##(2008-10#1)(2009-10#1)
method allowed a##2##3##(1997-2#1)(2008-10#1)
method allowed the determination of##3##5##(2008-10#3)
method allowed the##5##3##(2008-10#5)
method allowed us to determine##2##5##(2008-10#1)(2009-8#1)
method allowed us to##3##4##(2008-10#2)(2009-8#1)
method allowed##17##2##(1996-12#1)(1997-2#1)(2008-10#13)(2009-8#2)
method allows a rapid##2##4##(2008-10#1)(2008-11#1)
method allows a##7##3##(2008-10#3)(2008-11#2)(2008-4#2)
method allows for the##2##4##(2008-10#1)(2010-11#1)
method allows for##4##3##(2008-10#2)(2010-11#1)(2012-3#1)
method allows the determination of 0##2##6##(2008-10#2)
method allows the determination of##15##5##(2008-10#15)
method allows the##18##3##(2008-10#18)
method allows##42##2##(2008-10#34)(2008-11#2)(2008-3#1)(2008-4#2)(2010-11#1)(2012-3#1)(2013-1#1)
method also##7##2##(1996-5#1)(2007-8#1)(2008-10#4)(2009-6#1)
method and HPLC##2##3##(2008-10#2)
method and a##7##3##(2008-10#5)(2008-3#1)(2008-4#1)
method and an##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
method and by##6##3##(1997-2#1)(2008-10#5)
method and for##2##3##(2008-10#1)(2008-3#1)
method and its##4##3##(2008-10#3)(2010-9#1)
method and other##2##3##(1995-1#1)(2008-10#1)
method and refined##2##3##(1992-12#1)(2008-8#1)
method and results##2##3##(2008-11#1)(2012-2#1)
method and the atomic absorption##2##5##(2008-10#2)
method and the conventional##2##4##(2008-10#1)(2010-6#1)
method and the reference##3##4##(2008-10#3)
method and the results were##2##5##(2008-10#2)
method and the results##6##4##(2008-10#5)(2008-5#1)
method and the##39##3##(1992-4#1)(1994-3#1)(1995-1#1)(1995-8#1)(2008-10#26)(2008-11#1)(2008-5#3)(2008-7#1)(2010-6#1)(2012-2#1)(2012-3#2)
method and their##3##3##(2008-10#3)
method and those##4##3##(2008-10#4)
method and to##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
method and##152##2##(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#93)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-11#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
method appears to be##2##4##(1996-2#1)(2008-10#1)
method appears##3##2##(1996-2#1)(2008-10#2)
method applied for##2##3##(2008-10#1)(2008-3#1)
method applied to the##2##4##(1996-6#1)(2008-10#1)
method applied to##5##3##(1996-6#1)(2008-10#4)
method applied##7##2##(1996-6#1)(2008-10#5)(2008-3#1)
method are compared##2##3##(2008-2#1)(2008-3#1)
method are discussed##2##3##(1997-2#1)(2008-10#1)
method are illustrated##2##3##(2008-10#2)
method are in##3##3##(2008-10#3)
method are less than##3##4##(2008-10#3)
method are not##2##3##(1992-12#1)(2008-10#1)
method are outlined##2##3##(1994-9#1)(2008-11#1)
method are presented##2##3##(2008-10#2)
method are##47##2##(1992-12#1)(1992-4#1)(1994-9#1)(1995-12#1)(1997-2#2)(2008-10#31)(2008-11#1)(2008-2#1)(2008-3#6)(2011-2#1)(2013-8#1)
method as a##3##3##(2008-10#2)(2010-7#1)
method as well as##3##4##(2008-3#2)(2008-5#1)
method as##12##2##(2008-10#7)(2008-3#2)(2008-5#1)(2010-7#1)(2011-3#1)
method at the##6##3##(1990-3#1)(2008-10#5)
method at##11##2##(1990-3#1)(2008-10#9)(2010-8#1)
method available##3##2##(1990-5#1)(1994-5#1)(2008-5#1)
method based on a##5##4##(2008-10#2)(2008-3#1)(2010-6#1)(2013-8#1)
method based on capillary##2##4##(2008-10#1)(2008-5#1)
method based on solid-phase extraction##2##5##(2008-10#2)
method based on solid-phase##3##4##(2008-10#3)
method based on the reaction of luminol with##2##8##(2008-10#2)
method based on the use of##2##6##(2008-10#2)
method based on the##17##4##(2008-10#16)(2008-11#1)
method based on##72##3##(1990-9#1)(1994-9#1)(1997-2#1)(2008-10#58)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
method by which##2##3##(2008-4#2)
method by##18##2##(1994-12#1)(2008-10#10)(2008-11#1)(2008-3#3)(2008-4#2)(2010-7#1)
method called##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
method can also be##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
method can be applied in##2##5##(2010-8#1)(2013-8#1)
method can be applied to the determination of##3##8##(2008-10#3)
method can be applied to the determination##4##7##(2008-10#4)
method can be applied to the##6##6##(2008-10#6)
method can be applied to##11##5##(2008-10#10)(2009-11#1)
method can be applied##17##4##(1995-6#1)(2008-10#12)(2008-6#1)(2009-11#1)(2010-8#1)(2013-8#1)
method can be implemented in##2##5##(2011-2#1)(2013-1#1)
method can be successfully applied to the##2##7##(2008-10#2)
method can be successfully##4##4##(2008-10#3)(2012-2#1)
method can be used for##3##5##(2008-10#3)
method can be used to determine##2##6##(2008-10#2)
method can be used to##8##5##(1996-3#1)(2008-10#6)(2008-4#1)
method can be used##15##4##(1996-3#1)(2008-10#13)(2008-4#1)
method can be utilized in##2##5##(2008-10#2)
method can be##51##3##(1992-5#1)(1995-6#1)(1996-3#1)(2008-10#37)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
method can##65##2##(1990-3#1)(1992-5#1)(1995-6#1)(1996-3#1)(2008-10#44)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
method capable of##2##3##(2008-10#2)
method compared##2##2##(2008-10#1)(2008-2#1)
method consists of##5##3##(2008-10#4)(2008-3#1)
method could be applied in##2##5##(2008-10#2)
method could be applied##5##4##(2008-10#5)
method could be used as##2##5##(2008-10#2)
method could be used for the determination of##2##8##(2008-10#2)
method could be used for##3##5##(2008-10#3)
method could be used##10##4##(2008-10#8)(2008-11#1)(2010-7#1)
method could be##18##3##(2008-10#14)(2008-11#3)(2010-7#1)
method could##26##2##(2008-10#21)(2008-11#4)(2010-7#1)
method coupled with a##3##4##(2008-10#3)
method coupled with##4##3##(2008-10#3)(2010-12#1)
method currently##3##2##(2008-10#2)(2008-9#1)
method demonstrated##3##2##(2008-10#2)(2008-9#1)
method depends on##2##3##(2008-4#1)(2008-7#1)
method depends##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
method described by##2##3##(2008-10#1)(2008-11#1)
method described here is##2##4##(1996-3#1)(2008-11#1)
method described here##6##3##(1996-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#2)
method described in##2##3##(2008-10#2)
method described##20##2##(1990-2#1)(1995-12#1)(1996-3#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#2)
method detection limit (MDL)##4##4##(2008-10#4)
method detection limit##11##3##(2008-10#11)
method detection limits were##2##4##(2008-10#2)
method detection##13##2##(2008-10#13)
method developed for##2##3##(2008-10#1)(2009-6#1)
method developed in this work##2##5##(2008-10#2)
method developed in this##3##4##(2008-10#3)
method developed in##5##3##(2008-10#5)
method developed was found to be##2##6##(2008-10#2)
method developed was##6##3##(2008-10#6)
method developed##26##2##(2008-10#24)(2008-5#1)(2009-6#1)
method development##6##2##(2008-10#2)(2008-11#1)(2010-11#3)
method did not##2##3##(2008-10#2)
method does not require a##2##5##(1992-3#1)(2008-10#1)
method does not require any separation##2##6##(2008-10#2)
method does not require##5##4##(1992-3#1)(2008-10#4)
method does not suffer##3##4##(2008-10#3)
method does not##11##3##(1992-3#1)(1996-3#1)(2008-10#8)(2008-3#1)
method due to the##2##4##(2008-10#2)
method due to##4##3##(1997-2#1)(2008-10#3)
method during##2##2##(2008-10#1)(2008-11#1)
method employed for the##2##4##(2008-10#1)(2012-2#1)
method employed##6##2##(1994-12#1)(2008-10#4)(2012-2#1)
method employing##6##2##(2008-10#4)(2008-9#1)(2012-12#1)
method employs the reaction##2##4##(2008-10#2)
method employs##6##2##(2008-10#5)(2009-12#1)
method enabled##3##2##(2008-10#3)
method enables##3##2##(2008-10#2)(2008-3#1)
method established in##2##3##(2008-10#2)
method established##3##2##(2008-10#3)
method evaluated##2##2##(2008-10#2)
method evaluation##2##2##(2008-10#2)
method exhibits##4##2##(2008-10#3)(2008-11#1)
method features##2##2##(2008-10#2)
method following CLSI guidelines##2##4##(2012-3#2)
method for Cd##2##3##(2008-10#2)
method for DNA detection##2##4##(2008-10#2)
method for P##2##3##(2008-10#2)
method for a##8##3##(2008-10#6)(2008-3#2)
method for absolute measurement of refractive index and thickness of optically transparent media##2##13##(2007-11#2)
method for all##2##3##(2008-10#1)(2008-3#1)
method for analysis of##7##4##(1995-9#1)(2008-10#6)
method for analyzing##4##3##(2008-10#3)(2008-4#1)
method for arsenic##3##3##(2008-10#3)
method for ascorbic acid##2##4##(2008-10#2)
method for calculating the##2##4##(2008-10#1)(2008-3#1)
method for calculating##4##3##(2008-10#2)(2008-3#2)
method for correcting##2##3##(2008-3#2)
method for delivering##3##3##(1996-1#1)(1996-2#1)(2008-5#1)
method for designing##4##3##(1994-3#1)(2008-6#1)(2013-8#2)
method for detecting##13##3##(1995-2#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
method for detection of##3##4##(2008-10#2)(2009-6#1)
method for determination of acid##2##5##(2008-10#2)
method for determination of copper##2##5##(2008-10#2)
method for determination of selenium##2##5##(2008-10#2)
method for determination of trace##5##5##(2008-10#5)
method for determination of##42##4##(2008-10#42)
method for determination##43##3##(2008-10#43)
method for determining the##4##4##(1995-12#1)(2008-10#3)
method for determining##22##3##(1991-2#1)(1994-12#1)(1995-12#1)(1997-2#1)(2008-10#16)(2008-11#1)(2008-4#1)
method for direct determination of##2##5##(2008-10#2)
method for estimating##7##3##(1994-12#1)(1995-3#1)(2008-7#2)(2013-1#2)(2013-3#1)
method for estimation of##2##4##(2008-10#2)
method for evaluating the##3##4##(1994-2#1)(2011-2#1)(2012-2#1)
method for evaluating##5##3##(1994-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
method for examining##2##3##(2008-9#1)(2012-2#1)
method for extraction of##2##4##(2008-10#1)(2012-2#1)
method for flow injection##2##4##(2008-10#2)
method for generating##5##3##(1990-12#1)(1995-8#2)(2007-11#1)(2008-4#1)
method for genotyping##2##3##(2008-10#1)(2008-4#1)
method for identification of##2##4##(1995-12#1)(2008-10#1)
method for identifying##7##3##(1991-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-3#1)
method for improving the##2##4##(2008-9#1)(2012-12#1)
method for improving##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
method for in situ##3##4##(2008-10#2)(2008-3#1)
method for investigating##2##3##(2010-6#1)(2012-2#1)
method for isolating##2##3##(1993-8#1)(2008-2#1)
method for measuring the##5##4##(2008-11#1)(2008-3#3)(2011-2#1)
method for measuring##15##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-3#4)(2011-2#1)(2012-2#2)(2013-1#1)
method for monitoring and##2##4##(1994-9#1)(2008-11#1)
method for monitoring the conservation state of pigmented##2##8##(2008-10#2)
method for monitoring##7##3##(1994-9#1)(2008-10#5)(2008-11#1)
method for obtaining##3##3##(1996-3#1)(2008-11#1)(2008-4#1)
method for on-line##4##3##(2008-10#4)
method for precise##2##3##(2008-10#1)(2008-3#1)
method for preconcentration and##2##4##(2008-10#2)
method for preconcentration##3##3##(2008-10#3)
method for primary##2##3##(2008-9#1)(2012-2#1)
method for quantifying##2##3##(2008-10#1)(2011-2#1)
method for quantitation of##2##4##(1993-3#1)(2008-10#1)
method for quantitation##3##3##(1993-3#1)(2008-10#2)
method for quantitative analysis of undefined mixtures##2##7##(2008-10#2)
method for quantitative analysis of##4##5##(2008-10#4)
method for quantitative analysis##5##4##(2008-10#5)
method for rapid and selective extraction##2##6##(2008-10#2)
method for rapid and##3##4##(2008-10#3)
method for rapid extraction##2##4##(2008-10#2)
method for rapid##7##3##(2008-10#7)
method for removing##2##3##(2008-10#1)(2010-3#1)
method for routine analysis##2##4##(2008-10#2)
method for sample##3##3##(2008-10#3)
method for screening##3##3##(1993-2#1)(2008-10#1)(2008-4#1)
method for separating##2##3##(2008-10#2)
method for separation and determination of##2##6##(2008-10#1)(2009-8#1)
method for separation and##3##4##(2008-10#2)(2009-8#1)
method for separation##4##3##(2008-10#3)(2009-8#1)
method for simultaneous determination of uric acid##2##7##(2008-10#2)
method for simultaneous determination of##14##5##(2008-10#12)(2011-3#1)(2012-2#1)
method for simultaneous##20##3##(2008-10#16)(2008-8#1)(2011-3#2)(2012-2#1)
method for solving##2##3##(1993-5#1)(2008-6#1)
method for speciation##2##3##(2008-10#2)
method for studying the##2##4##(1993-8#1)(2008-9#1)
method for synthesizing##2##3##(1994-11#1)(2010-6#1)
method for the accurate and precise spectrophotometric determination of##2##9##(2008-10#2)
method for the accurate and precise##3##6##(2008-10#3)
method for the analysis of##11##5##(2008-10#11)
method for the analysis##12##4##(2008-10#11)(2008-4#1)
method for the assay of perphenazine##3##6##(2008-10#3)
method for the assay of##6##5##(2008-10#6)
method for the assessment of##2##5##(1990-12#1)(2008-10#1)
method for the detection and##4##5##(1990-12#1)(2008-10#1)(2008-11#2)
method for the detection of##7##5##(2008-10#4)(2009-1#1)(2010-8#1)(2013-8#1)
method for the detection##11##4##(1990-12#1)(2008-10#5)(2008-11#2)(2009-1#1)(2010-8#1)(2013-8#1)
method for the determination of Hg(II)##2##6##(2008-10#2)
method for the determination of Se##2##6##(2008-10#2)
method for the determination of a##2##6##(2008-10#2)
method for the determination of acid##2##6##(2008-10#2)
method for the determination of arsenic##3##6##(2008-10#3)
method for the determination of ascorbic acid##2##7##(2008-10#2)
method for the determination of chloride##2##6##(2008-10#2)
method for the determination of cysteine and##2##7##(2008-10#2)
method for the determination of cysteine##5##6##(2008-10#5)
method for the determination of ethanol##2##6##(2008-10#2)
method for the determination of hydroxyl##2##6##(2008-10#2)
method for the determination of inorganic##2##6##(2008-10#2)
method for the determination of nitrate in##2##7##(2008-10#2)
method for the determination of nucleic acids##2##7##(2008-10#2)
method for the determination of peroxynitrite##2##6##(2008-10#2)
method for the determination of phosphatidylcholine##2##6##(2008-10#2)
method for the determination of serine using##2##7##(2008-10#2)
method for the determination of some##2##6##(2008-10#2)
method for the determination of the concentration of diethylenetriamine (DETA) in aqueous mineral flotation solutions##2##15##(2008-10#2)
method for the determination of the##9##6##(2008-10#9)
method for the determination of total##6##6##(2008-10#6)
method for the determination of trace amount of##2##8##(2008-10#2)
method for the determination of trace amounts of##11##8##(2008-10#11)
method for the determination of trace##20##6##(2008-10#20)
method for the determination of uric acid##2##7##(2008-10#2)
method for the determination of vanadium##2##6##(2008-10#2)
method for the determination of##228##5##(2008-10#228)
method for the determination##229##4##(2008-10#229)
method for the direct determination of##2##6##(2008-10#2)
method for the direct##5##4##(2008-10#4)(2011-2#1)
method for the estimation of##2##5##(2008-10#2)
method for the extraction and##2##5##(2008-10#2)
method for the extraction##3##4##(2008-10#3)
method for the fluorometric determination of##2##6##(2008-10#2)
method for the identification of##2##5##(1997-2#1)(2008-1#1)
method for the identification##3##4##(1997-2#1)(2008-1#1)(2008-10#1)
method for the in##2##4##(2008-11#1)(2008-5#1)
method for the measurement of oxygen##2##6##(1993-1#1)(2008-11#1)
method for the measurement of##10##5##(1990-11#1)(1992-11#1)(1992-12#1)(1993-1#1)(2008-10#5)(2008-11#1)
method for the on-line##2##4##(2008-10#2)
method for the preconcentration of##2##5##(2008-10#2)
method for the preconcentration##4##4##(2008-10#4)
method for the prediction of##2##5##(2008-10#1)(2008-5#1)
method for the preparation of##5##5##(1990-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
method for the quantitation of##5##5##(1997-2#2)(2008-10#3)
method for the quantitative analysis of##4##6##(2008-10#1)(2008-12#1)(2008-3#1)(2010-1#1)
method for the quantitative determination of##8##6##(1997-2#1)(2008-10#7)
method for the quantitative##12##4##(1997-2#1)(2008-10#8)(2008-12#1)(2008-3#1)(2010-1#1)
method for the rapid and simultaneous##2##6##(2008-10#1)(2008-9#1)
method for the rapid determination of##3##6##(2008-10#3)
method for the rapid##7##4##(2008-10#5)(2008-9#1)(2009-6#1)
method for the reduction of##2##5##(2008-2#1)(2010-7#1)
method for the resolution of##2##5##(2008-10#2)
method for the routine##2##4##(2008-10#1)(2010-4#1)
method for the screening of##2##5##(2008-10#2)
method for the selective##5##4##(2008-10#5)
method for the sensitive determination of##3##6##(2008-10#3)
method for the separation and determination of##2##7##(2008-10#2)
method for the separation and##3##5##(2008-10#3)
method for the separation of beryllium from##2##7##(2008-10#2)
method for the separation of##6##5##(1991-12#1)(2008-10#5)
method for the separation##12##4##(1991-12#1)(2008-10#10)(2008-5#1)
method for the simultaneous determination of##19##6##(1995-3#1)(2008-10#18)
method for the simultaneous##26##4##(1995-3#1)(2008-10#24)(2008-5#1)
method for the speciation of##3##5##(2008-10#3)
method for the speciation##4##4##(2008-10#4)
method for the spectrophotometric determination of nickel naphthenate in gasoline in a microemulsion##2##13##(2008-10#2)
method for the spectrophotometric determination of nitrite in water##2##9##(2008-10#2)
method for the spectrophotometric determination of##7##6##(2008-10#7)
method for the study of##2##5##(1994-5#1)(2008-10#1)
method for the trace determination of##2##6##(2008-10#2)
method for the trace##7##4##(2008-10#7)
method for the##450##3##(1990-11#1)(1990-12#3)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-3#1)(1997-2#4)(2008-1#1)(2008-10#401)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-9#2)(2009-1#1)(2009-6#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2013-8#2)
method for total##3##3##(2008-10#3)
method for trace analysis##2##4##(2008-10#2)
method for trace##4##3##(2008-10#4)
method for treating##2##3##(2008-11#1)(2011-2#1)
method for using##2##3##(2008-9#1)(2012-5#1)
method for wavelength selection##2##4##(2008-10#2)
method for##967##2##(1990-11#2)(1990-12#5)(1990-2#1)(1990-5#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#6)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#714)(2008-11#28)(2008-12#4)(2008-2#5)(2008-3#23)(2008-4#15)(2008-5#9)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#17)(2009-1#1)(2009-10#1)(2009-3#2)(2009-6#3)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-2#7)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#7)(2013-3#1)(2013-8#5)
method from the##4##3##(2008-10#2)(2010-6#1)(2013-8#1)
method from##5##2##(2008-10#2)(2008-8#1)(2010-6#1)(2013-8#1)
method fulfills all the##2##4##(2008-10#2)
method gave good results##2##4##(2008-10#2)
method gave##8##2##(2008-10#5)(2008-7#1)(2009-6#1)(2013-1#1)
method gives the##3##3##(2008-10#2)(2008-11#1)
method gives##7##2##(2008-10#4)(2008-11#1)(2008-4#1)(2010-6#1)
method had been applied to the determination of trace molybdenum in tungsten##2##12##(2008-10#2)
method had been##4##3##(2008-10#4)
method had##9##2##(1992-11#1)(2008-10#8)
method has a detection limit of##3##6##(2008-10#3)
method has a detection limit##4##5##(2008-10#4)
method has a linear calibration range from##2##7##(2008-10#2)
method has a linear calibration range##3##6##(2008-10#3)
method has a linear##4##4##(2008-10#4)
method has a##20##3##(1990-2#1)(2008-10#18)(2009-1#1)
method has also been successfully applied##2##6##(2008-10#2)
method has also been##5##4##(2008-10#4)(2008-11#1)
method has an##2##3##(2008-10#2)
method has been applied for the##3##6##(2008-10#3)
method has been applied for##6##5##(2008-10#6)
method has been applied in##2##5##(2008-10#2)
method has been applied satisfactorily to the##2##7##(2008-10#2)
method has been applied satisfactorily to##3##6##(2008-10#3)
method has been applied satisfactorily##4##5##(2008-10#4)
method has been applied successfully to the determination of##2##9##(2008-10#2)
method has been applied successfully to the##3##7##(2008-10#3)
method has been applied successfully to##4##6##(2008-10#4)
method has been applied successfully##5##5##(2008-10#5)
method has been applied to determine##4##6##(2008-10#4)
method has been applied to the analysis of##3##8##(2008-10#3)
method has been applied to the determination of total##3##9##(2008-10#3)
method has been applied to the determination of trace mercury in##2##11##(2008-10#2)
method has been applied to the determination of trace##7##9##(2008-10#7)
method has been applied to the determination of##40##8##(2008-10#40)
method has been applied to the##54##6##(2008-10#53)(2010-7#1)
method has been applied to##72##5##(2008-10#71)(2010-7#1)
method has been applied##90##4##(2008-10#89)(2010-7#1)
method has been developed by##3##5##(2008-10#3)
method has been developed for determination of##2##7##(2008-10#2)
method has been developed for spectrophotometric##2##6##(2008-10#2)
method has been developed for the assay of##2##8##(2008-10#2)
method has been developed for the determination of trace amount of##4##11##(2008-10#4)
method has been developed for the determination of trace##6##9##(2008-10#6)
method has been developed for the determination of##23##8##(2008-10#23)
method has been developed for the determination##24##7##(2008-10#24)
method has been developed for the direct determination of##4##9##(2008-10#4)
method has been developed for the direct##5##7##(2008-10#5)
method has been developed for the quantitative determination of##2##9##(2008-10#2)
method has been developed for the separation and determination of##2##10##(2008-10#2)
method has been developed for the separation##3##7##(2008-10#3)
method has been developed for the simultaneous determination of##4##9##(2008-10#4)
method has been developed for the##48##6##(2008-10#47)(2008-11#1)
method has been developed for##59##5##(2008-10#57)(2008-11#1)(2008-3#1)
method has been developed in##3##5##(2008-10#3)
method has been developed to determine##2##6##(2008-10#2)
method has been developed to selectively separate and concentrate##2##9##(2008-10#2)
method has been developed to##8##5##(1992-12#1)(2008-10#7)
method has been developed##76##4##(1992-12#1)(2008-10#73)(2008-11#1)(2008-3#1)
method has been employed to##2##5##(2008-10#2)
method has been employed##3##4##(2008-10#3)
method has been evaluated##3##4##(2008-10#3)
method has been proposed for the##2##6##(2008-10#2)
method has been proposed##3##4##(2008-10#3)
method has been satisfactorily applied to the determination of##6##9##(2008-10#6)
method has been satisfactorily applied to the##8##7##(2008-10#8)
method has been satisfactorily applied to##9##6##(2008-10#9)
method has been satisfactorily applied##10##5##(2008-10#10)
method has been satisfactorily##11##4##(2008-10#11)
method has been studied##3##4##(2008-10#3)
method has been successfully applied for the##4##7##(2008-10#4)
method has been successfully applied for##7##6##(2008-10#7)
method has been successfully applied to determine##4##7##(2008-10#4)
method has been successfully applied to the determination of##16##9##(2008-10#16)
method has been successfully applied to the##21##7##(2008-10#21)
method has been successfully applied to##30##6##(2008-10#30)
method has been successfully applied##37##5##(2008-10#37)
method has been successfully used##4##5##(2008-10#3)(2008-3#1)
method has been successfully##42##4##(2008-10#41)(2008-3#1)
method has been used for the determination of##4##8##(2008-10#4)
method has been used for##5##5##(2008-10#5)
method has been used to##6##5##(2008-10#5)(2008-11#1)
method has been used##14##4##(2008-10#13)(2008-11#1)
method has been validated by##2##5##(2008-10#2)
method has been validated##4##4##(2008-10#4)
method has been##276##3##(1991-6#1)(1992-12#1)(1993-3#1)(1997-2#1)(2008-10#263)(2008-11#3)(2008-3#2)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)
method has high##3##3##(2008-10#3)
method has higher sensitivity and##2##5##(2008-10#2)
method has the advantage of##3##5##(2008-10#2)(2008-2#1)
method has the##7##3##(2008-10#5)(2008-2#1)(2008-8#1)
method has##334##2##(1990-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1997-2#1)(2008-10#308)(2008-11#6)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#1)
method have been##8##3##(2008-10#7)(2008-3#1)
method have##10##2##(1994-8#1)(2008-10#8)(2008-3#1)
method here proposed##2##3##(2008-10#2)
method here##3##2##(2008-10#3)
method in a##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2010-4#1)
method in conjunction with##2##4##(2008-10#2)
method in industrial##2##3##(2008-10#1)(2008-12#1)
method in order to##3##4##(2008-10#2)(2008-5#1)
method in terms of##2##4##(2008-10#2)
method in the##17##3##(1991-3#1)(2008-10#12)(2008-11#1)(2008-7#1)(2010-7#1)(2012-3#1)
method in this##2##3##(1992-2#1)(2008-10#1)
method in##71##2##(1990-11#2)(1991-3#2)(1992-2#1)(1996-3#1)(2007-12#1)(2008-10#45)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
method includes##2##2##(2008-10#2)
method including##3##2##(2008-3#1)(2012-2#1)(2013-8#1)
method involves a##11##3##(1990-12#1)(2008-10#9)(2011-2#1)
method involves the##15##3##(1990-2#1)(1996-5#1)(2008-10#13)
method involves##36##2##(1990-12#1)(1990-2#1)(1996-5#1)(2008-10#30)(2008-11#1)(2008-4#1)(2011-2#1)
method involving##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
method is 0##17##3##(2008-10#17)
method is 1##4##3##(2008-10#4)
method is a##8##3##(1991-12#1)(1994-9#1)(2008-10#3)(2008-3#1)(2011-2#1)(2013-1#1)
method is able to##2##4##(2008-10#2)
method is accurate and precise##2##5##(2008-10#2)
method is accurate and##4##4##(2008-10#4)
method is accurate##5##3##(1997-2#1)(2008-10#4)
method is adequate##2##3##(1991-6#1)(2008-10#1)
method is also suitable for##2##5##(2008-10#2)
method is also##8##3##(2008-10#5)(2008-2#1)(2008-4#1)(2010-8#1)
method is an##2##3##(2008-10#1)(2012-2#1)
method is applicable for the##2##5##(2008-10#2)
method is applicable to the##3##5##(2008-10#3)
method is applicable to##6##4##(2008-10#5)(2008-11#1)
method is applicable##8##3##(2008-10#7)(2008-11#1)
method is applied for##4##4##(2008-10#3)(2008-3#1)
method is applied to determine##2##5##(2008-10#2)
method is applied to the determination of##5##7##(2008-10#5)
method is applied to the##11##5##(2008-10#11)
method is applied to##20##4##(2008-10#19)(2008-11#1)
method is applied##27##3##(2008-10#24)(2008-11#1)(2008-3#1)(2010-7#1)
method is as##3##3##(1992-3#1)(1995-8#1)(2008-10#1)
method is based on a##7##5##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)
method is based on an##2##5##(2008-10#2)
method is based on selective##2##5##(2008-10#2)
method is based on the application of##2##7##(2008-10#1)(2008-11#1)
method is based on the complexation reaction##2##7##(2008-10#2)
method is based on the continuous precipitation of##2##8##(2008-10#2)
method is based on the detection of##3##7##(2008-10#3)
method is based on the development of the reaction between the analytes and##2##13##(2008-10#2)
method is based on the difference##5##6##(2008-10#5)
method is based on the fact that the##2##8##(2008-10#2)
method is based on the fact that##3##7##(2008-10#3)
method is based on the formation of a##3##8##(2008-10#3)
method is based on the formation of##8##7##(2008-10#8)
method is based on the interaction of##3##7##(2008-10#3)
method is based on the reaction between##7##7##(2008-10#7)
method is based on the reaction##13##6##(2008-10#13)
method is based on the reduction of##4##7##(2008-10#4)
method is based on the use of##4##7##(2008-10#3)(2008-11#1)
method is based on the##146##5##(1995-6#1)(2008-10#140)(2008-11#2)(2008-2#1)(2011-2#2)
method is based on##186##4##(1995-6#1)(2007-11#1)(2008-10#176)(2008-11#2)(2008-2#2)(2008-3#2)(2011-2#2)
method is based##191##3##(1995-6#1)(2007-11#1)(2008-10#181)(2008-11#2)(2008-2#2)(2008-3#2)(2011-2#2)
method is being##2##3##(1995-2#1)(2008-3#1)
method is capable of##4##4##(1995-3#1)(2008-10#3)
method is characterized by##3##4##(2008-10#3)
method is compared with##2##4##(2008-10#1)(2008-2#1)
method is convenient##2##3##(2008-10#1)(2008-7#1)
method is demonstrated by##5##4##(2007-11#1)(2008-10#3)(2008-5#1)
method is demonstrated##6##3##(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)
method is described for the determination of trace amounts of##3##10##(2008-10#3)
method is described for the determination of trace##4##8##(2008-10#4)
method is described for the determination of traces of##2##9##(2008-10#2)
method is described for the determination of##30##7##(2008-10#30)
method is described for the simultaneous determination of##2##8##(2008-10#2)
method is described for the##43##5##(2008-10#42)(2008-2#1)
method is described for##54##4##(1992-8#1)(2008-10#47)(2008-11#3)(2008-2#1)(2008-4#2)
method is described which##2##4##(1991-2#1)(1992-9#1)
method is described##61##3##(1991-2#1)(1992-8#1)(1992-9#1)(1997-2#1)(2008-10#48)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)
method is designed##2##3##(2008-4#1)(2008-6#1)
method is developed for determination of##2##6##(2008-10#2)
method is developed for the determination of##3##7##(2008-10#3)
method is developed for the on-line determination of##2##8##(2008-10#2)
method is developed for the##7##5##(2008-10#7)
method is developed for##10##4##(2008-10#10)
method is developed##14##3##(2008-10#14)
method is effective for##2##4##(1996-1#1)(2008-10#1)
method is employed##2##3##(2008-10#1)(2008-3#1)
method is evaluated using##2##4##(2008-10#2)
method is evaluated##4##3##(2008-10#4)
method is fast##5##3##(2008-10#5)
method is free from interference##2##5##(2008-10#2)
method is free from##6##4##(2008-10#6)
method is free##7##3##(2008-10#7)
method is highly sensitive##2##4##(2008-10#2)
method is highly##7##3##(2008-10#5)(2008-9#1)(2012-2#1)
method is inherently##2##3##(2008-10#1)(2010-7#1)
method is introduced##3##3##(2008-3#2)(2008-6#1)
method is its##2##3##(2007-12#1)(2008-10#1)
method is limited##2##3##(1997-2#1)(2011-2#1)
method is more##3##3##(2008-10#3)
method is not##4##3##(2008-10#1)(2008-9#1)(2010-5#1)(2010-7#1)
method is of##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
method is one of the most##2##6##(2008-10#1)(2013-8#1)
method is one of##3##4##(2008-10#1)(2010-7#1)(2013-8#1)
method is particularly useful##2##4##(2008-10#1)(2008-4#1)
method is particularly##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
method is performed##2##3##(2008-10#1)(2008-4#1)
method is potentially##2##3##(2008-10#1)(2008-2#1)
method is presented and##2##4##(2008-10#2)
method is presented for the determination of##5##7##(2008-10#5)
method is presented for the##9##5##(2008-10#9)
method is presented for##13##4##(2008-10#11)(2008-3#2)
method is presented to##2##4##(2008-2#1)(2008-3#1)
method is presented##21##3##(2008-10#15)(2008-2#1)(2008-3#3)(2011-3#1)(2013-8#1)
method is proposed for the determination of trace amounts of##2##10##(2008-10#2)
method is proposed for the determination of##19##7##(2008-10#19)
method is proposed for the extraction##3##6##(2008-10#3)
method is proposed for the simultaneous determination of##5##8##(2008-10#5)
method is proposed for the spectrophotometric determination of##2##8##(2008-10#2)
method is proposed for the successive determination of nanogram levels of##2##11##(2008-10#2)
method is proposed for the##34##5##(2008-10#34)
method is proposed for##37##4##(2008-10#36)(2008-11#1)
method is proposed to##2##4##(2008-10#2)
method is proposed##47##3##(2008-10#44)(2008-11#2)(2012-12#1)
method is quite##2##3##(2008-10#2)
method is rapid and##2##4##(2008-10#2)
method is rapid##11##3##(2008-10#8)(2008-9#1)(2009-12#1)(2010-6#1)
method is readily##2##3##(2008-10#1)(2008-7#1)
method is relatively##3##3##(2008-10#3)
method is reliable##2##3##(2008-10#2)
method is reported for the determination of##2##7##(2008-10#2)
method is reported for the##5##5##(2008-10#5)
method is reported##6##3##(2008-10#5)(2008-2#1)
method is reproducible and##2##4##(2008-10#2)
method is sensitive enough to detect##2##6##(1995-12#1)(1996-2#1)
method is sensitive to##2##4##(2008-10#1)(2009-5#1)
method is sensitive##14##3##(1995-12#1)(1996-2#1)(2008-10#10)(2008-3#1)(2009-5#1)
method is simple and rapid##2##5##(2008-10#2)
method is simple and##14##4##(1996-2#1)(2008-10#12)(2008-11#1)
method is simple to##2##4##(1990-2#1)(2008-10#1)
method is simple##35##3##(1990-2#1)(1996-2#1)(2008-10#31)(2008-11#1)(2008-5#1)
method is successfully applied for the determination of##2##8##(2008-10#2)
method is successfully applied to determine##2##6##(2008-10#2)
method is successfully applied to the determination of##2##8##(2008-10#2)
method is successfully applied to the simultaneous##2##7##(2008-10#1)(2008-5#1)
method is successfully applied to the##4##6##(2008-10#3)(2008-5#1)
method is successfully applied to##8##5##(2008-10#7)(2008-5#1)
method is successfully applied##10##4##(2008-10#9)(2008-5#1)
method is suggested##2##3##(2008-10#2)
method is suitable for the simultaneous determination of##2##8##(2008-10#2)
method is suitable for the##6##5##(2008-10#6)
method is suitable for##17##4##(1991-2#1)(2008-10#13)(2008-9#1)(2010-8#1)(2012-3#1)
method is suitable##18##3##(1991-2#1)(2008-10#14)(2008-9#1)(2010-8#1)(2012-3#1)
method is superior to the##3##5##(2008-10#2)(2008-11#1)
method is superior to##4##4##(2008-10#3)(2008-11#1)
method is superior##6##3##(2008-10#5)(2008-11#1)
method is that it##2##4##(2008-10#1)(2010-5#1)
method is that the##2##4##(2008-10#2)
method is that##7##3##(2008-10#5)(2008-3#1)(2010-5#1)
method is the##5##3##(1996-3#1)(2008-10#4)
method is to##2##3##(2008-10#1)(2008-4#1)
method is used for##4##4##(2008-10#4)
method is used to##4##4##(2008-10#1)(2008-3#2)(2009-10#1)
method is used##10##3##(2008-10#7)(2008-3#2)(2009-10#1)
method is very sensitive and##2##5##(2008-10#1)(2008-11#1)
method is very sensitive##4##4##(2008-10#3)(2008-11#1)
method is very simple##2##4##(2008-10#2)
method is very useful for monitoring##2##6##(2008-10#2)
method is very##12##3##(2008-10#11)(2008-11#1)
method is##756##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-3#1)(1992-8#1)(1992-9#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#5)(2007-11#3)(2007-12#1)(2008-10#612)(2008-11#18)(2008-12#2)(2008-2#9)(2008-3#20)(2008-4#9)(2008-5#6)(2008-6#3)(2008-7#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
method makes use of two##2##5##(2008-10#1)(2008-3#1)
method makes use of##3##4##(2008-10#2)(2008-3#1)
method makes##4##2##(2008-10#3)(2008-3#1)
method matched##2##2##(2008-10#2)
method may be applied##2##4##(2008-8#1)(2013-1#1)
method may be used to##2##5##(2008-10#1)(2010-7#1)
method may be used##3##4##(1995-2#1)(2008-10#1)(2010-7#1)
method may be##7##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2013-1#1)
method may provide a##3##4##(2008-10#2)(2012-2#1)
method may##10##2##(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
method not only##2##3##(2008-10#2)
method of DNA##3##3##(2008-10#2)(2008-11#1)
method of a##2##3##(1996-3#1)(2008-10#1)
method of active##2##3##(2008-4#1)(2008-8#1)
method of analysis of##3##4##(2008-10#3)
method of analysis##12##3##(2008-10#10)(2008-9#1)(2011-2#1)
method of assessing##2##3##(1994-3#1)(2008-11#1)
method of choice in##2##4##(2010-12#1)(2011-2#1)
method of choice##12##3##(1992-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-3#1)
method of combining##2##3##(1995-9#1)(2008-9#1)
method of comparative##2##3##(1997-6#1)(2008-9#1)
method of composite interval mapping##2##5##(2008-10#2)
method of control##2##3##(2008-10#2)
method of data collection##3##4##(1993-3#1)(2008-11#1)(2009-10#1)
method of data##5##3##(1993-3#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-8#1)
method of detecting##4##3##(1993-3#1)(2008-10#1)(2008-2#2)
method of detection##5##3##(1996-8#1)(1997-2#1)(2008-10#3)
method of determination of##4##4##(2008-10#4)
method of determination##8##3##(2008-10#7)(2008-11#1)
method of determining the##2##4##(2008-10#1)(2011-2#1)
method of determining##5##3##(1994-1#1)(2008-10#2)(2008-3#1)(2011-2#1)
method of explosives##2##3##(2008-10#2)
method of fixation##3##3##(1991-9#1)(2013-1#2)
method of human##2##3##(2008-11#2)
method of learning##2##3##(2008-11#1)(2008-12#1)
method of measuring##6##3##(1990-2#1)(1992-3#1)(1993-11#1)(2007-12#1)(2008-4#1)(2009-7#1)
method of preparing##4##3##(2008-4#1)(2008-9#2)(2009-12#1)
method of sample##2##3##(2008-10#2)
method of screening for##2##4##(1991-7#1)(2008-10#1)
method of solventless extraction##2##4##(2008-10#2)
method of standard additions##7##4##(2008-10#7)
method of standard##8##3##(2008-10#8)
method of the##6##3##(1994-12#1)(2008-10#5)
method of treating##3##3##(2008-10#2)(2011-2#1)
method of treatment for##2##4##(2008-10#1)(2010-7#1)
method of treatment##8##3##(1995-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-7#1)(2013-1#2)
method of using##2##3##(1996-12#1)(1997-3#1)
method of##334##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#138)(2008-11#26)(2008-12#11)(2008-2#3)(2008-3#14)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#10)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#9)(2013-1#11)(2013-8#4)
method offers the##2##3##(2008-10#2)
method offers##8##2##(2008-10#6)(2008-11#1)(2012-2#1)
method on the##5##3##(1997-5#1)(2008-10#3)(2008-7#1)
method on##12##2##(1990-2#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
method or##4##2##(2008-10#4)
method over##2##2##(2008-10#2)
method owing to##2##3##(2008-10#2)
method performance was evaluated##3##4##(2008-10#3)
method permits the determination of##2##5##(2008-10#2)
method permits the##4##3##(2008-10#3)(2008-2#1)
method permits##8##2##(2007-12#1)(2008-10#6)(2008-2#1)
method permitted the##3##3##(2008-10#3)
method permitted##6##2##(2008-10#6)
method precision##2##2##(2008-10#2)
method presented a linear response##2##5##(2008-10#2)
method presented a##3##3##(2008-10#3)
method presented here is##3##4##(2008-10#3)
method presented here##5##3##(2008-10#4)(2008-11#1)
method presented in##2##3##(2008-3#1)(2008-9#1)
method presented##12##2##(2008-10#8)(2008-11#1)(2008-3#2)(2008-9#1)
method presents a##2##3##(2008-10#2)
method presents##3##2##(2008-10#3)
method preserves##2##2##(2008-10#1)(2008-9#1)
method previously developed for##2##4##(2008-10#2)
method previously##5##2##(2008-10#5)
method proposed by##5##3##(2008-10#4)(2008-6#1)
method proposed here##3##3##(1991-5#1)(1994-1#1)(2008-10#1)
method proposed in this paper##2##5##(2008-10#1)(2013-8#1)
method proposed in this##3##4##(2008-10#2)(2013-8#1)
method proposed was##7##3##(2008-10#7)
method proposed##28##2##(1991-5#1)(1993-6#1)(1994-1#1)(2008-10#22)(2008-6#1)(2009-8#1)(2013-8#1)
method proved to be##5##4##(2008-10#5)
method proved to##6##3##(1990-6#1)(2008-10#5)
method provided a##3##3##(2008-10#3)
method provided##9##2##(2008-10#7)(2008-11#1)(2008-7#1)
method provides a simple way to##2##6##(2008-3#2)
method provides a simple##3##4##(2008-3#2)(2008-4#1)
method provides a##19##3##(1993-1#1)(1995-1#1)(1995-12#1)(2008-10#9)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
method provides high##2##3##(2007-11#1)(2008-11#1)
method provides the##2##3##(1994-12#1)(2008-3#1)
method provides##37##2##(1992-11#1)(1993-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(2007-11#2)(2008-10#16)(2008-11#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-8#1)(2012-12#1)(2013-8#1)
method reduces##3##2##(1991-2#1)(2008-10#1)(2009-8#1)
method relies on the##5##4##(2008-10#3)(2008-3#2)
method relies on##6##3##(2008-10#3)(2008-3#3)
method relies##7##2##(2008-10#4)(2008-3#3)
method requires a##2##3##(2008-10#2)
method requires only##2##3##(2008-3#1)(2011-2#1)
method requires##7##2##(2008-10#4)(2008-3#2)(2011-2#1)
method resulted##2##2##(2008-10#2)
method results in##2##3##(2008-10#2)
method should be##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
method showed a good##5##4##(2008-10#4)(2011-3#1)
method showed a##10##3##(2008-10#9)(2011-3#1)
method showed excellent##2##3##(2008-10#2)
method showed good##3##3##(2008-10#3)
method showed linear calibration##2##4##(2008-10#2)
method showed linear##3##3##(2008-10#3)
method showed no##2##3##(2008-10#1)(2008-12#1)
method showed that##3##3##(2008-10#3)
method showed to be##2##4##(2008-10#2)
method showed##30##2##(2008-10#28)(2008-12#1)(2011-3#1)
method shows a good##2##4##(2008-10#2)
method shows a linear range between##3##6##(2008-10#3)
method shows a linear##4##4##(2008-10#4)
method shows a##7##3##(2008-10#7)
method shows good##4##3##(2008-10#4)
method shows##14##2##(2008-10#13)(2012-12#1)
method so##2##2##(2008-10#1)(2010-3#1)
method study##2##2##(2008-10#1)(2008-12#1)
method such as##3##3##(2008-10#2)(2012-2#1)
method suffers no##2##3##(2008-10#2)
method suffers##4##2##(2008-10#4)
method suitable for the##2##4##(2008-10#2)
method suitable for##6##3##(1991-2#1)(2008-10#4)(2008-2#1)
method takes##4##2##(2008-10#3)(2008-3#1)
method than##3##2##(2008-10#3)
method that allows##4##3##(2008-11#1)(2008-3#2)(2013-1#1)
method that can be used##2##5##(2008-2#1)(2010-10#1)
method that can be##3##4##(2008-10#1)(2008-2#1)(2010-10#1)
method that combines##4##3##(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
method that gives##2##3##(1994-9#1)(2008-11#1)
method that is##3##3##(2008-10#1)(2008-3#2)
method that uses##3##3##(2008-3#2)(2008-9#1)
method that##47##2##(1990-12#1)(1993-12#1)(1994-9#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
method the##7##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)
method to a##3##3##(2008-10#1)(2008-8#1)(2009-5#1)
method to an##2##3##(2008-10#1)(2008-3#1)
method to analyze the##2##4##(2008-8#1)(2008-9#1)
method to analyze##7##3##(1994-6#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-4#1)
method to assay##2##3##(2008-10#2)
method to assess the##2##4##(2008-5#1)(2013-1#1)
method to assess##6##3##(1995-3#1)(1995-5#1)(2008-10#1)(2008-5#2)(2013-1#1)
method to be##6##3##(1990-12#1)(2008-10#4)(2008-11#1)
method to calculate##2##3##(2008-10#2)
method to confirm##2##3##(1997-8#1)(2008-10#1)
method to control##2##3##(2008-10#1)(2011-3#1)
method to correct##3##3##(2008-11#1)(2008-3#2)
method to demonstrate##2##3##(2008-7#1)(2008-9#1)
method to detect and quantify##2##5##(2008-10#1)(2008-5#1)
method to detect and##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
method to detect##10##3##(1991-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-8#1)(2010-6#1)(2013-1#1)
method to determine the##7##4##(1993-3#1)(2008-10#4)(2008-8#1)(2009-7#1)
method to determine##18##3##(1993-3#1)(2008-10#13)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)
method to develop##2##3##(2008-10#2)
method to estimate the##3##4##(1995-12#1)(2008-3#1)(2008-5#1)
method to evaluate the##5##4##(1994-12#1)(2008-10#2)(2008-5#1)(2008-9#1)
method to evaluate##8##3##(1994-12#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#2)
method to generate##2##3##(2008-11#1)(2010-5#1)
method to improve the##2##4##(2008-3#2)
method to improve##3##3##(2008-10#1)(2008-3#2)
method to increase##3##3##(1995-5#1)(2008-10#2)
method to measure the##4##4##(2008-10#1)(2008-4#1)(2012-2#1)(2013-7#1)
method to measure##9##3##(1996-12#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-7#1)
method to monitor##2##3##(2008-10#1)(2011-2#1)
method to obtain##2##3##(2008-9#1)(2009-3#1)
method to optimize##3##3##(2008-10#2)(2008-11#1)
method to other##2##3##(2008-10#1)(2008-3#1)
method to prepare##2##3##(2008-10#1)(2008-11#1)
method to quantify##2##3##(2008-10#2)
method to quantitatively##2##3##(2008-10#2)
method to real##5##3##(2008-10#4)(2012-2#1)
method to reduce##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
method to solve##2##3##(1990-12#1)(2008-3#1)
method to study the##2##4##(2008-10#2)
method to study##7##3##(2008-10#3)(2008-4#1)(2012-9#1)(2013-1#2)
method to the analysis of##5##5##(2008-10#5)
method to the determination of##5##5##(2008-10#5)
method to the##16##3##(1995-12#1)(2008-10#14)(2008-3#1)
method to treat##2##3##(2008-9#1)(2011-2#1)
method to use##2##3##(2008-10#2)
method to##237##2##(1990-12#3)(1991-2#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#3)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#3)(2008-10#106)(2008-11#15)(2008-12#1)(2008-2#4)(2008-3#20)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#10)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#5)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#2)
method used at##2##3##(2008-10#1)(2013-1#1)
method used for the##2##4##(2008-10#1)(2008-11#1)
method used for##10##3##(2008-10#7)(2008-11#1)(2008-3#1)(2009-8#1)
method used in##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
method used to##6##3##(2008-10#3)(2008-11#1)(2010-6#1)(2013-1#1)
method used##31##2##(1990-11#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-3#2)(2009-8#1)(2010-6#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
method uses a##8##3##(2008-10#5)(2008-3#1)(2008-4#1)(2012-3#1)
method uses an##2##3##(2008-10#2)
method uses the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
method uses##16##2##(2008-10#11)(2008-11#1)(2008-3#2)(2008-4#1)(2012-3#1)
method using a##17##3##(1991-3#1)(1994-11#1)(1995-8#1)(2008-10#11)(2008-5#1)(2009-11#1)(2011-2#1)
method using an##3##3##(2008-10#3)
method using flow injection##5##4##(2008-10#5)
method using the##6##3##(1993-2#1)(1996-2#1)(2008-10#3)(2008-5#1)
method using##67##2##(1990-5#1)(1991-3#1)(1993-2#1)(1994-11#1)(1995-8#2)(1996-2#1)(2008-10#49)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#2)
method utilizes the##3##3##(2008-3#2)(2008-9#1)
method utilizes##6##2##(1991-2#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)
method utilizing##2##2##(2008-10#2)
method validation##3##2##(2008-10#3)
method varied between##2##3##(2008-10#2)
method varied from##3##3##(2008-10#3)
method varied##5##2##(2008-10#5)
method was 0##4##3##(2008-10#4)
method was 1##3##3##(2008-10#3)
method was 2##4##3##(2008-10#4)
method was 5##2##3##(2008-10#2)
method was also applied to##2##5##(2008-10#2)
method was also applied##4##4##(2008-10#4)
method was also used for##2##5##(2008-10#2)
method was also used##3##4##(2008-10#3)
method was also##16##3##(2008-10#13)(2009-6#1)(2011-2#1)(2012-2#1)
method was applicable to##2##4##(2008-10#2)
method was applicable##5##3##(2008-10#5)
method was applied for metal ion determination from water samples##2##10##(2008-10#2)
method was applied for the analysis of##2##7##(2008-10#2)
method was applied for the determination of##13##7##(2008-10#13)
method was applied for the##24##5##(2008-10#24)
method was applied for##34##4##(2008-10#33)(2010-4#1)
method was applied in##4##4##(2008-10#3)(2011-3#1)
method was applied on##4##4##(2008-10#4)
method was applied satisfactorily to the determination of##2##8##(2008-10#2)
method was applied satisfactorily to##3##5##(2008-10#3)
method was applied successfully to the determination of##8##8##(2008-10#8)
method was applied successfully to##9##5##(2008-10#9)
method was applied successfully##10##4##(2008-10#10)
method was applied to a##2##5##(2008-10#2)
method was applied to detect##2##5##(2008-10#2)
method was applied to determine the##4##6##(2008-10#4)
method was applied to determine##11##5##(2008-10#11)
method was applied to the analyses of##2##7##(2008-10#2)
method was applied to the analysis of##12##7##(2008-10#12)
method was applied to the determination of As(III) in##2##9##(2008-10#2)
method was applied to the determination of the##2##8##(2008-10#2)
method was applied to the determination of these##4##8##(2008-10#4)
method was applied to the determination of##57##7##(2008-10#57)
method was applied to the simultaneous##3##6##(2008-10#3)
method was applied to the##90##5##(2008-10#89)(2008-11#1)
method was applied to##146##4##(2008-10#141)(2008-11#2)(2008-2#1)(2011-2#1)(2013-8#1)
method was applied##206##3##(2008-10#199)(2008-11#2)(2008-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-8#1)
method was assessed by##3##4##(2008-10#3)
method was based on separation of##2##6##(2008-10#2)
method was based on the reaction of##2##7##(2008-10#2)
method was based on the##13##5##(2008-10#13)
method was based on##17##4##(2008-10#17)
method was based##18##3##(2008-10#18)
method was below##2##3##(2008-10#2)
method was calculated##2##3##(2008-10#2)
method was carried out##5##4##(2008-10#5)
method was checked by##3##4##(2008-10#3)
method was checked using##2##4##(2008-10#2)
method was checked##7##3##(2008-10#7)
method was compared with an##2##5##(2008-10#2)
method was compared with the##4##5##(2008-10#4)
method was compared with##13##4##(2008-10#12)(2012-2#1)
method was confirmed by##3##4##(2008-10#3)
method was confirmed##4##3##(2008-10#4)
method was coupled##2##3##(1995-11#1)(2008-10#1)
method was demonstrated by analyzing##5##5##(2008-10#5)
method was demonstrated by##12##4##(2008-10#12)
method was demonstrated##13##3##(2008-10#13)
method was described for##2##4##(2008-10#2)
method was described##3##3##(2008-10#3)
method was designed for the##2##5##(2008-10#2)
method was designed for##3##4##(2008-10#3)
method was determined by comparison##2##5##(2008-10#1)(2008-3#1)
method was determined##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
method was developed and##2##4##(2008-10#2)
method was developed as##2##4##(1997-2#1)(2008-10#1)
method was developed for determination of##2##6##(2008-10#2)
method was developed for on-line##2##5##(2008-10#2)
method was developed for simultaneous##2##5##(2008-10#2)
method was developed for the analysis of##2##7##(2008-10#2)
method was developed for the detection of##2##7##(2008-10#2)
method was developed for the determination of trace##2##8##(2008-10#2)
method was developed for the determination of##20##7##(2008-10#19)(2011-3#1)
method was developed for the separation and determination of##2##9##(2008-10#2)
method was developed for the simultaneous determination of##2##8##(2008-10#2)
method was developed for the simultaneous##4##6##(2008-10#4)
method was developed for the##37##5##(2008-10#36)(2011-3#1)
method was developed for##49##4##(1997-2#1)(2008-10#47)(2011-3#1)
method was developed in order to##2##6##(1996-12#1)(2008-11#1)
method was developed to determine##5##5##(2008-10#5)
method was developed to separate the##2##6##(2008-3#1)(2011-1#1)
method was developed to##12##4##(1997-2#1)(2008-10#8)(2008-3#1)(2011-1#1)(2013-1#1)
method was developed##79##3##(1996-12#1)(1997-2#3)(2008-10#69)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-3#1)(2013-1#1)
method was directly##2##3##(2008-10#2)
method was employed for the##3##5##(2008-10#3)
method was employed to##2##4##(2008-10#2)
method was employed##6##3##(2008-10#6)
method was established##2##3##(2008-10#2)
method was evaluated by the##2##5##(2008-10#2)
method was evaluated by##10##4##(2008-10#10)
method was evaluated through##2##4##(2008-10#2)
method was evaluated##17##3##(2008-10#17)
method was examined by##2##4##(2008-10#2)
method was extended##2##3##(2008-10#1)(2008-11#1)
method was found to be a powerful##2##7##(1993-8#1)(2008-11#1)
method was found to be a quick and effective technique##2##10##(2008-10#1)(2009-8#1)
method was found to be a##4##6##(1993-8#1)(2008-10#1)(2008-11#1)(2009-8#1)
method was found to be applicable##3##6##(2008-10#3)
method was found to be suitable for##2##7##(2008-10#2)
method was found to be##20##5##(1993-8#1)(2008-10#16)(2008-11#1)(2009-8#1)(2012-2#1)
method was found##22##3##(1993-8#1)(2008-10#17)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
method was further validated##2##4##(2008-10#2)
method was further##4##3##(2008-10#4)
method was implemented by using##2##5##(2008-10#2)
method was implemented##3##3##(2008-10#2)(2010-8#1)
method was in the range##2##5##(2008-10#2)
method was in##3##3##(2008-10#3)
method was linear in the range##2##6##(2008-10#2)
method was linear over the range##3##6##(2008-10#3)
method was linear over the##4##5##(2008-10#4)
method was linear##6##3##(2008-10#6)
method was more sensitive than##2##5##(2008-10#1)(2009-6#1)
method was optimized for##2##4##(2008-10#2)
method was optimized##5##3##(2008-10#5)
method was proposed for the determination of##4##7##(2008-10#4)
method was proposed for##6##4##(2008-10#6)
method was required##2##3##(2008-10#2)
method was satisfactorily applied to the determination of##4##8##(2008-10#4)
method was satisfactorily applied to the##5##6##(2008-10#5)
method was satisfactorily applied##6##4##(2008-10#6)
method was satisfactorily used##2##4##(2008-10#2)
method was satisfactorily##8##3##(2008-10#8)
method was selective##4##3##(2008-10#2)(2011-3#2)
method was sensitive##3##3##(2008-10#2)(2008-5#1)
method was simple and##2##4##(2008-10#2)
method was simple##4##3##(2008-10#4)
method was successfully applied for the determination of##5##8##(2008-10#5)
method was successfully applied for the##9##6##(2008-10#9)
method was successfully applied for##13##5##(2008-10#13)
method was successfully applied in the##2##6##(2008-10#2)
method was successfully applied in##4##5##(2008-10#3)(2011-3#1)
method was successfully applied to determine##6##6##(2008-10#6)
method was successfully applied to the analysis of##6##8##(2008-10#6)
method was successfully applied to the determination of nickel##2##9##(2008-10#2)
method was successfully applied to the determination of trace##3##9##(2008-10#3)
method was successfully applied to the determination of vanadium in##3##10##(2008-10#3)
method was successfully applied to the determination of##41##8##(2008-10#41)
method was successfully applied to the determination##42##7##(2008-10#42)
method was successfully applied to the simultaneous##9##7##(2008-10#9)
method was successfully applied to the speciation##2##7##(2008-10#2)
method was successfully applied to the##65##6##(2008-10#65)
method was successfully applied to##76##5##(2008-10#75)(2008-11#1)
method was successfully applied##94##4##(2008-10#91)(2008-11#1)(2008-3#1)(2011-3#1)
method was successfully used for the##3##6##(2008-10#3)
method was successfully used##4##4##(2008-10#4)
method was successfully##102##3##(2008-10#99)(2008-11#1)(2008-3#1)(2011-3#1)
method was suitable for##2##4##(2008-10#2)
method was superior in##2##4##(2008-10#2)
method was tested by determining##2##5##(2008-10#2)
method was tested by##9##4##(2008-10#8)(2011-2#1)
method was tested in##2##4##(2008-10#2)
method was tested on##3##4##(2008-10#2)(2008-12#1)
method was tested##20##3##(2008-10#16)(2008-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
method was then##3##3##(2008-10#3)
method was used for the##8##5##(2008-10#8)
method was used for##14##4##(1996-1#1)(2008-10#12)(2008-11#1)
method was used in##5##4##(2008-10#3)(2012-12#1)(2013-8#1)
method was used to determine the##6##6##(2008-10#5)(2008-5#1)
method was used to determine##9##5##(2008-10#8)(2008-5#1)
method was used to examine the##2##6##(1991-10#1)(2008-8#1)
method was used to measure##2##5##(2008-10#1)(2008-3#1)
method was used to the##2##5##(2008-10#2)
method was used to##35##4##(1991-10#1)(2008-10#28)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
method was used##64##3##(1991-10#1)(1995-12#1)(1996-1#1)(2008-10#47)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
method was utilized for##2##4##(2008-10#2)
method was utilized to##2##4##(2008-10#1)(2010-3#1)
method was utilized##5##3##(2008-10#3)(2008-11#1)(2010-3#1)
method was validated by##7##4##(1996-3#1)(2008-10#6)
method was validated in terms of##3##6##(2008-10#2)(2012-2#1)
method was validated using##5##4##(2008-10#5)
method was validated##28##3##(1996-3#1)(2008-10#25)(2011-3#1)(2012-2#1)
method was##811##2##(1990-2#1)(1990-8#1)(1991-10#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#4)(2008-10#733)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#5)(2008-7#1)(2008-8#5)(2008-9#1)(2009-6#2)(2009-8#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#7)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#4)
method we##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
method were 0##2##3##(1990-2#1)(2008-10#1)
method were compared to##2##4##(2008-10#2)
method were compared with##5##4##(2008-10#5)
method were compared##8##3##(2008-10#8)
method were demonstrated##2##3##(2008-10#2)
method were employed##2##3##(2008-3#1)(2011-3#1)
method were found to be##2##5##(2008-10#2)
method were found to##3##4##(2008-10#2)(2008-11#1)
method were in good agreement with those obtained by##2##9##(2008-10#2)
method were in good agreement with##5##6##(2008-10#5)
method were in##6##3##(2008-10#5)(2008-5#1)
method were used##2##3##(2008-10#1)(2012-2#1)
method were##62##2##(1990-12#1)(1990-2#1)(2008-10#53)(2008-11#2)(2008-3#1)(2008-5#2)(2011-3#1)(2012-2#1)
method when##6##2##(2008-10#5)(2008-3#1)
method which has##2##3##(1994-2#1)(2008-10#1)
method which uses streptavidin-coated magnetic beads##2##6##(1995-6#2)
method which##12##2##(1990-12#1)(1991-9#1)(1994-2#1)(1994-8#1)(1995-6#2)(1996-2#1)(2008-10#4)(2008-11#1)
method will be useful for##2##5##(2008-10#1)(2011-1#1)
method will be##5##3##(1995-3#1)(2008-10#3)(2011-1#1)
method will##9##2##(1995-3#1)(2008-10#5)(2008-11#1)(2011-1#1)(2011-2#1)
method with a high##2##4##(1996-11#1)(2008-10#1)
method with a##7##3##(1996-11#1)(2008-10#6)
method with arithmetic averages##2##4##(2008-10#2)
method with arithmetic##8##3##(2008-10#8)
method with direct##2##3##(2008-10#1)(2008-3#1)
method with fluorescence detection##2##4##(2008-10#2)
method with good##3##3##(2008-10#2)(2011-3#1)
method with high##3##3##(2008-10#3)
method with on-line##3##3##(2008-10#3)
method with standard##2##3##(2008-10#2)
method with the##3##3##(2008-10#2)(2011-2#1)
method with those obtained by##2##5##(2008-10#2)
method with those##4##3##(2008-10#4)
method with##83##2##(1993-12#1)(1994-9#1)(1995-5#1)(1996-11#1)(2008-10#64)(2008-11#2)(2008-3#4)(2008-5#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#1)
method within##2##2##(2008-10#1)(2008-11#1)
method without##4##2##(2008-10#4)
method would##4##2##(2008-10#3)(2008-5#1)
method yielded##4##2##(2008-10#3)(2008-7#1)
method yields##2##2##(1993-2#1)(2008-2#1)
method##6173##1##(1990-11#11)(1990-12#13)(1990-2#16)(1990-3#3)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#12)(1991-3#7)(1991-5#3)(1991-6#4)(1991-7#1)(1991-9#3)(1992-11#4)(1992-12#6)(1992-2#7)(1992-3#4)(1992-4#2)(1992-5#3)(1992-8#2)(1992-9#7)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#7)(1993-3#9)(1993-5#1)(1993-6#3)(1993-8#9)(1994-1#3)(1994-11#9)(1994-12#10)(1994-2#3)(1994-3#9)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#13)(1995-1#6)(1995-11#5)(1995-12#13)(1995-2#5)(1995-3#6)(1995-5#7)(1995-6#5)(1995-8#9)(1995-9#2)(1996-1#5)(1996-11#1)(1996-12#9)(1996-2#8)(1996-3#15)(1996-5#3)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#28)(1997-3#4)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#9)(2007-11#11)(2007-12#10)(2007-8#2)(2008-1#5)(2008-10#4471)(2008-11#207)(2008-12#41)(2008-2#40)(2008-3#196)(2008-4#63)(2008-5#75)(2008-6#17)(2008-7#39)(2008-8#44)(2008-9#83)(2009-1#3)(2009-10#9)(2009-11#3)(2009-12#8)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#9)(2009-7#7)(2009-8#20)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#16)(2010-12#10)(2010-2#1)(2010-3#7)(2010-4#6)(2010-5#7)(2010-6#18)(2010-7#21)(2010-8#23)(2010-9#6)(2011-1#4)(2011-2#62)(2011-3#22)(2011-7#2)(2012-12#12)(2012-2#57)(2012-3#31)(2012-4#1)(2012-5#1)(2012-9#1)(2013-1#57)(2013-3#1)(2013-7#1)(2013-8#38)
method&quot##2##1##(1990-5#1)(2008-10#1)
method'##6##1##(2008-10#2)(2008-12#1)(2013-8#3)
method's ability to##2##3##(2008-10#1)(2008-5#1)
method's##7##1##(2008-10#5)(2008-5#1)(2008-8#1)
method) and two##2##3##(2008-10#1)(2008-7#1)
method) and##5##2##(2008-10#4)(2008-7#1)
method) is##3##2##(2008-10#2)(2008-7#1)
method) was##2##2##(2008-8#1)(2011-2#1)
method)##32##1##(1992-9#1)(2008-10#20)(2008-11#2)(2008-4#1)(2008-7#5)(2008-8#1)(2011-2#1)(2013-1#1)
method]##5##1##(1990-5#1)(1994-8#1)(1995-5#1)(2010-12#1)(2011-2#1)
methodical##5##1##(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
methodologic##4##1##(1993-12#2)(1994-6#1)(1997-1#1)
methodological and conceptual##3##3##(2008-8#1)(2009-7#1)(2012-3#1)
methodological and##6##2##(1995-11#1)(1996-2#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-3#1)
methodological approach##4##2##(2008-10#3)(2008-5#1)
methodological aspects of##2##3##(1995-5#1)(2008-4#1)
methodological considerations##2##2##(2008-9#1)(2011-1#1)
methodological errors##2##2##(1995-5#1)(2011-2#1)
methodological issues in##2##3##(1997-1#1)(2008-9#1)
methodological issues that##2##3##(2008-12#1)(2008-6#1)
methodological issues##6##2##(1997-1#1)(2008-12#3)(2008-6#1)(2008-9#1)
methodological quality##2##2##(2008-10#1)(2008-12#1)
methodological##51##1##(1991-11#1)(1992-1#1)(1992-12#1)(1992-3#3)(1993-11#1)(1994-6#1)(1995-11#1)(1995-5#2)(1996-2#4)(1997-1#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
methodologically##2##1##(2008-11#1)(2013-1#1)
methodologies and##4##2##(1995-5#1)(2008-11#2)(2008-4#1)
methodologies are##5##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
methodologies for assessing##2##3##(1992-3#1)(2013-1#1)
methodologies for the##2##3##(2008-10#2)
methodologies for##14##2##(1992-3#1)(1993-3#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
methodologies to##4##2##(2008-10#3)(2013-8#1)
methodologies used to##2##3##(1997-3#1)(2008-7#1)
methodologies used##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
methodologies were developed##2##3##(2008-10#2)
methodologies were##6##2##(1993-1#1)(2008-10#5)
methodologies##72##1##(1990-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#2)(1995-2#2)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#36)(2008-11#4)(2008-4#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#2)(2013-1#1)(2013-8#1)
methodology allows the##2##3##(2008-10#2)
methodology allows##4##2##(2008-10#4)
methodology and##17##2##(1993-12#1)(1993-3#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)
methodology are##2##2##(2008-10#1)(2010-10#1)
methodology based on the##2##4##(2008-10#2)
methodology based on##7##3##(2008-10#6)(2011-2#1)
methodology by##2##2##(1995-2#1)(2008-10#1)
methodology can be##2##3##(2008-10#1)(2008-3#1)
methodology can##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
methodology could be applied##2##4##(2008-10#1)(2008-6#1)
methodology could be##4##3##(2008-10#3)(2008-6#1)
methodology developed##8##2##(2008-10#6)(2008-5#1)(2009-10#1)
methodology enables the##2##3##(2008-10#1)(2008-8#1)
methodology exhibited a##2##3##(2008-10#2)
methodology for the analysis of##3##5##(2008-10#3)
methodology for the determination of lead##2##6##(2008-10#2)
methodology for the determination of the##2##6##(2008-10#2)
methodology for the determination of##9##5##(2008-10#8)(2011-2#1)
methodology for the direct determination of##2##6##(2008-10#2)
methodology for the##22##3##(2008-10#19)(2008-11#1)(2008-7#1)(2011-2#1)
methodology for##50##2##(1990-5#1)(1992-1#1)(1992-12#1)(1994-12#1)(1996-6#1)(1997-3#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
methodology from##3##2##(1996-2#1)(2008-6#1)(2012-3#1)
methodology has been applied##2##4##(2008-10#2)
methodology has been developed for the##2##6##(2008-10#2)
methodology has been##8##3##(2008-10#6)(2008-7#1)(2009-10#1)
methodology has##13##2##(1997-3#1)(2008-10#8)(2008-12#1)(2008-7#1)(2009-10#1)(2012-2#1)
methodology in order to##2##4##(1997-1#1)(2008-10#1)
methodology in the##3##3##(1990-8#1)(1991-3#1)(2008-10#1)
methodology in##11##2##(1990-8#1)(1991-3#1)(1997-1#1)(2008-10#5)(2008-11#1)(2009-8#1)(2013-8#1)
methodology involves##2##2##(2008-10#2)
methodology is applied to the##2##5##(2008-10#1)(2008-8#1)
methodology is described##2##3##(1995-12#1)(2008-10#1)
methodology is not##2##3##(1994-12#1)(2008-10#1)
methodology is proposed to##2##4##(2008-10#2)
methodology is##22##2##(1992-12#1)(1994-12#1)(1995-12#1)(1996-5#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)
methodology known as##2##3##(1996-1#1)(2008-10#1)
methodology of##9##2##(1993-2#1)(2008-10#2)(2008-12#1)(2010-10#1)(2012-3#2)(2013-1#2)
methodology offers##2##2##(2008-10#2)
methodology or##2##2##(2008-10#1)(2008-6#1)
methodology overcomes the##2##3##(2008-10#2)
methodology provides##2##2##(1994-12#1)(2008-10#1)
methodology requires##2##2##(2008-10#1)(2008-12#1)
methodology suitable for##2##3##(2008-10#1)(2010-12#1)
methodology that##4##2##(1993-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
methodology to detect and quantify##2##5##(2008-10#2)
methodology to determine##2##3##(2008-10#1)(2008-5#1)
methodology to##24##2##(1995-3#2)(1995-9#1)(1996-3#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-8#1)(2011-2#1)
methodology used to##3##3##(1995-2#1)(2008-10#1)(2008-12#1)
methodology used##8##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
methodology using##7##2##(2008-10#7)
methodology was applied##3##3##(2008-10#2)(2013-1#1)
methodology was developed to determine##2##5##(2008-10#2)
methodology was developed##3##3##(2008-10#3)
methodology was evaluated##2##3##(2008-10#2)
methodology was successfully applied to the##2##6##(2008-10#2)
methodology was successfully applied to##3##5##(2008-10#2)(2012-2#1)
methodology was successfully##4##3##(2008-10#3)(2012-2#1)
methodology was used to##2##4##(1995-3#1)(2008-9#1)
methodology was used##4##3##(1995-3#1)(2008-10#1)(2008-9#2)
methodology was validated##2##3##(2008-10#2)
methodology was##27##2##(1995-3#1)(1996-3#1)(2008-10#20)(2008-9#2)(2009-7#1)(2012-2#1)(2013-1#1)
methodology we##2##2##(2008-10#1)(2012-2#1)
methodology were##2##2##(2008-10#2)
methodology with those##2##3##(1992-12#1)(2008-10#1)
methodology with##3##2##(1992-12#1)(2008-10#1)(2010-10#1)
methodology##373##1##(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#3)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#2)(1994-12#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#2)(2008-10#223)(2008-11#13)(2008-12#10)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#8)(2009-10#5)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#8)(2012-3#3)(2013-1#6)(2013-8#3)
methodology]##2##1##(2010-6#1)(2012-3#1)
methods (i##4##2##(2008-10#1)(2008-3#1)(2012-12#2)
methods allow##4##2##(2008-1#1)(2008-10#2)(2008-4#1)
methods allowing##2##2##(2008-10#2)
methods along with##2##3##(1993-12#1)(2008-10#1)
methods and by##3##3##(2008-10#3)
methods and new##2##3##(1996-2#1)(2010-11#1)
methods and payment##2##3##(1992-2#1)(1994-12#1)
methods and results##3##3##(2008-1#1)(2008-3#1)(2010-7#1)
methods and the##6##3##(1990-9#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#2)
methods and their##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
methods and##76##2##(1990-9#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#8)(2008-3#1)(2008-4#2)(2008-8#3)(2008-9#6)(2009-4#1)(2009-5#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#4)
methods applied to the##3##4##(2008-10#3)
methods applied to##4##3##(2008-10#3)(2010-7#1)
methods applied##5##2##(2008-10#4)(2010-7#1)
methods are also##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
methods are applied to the##2##5##(2008-10#2)
methods are applied##4##3##(2008-10#4)
methods are available##3##3##(1994-1#1)(1997-5#2)
methods are based on the formation of##2##7##(2008-10#2)
methods are based on the##6##5##(2008-10#4)(2008-11#1)(2012-2#1)
methods are based on##10##4##(2008-10#5)(2008-11#1)(2008-3#2)(2011-2#1)(2012-2#1)
methods are briefly##2##3##(1990-9#1)(1995-12#1)
methods are commonly##2##3##(2008-10#2)
methods are currently##2##3##(2008-10#1)(2009-1#1)
methods are described for the determination of##2##7##(2008-10#2)
methods are described for the##3##5##(2008-10#3)
methods are described for##5##4##(2008-10#3)(2008-9#2)
methods are described##7##3##(2008-10#4)(2008-4#1)(2008-9#2)
methods are developed for the##2##5##(2008-10#1)(2011-2#1)
methods are developed##4##3##(2008-10#1)(2011-2#1)(2011-7#1)(2012-3#1)
methods are discussed##2##3##(1997-2#1)(2008-10#1)
methods are given for##2##4##(2008-3#1)(2008-4#1)
methods are in good agreement##3##5##(2008-10#3)
methods are needed##2##3##(2008-10#2)
methods are often##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
methods are presented for##2##4##(2008-10#1)(2008-9#1)
methods are presented##5##3##(1991-3#1)(2008-10#2)(2008-9#2)
methods are provided for##2##4##(2008-9#2)
methods are provided##3##3##(2008-10#1)(2008-9#2)
methods are reviewed##2##3##(2008-10#1)(2008-4#1)
methods are suitable for##2##4##(2008-10#1)(2008-4#1)
methods are used to##2##4##(2008-8#1)(2010-11#1)
methods are used##4##3##(2008-10#1)(2008-8#1)(2010-11#1)(2010-8#1)
methods are##106##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1994-1#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#2)(2008-10#53)(2008-11#4)(2008-3#4)(2008-4#7)(2008-8#1)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
methods as well as##2##4##(2008-10#2)
methods as##6##2##(1994-1#1)(2008-10#3)(2008-11#2)
methods at 95% confidence level##2##5##(2008-10#2)
methods at##5##2##(1991-12#1)(1995-5#1)(2008-10#3)
methods available for##3##3##(2008-11#1)(2008-9#2)
methods available##6##2##(2008-10#1)(2008-11#1)(2008-9#2)(2012-2#1)(2013-1#1)
methods based on##16##3##(2008-10#12)(2008-7#1)(2008-9#2)(2010-11#1)
methods but##3##2##(1992-9#1)(2008-10#1)(2008-12#1)
methods by which##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
methods by##7##2##(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-7#1)(2013-8#1)
methods can be used for the##3##6##(2008-10#3)
methods can be used for##4##5##(2008-10#4)
methods can be used##8##4##(1990-12#1)(1993-3#1)(2008-10#5)(2008-4#1)
methods can be##12##3##(1990-12#1)(1993-3#1)(2008-10#6)(2008-4#2)(2008-9#1)(2012-2#1)
methods can provide##2##3##(2008-4#1)(2012-2#1)
methods can##21##2##(1990-12#1)(1993-3#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#2)(2012-2#2)
methods commonly used for##2##4##(2008-11#1)(2010-11#1)
methods commonly used to##2##4##(2008-10#1)(2008-5#1)
methods commonly used##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
methods commonly##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
methods could be##4##3##(2008-10#2)(2010-7#1)(2012-2#1)
methods could##5##2##(2008-10#3)(2010-7#1)(2012-2#1)
methods currently##2##2##(1994-2#1)(2008-10#1)
methods demonstrated##2##2##(2008-10#2)
methods depend on the##2##4##(2008-10#2)
methods described for##2##3##(2008-10#2)
methods described in##2##3##(2008-10#2)
methods described##8##2##(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)
methods developed in this##2##4##(2008-10#1)(2011-2#1)
methods developed in##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
methods developed##7##2##(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)
methods do not##4##3##(1997-2#1)(2007-8#1)(2008-10#1)(2010-7#1)
methods do##5##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-7#1)
methods due to##2##3##(2008-10#1)(2008-4#1)
methods employ##2##2##(2008-4#1)(2009-8#1)
methods employed for##4##3##(1994-2#1)(2008-10#2)(2010-7#1)
methods employed to##2##3##(2008-11#1)(2008-12#1)
methods employed##10##2##(1991-3#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2010-7#1)(2013-8#1)
methods exist##3##2##(2008-11#1)(2008-9#1)(2010-6#1)
methods for a##2##3##(1990-5#1)(1990-9#1)
methods for analysis of##3##4##(2008-10#2)(2012-12#1)
methods for analyzing##2##3##(2008-4#1)(2010-1#1)
methods for detecting##3##3##(2008-10#2)(2008-4#1)
methods for determination of##3##4##(1993-2#1)(2008-10#2)
methods for evaluation##2##3##(1995-12#1)(2009-4#1)
methods for isolating##2##3##(2008-4#1)(2008-9#1)
methods for its##3##3##(2007-12#1)(2008-10#2)
methods for making##2##3##(2008-11#1)(2008-4#1)
methods for monitoring##3##3##(2008-4#3)
methods for presbyopia treatment##2##4##(2011-2#2)
methods for quantifying##2##3##(2008-10#1)(2008-4#1)
methods for recording##2##3##(2008-10#1)(2008-4#1)
methods for routine##2##3##(2008-10#2)
methods for such##2##3##(2008-10#1)(2011-3#1)
methods for the analysis of##4##5##(2008-10#3)(2008-2#1)
methods for the analysis##6##4##(2008-10#3)(2008-2#1)(2008-4#1)(2012-2#1)
methods for the detection of##5##5##(1992-11#1)(2008-10#4)
methods for the determination of total##3##6##(2008-10#3)
methods for the determination of##28##5##(2008-10#26)(2008-11#1)(2012-2#1)
methods for the in##2##4##(2008-11#1)(2008-4#1)
methods for the isolation and##2##5##(2008-4#1)(2008-9#1)
methods for the simultaneous##2##4##(2008-10#2)
methods for the##70##3##(1992-11#2)(1994-12#1)(1995-8#1)(2008-10#47)(2008-11#4)(2008-2#1)(2008-4#4)(2008-9#3)(2009-10#1)(2009-8#1)(2012-2#4)(2013-1#1)
methods for their##2##3##(2008-10#1)(2011-3#1)
methods for these compounds##2##4##(2008-10#2)
methods for these##3##3##(2008-10#3)
methods for##243##2##(1990-5#1)(1990-9#2)(1992-11#2)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#3)(1995-8#1)(1995-9#2)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#104)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#27)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#16)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#3)(2010-12#1)(2010-5#2)(2010-7#2)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#3)
methods from the##4##3##(1994-1#1)(2008-10#1)(2008-6#1)(2009-8#1)
methods from##6##2##(1994-1#1)(2008-10#2)(2008-6#1)(2009-8#2)
methods gave##2##2##(2008-10#2)
methods has been##3##3##(1990-5#1)(2008-10#1)(2012-3#1)
methods has##5##2##(1990-5#1)(2008-10#1)(2009-11#1)(2012-3#1)(2013-8#1)
methods have also been##2##4##(2008-10#1)(2012-2#1)
methods have been applied for the determination of##2##8##(2008-10#2)
methods have been applied to##2##5##(2008-10#2)
methods have been applied##5##4##(2008-10#4)(2008-11#1)
methods have been described for##2##5##(2008-10#1)(2013-1#1)
methods have been described##3##4##(2008-10#2)(2013-1#1)
methods have been developed for the determination of##2##8##(2008-10#2)
methods have been developed for the##3##6##(2008-10#3)
methods have been developed for##4##5##(2008-10#3)(2008-9#1)
methods have been developed to##2##5##(2008-10#1)(2008-11#1)
methods have been developed##8##4##(2008-10#5)(2008-11#1)(2008-9#1)(2009-10#1)
methods have been proposed for##3##5##(2009-1#1)(2011-2#1)(2012-2#1)
methods have been successfully applied to##4##6##(2008-10#4)
methods have been used for##2##5##(2008-10#1)(2008-9#1)
methods have been used to##3##5##(1990-9#1)(2008-10#2)
methods have been used##5##4##(1990-9#1)(2008-10#3)(2008-9#1)
methods have been##35##3##(1990-9#1)(1995-12#1)(1997-8#1)(2008-10#21)(2008-11#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
methods have recently been##2##4##(1995-12#1)(2008-5#1)
methods have##51##2##(1990-9#1)(1995-12#2)(1996-9#1)(1997-8#1)(2008-10#27)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
methods in a##2##3##(2008-10#1)(2008-8#1)
methods in terms of##2##4##(2008-10#2)
methods in the##6##3##(1990-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2009-11#1)(2010-11#1)
methods in##43##2##(1990-5#1)(1991-1#1)(1991-2#1)(1992-12#2)(1993-2#1)(1993-3#1)(1994-9#1)(1997-2#1)(1997-4#1)(2008-10#14)(2008-12#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#3)(2010-12#1)(2010-9#2)(2012-2#1)(2013-1#1)(2013-8#2)
methods include##4##2##(2008-10#2)(2008-6#1)(2008-9#1)
methods included##2##2##(2008-10#1)(2010-7#1)
methods including the##2##3##(2008-11#1)(2008-4#1)
methods including##5##2##(2008-10#3)(2008-11#1)(2008-4#1)
methods indicated##3##2##(2008-10#3)
methods indicates that##2##3##(1992-6#1)(2008-10#1)
methods involved##2##2##(2008-10#1)(2010-7#1)
methods is a##3##3##(2008-10#2)(2013-1#1)
methods is##16##2##(1995-9#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#3)
methods led to a##2##4##(1993-11#1)(2011-2#1)
methods like##7##2##(2008-10#6)(2008-11#1)
methods may be##4##3##(1994-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
methods may##9##2##(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
methods of DNA##2##3##(2008-5#1)(2008-9#1)
methods of a##2##3##(2008-10#1)(2008-11#1)
methods of analysis for##2##4##(2008-10#1)(2008-9#1)
methods of analysis##9##3##(1990-2#1)(1994-9#1)(2008-10#5)(2008-3#1)(2008-9#1)
methods of assessment##3##3##(1992-3#1)(2008-11#2)
methods of birth##2##3##(1994-9#1)(2013-8#1)
methods of combined inhalational and epidural anesthesia##2##7##(2012-3#2)
methods of combined##3##3##(2012-3#3)
methods of control have##2##4##(1997-7#2)
methods of data analysis##3##4##(2008-11#2)(2009-7#1)
methods of detection##3##3##(2008-10#3)
methods of evaluating and##2##4##(2007-11#1)(2008-6#1)
methods of immobilization on##2##4##(1997-2#1)(2008-10#1)
methods of investigation##2##3##(1991-11#1)(1993-11#1)
methods of management##2##3##(1994-3#1)(2013-8#1)
methods of measurement##2##3##(2008-10#1)(2008-11#1)
methods of multivariate##2##3##(2008-10#2)
methods of the##2##3##(2008-10#1)(2008-11#1)
methods of treatment of##4##4##(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
methods of treatment##8##3##(1997-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
methods of##149##2##(1990-2#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#3)(2007-11#2)(2008-10#43)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-12#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#6)(2013-8#2)
methods offers##2##2##(2008-10#1)(2009-12#1)
methods on##7##2##(2008-10#7)
methods only##2##2##(1995-12#1)(2008-10#1)
methods or##2##2##(2008-10#2)
methods produced##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
methods proposed were##2##3##(2008-10#2)
methods proposed##4##2##(2008-10#4)
methods provide important##2##3##(1991-2#2)
methods provide##6##2##(1991-2#2)(1995-9#1)(2008-11#1)(2008-9#1)(2009-11#1)
methods remain##2##2##(2008-10#1)(2010-7#1)
methods reported##4##2##(2008-10#4)
methods require##3##2##(1994-8#1)(2008-10#2)
methods required##2##2##(2008-10#1)(2008-11#1)
methods should be##2##3##(1992-12#1)(2008-9#1)
methods should##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
methods show##2##2##(2008-10#1)(2008-7#1)
methods showed##7##2##(2008-10#5)(2008-5#1)(2011-2#1)
methods such as##21##3##(1993-3#1)(1996-2#1)(2008-10#12)(2008-11#2)(2008-6#1)(2010-11#1)(2010-6#1)(2011-2#1)(2011-3#1)
methods suitable for##3##3##(1990-2#1)(2008-10#1)(2012-3#1)
methods that are##2##3##(2008-10#1)(2008-5#1)
methods that can##2##3##(2008-4#1)(2008-9#1)
methods that have been##2##4##(2008-4#1)(2012-2#1)
methods that have##3##3##(2008-4#1)(2012-2#2)
methods that permit##2##3##(2008-12#1)(2008-2#1)
methods that provide##2##3##(2008-10#1)(2008-5#1)
methods that rely on##2##4##(1995-2#1)(2008-10#1)
methods that use##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
methods that##35##2##(1992-12#1)(1992-9#2)(1994-2#2)(1995-2#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#3)(2010-12#1)(2011-2#1)(2012-2#3)(2013-1#1)
methods to a##2##3##(2008-10#2)
methods to analyze##2##3##(2008-10#1)(2013-1#1)
methods to assess##4##3##(2008-11#1)(2008-4#1)(2008-6#1)(2009-4#1)
methods to be##3##3##(1997-1#1)(2008-10#2)
methods to classify##2##3##(2008-10#2)
methods to control the##2##4##(1997-7#1)(2008-11#1)
methods to detect##6##3##(1994-11#1)(2008-10#2)(2008-9#2)(2011-2#1)
methods to determine the##2##4##(1995-2#1)(2008-3#1)
methods to determine##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
methods to evaluate the##2##4##(2008-9#1)(2012-3#1)
methods to evaluate##4##3##(1995-5#1)(2008-10#1)(2008-9#1)(2012-3#1)
methods to improve##2##3##(1993-1#1)(2008-10#1)
methods to investigate##2##3##(2007-12#1)(2008-10#1)
methods to measure##9##3##(1997-1#1)(2008-10#3)(2008-9#2)(2010-12#1)(2010-5#1)(2012-3#1)
methods to quantify##2##3##(2008-10#2)
methods to the determination of##2##5##(2008-10#1)(2008-3#1)
methods to the##6##3##(1990-3#1)(2008-10#4)(2008-3#1)
methods to##96##2##(1990-3#1)(1990-5#1)(1991-12#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-5#2)(1997-1#2)(1997-7#1)(2007-12#1)(2008-10#34)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#10)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-5#1)(2010-7#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
methods used and the##2##4##(1991-2#1)(1997-1#1)
methods used are##2##3##(2008-9#1)(2013-1#1)
methods used for the##2##4##(2008-10#1)(2008-11#1)
methods used for##10##3##(1997-3#1)(2008-10#4)(2008-11#2)(2011-2#2)(2013-1#1)
methods used in the##5##4##(2008-10#3)(2008-11#1)(2008-3#1)
methods used in##8##3##(2008-10#4)(2008-11#2)(2008-3#1)(2013-8#1)
methods used to##10##3##(1991-2#1)(1993-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)
methods used##38##2##(1991-2#2)(1993-2#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
methods using a##2##3##(2008-10#1)(2008-8#1)
methods using an##2##3##(2008-12#1)(2008-5#1)
methods using##16##2##(1992-3#1)(1997-2#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2013-1#1)
methods usually##2##2##(2008-10#2)
methods was observed##2##3##(2008-10#2)
methods was tested##2##3##(2008-10#2)
methods was##16##2##(2008-10#15)(2011-2#1)
methods we##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
methods were 0##3##3##(2008-10#3)
methods were also used to##3##5##(2008-10#2)(2010-7#1)
methods were applied to the analysis of##2##7##(2008-10#2)
methods were applied to the determination of the##2##8##(2008-10#2)
methods were applied to the determination of##7##7##(2008-10#7)
methods were applied to the determination##8##6##(2008-10#8)
methods were applied to the##11##5##(2008-10#11)
methods were applied to##17##4##(1997-2#1)(2008-10#16)
methods were applied##20##3##(1997-2#1)(2008-10#19)
methods were compared and##2##4##(2008-10#1)(2008-3#1)
methods were compared using##2##4##(2008-10#2)
methods were compared with##2##4##(1994-12#1)(2008-10#1)
methods were compared##10##3##(1994-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2012-3#1)
methods were developed for the determination of##2##7##(2008-10#2)
methods were developed for the##3##5##(2008-10#3)
methods were developed##5##3##(2008-10#5)
methods were employed##2##3##(2008-10#1)(2008-6#1)
methods were evaluated##2##3##(1993-2#1)(2008-10#1)
methods were found to be##2##5##(2008-10#2)
methods were found##3##3##(2008-10#3)
methods were in##3##3##(2008-10#3)
methods were investigated##2##3##(2008-10#1)(2011-2#1)
methods were proposed##2##3##(2008-10#2)
methods were successfully applied to##4##5##(2008-10#4)
methods were tested##2##3##(2008-10#1)(2008-5#1)
methods were used for the##5##5##(2008-10#4)(2008-11#1)
methods were used for##7##4##(2008-10#6)(2008-11#1)
methods were used to##9##4##(1992-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
methods were used##20##3##(1992-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
methods were validated by##3##4##(2008-10#3)
methods were validated##4##3##(2008-10#4)
methods were well##2##3##(2008-10#2)
methods were##122##2##(1992-11#1)(1993-2#2)(1993-9#1)(1994-12#1)(1995-1#1)(1997-2#1)(2008-10#96)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-3#3)
methods where##2##2##(2008-10#2)
methods which are##2##3##(1990-2#1)(1994-9#1)
methods which can be used##2##5##(1991-3#1)(2008-10#1)
methods which##9##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-12#1)(1994-3#1)(1994-9#1)(2008-10#3)
methods will also##2##3##(1997-1#1)(2008-10#1)
methods will##6##2##(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
methods with##11##2##(1992-1#1)(1993-2#1)(1993-3#1)(2008-10#5)(2008-5#1)(2010-11#1)(2011-2#1)
methods within##2##2##(2008-11#1)(2008-12#1)
methods work##2##2##(2012-3#1)(2013-1#1)
methods##2018##1##(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#4)(1990-6#3)(1990-8#2)(1990-9#9)(1991-1#2)(1991-11#1)(1991-12#7)(1991-2#8)(1991-3#8)(1992-1#4)(1992-11#5)(1992-12#5)(1992-2#3)(1992-3#5)(1992-5#2)(1992-6#2)(1992-9#7)(1993-1#2)(1993-11#4)(1993-12#3)(1993-2#10)(1993-3#10)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#4)(1994-11#2)(1994-12#7)(1994-2#11)(1994-3#5)(1994-5#5)(1994-6#2)(1994-8#6)(1994-9#9)(1995-1#5)(1995-11#2)(1995-12#10)(1995-2#6)(1995-5#5)(1995-6#1)(1995-8#2)(1995-9#6)(1996-1#1)(1996-12#4)(1996-2#8)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#12)(1997-3#5)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#7)(1997-8#2)(2006-6#1)(2007-11#6)(2007-12#7)(2007-8#7)(2008-1#9)(2008-10#956)(2008-11#105)(2008-12#35)(2008-2#7)(2008-3#33)(2008-4#63)(2008-5#46)(2008-6#21)(2008-7#16)(2008-8#23)(2008-9#84)(2009-1#3)(2009-10#5)(2009-11#3)(2009-12#4)(2009-3#2)(2009-4#6)(2009-5#3)(2009-7#5)(2009-8#15)(2009-9#1)(2010-1#6)(2010-10#4)(2010-11#15)(2010-12#9)(2010-4#2)(2010-5#6)(2010-6#8)(2010-7#26)(2010-8#5)(2010-9#3)(2011-2#43)(2011-3#8)(2011-7#1)(2012-12#28)(2012-2#33)(2012-3#27)(2012-5#1)(2013-1#45)(2013-8#19)
methods)##5##1##(1990-12#1)(2008-10#4)
methods]##2##1##(1991-2#1)(1997-4#1)
methohexital##2##1##(1993-1#1)(2008-10#1)
methosulfate##3##1##(1992-3#1)(2008-10#1)(2008-11#1)
methosulphate##2##1##(2008-10#1)(2008-11#1)
methotrexate (MTX)##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
methotrexate and##3##2##(1995-8#1)(2010-12#2)
methotrexate in##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
methotrexate##32##1##(1990-8#1)(1991-8#1)(1992-12#1)(1995-8#3)(1997-8#1)(2007-11#1)(2008-10#7)(2008-11#7)(2009-5#1)(2010-12#3)(2012-3#3)(2013-1#2)(2013-8#1)
methotrexate-containing##2##1##(1992-12#1)(2008-11#1)
methoxamine##3##1##(2008-10#3)
methoxy group on the##2##4##(2008-10#2)
methoxy##7##1##(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#2)
methoxycinnamate##7##1##(2008-5#7)
methoxyindoles##3##1##(1995-12#3)
methoxyl group##2##2##(1993-8#1)(2008-10#1)
methoxyl##5##1##(1993-8#2)(2008-10#1)(2011-2#2)
methoxyresorufin##4##1##(1994-8#4)
methsulfuron-methyl##3##1##(2008-10#3)
methyl 4##2##2##(1996-5#2)
methyl acrylate and##2##3##(1996-5#1)(2008-10#1)
methyl acrylate##3##2##(1996-5#1)(2008-10#2)
methyl borate##3##2##(2008-10#3)
methyl bromide has##2##3##(2008-10#2)
methyl bromide##16##2##(2008-10#16)
methyl chloride##2##2##(2008-11#2)
methyl ester and##2##3##(2008-10#2)
methyl ester##35##2##(1992-10#1)(1995-11#2)(1996-5#1)(1997-2#1)(2008-10#15)(2008-11#8)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)
methyl ester)##4##2##(1995-11#1)(1997-2#1)(2008-10#2)
methyl esters##10##2##(2008-10#7)(2009-8#3)
methyl ethyl ketone##5##3##(2008-10#5)
methyl group##5##2##(1995-11#1)(1996-5#1)(2008-10#2)(2013-8#1)
methyl groups##3##2##(1992-3#1)(1994-5#1)(2008-10#1)
methyl iodide##2##2##(2008-10#2)
methyl isobutyl ketone and cyclohexanone##4##5##(2008-10#4)
methyl isobutyl ketone and##5##4##(2008-10#5)
methyl isobutyl ketone##9##3##(2008-10#9)
methyl jasmonate (MeJA)##2##3##(2011-10#2)
methyl jasmonate was##2##3##(2008-10#2)
methyl jasmonate##10##2##(2008-10#7)(2011-10#3)
methyl ketone and##2##3##(2008-10#2)
methyl ketone##8##2##(2008-10#8)
methyl mercury##5##2##(2008-10#5)
methyl methacrylate and##2##3##(1994-8#1)(2008-10#1)
methyl methacrylate solution##2##3##(2008-10#2)
methyl methacrylate were##2##3##(1994-8#1)(2008-7#1)
methyl methacrylate##11##2##(1994-8#2)(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#2)
methyl orange (MO)##2##3##(2008-10#2)
methyl orange##8##2##(2008-10#7)(2009-11#1)
methyl parathion and malathion##2##4##(1994-5#2)
methyl parathion##3##2##(1994-5#2)(2008-10#1)
methyl thymol blue##5##3##(2008-10#5)
methyl transferase##2##2##(1991-5#2)
methyl vinyl ketone##2##3##(1995-11#1)(1996-5#1)
methyl vinyl##4##2##(1995-11#1)(1996-5#3)
methyl viologen##3##2##(1991-5#1)(2008-10#2)
methyl##208##1##(1990-9#1)(1991-5#3)(1991-9#1)(1992-10#1)(1992-12#7)(1992-3#1)(1994-5#4)(1994-8#6)(1995-11#5)(1995-5#1)(1996-12#2)(1996-5#9)(1997-2#2)(1997-4#1)(2007-12#1)(2008-10#126)(2008-11#12)(2008-12#2)(2008-3#2)(2008-7#7)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#4)(2011-10#3)(2011-2#1)(2012-12#1)(2013-8#2)
methyl-beta-cyclodextrin##2##1##(2008-10#2)
methyl-mercury##4##1##(2008-10#4)
methyl-β-cyclodextrin##5##1##(2011-2#5)
methylamine##7##1##(1995-9#2)(2008-10#4)(2008-11#1)
methylamphetamine and##3##2##(2008-10#3)
methylamphetamine##4##1##(2008-10#4)
methylarsonic acid##2##2##(2008-10#2)
methylase##2##1##(2008-4#1)(2011-1#1)
methylate##4##1##(1992-3#1)(1994-8#1)(2008-10#2)
methylated by##2##2##(2008-10#1)(2010-11#1)
methylated species##2##2##(2008-10#2)
methylated##17##1##(1991-6#1)(1994-8#1)(1997-2#1)(2008-10#10)(2009-10#1)(2009-12#1)(2010-11#2)
methylation analysis##2##2##(2008-11#1)(2008-9#1)
methylation and##5##2##(1993-12#1)(2008-10#1)(2009-4#1)(2011-2#2)
methylation at##3##2##(1995-12#1)(2008-8#2)
methylation in##2##2##(2011-1#1)(2013-8#1)
methylation of 2-mercaptoethanol##2##3##(1994-8#2)
methylation of the##2##3##(1994-8#1)(2008-9#1)
methylation of##9##2##(1993-8#1)(1994-8#5)(2008-9#1)(2009-10#1)(2009-7#1)
methylation on the##2##3##(1994-5#1)(2009-12#1)
methylation on##3##2##(1994-5#1)(2008-8#1)(2009-12#1)
methylation patterns##2##2##(1995-12#1)(2011-2#1)
methylation reactions##2##2##(1993-9#1)(2008-10#1)
methylation##57##1##(1993-12#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#6)(1995-12#3)(1995-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#5)(2009-4#2)(2009-7#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#5)(2011-9#2)(2013-1#1)(2013-8#3)
methylcobalamin##2##1##(2010-1#2)
methylcytosine binding##2##2##(2011-2#2)
methyldopa in##2##2##(2008-10#2)
methyldopa##8##1##(2008-10#7)(2008-11#1)
methylene bis-benzotriazolyl tetramethylbutylphenol##2##3##(2008-5#2)
methylene blue (MB)##11##3##(2008-10#11)
methylene blue##33##2##(1993-8#2)(2008-10#26)(2008-11#2)(2011-3#1)(2012-2#2)
methylene chloride##7##2##(1996-5#1)(2008-10#6)
methylene green##2##2##(2008-10#2)
methylene group in##2##3##(1997-1#1)(2008-10#1)
methylene group of##2##3##(1997-1#1)(2008-10#1)
methylene group##7##2##(1997-1#2)(2008-10#5)
methylene groups##3##2##(2008-10#2)(2008-5#1)
methylene##65##1##(1993-8#2)(1996-5#1)(1997-1#4)(2006-6#1)(2008-10#48)(2008-11#3)(2008-5#3)(2011-3#1)(2012-2#2)
methylene] thiocarbonohydrazide##2##2##(2008-10#2)
methylenetetrahydrofolate reductase##2##2##(2008-11#1)(2012-3#1)
methylglucose##2##1##(2012-2#2)
methylglyoxal##8##1##(2008-10#1)(2008-11#7)
methylisocyanide##2##1##(1990-8#2)
methylmalonic##2##1##(1993-12#1)(2008-10#1)
methylmercaptan##2##1##(2008-6#2)
methylmercuric chloride##3##2##(2006-6#1)(2008-7#2)
methylmercuric##4##1##(2006-6#2)(2008-7#2)
methylmercury and##3##2##(2008-10#3)
methylmercury chloride##3##2##(2008-10#3)
methylmercury##20##1##(2008-10#20)
methylotrophic yeast Pichia pastoris##4##4##(1994-11#1)(1997-7#1)(2008-7#1)(2009-9#1)
methylotrophic yeast##6##2##(1994-11#2)(1997-7#1)(2008-7#1)(2009-9#1)(2010-5#1)
methylparaben and thimerosal##2##3##(2008-10#2)
methylparaben and##3##2##(2008-10#3)
methylparaben##8##1##(2008-10#8)
methylphenidate (Ritalin)##3##2##(2008-9#3)
methylphenidate hydrochloride##3##2##(1995-11#3)
methylphenidate##16##1##(1995-11#6)(2008-9#4)(2011-2#4)(2012-2#2)
methylprednisolone and##2##2##(1996-11#1)(2013-8#1)
methylprednisolone##9##1##(1993-6#1)(1996-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
methylpyrrolidone and pyridine##3##3##(2008-10#3)
methylpyrrolidone##4##1##(2008-10#4)
methylthiohydantoin-glycine##2##1##(2008-10#2)
methylthiotriazines and one##2##3##(2008-10#2)
methylthymol blue##3##2##(2008-10#3)
methyltransferase (S-adenosyl-L-methionine##2##2##(1994-8#2)
methyltransferase in##2##2##(1994-8#1)(2008-9#1)
methyltransferase##21##1##(1991-12#3)(1991-9#2)(1992-3#1)(1993-8#3)(1993-9#1)(1994-8#7)(2008-10#3)(2008-9#1)
methyltransferase-DNA interactions beyond the site of substitution##2##7##(1992-3#2)
methyltransferase-DNA interactions##5##2##(1992-3#5)
methyltransferase-DNA##6##1##(1992-3#6)
methyltransferases##2##1##(2009-7#1)(2011-2#1)
methyltrioctylammonium##2##1##(2008-10#2)
methylxanthines##4##1##(2008-10#4)
meticulous and##2##2##(2008-10#1)(2010-12#1)
meticulous surgical technique##2##3##(1991-3#1)(2013-1#1)
meticulous##6##1##(1991-3#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
meticulously##2##1##(1991-3#1)(2011-2#1)
metoclopramide and tetracaine hydrochloride##3##4##(2008-10#3)
metoclopramide##23##1##(1990-6#1)(2008-10#15)(2012-12#7)
metol-sulphanilamide##2##1##(2008-10#2)
metoprolol tartrate##2##2##(2012-2#2)
metoprolol##13##1##(1996-3#3)(2008-10#2)(2010-4#6)(2012-2#2)
metribuzin##6##1##(2008-10#5)(2011-2#1)
metric for##2##2##(2008-9#1)(2010-11#1)
metric##9##1##(1995-5#1)(1997-6#1)(2008-6#3)(2008-9#1)(2009-10#2)(2010-11#1)
metrics of##2##2##(2011-2#1)(2013-1#1)
metrics were selected to track success of pilots and eventual implementation##2##11##(2012-2#2)
metrics##12##1##(2008-10#2)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#1)
metrological##2##1##(2008-10#2)
metrology##4##1##(2008-10#1)(2008-5#1)(2010-7#1)(2012-3#1)
metronidazole in##2##2##(2008-10#2)
metronidazole on##2##2##(1996-6#1)(2008-10#1)
metronidazole##18##1##(1996-11#1)(1996-6#5)(2008-10#11)(2010-12#1)
metropolis##2##1##(2011-2#1)(2012-3#1)
metropolitan area##3##2##(1995-3#1)(2008-5#1)(2013-1#1)
metropolitan areas##7##2##(1991-2#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-3#1)(2011-2#2)
metropolitan##22##1##(1991-2#1)(1992-3#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-3#2)(1996-3#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
metyrapone##2##1##(2008-11#1)(2011-2#1)
mevalonate##3##1##(1990-12#3)
mevastatin##2##1##(2008-10#2)
mexicanus##2##1##(2008-8#2)
meyeriana (Zoll##2##2##(2008-8#2)
mfa1 and##2##2##(2008-10#2)
mfa1##4##1##(2008-10#4)
mg (7##2##2##(1994-12#1)(1996-3#1)
mg (KOH) g(-1) (oil)##2##4##(2008-10#2)
mg 1##2##2##(2008-10#2)
mg Cr##2##2##(2008-10#2)
mg DBTC/L##4##2##(2008-10#4)
mg DBTC/kg BW##3##3##(2008-10#3)
mg DBTC/kg##4##2##(2008-10#4)
mg L(-1) 2##3##3##(2008-12#3)
mg L(-1) BA)##2##3##(2008-12#2)
mg L(-1) BAP + 0##2##5##(2008-12#2)
mg L(-1) BAP##4##3##(2008-12#4)
mg L(-1) NAA and##2##4##(2008-12#2)
mg L(-1) NAA##3##3##(2008-12#3)
mg L(-1) for##5##3##(2008-10#5)
mg L(-1) of N##3##4##(2008-10#3)
mg L(-1)##26##2##(2008-10#9)(2008-11#1)(2008-12#15)(2008-7#1)
mg L(-1))##4##2##(2008-11#1)(2008-12#3)
mg L-1 at##2##3##(2008-11#2)
mg M/kg feed##2##3##(2008-5#2)
mg M/kg##8##2##(2008-5#8)
mg O(2) kg(-1) m(-1))##2##4##(2010-8#2)
mg Sb##2##2##(2008-10#2)
mg TNT/kg and the EC50(28d)##2##5##(2008-11#2)
mg TNT/kg soil##2##3##(2008-11#2)
mg TNT/kg##4##2##(2008-11#4)
mg ammonium##2##2##(2008-10#2)
mg and##6##2##(1991-3#1)(1993-2#3)(2008-10#1)(2011-2#1)
mg clopidogrel##2##2##(2011-2#2)
mg cm(-2) is##2##3##(2008-5#2)
mg cm(-2)##5##2##(2008-5#5)
mg concentration##2##2##(2011-1#1)(2012-2#1)
mg daily##4##2##(1990-11#1)(1997-8#1)(2008-11#1)(2008-9#1)
mg daily)##5##2##(1992-11#1)(1992-5#1)(2009-11#1)(2013-1#2)
mg dichloroacetic acid/kg body weight##2##5##(2008-9#2)
mg dm(-3)##2##2##(2008-10#2)
mg equol/kg/day)##2##2##(2010-1#2)
mg g(-1) (RSD = 3%) for carbon##2##7##(2008-10#2)
mg g(-1) for Ni(II)##2##4##(2008-10#2)
mg g(-1) for Pb(II)##4##4##(2008-10#4)
mg g(-1) for##9##3##(2008-10#9)
mg g(-1)##14##2##(2008-10#14)
mg kg(-1) bw##3##3##(2008-10#3)
mg kg(-1) i##3##3##(2008-12#3)
mg kg(-1) of##2##3##(2008-10#1)(2008-11#1)
mg kg(-1)##22##2##(2008-10#14)(2008-11#1)(2008-12#6)(2009-8#1)
mg kg(-1)) and##3##3##(2008-12#3)
mg kg(-1)) concentrations##2##3##(2008-12#2)
mg kg(-1))##10##2##(1997-4#1)(2008-10#1)(2008-12#8)
mg l(-1) AsA##2##3##(2008-10#2)
mg l(-1) COD (n=11)##2##4##(2008-10#2)
mg l(-1) CPL##2##3##(2008-10#2)
mg l(-1) Cl##3##3##(2008-10#3)
mg l(-1) P(2)O(5) and##2##4##(2008-10#2)
mg l(-1) S(2-)##2##3##(2008-10#2)
mg l(-1) and a##2##4##(2008-10#2)
mg l(-1) and c(L##2##4##(2008-10#2)
mg l(-1) and the##4##4##(2008-10#4)
mg l(-1) and##12##3##(2008-10#12)
mg l(-1) chloride##2##3##(2008-10#2)
mg l(-1) copper##3##3##(2008-10#3)
mg l(-1) for copper##2##4##(2008-10#2)
mg l(-1) for the##2##4##(2008-10#2)
mg l(-1) for##16##3##(2008-10#16)
mg l(-1) in##4##3##(2008-10#4)
mg l(-1) level)##6##3##(2008-10#6)
mg l(-1) of ET##3##4##(2008-10#3)
mg l(-1) of Ponceau 4R##2##5##(2008-10#2)
mg l(-1) of Sunset Yellow##2##5##(2008-10#2)
mg l(-1) of Tartrazine##2##4##(2008-10#2)
mg l(-1) of##23##3##(2008-10#23)
mg l(-1) was obtained##2##4##(2008-10#2)
mg l(-1) was##3##3##(2008-10#3)
mg l(-1) with a##3##4##(2008-10#3)
mg l(-1) with an##2##4##(2008-10#2)
mg l(-1) with the##2##4##(2008-10#2)
mg l(-1) with##8##3##(2008-10#8)
mg l(-1)##191##2##(2008-10#187)(2008-11#4)
mg l(-1)) and##2##3##(2008-10#2)
mg l(-1)) individually##2##3##(2008-10#2)
mg l(-1)) was quite satisfactory##2##5##(2008-10#2)
mg l(-1)) was##5##3##(2008-10#5)
mg l(-1)) were##2##3##(2008-10#2)
mg l(-1))##25##2##(2008-10#24)(2008-11#1)
mg l-1##3##2##(2008-11#3)
mg mL(-1)##7##2##(2008-10#2)(2008-5#5)
mg ml(-1) and##3##3##(2008-10#3)
mg ml(-1) for##2##3##(2008-10#2)
mg ml(-1) in##2##3##(2008-10#1)(2008-11#1)
mg ml(-1) solution (pH##2##4##(2008-10#2)
mg ml(-1) solution##3##3##(2008-10#3)
mg ml(-1)##16##2##(2008-10#13)(2008-11#3)
mg ml(-1))##2##2##(2008-10#2)
mg of C(60) and##2##4##(2008-10#2)
mg of C(70) in##2##4##(2008-10#2)
mg of the##5##3##(2008-10#3)(2008-11#1)(2010-12#1)
mg of##46##2##(1991-11#1)(1991-3#1)(1992-12#1)(1993-1#1)(1994-3#1)(1994-5#1)(1997-1#1)(2008-10#22)(2008-11#8)(2010-12#4)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)
mg on##2##2##(1991-8#1)(2009-12#1)
mg per tablet)##2##3##(2008-10#2)
mg per##9##2##(1991-2#1)(1991-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
mg sodium##3##2##(2008-9#3)
mg twice a##2##3##(1993-1#1)(2010-6#1)
mg were##2##2##(2008-10#1)(2008-11#1)
mg x L(-1))##4##3##(2011-3#4)
mg x##8##2##(2011-2#3)(2011-3#5)
mg##592##1##(1990-11#2)(1990-2#2)(1990-6#1)(1990-9#4)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#7)(1991-4#1)(1991-6#3)(1991-8#2)(1992-11#1)(1992-12#2)(1992-5#1)(1993-1#2)(1993-2#9)(1994-12#6)(1994-3#1)(1994-5#1)(1994-8#5)(1995-11#2)(1995-8#1)(1996-11#3)(1996-3#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2008-10#359)(2008-11#38)(2008-12#39)(2008-5#22)(2008-7#5)(2008-9#9)(2009-11#1)(2009-12#1)(2009-8#2)(2010-1#2)(2010-12#6)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#20)(2011-3#5)(2012-2#1)(2012-3#1)(2013-1#3)
mg%##4##1##(2008-10#2)(2009-11#2)
mg(-1)##9##1##(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#1)(2010-7#1)
mg) and##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
mg)##21##1##(1990-12#1)(1990-6#3)(1991-8#1)(1993-1#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-5#1)(2011-2#1)(2012-2#1)
mg-1##4##1##(1990-11#2)(1994-11#1)(1996-2#1)
mg/0##3##1##(2011-2#3)
mg/100 ml for##2##3##(2008-7#2)
mg/100 ml##3##2##(2008-10#1)(2008-7#2)
mg/6##2##1##(1993-2#2)
mg/L (final concentration in the chemostat) formaldehyde to the chemostat##2##10##(2008-7#2)
mg/L female##2##2##(2008-9#2)
mg/L females and##2##3##(2008-9#2)
mg/L females at##4##3##(2008-9#4)
mg/L females##9##2##(2008-9#9)
mg/L for 1##3##3##(2008-10#2)(2008-9#1)
mg/L for catechol##2##3##(2008-10#2)
mg/L for hydroquinone##2##3##(2008-10#2)
mg/L for resorcinol and##2##4##(2008-10#2)
mg/L for##13##2##(2008-10#8)(2008-8#1)(2008-9#4)
mg/L males and females were less than those of the##2##10##(2008-9#2)
mg/L males and females were##3##5##(2008-9#3)
mg/L males and females##8##4##(2008-9#8)
mg/L males and##9##3##(2008-9#9)
mg/L males##13##2##(2008-9#13)
mg/L was##2##2##(2008-7#1)(2008-9#1)
mg/L##64##1##(1990-8#1)(2008-10#9)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#37)(2011-2#1)(2013-1#1)
mg/L) gave the highest potentiality of shoot##2##7##(2013-1#2)
mg/L)##14##1##(2008-7#4)(2010-4#2)(2011-2#1)(2013-1#7)
mg/d) for##2##2##(1991-11#2)
mg/d)##5##1##(1991-11#2)(2013-1#3)
mg/dL (p = 0##2##4##(2012-3#2)
mg/dL##6##1##(1997-3#1)(2010-2#2)(2012-3#3)
mg/day orally##2##2##(1990-2#1)(1992-12#1)
mg/day##9##1##(1990-2#1)(1992-12#1)(1993-1#2)(1997-7#3)(2008-1#1)(2008-5#1)
mg/day) and##2##2##(2008-6#1)(2011-1#1)
mg/day)##9##1##(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
mg/dl and##2##2##(1994-11#1)(2013-8#1)
mg/dl##13##1##(1994-11#2)(1994-12#3)(2008-10#4)(2008-7#1)(2012-3#1)(2013-8#2)
mg/dl) and##4##2##(1990-12#1)(1991-11#3)
mg/dl)##11##1##(1990-12#1)(1991-11#7)(2011-1#1)(2012-3#2)
mg/g##7##1##(1990-2#3)(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
mg/g)##2##1##(2010-4#2)
mg/kg BW##3##2##(2012-3#2)(2013-8#1)
mg/kg BW) for##2##3##(2012-3#2)
mg/kg BW)##4##2##(2012-3#4)
mg/kg NBQX significantly##2##3##(1994-2#2)
mg/kg NBQX##3##2##(1994-2#3)
mg/kg THC##2##2##(1991-10#2)
mg/kg amphetamine in Experiment##2##4##(1994-2#2)
mg/kg and##5##2##(1993-3#1)(1996-2#1)(2008-10#1)(2012-2#2)
mg/kg at##2##2##(2008-7#1)(2008-9#1)
mg/kg b##3##2##(1992-12#1)(2010-1#2)
mg/kg body weight##5##3##(2008-10#2)(2008-12#1)(2008-7#1)(2012-3#1)
mg/kg body weight)##2##3##(2008-10#1)(2012-2#1)
mg/kg body wt##3##3##(1993-11#1)(2013-1#2)
mg/kg body##10##2##(1993-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
mg/kg dry soil##2##3##(2008-11#2)
mg/kg females at##2##3##(2008-9#2)
mg/kg females were##3##3##(2008-9#3)
mg/kg females##10##2##(2008-9#10)
mg/kg group##2##2##(2008-9#2)
mg/kg i##21##2##(1991-2#2)(1991-6#1)(1992-3#6)(1993-6#1)(1994-2#1)(1994-6#1)(1996-2#9)
mg/kg in grain from field trials and from 0##2##9##(2008-10#2)
mg/kg in grain incubated in vitro##2##6##(2008-10#2)
mg/kg in grain##4##3##(2008-10#4)
mg/kg in##8##2##(1994-8#1)(2008-10#5)(2008-9#2)
mg/kg males and females at 26 weeks##2##7##(2008-9#2)
mg/kg males and females at##3##5##(2008-9#3)
mg/kg males and females##6##4##(2008-9#6)
mg/kg males and##8##3##(2008-9#8)
mg/kg males##15##2##(2008-9#15)
mg/kg of##8##2##(1991-3#1)(1991-5#1)(1993-2#1)(1994-12#1)(2008-10#2)(2008-11#2)
mg/kg per day##2##3##(1992-3#2)
mg/kg reduced##2##2##(2008-10#2)
mg/kg rocuronium##3##2##(2011-2#3)
mg/kg s##4##2##(1996-2#4)
mg/kg sc##2##2##(2008-10#2)
mg/kg to female mice)##2##4##(2008-9#2)
mg/kg to females##2##3##(2008-9#2)
mg/kg to females)##2##3##(2008-9#2)
mg/kg to male mice and 15##2##6##(2008-9#2)
mg/kg to males and##3##4##(2008-9#3)
mg/kg to##11##2##(2008-9#11)
mg/kg x 3 pairings)##2##4##(1994-2#2)
mg/kg##210##1##(1990-6#1)(1990-7#1)(1991-10#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#3)(1992-3#10)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1994-12#1)(1994-2#9)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1996-12#1)(1996-2#20)(1997-2#7)(2008-10#24)(2008-11#12)(2008-12#2)(2008-5#1)(2008-7#6)(2008-9#50)(2010-1#2)(2011-2#9)(2012-2#7)(2012-3#8)(2013-1#2)(2013-8#1)
mg/kg) and D-amphetamine (2 mg/kg)##2##5##(1993-3#2)
mg/kg) and##5##2##(1991-7#1)(1992-8#1)(1993-3#3)
mg/kg) for##2##2##(2008-10#1)(2012-2#1)
mg/kg) on##2##2##(1991-10#1)(2012-2#1)
mg/kg) or saline##2##3##(1994-8#1)(2010-6#1)
mg/kg) or##4##2##(1993-3#1)(1993-6#1)(1994-8#1)(2010-6#1)
mg/kg) was##2##2##(1992-8#1)(1994-2#1)
mg/kg) were##2##2##(1993-3#1)(2012-2#1)
mg/kg)##58##1##(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#4)(1992-3#1)(1992-8#5)(1993-3#7)(1993-6#3)(1994-2#2)(1994-5#1)(1994-8#3)(1995-2#1)(1996-2#2)(1997-2#1)(2006-6#2)(2008-10#4)(2008-11#4)(2008-12#1)(2009-11#1)(2010-6#1)(2011-2#5)(2012-2#5)(2013-1#1)
mg/kg/24 h)##2##2##(2011-2#2)
mg/kg/day for##2##2##(1995-11#2)
mg/kg/day of##4##2##(1995-8#1)(2011-2#3)
mg/kg/day##19##1##(1992-11#3)(1995-11#2)(1995-8#3)(2010-1#3)(2011-1#1)(2011-2#7)
mg/kg/day)##5##1##(1994-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
mg/l and##4##2##(1990-12#1)(1993-12#1)(1995-11#1)(2008-7#1)
mg/l##22##1##(1990-12#2)(1990-2#1)(1993-12#2)(1995-11#4)(1996-8#1)(2008-10#6)(2008-12#1)(2008-7#2)(2013-1#3)
mg/l)##4##1##(1991-2#1)(1996-8#1)(2008-10#2)
mg/liter and##3##2##(2008-10#3)
mg/liter##21##1##(2008-10#21)
mg/m(3)##2##1##(2008-10#2)
mg/m2 every##2##2##(1991-6#2)
mg/m2 i##6##2##(1991-2#1)(1991-6#3)(1992-2#2)
mg/m2##18##1##(1990-12#2)(1991-2#2)(1991-6#5)(1992-12#5)(1992-2#2)(1994-8#1)(2008-5#1)
mg/m2)##3##1##(1990-12#1)(1990-6#2)
mg/mL##2##1##(2008-10#1)(2012-3#1)
mg/ml for##2##2##(2012-2#2)
mg/ml in##2##2##(1990-12#1)(2008-5#1)
mg/ml of##2##2##(2008-5#2)
mg/ml##19##1##(1990-12#1)(1990-9#1)(1994-12#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#4)(2011-1#1)(2012-2#2)(2012-3#3)
mg/ml)##3##1##(2012-3#3)
mg/patch level##2##2##(2008-5#2)
mg/rat) and##2##2##(1997-4#2)
mgCl(2)l(-1)##2##1##(2008-10#2)
mgkg(-1)##5##1##(2008-10#5)
mgl(-1) (0##3##2##(2008-10#3)
mgl(-1)##20##1##(2008-10#18)(2008-11#2)
mgs##2##1##(1996-3#2)
miR-210 levels were##2##3##(2012-3#2)
miR-210##6##1##(2012-3#6)
miR-218##3##1##(2011-2#3)
miRNA can bind##2##3##(2011-2#2)
miRNA can##3##2##(2008-11#1)(2011-2#2)
miRNA expression##5##2##(2008-11#1)(2013-1#3)(2013-8#1)
miRNA target##2##2##(2013-1#1)(2013-8#1)
miRNA##26##1##(2008-11#2)(2011-2#11)(2013-1#9)(2013-8#4)
miRNAs are##4##2##(2010-7#3)(2011-2#1)
miRNAs could##2##2##(2010-1#1)(2011-2#1)
miRNAs has##2##2##(2008-11#1)(2013-1#1)
miRNAs may be##2##3##(2011-2#1)(2013-8#1)
miRNAs may##4##2##(2011-2#2)(2013-8#2)
miRNAs of##2##2##(2013-1#1)(2013-8#1)
miRNAs were##4##2##(2013-1#2)(2013-8#2)
miRNAs##42##1##(2008-10#2)(2008-11#4)(2010-1#2)(2010-7#7)(2011-2#10)(2013-1#11)(2013-8#6)
micafungin##3##1##(2008-10#3)
mice (dermal and drinking water studies) and carcinogenicity studies of##2##10##(2008-9#2)
mice (dermal##3##2##(2008-9#3)
mice (n = 20)##2##4##(1993-3#2)
mice administered 4##2##3##(2008-9#2)
mice administered##3##2##(2008-9#3)
mice after##5##2##(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2013-8#1)
mice against##3##2##(2008-7#1)(2009-6#2)
mice also##2##2##(2008-8#1)(2011-2#1)
mice and grade##2##3##(2008-8#2)
mice and guinea pigs##5##4##(1995-12#5)
mice and in##2##3##(1997-3#1)(2013-1#1)
mice and rats##6##3##(1992-9#1)(1993-12#1)(2008-10#3)(2008-11#1)
mice and the##2##3##(2008-4#2)
mice and##49##2##(1990-6#1)(1992-9#2)(1993-12#3)(1994-12#1)(1994-3#1)(1995-12#6)(1997-3#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#1)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
mice are##12##2##(1993-12#2)(1993-3#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2012-3#1)(2013-8#1)
mice as##5##2##(1997-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)
mice at the##4##3##(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)
mice at##10##2##(1990-5#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-12#1)
mice bearing##3##2##(1994-8#1)(1997-3#1)(1997-7#1)
mice but not in##3##4##(1995-2#1)(2008-10#1)(2009-8#1)
mice but##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-3#1)
mice by##15##2##(1991-1#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
mice can##2##2##(1993-12#1)(1995-2#1)
mice carrying the Wld(S) mutation##2##5##(1997-3#2)
mice carrying##6##2##(1993-12#1)(1996-2#1)(1997-3#4)
mice compared to the##2##4##(1996-12#1)(2008-10#1)
mice compared to##5##3##(1996-12#1)(1997-2#1)(2008-10#1)(2013-1#2)
mice contained##2##2##(2012-3#2)
mice develop thyroiditis##2##3##(1995-12#2)
mice develop##3##2##(1993-3#1)(1995-12#2)
mice developed##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
mice differ in their##2##4##(1996-12#1)(2013-1#1)
mice displayed##3##2##(1995-12#1)(2011-2#1)(2013-1#1)
mice dosed##2##2##(1994-8#1)(2008-9#1)
mice exhibit##3##2##(1993-12#1)(1994-12#1)(1995-6#1)
mice exhibited##4##2##(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
mice exposed to 1##2##4##(2008-9#2)
mice exposed to dichloroacetic acid in##2##6##(2008-9#2)
mice exposed to dichloroacetic acid##4##5##(2008-9#4)
mice exposed to##14##3##(2008-10#2)(2008-7#1)(2008-9#11)
mice exposed##17##2##(2008-10#2)(2008-7#1)(2008-9#14)
mice expressing##4##2##(1997-7#2)(2008-4#1)(2013-8#1)
mice failed to kill##2##4##(1995-2#2)
mice fed a##3##3##(1994-11#1)(1995-8#1)(2008-11#1)
mice fed##5##2##(1994-11#2)(1995-8#1)(2008-11#2)
mice following##4##2##(1990-6#1)(1997-2#1)(2008-10#1)(2012-3#1)
mice for the##2##3##(2008-4#1)(2011-2#1)
mice for##7##2##(1990-6#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-2#1)
mice from candidiasis##2##3##(2008-5#2)
mice from##5##2##(1995-5#1)(2008-5#2)(2008-7#1)(2012-12#1)
mice had##4##2##(1995-12#1)(2012-12#2)(2012-3#1)
mice has##2##2##(2008-11#1)(2008-4#1)
mice have demonstrated##2##3##(1994-8#1)(2012-2#1)
mice have##5##2##(1993-12#1)(1994-8#1)(1995-5#1)(2008-11#1)(2012-2#1)
mice homozygous for##3##3##(1995-6#1)(2011-2#2)
mice immunized intranasally with##2##4##(1995-2#2)
mice immunized with the##2##4##(2008-11#2)
mice immunized with##5##3##(2008-10#1)(2008-11#3)(2008-8#1)
mice immunized##7##2##(1995-2#2)(2008-10#1)(2008-11#3)(2008-8#1)
mice in the##6##3##(1995-5#1)(1995-9#1)(2008-10#2)(2008-8#1)(2008-9#1)
mice in##14##2##(1994-5#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)
mice increased##2##2##(2008-7#1)(2013-8#1)
mice induced##2##2##(1996-12#1)(2011-2#1)
mice infected with##4##3##(1993-8#1)(1996-12#3)
mice infected##6##2##(1993-8#1)(1995-9#1)(1996-12#3)(2012-3#1)
mice injected with##4##3##(2008-8#3)(2012-2#1)
mice is##5##2##(1992-12#1)(1995-2#1)(2008-4#2)(2009-9#1)
mice lacking both##2##3##(1993-12#1)(2013-1#1)
mice lacking##4##2##(1993-12#1)(2012-2#1)(2013-1#2)
mice may##2##2##(1994-3#1)(1996-12#1)
mice not only##2##3##(2011-2#2)
mice of both sexes##2##4##(1993-8#2)
mice of##7##2##(1993-8#2)(1994-8#1)(1995-12#2)(1997-3#1)(2008-7#1)
mice or##2##2##(2008-8#1)(2011-2#1)
mice presented##2##2##(2008-9#1)(2013-8#1)
mice received dermal applications of 0##3##6##(2008-9#3)
mice received##5##2##(2008-10#1)(2008-9#4)
mice reduced##2##2##(2008-11#1)(2011-2#1)
mice results in##2##3##(1996-12#1)(2008-11#1)
mice revealed##2##2##(1993-12#1)(1995-6#1)
mice show##3##2##(1997-2#1)(2008-12#1)(2008-4#1)
mice showed##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
mice than in##6##3##(2008-10#4)(2008-9#1)(2013-1#1)
mice that are##2##3##(1995-2#1)(1995-6#1)
mice that##7##2##(1993-12#1)(1994-5#1)(1995-2#2)(1995-6#1)(2011-2#1)(2013-7#1)
mice the##2##2##(1997-2#1)(2009-8#1)
mice to##10##2##(1993-12#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
mice transgenic for##2##3##(1995-2#1)(2008-8#1)
mice treated by##2##3##(2008-9#2)
mice treated with##4##3##(1990-11#1)(2008-10#2)(2008-11#1)
mice treated##7##2##(1990-11#1)(1991-6#1)(2008-10#2)(2008-11#1)(2008-9#2)
mice under##2##2##(1996-2#1)(1997-7#1)
mice using the##2##3##(2008-4#1)(2010-1#1)
mice using##4##2##(2008-10#1)(2008-4#2)(2010-1#1)
mice was inhibited##2##3##(2008-10#1)(2008-9#1)
mice was##13##2##(1993-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-9#5)(2010-11#1)(2010-6#1)(2011-3#1)
mice were administered##4##3##(2008-10#1)(2008-11#1)(2008-9#2)
mice were established##2##3##(2008-9#2)
mice were exposed to drinking water containing 0##6##8##(2008-9#6)
mice were exposed to##10##4##(2008-10#2)(2008-9#8)
mice were exposed##11##3##(2008-10#2)(2008-9#9)
mice were fed##2##3##(2008-10#1)(2013-1#1)
mice were sacrificed##2##3##(1995-12#1)(2012-3#1)
mice were treated with##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
mice were treated##5##3##(2008-10#1)(2008-7#1)(2008-9#2)(2010-6#1)
mice were##49##2##(1990-6#1)(1993-3#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-12#4)(1997-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#19)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#3)(2013-1#1)
mice when##3##2##(1994-5#1)(2008-10#1)(2008-5#1)
mice which##4##2##(1995-12#1)(1995-9#1)(1996-12#1)(2008-10#1)
mice with a##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
mice with recombinant##2##3##(1995-12#1)(2008-4#1)
mice with the##6##3##(1994-3#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-8#1)(2012-2#1)
mice with##35##2##(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-8#3)(2008-11#4)(2008-12#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#2)(2010-12#1)(2010-7#2)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
mice without##2##2##(2008-4#1)(2011-2#1)
mice##889##1##(1990-11#1)(1990-12#1)(1990-5#4)(1990-6#7)(1990-8#1)(1991-1#3)(1991-12#1)(1991-6#2)(1992-12#3)(1992-3#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#3)(1993-12#23)(1993-2#2)(1993-3#8)(1993-8#3)(1994-11#7)(1994-12#10)(1994-3#10)(1994-5#12)(1994-8#10)(1995-11#10)(1995-12#25)(1995-2#30)(1995-5#6)(1995-6#5)(1995-8#2)(1995-9#6)(1996-1#1)(1996-10#1)(1996-12#31)(1996-2#11)(1996-5#4)(1997-2#14)(1997-3#12)(1997-7#5)(1997-8#11)(2008-1#1)(2008-10#99)(2008-11#57)(2008-12#29)(2008-2#2)(2008-4#33)(2008-5#15)(2008-6#6)(2008-7#19)(2008-8#31)(2008-9#86)(2009-10#2)(2009-12#2)(2009-6#10)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#7)(2010-11#12)(2010-12#1)(2010-2#1)(2010-6#3)(2010-7#5)(2010-8#1)(2011-2#32)(2011-3#5)(2012-12#9)(2012-2#22)(2012-3#23)(2013-1#40)(2013-7#8)(2013-8#25)
mice) have##2##2##(2011-2#1)(2012-2#1)
mice)##9##1##(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
micellar and##3##2##(2008-10#2)(2013-1#1)
micellar catalyzed reactions of 1-fluoro-2##2##5##(2008-10#2)
micellar catalyzed##3##2##(2008-10#3)
micellar electrokinetic capillary chromatography (MECC) method##2##6##(2008-10#2)
micellar electrokinetic capillary chromatography (MEKC) with##2##6##(2008-10#2)
micellar electrokinetic capillary chromatography##7##4##(2008-10#7)
micellar electrokinetic chromatography (MEKC)##6##4##(2008-10#6)
micellar electrokinetic chromatography##14##3##(2008-10#13)(2010-7#1)
micellar electrokinetic##21##2##(2008-10#20)(2010-7#1)
micellar extraction at cloud point##2##5##(2008-10#2)
micellar extraction##3##2##(2008-10#3)
micellar liquid chromatography##2##3##(2008-10#2)
micellar media##13##2##(1995-3#1)(2008-10#12)
micellar medium as##2##3##(2008-10#2)
micellar medium composed of##2##4##(2008-10#2)
micellar medium of##3##3##(2008-10#3)
micellar medium was##2##3##(2008-10#2)
micellar medium##29##2##(2008-10#29)
micellar mobile phase##2##3##(2008-10#1)(2009-8#1)
micellar mobile##3##2##(2008-10#2)(2009-8#1)
micellar phase##2##2##(1996-5#1)(2008-10#1)
micellar sodium dodecyl sulfate (SDS)##2##5##(2008-10#2)
micellar solution of##3##3##(2008-10#3)
micellar solution##9##2##(2008-10#9)
micellar solutions of##4##3##(2008-10#2)(2008-7#2)
micellar solutions##9##2##(2008-10#7)(2008-7#2)
micellar system##8##2##(1990-5#5)(2008-10#3)
micellar systems##3##2##(1990-5#2)(2008-10#1)
micellar##129##1##(1990-5#8)(1995-3#1)(1996-5#1)(1997-2#1)(2008-10#112)(2008-7#2)(2009-8#1)(2010-11#1)(2010-7#1)(2013-1#1)
micellar-enhanced##2##1##(2008-10#2)
micellar-stabilized room temperature phosphorescence##2##4##(2008-10#2)
micelle formation##2##2##(1991-5#1)(2008-10#1)
micelle##20##1##(1991-5#1)(2008-10#15)(2008-8#1)(2010-7#2)(2013-1#1)
micelles and##2##2##(2008-10#1)(2010-7#1)
micelles as a##2##3##(2008-10#2)
micelles as##5##2##(2008-10#4)(2013-1#1)
micelles in octane##2##3##(1990-5#2)
micelles in##5##2##(1990-5#2)(2008-10#3)
micelles is##2##2##(2008-10#2)
micelles of##5##2##(1995-3#1)(2008-10#4)
micelles on the##2##3##(2008-10#2)
micelles to##2##2##(2008-10#2)
micelles##44##1##(1990-2#1)(1990-5#3)(1994-5#2)(1995-3#4)(1996-5#1)(2008-10#30)(2009-7#1)(2010-7#1)(2013-1#1)
michiganensis subsp##16##2##(2008-10#16)
michiganensis##26##1##(2008-10#26)
miconazole and forskolin##2##3##(1997-2#2)
miconazole##5##1##(1991-5#2)(1997-2#2)(2008-5#1)
micro amounts of nucleic acids##3##5##(2008-10#3)
micro catheter into##2##3##(1997-3#2)
micro determination of##3##3##(2008-10#3)
micro flow injection wetting film##2##5##(2008-10#2)
micro flow sensor##2##3##(2008-10#2)
micro flow##4##2##(2008-10#4)
micro hollow##2##2##(2008-11#2)
micro liquid-liquid extraction##2##3##(2008-10#2)
micro shoots##2##2##(2013-1#2)
micro total analysis##2##3##(2008-10#2)
micro##44##1##(1997-3#2)(2008-10#27)(2008-11#4)(2008-5#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
micro(calc)##2##1##(2008-7#2)
micro(obs)##2##1##(2008-7#2)
micro- and##6##2##(2008-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
micro-##8##1##(2008-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
micro-XRF##4##1##(2008-10#4)
micro-analytical##2##1##(2008-10#2)
micro-cantilever##3##1##(2008-10#3)
micro-carriers or##2##2##(2008-11#2)
micro-colorimetric##4##1##(2008-10#4)
micro-column##8##1##(2008-10#8)
micro-columns##2##1##(2008-10#2)
micro-environment##3##1##(2008-11#1)(2008-8#1)(2013-8#1)
micro-extraction##5##1##(2008-10#5)
micro-flow##2##1##(2008-10#2)
micro-gravimetric##2##1##(2008-10#2)
micro-level##2##1##(2009-7#1)(2011-2#1)
micro-oil bodies##4##2##(2009-10#4)
micro-optic##2##1##(2008-2#1)(2008-3#1)
micro-optical##6##1##(2008-2#1)(2008-3#5)
micro-optical-electromechanical systems##2##2##(2008-3#2)
micro-optics##4##1##(2008-3#4)
micro-organism##3##1##(2006-6#1)(2011-2#2)
micro-organisms and##2##2##(2008-11#1)(2009-12#1)
micro-organisms##4##1##(2008-11#2)(2009-12#1)(2011-2#1)
micro-probabilities##2##1##(2008-12#2)
micro-pumps##3##1##(2008-10#3)
micro-sequential injection##2##2##(2008-10#2)
micro-vesiculation##4##1##(2006-6#4)
micro-volume##4##1##(2008-10#4)
microA##2##1##(2008-10#2)
microCi##3##1##(1993-3#1)(1994-5#1)(1996-2#1)
microL##2##1##(2008-10#1)(2010-5#1)
microM Ca2+##2##2##(1990-2#1)(1990-8#1)
microM PQ##3##2##(1995-8#3)
microM and 50##2##3##(1990-12#1)(1995-6#1)
microM and Vmax values of##2##5##(1995-8#2)
microM and a##2##3##(1992-3#1)(2008-10#1)
microM and incubation time of##2##5##(1996-2#2)
microM and##21##2##(1990-12#2)(1990-8#1)(1991-5#2)(1992-3#3)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#3)(1996-2#2)(1997-1#1)(2008-10#1)(2008-7#1)
microM arachidonic acid##2##3##(1995-11#2)
microM at##3##2##(1990-10#1)(2008-10#1)(2009-9#1)
microM concentration##2##2##(2008-12#2)
microM for the##2##3##(1994-8#2)
microM for##7##2##(1992-12#1)(1992-3#1)(1994-8#2)(1997-4#1)(2008-10#2)
microM in domains with##2##4##(1996-2#2)
microM in##3##2##(1993-8#1)(1996-2#2)
microM of##4##2##(1990-11#2)(1994-8#1)(2010-3#1)
microM to##2##2##(1993-6#2)
microM was##2##2##(1995-8#1)(2008-10#1)
microM with##3##2##(1992-3#2)(2008-10#1)
microM##176##1##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#4)(1990-5#3)(1990-8#4)(1991-12#2)(1991-5#6)(1992-12#1)(1992-3#9)(1992-6#3)(1992-8#1)(1993-12#1)(1993-3#4)(1993-6#8)(1993-8#8)(1993-9#1)(1994-11#3)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#12)(1995-11#10)(1995-12#2)(1995-2#4)(1995-6#4)(1995-8#13)(1996-2#7)(1997-1#3)(1997-4#3)(1997-8#3)(2008-10#14)(2008-11#6)(2008-12#4)(2008-7#3)(2008-8#3)(2009-6#1)(2009-9#1)(2010-3#2)(2010-6#1)(2011-2#1)
microM) also##3##2##(1994-8#1)(1996-2#1)(1997-1#1)
microM) and##17##2##(1993-8#1)(1995-11#4)(1995-8#1)(1996-2#3)(1997-2#1)(1997-4#3)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
microM) both##2##2##(1996-2#2)
microM) caused a rapid##2##4##(1991-6#1)(1997-1#1)
microM) caused a##3##3##(1990-6#1)(1991-6#1)(1997-1#1)
microM) did##3##2##(1995-12#1)(1995-8#1)(1997-4#1)
microM) for##3##2##(1993-6#1)(1995-12#1)(1996-2#1)
microM) in##4##2##(1990-10#1)(1995-11#1)(1997-1#1)(2013-1#1)
microM) on##2##2##(1992-8#1)(1994-11#1)
microM) or##4##2##(1993-8#3)(1995-12#1)
microM) was##4##2##(1992-3#1)(1996-2#1)(1997-2#2)
microM) were##3##2##(1991-5#1)(1995-11#1)(2008-8#1)
microM)##110##1##(1990-10#1)(1990-11#4)(1990-2#2)(1990-6#1)(1991-5#4)(1991-6#3)(1992-3#2)(1992-6#1)(1992-8#2)(1993-6#3)(1993-8#8)(1994-11#4)(1994-6#1)(1994-8#7)(1995-11#10)(1995-12#4)(1995-6#2)(1995-8#3)(1996-2#16)(1997-1#4)(1997-2#3)(1997-4#13)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-9#1)(2013-1#4)
microM-1 x s-1 of##2##4##(1993-8#2)
microM-1 x s-1##3##3##(1993-8#3)
microM-1##4##1##(1993-8#3)(1994-5#1)
microM/s##2##1##(1995-8#2)
microRNA expression in##2##3##(2010-7#2)
microRNA expression##3##2##(2010-7#3)
microRNA##12##1##(2010-4#1)(2010-7#6)(2011-2#2)(2012-3#2)(2013-8#1)
microRNAs (miRNAs)##4##2##(2008-10#1)(2010-7#1)(2011-2#2)
microRNAs##11##1##(2008-10#1)(2010-7#6)(2011-2#3)(2013-1#1)
microW##4##1##(2007-12#2)(2008-9#2)
microW/cm(2) UVB##2##2##(2008-11#2)
microW/cm(2)##5##1##(2008-11#5)
microalbuminuria assay using bromphenol##2##4##(1990-2#2)
microalbuminuria##7##1##(1990-2#2)(1995-11#1)(1997-8#1)(2010-4#2)(2013-1#1)
microalbuminuric##4##1##(1992-9#2)(1997-8#2)
microalgal##2##1##(2008-7#1)(2010-11#1)
microamounts of##3##2##(2008-10#3)
microanalysis of##3##2##(1995-8#1)(2008-10#2)
microanalysis##12##1##(1995-8#1)(2008-10#9)(2008-9#1)(2013-1#1)
microanalytical system##3##2##(2008-10#3)
microanalytical##4##1##(2008-10#4)
microangiopathy##3##1##(2008-7#1)(2011-2#1)(2013-8#1)
microarray analyses##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
microarray analysis##9##2##(2008-10#2)(2008-11#2)(2009-10#2)(2010-3#1)(2010-6#1)(2011-2#1)
microarray and##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2012-3#1)
microarray contains##2##2##(2007-12#1)(2011-2#1)
microarray data##8##2##(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-2#1)
microarray experiments##9##2##(2008-10#1)(2008-4#4)(2009-10#2)(2011-2#1)(2013-8#1)
microarray for##3##2##(2008-7#1)(2011-2#2)
microarray format##3##2##(2008-10#2)(2009-12#1)
microarray in##2##2##(2008-11#2)
microarray technologies##2##2##(2009-10#1)(2009-12#1)
microarray technology##6##2##(2008-10#1)(2008-7#3)(2012-2#1)(2012-3#1)
microarray##85##1##(2007-12#2)(2008-10#17)(2008-11#6)(2008-4#8)(2008-6#1)(2008-7#13)(2008-9#3)(2009-10#8)(2009-12#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-3#1)(2010-6#1)(2011-2#7)(2012-2#3)(2012-3#5)(2013-8#2)
microarrays for##4##2##(2007-12#1)(2008-7#1)(2008-8#1)(2010-4#1)
microarrays to##3##2##(2008-10#1)(2009-12#1)(2012-3#1)
microarrays##29##1##(2007-12#2)(2008-10#5)(2008-4#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
microarthropods##2##1##(2008-10#1)(2008-11#1)
microassay for##2##2##(1990-2#1)(1992-11#1)
microassay##6##1##(1990-12#4)(1990-2#1)(1992-11#1)
microbalance (QCM)##12##2##(2008-10#12)
microbalance##29##1##(2008-10#29)
microbe being used##2##3##(2011-2#2)
microbe is##2##2##(1991-2#1)(2011-2#1)
microbe##9##1##(1991-2#1)(2008-10#4)(2011-2#3)(2012-2#1)
microbeads were##2##2##(2008-10#2)
microbeads##13##1##(2008-10#10)(2008-4#1)(2008-9#1)(2009-5#1)
microbeam free-space optical##2##3##(2008-3#2)
microbeam##6##1##(2008-10#2)(2008-3#2)(2008-8#2)
microbes and##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
microbes in##4##2##(2008-3#1)(2011-2#1)(2012-2#2)
microbes present in##2##3##(2012-2#2)
microbes that##2##2##(1996-9#1)(2012-2#1)
microbes##46##1##(1996-9#2)(2007-12#1)(2008-10#14)(2008-11#8)(2008-3#1)(2008-5#1)(2008-9#2)(2009-6#2)(2010-3#2)(2011-2#6)(2012-2#7)
microbial activity##11##2##(2008-10#9)(2008-11#1)(2013-8#1)
microbial and##4##2##(2008-10#1)(2008-11#3)
microbial biomass##5##2##(2008-10#4)(2008-11#1)
microbial communities and##2##3##(2008-10#2)
microbial communities were##2##3##(2008-10#2)
microbial communities##12##2##(2008-10#9)(2011-2#2)(2012-2#1)
microbial community structure##3##3##(2008-10#3)
microbial community##15##2##(2008-10#14)(2011-2#1)
microbial contamination##6##2##(1994-3#1)(2008-11#1)(2008-5#1)(2012-2#3)
microbial contaminations in##2##3##(2008-11#2)
microbial diversity within##2##3##(2008-9#1)(2011-2#1)
microbial diversity##6##2##(2008-10#1)(2008-9#3)(2011-2#1)(2012-2#1)
microbial ecology##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
microbial extracellular##3##2##(2008-11#3)
microbial flora##2##2##(1990-6#1)(2008-9#1)
microbial genomes##2##2##(2011-1#2)
microbial groups in##2##3##(2008-10#1)(2012-2#1)
microbial groups##3##2##(2008-10#1)(2012-2#2)
microbial growth##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
microbial load##2##2##(1997-5#1)(2012-2#1)
microbial pathogenesis##2##2##(2011-2#1)(2012-2#1)
microbial pathogens for##2##3##(2008-10#2)
microbial pathogens##5##2##(2008-10#4)(2008-11#1)
microbial population##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
microbial populations##3##2##(2008-10#3)
microbial reduction##2##2##(1995-3#1)(2008-10#1)
microbial research##2##2##(2008-10#1)(2011-1#1)
microbial sensor##3##2##(2008-10#3)
microbial systems##2##2##(2008-11#1)(2008-7#1)
microbial transformation of##2##3##(2008-11#2)
microbial transformation##3##2##(2008-10#1)(2008-11#2)
microbial##177##1##(1990-6#1)(1991-7#1)(1992-11#1)(1992-8#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-5#1)(2007-12#1)(2008-10#80)(2008-11#20)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#6)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#5)(2011-2#19)(2012-12#1)(2012-2#17)(2013-1#1)(2013-8#1)
microbially##4##1##(1990-11#1)(1993-3#1)(2008-10#2)
microbicide##2##1##(1996-9#2)
microbioassay##2##1##(2008-10#2)
microbiologic diagnosis##2##2##(2011-2#2)
microbiologic##7##1##(1990-9#1)(2011-2#4)(2011-3#1)(2013-1#1)
microbiological contamination##2##2##(1994-3#1)(2012-2#1)
microbiological environmental monitoring##2##3##(2012-2#2)
microbiological tests##3##2##(2012-2#3)
microbiological##31##1##(1994-3#2)(1994-6#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-5#6)(2010-5#1)(2010-6#2)(2011-2#2)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
microbiologically##2##1##(2008-11#1)(2010-3#1)
microbiologist and##2##2##(1992-12#1)(1994-6#1)
microbiologists##2##1##(1996-6#1)(2008-9#1)
microbiology and##4##2##(1992-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
microbiology of##3##2##(1997-5#1)(2011-2#1)(2012-2#1)
microbiology##24##1##(1992-12#1)(1994-12#4)(1997-5#1)(2008-10#1)(2008-5#1)(2008-9#6)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
microbiome##3##1##(2010-5#2)(2012-2#1)
microbioreactor##3##1##(2008-11#3)
microbiota and##2##2##(2011-2#2)
microbiota in##2##2##(2008-10#1)(2010-5#1)
microbiota with##2##2##(2011-2#2)
microbiota##23##1##(2008-10#2)(2008-5#1)(2010-10#1)(2010-5#1)(2011-2#15)(2012-2#2)(2013-1#1)
microbleeds have##2##2##(2008-8#2)
microbleeds##9##1##(2008-8#8)(2012-2#1)
microbodies##9##1##(2008-10#6)(2011-1#3)
microbody-lipid globule complexes##2##3##(2008-10#2)
microbore##2##1##(2008-10#1)(2008-4#1)
microcalorimetric##3##1##(2008-10#3)
microcalorimetry##3##1##(1990-5#1)(2011-3#2)
microcapsule colonization##2##2##(2008-11#2)
microcapsule##5##1##(2008-11#5)
microcapsules were##2##2##(2008-11#1)(2008-7#1)
microcapsules##12##1##(1991-1#1)(2008-11#9)(2008-7#1)(2013-1#1)
microcarrier beads##2##2##(2008-11#2)
microcarrier culture##5##2##(2008-11#5)
microcarrier cultures in##2##3##(2008-11#2)
microcarrier cultures##4##2##(2008-11#4)
microcarrier##25##1##(2008-11#23)(2008-9#2)
microcarriers are##2##2##(2008-11#2)
microcarriers by##2##2##(2008-11#2)
microcarriers in##7##2##(2008-11#7)
microcarriers##42##1##(2008-11#42)
microcatheter in the##2##3##(1997-3#1)(2008-7#1)
microcatheter into##2##2##(2008-7#2)
microcatheter was##2##2##(1997-6#1)(2008-7#1)
microcatheter##9##1##(1997-3#2)(1997-6#1)(2008-7#6)
microcatheters##3##1##(1997-3#2)(2008-7#1)
microcavity##5##1##(2007-12#2)(2008-10#2)(2008-2#1)
microcephaly##7##1##(1997-3#6)(2012-3#1)
microchannel##13##1##(2008-10#11)(2009-5#1)(2009-9#1)
microchannels##6##1##(1997-6#1)(2008-10#4)(2008-5#1)
microchemielectronic devices for##2##3##(2008-10#2)
microchip and##2##2##(2008-10#2)
microchip capillary electrophoresis##6##3##(2008-10#6)
microchip electrochromatography with##2##3##(2008-10#2)
microchip electrochromatography##4##2##(2008-10#4)
microchip electrophoresis##3##2##(2008-10#3)
microchip flow cell##2##3##(2008-10#2)
microchip for##2##2##(2008-10#2)
microchip solid-state lasers##2##3##(2007-11#1)(2007-12#1)
microchip##48##1##(2007-11#1)(2007-12#3)(2008-10#40)(2008-2#2)(2008-3#2)
microchips##3##1##(2008-10#1)(2008-2#1)(2013-8#1)
microcirculation in sepsis##2##3##(2010-7#2)
microcirculation in##3##2##(1996-3#1)(2010-7#2)
microcirculation##14##1##(1992-12#1)(1996-3#1)(1997-8#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#4)(2011-2#2)(2013-8#1)
microcirculatory disorders##2##2##(2011-2#2)
microcirculatory disturbances##3##2##(2009-7#3)
microcirculatory perfusion##2##2##(1997-2#2)
microcirculatory##12##1##(1992-9#1)(1997-2#3)(2009-7#3)(2011-2#5)
microclimate##6##1##(1996-3#1)(2008-10#5)
micrococcal nuclease##2##2##(2008-8#2)
microcolumn and##3##2##(2008-10#3)
microcolumn in##2##2##(2008-10#2)
microcolumn packed with activated##2##4##(2008-10#2)
microcolumn packed with##6##3##(2008-10#6)
microcolumn##30##1##(2008-10#29)(2012-2#1)
microcolumns and##3##2##(2008-10#3)
microcolumns in a sequential injection system##2##6##(2008-10#2)
microcolumns##9##1##(2008-10#9)
microcomputer##11##1##(2008-10#10)(2008-3#1)
microcomputers##2##1##(1991-3#1)(1994-3#1)
microconidia##3##1##(2008-10#3)
microcosm##5##1##(1991-2#1)(2008-10#3)(2008-8#1)
microcosms##4##1##(2008-10#1)(2008-8#3)
microcracks interaction##2##2##(2009-7#2)
microcracks##6##1##(2008-2#1)(2009-7#5)
microcrystalline naphthalene or by column method##2##6##(2008-10#2)
microcrystalline naphthalene or by##4##4##(2008-10#4)
microcrystalline naphthalene or##5##3##(2008-10#5)
microcrystalline naphthalene##13##2##(2008-10#13)
microcrystalline phenolphthalein##3##2##(2008-10#3)
microcrystalline##20##1##(2008-10#20)
microcycle conidiation##2##2##(2008-10#2)
microcystin##3##1##(1995-8#1)(2008-10#1)(2012-12#1)
microcystin-LR analysis##2##2##(2008-10#2)
microcystin-LR in##3##2##(2008-10#3)
microcystin-LR##8##1##(1995-8#1)(2008-10#6)(2008-4#1)
microcystins##6##1##(2008-10#4)(2010-5#2)
microcysts##6##1##(1990-11#5)(2010-6#1)
microdebridement for##2##2##(2010-3#2)
microdeletion##3##1##(1993-11#1)(1997-3#2)
microdialysate##2##1##(2008-10#2)
microdialysis and##3##2##(1997-2#1)(2008-10#2)
microdialysis probe was##2##3##(1997-2#1)(2008-10#1)
microdialysis probe##9##2##(1993-6#1)(1994-8#1)(1997-2#3)(2008-10#3)(2008-7#1)
microdialysis sampling coupled with flame atomic absorption spectrometry##2##8##(2008-10#2)
microdialysis sampling##6##2##(2008-10#5)(2008-8#1)
microdialysis##39##1##(1993-6#1)(1994-2#1)(1994-8#4)(1997-2#7)(2008-10#21)(2008-7#4)(2008-8#1)
microdiffractive-microrefractive lens with a continuous relief##2##6##(2008-3#2)
microdisk electrodes##3##2##(2008-10#3)
microdisk##10##1##(2008-10#10)
microdissected##3##1##(2008-5#1)(2008-9#1)(2010-12#1)
microdissection of##3##2##(2008-4#2)(2010-1#1)
microdissection##10##1##(2008-12#2)(2008-2#1)(2008-4#4)(2009-8#1)(2010-1#1)(2011-2#1)
microdistillation##2##1##(2008-10#2)
microdistribution of mineral ions in roots##2##6##(2008-9#2)
microdistribution of mineral ions in##3##5##(2008-9#3)
microdomain structures##2##2##(2009-8#2)
microdomain##5##1##(2008-10#1)(2009-8#2)(2009-9#1)(2012-2#1)
microdomains##3##1##(1995-2#2)(2008-5#1)
microdosing is##2##2##(2010-11#2)
microdosing studies##2##2##(2010-11#2)
microdosing##4##1##(2010-11#4)
microdrop and sample##2##3##(2008-10#2)
microdrop and##3##2##(2008-10#3)
microdrop##11##1##(2008-10#9)(2008-11#2)
microdroplets##2##1##(2008-2#1)(2008-9#1)
microelectrode array##3##2##(2008-10#3)
microelectrode in##2##2##(2008-10#2)
microelectrode was##4##2##(2008-10#4)
microelectrode##29##1##(2008-10#28)(2013-1#1)
microelectrodes##15##1##(2008-10#9)(2008-4#2)(2009-12#3)(2010-6#1)
microelement metabolism##2##2##(2011-2#2)
microelements##3##1##(2008-10#2)(2013-8#1)
microemulsion system##2##2##(2008-10#2)
microemulsion technique##2##2##(2008-10#2)
microemulsion##19##1##(2008-10#16)(2008-11#1)(2008-5#2)
microemulsions##4##1##(2008-10#3)(2008-5#1)
microencapsulated##2##1##(2008-10#1)(2011-2#1)
microenvironment in the##2##3##(2009-10#1)(2012-2#1)
microenvironment in##3##2##(2009-10#1)(2012-2#1)(2013-1#1)
microenvironment is##3##2##(2009-3#3)
microenvironment of a##2##3##(2009-4#1)(2010-1#1)
microenvironment of##9##2##(1990-5#1)(1994-5#1)(2008-10#4)(2008-8#1)(2009-4#1)(2010-1#1)
microenvironment##53##1##(1990-5#2)(1991-5#1)(1994-5#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-8#1)(2009-10#2)(2009-12#2)(2009-3#10)(2009-4#1)(2010-1#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
microenvironments of##3##2##(2008-11#1)(2009-3#1)(2012-3#1)
microenvironments##8##1##(1990-5#1)(2008-10#2)(2008-11#1)(2009-12#1)(2009-3#2)(2012-3#1)
microextraction (SPME) and##2##3##(2008-10#2)
microextraction (SPME) coupled##2##3##(2008-10#2)
microextraction (SPME) to##3##3##(2008-10#3)
microextraction (SPME) was##2##3##(2008-10#2)
microextraction (SPME)##25##2##(2008-10#23)(2009-8#1)(2012-12#1)
microextraction and gas##3##3##(2008-10#3)
microextraction and thermal desorption##2##4##(2008-10#2)
microextraction and##8##2##(2008-10#8)
microextraction coupled to##2##3##(2008-10#2)
microextraction coupled with gas##2##4##(2008-10#2)
microextraction coupled with high-performance liquid chromatography##3##6##(2008-10#3)
microextraction coupled with liquid##2##4##(2008-10#2)
microextraction coupled with##8##3##(2008-10#8)
microextraction coupled##10##2##(2008-10#10)
microextraction for the##2##3##(2008-10#2)
microextraction of##3##2##(2008-10#3)
microextraction solvent##2##2##(2008-10#2)
microextraction systems##3##2##(2008-10#3)
microextraction technique##2##2##(2008-10#2)
microextraction with##3##2##(2008-10#3)
microextraction##99##1##(1997-2#1)(2008-10#95)(2009-8#1)(2012-12#2)
microextraction-gas##3##1##(2008-10#3)
microfabricated##11##1##(2007-11#1)(2008-10#9)(2008-3#1)
microfabrication##4##1##(2008-10#2)(2008-3#1)(2008-7#1)
microfiber##2##1##(2008-10#2)
microfibril##4##1##(2008-11#1)(2008-5#2)(2012-2#1)
microfibrils##5##1##(1993-3#3)(2008-11#1)(2008-5#1)
microfilled##2##1##(2011-2#2)
microfiltration membranes were##2##3##(2008-7#2)
microfiltration membranes##5##2##(2008-7#5)
microfiltration##6##1##(2008-7#6)
microfine TiO(2)##3##2##(2008-5#3)
microfine ZnO##2##2##(2008-5#2)
microfine oxides##3##2##(2008-5#3)
microfine##10##1##(2008-5#10)
microflora in##3##2##(2008-10#2)(2012-3#1)
microflora of the##2##3##(2008-5#1)(2012-3#1)
microflora of##6##2##(1993-8#2)(2008-5#3)(2012-3#1)
microflora or##2##2##(2008-10#1)(2008-11#1)
microflora to##2##2##(1993-8#1)(2008-10#1)
microflora were##2##2##(2008-11#1)(2008-5#1)
microflora##39##1##(1993-8#4)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#9)(2011-2#2)(2012-2#1)(2012-3#5)
microfluidic analysis systems##2##3##(2008-10#2)
microfluidic approach##2##2##(2009-12#2)
microfluidic capillary electrophoresis (CE)##2##4##(2008-10#2)
microfluidic capillary electrophoresis system##2##4##(2008-10#2)
microfluidic capillary electrophoresis##5##3##(2008-10#5)
microfluidic channels##2##2##(2008-10#1)(2008-12#1)
microfluidic device##7##2##(2008-10#6)(2009-5#1)
microfluidic devices##9##2##(2008-10#8)(2009-12#1)
microfluidic flow cells##3##3##(2008-10#3)
microfluidic flow##5##2##(2008-10#5)
microfluidic system##3##2##(2008-10#2)(2009-9#1)
microfluidic systems##3##2##(2008-10#3)
microfluidic##54##1##(2008-10#42)(2008-12#1)(2009-12#8)(2009-5#1)(2009-9#1)(2011-2#1)
microfluidics##2##1##(2008-10#2)
microg L(-1)##7##2##(2008-10#6)(2008-9#1)
microg L(-1))##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
microg Pl(-1)##4##2##(2008-10#4)
microg g(-1) level##2##3##(2008-10#2)
microg g(-1) of##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
microg g(-1)##9##2##(2008-10#5)(2008-12#1)(2010-8#3)
microg kg(-1)##2##2##(2008-10#1)(2010-5#1)
microg l(-1) Ru##2##3##(2008-10#2)
microg l(-1) and##5##3##(2008-10#5)
microg l(-1) for CK-MB mass)##2##5##(2008-10#2)
microg l(-1) for troponin I##2##5##(2008-10#2)
microg l(-1) for##8##3##(2008-10#8)
microg l(-1) level for##3##4##(2008-10#3)
microg l(-1) of##4##3##(2008-10#4)
microg l(-1)##51##2##(2008-10#51)
microg mL(-1) almost##2##3##(2008-12#1)(2011-2#1)
microg mL(-1)##3##2##(2008-12#1)(2011-2#1)(2011-3#1)
microg min(-1) mm(-2)##2##3##(2008-5#2)
microg ml(-1) (r=0##2##3##(2008-10#2)
microg ml(-1) for Sb(III) and Sb(V)##2##6##(2008-10#2)
microg ml(-1) for##4##3##(2008-10#4)
microg ml(-1) of V(v)##2##4##(2008-10#2)
microg ml(-1) of##4##3##(2008-10#3)(2008-11#1)
microg ml(-1) with##2##3##(2008-10#2)
microg ml(-1)##31##2##(2008-10#30)(2008-11#1)
microg ml(-1))##2##2##(2008-10#2)
microg of water##2##3##(2008-10#2)
microg of##8##2##(2008-10#7)(2008-4#1)
microg x##2##2##(2011-3#2)
microg##141##1##(2008-10#119)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-5#1)(2010-8#3)(2011-2#2)(2011-3#3)
microg/10 ml##2##2##(2008-10#2)
microg/L##5##1##(2008-10#2)(2008-8#3)
microg/day administered with a##2##4##(2007-11#2)
microg/day##6##1##(2007-11#4)(2011-2#2)
microg/g for##4##2##(2008-10#2)(2008-11#2)
microg/g##8##1##(2008-10#4)(2008-11#4)
microg/insect for##2##2##(2008-11#2)
microg/l (for 1##2##3##(2008-10#2)
microg/l for 1##2##3##(2008-10#2)
microg/l for##3##2##(2008-10#3)
microg/l##13##1##(2008-10#13)
microg/m(2)/d)##2##1##(2008-11#2)
microg/m(3)##3##1##(2008-11#3)
microg/mL##9##1##(2008-10#4)(2011-2#1)(2012-3#4)
microg/mL)##4##1##(2008-8#1)(2011-2#1)(2012-3#2)
microg/ml and##4##2##(2008-5#3)(2010-3#1)
microg/ml for E##2##3##(2008-10#2)
microg/ml for NE##2##3##(2008-10#2)
microg/ml for##4##2##(2008-10#4)
microg/ml of##3##2##(2008-10#1)(2008-7#2)
microg/ml##23##1##(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#9)(2008-7#2)(2010-3#1)
microg/ml)##6##1##(2008-5#6)
microgL(-1)##2##1##(2008-10#2)
microgels##6##1##(2008-10#6)
microgl(-1)##3##1##(2008-10#3)
microglandular##3##1##(1994-12#2)(2011-2#1)
microglia in##4##2##(1997-3#3)(2008-7#1)
microglia##11##1##(1995-12#1)(1997-3#4)(2008-7#3)(2010-1#1)(2012-2#1)(2013-7#1)
microglial activation and##2##3##(1996-12#1)(2012-2#1)
microglial##6##1##(1995-12#2)(1996-12#1)(1997-2#1)(1997-3#1)(2012-2#1)
microglobulin##5##1##(1990-12#1)(1995-1#3)(2008-7#1)
microgml(-1) and##2##2##(2008-10#2)
microgml(-1)##6##1##(2008-10#6)
microgram quantities##2##2##(2008-10#1)(2010-3#1)
microgram##7##1##(1990-2#1)(1996-2#1)(2008-10#4)(2010-3#1)
microgram/microgram for brain and##2##4##(1996-2#2)
microgram/microgram for liver)##2##3##(1996-2#2)
microgram/microgram for##4##2##(1996-2#4)
microgram/ml##3##1##(1990-2#1)(1995-5#1)(1997-2#1)
micrograms GLP-1 i##2##3##(1996-2#2)
micrograms ml-1 for##2##3##(1996-2#2)
micrograms ml-1##4##2##(1996-2#4)
micrograms of PG##2##3##(1990-2#2)
micrograms of##8##2##(1990-2#2)(1994-11#1)(1995-12#1)(1996-1#1)(2008-10#3)
micrograms twice daily##2##3##(1996-2#2)
micrograms##36##1##(1990-2#3)(1990-5#2)(1990-6#2)(1991-12#3)(1991-3#1)(1992-3#2)(1992-8#1)(1993-6#2)(1994-11#1)(1994-8#1)(1995-12#2)(1996-1#2)(1996-12#1)(1996-2#10)(2008-10#3)
micrograms) and##2##2##(1996-1#1)(1996-2#1)
micrograms) twice daily##2##3##(1996-1#2)
micrograms)##9##1##(1993-6#1)(1995-12#2)(1996-1#4)(1996-2#2)
micrograms/g##8##1##(1990-5#5)(1990-8#3)
micrograms/kg i##3##2##(1994-8#1)(1996-2#2)
micrograms/kg##7##1##(1992-12#1)(1993-1#1)(1994-8#3)(1996-2#2)
micrograms/kg)##4##1##(1991-5#1)(1994-5#1)(1994-8#2)
micrograms/l##2##1##(1990-9#2)
micrograms/mg cell##2##2##(1990-8#2)
micrograms/mg##3##1##(1990-5#1)(1990-8#2)
micrograms/ml conjugate##2##2##(1994-11#2)
micrograms/ml of lipoprotein cholesterol)##2##4##(1990-8#2)
micrograms/ml of##4##2##(1990-12#1)(1990-8#2)(1994-11#1)
micrograms/ml##19##1##(1990-12#1)(1990-2#3)(1990-6#2)(1990-8#2)(1991-6#1)(1993-12#2)(1993-6#2)(1994-11#4)(1995-2#1)(1997-2#1)
micrograms/ml) induced##3##2##(1990-2#2)(1993-12#1)
micrograms/ml)##14##1##(1990-2#3)(1993-1#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)
micrograph##2##1##(2008-10#1)(2008-9#1)
micrographs and##2##2##(2008-10#2)
micrographs of##6##2##(1991-5#1)(1997-3#1)(2008-10#2)(2008-5#2)
micrographs showed that##2##3##(2008-8#1)(2013-1#1)
micrographs showed##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
micrographs##17##1##(1991-5#1)(1997-3#1)(2008-10#7)(2008-5#6)(2008-8#1)(2013-1#1)
microgravimetric##3##1##(2008-10#3)
microgravity on##4##2##(2008-8#1)(2008-9#3)
microgravity##9##1##(2008-8#1)(2008-9#8)
microheterogeneity##2##1##(2008-10#2)
microinfusion of##2##2##(1996-12#1)(1997-7#1)
microinfusion##4##1##(1996-12#2)(1996-2#1)(1997-7#1)
microinjected into the nucleus tractus solitarius (NTS) of unanesthetized rats##2##10##(1997-2#2)
microinjected into the##3##3##(1997-2#3)
microinjected into##4##2##(1997-2#3)(2010-5#1)
microinjected##8##1##(1993-6#2)(1994-11#1)(1997-2#3)(2008-11#1)(2010-5#1)
microinjection of##4##2##(1990-5#1)(1994-8#1)(1997-2#1)(2010-5#1)
microinjection to generate##2##3##(2008-4#1)(2008-9#1)
microinjection to##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
microinjection##17##1##(1990-5#1)(1992-6#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-11#2)(2008-4#3)(2008-9#3)(2010-4#1)(2010-5#3)
microjoule##2##1##(2007-11#1)(2007-12#1)
microl 0##2##2##(2008-10#2)
microl l(-1)##3##2##(2008-10#3)
microl min(-1)g(-1)kPa(-1) for the##2##4##(2007-12#2)
microl of##7##2##(2008-10#7)
microl##31##1##(1997-4#1)(2007-12#2)(2008-10#25)(2008-11#1)(2008-5#1)(2008-7#1)
microl) and##2##2##(2008-10#2)
microl)##10##1##(1997-4#1)(2008-10#9)
microlens array##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
microlens##6##1##(2007-11#2)(2008-2#1)(2008-3#3)
microlenses##2##1##(2008-3#2)
microliter##5##1##(1993-6#1)(1997-6#1)(2008-10#3)
microliters of sample##2##3##(2008-10#2)
microliters of##6##2##(1990-5#1)(1994-2#1)(2008-10#4)
microliters##7##1##(1990-5#1)(1994-2#1)(2008-10#5)
microliters/mg dry weight##3##3##(1991-11#3)
microliters/mg dry##4##2##(1991-11#4)
microm at##2##2##(2008-2#1)(2008-3#1)
microm by use of a##2##5##(2007-12#1)(2008-2#1)
microm by##3##2##(2007-12#2)(2008-2#1)
microm for an ice particle)##2##5##(2008-3#2)
microm for##5##2##(2008-2#2)(2008-3#3)
microm is used##2##3##(2008-3#2)
microm is##4##2##(2007-12#1)(2008-3#3)
microm particle packed analytical columns##2##5##(2008-10#2)
microm was##2##2##(2008-3#2)
microm were##2##2##(2007-12#1)(2008-3#1)
microm wide##2##2##(2008-10#1)(2010-8#1)
microm x##2##2##(2008-2#1)(2013-8#1)
microm##74##1##(1991-5#2)(1996-12#2)(2007-12#10)(2008-10#12)(2008-11#3)(2008-2#11)(2008-3#22)(2008-5#2)(2008-7#4)(2009-12#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-8#2)
microm) as##2##2##(2008-10#1)(2008-2#1)
microm) with a##2##3##(2007-12#2)
microm)##27##1##(1997-3#3)(1997-4#1)(2007-12#5)(2008-10#4)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2011-3#1)
micromachined##4##1##(2008-10#1)(2008-2#2)(2008-3#1)
micromachining##4##1##(2008-10#1)(2008-3#2)(2008-8#1)
micromechanical##7##1##(2008-3#3)(2009-7#1)(2010-4#3)
micromechanics##2##1##(2009-7#1)(2012-2#1)
micrometeorological data##2##2##(2008-10#2)
micrometeorological##4##1##(2008-10#2)(2008-11#1)(2008-3#1)
micrometer range##3##2##(1997-2#1)(2008-10#2)
micrometer##10##1##(1997-2#1)(2008-10#3)(2008-3#1)(2011-2#1)(2013-1#4)
micrometer-size tumor##2##2##(2008-11#2)
micrometer-size##4##1##(2008-11#3)(2008-3#1)
micrometer-sized polymer elements at the##2##5##(2008-3#2)
micrometer-sized polymer##3##2##(2008-10#1)(2008-3#2)
micrometers##2##1##(1991-5#1)(2008-4#1)
micromol Fe/mg protein)##2##3##(1996-2#2)
micromol L(-1) and##2##3##(2008-10#1)(2011-3#1)
micromol L(-1)##9##2##(2008-10#6)(2011-3#3)
micromol TE/g)##6##2##(2008-10#6)
micromol l(-1)##5##2##(2008-10#5)
micromol of##2##2##(2008-10#2)
micromol x L(-1) x min(-1)##2##5##(2011-3#2)
micromol x L(-1)##4##3##(2011-3#4)
micromol x##5##2##(2011-3#5)
micromol##35##1##(1996-2#3)(1997-1#2)(2008-10#22)(2011-3#8)
micromol/L had an increase of##2##5##(2008-1#2)
micromol/L##7##1##(2008-1#4)(2008-8#3)
micromol/L)##2##1##(2008-10#2)
micromol/L/year##3##1##(2008-1#3)
micromol/l##6##1##(2008-1#2)(2008-11#1)(2008-7#3)
micromol/l)##2##1##(2006-6#1)(2008-7#1)
micromolar concentrations of the##2##4##(1995-11#1)(2008-10#1)
micromolar concentrations of##4##3##(1994-6#1)(1995-11#1)(2008-10#1)(2008-11#1)
micromolar concentrations##6##2##(1994-6#1)(1995-11#1)(2008-10#3)(2008-11#1)
micromolar levels##3##2##(2008-10#2)(2008-7#1)
micromolar range##2##2##(2008-10#2)
micromolar##19##1##(1990-12#2)(1992-3#1)(1994-6#1)(1995-11#1)(2008-10#11)(2008-11#2)(2008-7#1)
micron sized##3##2##(2008-10#3)
micron##15##1##(1992-12#1)(1993-9#1)(1995-3#1)(1996-1#1)(1996-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-5#1)(2012-3#1)
micron-sized##3##1##(2008-10#1)(2009-5#1)(2010-10#1)
micronized##2##1##(2008-5#2)
micronodular##2##1##(1993-6#1)(2010-12#1)
micronodules##2##1##(1993-12#1)(2012-12#1)
microns and##2##2##(1995-3#1)(1996-3#1)
microns diam##2##2##(1996-12#2)
microns s-1##7##2##(1991-5#5)(1993-9#2)
microns##32##1##(1991-2#1)(1991-5#9)(1993-9#6)(1994-11#1)(1995-12#1)(1995-3#4)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#2)(1997-1#1)(2008-5#1)
microns)##7##1##(1990-5#1)(1991-5#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-1#2)
micronsized##3##1##(2008-10#3)
micronucleated##4##1##(2008-9#3)(2011-2#1)
micronuclei (MN)##2##2##(2008-10#1)(2010-1#1)
micronuclei##7##1##(1993-8#1)(2008-10#1)(2008-9#3)(2009-12#1)(2010-1#1)
micronucleus test##2##2##(2008-9#1)(2011-1#1)
micronucleus##10##1##(1993-8#2)(2008-9#4)(2011-1#3)(2012-3#1)
micronucleus-containing##3##1##(2008-9#3)
micronutrient for##2##2##(1993-11#1)(2012-3#1)
micronutrient##5##1##(1993-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
micronutrients##14##1##(1992-9#1)(2008-10#5)(2010-11#1)(2010-6#1)(2012-2#1)(2013-8#5)
microorganism##13##1##(1991-12#1)(2006-6#1)(2008-10#5)(2009-3#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
microorganisms and the##2##3##(2008-10#1)(2008-11#1)
microorganisms and##6##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
microorganisms for##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2013-7#1)
microorganisms in the##3##3##(2008-10#3)
microorganisms in##8##2##(2008-10#4)(2008-9#1)(2011-1#1)(2011-2#2)
microorganisms that##6##2##(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#2)
microorganisms to##2##2##(2008-10#1)(2008-7#1)
microorganisms under##2##2##(2008-10#1)(2008-7#1)
microorganisms were##3##2##(2008-10#3)
microorganisms##102##1##(1990-12#2)(1991-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-12#1)(1997-5#1)(2008-10#31)(2008-11#10)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#5)(2009-11#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#12)(2012-2#9)(2012-3#2)(2013-1#2)(2013-7#1)
microorganisms) did##2##2##(2008-10#2)
microparticle##2##1##(2008-10#1)(2008-9#1)
microparticles are##2##2##(2008-3#2)
microparticles were##2##2##(1992-12#1)(2008-10#1)
microparticles##12##1##(1992-12#1)(2008-10#4)(2008-3#6)(2008-9#1)
micropatterning##2##1##(2008-11#1)(2008-3#1)
micropenis##3##1##(2008-10#2)(2011-1#1)
microphone##6##1##(2008-10#3)(2008-9#1)(2011-1#2)
microphysical properties##3##2##(2008-3#3)
micropigment##2##1##(2008-5#2)
microplate format##2##2##(2008-10#1)(2010-6#1)
microplate##7##1##(2008-10#2)(2008-11#3)(2010-6#2)
microplates##5##1##(1990-12#1)(2008-11#4)
microplot experiments##2##2##(2008-10#2)
microplot##9##1##(2008-10#9)
microplots##5##1##(2008-10#5)
microplus host##2##2##(2010-10#2)
microplus##5##1##(1997-7#1)(2010-10#4)
microporous##9##1##(2008-10#8)(2008-7#1)
microprobe##5##1##(1990-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
microprocessor##2##1##(2008-10#2)
microprocessor-based##2##1##(2008-10#2)
micropropagated plants##2##2##(2008-10#2)
micropropagated##5##1##(2008-10#4)(2009-8#1)
micropump##5##1##(2008-10#5)
micropylar opening##2##2##(2008-12#2)
micropylar##7##1##(2008-11#1)(2008-12#2)(2008-9#1)(2009-12#2)(2009-8#1)
micropyle##4##1##(1994-5#1)(2007-12#1)(2008-12#1)(2009-8#1)
microreaction chamber and##2##3##(2008-10#2)
microreaction chamber##3##2##(2008-10#3)
microreactor##4##1##(1997-6#1)(2008-10#3)
microreactors##6##1##(2008-10#6)
microrelief##4##1##(2008-3#2)(2008-5#2)
microrheological characteristics of reticulocytes##2##4##(2008-9#2)
microrheological characteristics##4##2##(2008-9#4)
microring resonators for##2##3##(2009-5#2)
microring resonators##4##2##(2009-5#4)
micros##3##1##(2008-10#1)(2008-3#2)
micros)##2##1##(2009-3#2)
microsatellite DNA##3##2##(2008-11#1)(2008-9#2)
microsatellite and##2##2##(2008-10#1)(2010-5#1)
microsatellite loci were##3##3##(2008-9#1)(2013-8#2)
microsatellite loci##10##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2013-8#5)
microsatellite locus##3##2##(2008-10#1)(2010-8#2)
microsatellite marker##4##2##(2008-10#2)(2008-7#1)(2008-9#1)
microsatellite markers and##4##3##(1994-9#1)(2008-10#2)(2013-8#1)
microsatellite markers to##2##3##(2008-10#1)(2008-11#1)
microsatellite markers were##3##3##(1997-9#1)(2010-8#1)(2013-8#1)
microsatellite markers##21##2##(1994-9#1)(1997-9#1)(2008-10#12)(2008-11#1)(2008-9#1)(2010-8#1)(2013-8#4)
microsatellite primers##2##2##(2008-10#2)
microsatellite##60##1##(1994-9#1)(1997-9#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#5)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-2#1)(2012-3#2)(2013-8#11)
microsatellite-primed polymerase chain reaction (MP-PCR)##2##5##(2008-10#2)
microsatellite-primed polymerase chain reaction##3##4##(2008-10#3)
microsatellites##22##1##(1994-11#1)(1995-2#1)(1997-6#3)(2008-10#7)(2008-11#1)(2008-9#2)(2010-7#2)(2010-8#1)(2012-3#3)(2013-8#1)
microscale##7##1##(2008-10#4)(2008-11#1)(2010-10#1)(2013-1#1)
microsclerotia in##2##2##(2008-10#2)
microsclerotia of V##3##3##(2008-10#3)
microsclerotia of##4##2##(2008-10#4)
microsclerotia per g of soil##3##5##(2008-10#3)
microsclerotia per g of##4##4##(2008-10#4)
microsclerotia was##2##2##(2008-10#2)
microsclerotia##24##1##(2008-10#24)
microscope and the##2##3##(2008-12#1)(2010-1#1)
microscope and##5##2##(1991-12#1)(1991-9#1)(2008-12#1)(2008-9#1)(2010-1#1)
microscope did not show any##2##5##(1990-2#2)
microscope has been used to##2##5##(1990-11#1)(1994-9#1)
microscope has##3##2##(1990-11#1)(1994-9#1)(2008-4#1)
microscope is a##3##3##(2008-11#1)(2008-4#2)
microscope observations##2##2##(2008-10#2)
microscope slides##4##2##(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)
microscope was used##2##3##(2008-10#1)(2008-8#1)
microscope was##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
microscope with##4##2##(2008-2#2)(2008-8#1)(2008-9#1)
microscope##114##1##(1990-11#1)(1990-2#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-9#2)(1997-3#1)(2007-12#9)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#10)(2009-11#2)(2009-12#3)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
microscope-mounted##2##1##(2011-7#2)
microscopes##7##1##(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)
microscopic activity##4##2##(2008-11#4)
microscopic analyses of##2##3##(1994-9#1)(2009-12#1)
microscopic analysis of##2##3##(1997-3#1)(2008-11#1)
microscopic analysis##5##2##(1997-3#1)(2008-11#3)(2008-4#1)
microscopic appearance##2##2##(1991-6#1)(2011-2#1)
microscopic determination##2##2##(2008-10#2)
microscopic examination of##4##3##(1993-6#1)(1996-6#1)(2008-7#1)(2012-7#1)
microscopic examination revealed that##2##4##(2008-10#1)(2011-2#1)
microscopic examination revealed##3##3##(2008-10#1)(2009-1#1)(2011-2#1)
microscopic examination##14##2##(1993-6#1)(1996-12#1)(1996-6#1)(2008-10#3)(2008-4#1)(2008-7#2)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)
microscopic examinations##2##2##(1990-8#1)(2008-10#1)
microscopic findings##2##2##(2008-12#1)(2008-5#1)
microscopic ionization constants##2##3##(2008-10#2)
microscopic lesion scores regressed with significant##2##6##(2008-5#2)
microscopic lesion scores##4##3##(2008-5#4)
microscopic lesion##5##2##(2008-5#5)
microscopic lesions##2##2##(2008-12#1)(2008-5#1)
microscopic level##5##2##(1995-3#1)(2008-7#2)(2009-7#1)(2013-8#1)
microscopic observation of##2##3##(2008-10#1)(2008-5#1)
microscopic observation##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
microscopic observations of##2##3##(2008-10#2)
microscopic observations##7##2##(1994-2#1)(2008-10#6)
microscopic structures##2##2##(2008-3#1)(2011-2#1)
microscopic studies showed that##2##4##(2008-10#1)(2009-10#1)
microscopic studies##3##2##(2008-10#1)(2009-10#1)(2011-2#1)
microscopic study##2##2##(1995-8#1)(2012-2#1)
microscopic techniques##3##2##(1991-12#1)(2008-3#1)(2008-7#1)
microscopic##112##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-6#2)(1993-6#1)(1994-2#1)(1994-9#1)(1995-3#4)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#27)(2008-11#12)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#15)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#3)(2009-8#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-7#1)(2013-1#2)(2013-8#3)
microscopical and##2##2##(2007-12#1)(2008-5#1)
microscopical localization of##2##3##(2008-7#2)
microscopical##9##1##(2007-12#3)(2008-10#2)(2008-5#1)(2008-7#3)
microscopically examined##2##2##(2008-10#1)(2011-2#1)
microscopically##8##1##(1996-3#1)(2008-10#4)(2008-9#1)(2011-2#1)(2012-2#1)
microscopists##2##1##(2011-2#1)(2012-12#1)
microscopy (EM)##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
microscopy after##2##2##(2008-10#1)(2009-12#1)
microscopy analysis##3##2##(2009-7#2)(2011-2#1)
microscopy and by##2##3##(2008-10#1)(2008-7#1)
microscopy and compared to the##2##5##(1990-5#1)(2008-9#1)
microscopy and image analysis##2##4##(2008-10#1)(2010-10#1)
microscopy and scanning electron microscopy##2##5##(2008-10#2)
microscopy and scanning##3##3##(2008-10#2)(2010-7#1)
microscopy and##47##2##(1990-5#1)(1991-5#1)(1994-11#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
microscopy as##2##2##(2008-10#1)(2008-7#1)
microscopy assay##2##2##(2008-1#1)(2013-8#1)
microscopy confirmed##2##2##(2008-10#1)(2013-8#1)
microscopy for##5##2##(1991-5#1)(2008-10#2)(2008-9#1)(2012-2#1)
microscopy in##10##2##(1996-6#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
microscopy is##3##2##(2008-3#1)(2008-9#2)
microscopy observation##3##2##(2006-6#1)(2008-9#2)
microscopy of##20##2##(1990-12#1)(1991-11#1)(1992-9#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#3)
microscopy revealed that##7##3##(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-8#1)
microscopy revealed##11##2##(1996-12#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-8#1)
microscopy reveals that##2##3##(1995-2#1)(2007-12#1)
microscopy showed that the##2##4##(2008-8#1)(2011-2#1)
microscopy showed that##8##3##(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
microscopy showed##13##2##(1996-1#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)
microscopy studies##3##2##(2008-10#2)(2008-7#1)
microscopy to determine##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
microscopy to observe##2##3##(1997-8#1)(2008-10#1)
microscopy to##12##2##(1997-8#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-10#1)
microscopy using##6##2##(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#1)
microscopy was used to##7##4##(2007-12#1)(2008-10#3)(2008-5#1)(2009-12#1)(2011-3#1)
microscopy was used##8##3##(2007-12#1)(2008-10#4)(2008-5#1)(2009-12#1)(2011-3#1)
microscopy was##11##2##(2007-12#1)(2008-10#4)(2008-5#2)(2009-12#1)(2010-6#1)(2011-2#1)(2011-3#1)
microscopy we##2##2##(2008-5#1)(2008-7#1)
microscopy were used to##2##4##(2008-3#1)(2008-7#1)
microscopy were used##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
microscopy were##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
microscopy with##2##2##(2008-5#1)(2012-2#1)
microscopy##435##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-5#2)(1992-2#4)(1992-9#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-6#5)(1996-1#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-7#2)(1997-8#1)(2006-6#1)(2007-12#20)(2008-1#7)(2008-10#144)(2008-11#39)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#28)(2008-7#24)(2008-8#11)(2008-9#30)(2009-10#1)(2009-11#2)(2009-12#5)(2009-3#1)(2009-5#1)(2009-7#17)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#19)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#7)(2013-8#3)
microscopy-based techniques##2##2##(2008-11#1)(2008-7#1)
microscopy-based##3##1##(2008-1#1)(2008-11#1)(2008-7#1)
microsecond time##2##2##(1990-8#1)(2009-7#1)
microseconds##3##1##(1995-6#1)(2008-8#1)(2008-9#1)
microsensor for pCO(2) measurements##2##4##(2008-10#2)
microsensor for##3##2##(2008-10#3)
microsensor##8##1##(2008-10#8)
microsensors##6##1##(2008-10#4)(2008-7#1)(2010-7#1)
microsequencing and##2##2##(1991-5#1)(2008-9#1)
microsequencing of##2##2##(1992-3#1)(1994-11#1)
microsequencing##6##1##(1991-5#2)(1992-3#1)(1994-11#1)(1994-5#1)(2008-9#1)
microshear bond strength##5##3##(2013-1#5)
microsoma##10##1##(2011-2#10)
microsoma-Gruppe&quot##2##1##(2011-2#2)
microsomal and##2##2##(1991-8#1)(1996-2#1)
microsomal b5 cDNA##2##3##(1992-6#2)
microsomal b5##5##2##(1992-6#5)
microsomal fractions of##2##3##(1990-11#1)(1993-8#1)
microsomal fractions##5##2##(1990-11#1)(1991-8#1)(1993-11#1)(1993-8#1)(1994-8#1)
microsomal glucose-6-phosphatase activity##3##3##(1994-11#3)
microsomal lipids##2##2##(1994-5#2)
microsomal membranes##4##2##(1991-6#1)(1993-3#1)(1994-8#1)(1995-2#1)
microsomal##48##1##(1990-11#1)(1990-5#1)(1991-6#1)(1991-8#2)(1992-6#7)(1993-11#3)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#4)(1994-11#4)(1994-5#2)(1994-6#2)(1994-8#5)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(2011-3#2)(2012-2#2)
microsome##3##1##(1994-11#1)(2010-12#1)(2011-1#1)
microsomes and##4##2##(1994-8#2)(1997-1#1)(2011-1#1)
microsomes but##3##2##(1994-11#1)(1994-8#2)
microsomes by##3##2##(1991-5#1)(1994-6#1)(1994-8#1)
microsomes from##5##2##(1991-5#1)(1993-11#1)(1993-8#1)(1994-8#1)(2011-3#1)
microsomes in##2##2##(1991-5#1)(1994-11#1)
microsomes isolated from##2##3##(1991-5#1)(1991-6#1)
microsomes of the##3##3##(1992-12#1)(2011-3#2)
microsomes of##6##2##(1991-6#1)(1992-12#1)(2008-8#1)(2011-3#3)
microsomes were##3##2##(1993-8#1)(2011-3#2)
microsomes##58##1##(1990-5#1)(1991-10#2)(1991-5#8)(1991-6#2)(1992-12#1)(1992-8#2)(1993-11#2)(1993-8#3)(1994-11#5)(1994-6#1)(1994-8#15)(1995-6#2)(1997-1#1)(2008-8#1)(2011-1#3)(2011-3#9)
microspectrometry##2##1##(2008-5#2)
microspectroscopy##5##1##(2008-5#2)(2010-10#3)
microsphere size##2##2##(2008-7#2)
microsphere##7##1##(2008-7#2)(2008-9#4)(2013-1#1)
microspheres and flow cytometry##2##4##(2008-9#2)
microspheres and##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
microspheres bearing##2##2##(2008-9#2)
microspheres containing##2##2##(1993-1#1)(2008-10#1)
microspheres in##2##2##(1993-1#1)(2008-10#1)
microspheres with##2##2##(2008-10#2)
microspheres##35##1##(1993-1#2)(1994-12#1)(1994-2#1)(2008-10#14)(2008-3#1)(2008-4#2)(2008-7#5)(2008-9#6)(2012-3#2)(2013-1#1)
microsporocytes of##2##2##(2009-12#2)
microsporocytes##5##1##(2009-10#1)(2009-12#4)
microstomia##2##1##(2008-5#1)(2013-1#1)
microstructural changes##2##2##(2011-7#1)(2012-2#1)
microstructural##6##1##(2008-10#1)(2009-7#3)(2011-7#1)(2012-2#1)
microstructure and##4##2##(2009-7#2)(2011-2#1)(2013-1#1)
microstructure of the##4##3##(2008-10#1)(2008-5#1)(2009-7#2)
microstructure of##11##2##(2008-10#2)(2008-5#6)(2009-7#2)(2011-2#1)
microstructure##31##1##(2007-11#3)(2008-10#2)(2008-3#3)(2008-5#6)(2009-7#9)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
microstructures##7##1##(1997-6#2)(2007-11#1)(2008-10#1)(2008-3#2)(2013-1#1)
microsupport with two-dimensional geometry##2##4##(2008-11#2)
microsupport##3##1##(2008-11#3)
microsurgery##15##1##(1990-9#1)(1992-3#5)(1993-1#1)(1994-12#1)(1996-3#1)(2008-3#1)(2008-7#4)(2011-2#1)
microsurgical excision##2##2##(2008-7#2)
microsurgical##9##1##(1991-6#1)(1992-3#1)(1996-9#1)(2008-3#1)(2008-7#3)(2008-9#1)(2012-3#1)
microsurgically##3##1##(1992-3#2)(1994-12#1)
microsymbiont of annual##2##3##(2011-2#2)
microsymbiont of##6##2##(2011-2#6)
microsymbiont##7##1##(2011-2#7)
microsyringe##7##1##(2008-10#7)
microteaching to##2##2##(2008-11#2)
microteaching##6##1##(2008-11#6)
microtia reconstruction##2##2##(2009-1#2)
microtia##3##1##(2009-1#3)
microtiter plate##11##2##(2008-1#1)(2008-10#7)(2008-11#2)(2008-9#1)
microtiter plates and##2##3##(2008-10#1)(2011-2#1)
microtiter plates##8##2##(2008-10#4)(2008-12#1)(2010-11#1)(2011-2#2)
microtiter##23##1##(1994-5#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)
microtitration set up##3##3##(2008-10#3)
microtitration##5##1##(2008-10#5)
microtubular##4##1##(2008-11#1)(2010-7#1)(2012-2#2)
microtubule assembly##2##2##(2008-11#1)(2011-2#1)
microtubule associated protein-2 (MAP-2)##2##4##(1991-1#1)(2008-7#1)
microtubule associated proteins##2##3##(1991-1#1)(2009-8#1)
microtubule associated##4##2##(1991-1#2)(2008-7#1)(2009-8#1)
microtubule organization##2##2##(1994-9#1)(2011-2#1)
microtubule##26##1##(1991-1#2)(1993-6#2)(1993-8#1)(1994-9#2)(1995-2#3)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#3)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
microtubule-associated proteins##2##2##(1993-8#1)(2011-2#1)
microtubule-associated##3##1##(1993-6#1)(1993-8#1)(2011-2#1)
microtubule-based##2##1##(1995-2#1)(2009-10#1)
microtubule-dependent##4##1##(1994-12#2)(1994-9#2)
microtubules (MTs)##2##2##(2008-11#1)(2009-10#1)
microtubules and##4##2##(1993-8#1)(1995-2#2)(2008-1#1)
microtubules are##3##2##(2008-7#1)(2011-2#2)
microtubules in the##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
microtubules in##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-7#1)
microtubules were##2##2##(2008-7#1)(2009-12#1)
microtubules##33##1##(1993-8#2)(1995-2#3)(2007-12#2)(2008-1#2)(2008-11#2)(2008-5#2)(2008-7#6)(2008-8#1)(2009-10#2)(2009-12#1)(2009-7#1)(2010-7#3)(2011-2#4)(2012-2#1)(2012-4#1)
microvascular decompression for trigeminal neuralgia##3##5##(2011-2#2)(2013-1#1)
microvascular decompression##6##2##(2011-2#3)(2012-3#2)(2013-1#1)
microvascular##28##1##(1990-5#1)(1990-9#1)(1994-8#4)(1995-11#1)(1997-1#1)(1997-2#2)(2008-1#1)(2008-9#2)(2009-10#3)(2011-2#6)(2012-12#1)(2012-3#2)(2012-4#2)(2013-1#1)
microvascularization##2##1##(2008-5#1)(2012-2#1)
microvasculature##4##1##(2009-10#1)(2009-12#2)(2011-2#1)
microvesicles##10##1##(1990-12#3)(1997-3#5)(2010-4#1)(2013-8#1)
microvessel density (MVD)##2##3##(2011-2#2)
microvessel density##5##2##(2009-8#2)(2011-2#3)
microvessel endothelial cells##2##3##(1991-5#2)
microvessel endothelial##3##2##(1991-5#3)
microvessel##9##1##(1991-5#3)(2009-8#2)(2011-2#3)(2011-3#1)
microvessels in##2##2##(1994-12#1)(1997-2#1)
microvessels##8##1##(1990-5#1)(1994-12#1)(1997-2#2)(2008-11#1)(2009-8#1)(2010-12#1)(2012-2#1)
microvillar membranes##2##2##(2007-12#2)
microvillar##4##1##(2007-12#3)(2008-7#1)
microvillate##2##1##(2007-12#1)(2008-7#1)
microvilli and##3##2##(1995-2#1)(2008-5#1)(2008-7#1)
microvilli of##2##2##(2007-12#1)(2008-7#1)
microvilli##21##1##(1995-2#1)(1995-6#1)(2007-12#6)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#6)(2009-8#2)
microvillous membrane##3##2##(1991-12#3)
microvillous##4##1##(1991-12#3)(2008-6#1)
microvolume back-extraction##2##2##(2008-10#2)
microvolume##4##1##(2008-10#2)(2008-11#1)(2008-4#1)
microwave (MW)##3##2##(2008-10#3)
microwave assisted digestion##3##3##(2008-10#3)
microwave assisted extraction##2##3##(2008-10#2)
microwave assisted##9##2##(2008-10#8)(2011-2#1)
microwave decomposition##2##2##(2008-10#2)
microwave digested##2##2##(2008-10#2)
microwave digestion for##2##3##(2008-10#2)
microwave digestion method##2##3##(2008-10#2)
microwave digestion of##3##3##(2008-10#3)
microwave digestion system##5##3##(2008-10#5)
microwave digestion was##2##3##(2008-10#2)
microwave digestion with##4##3##(2008-10#4)
microwave digestion##26##2##(2008-10#26)
microwave digestion-hydride generation##2##3##(2008-10#2)
microwave dissolution##2##2##(2008-10#2)
microwave energy##4##2##(2008-10#4)
microwave heating##5##2##(2008-10#5)
microwave induced plasma##3##3##(2008-10#3)
microwave induced##4##2##(2008-10#3)(2012-2#1)
microwave irradiation to##2##3##(2008-10#1)(2009-7#1)
microwave irradiation##9##2##(2008-10#8)(2009-7#1)
microwave oven and##3##3##(2008-10#3)
microwave oven at##3##3##(2008-10#3)
microwave oven for##2##3##(2008-10#2)
microwave oven##20##2##(2008-10#20)
microwave plasma torch atomic emission spectrometry (MPT-AES)##2##7##(2008-10#2)
microwave plasma torch atomic emission spectrometry##4##6##(2008-10#4)
microwave plasma##6##2##(2008-10#6)
microwave power##5##2##(2008-10#5)
microwave procedure##2##2##(2008-10#2)
microwave programs##2##2##(2008-10#2)
microwave radiation##7##2##(2008-10#4)(2009-7#1)(2011-2#2)
microwave system##5##2##(2008-10#5)
microwave##153##1##(1995-6#1)(2008-10#133)(2008-2#1)(2008-3#6)(2008-5#2)(2009-10#1)(2009-7#2)(2010-4#2)(2011-2#3)(2012-12#1)(2012-2#1)
microwave-assisted Soxhlet extraction##2##3##(2008-10#2)
microwave-assisted acid digestion##2##3##(2008-10#2)
microwave-assisted acid##4##2##(2008-10#4)
microwave-assisted acid-digestion for the determination of metals in coal by##2##10##(2008-10#2)
microwave-assisted digestion and##2##3##(2008-10#2)
microwave-assisted digestion procedure##2##3##(2008-10#2)
microwave-assisted digestion with##2##3##(2008-10#2)
microwave-assisted digestion##11##2##(2008-10#11)
microwave-assisted extraction (MAE)##2##3##(2008-10#2)
microwave-assisted extraction and##2##3##(2008-10#2)
microwave-assisted extraction of##2##3##(2008-10#2)
microwave-assisted extraction##11##2##(2008-10#11)
microwave-assisted sample digestion##4##3##(2008-10#4)
microwave-assisted sample##5##2##(2008-10#5)
microwave-assisted solvent extraction##2##3##(2008-10#2)
microwave-assisted##50##1##(2008-10#50)
microwaves as##2##2##(2008-10#2)
microwaves at##2##2##(1994-2#1)(2008-10#1)
microwaves##19##1##(1994-2#1)(2008-10#12)(2008-3#1)(2008-5#1)(2011-2#4)
microwindow##2##1##(2008-3#2)
microwindows for##3##2##(2008-3#3)
microwindows##5##1##(2008-3#5)
microzone##3##1##(1994-2#1)(2008-10#2)
mid R##2##2##(2008-10#2)
mid left##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
mid to##3##2##(2011-2#2)(2012-3#1)
mid##26##1##(1992-9#2)(1996-1#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#1)(2011-2#3)(2012-3#2)(2013-1#1)
mid- and##4##2##(2008-10#3)(2011-2#1)
mid-##6##1##(2008-10#4)(2011-1#1)(2011-2#1)
mid-Holocene##2##1##(2012-9#2)
mid-IR##10##1##(2007-12#2)(2008-10#5)(2008-3#3)
mid-January##2##1##(1992-6#2)
mid-May##2##1##(2008-10#2)
mid-P)##3##1##(2008-11#3)
mid-elevation##2##1##(2008-10#2)
mid-exponential phase##2##2##(2008-11#2)
mid-illness##2##1##(1995-2#2)
mid-infrared radiation##3##2##(2007-12#2)(2008-10#1)
mid-infrared spectroscopic##2##2##(2008-10#1)(2008-3#1)
mid-infrared spectroscopy##3##2##(2008-10#3)
mid-infrared##23##1##(2007-12#4)(2008-10#7)(2008-2#2)(2008-3#9)(2008-5#1)
mid-managers##3##1##(1990-12#3)
mid-plane##2##1##(2009-11#2)
mid-portion of the##2##3##(2008-12#1)(2008-5#1)
mid-summer##2##1##(2012-7#2)
mid-temporal##2##1##(1996-12#2)
mid-term follow-up##2##2##(2009-4#1)(2012-12#1)
mid-term##8##1##(2008-10#1)(2008-12#2)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
midazolam sedation##2##2##(1993-1#2)
midazolam##8##1##(1993-1#5)(1994-2#1)(1995-11#1)(2010-7#1)
midbrain and##6##2##(1992-1#1)(1996-12#1)(1997-2#2)(2008-7#2)
midbrain##21##1##(1992-1#2)(1993-8#1)(1996-12#4)(1997-2#3)(1997-3#1)(2008-6#3)(2008-7#5)(2013-7#2)
midcarpal injection of lidocaine##4##4##(2008-9#4)
midcarpal##7##1##(2008-9#7)
midday##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
middle adolescence##2##2##(2009-7#2)
middle age males##2##3##(2008-10#2)
middle age##6##2##(1991-6#1)(2008-10#2)(2011-2#3)
middle aged##2##2##(1997-8#1)(2013-1#1)
middle and lower parts##2##4##(2013-1#2)
middle and posterior##3##3##(2008-12#1)(2008-7#1)(2010-6#1)
middle and##9##2##(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#1)(2013-1#3)
middle cerebral artery aneurysms##4##4##(2011-2#3)(2013-8#1)
middle cerebral artery occlusion##2##4##(1997-2#1)(2011-2#1)
middle cerebral artery territory##2##4##(2008-7#2)
middle cerebral artery with##2##4##(2008-7#2)
middle cerebral artery##21##3##(1996-3#1)(1997-2#1)(2008-12#2)(2008-4#1)(2008-7#8)(2010-11#1)(2011-2#4)(2013-8#3)
middle cerebral##23##2##(1996-2#1)(1996-3#1)(1997-2#1)(2008-12#2)(2008-4#1)(2008-7#9)(2010-11#1)(2011-2#4)(2013-8#3)
middle class##3##2##(1996-9#1)(2010-1#2)
middle cranial fossa##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
middle ear##10##2##(1991-3#4)(1994-2#1)(1995-5#1)(2008-10#2)(2013-1#1)(2013-7#1)
middle fossa##6##2##(2008-7#1)(2011-2#5)
middle frontal gyrus (BA6)##2##4##(2008-11#2)
middle layer##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
middle mesial##2##2##(2012-12#2)
middle of the##9##3##(1993-2#1)(1993-8#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)
middle of##15##2##(1991-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-6#2)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-3#1)
middle promoters##3##2##(1995-2#3)
middle school students##2##3##(2010-1#1)(2012-12#1)
middle school##5##2##(1993-1#1)(2010-1#1)(2012-12#1)(2012-2#2)
middle temporal artery##2##3##(2008-9#2)
middle temporal##4##2##(1996-2#1)(2008-9#3)
middle third##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
middle to late##2##3##(1990-11#1)(2009-7#1)
middle trunk of the MCA trifurcation##2##6##(2008-12#2)
middle##161##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#7)(1995-5#2)(1995-6#3)(1996-2#3)(1996-3#3)(1996-9#3)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#22)(2008-11#7)(2008-12#10)(2008-3#1)(2008-4#1)(2008-7#14)(2008-8#2)(2008-9#10)(2009-10#1)(2009-3#2)(2009-7#4)(2010-1#4)(2010-11#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#16)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#6)
middle- and##2##2##(1994-1#1)(2010-7#1)
middle-aged and older adults##2##4##(2008-4#1)(2013-1#1)
middle-aged and##4##2##(1995-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
middle-aged man##2##2##(2008-11#2)
middle-aged##20##1##(1991-6#2)(1991-8#1)(1995-3#1)(2008-11#2)(2008-4#2)(2008-7#6)(2009-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
middle-class##2##1##(2008-11#1)(2009-10#1)
middle-income##7##1##(1993-3#1)(2008-10#3)(2010-11#1)(2011-2#1)(2012-12#1)
midgestation##2##1##(1994-11#1)(1995-2#1)
midgut cells##3##2##(2007-12#1)(2008-10#2)
midgut epithelia##3##2##(2008-10#3)
midgut of##3##2##(2007-12#1)(2008-10#2)
midgut walls##2##2##(2007-12#2)
midgut##34##1##(1997-3#1)(2007-12#10)(2008-10#17)(2008-12#2)(2008-6#1)(2008-7#2)(2013-1#1)
midguts##2##1##(2007-12#1)(2008-10#1)
midline neuropil in##2##3##(2007-12#2)
midline neuropil##4##2##(2007-12#4)
midline neuropils in##3##3##(2007-12#3)
midline neuropils of##2##3##(2007-12#2)
midline neuropils##5##2##(2007-12#5)
midline suboccipital##2##2##(2011-2#1)(2013-1#1)
midline tissues##2##2##(1994-12#2)
midline##27##1##(1990-8#1)(1991-11#1)(1994-12#2)(1994-3#1)(1996-9#1)(1997-3#2)(2007-12#10)(2008-10#2)(2008-12#1)(2008-7#1)(2009-1#1)(2011-2#2)(2013-1#2)
midparent value##2##2##(2008-10#2)
midpiece##4##1##(2008-7#4)
midpoint of##3##2##(1993-8#1)(1997-2#1)(2008-12#1)
midpoint potential##2##2##(1997-7#2)
midpoint potentials##5##2##(1993-8#1)(2008-10#3)(2009-9#1)
midpoint##10##1##(1993-8#2)(1997-2#1)(1997-7#2)(2008-10#3)(2008-12#1)(2009-9#1)
midrange##4##1##(1993-2#4)
midrib##4##1##(2008-10#1)(2009-8#3)
midsagittal magnetic resonance##2##3##(1995-5#2)
midsagittal##4##1##(1995-5#4)
midseason##3##1##(2008-10#2)(2008-8#1)
midtherapy##2##1##(2012-2#2)
midtrimester blood pressure##2##3##(1994-3#2)
midtropospheric aerosol backscatter background mode##2##5##(2008-2#1)(2008-3#1)
midway##2##1##(2009-9#1)(2012-2#1)
midwest##2##1##(2008-10#1)(2010-9#1)
midwestern##4##1##(1995-3#1)(2008-10#2)(2009-7#1)
midwifery and##2##2##(2008-11#1)(2008-12#1)
midwifery in##2##2##(2008-12#1)(2013-1#1)
midwifery programme##2##2##(2008-12#2)
midwifery##12##1##(2008-11#5)(2008-12#6)(2013-1#1)
midwives##12##1##(1990-6#1)(1993-12#1)(2008-11#7)(2008-12#2)(2013-1#1)
might account for the##2##4##(2008-10#1)(2013-1#1)
might act as a##2##4##(2008-10#1)(2009-10#1)
might act##3##2##(1993-9#1)(2008-10#1)(2009-10#1)
might affect the##2##3##(2008-6#1)(2008-9#1)
might affect##6##2##(1993-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
might aid in##2##3##(2008-7#2)
might allow##2##2##(1991-6#1)(2013-1#1)
might also be##12##3##(1990-9#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-9#1)(2011-2#1)
might also##18##2##(1990-9#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#2)
might be a##14##3##(1992-6#1)(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-4#2)(2010-5#1)
might be achieved##3##3##(1992-2#1)(2008-10#1)(2008-5#1)
might be affected##2##3##(2008-10#1)(2008-11#1)
might be an##10##3##(1993-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#2)
might be associated with##3##4##(1995-2#1)(2008-9#1)(2012-2#1)
might be associated##4##3##(1995-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
might be attributed to##3##4##(1990-12#1)(2008-10#2)
might be better##3##3##(1996-3#1)(2008-9#1)(2011-2#1)
might be caused by##2##4##(2008-11#1)(2008-7#1)
might be considered an##2##4##(1991-12#1)(2008-5#1)
might be considered as a##2##5##(2008-10#1)(2010-1#1)
might be considered##8##3##(1991-12#1)(1992-12#2)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)
might be derived from pre-karyote##3##5##(2009-6#3)
might be determined##2##3##(2008-10#1)(2008-7#1)
might be due to a##3##5##(1993-1#1)(1993-8#1)(1994-5#1)
might be due to the##2##5##(1991-2#1)(2008-9#1)
might be due to##11##4##(1991-2#2)(1993-1#1)(1993-8#1)(1994-5#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
might be expected to##2##4##(1994-5#1)(1996-11#1)
might be expected##6##3##(1991-12#1)(1994-3#1)(1994-5#1)(1996-11#1)(2008-10#1)(2012-3#1)
might be explained by##3##4##(1993-1#1)(2008-10#2)
might be important for##2##4##(1997-8#1)(2011-2#1)
might be important##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
might be improved##2##3##(2008-10#2)
might be involved in the##7##5##(1993-3#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-7#2)(2013-1#1)
might be involved in##11##4##(1990-4#1)(1993-3#1)(1994-11#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2013-1#1)
might be involved##13##3##(1990-4#1)(1993-3#1)(1994-11#2)(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#2)(2013-1#1)
might be more##6##3##(1993-8#1)(1995-8#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
might be obtained##2##3##(2008-11#1)(2008-8#1)
might be of##5##3##(1997-5#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
might be one of the factors##2##6##(1997-8#1)(2008-12#1)
might be one of the##3##5##(1997-8#1)(2008-12#1)(2008-8#1)
might be one##4##3##(1997-8#1)(2008-12#1)(2008-8#1)(2011-1#1)
might be related to##4##4##(1995-8#1)(2008-11#1)(2009-12#1)(2011-1#1)
might be relevant to##2##4##(2008-6#1)(2011-2#1)
might be relevant##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
might be responsible for the##2##5##(1991-9#1)(1993-6#1)
might be similar##2##3##(2011-10#1)(2011-2#1)
might be the##16##3##(1990-3#1)(1990-4#1)(1994-11#1)(2008-10#3)(2008-4#1)(2008-8#3)(2008-9#3)(2010-10#1)(2012-2#1)(2013-8#1)
might be transmitted##2##3##(1995-9#1)(1996-5#1)
might be used##2##3##(1992-9#1)(2009-8#1)
might be useful for##2##4##(2008-5#1)(2011-2#1)
might be useful in the##2##5##(2008-10#1)(2011-2#1)
might be useful in##4##4##(1996-3#1)(1997-8#1)(2008-10#1)(2011-2#1)
might be useful##8##3##(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)
might be##229##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#3)(1994-3#2)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#3)(1997-7#2)(1997-8#7)(1997-9#1)(2007-12#2)(2008-10#33)(2008-11#18)(2008-12#4)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-6#4)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-10#2)(2011-2#10)(2012-12#2)(2012-2#12)(2012-3#4)(2013-1#4)(2013-8#2)
might benefit from##4##3##(1991-12#1)(2007-12#1)(2008-10#1)(2012-7#1)
might benefit##6##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-7#1)(2013-8#1)
might cause the##2##3##(1997-2#1)(2008-11#1)
might cause##4##2##(1997-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
might contribute to the##3##4##(2008-8#1)(2011-2#1)(2012-2#1)
might contribute to##7##3##(1991-5#1)(1993-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
might correspond to##2##3##(2008-10#1)(2008-5#1)
might exist##2##2##(1992-9#1)(2008-9#1)
might explain the##7##3##(1991-11#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-1#1)
might explain##10##2##(1991-11#1)(1992-12#1)(1994-5#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-6#1)(2010-1#1)
might facilitate##2##2##(2008-12#1)(2008-7#1)
might find##3##2##(1992-8#1)(2008-10#1)(2008-11#1)
might form a##2##3##(1995-6#1)(1997-7#1)
might form##5##2##(1995-12#1)(1995-6#1)(1997-7#1)(2008-5#1)(2008-9#1)
might function as a##2##4##(1997-4#1)(2008-5#1)
might function##4##2##(1993-8#1)(1997-4#1)(2008-5#1)(2008-7#1)
might have a common##2##4##(2008-4#1)(2008-8#1)
might have a##7##3##(1993-11#1)(1996-3#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
might have an important##2##4##(1994-5#1)(2009-6#1)
might have an##3##3##(1994-5#1)(2009-6#1)(2012-2#1)
might have been##10##3##(1990-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#2)(2010-4#1)
might have contributed to##2##4##(2009-8#1)(2011-2#1)
might have##37##2##(1990-3#1)(1991-6#1)(1992-6#1)(1993-11#1)(1994-5#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-6#6)(2009-8#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
might help to##2##3##(2008-10#1)(2009-12#1)
might help##6##2##(2008-10#2)(2009-1#1)(2009-12#1)(2009-5#1)(2013-1#1)
might impair##2##2##(1992-12#1)(2008-8#1)
might improve##2##2##(1995-6#1)(2010-9#1)
might indicate that##2##3##(1997-7#1)(2008-7#1)
might indicate##4##2##(1997-7#1)(2008-7#1)(2009-8#1)(2011-2#1)
might induce##7##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)
might influence##5##2##(1993-1#1)(2008-10#1)(2010-2#1)(2010-4#1)(2012-3#1)
might interact with##2##3##(1990-2#1)(2013-1#1)
might interact##3##2##(1990-2#1)(2008-9#1)(2013-1#1)
might interfere with##2##3##(1991-12#1)(2008-10#1)
might involve##3##2##(1992-3#1)(2008-7#1)(2008-8#1)
might lead to##7##3##(1991-6#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)
might lead##8##2##(1991-6#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)
might limit##2##2##(1994-8#1)(2008-9#1)
might not be##6##3##(2008-10#3)(2008-7#1)(2010-11#1)(2011-2#1)
might not have been##2##4##(1997-1#1)(2012-12#1)
might not##15##2##(1991-12#1)(1994-5#1)(1996-3#2)(1997-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#2)(2012-12#1)
might occur##5##2##(1994-11#1)(1996-3#1)(2008-10#1)(2008-9#2)
might originate from##2##3##(1997-3#1)(1997-8#1)
might otherwise##2##2##(1991-6#1)(2008-10#1)
might participate in the##2##4##(1996-12#1)(2008-11#1)
might play a critical role in the##2##7##(2008-11#1)(2008-8#1)
might play a critical role in##3##6##(2008-11#1)(2008-8#1)(2008-9#1)
might play a critical role##4##5##(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
might play a role in##2##5##(2008-7#1)(2012-2#1)
might play a role##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
might play a##9##3##(1996-12#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)
might play an important role in##3##6##(1997-2#1)(2008-11#1)(2008-9#1)
might play an important role##4##5##(1997-2#1)(2008-11#1)(2008-8#1)(2008-9#1)
might play##17##2##(1993-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-7#2)(2008-8#3)(2008-9#3)(2011-2#1)(2012-2#1)
might possibly##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
might produce a##2##3##(2008-10#1)(2013-1#1)
might produce##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
might promote##2##2##(2009-6#1)(2013-1#1)
might prove##2##2##(1991-5#1)(2008-10#1)
might provide a##4##3##(2008-11#2)(2008-9#1)(2010-12#1)
might provide new##2##3##(2008-4#1)(2008-7#1)
might provide##7##2##(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)
might reduce the##2##3##(1995-6#1)(2008-10#1)
might represent a##2##3##(1990-8#1)(2010-11#1)
might represent##5##2##(1990-8#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
might require##3##2##(2008-3#1)(2010-12#1)(2013-1#1)
might respond to##2##3##(1991-2#1)(2008-6#1)
might result from##2##3##(2008-11#1)(2009-8#1)
might result in##2##3##(2010-12#1)(2013-8#1)
might result##4##2##(2008-11#1)(2009-8#1)(2010-12#1)(2013-8#1)
might serve to##2##3##(1997-7#1)(2008-8#1)
might serve##3##2##(1997-7#1)(2008-8#1)(2010-12#1)
might stem from##2##3##(1990-11#1)(2008-11#1)
might therefore be##3##3##(1991-12#1)(1993-12#1)(2008-9#1)
might therefore##4##2##(1991-12#1)(1993-12#1)(2008-9#1)(2009-7#1)
might trigger##2##2##(1995-8#1)(2008-11#1)
might##555##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#4)(1991-9#1)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#3)(1993-3#2)(1993-6#3)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#5)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#5)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#8)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#5)(1997-8#9)(1997-9#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#70)(2008-11#40)(2008-12#12)(2008-3#3)(2008-4#8)(2008-5#16)(2008-6#5)(2008-7#24)(2008-8#31)(2008-9#28)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#5)(2009-3#1)(2009-5#3)(2009-6#14)(2009-7#3)(2009-8#8)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-10#2)(2011-2#28)(2012-12#4)(2012-2#18)(2012-3#6)(2012-7#1)(2013-1#13)(2013-8#7)
migraine across the lifespan##2##4##(2008-9#2)
migraine and##5##2##(1990-3#1)(1991-3#1)(2008-5#1)(2008-9#2)
migraine as##2##2##(2008-9#2)
migraine attacks##4##2##(2008-9#4)
migraine is a##2##3##(2008-9#2)
migraine is##4##2##(2008-9#4)
migraine pain##2##2##(2008-9#2)
migraine prophylaxis##2##2##(2008-6#1)(2013-7#1)
migraine with and migraine without aura##2##6##(2008-9#2)
migraine with aura##5##3##(2008-9#4)(2011-2#1)
migraine with##9##2##(2008-6#1)(2008-9#7)(2011-2#1)
migraine without aura##4##3##(2008-9#4)
migraine##57##1##(1990-3#1)(1991-3#1)(2008-5#1)(2008-6#2)(2008-9#45)(2009-9#1)(2010-2#1)(2011-2#2)(2012-3#2)(2013-7#1)
migraineurs##3##1##(2008-9#2)(2010-9#1)
migrans##3##1##(2008-9#1)(2012-2#2)
migrant farmworker##2##2##(2010-9#2)
migrant##6##1##(2008-10#1)(2009-10#1)(2010-9#2)(2012-3#1)(2013-8#1)
migrants and##3##2##(1994-2#1)(2010-8#2)
migrants from the##2##3##(2008-10#1)(2008-6#1)
migrants from##4##2##(1994-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
migrants##20##1##(1994-12#1)(1994-2#6)(1997-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#4)(2013-8#1)
migrate from##3##2##(1995-8#1)(2008-10#1)(2010-8#1)
migrate in##2##2##(1992-10#1)(1994-11#1)
migrate into the##2##3##(1997-8#1)(2008-4#1)
migrate to the##2##3##(1996-2#1)(2008-11#1)
migrate to##5##2##(1996-2#1)(2008-10#1)(2008-11#2)(2013-8#1)
migrate towards##2##2##(2013-1#2)
migrate##18##1##(1992-10#2)(1994-11#1)(1995-8#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2010-8#1)(2013-1#2)(2013-8#1)
migrated as a##2##3##(1992-12#1)(2008-10#1)
migrated from##2##2##(2008-10#1)(2010-12#1)
migrated microcatheter##2##2##(2008-7#2)
migrated to##2##2##(2008-5#2)
migrated towards the##2##3##(2008-10#1)(2010-8#1)
migrated##22##1##(1992-12#1)(1992-6#1)(1992-8#1)(1994-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2009-4#1)(2010-12#1)(2010-8#2)(2011-2#1)(2013-1#1)
migrates##3##1##(1992-10#1)(2008-4#1)(2008-7#1)
migrating##12##1##(1992-6#2)(1993-12#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
migration across##2##2##(1995-2#1)(2009-9#1)
migration after##3##2##(2010-8#1)(2012-12#2)
migration and proliferation##2##3##(2008-4#1)(2010-3#1)
migration and##20##2##(1996-12#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-6#1)(2013-1#1)
migration appears to be##2##4##(1992-6#1)(2012-2#1)
migration began##2##2##(2011-2#2)
migration between sites##2##3##(2008-8#2)
migration between##4##2##(2008-10#2)(2008-8#2)
migration by##3##2##(1995-2#1)(2008-5#1)(2010-8#1)
migration could##2##2##(1995-2#1)(2011-2#1)
migration from##4##2##(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
migration has##3##2##(2008-3#1)(2008-9#1)(2013-8#1)
migration in a##2##3##(1992-6#1)(2008-10#1)
migration in the##4##3##(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
migration in##17##2##(1992-6#1)(1994-2#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#4)(2011-2#2)(2012-2#1)(2013-1#1)
migration index##2##2##(1992-6#2)
migration inhibition factor activity##2##4##(1991-12#2)
migration inhibition factor##4##3##(1991-12#4)
migration into##4##2##(1992-6#1)(1995-8#1)(1997-8#1)(2008-11#1)
migration is a rare##2##4##(2008-7#1)(2011-2#1)
migration is##4##2##(2008-7#1)(2008-8#1)(2011-2#2)
migration of hMSCs##2##3##(2010-8#2)
migration of human##2##3##(2008-1#1)(2010-8#1)
migration of myogenic precursor cells into the limb##2##8##(1995-8#2)
migration of myogenic precursor cells##4##5##(1995-8#4)
migration of oligodendrocyte precursor cells##2##5##(2008-7#2)
migration of subureterically injected calcium hydroxylapatite##2##6##(2008-10#2)
migration of the##13##3##(1990-9#1)(1992-6#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-9#1)(2010-7#1)(2012-3#1)
migration of##59##2##(1990-12#1)(1990-9#1)(1992-6#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-8#4)(1997-6#1)(2008-1#2)(2008-10#13)(2008-11#6)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-7#2)(2010-8#5)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
migration parameters##2##2##(2008-1#1)(2008-10#1)
migration patterns##3##2##(2008-5#3)
migration rate and##3##3##(2008-8#3)
migration rate was##2##3##(2008-10#1)(2010-8#1)
migration rate##11##2##(2008-10#2)(2008-8#8)(2010-8#1)
migration rates##4##2##(2008-8#2)(2013-1#2)
migration through##2##2##(1994-5#1)(2008-1#1)
migration time and peak##3##4##(2008-10#3)
migration time and##8##3##(2008-10#8)
migration time of##3##3##(2008-10#3)
migration time##18##2##(2008-10#18)
migration times (&lt##2##3##(2008-10#2)
migration times and peak##3##4##(2008-10#3)
migration times and##5##3##(2008-10#5)
migration times of##2##3##(2008-10#2)
migration times##14##2##(2008-10#14)
migration to the##3##3##(2011-2#2)(2013-1#1)
migration to##7##2##(2007-12#1)(2008-4#1)(2009-1#1)(2011-2#3)(2013-1#1)
migration was##3##2##(1994-8#2)(2008-10#1)
migration within the##2##3##(2008-9#1)(2009-10#1)
migration within##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
migration##318##1##(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#4)(1991-5#1)(1992-3#1)(1992-6#8)(1993-2#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#11)(1995-12#1)(1995-2#6)(1995-5#3)(1995-8#6)(1996-12#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#7)(2008-10#69)(2008-11#13)(2008-12#5)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#35)(2008-9#15)(2009-1#1)(2009-10#4)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#13)(2011-1#2)(2011-2#37)(2012-12#3)(2012-2#4)(2012-3#3)(2012-6#1)(2013-1#9)(2013-8#5)
migration/invasion##3##1##(2013-1#3)
migrations of the##2##3##(2008-10#1)(2008-9#1)
migrations of##3##2##(2008-10#1)(2008-9#2)
migrations##4##1##(2008-10#2)(2008-9#2)
migratory behavior##2##2##(2008-8#1)(2012-3#1)
migratory behaviour##3##2##(2010-8#3)
migratory fascia hypothesis##2##3##(2009-9#2)
migratory fascia##3##2##(2009-9#3)
migratory flocks##2##2##(2011-2#2)
migratory species##2##2##(2008-8#2)
migratory##25##1##(1994-2#1)(1995-3#2)(2008-11#1)(2008-7#1)(2008-8#4)(2009-8#1)(2009-9#3)(2010-8#5)(2011-2#5)(2012-3#2)
milacemide##3##1##(1994-8#3)
mild Delta5 steroid abnormality##2##4##(2008-4#2)
mild acid hydrolysis##2##3##(1994-11#2)
mild acid##3##2##(1994-11#2)(2008-10#1)
mild and moderate##2##3##(1997-8#1)(2008-7#1)
mild and self-limited##2##3##(2010-12#1)(2013-1#1)
mild and severe##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
mild and transient##2##3##(2008-10#1)(2008-7#1)
mild and##14##2##(1995-2#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
mild cerebral##2##2##(1994-2#1)(1997-3#1)
mild cognitive impairment##8##3##(2008-2#1)(2008-6#1)(2009-10#4)(2010-11#1)(2011-2#1)
mild cognitive##9##2##(1994-1#1)(2008-2#1)(2008-6#1)(2009-10#4)(2010-11#1)(2011-2#1)
mild conditions for##3##3##(1997-2#1)(2008-10#2)
mild conditions##7##2##(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-12#1)
mild curly top virus##4##4##(2008-10#4)
mild deficits##2##2##(1993-12#2)
mild demented##2##2##(2008-7#2)
mild epidemics##4##2##(2008-10#4)
mild heat treatment##2##3##(2011-2#2)
mild heat##3##2##(2011-2#3)
mild hypothermia and##2##3##(1995-11#1)(2011-2#1)
mild hypothermia##3##2##(1995-11#1)(2011-2#2)
mild leaf##2##2##(2008-10#2)
mild mosaic##2##2##(2008-10#1)(2008-9#1)
mild or##3##2##(1997-8#1)(2011-1#2)
mild sensory##2##2##(1991-6#1)(2008-11#1)
mild signs of##2##3##(2008-7#1)(2013-1#1)
mild steel##4##2##(2008-10#3)(2011-2#1)
mild strain##4##2##(2008-10#4)
mild stress##3##2##(2008-11#2)(2013-1#1)
mild stresses##2##2##(2008-7#1)(2009-8#1)
mild symptoms##4##2##(2007-12#1)(2008-10#2)(2013-8#1)
mild to moderate asthma##2##4##(1996-1#1)(2008-5#1)
mild to moderate##8##3##(1995-10#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
mild to severe##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
mild to##12##2##(1995-10#1)(1995-2#1)(1996-1#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#1)
mild traumatic brain injury##4##4##(1991-12#1)(2010-1#2)(2013-1#1)
mild traumatic brain-injured##2##3##(2009-8#2)
mild traumatic##6##2##(1991-12#1)(2009-8#2)(2010-1#2)(2013-1#1)
mild whole body hyperthermia##2##4##(2008-7#2)
mild##222##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#5)(1996-9#2)(1997-2#2)(1997-3#4)(1997-5#1)(1997-8#3)(2007-11#1)(2007-12#3)(2008-10#47)(2008-11#7)(2008-12#3)(2008-2#2)(2008-4#7)(2008-5#11)(2008-6#1)(2008-7#20)(2008-8#2)(2008-9#5)(2009-10#4)(2009-12#1)(2009-3#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-9#1)(2011-1#2)(2011-2#16)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#13)(2013-8#6)
mild-moderate##2##1##(2008-7#1)(2010-12#1)
mild-to-moderate##7##1##(1991-6#1)(1992-9#1)(2008-10#1)(2008-5#1)(2010-12#2)(2013-1#1)
mild/moderate##2##1##(1995-1#1)(2011-2#1)
milder and##2##2##(2008-10#2)
milder symptoms##2##2##(2008-10#2)
milder##11##1##(1994-12#1)(1995-1#1)(1995-8#1)(2008-10#6)(2011-2#1)(2013-1#1)
mildew and##5##2##(2008-10#5)
mildew caused by##2##3##(2008-10#2)
mildew colonies##3##2##(2008-10#3)
mildew development on##3##3##(2008-10#3)
mildew development##6##2##(2008-10#6)
mildew disease on##2##3##(2008-10#2)
mildew disease##3##2##(2008-10#3)
mildew epidemiology##2##2##(2008-10#2)
mildew for##2##2##(2008-10#2)
mildew in grape berries##2##4##(2008-10#2)
mildew in##5##2##(2008-10#5)
mildew incidence##4##2##(2008-10#4)
mildew infection##2##2##(2008-10#2)
mildew on##5##2##(2008-10#5)
mildew pathogen##2##2##(2008-10#2)
mildew resistance##17##2##(2008-10#15)(2012-3#2)
mildew were##3##2##(2008-10#3)
mildew##126##1##(2008-10#124)(2012-3#2)
mildly##10##1##(1993-3#1)(1997-2#1)(1997-3#1)(2008-10#2)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
milestones in##4##2##(1992-1#1)(2008-11#1)(2010-6#1)(2012-2#1)
milestones##7##1##(1992-1#1)(2008-11#2)(2010-6#2)(2011-2#1)(2012-2#1)
milieu and##4##2##(1990-2#1)(1993-2#1)(2008-11#1)(2010-5#1)
milieu for##3##2##(1996-2#1)(2013-8#2)
milieu in##2##2##(2008-4#1)(2008-7#1)
milieu therapy##2##2##(1991-2#1)(2013-1#1)
milieu to##2##2##(1992-3#1)(2009-8#1)
milieu##25##1##(1990-2#1)(1991-2#1)(1992-3#1)(1993-1#2)(1993-2#3)(1996-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#2)(2009-8#1)(2010-5#1)(2013-1#3)(2013-8#3)
military expenditures##2##2##(1990-2#2)
military facilities##4##2##(1995-6#1)(1996-5#3)
military hospitals##4##2##(1992-3#1)(1995-6#3)
military recruits##2##2##(1996-11#1)(2011-2#1)
military service##4##2##(1993-8#1)(2008-11#1)(2011-2#2)
military##41##1##(1990-2#2)(1991-3#1)(1992-12#1)(1992-3#4)(1993-8#1)(1994-3#1)(1995-6#7)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#5)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2011-2#4)(2012-2#1)(2013-1#1)
milk (SM)##2##2##(2013-1#2)
milk TG structures##2##3##(2012-2#2)
milk TG##4##2##(2012-2#4)
milk and plasma of##2##4##(2013-1#2)
milk and##25##2##(1993-1#1)(1997-1#1)(2008-10#17)(2008-12#1)(2009-8#1)(2011-2#1)(2013-1#3)
milk as a##2##3##(2012-2#1)(2013-1#1)
milk as##3##2##(2012-2#1)(2013-1#2)
milk by##10##2##(2008-10#8)(2009-8#1)(2011-2#1)
milk from Indonesian women##2##4##(2008-11#2)
milk from##5##2##(1991-6#1)(2008-11#2)(2013-1#2)
milk has##2##2##(2008-10#1)(2012-2#1)
milk in##2##2##(2008-12#1)(2011-2#1)
milk is##7##2##(2008-10#5)(2012-2#2)
milk powder and##3##3##(2008-10#3)
milk powder##7##2##(2008-10#7)
milk powder)##2##2##(2008-10#2)
milk production in##2##3##(1990-11#1)(2011-2#1)
milk production##7##2##(1990-11#1)(1992-2#1)(2008-12#2)(2010-12#2)(2011-2#1)
milk products##3##2##(1991-3#1)(2008-10#1)(2012-2#1)
milk sample##3##2##(2008-10#2)(2008-12#1)
milk samples##19##2##(2008-10#16)(2008-12#1)(2009-8#1)(2011-2#1)
milk was##5##2##(2008-10#4)(2013-1#1)
milk were##4##2##(2008-10#3)(2013-1#1)
milk yield##3##2##(1992-2#1)(2010-12#2)
milk##213##1##(1990-11#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-2#3)(1993-1#1)(1993-11#2)(1995-10#2)(1996-3#1)(1996-8#1)(1997-1#1)(2008-10#107)(2008-11#8)(2008-12#9)(2008-5#2)(2008-8#4)(2009-8#5)(2010-12#4)(2010-6#1)(2011-1#1)(2011-2#6)(2012-2#24)(2013-1#25)
milk)##5##1##(1996-12#1)(2008-10#4)
milking##3##1##(1990-6#2)(1992-2#1)
milks##2##1##(2008-5#1)(2013-1#1)
milkvetch##3##1##(2008-10#3)
mill##9##1##(1991-12#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-3#1)
milled##3##1##(2008-10#1)(2008-11#1)(2010-4#1)
millennium##9##1##(2008-11#1)(2008-4#6)(2009-10#1)(2012-9#1)
millerite##2##1##(2008-10#2)
millet##12##1##(2008-10#11)(2008-11#1)
milligram amounts of##3##3##(2008-11#1)(2008-4#2)
milligram of##2##2##(2008-10#1)(2008-11#1)
milligram quantities##2##2##(1992-7#1)(1993-8#1)
milligram##7##1##(1992-7#1)(1993-8#1)(2008-10#1)(2008-11#2)(2008-4#2)
milligrams of purified##2##3##(2008-10#1)(2012-2#1)
milligrams of##6##2##(2008-10#4)(2011-2#1)(2012-2#1)
milligrams##8##1##(1996-2#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-2#1)
millimeter##2##1##(2008-10#1)(2008-3#1)
millimeters##5##1##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
millimetres##2##1##(2008-5#1)(2013-1#1)
millimolar##3##1##(1994-12#1)(1994-5#1)(2008-10#1)
milling technique##3##2##(2009-7#1)(2012-3#2)
milling technology##2##2##(2008-11#1)(2008-3#1)
milling##8##1##(2008-11#1)(2008-3#3)(2009-7#1)(2010-4#1)(2012-3#2)
million SNPs##2##2##(2012-3#2)
million annually##4##2##(1991-12#1)(1996-3#1)(2007-12#1)(2013-1#1)
million cells##3##2##(2008-11#2)(2008-8#1)
million children##3##2##(1994-9#1)(1997-2#1)(2008-11#1)
million enrollees##2##2##(1991-3#1)(1997-3#1)
million for##3##2##(1992-8#1)(1995-12#2)
million in##14##2##(1991-12#1)(1992-6#5)(1993-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-3#1)
million people are##2##3##(2008-10#1)(2010-11#1)
million people in the UK##2##5##(2012-12#2)
million people in the##3##4##(2012-12#2)(2013-8#1)
million people in##5##3##(2008-10#2)(2012-12#2)(2013-8#1)
million people worldwide##3##3##(2008-10#2)(2009-5#1)
million people##16##2##(2008-10#7)(2008-11#1)(2009-5#1)(2010-11#2)(2010-5#1)(2012-12#3)(2013-8#1)
million per##2##2##(1997-5#1)(2008-11#1)
million to##3##2##(1993-5#1)(1995-12#2)
million years ago##4##3##(1991-5#1)(2009-10#2)(2009-8#1)
million years of##4##3##(1994-11#1)(1994-3#1)(2007-12#1)(2009-8#1)
million years##18##2##(1991-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#4)(1995-11#1)(2007-12#1)(2008-10#2)(2009-10#2)(2009-8#2)(2010-7#1)(2012-2#1)
million##144##1##(1990-11#1)(1990-3#1)(1991-1#3)(1991-12#4)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-6#11)(1992-8#1)(1993-1#1)(1993-12#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#4)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#7)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-5#2)(1997-6#2)(2007-12#2)(2008-10#20)(2008-11#10)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
million)##6##1##(1993-3#1)(1994-9#1)(1996-11#3)(2008-10#1)
millions of individuals##2##3##(1991-2#1)(2010-1#1)
millions of people##3##3##(2008-1#1)(2012-2#1)(2013-8#1)
millions of##13##2##(1991-2#1)(1993-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
millions##16##1##(1991-2#1)(1993-3#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)(2012-2#2)(2013-8#1)
millisecond time scale##2##3##(2008-11#1)(2008-4#1)
millisecond##5##1##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
milliseconds##3##1##(2008-11#1)(2009-7#1)(2010-8#1)
mills##3##1##(2008-10#2)(2008-12#1)
milnacipran##2##1##(2008-4#1)(2012-3#1)
miltiorrhiza Bunge##3##2##(2008-10#2)(2008-11#1)
miltiorrhiza##8##1##(2008-10#5)(2008-11#3)
mimetic peroxidase-catalyzed##2##2##(2008-10#2)
mimetic##14##1##(2008-10#6)(2008-7#2)(2008-8#1)(2009-8#1)(2010-5#2)(2012-3#1)(2013-1#1)
mimetics of##2##2##(2008-12#1)(2011-2#1)
mimetics##3##1##(2008-12#1)(2011-2#2)
mimic a##2##2##(1991-6#1)(2012-2#1)
mimic of##3##2##(1992-3#1)(2008-12#1)(2010-12#1)
mimic the action of##3##4##(1991-5#1)(1996-2#1)(2008-5#1)
mimic the effects of##2##4##(1992-4#1)(2008-8#1)
mimic the extracellular matrix##2##4##(2009-12#1)(2009-7#1)
mimic the##24##2##(1991-5#1)(1992-4#1)(1995-6#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-8#1)(2009-12#2)(2009-7#3)(2010-11#1)(2010-7#1)(2012-2#1)(2012-4#1)(2013-1#1)
mimic those##3##2##(1992-1#1)(2008-4#1)(2013-7#1)
mimic##71##1##(1991-5#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-4#1)(1994-12#1)(1994-5#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-8#1)(1997-6#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#2)(2009-7#3)(2009-9#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#5)(2013-7#1)(2013-8#1)
mimic-enzyme catalyst in##2##3##(2008-10#2)
mimicked by##4##2##(1994-11#1)(1995-12#1)(1997-1#1)(2012-2#1)
mimicked the##5##2##(1994-3#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#1)
mimicked##11##1##(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#2)(1997-1#1)(1997-4#1)(2008-10#3)(2012-2#1)
mimicking a##4##2##(2008-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
mimicking acute##2##2##(2008-11#1)(2008-12#1)
mimicking cloacal exstrophy##2##3##(2008-10#2)
mimicking pilocytic astrocytoma##3##3##(2013-1#3)
mimicking rectal cancer##2##3##(2013-8#2)
mimicking the##7##2##(1991-5#1)(1995-2#2)(2008-12#1)(2008-8#1)(2012-2#1)(2012-4#1)
mimicking##46##1##(1990-5#1)(1991-5#1)(1993-8#1)(1995-2#2)(1996-8#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#6)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#3)
mimicry evolution##3##2##(2012-3#3)
mimicry##16##1##(1995-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-3#10)(2013-1#2)
mimics of##3##2##(1997-1#1)(2009-8#1)(2012-2#1)
mimics the##3##2##(2008-4#1)(2008-8#1)(2012-2#1)
mimics##21##1##(1993-8#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2012-2#4)(2012-3#1)(2013-1#2)
mimosine##8##1##(1994-3#1)(2008-10#6)(2008-11#1)
min a day of##2##4##(2008-12#2)
min a##3##2##(2008-11#1)(2008-12#2)
min accumulation time##2##3##(2008-10#2)
min accumulation##6##2##(2008-10#6)
min after injection##2##3##(1993-1#1)(1997-2#1)
min after the##5##3##(1996-5#1)(2008-10#1)(2010-10#1)(2011-2#1)(2013-8#1)
min after##29##2##(1991-3#1)(1992-12#2)(1993-1#1)(1993-8#1)(1994-2#2)(1994-8#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#1)(2010-10#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
min and at##2##3##(2012-3#1)(2013-1#1)
min and the##5##3##(1990-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(2008-10#1)
min and then##3##3##(1994-8#1)(2008-10#2)
min and was##2##3##(1990-5#1)(2008-10#1)
min and##29##2##(1990-12#1)(1990-5#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(2008-10#11)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
min at 37##2##3##(2010-1#2)
min at##19##2##(1997-1#1)(2008-10#14)(2010-1#2)(2013-1#1)(2013-8#1)
min before the##4##3##(1994-2#1)(1995-12#1)(2006-6#1)(2011-2#1)
min before##12##2##(1994-2#2)(1994-5#4)(1995-12#1)(2006-6#1)(2008-11#1)(2011-2#2)(2012-3#1)
min by##4##2##(2008-10#4)
min dynamic##3##2##(2008-10#3)
min even##2##2##(2008-10#2)
min except for##2##3##(2008-10#2)
min extraction##2##2##(2008-10#2)
min followed by##2##3##(2010-1#1)(2013-8#1)
min for a##2##3##(2008-10#1)(2008-3#1)
min for females##2##3##(2008-10#2)
min for the##4##3##(1993-2#1)(2008-10#2)(2008-7#1)
min for##21##2##(1993-2#1)(1994-3#1)(1994-8#1)(1996-1#2)(2008-10#14)(2008-3#1)(2008-7#1)
min from##2##2##(2008-10#1)(2013-8#1)
min in a##7##3##(1990-12#1)(2008-10#6)
min in the##4##3##(1993-1#1)(2008-10#3)
min in##18##2##(1990-12#1)(1992-8#1)(1993-1#1)(1994-2#1)(1997-1#1)(2008-10#11)(2008-11#1)(2010-7#1)
min incubation at 37 degrees##2##5##(1992-3#1)(1994-8#1)
min incubation at##3##3##(1992-3#1)(1994-8#1)(1997-8#1)
min incubation##9##2##(1992-3#1)(1994-3#2)(1994-8#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
min is##2##2##(2008-10#2)
min observations##2##2##(2008-11#1)(2008-12#1)
min of KB##2##3##(1991-12#2)
min of accumulation##2##3##(2008-10#2)
min of incubation##2##3##(1990-12#1)(1997-2#1)
min of irradiation##2##3##(2008-10#2)
min of preconcentration time##3##4##(2008-10#3)
min of##46##2##(1990-12#1)(1990-5#1)(1991-12#2)(1993-1#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1996-12#3)(1997-2#1)(2008-10#18)(2008-7#1)(2009-1#1)(2009-12#1)(2010-3#2)(2011-2#2)(2012-3#1)(2013-8#6)
min on the tongue and##2##5##(1993-1#2)
min on the##3##3##(1993-1#3)
min on##5##2##(1993-1#3)(1995-11#1)(2008-10#1)
min or##3##2##(2008-10#2)(2011-2#1)
min per##3##2##(2008-10#3)
min preconcentration##3##2##(2008-10#3)
min prior to##4##3##(1994-8#1)(1997-4#1)(2011-2#2)
min recording##2##2##(1994-6#1)(2008-7#1)
min region on the genetic map of Escherichia coli K-12 (W3110) was determined##2##13##(1996-12#2)
min region on the linkage map (supplement)##3##7##(1996-12#2)(1996-6#1)
min region on the linkage map##6##6##(1996-12#4)(1996-6#2)
min region on the##8##4##(1996-12#6)(1996-6#2)
min region##9##2##(1996-12#7)(1996-6#2)
min static##3##2##(2008-10#3)
min the##2##2##(1993-1#1)(2008-10#1)
min there##2##2##(1997-1#1)(2010-8#1)
min to##10##2##(1990-12#1)(1992-3#1)(1994-8#2)(1997-2#1)(1997-7#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
min using a##3##3##(2008-10#3)
min using##4##2##(2008-10#4)
min was##7##2##(1994-3#3)(2008-10#2)(2008-7#1)(2013-8#1)
min were used##2##3##(2008-10#1)(2008-9#1)
min were##4##2##(2008-10#3)(2008-9#1)
min with a relative standard deviation of less than##2##9##(2008-10#2)
min with a relative standard deviation of##3##7##(2008-10#3)
min with only##2##3##(2008-10#2)
min with##14##2##(1991-5#1)(1994-3#1)(1994-6#1)(2008-10#11)
min x##2##2##(1992-2#1)(2011-3#1)
min##599##1##(1990-11#3)(1990-12#4)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-6#1)(1992-8#1)(1993-1#14)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#7)(1994-3#13)(1994-5#6)(1994-6#2)(1994-8#13)(1995-11#4)(1995-12#4)(1995-2#6)(1995-3#2)(1995-8#1)(1996-1#7)(1996-12#14)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#2)(1997-1#9)(1997-2#8)(1997-4#1)(1997-7#1)(1997-8#4)(2006-6#3)(2008-1#1)(2008-10#297)(2008-11#21)(2008-12#10)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#9)(2009-1#1)(2009-12#1)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-2#13)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#14)(2013-8#17)
min(-1) and UV detection##2##4##(2008-10#1)(2008-5#1)
min(-1) and##7##2##(2008-10#6)(2008-5#1)
min(-1) for##8##2##(2008-10#8)
min(-1) was##5##2##(2008-10#3)(2008-5#1)(2011-3#1)
min(-1)##107##1##(2008-10#95)(2008-5#4)(2008-8#1)(2010-4#1)(2011-3#6)
min(-1))##12##1##(2008-10#11)(2010-4#1)
min) and##9##2##(1993-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2012-2#1)
min) ischaemia##3##2##(2008-7#3)
min) of##2##2##(1995-5#1)(2008-5#1)
min) resulted in##2##3##(1996-12#1)(2008-6#1)
min) were##2##2##(1997-2#1)(2008-10#1)
min)##69##1##(1990-12#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-1#3)(1993-3#1)(1993-8#2)(1994-3#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-9#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)
min-1 for##4##2##(1993-1#2)(1997-2#2)
min-1##15##1##(1990-11#2)(1991-3#2)(1993-1#6)(1995-6#1)(1997-2#4)
min/cycle)##2##1##(2009-7#1)(2011-2#1)
min2 and##2##2##(2012-3#2)
min2##3##1##(2012-3#3)
minced fish products##2##3##(2011-2#2)
minced##4##1##(2008-10#1)(2008-4#1)(2011-2#2)
mind and brain##2##3##(2008-11#2)
mind and##4##2##(2008-11#3)(2008-12#1)
mind for##2##2##(2013-1#1)(2013-8#1)
mind in##4##2##(2010-6#1)(2011-1#1)(2013-8#2)
mind wandering##3##2##(2013-8#3)
mind##63##1##(1990-11#1)(1990-12#1)(1990-6#1)(1992-3#1)(1994-6#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#8)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#3)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#8)
mindful awareness##2##2##(2012-2#2)
mindful of##4##2##(1991-2#2)(2008-11#1)(2011-2#1)
mindful##7##1##(1991-2#2)(2008-11#1)(2011-2#1)(2012-2#3)
mindfulness practice and##2##3##(2013-1#2)
mindfulness##9##1##(2012-2#2)(2013-1#7)
mindfulness-based teachers##2##2##(2013-1#2)
mindfulness-based training##2##2##(2013-1#2)
mindfulness-based##8##1##(2013-1#8)
minds##6##1##(1991-3#1)(1995-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
mindset##4##1##(1994-12#1)(1997-3#1)(2008-1#1)(2008-10#1)
mine##17##1##(2008-10#16)(2011-2#1)
mineral acid##2##2##(2008-10#2)
mineral acids##5##2##(2008-10#5)
mineral and##5##2##(2008-10#4)(2008-7#1)
mineral aragonite##2##2##(2008-7#2)
mineral bioavailability##2##2##(2008-10#1)(2013-8#1)
mineral composition##2##2##(2008-10#2)
mineral content##8##2##(1991-11#2)(2008-10#5)(2013-8#1)
mineral density##24##2##(1991-11#2)(1996-8#2)(2007-8#1)(2008-11#1)(2008-7#2)(2008-8#3)(2010-1#2)(2010-10#1)(2010-3#3)(2011-2#6)(2012-3#1)
mineral feed additives##4##3##(2008-10#4)
mineral for##2##2##(2008-10#1)(2013-8#1)
mineral oil##4##2##(2008-10#4)
mineral ore##3##2##(2008-10#3)
mineral phases##4##2##(2008-10#4)
mineral salts##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
mineral sample##3##2##(2008-10#3)
mineral samples##2##2##(2008-10#2)
mineral water samples##4##3##(2008-10#4)
mineral water##11##2##(2008-10#9)(2008-11#2)
mineral waters using##2##3##(2008-10#2)
mineral waters with##2##3##(2008-10#2)
mineral waters##11##2##(2008-10#11)
mineral##151##1##(1990-11#1)(1991-11#4)(1991-12#2)(1994-9#1)(1995-8#1)(1996-8#2)(1997-2#1)(2007-8#1)(2008-10#85)(2008-11#5)(2008-5#1)(2008-7#9)(2008-8#4)(2008-9#3)(2009-1#4)(2009-7#3)(2009-8#2)(2010-1#2)(2010-10#1)(2010-3#3)(2011-2#8)(2012-3#1)(2013-1#1)(2013-8#6)
mineralisation and##2##2##(2007-8#2)
mineralisation##8##1##(2007-8#5)(2008-10#3)
mineralised##5##1##(2008-10#5)
mineralization in##3##2##(1995-3#1)(2008-11#1)(2009-7#1)
mineralization of the##3##3##(2008-10#2)(2008-11#1)
mineralization of##6##2##(2008-10#2)(2008-11#2)(2008-12#2)
mineralization process##2##2##(2009-7#1)(2013-8#1)
mineralization was##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-4#1)
mineralization##37##1##(1995-11#1)(1995-3#1)(2008-10#12)(2008-11#7)(2008-12#2)(2008-7#1)(2009-7#8)(2011-1#1)(2012-4#2)(2013-8#2)
mineralize##2##1##(2008-11#2)
mineralized by##2##2##(2008-10#1)(2008-11#1)
mineralized rock##6##2##(2013-8#6)
mineralized##19##1##(2008-10#5)(2008-11#3)(2008-7#2)(2012-4#1)(2013-1#1)(2013-8#7)
mineralocorticoid##6##1##(1990-11#1)(1994-2#1)(1997-1#2)(2008-4#1)(2011-1#1)
mineralogical and morphological##2##3##(2008-10#2)
mineralogical and##3##2##(2008-10#3)
mineralogical composition##2##2##(2008-10#2)
mineralogical##10##1##(2008-10#10)
minerals and##2##2##(2008-10#1)(2008-3#1)
minerals by##3##2##(2008-10#3)
minerals containing##2##2##(2008-10#2)
minerals to##2##2##(2008-10#1)(2013-8#1)
minerals##22##1##(2008-10#14)(2008-11#1)(2008-3#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-8#3)
minerals)##2##1##(2008-10#1)(2013-8#1)
mines in##2##2##(2008-10#2)
mines##13##1##(2008-10#13)
mingling##2##1##(1991-5#1)(2008-8#1)
mini dental implants##3##3##(2013-1#3)
mini##8##1##(2008-10#2)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#3)
mini-Tn5-phoA##2##1##(2008-10#2)
mini-column filled with##2##3##(2008-10#2)
mini-column in the flow##2##4##(2008-10#2)
mini-column to be##2##3##(2008-10#2)
mini-column##23##1##(2008-10#23)
mini-columns##2##1##(2008-10#2)
mini-gene##3##1##(1993-8#3)
mini-orchards of##3##2##(2008-10#3)
mini-orchards##5##1##(2008-10#5)
mini-review##4##1##(2008-10#1)(2008-11#1)(2009-7#1)(2012-3#1)
mini-white repression##2##2##(2012-3#2)
mini-white##4##1##(2012-3#4)
miniature mass##3##2##(2010-7#3)
miniature roses##2##2##(2008-10#2)
miniature##21##1##(1996-2#1)(2008-10#14)(2008-3#2)(2010-7#3)(2011-2#1)
miniaturisation##4##1##(2008-10#2)(2008-12#2)
miniaturised##2##1##(2008-10#1)(2008-11#1)
miniaturization and##5##2##(2008-10#5)
miniaturization of##3##2##(2008-10#2)(2010-11#1)
miniaturization##13##1##(2008-10#10)(2010-11#1)(2010-7#2)
miniaturized analytical##2##2##(2008-10#2)
miniaturized##19##1##(1992-3#1)(2008-10#16)(2009-12#1)(2013-1#1)
minibioreactor for the culture of human hematopoietic cells##2##8##(2008-11#2)
minibioreactor##3##1##(2008-11#3)
minicolumn is proposed##3##3##(2008-10#3)
minicolumn packed with##9##3##(2008-10#9)
minicolumn with##4##2##(2008-10#4)
minicolumn##39##1##(2008-10#39)
minicolumns##2##1##(1990-2#1)(2008-10#1)
minicontainers##2##1##(2008-11#2)
minicraniotomy##2##1##(2011-2#2)
minigene##6##1##(2008-11#2)(2008-8#4)
minigenes##4##1##(2008-8#4)
miniinvasive##3##1##(2012-12#3)
minilaparotomy##2##1##(1993-3#1)(1995-1#1)
minima of##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
minima##7##1##(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
minimal amount of##7##3##(2008-10#7)
minimal and##3##2##(1990-12#1)(2008-3#1)(2008-7#1)
minimal bias##2##2##(2008-12#1)(2010-8#1)
minimal change##2##2##(2011-2#1)(2013-8#1)
minimal changes in##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
minimal complications##2##2##(1993-3#1)(2011-2#1)
minimal decrease in##2##3##(2008-9#2)
minimal effect on##4##3##(2008-10#1)(2008-4#1)(2013-1#2)
minimal effects on the##2##4##(1995-6#1)(1996-2#1)
minimal effects on##3##3##(1995-6#1)(1996-2#1)(2013-8#1)
minimal inhibitory concentration (MIC)##4##4##(2008-5#2)(2009-6#1)(2013-8#1)
minimal inhibitory concentration##5##3##(2008-5#2)(2009-6#1)(2011-2#1)(2013-8#1)
minimal inhibitory concentrations##2##3##(2008-10#1)(2008-5#1)
minimal inhibitory##7##2##(2008-10#1)(2008-5#3)(2009-6#1)(2011-2#1)(2013-8#1)
minimal instrumentation##2##2##(2008-11#1)(2013-1#1)
minimal invasive##2##2##(2008-10#1)(2011-2#1)
minimal manipulation##2##2##(2008-11#1)(2008-9#1)
minimal media##2##2##(2008-10#1)(2008-11#1)
minimal medium containing##3##3##(2008-10#2)(2012-2#1)
minimal medium##8##2##(2008-10#6)(2012-2#2)
minimal number of##2##3##(2008-10#1)(2011-2#1)
minimal or no##2##3##(2008-12#1)(2009-12#1)
minimal or##3##2##(1992-3#1)(2008-12#1)(2009-12#1)
minimal promoter##2##2##(1994-2#2)
minimal residual disease monitoring and##2##5##(2010-11#1)(2011-3#1)
minimal residual disease##6##3##(1995-12#1)(2008-10#1)(2009-12#1)(2010-11#1)(2011-2#1)(2011-3#1)
minimal residual##7##2##(1995-12#1)(2008-10#1)(2009-12#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#1)
minimal risk##2##2##(1995-2#1)(2010-6#1)
minimal sample preparation##2##3##(2008-10#2)
minimal sample pretreatment##2##3##(2008-10#2)
minimal sample##5##2##(2008-10#5)
minimal thermal##2##2##(1992-12#1)(2008-3#1)
minimal volume of##2##3##(2008-10#1)(2008-8#1)
minimal##212##1##(1990-11#1)(1990-12#2)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#7)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#52)(2008-11#15)(2008-12#4)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#16)(2011-3#2)(2012-2#6)(2012-3#9)(2013-1#14)(2013-8#4)
minimal-scan reconstruction algorithms##2##3##(2008-3#2)
minimal-scan##4##1##(2008-3#4)
minimalism##4##1##(2008-10#4)
minimally invasive approach to##3##4##(2008-12#1)(2011-2#2)
minimally invasive approach##6##3##(2008-12#1)(2011-2#4)(2013-1#1)
minimally invasive approaches to##2##4##(2013-1#2)
minimally invasive approaches##5##3##(2008-10#1)(2013-1#4)
minimally invasive lateral##2##3##(2012-3#1)(2013-1#1)
minimally invasive procedures in##2##4##(2009-12#1)(2011-2#1)
minimally invasive procedures##3##3##(2008-9#1)(2009-12#1)(2011-2#1)
minimally invasive surgical##2##3##(2011-2#1)(2013-1#1)
minimally invasive techniques##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
minimally invasive##36##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#2)(2010-8#1)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#11)
minimally##54##1##(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-12#2)(2010-8#1)(2010-9#1)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#12)(2013-8#1)
minimisation##2##1##(1992-5#1)(2008-10#1)
minimise the##5##2##(2008-10#2)(2010-12#1)(2011-2#1)(2012-2#1)
minimise##8##1##(2008-1#1)(2008-10#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
minimised##2##1##(1996-1#1)(2008-10#1)
minimises the##2##2##(2008-10#2)
minimises##3##1##(2008-10#3)
minimising##6##1##(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)
minimization and##2##2##(1992-4#1)(2008-8#1)
minimization of##8##2##(2006-6#1)(2008-10#5)(2008-11#1)(2008-3#1)
minimization##15##1##(1991-5#1)(1992-4#2)(2006-6#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-8#1)
minimize complications##2##2##(2008-7#1)(2012-3#1)
minimize non-specific adsorption##2##3##(2008-10#2)
minimize the effect of##3##4##(1995-3#1)(2008-10#2)
minimize the overall##2##3##(2008-3#1)(2008-8#1)
minimize the risk of##3##4##(1992-9#1)(2010-7#1)(2013-1#1)
minimize the##43##2##(1992-12#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-10#15)(2008-11#3)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#2)(2010-7#1)(2011-2#4)(2012-12#1)(2013-1#3)
minimize##92##1##(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#26)(2008-11#8)(2008-12#1)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)
minimized by the use of##2##5##(2008-10#1)(2008-5#1)
minimized by the##4##3##(2008-10#3)(2008-5#1)
minimized by##15##2##(1997-2#1)(2008-10#9)(2008-3#2)(2008-5#1)(2011-2#2)
minimized##40##1##(1993-12#1)(1995-5#2)(1995-9#1)(1997-2#1)(2008-10#22)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2011-2#4)(2012-2#3)
minimizes potential##2##2##(2008-10#2)
minimizes the##7##2##(1990-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)
minimizes##17##1##(1990-8#1)(1996-12#1)(2008-10#9)(2008-3#2)(2008-7#1)(2008-8#2)(2012-12#1)
minimizing risks##2##2##(1993-2#1)(1995-12#1)
minimizing the##11##2##(1993-1#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-6#1)(2013-1#1)
minimizing##31##1##(1992-12#1)(1993-1#1)(1993-2#1)(1995-12#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#2)(2010-11#1)(2011-2#2)(2011-9#2)(2013-1#3)(2013-8#1)
minimum amount##3##2##(1997-8#1)(2008-10#2)
minimum and maximum##4##3##(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
minimum are##2##2##(2008-10#1)(2008-3#1)
minimum concentration##4##2##(1993-1#1)(2008-10#3)
minimum detectability##3##2##(2008-10#3)
minimum detectable absorption##2##3##(2008-3#2)
minimum detectable##3##2##(2008-10#1)(2008-3#2)
minimum infection times##2##3##(2008-10#2)
minimum infective dose##4##3##(2009-6#4)
minimum inhibitory concentration##2##3##(2008-12#1)(2012-3#1)
minimum inhibitory concentrations (MICs)##3##4##(2008-5#1)(2011-2#1)(2012-3#1)
minimum inhibitory##6##2##(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
minimum number of##6##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-6#1)
minimum number##7##2##(1992-9#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-6#1)
minimum of##20##2##(1990-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-8#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
minimum sample size##3##3##(1992-9#2)(2013-1#1)
minimum sample##4##2##(1992-9#2)(2008-10#1)(2013-1#1)
minimum sampling##3##2##(2012-2#3)
minimum temperature##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
minimum tillage##4##2##(2008-10#4)
minimum values##2##2##(2008-10#1)(2008-5#1)
minimum waste generation##2##3##(2008-10#2)
minimum waste##3##2##(2008-10#3)
minimum##179##1##(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#5)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-12#2)(1996-3#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#69)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#11)(2008-5#5)(2008-7#3)(2008-8#7)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#1)
mining and##2##2##(2008-4#1)(2011-2#1)
mining area in the province of##2##6##(1997-5#1)(2008-10#1)
mining area##3##2##(1997-5#1)(2008-10#1)(2013-8#1)
mining is##2##2##(2008-9#1)(2011-1#1)
mining to##2##2##(2008-9#1)(2012-2#1)
mining##25##1##(1991-12#1)(1997-5#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-10#2)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
miniorbitofrontal craniotomy##2##2##(2011-2#2)
miniprep procedure##2##2##(2008-10#2)
minisatellite##4##1##(2008-10#1)(2008-7#3)
minister##3##1##(1992-2#1)(1993-12#1)(1995-12#1)
ministry of care##2##3##(1993-12#2)
ministry of##3##2##(1992-2#1)(1993-12#2)
ministry##9##1##(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#4)(1996-8#1)(1997-6#1)
minitans and##4##2##(2008-10#4)
minitans applied as a##2##4##(2008-10#2)
minitans##22##1##(2008-10#22)
mink M##2##2##(2008-6#2)
minnows##2##1##(2008-8#2)
minocycline##9##1##(1997-8#1)(2008-7#7)(2012-3#1)
minor NORs##3##2##(1993-12#3)
minor QTL##2##2##(2009-10#2)
minor and S##5##3##(2008-10#5)
minor and major##2##3##(2008-12#1)(2009-3#1)
minor and trace elements##2##4##(2008-10#2)
minor and trace##4##3##(2008-10#4)
minor and##13##2##(2008-10#10)(2008-12#2)(2009-3#1)
minor band##2##2##(1992-3#1)(1997-7#1)
minor bleeding##2##2##(2008-10#1)(2009-8#1)
minor categories##2##2##(2008-11#2)
minor change##2##2##(1995-2#1)(2008-10#1)
minor changes in the##2##4##(2008-10#2)
minor changes in##3##3##(1994-5#1)(2008-10#2)
minor changes##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
minor complications##6##2##(1990-9#2)(1995-3#1)(2009-3#2)(2013-1#1)
minor components##5##2##(1994-5#1)(2008-10#4)
minor criteria##2##2##(1997-8#2)
minor differences in##3##3##(2008-10#3)
minor differences##5##2##(1995-6#1)(2008-10#4)
minor effect on##3##3##(2008-10#2)(2008-3#1)
minor effect##6##2##(1993-8#1)(2008-10#4)(2008-3#1)
minor effects on the##2##4##(2008-10#1)(2013-1#1)
minor effects on##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
minor effects##5##2##(2008-10#3)(2008-11#1)(2013-1#1)
minor elements##3##2##(2008-10#3)
minor genes##5##2##(2008-10#5)
minor groove of##4##3##(1993-1#1)(1994-5#1)(1995-8#1)(1996-3#1)
minor groove##12##2##(1993-1#2)(1993-8#1)(1994-5#2)(1995-8#2)(1996-3#2)(2008-10#1)(2008-4#2)
minor groups of##2##3##(2008-10#2)
minor groups##3##2##(2008-10#3)
minor head injury##3##3##(1992-6#3)
minor head##5##2##(1992-6#3)(2008-11#2)
minor heavy##2##2##(2009-12#2)
minor in##3##2##(1991-8#1)(1993-11#1)(2008-10#1)
minor injuries##2##2##(1990-2#1)(1992-6#1)
minor intron-containing##2##2##(2013-8#2)
minor introns##2##2##(2013-8#2)
minor loci##4##2##(2008-10#3)(2010-5#1)
minor metabolite##2##2##(2008-10#1)(2011-1#1)
minor new##2##2##(2011-2#2)
minor nucleoli##2##2##(1993-12#2)
minor or##3##2##(2008-1#1)(2008-10#2)
minor pathogens##3##2##(1990-6#1)(2008-10#1)(2010-3#1)
minor process##2##2##(1997-3#1)(2008-11#1)
minor salivary gland##3##3##(2007-11#1)(2013-1#2)
minor salivary glands##3##3##(1990-6#2)(1991-11#1)
minor salivary##6##2##(1990-6#2)(1991-11#1)(2007-11#1)(2013-1#2)
minor sclerotia##4##2##(2008-10#4)
minor sequence##2##2##(1997-3#1)(2008-10#1)
minor species##2##2##(2008-10#2)
minor spliceosome's##2##2##(2013-8#2)
minor surgery##2##2##(2008-11#2)
minor to##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
minor trauma##3##2##(1991-11#2)(1991-8#1)
minor was##3##2##(2008-10#2)(2013-1#1)
minor##289##1##(1990-12#1)(1990-2#2)(1990-6#3)(1990-9#2)(1991-11#3)(1991-3#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#7)(1993-1#2)(1993-11#1)(1993-12#7)(1993-3#1)(1993-8#3)(1994-2#2)(1994-3#1)(1994-5#5)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#5)(1997-6#3)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#107)(2008-11#19)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#2)(2009-3#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-9#5)(2011-1#2)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#13)(2013-8#9)
minorities##11##1##(1990-6#1)(1991-8#1)(1994-12#3)(1996-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
minority adolescents##3##2##(2010-1#2)(2011-1#1)
minority composition##2##2##(2011-2#2)
minority of patients##6##3##(2006-6#1)(2008-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
minority of##12##2##(1997-4#1)(2006-6#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#2)
minority smokers##4##2##(2010-11#4)
minority students##2##2##(1997-2#2)
minority women##2##2##(1995-9#1)(2008-12#1)
minority##48##1##(1991-9#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(2006-6#1)(2008-10#2)(2008-12#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-2#2)(2013-1#3)(2013-8#2)
minors##6##1##(1996-1#2)(1996-5#2)(2008-10#1)(2008-11#1)
minoxidil##6##1##(2008-10#3)(2008-5#1)(2008-8#1)(2012-3#1)
mins##3##1##(1996-2#1)(2008-8#1)(2013-1#1)
mint##5##1##(2008-10#5)
minus the##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
minus##11##1##(1991-8#1)(1992-3#1)(1995-3#1)(2008-10#3)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
minus-strand##3##1##(2008-9#3)
minute after##2##2##(1990-5#1)(2011-2#1)
minute amount of##2##3##(2008-10#2)
minute patch test##2##3##(2008-5#2)
minute pattern of changes occurring##2##5##(2008-11#2)
minute quantities of##2##3##(1992-9#1)(2008-10#1)
minute ventilation##2##2##(2012-2#1)(2012-3#1)
minute##40##1##(1990-5#1)(1990-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#5)(2008-5#2)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)
minute)##2##1##(2008-10#2)
minutes after lactulose##2##3##(1996-6#2)
minutes after the initiation of##2##5##(1992-1#1)(2010-5#1)
minutes after the##4##3##(1990-5#1)(1992-1#1)(2008-7#1)(2010-5#1)
minutes after##11##2##(1990-5#1)(1992-1#1)(1996-1#1)(1996-6#2)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
minutes and the##2##3##(1991-2#1)(2008-4#1)
minutes and##7##2##(1991-11#1)(1991-2#1)(1994-11#1)(2008-11#2)(2008-3#1)(2008-4#1)
minutes at##3##2##(1992-6#1)(2008-11#1)(2012-2#1)
minutes for##3##2##(2011-2#2)(2013-8#1)
minutes in##2##2##(1991-1#1)(2012-3#1)
minutes later##3##2##(1993-1#1)(2009-6#1)(2013-8#1)
minutes of MPA/VPA##2##3##(2013-1#2)
minutes of##15##2##(1991-12#2)(2008-1#1)(2008-10#2)(2010-1#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#6)
minutes on average##2##3##(2008-7#1)(2010-6#1)
minutes on##3##2##(1996-6#1)(2008-7#1)(2010-6#1)
minutes with a##2##3##(1997-3#1)(2008-10#1)
minutes##91##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#2)(1994-11#3)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-3#1)(1996-6#3)(1997-2#1)(1997-3#1)(1997-6#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#4)(2008-8#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-5#1)(2010-6#1)(2010-7#4)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
minutes' of##2##2##(2012-2#2)
minutes'##4##1##(2012-2#4)
minutes)##7##1##(1990-8#1)(1993-6#1)(2008-10#2)(2008-3#1)(2010-5#1)(2012-2#1)
mirabilis##4##1##(2008-10#1)(2009-6#2)(2010-6#1)
mirror and##3##2##(2008-10#1)(2008-3#2)
mirror as##2##2##(2008-2#1)(2008-3#1)
mirror effect##2##2##(2008-6#2)
mirror effects##3##2##(2008-6#3)
mirror for##2##2##(2008-10#1)(2008-3#1)
mirror images##4##2##(1996-2#2)(2008-6#1)(2009-10#1)
mirror in the##2##3##(2008-3#2)
mirror is##2##2##(2007-11#1)(2008-3#1)
mirror neuron system (MNS)##2##4##(2008-11#2)
mirror neuron system##5##3##(2008-11#5)
mirror neurons##2##2##(2008-11#2)
mirror of##3##2##(2008-3#1)(2013-8#2)
mirror pyramid cameras##2##3##(2008-6#2)
mirror pyramid##5##2##(2008-6#5)
mirror reflectivity##2##2##(2008-2#1)(2008-3#1)
mirror that##2##2##(2008-3#1)(2008-5#1)
mirror with##3##2##(2008-2#1)(2008-3#2)
mirror##78##1##(1990-12#1)(1993-6#1)(1995-1#1)(1996-2#2)(2007-11#1)(2008-10#5)(2008-11#7)(2008-2#10)(2008-3#31)(2008-5#1)(2008-6#14)(2009-10#1)(2013-8#3)
mirror-image##2##1##(1993-12#1)(1994-11#1)
mirrored##5##1##(1996-5#1)(2008-12#1)(2008-8#1)(2009-8#1)(2012-5#1)
mirroring##2##1##(1992-10#1)(2008-11#1)
mirrors in##3##2##(2008-2#1)(2008-3#2)
mirrors the##2##2##(2008-11#1)(2008-4#1)
mirrors##19##1##(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#1)(2012-3#1)
mirtazapine##3##1##(2008-6#3)
mis-match ODN##2##2##(2011-2#2)
misaligned##2##1##(2008-10#1)(2013-1#1)
misalignment and##2##2##(2008-3#2)
misalignment of##2##2##(1992-12#1)(2008-3#1)
misalignment##10##1##(1992-12#1)(2008-3#9)
misbehaviors##2##1##(2010-11#2)
miscarriage##6##1##(2007-7#1)(2008-12#1)(2010-11#2)(2012-3#2)
miscellaneous disorders##2##2##(2011-2#1)(2012-2#1)
miscellaneous##11##1##(1991-3#1)(1995-2#1)(2008-10#3)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#2)
miscibility##3##1##(2008-10#3)
miscible with##3##2##(1993-8#1)(2008-10#2)
miscible##8##1##(1993-8#1)(2008-10#4)(2008-2#2)(2011-2#1)
misclassification of##2##2##(2008-10#1)(2012-2#1)
misclassification##8##1##(1991-6#1)(1996-3#1)(2008-10#3)(2011-2#2)(2012-2#1)
misclassified as##2##2##(1996-3#1)(2008-10#1)
misclassified##4##1##(1991-6#1)(1996-3#1)(2008-10#2)
misconceptions about##4##2##(2010-11#1)(2010-3#2)(2011-2#1)
misconceptions##12##1##(1997-1#1)(2008-10#2)(2010-11#1)(2010-3#6)(2010-7#1)(2011-2#1)
misconduct##6##1##(1992-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-12#2)
misdiagnosed as a##2##3##(2008-10#1)(2011-2#1)
misdiagnosed as##4##2##(2008-10#2)(2010-10#1)(2011-2#1)
misdiagnosed##9##1##(2008-10#2)(2008-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-12#1)
misdiagnosis of##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
misdiagnosis##4##1##(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
misfit##2##1##(2008-3#1)(2013-1#1)
misfolding##2##1##(2008-11#1)(2013-1#1)
misidentification and##2##2##(2008-11#2)
misidentification of##2##2##(2008-10#1)(2011-2#1)
misidentification##6##1##(2008-10#2)(2008-11#2)(2011-2#2)
misidentified##2##1##(2008-11#1)(2010-1#1)
misinformation##2##1##(1992-2#1)(1992-5#1)
misinterpretations##3##1##(1991-12#1)(2008-10#2)
misinterpreted##2##1##(2008-10#1)(2009-3#1)
misleading if##2##2##(1994-12#1)(2008-11#1)
misleading##23##1##(1990-6#1)(1994-12#2)(1997-2#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-5#1)(2012-2#4)(2013-1#1)
mislocalized##2##1##(2009-10#1)(2012-3#1)
mismanagement##2##1##(1992-3#1)(2008-12#1)
mismatch are discussed##2##3##(2007-11#1)(2008-12#1)
mismatch between the##2##3##(2008-2#1)(2008-3#1)
mismatch between##4##2##(1996-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
mismatch in the##2##3##(2008-10#1)(2008-3#1)
mismatch in##3##2##(2008-10#2)(2008-3#1)
mismatch negativity (MMN)##3##3##(1995-12#1)(2008-9#1)(2013-8#1)
mismatch negativity in##2##3##(2008-9#1)(2013-8#1)
mismatch negativity##7##2##(1995-12#1)(2008-9#2)(2013-8#4)
mismatch##26##1##(1995-12#2)(1996-1#2)(1997-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#5)
mismatched and random targets##2##4##(2008-10#2)
mismatched cords##2##2##(2010-11#2)
mismatched##13##1##(1995-12#1)(2008-10#4)(2008-2#2)(2008-9#1)(2010-11#5)
mismatches##10##1##(1990-11#1)(1993-12#1)(1995-12#3)(2008-10#2)(2008-4#2)(2008-9#1)
misogynist theme##2##2##(2009-10#2)
misogynist##3##1##(2009-10#3)
misogyny##2##1##(2009-10#2)
misoprostol##9##1##(1995-8#7)(2008-11#2)
misperceptions##2##1##(2009-7#1)(2010-4#1)
misplaced##2##1##(2010-2#1)(2011-2#1)
misplacement##2##1##(2008-9#1)(2012-12#1)
miss##3##1##(1990-12#1)(1991-1#1)(2007-12#1)
missed a##2##2##(1997-2#1)(2008-10#1)
missed an opportunity##2##3##(1997-5#1)(2013-1#1)
missed by##3##2##(1996-2#1)(2008-11#1)(2011-2#1)
missed opportunities##8##2##(1996-12#8)
missed or significantly delayed##2##4##(2012-12#2)
missed or##3##2##(2010-1#1)(2012-12#2)
missed##34##1##(1991-1#1)(1994-12#1)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
missense mutation in##3##3##(1994-12#1)(1996-2#1)(2008-8#1)
missense mutation of the##2##4##(1993-3#1)(1994-12#1)
missense mutation##9##2##(1993-3#1)(1994-12#2)(1996-2#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-1#1)
missense mutations in##2##3##(1995-8#2)
missense mutations##6##2##(1993-3#1)(1995-8#2)(1997-8#1)(2008-9#1)(2011-2#1)
missense##16##1##(1993-3#2)(1994-12#2)(1995-8#3)(1996-2#1)(1997-8#1)(2008-8#1)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#1)
missile##2##1##(1996-5#1)(2008-9#1)
missing data mechanisms##2##3##(1995-12#2)
missing data patterns##3##3##(1994-9#1)(2012-2#2)
missing data##14##2##(1994-9#2)(1995-12#7)(2008-10#1)(2012-2#4)
missing from the##2##3##(1996-2#2)
missing from##4##2##(1996-2#2)(2008-8#1)(2009-10#1)
missing in##3##2##(1990-5#1)(2007-12#1)(2008-11#1)
missing link between##2##3##(1997-4#1)(2009-8#1)
missing link##4##2##(1997-4#1)(2009-6#1)(2009-8#2)
missing of##2##2##(2008-9#1)(2009-8#1)
missing teeth##3##2##(2008-1#1)(2008-7#1)(2013-1#1)
missing values##2##2##(2008-7#1)(2013-1#1)
missing##64##1##(1990-3#1)(1990-5#1)(1991-2#1)(1992-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#2)(1995-11#1)(1995-12#9)(1995-8#1)(1996-2#2)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-5#2)(2011-2#2)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#1)
missingness##3##1##(1994-9#3)
mission and##2##2##(2008-11#1)(2009-8#1)
mission education##2##2##(1992-2#2)
mission of the##3##3##(2008-11#1)(2009-10#1)(2013-1#1)
mission of##4##2##(2008-11#1)(2008-6#1)(2009-10#1)(2013-1#1)
mission statement##2##2##(1995-12#1)(2010-6#1)
mission to##2##2##(1997-3#1)(2012-3#1)
mission##39##1##(1991-2#1)(1991-3#1)(1992-2#4)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-3#2)(2008-11#7)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#2)(2010-6#1)(2012-3#3)(2013-1#1)
missions##6##1##(1996-1#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-3#1)(2012-3#1)
mist and##2##2##(2008-10#1)(2011-2#1)
mist##13##1##(1990-3#1)(1991-2#3)(2008-10#6)(2010-12#1)(2011-2#2)
mistaken for##3##2##(2009-9#1)(2011-2#2)
mistaken##5##1##(1996-9#1)(2008-10#1)(2009-9#1)(2011-2#2)
mistakenly##4##1##(1995-11#1)(2008-8#1)(2009-8#1)(2012-3#1)
mistakes of##2##2##(2011-2#1)(2012-3#1)
mistakes##10##1##(1992-1#1)(1993-12#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
mistletoe incidence on white fir##2##5##(2008-10#2)
mistletoe incidence##3##2##(2008-10#3)
mistletoe##8##1##(2008-10#8)
misty mesentery##2##2##(2011-2#2)
misty##3##1##(2011-2#3)
misunderstanding of the crystal-meth##2##4##(2012-12#2)
misunderstanding of the##3##3##(1995-1#1)(2012-12#2)
misunderstanding of##4##2##(1995-1#1)(1996-3#1)(2012-12#2)
misunderstanding##6##1##(1995-1#1)(1996-3#1)(2008-10#1)(2009-10#1)(2012-12#2)
misunderstood##3##1##(1993-1#1)(2009-7#1)(2013-8#1)
misuse and##2##2##(2008-11#1)(2013-8#1)
misuse of##7##2##(1991-12#1)(1993-3#1)(1994-2#1)(1996-2#1)(2008-9#1)(2013-1#1)(2013-8#1)
misuse##18##1##(1991-12#2)(1992-5#1)(1993-3#1)(1994-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#4)(2013-8#4)
misused in##3##2##(2013-1#1)(2013-8#2)
misused##5##1##(1996-2#1)(2013-1#2)(2013-8#2)
mite allergen##2##2##(2008-10#1)(2008-11#1)
mite##16##1##(1997-5#3)(2008-10#3)(2008-11#1)(2008-8#3)(2011-2#2)(2013-1#4)
mite-transmitted##4##1##(2008-10#4)
mites and##2##2##(1994-9#1)(2008-8#1)
mites but##2##2##(2008-10#2)
mites that were##2##3##(2008-8#2)
mites##23##1##(1991-11#1)(1994-9#2)(1996-12#1)(1997-5#1)(2007-12#6)(2008-10#5)(2008-8#6)(2013-1#1)
mitigate the##5##2##(2008-11#2)(2008-3#2)(2011-2#1)
mitigate these##3##2##(1994-2#1)(2008-11#1)(2009-5#1)
mitigate this##2##2##(2010-5#1)(2012-3#1)
mitigate##18##1##(1991-2#1)(1992-1#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#3)(2008-3#3)(2009-5#1)(2010-5#1)(2011-2#2)(2012-3#3)
mitigated by##2##2##(2008-10#1)(2011-2#1)
mitigated##7##1##(1992-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#2)(2012-7#1)
mitigating##3##1##(1996-3#1)(2008-11#1)(2008-3#1)
mitigation##4##1##(2009-10#2)(2012-3#2)
mitochondria and ATPases##6##3##(2008-7#6)
mitochondria and##22##2##(1990-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#6)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2011-2#4)(2012-2#1)(2013-1#1)
mitochondria from different##2##3##(1995-11#1)(2008-9#1)
mitochondria from normoxic hearts##2##4##(1994-5#2)
mitochondria from rats fed vitamin E sufficient##2##7##(1994-5#2)
mitochondria from rats##3##3##(1994-5#3)
mitochondria from vitamin E sufficient##2##5##(1994-5#2)
mitochondria from vitamin E##3##4##(1994-5#3)
mitochondria from##13##2##(1994-5#10)(1995-11#1)(2008-10#1)(2008-9#1)
mitochondria in the##3##3##(1991-5#1)(1994-8#1)(2009-8#1)
mitochondria in##9##2##(1990-2#1)(1991-3#1)(1991-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)
mitochondria of Physarum##2##3##(1997-2#2)
mitochondria was##2##2##(1990-2#1)(2013-8#1)
mitochondria##106##1##(1990-11#2)(1990-2#4)(1990-5#1)(1991-3#3)(1991-5#1)(1993-12#1)(1994-11#1)(1994-5#11)(1994-8#4)(1995-11#3)(1995-6#2)(1997-2#4)(2007-12#2)(2008-10#4)(2008-11#6)(2008-12#1)(2008-5#3)(2008-7#19)(2008-8#3)(2008-9#6)(2009-10#5)(2009-12#1)(2009-6#1)(2009-7#5)(2009-8#2)(2011-2#4)(2012-2#4)(2013-1#2)(2013-8#1)
mitochondria-targeted##2##1##(2008-11#1)(2012-2#1)
mitochondrial (mt) DNA##2##3##(2008-10#1)(2008-12#1)
mitochondrial (mt)##6##2##(1991-6#1)(1993-12#1)(1993-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
mitochondrial 12S rRNA gene##2##4##(2008-6#1)(2010-4#1)
mitochondrial C1-THF synthase##2##3##(1992-10#2)
mitochondrial DNA (mtDNA) haplotype##2##4##(2008-10#2)
mitochondrial DNA (mtDNA)##10##3##(1997-2#1)(2008-10#3)(2008-12#2)(2008-8#1)(2008-9#1)(2009-8#1)(2013-8#1)
mitochondrial DNA 4977-bp deletion and##2##5##(1994-11#2)
mitochondrial DNA haplotype##2##3##(2008-10#2)
mitochondrial DNA in##3##3##(1994-11#2)(2008-8#1)
mitochondrial DNA polymorphisms##2##3##(2008-10#2)
mitochondrial DNA restriction fragment length##2##5##(2008-10#2)
mitochondrial DNA revealed##2##3##(2008-10#1)(2013-8#1)
mitochondrial DNA sequence##2##3##(2008-10#1)(2008-4#1)
mitochondrial DNA sequences##2##3##(1991-5#1)(2008-10#1)
mitochondrial DNA##44##2##(1991-5#3)(1994-11#7)(1995-6#1)(1997-2#1)(2008-10#17)(2008-12#4)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#1)(2013-8#3)
mitochondrial and cytoplasmic##2##3##(1993-2#1)(2008-7#1)
mitochondrial and nuclear DNA##2##4##(2008-10#1)(2013-8#1)
mitochondrial and nuclear##4##3##(2008-10#2)(2010-4#1)(2013-8#1)
mitochondrial and##8##2##(1993-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#2)
mitochondrial biogenesis##2##2##(2008-1#2)
mitochondrial citrate synthase##3##3##(1997-4#1)(1997-8#2)
mitochondrial cristae##2##2##(2008-12#1)(2008-7#1)
mitochondrial cytochrome b gene##3##4##(2008-10#1)(2008-6#1)(2010-4#1)
mitochondrial cytochrome oxidase II##3##4##(2008-10#2)(2008-8#1)
mitochondrial cytochrome##7##2##(2008-10#3)(2008-6#2)(2008-8#1)(2010-4#1)
mitochondrial dysfunction in##2##3##(2007-8#1)(2013-1#1)
mitochondrial dysfunction##5##2##(1997-1#1)(2007-8#3)(2013-1#1)
mitochondrial electron transport##3##3##(2009-9#1)(2010-12#1)(2013-1#1)
mitochondrial encephalomyopathy##2##2##(1991-5#1)(2008-8#1)
mitochondrial function##9##2##(1994-5#3)(1997-1#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#2)
mitochondrial gene##5##2##(1993-2#1)(2008-10#2)(2008-6#1)(2008-8#1)
mitochondrial genes##5##2##(1991-6#1)(2008-10#1)(2008-6#2)(2012-2#1)
mitochondrial localization##2##2##(2008-10#1)(2011-2#1)
mitochondrial membrane depolarisation##2##3##(2008-11#2)
mitochondrial membrane of##2##3##(1990-11#1)(2012-2#1)
mitochondrial membrane potential (ΔΨm)##2##4##(2012-2#2)
mitochondrial membrane potential##11##3##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#4)(2011-2#1)(2012-2#2)
mitochondrial membrane##27##2##(1990-11#1)(1990-2#2)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-9#1)(2011-2#1)(2012-2#7)
mitochondrial membranes##3##2##(1990-2#1)(1994-5#1)(2012-2#1)
mitochondrial myopathy##2##2##(1990-3#1)(1994-11#1)
mitochondrial permeability transition pore##2##4##(2010-12#1)(2012-2#1)
mitochondrial permeability transition##5##3##(2008-11#2)(2009-9#1)(2010-12#1)(2012-2#1)
mitochondrial phosphoenol-pyruate carboxykinase##2##3##(2008-12#2)
mitochondrial plasmid##2##2##(1997-2#2)
mitochondrial protein##2##2##(2012-2#1)(2013-8#1)
mitochondrial respiration by##2##3##(1990-5#2)
mitochondrial respiration##4##2##(1990-5#3)(2008-7#1)
mitochondrial ribosomal##2##2##(1995-6#1)(2013-8#1)
mitochondrial small subunit##4##3##(2008-10#4)
mitochondrial structures##2##2##(1994-11#1)(2008-7#1)
mitochondrial##258##1##(1990-11#1)(1990-2#7)(1990-3#1)(1990-5#4)(1991-2#1)(1991-3#2)(1991-5#8)(1991-6#2)(1992-10#7)(1993-12#1)(1993-2#8)(1993-3#1)(1993-6#1)(1994-11#11)(1994-5#4)(1994-8#2)(1995-11#1)(1995-6#12)(1995-8#1)(1996-2#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#2)(2007-8#3)(2008-1#3)(2008-10#42)(2008-11#9)(2008-12#10)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#10)(2008-8#13)(2008-9#8)(2009-8#7)(2009-9#3)(2010-11#1)(2010-12#4)(2010-4#5)(2010-7#1)(2011-2#4)(2012-2#18)(2012-3#2)(2013-1#4)(2013-8#13)
mitochondrially encoded##2##2##(2008-10#1)(2013-8#1)
mitochondrially##3##1##(1995-6#1)(2008-10#1)(2013-8#1)
mitochondrion##3##1##(2008-11#1)(2008-7#1)(2009-8#1)
mitogen activated protein##2##3##(1994-11#1)(1996-2#1)
mitogen##15##1##(1992-6#1)(1994-11#2)(1995-2#4)(1996-2#1)(1997-1#1)(2008-11#2)(2009-10#1)(2011-2#3)
mitogen-activated protein (MAP)##2##3##(1993-8#1)(2008-7#1)
mitogen-activated protein kinase (MAPK)##7##4##(1995-2#2)(1996-2#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-3#1)
mitogen-activated protein kinase in##2##4##(1993-8#1)(2010-10#1)
mitogen-activated protein kinase##14##3##(1993-8#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-3#2)
mitogen-activated protein kinases (MAPKs)##4##4##(1995-2#1)(1995-6#1)(1996-2#1)(2010-10#1)
mitogen-activated protein kinases##5##3##(1995-2#1)(1995-6#1)(1996-2#2)(2010-10#1)
mitogen-activated protein##21##2##(1993-8#2)(1994-6#1)(1995-2#3)(1995-6#2)(1996-2#3)(2008-10#1)(2008-11#1)(2008-7#2)(2009-6#1)(2010-10#2)(2011-2#1)(2012-3#2)
mitogen-activated##22##1##(1993-8#2)(1994-6#1)(1995-2#3)(1995-6#2)(1996-2#3)(2008-10#1)(2008-11#1)(2008-7#3)(2009-6#1)(2010-10#2)(2011-2#1)(2012-3#2)
mitogen-stimulated##4##1##(1994-3#1)(1995-12#1)(2008-10#2)
mitogenesis and##2##2##(1997-7#2)
mitogenesis in##2##2##(1997-7#2)
mitogenesis through the##2##3##(1997-7#2)
mitogenesis##16##1##(1991-3#1)(1994-6#3)(1995-2#1)(1995-8#1)(1997-7#10)
mitogenic activity and stability##2##4##(1994-11#2)
mitogenic activity of##3##3##(1990-12#1)(2008-11#1)(2008-9#1)
mitogenic activity##9##2##(1990-12#1)(1993-3#1)(1994-11#3)(1995-11#1)(2008-11#2)(2008-9#1)
mitogenic effect of##3##3##(1997-1#2)(2008-6#1)
mitogenic effect on##2##3##(2008-11#2)
mitogenic effect##7##2##(1990-12#1)(1995-2#1)(1997-1#2)(2008-11#2)(2008-6#1)
mitogenic for##3##2##(1990-2#1)(1991-3#1)(2010-3#1)
mitogenic response##2##2##(1992-10#1)(2008-10#1)
mitogenic signaling##2##2##(1997-7#1)(2010-12#1)
mitogenic##42##1##(1990-12#3)(1990-2#1)(1991-3#1)(1992-10#1)(1992-6#1)(1993-3#1)(1994-11#4)(1994-3#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-8#1)(1996-2#2)(1997-1#2)(1997-7#1)(2008-10#1)(2008-11#7)(2008-4#2)(2008-6#3)(2008-9#2)(2010-12#1)(2010-3#1)(2013-7#1)
mitogens##4##1##(1990-12#1)(1991-1#1)(1992-4#1)(2008-11#1)
mitomycin C (MMC)##3##3##(1992-12#1)(1997-7#1)(2008-11#1)
mitomycin C instillation##3##3##(2008-11#1)(2011-2#2)
mitomycin C##10##2##(1992-12#1)(1994-8#1)(1995-8#1)(1997-7#2)(2008-11#2)(2011-2#3)
mitoses##8##1##(1992-6#1)(2012-3#4)(2013-1#3)
mitosis and##3##2##(1995-2#1)(2008-11#1)(2009-10#1)
mitosis in##3##2##(1995-11#2)(1995-2#1)
mitosis##36##1##(1992-6#1)(1993-9#3)(1995-11#3)(1995-2#3)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-5#2)(2009-8#1)(2011-2#5)(2012-2#4)(2013-1#1)
mitotic activity##4##2##(1991-8#1)(1994-12#1)(1995-11#1)(2009-1#1)
mitotic and meiotic divisions##2##4##(2008-7#1)(2009-10#1)
mitotic and##3##2##(1990-8#1)(2008-7#1)(2009-10#1)
mitotic count ≥2/10 hpf##2##3##(2011-2#2)
mitotic figures##2##2##(2008-11#1)(2008-7#1)
mitotic index (MI)##2##3##(2008-10#1)(2010-1#1)
mitotic index##6##2##(1994-6#1)(2008-10#1)(2008-11#2)(2010-1#1)(2012-3#1)
mitotic recombination##5##2##(1993-12#1)(1994-9#1)(1995-9#1)(2008-10#2)
mitotic spermatogonia##2##2##(2009-10#1)(2012-2#1)
mitotic spindle##7##2##(2008-1#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#3)
mitotic stability##2##2##(1993-9#1)(2008-10#1)
mitotic##53##1##(1990-8#1)(1991-8#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-9#2)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2010-1#1)(2010-5#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#4)
mitotically stable##3##2##(1993-9#1)(2008-10#2)
mitotically##5##1##(1993-9#1)(1995-9#2)(2008-10#2)
mitovirus##4##1##(2008-10#4)
mitoxantrone##10##1##(1991-6#6)(1994-12#1)(1994-8#1)(2010-12#1)(2012-3#1)
mitral annulus##3##2##(2008-10#3)
mitral layer##2##2##(1993-3#2)
mitral leaflet##2##2##(2008-10#2)
mitral regurgitation##5##2##(1997-5#1)(2008-11#1)(2009-10#1)(2010-5#2)
mitral valve insufficiency##2##3##(2011-2#1)(2012-2#1)
mitral valve repair##8##3##(2008-10#2)(2011-2#5)(2013-1#1)
mitral valve replacement in##2##4##(2011-2#2)
mitral valve replacement##4##3##(2011-2#3)(2013-1#1)
mitral valve##25##2##(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#11)(2012-2#1)(2013-1#9)
mitral##50##1##(1993-3#2)(1997-5#1)(2008-10#8)(2008-11#3)(2008-12#1)(2009-10#1)(2009-5#2)(2010-12#3)(2010-5#2)(2011-2#13)(2012-2#1)(2013-1#13)
mitral/tufted cells##2##2##(2009-12#2)
mivacurium in##3##2##(2008-10#3)
mivacurium##4##1##(2008-10#4)
mix and##7##2##(1992-12#2)(1993-12#2)(1995-2#1)(2008-10#1)(2008-2#1)
mix in##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
mix management##2##2##(1992-12#2)
mix measures##3##2##(1995-2#3)
mix of students##2##3##(2008-11#2)
mix of##7##2##(1992-4#1)(1993-1#1)(1993-3#1)(2008-11#2)(2008-8#1)(2009-12#1)
mix or##2##2##(2008-10#2)
mix than##2##2##(1991-3#1)(2008-10#1)
mix was##4##2##(2008-10#4)
mix were##3##2##(2008-10#3)
mix with##3##2##(2008-10#3)
mix##118##1##(1991-12#3)(1991-3#1)(1992-12#7)(1992-2#1)(1992-4#1)(1993-1#1)(1993-12#5)(1993-3#2)(1994-1#1)(1994-12#3)(1995-2#23)(1996-3#1)(1997-2#3)(1997-3#1)(2008-10#50)(2008-11#6)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#2)(2011-2#1)(2013-1#1)
mix)##2##1##(1992-12#1)(2008-11#1)
mixed LB films##2##3##(2008-10#2)
mixed and the##2##3##(2008-10#2)
mixed and##8##2##(2008-10#5)(2008-9#1)(2009-9#1)(2010-10#1)
mixed aza-thioether crowns containing a 1##2##6##(2008-10#2)
mixed by##2##2##(2008-10#1)(2008-11#1)
mixed cation sodalites##3##3##(2008-10#3)
mixed cation##5##2##(2008-10#5)
mixed chimera##2##2##(2013-1#2)
mixed complexes##4##2##(2008-10#4)
mixed connective tissue disease##2##4##(1991-11#1)(2012-3#1)
mixed cropping##3##2##(2008-10#3)
mixed cultures##9##2##(2008-10#3)(2011-1#1)(2013-1#5)
mixed cystomas##2##2##(1990-2#2)
mixed dissociation##2##2##(2008-10#2)
mixed effects model##2##3##(2008-11#2)
mixed effects##6##2##(2008-10#1)(2008-11#3)(2012-3#2)
mixed emulsifier##2##2##(2008-5#2)
mixed genotype infection##2##3##(2008-10#2)
mixed in a##2##3##(2008-10#2)
mixed in sandy soil at concentrations of##2##7##(2008-10#2)
mixed in##11##2##(1990-12#1)(1991-8#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-2#1)(2013-8#1)
mixed infection of##2##3##(2008-10#2)
mixed infection with ZYMV##2##4##(2008-10#2)
mixed infection with##4##3##(2008-10#4)
mixed infection##10##2##(2008-10#9)(2008-5#1)
mixed infections of##5##3##(2008-10#4)(2013-8#1)
mixed infections##16##2##(2008-10#13)(2013-1#2)(2013-8#1)
mixed interdigitated##2##2##(1993-8#2)
mixed ion-pair reversed phase##2##4##(2008-10#2)
mixed laser##2##2##(2008-3#2)
mixed light##2##2##(2008-11#2)
mixed liposomes##2##2##(1990-8#1)(1991-5#1)
mixed meal##5##2##(1994-12#4)(2012-3#1)
mixed method##3##2##(2008-12#1)(2013-1#2)
mixed micellar medium##2##3##(2008-10#2)
mixed micellar##4##2##(2008-10#4)
mixed micelles##4##2##(1990-2#1)(1994-5#1)(2008-10#2)
mixed mode matrices##2##3##(2008-7#2)
mixed mode##3##2##(2008-7#3)
mixed model##2##2##(2008-11#1)(2013-1#1)
mixed models##5##2##(2008-10#2)(2008-7#1)(2010-2#1)(2012-2#1)
mixed modifier components##2##3##(2008-10#2)
mixed multilayer LB films is##2##5##(2008-10#2)
mixed multilayer##3##2##(2008-10#3)
mixed on-line with ammonium pyrrolidine dithiocarbamate (APDC) and the##2##9##(2008-10#2)
mixed on-line with##5##3##(2008-10#5)
mixed population##3##2##(1992-6#1)(1994-11#1)(2008-10#1)
mixed populations##2##2##(2008-8#1)(2008-9#1)
mixed results##2##2##(2011-2#1)(2012-2#1)
mixed signals##3##2##(2008-10#3)
mixed solution of##4##3##(2008-10#4)
mixed solution##10##2##(2008-10#10)
mixed solutions##2##2##(2008-10#2)
mixed solvent of##2##3##(2008-10#2)
mixed solvent##6##2##(2008-10#6)
mixed solvents##10##2##(2008-10#10)
mixed strategy##3##2##(2008-8#3)
mixed surfactant##2##2##(2008-10#2)
mixed thoroughly##2##2##(2008-8#1)(2009-7#1)
mixed to##2##2##(2008-10#1)(2008-8#1)
mixed tungsten##2##2##(2008-10#2)
mixed type##4##2##(1990-11#1)(1990-2#2)(1996-6#1)
mixed viral##2##2##(2008-10#2)
mixed with 0##3##3##(2008-10#3)
mixed with HCl-iodine##2##3##(2008-10#2)
mixed with a##3##3##(2008-10#2)(2008-8#1)
mixed with fibrin##4##3##(2008-11#4)
mixed with the##12##3##(1995-3#1)(2008-10#10)(2008-3#1)
mixed with various##2##3##(2008-10#2)
mixed with##61##2##(1991-5#1)(1992-6#1)(1994-1#1)(1994-5#2)(1994-8#1)(1995-3#1)(2008-10#41)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-3#2)(2012-2#1)(2012-3#1)
mixed α##2##2##(2013-1#2)
mixed##420##1##(1990-11#1)(1990-12#2)(1990-2#8)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-6#2)(1992-8#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#5)(1994-5#4)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#238)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#11)(2008-9#6)(2009-12#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#10)(2011-3#2)(2012-12#1)(2012-2#9)(2012-3#6)(2012-5#2)(2013-1#25)(2013-8#5)
mixed-bed##2##1##(2008-10#2)
mixed-conifer##2##1##(2008-10#2)
mixed-family groups##2##2##(2010-8#2)
mixed-grade classrooms##2##2##(2008-12#2)
mixed-metal complexes##2##2##(2008-10#2)
mixed-metal##3##1##(2008-10#3)
mixed-method##2##1##(2009-5#2)
mixed-methods approach##2##2##(2008-12#1)(2013-8#1)
mixed-methods##3##1##(2008-12#1)(2010-10#1)(2013-8#1)
mixed-mode##3##1##(1997-2#1)(2008-10#2)
mixed-nativity##4##1##(2011-2#4)
mixed-species microarray##2##2##(2011-2#2)
mixed-species##4##1##(2008-8#1)(2011-2#3)
mixed-substrate maximum specific growth##2##4##(2008-7#2)
mixed-substrate##3##1##(2008-7#3)
mixer##10##1##(1993-2#1)(2008-10#2)(2008-5#3)(2008-7#2)(2009-4#1)(2011-1#1)
mixes prepared with##2##3##(2008-10#2)
mixes with a##2##3##(2008-10#1)(2011-2#1)
mixes with##5##2##(2008-10#4)(2011-2#1)
mixes##22##1##(1995-5#1)(1997-3#1)(2008-10#17)(2010-4#1)(2011-2#2)
mixing and##3##2##(2008-10#2)(2008-7#1)
mixing chamber##3##2##(2008-10#3)
mixing coil##3##2##(2008-10#3)
mixing conditions##2##2##(2008-10#2)
mixing for##2##2##(2008-10#1)(2008-3#1)
mixing in a##2##3##(2008-10#2)
mixing in##11##2##(2007-11#3)(2008-10#3)(2008-2#1)(2008-3#4)
mixing it with##2##3##(2008-10#2)
mixing of the##2##3##(2008-10#1)(2008-5#1)
mixing of##12##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)
mixing process##4##2##(2007-12#1)(2008-3#2)(2008-5#1)
mixing processes##2##2##(2008-2#1)(2008-8#1)
mixing ratio profiles##2##3##(2008-3#2)
mixing ratio##6##2##(2008-3#6)
mixing ratios##4##2##(2008-10#2)(2008-3#2)
mixing speed and time##4##4##(2008-5#4)
mixing technique##8##2##(2008-10#8)
mixing the reagents##3##3##(2008-10#3)
mixing the##9##2##(1993-8#1)(2008-10#5)(2008-2#1)(2008-3#2)
mixing time and##2##3##(2008-5#1)(2008-7#1)
mixing time##6##2##(2008-5#2)(2008-7#4)
mixing times##2##2##(2008-11#1)(2008-7#1)
mixing was##2##2##(1997-2#1)(2008-10#1)
mixing with the##2##3##(2008-10#1)(2009-7#1)
mixing with##7##2##(2008-10#4)(2008-11#1)(2008-3#1)(2009-7#1)
mixing zone##2##2##(2008-10#2)
mixing##155##1##(1990-2#1)(1991-9#1)(1992-9#2)(1993-8#1)(1995-5#1)(1997-2#3)(2007-11#6)(2007-12#4)(2008-10#72)(2008-11#5)(2008-2#4)(2008-3#26)(2008-5#12)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#1)(2009-7#2)(2010-8#1)(2013-1#1)
mixing-ratio measurements##2##2##(2007-12#2)
mixture analysis##2##2##(2008-10#2)
mixture and the##3##3##(1995-8#1)(2008-10#2)
mixture and##19##2##(1992-4#1)(1995-8#1)(2008-10#15)(2008-11#1)(2008-5#1)
mixture as a mobile phase##2##5##(2008-10#2)
mixture as a##3##3##(2008-10#3)
mixture as##5##2##(2008-10#5)
mixture at##4##2##(2008-10#3)(2008-5#1)
mixture by##4##2##(2008-10#4)
mixture can be##2##3##(2008-10#2)
mixture can##3##2##(2008-10#3)
mixture composition##2##2##(2008-10#1)(2008-2#1)
mixture consisting of##4##3##(2008-10#3)(2008-7#1)
mixture containing##10##2##(2008-10#9)(2008-5#1)
mixture designs##2##2##(2008-10#2)
mixture from##4##2##(1990-2#1)(2008-9#2)(2013-8#1)
mixture has##3##2##(2008-10#2)(2008-5#1)
mixture in the##5##3##(1997-8#1)(2007-12#1)(2008-10#3)
mixture is##12##2##(1990-12#2)(1993-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)
mixture modelling framework##2##3##(2012-3#2)
mixture of 0##3##3##(2008-10#3)
mixture of 2-propanol with water##2##5##(2008-10#2)
mixture of 2-propanol##3##3##(2008-10#3)
mixture of 5%##2##3##(2008-10#2)
mixture of HNO(3)##2##3##(2008-10#2)
mixture of a##3##3##(1990-9#1)(2008-10#1)(2010-3#1)
mixture of all##2##3##(2008-10#2)
mixture of both##5##3##(1990-5#1)(2008-10#4)
mixture of compounds##2##3##(2008-10#2)
mixture of concentrated##2##3##(2008-10#2)
mixture of ethyl acetate##2##4##(2008-10#1)(2012-2#1)
mixture of ethyl##3##3##(2008-10#2)(2012-2#1)
mixture of five##3##3##(2008-10#2)(2008-11#1)
mixture of free TNT##2##4##(2008-10#2)
mixture of free##3##3##(2008-10#3)
mixture of phenols##2##3##(2008-10#2)
mixture of six##2##3##(2008-10#2)
mixture of the three##2##4##(2008-10#2)
mixture of the two##4##4##(2008-10#3)(2008-9#1)
mixture of the##15##3##(1996-3#1)(1996-5#1)(2008-10#10)(2008-11#1)(2008-8#1)(2008-9#1)
mixture of three##2##3##(1990-12#1)(2008-11#1)
mixture of two##2##3##(1990-3#1)(2008-10#1)
mixture of##215##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#158)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
mixture samples##3##2##(2008-10#3)
mixture solution##4##2##(2008-10#4)
mixture solutions in##2##3##(2008-10#2)
mixture solutions##5##2##(2008-10#5)
mixture to##4##2##(2008-10#4)
mixture using##3##2##(2008-10#3)
mixture was found to be##3##5##(2008-10#3)
mixture was found to##5##4##(2008-10#5)
mixture was##20##2##(1990-2#1)(1997-2#1)(2008-10#15)(2008-5#1)(2008-9#1)(2010-4#1)
mixture were##7##2##(1990-12#1)(1994-5#1)(2008-10#4)(2008-11#1)
mixture where##2##2##(2008-10#2)
mixture with##6##2##(1991-9#1)(2008-10#3)(2008-8#1)(2008-9#1)
mixture##498##1##(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-9#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-8#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-8#4)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#371)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#15)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#6)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
mixture)##2##1##(2008-10#2)
mixtures and commercial formulations were##2##5##(2008-10#2)
mixtures and subsequent##2##3##(2008-10#1)(2008-5#1)
mixtures and the##6##3##(2008-10#6)
mixtures and##33##2##(2008-10#29)(2008-2#1)(2008-3#1)(2008-5#2)
mixtures are##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
mixtures as well as##2##4##(2008-10#2)
mixtures as well##3##3##(2008-10#3)
mixtures as##4##2##(2008-10#4)
mixtures at##6##2##(2008-10#5)(2010-4#1)
mixtures by using spectrophotometric methods is a difficult problem in analytical chemistry##2##12##(2008-10#2)
mixtures by using##3##3##(2008-10#3)
mixtures by##9##2##(2008-10#9)
mixtures can##3##2##(2008-10#2)(2008-2#1)
mixtures containing##17##2##(1992-3#1)(2008-10#15)(2008-7#1)
mixtures developed##2##2##(2008-10#2)
mixtures for the##2##3##(2008-10#2)
mixtures for##6##2##(2008-10#5)(2008-11#1)
mixtures has been##2##3##(2008-10#2)
mixtures have##2##2##(2008-10#1)(2008-7#1)
mixtures in reducing##2##3##(2008-10#2)
mixtures in the##5##3##(2008-10#4)(2008-4#1)
mixtures in##16##2##(1990-5#1)(1996-5#1)(2008-10#13)(2008-4#1)
mixtures is##4##2##(2008-10#3)(2009-7#1)
mixtures of 3-phenyl-4-benzoyl-5-isoxazolone##2##3##(2008-10#2)
mixtures of both##2##3##(2008-10#1)(2012-7#1)
mixtures of host genotypes##2##4##(2008-10#2)
mixtures of the##8##3##(1994-5#1)(2008-10#6)(2008-4#1)
mixtures of these##5##3##(2008-10#5)
mixtures of two##5##3##(2008-10#2)(2008-12#2)(2011-1#1)
mixtures of weak acids##2##4##(2008-10#1)(2008-9#1)
mixtures of##124##2##(1990-12#1)(1993-8#1)(1994-5#1)(1996-5#1)(2008-10#99)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-7#1)
mixtures on##2##2##(2008-10#2)
mixtures such as##2##3##(2008-10#1)(2008-4#1)
mixtures to##3##2##(2008-10#3)
mixtures under##3##2##(2008-10#3)
mixtures used##3##2##(2008-10#3)
mixtures using the##2##3##(2008-10#2)
mixtures using##12##2##(2008-1#1)(2008-10#10)(2011-2#1)
mixtures was investigated##2##3##(2008-10#1)(2011-2#1)
mixtures was##6##2##(2008-10#5)(2011-2#1)
mixtures were studied##5##3##(1990-5#1)(2008-10#3)(2011-2#1)
mixtures were used to##2##4##(2008-10#2)
mixtures were used##3##3##(2008-10#3)
mixtures were##20##2##(1990-5#1)(1993-8#1)(2008-10#17)(2011-2#1)
mixtures with water##2##3##(2008-10#2)
mixtures with##19##2##(2008-10#17)(2008-3#1)(2008-5#1)
mixtures without##2##2##(2008-10#2)
mixtures##447##1##(1990-12#1)(1990-5#2)(1991-9#1)(1992-3#1)(1993-8#4)(1994-5#1)(1996-12#1)(1996-5#2)(1997-2#1)(2008-1#2)(2008-10#374)(2008-11#3)(2008-12#6)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#3)(2011-1#2)(2011-2#4)(2012-3#1)(2012-7#1)
mixtures)##2##1##(2008-10#2)
miyabeanus##13##1##(2008-10#13)
ml 10kg-1 body weight per animal##2##6##(1996-12#2)
ml 48% HF and##2##4##(2008-10#2)
ml aliquot of##2##3##(2008-10#2)
ml and##9##2##(1990-2#1)(1993-2#1)(1993-3#1)(2008-10#5)(2008-11#1)
ml aqueous##3##2##(2008-10#3)
ml bags)##2##2##(2008-11#2)
ml for the##2##3##(2008-10#2)
ml for##6##2##(2008-10#3)(2008-7#2)(2011-2#1)
ml in a##2##3##(2008-10#1)(2008-11#1)
ml in##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
ml instead of##2##3##(2008-10#2)
ml min(-1) and##3##3##(2008-10#3)
ml min(-1) at##2##3##(2008-10#2)
ml min(-1) flow rate##2##4##(2008-10#2)
ml min(-1) flow##3##3##(2008-10#3)
ml min(-1) for##7##3##(2008-10#7)
ml min(-1) the##2##3##(2008-10#2)
ml min(-1)##68##2##(2008-10#67)(2010-4#1)
ml min(-1)) and##2##3##(2008-10#2)
ml min(-1))##8##2##(2008-10#7)(2010-4#1)
ml of 0##9##3##(1995-3#1)(2008-10#8)
ml of 1 M##2##4##(2008-10#2)
ml of 1##6##3##(2008-10#6)
ml of 2##2##3##(2008-10#2)
ml of 2%##2##3##(2008-10#2)
ml of 4 M##3##4##(2008-10#3)
ml of 50%##2##3##(1994-5#1)(2008-10#1)
ml of 6 M##2##4##(2008-10#2)
ml of a##6##3##(2008-10#6)
ml of aqueous##2##3##(2008-10#2)
ml of blood##2##3##(1993-3#1)(2013-1#1)
ml of digested blood##2##4##(2008-10#2)
ml of digested sample##2##4##(2008-10#2)
ml of digested##4##3##(2008-10#4)
ml of irrigation##2##3##(2008-10#2)
ml of methanol##3##3##(2008-10#3)
ml of methanol-acetate buffer##2##4##(2008-10#2)
ml of sample solution is##2##5##(2008-10#2)
ml of sample solution##6##4##(2008-10#6)
ml of sample##12##3##(2008-10#12)
ml of serum##2##3##(1992-3#1)(2008-10#1)
ml of the##4##3##(2008-10#4)
ml of virus harvest##2##4##(2008-11#2)
ml of water sample##2##4##(2008-10#2)
ml of water##3##3##(2008-10#3)
ml of##119##2##(1990-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(2008-10#105)(2008-11#4)(2008-12#3)(2013-1#1)
ml saline##2##2##(1996-2#1)(2011-2#1)
ml sample consumed per determination##2##5##(2008-10#2)
ml sample volume##7##3##(2008-10#7)
ml sample##16##2##(2008-10#16)
ml solution##2##2##(2008-10#2)
ml solvent##2##2##(1994-9#1)(2008-10#1)
ml spinner flask##2##3##(2008-11#2)
ml volume##2##2##(2008-10#2)
ml was##3##2##(1993-3#1)(2008-10#2)
ml##351##1##(1990-11#1)(1990-2#2)(1991-2#1)(1992-2#1)(1992-3#1)(1993-2#4)(1993-3#3)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-12#2)(1996-2#2)(1997-1#2)(1997-8#1)(2008-1#1)(2008-10#291)(2008-11#15)(2008-12#5)(2008-7#3)(2009-8#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
ml(-1) (0##2##2##(2008-10#2)
ml(-1) (3##2##2##(2008-10#2)
ml(-1) (3S/N)##2##2##(2008-10#2)
ml(-1) (S/N=3)##5##2##(2008-10#5)
ml(-1) (r=0##4##2##(2008-10#4)
ml(-1) and 0##4##3##(2008-10#4)
ml(-1) and 1##6##3##(2008-10#6)
ml(-1) and a sample##2##4##(2008-10#2)
ml(-1) and a##5##3##(2008-10#4)(2008-11#1)
ml(-1) and the detection limit is##2##6##(2008-10#2)
ml(-1) and the detection limit was 0##2##7##(2008-10#2)
ml(-1) and the detection limit was##3##6##(2008-10#3)
ml(-1) and the detection limit##5##5##(2008-10#5)
ml(-1) and the relative standard deviation##4##6##(2008-10#4)
ml(-1) and the relative standard##6##5##(2008-10#6)
ml(-1) and the##21##3##(2008-10#21)
ml(-1) and##52##2##(2008-10#51)(2008-11#1)
ml(-1) at##2##2##(2008-10#2)
ml(-1) by##2##2##(2008-10#2)
ml(-1) can be determined##2##4##(2008-10#2)
ml(-1) can be##3##3##(2008-10#3)
ml(-1) concentration##3##2##(2008-10#2)(2008-11#1)
ml(-1) each##3##2##(2008-10#3)
ml(-1) for 2##3##3##(2008-10#2)(2008-11#1)
ml(-1) for Mn(II)##2##3##(2008-10#2)
ml(-1) for calf thymus DNA##5##5##(2008-10#5)
ml(-1) for each##4##3##(2008-10#4)
ml(-1) for fish sperm DNA##5##5##(2008-10#5)
ml(-1) for human##2##3##(2008-10#2)
ml(-1) for nitrite##2##3##(2008-10#2)
ml(-1) for the##5##3##(2008-10#5)
ml(-1) for yeast RNA##5##4##(2008-10#5)
ml(-1) for##102##2##(2008-10#101)(2008-11#1)
ml(-1) in the##3##3##(2008-10#2)(2008-11#1)
ml(-1) in##10##2##(2008-10#7)(2008-11#3)
ml(-1) is##5##2##(2008-10#5)
ml(-1) level were##4##3##(2008-10#4)
ml(-1) level##10##2##(2008-10#10)
ml(-1) levels in##2##3##(2008-10#1)(2008-11#1)
ml(-1) levels##5##2##(2008-10#4)(2008-11#1)
ml(-1) nitrite##3##2##(2008-10#3)
ml(-1) of CTAB##2##3##(2008-11#2)
ml(-1) of iron##2##3##(2008-10#2)
ml(-1) of manganese##3##3##(2008-10#3)
ml(-1) of mercury##2##3##(2008-10#2)
ml(-1) of mercury(II)##2##3##(2008-10#2)
ml(-1) of nitrite##4##3##(2008-10#4)
ml(-1) of selenium##2##3##(2008-10#2)
ml(-1) of##75##2##(2008-10#71)(2008-11#4)
ml(-1) on##3##2##(2008-10#2)(2008-11#1)
ml(-1) range##4##2##(2008-10#4)
ml(-1) the##3##2##(2008-10#2)(2008-11#1)
ml(-1) to##3##2##(2008-10#1)(2008-11#2)
ml(-1) using##3##2##(2008-10#2)(2008-11#1)
ml(-1) vanadium##4##2##(2008-10#4)
ml(-1) was##6##2##(2008-10#5)(2008-11#1)
ml(-1) were obtained##2##3##(2008-10#1)(2008-11#1)
ml(-1) were##4##2##(2008-10#3)(2008-11#1)
ml(-1) when##2##2##(2008-10#2)
ml(-1) with a detection limit of 0##4##7##(2008-10#4)
ml(-1) with a detection limit of 6##2##7##(2008-10#2)
ml(-1) with a detection limit of##10##6##(2008-10#10)
ml(-1) with a limit of detection of 0##2##8##(2008-10#2)
ml(-1) with a limit of detection of##3##7##(2008-10#3)
ml(-1) with a limit of detection##5##6##(2008-10#5)
ml(-1) with a relative standard deviation of##2##7##(2008-10#2)
ml(-1) with a relative standard deviation##3##6##(2008-10#3)
ml(-1) with a##22##3##(2008-10#22)
ml(-1) with an##2##3##(2008-10#2)
ml(-1) with detection limits##2##4##(2008-10#2)
ml(-1) with detection##3##3##(2008-10#3)
ml(-1) with##34##2##(2008-10#33)(2008-11#1)
ml(-1)##683##1##(2008-10#624)(2008-11#59)
ml(-1)) and a detection limit of##2##6##(2008-10#2)
ml(-1)) and##15##2##(2008-10#14)(2008-11#1)
ml(-1)) or##2##2##(2008-10#2)
ml(-1)) to##2##2##(2008-10#2)
ml(-1)) were##2##2##(2008-10#2)
ml(-1)) with##2##2##(2008-10#1)(2008-11#1)
ml(-1))##65##1##(2008-10#53)(2008-11#12)
ml(-1)and the##2##2##(2008-10#1)(2008-11#1)
ml) and the##2##3##(2008-7#2)
ml) and##5##2##(2008-10#2)(2008-11#1)(2008-7#2)
ml) is##2##2##(2008-10#2)
ml) of##3##2##(2008-10#3)
ml) was##2##2##(2008-10#2)
ml) were##2##2##(1993-2#1)(2008-10#1)
ml)##24##1##(1993-2#1)(1993-3#1)(2008-10#17)(2008-11#2)(2008-5#1)(2008-7#2)
ml-1 and##2##2##(1990-5#1)(1996-2#1)
ml-1 of beads##3##3##(1997-2#3)
ml-1 of##4##2##(1997-2#4)
ml-1##13##1##(1990-5#1)(1996-12#1)(1996-2#7)(1997-2#4)
ml-1)##3##1##(1990-5#1)(1996-2#1)(2008-11#1)
ml/kg##3##1##(1994-5#1)(2008-10#2)
ml/kg)##3##1##(1994-5#1)(2008-7#2)
ml/min##9##1##(1997-2#3)(2008-10#2)(2008-4#1)(2009-8#2)(2012-2#1)
ml/min) and##2##2##(2008-10#1)(2008-7#1)
ml/min)##4##1##(2008-10#2)(2008-7#2)
mlmin(-1)##7##1##(2008-10#7)
mlt1##3##1##(2012-3#3)
mm (range##3##2##(1995-3#2)(2008-7#1)
mm Hg and##2##3##(2008-11#1)(2010-4#1)
mm Hg it was##2##4##(1997-5#2)
mm Hg pCO2##2##3##(2008-11#2)
mm Hg##17##2##(1990-11#1)(1994-6#1)(1996-6#1)(1997-5#2)(2008-1#1)(2008-11#7)(2010-4#3)(2013-8#1)
mm Phi##2##2##(2008-10#2)
mm and 23##2##3##(1992-5#1)(2013-1#1)
mm and 3##2##3##(2013-1#2)
mm and a##2##3##(2007-12#1)(2008-3#1)
mm and##14##2##(1992-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#8)
mm at##2##2##(1996-11#1)(2012-12#1)
mm beyond the tip##2##4##(1995-2#2)
mm beyond the##3##3##(1995-2#3)
mm diameter##3##2##(1991-2#1)(2008-10#1)(2009-5#1)
mm for steel wire and UHMWPE cable##2##7##(2009-3#2)
mm for##7##2##(1993-1#1)(2009-2#2)(2009-3#2)(2010-7#1)(2013-1#1)
mm from the##2##3##(1992-1#1)(1994-12#1)
mm i##12##2##(2008-10#11)(2008-5#1)
mm in diameter and##2##4##(2008-10#1)(2008-8#1)
mm in diameter were##2##4##(2008-10#1)(2008-5#1)
mm in diameter##13##3##(1995-12#4)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
mm in diameter) and##2##4##(2008-10#2)
mm in diameter)##6##3##(2008-10#5)(2013-1#1)
mm in length##4##3##(2008-10#1)(2008-8#2)(2013-1#1)
mm in size##4##3##(1990-2#2)(2007-12#1)(2008-3#1)
mm in the##5##3##(2008-9#1)(2009-11#1)(2010-12#2)(2010-7#1)
mm in##39##2##(1990-2#2)(1991-2#1)(1995-12#5)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
mm internal##2##2##(2008-10#2)
mm long##2##2##(2008-10#2)
mm of the##3##3##(2008-10#2)(2011-2#1)
mm of##6##2##(2008-10#4)(2011-2#1)(2013-1#1)
mm or##4##2##(1990-5#1)(1992-5#2)(2008-10#1)
mm path##2##2##(2008-10#2)
mm ranging from##3##3##(2010-8#1)(2013-8#2)
mm respectively and##2##3##(2013-1#2)
mm respectively##6##2##(2013-1#6)
mm standard##2##2##(2008-11#1)(2010-8#1)
mm were##2##2##(2008-11#1)(2013-1#1)
mm with##3##2##(2008-12#1)(2013-1#2)
mm x 4##2##3##(1997-2#1)(2008-5#1)
mm x 40 mm x##2##5##(2008-10#1)(2008-3#1)
mm x 40 mm##3##4##(2008-10#1)(2008-3#2)
mm x##11##2##(1997-2#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2011-2#1)(2011-3#1)
mm x4##4##2##(2008-10#4)
mm##315##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#3)(1991-2#5)(1991-6#1)(1991-9#1)(1992-1#1)(1992-5#3)(1993-1#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#5)(1995-2#3)(1995-3#3)(1996-11#1)(1996-6#3)(1997-2#2)(1997-5#2)(1997-8#1)(2007-12#3)(2008-1#4)(2008-10#83)(2008-11#18)(2008-12#3)(2008-2#5)(2008-3#11)(2008-5#6)(2008-7#15)(2008-8#6)(2008-9#4)(2009-11#3)(2009-2#3)(2009-3#4)(2009-5#2)(2009-7#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#8)(2011-2#9)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#51)(2013-8#6)
mm(-2)##4##1##(2008-5#4)
mm(2) of##5##2##(2008-10#5)
mm(2)##10##1##(2008-10#9)(2008-11#1)
mm(3)##2##1##(2008-10#1)(2010-8#1)
mm) and##2##2##(2008-10#1)(2008-12#1)
mm) areas##2##2##(2008-10#2)
mm) was used##2##3##(1990-11#1)(2013-1#1)
mm)##49##1##(1990-11#1)(1995-3#2)(2008-10#10)(2008-11#3)(2008-12#4)(2008-7#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#7)(2012-3#3)(2013-1#5)
mm/day)##5##1##(2008-10#5)
mm/h##3##1##(2008-10#3)
mm/s##2##1##(2012-12#2)
mmHg at##3##2##(2008-11#3)
mmHg is##2##2##(2008-7#1)(2010-5#1)
mmHg on the##2##3##(2011-2#2)
mmHg or##2##2##(1997-5#1)(2008-7#1)
mmHg to##4##2##(1990-11#2)(1991-6#2)
mmHg##31##1##(1990-11#4)(1991-6#6)(1997-5#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-5#1)(2011-2#4)
mmHg)##12##1##(1991-6#2)(1997-3#2)(2008-10#2)(2008-11#3)(2011-2#1)(2012-12#1)(2012-3#1)
mmoL/L##2##1##(2008-10#2)
mmol L(-1) iodate##2##3##(2008-10#2)
mmol L(-1)##6##2##(2008-10#6)
mmol dm(-3) potassium##2##3##(2008-10#2)
mmol dm(-3) with##2##3##(2008-10#2)
mmol dm(-3)##8##2##(2008-10#8)
mmol g(-1) (log##2##3##(2008-10#2)
mmol g(-1) for##3##3##(2008-10#3)
mmol g(-1) of##4##3##(2008-10#4)
mmol g(-1)##18##2##(2008-10#17)(2008-5#1)
mmol l(-1) of##2##3##(2008-10#2)
mmol l(-1) tetrabutylammonium bromide##2##4##(2008-10#2)
mmol l(-1)##26##2##(2008-10#26)
mmol##76##1##(1991-12#1)(1997-8#1)(2008-10#66)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#3)(2010-11#1)
mmol/L##16##1##(1993-1#4)(2007-12#1)(2008-10#1)(2008-8#4)(2008-9#4)(2012-2#1)(2013-1#1)
mmol/kg treatment group##2##3##(1994-5#2)
mmol/kg##10##1##(1992-12#3)(1994-5#5)(2008-11#2)
mmol/kg) and##3##2##(1992-12#1)(2008-11#2)
mmol/kg)##11##1##(1992-12#2)(1994-5#5)(2008-11#4)
mmol/l [normal &lt##2##3##(1994-3#2)
mmol/l for##4##2##(1990-6#2)(1991-6#2)
mmol/l had##2##2##(1990-6#1)(1994-12#1)
mmol/l in men and##2##4##(1991-6#2)
mmol/l in women)##2##3##(1991-6#2)
mmol/l in##5##2##(1991-6#5)
mmol/l##35##1##(1990-2#2)(1990-3#1)(1990-6#3)(1991-11#8)(1991-6#7)(1992-12#3)(1994-12#2)(1994-3#2)(1994-6#2)(2008-7#2)(2010-4#2)(2011-2#1)
mmol/l) and##2##2##(1994-12#1)(2010-3#1)
mmol/l)##9##1##(1990-2#3)(1990-3#1)(1992-9#1)(1994-12#2)(1994-3#1)(2010-3#1)
mmoll(-1)##2##1##(2008-10#2)
mn##4##1##(2007-8#4)
mnemonic##3##1##(1993-9#1)(2008-11#1)(2008-8#1)
mnp3##3##1##(2011-1#3)
mo##4##1##(2010-12#1)(2012-2#3)
mo1(1) and mo1(2)##2##3##(2008-10#2)
mo1(1)##5##1##(2008-10#5)
mo1(2)##6##1##(2008-10#6)
mo1-carrying##2##1##(2008-10#2)
mobile bearing in a medial unicompartmental knee replacement##2##8##(2012-12#2)
mobile carrier##4##2##(2008-10#4)
mobile drilling units##2##3##(2009-10#2)
mobile group I intron##2##4##(1995-6#2)
mobile in the##2##3##(2008-10#2)
mobile offshore drilling units##2##4##(2009-10#2)
mobile phase and UV detection##2##5##(2008-10#1)(2011-1#1)
mobile phase and a##2##4##(2008-10#2)
mobile phase and##14##3##(2008-10#12)(2011-1#1)(2011-3#1)
mobile phase at##3##3##(2008-10#2)(2008-5#1)
mobile phase by##2##3##(2008-10#1)(2008-5#1)
mobile phase composition##5##3##(2008-10#5)
mobile phase consisted of##2##4##(2008-10#1)(2011-3#1)
mobile phase consisting of##4##4##(2008-10#4)
mobile phase containing##8##3##(2008-10#8)
mobile phase for##2##3##(2008-10#2)
mobile phase in the##2##4##(2008-10#2)
mobile phase in##5##3##(2008-10#5)
mobile phase is##5##3##(2008-10#5)
mobile phase of methanol-water##2##4##(2008-10#2)
mobile phase of##12##3##(2008-10#12)
mobile phase on##2##3##(2008-10#2)
mobile phase pH##3##3##(2008-10#3)
mobile phase used was##6##4##(1997-2#1)(2008-10#4)(2012-2#1)
mobile phase was##9##3##(2008-10#9)
mobile phase were##4##3##(2008-10#4)
mobile phase with##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)
mobile phase within##2##3##(2008-10#2)
mobile phase##162##2##(1991-7#1)(1993-11#1)(1997-2#2)(2008-10#145)(2008-11#1)(2008-5#4)(2008-7#1)(2009-8#2)(2011-1#1)(2011-3#2)(2012-2#2)
mobile phase)##5##2##(2008-10#5)
mobile phases and##3##3##(2008-10#2)(2010-11#1)
mobile phases of##2##3##(2008-10#1)(2010-11#1)
mobile phases##14##2##(2008-10#12)(2010-11#2)
mobile phone##3##2##(2012-3#3)
mobile species##2##2##(2008-9#2)
mobile teeth##2##2##(2008-1#2)
mobile telemedicine##2##2##(2007-9#2)
mobile##243##1##(1991-7#1)(1993-11#1)(1995-6#3)(1997-2#2)(2007-9#3)(2008-1#4)(2008-10#176)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#4)(2009-8#2)(2010-11#3)(2010-3#1)(2010-8#4)(2011-1#1)(2011-2#3)(2011-3#3)(2012-12#2)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#3)
mobile-wireless infrastructure and mobile health care computing devices##2##8##(2010-8#2)
mobile-wireless infrastructure##3##2##(2010-8#3)
mobilities in##2##2##(2008-10#2)
mobilities of##4##2##(1994-11#1)(2008-10#3)
mobilities##10##1##(1994-11#1)(2008-10#8)(2010-9#1)
mobility (p=0##3##2##(2008-10#3)
mobility and##6##2##(1992-6#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)
mobility are##2##2##(2008-10#1)(2008-7#1)
mobility at##2##2##(2008-8#1)(2013-1#1)
mobility compared##2##2##(2008-9#1)(2011-2#1)
mobility decline##3##2##(2008-7#3)
mobility in the##3##3##(2008-10#2)(2008-7#1)
mobility in##5##2##(2008-10#3)(2008-7#2)
mobility increment##3##2##(2008-10#3)
mobility of the##3##3##(1994-11#1)(2008-10#2)
mobility of##20##2##(1991-12#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(2008-10#11)(2008-7#1)(2008-8#2)(2011-2#1)
mobility shift assay revealed##2##4##(2008-11#2)
mobility shift assay showed that##2##5##(2008-9#1)(2011-2#1)
mobility shift assay showed##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
mobility shift assay##9##3##(1995-8#1)(2008-11#4)(2008-4#1)(2008-9#2)(2011-2#1)
mobility shift assays using##3##4##(1995-6#2)(2011-1#1)
mobility shift assays##6##3##(1995-6#2)(1997-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
mobility shift##18##2##(1993-8#1)(1995-6#2)(1995-8#1)(1997-7#1)(2008-11#5)(2008-4#1)(2008-8#1)(2008-9#4)(2011-1#1)(2011-2#1)
mobility spectra##4##2##(2008-10#4)
mobility spectrometer##8##2##(2008-10#7)(2010-9#1)
mobility spectrometers##3##2##(2008-10#3)
mobility spectrometry for the##2##4##(2008-10#1)(2010-9#1)
mobility spectrometry##28##2##(2008-10#26)(2010-9#2)
mobility were##3##2##(2008-10#1)(2008-7#2)
mobility##169##1##(1990-11#1)(1990-3#1)(1991-12#2)(1991-3#1)(1991-7#3)(1992-6#3)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#82)(2008-11#7)(2008-4#2)(2008-7#19)(2008-8#6)(2008-9#10)(2010-1#1)(2010-11#1)(2010-9#3)(2011-1#1)(2011-2#7)(2012-3#1)(2013-1#5)
mobilization and##6##2##(1990-5#1)(1996-2#2)(2008-12#1)(2009-6#1)(2010-5#1)
mobilization in whole-blood platelets##2##4##(2008-9#2)
mobilization in##7##2##(1990-8#1)(1991-5#1)(2008-10#1)(2008-6#1)(2008-9#2)(2009-10#1)
mobilization of##12##2##(1990-8#1)(1992-3#1)(1993-2#1)(1994-11#2)(1996-3#1)(2008-12#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
mobilization results##2##2##(2011-2#2)
mobilization##42##1##(1990-5#2)(1990-8#2)(1991-5#1)(1992-3#1)(1993-2#1)(1994-11#2)(1995-11#1)(1995-2#1)(1996-2#3)(1996-3#1)(2008-10#4)(2008-12#4)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-6#3)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#4)(2013-8#1)
mobilizations##4##1##(2008-12#1)(2009-4#1)(2012-2#2)
mobilize##7##1##(1996-2#1)(2008-10#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
mobilized##5##1##(1993-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
mobilizing##3##1##(1992-12#2)(1994-11#1)
mock##7##1##(1993-12#2)(2008-10#1)(2008-8#1)(2009-10#1)(2010-7#1)(2012-3#1)
mock-inoculated plants##2##2##(2008-10#1)(2012-2#1)
mock-inoculated##3##1##(2008-10#2)(2012-2#1)
moclobemide or omeprazole##2##3##(2008-11#2)
modafinil for cocaine##2##3##(2009-7#2)
modafinil##7##1##(2009-7#7)
modal interference##2##2##(2007-11#1)(2008-3#1)
modal##15##1##(2007-11#3)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#8)
modalities and##6##2##(1995-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#1)
modalities are##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-1#1)(2009-4#1)
modalities depending on##2##3##(1993-11#1)(2009-8#1)
modalities for the##2##3##(2009-11#1)(2010-6#1)
modalities for##7##2##(1990-6#1)(1993-1#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-6#1)(2010-9#1)
modalities have##5##2##(1995-1#1)(1997-8#1)(2008-9#1)(2010-6#1)(2012-2#1)
modalities in##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
modalities of##8##2##(1993-8#1)(1994-2#1)(1996-3#1)(2008-11#2)(2010-8#1)(2011-2#1)(2013-1#1)
modalities require##2##2##(1995-12#1)(2008-7#1)
modalities such as##3##3##(2008-3#1)(2010-12#1)(2013-1#1)
modalities to##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
modalities used##3##2##(1994-5#1)(1996-1#1)(2011-2#1)
modalities##85##1##(1990-6#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#4)(1995-5#1)(1996-1#2)(1996-3#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#2)(2009-11#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#3)(2011-2#6)(2011-7#1)(2012-2#3)(2013-1#11)(2013-8#1)
modality for the##3##3##(1990-11#1)(2010-6#1)(2012-2#1)
modality for##7##2##(1990-11#1)(1997-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
modality is##3##2##(2010-12#1)(2010-5#1)(2010-7#1)
modality of treatment##2##3##(1994-12#1)(2012-3#1)
modality of##5##2##(1994-12#1)(2008-12#1)(2008-9#1)(2012-12#1)(2012-3#1)
modality that##2##2##(2010-6#1)(2011-2#1)
modality to##5##2##(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-8#1)
modality##47##1##(1990-11#1)(1991-2#1)(1991-9#1)(1992-1#1)(1994-12#1)(1997-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#3)(2011-2#6)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
modality-specific##2##1##(1991-2#2)
mode AFM##2##2##(2008-10#2)
mode I fracture energy##2##4##(2009-7#2)
mode and the##5##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#2)
mode and##20##2##(1990-8#1)(1993-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
mode are##2##2##(2008-10#1)(2009-7#1)
mode at 230 nm##2##4##(2008-10#2)
mode at##7##2##(2008-10#6)(2008-3#1)
mode by##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
mode can be##3##3##(2008-10#2)(2008-11#1)
mode coupling##5##2##(2008-3#5)
mode for##7##2##(2008-10#4)(2008-11#1)(2008-3#2)
mode has##2##2##(2007-12#1)(2008-10#1)
mode have been##2##3##(2008-10#2)
mode in the##2##3##(2008-3#1)(2012-3#1)
mode in##9##2##(1991-12#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#1)
mode is##8##2##(1991-12#1)(1996-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
mode locking and##2##3##(2008-3#2)
mode locking##3##2##(2008-3#3)
mode network##3##2##(2013-8#3)
mode of Melbourne Categories in this group (n =##2##9##(2008-9#2)
mode of action as well as their##2##7##(2011-2#2)
mode of action of##12##4##(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2010-10#1)
mode of action##19##3##(1990-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#2)(2011-2#2)
mode of administration in##2##4##(1996-2#1)(2008-1#1)
mode of administration##3##3##(1992-9#1)(1996-2#1)(2008-1#1)
mode of chelation##2##3##(2008-10#2)
mode of communication##3##3##(2008-9#3)
mode of delivery##2##3##(1993-11#1)(2012-3#1)
mode of extraction##2##3##(2008-10#2)
mode of inheritance##3##3##(1997-3#1)(2008-10#2)
mode of interaction##2##3##(1997-2#1)(2008-10#1)
mode of operation is##2##4##(2008-11#1)(2008-3#1)
mode of operation##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
mode of presentation##3##3##(1997-8#1)(2011-1#2)
mode of speech##6##3##(2011-1#6)
mode of the##5##3##(2008-10#3)(2008-3#2)
mode of transmission##3##3##(1996-1#1)(2008-10#2)
mode of treatment##2##3##(1996-3#1)(2008-12#1)
mode of##112##2##(1990-12#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#37)(2008-11#6)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#7)(2009-8#3)(2010-10#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#8)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
mode operation##2##2##(2008-10#2)
mode over##3##2##(2008-10#2)(2008-9#1)
mode sampling##4##2##(2008-10#4)
mode shaping##2##2##(2008-2#2)
mode to##6##2##(1990-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
mode using##7##2##(2008-10#6)(2008-11#1)
mode was applied##2##3##(2008-10#1)(2013-1#1)
mode was##9##2##(2008-10#4)(2008-11#2)(2008-7#1)(2013-1#2)
mode with a##5##3##(2007-12#1)(2008-10#2)(2008-3#2)
mode with an##3##3##(2008-10#3)
mode with the##2##3##(2008-10#2)
mode with##17##2##(2007-12#1)(2008-10#11)(2008-3#3)(2011-3#1)(2013-1#1)
mode##420##1##(1990-12#1)(1990-8#2)(1991-12#5)(1992-10#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#8)(2008-1#1)(2008-10#184)(2008-11#27)(2008-12#1)(2008-2#11)(2008-3#47)(2008-4#2)(2008-5#8)(2008-7#10)(2008-8#2)(2008-9#17)(2009-7#4)(2009-8#3)(2010-10#6)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#10)(2011-2#5)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#5)
mode-locked Cr(4+)##3##2##(2008-3#3)
mode-locked laser##2##2##(2008-3#2)
mode-locked##18##1##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#11)
mode-matching##2##1##(2008-3#2)
model (TTM)##3##2##(2008-12#1)(2010-2#1)(2013-1#1)
model (in the limit v →##2##6##(2013-8#2)
model (mx =##2##3##(2008-9#2)
model 1##4##2##(2008-10#2)(2008-8#2)
model 2##3##2##(2008-10#2)(2008-8#1)
model CA3 pyramidal cell##3##4##(2008-11#3)
model FAD##2##2##(2008-10#2)
model SC lipid##2##3##(2008-5#2)
model a##2##2##(1990-8#1)(2013-1#1)
model accounted for##2##3##(2008-10#2)
model accounts for##4##3##(2008-3#1)(2008-7#1)(2013-8#2)
model accounts##6##2##(2008-3#1)(2008-7#1)(2010-11#1)(2011-3#1)(2013-8#2)
model accurately##2##2##(2008-10#1)(2008-7#1)
model allowed##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
model allows for##2##3##(2008-8#1)(2010-7#1)
model allows##5##2##(2008-10#1)(2008-8#1)(2010-7#2)(2013-8#1)
model also##8##2##(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2012-2#1)
model analysis tools##2##3##(2013-1#2)
model analysis##5##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#2)
model analyte##2##2##(2008-10#2)
model analytes##3##2##(2008-10#3)
model and a##7##3##(1992-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
model and discuss##2##3##(1991-2#1)(2008-8#1)
model and experimental##2##3##(2008-11#1)(2011-2#1)
model and human##2##3##(2008-5#1)(2012-2#1)
model and its##2##3##(2008-3#1)(2012-2#1)
model and methods##2##3##(2008-10#1)(2010-11#1)
model and the##10##3##(1992-5#1)(1994-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#1)
model and##70##2##(1990-2#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#3)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#1)
model applied to##2##3##(2008-10#2)
model applied##4##2##(2008-10#4)
model are##10##2##(1992-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)
model as a##5##3##(2008-11#2)(2008-3#1)(2010-11#1)(2013-1#1)
model as##9##2##(1996-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-11#1)(2012-2#1)(2013-1#1)
model assessment##6##2##(1994-12#1)(2008-11#1)(2011-1#2)(2012-5#1)(2013-8#1)
model assumed##2##2##(2008-12#1)(2008-8#1)
model assumes that##4##3##(1994-5#1)(1995-12#1)(2008-8#1)(2008-9#1)
model assumptions##5##2##(1995-9#3)(2008-8#1)(2013-1#1)
model at##2##2##(1993-8#1)(2008-11#1)
model averaging##2##2##(2010-11#1)(2012-3#1)
model based on a##2##4##(2009-8#1)(2010-7#1)
model based on the##10##4##(1994-3#1)(2008-10#5)(2009-10#1)(2010-7#1)(2010-8#1)(2011-1#1)
model based on##22##3##(1994-3#1)(2008-10#10)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-1#1)
model based##23##2##(1994-3#1)(2008-10#11)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-1#1)
model because of##2##3##(2008-10#1)(2008-3#1)
model behavior##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
model best described the##2##4##(2008-10#2)
model best##3##2##(2008-10#2)(2008-9#1)
model between##3##2##(1996-2#1)(1997-4#1)(2008-5#1)
model building##3##2##(2008-10#2)(2008-11#1)
model by assuming that##2##4##(1995-9#1)(2011-2#1)
model by assuming##3##3##(1995-9#2)(2011-2#1)
model by means of##2##4##(1995-9#1)(2008-5#1)
model by##13##2##(1993-11#1)(1995-3#1)(1995-9#3)(2006-6#1)(2008-10#3)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
model calculates the##2##3##(2008-10#1)(2008-7#1)
model calculations##2##2##(1997-6#1)(2008-3#1)
model can be applied##3##4##(1996-12#1)(2008-10#2)
model can be extended to##2##5##(2008-11#1)(2008-6#1)
model can be used to##4##5##(2008-10#1)(2008-3#2)(2013-8#1)
model can be used##6##4##(2008-10#2)(2008-3#3)(2013-8#1)
model can be##19##3##(1996-12#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#2)(2009-11#1)(2013-8#2)
model can##26##2##(1996-12#1)(2008-10#7)(2008-11#3)(2008-3#6)(2008-4#1)(2008-6#2)(2009-11#1)(2009-8#1)(2010-11#1)(2013-1#1)(2013-8#2)
model compound##9##2##(1993-8#1)(1995-12#1)(1997-2#1)(2008-10#6)
model compounds##11##2##(1994-5#1)(1997-2#1)(2008-10#9)
model considered##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
model consists of##2##3##(1992-4#1)(1995-9#1)
model constructed##2##2##(2008-10#1)(2011-2#1)
model correctly##2##2##(2008-10#2)
model could be##4##3##(1995-2#1)(2008-5#2)(2011-3#1)
model could##7##2##(1995-2#1)(1996-3#1)(2008-10#1)(2008-5#2)(2008-9#1)(2011-3#1)
model derived##2##2##(2008-3#1)(2009-12#1)
model described in this unit##2##5##(2008-4#2)
model described the##2##3##(2008-10#2)
model described##5##2##(2008-10#2)(2008-11#1)(2008-4#2)
model describes the##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
model describes##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
model describing the##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
model describing##9##2##(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)
model designed to##2##3##(2008-10#1)(2008-9#1)
model designed##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
model developed for##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
model developed##9##2##(1992-3#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)
model discrimination##2##2##(2008-11#1)(2008-7#1)
model does##2##2##(1994-6#1)(2008-3#1)
model ecosystem##2##2##(2008-9#1)(2012-9#1)
model ecosystems##3##2##(2008-11#1)(2008-9#1)(2012-9#1)
model encompasses##2##2##(2010-6#1)(2010-8#1)
model enzyme##2##2##(2008-10#2)
model equation##3##2##(2008-3#1)(2008-8#1)(2009-8#1)
model equations##4##2##(2007-11#1)(2008-10#1)(2008-9#1)(2009-8#1)
model exhibited##2##2##(2008-11#1)(2013-1#1)
model explained##2##2##(1996-3#1)(2008-10#1)
model explaining##2##2##(2008-10#1)(2010-2#1)
model failed to predict##2##4##(2008-10#1)(2008-7#1)
model fits##3##2##(1997-7#1)(2008-11#1)(2008-6#1)
model fitted##2##2##(2008-3#1)(2008-5#1)
model fitting##2##2##(2008-8#2)
model for a##6##3##(1996-1#1)(2008-10#3)(2008-12#1)(2008-9#1)
model for an##2##3##(1996-3#1)(2011-2#1)
model for analyzing the##2##4##(2008-4#1)(2013-1#1)
model for assessment of##2##4##(1993-1#1)(2008-12#1)
model for chemiluminescence##2##3##(2008-10#2)
model for development##2##3##(1996-2#1)(2010-5#1)
model for disease##2##3##(2008-10#2)
model for emerging##5##3##(2010-8#5)
model for estimating##2##3##(2008-5#1)(2013-1#1)
model for evaluating##3##3##(1994-12#1)(2008-11#1)(2012-12#1)
model for evolution of male parental care and female multiple mating##2##11##(2008-8#2)
model for further##2##3##(1994-5#1)(2008-10#1)
model for gain##2##3##(2008-9#2)
model for long-term##2##3##(2008-9#1)(2011-2#1)
model for multiple sclerosis##2##4##(1995-12#1)(2010-12#1)
model for post-crash aircraft##2##4##(1996-12#2)
model for predicting the##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
model for predicting##7##3##(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)
model for rating##2##3##(2008-10#1)(2012-2#1)
model for screening##2##3##(1995-2#1)(2008-5#1)
model for studies##2##3##(1994-3#1)(1995-8#1)
model for studying the##3##4##(1990-5#1)(2008-11#1)(2012-12#1)
model for studying##6##3##(1990-5#2)(1995-2#1)(1996-12#1)(2008-11#1)(2012-12#1)
model for the assessment of##3##5##(1991-1#1)(2008-11#2)
model for the future##2##4##(1993-3#1)(2008-11#1)
model for the prediction of##2##5##(2008-10#1)(2008-7#1)
model for the solution structure of oxidized putidaredoxin##2##8##(1994-5#2)
model for the solution structure of##3##6##(1994-5#3)
model for the solution structure##4##5##(1994-5#4)
model for the study of##3##5##(2008-1#1)(2012-3#2)
model for the##54##3##(1990-5#1)(1991-1#1)(1991-7#1)(1992-1#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#6)(1995-12#2)(1995-9#1)(1996-3#2)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
model for this##5##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-6#1)(2009-3#1)
model for##271##2##(1990-11#1)(1990-5#4)(1990-8#2)(1991-1#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#12)(1995-12#6)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#4)(1996-6#2)(1997-2#3)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#4)(2008-10#53)(2008-11#14)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#13)(2008-9#8)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#15)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#7)
model formulation##3##2##(2008-10#2)(2008-8#1)
model from which##2##3##(2007-11#1)(2008-9#1)
model gave##3##2##(2008-10#2)(2008-7#1)
model genetic##2##2##(2008-8#1)(2008-9#1)
model had##2##2##(2008-10#1)(2011-2#1)
model has a##5##3##(1995-5#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
model has been developed to##2##5##(2008-10#2)
model has been developed##4##4##(2008-10#3)(2008-3#1)
model has been used to##2##5##(1990-11#1)(2008-7#1)
model has been##15##3##(1990-11#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-7#3)(2010-8#1)(2011-2#1)
model has two##2##3##(2008-10#1)(2008-6#1)
model has##33##2##(1990-11#1)(1991-11#1)(1995-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
model have##2##2##(1991-6#1)(2008-10#1)
model in the##3##3##(1994-2#1)(2008-11#1)(2008-3#1)
model in which a##2##4##(2008-10#1)(2008-8#1)
model in which the host##2##5##(2008-8#2)
model in which the##8##4##(2008-10#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-7#1)
model in which##16##3##(1994-8#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#2)(2010-7#1)
model in##35##2##(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-7#3)(2010-10#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
model included##4##2##(1992-9#1)(2008-10#1)(2008-11#1)(2009-7#1)
model includes##6##2##(1992-12#1)(1993-8#1)(1996-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
model including##4##2##(2008-3#1)(2008-7#2)(2011-2#1)
model incorporating##6##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2013-8#1)
model involving##2##2##(1990-11#1)(2008-11#1)
model is a##7##3##(1994-8#1)(1995-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-8#1)
model is able to##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
model is applied to##3##4##(2008-11#1)(2008-3#1)(2013-8#1)
model is based on the assumption##2##6##(2008-10#2)
model is based on the##5##5##(2008-10#3)(2008-11#1)(2013-1#1)
model is based on##10##4##(1997-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2013-1#1)
model is consistent with##2##4##(2008-8#1)(2010-10#1)
model is constructed##2##3##(1995-9#1)(2011-2#1)
model is demonstrated##2##3##(2008-6#1)(2009-9#1)
model is developed for##3##4##(1993-12#1)(2008-10#1)(2008-9#1)
model is developed##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
model is intended##2##3##(2008-10#1)(2010-8#1)
model is particularly##2##3##(2008-10#1)(2008-9#1)
model is presented##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)
model is proposed for##2##4##(1996-2#1)(2008-10#1)
model is proposed##6##3##(1995-1#1)(1996-2#1)(2008-10#2)(2008-8#1)(2012-3#1)
model is robust##2##3##(2008-4#1)(2008-8#1)
model is that##3##3##(1995-1#1)(2008-10#1)(2008-7#1)
model is then##2##3##(2008-7#1)(2008-9#1)
model is used to predict##2##5##(2008-11#1)(2008-6#1)
model is used to##12##4##(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2013-8#1)
model is used##14##3##(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2013-8#1)
model is##117##2##(1993-12#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-9#3)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#10)(2008-2#1)(2008-3#12)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#9)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-8#3)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#5)
model it is##2##3##(1995-12#1)(2008-11#1)
model it##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
model lipid##4##2##(2008-10#1)(2008-5#3)
model make it##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
model makes the##2##3##(2008-8#1)(2013-8#1)
model makes##5##2##(2008-8#3)(2008-9#1)(2013-8#1)
model may be##5##3##(2008-10#3)(2008-7#1)(2010-2#1)
model may##11##2##(1991-2#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#1)
model membrane##2##2##(1994-5#1)(2008-10#1)
model membranes##5##2##(2008-10#3)(2009-7#1)(2012-2#1)
model monocot##2##2##(2008-10#1)(2013-8#1)
model must##2##2##(1997-3#1)(2010-6#1)
model of HA##2##3##(2008-10#1)(2011-2#1)
model of Parkinson's disease##2##4##(2008-12#1)(2013-7#1)
model of a red blood cell##2##6##(2013-1#2)
model of a##12##3##(1991-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
model of an##3##3##(1993-8#1)(2008-11#1)(2011-2#1)
model of assessment##2##3##(2008-11#2)
model of atherosclerosis##3##3##(1993-6#1)(2008-11#1)(2008-6#1)
model of chronic##3##3##(2008-4#1)(2009-6#1)(2011-2#1)
model of cutaneous candidosis##2##4##(2008-5#2)
model of degenerative disc disease##2##5##(2012-3#2)
model of epilepsy##2##3##(1994-2#2)
model of heart failure##3##4##(2010-6#3)
model of human##9##3##(1992-12#1)(1992-3#1)(1995-2#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)
model of invasive##2##3##(2013-8#2)
model of leptospirosis##2##3##(2008-9#2)
model of neural##3##3##(2008-11#2)(2010-1#1)
model of resource##2##3##(1995-2#1)(2008-8#1)
model of sex chromosome evolution##2##5##(2010-5#2)
model of social##2##3##(2010-2#1)(2012-3#1)
model of support##2##3##(1992-3#1)(1994-3#1)
model of the NPC##3##4##(2011-2#3)
model of the effects of##2##5##(1992-1#1)(2008-10#1)
model of the##48##3##(1990-8#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#1)(1993-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-5#1)(2009-7#1)(2010-10#2)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#1)
model of this##2##3##(2008-10#1)(2008-7#1)
model of ulcerative##2##3##(2008-12#2)
model of visual##2##3##(2008-11#2)
model of##309##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#3)(1992-3#2)(1992-4#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-1#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#4)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-6#2)(2008-1#1)(2008-10#31)(2008-11#37)(2008-12#8)(2008-3#2)(2008-4#12)(2008-5#8)(2008-6#5)(2008-7#12)(2008-8#28)(2008-9#17)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#5)(2010-2#2)(2010-5#4)(2010-6#5)(2010-8#3)(2011-2#13)(2011-3#1)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#14)
model on the##3##3##(1994-2#1)(2008-10#2)
model on##4##2##(1994-2#1)(2008-10#2)(2008-8#1)
model only##2##2##(2008-10#1)(2013-1#1)
model or##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
model organism for studying##2##4##(2011-2#2)
model organism to##2##3##(2008-11#1)(2009-9#1)
model organism##7##2##(2008-11#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#2)
model organisms for##2##3##(2008-10#1)(2008-8#1)
model organisms##7##2##(2008-10#1)(2008-8#3)(2008-9#1)(2009-6#1)(2012-2#1)
model outputs##3##2##(2008-10#1)(2013-1#2)
model parameter##5##2##(2008-10#3)(2008-2#1)(2013-8#1)
model parameters##16##2##(2008-10#6)(2008-2#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
model performance was##2##3##(2008-10#1)(2009-7#1)
model performance##3##2##(2008-10#1)(2009-7#2)
model permitted the##2##3##(1990-12#1)(2008-10#1)
model plant##6##2##(1996-12#1)(2008-10#1)(2008-9#2)(2009-8#1)(2011-2#1)
model predicted a##2##3##(2008-7#1)(2008-9#1)
model predicted that the optimal offspring size##2##7##(2008-8#2)
model predicted that##4##3##(2008-7#1)(2008-8#3)
model predicted the##2##3##(2008-10#1)(2008-7#1)
model predicted##10##2##(2008-10#2)(2008-7#4)(2008-8#3)(2008-9#1)
model prediction##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
model predictions were less##2##4##(2008-8#1)(2009-7#1)
model predictions were##3##3##(2008-10#1)(2008-8#1)(2009-7#1)
model predictions##11##2##(2008-10#4)(2008-11#1)(2008-8#3)(2008-9#1)(2009-7#1)(2013-8#1)
model predictive performance##2##3##(2008-7#2)
model predictive##3##2##(2008-7#2)(2013-1#1)
model predicts a##4##3##(2008-10#2)(2008-5#1)(2008-8#1)
model predicts that##10##3##(2008-10#1)(2008-7#1)(2008-8#6)(2008-9#1)(2011-2#1)
model predicts##19##2##(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#9)(2008-9#2)(2010-7#1)(2011-2#1)(2013-8#1)
model presented##2##2##(2008-10#1)(2008-11#1)
model protein##4##2##(1997-8#2)(2008-10#1)(2008-11#1)
model provided the##2##3##(2008-10#2)
model provided##3##2##(2008-10#2)(2008-11#1)
model provides a##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
model provides an##3##3##(1995-9#1)(2008-10#1)(2008-3#1)
model provides##9##2##(1995-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
model quality##2##2##(1997-1#1)(2008-10#1)
model ranged from##2##3##(2008-10#2)
model rats with##2##3##(2008-8#1)(2013-8#1)
model rats##5##2##(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
model reaction##2##2##(2008-10#1)(2008-7#1)
model recombination and repair intermediates##2##5##(1994-9#2)
model relative##2##2##(2008-10#2)
model represents##2##2##(2008-10#1)(2008-9#1)
model requires##3##2##(1996-2#1)(2008-10#2)
model results##6##2##(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)
model revealed a##2##3##(2008-10#1)(2008-11#1)
model revealed##3##2##(2008-10#1)(2008-11#1)(2009-3#1)
model rural hospitals##3##3##(1993-12#3)
model sample##3##2##(2008-10#3)
model selected##2##2##(2008-10#2)
model selection##4##2##(2008-10#1)(2008-4#1)(2009-12#1)(2011-2#1)
model should##3##2##(2008-11#2)(2008-8#1)
model showed that##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
model showed##4##2##(1992-9#1)(2008-10#1)(2008-8#1)(2012-12#1)
model showing##2##2##(1992-12#1)(2008-9#1)
model shows that the##2##4##(2008-8#2)
model shows that##9##3##(2008-11#3)(2008-8#5)(2008-9#1)
model shows##10##2##(2008-11#3)(2008-8#6)(2008-9#1)
model simulates##3##2##(2008-10#2)(2013-8#1)
model simulation##3##2##(2008-7#3)
model simulations##2##2##(2008-3#2)
model solution##2##2##(2008-10#1)(2008-7#1)
model solutions##4##2##(2008-10#4)
model species##4##2##(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#1)
model states that##2##3##(1997-1#1)(2008-8#1)
model structure##3##2##(1992-2#1)(2008-8#2)
model studies##2##2##(1995-6#1)(2008-7#1)
model study##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
model substrate##4##2##(2008-10#3)(2008-4#1)
model suggests a##2##3##(1991-9#1)(2007-12#1)
model suggests that##7##3##(1992-4#1)(1995-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
model suggests##10##2##(1991-9#1)(1992-4#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
model system for studying##2##4##(2008-10#1)(2009-8#1)
model system for the##3##4##(2008-9#1)(2011-1#1)(2012-3#1)
model system for##11##3##(1992-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-3#2)
model system in##2##3##(1997-3#1)(2008-9#1)
model system to study##5##4##(1995-9#1)(1996-3#1)(2008-10#1)(2008-11#2)
model system to##9##3##(1995-9#1)(1996-3#1)(2008-10#3)(2008-11#2)(2009-8#1)(2013-1#1)
model system##56##2##(1992-6#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(2007-12#2)(2008-10#20)(2008-11#10)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#2)(2010-1#1)(2011-1#2)(2012-12#1)(2012-3#3)(2013-1#2)
model systems for##2##3##(2008-10#1)(2008-9#1)
model systems using##2##3##(2008-10#1)(2008-7#1)
model systems with##2##3##(1997-6#1)(2008-10#1)
model systems##18##2##(1993-8#1)(1996-12#1)(1997-6#3)(2008-10#5)(2008-11#4)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
model that accounts for##2##4##(1992-9#1)(2008-3#1)
model that allows##2##3##(2008-12#1)(2008-8#1)
model that can be##2##4##(2008-11#1)(2008-3#1)
model that describes the##2##4##(2008-10#1)(2008-8#1)
model that describes##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
model that has##2##3##(2008-3#1)(2008-8#1)
model that includes##3##3##(1994-1#1)(2008-8#1)(2010-10#1)
model that incorporates the##2##4##(2008-11#1)(2008-7#1)
model that incorporates##4##3##(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
model that may##2##3##(2008-10#1)(2009-8#1)
model that predicts##4##3##(2008-11#1)(2008-2#1)(2008-8#2)
model that simulates the##2##4##(2008-10#2)
model that uses##4##3##(1997-2#1)(2008-3#1)(2008-8#2)
model that utilizes##2##3##(1996-3#1)(2010-8#1)
model that was##3##3##(2008-10#3)
model that##60##2##(1990-8#1)(1991-3#1)(1992-9#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#13)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
model the##30##2##(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
model therefore##2##2##(2013-1#2)
model this##2##2##(2008-11#1)(2008-3#1)
model to a set of##2##5##(2008-10#1)(2013-8#1)
model to a##3##3##(2008-10#1)(2009-11#1)(2013-8#1)
model to analyze the##2##4##(1997-1#1)(2012-2#1)
model to analyze##3##3##(1997-1#1)(2008-10#1)(2012-2#1)
model to assess the##2##4##(2008-5#1)(2008-8#1)
model to describe the##3##4##(1991-11#1)(1992-9#1)(2008-10#1)
model to describe##6##3##(1991-11#1)(1992-9#1)(2008-10#2)(2008-7#2)
model to estimate the##2##4##(2008-3#1)(2008-7#1)
model to estimate##3##3##(1993-12#1)(2008-3#1)(2008-7#1)
model to explain the##2##4##(2012-3#1)(2013-1#1)
model to explain##3##3##(2009-5#1)(2012-3#1)(2013-1#1)
model to guide##2##3##(1993-12#1)(2008-10#1)
model to include##3##3##(1992-3#1)(2008-11#1)(2009-7#1)
model to investigate##2##3##(2008-10#1)(2008-8#1)
model to link##2##3##(2008-10#1)(2012-3#1)
model to predict the##5##4##(2008-10#1)(2008-3#2)(2010-8#1)(2011-2#1)
model to predict##9##3##(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)
model to provide a##2##4##(2008-3#2)
model to show##2##3##(2008-8#2)
model to simulate##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
model to study the##4##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
model to study##6##3##(1994-5#1)(2008-10#3)(2008-11#1)(2008-8#1)
model to the##4##3##(1991-1#1)(2008-2#1)(2011-2#1)(2012-3#1)
model to understand##2##3##(1995-12#1)(2011-10#1)
model to##102##2##(1990-8#1)(1991-1#1)(1991-11#1)(1992-3#2)(1992-9#1)(1993-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-1#1)(2008-10#24)(2008-11#3)(2008-2#2)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#4)(2009-11#2)(2009-5#1)(2009-7#2)(2010-4#1)(2010-8#3)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#3)
model under##2##2##(2008-10#1)(2013-1#1)
model used to##2##3##(2008-11#1)(2012-2#1)
model used##6##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
model uses##2##2##(1996-12#1)(2010-8#1)
model using the##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
model using##19##2##(1994-5#1)(1995-5#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-3#1)
model was able to##2##4##(2008-10#2)
model was also##4##3##(1995-8#1)(2008-10#2)(2008-7#1)
model was applied to##3##4##(2008-10#2)(2011-3#1)
model was constructed##2##3##(2008-12#1)(2010-8#1)
model was developed and##2##4##(2008-10#2)
model was developed for##2##4##(2008-10#1)(2008-3#1)
model was developed in##3##4##(2008-10#2)(2008-11#1)
model was developed to##8##4##(1992-2#1)(2008-10#6)(2008-9#1)
model was developed##20##3##(1992-2#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
model was employed to##2##4##(2008-10#1)(2013-8#1)
model was found to##2##4##(2008-5#1)(2013-8#1)
model was tested against##2##4##(2008-10#2)
model was tested in the##2##5##(2008-10#1)(2008-7#1)
model was tested##4##3##(2008-10#3)(2008-7#1)
model was used for##4##4##(2008-10#2)(2008-7#1)(2012-12#1)
model was used to construct a##2##6##(2008-10#2)
model was used to##12##4##(1991-2#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
model was used##18##3##(1991-2#1)(1995-2#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
model was validated##4##3##(2008-10#3)(2008-11#1)
model was##97##2##(1991-2#1)(1992-2#1)(1992-3#1)(1995-2#2)(1995-8#1)(1995-9#1)(2006-6#1)(2008-10#48)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#10)(2008-8#2)(2008-9#3)(2009-3#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
model we##4##2##(1992-9#1)(1995-5#1)(2009-12#1)(2011-3#1)
model well##2##2##(2008-11#1)(2011-2#1)
model were used##2##3##(2008-10#1)(2013-1#1)
model were##8##2##(2008-10#6)(2011-2#1)(2013-1#1)
model when##4##2##(2008-10#2)(2008-8#2)
model where##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2009-8#1)
model which could##2##3##(2008-10#1)(2010-8#1)
model which##14##2##(1992-4#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-5#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
model will be##3##3##(1995-2#1)(2008-11#1)(2010-8#1)
model will##5##2##(1992-12#1)(1995-2#1)(2008-11#1)(2010-8#1)(2013-8#1)
model with a##6##3##(2008-10#3)(2008-7#1)(2011-3#1)(2013-8#1)
model with three##2##3##(2008-10#1)(2008-9#1)
model with two##2##3##(2008-10#2)
model with##36##2##(1995-9#1)(1996-2#1)(1996-3#1)(2008-10#12)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-1#2)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#5)
model without##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
model##2728##1##(1990-11#3)(1990-12#9)(1990-2#1)(1990-5#5)(1990-8#7)(1991-1#7)(1991-11#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#8)(1991-6#2)(1991-7#1)(1991-9#5)(1992-1#8)(1992-10#2)(1992-11#2)(1992-12#11)(1992-2#5)(1992-3#10)(1992-4#6)(1992-5#5)(1992-6#1)(1992-8#1)(1992-9#14)(1993-1#6)(1993-11#2)(1993-12#13)(1993-2#5)(1993-3#3)(1993-5#2)(1993-6#1)(1993-8#14)(1994-1#3)(1994-11#1)(1994-12#7)(1994-2#9)(1994-3#7)(1994-5#25)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#5)(1995-11#2)(1995-12#17)(1995-2#25)(1995-3#5)(1995-5#7)(1995-6#3)(1995-8#3)(1995-9#23)(1996-1#6)(1996-12#22)(1996-2#17)(1996-3#19)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#7)(1997-2#16)(1997-3#11)(1997-4#3)(1997-6#9)(1997-7#3)(1997-8#5)(2006-6#4)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#7)(2008-10#659)(2008-11#203)(2008-12#43)(2008-2#13)(2008-3#103)(2008-4#54)(2008-5#70)(2008-6#27)(2008-7#118)(2008-8#228)(2008-9#116)(2009-1#1)(2009-10#11)(2009-11#8)(2009-12#10)(2009-2#2)(2009-3#12)(2009-4#3)(2009-5#6)(2009-6#5)(2009-7#26)(2009-8#28)(2009-9#4)(2010-1#7)(2010-10#12)(2010-11#13)(2010-12#4)(2010-2#7)(2010-3#1)(2010-4#9)(2010-5#11)(2010-6#13)(2010-7#11)(2010-8#45)(2011-1#10)(2011-10#1)(2011-2#86)(2011-3#16)(2012-12#14)(2012-2#40)(2012-3#42)(2012-4#4)(2012-5#1)(2012-9#2)(2013-1#75)(2013-7#3)(2013-8#89)
model'##3##1##(1992-9#1)(2008-11#1)(2008-9#1)
model's##7##1##(2008-11#1)(2008-8#2)(2010-8#1)(2011-3#1)(2013-8#2)
model)##11##1##(1995-11#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#2)(2013-8#3)
model-based##7##1##(2008-10#2)(2008-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
model]##2##1##(2011-3#1)(2012-3#1)
modeled and##2##2##(2010-5#1)(2011-2#1)
modeled as a function of##2##5##(2008-10#2)
modeled as a##7##3##(2008-10#3)(2008-3#1)(2008-8#1)(2010-3#1)(2013-1#1)
modeled as##8##2##(2008-10#3)(2008-3#2)(2008-8#1)(2010-3#1)(2013-1#1)
modeled by##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2009-8#1)
modeled using##2##2##(2008-10#2)
modeled with a##2##3##(2008-10#2)
modeled with##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
modeled##41##1##(1993-1#1)(1994-5#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-3#8)(2008-8#4)(2008-9#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#4)
modeling and experimental uncertainty##2##4##(2008-7#2)
modeling and the##2##3##(1997-3#1)(2011-2#1)
modeling and##15##2##(1997-3#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#1)
modeling applications##2##2##(2008-10#1)(2009-11#1)
modeling approach was##2##3##(2008-10#1)(2013-8#1)
modeling approach##11##2##(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2013-1#1)(2013-8#3)
modeling approaches to##2##3##(2012-2#1)(2013-8#1)
modeling approaches were##2##3##(2008-10#2)
modeling approaches##6##2##(1994-5#1)(2008-10#2)(2012-2#1)(2013-8#2)
modeling as##2##2##(1991-2#1)(2008-10#1)
modeling for the##2##3##(2008-10#1)(2008-2#1)
modeling framework##2##2##(2009-12#1)(2012-2#1)
modeling in##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
modeling is##3##2##(1997-3#1)(2008-10#2)
modeling methods##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
modeling motion fields##2##3##(2008-10#2)
modeling of nucleic##4##3##(2008-4#4)
modeling of spectral data##2##4##(2008-10#2)
modeling of such systems##2##4##(1997-6#1)(2009-8#1)
modeling of the##2##3##(2008-3#1)(2009-10#1)
modeling of##35##2##(1993-9#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-4#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2011-2#4)(2012-2#1)(2013-8#3)
modeling on##2##2##(2008-12#1)(2010-9#1)
modeling results##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
modeling revealed that the##2##4##(2008-10#1)(2008-12#1)
modeling revealed that##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
modeling studies##3##2##(1994-5#2)(2012-2#1)
modeling techniques##4##2##(2008-10#1)(2008-4#2)(2008-8#1)
modeling the##12##2##(1990-2#1)(2008-10#3)(2008-11#1)(2008-3#3)(2009-7#1)(2013-1#2)(2013-8#1)
modeling to##5##2##(2008-10#2)(2008-3#1)(2012-2#2)
modeling was used to##2##4##(1994-5#1)(2010-6#1)
modeling was##4##2##(1994-5#1)(2008-4#1)(2009-7#1)(2010-6#1)
modeling with##2##2##(2008-10#1)(2008-12#1)
modeling##211##1##(1990-2#2)(1990-8#1)(1991-2#1)(1992-4#1)(1993-9#1)(1994-3#1)(1994-5#5)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#4)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#50)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#17)(2008-4#12)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#2)(2009-4#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-6#1)(2010-9#2)(2011-2#8)(2012-2#9)(2012-3#1)(2013-1#9)(2013-8#14)
modeling)##2##1##(1992-4#1)(2008-10#1)
modelled by##2##2##(2008-10#2)
modelled the##2##2##(1992-9#1)(2008-11#1)
modelled using##4##2##(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
modelled with##2##2##(2008-10#2)
modelled##13##1##(1992-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2010-4#1)(2010-6#1)(2011-2#1)
modelling and##6##2##(2008-10#1)(2008-11#3)(2008-8#1)(2011-3#1)
modelling as##2##2##(2007-12#1)(2012-3#1)
modelling has been##2##3##(2008-7#1)(2008-8#1)
modelling in##2##2##(2008-10#1)(2008-12#1)
modelling of the##5##3##(2008-10#2)(2011-1#1)(2012-2#1)(2013-1#1)
modelling of##21##2##(1994-8#1)(1995-12#1)(2008-10#8)(2008-11#2)(2008-7#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
modelling studies##2##2##(1994-11#1)(1995-11#1)
modelling the##5##2##(1992-9#1)(1993-9#1)(2008-10#1)(2008-12#1)(2010-11#1)
modelling was##2##2##(2008-10#1)(2010-10#1)
modelling##76##1##(1992-9#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#23)(2008-11#7)(2008-12#6)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#1)(2009-7#3)(2010-10#5)(2010-11#2)(2011-1#2)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
modelof##2##1##(2008-11#2)
models and numerical simulations##2##4##(2008-10#2)
models and treatment##2##3##(1992-1#1)(2011-2#1)
models and##44##2##(1992-1#2)(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-5#1)(1995-9#1)(1997-1#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
models are built##2##3##(1993-12#1)(2008-10#1)
models are discussed##2##3##(1994-3#1)(2008-9#1)
models are estimated##2##3##(1995-3#1)(2011-2#1)
models are presented##2##3##(1993-1#1)(2008-8#1)
models are required##2##3##(2008-7#1)(2013-1#1)
models are suitable for##2##4##(2008-10#1)(2008-11#1)
models are used to##4##4##(2008-7#2)(2008-8#1)(2009-12#1)
models are##51##2##(1991-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-3#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
models as##5##2##(2008-11#1)(2008-2#1)(2008-9#1)(2010-6#1)(2012-2#1)
models assume##2##2##(2008-8#2)
models based on##8##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-8#1)
models based##10##2##(1992-9#1)(1993-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-8#1)
models because##2##2##(2008-8#1)(2011-2#1)
models by##7##2##(1997-1#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-9#1)
models can be used to##3##5##(2008-10#1)(2008-7#1)(2012-2#1)
models can be##7##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
models can##12##2##(1997-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
models cannot explain##2##3##(2010-10#1)(2012-2#1)
models cannot##3##2##(2008-8#1)(2010-10#1)(2012-2#1)
models correctly classified##3##3##(2008-10#3)
models dealing with##2##3##(2008-9#2)
models did not##2##3##(2008-12#1)(2008-8#1)
models do not##2##3##(2009-7#1)(2010-10#1)
models estimated##2##2##(2008-10#1)(2012-3#1)
models explained##3##2##(2008-10#2)(2010-8#1)
models for studying thyroid biology and disorders##2##7##(2012-3#2)
models for studying##3##3##(2012-3#3)
models for the development of##2##5##(2008-1#1)(2008-4#1)
models for the study of##3##5##(2008-11#1)(2008-9#1)(2010-6#1)
models for the##22##3##(1991-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-6#1)(2013-8#1)
models for these##2##3##(1991-1#1)(1996-3#1)
models for wheat##2##3##(2008-10#2)
models for##78##2##(1991-1#1)(1991-9#1)(1993-1#1)(1993-8#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)(2012-4#2)(2013-1#1)(2013-8#2)
models from##7##2##(2008-6#1)(2008-9#1)(2009-11#2)(2010-10#1)(2011-2#2)
models gave##2##2##(2008-10#1)(2008-12#1)
models generated by##2##3##(2008-11#1)(2012-2#1)
models had##4##2##(2008-10#2)(2008-11#1)(2009-7#1)
models has##4##2##(2008-10#2)(2010-1#1)(2012-2#1)
models have been created##2##4##(2010-6#2)
models have been used to##2##5##(2008-10#1)(2008-9#1)
models have been used##3##4##(2008-10#2)(2008-9#1)
models have been##11##3##(1990-5#1)(1992-11#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-6#2)(2013-1#1)
models have potential##2##3##(2008-10#1)(2008-5#1)
models have shown that##3##4##(2008-8#1)(2009-10#1)(2013-7#1)
models have##24##2##(1990-5#1)(1992-11#1)(1996-3#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#1)(2010-6#2)(2013-1#1)(2013-7#1)
models in health##2##3##(1996-3#1)(2008-11#1)
models in the##7##3##(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
models in which the##2##4##(2008-5#1)(2010-1#1)
models in which##7##3##(1994-12#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-1#2)
models in##30##2##(1992-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#1)(2008-10#3)(2008-11#6)(2008-5#2)(2008-7#1)(2008-8#3)(2009-8#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
models included##2##2##(2008-8#1)(2010-1#1)
models indicate that##2##3##(2008-10#1)(2008-11#1)
models is to##2##3##(2008-11#2)
models is##10##2##(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2013-1#1)
models make##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
models may##4##2##(1993-12#1)(2008-8#1)(2008-9#1)(2010-7#1)
models of ALS##2##3##(2008-4#2)
models of adaptive##2##3##(2008-8#2)
models of cancer##2##3##(2008-11#1)(2013-8#1)
models of competition##2##3##(2008-8#1)(2008-9#1)
models of human disease##2##4##(2008-11#1)(2008-9#1)
models of human##6##3##(2008-11#2)(2008-12#1)(2008-9#1)(2009-8#1)(2010-8#1)
models of infection##4##3##(2008-7#4)
models of interacting phenotypes##2##4##(2008-8#2)
models of natural enemies##2##4##(2008-8#2)
models of permanent##2##3##(2008-4#1)(2011-2#1)
models of social phobia##2##4##(2008-4#2)
models of social##3##3##(2008-4#2)(2012-3#1)
models of stem cell##3##4##(2008-11#2)(2013-8#1)
models of the evolution of##2##5##(2008-8#2)
models of the##16##3##(1991-12#1)(1992-5#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#4)(2009-1#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
models of##165##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-6#1)(1997-2#3)(2007-12#1)(2008-10#17)(2008-11#14)(2008-12#5)(2008-3#1)(2008-4#10)(2008-5#4)(2008-7#7)(2008-8#24)(2008-9#13)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#1)(2013-8#2)
models on##2##2##(1991-12#1)(2008-12#1)
models or##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)
models predict that##6##3##(2008-10#1)(2008-8#3)(2008-9#2)
models predict##10##2##(1990-12#1)(1997-1#2)(2008-10#1)(2008-8#4)(2008-9#2)
models predicting##2##2##(2008-11#1)(2013-1#1)
models presented##2##2##(2009-3#1)(2013-8#1)
models provide##3##2##(2008-8#1)(2008-9#1)(2010-10#1)
models requires##2##2##(2008-11#1)(2008-5#1)
models should be##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
models should##5##2##(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
models show that##2##3##(2008-8#1)(2012-3#1)
models such as##6##3##(1992-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)
models suggest that the##2##4##(1995-12#1)(2008-8#1)
models suggest that##4##3##(1995-12#1)(2008-8#3)
models suggest##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#4)
models that allow for##2##4##(1994-9#1)(2008-2#1)
models that allow##3##3##(1994-9#1)(2008-2#1)(2010-11#1)
models that are##3##3##(2008-6#1)(2008-8#1)(2011-2#1)
models that incorporate##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
models that recapitulate##2##3##(2012-2#1)(2013-1#1)
models that##32##2##(1994-9#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#4)(2008-9#3)(2009-5#2)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
models the##2##2##(2008-9#1)(2012-2#1)
models to determine##2##3##(2008-7#1)(2008-9#1)
models to estimate##2##3##(2008-10#1)(2012-8#1)
models to evaluate the##2##4##(2008-8#1)(2008-9#1)
models to explore##2##3##(2008-8#2)
models to improve##2##3##(2008-11#2)
models to predict the##2##4##(2008-10#2)
models to predict##3##3##(2008-10#3)
models to study the##3##4##(1991-5#1)(2008-11#1)(2008-9#1)
models to study##6##3##(1991-5#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-7#1)
models to##52##2##(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1997-1#1)(2007-12#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#8)(2008-9#7)(2009-10#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#3)(2012-8#1)
models used##3##2##(2008-10#2)(2012-2#1)
models using a##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
models using##6##2##(2008-10#4)(2008-6#1)(2008-8#1)
models was##4##2##(2008-10#1)(2008-3#1)(2008-5#2)
models were built##2##3##(2008-10#2)
models were designed to##2##4##(2008-5#1)(2009-8#1)
models were developed to##3##4##(1994-9#1)(2008-10#1)(2010-4#1)
models were developed##7##3##(1994-9#1)(2008-10#4)(2010-4#1)(2011-2#1)
models were estimated##2##3##(1993-3#1)(2013-1#1)
models were evaluated by##2##4##(2008-10#2)
models were fit to##2##4##(2008-10#1)(2013-1#1)
models were obtained##3##3##(2008-10#2)(2011-3#1)
models were used for##2##4##(2008-10#2)
models were used in##2##4##(2009-2#1)(2011-3#1)
models were used to analyze##2##5##(2008-12#1)(2013-1#1)
models were used to##11##4##(2008-10#3)(2008-12#2)(2008-5#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-1#2)
models were used##16##3##(1995-9#1)(2008-10#5)(2008-12#2)(2008-5#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-3#1)(2012-2#1)(2013-1#2)
models were validated##2##3##(2008-10#2)
models were##63##2##(1991-2#1)(1993-3#1)(1994-9#2)(1995-9#1)(2008-10#34)(2008-11#1)(2008-12#3)(2008-5#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#4)
models when##2##2##(1995-5#1)(2008-8#1)
models which##5##2##(1991-12#1)(1992-9#1)(2009-8#1)(2011-2#2)
models will##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
models with a##2##3##(1993-1#1)(2008-5#1)
models with##15##2##(1993-1#1)(1996-3#1)(2006-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-4#1)(2011-2#1)
models would##2##2##(2008-10#1)(2008-8#1)
models##1119##1##(1990-12#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-12#6)(1991-2#3)(1991-5#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-9#10)(1993-1#3)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#3)(1993-8#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#6)(1994-9#7)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#3)(1995-5#8)(1995-6#1)(1995-8#2)(1995-9#5)(1996-1#2)(1996-11#2)(1996-12#3)(1996-3#9)(1996-6#2)(1997-1#10)(1997-2#5)(1997-3#2)(1997-5#1)(1997-7#2)(2006-6#2)(2007-12#2)(2008-1#4)(2008-10#228)(2008-11#76)(2008-12#26)(2008-2#8)(2008-3#15)(2008-4#38)(2008-5#29)(2008-6#6)(2008-7#33)(2008-8#113)(2008-9#70)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#4)(2009-5#7)(2009-6#5)(2009-7#11)(2009-8#15)(2009-9#1)(2010-1#12)(2010-10#17)(2010-11#6)(2010-12#6)(2010-2#3)(2010-4#5)(2010-5#7)(2010-6#10)(2010-7#13)(2010-8#6)(2010-9#3)(2011-1#1)(2011-2#44)(2011-3#5)(2011-9#1)(2012-12#5)(2012-2#30)(2012-3#19)(2012-4#8)(2012-8#1)(2013-1#30)(2013-7#1)(2013-8#22)
models)##6##1##(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-8#1)
modem##3##1##(1991-12#1)(2008-8#1)(2008-9#1)
moderate GI##2##2##(2008-1#2)
moderate agreement##2##2##(2008-3#1)(2008-5#1)
moderate and severe airways obstruction##3##5##(2008-7#3)
moderate and severe##6##3##(2008-7#3)(2011-2#3)
moderate and##16##2##(1990-12#1)(1991-2#1)(1992-2#1)(1993-8#1)(2008-10#2)(2008-7#3)(2008-8#1)(2010-12#1)(2011-2#4)(2013-1#1)
moderate carrier pressure##2##3##(2008-10#2)
moderate expression##2##2##(1996-12#2)
moderate for##2##2##(2008-10#1)(2012-5#1)
moderate growth##2##2##(1994-3#1)(2010-6#1)
moderate hypothermia##2##2##(2010-1#1)(2011-2#1)
moderate intake of alcohol##2##4##(2008-10#2)
moderate level of##4##3##(2008-10#1)(2008-11#1)(2010-6#1)(2013-1#1)
moderate level##5##2##(2008-10#2)(2008-11#1)(2010-6#1)(2013-1#1)
moderate levels of##10##3##(1990-3#1)(2008-10#5)(2008-8#2)(2008-9#1)(2013-8#1)
moderate or severe hypothermia##3##4##(2011-2#3)
moderate or severe##9##3##(1990-3#1)(2008-11#4)(2010-11#1)(2011-2#3)
moderate or vigorous physical activity##4##5##(2010-11#4)
moderate or##19##2##(1990-3#1)(1993-8#1)(1994-2#1)(1996-12#1)(2008-11#4)(2009-4#1)(2010-1#2)(2010-11#5)(2011-2#3)
moderate relationship##2##2##(1991-2#2)
moderate resistance to##3##3##(2008-10#3)
moderate resistance##4##2##(2008-10#4)
moderate size##3##2##(2008-10#1)(2008-3#2)
moderate the##5##2##(2008-10#1)(2009-11#1)(2009-7#3)
moderate to high##3##3##(2008-10#2)(2010-10#1)
moderate to severe ACR##2##4##(2008-10#2)
moderate to severe##7##3##(2008-10#3)(2008-6#1)(2008-7#1)(2010-7#1)(2013-1#1)
moderate to##15##2##(1994-5#1)(1994-9#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-7#1)(2013-1#1)
moderate weight##2##2##(2012-3#1)(2013-8#1)
moderate##211##1##(1990-12#1)(1990-3#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-5#1)(1992-12#2)(1992-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#5)(2007-11#1)(2008-1#2)(2008-10#51)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#4)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#11)(2012-12#3)(2012-2#2)(2012-3#2)(2012-5#5)(2013-1#11)(2013-8#3)
moderate-severe##3##1##(2012-12#1)(2013-1#2)
moderate-sized##2##1##(2008-10#1)(2008-3#1)
moderate-to-high##2##1##(1992-12#1)(1995-2#1)
moderate-to-severe##2##1##(2010-5#1)(2013-1#1)
moderated the##2##2##(2010-1#1)(2012-2#1)
moderated##10##1##(2008-6#1)(2009-11#2)(2009-7#1)(2010-1#2)(2010-2#2)(2012-2#1)(2013-1#1)
moderately alkaline##2##2##(2008-10#2)
moderately and##2##2##(1995-2#1)(2010-12#1)
moderately differentiated##2##2##(2008-10#2)
moderately high##5##2##(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)
moderately in##2##2##(2008-8#1)(2011-10#1)
moderately or##2##2##(2008-10#1)(2013-1#1)
moderately resistant cultivars##2##3##(2008-10#2)
moderately resistant##15##2##(2008-10#15)
moderately severe##3##2##(1994-9#1)(1997-3#1)(2007-12#1)
moderately susceptible##3##2##(2008-10#3)
moderately##74##1##(1990-2#1)(1990-8#2)(1991-6#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#37)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-4#2)(2011-10#1)(2011-2#4)(2013-1#1)
moderating effect of##2##3##(2010-10#1)(2010-7#1)
moderating effects##2##2##(1996-2#2)
moderating role##2##2##(1996-2#1)(2008-12#1)
moderating##10##1##(1996-2#3)(2008-12#2)(2008-6#1)(2010-1#2)(2010-10#1)(2010-7#1)
moderation##2##1##(2011-2#2)
moderator##4##1##(2008-6#1)(2009-11#1)(2010-1#2)
moderators of##3##2##(1995-12#1)(2008-12#1)(2013-1#1)
moderators##5##1##(1995-12#1)(2008-12#1)(2009-11#1)(2012-2#1)(2013-1#1)
modern analytical##3##2##(2008-10#2)(2010-7#1)
modern and##5##2##(1990-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2012-9#1)
modern animals##2##2##(2010-4#2)
modern biology##2##2##(1993-6#1)(2012-3#1)
modern clinical##2##2##(1994-12#1)(2012-2#1)
modern clothes##2##2##(2011-1#2)
modern cochlear implant##2##3##(2008-9#2)
modern diagnostic##3##2##(1992-9#1)(1997-5#1)(2011-2#1)
modern environment##2##2##(2008-10#1)(2008-5#1)
modern examinations##2##2##(2011-3#2)
modern forensic psychiatry##2##3##(2011-2#2)
modern health##2##2##(2008-1#2)
modern human##2##2##(1994-3#1)(2008-8#1)
modern humans##5##2##(1994-3#2)(2008-8#1)(2010-5#2)
modern medical##4##2##(2008-10#2)(2013-1#2)
modern medicine##6##2##(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
modern mental health##2##3##(2008-11#2)
modern molecular##2##2##(2008-5#1)(2013-1#1)
modern state##2##2##(2008-11#1)(2011-2#1)
modern techniques##3##2##(2008-10#2)(2008-7#1)
modern technology##2##2##(2008-10#1)(2010-7#1)
modern total knee designs##2##4##(2008-8#2)
modern##157##1##(1990-11#1)(1990-2#1)(1990-6#3)(1991-2#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#6)(1994-5#1)(1995-3#2)(1995-5#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#24)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#3)(2010-5#5)(2010-7#4)(2011-1#2)(2011-2#10)(2011-3#4)(2012-12#2)(2012-2#7)(2012-3#4)(2012-9#4)(2013-1#9)(2013-8#2)
modernisation##2##1##(2008-11#1)(2011-2#1)
modes and##4##2##(1996-1#1)(2007-11#1)(2008-3#2)
modes are discussed##2##3##(2008-10#1)(2008-4#1)
modes are##8##2##(1992-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
modes at##3##2##(2008-3#3)
modes for the##2##3##(1994-5#1)(2008-10#1)
modes for##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
modes in##9##2##(1992-8#1)(2008-10#1)(2008-2#3)(2008-3#3)(2011-2#1)
modes is##2##2##(2008-10#1)(2008-5#1)
modes observed##2##2##(1992-8#1)(2007-12#1)
modes of action of##2##4##(2008-10#2)
modes of action##9##3##(1995-2#1)(2008-10#5)(2008-11#3)
modes of selection##2##3##(2008-4#1)(2012-3#1)
modes of the##3##3##(2007-12#1)(2008-10#1)(2010-7#1)
modes of##49##2##(1992-3#1)(1995-2#1)(1996-2#2)(2007-12#1)(2008-10#12)(2008-11#8)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#4)(2009-10#4)(2009-12#1)(2009-8#1)(2010-11#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
modes that##2##2##(2008-3#1)(2008-9#1)
modes to##2##2##(2008-3#1)(2009-3#1)
modes were classified##2##3##(2013-1#2)
modes were##4##2##(2007-11#1)(2008-10#1)(2013-1#2)
modes with##2##2##(2007-12#1)(2008-3#1)
modes##168##1##(1992-1#1)(1992-3#2)(1992-8#2)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#2)(2007-11#7)(2007-12#5)(2008-10#44)(2008-11#10)(2008-2#5)(2008-3#33)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#11)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-7#5)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#3)
modes)##2##1##(2007-11#1)(2008-10#1)
modest but significant##2##3##(2008-10#1)(2009-7#1)
modest but##4##2##(2008-10#1)(2009-7#1)(2010-12#1)(2011-2#1)
modest efficacy and##2##3##(2011-2#1)(2013-1#1)
modest hypothermia##3##2##(2008-9#3)
modest increases##2##2##(1997-3#1)(2008-11#1)
modest to##2##2##(1992-12#1)(2010-3#1)
modest##51##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1997-3#2)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#5)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
modestly hypoglycemic piglets##2##3##(1994-2#2)
modestly##6##1##(1991-12#1)(1992-3#1)(1993-12#1)(1994-2#2)(2010-12#1)
modifiable risk factors##4##3##(2008-1#2)(2011-2#1)(2012-2#1)
modifiable##7##1##(2008-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
modification and##8##2##(1991-12#2)(1995-6#1)(2008-10#3)(2008-4#1)(2011-2#1)
modification are##5##2##(1992-3#1)(2008-10#3)(2008-5#1)
modification as##2##2##(1993-3#1)(2013-1#1)
modification at the##2##3##(1994-5#1)(2009-8#1)
modification at##4##2##(1990-5#1)(1992-3#1)(1994-5#1)(2009-8#1)
modification by##8##2##(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#2)(2008-10#2)(2009-8#1)
modification consists of##2##3##(2008-3#1)(2013-1#1)
modification for##4##2##(1991-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
modification in the##5##3##(2008-10#4)(2009-8#1)
modification in##8##2##(1991-3#1)(2008-10#5)(2008-9#1)(2009-8#1)
modification is not##2##3##(1990-8#1)(1991-12#1)
modification is##5##2##(1990-8#1)(1991-12#1)(1997-7#1)(2008-10#1)(2008-11#1)
modification may##2##2##(2008-10#1)(2009-10#1)
modification method##2##2##(2008-10#2)
modification of HLA##2##3##(2008-10#2)
modification of LDL##4##3##(1991-5#1)(2008-10#2)(2009-8#1)
modification of a##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
modification of cell##2##3##(2008-11#1)(2008-9#1)
modification of our##2##3##(2008-10#1)(2011-2#1)
modification of proteins##2##3##(1992-6#1)(2008-11#1)
modification of risk factors may##2##5##(2012-3#1)(2013-1#1)
modification of the method of##2##5##(1993-8#1)(2008-10#1)
modification of the method##3##4##(1993-8#1)(2008-10#1)(2008-11#1)
modification of the original##2##4##(1994-8#1)(2008-10#1)
modification of the surface##2##4##(2008-10#2)
modification of the##46##3##(1992-2#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-8#1)(1995-3#1)(1997-1#1)(2008-10#19)(2008-11#6)(2008-5#1)(2008-7#6)(2008-9#1)(2009-8#1)(2010-7#1)(2012-2#3)
modification of this##2##3##(2008-10#1)(2008-4#1)
modification of##127##2##(1990-2#1)(1990-5#1)(1991-5#4)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#3)(1993-12#2)(1993-6#3)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#2)(2008-10#41)(2008-11#11)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#3)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
modification procedure##2##2##(2008-10#2)
modification process##3##2##(2008-10#3)
modification to be##2##3##(1993-8#1)(2008-9#1)
modification to the##2##3##(1992-12#1)(2011-7#1)
modification to##7##2##(1992-12#1)(1993-8#1)(2008-8#1)(2008-9#1)(2011-3#1)(2011-7#1)(2013-1#1)
modification was##3##2##(1991-2#1)(2008-10#2)
modification with##4##2##(1990-5#1)(2008-10#3)
modification##262##1##(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#2)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#4)(1992-12#1)(1992-2#1)(1992-3#6)(1992-6#2)(1992-9#3)(1993-12#3)(1993-3#3)(1993-6#5)(1993-8#3)(1994-11#5)(1994-2#1)(1994-5#2)(1994-8#2)(1995-3#1)(1995-6#2)(1996-11#2)(1996-12#2)(1996-6#1)(1997-1#2)(1997-7#1)(1997-9#1)(2008-10#90)(2008-11#15)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#8)(2009-10#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#8)(2010-1#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#4)(2011-3#2)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#3)
modification)##2##1##(2008-10#2)
modifications and##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
modifications are##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
modifications have been##2##3##(1997-4#1)(1997-8#1)
modifications have##3##2##(1997-4#1)(1997-8#1)(2013-1#1)
modifications in the##7##3##(1990-8#2)(1992-6#1)(1995-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
modifications in##19##2##(1990-8#3)(1991-2#1)(1991-5#1)(1992-6#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#2)(2009-9#1)(2011-9#1)(2013-1#2)
modifications include##2##2##(1997-8#1)(2008-11#1)
modifications is##2##2##(2008-10#1)(2009-5#1)
modifications observed##2##2##(1996-12#1)(2008-7#1)
modifications of birch##2##3##(2008-11#2)
modifications of the##13##3##(1991-12#2)(1992-3#1)(1994-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-8#1)(2013-8#1)
modifications of##26##2##(1991-12#2)(1992-3#1)(1992-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(2008-10#7)(2008-11#4)(2008-7#1)(2009-8#4)(2011-2#1)(2013-1#1)(2013-8#1)
modifications on the##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
modifications on##5##2##(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-8#1)
modifications or##2##2##(2008-11#1)(2013-1#1)
modifications that##2##2##(2008-11#1)(2012-2#1)
modifications to the##3##3##(1996-1#1)(2008-10#2)
modifications to##6##2##(1991-12#1)(1996-1#1)(2008-10#3)(2008-12#1)
modifications were##2##2##(2009-10#1)(2009-8#1)
modifications##125##1##(1990-8#3)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#3)(1993-12#1)(1994-8#2)(1995-12#1)(1996-1#1)(1996-12#3)(1996-2#1)(1997-4#1)(1997-8#2)(2008-10#25)(2008-11#16)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#3)(2009-8#10)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-9#1)(2012-2#2)(2013-1#7)(2013-8#3)
modified American Orthopaedic Foot and Ankle Society##2##7##(2009-10#2)
modified CBH I##2##3##(1993-8#2)
modified CCE prepared##2##3##(2008-10#2)
modified CCEs##2##2##(2008-10#2)
modified CHO##2##2##(2008-11#2)
modified DNA##4##2##(1991-5#2)(2008-10#1)(2008-4#1)
modified GCE##3##2##(2008-10#3)
modified Gran I method##2##4##(2008-10#2)
modified HA##2##2##(2008-10#2)
modified NEECHAM##2##2##(2010-10#2)
modified PLGA particles##4##3##(2009-7#4)
modified PQC##3##2##(2008-10#3)
modified Quad procedure in##2##4##(2013-1#2)
modified Quad procedure##4##3##(2013-1#4)
modified Quad##5##2##(2013-1#5)
modified Rankin Scale##3##3##(2012-3#3)
modified Ziehl-Neelsen##2##2##(1996-12#1)(2012-12#1)
modified after##2##2##(1994-3#1)(2008-10#1)
modified amperometric##2##2##(2008-10#2)
modified and unmodified##4##3##(1995-12#1)(2008-10#3)
modified and##9##2##(1995-12#1)(2008-10#8)
modified approach##2##2##(2008-3#1)(2008-8#1)
modified as##2##2##(1991-2#1)(2011-2#1)
modified at##3##2##(1992-3#1)(1996-6#1)(2008-10#1)
modified by Gregor et al##2##5##(2008-10#2)
modified by a recently synthesized##3##5##(2008-10#3)
modified by a##9##3##(1997-2#1)(2008-10#8)
modified by one##2##3##(2008-5#1)(2009-5#1)
modified by the##6##3##(2008-10#4)(2008-8#1)(2008-9#1)
modified by##78##2##(1990-5#1)(1991-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#46)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#3)(2010-10#1)(2011-2#1)
modified cDNA RDA##2##3##(2008-9#2)
modified cam clay##2##3##(2009-7#2)
modified carbon ceramic electrode##3##4##(2008-10#3)
modified carbon electrodes##2##3##(2008-10#2)
modified carbon fiber##3##3##(2008-10#3)
modified carbon paste electrode for determination of##2##7##(2008-10#2)
modified carbon paste electrode for the determination of##2##8##(2008-10#2)
modified carbon paste electrode for##6##5##(2008-10#6)
modified carbon paste electrode has been developed##2##7##(2008-10#2)
modified carbon paste electrode in##2##5##(2008-10#2)
modified carbon paste electrode was##4##5##(2008-10#4)
modified carbon paste electrode##28##4##(2008-10#28)
modified carbon##42##2##(2008-10#41)(2009-3#1)
modified cellulose##2##2##(2008-10#1)(2008-7#1)
modified ceria-zirconia##2##2##(2008-10#2)
modified cyclodextrins##2##2##(2008-10#2)
modified either with##2##3##(2008-10#2)
modified electrode and its application##2##5##(2008-10#2)
modified electrode and##4##3##(2008-10#4)
modified electrode as##2##3##(2008-10#2)
modified electrode by##3##3##(2008-10#3)
modified electrode can be used##4##5##(2008-10#4)
modified electrode can##5##3##(2008-10#5)
modified electrode exhibited##2##3##(2008-10#2)
modified electrode exhibits a##2##4##(2008-10#2)
modified electrode exhibits##4##3##(2008-10#4)
modified electrode for the determination of##2##6##(2008-10#2)
modified electrode for the##3##4##(2008-10#3)
modified electrode for##4##3##(2008-10#4)
modified electrode has been##3##4##(2008-10#3)
modified electrode in##4##3##(2008-10#4)
modified electrode is##2##3##(2008-10#2)
modified electrode showed an##2##4##(2008-10#2)
modified electrode showed##6##3##(2008-10#6)
modified electrode was prepared##2##4##(2008-10#2)
modified electrode was studied##2##4##(2008-10#2)
modified electrode was##16##3##(2008-10#16)
modified electrode were studied##2##4##(2008-10#2)
modified electrode were##4##3##(2008-10#4)
modified electrode with a##2##4##(2008-10#2)
modified electrode##109##2##(2008-10#109)
modified electrodes are##2##3##(2008-10#2)
modified electrodes exhibited good##2##4##(2008-10#2)
modified electrodes for##2##3##(2008-10#1)(2010-6#1)
modified electrodes have been##2##4##(2008-10#2)
modified electrodes were##3##3##(2008-10#3)
modified electrodes##34##2##(2008-10#33)(2010-6#1)
modified enzyme##4##2##(1993-6#1)(2008-10#3)
modified films were##2##3##(2008-10#2)
modified for##2##2##(2009-10#1)(2010-8#1)
modified glassy carbon electrode##11##4##(2008-10#11)
modified glassy carbon##13##3##(2008-10#13)
modified gold electrode##8##3##(2008-10#8)
modified gold electrodes##4##3##(2008-10#4)
modified gold##15##2##(2008-10#15)
modified in patients with##2##4##(1991-2#1)(2008-7#1)
modified in##6##2##(1991-2#1)(1992-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
modified low-density##2##2##(1993-8#2)
modified matrixes##2##2##(2008-10#2)
modified method of##3##3##(1996-3#1)(2008-11#1)(2013-1#1)
modified method##6##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
modified microwave##2##2##(2008-10#2)
modified nucleotides##4##2##(2008-4#3)(2008-8#1)
modified oligodeoxynucleotides##3##2##(2008-4#3)
modified oligonucleotides##2##2##(2008-10#1)(2008-11#1)
modified or not by##2##4##(2008-10#1)(2008-5#1)
modified or##6##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)
modified proteins##3##2##(2008-10#1)(2008-4#1)(2009-5#1)
modified radical mastectomy##3##3##(1994-12#2)(2008-10#1)
modified radical##6##2##(1992-9#1)(1994-12#2)(2008-10#1)(2008-9#2)
modified residues##3##2##(2008-4#2)(2011-1#1)
modified resin##8##2##(2008-10#8)
modified screen-printed carbon electrode##2##4##(2008-10#2)
modified screen-printed carbon##4##3##(2008-10#4)
modified screen-printed##6##2##(2008-10#6)
modified sensor##2##2##(2008-10#2)
modified sensors##2##2##(2008-10#2)
modified silica gel##9##3##(2008-10#9)
modified silica##14##2##(2008-10#14)
modified silicon##2##2##(2008-10#1)(2008-7#1)
modified simplex algorithm##2##3##(2008-10#2)
modified simplex method##4##3##(2008-10#4)
modified simplex##9##2##(2008-10#9)
modified surface##3##2##(2008-10#3)
modified surgical##2##2##(2008-7#1)(2008-9#1)
modified technique##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
modified the##10##2##(1995-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-7#2)(2010-6#2)
modified to 0##2##3##(2008-10#2)
modified to minimize the##2##4##(2008-8#1)(2008-9#1)
modified to represent the##2##4##(2008-10#1)(2008-9#1)
modified to work##2##3##(1997-6#1)(2008-10#1)
modified to##23##2##(1994-3#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)
modified trichromic Gomori stain##2##4##(1990-3#2)
modified version of the##6##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-4#1)
modified version of##8##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2009-10#1)(2009-4#1)
modified with 10% methanol##2##4##(2008-10#2)
modified with 8-hydroxy quinoline##2##4##(2008-10#2)
modified with Co(3+)-TCPP##2##3##(2008-10#2)
modified with Prussian##2##3##(2008-10#2)
modified with a##17##3##(2008-10#15)(2009-5#1)(2013-1#1)
modified with acetonitrile##2##3##(2008-10#2)
modified with manganese##2##3##(2008-10#2)
modified with molecular sieves##2##4##(2008-10#2)
modified with niobium(V) oxide (Nb(2)O(5)-SiO(2))##2##5##(2008-10#2)
modified with single layer##2##4##(2008-10#2)
modified with the self-assembled##2##4##(2008-10#2)
modified with the##3##3##(1997-2#1)(2008-10#2)
modified with##125##2##(1997-2#1)(2008-10#120)(2009-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
modified zirconia##3##2##(2008-10#3)
modified##954##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#6)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#2)(1993-1#2)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#5)(1994-11#2)(1994-12#2)(1994-3#5)(1994-5#1)(1994-8#3)(1994-9#1)(1995-12#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#638)(2008-11#23)(2008-12#8)(2008-2#4)(2008-3#15)(2008-4#20)(2008-5#15)(2008-7#12)(2008-8#14)(2008-9#22)(2009-10#7)(2009-3#4)(2009-4#2)(2009-5#6)(2009-7#13)(2009-9#1)(2010-10#4)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#4)(2011-2#11)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#18)(2013-8#3)
modifier and its##2##3##(2008-10#2)
modifier and##15##2##(2008-10#15)
modifier concentration##6##2##(2008-10#6)
modifier content##2##2##(2008-10#2)
modifier for the determination of##3##5##(2008-10#3)
modifier for the##6##3##(2008-10#6)
modifier for##10##2##(2008-10#10)
modifier in the case of##2##5##(2008-10#2)
modifier in the##4##3##(2008-10#4)
modifier in##7##2##(2008-10#7)
modifier is##3##2##(1997-2#1)(2008-10#2)
modifier mixture was found to be preferable for the determination of##2##11##(2008-10#2)
modifier mixture##4##2##(2008-10#4)
modifier of##2##2##(2008-10#1)(2009-7#1)
modifier to##3##2##(2008-10#3)
modifier use##2##2##(2008-10#2)
modifier was added##2##3##(2008-10#2)
modifier was used for##2##4##(2008-10#2)
modifier was##11##2##(2008-10#11)
modifier were##3##2##(2008-10#3)
modifier##160##1##(1991-12#1)(1997-2#2)(1997-4#1)(2008-10#151)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#2)
modifier)##4##1##(2008-10#3)(2009-7#1)
modifiers and##3##2##(2008-10#2)(2010-1#1)
modifiers are##2##2##(1991-3#1)(2008-10#1)
modifiers for the##2##3##(2008-10#2)
modifiers for##9##2##(2008-10#8)(2008-5#1)
modifiers in the determination of##2##5##(2008-10#2)
modifiers in the##4##3##(2008-10#4)
modifiers in##8##2##(2008-10#7)(2010-12#1)
modifiers of##3##2##(1991-3#1)(2008-11#1)(2012-3#1)
modifiers were##3##2##(2008-10#3)
modifiers##64##1##(1991-3#2)(2008-10#54)(2008-11#1)(2008-5#1)(2010-1#2)(2010-12#1)(2012-3#2)(2013-1#1)
modifies its##2##2##(2008-3#1)(2009-11#1)
modifies the##4##2##(2007-12#1)(2008-5#1)(2009-8#1)(2012-2#1)
modifies##10##1##(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2012-2#1)
modify a##3##2##(2008-10#1)(2008-11#2)
modify its##2##2##(2009-8#1)(2011-2#1)
modify the natural##2##3##(1990-6#1)(2013-7#1)
modify the##30##2##(1990-6#2)(1991-12#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-3#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2011-10#2)(2011-2#4)(2012-12#1)(2013-7#1)
modify your##2##2##(1993-12#1)(1995-2#1)
modify##67##1##(1990-6#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#2)(2009-8#2)(2011-1#1)(2011-10#2)(2011-2#6)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
modifying its##2##2##(1993-12#1)(2008-10#1)
modifying the##10##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)
modifying##32##1##(1990-6#1)(1991-3#1)(1992-2#1)(1993-12#1)(1995-12#1)(1997-2#1)(2008-10#10)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
modular##15##1##(1991-9#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-11#4)(2008-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
modularity##4##1##(2008-11#1)(2008-8#1)(2012-3#2)
modulate cell function##2##3##(2008-11#2)
modulate cell##4##2##(1995-8#1)(1996-2#1)(2008-11#2)
modulate cellular##3##2##(2008-7#1)(2010-1#1)(2011-2#1)
modulate enzyme##2##2##(1994-8#1)(2008-5#1)
modulate neuronal##2##2##(2008-5#1)(2008-7#1)
modulate the degree##2##3##(1997-2#1)(2008-11#1)
modulate the expression of key##2##5##(2008-10#1)(2008-4#1)
modulate the expression of the##2##5##(2008-5#1)(2013-1#1)
modulate the expression of##6##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
modulate the release of##2##4##(1997-4#2)
modulate the##32##2##(1993-8#1)(1994-11#2)(1994-5#1)(1997-2#1)(1997-4#2)(2006-6#1)(2007-12#2)(2008-10#4)(2008-11#9)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2013-1#1)(2013-7#1)
modulate their##2##2##(1997-7#1)(2008-10#1)
modulate##79##1##(1990-11#1)(1990-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-6#1)(2007-12#2)(2008-10#6)(2008-11#15)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#5)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
modulated at the##2##3##(1992-10#1)(2008-10#1)
modulated at##4##2##(1992-10#1)(1996-2#1)(2008-10#1)(2008-3#1)
modulated by a##3##3##(1995-2#1)(2008-3#1)(2008-5#1)
modulated by the##8##3##(1994-8#1)(1996-11#1)(2008-10#1)(2008-11#4)(2010-12#1)
modulated by##36##2##(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#5)
modulated the expression of##2##4##(1991-5#1)(2008-10#1)
modulated the##5##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
modulated##81##1##(1990-5#1)(1991-5#1)(1992-10#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#5)(2007-12#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-3#6)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#6)
modulates the function of##2##4##(1997-4#1)(2008-10#1)
modulates the##10##2##(1991-1#1)(1993-8#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#1)(2009-8#1)(2013-1#1)
modulates##44##1##(1991-1#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-4#2)(2008-10#7)(2008-11#4)(2008-7#3)(2009-6#1)(2009-8#2)(2010-10#1)(2010-6#1)(2012-2#2)(2013-1#3)(2013-8#2)
modulating activity of##2##3##(2008-11#1)(2009-10#1)
modulating the activity##2##3##(1994-6#1)(2009-10#1)
modulating the##18##2##(1990-12#1)(1992-1#1)(1994-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
modulating##49##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-1#1)(1993-12#1)(1994-6#3)(1995-12#1)(1996-12#1)(1997-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#3)(2008-9#1)(2009-10#5)(2009-6#1)(2009-8#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#2)
modulation amplitude##3##2##(2008-3#3)
modulation and of##2##3##(2008-5#1)(2013-1#1)
modulation and the##2##3##(2008-3#1)(2008-5#1)
modulation and##11##2##(1997-2#2)(2007-12#1)(2008-3#4)(2008-5#2)(2008-9#1)(2013-1#1)
modulation by different##2##3##(1990-3#1)(2008-5#1)
modulation by spermine##2##3##(1990-3#1)(1991-5#1)
modulation by##10##2##(1990-11#1)(1990-3#2)(1991-5#1)(1993-2#2)(1996-12#1)(2008-5#1)(2008-8#1)(2013-8#1)
modulation depth##3##2##(2008-2#2)(2008-3#1)
modulation frequency##2##2##(2007-11#1)(2008-10#1)
modulation has##2##2##(2008-3#2)
modulation in the##3##3##(1993-12#1)(2008-3#1)(2009-5#1)
modulation in##9##2##(1993-12#1)(1994-9#1)(2007-11#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-5#1)
modulation is##3##2##(2008-3#1)(2009-8#1)(2013-8#1)
modulation of Ca2+##2##3##(1994-6#1)(1995-11#1)
modulation of apoptosis##2##3##(1995-2#1)(2009-3#1)
modulation of cell##2##3##(2008-11#1)(2008-5#1)
modulation of cytoskeleton assembly-disassembly##2##4##(1993-6#2)
modulation of human breast cancer cell growth##2##7##(2008-11#2)
modulation of human##3##3##(1994-3#1)(2008-11#2)
modulation of synaptic##2##3##(1990-9#1)(2008-5#1)
modulation of the##15##3##(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2013-8#2)
modulation of this##2##3##(1993-6#1)(2008-11#1)
modulation of##95##2##(1990-12#1)(1990-3#1)(1990-9#1)(1992-2#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1994-3#5)(1994-5#2)(1994-6#5)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-3#4)(2008-5#5)(2008-7#6)(2009-3#3)(2009-8#3)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#7)
modulation skewing effect in white-light vertical scanning interferometry##2##8##(2008-3#2)
modulation spectroscopy##4##2##(2008-3#4)
modulation technique##6##2##(2008-2#2)(2008-3#3)(2013-8#1)
modulation transfer function##3##3##(2008-3#3)
modulation was##4##2##(2007-11#1)(2008-11#1)(2013-8#2)
modulation##213##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-9#1)(1991-5#1)(1992-2#2)(1992-6#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#4)(1994-3#5)(1994-5#2)(1994-6#5)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#1)(2007-11#7)(2007-12#7)(2008-10#19)(2008-11#13)(2008-2#6)(2008-3#42)(2008-5#10)(2008-7#6)(2008-8#1)(2008-9#2)(2009-3#3)(2009-5#2)(2009-7#1)(2009-8#6)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#19)
modulations##4##1##(1994-8#1)(2007-11#1)(2008-3#1)(2009-5#1)
modulator in##3##2##(1990-2#1)(2008-3#2)
modulator of the##2##3##(1995-12#1)(2011-2#1)
modulator of##6##2##(1990-12#1)(1992-6#1)(1995-12#1)(2008-10#1)(2009-8#1)(2011-2#1)
modulator##18##1##(1990-12#1)(1990-2#1)(1992-6#1)(1995-12#1)(2008-10#2)(2008-2#2)(2008-3#6)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
modulators of##5##2##(2008-11#1)(2008-5#2)(2009-3#1)(2013-8#1)
modulators##16##1##(1992-9#1)(1996-11#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#4)(2009-10#1)(2009-3#1)(2013-8#1)
modulatory effect of##4##3##(1993-3#1)(1995-11#1)(2008-8#1)(2013-8#1)
modulatory effect on##2##3##(1992-7#1)(2008-7#1)
modulatory effect##6##2##(1992-7#1)(1993-3#1)(1995-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
modulatory effects of##2##3##(2008-12#1)(2008-7#1)
modulatory mechanisms##2##2##(2009-12#1)(2013-8#1)
modulatory role##2##2##(1996-2#1)(2008-5#1)
modulatory systems##2##2##(2009-12#2)
modulatory##24##1##(1990-2#1)(1992-7#1)(1993-3#1)(1993-6#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#6)(2011-2#1)(2012-2#1)(2013-8#2)
module and##2##2##(2008-11#2)
module can##2##2##(2009-8#1)(2012-3#1)
module for##2##2##(2008-10#2)
module in##3##2##(2008-11#2)(2012-3#1)
module is##7##2##(2008-11#1)(2008-12#2)(2008-3#1)(2009-8#3)
module of study##3##3##(2008-11#3)
module on##2##2##(1996-1#1)(2008-12#1)
module system##2##2##(2013-1#2)
module##67##1##(1993-8#1)(1996-1#4)(2008-10#11)(2008-11#20)(2008-12#5)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#3)(2009-11#1)(2009-8#5)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
modules for##2##2##(2008-9#1)(2012-3#1)
modules in##4##2##(1994-5#1)(1997-6#1)(2008-3#1)(2008-6#1)
modules of##2##2##(2008-11#2)
modules that##3##2##(2008-3#1)(2011-2#1)(2012-3#1)
modules to##2##2##(2008-6#1)(2008-9#1)
modules were##2##2##(2008-11#1)(2008-12#1)
modules##29##1##(1994-5#1)(1997-6#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#4)(2008-6#2)(2008-9#5)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#5)
moduli of##2##2##(2009-7#2)
moduli##3##1##(2009-7#3)
modulus and##6##2##(2008-10#1)(2009-11#1)(2009-7#2)(2010-10#1)(2013-1#1)
modulus at##2##2##(2009-7#2)
modulus in##3##2##(2008-10#1)(2009-7#2)
modulus increases##2##2##(2009-7#1)(2011-3#1)
modulus of the##4##3##(2009-7#3)(2010-4#1)
modulus of##8##2##(2009-7#5)(2010-4#2)(2010-8#1)
modulus##56##1##(2008-10#3)(2008-5#6)(2008-9#2)(2009-11#1)(2009-5#2)(2009-7#25)(2010-10#3)(2010-4#5)(2010-8#2)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)
modulus)##2##1##(2009-7#2)
mofetil##4##1##(2010-12#1)(2011-2#1)(2012-3#2)
moieties are##2##2##(1990-5#1)(2009-8#1)
moieties in##2##2##(2008-10#2)
moieties of the##2##3##(1993-8#1)(1994-8#1)
moieties of##4##2##(1993-8#2)(1994-8#1)(1996-12#1)
moieties with##2##2##(1995-3#1)(2008-10#1)
moieties##36##1##(1990-5#2)(1993-8#2)(1994-8#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)
moiety at##2##2##(1991-5#1)(2008-11#1)
moiety for##2##2##(1995-5#1)(2008-10#1)
moiety in the##2##3##(1995-11#1)(2008-10#1)
moiety in##3##2##(1995-11#1)(2008-10#2)
moiety is attached to##2##4##(2008-10#2)
moiety is##7##2##(1993-8#1)(1996-5#1)(2008-10#3)(2008-4#1)(2012-2#1)
moiety of the##7##3##(1991-5#1)(1994-8#1)(2008-10#4)(2011-2#1)
moiety of##21##2##(1991-12#2)(1991-5#1)(1994-8#1)(1995-11#1)(1997-6#1)(2008-10#7)(2008-11#6)(2011-2#1)(2013-1#1)
moiety on the##3##3##(1996-5#1)(2008-10#2)
moiety was##4##2##(1992-10#1)(1995-12#1)(2008-10#2)
moiety with##3##2##(1994-8#1)(2008-10#1)(2008-4#1)
moiety##76##1##(1991-12#3)(1991-5#2)(1992-10#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-5#2)(1995-6#1)(1996-5#4)(1997-2#1)(1997-6#1)(2006-6#1)(2008-10#34)(2008-11#8)(2008-4#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
moiré fringes in Talbot interferometry are##2##6##(2008-3#2)
moiré fringes##4##2##(2008-3#4)
moist incubation##3##2##(2008-10#3)
moist##18##1##(1994-12#1)(2008-10#17)
moistened##2##1##(1992-1#1)(2008-10#1)
moisture and temperature##6##3##(2008-10#5)(2008-12#1)
moisture and##16##2##(2008-10#10)(2008-12#1)(2008-5#2)(2008-9#1)(2010-4#1)(2012-7#1)
moisture content and##3##3##(2008-12#1)(2009-7#1)(2012-7#1)
moisture content##12##2##(1997-2#1)(2008-10#2)(2008-12#2)(2009-7#1)(2010-4#3)(2012-2#1)(2012-7#2)
moisture contents##3##2##(2008-10#2)(2012-2#1)
moisture deficit stress##2##3##(2008-10#2)
moisture during the##2##3##(2008-10#2)
moisture in the##2##3##(2008-10#2)
moisture in##6##2##(2008-10#5)(2008-5#1)
moisture is##2##2##(1996-2#1)(2008-10#1)
moisture occurrence##3##2##(2008-10#3)
moisture on##4##2##(2008-10#4)
moisture regime##2##2##(2008-10#1)(2011-1#1)
moisture sensor##2##2##(2008-10#2)
moisture##102##1##(1992-2#2)(1995-3#1)(1996-2#2)(1996-5#1)(1997-2#1)(2008-10#70)(2008-12#3)(2008-2#2)(2008-5#4)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#6)(2010-7#1)(2011-1#1)(2012-2#2)(2012-7#3)
moisture)##2##1##(2008-10#1)(2012-3#1)
moisture-sensitive##2##1##(2008-10#2)
moistures##2##1##(1997-2#1)(2008-10#1)
moisturisation and elasticity are##2##4##(2008-5#2)
moisturisation and elasticity##3##3##(2008-5#3)
moisturisation and##4##2##(2008-5#4)
moisturisation##8##1##(2008-5#8)
moisturization##10##1##(2008-5#10)
moisturizer##6##1##(2008-10#1)(2008-5#5)
moisturizing cream##2##2##(2008-5#2)
moisturizing efficacy and##2##3##(2008-5#2)
moisturizing##10##1##(2008-5#10)
mojavensis##6##1##(2008-8#3)(2008-9#3)
mol %##3##2##(1994-5#2)(2010-4#1)
mol 1(-1) with##2##3##(2008-10#2)
mol 1(-1)##11##2##(2008-10#11)
mol L(-1)##4##2##(2008-10#4)
mol dm(-3) NH(4)NO(3)##2##3##(2008-10#2)
mol dm(-3) and##2##3##(2008-10#2)
mol dm(-3) in##2##3##(2008-10#2)
mol dm(-3) of##6##3##(2008-10#6)
mol dm(-3) sulphuric acid##3##4##(2008-10#3)
mol dm(-3) with##3##3##(2008-10#3)
mol dm(-3)##52##2##(2008-10#52)
mol dm(-3)) and##2##3##(2008-10#2)
mol dm(-3))##8##2##(2008-10#8)
mol g(-1)##2##2##(2008-10#2)
mol kg(-1)##6##2##(2008-10#6)
mol l(-1) (Cd(2+))##2##3##(2008-10#2)
mol l(-1) (N=11)##2##3##(2008-10#2)
mol l(-1) (Pb(2+)) and##2##4##(2008-10#2)
mol l(-1) H(2)SO(4)##3##3##(2008-10#3)
mol l(-1) HCl and##2##4##(2008-10#2)
mol l(-1) HCl were##2##4##(2008-10#2)
mol l(-1) HCl##18##3##(2008-10#18)
mol l(-1) HNO(3)##6##3##(2008-10#6)
mol l(-1) NaCl##6##3##(2008-10#6)
mol l(-1) NaOH solution##3##4##(2008-10#3)
mol l(-1) NaOH##7##3##(2008-10#7)
mol l(-1) UO(2)(2+) with##2##4##(2008-10#2)
mol l(-1) ammonium##3##3##(2008-10#3)
mol l(-1) and the detection##2##5##(2008-10#2)
mol l(-1) and the relative standard deviation##2##7##(2008-10#2)
mol l(-1) and the##7##4##(2008-10#7)
mol l(-1) and##16##3##(2008-10#16)
mol l(-1) ascorbic acid##2##4##(2008-10#2)
mol l(-1) at pH##2##4##(2008-10#2)
mol l(-1) at##4##3##(2008-10#4)
mol l(-1) carminic acid##2##4##(2008-10#2)
mol l(-1) citric acid##2##4##(2008-10#2)
mol l(-1) cobalt(II)##2##3##(2008-10#2)
mol l(-1) concentration range##3##4##(2008-10#3)
mol l(-1) for 3 min##2##5##(2008-10#2)
mol l(-1) for the##2##4##(2008-10#2)
mol l(-1) for##20##3##(2008-10#20)
mol l(-1) fosfestrol##2##3##(2008-10#2)
mol l(-1) hydrochloric acid##4##4##(2008-10#4)
mol l(-1) hydrochloric##5##3##(2008-10#5)
mol l(-1) hydrogen peroxide##2##4##(2008-10#2)
mol l(-1) in##4##3##(2008-10#4)
mol l(-1) nitric acid##2##4##(2008-10#2)
mol l(-1) of ascorbic acid##2##5##(2008-10#2)
mol l(-1) of##12##3##(2008-10#12)
mol l(-1) permanganate##2##3##(2008-10#2)
mol l(-1) phosphate buffer##4##4##(2008-10#4)
mol l(-1) phosphoric acid##2##4##(2008-10#2)
mol l(-1) recovery##2##3##(2008-10#2)
mol l(-1) sodium fluoride##2##4##(2008-10#2)
mol l(-1) sodium hydroxide##2##4##(2008-10#2)
mol l(-1) sodium##5##3##(2008-10#5)
mol l(-1) sulfuric acid##4##4##(2008-10#4)
mol l(-1) with a detection limit of 1##4##8##(2008-10#4)
mol l(-1) with a detection limit of##5##7##(2008-10#5)
mol l(-1) with a##8##4##(2008-10#8)
mol l(-1) with the detection limit of##2##7##(2008-10#2)
mol l(-1) with the detection limit##3##6##(2008-10#3)
mol l(-1) with the##5##4##(2008-10#5)
mol l(-1) with##15##3##(2008-10#15)
mol l(-1)##314##2##(2008-10#314)
mol l(-1)) and##4##3##(2008-10#4)
mol l(-1)) with##2##3##(2008-10#2)
mol l(-1))##19##2##(2008-10#19)
mol l(-3)##2##2##(2008-10#2)
mol of zinc per##3##4##(1994-5#3)
mol of##17##2##(1990-10#4)(1990-2#2)(1991-5#3)(1994-5#6)(2008-10#2)
mol ratio of##2##3##(2008-10#2)
mol##468##1##(1990-10#5)(1990-12#3)(1990-2#2)(1991-12#1)(1991-5#3)(1993-8#4)(1994-5#8)(2008-10#439)(2008-9#2)(2010-4#1)
mol%)##6##1##(1992-12#2)(2008-10#4)
mol(-1) * L * s(-1)##2##5##(2008-9#2)
mol(-1) *##3##2##(2008-8#1)(2008-9#2)
mol(-1) at##4##2##(2008-10#4)
mol(-1) cm(-1) and 0##3##4##(2008-10#3)
mol(-1) cm(-1) and##13##3##(2008-10#13)
mol(-1) cm(-1) at##13##3##(2008-10#13)
mol(-1) cm(-1)##50##2##(2008-10#50)
mol(-1) cm(-1))##4##2##(2008-10#4)
mol(-1) dm(3) and##2##3##(2008-10#2)
mol(-1) dm(3)##3##2##(2008-10#3)
mol(-1) dm(3))##2##2##(2008-10#2)
mol(-1) respectively##2##2##(2008-10#2)
mol(-1)##107##1##(2008-10#101)(2008-5#2)(2008-8#1)(2008-9#3)
mol(-1))##4##1##(2008-10#2)(2011-1#2)
mol(-1)cm(-1)##3##1##(2008-10#3)
mol(-1)cm(-1))##2##1##(2008-10#2)
mol(-2) dm(6)##2##2##(2008-10#2)
mol(-2)##3##1##(2008-10#3)
mol(t-1)##2##1##(2008-9#2)
mol/L##7##1##(2008-10#3)(2008-8#2)(2008-9#2)
mol/l (0##3##2##(2008-10#3)
mol/l and##3##2##(2008-10#1)(2011-2#2)
mol/l for##3##2##(2008-10#3)
mol/l##29##1##(2008-10#24)(2008-11#1)(2011-2#4)
molar absorption coefficient and##3##4##(2008-10#3)
molar absorption coefficient##8##3##(2008-10#7)(2008-5#1)
molar absorptivities of the##4##4##(2008-10#4)
molar absorptivities of##7##3##(2008-10#7)
molar absorptivities##12##2##(2008-10#12)
molar absorptivity 1##2##3##(2008-10#2)
molar absorptivity and Sandell's sensitivity are##4##6##(2008-10#4)
molar absorptivity and Sandell's sensitivity of##2##6##(2008-10#2)
molar absorptivity and Sandell's sensitivity##7##5##(2008-10#7)
molar absorptivity and##9##3##(2008-10#9)
molar absorptivity being##3##3##(2008-10#3)
molar absorptivity for##4##3##(2008-10#4)
molar absorptivity is 2##2##4##(2008-10#2)
molar absorptivity is##12##3##(2008-10#12)
molar absorptivity of 1##4##4##(2008-10#4)
molar absorptivity of 2##2##4##(2008-10#2)
molar absorptivity of the##7##4##(2008-10#7)
molar absorptivity of##17##3##(2008-10#17)
molar absorptivity value of##2##4##(2008-10#2)
molar absorptivity value##3##3##(2008-10#3)
molar absorptivity##61##2##(2008-10#61)
molar excess of##5##3##(1990-11#1)(1994-5#1)(1995-12#1)(2008-10#2)
molar excess##8##2##(1990-11#2)(1992-6#1)(1994-5#1)(1995-12#1)(2008-10#3)
molar input rates##3##3##(2008-10#3)
molar mass of##2##3##(2008-10#1)(2013-1#1)
molar mass##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
molar masses##2##2##(2008-4#1)(2013-1#1)
molar ratio 1##2##3##(2008-10#2)
molar ratio between the##2##4##(2008-10#2)
molar ratio of 1##2##4##(2008-10#1)(2008-11#1)
molar ratio of the inclusion complex was 1##2##8##(2008-10#2)
molar ratio of the##5##4##(2008-10#5)
molar ratio of##24##3##(1992-12#1)(1993-6#1)(1994-5#1)(2008-10#16)(2008-11#3)(2011-2#2)
molar ratio was##2##3##(2008-8#1)(2010-4#1)
molar ratio##42##2##(1990-12#1)(1990-5#2)(1991-12#1)(1992-12#2)(1993-6#1)(1993-8#1)(1994-5#1)(2008-10#25)(2008-11#3)(2008-8#2)(2010-4#1)(2011-2#2)
molar ratios of##7##3##(1997-3#1)(2008-10#4)(2008-8#1)(2009-8#1)
molar ratios##14##2##(1997-3#1)(2008-10#8)(2008-8#2)(2009-8#2)(2010-4#1)
molar reagent excess##2##3##(2008-10#2)
molar volume##4##2##(2008-10#4)
molar volumes and##2##3##(2008-10#2)
molar was restored with a##2##5##(2013-1#2)
molar##193##1##(1990-11#3)(1990-12#1)(1990-5#2)(1991-12#1)(1992-12#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#142)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#4)(2009-8#2)(2010-10#1)(2010-4#2)(2011-2#6)(2012-12#2)(2013-1#11)
molarity##2##1##(2008-10#2)
molars##13##1##(1993-1#1)(2012-12#3)(2013-1#9)
molasses##3##1##(2008-10#1)(2008-5#2)
molasses-based additive##2##2##(2008-10#2)
mold and##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
mold caused by Penicillium expansum##2##5##(2008-10#2)
mold disease##4##2##(1997-4#1)(2008-10#3)
mold was##2##2##(2008-10#2)
mold##42##1##(1991-12#1)(1995-6#1)(1997-4#1)(2008-10#27)(2008-11#2)(2008-12#6)(2008-3#1)(2008-7#1)(2012-2#2)
mold)##2##1##(2008-10#2)
molding temperature##3##2##(2008-5#3)
molding##5##1##(2008-5#4)(2012-3#1)
molds are##2##2##(2008-10#2)
molds inside##2##2##(2008-3#2)
molds was##2##2##(2008-10#1)(2013-1#1)
molds##19##1##(1993-2#1)(2008-10#8)(2008-3#3)(2008-7#1)(2008-8#2)(2013-1#4)
mole fraction of##7##3##(2008-10#7)
mole fraction##12##2##(2008-10#10)(2008-2#2)
mole fractions##4##2##(2008-10#1)(2008-2#2)(2008-7#1)
mole of##9##2##(1993-6#1)(1994-5#2)(2008-10#4)(2008-4#1)(2010-11#1)
mole ratio of##6##3##(1992-3#1)(2008-10#5)
mole ratio##9##2##(1992-3#1)(2008-10#8)
mole##36##1##(1992-3#1)(1993-6#1)(1994-5#2)(2008-10#24)(2008-2#4)(2008-4#1)(2008-7#1)(2010-11#1)(2013-8#1)
molecular absorption is##3##3##(2008-10#2)(2008-3#1)
molecular absorption spectrometry as##2##4##(2008-10#2)
molecular absorption spectrometry using##2##4##(2008-10#2)
molecular absorption spectrometry##13##3##(2008-10#13)
molecular absorption##21##2##(2008-10#19)(2008-3#2)
molecular alteration##2##2##(2008-8#1)(2011-2#1)
molecular analyses##10##2##(1993-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2009-8#1)
molecular analysis of##7##3##(1993-2#1)(1994-8#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
molecular analysis##17##2##(1993-2#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
molecular and cellular##4##3##(2008-2#1)(2008-7#1)(2010-12#1)(2012-2#1)
molecular and functional##2##3##(2008-11#1)(2010-12#1)
molecular and genetic##3##3##(2008-1#1)(2011-1#1)(2012-3#1)
molecular and phylogenetic relationships##2##4##(2008-10#2)
molecular and##24##2##(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
molecular and/or##2##2##(1997-1#1)(2008-5#1)
molecular approaches##3##2##(2008-10#2)(2011-2#1)
molecular assays##2##2##(2008-9#1)(2013-1#1)
molecular backscattering##2##2##(2008-3#2)
molecular basis for the##2##4##(1996-12#1)(2008-8#1)
molecular basis for##5##3##(1996-12#1)(2008-8#2)(2011-2#2)
molecular basis of the##4##4##(1993-2#1)(1997-2#1)(2008-10#1)(2008-9#1)
molecular basis of##22##3##(1993-2#1)(1993-3#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-10#3)(2008-11#4)(2008-8#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
molecular basis##29##2##(1993-2#1)(1993-3#1)(1996-12#2)(1996-2#2)(1997-2#1)(2008-10#3)(2008-11#5)(2008-8#3)(2008-9#2)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
molecular beacon##4##2##(2008-10#4)
molecular beacons (MB)##2##3##(2008-10#2)
molecular beacons##7##2##(2008-10#6)(2008-9#1)
molecular beam epitaxy##5##3##(1995-3#1)(2007-12#1)(2009-11#3)
molecular beam##6##2##(1992-11#1)(1995-3#1)(2007-12#1)(2009-11#3)
molecular binding##2##2##(2009-12#1)(2013-1#1)
molecular biological##3##2##(1992-6#1)(2008-11#1)(2008-8#1)
molecular biologists##2##2##(2008-10#1)(2008-9#1)
molecular biology of##2##3##(1997-1#1)(1997-7#1)
molecular biology techniques##2##3##(1997-6#1)(1997-7#1)
molecular biology to##4##3##(1995-9#1)(1997-7#1)(2008-10#1)(2011-2#1)
molecular biology##36##2##(1995-9#1)(1997-1#1)(1997-6#1)(1997-7#6)(2008-10#2)(2008-11#1)(2008-4#5)(2008-5#1)(2008-8#1)(2008-9#5)(2009-1#1)(2009-12#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
molecular biomarkers in##2##3##(2011-2#1)(2012-2#1)
molecular biomarkers##4##2##(2010-5#1)(2011-2#1)(2012-2#2)
molecular chains##2##2##(2009-7#2)
molecular changes and##2##3##(2009-4#2)
molecular changes in##2##3##(1990-2#1)(2010-1#1)
molecular changes##7##2##(1990-2#1)(1997-7#1)(2009-4#2)(2009-6#1)(2010-1#1)(2012-12#1)
molecular chaperone##3##2##(1997-4#2)(2011-2#1)
molecular characteristics##5##2##(1990-5#1)(2008-10#2)(2010-7#1)(2013-8#1)
molecular characterization of a##5##4##(1995-12#1)(1995-6#1)(2008-10#2)(2012-12#1)
molecular characterization of the##3##4##(1995-11#1)(1995-2#1)(2010-12#1)
molecular characterization of##16##3##(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-8#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
molecular characterization##17##2##(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-8#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
molecular characterizations of human##2##4##(2013-8#2)
molecular chlorine##2##2##(2008-10#2)
molecular cloning and##2##3##(1991-5#1)(2010-5#1)
molecular cloning of##6##3##(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1997-7#1)
molecular cloning##12##2##(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#1)(1995-11#1)(1997-7#1)(2010-5#1)
molecular combing##2##2##(2008-9#2)
molecular complexes were##2##3##(2008-10#2)
molecular complexes##3##2##(2008-10#2)(2008-4#1)
molecular complexity##2##2##(2012-2#2)
molecular components of##2##3##(2009-3#1)(2012-2#1)
molecular components##7##2##(1993-12#1)(1994-8#1)(2008-1#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
molecular composition##3##2##(1994-11#1)(2008-11#1)(2008-12#1)
molecular conformation##2##2##(2008-10#1)(2008-4#1)
molecular connectivity calculations##2##3##(2008-10#2)
molecular connectivity##3##2##(2008-10#3)
molecular constituents##2##2##(2008-10#1)(2010-10#1)
molecular cytogenetic##3##2##(2008-9#1)(2010-1#1)(2013-1#1)
molecular cytogenetics##6##2##(1997-3#1)(2008-11#1)(2008-9#4)
molecular data##5##2##(2007-12#1)(2008-10#2)(2008-9#1)(2010-12#1)
molecular descriptors##8##2##(2008-10#5)(2008-5#2)(2009-3#1)
molecular detection##3##2##(2008-10#2)(2010-3#1)
molecular diagnosis##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
molecular diagnostic##6##2##(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
molecular diagnostics##5##2##(2008-10#3)(2009-4#1)(2011-2#1)
molecular differences##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
molecular diffusion##2##2##(2008-10#2)
molecular diversity of##2##3##(2008-10#2)
molecular dynamics (MD)##3##3##(1992-9#1)(2008-10#2)
molecular dynamics and##2##3##(1994-8#1)(2008-10#1)
molecular dynamics simulations of##3##4##(1993-5#1)(2012-2#1)(2013-1#1)
molecular dynamics simulations##4##3##(1993-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
molecular dynamics##17##2##(1992-8#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-8#1)(2008-10#3)(2008-4#3)(2008-8#2)(2012-2#2)(2013-1#1)(2013-8#1)
molecular ecology##2##2##(1997-6#1)(2013-1#1)
molecular environment##2##2##(2008-10#1)(2008-4#1)
molecular epidemiology of##2##3##(2008-10#2)
molecular epidemiology##4##2##(1997-7#1)(2008-10#2)(2010-11#1)
molecular events##4##2##(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#1)
molecular evidence##2##2##(2008-9#1)(2010-11#1)
molecular evolution##9##2##(1997-6#5)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
molecular features of##3##3##(2011-2#3)
molecular features##6##2##(2008-10#1)(2011-2#5)
molecular field analysis##4##3##(2009-3#2)(2010-12#1)(2011-2#1)
molecular fluorescence##3##2##(2008-10#3)
molecular forms of##4##3##(1991-5#2)(1992-9#1)(1993-8#1)
molecular forms##8##2##(1990-5#2)(1991-5#2)(1992-6#1)(1992-9#1)(1993-8#1)(2008-6#1)
molecular function##4##2##(2008-10#1)(2008-2#1)(2012-2#1)(2013-1#1)
molecular functions##3##2##(2009-9#1)(2012-2#1)(2013-1#1)
molecular genetic analysis of##2##4##(1997-6#1)(2008-10#1)
molecular genetic approaches##2##3##(1991-10#1)(2008-9#1)
molecular genetic techniques##3##3##(2008-8#1)(2008-9#2)
molecular genetic##20##2##(1991-10#1)(1994-5#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-11#1)(2011-2#4)
molecular genetics of##4##3##(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#1)
molecular genetics##9##2##(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2012-3#2)(2013-1#1)
molecular haplotypes##2##2##(2008-10#2)
molecular hybridization and multiplex reverse-transcription polymerase chain reaction##2##8##(2008-10#2)
molecular imaging techniques##2##3##(2011-1#2)
molecular imaging##8##2##(2009-12#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#2)(2012-2#1)
molecular imprinting##10##2##(2008-10#9)(2010-7#1)
molecular information##3##2##(1997-7#1)(2010-7#1)(2011-2#1)
molecular interaction pathways using a##2##5##(2008-11#2)
molecular interaction##7##2##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-10#1)
molecular interactions and##2##3##(2009-12#1)(2010-10#1)
molecular interactions between##4##3##(1992-9#1)(2008-10#2)(2013-8#1)
molecular interactions##11##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)(2009-12#1)(2010-10#1)(2012-2#1)(2013-8#1)
molecular interventions##2##2##(2008-11#1)(2009-4#1)
molecular layer##4##2##(1991-10#1)(1994-8#1)(1995-8#1)(2013-8#1)
molecular level##22##2##(1992-6#1)(1997-8#1)(2008-10#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#2)
molecular linkage map##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
molecular machinery is##2##3##(2008-7#1)(2009-8#1)
molecular machinery##4##2##(1993-12#1)(2008-7#1)(2009-8#2)
molecular machines##4##2##(2008-7#3)(2010-7#1)
molecular manipulations of##2##3##(2011-1#1)(2012-3#1)
molecular manipulations##3##2##(2011-1#1)(2012-2#1)(2012-3#1)
molecular mapping of##2##3##(2008-10#2)
molecular mapping##4##2##(2008-10#4)
molecular marker for##4##3##(2008-10#2)(2008-9#1)(2013-8#1)
molecular marker##11##2##(2008-10#9)(2008-9#1)(2013-8#1)
molecular markers and##4##3##(2008-10#4)
molecular markers for##7##3##(1997-8#1)(2008-10#6)
molecular markers in##5##3##(2008-10#2)(2010-11#1)(2011-2#1)(2012-5#1)
molecular markers linked to##5##4##(2008-10#4)(2008-8#1)
molecular markers that##2##3##(1997-8#1)(2008-10#1)
molecular markers to##6##3##(1997-7#1)(2008-10#4)(2011-2#1)
molecular markers were used to##3##5##(2008-10#3)
molecular markers##46##2##(1997-7#1)(1997-8#2)(2008-10#34)(2008-8#2)(2010-10#1)(2010-11#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-8#1)
molecular mass and##2##3##(1992-9#1)(2008-10#1)
molecular mass cut-off##2##3##(1992-12#1)(2008-10#1)
molecular mass of the##5##4##(1995-6#2)(2008-10#3)
molecular mass of##42##3##(1990-5#3)(1991-12#2)(1992-10#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#17)(2008-11#3)(2013-1#1)
molecular mass##66##2##(1990-5#4)(1991-12#3)(1992-10#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#4)(1996-12#1)(1996-6#1)(1997-2#2)(1997-7#1)(2008-10#25)(2008-11#5)(2008-5#2)(2009-12#1)(2009-8#1)(2010-4#1)(2013-1#1)
molecular masses of##7##3##(1990-12#1)(1990-5#1)(1993-8#1)(2008-10#3)(2008-8#1)
molecular masses##14##2##(1990-12#3)(1990-5#1)(1993-3#1)(1993-8#1)(1997-2#1)(2008-10#6)(2008-8#1)
molecular mechanics calculation##2##3##(2008-10#2)
molecular mechanics calculations##2##3##(1996-5#2)
molecular mechanics##6##2##(1996-5#3)(2008-10#2)(2008-4#1)
molecular mechanism behind##2##3##(2008-10#1)(2012-2#1)
molecular mechanism of action##2##4##(2008-10#1)(2008-11#1)
molecular mechanism of##12##3##(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-3#1)
molecular mechanism underlying##3##3##(2009-10#1)(2010-12#1)(2010-5#1)
molecular mechanism##27##2##(1994-11#1)(1995-11#1)(1995-6#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
molecular mechanisms and##2##3##(2008-11#1)(2012-2#1)
molecular mechanisms by which they##2##5##(2011-2#2)
molecular mechanisms by which##5##4##(2008-10#1)(2011-2#3)(2013-1#1)
molecular mechanisms by##6##3##(2008-10#1)(2011-2#3)(2011-3#1)(2013-1#1)
molecular mechanisms involved in##2##4##(2008-10#1)(2008-11#1)
molecular mechanisms of the##2##4##(2008-7#1)(2010-12#1)
molecular mechanisms of##16##3##(1993-2#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-1#1)(2010-12#2)(2011-2#3)
molecular mechanisms underlying the##2##4##(2008-8#1)(2011-2#1)
molecular mechanisms underlying##7##3##(2008-10#2)(2008-8#1)(2009-10#1)(2009-9#1)(2011-2#2)
molecular mechanisms##49##2##(1991-6#1)(1993-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-7#2)(2008-10#4)(2008-11#6)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-10#1)(2011-2#8)(2011-3#1)(2012-2#5)(2013-1#1)
molecular memory in the##2##4##(2012-2#2)
molecular memory in##3##3##(2012-2#3)
molecular memory##4##2##(2012-2#4)
molecular methods in##2##3##(2008-10#1)(2009-4#1)
molecular methods##10##2##(2008-10#7)(2008-4#1)(2009-4#1)(2011-2#1)
molecular modeling##10##2##(1992-4#1)(1994-5#2)(1996-5#1)(2008-10#1)(2008-4#3)(2011-2#2)
molecular modelling##3##2##(1994-11#1)(1995-11#1)(2008-8#1)
molecular models of##2##3##(1992-4#1)(1994-5#1)
molecular models##4##2##(1992-4#1)(1994-3#1)(1994-5#1)(2008-11#1)
molecular motion##2##2##(1994-5#1)(2008-7#1)
molecular nitrogen##4##2##(2008-3#4)
molecular orbital method##2##3##(1993-8#1)(2008-11#1)
molecular orbital theory##2##3##(1994-5#1)(2008-10#1)
molecular orbital##6##2##(1991-5#1)(1993-8#2)(1994-5#1)(2008-10#1)(2008-11#1)
molecular organization of the##2##4##(1997-2#1)(2008-5#1)
molecular orientation for##2##3##(2008-10#2)
molecular orientation##4##2##(2008-10#3)(2008-3#1)
molecular origin of##2##3##(2008-12#1)(2010-7#1)
molecular oxygen##4##2##(1992-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
molecular packing##2##2##(1991-3#1)(2008-8#1)
molecular pathogenesis##2##2##(1992-6#1)(1995-2#1)
molecular pathway##3##2##(2008-9#1)(2009-12#1)(2010-4#1)
molecular pathways##9##2##(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-10#1)(2011-2#1)
molecular patterns##3##2##(2008-4#1)(2008-7#1)(2012-2#1)
molecular phenotype##2##2##(2009-6#1)(2013-1#1)
molecular phylogenetic##6##2##(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-2#1)
molecular phylogenies of##2##3##(2008-10#1)(2012-3#1)
molecular phylogeny##3##2##(2008-10#2)(2008-6#1)
molecular polymorphism and##2##3##(2008-10#2)
molecular probe##3##2##(2008-10#2)(2008-11#1)
molecular processes##4##2##(2010-12#1)(2011-2#1)(2013-1#2)
molecular profiles##2##2##(2009-4#1)(2010-12#1)
molecular properties##5##2##(1994-3#1)(2008-10#3)(2012-2#1)
molecular ratios##2##2##(2008-10#2)
molecular recognition between##2##3##(1992-6#1)(2008-10#1)
molecular recognition##8##2##(1992-6#1)(1994-5#1)(2008-10#2)(2009-3#4)
molecular remission##2##2##(2009-3#1)(2010-11#1)
molecular replacement##10##2##(1992-4#2)(1992-9#1)(1993-8#2)(2008-8#3)(2008-9#2)
molecular ruler##4##2##(2008-6#1)(2008-7#1)(2012-2#2)
molecular scattering##3##2##(2008-2#1)(2008-3#2)
molecular self-assembly on##2##3##(2013-8#2)
molecular self-assembly##5##2##(2013-8#5)
molecular shapes##2##2##(1991-7#1)(1992-6#1)
molecular sieves##3##2##(2008-10#3)
molecular signals governing##2##3##(2008-4#1)(2008-9#1)
molecular signals##3##2##(2008-4#1)(2008-5#1)(2008-9#1)
molecular signature of##2##3##(2010-1#1)(2011-2#1)
molecular signature##3##2##(2010-1#1)(2011-2#1)(2013-8#1)
molecular signatures##3##2##(2010-1#1)(2013-8#2)
molecular similarities##2##2##(1991-5#1)(2008-10#1)
molecular simulations##2##2##(2008-12#1)(2013-1#1)
molecular size of the##2##4##(1997-1#1)(2008-10#1)
molecular size##11##2##(1991-7#1)(1997-1#1)(2008-10#8)(2012-2#1)
molecular sizes##2##2##(2007-12#1)(2008-10#1)
molecular species of##4##3##(1991-5#2)(1995-12#1)(2008-10#1)
molecular species##7##2##(1991-5#2)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#2)
molecular strategies##2##2##(2008-10#2)
molecular structure of##5##3##(1991-3#1)(1996-5#1)(2008-10#2)(2012-2#1)
molecular structure##12##2##(1991-2#1)(1991-3#1)(1992-12#1)(1996-5#1)(2006-6#1)(2008-10#6)(2012-2#1)
molecular structures##5##2##(1993-2#1)(2008-10#3)(2012-2#1)
molecular studies have##2##3##(2008-10#1)(2011-2#1)
molecular studies##8##2##(1997-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2011-2#1)
molecular systems##4##2##(1997-6#1)(2008-7#1)(2009-11#1)(2013-1#1)
molecular target for##2##3##(2010-10#1)(2010-7#1)
molecular target##4##2##(2008-10#1)(2010-10#1)(2010-7#1)(2012-3#1)
molecular targets in##2##3##(2009-1#1)(2013-1#1)
molecular targets of adjudin##2##4##(2012-2#2)
molecular targets##10##2##(2008-6#1)(2009-1#1)(2009-12#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
molecular technique##2##2##(2008-3#1)(2008-5#1)
molecular techniques are##2##3##(2008-10#1)(2013-1#1)
molecular techniques for the##2##4##(2011-2#2)
molecular techniques for##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
molecular techniques##14##2##(2008-10#4)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
molecular tests##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
molecular tools##7##2##(2008-10#4)(2010-10#2)(2011-1#1)
molecular transport##3##2##(2008-10#1)(2010-7#2)
molecular tweezer-type neutral##2##3##(2008-10#2)
molecular tweezer-type##3##2##(2008-10#3)
molecular typing##2##2##(2011-2#2)
molecular understanding##2##2##(2009-8#1)(2011-2#1)
molecular variability##3##2##(2008-10#3)
molecular variance (AMOVA)##4##3##(2008-10#4)
molecular variance##15##2##(2008-10#15)
molecular variation##6##2##(2008-10#6)
molecular weight (MW)##2##3##(2008-10#2)
molecular weight B cell growth factor (HMW-BCGF) and the complement##2##10##(1991-3#2)
molecular weight and##8##3##(1992-11#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-4#1)
molecular weight compounds##6##3##(2008-10#6)
molecular weight distribution##2##3##(2008-10#2)
molecular weight form of##3##4##(1990-11#1)(1991-9#2)
molecular weight fractions##3##3##(2008-10#3)
molecular weight heparin##6##3##(2008-10#2)(2008-3#1)(2013-1#3)
molecular weight is##2##3##(2008-10#1)(2008-8#1)
molecular weight of 1##2##4##(2008-8#2)
molecular weight of the##7##4##(1990-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)
molecular weight of##47##3##(1990-11#2)(1990-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-6#1)(1997-2#1)(2008-10#13)(2008-11#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#1)(2009-9#1)(2010-3#2)(2011-2#1)
molecular weight protein##3##3##(1991-5#1)(1996-2#1)(2008-10#1)
molecular weight range##2##3##(2008-11#2)
molecular weight selenium##5##3##(2010-11#5)
molecular weight##184##2##(1990-11#3)(1990-12#4)(1990-5#2)(1990-6#1)(1991-10#1)(1991-3#2)(1991-5#4)(1991-9#5)(1992-10#2)(1992-11#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-6#2)(1995-8#3)(1996-12#3)(1996-2#2)(1997-2#1)(1997-8#1)(2008-10#60)(2008-11#13)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#1)(2009-10#3)(2009-3#1)(2009-4#2)(2009-9#2)(2010-11#6)(2010-3#2)(2010-4#1)(2010-8#2)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
molecular weights are##3##3##(2008-8#1)(2008-9#1)(2011-3#1)
molecular weights of the##2##4##(1997-7#1)(2008-11#1)
molecular weights of##12##3##(1990-12#1)(1990-5#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#3)
molecular weights##24##2##(1990-12#1)(1990-5#1)(1990-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-9#1)(2011-3#1)
molecular##1403##1##(1990-11#3)(1990-12#9)(1990-2#1)(1990-5#11)(1990-6#2)(1990-8#1)(1991-10#3)(1991-12#3)(1991-2#1)(1991-3#5)(1991-5#12)(1991-6#1)(1991-7#2)(1991-9#5)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#9)(1992-7#1)(1992-8#4)(1992-9#9)(1993-12#7)(1993-2#6)(1993-3#3)(1993-5#2)(1993-6#3)(1993-8#11)(1994-1#1)(1994-11#6)(1994-2#3)(1994-3#4)(1994-5#7)(1994-8#10)(1995-11#6)(1995-12#4)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#10)(1995-8#4)(1995-9#1)(1996-12#7)(1996-2#6)(1996-5#5)(1996-6#2)(1997-1#3)(1997-2#7)(1997-3#6)(1997-4#2)(1997-6#11)(1997-7#21)(1997-8#7)(2006-6#1)(2007-12#4)(2008-1#2)(2008-10#443)(2008-11#58)(2008-12#10)(2008-2#4)(2008-3#26)(2008-4#34)(2008-5#29)(2008-6#7)(2008-7#26)(2008-8#48)(2008-9#51)(2009-1#3)(2009-10#9)(2009-11#4)(2009-12#10)(2009-3#13)(2009-4#12)(2009-6#10)(2009-7#5)(2009-8#18)(2009-9#5)(2010-1#8)(2010-10#9)(2010-11#12)(2010-12#18)(2010-3#4)(2010-4#6)(2010-5#8)(2010-6#1)(2010-7#15)(2010-8#2)(2010-9#10)(2011-1#8)(2011-10#1)(2011-2#72)(2011-3#5)(2012-12#5)(2012-2#46)(2012-3#16)(2012-5#2)(2013-1#31)(2013-8#21)
molecular-based factors##2##2##(2009-4#2)
molecular-based##5##1##(2008-10#3)(2009-4#2)
molecular-mass distribution of food-grade protein hydrolyzates##2##6##(1997-2#2)
molecular-size##3##1##(2008-10#3)
molecular-weight##2##1##(2008-10#2)
molecularly characterize the##2##3##(1997-7#1)(2012-3#1)
molecularly cloned and sequenced##2##4##(1995-2#1)(2008-10#1)
molecularly cloned##3##2##(1995-2#1)(1997-8#1)(2008-10#1)
molecularly imprinted polymer (MIP) as the##2##6##(2008-10#2)
molecularly imprinted polymer (MIP)##3##4##(2008-10#3)
molecularly imprinted polymer##4##3##(2008-10#4)
molecularly imprinted polymers##2##3##(2008-10#2)
molecularly imprinted##9##2##(2008-10#9)
molecularly similar##2##2##(2008-10#2)
molecularly smooth titanium##2##3##(2012-2#2)
molecularly##27##1##(1994-9#1)(1995-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#15)(2009-8#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#2)
molecule L1##3##2##(1996-12#1)(2008-7#2)
molecule and the##2##3##(2008-10#2)
molecule and##8##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)
molecule are##4##2##(1991-5#1)(1993-8#1)(1995-12#1)(2008-1#1)
molecule as##2##2##(1995-2#1)(2008-8#1)
molecule at##3##2##(2008-10#1)(2009-7#1)(2012-2#1)
molecule bound##2##2##(2008-10#1)(2008-4#1)
molecule by the##3##3##(2008-10#1)(2012-2#2)
molecule by##7##2##(1993-12#1)(2008-10#2)(2008-8#1)(2012-2#2)(2012-3#1)
molecule for the##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
molecule for##7##2##(1993-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)
molecule has been##3##3##(1993-2#1)(1995-2#1)(2008-11#1)
molecule has##4##2##(1993-2#1)(1993-3#1)(1995-2#1)(2008-11#1)
molecule in the##4##3##(2008-10#2)(2008-9#1)(2010-6#1)
molecule in##13##2##(1992-3#1)(1994-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-2#1)
molecule involved in##3##3##(1993-3#1)(1997-2#1)(2008-11#1)
molecule is##12##2##(1990-5#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2009-7#1)(2010-7#1)
molecule may be##2##3##(1990-5#1)(2008-10#1)
molecule may##3##2##(1990-5#1)(1991-11#1)(2008-10#1)
molecule of interest##2##3##(2008-10#1)(2008-7#1)
molecule of the##2##3##(1993-3#1)(1995-11#1)
molecule of##15##2##(1990-9#2)(1991-5#1)(1993-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)
molecule on the##2##3##(2008-10#1)(2008-5#1)
molecule on##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
molecule target##3##2##(2008-11#1)(2008-4#2)
molecule that is##2##3##(1994-5#1)(2008-5#1)
molecule that##4##2##(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#1)
molecule to the substrate##2##4##(2008-10#1)(2008-7#1)
molecule to the##4##3##(1992-12#1)(2008-10#2)(2008-7#1)
molecule to##12##2##(1992-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
molecule was##6##2##(1990-5#1)(1992-6#1)(1997-2#1)(1997-8#1)(2008-8#1)(2009-6#1)
molecule which##3##2##(1991-3#1)(1995-11#1)(1997-9#1)
molecule with##6##2##(2008-10#3)(2008-8#1)(2012-2#1)(2013-1#1)
molecule##296##1##(1990-2#1)(1990-5#5)(1990-8#2)(1990-9#3)(1991-11#1)(1991-3#1)(1991-5#5)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#4)(1994-11#2)(1994-5#5)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#8)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#4)(1997-6#2)(1997-8#3)(1997-9#2)(2008-1#2)(2008-10#81)(2008-11#24)(2008-12#2)(2008-3#4)(2008-4#11)(2008-5#15)(2008-6#1)(2008-7#10)(2008-8#14)(2008-9#5)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#4)(2011-2#3)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#5)(2013-8#2)
molecule-based##2##1##(2008-5#1)(2010-5#1)
molecules and suggests##2##3##(1993-8#1)(2008-11#1)
molecules and the##4##3##(1990-8#1)(2008-10#2)(2009-9#1)
molecules and##40##2##(1990-8#1)(1992-3#2)(1992-9#1)(1993-8#1)(1996-1#1)(1996-12#2)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
molecules and/or##2##2##(2008-10#1)(2008-5#1)
molecules are formed in the mixtures##2##6##(2008-10#2)
molecules are formed in##3##4##(2008-10#2)(2008-9#1)
molecules are##23##2##(1991-5#1)(1994-12#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#4)(2009-12#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
molecules as##7##2##(1990-8#1)(1993-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-7#1)(2011-3#1)
molecules at the##3##3##(1991-3#1)(1993-8#1)(2013-8#1)
molecules at##6##2##(1991-3#1)(1993-8#1)(2008-10#2)(2008-8#1)(2013-8#1)
molecules based on the##2##4##(1996-2#1)(2008-10#1)
molecules based##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
molecules between the##2##3##(2008-5#1)(2011-2#1)
molecules between##4##2##(1994-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
molecules by##6##2##(1993-6#1)(2008-10#2)(2008-11#2)(2008-5#1)
molecules can be##3##3##(1992-6#1)(1994-5#1)(2008-10#1)
molecules can##5##2##(1992-6#1)(1994-5#1)(2008-10#2)(2008-11#1)
molecules expressed in##2##3##(1995-5#1)(2008-11#1)
molecules expressed##5##2##(1995-5#1)(2008-11#2)(2008-7#1)(2013-1#1)
molecules for##6##2##(2008-10#3)(2008-4#1)(2009-8#1)(2011-2#1)
molecules from the##3##3##(1993-3#1)(2008-7#1)(2012-2#1)
molecules from##7##2##(1993-3#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
molecules in a##5##3##(2008-10#3)(2010-12#1)(2011-2#1)
molecules in cardiovascular##2##3##(2008-5#1)(2009-10#1)
molecules in the asymmetric unit##3##5##(1992-4#1)(2008-8#1)(2008-9#1)
molecules in the##22##3##(1990-5#1)(1992-4#1)(1992-9#3)(1993-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#2)(2010-1#1)(2010-11#1)(2012-2#1)
molecules in##50##2##(1990-5#2)(1991-2#1)(1992-4#1)(1992-9#4)(1993-8#1)(1996-12#1)(1997-6#2)(2007-12#2)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#4)
molecules into##2##2##(1994-8#1)(1996-12#1)
molecules involved in##6##3##(2008-4#2)(2008-5#1)(2009-12#2)(2013-8#1)
molecules involved##7##2##(2008-4#2)(2008-5#1)(2009-12#2)(2012-2#1)(2013-8#1)
molecules may be involved in##2##5##(1991-3#1)(1994-11#1)
molecules may be##3##3##(1991-3#1)(1994-11#1)(1995-8#1)
molecules may##5##2##(1991-3#1)(1994-11#2)(1995-8#2)
molecules of pharmaceutical interest##2##4##(2008-10#2)
molecules of target antigen per cell##2##6##(2008-9#2)
molecules of the##4##3##(1990-5#1)(2008-10#2)(2008-8#1)
molecules of##32##2##(1990-5#2)(1990-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-8#1)(2008-10#11)(2008-11#2)(2008-8#3)(2008-9#3)(2011-2#2)
molecules on a##2##3##(2008-10#1)(2009-11#1)
molecules on the surface of##2##5##(2008-10#1)(2008-11#1)
molecules on the##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2010-10#1)
molecules on##13##2##(1995-5#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-10#1)
molecules onto##2##2##(2008-10#1)(2008-7#1)
molecules or##4##2##(2008-11#1)(2008-7#1)(2009-8#1)(2010-7#1)
molecules per##5##2##(1990-12#1)(2008-10#2)(2008-9#2)
molecules present in##2##3##(1997-3#1)(2008-10#1)
molecules present##3##2##(1997-3#1)(2008-10#1)(2013-8#1)
molecules such as##9##3##(1995-2#1)(2008-10#4)(2008-4#1)(2009-5#1)(2009-9#1)(2010-11#1)
molecules that are important##2##4##(2010-11#1)(2013-1#1)
molecules that are##5##3##(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
molecules that specifically##2##3##(1993-9#1)(2008-4#1)
molecules that##25##2##(1992-9#1)(1993-9#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
molecules to##8##2##(1995-8#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
molecules using##3##2##(2008-10#1)(2011-2#2)
molecules was##3##2##(1994-11#1)(2008-10#2)
molecules were##8##2##(1990-2#1)(2008-10#5)(2008-8#1)(2008-9#1)
molecules which##3##2##(2008-10#2)(2008-5#1)
molecules with a##3##3##(2008-10#2)(2008-11#1)
molecules with##17##2##(1997-6#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-4#1)(2009-10#1)(2010-4#1)(2011-2#1)
molecules within the##2##3##(1994-9#1)(2008-8#1)
molecules within##3##2##(1992-9#1)(1994-9#1)(2008-8#1)
molecules##576##1##(1990-12#4)(1990-2#1)(1990-5#9)(1990-8#4)(1990-9#2)(1991-2#2)(1991-3#2)(1991-5#5)(1991-9#1)(1992-12#2)(1992-3#6)(1992-4#4)(1992-6#1)(1992-9#11)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#11)(1993-9#1)(1994-11#4)(1994-12#4)(1994-5#4)(1994-8#5)(1994-9#1)(1995-12#3)(1995-2#9)(1995-3#1)(1995-5#7)(1995-6#1)(1995-8#5)(1996-1#2)(1996-12#7)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-6#6)(1997-9#2)(2006-6#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#5)(2008-10#141)(2008-11#32)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#23)(2008-5#24)(2008-6#3)(2008-7#18)(2008-8#25)(2008-9#24)(2009-10#5)(2009-11#2)(2009-12#8)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#6)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#3)(2010-7#9)(2011-1#2)(2011-2#18)(2011-3#2)(2012-12#1)(2012-2#16)(2012-3#2)(2012-6#2)(2013-1#10)(2013-8#16)
molecules)##4##1##(2008-10#3)(2009-12#1)
molecules/pg##2##1##(1990-5#2)
moles of PAR##2##3##(2008-10#2)
moles of##9##2##(1993-6#1)(1994-5#1)(2008-10#6)(2010-11#1)
moll(-1) HNO(3)##3##2##(2008-10#3)
moll(-1) Mn(II) for##2##3##(2008-10#2)
moll(-1) Mn(II)##3##2##(2008-10#3)
moll(-1) for Ru(bpy)(3)(2+)/TPrA system##2##4##(2008-10#2)
moll(-1) for Ru(phen)(3)(2+)/TPrA system##2##4##(2008-10#2)
moll(-1) for##6##2##(2008-10#6)
moll(-1) with DL of##3##4##(2008-10#3)
moll(-1) with##4##2##(2008-10#4)
moll(-1)##28##1##(2008-10#28)
moll(-1))##2##1##(2008-10#2)
mollicute##2##1##(2008-10#2)
mollicutes##2##1##(2008-10#2)
mollusc##3##1##(1990-2#1)(1990-5#2)
molluscan hemocytes##3##2##(1995-8#1)(2008-7#2)
molluscan##6##1##(1990-2#2)(1995-8#1)(2008-7#2)(2013-8#1)
molluscs##3##1##(2008-10#1)(2008-7#2)
mols##2##1##(1991-5#1)(2008-10#1)
molt cycle##4##2##(2008-6#4)
molt##15##1##(1992-6#1)(1993-12#1)(2007-12#2)(2008-12#3)(2008-6#7)(2008-7#1)
molt-inhibiting hormone##2##2##(2008-5#1)(2008-6#1)
molten##7##1##(2008-10#7)
molting to##2##2##(2007-12#1)(2008-10#1)
molting##7##1##(1995-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)
molts##3##1##(1993-12#1)(2007-12#1)(2012-2#1)
molybdate and##2##2##(2008-10#2)
molybdate as##2##2##(2008-10#2)
molybdate concentration in the carrier##2##5##(2008-10#2)
molybdate concentration##3##2##(2008-10#3)
molybdate in##4##2##(2008-10#4)
molybdate to##4##2##(2008-10#4)
molybdate##39##1##(1990-11#3)(2008-10#36)
molybdenite##6##1##(2008-10#6)
molybdenum and tungsten in##2##4##(2008-10#2)
molybdenum and tungsten##4##3##(2008-10#4)
molybdenum and##10##2##(2008-10#9)(2009-7#1)
molybdenum blue method##5##3##(2008-10#5)
molybdenum blue##13##2##(2008-10#13)
molybdenum by catalytic adsorptive stripping voltammetry##2##6##(2008-10#2)
molybdenum by##4##2##(2008-10#4)
molybdenum column##2##2##(2008-10#2)
molybdenum concentration##3##2##(2008-10#3)
molybdenum determination##3##2##(2008-10#3)
molybdenum in blood serum and whole blood##2##7##(2008-10#2)
molybdenum in human##2##3##(2008-10#2)
molybdenum in##20##2##(2008-10#20)
molybdenum using##2##2##(2008-10#2)
molybdenum was##3##2##(2008-10#3)
molybdenum with##4##2##(2008-10#4)
molybdenum##91##1##(2008-10#89)(2009-7#1)(2010-4#1)
molybdenum(VI) and tungsten(VI)##3##3##(2008-10#3)
molybdenum(VI) and##4##2##(2008-10#4)
molybdenum(VI) in natural##3##3##(2008-10#3)
molybdenum(VI) in the##2##3##(2008-10#2)
molybdenum(VI) in##5##2##(2008-10#5)
molybdenum(VI)##16##1##(2008-10#16)
molybdenum-3-methoxy-4-hydroxymandelic acid##2##2##(2008-10#2)
molybdoarsenate##3##1##(2008-10#3)
molybdophosphate and##2##2##(2008-10#2)
molybdophosphate##4##1##(2008-10#4)
molybdotungstophosphate-3##2##1##(2008-10#2)
moment of the##3##3##(1990-3#1)(2008-10#1)(2008-5#1)
moment of##7##2##(1990-3#1)(1990-9#1)(2008-10#1)(2008-5#2)(2013-1#1)(2013-8#1)
moment##33##1##(1990-3#2)(1990-9#1)(1995-11#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#3)(2011-2#6)(2013-1#1)(2013-8#1)
momentary##3##1##(2008-11#1)(2008-3#1)(2008-5#1)
moments of the##3##3##(1997-6#1)(2008-8#1)(2011-2#1)
moments of##6##2##(1997-6#3)(2008-10#1)(2008-8#1)(2011-2#1)
moments##19##1##(1991-12#1)(1997-6#6)(2008-10#1)(2008-8#2)(2008-9#2)(2011-2#5)(2012-2#2)
momentum term##3##2##(2008-10#3)
momentum theory##3##2##(2010-10#3)
momentum to##2##2##(2008-3#1)(2008-9#1)
momentum##21##1##(1991-12#1)(1992-9#1)(1994-2#2)(2007-11#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#5)(2010-8#1)(2012-2#1)(2013-1#1)
moms##2##1##(1997-3#1)(2008-9#1)
monastery##3##1##(2011-2#3)
monazite sand##2##2##(2008-10#2)
monazite##3##1##(2008-10#3)
monetary gain##2##2##(2008-11#2)
monetary##3##1##(2008-11#2)(2013-8#1)
money for##4##2##(1994-12#1)(1994-3#1)(2008-6#2)
money from##5##2##(1992-11#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-9#1)
money in##3##2##(1992-8#1)(1995-12#1)(1997-3#1)
money than##2##2##(1996-5#1)(1997-8#1)
money to##2##2##(1991-1#1)(1995-2#1)
money##39##1##(1990-3#1)(1991-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2008-11#2)(2008-6#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
moniliforme in##2##2##(2008-10#2)
moniliforme treatment##2##2##(2008-10#2)
moniliforme##28##1##(2008-10#27)(2008-5#1)
moniliforme) and##2##2##(2008-10#2)
moniliformin##6##1##(2008-10#3)(2008-5#3)
monitor and control##3##3##(2008-11#2)(2011-1#1)
monitor and##11##2##(1992-3#1)(1994-1#2)(1994-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2010-9#1)(2011-1#1)
monitor changes##2##2##(1994-12#1)(2008-7#1)
monitor expression of##2##3##(2008-10#1)(2008-7#1)
monitor for##6##2##(2008-10#3)(2008-3#1)(2008-7#2)
monitor response to treatment of##2##5##(2008-10#1)(2011-7#1)
monitor response to treatment##3##4##(2008-10#1)(2011-7#1)(2012-2#1)
monitor response to##4##3##(2008-10#1)(2011-7#1)(2012-2#1)(2012-3#1)
monitor the##54##2##(1991-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-8#1)
monitor their##3##2##(2008-11#1)(2008-9#2)
monitor was##2##2##(1997-8#1)(2010-8#1)
monitor##150##1##(1990-2#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#57)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#5)(2008-9#5)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
monitored amperometrically##2##2##(2008-10#2)
monitored and related to the glucose concentration##2##7##(2008-10#2)
monitored and the##2##3##(2008-10#2)
monitored and##8##2##(2008-10#4)(2008-11#2)(2013-1#2)
monitored as##2##2##(2008-10#2)
monitored at 435 nm##2##4##(2008-10#2)
monitored at 503nm##2##3##(2008-10#2)
monitored at the##3##3##(2008-10#3)
monitored at##31##2##(2008-10#31)
monitored by UV-Vis##2##3##(2008-10#2)
monitored by a##4##3##(1993-2#1)(2008-10#3)
monitored by an##2##3##(2008-10#1)(2008-11#1)
monitored by measuring the##4##4##(2008-10#4)
monitored by measuring##5##3##(2008-10#5)
monitored by optical##2##3##(2008-10#2)
monitored by the##6##3##(1990-8#1)(2008-10#3)(2008-11#1)(2010-8#1)
monitored by##55##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-3#2)(1992-1#1)(1993-12#1)(1993-2#1)(1994-5#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#34)(2008-11#4)(2008-7#1)(2008-9#2)(2010-8#2)
monitored during##7##2##(1991-2#1)(2008-10#4)(2008-7#1)(2013-8#1)
monitored fluorimetrically##2##2##(2008-10#2)
monitored for##15##2##(1994-5#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
monitored in real time##5##4##(1995-12#1)(2008-10#3)(2008-4#1)
monitored in situ##2##3##(1997-1#1)(2008-3#1)
monitored in soil##2##3##(2008-10#2)
monitored in##27##2##(1995-12#1)(1997-1#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-8#1)
monitored on##2##2##(2008-10#2)
monitored on-line##2##2##(2008-10#1)(2008-11#1)
monitored postoperatively##2##2##(1993-1#1)(2012-2#1)
monitored simultaneously##2##2##(2008-10#1)(2008-4#1)
monitored spectrophotometrically (at##2##3##(2008-10#2)
monitored spectrophotometrically at##9##3##(2008-10#9)
monitored spectrophotometrically by measuring the decrease in absorbance of##3##9##(2008-10#3)
monitored spectrophotometrically by measuring the decrease in absorbance##4##8##(2008-10#4)
monitored spectrophotometrically by measuring the decrease in the absorbance of##2##10##(2008-10#2)
monitored spectrophotometrically by measuring the decrease in##6##7##(2008-10#6)
monitored spectrophotometrically by measuring the##9##5##(2008-10#9)
monitored spectrophotometrically##22##2##(2008-10#22)
monitored the##2##2##(2008-10#1)(2008-11#1)
monitored through the##2##3##(2008-10#2)
monitored through##3##2##(2008-10#2)(2012-7#1)
monitored throughout##2##2##(2008-10#1)(2008-6#1)
monitored to assess##2##3##(2008-10#2)
monitored to##3##2##(2008-10#3)
monitored using##11##2##(1990-8#1)(1996-2#1)(2008-10#6)(2010-4#1)(2010-8#1)(2012-2#1)
monitored with a##3##3##(2008-10#3)
monitored with##13##2##(1990-9#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2012-2#3)
monitored##286##1##(1990-12#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#3)(1995-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-6#3)(1997-8#1)(2007-12#1)(2008-10#189)(2008-11#16)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#1)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#3)(2013-8#2)
monitoring (SIM) mode##4##3##(2008-10#3)(2008-5#1)
monitoring (SIM)##8##2##(2008-10#7)(2008-5#1)
monitoring access in Medicare managed care##2##6##(1997-2#2)
monitoring access##4##2##(1997-2#4)
monitoring an##2##2##(2008-10#2)
monitoring and control##6##3##(2008-10#3)(2008-11#2)(2008-7#1)
monitoring and controlling##2##3##(2008-10#1)(2008-11#1)
monitoring and rational##2##3##(2011-2#2)
monitoring and treatment##2##3##(2008-11#1)(2010-8#1)
monitoring and##37##2##(1994-9#2)(1996-3#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#2)(2009-7#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-2#2)(2013-7#1)
monitoring as a##3##3##(1994-3#1)(2008-10#1)(2010-8#1)
monitoring as##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
monitoring at##3##2##(2008-10#2)(2008-8#1)
monitoring by##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
monitoring can be##2##3##(1996-3#1)(2008-7#1)
monitoring data##3##2##(2008-10#1)(2008-9#1)(2009-7#1)
monitoring devices##5##2##(2008-10#2)(2008-7#1)(2010-8#1)(2012-3#1)
monitoring did not##2##3##(1994-3#1)(2008-10#1)
monitoring during##2##2##(2008-7#2)
monitoring environmental##3##2##(2008-10#2)(2012-3#1)
monitoring for the##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
monitoring for##8##2##(1991-3#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-8#1)
monitoring formaldehyde##4##2##(2008-10#4)
monitoring has##2##2##(2008-10#2)
monitoring health##2##2##(1996-1#1)(2008-10#1)
monitoring in food and feed##2##5##(2008-10#2)
monitoring in the##6##3##(2008-10#2)(2008-3#1)(2009-1#1)(2010-1#2)
monitoring in##23##2##(1994-3#1)(1994-9#1)(2006-6#1)(2008-1#1)(2008-10#12)(2008-3#1)(2009-1#1)(2010-1#2)(2010-7#1)(2013-1#2)
monitoring is a##2##3##(2010-11#1)(2011-2#1)
monitoring is##6##2##(2008-10#2)(2010-11#1)(2011-2#3)
monitoring light##2##2##(2007-12#1)(2008-10#1)
monitoring may##2##2##(1997-8#1)(2008-11#1)
monitoring method##2##2##(2008-10#1)(2008-5#1)
monitoring of 13C-labeled##2##3##(1993-3#2)
monitoring of a##2##3##(1996-6#1)(2008-10#1)
monitoring of adverse##2##3##(2008-11#1)(2010-2#1)
monitoring of blood pressure##3##4##(2008-1#1)(2008-10#2)
monitoring of blood##4##3##(1993-3#1)(2008-1#1)(2008-10#2)
monitoring of clinical trials##2##4##(1996-6#2)
monitoring of continuous beer fermentation##2##5##(2008-10#2)
monitoring of dissolution profiles##2##4##(2008-10#2)
monitoring of drug##2##3##(1997-7#1)(2008-4#1)
monitoring of fish##2##3##(2008-10#2)
monitoring of health status##2##4##(1997-1#2)
monitoring of individual##2##3##(2008-9#1)(2012-2#1)
monitoring of mutagenic process##2##4##(2008-10#2)
monitoring of nitrate##2##3##(2008-10#2)
monitoring of organic##2##3##(2008-10#2)
monitoring of patients with##2##4##(1990-9#1)(2013-1#1)
monitoring of patients##3##3##(1990-9#1)(2008-10#1)(2013-1#1)
monitoring of several##2##3##(2008-10#1)(2012-3#1)
monitoring of the disease##2##4##(1992-3#1)(1992-9#1)
monitoring of the##23##3##(1992-3#1)(1992-9#1)(1997-8#1)(2008-10#14)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
monitoring of these##2##3##(2008-10#1)(2012-3#1)
monitoring of waste water##3##4##(2008-10#3)
monitoring of water##2##3##(2008-10#2)
monitoring of##184##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-3#3)(1994-3#1)(1995-1#1)(1995-5#1)(1996-6#5)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#100)(2008-11#11)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#3)(2009-6#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#7)(2013-8#1)
monitoring program of##2##3##(2008-10#2)
monitoring programme##2##2##(2008-10#1)(2008-11#1)
monitoring programs##2##2##(2008-10#2)
monitoring schemes##2##2##(2008-10#2)
monitoring should help to##2##4##(2011-2#1)(2012-3#1)
monitoring should##4##2##(2009-8#1)(2011-2#2)(2012-3#1)
monitoring sites##4##2##(2008-10#4)
monitoring stations##3##2##(2008-10#1)(2008-11#2)
monitoring system and##2##3##(2008-1#1)(2012-3#1)
monitoring system for##2##3##(2008-10#1)(2008-3#1)
monitoring system##12##2##(1994-6#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-11#1)(2012-3#1)(2012-5#1)
monitoring systems have##2##3##(2008-1#1)(2010-8#1)
monitoring systems##5##2##(2008-1#1)(2008-10#3)(2010-8#1)
monitoring techniques##4##2##(2008-10#1)(2011-1#1)(2012-3#2)
monitoring the absorbance of##2##4##(2008-10#2)
monitoring the absorbance##3##3##(2008-10#3)
monitoring the change in##4##4##(1995-6#1)(2008-10#2)(2008-11#1)
monitoring the##63##2##(1991-2#1)(1992-12#1)(1994-9#1)(1995-6#1)(1997-7#1)(2006-6#1)(2008-10#39)(2008-11#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#4)(2012-3#1)
monitoring their##3##2##(1992-1#1)(1994-12#1)(2008-11#1)
monitoring therapy##2##2##(2008-2#1)(2010-12#1)
monitoring to##3##2##(1992-5#1)(1994-1#1)(2010-1#1)
monitoring tool##2##2##(2008-10#1)(2008-11#1)
monitoring tools that##2##3##(2008-10#1)(2011-1#1)
monitoring utilization##2##2##(1994-1#1)(1996-1#1)
monitoring was performed##2##3##(2008-10#1)(2008-5#1)
monitoring was##7##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
monitoring##656##1##(1990-11#4)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#3)(1994-1#2)(1994-11#2)(1994-12#2)(1994-3#7)(1994-6#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#7)(1997-1#3)(1997-2#10)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-6#3)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#8)(2008-10#319)(2008-11#46)(2008-12#5)(2008-2#3)(2008-3#16)(2008-4#9)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#2)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#6)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#7)(2010-10#2)(2010-11#6)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#7)(2011-1#2)(2011-2#26)(2011-3#4)(2012-12#2)(2012-2#14)(2012-3#16)(2012-4#2)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#4)
monitoring)##2##1##(2008-4#1)(2012-3#1)
monitors (who are more##2##4##(2008-4#2)
monitors for##2##2##(1990-8#1)(1992-3#1)
monitors the##3##2##(2008-10#2)(2008-3#1)
monitors##18##1##(1990-8#1)(1992-3#1)(1993-12#1)(1996-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2011-2#1)(2011-7#1)
monkey (Macaca##2##2##(1997-2#1)(2012-2#1)
monkey and human retina##2##4##(1991-10#2)
monkey and human##5##3##(1991-10#3)(1997-2#1)(1997-7#1)
monkey and##7##2##(1991-1#1)(1991-10#3)(1997-2#1)(1997-7#1)(2008-8#1)
monkey##35##1##(1991-1#2)(1991-10#3)(1991-2#1)(1991-4#2)(1992-6#1)(1993-6#2)(1995-11#1)(1997-2#5)(1997-7#1)(2008-10#1)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#2)(2012-2#3)
monkeys and##4##2##(1990-11#1)(1994-3#1)(1997-2#1)(2008-8#1)
monkeys were##3##2##(1994-3#2)(2008-10#1)
monkeys##40##1##(1990-11#2)(1991-1#5)(1991-3#1)(1991-6#1)(1991-9#1)(1993-6#2)(1994-3#7)(1996-2#4)(1997-2#2)(2008-10#3)(2008-11#3)(2008-4#2)(2008-5#3)(2008-8#1)(2012-3#3)
mono##4##1##(1994-11#2)(2008-10#1)(2008-7#1)
mono- and disaccharides##2##3##(1992-6#1)(2008-10#1)
mono- and divalent##2##3##(2008-10#2)
mono- and##19##2##(1991-7#1)(1992-6#1)(1997-2#1)(2008-10#13)(2008-11#1)(2008-8#1)(2011-1#1)
mono-##30##1##(1991-7#1)(1992-6#1)(1996-5#1)(1997-1#2)(1997-2#1)(2008-10#19)(2008-11#2)(2008-8#1)(2010-6#1)(2011-1#1)
mono-female lines of a M##2##5##(2008-10#2)
mono-female lines of##3##3##(2008-10#3)
mono-isopropylamine salt##3##2##(2008-10#3)
monoalkyl esters of meso-2##2##4##(1992-12#2)
monoalkyl##3##1##(1992-12#2)(2008-10#1)
monoamine neurotransmitters##4##2##(1996-12#1)(2008-10#3)
monoamine oxidase##7##2##(1994-3#1)(1994-8#1)(1995-8#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)
monoamine##22##1##(1993-1#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-8#4)(1995-8#1)(1996-12#4)(1996-2#1)(2008-10#3)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)
monoamines in##3##2##(1993-1#2)(2008-10#1)
monoamines##4##1##(1993-1#2)(2008-10#2)
monoanion##3##1##(2008-10#3)
monoarthritis##3##1##(2008-12#2)(2013-8#1)
monoaza crown ethers##2##3##(2008-10#2)
monoaza##3##1##(2008-10#3)
monoaza-12-crown-4 ether##2##2##(2008-10#2)
monobromobenzoic acids##3##2##(2008-10#3)
monobutyltin chloride##2##2##(2008-10#2)
monobutyltin hydride##2##2##(2008-10#2)
monobutyltin##4##1##(2008-10#4)
monocarboxylic acids##2##2##(2008-10#2)
monochannel##3##1##(2008-10#3)
monochloramine in##2##2##(2008-7#2)
monochloramine##5##1##(2008-10#1)(2008-7#4)
monochloro-##2##1##(2008-10#2)
monochlorobenzene##2##1##(2008-10#2)
monochromatic spectrum##2##2##(2013-8#2)
monochromatic##6##1##(2008-11#1)(2008-3#2)(2011-2#1)(2013-8#2)
monochromator##6##1##(2008-10#2)(2008-2#4)
monocistronic expression vectors##2##3##(1993-6#2)
monoclinic##4##1##(1993-8#1)(1996-5#1)(2008-10#2)
monoclonal and polyclonal antibodies##3##4##(1990-5#2)(2008-1#1)
monoclonal and##5##2##(1990-5#2)(2008-1#1)(2008-5#2)
monoclonal anti-fluorescein##2##2##(1992-6#2)
monoclonal antibodies (MAbs) to##2##4##(2008-10#2)
monoclonal antibodies (MAbs)##11##3##(1990-12#1)(1992-2#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)
monoclonal antibodies (MoAbs)##3##3##(1993-1#1)(1995-12#1)(2008-7#1)
monoclonal antibodies (mAbs) against##2##4##(1996-12#2)
monoclonal antibodies (mAbs)##8##3##(1994-5#1)(1996-12#2)(2008-10#1)(2008-11#3)(2008-8#1)
monoclonal antibodies against##11##3##(1990-2#1)(1995-12#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-2#1)
monoclonal antibodies and##6##3##(2008-10#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-3#1)
monoclonal antibodies directed against##3##4##(1992-12#1)(1992-2#1)(1994-5#1)
monoclonal antibodies for##3##3##(1993-2#1)(2008-11#1)(2008-5#1)
monoclonal antibodies in##3##3##(1990-12#1)(2008-11#1)(2008-7#1)
monoclonal antibodies raised against##2##4##(1995-12#1)(2008-10#1)
monoclonal antibodies that##3##3##(1993-9#1)(1995-2#1)(1996-12#1)
monoclonal antibodies to##5##3##(1990-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(2008-11#1)
monoclonal antibodies was##2##3##(2007-12#1)(2008-10#1)
monoclonal antibodies were used to##2##5##(2008-10#1)(2008-9#1)
monoclonal antibodies were##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
monoclonal antibodies with##2##3##(1995-3#1)(2008-9#1)
monoclonal antibodies##123##2##(1990-12#3)(1990-2#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-5#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#4)(1997-8#1)(1997-9#1)(2006-6#1)(2007-12#2)(2008-10#24)(2008-11#24)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#7)(2008-9#11)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#3)(2012-3#3)
monoclonal antibody (MAb) was produced##2##5##(2008-10#1)(2008-11#1)
monoclonal antibody (MAb)##6##3##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)
monoclonal antibody (Mab)##2##3##(2008-10#1)(2008-11#1)
monoclonal antibody (mAb)##6##3##(1996-12#1)(2008-11#3)(2008-5#1)(2009-8#1)
monoclonal antibody 6B10 was##2##4##(2008-8#2)
monoclonal antibody 6B10##4##3##(2008-8#4)
monoclonal antibody P37##2##3##(2006-6#2)
monoclonal antibody against a##2##4##(1995-6#1)(2008-11#1)
monoclonal antibody against##11##3##(1992-11#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-11#4)
monoclonal antibody alpha##2##3##(1994-5#2)
monoclonal antibody and##4##3##(1993-1#1)(2008-10#1)(2008-9#2)
monoclonal antibody for##3##3##(2008-10#1)(2008-11#2)
monoclonal antibody in##3##3##(1990-2#1)(1993-2#1)(2008-11#1)
monoclonal antibody on the##2##4##(2008-10#2)
monoclonal antibody production by##3##4##(2008-11#3)
monoclonal antibody production##14##3##(2008-11#12)(2008-7#1)(2011-2#1)
monoclonal antibody specific for##5##4##(1990-12#2)(1995-2#1)(2008-10#1)(2008-11#1)
monoclonal antibody specific##6##3##(1990-12#2)(1995-2#1)(2008-10#2)(2008-11#1)
monoclonal antibody that##3##3##(1992-9#1)(1993-12#1)(2012-3#1)
monoclonal antibody to##8##3##(1992-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#1)
monoclonal antibody using##2##3##(2008-11#2)
monoclonal antibody was immobilized##2##4##(2008-10#2)
monoclonal antibody was##10##3##(1990-12#1)(1990-5#1)(1992-11#1)(2008-10#3)(2008-11#2)(2008-8#2)
monoclonal antibody were##3##3##(2008-10#2)(2011-2#1)
monoclonal antibody with##2##3##(2010-12#1)(2013-1#1)
monoclonal antibody##166##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#1)(1990-8#1)(1992-11#3)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-5#2)(1994-6#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#2)(1996-12#3)(1996-2#1)(1997-1#3)(1997-3#1)(1997-7#1)(2006-6#2)(2008-10#29)(2008-11#58)(2008-5#4)(2008-7#3)(2008-8#9)(2008-9#4)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
monoclonal gammopathy##2##2##(1992-12#1)(2008-9#1)
monoclonal nodules##2##2##(2008-5#2)
monoclonal or polyclonal antibodies##2##4##(1991-5#1)(2008-9#1)
monoclonal or polyclonal##4##3##(1991-5#1)(2008-5#1)(2008-9#1)(2012-2#1)
monoclonal##334##1##(1990-11#2)(1990-12#7)(1990-2#3)(1990-5#3)(1990-6#2)(1990-8#2)(1991-2#2)(1991-5#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#5)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#6)(1993-9#2)(1994-5#4)(1994-6#1)(1995-11#2)(1995-12#8)(1995-2#6)(1995-3#3)(1995-6#3)(1995-9#1)(1996-12#7)(1996-2#1)(1997-1#3)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#4)(2007-12#2)(2008-1#1)(2008-10#55)(2008-11#85)(2008-4#4)(2008-5#19)(2008-6#1)(2008-7#5)(2008-8#16)(2008-9#19)(2009-8#3)(2010-11#2)(2010-12#2)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)(2013-8#2)
monoclonalantibody production##2##2##(2008-11#2)
monoclonalantibody##4##1##(2008-11#4)
monoconidial isolates##2##2##(2008-10#2)
monocot##4##1##(1991-6#1)(2008-10#1)(2008-9#1)(2013-8#1)
monocots and##2##2##(2010-5#2)
monocots##4##1##(2008-10#1)(2008-9#1)(2010-5#2)
monocotyledonous##3##1##(2008-10#1)(2008-9#1)(2009-10#1)
monocrystalline##2##1##(2008-10#2)
monocular##2##1##(2010-3#1)(2013-8#1)
monoculture##8##1##(2008-10#3)(2008-11#1)(2008-8#4)
monocultures##2##1##(2008-10#1)(2008-5#1)
monocyclic beta-lactams##2##2##(1993-8#2)
monocyclic##5##1##(1993-8#2)(2008-10#2)(2011-2#1)
monocyte and##2##2##(2006-6#1)(2008-10#1)
monocyte chemoattractant##4##2##(2008-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
monocyte##13##1##(1991-7#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#2)(2013-1#2)
monocyte-derived dendritic cells##3##3##(2008-11#3)
monocyte-derived##5##1##(2008-11#3)(2010-3#1)(2011-2#1)
monocyte-macrophages##2##1##(2008-11#2)
monocyte/macrophage##3##1##(1991-2#1)(1995-3#2)
monocytes and T##2##3##(1997-8#1)(2008-1#1)
monocytes and##5##2##(1991-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
monocytes that##3##2##(1991-7#1)(1992-12#1)(1994-5#1)
monocytes via##2##2##(1995-8#1)(2008-11#1)
monocytes##38##1##(1990-5#2)(1991-6#1)(1991-7#2)(1992-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#5)(1996-12#1)(1997-8#1)(2006-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#7)(2012-2#3)(2013-1#1)
monocytes/macrophages##5##1##(2008-10#2)(2008-5#1)(2010-1#2)
monocytic differentiation and##2##3##(1995-6#1)(1997-7#1)
monocytic differentiation##9##2##(1993-8#1)(1995-6#2)(1997-7#6)
monocytic erlychiosis##3##2##(2013-1#3)
monocytic##17##1##(1993-6#1)(1993-8#1)(1995-6#3)(1997-1#1)(1997-7#6)(2008-10#1)(2013-1#4)
monocytogenes in mice##2##3##(1996-12#2)
monocytogenes in##6##2##(1996-12#3)(2008-10#1)(2011-2#1)(2012-2#1)
monocytogenes infection##3##2##(1996-12#2)(2012-12#1)
monocytogenes was##2##2##(1996-12#2)
monocytogenes were##4##2##(1996-12#1)(2008-10#1)(2010-4#2)
monocytogenes##41##1##(1996-12#15)(2006-5#1)(2008-10#6)(2008-11#1)(2010-4#7)(2011-2#5)(2012-12#1)(2012-2#5)
monodii##2##1##(2008-10#2)
monodisperse aerosol##2##2##(1996-2#1)(2008-7#1)
monodisperse##12##1##(1990-6#1)(1992-12#2)(1994-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2010-10#1)
monodominant##2##1##(2008-8#2)
monoecious##2##1##(2009-12#1)(2012-3#1)
monoenzyme electrode##2##2##(2008-10#2)
monoenzyme##3##1##(2008-10#3)
monoester##3##1##(2008-10#1)(2008-4#1)(2008-7#1)
monoesters##5##1##(1992-12#5)
monoethylene glycol##2##2##(2008-10#2)
monofunctional##6##1##(1990-7#1)(1993-12#2)(2008-10#2)(2008-11#1)
monogamous and##3##2##(2008-8#2)(2012-2#1)
monogamous##7##1##(2008-8#3)(2008-9#3)(2012-2#1)
monogamy##4##1##(2008-9#4)
monogenic inheritance of resistance##2##4##(2008-10#2)
monogenic##5##1##(2008-10#4)(2012-3#1)
monoglucoside (TMG)##2##2##(2008-10#2)
monoglucoside##3##1##(2008-10#2)(2008-11#1)
monoglycerides##3##1##(2008-5#3)
monographs##4##1##(2008-10#2)(2012-2#2)
monohydrate in##2##2##(2008-10#2)
monohydrate##10##1##(1992-12#1)(1995-8#2)(2008-10#7)
monohydrochloride##6##1##(1993-1#1)(1996-2#1)(2008-10#4)
monokaryotic##2##1##(2008-10#2)
monolayer (SAM) of##4##3##(2008-10#4)
monolayer (SAM)##9##2##(2008-10#9)
monolayer and##6##2##(2008-10#1)(2008-11#3)(2011-2#1)(2012-3#1)
monolayer by##3##2##(2008-10#1)(2008-11#2)
monolayer cell cultures##3##3##(2008-11#1)(2008-2#1)(2008-5#1)
monolayer culture##14##2##(1990-8#1)(1997-1#1)(2008-11#12)
monolayer cultures of##2##3##(1990-5#1)(1992-6#1)
monolayer cultures##3##2##(1990-5#1)(1992-6#1)(2008-9#1)
monolayer film##6##2##(1997-2#1)(2008-10#3)(2008-8#2)
monolayer for##2##2##(2008-10#2)
monolayer in the presence of##2##5##(2008-10#1)(2008-11#1)
monolayer in the##5##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)
monolayer in##7##2##(1992-9#1)(1994-5#1)(2008-10#2)(2008-11#2)(2008-5#1)
monolayer is##4##2##(1991-5#2)(2008-10#2)
monolayer modified chitosan-entrapped carbon paste electrode##2##6##(2008-10#2)
monolayer modified gold electrode##2##4##(2008-10#2)
monolayer modified gold##3##3##(2008-10#3)
monolayer modified##6##2##(2008-10#6)
monolayer of##14##2##(1995-2#2)(2008-10#7)(2008-11#2)(2008-8#1)(2009-3#1)(2009-5#1)
monolayer on##4##2##(2008-10#4)
monolayer##134##1##(1990-5#4)(1990-8#1)(1991-3#2)(1991-5#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-5#1)(1995-2#2)(1995-8#1)(1997-1#1)(1997-2#2)(2008-10#52)(2008-11#37)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-11#2)(2009-3#1)(2009-5#1)(2011-2#1)(2011-3#3)(2012-3#1)(2013-1#2)
monolayer)##2##1##(2008-10#2)
monolayer-protected##2##1##(2008-10#2)
monolayered##2##1##(2007-12#1)(2008-5#1)
monolayers and##6##2##(1994-5#2)(2008-10#1)(2008-11#1)(2010-7#2)
monolayers in a##2##3##(1990-5#1)(2008-11#1)
monolayers of##4##2##(1991-3#1)(1992-12#1)(2008-10#1)(2008-11#1)
monolayers to##2##2##(1990-5#1)(2008-10#1)
monolayers were##2##2##(2008-10#1)(2008-11#1)
monolayers##52##1##(1990-5#3)(1991-3#2)(1992-12#1)(1992-8#1)(1994-3#1)(1994-5#5)(1994-9#1)(1997-2#1)(2008-10#21)(2008-11#14)(2010-7#2)
monolingual##2##1##(2008-11#1)(2008-2#1)
monolith with##3##2##(2008-10#3)
monolith##6##1##(2008-10#6)
monolith-based##2##1##(2008-10#2)
monolithic column##10##2##(2008-10#10)
monolithic columns##4##2##(2008-10#4)
monolithic multiple-face##2##2##(2008-3#2)
monolithic silica##3##2##(2008-10#3)
monolithic##28##1##(2008-10#23)(2008-2#1)(2008-3#3)(2009-7#1)
monoliths##4##1##(2008-10#4)
monomer and dimer##2##3##(2008-10#2)
monomer and the##2##3##(2008-10#2)
monomer and##6##2##(2008-10#6)
monomer concentration##2##2##(1994-11#1)(2008-10#1)
monomer contains##2##2##(1992-4#1)(1993-8#1)
monomer in##3##2##(1993-8#1)(2008-7#1)(2008-8#1)
monomer of##6##2##(2008-10#3)(2008-11#2)(2008-8#1)
monomer that##2##2##(1992-4#1)(2007-12#1)
monomer##60##1##(1990-5#1)(1991-5#1)(1992-12#3)(1992-4#4)(1993-8#3)(1994-11#2)(1995-8#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#27)(2008-11#4)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#3)(2011-1#1)
monomer-dimer##3##1##(1993-8#1)(2008-10#2)
monomer-monomer##2##1##(1992-4#1)(1994-5#1)
monomeric alpha##2##2##(2008-7#2)
monomeric analogs##2##2##(2008-10#2)
monomeric and##4##2##(1994-11#1)(1995-6#1)(2008-10#1)(2008-7#1)
monomeric##32##1##(1991-7#1)(1993-8#1)(1994-11#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-7#5)(2008-8#1)(2010-4#1)(2011-2#1)
monomers in the asymmetric unit##2##5##(1992-4#1)(1993-8#1)
monomers in the##3##3##(1992-4#1)(1993-8#1)(1994-11#1)
monomers in##6##2##(1992-4#1)(1993-8#1)(1994-11#1)(2008-11#1)(2008-7#1)(2011-1#1)
monomers is##3##2##(1993-8#1)(2008-2#1)(2008-4#1)
monomers on##2##2##(2008-10#1)(2011-2#1)
monomers with##2##2##(2008-10#2)
monomers##45##1##(1990-5#1)(1990-8#1)(1991-5#3)(1992-4#1)(1993-11#1)(1993-8#4)(1994-11#1)(1997-2#1)(1997-6#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)
monomethylarsonate and dimethylarsinate)##2##3##(2008-10#2)
monomethylarsonate##3##1##(2008-10#3)
monomethylarsonic acid (MMA)##5##3##(2008-10#5)
monomethylarsonic acid and dimethylarsinic acid)##2##5##(2008-10#2)
monomethylarsonic acid and dimethylarsinic##3##4##(2008-10#3)
monomethylarsonic acid##15##2##(2008-10#15)
monomethylarsonic##16##1##(2008-10#16)
monomodal##2##1##(2008-10#1)(2009-7#1)
monomolecular model##2##2##(2008-10#2)
monomolecular##9##1##(2008-10#7)(2008-8#1)(2012-2#1)
monomorphic and polymorphic##2##3##(1992-6#2)
monomorphic and##3##2##(1992-6#2)(2008-10#1)
monomorphic##6##1##(1992-6#3)(2008-10#2)(2008-8#1)
mononeuritis##2##1##(2008-7#2)
mononuclear cell##4##2##(2008-7#1)(2009-10#1)(2010-6#2)
mononuclear cells and##3##3##(2008-11#1)(2009-10#1)(2010-6#1)
mononuclear cells from##3##3##(1992-3#1)(2008-4#1)(2008-9#1)
mononuclear cells in##2##3##(2008-7#1)(2010-6#1)
mononuclear cells of##2##3##(2008-11#1)(2013-7#1)
mononuclear cells##37##2##(1990-2#1)(1992-3#1)(1992-6#2)(2008-10#4)(2008-11#7)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#6)(2009-10#1)(2009-3#1)(2010-6#4)(2011-2#2)(2011-3#1)(2012-3#1)(2013-7#1)
mononuclear##52##1##(1990-2#1)(1991-11#4)(1992-3#1)(1992-6#2)(1997-8#1)(2008-10#7)(2008-11#8)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#6)(2009-10#2)(2009-3#1)(2010-6#6)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
mononucleosis syndrome##4##2##(2011-2#4)
mononucleosis##12##1##(1992-2#1)(1993-11#1)(2008-5#2)(2008-9#1)(2011-2#7)
mononucleotide##2##1##(1991-5#1)(2009-3#1)
monooxygenase activity##2##2##(1991-12#1)(1992-3#1)
monooxygenase##10##1##(1991-12#3)(1991-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(2008-11#1)(2009-6#2)
monooxygenases##7##1##(1994-5#1)(2008-11#2)(2009-8#1)(2009-9#3)
monoparentalité et##2##2##(2008-11#2)
monopartite begomoviruses##2##2##(2008-10#2)
monopartite##9##1##(2008-10#9)
monophasic##4##1##(1995-12#1)(1995-8#1)(2010-8#1)(2013-1#1)
monophosphate (cAMP)##3##2##(1994-11#1)(1994-8#1)(1995-8#1)
monophosphate##15##1##(1993-2#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-8#4)(2008-10#3)(2008-12#2)(2008-7#1)(2009-3#1)
monophosphosphorothioate##2##1##(1993-6#2)
monophyletic cluster##2##2##(2013-8#2)
monophyletic group##5##2##(2008-10#2)(2008-6#1)(2010-10#1)(2010-8#1)
monophyletic groups##4##2##(2008-10#3)(2008-8#1)
monophyletic##20##1##(2008-10#13)(2008-6#1)(2008-8#1)(2010-10#1)(2010-8#1)(2013-8#3)
monophyly of##4##2##(2008-10#3)(2008-6#1)
monophyly##5##1##(2007-12#1)(2008-10#3)(2008-6#1)
monoplex##2##1##(2008-10#1)(2011-2#1)
monopolar modes##2##2##(2008-9#2)
monopolar##4##1##(1992-12#1)(2008-9#2)(2010-7#1)
monopoly##4##1##(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
monoracial/ethnic##3##1##(2013-8#3)
monosaccharide composition analysis##2##3##(1997-2#2)
monosaccharide composition##3##2##(1997-2#3)
monosaccharide##12##1##(1990-8#1)(1993-8#2)(1997-2#4)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)
monosaccharides##8##1##(1991-7#1)(1992-6#1)(1997-2#1)(2008-10#3)(2011-2#2)
monosegmented flow analysis##3##3##(2008-10#3)
monosegmented flow system##2##3##(2008-10#2)
monosegmented flow##6##2##(2008-10#6)
monosodium glutamate##2##2##(2008-10#1)(2012-3#1)
monosodium##4##1##(1990-5#1)(2008-10#2)(2012-3#1)
monosomic##2##1##(2008-10#2)
monosomy 7##2##2##(2013-1#2)
monosomy##4##1##(1992-12#1)(2012-3#1)(2013-1#2)
monospecific##3##1##(2008-10#1)(2008-8#1)(2011-2#1)
monosubstituted##4##1##(2008-10#2)(2008-8#1)(2010-3#1)
monosyllabic##3##1##(2008-9#3)
monosynaptic##2##1##(1996-2#1)(1997-3#1)
monoterpene##9##1##(2008-10#2)(2008-11#5)(2008-12#1)(2011-10#1)
monoterpenes were##3##2##(2008-10#1)(2011-10#1)(2013-8#1)
monoterpenes##15##1##(2008-10#7)(2008-11#2)(2008-12#1)(2011-10#2)(2013-1#2)(2013-8#1)
monoterpenic compounds##2##2##(2008-10#2)
monotherapy in##2##2##(2011-10#1)(2012-3#1)
monotherapy##16##1##(1990-6#1)(1992-3#1)(1996-3#1)(1997-5#1)(2008-10#2)(2009-10#1)(2010-3#1)(2011-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
monotone##7##1##(2008-11#5)(2008-8#2)
monotonic loading##2##2##(2009-3#2)
monotonic##5##1##(2008-10#1)(2008-7#1)(2009-3#2)(2009-7#1)
monotonically##9##1##(1993-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-7#1)
monotonously##2##1##(2008-11#2)
monovalent and divalent cations##2##4##(2008-10#2)
monovalent and divalent##4##3##(2008-10#2)(2011-2#2)
monovalent anions and cations##2##4##(2008-10#2)
monovalent cations##3##2##(1993-6#1)(1994-12#1)(2008-10#1)
monovalent ions##5##2##(2008-10#4)(2010-7#1)
monovalent##24##1##(1990-3#1)(1993-6#1)(1994-12#1)(2008-1#1)(2008-10#16)(2010-7#1)(2011-2#2)(2012-3#1)
monovision##6##1##(2011-2#6)
monoxide (CO)##4##2##(1990-5#1)(1995-2#1)(1996-12#2)
monoxide poisoning##4##2##(1990-5#1)(2009-11#3)
monoxide was##2##2##(2008-10#1)(2010-10#1)
monoxide##22##1##(1990-5#2)(1991-3#1)(1993-8#2)(1995-2#2)(1996-12#3)(2008-10#5)(2008-11#1)(2009-11#3)(2009-5#1)(2010-10#1)(2010-12#1)
monozygotic twin##4##2##(2008-12#1)(2010-12#3)
monozygotic twins##6##2##(2008-7#3)(2010-1#2)(2010-12#1)
monozygotic##13##1##(2008-11#1)(2008-12#1)(2008-7#3)(2010-1#3)(2010-12#4)(2010-8#1)
monster##7##1##(2009-10#7)
montage##3##1##(2008-10#2)(2010-8#1)
montane##2##1##(2008-8#2)
montanus)##2##1##(2008-5#2)
montelukast##5##1##(2008-1#3)(2008-11#2)
month after cauliflower transplanting and##2##5##(2008-10#2)
month after inoculation##2##3##(2008-10#1)(2008-8#1)
month after the##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
month after##19##2##(1991-2#1)(1991-3#1)(1993-2#1)(1997-3#1)(2008-10#7)(2008-5#2)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#2)
month alcohol##2##2##(2010-9#1)(2012-12#1)
month and##6##2##(2008-10#3)(2008-12#1)(2012-12#1)(2013-8#1)
month before##2##2##(1993-6#1)(2008-10#1)
month follow-up##6##2##(1993-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
month for##5##2##(1996-3#1)(1996-8#1)(1997-8#3)
month from##3##2##(2008-10#2)(2008-11#1)
month in##7##2##(1995-12#2)(2008-11#2)(2008-8#2)(2011-2#1)
month of age##3##3##(2012-2#2)(2013-1#1)
month of treatment##2##3##(1993-2#1)(2008-7#1)
month of##20##2##(1991-12#1)(1992-12#1)(1993-2#1)(1996-12#2)(1996-8#1)(1997-8#1)(2007-8#2)(2008-10#4)(2008-7#1)(2010-6#1)(2011-1#2)(2012-2#2)(2013-1#1)
month old##4##2##(1990-2#1)(1993-3#1)(1995-8#1)(1996-6#1)
month period##2##2##(1994-3#1)(2008-12#1)
month to##3##2##(1991-9#1)(2011-2#2)
month##147##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-12#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-6#2)(1994-3#1)(1995-12#2)(1995-2#2)(1995-8#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-8#6)(2007-8#2)(2008-10#33)(2008-11#15)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2009-3#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-9#6)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#4)
month) of##2##2##(2008-10#2)
month)##6##1##(1990-12#1)(2007-11#1)(2008-10#3)(2008-11#1)
monthly and##2##2##(2008-6#1)(2011-2#1)
monthly from##4##2##(2008-10#4)
monthly##35##1##(1991-1#1)(1991-11#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-5#2)(1997-3#2)(2008-10#9)(2008-12#3)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#3)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
months (mean##4##2##(1990-6#1)(2009-3#1)(2013-1#2)
months (p &lt##2##3##(1995-12#1)(1997-5#1)
months (p##4##2##(1995-12#1)(1997-5#3)
months (range 3-7 months)##2##4##(1993-2#1)(2010-3#1)
months (range##23##2##(1990-12#2)(1991-6#2)(1992-12#1)(1992-2#1)(1993-2#1)(1996-3#1)(2008-10#2)(2008-9#3)(2009-3#2)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#1)
months a##2##2##(1990-3#1)(2008-10#1)
months after a##2##3##(2008-10#1)(2008-8#1)
months after completion of##2##4##(1991-6#2)
months after diagnosis##2##3##(1991-6#1)(2009-8#1)
months after embolisation##3##3##(1997-3#2)(1997-6#1)
months after his##2##3##(2008-11#1)(2011-2#1)
months after initial##4##3##(2009-1#1)(2011-2#2)(2013-1#1)
months after intervention##2##3##(2013-1#2)
months after operation##3##3##(2008-9#2)(2011-2#1)
months after release from prison##2##5##(2009-11#2)
months after stroke##2##3##(2008-7#1)(2009-10#1)
months after surgery and##2##4##(1993-3#2)
months after surgery##16##3##(1990-6#1)(1992-9#1)(1993-3#3)(1994-12#1)(1994-8#1)(2008-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
months after the acute episode##2##5##(1991-8#1)(2010-10#1)
months after the operation##5##4##(1991-12#1)(2011-2#3)(2013-1#1)
months after the procedure##4##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
months after the second injection##2##5##(1996-12#2)
months after the##28##3##(1991-12#1)(1991-3#1)(1991-8#1)(1994-1#1)(1995-9#1)(1996-12#2)(1997-8#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-11#1)(2010-10#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
months after treatment##6##3##(1994-12#1)(1995-2#1)(2013-1#4)
months after undergoing##2##3##(2008-7#1)(2011-2#1)
months after##127##2##(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-3#3)(1993-8#1)(1994-1#1)(1994-12#4)(1994-8#1)(1995-2#2)(1995-9#2)(1996-11#1)(1996-12#4)(1996-5#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#3)(2009-8#1)(2010-10#2)(2010-5#1)(2011-1#1)(2011-2#18)(2012-12#2)(2012-2#1)(2013-1#17)(2013-8#3)
months and 12 months##2##4##(2008-11#1)(2008-12#1)
months and four##2##3##(1990-9#1)(2008-11#1)
months and one year##2##4##(1991-11#2)
months and the##5##3##(2008-10#4)(2013-1#1)
months and their neonates##2##4##(2011-1#2)
months and##45##2##(1990-12#2)(1990-9#2)(1991-11#2)(1991-8#1)(1993-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(2008-10#9)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#2)
months as##3##2##(1995-8#1)(2008-10#1)(2012-2#1)
months at 4 degrees C##2##5##(2008-10#2)
months at##10##2##(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
months before the##2##3##(2013-1#1)(2013-8#1)
months before##7##2##(1996-5#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
months but##3##2##(1992-5#1)(2008-7#1)(2012-12#1)
months compared with##4##3##(2008-7#1)(2010-1#1)(2013-1#2)
months duration##2##2##(2010-11#1)(2012-3#1)
months earlier than##2##3##(1997-2#1)(2008-10#1)
months earlier##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
months follow-up were considered##2##4##(2008-7#1)(2012-12#1)
months follow-up##5##2##(1993-1#1)(2008-7#2)(2011-2#1)(2012-12#1)
months following surgery##3##3##(1995-2#1)(2011-2#1)(2013-1#1)
months following the##4##3##(2008-1#1)(2008-10#1)(2008-12#2)
months following##14##2##(1992-1#1)(1995-2#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2009-10#1)(2011-2#2)(2013-1#2)
months for##8##2##(1991-11#1)(1991-8#2)(1994-8#2)(2011-2#3)
months from the##3##3##(1990-12#2)(2013-1#1)
months from##8##2##(1990-12#2)(1991-8#1)(1992-5#1)(1996-6#1)(1997-7#1)(2010-6#1)(2013-1#1)
months in cold storage##2##4##(2008-10#2)
months in the##9##3##(1992-12#1)(1993-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2012-12#1)
months in##37##2##(1990-5#1)(1990-6#2)(1991-12#1)(1992-12#2)(1993-1#1)(1993-2#1)(1994-6#3)(1994-8#1)(1996-3#1)(1997-3#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-12#1)
months into the##2##3##(1997-2#1)(2008-11#1)
months later and##2##3##(2008-10#1)(2008-7#1)
months later##30##2##(1990-6#1)(1993-1#1)(1993-12#1)(1994-6#1)(1995-6#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-7#4)(2008-8#1)(2009-1#2)(2009-6#1)(2011-1#1)(2011-2#4)(2013-1#3)(2013-8#2)
months of age is##3##4##(1995-8#2)(2008-10#1)
months of age was##2##4##(1991-11#1)(2012-3#1)
months of age##32##3##(1991-11#2)(1991-2#1)(1991-6#1)(1993-12#3)(1995-12#1)(1995-5#1)(1995-8#3)(2006-5#2)(2008-10#2)(2008-11#2)(2008-7#2)(2008-9#4)(2009-10#1)(2010-6#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
months of follow up##2##4##(2008-10#1)(2013-1#1)
months of follow-up##6##3##(1990-2#1)(1993-1#1)(1993-3#1)(2010-9#1)(2013-1#2)
months of intervention##2##3##(2008-9#1)(2013-1#1)
months of life is##2##4##(1995-1#1)(2008-10#1)
months of life##7##3##(1995-1#2)(2008-10#3)(2010-6#1)(2012-2#1)
months of median follow-up##2##4##(1992-5#2)
months of storage at 4 degrees C##3##7##(2008-10#3)
months of the##3##3##(1990-12#1)(1990-6#1)(2011-2#1)
months of therapy##3##3##(1991-12#1)(1991-6#1)(2013-1#1)
months of treatment##8##3##(1991-8#2)(1992-1#1)(2007-11#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
months of##100##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#4)(1992-1#1)(1992-5#2)(1993-1#1)(1993-12#3)(1993-3#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#1)(2006-5#2)(2007-11#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#7)(2009-10#1)(2009-12#1)(2009-7#1)(2010-6#4)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#9)
months old##7##2##(1990-12#1)(1993-12#1)(2008-10#2)(2010-6#1)(2011-1#1)(2012-12#1)
months old) and old##2##4##(2008-7#2)
months old) and##3##3##(1993-12#1)(2008-7#2)
months old) animals##3##3##(1993-12#3)
months old)##10##2##(1993-12#4)(2008-7#6)
months or##3##2##(1991-11#1)(2009-5#1)(2011-2#1)
months postoperatively##9##2##(1991-3#1)(1994-3#2)(2008-7#1)(2008-9#2)(2010-12#1)(2012-3#1)(2013-1#1)
months previously##5##2##(1990-8#1)(1995-9#1)(2010-6#3)
months prior to##2##3##(1995-1#1)(2008-10#1)
months product use##2##3##(2008-10#2)
months respectively##3##2##(1991-3#1)(2008-10#1)(2013-1#1)
months showed##3##2##(1990-6#1)(2008-7#1)(2013-1#1)
months the##4##2##(1990-3#1)(1996-3#1)(1996-9#1)(2008-10#1)
months to 6##2##3##(1996-12#1)(2008-9#1)
months to years##2##3##(1991-11#1)(2008-11#1)
months to##15##2##(1990-12#1)(1991-11#1)(1991-2#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-6#1)(2012-12#1)(2013-1#1)
months using the##2##3##(2008-10#1)(2012-3#1)
months using##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
months was##7##2##(2008-10#3)(2009-5#1)(2010-10#1)(2013-1#2)
months were found##2##3##(2011-2#1)(2012-12#1)
months were##7##2##(1991-12#1)(1991-8#1)(1994-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
months when##2##2##(2008-10#1)(2013-1#1)
months with good reproducibility##5##4##(2008-10#5)
months with##13##2##(2008-10#8)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#1)
months without any considerable change in##2##6##(2008-10#2)
months without any considerable divergence in##3##6##(2008-10#3)
months without any considerable##5##4##(2008-10#5)
months without any measurable divergence in##2##6##(2008-10#2)
months without any significant##2##4##(2008-10#2)
months without any##13##3##(2008-10#12)(2011-2#1)
months without observing any divergence##2##5##(2008-10#2)
months without observing any##4##4##(2008-10#4)
months without##19##2##(2008-10#18)(2011-2#1)
months##928##1##(1990-12#13)(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#12)(1990-8#1)(1990-9#6)(1991-1#1)(1991-11#13)(1991-12#4)(1991-2#13)(1991-3#7)(1991-6#8)(1991-8#22)(1991-9#1)(1992-1#2)(1992-12#4)(1992-2#3)(1992-5#7)(1992-6#1)(1992-9#3)(1993-1#5)(1993-11#4)(1993-12#12)(1993-2#3)(1993-3#6)(1993-6#2)(1993-8#2)(1994-1#2)(1994-12#9)(1994-2#1)(1994-3#2)(1994-6#5)(1994-8#7)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#8)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#7)(1995-9#3)(1996-1#3)(1996-11#3)(1996-12#11)(1996-2#5)(1996-3#5)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#8)(1997-4#3)(1997-5#9)(1997-6#3)(1997-7#1)(1997-8#2)(1997-9#1)(2006-5#2)(2007-11#2)(2008-1#14)(2008-10#150)(2008-11#36)(2008-12#16)(2008-3#2)(2008-4#7)(2008-5#13)(2008-6#1)(2008-7#39)(2008-8#9)(2008-9#28)(2009-1#3)(2009-10#7)(2009-11#6)(2009-12#4)(2009-3#7)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#7)(2010-10#3)(2010-11#4)(2010-12#2)(2010-2#3)(2010-3#8)(2010-4#1)(2010-5#2)(2010-6#20)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#72)(2011-3#2)(2012-12#16)(2012-2#19)(2012-3#24)(2013-1#79)(2013-8#11)
months'##2##1##(1995-11#1)(2008-11#1)
months) after##2##2##(1993-2#1)(1996-1#1)
months) and average patient age at surgery was##2##8##(2009-3#2)
months) and##8##2##(1996-9#1)(1997-9#1)(2008-10#1)(2008-7#2)(2009-3#2)(2009-5#1)
months) of##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
months) to##2##2##(1996-11#1)(2008-7#1)
months) with good reproducibility (S##2##5##(2008-10#2)
months)##72##1##(1990-6#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-11#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-9#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-7#9)(2008-8#1)(2008-9#3)(2009-3#4)(2009-5#3)(2010-12#1)(2010-3#1)(2011-2#4)(2011-3#2)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#3)
months)]##2##1##(2011-2#2)
monticola##6##1##(2008-10#5)(2008-6#1)
montmorillonite suspensions##2##2##(2008-10#2)
montmorillonite##6##1##(1994-11#1)(2008-10#5)
monuments##4##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
mood after##2##2##(1997-8#1)(2008-11#1)
mood and anxiety disorders##2##4##(1993-2#1)(2010-2#1)
mood and##10##2##(1993-2#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-8#2)
mood disorders##12##2##(1995-5#1)(2008-11#1)(2008-4#2)(2008-7#5)(2012-3#2)(2013-8#1)
mood is##2##2##(2008-11#1)(2013-8#1)
mood of##2##2##(2008-5#1)(2011-2#1)
mood regulatory sensorimotor stimulation##2##4##(2013-8#2)
mood scales##3##2##(1991-8#2)(2008-11#1)
mood stabilizers##2##2##(2008-7#2)
mood stabilizing##2##2##(2008-4#1)(2011-2#1)
mood##79##1##(1991-1#2)(1991-8#8)(1993-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-8#1)(2007-12#1)(2008-11#9)(2008-12#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#12)(2009-10#1)(2009-11#2)(2009-3#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#9)
moods##3##1##(2013-1#3)
moor frog##4##2##(2011-2#2)(2012-3#2)
moral actions##3##2##(2013-8#3)
moral awareness##2##2##(2008-11#2)
moral dilemmas##4##2##(2008-11#4)
moral emotion expectancies##5##3##(2013-8#5)
moral faculty##2##2##(2008-11#2)
moral hazard##2##2##(1992-1#1)(2008-7#1)
moral issues##3##2##(2008-11#2)(2008-12#1)
moral judgment##3##2##(2008-11#3)
moral judgments##3##2##(2008-11#2)(2011-2#1)
moral organ##2##2##(2008-11#2)
moral reasoning##2##2##(2008-11#2)
moral##76##1##(1991-2#3)(1992-1#1)(1994-1#4)(1994-9#1)(1997-8#1)(2008-1#1)(2008-11#37)(2008-12#1)(2008-7#2)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#6)(2013-8#12)
morale and##2##2##(1992-12#1)(2010-10#1)
morale##6##1##(1991-3#1)(1992-12#1)(1996-12#1)(1996-3#1)(2008-9#1)(2010-10#1)
morality in##2##2##(1991-2#1)(1997-2#1)
morality##6##1##(1991-2#1)(1997-2#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
morally##5##1##(1991-2#2)(1992-1#1)(2012-2#1)(2013-8#1)
morbid condition##3##2##(1997-8#2)(2013-1#1)
morbid obesity##2##2##(1993-3#1)(2012-12#1)
morbid##9##1##(1993-3#1)(1994-12#1)(1997-8#2)(2008-7#1)(2008-9#1)(2011-7#1)(2012-12#1)(2013-1#1)
morbidities and##2##2##(1994-2#1)(2009-7#1)
morbidities##6##1##(1994-2#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
morbidity after##5##2##(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
morbidity among the exposed workers##2##5##(2009-12#2)
morbidity among the##3##3##(2009-12#2)(2013-1#1)
morbidity and improve##2##3##(2008-2#1)(2012-12#1)
morbidity and mortality associated with##2##5##(1993-9#1)(2012-2#1)
morbidity and mortality can be##2##5##(2011-2#1)(2013-1#1)
morbidity and mortality from##2##4##(1993-2#1)(2011-2#1)
morbidity and mortality globally##2##4##(2008-8#1)(2009-9#1)
morbidity and mortality in##10##4##(1993-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2011-2#1)
morbidity and mortality worldwide##2##4##(2011-2#2)
morbidity and mortality##67##3##(1992-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1996-3#1)(1997-1#3)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)
morbidity and##89##2##(1992-11#1)(1992-5#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1996-1#1)(1996-3#2)(1997-1#3)(1997-3#1)(2007-12#1)(2008-1#5)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#2)
morbidity as well as##2##4##(1991-9#1)(2012-3#1)
morbidity as##3##2##(1991-9#1)(2008-7#1)(2012-3#1)
morbidity associated with these##2##4##(1990-11#1)(2008-7#1)
morbidity associated with##4##3##(1990-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
morbidity but##2##2##(2008-7#1)(2012-12#1)
morbidity due to##3##3##(1997-3#1)(2008-10#1)(2012-3#1)
morbidity in##9##2##(1993-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
morbidity including##2##2##(2008-7#1)(2012-3#1)
morbidity is##3##2##(1991-8#1)(2012-3#1)(2013-1#1)
morbidity of the##3##3##(1991-9#2)(2008-8#1)
morbidity of##9##2##(1991-9#2)(1993-1#1)(1996-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
morbidity rate##5##2##(1992-9#1)(1994-2#1)(1995-12#1)(2008-7#1)(2011-2#1)
morbidity rates##4##2##(2008-12#1)(2008-7#1)(2010-1#1)(2013-1#1)
morbidity was##4##2##(1994-2#1)(2008-7#3)
morbidity##222##1##(1990-11#1)(1991-2#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#2)(1995-12#4)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-1#6)(2008-10#9)(2008-11#8)(2008-12#3)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#33)(2008-8#4)(2009-10#2)(2009-12#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#29)(2011-3#2)(2011-7#1)(2012-12#8)(2012-2#4)(2012-3#19)(2013-1#10)(2013-7#1)(2013-8#1)
morbidly obese##3##2##(2012-12#1)(2012-5#2)
morbidly##4##1##(2012-12#1)(2012-5#2)(2013-1#1)
more (p ・・0##2##3##(2011-2#2)
more IAA than the wild type##2##6##(2008-10#2)
more about the##6##3##(1990-2#1)(1993-11#1)(2008-11#1)(2008-7#1)(2010-11#1)(2013-8#1)
more about##10##2##(1990-2#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-11#1)(2011-2#1)(2013-8#1)
more abundant in##3##3##(2008-10#2)(2009-10#1)
more abundant than the##3##4##(1991-5#1)(1994-11#1)(2008-10#1)
more abundant than##5##3##(1991-5#1)(1994-11#1)(2008-10#2)(2010-5#1)
more abundant##14##2##(1991-5#1)(1992-3#1)(1994-11#2)(2008-10#6)(2009-10#2)(2010-5#1)(2013-1#1)
more acceptable##4##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
more accessible##5##2##(1991-12#1)(1993-12#1)(1993-3#1)(2008-6#1)(2013-8#1)
more accurate and##4##3##(1991-3#1)(2008-10#2)(2008-9#1)
more accurate identification of##5##4##(1990-11#1)(1994-3#1)(2008-12#1)(2012-2#2)
more accurate information on the##2##5##(1992-9#1)(1993-12#1)
more accurate information##3##3##(1992-9#1)(1993-12#1)(2010-6#1)
more accurate results##5##3##(1990-3#1)(2008-10#4)
more accurate than the##2##4##(2008-10#2)
more accurate than##8##3##(2008-10#4)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
more accurate##41##2##(1990-11#1)(1990-3#3)(1990-8#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
more accurately than##3##3##(1993-12#1)(1997-1#1)(2012-4#1)
more accurately##7##2##(1991-12#1)(1993-12#1)(1997-1#1)(2008-9#2)(2011-3#1)(2012-4#1)
more acidic##2##2##(2008-10#2)
more active in the##3##4##(1993-12#1)(1993-6#1)(1995-8#1)
more active in##6##3##(1993-12#1)(1993-6#1)(1994-5#1)(1995-8#1)(2008-11#1)(2011-2#1)
more active than##3##3##(1990-11#1)(1992-10#1)(2011-2#1)
more active##20##2##(1990-11#1)(1991-3#1)(1992-10#1)(1993-12#2)(1993-6#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#3)
more actively##4##2##(1991-12#1)(1997-8#1)(2008-11#2)
more adaptive##3##2##(2008-11#1)(2008-4#1)(2010-12#1)
more adequate##4##2##(1995-3#1)(2008-12#1)(2013-1#2)
more advanced in##2##3##(1990-12#1)(2008-11#1)
more advanced##9##2##(1990-12#1)(1990-8#1)(1993-2#1)(1995-2#1)(2008-11#2)(2008-4#1)(2009-8#1)(2012-3#1)
more advantageous in##2##3##(2008-8#1)(2011-2#1)
more advantageous##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
more affected by##5##3##(2010-2#1)(2011-2#3)(2012-7#1)
more affected##6##2##(2008-10#1)(2010-2#1)(2011-2#3)(2012-7#1)
more affordable##5##2##(1994-2#1)(1995-6#1)(2008-10#1)(2008-11#2)
more after##2##2##(2008-10#1)(2013-8#1)
more aggressive and##2##3##(1990-2#1)(2010-12#1)
more aggressive than##3##3##(2008-10#3)
more aggressive##23##2##(1990-2#1)(1990-3#1)(1993-11#1)(1993-2#1)(1997-8#1)(2008-10#11)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
more alkaline##3##2##(1990-11#1)(2008-5#2)
more amenable to##2##3##(2008-10#2)
more and more##18##3##(1991-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-7#2)(2011-3#1)(2012-12#1)
more and##21##2##(1990-8#1)(1991-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
more applied##2##2##(2008-8#1)(2009-4#1)
more appropriate than##2##3##(2008-10#1)(2011-2#1)
more appropriate to##2##3##(2008-10#1)(2008-8#1)
more appropriate##18##2##(1994-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#2)(2009-8#1)(2010-2#1)(2011-2#2)(2012-3#1)
more arid##2##2##(2012-7#1)(2012-9#1)
more at risk##2##3##(2008-12#1)(2012-12#1)
more at##3##2##(1994-12#1)(2008-12#1)(2012-12#1)
more attention to##4##3##(2008-11#1)(2010-1#1)(2010-4#1)(2011-2#1)
more attention##6##2##(1995-5#1)(1997-1#1)(2008-11#1)(2010-1#1)(2010-4#1)(2011-2#1)
more attractive than the buffer##2##5##(2008-10#2)
more attractive than the##3##4##(2008-10#2)(2008-5#1)
more attractive to females##2##4##(1990-8#1)(2009-8#1)
more attractive##8##2##(1990-8#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)
more aware of##5##3##(2008-10#1)(2010-6#2)(2010-9#1)(2013-1#1)
more aware##6##2##(2008-10#1)(2010-6#2)(2010-9#1)(2012-2#1)(2013-1#1)
more basal##4##2##(2008-8#3)(2011-2#1)
more beneficial##2##2##(2008-8#1)(2013-1#1)
more broadly##4##2##(1997-3#1)(2009-3#1)(2010-10#1)(2010-2#1)
more by##3##2##(2008-7#1)(2009-6#1)(2009-8#1)
more carefully##2##2##(2008-10#1)(2008-11#1)
more cases of##2##3##(2011-1#1)(2011-2#1)
more cases##6##2##(1997-3#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
more challenging##3##2##(2008-10#2)(2013-1#1)
more chemical##2##2##(2008-10#2)
more children##6##2##(1990-6#1)(1994-2#1)(1994-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
more chronic##4##2##(1991-6#1)(1993-3#1)(1994-6#1)(2011-1#1)
more clearly defined##2##3##(2008-11#1)(2008-5#1)
more clearly##7##2##(1991-6#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-11#1)(2013-1#1)
more clinical##4##2##(1996-12#1)(2008-11#2)(2011-2#1)
more closely related to each other than##2##7##(2008-10#1)(2008-8#1)
more closely related to each other##4##6##(2008-10#2)(2008-8#1)(2011-2#1)
more closely related to the##2##5##(2008-5#1)(2011-2#1)
more closely related to##14##4##(1995-6#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#4)
more closely related##16##3##(1995-6#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#4)
more closely together##2##3##(1996-1#1)(2008-11#1)
more closely##27##2##(1994-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#3)(2011-2#6)
more collaborative##3##2##(2008-11#1)(2009-3#1)(2009-9#1)
more common among##2##3##(1997-4#1)(2012-3#1)
more common in females##2##4##(2010-4#1)(2012-3#1)
more common in the##2##4##(2008-7#1)(2008-9#1)
more common in##21##3##(1993-12#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
more common than##3##3##(2008-8#2)(2011-2#1)
more common##48##2##(1991-6#1)(1993-11#1)(1993-12#2)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#6)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
more commonly seen in##2##4##(2009-1#1)(2012-3#1)
more commonly##11##2##(1990-5#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-1#1)(2011-2#2)(2012-3#1)
more communication##3##2##(2007-12#1)(2011-1#2)
more compact##4##2##(1994-5#1)(1996-5#1)(2008-7#1)(2008-8#1)
more competitive##2##2##(1997-3#1)(2008-8#1)
more complete picture##3##3##(2009-8#2)(2010-4#1)
more complete understanding of the##3##5##(1996-12#1)(2008-4#1)(2011-2#1)
more complete understanding of##4##4##(1996-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
more complete##13##2##(1996-12#1)(2008-10#3)(2008-4#3)(2008-8#1)(2009-8#2)(2010-4#1)(2011-2#1)(2013-7#1)
more complex and##4##3##(1992-3#2)(2008-10#1)(2009-10#1)
more complex methods##2##3##(1993-3#1)(2008-6#1)
more complex than a##2##4##(2008-10#1)(2008-9#1)
more complex than##3##3##(2008-10#2)(2008-9#1)
more complex##46##2##(1992-3#2)(1993-11#1)(1993-3#1)(1994-2#2)(1995-3#2)(1996-1#1)(1996-11#1)(1997-2#1)(2008-10#10)(2008-11#4)(2008-6#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#1)(2013-1#3)
more complicated than a##2##4##(1992-8#1)(2008-10#1)
more complicated than##3##3##(1992-8#1)(2007-12#1)(2008-10#1)
more complicated##10##2##(1991-6#1)(1992-8#1)(1993-12#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#1)
more complications##2##2##(2013-1#2)
more comprehensive and##2##3##(1995-2#1)(2013-1#1)
more comprehensive##11##2##(1992-2#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2012-3#1)(2013-1#1)
more concentrated in the##2##4##(2008-11#1)(2008-8#1)
more concentrated##6##2##(2008-10#3)(2008-11#2)(2008-8#1)
more confident##3##2##(2008-11#1)(2010-8#1)(2013-7#1)
more conflictual relationships with##2##4##(2008-12#2)
more conflictual##3##2##(2008-12#3)
more conidia in##2##3##(2008-10#2)
more conscious about##2##3##(2010-3#1)(2012-3#1)
more conservative##5##2##(1993-6#1)(1994-6#1)(1997-8#1)(2008-10#1)(2010-12#1)
more consistent##6##2##(1995-5#1)(2008-10#3)(2008-11#1)(2010-1#1)
more convenient##5##2##(2008-10#4)(2008-11#1)
more conventional##4##2##(1994-5#1)(2008-10#1)(2008-3#2)
more correlated##2##2##(2008-3#1)(2013-1#1)
more cost effective##5##3##(1994-1#2)(2008-7#1)(2011-2#2)
more cost-effective than##2##3##(2008-2#1)(2011-2#1)
more cost-effective##3##2##(1996-1#1)(2008-2#1)(2011-2#1)
more costly##6##2##(1991-1#1)(1992-3#1)(1993-1#1)(1996-2#1)(2010-10#1)(2010-12#1)
more critical than##2##3##(2008-10#1)(2008-8#1)
more critical##5##2##(1995-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
more cytotoxic than##3##3##(1994-8#1)(1996-12#1)(1997-3#1)
more cytotoxic##4##2##(1994-8#1)(1996-12#1)(1997-3#1)(2009-9#1)
more damage##2##2##(2008-10#1)(2008-11#1)
more dangerous##2##2##(2008-10#1)(2008-9#1)
more data are available##2##4##(2008-10#1)(2011-2#1)
more data are##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
more data##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
more decisively##2##2##(1993-12#1)(2008-8#1)
more deeply##3##2##(1990-5#1)(2008-10#2)
more definitive##4##2##(1991-1#1)(1994-6#1)(2011-2#1)(2013-8#1)
more demanding##3##2##(1993-12#1)(1996-2#1)(2013-1#1)
more dependent on##5##3##(1996-2#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-9#1)
more derived##2##2##(2009-8#2)
more desirable##2##2##(2008-10#1)(2010-12#1)
more detail##9##2##(1991-2#1)(1995-6#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2011-2#1)
more detailed analysis of##2##4##(1995-12#1)(2008-4#1)
more detailed description of##2##4##(1996-3#1)(2008-4#1)
more detailed information##3##3##(1996-3#1)(2008-10#1)(2010-3#1)
more detailed studies##2##3##(2008-10#1)(2008-8#1)
more detailed##25##2##(1991-3#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-12#2)(1996-3#2)(1997-8#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-7#1)(2012-12#1)(2013-8#1)
more detectable##2##2##(1990-5#1)(2008-3#1)
more difficult than##3##3##(1992-1#1)(1993-12#1)(2012-2#1)
more difficult to##11##3##(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#3)(2011-2#1)
more difficult##21##2##(1992-1#1)(1992-9#1)(1993-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#3)(2011-2#1)(2012-2#2)
more diffusely##3##2##(1994-2#1)(2007-12#1)(2011-2#1)
more diluted##2##2##(1997-3#1)(2008-10#1)
more direct##2##2##(2008-5#1)(2012-2#1)
more directly##2##2##(1995-12#1)(2011-2#1)
more disease##2##2##(2008-10#2)
more diseased##4##2##(2008-10#4)
more dispersed##2##2##(2008-10#1)(2008-7#1)
more distant##2##2##(2008-10#1)(2008-8#1)
more distantly related##2##3##(2008-10#2)
more distinct##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
more distress##2##2##(2008-12#1)(2008-9#1)
more diverse than##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
more diverse##9##2##(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
more dynamic##3##2##(2008-11#1)(2010-12#1)(2012-3#1)
more easily than##3##3##(1997-3#1)(2008-8#1)(2012-2#1)
more easily##9##2##(1994-1#1)(1994-6#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
more economical##5##2##(2008-10#2)(2008-11#2)(2008-3#1)
more educated##2##2##(1994-6#2)
more education##2##2##(1992-3#1)(2011-1#1)
more effective and##2##3##(1997-2#1)(2008-7#1)
more effective anticancer therapies##2##4##(2009-12#1)(2012-2#1)
more effective at preventing##2##4##(2008-10#2)
more effective at##10##3##(1990-5#1)(2008-10#6)(2010-4#1)(2012-3#1)(2013-1#1)
more effective disease##2##3##(2008-10#2)
more effective for##7##3##(1991-3#1)(2008-10#1)(2008-4#1)(2010-4#2)(2011-2#1)(2012-2#1)
more effective in the##2##4##(1995-8#1)(2008-10#1)
more effective in##14##3##(1995-5#1)(1995-8#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#2)(2009-1#1)(2013-1#1)
more effective methods##2##3##(2007-12#1)(2013-1#1)
more effective than that##2##4##(2008-11#1)(2008-3#1)
more effective than the##5##4##(1995-9#1)(1996-5#1)(2008-10#2)(2008-7#1)
more effective than##33##3##(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
more effective with the##2##4##(1993-12#1)(2008-10#1)
more effective##115##2##(1990-12#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-2#1)(1994-1#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#7)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#3)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)
more effectively than the##2##4##(1993-2#1)(1994-8#1)
more effectively than##3##3##(1993-2#1)(1994-8#1)(1996-2#1)
more effectively with##3##3##(1995-1#1)(2008-11#1)(2008-6#1)
more effectively##12##2##(1991-3#1)(1993-2#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2011-2#1)
more efficacious##5##2##(1995-11#2)(2008-10#2)(2008-8#1)
more efficient and##3##3##(2008-11#1)(2008-7#1)(2012-3#1)
more efficient for##2##3##(2008-12#2)
more efficient in the##2##4##(2008-10#1)(2012-2#1)
more efficient in##7##3##(2008-10#3)(2008-3#1)(2009-3#1)(2012-2#1)(2012-3#1)
more efficient than Cartapip 97##2##5##(2008-10#2)
more efficient than the##3##4##(1990-5#1)(2008-10#2)
more efficient than##12##3##(1990-5#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#1)(2012-3#1)
more efficient##52##2##(1990-11#1)(1990-5#1)(1992-3#1)(1993-2#1)(1994-3#1)(2008-10#21)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#4)
more efficiently and##2##3##(1997-1#1)(2009-8#1)
more efficiently than##6##3##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
more efficiently##17##2##(1991-7#1)(1997-1#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
more effort##2##2##(1996-11#1)(2008-1#1)
more efforts##2##2##(1995-1#1)(2008-1#1)
more elaborate##3##2##(1997-3#1)(2008-3#1)(2010-1#1)
more emphasis on##2##3##(1995-9#1)(2008-10#1)
more emphasis##3##2##(1995-9#1)(2008-10#1)(2008-11#1)
more empirical##2##2##(1990-11#1)(2008-10#1)
more energy##4##2##(2008-9#3)(2010-8#1)
more enhanced than##2##3##(2008-10#2)
more episodes of##2##3##(1993-1#1)(1994-6#1)
more equitable##4##2##(1991-1#1)(1995-12#1)(2008-11#1)(2010-10#1)
more established##2##2##(2008-10#2)
more evident in##4##3##(1992-12#1)(2008-10#2)(2010-7#1)
more evident##8##2##(1992-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-7#1)
more expensive than##2##3##(1994-12#1)(2008-8#1)
more expensive##9##2##(1991-3#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
more experience##2##2##(1992-2#1)(1996-2#1)
more experienced##2##2##(1994-3#1)(2008-11#1)
more experimental##2##2##(2008-11#1)(2009-10#1)
more expert##2##2##(1995-3#1)(2008-11#1)
more explicit##3##2##(1997-3#1)(2008-8#1)(2012-3#1)
more exposed to the sun radiation##2##6##(2011-2#2)
more extended##2##2##(2008-3#1)(2008-9#1)
more extensive and##2##3##(1996-12#1)(2008-10#1)
more extensive##13##2##(1990-9#1)(1993-8#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-1#1)(2013-1#1)
more extensively than##2##3##(2008-10#2)
more extensively##3##2##(2008-10#3)
more familiar##2##2##(2008-8#1)(2010-7#1)
more favorable than##2##3##(1991-3#1)(2008-10#1)
more favorable##12##2##(1990-8#1)(1991-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-4#1)(2013-1#1)(2013-8#1)
more favourable##7##2##(1990-9#1)(1995-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#1)
more feasible##3##2##(1997-1#1)(2011-2#2)
more female##2##2##(2008-7#1)(2011-2#1)
more females##2##2##(1997-2#1)(2010-4#1)
more fit than##2##3##(2008-10#1)(2013-8#1)
more flexibility in##2##3##(1991-1#1)(2013-8#1)
more flexibility##3##2##(1991-1#1)(2008-10#1)(2013-8#1)
more flexible##5##2##(1997-6#1)(2008-10#1)(2008-11#3)
more focused##3##2##(1994-2#1)(2008-10#1)(2008-7#1)
more for##5##2##(1994-1#1)(1994-2#1)(2008-12#2)(2009-11#1)
more frequent daily##2##3##(2009-11#2)
more frequent in##9##3##(1990-8#1)(1991-3#1)(1991-6#1)(1996-3#1)(2008-12#1)(2010-12#1)(2013-1#3)
more frequent than##7##3##(1994-3#1)(1997-3#2)(2008-10#1)(2008-7#1)(2012-2#2)
more frequent##36##2##(1990-8#2)(1991-3#2)(1991-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1996-3#1)(1996-6#1)(1997-3#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#6)
more frequently associated with##2##4##(2008-7#1)(2013-1#1)
more frequently encountered##2##3##(2008-5#1)(2012-2#1)
more frequently from##2##3##(2008-10#1)(2008-5#1)
more frequently in the##3##4##(1993-6#1)(2008-12#1)(2011-2#1)
more frequently in##5##3##(1993-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
more frequently observed##2##3##(2008-10#1)(2008-5#1)
more frequently than##6##3##(1993-11#1)(1994-5#1)(1996-11#1)(2008-4#1)(2010-10#1)(2012-2#1)
more frequently##44##2##(1990-12#3)(1991-3#1)(1991-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-10#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
more from the##2##3##(1990-11#1)(1996-2#1)
more from##5##2##(1990-11#1)(1996-2#1)(2008-12#1)(2008-5#1)(2012-12#1)
more fully##3##2##(2008-12#1)(2010-4#1)(2012-2#1)
more functional##5##2##(1997-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
more fundamental##4##2##(1993-6#1)(1997-3#1)(2009-4#1)(2011-2#1)
more general##10##2##(1991-6#1)(1993-11#1)(1995-8#1)(1996-8#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-8#1)(2013-8#1)
more generalized##2##2##(2008-8#1)(2012-3#1)
more generally##7##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#3)
more genes##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
more genetically diverse##2##3##(2008-10#2)
more global##3##2##(2006-6#1)(2009-10#1)(2013-1#1)
more help##2##2##(1994-1#2)
more highly phosphorylated##2##3##(1995-2#1)(2010-12#1)
more highly##9##2##(1991-12#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
more holistic##5##2##(2008-11#1)(2009-8#2)(2010-12#1)(2010-8#1)
more homogeneous##5##2##(1993-12#1)(2008-10#3)(2011-2#1)
more homogenous##2##2##(2008-11#1)(2008-5#1)
more human##2##2##(2008-9#1)(2012-3#1)
more hydrogen was exhaled##2##4##(1996-6#2)
more impaired in##3##3##(2008-12#3)
more impaired than##3##3##(2008-12#3)
more impaired##6##2##(2008-12#6)
more importance##4##2##(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
more important because##2##3##(1992-3#1)(2008-7#1)
more important in##5##3##(1991-11#1)(2007-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
more important ones were Aseptic technique(4##2##6##(1991-2#2)
more important than the##3##4##(1995-1#1)(2008-11#1)(2008-8#1)
more important than##8##3##(1995-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2013-8#1)
more important to##2##3##(1991-7#1)(2008-10#1)
more important##39##2##(1991-11#1)(1991-2#3)(1991-7#1)(1992-3#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2010-1#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
more importantly##3##2##(1995-5#1)(2008-10#1)(2008-5#1)
more in the##3##3##(1994-8#1)(2008-10#1)(2011-3#1)
more in##16##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-2#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
more in-depth##2##2##(2008-10#1)(2013-1#1)
more inclined##2##2##(2010-6#1)(2012-2#1)
more individual##2##2##(2009-10#1)(2011-7#1)
more individualized##2##2##(2008-11#1)(2010-12#1)
more individuals##2##2##(2008-8#1)(2008-9#1)
more infected##2##2##(2008-10#2)
more information about##4##3##(1994-1#1)(1996-11#1)(2007-12#1)(2012-12#1)
more information on the##2##4##(1996-3#1)(1997-7#1)
more information##12##2##(1993-2#1)(1994-1#1)(1995-10#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2012-12#1)
more informative##4##2##(2008-10#3)(2008-11#1)
more informed##4##2##(1993-12#1)(1993-2#1)(1997-3#1)(2012-3#1)
more inhibitory than the##2##4##(1997-1#1)(2008-10#1)
more inhibitory than##4##3##(1997-1#1)(2008-10#2)(2008-11#1)
more insight into the##3##4##(2008-10#2)(2008-11#1)
more intense for##2##3##(2008-10#1)(2012-2#1)
more intense in##3##3##(1993-11#1)(1996-12#1)(2012-7#1)
more intense##18##2##(1993-11#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-8#1)(2012-2#1)(2012-7#2)(2013-1#1)
more intensive##5##2##(1994-3#1)(2008-4#1)(2008-8#2)(2013-1#1)
more internal##5##2##(1994-11#2)(1995-12#1)(1996-1#1)(2008-10#1)
more invasive than##2##3##(1997-3#1)(2011-2#1)
more invasive##3##2##(1997-3#1)(2010-12#1)(2011-2#1)
more investigation##2##2##(2008-10#1)(2013-1#1)
more knowledge##2##2##(1993-12#1)(1993-2#1)
more like##3##2##(1995-3#1)(1996-5#1)(1997-2#1)
more likely in##2##3##(2008-8#1)(2008-9#1)
more likely than men to##2##5##(2008-12#1)(2008-4#1)
more likely than##8##3##(1993-1#1)(1993-8#1)(2008-12#2)(2008-4#1)(2010-10#1)(2012-3#1)(2013-1#1)
more likely to be male##2##5##(2008-11#1)(2013-1#1)
more likely to be##23##4##(1993-12#2)(1994-3#1)(1995-2#1)(1996-3#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-9#2)(2009-5#2)(2010-3#1)(2011-3#1)(2013-1#5)
more likely to become##2##4##(1993-12#1)(2009-7#1)
more likely to develop##2##4##(2010-12#1)(2013-8#1)
more likely to engage in##2##5##(2008-1#1)(2013-1#1)
more likely to evolve##2##4##(2010-10#2)
more likely to have##11##4##(1992-2#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#2)
more likely to involve##2##4##(1997-3#1)(2008-11#1)
more likely to occur in##2##5##(1990-6#1)(2008-10#1)
more likely to occur##3##4##(1990-6#1)(1996-11#1)(2008-10#1)
more likely to practice##2##4##(2010-11#1)(2013-1#1)
more likely to present with##2##5##(2009-11#1)(2011-2#1)
more likely to provide##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
more likely to receive##2##4##(2012-3#1)(2013-1#1)
more likely to report##5##4##(1995-12#1)(2008-12#1)(2009-5#2)(2013-1#1)
more likely to succeed##2##4##(2008-8#2)
more likely to##98##3##(1990-6#1)(1991-12#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#4)(1994-3#1)(1995-12#2)(1995-2#2)(1996-11#1)(1996-3#2)(1997-3#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#6)(2008-4#1)(2008-6#1)(2008-8#10)(2008-9#8)(2009-11#1)(2009-12#1)(2009-5#5)(2009-6#1)(2009-7#2)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#12)(2013-8#1)
more likely##120##2##(1990-6#1)(1991-12#2)(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-8#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-11#1)(1996-3#2)(1997-3#1)(2008-1#2)(2008-10#5)(2008-11#8)(2008-12#9)(2008-4#2)(2008-6#1)(2008-8#14)(2008-9#10)(2009-11#1)(2009-12#1)(2009-5#5)(2009-6#1)(2009-7#2)(2010-10#4)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#13)(2013-8#1)
more limited in##2##3##(2011-2#1)(2012-2#1)
more limited##8##2##(1991-1#1)(1992-3#1)(1993-1#1)(1997-3#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
more lipophilic##3##2##(2008-10#3)
more marked##5##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
more mature##5##2##(1993-12#1)(1995-8#1)(2008-4#1)(2009-12#1)(2012-2#1)
more medical##2##2##(2008-12#1)(2008-8#1)
more modern##5##2##(2008-8#2)(2009-10#1)(2012-2#2)
more natural##3##2##(2008-11#1)(2008-9#2)
more needs##2##2##(1995-1#1)(2011-2#1)
more negative than##4##3##(1993-3#1)(1997-2#1)(2008-10#2)
more negative##17##2##(1990-5#2)(1993-3#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-7#1)(2010-1#2)(2010-12#1)
more negatively##2##2##(2008-4#1)(2011-1#1)
more new##3##2##(1993-1#1)(2012-2#2)
more numerous##3##2##(1994-2#1)(2008-10#1)(2012-2#1)
more objective##6##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)
more obvious##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
more of a problem with##2##5##(2008-9#1)(2012-2#1)
more of the##12##3##(1992-5#1)(1994-2#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#1)
more of these##6##3##(1994-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
more of##25##2##(1992-5#1)(1994-1#1)(1994-2#2)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-2#1)
more offspring##2##2##(2008-10#1)(2009-8#1)
more often as##3##3##(2009-12#1)(2011-2#1)(2012-3#1)
more often associated with##2##4##(2008-4#1)(2009-3#1)
more often had##2##3##(1991-11#1)(1994-12#1)
more often in##4##3##(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#1)
more often than the##3##4##(1994-12#1)(1997-4#1)(2008-10#1)
more often than##8##3##(1994-12#1)(1994-3#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2009-11#1)
more often##40##2##(1991-11#1)(1992-3#1)(1993-8#1)(1994-12#3)(1994-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2011-2#3)(2012-12#1)(2012-3#3)(2012-7#1)(2013-1#5)
more on the##4##3##(1992-1#2)(2008-10#1)(2013-1#1)
more on##14##2##(1991-3#1)(1992-1#2)(1992-12#1)(1996-3#2)(2008-10#3)(2008-5#2)(2008-8#1)(2012-2#1)(2013-1#1)
more open##4##2##(1990-11#1)(1994-1#1)(2011-2#1)(2013-1#1)
more or less##21##3##(1990-5#1)(1991-2#1)(1992-9#1)(1995-12#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#3)(2013-8#1)
more or##22##2##(1990-5#1)(1991-2#1)(1992-9#1)(1993-3#1)(1995-12#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#3)(2013-8#1)
more ordered##2##2##(2008-10#1)(2008-5#1)
more oriented##2##2##(1993-2#1)(2011-2#1)
more painful##2##2##(2011-2#1)(2013-1#1)
more participatory##2##2##(1992-1#1)(2008-11#1)
more pathogenic##4##2##(2008-10#4)
more patients with##2##3##(1994-12#1)(1995-10#1)
more patients##12##2##(1991-12#1)(1991-2#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-10#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
more people##4##2##(1992-2#1)(1995-1#1)(1996-1#1)(1996-5#1)
more personalized##3##2##(1992-3#1)(2010-4#1)(2013-8#1)
more persons##2##2##(1996-3#1)(1997-2#1)
more phenotypic##2##2##(2008-10#1)(2008-9#1)
more physical##6##2##(1993-2#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#2)
more plausible##2##2##(1994-8#1)(2009-6#1)
more polar##4##2##(1991-5#2)(2008-10#1)(2010-7#1)
more popular in##2##3##(1995-2#1)(2009-12#1)
more positive potential##2##3##(2008-10#2)
more positive potentials##2##3##(1990-5#2)
more positive than##3##3##(1993-3#1)(1997-2#1)(2008-10#1)
more positive##19##2##(1990-2#1)(1990-5#2)(1991-3#1)(1993-3#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-5#1)(2009-6#1)(2013-1#3)
more positively##2##2##(2008-12#1)(2008-4#1)
more postoperative##2##2##(1995-3#1)(2011-2#1)
more potent activity##2##3##(2008-11#1)(2008-5#1)
more potent at##2##3##(1994-8#1)(1996-2#1)
more potent in the##2##4##(1990-12#1)(1992-3#1)
more potent in##4##3##(1990-12#1)(1992-3#2)(2008-12#1)
more potent inhibitors of##2##4##(1992-8#1)(2009-9#1)
more potent inhibitors##3##3##(1992-8#1)(2009-9#1)(2012-2#1)
more potent than the parent##2##5##(1990-12#1)(1992-4#1)
more potent than the##3##4##(1990-12#1)(1992-4#1)(1994-5#1)
more potent than##9##3##(1990-12#1)(1992-12#1)(1992-3#1)(1992-4#1)(1994-5#1)(1995-11#1)(1996-2#1)(2008-12#1)(2008-7#1)
more potent##31##2##(1990-12#2)(1991-5#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-8#1)(1993-8#2)(1994-11#2)(1994-5#2)(1994-8#1)(1995-11#2)(1996-2#2)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#1)(2009-9#1)(2012-2#1)(2012-3#1)
more powerful##5##2##(1993-11#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-8#1)
more practical##5##2##(2008-10#3)(2008-9#1)(2010-5#1)
more precise and##4##3##(2008-10#4)
more precise evaluation of##2##4##(1994-12#1)(2011-7#1)
more precise than##2##3##(1997-2#1)(2008-10#1)
more precise##19##2##(1994-12#1)(1994-5#1)(1994-9#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-7#1)(2012-2#1)(2013-8#1)
more precisely the##2##3##(2008-10#1)(2013-1#1)
more precisely##7##2##(1993-12#1)(2008-10#2)(2009-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
more prepared to##2##3##(2008-11#1)(2008-7#1)
more prevalent in##11##3##(1991-1#1)(1996-12#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2010-1#1)(2012-12#1)
more prevalent##20##2##(1991-1#1)(1991-6#1)(1993-3#1)(1996-12#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-5#1)(2009-5#1)(2010-1#1)(2012-12#2)
more problems than##2##3##(1992-1#1)(1994-3#1)
more problems##3##2##(1990-12#1)(1992-1#1)(1994-3#1)
more productive sites##2##3##(2008-9#2)
more productive##5##2##(1994-5#1)(1997-1#1)(2008-9#3)
more profound##3##2##(1991-6#1)(1992-8#1)(2008-11#1)
more prominent and##2##3##(2008-11#1)(2008-7#1)
more prominent##5##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
more promising##3##2##(2008-10#3)
more prone to##2##3##(2008-4#1)(2011-2#1)
more pronounced at##5##3##(1991-2#1)(2008-10#4)
more pronounced in the case of##2##6##(1995-12#1)(2008-7#1)
more pronounced in the##5##4##(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
more pronounced in##12##3##(1993-2#1)(1995-12#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2010-12#1)
more pronounced##25##2##(1990-11#1)(1991-2#1)(1993-2#1)(1995-12#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#11)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
more protein##3##2##(1991-6#1)(2008-10#1)(2008-11#1)
more prudent##2##2##(1997-3#1)(2008-8#1)
more quickly than##2##3##(2008-3#1)(2008-9#1)
more quickly##11##2##(1993-2#1)(1994-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2011-1#1)
more rapid and##3##3##(2008-10#2)(2008-9#1)
more rapid##16##2##(1992-1#1)(1993-6#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)
more rapidly and##6##3##(1996-12#1)(2008-10#3)(2008-11#1)(2010-6#1)
more rapidly by the##2##4##(1992-5#1)(2008-11#1)
more rapidly than##9##3##(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
more rapidly##28##2##(1991-6#1)(1992-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
more rarely##5##2##(1990-3#1)(1994-9#1)(2008-8#1)(2010-12#1)(2012-12#1)
more rational##6##2##(2008-11#1)(2008-12#2)(2008-5#1)(2010-10#1)(2010-5#1)
more reactive than##2##3##(1993-8#1)(2008-5#1)
more reactive##4##2##(1993-8#1)(2008-5#1)(2010-4#1)(2012-12#1)
more readily##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-8#1)
more realistic##13##2##(1993-12#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2012-3#1)(2013-8#1)
more recent findings##2##3##(1991-2#1)(2011-2#1)
more recent##14##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1997-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-11#1)(2011-2#2)(2012-12#1)
more recently and##2##3##(2008-9#1)(2009-12#1)
more recently developed##2##3##(2008-9#1)(2012-2#1)
more recently##26##2##(1994-1#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-11#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
more refined##2##2##(1990-8#1)(1997-8#1)
more related to##4##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
more related##5##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#2)
more relevant##4##2##(1990-9#1)(1993-2#1)(1995-5#1)(2008-10#1)
more reliable and##2##3##(2008-10#2)
more reliable than##3##3##(2008-10#1)(2008-12#1)(2010-6#1)
more reliable##16##2##(1993-12#1)(1996-3#1)(2008-10#9)(2008-12#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
more remarkable##2##2##(2008-10#1)(2008-11#1)
more reproducible##5##2##(1997-2#1)(2008-10#2)(2008-4#1)(2008-7#1)
more research is needed to##2##5##(2008-11#2)
more research is needed##4##4##(2008-11#3)(2008-8#1)
more research##8##2##(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2010-12#1)
more resistant than##7##3##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
more resistant to##13##3##(1993-12#1)(2008-10#7)(2008-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)
more resistant##27##2##(1990-2#1)(1993-12#1)(1996-12#2)(2008-10#14)(2008-11#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
more resources and##2##3##(2008-10#1)(2012-2#1)
more resources to##2##3##(2008-8#2)
more resources##7##2##(2008-10#1)(2008-8#2)(2008-9#2)(2009-5#1)(2012-2#1)
more responsibility for##2##3##(1994-2#1)(2008-11#1)
more responsive to##6##3##(1993-12#1)(1994-11#1)(1995-8#1)(2008-10#2)(2012-2#1)
more rigid##3##2##(2008-4#1)(2008-5#1)(2009-10#1)
more rigorous##6##2##(1997-3#1)(2008-10#1)(2008-2#1)(2010-5#2)(2013-8#1)
more robust than##2##3##(2008-10#1)(2008-11#1)
more robust##5##2##(2008-10#3)(2008-11#2)
more root##2##2##(2008-10#2)
more satisfied than Asians##2##4##(2012-2#2)
more satisfied than##3##3##(2009-11#1)(2012-2#2)
more scientific##2##2##(1993-3#1)(2008-12#1)
more secure##2##2##(2008-11#1)(2008-12#1)
more selective##8##2##(1995-11#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-5#1)
more selectively##2##2##(2008-10#2)
more sensitive and##5##3##(1990-12#1)(2008-10#3)(2011-2#1)
more sensitive for##2##3##(2008-10#1)(2008-11#1)
more sensitive than a##2##4##(2008-10#1)(2008-11#1)
more sensitive than the##8##4##(1994-12#1)(2008-10#5)(2008-7#1)(2008-8#1)
more sensitive than##25##3##(1990-3#1)(1991-8#1)(1994-12#1)(1996-8#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
more sensitive to the##5##4##(1991-5#1)(2008-10#2)(2008-9#1)(2010-8#1)
more sensitive to##27##3##(1991-10#1)(1991-5#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-5#1)(1997-7#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-8#1)(2012-2#1)
more sensitive##79##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-7#1)(1992-8#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-5#1)(1996-8#1)(1997-7#1)(2008-10#33)(2008-11#8)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)
more sensitively##2##2##(2008-10#1)(2010-4#1)
more serious than##4##3##(1990-6#1)(2008-10#2)(2009-7#1)
more serious##9##2##(1990-6#1)(1991-3#1)(1993-12#1)(2008-10#2)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
more severe and##2##3##(1994-5#1)(2008-5#1)
more severe disease and##2##4##(2008-10#1)(2011-2#1)
more severe disease##4##3##(2008-10#2)(2011-2#1)(2013-8#1)
more severe grades##2##3##(2012-2#2)
more severe in##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
more severe than##2##3##(2008-10#1)(2011-2#1)
more severe##34##2##(1991-8#1)(1994-5#1)(1995-11#1)(1997-2#1)(1997-3#2)(2008-10#9)(2008-11#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-6#1)(2013-1#1)(2013-8#1)
more severely##6##2##(1994-1#1)(2008-10#3)(2008-11#1)(2008-3#1)
more significant##5##2##(2008-10#2)(2008-9#1)(2009-8#1)(2011-2#1)
more similar to each other than##2##6##(1993-6#1)(2008-10#1)
more similar to each other##3##5##(1993-6#1)(2008-10#2)
more similar to##8##3##(1993-6#1)(2008-10#5)(2008-7#1)(2012-2#1)
more similar##12##2##(1993-6#1)(2008-10#7)(2008-7#1)(2011-2#2)(2012-2#1)
more slowly in##3##3##(2008-10#2)(2008-5#1)
more slowly than did##2##4##(1994-8#1)(2008-10#1)
more slowly than the##2##4##(1993-3#1)(2008-9#1)
more slowly than those##2##4##(1992-9#1)(2008-10#1)
more slowly than##7##3##(1992-9#1)(1993-3#1)(1994-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
more slowly##17##2##(1991-2#1)(1992-9#1)(1993-3#1)(1994-8#2)(2008-10#7)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)
more so than##2##3##(2009-11#1)(2013-1#1)
more so##7##2##(2008-11#1)(2008-6#1)(2009-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
more sophisticated and##2##3##(2008-11#1)(2008-7#1)
more sophisticated##12##2##(1991-3#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#2)(2012-2#2)(2012-3#1)(2013-1#1)
more species##8##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#2)
more specific and##2##3##(2008-10#1)(2013-8#1)
more specific than##2##3##(1990-2#1)(2008-3#1)
more specific##20##2##(1990-2#1)(1993-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
more specifically##3##2##(1994-8#1)(1995-8#1)(2008-6#1)
more stable and##2##3##(1994-11#1)(2008-12#1)
more stable complexes with##2##4##(2008-10#2)
more stable in##2##3##(2008-5#2)
more stable than the##4##4##(2008-10#2)(2009-10#1)(2009-8#1)
more stable than##8##3##(1994-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-10#1)(2009-8#1)
more stable##37##2##(1990-12#1)(1994-11#2)(1997-2#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#1)(2012-3#2)
more steeply declining size distributions##2##5##(2008-9#2)
more stem##2##2##(2008-10#1)(2012-5#1)
more strategic##2##2##(1997-1#1)(2008-12#1)
more stress than##2##3##(2008-4#2)
more stress##3##2##(2008-4#2)(2013-1#1)
more stringent than##2##3##(2008-8#1)(2008-9#1)
more stringent##8##2##(1991-6#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-11#1)
more strongly correlated with##2##4##(2012-3#2)
more strongly related to##2##4##(2010-2#1)(2011-2#1)
more strongly than##4##3##(1992-6#1)(2008-11#2)(2008-12#1)
more strongly to##2##3##(2008-10#1)(2008-8#1)
more strongly##18##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-3#2)(2012-5#1)(2013-8#1)
more studies##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
more subtle##2##2##(1996-2#1)(1997-2#1)
more successful##8##2##(1993-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1996-3#1)(2008-10#2)(2008-11#1)
more suitable for the##2##4##(2008-10#1)(2010-7#1)
more suitable for##10##3##(2008-10#3)(2008-11#1)(2008-9#1)(2010-4#2)(2010-7#1)(2011-2#1)(2013-1#1)
more suitable##15##2##(2008-10#4)(2008-11#2)(2008-12#1)(2008-9#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
more supportive##4##2##(1991-2#1)(1997-2#1)(2009-7#1)(2010-1#1)
more suppressive##2##2##(2008-10#2)
more susceptible to##18##3##(1991-12#1)(1992-3#1)(1994-11#1)(1994-5#2)(1994-8#2)(1995-11#1)(2008-10#6)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
more susceptible##22##2##(1991-12#1)(1992-3#1)(1994-11#1)(1994-5#2)(1994-8#2)(1995-11#1)(2008-10#9)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
more systematic##5##2##(1997-2#1)(2008-5#1)(2010-1#1)(2013-1#2)
more targeted##4##2##(1991-2#1)(2008-7#2)(2011-2#1)
more technical##2##2##(1992-2#1)(2008-10#1)
more than 0##3##3##(2008-10#2)(2008-5#1)
more than 1 order of magnitude##2##6##(2008-3#2)
more than 1 year##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
more than 1##19##3##(1993-6#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)
more than 10 days##3##4##(2008-10#2)(2008-11#1)
more than 10 times##2##4##(1994-11#1)(2008-8#1)
more than 10##9##3##(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-8#1)(2013-1#1)
more than 10-fold##3##3##(1996-3#1)(2008-10#2)
more than 100##14##3##(1993-2#1)(1996-3#1)(2008-10#7)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
more than 1000##3##3##(1991-12#1)(1994-12#1)(2013-1#1)
more than 110##2##3##(1992-8#1)(2011-2#1)
more than 12##7##3##(1990-12#1)(1992-4#1)(1996-6#1)(2008-11#2)(2008-2#1)(2012-2#1)
more than 15 years##3##4##(2008-10#2)(2012-2#1)
more than 15##6##3##(2008-10#3)(2008-9#2)(2012-2#1)
more than 15% of##2##4##(1997-6#1)(2013-1#1)
more than 18##2##3##(2009-10#1)(2013-1#1)
more than 2##12##3##(2008-10#7)(2008-11#2)(2008-7#1)(2011-2#2)
more than 20 years##5##4##(1993-3#1)(2008-7#1)(2010-12#1)(2011-2#2)
more than 20##11##3##(1993-3#1)(1997-3#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
more than 200 patients##2##4##(1996-3#1)(1997-8#1)
more than 200##7##3##(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-8#1)
more than 24 h##2##4##(2008-10#1)(2008-11#1)
more than 24##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
more than 25##4##3##(1990-12#1)(2008-10#2)(2008-12#1)
more than 25%##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
more than 3 months##6##4##(1991-8#1)(2008-10#5)
more than 3##9##3##(1991-8#1)(2008-10#6)(2008-2#1)(2012-2#1)
more than 30 years##5##4##(1996-11#1)(2009-8#1)(2011-2#2)(2013-1#1)
more than 30##10##3##(1996-11#1)(2008-10#4)(2009-8#1)(2011-2#2)(2013-1#2)
more than 300##5##3##(2008-11#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
more than 3000##2##3##(1997-6#1)(2012-2#1)
more than 350##2##3##(2008-2#1)(2010-11#1)
more than 4##6##3##(1990-12#1)(2008-10#4)(2008-5#1)
more than 40##4##3##(2007-12#1)(2008-10#2)(2012-2#1)
more than 40%##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
more than 400##3##3##(2008-1#1)(2008-10#2)
more than 5 times##2##4##(2008-11#1)(2008-8#1)
more than 5 years##3##4##(1990-6#1)(1991-6#1)(1991-8#1)
more than 5##9##3##(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
more than 5%##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
more than 50 and##2##4##(2008-10#2)
more than 50 years##2##4##(2008-10#1)(2011-3#1)
more than 50##12##3##(1993-2#1)(1996-3#1)(2008-10#7)(2011-3#1)(2012-12#2)
more than 50% of the##5##5##(1994-11#1)(1997-6#1)(2008-5#1)(2011-2#1)(2012-12#1)
more than 50% of##9##4##(1990-12#1)(1993-3#1)(1994-11#1)(1995-2#1)(1997-6#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
more than 50%##16##3##(1990-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-2#1)(1997-6#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)
more than 50-fold##2##3##(1997-8#1)(2008-10#1)
more than 500##2##3##(1993-3#1)(2008-8#1)
more than 6 months##5##4##(1991-2#1)(2008-10#3)(2012-12#1)
more than 6##10##3##(1991-2#1)(1993-12#1)(2008-10#5)(2008-5#1)(2012-12#1)(2012-2#1)
more than 60##3##3##(1991-12#1)(2007-12#1)(2011-3#1)
more than 60% of the##2##5##(1990-12#1)(2012-12#1)
more than 60% of##3##4##(1990-12#1)(2008-8#1)(2012-12#1)
more than 60%##5##3##(1990-12#1)(1996-12#1)(2008-8#1)(2010-5#1)(2012-12#1)
more than 600##2##3##(2010-7#1)(2010-8#1)
more than 65%##2##3##(2008-5#1)(2009-7#1)
more than 70##2##3##(1991-12#1)(1993-11#1)
more than 70% of the##5##5##(2008-10#4)(2008-8#1)
more than 70%##6##3##(2008-10#4)(2008-5#1)(2008-8#1)
more than 75##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
more than 80##4##3##(1996-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
more than 80% of##4##4##(1993-6#1)(2008-10#1)(2009-8#1)(2011-3#1)
more than 80%##6##3##(1993-6#1)(2008-10#2)(2009-4#1)(2009-8#1)(2011-3#1)
more than 800##2##3##(2008-11#1)(2008-7#1)
more than 90##3##3##(2008-10#2)(2013-1#1)
more than 90% at##2##4##(2008-10#2)
more than 90% of the##6##5##(1991-12#1)(1994-9#1)(1997-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
more than 90% of##10##4##(1991-12#1)(1994-9#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
more than 90%##16##3##(1991-12#1)(1994-9#1)(1996-11#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#2)
more than 95%##3##3##(2008-10#3)
more than 97%##2##3##(2008-10#2)
more than 99%##3##3##(1996-12#1)(2012-12#1)(2012-2#1)
more than a century##8##4##(1992-5#1)(1994-3#2)(1997-3#1)(2008-8#1)(2009-8#2)(2013-8#1)
more than a decade ago##2##5##(2009-3#1)(2012-2#1)
more than a decade##6##4##(1993-12#1)(1994-12#1)(1996-5#1)(2009-3#1)(2011-2#1)(2012-2#1)
more than a factor of##2##5##(2008-10#2)
more than a year##2##4##(2010-10#1)(2012-3#1)
more than a##26##3##(1990-7#1)(1990-9#1)(1991-12#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-3#2)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
more than compensated for##2##4##(2008-8#1)(2008-9#1)
more than did##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
more than doubled in##2##4##(1991-9#1)(2008-12#1)
more than doubled##3##3##(1990-8#1)(1991-9#1)(2008-12#1)
more than eight##2##3##(1992-5#1)(2008-10#1)
more than five##3##3##(1996-3#1)(2008-10#2)
more than forty##2##3##(2008-11#1)(2008-9#1)
more than four primary##2##4##(1990-12#2)
more than four##7##3##(1990-12#2)(2008-10#2)(2008-4#1)(2012-12#2)
more than half of the##3##5##(1991-5#1)(2007-12#1)(2008-10#1)
more than half of##8##4##(1991-5#1)(2007-12#1)(2008-10#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
more than half the##4##4##(1990-11#1)(1994-12#1)(2011-2#1)(2013-1#1)
more than half##15##3##(1990-11#1)(1991-5#1)(1991-9#1)(1994-12#1)(2007-12#1)(2008-10#3)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
more than in##2##3##(2008-12#1)(2012-3#1)
more than just the##2##4##(2008-11#1)(2011-2#1)
more than just##3##3##(2008-11#1)(2010-10#1)(2011-2#1)
more than likely##2##3##(1995-12#1)(2008-10#1)
more than once##2##3##(2008-10#1)(2008-12#1)
more than one developmental##2##4##(1997-6#1)(2009-11#1)
more than one isolate##2##4##(2008-10#2)
more than one reproduction##2##4##(2008-8#2)
more than one year##2##4##(1992-5#1)(2010-8#1)
more than one##49##3##(1992-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#2)(2008-10#14)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#2)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#6)(2013-1#1)
more than one-third of##2##4##(1995-1#1)(1997-2#1)
more than seven##2##3##(2008-10#1)(2012-2#1)
more than ten times##2##4##(1990-6#2)
more than ten##6##3##(1990-6#2)(1991-11#1)(1994-9#1)(2008-3#1)(2008-8#1)
more than that of the control##2##6##(2008-9#1)(2011-2#1)
more than that of the##4##5##(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
more than that of##5##4##(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
more than that##7##3##(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)
more than the control##2##4##(2008-10#1)(2013-1#1)
more than the##16##3##(1994-1#1)(1994-11#1)(2008-10#5)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#2)
more than those##2##3##(2008-8#1)(2013-1#1)
more than three##10##3##(1990-12#2)(1996-3#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-5#1)(2012-3#2)(2013-1#1)
more than twice as high##2##5##(2008-10#1)(2013-1#1)
more than twice the##5##4##(1990-11#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-2#1)
more than twice##9##3##(1990-11#1)(2008-1#1)(2008-10#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
more than two##10##3##(1990-6#1)(1990-9#1)(1991-9#1)(1994-6#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
more than##573##2##(1990-11#2)(1990-12#9)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#8)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#7)(1997-7#1)(1997-8#2)(2006-6#1)(2007-12#5)(2008-1#5)(2008-10#147)(2008-11#35)(2008-12#10)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#11)(2008-8#22)(2008-9#18)(2009-10#2)(2009-11#3)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#2)(2010-5#2)(2010-7#5)(2010-8#4)(2011-1#1)(2011-2#39)(2011-3#6)(2012-12#8)(2012-2#14)(2012-3#7)(2012-9#2)(2013-1#27)(2013-8#3)
more the##2##2##(2008-5#1)(2012-12#1)
more tightly than##2##3##(1994-5#1)(1996-5#1)
more tightly##4##2##(1994-5#1)(1996-5#1)(2008-9#2)
more time in the##2##4##(1992-3#1)(2009-8#1)
more time in##5##3##(1992-3#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
more time than##2##3##(1991-6#1)(2008-11#1)
more time to##3##3##(1996-5#1)(2008-5#1)(2008-7#1)
more time##15##2##(1991-6#1)(1992-3#1)(1996-5#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)
more to the##6##3##(1994-12#2)(1995-2#1)(2008-10#2)(2011-3#1)
more to##16##2##(1994-12#2)(1995-2#1)(2008-10#5)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-3#1)(2012-2#1)(2012-3#1)
more tolerant##3##2##(2008-10#1)(2008-12#1)(2012-9#1)
more total walking##2##3##(2013-1#2)
more total##3##2##(2011-2#1)(2013-1#2)
more toxic than##4##3##(1990-5#1)(1990-6#1)(2008-10#1)(2008-11#1)
more toxic##6##2##(1990-5#1)(1990-6#1)(1996-12#1)(2008-10#2)(2008-11#1)
more traditional##7##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)
more training##2##2##(2010-11#1)(2010-8#1)
more trustworthy##2##2##(2008-10#1)(2010-10#1)
more typical##2##2##(2008-10#1)(2010-1#1)
more uniform##5##2##(1995-3#1)(2008-10#2)(2009-7#1)(2011-2#1)
more urgent##2##2##(1997-7#1)(2010-1#1)
more useful for##5##3##(1993-9#1)(1997-3#1)(2008-3#1)(2009-8#1)(2010-12#1)
more useful if##2##3##(2008-10#1)(2011-2#1)
more useful than##3##3##(1994-8#1)(2008-11#1)(2008-7#1)
more useful##16##2##(1993-2#1)(1993-9#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
more variability in##2##3##(2008-10#1)(2008-11#1)
more variable##8##2##(1996-2#1)(2008-10#2)(2008-8#1)(2008-9#3)(2010-8#1)
more variation##3##2##(1993-12#1)(2008-10#2)
more viable##2##2##(2008-1#1)(2013-8#1)
more virulent than##5##3##(2008-10#4)(2008-5#1)
more virulent##13##2##(2006-6#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-9#1)
more vulnerable to##5##3##(2007-12#1)(2008-10#3)(2008-4#1)
more vulnerable##9##2##(1990-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)
more weakly##3##2##(1994-3#1)(1996-6#1)(2010-7#1)
more weight##2##2##(1991-12#1)(2008-3#1)
more when##2##2##(1996-9#1)(2008-10#1)
more widely used##2##3##(1997-1#1)(2012-3#1)
more widely##4##2##(1997-1#1)(2008-11#1)(2008-6#1)(2012-3#1)
more widespread than previously##3##4##(1996-3#1)(2008-10#2)
more widespread than##4##3##(1996-3#1)(2008-10#2)(2008-8#1)
more widespread use##2##3##(1990-2#1)(2008-11#1)
more widespread##10##2##(1990-2#1)(1990-6#1)(1991-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#2)
more with less##4##3##(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#1)
more with##9##2##(1993-3#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-8#1)(2008-10#1)(2010-7#3)
more women##2##2##(2008-5#1)(2013-1#1)
more you##2##2##(2008-11#2)
more##3887##1##(1990-11#13)(1990-12#25)(1990-2#12)(1990-3#6)(1990-5#13)(1990-6#12)(1990-7#1)(1990-8#11)(1990-9#7)(1991-1#9)(1991-10#1)(1991-11#6)(1991-12#26)(1991-2#19)(1991-3#18)(1991-5#9)(1991-6#18)(1991-7#3)(1991-8#5)(1991-9#6)(1992-1#8)(1992-10#1)(1992-12#17)(1992-2#8)(1992-3#26)(1992-4#2)(1992-5#6)(1992-6#5)(1992-7#1)(1992-8#8)(1992-9#12)(1993-1#9)(1993-11#18)(1993-12#46)(1993-2#22)(1993-3#19)(1993-5#1)(1993-6#10)(1993-8#11)(1993-9#1)(1994-1#21)(1994-11#13)(1994-12#27)(1994-2#22)(1994-3#15)(1994-5#22)(1994-6#13)(1994-8#17)(1994-9#7)(1995-1#11)(1995-10#2)(1995-11#11)(1995-12#16)(1995-2#17)(1995-3#10)(1995-5#17)(1995-6#4)(1995-8#9)(1995-9#2)(1996-1#8)(1996-11#9)(1996-12#21)(1996-2#23)(1996-3#26)(1996-5#7)(1996-6#9)(1996-8#2)(1996-9#4)(1997-1#22)(1997-2#32)(1997-3#30)(1997-4#9)(1997-5#5)(1997-6#9)(1997-7#8)(1997-8#25)(2006-6#5)(2007-11#2)(2007-12#25)(2007-8#3)(2008-1#26)(2008-10#868)(2008-11#287)(2008-12#97)(2008-2#13)(2008-3#44)(2008-4#42)(2008-5#100)(2008-6#19)(2008-7#87)(2008-8#152)(2008-9#133)(2009-1#2)(2009-10#19)(2009-11#13)(2009-12#11)(2009-3#16)(2009-4#8)(2009-5#12)(2009-6#8)(2009-7#25)(2009-8#35)(2009-9#6)(2010-1#27)(2010-10#18)(2010-11#22)(2010-12#31)(2010-2#5)(2010-3#10)(2010-4#16)(2010-5#10)(2010-6#13)(2010-7#30)(2010-8#20)(2010-9#4)(2011-1#21)(2011-2#196)(2011-3#14)(2011-7#6)(2012-12#34)(2012-2#93)(2012-3#62)(2012-4#2)(2012-5#5)(2012-6#1)(2012-7#5)(2012-8#1)(2012-9#7)(2013-1#161)(2013-7#3)(2013-8#56)
more)##5##1##(1991-6#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
moreover##16##1##(1990-12#1)(1990-5#1)(1990-9#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-8#1)(2012-3#2)(2013-8#1)
morhua##7##1##(2010-8#7)
mori was##2##2##(2008-5#1)(2008-7#1)
mori##23##1##(1995-11#2)(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2012-2#1)
moribund##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
morin##6##1##(2008-10#6)
morin-APSG##2##1##(2008-10#2)
morning hours##4##2##(2008-10#1)(2012-5#2)(2013-1#1)
morning leaf wetness##2##3##(2008-10#2)
morning##34##1##(1994-3#1)(1995-11#1)(1996-1#2)(1996-2#1)(1996-5#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2010-5#1)(2010-8#1)(2011-2#2)(2012-5#2)(2013-1#2)(2013-7#1)
morosus##4##1##(2007-12#4)
morph##4##1##(2007-12#2)(2008-5#1)(2008-8#1)
morphine and beta-endorphin##4##3##(1992-3#4)
morphine and noscapine##2##3##(2008-10#2)
morphine and other##2##3##(1995-6#2)
morphine and##14##2##(1991-1#1)(1992-3#4)(1994-2#1)(1995-11#1)(1995-6#3)(1996-2#1)(2008-10#2)(2008-7#1)
morphine antinociception and##2##3##(1997-2#2)
morphine antinociception##6##2##(1996-2#1)(1997-2#5)
morphine at##2##2##(2008-10#1)(2008-12#1)
morphine concentration##2##2##(2008-10#2)
morphine in the##3##3##(1995-12#1)(1997-2#1)(2008-7#1)
morphine in##10##2##(1991-1#2)(1995-12#1)(1996-2#2)(1997-2#2)(2008-10#2)(2008-7#1)
morphine inhibited##3##2##(2008-12#3)
morphine levels##3##2##(1995-12#1)(1997-2#2)
morphine on##5##2##(1994-2#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-12#1)
morphine sulfate on##2##3##(1996-2#1)(2008-7#1)
morphine sulfate##4##2##(1995-11#1)(1996-2#2)(2008-7#1)
morphine were##4##2##(1990-8#1)(1995-11#2)(2008-12#1)
morphine with##2##2##(2008-10#1)(2009-7#1)
morphine##110##1##(1990-8#1)(1991-1#8)(1992-3#5)(1994-2#7)(1995-11#9)(1995-12#8)(1995-6#3)(1996-2#20)(1997-2#13)(2008-10#15)(2008-11#2)(2008-12#11)(2008-7#5)(2009-7#3)
morphine-induced##4##1##(1991-1#1)(1994-2#1)(1997-2#1)(2009-7#1)
morphine-treated##2##1##(1991-5#2)
morphofunctional##3##1##(2008-11#1)(2008-7#1)(2013-1#1)
morphogenesis and growth of the male phallus##2##7##(2008-10#2)
morphogenesis and##5##2##(2008-10#2)(2009-8#2)(2011-2#1)
morphogenesis in##3##2##(2008-10#2)(2011-2#1)
morphogenesis of##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
morphogenesis##19##1##(1991-5#1)(1993-12#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-8#1)(2009-5#1)(2009-8#2)(2009-9#1)(2011-2#3)
morphogenetic processes##2##2##(1990-8#1)(2009-8#1)
morphogenetic protein-7##2##2##(2011-2#2)
morphogenetic proteins##4##2##(1991-5#1)(2011-2#3)
morphogenetic##15##1##(1990-8#1)(1991-5#1)(1994-9#1)(1996-11#1)(2008-10#1)(2009-6#1)(2009-8#1)(2011-2#8)
morphologic abnormalities##2##2##(1993-8#1)(1996-3#1)
morphologic and functional##2##3##(2012-3#2)
morphologic and##4##2##(1992-9#1)(2008-10#1)(2012-3#2)
morphologic changes##2##2##(1990-12#1)(1996-3#1)
morphologic features##3##2##(2010-9#1)(2011-2#2)
morphologic studies##2##2##(1995-6#1)(2009-8#1)
morphologic##32##1##(1990-12#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-8#2)(1995-6#1)(1996-3#2)(2008-10#3)(2008-5#2)(2009-8#2)(2010-9#1)(2011-2#8)(2012-3#3)
morphological and functional##4##3##(1994-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
morphological and physiological traits##2##4##(2008-10#2)
morphological and physiological##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)
morphological and##29##2##(1991-12#1)(1992-6#1)(1993-9#1)(1994-12#1)(2007-12#2)(2008-10#7)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2012-9#1)
morphological aspect of the##2##4##(2007-12#1)(2008-6#1)
morphological aspects##3##2##(1991-8#1)(2008-7#1)(2009-8#1)
morphological change##2##2##(2008-11#2)
morphological changes in##3##3##(1995-8#1)(2008-12#1)(2012-3#1)
morphological changes of##2##3##(2008-11#1)(2008-9#1)
morphological changes##20##2##(1994-11#1)(1994-8#2)(1995-8#2)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#2)(2012-2#1)(2012-3#1)
morphological character##2##2##(2008-8#1)(2008-9#1)
morphological characteristics and##2##3##(1994-8#1)(2008-12#1)
morphological characteristics of the##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
morphological characteristics of##6##3##(1995-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
morphological characteristics##13##2##(1994-2#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
morphological characterization##2##2##(2008-10#2)
morphological characters##9##2##(1996-12#2)(2008-10#4)(2009-8#1)(2010-3#2)
morphological criteria##8##2##(1996-6#1)(2008-10#4)(2008-5#1)(2009-12#1)(2012-3#1)
morphological data##2##2##(2008-7#1)(2008-8#1)
morphological differences##3##2##(2008-10#1)(2010-10#1)(2012-5#1)
morphological differentiation##4##2##(1992-6#1)(1993-3#1)(2009-8#1)(2012-3#1)
morphological evidence that##2##3##(1992-3#1)(1997-4#1)
morphological evidence##3##2##(1992-3#1)(1997-4#1)(2010-10#1)
morphological evolution of##2##3##(2008-3#1)(2010-3#1)
morphological evolution##4##2##(2008-3#2)(2010-3#1)(2010-5#1)
morphological features of##3##3##(1997-1#1)(2009-10#1)(2012-2#1)
morphological features##13##2##(1993-3#1)(1994-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
morphological identification##4##2##(2008-10#4)
morphological index and its related taxonomic traits##2##7##(2008-8#2)
morphological index##3##2##(2008-8#3)
morphological marker##2##2##(2008-10#2)
morphological markers##4##2##(2008-10#3)(2008-8#1)
morphological parameters##6##2##(1997-8#1)(2008-11#1)(2011-2#3)(2012-3#1)
morphological patterns##2##2##(2008-8#2)
morphological plasticity##2##2##(2008-8#2)
morphological responses##2##2##(2008-8#2)
morphological study of the##2##4##(2008-10#1)(2011-2#1)
morphological study##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
morphological traits can##2##3##(2008-10#1)(2008-8#1)
morphological traits##8##2##(2008-10#2)(2008-8#2)(2010-10#1)(2012-3#1)(2012-5#1)(2012-9#1)
morphological type##2##2##(1991-12#1)(2008-12#1)
morphological types and six VCGs##2##5##(2008-10#2)
morphological types and##3##3##(2008-10#3)
morphological types of the##2##4##(2007-12#1)(2008-12#1)
morphological types of##3##3##(2007-12#2)(2008-12#1)
morphological types##7##2##(1996-6#1)(2007-12#2)(2008-10#3)(2008-12#1)
morphological##222##1##(1990-11#3)(1991-12#2)(1991-3#2)(1991-8#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#5)(1995-12#1)(1995-8#3)(1996-12#2)(1996-6#2)(1997-1#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#2)(2007-12#9)(2008-10#50)(2008-11#17)(2008-12#6)(2008-3#3)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#21)(2008-9#10)(2009-10#1)(2009-12#4)(2009-8#5)(2010-10#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#10)(2012-5#2)(2012-9#2)
morphologically ambiguous endometrial##2##3##(2011-2#2)
morphologically and phylogenetically##2##3##(2010-3#2)
morphologically and##8##2##(1990-3#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-3#2)
morphologically as##2##2##(2008-10#1)(2008-11#1)
morphologically distinct##5##2##(1995-2#1)(2007-12#1)(2008-5#1)(2008-8#1)(2012-3#1)
morphologically indistinguishable from F##2##4##(2008-10#2)
morphologically indistinguishable from##3##3##(2008-10#3)
morphologically indistinguishable##4##2##(2008-10#4)
morphologically normal cells##2##3##(2011-2#2)
morphologically normal##5##2##(2008-10#1)(2011-2#4)
morphologically resembling##2##2##(2008-10#2)
morphologically similar to psittacine beak and feather disease##2##8##(2008-5#2)
morphologically similar to##6##3##(2008-10#1)(2008-5#2)(2009-8#1)(2010-3#2)
morphologically similar##15##2##(2007-12#1)(2008-10#7)(2008-5#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-3#2)
morphologically##71##1##(1990-3#1)(1994-2#1)(1995-2#3)(1996-6#1)(2007-12#3)(2008-10#20)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#5)(2010-4#1)(2011-2#10)(2012-12#1)(2012-3#3)(2013-8#1)
morphologies and##2##2##(2008-10#1)(2012-12#1)
morphologies of##2##2##(2008-10#1)(2008-3#1)
morphologies were##2##2##(2008-10#1)(2009-7#1)
morphologies##17##1##(1997-3#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-5#1)(2009-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
morphology and function##2##3##(2008-11#1)(2012-3#1)
morphology and the##4##3##(2007-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
morphology and##42##2##(1996-2#1)(1997-8#1)(2007-12#4)(2008-10#9)(2008-11#7)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-6#1)(2010-7#2)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
morphology are##2##2##(2008-10#1)(2009-8#1)
morphology as##2##2##(1995-6#1)(2012-2#1)
morphology but##2##2##(2008-10#1)(2008-9#1)
morphology in##5##2##(1997-3#1)(2008-11#1)(2008-7#2)(2009-12#1)
morphology is##4##2##(2007-12#1)(2008-8#1)(2012-3#2)
morphology of a##3##3##(2008-11#1)(2008-7#1)(2009-12#1)
morphology of genetic tumours was##2##5##(2008-7#2)
morphology of the gland opening##2##5##(2007-12#2)
morphology of the##25##3##(2007-12#6)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)
morphology of these##2##3##(2008-10#1)(2013-1#1)
morphology of##61##2##(1991-12#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#6)(2008-10#16)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#2)
morphology on##7##2##(2008-10#4)(2008-9#1)(2009-7#1)(2010-4#1)
morphology through##2##2##(1996-2#1)(2010-8#1)
morphology to##3##2##(1992-12#1)(2010-4#1)(2011-2#1)
morphology was not##2##3##(1996-6#1)(2008-10#1)
morphology was studied##2##3##(1992-2#1)(2013-1#1)
morphology was##8##2##(1992-2#1)(1996-6#1)(2008-10#3)(2008-8#1)(2013-1#2)
morphology were observed##2##3##(1994-5#1)(2008-10#1)
morphology were##6##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
morphology with##2##2##(2011-2#1)(2013-1#1)
morphology##232##1##(1991-12#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1993-12#2)(1993-8#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#2)(1997-8#3)(2007-12#13)(2007-8#1)(2008-10#56)(2008-11#26)(2008-12#3)(2008-4#1)(2008-5#7)(2008-7#11)(2008-8#10)(2008-9#8)(2009-11#1)(2009-12#4)(2009-3#2)(2009-7#4)(2009-8#10)(2010-4#3)(2010-6#3)(2010-7#2)(2010-8#4)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#1)
morphology)##2##1##(2008-10#1)(2009-7#1)
morphometric analysis##2##2##(2006-6#1)(2008-6#1)
morphometric and stereological studies##2##4##(2008-5#2)
morphometric and stereological##3##3##(2008-5#3)
morphometric and##5##2##(2008-5#3)(2008-7#1)(2011-2#1)
morphometric data##2##2##(2008-7#2)
morphometric indices##2##2##(2008-12#2)
morphometric methods##2##2##(2007-12#1)(2012-3#1)
morphometric parameters##2##2##(2008-7#2)
morphometric study of##2##3##(2012-3#2)
morphometric##22##1##(1995-5#1)(1996-2#1)(2006-6#1)(2007-12#1)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#5)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#1)
morphometry and##2##2##(2008-7#1)(2013-1#1)
morphometry of##4##2##(1996-2#1)(2011-2#2)(2013-1#1)
morphometry##16##1##(1994-8#1)(1995-8#1)(1996-2#3)(1997-2#3)(2008-11#1)(2008-7#1)(2011-2#3)(2013-1#3)
morphotype A##6##2##(2008-10#6)
morphotype##8##1##(1991-11#1)(2008-10#7)
morphotypes were##2##2##(2013-1#2)
morphotypes##7##1##(2008-10#1)(2010-8#2)(2013-1#4)
morphs##2##1##(2008-8#1)(2008-9#1)
morsellized bone graft##2##3##(2010-5#2)
morsitans##5##1##(2010-4#5)
mortalities and##2##2##(2009-7#1)(2010-1#1)
mortalities in##2##2##(2009-6#1)(2010-1#1)
mortalities##4##1##(2009-6#1)(2009-7#1)(2010-1#2)
mortality after##5##2##(1990-12#1)(1992-12#1)(1992-5#1)(2012-2#1)(2013-1#1)
mortality among##2##2##(1993-12#1)(1997-8#1)
mortality and morbidity after##3##4##(2009-10#1)(2011-2#2)
mortality and morbidity from##2##4##(1997-2#1)(2011-2#1)
mortality and morbidity rates##3##4##(2008-7#1)(2010-1#1)(2013-1#1)
mortality and morbidity##19##3##(1992-12#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
mortality and##49##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
mortality are##3##2##(1995-3#1)(1997-8#1)(2008-10#1)
mortality associated with##5##3##(1993-9#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-2#1)
mortality at##4##2##(1991-3#1)(2008-8#1)(2012-3#1)(2013-8#1)
mortality between##5##2##(1990-8#1)(1992-12#1)(1994-2#1)(2011-2#1)(2012-3#1)
mortality by cancer##2##3##(2008-1#2)
mortality by malaria##2##3##(2012-12#2)
mortality by##8##2##(1990-11#1)(1995-12#1)(2008-1#2)(2009-10#1)(2010-11#1)(2012-12#2)
mortality can be##4##3##(1993-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
mortality data##8##2##(1991-8#1)(1992-2#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
mortality decreased##2##2##(2008-12#1)(2011-2#1)
mortality due to##4##3##(1996-3#1)(2008-11#1)(2011-2#1)(2013-8#1)
mortality during##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
mortality exceeds##2##2##(2008-12#1)(2008-8#1)
mortality following##2##2##(1990-12#1)(2008-11#1)
mortality for##6##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-3#1)
mortality from a##2##3##(1995-3#1)(2008-8#1)
mortality from carcinoma of the prostate##2##6##(1995-8#2)
mortality from colorectal cancer##2##4##(1995-9#1)(2009-12#1)
mortality from##15##2##(1990-8#1)(1992-6#1)(1993-2#1)(1995-12#1)(1995-3#2)(1995-8#2)(1995-9#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#2)(2013-1#1)
mortality has##2##2##(2011-2#1)(2011-3#1)
mortality in Italian##2##3##(1994-2#2)
mortality in Italy##4##3##(1991-2#1)(1993-3#1)(1994-12#1)(1994-2#1)
mortality in merchant seamen##2##4##(1991-12#2)
mortality in patients with##3##4##(2009-8#1)(2010-1#1)(2011-2#1)
mortality in patients##7##3##(1993-12#2)(2009-8#1)(2010-1#1)(2011-2#3)
mortality in the United##2##4##(1997-1#1)(2008-12#1)
mortality in the##10##3##(1990-11#2)(1990-2#1)(1996-6#1)(1997-1#1)(1997-6#1)(2008-12#1)(2011-2#3)
mortality in this##2##3##(1996-3#1)(2008-7#1)
mortality in##67##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#2)(1991-2#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#13)(2011-3#1)(2012-12#1)(2013-1#4)(2013-8#1)
mortality is not##2##3##(2008-8#1)(2009-10#1)
mortality is##17##2##(1993-2#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2009-10#1)(2009-6#1)(2010-12#2)(2011-2#4)(2013-1#1)
mortality occurred##2##2##(2008-5#1)(2008-9#1)
mortality of the##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
mortality of##27##2##(1990-12#1)(1992-11#1)(1994-12#1)(1994-9#2)(1995-2#2)(1995-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-7#3)(2008-8#1)(2010-2#3)(2011-2#1)
mortality on the##2##3##(2008-8#1)(2009-10#1)
mortality or development of##2##4##(2008-7#2)
mortality or##10##2##(2008-7#3)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
mortality over the##2##3##(2008-9#1)(2013-8#1)
mortality over##3##2##(2008-9#1)(2009-5#1)(2013-8#1)
mortality pockets##3##2##(2008-10#3)
mortality rate decreased##2##3##(1996-11#1)(2012-12#1)
mortality rate for##2##3##(1992-5#1)(2008-8#1)
mortality rate is##2##3##(1992-9#1)(2013-1#1)
mortality rate was##7##3##(1990-3#1)(1995-12#2)(2008-7#3)(2011-3#1)
mortality rate##56##2##(1990-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-12#4)(1995-3#5)(1995-8#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#5)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#6)(2012-3#1)(2013-1#5)
mortality rates in##4##3##(1993-12#1)(2008-11#1)(2012-12#1)(2013-8#1)
mortality rates of##3##3##(2008-8#2)(2013-8#1)
mortality rates##19##2##(1993-12#2)(1993-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-6#1)(2010-6#1)(2012-12#1)(2013-8#3)
mortality risk##6##2##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#2)
mortality statistics##2##2##(1992-6#1)(1993-2#1)
mortality studies##3##2##(1991-12#1)(1992-2#1)(1992-3#1)
mortality using##2##2##(2009-6#1)(2010-1#1)
mortality was 1##2##3##(2008-7#1)(2011-3#1)
mortality was found##2##3##(1992-6#1)(1995-3#1)
mortality was observed##3##3##(1991-12#1)(2008-10#2)
mortality was significantly increased in##2##5##(2008-7#1)(2011-2#1)
mortality was##26##2##(1991-12#1)(1992-6#2)(1995-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)
mortality were##4##2##(1996-3#1)(1997-1#1)(2008-7#1)(2013-1#1)
mortality when##3##2##(2008-7#1)(2008-8#1)(2012-12#1)
mortality within##3##2##(1993-12#1)(1994-12#1)(1995-1#1)
mortality##585##1##(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-8#5)(1991-1#1)(1991-12#7)(1991-2#1)(1991-3#6)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-5#2)(1992-6#4)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#14)(1993-2#8)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#5)(1994-2#6)(1994-3#2)(1994-9#2)(1995-1#4)(1995-12#8)(1995-2#6)(1995-3#13)(1995-8#3)(1995-9#1)(1996-11#5)(1996-12#1)(1996-2#1)(1996-3#6)(1996-6#2)(1997-1#11)(1997-2#3)(1997-3#2)(1997-6#2)(1997-7#3)(1997-8#6)(2008-1#9)(2008-10#37)(2008-11#19)(2008-12#11)(2008-2#1)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#49)(2008-8#31)(2008-9#21)(2009-10#5)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#8)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#4)(2010-12#7)(2010-2#11)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#3)(2011-2#60)(2011-3#7)(2012-12#19)(2012-2#6)(2012-3#17)(2013-1#25)(2013-8#16)
mortality)##2##1##(2008-10#1)(2008-11#1)
mortality/morbidity##2##1##(2008-7#1)(2009-5#1)
mortalité##4##1##(2009-10#1)(2011-2#1)(2013-1#2)
mortem##10##1##(1991-11#1)(1995-9#2)(2008-11#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-4#1)(2012-3#1)
morula-like cells##3##2##(2008-5#3)
morula-like##5##1##(2008-5#5)
morule-like features and##2##3##(2008-11#2)
morule-like features##4##2##(2008-11#4)
mosaic disease##3##2##(2008-10#2)(2008-9#1)
mosaic geminivirus##2##2##(2008-10#2)
mosaic is##2##2##(2008-10#2)
mosaic mutation in mice##2##4##(2008-12#2)
mosaic pattern##2##2##(1997-3#1)(2010-12#1)
mosaic potexvirus##2##2##(2008-10#2)
mosaic potyvirus##3##2##(2008-10#3)
mosaic symptoms##9##2##(2008-10#9)
mosaic virus (CMV)##12##3##(2008-10#9)(2008-8#2)(2012-2#1)
mosaic virus (CaMV)##4##3##(2008-10#4)
mosaic virus (SCMV)##2##3##(2008-10#1)(2008-9#1)
mosaic virus (SMV)##5##3##(2008-10#5)
mosaic virus (TMV)##4##3##(2008-10#4)
mosaic virus (TuMV)##3##3##(2008-10#3)
mosaic virus Resistance in##2##4##(2008-10#2)
mosaic virus and Cucumber##2##4##(2008-10#2)
mosaic virus and##11##3##(2008-10#9)(2008-8#1)(2012-2#1)
mosaic virus in##13##3##(2008-10#13)
mosaic virus isolate##2##3##(2008-8#1)(2008-9#1)
mosaic virus mixed with Blackeye cowpea mosaic virus##2##8##(2008-10#2)
mosaic virus mixed with##3##4##(2008-10#3)
mosaic virus##181##2##(1997-3#3)(2008-10#153)(2008-7#2)(2008-8#14)(2008-9#7)(2012-2#2)
mosaic##237##1##(1997-3#5)(2008-10#198)(2008-12#4)(2008-5#1)(2008-7#2)(2008-8#14)(2008-9#9)(2010-12#1)(2012-2#3)
mosaicism##3##1##(2008-12#2)(2012-3#1)
moschata##2##1##(2008-10#2)
mosquito larvae##3##2##(2008-12#1)(2008-5#2)
mosquito##13##1##(2008-10#1)(2008-12#2)(2008-5#3)(2010-1#2)(2011-2#3)(2011-3#2)
mosquitoes##8##1##(2007-12#1)(2008-12#4)(2010-1#1)(2011-3#1)(2012-12#1)
moss amended with compost##2##4##(2008-10#2)
moss and vascular plants##2##4##(2008-8#2)
moss and##5##2##(2008-10#2)(2008-8#3)
moss monoculture and##3##3##(2008-8#3)
moss samples##2##2##(2008-10#2)
moss##24##1##(2008-10#14)(2008-11#1)(2008-5#1)(2008-8#7)(2008-9#1)
mosses##3##1##(2008-10#1)(2008-8#2)
most 2##3##2##(2008-10#2)(2008-11#1)
most IHs##2##2##(2013-8#2)
most REEs##2##2##(2008-10#2)
most S##2##2##(1993-12#1)(2008-11#1)
most abundant in##2##3##(2008-10#1)(2008-5#1)
most abundant##36##2##(1992-9#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
most acceptable##2##2##(2013-1#2)
most accurate##8##2##(1994-9#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2013-8#1)
most accurately##3##2##(1995-1#1)(2008-11#1)(2008-6#1)
most active##12##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#3)(2013-1#1)(2013-8#1)
most adequate##3##2##(1992-1#1)(1996-5#1)(2013-1#1)
most affected by##3##3##(2008-10#2)(2008-8#1)
most affected##10##2##(1992-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-1#1)
most aggressive##6##2##(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-3#1)
most analyzed##2##2##(2009-8#1)(2013-1#1)
most animal##2##2##(2008-11#1)(2008-9#1)
most appropriate for##3##3##(1990-2#1)(2008-10#1)(2008-3#1)
most appropriate to##3##3##(1995-1#1)(2008-11#1)(2008-2#1)
most appropriate##32##2##(1990-2#1)(1990-5#1)(1990-9#1)(1993-6#1)(1995-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-9#1)(2013-1#1)
most are##2##2##(1994-1#1)(2013-1#1)
most associated##2##2##(2010-10#1)(2011-2#1)
most at risk##3##3##(1996-5#1)(2012-3#1)(2013-8#1)
most attention##2##2##(1994-3#1)(2011-1#1)
most attractive##3##2##(1992-3#1)(2008-5#1)(2008-8#1)
most bacteria##2##2##(1990-2#1)(2010-12#1)
most basal##4##2##(1995-12#1)(2008-10#2)(2011-2#1)
most basic##2##2##(1994-1#1)(1994-12#1)
most benefit from##2##3##(2011-2#1)(2012-3#1)
most cases of##4##3##(1991-11#1)(1997-1#1)(2008-5#1)(2012-2#1)
most cases##60##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
most cells##4##2##(1996-12#2)(2008-10#1)(2008-11#1)
most challenging##3##2##(1991-12#1)(2011-1#1)(2011-2#1)
most characteristic##4##2##(1997-8#1)(2008-10#3)
most chemotherapy agents##2##3##(2008-8#2)
most chicks##2##2##(2008-6#2)
most children##3##2##(2008-10#1)(2008-11#2)
most clinical laboratories##2##3##(2008-10#1)(2008-9#1)
most clinical##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
most closely related to the##3##5##(2008-10#3)
most closely related to##14##4##(1997-8#1)(2008-10#11)(2008-9#1)(2013-1#1)
most closely related##15##3##(1997-8#1)(2008-10#12)(2008-9#1)(2013-1#1)
most closely##19##2##(1993-2#1)(1994-5#1)(1997-8#1)(2008-10#13)(2008-7#1)(2008-9#1)(2013-1#1)
most common and##9##3##(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#2)
most common cancer##4##3##(2007-8#1)(2008-11#1)(2010-12#1)(2013-8#1)
most common cause of death##2##5##(1993-9#1)(2008-11#1)
most common cause of##16##4##(1993-9#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
most common causes of##6##4##(1990-3#1)(1990-6#1)(1997-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
most common clinical sign##2##4##(1991-8#1)(2008-10#1)
most common clinical##4##3##(1991-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
most common complaint##2##3##(1990-6#1)(2008-9#1)
most common diagnosis##2##3##(2011-2#2)
most common disease##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
most common in##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
most common malignancy##3##3##(2009-2#1)(2010-8#1)(2013-8#1)
most common pathogens##2##3##(2008-12#1)(2011-2#1)
most common presenting##2##3##(2011-2#1)(2012-3#1)
most common reasons for##3##4##(2008-11#1)(2010-8#1)(2011-2#1)
most common type of##7##4##(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
most common type##8##3##(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
most common types of##2##4##(2010-10#1)(2013-1#1)
most common types##4##3##(2010-10#1)(2012-3#1)(2013-1#2)
most common##243##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#4)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#27)(2008-11#15)(2008-12#6)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#18)(2009-1#1)(2009-12#3)(2009-2#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#25)(2011-3#1)(2012-12#7)(2012-2#11)(2012-3#10)(2013-1#25)(2013-7#1)(2013-8#6)
most commonly adopted##2##3##(2009-11#1)(2013-1#1)
most commonly affected##2##3##(2008-5#1)(2010-12#1)
most commonly found in##3##4##(2008-12#1)(2008-9#1)(2013-1#1)
most commonly found##4##3##(2008-12#1)(2008-9#1)(2009-8#1)(2013-1#1)
most commonly in the##5##4##(1993-6#1)(2008-10#1)(2008-12#2)(2011-2#1)
most commonly in##7##3##(1993-6#1)(2008-10#1)(2008-12#2)(2008-8#1)(2009-3#1)(2011-2#1)
most commonly isolated##2##3##(2008-10#2)
most commonly reported in the##2##5##(2013-1#1)(2013-8#1)
most commonly reported##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
most commonly used in##2##4##(2008-10#1)(2010-11#1)
most commonly used##19##3##(1994-12#1)(1994-6#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#5)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
most commonly##71##2##(1991-2#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-2#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#6)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#7)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#1)
most complex##6##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-8#1)
most comprehensive##2##2##(1997-3#1)(2008-10#1)
most conducive##3##2##(1994-12#1)(2008-10#2)
most consistent with##3##3##(1993-8#1)(2008-10#1)(2012-3#1)
most consistent##7##2##(1993-8#1)(2008-10#4)(2012-2#1)(2012-3#1)
most conspicuous##4##2##(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#1)
most correlated with##2##3##(2008-10#2)
most countries##5##2##(1990-8#1)(1992-11#1)(1994-3#1)(1997-8#1)(2008-11#1)
most critical##10##2##(1991-3#1)(1994-3#1)(2008-10#3)(2008-3#1)(2008-9#1)(2012-3#2)(2013-8#1)
most crucial##3##2##(1993-8#1)(1996-2#1)(2010-8#1)
most current##2##2##(2008-4#1)(2010-10#1)
most damaging##3##2##(2008-10#3)
most dangerous##3##2##(1991-8#1)(2007-11#1)(2011-2#1)
most devastating##6##2##(1997-7#1)(2008-10#4)(2012-3#1)
most developed##2##2##(1994-2#1)(2012-3#1)
most difficult##6##2##(1992-1#1)(1994-3#1)(1994-9#1)(2008-8#1)(2011-2#2)
most discriminant##3##2##(2008-10#2)(2011-2#1)
most distant from##3##3##(2008-10#3)
most diverse##3##2##(2008-10#3)
most dramatic##4##2##(1995-8#1)(2008-10#3)
most easily##2##2##(2008-10#2)
most economically##2##2##(2008-10#2)
most effective in reducing##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
most effective in##6##3##(1996-1#1)(1997-8#1)(2008-10#2)(2008-4#1)(2013-8#1)
most effective measure##2##3##(2008-12#1)(2011-3#1)
most effective use##3##3##(1993-12#1)(2008-10#2)
most effective when it##2##4##(1994-1#1)(2008-10#1)
most effective when##3##3##(1994-1#1)(2008-10#1)(2008-9#1)
most effective##76##2##(1990-5#1)(1991-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-8#1)(2008-10#37)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#4)(2013-8#1)
most effectively##6##2##(1992-3#1)(1996-1#1)(1997-1#2)(2008-9#1)(2010-7#1)
most efficacious##2##2##(1990-5#1)(2010-12#1)
most efficient separation##2##3##(2008-10#2)
most efficient##16##2##(1992-2#1)(1996-2#1)(1997-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
most efficiently##2##2##(2008-10#2)
most elements##5##2##(2008-10#5)
most employed##2##2##(2008-10#2)
most essential##2##2##(2008-10#1)(2008-9#1)
most evident in##2##3##(1996-12#1)(2013-8#1)
most evident##4##2##(1996-12#1)(2008-11#1)(2011-1#1)(2013-8#1)
most expensive##4##2##(1992-12#2)(1993-2#1)(1993-3#1)
most extended##2##2##(1990-8#1)(2008-10#1)
most extreme##3##2##(2008-8#2)(2008-9#1)
most favorable##6##2##(2008-10#5)(2008-8#1)
most frequent cause of##4##4##(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
most frequent complication of##2##4##(2011-2#1)(2013-1#1)
most frequent in##2##3##(2009-8#1)(2011-2#1)
most frequent##50##2##(1990-3#1)(1990-9#1)(1991-6#1)(1991-8#2)(1992-5#1)(1992-9#1)(1993-2#1)(1995-11#1)(1996-8#1)(1997-3#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#9)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)
most frequently affected##2##3##(2012-3#1)(2013-1#1)
most frequently as##2##3##(1996-6#1)(2013-1#1)
most frequently associated with##2##4##(2012-3#1)(2013-1#1)
most frequently detected in##2##4##(1996-12#1)(2008-10#1)
most frequently detected##7##3##(1996-12#1)(2008-10#6)
most frequently found##5##3##(1994-3#1)(1996-8#2)(2008-10#2)
most frequently observed##5##3##(1997-4#1)(2008-10#1)(2008-5#1)(2010-1#2)
most frequently performed##2##3##(1992-2#1)(2013-1#1)
most frequently prescribed##5##3##(2008-11#4)(2008-7#1)
most frequently reported##2##3##(2008-11#1)(2008-7#1)
most frequently used##8##3##(2008-10#1)(2008-11#3)(2008-5#2)(2011-2#2)
most frequently##67##2##(1991-10#1)(1991-12#1)(1991-8#1)(1992-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-4#1)(2007-12#1)(2008-10#18)(2008-11#8)(2008-5#4)(2008-7#4)(2008-8#1)(2009-3#2)(2010-1#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)
most from##3##2##(2008-8#1)(2010-12#1)(2012-2#1)
most gene##2##2##(2008-10#1)(2009-6#1)
most genes##3##2##(1997-6#1)(2008-10#2)
most health##3##2##(1992-1#1)(1992-2#1)(2008-12#1)
most highly conserved##2##3##(1993-12#1)(2008-10#1)
most highly##6##2##(1993-12#1)(2008-10#3)(2013-8#2)
most human##2##2##(2008-11#1)(2008-9#1)
most important and##7##3##(1994-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#2)(2010-7#1)
most important are##2##3##(1991-11#1)(2008-10#1)
most important aspect##2##3##(1997-3#1)(2013-8#1)
most important factors##6##3##(1993-1#1)(1994-1#2)(2008-7#1)(2013-1#1)(2013-8#1)
most important for##3##3##(1994-6#1)(2008-10#1)(2012-12#1)
most important in the##2##4##(1994-3#1)(2008-10#1)
most important in##5##3##(1990-11#1)(1994-3#1)(1994-9#1)(2008-10#2)
most important is##2##3##(1997-5#1)(2012-3#1)
most important##164##2##(1990-11#1)(1990-12#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#3)(1992-1#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-1#3)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#45)(2008-11#8)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#7)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#6)(2011-3#2)(2011-4#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#5)
most importantly##7##2##(1995-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2013-8#1)
most in##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
most influential##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
most informative##3##2##(1997-3#1)(2008-5#1)(2008-9#1)
most inhibitory to##2##3##(2008-10#2)
most instances##7##2##(1992-1#1)(1997-4#1)(1997-5#1)(2008-10#3)(2012-3#1)
most intense peak##2##3##(2008-10#2)
most intense##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2012-3#1)
most intensely##3##2##(1995-5#1)(2010-10#1)(2012-2#1)
most interesting##5##2##(1991-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
most ions##2##2##(2008-10#2)
most isolates##6##2##(2008-10#6)
most laboratories##2##2##(1997-5#1)(2012-2#1)
most lesions##2##2##(1997-8#1)(2008-5#1)
most likely a##4##3##(1995-11#1)(2008-10#1)(2008-4#1)(2009-8#1)
most likely due to the##3##5##(2008-10#2)(2013-8#1)
most likely due to##8##4##(1993-6#1)(2008-10#4)(2012-2#1)(2012-6#1)(2013-8#1)
most likely not##2##3##(2008-10#2)
most likely related to##2##4##(1997-2#1)(2008-7#1)
most likely the##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
most likely to be##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
most likely to benefit from##2##5##(1997-6#1)(2013-8#1)
most likely to##17##3##(1990-2#1)(1993-12#1)(1995-3#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
most likely##81##2##(1990-12#1)(1990-2#1)(1991-11#2)(1991-12#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2012-6#1)(2012-7#1)(2013-1#1)(2013-8#2)
most marked##4##2##(1995-11#1)(1997-2#1)(2008-11#1)(2008-7#1)
most methods##2##2##(1991-3#1)(2012-3#1)
most natural##3##2##(2008-10#2)(2011-3#1)
most needed##2##2##(1995-3#1)(2008-10#1)
most notably##9##2##(1993-8#1)(1994-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
most of it##2##3##(1994-12#1)(2009-6#1)
most of its##2##3##(2010-7#1)(2013-8#1)
most of that##2##3##(1994-12#1)(2011-2#1)
most of the amino##2##4##(2008-11#1)(2009-8#1)
most of the cases##5##4##(2008-10#3)(2008-12#1)(2008-8#1)
most of the cells##3##4##(1993-8#1)(2008-10#1)(2008-12#1)
most of the complications##2##4##(1994-6#1)(2010-1#1)
most of the elements were##2##5##(2008-10#2)
most of the elements##4##4##(2008-10#4)
most of the metal ions##3##5##(2008-10#3)
most of the methods##2##4##(2008-10#2)
most of the patients##3##4##(1992-2#1)(2008-1#1)(2011-2#1)
most of the phenotypic variance##2##5##(2008-10#2)
most of the populations##2##4##(2008-10#1)(2008-8#1)
most of the samples##3##4##(2008-10#2)(2008-11#1)
most of the studied##2##4##(2008-10#2)
most of the studies##2##4##(2008-9#1)(2013-1#1)
most of the variability in##2##5##(2008-10#2)
most of the variability##3##4##(2008-10#3)
most of the variation##2##4##(2008-8#1)(2013-8#1)
most of the##165##3##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1995-9#2)(1996-2#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-8#1)(2008-1#1)(2008-10#65)(2008-11#8)(2008-12#4)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#6)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#4)
most of their##3##3##(1996-2#1)(1996-3#1)(2008-8#1)
most of them were##2##4##(2008-10#1)(2008-5#1)
most of them##13##3##(1990-11#1)(1992-12#1)(1993-2#1)(1995-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-8#1)(2012-4#1)
most of these elements##2##4##(2008-10#1)(2012-3#1)
most of these genes##2##4##(1993-12#1)(2008-9#1)
most of these##22##3##(1991-10#1)(1991-3#1)(1992-2#1)(1993-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-3#2)(2012-3#2)
most of this##2##3##(1991-12#1)(1991-8#1)
most of which are##2##4##(1995-6#1)(2008-11#1)
most of which##6##3##(1993-2#1)(1995-6#2)(2008-10#1)(2008-11#2)
most of##240##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-2#3)(1996-3#3)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#2)(2008-1#1)(2008-10#86)(2008-11#14)(2008-12#4)(2008-3#4)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#8)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#5)
most often associated with##2##4##(2008-10#1)(2008-11#1)
most often in##2##3##(1991-6#1)(1992-3#1)
most often involved##3##3##(2008-7#1)(2010-1#1)(2010-12#1)
most often seen in##2##4##(1992-5#1)(2012-12#1)
most often seen##3##3##(1992-5#1)(2008-10#1)(2012-12#1)
most often used##5##3##(2008-10#2)(2008-5#2)(2009-8#1)
most often##43##2##(1991-12#1)(1991-6#1)(1992-3#1)(1992-5#1)(1994-2#2)(1996-1#1)(1996-11#1)(1997-4#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
most optimal##2##2##(2008-7#1)(2008-9#1)
most or##2##2##(1992-12#1)(2008-10#1)
most other##7##2##(1991-10#1)(1997-6#1)(2008-10#3)(2008-4#1)(2009-10#1)
most patients with##3##3##(2008-7#1)(2008-9#1)(2010-10#1)
most patients##17##2##(1990-11#2)(1990-2#1)(1990-3#1)(1992-12#2)(1994-5#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2012-3#1)(2013-1#2)
most people##3##2##(1996-5#1)(1997-6#1)(2008-5#1)
most persistent##3##2##(1992-2#1)(2008-8#1)(2012-2#1)
most pesticides##2##2##(2008-10#2)
most plant##2##2##(2008-8#1)(2011-1#1)
most plants##3##2##(2008-10#2)(2008-8#1)
most plausible##2##2##(1990-12#1)(2008-12#1)
most popular##12##2##(1996-1#1)(2008-10#6)(2008-11#1)(2008-6#1)(2009-8#1)(2012-2#1)(2012-3#1)
most population##2##2##(2011-2#1)(2012-3#1)
most positive##3##2##(1996-2#1)(1997-5#1)(2009-7#1)
most potent in##2##3##(1993-1#1)(2013-1#1)
most potent inhibitors##3##3##(1994-11#1)(1994-8#1)(2008-10#1)
most potent##23##2##(1991-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-8#2)(1996-2#1)(1997-1#1)(2008-10#3)(2008-8#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
most powerful##8##2##(1994-3#1)(1996-3#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-1#1)
most predominant##2##2##(2008-10#1)(2013-8#1)
most prevalent in##3##3##(2008-10#2)(2010-5#1)
most prevalent##31##2##(1990-5#1)(1992-3#1)(1994-12#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-5#4)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
most previous##3##2##(1997-7#1)(2008-10#1)(2013-8#1)
most probable number##2##3##(2008-10#2)
most probable##12##2##(1991-10#1)(1991-12#1)(1994-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2013-1#1)
most probably##9##2##(1990-5#1)(1995-8#1)(1997-8#1)(2006-6#2)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
most profound##2##2##(1995-11#1)(2008-5#1)
most profoundly##2##2##(2011-2#2)
most prominent in the##2##4##(2008-5#1)(2008-6#1)
most prominent in##3##3##(1992-6#1)(2008-5#1)(2008-6#1)
most prominent##15##2##(1992-6#1)(1993-8#1)(1995-8#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
most prominently##2##2##(2008-7#1)(2012-2#1)
most promising##12##2##(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-3#1)(2011-2#2)(2011-3#1)
most pronounced in##2##3##(1993-8#1)(2009-8#1)
most pronounced##11##2##(1993-8#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
most proteins##2##2##(2008-11#2)
most rapid##4##2##(1994-3#1)(2008-10#2)(2008-11#1)
most rapidly##8##2##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#1)(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
most recent##36##2##(1991-12#1)(1991-2#1)(1992-1#1)(1993-1#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2013-8#1)
most recently acquired##2##3##(1990-5#1)(2009-8#1)
most recently##12##2##(1990-5#1)(1993-11#1)(1993-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
most relevant to##2##3##(1992-1#1)(2012-3#1)
most relevant##17##2##(1992-1#1)(1993-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
most reliable##9##2##(1993-12#3)(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
most reliably##2##2##(1990-12#1)(2008-4#1)
most remarkable##3##2##(1993-8#1)(1994-3#1)(2009-7#1)
most representative##4##2##(2008-10#1)(2008-5#1)(2010-1#1)(2013-8#1)
most research##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
most respected##2##2##(2008-10#1)(2008-9#1)
most responsive##3##2##(1991-6#1)(1997-3#1)(2008-9#1)
most robust##3##2##(2008-10#1)(2009-11#1)(2010-1#1)
most samples##3##2##(2008-10#2)(2008-11#1)
most selective##2##2##(1996-2#1)(2008-10#1)
most sensitive and##3##3##(2008-10#1)(2008-12#1)(2010-6#1)
most sensitive to##4##3##(1995-12#1)(2008-10#2)(2008-8#1)
most sensitive##32##2##(1992-9#1)(1995-12#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2012-2#1)
most serious complications##2##3##(1991-3#1)(2011-3#1)
most serious problem##2##3##(1991-2#1)(1991-3#1)
most serious##15##2##(1991-11#1)(1991-2#1)(1991-3#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-3#1)(2012-2#1)
most severe##12##2##(1995-2#1)(2008-10#7)(2008-12#1)(2012-3#1)(2013-8#2)
most significant##27##2##(1990-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
most similar to the##2##4##(2008-10#2)
most similar to##6##3##(1997-7#1)(2008-10#4)(2008-5#1)
most similar##8##2##(1997-7#1)(2008-10#5)(2008-5#1)(2010-4#1)
most sites##2##2##(2008-10#2)
most sophisticated##2##2##(1994-2#1)(2010-8#1)
most species##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
most specific##2##2##(2008-11#1)(2010-6#1)
most stable##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2012-3#1)
most stressful##2##2##(1992-2#2)
most striking##7##2##(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
most students##2##2##(2008-12#1)(2012-2#1)
most studies have##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
most studies##12##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
most successful##6##2##(1995-5#1)(1996-12#1)(2008-10#3)(2008-8#1)
most suitable for the##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
most suitable for##8##3##(1993-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-8#1)
most suitable##27##2##(1993-12#1)(1993-3#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
most surgeons##2##2##(1990-2#1)(2012-12#1)
most susceptible to##4##3##(2008-10#4)
most susceptible##13##2##(1994-8#1)(1995-6#1)(2008-10#11)
most temperatures##2##2##(2008-10#2)
most therapeutic##2##2##(2008-11#1)(2010-12#1)
most to the##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
most to##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
most toxic##5##2##(2008-10#5)
most typical##2##2##(2008-9#1)(2013-7#1)
most used##7##2##(1990-5#1)(2008-10#4)(2009-1#1)(2012-2#1)
most useful for##2##3##(2008-10#2)
most useful in##2##3##(2010-6#1)(2012-3#1)
most useful to##2##3##(2008-1#1)(2012-2#1)
most useful##16##2##(1991-6#1)(1992-1#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
most usual##2##2##(1990-9#1)(2008-12#1)
most valuable##3##2##(1991-2#1)(1992-2#1)(2008-9#1)
most variance in##2##3##(2008-9#2)
most variance##3##2##(2008-9#3)
most volatile##2##2##(2008-10#2)
most vulnerable##3##2##(1996-1#1)(2008-11#1)(2012-12#1)
most were##4##2##(2008-11#1)(2011-2#2)(2012-12#1)
most widely distributed##3##3##(1995-5#1)(2008-10#2)
most widely prescribed##2##3##(1996-2#1)(2008-11#1)
most widely used##17##3##(1991-3#1)(1996-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-2#1)
most widely##28##2##(1991-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-2#1)
most widespread used##2##3##(2010-10#1)(2012-2#1)
most widespread##7##2##(1991-3#1)(1994-3#1)(2008-10#2)(2010-10#1)(2011-2#1)(2012-2#1)
most##2703##1##(1990-11#8)(1990-12#7)(1990-2#11)(1990-3#4)(1990-5#10)(1990-6#4)(1990-7#1)(1990-8#6)(1990-9#9)(1991-1#3)(1991-10#6)(1991-11#5)(1991-12#13)(1991-2#11)(1991-3#18)(1991-6#11)(1991-8#6)(1991-9#2)(1992-1#8)(1992-11#1)(1992-12#11)(1992-2#16)(1992-3#8)(1992-5#7)(1992-6#3)(1992-8#1)(1992-9#9)(1993-1#8)(1993-11#3)(1993-12#16)(1993-2#11)(1993-3#8)(1993-6#10)(1993-8#11)(1993-9#1)(1994-1#15)(1994-11#2)(1994-12#13)(1994-2#8)(1994-3#21)(1994-5#8)(1994-6#7)(1994-8#9)(1994-9#6)(1995-1#6)(1995-11#6)(1995-12#12)(1995-2#15)(1995-3#4)(1995-5#6)(1995-6#9)(1995-8#5)(1995-9#2)(1996-1#9)(1996-11#11)(1996-12#10)(1996-2#19)(1996-3#14)(1996-5#3)(1996-6#5)(1996-8#7)(1996-9#1)(1997-1#17)(1997-2#16)(1997-3#13)(1997-4#7)(1997-5#6)(1997-6#7)(1997-7#9)(1997-8#18)(1997-9#2)(2006-6#3)(2007-11#4)(2007-12#11)(2007-8#5)(2008-1#13)(2008-10#765)(2008-11#147)(2008-12#48)(2008-2#5)(2008-3#20)(2008-4#29)(2008-5#80)(2008-6#17)(2008-7#59)(2008-8#82)(2008-9#106)(2009-1#3)(2009-10#11)(2009-11#7)(2009-12#8)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#9)(2009-6#12)(2009-7#7)(2009-8#23)(2010-1#13)(2010-10#11)(2010-11#11)(2010-12#26)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#8)(2010-6#11)(2010-7#17)(2010-8#20)(2010-9#4)(2011-1#18)(2011-10#3)(2011-2#131)(2011-3#18)(2011-4#1)(2011-7#1)(2012-12#26)(2012-2#67)(2012-3#66)(2012-4#2)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#103)(2013-7#5)(2013-8#49)
mostly as a##2##3##(2008-10#1)(2008-5#1)
mostly at the##2##3##(2008-10#2)
mostly at##3##2##(2008-10#3)
mostly attributed to##2##3##(2008-10#1)(2008-12#1)
mostly by the##2##3##(2008-10#1)(2008-5#1)
mostly by##5##2##(2008-10#1)(2008-12#2)(2008-5#1)(2010-2#1)
mostly due to the##2##4##(2008-1#1)(2011-3#1)
mostly due to##7##3##(2008-1#1)(2008-10#3)(2009-12#1)(2010-6#1)(2011-3#1)
mostly expressed##2##2##(2010-4#1)(2013-1#1)
mostly focused on##2##3##(2008-11#1)(2008-8#1)
mostly found in##3##3##(1997-8#1)(2008-12#1)(2011-2#1)
mostly from##5##2##(1995-12#1)(2008-10#2)(2008-11#2)
mostly in the form of##2##5##(2008-10#2)
mostly in the##8##3##(1991-12#1)(1993-11#1)(2008-10#4)(2011-2#1)(2012-2#1)
mostly in##20##2##(1991-12#1)(1991-2#1)(1993-11#1)(1997-3#1)(2008-10#7)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
mostly of##6##2##(1991-8#1)(1995-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2009-9#1)
mostly primary##2##2##(1997-4#1)(2009-10#1)
mostly reactive##2##2##(2009-3#1)(2012-3#1)
mostly similar##2##2##(1997-2#1)(2011-2#1)
mostly through##2##2##(1996-11#1)(2008-10#1)
mostly to##2##2##(2009-12#1)(2012-3#1)
mostly used##2##2##(2012-12#1)(2012-3#1)
mostly within##2##2##(2011-2#1)(2013-1#1)
mostly young women##2##3##(1997-8#1)(2012-3#1)
mostly##163##1##(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-11#2)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-6#1)(1996-11#2)(1996-12#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#46)(2008-11#9)(2008-12#6)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#4)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#10)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#13)(2013-1#8)(2013-8#1)
moth##10##1##(1990-8#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)
mother and child##2##3##(1994-6#1)(1995-1#1)
mother and fetus##2##3##(2008-10#1)(2008-7#1)
mother and foetus##2##3##(1992-5#1)(2008-1#1)
mother and her infant##2##4##(1990-12#1)(2010-10#1)
mother and the##2##3##(1997-8#1)(2008-12#1)
mother and##16##2##(1990-12#1)(1991-6#1)(1992-5#1)(1994-6#1)(1995-1#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-10#1)(2012-12#1)(2012-3#2)
mother cells##2##2##(2008-10#2)
mother condition##2##2##(2008-9#2)
mother has##2##2##(1997-3#1)(2012-2#1)
mother liquor containing##2##3##(1993-8#1)(2008-9#1)
mother or##2##2##(1994-2#1)(2008-8#1)
mother plants##4##2##(2008-10#4)
mother to##3##2##(1990-9#1)(2008-8#1)(2013-1#1)
mother##76##1##(1990-12#2)(1990-6#1)(1990-9#4)(1991-11#1)(1991-6#1)(1991-9#2)(1992-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-6#1)(1997-3#3)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-4#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-6#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#2)
mother's##6##1##(1990-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)
mother-child##3##1##(2009-10#1)(2010-7#1)(2011-2#1)
mother-infant interaction in teaching##2##4##(1990-12#2)
mother-infant interaction in##3##3##(1990-12#3)
mother-infant interaction##6##2##(1990-12#5)(2010-10#1)
mother-infant##7##1##(1990-12#5)(2009-11#1)(2010-10#1)
mother-offspring##2##1##(2008-8#2)
mother-preterm infant##2##2##(1992-2#2)
motherhood##3##1##(1995-1#2)(2013-8#1)
mothering loss##2##2##(2009-9#2)
mothers and children##3##3##(1992-2#1)(2008-6#1)(2012-12#1)
mothers and their neonates##2##4##(2011-1#2)
mothers and their##4##3##(1992-2#1)(2009-11#1)(2011-1#2)
mothers and##19##2##(1992-12#1)(1992-2#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#2)
mothers are##2##2##(2008-11#1)(2012-3#1)
mothers as##2##2##(2010-1#1)(2010-2#1)
mothers could##2##2##(1993-12#2)
mothers did not have##4##4##(2011-2#3)(2012-2#1)
mothers had##4##2##(1993-12#1)(2008-12#1)(2011-2#2)
mothers in caring for their##2##5##(2011-2#1)(2012-3#1)
mothers in the##2##3##(1995-1#1)(2010-2#1)
mothers in##7##2##(1991-8#1)(1995-1#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
mothers of children with##5##4##(1996-1#2)(2008-9#1)(2010-1#1)(2010-9#1)
mothers of very low birthweight infants##2##6##(2010-10#2)
mothers of##14##2##(1991-1#2)(1993-12#1)(1996-1#2)(1997-3#1)(2008-11#1)(2008-9#2)(2010-1#1)(2010-10#2)(2010-9#1)(2011-1#1)
mothers to##3##2##(1995-1#1)(2008-8#1)(2008-9#1)
mothers were##4##2##(1994-1#1)(1997-3#1)(2008-4#1)(2011-2#1)
mothers who##7##2##(1990-9#1)(1991-11#2)(2008-11#2)(2013-1#2)
mothers with depression##2##3##(2009-12#1)(2012-2#1)
mothers with diabetes##2##3##(1996-11#2)
mothers with##10##2##(1996-11#2)(2009-12#1)(2009-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
mothers##151##1##(1990-2#1)(1990-6#2)(1990-9#1)(1991-1#3)(1991-11#6)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#3)(1993-12#4)(1993-3#3)(1994-1#1)(1994-3#2)(1994-9#1)(1995-1#5)(1996-1#2)(1996-11#2)(1997-3#5)(2008-10#4)(2008-11#5)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#5)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-2#4)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#14)(2011-2#15)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#8)(2013-8#2)
mothers' confidence to care for##3##5##(2012-2#3)
mothers' intention to vaccinate their daughters##3##6##(2011-1#3)
mothers'##16##1##(1991-1#1)(2008-11#1)(2009-10#1)(2009-7#3)(2010-10#1)(2011-1#4)(2012-2#4)(2013-1#1)
moths##2##1##(2009-6#1)(2009-8#1)
motif and a##2##3##(1992-3#1)(1993-12#1)
motif and##6##2##(1992-3#1)(1993-12#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
motif as##2##2##(1997-8#1)(2008-7#1)
motif found in##2##3##(1993-2#1)(2008-8#1)
motif in the##3##3##(1993-9#1)(2008-8#1)(2008-9#1)
motif in##9##2##(1991-12#1)(1993-9#1)(1996-8#1)(1997-3#1)(2008-8#1)(2008-9#3)(2009-8#1)
motif is##3##2##(1995-6#1)(2008-9#1)(2012-2#1)
motif of the##3##3##(1993-3#1)(1994-11#1)(2008-10#1)
motif of##6##2##(1992-4#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-8#2)
motif was##4##2##(1991-7#1)(1995-6#2)(2012-2#1)
motif with##2##2##(1996-2#1)(2008-9#1)
motif##96##1##(1991-12#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-3#1)(1992-4#3)(1992-6#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#2)(1994-11#3)(1994-3#1)(1995-2#1)(1995-6#13)(1995-8#1)(1996-2#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#4)(1997-9#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#5)(2008-9#11)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#7)(2013-1#3)
motif)##2##1##(1995-6#1)(2008-10#1)
motifs A##2##2##(1997-8#1)(2008-5#1)
motifs and##4##2##(1996-2#2)(2008-4#1)(2013-1#1)
motifs are##2##2##(1997-7#1)(2012-2#1)
motifs can be##2##3##(2008-11#1)(2008-7#1)
motifs characteristic of the##2##4##(1997-7#1)(2008-8#1)
motifs in the##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
motifs in##12##2##(1993-12#1)(1994-12#2)(1995-2#2)(2008-10#2)(2008-11#2)(2008-9#2)(2010-6#1)
motifs of the##3##3##(2008-10#2)(2008-8#1)
motifs of##8##2##(1996-2#1)(1997-8#1)(2008-10#3)(2008-8#1)(2010-7#2)
motifs present##2##2##(1992-3#1)(2008-4#1)
motifs##78##1##(1990-4#1)(1991-7#1)(1992-3#2)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#2)(1995-2#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#8)(1996-6#1)(1997-7#5)(1997-8#2)(1997-9#1)(2008-10#7)(2008-11#6)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-7#1)(2010-10#1)(2010-6#1)(2010-7#4)(2012-2#5)(2012-3#2)(2013-1#2)
motile##8##1##(1997-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#3)(2012-2#1)
motilin 1-12 [CH2 NH]10-11##4##4##(1994-11#4)
motilin 1-12 [CH2##5##3##(1994-11#5)
motilin receptor##4##2##(1994-11#4)
motilin##12##1##(1994-11#12)
motility and invasion##5##3##(2013-8#5)
motility and##12##2##(1995-8#1)(2008-10#1)(2008-5#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-8#5)
motility factor##2##2##(2008-5#2)
motility in the##2##3##(1992-6#1)(2013-8#1)
motility in##3##2##(1992-6#1)(2008-11#1)(2013-8#1)
motility of the##2##3##(1992-12#1)(2011-2#1)
motility of##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
motility##56##1##(1992-12#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-9#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#7)(2008-12#2)(2008-5#3)(2008-7#3)(2009-6#1)(2009-8#4)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#7)
motion analysis system##2##3##(2011-2#2)
motion analysis##4##2##(2008-3#2)(2011-2#2)
motion and##6##2##(2008-8#1)(2009-1#1)(2010-12#2)(2010-9#1)(2012-2#1)
motion artifacts##2##2##(2010-8#1)(2012-12#1)
motion as##2##2##(2008-11#1)(2008-12#1)
motion at the##3##3##(2008-7#1)(2008-9#1)(2010-1#1)
motion during##3##2##(1995-5#1)(2011-2#1)(2013-8#1)
motion estimation##2##2##(2008-3#2)
motion for summary##2##3##(1995-12#2)
motion in the##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
motion in##9##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
motion is##3##2##(1994-5#1)(2008-11#1)(2008-9#1)
motion of the##6##3##(2007-12#2)(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#1)
motion of##13##2##(2007-12#2)(2008-11#1)(2008-3#4)(2009-11#2)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
motion primitives##2##2##(2008-11#2)
motion that##2##2##(2008-11#1)(2008-8#1)
motion to##2##2##(1995-5#1)(2008-11#1)
motion was##4##2##(1995-5#1)(2008-9#1)(2012-12#1)(2013-8#1)
motion##133##1##(1991-2#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-12#2)(1995-5#4)(1995-6#1)(2007-12#2)(2008-10#7)(2008-11#19)(2008-12#10)(2008-3#9)(2008-7#3)(2008-8#7)(2008-9#8)(2009-1#2)(2009-11#2)(2009-7#1)(2010-1#1)(2010-12#4)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#16)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#2)
motional resistance##2##2##(2008-10#2)
motionless##2##1##(2008-10#1)(2010-12#1)
motions and##4##2##(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
motions of the object in two-dimensional space##2##7##(2008-11#2)
motions of the##3##3##(2008-11#2)(2013-1#1)
motions of##6##2##(2008-11#4)(2013-1#2)
motions that##2##2##(1992-9#1)(2009-5#1)
motions##23##1##(1992-9#3)(1995-3#1)(2008-11#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-4#2)(2010-8#2)(2011-2#1)(2013-1#3)(2013-8#2)
motivate the##2##2##(1995-11#1)(1996-3#1)
motivate##4##1##(1995-11#1)(1996-3#1)(2008-11#1)(2008-12#1)
motivated by a##2##3##(1992-3#1)(2012-12#1)
motivated by##8##2##(1992-3#2)(2008-11#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-12#1)
motivated patients##2##2##(1990-2#1)(1995-11#1)
motivated to##2##2##(2013-1#1)(2013-8#1)
motivated##19##1##(1990-2#1)(1992-12#1)(1992-3#2)(1994-3#1)(1995-11#1)(1996-6#2)(2008-11#2)(2008-9#2)(2009-8#1)(2010-11#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
motivates the##2##2##(2008-11#1)(2008-3#1)
motivates##3##1##(2008-11#1)(2008-3#1)(2013-1#1)
motivating##3##1##(2008-11#3)
motivation and##5##2##(1994-1#2)(2008-12#1)(2009-7#1)(2011-2#1)
motivation for##3##2##(1990-6#1)(1997-3#1)(2013-8#1)
motivation system##2##2##(2008-11#2)
motivation to change##2##3##(2013-8#2)
motivation to##6##2##(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)(2013-8#2)
motivation##35##1##(1990-12#1)(1990-6#1)(1992-1#1)(1993-6#3)(1994-1#2)(1995-2#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-4#1)(2008-9#1)(2009-7#2)(2009-9#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#4)
motivational and##2##2##(1996-5#1)(2010-1#1)
motivational approach##3##2##(2008-4#2)(2008-6#1)
motivational beliefs and##2##3##(2010-1#2)
motivational beliefs##3##2##(2010-1#3)
motivational factors##2##2##(1991-1#1)(2008-12#1)
motivational interventions##2##2##(2008-11#1)(2008-6#1)
motivational interviewing##2##2##(2008-12#1)(2013-1#1)
motivational needs##3##2##(1995-2#3)
motivational or##2##2##(1994-3#1)(2008-4#1)
motivational stepped care##2##3##(2008-6#2)
motivational videotape##2##2##(2008-8#2)
motivational##35##1##(1991-1#1)(1994-3#1)(1995-2#4)(1996-5#2)(2008-11#2)(2008-12#3)(2008-4#6)(2008-6#6)(2008-8#2)(2010-1#4)(2010-10#1)(2013-1#1)(2013-8#2)
motivations of##2##2##(1992-2#1)(1993-12#1)
motivations##8##1##(1992-2#1)(1993-12#3)(2008-1#1)(2008-12#1)(2009-7#1)(2013-1#1)
motives for##4##2##(1991-12#1)(1993-6#1)(2010-11#2)
motives##10##1##(1991-12#3)(1992-3#1)(1993-6#1)(2010-11#5)
motoneuronal##2##1##(1990-5#1)(1996-5#1)
motoneurone##3##1##(1996-2#1)(1996-5#1)(1997-2#1)
motoneurones##7##1##(1996-2#1)(1997-2#6)
motoneurons##3##1##(1990-9#1)(1992-6#1)(2007-12#1)
motor abilities##3##2##(1997-2#1)(2008-2#1)(2008-7#1)
motor activity in##3##3##(1997-4#1)(2008-12#1)(2011-2#1)
motor activity##8##2##(1990-5#1)(1994-2#1)(1994-8#1)(1997-4#1)(2008-12#3)(2011-2#1)
motor and sensory##2##3##(2013-1#2)
motor and##5##2##(1996-12#1)(2008-11#1)(2010-7#1)(2013-1#2)
motor axonal polyneuropathy##2##3##(2012-3#2)
motor branch of the##2##4##(2008-9#2)
motor branch##3##2##(2008-9#3)
motor complications##7##2##(2008-7#2)(2010-12#5)
motor control##4##2##(1990-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
motor coordination##3##2##(1997-2#1)(2008-12#1)(2013-1#1)
motor cortex neurons##2##3##(1991-6#2)
motor cortex stimulation##4##3##(2010-7#4)
motor cortex##22##2##(1991-6#5)(1997-2#1)(2008-7#3)(2010-7#8)(2011-2#2)(2012-2#1)(2013-8#2)
motor cortical##2##2##(2008-11#1)(2010-7#1)
motor deficit##3##2##(2008-7#2)(2010-7#1)
motor development milestones##2##3##(2010-6#2)
motor development##3##2##(2010-6#2)(2012-3#1)
motor evoked potential##4##3##(2008-7#2)(2011-2#2)
motor evoked potentials in##2##4##(1996-6#1)(2011-2#1)
motor evoked potentials##3##3##(1996-6#2)(2011-2#1)
motor evoked##7##2##(1996-6#2)(2008-7#2)(2011-2#3)
motor fluctuations##3##2##(2008-7#3)
motor function in##2##3##(2008-7#1)(2011-2#1)
motor function##10##2##(2008-7#4)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
motor functions##2##2##(2008-7#1)(2010-9#1)
motor imagery (MI)##2##3##(2013-8#2)
motor imagery##4##2##(2013-8#4)
motor impairment by intracerebellar##2##4##(1997-2#2)
motor impairment by##3##3##(1997-2#3)
motor impairment##8##2##(1992-3#1)(1997-2#7)
motor initiation##3##2##(1991-6#3)
motor involvement##2##2##(1991-6#1)(2008-7#1)
motor manifestations##2##2##(1990-5#1)(2011-8#1)
motor nerves##2##2##(2008-9#1)(2010-1#1)
motor neuron##6##2##(1990-5#1)(1996-12#1)(2007-12#1)(2012-3#1)(2013-1#2)
motor neurone loss##2##3##(1996-5#2)
motor neurone##4##2##(1994-11#1)(1996-5#3)
motor neurons and##2##3##(1990-5#1)(2009-8#1)
motor neurons is##2##3##(1990-5#1)(2013-1#1)
motor neurons##8##2##(1990-5#4)(1996-12#1)(2008-4#1)(2009-8#1)(2013-1#1)
motor nucleus##4##2##(1990-9#1)(1994-2#1)(1997-2#2)
motor output##3##2##(1993-6#1)(1994-2#1)(2008-4#1)
motor performance##5##2##(2008-7#2)(2011-2#3)
motor preparation##2##2##(2008-7#2)
motor protein##2##2##(1995-2#1)(2008-11#1)
motor proteins##4##2##(2008-11#2)(2012-2#2)
motor recovery##2##2##(2013-1#2)
motor response##4##2##(1990-5#2)(2008-9#1)(2010-1#1)
motor seizure##4##2##(1994-2#2)(2010-1#2)
motor seizures##2##2##(2008-4#1)(2010-1#1)
motor skills##2##2##(2008-12#1)(2010-8#1)
motor stimulating effects##2##3##(1994-2#1)(1996-5#1)
motor symptoms of##2##3##(2008-7#2)
motor symptoms##4##2##(2008-7#2)(2010-12#1)(2013-8#1)
motor systems##3##2##(1990-11#1)(2008-12#1)(2008-7#1)
motor units##5##2##(1996-5#1)(2013-1#1)(2013-8#3)
motor vehicle accident##3##3##(2008-7#1)(2009-4#1)(2012-3#1)
motor vehicle accidents##3##3##(1990-9#1)(2009-4#1)(2010-12#1)
motor vehicle##9##2##(1990-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#2)(2010-12#1)(2012-2#1)(2012-3#1)
motor vehicles##2##2##(1990-6#1)(1996-1#1)
motor##276##1##(1990-11#1)(1990-12#1)(1990-5#14)(1990-6#1)(1990-9#2)(1991-1#1)(1991-6#9)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-2#7)(1994-3#1)(1994-8#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-5#6)(1996-6#2)(1997-2#19)(1997-4#1)(1997-5#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#12)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#36)(2008-8#2)(2008-9#7)(2009-1#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#5)(2010-12#10)(2010-5#3)(2010-6#2)(2010-7#12)(2010-8#3)(2010-9#1)(2011-2#17)(2011-8#1)(2012-12#1)(2012-2#7)(2012-3#10)(2013-1#15)(2013-8#14)
motor-evoked potentials (MEPs)##2##3##(2010-7#1)(2011-2#1)
motor-evoked potentials##3##2##(2010-7#2)(2011-2#1)
motor-evoked##4##1##(2008-7#1)(2010-7#2)(2011-2#1)
motorways##2##1##(2008-10#1)(2008-11#1)
mottle mosaic virus and##2##4##(2008-10#2)
mottle mosaic virus##8##3##(2008-10#8)
mottle potyvirus##3##2##(2008-10#3)
mottle virus and##3##3##(2008-10#3)
mottle virus in##2##3##(2008-10#2)
mottle virus##40##2##(2008-10#37)(2008-9#3)
mottle##64##1##(1995-12#2)(2008-10#59)(2008-9#3)
mottled##3##1##(2008-10#1)(2008-12#2)
mottling##3##1##(2008-10#3)
mould and##2##2##(2008-11#1)(2008-5#1)
mould##4##1##(2008-11#1)(2008-5#3)
moulds##3##1##(2008-11#1)(2008-5#2)
mount a##4##2##(1995-12#1)(1997-6#1)(2008-10#1)(2008-8#1)
mount##12##1##(1995-12#1)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#1)
mountain##16##1##(1991-2#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#4)(2013-1#2)(2013-8#1)
mountainous##4##1##(1996-12#2)(2008-10#1)(2008-3#1)
mountains##6##1##(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2013-8#1)
mounted a##2##2##(1992-2#1)(1994-12#1)
mounted in##5##2##(1993-8#1)(2008-10#2)(2008-3#1)(2013-1#1)
mounted on a##2##3##(2008-10#1)(2008-3#1)
mounted on the##2##3##(2011-2#1)(2013-1#1)
mounted on##5##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
mounted##18##1##(1992-2#1)(1993-8#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#3)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
mounting##5##1##(1991-3#1)(1997-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
mounts##4##1##(2008-11#1)(2008-9#1)(2011-2#2)
mouse 2##2##2##(1990-8#2)
mouse ES cell lines##2##4##(2012-2#2)
mouse ES cells##4##3##(2008-11#1)(2008-9#2)(2011-2#1)
mouse ES##6##2##(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#2)
mouse IL-18##3##2##(2008-4#3)
mouse IgG##9##2##(1994-5#1)(2008-10#7)(2008-12#1)
mouse and human##15##3##(1991-6#2)(1993-3#1)(1993-6#2)(1994-5#1)(1997-7#2)(1997-8#1)(2008-11#1)(2008-4#2)(2012-2#2)(2013-8#1)
mouse and rat##7##3##(1991-5#1)(1993-12#1)(1993-2#3)(1995-11#1)(2008-9#1)
mouse and##27##2##(1991-5#1)(1991-6#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-7#2)(1997-8#1)(2008-11#1)(2008-4#2)(2008-9#3)(2012-2#2)(2013-8#1)
mouse anterior pituitary cells##2##4##(1990-5#2)
mouse anterior pituitary##4##3##(1990-5#4)
mouse beta2m##2##2##(1997-9#2)
mouse blastocyst##2##2##(2008-5#2)
mouse blastocysts##4##2##(2008-11#2)(2008-5#1)(2013-8#1)
mouse blood##2##2##(2008-10#2)
mouse bone marrow##6##3##(2008-11#3)(2008-9#1)(2010-1#1)(2011-2#1)
mouse bone##7##2##(1992-10#1)(2008-11#3)(2008-9#1)(2010-1#1)(2011-2#1)
mouse brain##14##2##(1991-1#1)(1992-6#1)(1993-8#2)(1995-2#3)(1995-6#1)(1996-12#2)(1996-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
mouse cancer##2##2##(2008-8#1)(2008-9#1)
mouse cell##2##2##(1990-2#1)(1992-6#1)
mouse cells##7##2##(1990-2#1)(1992-6#1)(1993-12#1)(1997-7#3)(2008-11#1)
mouse chromosome 6##2##3##(1995-2#2)
mouse chromosome##4##2##(1995-2#2)(1995-6#1)(1997-2#1)
mouse chromosomes##2##2##(2008-11#1)(2008-9#1)
mouse development##2##2##(1994-9#1)(1995-2#1)
mouse dorsal##2##2##(2008-10#1)(2013-8#1)
mouse embryo##4##2##(1991-6#1)(2008-10#1)(2008-11#2)
mouse embryonic fibroblasts enhanced##2##4##(2013-1#2)
mouse embryonic fibroblasts##4##3##(2008-2#2)(2013-1#2)
mouse embryonic stem (ES) cells##2##5##(2008-11#2)
mouse embryonic stem cells##6##4##(1995-2#2)(2008-11#3)(2008-9#1)
mouse embryonic stem##8##3##(1995-2#2)(2008-11#5)(2008-9#1)
mouse embryonic##15##2##(1995-2#3)(2008-11#5)(2008-2#2)(2008-8#1)(2008-9#1)(2013-1#3)
mouse embryos##11##2##(1995-8#1)(1997-7#2)(2008-10#2)(2008-2#2)(2008-5#2)(2008-6#1)(2012-3#1)
mouse erythroleukemia cell line##2##4##(2008-9#2)
mouse fibroblast##3##2##(1993-6#1)(1995-11#1)(2008-8#1)
mouse fibroblasts##3##2##(1994-9#1)(1997-7#1)(2013-1#1)
mouse gene##4##2##(1992-6#1)(1995-6#1)(2008-4#2)
mouse genomic DNA##2##3##(1993-12#1)(1997-2#1)
mouse glycophorin A##2##3##(1991-5#2)
mouse glycophorin gene##2##3##(1991-5#2)
mouse glycophorin##4##2##(1991-5#4)
mouse hepa 1 cells##2##4##(2008-11#2)
mouse hippocampal##2##2##(1995-8#1)(2012-2#1)
mouse homologues##2##2##(1993-8#1)(2008-7#1)
mouse hybridoma cell##2##3##(1990-8#1)(2008-10#1)
mouse hybridoma##4##2##(1990-8#1)(2008-10#1)(2008-11#2)
mouse hypothalamus and cortex##2##4##(1994-2#2)
mouse immunoglobulin G##2##3##(2008-10#2)
mouse in##2##2##(2008-4#1)(2008-8#1)
mouse is##2##2##(1992-9#1)(2008-11#1)
mouse kidney##2##2##(1990-12#1)(1997-7#1)
mouse limb mesenchyme##2##3##(2008-11#2)
mouse liver and skeletal muscle##2##5##(1990-5#2)
mouse liver and##3##3##(1990-5#2)(2008-9#1)
mouse liver##12##2##(1990-5#2)(1991-8#2)(1994-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
mouse low density lipoprotein receptor##2##5##(1993-3#2)
mouse lung##3##2##(1991-8#1)(1994-8#1)(1996-12#1)
mouse macrophages##6##2##(1994-8#1)(1995-2#4)(2012-12#1)
mouse mammary tumor virus (MMTV)##2##5##(1994-11#1)(1994-12#1)
mouse mammary tumor virus##3##4##(1994-11#2)(1994-12#1)
mouse mammary tumor##4##3##(1990-11#1)(1994-11#2)(1994-12#1)
mouse mammary##7##2##(1990-11#1)(1993-1#1)(1994-11#2)(1994-12#1)(2008-11#2)
mouse melanoma cell##2##3##(2008-11#2)
mouse melanoma cells##2##3##(1993-5#1)(2008-11#1)
mouse melanoma##6##2##(1993-5#1)(2008-11#4)(2008-9#1)
mouse model for##4##3##(1995-2#1)(1995-6#1)(2008-4#1)(2011-2#1)
mouse model of##10##3##(1995-2#1)(1996-5#1)(2008-10#1)(2009-6#1)(2012-12#2)(2012-2#3)(2013-7#1)
mouse model##33##2##(1994-11#1)(1994-5#1)(1995-2#3)(1995-6#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
mouse models of##4##3##(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
mouse models##21##2##(1997-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#3)(2010-7#6)(2011-2#3)(2011-9#1)(2012-2#2)
mouse monoclonal##4##2##(1996-12#1)(2008-10#2)(2008-7#1)
mouse myeloma cell line##4##4##(2008-11#4)
mouse myeloma cells##3##3##(2008-11#3)
mouse myeloma##7##2##(2008-11#7)
mouse neuroblastoma##2##2##(1992-6#1)(1994-11#1)
mouse organs##2##2##(1991-8#1)(1997-7#1)
mouse ovaries and##2##3##(1994-2#1)(1995-2#1)
mouse ovaries##3##2##(1994-2#1)(1995-2#1)(2012-3#1)
mouse peritoneal macrophages##3##3##(1995-2#2)(2008-10#1)
mouse peritoneal##5##2##(1992-5#1)(1995-2#2)(2008-10#1)(2008-11#1)
mouse purH-negative mutant##2##3##(1995-12#2)
mouse serum##2##2##(2008-10#1)(2008-4#1)
mouse skin##2##2##(2008-5#1)(2012-2#1)
mouse spinal cord##2##3##(1993-9#1)(2008-11#1)
mouse splenocytes##2##2##(1991-1#1)(2008-9#1)
mouse stomach##2##2##(1995-2#1)(1995-6#1)
mouse strain##2##2##(1993-3#1)(2008-8#1)
mouse strains with##2##3##(2008-2#1)(2008-8#1)
mouse strains##9##2##(1996-12#2)(2008-10#1)(2008-2#3)(2008-5#1)(2008-8#1)(2011-2#1)
mouse testis##2##2##(1995-6#1)(1995-8#1)
mouse thymic dendritic cells##2##4##(2008-8#2)
mouse thymic medullary##2##3##(2008-8#2)
mouse thymic##5##2##(2008-8#5)
mouse thymocytes##3##2##(1994-3#1)(1995-8#2)
mouse tissues and##2##3##(1993-8#1)(1995-6#1)
mouse tissues by##2##3##(2008-11#2)
mouse tissues##8##2##(1990-3#1)(1991-6#1)(1993-8#1)(1995-6#1)(2008-11#4)
mouse transformant cells##2##3##(1995-12#2)
mouse transformant##3##2##(1995-12#3)
mouse uterine##2##2##(2008-6#1)(2012-2#1)
mouse visual cortex##2##3##(2008-11#2)
mouse was##2##2##(1991-6#1)(2008-9#1)
mouse##568##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#7)(1990-7#1)(1990-8#3)(1991-1#3)(1991-12#1)(1991-5#7)(1991-6#12)(1991-8#5)(1992-10#1)(1992-3#3)(1992-5#1)(1992-6#9)(1992-9#2)(1993-1#2)(1993-12#7)(1993-2#6)(1993-3#7)(1993-5#1)(1993-6#10)(1993-8#11)(1993-9#1)(1994-11#6)(1994-12#4)(1994-2#5)(1994-3#3)(1994-5#5)(1994-8#6)(1994-9#2)(1995-11#2)(1995-12#5)(1995-2#32)(1995-3#1)(1995-6#14)(1995-8#9)(1995-9#2)(1996-12#14)(1996-2#4)(1996-5#1)(1997-1#1)(1997-2#8)(1997-7#16)(1997-8#4)(1997-9#7)(2008-10#41)(2008-11#70)(2008-12#4)(2008-2#9)(2008-4#28)(2008-5#7)(2008-6#4)(2008-7#6)(2008-8#21)(2008-9#26)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-3#1)(2010-6#3)(2010-7#6)(2010-8#2)(2011-1#1)(2011-2#16)(2011-9#1)(2012-12#4)(2012-2#21)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#9)
mouse)##3##1##(1994-12#1)(1997-9#1)(2008-11#1)
mouse/human##2##1##(1994-12#1)(2010-12#1)
mouth and pharynx##3##3##(1990-8#2)(2011-2#1)
mouth and##7##2##(1990-6#1)(1990-8#2)(2008-10#1)(2008-11#1)(2011-2#2)
mouth in##6##2##(2008-11#2)(2008-5#2)(2010-5#1)(2013-1#1)
mouth parts##2##2##(2008-10#2)
mouth system##4##2##(2008-10#4)
mouth##82##1##(1990-6#1)(1990-8#3)(1991-2#2)(1991-4#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#17)(2008-11#7)(2008-12#6)(2008-5#11)(2008-6#1)(2008-8#1)(2009-10#2)(2010-5#5)(2010-8#3)(2011-2#9)(2012-2#2)(2013-1#4)(2013-8#2)
mouth-opening##3##1##(2008-10#1)(2008-5#2)
mouthparts##3##1##(2007-12#2)(2008-12#1)
mouths##3##1##(2008-10#2)(2010-5#1)
movable##4##1##(2008-10#1)(2008-2#1)(2008-3#2)
move beyond##5##2##(1993-12#1)(1994-1#1)(2008-12#1)(2009-8#1)(2013-1#1)
move from##7##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)(2012-3#1)
move in##3##2##(1994-12#1)(2008-8#1)(2011-2#1)
move into the##2##3##(2008-10#1)(2008-8#1)
move into##4##2##(1994-5#1)(2008-10#2)(2008-8#1)
move through a##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
move to neighboring cells##2##4##(2008-10#2)
move to##8##2##(1996-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-10#1)
move toward##4##2##(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)
move##58##1##(1992-9#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-1#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#9)(2008-12#3)(2008-5#2)(2008-6#1)(2008-8#6)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
moved at##2##2##(1996-12#1)(2008-5#1)
moved away from##3##3##(1991-3#1)(2010-7#1)(2011-2#1)
moved away##4##2##(1991-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
moved from the##2##3##(2008-9#1)(2011-2#1)
moved from##4##2##(2008-7#1)(2008-9#2)(2011-2#1)
moved into the##2##3##(2008-10#2)
moved the##3##2##(2008-10#2)(2010-8#1)
moved to the##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
moved to##14##2##(1994-3#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)
moved##43##1##(1990-2#1)(1991-1#1)(1991-3#1)(1991-5#1)(1994-2#1)(1994-3#2)(1996-11#1)(1996-12#2)(2008-10#11)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#1)(2009-4#2)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#2)
movement after##2##2##(2008-7#1)(2011-2#1)
movement analysis##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
movement and##11##2##(1990-9#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-8#1)
movement are controlled by##2##4##(1990-5#2)
movement as##3##2##(2008-12#1)(2008-7#1)(2009-8#1)
movement at##2##2##(1991-2#1)(2011-2#1)
movement disorder##5##2##(2008-7#3)(2012-3#1)(2013-8#1)
movement disorders##7##2##(2008-12#1)(2008-7#3)(2010-12#1)(2010-5#2)
movement during##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
movement dysfunction##3##2##(2008-12#2)(2013-1#1)
movement from a##2##3##(2008-10#1)(2008-11#1)
movement from##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
movement has##2##2##(1992-1#1)(1994-3#1)
movement in the opposite##2##4##(1991-5#2)
movement in the##7##3##(1991-5#2)(1994-8#1)(2008-10#1)(2012-2#3)
movement in##14##2##(1990-5#1)(1991-5#2)(1994-8#1)(1996-3#1)(2008-10#2)(2008-8#2)(2010-8#1)(2011-2#1)(2012-2#3)
movement into the##2##3##(1991-5#1)(2008-11#1)
movement is##4##2##(2008-10#2)(2008-11#2)
movement may be##2##3##(1990-5#1)(2007-12#1)
movement observation and##2##3##(2013-8#2)
movement observation or MI##2##4##(2013-8#2)
movement observation##5##2##(2013-8#5)
movement of a##2##3##(1991-5#1)(2008-10#1)
movement of the virus##2##4##(2008-10#2)
movement of the##14##3##(1992-1#1)(1994-5#1)(1995-12#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)
movement of valeric acid##2##4##(1991-5#2)
movement of##51##2##(1990-2#1)(1991-5#4)(1992-1#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-10#25)(2008-11#3)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
movement on##2##2##(2008-12#1)(2010-3#1)
movement onset##2##2##(1991-6#1)(1996-2#1)
movement onset-related neurons##2##3##(1991-6#2)
movement pattern##2##2##(2013-8#2)
movement patterns##5##2##(2008-12#2)(2008-8#1)(2009-9#1)(2013-1#1)
movement protein (MP) genes of##2##5##(2008-10#1)(2008-9#1)
movement protein (MP)##4##3##(2008-10#3)(2008-9#1)
movement protein##11##2##(1997-3#1)(2008-10#8)(2008-9#2)
movement related##2##2##(2008-11#1)(2008-12#1)
movement restrictions##2##2##(2011-2#2)
movement strategy##3##2##(2010-3#2)(2011-2#1)
movement therapies##2##2##(2008-12#1)(2010-6#1)
movement through##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
movement to the##2##3##(1994-12#1)(2008-10#1)
movement to##9##2##(1994-12#1)(1997-3#1)(2008-10#5)(2013-1#1)(2013-8#1)
movement toward##3##2##(1996-2#1)(1997-1#1)(2013-8#1)
movement was##8##2##(1991-5#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-8#1)
movement##278##1##(1990-11#2)(1990-2#2)(1990-5#5)(1990-9#3)(1991-2#1)(1991-5#9)(1991-6#4)(1991-9#1)(1992-1#3)(1992-11#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-9#2)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-5#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#71)(2008-11#17)(2008-12#15)(2008-4#1)(2008-7#19)(2008-8#16)(2008-9#5)(2009-1#1)(2009-10#4)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2011-2#14)(2012-2#6)(2012-3#5)(2013-1#7)(2013-8#14)
movement)##2##1##(2008-10#1)(2011-2#1)
movement-defective##3##1##(2008-10#3)
movement-related##3##1##(1994-2#1)(2008-11#1)(2008-7#1)
movements and##7##2##(1995-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2013-8#1)
movements by##2##2##(1996-2#1)(2010-6#1)
movements can##2##2##(1995-6#1)(2011-2#1)
movements during##2##2##(2012-3#1)(2013-1#1)
movements in Parkinson's disease##2##4##(2008-7#2)
movements in a 2-dimensional##2##4##(1990-11#2)
movements in sleep##2##3##(1997-4#1)(2008-11#1)
movements in##12##2##(1990-11#2)(1990-5#1)(1990-9#1)(1997-4#1)(2008-11#1)(2008-7#3)(2008-8#2)(2012-2#1)
movements of the##4##3##(1990-5#1)(1995-12#1)(2008-10#1)(2010-9#1)
movements of##7##2##(1990-5#1)(1995-12#1)(2008-10#2)(2010-9#1)(2011-2#1)(2013-8#1)
movements on##2##2##(2008-7#1)(2012-3#1)
movements to##3##2##(2008-11#2)(2008-7#1)
movements were##3##2##(2008-11#2)(2011-2#1)
movements with##2##2##(2008-7#1)(2010-9#1)
movements##80##1##(1990-11#3)(1990-5#2)(1990-9#2)(1993-1#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-2#5)(1996-6#1)(1997-4#2)(2008-10#3)(2008-11#15)(2008-12#2)(2008-5#1)(2008-7#10)(2008-8#2)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-2#5)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
moves are predicted by perceived declines in productivity##2##8##(2011-2#2)
moves from##2##2##(1997-2#1)(2008-10#1)
moves into the##2##3##(2008-10#1)(2008-11#1)
moves the##2##2##(2008-10#1)(2008-9#1)
moves to##2##2##(1997-3#1)(2008-7#1)
moves toward##2##2##(1991-3#1)(2008-11#1)
moves##24##1##(1991-3#1)(1993-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-11#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2011-2#3)
movies of facial expressions##2##4##(2008-11#2)
movies##3##1##(2008-11#2)(2008-6#1)
moving and handling##4##3##(2008-11#4)
moving forward##2##2##(2009-3#1)(2010-9#1)
moving from##2##2##(1997-1#1)(2008-10#1)
moving in##2##2##(2008-10#2)
moving into##2##2##(1994-3#1)(2010-4#1)
moving objects##4##2##(2008-3#3)(2011-2#1)
moving target##5##2##(2008-11#4)(2009-8#1)
moving the records to storage and retrieving them if the patient is re-established##2##13##(1994-3#2)
moving the##3##2##(1991-1#1)(1994-3#2)
moving to the##2##3##(1996-1#1)(2009-12#1)
moving toward##3##2##(1996-1#1)(1997-3#1)(2010-9#1)
moving water##2##2##(2008-10#2)
moving window##3##2##(2008-10#1)(2010-6#1)(2010-9#1)
moving##77##1##(1991-1#1)(1993-5#1)(1994-1#1)(1994-3#3)(1994-8#1)(1995-6#1)(1996-1#2)(1997-1#1)(1997-2#2)(1997-3#2)(2008-10#17)(2008-11#8)(2008-3#9)(2008-5#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-6#2)(2010-9#3)(2011-1#1)(2011-10#1)(2011-2#3)(2013-1#1)(2013-8#1)
moxibustion for##2##2##(2008-10#1)(2013-1#1)
moxibustion##10##1##(2008-10#8)(2013-1#2)
moxonidine##2##1##(1997-2#2)
mrad##3##1##(2008-2#2)(2013-8#1)
mrr##4##1##(2008-11#4)
mrrH-RNA##2##1##(2008-11#2)
mrrH-RNAs##2##1##(2008-11#2)
mrrL-RNAs##2##1##(2008-11#2)
ms and (0##2##3##(2008-8#2)
ms and a##2##3##(2008-10#1)(2013-8#1)
ms and##5##2##(2008-10#2)(2008-8#2)(2013-8#1)
ms for##3##2##(2008-10#3)
ms post-stimulus period##2##3##(1996-2#2)
ms to##3##2##(1991-2#1)(2008-11#2)
ms##42##1##(1991-2#2)(1993-3#1)(1996-2#3)(1997-2#1)(1997-8#3)(2008-10#11)(2008-11#5)(2008-3#6)(2008-7#1)(2008-8#2)(2008-9#2)(2010-6#1)(2010-9#1)(2011-2#1)(2013-8#2)
ms)##10##1##(1994-8#2)(1996-5#2)(1997-2#1)(1997-8#2)(2008-6#1)(2012-12#2)
msec##4##1##(1995-2#1)(2008-11#2)(2008-4#1)
mt##4##1##(1991-6#1)(1993-12#1)(1993-2#1)(2008-10#1)
mt-haplotype##3##1##(2008-10#3)
mtDNA RFLP haplotypes##2##3##(2008-10#2)
mtDNA RFLP##3##2##(2008-10#3)
mtDNA SNP##2##2##(2008-12#2)
mtDNA control region##3##3##(2008-12#3)
mtDNA haplotype##3##2##(2008-10#3)
mtDNA profiles##2##2##(2008-12#2)
mtDNA##38##1##(1994-11#3)(1995-6#1)(1997-2#2)(2008-10#9)(2008-12#15)(2008-5#1)(2008-8#5)(2009-8#2)
mtDNAs##3##1##(2008-5#2)(2009-8#1)
mtRNA(Leu(M))##3##1##(2008-8#3)
mtRNA(Leu(UUR)) and##2##2##(2008-8#2)
mtRNA(Leu(UUR))##3##1##(2008-8#3)
mtSSU rDNA haplotypes##2##3##(2008-10#2)
mtSSU rDNA##4##2##(2008-10#4)
mtSSU##5##1##(2008-10#5)
mtrm(126)##2##1##(2012-3#2)
mu M##2##2##(2008-10#2)
mu and delta opioid receptors##3##5##(2009-7#3)
mu and delta##4##3##(2009-7#4)
mu and##8##2##(1993-3#1)(2008-10#3)(2009-7#4)
mu g ml(-1)##3##3##(2008-11#3)
mu opioid receptor gene##2##4##(1995-6#2)
mu opioid receptor##6##3##(1995-6#4)(2008-11#2)
mu opioid receptors##2##3##(1995-6#1)(1996-2#1)
mu opioid##8##2##(1995-6#5)(1996-2#1)(2008-11#2)
mu receptor##5##2##(1992-3#1)(1995-6#3)(2009-7#1)
mu was##4##2##(2008-10#3)(2008-11#1)
mu wave##2##2##(2008-11#2)
mu##54##1##(1991-6#1)(1992-3#1)(1993-3#1)(1995-6#9)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#20)(2008-11#11)(2008-3#1)(2008-9#1)(2009-7#5)(2010-4#1)
mu(d)##2##1##(2008-3#2)
mu(m)##2##1##(2008-10#2)
mu- and##2##2##(1996-2#2)
mu-##7##1##(1995-11#5)(1996-2#2)
mu-opioid receptor agonist##2##3##(1996-2#1)(1997-2#1)
mu-opioid receptor agonists##3##3##(1993-3#1)(1996-2#2)
mu-opioid receptor antagonist##2##3##(1996-2#2)
mu-opioid receptor##9##2##(1993-3#1)(1995-11#1)(1996-2#6)(1997-2#1)
mu-opioid##14##1##(1993-3#1)(1995-11#1)(1996-2#8)(1997-2#3)(2008-7#1)
muA mM(-1) cm(-2)##2##3##(2008-10#2)
muA mM(-1)##3##2##(2008-10#3)
muA##5##1##(2008-10#5)
muIMERs were##2##2##(2008-10#2)
muIMERs##3##1##(2008-10#3)
muM CN(-)##2##2##(2008-10#2)
muM H(2)O(2)##2##2##(2008-10#2)
muM and##5##2##(2008-10#2)(2008-11#2)(2009-8#1)
muM at##2##2##(2008-10#2)
muM concentrations##2##2##(2008-10#1)(2008-11#1)
muM for##9##2##(2008-10#8)(2008-11#1)
muM in##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
muM linoleic acid##2##3##(2008-11#2)
muM of##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
muM to 1 mM##2##4##(2008-10#2)
muM were##2##2##(2008-10#2)
muM with a##2##3##(2008-10#2)
muM with##5##2##(2008-10#5)
muM##136##1##(2008-10#92)(2008-11#33)(2008-6#4)(2008-7#6)(2009-8#1)
muM)##19##1##(2008-10#14)(2008-11#5)
muSv##2##1##(2009-11#2)
muTAS##2##1##(2008-10#2)
muW##2##1##(2008-2#1)(2009-5#1)
muW/cm(2) at 725 nm##2##4##(2008-10#2)
muW/cm(2)##3##1##(2008-10#2)(2008-9#1)
muatm##2##1##(2008-10#2)
much about the##2##3##(2008-10#1)(2012-2#1)
much about##6##2##(1996-3#1)(2008-1#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
much an##2##2##(1997-1#1)(2013-1#1)
much attention has been##3##4##(2008-11#2)(2013-8#1)
much attention in##2##3##(2008-5#1)(2013-1#1)
much attention##8##2##(1996-12#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
much better than##5##3##(2008-10#4)(2008-3#1)
much better##13##2##(1992-2#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
much commoner##2##2##(1996-12#1)(2008-8#1)
much controversy##3##2##(1990-9#1)(2008-9#1)(2009-10#1)
much debate##3##2##(2008-11#2)(2013-7#1)
much debated##2##2##(1993-3#1)(2008-8#1)
much different from##2##3##(2008-10#1)(2008-3#1)
much different##4##2##(1994-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
much do##2##2##(1994-2#1)(2008-8#1)
much earlier##2##2##(2008-11#1)(2011-2#1)
much easier##2##2##(2008-10#1)(2008-7#1)
much effort has been##4##4##(1992-9#1)(2008-1#1)(2008-11#1)(2009-8#1)
much effort##5##2##(1992-9#1)(2008-1#2)(2008-11#1)(2009-8#1)
much enhanced##2##2##(1995-12#1)(2008-10#1)
much faster and easier##2##4##(2008-4#1)(2010-6#1)
much faster and more##3##4##(2008-10#2)(2008-7#1)
much faster and##5##3##(2008-10#2)(2008-4#1)(2008-7#1)(2010-6#1)
much faster than##4##3##(1993-8#1)(2007-8#1)(2008-10#1)(2012-3#1)
much faster##15##2##(1992-12#1)(1993-8#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#1)(2010-6#1)(2012-3#1)
much fewer##3##2##(1992-2#1)(2008-5#1)(2008-9#1)
much greater than that of##2##5##(2008-10#2)
much greater than that##5##4##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
much greater than##9##3##(1990-11#2)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)
much greater##25##2##(1990-11#2)(1992-1#1)(1993-8#2)(1995-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2012-5#1)
much has been learned about##3##5##(2008-4#1)(2008-8#1)(2011-3#1)
much has been##4##3##(2008-11#1)(2008-4#1)(2008-8#1)(2011-3#1)
much higher concentrations##2##3##(1994-3#1)(2011-2#1)
much higher in##5##3##(1997-2#1)(2008-10#3)(2008-9#1)
much higher levels of##2##4##(1993-6#1)(1994-11#1)
much higher than that of the##2##6##(2008-10#1)(2010-3#1)
much higher than that of##5##5##(2008-10#2)(2008-8#1)(2009-7#1)(2010-3#1)
much higher than that##6##4##(2008-10#3)(2008-8#1)(2009-7#1)(2010-3#1)
much higher than the one##2##5##(2008-8#1)(2008-9#1)
much higher than the##4##4##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
much higher than those in the##2##6##(2008-10#2)
much higher than those of##2##5##(2008-10#1)(2008-8#1)
much higher than those##4##4##(2008-10#3)(2008-8#1)
much higher than##20##3##(1993-12#1)(1994-3#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-7#1)(2010-3#1)
much higher##50##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#22)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-7#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
much improved##2##2##(1990-11#1)(2008-10#1)
much in##4##2##(1990-9#1)(1996-1#1)(2008-10#1)(2008-4#1)
much influence##2##2##(2008-10#2)
much information on the##2##4##(1994-3#1)(2008-6#1)
much information##4##2##(1990-3#1)(1994-3#1)(2008-6#1)(2009-12#1)
much interest##2##2##(2008-10#1)(2013-1#1)
much is known about the##2##5##(2012-2#1)(2013-8#1)
much is##3##2##(2008-1#1)(2012-2#1)(2013-8#1)
much larger for##2##3##(1997-2#1)(2008-10#1)
much larger than##5##3##(1995-6#1)(2008-10#2)(2008-3#1)(2010-7#1)
much larger##13##2##(1995-5#1)(1995-6#1)(1997-2#1)(2008-10#7)(2008-2#1)(2008-3#1)(2010-7#1)
much later##2##2##(1993-3#1)(2008-10#1)
much less effective##2##3##(1994-8#1)(2008-8#1)
much less potent##2##3##(1992-1#1)(1994-11#1)
much less than##2##3##(2008-10#1)(2010-4#1)
much less##39##2##(1990-8#1)(1991-5#1)(1992-1#1)(1993-1#1)(1993-2#2)(1994-11#2)(1994-2#1)(1994-8#2)(1996-1#2)(1996-11#1)(1996-2#3)(1997-4#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-6#2)(2009-9#1)(2010-4#1)(2011-2#3)(2012-3#1)
much longer period##2##3##(1994-3#1)(2008-11#1)
much longer##9##2##(1994-1#1)(1994-3#1)(2008-10#4)(2008-11#3)
much lower compared##2##3##(2008-5#1)(2011-3#1)
much lower in##3##3##(1997-7#1)(2008-10#1)(2010-6#1)
much lower levels of##2##4##(2008-11#1)(2012-3#1)
much lower levels##3##3##(1995-2#1)(2008-11#1)(2012-3#1)
much lower than in##2##4##(1992-3#1)(2011-1#1)
much lower than that##6##4##(1996-2#1)(2008-10#2)(2008-7#1)(2008-8#2)
much lower than the##2##4##(2008-8#2)
much lower than##15##3##(1992-3#1)(1996-2#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#4)(2011-1#1)(2013-8#1)
much lower##41##2##(1990-11#1)(1992-3#1)(1994-1#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#16)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#5)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
much more abundant than the##2##5##(1991-5#1)(2008-10#1)
much more complex##2##3##(2008-10#1)(2008-11#1)
much more important##2##3##(1991-11#1)(2008-8#1)
much more likely to##2##4##(2008-8#1)(2009-12#1)
much more likely##3##3##(2008-8#2)(2009-12#1)
much more negative than##2##4##(2008-10#2)
much more positive##2##3##(1990-2#1)(2008-11#1)
much more prominent##2##3##(2008-10#1)(2008-7#1)
much more rapid and simpler##2##5##(2008-10#2)
much more rapid##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
much more rapidly##3##3##(1994-5#1)(1994-8#1)(2007-12#1)
much more sensitive to##3##4##(1993-8#1)(1994-5#1)(2008-8#1)
much more sensitive##4##3##(1993-8#1)(1994-5#1)(2008-10#1)(2008-8#1)
much more stable##2##3##(2008-10#1)(2008-11#1)
much more than##4##3##(1990-6#1)(1991-3#1)(1993-2#1)(2008-8#1)
much more##77##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-5#2)(1994-8#1)(1995-5#2)(1997-7#1)(2007-12#1)(2008-10#22)(2008-11#9)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#7)(2009-12#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-8#1)
much of his##2##3##(1993-5#1)(2010-5#1)
much of the research##2##4##(2009-7#1)(2013-1#1)
much of the##24##3##(1990-11#1)(1993-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
much of their##4##3##(1990-5#1)(2008-10#2)(2010-5#1)
much of this##3##3##(1992-2#1)(2008-11#1)(2008-4#1)
much of##40##2##(1990-11#1)(1990-5#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
much progress in##2##3##(2008-10#1)(2008-11#1)
much progress##3##2##(1996-11#1)(2008-10#1)(2008-11#1)
much public attention##2##3##(1990-6#1)(1991-12#1)
much reduced##5##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-7#1)
much remains to be##2##4##(1992-3#1)(2008-8#1)
much research##3##2##(2008-10#1)(2008-11#1)(2009-1#1)
much shorter than the##2##4##(1991-12#1)(2010-10#1)
much shorter than##3##3##(1991-12#1)(2008-10#1)(2010-10#1)
much shorter##5##2##(1991-12#1)(2008-10#2)(2008-3#1)(2010-10#1)
much simpler than##2##3##(2008-11#1)(2008-9#1)
much simpler##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)
much slower##5##2##(1990-9#1)(1992-2#1)(1993-8#1)(2008-6#1)(2008-8#1)
much smaller than that of the##2##6##(2008-10#1)(2008-6#1)
much smaller than the##2##4##(2008-10#1)(2008-3#1)
much smaller than##7##3##(2008-10#3)(2008-3#2)(2008-6#1)(2011-2#1)
much smaller##10##2##(1991-12#1)(1994-3#1)(2008-10#3)(2008-3#2)(2008-6#1)(2009-7#1)(2011-2#1)
much stronger##8##2##(2008-10#4)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
much superior##2##2##(2008-10#2)
much the##3##2##(1994-9#1)(1997-8#1)(2008-1#1)
much thinner than that of##2##5##(2008-5#1)(2011-3#1)
much time##2##2##(2008-12#1)(2012-3#1)
much to offer##2##3##(2008-12#1)(2012-2#1)
much to##6##2##(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
much wider##2##2##(2008-10#1)(2013-8#1)
much with##2##2##(2008-11#1)(2009-3#1)
much work remains to##2##4##(2009-7#1)(2012-3#1)
much##598##1##(1990-10#1)(1990-11#7)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#5)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#5)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#6)(1994-1#3)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#8)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#4)(1995-6#2)(1995-8#3)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#6)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2006-6#1)(2007-11#4)(2007-12#7)(2007-8#1)(2008-1#6)(2008-10#153)(2008-11#46)(2008-12#7)(2008-2#5)(2008-3#28)(2008-4#8)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#27)(2008-9#12)(2009-1#3)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#7)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#15)(2011-3#3)(2011-4#1)(2012-12#3)(2012-2#13)(2012-3#8)(2012-5#1)(2012-8#1)(2013-1#9)(2013-7#3)(2013-8#7)
mucilage##7##1##(2009-8#7)
mucilaginosa##3##1##(2008-10#1)(2009-11#2)
mucin and##2##2##(1991-12#1)(1993-1#1)
mucin gene##2##2##(1990-8#2)
mucin genes##2##2##(1990-8#1)(1991-12#1)
mucin glycoprotein##2##2##(1994-11#2)
mucin##23##1##(1990-8#5)(1991-12#7)(1993-1#5)(1993-2#1)(1994-11#3)(2008-7#2)
mucinous cystic##2##2##(1990-2#1)(2008-12#1)
mucinous ovarian cystomas##3##3##(1990-2#3)
mucinous##16##1##(1990-2#6)(1990-6#1)(2008-12#1)(2010-3#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
mucins##5##1##(1991-12#1)(1993-1#2)(1993-2#2)
muco-cutaneous##2##1##(2008-11#1)(2012-2#1)
muco-inositol##3##1##(2008-11#3)
mucocele##3##1##(2013-1#3)
mucoceles are##2##2##(2013-1#2)
mucoceles##5##1##(2013-1#5)
mucociliary clearance##4##2##(1996-1#1)(1997-1#3)
mucociliary transport##2##2##(1997-1#2)
mucociliary##8##1##(1996-1#1)(1997-1#7)
mucocutaneous candidiasis##2##2##(2012-3#2)
mucocutaneous##7##1##(1991-2#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#3)
mucoepidermoid carcinoma of the liver##2##5##(1992-2#2)
mucoepidermoid carcinoma##5##2##(1992-2#3)(2009-6#1)(2012-2#1)
mucoepidermoid##6##1##(1991-11#1)(1992-2#3)(2009-6#1)(2012-2#1)
mucoid##6##1##(1991-12#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#1)
mucolytic##2##1##(1991-11#1)(2009-7#1)
mucormycosis in a##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
mucormycosis##18##1##(1995-8#1)(2008-12#2)(2010-10#3)(2011-2#10)(2013-1#2)
mucosa and the##3##3##(1991-12#1)(1993-8#1)(1996-6#1)
mucosa and##10##2##(1990-3#1)(1990-9#1)(1991-12#2)(1991-5#1)(1993-8#1)(1996-6#1)(1997-5#1)(2010-12#1)(2011-2#1)
mucosa is##2##2##(1997-1#1)(2008-12#1)
mucosa of##2##2##(1992-9#1)(2013-1#1)
mucosa to##3##2##(1990-9#1)(1991-5#1)(1997-2#1)
mucosa was##2##2##(1990-2#1)(2012-3#1)
mucosa were##2##2##(1991-3#1)(2013-1#1)
mucosa##66##1##(1990-11#1)(1990-2#3)(1990-3#3)(1990-5#1)(1990-9#5)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-1#3)(1993-8#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-5#2)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-12#7)(2011-2#3)(2011-3#1)(2012-3#3)(2013-1#4)(2013-8#1)
mucosa-associated lymphoid tissue lymphoma##2##4##(2009-3#1)(2009-5#1)
mucosa-associated lymphoid tissue##5##3##(2009-3#1)(2009-5#1)(2009-8#3)
mucosae##4##1##(1993-3#2)(1997-1#1)(1997-3#1)
mucosal DNA##2##2##(1993-8#2)
mucosal adjuvants##2##2##(1995-2#2)
mucosal and##3##2##(1993-8#1)(2012-2#1)(2013-8#1)
mucosal blood flow##4##3##(1992-6#2)(1997-1#1)(1997-4#1)
mucosal damage##2##2##(1997-1#1)(2012-2#1)
mucosal immunity##6##2##(1995-5#1)(2008-5#3)(2013-1#2)
mucosal inflammation##2##2##(2012-2#2)
mucosal injury##3##2##(1997-1#1)(2008-11#1)(2012-2#1)
mucosal integrity##2##2##(1997-1#2)
mucosal layer##3##2##(2008-12#1)(2009-8#1)(2012-12#1)
mucosal lesions##2##2##(1990-3#1)(1997-8#1)
mucosal prolapse and hemorrhoidal prolapse##3##5##(2013-1#3)
mucosal prolapse and##4##3##(2013-1#4)
mucosal prolapse was##3##3##(2013-1#3)
mucosal prolapse##13##2##(1992-5#1)(2013-1#12)
mucosal##80##1##(1990-3#1)(1990-5#2)(1991-12#2)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#2)(1993-8#3)(1994-8#1)(1995-2#3)(1995-5#1)(1996-3#1)(1997-1#7)(1997-3#3)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-5#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#8)(2013-1#14)(2013-8#2)
mucositis##2##1##(1990-6#1)(2008-7#1)
mucous and##2##2##(2008-6#1)(2011-2#1)
mucous cells##2##2##(1995-2#1)(2008-6#1)
mucous membranes##4##2##(2010-1#1)(2010-6#1)(2011-2#1)(2012-3#1)
mucous##13##1##(1995-2#1)(1997-1#3)(1997-2#1)(2008-6#3)(2010-1#1)(2010-6#1)(2011-2#2)(2012-3#1)
mucus is##2##2##(1997-1#2)
mucus production##2##2##(2008-10#1)(2008-4#1)
mucus##12##1##(1992-5#1)(1994-11#1)(1996-1#3)(1996-9#1)(1997-1#2)(2008-10#1)(2008-4#1)(2011-1#1)(2013-7#1)
mug (Sn) kg(-1)##2##3##(2008-10#2)
mug 1(-1)##2##2##(2008-10#2)
mug 10 ml(-1)##2##3##(2008-10#2)
mug 10(-6)##2##2##(2008-11#2)
mug As l(-1) range##2##4##(2008-10#2)
mug As l(-1)##3##3##(2008-10#3)
mug As##6##2##(2008-10#6)
mug Cd l(-1)##3##3##(2008-10#3)
mug Cr##2##2##(2008-10#2)
mug Mo l(-1)##3##3##(2008-10#3)
mug Mo##4##2##(2008-10#4)
mug Sb(V)##2##2##(2008-10#2)
mug Se/g sample##2##3##(2008-10#2)
mug a##10##2##(2008-10#10)
mug and##5##2##(2008-10#4)(2010-2#1)
mug cm(-2)##8##2##(2008-10#7)(2008-5#1)
mug cm(-3) for##2##3##(2010-8#2)
mug cm(-3)##3##2##(2008-10#1)(2010-8#2)
mug cyanide##3##2##(2008-10#3)
mug for##2##2##(2008-10#2)
mug g (-)(1) creatinine##2##4##(2008-10#2)
mug g(-1) and##2##3##(2008-10#2)
mug g(-1) for Mg##2##4##(2008-10#2)
mug g(-1) for the procedure##2##5##(2008-10#2)
mug g(-1) for##8##3##(2008-10#8)
mug g(-1) in##3##3##(2008-10#3)
mug g(-1) level##4##3##(2008-10#4)
mug g(-1)##41##2##(2008-10#41)
mug g(-1))##4##2##(2008-10#4)
mug hIL-6##2##2##(2008-11#2)
mug in the##3##3##(2008-10#3)
mug in##5##2##(2008-10#5)
mug kg(-1) for the##3##4##(2008-10#3)
mug kg(-1) for##5##3##(2008-10#5)
mug kg(-1)##9##2##(2008-10#7)(2008-5#2)
mug kg(-1))##2##2##(2008-10#2)
mug l(-1) (for##2##3##(2008-10#2)
mug l(-1) As##4##3##(2008-10#4)
mug l(-1) Cr(VI)##2##3##(2008-10#2)
mug l(-1) Cu(II)##2##3##(2008-10#2)
mug l(-1) N##3##3##(2008-10#3)
mug l(-1) and a relative standard deviation##2##7##(2008-10#2)
mug l(-1) and a##3##4##(2008-10#3)
mug l(-1) and the##3##4##(2008-10#3)
mug l(-1) and##14##3##(2008-10#14)
mug l(-1) by##3##3##(2008-10#3)
mug l(-1) cobalt##2##3##(2008-10#2)
mug l(-1) concentration##2##3##(2008-10#2)
mug l(-1) for 20 mul##2##5##(2008-10#2)
mug l(-1) for Cd and##2##5##(2008-10#2)
mug l(-1) for Cd##3##4##(2008-10#3)
mug l(-1) for Cr(III)##2##4##(2008-10#2)
mug l(-1) for Cu##2##4##(2008-10#2)
mug l(-1) for Zn##3##4##(2008-10#3)
mug l(-1) for monoterpenes to##2##5##(2008-10#2)
mug l(-1) for most of the analytes##2##7##(2008-10#2)
mug l(-1) for supernatant and slurry analysis##2##7##(2008-10#2)
mug l(-1) for the##4##4##(2008-10#4)
mug l(-1) for##44##3##(2008-10#44)
mug l(-1) in the##2##4##(2008-10#2)
mug l(-1) in##3##3##(2008-10#3)
mug l(-1) level of cobalt##2##5##(2008-10#2)
mug l(-1) level##9##3##(2008-10#9)
mug l(-1) levels using##2##4##(2008-10#2)
mug l(-1) levels##5##3##(2008-10#5)
mug l(-1) of##8##3##(2008-10#8)
mug l(-1) was achieved##2##4##(2008-10#2)
mug l(-1) was##4##3##(2008-10#4)
mug l(-1) were##2##3##(2008-10#2)
mug l(-1) with a detection limit of##2##7##(2008-10#2)
mug l(-1) with a##3##4##(2008-10#3)
mug l(-1) with##5##3##(2008-10#5)
mug l(-1)##218##2##(2008-10#218)
mug l(-1)) and##4##3##(2008-10#4)
mug l(-1))##12##2##(2008-10#12)
mug mL(-1) for HNE)##2##4##(2008-5#2)
mug mL(-1) for PPE##2##4##(2008-5#2)
mug mL(-1) for##6##3##(2008-5#6)
mug mL(-1)##7##2##(2008-5#7)
mug ml(-1) (r=0##2##3##(2008-10#2)
mug ml(-1) NO(2)(-)##2##3##(2008-10#2)
mug ml(-1) Pb(II)##3##3##(2008-10#3)
mug ml(-1) and 0##2##4##(2008-10#2)
mug ml(-1) and a##2##4##(2008-10#2)
mug ml(-1) and relative##2##4##(2008-10#2)
mug ml(-1) and the relative standard deviation##2##7##(2008-10#2)
mug ml(-1) and the##7##4##(2008-10#7)
mug ml(-1) and##18##3##(2008-10#18)
mug ml(-1) cobalt##3##3##(2008-10#3)
mug ml(-1) concentration of##2##4##(2008-10#1)(2008-11#1)
mug ml(-1) each##2##3##(2008-10#2)
mug ml(-1) for 2##2##4##(2008-10#1)(2008-11#1)
mug ml(-1) for calf thymus DNA##3##6##(2008-10#3)
mug ml(-1) for the##2##4##(2008-10#2)
mug ml(-1) for##40##3##(2008-10#39)(2008-11#1)
mug ml(-1) hr(-1)##2##3##(2008-11#2)
mug ml(-1) level##2##3##(2008-10#2)
mug ml(-1) of B(2)O(3)##3##4##(2008-10#3)
mug ml(-1) of I##3##4##(2008-10#3)
mug ml(-1) of Si(IV)##2##4##(2008-10#2)
mug ml(-1) of europium (III)##2##5##(2008-10#2)
mug ml(-1) of manganese##2##4##(2008-10#2)
mug ml(-1) of nitrite##2##4##(2008-10#2)
mug ml(-1) of the analyte##2##5##(2008-10#2)
mug ml(-1) of the##3##4##(2008-10#3)
mug ml(-1) of##40##3##(2008-10#40)
mug ml(-1) protein##2##3##(2008-10#2)
mug ml(-1) range##2##3##(2008-10#2)
mug ml(-1) with a detection limit of 0##3##8##(2008-10#3)
mug ml(-1) with a detection limit of##5##7##(2008-10#5)
mug ml(-1) with a limit of detection 0##2##8##(2008-10#2)
mug ml(-1) with a limit of detection##3##7##(2008-10#3)
mug ml(-1) with a##10##4##(2008-10#10)
mug ml(-1) with detection##2##4##(2008-10#2)
mug ml(-1) with##16##3##(2008-10#16)
mug ml(-1)##268##2##(2008-10#255)(2008-11#13)
mug ml(-1)) and##5##3##(2008-10#5)
mug ml(-1))##17##2##(2008-10#16)(2008-11#1)
mug of CBZ##2##3##(2008-10#2)
mug of total Se/g sample##2##5##(2008-10#2)
mug of##31##2##(2008-10#29)(2008-11#2)
mug s(-1)##2##2##(2008-10#2)
mug##736##1##(2008-10#688)(2008-11#31)(2008-5#11)(2009-7#2)(2010-2#2)(2010-8#2)
mug(-1)##2##1##(2008-10#2)
mug) and##2##2##(2008-10#2)
mug) or W##2##3##(2008-10#2)
mug)##8##1##(2008-10#8)
mug/L(-1)##2##1##(2009-8#2)
mug/g (0##4##2##(2008-10#4)
mug/g##6##1##(2008-10#6)
mug/kg##8##1##(2008-10#3)(2008-11#3)(2008-7#2)
mug/l for##5##2##(2008-10#5)
mug/l##10##1##(2008-10#10)
mug/l)##2##1##(2008-10#2)
mug/mL##4##1##(2008-11#3)(2008-9#1)
mug/ml DNA##2##2##(2008-11#2)
mug/ml and##3##2##(2008-10#2)(2008-11#1)
mug/ml concentration##2##2##(2008-11#1)(2008-5#1)
mug/ml for cefepime##2##3##(2008-7#2)
mug/ml for cefotaxime and ceftriaxone##2##5##(2008-7#2)
mug/ml for##10##2##(2008-10#4)(2008-5#2)(2008-7#4)
mug/ml of##3##2##(2008-11#3)
mug/ml##56##1##(2008-10#32)(2008-11#14)(2008-5#4)(2008-7#5)(2010-6#1)
mug/ml) and##4##2##(2008-10#2)(2008-5#2)
mug/ml) were##2##2##(2008-10#1)(2008-11#1)
mug/ml)##22##1##(2008-10#8)(2008-11#1)(2008-5#13)
mugSil(-1)##2##1##(2008-10#2)
mugdm(-3)##3##1##(2008-10#3)
mugkg(-1)##2##1##(2008-10#2)
mugl(-1) and the##2##3##(2008-10#2)
mugl(-1) and##3##2##(2008-10#3)
mugl(-1) for##8##2##(2008-10#8)
mugl(-1) level##2##2##(2008-10#2)
mugl(-1) with a##2##3##(2008-10#2)
mugl(-1) with##3##2##(2008-10#3)
mugl(-1)##24##1##(2008-10#24)
mugml(-1) for##5##2##(2008-10#5)
mugml(-1) of Pb##2##3##(2008-10#2)
mugml(-1) of TCMTB##2##3##(2008-10#2)
mugml(-1) of##4##2##(2008-10#4)
mugml(-1)##25##1##(2008-10#25)
mugml(-1))##3##1##(2008-10#3)
mul and##3##2##(2008-10#3)
mul for##2##2##(2008-10#2)
mul injection volume##3##3##(2008-10#3)
mul injection##5##2##(2008-10#5)
mul min(-1)##3##2##(2008-10#3)
mul of 0##4##3##(2008-10#4)
mul of 5##2##3##(2008-10#2)
mul of a test##2##4##(2008-10#1)(2008-11#1)
mul of a##3##3##(2008-10#2)(2008-11#1)
mul of ethyl acetate##2##4##(2008-10#2)
mul of sample##7##3##(2008-10#7)
mul of the##2##3##(2008-10#2)
mul of##36##2##(2008-10#34)(2008-11#2)
mul s(-1) and##2##3##(2008-10#2)
mul s(-1)##4##2##(2008-10#4)
mul sample##4##2##(2008-10#4)
mul volumes##4##2##(2008-10#4)
mul was injected##2##3##(2008-10#2)
mul was##3##2##(2008-10#3)
mul##103##1##(2008-10#95)(2008-11#8)
mul) of##2##2##(2008-10#2)
mul) on##2##2##(2008-10#1)(2008-11#1)
mul) was##6##2##(2008-10#6)
mul)##22##1##(2008-10#21)(2008-11#1)
mul/liter##2##1##(2008-10#2)
mulberrofuran##2##1##(2011-3#2)
mulberry anthracnose##3##2##(2008-10#3)
mulberry leaves##9##2##(2008-10#9)
mulberry##18##1##(2008-10#17)(2008-11#1)
mulch and##2##2##(2008-10#2)
mulch layers##3##2##(2008-10#3)
mulch##10##1##(2008-10#9)(2010-7#1)
mulched##2##1##(2008-10#2)
mulches##3##1##(2008-10#3)
mull(-1)##2##1##(2008-10#2)
multi##9##1##(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
multi-analyte##4##1##(2008-10#3)(2013-1#1)
multi-array chemical##2##2##(2008-10#2)
multi-bilinear model##3##2##(2008-10#3)
multi-center##6##1##(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2010-11#1)
multi-channel##5##1##(2008-10#3)(2008-9#2)
multi-commutation##3##1##(2008-10#3)
multi-component##4##1##(1994-3#1)(2008-10#3)
multi-datatype analysis##2##2##(2011-2#2)
multi-disciplinary team##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
multi-disciplinary##9##1##(1996-3#1)(2008-11#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-2#1)
multi-dose powder##2##2##(1996-2#2)
multi-drug resistant##3##2##(2010-2#1)(2012-2#2)
multi-drug##4##1##(2010-2#1)(2011-3#1)(2012-2#2)
multi-element analysis of glass##2##4##(2008-10#2)
multi-element analysis of##4##3##(2008-10#4)
multi-element analysis##5##2##(2008-10#5)
multi-element determination in##3##3##(2008-10#3)
multi-element determination##4##2##(2008-10#4)
multi-element##18##1##(2008-10#18)
multi-elemental##2##1##(2008-10#2)
multi-faceted##6##1##(1992-11#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2013-8#1)
multi-factorial##3##1##(2009-1#1)(2011-2#1)(2012-2#1)
multi-frequency laser##5##2##(2008-10#5)
multi-frequency##6##1##(2008-10#5)(2008-11#1)
multi-gene##4##1##(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
multi-institutional##6##1##(1991-3#1)(1993-12#1)(1994-2#2)(2010-12#1)(2010-5#1)
multi-locus DNA##2##2##(1995-6#1)(2008-10#1)
multi-locus##3##1##(1995-6#1)(2008-10#2)
multi-method approach to data collection##2##5##(2008-11#2)
multi-method research##2##2##(2008-11#1)(2008-12#1)
multi-method##4##1##(2008-11#3)(2008-12#1)
multi-modality imaging##2##2##(2012-2#2)
multi-modality##3##1##(1990-6#1)(2012-2#2)
multi-organ##2##1##(1993-2#1)(2008-8#1)
multi-parameter observation of##2##3##(2008-8#2)
multi-parameter##3##1##(1994-8#1)(2008-8#2)
multi-phase##2##1##(2008-10#1)(2008-5#1)
multi-port selection valve##2##3##(2008-10#2)
multi-port selection##3##2##(2008-10#3)
multi-potent##2##1##(2008-11#1)(2009-12#1)
multi-professional##4##1##(2008-11#3)(2008-12#1)
multi-protein##3##1##(2008-7#1)(2012-2#1)(2013-8#1)
multi-pumping flow##3##2##(2008-10#3)
multi-residue##3##1##(2008-10#3)
multi-sample##3##1##(2008-10#2)(2008-11#1)
multi-sensor##2##1##(2008-10#2)
multi-site##8##1##(1995-3#3)(2008-1#1)(2012-3#1)(2013-1#3)
multi-skilling##2##1##(1993-12#1)(2008-12#1)
multi-spectral canopy##2##2##(2008-10#2)
multi-stage##5##1##(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
multi-stakeholder alliances##4##2##(2013-1#4)
multi-stakeholder##6##1##(2013-1#6)
multi-state model##2##2##(1995-9#2)
multi-state##6##1##(1995-2#2)(1995-9#2)(2009-4#1)(2013-1#1)
multi-step##7##1##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
multi-syringe flow-injection##2##2##(2008-10#2)
multi-syringe##4##1##(2008-10#4)
multi-wall carbon nanotubes##2##3##(2008-10#2)
multi-wall carbon##4##2##(2008-10#4)
multi-walled carbon nanotubes##2##3##(2008-10#2)
multi-walled carbon nanotubes/(3-mercaptopropyl)trimethoxysilane##2##3##(2008-10#2)
multi-walled carbon##4##2##(2008-10#4)
multi-wavelength##2##1##(2008-10#2)
multi-well##3##1##(2008-11#3)
multianalyte##6##1##(2008-10#6)
multiaxial##3##1##(2008-11#2)(2013-8#1)
multibacillary##2##1##(2011-2#2)
multibiosensor##2##1##(2008-10#2)
multicatalytic proteinase complex##2##3##(1994-5#2)
multicellular aggregates##3##2##(2008-11#3)
multicellular hypersensitive##2##2##(2008-10#2)
multicellular organisms##3##2##(1997-2#1)(2008-2#1)(2008-8#1)
multicellular resistance##2##2##(2008-11#2)
multicellular##22##1##(1997-2#1)(2008-10#2)(2008-11#8)(2008-2#1)(2008-8#2)(2008-9#1)(2009-6#5)(2011-2#1)(2012-3#1)
multicenter randomized##4##2##(1993-1#2)(2013-1#2)
multicenter study in##2##3##(2010-6#1)(2012-3#1)
multicenter study##6##2##(2008-5#1)(2008-6#1)(2009-10#1)(2010-6#1)(2012-2#1)(2012-3#1)
multicenter trial##2##2##(2008-10#1)(2008-7#1)
multicenter##27##1##(1990-12#1)(1993-1#2)(1994-3#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#2)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
multicentre study##2##2##(2008-5#1)(2012-3#1)
multicentre##12##1##(1992-5#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
multicentric##6##1##(1993-8#1)(1994-8#1)(1997-1#1)(1997-8#1)(2008-7#1)(2009-8#1)
multichannel cochlear implants on the##2##5##(2008-9#2)
multichannel cochlear##3##2##(2008-9#3)
multichannel##12##1##(1997-6#1)(2008-10#4)(2008-3#3)(2008-9#4)
multicistronic expression technology##4##3##(2008-11#4)
multicistronic expression units##2##3##(2008-11#2)
multicistronic expression##8##2##(2008-11#8)
multicistronic##9##1##(2008-11#9)
multicollector##2##1##(2008-10#2)
multicollinearity##3##1##(1994-12#2)(2008-10#1)
multicolor flow cytometry##3##3##(2008-4#1)(2008-9#2)
multicolor flow##4##2##(2008-4#1)(2008-9#3)
multicolor polarizing##2##2##(2008-3#2)
multicolor##12##1##(2008-3#2)(2008-4#1)(2008-9#6)(2009-11#1)(2009-9#1)(2013-8#1)
multicommutation and##3##2##(2008-10#3)
multicommutation approach allowed##2##3##(2008-10#2)
multicommutation approach##4##2##(2008-10#4)
multicommutation for the##2##3##(2008-10#2)
multicommutation to##2##2##(2008-10#2)
multicommutation##23##1##(2008-10#23)
multicommuted flow system##4##3##(2008-10#4)
multicommuted flow##5##2##(2008-10#5)
multicommuted##8##1##(2008-10#8)
multicomponent determination##2##2##(2008-10#2)
multicomponent mixtures##2##2##(1991-9#1)(2008-10#1)
multicomponent systems##2##2##(2008-10#1)(2008-11#1)
multicomponent##24##1##(1990-8#1)(1991-9#1)(2008-10#17)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
multicopper oxidases##3##2##(2008-10#1)(2012-2#2)
multicopper##4##1##(2008-10#2)(2012-2#2)
multicopy plasmid##7##2##(1990-11#2)(1990-5#1)(1993-9#1)(1995-5#2)(1997-3#1)
multicopy##9##1##(1990-11#2)(1990-5#1)(1993-9#1)(1995-5#2)(1995-6#1)(1997-3#1)(2008-10#1)
multicriteria approach to the iterative##2##5##(2008-3#2)
multicriteria##4##1##(2008-3#4)
multicultural groups##2##2##(2008-11#2)
multicultural##5##1##(1995-3#1)(2008-11#3)(2013-8#1)
multicystic dysplastic kidney##2##3##(2008-10#2)
multicystic##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
multidetection##2##1##(2008-10#2)
multidetector computed tomography (MDCT) in##2##5##(2011-2#2)
multidetector computed tomography##6##3##(2008-12#2)(2011-2#2)(2012-2#2)
multidetector##8##1##(2008-12#2)(2009-10#1)(2011-2#3)(2012-2#2)
multidetector-row computed tomography##2##3##(2011-2#1)(2012-2#1)
multidetector-row##3##1##(2011-2#2)(2012-2#1)
multidimensional analysis##2##2##(2008-10#2)
multidimensional approach##2##2##(1994-1#1)(1997-1#1)
multidimensional counseling##2##2##(2008-7#2)
multidimensional data##2##2##(2008-10#2)
multidimensional measure of##2##3##(2012-2#2)
multidimensional measure##3##2##(2012-2#3)
multidimensional scaling##6##2##(1995-5#4)(2008-10#2)
multidimensional##40##1##(1992-12#1)(1994-1#1)(1995-2#1)(1995-3#2)(1995-5#4)(1995-8#1)(1997-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-2#2)(2010-7#2)(2012-2#4)(2012-3#2)
multidirectional##2##1##(2008-6#1)(2012-2#1)
multidisciplinary European expert panel##2##4##(2010-12#2)
multidisciplinary and##2##2##(2010-10#1)(2011-3#1)
multidisciplinary approach to##5##3##(1994-1#1)(1996-1#1)(2008-7#2)(2011-2#1)
multidisciplinary approach##11##2##(1991-3#1)(1994-1#1)(1994-3#1)(1996-1#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#2)
multidisciplinary care##3##2##(1996-1#1)(2008-10#1)(2010-11#1)
multidisciplinary documentation##2##2##(2008-3#2)
multidisciplinary field##2##2##(2008-2#1)(2011-2#1)
multidisciplinary pain rehabilitation##4##3##(2013-1#4)
multidisciplinary pain##5##2##(1994-1#1)(2013-1#4)
multidisciplinary program to quit smoking##2##5##(2013-8#2)
multidisciplinary program to quit##3##4##(2013-8#3)
multidisciplinary study##2##2##(1991-6#1)(2013-1#1)
multidisciplinary team##8##2##(1990-6#1)(1997-2#1)(2008-7#1)(2009-8#1)(2013-1#4)
multidisciplinary teams##2##2##(1993-2#1)(1994-1#1)
multidisciplinary treatment##6##2##(1993-11#1)(1993-6#1)(2012-3#4)
multidisciplinary##81##1##(1990-6#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#1)(1994-3#1)(1996-1#4)(1996-11#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-1#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#2)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#12)(2013-8#3)
multidomain##3##1##(1994-5#1)(2008-10#1)(2009-6#1)
multidrug resistance##16##2##(1990-2#1)(1996-8#1)(2008-11#13)(2011-2#1)
multidrug resistance-associated protein##2##3##(2008-11#2)
multidrug resistant##9##2##(1990-2#1)(1996-3#1)(2008-11#2)(2009-5#1)(2012-2#3)(2013-8#1)
multidrug##33##1##(1990-2#2)(1991-8#1)(1996-3#1)(1996-8#1)(2008-11#19)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
multidrug-resistant (MDR)##2##2##(1993-3#1)(2011-2#1)
multidrug-resistant TB##2##2##(2008-10#1)(2010-5#1)
multidrug-resistant phenotype##2##2##(1993-3#1)(2008-11#1)
multidrug-resistant##9##1##(1993-3#2)(1996-3#1)(2008-10#1)(2008-11#1)(2010-5#1)(2010-6#1)(2011-2#2)
multielement analysis##2##2##(2008-10#1)(2010-11#1)
multielement determination##6##2##(2008-10#6)
multielement##14##1##(2008-10#13)(2010-11#1)
multielemental analysis by##2##3##(2008-10#2)
multielemental analysis##8##2##(2008-10#8)
multielemental##14##1##(2008-10#14)
multienzyme redox system##2##3##(2008-10#2)
multienzyme##3##1##(1996-6#1)(2008-10#2)
multiethnic##2##1##(2008-1#1)(2012-12#1)
multiexponential diffusion##2##2##(2012-2#2)
multifaceted##14##1##(1996-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
multifactor##2##1##(2008-10#2)
multifactorial diseases##2##2##(2011-2#1)(2012-2#1)
multifactorial##14##1##(1992-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)
multifocal intraocular lens##3##3##(2011-2#3)
multifocal renal cell##2##3##(2011-2#2)
multifocal##13##1##(1994-5#1)(1996-11#1)(1997-1#1)(2009-9#1)(2010-6#1)(2011-2#6)(2012-2#1)(2013-8#1)
multifold##3##1##(2008-10#2)(2011-2#1)
multiforme##8##1##(1994-2#1)(2008-11#1)(2009-5#1)(2011-2#2)(2011-3#2)(2013-1#1)
multifractal##3##1##(2008-8#3)
multifractals##2##1##(2008-8#2)
multifunction cable##2##2##(2010-9#2)
multifunctional anaesthesia system##2##3##(2011-2#2)
multifunctional anaesthesia##3##2##(2011-2#3)
multifunctional column##4##2##(2008-10#4)
multifunctional protein##6##2##(1990-7#3)(1995-8#1)(2008-9#1)(2009-3#1)
multifunctional roles##2##2##(2008-11#1)(2012-2#1)
multifunctional##33##1##(1990-7#3)(1995-2#1)(1995-3#2)(1995-8#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-5#4)(2008-9#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#1)
multigene family##11##2##(1993-6#1)(1993-9#2)(1994-11#2)(1995-2#1)(1996-12#1)(1997-7#2)(2008-11#1)(2008-8#1)
multigene metabolic engineering##4##3##(2008-11#4)
multigene##20##1##(1993-6#1)(1993-9#3)(1994-11#2)(1995-2#1)(1996-12#2)(1997-7#2)(2008-10#1)(2008-11#6)(2008-8#1)(2009-9#1)
multigenic families##3##2##(1997-9#3)
multigenic##5##1##(1994-12#2)(1997-9#3)
multigenomic##2##1##(2008-8#2)
multihospital##3##1##(1991-1#1)(1994-1#1)(1996-1#1)
multijoint multiwaveform##3##2##(2013-1#3)
multilamellar liposomes##2##2##(1990-2#1)(2008-10#1)
multilamellar vesicles##2##2##(2008-5#2)
multilamellar##5##1##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#2)
multilayer Langmuir-Blodgett##2##2##(2008-10#2)
multilayer coatings##4##2##(2008-3#4)
multilayer film##5##2##(2008-10#5)
multilayer films on##2##3##(2008-10#2)
multilayer films##6##2##(2008-10#6)
multilayer perceptron##2##2##(2008-10#1)(2010-8#1)
multilayer##42##1##(2007-8#2)(2008-10#24)(2008-11#4)(2008-2#1)(2008-3#5)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
multilayered films##2##2##(2008-12#2)
multilayered##9##1##(2007-12#1)(2008-10#2)(2008-12#3)(2008-7#1)(2009-9#1)(2010-4#1)
multilayers on##2##2##(2008-10#2)
multilayers were##3##2##(2008-10#3)
multilayers##9##1##(2008-10#9)
multilevel C-ADR with multilevel##2##4##(2012-12#2)
multilevel C-ADR with##3##3##(2012-12#3)
multilevel C-ADR##7##2##(2012-12#7)
multilevel analysis##3##2##(2010-1#2)(2013-8#1)
multilevel modeling##2##2##(2008-12#1)(2011-2#1)
multilevel selection##3##2##(2008-8#3)
multilevel##27##1##(2008-11#1)(2008-12#2)(2008-3#2)(2008-8#3)(2009-12#1)(2009-6#1)(2010-1#3)(2011-2#1)(2012-12#12)(2013-8#1)
multiline population##2##2##(2008-10#2)
multiline##5##1##(2008-10#4)(2008-2#1)
multilineage##2##1##(2008-11#1)(2011-2#1)
multilinear regression##2##2##(2008-10#2)
multilinear##4##1##(2008-10#3)(2009-8#1)
multilocularis##5##1##(1996-12#3)(2010-11#1)(2011-2#1)
multilocus AFLP genotypes##2##3##(2008-10#2)
multilocus association and##2##3##(2008-10#2)
multilocus genotypes##4##2##(2008-10#4)
multilocus haplotypes were identified##2##4##(2008-10#2)
multilocus haplotypes##5##2##(2008-10#5)
multilocus##38##1##(2008-10#31)(2008-9#1)(2011-2#2)(2012-3#4)
multimedia learning##5##2##(2013-8#5)
multimedia##16##1##(1995-2#1)(2008-11#5)(2008-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2013-8#5)
multimember VCGs##3##2##(2008-10#3)
multimember##4##1##(2008-10#4)
multimeric form##2##2##(2008-10#2)
multimeric##3##1##(1990-5#1)(2008-10#2)
multimerization function of NifA central domain##3##6##(2008-9#3)
multimerization##11##1##(1993-8#4)(1995-2#1)(2008-10#1)(2008-9#5)
multimerized##2##1##(1993-8#1)(1995-6#1)
multimers of##2##2##(1994-11#2)
multimers##9##1##(1993-3#2)(1994-11#3)(1995-6#1)(1997-3#1)(2009-7#1)(2009-9#1)
multimodal treatment with##2##3##(2012-3#2)
multimodal treatment##3##2##(2012-3#3)
multimodal##13##1##(1992-2#1)(2008-10#1)(2008-12#2)(2010-12#1)(2011-7#1)(2012-2#1)(2012-3#5)(2013-8#1)
multimodality##5##1##(1991-2#1)(1994-6#1)(2009-11#1)(2013-1#2)
multimode emissions##2##2##(2008-2#2)
multimode fiber##7##2##(2008-10#1)(2008-3#6)
multimode fibers##2##2##(2008-2#1)(2008-3#1)
multimode laser##5##2##(1992-11#1)(2008-3#4)
multimode##33##1##(1992-11#1)(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#22)(2010-4#2)(2013-1#1)
multinational##4##1##(1994-2#1)(2008-7#1)(2011-2#1)(2011-8#1)
multinodular goiter##2##2##(1990-6#1)(2012-3#1)
multinodular##6##1##(1990-6#1)(1990-9#1)(1993-6#2)(2008-4#1)(2012-3#1)
multinomial logistic regression##2##3##(2012-3#1)(2013-1#1)
multinomial probit models##2##3##(2009-4#2)
multinomial probit##3##2##(2009-4#3)
multinomial##7##1##(1995-9#1)(2008-8#1)(2009-4#3)(2012-3#1)(2013-1#1)
multinuclear MRS##3##2##(2012-2#3)
multinuclear##4##1##(2009-7#1)(2012-2#3)
multinucleate##2##1##(2008-10#2)
multinucleated cells##2##2##(2008-11#1)(2008-12#1)
multinucleated giant cells##5##3##(1991-12#1)(2009-3#1)(2012-2#1)(2013-1#2)
multinucleated##12##1##(1991-11#1)(1991-12#1)(1995-2#1)(2008-11#3)(2008-12#2)(2009-3#1)(2012-2#1)(2013-1#2)
multinucleatedcells##2##1##(2008-11#2)
multiorgan failure (MOF)##2##3##(1992-5#1)(2009-7#1)
multiorgan failure##4##2##(1992-5#1)(1997-3#1)(2009-7#1)(2012-12#1)
multiorgan involvement##2##2##(2008-7#1)(2012-3#1)
multiorgan##8##1##(1992-5#1)(1997-3#1)(2008-12#1)(2008-7#1)(2009-7#2)(2012-12#1)(2012-3#1)
multiparameter analysis##2##2##(2008-11#1)(2008-4#1)
multiparameter##3##1##(2008-11#1)(2008-4#1)(2008-9#1)
multiparametric##6##1##(1991-12#1)(2008-10#3)(2008-4#1)(2008-9#1)
multiparous##3##1##(2012-12#1)(2013-1#2)
multiparticle##2##1##(1993-5#1)(2008-3#1)
multipass pumping##2##2##(2007-11#2)
multipass##4##1##(2007-11#2)(2008-3#2)
multiphasic##2##1##(1991-6#1)(2010-1#1)
multiphoton fluorescence microscopy##2##3##(2012-2#2)
multiphoton imaging##2##2##(2008-9#2)
multiphoton ionization##3##2##(1992-11#1)(2008-3#2)
multiphoton##11##1##(1992-11#1)(2008-10#1)(2008-3#3)(2008-9#4)(2012-2#2)
multiplanar##4##1##(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
multiple &quot##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
multiple DNA##2##2##(2008-10#1)(2012-2#1)
multiple activities##2##2##(2011-2#1)(2012-3#1)
multiple alleles##3##2##(2008-10#1)(2012-3#2)
multiple analyses of the spiked samples##4##6##(2008-10#4)
multiple and##4##2##(1996-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
multiple array sensing and##2##4##(2010-8#2)
multiple aspects of##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
multiple bacterial##2##2##(2007-8#1)(2008-10#1)
multiple bands of zebrafish##2##4##(2008-9#2)
multiple bands of##3##3##(2008-5#1)(2008-9#2)
multiple bands##5##2##(2008-5#2)(2008-9#3)
multiple benefits##3##2##(2008-10#1)(2008-9#1)(2009-6#1)
multiple bilateral##2##2##(2008-10#2)
multiple biological##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
multiple brain##2##2##(1996-12#1)(2010-9#1)
multiple causes##3##2##(2008-12#1)(2010-10#1)(2011-2#1)
multiple cell surface##2##3##(2008-8#1)(2011-2#1)
multiple cell##5##2##(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
multiple cellular##2##2##(1994-8#1)(1996-2#1)
multiple choice##2##2##(1991-12#1)(1993-2#1)
multiple cloning sites##2##3##(1993-12#1)(2011-1#1)
multiple cloning##3##2##(1993-12#1)(1995-8#1)(2011-1#1)
multiple coexisting##2##2##(1991-3#1)(1997-1#1)
multiple components##2##2##(2008-10#1)(2010-8#1)
multiple congenital##2##2##(1997-6#1)(2010-7#1)
multiple copies of this##2##4##(2008-10#2)
multiple copies of##7##3##(1995-5#1)(1997-7#1)(2008-10#3)(2008-4#1)(2011-2#1)
multiple copies##8##2##(1990-6#1)(1995-5#1)(1997-7#1)(2008-10#3)(2008-4#1)(2011-2#1)
multiple correlation##2##2##(2008-10#1)(2008-3#1)
multiple correspondence analysis##3##3##(2008-10#1)(2008-5#2)
multiple cranial nerve palsies##2##4##(2008-7#2)
multiple cranial##3##2##(2008-11#1)(2008-7#2)
multiple cucumber pathogens##3##3##(2008-10#3)
multiple cutaneous##2##2##(1992-12#1)(2013-8#1)
multiple detection##2##2##(2008-10#2)
multiple dimensions##2##2##(2012-2#1)(2013-8#1)
multiple disciplines##2##2##(1996-1#1)(2012-3#1)
multiple diseases##3##2##(2008-10#2)(2008-7#1)
multiple dose##2##2##(1996-3#1)(2012-3#1)
multiple doses##2##2##(1996-3#1)(2008-10#1)
multiple emulsion##5##2##(2008-5#5)
multiple emulsions##3##2##(2008-5#3)
multiple endocrine neoplasia type##2##4##(1997-1#1)(2013-1#1)
multiple endocrine neoplasia##4##3##(1997-1#1)(2009-1#1)(2013-1#2)
multiple enhancing##2##2##(2013-8#2)
multiple episodes of##2##3##(2008-11#1)(2013-1#1)
multiple evolutionary##2##2##(2008-10#1)(2012-3#1)
multiple flow reversals##2##3##(2008-10#2)
multiple forms##2##2##(2006-6#1)(2008-12#1)
multiple functional##2##2##(2008-10#2)
multiple functions in##2##3##(1991-2#1)(2011-2#1)
multiple functions##5##2##(1991-2#1)(1997-7#1)(2009-10#1)(2011-2#1)(2012-3#1)
multiple gene##4##2##(1997-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
multiple generations##3##2##(2008-10#2)(2011-2#1)
multiple genes##6##2##(2008-11#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-3#2)
multiple genetic##5##2##(2008-10#1)(2008-7#1)(2009-6#1)(2012-3#2)
multiple genotypes##2##2##(2008-10#2)
multiple gestation##2##2##(2012-3#2)
multiple goals##3##2##(1992-12#1)(1995-3#1)(2010-8#1)
multiple handicap signals##2##3##(2008-8#2)
multiple harvest process mode##2##4##(2008-11#2)
multiple harvest process##4##3##(2008-11#4)
multiple host##3##2##(2008-10#3)
multiple hot##2##2##(2008-10#2)
multiple hydatid cysts localizing in the petroclival##2##7##(2008-7#2)
multiple hydatid cysts##5##3##(2008-7#5)
multiple independent##2##2##(2008-12#1)(2009-10#1)
multiple infections do##2##3##(2008-10#2)
multiple infections within a single gall##2##6##(2008-10#2)
multiple infections##8##2##(2008-10#6)(2008-9#2)
multiple injection##4##2##(2008-10#4)
multiple intracellular##2##2##(1991-6#1)(1994-8#1)
multiple isolates##3##2##(2008-10#3)
multiple large intestinal perforations##2##4##(2011-2#2)
multiple layers of##2##3##(1992-8#1)(2009-6#1)
multiple lectins of##2##3##(1990-5#2)
multiple lectins##3##2##(1990-5#3)
multiple lesions in the##2##4##(1997-1#1)(2013-1#1)
multiple lesions##5##2##(1997-1#1)(2010-6#1)(2011-2#2)(2013-1#1)
multiple light scattering in a disperse medium##2##7##(2008-3#2)
multiple light scattering in##3##4##(2008-3#3)
multiple light scattering##5##3##(2008-10#1)(2008-3#4)
multiple lineages##3##2##(2008-11#2)(2010-6#1)
multiple linear regression (MLR)##4##4##(2008-10#4)
multiple linear regression and##2##4##(2008-10#2)
multiple linear regression##13##3##(2008-10#9)(2009-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
multiple locations##3##2##(2008-10#3)
multiple loci##3##2##(1995-2#1)(2008-9#1)(2012-3#1)
multiple logistic regression##3##3##(1991-3#1)(2008-11#2)
multiple low##2##2##(2008-10#1)(2008-4#1)
multiple mRNAs##2##2##(1993-2#2)
multiple males##4##2##(1997-3#1)(2008-8#3)
multiple mating in##2##3##(2008-8#2)
multiple mating##11##2##(2008-8#10)(2009-6#1)
multiple measures##2##2##(2008-5#1)(2013-1#1)
multiple mechanisms of##3##3##(2008-11#1)(2010-1#1)(2012-2#1)
multiple mechanisms##12##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)
multiple media##2##2##(2010-5#1)(2012-3#1)
multiple modes of##2##3##(2008-10#1)(2009-10#1)
multiple mutations##3##2##(1993-2#2)(2008-9#1)
multiple myeloma (MM)##2##3##(2010-12#1)(2012-12#1)
multiple myeloma##14##2##(1991-12#2)(1997-5#1)(2008-5#1)(2009-3#1)(2010-12#2)(2011-2#3)(2012-12#4)
multiple nodules##2##2##(2008-5#1)(2011-2#1)
multiple nuclear##2##2##(1995-12#1)(2012-3#1)
multiple nucleoli##3##2##(2007-12#3)
multiple objective optimization##2##3##(2008-11#2)
multiple objects##2##2##(2008-3#2)
multiple organ failure##4##3##(1996-3#1)(1997-1#1)(2009-5#1)(2011-2#1)
multiple organ##8##2##(1996-3#1)(1997-1#1)(2008-1#1)(2009-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
multiple outputs##3##2##(2008-10#3)
multiple pathological##2##2##(2008-12#1)(2013-1#1)
multiple perspectives imaging##2##3##(2008-3#2)
multiple perspectives##4##2##(2008-12#1)(2008-3#2)(2010-12#1)
multiple pituitary hormone##2##3##(2011-1#1)(2013-1#1)
multiple pituitary##3##2##(1996-11#1)(2011-1#1)(2013-1#1)
multiple posterior extension osteotomies##2##4##(2008-8#2)
multiple pregnancies##4##2##(1996-11#1)(2008-11#2)(2010-8#1)
multiple primary melanoma##2##3##(2011-2#2)
multiple proteins##4##2##(2008-4#1)(2009-7#1)(2011-2#2)
multiple putative##2##2##(1997-2#1)(2008-10#1)
multiple reaction monitoring (MRM)##3##4##(2008-10#1)(2011-3#2)
multiple reaction monitoring##5##3##(2008-10#3)(2011-3#2)
multiple reaction##7##2##(2008-10#4)(2008-3#1)(2011-3#2)
multiple reflection##2##2##(2008-10#1)(2008-2#1)
multiple reflections##2##2##(2008-3#2)
multiple regions##2##2##(1992-6#1)(2012-3#1)
multiple regression analyses were##2##4##(2008-4#1)(2010-4#1)
multiple regression analyses##5##3##(1992-2#1)(1994-12#1)(2008-10#1)(2008-4#1)(2010-4#1)
multiple regression analysis##8##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
multiple regression##24##2##(1992-1#1)(1992-2#1)(1992-9#1)(1994-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
multiple regulatory##2##2##(1992-12#1)(2010-7#1)
multiple roles##3##2##(1994-12#1)(2010-5#1)(2013-1#1)
multiple samples##5##2##(2008-10#4)(2008-4#1)
multiple scattering by##2##3##(2008-3#2)
multiple scattering##6##2##(2008-3#6)
multiple sclerosis (MS) patients##2##4##(2010-12#1)(2010-2#1)
multiple sclerosis (MS)##10##3##(1995-12#2)(2008-11#1)(2008-5#1)(2010-12#2)(2010-2#1)(2011-2#1)(2011-7#1)(2012-2#1)
multiple sclerosis and##4##3##(1995-12#1)(1997-8#1)(2010-12#1)(2011-2#1)
multiple sclerosis patients in##2##4##(1996-8#1)(2012-12#1)
multiple sclerosis patients##4##3##(1996-8#2)(2010-2#1)(2012-12#1)
multiple sclerosis##47##2##(1994-9#1)(1995-12#5)(1996-8#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#11)(2010-2#2)(2010-4#1)(2011-2#7)(2011-7#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
multiple sclerosis]##3##2##(1994-12#1)(1996-3#1)(2008-11#1)
multiple sequence alignments##2##3##(2008-4#1)(2010-4#1)
multiple sequence##3##2##(2008-4#2)(2010-4#1)
multiple shoot clumps##5##3##(2008-8#2)(2008-9#3)
multiple signaling##2##2##(2008-9#1)(2009-8#1)
multiple sites of##3##3##(1993-6#1)(2008-7#1)(2012-2#1)
multiple sites##9##2##(1993-6#1)(1995-11#1)(2008-10#5)(2008-7#1)(2012-2#1)
multiple solenoid##2##2##(2008-10#2)
multiple solutions##2##2##(2008-10#1)(2008-3#1)
multiple sources of##2##3##(2010-1#1)(2011-3#1)
multiple sources##6##2##(2008-10#1)(2009-8#1)(2010-1#1)(2010-11#2)(2011-3#1)
multiple sperm##2##2##(2007-12#1)(2008-8#1)
multiple square##2##2##(2008-10#2)
multiple stages##2##2##(1992-12#1)(2008-10#1)
multiple standard##2##2##(2008-10#1)(2013-8#1)
multiple steps##2##2##(2009-12#1)(2009-3#1)
multiple strains of##2##3##(2008-10#2)
multiple studies##3##2##(2008-4#1)(2008-6#1)(2012-12#1)
multiple subcutaneous##2##2##(1990-2#1)(2008-7#1)
multiple system atrophy##5##3##(2008-7#4)(2009-11#1)
multiple systems##2##2##(2008-5#2)
multiple tactics##2##2##(2008-10#2)
multiple targets##5##2##(2008-10#1)(2009-12#1)(2010-5#1)(2011-2#1)(2011-3#1)
multiple times##2##2##(2008-9#2)
multiple trials##2##2##(1994-2#1)(2008-12#1)
multiple types of##3##3##(2008-11#1)(2010-8#1)(2012-2#1)
multiple unit##2##2##(2008-4#2)
multiple ways##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
multiple##923##1##(1990-2#3)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#3)(1992-1#1)(1992-10#3)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#3)(1993-12#5)(1993-2#7)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#5)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#8)(1996-5#1)(1996-8#2)(1997-1#4)(1997-2#1)(1997-3#8)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#4)(2006-6#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#201)(2008-11#49)(2008-12#10)(2008-2#3)(2008-3#26)(2008-4#17)(2008-5#27)(2008-6#7)(2008-7#26)(2008-8#35)(2008-9#42)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#6)(2010-10#7)(2010-11#7)(2010-12#19)(2010-2#3)(2010-4#8)(2010-5#4)(2010-6#5)(2010-7#8)(2010-8#7)(2010-9#3)(2011-1#8)(2011-2#60)(2011-3#5)(2011-7#2)(2012-12#13)(2012-2#24)(2012-3#34)(2012-4#1)(2013-1#34)(2013-8#15)
multiple-choice questions##5##2##(1991-2#1)(2008-11#2)(2008-12#2)
multiple-choice##7##1##(1991-2#1)(1997-3#1)(2008-11#2)(2008-12#2)(2010-8#1)
multiple-component intervention##2##2##(2008-8#2)
multiple-component##4##1##(1995-6#1)(2008-7#1)(2008-8#2)
multiple-eyespot##2##1##(2012-3#2)
multiple-pass cell based on the use of##2##7##(2008-3#2)
multiple-pass cell##3##2##(2008-3#3)
multiple-pass##4##1##(2007-12#1)(2008-3#3)
multiple-pulse##4##1##(2008-3#4)
multiple-return-pass##2##1##(2008-3#2)
multiple-scattering##5##1##(2008-2#2)(2008-3#3)
multiple-stage MS(n)##2##2##(2011-2#2)
multiple-stage mass##2##2##(2008-10#1)(2011-2#1)
multiple-stage##5##1##(2008-10#1)(2008-12#1)(2011-2#3)
multiple-step##3##1##(2008-10#2)(2008-8#1)
multiple-use##2##1##(2008-10#2)
multiples of the##2##3##(1993-2#1)(1996-1#1)
multiples of##4##2##(1992-3#1)(1993-2#1)(1996-1#1)(2008-9#1)
multiples##7##1##(1992-3#1)(1993-2#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-9#1)
multiplex PCR##12##2##(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
multiplex RT-PCR##6##2##(2008-10#3)(2008-9#1)(2011-2#1)(2013-8#1)
multiplex assay##3##2##(2008-10#2)(2008-12#1)
multiplex nested##2##2##(2008-10#2)
multiplex polymerase chain reaction assays##2##5##(2008-10#2)
multiplex polymerase chain reaction##3##4##(2008-10#2)(2013-1#1)
multiplex reaction##2##2##(1995-11#1)(2008-10#1)
multiplex real-time polymerase chain reaction (PCR)##2##6##(2008-10#2)
multiplex real-time##4##2##(2008-10#4)
multiplex reverse transcription-polymerase chain reaction##2##5##(2008-10#2)
multiplex with##2##2##(2008-10#1)(2012-3#1)
multiplex##55##1##(1995-11#1)(2008-10#34)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#5)(2009-5#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
multiplexed##21##1##(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#4)(2008-9#6)(2009-10#1)(2010-11#1)(2010-12#1)
multiplexing##9##1##(2007-12#2)(2008-3#4)(2009-10#1)(2012-2#2)
multiplication and##4##2##(2008-10#4)
multiplication of the pathogen##2##4##(2008-10#2)
multiplication of##7##2##(2008-10#5)(2010-11#1)(2012-12#1)
multiplication was##3##2##(2008-10#1)(2008-11#2)
multiplication##28##1##(2008-10#19)(2008-11#3)(2008-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
multiplicative model##2##2##(1996-3#2)
multiplicative##8##1##(1990-8#1)(1994-9#1)(1996-3#3)(2008-10#1)(2008-11#1)(2008-8#1)
multiplicities of##2##2##(1997-3#1)(2008-11#1)
multiplicity of infection (MOI)##3##4##(2008-11#3)
multiplicity of infection##7##3##(1995-12#1)(1997-3#1)(2008-11#5)
multiplicity of##17##2##(1990-8#1)(1993-2#1)(1993-8#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-11#8)(2008-9#1)(2010-9#1)(2012-2#1)
multiplicity##22##1##(1990-8#1)(1993-2#1)(1993-8#1)(1994-5#2)(1995-12#1)(1997-3#1)(1997-8#2)(2008-11#8)(2008-9#2)(2010-9#1)(2011-2#1)(2012-2#1)
multiplied by the##2##3##(2008-3#1)(2012-2#1)
multiplied by##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)
multiplied in##2##2##(2008-10#2)
multiplied##16##1##(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#2)
multiply in##5##2##(1995-2#1)(2008-10#3)(2013-8#1)
multiply##13##1##(1990-12#1)(1995-2#1)(2008-10#7)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
multiplying##4##1##(2008-10#1)(2008-11#2)(2010-5#1)
multipoint##3##1##(2008-2#1)(2008-3#2)
multipolar##4##1##(1991-7#1)(1994-11#1)(1994-2#1)(2007-11#1)
multiporous##2##1##(2007-12#1)(2008-7#1)
multiport##3##1##(2008-3#1)(2012-12#2)
multiposition##3##1##(2008-10#3)
multipotent##6##1##(1995-6#1)(2008-11#1)(2008-9#3)(2012-4#1)
multipotential##4##1##(1993-3#1)(2008-7#2)(2010-10#1)
multiprobe##2##1##(2008-11#1)(2008-4#1)
multiprofessional##3##1##(1997-8#1)(2009-10#1)(2012-3#1)
multiprotein complex##3##2##(1993-12#1)(2010-5#1)(2012-2#1)
multiprotein##4##1##(1992-6#1)(1993-12#1)(2010-5#1)(2012-2#1)
multipurpose##5##1##(1993-12#1)(1997-3#1)(2008-10#2)(2008-9#1)
multiresistant##3##1##(2009-6#1)(2012-3#2)
multiresolution analysis##2##2##(2008-10#2)
multiresolution histogram##4##2##(2008-6#4)
multiresolution##8##1##(2008-10#3)(2008-6#5)
multiscale##4##1##(2009-7#1)(2013-1#3)
multisensor array##2##2##(2008-10#2)
multisensor system##4##2##(2008-10#4)
multisensor systems like an &quot##2##5##(2008-10#2)
multisensor systems##3##2##(2008-10#3)
multisensor##15##1##(2008-10#15)
multislice##3##1##(2008-2#1)(2009-8#1)(2011-2#1)
multispecialty group##4##2##(1996-1#3)(2008-11#1)
multispecialty##6##1##(1995-2#1)(1996-1#3)(2008-11#2)
multispecies##3##1##(2008-8#2)(2008-9#1)
multispecific##2##1##(2008-11#1)(2012-2#1)
multispectral radiometry##2##2##(2008-10#2)
multispectral scanners##3##2##(2008-10#2)(2008-3#1)
multispectral##11##1##(2008-10#5)(2008-2#2)(2008-3#4)
multistage process for the##2##4##(2013-1#2)
multistage process##3##2##(2013-1#3)
multistage ultrafiltration##2##2##(2008-10#2)
multistage ultramarathon competition##2##3##(2013-8#2)
multistage ultramarathon##3##2##(2013-8#3)
multistage##13##1##(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#2)(2013-1#4)(2013-8#3)
multistate life##2##2##(2011-2#2)
multistate##5##1##(1995-12#1)(2011-2#4)
multistep process##3##2##(1995-9#1)(2008-10#1)(2008-12#1)
multistep##13##1##(1995-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2010-10#2)(2010-11#1)(2011-2#1)
multisubunit##3##1##(1991-2#2)(2010-7#1)
multisyringe flow injection analysis (MSFIA)##2##5##(2008-10#2)
multisyringe flow injection analysis##3##4##(2008-10#3)
multisyringe flow injection system##3##4##(2008-10#3)
multisyringe flow injection##10##3##(2008-10#10)
multisyringe flow##11##2##(2008-10#11)
multisyringe##16##1##(2008-10#16)
multisystem disease##4##2##(1997-8#1)(2012-3#3)
multisystem disorder##4##2##(1993-12#1)(2008-9#1)(2012-3#2)
multisystem##13##1##(1993-12#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#5)
multisystemic disease##2##2##(1990-2#1)(2011-2#1)
multisystemic##3##1##(1990-2#1)(2010-6#1)(2011-2#1)
multitarget##2##1##(2008-9#1)(2013-1#1)
multitemporal synthetic aperture radar##2##4##(2008-3#2)
multitrophic##5##1##(2008-8#1)(2008-9#4)
multitude of##13##2##(1992-12#1)(1992-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
multitude##14##1##(1992-12#1)(1992-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
multivalent##4##1##(1995-5#2)(2008-11#1)(2008-4#1)
multivariable linear##2##2##(2008-10#2)
multivariable logistic regression##4##3##(2013-1#3)(2013-8#1)
multivariable model##2##2##(2013-8#2)
multivariable##10##1##(2008-10#4)(2013-1#3)(2013-8#3)
multivariate Shewhart##3##2##(2008-10#3)
multivariate analyses##11##2##(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
multivariate analysis of##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
multivariate analysis were##3##3##(1991-8#1)(2012-3#1)(2013-1#1)
multivariate analysis##28##2##(1990-8#1)(1991-8#2)(1993-1#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(2008-10#9)(2008-7#2)(2011-2#1)(2012-3#3)(2012-5#1)(2013-1#4)
multivariate analytical##2##2##(2008-10#2)
multivariate approach##2##2##(2008-10#2)
multivariate calibration in the##2##4##(2008-10#2)
multivariate calibration in##5##3##(2008-10#5)
multivariate calibration method##3##3##(2008-10#3)
multivariate calibration methods to##2##4##(2008-10#2)
multivariate calibration methods##13##3##(2008-10#13)
multivariate calibration model##3##3##(2008-10#3)
multivariate calibration to##2##3##(2008-10#2)
multivariate calibration with##2##3##(2008-10#2)
multivariate calibration##61##2##(2008-10#61)
multivariate chemical##2##2##(2008-11#1)(2010-7#1)
multivariate classification of##2##3##(2008-10#2)
multivariate classification##5##2##(1991-3#1)(2008-10#4)
multivariate control charts##5##3##(2008-10#5)
multivariate correlation##2##2##(2009-4#1)(2009-8#1)
multivariate curve##2##2##(2008-10#2)
multivariate data analysis##3##3##(2008-10#3)
multivariate data##4##2##(2008-10#3)(2008-6#1)
multivariate dependent##2##2##(2008-8#1)(2010-1#1)
multivariate experimental design##2##3##(2008-10#2)
multivariate logistic regression analysis of##2##5##(2012-3#2)
multivariate logistic regression##4##3##(2010-12#1)(2011-2#1)(2012-3#2)
multivariate logistic##5##2##(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
multivariate methods##8##2##(2008-10#6)(2008-11#2)
multivariate model##2##2##(1993-12#1)(1996-12#1)
multivariate nominal##2##2##(2009-12#1)(2009-4#1)
multivariate optimization of the main variables##2##6##(2008-10#2)
multivariate optimization of##3##3##(2008-10#3)
multivariate optimization##4##2##(2008-10#4)
multivariate partial least squares (PLS)##2##5##(2008-10#2)
multivariate prediction of##2##3##(2008-10#1)(2008-7#1)
multivariate prediction##3##2##(2008-10#2)(2008-7#1)
multivariate regression##4##2##(1991-1#1)(2008-10#3)
multivariate spectrophotometric calibration##4##3##(2008-10#4)
multivariate statistical analysis##2##3##(2008-11#1)(2012-3#1)
multivariate statistical methods##2##3##(2008-10#2)
multivariate statistical tools##2##3##(2008-10#1)(2010-8#1)
multivariate statistical##10##2##(2008-10#7)(2008-11#1)(2010-8#1)(2012-3#1)
multivariate statistics##2##2##(2008-10#2)
multivariate technique##2##2##(2008-10#1)(2013-1#1)
multivariate techniques##3##2##(2008-10#2)(2008-3#1)
multivariate##219##1##(1990-8#1)(1991-1#1)(1991-3#2)(1991-8#2)(1992-1#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-12#1)(2008-10#150)(2008-11#5)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#2)(2009-4#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#7)(2012-5#1)(2013-1#8)(2013-8#2)
multivesicular##2##1##(2008-10#1)(2008-6#1)
multivessel##4##1##(2008-10#2)(2008-11#1)(2011-2#1)
multiview panoramic##3##2##(2008-6#3)
multiview##4##1##(2008-6#4)
multivitamin##6##1##(2008-10#4)(2009-9#2)
multivora is##2##2##(2010-3#2)
multivora##4##1##(2010-3#4)
multivorans##3##1##(2011-1#3)
multiwall carbon nanotubes##7##3##(2008-10#6)(2011-2#1)
multiwall carbon##9##2##(2008-10#7)(2009-11#1)(2011-2#1)
multiwall##10##1##(2008-10#7)(2009-11#2)(2011-2#1)
multiwalled carbon nanotubes as the##2##5##(2008-10#2)
multiwalled carbon nanotubes as##3##4##(2008-10#3)
multiwalled carbon nanotubes##5##3##(2008-10#4)(2009-3#1)
multiwalled##6##1##(2008-10#4)(2008-7#1)(2009-3#1)
multiwaveform##4##1##(2013-1#4)
multiwavelength spectrophotometric##2##2##(2008-10#2)
multiwavelength##16##1##(2007-12#1)(2008-10#10)(2008-3#5)
multocida##9##1##(2008-5#7)(2011-2#1)(2012-2#1)
mum and a##6##3##(2008-10#3)(2008-3#3)
mum and the##2##3##(2008-10#1)(2008-5#1)
mum and##19##2##(1993-2#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#8)(2008-5#1)
mum by##3##2##(2008-10#1)(2008-3#2)
mum channel##2##2##(2008-10#2)
mum diameter##2##2##(2008-10#2)
mum for the##2##3##(1993-2#1)(2008-3#1)
mum for##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
mum has been##2##3##(2008-10#1)(2008-3#1)
mum i##4##2##(2008-10#4)
mum in diameter##3##3##(2008-11#2)(2008-5#1)
mum in diameter)##4##3##(2008-10#2)(2008-5#2)
mum in##11##2##(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)
mum liquid core microcapsules##3##4##(2008-11#3)
mum long##5##2##(2008-7#4)(2008-8#1)
mum of##2##2##(2008-10#1)(2008-11#1)
mum pore diameter)##2##3##(2008-11#2)
mum pore##5##2##(2008-11#5)
mum thickness##2##2##(2008-10#2)
mum was used as a##2##5##(2008-3#2)
mum was##3##2##(2008-11#1)(2008-3#2)
mum wide##3##2##(2008-3#2)(2008-8#1)
mum with##2##2##(2008-3#2)
mum##173##1##(1992-1#1)(1992-2#8)(1993-2#4)(2007-11#1)(2007-12#3)(2008-10#50)(2008-11#23)(2008-2#6)(2008-3#51)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#2)(2009-5#4)(2009-8#3)
mum(2)##2##1##(2008-10#2)
mum) were##3##2##(2008-10#2)(2009-8#1)
mum)##21##1##(1991-2#3)(1992-2#2)(2008-10#13)(2008-3#1)(2008-5#1)(2009-8#1)
mummies in the##2##3##(2008-10#2)
mummies##6##1##(1992-2#1)(2008-10#5)
mummified##2##1##(2008-10#2)
mummy berry disease##3##3##(2008-10#3)
mummy berry##4##2##(2008-10#4)
mummy##6##1##(1991-2#1)(1995-3#1)(2008-10#4)
mumol dm(-3)##3##2##(2008-10#3)
mumol for 2-mercapto-4-methylpyrimidine (II)##2##4##(2008-10#2)
mumol for 4##3##3##(2008-10#3)
mumol for##7##2##(2008-10#7)
mumol g(-1) and##2##3##(2008-10#2)
mumol g(-1) for##2##3##(2008-10#2)
mumol g(-1)##5##2##(2008-10#5)
mumol l(-1) and##3##3##(2008-10#3)
mumol l(-1) dipyrone##2##3##(2008-10#2)
mumol l(-1) for##5##3##(2008-10#5)
mumol l(-1) of##3##3##(2008-10#3)
mumol l(-1) with a detection limit of 0##2##8##(2008-10#2)
mumol l(-1) with a detection limit of##3##7##(2008-10#3)
mumol l(-1) with a##4##4##(2008-10#4)
mumol l(-1)##28##2##(2008-10#28)
mumol m(-2) s(-1)##3##3##(2008-10#3)
mumol ml(-1)##3##2##(2008-10#3)
mumol mol(-1) creatinine##2##3##(2008-10#2)
mumol mol(-1)##3##2##(2008-10#3)
mumol of##5##2##(2008-10#5)
mumol##68##1##(1992-3#1)(1993-12#1)(1994-11#1)(1994-5#1)(2008-10#63)(2008-9#1)
mumol/L [Ca(2+)](o)##2##2##(2008-8#2)
mumol/L riboflavin##3##2##(2008-9#3)
mumol/L##10##1##(2007-12#2)(2008-8#3)(2008-9#5)
mumol/L) or##2##2##(2008-8#2)
mumol/L)##8##1##(2008-8#7)(2008-9#1)
mumol/kg##4##1##(1993-12#4)
mumol/kg)##2##1##(1996-12#2)
mumol/l (median =##2##3##(1991-2#2)
mumol/l for##5##2##(1992-3#2)(1994-6#3)
mumol/l##14##1##(1991-12#1)(1991-2#2)(1992-3#3)(1994-6#5)(2008-10#2)(2009-8#1)
mumol/l) and##3##2##(1992-3#2)(2008-11#1)
mumol/l)##6##1##(1992-3#3)(1994-6#1)(2008-10#1)(2008-11#1)
mumol/ml for##2##2##(2008-10#2)
mumol/ml##3##1##(2008-10#3)
mumoles##2##1##(1993-8#1)(2008-10#1)
mumoll(-1)##2##1##(2008-10#2)
mumoll(-1))##4##1##(2008-10#4)
mumps##2##1##(1992-5#1)(1995-3#1)
mung bean##6##2##(2008-10#2)(2008-11#1)(2008-9#3)
municipal##14##1##(1991-12#1)(1991-6#2)(1995-9#1)(2008-10#6)(2008-11#1)(2010-1#1)(2010-8#2)
municipalities of the##3##3##(1991-6#1)(1992-2#1)(2012-12#1)
municipalities of##5##2##(1991-6#1)(1992-2#1)(1993-2#1)(2012-12#2)
municipalities##27##1##(1990-2#1)(1991-6#2)(1992-2#1)(1993-2#1)(1994-6#4)(1996-6#1)(2012-12#12)(2013-8#5)
municipality of##6##2##(1991-9#1)(1997-4#1)(2008-12#1)(2012-12#3)
municipality##15##1##(1990-11#1)(1991-6#1)(1991-9#1)(1996-11#1)(1997-4#1)(2008-12#1)(2011-2#1)(2012-12#7)(2012-3#1)
mural nodule##2##2##(1992-2#1)(2008-12#1)
mural##9##1##(1992-2#1)(1992-9#1)(1996-9#1)(1997-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
murale##2##1##(2013-1#2)
muramic acid##2##2##(1996-12#2)
muramyl dipeptide##2##2##(1995-5#1)(2008-11#1)
muramyl dipeptides##2##2##(2008-11#1)(2009-8#1)
muramyl##4##1##(1995-5#1)(2008-11#2)(2009-8#1)
murdochii##3##1##(2011-2#3)
murexide##7##1##(2008-10#7)
murine B##2##2##(2008-11#1)(2008-4#1)
murine IL-10##5##2##(1993-8#5)
murine alpha##2##2##(1996-12#1)(1997-1#1)
murine and human melanoma cell##2##5##(1992-2#2)
murine and human##9##3##(1992-2#2)(1994-5#1)(1995-11#1)(1995-2#1)(2008-4#3)(2010-6#1)
murine and##10##2##(1992-2#3)(1994-5#1)(1995-11#1)(1995-2#1)(2008-4#3)(2010-6#1)
murine bone marrow##2##3##(2008-11#1)(2008-8#1)
murine bone##3##2##(2008-11#2)(2008-8#1)
murine brain##2##2##(2008-7#1)(2012-2#1)
murine cell line##2##3##(1992-3#1)(2008-11#1)
murine cyclin D2##2##3##(1997-8#2)
murine embryonic fibroblasts##2##3##(1997-1#1)(2008-4#1)
murine embryonic stem cells##2##4##(2008-10#1)(2008-11#1)
murine embryonic stem##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
murine embryonic##6##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)
murine gene encoding##2##3##(1993-6#2)
murine hematopoietic stem cells##4##4##(1993-2#2)(1994-5#1)(2008-9#1)
murine hybridoma cell line##2##4##(2008-10#1)(2008-11#1)
murine hybridoma cell##4##3##(2008-10#1)(2008-11#3)
murine hybridoma cells##3##3##(2008-11#3)
murine hybridoma##12##2##(2008-10#1)(2008-11#11)
murine insulinoma##2##2##(2008-11#2)
murine interferon##2##2##(1997-1#2)
murine intestinal##2##2##(2008-11#2)
murine leukemia virus##3##3##(1990-8#1)(1997-8#1)(2008-11#1)
murine macrophages##4##2##(1990-8#2)(1994-6#1)(1994-8#1)
murine mammary##2##2##(1990-8#1)(2008-11#1)
murine model of retroviral encephalopathy##2##5##(2008-4#2)
murine model of##8##3##(2008-4#2)(2010-6#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
murine model systems##2##3##(2008-11#1)(2008-9#1)
murine model##14##2##(2008-11#2)(2008-4#3)(2008-9#1)(2010-6#1)(2010-8#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
murine models##7##2##(1995-5#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
murine monoclonal antibodies##4##3##(1996-12#1)(2006-6#1)(2008-10#2)
murine mu opioid receptor##2##4##(1995-6#2)
murine myeloma##2##2##(1995-8#1)(2008-11#1)
murine peritoneal##2##2##(2008-8#1)(2008-9#1)
murine producer cell##2##3##(2008-11#2)
murine thymocytes##2##2##(2008-9#2)
murine##210##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#5)(1991-5#1)(1991-6#1)(1992-2#7)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-3#5)(1993-6#3)(1993-8#7)(1994-11#5)(1994-5#4)(1994-6#2)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#5)(1995-5#2)(1995-6#6)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#2)(1997-1#4)(1997-7#6)(1997-8#6)(2006-6#1)(2008-10#11)(2008-11#42)(2008-4#15)(2008-5#2)(2008-7#2)(2008-8#9)(2008-9#10)(2010-11#2)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-2#6)(2013-1#5)(2013-7#1)(2013-8#3)
muris##4##1##(2012-2#1)(2013-1#3)
murismusculi##2##1##(2007-12#2)
musayevi##2##1##(2012-2#2)
muscarinic K+##2##2##(1996-2#2)
muscarinic and##2##2##(1990-9#1)(1995-11#1)
muscarinic receptor##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
muscarinic receptors can##2##3##(1995-11#1)(1996-12#1)
muscarinic receptors in the CNS##2##5##(1992-10#2)
muscarinic receptors in##3##3##(1992-10#2)(1995-11#1)
muscarinic receptors##12##2##(1992-10#2)(1995-11#4)(1996-12#2)(2008-10#1)(2008-11#1)(2010-4#2)
muscarinic##27##1##(1990-9#1)(1992-10#3)(1995-11#8)(1996-12#4)(1996-2#3)(2008-10#2)(2008-11#2)(2008-9#1)(2010-4#2)(2012-3#1)
muscle (n =##2##3##(2010-9#2)
muscle (n##3##2##(2010-9#3)
muscle actin##8##2##(1994-12#1)(2008-11#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
muscle activity in##2##3##(2010-7#2)
muscle activity##6##2##(1997-2#1)(2008-7#1)(2010-7#2)(2010-8#1)(2011-2#1)
muscle afferents##4##2##(1997-2#4)
muscle after##2##2##(2008-10#1)(2008-8#1)
muscle and the##3##3##(1996-2#1)(2010-4#1)(2010-6#1)
muscle and##28##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-8#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
muscle are##3##2##(1994-8#2)(2010-1#1)
muscle atrophy##3##2##(2008-7#1)(2011-2#2)
muscle atypical protein kinase C##2##5##(2008-3#2)
muscle biopsies##2##2##(2008-3#1)(2008-7#1)
muscle biopsy##4##2##(1997-3#1)(2008-7#2)(2013-8#1)
muscle bulk##2##2##(2008-9#1)(2012-2#1)
muscle by##8##2##(1990-8#1)(1992-6#1)(1993-6#1)(1994-11#1)(1997-8#2)(2008-10#1)(2008-4#1)
muscle cell##10##2##(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-12#1)
muscle cells and##6##3##(1990-2#2)(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#1)
muscle cells to##2##3##(2008-10#1)(2008-11#1)
muscle cells##74##2##(1990-12#2)(1990-2#3)(1990-5#2)(1990-8#5)(1991-5#1)(1992-8#3)(1992-9#1)(1993-2#1)(1993-3#2)(1994-11#8)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#7)(1997-1#2)(1997-4#1)(1997-7#2)(2006-6#2)(2008-1#1)(2008-10#9)(2008-11#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-7#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-8#1)
muscle contraction##6##2##(1991-5#1)(1992-3#1)(1994-8#1)(2011-2#2)(2013-1#1)
muscle contractions##2##2##(2009-11#1)(2010-1#1)
muscle diseases##2##2##(1990-9#1)(2013-1#1)
muscle during##3##2##(1991-2#2)(2010-8#1)
muscle energy##3##2##(2013-1#3)
muscle fatigue##2##2##(1991-6#1)(2010-8#1)
muscle fibers##12##2##(1995-12#1)(1995-6#1)(2008-7#1)(2009-8#1)(2010-1#3)(2010-12#2)(2010-5#1)(2011-2#2)
muscle fibre##2##2##(1995-12#1)(2010-4#1)
muscle fibres##6##2##(1996-2#2)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
muscle flap##2##2##(2008-7#1)(2010-11#1)
muscle from##2##2##(2008-11#1)(2011-2#1)
muscle function##5##2##(1991-6#1)(2010-8#1)(2010-9#1)(2013-1#2)
muscle glycogen##2##2##(2013-1#1)(2013-8#1)
muscle group##3##2##(2010-3#1)(2010-7#2)
muscle growth##3##2##(2010-4#1)(2012-12#2)
muscle in this##2##3##(2012-2#1)(2013-1#1)
muscle in##11##2##(1995-12#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#2)
muscle is not##2##3##(1991-9#1)(1994-8#1)
muscle is##10##2##(1990-8#1)(1991-9#1)(1993-11#1)(1994-8#1)(1995-8#1)(2008-1#3)(2008-7#1)(2012-2#1)
muscle mass##3##2##(2008-7#1)(2010-6#1)(2011-2#1)
muscle microsomes##2##2##(1991-6#2)
muscle myosin light##3##3##(1993-8#2)(1993-9#1)
muscle myosin##8##2##(1993-6#1)(1993-8#2)(1993-9#2)(1995-12#3)
muscle of rats##2##3##(2008-8#1)(2012-3#1)
muscle of the##6##3##(1990-2#1)(1996-6#2)(1997-4#3)
muscle of##19##2##(1990-2#1)(1993-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-6#2)(1997-4#4)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2012-3#2)
muscle pain##3##2##(1997-4#2)(2013-8#1)
muscle performance##2##2##(2013-1#2)
muscle phosphoglucomutase##2##2##(1992-4#2)
muscle precursors##2##2##(2008-11#2)
muscle proteins##2##2##(2008-9#1)(2010-4#1)
muscle regeneration by##2##3##(1995-12#2)
muscle regeneration##3##2##(1995-12#3)
muscle relaxant##5##2##(1992-3#2)(1996-2#2)(1997-4#1)
muscle relaxation##4##2##(1992-6#2)(1993-6#1)(2012-3#1)
muscle specific##2##2##(1997-8#1)(2010-7#1)
muscle strength and##4##3##(2009-1#1)(2009-3#1)(2012-2#1)(2012-3#1)
muscle strength as measured##2##4##(2008-12#1)(2013-1#1)
muscle strength in##3##3##(2009-3#1)(2011-2#2)
muscle strength##18##2##(2008-12#2)(2009-1#1)(2009-3#3)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)
muscle tension##6##2##(1994-6#1)(2009-3#1)(2010-12#3)(2013-1#1)
muscle that##2##2##(2008-11#1)(2008-9#1)
muscle tissue##6##2##(1995-2#1)(2008-10#2)(2008-12#1)(2010-4#1)(2012-2#1)
muscle to##3##2##(1990-8#1)(1995-8#1)(2010-6#1)
muscle tone of injecting##2##4##(1995-2#2)
muscle tone##11##2##(1995-2#9)(2008-12#2)
muscle toxicity##2##2##(2013-1#2)
muscle tumors of##2##3##(1994-6#2)
muscle tumours##2##2##(2008-12#2)
muscle was##6##2##(2008-10#2)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
muscle wasting##2##2##(1994-9#1)(1997-3#1)
muscle weakness##11##2##(1990-9#1)(1991-12#2)(1997-8#1)(2008-12#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
muscle were##2##2##(1990-9#1)(2008-8#1)
muscle when##2##2##(1991-5#1)(1994-11#1)
muscle with##6##2##(1996-2#1)(2008-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
muscle##650##1##(1990-12#3)(1990-2#6)(1990-3#1)(1990-5#8)(1990-8#10)(1990-9#4)(1991-12#4)(1991-2#3)(1991-5#8)(1991-6#11)(1991-8#1)(1991-9#3)(1992-12#2)(1992-3#6)(1992-4#2)(1992-6#5)(1992-8#4)(1992-9#8)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#6)(1993-9#3)(1994-11#15)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#7)(1994-9#1)(1995-11#2)(1995-12#17)(1995-2#22)(1995-3#1)(1995-6#2)(1995-8#5)(1996-1#2)(1996-12#4)(1996-2#13)(1996-6#2)(1997-1#4)(1997-2#7)(1997-3#7)(1997-4#10)(1997-7#2)(1997-8#6)(1997-9#1)(2006-6#2)(2008-1#11)(2008-10#32)(2008-11#38)(2008-12#19)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#5)(2008-7#19)(2008-8#14)(2008-9#27)(2009-1#4)(2009-11#1)(2009-2#1)(2009-3#11)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#5)(2010-11#1)(2010-12#15)(2010-3#1)(2010-4#8)(2010-5#2)(2010-6#8)(2010-7#8)(2010-8#6)(2010-9#10)(2011-2#42)(2011-3#2)(2012-12#3)(2012-2#18)(2012-3#13)(2013-1#37)(2013-7#1)(2013-8#18)
muscle)##5##1##(2008-10#4)(2011-2#1)
muscle-specific expression of##2##3##(2008-8#2)
muscle-specific expression##3##2##(1995-2#1)(2008-8#2)
muscle-specific##10##1##(1993-12#1)(1993-8#3)(1995-2#3)(1995-6#1)(2008-8#2)
muscles and other##2##3##(2008-7#1)(2012-3#1)
muscles and the##2##3##(1996-6#1)(2013-1#1)
muscles and##14##2##(1991-6#1)(1994-5#1)(1996-6#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
muscles are##2##2##(1990-8#1)(2013-8#1)
muscles during##2##2##(1995-8#1)(2010-6#1)
muscles have##2##2##(2012-2#2)
muscles in a##2##3##(2008-9#1)(2012-12#1)
muscles in the##2##3##(2008-9#2)
muscles in##8##2##(2008-10#1)(2008-6#1)(2008-9#3)(2010-9#1)(2012-12#1)(2012-2#1)
muscles may##2##2##(2012-2#1)(2013-8#1)
muscles of the##4##3##(1995-8#1)(2007-12#1)(2010-9#1)(2013-8#1)
muscles of##10##2##(1995-2#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
muscles was##2##2##(2009-3#1)(2013-8#1)
muscles were##6##2##(1995-12#1)(2009-3#1)(2010-4#1)(2010-9#2)(2011-2#1)
muscles##136##1##(1990-2#1)(1990-5#2)(1990-8#3)(1991-2#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-11#3)(1994-2#3)(1994-5#1)(1995-12#5)(1995-2#4)(1995-8#6)(1996-6#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-1#4)(2009-11#1)(2009-3#6)(2010-4#6)(2010-6#2)(2010-8#1)(2010-9#11)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#12)(2012-3#3)(2013-1#4)(2013-8#6)
muscovy duckling liver##2##3##(1997-1#2)
muscovy duckling##3##2##(1997-1#3)
muscular (patho)physiology##2##2##(2012-2#2)
muscular activity##4##2##(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)
muscular disorders##2##2##(1990-9#1)(2012-2#1)
muscular dystrophy##11##2##(1993-3#1)(1995-12#1)(1996-8#1)(1997-3#3)(2011-2#4)(2012-3#1)
muscular fibers##2##2##(2013-1#2)
muscular force##2##2##(2013-1#2)
muscular##57##1##(1990-3#1)(1990-9#1)(1992-12#1)(1993-3#2)(1993-8#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-3#3)(1997-5#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-9#1)(2010-3#1)(2011-2#7)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#6)
musculature##8##1##(1997-6#1)(2007-12#1)(2009-8#1)(2011-2#2)(2012-2#3)
musculoskeletal disorders##3##2##(1990-9#1)(2009-12#1)(2012-2#1)
musculoskeletal injuries in##3##3##(2013-1#3)
musculoskeletal injuries##6##2##(2008-12#1)(2013-1#5)
musculoskeletal injury##4##2##(2013-1#4)
musculoskeletal pain and##3##3##(2008-12#2)(2013-1#1)
musculoskeletal pain##4##2##(1997-4#1)(2008-12#2)(2013-1#1)
musculoskeletal system diseases##2##3##(2013-1#2)
musculoskeletal system##4##2##(2010-9#1)(2012-3#1)(2013-1#2)
musculoskeletal##31##1##(1990-9#1)(1997-4#1)(2008-12#6)(2008-7#1)(2008-8#2)(2009-12#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#13)
musculus flexor digitorum##2##3##(2008-5#2)
musculus##3##1##(2008-5#2)(2008-9#1)
mushroom (Agaricus bisporus) tissue##2##4##(2008-10#2)
mushroom (Agaricus bisporus)##3##3##(2008-10#3)
mushroom Thelephora ganbajun##2##3##(2008-11#2)
mushroom compost##2##2##(2008-10#2)
mushroom farms##2##2##(2008-10#2)
mushroom was##2##2##(2008-10#2)
mushroom##28##1##(2008-10#22)(2008-11#2)(2008-5#1)(2010-11#1)(2010-3#2)
mushrooms##6##1##(1991-11#1)(2008-10#1)(2008-5#3)(2012-3#1)
music after##4##2##(2008-9#4)
music appreciation##2##2##(2008-9#2)
music in##2##2##(2008-9#2)
music stimulation##3##2##(1991-12#3)
music therapists##4##2##(1991-12#3)(1993-2#1)
music therapy##5##2##(1991-12#1)(1993-2#4)
music##47##1##(1991-12#11)(1993-2#5)(1997-6#1)(2008-11#3)(2008-9#19)(2011-2#1)(2013-1#3)(2013-8#4)
musical cues##3##2##(2013-8#3)
musical instruments##5##2##(2008-9#4)(2012-12#1)
musical##21##1##(2008-11#3)(2008-9#4)(2012-12#3)(2013-1#5)(2013-8#6)
musicola in Australia##2##3##(2008-10#2)
musicola##7##1##(2008-10#7)
musk##2##1##(2008-5#1)(2009-3#1)
muskmelon cultivars##2##2##(2008-10#2)
muskmelon seedlings##2##2##(2008-10#2)
muskmelon##8##1##(2008-10#8)
mussel samples##2##2##(2008-10#2)
mussel soft tissue by##2##4##(2008-10#2)
mussel tissue##3##2##(2008-10#3)
mussel tissues##2##2##(2008-10#2)
mussel##20##1##(1990-9#1)(1995-8#1)(2008-10#12)(2008-12#1)(2009-6#2)(2010-8#2)(2013-1#1)
mussel)##2##1##(1995-8#1)(2008-10#1)
mussels##14##1##(2008-10#12)(2008-9#1)(2010-8#1)
must act##2##2##(1997-3#1)(2008-9#1)
must address##2##2##(2009-10#1)(2010-3#1)
must also be considered##3##4##(2008-11#1)(2011-2#2)
must also be##7##3##(1992-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#2)
must also##15##2##(1992-12#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-12#1)(2010-12#2)(2011-2#2)
must always be##2##3##(1997-8#1)(2011-2#1)
must balance##2##2##(1996-1#1)(2013-8#1)
must be a##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
must be added to the##2##5##(2008-10#1)(2008-5#1)
must be addressed##3##3##(1995-2#1)(2008-11#1)(2009-12#1)
must be applied##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
must be assessed##2##3##(1994-2#1)(2011-2#1)
must be aware of##4##4##(1996-12#1)(2008-6#1)(2013-1#1)(2013-8#1)
must be balanced against the##2##5##(1997-3#1)(2008-3#1)
must be based on##3##4##(1991-6#1)(1994-8#1)(1997-1#1)
must be capable of##2##4##(1995-5#1)(2009-8#1)
must be carefully##6##3##(2007-8#1)(2008-11#1)(2008-3#1)(2010-6#1)(2011-2#2)
must be considered as##3##4##(1990-8#1)(2007-12#1)(2008-8#1)
must be considered in the##2##5##(1996-11#1)(2013-8#1)
must be considered in##5##4##(1996-11#1)(1997-2#1)(2008-10#2)(2013-8#1)
must be considered when##6##4##(1994-5#1)(1997-8#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
must be considered##25##3##(1990-8#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
must be controlled##2##3##(2008-12#1)(2011-2#1)
must be coordinated##2##3##(1994-12#1)(1997-3#1)
must be designed##2##3##(1996-2#1)(2008-11#1)
must be determined in##2##4##(2008-10#1)(2012-2#1)
must be developed##5##3##(1993-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-11#1)
must be distinguished from##2##4##(1994-9#1)(2009-3#1)
must be done##5##3##(1997-2#1)(2008-10#1)(2010-7#1)(2010-8#1)(2013-1#1)
must be embolized##2##3##(2008-7#2)
must be engineered##2##3##(2008-11#1)(2012-3#1)
must be evaluated##4##3##(1994-6#1)(2007-11#1)(2008-9#1)(2009-2#1)
must be fitted##2##3##(2008-3#1)(2008-9#1)
must be focused on##2##4##(1992-12#1)(1997-1#1)
must be free##2##3##(1993-8#1)(2012-2#1)
must be given##3##3##(1991-2#1)(1993-2#1)(2008-11#1)
must be improved##2##3##(1990-6#1)(2013-8#1)
must be in place##2##4##(2008-10#1)(2008-11#1)
must be in##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
must be included in the##2##5##(2008-10#1)(2013-8#1)
must be incorporated##2##3##(2008-11#1)(2008-4#1)
must be made##4##3##(1994-5#1)(1997-8#1)(2010-8#1)(2011-2#1)
must be met##3##3##(1991-12#1)(1994-3#1)(2008-11#1)
must be modified##2##3##(2008-10#1)(2008-3#1)
must be more##3##3##(1997-3#1)(2008-11#1)(2008-8#1)
must be overcome before##2##4##(1994-2#1)(2012-3#1)
must be performed in##3##4##(2012-3#1)(2013-1#2)
must be performed##5##3##(1991-6#1)(1996-1#1)(2012-3#1)(2013-1#2)
must be prepared to##2##4##(1991-1#1)(2008-10#1)
must be prepared##6##3##(1991-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
must be realigned##2##3##(1993-3#1)(2009-3#1)
must be removed from##2##4##(2008-10#1)(2008-5#1)
must be replaced##2##3##(1991-3#1)(1996-1#1)
must be responsible for##2##4##(2008-10#2)
must be selected##3##3##(1995-5#1)(2008-10#1)(2010-12#1)
must be similarly##2##3##(1991-3#1)(2007-12#1)
must be sought##2##3##(1995-5#1)(2008-8#1)
must be taken into account in the##2##7##(1995-3#1)(2008-10#1)
must be taken into account##7##5##(1995-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)
must be taken into##8##4##(1991-11#1)(1995-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)
must be taken to##4##4##(1993-12#1)(2008-10#2)(2008-4#1)
must be taken##15##3##(1991-11#1)(1993-12#1)(1995-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-3#1)
must be to##2##3##(1990-5#1)(1997-7#1)
must be transported##2##3##(2008-11#1)(2008-9#1)
must be used in##2##4##(2008-6#1)(2013-1#1)
must be used##6##3##(1997-5#1)(2008-10#3)(2008-6#1)(2013-1#1)
must be viewed as##2##4##(1992-12#1)(2008-11#1)
must be weighed against the##2##5##(1994-6#1)(2013-1#1)
must be##315##2##(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#3)(1991-6#2)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-8#2)(1994-1#1)(1994-12#5)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#6)(1994-8#2)(1994-9#4)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#8)(1996-1#5)(1996-11#3)(1996-12#2)(1996-2#3)(1997-1#2)(1997-2#3)(1997-3#5)(1997-5#5)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#46)(2008-11#24)(2008-12#4)(2008-2#2)(2008-3#9)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#10)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#2)(2009-8#1)(2010-11#3)(2010-12#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#13)(2011-3#4)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#12)(2013-8#10)
must begin to##2##3##(1992-1#1)(2010-12#1)
must change##2##2##(1996-1#1)(1997-2#1)
must conclude that##2##3##(1991-12#1)(2008-10#1)
must consider##5##2##(1993-1#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#1)
must continue##2##2##(1991-12#1)(2008-10#1)
must determine##2##2##(1997-8#1)(2010-3#1)
must first##3##2##(1996-3#1)(2008-10#1)(2009-10#1)
must focus on##4##3##(1993-12#1)(1994-12#1)(1997-3#1)(2008-12#1)
must for the##2##3##(1992-3#1)(1996-11#1)
must for##3##2##(1992-3#1)(1996-11#1)(2008-11#1)
must have a##2##3##(2008-11#1)(2013-8#1)
must have the##3##3##(1993-8#1)(2008-8#1)(2012-3#1)
must have##15##2##(1990-2#1)(1993-8#1)(1994-5#1)(1996-5#1)(1997-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
must include the##2##3##(2008-9#1)(2010-6#1)
must include##5##2##(1991-11#1)(1994-12#1)(2008-9#1)(2010-6#1)(2012-2#1)
must make##4##2##(1994-12#1)(1994-8#1)(1994-9#1)(2008-4#1)
must meet certain##2##3##(1992-5#1)(2009-8#1)
must meet the##2##3##(1995-5#1)(2010-7#1)
must meet##5##2##(1992-5#1)(1993-2#1)(1995-5#1)(2009-8#1)(2010-7#1)
must not be##5##3##(1991-1#1)(1995-9#2)(1997-5#1)(2008-8#1)
must not only##2##3##(1994-5#1)(2008-2#1)
must not##8##2##(1991-1#1)(1991-12#1)(1994-5#1)(1995-9#2)(1997-5#1)(2008-2#1)(2008-8#1)
must now##2##2##(1993-12#1)(2010-12#1)
must occur to##2##3##(2009-10#2)
must occur##6##2##(1991-3#1)(1994-2#1)(1996-9#1)(2008-7#1)(2009-10#2)
must pay##3##2##(1995-2#1)(1996-5#1)(2008-11#1)
must rely on##3##3##(2008-11#2)(2013-1#1)
must take into account##2##4##(2009-12#1)(2011-2#1)
must take into##3##3##(2008-11#1)(2009-12#1)(2011-2#1)
must take responsibility for##2##4##(1995-1#1)(2008-12#1)
must take##7##2##(1993-2#1)(1995-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-12#1)(2011-2#1)
must therefore be##4##3##(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
must therefore##5##2##(1994-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
must undergo a##2##3##(1994-3#1)(1994-5#1)
must undergo##4##2##(1993-6#1)(1994-3#1)(1994-5#1)(2012-3#1)
must understand##3##2##(1993-2#1)(1994-2#1)(1997-1#1)
must use##2##2##(1997-2#1)(2012-2#1)
must we##2##2##(1994-1#1)(2008-11#1)
must work together to##2##4##(1995-1#1)(1996-3#1)
must work together##3##3##(1991-12#1)(1995-1#1)(1996-3#1)
must work##5##2##(1991-12#1)(1995-1#1)(1996-1#1)(1996-3#1)(2010-10#1)
must##553##1##(1990-2#1)(1990-5#2)(1990-6#4)(1990-8#1)(1991-1#3)(1991-11#5)(1991-12#6)(1991-2#7)(1991-3#6)(1991-6#2)(1991-7#2)(1992-1#3)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#9)(1993-3#7)(1993-6#1)(1993-8#4)(1994-1#3)(1994-12#8)(1994-2#9)(1994-3#9)(1994-5#6)(1994-6#7)(1994-8#3)(1994-9#6)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#11)(1995-6#2)(1995-9#2)(1996-1#9)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#8)(1997-3#9)(1997-5#8)(1997-6#1)(1997-7#1)(1997-8#6)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#1)(2008-10#59)(2008-11#39)(2008-12#9)(2008-2#3)(2008-3#12)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#18)(2008-8#18)(2008-9#11)(2009-10#9)(2009-12#3)(2009-2#1)(2009-3#2)(2009-7#3)(2009-8#6)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#7)(2010-3#2)(2010-6#4)(2010-7#2)(2010-8#3)(2011-2#23)(2011-3#4)(2012-12#3)(2012-2#7)(2012-3#12)(2013-1#15)(2013-8#13)
mustard##4##1##(2008-10#3)(2010-4#1)
mutability##2##1##(2008-12#1)(2008-8#1)
mutagenesis and carcinogenesis##2##3##(1993-11#1)(1995-9#1)
mutagenesis and##7##2##(1992-3#1)(1993-11#1)(1994-5#1)(1995-9#1)(2008-9#1)(2011-1#1)(2011-2#1)
mutagenesis at##3##2##(1992-1#1)(2008-9#1)(2011-1#1)
mutagenesis experiments##2##2##(1994-8#1)(2008-10#1)
mutagenesis in the##2##3##(2008-8#1)(2012-3#1)
mutagenesis in##4##2##(1990-5#1)(2008-8#1)(2012-3#2)
mutagenesis of the##5##3##(1990-5#1)(1995-3#1)(2008-10#2)(2008-9#1)
mutagenesis of##10##2##(1990-10#1)(1990-5#1)(1991-9#2)(1992-3#1)(1995-3#1)(2008-10#2)(2008-9#1)(2011-2#1)
mutagenesis studies##4##2##(1995-2#2)(1995-6#1)(2011-2#1)
mutagenesis to##3##2##(1992-1#1)(2008-10#2)
mutagenesis using##2##2##(2008-10#1)(2011-1#1)
mutagenesis was used to##2##4##(1993-8#1)(1994-5#1)
mutagenesis was##4##2##(1993-8#1)(1994-5#1)(1995-2#1)(2008-9#1)
mutagenesis##75##1##(1990-10#2)(1990-5#2)(1991-10#2)(1991-5#2)(1991-9#2)(1992-1#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-5#5)(1994-8#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(2008-10#15)(2008-7#1)(2008-8#3)(2008-9#11)(2009-5#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-3#2)(2013-8#1)
mutagenic heterocyclic##2##2##(1997-2#2)
mutagenic in##3##2##(1995-11#1)(2008-9#2)
mutagenic process of##2##3##(2008-10#2)
mutagenic process##5##2##(2008-10#5)
mutagenic##27##1##(1990-6#2)(1991-12#1)(1993-8#1)(1995-11#1)(1997-2#3)(2008-10#9)(2008-11#5)(2008-7#1)(2008-9#2)(2010-6#1)(2012-3#1)
mutagenicity##4##1##(2008-11#1)(2011-1#1)(2011-2#2)
mutagenized##3##1##(1995-2#1)(1997-8#1)(2008-10#1)
mutagens##3##1##(2008-11#1)(2008-12#1)(2010-8#1)
mutans##8##1##(1997-8#1)(2008-5#1)(2013-1#6)
mutant (Rev##2##2##(1993-8#2)
mutant DPR1 gene##2##3##(1995-2#2)
mutant EF-3s did not##2##4##(1996-2#2)
mutant LPL##3##2##(1992-3#2)(1994-11#1)
mutant TRbeta1##2##2##(1995-8#2)
mutant alleles##5##2##(1997-3#2)(2008-10#2)(2008-8#1)
mutant alpha2Ms##2##2##(2008-11#2)
mutant and the##4##3##(1993-8#1)(1994-11#1)(2008-10#2)
mutant and wild-type##3##3##(2008-10#2)(2008-7#1)
mutant and##11##2##(1993-8#1)(1994-11#1)(1995-2#1)(2008-10#7)(2008-7#1)
mutant animals##2##2##(1993-12#2)
mutant background##2##2##(2009-10#1)(2009-8#1)
mutant cell line##3##3##(1995-12#1)(2008-4#1)(2012-2#1)
mutant cell##5##2##(1995-12#1)(1996-2#1)(2008-4#1)(2012-2#1)(2013-8#1)
mutant cells##5##2##(1995-12#1)(1996-3#1)(1997-7#1)(2012-3#1)(2013-8#1)
mutant classes##2##2##(2008-10#2)
mutant containing##3##2##(1995-2#2)(2008-10#1)
mutant derivatives of##2##3##(1997-3#2)
mutant did not##2##3##(2008-10#2)
mutant enzyme showed##2##3##(1990-10#1)(1992-6#1)
mutant enzyme was##2##3##(1990-10#2)
mutant enzyme##15##2##(1990-10#5)(1992-6#1)(1994-5#2)(1995-2#2)(1995-6#4)(1997-7#1)
mutant enzymes##3##2##(1994-5#1)(1995-6#1)(1997-7#1)
mutant failed to form##2##4##(2008-8#2)
mutant failed to##4##3##(1997-4#1)(2008-10#1)(2008-8#2)
mutant forms of##2##3##(1995-6#1)(2011-2#1)
mutant gene##3##2##(1995-12#1)(1995-2#2)
mutant genes##5##2##(1991-9#1)(1992-6#1)(1994-5#1)(2008-9#1)(2011-2#1)
mutant had##2##2##(1993-8#1)(2008-10#1)
mutant has##3##2##(1996-2#1)(2008-8#1)(2008-9#1)
mutant human cell##2##3##(1990-5#1)(1996-2#1)
mutant human##4##2##(1990-5#1)(1996-2#1)(2008-6#1)(2008-9#1)
mutant in the##2##3##(1995-2#1)(2009-8#1)
mutant in##5##2##(1992-9#1)(1995-2#1)(2008-9#2)(2009-8#1)
mutant induced##2##2##(2008-10#2)
mutant insulin##2##2##(1995-6#2)
mutant libraries that##2##3##(1997-6#2)
mutant line##2##2##(2008-10#2)
mutant mice##4##2##(1993-12#1)(1995-12#1)(1997-3#1)(2009-8#1)
mutant mouse##4##2##(1992-9#2)(1996-12#1)(2008-2#1)
mutant of Arabidopsis##2##3##(2008-9#1)(2009-8#1)
mutant of F##2##3##(2008-10#2)
mutant of the##4##3##(2008-10#2)(2009-7#2)
mutant of##33##2##(1990-2#1)(1993-12#1)(1995-6#1)(1997-7#1)(2008-10#14)(2008-11#2)(2008-8#4)(2008-9#4)(2009-7#2)(2009-8#1)(2010-10#1)(2013-1#1)
mutant ofGossypium hirsutum L##2##4##(2008-8#2)
mutant or##3##2##(2008-10#1)(2008-8#1)(2009-4#1)
mutant p53 protein##4##3##(1990-12#1)(1991-2#3)
mutant p53##15##2##(1990-12#1)(1991-2#5)(1991-5#3)(2009-4#4)(2011-2#2)
mutant phenotype##4##2##(1996-3#1)(2008-10#1)(2008-9#1)(2012-3#1)
mutant phenotypes##2##2##(2010-5#1)(2012-3#1)
mutant plants##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
mutant produced aflatoxin in##2##4##(2008-10#2)
mutant promoter##2##2##(1990-5#1)(1991-9#1)
mutant protein##8##2##(1991-12#1)(1991-5#1)(1993-8#1)(1994-5#1)(2008-9#2)(2011-1#1)(2011-2#1)
mutant proteins##4##2##(1990-5#1)(1991-6#1)(2011-1#2)
mutant receptor##4##2##(1993-12#1)(1995-6#2)(1996-2#1)
mutant receptors##5##2##(1995-6#5)
mutant reduced##2##2##(2008-10#1)(2009-6#1)
mutant strain (BDCS-N-M36)##3##3##(2008-12#3)
mutant strain of##2##3##(2008-10#2)
mutant strain##18##2##(1996-6#1)(1997-7#1)(2008-10#7)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2011-2#1)
mutant strains of##3##3##(2008-10#1)(2009-10#1)(2012-3#1)
mutant strains##15##2##(1990-5#2)(1997-4#1)(2008-10#5)(2009-10#3)(2012-3#4)
mutant that##5##2##(1993-11#1)(1995-2#1)(1997-3#1)(2008-10#2)
mutant the##3##2##(2008-8#3)
mutant to##2##2##(2008-10#1)(2012-3#1)
mutant virus##3##2##(2008-10#1)(2013-1#2)
mutant viruses##3##2##(2008-10#1)(2013-1#2)
mutant was##10##2##(1993-8#1)(1993-9#1)(1997-8#1)(2008-10#5)(2008-8#2)
mutant were##5##2##(2008-10#4)(2008-8#1)
mutant with##2##2##(1993-8#1)(2008-8#1)
mutant##469##1##(1990-10#5)(1990-12#1)(1990-2#1)(1990-5#6)(1990-8#4)(1991-12#1)(1991-2#5)(1991-5#7)(1991-6#1)(1991-9#3)(1992-3#2)(1992-4#2)(1992-6#3)(1992-9#3)(1993-11#2)(1993-12#7)(1993-3#2)(1993-8#10)(1993-9#4)(1994-11#2)(1994-12#1)(1994-5#8)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#18)(1995-6#24)(1995-8#6)(1995-9#1)(1996-12#1)(1996-2#9)(1996-3#2)(1996-6#1)(1997-1#2)(1997-3#9)(1997-4#2)(1997-6#2)(1997-7#10)(1997-8#6)(2007-12#1)(2008-10#116)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#42)(2008-9#35)(2009-10#8)(2009-4#7)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#8)(2010-10#3)(2010-5#1)(2011-1#4)(2011-2#12)(2011-3#1)(2012-2#2)(2012-3#13)(2013-1#6)(2013-8#4)
mutant)##5##1##(1995-6#3)(1996-3#1)(2008-8#1)
mutants affected in##2##3##(2008-10#2)
mutants also##3##2##(2008-10#2)(2011-1#1)
mutants and##12##2##(1993-8#1)(1994-5#1)(2008-10#5)(2008-12#3)(2008-7#1)(2008-9#1)
mutants are complemented by##2##4##(1995-6#1)(1997-7#1)
mutants are not##3##3##(1992-6#1)(2008-10#1)(2008-9#1)
mutants are##10##2##(1992-6#1)(1995-2#1)(1995-6#1)(1997-7#2)(2008-10#2)(2008-9#3)
mutants at##2##2##(1995-2#1)(2008-9#1)
mutants by##2##2##(1993-2#1)(2008-10#1)
mutants did not##3##3##(2008-10#3)
mutants displayed##2##2##(1995-2#1)(2013-1#1)
mutants exhibited##2##2##(1994-12#1)(2008-10#1)
mutants for##5##2##(2008-10#3)(2008-9#1)(2011-1#1)
mutants had##2##2##(1993-8#1)(1995-2#1)
mutants have##4##2##(1995-2#1)(1995-6#1)(1995-8#1)(2009-8#1)
mutants in Loop7 region##2##4##(2008-9#2)
mutants in which##2##3##(2009-10#1)(2009-5#1)
mutants in##16##2##(1993-8#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-9#5)(2009-10#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-3#1)
mutants induced##3##2##(2008-10#2)(2008-8#1)
mutants is##4##2##(1995-9#1)(2008-9#2)(2013-1#1)
mutants of X##3##3##(2008-10#3)
mutants of recombinant##2##3##(1994-11#1)(1995-2#1)
mutants of the##4##3##(1992-6#1)(1997-7#1)(2008-10#1)(2011-1#1)
mutants of##35##2##(1990-5#1)(1992-6#1)(1993-9#1)(1994-11#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#2)(1997-7#2)(1997-9#1)(2008-10#15)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)
mutants show##2##2##(1996-2#1)(2011-2#1)
mutants showed that##2##3##(1995-6#1)(1995-9#1)
mutants showed##3##2##(1995-6#1)(1995-9#1)(2008-10#1)
mutants suggests that the##2##4##(1995-6#1)(1995-8#1)
mutants suggests##3##2##(1995-6#1)(1995-8#1)(1996-3#1)
mutants tested##2##2##(1994-12#1)(2008-10#1)
mutants than##3##2##(2008-10#1)(2008-8#2)
mutants that##5##2##(1997-3#1)(2008-10#2)(2008-7#1)(2012-3#1)
mutants to##3##2##(1993-2#1)(1995-2#1)(2008-10#1)
mutants was constructed##2##3##(1994-5#1)(1995-6#1)
mutants was##7##2##(1994-5#1)(1995-2#2)(1995-6#1)(2008-10#3)
mutants were characterized##2##3##(1995-6#1)(2008-10#1)
mutants were isolated##2##3##(1991-10#1)(2008-10#1)
mutants were used to assess vegetative compatibility##2##7##(2008-10#2)
mutants were##20##2##(1991-10#1)(1992-9#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-3#1)(2008-10#8)(2008-8#1)(2008-9#3)(2009-6#1)
mutants which##2##2##(1996-2#1)(2008-9#1)
mutants with##7##2##(1993-8#1)(1995-8#1)(2008-10#2)(2008-9#1)(2011-1#2)
mutants##315##1##(1990-5#2)(1991-10#1)(1992-6#2)(1992-9#3)(1993-12#2)(1993-2#2)(1993-8#6)(1993-9#1)(1994-11#3)(1994-12#6)(1994-5#3)(1994-8#1)(1995-2#14)(1995-3#2)(1995-6#17)(1995-8#12)(1995-9#8)(1996-2#2)(1996-3#5)(1997-3#5)(1997-4#2)(1997-7#6)(1997-9#1)(2007-12#2)(2008-10#105)(2008-12#6)(2008-4#1)(2008-7#5)(2008-8#13)(2008-9#37)(2009-10#4)(2009-5#3)(2009-6#1)(2009-8#5)(2011-1#7)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#9)(2013-1#3)
mutants)##3##1##(1994-11#1)(1995-9#1)(2008-8#1)
mutarotase##2##1##(2008-10#2)
mutase##5##1##(1993-3#1)(2010-12#2)(2011-1#1)(2012-2#1)
mutated and##3##2##(1992-6#1)(2008-10#1)(2013-8#1)
mutated form of##2##3##(1996-5#1)(2008-10#1)
mutated gene##2##2##(1994-9#1)(2008-2#1)
mutated in##3##2##(1990-8#1)(2008-10#1)(2008-9#1)
mutated or##2##2##(1997-7#2)
mutated##36##1##(1990-8#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-3#1)(1997-7#2)(1997-8#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-8#2)(2008-9#5)(2009-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
mutating##3##1##(1993-8#1)(1997-7#1)(2010-5#1)
mutation (position##2##2##(2008-10#2)
mutation accumulation##2##2##(2008-8#1)(2008-9#1)
mutation analysis of##2##3##(2008-10#1)(2008-9#1)
mutation analysis##4##2##(1997-3#1)(2008-10#2)(2008-9#1)
mutation and##5##2##(1995-10#1)(1997-8#2)(2010-4#1)(2012-3#1)
mutation assay##2##2##(2008-7#2)
mutation at the##4##3##(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)
mutation at##9##2##(1990-5#1)(1991-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(2008-10#1)(2011-3#1)
mutation because##2##2##(1995-6#1)(1996-12#1)
mutation carriers##3##2##(2011-2#3)
mutation caused a##2##3##(1991-7#1)(1995-9#1)
mutation for##2##2##(2008-10#1)(2010-4#1)
mutation frequency##8##2##(1997-3#6)(2008-9#1)(2012-3#1)
mutation in the gene##3##4##(1991-12#1)(2008-4#1)(2011-1#1)
mutation in the##28##3##(1991-12#1)(1991-5#1)(1992-8#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
mutation in this##2##3##(2008-10#1)(2013-1#1)
mutation in##50##2##(1990-8#1)(1991-12#3)(1991-5#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-2#3)(1995-6#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
mutation is##5##2##(1991-12#1)(1991-6#1)(1994-12#1)(2008-12#1)(2009-8#1)
mutation leading to##2##3##(1997-3#1)(2011-1#1)
mutation locus##3##2##(2008-8#3)
mutation may##2##2##(1993-8#1)(2011-2#1)
mutation occurred##2##2##(1992-8#1)(2008-9#1)
mutation of T to C at position##2##7##(2008-12#2)
mutation of the five##2##4##(2008-8#2)
mutation of the##13##3##(1993-11#1)(1993-3#1)(1994-12#2)(1995-8#2)(2008-11#1)(2008-8#3)(2008-9#2)(2013-1#1)
mutation of##26##2##(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#2)(1995-3#1)(1995-8#2)(1997-3#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#4)(2008-9#3)(2011-3#1)(2012-3#1)(2013-1#1)
mutation on the##2##3##(1993-8#1)(1996-12#1)
mutation on##4##2##(1993-8#1)(1996-12#1)(1997-3#1)(2009-10#1)
mutation or##2##2##(2008-10#2)
mutation parameters##2##2##(2008-12#2)
mutation rates from paternity casework##2##5##(2008-12#2)
mutation rates##8##2##(2008-10#2)(2008-12#4)(2012-3#2)
mutation sites of##2##3##(2008-8#1)(2012-3#1)
mutation sites##3##2##(1997-7#1)(2008-8#1)(2012-3#1)
mutation studies##2##2##(2008-7#1)(2008-8#1)
mutation that causes##4##3##(1991-7#1)(2008-10#2)(2012-3#1)
mutation that results in##2##4##(1994-12#1)(1997-7#1)
mutation that##10##2##(1991-12#1)(1991-7#1)(1993-9#1)(1994-12#1)(1997-7#1)(2008-10#2)(2009-12#1)(2009-8#1)(2012-3#1)
mutation was detected##2##3##(1992-8#1)(2013-1#1)
mutation was found in##3##4##(2008-10#1)(2009-8#1)(2011-1#1)
mutation was present in##2##4##(1990-8#1)(2008-10#1)
mutation was##7##2##(1990-8#1)(1992-8#1)(2008-10#2)(2009-8#1)(2011-1#1)(2013-1#1)
mutation with##2##2##(1997-3#1)(2012-3#1)
mutation##292##1##(1990-12#1)(1990-2#1)(1990-5#4)(1990-8#3)(1991-11#1)(1991-12#5)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#3)(1992-3#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#4)(1993-9#4)(1994-11#4)(1994-12#7)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#6)(1995-3#1)(1995-6#7)(1995-8#4)(1995-9#4)(1996-12#4)(1996-2#4)(1996-3#1)(1997-1#1)(1997-3#24)(1997-7#6)(1997-8#5)(2008-10#35)(2008-11#4)(2008-12#18)(2008-4#3)(2008-5#1)(2008-7#7)(2008-8#13)(2008-9#17)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#3)(2009-8#4)(2009-9#1)(2010-11#1)(2010-4#4)(2010-5#2)(2010-7#1)(2011-1#6)(2011-2#8)(2011-3#4)(2012-12#2)(2012-2#4)(2012-3#16)(2013-1#6)(2013-8#3)
mutation)##5##1##(2008-10#3)(2008-4#1)(2008-8#1)
mutational analysis##2##2##(2009-6#1)(2010-10#1)
mutational##15##1##(1992-4#1)(1993-8#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2009-6#1)(2010-10#1)(2013-1#2)(2013-8#1)
mutations among##2##2##(1991-5#1)(2013-1#1)
mutations and the##3##3##(1993-2#1)(1996-2#1)(2008-12#1)
mutations and##16##2##(1991-12#1)(1993-2#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-8#2)(2011-2#3)(2012-3#2)
mutations are selfish##2##3##(2008-8#2)
mutations are##16##2##(1993-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#3)
mutations as##2##2##(1990-5#1)(2013-1#1)
mutations associated with##2##3##(2012-3#1)(2013-1#1)
mutations at the##4##3##(1992-9#1)(1997-3#1)(2008-10#1)(2008-8#1)
mutations at##8##2##(1992-9#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#2)
mutations can##3##2##(1990-12#1)(2008-4#1)(2010-8#1)
mutations cause a##2##3##(2009-8#1)(2013-1#1)
mutations cause##3##2##(1993-6#1)(2009-8#1)(2013-1#1)
mutations found in##3##3##(1991-5#1)(1995-12#1)(1997-6#1)
mutations from##2##2##(1991-7#1)(2013-8#1)
mutations have been##4##3##(1990-12#1)(1993-11#1)(1995-12#1)(1995-8#1)
mutations have##5##2##(1990-12#1)(1993-11#1)(1995-12#1)(1995-8#1)(2012-2#1)
mutations in a##3##3##(1990-12#1)(1995-8#1)(2011-1#1)
mutations in genes##2##3##(2008-10#1)(2011-2#1)
mutations in the gene##5##4##(1990-5#1)(1996-2#1)(2008-4#1)(2011-1#1)(2013-1#1)
mutations in the vasopressin V2 receptor gene##2##7##(1994-11#2)
mutations in the##43##3##(1990-5#1)(1991-12#2)(1992-3#1)(1993-12#1)(1994-11#2)(1994-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
mutations in these##2##3##(2008-4#1)(2009-8#1)
mutations in this gene##3##4##(1994-11#1)(1996-2#1)(1997-7#1)
mutations in this##5##3##(1994-11#1)(1995-6#1)(1996-2#1)(1997-7#2)
mutations in##97##2##(1990-12#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#3)(1994-12#1)(1995-2#2)(1995-6#2)(1995-8#3)(1996-2#3)(1997-1#1)(1997-3#3)(1997-6#1)(1997-7#3)(2007-12#2)(2008-10#9)(2008-11#4)(2008-4#2)(2008-7#3)(2008-9#3)(2009-10#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-4#4)(2010-5#1)(2011-1#5)(2011-2#6)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#5)
mutations into##3##2##(1993-11#1)(2008-4#2)
mutations may##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
mutations of a##2##3##(1993-3#1)(1995-2#1)
mutations of the##6##3##(1994-11#1)(1996-2#1)(2008-10#2)(2009-8#1)(2011-1#1)
mutations of##16##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(2008-10#2)(2009-8#1)(2011-1#1)
mutations on the##4##3##(2008-10#1)(2012-2#2)(2013-1#1)
mutations on##9##2##(1991-10#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-11#2)(2012-2#2)(2013-1#1)
mutations or##2##2##(1992-12#1)(2008-9#1)
mutations resulted in##2##3##(2011-1#1)(2012-3#1)
mutations that##10##2##(1992-9#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#2)
mutations to the##2##3##(2008-11#2)
mutations to##9##2##(1992-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-4#2)(2012-3#1)
mutations was observed##2##3##(2008-9#2)
mutations was##4##2##(1997-8#1)(2008-10#1)(2008-9#2)
mutations were##15##2##(1991-5#1)(1993-11#2)(1993-3#1)(1993-8#1)(1995-6#1)(1997-3#2)(1997-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
mutations with##3##2##(2008-9#1)(2012-3#1)(2013-8#1)
mutations within the##2##3##(1992-9#1)(2008-10#1)
mutations within##4##2##(1992-9#1)(2008-10#2)(2012-2#1)
mutations##358##1##(1990-12#4)(1990-5#4)(1991-10#1)(1991-12#4)(1991-2#1)(1991-5#8)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#3)(1993-11#7)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#2)(1994-11#5)(1994-12#4)(1994-9#1)(1995-12#2)(1995-2#5)(1995-5#1)(1995-6#10)(1995-8#4)(1996-2#6)(1996-5#1)(1997-1#1)(1997-3#8)(1997-4#1)(1997-6#4)(1997-7#8)(1997-8#2)(1997-9#1)(2007-12#3)(2008-1#1)(2008-10#30)(2008-11#9)(2008-12#6)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#16)(2008-8#8)(2008-9#22)(2009-10#2)(2009-12#1)(2009-4#3)(2009-7#1)(2009-8#9)(2010-11#1)(2010-4#9)(2010-5#1)(2010-8#2)(2011-1#11)(2011-2#14)(2011-3#2)(2012-2#18)(2012-3#18)(2013-1#34)(2013-8#7)
mutator effects##2##2##(1997-4#2)
mutator##4##1##(1997-4#2)(2011-2#1)(2012-3#1)
mutica##3##1##(2008-5#3)
mutual aid and social support##2##5##(1996-3#2)
mutual aid and##3##3##(1995-3#1)(1996-3#2)
mutual aid##6##2##(1994-2#1)(1995-3#1)(1996-3#4)
mutual concern##2##2##(1990-12#1)(1992-2#1)
mutual influence of##2##3##(2008-10#1)(2008-11#1)
mutual information##3##2##(1996-6#1)(2008-7#1)(2010-8#1)
mutual interaction of##2##3##(2008-10#1)(2008-9#1)
mutual interactions##2##2##(1990-11#1)(2008-9#1)
mutual proportions##2##2##(2008-10#2)
mutual separation of##2##3##(2008-10#2)
mutual separation##3##2##(2008-10#3)
mutual##51##1##(1990-11#1)(1990-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-3#5)(1996-6#1)(1997-1#1)(1997-2#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2009-9#1)(2010-8#1)(2012-2#2)(2013-1#1)
mutual-aid##3##1##(1996-3#3)
mutualism##11##1##(2008-8#9)(2008-9#2)
mutualistic##6##1##(2008-10#1)(2008-8#4)(2008-9#1)
mutually beneficial##5##2##(1994-1#1)(1996-1#1)(2008-8#3)
mutually exclusive home ranges##3##4##(2008-8#1)(2008-9#2)
mutually exclusive##9##2##(1995-9#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-10#1)(2011-2#2)
mutually##24##1##(1990-6#1)(1994-1#1)(1995-9#1)(1996-1#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-8#4)(2008-9#5)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2011-2#3)
my mind##2##2##(2008-10#1)(2011-2#1)
my perspective##2##2##(1994-8#1)(2008-4#1)
my##36##1##(1991-8#1)(1992-3#2)(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#6)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
mya##3##1##(2009-10#2)(2009-8#1)
myalgia##3##1##(1990-3#1)(2012-3#1)(2013-1#1)
myalgias which##2##2##(2008-7#2)
myalgias##4##1##(1994-9#1)(2008-7#2)(2013-1#1)
myastenia gravis##2##2##(1997-5#2)
myasthenia gravis##6##2##(1991-2#1)(1997-8#1)(2012-3#4)
myasthenia##7##1##(1991-2#1)(1997-5#1)(1997-8#1)(2012-3#4)
myb##2##1##(1990-6#1)(2008-8#1)
myc##2##1##(1995-9#1)(2008-11#1)
mycelia and##2##2##(2008-10#1)(2008-7#1)
mycelia in##4##2##(2008-10#2)(2008-6#1)(2008-7#1)
mycelia of##3##2##(2008-10#3)
mycelia were##2##2##(2008-10#2)
mycelia##22##1##(2008-10#17)(2008-6#1)(2008-7#2)(2008-9#1)(2011-10#1)
mycelial colonies##2##2##(2008-10#2)
mycelial colonization of##4##3##(2008-10#4)
mycelial colonization##6##2##(2008-10#6)
mycelial compatibility groups (MCGs)##3##4##(2008-10#3)
mycelial compatibility groups##4##3##(2008-10#4)
mycelial compatibility##7##2##(2008-10#7)
mycelial growth and##4##3##(2008-10#3)(2008-7#1)
mycelial growth of##4##3##(2008-10#4)
mycelial growth rate##2##3##(2008-10#2)
mycelial growth##22##2##(2008-10#21)(2008-7#1)
mycelial mass##4##2##(2008-10#3)(2008-7#1)
mycelial phase##2##2##(2008-5#2)
mycelial##53##1##(2008-10#48)(2008-5#3)(2008-7#2)
mycelium and##5##2##(2008-10#5)
mycelium in##5##2##(2008-10#4)(2008-8#1)
mycelium morphological##2##2##(1994-8#2)
mycelium of P##4##3##(2008-10#4)
mycelium of the##3##3##(2008-10#3)
mycelium of##14##2##(1997-1#1)(2008-10#13)
mycelium was##5##2##(2008-10#5)
mycelium were##2##2##(2008-10#2)
mycelium##62##1##(1994-8#2)(1997-1#1)(2008-10#52)(2008-11#3)(2008-7#1)(2008-8#3)
mycetisms and##2##2##(2008-5#2)
mycetisms##3##1##(2008-5#3)
mycetoma##2##1##(2008-5#2)
myclobutanil##2##1##(2008-10#2)
mycobacteria (NTM)##2##2##(2011-2#2)
mycobacteria##14##1##(1995-5#2)(2007-12#2)(2008-11#1)(2008-7#1)(2011-2#6)(2013-1#2)
mycobacterial gene expression##2##3##(2008-7#2)
mycobacterial infections##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
mycobacterial proteins##4##2##(2011-2#4)
mycobacterial##22##1##(1995-5#2)(2007-12#4)(2008-7#2)(2008-9#2)(2011-2#8)(2012-2#3)(2013-1#1)
mycobacteriosis##5##1##(1992-2#1)(1996-11#2)(2008-11#2)
mycobacterium##2##1##(2008-10#1)(2008-7#1)
mycoflora##2##1##(2008-10#1)(2008-5#1)
mycoherbicide##6##1##(2008-10#6)
mycoides##6##1##(2008-10#6)
mycolic acids and##2##3##(2008-9#1)(2013-1#1)
mycolic acids##5##2##(2008-9#4)(2013-1#1)
mycolic##6##1##(2008-9#5)(2013-1#1)
mycological##10##1##(2008-10#2)(2008-5#8)
mycoparasite##11##1##(2008-10#11)
mycoparasitism and##2##2##(2008-10#2)
mycoparasitism##11##1##(2008-10#10)(2013-8#1)
mycophagous Drosophila and##2##3##(2008-8#2)
mycophagous Drosophila##3##2##(2008-8#2)(2008-9#1)
mycophagous##4##1##(2008-8#2)(2008-9#1)(2012-3#1)
mycophenolate mofetil##3##2##(2010-12#1)(2012-3#2)
mycophenolate##4##1##(2010-12#1)(2012-3#3)
mycophenolic acid##3##2##(1990-10#1)(2010-3#2)
mycoplasma and##2##2##(1994-11#1)(2008-11#1)
mycoplasma##9##1##(1993-12#1)(1994-11#2)(2008-11#6)
mycoplasmas##9##1##(1993-12#2)(2008-10#1)(2008-11#5)(2011-2#1)
mycorrhizal colonization##3##2##(2008-10#3)
mycorrhizal fungi##4##2##(2008-11#1)(2008-8#2)(2013-8#1)
mycorrhizal fungus Laccaria bicolor##2##4##(2011-1#2)
mycorrhizal fungus##3##2##(2008-10#1)(2011-1#2)
mycorrhizal##17##1##(2008-10#9)(2008-11#2)(2008-8#2)(2010-10#1)(2011-1#2)(2013-8#1)
mycorrhizosphere soil##2##2##(2008-10#2)
mycorrhizosphere##5##1##(2008-10#5)
mycoses in##2##2##(2011-2#2)
mycoses##9##1##(2008-5#5)(2011-2#4)
mycosis fungoides##3##2##(2010-6#3)
mycosis##8##1##(2008-5#4)(2010-6#3)(2011-2#1)
mycotic##3##1##(1997-8#1)(2008-5#2)
mycotoxin contamination##4##2##(2008-10#3)(2011-10#1)
mycotoxin produced##2##2##(1993-12#1)(2008-10#1)
mycotoxin production##4##2##(2008-10#1)(2010-3#1)(2010-7#1)(2011-10#1)
mycotoxin##24##1##(1993-12#1)(2008-10#17)(2010-3#1)(2010-7#2)(2011-10#2)(2011-2#1)
mycotoxins in##2##2##(2010-3#1)(2010-7#1)
mycotoxins##20##1##(1993-12#1)(2008-10#10)(2008-11#2)(2010-3#2)(2010-7#5)
mydriatic##2##1##(2008-7#1)(2011-2#1)
myelin basic protein (MBP)##2##4##(1995-12#1)(2008-8#1)
myelin basic protein##6##3##(1990-10#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-8#1)
myelin is##2##2##(1995-12#1)(2008-7#1)
myelin oligodendrocyte glycoprotein (MOG)##2##4##(1995-12#1)(1996-12#1)
myelin oligodendrocyte glycoprotein##3##3##(1995-12#1)(1996-12#2)
myelin##29##1##(1990-10#1)(1994-6#1)(1995-12#4)(1996-12#4)(1996-6#1)(2008-7#6)(2008-8#1)(2009-6#8)(2010-12#1)(2012-2#2)
myelinated axons##2##2##(2008-7#2)
myelinated primary afferents##2##3##(1997-3#2)
myelinated primary##3##2##(1997-3#3)
myelinated##8##1##(1997-3#5)(2008-7#3)
myelinating cells##4##2##(2008-7#4)
myelinating##6##1##(2008-7#6)
myelination of##2##2##(2008-5#2)
myelination##20##1##(1996-12#1)(2008-5#7)(2008-7#10)(2009-6#2)
myelitis##10##1##(1996-11#1)(1996-8#1)(2012-3#8)
myeloblast counts##3##2##(2008-11#3)
myeloblast##4##1##(2008-11#4)
myeloblastic##4##1##(1993-3#1)(1997-5#1)(2011-3#1)(2012-12#1)
myeloblasts##2##1##(2008-11#2)
myelocytes##2##1##(2008-11#1)(2010-8#1)
myelodysplastic syndrome##3##2##(2010-11#1)(2011-2#2)
myelodysplastic syndromes (MDS)##2##3##(2008-11#1)(2010-1#1)
myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria##2##6##(1992-12#2)
myelodysplastic syndromes and##4##3##(1992-12#2)(2010-1#1)(2010-11#1)
myelodysplastic syndromes##11##2##(1990-8#1)(1992-12#2)(2008-11#1)(2010-1#2)(2010-11#5)
myelodysplastic##17##1##(1990-8#3)(1992-12#2)(2008-10#1)(2008-11#1)(2010-1#2)(2010-11#6)(2011-2#2)
myelogenous leukemia##4##2##(1992-9#1)(2008-4#1)(2008-7#1)(2009-7#1)
myelogenous##7##1##(1992-9#1)(2006-6#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)
myeloid and##2##2##(1991-2#1)(2012-3#1)
myeloid cell lines##2##3##(1995-6#1)(2008-10#1)
myeloid cell##4##2##(1995-6#1)(2008-10#1)(2010-11#1)(2013-1#1)
myeloid leukemia (AML)##6##3##(2010-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
myeloid leukemia (CML)##3##3##(1990-2#1)(2010-11#1)(2011-2#1)
myeloid leukemia##26##2##(1990-2#2)(1990-8#2)(1993-3#2)(1994-5#1)(1997-5#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-1#2)(2010-11#3)(2011-2#6)(2012-12#1)(2013-1#1)
myeloid progenitor cells##3##3##(1994-5#1)(1997-7#2)
myeloid##50##1##(1990-2#2)(1990-8#2)(1991-2#1)(1991-9#1)(1993-3#2)(1993-8#1)(1994-5#2)(1995-6#1)(1997-5#1)(1997-7#3)(2008-10#4)(2008-11#5)(2009-12#1)(2009-3#2)(2009-7#1)(2010-1#2)(2010-11#4)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
myeloma and##3##2##(1991-12#1)(2008-11#2)
myeloma cell line##5##3##(2008-11#5)
myeloma cell##6##2##(2008-11#6)
myeloma cells##15##2##(1990-12#1)(1991-12#1)(1995-8#2)(2008-11#5)(2008-7#1)(2011-2#1)(2013-1#4)
myeloma group##2##2##(1991-12#2)
myeloma##51##1##(1990-12#1)(1990-9#1)(1991-12#7)(1995-8#3)(1997-5#1)(2008-11#15)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-5#1)(2010-12#2)(2011-2#4)(2012-12#4)(2013-1#5)
myelomas##4##1##(2008-11#4)
myelomeningocele##3##1##(2008-10#1)(2009-3#1)(2011-2#1)
myelomonocytic##4##1##(1995-2#1)(2008-10#1)(2013-1#2)
myelopathy##5##1##(1991-3#1)(2008-12#2)(2008-7#1)(2012-12#1)
myeloperoxidase##3##1##(1992-10#1)(2012-2#2)
myeloproliferative disorders##2##2##(2008-10#1)(2010-11#1)
myeloproliferative##4##1##(1993-9#1)(1997-5#1)(2008-10#1)(2010-11#1)
myelosuppression##5##1##(1991-2#1)(1997-3#1)(1997-7#1)(2013-1#2)
myelosuppressive##2##1##(1991-8#1)(2008-7#1)
myenteric##3##1##(1990-5#1)(1994-12#1)(1997-4#1)
myiasis##2##1##(2010-10#1)(2013-1#1)
mykiss were##2##2##(2010-8#2)
mykiss##8##1##(2008-10#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-8#4)
mykiss)##4##1##(2008-11#1)(2008-5#1)(2008-6#1)(2010-8#1)
myo-cutaneous flap##2##2##(1990-9#2)
myo-inositol##6##1##(1992-12#2)(1993-6#1)(2008-11#2)(2008-7#1)
myoblast 45Ca2+ uptake##2##3##(1997-1#2)
myoblast cell line##2##3##(2008-11#2)
myoblast##8##1##(1997-1#3)(2008-11#3)(2008-4#1)(2008-8#1)
myoblasts and##3##2##(1995-8#1)(2008-4#1)(2010-10#1)
myoblasts for##2##2##(2008-11#2)
myoblasts with##2##2##(1993-3#1)(1997-1#1)
myoblasts##24##1##(1990-5#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-8#2)(1997-1#6)(2008-11#6)(2008-4#2)(2008-8#2)(2009-12#1)(2010-10#1)
myocardial contractility##2##2##(1996-3#1)(2013-1#1)
myocardial damage##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
myocardial dysfunction##2##2##(2008-11#1)(2009-5#1)
myocardial function##4##2##(1996-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
myocardial infarction (MI)##4##3##(2008-10#1)(2008-11#1)(2009-5#1)(2013-8#1)
myocardial infarction (NSTEMI)##2##3##(2011-2#1)(2012-3#1)
myocardial infarction and##12##3##(1993-2#1)(1995-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2011-2#2)(2012-2#1)
myocardial infarction by##2##3##(1991-6#1)(2008-3#1)
myocardial infarction detection##2##3##(2008-10#1)(2008-3#1)
myocardial infarction during##2##3##(1991-3#1)(1995-12#1)
myocardial infarction in the##2##4##(1994-12#1)(2008-3#1)
myocardial infarction in##8##3##(1991-6#1)(1994-12#2)(2008-11#2)(2008-12#1)(2008-3#1)(2013-1#1)
myocardial infarction or##2##3##(1992-9#1)(2009-6#1)
myocardial infarction patients##2##3##(1995-2#1)(2012-3#1)
myocardial infarction with##3##3##(1990-9#1)(2008-11#1)(2010-5#1)
myocardial infarction##108##2##(1990-12#1)(1990-9#4)(1991-3#2)(1991-6#6)(1992-12#2)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1994-12#3)(1995-12#4)(1995-2#2)(1995-8#2)(1996-2#3)(1996-8#1)(1997-5#1)(2008-10#5)(2008-11#8)(2008-12#3)(2008-3#14)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
myocardial infarction]##5##2##(1990-12#1)(1994-6#1)(1995-5#1)(2008-10#1)(2013-8#1)
myocardial ischaemia in a patient##2##5##(1990-9#1)(2009-11#1)
myocardial ischaemia##3##2##(1990-9#1)(1991-2#1)(2009-11#1)
myocardial ischemia and##2##3##(2008-10#1)(2009-5#1)
myocardial ischemia##8##2##(1991-3#1)(1992-11#1)(1992-6#1)(2008-10#2)(2008-7#1)(2009-5#1)(2010-5#1)
myocardial ischemic##2##2##(1991-3#1)(2009-10#1)
myocardial perfusion imaging##3##3##(2009-10#1)(2009-5#1)(2012-2#1)
myocardial perfusion##7##2##(1996-3#1)(2008-3#1)(2009-10#2)(2009-5#1)(2012-2#1)(2013-8#1)
myocardial protection##2##2##(1991-3#2)
myocardial regeneration##3##2##(2010-6#3)
myocardial revascularization##2##2##(1993-12#1)(2013-8#1)
myocardial stunning##4##2##(1991-3#3)(2008-10#1)
myocardial viability##4##2##(1992-5#1)(2009-10#1)(2012-2#2)
myocardial##202##1##(1990-11#1)(1990-12#2)(1990-9#5)(1991-2#1)(1991-3#10)(1991-6#6)(1992-11#1)(1992-12#2)(1992-3#4)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#2)(1994-12#3)(1994-6#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#1)(1995-8#2)(1996-2#3)(1996-3#3)(1996-8#1)(1997-3#1)(1997-5#1)(2008-10#14)(2008-11#11)(2008-12#7)(2008-3#16)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2009-10#6)(2009-11#1)(2009-5#5)(2009-6#2)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#2)(2011-2#12)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#7)(2013-8#14)
myocarditis presenting as##2##3##(2008-11#2)
myocarditis##9##1##(1997-8#1)(2008-11#2)(2010-7#3)(2012-3#3)
myocardium##24##1##(1990-9#2)(1992-5#1)(1992-6#1)(1994-8#2)(2008-10#3)(2008-7#3)(2008-8#1)(2010-6#4)(2011-2#2)(2012-3#3)(2013-1#2)
myoclonus##3##1##(1995-8#1)(2008-5#1)(2008-7#1)
myocutaneous flap##5##2##(1990-9#2)(1993-11#1)(2013-1#2)
myocutaneous##6##1##(1990-9#2)(1993-11#1)(1994-12#1)(2013-1#2)
myocyte##4##1##(1994-11#1)(2008-10#3)
myocytes in##3##2##(1993-3#1)(2008-7#2)
myocytes##27##1##(1992-3#1)(1992-6#2)(1993-3#7)(1994-11#2)(1994-8#3)(1995-11#2)(1996-2#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-7#1)(2013-1#1)
myoelectric activity##3##2##(2008-12#2)(2008-9#1)
myoelectric##5##1##(2008-12#3)(2008-9#2)
myoepithelial cells##4##2##(1994-12#1)(2008-7#1)(2011-2#2)
myoepithelial##7##1##(1994-12#1)(2008-7#1)(2009-12#1)(2011-2#4)
myoepithelioma##3##1##(2013-1#3)
myofascial pain##2##2##(1991-2#1)(2008-12#1)
myofascial trigger points in##2##4##(2008-12#1)(2010-9#1)
myofascial trigger points##6##3##(2008-12#2)(2010-12#2)(2010-9#2)
myofascial trigger##7##2##(2008-12#2)(2010-12#2)(2010-9#2)(2013-1#1)
myofascial##13##1##(1991-2#1)(2008-12#3)(2009-1#3)(2009-9#1)(2010-12#2)(2010-9#2)(2013-1#1)
myofibrillar##2##1##(2010-12#1)(2010-4#1)
myofibrils##5##1##(1994-5#1)(2009-7#3)(2010-12#1)
myofibroblasts##2##1##(1997-8#2)
myofibroma##3##1##(2010-6#3)
myogenesis##7##1##(1993-12#3)(1993-3#2)(2008-11#1)(2008-9#1)
myogenic autoregulation##3##2##(2009-1#3)
myogenic cells##2##2##(1993-8#1)(2008-11#1)
myogenic differentiation##2##2##(1993-3#1)(2010-12#1)
myogenic factors##5##2##(1995-6#5)
myogenic precursor cells##5##3##(1995-8#5)
myogenic regulatory factors##2##3##(1993-12#1)(1995-6#1)
myogenic##26##1##(1990-8#1)(1993-12#1)(1993-3#2)(1993-8#2)(1995-6#6)(1995-8#5)(2008-11#4)(2009-1#4)(2010-12#1)
myoglobin (MG)##2##2##(2008-10#2)
myoglobin (Mb)##5##2##(1994-5#1)(2008-10#3)(2010-4#1)
myoglobin##16##1##(1990-8#2)(1994-5#3)(2008-10#8)(2010-4#2)(2011-2#1)
myoglobins##2##1##(2010-4#2)
myoid##4##1##(2009-10#2)(2010-6#2)
myoinositol##2##1##(2008-7#2)
myolipoma##4##1##(2008-7#4)
myolysis##3##1##(1994-2#3)
myomatous polyps##2##2##(1994-2#2)
myomatous##4##1##(1994-2#3)(2011-2#1)
myomectomy for##2##2##(1993-3#1)(2012-3#1)
myomectomy using the argon beam coagulator##2##6##(1993-12#2)
myomectomy##7##1##(1993-12#2)(1993-3#1)(1994-2#2)(2011-1#1)(2012-3#1)
myometrial activity and##2##3##(1994-3#2)
myometrial activity##4##2##(1994-3#4)
myometrial invasion##2##2##(2011-2#2)
myometrial##14##1##(1992-6#1)(1993-1#1)(1994-3#8)(1994-8#1)(2011-2#3)
myometrium by##2##2##(1994-3#2)
myometrium##7##1##(1990-11#1)(1994-3#2)(1994-8#3)(2012-2#1)
myopathic##2##1##(2008-7#1)(2012-2#1)
myopathies##6##1##(1995-2#1)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#2)
myopathy in##2##2##(1995-12#1)(2013-1#1)
myopathy with##2##2##(2008-10#1)(2008-7#1)
myopathy##15##1##(1990-3#1)(1994-11#1)(1995-12#2)(2008-10#2)(2008-5#1)(2008-7#4)(2011-2#1)(2012-3#1)(2013-1#2)
myopathy'##2##1##(2008-7#2)
myopia progression##4##2##(2010-1#4)
myopia##9##1##(1991-2#1)(2010-1#6)(2011-2#1)(2013-1#1)
myopic shift in absence of anterior##2##6##(2011-2#2)
myopic##5##1##(2010-1#1)(2011-2#2)(2013-1#2)
myosin S1##2##2##(1994-5#2)
myosin head##4##2##(1991-5#3)(1993-9#1)
myosin heads were##2##3##(1991-5#1)(1995-2#1)
myosin heads##3##2##(1991-5#1)(1994-5#1)(1995-2#1)
myosin heavy chain gene expression##4##5##(1992-3#4)
myosin heavy chain gene##5##4##(1992-3#5)
myosin heavy chain##12##3##(1992-3#7)(1995-6#1)(1995-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
myosin light chain kinase##6##4##(1992-6#2)(1993-8#4)
myosin light chain##10##3##(1990-5#1)(1992-6#2)(1993-8#4)(1994-11#3)
myosin light##11##2##(1990-5#1)(1992-6#2)(1993-8#4)(1993-9#1)(1994-11#3)
myosin subfragment 1##2##3##(1992-4#1)(1994-5#1)
myosin##56##1##(1990-5#1)(1991-5#5)(1992-3#8)(1992-4#2)(1992-6#2)(1992-9#1)(1993-6#4)(1993-8#4)(1993-9#5)(1994-11#3)(1994-5#4)(1995-12#4)(1995-2#2)(1995-6#1)(1995-8#1)(1996-8#1)(2008-11#1)(2008-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
myosin-dependent##2##1##(2008-11#2)
myosins##5##1##(2008-11#5)
myositis is##4##2##(2011-2#3)(2013-1#1)
myositis##17##1##(2008-7#2)(2011-2#6)(2012-2#3)(2013-1#5)(2013-8#1)
myotatic reflexes##2##2##(1995-8#2)
myotatic##3##1##(1995-8#3)
myotomy and##3##2##(1992-9#2)(2011-2#1)
myotomy##10##1##(1990-12#4)(1992-6#2)(1992-9#3)(2011-2#1)
myotonic dystrophy##4##2##(2008-7#2)(2013-1#2)
myotonic myopathy##2##2##(2008-7#2)
myotonic##8##1##(2008-7#6)(2013-1#2)
myotubes and##2##2##(1993-3#1)(1995-6#1)
myotubes as##2##2##(1990-5#1)(2008-11#1)
myotubes in culture##2##3##(1995-6#2)
myotubes in##4##2##(1994-11#1)(1995-6#2)(2008-11#1)
myotubes##28##1##(1990-5#1)(1993-3#1)(1994-11#4)(1995-6#5)(1995-8#1)(2008-11#16)
myriad of##12##2##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
myriad##14##1##(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
myriotylum##3##1##(2008-10#3)
myristic acid co-chemisorption##3##3##(2008-10#3)
myristic acid##6##2##(2008-10#6)
myristic acids##2##2##(2008-10#2)
myristic##11##1##(2008-10#11)
myristoyl##2##1##(1990-12#2)
myristoylated pp60c-src##2##2##(1990-12#2)
myristoylated##4##1##(1990-10#1)(1990-12#2)(2008-9#1)
myristoylation of##2##2##(1990-12#2)
myristoylation##5##1##(1990-12#3)(2009-8#2)
myrmecophagy##2##1##(2012-3#2)
mysteries##3##1##(1997-1#1)(2008-5#1)(2009-1#1)
mystery##9##1##(1990-11#1)(1996-12#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-8#1)(2011-2#1)
myth or reality?##2##3##(1991-8#1)(2008-11#1)
myth##5##1##(1991-8#1)(2008-11#2)(2010-4#1)(2011-2#1)
myths about##2##2##(1993-3#1)(1997-6#1)
myths##6##1##(1992-1#1)(1993-3#1)(1997-1#1)(1997-6#1)(2008-4#1)(2010-4#1)
myxoid##7##1##(1993-2#2)(2008-11#1)(2010-6#2)(2013-1#2)
myxoma arising from the inferior vena cava##2##7##(2008-11#2)
myxoma##10##1##(2007-12#2)(2008-11#4)(2009-6#1)(2012-12#2)(2013-1#1)
myxomatous##4##1##(2008-11#1)(2008-12#1)(2010-12#2)
myxome##2##1##(2013-1#2)
mécanique##3##1##(2011-2#1)(2013-1#2)
médicale##3##1##(2011-2#2)(2013-1#1)
müllerian##3##1##(1990-2#1)(2011-2#2)
n = 10##2##3##(2010-1#2)
n = 10)##4##3##(1992-11#1)(2008-10#2)(2008-5#1)
n = 12)##2##3##(1994-3#1)(2008-10#1)
n = 14##2##3##(1990-8#1)(2008-5#1)
n = 15##3##3##(2008-10#3)
n = 16)##2##3##(1990-8#1)(1997-1#1)
n = 18##2##3##(2008-10#2)
n = 3##2##3##(1994-3#1)(2008-10#1)
n = 5)##3##3##(2008-10#1)(2009-11#2)
n = 9)##3##3##(1993-3#1)(2008-10#2)
n =##59##2##(1990-8#2)(1991-5#1)(1992-11#2)(1993-11#2)(1993-3#2)(1994-3#4)(1996-2#2)(1997-1#2)(2008-10#19)(2008-11#1)(2008-3#3)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-7#4)(2009-9#1)(2010-1#2)(2010-4#1)(2012-3#1)
n in##2##2##(2008-10#1)(2008-3#1)
n of the##2##3##(1991-7#1)(2008-2#1)
n value##2##2##(1994-5#2)
n##100##1##(1990-3#3)(1990-8#2)(1990-9#3)(1991-5#1)(1991-7#2)(1992-11#2)(1992-12#1)(1993-11#2)(1993-3#2)(1994-3#4)(1994-5#2)(1996-2#2)(1997-1#2)(2008-10#33)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#2)(2009-7#4)(2009-9#1)(2010-1#2)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-3#1)
n(2)##2##1##(2008-3#2)
n- and##3##2##(1994-8#1)(1996-12#1)(2012-2#1)
n-3 FAs##2##2##(2013-1#2)
n-3 PUFA##6##2##(2010-6#2)(2013-1#4)
n-3 PUFAs##9##2##(2010-6#1)(2013-1#8)
n-3 fatty##2##2##(2013-1#2)
n-3##21##1##(2010-6#3)(2013-1#17)(2013-8#1)
n-6##2##1##(2013-1#2)
n-6/n-3##2##1##(2010-4#1)(2013-1#1)
n-alkane assimilation##3##2##(1991-9#1)(1993-12#2)
n-alkane##5##1##(1991-9#2)(1993-12#2)(2008-10#1)
n-alkanes##6##1##(2008-10#2)(2010-3#3)(2013-8#1)
n-butanol fraction##3##2##(2008-10#3)
n-butanol##5##1##(2008-10#4)(2008-5#1)
n-butyl##5##1##(1992-12#1)(2008-10#4)
n-butylamine in the range of##2##5##(2008-10#2)
n-butylamine##4##1##(2008-10#4)
n-butyric##4##1##(2008-10#4)
n-dodecane##2##1##(1996-5#2)
n-heptane##2##1##(2008-10#2)
n-hexane and##2##2##(2008-10#2)
n-hexane##11##1##(2008-10#9)(2008-7#2)
n-octylphenol##2##1##(2008-11#2)
n-valeric##2##1##(2008-10#2)
n=10##2##1##(2008-10#2)
n=10) and in agreement with##2##5##(2008-10#2)
n=10)##12##1##(2008-10#12)
n=11)##5##1##(2008-10#5)
n=12)##2##1##(2008-10#2)
n=14)##2##1##(2008-10#2)
n=20)##2##1##(2008-10#2)
n=3##3##1##(2008-10#2)(2008-6#1)
n=3)##5##1##(2008-10#4)(2013-1#1)
n=30) as##2##2##(2010-7#2)
n=30)##3##1##(2010-7#3)
n=36##2##1##(2008-10#2)
n=36)##2##1##(2008-10#2)
n=4##3##1##(2008-10#3)
n=5) was##2##2##(2008-10#2)
n=5) were##2##2##(2008-10#2)
n=5)##9##1##(2008-10#8)(2013-1#1)
n=6 per concentration level)##3##4##(2008-10#3)
n=6)##5##1##(2008-10#5)
n=7##2##1##(2008-10#2)
n=7) and##2##2##(2008-10#2)
n=7)##9##1##(2008-10#9)
n=8)##3##1##(2008-10#3)
nA and##2##2##(2008-10#2)
nA microg(-1) ml(-1)##2##3##(2008-10#2)
nA##13##1##(1991-5#1)(2008-10#12)
nA/muM for##2##2##(2008-10#2)
nG-hPRL##2##1##(2008-11#2)
nH = 1##2##3##(1994-5#2)
nH(2)O##2##1##(2008-10#2)
nJ##2##1##(2008-3#2)
nL cell(-1) day(-1)##3##3##(2008-11#3)
nLM##2##1##(2008-8#2)
nM and##7##2##(1990-8#1)(1993-6#1)(1994-8#1)(1995-11#1)(2008-10#3)
nM detection##2##2##(2008-10#2)
nM for##3##2##(1990-8#1)(1994-3#2)
nM in##2##2##(1990-2#1)(1994-8#1)
nM of##3##2##(1992-6#1)(2008-11#1)(2008-5#1)
nM to##5##2##(1993-8#1)(1994-5#1)(2008-10#2)(2008-11#1)
nM with##2##2##(1990-11#1)(1995-8#1)
nM##100##1##(1990-11#1)(1990-2#4)(1990-5#1)(1990-8#4)(1991-5#3)(1992-6#4)(1993-3#2)(1993-6#4)(1993-8#2)(1994-11#4)(1994-3#2)(1994-5#1)(1994-8#7)(1995-11#3)(1995-12#4)(1995-2#6)(1995-8#3)(1996-12#1)(1996-2#5)(1997-4#1)(2008-10#23)(2008-11#10)(2008-12#1)(2008-5#1)(2008-6#3)
nM) and okadaic acid##2##4##(1995-8#2)
nM) and##14##2##(1992-8#1)(1993-6#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-8#4)(2006-6#1)(2008-6#1)
nM) in the##2##3##(1994-11#1)(1994-2#1)
nM) is##2##2##(1990-11#1)(1992-8#1)
nM) produced a concentration-dependent potentiation of the##2##7##(1997-4#2)
nM) with a##2##3##(1994-11#1)(1994-8#1)
nM)##67##1##(1990-11#3)(1991-5#3)(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#4)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-2#2)(1994-3#2)(1994-8#6)(1995-11#3)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#7)(1996-12#1)(1997-1#2)(1997-4#5)(2006-6#1)(2008-10#4)(2008-11#3)(2008-6#2)(2009-12#1)(2013-1#1)
nM-1##2##1##(1995-11#1)(1997-4#1)
nNOS protein##3##2##(1996-12#3)
nNOS##7##1##(1996-12#6)(2009-10#1)
nPEP##2##1##(2012-3#2)
nW of##2##2##(2008-3#2)
nacre##4##1##(2012-2#4)
nadir##4##1##(2007-12#1)(2008-3#3)
naevi##3##1##(2011-2#2)(2012-3#1)
nafion coating##2##2##(2008-10#2)
nafion film coated glassy carbon electrode##2##6##(2008-10#2)
nafion##15##1##(2008-10#15)
nagging##2##1##(1995-1#1)(2010-6#1)
nail enamel##2##2##(2008-5#2)
nail enamels##3##2##(2008-5#3)
nail fixation##2##2##(2010-5#1)(2013-1#1)
nail##32##1##(2008-5#9)(2008-8#3)(2008-9#2)(2009-3#2)(2010-11#1)(2010-5#3)(2010-6#2)(2011-2#2)(2012-2#1)(2013-1#7)
nailing##2##1##(2008-8#1)(2009-3#1)
nails##9##1##(2008-5#9)
naive CD4(+) T cells##5##4##(2008-11#5)
naive and##2##2##(1994-11#1)(1995-12#1)
naive rats##2##2##(1994-2#2)
naive##20##1##(1994-11#1)(1994-2#2)(1995-12#4)(2008-10#1)(2008-11#6)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#2)
naked eye##3##2##(2008-10#3)
naked##9##1##(2008-10#3)(2008-5#3)(2008-8#2)(2013-1#1)
naked-eye##2##1##(1995-11#1)(2008-10#1)
nalbuphine##4##1##(1993-1#4)
nalidixic acid (NA) and##2##4##(2008-10#1)(2011-1#1)
nalidixic acid and##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
nalidixic acid##14##2##(2008-10#6)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)
naloxonazine##5##1##(1996-2#5)
naloxone##6##1##(1991-1#1)(1991-8#1)(1992-3#1)(1995-12#1)(1996-2#2)
naloxone-induced jumping behaviour in morphine-dependent mice##2##6##(1996-2#2)
naloxone-induced jumping##3##2##(1996-2#3)
naltrexone##7##1##(1991-1#3)(2008-12#2)(2008-6#1)(2009-7#1)
name Tomato leaf curl##2##4##(2008-10#2)
name a##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
name and##3##2##(2008-11#1)(2013-8#2)
name are##2##2##(2008-10#1)(2008-4#1)
name for a##2##3##(1990-11#1)(1991-11#1)
name for the##2##3##(2008-10#1)(2011-2#1)
name for##5##2##(1990-11#1)(1991-11#1)(2008-10#2)(2011-2#1)
name of P##2##3##(2008-10#2)
name of the##5##3##(1990-11#1)(1993-12#1)(1995-3#1)(2008-11#1)(2012-12#1)
name of##9##2##(1990-11#1)(1993-12#1)(1995-3#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)
name to##2##2##(2008-10#1)(2012-3#1)
name##83##1##(1990-11#4)(1990-6#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#2)(1994-2#1)(1995-3#1)(1996-11#1)(2008-10#28)(2008-11#8)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#4)
named &quot##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
named as &quot##2##3##(2010-7#1)(2011-1#1)
named as##8##2##(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)
named gene##2##2##(2008-10#2)
named human##2##2##(2008-11#1)(2008-8#1)
named species and##3##3##(2008-10#2)(2011-2#1)
named species##4##2##(2008-10#3)(2011-2#1)
named the##6##2##(1996-12#1)(2008-10#4)(2008-11#1)
named##125##1##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-8#1)(1993-2#2)(1993-8#1)(1994-11#1)(1995-12#2)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-7#2)(1997-8#2)(2008-10#47)(2008-11#8)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#14)(2008-9#4)(2009-10#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
namely a##4##2##(2008-10#2)(2008-7#1)(2011-1#1)
namely gallic acid##2##3##(2008-10#1)(2011-1#1)
namely in##4##2##(1997-7#1)(2008-10#2)(2009-6#1)
namely that##2##2##(2011-2#1)(2013-8#1)
namely the input layer##2##4##(2010-8#2)
namely the##18##2##(1996-3#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#2)(2011-2#1)(2013-8#1)
namely##186##1##(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-1#2)(2008-10#66)(2008-11#21)(2008-12#6)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#3)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#7)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
names for##2##2##(1990-11#2)
names of cities##2##3##(1990-11#2)
names of##4##2##(1990-11#2)(2008-10#2)
names##14##1##(1990-11#4)(1991-2#1)(1995-6#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-8#3)
naming and##2##2##(1994-3#1)(2011-1#1)
naming##11##1##(1994-3#4)(1996-2#4)(1997-3#1)(2008-10#1)(2011-1#1)
nanjiensis##2##1##(2008-8#2)
nano##3##1##(2009-12#1)(2009-7#1)(2010-9#1)
nano-Au##4##1##(2008-10#4)
nano-LC and##2##2##(2010-11#2)
nano-fibrous##2##1##(2009-7#2)
nano-scale##4##1##(2008-10#2)(2010-9#1)(2012-2#1)
nano-sized##2##1##(2008-10#1)(2008-8#1)
nano-structured##2##1##(2008-10#1)(2009-12#1)
nanoFePc##2##1##(2008-10#2)
nanoadjuvants##2##1##(2012-2#2)
nanoarrays##3##1##(2008-10#3)
nanocapsules##2##1##(2008-10#1)(2013-1#1)
nanoceria particles##3##2##(2008-7#3)
nanochannel##2##1##(2008-10#2)
nanochannels##4##1##(2008-10#4)
nanoclusters was##2##2##(2008-10#2)
nanoclusters##6##1##(2008-10#4)(2009-8#1)(2010-4#1)
nanocomposite##5##1##(2008-10#3)(2009-12#1)(2010-6#1)
nanocomposites##3##1##(2008-10#3)
nanocrystal##3##1##(2008-10#2)(2008-2#1)
nanocrystalline##6##1##(1995-3#1)(2008-10#1)(2009-11#2)(2010-4#2)
nanocrystals##8##1##(2008-10#7)(2010-7#1)
nanoelectrode##2##1##(2008-10#2)
nanoelectrodes##6##1##(2008-10#6)
nanoelectronics##2##1##(2008-10#1)(2008-7#1)
nanoemulsion##3##1##(2008-5#2)(2011-3#1)
nanoemulsion-in situ gel system##2##4##(2011-3#2)
nanoemulsion-in situ gel##3##3##(2011-3#3)
nanofibers can##2##2##(2009-12#2)
nanofibers##3##1##(2009-12#3)
nanofilter array chip##2##3##(2008-10#2)
nanofilter##4##1##(2008-10#4)
nanofluidic##2##1##(2008-10#2)
nanoformulations##2##1##(2013-1#2)
nanogram amounts of##4##3##(1990-12#1)(2008-10#2)(2009-12#1)
nanogram amounts##5##2##(1990-12#1)(1991-2#1)(2008-10#2)(2009-12#1)
nanogram level of##3##3##(2008-10#3)
nanogram level##6##2##(2008-10#6)
nanogram levels##4##2##(2008-10#4)
nanogram quantities##4##2##(2008-10#4)
nanogram##24##1##(1990-12#1)(1991-2#1)(1993-1#1)(1997-2#1)(2008-10#18)(2008-4#1)(2009-12#1)
nanograms per milliliter##2##3##(2008-10#2)
nanograms per##4##2##(2008-10#4)
nanoindentation and Raman microspectroscopy##2##4##(2010-10#2)
nanoindentation techniques##2##2##(2008-10#1)(2009-7#1)
nanoindentation##10##1##(2008-10#1)(2009-7#2)(2010-10#3)(2010-4#3)(2012-2#1)
nanomaterial##4##1##(2008-10#3)(2010-4#1)
nanomaterials##9##1##(2010-12#2)(2010-4#1)(2010-7#6)
nanomatrices##2##1##(2010-6#2)
nanometer scale and##2##3##(2008-3#1)(2009-12#1)
nanometer scale##3##2##(2008-3#1)(2008-8#1)(2009-12#1)
nanometer##11##1##(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)
nanometer-sized##6##1##(2008-10#4)(2008-12#2)
nanometers##5##1##(1995-6#1)(2008-10#4)
nanomolar and##2##2##(2008-10#2)
nanomolar concentrations of##3##3##(1994-6#1)(2008-10#2)
nanomolar concentrations##6##2##(1994-6#1)(2008-10#4)(2012-2#1)
nanomolar levels##2##2##(2008-10#2)
nanomolar##24##1##(1990-12#3)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(2008-10#15)(2008-5#1)(2012-2#1)
nanomoles##2##1##(1993-8#2)
nanoparticle##14##1##(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
nanoparticle-based electrode##2##2##(2008-12#2)
nanoparticle-based##3##1##(2008-10#1)(2008-12#2)
nanoparticles and##2##2##(2008-10#2)
nanoparticles are##4##2##(2008-7#1)(2010-4#2)(2012-2#1)
nanoparticles for##5##2##(2008-10#3)(2008-7#1)(2012-12#1)
nanoparticles has##2##2##(2008-10#1)(2012-2#1)
nanoparticles have been##2##3##(2008-10#1)(2008-11#1)
nanoparticles have##4##2##(2008-10#3)(2008-11#1)
nanoparticles in##5##2##(2008-10#1)(2011-2#1)(2012-2#3)
nanoparticles modified##2##2##(2008-10#1)(2011-2#1)
nanoparticles network##2##2##(2008-10#2)
nanoparticles of##3##2##(2008-10#2)(2010-4#1)
nanoparticles was investigated##2##3##(2008-10#1)(2010-4#1)
nanoparticles was##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
nanoparticles were##6##2##(2008-10#4)(2010-4#1)(2011-2#1)
nanoparticles with##2##2##(2008-10#1)(2012-2#1)
nanoparticles##114##1##(1997-1#2)(2008-10#66)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#10)(2009-5#1)(2009-7#1)(2010-4#8)(2011-2#7)(2012-12#3)(2012-2#8)(2013-1#1)
nanoparticulate##2##1##(2010-4#2)
nanopatterning##3##1##(2008-10#3)
nanopore##3##1##(2009-7#3)
nanorods##5##1##(2008-10#1)(2010-1#1)(2012-12#2)(2013-1#1)
nanoscale##14##1##(2008-10#3)(2009-11#3)(2009-7#2)(2010-4#2)(2010-6#1)(2010-7#2)(2012-2#1)
nanosecond##5##1##(1990-8#2)(1996-5#1)(2007-12#1)(2008-10#1)
nanosensor##5##1##(2008-10#5)
nanosensors and##2##2##(2008-10#2)
nanosensors based on##2##3##(2008-10#2)
nanosensors##7##1##(2008-10#7)
nanosize##2##1##(2009-7#2)
nanosized LaCoO(3)##2##2##(2008-10#2)
nanosized Y(2)O(3)-based catalytic##2##3##(2008-10#2)
nanosized catalysts##2##2##(2008-10#2)
nanosized gamma-Fe(2)O(3)##2##2##(2008-10#2)
nanosized materials##2##2##(2008-10#2)
nanosized##13##1##(2008-10#13)
nanosphere##2##1##(2008-10#2)
nanostructure##6##1##(1992-11#1)(2008-10#2)(2010-12#2)(2010-4#1)
nanostructured diamond##3##2##(2008-10#3)
nanostructured electrochemical##2##2##(2008-10#2)
nanostructured gold##2##2##(2008-10#2)
nanostructured##18##1##(2008-10#10)(2009-12#8)
nanostructures that are##2##3##(2008-10#1)(2011-2#1)
nanostructures that##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
nanostructures##20##1##(2008-10#5)(2008-7#1)(2009-12#2)(2010-12#5)(2010-7#3)(2011-2#3)(2012-2#1)
nanotech familiarity##2##2##(2010-12#2)
nanotechnology development##2##2##(2010-12#2)
nanotechnology patent applications##4##3##(2010-12#4)
nanotechnology##28##1##(1994-8#1)(2008-10#3)(2008-7#1)(2009-5#1)(2010-12#19)(2010-7#1)(2011-2#1)(2013-1#1)
nanotube powder##2##2##(2008-10#2)
nanotube##17##1##(2008-10#11)(2008-7#4)(2009-11#2)
nanotubes (MWNTs)##4##2##(2008-10#3)(2009-3#1)
nanotubes and nanotori##2##3##(2009-3#2)
nanotubes and##6##2##(2008-10#3)(2008-7#1)(2009-3#2)
nanotubes by##3##2##(2008-7#2)(2009-3#1)
nanotubes##59##1##(2008-10#34)(2008-7#8)(2009-10#2)(2009-3#6)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#4)(2013-1#1)(2013-8#1)
nanovesicles as universal##2##3##(2008-10#2)
nanovesicles as##3##2##(2008-10#3)
nanovesicles##15##1##(2008-10#15)
nanowells##2##1##(2008-10#2)
nanowires of##3##2##(2008-10#1)(2009-11#2)
nanowires##13##1##(2008-10#2)(2008-7#3)(2009-11#3)(2010-3#3)(2010-7#1)(2012-2#1)
napellus##3##1##(2008-10#3)
naphazoline nitrate and##3##3##(2008-10#3)
naphazoline##9##1##(2008-10#9)
naphthaldehyde##2##1##(2008-10#2)
naphthalene and##2##2##(2008-10#1)(2008-11#1)
naphthalene derivatives##3##2##(1993-8#1)(2008-10#2)
naphthalene diimide endcap##2##3##(2008-4#2)
naphthalene diimide##3##2##(2008-10#1)(2008-4#2)
naphthalene in the pH range of##3##6##(2008-10#3)
naphthalene in the pH range##6##5##(2008-10#6)
naphthalene is##2##2##(2008-10#1)(2008-11#1)
naphthalene was##4##2##(2008-10#4)
naphthalene##48##1##(1993-8#1)(1994-5#1)(2008-10#38)(2008-11#5)(2008-12#1)(2008-4#2)
naphthalene-2##2##1##(2008-10#2)
naphthalenesulfonate derivatives##3##2##(2008-10#3)
naphthenate in gasoline##5##3##(2008-10#5)
naphthol green B##3##3##(2008-10#3)
naphthol##7##1##(1996-5#1)(2008-10#6)
naphthyl group##3##2##(2008-10#3)
naphthyl##6##1##(2008-10#5)(2008-11#1)
naproxen and indomethacin##2##3##(2008-11#2)
naproxen and##3##2##(2008-10#1)(2008-11#2)
naproxen in pharmaceutical##2##3##(2008-10#2)
naproxen##26##1##(1994-3#3)(2008-10#19)(2008-11#4)
naproxen-induced##2##1##(2008-11#2)
napus (AC genome)##2##3##(2008-10#2)
napus L##2##2##(2008-12#2)
napus cv##3##2##(2008-10#3)
napus from the##2##3##(2008-10#2)
napus plants##2##2##(2008-10#2)
napus seed meal amendments##2##4##(2008-10#2)
napus seed meal##7##3##(2008-10#7)
napus##41##1##(2008-10#38)(2008-12#2)(2012-3#1)
napus-B##6##1##(2008-10#6)
narcolepsy##5##1##(1997-9#4)(2011-2#1)
narcotic plant##2##2##(2008-10#2)
narcotic##11##1##(1991-11#1)(1991-6#1)(1996-12#2)(1996-6#1)(2008-10#3)(2012-12#2)(2012-3#1)
narcotics and other##2##3##(2008-10#2)
narcotics and##3##2##(2008-10#3)
naringenin##5##1##(2008-11#3)(2011-2#1)(2013-8#1)
naringin##4##1##(2008-10#1)(2008-11#3)
narrative devices##2##2##(2010-3#2)
narrative of the##2##3##(2009-10#1)(2009-8#1)
narrative of##4##2##(2008-12#1)(2009-10#1)(2009-11#1)(2009-8#1)
narrative review of##2##3##(2012-3#1)(2013-1#1)
narrative review##3##2##(2012-3#2)(2013-1#1)
narrative##20##1##(2008-11#3)(2008-12#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-3#3)(2010-8#1)(2012-2#1)(2012-3#3)(2013-1#2)
narratives of##2##2##(2008-12#1)(2011-2#1)
narratives##10##1##(1993-1#1)(1994-6#2)(2008-12#4)(2010-6#1)(2011-2#1)(2013-8#1)
narrow and##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
narrow down the##2##3##(2008-12#1)(2008-8#1)
narrow in##3##2##(1997-1#1)(2008-10#1)(2008-9#1)
narrow range of##2##3##(2008-10#1)(2008-11#1)
narrow range##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
narrow spectral##2##2##(2008-3#2)
narrow the##5##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
narrow time##2##2##(1997-1#1)(2008-10#1)
narrow##75##1##(1991-2#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-3#1)(1997-1#3)(1997-3#2)(2006-6#1)(2007-12#5)(2008-10#23)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#2)(2013-1#2)
narrow-band algorithm##2##2##(2008-6#2)
narrow-band filter##2##2##(2007-12#1)(2008-10#1)
narrow-band##10##1##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#2)
narrow-bandpass optical detection system##2##4##(2008-3#2)
narrow-bore column##2##2##(2008-5#2)
narrow-bore##4##1##(1997-2#1)(2008-4#1)(2008-5#2)
narrow-linewidth##2##1##(2008-2#1)(2008-3#1)
narrow-sense heritability##5##2##(2008-10#4)(2008-8#1)
narrow-sense##6##1##(2008-10#5)(2008-8#1)
narrowed at##2##2##(2008-7#2)
narrowed##9##1##(1995-12#1)(1995-8#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-10#1)(2012-12#1)
narrower and##2##2##(2008-10#1)(2008-7#1)
narrower than for the##2##4##(1996-2#2)
narrower than##5##2##(1996-2#2)(2008-10#3)
narrower##10##1##(1994-5#1)(1995-5#1)(1996-2#2)(2008-10#5)(2008-7#1)
narrowing of the##5##3##(1994-2#1)(1996-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
narrowing##15##1##(1993-6#1)(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-1#1)(2010-7#1)(2011-2#6)
narrowly on##2##2##(2008-11#1)(2009-5#1)
narrowly##5##1##(1993-12#1)(2007-12#1)(2008-11#2)(2009-5#1)
narrows the##2##2##(1993-1#1)(2009-9#1)
nasal airway##5##2##(2008-11#3)(2013-1#2)
nasal and oral##3##3##(2008-11#2)(2011-2#1)
nasal carriers##2##2##(2011-2#2)
nasal cavity and##2##3##(1990-6#1)(2008-11#1)
nasal cavity##6##2##(1990-6#1)(1993-8#1)(1995-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
nasal discharge##4##2##(2011-2#3)(2013-1#1)
nasal mucosa##3##2##(1993-8#1)(1996-5#1)(2012-3#1)
nasal obstruction and foul smell##2##5##(2013-1#2)
nasal obstruction and##3##3##(2008-11#1)(2013-1#2)
nasal obstruction##4##2##(2008-11#1)(2012-12#1)(2013-1#2)
nasal spray##3##2##(2008-10#2)(2008-5#1)
nasal swab##2##2##(2011-2#2)
nasal swabs##3##2##(2011-2#3)
nasal tip##3##2##(1997-3#2)(2008-5#1)
nasal##68##1##(1990-6#1)(1990-9#2)(1993-2#1)(1993-8#4)(1993-9#1)(1995-9#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#5)(2007-11#1)(2008-10#4)(2008-11#10)(2008-5#2)(2009-1#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#15)(2012-12#2)(2012-3#2)(2013-1#9)
nascent RNA##2##2##(2008-9#1)(2011-2#1)
nascent protein##2##2##(1995-2#2)
nascent proteins##2##2##(1994-12#1)(1995-2#1)
nascent##20##1##(1990-5#1)(1991-5#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-3#2)
nashicola##14##1##(2008-10#14)
nasobiliary drainage##2##2##(2013-1#2)
nasolabial fold and chin of##2##5##(2008-5#2)
nasolabial fold and chin##5##4##(2008-5#5)
nasolabial fold##6##2##(2008-5#6)
nasolabial##8##1##(2008-5#8)
nasopharyngeal carcinoma##8##2##(1991-8#2)(1993-9#1)(2008-8#2)(2008-9#3)
nasopharyngeal##18##1##(1991-8#2)(1993-9#1)(1995-10#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#3)(2011-2#3)(2013-1#1)
nasopharynx##4##1##(1993-9#1)(1994-2#1)(1995-5#2)
nasus)##2##1##(2008-10#2)
nat##5##1##(1996-9#2)(1997-2#1)(1997-8#2)
natal philopatry##2##2##(2008-8#2)
natal##7##1##(2008-8#5)(2008-9#1)(2010-4#1)
natalizumab##2##1##(2010-12#1)(2012-3#1)
nation##13##1##(1991-2#1)(1991-8#1)(1992-12#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2011-2#1)
nation's health##5##2##(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2010-1#1)
nation's##12##1##(1992-11#1)(1992-2#1)(1992-8#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-11#1)(2010-1#1)
nation-wide##3##1##(1990-9#1)(1994-12#2)
national 5 A Day##2##4##(1997-1#2)
national agenda##3##2##(2008-1#1)(2008-11#2)
national and international##6##3##(1997-7#1)(2008-10#1)(2008-11#2)(2012-2#1)(2012-3#1)
national and state##3##3##(1995-1#1)(2008-11#2)
national and##11##2##(1991-1#1)(1995-1#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2012-2#1)(2012-3#1)
national average##7##2##(1992-12#1)(1993-12#1)(2008-10#4)(2008-11#1)
national cancer control##2##3##(2011-3#2)
national data##3##2##(1992-2#1)(1997-3#1)(2007-12#1)
national debate##2##2##(1991-3#1)(1993-12#1)
national diet##2##2##(2008-3#2)
national economic indicators##5##3##(1991-1#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-2#1)
national economy##3##2##(1994-2#1)(2008-9#1)(2010-1#1)
national guidelines##2##2##(1996-12#1)(2013-1#1)
national health care reform##2##4##(1995-12#1)(1995-2#1)
national health care system##2##4##(1994-2#2)
national health care##7##3##(1994-2#2)(1995-12#3)(1995-2#1)(2008-11#1)
national health insurance##3##3##(1991-3#1)(1994-2#1)(2008-11#1)
national health##19##2##(1991-2#1)(1991-3#1)(1993-2#1)(1994-12#1)(1994-2#3)(1995-12#3)(1995-2#1)(1997-2#1)(2008-1#3)(2008-11#2)(2008-7#1)(2011-2#1)
national hospital##2##2##(1992-2#1)(2013-1#1)
national identity##2##2##(2008-10#1)(2011-2#1)
national level##3##2##(1994-2#1)(1995-12#1)(2008-10#1)
national monitoring##2##2##(1995-12#1)(2008-10#1)
national policy##4##2##(2008-1#1)(2008-11#1)(2010-10#1)(2010-7#1)
national priorities##2##2##(1994-2#1)(2008-11#1)
national problem##2##2##(2011-2#2)
national program##2##2##(1997-2#1)(2008-10#1)
national public health surveillance##3##4##(1997-3#3)
national public health##4##3##(1997-3#4)
national requirements##2##2##(1994-12#1)(2009-12#1)
national sample##4##2##(1993-12#1)(1994-1#1)(1995-12#1)(2009-7#1)
national standard##2##2##(1996-12#1)(2008-10#1)
national standards for##2##3##(1996-12#1)(2008-11#1)
national standards##7##2##(1994-3#2)(1996-12#1)(2008-11#1)(2008-12#1)(2012-3#2)
national surveillance##2##2##(1997-3#1)(2008-10#1)
national survey##7##2##(1991-11#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(2011-2#1)(2012-2#1)
national surveys to##2##3##(1991-9#1)(1992-1#1)
national system##2##2##(1992-1#1)(1994-6#1)
national##229##1##(1990-3#1)(1990-6#1)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#4)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#4)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#9)(1994-2#9)(1994-3#5)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#2)(1997-1#5)(1997-2#5)(1997-3#7)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#3)(2007-8#1)(2008-1#9)(2008-10#21)(2008-11#20)(2008-12#5)(2008-3#3)(2008-7#3)(2008-9#4)(2009-11#1)(2009-12#2)(2009-5#3)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#3)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#2)
nationality##5##1##(1991-2#1)(1994-6#1)(2009-8#1)(2011-2#2)
nationally and internationally##2##3##(1993-2#1)(2008-12#1)
nationally in the##2##3##(2012-12#1)(2013-1#1)
nationally representative##9##2##(1993-1#1)(1997-1#1)(2009-10#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
nationally##26##1##(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#2)(1996-5#1)(1997-1#1)(1997-3#1)(2008-11#2)(2008-12#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
nations are##2##2##(1992-1#1)(2007-12#1)
nations have##2##2##(2008-11#2)
nations##18##1##(1992-1#2)(1993-2#1)(2007-12#2)(2008-1#3)(2008-10#1)(2008-11#2)(2010-3#1)(2012-2#2)(2012-3#2)(2013-1#2)
nationwide and##2##2##(1991-3#1)(1992-12#1)
nationwide##21##1##(1990-12#1)(1990-6#1)(1991-11#2)(1991-3#1)(1992-12#1)(1993-12#2)(1994-12#1)(1995-1#1)(1997-1#3)(2008-11#1)(2008-6#1)(2009-7#1)(2009-8#1)(2011-9#2)(2012-2#1)(2013-8#1)
nativa (T2)##2##2##(1996-12#2)
native LDL##3##2##(2008-10#1)(2009-8#2)
native Solanum spp##2##3##(2008-10#2)
native Ssh7##2##2##(2008-9#2)
native and denatured##5##3##(1990-5#1)(1995-3#1)(2008-10#2)(2008-8#1)
native and recombinant##2##3##(2008-9#1)(2011-2#1)
native and##19##2##(1990-5#2)(1992-8#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-3#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
native arteries##5##2##(2011-2#5)
native disease##2##2##(2011-2#2)
native enzyme##14##2##(1990-5#3)(1992-3#1)(1993-8#2)(1994-11#1)(1994-6#1)(1995-6#4)(2008-10#1)(2008-8#1)
native fluorescence of##3##3##(2008-10#3)
native fluorescence##11##2##(2008-10#11)
native form##2##2##(2008-10#1)(2010-5#1)
native gel##3##2##(2008-10#1)(2008-11#2)
native habitats##2##2##(2008-10#1)(2011-2#1)
native host isolates##2##3##(2008-10#2)
native human##4##2##(1994-11#2)(2008-11#1)(2008-5#1)
native liver##2##2##(1993-8#1)(1994-8#1)
native peptide##2##2##(1994-8#1)(2011-2#1)
native phycoerythrin##2##2##(2008-8#2)
native polyacrylamide gel electrophoresis##2##4##(2008-11#1)(2010-3#1)
native populations##3##2##(2008-10#3)
native promoter##2##2##(2008-7#1)(2009-8#1)
native protein##8##2##(1990-5#1)(1992-8#1)(1993-8#2)(1994-11#1)(1997-7#1)(2008-10#1)(2008-11#1)
native proteins##2##2##(1994-5#1)(2008-4#1)
native receptors##2##2##(1993-8#1)(1995-11#1)
native state##5##2##(1997-2#1)(1997-4#1)(2008-10#3)
native to the##6##3##(2008-1#1)(2008-10#4)(2008-11#1)
native to##10##2##(2008-1#1)(2008-10#5)(2008-11#2)(2008-8#1)(2010-3#1)
native uPA##4##2##(2008-11#4)
native virus and##2##3##(2008-10#2)
native##225##1##(1990-11#2)(1990-2#2)(1990-5#7)(1990-8#1)(1991-10#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#3)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#11)(1994-11#7)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#7)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#6)(1995-8#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#66)(2008-11#12)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#16)(2008-9#9)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#14)(2011-3#1)(2012-2#3)(2013-1#5)(2013-8#1)
native-born##5##1##(2011-2#5)
nativity##2##1##(1994-12#1)(2011-2#1)
natriuretic factor##3##2##(1990-9#2)(1994-8#1)
natriuretic peptide (ANP)##5##3##(1991-5#1)(1993-8#1)(2008-5#1)(2009-5#1)(2011-2#1)
natriuretic peptide (BNP)##2##3##(1991-5#1)(2009-5#1)
natriuretic peptide (CNP) and##2##4##(1994-8#1)(2009-5#1)
natriuretic peptide in##2##3##(1991-5#1)(1994-11#1)
natriuretic peptide levels##2##3##(2008-3#1)(2011-2#1)
natriuretic peptide##24##2##(1991-5#3)(1993-8#2)(1994-11#1)(1994-8#4)(1995-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#6)(2011-2#4)
natriuretic peptides##5##2##(1994-8#1)(2009-5#4)
natriuretic##35##1##(1990-9#2)(1991-5#3)(1993-8#2)(1994-11#2)(1994-8#6)(1995-11#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-5#10)(2011-2#4)
natural abundance##4##2##(1992-4#1)(2008-10#3)
natural agents##4##2##(2009-1#3)(2010-7#1)
natural allogeneic mature DCs##2##4##(2011-2#2)
natural allogeneic mature##3##3##(2011-2#3)
natural analogs of##2##3##(1995-2#2)
natural and industrial##3##3##(2008-10#3)
natural and man-made##2##3##(2008-11#2)
natural and recombinant##2##3##(1992-8#1)(1997-2#1)
natural and sexual selection##2##4##(2012-3#2)
natural and synthetic##8##3##(2008-10#3)(2008-11#2)(2009-7#1)(2012-2#1)(2012-3#1)
natural and the##2##3##(2008-10#1)(2008-11#1)
natural and waste waters##2##4##(2008-10#2)
natural and##40##2##(1992-11#1)(1992-8#1)(1997-2#1)(2008-10#21)(2008-11#6)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#3)
natural antibodies##2##2##(1991-5#1)(1997-9#1)
natural antioxidant##3##2##(2008-5#1)(2009-8#1)(2010-4#1)
natural bacterial##2##2##(2008-10#1)(2010-6#1)
natural barrier##2##2##(2008-10#1)(2008-5#1)
natural barriers##3##2##(1996-9#1)(2008-11#1)(2011-3#1)
natural biological##2##2##(2008-10#1)(2008-11#1)
natural brines##4##2##(2008-10#4)
natural caregivers##5##2##(1992-3#5)
natural chemicals##2##2##(2008-11#1)(2011-1#1)
natural communities##2##2##(2008-8#1)(2008-9#1)
natural compounds derived from traditional Chinese##2##6##(2011-3#2)
natural compounds from traditional Chinese medicines##2##6##(2011-3#2)
natural compounds##7##2##(2011-2#1)(2011-3#6)
natural conditions##12##2##(2008-10#8)(2008-11#1)(2008-9#1)(2013-1#2)
natural cooling##2##2##(2008-10#1)(2008-5#1)
natural cosmetics##2##2##(2008-5#2)
natural course##6##2##(1990-6#1)(1992-9#1)(1997-3#1)(2008-7#1)(2010-12#1)(2013-8#1)
natural cytotoxicity##2##2##(2008-4#2)
natural dead wood##2##3##(2008-10#2)
natural diamond##2##2##(2008-10#2)
natural disaster##3##2##(1991-2#2)(2008-9#1)
natural disasters##2##2##(1991-2#1)(2012-3#1)
natural dye##2##2##(2008-10#1)(2013-1#1)
natural ecosystems##3##2##(2008-10#2)(2008-8#1)
natural enemies in##2##3##(2008-8#1)(2008-9#1)
natural enemies of##2##3##(1990-11#1)(2008-12#1)
natural enemies that##2##3##(2008-8#1)(2009-8#1)
natural enemies##10##2##(1990-11#1)(2008-12#1)(2008-8#5)(2008-9#2)(2009-8#1)
natural enemy##3##2##(2008-8#2)(2013-8#1)
natural environment##6##2##(1997-7#1)(2008-10#3)(2008-4#1)(2009-6#1)
natural environmental##2##2##(2008-10#2)
natural evolution##3##2##(1991-3#1)(1997-6#1)(1997-8#1)
natural evolutionary##2##2##(1997-6#1)(2008-10#1)
natural experiment##3##2##(1992-2#1)(1997-3#1)(2008-12#1)
natural exposure##2##2##(2008-11#1)(2008-12#1)
natural fluids##3##2##(2008-10#3)
natural food samples##3##3##(2008-10#3)
natural food##4##2##(2008-10#4)
natural forces##2##2##(2008-11#1)(2013-8#1)
natural forest##3##2##(2012-2#2)(2012-6#1)
natural forests and##2##3##(2008-10#1)(2010-4#1)
natural forests##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
natural gas##4##2##(2008-10#1)(2008-2#1)(2012-12#2)
natural groundwater##2##2##(2008-10#1)(2013-1#1)
natural habitat##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
natural health##3##2##(2008-11#2)(2010-3#1)
natural history and##2##3##(2008-10#1)(2009-8#1)
natural history of##18##3##(1990-12#1)(1991-1#1)(1991-6#2)(1993-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(2008-11#1)(2008-7#3)(2009-8#1)(2010-10#2)(2011-2#1)(2011-3#1)(2011-7#1)
natural history##29##2##(1990-12#1)(1991-1#1)(1991-6#2)(1993-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#4)(2009-8#2)(2010-10#2)(2011-2#3)(2011-3#1)(2011-7#2)(2012-12#1)(2013-8#1)
natural host##2##2##(2008-10#2)
natural human IFNalpha##2##3##(2007-11#2)
natural human##3##2##(2007-11#2)(2008-11#1)
natural humic acids##2##3##(2008-10#2)
natural humic##3##2##(2008-10#3)
natural hybrid zones##3##3##(2008-8#3)
natural image##2##2##(2008-11#1)(2008-8#1)
natural images##3##2##(2008-11#2)(2008-6#1)
natural increase##2##2##(1993-12#1)(2008-8#1)
natural infection##3##2##(2012-12#1)(2012-2#1)(2013-8#1)
natural infections in##2##3##(2008-5#1)(2012-12#1)
natural infections##4##2##(2008-10#2)(2008-5#1)(2012-12#1)
natural inoculum in##2##3##(2008-10#2)
natural inoculum##5##2##(2008-10#5)
natural isolates##2##2##(2012-3#2)
natural killer (NK) cell##5##4##(2008-10#2)(2008-9#1)(2013-1#2)
natural killer (NK) cells##4##4##(1995-2#1)(2010-1#1)(2012-3#1)(2013-1#1)
natural killer (NK)##9##3##(1995-2#1)(2008-10#2)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#3)
natural killer activity##2##3##(1994-6#1)(2008-7#1)
natural killer cell activity##4##4##(2007-11#1)(2008-10#3)
natural killer cell assay##2##4##(2008-10#2)
natural killer cell##11##3##(2007-11#1)(2008-10#6)(2008-4#2)(2008-9#1)(2012-3#1)
natural killer cells##11##3##(1990-12#3)(1995-2#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#3)
natural killer##35##2##(1990-12#3)(1994-6#1)(1995-2#2)(1996-12#2)(2007-11#1)(2008-10#9)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#3)(2010-1#1)(2012-3#2)(2013-1#6)
natural killer-like activity of##2##4##(2008-11#2)
natural killer-like activity##5##3##(2008-11#5)
natural membranes##2##2##(1991-5#2)
natural nests##2##2##(2008-8#1)(2012-2#1)
natural or##5##2##(1997-3#1)(2008-10#2)(2009-3#1)(2011-1#1)
natural organic matter##7##3##(1992-5#1)(2008-10#4)(2008-11#2)
natural origin##2##2##(2008-12#1)(2011-2#1)
natural peptides##2##2##(2008-5#1)(2013-1#1)
natural perturbations are##2##3##(2008-10#2)
natural perturbations##4##2##(2008-10#4)
natural polymers##6##2##(2008-10#3)(2008-5#1)(2012-2#2)
natural population of##4##3##(2008-10#1)(2008-9#3)
natural population##6##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#3)
natural populations of An##2##4##(2012-12#2)
natural populations of the##3##4##(2008-10#2)(2008-9#1)
natural populations of##12##3##(2008-10#5)(2008-8#1)(2008-9#2)(2012-12#2)(2012-3#2)
natural populations##30##2##(2008-10#9)(2008-8#6)(2008-9#7)(2012-12#2)(2012-3#6)
natural preservative system##3##3##(2008-5#3)
natural product HIF-1 inhibitors##2##4##(2010-7#2)
natural product##14##2##(1996-5#1)(2008-10#4)(2008-11#3)(2008-5#1)(2009-8#1)(2010-7#2)(2011-2#2)
natural products and chemical entities##2##5##(2009-2#2)
natural products and##3##3##(2009-10#1)(2009-2#2)
natural products have##2##3##(2010-7#2)
natural products##15##2##(1996-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2009-10#1)(2009-2#2)(2009-6#1)(2010-7#3)(2011-3#1)
natural progression##3##2##(2008-7#1)(2010-12#1)(2013-7#1)
natural protection##2##2##(2008-12#1)(2008-8#1)
natural rainfall##2##2##(2008-10#2)
natural reservoir##3##2##(2008-10#2)(2008-12#1)
natural resistance##3##2##(2008-10#2)(2009-6#1)
natural resources##4##2##(2008-1#1)(2008-11#1)(2010-7#2)
natural route of##2##3##(2008-9#2)
natural samples##4##2##(2008-10#3)(2011-2#1)
natural science##2##2##(2008-12#2)
natural scientists##2##2##(2008-12#1)(2009-8#1)
natural selection acting##2##3##(2008-8#1)(2012-3#1)
natural selection favors##3##3##(1995-2#1)(2008-8#1)(2009-8#1)
natural selection has##2##3##(2008-8#1)(2012-3#1)
natural selection in##6##3##(2008-9#3)(2010-4#1)(2010-5#1)(2012-3#1)
natural selection on##2##3##(2010-4#1)(2012-3#1)
natural selection##29##2##(1995-2#1)(2008-10#1)(2008-8#6)(2008-9#4)(2009-8#1)(2010-4#3)(2010-5#3)(2012-3#10)
natural shampoos##4##2##(2008-5#4)
natural soil##5##2##(2008-10#4)(2008-11#1)
natural spiked samples##2##3##(2008-10#2)
natural spring water##2##3##(2008-10#2)
natural substances##2##2##(2008-10#1)(2008-5#1)
natural succession##2##2##(2008-10#1)(2008-9#1)
natural sunlight##2##2##(2008-5#1)(2011-2#1)
natural systems##5##2##(2008-10#1)(2008-8#2)(2010-8#1)(2012-3#1)
natural tendency to##2##3##(2008-10#1)(2013-1#1)
natural transformation and electro-transformation##2##4##(1993-9#2)
natural transmission##2##2##(2008-10#1)(2012-12#1)
natural variation in##2##3##(2008-8#2)
natural virulent##2##2##(2008-10#2)
natural water sample##3##3##(2008-10#3)
natural water samples and##2##4##(2008-10#2)
natural water samples were##2##4##(2008-10#1)(2008-11#1)
natural water samples##38##3##(2008-10#37)(2008-11#1)
natural water##76##2##(2008-10#75)(2008-11#1)
natural waters and biological samples##3##5##(2008-10#3)
natural waters and soils##2##4##(2008-10#2)
natural waters and urine##2##4##(2008-10#2)
natural waters and##14##3##(2008-10#14)
natural waters##76##2##(2008-10#75)(2008-12#1)
natural##889##1##(1990-11#1)(1990-12#6)(1990-5#3)(1990-6#2)(1991-1#2)(1991-2#4)(1991-3#3)(1991-5#4)(1991-6#3)(1992-11#2)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-3#4)(1996-5#3)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-6#3)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#3)(2008-1#2)(2008-10#393)(2008-11#53)(2008-12#15)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#40)(2008-6#4)(2008-7#10)(2008-8#46)(2008-9#35)(2009-1#3)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#3)(2009-8#9)(2010-1#3)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#10)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#24)(2011-3#9)(2011-7#2)(2012-12#9)(2012-2#13)(2012-3#28)(2012-6#1)(2013-1#16)(2013-7#2)(2013-8#7)
natural&quot##3##1##(2008-1#1)(2008-10#1)(2008-9#1)
naturalism##2##1##(2008-12#1)(2013-8#1)
naturalistic##5##1##(1995-3#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-8#1)
naturally and artificially infected##2##4##(2008-10#2)
naturally and##4##2##(2008-10#3)(2011-2#1)
naturally by##2##2##(1995-2#1)(2008-10#1)
naturally contaminated raisins##4##3##(2008-10#4)
naturally contaminated##6##2##(2008-10#6)
naturally in##3##2##(2008-10#2)(2009-8#1)
naturally infected mouse##2##3##(1995-9#2)
naturally infected vines##2##3##(2008-10#2)
naturally infected##27##2##(1995-9#2)(2008-10#25)
naturally infested field##2##3##(2008-10#2)
naturally infested##13##2##(1996-12#1)(2008-10#12)
naturally inoculated##2##2##(2008-10#2)
naturally occurring dietary##2##3##(1993-11#1)(1995-9#1)
naturally occurring flightless##2##3##(2008-9#2)
naturally occurring in the##2##4##(1992-6#1)(1995-6#1)
naturally occurring in##3##3##(1992-6#1)(1995-6#1)(2011-1#1)
naturally occurring polyphenols##2##3##(2008-5#1)(2009-12#1)
naturally occurring populations##2##3##(2008-10#1)(2013-1#1)
naturally occurring resistance##2##3##(2008-10#2)
naturally occurring##59##2##(1990-11#2)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-11#4)(1994-12#1)(1995-6#1)(1995-9#2)(1996-5#1)(2008-10#24)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-7#1)(2011-1#3)(2013-1#1)
naturally or##2##2##(1992-2#1)(1996-12#1)
naturally##161##1##(1990-11#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-11#4)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#5)(1996-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(2008-10#90)(2008-11#9)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#2)
naturally-occurring##4##1##(1990-12#1)(2008-11#3)
nature and composition of the##3##5##(2008-10#3)
nature and concentration##2##3##(2008-10#2)
nature and extent of##4##4##(1997-3#1)(2008-11#1)(2008-5#1)(2012-2#1)
nature and may##3##3##(1991-2#1)(2008-8#2)
nature and##58##2##(1991-2#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#16)(2008-11#6)(2008-12#1)(2008-5#4)(2008-8#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)
nature as##2##2##(2008-12#1)(2013-1#1)
nature has##2##2##(1996-2#1)(2009-7#1)
nature in##6##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-5#1)
nature is##5##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#2)
nature of B##2##3##(2008-10#1)(2011-2#1)
nature of PVY##2##3##(2008-10#2)
nature of clinical##3##3##(2008-11#3)
nature of many##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
nature of serum##2##3##(1995-5#1)(2008-11#1)
nature of the buffer was investigated##2##6##(2008-10#2)
nature of the buffer##4##4##(2008-10#4)
nature of the data##2##4##(2008-10#1)(2008-8#1)
nature of the disease##3##4##(1991-3#1)(2010-12#1)(2012-12#1)
nature of the extracted species##2##5##(2008-10#2)
nature of the extracting##2##4##(2008-10#2)
nature of the interaction##2##4##(2008-10#1)(2008-9#1)
nature of the proteins lost from##2##6##(1991-2#2)
nature of the supporting##2##4##(2008-10#2)
nature of the##126##3##(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-5#2)(1997-1#1)(1997-8#1)(2007-12#2)(2008-10#50)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#2)
nature of their##2##3##(2008-10#1)(2013-8#1)
nature of these##9##3##(1993-8#1)(2008-10#3)(2008-11#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
nature of this##7##3##(1993-8#1)(2008-10#4)(2008-8#1)(2009-6#1)
nature of##262##2##(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#2)(2008-10#92)(2008-11#34)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#6)(2009-1#1)(2009-11#1)(2009-4#1)(2009-6#3)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#6)
nature that##2##2##(2008-12#1)(2013-1#1)
nature water##2##2##(2008-10#2)
nature##452##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-5#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#4)(1993-8#3)(1994-1#3)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#3)(2007-11#2)(2007-12#4)(2008-10#148)(2008-11#45)(2008-12#17)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#26)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#12)(2013-8#7)
nature's##2##1##(1997-6#1)(2008-10#1)
naturelle##2##1##(2008-12#1)(2010-1#1)
natures##3##1##(2008-10#2)(2008-11#1)
naturopathy##2##1##(1991-2#1)(2011-2#1)
nausea and vomiting##12##3##(1990-12#1)(1990-6#1)(2008-10#3)(2008-7#3)(2010-12#3)(2010-7#1)
nausea and##14##2##(1990-12#1)(1990-6#1)(1992-12#1)(2008-10#3)(2008-7#3)(2010-12#3)(2010-7#1)(2013-1#1)
nausea or vomiting##5##3##(2008-10#1)(2008-7#4)
nausea with##2##2##(2007-12#2)
nausea##33##1##(1990-12#2)(1990-6#1)(1992-12#2)(1997-8#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-7#11)(2010-12#3)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
nausea/vomiting##3##1##(1990-12#1)(1991-6#1)(1997-7#1)
nautilei##4##1##(2008-6#4)
nautilus##4##1##(2009-8#4)
naval##2##1##(1991-12#1)(2012-2#1)
navel orange worm##2##3##(2009-7#2)
navigate the##2##2##(1997-1#1)(1997-3#1)
navigate through##2##2##(2008-4#1)(2008-6#1)
navigate##6##1##(1997-1#1)(1997-3#2)(2008-4#1)(2008-6#1)(2009-8#1)
navigating the##3##2##(2010-9#1)(2011-1#1)(2013-1#1)
navigation of the##2##3##(1997-1#1)(1997-3#1)
navigation of##3##2##(1997-1#1)(1997-3#1)(2008-6#1)
navigation on##2##2##(1994-3#1)(2009-12#1)
navigation system##2##2##(2008-8#1)(2008-9#1)
navigation task##3##2##(2008-11#3)
navigation##20##1##(1994-3#1)(1997-1#1)(1997-3#1)(2008-11#3)(2008-6#2)(2008-8#3)(2008-9#2)(2009-12#2)(2010-11#1)(2010-6#1)(2010-7#1)(2013-1#2)
navigational##3##1##(1990-11#2)(1994-2#1)
naïve CD4(+) T cells##3##4##(2008-11#3)
naïve##10##1##(2008-11#3)(2010-10#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-8#2)
ncRNA##2##1##(2012-3#2)
ncRNAs are##2##2##(2012-3#2)
ncRNAs has##2##2##(2012-3#2)
ncRNAs##10##1##(2012-3#10)
ndsu-1A##3##1##(2008-10#3)
near 0##4##2##(1992-12#1)(2008-10#2)(2008-3#1)
near 1##4##2##(2007-11#2)(2008-3#2)
near 100%##4##2##(2008-10#4)
near 2##5##2##(2008-3#4)(2011-2#1)
near 227 nm##3##3##(2008-3#3)
near IR##2##2##(2008-3#2)
near Nernstian response##2##3##(2008-10#2)
near Nernstian##3##2##(2008-10#3)
near Quito##2##2##(2008-10#2)
near a##2##2##(2008-11#1)(2008-8#1)
near an##2##2##(1997-3#1)(2008-10#1)
near and far##2##3##(2008-11#1)(2008-2#1)
near and##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
near complete##2##2##(2009-7#2)
near equal##2##2##(2008-10#1)(2011-10#1)
near field##2##2##(2007-12#1)(2008-2#1)
near full-length##2##2##(1994-12#1)(2009-6#1)
near future##22##2##(1991-1#1)(1991-12#1)(1994-12#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-7#1)
near infra-red spectroscopy##2##3##(2008-10#1)(2013-1#1)
near infrared (NIR)##3##3##(2008-10#2)(2010-1#1)
near infrared reflectance spectroscopy (NIRS)##2##5##(2008-10#2)
near infrared region##2##3##(2008-10#2)
near infrared spectroscopy##4##3##(2008-10#4)
near infrared##21##2##(2008-10#17)(2010-1#1)(2013-8#3)
near isogenic lines for##2##4##(2008-10#2)
near isogenic lines##3##3##(2008-10#2)(2008-8#1)
near its##4##2##(1993-3#1)(1995-2#1)(2009-8#1)(2011-2#1)
near neutral##6##2##(2008-10#4)(2011-2#1)(2012-3#1)
near normal##8##2##(2008-1#2)(2008-11#1)(2010-5#1)(2010-7#1)(2012-2#3)
near nuclear##3##2##(1991-3#3)
near or##2##2##(1995-12#1)(2008-10#1)
near ore body rock##3##4##(2013-8#3)
near ore body##4##3##(2013-8#4)
near room temperature##2##3##(2008-3#1)(2009-5#1)
near term##2##2##(1992-12#1)(2010-12#1)
near the 3' end##2##4##(1993-9#1)(2008-10#1)
near the 3'##3##3##(1993-9#1)(2008-10#2)
near the end of the##3##5##(1992-12#2)(1997-2#1)
near the end of##4##4##(1992-12#2)(1997-1#1)(1997-2#1)
near the end##5##3##(1992-12#2)(1997-1#1)(1997-2#1)(1997-6#1)
near the ground##2##3##(2008-10#1)(2008-3#1)
near the left##2##3##(1990-6#1)(1997-7#1)
near the replication##2##3##(1994-11#1)(1996-12#1)
near the subsolar point##2##4##(2008-3#2)
near the telomeric region##2##4##(2008-11#2)
near the top##2##3##(1993-3#1)(2008-8#1)
near the##103##2##(1990-12#1)(1990-6#1)(1991-10#2)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#3)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#7)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-7#1)(2010-8#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
near their##2##2##(1996-11#1)(2008-8#1)
near to term##2##3##(1990-5#2)
near to the##2##3##(1990-2#1)(2008-11#1)
near to##7##2##(1990-2#1)(1990-5#2)(2008-10#3)(2008-11#1)
near total##2##2##(2008-10#2)
near vision##2##2##(2011-1#1)(2011-2#1)
near##347##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#3)(1991-6#1)(1992-10#1)(1992-12#4)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#5)(2008-1#3)(2008-10#107)(2008-11#12)(2008-12#4)(2008-2#5)(2008-3#35)(2008-5#4)(2008-7#6)(2008-8#10)(2008-9#9)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-10#1)(2011-2#9)(2011-3#2)(2012-2#6)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#10)
near-IR##4##1##(2008-3#3)(2012-12#1)
near-Nernstian response for##2##3##(2008-10#2)
near-Nernstian response over the concentration##2##5##(2008-10#2)
near-Nernstian response over the##3##4##(2008-10#3)
near-Nernstian response over##4##3##(2008-10#4)
near-Nernstian response to##2##3##(2008-10#2)
near-Nernstian response##8##2##(2008-10#8)
near-Nernstian slope of##4##3##(2008-10#4)
near-Nernstian slope##5##2##(2008-10#5)
near-Nernstian##17##1##(2008-10#17)
near-colorless##2##1##(2012-3#2)
near-field intensity##3##2##(2007-12#2)(2008-3#1)
near-field optical##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
near-field##17##1##(2007-12#4)(2008-2#2)(2008-3#10)(2009-5#1)
near-infrared (NIR) spectroscopy##2##3##(2008-10#2)
near-infrared (NIR)##8##2##(2008-10#7)(2012-2#1)
near-infrared absorption of##2##3##(2008-3#2)
near-infrared absorption##3##2##(2008-3#3)
near-infrared bands##2##2##(2008-3#2)
near-infrared diode laser##2##3##(2008-3#2)
near-infrared diode##3##2##(2008-3#3)
near-infrared fluorescence##2##2##(2007-11#1)(2008-10#1)
near-infrared lasers##2##2##(2008-3#2)
near-infrared reflectance spectroscopy##2##3##(2008-10#1)(2008-5#1)
near-infrared spectral##4##2##(2008-3#4)
near-infrared spectroscopy##6##2##(2008-10#5)(2008-7#1)
near-infrared wavelengths##3##2##(2008-2#2)(2008-3#1)
near-infrared##55##1##(2007-11#1)(2008-10#25)(2008-2#3)(2008-3#22)(2008-5#2)(2008-7#1)(2012-2#1)
near-isogenic lines (NILs)##2##3##(2008-10#2)
near-isogenic lines of Thatcher##2##4##(2008-10#2)
near-isogenic lines of##4##3##(2008-10#4)
near-isogenic lines##10##2##(2008-10#10)
near-isogenic##17##1##(2008-10#16)(2012-3#1)
near-neutral##3##1##(2008-10#1)(2010-4#2)
near-physiological conditions##2##2##(2008-9#2)
near-surface##3##1##(2008-10#1)(2008-3#2)
near-term##2##1##(2008-10#1)(2010-12#1)
near-ultraviolet##2##1##(1993-8#1)(2008-3#1)
near-zero##2##1##(1992-3#1)(2008-11#1)
nearby islands##2##2##(2008-8#2)
nearby non-AP site##3##3##(2008-10#3)
nearby##25##1##(1991-2#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-8#3)(2009-10#2)(2009-7#1)(2011-2#1)
neared##2##1##(2008-10#2)
nearer to##3##2##(2008-10#3)
nearest##10##1##(1992-12#1)(1997-4#2)(2008-10#5)(2008-6#1)(2008-9#1)
nearest-neighbor interactions##2##2##(1992-3#1)(2008-10#1)
nearly 1##2##2##(2008-11#1)(2008-9#1)
nearly 100%##2##2##(2008-10#1)(2008-11#1)
nearly 2##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
nearly 20 percent##2##3##(1994-12#1)(1996-1#1)
nearly 20 years##2##3##(2008-10#1)(2008-7#1)
nearly 20##5##2##(1992-8#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-7#1)
nearly 50% of the##2##4##(1992-3#1)(2009-8#1)
nearly 50% of##3##3##(1992-3#1)(2009-8#1)(2011-2#1)
nearly 50%##5##2##(1992-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
nearly 500##2##2##(2008-3#1)(2012-2#1)
nearly 6 weeks before##2##4##(2008-10#2)
nearly 6##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
nearly 80%##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
nearly a##3##2##(1997-7#1)(2011-1#1)(2013-1#1)
nearly all##15##2##(1990-9#1)(1995-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#2)(2010-10#1)(2011-3#1)(2012-2#2)
nearly always##2##2##(2008-8#1)(2010-4#1)
nearly as common as##2##4##(1992-11#1)(2010-6#1)
nearly as well as##2##4##(1997-1#1)(2008-10#1)
nearly as##6##2##(1992-11#1)(1997-1#1)(2008-10#2)(2008-8#1)(2010-6#1)
nearly complete##8##2##(1992-1#1)(2008-10#2)(2008-7#1)(2009-7#3)(2012-3#1)
nearly completely##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
nearly constant##4##2##(2007-12#1)(2008-10#2)(2009-1#1)
nearly equal##3##2##(2008-10#2)(2008-11#1)
nearly every##2##2##(2008-10#1)(2013-1#1)
nearly half of##2##3##(1996-11#1)(2008-10#1)
nearly half##5##2##(1996-11#1)(2008-10#2)(2009-8#1)(2013-8#1)
nearly identical to that of##2##5##(1997-2#1)(2008-10#1)
nearly identical to##6##3##(1992-3#1)(1996-8#1)(1997-2#1)(2008-10#3)
nearly identical##17##2##(1992-3#1)(1992-6#1)(1993-9#1)(1995-11#1)(1996-8#1)(1997-2#1)(2008-10#10)(2011-2#1)
nearly immune to infection within 4 weeks after##2##8##(2008-10#2)
nearly immune to infection within##3##5##(2008-10#3)
nearly immune to infection##4##4##(2008-10#4)
nearly independent of##2##3##(2008-2#1)(2008-3#1)
nearly normal life##2##3##(1996-11#1)(2011-3#1)
nearly normal##3##2##(1995-8#1)(1996-11#1)(2011-3#1)
nearly one-half##2##2##(1992-1#1)(2012-2#1)
nearly perfect##2##2##(2008-10#1)(2008-9#1)
nearly##167##1##(1990-11#1)(1990-9#1)(1991-3#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#58)(2008-11#9)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#3)
nearshore##2##1##(2008-9#1)(2010-8#1)
neat##3##1##(2008-10#1)(2008-5#1)(2011-1#1)
nebraskensis and P##2##3##(2008-10#2)
nebraskensis##4##1##(2008-10#4)
nebulin##10##1##(2008-6#10)
nebulisation##7##1##(1995-3#2)(2008-10#5)
nebulised##3##1##(1995-3#1)(2008-10#2)
nebuliser##2##1##(1995-3#2)
nebulisers##2##1##(1995-3#1)(1997-1#1)
nebulization and##3##2##(2008-10#3)
nebulization inductively coupled plasma atomic emission##2##6##(2008-10#2)
nebulization of##2##2##(1995-3#1)(1996-3#1)
nebulization were##2##2##(1993-2#1)(2008-10#1)
nebulization##29##1##(1991-1#2)(1992-3#1)(1993-2#2)(1995-3#2)(1996-3#1)(2008-10#21)
nebulized pentamidine##2##2##(1993-2#2)
nebulized##11##1##(1991-1#1)(1992-3#1)(1993-2#3)(1996-1#1)(1996-3#3)(2008-10#2)
nebulizer and countercurrent gas flow##2##5##(2008-10#2)
nebulizer and##3##2##(1995-12#1)(2008-10#2)
nebulizer function##2##2##(1992-3#2)
nebulizer gas flow rate##2##4##(2008-10#2)
nebulizer gas flow rates##2##4##(2008-10#2)
nebulizer gas flow##4##3##(2008-10#4)
nebulizer is##2##2##(1994-12#1)(2008-10#1)
nebulizer of##3##2##(2008-10#3)
nebulizer output##2##2##(1994-12#2)
nebulizer system##3##2##(1995-3#3)
nebulizer systems##3##2##(1992-3#1)(1995-3#1)(1997-2#1)
nebulizer with##2##2##(1995-12#1)(2008-10#1)
nebulizer##64##1##(1991-1#6)(1992-3#6)(1993-2#3)(1994-12#10)(1995-12#4)(1995-3#5)(1996-1#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(2008-10#22)(2008-8#1)
nebulizer)##2##1##(1994-12#1)(2008-10#1)
nebulizers and##2##2##(1992-3#2)
nebulizers for##2##2##(1994-12#1)(1997-1#1)
nebulizers the##2##2##(1992-3#1)(1995-3#1)
nebulizers##30##1##(1991-1#1)(1992-3#5)(1993-2#6)(1994-12#2)(1995-3#12)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)
nebulizing##2##1##(1995-3#1)(1996-3#1)
nec1##3##1##(2008-10#3)
necator##13##1##(2008-10#13)
necatrix##9##1##(2008-10#9)
necessarily mean##2##2##(1996-5#1)(2010-9#1)
necessarily##51##1##(1991-11#1)(1991-2#2)(1992-1#1)(1992-11#1)(1992-3#2)(1994-2#1)(1995-11#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-5#1)(2008-10#12)(2008-11#3)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#3)(2009-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
necessary and sufficient to##2##4##(1995-2#1)(1997-3#1)
necessary and sufficient##7##3##(1991-2#2)(1992-9#1)(1993-8#1)(1995-2#1)(1997-3#1)(2009-10#1)
necessary and##10##2##(1991-2#2)(1992-9#1)(1993-8#1)(1995-2#2)(1996-3#1)(1997-3#1)(2009-10#1)(2009-8#1)
necessary because##2##2##(2008-11#1)(2010-7#1)
necessary before the##2##3##(2008-10#2)
necessary before##4##2##(2008-10#2)(2009-8#1)(2012-12#1)
necessary chemicals##2##2##(2008-10#2)
necessary condition##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)
necessary data##2##2##(2008-10#1)(2008-11#1)
necessary during##2##2##(2008-10#1)(2011-2#1)
necessary for a##6##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
necessary for achieving satisfactory perceived##2##5##(2008-5#2)
necessary for all##3##3##(2008-10#2)(2012-2#1)
necessary for both##2##3##(2008-12#1)(2009-1#1)
necessary for infection##2##3##(2008-10#2)
necessary for normal##2##3##(2012-2#1)(2012-3#1)
necessary for replication##2##3##(2008-10#2)
necessary for the expression of##2##5##(1993-3#1)(1994-2#1)
necessary for the initiation##2##4##(1994-11#1)(2008-8#1)
necessary for the##30##3##(1990-9#1)(1991-1#1)(1991-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-12#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-8#2)(2009-5#1)(2010-7#1)(2011-2#1)
necessary for##139##2##(1990-5#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#35)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-5#2)(2009-8#5)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
necessary in some##2##3##(1995-12#1)(2008-4#1)
necessary in##18##2##(1992-5#1)(1995-12#1)(1996-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
necessary information##2##2##(1997-6#1)(2012-12#1)
necessary prerequisite##2##2##(1994-12#1)(2008-8#1)
necessary so##2##2##(2008-10#1)(2012-3#1)
necessary step in##2##3##(1993-8#1)(1994-1#1)
necessary step##4##2##(1993-8#1)(1994-1#2)(2012-2#1)
necessary to achieve a##2##4##(1992-3#1)(2008-11#1)
necessary to achieve##5##3##(1992-3#1)(1993-3#1)(1997-5#1)(2008-11#1)(2011-2#1)
necessary to assess##2##3##(2008-10#1)(2008-11#1)
necessary to avoid##2##3##(2008-10#2)
necessary to be##2##3##(1993-2#1)(2009-9#1)
necessary to carry out##4##4##(1992-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
necessary to confirm the diagnosis##2##5##(1990-9#1)(2008-11#1)
necessary to confirm the##3##4##(1990-9#1)(2008-11#1)(2012-12#1)
necessary to convert##2##3##(2008-10#2)
necessary to design##2##3##(2008-5#2)
necessary to detect##2##3##(1990-3#1)(2008-7#1)
necessary to determine the##3##4##(2008-10#1)(2008-11#1)(2009-12#1)
necessary to determine##6##3##(1991-8#1)(2008-10#2)(2008-11#1)(2009-12#1)(2009-8#1)
necessary to develop##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
necessary to ensure##2##3##(1996-11#1)(2008-10#1)
necessary to establish##2##3##(2008-10#1)(2008-2#1)
necessary to find a##2##4##(2008-10#1)(2011-2#1)
necessary to identify##4##3##(1995-5#1)(2008-10#1)(2008-12#1)(2013-8#1)
necessary to improve##2##3##(2008-11#1)(2009-6#1)
necessary to induce##2##3##(1991-5#1)(1993-12#1)
necessary to inhibit##2##3##(1995-2#1)(2008-10#1)
necessary to know the##2##4##(1997-8#1)(2008-8#1)
necessary to obtain##6##3##(1996-12#1)(2008-10#3)(2008-5#1)(2013-8#1)
necessary to perform##4##3##(2008-10#1)(2009-3#1)(2010-5#1)(2013-8#1)
necessary to prevent##4##3##(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
necessary to produce##2##3##(1994-5#1)(2008-10#1)
necessary to save##2##3##(1997-7#1)(2010-8#1)
necessary to use the##2##4##(2008-10#1)(2012-3#1)
necessary to use##4##3##(2008-10#2)(2010-5#1)(2012-3#1)
necessary to##177##2##(1990-2#2)(1990-3#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#2)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#42)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#3)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#6)(2013-8#5)
necessary when##2##2##(2008-11#1)(2008-3#1)
necessary##517##1##(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#4)(1991-1#5)(1991-12#4)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-5#3)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-8#3)(1993-9#2)(1994-1#4)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-9#1)(1995-10#1)(1995-12#4)(1995-2#7)(1995-5#5)(1995-6#2)(1996-1#3)(1996-11#4)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#3)(1996-6#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#2)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#115)(2008-11#40)(2008-12#11)(2008-2#5)(2008-3#11)(2008-4#9)(2008-5#13)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#9)(2009-9#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#9)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#25)(2011-3#3)(2012-12#8)(2012-2#17)(2012-3#9)(2013-1#16)(2013-8#12)
necessitate##4##1##(1993-6#1)(2008-10#1)(2008-9#1)(2009-11#1)
necessitated a##2##2##(1995-9#1)(2008-2#1)
necessitated the##4##2##(1996-3#1)(2008-1#1)(2008-10#2)
necessitated##9##1##(1995-9#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#1)
necessitates the##2##2##(2008-10#1)(2012-2#1)
necessitates##8##1##(1991-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
necessitating a##3##2##(2010-7#1)(2012-12#1)(2013-1#1)
necessitating##9##1##(1996-3#1)(1997-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#1)
necessity for##8##2##(1993-11#1)(1993-2#1)(1995-8#1)(2008-10#2)(2008-9#1)(2009-8#1)(2011-3#1)
necessity of##20##2##(1991-2#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-9#2)(2009-10#1)(2011-2#1)(2013-1#1)
necessity to##9##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)(2010-6#1)(2010-7#1)(2012-12#1)
necessity##44##1##(1991-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#1)
neck and back##3##3##(2010-6#1)(2011-2#2)
neck and shoulder##2##3##(2010-9#2)
neck and##19##2##(2008-12#2)(2008-5#4)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-12#1)(2013-1#2)
neck blast##3##2##(2008-10#3)
neck function##2##2##(2010-12#2)
neck in##3##2##(2008-1#1)(2008-12#1)(2009-3#1)
neck injury##2##2##(1996-6#1)(2010-12#1)
neck mass##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
neck of incompletely occluded##2##4##(2013-1#2)
neck of the##2##3##(2008-10#1)(2008-12#1)
neck of##5##2##(1991-11#1)(2008-10#1)(2008-12#1)(2013-1#2)
neck or##2##2##(1997-3#1)(2011-2#1)
neck pain##18##2##(1991-8#1)(2008-11#1)(2008-12#8)(2008-7#1)(2009-3#1)(2010-12#5)(2010-8#1)
neck region##8##2##(1992-5#1)(1992-6#2)(1997-6#1)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
neck to##2##2##(1995-6#1)(2008-7#1)
neck trauma##3##2##(2010-7#1)(2010-9#2)
neck##208##1##(1990-12#6)(1990-6#5)(1990-9#1)(1991-11#2)(1991-8#4)(1991-9#4)(1992-12#1)(1992-5#1)(1992-6#2)(1993-9#4)(1994-3#1)(1994-6#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-6#1)(1997-3#6)(1997-6#7)(1997-7#2)(1997-8#1)(2007-11#2)(2008-1#5)(2008-10#8)(2008-11#6)(2008-12#20)(2008-5#10)(2008-7#8)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#5)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#11)(2010-3#3)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#8)(2011-2#21)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#22)(2013-8#3)
necks##2##1##(2008-11#1)(2010-12#1)
necrogenic satRNAs##3##2##(2008-10#3)
necrogenic##4##1##(1994-5#1)(2008-10#3)
necropsied##3##1##(1993-3#1)(2008-5#2)
necropsy and##2##2##(2008-5#1)(2010-7#1)
necropsy##9##1##(1991-3#1)(1996-12#1)(2008-5#3)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
necroses##2##1##(2008-10#2)
necrosis after an immediate##2##4##(2011-2#2)
necrosis after##4##2##(1996-11#1)(2008-7#1)(2011-2#2)
necrosis and chlorosis##2##3##(2008-10#2)
necrosis and##23##2##(1991-8#3)(1994-6#1)(2008-10#12)(2008-5#2)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)
necrosis around##2##2##(2008-10#2)
necrosis factor (TNF)##13##3##(1992-12#1)(1994-8#1)(1996-2#2)(1997-2#1)(1997-4#1)(2008-4#1)(2008-9#1)(2011-2#3)(2012-3#2)
necrosis factor (TNF)-alpha##2##3##(1996-12#1)(2011-2#1)
necrosis factor alpha##11##3##(1990-5#1)(1992-7#1)(1994-11#1)(1994-8#1)(1995-2#2)(2008-11#2)(2008-8#2)(2011-2#1)
necrosis factor therapies##2##3##(2011-2#2)
necrosis factor##41##2##(1990-5#1)(1992-12#1)(1992-7#2)(1994-11#1)(1994-8#2)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#2)(1997-2#2)(1997-4#1)(2008-11#3)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#9)(2012-2#2)(2012-3#4)(2013-1#1)
necrosis factor-alpha (TNF-alpha)##12##3##(1992-8#1)(1995-12#2)(1995-9#1)(1996-12#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-7#1)(2012-2#1)
necrosis factor-alpha (TNF-α)##2##3##(2010-12#1)(2012-3#1)
necrosis factor-alpha##24##2##(1992-8#2)(1994-8#1)(1995-10#1)(1995-12#2)(1995-9#1)(1996-12#2)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#4)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
necrosis factor-related apoptosis-inducing ligand (TRAIL)##2##5##(2009-3#2)
necrosis factor-α##6##2##(2010-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
necrosis in the##4##3##(1994-5#1)(1996-12#1)(2008-10#1)(2013-1#1)
necrosis in##11##2##(1993-12#1)(1994-5#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2013-1#1)
necrosis index##2##2##(1993-2#2)
necrosis induced by##3##3##(2008-10#3)
necrosis is##2##2##(2008-10#1)(2008-12#1)
necrosis of the##11##3##(1996-11#1)(2008-10#4)(2008-5#1)(2011-2#3)(2012-2#2)
necrosis of##18##2##(1993-12#1)(1996-11#1)(2008-10#7)(2008-5#1)(2008-9#1)(2011-2#4)(2012-2#2)(2013-1#1)
necrosis on##3##2##(2008-10#3)
necrosis or##5##2##(2008-10#4)(2012-2#1)
necrosis that##2##2##(2008-10#2)
necrosis virus##16##2##(2008-10#16)
necrosis was##7##2##(1994-5#1)(2008-10#4)(2010-3#1)(2011-1#1)
necrosis were##3##2##(2008-10#1)(2008-5#1)(2010-11#1)
necrosis with##2##2##(2009-1#1)(2013-1#1)
necrosis##267##1##(1990-12#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#3)(1992-12#1)(1992-5#1)(1992-7#2)(1992-8#2)(1993-12#3)(1993-2#2)(1994-11#1)(1994-5#4)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#3)(1995-2#2)(1995-8#1)(1995-9#1)(1996-11#4)(1996-12#4)(1996-2#3)(1997-2#2)(1997-4#1)(2008-10#107)(2008-11#8)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-3#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#22)(2012-2#8)(2012-3#7)(2013-1#14)(2013-8#2)
necrosis)##5##1##(1991-8#1)(2008-10#2)(2012-3#1)(2013-1#1)
necrosis-inducing##3##1##(2008-10#3)
necrosis-regeneration##2##1##(1995-12#2)
necrotic and##4##2##(2008-10#3)(2008-12#1)
necrotic areas of##2##3##(2008-10#1)(2008-5#1)
necrotic areas##7##2##(2008-10#5)(2008-5#1)(2010-12#1)
necrotic cells##2##2##(2008-10#2)
necrotic flecking##3##2##(2008-10#3)
necrotic leaf tissues##2##3##(2008-10#2)
necrotic leaf##6##2##(2008-10#6)
necrotic lesion##2##2##(2008-10#1)(2008-8#1)
necrotic lesions on susceptible##2##4##(2008-10#2)
necrotic lesions on##4##3##(2008-10#4)
necrotic lesions##10##2##(2008-10#10)
necrotic mass##2##2##(2013-1#2)
necrotic response##2##2##(2008-10#2)
necrotic ringspot##5##2##(2008-10#5)
necrotic spot virus##4##3##(2008-10#4)
necrotic spots or##2##3##(2008-10#2)
necrotic spots##9##2##(2008-10#9)
necrotic symptoms##4##2##(2008-10#4)
necrotic tissue##5##2##(2008-10#3)(2011-2#1)(2013-8#1)
necrotic tissues##2##2##(2008-10#2)
necrotic yellow vein virus (BNYVV)##2##5##(2008-10#2)
necrotic yellow vein virus##5##4##(2008-10#5)
necrotic##112##1##(1997-8#1)(2008-1#1)(2008-10#89)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
necroticoinflammatory##2##1##(2007-8#2)
necrotizing lymphadenitis##2##2##(1991-3#2)
necrotizing pancreatitis##2##2##(2012-3#2)
necrotizing pathogens##2##2##(2008-10#2)
necrotizing sialometaplasia##2##2##(1991-11#1)(2009-1#1)
necrotizing##16##1##(1991-11#1)(1991-3#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2009-1#1)(2011-2#2)(2012-3#3)(2013-1#1)
necrotrophic fungi##2##2##(2008-10#1)(2009-6#1)
necrotrophic fungus##2##2##(2008-10#2)
necrotrophic growth##2##2##(2008-10#2)
necrotrophic pathogen##2##2##(2008-10#2)
necrotrophic pathogens##2##2##(2008-10#2)
necrotrophic##17##1##(2008-10#16)(2009-6#1)
nectar and##2##2##(2008-10#1)(2008-6#1)
nectar##4##1##(2008-10#2)(2008-6#1)(2009-6#1)
nectarine fruit##2##2##(2008-10#2)
nectarine##3##1##(2008-10#3)
need a##8##2##(1991-1#1)(1991-3#2)(2008-10#1)(2011-2#3)(2013-1#1)
need among##3##2##(1994-1#1)(1996-3#1)(2008-5#1)
need and##6##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(2008-11#1)
need for SLT##2##3##(2012-2#2)
need for a global##2##4##(2008-10#1)(2012-12#1)
need for a rapid##2##4##(2008-10#2)
need for a regular##2##4##(2008-7#1)(2011-2#1)
need for a##46##3##(1990-6#1)(1992-1#2)(1993-12#1)(1993-3#1)(1994-1#2)(1995-1#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)
need for accurate##3##3##(1994-2#1)(1995-2#1)(2008-9#1)
need for additional##4##3##(2008-10#2)(2010-10#1)(2011-2#1)
need for alternatives##2##3##(1995-2#1)(2008-11#1)
need for an##8##3##(1991-3#2)(1994-3#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
need for any##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
need for better##4##3##(2007-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
need for caution in##2##4##(2008-11#1)(2008-9#1)
need for caution##4##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
need for change##2##3##(1996-1#1)(1997-8#1)
need for clinical##2##3##(1991-10#1)(2008-10#1)
need for data##2##3##(1994-9#1)(2008-11#1)
need for further##11##3##(1992-9#1)(1993-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#2)(2010-4#1)(2013-1#2)
need for greater##2##3##(2008-5#1)(2011-1#1)
need for health##3##3##(1995-12#1)(2008-11#1)(2009-5#1)
need for increased##4##3##(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
need for information##2##3##(1994-6#1)(2008-10#1)
need for invasive procedures##2##4##(2012-2#1)(2013-1#1)
need for long-term##5##3##(1992-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-1#1)
need for more##8##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
need for new##3##3##(2008-1#1)(2008-11#2)
need for novel##2##3##(2011-2#1)(2012-12#1)
need for ongoing##2##3##(2008-11#2)
need for preconcentration##2##3##(2008-10#2)
need for preventive##2##3##(1995-12#1)(1996-1#1)
need for repeated##3##3##(2008-1#1)(2008-3#1)(2012-2#1)
need for research##4##3##(1994-1#1)(1996-3#1)(1997-7#1)(2008-11#1)
need for specialized##2##3##(1992-1#1)(1993-12#1)
need for the##17##3##(1992-2#1)(1995-11#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
need for treatment##2##3##(2008-10#1)(2011-2#1)
need for##365##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#3)(1992-1#3)(1992-2#3)(1992-9#1)(1993-1#3)(1993-12#7)(1993-3#3)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1996-1#7)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#4)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#3)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#6)(2008-10#71)(2008-11#39)(2008-12#11)(2008-3#5)(2008-4#4)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#13)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#4)(2010-1#2)(2010-10#8)(2010-11#1)(2010-12#5)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#20)(2011-3#1)(2012-12#6)(2012-2#10)(2012-3#7)(2013-1#18)(2013-8#4)
need further##3##2##(1997-7#1)(2008-11#1)(2013-1#1)
need in##4##2##(1994-1#1)(1995-1#1)(2008-10#1)(2013-8#1)
need it##2##2##(1991-3#1)(1994-9#1)
need more##4##2##(2008-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
need not be##6##3##(1992-2#1)(1995-2#1)(2008-10#3)(2013-8#1)
need not##11##2##(1992-2#1)(1992-6#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-8#2)(2013-8#1)
need of a##5##3##(1994-2#1)(2008-10#2)(2008-11#1)(2013-1#1)
need of high##2##3##(1993-2#1)(2010-8#1)
need of home##2##3##(1995-2#2)
need of improvement##2##3##(2008-10#1)(2008-11#1)
need of##41##2##(1990-11#1)(1990-3#1)(1991-6#2)(1991-8#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#2)(2008-10#10)(2008-11#7)(2008-12#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
need protection##2##2##(2008-10#1)(2011-2#1)
need the##4##2##(1993-1#1)(1995-1#1)(2008-10#2)
need them##2##2##(1994-3#1)(2012-2#1)
need to actively##2##3##(1995-3#1)(2008-11#1)
need to address##3##3##(1991-12#1)(1992-1#1)(2008-11#1)
need to analyze##2##3##(2008-10#1)(2008-2#1)
need to assess the##2##4##(1995-12#1)(1995-3#1)
need to be addressed##8##4##(1992-9#1)(1994-1#2)(1994-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
need to be aware of##2##5##(2008-8#1)(2012-3#1)
need to be aware##3##4##(2008-8#1)(2012-2#1)(2012-3#1)
need to be carried out##2##5##(2008-10#1)(2010-12#1)
need to be conducted##3##4##(2008-10#1)(2008-9#1)(2010-11#1)
need to be considered##4##4##(2008-11#1)(2008-6#1)(2009-1#1)(2011-2#1)
need to be determined experimentally##2##5##(2008-7#1)(2013-1#1)
need to be developed##4##4##(1992-12#1)(1995-1#1)(2008-10#1)(2010-11#1)
need to be distinguished##2##4##(2008-8#1)(2008-9#1)
need to be hospitalized##2##4##(1995-6#1)(2008-3#1)
need to be identified##2##4##(2010-11#1)(2011-1#1)
need to be incorporated##2##4##(2008-12#1)(2008-5#1)
need to be made##2##4##(1996-1#1)(2008-9#1)
need to be trained##2##4##(2008-11#1)(2011-2#1)
need to be##91##3##(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-12#1)(1994-1#2)(1994-2#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-3#2)(1996-8#1)(1997-8#2)(2008-1#1)(2008-10#11)(2008-11#12)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-1#1)(2009-6#1)(2010-11#4)(2010-12#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
need to care for##2##4##(1995-12#1)(2010-7#1)
need to change##2##3##(2010-12#1)(2012-2#1)
need to consider the##4##4##(2008-7#1)(2009-6#1)(2010-12#1)(2013-8#1)
need to consider##10##3##(1995-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
need to define##3##3##(2008-2#1)(2010-12#1)(2013-1#1)
need to determine##6##3##(1990-5#1)(2008-10#4)(2010-4#1)
need to develop an##2##4##(1997-2#1)(2008-11#1)
need to develop##17##3##(1991-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#2)
need to educate##3##3##(1993-12#2)(1995-2#1)
need to evolve to##2##4##(1997-3#1)(2011-2#1)
need to examine the##2##4##(2008-11#2)
need to find##2##3##(1992-12#1)(1995-9#1)
need to go##2##3##(1995-9#1)(2012-2#1)
need to identify##4##3##(1991-1#1)(2008-10#1)(2008-6#1)(2010-7#1)
need to improve##5##3##(1993-12#1)(1996-1#1)(2008-10#1)(2010-5#1)(2011-2#1)
need to integrate##2##3##(1994-12#1)(2012-2#1)
need to keep##2##3##(1995-3#1)(2008-7#1)
need to know##3##3##(1993-3#1)(1996-2#1)(2008-10#1)
need to learn how to##2##5##(1991-3#1)(1995-9#1)
need to learn##3##3##(1991-3#1)(1995-9#1)(2010-11#1)
need to make##3##3##(1991-6#1)(1993-1#1)(2010-12#1)
need to monitor##2##3##(2008-10#1)(2013-1#1)
need to move beyond##2##4##(1994-1#1)(2009-8#1)
need to move##3##3##(1994-1#1)(1997-4#1)(2009-8#1)
need to prepare##2##3##(2008-11#1)(2010-4#1)
need to provide##5##3##(1995-2#1)(1995-9#1)(2008-11#1)(2013-8#2)
need to put##3##3##(1991-3#1)(2008-10#1)(2010-5#1)
need to re-examine##2##3##(1992-12#1)(1996-3#1)
need to reassess##3##3##(1991-3#1)(2009-8#1)(2013-1#1)
need to recognize and##3##4##(2008-11#1)(2010-9#1)(2012-3#1)
need to recognize##4##3##(2008-11#1)(2008-7#1)(2010-9#1)(2012-3#1)
need to reduce##3##3##(1996-1#1)(2008-11#1)(2008-9#1)
need to remove the##2##4##(2008-10#2)
need to search for##2##4##(1997-1#1)(2008-10#1)
need to share##2##3##(2008-11#1)(2010-11#1)
need to shift##2##3##(1997-1#1)(2013-8#1)
need to support##2##3##(1993-12#1)(1997-1#1)
need to take##4##3##(1995-5#1)(2008-12#1)(2009-4#1)(2010-10#1)
need to understand and##2##4##(2010-7#1)(2011-1#1)
need to understand the##2##4##(2008-10#1)(2008-5#1)
need to understand##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)
need to use##2##3##(2008-12#1)(2010-5#1)
need to##327##2##(1990-5#1)(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#6)(1991-6#3)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-9#2)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#4)(1996-1#7)(1996-2#1)(1996-3#4)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-4#2)(1997-8#2)(2007-12#1)(2008-1#4)(2008-10#37)(2008-11#44)(2008-12#14)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#11)(2009-1#1)(2009-4#1)(2009-6#2)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#7)(2010-12#7)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#4)(2010-9#1)(2011-1#6)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#9)(2012-3#6)(2013-1#11)(2013-8#5)
need##861##1##(1990-11#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#7)(1991-3#12)(1991-6#5)(1991-8#1)(1992-1#7)(1992-11#1)(1992-12#5)(1992-2#7)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#4)(1993-1#6)(1993-12#15)(1993-2#4)(1993-3#5)(1993-6#1)(1994-1#10)(1994-12#5)(1994-2#7)(1994-3#7)(1994-6#3)(1994-9#3)(1995-1#9)(1995-11#4)(1995-12#7)(1995-2#11)(1995-3#4)(1995-5#2)(1995-6#1)(1995-9#4)(1996-1#14)(1996-12#2)(1996-2#3)(1996-3#9)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#3)(1997-3#10)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#5)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#13)(2008-10#133)(2008-11#102)(2008-12#30)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#13)(2008-6#3)(2008-7#15)(2008-8#11)(2008-9#27)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#5)(2009-8#10)(2009-9#1)(2010-1#3)(2010-10#14)(2010-11#8)(2010-12#12)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#3)(2010-9#3)(2011-1#11)(2011-2#43)(2011-3#2)(2012-12#14)(2012-2#21)(2012-3#15)(2013-1#35)(2013-8#11)
needed and the##2##3##(2008-10#1)(2008-3#1)
needed and##8##2##(1996-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
needed are##2##2##(2008-3#1)(2013-1#1)
needed at##2##2##(1993-6#1)(2008-10#1)
needed before##3##2##(1993-3#1)(2008-3#1)(2010-10#1)
needed by##2##2##(1991-1#1)(1994-12#1)
needed for cell##2##3##(2009-12#1)(2012-2#1)
needed for quantitative##2##3##(2008-10#2)
needed for the##12##3##(1994-8#1)(2008-10#8)(2008-2#2)(2008-4#1)
needed for##62##2##(1991-3#1)(1993-1#1)(1993-12#2)(1994-8#1)(1995-2#1)(1995-6#1)(1997-6#1)(1997-7#2)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-7#1)
needed in future determinations##2##4##(2008-10#2)
needed in order to##9##4##(2008-10#3)(2008-11#2)(2008-4#1)(2009-3#1)(2013-1#2)
needed in the health care industry##2##6##(1992-3#1)(1995-3#1)
needed in the way##2##4##(1991-3#1)(2008-3#1)
needed in the##7##3##(1991-3#1)(1992-3#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
needed in##33##2##(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-7#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#2)(2013-1#2)
needed is##2##2##(1994-1#1)(1996-3#1)
needed on##5##2##(1993-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
needed to achieve##2##3##(2008-10#1)(2008-8#1)
needed to address the##5##4##(1993-1#1)(1994-12#1)(1997-1#1)(2008-11#1)(2010-9#1)
needed to address##6##3##(1993-1#1)(1994-12#1)(1997-1#1)(2008-11#1)(2010-9#1)(2012-12#1)
needed to be##6##3##(1993-1#1)(2008-10#1)(2008-11#3)(2011-1#1)
needed to better understand the##3##5##(2008-11#1)(2009-5#1)(2013-1#1)
needed to better##4##3##(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
needed to confirm the##4##4##(1991-12#1)(2010-12#1)(2011-2#2)
needed to confirm whether##2##4##(2008-10#2)
needed to confirm##9##3##(1991-12#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#3)
needed to control the disease##2##5##(2011-2#2)
needed to determine if##3##4##(1994-12#1)(1997-3#1)(2008-10#1)
needed to determine the##4##4##(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
needed to determine##12##3##(1994-12#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2013-1#1)(2013-8#1)
needed to evaluate##4##3##(2008-11#1)(2009-12#1)(2010-7#1)(2013-1#1)
needed to further##2##3##(2008-11#1)(2010-12#1)
needed to identify##5##3##(1992-11#1)(2009-12#1)(2010-10#1)(2010-11#1)(2013-8#1)
needed to improve##3##3##(1996-12#1)(2013-1#2)
needed to measure##2##3##(2008-10#1)(2008-9#1)
needed to observe##2##3##(2008-10#1)(2008-11#1)
needed to obtain##2##3##(1994-3#1)(2008-10#1)
needed to provide##4##3##(1994-9#1)(1996-2#1)(2011-2#1)(2012-12#1)
needed to separate##2##3##(2008-10#2)
needed to simulate##2##3##(1994-12#1)(2008-8#1)
needed to support##3##3##(1994-1#1)(1994-12#1)(1997-1#1)
needed to understand the##2##4##(1997-3#1)(2013-1#1)
needed to understand##4##3##(1997-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
needed to##158##2##(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#4)(1994-3#4)(1994-9#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#2)(1997-1#2)(1997-2#3)(1997-3#3)(2008-1#3)(2008-10#30)(2008-11#15)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#4)(2009-12#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#2)(2010-12#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#9)(2013-8#2)
needed using##2##2##(2008-10#2)
needed with##2##2##(1992-1#1)(1996-5#1)
needed##426##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#1)(1993-1#4)(1993-11#1)(1993-12#5)(1993-3#3)(1993-6#2)(1994-1#4)(1994-12#7)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#4)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#7)(1997-2#5)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#1)(2008-1#9)(2008-10#102)(2008-11#35)(2008-12#7)(2008-2#5)(2008-3#11)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#11)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#4)(2010-11#4)(2010-12#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#23)(2012-12#7)(2012-2#11)(2012-3#9)(2013-1#21)(2013-7#2)(2013-8#3)
needed?##2##1##(1993-1#1)(2008-9#1)
needing further##2##2##(2007-11#1)(2008-5#1)
needing more##2##2##(1994-1#1)(2008-11#1)
needing the##2##2##(2008-10#1)(2011-2#1)
needing##10##1##(1994-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
needle and##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
needle aspiration cytology (FNAC)##2##4##(1990-6#1)(2008-7#1)
needle aspiration cytology##6##3##(1990-6#2)(2008-7#1)(2010-11#2)(2010-8#1)
needle aspiration##14##2##(1990-6#2)(1991-3#1)(1991-6#2)(1997-2#1)(2008-2#1)(2008-7#3)(2009-6#1)(2010-11#2)(2010-8#1)
needle biopsy##2##2##(1991-3#1)(2008-1#1)
needle blight##6##2##(2008-10#6)
needle cannulation of the internal jugular vein##2##7##(1992-12#2)
needle cast disease##2##3##(2008-10#2)
needle cast##6##2##(2008-10#6)
needle exchange##2##2##(1991-1#1)(1996-11#1)
needle pain in clinical settings##2##5##(2008-11#2)
needle pain##4##2##(2008-11#4)
needle procedures##4##2##(2008-11#4)
needle puncture##2##2##(1991-12#1)(2008-10#1)
needle to##2##2##(2008-10#2)
needle##89##1##(1990-6#2)(1991-1#1)(1991-12#2)(1991-3#2)(1991-6#2)(1992-12#4)(1994-9#1)(1995-12#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#2)(2008-1#1)(2008-10#39)(2008-11#9)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
needlelike##2##1##(2008-3#2)
needles and##5##2##(2008-10#1)(2008-11#1)(2011-10#1)(2011-2#1)(2013-1#1)
needles from a##2##3##(2008-10#2)
needles from seedlings that##2##4##(2008-10#2)
needles from##4##2##(2008-10#4)
needles in##2##2##(2008-9#1)(2013-1#1)
needles was##2##2##(2008-10#2)
needles##27##1##(1990-3#2)(1992-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-9#1)(2011-10#1)(2011-2#2)(2013-1#2)
needlestick##3##1##(1991-3#1)(1996-5#2)
needs a##5##2##(1995-11#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-3#1)
needs and their families##2##4##(2008-11#2)
needs and their##4##3##(1993-1#1)(1997-3#1)(2008-11#2)
needs and##34##2##(1991-2#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#1)(1993-3#2)(1994-12#2)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-3#4)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-7#1)(2010-10#2)(2012-12#1)(2012-2#1)(2012-3#1)
needs are discussed##2##3##(1994-1#1)(1995-2#1)
needs are##7##2##(1992-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-2#1)(2008-11#2)
needs assessment and##3##3##(1994-3#2)(1996-2#1)
needs assessment##8##2##(1994-3#3)(1995-2#1)(1996-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
needs behind##2##2##(1995-2#1)(2012-3#1)
needs do##2##2##(1997-3#1)(2009-5#1)
needs during##2##2##(1994-2#1)(2010-8#1)
needs for the##3##3##(1997-1#1)(1997-3#1)(2009-12#1)
needs for##20##2##(1990-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-1#2)(1995-12#1)(1997-1#2)(1997-3#2)(2008-1#1)(2008-10#2)(2008-6#1)(2009-12#1)(2011-1#1)(2012-12#1)
needs further investigation##2##3##(2008-12#1)(2008-8#1)
needs further##6##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
needs have##4##2##(1992-2#1)(1994-3#3)
needs in a##2##3##(1997-3#1)(2012-3#1)
needs in the##2##3##(1993-2#1)(2009-4#1)
needs in this area##2##4##(2010-7#1)(2012-12#1)
needs in##12##2##(1993-2#1)(1997-2#1)(1997-3#2)(2008-11#2)(2008-12#1)(2009-4#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
needs is##2##2##(1991-12#1)(1993-3#1)
needs more##2##2##(2008-10#1)(2011-1#1)
needs of a##6##3##(1991-3#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
needs of children in##2##4##(1992-3#1)(2011-1#1)
needs of children with##2##4##(1997-2#1)(2008-11#1)
needs of children##6##3##(1992-3#1)(1994-1#1)(1997-2#1)(2008-11#1)(2011-1#1)(2012-3#1)
needs of nurses##2##3##(2010-11#2)
needs of patients##5##3##(2008-11#2)(2008-4#1)(2010-1#1)(2010-10#1)
needs of the##21##3##(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-2#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#2)(2008-10#1)(2008-11#4)(2010-7#1)(2012-2#1)(2013-1#2)
needs of their##5##3##(1992-1#1)(1993-1#1)(1994-1#1)(1994-3#2)
needs of these patients##2##4##(1997-8#1)(2013-1#1)
needs of##99##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1993-1#3)(1993-12#1)(1993-2#1)(1994-1#4)(1994-12#2)(1994-2#5)(1994-3#5)(1995-1#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#4)(1997-1#2)(1997-2#1)(1997-3#3)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#13)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-11#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
needs related to their children's disorders##2##6##(1995-1#2)
needs related to##3##3##(1995-1#2)(1995-2#1)
needs that##4##2##(1995-1#1)(2008-6#1)(2012-2#2)
needs to be addressed##2##4##(2008-1#1)(2011-1#1)
needs to be considered in##2##5##(1992-9#1)(2012-3#1)
needs to be considered##4##4##(1992-9#1)(1996-8#1)(2008-12#1)(2012-3#1)
needs to be done##2##4##(1994-3#1)(2011-2#1)
needs to be explored##2##4##(2013-1#1)(2013-7#1)
needs to be further##2##4##(2008-12#1)(2013-1#1)
needs to be incorporated##2##4##(1991-12#1)(2012-12#1)
needs to be properly##2##4##(2008-10#2)
needs to be taken##2##4##(1996-12#1)(1997-3#1)
needs to be##53##3##(1991-12#2)(1992-9#1)(1993-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#5)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
needs to##71##2##(1991-12#2)(1992-9#1)(1993-2#1)(1994-3#1)(1995-2#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-12#1)(2008-1#3)(2008-10#8)(2008-11#7)(2008-12#7)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#2)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
needs were##2##2##(1995-1#1)(2008-1#1)
needs will##3##2##(1992-3#1)(1994-1#2)
needs with##2##2##(2010-1#1)(2011-1#1)
needs##431##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-6#2)(1992-1#8)(1992-12#5)(1992-2#6)(1992-3#11)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#4)(1993-12#5)(1993-2#3)(1993-3#6)(1994-1#13)(1994-12#4)(1994-2#11)(1994-3#16)(1995-1#10)(1995-11#1)(1995-12#8)(1995-2#7)(1995-3#4)(1995-5#1)(1996-1#4)(1996-12#2)(1996-2#4)(1996-3#7)(1996-8#1)(1997-1#6)(1997-2#6)(1997-3#19)(1997-4#2)(1997-7#1)(1997-8#3)(2007-12#1)(2008-1#10)(2008-10#26)(2008-11#43)(2008-12#20)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#5)(2009-4#1)(2009-5#1)(2009-6#2)(2010-1#4)(2010-10#6)(2010-11#8)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#8)(2011-2#11)(2011-3#2)(2011-7#1)(2012-12#6)(2012-2#11)(2012-3#11)(2013-1#16)(2013-7#1)(2013-8#2)
needy recipients##2##2##(1995-1#2)
needy##6##1##(1994-2#2)(1995-1#2)(2008-9#2)
negate the##2##2##(2009-10#1)(2010-4#1)
negate##3##1##(2008-11#1)(2009-10#1)(2010-4#1)
negated the##3##2##(2008-10#1)(2008-8#2)
negated##7##1##(2008-10#4)(2008-6#1)(2008-8#2)
negation of##3##2##(2013-1#3)
negative T waves##4##3##(1991-3#1)(1993-1#3)
negative activity on##2##3##(1993-11#1)(1995-8#1)
negative affect and##2##3##(2009-11#1)(2010-1#1)
negative affect##7##2##(2008-11#2)(2008-12#1)(2009-11#2)(2009-7#1)(2010-1#1)
negative affectivity##6##2##(2010-6#6)
negative and positive##5##3##(2008-10#2)(2008-9#3)
negative and##13##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-1#1)(2013-1#2)
negative association##2##2##(1995-12#1)(2010-1#1)
negative at##2##2##(1997-2#1)(2011-2#1)
negative attitude towards screening##2##4##(1992-2#2)
negative attitude##3##2##(1992-2#2)(2010-12#1)
negative attitudes toward##2##3##(1996-2#1)(2008-11#1)
negative attitudes##4##2##(1996-2#1)(2008-11#3)
negative attributional style and##2##4##(2010-10#2)
negative attributional style##5##3##(2010-10#5)
negative bacteria##5##2##(1994-11#1)(1997-8#1)(2008-11#1)(2008-12#1)(2012-2#1)
negative binomial distribution##5##3##(2008-10#4)(2008-3#1)
negative biopsy##2##2##(1991-6#1)(2010-12#1)
negative cases##3##2##(2008-10#2)(2009-8#1)
negative charge##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
negative charges##3##2##(2008-10#2)(2008-11#1)
negative clinical##2##2##(1991-6#1)(2010-7#1)
negative cognitive style##2##3##(2010-10#2)
negative consequences of##2##3##(1993-3#1)(2008-11#1)
negative consequences##4##2##(1993-3#1)(1997-2#1)(2008-11#1)(2008-6#1)
negative control of##2##3##(1993-3#1)(1997-1#1)
negative control##9##2##(1990-6#1)(1993-3#1)(1997-1#1)(2008-10#2)(2008-8#2)(2010-7#1)(2013-1#1)
negative controls##4##2##(1993-3#1)(2008-10#1)(2012-3#2)
negative corona discharge ion mobility spectrometry##2##6##(2008-10#2)
negative corona discharge##3##3##(2008-10#3)
negative correlation between the##4##4##(1994-2#1)(2008-10#1)(2010-12#1)(2011-2#1)
negative correlation between##12##3##(1994-2#1)(2008-10#2)(2008-8#2)(2008-9#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-6#1)
negative correlation in##2##3##(2008-9#1)(2012-3#1)
negative correlation was found##2##4##(2008-11#1)(2008-7#1)
negative correlation with the##2##4##(1991-11#1)(2010-6#1)
negative correlation with##5##3##(1991-11#1)(2010-6#1)(2011-1#1)(2011-2#2)
negative correlation##29##2##(1991-11#1)(1994-2#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)
negative correlations were##2##3##(2008-10#1)(2011-3#1)
negative correlations##4##2##(2008-10#1)(2008-9#2)(2011-3#1)
negative direction##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
negative effect of##6##3##(1992-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
negative effect on##13##3##(1991-2#1)(1992-5#1)(1993-6#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-7#1)(2011-2#1)
negative effect##23##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-6#2)(1994-3#1)(2008-10#3)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
negative effects of##4##3##(2008-12#2)(2010-7#1)(2011-2#1)
negative effects on the##2##4##(2008-10#2)
negative effects on##7##3##(1992-3#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-7#1)(2012-3#1)
negative effects##16##2##(1991-1#1)(1992-3#1)(2008-10#2)(2008-12#2)(2008-8#2)(2009-12#1)(2010-7#3)(2011-2#1)(2012-3#1)(2013-1#2)
negative element##3##2##(2008-11#3)
negative emotions##3##2##(2008-11#2)(2010-11#1)
negative explicit attitudes##2##3##(2009-9#2)
negative exponential##3##2##(2008-10#2)(2008-3#1)
negative factor##2##2##(1991-2#1)(2009-8#1)
negative factors##2##2##(2009-8#2)
negative feedback mechanism is##2##4##(2010-10#2)
negative feedback mechanism##4##3##(2010-10#4)
negative feedback regulation of##2##4##(1990-8#1)(2012-2#1)
negative feedback signals##3##3##(2008-11#3)
negative feedback##15##2##(1990-8#1)(2008-11#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#7)(2012-2#1)
negative for##17##2##(1990-12#1)(1990-2#1)(1991-6#1)(1992-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
negative health outcomes##2##3##(2009-5#1)(2010-10#1)
negative health##3##2##(2008-1#1)(2009-5#1)(2010-10#1)
negative images##2##2##(2008-7#2)
negative impact on the##4##4##(1994-12#1)(2008-10#1)(2008-12#1)(2011-7#1)
negative impact on##10##3##(1992-1#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)(2011-7#1)(2013-8#1)
negative impact##14##2##(1992-1#2)(1992-3#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-7#1)(2013-8#1)
negative implications##2##2##(1997-2#1)(2012-2#1)
negative in##7##2##(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2011-10#1)(2011-2#1)
negative influence of the##2##4##(2008-10#2)
negative influence of##3##3##(2008-10#2)(2012-2#1)
negative influence##5##2##(1993-8#1)(2008-10#3)(2012-2#1)
negative information##3##2##(1993-12#3)
negative ionization##2##2##(2008-10#2)
negative margins##5##2##(1994-6#1)(1997-7#2)(2008-9#1)(2011-2#1)
negative messages##2##2##(2008-11#1)(2010-11#1)
negative mode##4##2##(2008-10#4)
negative mood##2##2##(2007-12#1)(2009-11#1)
negative ones##2##2##(1997-2#1)(2008-5#1)
negative or##2##2##(1996-12#1)(2011-2#1)
negative patients with##2##3##(1990-8#1)(1993-11#1)
negative patients##6##2##(1990-8#2)(1993-11#1)(2008-10#1)(2008-5#1)(2009-3#1)
negative peak##2##2##(1990-5#1)(2008-10#1)
negative phototropism of rice root##2##5##(2008-9#2)
negative phototropism##6##2##(2008-9#6)
negative potential##5##2##(2008-10#4)(2008-8#1)
negative potentials##3##2##(2008-10#3)
negative predictive value##14##3##(1992-11#1)(2008-10#2)(2008-3#1)(2011-2#7)(2012-12#2)(2013-8#1)
negative predictive##16##2##(1992-11#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#7)(2012-12#2)(2013-8#1)
negative pressure##5##2##(2008-10#3)(2008-11#1)(2012-2#1)
negative prognostic factor##2##3##(2012-2#1)(2012-3#1)
negative proteome##2##2##(2008-9#2)
negative rate##2##2##(1997-4#1)(2012-12#1)
negative regulation##3##2##(1993-2#1)(2008-11#1)(2008-4#1)
negative regulator of##6##3##(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-1#1)
negative regulators of##3##3##(2009-8#2)(2011-2#1)
negative regulators##5##2##(1997-7#1)(2009-8#3)(2011-2#1)
negative regulatory##3##2##(2007-12#1)(2008-11#2)
negative relation to the##2##4##(1994-12#2)
negative relationship##4##2##(1996-3#1)(2008-8#2)(2008-9#1)
negative religious coping##3##3##(2008-12#3)
negative responses##4##2##(1992-12#1)(2008-10#2)(2012-2#1)
negative results##10##2##(1990-6#1)(1995-11#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2012-2#1)
negative selection of##3##3##(2008-8#2)(2008-9#1)
negative selection##4##2##(2008-8#3)(2008-9#1)
negative stereotypes##2##2##(2008-11#1)(2011-2#1)
negative supercoils##2##2##(1995-6#1)(2008-9#1)
negative symptoms##3##2##(2008-8#1)(2011-2#2)
negative thermal ion mass spectrometry##2##5##(2008-10#2)
negative thermal##3##2##(2008-10#3)
negative transcriptional##2##2##(1993-2#1)(1995-8#1)
negative values##4##2##(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
negative##616##1##(1990-12#1)(1990-2#4)(1990-5#4)(1990-6#3)(1990-8#3)(1991-1#2)(1991-11#1)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#6)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#7)(1992-3#5)(1992-5#1)(1993-1#5)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#7)(1993-6#4)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#10)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#7)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#2)(1997-1#3)(1997-2#7)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#3)(2007-12#4)(2008-1#3)(2008-10#105)(2008-11#53)(2008-12#16)(2008-3#5)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#10)(2008-8#23)(2008-9#30)(2009-10#1)(2009-11#5)(2009-12#5)(2009-3#2)(2009-5#2)(2009-6#3)(2009-7#7)(2009-8#13)(2009-9#2)(2010-1#5)(2010-10#19)(2010-11#4)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#8)(2010-7#8)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#40)(2011-3#1)(2011-7#1)(2012-12#6)(2012-2#14)(2012-3#14)(2012-6#1)(2013-1#24)(2013-8#3)
negative)##4##1##(1991-12#1)(1995-11#1)(1997-5#1)(2008-8#1)
negative-branch##4##1##(2008-3#4)
negative-ion##4##1##(1991-5#1)(1991-9#1)(2008-10#2)
negative-sense##3##1##(2008-10#2)(2008-9#1)
negative-strand RNA##2##2##(2008-10#1)(2013-8#1)
negatively affect the##2##3##(2010-10#1)(2012-5#1)
negatively affect##8##2##(2008-10#1)(2008-11#2)(2008-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-5#1)
negatively affected by##2##3##(2008-10#2)
negatively affected##4##2##(2008-10#3)(2008-11#1)
negatively and positively##2##3##(1990-5#1)(2008-11#1)
negatively and##3##2##(1990-5#1)(2008-11#1)(2008-7#1)
negatively associated with##5##3##(1992-9#1)(2010-1#1)(2011-2#2)(2013-8#1)
negatively charged Al complexes##3##4##(2008-10#3)
negatively charged complexes##2##3##(2008-10#2)
negatively charged phosphate##2##3##(2008-10#2)
negatively charged##27##2##(1991-9#1)(1995-11#1)(1995-8#1)(2008-10#20)(2008-11#1)(2011-1#2)(2013-8#1)
negatively correlated with soil pH##2##5##(2008-10#2)
negatively correlated with the##5##4##(2008-10#3)(2008-8#2)
negatively correlated with##32##3##(2008-10#17)(2008-8#3)(2008-9#2)(2009-7#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
negatively correlated##40##2##(2008-10#21)(2008-8#3)(2008-9#4)(2009-7#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
negatively impact##3##2##(2010-7#1)(2013-1#2)
negatively impacting the##2##3##(2008-2#1)(2009-9#1)
negatively influenced##2##2##(2009-3#1)(2011-2#1)
negatively regulate the##2##3##(1995-6#1)(2008-8#1)
negatively regulate##4##2##(1995-6#1)(2008-8#1)(2010-7#1)(2011-2#1)
negatively regulated by##2##3##(1991-5#1)(1995-8#1)
negatively regulated##3##2##(1991-5#1)(1995-8#1)(2009-8#1)
negatively regulates##3##2##(1995-2#1)(2009-6#1)(2013-1#1)
negatively related to##6##3##(1991-12#1)(1992-2#2)(2008-10#1)(2008-5#1)(2013-1#1)
negatively related##8##2##(1991-12#1)(1992-2#2)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
negatively supercoiled##2##2##(2008-9#2)
negatively to##2##2##(2008-10#1)(2008-7#1)
negatively with##7##2##(1991-12#1)(1992-9#1)(1994-6#1)(1995-8#2)(2008-10#1)(2008-11#1)
negatively##151##1##(1990-11#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-2#2)(1992-9#2)(1994-6#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#4)(1997-8#1)(2008-1#1)(2008-10#54)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-7#2)(2011-1#4)(2011-2#10)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#3)
negatives and##2##2##(1997-8#1)(2009-12#1)
negatives were##2##2##(2008-10#2)
negatives##9##1##(1990-8#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-8#1)(2008-10#3)(2009-12#1)
negativity##15##1##(1991-2#1)(1995-12#1)(2008-11#3)(2008-5#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#4)
neglect and##2##2##(2010-7#1)(2011-2#1)
neglect of##2##2##(1995-5#2)
neglect##19##1##(1991-6#1)(1995-5#3)(1996-2#4)(1996-3#1)(2009-10#6)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
neglected area of##2##3##(1991-6#1)(2008-5#1)
neglected for##2##2##(2008-3#1)(2008-5#1)
neglected the##2##2##(1993-11#1)(2010-10#1)
neglected##33##1##(1991-6#1)(1993-11#2)(1995-12#1)(1995-5#5)(1996-3#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
neglecting##3##1##(1993-11#1)(2008-11#1)(2008-8#1)
neglects##2##1##(2007-12#1)(2008-10#1)
neglectus##2##1##(2008-10#2)
negligence##7##1##(1992-2#2)(1993-12#1)(1995-12#1)(1996-2#1)(2008-10#2)
negligent##6##1##(1991-12#1)(1993-12#1)(1995-3#1)(1995-6#2)(2011-2#1)
negligible amount##2##2##(2008-11#1)(2008-3#1)
negligible at##2##2##(2008-10#1)(2008-2#1)
negligible effect on##3##3##(1991-3#1)(1993-3#1)(2008-10#1)
negligible for most##2##3##(1991-9#1)(2008-3#1)
negligible for##5##2##(1991-5#1)(1991-9#1)(2008-10#2)(2008-3#1)
negligible in the##2##3##(1996-12#1)(2008-10#1)
negligible in##5##2##(1990-12#1)(1996-12#1)(2008-10#2)(2008-6#1)
negligible influence##2##2##(1995-11#1)(2008-3#1)
negligible interference##3##2##(2008-10#3)
negligible level##2##2##(2008-3#1)(2010-6#1)
negligible proportion##2##2##(1990-6#1)(1990-9#1)
negligible##70##1##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-6#1)(2009-10#2)(2009-6#1)(2010-5#1)(2010-6#1)(2010-7#1)
negligibly##3##1##(2008-10#2)(2008-11#1)
negotiate the##2##2##(1994-1#1)(2010-9#1)
negotiate##5##1##(1994-1#1)(1994-12#1)(1996-5#1)(2010-9#1)(2011-2#1)
negotiated##7##1##(1991-3#1)(1994-3#1)(1995-2#1)(1995-3#2)(2008-11#1)(2008-12#1)
negotiating##11##1##(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#3)(1993-2#1)(1996-3#1)(1997-6#1)(2008-11#1)(2010-9#1)
negotiation and##2##2##(1992-2#1)(2008-10#1)
negotiation##6##1##(1992-2#4)(2008-10#1)(2008-11#1)
negotiations##4##1##(1991-6#1)(1992-2#1)(1996-5#1)(2008-11#1)
neighbor##6##1##(1990-12#1)(2008-10#1)(2008-8#1)(2008-9#2)(2013-1#1)
neighbor-joining and##2##2##(2008-10#1)(2008-6#1)
neighbor-joining phylogenetic tree##2##3##(2013-8#2)
neighbor-joining##7##1##(2008-10#3)(2008-12#1)(2008-6#1)(2013-8#2)
neighborhood density##3##2##(2008-11#3)
neighborhood disadvantage##5##2##(2009-7#5)
neighborhood##27##1##(1990-2#1)(1991-12#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-11#6)(2008-3#2)(2008-9#1)(2009-7#11)(2010-9#2)
neighborhoods##5##1##(1997-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2010-7#1)
neighboring cells##3##2##(2008-10#2)(2010-5#1)
neighboring countries##2##2##(1997-6#2)
neighboring populations##2##2##(2008-12#1)(2008-9#1)
neighboring##29##1##(1991-1#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-6#2)(2007-11#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-7#1)(2010-5#1)(2010-8#1)(2012-3#1)
neighbors present##2##2##(2008-9#2)
neighbors##16##1##(1997-1#1)(1997-2#1)(2008-8#7)(2008-9#6)(2009-10#1)
neighbourhood##6##1##(1995-3#2)(1996-6#1)(1997-1#1)(2008-9#1)(2013-8#1)
neighbourhoods##4##1##(2008-11#3)(2010-10#1)
neighbouring areas of##2##3##(1997-3#1)(2011-2#1)
neighbouring##10##1##(1991-6#1)(1993-9#1)(1995-8#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
neighbours and##3##2##(1992-3#2)(1997-1#1)
neighbours##9##1##(1991-5#1)(1992-3#3)(1997-1#1)(2008-10#1)(2008-11#1)(2011-3#2)
neither a##4##2##(1991-12#1)(1993-8#1)(2008-11#1)(2009-5#1)
neither did##2##2##(1993-12#1)(2008-10#1)
neither in the##3##3##(1994-2#1)(2008-11#1)(2012-2#1)
neither in##8##2##(1991-5#1)(1992-1#1)(1994-2#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-8#1)
neither of the##2##3##(1994-6#1)(2009-1#1)
neither of these##2##3##(1991-9#1)(1994-2#1)
neither of which##2##3##(1991-5#1)(2012-3#1)
neither of##7##2##(1991-5#1)(1991-9#1)(1992-6#1)(1994-2#1)(1994-6#1)(2009-1#1)(2012-3#1)
neither the presence##2##3##(1991-3#1)(1994-8#1)
neither the##14##2##(1991-3#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-11#1)(2013-8#1)
neither was##2##2##(1992-6#1)(2008-10#1)
neither##133##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#2)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#3)(1993-8#2)(1994-11#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#7)(1995-12#3)(1995-6#1)(1996-12#3)(1996-6#1)(1996-9#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#6)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#9)(2009-1#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#2)
nematic##2##1##(1995-6#1)(2008-3#1)
nematicidal activity##3##2##(2008-10#3)
nematicidal##4##1##(2008-10#4)
nematicide##4##1##(2008-10#4)
nematicides##3##1##(2008-10#3)
nematode (Meloidogyne incognita)##2##3##(2008-10#2)
nematode +##2##2##(2008-12#2)
nematode and##3##2##(2008-10#1)(2008-12#2)
nematode eggs##2##2##(2008-10#2)
nematode feeding sites##2##3##(2008-10#2)
nematode infections##2##2##(1996-12#2)
nematode infestation##3##2##(1996-6#1)(2008-10#2)
nematode invasion and##2##3##(2008-10#2)
nematode invasion##3##2##(2008-10#3)
nematode management##3##2##(2008-10#3)
nematode parasite##3##2##(1996-12#1)(1997-7#1)(2008-9#1)
nematode parasites of##2##3##(1996-12#1)(1997-7#1)
nematode parasites##3##2##(1996-12#1)(1997-7#1)(2008-8#1)
nematode plus fungus##2##3##(2008-12#2)
nematode population densities##2##3##(2008-10#2)
nematode population##7##2##(2008-10#7)
nematode populations##8##2##(2008-10#8)
nematode reproduction##2##2##(2008-10#2)
nematode resistance##2##2##(2008-10#2)
nematode species##4##2##(2008-10#4)
nematode to##3##2##(2008-10#3)
nematode##139##1##(1990-5#1)(1990-8#1)(1993-12#1)(1994-11#4)(1995-3#1)(1995-6#1)(1996-12#4)(1996-6#3)(1997-7#3)(2008-10#103)(2008-11#1)(2008-12#9)(2008-3#1)(2008-8#3)(2008-9#2)(2011-2#1)
nematode-susceptible##2##1##(2008-10#2)
nematode-trapping fungi##6##2##(2008-10#6)
nematode-trapping##7##1##(2008-10#7)
nematodes (Meloidogyne##2##2##(2008-10#2)
nematodes Heterodera##2##2##(2008-10#2)
nematodes and##4##2##(2008-10#4)
nematodes as##2##2##(2008-10#1)(2008-12#1)
nematodes did not##2##3##(2008-10#2)
nematodes from##2##2##(2008-10#2)
nematodes in soil##2##3##(2008-10#2)
nematodes in##7##2##(1996-11#1)(1996-12#1)(2008-10#5)
nematodes of##4##2##(1996-12#2)(2008-10#2)
nematodes were##7##2##(2008-10#6)(2008-12#1)
nematodes##92##1##(1996-11#1)(1996-12#4)(2008-10#75)(2008-12#3)(2008-7#1)(2008-8#5)(2008-9#3)
nematophagous fungi##2##2##(2008-10#2)
nematophagous##3##1##(2008-10#3)
nemorosa##3##1##(2008-10#3)
neo gene##6##2##(1993-12#1)(1993-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-8#1)
neo##9##1##(1993-12#1)(1993-2#1)(1996-6#1)(1997-1#1)(1997-8#2)(2008-11#1)(2008-8#1)(2009-12#1)
neo-epitopes##3##1##(2013-8#3)
neoadjuvant chemotherapy##8##2##(1992-12#2)(1993-11#4)(2010-12#1)(2012-3#1)
neoadjuvant therapy##4##2##(2010-12#3)(2013-8#1)
neoadjuvant treatment##4##2##(2010-12#1)(2010-7#2)(2012-3#1)
neoadjuvant##22##1##(1992-12#2)(1993-11#5)(2010-12#5)(2010-7#2)(2011-3#1)(2012-3#4)(2013-8#3)
neoantigens##2##1##(1997-8#1)(2013-7#1)
neobrevipes##2##1##(2008-10#2)
neocortex is##4##2##(1994-3#2)(2008-11#2)
neocortex##21##1##(1994-3#3)(1995-2#1)(1997-2#1)(2008-11#13)(2009-5#1)(2010-7#2)
neocortical##13##1##(1991-10#1)(1991-9#1)(1992-12#2)(1993-6#1)(1994-3#1)(2008-11#6)(2010-7#1)
neocuproine##4##1##(2008-10#4)
neodymium magnet##3##2##(2008-10#3)
neodymium yttrium aluminum borate##2##4##(2008-2#2)
neodymium##11##1##(2008-10#6)(2008-11#1)(2008-2#3)(2012-2#1)
neodymium(III)##2##1##(2008-10#2)
neodymium-doped fiber laser##2##3##(2008-2#2)
neoformans and##2##2##(2008-5#2)
neoformans from bronchial##2##3##(2008-5#2)
neoformans in##2##2##(2008-5#2)
neoformans var##14##2##(2008-5#14)
neoformans was##2##2##(2008-5#2)
neoformans##31##1##(2008-11#1)(2008-5#29)(2010-7#1)
neointima##2##1##(1994-11#1)(1997-8#1)
neomycin##9##1##(1990-8#1)(1995-8#1)(2008-11#5)(2008-8#1)(2011-2#1)
neonatal and##6##2##(1991-2#2)(1994-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
neonatal care##2##2##(2008-10#1)(2012-3#1)
neonatal development##2##2##(2008-10#1)(2012-3#1)
neonatal follow-up programs##3##3##(2008-11#3)
neonatal follow-up##8##2##(2008-11#8)
neonatal intensive care unit (NICU)##2##5##(1991-1#1)(1993-3#1)
neonatal intensive care unit##10##4##(1991-1#2)(1993-3#1)(1997-3#1)(2008-11#3)(2008-5#1)(2010-10#1)(2010-8#1)
neonatal intensive care units (NICUs)##2##5##(1994-3#1)(2008-10#1)
neonatal intensive care units##7##4##(1991-2#1)(1994-3#2)(2008-10#1)(2008-11#1)(2010-8#2)
neonatal intensive care##24##3##(1990-6#1)(1991-1#2)(1991-2#1)(1993-3#1)(1994-3#2)(1997-3#1)(2008-10#1)(2008-11#10)(2008-5#1)(2010-10#1)(2010-8#3)
neonatal isosporosis##3##2##(1996-12#3)
neonatal morbidity##2##2##(2012-3#2)
neonatal mortality##3##2##(1990-11#1)(1996-11#1)(1996-6#1)
neonatal period##7##2##(1992-8#1)(1996-3#1)(2008-10#1)(2010-8#1)(2011-1#2)(2011-2#1)
neonatal rat cardiac myocytes##2##4##(1993-3#2)
neonatal rat cardiomyocytes##3##3##(1995-11#1)(2010-12#2)
neonatal rat##10##2##(1992-3#1)(1993-3#2)(1995-11#2)(2008-10#1)(2009-12#1)(2010-12#2)(2013-8#1)
neonatal rats##7##2##(1992-8#2)(1997-2#1)(2008-7#1)(2009-12#1)(2013-1#2)
neonatal screening##3##2##(1991-2#2)(2011-1#1)
neonatal sepsis and meningitis##2##4##(2009-12#2)
neonatal sepsis##4##2##(2008-5#1)(2009-12#2)(2011-1#1)
neonatal surgery##2##2##(2008-11#2)
neonatal##153##1##(1990-11#1)(1990-3#3)(1990-6#2)(1991-1#2)(1991-11#1)(1991-2#5)(1992-3#1)(1992-8#4)(1993-12#1)(1993-3#5)(1993-6#1)(1994-11#1)(1994-3#6)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#3)(1996-11#3)(1996-12#3)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#35)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#6)(2011-1#7)(2011-2#4)(2012-2#3)(2012-3#7)(2013-1#6)(2013-8#1)
neonate and##3##2##(1991-12#1)(1994-2#1)(2008-5#1)
neonate born from an##2##4##(2012-3#2)
neonate with##4##2##(2012-3#1)(2013-1#1)(2013-8#2)
neonate##20##1##(1990-11#1)(1991-12#1)(1994-2#1)(2008-5#3)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#8)(2013-1#1)(2013-8#2)
neonates and##6##2##(1994-6#1)(1996-9#1)(2008-11#1)(2010-11#1)(2011-1#2)
neonates during sleep##2##3##(2009-8#2)
neonates had##3##2##(2011-1#2)(2011-2#1)
neonates in##2##2##(1991-12#1)(1996-6#1)
neonates with##4##2##(2008-10#1)(2008-11#2)(2011-1#1)
neonates##35##1##(1991-1#1)(1991-12#2)(1994-2#1)(1994-6#2)(1994-9#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#7)(2009-8#2)(2010-11#1)(2011-1#10)(2011-2#1)(2012-2#2)(2013-1#1)
neoplasia and##4##2##(1990-6#1)(1991-2#1)(2011-1#1)(2013-1#1)
neoplasia grade##3##2##(1994-2#1)(2012-3#1)(2013-1#1)
neoplasia in Barrett's esophagus##2##4##(2008-12#1)(2010-12#1)
neoplasia or##2##2##(1991-8#1)(2008-7#1)
neoplasia##45##1##(1990-12#1)(1990-6#1)(1990-9#2)(1991-2#4)(1991-8#1)(1992-2#1)(1992-9#2)(1993-9#1)(1994-12#2)(1994-2#1)(1997-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-12#6)(2010-12#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#5)
neoplasias##3##1##(2008-11#1)(2011-2#2)
neoplasm and##2##2##(1992-5#1)(2008-12#1)
neoplasm in a##2##3##(1991-3#1)(2011-2#1)
neoplasm in##4##2##(1991-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
neoplasm of the##2##3##(2013-1#2)
neoplasm of##3##2##(2010-6#1)(2013-1#2)
neoplasm that##4##2##(1997-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
neoplasm was##3##2##(1992-9#1)(2008-7#1)(2011-2#1)
neoplasm with##2##2##(2011-2#1)(2013-1#1)
neoplasm##55##1##(1990-3#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-2#2)(1992-5#1)(1992-9#2)(1993-3#1)(1993-6#2)(1994-6#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#3)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)
neoplasma##2##1##(2008-9#2)
neoplasms and##2##2##(1990-5#1)(2012-2#1)
neoplasms are characterized by##2##4##(2011-2#1)(2012-3#1)
neoplasms are##4##2##(2010-1#1)(2011-2#1)(2012-3#2)
neoplasms in##5##2##(1995-2#1)(2008-9#2)(2011-2#1)(2012-12#1)
neoplasms of the pancreas##2##4##(1992-5#1)(2012-2#1)
neoplasms of the##5##3##(1990-3#1)(1992-5#1)(2012-2#1)(2012-3#2)
neoplasms of##6##2##(1990-3#1)(1992-5#1)(2008-1#1)(2012-2#1)(2012-3#2)
neoplasms or nonneoplastic lesions in##2##5##(2008-9#2)
neoplasms or nonneoplastic lesions##3##4##(2008-9#3)
neoplasms or##4##2##(1990-8#1)(2008-9#3)
neoplasms that##2##2##(1991-2#1)(1991-8#1)
neoplasms were##4##2##(1995-11#1)(2008-9#3)
neoplasms##73##1##(1990-12#1)(1990-3#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#4)(1993-2#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-6#3)(1995-11#1)(1995-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#10)(2010-1#1)(2011-2#10)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#5)
neoplasms]##2##1##(1991-3#1)(1992-9#1)
neoplastic MC##3##2##(2011-2#3)
neoplastic cells##11##2##(1990-6#2)(1992-2#2)(1997-1#1)(2009-1#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-7#1)
neoplastic disease##4##2##(1992-12#1)(1994-5#1)(2010-12#1)(2011-2#1)
neoplastic diseases##4##2##(1990-12#1)(1994-5#1)(2008-11#1)(2011-2#1)
neoplastic lesions##2##2##(2012-2#1)(2012-3#1)
neoplastic process##4##2##(1990-3#1)(1991-12#2)(2010-12#1)
neoplastic##51##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#3)(1991-12#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1994-5#2)(1995-12#1)(1997-1#3)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-2#8)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
neopterin and##3##2##(1992-12#1)(2008-10#2)
neopterin concentrations in##2##3##(1990-2#2)
neopterin concentrations##5##2##(1990-2#5)
neopterin##13##1##(1990-2#5)(1992-12#1)(2008-10#5)(2009-12#2)
neopulchra hemipopulation##2##2##(2011-2#2)
neopulchra##4##1##(2011-2#4)
neosalpingostomy##5##1##(1991-12#3)(1994-12#2)
neostigmine##5##1##(2008-10#5)
neostriatal##3##1##(1991-1#1)(1992-3#1)(1993-3#1)
neostriatum##8##1##(1992-3#2)(1993-3#2)(1994-8#4)
neosynthesized subunits##2##2##(1996-2#2)
neosynthesized##3##1##(1996-2#3)
neotenic reproductives##3##2##(2007-12#3)
neotropical##3##1##(2008-5#1)(2008-7#1)(2010-1#1)
neotype##2##1##(2008-10#2)
neovascular##6##1##(2010-10#2)(2010-9#1)(2011-7#3)
neovascularization##7##1##(1992-3#1)(1995-3#1)(2008-1#1)(2009-10#1)(2010-1#1)(2010-9#1)(2012-3#1)
nephelometer is##2##2##(2008-3#2)
nephelometer##5##1##(2008-2#2)(2008-3#3)
nephrectomies and##2##2##(1996-9#1)(2008-10#1)
nephrectomy and##4##2##(1997-8#1)(2011-2#3)
nephrectomy for##2##2##(2009-5#1)(2013-1#1)
nephrectomy in children##2##3##(2008-10#2)
nephrectomy in##4##2##(2008-10#3)(2011-2#1)
nephrectomy was performed##2##3##(2008-10#1)(2011-2#1)
nephrectomy was##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
nephrectomy##22##1##(1997-8#1)(2008-10#7)(2009-3#1)(2009-5#1)(2011-2#9)(2013-1#3)
nephritis##9##1##(2008-1#2)(2008-4#1)(2008-5#2)(2011-2#2)(2013-1#1)(2013-8#1)
nephrogenic adenoma of the##2##4##(2008-10#2)
nephrogenic adenoma##4##2##(2008-10#4)
nephrogenic##8##1##(1994-11#2)(2008-10#6)
nephrolithiasis treatment##2##2##(2008-12#2)
nephrolithiasis##10##1##(1991-12#2)(2008-10#1)(2008-12#4)(2011-2#2)(2012-12#1)
nephrology##5##1##(1991-11#1)(2008-1#3)(2008-10#1)
nephron##3##1##(1991-5#1)(2008-6#1)(2013-1#1)
nephropathies in##3##2##(2008-1#3)
nephropathies were##2##2##(2008-1#2)
nephropathies##6##1##(2008-1#6)
nephropathy and##5##2##(1997-5#1)(1997-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
nephropathy##35##1##(1991-11#1)(1994-3#3)(1997-5#2)(1997-8#3)(2008-1#3)(2008-12#1)(2008-7#2)(2008-9#2)(2009-6#2)(2010-12#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
nephropathy&quot##2##1##(2008-1#2)
nephropathy]##2##1##(1997-8#1)(2013-8#1)
nephrosclerosis##3##1##(2008-12#1)(2011-2#1)(2012-12#1)
nephrosis##6##1##(1993-12#1)(1996-6#1)(2009-6#3)(2011-2#1)
nephrotic syndrome##8##2##(1995-12#1)(2008-1#2)(2009-6#2)(2011-2#1)(2013-8#2)
nephrotoxic##3##1##(1994-5#1)(2012-3#1)(2013-1#1)
nephrotoxicity and hepatotoxicity##2##3##(1994-5#2)
nephrotoxicity##6##1##(1990-12#3)(1993-12#1)(1994-5#2)
neplanocin A##3##2##(1994-8#1)(2008-11#2)
nepovirus##2##1##(2008-10#2)
nepoviruses##2##1##(2008-10#2)
nerfs à fleur de##2##4##(2008-5#2)
nerka##4##1##(2010-8#4)
nernstian##2##1##(2008-10#2)
nerve agent##2##2##(2008-10#1)(2008-11#1)
nerve and the##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
nerve and##11##2##(1992-3#1)(2007-12#1)(2008-9#5)(2011-2#2)(2012-3#1)(2013-1#1)
nerve are##2##2##(2008-8#1)(2012-3#1)
nerve block##2##2##(1993-1#1)(2012-2#1)
nerve branches##3##2##(1996-2#1)(2011-2#2)
nerve by the##2##3##(2008-9#2)
nerve by##4##2##(2008-12#1)(2008-9#3)
nerve cell##4##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-7#1)
nerve cells by##2##3##(1995-8#2)
nerve cells within##2##3##(1995-8#1)(2008-11#1)
nerve cells##10##2##(1995-8#5)(2008-11#4)(2008-7#1)
nerve compression##5##2##(2008-12#1)(2008-7#1)(2008-9#3)
nerve conduction##2##2##(1997-3#1)(2012-3#1)
nerve cord##4##2##(1997-7#1)(2007-12#1)(2008-5#1)(2008-7#1)
nerve cords##2##2##(2007-12#1)(2008-5#1)
nerve distribution (n = 55)##2##5##(2008-9#2)
nerve endings##7##2##(1992-6#3)(1997-2#1)(2008-5#1)(2008-6#1)(2009-1#1)
nerve fiber layer##2##3##(1991-10#1)(2008-3#1)
nerve fiber##3##2##(1991-10#1)(2008-3#1)(2010-1#1)
nerve fibers in the##2##4##(1992-6#1)(1997-4#1)
nerve fibers of##2##3##(1990-5#2)
nerve fibers were##2##3##(1990-5#1)(1992-12#1)
nerve fibers##12##2##(1990-5#5)(1992-12#1)(1992-6#2)(1997-4#2)(2010-1#1)(2013-8#1)
nerve fibres##10##2##(1994-9#1)(1997-3#4)(1997-4#1)(2008-12#1)(2008-5#3)
nerve for##2##2##(2008-12#1)(2008-9#1)
nerve function in##2##3##(2008-11#1)(2008-9#1)
nerve function##8##2##(2008-11#1)(2008-9#2)(2009-7#1)(2012-2#2)(2012-3#2)
nerve graft##2##2##(2008-7#1)(2011-2#1)
nerve grafting##4##2##(2008-8#1)(2008-9#2)(2011-2#1)
nerve growth factor (NGF)##11##4##(1991-12#2)(1996-12#2)(1996-2#1)(1997-2#1)(2008-11#2)(2008-5#1)(2010-8#2)
nerve growth factor##21##3##(1990-5#1)(1990-8#1)(1991-12#2)(1995-12#1)(1996-12#4)(1996-2#1)(1997-2#1)(2008-11#5)(2008-5#3)(2010-8#2)
nerve growth##22##2##(1990-5#1)(1990-8#1)(1991-12#2)(1995-12#1)(1996-12#4)(1996-2#1)(1997-2#1)(2008-11#6)(2008-5#3)(2010-8#2)
nerve hypoplasia##2##2##(1997-3#1)(2008-9#1)
nerve imaging##2##2##(2011-2#1)(2012-2#1)
nerve in the##6##3##(1995-12#2)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)
nerve in##9##2##(1995-12#2)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#2)(2013-1#1)
nerve injuries##2##2##(2012-2#1)(2012-3#1)
nerve injury##11##2##(1995-12#1)(2008-8#1)(2008-9#4)(2011-2#4)(2011-7#1)
nerve is##4##2##(1996-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
nerve lesions##2##2##(2011-2#1)(2012-2#1)
nerve of the##2##3##(1997-3#1)(2008-5#1)
nerve palsies##12##2##(1996-9#2)(2008-7#4)(2011-2#5)(2012-3#1)
nerve palsy##11##2##(1996-9#1)(2008-1#1)(2011-2#5)(2012-3#3)(2013-8#1)
nerve paresis##2##2##(2011-2#2)
nerve regeneration##5##2##(1992-6#1)(2007-12#1)(2008-11#1)(2011-2#2)
nerve root and##2##3##(2012-2#1)(2012-3#1)
nerve root##7##2##(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#1)
nerve schwannoma##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
nerve sheath diameter##2##3##(2010-5#2)
nerve sheath tumor##2##3##(2008-8#1)(2009-1#1)
nerve sheath##5##2##(1997-8#1)(2008-8#1)(2009-1#1)(2010-5#2)
nerve stimulation##7##2##(1992-6#1)(2008-7#2)(2008-9#3)(2012-3#1)
nerve stimulators##3##2##(2008-10#2)(2008-7#1)
nerve supply##2##2##(1993-1#1)(2008-10#1)
nerve system##2##2##(2008-8#1)(2012-3#1)
nerve terminal##4##2##(1995-6#1)(1996-12#1)(1996-2#1)(2012-3#1)
nerve terminals##10##2##(1990-5#1)(1995-11#2)(1995-12#1)(1996-12#1)(1997-7#2)(2009-8#1)(2012-3#1)(2013-8#1)
nerve that##3##2##(1992-3#1)(2008-5#2)
nerve tissue##2##2##(1994-3#1)(1997-3#1)
nerve to the##2##3##(2008-9#1)(2012-3#1)
nerve to##4##2##(2008-8#1)(2008-9#1)(2010-1#1)(2012-3#1)
nerve transfer##3##2##(2008-8#2)(2008-9#1)
nerve trunk##2##2##(1997-3#1)(2008-9#1)
nerve tumors##2##2##(2008-8#2)
nerve was##4##2##(1992-3#1)(1996-2#1)(2008-7#2)
nerve with##4##2##(1997-8#1)(2008-9#2)(2011-2#1)
nerve without##2##2##(2011-2#1)(2012-3#1)
nerve##400##1##(1990-12#1)(1990-5#8)(1990-8#1)(1991-10#1)(1991-12#2)(1992-12#1)(1992-3#3)(1992-6#7)(1992-9#1)(1993-1#2)(1993-3#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#6)(1995-6#1)(1995-8#5)(1996-12#8)(1996-2#6)(1996-3#1)(1996-5#1)(1996-9#3)(1997-2#2)(1997-3#18)(1997-4#3)(1997-7#3)(1997-8#2)(2007-12#9)(2008-1#1)(2008-10#7)(2008-11#21)(2008-12#6)(2008-3#1)(2008-5#18)(2008-6#1)(2008-7#28)(2008-8#19)(2008-9#61)(2009-1#2)(2009-11#1)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#4)(2010-5#3)(2010-8#3)(2011-2#57)(2011-7#2)(2012-12#2)(2012-2#14)(2012-3#28)(2013-1#6)(2013-8#4)
nerves and##5##2##(1997-1#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
nerves are##4##2##(2008-1#1)(2008-5#1)(2012-3#2)
nerves at the##2##3##(2011-2#2)
nerves because##2##2##(1992-6#1)(2011-2#1)
nerves by##3##2##(2008-7#2)(2013-1#1)
nerves have##2##2##(1997-3#1)(2008-9#1)
nerves in the##2##3##(1992-6#1)(2008-9#1)
nerves in##5##2##(1992-6#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
nerves of the##3##3##(1993-2#1)(1993-9#1)(2010-1#1)
nerves on##2##2##(1992-6#1)(2008-9#1)
nerves that release##3##3##(1997-1#3)
nerves to##2##2##(1995-11#1)(2008-2#1)
nerves##74##1##(1991-3#1)(1992-6#5)(1993-2#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#4)(1997-3#3)(1997-4#3)(2008-1#5)(2008-11#1)(2008-2#1)(2008-5#5)(2008-7#7)(2008-8#1)(2008-9#4)(2009-11#1)(2009-5#1)(2010-1#1)(2011-2#14)(2012-3#4)(2013-1#6)
nervosa##10##1##(1991-1#1)(1991-11#2)(2012-3#4)(2013-1#3)
nervous and##3##2##(2008-5#2)(2011-2#1)
nervous system activity##3##3##(2008-4#1)(2008-7#2)
nervous system and##10##3##(1996-12#2)(1997-8#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-7#1)(2013-1#1)
nervous system are##4##3##(1995-2#1)(2008-5#1)(2010-12#1)(2012-2#1)
nervous system effects##3##3##(2008-4#2)(2009-12#1)
nervous system in the##3##4##(2007-12#2)(2013-1#1)
nervous system in##6##3##(2007-12#2)(2008-8#2)(2012-2#1)(2013-1#1)
nervous system may be##2##4##(1996-2#1)(2012-3#1)
nervous system may##3##3##(1996-11#1)(1996-2#1)(2012-3#1)
nervous system of##6##3##(1992-6#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-7#1)(2011-2#1)
nervous system plays##2##3##(1993-12#1)(2007-8#1)
nervous system that##4##3##(2008-12#1)(2008-9#1)(2012-2#2)
nervous system was##2##3##(2008-2#1)(2008-5#1)
nervous system##202##2##(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#3)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#2)(1996-11#2)(1996-12#13)(1996-2#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#3)(2007-8#2)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#2)(2008-4#7)(2008-5#9)(2008-6#1)(2008-7#22)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#2)(2009-8#5)(2010-1#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#10)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#11)(2013-1#8)(2013-7#1)(2013-8#5)
nervous systems##2##2##(2009-8#1)(2010-1#1)
nervous tissue##4##2##(1996-2#1)(2008-10#1)(2008-4#2)
nervous##221##1##(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#3)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-5#1)(1995-8#2)(1996-11#2)(1996-12#13)(1996-2#4)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#3)(2007-8#2)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#2)(2008-4#9)(2008-5#12)(2008-6#1)(2008-7#22)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#3)(2009-7#3)(2009-8#6)(2010-1#2)(2010-11#1)(2010-12#3)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#11)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#11)(2013-1#8)(2013-7#1)(2013-8#5)
nest##22##1##(1992-6#1)(2008-10#1)(2008-5#2)(2008-8#11)(2008-9#4)(2012-2#3)
nested PCR with type specific primers##2##6##(2008-12#2)
nested PCR##9##2##(1993-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-9#1)
nested RT-PCR##3##2##(2008-10#2)(2013-8#1)
nested deletion method##2##3##(1996-2#2)
nested deletion##4##2##(1995-8#1)(1996-2#3)
nested deletions##4##2##(1995-8#2)(1996-12#2)
nested polymerase chain reaction (PCR)##5##5##(2008-10#4)(2011-2#1)
nested polymerase chain reaction##8##4##(2008-10#5)(2008-11#1)(2011-2#2)
nested reverse transcription-polymerase chain reaction (RT-PCR)##2##6##(2008-10#2)
nested reverse##3##2##(2008-10#2)(2013-8#1)
nested within the##2##3##(2008-10#1)(2013-8#1)
nested within##4##2##(2008-1#1)(2008-10#2)(2013-8#1)
nested##56##1##(1993-12#1)(1994-9#1)(1995-8#3)(1996-12#2)(1996-2#3)(1997-7#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#3)(2013-8#3)
nested-PCR protocol##2##2##(2008-10#2)
nested-PCR##3##1##(2008-10#2)(2008-12#1)
nesting guilds##2##2##(2008-9#2)
nesting##6##1##(1995-3#2)(2008-9#4)
nestlings##3##1##(2008-5#2)(2008-8#1)
nests of the##2##3##(2008-8#1)(2012-2#1)
nests of##4##2##(2008-8#1)(2010-6#1)(2010-8#1)(2012-2#1)
nests##22##1##(1990-6#1)(2008-10#1)(2008-5#3)(2008-8#9)(2008-9#5)(2010-6#1)(2010-8#1)(2012-2#1)
nests)##2##1##(2008-9#1)(2010-8#1)
net CO(2) assimilation##2##3##(2008-10#2)
net analyte signal regression##2##4##(2008-10#2)
net analyte signal##4##3##(2008-10#4)
net analyte##5##2##(2008-10#5)
net assimilation rate##2##3##(2008-8#1)(2012-5#1)
net blotch pathogen##2##3##(2008-10#2)
net blotch##5##2##(2008-10#5)
net charge##2##2##(1991-10#1)(2008-10#1)
net cost savings##4##3##(2008-11#4)
net effect of##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
net effect##6##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
net effects##2##2##(2008-8#2)
net flux##3##2##(2008-10#1)(2008-7#2)
net form##2##2##(2008-10#2)
net gain##2##2##(2007-11#1)(2008-9#1)
net increase in olfactory sensory units in##2##7##(2007-12#2)
net increase##3##2##(2007-12#3)
net joint moments##2##3##(2011-2#2)
net losses##2##2##(1993-3#2)
net of##2##2##(1992-12#1)(2011-2#1)
net photosynthesis##5##2##(2008-10#3)(2012-5#1)(2012-7#1)
net profits##3##2##(1993-1#1)(1993-3#2)
net result of##2##3##(2008-10#1)(2008-5#1)
net result##3##2##(2008-10#2)(2008-5#1)
net return##2##2##(2008-10#2)
net yield##2##2##(2008-11#2)
net##113##1##(1991-10#1)(1991-2#1)(1991-8#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#4)(1994-6#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#35)(2008-11#11)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#10)(2008-9#4)(2009-5#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-5#2)(2012-7#1)(2013-1#2)(2013-8#3)
net&quot##2##1##(1994-3#1)(1996-3#1)
nets##7##1##(2008-10#5)(2008-7#1)(2013-1#1)
netted##2##1##(2008-10#2)
network (PNN)##2##2##(2008-10#2)
network activity##3##2##(2013-8#3)
network analysis##3##2##(2008-12#2)(2010-1#1)
network and the##3##3##(2009-10#1)(2010-3#1)(2012-2#1)
network and##16##2##(1990-12#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-8#1)
network are##2##2##(2008-10#1)(2009-8#1)
network as an example##2##4##(2008-11#1)(2010-1#1)
network as##3##2##(2008-11#1)(2010-1#1)(2013-8#1)
network between##2##2##(1991-3#1)(2008-10#1)
network can be##5##3##(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-8#1)
network can##7##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-8#2)
network consisting of##4##3##(2008-10#3)(2008-12#1)
network data##6##2##(2008-11#1)(2010-1#4)(2012-3#1)
network dynamics##2##2##(2008-11#1)(2009-8#1)
network for the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
network for##8##2##(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#3)
network from##2##2##(2008-11#1)(2011-2#1)
network has##3##2##(1996-5#1)(2010-8#1)(2011-2#1)
network in the##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
network in##10##2##(1991-9#1)(1995-5#1)(1996-3#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-10#1)(2012-12#1)(2012-2#1)
network including##2##2##(2008-11#1)(2008-7#1)
network involving the##2##3##(1996-5#1)(2008-11#1)
network is a##2##3##(1996-3#1)(2008-10#1)
network is##11##2##(1995-2#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#2)(2011-2#1)
network linking##2##2##(1993-2#1)(2008-7#1)
network model of##6##3##(2008-11#6)
network model##12##2##(1996-2#1)(2008-11#9)(2008-8#2)
network models##4##2##(2008-10#1)(2009-8#1)(2010-9#1)(2013-8#1)
network of the##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
network of##42##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
network on##2##2##(1996-1#1)(2009-8#1)
network organization##2##2##(2009-9#1)(2010-4#1)
network oscillations##3##2##(1990-5#2)(2013-8#1)
network parameters##2##2##(2008-10#2)
network structure##6##2##(2008-10#1)(2010-4#1)(2012-2#2)(2012-3#2)
network structures##2##2##(2010-10#1)(2010-5#1)
network technology##2##2##(2008-10#2)
network that##6##2##(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#2)(2013-8#1)
network to##8##2##(2008-10#3)(2008-9#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
network training##2##2##(2008-10#2)
network was applied to##2##4##(2008-10#2)
network was used##2##3##(2008-10#2)
network was##12##2##(1992-12#1)(2008-10#11)
network which##5##2##(1996-2#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-8#1)
network with the##2##3##(2008-10#1)(2013-8#1)
network with##7##2##(2008-10#3)(2008-11#2)(2008-7#1)(2013-8#1)
network##423##1##(1990-12#3)(1990-5#3)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#4)(1996-3#7)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#95)(2008-11#48)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#13)(2008-6#4)(2008-7#14)(2008-8#16)(2008-9#8)(2009-10#5)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#8)(2009-9#2)(2010-1#9)(2010-10#10)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#10)(2010-9#1)(2011-2#21)(2011-3#2)(2011-9#2)(2012-12#6)(2012-2#15)(2012-3#13)(2013-1#9)(2013-7#2)(2013-8#26)
network's##6##1##(1997-2#2)(2008-10#1)(2008-11#1)(2010-10#2)
network)##7##1##(1996-1#5)(2008-10#1)(2010-10#1)
network-based drug discovery##2##3##(2011-3#2)
network-based##3##1##(1996-12#1)(2011-3#2)
networked##5##1##(1993-2#1)(2008-10#2)(2008-12#1)(2008-7#1)
networking##7##1##(1995-2#1)(2008-10#1)(2010-12#1)(2012-2#3)(2013-1#1)
networks and the##2##3##(2010-10#1)(2011-2#1)
networks and their##2##3##(2009-5#1)(2011-3#1)
networks and##14##2##(2008-10#2)(2008-11#3)(2008-4#2)(2009-5#1)(2010-10#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
networks are##5##2##(2008-11#2)(2010-10#1)(2010-8#1)(2012-3#1)
networks as##3##2##(1996-3#1)(2008-10#1)(2012-2#1)
networks can##4##2##(2008-10#1)(2008-11#1)(2009-9#1)(2010-10#1)
networks for##7##2##(1996-3#1)(2008-10#3)(2010-10#1)(2010-8#1)(2013-8#1)
networks have been##5##3##(2008-10#2)(2009-6#1)(2010-8#2)
networks have##7##2##(2008-10#3)(2009-6#1)(2010-10#1)(2010-8#2)
networks in simulated neural systems##2##5##(2008-11#2)
networks in the##5##3##(1994-1#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
networks in##18##2##(1994-1#1)(1995-2#1)(2008-10#3)(2008-11#4)(2008-7#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
networks of##14##2##(1990-5#1)(1992-3#2)(1997-7#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2012-2#2)(2013-1#1)
networks studied##2##2##(2008-10#1)(2010-10#1)
networks that are##2##3##(1997-2#1)(2008-6#1)
networks that##9##2##(1996-2#1)(1996-3#1)(1997-2#1)(2008-6#1)(2009-9#1)(2010-4#2)(2010-6#1)(2011-2#1)
networks to##4##2##(1996-2#1)(2008-10#2)(2008-8#1)
networks using##3##2##(2008-7#2)(2009-8#1)
networks was##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
networks were##5##2##(2008-10#4)(2011-2#1)
networks with##7##2##(2008-10#3)(2008-11#1)(2009-8#1)(2010-10#1)(2010-8#1)
networks##283##1##(1990-11#1)(1990-5#3)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#3)(1995-5#2)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#8)(1997-2#4)(1997-3#1)(1997-7#2)(2007-11#1)(2008-10#86)(2008-11#36)(2008-2#1)(2008-3#2)(2008-4#5)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#12)(2009-9#3)(2010-1#2)(2010-10#20)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#11)(2011-2#10)(2011-3#2)(2012-2#10)(2012-3#3)(2013-1#3)(2013-8#4)
networks)##3##1##(1996-1#1)(2008-10#2)
neural activation##2##2##(2008-11#2)
neural activities##3##2##(1996-2#1)(2008-11#2)
neural activity and##2##3##(2008-11#1)(2013-8#1)
neural activity in##2##3##(1991-2#1)(2008-11#1)
neural activity##11##2##(1990-5#1)(1991-2#2)(2008-11#7)(2013-8#1)
neural and##5##2##(1994-2#1)(2008-8#2)(2010-11#1)(2012-3#1)
neural cell##4##2##(1992-6#1)(1994-8#1)(1996-12#2)
neural cells##8##2##(1992-6#1)(1995-12#3)(2008-11#1)(2008-8#1)(2009-1#1)(2009-7#1)
neural circuit##3##2##(2008-11#3)
neural circuitry##6##2##(1994-8#2)(2008-11#3)(2013-8#1)
neural circuits that##2##3##(2008-11#1)(2013-8#1)
neural circuits##8##2##(1990-5#3)(2008-11#3)(2008-9#1)(2013-8#1)
neural coding##4##2##(2008-11#3)(2008-8#1)
neural control##2##2##(1993-6#1)(1997-4#1)
neural crest-derived cell lineages##2##4##(1994-12#2)
neural development in##2##3##(1997-7#1)(2008-9#1)
neural development##6##2##(1995-2#1)(1996-12#1)(1997-7#1)(2008-9#1)(2009-9#1)(2010-1#1)
neural dynamics##4##2##(2008-11#2)(2013-8#2)
neural ensembles##2##2##(2013-8#2)
neural foramen##2##2##(1997-8#1)(2008-1#1)
neural foraminal widening##2##3##(1997-8#2)
neural function##2##2##(2008-7#1)(2008-9#1)
neural hypothesis##2##2##(2008-9#2)
neural injury##2##2##(2011-2#2)
neural lesions##3##2##(2008-12#1)(2011-2#2)
neural mechanisms of##3##3##(1992-3#1)(1995-12#1)(2013-1#1)
neural mechanisms underlying the##2##4##(2012-2#1)(2013-1#1)
neural mechanisms underlying##4##3##(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
neural mechanisms##11##2##(1992-3#1)(1995-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#2)
neural net##3##2##(2007-8#1)(2008-11#2)
neural network (ANN) and##2##4##(2008-10#2)
neural network (ANN)##15##3##(2008-10#14)(2013-1#1)
neural network algorithm##2##3##(2008-10#2)
neural network and##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
neural network can##2##3##(2008-11#1)(2013-8#1)
neural network for##4##3##(2008-10#2)(2008-11#2)
neural network model of##2##4##(2008-11#2)
neural network model##7##3##(2008-11#5)(2008-8#2)
neural network to##3##3##(2008-10#2)(2013-8#1)
neural network was##4##3##(2008-10#4)
neural network with##3##3##(2008-10#2)(2008-11#1)
neural network##84##2##(1997-7#1)(2008-10#53)(2008-11#10)(2008-3#1)(2008-8#3)(2009-5#1)(2010-8#7)(2011-2#1)(2013-1#2)(2013-8#5)
neural networks (ANNs)##12##3##(2008-10#12)
neural networks and##3##3##(2008-10#2)(2008-11#1)
neural networks for##4##3##(2008-10#3)(2010-8#1)
neural networks have been trained to quantify considered metal ions in mixtures under optimum conditions##2##15##(2008-10#2)
neural networks have been##4##4##(2008-10#2)(2010-8#2)
neural networks to##2##3##(2008-10#2)
neural networks with##2##3##(2008-10#1)(2010-8#1)
neural networks##83##2##(1990-11#1)(1995-5#2)(1996-2#1)(1997-7#1)(2008-10#64)(2008-11#5)(2010-8#9)
neural optimal control system##2##4##(2009-5#2)
neural optimal control systems##2##4##(2009-5#2)
neural optimal control##4##3##(2009-5#4)
neural pathway##2##2##(1996-2#1)(2007-12#1)
neural populations##2##2##(2009-8#2)
neural precursor cell lines##3##4##(1995-2#1)(2008-11#2)
neural precursor cells##9##3##(2008-11#7)(2008-7#1)(2013-1#1)
neural precursor##13##2##(1995-2#1)(2008-11#10)(2008-7#1)(2013-1#1)
neural processes##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
neural processing of##3##3##(2008-11#3)
neural processing##4##2##(2008-11#3)(2010-7#1)
neural recordings##2##2##(2013-8#2)
neural response##2##2##(2008-11#1)(2008-9#1)
neural responses to##4##3##(2008-11#4)
neural responses##6##2##(2008-11#6)
neural retina##3##2##(1996-12#2)(2008-4#1)
neural stem cell##4##3##(2008-10#2)(2008-11#1)(2009-10#1)
neural stem cells and##2##4##(2008-11#2)
neural stem cells##14##3##(1994-11#3)(2008-10#1)(2008-11#6)(2008-5#1)(2009-10#1)(2011-2#2)
neural stem##18##2##(1994-11#3)(2008-10#3)(2008-11#7)(2008-5#1)(2009-10#2)(2011-2#2)
neural stimulation##2##2##(1990-5#1)(2010-6#1)
neural structures##4##2##(1996-12#1)(1997-4#1)(2008-11#1)(2008-7#1)
neural system##3##2##(1993-6#2)(1995-8#1)
neural systems##7##2##(1991-2#1)(1993-3#2)(2008-11#4)
neural tissue##6##2##(1990-9#1)(1991-2#1)(1994-2#1)(2008-11#1)(2008-4#1)(2008-6#1)
neural tissues##4##2##(1991-7#1)(1992-9#1)(1997-4#1)(2008-6#1)
neural tube##5##2##(1994-12#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-5#1)
neural##427##1##(1990-10#1)(1990-11#2)(1990-5#6)(1990-8#1)(1990-9#1)(1991-2#5)(1991-7#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#3)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#1)(1994-8#3)(1995-12#5)(1995-2#3)(1995-5#2)(1995-8#1)(1996-12#8)(1996-2#3)(1997-3#1)(1997-4#3)(1997-7#3)(1997-8#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#125)(2008-11#101)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#9)(2008-9#10)(2009-1#1)(2009-10#2)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#2)(2010-11#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#17)(2011-2#12)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#20)
neural-specific##2##1##(1995-2#2)
neuralgia##14##1##(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#8)(2013-1#1)
neurally evoked##3##2##(1990-5#3)
neuralprecursor cell lines##2##3##(2008-11#2)
neuralprecursor##3##1##(2008-11#3)
neuraminidase (NA)##2##2##(2008-11#1)(2008-9#1)
neuraminidase activity##2##2##(2008-7#2)
neuraminidase treatment##3##2##(1990-12#3)
neuraminidase##14##1##(1990-12#3)(1995-11#1)(2008-11#2)(2008-5#1)(2008-7#4)(2008-9#1)(2011-2#2)
neurectomy##10##1##(1994-3#5)(2008-9#5)
neurinosarcoma##2##1##(1990-5#2)
neurite formation##5##2##(1992-6#1)(1996-12#4)
neurite outgrowth and##3##3##(1995-6#1)(1996-12#1)(2008-11#1)
neurite outgrowth from PC12##2##4##(1990-8#1)(2008-11#1)
neurite outgrowth in PC12##2##4##(2008-11#2)
neurite outgrowth in##4##3##(1995-6#1)(2008-11#3)
neurite outgrowth of##2##3##(2008-11#2)
neurite outgrowth promoting activity##2##4##(2008-11#2)
neurite outgrowth was observed during cultivation##2##6##(2008-11#2)
neurite outgrowth was##4##3##(2008-11#4)
neurite outgrowth##21##2##(1990-8#1)(1995-6#3)(1996-12#1)(2008-11#16)
neurite patterning##2##2##(2008-11#2)
neurite##38##1##(1990-8#1)(1992-6#1)(1995-6#4)(1996-12#7)(2008-11#23)(2008-9#1)(2013-1#1)
neurites from##2##2##(1997-3#1)(2008-11#1)
neurites of##3##2##(1995-2#1)(2008-11#1)(2009-10#1)
neurites##18##1##(1991-1#1)(1991-10#1)(1992-12#1)(1995-2#1)(1997-3#2)(2008-11#7)(2008-7#3)(2009-10#2)
neuritic plaques##4##2##(1991-1#1)(1992-12#1)(1996-12#1)(1996-2#1)
neuritis (ON)##2##2##(1995-12#1)(2011-7#1)
neuritis##10##1##(1992-3#1)(1994-6#1)(1995-12#3)(2008-1#1)(2011-7#2)(2012-3#1)(2013-1#1)
neuritogenic##3##1##(1995-12#3)
neuro-muscular##5##1##(1995-12#1)(2008-9#4)
neuroanatomical studies##2##2##(1995-5#1)(2007-12#1)
neuroanatomical##9##1##(1995-5#4)(2007-12#2)(2008-4#3)
neurobehavioral##5##1##(1992-6#1)(1997-2#1)(2008-7#2)(2012-2#1)
neurobiological substrate of##2##3##(2008-12#1)(2008-7#1)
neurobiological##15##1##(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
neurobiologically##2##1##(1992-3#1)(2008-11#1)
neurobiology of##3##2##(2008-11#1)(2008-12#1)(2008-6#1)
neurobiology##8##1##(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2009-7#2)
neuroblastoma cell##2##2##(1991-6#1)(2011-2#1)
neuroblastoma cells induced by dimethyl sulfoxide and##2##7##(1993-3#2)
neuroblastoma cells##11##2##(1992-6#1)(1993-3#4)(1995-12#1)(1995-2#1)(1996-12#1)(2008-8#2)(2010-6#1)
neuroblastoma patients##2##2##(1994-5#1)(2011-2#1)
neuroblastoma##26##1##(1990-8#1)(1991-6#1)(1992-6#2)(1993-3#4)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-8#2)(2009-1#2)(2010-6#1)(2011-2#2)
neuroblastomas##4##1##(1990-8#2)(1995-12#2)
neuroblasts##6##1##(1993-8#1)(2007-12#5)
neurochemical transmission in the##2##4##(2008-7#2)
neurochemical##16##1##(1993-6#1)(1995-11#2)(1996-12#1)(1997-2#2)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
neurocognitive performance##2##2##(2009-10#2)
neurocognitive##12##1##(1996-3#1)(2008-11#1)(2009-10#5)(2010-1#2)(2011-2#2)(2013-1#1)
neurocysticercosis##2##1##(2008-7#1)(2011-2#1)
neurodegeneration in##3##2##(1990-5#1)(1992-9#1)(2010-12#1)
neurodegeneration##12##1##(1990-5#1)(1992-9#2)(2008-4#1)(2008-7#2)(2010-12#2)(2013-7#1)(2013-8#3)
neurodegenerative conditions##2##2##(2008-11#1)(2011-9#1)
neurodegenerative disease##5##2##(1997-3#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-7#1)
neurodegenerative diseases and##2##3##(2008-11#1)(2012-2#1)
neurodegenerative diseases##14##2##(1990-5#1)(1992-12#1)(1997-7#1)(1997-8#1)(2008-11#2)(2008-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-8#1)
neurodegenerative disorder##5##2##(1993-3#1)(2008-7#2)(2010-12#1)(2013-7#1)
neurodegenerative disorders##9##2##(1994-11#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-2#1)
neurodegenerative processes##2##2##(1995-12#2)
neurodegenerative##41##1##(1990-5#1)(1992-12#1)(1993-3#1)(1994-11#3)(1995-12#2)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-5#1)(2011-2#1)(2011-9#2)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
neurodevelopment##3##1##(2008-11#2)(2013-1#1)
neurodevelopmental disorder##3##2##(2008-11#1)(2012-3#2)
neurodevelopmental##8##1##(2008-11#4)(2012-2#1)(2012-3#3)
neurodynamic##2##1##(2008-12#1)(2011-2#1)
neurodynamical##2##1##(2008-11#2)
neurodynamics##6##1##(2008-11#6)
neuroectodermal##5##1##(2008-7#2)(2009-1#3)
neuroendocrine carcinoma of the##2##4##(2011-2#1)(2012-3#1)
neuroendocrine carcinoma of##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
neuroendocrine carcinoma##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
neuroendocrine markers##2##2##(1992-2#1)(2008-11#1)
neuroendocrine responses##2##2##(1996-12#1)(2008-11#1)
neuroendocrine stress response##2##3##(1997-2#1)(2008-10#1)
neuroendocrine systems##2##2##(2008-2#2)
neuroendocrine tumor##8##2##(1997-1#6)(1997-8#1)(2012-3#1)
neuroendocrine tumors##4##2##(1997-1#2)(1997-8#1)(2012-3#1)
neuroendocrine tumour of##2##3##(2008-12#1)(2013-1#1)
neuroendocrine tumours##4##2##(1992-11#4)
neuroendocrine##49##1##(1992-11#5)(1992-12#1)(1992-2#1)(1995-12#1)(1995-2#1)(1996-12#3)(1997-1#8)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#3)(2008-4#2)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#3)
neuroendocrine-thymus interaction in ageing##2##4##(2013-7#2)
neuroendocrine-thymus##3##1##(2013-7#3)
neuroepithelial##4##1##(2008-11#1)(2008-7#2)(2013-1#1)
neuroethics##3##1##(2008-11#1)(2012-2#2)
neurofibrillary tangles in##2##3##(1991-1#1)(2008-7#1)
neurofibrillary tangles##7##2##(1991-1#3)(2008-5#1)(2008-7#3)
neurofibrillary##8##1##(1991-1#3)(2008-5#1)(2008-7#4)
neurofibroma cells##3##2##(2008-8#3)
neurofibroma##8##1##(1992-9#3)(2008-8#4)(2011-2#1)
neurofibromas##3##1##(1992-9#1)(1997-8#1)(2008-8#1)
neurofibromatosis type 1##3##3##(2009-1#2)(2012-3#1)
neurofibromatosis##8##1##(2009-1#3)(2011-2#3)(2012-3#2)
neurofilament phosphorylation##2##2##(1996-12#2)
neurofilament protein##3##2##(1996-12#3)
neurofilament##12##1##(1991-1#1)(1995-12#3)(1996-12#7)(1997-2#1)
neurofilaments##2##1##(1990-8#1)(1995-12#1)
neurogenesis and##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
neurogenesis in##3##2##(1993-3#1)(2008-11#1)(2008-7#1)
neurogenesis##20##1##(1993-12#1)(1993-3#1)(1993-9#1)(1995-12#1)(2008-11#3)(2008-7#5)(2008-8#1)(2008-9#2)(2010-4#1)(2012-2#3)(2013-7#1)
neurogenic##9##1##(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#2)(2013-7#1)
neuroglial##2##1##(2010-12#1)(2013-1#1)
neurohypophyseal diabetes insipidus##3##3##(1997-8#1)(2008-4#2)
neurohypophyseal##7##1##(1997-8#5)(2008-4#2)
neuroimaging and##2##2##(2013-8#2)
neuroimaging data##2##2##(2008-11#1)(2010-7#1)
neuroimaging findings##2##2##(2008-4#1)(2013-8#1)
neuroimaging of##2##2##(2008-11#1)(2009-9#1)
neuroimaging studies##5##2##(2008-11#3)(2009-9#1)(2010-5#1)
neuroimaging techniques##3##2##(2008-4#1)(2009-5#1)(2011-2#1)
neuroimaging##32##1##(2008-11#12)(2008-4#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#2)(2010-5#2)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
neuroimmunoendocrine##2##1##(2013-7#2)
neuroinflammation##3##1##(2010-10#1)(2012-2#1)(2013-1#1)
neuroinflammatory##3##1##(2012-2#1)(2013-1#1)(2013-7#1)
neurokinin A##4##2##(1994-8#1)(1997-1#1)(1997-4#1)(2008-8#1)
neurokinin##6##1##(1994-8#3)(1997-1#1)(1997-4#1)(2008-8#1)
neurolathyrism##2##1##(2008-7#2)
neuroleptic##7##1##(1992-12#1)(1992-6#1)(1995-2#1)(2008-7#2)(2009-11#1)(2012-3#1)
neuroleptics##5##1##(1993-9#1)(1995-2#2)(2008-10#1)(2012-3#1)
neurologic complications##2##2##(1996-9#1)(2011-2#1)
neurologic damage##2##2##(2008-12#1)(2009-8#1)
neurologic deficit##3##2##(1992-12#1)(1993-2#1)(2008-7#1)
neurologic deficits##11##2##(1997-3#1)(2008-7#3)(2011-2#3)(2012-3#4)
neurologic disease##3##2##(2008-7#2)(2012-3#1)
neurologic diseases##3##2##(2012-3#3)
neurologic examination##2##2##(2012-3#2)
neurologic motor function##3##3##(2008-7#3)
neurologic motor##5##2##(2008-7#5)
neurologic##46##1##(1991-8#1)(1992-12#1)(1993-2#1)(1996-11#1)(1996-9#1)(1997-3#4)(2008-12#1)(2008-7#12)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#5)(2012-3#15)(2013-1#1)
neurological abnormalities##2##2##(1995-5#1)(2010-3#1)
neurological and##5##2##(1990-2#1)(1994-6#1)(1997-8#1)(2008-11#1)(2008-8#1)
neurological complications##6##2##(2007-8#1)(2008-7#1)(2012-3#1)(2013-1#3)
neurological condition##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
neurological conditions and##2##3##(1997-6#1)(2010-8#1)
neurological conditions##4##2##(1992-12#1)(1993-2#1)(1997-6#1)(2010-8#1)
neurological decompression sickness##2##3##(1991-6#2)
neurological deficit due to##2##4##(1996-8#1)(2008-12#1)
neurological deficit was##3##3##(2008-7#1)(2011-2#2)
neurological deficit##22##2##(1992-6#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-6#2)(2008-12#3)(2008-7#3)(2011-2#8)(2012-12#1)
neurological deficits in##2##3##(2008-7#1)(2011-2#1)
neurological deficits##13##2##(1991-9#1)(1995-12#1)(1996-11#1)(1996-9#1)(2008-12#1)(2008-7#4)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
neurological departments##2##2##(1997-8#2)
neurological deterioration##4##2##(1996-9#1)(2008-12#1)(2011-2#1)(2012-12#1)
neurological development##2##2##(2008-11#1)(2011-1#1)
neurological disease##7##2##(1996-11#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
neurological diseases##3##2##(1996-12#1)(2008-11#1)(2009-8#1)
neurological disorders##5##2##(1990-2#2)(1996-12#1)(1997-8#1)(2011-2#1)
neurological examination##3##2##(2007-9#1)(2008-7#2)
neurological function##4##2##(1991-9#1)(1997-6#1)(2012-12#1)(2012-3#1)
neurological impairment and##2##3##(2008-11#1)(2012-12#1)
neurological impairment##7##2##(1991-11#1)(1997-6#1)(2008-11#2)(2012-12#1)(2013-1#1)(2013-7#1)
neurological lesions##2##2##(1991-11#1)(1992-5#1)
neurological manifestations##2##2##(2008-6#1)(2013-1#1)
neurological or##3##2##(1992-6#1)(1997-8#1)(2013-1#1)
neurological recovery##2##2##(1997-6#1)(2012-12#1)
neurological signs##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
neurological symptoms and##2##3##(2008-7#2)
neurological symptoms##10##2##(1991-6#1)(1997-6#1)(2007-11#1)(2008-12#1)(2008-7#5)(2011-2#1)
neurological syndromes##4##2##(1996-11#4)
neurological##159##1##(1990-2#3)(1991-11#4)(1991-6#3)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#8)(1996-12#2)(1996-3#2)(1996-8#1)(1996-9#2)(1997-5#1)(1997-6#8)(1997-8#5)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#7)(2008-12#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#29)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#15)(2011-7#1)(2012-12#9)(2012-2#1)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#3)
neurologically intact##3##2##(2008-7#1)(2011-2#2)
neurologically normal and##2##3##(1997-2#1)(1997-6#1)
neurologically normal##5##2##(1995-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-5#1)
neurologically##14##1##(1995-11#1)(1996-3#2)(1997-2#1)(1997-6#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)
neurologique##2##1##(2013-1#2)
neurologist##3##1##(2007-9#2)(2010-5#1)
neurologists##7##1##(1996-8#1)(2008-4#1)(2008-7#2)(2010-12#2)(2011-2#1)
neurology##7##1##(2008-4#1)(2008-7#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)
neurolysis##3##1##(2008-8#1)(2013-1#2)
neuroma##10##1##(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#4)(2012-2#1)
neuromediators##5##1##(2008-10#4)(2008-5#1)
neuromere##3##1##(2007-12#3)
neuromodulator##2##1##(2008-7#2)
neuromodulatory factors##2##2##(1991-12#2)
neuromodulatory##4##1##(1990-12#1)(1991-12#2)(1995-2#1)
neuromuscular blockade##5##2##(1993-1#2)(2010-7#3)
neuromuscular blocking agents##2##3##(1993-1#2)
neuromuscular disease##3##2##(2008-5#2)(2013-1#1)
neuromuscular disorders##8##2##(1994-3#1)(2009-3#1)(2010-8#1)(2012-3#3)(2013-1#2)
neuromuscular junction##5##2##(2009-8#1)(2012-3#4)
neuromuscular stimulation systems##3##3##(2010-8#3)
neuromuscular stimulation##5##2##(2010-8#3)(2013-1#2)
neuromuscular transmission##2##2##(2008-9#1)(2012-3#1)
neuromuscular##47##1##(1993-1#4)(1994-3#1)(1995-12#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-1#1)(2009-3#3)(2009-8#1)(2010-1#1)(2010-7#3)(2010-8#4)(2012-2#1)(2012-3#9)(2013-1#8)
neuromyelitis optica##3##2##(2010-12#1)(2012-3#2)
neuron and##3##2##(1997-7#2)(2009-9#1)
neuron in the##3##3##(2008-11#1)(2008-5#1)(2010-8#1)
neuron in##5##2##(1994-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)
neuron loss is##2##3##(1991-9#1)(2013-7#1)
neuron specific enolase##3##3##(1990-2#3)
neuron specific##4##2##(1990-2#3)(2008-11#1)
neuron##60##1##(1990-2#3)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#1)(1994-2#3)(1995-2#2)(1996-12#4)(1997-3#2)(1997-7#4)(2007-12#2)(2008-10#3)(2008-11#16)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-9#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
neuron-specific enolase (NSE)##2##3##(2011-2#2)
neuron-specific enolase##7##2##(1991-8#1)(1992-2#1)(2011-2#5)
neuron-specific##9##1##(1991-8#1)(1992-2#1)(1993-8#2)(2011-2#5)
neuronal NOS##3##2##(2008-7#1)(2009-10#1)(2010-12#1)
neuronal activity and##2##3##(2008-5#1)(2009-5#1)
neuronal activity in##3##3##(2008-4#2)(2009-8#1)
neuronal activity##13##2##(1991-1#1)(1991-6#1)(1997-3#1)(2008-11#1)(2008-4#3)(2008-5#2)(2009-5#3)(2009-8#1)
neuronal and##8##2##(1993-8#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-7#2)(2009-8#1)(2010-1#1)
neuronal cell bodies in the##2##5##(1995-12#1)(1995-6#1)
neuronal cell bodies##4##3##(1991-12#1)(1995-12#1)(1995-6#1)(2008-7#1)
neuronal cell death##4##3##(1995-12#1)(1996-12#1)(2008-7#1)(2009-12#1)
neuronal cell line##4##3##(2008-11#3)(2009-12#1)
neuronal cell##22##2##(1991-12#1)(1992-6#1)(1993-6#2)(1993-8#2)(1995-12#3)(1995-2#2)(1995-6#1)(1996-12#1)(2008-11#3)(2008-5#2)(2008-7#2)(2009-12#2)
neuronal cells##8##2##(1993-6#1)(1994-11#1)(1995-12#2)(1995-6#2)(2008-11#1)(2009-10#1)
neuronal circuitry##2##2##(2008-10#1)(2008-4#1)
neuronal circuits##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
neuronal cultures##6##2##(1994-8#1)(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)
neuronal cytoskeleton##2##2##(1990-5#1)(1997-2#1)
neuronal death and##2##3##(2008-7#1)(2010-1#1)
neuronal death following cerebral ischaemia##2##5##(2008-7#2)
neuronal death following##3##3##(1996-12#1)(2008-7#2)
neuronal death in the##2##4##(1996-12#2)
neuronal death##12##2##(1996-12#3)(2008-5#1)(2008-7#7)(2010-1#1)
neuronal degeneration##3##2##(2008-4#1)(2011-2#2)
neuronal development##3##2##(1995-3#1)(1997-7#1)(2010-12#1)
neuronal differentiation of##3##3##(2009-10#3)
neuronal differentiation##10##2##(1991-8#1)(1994-11#1)(1996-12#1)(2009-10#5)(2010-11#1)(2012-2#1)
neuronal discharge rate##2##3##(1996-2#2)
neuronal discharges##2##2##(2009-8#2)
neuronal excitability##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
neuronal firing##3##2##(1995-12#1)(1996-2#1)(2009-10#1)
neuronal function##3##2##(1997-3#1)(2008-7#2)
neuronal functions##3##2##(2008-7#1)(2009-8#1)(2013-1#1)
neuronal genes##2##2##(2008-9#1)(2012-3#1)
neuronal growth##5##2##(1996-11#2)(2008-6#1)(2008-9#2)
neuronal labeling##4##2##(1991-12#3)(1997-2#1)
neuronal layers##2##2##(1996-12#2)
neuronal migration and##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
neuronal migration##5##2##(1995-5#2)(2008-11#1)(2008-7#1)(2013-1#1)
neuronal network##3##2##(2007-8#1)(2008-10#1)(2009-9#1)
neuronal networks##7##2##(1990-5#1)(1996-2#1)(2008-11#2)(2009-8#1)(2012-2#1)(2013-1#1)
neuronal nicotinic acetylcholine##4##3##(1995-11#4)
neuronal numbers##2##2##(2013-1#2)
neuronal outgrowths##2##2##(2008-11#2)
neuronal populations##3##2##(1991-12#1)(2008-11#2)
neuronal properties and##2##3##(1992-6#1)(2008-11#1)
neuronal properties##4##2##(1992-6#2)(2008-11#1)(2008-7#1)
neuronal relay##2##2##(2010-11#2)
neuronal responses##2##2##(1994-2#1)(1997-2#1)
neuronal somata##6##2##(1995-12#5)(2008-7#1)
neuronal survival##4##2##(1993-3#1)(2008-7#2)(2010-8#1)
neuronal##245##1##(1990-5#4)(1990-7#1)(1991-1#1)(1991-12#7)(1991-6#2)(1991-8#1)(1992-6#4)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#4)(1994-2#7)(1994-8#1)(1995-11#5)(1995-12#13)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-11#2)(1996-12#11)(1996-2#4)(1997-1#1)(1997-2#6)(1997-3#2)(1997-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#29)(2008-12#1)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#34)(2008-9#5)(2009-10#9)(2009-12#2)(2009-5#3)(2009-6#1)(2009-8#9)(2009-9#2)(2010-1#2)(2010-11#3)(2010-12#2)(2010-8#1)(2011-2#3)(2011-9#1)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#3)
neuronal-specific##2##1##(1994-2#2)
neuronally##2##1##(1993-1#1)(1996-12#1)
neurone##8##1##(1991-5#1)(1994-11#1)(1994-2#1)(1995-8#1)(1996-5#3)(2008-11#1)
neurone-specific enolase##2##2##(1992-11#2)
neurones and##2##2##(2008-11#2)
neurones in rat##2##3##(1995-12#1)(1996-2#1)
neurones in the##3##3##(1994-2#2)(1997-3#1)
neurones in##7##2##(1994-2#2)(1995-12#2)(1996-2#2)(1997-3#1)
neurones##30##1##(1991-5#1)(1994-2#10)(1995-12#2)(1995-8#1)(1996-2#3)(1996-5#5)(1997-3#5)(2008-11#3)
neurons after##2##2##(1990-5#1)(1991-12#1)
neurons and astrocytes##5##3##(1994-2#1)(2008-7#4)
neurons and glial cells##2##4##(2008-11#1)(2008-5#1)
neurons and neuronal##2##3##(2008-11#1)(2013-1#1)
neurons and oligodendrocytes##2##3##(2008-11#2)
neurons and their##2##3##(2008-4#1)(2009-8#1)
neurons and##41##2##(1990-5#1)(1992-12#1)(1992-3#1)(1993-12#2)(1994-12#1)(1994-2#2)(1995-2#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#2)(2009-8#3)(2013-1#1)(2013-7#1)
neurons are not##2##3##(1994-2#1)(2013-7#1)
neurons are##13##2##(1992-3#1)(1994-2#1)(1995-12#2)(1995-5#1)(1995-8#1)(2008-7#1)(2009-10#2)(2011-9#1)(2013-7#1)(2013-8#2)
neurons as##3##2##(1990-5#1)(1997-3#1)(2013-1#1)
neurons at##4##2##(1991-12#1)(1995-11#1)(1996-12#2)
neurons but##2##2##(2007-12#1)(2008-7#1)
neurons by##7##2##(1991-12#1)(1992-6#1)(1995-2#1)(1996-12#2)(2008-8#1)(2009-8#1)
neurons can be##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
neurons can##6##2##(1992-3#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-8#1)
neurons derived from##2##3##(2008-7#1)(2011-2#1)
neurons displaying##2##2##(1995-8#1)(2008-7#1)
neurons during##2##2##(1994-2#1)(2012-2#1)
neurons exhibit##2##2##(1996-2#1)(2008-11#1)
neurons express multiple sodium channel##2##5##(1996-12#2)
neurons express##6##2##(1996-12#4)(2008-11#2)
neurons expressing##5##2##(1996-12#2)(1997-2#1)(2008-7#1)(2013-8#1)
neurons following##2##2##(1996-12#1)(2008-7#1)
neurons from ischemic damage##2##4##(2008-11#2)
neurons from the##2##3##(1990-7#1)(2013-8#1)
neurons from##10##2##(1990-7#1)(1997-3#1)(2008-11#4)(2008-7#2)(2012-2#1)(2013-8#1)
neurons had been##2##3##(1997-3#1)(2008-5#1)
neurons had##3##2##(1994-2#1)(1997-3#1)(2008-5#1)
neurons have##3##2##(2007-12#1)(2008-11#2)
neurons in a##2##3##(1992-6#1)(2008-11#1)
neurons in cortex##2##3##(2008-4#1)(2008-8#1)
neurons in culture##2##3##(1995-12#1)(1997-3#1)
neurons in the CNS##2##4##(1991-12#2)
neurons in the brain##2##4##(1997-3#1)(2009-5#1)
neurons in the central nervous system##2##6##(1993-3#1)(1996-12#1)
neurons in the hidden layer and##2##6##(2008-10#1)(2010-8#1)
neurons in the hidden layer##3##5##(2008-10#2)(2010-8#1)
neurons in the pePOA##2##4##(1992-3#2)
neurons in the preoptic area##2##5##(1992-3#1)(2008-8#1)
neurons in the raphe nuclei##2##5##(2008-7#2)
neurons in the rat##2##4##(1996-2#1)(2009-10#1)
neurons in the trigeminal nucleus caudalis##2##6##(1997-2#1)(2008-9#1)
neurons in the##51##3##(1990-5#1)(1991-12#2)(1991-2#1)(1992-3#4)(1993-3#1)(1993-6#1)(1994-2#5)(1996-12#4)(1996-2#1)(1997-2#3)(1997-3#3)(1997-7#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#4)(2009-5#1)(2010-8#2)(2012-2#2)(2013-7#1)(2013-8#1)
neurons in vitro##3##3##(1996-12#1)(1996-2#1)(2008-11#1)
neurons in vivo##2##3##(2008-11#1)(2008-4#1)
neurons in##83##2##(1990-5#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-3#4)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#5)(1995-12#1)(1996-12#8)(1996-2#2)(1997-2#4)(1997-3#4)(1997-7#1)(2007-12#4)(2008-10#2)(2008-11#6)(2008-4#3)(2008-5#1)(2008-7#7)(2008-8#7)(2008-9#2)(2009-10#4)(2009-5#1)(2010-8#2)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#1)
neurons induced by##2##3##(1997-3#1)(2008-11#1)
neurons is##5##2##(1990-5#1)(1991-2#1)(1996-2#1)(2008-8#1)(2013-1#1)
neurons may##3##2##(1991-2#1)(2008-11#1)(2008-7#1)
neurons of cold-exposed##2##3##(2008-7#2)
neurons of rats##2##3##(1994-2#1)(2008-10#1)
neurons of the olfactory bulb##2##5##(2009-12#2)
neurons of the##18##3##(1991-7#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-12#6)(1997-4#1)(2008-11#1)(2008-7#3)(2009-12#2)(2013-8#1)
neurons of##29##2##(1991-7#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-3#1)(1996-12#6)(1996-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#6)(2009-12#2)(2009-8#1)(2010-12#1)(2013-8#1)
neurons on##4##2##(1997-3#3)(2007-12#1)
neurons or##5##2##(1994-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-11#1)
neurons plated##2##2##(1997-3#2)
neurons receive##2##2##(2008-11#1)(2013-8#1)
neurons represent##2##2##(1991-6#2)
neurons responded to##2##3##(1993-6#1)(2008-11#1)
neurons show##3##2##(1994-2#1)(1997-7#1)(2009-10#1)
neurons than in##3##3##(1996-12#2)(2008-7#1)
neurons than##4##2##(1996-12#3)(2008-7#1)
neurons that##9##2##(1991-2#1)(1995-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)
neurons to optic flow##2##4##(2008-9#2)
neurons to the##2##3##(2008-11#1)(2008-7#1)
neurons to##16##2##(1990-5#1)(1995-12#1)(1996-2#2)(1997-2#2)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2011-2#1)
neurons was observed for##2##4##(1991-12#2)
neurons was##6##2##(1991-12#2)(1996-12#1)(1996-2#1)(1997-2#1)(2009-10#1)
neurons were also##2##3##(1994-2#1)(1997-2#1)
neurons were distributed in the##2##5##(1996-12#1)(2013-8#1)
neurons were##18##2##(1992-3#1)(1993-6#1)(1994-2#3)(1995-8#1)(1996-12#1)(1997-2#4)(1997-3#2)(2008-10#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-8#1)
neurons which##4##2##(1991-6#1)(1993-6#1)(1997-2#1)(2007-12#1)
neurons with a##2##3##(1997-3#1)(2008-11#1)
neurons with##8##2##(1993-6#1)(1996-12#1)(1997-3#2)(2008-11#1)(2008-4#1)(2009-5#1)(2013-8#1)
neurons##557##1##(1990-12#1)(1990-5#9)(1990-7#5)(1990-8#1)(1991-12#12)(1991-2#8)(1991-6#8)(1991-7#2)(1991-9#1)(1992-12#5)(1992-3#11)(1992-6#4)(1993-12#2)(1993-3#2)(1993-6#6)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#26)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#8)(1995-2#5)(1995-3#2)(1995-5#1)(1995-8#9)(1996-12#61)(1996-2#11)(1996-5#1)(1996-6#1)(1997-2#17)(1997-3#23)(1997-4#1)(1997-7#6)(2007-12#22)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#64)(2008-12#1)(2008-4#7)(2008-5#11)(2008-6#1)(2008-7#70)(2008-8#21)(2008-9#6)(2009-10#19)(2009-12#5)(2009-5#2)(2009-8#16)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#2)(2011-2#4)(2011-9#1)(2012-2#10)(2013-1#3)(2013-7#4)(2013-8#17)
neurons)##2##1##(1993-6#1)(2013-8#1)
neurons]##2##1##(2010-12#2)
neuropathic pain with##3##3##(1997-3#1)(2008-12#1)(2008-9#1)
neuropathic pain##29##2##(1997-3#2)(2008-12#5)(2008-7#1)(2008-9#15)(2009-12#1)(2010-4#1)(2010-7#2)(2011-2#2)
neuropathic##33##1##(1997-3#2)(2008-10#2)(2008-12#5)(2008-7#1)(2008-9#15)(2009-12#2)(2010-4#1)(2010-7#2)(2011-2#2)(2013-8#1)
neuropathies##10##1##(1993-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-3#2)
neuropathologic##4##1##(1991-1#2)(2008-4#1)(2008-7#1)
neuropathological examination##2##2##(2008-7#2)
neuropathological##9##1##(1995-12#1)(1996-11#1)(1997-2#1)(2008-12#1)(2008-7#3)(2013-1#1)(2013-8#1)
neuropathy and##4##2##(2008-12#1)(2008-8#2)(2011-2#1)
neuropathy associated with##2##3##(2008-2#1)(2012-3#1)
neuropathy in##8##2##(2008-11#2)(2008-12#1)(2008-7#4)(2012-2#1)
neuropathy of##2##2##(2008-9#1)(2013-1#1)
neuropathy##53##1##(1996-2#1)(1997-3#2)(2007-7#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-2#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#6)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#3)
neuropeptide Y (NPY)##3##3##(1996-12#1)(2008-8#1)(2009-8#1)
neuropeptide Y##10##2##(1990-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-4#2)(2008-8#1)(2009-8#1)(2012-3#1)
neuropeptide prothoracicotropic##2##2##(1995-11#2)
neuropeptide##25##1##(1990-2#1)(1990-5#1)(1992-6#3)(1994-11#2)(1994-3#1)(1994-8#3)(1995-11#3)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#3)(2008-5#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-7#1)
neuropeptides in##2##2##(1997-4#1)(2008-7#1)
neuropeptides on##2##2##(1995-11#1)(2008-10#1)
neuropeptides##15##1##(1992-6#2)(1995-11#4)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)
neuropharmacological##2##1##(2009-7#2)
neurophysiologic##2##1##(2008-4#1)(2010-7#1)
neurophysiological##6##1##(1991-1#1)(1995-8#1)(2007-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
neuropil in##3##2##(1997-3#1)(2007-12#2)
neuropil of##3##2##(1997-3#1)(2007-12#1)(2013-8#1)
neuropil##18##1##(1995-12#1)(1997-2#1)(1997-3#9)(2007-12#6)(2013-8#1)
neuropils in##4##2##(2007-12#4)
neuropils##6##1##(2007-12#6)
neuroprostheses##2##1##(2008-11#1)(2013-1#1)
neuroprosthesis##2##1##(2013-1#2)
neuroprotection against glutamate##2##3##(2008-7#2)
neuroprotection and##2##2##(2008-7#1)(2013-7#1)
neuroprotection##8##1##(1996-12#1)(2008-7#4)(2009-6#1)(2013-7#1)(2013-8#1)
neuroprotective activity against##3##3##(2008-11#1)(2013-8#2)
neuroprotective activity##4##2##(2008-11#1)(2013-8#3)
neuroprotective effect##5##2##(2008-11#2)(2009-12#2)(2012-2#1)
neuroprotective effects##4##2##(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
neuroprotective##24##1##(2008-11#7)(2008-7#4)(2009-12#2)(2011-2#2)(2011-9#1)(2012-2#2)(2013-7#2)(2013-8#4)
neuropsychiatric conditions##2##2##(1990-2#1)(2008-12#1)
neuropsychiatric disorders##5##2##(2008-12#2)(2011-2#1)(2012-12#1)(2013-8#1)
neuropsychiatric manifestations##2##2##(1993-11#1)(2012-3#1)
neuropsychiatric##12##1##(1990-2#1)(1993-11#1)(2008-12#3)(2008-4#2)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
neuropsychological and##2##2##(1997-2#1)(2008-11#1)
neuropsychological data##2##2##(1996-2#1)(2008-10#1)
neuropsychological deficits##2##2##(1992-6#1)(2010-12#1)
neuropsychological test##2##2##(2008-7#1)(2010-1#1)
neuropsychological testing##2##2##(2010-1#1)(2011-2#1)
neuropsychological tests##4##2##(2008-11#1)(2008-2#1)(2008-7#2)
neuropsychological##33##1##(1990-2#4)(1991-1#1)(1991-2#1)(1992-6#1)(1994-6#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-6#1)(2008-7#6)(2009-10#2)(2010-1#3)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
neuroradiological##5##1##(2008-7#3)(2009-10#1)(2013-1#1)
neuroradiologists##3##1##(1995-11#1)(1996-3#1)(2009-2#1)
neuroradiology##2##1##(1997-6#2)
neuroreceptor imaging##3##2##(2011-1#3)
neuroreceptors##2##1##(1993-3#1)(1993-9#1)
neurorehabilitation##2##1##(2013-1#2)
neurorepair##3##1##(2013-7#3)
neurosarcoidosis##4##1##(2008-7#1)(2012-3#3)
neuroscience has##2##2##(2008-11#1)(2011-2#1)
neuroscience is##3##2##(2008-11#3)
neuroscience research##4##2##(2008-4#4)
neuroscience##20##1##(1997-6#1)(2008-11#6)(2008-4#5)(2009-5#2)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
neurosciences that##2##2##(2008-4#1)(2009-5#1)
neurosciences##6##1##(1992-12#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-5#1)
neuroscientific##2##1##(2008-11#1)(2011-2#1)
neuroscientists##2##1##(2008-11#1)(2010-7#1)
neurosecretory cells of##2##3##(2008-5#1)(2008-6#1)
neurosecretory cells which##3##3##(1995-11#1)(2008-5#2)
neurosecretory cells##9##2##(1990-5#1)(1995-11#2)(2008-5#5)(2008-6#1)
neurosecretory##11##1##(1990-5#3)(1995-11#2)(2008-5#5)(2008-6#1)
neurosis##2##1##(1991-6#1)(2008-4#1)
neurospheres##2##1##(2009-10#2)
neurosurgeons and##2##2##(1996-3#1)(2013-1#1)
neurosurgeons##6##1##(1996-3#1)(2008-7#1)(2012-3#2)(2013-1#2)
neurosurgery##12##1##(1991-6#1)(1997-4#1)(2007-9#1)(2008-12#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
neurosurgical patients##2##2##(2008-11#1)(2010-7#1)
neurosurgical##12##1##(1996-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#5)(2013-1#1)
neurosyphilis##4##1##(1997-5#1)(2010-3#3)
neurotensin (NT)##2##2##(1994-3#1)(1996-2#1)
neurotensin##7##1##(1991-5#1)(1994-3#1)(1994-8#1)(1995-2#2)(1996-2#2)
neuroticism##7##1##(2008-11#7)
neurotomy##3##1##(1994-3#3)
neurotoxic action##2##2##(1990-5#1)(2008-7#1)
neurotoxic lesions of the##2##4##(1993-3#1)(1993-6#1)
neurotoxic lesions of##3##3##(1991-2#1)(1993-3#1)(1993-6#1)
neurotoxic properties##2##2##(1994-8#1)(1996-12#1)
neurotoxic stimuli##2##2##(2011-9#2)
neurotoxic##19##1##(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-8#1)(1995-11#1)(1996-12#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-9#2)(2012-3#1)
neurotoxicity##19##1##(1990-12#1)(1991-8#2)(1992-2#1)(1994-2#1)(2008-5#2)(2008-7#9)(2009-7#1)(2010-6#1)(2013-1#1)
neurotoxin and##2##2##(1992-3#1)(1994-11#1)
neurotoxin in##2##2##(2008-7#1)(2008-9#1)
neurotoxin##25##1##(1990-5#2)(1992-3#2)(1992-6#1)(1994-11#7)(1996-12#2)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#2)(2011-2#3)
neurotoxins##2##1##(2008-5#1)(2008-9#1)
neurotransmission and##2##2##(1997-1#1)(2009-8#1)
neurotransmission in the##3##3##(1990-12#1)(1994-2#1)(1995-12#1)
neurotransmission to##2##2##(1997-4#1)(2012-3#1)
neurotransmission##15##1##(1990-12#1)(1990-5#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#2)(2013-8#2)
neurotransmitter metabolites##2##2##(2008-10#2)
neurotransmitter receptors and##2##3##(1993-8#1)(1995-11#1)
neurotransmitter receptors##3##2##(1993-8#1)(1995-11#1)(1996-12#1)
neurotransmitter release##7##2##(1994-11#1)(1995-2#1)(2008-5#2)(2008-7#2)(2013-1#1)
neurotransmitter systems##3##2##(2008-5#1)(2009-7#1)(2012-12#1)
neurotransmitter##32##1##(1990-5#1)(1991-5#2)(1993-8#1)(1994-11#1)(1995-11#2)(1995-2#1)(1996-12#5)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#4)(2008-7#3)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
neurotransmitters in the##4##3##(1992-12#1)(1993-3#1)(2008-10#2)
neurotransmitters such as##2##3##(2008-10#1)(2008-11#1)
neurotransmitters##23##1##(1992-12#1)(1993-3#1)(1995-2#2)(1996-12#2)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-7#1)(2010-5#1)
neurotrophic activity in##2##3##(1990-5#1)(2008-11#1)
neurotrophic factor (BDNF)##8##3##(1996-12#1)(1997-2#2)(2008-7#2)(2009-8#1)(2012-12#1)(2012-2#1)
neurotrophic factor##22##2##(1990-5#2)(1996-12#1)(1996-2#3)(1997-2#4)(1997-6#1)(2008-11#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
neurotrophic factors##5##2##(2013-1#4)(2013-7#1)
neurotrophic molecule##2##2##(1990-5#1)(1997-2#1)
neurotrophic##31##1##(1990-5#4)(1996-12#1)(1996-2#3)(1997-2#5)(1997-6#1)(2008-11#2)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-7#1)
neurotrophin receptor##3##2##(1995-8#1)(1996-12#1)(2008-7#1)
neurotrophin receptors in##2##3##(1995-8#1)(1996-12#1)
neurotrophin receptors##5##2##(1995-8#1)(1996-12#4)
neurotrophin##13##1##(1995-8#2)(1996-12#6)(2008-7#2)(2009-8#1)(2012-12#1)(2013-8#1)
neurotrophin-3##2##1##(2009-10#2)
neurotrophins in##4##2##(1995-8#1)(1996-12#2)(2008-7#1)
neurotrophins##14##1##(1995-8#2)(1996-12#4)(2008-7#6)(2009-10#1)(2010-8#1)
neurovascular complications##3##2##(2010-3#1)(2012-12#1)(2013-1#1)
neurovascular##7##1##(2009-5#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
neurula##3##1##(1997-7#2)(2008-6#1)
neutral acidities##2##2##(2008-10#2)
neutral amino acids##4##3##(1994-5#3)(2008-10#1)
neutral amino##5##2##(1994-5#4)(2008-10#1)
neutral analytes##2##2##(2008-10#1)(2010-7#1)
neutral and alkaline##4##3##(2008-10#3)(2008-11#1)
neutral and cationic##2##3##(2008-10#2)
neutral and##14##2##(1990-5#1)(2008-10#9)(2008-11#1)(2010-7#1)(2013-1#2)
neutral anion##2##2##(2008-10#2)
neutral carrier for##2##3##(2008-10#2)
neutral carrier##17##2##(2008-10#17)
neutral carriers in##2##3##(2008-10#2)
neutral carriers##11##2##(2008-10#11)
neutral compounds##2##2##(2008-10#2)
neutral conditions##4##2##(2008-10#2)(2008-11#1)(2010-11#1)
neutral effect##2##2##(2012-2#1)(2012-9#1)
neutral endopeptidase 24##2##3##(1990-5#1)(1992-6#1)
neutral endopeptidase##5##2##(1990-5#4)(1992-6#1)
neutral form##3##2##(2008-10#3)
neutral frame##2##2##(2008-4#2)
neutral ionophores were##2##3##(2008-10#2)
neutral ionophores##5##2##(2008-10#5)
neutral lipid##2##2##(2008-11#1)(2009-8#1)
neutral lipids##3##2##(2008-11#3)
neutral lipophilic##2##2##(2008-10#2)
neutral loci##2##2##(2012-3#2)
neutral markers##3##2##(2008-10#2)(2012-3#1)
neutral media##3##2##(2008-10#3)
neutral pH##14##2##(1993-8#1)(1994-5#1)(2008-10#9)(2008-11#1)(2008-4#1)(2009-10#1)
neutral processes##2##2##(2012-3#2)
neutral saccharides##2##2##(1991-7#2)
neutral site##2##2##(2008-10#1)(2012-3#1)
neutral solution##2##2##(2008-10#2)
neutral solutions##2##2##(2008-10#2)
neutral species##3##2##(2008-10#3)
neutral surfactant##3##2##(2008-10#3)
neutral##224##1##(1990-5#6)(1991-12#1)(1991-6#1)(1991-7#3)(1992-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-5#5)(1994-8#2)(1995-2#3)(1995-6#1)(1996-5#1)(1997-6#1)(1997-8#3)(2008-10#123)(2008-11#13)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#3)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#9)(2012-9#1)(2013-1#5)(2013-8#1)
neutral)##3##1##(2008-11#2)(2010-8#1)
neutral- and##2##2##(1997-2#1)(2008-11#1)
neutralisation##8##1##(1991-3#4)(2008-10#4)
neutralising##3##1##(1996-12#1)(2008-10#2)
neutrality in##2##2##(2009-8#1)(2012-3#1)
neutrality##4##1##(2009-8#1)(2012-3#2)(2013-8#1)
neutralization assay##2##2##(1995-5#1)(2008-10#1)
neutralization of the##2##3##(2008-10#1)(2010-6#1)
neutralization of##8##2##(1993-5#1)(1996-12#2)(2008-10#3)(2010-6#1)(2013-1#1)
neutralization##19##1##(1993-5#1)(1995-5#2)(1996-12#2)(2008-10#11)(2008-12#1)(2010-6#1)(2013-1#1)
neutralize the##5##2##(1991-8#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
neutralize##10##1##(1991-5#1)(1991-8#1)(1993-3#1)(2008-10#5)(2008-11#1)(2008-8#1)
neutralized by##4##2##(1996-12#1)(1997-1#1)(2008-5#1)(2009-8#1)
neutralized to##2##2##(2008-10#1)(2008-11#1)
neutralized##11##1##(1996-12#3)(1997-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-8#1)
neutralizing and##2##2##(1995-5#1)(2011-2#1)
neutralizing antibodies##5##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
neutralizing##19##1##(1995-2#1)(1995-5#6)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
neutrino##3##1##(1991-9#1)(1992-11#2)
neutron activation analysis##4##3##(2008-10#4)
neutron scattering##5##2##(1995-3#2)(2008-10#3)
neutron##17##1##(1993-5#1)(1995-3#2)(2008-10#11)(2010-7#1)(2013-1#2)
neutrons##2##1##(2008-5#1)(2013-1#1)
neutropenia risk##2##2##(2008-7#2)
neutropenia##14##1##(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#7)(2013-1#1)
neutropenic##2##1##(2008-5#1)(2013-1#1)
neutrophil NADPH oxidase##2##3##(1991-5#2)
neutrophil activation##2##2##(1997-1#1)(2008-11#1)
neutrophil apoptosis##2##2##(2008-11#1)(2009-10#1)
neutrophil chemotaxis in##2##3##(1994-11#2)
neutrophil chemotaxis##4##2##(1994-11#4)
neutrophil elastase and##2##3##(1994-5#1)(2008-6#1)
neutrophil elastase##7##2##(1993-3#1)(1994-5#4)(2008-5#1)(2008-6#1)
neutrophil functions##2##2##(1993-3#1)(2008-10#1)
neutrophil migration##4##2##(1994-11#1)(1994-8#3)
neutrophil progenitors##2##2##(2008-11#2)
neutrophil##56##1##(1990-5#2)(1991-12#1)(1991-5#2)(1992-8#1)(1993-3#3)(1993-6#1)(1993-8#4)(1994-11#8)(1994-3#1)(1994-5#5)(1994-8#3)(1996-11#1)(1996-2#1)(1997-1#2)(2008-10#5)(2008-11#11)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#1)
neutrophilic##3##1##(2009-8#2)(2011-2#1)
neutrophils and##8##2##(1991-2#1)(1994-8#1)(2008-10#2)(2009-10#1)(2010-6#1)(2012-12#1)(2012-2#1)
neutrophils by##2##2##(2008-10#1)(2008-11#1)
neutrophils from healthy controls and SLE patients were stimulated with different IC##2##12##(2008-10#2)
neutrophils from##4##2##(2008-10#4)
neutrophils in response to##2##4##(1993-6#1)(1994-11#1)
neutrophils in##4##2##(1993-6#1)(1994-11#1)(2008-1#1)(2008-10#1)
neutrophils using##2##2##(1992-12#1)(2011-2#1)
neutrophils was##5##2##(1992-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(2008-10#1)
neutrophils##65##1##(1990-12#2)(1991-2#1)(1992-10#1)(1992-12#3)(1992-8#1)(1993-3#1)(1993-6#6)(1993-8#1)(1994-11#1)(1994-6#2)(1994-8#3)(1995-6#1)(1996-12#1)(2008-1#3)(2008-10#18)(2008-11#5)(2008-6#1)(2008-9#4)(2009-10#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
never associated with##2##3##(2008-5#1)(2012-3#1)
never been##20##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#2)(2009-6#1)(2012-12#1)(2012-5#1)
never before##3##2##(1991-2#1)(2008-11#1)(2009-10#1)
never cleaned##2##2##(2009-6#2)
never had##3##2##(1990-6#1)(1990-8#1)(2009-12#1)
never in##3##2##(1992-6#1)(2008-10#2)
never occurred##3##2##(1992-2#1)(1994-3#1)(2008-10#1)
never used##5##2##(1992-3#1)(2013-1#2)(2013-8#2)
never##96##1##(1990-6#2)(1990-8#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-11#2)(1996-6#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#2)
never-ending##2##1##(2008-9#1)(2011-2#1)
nevertheless the##3##2##(1991-3#1)(1995-3#1)(2008-10#1)
nevertheless##18##1##(1991-11#1)(1991-3#1)(1993-8#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
nevi and##2##2##(2011-2#1)(2012-3#1)
nevi are##3##2##(2011-2#3)
nevi##18##1##(2011-2#11)(2012-3#6)(2013-8#1)
nevirapine##5##1##(2008-10#4)(2011-2#1)
nevoid basal cell carcinoma syndrome##2##5##(1997-3#2)
nevoid melanoma##7##2##(2011-2#7)
nevoid##9##1##(1997-3#2)(2011-2#7)
nevus##4##1##(2011-2#2)(2012-12#1)(2012-3#1)
new &quot##3##2##(1994-9#1)(2008-10#1)(2008-12#1)
new 1##2##2##(2008-10#1)(2012-3#1)
new 14- and 15-crown-formazans##3##4##(2008-10#3)
new AIDS##2##2##(1993-9#1)(1995-6#1)
new Ektacytometry##3##2##(2008-8#3)
new FFT-based method##2##3##(2008-3#2)
new HIV-1 nonnucleoside reverse transcriptase##2##5##(2011-3#2)
new HIV-1##4##2##(1992-9#1)(2011-3#3)
new Medicare##3##2##(1992-1#2)(2008-4#1)
new Mu##2##2##(2012-3#2)
new ORFs##2##2##(1996-6#2)
new Phytophthora##2##2##(2008-10#1)(2010-3#1)
new QTL##2##2##(2008-10#2)
new adult##2##2##(1994-1#1)(2008-7#1)
new agents for##2##3##(2008-10#2)
new agents##4##2##(1997-5#1)(2008-10#3)
new algorithm is##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
new algorithm##10##2##(2008-10#3)(2008-3#3)(2008-6#2)(2012-12#1)(2013-8#1)
new algorithms##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
new alloy##3##2##(2009-7#3)
new amperometric##4##2##(2008-10#4)
new analytical method for the##5##5##(2008-10#5)
new analytical method for##6##4##(2008-10#6)
new analytical method##7##3##(2008-10#7)
new analytical##19##2##(2007-12#1)(2008-10#17)(2010-11#1)
new and effective##3##3##(2007-8#1)(2011-3#1)(2013-8#1)
new and highly##2##3##(2009-12#1)(2012-2#1)
new and innovative##4##3##(1995-3#1)(1996-3#1)(1997-2#1)(2012-2#1)
new and more effective##3##4##(1994-1#1)(2010-11#1)(2012-3#1)
new and more##5##3##(1994-1#1)(2008-11#1)(2010-11#1)(2011-1#1)(2012-3#1)
new and old##2##3##(2008-12#1)(2008-8#1)
new and simple##4##3##(1996-5#1)(2008-10#2)(2012-2#1)
new and##54##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-6#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#3)(2007-8#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#2)(2013-8#1)
new antibody##3##2##(2008-10#3)
new antigens##2##2##(1995-5#1)(1997-8#1)
new applications##6##2##(1991-2#1)(1992-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
new approach for the##6##4##(2008-10#5)(2008-3#1)
new approach for##12##3##(1997-3#1)(2008-10#8)(2008-3#1)(2009-7#1)(2012-2#1)
new approach in##2##3##(2008-10#1)(2008-11#1)
new approach is##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
new approach to the##5##4##(2008-10#1)(2008-3#1)(2010-5#1)(2012-2#1)(2012-3#1)
new approach to##20##3##(1992-1#2)(1993-12#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
new approach##57##2##(1992-1#2)(1993-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#23)(2008-11#4)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2009-10#1)(2009-7#1)(2010-5#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
new approaches for##2##3##(2008-12#1)(2010-12#1)
new approaches to##4##3##(1995-12#1)(2008-11#1)(2009-6#1)(2009-8#1)
new approaches##10##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)
new area of##2##3##(2008-11#1)(2008-9#1)
new area##4##2##(2008-11#1)(2008-9#1)(2010-4#1)(2013-8#1)
new areas of##2##3##(1994-12#1)(2012-2#1)
new areas##5##2##(1994-12#1)(2008-10#1)(2010-3#1)(2010-4#1)(2012-2#1)
new aspect##3##2##(1993-8#1)(1994-3#1)(2008-11#1)
new aspects of##2##3##(1994-11#1)(1994-9#1)
new aspects##3##2##(1994-11#1)(1994-9#1)(2013-1#1)
new assay for##2##3##(1991-12#2)
new assay##7##2##(1991-12#2)(2008-10#5)
new attitude##2##2##(1991-12#2)
new automated##2##2##(1997-2#1)(2008-10#1)
new avenue##2##2##(1991-1#1)(2008-4#1)
new avenues for##5##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
new avenues##7##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2012-2#1)
new bacterial life model##3##4##(2008-8#3)
new biological##3##2##(1990-9#1)(2008-10#1)(2012-3#1)
new biomarker##2##2##(2010-12#1)(2012-2#1)
new book##2##2##(2008-10#1)(2008-11#1)
new brain##2##2##(2008-5#1)(2009-5#1)
new bulk##3##2##(2008-10#3)
new calibration method based on linear correlation##2##7##(2008-10#2)
new calibration method##3##3##(2008-10#3)
new calibration##5##2##(2008-10#4)(2008-6#1)
new capillary electrophoresis (CE) method##2##5##(2008-10#2)
new capillary electrophoresis (CE) procedure##2##5##(2008-10#2)
new capillary electrophoresis (CE)##4##4##(2008-10#4)
new case of##3##3##(1990-12#1)(2007-8#1)(2008-7#1)
new case##5##2##(1990-12#1)(1991-11#1)(2007-8#1)(2008-7#1)(2009-1#1)
new cases of##4##3##(1992-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
new cases##12##2##(1992-9#1)(1994-12#1)(1996-11#3)(1997-6#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
new cell line##2##3##(2008-11#2)
new cell##6##2##(2008-10#1)(2008-11#5)
new challenges and##3##3##(1993-1#1)(2008-12#1)(2013-8#1)
new challenges for##2##3##(1992-3#1)(1993-1#1)
new challenges##12##2##(1991-1#1)(1991-9#1)(1992-3#1)(1993-1#2)(1994-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#1)(2013-8#1)
new chelating ion-exchange##2##3##(2008-10#2)
new chelating resin##6##3##(2008-10#6)
new chelating sorbent##2##3##(2008-10#2)
new chelating##14##2##(2008-10#14)
new chemical##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)(2010-7#1)
new chemiluminescence##4##2##(2008-10#4)
new chemiluminescent##2##2##(2008-10#2)
new chromatographic##3##2##(2008-10#1)(2010-11#1)(2010-7#1)
new chromatography##2##2##(2008-10#2)
new chromogenic reagent##4##3##(2008-10#4)
new chromogenic##5##2##(1996-5#1)(2008-10#4)
new class of antitumor agents##2##5##(2008-5#2)
new class of##24##3##(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#5)(2008-9#1)(2009-10#1)(2009-9#1)(2011-3#1)(2013-1#1)
new classification##7##2##(1991-1#1)(1991-9#2)(1997-8#3)(2008-7#1)
new clinical##2##2##(1996-6#1)(2012-2#1)
new coding##2##2##(1995-12#1)(2008-11#1)
new column##2##2##(1993-1#2)
new compound##2##2##(2008-11#1)(2011-3#1)
new compounds##9##2##(1991-1#2)(1992-3#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)(2012-3#1)
new computer program##2##3##(2008-10#2)
new concentration##2##2##(2008-10#2)
new concept for##2##3##(1997-6#1)(2011-2#1)
new concept in##4##3##(1991-12#1)(2008-5#1)(2008-8#1)(2010-7#1)
new concept of the brain##2##5##(2009-5#2)
new concept of the##3##4##(2007-8#1)(2009-5#2)
new concept of##5##3##(2007-8#1)(2008-8#1)(2009-5#2)(2012-2#1)
new concept##15##2##(1991-12#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-7#1)(2011-2#1)(2012-2#3)
new concepts##4##2##(1997-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
new conceptual##4##2##(2008-8#1)(2009-5#2)(2012-3#1)
new conditions##2##2##(1997-3#1)(2008-10#1)
new consensus##2##2##(1994-6#1)(2008-6#1)
new context##2##2##(1996-1#1)(2012-2#1)
new control##2##2##(1990-8#1)(2011-3#1)
new convexity measure for##2##4##(2008-6#2)
new convexity measure##7##3##(2008-6#7)
new cosmetic##4##2##(2008-5#3)(2011-1#1)
new crown-formazans##3##2##(2008-10#3)
new cultivars##2##2##(2008-10#1)(2012-4#1)
new culture##2##2##(2008-11#1)(2011-2#1)
new data from##2##3##(1996-2#1)(2008-10#1)
new data##9##2##(1996-2#1)(2008-10#2)(2008-11#2)(2009-8#3)(2013-8#1)
new delivery system##2##3##(1997-2#1)(2008-5#1)
new demands##2##2##(1991-2#1)(2010-7#1)
new derivatives of##2##3##(2008-10#2)
new design##2##2##(2008-10#2)
new detector##3##2##(2008-10#3)
new development##2##2##(2008-10#1)(2010-7#1)
new developments have##2##3##(2007-12#1)(2008-6#1)
new developments in##2##3##(2008-10#1)(2008-7#1)
new developments##5##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-10#1)
new device##7##2##(1995-1#2)(2008-2#1)(2008-3#2)(2008-5#2)
new diagnostic##3##2##(1992-9#1)(2008-5#1)(2011-2#1)
new diethyl##3##2##(2012-3#3)
new dimension##2##2##(1991-5#1)(2008-11#1)
new direct##2##2##(2008-10#2)
new directions in##2##3##(1996-9#1)(2010-2#1)
new directions##4##2##(1991-2#1)(1996-9#1)(2010-2#1)(2011-2#1)
new discipline##3##2##(2008-11#1)(2008-4#1)(2010-1#1)
new disease##3##2##(2008-10#2)(2008-12#1)
new drug##8##2##(1993-2#1)(1995-1#1)(2008-10#2)(2008-5#1)(2009-10#1)(2011-3#1)(2013-1#1)
new drugs for##2##3##(2008-10#1)(2008-5#1)
new drugs##13##2##(1993-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
new dynamic##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
new ecological##2##2##(2008-10#1)(2009-8#1)
new efficacy measure##2##3##(1994-9#2)
new electrochemical##4##2##(2008-10#4)
new electrode material##2##3##(2008-10#2)
new electrode##4##2##(2008-10#4)
new emerging##2##2##(2011-2#1)(2013-8#1)
new endemic##2##2##(1996-11#2)
new environment##4##2##(1995-5#1)(2008-11#1)(2008-6#1)(2012-2#1)
new enzyme##3##2##(1991-9#1)(2008-10#1)(2011-1#1)
new equations for##2##3##(2008-2#1)(2011-2#1)
new era for##3##3##(1993-12#1)(1995-8#1)(2011-2#1)
new era in##4##3##(1991-2#1)(1991-8#1)(2008-11#1)(2009-5#1)
new era##13##2##(1991-2#1)(1991-8#1)(1993-12#1)(1995-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2011-2#1)(2011-7#1)
new evidence that##2##3##(2008-12#1)(2008-9#1)
new evidence##5##2##(1993-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-8#1)
new excipients##3##2##(2012-2#3)
new experimental design##2##3##(2008-10#1)(2008-5#1)
new experimental##8##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)
new explanation for the##2##4##(1995-6#1)(2008-3#1)
new expression##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
new extraction chromatographic##2##3##(2008-10#2)
new extraction##4##2##(2008-10#4)
new family of##7##3##(1991-9#1)(1993-2#1)(1995-6#1)(1996-5#1)(2008-12#1)(2008-3#1)(2012-2#1)
new family##9##2##(1991-9#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
new features##2##2##(2008-10#2)
new feeding strategy##2##3##(2008-7#2)
new female##2##2##(2008-9#1)(2011-2#1)
new field of##3##3##(1997-7#1)(2008-12#1)(2008-7#1)
new field##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
new findings##2##2##(2008-10#1)(2008-5#1)
new flow cell##2##3##(2008-10#2)
new flow injection chemiluminescence##2##4##(2008-10#2)
new flow injection##7##3##(2008-10#7)
new flow##11##2##(1995-9#1)(2008-10#10)
new flow-injection##3##2##(2008-10#3)
new fluorescence probe##2##3##(2008-10#2)
new fluorescence##4##2##(2008-10#4)
new fluorescent probe 1##3##4##(2008-10#3)
new fluorescent##5##2##(2008-10#5)
new food acceptance##4##3##(2008-4#4)
new food##7##2##(2008-4#4)(2011-2#2)(2012-2#1)
new form of##2##3##(1996-11#1)(2008-11#1)
new formulation of the##2##4##(2007-12#1)(2008-10#1)
new formulation of##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
new formulation##4##2##(2007-12#2)(2008-10#1)(2010-12#1)
new formulations##3##2##(2008-11#2)(2008-5#1)
new frontiers##2##2##(1993-1#1)(2008-10#1)
new fruits and##2##3##(2008-4#2)
new gas##2##2##(2008-10#1)(2008-11#1)
new gene origination in rice##2##5##(2009-10#2)
new gene was##2##3##(1995-6#1)(2008-10#1)
new gene with WD domains##2##5##(2008-8#2)
new gene##16##2##(1995-6#1)(1997-7#1)(2008-10#4)(2008-4#1)(2008-8#5)(2008-9#2)(2009-10#2)
new generation of##9##3##(1991-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
new generation##10##2##(1991-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
new genes##13##2##(1995-8#1)(1995-9#2)(1996-2#2)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-9#1)(2009-10#3)
new genetic##3##2##(1995-12#1)(2011-2#1)(2011-3#1)
new genotypes##6##2##(2008-10#6)
new graduates##2##2##(1993-11#1)(2008-11#1)
new graphical##4##2##(1995-12#1)(2008-10#2)(2009-7#1)
new group of##3##3##(1997-2#1)(1997-3#1)(2008-10#1)
new group##4##2##(1997-2#1)(1997-3#1)(2008-10#1)(2010-4#1)
new groups##2##2##(2008-10#1)(2011-2#1)
new guidelines##3##2##(2008-11#1)(2008-3#1)(2009-8#1)
new health##4##2##(1992-2#1)(1995-2#1)(1996-2#2)
new highly##5##2##(2008-10#5)
new hope##2##2##(1996-9#1)(2011-3#1)
new horizons##2##2##(2008-11#2)
new host##12##2##(2008-10#3)(2008-8#5)(2011-2#1)(2012-2#3)
new host-vector systems##2##3##(1993-12#2)
new ideas##3##2##(1995-1#1)(2008-8#1)(2010-10#1)
new imaging##3##2##(2008-6#1)(2010-8#1)(2012-2#1)
new implant##2##2##(2008-9#1)(2009-7#1)
new in##5##2##(2008-10#1)(2008-4#1)(2009-5#1)(2009-8#1)(2013-1#1)
new indicator##2##2##(2008-10#1)(2013-1#1)
new infected##2##2##(2008-10#2)
new infection##2##2##(1997-5#1)(2008-10#1)
new infections##2##2##(1990-6#1)(2008-10#1)
new information on##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
new information##9##2##(1997-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
new initiatives##2##2##(1995-12#1)(2008-11#1)
new insight into the##7##4##(1993-2#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-3#1)(2009-5#1)
new insight into##10##3##(1991-5#1)(1993-2#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-4#1)(2010-7#1)
new insight##13##2##(1991-5#1)(1993-2#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-3#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2013-8#1)
new insights in the##2##4##(2008-10#1)(2011-2#1)
new insights in##6##3##(2008-10#2)(2008-11#2)(2011-2#2)
new insights into the##18##4##(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#2)(2010-12#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
new insights into##23##3##(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-7#2)(2010-12#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
new insights##35##2##(1992-3#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-7#2)(2010-12#1)(2011-10#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-8#1)
new instrument to measure##2##4##(1997-1#1)(2008-3#1)
new instrument##3##2##(1992-3#1)(1997-1#1)(2008-3#1)
new integrated##2##2##(2008-10#1)(2008-3#1)
new interpretation##2##2##(1992-8#1)(2007-12#1)
new ion-selective##3##2##(2008-10#3)
new isoform##3##2##(1992-3#2)(1993-6#1)
new isolates and##2##3##(2008-10#2)
new isolates##3##2##(2008-10#2)(2011-1#1)
new kind of##7##3##(1994-3#1)(1995-6#1)(2008-10#3)(2008-11#2)
new kinetic method##2##3##(2008-10#2)
new kinetic##3##2##(2008-10#3)
new knowledge related to##2##4##(2011-2#1)(2012-2#1)
new knowledge##5##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
new laser##4##2##(1992-12#2)(2008-10#1)(2008-3#1)
new leaf rust resistance##2##4##(2008-10#2)
new level of##5##3##(1993-12#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
new level##6##2##(1993-12#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
new light on the##4##4##(1997-2#1)(2008-9#1)(2012-2#2)
new light on##7##3##(1994-12#1)(1997-2#1)(2008-9#1)(2009-3#1)(2012-2#2)(2012-3#1)
new light##8##2##(1994-12#1)(1997-2#2)(2008-9#1)(2009-3#1)(2012-2#2)(2012-3#1)
new lipophilic##3##2##(2008-10#3)
new look at##2##3##(1993-2#1)(2008-9#1)
new look##3##2##(1993-2#1)(2008-8#1)(2008-9#1)
new major##2##2##(2008-10#2)
new markers##4##2##(1994-12#1)(1996-12#1)(1997-8#1)(1997-9#1)
new material for##2##3##(2008-10#1)(2008-11#1)
new material##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
new materials and##2##3##(2010-7#1)(2012-3#1)
new materials for##3##3##(2010-11#1)(2010-7#1)(2013-1#1)
new materials##6##2##(2010-11#1)(2010-7#2)(2012-3#1)(2013-1#2)
new mathematical##2##2##(2008-10#1)(2008-3#1)
new measures of##2##3##(1992-9#1)(1995-2#1)
new measures##3##2##(1992-9#2)(1995-2#1)
new mechanism of action##2##4##(2008-10#1)(2008-5#1)
new mechanism of##5##3##(1992-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
new mechanism##6##2##(1992-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
new medical##3##2##(1992-2#1)(1993-2#1)(2013-1#1)
new member of the genus##7##5##(2008-10#7)
new member of the##9##4##(1995-12#1)(2008-10#7)(2009-3#1)
new member of##12##3##(1995-12#1)(2008-10#7)(2008-8#2)(2008-9#1)(2009-3#1)
new member##13##2##(1995-12#1)(1997-8#1)(2008-10#7)(2008-8#2)(2008-9#1)(2009-3#1)
new members of the##5##4##(1993-6#1)(1993-9#2)(2008-10#1)(2013-8#1)
new members##7##2##(1993-6#1)(1993-9#2)(1997-9#2)(2008-10#1)(2013-8#1)
new membrane##2##2##(2008-10#1)(2008-7#1)
new metabolite##3##2##(1994-8#1)(2008-11#2)
new metal##2##2##(2008-10#1)(2010-5#1)
new method called##3##3##(2008-10#2)(2008-5#1)
new method for the determination of the##2##7##(2008-10#2)
new method for the determination of##11##6##(2008-10#11)
new method for the preparation of##2##6##(2008-10#2)
new method for the##22##4##(2008-10#21)(2008-5#1)
new method for##45##3##(1995-3#1)(2008-10#35)(2008-2#1)(2008-3#4)(2008-5#1)(2010-9#1)(2012-2#2)
new method has##3##3##(2008-10#3)
new method is described for the determination of##2##8##(2008-10#2)
new method is##11##3##(2008-10#10)(2008-2#1)
new method of##14##3##(1990-2#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-8#1)
new method proposed##2##3##(2008-10#2)
new method to##9##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)
new method was developed for##2##5##(2008-10#2)
new method was developed##3##4##(2008-10#3)
new method was##6##3##(2008-10#5)(2011-2#1)
new method##123##2##(1990-2#2)(1991-12#1)(1993-3#1)(1995-3#1)(1996-3#1)(2008-10#84)(2008-11#2)(2008-2#5)(2008-3#7)(2008-5#5)(2008-9#4)(2009-12#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-8#1)
new methodological##2##2##(1996-2#1)(2013-8#1)
new methodology##3##2##(2008-10#2)(2008-8#1)
new methods for##4##3##(1993-3#1)(1997-8#1)(2008-10#1)(2013-8#1)
new methods of##3##3##(2007-11#1)(2008-10#1)(2009-8#1)
new methods##15##2##(1993-3#1)(1993-6#1)(1994-6#1)(1997-1#2)(1997-8#1)(2007-11#1)(2008-10#5)(2009-8#1)(2010-1#1)(2013-8#1)
new methylene##3##2##(2006-6#1)(2008-10#2)
new model for##6##3##(1991-7#1)(1994-12#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)
new model of##7##3##(1995-5#1)(1996-3#1)(1997-4#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-6#1)
new model##19##2##(1990-8#1)(1991-7#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-3#1)
new models of##2##3##(2008-11#1)(2010-8#1)
new models##3##2##(2008-11#1)(2009-7#1)(2010-8#1)
new modified##5##2##(1993-8#1)(2008-10#4)
new molecular entities##2##3##(2008-10#1)(2010-10#1)
new molecular##6##2##(2008-10#2)(2008-8#1)(2009-1#1)(2010-10#1)(2013-1#1)
new monoclonal##2##2##(1992-2#1)(1993-12#1)
new mutations##2##2##(2010-4#2)
new national##5##2##(1994-9#1)(1995-2#1)(1997-2#1)(2008-11#1)(2008-3#1)
new natural##2##2##(2008-5#1)(2011-2#1)
new neurological##2##2##(1997-6#1)(2012-12#1)
new neurons from##2##3##(2008-7#1)(2012-2#1)
new neurons##3##2##(2008-7#1)(2012-2#2)
new non-cavitated caries##3##3##(2012-2#3)
new non-cavitated##4##2##(2012-2#4)
new nucleic##2##2##(2008-10#1)(2010-6#1)
new nursing curriculum##2##3##(2008-11#2)
new nursing roles##2##3##(2008-11#2)
new nursing##4##2##(2008-11#4)
new observations##2##2##(2008-10#1)(2008-3#1)
new one##4##2##(1992-9#1)(1996-6#2)(2008-11#1)
new ones##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
new open reading frames##4##4##(1995-9#1)(1996-3#2)(1996-6#1)
new opportunities for##4##3##(1993-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
new opportunities to##2##3##(1997-8#1)(2011-2#1)
new opportunities##9##2##(1993-12#1)(1995-1#1)(1997-1#1)(1997-8#1)(2008-5#1)(2008-6#1)(2011-2#3)
new optical##3##2##(2008-10#2)(2008-3#1)
new or ancient##2##3##(2013-1#2)
new or##6##2##(1994-12#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
new organizational structure##2##3##(1992-5#2)
new organizational structures##2##3##(1991-3#1)(1995-1#1)
new organizational##5##2##(1991-3#1)(1992-5#2)(1995-1#1)(1996-1#1)
new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase (CABS)##2##7##(2008-10#2)
new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##3##6##(2008-10#3)
new packing material##2##3##(2008-10#2)
new packing##4##2##(2008-10#4)
new paradigm for##7##3##(1996-3#1)(2008-4#2)(2009-12#1)(2010-4#1)(2013-1#2)
new paradigm##8##2##(1996-3#1)(2008-4#2)(2009-12#1)(2010-4#1)(2012-3#1)(2013-1#2)
new paradigms##3##2##(1994-2#1)(2008-9#1)(2009-12#1)
new pattern of##2##3##(1992-1#1)(2008-10#1)
new payment##2##2##(1992-2#1)(1997-1#1)
new peak##2##2##(2008-10#2)
new perspective##3##2##(1994-1#1)(2008-1#1)(2012-3#1)
new perspectives in the##2##4##(2008-5#1)(2010-4#1)
new perspectives##6##2##(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-3#1)
new pharmaceutical##3##2##(1991-12#1)(2008-10#1)(2008-8#1)
new phase separator##2##3##(2008-10#2)
new phenotypes##2##2##(2010-4#2)
new plants##2##2##(2008-10#2)
new polypeptide##2##2##(2008-10#2)
new positions were advertised in##2##5##(1990-6#2)
new possibilities##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
new potential##4##2##(1997-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
new practice##3##2##(1992-8#1)(2008-11#2)
new primer##2##2##(1992-3#1)(2008-10#1)
new probes##2##2##(2008-10#2)
new problems##2##2##(1990-12#1)(2008-10#1)
new procedure for the determination of##2##6##(2008-10#2)
new procedure for the##3##4##(2008-10#2)(2008-12#1)
new procedure for##5##3##(2008-10#3)(2008-12#1)(2011-2#1)
new procedure is##3##3##(2008-10#3)
new procedure was applied to##2##5##(2008-10#2)
new procedure##18##2##(1992-3#1)(2008-10#14)(2008-12#1)(2008-5#1)(2011-2#1)
new procedures##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
new products have been approved##2##5##(2012-2#2)
new professional##2##2##(1997-2#1)(2008-11#1)
new program##3##2##(1991-2#1)(1996-2#1)(2008-8#1)
new programs and##2##3##(1992-8#1)(1994-1#1)
new programs##5##2##(1991-1#1)(1992-1#1)(1992-8#1)(1994-1#1)(1996-1#1)
new project##2##2##(2008-10#2)
new prospects for##2##3##(2008-5#1)(2008-9#1)
new prospects##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
new protein##3##2##(2008-10#3)
new proteins has been##2##4##(1997-6#2)
new proteins has##3##3##(1997-6#2)(2010-4#1)
new proteins##4##2##(1997-6#2)(2008-10#1)(2010-4#1)
new protocol##5##2##(2008-10#4)(2008-9#1)
new public health##6##3##(1992-1#6)
new quantitative##5##2##(1996-12#1)(2008-10#3)(2012-2#1)
new questions##2##2##(2010-5#1)(2012-3#1)
new races##4##2##(2008-10#4)
new radiation##2##2##(2008-12#1)(2008-3#1)
new rapid##3##2##(1994-5#1)(2008-10#2)
new reagent##6##2##(2008-10#6)
new redox##2##2##(2008-10#2)
new regression method##2##3##(2008-10#2)
new regulations##2##2##(1991-1#2)
new relationship##2##2##(1995-1#1)(2008-5#1)
new research##4##2##(2008-11#2)(2008-3#1)(2009-10#1)
new resin##5##2##(2008-10#5)
new resistance##3##2##(2008-10#3)
new resonance##2##2##(2008-10#2)
new retroviral vector##2##3##(1997-8#1)(2008-11#1)
new retroviral##4##2##(1997-8#3)(2008-11#1)
new risk##3##2##(2009-7#1)(2011-2#1)(2012-2#1)
new role for##3##3##(1990-11#1)(1991-3#1)(1996-2#1)
new role##4##2##(1990-11#1)(1991-1#1)(1991-3#1)(1996-2#1)
new roles and##2##3##(1993-12#1)(1995-12#1)
new roles for##2##3##(1992-8#1)(2008-11#1)
new roles##5##2##(1992-8#1)(1993-12#1)(1995-12#1)(2008-11#2)
new root-knot nematode##2##3##(2008-10#2)
new sample##6##2##(2008-10#5)(2012-2#1)
new sampling methods for##2##4##(2008-10#2)
new sampling##4##2##(2008-10#4)
new science##2##2##(2008-11#1)(2008-4#1)
new scientific##2##2##(2008-11#2)
new screening##2##2##(2008-10#1)(2008-8#1)
new selective##2##2##(2008-10#2)
new semi-dwarf gene##2##3##(2008-9#2)
new sensitive and selective##3##4##(2008-10#3)
new sensitive##9##2##(1990-2#1)(2008-10#8)
new sensor##3##2##(2008-10#3)
new sequence##2##2##(1992-6#1)(1996-3#1)
new sequences##2##2##(2008-10#1)(2012-3#1)
new serotypes##2##2##(1996-12#1)(2013-8#1)
new serum-free##2##2##(2008-11#2)
new short-acting##2##2##(1997-4#2)
new simple and##6##3##(2008-10#6)
new simple##10##2##(2008-10#9)(2008-2#1)
new skill##3##2##(1995-2#1)(1996-2#1)(2008-11#1)
new skills and##2##3##(1993-12#1)(2008-11#1)
new skills##3##2##(1993-12#1)(2008-11#2)
new software##4##2##(1991-2#1)(1992-12#1)(2008-2#1)(2009-1#1)
new solid-phase##3##2##(1995-6#2)(2008-10#1)
new sorbent##2##2##(2008-10#1)(2009-8#1)
new source of##5##3##(1995-2#1)(2008-10#2)(2012-2#2)
new source##6##2##(1995-2#1)(2008-10#3)(2012-2#2)
new sources of##3##3##(1991-1#1)(2008-10#1)(2008-11#1)
new sources##4##2##(1991-1#1)(2008-10#1)(2008-11#1)(2009-3#1)
new species have##2##3##(2008-10#2)
new species in##3##3##(2008-10#3)
new species of##5##3##(2008-10#1)(2008-5#1)(2008-6#2)(2011-2#1)
new species##24##2##(2008-10#13)(2008-12#1)(2008-5#3)(2008-6#2)(2008-9#1)(2010-3#1)(2011-2#1)(2013-8#2)
new specific##2##2##(2008-10#2)
new specimens##2##2##(1994-3#2)
new spectrofluorimetric method for the determination of##3##7##(2008-10#3)
new spectrofluorimetric##4##2##(2008-10#4)
new spectrophotometric method##3##3##(2008-10#3)
new spectrophotometric##5##2##(2008-10#5)
new spray reagent for##2##4##(2008-10#2)
new stationary##3##2##(2008-10#3)
new strain##4##2##(1993-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
new strains##2##2##(2008-10#1)(2008-5#1)
new strategies and##3##3##(2008-11#2)(2011-10#1)
new strategies for##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
new strategies##10##2##(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-12#1)(2010-5#1)(2011-10#1)(2011-2#1)
new strategy for##7##3##(1995-3#1)(2008-10#5)(2011-2#1)
new strategy to##2##3##(1993-9#1)(2008-10#1)
new strategy##11##2##(1993-9#1)(1995-3#1)(2008-10#7)(2008-8#1)(2011-2#1)
new structural##4##2##(1992-6#1)(1994-9#1)(2008-8#1)(2011-3#1)
new structure##2##2##(1992-5#1)(2011-3#1)
new subgroup##2##2##(2008-10#2)
new sunscreen of the cinnamate class##2##6##(2008-5#2)
new surgery##2##2##(1993-2#1)(2010-12#1)
new surgical technique##2##3##(2011-7#1)(2012-2#1)
new surgical techniques##2##3##(1994-6#1)(2011-2#1)
new surgical##5##2##(1993-6#1)(1994-6#1)(2011-2#1)(2011-7#1)(2012-2#1)
new survey##2##2##(1993-12#1)(2008-10#1)
new synthetic##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
new system can##2##3##(2008-3#1)(2010-8#1)
new system is##2##3##(2008-10#1)(2008-9#1)
new system of##2##3##(1995-12#1)(2008-10#1)
new system##9##2##(1991-1#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-8#2)
new systems and##2##3##(1997-3#1)(2011-2#1)
new systems##7##2##(1993-2#1)(1997-3#3)(2008-11#2)(2011-2#1)
new targets##3##2##(2008-11#1)(2009-12#1)(2012-2#1)
new technique for##9##3##(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-9#1)(2008-10#3)(2010-1#1)
new technique is##2##3##(2008-10#2)
new technique that##2##3##(2008-3#1)(2012-2#1)
new technique to##3##3##(1997-3#1)(2008-10#1)(2008-3#1)
new technique##36##2##(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1997-3#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
new techniques##6##2##(1991-3#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#2)
new technologies in##3##3##(1992-2#1)(2008-11#1)(2010-7#1)
new technologies such as##2##4##(2008-10#1)(2013-1#1)
new technologies##14##2##(1992-2#1)(2008-10#3)(2008-11#4)(2010-11#1)(2010-7#2)(2013-1#3)
new technology for##2##3##(1997-7#1)(2008-10#1)
new technology of##2##3##(1994-1#1)(2008-11#1)
new technology##15##2##(1994-1#1)(1997-7#1)(2008-10#4)(2008-11#3)(2010-6#1)(2010-7#1)(2011-2#2)(2011-7#1)(2013-8#1)
new term##2##2##(1990-11#1)(2008-7#1)
new therapeutic approach##4##3##(1994-5#1)(1997-8#1)(2008-7#1)(2013-8#1)
new therapeutic approaches##3##3##(2008-4#1)(2008-5#1)(2011-3#1)
new therapeutic strategies##4##3##(2008-6#1)(2009-12#1)(2011-2#1)(2013-1#1)
new therapeutic##22##2##(1991-3#1)(1993-11#1)(1994-5#1)(1994-6#1)(1996-11#1)(1997-8#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#2)
new therapies in##2##3##(2008-4#1)(2011-2#1)
new therapies that##2##3##(2008-8#1)(2011-2#1)
new therapies##10##2##(2008-11#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-2#2)
new therapy##2##2##(2012-3#1)(2013-8#1)
new to##6##2##(2008-11#3)(2008-12#1)(2008-6#1)(2011-2#1)
new tombusvirus##2##2##(2008-10#2)
new tool for##4##3##(1993-3#1)(1996-12#1)(2008-10#1)(2008-3#1)
new tool in##3##3##(2008-10#1)(2009-10#1)(2013-1#1)
new tool to##3##3##(1996-12#1)(2008-11#1)(2011-1#1)
new tool##11##2##(1993-3#1)(1996-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-1#1)(2013-1#1)
new tools for##2##3##(2008-11#1)(2008-9#1)
new tools##4##2##(2008-1#1)(2008-11#1)(2008-9#1)(2010-9#1)
new toothpaste##3##2##(2011-2#3)
new tospovirus species##3##3##(2008-10#3)
new tospovirus##4##2##(2008-10#4)
new training##2##2##(1994-12#1)(2008-11#1)
new traits##5##2##(2010-4#5)
new transvaginal##2##2##(2011-2#2)
new treatment modalities##2##3##(1997-8#1)(2008-8#1)
new treatment##11##2##(1994-5#1)(1995-9#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
new treatments for##2##3##(2010-7#1)(2013-8#1)
new treatments##6##2##(2008-11#1)(2009-7#1)(2010-7#1)(2012-3#1)(2013-8#2)
new trends##2##2##(1996-1#1)(2008-10#1)
new trial##5##2##(1992-2#1)(1996-6#4)
new type of##26##3##(1992-6#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2012-2#1)(2012-3#2)
new type##27##2##(1992-6#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2012-2#1)(2012-3#2)
new types of human adenovirus##3##5##(2013-8#3)
new types of human##4##4##(2013-8#4)
new types of##8##3##(1993-2#1)(2008-10#2)(2010-11#1)(2013-8#4)
new types##9##2##(1993-2#1)(2008-10#2)(2010-11#1)(2010-8#1)(2013-8#4)
new understanding of##3##3##(2008-11#2)(2009-5#1)
new utility for multipurpose analysis##2##5##(2008-10#2)
new vaccines##3##2##(1995-5#1)(2007-11#1)(2008-11#1)
new variant##2##2##(1997-6#1)(2008-10#1)
new varieties##2##2##(2008-8#2)
new variety of##2##3##(2008-10#1)(2008-8#1)
new variety##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
new viral##2##2##(2008-10#1)(2011-3#1)
new virulence##2##2##(2008-10#2)
new virus##3##2##(2008-10#3)
new wave##2##2##(2008-10#2)
new way of doing##2##4##(1991-3#1)(2012-2#1)
new way of##6##3##(1991-3#1)(2008-10#2)(2008-6#1)(2008-9#1)(2012-2#1)
new way to##4##3##(1991-2#1)(1995-12#1)(2008-6#1)(2008-9#1)
new way##11##2##(1991-2#1)(1991-3#1)(1995-12#1)(2008-10#2)(2008-6#2)(2008-8#1)(2008-9#2)(2012-2#1)
new ways of##2##3##(2008-10#1)(2013-1#1)
new ways##5##2##(2008-10#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
new words##2##2##(2011-1#2)
new world##3##2##(1991-3#1)(1995-2#1)(1997-2#1)
new zirconia stationary phase##2##4##(2008-10#2)
new##2903##1##(1990-11#5)(1990-12#12)(1990-2#7)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#7)(1990-9#5)(1991-1#16)(1991-11#2)(1991-12#18)(1991-2#18)(1991-3#13)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#10)(1992-1#17)(1992-11#5)(1992-12#10)(1992-2#9)(1992-3#17)(1992-4#1)(1992-5#4)(1992-6#6)(1992-8#8)(1992-9#6)(1993-1#7)(1993-11#4)(1993-12#15)(1993-2#14)(1993-3#7)(1993-5#1)(1993-6#10)(1993-8#4)(1993-9#6)(1994-1#8)(1994-11#3)(1994-12#15)(1994-2#4)(1994-3#9)(1994-5#3)(1994-6#5)(1994-8#7)(1994-9#9)(1995-1#12)(1995-10#1)(1995-11#2)(1995-12#20)(1995-2#12)(1995-3#6)(1995-5#9)(1995-6#12)(1995-8#7)(1995-9#8)(1996-1#17)(1996-11#11)(1996-12#11)(1996-2#22)(1996-3#18)(1996-5#11)(1996-6#13)(1996-8#3)(1996-9#3)(1997-1#12)(1997-2#22)(1997-3#19)(1997-4#6)(1997-5#5)(1997-6#10)(1997-7#9)(1997-8#21)(1997-9#7)(2006-6#1)(2007-11#2)(2007-12#16)(2007-8#4)(2008-1#6)(2008-10#936)(2008-11#200)(2008-12#38)(2008-2#22)(2008-3#84)(2008-4#29)(2008-5#80)(2008-6#37)(2008-7#27)(2008-8#81)(2008-9#62)(2009-1#4)(2009-10#12)(2009-11#3)(2009-12#12)(2009-3#5)(2009-4#7)(2009-5#11)(2009-6#7)(2009-7#17)(2009-8#20)(2009-9#6)(2010-1#6)(2010-10#5)(2010-11#12)(2010-12#14)(2010-2#2)(2010-3#6)(2010-4#23)(2010-5#9)(2010-6#7)(2010-7#20)(2010-8#11)(2010-9#3)(2011-1#11)(2011-10#2)(2011-2#109)(2011-3#34)(2011-7#4)(2012-12#13)(2012-2#87)(2012-3#51)(2012-4#1)(2013-1#45)(2013-8#46)
new&quot##2##1##(2008-10#1)(2012-2#1)
new-generation##2##1##(1995-5#1)(2013-1#1)
new-onset##2##1##(2011-2#1)(2012-3#1)
newborn Turkish boys##3##3##(2011-1#3)
newborn and adult##2##3##(1994-2#1)(2008-4#1)
newborn cells##4##2##(2008-11#3)(2012-2#1)
newborn children in##2##3##(1990-11#1)(2011-2#1)
newborn children##4##2##(1990-11#2)(2011-2#2)
newborn guinea##2##2##(1991-12#1)(2009-9#1)
newborn hearing screening##2##3##(2008-9#2)
newborn infant##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
newborn infants##13##2##(1994-6#4)(1995-2#1)(2007-12#1)(2008-11#2)(2010-11#1)(2011-1#1)(2012-12#2)(2012-2#1)
newborn infants]##2##2##(1990-11#1)(1994-6#1)
newborn intensive care##3##3##(1991-12#3)
newborn mice##2##2##(1993-2#1)(2008-9#1)
newborn pig##2##2##(2008-11#2)
newborn rat##3##2##(1990-11#1)(1990-5#1)(1996-2#1)
newborn rats##2##2##(1994-5#2)
newborn screening##6##2##(2010-8#6)
newborn was##2##2##(1997-8#1)(2012-3#1)
newborn##98##1##(1990-11#4)(1990-5#3)(1990-9#1)(1991-12#4)(1991-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#5)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#11)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-9#2)(2010-11#2)(2010-8#6)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#3)
newborns and##5##2##(1991-3#1)(2008-10#2)(2008-5#1)(2011-1#1)
newborns delivered by mothers with preeclampsia##2##6##(2009-8#2)
newborns delivered by##3##3##(2009-8#3)
newborns of mothers##2##3##(2012-12#1)(2012-3#1)
newborns of##3##2##(2012-12#1)(2012-3#2)
newborns were##2##2##(1993-3#1)(2011-1#1)
newborns##41##1##(1991-12#2)(1991-3#3)(1992-11#1)(1993-2#1)(1993-3#2)(1994-6#2)(1996-3#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2009-8#3)(2009-9#1)(2011-1#7)(2011-2#1)(2012-12#1)(2012-3#3)
newcomers##3##1##(1993-1#1)(1995-3#1)(2008-11#1)
newer and##3##2##(1991-1#1)(1991-12#1)(1997-8#1)
newer approaches##2##2##(1993-3#1)(2008-1#1)
newer models##2##2##(2008-10#1)(2008-9#1)
newer##35##1##(1991-1#4)(1991-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-6#4)(2010-7#1)(2011-2#6)(2012-2#2)(2013-1#1)(2013-7#1)
newest##8##1##(1991-9#1)(1992-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)
newly described HG-III##2##3##(2008-10#2)
newly described##20##2##(1990-5#1)(1993-6#1)(1996-2#1)(2007-12#1)(2008-10#11)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
newly designed cochlear implant electrodes##2##5##(2008-9#2)
newly designed##6##2##(2008-10#3)(2008-9#2)(2011-2#1)
newly developed flow##2##3##(2008-10#2)
newly developed method##9##3##(2008-10#9)
newly developed##38##2##(1991-1#1)(1994-11#2)(1994-12#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-3#1)(2010-11#1)(2010-6#1)(2010-8#1)
newly devised##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
newly diagnosed and##2##3##(1991-2#2)
newly diagnosed diabetic##2##3##(1993-11#1)(2013-1#1)
newly diagnosed##21##2##(1991-2#4)(1993-11#1)(1994-12#2)(1996-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#4)
newly discovered##9##2##(1992-8#1)(2007-11#1)(2008-10#4)(2009-7#1)(2011-2#2)
newly diseased plants##2##3##(2008-10#2)
newly diseased##3##2##(2008-10#3)
newly emerged##5##2##(1997-8#1)(2008-10#4)
newly emerging##4##2##(1996-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
newly established##6##2##(1991-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2013-8#1)
newly formed material##2##3##(2008-10#2)
newly formed##7##2##(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)
newly found##2##2##(2008-10#2)
newly graduated##2##2##(2008-11#2)
newly hatched##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
newly identified ORFs##2##3##(1996-6#2)
newly identified gene##3##3##(1995-12#1)(2008-10#2)
newly identified##15##2##(1995-12#2)(1995-2#1)(1996-6#2)(1997-9#1)(2008-10#4)(2008-12#1)(2008-7#2)(2010-7#1)(2013-8#1)
newly infected trees##2##3##(2008-10#2)
newly infected##3##2##(2008-10#3)
newly introduced##2##2##(1994-5#1)(2008-10#1)
newly isolated##6##2##(1994-12#3)(2011-2#1)(2013-1#1)(2013-8#1)
newly opened flowers##2##3##(2008-10#2)
newly prepared##2##2##(2008-10#1)(2008-11#1)
newly prescribed antihypertensive##3##3##(2008-11#3)
newly presented##2##2##(2008-11#1)(2013-1#1)
newly synthesised##2##2##(2008-10#2)
newly synthesized silica gel phases (I-V)##2##6##(2008-10#2)
newly synthesized##25##2##(1990-11#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2012-2#1)
newly##232##1##(1990-11#2)(1990-5#1)(1990-9#1)(1991-1#3)(1991-2#5)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-12#6)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-6#2)(1997-1#1)(1997-4#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#101)(2008-11#19)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#10)(2012-2#2)(2012-5#1)(2013-1#6)(2013-8#3)
newly-formed##3##1##(1997-8#1)(2008-5#1)(2012-2#1)
news media##3##2##(1992-12#1)(2010-2#1)(2010-8#1)
news##20##1##(1991-2#1)(1992-12#1)(1993-12#2)(1997-6#4)(2008-10#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-2#2)(2010-8#1)(2013-1#3)(2013-8#1)
newsletter##5##1##(1994-12#1)(1995-1#2)(2008-10#1)(2008-4#1)
newspaper##3##1##(1995-2#1)(1997-6#2)
newspapers##8##1##(1992-9#3)(1996-5#1)(1997-3#1)(2008-9#1)(2009-4#1)(2013-1#1)
next decade##10##2##(1991-2#1)(1992-1#1)(1992-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-9#3)
next generation##19##2##(1991-6#1)(1992-3#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-8#1)(2010-10#1)(2012-2#4)(2013-1#1)
next most##2##2##(1995-2#1)(2008-11#1)
next step in##2##3##(2007-8#1)(2008-10#1)
next step##7##2##(1995-9#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)
next to the##9##3##(1992-10#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)
next to##12##2##(1992-10#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#3)
next year##3##2##(1992-8#1)(1996-5#1)(2008-11#1)
next##146##1##(1990-2#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#13)(2008-12#1)(2008-3#1)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#3)(2010-10#1)(2010-5#2)(2010-9#1)(2011-2#8)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#3)
next-generation NNRTIs##2##2##(2011-3#2)
next-generation##9##1##(2008-10#1)(2008-3#1)(2008-7#2)(2010-10#1)(2011-3#4)
next?##3##1##(1993-1#1)(1997-2#1)(2008-1#1)
nexus between##3##2##(1991-12#1)(2009-8#1)(2010-10#1)
nexus##5##1##(1991-12#1)(2009-8#1)(2010-10#2)(2013-1#1)
ng As##2##2##(2008-10#2)
ng L(-1)##5##2##(2008-10#3)(2008-12#2)
ng L(-1))##2##2##(2008-10#1)(2008-12#1)
ng Se(IV) ml(-1)##2##3##(2008-10#2)
ng cm(-2)##7##2##(2008-10#7)
ng cm(-3)##6##2##(2008-10#6)
ng for##6##2##(2008-10#6)
ng g(-1) and 0##2##4##(2010-5#2)
ng g(-1) and##3##3##(2008-10#1)(2010-5#2)
ng g(-1) for##4##3##(2008-10#4)
ng g(-1) range##2##3##(2008-10#2)
ng g(-1)##22##2##(2008-10#19)(2010-5#2)(2012-12#1)
ng g(-1))##2##2##(2008-10#2)
ng in##4##2##(2008-10#2)(2012-3#2)
ng l(-1) (as##2##3##(2008-10#2)
ng l(-1) and the relative standard##2##6##(2008-10#2)
ng l(-1) for##6##3##(2008-10#6)
ng l(-1) in HG mode##2##5##(2008-10#2)
ng l(-1) in##3##3##(2008-10#3)
ng l(-1) was obtained##2##4##(2008-10#2)
ng l(-1)##34##2##(2008-10#34)
ng m(-3)##10##2##(2008-10#10)
ng mL(-1) for##3##3##(2008-10#1)(2011-3#2)
ng mL(-1) in dust and juice##2##6##(2010-5#2)
ng mL(-1)##5##2##(2008-10#1)(2010-5#2)(2011-3#2)
ng ml(-1) (S/N=3)##4##3##(2008-10#4)
ng ml(-1) Se##2##3##(2008-10#2)
ng ml(-1) The##2##3##(2008-10#2)
ng ml(-1) and 1##4##4##(2008-10#4)
ng ml(-1) and a##2##4##(2008-10#2)
ng ml(-1) and determination limits of##2##6##(2008-10#2)
ng ml(-1) and the detection limit was##2##7##(2008-10#2)
ng ml(-1) and the detection limit##3##6##(2008-10#3)
ng ml(-1) and the relative standard deviation was 1##2##9##(2008-10#2)
ng ml(-1) and the relative standard deviations were 1##2##9##(2008-10#2)
ng ml(-1) and the relative standard##4##6##(2008-10#4)
ng ml(-1) and the##11##4##(2008-10#11)
ng ml(-1) and##22##3##(2008-10#22)
ng ml(-1) can be##2##4##(2008-10#2)
ng ml(-1) for AM1##2##4##(2008-10#2)
ng ml(-1) for Cu(II) and##2##5##(2008-10#2)
ng ml(-1) for Cu(II)##3##4##(2008-10#3)
ng ml(-1) for NAA and##2##5##(2008-10#2)
ng ml(-1) for NAD##2##4##(2008-10#2)
ng ml(-1) for all##2##4##(2008-10#2)
ng ml(-1) for calf thymus DNA##2##6##(2008-10#2)
ng ml(-1) for each##3##4##(2008-10#3)
ng ml(-1) for fish sperm DNA##2##6##(2008-10#2)
ng ml(-1) for the##2##4##(2008-10#2)
ng ml(-1) for yeast RNA##2##5##(2008-10#2)
ng ml(-1) for##48##3##(2008-10#48)
ng ml(-1) in##5##3##(2008-10#5)
ng ml(-1) is##3##3##(2008-10#3)
ng ml(-1) level##5##3##(2008-10#5)
ng ml(-1) levels##3##3##(2008-10#3)
ng ml(-1) nitrite##2##3##(2008-10#2)
ng ml(-1) of Be(II)##2##4##(2008-10#2)
ng ml(-1) of copper(II)##2##4##(2008-10#2)
ng ml(-1) of nitrite##2##4##(2008-10#2)
ng ml(-1) of##23##3##(2008-10#22)(2008-11#1)
ng ml(-1) range##2##3##(2008-10#2)
ng ml(-1) vanadium##3##3##(2008-10#3)
ng ml(-1) vanadium(IV) and##2##4##(2008-10#2)
ng ml(-1) was##5##3##(2008-10#5)
ng ml(-1) were##3##3##(2008-10#3)
ng ml(-1) with a detection limit of##3##7##(2008-10#3)
ng ml(-1) with a limit of detection of##2##8##(2008-10#2)
ng ml(-1) with a relative standard deviation##2##7##(2008-10#2)
ng ml(-1) with a##10##4##(2008-10#10)
ng ml(-1) with##14##3##(2008-10#14)
ng ml(-1)##254##2##(2008-10#250)(2008-11#4)
ng ml(-1)) and##5##3##(2008-10#5)
ng ml(-1))##16##2##(2008-10#15)(2008-11#1)
ng ml-1##2##2##(1996-2#2)
ng of##19##2##(1995-2#1)(2008-10#17)(2008-11#1)
ng per injection (5 microl)##2##5##(2008-10#2)
ng per##5##2##(2008-10#5)
ng to##2##2##(2008-10#1)(2008-11#1)
ng x mL(-1) for##2##4##(2011-3#2)
ng##455##1##(1991-2#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-10#424)(2008-11#10)(2008-12#3)(2010-5#4)(2011-3#4)(2012-12#1)(2012-3#2)
ng)##5##1##(1993-6#2)(1996-2#1)(1997-2#1)(2008-10#1)
ng/10(6) cell/24 h##2##3##(2008-9#2)
ng/10(6)##5##1##(1995-8#1)(2008-8#1)(2008-9#3)
ng/L##5##1##(2008-10#5)
ng/dl##2##1##(1990-3#1)(2013-1#1)
ng/g for##6##2##(2008-10#2)(2008-11#4)
ng/g of PhIP##2##3##(1997-2#2)
ng/g##22##1##(1995-2#1)(1997-2#5)(2008-10#8)(2008-11#7)(2008-6#1)
ng/kg##2##1##(2008-11#2)
ng/l##2##1##(2008-10#2)
ng/mL in##4##2##(1993-1#4)
ng/mL##14##1##(1993-1#5)(2008-10#3)(2008-8#2)(2010-12#1)(2010-4#1)(2011-1#2)
ng/ml CP-870##2##2##(2008-10#2)
ng/ml TGF alpha)##2##3##(1997-1#2)
ng/ml for##2##2##(2008-10#2)
ng/ml in##3##2##(1990-12#2)(1993-3#1)
ng/ml of##5##2##(1995-11#1)(2008-10#3)(2008-11#1)
ng/ml##54##1##(1990-12#2)(1990-2#1)(1992-11#3)(1992-12#1)(1992-6#2)(1993-1#1)(1993-3#2)(1994-11#4)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#3)(1997-1#2)(1997-2#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-6#1)(2010-3#1)(2011-1#3)(2011-2#3)
ng/ml) and##3##2##(1990-2#1)(1993-2#1)(2010-5#1)
ng/ml) or##2##2##(1993-2#2)
ng/ml)##19##1##(1990-12#2)(1990-2#1)(1990-5#1)(1992-11#1)(1993-12#1)(1993-2#8)(1994-3#1)(2008-11#1)(2008-6#2)(2010-5#1)
ng/spot for##2##2##(2012-2#2)
ng/spot##4##1##(2012-2#4)
ngcm(-3) and##3##2##(2008-10#3)
ngcm(-3)##10##1##(2008-10#10)
ngcm(-3))##4##1##(2008-10#4)
ngl(-1)##4##1##(2008-10#4)
ngml(-1) and##2##2##(2008-10#2)
ngml(-1) for##2##2##(2008-10#2)
ngml(-1) of##2##2##(2008-10#2)
ngml(-1)##24##1##(2008-10#24)
nia##3##1##(1993-6#3)
nicardipine##3##1##(1996-2#2)(2008-10#1)
nice##2##1##(2008-10#1)(2009-12#1)
niche and##2##2##(1991-1#1)(2009-8#1)
niche of##2##2##(2009-8#1)(2012-2#1)
niche##21##1##(1991-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#4)(2008-9#2)(2009-12#2)(2009-6#2)(2009-8#3)(2010-7#1)(2012-2#2)
niches and##3##2##(2008-10#2)(2008-8#1)
niches##18##1##(2008-10#10)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-12#1)
nick end labeling (TUNEL)##3##4##(2008-8#2)(2008-9#1)
nick translation##4##2##(2008-4#4)
nick##10##1##(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)
nicked##2##1##(1990-5#1)(1990-7#1)
nickel (II)##2##2##(2008-10#2)
nickel and 0##2##3##(2008-10#2)
nickel and chromium##3##3##(2008-10#3)
nickel and cobalt##2##3##(2008-10#2)
nickel and copper using##2##4##(2008-10#2)
nickel and copper##8##3##(2008-10#8)
nickel and iron##2##3##(2008-10#2)
nickel and palladium##3##3##(2008-10#3)
nickel and zinc##7##3##(2008-10#7)
nickel and##32##2##(1994-5#1)(2008-10#31)
nickel by##10##2##(2008-10#8)(2008-12#2)
nickel compounds##3##2##(2008-10#3)
nickel determination##7##2##(2008-10#7)
nickel hydroxide##2##2##(2008-10#2)
nickel in aqueous solutions##2##4##(2008-10#2)
nickel in aqueous##3##3##(2008-10#3)
nickel in table salt and baking soda##3##7##(2008-10#3)
nickel in the##3##3##(2008-10#3)
nickel in##38##2##(2008-10#38)
nickel ion##4##2##(2008-10#3)(2009-3#1)
nickel oxide##2##2##(2008-10#2)
nickel phthalocyanine##4##2##(2008-10#4)
nickel preconcentration##2##2##(2008-10#2)
nickel sulphide fire assay##2##4##(2008-10#2)
nickel sulphide##3##2##(2008-10#3)
nickel was##3##2##(2008-10#3)
nickel were##5##2##(2008-10#5)
nickel with##3##2##(2008-10#3)
nickel##205##1##(1994-5#3)(1996-12#2)(2008-10#192)(2008-11#1)(2008-12#4)(2009-12#1)(2009-3#1)(2010-2#1)
nickel(II) and copper(II)##2##3##(2008-10#2)
nickel(II) and##7##2##(2008-10#7)
nickel(II) complex##3##2##(2008-10#3)
nickel(II) hexacyanoferrate (NiHCF)##2##3##(2008-10#2)
nickel(II) hexacyanoferrate-modified##2##2##(2008-10#2)
nickel(II) in##7##2##(2008-10#7)
nickel(II) ions##2##2##(2008-10#2)
nickel(II)##44##1##(2008-10#44)
nickel)##2##1##(2008-10#2)
nicotianae and P##6##3##(2008-10#6)
nicotianae and##11##2##(2008-10#11)
nicotianae in##4##2##(2008-10#4)
nicotianae was##2##2##(2008-10#2)
nicotianae x P##2##3##(2008-10#2)
nicotianae##40##1##(2008-10#40)
nicotinamide adenine dinucleotide phosphate##3##4##(1992-12#1)(2011-2#2)
nicotinamide adenine dinucleotide##4##3##(1992-12#1)(2008-10#1)(2011-2#2)
nicotinamide adenine##6##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)
nicotinamide##8##1##(1992-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#2)
nicotine a##2##2##(2013-1#2)
nicotine addiction##3##2##(2008-6#3)
nicotine and##5##2##(1990-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
nicotine in##4##2##(2008-10#1)(2009-7#3)
nicotine on##4##2##(1996-2#2)(2008-8#1)(2010-8#1)
nicotine replacement therapy##2##3##(2009-7#1)(2013-8#1)
nicotine##50##1##(1990-6#1)(1990-7#1)(1991-1#1)(1992-6#1)(1996-2#5)(2008-10#3)(2008-6#3)(2008-7#1)(2008-8#4)(2009-7#8)(2010-8#4)(2011-2#6)(2013-1#9)(2013-8#3)
nicotinic acetylcholine receptor subunit##2##4##(1995-11#1)(1996-12#1)
nicotinic acetylcholine receptor was##2##4##(2008-8#2)
nicotinic acetylcholine receptor##11##3##(1994-5#2)(1995-11#1)(1996-12#1)(2008-8#6)(2010-8#1)
nicotinic acetylcholine##15##2##(1994-5#2)(1995-11#5)(1996-12#1)(2008-8#6)(2010-8#1)
nicotinic antagonist##2##2##(1996-2#2)
nicotinic receptor##3##2##(1995-11#1)(1996-12#1)(2008-8#1)
nicotinic receptor-mediated inward currents##3##4##(1995-11#3)
nicotinic receptor-mediated inward##4##3##(1995-11#4)
nicotinic receptors##4##2##(1994-5#1)(1995-11#2)(1996-2#1)
nicotinic##32##1##(1994-5#4)(1995-11#12)(1996-12#2)(1996-2#3)(2008-10#1)(2008-11#1)(2008-8#7)(2010-8#1)(2012-2#1)
nidi##4##1##(2008-7#4)
nidulans and##4##2##(1997-4#1)(2008-5#3)
nidulans##28##1##(1996-6#1)(1997-2#2)(1997-4#5)(1997-7#2)(1997-8#3)(2008-10#1)(2008-5#4)(2009-6#1)(2009-8#4)(2010-7#4)(2011-1#1)
nidus and surrounding brain tissue##2##5##(2008-7#2)
nidus and the##2##3##(2008-7#2)
nidus and##6##2##(2008-7#6)
nidus in the##2##3##(2008-7#2)
nidus in##3##2##(1996-3#1)(2008-7#2)
nidus of##2##2##(1997-3#1)(2011-2#1)
nidus##29##1##(1991-2#1)(1996-3#1)(1997-3#1)(2008-3#1)(2008-7#22)(2011-2#1)(2012-3#2)
nifedipine in##2##2##(1991-11#1)(1997-8#1)
nifedipine##6##1##(1991-11#1)(1994-11#1)(1997-1#1)(1997-8#1)(2008-10#1)(2012-12#1)
niger T21##3##2##(2008-8#2)(2008-9#1)
niger glucoamylase were##2##3##(2008-8#2)
niger glucoamylase##5##2##(2008-7#2)(2008-8#3)
niger was##2##2##(1991-9#1)(2008-7#1)
niger were##2##2##(2008-5#2)
niger##33##1##(1991-9#4)(1993-2#2)(1997-2#4)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#5)(2008-8#9)(2008-9#2)(2012-2#1)
night and##3##2##(1997-4#1)(2009-3#1)(2010-7#1)
night nursing##5##2##(2010-7#5)
night temperatures##5##2##(2008-10#1)(2012-5#4)
night##57##1##(1990-5#1)(1991-5#2)(1991-8#2)(1992-3#1)(1992-5#1)(1993-2#1)(1994-2#1)(1995-10#2)(1997-4#4)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#5)(2009-3#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#7)(2010-8#1)(2012-3#1)(2012-5#5)
nightly##3##1##(2008-10#2)(2009-8#1)
nightmare##3##1##(1993-12#1)(1996-2#1)(1996-3#1)
nights and##2##2##(2008-10#1)(2012-5#1)
nights##3##1##(2008-10#1)(2008-8#1)(2012-5#1)
nightshade##2##1##(2008-10#2)
nighttime and##2##2##(2008-3#1)(2013-7#1)
nighttime performance##2##2##(2008-2#1)(2008-3#1)
nighttime##11##1##(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2009-9#1)(2010-7#2)(2013-7#1)
nigra addition line##2##3##(2008-10#2)
nigra chromosome##2##2##(2008-10#2)
nigra pars compacta (SNpc)##2##4##(1996-12#1)(2013-7#1)
nigra pars compacta##4##3##(1996-12#2)(2008-7#1)(2013-7#1)
nigra pars##5##2##(1995-2#1)(1996-12#2)(2008-7#1)(2013-7#1)
nigra##47##1##(1990-5#9)(1991-12#1)(1994-11#1)(1994-2#2)(1995-2#4)(1995-8#1)(1996-12#6)(1997-3#1)(2008-10#12)(2008-7#7)(2012-2#2)(2013-7#1)
nigral cell death in Parkinson's disease##2##6##(2008-7#2)
nigral cell degeneration##3##3##(2008-7#3)
nigral cell##6##2##(1995-8#1)(2008-7#5)
nigral dopaminergic neurons##2##3##(2008-7#2)
nigral grafts##3##2##(1997-2#3)
nigral##15##1##(1995-8#2)(1996-2#3)(1997-2#3)(2008-7#7)
nigrescens and##2##2##(2013-1#2)
nigrescens##3##1##(2013-1#3)
nigricans##3##1##(2008-4#1)(2012-12#2)
nigrificans##2##1##(2008-10#2)
nigrivenella##2##1##(2008-10#2)
nigrosin##3##1##(2008-11#2)(2008-12#1)
nigrostriatal dopaminergic##2##2##(1996-12#1)(2013-7#1)
nigrostriatal##11##1##(1994-8#1)(1995-11#1)(1996-12#3)(2012-2#2)(2013-7#4)
nigrum L##2##2##(2012-4#1)(2013-8#1)
nikkomycin biosynthesis##3##2##(2008-9#3)
nikkomycin##6##1##(1992-8#1)(2008-9#5)
nil was##2##2##(2008-10#2)
nil##10##1##(1994-6#1)(2008-10#8)(2008-7#1)
nile##5##1##(2008-10#4)(2010-8#1)
nine States##2##2##(1991-12#1)(1997-2#1)
nine commercial##2##2##(2008-10#2)
nine commonly used##2##3##(2008-10#2)
nine different##8##2##(1993-2#1)(2008-10#6)(2008-3#1)
nine female##2##2##(2008-12#1)(2008-5#1)
nine field sites##2##3##(2008-10#2)
nine field##3##2##(2008-10#3)
nine genes##4##2##(2008-10#2)(2011-1#2)
nine groups##2##2##(1992-2#1)(2008-10#1)
nine had##2##2##(2008-10#1)(2008-7#1)
nine introns##2##2##(1990-12#1)(2008-6#1)
nine isolates of##2##3##(2008-10#2)
nine isolates##4##2##(1997-8#1)(2008-10#3)
nine kinds of##2##3##(2008-10#1)(2008-11#1)
nine major##2##2##(1992-2#1)(2009-10#1)
nine monoclonal antibodies##2##3##(2008-10#1)(2008-5#1)
nine months of##2##3##(1993-3#1)(2013-1#1)
nine months##7##2##(1992-5#1)(1993-1#1)(1993-3#1)(2009-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
nine mutations##2##2##(2012-3#2)
nine of these##2##3##(2008-10#1)(2012-3#1)
nine of##4##2##(1993-2#1)(1996-8#1)(2008-10#1)(2012-3#1)
nine patients with##2##3##(2008-10#1)(2010-12#1)
nine patients##8##2##(1993-8#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
nine populations from##2##3##(2008-10#2)
nine populations##4##2##(2008-10#3)(2012-3#1)
nine random##2##2##(2008-10#2)
nine species##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
nine standards##2##2##(2008-10#2)
nine strains of##2##3##(1993-9#1)(1997-2#1)
nine strains##3##2##(1993-9#1)(1997-2#1)(2008-10#1)
nine studies##2##2##(1993-1#1)(2012-2#1)
nine subjects##3##2##(2008-11#1)(2008-7#1)(2009-1#1)
nine subpopulations##2##2##(2008-10#2)
nine surfactants##2##2##(2008-10#2)
nine times##2##2##(2008-10#2)
nine trials##3##2##(2008-5#3)
nine years##3##2##(1996-3#1)(2010-9#1)(2011-2#1)
nine##228##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#4)(1992-5#1)(1993-1#2)(1993-2#2)(1993-3#2)(1993-8#3)(1993-9#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#102)(2008-11#12)(2008-12#3)(2008-3#1)(2008-5#14)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#2)
nine-amino-acid##5##1##(1992-9#5)
nine-banded##3##1##(2008-5#2)(2008-9#1)
nineteen##3##1##(1993-12#1)(2008-12#1)(2011-2#1)
nineteenth century##11##2##(1991-12#2)(2010-1#5)(2011-2#4)
nineteenth##13##1##(1991-12#2)(2010-1#7)(2011-2#4)
ninety##2##1##(1995-6#1)(2012-3#1)
ninhydrin##2##1##(2008-10#1)(2012-2#1)
ninth##3##1##(1997-7#1)(2011-2#1)(2013-1#1)
ninth-grade students##2##2##(1996-1#2)
ninth-grade##3##1##(1996-1#2)(2009-7#1)
niobate##6##1##(2007-12#1)(2008-3#5)
niobium##3##1##(2008-10#3)
niobium(V) oxide##5##2##(2008-10#5)
niobium(V)##6##1##(2008-10#6)
nioxime##3##1##(2008-10#3)
nipple and areolar##2##3##(2011-2#2)
nipple##12##1##(1990-11#1)(1994-12#2)(1997-5#1)(2010-5#4)(2011-2#4)
nipple-areola complex##2##2##(1994-12#2)
nisin##3##1##(2011-2#3)
nit mutants##7##2##(2008-10#7)
nit##12##1##(2008-10#12)
nit1 and NitM##2##3##(2008-10#2)
nit1##3##1##(2008-10#3)
nitens##5##1##(2008-10#5)
nitramine##4##1##(2008-10#4)
nitrate and ammonium##3##3##(2008-10#3)
nitrate and nitrite was##2##4##(2008-10#2)
nitrate and nitrite##7##3##(2008-10#7)
nitrate and sodium##2##3##(2008-10#2)
nitrate and sulfate)##2##3##(2008-10#2)
nitrate and##35##2##(1993-12#1)(2008-10#30)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)
nitrate and/or##2##2##(2008-10#1)(2008-11#1)
nitrate as##4##2##(2008-10#3)(2008-11#1)
nitrate by##2##2##(2008-10#2)
nitrate determination##2##2##(2008-10#2)
nitrate from##3##2##(2008-10#2)(2008-12#1)
nitrate in the##2##3##(2008-10#2)
nitrate in water samples##3##4##(2008-10#3)
nitrate in water##5##3##(2008-10#5)
nitrate in##25##2##(2008-10#25)
nitrate ion##3##2##(2008-10#3)
nitrate ions was##2##3##(2008-10#2)
nitrate ions##4##2##(2008-10#4)
nitrate is described##2##3##(2008-10#2)
nitrate is##3##2##(2008-10#2)(2008-11#1)
nitrate level##3##2##(2009-8#3)
nitrate media##2##2##(2008-10#2)
nitrate nonutilizing (nit) mutants##2##4##(2008-10#2)
nitrate nonutilizing (nit)##5##3##(2008-10#5)
nitrate reductase (NR)##2##3##(1993-6#1)(2008-10#1)
nitrate reductase##7##2##(1993-6#2)(2008-10#3)(2011-1#2)
nitrate reduction##3##2##(2008-10#1)(2011-2#2)
nitrate sensing system##2##3##(2008-10#2)
nitrate solution##3##2##(2008-10#3)
nitrate supporting electrolytes##2##3##(2008-10#2)
nitrate to##5##2##(2008-10#4)(2011-2#1)
nitrate uptake##2##2##(2008-10#1)(2013-8#1)
nitrate was used as the chemical modifier to determine##2##9##(2008-10#2)
nitrate was##6##2##(2008-10#5)(2011-2#1)
nitrate were##3##2##(2008-10#3)
nitrate with a##2##3##(2008-10#2)
nitrate with##5##2##(2008-10#5)
nitrate##228##1##(1991-12#3)(1993-12#1)(1993-6#2)(1994-5#2)(2008-10#188)(2008-11#9)(2008-12#3)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#5)(2010-4#1)(2011-1#3)(2011-2#6)(2013-8#1)
nitrate)##3##1##(2008-10#1)(2008-12#1)(2008-9#1)
nitrate-nitrogen##3##1##(2008-10#2)(2008-12#1)
nitrate-selective##2##1##(2008-10#2)
nitrated##2##1##(2008-11#1)(2008-5#1)
nitrates##7##1##(2008-10#5)(2008-3#2)
nitrendipine##5##1##(1991-5#1)(1994-8#2)(2008-10#2)
nitric acid and determined spectrophotometrically##2##5##(2008-10#2)
nitric acid and hydrogen peroxide##3##5##(2008-10#3)
nitric acid and##13##3##(2008-10#13)
nitric acid as##2##3##(2008-10#2)
nitric acid at##3##3##(2008-10#3)
nitric acid concentrations##2##3##(2008-10#2)
nitric acid digestion##2##3##(2008-10#2)
nitric acid medium was##2##4##(2008-10#2)
nitric acid medium##6##3##(2008-10#6)
nitric acid solution##8##3##(2008-10#8)
nitric acid solutions##2##3##(2008-10#2)
nitric acid to##2##3##(2008-10#2)
nitric acid was##2##3##(2008-10#2)
nitric acid were##3##3##(2008-10#3)
nitric acid##86##2##(2008-10#85)(2008-8#1)
nitric acid)##2##2##(2008-10#2)
nitric and hydrochloric##3##3##(2008-10#3)
nitric and##7##2##(2008-10#7)
nitric oxide (NO) and nitrite (NO(2)(-))##2##6##(2008-10#2)
nitric oxide (NO) from##2##4##(1992-12#1)(1992-5#1)
nitric oxide (NO) in##3##4##(2008-10#3)
nitric oxide (NO) production##4##4##(1994-11#1)(1995-11#1)(2008-10#1)(2010-4#1)
nitric oxide (NO) synthase##2##4##(1995-11#1)(1996-2#1)
nitric oxide (NO)##30##3##(1992-12#2)(1992-5#1)(1994-11#1)(1995-11#2)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#10)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2010-4#1)
nitric oxide and##8##3##(1996-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)(2012-3#1)
nitric oxide bioavailability##2##3##(2010-10#1)(2012-3#1)
nitric oxide disturbances##2##3##(2009-8#2)
nitric oxide for##2##3##(1997-1#1)(2008-10#1)
nitric oxide in##6##3##(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)
nitric oxide is##2##3##(2008-10#1)(2008-12#1)
nitric oxide production in##2##4##(2008-10#1)(2011-1#1)
nitric oxide production##5##3##(2008-10#1)(2008-11#2)(2011-1#1)(2013-8#1)
nitric oxide reductase##2##3##(1992-3#2)
nitric oxide release##2##3##(2008-11#1)(2012-2#1)
nitric oxide synthase (NOS)##5##4##(1992-12#1)(1995-12#1)(1996-12#1)(2009-10#1)(2009-7#1)
nitric oxide synthase gene##3##4##(1996-12#1)(2008-12#1)(2008-7#1)
nitric oxide synthase in##3##4##(1996-12#1)(1997-3#1)(2008-5#1)
nitric oxide synthase##19##3##(1992-12#2)(1994-11#1)(1995-12#1)(1996-12#4)(1997-3#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)
nitric oxide##124##2##(1991-6#1)(1992-12#4)(1992-3#2)(1992-5#1)(1993-3#4)(1994-11#2)(1995-11#4)(1995-12#1)(1995-2#1)(1996-12#5)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#29)(2008-11#7)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
nitric##231##1##(1991-6#1)(1992-12#4)(1992-3#2)(1992-5#1)(1993-3#4)(1994-11#2)(1995-11#4)(1995-12#1)(1995-2#1)(1996-12#5)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#133)(2008-11#7)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#3)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
nitrile group##2##2##(2008-10#2)
nitrile groups##2##2##(2008-10#2)
nitrile##4##1##(2008-10#4)
nitriles##5##1##(2012-3#5)
nitrilotriacetic acid##3##2##(2008-10#3)
nitrite (NO(2)(-))##4##2##(2008-10#4)
nitrite IRMs are##2##3##(2008-10#2)
nitrite accumulated##2##2##(2008-10#2)
nitrite and 0##2##3##(2008-10#2)
nitrite and nitrate in##9##4##(2008-10#9)
nitrite and nitrate##21##3##(2008-10#21)
nitrite and##31##2##(2008-10#31)
nitrite based on##5##3##(2008-10#5)
nitrite by##6##2##(2008-10#6)
nitrite concentration##7##2##(2008-10#7)
nitrite determination in##4##3##(2008-10#4)
nitrite determination##5##2##(2008-10#5)
nitrite formation##2##2##(1995-11#1)(2008-10#1)
nitrite in a##2##3##(2008-10#2)
nitrite in the##5##3##(2008-10#5)
nitrite in##27##2##(1990-6#1)(2008-10#26)
nitrite ion in##3##3##(2008-10#3)
nitrite ion##14##2##(2008-10#14)
nitrite ionophore##2##2##(2008-10#2)
nitrite ions##3##2##(2008-10#3)
nitrite is##6##2##(2008-10#6)
nitrite on##5##2##(1990-6#1)(2008-10#4)
nitrite reductase##4##2##(1994-11#3)(2011-2#1)
nitrite release by Kupffer cells##2##5##(1997-4#2)
nitrite release by##3##3##(1996-2#1)(1997-4#2)
nitrite solution##2##2##(2008-10#2)
nitrite solutions##2##2##(2008-10#2)
nitrite using a##3##3##(2008-10#3)
nitrite using##5##2##(2008-10#5)
nitrite was##7##2##(1990-6#1)(2008-10#6)
nitrite were##5##2##(1990-6#1)(1996-2#1)(2008-10#3)
nitrite with a##2##3##(2008-10#2)
nitrite with##3##2##(2008-10#3)
nitrite##223##1##(1990-6#6)(1993-8#2)(1994-11#3)(1995-11#1)(1996-12#3)(1996-2#3)(1997-4#3)(2008-10#200)(2008-11#1)(2011-2#1)
nitrite-nitrogen##4##1##(2008-10#4)
nitrites##2##1##(2008-10#1)(2008-11#1)
nitro group##5##2##(2008-10#5)
nitro groups##3##2##(1996-5#1)(2008-10#2)
nitro##10##1##(1996-5#2)(2008-10#8)
nitro-PAHs##3##1##(2008-11#3)
nitroalkenes##2##1##(1996-5#2)
nitroaniline##7##1##(2008-10#7)
nitroaromatic and nitramine explosives##2##4##(2008-10#2)
nitroaromatic compounds in landfill gas##2##5##(2008-10#2)
nitroaromatic compounds##3##2##(2008-10#3)
nitroaromatic pollutants##2##2##(2008-10#2)
nitroaromatic##12##1##(1991-3#1)(2008-10#9)(2008-11#2)
nitrobenzene##10##1##(2008-10#9)(2008-11#1)
nitrobenzenes##2##1##(2008-10#2)
nitrobenzylthioinosine##2##1##(1994-8#1)(1995-8#1)
nitroblue##2##1##(2008-10#1)(2008-11#1)
nitrocellulose##7##1##(1990-12#1)(1995-2#1)(2008-10#4)(2012-2#1)
nitrocompounds##5##1##(1995-8#5)
nitrofigilis##3##1##(2011-2#3)
nitrofurantoin and##4##2##(2008-10#3)(2008-11#1)
nitrofurantoin##6##1##(2008-10#4)(2008-11#1)(2011-2#1)
nitrogen (BUN)##3##2##(1994-12#1)(1994-5#2)
nitrogen (N) composition##2##3##(2012-8#1)(2012-9#1)
nitrogen (N)##5##2##(2008-2#1)(2012-5#1)(2012-8#1)(2012-9#1)(2013-8#1)
nitrogen and methane##3##3##(2008-2#3)
nitrogen and oxygen as##2##4##(2008-10#1)(2008-3#1)
nitrogen and oxygen##4##3##(2008-10#3)(2008-3#1)
nitrogen and phosphorus forms##2##4##(2008-10#2)
nitrogen and phosphorus##3##3##(2008-10#3)
nitrogen and##23##2##(2008-10#16)(2008-12#1)(2008-2#3)(2008-3#2)(2012-5#1)
nitrogen as##2##2##(2008-10#2)
nitrogen at##3##2##(1993-1#1)(2007-12#1)(2008-3#1)
nitrogen atmosphere##2##2##(2008-10#2)
nitrogen atoms##3##2##(1993-12#1)(2008-10#2)
nitrogen balance##3##2##(2008-3#1)(2013-8#2)
nitrogen compounds in##3##3##(2008-10#3)
nitrogen compounds##5##2##(2008-10#5)
nitrogen concentration##2##2##(2008-10#1)(2008-2#1)
nitrogen content##9##2##(2008-10#9)
nitrogen contents##3##2##(2008-10#2)(2008-5#1)
nitrogen deprivation##3##2##(2008-7#3)
nitrogen determination in bean samples##2##5##(2008-10#2)
nitrogen determination in##5##3##(2008-10#5)
nitrogen dioxide (NO2)##2##3##(1996-12#2)
nitrogen dioxide in air##2##4##(2008-10#2)
nitrogen dioxide in##3##3##(2008-10#3)
nitrogen dioxide##15##2##(1991-3#1)(1996-12#2)(2008-10#11)(2008-11#1)
nitrogen evaporation##2##2##(2008-11#2)
nitrogen fertilization##3##2##(2008-10#3)
nitrogen fixation in the##2##4##(2008-11#1)(2009-7#1)
nitrogen fixation##7##2##(2008-11#1)(2008-9#2)(2009-7#2)(2011-2#2)
nitrogen fixing microsymbiont of a##3##5##(2011-2#3)
nitrogen for##2##2##(1991-2#1)(2008-8#1)
nitrogen gas##3##2##(2008-10#3)
nitrogen in the##2##3##(1995-11#1)(2008-3#1)
nitrogen in##8##2##(1994-8#1)(1995-11#2)(2008-10#4)(2008-3#1)
nitrogen is##2##2##(1996-5#1)(2008-2#1)
nitrogen metabolism##2##2##(1997-1#1)(2008-11#1)
nitrogen of the##2##3##(1992-3#2)
nitrogen of##4##2##(1992-3#2)(2008-9#1)(2010-8#1)
nitrogen or##5##2##(1995-11#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
nitrogen oxides##6##2##(1991-6#2)(2008-10#4)
nitrogen source##3##2##(1993-6#1)(1995-9#1)(2008-10#1)
nitrogen sources##3##2##(1995-9#2)(2008-10#1)
nitrogen species##3##2##(2009-8#1)(2011-2#2)
nitrogen to cause a dramatic decrease in##2##7##(2008-10#2)
nitrogen to##6##2##(1993-1#1)(2008-10#3)(2008-11#1)(2011-2#1)
nitrogen utilization##3##2##(2012-3#3)
nitrogen was##7##2##(1991-5#1)(1995-11#1)(1996-5#1)(2008-10#3)(2008-7#1)
nitrogen##237##1##(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-3#2)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#7)(1995-9#3)(1996-12#2)(1996-5#4)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#121)(2008-11#8)(2008-12#2)(2008-2#10)(2008-3#11)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#9)(2009-10#1)(2009-7#2)(2009-8#1)(2010-8#1)(2011-2#11)(2012-2#1)(2012-3#3)(2012-5#2)(2012-8#1)(2012-9#1)(2013-8#3)
nitrogen-containing polycyclic aromatic compounds##2##4##(2008-10#2)
nitrogen-fixing##3##1##(2008-11#2)(2011-2#1)
nitrogen-regulatory/oxygen-sensing consensus sequences##2##3##(1993-12#2)
nitrogenous##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
nitroglycerin##3##1##(1996-3#1)(2011-2#1)(2012-12#1)
nitrones##2##1##(1993-6#2)
nitrophenol isomers##2##2##(2008-10#2)
nitroprusside##12##1##(1995-11#1)(1995-8#3)(2008-10#4)(2008-11#3)(2012-3#1)
nitroreductase##3##1##(1990-6#2)(2008-11#1)
nitrosamine##2##1##(1993-11#1)(2008-10#1)
nitrosamines in##2##2##(2008-10#1)(2013-8#1)
nitrosamines##3##1##(2008-10#2)(2013-8#1)
nitrosation##2##1##(2008-10#2)
nitroso##4##1##(1996-5#1)(2008-10#2)(2008-11#1)
nitrosothiols##2##1##(2008-10#1)(2010-5#1)
nitrotriazole explosives##2##2##(2008-11#2)
nitrous acid accumulated##2##3##(2008-10#2)
nitrous acid and##2##3##(2008-10#1)(2011-2#1)
nitrous acid was##2##3##(2008-10#2)
nitrous acid##9##2##(2008-10#8)(2011-2#1)
nitrous oxide##15##2##(1991-6#3)(1993-1#2)(1996-6#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#2)
nitrous##26##1##(1991-6#3)(1993-1#2)(1996-6#3)(2008-10#10)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#3)
nitroxide##3##1##(1993-8#1)(2008-10#1)(2008-8#1)
nitroxides##2##1##(1993-6#1)(1996-10#1)
nivale##5##1##(2008-10#5)
nivalenol (NIV)##3##2##(2008-10#3)
nivea##3##1##(2010-3#3)
niveau##2##1##(2009-10#1)(2011-2#1)
niveum race 1##3##3##(2008-10#3)
niveum race##4##2##(2008-10#4)
niveum##11##1##(2008-10#11)
nkx-2##6##1##(1995-6#6)
nl)##3##1##(1997-2#2)(2008-6#1)
nm (##2##2##(2008-10#2)
nm (idler)##2##2##(2007-12#2)
nm (signal) and##2##3##(2007-12#2)
nm after 3 min of mixing the reagents##2##8##(2008-10#2)
nm after##6##2##(2008-10#5)(2010-1#1)
nm and 1##2##3##(2008-11#1)(2008-3#1)
nm and Beer's law##2##4##(2008-10#2)
nm and a shoulder at##2##5##(2008-10#2)
nm and a##6##3##(2008-10#3)(2008-3#3)
nm and an emission wavelength##2##5##(2008-10#2)
nm and an##4##3##(2008-10#3)(2008-2#1)
nm and emission##2##3##(1997-2#1)(2008-10#1)
nm and lambda (em##2##4##(2008-10#2)
nm and measured at##2##4##(2008-10#2)
nm and the average transmissions strength is##2##7##(2013-8#2)
nm and the emission##4##4##(1996-2#1)(2008-10#3)
nm and the##10##3##(1996-2#1)(2008-10#6)(2008-3#1)(2013-8#2)
nm and##60##2##(1996-2#1)(1997-2#1)(2008-10#38)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2013-1#1)(2013-8#2)
nm are##5##2##(2008-10#2)(2008-3#2)(2013-8#1)
nm as##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
nm at##2##2##(2008-10#2)
nm by frequency mixing##2##4##(2008-2#2)
nm by##8##2##(2008-10#1)(2008-2#4)(2008-3#3)
nm diameter##2##2##(2008-8#1)(2010-4#1)
nm emission##2##2##(2008-10#2)
nm excitation##2##2##(2008-10#2)
nm for bond lengths and##2##5##(2008-8#1)(2008-9#1)
nm for the##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
nm for##24##2##(2008-10#18)(2008-3#3)(2008-8#1)(2008-9#2)
nm from##2##2##(2008-10#2)
nm has been##2##3##(2008-3#2)
nm have been##2##3##(2008-10#1)(2008-3#1)
nm have##3##2##(2008-10#1)(2008-3#2)
nm in aqueous solution##2##4##(2008-10#2)
nm in aqueous##3##3##(2008-10#3)
nm in diameter##12##3##(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-6#1)
nm in length##3##3##(2008-10#2)(2008-8#1)
nm in width##2##3##(2008-10#1)(2009-12#1)
nm in##36##2##(1996-2#1)(2007-12#1)(2008-10#20)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-7#1)(2010-11#1)(2010-6#1)
nm is linear##2##3##(2008-10#2)
nm is##7##2##(2007-12#1)(2008-10#5)(2008-2#1)
nm long##2##2##(2008-10#1)(2008-5#1)
nm of the##2##3##(2008-10#2)
nm resolution##6##2##(2008-8#4)(2008-9#2)
nm spectral##2##2##(2008-10#1)(2008-3#1)
nm that##2##2##(2008-10#2)
nm thick##3##2##(2008-12#1)(2009-5#2)
nm to##6##2##(2008-10#2)(2008-2#2)(2008-3#2)
nm using a##3##3##(2008-10#3)
nm using##7##2##(2008-10#5)(2008-8#1)(2012-2#1)
nm was used for##2##4##(2008-10#2)
nm was used to##2##4##(1991-3#1)(2008-10#1)
nm was used##4##3##(1991-3#1)(2008-10#3)
nm was##15##2##(1991-3#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)
nm wavelength##2##2##(2008-10#2)
nm were 3##2##3##(2008-10#2)
nm were measured##2##3##(2008-2#1)(2008-3#1)
nm were observed##2##3##(2008-10#1)(2008-5#1)
nm were##9##2##(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)
nm with a molar absorptivity##2##5##(2008-10#2)
nm with a##8##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)
nm with an excitation wavelength of##2##6##(2008-10#2)
nm with an##7##3##(2008-10#5)(2008-3#2)
nm with excitation at##3##4##(2008-10#3)
nm with molar absorptivity##3##4##(2008-10#3)
nm with the##3##3##(2008-10#3)
nm with##29##2##(2007-12#1)(2008-10#21)(2008-2#3)(2008-3#3)(2012-2#1)
nm##710##1##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#2)(1991-5#1)(1993-2#2)(1993-3#1)(1993-8#4)(1994-3#1)(1994-5#3)(1996-11#1)(1996-2#2)(1997-2#3)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#14)(2008-10#453)(2008-11#10)(2008-12#1)(2008-2#31)(2008-3#73)(2008-5#14)(2008-7#7)(2008-8#28)(2008-9#11)(2009-10#1)(2009-11#2)(2009-12#3)(2009-5#6)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#4)(2010-4#1)(2010-6#3)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#7)(2013-1#1)(2013-8#5)
nm) after##3##2##(2008-10#3)
nm) and Q(Y)##2##3##(2008-9#2)
nm) and##12##2##(2007-11#1)(2008-10#7)(2008-8#1)(2008-9#2)(2012-12#1)
nm) as##2##2##(2008-10#2)
nm) at##2##2##(2008-10#2)
nm) between##2##2##(1994-5#1)(2008-10#1)
nm) has##2##2##(2008-10#1)(2011-7#1)
nm) in the presence of hydrogen peroxide##3##7##(2008-10#3)
nm) in the presence of##5##5##(2008-10#4)(2008-11#1)
nm) in the##7##3##(2008-10#6)(2008-11#1)
nm) of a Nd##2##4##(2008-3#2)
nm) of##5##2##(1994-5#1)(2008-3#2)(2008-9#2)
nm) or##2##2##(1991-7#1)(2008-10#1)
nm) was##3##2##(2008-10#2)(2008-11#1)
nm) with a relative standard deviation of 1##2##8##(2008-10#2)
nm) with a##3##3##(2008-10#2)(2008-3#1)
nm) with##4##2##(2008-10#3)(2008-3#1)
nm)##118##1##(1990-8#1)(1991-7#1)(1992-1#1)(1994-5#2)(1996-5#2)(1997-2#1)(2007-11#3)(2008-10#79)(2008-11#4)(2008-3#12)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2010-1#1)(2010-11#1)(2011-2#1)(2011-7#1)(2012-12#1)
nm23##5##1##(1993-8#5)
nm23/NDP-K##2##1##(1993-8#2)
nm2798##2##1##(2008-8#2)
nmol L(-1)##4##2##(2008-10#3)(2008-12#1)
nmol Pi/mg of protein per min##2##6##(2008-10#2)
nmol h(-1) for##2##3##(2008-10#2)
nmol l(-1) (S/N=3)##2##3##(2008-10#2)
nmol l(-1) with a detection limit of 0##2##8##(2008-10#2)
nmol l(-1)##14##2##(2008-10#14)
nmol min-1 mg-1##2##3##(1990-11#2)
nmol of##2##2##(1993-8#1)(1997-2#1)
nmol##43##1##(1990-11#2)(1991-3#2)(1991-9#3)(1992-11#1)(1993-2#1)(1993-8#1)(1997-2#4)(2008-10#26)(2008-12#1)(2010-4#1)(2013-8#1)
nmol) and##2##2##(1996-2#1)(1997-4#1)
nmol) or##2##2##(1995-12#1)(1997-4#1)
nmol)##15##1##(1991-9#1)(1994-8#1)(1995-12#2)(1996-2#2)(1997-2#1)(1997-4#7)(2008-10#1)
nmol/10##2##1##(1997-4#2)
nmol/100 nl)##2##2##(1997-2#2)
nmol/h/mg protein##3##2##(1990-5#1)(1991-12#2)
nmol/h/mg##4##1##(1990-5#1)(1991-12#3)
nmol/hour/mg protein##2##2##(1993-3#2)
nmol/l##7##1##(1992-6#1)(1995-8#3)(2008-10#1)(2011-2#2)
nmol/mol##4##1##(2008-3#4)
nmolar range##2##2##(2008-10#2)
nmole##2##1##(1994-11#1)(2008-10#1)
nmole)##2##1##(1994-11#2)
nmoll(-1)##3##1##(2008-10#3)
nmol·l-1##2##1##(2013-1#2)
nmol·l-1)##3##1##(2013-1#3)
no &quot##4##2##(1993-8#1)(1997-1#1)(2008-10#1)(2008-9#1)
no A5'ppA-containing##2##2##(1994-11#2)
no Al##2##2##(2008-10#2)
no CO(2) supply was about##2##5##(2008-11#2)
no CO(2) supply was##4##4##(2008-11#4)
no CO(2) supply##6##3##(2008-11#6)
no CO(2)##7##2##(2008-11#7)
no DNA##2##2##(2008-10#1)(2008-8#1)
no GTN##2##2##(2008-8#2)
no absolute##3##2##(1992-6#1)(2008-10#1)(2008-3#1)
no accumulation of##2##3##(2008-10#1)(2008-11#1)
no accumulation##3##2##(2008-10#1)(2008-11#2)
no activation of##2##3##(1990-5#1)(2008-10#1)
no activation##3##2##(1990-5#1)(1995-2#1)(2008-10#1)
no activity##7##2##(1992-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-3#1)(2012-2#1)
no additional##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
no advantage##3##2##(1994-2#2)(2008-10#1)
no adverse effects##2##3##(1993-1#1)(2012-3#1)
no adverse##7##2##(1993-1#1)(2008-10#1)(2008-5#2)(2010-6#1)(2012-3#1)(2013-1#1)
no aggregation##2##2##(1990-5#1)(2008-10#1)
no agreement on##2##3##(2008-7#1)(2011-2#1)
no alternative##3##2##(1992-3#1)(1996-1#1)(2010-6#1)
no animal##2##2##(2008-10#1)(2008-11#1)
no antifungal activity##2##3##(2008-10#2)
no apparent changes##2##3##(2008-11#1)(2008-5#1)
no apparent correlation between genetic distance and##2##7##(2008-10#2)
no apparent difference in##2##4##(2008-10#1)(2008-11#1)
no apparent similarity to any##2##5##(1995-8#1)(1996-6#1)
no apparent##21##2##(1993-8#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-6#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)
no appreciable effect##2##3##(2008-10#1)(2008-11#1)
no appreciable##3##2##(2008-10#1)(2008-11#2)
no artificial##2##2##(1996-3#1)(2012-3#1)
no associated##2##2##(1990-11#1)(1994-12#1)
no association between##4##3##(1993-1#1)(1997-8#1)(2008-8#1)(2013-1#1)
no association was found between the##2##6##(1990-8#1)(2008-10#1)
no association with##4##3##(1997-1#1)(2008-12#2)(2008-9#1)
no association##11##2##(1990-8#1)(1993-1#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
no attempt##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
no attention##2##2##(1990-6#1)(2013-1#1)
no better than##2##3##(1993-1#1)(1994-12#1)
no broccoli##2##2##(2008-10#2)
no case of##2##3##(1995-3#1)(2008-10#1)
no case##8##2##(1991-3#1)(1991-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
no cases of##6##3##(1991-2#1)(1997-8#1)(2008-7#2)(2011-2#2)
no casting##2##2##(2008-9#2)
no change in the number of##3##6##(1990-6#1)(1997-2#1)(2008-7#1)
no change in the##9##4##(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
no change in##20##3##(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1995-11#1)(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#1)(2013-8#2)
no change was observed##2##4##(1993-11#1)(2009-1#1)
no change##30##2##(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1993-11#1)(1995-11#1)(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-1#1)(2009-11#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
no changes in the##2##4##(2008-12#1)(2008-3#1)
no changes in##7##3##(1990-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-3#1)
no changes were observed in##4##5##(1994-8#1)(2008-7#1)(2013-1#2)
no changes were##6##3##(1994-8#1)(1995-11#1)(2008-7#1)(2012-3#1)(2013-1#2)
no changes##15##2##(1990-11#1)(1992-2#1)(1994-8#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-3#2)(2013-1#2)
no chemical##4##2##(2008-10#4)
no clear association##2##3##(2008-7#2)
no clear evidence##3##3##(1996-3#1)(2008-11#1)(2013-1#1)
no clear##16##2##(1992-3#1)(1994-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-5#1)(2013-1#1)(2013-8#1)
no clearly defined##2##3##(2008-7#1)(2009-8#1)
no clinical##8##2##(1990-11#1)(1990-9#1)(1991-9#1)(1997-3#1)(2010-5#1)(2012-3#2)(2013-1#1)
no clustering##2##2##(1996-12#1)(2008-10#1)
no common##4##2##(2008-10#2)(2008-6#1)(2011-4#1)
no compelling##2##2##(1995-3#1)(2008-10#1)
no competition##3##2##(1993-2#1)(2008-8#1)(2010-8#1)
no complete##2##2##(1990-12#1)(1991-2#1)
no complications##5##2##(1996-3#1)(1997-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
no compounds##2##2##(2008-10#2)
no conflict##2##2##(1995-12#1)(2008-9#1)
no consensus has##2##3##(1995-2#1)(2013-8#1)
no consensus##8##2##(1994-12#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#2)
no consistent##8##2##(1990-12#1)(2008-10#4)(2010-6#1)(2011-2#1)(2012-2#1)
no contact##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
no contamination##2##2##(2008-10#1)(2008-12#1)
no control##2##2##(1996-2#1)(2008-7#1)
no convincing evidence##3##3##(1992-2#1)(1995-11#1)(2011-2#1)
no correlation between the##5##4##(1992-11#1)(2008-10#3)(2008-5#1)
no correlation between##13##3##(1991-8#2)(1992-11#1)(1993-2#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-5#1)(2011-2#2)
no correlation was found between the##2##6##(1992-2#1)(2008-11#1)
no correlation with age##2##4##(1990-2#1)(2011-2#1)
no correlation with##4##3##(1990-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
no correlation##22##2##(1990-2#1)(1991-8#2)(1992-11#1)(1992-2#1)(1993-2#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#4)(2012-3#1)
no corresponding##2##2##(1996-2#1)(2008-4#1)
no cost##2##2##(2008-10#1)(2008-8#1)
no cross-reaction##2##2##(2008-11#1)(2010-4#1)
no cross-reactivity with##2##3##(1990-11#1)(2008-10#1)
no data on##2##3##(1993-3#1)(2008-5#1)
no data##8##2##(1993-3#1)(1994-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#2)
no decline in##2##3##(2008-10#1)(2010-8#1)
no definitive##7##2##(2008-11#1)(2008-12#1)(2008-9#2)(2010-12#3)
no degradation##2##2##(2008-10#1)(2008-5#1)
no detailed##2##2##(2008-1#1)(2013-1#1)
no detectable activity in##2##4##(2009-6#2)
no detectable change in##2##4##(2008-8#1)(2008-9#1)
no detectable##23##2##(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-2#2)(1996-12#1)(1996-5#1)(2008-10#6)(2008-11#2)(2008-8#2)(2008-9#1)(2009-6#2)
no difference between the two##2##5##(1995-8#1)(2008-7#1)
no difference between the##4##4##(1990-2#1)(1995-8#1)(2008-7#1)(2008-9#1)
no difference between##9##3##(1990-2#1)(1994-3#1)(1995-8#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)
no difference in the##10##4##(1990-6#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
no difference in##31##3##(1990-6#2)(1992-12#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#4)
no difference of##2##3##(2008-9#1)(2009-6#1)
no difference regarding##2##3##(1997-3#1)(2010-1#1)
no difference was found##2##4##(1996-2#1)(2011-2#1)
no difference was seen##2##4##(1991-6#1)(2008-5#1)
no difference was##4##3##(1991-6#1)(1996-2#1)(2008-5#1)(2011-2#1)
no difference##54##2##(1990-2#1)(1990-6#2)(1991-1#1)(1991-6#1)(1992-12#2)(1992-3#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-6#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#4)
no differences between the##3##4##(1995-5#1)(2008-10#1)(2008-2#1)
no differences between##8##3##(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#3)(2008-2#1)(2012-3#1)
no differences in the##6##4##(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-8#1)
no differences in##14##3##(1990-8#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
no differences were found between##3##5##(1996-1#1)(2008-11#1)(2010-12#1)
no differences were found##4##4##(1996-1#1)(2008-10#1)(2008-11#1)(2010-12#1)
no differences were observed between##2##5##(2008-7#2)
no differences were observed##3##4##(2008-10#1)(2008-7#2)
no differences were##7##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-12#1)
no differences##32##2##(1990-8#1)(1993-1#1)(1993-3#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
no different from##2##3##(2008-10#1)(2011-2#1)
no direct effect##2##3##(1992-6#1)(1995-2#1)
no direct evidence to support##2##5##(2008-10#2)
no direct##10##2##(1992-6#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-5#1)(2009-8#1)(2012-2#1)
no discernable##2##2##(2008-10#1)(2008-9#1)
no disease##3##2##(2008-10#2)(2012-12#1)
no displacement##2##2##(2008-10#1)(2013-1#1)
no distinct##4##2##(2007-12#1)(2008-10#2)(2008-9#1)
no documented##2##2##(1993-11#1)(1996-5#1)
no effect of the##2##4##(2008-10#1)(2008-11#1)
no effect of##6##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)
no effect on lesion development##2##5##(2008-10#2)
no effect on lesion##3##4##(1995-12#1)(2008-10#2)
no effect on the determination##3##5##(2008-10#3)
no effect on the secretion##2##5##(1990-5#1)(1995-8#1)
no effect on the##33##4##(1990-5#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-6#1)(2008-10#10)(2008-11#3)(2008-8#1)(2013-8#3)
no effect on##108##3##(1990-2#1)(1990-5#5)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-12#2)(1996-2#4)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-6#2)(2008-10#25)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#3)
no effect was observed for##2##5##(2008-10#1)(2008-11#1)
no effect was observed##5##4##(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)
no effect was##6##3##(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#1)
no effect##151##2##(1990-11#2)(1990-2#1)(1990-5#6)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#3)(1995-12#1)(1995-2#8)(1995-3#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-12#4)(1996-2#6)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#2)(2008-10#37)(2008-11#12)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#7)(2008-9#2)(2009-3#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
no effective treatment##2##3##(2012-2#1)(2013-1#1)
no effective##5##2##(1990-2#1)(1990-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
no effects on the##3##4##(1991-2#1)(2008-10#1)(2008-9#1)
no effects on##5##3##(1991-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-4#1)
no effects##9##2##(1991-2#1)(1991-5#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-1#1)(2012-3#1)(2012-4#1)
no empirical studies##2##3##(1996-1#1)(2008-7#1)
no enhancer##2##2##(1994-6#1)(2008-10#1)
no enzymatic##2##2##(1991-3#1)(2008-10#1)
no eutectic formation##2##3##(2013-1#2)
no evidence for a##3##4##(2009-10#1)(2009-8#1)(2011-2#1)
no evidence for an##3##4##(1995-12#1)(2008-11#1)(2012-3#1)
no evidence for##10##3##(1995-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-3#1)
no evidence of a##3##4##(1995-11#1)(2008-10#1)(2013-1#1)
no evidence of any##2##4##(1996-3#1)(2010-12#1)
no evidence of disease recurrence##2##5##(2012-2#1)(2013-1#1)
no evidence of excess##2##4##(1991-6#1)(1992-6#1)
no evidence of local recurrence##2##5##(2010-3#1)(2013-1#1)
no evidence of malignancy##2##4##(1994-12#1)(2008-10#1)
no evidence of recurrence##3##4##(1993-1#1)(2011-2#1)(2013-8#1)
no evidence of##52##3##(1990-2#1)(1991-1#2)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-10#12)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
no evidence that C##2##4##(2008-10#2)
no evidence that##11##3##(1993-3#1)(1993-6#1)(1996-3#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-9#1)(2012-12#1)
no evidence to##3##3##(2008-10#1)(2010-11#1)(2013-1#1)
no evidence was found##2##4##(2008-10#2)
no evidence was##3##3##(2008-10#2)(2010-11#1)
no evidence##86##2##(1990-2#1)(1991-1#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#1)
no excipient##2##2##(2008-10#2)
no experience##2##2##(1991-2#1)(2008-11#1)
no experimental##2##2##(2008-10#1)(2008-9#1)
no extraction##2##2##(2008-10#2)
no family history##3##3##(2008-6#1)(2012-3#1)(2013-1#1)
no family##4##2##(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
no fertilizer plots##2##3##(2008-12#2)
no formal##4##2##(1991-12#1)(1992-3#1)(1994-12#2)
no free##2##2##(2008-3#1)(2012-2#1)
no functional##3##2##(1991-5#1)(2010-3#1)(2010-5#1)
no fungus##2##2##(2013-1#2)
no further signs of##2##4##(2011-2#2)
no further##13##2##(1990-6#1)(1992-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)(2013-1#1)
no general##3##2##(1991-12#1)(2008-8#1)(2008-9#1)
no genetic##2##2##(2008-10#1)(2012-2#1)
no gross##3##2##(1993-12#1)(1995-12#1)(2008-11#1)
no group##2##2##(1992-12#1)(2013-1#1)
no growth##3##2##(2008-10#2)(2008-11#1)
no guidelines for##2##3##(2012-12#1)(2012-3#1)
no higher than the##2##4##(2008-10#2)
no history of##10##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
no homologous##2##2##(1990-2#1)(1991-9#1)
no homology with any##2##4##(1996-3#1)(2008-9#1)
no homology with the##2##4##(2008-10#1)(2008-8#1)
no homology with##5##3##(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#2)
no homology##7##2##(1996-3#1)(1997-4#1)(2008-10#2)(2008-8#1)(2008-9#2)
no impact on the##4##4##(1995-5#1)(2008-7#1)(2008-9#1)(2011-10#1)
no impact on##6##3##(1991-6#1)(1995-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-10#1)
no improvement in##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
no improvement of##2##3##(1990-12#1)(2008-12#1)
no improvement##7##2##(1990-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-5#1)(2011-1#1)(2013-8#1)
no incidence of##2##3##(2008-7#1)(2009-12#1)
no increase in the##2##4##(1994-3#1)(1996-6#1)
no increase in##10##3##(1991-3#1)(1994-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
no increase##12##2##(1991-2#1)(1991-3#1)(1994-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)
no increased##3##2##(1994-2#1)(2008-9#2)
no indication of##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
no indications for##2##3##(1990-11#1)(2008-11#1)
no infection##3##2##(2008-10#3)
no influence##7##2##(1990-3#1)(1994-3#1)(1995-2#2)(2008-10#1)(2008-11#2)
no information on the##2##4##(1996-11#1)(2008-10#1)
no information##3##2##(1996-11#1)(2008-10#2)
no inhibition was##2##3##(1994-8#2)
no inhibition##3##2##(1990-5#1)(1994-8#2)
no inhibitory effect##2##3##(1994-8#1)(1995-6#1)
no inhibitory##3##2##(1994-8#2)(1995-6#1)
no interaction between##2##3##(1990-11#1)(2008-10#1)
no interaction##4##2##(1990-11#1)(2008-10#3)
no interference by##2##3##(2008-10#2)
no interference can be observed from##2##6##(2008-10#2)
no interference from excipients##2##4##(2008-10#2)
no interference from##8##3##(2008-10#8)
no interference in the determination of these ions by##2##9##(2008-10#2)
no interference of##3##3##(2008-10#3)
no interference was observed##2##4##(2008-10#2)
no interference##27##2##(1993-2#1)(2008-10#26)
no interferences##3##2##(2008-10#3)
no intervention##2##2##(1997-2#1)(2013-1#1)
no intrinsic##4##2##(1992-3#1)(1995-11#1)(1996-2#1)(2008-8#1)
no introns##2##2##(2008-6#1)(2010-5#1)
no known sexual stage##2##4##(2008-10#2)
no known sexual##3##3##(2008-10#3)
no known##15##2##(1993-2#1)(1995-6#1)(2006-6#1)(2008-10#6)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
no laboratory tests##2##3##(2010-12#1)(2010-5#1)
no less##2##2##(1993-12#1)(1995-5#1)
no local or systemic side-effects and toxicity associated with the gene transfer were found##2##14##(2008-9#2)
no long-term##2##2##(2008-4#1)(2011-2#1)
no longer an##2##3##(2008-10#1)(2011-3#1)
no longer be##5##3##(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)
no longer than##2##3##(2008-10#1)(2009-4#1)
no longer##54##2##(1990-5#1)(1991-2#2)(1993-1#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-11#1)(1997-2#1)(1997-5#1)(2008-10#11)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-3#1)(2012-2#2)(2012-5#1)(2013-1#1)
no loss in##2##3##(2008-10#2)
no loss of##5##3##(1996-2#1)(2008-10#3)(2008-7#1)
no loss##7##2##(1996-2#1)(2008-10#5)(2008-7#1)
no major##5##2##(1994-12#1)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#1)
no make-up##2##2##(2008-5#2)
no males##2##2##(2008-9#2)
no marked##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
no matter how the inoculum is precultured##2##7##(2008-7#2)
no matter how##5##3##(1994-12#1)(2008-7#4)
no matter##8##2##(1994-12#1)(1995-12#1)(2008-10#1)(2008-7#4)(2011-2#1)
no meaning##3##2##(2008-5#1)(2013-1#2)
no means##5##2##(1995-1#1)(2008-11#2)(2008-9#1)(2009-3#1)
no measurable##5##2##(1992-12#1)(1993-1#1)(1993-3#1)(2008-10#2)
no measurement##3##2##(2008-10#1)(2013-1#2)
no methods##2##2##(2008-10#1)(2011-2#1)
no modification##2##2##(1991-3#1)(1994-8#1)
no modifier was##2##3##(2008-10#2)
no molecular##2##2##(1997-7#1)(2010-11#1)
no more than##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
no more##14##2##(1990-5#1)(1991-6#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-11#1)(2010-12#1)(2013-1#1)
no morphological##2##2##(1990-11#1)(2008-10#1)
no mortality##6##2##(1996-3#1)(1997-8#1)(2008-5#1)(2008-7#3)
no mutations##2##2##(1997-7#1)(2008-12#1)
no need for##2##3##(2008-10#2)
no need of##2##3##(2008-10#1)(2012-3#1)
no need##6##2##(1994-1#1)(2008-10#4)(2012-3#1)
no negative##3##2##(2008-10#1)(2008-9#2)
no neurologic##2##2##(1996-9#1)(2010-6#1)
no neurological deficits##2##3##(2008-7#1)(2013-1#1)
no neurological##5##2##(1995-5#1)(2008-7#2)(2012-12#1)(2013-1#1)
no new##4##2##(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
no nucleotide##3##2##(1994-12#1)(2011-2#1)(2013-8#1)
no objective##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
no observed##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
no obvious difference##3##3##(1995-3#1)(2008-11#1)(2012-2#1)
no obvious reason##3##3##(1992-5#1)(2008-11#1)(2010-12#1)
no obvious##15##2##(1992-5#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#1)
no occurrence of##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
no one##6##2##(1995-12#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-12#1)
no or little##3##3##(2008-10#2)(2008-11#1)
no or only##2##3##(2008-10#1)(2008-8#1)
no or very##3##3##(1992-12#1)(1997-6#1)(2010-12#1)
no or##14##2##(1990-2#1)(1992-12#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-8#1)(2010-1#1)(2010-12#1)
no other cause for##2##4##(1991-4#1)(2012-3#1)
no other##17##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-4#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#2)(2013-8#1)
no overall##2##2##(2008-10#1)(2012-2#1)
no overlap##2##2##(2008-10#1)(2009-8#1)
no parental##2##2##(1995-6#1)(2010-4#1)
no particular##2##2##(2007-12#1)(2009-10#1)
no patient##3##2##(1990-6#1)(1993-1#1)(1995-11#1)
no personal##2##2##(2008-11#1)(2010-6#1)
no point##2##2##(1992-8#1)(1994-11#1)
no population##2##2##(2008-10#2)
no positive##2##2##(1996-9#1)(2008-10#1)
no potential for##3##3##(1997-7#1)(2008-10#2)
no practical##2##2##(2008-10#1)(2008-3#1)
no predilection for##2##3##(1991-8#1)(1997-1#1)
no previous reports##2##3##(2008-10#1)(2008-12#1)
no previous##6##2##(1991-2#1)(2008-10#2)(2008-12#2)(2013-8#1)
no previously##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
no prior##9##2##(2008-10#3)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
no problems##3##2##(1997-5#1)(2008-10#2)
no processing##2##2##(1991-10#1)(2008-11#1)
no protein##2##2##(1993-8#1)(2008-10#1)
no published##2##2##(1990-2#1)(2010-1#1)
no reactive##2##2##(1990-2#1)(2008-11#1)
no reactivity##2##2##(1991-9#1)(1993-8#1)
no reason to##2##3##(1996-5#1)(1997-5#1)
no recurrence##8##2##(1993-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
no reduction in##4##3##(1990-6#1)(1993-8#1)(2008-10#2)
no reduction##6##2##(1990-6#1)(1992-12#1)(1993-8#1)(1996-12#1)(2008-10#2)
no regular##3##2##(1994-9#1)(1996-1#1)(2007-12#1)
no relation between##3##3##(1994-6#1)(1995-8#1)(1997-3#1)
no relation##4##2##(1994-6#1)(1995-8#1)(1997-3#1)(2008-10#1)
no relationship between the number of##2##6##(2008-11#1)(2008-12#1)
no relationship between the##6##4##(1991-11#1)(2008-11#1)(2008-12#2)(2008-8#1)(2013-1#1)
no relationship between##20##3##(1991-11#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-8#4)(2011-2#3)(2013-1#2)
no relationship##22##2##(1991-11#1)(1997-2#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-8#4)(2011-2#4)(2013-1#2)
no report##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
no reported case##2##3##(2008-10#1)(2012-2#1)
no reported##6##2##(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
no reports of##2##3##(2008-12#1)(2011-1#1)
no reports##4##2##(2008-10#1)(2008-12#1)(2011-1#1)(2013-1#1)
no research##2##2##(2008-11#2)
no residual##2##2##(2008-11#1)(2011-2#1)
no resistance##6##2##(1997-5#1)(2008-10#3)(2008-8#2)
no response to##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
no response##9##2##(1996-5#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-12#1)
no right##3##2##(1993-12#1)(1994-1#2)
no risk##3##2##(1997-5#1)(2007-12#1)(2008-12#1)
no role in##2##3##(2008-10#1)(2010-7#1)
no role##4##2##(2006-6#1)(2008-10#1)(2008-7#1)(2010-7#1)
no sample##6##2##(2008-10#6)
no scientific##2##2##(2008-11#1)(2009-7#1)
no secondary##3##2##(2008-10#3)
no separation##2##2##(2008-10#1)(2011-2#1)
no sequence##4##2##(1993-6#1)(1997-7#1)(2008-10#1)(2010-3#1)
no serious##7##2##(1990-11#1)(1990-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2013-1#1)
no set##2##2##(2010-3#1)(2011-2#1)
no side effect##2##3##(1997-3#2)
no side##3##2##(1991-3#1)(1997-3#2)
no sign of##6##3##(1992-9#1)(1994-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
no significant association##3##3##(1991-6#1)(1994-12#1)(2013-8#1)
no significant change in the##5##5##(1997-2#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)
no significant change in##12##4##(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
no significant change##13##3##(1993-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
no significant changes in##7##4##(1994-2#1)(2007-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2011-3#1)
no significant changes were found##2##5##(2012-3#1)(2013-1#1)
no significant changes were##4##4##(1996-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
no significant changes##15##3##(1994-2#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
no significant complications##2##3##(1993-1#1)(2013-1#1)
no significant correlation with##2##4##(2006-6#1)(2008-8#1)
no significant correlation##11##3##(1994-12#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#4)(2008-12#1)(2008-8#1)
no significant correlations##2##3##(2008-10#1)(2011-2#1)
no significant difference among the##2##5##(2008-10#2)
no significant difference among##4##4##(2008-10#3)(2013-1#1)
no significant difference at 95% confidence level##3##7##(2008-10#3)
no significant difference at the 95% confidence level was observed##2##10##(2008-10#2)
no significant difference at##6##4##(2008-10#6)
no significant difference between##17##4##(1991-8#1)(1993-2#1)(1997-8#1)(1997-9#1)(2008-10#6)(2008-12#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)
no significant difference in the##14##5##(1991-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2011-2#2)(2012-3#2)(2013-1#2)
no significant difference in##39##4##(1991-2#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#2)
no significant difference of##2##4##(2008-9#1)(2011-2#1)
no significant difference was found between##2##6##(2008-10#1)(2008-12#1)
no significant difference was found##4##5##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
no significant difference was##6##4##(1993-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
no significant difference##74##3##(1991-2#1)(1991-8#2)(1993-11#2)(1993-2#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1996-6#1)(1997-8#2)(1997-9#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#4)(2013-1#3)
no significant differences between groups##3##5##(2011-2#1)(2013-1#2)
no significant differences between the two##2##6##(1991-3#1)(1993-8#1)
no significant differences between the##4##5##(1991-3#1)(1993-8#1)(2008-10#2)
no significant differences between these##2##5##(1997-7#1)(2008-10#1)
no significant differences between##12##4##(1991-3#1)(1993-8#1)(1997-7#1)(2008-1#1)(2008-10#4)(2009-11#1)(2011-2#1)(2013-1#2)
no significant differences in outcome##2##5##(1990-2#1)(1997-3#1)
no significant differences in the##6##5##(1994-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2010-12#1)(2013-1#1)
no significant differences in##25##4##(1990-2#1)(1991-2#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
no significant differences were found between##2##6##(2008-10#1)(2011-3#1)
no significant differences were found##5##5##(1993-2#1)(2008-10#2)(2011-3#1)(2013-1#1)
no significant differences were observed##2##5##(1995-11#1)(2008-10#1)
no significant differences were##10##4##(1993-2#1)(1994-2#1)(1995-11#1)(2008-10#4)(2008-12#1)(2011-3#1)(2013-1#1)
no significant differences##59##3##(1990-2#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
no significant effect of##2##4##(2008-10#1)(2013-8#1)
no significant effect on##18##4##(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-3#1)(2012-2#1)
no significant effect##31##3##(1990-5#1)(1990-6#1)(1991-3#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-10#10)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
no significant effects on the##2##5##(2008-11#2)
no significant effects on##4##4##(2008-10#1)(2008-11#2)(2008-5#1)
no significant effects##5##3##(2008-10#2)(2008-11#2)(2008-5#1)
no significant homology##2##3##(1995-9#1)(2008-8#1)
no significant impact##2##3##(1994-12#1)(2008-1#1)
no significant improvement##2##3##(2008-10#2)
no significant increase##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
no significant influence on the##2##5##(1990-2#1)(2008-5#1)
no significant influence on##3##4##(1990-2#1)(2008-10#1)(2008-5#1)
no significant influence##4##3##(1990-2#1)(2008-10#1)(2008-5#1)(2012-6#1)
no significant interference from##2##4##(1990-2#1)(2008-10#1)
no significant interference##4##3##(1990-2#2)(2008-10#2)
no significant loss of##2##4##(2008-10#1)(2008-11#1)
no significant relationship##3##3##(1992-2#1)(2008-10#2)
no significant sequence##2##3##(1994-12#1)(2008-10#1)
no significant similarity to##2##4##(1995-2#1)(2008-10#1)
no significant similarity##3##3##(1995-2#1)(1995-9#1)(2008-10#1)
no significant statistical difference##2##4##(2011-2#1)(2013-8#1)
no significant statistical##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
no significant variation##2##3##(2008-10#1)(2008-11#1)
no significant##302##2##(1990-11#1)(1990-2#5)(1990-5#1)(1990-6#2)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#3)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#4)(1997-9#1)(2006-6#1)(2007-8#1)(2008-1#3)(2008-10#86)(2008-11#16)(2008-12#11)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#17)(2011-3#3)(2012-12#2)(2012-2#5)(2012-3#6)(2012-6#1)(2013-1#14)(2013-7#1)(2013-8#8)
no significantly##2##2##(2008-10#1)(2008-11#1)
no signs of##13##3##(1991-2#1)(1993-1#1)(1993-6#1)(1994-6#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
no simple##3##2##(1994-8#1)(2008-8#1)(2008-9#1)
no single##14##2##(1992-3#1)(1993-2#1)(1996-2#1)(2008-10#3)(2008-11#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2012-3#1)
no special##2##2##(2008-9#1)(2011-2#1)
no specific treatment##4##3##(1994-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
no specific##15##2##(1993-8#1)(1994-11#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-7#1)(2011-2#3)(2013-1#3)
no standard treatment##2##3##(1990-2#1)(2009-3#1)
no standard##4##2##(1990-2#1)(2008-10#1)(2009-3#1)(2013-1#1)
no statistical correlation##2##3##(2008-7#1)(2013-1#1)
no statistical difference between groups##2##5##(2012-3#1)(2013-1#1)
no statistical difference between##5##4##(1996-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
no statistical difference##7##3##(1990-12#1)(1996-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
no statistical differences##3##3##(2008-10#2)(2008-12#1)
no statistical##15##2##(1990-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
no statistically significant difference in the##2##6##(2008-11#1)(2013-1#1)
no statistically significant difference in##3##5##(2008-11#1)(2008-12#1)(2013-1#1)
no statistically significant difference##6##4##(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#3)
no statistically significant differences between the two groups##2##8##(2013-1#2)
no statistically significant differences between##6##5##(1997-7#1)(2010-12#2)(2013-1#3)
no statistically significant differences##7##4##(1997-7#1)(2010-12#2)(2013-1#4)
no statistically significant##16##3##(1994-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#7)
no statistically##18##2##(1994-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#7)
no strong evidence##2##3##(2012-12#2)
no strong##3##2##(1994-6#1)(2012-12#2)
no studies have##2##3##(2008-8#1)(2013-8#1)
no studies on##2##3##(2008-10#1)(2011-1#1)
no studies##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-8#1)
no study has##2##3##(2008-10#2)
no substantial##2##2##(1996-2#1)(2013-8#1)
no such case has been reported##2##6##(2010-6#1)(2013-1#1)
no such##22##2##(1990-2#1)(1992-9#2)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#2)(2010-6#1)(2011-2#1)(2013-1#3)
no sugary##2##2##(2010-8#2)
no symptoms in##3##3##(2008-10#3)
no symptoms on##2##3##(2008-10#2)
no symptoms##9##2##(2008-10#7)(2008-7#1)(2008-9#1)
no synergistic##2##2##(2008-10#2)
no systematic##5##2##(2008-10#3)(2008-5#1)(2012-2#1)
no systemic##2##2##(2008-5#1)(2011-2#1)
no theoretical##2##2##(2008-3#2)
no threshold (LNT) model##2##4##(2008-7#1)(2013-1#1)
no tillage and ridge tillage treatments##2##6##(2008-10#2)
no tillage and ridge tillage##3##5##(2008-10#3)
no tillage##7##2##(2008-10#7)
no transmission##4##2##(2008-10#4)
no treatment or##2##3##(1995-12#1)(2008-10#1)
no treatment##6##2##(1995-12#1)(1997-2#1)(2008-10#4)
no treatment-related clinical findings##2##4##(2008-9#2)
no treatment-related##5##2##(1997-1#1)(2008-9#4)
no trend##2##2##(1990-12#1)(2010-8#1)
no true##2##2##(2008-11#1)(2013-1#1)
no tumor recurrence##2##3##(2011-2#2)
no tumor##3##2##(2011-2#2)(2012-3#1)
no universal##3##2##(1996-6#1)(2008-9#1)(2013-1#1)
no universally##2##2##(2008-1#1)(2008-11#1)
no use##4##2##(2008-10#1)(2009-5#3)
no variation in the##2##4##(1993-2#1)(2008-10#1)
no variation in##3##3##(1990-5#1)(1993-2#1)(2008-10#1)
no vascular##2##2##(1992-9#1)(1993-2#1)
no viable##2##2##(1995-2#1)(2008-9#1)
no virus##2##2##(2008-10#1)(2008-5#1)
no visible symptoms##2##3##(2008-10#2)
no visible##7##2##(1991-2#1)(2008-10#4)(2008-5#1)(2010-7#1)
no visual##2##2##(2008-10#1)(2008-11#1)
no way##2##2##(2010-4#1)(2010-7#1)
no##2449##1##(1990-11#16)(1990-12#7)(1990-2#19)(1990-3#4)(1990-5#19)(1990-6#13)(1990-8#3)(1990-9#5)(1991-1#4)(1991-10#1)(1991-11#5)(1991-12#7)(1991-2#17)(1991-3#12)(1991-4#1)(1991-5#5)(1991-6#6)(1991-7#1)(1991-8#7)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#12)(1992-2#9)(1992-3#11)(1992-4#3)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#8)(1993-1#18)(1993-11#7)(1993-12#14)(1993-2#14)(1993-3#7)(1993-6#16)(1993-8#17)(1994-1#5)(1994-11#11)(1994-12#21)(1994-2#16)(1994-3#15)(1994-5#7)(1994-6#8)(1994-8#16)(1994-9#2)(1995-1#3)(1995-11#13)(1995-12#10)(1995-2#29)(1995-3#8)(1995-5#9)(1995-6#9)(1995-8#13)(1995-9#4)(1996-1#10)(1996-10#1)(1996-11#4)(1996-12#20)(1996-2#23)(1996-3#13)(1996-5#5)(1996-6#7)(1996-9#3)(1997-1#9)(1997-2#13)(1997-3#15)(1997-4#5)(1997-5#6)(1997-6#5)(1997-7#15)(1997-8#14)(1997-9#1)(2006-6#6)(2007-11#4)(2007-12#12)(2007-8#1)(2008-1#11)(2008-10#633)(2008-11#149)(2008-12#56)(2008-2#6)(2008-3#25)(2008-4#7)(2008-5#46)(2008-6#10)(2008-7#76)(2008-8#69)(2008-9#91)(2009-1#2)(2009-10#9)(2009-11#3)(2009-12#4)(2009-3#8)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#5)(2009-8#13)(2009-9#1)(2010-1#11)(2010-10#7)(2010-11#12)(2010-12#19)(2010-2#1)(2010-3#8)(2010-4#11)(2010-5#7)(2010-6#16)(2010-7#8)(2010-8#9)(2010-9#3)(2011-1#17)(2011-10#1)(2011-2#107)(2011-3#7)(2011-4#1)(2012-12#25)(2012-2#35)(2012-3#53)(2012-4#1)(2012-5#2)(2012-6#1)(2012-8#1)(2013-1#106)(2013-7#1)(2013-8#45)
no-load##2##1##(2008-9#1)(2013-8#1)
no-till fields##4##2##(2008-10#4)
no-till##9##1##(2008-10#8)(2010-7#1)
no-tillage##2##1##(2008-10#2)
nobilis##3##1##(2008-5#1)(2013-8#2)
noble metal permanent##2##3##(2008-10#2)
noble metal##5##2##(2008-10#5)
noble metals was##2##3##(2008-10#2)
noble metals##8##2##(2008-10#8)
noble##20##1##(2008-10#15)(2008-11#2)(2010-6#1)(2013-8#2)
nocardioform##2##1##(2008-11#1)(2008-5#1)
nocardioforms##2##1##(2008-11#1)(2008-5#1)
nocardiosis##2##1##(2009-9#2)
nocere##2##1##(1994-6#1)(2008-11#1)
nociception##3##1##(1996-2#1)(1997-2#2)
nociceptive##12##1##(1996-2#1)(1997-2#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#3)(2010-9#1)
nocodazole##2##1##(1994-11#1)(1996-3#1)
nocturnal foragers##2##2##(2007-12#2)
nocturnal hemoglobinuria##3##2##(1992-12#2)(2008-9#1)
nocturnal##17##1##(1992-12#2)(1994-8#2)(1997-8#2)(2007-12#2)(2008-10#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-8#1)(2013-7#2)
nodD3 P1##2##2##(2008-8#1)(2008-9#1)
nodD3 gene##2##2##(2008-8#1)(2008-9#1)
nodD3##6##1##(2008-8#3)(2008-9#3)
nodal and##3##2##(2008-5#1)(2012-2#1)(2012-3#1)
nodal irradiation##2##2##(1993-9#1)(2008-10#1)
nodal or##2##2##(1997-7#1)(2008-2#1)
nodal segments##3##2##(2013-1#3)
nodal status of the first##2##5##(1990-8#2)
nodal status##3##2##(1990-8#2)(1997-8#1)
nodal##27##1##(1990-12#3)(1990-8#2)(1993-9#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2010-4#2)(2012-2#1)(2012-3#2)(2013-1#5)
node and##2##2##(1995-1#1)(2008-10#1)
node biopsies##3##2##(2008-5#1)(2010-11#1)(2012-12#1)
node biopsy##6##2##(1991-3#1)(2008-1#1)(2008-5#1)(2010-7#1)(2011-2#2)
node cells##3##2##(1993-2#1)(2008-11#2)
node dissection##4##2##(1994-2#3)(2013-1#1)
node estimates##2##2##(2008-8#2)
node involvement##5##2##(1990-2#1)(1990-6#1)(1994-12#1)(2011-2#2)
node localization of gastrinoma##2##4##(1991-6#2)
node metastases##12##2##(1990-6#1)(1992-5#1)(1994-12#1)(1997-3#2)(2008-9#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
node metastasis##16##2##(1990-12#1)(1990-2#1)(1991-12#1)(1994-12#1)(2008-12#1)(2009-12#1)(2010-6#2)(2011-2#4)(2013-1#4)
node of##2##2##(2008-5#1)(2008-7#1)
node values##4##2##(2008-8#4)
node##106##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#4)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#3)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#3)(1994-2#3)(1995-1#2)(1996-9#1)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-5#6)(2008-7#2)(2008-8#8)(2008-9#4)(2009-12#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#10)(2012-12#5)(2012-3#3)(2013-1#5)(2013-8#2)
node-negative patients##4##2##(1993-1#3)(1997-7#1)
nodes and##8##2##(1990-12#1)(1990-8#1)(1992-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-12#2)
nodes are##2##2##(1997-8#1)(2010-7#1)
nodes of the##2##3##(2008-10#2)
nodes of##4##2##(2008-10#3)(2012-3#1)
nodes the survival rate was##2##5##(2011-2#2)
nodes was##6##2##(1994-12#2)(2008-10#4)
nodes were##7##2##(1993-2#1)(1994-12#1)(2008-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
nodes##82##1##(1990-12#4)(1990-3#1)(1990-8#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#2)(1994-12#5)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#3)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-1#1)(2009-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#6)(2012-2#2)(2012-3#5)(2013-8#3)
nodes)##3##1##(1997-8#1)(2008-10#2)
nodorum across##2##2##(2008-10#2)
nodorum and##2##2##(2008-10#2)
nodorum blotch in##2##3##(2008-10#2)
nodorum blotch##4##2##(2008-10#4)
nodorum in##3##2##(2008-10#3)
nodorum isolates##2##2##(2008-10#2)
nodorum was##3##2##(2008-10#3)
nodorum were##3##2##(2008-10#3)
nodorum##42##1##(2008-10#42)
nodosa is a##2##3##(1990-9#1)(1997-8#1)
nodosa##4##1##(1990-9#1)(1997-8#3)
nodose ganglion##2##2##(1996-12#2)
nodosum##7##1##(1993-8#2)(1997-8#1)(2008-8#1)(2009-1#1)(2012-12#1)(2013-1#1)
nodosus##4##1##(1993-12#3)(2011-2#1)
nodular lesion##2##2##(2010-3#1)(2013-1#1)
nodular##21##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-3#2)(2013-1#1)(2013-8#2)
nodulation##4##1##(2008-11#2)(2008-8#1)(2008-9#1)
nodule formation##5##2##(2008-11#4)(2011-2#1)
nodule in the left##2##4##(2008-12#1)(2012-12#1)
nodule in##4##2##(2008-12#2)(2012-12#1)(2012-3#1)
nodule with##2##2##(1992-2#1)(2007-8#1)
nodule##31##1##(1990-2#1)(1992-2#1)(1992-9#1)(1994-5#1)(1997-2#1)(2007-8#1)(2008-11#4)(2008-12#4)(2008-5#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#7)
nodules and##4##2##(2008-5#2)(2010-7#1)(2011-1#1)
nodules in##7##2##(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
nodules of##2##2##(1991-11#1)(2008-5#1)
nodules showed a##2##3##(2008-5#2)
nodules was##2##2##(2008-11#1)(2012-3#1)
nodules were##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
nodules with##2##2##(1997-2#1)(2008-5#1)
nodules##61##1##(1990-2#2)(1991-11#2)(1997-2#2)(2008-10#2)(2008-11#9)(2008-5#13)(2008-8#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#2)(2012-12#2)(2012-3#10)(2013-1#3)(2013-8#2)
nogo##4##1##(2013-8#4)
noise added in the##2##4##(2007-11#2)
noise added in##3##3##(2007-11#3)
noise and low##2##3##(2008-3#1)(2009-12#1)
noise and##14##2##(1993-2#1)(2008-10#2)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-8#1)(2013-8#1)
noise background##2##2##(2008-10#2)
noise cancellation##2##2##(2008-3#2)
noise caused##2##2##(2008-10#1)(2008-3#1)
noise components##2##2##(2008-3#1)(2008-8#1)
noise due to##2##3##(2008-10#1)(2008-8#1)
noise exposure##2##2##(2010-8#1)(2013-8#1)
noise in##11##2##(1992-8#1)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)(2010-10#1)(2012-3#1)
noise is##9##2##(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2010-10#2)(2011-2#1)
noise level of##3##3##(2008-10#2)(2009-5#1)
noise level##13##2##(1996-12#1)(2008-10#7)(2008-3#2)(2009-5#1)(2009-8#1)(2011-2#1)
noise levels##3##2##(2008-10#1)(2008-3#2)
noise of##4##2##(2008-10#4)
noise on##4##2##(2008-3#2)(2008-9#1)(2011-2#1)
noise patterns##2##2##(2008-3#2)
noise ratio (SNR)##2##3##(2008-10#1)(2008-9#1)
noise ratio##8##2##(2008-10#7)(2008-9#1)
noise reduction##2##2##(2008-10#2)
noise suppression##2##2##(2008-9#2)
noise that##2##2##(2008-3#1)(2009-8#1)
noise was##2##2##(2008-10#1)(2011-2#1)
noise with##2##2##(2008-3#1)(2008-9#1)
noise##186##1##(1990-12#1)(1991-2#1)(1992-8#1)(1993-2#1)(1996-12#1)(2007-11#7)(2008-10#41)(2008-11#7)(2008-2#2)(2008-3#51)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#11)(2008-9#22)(2009-12#1)(2009-5#1)(2009-8#6)(2010-10#4)(2010-8#4)(2011-1#1)(2011-2#10)(2012-2#2)(2012-3#1)(2013-8#3)
noise)##2##1##(2008-10#1)(2008-3#1)
noise-equivalent##4##1##(2008-2#1)(2008-3#2)(2009-5#1)
noises in##2##2##(2008-10#2)
noises##5##1##(1990-11#1)(2008-10#3)(2008-2#1)
noisy environment##2##2##(2008-10#1)(2008-11#1)
noisy##11##1##(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#2)(2010-8#1)
noma##2##1##(2013-1#2)
nomadic##7##1##(2008-9#1)(2011-2#6)
nomads and##2##2##(2011-2#2)
nomenclature and##2##2##(2008-11#1)(2008-4#1)
nomenclature is##2##2##(2008-4#2)
nomenclature##19##1##(1990-5#1)(2008-10#5)(2008-11#1)(2008-4#11)(2008-5#1)
nominal resolution##3##2##(2008-10#3)
nominal##28##1##(1991-2#1)(1993-3#1)(1995-3#1)(1995-9#1)(1996-3#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-3#1)(2009-12#2)(2009-4#3)(2009-7#1)(2011-2#1)
nominated##7##1##(2008-9#4)(2009-7#2)(2012-12#1)
nominations##4##1##(1996-1#2)(2009-7#1)(2013-1#1)
nomogram##2##1##(1994-6#1)(2008-10#1)
nomograms##2##1##(2008-10#1)(2010-12#1)
non alcoholic steatohepatitis##2##3##(2007-8#2)
non aqueous solvents##3##3##(2008-10#3)
non complementary target##2##3##(2008-10#2)
non faradaic electrochemical impedance spectroscopy##2##5##(2008-10#2)
non fat milk and##2##4##(2008-10#2)
non fat milk##3##3##(2008-10#3)
non gland-bearing##2##2##(2007-12#2)
non infected##3##2##(1996-12#1)(2008-11#2)
non obese diabetic (NOD) mice##2##5##(2008-10#1)(2010-11#1)
non polluted river waters##2##4##(2008-10#2)
non reactional patients##3##3##(2011-2#3)
non reactional##4##2##(2011-2#4)
non reversible##2##2##(1996-11#1)(2008-10#1)
non selective##2##2##(2008-10#2)
non small cell lung cancer (NSCLC)##2##6##(1993-2#1)(2008-10#1)
non small cell lung cancer##3##5##(1993-2#1)(2008-10#2)
non smoker##2##2##(1996-1#1)(2012-3#1)
non specific##8##2##(1991-11#1)(1992-9#1)(1995-1#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-3#2)
non variceal##3##2##(2011-2#3)
non##96##1##(1990-12#2)(1990-2#1)(1990-9#1)(1991-11#2)(1991-3#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-4#1)(2007-12#2)(2007-8#3)(2008-10#31)(2008-11#11)(2008-12#1)(2008-3#3)(2008-7#3)(2009-1#1)(2009-8#1)(2010-11#2)(2010-12#1)(2011-2#9)(2012-2#2)(2012-3#4)(2013-1#1)
non- or##2##2##(2009-8#1)(2012-3#1)
non-##10##1##(2008-11#4)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
non-A##2##1##(1992-12#1)(1993-8#1)
non-B##2##1##(1992-12#1)(2008-10#1)
non-Bayesian analysis##3##2##(2008-10#3)
non-Bayesian and Bayesian methods##2##4##(2008-10#2)
non-Bayesian and Bayesian##3##3##(2008-10#3)
non-Bayesian##6##1##(2008-10#6)
non-CFC propellants##3##2##(1992-3#2)(1996-1#1)
non-CFC##6##1##(1992-3#2)(1996-1#4)
non-Chinese##2##1##(2008-5#2)
non-CpG ODN##2##2##(2008-10#2)
non-CpG##3##1##(2008-10#3)
non-English##4##1##(2008-11#1)(2008-12#2)(2012-12#1)
non-European##3##1##(1991-11#2)(2008-10#1)
non-Hispanic Whites##4##2##(2010-10#3)(2012-12#1)
non-Hispanic##8##1##(2010-10#3)(2010-12#2)(2011-2#1)(2012-12#2)
non-Hodgkin lymphoma and##2##3##(1994-3#1)(2009-8#1)
non-Hodgkin lymphoma##7##2##(1990-9#1)(1991-6#1)(1994-3#1)(2009-8#2)(2013-1#2)
non-Hodgkin lymphomas of the##2##4##(1990-8#2)
non-Hodgkin##9##1##(1990-8#2)(1990-9#1)(1991-6#1)(1994-3#1)(2009-8#2)(2013-1#2)
non-Hodgkin's lymphoma in##2##3##(1993-6#1)(1994-2#1)
non-Hodgkin's lymphoma is##2##3##(1991-6#1)(2013-8#1)
non-Hodgkin's lymphoma##11##2##(1991-6#1)(1992-12#2)(1993-6#2)(1994-2#1)(2008-10#1)(2008-12#1)(2013-1#2)(2013-8#1)
non-Hodgkin's lymphomas##4##2##(1990-12#2)(2009-8#2)
non-Hodgkin's##16##1##(1990-12#2)(1991-6#1)(1992-12#2)(1993-6#2)(1994-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-8#2)(2013-1#2)(2013-8#1)
non-Lambertian##2##1##(2008-3#2)
non-Medicare patients##2##2##(1991-12#1)(1994-12#1)
non-Medicare payers##3##2##(1994-12#3)
non-Medicare##10##1##(1991-12#2)(1992-2#1)(1993-3#1)(1994-12#4)(1995-12#1)(1997-3#1)
non-Māori##4##1##(2012-12#4)
non-N-methyl-D-aspartate##2##1##(1995-2#2)
non-NHS##3##1##(2013-8#3)
non-NMDA receptors##5##2##(1994-2#2)(1997-2#1)(2008-7#2)
non-NMDA##7##1##(1994-2#2)(1997-2#2)(2008-11#1)(2008-7#2)
non-Nernstian##2##1##(2008-10#2)
non-PD##2##1##(2008-7#2)
non-REM sleep##2##2##(1994-8#1)(2012-3#1)
non-REM##3##1##(1994-8#1)(2012-3#2)
non-ST elevation##2##2##(2008-3#1)(2012-3#1)
non-ST##4##1##(2008-3#2)(2011-2#1)(2012-3#1)
non-activated##2##1##(1993-8#1)(1995-12#1)
non-acute settings##2##2##(2010-5#1)(2013-8#1)
non-acute##4##1##(2010-5#1)(2011-3#1)(2013-8#2)
non-additive effects##3##2##(2008-10#3)
non-additive##6##1##(2008-10#6)
non-additivity##3##1##(1995-11#3)
non-adhesive material##2##2##(2008-7#2)
non-adhesive##3##1##(2008-11#1)(2008-7#2)
non-adipogenic##2##1##(2008-11#2)
non-adoption##2##1##(2010-8#1)(2012-3#1)
non-aggressive##2##1##(1993-12#1)(2009-8#1)
non-albicans##2##1##(2011-2#1)(2013-1#1)
non-alcoholic fatty liver disease##2##4##(2010-10#1)(2011-2#1)
non-alcoholic##10##1##(2007-8#1)(2008-10#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#2)
non-amphiphilic##2##1##(1990-5#2)
non-analytes##2##1##(2008-10#2)
non-animal##4##1##(2008-10#3)(2008-11#1)
non-apex##3##1##(2009-2#3)
non-aqueous media##5##2##(2008-10#5)
non-aqueous medium up to##2##4##(2008-10#2)
non-aqueous medium##6##2##(2008-10#6)
non-aqueous solvents##2##2##(2008-10#2)
non-aqueous##20##1##(2008-10#20)
non-athlete)##2##1##(2009-7#2)
non-athletes##3##1##(2009-7#3)
non-attendance to mammographic##2##3##(1992-2#2)
non-attendance##6##1##(1991-6#3)(1992-2#3)
non-attenders##5##1##(1991-6#2)(1992-2#3)
non-bacterial##3##1##(1992-5#2)(2006-6#1)
non-beating##2##1##(1996-2#2)
non-bilayer##2##1##(2008-8#2)
non-biodegradable##3##1##(1997-1#1)(2008-10#1)(2010-6#1)
non-biological##6##1##(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)
non-black women##2##2##(2013-1#2)
non-blood contacting pneumatic ventricle assistance device##2##6##(2012-3#2)
non-blood contacting pneumatic ventricle assistance##3##5##(2012-3#3)
non-cancer##2##1##(1994-12#1)(2013-1#1)
non-cancerous##3##1##(1993-8#2)(2011-2#1)
non-cardiac##4##1##(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
non-cavitated caries##4##2##(2012-2#4)
non-cavitated##6##1##(2012-2#6)
non-certified##2##1##(2008-10#2)
non-charged##4##1##(2008-10#4)
non-chemotactic##3##1##(1995-8#3)
non-chromatographic##2##1##(2008-10#2)
non-classical##3##1##(2012-2#3)
non-clinical sample##2##2##(2008-1#2)
non-clinical##6##1##(1993-3#1)(2008-1#4)(2009-6#1)
non-coated##2##1##(2008-11#2)
non-coded amino##2##2##(2013-1#2)
non-coders were##2##2##(2007-12#2)
non-coders##5##1##(2007-12#5)
non-coding region##6##2##(1991-9#1)(1993-12#1)(1995-6#1)(2008-8#2)(2010-7#1)
non-coding sequence of the##2##4##(1993-12#1)(1997-7#1)
non-coding sequence##3##2##(1993-12#1)(1997-7#1)(2008-8#1)
non-coding##21##1##(1990-7#1)(1991-9#1)(1993-12#2)(1995-6#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-12#2)(2008-7#1)(2008-8#3)(2010-7#2)(2011-2#3)(2012-5#1)
non-competitive##11##1##(1990-5#3)(1991-5#1)(1992-3#3)(1992-6#1)(2008-10#3)
non-complementing cell##2##2##(2008-11#2)
non-compliance with##3##2##(1997-1#1)(2011-2#1)(2012-2#1)
non-compliance##9##1##(1996-3#3)(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#2)
non-conscious##3##1##(2008-11#1)(2009-8#1)(2010-6#1)
non-constant##2##1##(2008-10#2)
non-contact mode##2##2##(2008-10#2)
non-contact##7##1##(1990-6#1)(2008-10#2)(2009-7#2)(2010-12#1)(2013-1#1)
non-conventional##4##1##(1994-8#1)(2008-10#2)(2008-4#1)
non-covalent binding##2##2##(1996-8#1)(2013-1#1)
non-covalent bond complex of rhFKBP12##2##5##(2008-9#2)
non-covalent bond complex of##3##4##(2008-9#3)
non-covalent##9##1##(1996-8#1)(2008-10#4)(2008-9#3)(2013-1#1)
non-covalently##2##1##(1996-8#1)(2008-9#1)
non-crystallographic##2##1##(2008-8#1)(2008-9#1)
non-cytotoxic##3##1##(1990-5#1)(2008-11#1)(2008-5#1)
non-cytotoxic&quot##2##1##(1991-8#2)
non-dairy##2##1##(2009-11#2)
non-defective##3##1##(2008-5#3)
non-demented patients##3##2##(2008-7#3)
non-demented##12##1##(1996-12#1)(2008-7#11)
non-denaturing polyacrylamide gel##2##3##(1991-12#1)(1992-8#1)
non-denaturing##4##1##(1991-12#1)(1991-7#1)(1992-8#1)(2010-11#1)
non-depressed PD patients##2##3##(2008-7#2)
non-depressed##4##1##(2007-12#1)(2008-7#3)
non-desmoplastic##3##1##(1991-2#3)
non-destructive and##3##2##(2008-10#2)(2008-9#1)
non-destructive##11##1##(2008-10#8)(2008-11#1)(2008-9#1)(2012-2#1)
non-detachable balloon catheter##3##3##(1997-3#3)
non-detachable balloon##4##2##(1997-3#4)
non-detectable##3##1##(2008-10#1)(2008-8#1)(2012-2#1)
non-deterministic Cannon's##2##2##(2009-12#2)
non-diabetic ddY mice##2##3##(2010-11#2)
non-diabetic subjects##3##2##(1994-12#1)(2008-1#1)(2008-7#1)
non-diabetic##9##1##(1994-12#2)(2008-1#1)(2008-12#1)(2008-7#1)(2010-11#2)(2011-2#1)(2012-5#1)
non-displaced hip fracture##3##3##(2008-12#3)
non-displaced southern##3##2##(2013-1#3)
non-displaced##11##1##(1993-11#1)(2008-12#3)(2013-1#7)
non-dog##3##1##(2013-1#3)
non-drug-using##2##1##(1992-9#2)
non-elasticity index##2##2##(2008-5#2)
non-elasticity##5##1##(2008-5#5)
non-electrolytic preconcentration via##2##3##(2008-10#2)
non-empirical##2##1##(1992-12#2)
non-enzymatic##4##1##(2008-10#1)(2008-12#1)(2008-5#2)
non-equilibrium conditions##2##2##(1995-11#1)(2008-5#1)
non-equilibrium##6##1##(1995-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2010-8#1)
non-equivalence##2##1##(2009-11#2)
non-equivalent##2##1##(2008-11#1)(2008-8#1)
non-esterified fatty acids in plasma##2##5##(1991-12#2)
non-esterified fatty##3##2##(1991-12#2)(1994-12#1)
non-existent##4##1##(1994-3#1)(2008-10#1)(2008-12#1)(2013-8#1)
non-exposed##2##1##(2008-10#1)(2013-1#1)
non-extractable##4##1##(2008-10#1)(2008-11#3)
non-extraction##2##1##(2008-10#1)(2013-1#1)
non-fluorescent##12##1##(1993-11#1)(2008-10#11)
non-food packaging materials##2##3##(2008-10#2)
non-food##4##1##(1993-6#2)(2008-10#2)
non-fucosylated##3##1##(2008-11#3)
non-functional iron##3##2##(1992-8#3)
non-functional##4##1##(1992-8#4)
non-functioning paraganglioma of##2##3##(2012-2#2)
non-functioning##6##1##(2008-7#2)(2012-2#3)(2013-1#1)
non-genomic##2##1##(2008-4#1)(2008-7#1)
non-glycosylated##2##1##(1995-8#2)
non-growing##3##1##(1991-11#2)(2008-11#1)
non-heme iron##2##2##(1992-8#1)(2012-12#1)
non-heme##5##1##(1991-12#2)(1992-8#1)(2012-12#2)
non-histone proteins##3##2##(1990-3#1)(1990-5#1)(2008-8#1)
non-histone##5##1##(1990-3#1)(1990-5#1)(1991-5#1)(1993-2#1)(2008-8#1)
non-homogeneous##4##1##(2008-10#2)(2008-7#1)(2013-8#1)
non-homologous##6##1##(1997-7#2)(2008-10#2)(2008-9#1)(2010-8#1)
non-hormonal regulation of glutamine synthetase##2##5##(1996-12#2)
non-host plants##2##2##(2008-10#1)(2009-6#1)
non-host##6##1##(2007-12#2)(2008-10#2)(2009-6#1)(2012-2#1)
non-human primates##2##2##(1997-8#1)(2008-10#1)
non-human subjects##3##2##(2010-10#1)(2012-12#2)
non-human##8##1##(1997-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-3#1)(2012-12#2)(2013-8#1)
non-hydrolyzable##2##1##(1993-6#1)(1995-8#1)
non-hydrolyzed##2##1##(2008-11#1)(2008-5#1)
non-ideal conditions##2##2##(2008-10#2)
non-ideal##3##1##(2008-10#2)(2008-5#1)
non-ideality##2##1##(1991-11#1)(2008-4#1)
non-immunized##3##1##(2008-9#3)
non-immunosuppressed##2##1##(2008-5#2)
non-imprinted##2##1##(2008-10#2)
non-induced##2##1##(1994-8#1)(2008-10#1)
non-infectious##4##1##(1992-2#1)(1997-5#1)(2008-9#1)(2013-1#1)
non-inflammatory##2##1##(2012-2#1)(2013-1#1)
non-informative and##2##2##(1994-9#1)(2008-7#1)
non-inoculated##2##1##(2008-10#1)(2011-10#1)
non-institutionalized##2##1##(1994-2#1)(1996-3#1)
non-insulin dependent diabetes mellitus (NIDDM)##3##5##(2008-11#1)(2008-7#2)
non-insulin dependent diabetes mellitus##5##4##(1994-12#2)(2008-11#1)(2008-7#2)
non-insulin dependent##6##2##(1994-12#2)(1996-11#1)(2008-11#1)(2008-7#2)
non-insulin-dependent diabetes mellitus##8##3##(1992-9#2)(1994-11#1)(1994-12#1)(1995-8#2)(2008-10#1)(2011-1#1)
non-insulin-dependent diabetes##9##2##(1992-9#2)(1994-11#1)(1994-12#2)(1995-8#2)(2008-10#1)(2011-1#1)
non-insulin-dependent##10##1##(1992-9#2)(1994-11#1)(1994-12#2)(1995-8#2)(2008-10#1)(2008-4#1)(2011-1#1)
non-intrusive##2##1##(2008-10#2)
non-invasive and##2##2##(1991-2#1)(1997-4#1)
non-invasive diagnostic method##2##3##(1997-2#1)(2010-10#1)
non-invasive diagnostic##3##2##(1993-3#1)(1997-2#1)(2010-10#1)
non-invasive evaluation in##2##3##(2008-5#2)
non-invasive evaluation##4##2##(1993-6#1)(2008-5#2)(2008-7#1)
non-invasive imaging techniques##2##3##(2008-7#1)(2013-1#1)
non-invasive imaging##3##2##(1990-3#1)(2008-7#1)(2013-1#1)
non-invasive method##3##2##(2008-2#1)(2008-5#1)(2009-1#1)
non-invasive monitoring of##2##3##(1993-3#1)(2008-7#1)
non-invasive nature##2##2##(1990-11#1)(2010-10#1)
non-invasive predictor for##2##3##(2009-8#2)
non-invasive way##2##2##(2008-4#1)(2013-8#1)
non-invasive##52##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#6)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
non-invasively##6##1##(1995-2#1)(1996-2#1)(2008-5#1)(2009-12#1)(2010-12#1)(2013-1#1)
non-involved adolescents##3##2##(2009-7#3)
non-involved##5##1##(2009-7#5)
non-ionic surfactant Triton##2##3##(2008-10#2)
non-ionic surfactant##13##2##(2008-10#13)
non-ionic surfactants##9##2##(2008-10#8)(2008-5#1)
non-ionic##35##1##(1997-7#1)(2008-10#32)(2008-5#2)
non-irradiated##4##1##(2008-5#1)(2009-7#2)(2012-2#1)
non-ischaemic cardiomyopathy##2##2##(2008-10#2)
non-ischaemic##6##1##(2008-10#6)
non-islet cells##3##2##(1995-8#3)
non-labeled##2##1##(1990-12#1)(2008-10#1)
non-lamellar##2##1##(1990-2#1)(2008-5#1)
non-lethal##3##1##(2008-9#1)(2010-8#1)(2011-2#1)
non-linear and##3##2##(1995-8#1)(2007-8#1)(2010-8#1)
non-linear calibration##2##2##(2008-10#2)
non-linear classifier##2##2##(2008-10#2)
non-linear equations##2##2##(2008-10#2)
non-linear least squares regression##3##4##(2008-10#3)
non-linear least-squares##2##2##(2008-10#2)
non-linear method##5##2##(2008-10#4)(2010-8#1)
non-linear regression analysis##4##3##(2008-10#3)(2012-2#1)
non-linear regression##9##2##(2008-10#8)(2012-2#1)
non-linear spectral subtraction##2##3##(2008-9#2)
non-linear##58##1##(1995-8#1)(1997-2#2)(2007-8#1)(2008-10#37)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-8#3)(2012-2#1)(2012-8#1)(2013-8#2)
non-malignant pain##2##2##(2012-3#2)
non-malignant##8##1##(1990-2#2)(1993-2#2)(2010-11#2)(2012-3#2)
non-mammalian##3##1##(1995-11#1)(2008-10#1)(2013-8#1)
non-matching##2##1##(1993-3#2)
non-medical##7##1##(1994-12#4)(2008-11#1)(2008-12#1)(2012-12#1)
non-metric multidimensional scaling (NMDS)##2##4##(1995-5#2)
non-metropolitan##5##1##(1994-1#2)(1996-3#3)
non-modified##2##1##(2008-10#2)
non-motile##2##1##(2011-2#2)
non-muscle##2##1##(1993-12#1)(2008-11#1)
non-negative##3##1##(2008-10#2)(2013-1#1)
non-negativity##2##1##(2008-10#2)
non-neoplastic##5##1##(1992-2#1)(2008-10#1)(2011-3#1)(2012-2#1)(2013-8#1)
non-neural##5##1##(1994-2#2)(2008-9#1)(2010-8#2)
non-neurological brain tissues##2##3##(1997-2#2)
non-neurological##4##1##(1997-2#3)(2008-7#1)
non-neuronal##3##1##(1994-11#1)(1995-8#1)(2009-10#1)
non-normal##2##1##(1991-12#1)(2013-1#1)
non-nucleoside reverse transcriptase inhibitor##2##4##(2011-2#2)
non-nucleoside reverse transcriptase inhibitors##4##4##(2011-2#2)(2011-3#2)
non-nucleoside reverse transcriptase##7##3##(2007-12#1)(2011-2#4)(2011-3#2)
non-nucleoside##8##1##(2007-12#1)(2008-10#1)(2011-2#4)(2011-3#2)
non-nutritional##2##1##(2008-11#1)(2008-7#1)
non-obese subjects##2##2##(2012-2#1)(2013-7#1)
non-obese##7##1##(2011-2#2)(2012-2#4)(2013-7#1)
non-operative treatment##3##2##(2007-8#1)(2010-11#1)(2012-3#1)
non-optimised##2##1##(2008-10#2)
non-overlapping##5##1##(1994-11#1)(1995-9#1)(2008-11#2)(2013-1#1)
non-oxidative##4##1##(1992-6#1)(2008-10#3)
non-oxidized##2##1##(2008-10#1)(2013-1#1)
non-parametric method##2##2##(1995-12#2)
non-parametric statistic##2##2##(2008-10#2)
non-parametric##10##1##(1995-12#2)(2008-10#3)(2010-6#1)(2012-12#1)(2013-1#3)
non-parasitic##3##1##(2007-12#1)(2010-8#2)
non-pathogenic##4##1##(2008-9#1)(2011-2#3)
non-peptide##2##1##(2008-11#1)(2008-8#1)
non-permissive##4##1##(1993-8#1)(1995-6#1)(2008-5#1)(2013-1#1)
non-phagocytic cell infections##2##3##(2012-2#2)
non-phagocytic##4##1##(2012-2#4)
non-pharmacological treatment##3##2##(1993-2#1)(2008-7#1)(2012-3#1)
non-pharmacological##9##1##(1993-2#1)(2008-5#1)(2008-7#3)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
non-phase-matched second-harmonic generation##2##3##(2008-2#2)
non-photosynthetic##2##1##(2011-2#2)
non-physician##2##1##(1991-1#1)(1994-12#1)
non-polar and##2##2##(2008-10#1)(2008-11#1)
non-polar##22##1##(1994-3#1)(2008-10#17)(2008-11#1)(2008-5#2)(2009-7#1)
non-porous poly(glycidylmethacrylate-co-ethylenedimethacrylate)##2##2##(2008-10#2)
non-porous##4##1##(2008-10#4)
non-potato##2##1##(2008-10#2)
non-pregnant women##4##2##(1994-8#1)(2010-6#2)(2013-1#1)
non-pregnant##10##1##(1990-11#2)(1994-3#1)(1994-8#3)(2010-6#2)(2011-2#1)(2013-1#1)
non-probabilistic##3##1##(2009-11#2)(2012-12#1)
non-producing cells##3##2##(2008-11#3)
non-producing##4##1##(2008-11#4)
non-profit##4##1##(1991-3#1)(1996-3#1)(2008-11#1)(2012-2#1)
non-protein##6##1##(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)
non-proteolytic C##4##2##(2011-2#4)
non-proteolytic##6##1##(2011-2#6)
non-radiative energy##2##2##(2008-10#1)(2008-9#1)
non-random missing data##2##3##(1995-12#1)(2012-2#1)
non-random##6##1##(1995-12#1)(2008-11#1)(2009-10#1)(2012-2#2)(2012-5#1)
non-randomized##3##1##(2008-9#1)(2012-2#1)(2013-1#1)
non-randomly missing data on##2##4##(1995-12#2)
non-randomly##3##1##(1995-12#2)(2012-2#1)
non-randomness##3##1##(1995-12#3)
non-reactive##2##1##(2008-10#1)(2009-6#1)
non-receptor##3##1##(1992-6#1)(1995-8#1)(2008-9#1)
non-reducing conditions##3##2##(1995-12#2)(1995-8#1)
non-reducing##4##1##(1992-12#1)(1995-12#2)(1995-8#1)
non-redundant##3##1##(1997-8#1)(2011-2#2)
non-refluxing##3##1##(2008-10#3)
non-resonant##2##1##(2012-2#2)
non-responders##5##1##(1991-2#1)(1991-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
non-reward##2##1##(1993-6#2)
non-ribosomal##3##1##(2008-8#2)(2011-1#1)
non-selectable##2##1##(1993-9#2)
non-selected##2##1##(1991-11#1)(1993-3#1)
non-selective COX-2 inhibitor##2##3##(2008-12#2)
non-selective NSAID##2##2##(2011-2#2)
non-selective NSAIDs##4##2##(2011-2#4)
non-selective medium##2##2##(2008-7#2)
non-selective##20##1##(1993-9#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-12#3)(2008-7#3)(2008-8#1)(2009-7#1)(2011-2#6)
non-self##4##1##(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)
non-self-specific stimuli##2##2##(2013-8#2)
non-self-specific##4##1##(2013-8#4)
non-septic patients after major surgery##2##5##(2009-6#2)
non-septic patients##3##2##(1997-8#1)(2009-6#2)
non-significant##7##1##(1993-2#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-2#1)
non-small cell lung cancer (NSCLC)##2##5##(2008-11#1)(2013-8#1)
non-small cell lung cancer##12##4##(1993-9#1)(1994-12#2)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#2)(2013-8#2)
non-small cell lung##15##3##(1993-9#1)(1994-12#2)(1994-8#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#3)(2013-8#2)
non-small cell##16##2##(1993-9#1)(1994-12#2)(1994-8#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2013-1#3)(2013-8#2)
non-small lung cancer##2##3##(2008-5#1)(2009-4#1)
non-small lung##3##2##(2008-5#1)(2009-4#1)(2013-1#1)
non-small##19##1##(1993-9#1)(1994-12#2)(1994-8#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-4#1)(2013-1#4)(2013-8#2)
non-small-cell lung cancer##5##3##(1992-12#2)(1994-12#1)(1994-6#1)(2010-5#1)
non-smokers and##4##2##(2008-10#1)(2013-1#3)
non-smokers at##2##2##(1993-2#2)
non-smokers##20##1##(1991-1#1)(1991-11#1)(1992-9#1)(1993-2#2)(1996-3#3)(2008-10#6)(2008-12#1)(2011-2#2)(2013-1#3)
non-smoking female physicians##2##3##(2011-2#2)
non-smoking##5##1##(1991-11#2)(1991-8#1)(2011-2#2)
non-spatial##5##1##(1993-3#4)(1995-5#1)
non-specific adsorption of protein and##2##5##(2008-10#2)
non-specific adsorption of##3##3##(1990-2#1)(2008-10#2)
non-specific adsorption##5##2##(1990-2#2)(2008-10#3)
non-specific binding##3##2##(1997-2#1)(2008-10#2)
non-specific inflammatory##2##2##(1997-8#1)(2008-10#1)
non-specific protein adsorption from serum##2##5##(2008-10#2)
non-specific protein adsorption##3##3##(2008-10#3)
non-specific##44##1##(1990-11#2)(1990-2#2)(1990-5#2)(1992-12#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#2)(2008-10#22)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
non-specifically##2##1##(2008-10#1)(2008-11#1)
non-specificity##2##1##(1997-2#1)(2008-7#1)
non-spore forming##3##2##(2008-1#1)(2011-2#2)
non-sporulating##4##1##(2008-10#1)(2011-2#3)
non-standard##3##1##(2008-10#1)(2008-11#2)
non-stationary##2##1##(2008-11#1)(2010-8#1)
non-sterile##2##1##(2012-2#2)
non-steroidal anti-inflammatory drug##2##3##(2008-10#1)(2008-5#1)
non-steroidal anti-inflammatory drugs##8##3##(1993-11#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-12#1)(2013-8#1)
non-steroidal anti-inflammatory##12##2##(1991-8#1)(1993-11#1)(1997-1#2)(1997-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2013-8#1)
non-steroidal##15##1##(1991-8#1)(1993-11#1)(1995-12#1)(1997-1#2)(1997-6#1)(2008-10#6)(2008-12#1)(2008-5#1)(2013-8#1)
non-stoichiometric##2##1##(2008-10#2)
non-stomatal##2##1##(2012-5#1)(2012-7#1)
non-stop##2##1##(2008-10#2)
non-structural protein##2##2##(2008-10#2)
non-structural##5##1##(2008-10#2)(2008-8#2)(2012-5#1)
non-stunted##2##1##(2010-6#2)
non-sulfur diiron site##2##3##(1991-12#2)
non-suppressed##3##1##(2008-10#3)
non-surgical therapy##3##2##(1991-3#1)(2008-10#2)
non-surgical treatment##3##2##(1991-8#1)(2007-8#1)(2008-10#1)
non-surgical##12##1##(1991-3#2)(1991-8#1)(1993-12#1)(1994-3#1)(2007-8#1)(2008-10#3)(2010-3#1)(2011-3#1)(2013-1#1)
non-synonymous##2##1##(2012-5#2)
non-target##2##1##(2008-11#1)(2010-4#1)
non-thermal##3##1##(1993-8#1)(2008-5#1)(2011-2#1)
non-threatening##2##1##(2008-12#1)(2009-4#1)
non-thrust##4##1##(2008-12#4)
non-tolerant cultivars##2##2##(2011-10#2)
non-tolerant##4##1##(2008-12#1)(2011-10#3)
non-toxic##18##1##(1991-12#1)(1993-6#2)(1996-1#1)(2008-10#8)(2008-5#4)(2010-8#1)(2012-2#1)
non-traditional##2##1##(1996-3#2)
non-transfers##2##1##(1993-12#2)
non-transformed##2##1##(1993-6#1)(1993-8#1)
non-transgenic##5##1##(2008-11#1)(2008-12#3)(2010-5#1)
non-traumatic MO##2##2##(2013-8#2)
non-traumatic##5##1##(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#2)
non-treated##15##1##(1996-2#1)(1997-7#1)(2008-10#7)(2008-11#5)(2008-5#1)
non-treatment##3##1##(1990-2#1)(2008-10#1)(2013-8#1)
non-tumor-bearing##2##1##(2012-2#2)
non-tweezer-type ionophores##2##2##(2008-10#2)
non-twin siblings##2##2##(1997-7#1)(2008-7#1)
non-typhoid salmonellosis##2##2##(1997-3#2)
non-uniform##3##1##(2008-10#1)(2009-10#1)(2013-8#1)
non-union##2##1##(2008-7#1)(2013-1#1)
non-use##4##1##(1997-6#1)(2008-5#1)(2008-9#1)(2013-8#1)
non-users##5##1##(2008-11#1)(2013-8#4)
non-vaccinated hens##2##2##(2008-5#2)
non-vaccinated##3##1##(2008-5#3)
non-verbal##6##1##(1990-11#1)(2008-7#2)(2008-8#2)(2008-9#1)
non-viral gene delivery##2##3##(2008-11#2)
non-viral##3##1##(2008-11#3)
non-virulent NDV##2##2##(2008-5#2)
non-virulent##7##1##(1993-12#1)(2008-5#6)
non-visual##3##1##(2008-11#2)(2012-2#1)
non-vocationally registered##2##2##(1994-12#2)
non-volatile ions##4##2##(2008-10#4)
non-volatile##6##1##(2008-10#6)
non-white rot##2##2##(2008-10#2)
non-white##3##1##(1997-2#1)(2008-10#2)
non-whitening##2##1##(2011-2#2)
non-words##2##1##(1996-2#2)
non-zero##2##1##(1993-8#1)(1995-9#1)
nonabsorbing##2##1##(2008-3#2)
nonactin##3##1##(2008-10#3)
nonadaptive##2##1##(2008-8#2)
nonadditive##4##1##(2008-8#4)
nonadherence to##2##2##(1994-3#1)(2008-4#1)
nonadherence##4##1##(1994-3#3)(2008-4#1)
nonadherent populations of##2##3##(2008-10#2)
nonadherent##4##1##(1994-3#1)(2008-10#3)
nonadiabatically##2##1##(2007-11#2)
nonadrenergic##2##1##(1992-6#1)(1997-4#1)
nonagenarians##6##1##(2008-10#5)(2008-7#1)
nonaggressive bark beetles##3##3##(2008-10#3)
nonaggressive bark##4##2##(2008-10#4)
nonagricultural environments##3##2##(2008-10#3)
nonallelic##2##1##(1993-3#1)(2008-10#1)
nonalternant PAHs##5##2##(2008-10#5)
nonalternant polycyclic aromatic hydrocarbons (PAHs)##3##5##(2008-10#3)
nonalternant polycyclic aromatic hydrocarbons##5##4##(2008-10#5)
nonalternant##11##1##(2008-10#11)
nonamended##9##1##(2008-10#9)
nonantineoplastic##2##1##(2011-2#2)
nonapeptide##3##1##(1994-3#2)(2008-10#1)
nonaphasic##2##1##(2009-10#2)
nonaqueous media##2##2##(2008-10#1)(2008-7#1)
nonaqueous solvents##2##2##(2008-10#1)(2008-7#1)
nonaqueous##9##1##(2008-10#7)(2008-7#2)
nonautoclaved##6##1##(2008-10#6)
nonautoimmune##2##1##(2012-3#2)
nonbacterial##4##1##(1996-11#1)(2008-10#2)(2011-2#1)
nonbacterized##2##1##(2008-10#2)
nonbeating HL-1##2##2##(2008-7#2)
nonbilayer lipids##2##2##(1997-2#2)
nonbilayer##3##1##(1997-2#3)
nonbreeders##2##1##(2008-8#2)
nonbusiness bankruptcy filings##2##3##(2008-11#2)
nonbusiness bankruptcy##4##2##(2008-11#4)
noncancer##2##1##(1993-11#1)(2013-1#1)
noncardiac##2##1##(1992-6#1)(2008-7#1)
noncardiogenic pulmonary##2##2##(2010-1#1)(2011-2#1)
noncaseating##2##1##(2011-2#1)(2012-3#1)
nonchaotic##2##1##(2007-11#1)(2008-9#1)
nonchilled##2##1##(2008-10#2)
noncholinergic##2##1##(1992-6#1)(1997-4#1)
nonclinical safety##3##2##(1992-3#1)(2010-11#2)
nonclinical##7##1##(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(2010-11#3)
noncoding RNAs##2##2##(2008-9#1)(2011-3#1)
noncoding region##3##2##(1995-5#1)(2008-9#2)
noncoding regions of the##2##4##(2008-10#2)
noncoding regions of##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
noncoding regions##6##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)
noncoding sequences##3##2##(2008-10#2)(2008-4#1)
noncoding##19##1##(1995-2#2)(1995-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#4)(2011-3#1)(2012-3#2)
noncompetitive antagonist##2##2##(1991-5#1)(1995-11#1)
noncompetitive##10##1##(1991-5#2)(1992-3#3)(1994-11#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-5#1)
noncompliance and##2##2##(2007-11#1)(2009-11#1)
noncompliance##11##1##(1992-12#1)(2007-11#8)(2008-10#1)(2009-11#1)
nonconducive##3##1##(2008-10#3)
nonconformity##4##1##(2008-12#4)
nonconfrontation##3##1##(2011-2#3)
noncontact mapping##2##2##(2009-10#2)
noncontact##7##1##(2007-11#1)(2008-10#1)(2008-3#2)(2009-10#2)(2013-1#1)
noncontinuous particulate##2##2##(2009-5#2)
noncooperative##3##1##(1993-1#1)(2008-3#1)(2008-8#1)
noncovalent interactions##2##2##(1992-4#1)(2008-10#1)
noncovalent##3##1##(1992-4#1)(2008-10#2)
noncovered##2##1##(2008-10#2)
noncruciferous hosts##4##2##(2008-10#4)
noncruciferous##5##1##(2008-10#5)
noncultivated and##2##2##(2008-10#2)
noncultivated orchard soil##2##3##(2008-10#2)
noncultivated soil##4##2##(2008-10#4)
noncultivated##9##1##(2008-10#9)
nonculturable##2##1##(2008-10#2)
nondegenerate##3##1##(1992-11#1)(2007-12#1)(2008-2#1)
nondestructive##7##1##(2008-10#2)(2008-3#5)
nondiagnostic information##3##2##(2008-11#3)
nondiagnostic##5##1##(2008-11#5)
nondifferentiated PC12##2##2##(1993-8#2)
nondifferentiated##4##1##(1993-8#4)
nondisabled##7##1##(1993-3#2)(2013-1#5)
nondividing##2##1##(2009-8#1)(2012-3#1)
nondominant eye##2##2##(2011-2#2)
nondominant##4##1##(2008-7#1)(2008-9#1)(2011-2#2)
nondopaminergic neurons##5##2##(2008-7#5)
none are##2##2##(2010-1#1)(2012-3#1)
none at##2##2##(2008-10#1)(2008-8#1)
none had##4##2##(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
none have##2##2##(2008-11#1)(2008-9#1)
none in##2##2##(2008-9#1)(2010-12#1)
none of the cases##2##4##(1991-9#1)(2011-2#1)
none of the##41##3##(1990-12#2)(1990-9#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1997-4#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
none of them##3##3##(1995-12#1)(2008-11#1)(2008-12#1)
none of these were##2##4##(1997-2#1)(1997-8#1)
none of these##9##3##(1991-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2012-2#1)
none of which##5##3##(1994-12#1)(1995-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
none of##62##2##(1990-12#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-12#2)(1995-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#12)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
none the less##2##3##(1991-1#1)(1996-6#1)
none to##4##2##(2008-10#2)(2008-9#1)(2011-1#1)
none was##3##2##(1990-5#1)(1991-7#1)(2011-1#1)
none were##4##2##(1994-2#1)(1995-12#1)(2008-10#2)
none##112##1##(1990-12#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-9#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#20)(2008-11#7)(2008-12#5)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#8)(2009-11#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
nonelderly##3##1##(2013-8#3)
nonelectrostatic##2##1##(2008-10#1)(2008-7#1)
nonequilibrium##5##1##(1992-8#1)(2008-8#3)(2008-9#1)
nonessential##6##1##(1994-5#1)(1997-3#2)(2009-8#1)(2012-3#2)
nonetheless##6##1##(1991-12#1)(1993-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
nonexercised##3##1##(2008-10#3)
nonexistent##3##1##(1994-12#1)(2008-10#1)(2011-2#1)
nonexperimental##2##1##(2008-8#1)(2008-9#1)
nonexposed roots##2##2##(2008-10#2)
nonexposed##3##1##(2008-10#3)
nonfederally funded research##2##3##(1995-2#2)
nonfederally funded##3##2##(1995-2#3)
nonfertilized##2##1##(2008-10#2)
nonfluorescent##4##1##(2007-11#1)(2008-10#3)
nonflying##2##1##(2008-8#2)
nonfumigated soil##5##2##(2008-10#5)
nonfumigated##8##1##(2008-10#8)
nonfunctional##7##1##(1991-5#2)(1997-8#1)(2008-10#1)(2008-9#1)(2012-3#2)
nonglutinous##5##1##(2008-10#5)
nonhealing##2##1##(2008-8#1)(2013-1#1)
nonhomologous DNA##5##2##(1993-2#2)(2008-10#3)
nonhomologous EJ##2##2##(1993-2#2)
nonhomologous##9##1##(1993-2#4)(2008-10#4)(2013-1#1)
nonhospital##2##1##(1991-12#1)(1996-1#1)
nonhost plants and##2##3##(2008-10#2)
nonhost plants##3##2##(2008-10#3)
nonhost##14##1##(2008-10#14)
nonhosts##3##1##(2008-10#3)
nonhuman primate##3##2##(1993-6#1)(2008-9#2)
nonhuman##5##1##(1993-6#1)(2008-4#1)(2008-9#3)
nonhydrolyzable##2##1##(1991-5#1)(1991-6#1)
nonidentical subunits##3##2##(1990-5#1)(1992-9#1)(2008-8#1)
nonidentical##4##1##(1990-5#1)(1992-9#1)(1994-5#1)(2008-8#1)
noninduced control##2##2##(2008-10#2)
noninduced##3##1##(2008-10#3)
noninfected##7##1##(1997-3#1)(2008-10#6)
noninfested soil##3##2##(2008-10#3)
noninfested##5##1##(2008-10#5)
noninflammatory##3##1##(1995-5#1)(2008-10#1)(2008-9#1)
noninoculated leaves was significantly##2##4##(2008-10#2)
noninoculated leaves##5##2##(2008-10#5)
noninoculated plants##2##2##(2008-10#2)
noninoculated trees##2##2##(2008-10#2)
noninoculated##19##1##(2008-10#19)
noninstitutionalization##2##1##(1993-1#2)
nonintrusive##2##1##(2008-3#2)
noninvasive biochemical analysis##3##3##(2013-8#3)
noninvasive biochemical##4##2##(2013-8#4)
noninvasive imaging##5##2##(2008-12#2)(2010-9#1)(2012-2#1)(2013-1#1)
noninvasive monitoring##2##2##(2008-10#1)(2012-2#1)
noninvasive technology##2##2##(2010-9#1)(2013-7#1)
noninvasive tool##2##2##(2011-2#1)(2013-1#1)
noninvasive##42##1##(1991-3#1)(1993-1#1)(1993-11#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#3)(2010-9#3)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#4)
noninvasively in##2##2##(1997-1#1)(1997-8#1)
noninvasively##5##1##(1997-1#1)(1997-8#1)(2010-7#1)(2010-9#1)(2012-2#1)
nonionic detergent##2##2##(2008-8#1)(2013-1#1)
nonionic microemulsion##3##2##(2008-10#3)
nonionic surfactant##8##2##(2008-10#5)(2008-5#2)(2011-2#1)
nonionic surfactants##8##2##(2008-10#7)(2008-5#1)
nonionic##25##1##(2008-10#19)(2008-5#3)(2008-8#1)(2011-2#1)(2013-1#1)
nonisotopic##2##1##(2008-10#1)(2008-11#1)
nonketotic hyperglycinemia##3##2##(2010-12#3)
nonketotic##4##1##(1990-3#1)(2010-12#3)
nonlinear absorption coefficient##2##3##(2008-3#2)
nonlinear absorption##7##2##(2008-3#7)
nonlinear and##3##2##(2008-2#1)(2008-8#1)(2008-9#1)
nonlinear calibration##4##2##(2008-10#4)
nonlinear correlation##3##2##(2008-10#2)(2008-3#1)
nonlinear crystal##2##2##(2007-12#1)(2008-2#1)
nonlinear delayed feedback##4##3##(2009-8#4)
nonlinear deterministic##2##2##(2009-8#2)
nonlinear dynamical systems##2##3##(2009-8#2)
nonlinear dynamical##3##2##(2009-8#3)
nonlinear dynamics##2##2##(2008-8#1)(2009-8#1)
nonlinear effects##4##2##(2007-11#4)
nonlinear gain##2##2##(2007-11#1)(2008-3#1)
nonlinear in the##2##3##(1990-8#1)(2008-2#1)
nonlinear in##3##2##(1990-8#1)(2008-2#2)
nonlinear interactions##4##2##(2007-12#1)(2008-8#2)(2010-11#1)
nonlinear least-squares##3##2##(2008-10#1)(2008-3#2)
nonlinear lensing##3##2##(2008-3#3)
nonlinear models##4##2##(2008-10#2)(2008-9#2)
nonlinear optical crystal##4##3##(2007-11#1)(2008-3#3)
nonlinear optical effects##2##3##(2008-2#1)(2008-3#1)
nonlinear optical##13##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#5)
nonlinear processes##2##2##(2007-12#1)(2008-3#1)
nonlinear regression##7##2##(1993-3#1)(2008-10#5)(2008-8#1)
nonlinear relationship##2##2##(2008-10#2)
nonlinear response of the##2##4##(2008-2#1)(2008-3#1)
nonlinear response##3##2##(2008-2#2)(2008-3#1)
nonlinear social effects##2##3##(2008-8#2)
nonlinear##152##1##(1990-12#1)(1990-8#1)(1993-3#1)(2007-11#10)(2007-12#14)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#15)(2008-3#38)(2008-6#3)(2008-7#3)(2008-8#10)(2008-9#3)(2009-12#1)(2009-8#11)(2010-11#1)(2010-8#2)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#1)
nonlinearities##6##1##(2007-11#3)(2008-10#2)(2008-7#1)
nonlinearity and##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
nonlinearity in##4##2##(2008-3#2)(2008-9#2)
nonlinearity of##2##2##(2007-12#1)(2008-3#1)
nonlinearity##16##1##(1990-8#1)(2007-12#3)(2008-2#2)(2008-3#6)(2008-9#2)(2012-2#2)
nonliving##2##1##(2008-10#1)(2008-3#1)
nonlocal##2##1##(2009-8#2)
nonmammalian##3##1##(1994-5#2)(2008-8#1)
nonmatrix##2##1##(1997-2#2)
nonmedical##3##1##(2009-6#1)(2012-2#1)(2013-1#1)
nonmethane hydrocarbons##2##2##(2008-11#2)
nonmigrant##2##1##(2012-3#2)
nonmonogamous##2##1##(2008-12#2)
nonmonotonic##2##1##(2007-12#1)(2008-7#1)
nonmotile##3##1##(2011-2#3)
nonmyeloid##2##1##(2008-7#2)
nonnative##2##1##(2008-10#2)
nonnecrogenic##2##1##(2008-10#2)
nonnecrotic##2##1##(2008-10#2)
nonneoplastic lesions in##3##3##(2008-9#3)
nonneoplastic lesions##4##2##(2008-9#4)
nonneoplastic##8##1##(1990-12#1)(2008-9#4)(2011-2#2)(2013-1#1)
nonneuronal##2##1##(1993-8#1)(1995-2#1)
nonobese patients##5##2##(2011-2#5)
nonobese##9##1##(1995-2#1)(2011-2#8)
nonoperative management##2##2##(2012-3#1)(2013-1#1)
nonoverlapping host ranges##2##3##(2008-10#2)
nonoverlapping##4##1##(1995-2#1)(2008-10#2)(2008-8#1)
nonpalpable##3##1##(1997-8#2)(2011-1#1)
nonparametric analysis of##2##3##(2008-10#2)
nonparametric approaches##2##2##(2008-10#2)
nonparametric component estimator##2##3##(2009-10#2)
nonparametric component##3##2##(2009-10#3)
nonparametric methods##2##2##(2008-10#2)
nonparametric##17##1##(1991-12#1)(2008-10#10)(2008-11#1)(2008-9#1)(2009-10#4)
nonparental##3##1##(2009-10#1)(2009-7#2)
nonpathogenic F##5##2##(2008-10#5)
nonpathogenic Fusarium oxysporum##4##3##(2008-10#4)
nonpathogenic Fusarium##5##2##(2008-10#5)
nonpathogenic and##2##2##(2008-10#2)
nonpathogenic binucleate Rhizoctonia##2##3##(2008-10#2)
nonpathogenic isolates of##2##3##(2008-10#2)
nonpathogenic isolates##9##2##(2008-10#9)
nonpathogenic mutant##5##2##(2008-10#5)
nonpathogenic on##6##2##(2008-10#6)
nonpathogenic or##2##2##(2008-10#2)
nonpathogenic strain##2##2##(2008-10#2)
nonpathogenic strains from carnation and lily##2##6##(2008-10#2)
nonpathogenic strains of##2##3##(2008-10#2)
nonpathogenic strains##4##2##(2008-10#4)
nonpathogenic to##4##2##(2008-10#4)
nonpathogenic##66##1##(1997-8#1)(2008-10#65)
nonpathogens or##2##2##(2008-10#2)
nonpathogens##5##1##(2008-10#5)
nonpeptide angiotensin II##2##3##(1991-5#2)
nonpeptide##3##1##(1991-5#2)(2012-2#1)
nonperspective##2##1##(2008-6#2)
nonpharmacologic therapies##2##2##(2010-11#2)
nonpharmacologic##4##1##(2008-4#1)(2008-7#1)(2010-11#2)
nonpharmacological##6##1##(2008-11#2)(2010-7#1)(2013-1#2)(2013-8#1)
nonpolar compounds##4##2##(2008-10#4)
nonpolar fraction##3##2##(2013-8#3)
nonpolar organic##2##2##(2008-10#1)(2008-3#1)
nonpolar##14##1##(1990-11#1)(1991-2#1)(1994-3#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2013-8#3)
nonpolyadenylated##5##1##(2008-10#1)(2008-9#4)
nonpolyposis colorectal##2##2##(2009-12#1)(2011-2#1)
nonpolyposis##4##1##(2009-12#2)(2011-2#2)
nonprecooled donor cells##3##3##(2008-9#3)
nonprecooled##4##1##(2008-9#4)
nonpreferred resources##3##2##(2008-9#3)
nonpregnant female##2##2##(1990-11#2)
nonpregnant##3##1##(1990-11#2)(2011-1#1)
nonprescription##4##1##(1995-2#4)
nonprimed##2##1##(2008-10#2)
nonproducing##2##1##(2008-10#2)
nonprofit boards##3##2##(1992-3#2)(1994-12#1)
nonprofit health care##2##3##(2008-11#2)
nonprofit health##3##2##(1994-1#1)(2008-11#2)
nonprofit hospital##6##2##(1991-1#1)(1991-3#1)(1992-3#2)(1996-2#1)(2008-11#1)
nonprofit hospitals and medical groups##2##5##(2008-11#2)
nonprofit hospitals and##3##3##(1993-1#1)(2008-11#2)
nonprofit hospitals##10##2##(1992-3#2)(1993-1#2)(1994-3#1)(1996-2#2)(2008-11#3)
nonprofit human service organizations##3##4##(1991-12#1)(1994-12#1)(1996-2#1)
nonprofit managers##3##2##(1991-12#1)(1994-12#2)
nonprofit nursing homes pay higher##2##5##(1992-3#2)
nonprofit nursing homes##4##3##(1992-3#4)
nonprofit organization##2##2##(1992-3#1)(1995-12#1)
nonprofit organizations##6##2##(1991-12#1)(1992-3#1)(1993-12#2)(1994-12#1)(1995-3#1)
nonprofit##48##1##(1991-1#1)(1991-12#4)(1991-3#1)(1992-3#12)(1993-1#2)(1993-12#4)(1994-1#1)(1994-12#5)(1994-3#2)(1995-12#1)(1995-3#2)(1996-2#5)(1996-3#1)(2008-11#7)
nonprofits##6##1##(1994-12#1)(1995-3#4)(1996-2#1)
nonproliferating##2##1##(1995-6#1)(2008-9#1)
nonpsychiatric settings##2##2##(2009-6#1)(2009-9#1)
nonradioactive##3##1##(2008-10#1)(2008-4#1)(2008-9#1)
nonradiolabeled##2##1##(1992-2#1)(1995-6#1)
nonrandom##7##1##(2008-10#5)(2008-4#1)(2008-8#1)
nonrandomized trials##2##2##(2008-7#2)
nonrandomized##4##1##(2008-7#3)(2012-12#1)
nonrandomness caused by the##2##4##(2008-10#2)
nonreactive##3##1##(1997-3#1)(2008-3#1)(2008-8#1)
nonreceptor##2##1##(2012-2#1)(2012-3#1)
nonreciprocal phase shifter##2##3##(2008-3#2)
nonreciprocal phase##4##2##(2008-3#4)
nonreciprocal##6##1##(2008-3#6)
nonreducing##7##1##(1992-12#1)(1994-11#1)(1994-5#4)(2008-7#1)
nonreferred##2##1##(2009-11#1)(2010-8#1)
nonreleased genotypes##2##2##(2008-10#2)
nonreleased##3##1##(2008-10#3)
nonresonant laser-induced thermal acoustics##2##4##(2008-3#2)
nonresonant##4##1##(2008-3#4)
nonresponders##3##1##(1993-11#1)(1994-2#1)(2011-2#1)
nonresponding patients##2##2##(1993-11#1)(2007-11#1)
nonresponding##3##1##(1993-11#1)(2007-11#1)(2012-3#1)
nonresponse##3##1##(2008-12#1)(2012-3#2)
nonrhizosphere soil##2##2##(2008-10#2)
nonrhizosphere##3##1##(2008-10#3)
nonrice##2##1##(2008-10#2)
nonroutine##2##1##(2010-11#2)
nonsecreted##2##1##(1995-2#2)
nonselected##2##1##(2008-10#1)(2012-12#1)
nonselective media##5##2##(2008-10#1)(2008-12#4)
nonselective##15##1##(1994-2#1)(2008-10#5)(2008-12#4)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)
nonselenoprotein##2##1##(2012-2#2)
nonsense##4##1##(1990-8#1)(2012-2#1)(2012-3#2)
nonsevere##2##1##(2013-1#2)
nonsexters##2##1##(2013-1#2)
nonsexual contacts##2##2##(2008-9#2)
nonsexual transmission##2##2##(2008-9#2)
nonsexual##7##1##(2008-9#5)(2012-3#2)
nonsignificant##4##1##(2008-10#2)(2008-3#1)(2013-1#1)
nonsmoker men##2##2##(2008-12#2)
nonsmoker##3##1##(2008-12#3)
nonsmokers##7##1##(1992-9#1)(1993-1#1)(2008-10#2)(2008-12#2)(2012-12#1)
nonspatial##3##1##(1993-3#1)(2008-8#2)
nonspecific adsorption##2##2##(2008-10#2)
nonspecific and##2##2##(2008-10#2)
nonspecific binding##4##2##(2008-10#3)(2008-7#1)
nonspecific clinical##2##2##(2011-2#1)(2012-12#1)
nonspecific lipid-transfer protein##2##3##(1990-5#2)
nonspecific lipid-transfer##3##2##(1990-5#3)
nonspecific##45##1##(1990-5#3)(1991-12#1)(1992-6#1)(1993-3#1)(1993-8#2)(1997-3#2)(2008-10#14)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-2#7)(2012-12#1)
nonspecifically##3##1##(1991-12#1)(1991-9#1)(2008-10#1)
nonspherical droplets##2##2##(2008-2#1)(2008-3#1)
nonspherical particles with flat surfaces##2##5##(2008-3#2)
nonspherical particles with##4##3##(2008-3#4)
nonspherical particles##6##2##(2008-3#6)
nonspherical##15##1##(2008-2#2)(2008-3#13)
nonspotted kernels##2##2##(2012-3#2)
nonstationary##2##1##(2008-3#2)
nonsteroidal anti-inflammatory drug (NSAID)##2##4##(2008-10#1)(2008-11#1)
nonsteroidal anti-inflammatory drug##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
nonsteroidal anti-inflammatory drugs##6##3##(2008-10#2)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
nonsteroidal anti-inflammatory##10##2##(1997-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
nonsteroidal antiinflammatory drugs##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
nonsteroidal##13##1##(1997-1#1)(1997-4#1)(2008-10#4)(2008-11#2)(2009-12#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
nonstress environment##3##2##(2008-9#3)
nonstress##5##1##(2008-3#1)(2008-9#4)
nonstructural (NSs) protein##2##3##(2008-10#2)
nonstructural protein##3##2##(2008-10#3)
nonstructural##12##1##(1994-11#2)(2008-10#10)
nonsuppressive soils##2##2##(2008-10#2)
nonsurgical##2##1##(2008-7#1)(2012-12#1)
nonsusceptible##2##1##(2008-10#2)
nonsustained##2##1##(2008-12#1)(2013-8#1)
nonsynonymous##2##1##(2011-2#1)(2012-3#1)
nonteaching##2##1##(1994-3#1)(2012-3#1)
nonthermal##2##1##(1991-9#1)(1995-6#1)
nonthyroidal illness##3##2##(2008-4#1)(2008-7#2)
nontoxic crop protection##2##3##(2008-10#2)
nontoxic##8##1##(1994-11#1)(1995-2#4)(2008-10#2)(2010-4#1)
nontoxic-nonhemagglutinin component of Clostridium botulinum type C progenitor toxin##2##9##(1992-3#2)
nontraditional##3##1##(1994-2#1)(2008-10#1)(2009-5#1)
nontransformed and transformed##2##3##(1993-8#1)(1997-1#1)
nontransformed and##3##2##(1993-8#1)(1997-1#1)(2008-10#1)
nontransformed plants##3##2##(2008-10#3)
nontransformed##12##1##(1993-8#1)(1997-1#1)(2008-10#10)
nontransgenic hybrids##2##2##(2008-10#2)
nontransgenic ones##2##2##(2008-10#1)(2008-8#1)
nontransgenic tomato##2##2##(2008-10#2)
nontransgenic##19##1##(1992-8#4)(1995-2#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-8#1)
nontranslatable##2##1##(1997-3#2)
nontranslated region##3##2##(2008-10#3)
nontranslated##4##1##(1993-3#1)(2008-10#3)
nontransmissible viruses in##2##3##(2008-10#2)
nontransmissible##4##1##(2008-10#4)
nontreated cells##2##2##(2008-11#1)(2008-9#1)
nontreated control##3##2##(2008-10#3)
nontreated plots in##2##3##(2008-10#2)
nontreated##20##1##(2008-10#18)(2008-11#1)(2008-9#1)
nontuberculous mycobacteria##2##2##(2007-12#1)(2011-2#1)
nontuberculous mycobacterial disease##4##3##(2007-12#3)(2011-2#1)
nontuberculous mycobacterial##5##2##(2007-12#4)(2011-2#1)
nontuberculous##7##1##(2007-12#5)(2011-2#2)
nonuniform##6##1##(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#2)
nonuniformity##4##1##(2008-3#4)
nonunion of the ulna in a child##2##7##(2011-2#2)
nonunion of the##3##3##(2009-3#1)(2011-2#2)
nonunion##11##1##(2008-12#2)(2008-8#1)(2009-10#2)(2009-3#2)(2011-2#4)
nonunique##2##1##(2008-3#2)
nonutilizing##7##1##(2008-10#7)
nonvalidated instruments##4##2##(2013-1#4)
nonvascularized bone##2##2##(2010-6#2)
nonvascularized##3##1##(2009-3#1)(2010-6#2)
nonvector species##2##2##(2008-10#2)
nonvector whiteflies##4##2##(2008-10#4)
nonvector##11##1##(2008-10#11)
nonviable cells##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
nonviable##9##1##(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#2)(2009-10#1)(2010-6#1)
nonviral DNA##2##2##(2008-8#2)
nonviral gene delivery##2##3##(2009-10#2)
nonviral##6##1##(1997-3#2)(2008-8#2)(2009-10#2)
nonvisible##2##1##(1993-12#1)(2008-10#1)
nonvolatile##3##1##(1997-2#1)(2008-10#2)
nonvolitional##2##1##(2008-11#2)
nonwords##4##1##(1990-8#1)(2008-11#3)
nonylphenol##5##1##(2008-10#3)(2008-11#2)
nonylphenoxypolyethoxyethanol (OP)##2##2##(2008-10#2)
nonzero##2##1##(2007-11#1)(2010-1#1)
nor a##4##2##(1996-3#1)(2008-10#2)(2009-5#1)
nor an##3##2##(1991-12#1)(1993-8#1)(1994-2#1)
nor any##2##2##(1992-1#1)(2008-9#1)
nor are they##2##3##(1997-2#1)(2008-10#1)
nor are##3##2##(1997-2#1)(2008-10#1)(2010-10#1)
nor between##2##2##(1990-3#1)(1993-11#1)
nor by##2##2##(2008-10#1)(2008-7#1)
nor caffeic acid##2##3##(2008-11#2)
nor did it##4##3##(1996-12#1)(2008-10#3)
nor did they##3##3##(1995-8#1)(2008-10#2)
nor did##11##2##(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#7)(2011-2#1)
nor does it##3##3##(1994-5#1)(1997-7#1)(2008-11#1)
nor for##2##2##(1997-4#1)(2008-9#1)
nor has##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
nor in the##4##3##(1994-2#1)(2008-11#2)(2011-2#1)
nor in##12##2##(1990-8#2)(1991-5#1)(1994-2#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-2#1)(2012-8#1)
nor its##3##2##(1993-12#1)(1994-6#1)(2008-10#1)
nor of##2##2##(1994-8#1)(2009-6#1)
nor on##2##2##(1993-12#1)(1994-6#1)
nor the two##2##3##(2008-7#1)(2008-8#1)
nor the##28##2##(1991-11#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-12#1)(1996-12#1)(1996-2#1)(1997-7#2)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
nor to the##2##3##(1990-5#1)(2008-5#1)
nor to##6##2##(1990-5#1)(1991-11#1)(2008-5#2)(2008-8#1)(2009-6#1)
nor was##2##2##(2008-10#1)(2011-2#1)
nor were##3##2##(2008-10#1)(2009-7#1)(2011-3#1)
nor with the##2##3##(1995-11#1)(2008-10#1)
nor with##6##2##(1990-5#1)(1995-11#1)(1996-12#2)(2008-10#1)(2008-9#1)
nor##212##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#2)(1992-12#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-8#3)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#11)(1995-11#1)(1995-12#4)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#4)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#39)(2008-11#12)(2008-12#1)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#9)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#5)(2013-8#2)
noradrenaline and adrenaline##3##3##(1994-2#1)(2008-10#2)
noradrenaline and##7##2##(1994-2#1)(2008-10#5)(2009-7#1)
noradrenaline in the##2##3##(1997-3#1)(2008-10#1)
noradrenaline responses##2##2##(1997-4#2)
noradrenaline##24##1##(1990-5#1)(1994-2#1)(1996-2#4)(1997-3#2)(1997-4#7)(2008-10#6)(2008-7#1)(2009-7#1)(2013-1#1)
noradrenergic and##2##2##(1996-12#1)(2012-3#1)
noradrenergic cell bodies##2##3##(1996-5#2)
noradrenergic cell##3##2##(1996-5#3)
noradrenergic##13##1##(1993-3#2)(1995-12#2)(1996-12#2)(1996-5#3)(1997-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
norcantharidin##3##1##(2011-3#3)
norepinephrine (NE) and##2##3##(1996-12#1)(2008-7#1)
norepinephrine (NE)##6##2##(1993-3#1)(1996-12#1)(2008-10#3)(2008-7#1)
norepinephrine in##2##2##(1990-5#1)(2008-11#1)
norepinephrine release##3##2##(1990-5#1)(1993-8#2)
norepinephrine##28##1##(1990-12#1)(1990-5#3)(1993-1#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-8#2)(1995-11#1)(1996-12#2)(1997-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#2)
norfloxacin (NOR)##3##2##(2008-10#3)
norfloxacin and ciprofloxacin##3##3##(2008-10#3)
norfloxacin##12##1##(2008-10#11)(2012-3#1)
norm and##2##2##(2008-10#1)(2008-11#1)
norm##13##1##(1992-12#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-10#3)(2012-2#1)
normal FIA and reversed FIA##3##5##(2008-10#3)
normal a##2##2##(1997-8#1)(2010-10#1)
normal activities##3##2##(1996-3#1)(2008-10#1)(2008-7#1)
normal adult##3##2##(1990-5#1)(1991-7#1)(1994-2#1)
normal ageing and##2##3##(2009-10#2)
normal ageing##4##2##(2009-10#4)
normal aging##7##2##(1996-2#1)(2008-7#4)(2010-11#1)(2011-2#1)
normal alpha##2##2##(1990-8#1)(2013-7#1)
normal anatomy and##2##3##(1996-9#1)(2012-2#1)
normal anatomy##3##2##(1996-9#1)(2009-8#1)(2012-2#1)
normal and Graves'##2##3##(1995-12#2)
normal and a##2##3##(1994-8#1)(2008-10#1)
normal and abnormal##4##3##(2008-4#1)(2010-8#2)(2012-2#1)
normal and cancer groups##2##4##(2008-10#2)
normal and cancer##6##3##(2008-10#5)(2008-11#1)
normal and diabetic hepatocytes##2##4##(1994-8#2)
normal and diabetic##3##3##(1994-8#2)(2013-8#1)
normal and diseased states##2##4##(2008-4#1)(2013-1#1)
normal and neoplastic##3##3##(1992-3#1)(1995-12#1)(2011-2#1)
normal and pathological behaviors##3##4##(2009-5#3)
normal and pathological tissues##2##4##(2010-8#1)(2012-3#1)
normal and pathological##7##3##(1990-9#1)(2009-5#3)(2010-8#1)(2012-3#1)(2013-1#1)
normal and transformed epithelium##2##4##(2010-12#2)
normal and transformed##5##3##(1992-3#1)(1993-11#1)(1994-5#1)(2010-12#2)
normal and transgenic mice##2##4##(1995-6#1)(2008-9#1)
normal and##84##2##(1990-12#3)(1990-9#1)(1991-11#2)(1991-5#1)(1992-12#1)(1992-3#3)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#2)(1995-12#4)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#3)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#3)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
normal animals##5##2##(1991-2#2)(1993-6#1)(1995-12#1)(1995-2#1)
normal ano-genital##3##2##(2010-4#3)
normal as well as##2##4##(2008-10#1)(2012-3#1)
normal as##3##2##(1993-11#1)(2008-10#1)(2012-3#1)
normal behavior##2##2##(1995-8#1)(2008-8#1)
normal biological##2##2##(2008-4#1)(2011-2#1)
normal blood pressure##2##3##(1996-6#1)(2008-7#1)
normal blood##5##2##(1990-5#1)(1995-11#1)(1996-6#1)(1997-8#1)(2008-7#1)
normal body##3##2##(2008-10#2)(2011-2#1)
normal bone##3##2##(2008-9#1)(2010-6#1)(2011-1#1)
normal brain##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
normal breast epithelial and stromal cells##2##6##(2011-2#2)
normal breast epithelial##3##3##(1990-12#1)(2011-2#2)
normal breast##7##2##(1990-12#4)(1993-11#1)(2011-2#2)
normal breathing##2##2##(2008-1#1)(2012-3#1)
normal cardiac output##2##3##(2008-7#1)(2012-3#1)
normal cell functions##2##3##(2008-5#1)(2012-3#1)
normal cell##9##2##(2008-11#3)(2008-5#1)(2008-9#1)(2009-8#1)(2012-3#2)(2013-1#1)
normal cells##17##2##(1990-11#1)(1992-9#2)(1993-8#1)(1994-5#1)(2008-11#7)(2008-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
normal cellular##3##2##(1997-1#1)(2008-5#1)(2011-1#1)
normal colonic mucosa##2##3##(2010-12#2)
normal colonoscopy##4##2##(2012-3#4)
normal concentrations of##2##3##(1991-12#1)(1991-2#1)
normal condition##4##2##(2008-11#1)(2012-3#3)
normal control group##3##3##(2011-3#3)
normal control subjects##3##3##(1995-5#3)
normal control##9##2##(1995-5#3)(1997-3#1)(2011-3#5)
normal controls and##2##3##(1997-8#1)(2010-12#1)
normal controls were##2##3##(1991-12#1)(2008-7#1)
normal controls##18##2##(1991-12#1)(1992-12#1)(1997-8#3)(2008-10#3)(2008-11#2)(2008-7#7)(2010-12#1)
normal coordinate##2##2##(2008-10#2)
normal coronary arteries##3##3##(1991-3#1)(2008-12#1)(2011-2#1)
normal creatinine levels##2##3##(1993-2#1)(2012-3#1)
normal delivery##4##2##(1991-3#1)(1992-12#1)(2011-2#1)(2013-1#1)
normal development of the##2##4##(2010-11#1)(2011-1#1)
normal development of##4##3##(2008-9#1)(2010-1#1)(2010-11#1)(2011-1#1)
normal development##8##2##(1997-3#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#1)
normal diet##3##2##(2011-2#2)(2013-8#1)
normal distribution##6##2##(2008-10#4)(2012-3#2)
normal donors##3##2##(1990-12#2)(2008-10#1)
normal during##2##2##(1990-5#1)(2008-10#1)
normal endometrial##2##2##(1990-5#1)(1995-12#1)
normal except for##2##3##(2007-12#1)(2008-7#1)
normal except##3##2##(1995-8#1)(2007-12#1)(2008-7#1)
normal fetal##2##2##(2008-10#1)(2008-7#1)
normal fibroblasts##5##2##(1992-8#3)(1994-11#1)(1997-7#1)
normal fimbrial epithelial cells of HGSCs##2##6##(2012-12#2)
normal fimbrial epithelial cells of##4##5##(2012-12#4)
normal fimbrial epithelial cells##5##4##(2012-12#5)
normal function of##2##3##(1997-5#1)(2012-3#1)
normal function##3##2##(1997-5#1)(2008-7#1)(2012-3#1)
normal functional##2##2##(1994-5#1)(2010-11#1)
normal growth and##4##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
normal growth of##2##3##(1993-11#1)(2011-1#1)
normal growth##11##2##(1990-6#1)(1993-11#1)(1994-8#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
normal healthy##3##2##(1995-3#1)(2008-5#1)(2012-3#1)
normal hearing##2##2##(2008-9#2)
normal heart##4##2##(2008-12#3)(2011-2#1)
normal human fibroblasts##4##3##(1997-7#1)(2008-5#3)
normal human keratinocytes##3##3##(1994-3#1)(2008-5#2)
normal human serum (NHS)##2##4##(1994-8#1)(2008-10#1)
normal human serum##4##3##(1991-5#1)(1993-11#1)(1994-8#1)(2008-10#1)
normal human skin##8##3##(1990-2#1)(2008-11#2)(2008-5#5)
normal human##37##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#6)(2008-5#10)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
normal imaging appearances and##2##4##(2011-2#1)(2012-2#1)
normal in##14##2##(1990-2#1)(1990-9#1)(1993-3#1)(1996-9#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2010-12#1)(2013-1#1)
normal individuals##7##2##(1991-9#1)(1992-3#2)(1992-9#1)(1995-5#1)(2010-3#1)(2010-9#1)
normal insulin##2##2##(1994-12#1)(1995-6#1)
normal intelligence##5##2##(1997-3#5)
normal kidney and##2##3##(2008-1#1)(2011-2#1)
normal kidney##4##2##(2008-1#1)(2011-2#3)
normal left ventricular function##3##4##(2010-5#1)(2012-2#1)(2013-1#1)
normal left ventricular##5##3##(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
normal level##2##2##(1991-5#1)(2008-11#1)
normal levels of glucose##2##4##(1990-5#1)(2011-2#1)
normal levels of##6##3##(1990-5#1)(1996-12#1)(1997-7#1)(2011-2#1)(2012-3#2)
normal levels##8##2##(1990-5#1)(1996-12#1)(1996-6#1)(1997-7#1)(2011-2#2)(2012-3#2)
normal life##6##2##(1992-2#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-3#1)
normal lipid metabolism##2##3##(1992-3#1)(2012-2#1)
normal liver##5##2##(1990-2#2)(1990-5#2)(2006-6#1)
normal liver)##2##2##(1997-8#1)(2007-12#1)
normal lung##3##2##(1993-8#1)(1996-2#2)
normal male##4##2##(1992-3#1)(1997-3#1)(2008-11#1)(2012-2#1)
normal mammalian##3##2##(1990-5#1)(1994-11#1)(2008-11#1)
normal mammary epithelial cells##2##4##(1993-11#2)
normal maturation##2##2##(1994-8#1)(1995-11#1)
normal mice of##2##3##(1993-8#1)(1997-3#1)
normal mice##11##2##(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#3)(1997-3#3)(2008-11#1)(2011-2#1)
normal mode##2##2##(1995-3#1)(2008-10#1)
normal mouse##3##2##(1990-5#1)(1992-10#1)(1995-2#1)
normal numbers of##2##3##(1994-3#2)
normal on the##2##3##(1990-12#1)(2013-1#1)
normal on##3##2##(1990-12#1)(1997-8#1)(2013-1#1)
normal or##10##2##(1993-2#1)(1996-2#1)(1996-6#1)(2008-9#1)(2009-9#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
normal oral##2##2##(2011-2#1)(2013-1#1)
normal patients##2##2##(1993-11#1)(2010-10#1)
normal persons##2##2##(2008-9#2)
normal phase##5##2##(2008-10#5)
normal phenotype##3##2##(2008-11#2)(2012-3#1)
normal physiological##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
normal pituitary##2##2##(1990-12#1)(2011-2#1)
normal plasma##6##2##(1992-9#2)(1995-2#1)(2010-12#3)
normal platelets on##2##3##(2006-6#2)
normal platelets##5##2##(1990-5#1)(2006-6#4)
normal population is##2##3##(1990-6#1)(2008-12#1)
normal population##8##2##(1990-6#1)(1993-1#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-6#1)(2008-12#1)(2010-10#1)
normal post-operative##4##2##(2008-2#1)(2012-2#3)
normal pregnancy##4##2##(1990-9#1)(1993-2#1)(1994-5#1)(1996-11#1)
normal pregnant women##2##3##(2008-10#1)(2012-2#1)
normal pregnenolone production&quot##3##3##(2012-2#3)
normal pregnenolone##4##2##(2012-2#4)
normal protein##2##2##(1990-5#1)(2008-5#1)
normal range were##2##3##(2012-2#2)
normal range##18##2##(1992-9#2)(2006-6#1)(2008-12#1)(2008-7#6)(2008-9#1)(2009-7#1)(2011-2#3)(2012-2#2)(2013-1#1)
normal ranges of##2##3##(2010-1#1)(2010-4#1)
normal ranges##4##2##(1997-5#1)(2008-5#1)(2010-1#1)(2010-4#1)
normal rat pituitary cells##3##4##(1992-6#3)
normal rat trachea##2##3##(2008-9#2)
normal rat##12##2##(1991-5#1)(1992-6#4)(1996-2#2)(2008-7#2)(2008-9#3)
normal rats##3##2##(1994-2#1)(1994-8#1)(1997-2#1)
normal saline with##2##3##(2010-7#2)
normal saline##6##2##(2008-10#1)(2010-7#3)(2012-3#2)
normal scans##2##2##(1995-5#1)(2007-11#1)
normal serum##5##2##(1990-2#1)(1990-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
normal skin##22##2##(1992-8#1)(2008-5#14)(2008-6#1)(2008-9#2)(2012-3#4)
normal structure##2##2##(2008-10#1)(2008-9#1)
normal subjects and##2##3##(2006-6#1)(2008-7#1)
normal subjects performed##2##3##(2008-7#1)(2009-8#1)
normal subjects##21##2##(1991-1#1)(1991-2#1)(1991-8#1)(1992-6#1)(1994-12#2)(1995-5#1)(1995-8#1)(2006-6#1)(2008-5#1)(2008-7#6)(2008-9#1)(2009-8#2)(2012-2#1)(2012-3#1)
normal testicular##3##2##(2008-10#1)(2009-10#2)
normal thyroid tissue##2##3##(1994-11#1)(2008-12#1)
normal tissue##9##2##(1990-5#1)(1992-3#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-4#1)(2011-2#1)(2013-8#1)
normal tissues##9##2##(1990-12#1)(1990-5#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#1)
normal upright##2##2##(1994-8#2)
normal usage##3##2##(2008-10#1)(2008-5#2)
normal value in##2##3##(1992-9#1)(1993-3#1)
normal value##4##2##(1992-9#1)(1993-3#1)(2009-7#1)(2013-1#1)
normal values for##2##3##(2013-3#2)
normal values##9##2##(2008-12#1)(2008-5#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-3#2)
normal variants##6##2##(1996-9#1)(2010-1#4)(2010-4#1)
normal volunteers##2##2##(1996-2#2)
normal weight##2##2##(2009-1#1)(2011-2#1)
normal with##2##2##(2010-4#1)(2013-1#1)
normal##1152##1##(1990-11#3)(1990-12#17)(1990-2#8)(1990-5#16)(1990-6#5)(1990-8#1)(1990-9#5)(1991-1#2)(1991-11#7)(1991-12#6)(1991-2#7)(1991-3#4)(1991-5#7)(1991-6#5)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#13)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#4)(1992-9#10)(1993-1#6)(1993-11#10)(1993-12#10)(1993-2#6)(1993-3#6)(1993-6#7)(1993-8#5)(1994-11#12)(1994-12#5)(1994-2#2)(1994-3#5)(1994-5#6)(1994-6#1)(1994-8#14)(1994-9#1)(1995-11#5)(1995-12#8)(1995-2#15)(1995-3#2)(1995-5#9)(1995-6#6)(1995-8#9)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#1)(1996-2#10)(1996-3#5)(1996-6#5)(1996-8#1)(1996-9#4)(1997-1#6)(1997-2#6)(1997-3#16)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#23)(2006-6#9)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#10)(2008-10#110)(2008-11#65)(2008-12#16)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#53)(2008-6#4)(2008-7#61)(2008-8#14)(2008-9#39)(2009-1#3)(2009-10#11)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#6)(2009-7#5)(2009-8#11)(2009-9#1)(2010-1#8)(2010-10#7)(2010-11#12)(2010-12#16)(2010-3#1)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#10)(2010-8#5)(2010-9#3)(2011-1#14)(2011-2#64)(2011-3#7)(2012-12#10)(2012-2#41)(2012-3#43)(2012-7#1)(2013-1#44)(2013-3#2)(2013-7#2)(2013-8#10)
normal&quot##8##1##(1992-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
normal)##5##1##(1991-11#1)(1996-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
normal-appearing##2##1##(1993-11#1)(2011-2#1)
normal-hearing adults were##2##3##(2008-9#2)
normal-hearing adults##4##2##(2008-9#4)
normal-hearing##5##1##(2008-9#5)
normal-phase HPLC##2##2##(2008-10#2)
normal-phase LC##2##2##(2008-10#2)
normal-phase##8##1##(1997-2#1)(2008-10#7)
normalisation of##2##2##(2013-1#1)(2013-8#1)
normalised##3##1##(1993-8#1)(2008-10#1)(2011-2#1)
normality of##2##2##(2008-10#1)(2009-10#1)
normality##6##1##(1996-3#1)(2008-10#2)(2009-10#1)(2009-9#1)(2010-7#1)
normalization of##5##2##(1991-11#1)(1996-9#1)(2008-10#1)(2008-7#1)(2010-7#1)
normalization##14##1##(1991-11#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-7#4)(2009-10#1)(2009-8#1)(2010-7#1)(2013-1#2)
normalized by##3##2##(1993-2#1)(1996-2#1)(2008-5#1)
normalized concentrations##2##2##(2008-10#2)
normalized for##2##2##(2008-10#1)(2008-11#1)
normalized height of##3##3##(2008-10#3)
normalized integrated amplitude##2##3##(1990-9#2)
normalized the##2##2##(1996-2#1)(2011-2#1)
normalized to##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
normalized with##2##2##(1994-8#1)(2011-2#1)
normalized##50##1##(1990-6#1)(1990-9#3)(1993-2#3)(1994-8#1)(1996-2#3)(1996-3#1)(1997-5#1)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
normalizing##8##1##(1995-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#2)
normally a##2##2##(1994-11#1)(2008-10#1)
normally associated with##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
normally at##2##2##(2008-10#1)(2008-11#1)
normally distributed data##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
normally distributed response variables##2##4##(1995-12#2)
normally distributed##13##2##(1992-11#1)(1994-2#1)(1995-12#2)(1995-5#1)(2008-10#3)(2008-3#3)(2013-1#2)
normally found in the##2##4##(2008-1#1)(2008-10#1)
normally have##2##2##(2008-11#1)(2008-5#1)
normally heterothallic##2##2##(2008-10#2)
normally in##4##2##(1992-12#1)(1993-6#1)(1996-6#1)(2008-11#1)
normally involved in the regulation of the##2##7##(1993-6#2)
normally occurs in##2##3##(1995-6#1)(2008-5#1)
normally occurs##4##2##(1994-11#1)(1995-6#1)(2008-5#1)(2009-10#1)
normally only##2##2##(1997-3#2)
normally present in##2##3##(1992-9#1)(2008-10#1)
normally to##2##2##(1993-6#1)(2008-7#1)
normally used in##3##3##(2008-10#2)(2010-1#1)
normally used##4##2##(2008-10#2)(2008-3#1)(2010-1#1)
normally##126##1##(1990-12#1)(1990-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-6#4)(1994-11#3)(1994-2#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#5)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#24)(2008-11#16)(2008-3#6)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#5)(2009-11#1)(2009-12#3)(2009-9#1)(2010-1#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
normals and##2##2##(1995-12#1)(2008-6#1)
normals##5##1##(1990-9#1)(1995-12#1)(2008-6#3)
normative data for##2##3##(2011-1#2)
normative data##6##2##(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#3)
normative##16##1##(2008-1#1)(2008-11#3)(2008-12#4)(2008-9#1)(2009-10#2)(2010-9#1)(2011-1#4)
normo- and##2##2##(2008-10#1)(2011-2#1)
normoalbuminuric patients##2##2##(1992-9#1)(1997-8#1)
normocapnia##2##1##(1995-11#1)(2008-7#1)
normoglycemic##3##1##(1992-8#1)(2010-11#1)(2010-8#1)
normotensive and##2##2##(1994-2#1)(2010-4#1)
normotensive females##3##2##(2010-7#3)
normotensive subjects##2##2##(2008-10#1)(2012-2#1)
normotensive##13##1##(1994-2#1)(2008-10#1)(2008-11#1)(2010-4#3)(2010-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
normotensives##2##1##(2008-9#1)(2012-2#1)
normothermia##2##1##(1995-11#1)(2013-8#1)
normothermic CA1##2##2##(1996-12#2)
normothermic##9##1##(1990-11#1)(1994-2#2)(1996-12#4)(2008-7#2)
normovolemic##2##1##(1990-11#1)(1992-3#1)
normoxia##3##1##(1994-5#1)(1996-12#1)(2010-8#1)
normoxic##7##1##(1994-5#5)(1997-1#1)(2009-11#1)
norms and##5##2##(1993-3#1)(2008-1#2)(2011-1#1)(2013-1#1)
norms are##3##2##(1990-2#1)(1994-3#2)
norms for##4##2##(2008-10#1)(2008-8#2)(2012-3#1)
norms were flat##2##3##(2008-8#2)
norms were##3##2##(2008-8#2)(2013-1#1)
norms##43##1##(1990-2#1)(1991-12#1)(1993-3#2)(1994-3#4)(1995-2#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-8#8)(2010-10#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#11)
norovirus##7##1##(2013-8#7)
norscopolamine##2##1##(2008-10#2)
north Indian##3##2##(2008-12#2)(2009-6#1)
north america##6##2##(2008-10#6)
north and south of##2##4##(2008-10#2)
north and##5##2##(2008-10#3)(2008-12#1)(2012-3#1)
north central division meeting##7##4##(2008-11#7)
north central##10##2##(2008-10#2)(2008-11#7)(2008-12#1)
north in##2##2##(2008-10#1)(2008-9#1)
north of Iran##2##3##(2008-10#2)
north of the##2##3##(1995-6#1)(2008-12#1)
north of##10##2##(1995-6#1)(2008-10#5)(2008-12#1)(2010-7#1)(2011-1#1)(2012-2#1)
north##55##1##(1992-11#1)(1995-6#1)(1996-8#1)(2008-10#22)(2008-11#9)(2008-12#6)(2008-9#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
north-central United States##4##3##(2008-10#4)
north-central##10##1##(2008-10#10)
north-south##3##1##(2008-10#3)
north-west##3##1##(1996-11#2)(2010-8#1)
north-western##6##1##(2011-2#1)(2012-12#4)(2013-1#1)
northeast of##2##2##(2008-10#2)
northeast##5##1##(2008-10#4)(2008-9#1)
northeastern and potomac divisions meeting##2##5##(2008-11#2)
northeastern and##3##2##(2008-11#2)(2009-7#1)
northeastern division meeting##6##3##(2008-11#6)
northeastern##23##1##(1995-2#1)(1996-1#1)(2008-10#5)(2008-11#10)(2008-12#1)(2008-6#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
northern California##7##2##(1991-7#1)(1992-2#1)(2008-10#5)
northern Great Plains of##2##4##(2008-10#2)
northern Great Plains##3##3##(2008-10#3)
northern India##2##2##(2007-12#1)(2008-11#1)
northern Italy##7##2##(1990-2#1)(1990-8#1)(1993-2#2)(1994-8#1)(2011-2#1)(2012-7#1)
northern Japan##3##2##(2008-10#1)(2010-8#2)
northern Sudanese women##3##3##(2013-1#3)
northern United States##2##3##(2008-10#2)
northern and southern##2##3##(2008-10#2)
northern and##3##2##(2008-10#3)
northern blot analysis##2##3##(2008-10#2)
northern blot hybridization##3##3##(2008-10#2)(2008-4#1)
northern blot##8##2##(2008-10#7)(2008-4#1)
northern countries##2##2##(2011-2#2)
northern regions##2##2##(2008-10#1)(2011-2#1)
northern##94##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-11#1)(1997-8#1)(2007-12#1)(2008-10#44)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#4)(2010-3#1)(2010-8#3)(2010-9#4)(2011-2#7)(2012-7#2)(2013-1#4)(2013-8#1)
northward##3##1##(2008-10#1)(2008-8#1)(2010-1#1)
northwest##4##1##(1996-8#1)(2008-10#2)(2008-12#1)
northwestern##4##1##(1992-1#1)(2008-10#3)
norvancomycin##2##1##(2008-10#2)
norvancomycin-bonded chiral stationary phase##2##4##(2008-10#2)
norway##2##1##(2008-10#2)
nos##2##1##(2008-11#2)
noscapine##8##1##(2008-10#3)(2008-11#5)
nose and throat specialists##2##4##(1993-2#2)
nose and##3##2##(1993-2#2)(2008-5#1)
nose was##2##2##(2008-10#1)(2008-5#1)
nose##34##1##(1990-9#3)(1993-2#2)(1997-3#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#6)(2008-7#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
nosocomial infection##2##2##(2009-6#1)(2012-2#1)
nosocomial infections in##2##3##(2008-5#1)(2013-8#1)
nosocomial infections##6##2##(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
nosocomial##19##1##(1992-9#1)(1996-2#1)(2008-10#2)(2008-5#1)(2009-6#2)(2010-11#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#3)
nosological classification##2##2##(1990-3#1)(1991-2#1)
nosology of##2##2##(1993-11#1)(2008-7#1)
not &quot##5##2##(1995-3#1)(1997-3#1)(2008-11#1)(2008-8#1)(2013-8#1)
not a consequence of##2##4##(1991-5#1)(2008-10#1)
not a direct##2##3##(2008-9#1)(2013-1#1)
not a good##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
not a major##5##3##(1994-1#2)(1994-8#1)(2008-10#1)(2010-11#1)
not a prerequisite for##2##4##(1991-8#1)(1995-11#1)
not a problem##2##3##(1997-1#1)(2008-10#1)
not a strong##2##3##(1995-6#1)(2008-10#1)
not a substitute for##2##4##(1991-1#1)(2008-5#1)
not a##102##2##(1990-5#2)(1991-1#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-6#5)(1996-1#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#15)(2008-11#15)(2008-12#5)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-2#8)(2012-2#3)(2012-3#1)(2013-1#6)
not able to##14##3##(1992-3#1)(2008-10#3)(2008-11#2)(2008-8#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
not absorbed##2##2##(2008-3#2)
not abstract##2##2##(2009-4#1)(2009-6#1)
not accept##2##2##(1990-6#1)(2008-12#1)
not acclimated to##2##3##(2008-7#1)(2008-8#1)
not accompanied by any##2##4##(1995-2#1)(2008-10#1)
not accompanied by##4##3##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)
not account for the##6##4##(1994-3#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
not account for##10##3##(1994-3#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
not accounted for in##2##4##(2010-11#1)(2010-6#1)
not accounted for##5##3##(1993-12#1)(2008-12#2)(2010-11#1)(2010-6#1)
not accumulate##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
not accurately##2##2##(2008-8#1)(2010-5#1)
not achieve##5##2##(1994-2#1)(1997-7#1)(2008-10#1)(2008-7#2)
not act##7##2##(1993-8#2)(1995-6#1)(2008-10#1)(2008-8#2)(2010-10#1)
not activate##3##2##(1993-3#1)(1993-8#1)(2008-10#1)
not active##4##2##(1995-6#1)(2008-11#1)(2011-3#2)
not actually##4##2##(1991-11#1)(1994-8#1)(2008-11#1)(2012-12#1)
not additive##2##2##(1992-6#1)(1995-11#1)
not adequate##4##2##(1993-3#1)(1997-8#1)(2008-10#2)
not adequately##13##2##(1990-11#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
not adhere to##2##3##(1992-3#1)(1996-3#1)
not adopt##2##2##(1997-6#1)(2008-10#1)
not adversely##3##2##(1991-1#1)(1992-2#1)(2010-11#1)
not advocated##2##2##(1991-12#1)(2008-4#1)
not affect cell growth##2##4##(1995-6#1)(2008-11#1)
not affect growth rate##2##4##(1996-3#1)(2007-11#1)
not affect the determination##2##4##(2008-10#2)
not affect the overall##2##4##(1991-2#1)(2011-2#1)
not affect the##70##3##(1991-2#1)(1991-8#1)(1992-3#2)(1993-11#1)(1993-8#2)(1994-5#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#25)(2008-11#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
not affect this##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
not affect##123##2##(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1993-11#1)(1993-8#2)(1994-12#1)(1994-5#2)(1994-8#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#43)(2008-11#9)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)
not affected by the##14##4##(1990-11#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-9#2)
not affected by##44##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1992-3#1)(1992-6#1)(1993-2#2)(1994-2#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-8#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-4#1)(2008-9#2)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
not affected in##2##3##(2008-10#2)
not affected##67##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-6#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
not after##3##2##(1993-12#1)(1994-2#1)(2008-5#1)
not age##3##2##(1990-11#1)(2008-9#1)(2011-2#1)
not agree##3##2##(2008-8#1)(2011-10#1)(2013-1#1)
not all of the##3##4##(1994-5#1)(2010-3#1)(2012-12#1)
not all the##3##3##(1995-2#1)(1995-9#1)(2008-7#1)
not all##41##2##(1990-2#1)(1991-10#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-6#2)(1995-9#1)(1997-9#1)(2008-10#10)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)
not allow for##5##3##(1995-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
not allow##16##2##(1994-3#1)(1995-2#1)(2008-10#7)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-5#1)
not allowed to##2##3##(1995-1#1)(2008-10#1)
not alter the##17##3##(1990-3#1)(1990-5#1)(1991-10#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2009-9#1)(2010-9#1)(2011-2#1)
not alter##30##2##(1990-3#1)(1990-5#1)(1991-10#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-8#2)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
not altered by##6##3##(1990-5#1)(1993-8#1)(1994-3#1)(1995-11#1)(2008-11#2)
not altered in##2##3##(1997-2#1)(2011-2#1)
not altered##12##2##(1990-5#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#3)(2011-2#1)
not always be##2##3##(1996-12#1)(2009-1#1)
not always correlate##2##3##(2008-1#1)(2008-9#1)
not always easy##4##3##(1991-3#1)(2008-11#2)(2010-9#1)
not always lead to##2##4##(1990-11#1)(1991-2#1)
not always successful##2##3##(1993-9#1)(2008-10#1)
not always yield##2##3##(2008-10#2)
not always##62##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-8#1)
not amenable to##2##3##(2008-10#1)(2013-1#1)
not among##3##2##(2008-11#2)(2012-2#1)
not amplified##3##2##(2008-10#3)
not amplify##7##2##(2008-10#4)(2008-11#1)(2008-3#1)(2009-6#1)
not an important##2##3##(2008-10#1)(2011-3#1)
not an##16##2##(1990-5#1)(1996-11#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2011-3#1)(2012-12#1)
not answer##2##2##(1991-12#1)(1993-12#1)
not any##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
not apparent until##2##3##(1995-11#1)(2008-7#1)
not apparent##7##2##(1995-11#1)(1996-2#1)(2008-10#2)(2008-7#1)(2010-8#1)(2013-1#1)
not appear to affect##3##4##(1994-3#1)(2008-7#1)(2008-9#1)
not appear to be a##2##5##(1995-1#1)(2008-10#1)
not appear to be involved##3##5##(2008-10#3)
not appear to be##21##4##(1991-2#1)(1991-4#2)(1991-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#2)
not appear to influence##2##4##(2008-11#1)(2012-12#1)
not appear to result in##2##5##(1997-1#1)(2012-3#1)
not appear to##47##3##(1990-7#1)(1991-2#1)(1991-4#2)(1991-6#1)(1992-9#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#2)(1997-1#2)(1997-4#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
not appear##53##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1992-9#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#2)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
not applicable for##2##3##(1995-3#1)(2008-10#1)
not applicable to##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
not applicable##7##2##(1993-12#1)(1995-3#1)(2008-10#3)(2008-3#1)(2008-9#1)
not applied##3##2##(2008-10#2)(2010-5#1)
not apply to the##2##4##(1995-2#1)(2008-4#1)
not apply to##7##3##(1995-12#2)(1995-2#2)(1996-5#1)(2008-10#1)(2008-4#1)
not apply##9##2##(1994-12#1)(1995-12#2)(1995-2#2)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
not appropriate for##2##3##(2008-3#1)(2008-8#1)
not appropriate##5##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
not arise##2##2##(1996-5#1)(2008-10#1)
not as a##5##3##(1995-12#1)(1996-1#1)(2008-12#1)(2008-5#2)
not as clear##2##3##(2008-10#1)(2010-6#1)
not as good##2##3##(2009-6#1)(2010-7#1)
not as high as##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
not as##32##2##(1990-12#1)(1991-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-7#2)(2011-2#1)(2013-1#2)
not assessed##2##2##(1996-3#1)(2012-5#1)
not assigned##2##2##(1997-6#1)(2011-2#1)
not associated with a##3##4##(2008-12#1)(2008-4#1)(2012-2#1)
not associated with significant##2##4##(2008-7#1)(2011-1#1)
not associated with the##4##4##(1996-12#1)(2008-10#2)(2009-8#1)
not associated with##45##3##(1991-9#1)(1992-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#2)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
not at all##8##3##(1990-11#1)(1992-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#2)
not at##32##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-3#1)(1994-5#1)(1995-8#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#2)
not attached to##2##3##(2008-10#1)(2013-1#1)
not attended##2##2##(1991-6#2)
not attenuate the##2##3##(1990-2#1)(2013-1#1)
not automatically##2##2##(1993-12#1)(2010-2#1)
not available for##5##3##(1993-2#1)(2008-10#2)(2008-11#1)(2012-12#1)
not available##17##2##(1990-6#1)(1993-1#1)(1993-2#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#2)(2011-2#1)(2011-3#1)(2012-12#1)
not based on##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
not based##5##2##(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
not be able to##4##4##(1994-2#1)(1996-2#1)(2008-11#1)(2013-8#1)
not be affected##2##3##(2008-10#1)(2008-8#1)
not be appropriate for##2##4##(2008-10#1)(2008-8#1)
not be appropriate##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
not be associated with##3##4##(2006-6#1)(2008-8#1)(2013-1#1)
not be assumed##2##3##(1991-1#1)(1995-12#1)
not be attributed to##3##4##(1993-6#1)(1994-5#1)(2008-7#1)
not be available##4##3##(1997-8#1)(2008-10#2)(2008-12#1)
not be avoided##2##3##(1993-11#1)(1995-2#1)
not be considered as##2##4##(2008-8#1)(2013-1#1)
not be considered##7##3##(1996-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
not be detected by##4##4##(1991-3#1)(1996-12#1)(2008-10#1)(2010-12#1)
not be detected##10##3##(1991-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
not be effective##2##3##(2011-3#1)(2012-2#1)
not be expected to##2##4##(1993-1#1)(2008-10#1)
not be fully##2##3##(2008-11#1)(2010-8#1)
not be ignored##2##3##(2008-10#1)(2013-8#1)
not be involved in the##2##5##(2008-8#1)(2011-2#1)
not be involved##3##3##(2008-8#2)(2011-2#1)
not be necessary##2##3##(1992-12#1)(1996-12#1)
not be neglected##2##3##(2008-11#1)(2012-3#1)
not be observed##3##3##(1994-11#1)(2007-12#1)(2008-10#1)
not be obtained##3##3##(1994-12#1)(2008-10#1)(2008-2#1)
not be present in##2##4##(2008-10#1)(2010-11#1)
not be reached##2##3##(2011-1#1)(2013-8#1)
not be required to##2##4##(1996-1#1)(2008-7#1)
not be resolved##2##3##(2008-10#2)
not be sufficient to##2##4##(2008-7#1)(2010-11#1)
not be the primary##2##4##(2008-10#1)(2008-9#1)
not be the##8##3##(2008-10#2)(2008-8#1)(2008-9#2)(2011-2#2)(2012-3#1)
not be underestimated##2##3##(2008-11#1)(2013-1#1)
not be used for##2##4##(1997-5#1)(2008-10#1)
not be used##10##3##(1994-3#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
not be useful##2##3##(2008-10#1)(2008-4#1)
not be##274##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-8#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-8#3)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#76)(2008-11#14)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#14)(2008-8#14)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#8)(2013-8#5)
not because##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
not become##7##2##(1990-9#1)(1993-12#1)(2008-10#4)(2010-7#1)
not been associated##2##3##(2009-6#1)(2012-3#1)
not been available##2##3##(2008-10#1)(2012-3#1)
not been characterized##3##3##(1990-11#1)(1995-6#1)(2008-9#1)
not been clearly defined##2##4##(2011-2#1)(2012-2#1)
not been clearly elucidated##2##4##(2008-11#1)(2011-2#1)
not been clearly##5##3##(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#1)
not been completed##2##3##(1996-3#1)(2008-10#1)
not been considered##2##3##(2012-3#1)(2013-1#1)
not been described in##2##4##(2011-2#1)(2012-2#1)
not been described previously##3##4##(1995-6#1)(2008-10#1)(2008-12#1)
not been described##9##3##(1991-6#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)
not been detected##2##3##(2008-10#1)(2013-1#1)
not been determined##7##3##(1992-10#1)(1992-12#1)(2008-10#3)(2010-4#1)(2012-3#1)
not been documented##2##3##(2007-12#1)(2008-4#1)
not been established##5##3##(1995-12#1)(1996-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
not been evaluated##3##3##(2008-11#1)(2009-11#1)(2013-1#1)
not been extensively##5##3##(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
not been found##4##3##(1993-6#1)(2008-10#2)(2008-4#1)
not been fulfilled##2##3##(1997-1#1)(2012-12#1)
not been fully elucidated##3##4##(1990-2#1)(2007-11#1)(2008-6#1)
not been fully established##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
not been fully##12##3##(1990-2#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-8#1)(2011-2#1)
not been identified##7##3##(1992-6#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)
not been implemented##2##3##(1994-1#1)(2011-2#1)
not been implicated##2##3##(2008-10#1)(2011-2#1)
not been investigated##6##3##(2008-11#2)(2008-12#1)(2009-10#1)(2009-8#1)(2010-8#1)
not been observed in##2##4##(1993-2#1)(2008-2#1)
not been observed##6##3##(1993-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
not been previously described##3##4##(2008-7#2)(2010-1#1)
not been previously reported##8##4##(1996-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-7#1)(2010-6#1)
not been previously##15##3##(1996-12#1)(2008-10#5)(2008-3#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-1#1)(2010-6#1)(2012-3#1)
not been reported for##3##4##(2008-10#3)
not been reported previously##2##4##(1997-3#1)(2008-10#1)
not been reported##22##3##(1997-3#1)(1997-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-6#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
not been rigorously##3##3##(1997-3#1)(2008-10#1)(2009-7#1)
not been shown to##2##4##(2008-10#1)(2008-7#1)
not been studied##9##3##(1996-1#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
not been subjected to##4##4##(2008-11#2)(2012-3#2)
not been tested##5##3##(1990-6#1)(2008-8#2)(2013-1#1)(2013-8#1)
not been validated##4##3##(2011-2#2)(2013-1#2)
not been very##2##3##(2008-10#1)(2008-5#1)
not been well documented in##2##5##(1997-8#1)(2008-12#1)
not been well##7##3##(1991-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)
not been widely##4##3##(2009-4#1)(2009-6#1)(2010-6#1)(2011-1#1)
not been yet##2##3##(2010-12#1)(2011-2#1)
not been##241##2##(1990-11#2)(1990-2#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-8#1)(1997-9#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#49)(2008-11#27)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#8)(2012-3#8)(2012-7#1)(2013-1#9)(2013-8#2)
not being met##2##3##(2010-10#1)(2013-1#1)
not being##10##2##(1992-1#1)(1994-1#1)(1997-3#1)(2008-11#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
not believe that##2##3##(1993-6#1)(2010-8#1)
not belonging to the FS##2##5##(1991-12#2)
not benefit##2##2##(2008-8#1)(2013-8#1)
not between##5##2##(1991-12#1)(1994-8#1)(2008-7#1)(2008-8#1)(2010-9#1)
not bind##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
not bring about##2##3##(2008-10#1)(2013-8#1)
not bring##4##2##(2008-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
not by a##3##3##(1994-2#2)(2008-5#1)
not by##50##2##(1992-12#1)(1992-3#2)(1992-8#2)(1993-12#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#3)(1997-7#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-9#1)(2010-5#1)
not capable of##3##3##(1992-6#1)(2008-11#1)(2009-5#1)
not carry the##3##3##(1991-3#1)(1995-12#1)(2008-7#1)
not catalyze the##2##3##(1992-3#1)(2008-10#1)
not catalyze##4##2##(1992-3#2)(1996-2#1)(2008-10#1)
not cause a##2##3##(1991-5#1)(1996-6#1)
not cause any##5##3##(1990-2#1)(2008-10#2)(2008-5#1)(2013-1#1)
not cause symptoms##3##3##(2008-10#3)
not cause##29##2##(1990-2#1)(1991-5#1)(1994-11#1)(1994-5#1)(1996-6#1)(2008-10#16)(2008-12#2)(2008-5#2)(2013-1#3)(2013-8#1)
not caused by##6##3##(1996-5#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
not change either the##2##4##(1992-3#1)(2008-5#1)
not change the##13##3##(1990-11#1)(1992-4#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-8#1)
not change with##4##3##(1990-3#1)(2008-10#2)(2008-8#1)
not change##62##2##(1990-11#1)(1990-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#2)(1997-2#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
not changed by##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
not changed significantly##2##3##(1991-6#1)(2008-11#1)
not changed##13##2##(1991-12#1)(1991-6#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
not clear##24##2##(1993-12#1)(2008-10#5)(2008-11#7)(2008-5#2)(2008-8#1)(2009-8#2)(2009-9#1)(2013-1#4)(2013-7#1)
not clearly##8##2##(1997-4#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
not closely related to##3##4##(1990-5#1)(2008-10#2)
not coincide with the##2##4##(2008-10#1)(2010-8#1)
not come##2##2##(2008-10#2)
not comfortable with##2##3##(1996-5#1)(2011-2#1)
not common in Kent County##2##5##(2008-10#2)
not common##5##2##(1991-6#1)(2008-10#4)
not commonly used in##3##4##(1993-12#2)(2008-10#1)
not commonly##6##2##(1993-12#2)(2008-10#2)(2008-8#1)(2008-9#1)
not communicate##2##2##(1995-12#1)(2008-5#1)
not compatible with##2##3##(1995-6#1)(2008-7#1)
not compete with##2##3##(1990-8#1)(2008-11#1)
not compete##4##2##(1990-8#1)(2008-10#1)(2008-11#2)
not complete##5##2##(1995-9#1)(2008-10#3)(2008-4#1)
not completely understood##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
not completely##23##2##(1990-8#1)(1991-5#1)(1994-2#1)(1994-9#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
not comply with the##2##4##(2008-9#1)(2011-2#1)
not comply with##3##3##(1996-3#1)(2008-9#1)(2011-2#1)
not compromised##3##2##(1993-1#1)(1995-2#1)(2008-10#1)
not conclusive##3##2##(1997-4#2)(2012-2#1)
not conclusively##2##2##(2008-5#1)(2008-9#1)
not confer##3##2##(1994-9#1)(2008-10#1)(2009-6#1)
not confirm##3##2##(1991-8#1)(2008-12#1)(2011-2#1)
not confirmed##5##2##(1990-6#2)(1992-2#1)(2008-11#1)(2011-2#1)
not conform to##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
not connected##2##2##(2008-11#1)(2013-8#1)
not consider##5##2##(1996-1#1)(1997-2#1)(2008-10#2)(2008-8#1)
not considered##13##2##(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#1)(2013-1#2)
not consistent across##2##3##(2008-10#1)(2013-8#1)
not consistent with the hypothesis##2##5##(2008-10#2)
not consistent with the##3##4##(1996-5#1)(2008-10#2)
not consistent with##7##3##(1996-5#1)(2008-10#5)(2008-11#1)
not consistent##11##2##(1996-5#1)(2008-10#7)(2008-11#1)(2008-6#1)(2013-8#1)
not consistently##14##2##(1990-5#1)(1994-3#1)(2008-10#10)(2012-12#1)(2012-2#1)
not constant##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
not constitute##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
not contain a##2##3##(1991-6#1)(2008-10#1)
not contain any##4##3##(1992-6#1)(1993-12#1)(2008-11#1)(2011-1#1)
not contain the##6##3##(1996-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
not contain##19##2##(1991-6#1)(1992-10#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
not containing##6##2##(1994-11#1)(2008-10#4)(2008-11#1)
not contribute to##4##3##(1994-12#1)(1995-11#1)(1995-2#1)(2008-3#1)
not contribute##6##2##(1991-12#1)(1994-12#1)(1995-11#1)(1995-2#1)(2008-11#1)(2008-3#1)
not control##3##2##(2008-10#2)(2008-12#1)
not controlled by##5##3##(1994-2#1)(2008-10#3)(2011-2#1)
not controlled##6##2##(1994-2#1)(2008-10#3)(2011-2#1)(2012-2#1)
not conventionally##2##2##(2008-12#1)(2010-5#1)
not correlate to##2##3##(2011-2#1)(2012-2#1)
not correlate with##16##3##(1991-12#2)(1991-2#1)(1991-5#1)(1994-2#1)(1995-12#1)(1996-8#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#2)(2013-1#1)(2013-8#1)
not correlate##26##2##(1991-12#2)(1991-2#1)(1991-5#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-9#2)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
not correlated to##3##3##(1994-6#1)(2008-10#2)
not correlated with##14##3##(1991-8#1)(1992-9#1)(1995-8#1)(2008-10#8)(2008-9#1)(2010-6#1)(2011-1#1)
not correlated##21##2##(1991-8#1)(1992-9#1)(1994-6#1)(1995-8#1)(2008-10#13)(2008-11#1)(2008-9#1)(2010-6#1)(2011-1#1)
not correspond to##5##3##(2008-10#4)(2008-3#1)
not coupled##3##2##(1992-6#1)(1995-11#1)(2008-10#1)
not cover##3##2##(1994-8#2)(2008-10#1)
not covered##3##2##(1995-12#1)(2010-11#1)(2012-12#1)
not cross##2##2##(1990-8#1)(2009-4#1)
not cross-react with##2##3##(1992-6#1)(2008-4#1)
not currently##4##2##(1991-1#1)(1994-12#1)(2008-11#1)(2012-2#1)
not cytotoxic##2##2##(1994-8#1)(2008-11#1)
not decide##2##2##(1990-11#1)(2008-11#1)
not decrease the##2##3##(1990-12#1)(2008-5#1)
not decrease##11##2##(1990-12#1)(1994-2#2)(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-5#1)
not defined##4##2##(1990-3#1)(1995-12#1)(1997-4#1)(2008-7#1)
not degraded by##3##3##(1992-3#1)(1993-3#1)(1993-6#1)
not degraded##4##2##(1992-3#1)(1993-3#1)(1993-6#1)(1995-2#1)
not demonstrated##2##2##(1994-6#1)(1995-5#1)
not depend on the##2##4##(2008-7#1)(2008-8#1)
not depend on##7##3##(1995-2#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
not depend##9##2##(1991-12#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
not dependent on##11##3##(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
not dependent upon##2##3##(1995-6#1)(2008-10#1)
not dependent##13##2##(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(2006-6#1)(2008-10#3)(2008-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
not depurinate##2##2##(2008-10#2)
not derived from##2##3##(2008-10#2)
not describe##2##2##(1997-2#1)(2010-7#1)
not described in##2##3##(2008-10#1)(2011-2#1)
not described##4##2##(1991-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
not designed##3##2##(1994-3#1)(2008-9#1)(2009-10#1)
not destroyed##2##2##(1990-5#1)(2008-10#1)
not detect##13##2##(1990-5#1)(1993-8#1)(1994-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)
not detectable by##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
not detectable in##3##3##(1991-5#1)(1994-11#1)(2008-10#1)
not detectable##11##2##(1991-12#1)(1991-5#1)(1994-11#1)(2008-10#4)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
not detected any##2##3##(2008-10#1)(2012-2#1)
not detected at all##3##4##(1995-11#1)(2008-10#2)
not detected at##6##3##(1995-11#1)(2008-10#3)(2008-5#2)
not detected by##6##3##(1995-12#1)(2008-10#2)(2008-12#1)(2010-5#1)(2012-12#1)
not detected in either##2##4##(2008-10#2)
not detected in the##10##4##(1990-9#1)(1994-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
not detected in##29##3##(1990-9#1)(1991-12#1)(1994-12#1)(1996-2#1)(1997-3#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2012-12#1)(2013-1#1)
not detected with##2##3##(1995-2#1)(2012-12#1)
not detected##64##2##(1990-8#1)(1990-9#1)(1991-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-10#28)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#7)(2008-8#2)(2010-12#1)(2010-5#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
not determined##5##2##(1991-12#1)(1995-11#1)(1995-9#1)(2008-10#2)
not develop in##4##3##(1996-12#1)(2008-10#2)(2008-12#1)
not develop##9##2##(1996-12#1)(2008-10#4)(2008-12#2)(2008-5#1)(2012-2#1)
not developed##5##2##(1995-3#1)(1996-3#1)(2008-10#1)(2008-9#1)(2009-10#1)
not differ between the 2 groups##2##6##(1991-11#1)(2013-1#1)
not differ between the##6##4##(1991-11#1)(1993-3#1)(2008-10#2)(2013-1#1)(2013-8#1)
not differ between##17##3##(1991-11#1)(1992-1#1)(1993-12#1)(1993-3#1)(1996-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2013-1#1)(2013-8#3)
not differ from that##2##4##(2008-10#1)(2011-2#1)
not differ from##11##3##(1993-6#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)
not differ in##13##3##(1991-3#1)(1991-7#1)(1993-2#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-9#1)(2010-8#1)(2013-8#1)
not differ significantly from the##3##5##(2008-10#3)
not differ significantly from those##2##5##(1996-3#1)(2008-8#1)
not differ significantly from##9##4##(1994-2#1)(1996-2#1)(1996-3#1)(2008-10#5)(2008-8#1)
not differ significantly##28##3##(1993-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(2008-10#15)(2008-7#2)(2008-8#1)(2009-10#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
not differ substantially##2##3##(1994-5#1)(2013-1#1)
not differ##83##2##(1991-11#1)(1991-3#1)(1991-7#1)(1992-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(2008-10#33)(2008-11#2)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#4)
not different between the##2##4##(1991-11#1)(2008-7#1)
not different between##5##3##(1991-11#1)(1994-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
not different from##3##3##(1994-8#1)(2008-10#2)
not different##12##2##(1991-11#1)(1994-5#1)(1994-8#1)(2008-10#4)(2008-7#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
not differentiate between##2##3##(2008-11#1)(2008-8#1)
not differentiate##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
not diminish##4##2##(1994-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
not diminished##3##2##(1992-3#1)(2008-10#2)
not directly involved in##2##4##(2008-11#1)(2012-3#1)
not directly related to##2##4##(2008-10#1)(2008-7#1)
not directly##18##2##(1990-8#1)(1994-11#1)(1994-9#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2012-3#1)(2013-8#2)
not discernibly##2##2##(1990-5#1)(1994-2#1)
not discriminate##3##2##(1994-8#1)(2008-8#1)(2011-10#1)
not discussed in##2##3##(2008-10#1)(2012-2#1)
not displaced by##2##3##(1993-1#1)(2008-10#1)
not displaced##3##2##(1993-1#1)(2008-10#1)(2008-5#1)
not display##2##2##(1993-3#1)(1995-2#1)
not displayed##2##2##(2008-10#2)
not distinguish between##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
not distinguish##6##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)
not disturb the##2##3##(2008-10#1)(2012-3#1)
not disturb##4##2##(2008-10#2)(2008-6#1)(2012-3#1)
not do##2##2##(1995-11#1)(2008-11#1)
not done##2##2##(1994-8#1)(2013-1#1)
not due to a##4##4##(1990-5#1)(1994-3#1)(2008-10#1)(2008-4#1)
not due to an##4##4##(1990-8#1)(1993-6#1)(1994-2#1)(1997-1#1)
not due to any##2##4##(1995-11#1)(2008-10#1)
not due to changes in##2##5##(1993-6#1)(2008-10#1)
not due to the##8##4##(1991-10#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
not due to##33##3##(1990-5#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-2#4)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#3)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
not due##34##2##(1990-5#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-2#4)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#3)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2013-1#1)
not during##2##2##(2008-10#2)
not easily counted##2##3##(2012-2#2)
not easily##7##2##(2008-10#3)(2008-12#1)(2010-11#1)(2012-2#2)
not easy to##3##3##(1993-11#1)(1994-1#1)(2008-10#1)
not easy##6##2##(1993-11#1)(1994-1#1)(1996-3#1)(2008-10#1)(2011-7#1)(2013-1#1)
not economically##2##2##(2008-10#1)(2008-7#1)
not effective in##4##3##(2008-10#3)(2010-1#1)
not effective##11##2##(1994-11#1)(1997-1#1)(2008-10#5)(2008-11#2)(2010-1#1)(2010-6#1)
not efficient##2##2##(1997-8#1)(2008-10#1)
not eligible for##2##3##(1990-6#1)(1995-12#1)
not eliminated##3##2##(2008-5#1)(2012-3#1)(2013-8#1)
not encode##3##2##(1993-2#1)(2008-10#1)(2008-8#1)
not encountered in##2##3##(1992-3#1)(1992-4#1)
not engage in##3##3##(2008-11#1)(2010-7#1)(2013-8#1)
not engage##4##2##(2008-11#1)(2010-7#1)(2013-8#2)
not enhance##7##2##(1990-6#1)(1993-8#1)(2008-10#4)(2012-2#1)
not enough to meet##2##4##(1994-1#1)(2008-9#1)
not enough to##5##3##(1994-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
not enough##9##2##(1992-8#1)(1994-1#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)
not enter the##3##3##(1991-5#1)(2008-10#1)(2008-12#1)
not entirely clear##2##3##(2009-10#1)(2011-2#1)
not entirely##3##2##(2009-10#2)(2011-2#1)
not equal to##2##3##(2008-10#1)(2012-2#1)
not equal##6##2##(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
not equally##2##2##(2009-8#1)(2011-2#1)
not essential for##9##3##(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1995-2#1)(2008-10#2)
not essential##10##2##(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1995-2#1)(2008-10#2)(2008-11#1)
not even##3##2##(1993-2#1)(2008-10#2)
not evident##4##2##(1994-6#1)(2008-10#2)(2008-7#1)
not exactly##3##2##(2008-10#1)(2009-7#1)(2010-5#1)
not exceed##20##2##(1990-11#1)(1994-12#1)(1996-3#1)(1997-5#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
not exclude##2##2##(1991-12#1)(1997-3#1)
not exhibit any##3##3##(1997-3#1)(1997-6#1)(2011-2#1)
not exhibit##15##2##(1991-3#1)(1992-6#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2011-2#1)
not exist in##5##3##(1992-2#1)(1994-2#1)(1997-3#1)(2008-10#2)
not exist##11##2##(1990-3#1)(1992-2#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
not expect##2##2##(2008-8#2)
not expensive##4##2##(2008-10#4)
not experience##2##2##(2008-7#1)(2008-9#1)
not explain the##5##3##(1990-6#1)(1996-12#1)(1997-8#1)(2008-8#1)(2009-7#1)
not explain##6##2##(1990-6#1)(1996-12#1)(1997-8#1)(2008-8#2)(2009-7#1)
not exposed to the##2##4##(1995-12#1)(2008-10#1)
not exposed to##3##3##(1995-12#1)(2008-10#2)
not exposed##6##2##(1995-12#1)(2008-10#3)(2008-8#1)(2013-1#1)
not express##7##2##(1991-2#1)(2008-10#1)(2008-11#3)(2008-8#1)(2013-1#1)
not expressed in normal##2##4##(2008-9#1)(2013-1#1)
not expressed in##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
not expressed##5##2##(1995-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
not extend to##3##3##(2008-10#1)(2009-7#1)(2010-8#1)
not extend##4##2##(2008-10#1)(2009-7#1)(2010-8#1)(2013-1#1)
not facilitate the induction of##2##5##(1995-12#2)
not familiar with##3##3##(2010-12#1)(2010-8#1)(2013-8#1)
not far from##2##3##(2008-10#1)(2008-7#1)
not far##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
not feasible##6##2##(1991-8#1)(1995-11#1)(2008-10#3)(2013-1#1)
not find a##4##3##(1990-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
not find any##2##3##(2008-12#1)(2012-3#1)
not find##12##2##(1990-3#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
not fit the##2##3##(2008-10#1)(2013-1#1)
not fit##6##2##(1993-6#1)(1997-4#1)(2008-10#3)(2013-1#1)
not follow##6##2##(1994-9#1)(2008-3#1)(2009-11#1)(2009-4#1)(2010-11#1)(2013-1#1)
not followed by##4##3##(1997-3#1)(2009-8#1)(2010-12#1)(2013-8#1)
not for##29##2##(1990-12#1)(1990-5#1)(1992-6#1)(1993-11#1)(1993-8#2)(1996-2#2)(1997-3#1)(2008-10#10)(2008-8#1)(2008-9#2)(2009-7#2)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
not form a##2##3##(2008-10#1)(2008-5#1)
not form##14##2##(1990-5#1)(1995-8#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-9#1)
not formed##5##2##(2008-10#5)
not found for##2##3##(1996-2#1)(2008-10#1)
not found in normal##2##4##(2008-11#1)(2008-9#1)
not found in the##4##4##(1993-12#1)(1995-6#1)(2010-4#1)(2012-3#1)
not found in##19##3##(1990-3#1)(1991-9#1)(1992-8#1)(1993-12#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2012-3#1)
not found to be significantly##2##5##(1997-3#1)(2010-11#1)
not found to be##8##4##(1995-6#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
not found to##13##3##(1991-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
not found with##2##3##(1991-2#1)(2011-2#1)
not found##47##2##(1990-3#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-12#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-5#4)(2008-8#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
not free##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
not frequent##3##2##(2008-10#1)(2009-10#1)(2012-6#1)
not from the##4##3##(1990-5#1)(1996-12#1)(2008-10#1)(2008-5#1)
not from##12##2##(1990-5#1)(1994-12#1)(1996-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-9#1)
not fully explain the##3##4##(2008-7#1)(2010-9#1)(2013-8#1)
not fully known##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
not fully understood##15##3##(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
not fully##36##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
not further##5##2##(1996-2#1)(2008-10#1)(2008-11#2)(2012-2#1)
not gender##2##2##(2009-7#1)(2011-2#1)
not generally##5##2##(1991-12#1)(1994-2#1)(1996-2#1)(1997-3#1)(2008-7#1)
not generate##2##2##(2008-10#1)(2008-11#1)
not get##3##2##(2008-12#1)(2013-1#1)(2013-8#1)
not give a##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
not give##9##2##(1994-6#1)(1995-12#1)(2007-8#1)(2008-10#4)(2012-2#1)(2012-3#1)
not good##2##2##(2008-10#1)(2009-9#1)
not greater##2##2##(2008-10#1)(2008-5#1)
not greatly##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
not grow in##3##3##(2008-11#2)(2008-5#1)
not grow on##2##3##(2008-7#1)(2011-1#1)
not grow##8##2##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
not had##7##2##(1991-2#1)(1992-2#1)(1995-3#1)(2008-10#1)(2008-6#1)(2009-1#1)(2010-6#1)
not have a##19##3##(1992-2#1)(1992-5#1)(1993-12#1)(1993-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
not have an##5##3##(1995-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
not have any significant effect on##3##6##(1995-3#1)(2008-10#1)(2011-3#1)
not have any##10##3##(1990-12#1)(1994-5#1)(1995-3#1)(2008-10#5)(2008-11#1)(2011-3#1)
not have been##3##3##(1993-12#1)(1997-1#1)(2012-12#1)
not have had##2##3##(1994-12#1)(2009-3#1)
not have such##2##3##(2008-12#1)(2012-2#1)
not have the ability to##2##5##(2008-12#1)(2008-9#1)
not have the##7##3##(1992-12#1)(1996-5#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-1#1)
not have##85##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#3)(1993-8#1)(1994-12#2)(1994-5#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(2008-10#13)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)
not having##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
not help##3##2##(1997-8#1)(2008-3#1)(2008-8#1)
not high##4##2##(1993-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
not higher than 0##2##4##(2008-10#2)
not higher than##4##3##(1990-5#1)(2008-10#3)
not higher##5##2##(1990-5#1)(2008-10#3)(2008-11#1)
not hold for##2##3##(1990-8#1)(2008-5#1)
not hold##5##2##(1990-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
not host##2##2##(2008-10#2)
not hybridize##4##2##(1995-2#1)(2008-10#3)
not ideal for##2##3##(1992-3#1)(2008-1#1)
not identical to##2##3##(1993-9#1)(1997-3#1)
not identical##4##2##(1990-3#1)(1990-5#1)(1993-9#1)(1997-3#1)
not identified by##2##3##(1992-2#1)(2008-11#1)
not identified##8##2##(1990-11#1)(1992-2#1)(1994-9#1)(1996-2#1)(2008-10#2)(2008-11#1)(2012-3#1)
not impact##3##2##(2008-5#1)(2012-2#2)
not impair##3##2##(1993-1#1)(1997-7#1)(2008-7#1)
not impaired##2##2##(1994-3#1)(2008-10#1)
not impede##4##2##(1995-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
not implicated in##2##3##(2008-10#1)(2008-11#1)
not imply a##2##3##(1997-5#1)(2009-6#1)
not imply##3##2##(1990-11#1)(1997-5#1)(2009-6#1)
not important in the##2##4##(1992-8#1)(2008-10#1)
not important##4##2##(1992-8#1)(2008-10#1)(2008-8#2)
not improve the##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
not improve##21##2##(1996-12#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
not improved by##2##3##(1995-12#1)(2012-2#1)
not improved##5##2##(1995-12#1)(2008-10#2)(2009-12#1)(2012-2#1)
not in the nuclear##2##4##(1995-6#2)
not in the##49##3##(1990-5#1)(1991-1#2)(1991-2#1)(1992-1#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#2)(1995-8#2)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#4)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-3#1)(2010-5#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
not in##162##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#5)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#46)(2008-11#9)(2008-12#1)(2008-5#5)(2008-7#8)(2008-8#7)(2008-9#7)(2009-1#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-10#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
not include an##2##3##(1995-1#1)(2010-10#1)
not include##6##2##(1995-1#1)(2008-11#1)(2008-9#1)(2010-10#2)(2013-8#1)
not included in the##4##4##(2008-7#1)(2010-1#1)(2011-2#2)
not included in##6##3##(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#2)(2012-3#1)
not included##8##2##(1990-9#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#3)(2012-3#1)
not including##2##2##(1990-12#1)(2008-10#1)
not increase significantly##2##3##(2008-10#2)
not increase the##11##3##(1990-11#1)(1993-6#1)(1993-8#1)(2008-10#3)(2008-11#2)(2009-6#1)(2011-2#1)(2012-2#1)
not increase##32##2##(1990-11#1)(1991-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-6#1)(2008-10#9)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
not increased##4##2##(1992-12#1)(1997-1#1)(2008-9#1)(2011-2#1)
not induce##25##2##(1990-5#2)(1992-8#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#10)(2008-11#3)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
not induced by##4##3##(1993-8#1)(1996-12#1)(2011-2#1)(2012-2#1)
not induced##8##2##(1993-8#1)(1994-8#1)(1996-12#2)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
not infect##2##2##(2008-10#2)
not infectious##2##2##(1997-3#2)
not inferior to##2##3##(2008-11#1)(2013-1#1)
not influence the##13##3##(1990-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2010-4#1)(2013-1#1)
not influence##23##2##(1990-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2010-1#1)(2010-4#1)(2010-8#1)(2013-1#3)
not influenced by the##4##4##(1991-9#1)(2008-10#1)(2008-11#1)(2010-10#1)
not influenced by##8##3##(1990-12#1)(1991-9#1)(1995-2#1)(2008-10#3)(2008-11#1)(2010-10#1)
not influenced##12##2##(1990-12#1)(1991-9#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#1)
not inhibit##17##2##(1991-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1997-3#1)(2006-6#1)(2008-10#7)(2010-4#1)
not inhibited by##9##3##(1992-3#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
not inhibited##11##2##(1992-3#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-12#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
not inoculated with the##2##4##(2008-10#2)
not inoculated##4##2##(2008-10#4)
not intended to##2##3##(1991-1#1)(2013-8#1)
not interact with the##2##4##(1994-5#1)(2008-8#1)
not interact with##6##3##(1994-11#1)(1994-5#1)(1995-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
not interact##9##2##(1994-11#1)(1994-5#2)(1995-2#1)(1996-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
not interfere in the determination of##2##6##(2008-10#2)
not interfere in the determination##3##5##(2008-10#3)
not interfere in the##8##4##(2008-10#8)
not interfere in##10##3##(2008-10#10)
not interfere the determination##2##4##(2008-10#2)
not interfere the##5##3##(2008-10#5)
not interfere with determination##3##4##(2008-10#3)
not interfere with the proposed method##2##6##(2008-10#2)
not interfere with the##21##4##(1990-12#1)(1997-2#1)(2008-10#16)(2008-4#2)(2008-8#1)
not interfere with##34##3##(1990-12#1)(1991-5#1)(1995-2#1)(1996-6#1)(1997-2#1)(2008-10#23)(2008-11#1)(2008-4#2)(2008-8#1)(2010-8#1)(2013-8#1)
not interfere##60##2##(1990-12#1)(1991-5#1)(1995-2#1)(1996-6#1)(1997-2#1)(2008-10#49)(2008-11#1)(2008-4#2)(2008-8#1)(2010-8#1)(2013-8#1)
not interfered##2##2##(2008-10#2)
not investigated##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
not involve an##2##3##(2008-11#1)(2008-12#1)
not involve##9##2##(1995-8#2)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
not involved in the##6##4##(1993-3#1)(1995-2#1)(2008-10#3)(2008-4#1)
not involved in##13##3##(1993-3#1)(1993-6#1)(1995-2#1)(1995-8#1)(2008-10#6)(2008-4#1)(2008-6#1)(2013-1#1)
not involved##19##2##(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-9#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
not its##2##2##(2008-11#1)(2011-2#1)
not just a##3##3##(2008-7#1)(2012-12#1)(2013-1#1)
not just to##2##3##(2008-11#1)(2010-10#1)
not just##10##2##(1997-2#1)(1997-3#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-10#1)(2011-7#1)(2012-12#1)(2013-1#1)
not justified##4##2##(1992-2#1)(1992-6#1)(2008-10#2)
not know about##2##3##(1991-12#1)(2013-1#1)
not know the##2##3##(2008-10#2)
not know##14##2##(1991-12#1)(1991-3#2)(1993-3#1)(1994-12#1)(1995-1#1)(2008-10#4)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
not known to##3##3##(2010-10#1)(2012-2#1)(2012-3#1)
not known##43##2##(1990-11#1)(1990-5#1)(1992-10#1)(1992-12#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-7#2)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#6)(2010-10#1)(2010-2#1)(2010-8#1)(2012-2#3)(2012-3#3)(2013-1#1)
not large##2##2##(1992-6#1)(1993-6#1)
not lead to##10##3##(1992-6#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-5#1)(2011-3#1)
not least##5##2##(1991-3#1)(1992-3#1)(2008-11#1)(2008-5#1)(2010-11#1)
not legal##2##2##(1994-1#1)(2008-11#1)
not less than##2##3##(2008-10#2)
not lie##2##2##(2008-7#1)(2011-2#1)
not likely to be##4##4##(1992-2#1)(1995-9#1)(2008-11#1)(2009-6#1)
not likely to##8##3##(1992-12#1)(1992-2#1)(1995-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-6#1)
not likely##10##2##(1992-12#1)(1992-2#1)(1995-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-6#1)(2011-2#1)
not limit##2##2##(2007-11#1)(2008-3#1)
not limited by the##2##4##(2008-10#1)(2008-2#1)
not limited by##3##3##(2008-10#2)(2008-2#1)
not limited to##9##3##(2008-10#2)(2008-2#2)(2009-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
not limited##13##2##(2008-10#4)(2008-2#3)(2009-11#2)(2011-2#1)(2012-2#1)(2013-1#2)
not limiting##2##2##(2009-10#1)(2013-8#1)
not linear##3##2##(2008-10#3)
not linearly correlated##2##3##(2008-10#1)(2008-5#1)
not linked to the##3##4##(2008-10#3)
not linked to##8##3##(1995-2#1)(1996-3#1)(2008-10#5)(2010-1#1)
not live##2##2##(1996-2#1)(2009-6#1)
not loaded##2##2##(2013-1#2)
not located##2##2##(1994-12#1)(2008-10#1)
not lose##3##2##(1995-5#1)(2008-10#2)
not lost##2##2##(2008-9#1)(2011-2#1)
not lower than##2##3##(2008-10#1)(2008-9#1)
not lower##3##2##(2008-10#2)(2008-9#1)
not made##2##2##(2008-7#1)(2009-10#1)
not maintained##3##2##(1994-6#1)(2008-11#1)(2008-4#1)
not major contributors to##2##4##(2008-10#2)
not major##3##2##(2008-10#2)(2009-6#1)
not make##8##2##(1994-9#1)(1996-5#2)(2008-8#2)(2010-7#1)(2012-12#1)(2013-8#1)
not managed##2##2##(1994-3#1)(2013-1#1)
not manually##2##2##(2008-10#1)(2010-4#1)
not many##2##2##(1997-2#1)(2010-5#1)
not match the##4##3##(1997-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
not match##7##2##(1990-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
not matched##2##2##(2008-10#1)(2010-9#1)
not mean##2##2##(2008-10#1)(2010-12#1)
not measured##2##2##(1991-11#1)(2008-10#1)
not mediate##5##2##(1990-7#1)(1993-9#1)(1995-8#1)(1996-12#1)(2010-11#1)
not mediated by##6##3##(1994-3#2)(1994-8#1)(1996-12#1)(2008-7#1)(2009-7#1)
not mediated##8##2##(1994-3#2)(1994-8#2)(1996-12#1)(2008-5#1)(2008-7#1)(2009-7#1)
not meet the##3##3##(1991-8#1)(2008-11#1)(2012-2#1)
not meet##5##2##(1991-8#1)(1997-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
not mention##2##2##(1995-2#1)(2011-2#1)
not merely##3##2##(1990-5#1)(1990-8#1)(2012-3#1)
not met##3##2##(1991-1#1)(2010-3#1)(2013-8#1)
not modified by##3##3##(1994-3#1)(1994-8#1)(1995-12#1)
not modified##5##2##(1994-3#1)(1994-8#2)(1995-12#1)(2008-10#1)
not more##7##2##(1991-3#1)(2008-10#2)(2008-12#1)(2008-8#2)(2008-9#1)
not move##3##2##(2008-10#3)
not much##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
not naturally##2##2##(2008-10#2)
not necessarily equivalent##2##3##(2008-10#2)
not necessarily show the##2##4##(1996-9#1)(2008-10#1)
not necessarily the##4##3##(1992-3#1)(1996-3#1)(1997-5#1)(2008-10#1)
not necessarily##42##2##(1991-11#1)(1991-2#2)(1992-1#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-5#1)(2008-10#12)(2008-11#3)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
not necessary for##5##3##(1994-2#1)(2008-10#3)(2011-2#1)
not necessary to explain the##2##5##(2008-10#2)
not necessary to##8##3##(1992-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2010-7#1)(2013-8#1)
not necessary##23##2##(1990-2#1)(1990-9#1)(1992-5#1)(1994-2#1)(1995-2#1)(1997-6#1)(2008-10#11)(2008-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
not need any##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
not need the##2##3##(2008-10#2)
not need to##5##3##(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
not need##12##2##(1996-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#1)
not needed##5##2##(1994-8#1)(1996-5#1)(1997-1#1)(2008-11#1)(2011-2#1)
not negligible##3##2##(1990-6#1)(2008-1#1)(2009-10#1)
not new##3##2##(1994-12#1)(2008-12#1)(2009-10#1)
not normally distributed##2##3##(2008-3#1)(2013-1#1)
not normally##8##2##(1995-6#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
not now##2##2##(1991-12#1)(2008-6#1)
not obligated to##2##3##(1992-1#1)(1996-5#1)
not observed for##2##3##(2008-10#2)
not observed in the##11##4##(1994-11#1)(1995-11#1)(1996-2#1)(2008-10#3)(2008-11#2)(2010-10#1)(2010-12#1)(2011-1#1)
not observed in treatments with##2##5##(2008-10#2)
not observed in##31##3##(1991-12#1)(1992-3#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
not observed with##4##3##(1990-5#1)(1993-8#1)(1994-3#1)(1995-2#1)
not observed##65##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-6#2)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#22)(2008-11#6)(2008-12#2)(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
not occur in##7##3##(1990-3#1)(1990-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2013-8#1)
not occur##26##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-8#2)
not occurred##3##2##(2008-10#2)(2008-11#1)
not of the##2##3##(1993-3#1)(2008-10#1)
not of##16##2##(1990-5#2)(1993-2#1)(1993-3#1)(1995-8#1)(1996-3#1)(1997-7#2)(2008-10#4)(2008-11#1)(2009-6#1)(2010-11#1)(2013-8#1)
not offer##5##2##(1996-1#1)(1996-12#1)(2008-10#2)(2008-9#1)
not on any##2##3##(2008-9#1)(2010-12#1)
not on the##5##3##(1992-6#1)(1993-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
not on their##2##3##(1991-2#1)(1993-1#1)
not on##26##2##(1991-2#1)(1991-5#1)(1992-6#1)(1993-1#2)(1994-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(2008-10#9)(2008-5#2)(2008-8#1)(2008-9#2)(2010-12#1)(2012-2#1)(2013-8#1)
not only a##2##3##(2008-11#1)(2008-9#1)
not only able to##2##4##(2008-8#1)(2012-2#1)
not only affects##2##3##(2008-11#1)(2012-3#1)
not only an##2##3##(2008-12#1)(2008-9#1)
not only as a##2##4##(2008-10#1)(2008-9#1)
not only as##5##3##(2008-10#3)(2008-9#1)(2010-7#1)
not only at the##3##4##(2007-12#1)(2008-8#1)(2012-3#1)
not only be##2##3##(2008-10#1)(2008-9#1)
not only because##2##3##(1995-5#1)(1997-1#1)
not only by the##4##4##(1990-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
not only by##9##3##(1990-3#1)(1994-3#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
not only for##19##3##(1991-2#1)(1991-6#1)(1993-3#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
not only from##5##3##(1992-6#1)(2008-10#2)(2008-3#1)(2008-7#1)
not only improve##2##3##(2011-1#1)(2013-1#1)
not only in the##7##4##(1997-1#1)(2008-10#1)(2008-11#3)(2008-9#1)(2011-2#1)
not only in##18##3##(1994-11#1)(1995-6#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#1)
not only inhibited##2##3##(2008-10#2)
not only inhibits##2##3##(1997-6#1)(2012-2#1)
not only is the##2##4##(2008-10#1)(2008-3#1)
not only its own##2##4##(2008-9#1)(2010-6#1)
not only its##3##3##(1994-11#1)(2008-9#1)(2010-6#1)
not only of the##2##4##(2008-11#1)(2008-3#1)
not only of##7##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)
not only on the##5##4##(1991-2#2)(1995-5#1)(1997-1#1)(2008-8#1)
not only on##8##3##(1991-2#2)(1995-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-8#1)(2013-1#1)
not only provided##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
not only provides##2##3##(2008-8#1)(2012-3#1)
not only results in##2##4##(2008-8#1)(2011-2#1)
not only served##2##3##(1997-3#1)(2008-12#1)
not only the##22##3##(1991-2#1)(1992-2#2)(1992-6#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
not only to cations but also to low-molecular-weight solutes##2##9##(1990-5#2)
not only to study##2##4##(2008-11#1)(2010-3#1)
not only to the##4##4##(1993-6#1)(1994-1#1)(2008-10#1)(2009-3#1)
not only to##28##3##(1990-5#2)(1993-6#1)(1994-1#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-8#1)
not only with##4##3##(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)
not only##303##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1991-12#2)(1991-2#4)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#3)(1995-6#2)(1995-8#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#4)(1997-6#3)(1997-7#2)(1997-8#2)(2007-12#3)(2008-1#1)(2008-10#52)(2008-11#35)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#13)(2008-9#12)(2009-1#1)(2009-10#3)(2009-12#4)(2009-3#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#18)(2012-12#1)(2012-2#7)(2012-3#10)(2013-1#9)(2013-8#5)
not or##6##2##(1995-6#1)(2008-10#3)(2008-9#1)(2011-2#1)
not other##3##2##(1994-8#2)(2008-7#1)
not otherwise specified##2##3##(2012-2#1)(2012-3#1)
not otherwise##7##2##(1991-8#2)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
not ozone##2##2##(1996-1#1)(2008-10#1)
not parallel##3##2##(1991-5#1)(2008-11#2)
not part of##2##3##(1993-12#1)(2011-2#1)
not participate in the##2##4##(1997-2#1)(2008-10#1)
not pass through##3##3##(1990-5#1)(2008-10#1)(2008-6#1)
not pass##5##2##(1990-5#1)(1991-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
not pathogenic##4##2##(2008-10#4)
not penetrate into the##2##4##(2008-10#1)(2008-5#1)
not penetrate##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
not perfect##2##2##(1994-3#1)(1997-3#1)
not perform##5##2##(2008-10#1)(2008-2#1)(2008-5#1)(2009-1#1)(2009-3#1)
not performed##2##2##(1992-9#1)(1996-3#1)
not permit##3##2##(2008-10#2)(2008-9#1)
not place##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
not planning##2##2##(1993-1#1)(1997-3#1)
not play a major role in##2##6##(2009-8#2)
not play a role in##4##5##(1990-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
not play a##7##3##(1990-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#2)
not play##9##2##(1990-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#2)
not pose##2##2##(2008-10#1)(2012-12#1)
not possess the##2##3##(2008-10#2)
not possess##4##2##(2008-10#3)(2008-8#1)
not possible for##2##3##(2008-10#1)(2008-11#1)
not possible in##2##3##(2008-8#1)(2011-1#1)
not possible to confirm its##2##5##(2008-10#1)(2011-2#1)
not possible to##12##3##(1996-11#1)(2008-10#7)(2008-5#1)(2011-2#2)(2012-12#1)
not possible with the##2##4##(1993-3#1)(2008-10#1)
not possible with##4##3##(1993-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
not possible##36##2##(1990-11#1)(1991-11#1)(1993-3#1)(1994-6#1)(1996-11#1)(1996-3#1)(1997-3#2)(2008-10#15)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#5)(2012-12#1)
not potentiate the##3##3##(1993-3#1)(1996-2#1)(2008-5#1)
not practical##2##2##(2008-11#1)(2013-1#1)
not practising##2##2##(1993-1#2)
not precisely known##2##3##(1993-6#1)(1994-5#1)
not predict##16##2##(1995-12#2)(1995-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#3)(2013-1#1)
not predictive of##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)
not predictive##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)
not present any significant##2##4##(2008-10#2)
not present any##3##3##(2008-10#3)
not present in the##8##4##(1990-11#1)(2008-10#4)(2008-12#1)(2011-2#1)(2012-3#1)
not present in##11##3##(1990-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
not present##33##2##(1990-11#1)(1991-5#1)(1993-12#1)(1994-11#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#2)(2011-2#2)(2012-3#2)(2013-1#1)
not prevent##14##2##(1992-9#1)(1993-3#1)(1994-5#2)(1995-2#1)(1996-12#1)(2008-10#4)(2008-11#2)(2011-2#1)(2012-3#1)
not previously been##8##3##(1994-1#1)(1996-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2013-8#1)
not previously described##5##3##(2007-12#1)(2008-10#3)(2008-7#1)
not previously possible##2##3##(2010-4#1)(2012-2#1)
not previously reported in##2##4##(2008-10#2)
not previously reported##5##3##(1994-8#1)(2008-10#3)(2008-8#1)
not previously##28##2##(1991-6#1)(1994-1#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-7#1)(2008-8#4)(2010-4#1)(2012-2#1)(2013-8#1)
not produce a##2##3##(1993-6#1)(2008-8#1)
not produce any##2##3##(1995-2#1)(1997-1#1)
not produce significant##2##3##(2008-10#1)(2008-4#1)
not produce##32##2##(1990-12#1)(1991-7#1)(1993-6#1)(1995-2#2)(1997-1#1)(2008-10#19)(2008-4#1)(2008-5#1)(2008-8#3)(2013-1#2)
not produced by##2##3##(1994-2#1)(1995-12#1)
not produced##6##2##(1994-2#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
not promote##7##2##(1995-12#1)(2008-10#1)(2008-11#4)(2008-5#1)
not properly##5##2##(1995-6#2)(2008-10#2)(2008-11#1)
not protect##2##2##(1993-6#1)(1995-11#1)
not prove##7##2##(1990-2#1)(1991-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-4#1)
not provide any protection##2##4##(1995-11#1)(2008-10#1)
not provide any##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
not provide evidence##2##3##(1993-8#1)(2008-10#1)
not provide the##2##3##(2008-10#2)
not provide##19##2##(1991-12#1)(1991-2#1)(1992-3#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
not provided##2##2##(1991-2#1)(2008-7#1)
not purely##2##2##(2012-3#2)
not quite##3##2##(1991-6#1)(1992-11#1)(2008-9#1)
not random##3##2##(2008-10#2)(2008-8#1)
not rare##2##2##(2008-10#1)(2008-7#1)
not reach##8##2##(1991-2#1)(1993-1#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
not reached##4##2##(2008-10#2)(2009-5#1)(2012-12#1)
not react with##12##3##(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-5#1)
not react##14##2##(1990-8#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-5#1)
not read##2##2##(1994-2#1)(1996-2#1)
not readily available##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
not readily##10##2##(1991-5#1)(1993-2#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-8#1)
not real##2##2##(2009-3#1)(2013-8#1)
not realize##2##2##(1993-3#1)(1997-8#1)
not really##3##2##(1991-12#1)(1994-12#1)(2008-11#1)
not receive##12##2##(1993-1#1)(1994-5#1)(1994-6#1)(1995-1#2)(1997-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2012-3#1)(2013-8#1)
not received the##2##3##(2010-11#1)(2013-1#1)
not received##8##2##(1990-2#1)(1991-4#1)(1996-6#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
not receiving chemotherapy##3##3##(2008-7#3)
not receiving##7##2##(1994-3#1)(2008-10#2)(2008-7#3)(2011-2#1)
not recognize##4##2##(1995-6#1)(1996-2#1)(2008-4#1)(2008-8#1)
not recommend##3##2##(1996-6#1)(2012-3#2)
not recommended as##2##3##(2008-3#1)(2011-2#1)
not recommended##11##2##(1993-6#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-2#1)(2011-2#5)(2013-1#1)
not recover##6##2##(1991-9#2)(2008-7#1)(2008-8#2)(2013-8#1)
not recovered from##2##3##(2008-10#2)
not recovered##3##2##(2008-10#3)
not recur##2##2##(1993-3#1)(2008-7#1)
not reduce the##7##3##(1991-12#1)(1994-8#1)(1997-1#1)(2008-10#3)(2010-1#1)
not reduce##18##2##(1991-12#1)(1993-6#1)(1994-5#1)(1994-8#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-8#1)(2010-1#1)
not reduced in##2##3##(1993-3#1)(2011-2#1)
not reduced##9##2##(1993-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(2008-10#3)(2011-2#1)(2013-7#1)
not reflect the##2##3##(2008-5#1)(2008-7#1)
not reflect##4##2##(1996-6#1)(2008-1#1)(2008-5#1)(2008-7#1)
not reflected in the##2##4##(1996-2#1)(2009-7#1)
not reflected##4##2##(1996-2#1)(2008-11#1)(2009-7#1)(2011-2#1)
not regularly##3##2##(1993-1#1)(2008-11#1)(2008-12#1)
not related to diastolic suction##5##5##(2011-2#5)
not related to the##9##4##(1991-12#1)(1992-2#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-8#1)(2008-10#2)(2010-8#1)
not related to##41##3##(1990-8#1)(1991-12#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2013-1#1)
not related##42##2##(1990-8#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2013-1#1)
not release##5##2##(1990-11#2)(1990-2#1)(1996-2#1)(2008-11#1)
not relevant##2##2##(2008-7#1)(2010-3#1)
not reliably##3##2##(1994-8#1)(1996-11#1)(1997-5#1)
not replace##2##2##(1990-5#1)(2008-11#1)
not replaced##2##2##(1993-8#1)(2008-11#1)
not replicate##2##2##(1997-3#1)(2008-11#1)
not report##7##2##(1995-12#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
not reported in##2##3##(2008-10#1)(2010-12#1)
not reported##8##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
not represent a##5##3##(2007-12#1)(2008-10#1)(2008-5#3)
not represent the##3##3##(1996-2#1)(2008-10#1)(2010-9#1)
not represent##13##2##(1992-5#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-5#3)(2010-11#1)(2010-9#1)
not require a##6##3##(1992-3#1)(2008-10#4)(2011-2#1)
not require any separation step##3##5##(2008-10#3)
not require any separation##5##4##(2008-10#5)
not require any##15##3##(2008-10#12)(2008-11#1)(2008-9#1)(2013-8#1)
not require pretreatment of##2##4##(2008-10#2)
not require special##2##3##(1997-2#1)(2008-3#1)
not require the##9##3##(1992-6#1)(1995-6#1)(1996-2#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
not require##69##2##(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-10#28)(2008-11#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
not required for the##4##4##(1991-5#1)(1992-10#1)(1995-6#1)(2008-11#1)
not required for##11##3##(1991-5#1)(1992-10#1)(1993-12#1)(1993-6#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
not required to obtain##2##4##(2008-10#2)
not required to##4##3##(1995-2#1)(2008-10#3)
not required##25##2##(1991-5#1)(1992-10#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-12#2)(2008-10#10)(2008-11#1)(2009-5#1)(2012-2#1)(2013-1#2)
not requiring##3##2##(2009-5#1)(2009-8#1)(2010-4#1)
not resistant to##3##3##(1993-8#2)(2008-10#1)
not resolve##2##2##(2008-10#1)(2011-1#1)
not respond to conventional##2##4##(2011-2#1)(2012-12#1)
not respond to medical treatment##2##5##(1991-11#1)(1997-8#1)
not respond to##15##3##(1990-12#1)(1990-2#1)(1991-11#1)(1994-12#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
not responded to##3##3##(1997-7#1)(2011-2#1)(2013-7#1)
not responding to##2##3##(2008-1#1)(2008-9#1)
not restricted to##10##3##(1991-1#1)(1994-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
not restricted##11##2##(1991-1#1)(1994-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
not result in a##4##4##(1996-8#1)(1997-3#1)(2008-5#1)(2008-6#1)
not result in an##2##4##(1995-6#1)(2008-10#1)
not result in improved##2##4##(1997-1#1)(2009-6#1)
not result in##21##3##(1992-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-8#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)
not result##22##2##(1992-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)
not retained##5##2##(1992-6#1)(2008-10#4)
not reveal any##11##3##(1992-1#1)(1993-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
not reveal##22##2##(1992-1#1)(1993-6#1)(1997-7#1)(1997-8#1)(1997-9#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
not reverse##2##2##(1996-2#1)(1997-1#1)
not routinely##2##2##(1992-6#1)(2008-11#1)
not rule out##3##3##(1996-11#1)(2008-10#1)(2011-2#1)
not satisfactory##4##2##(1991-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
not scientifically##2##2##(2008-12#1)(2013-1#1)
not seem to be##6##4##(1991-6#1)(1992-12#1)(1995-2#1)(2010-1#1)(2011-2#1)(2012-3#1)
not seem to have a##2##5##(1990-8#1)(2009-6#1)
not seem to have##4##4##(1990-8#1)(1994-3#1)(2008-10#1)(2009-6#1)
not seem to##21##3##(1990-8#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#4)(2008-11#2)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
not seem##23##2##(1990-8#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
not seen in##3##3##(1994-5#2)(1995-11#1)
not seen on##2##3##(1997-8#1)(2012-2#1)
not seen with##2##3##(1997-8#1)(2008-8#1)
not seen##14##2##(1990-12#1)(1994-5#2)(1995-11#1)(1997-3#3)(1997-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
not selected##3##2##(2008-10#1)(2013-1#2)
not selective##2##2##(2008-10#2)
not sensitive to##10##3##(1991-6#1)(1992-8#1)(1993-9#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2012-3#1)
not sensitive##12##2##(1991-6#1)(1992-8#1)(1993-9#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2012-3#1)
not separate##5##2##(1995-6#1)(2008-10#3)(2008-12#1)
not serve as##2##3##(1996-3#1)(2008-7#1)
not share##4##2##(1992-5#1)(2013-1#1)(2013-8#2)
not shared by##2##3##(1992-6#1)(1995-11#1)
not show a significant similarity to any other gene##3##9##(1996-12#2)(1996-6#1)
not show a##9##3##(1996-12#2)(1996-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)
not show adverse##2##3##(1992-3#1)(2012-3#1)
not show any##28##3##(1990-2#2)(1990-6#1)(1992-6#1)(1994-5#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-10#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
not show significant##4##3##(2008-10#3)(2012-2#1)
not show the##4##3##(1992-9#1)(1996-2#1)(2008-11#1)(2008-7#1)
not show##68##2##(1990-2#2)(1990-6#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#1)(2013-8#2)
not shown##9##2##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2012-3#2)(2013-1#1)
not significant and##2##3##(1993-12#1)(2008-10#1)
not significant##32##2##(1992-12#1)(1992-2#2)(1993-12#1)(1994-12#2)(1996-8#1)(2008-10#13)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
not significantly affect the##3##4##(1997-7#1)(2008-2#1)(2010-8#1)
not significantly affect##4##3##(1997-7#1)(2008-10#1)(2008-2#1)(2010-8#1)
not significantly affected by##8##4##(1990-5#1)(1993-3#1)(1995-8#1)(1996-12#1)(2008-10#3)(2008-11#1)
not significantly affected##13##3##(1990-5#1)(1993-3#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-6#1)(2010-11#1)(2012-2#1)
not significantly altered by##2##4##(1992-1#1)(1992-3#1)
not significantly altered##6##3##(1992-1#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-9#1)(2012-12#1)
not significantly change the##2##4##(1994-5#1)(1995-1#1)
not significantly change##4##3##(1994-5#1)(1995-1#1)(2008-2#2)
not significantly changed by##2##4##(2008-10#1)(2008-11#1)
not significantly changed##4##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-11#1)
not significantly different among the##2##5##(2008-10#1)(2008-7#1)
not significantly different among##6##4##(2008-10#4)(2008-7#1)(2008-9#1)
not significantly different between##5##4##(1993-11#1)(1996-12#1)(2008-10#2)(2013-8#1)
not significantly different for##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
not significantly different from 1##2##5##(2008-10#2)
not significantly different from that##3##5##(2008-10#3)
not significantly different from the##5##5##(1993-1#1)(2008-10#3)(2012-3#1)
not significantly different from those##2##5##(1990-12#1)(2010-8#1)
not significantly different from##24##4##(1990-12#1)(1991-12#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-10#15)(2010-8#1)(2012-3#1)(2013-1#1)
not significantly different##56##3##(1990-12#1)(1990-6#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-12#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#28)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
not significantly improve##2##3##(1995-2#1)(2013-1#1)
not significantly induced##2##3##(2008-10#2)
not significantly lower than##2##4##(1991-11#1)(2008-10#1)
not significantly reduced by##2##4##(1992-12#1)(2008-10#1)
not significantly reduced##3##3##(1992-12#1)(2008-10#1)(2008-9#1)
not significantly##136##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-5#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#3)(1997-8#1)(2008-10#47)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
not simply##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-7#1)
not so much##2##3##(1991-6#1)(2008-4#1)
not so##16##2##(1991-12#1)(1991-6#2)(1992-2#1)(1993-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#1)(2013-8#1)
not solely##7##2##(1994-5#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
not spatially##3##2##(2008-10#3)
not specific for##3##3##(1993-8#1)(1994-11#1)(2009-11#1)
not specific##8##2##(1993-8#1)(1994-11#1)(1997-2#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
not specifically##4##2##(1997-4#1)(2008-10#2)(2008-11#1)
not spontaneously##2##2##(1997-7#1)(2008-11#1)
not stable##4##2##(2008-10#1)(2009-12#1)(2009-9#1)(2013-8#1)
not standardized##4##2##(1992-3#1)(1993-12#1)(2008-11#1)(2011-2#1)
not statistically different between##3##4##(1990-3#1)(2012-3#2)
not statistically different from##4##4##(2008-10#3)(2012-3#1)
not statistically different##12##3##(1990-3#1)(1994-2#1)(1997-8#1)(2008-10#4)(2009-1#1)(2011-2#1)(2012-3#3)
not statistically significant##30##3##(1990-11#1)(1992-2#1)(1992-4#1)(1995-5#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-8#1)(2009-3#2)(2010-7#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#1)
not statistically##43##2##(1990-11#1)(1990-3#1)(1992-2#1)(1992-4#1)(1994-2#1)(1995-5#1)(1996-3#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-8#1)(2009-1#1)(2009-3#2)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
not stimulate##5##2##(1994-6#1)(2008-10#3)(2008-11#1)
not straightforward##3##2##(1990-12#1)(2008-10#1)(2013-1#1)
not strictly##4##2##(1995-9#1)(2008-11#1)(2008-3#1)(2010-5#1)
not strongly##2##2##(2008-10#2)
not studies##2##2##(1990-11#1)(2009-8#1)
not subject to##6##3##(1991-7#1)(1995-12#1)(2008-10#2)(2008-11#1)(2012-3#1)
not subject##7##2##(1991-7#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-3#1)
not successful##7##2##(1990-5#1)(1991-2#1)(2008-10#4)(2008-7#1)
not suffer from##2##3##(2008-10#2)
not suffer##5##2##(2008-10#4)(2008-7#1)
not sufficient for##2##3##(2008-10#2)
not sufficient to##9##3##(1991-3#1)(1996-12#2)(1997-7#1)(2008-11#1)(2008-5#2)(2009-8#2)
not sufficient##18##2##(1991-3#1)(1994-5#1)(1996-12#2)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#2)(2009-8#2)(2010-3#1)(2011-2#1)
not sufficiently##3##2##(1990-9#1)(1997-4#1)(2008-10#1)
not suitable for##8##3##(2008-10#5)(2008-11#1)(2010-6#1)(2012-12#1)
not suitable##11##2##(2008-10#7)(2008-11#2)(2010-6#1)(2012-12#1)
not suited##2##2##(2008-10#1)(2008-11#1)
not superior to##2##3##(1997-8#1)(2008-3#1)
not superior##3##2##(1996-12#1)(1997-8#1)(2008-3#1)
not supplant##2##2##(1997-1#1)(2013-1#1)
not support the hypothesis##3##4##(1991-12#1)(2008-7#1)(2008-8#1)
not support the notion that##2##5##(1990-2#1)(1993-3#1)
not support the##16##3##(1990-2#2)(1991-12#1)(1992-12#1)(1993-3#1)(2008-10#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2013-8#1)
not support##30##2##(1990-2#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-5#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
not suppress the##2##3##(1996-12#1)(2008-11#1)
not suppress##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
not suppressive##2##2##(2008-10#2)
not surprising##6##2##(1991-12#1)(2008-4#1)(2008-5#2)(2010-1#1)(2011-2#1)
not survive##4##2##(2008-10#1)(2009-5#1)(2009-6#1)(2011-2#1)
not susceptible to##2##3##(2008-10#2)
not suspected##2##2##(1996-1#2)
not take into account##2##4##(2008-10#1)(2009-4#1)
not take place in##2##4##(2008-10#1)(2009-6#1)
not take place##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
not take##7##2##(1996-3#1)(2008-10#2)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
not taken##4##2##(1993-3#1)(1996-5#1)(2008-11#1)(2013-1#1)
not taking drugs##2##3##(2008-7#2)
not taking##7##2##(2008-10#1)(2008-7#2)(2010-1#4)
not the case for the##2##5##(2008-11#2)
not the case for##4##4##(2008-10#1)(2008-11#2)(2011-2#1)
not the case##6##3##(1991-6#1)(2008-10#1)(2008-11#2)(2010-3#1)(2011-2#1)
not the cause of##4##4##(1992-12#1)(1995-2#1)(1995-5#1)(2008-10#1)
not the consequence of##3##4##(1990-12#1)(1995-12#1)(2011-1#1)
not the direct cause of death##2##6##(1996-12#1)(2008-1#1)
not the limiting##2##3##(2008-10#2)
not the only##5##3##(2008-10#1)(2008-6#1)(2008-7#2)(2013-8#1)
not the physiological in vivo equilibrium volume and##5##8##(2011-2#5)
not the primary##2##3##(1996-12#1)(2008-10#1)
not the result of##6##4##(1996-2#1)(1997-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
not the same##7##3##(1997-2#1)(1997-8#1)(2008-10#5)
not the sole##2##3##(1993-3#1)(2011-2#1)
not the##117##2##(1990-12#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#3)(2008-10#26)(2008-11#9)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-3#2)(2013-8#2)
not their##2##2##(2008-10#1)(2008-11#1)
not tightly##2##2##(1992-4#1)(2008-9#1)
not time and labor consuming##2##5##(2008-10#2)
not time-consuming##2##2##(2008-10#2)
not to affect##2##3##(2007-11#1)(2009-8#1)
not to be statistically##2##4##(2008-10#1)(2008-5#1)
not to be##11##3##(1990-3#1)(1991-3#1)(1992-12#1)(1994-9#1)(1995-11#1)(1996-11#1)(1997-1#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
not to follow##2##3##(1996-3#1)(2011-2#1)
not to participate##3##3##(2010-11#1)(2013-1#2)
not to respond##2##3##(2010-4#1)(2010-5#1)
not to the##2##3##(1994-1#1)(1995-6#1)
not to##86##2##(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-6#2)(1994-1#2)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#9)(2008-11#7)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
not too##7##2##(2008-8#5)(2010-2#1)(2011-3#1)
not total##2##2##(1996-12#1)(2008-5#1)
not totally##3##2##(1991-12#1)(1996-11#1)(2008-10#1)
not toxic to##2##3##(2008-10#1)(2008-7#1)
not toxic##3##2##(1990-12#1)(2008-10#1)(2008-7#1)
not traditionally##3##2##(1991-12#1)(2008-11#1)(2008-3#1)
not translate to##2##3##(2012-12#1)(2013-8#1)
not translate##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
not transmit##3##2##(2008-10#3)
not transmitted by##2##3##(2008-10#2)
not transmitted##6##2##(2008-10#5)(2008-11#1)
not treat##2##2##(1995-12#1)(2008-7#1)
not treated with##6##3##(2008-10#4)(2011-2#1)(2012-3#1)
not treated##11##2##(1990-9#1)(1996-6#1)(2008-10#4)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#2)
not true##3##2##(1992-9#1)(2008-10#2)
not uncommon##5##2##(2008-9#1)(2009-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
not underestimate the##2##3##(1991-12#1)(2008-9#1)
not undergo##9##2##(1993-6#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#2)
not undergone##4##2##(1992-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
not understood##5##2##(1997-3#2)(2006-6#1)(2008-10#1)(2013-1#1)
not unequivocally##2##2##(2008-10#1)(2011-2#1)
not uniform##8##2##(1991-1#1)(1994-9#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-8#1)
not uniformly##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
not unique to##2##3##(2008-10#1)(2008-11#1)
not unique##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
not universally##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
not until##3##2##(1994-12#1)(1995-2#1)(2008-7#1)
not use##11##2##(1992-9#1)(1994-2#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
not used to##2##3##(1992-3#1)(2008-9#1)
not used##14##2##(1992-3#1)(1994-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
not useful in##2##3##(2008-9#1)(2011-2#1)
not useful##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)
not using condoms##4##3##(1997-6#1)(2010-7#3)
not using##5##2##(1997-6#1)(2010-7#3)(2011-2#1)
not usually associated with##2##4##(2008-12#1)(2008-5#1)
not usually##7##2##(1991-3#1)(1992-9#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
not utilized##2##2##(1994-12#1)(2008-10#1)
not validated##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
not vary as##2##3##(2008-11#1)(2009-4#1)
not vary significantly##4##3##(1996-1#1)(2008-8#2)(2009-7#1)
not vary with##5##3##(1995-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
not vary##19##2##(1991-2#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#1)
not verified##2##2##(2008-10#2)
not very effective##2##3##(2010-9#1)(2013-8#1)
not very##9##2##(1990-12#1)(1991-2#1)(1994-8#1)(2008-10#4)(2010-9#1)(2013-8#1)
not viable##2##2##(2008-10#1)(2010-4#1)
not visible in##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
not visible##6##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
not visualize##2##2##(1990-12#1)(1997-8#1)
not want##3##2##(1996-1#1)(1996-8#1)(2012-3#1)
not warranted##2##2##(1990-12#1)(2008-7#1)
not wear##2##2##(2010-1#1)(2012-2#1)
not well defined##2##3##(1990-2#1)(2008-10#1)
not well described##3##3##(2008-9#1)(2009-11#1)(2011-2#1)
not well documented##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
not well suited##2##3##(2008-10#1)(2008-5#1)
not well understood and##2##4##(1996-6#1)(1997-3#1)
not well understood in##2##4##(2008-10#2)
not well understood##19##3##(1993-9#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-7#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
not well##37##2##(1990-2#1)(1991-12#1)(1993-9#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2010-1#1)(2010-10#1)(2010-11#3)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
not widely appreciated##2##3##(1997-8#1)(2008-10#1)
not widely##5##2##(1997-8#1)(2008-10#1)(2010-6#1)(2013-1#2)
not with the##4##3##(1997-7#1)(2008-10#2)(2013-8#1)
not with##34##2##(1990-5#2)(1990-8#1)(1991-12#1)(1993-12#1)(1993-6#2)(1994-2#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#12)(2008-11#2)(2008-5#2)(2008-8#1)(2009-3#1)(2010-1#1)(2012-4#1)(2012-5#2)(2013-8#1)
not within the##2##3##(1995-12#1)(2008-9#1)
not within##6##2##(1995-12#1)(1997-9#1)(2008-10#2)(2008-9#1)(2010-11#1)
not without##6##2##(1996-1#1)(2008-10#1)(2008-12#2)(2010-10#1)(2010-11#1)
not working in physiotherapy##2##4##(1993-1#2)
not working##3##2##(1993-1#3)
not yet available##3##3##(2008-10#2)(2011-2#1)
not yet been tested##2##4##(1993-9#1)(2008-10#1)
not yet been##26##3##(1990-8#1)(1993-1#1)(1993-3#1)(1993-9#2)(1996-12#1)(2008-10#7)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-8#1)
not yet fully##4##3##(1991-2#1)(1997-8#1)(2009-6#1)(2009-7#1)
not yet ready to##2##4##(1995-5#1)(2008-6#1)
not yet well##2##3##(2008-10#1)(2013-1#1)
not yet##75##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2008-10#12)(2008-11#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
not yield##5##2##(2008-10#4)(2013-1#1)
not##6923##1##(1990-10#1)(1990-11#28)(1990-12#28)(1990-2#31)(1990-3#15)(1990-5#45)(1990-6#21)(1990-7#4)(1990-8#26)(1990-9#10)(1991-1#21)(1991-10#6)(1991-11#13)(1991-12#55)(1991-2#38)(1991-3#27)(1991-4#3)(1991-5#27)(1991-6#31)(1991-7#6)(1991-8#17)(1991-9#13)(1992-1#15)(1992-10#9)(1992-11#3)(1992-12#33)(1992-2#24)(1992-3#35)(1992-4#5)(1992-5#7)(1992-6#30)(1992-8#9)(1992-9#13)(1993-1#28)(1993-11#13)(1993-12#42)(1993-2#21)(1993-3#38)(1993-6#45)(1993-8#45)(1993-9#16)(1994-1#18)(1994-11#28)(1994-12#35)(1994-2#46)(1994-3#44)(1994-5#38)(1994-6#25)(1994-8#56)(1994-9#13)(1995-1#14)(1995-11#47)(1995-12#69)(1995-2#71)(1995-3#10)(1995-5#17)(1995-6#65)(1995-8#36)(1995-9#10)(1996-1#21)(1996-11#12)(1996-12#65)(1996-2#68)(1996-3#34)(1996-5#26)(1996-6#20)(1996-8#9)(1996-9#6)(1997-1#43)(1997-2#33)(1997-3#52)(1997-4#18)(1997-5#10)(1997-6#18)(1997-7#32)(1997-8#47)(1997-9#6)(2006-5#1)(2006-6#8)(2007-11#15)(2007-12#19)(2007-8#2)(2008-1#28)(2008-10#1797)(2008-11#478)(2008-12#121)(2008-2#21)(2008-3#63)(2008-4#45)(2008-5#149)(2008-6#37)(2008-7#209)(2008-8#203)(2008-9#169)(2009-1#10)(2009-10#36)(2009-11#11)(2009-12#21)(2009-3#15)(2009-4#17)(2009-5#11)(2009-6#31)(2009-7#31)(2009-8#40)(2009-9#16)(2010-1#34)(2010-10#37)(2010-11#37)(2010-12#24)(2010-2#5)(2010-3#10)(2010-4#16)(2010-5#21)(2010-6#29)(2010-7#28)(2010-8#45)(2010-9#12)(2011-1#33)(2011-10#4)(2011-2#274)(2011-3#15)(2011-7#3)(2012-12#61)(2012-2#131)(2012-3#113)(2012-4#2)(2012-5#7)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#204)(2013-7#7)(2013-8#104)
not)##3##1##(2008-10#1)(2008-5#1)(2012-3#1)
not-DT##2##1##(2011-1#2)
not-certified metals##2##2##(2008-10#2)
not-for-profit hospital##2##2##(1997-3#1)(2008-11#1)
not-for-profit hospitals##2##2##(1992-8#1)(2008-11#1)
not-for-profit##10##1##(1992-11#1)(1992-3#1)(1992-8#1)(1994-1#1)(1994-2#1)(1997-3#1)(2008-11#4)
not?##5##1##(1994-12#1)(1996-3#1)(2008-11#1)(2010-4#1)(2011-2#1)
notable differences##2##2##(1995-6#1)(2008-10#1)
notable exception##2##2##(1991-5#1)(2012-3#1)
notable for##4##2##(1997-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
notable in##2##2##(1992-8#1)(1996-12#1)
notable##27##1##(1990-3#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
notably in##3##2##(1997-7#1)(2008-10#1)(2008-12#1)
notably the##5##2##(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)
notably those##2##2##(2008-8#1)(2013-7#1)
notably##48##1##(1992-3#1)(1992-9#4)(1993-8#1)(1994-2#1)(1995-12#1)(1995-8#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-4#1)(2009-7#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
notamment##2##1##(2008-11#1)(2013-1#1)
notanthes##3##1##(2008-10#3)
notch and##2##2##(1996-3#1)(2012-3#1)
notch##6##1##(1996-3#1)(2008-7#1)(2008-9#1)(2012-3#2)(2013-1#1)
notched tunnel##2##2##(2013-1#2)
notching##3##1##(2013-1#3)
note from##2##2##(1995-6#1)(2008-6#1)
note of##3##2##(1991-3#1)(2008-9#1)(2012-2#1)
note on the##2##3##(1992-1#1)(1992-9#1)
note on##3##2##(1992-1#1)(1992-9#1)(2008-12#1)
note that##8##2##(1990-12#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-10#2)
note the##2##2##(1997-3#1)(2010-6#1)
note their##2##2##(2010-10#1)(2013-1#1)
note##43##1##(1990-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-9#1)(1994-9#2)(1995-6#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#3)(2009-10#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
noted a##2##2##(2008-10#1)(2013-8#1)
noted among##4##2##(1994-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
noted at##6##2##(1993-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2013-1#2)
noted between##7##2##(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-9#1)(2012-12#1)(2013-1#1)
noted by##3##2##(2008-11#2)(2008-12#1)
noted down##2##2##(2010-7#2)
noted during##3##2##(1990-3#1)(1990-8#1)(1993-1#1)
noted for##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
noted in any##2##3##(2011-2#2)
noted in sitting position##3##4##(2012-3#3)
noted in the##17##3##(1995-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2009-1#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-3#1)
noted in##49##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-12#2)(1996-9#1)(1997-1#2)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
noted that the##6##3##(1995-12#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)
noted that there##2##3##(1994-5#1)(2008-11#1)
noted that##16##2##(1994-5#1)(1995-12#2)(2008-10#5)(2008-11#3)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)
noted to have##3##3##(2008-1#1)(2012-2#1)(2013-1#1)
noted to##6##2##(1992-1#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
noted were##2##2##(1995-8#1)(1997-3#1)
noted when##4##2##(1996-3#1)(1997-2#1)(2008-10#2)
noted with##3##2##(1994-8#1)(2008-1#1)(2010-10#1)
noted##173##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-2#4)(1991-3#2)(1992-1#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#4)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#2)(2007-11#1)(2008-1#2)(2008-10#29)(2008-11#9)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#5)
notes and##3##2##(2008-1#1)(2012-2#1)(2013-1#1)
notes for##2##2##(2008-11#2)
notes on the##2##3##(1992-3#1)(2008-11#1)
notes that##5##2##(1995-12#1)(1995-3#2)(1995-9#1)(2010-12#1)
notes the importance of##2##4##(1994-12#1)(2010-10#1)
notes##27##1##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#2)(1994-12#1)(1995-12#1)(1995-3#2)(1995-9#1)(2007-11#1)(2008-1#1)(2008-11#4)(2009-12#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)
noteworthy that the##2##3##(1993-2#1)(2008-6#1)
noteworthy that##10##2##(1992-12#1)(1993-2#1)(1995-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-2#1)
noteworthy##15##1##(1992-12#1)(1993-2#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
nothing about##2##2##(1990-11#1)(2008-5#1)
nothing more##2##2##(2007-12#1)(2008-10#1)
nothing##12##1##(1990-11#1)(1992-2#1)(1993-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#2)
notice##4##1##(1996-5#1)(1997-6#2)(2008-10#1)
noticeable and##2##2##(2009-5#1)(2010-4#1)
noticeable differences##3##2##(1990-11#1)(1991-6#1)(2008-10#1)
noticeable##16##1##(1990-11#1)(1991-6#2)(1992-12#1)(1992-2#1)(2008-10#7)(2008-5#2)(2009-5#1)(2010-4#1)
noticeably##8##1##(1995-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2009-9#1)(2011-2#1)
noticed a##2##2##(1997-3#1)(2011-2#1)
noticed before##2##2##(2008-10#1)(2010-8#1)
noticed in##5##2##(1996-1#1)(2008-1#1)(2008-10#2)(2011-2#1)
noticed that##7##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#1)
noticed with##2##2##(1997-8#1)(2008-6#1)
noticed##33##1##(1990-12#1)(1994-2#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#1)
notices##2##1##(2009-4#1)(2011-2#1)
notifiable diseases##3##2##(1997-3#3)
notifiable##5##1##(1994-9#1)(1997-3#4)
notification of##4##2##(1992-9#1)(1994-6#1)(1996-3#1)(2010-6#1)
notification rates in##2##3##(2013-8#2)
notification##19##1##(1990-3#1)(1992-9#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-11#1)(2010-6#1)(2012-12#5)(2012-3#1)(2013-8#2)
notifications##2##1##(2008-9#1)(2011-2#1)
notified to the##2##3##(2008-11#2)
notified##10##1##(1990-3#1)(1991-9#1)(1996-5#1)(2008-11#2)(2010-10#1)(2012-12#3)(2013-8#1)
noting that##2##2##(2011-2#1)(2012-2#1)
noting the##2##2##(1990-3#1)(2008-12#1)
noting##8##1##(1990-3#1)(2008-12#4)(2008-6#1)(2011-2#1)(2012-2#1)
notion of##18##2##(1992-1#1)(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-6#1)(2009-3#1)(2009-7#2)(2011-1#2)(2011-2#1)(2013-8#1)
notion that##15##2##(1990-2#1)(1990-8#1)(1992-9#1)(1993-3#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#4)(2012-2#1)(2012-3#1)
notion##35##1##(1990-2#1)(1990-8#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-3#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-7#2)(2009-8#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-8#1)
notions of##5##2##(1994-3#1)(1997-6#1)(2008-11#1)(2009-3#1)(2010-10#1)
notions##9##1##(1992-3#1)(1994-3#2)(1997-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-10#1)
notochord and floor plate##4##4##(1994-12#4)
notochord##7##1##(1993-12#1)(1994-12#5)(2008-6#1)
notorious##2##1##(2008-6#1)(2008-7#1)
notoriously difficult to##4##3##(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
notoriously difficult##5##2##(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
notoriously##6##1##(2008-8#2)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
nouns##2##1##(1991-2#1)(1995-2#1)
nourished##3##1##(1990-9#1)(2008-10#1)(2009-11#1)
nourishing##3##1##(1993-12#1)(2008-10#2)
nouveau-né##5##1##(2013-1#5)
nov##14##1##(2008-10#2)(2010-10#2)(2010-3#2)(2011-2#2)(2013-8#6)
novalgin concentration##2##2##(2008-10#2)
novalgin in##2##2##(2008-10#2)
novalgin##9##1##(2008-10#9)
novel CL##2##2##(2008-10#2)
novel DNA##2##2##(1990-5#1)(1995-6#1)
novel ICS##2##2##(2008-8#2)
novel alternated dual task##2##4##(2012-2#2)
novel amperometric##2##2##(2008-10#2)
novel analytical##4##2##(2008-10#3)(2008-2#1)
novel and effective##2##3##(2013-1#1)(2013-8#1)
novel and highly efficient production system for##2##7##(2008-9#2)
novel and sensitive##2##3##(2008-10#2)
novel and simple##3##3##(2008-10#3)
novel and##25##2##(1997-7#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
novel anti-HIV-1 drugs##2##3##(2011-2#1)(2011-3#1)
novel anti-HIV-1##3##2##(2011-2#1)(2011-3#2)
novel applications##2##2##(1996-1#1)(2008-11#1)
novel approach for the##2##4##(2008-10#1)(2008-8#1)
novel approach for##8##3##(2008-10#2)(2008-6#1)(2008-8#1)(2010-10#1)(2013-1#3)
novel approach involving##2##3##(1993-8#1)(2008-10#1)
novel approach of##3##3##(2008-10#2)(2008-4#1)
novel approach to the##4##4##(1991-11#1)(1991-5#1)(2008-10#1)(2009-7#1)
novel approach to##10##3##(1991-11#1)(1991-5#1)(2008-10#5)(2008-8#1)(2009-7#1)(2013-1#1)
novel approach##33##2##(1991-11#1)(1991-5#1)(1993-8#1)(1996-12#1)(2008-10#13)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#1)(2012-3#1)(2013-1#4)(2013-8#1)
novel approaches in##2##3##(2008-5#1)(2011-2#1)
novel approaches##5##2##(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#2)
novel assay##3##2##(2008-10#2)(2008-11#1)
novel biological therapies##2##3##(2009-12#2)
novel biological##3##2##(2009-12#2)(2010-10#1)
novel biomarkers##3##2##(2010-5#1)(2011-2#1)(2012-2#1)
novel bioreactor##2##2##(2008-11#2)
novel cDNA##7##2##(1994-11#1)(1995-6#1)(2008-4#1)(2008-8#3)(2008-9#1)
novel calix[4]arene##2##2##(2008-10#2)
novel carbon##2##2##(2008-10#2)
novel carrier##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
novel cell death receptor##2##4##(2008-11#2)
novel cell##5##2##(1994-11#1)(2008-11#4)
novel chemiluminescence (CL)##10##3##(2008-10#10)
novel chemiluminescence##12##2##(2008-10#12)
novel class of compounds##2##4##(1996-5#1)(2008-10#1)
novel class of##9##3##(1991-5#1)(1994-3#1)(1994-6#1)(1996-5#1)(2008-10#3)(2010-11#1)(2012-2#1)
novel computational##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
novel concept##2##2##(2008-10#2)
novel configuration##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
novel dehalogenases##2##2##(2011-1#2)
novel deodorant##2##2##(2008-5#2)
novel design##3##2##(1997-1#1)(2008-2#1)(2008-3#1)
novel disease##3##2##(1993-3#2)(2011-2#1)
novel drugs##2##2##(2009-12#1)(2012-2#1)
novel electrochemical##7##2##(2008-10#7)
novel erythroid differentiation related##2##4##(2008-8#1)(2008-9#1)
novel evolutionary##2##2##(2008-8#1)(2011-2#1)
novel feature##2##2##(2008-7#1)(2008-8#1)
novel finding##2##2##(1996-2#1)(2011-1#1)
novel flow##4##2##(1990-12#1)(2008-10#2)(2010-8#1)
novel flow-injection##5##2##(2008-10#5)
novel fluorescent##3##2##(2008-10#3)
novel function of##2##3##(1992-6#1)(2012-12#1)
novel functional##4##2##(2008-10#2)(2009-10#1)(2013-1#1)
novel functions##2##2##(2009-6#1)(2011-2#1)
novel gene encoding##3##3##(1992-9#1)(1997-7#1)(2008-8#1)
novel gene which##2##3##(1996-2#1)(2008-9#1)
novel gene##13##2##(1992-9#1)(1995-8#1)(1996-2#1)(1997-7#2)(2008-10#1)(2008-8#3)(2008-9#4)
novel genes##11##2##(1993-8#1)(1994-9#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#1)
novel geometry##2##2##(2008-10#2)
novel habitats##2##2##(2008-8#2)
novel host##6##2##(2008-10#1)(2008-8#4)(2013-1#1)
novel hosts##3##2##(2008-8#3)
novel human gene##4##3##(1996-2#1)(1997-7#1)(1997-8#1)(2008-8#1)
novel human##9##2##(1990-8#2)(1992-9#1)(1996-2#1)(1997-7#1)(1997-8#2)(2008-8#2)
novel images##2##2##(2013-8#2)
novel inoculation techniques##2##3##(2008-10#2)
novel insights into the##3##4##(2010-12#1)(2013-1#1)(2013-8#1)
novel insights into##4##3##(2010-12#1)(2013-1#2)(2013-8#1)
novel insights##5##2##(1993-12#1)(2010-12#1)(2013-1#2)(2013-8#1)
novel instrumental##2##2##(2008-10#2)
novel interaction with B23##2##4##(2011-2#2)
novel ion##2##2##(2008-10#2)
novel mechanism of action##2##4##(2008-5#1)(2009-7#1)
novel mechanism of##6##3##(1994-3#1)(1997-3#1)(2008-11#1)(2008-5#2)(2009-7#1)
novel mechanism##8##2##(1994-3#1)(1997-3#1)(2008-11#1)(2008-5#2)(2009-7#1)(2010-11#1)(2013-8#1)
novel mechanisms of##2##3##(2008-10#1)(2011-3#1)
novel mechanisms##4##2##(2008-10#1)(2010-10#1)(2011-3#1)(2012-2#1)
novel member of##7##3##(1994-11#1)(1995-12#1)(2008-10#2)(2008-9#2)(2013-1#1)
novel members##2##2##(1995-6#1)(2008-9#1)
novel method for the determination of##5##6##(2008-10#5)
novel method for the##9##4##(2008-10#9)
novel method for##23##3##(1994-11#1)(1994-3#2)(2008-10#15)(2008-5#1)(2008-8#1)(2010-6#1)(2011-7#1)(2012-2#1)
novel method of wavelength selection##2##5##(2008-10#2)
novel method of##7##3##(2008-10#3)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
novel method##43##2##(1994-11#1)(1994-3#2)(2008-10#22)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#2)
novel methodology for##2##3##(2008-10#2)
novel methods##3##2##(2007-12#1)(2008-11#1)(2010-7#1)
novel molecule##2##2##(1996-12#1)(2012-2#1)
novel mutations in the##2##4##(1994-11#1)(1996-2#1)
novel nanocrystalline Pb(2)Sn(2)O(6) photocatalyst##2##4##(2009-11#2)
novel on-line##2##2##(2008-10#2)
novel or##3##2##(1995-12#1)(1997-7#1)(2008-11#1)
novel pH sensor##2##3##(2008-10#2)
novel pathogenic##2##2##(2008-10#2)
novel pathway##3##2##(2011-2#1)(2012-2#2)
novel pathways##3##2##(1995-2#1)(2010-10#1)(2010-6#1)
novel patterns##2##2##(2008-8#1)(2008-9#1)
novel physical##2##2##(2010-7#1)(2013-1#1)
novel plant##4##2##(1995-6#1)(2008-10#2)(2009-6#1)
novel post-transcriptional splicing form of##2##5##(2008-9#2)
novel post-transcriptional##3##2##(2008-9#2)(2013-8#1)
novel preparation##2##2##(2011-2#1)(2011-3#1)
novel probe##3##2##(1995-11#1)(2008-8#2)
novel properties##2##2##(2008-10#1)(2008-4#1)
novel property of##2##3##(1994-11#1)(2010-7#1)
novel protein of##2##3##(1993-8#1)(1993-9#1)
novel protein##4##2##(1990-5#1)(1993-8#1)(1993-9#1)(2008-4#1)
novel reversed-phase##3##2##(2008-10#3)
novel roles##2##2##(1993-6#1)(2011-2#1)
novel selective##2##2##(2008-10#2)
novel sensing##2##2##(2008-10#2)
novel sites##2##2##(1995-6#2)
novel snoRNA##2##2##(2008-8#2)
novel sorbent##2##2##(2008-10#2)
novel spectrofluorometric technique##2##3##(2008-11#2)
novel spectrophotometric method for##2##4##(2008-10#2)
novel spectrophotometric##3##2##(2008-10#3)
novel stimulus##2##2##(2008-5#2)
novel strains##2##2##(2008-10#1)(2008-5#1)
novel strategies##2##2##(2008-3#1)(2009-12#1)
novel strategy for##4##3##(2008-10#2)(2008-8#1)(2010-5#1)
novel strategy##9##2##(1992-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)
novel structural##3##2##(1995-8#1)(2008-5#1)(2011-2#1)
novel sulphonylurea##2##2##(1994-8#2)
novel surface##2##2##(2008-10#1)(2008-11#1)
novel technique to##2##3##(2008-10#1)(2008-9#1)
novel technique##9##2##(2008-10#3)(2008-9#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
novel techniques for the##2##4##(1997-6#1)(2008-10#1)
novel techniques for##3##3##(1997-6#1)(2008-10#1)(2012-2#1)
novel therapeutic agents##2##3##(2009-1#1)(2009-6#1)
novel therapeutic approaches##2##3##(2010-5#1)(2013-1#1)
novel therapeutic##16##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-6#1)(2012-2#4)(2013-1#3)(2013-8#1)
novel therapies for##3##3##(1996-2#1)(2008-5#1)(2008-7#1)
novel thermostable##2##2##(1995-8#2)
novel treatment##5##2##(2010-11#1)(2010-12#2)(2012-12#1)(2013-1#1)
novel treatments##2##2##(2008-6#1)(2012-12#1)
novel two-component system##2##3##(2009-6#2)
novel type of##3##3##(1990-5#1)(2008-11#1)(2013-8#1)
novel type##5##2##(1990-5#2)(1996-2#1)(2008-11#1)(2013-8#1)
novel uranyl##2##2##(2008-10#2)
novel visual stimuli##3##3##(1993-6#3)
novel ways##2##2##(2009-6#1)(2012-2#1)
novel whitefly-transmitted member of the family##2##6##(2008-10#2)
novel##1044##1##(1990-12#1)(1990-5#9)(1990-8#2)(1991-11#1)(1991-3#2)(1991-5#6)(1991-9#2)(1992-3#4)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#9)(1993-8#6)(1993-9#1)(1994-11#11)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#9)(1995-8#5)(1996-1#1)(1996-12#3)(1996-2#16)(1996-3#2)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#2)(1997-7#8)(1997-8#4)(2006-6#1)(2007-11#6)(2007-12#2)(2008-1#2)(2008-10#343)(2008-11#66)(2008-12#3)(2008-2#6)(2008-3#26)(2008-4#7)(2008-5#24)(2008-6#10)(2008-7#16)(2008-8#60)(2008-9#37)(2009-1#2)(2009-10#3)(2009-11#5)(2009-12#8)(2009-3#1)(2009-4#1)(2009-6#12)(2009-7#5)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#12)(2010-12#7)(2010-4#1)(2010-5#5)(2010-6#7)(2010-7#11)(2010-8#4)(2011-1#6)(2011-2#40)(2011-3#8)(2011-7#3)(2011-9#1)(2012-12#5)(2012-2#34)(2012-3#18)(2013-1#39)(2013-8#21)
novelty of##2##2##(2008-8#1)(2010-11#1)
novelty were##2##2##(1990-11#1)(1993-6#1)
novelty##7##1##(1990-11#1)(1993-6#3)(2008-10#1)(2008-8#1)(2010-11#1)
novice and experienced nurses##2##4##(2008-12#1)(2008-9#1)
novice teacher##3##2##(2008-11#1)(2008-12#2)
novice##13##1##(1991-1#1)(2008-11#2)(2008-12#5)(2008-7#2)(2008-9#2)(2010-11#1)
novo adipogenesis##3##2##(2008-11#3)
novo##41##1##(1990-5#1)(1990-7#1)(1991-12#1)(1993-11#2)(1993-12#3)(1993-2#2)(1994-11#3)(1994-6#1)(1994-8#2)(1995-12#2)(1995-6#1)(1997-1#1)(1997-3#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#3)(2008-9#1)(2010-1#2)(2011-1#1)(2013-8#1)
novo-ulmi mitovirus 3a-Ld from##2##4##(2008-10#2)
novo-ulmi mitovirus##3##2##(2008-10#3)
novo-ulmi##7##1##(2008-10#7)
now able to##2##3##(1991-3#1)(2008-11#1)
now and##2##2##(1993-2#1)(2012-12#1)
now available can##2##3##(1992-12#1)(2011-2#1)
now available for##2##3##(2008-10#1)(2008-5#1)
now available##13##2##(1990-3#1)(1991-3#1)(1992-12#1)(1995-5#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#3)
now be tested##2##3##(1996-12#1)(2010-12#1)
now be##21##2##(1990-11#1)(1990-12#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-8#1)
now becoming##6##2##(1993-11#1)(1997-2#1)(1997-3#1)(2008-6#1)(2008-7#1)(2009-3#1)
now been recognized##2##3##(2009-12#1)(2012-3#1)
now been##14##2##(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-12#3)(2010-7#1)(2011-2#2)(2012-3#1)
now being used in##2##4##(2008-10#1)(2008-11#1)
now being used to##4##4##(1990-11#1)(1994-5#1)(2008-7#1)(2011-2#1)
now being used##8##3##(1990-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)
now being##19##2##(1990-11#1)(1991-12#1)(1992-2#1)(1994-5#1)(1994-9#1)(1995-2#2)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-2#1)
now considered a##4##3##(2008-1#1)(2009-5#1)(2010-12#1)(2011-3#1)
now considered##7##2##(2008-1#1)(2008-9#1)(2009-5#1)(2010-12#2)(2011-2#1)(2011-3#1)
now demonstrate##2##2##(1994-12#1)(2008-3#1)
now emerging##4##2##(2008-11#1)(2008-8#2)(2010-10#1)
now established##4##2##(1992-3#1)(2008-10#1)(2008-5#1)(2010-12#1)
now exists##2##2##(2008-7#1)(2010-6#1)
now finds##2##2##(1995-2#1)(2008-11#1)
now found##2##2##(1997-1#1)(2008-10#1)
now has the##2##3##(1991-11#1)(2011-3#1)
now has##6##2##(1991-11#1)(1992-11#1)(1995-6#1)(2008-3#1)(2008-7#1)(2011-3#1)
now have##5##2##(1990-9#1)(1991-2#1)(1993-3#1)(1997-7#1)(2008-3#1)
now identified as##2##3##(1993-12#1)(1993-6#1)
now identified##4##2##(1993-12#1)(1993-2#1)(1993-6#1)(1997-7#1)
now in place##2##3##(2009-3#1)(2011-2#1)
now in use##2##3##(2008-7#1)(2012-2#1)
now in##10##2##(1997-2#2)(1997-5#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)
now know that##2##3##(1997-1#1)(2008-1#1)
now know##4##2##(1997-1#1)(2008-1#1)(2011-2#1)(2013-7#1)
now known as##2##3##(2008-10#1)(2008-5#1)
now known##8##2##(2008-10#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
now more##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
now only##2##2##(2010-12#1)(2012-2#1)
now possible##8##2##(1990-12#1)(1991-12#1)(1993-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
now rare##2##2##(1997-3#1)(2011-3#1)
now report that##3##3##(1990-2#1)(1991-12#1)(2009-10#1)
now report the##5##3##(1993-12#1)(1993-2#1)(1994-11#1)(2008-10#2)
now report##13##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(2008-10#3)(2008-8#1)(2009-10#1)(2009-8#1)
now routinely##2##2##(2008-10#1)(2013-1#1)
now show that##2##3##(1992-6#2)
now suggest that##2##3##(1991-2#1)(1994-5#1)
now that##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
now to##2##2##(1995-5#1)(2007-12#1)
now used in##2##3##(1993-1#1)(2011-7#1)
now used##3##2##(1993-1#1)(2008-10#1)(2011-7#1)
now well##6##2##(1996-2#1)(1997-1#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
now widely accepted as the most##2##6##(1993-12#1)(2008-11#1)
now widely accepted##4##3##(1993-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
now widely##7##2##(1990-2#1)(1993-12#1)(1993-2#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-3#1)
now##435##1##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#7)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#1)(1992-5#3)(1992-6#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#5)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#5)(1996-12#3)(1996-2#1)(1996-3#5)(1996-8#1)(1996-9#1)(1997-1#9)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#8)(1997-8#4)(2006-6#1)(2007-12#4)(2008-1#3)(2008-10#50)(2008-11#25)(2008-12#7)(2008-3#5)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#19)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#4)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#17)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#36)(2011-3#5)(2011-7#1)(2012-12#3)(2012-2#6)(2012-3#8)(2012-7#1)(2013-1#17)(2013-7#2)(2013-8#4)
now?##3##1##(1994-3#1)(2008-10#1)(2008-11#1)
nowadays is##2##2##(2011-3#1)(2012-2#1)
nowadays##18##1##(1993-11#2)(1993-3#1)(1994-5#1)(1996-1#1)(2008-10#4)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)
noxious##9##1##(1996-5#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
nozzle##6##1##(1994-2#3)(2008-10#1)(2008-2#1)(2008-3#1)
np-BNR##5##1##(2008-10#5)
npPLA2##4##1##(1992-8#4)
ns time##2##2##(1991-3#1)(1997-6#1)
ns were##2##2##(2007-12#2)
ns##15##1##(1991-3#1)(1993-6#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-8#1)(2009-5#1)
ns) than##3##2##(1991-5#3)
ns)##8##1##(1991-5#6)(2008-3#1)(2009-3#1)
nt and##2##2##(1990-11#1)(2008-8#1)
nt identity##2##2##(2008-10#2)
nt long and##2##3##(2008-10#2)
nt of the##2##3##(2008-10#1)(2008-8#1)
nt of##3##2##(1993-6#1)(2008-10#1)(2008-8#1)
nt sequence##5##2##(1991-6#1)(1993-12#4)
nt sequences##2##2##(1993-12#1)(1993-6#1)
nt##41##1##(1990-11#2)(1991-6#2)(1991-9#1)(1992-8#1)(1993-12#7)(1993-2#3)(1993-3#1)(1993-6#5)(1994-11#1)(1995-2#2)(1997-7#1)(2008-10#9)(2008-8#4)(2011-2#1)(2013-8#1)
nt)##4##1##(1993-6#1)(2008-10#2)(2012-3#1)
nts##3##1##(2008-10#1)(2008-9#2)
nts)##4##1##(2008-10#3)(2008-9#1)
nu##2##1##(2008-10#1)(2008-3#1)
nu(3)##2##1##(2007-12#1)(2008-3#1)
nuances##2##1##(2008-1#1)(2008-9#1)
nucellus##2##1##(2008-10#1)(2009-8#1)
nuchal translucency##2##2##(2008-11#1)(2013-1#1)
nuchal##4##1##(1997-3#1)(2008-11#1)(2008-7#1)(2013-1#1)
nucifera)##2##1##(2008-10#1)(2009-8#1)
nuclear DNA content and##2##4##(2008-11#1)(2008-9#1)
nuclear DNA content in##2##4##(1991-6#1)(2008-9#1)
nuclear DNA content##11##3##(1991-6#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-9#4)(2009-8#1)
nuclear DNA synthesis##2##3##(1994-5#2)
nuclear DNA##24##2##(1991-6#1)(1992-8#1)(1994-3#1)(1994-5#2)(1995-6#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#4)(2009-8#1)(2011-2#1)(2013-8#1)
nuclear Overhauser enhancement##2##3##(1990-5#1)(1993-8#1)
nuclear Overhauser##5##2##(1990-5#1)(1992-4#1)(1993-8#1)(1994-5#2)
nuclear accumulation of p53##2##4##(1997-7#2)
nuclear accumulation of##4##3##(1997-7#2)(2011-2#2)
nuclear accumulation##5##2##(1994-11#1)(1997-7#2)(2011-2#2)
nuclear alleles##2##2##(2008-9#2)
nuclear and cytoplasmic##3##3##(1996-2#1)(2008-2#1)(2011-2#1)
nuclear and mitochondrial DNA##3##4##(2008-10#3)
nuclear and mitochondrial##5##3##(2008-10#5)
nuclear and##13##2##(1994-8#1)(1996-2#2)(2008-10#7)(2008-12#1)(2008-2#1)(2011-2#1)
nuclear antigen##9##2##(1991-8#1)(1992-10#1)(1994-12#1)(1994-8#1)(1995-6#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
nuclear assembly##2##2##(2010-5#1)(2011-2#1)
nuclear bodies##2##2##(2007-12#2)
nuclear complex##3##2##(1991-2#1)(1996-12#2)
nuclear condensation##2##2##(2008-8#1)(2010-2#1)
nuclear development##2##2##(2009-8#2)
nuclear envelope in the##2##4##(1995-2#1)(2008-9#1)
nuclear envelope proteins##2##3##(1995-2#1)(2011-2#1)
nuclear envelope##21##2##(1994-11#1)(1995-2#4)(2007-12#1)(2008-9#2)(2011-2#13)
nuclear export of##2##3##(2011-2#1)(2011-3#1)
nuclear export##8##2##(2011-2#4)(2011-3#4)
nuclear extracts from##5##3##(1993-6#2)(1995-2#1)(2008-10#1)(2008-11#1)
nuclear extracts were##2##3##(1993-6#1)(1995-2#1)
nuclear extracts##16##2##(1993-6#7)(1993-8#1)(1995-2#3)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#2)
nuclear facilities in##2##3##(1991-3#1)(2008-10#1)
nuclear facilities##5##2##(1991-3#3)(2008-10#2)
nuclear factor kappa B##4##4##(1994-6#3)(2013-1#1)
nuclear factor##9##2##(1994-6#3)(2008-6#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
nuclear factor-κB (NF-κB)##2##3##(2012-2#1)(2012-3#1)
nuclear factor-κB##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
nuclear factors##7##2##(1992-6#2)(1993-8#1)(1994-11#1)(1996-2#1)(2008-10#2)
nuclear foci##2##2##(2011-2#1)(2013-1#1)
nuclear gene##7##2##(1991-2#2)(1995-6#1)(2008-10#2)(2010-4#1)(2012-3#1)
nuclear genes##5##2##(1991-2#2)(2008-10#1)(2008-8#1)(2011-2#1)
nuclear hormone receptor##3##3##(1994-12#1)(1995-2#2)
nuclear hormone receptors##2##3##(1995-2#1)(2008-10#1)
nuclear hormone##5##2##(1994-12#1)(1995-2#3)(2008-10#1)
nuclear imaging techniques##2##3##(1991-2#1)(2008-7#1)
nuclear import substrate##2##3##(1995-2#2)
nuclear inclusions##2##2##(2007-12#1)(2008-10#1)
nuclear installations##2##2##(1991-3#2)
nuclear irradiation##3##2##(2008-8#3)
nuclear lamina##3##2##(2008-8#3)
nuclear layer##3##2##(1991-10#2)(2010-1#1)
nuclear localization of 4##2##4##(2010-5#2)
nuclear localization of##4##3##(1994-5#1)(2009-8#1)(2010-5#2)
nuclear localization signal##6##3##(1994-11#4)(1997-7#1)(2011-2#1)
nuclear localization##13##2##(1994-11#4)(1994-5#2)(1995-2#1)(1997-7#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-2#1)
nuclear loci in##2##3##(2012-3#2)
nuclear loci##6##2##(2008-9#3)(2012-3#3)
nuclear magnetic resonance (NMR)##8##4##(1992-4#1)(1993-3#1)(1996-2#1)(2008-10#3)(2008-4#1)(2010-8#1)
nuclear magnetic resonance and##3##4##(1997-8#1)(2008-10#1)(2012-2#1)
nuclear magnetic resonance of##2##4##(1994-2#1)(2008-10#1)
nuclear magnetic resonance spectroscopy##4##4##(1994-5#1)(2008-10#3)
nuclear magnetic resonance spin-lattice relaxation##2##5##(2008-10#2)
nuclear magnetic resonance##33##3##(1990-3#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1996-2#1)(1997-8#1)(2008-10#10)(2008-4#2)(2008-5#1)(2008-8#2)(2009-6#1)(2010-8#2)(2012-2#1)
nuclear matrix##8##2##(1990-5#2)(2008-11#1)(2008-8#5)
nuclear medicine##5##2##(1994-3#1)(2008-3#1)(2012-2#3)
nuclear membrane##12##2##(2008-10#1)(2008-8#1)(2008-9#4)(2011-2#6)
nuclear migration in##3##3##(2008-9#3)
nuclear migration##5##2##(2008-9#5)
nuclear morphology##3##2##(2008-8#1)(2009-8#2)
nuclear polyhedrosis virus (AcMNPV)##2##4##(1993-12#1)(1995-12#1)
nuclear polyhedrosis virus##12##3##(1993-12#2)(1994-11#1)(1995-12#2)(1997-3#1)(2008-11#2)(2008-7#3)(2008-8#1)
nuclear pore complex##7##3##(1994-11#3)(1995-2#2)(2011-2#2)
nuclear pore##10##2##(1994-11#3)(1995-2#2)(2011-2#5)
nuclear pores##2##2##(2008-10#1)(2011-2#1)
nuclear power plants##4##3##(2008-10#1)(2008-7#1)(2009-12#2)
nuclear power##8##2##(2008-10#2)(2008-7#2)(2009-10#1)(2009-12#2)(2013-1#1)
nuclear protein complexes##2##3##(1993-8#1)(1995-8#1)
nuclear protein##7##2##(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-3#1)
nuclear proteins extracted##2##3##(1997-2#1)(2008-9#1)
nuclear proteins from##2##3##(1993-12#2)
nuclear proteins of terminal differentiated erythroid cells##2##7##(2008-8#1)(2008-9#1)
nuclear proteins##13##2##(1993-12#2)(1993-6#1)(1993-8#1)(1995-2#1)(1997-2#4)(2008-8#1)(2008-9#3)
nuclear rDNA##5##2##(2008-10#5)
nuclear reassembly##3##2##(2008-8#3)
nuclear receptor##9##2##(1996-12#1)(2008-5#1)(2008-9#6)(2011-2#1)
nuclear receptors##6##2##(1994-6#1)(2008-10#2)(2008-9#1)(2009-8#1)(2013-7#1)
nuclear ribonucleoprotein##4##2##(1993-8#1)(2008-8#2)(2008-9#1)
nuclear ribosomal DNA##8##3##(2008-10#5)(2008-12#2)(2010-3#1)
nuclear ribosomal internal transcribed spacer##2##5##(2008-10#1)(2008-9#1)
nuclear ribosomal##15##2##(2008-10#10)(2008-12#2)(2008-9#1)(2010-3#2)
nuclear run-on##2##2##(2012-3#2)
nuclear scaffold##2##2##(1995-8#1)(2008-8#1)
nuclear spent##2##2##(2008-10#2)
nuclear staining##2##2##(1991-5#1)(2007-12#1)
nuclear structure##5##2##(1993-8#1)(1995-2#1)(2011-2#3)
nuclear traffic##2##2##(2011-2#2)
nuclear transcription factors##3##3##(1995-8#1)(2008-10#1)(2009-6#1)
nuclear transfer##7##2##(2008-11#4)(2008-9#3)
nuclear translation elongation factor##3##4##(2008-10#3)
nuclear translocation of##2##3##(2010-10#2)
nuclear translocation##7##2##(2010-10#6)(2012-2#1)
nuclear transport of##2##3##(1994-11#1)(1997-3#1)
nuclear transport receptors##2##3##(2011-2#2)
nuclear transport##8##2##(1991-2#2)(1994-11#1)(1995-2#1)(1997-3#1)(2011-2#3)
nuclear waste##2##2##(2008-10#2)
nuclear wastes##2##2##(2008-10#2)
nuclear workers and the public##2##5##(2008-12#2)
nuclear##548##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#6)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#9)(1991-3#5)(1991-5#4)(1991-6#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#1)(1993-12#5)(1993-3#1)(1993-5#1)(1993-6#9)(1993-8#12)(1994-11#13)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#7)(1994-6#10)(1994-8#3)(1995-12#2)(1995-2#25)(1995-6#10)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#1)(1997-2#4)(1997-3#3)(1997-7#6)(1997-8#3)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#84)(2008-11#19)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#23)(2008-8#31)(2008-9#43)(2009-1#1)(2009-10#2)(2009-12#3)(2009-5#1)(2009-6#2)(2009-8#12)(2010-1#1)(2010-10#10)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#58)(2011-3#5)(2012-2#11)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#1)
nuclear-coded subunits##3##2##(1990-2#3)
nuclear-encoded##2##1##(2008-1#1)(2010-4#1)
nuclease hypersensitive##3##2##(1990-7#1)(1997-7#1)(2008-8#1)
nuclease protection assays##2##3##(1995-2#1)(2008-4#1)
nuclease protection##8##2##(1992-3#1)(1993-3#1)(1995-2#1)(2008-4#5)
nuclease##23##1##(1990-11#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-4#6)(2008-7#1)(2008-8#4)(2008-9#1)
nucleases##2##1##(2008-11#1)(2010-4#1)
nucleated cells##5##2##(2008-11#2)(2008-8#1)(2011-2#2)
nucleated differential cell count##2##4##(2008-11#2)
nucleated##11##1##(2008-11#5)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#3)
nucleation activity##3##2##(2008-10#3)
nucleation and growth##2##3##(2008-10#2)
nucleation and##5##2##(2008-10#4)(2012-2#1)
nucleation##18##1##(2008-10#11)(2009-7#1)(2009-9#1)(2012-2#5)
nuclei after##2##2##(1996-2#1)(2008-9#1)
nuclei along##2##2##(2008-11#2)
nuclei also##2##2##(1994-8#1)(2008-7#1)
nuclei and##14##2##(1991-8#1)(1995-8#1)(1996-12#3)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2012-2#1)
nuclei are##2##2##(1990-3#1)(2008-8#1)
nuclei as##2##2##(1993-12#1)(1994-2#1)
nuclei by##3##2##(1994-2#1)(2008-8#1)(2009-12#1)
nuclei for##2##2##(2008-10#1)(2010-8#1)
nuclei from##3##2##(1996-2#1)(2008-9#2)
nuclei in the##2##3##(1997-2#1)(2008-8#1)
nuclei in##5##2##(1993-3#1)(1997-2#1)(2007-12#1)(2008-5#1)(2008-8#1)
nuclei is##2##2##(2008-7#1)(2009-8#1)
nuclei of the##6##3##(1996-12#3)(2008-7#2)(2008-8#1)
nuclei of##13##2##(1992-3#1)(1993-8#1)(1994-2#1)(1994-6#2)(1996-12#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)
nuclei or##2##2##(1990-7#1)(2010-6#1)
nuclei per##2##2##(2008-10#2)
nuclei to##2##2##(2008-11#1)(2010-8#1)
nuclei were##10##2##(1991-5#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-8#1)(2012-3#1)
nuclei with##3##2##(2008-7#2)(2010-12#1)
nuclei within##2##2##(1995-2#1)(2008-11#1)
nuclei##149##1##(1990-3#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#7)(1994-6#4)(1994-8#3)(1995-2#1)(1995-8#1)(1996-12#8)(1996-2#5)(1997-2#3)(1997-3#2)(2007-12#2)(2008-10#15)(2008-11#17)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#13)(2008-8#9)(2008-9#10)(2009-12#4)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-6#2)(2010-8#5)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
nucleic acid amplification##3##3##(2009-6#1)(2010-6#1)(2011-2#1)
nucleic acid analysis##2##3##(2008-9#2)
nucleic acid extracts from##3##4##(1996-12#1)(2008-10#2)
nucleic acid extracts##4##3##(1996-12#1)(2008-10#3)
nucleic acid hybridization analysis##2##4##(2008-10#2)
nucleic acid hybridization##3##3##(2008-10#3)
nucleic acid in an##2##4##(1995-2#1)(2008-4#1)
nucleic acid in##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
nucleic acid libraries##2##3##(2008-4#2)
nucleic acid molecular 'light switch'##2##5##(2008-10#2)
nucleic acid probes##2##3##(2008-10#1)(2008-9#1)
nucleic acid samples##3##3##(2008-10#1)(2008-4#2)
nucleic acid sequence##2##3##(1996-12#1)(1996-6#1)
nucleic acid sequences##4##3##(1995-5#1)(1996-6#1)(2008-10#1)(2008-9#1)
nucleic acid structures##4##3##(2008-4#3)(2008-9#1)
nucleic acid##72##2##(1992-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-6#2)(2008-10#28)(2008-11#1)(2008-4#15)(2008-8#1)(2008-9#10)(2009-6#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-8#1)
nucleic acid-based##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
nucleic acid-binding property##2##3##(2008-8#2)
nucleic acid-binding proteins##2##3##(1993-2#1)(2008-8#1)
nucleic acid-binding##5##2##(1993-2#1)(2008-10#1)(2008-8#3)
nucleic acids by##4##3##(2008-10#4)
nucleic acids in##5##3##(2008-10#4)(2008-9#1)
nucleic acids is##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
nucleic acids to##2##3##(2008-10#1)(2012-2#1)
nucleic acids was##4##3##(2008-10#4)
nucleic acids##64##2##(1991-5#3)(1991-6#1)(1991-8#1)(1996-6#1)(1997-6#4)(2008-10#35)(2008-4#8)(2008-9#5)(2010-7#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
nucleic##145##1##(1991-5#3)(1991-6#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-6#3)(1997-6#4)(2008-10#65)(2008-11#1)(2008-4#24)(2008-8#4)(2008-9#15)(2009-6#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2013-8#2)
nucleic-acid##2##1##(2008-9#2)
nucleobase and##2##2##(1996-5#1)(2008-4#1)
nucleobase##4##1##(1995-6#1)(1996-5#1)(2008-10#1)(2008-4#1)
nucleobases##5##1##(1995-6#1)(2008-10#3)(2008-4#1)
nucleocapsid (N) protein##3##3##(2008-10#3)
nucleocapsid (N)##7##2##(2008-10#7)
nucleocapsid protein##5##2##(1996-12#1)(2008-10#4)
nucleocapsid##17##1##(1993-12#1)(1995-5#1)(1996-12#1)(2008-10#12)(2008-5#1)(2009-7#1)
nucleocapsids##2##1##(1993-12#1)(2008-10#1)
nucleocytoplasmic polymorphism##2##2##(2008-9#2)
nucleocytoplasmic transport##4##2##(2011-2#4)
nucleocytoplasmic##10##1##(1995-2#1)(2008-9#2)(2011-2#7)
nucleofection##3##1##(2008-11#3)
nucleoid##3##1##(2008-7#1)(2009-8#2)
nucleoids##4##1##(2008-7#1)(2009-8#3)
nucleolar dominance##3##2##(2011-2#3)
nucleolar organizer##3##2##(1993-12#1)(2007-12#1)(2008-12#1)
nucleolar skeleton (nucleolar matrix)##2##4##(2008-8#2)
nucleolar skeleton of HeLa cells##3##5##(2008-8#3)
nucleolar skeleton##6##2##(2008-8#6)
nucleolar##23##1##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#12)(2011-2#4)
nucleolar-organizing regions of chromosomes##2##4##(2013-1#2)
nucleolar-organizing regions of##3##3##(2013-1#3)
nucleoli were significantly greater##2##4##(2008-10#1)(2008-7#1)
nucleoli##17##1##(1993-12#7)(2007-12#4)(2008-10#1)(2008-7#2)(2008-8#1)(2010-12#1)(2013-1#1)
nucleolin##2##1##(2010-12#2)
nucleolus in##2##2##(2008-12#1)(2008-8#1)
nucleolus##11##1##(2007-12#1)(2008-12#4)(2008-7#3)(2008-8#3)
nucleophagy##5##1##(2011-2#5)
nucleophile of##2##2##(1995-6#1)(2010-11#1)
nucleophile##8##1##(1991-5#1)(1995-6#2)(2008-7#4)(2010-11#1)
nucleophiles##2##1##(2008-11#1)(2009-9#1)
nucleophilic attack##2##2##(1994-5#2)
nucleophilic substitution of##2##3##(2008-10#2)
nucleophilic##7##1##(1994-5#2)(1995-2#2)(1996-5#1)(2008-10#2)
nucleoplasm##2##1##(2008-12#1)(2009-6#1)
nucleopolyhedrovirus##12##1##(2008-11#10)(2008-12#2)
nucleoporin##4##1##(1995-2#2)(2011-2#2)
nucleoporins and##3##2##(2011-2#3)
nucleoporins##10##1##(1995-2#3)(2011-2#7)
nucleoprotein complex##3##2##(1995-8#1)(2008-11#2)
nucleoprotein complexes##2##2##(1996-3#2)
nucleoprotein##10##1##(1995-8#1)(1996-3#2)(2008-10#2)(2008-11#2)(2008-5#1)(2013-8#2)
nucleoside 2-deoxyribosyltransferase##3##2##(1995-6#3)
nucleoside analogues##4##2##(1994-8#1)(1996-11#1)(1996-5#1)(2012-3#1)
nucleoside diphosphate kinase##2##3##(1994-8#1)(1996-2#1)
nucleoside diphosphates##2##2##(1997-2#1)(1997-7#1)
nucleoside phosphorylase##3##2##(1994-8#2)(2008-10#1)
nucleoside transport##3##2##(1994-8#3)
nucleoside transporter##3##2##(1994-8#2)(1995-8#1)
nucleoside triphosphate##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
nucleoside##39##1##(1990-10#1)(1991-5#1)(1994-8#12)(1995-11#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
nucleosides and##3##2##(1990-11#1)(2008-10#2)
nucleosides is##2##2##(2008-4#2)
nucleosides##24##1##(1990-11#1)(1992-3#3)(1996-5#1)(1997-2#6)(2008-10#4)(2008-11#1)(2008-4#6)(2009-12#2)
nucleosomal##3##1##(1991-5#1)(2008-8#1)(2011-2#1)
nucleosome##4##1##(2008-8#2)(2011-2#1)(2011-9#1)
nucleosome/chromatin assembly##2##2##(2008-8#2)
nucleosomes##5##1##(2008-8#5)
nucleotide (nt) sequence of the##4##5##(1991-6#1)(1993-12#3)
nucleotide (nt) sequence of##6##4##(1991-6#1)(1993-12#3)(1997-7#1)(2008-10#1)
nucleotide (nt) sequence##8##3##(1991-6#1)(1993-12#5)(1997-7#1)(2008-10#1)
nucleotide (nt) sequences##4##3##(1993-12#1)(1993-6#2)(2008-10#1)
nucleotide (nt)##18##2##(1991-6#2)(1993-12#7)(1993-2#1)(1993-6#4)(1997-7#1)(2008-10#3)
nucleotide 1497##2##2##(1997-3#2)
nucleotide 5'-monophosphates##2##2##(2008-11#2)
nucleotide acid##2##2##(2013-8#2)
nucleotide analogue##2##2##(2008-11#2)
nucleotide and amino acid sequence##2##5##(1990-7#1)(2008-10#1)
nucleotide and amino acid sequences##2##5##(1991-5#1)(2013-8#1)
nucleotide and amino acid##6##4##(1990-7#1)(1991-5#1)(1995-8#1)(2008-10#2)(2013-8#1)
nucleotide and deduced amino acid sequences##2##6##(1993-12#1)(1994-11#1)
nucleotide and deduced##4##3##(1993-12#1)(1994-11#3)
nucleotide and##17##2##(1990-7#1)(1991-5#1)(1993-12#2)(1994-11#3)(1995-8#3)(2008-10#4)(2008-9#1)(2013-8#2)
nucleotide binding site##2##3##(2008-10#1)(2010-10#1)
nucleotide binding##9##2##(1992-1#1)(1994-2#1)(2008-10#3)(2008-11#3)(2010-10#1)
nucleotide change##2##2##(1994-11#1)(2008-10#1)
nucleotide difference##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
nucleotide differences##6##2##(1993-3#1)(1997-3#1)(1997-9#1)(2008-10#2)(2008-5#1)
nucleotide diversity##4##2##(2008-10#3)(2012-3#1)
nucleotide exchange factor##2##3##(1995-2#1)(2013-8#1)
nucleotide exchange factors that have##2##5##(1995-2#1)(2013-8#1)
nucleotide exchange##5##2##(1995-2#2)(1996-2#1)(2013-8#2)
nucleotide excision repair (NER)##2##4##(2008-11#2)
nucleotide excision repair##6##3##(1994-9#2)(2008-11#4)
nucleotide hydrolysis##2##2##(1994-8#1)(2011-2#1)
nucleotide identities and##4##3##(2008-10#4)
nucleotide identities##5##2##(2008-10#5)
nucleotide identity with##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
nucleotide identity##13##2##(2008-10#9)(2008-5#2)(2008-8#1)(2013-8#1)
nucleotide or##2##2##(2008-9#2)
nucleotide polymorphism analysis##2##3##(2008-8#1)(2010-11#1)
nucleotide polymorphism##10##2##(2008-10#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)
nucleotide polymorphisms (SNPs) in##2##4##(2008-10#1)(2010-6#1)
nucleotide polymorphisms (SNPs) of##2##4##(2008-10#1)(2009-8#1)
nucleotide polymorphisms (SNPs)##11##3##(2008-10#4)(2008-12#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
nucleotide polymorphisms##21##2##(1997-9#1)(2008-10#7)(2008-12#1)(2008-8#1)(2009-8#2)(2010-6#2)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
nucleotide pools##3##2##(2008-11#3)
nucleotide position##7##2##(1993-3#1)(1994-11#2)(2008-10#1)(2008-11#2)(2013-8#1)
nucleotide positions##2##2##(2008-11#1)(2008-12#1)
nucleotide ratios##2##2##(2008-11#2)
nucleotide sequence analysis##5##3##(1990-8#1)(2008-10#4)
nucleotide sequence data##6##3##(1997-6#5)(2008-9#1)
nucleotide sequence homology##2##3##(2008-8#1)(2010-5#1)
nucleotide sequence identities##4##3##(2008-10#3)(2008-11#1)
nucleotide sequence identity in##2##4##(1993-6#1)(2008-10#1)
nucleotide sequence identity##11##3##(1993-6#1)(2008-10#10)
nucleotide sequence of Saccharomyces cerevisiae chromosome VIII##2##7##(1994-9#2)
nucleotide sequence of a cDNA##2##5##(1993-3#1)(1996-2#1)
nucleotide sequence of a##14##4##(1993-3#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1997-4#1)(2008-10#4)(2009-3#1)
nucleotide sequence of the##26##4##(1990-8#1)(1991-5#2)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-8#2)(1997-7#1)(1997-8#1)(2008-10#10)(2008-8#1)
nucleotide sequence of this##2##4##(1990-2#1)(1993-2#1)
nucleotide sequence of##56##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-9#2)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#4)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#18)(2008-8#4)(2008-9#1)(2009-3#1)
nucleotide sequence revealed##2##3##(1994-12#1)(1997-2#1)
nucleotide sequence showed a##2##4##(1996-2#1)(2008-5#1)
nucleotide sequence was determined##3##4##(1993-9#1)(1997-7#1)(2008-10#1)
nucleotide sequence##110##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-5#2)(1991-9#2)(1992-3#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#3)(1994-9#2)(1995-12#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-2#3)(1996-3#2)(1996-6#1)(1996-8#4)(1997-2#1)(1997-4#1)(1997-6#6)(1997-7#2)(1997-8#1)(2008-10#45)(2008-11#1)(2008-5#1)(2008-8#6)(2008-9#5)(2009-3#1)(2010-5#1)
nucleotide sequences of the##13##4##(1991-9#1)(1993-12#1)(1997-7#1)(2008-10#8)(2008-6#2)
nucleotide sequences of##24##3##(1991-6#1)(1991-9#1)(1993-12#2)(1997-7#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-6#2)(2013-8#1)
nucleotide sequences were##3##3##(1997-3#1)(1997-6#1)(1997-8#1)
nucleotide sequences##42##2##(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#3)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#21)(2008-11#1)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#2)(2013-8#1)
nucleotide sequencing##2##2##(1995-12#1)(1996-12#1)
nucleotide substitution##5##2##(1991-2#1)(1993-8#1)(2008-4#2)(2008-6#1)
nucleotide substitutions in##3##3##(1993-12#1)(1994-12#1)(2008-10#1)
nucleotide substitutions##9##2##(1993-12#1)(1993-2#1)(1994-12#1)(2008-10#4)(2008-6#1)(2008-8#1)
nucleotide variation##3##2##(1994-12#1)(2011-2#1)(2012-3#1)
nucleotide##380##1##(1990-11#1)(1990-2#1)(1990-7#2)(1990-8#4)(1991-2#1)(1991-5#5)(1991-6#3)(1991-9#3)(1992-1#3)(1992-3#1)(1992-6#1)(1993-12#15)(1993-2#5)(1993-3#3)(1993-6#6)(1993-8#1)(1993-9#5)(1994-11#10)(1994-12#6)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#6)(1995-9#1)(1996-12#3)(1996-2#5)(1996-3#2)(1996-6#1)(1996-8#5)(1997-2#11)(1997-3#5)(1997-4#1)(1997-6#7)(1997-7#4)(1997-8#4)(1997-9#2)(2008-10#118)(2008-11#25)(2008-12#2)(2008-4#5)(2008-5#5)(2008-6#4)(2008-8#13)(2008-9#12)(2009-10#1)(2009-3#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#8)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#12)
nucleotide)##3##1##(1993-8#2)(2008-9#1)
nucleotide-binding domains of##2##3##(2008-11#2)
nucleotide-binding domains##3##2##(1997-4#1)(2008-11#2)
nucleotide-binding##7##1##(1992-9#1)(1993-12#1)(1997-4#1)(1997-7#1)(2008-11#2)(2009-8#1)
nucleotide-gated##2##1##(2009-10#2)
nucleotides (nt) and##3##3##(1993-2#1)(2008-8#2)
nucleotides (nt)##5##2##(1991-9#1)(1993-2#2)(2008-8#2)
nucleotides and##6##2##(1996-6#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)
nucleotides encoding a##3##3##(1992-3#1)(1995-2#1)(2008-8#1)
nucleotides encoding##4##2##(1992-3#1)(1995-2#1)(2008-10#1)(2008-8#1)
nucleotides from the##4##3##(1994-11#1)(1997-3#2)(2008-10#1)
nucleotides from##6##2##(1990-8#1)(1994-11#1)(1997-3#3)(2008-10#1)
nucleotides in length and##2##4##(1997-7#1)(2011-2#1)
nucleotides in length##7##3##(1992-8#1)(1997-7#1)(2008-10#3)(2011-2#1)(2013-8#1)
nucleotides in the##2##3##(1995-11#1)(2008-10#1)
nucleotides in##16##2##(1992-8#2)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-4#1)(2011-2#1)(2013-8#2)
nucleotides long##2##2##(2008-10#1)(2008-9#1)
nucleotides of the##4##3##(1990-5#1)(1991-5#1)(1993-3#1)(1996-12#1)
nucleotides of##10##2##(1990-5#1)(1991-5#1)(1991-7#1)(1993-3#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
nucleotides to##2##2##(1993-1#1)(2008-11#1)
nucleotides was##3##2##(1993-8#1)(1995-8#1)(2008-11#1)
nucleotides##125##1##(1990-5#1)(1990-8#3)(1991-5#4)(1991-6#1)(1991-7#3)(1991-9#1)(1992-3#1)(1992-8#2)(1993-1#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#4)(1997-7#2)(2008-10#33)(2008-11#12)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#3)(2011-2#1)(2012-2#1)(2013-8#2)
nucleotides) of the##2##3##(2008-10#2)
nucleotides)##8##1##(1997-7#1)(2008-10#6)(2008-5#1)
nucleotomy##3##1##(1996-6#3)
nucleus (PVN)##3##2##(1994-8#1)(1996-12#1)(2008-8#1)
nucleus accumbens in##3##3##(1993-6#1)(1994-3#1)(1994-8#1)
nucleus accumbens##37##2##(1993-6#16)(1994-2#4)(1994-3#2)(1994-8#4)(1995-2#2)(1996-12#2)(1996-5#2)(1997-3#3)(2008-7#2)
nucleus and a##2##3##(1996-12#1)(2013-8#1)
nucleus and the##4##3##(1991-12#1)(1994-2#1)(2008-7#1)(2011-2#1)
nucleus and##22##2##(1991-12#1)(1991-2#1)(1994-11#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(2007-12#2)(2008-10#3)(2008-7#3)(2008-8#1)(2008-9#3)(2011-2#2)(2013-8#1)
nucleus basalis lesions##3##3##(1990-5#2)(1991-9#1)
nucleus basalis magnocellularis (NBM)##3##4##(1991-12#1)(1993-3#1)(2008-8#1)
nucleus basalis magnocellularis##4##3##(1991-12#1)(1993-3#2)(2008-8#1)
nucleus basalis##9##2##(1990-5#3)(1991-12#1)(1991-9#2)(1993-3#2)(2008-8#1)
nucleus by##2##2##(1994-8#1)(1996-2#1)
nucleus can##2##2##(2008-9#1)(2011-2#1)
nucleus gigantocellularis##2##2##(1990-9#2)
nucleus in the##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
nucleus in##10##2##(1997-1#2)(2008-11#1)(2008-7#2)(2008-9#2)(2009-10#1)(2011-2#2)
nucleus is##6##2##(1993-8#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)
nucleus of the amygdala##4##4##(1993-6#3)(1996-12#1)
nucleus of the stria terminalis##2##5##(1994-2#1)(2008-9#1)
nucleus of the##21##3##(1991-2#1)(1993-6#3)(1994-2#2)(1996-12#3)(1997-3#5)(2008-11#1)(2008-9#3)(2012-2#1)(2012-3#2)
nucleus of##30##2##(1990-9#1)(1991-2#1)(1991-7#1)(1993-6#3)(1994-11#1)(1994-2#2)(1994-6#1)(1995-12#1)(1996-12#3)(1997-3#5)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#4)(2012-2#1)(2012-3#2)
nucleus or##4##2##(1994-8#1)(1995-8#1)(2011-2#2)
nucleus posterioris##2##2##(2008-6#2)
nucleus preopticus##2##2##(2008-6#2)
nucleus pulposus##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
nucleus through##2##2##(2011-2#2)
nucleus to the##2##3##(1997-3#1)(2011-2#1)
nucleus to##6##2##(1990-5#1)(1996-2#1)(1997-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
nucleus##306##1##(1990-12#1)(1990-5#4)(1990-9#6)(1991-12#9)(1991-2#4)(1991-3#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-10#1)(1992-6#1)(1993-12#2)(1993-3#3)(1993-6#19)(1993-8#2)(1994-11#3)(1994-2#16)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#7)(1995-12#2)(1995-2#3)(1995-8#3)(1996-12#14)(1996-2#5)(1996-5#5)(1997-1#3)(1997-2#6)(1997-3#13)(2007-12#7)(2008-10#9)(2008-11#11)(2008-4#4)(2008-5#1)(2008-6#11)(2008-7#18)(2008-8#18)(2008-9#34)(2009-10#4)(2009-12#4)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#18)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#1)(2013-8#4)
nucleus-side chain and side chain-side chain cross-linkages##2##7##(2008-10#2)
nuda##5##1##(2008-10#5)
nude mice##22##2##(1993-1#2)(1994-12#3)(1995-2#1)(2008-11#1)(2008-8#8)(2010-1#4)(2011-2#1)(2013-1#2)
nude mouse##2##2##(2008-11#1)(2008-9#1)
nude##25##1##(1993-1#2)(1994-12#3)(1995-2#2)(2008-11#2)(2008-8#8)(2008-9#1)(2010-1#4)(2011-2#1)(2013-1#2)
nuisance##5##1##(2008-10#1)(2010-2#1)(2010-5#2)(2012-2#1)
nujol-graphite and diphenylether-graphite##2##3##(2008-10#2)
null alleles##2##2##(1995-6#1)(2008-12#1)
null hypothesis of no difference##2##5##(1995-5#1)(1995-9#1)
null hypothesis of##5##3##(1995-5#1)(1995-9#2)(2008-10#2)
null hypothesis##11##2##(1995-5#2)(1995-9#3)(2008-10#5)(2008-8#1)
null model##4##2##(2008-10#1)(2008-8#3)
null models##4##2##(2008-8#3)(2009-8#1)
null mutants##3##2##(1996-3#1)(1997-4#2)
null mutations in##2##3##(1993-12#1)(2009-8#1)
null##38##1##(1993-12#1)(1995-5#2)(1995-6#1)(1995-9#3)(1996-3#2)(1997-4#2)(2008-10#6)(2008-12#1)(2008-8#8)(2008-9#3)(2009-10#2)(2009-8#3)(2011-2#1)(2013-1#3)
nullified the##2##2##(2008-10#1)(2010-4#1)
nullified##3##1##(2008-10#2)(2010-4#1)
nulliparous adolescents##3##2##(2013-1#3)
nulliparous women##2##2##(2013-1#1)(2013-8#1)
nulliparous##6##1##(2012-2#1)(2013-1#4)(2013-8#1)
nullisomic##3##1##(2008-10#3)
number and size of##6##4##(1990-5#1)(1995-8#1)(2008-10#2)(2010-12#1)(2013-7#1)
number and size##7##3##(1990-5#1)(1995-8#1)(2008-10#3)(2010-12#1)(2013-7#1)
number and the relevant positions of the alpha-helices and##2##9##(2008-10#2)
number and the##6##3##(2008-10#4)(2010-10#1)(2012-12#1)
number and type##2##3##(2008-10#1)(2008-11#1)
number and##62##2##(1990-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#3)(1997-2#1)(1997-6#2)(1997-8#1)(2008-10#18)(2008-11#6)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
number are##3##2##(2008-11#1)(2008-8#1)(2012-2#1)
number concentration of##2##3##(1993-8#1)(1995-3#1)
number density##10##2##(2008-10#1)(2008-2#1)(2008-3#8)
number determination##4##2##(2008-10#3)(2008-9#1)
number for##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
number higher than##2##3##(2008-10#1)(2008-12#1)
number in the##8##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
number in##20##2##(1992-3#1)(1993-12#2)(2008-10#3)(2008-11#3)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#2)
number increased##3##2##(2008-11#1)(2008-7#2)
number increases##2##2##(2008-12#1)(2008-5#1)
number is##6##2##(1996-3#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-10#1)(2012-3#1)
number nor##3##2##(1991-6#1)(2009-6#1)(2010-8#1)
number of &quot##2##3##(1992-2#1)(2008-1#1)
number of 12##2##3##(1994-8#1)(2008-10#1)
number of CTLs##2##3##(2008-11#2)
number of ER-L##2##3##(2010-12#2)
number of ICSS trains##4##4##(1991-2#4)
number of LS-11 cells##2##4##(2008-10#2)
number of abortions has##2##4##(1991-3#2)
number of active##5##3##(2008-10#3)(2008-4#1)(2010-9#1)
number of admissions##2##3##(1996-3#1)(1997-4#1)
number of adult##4##3##(1994-3#1)(1996-12#1)(2008-8#1)(2008-9#1)
number of alleles per locus##3##5##(2008-10#1)(2013-8#2)
number of amino##2##3##(2008-10#2)
number of analytical##2##3##(2008-10#2)
number of anamorph genera##2##4##(2008-10#2)
number of apoptotic cells##2##4##(2010-1#1)(2011-2#1)
number of apothecia##5##3##(2008-10#5)
number of arrivals##2##3##(2010-8#2)
number of ascospores discharged##2##4##(2008-10#2)
number of ascospores##3##3##(2008-10#3)
number of athletes##2##3##(1993-3#1)(2010-1#1)
number of audible pops##3##4##(2008-12#3)
number of available##3##3##(2008-9#1)(2009-10#1)(2010-11#1)
number of avoidances##2##3##(1991-2#2)
number of barriers##2##3##(1993-12#1)(2008-1#1)
number of beds##2##3##(1993-1#1)(1997-4#1)
number of beneficiaries##2##3##(1997-2#1)(1997-3#1)
number of bifidobacteria##2##3##(2008-12#2)
number of births##3##3##(1990-12#1)(1990-6#1)(1995-12#1)
number of bites##2##3##(2008-4#2)
number of brain regions##2##4##(1995-12#1)(1996-12#1)
number of brain##3##3##(1994-2#1)(1995-12#1)(1996-12#1)
number of branches plant(-1)##2##4##(2008-12#2)
number of branches##3##3##(2008-12#3)
number of bundles##2##3##(2008-10#2)
number of carbon atoms##3##4##(2008-10#3)
number of cases and##2##4##(1992-9#1)(2013-8#1)
number of cases in the##2##5##(1994-9#1)(1997-6#1)
number of cases in##3##4##(1994-9#2)(1997-6#1)
number of cases of##4##4##(1992-9#1)(2008-11#1)(2011-2#2)
number of cases that##2##4##(1993-12#1)(2008-6#1)
number of cases##24##3##(1990-12#1)(1992-9#5)(1993-12#1)(1994-9#5)(1995-2#1)(1997-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
number of cell##5##3##(1992-8#1)(1995-6#1)(2008-10#1)(2008-11#2)
number of cells differentiating to the##2##6##(2008-5#2)
number of cells##10##3##(1992-6#2)(1993-6#1)(1995-9#1)(1997-1#1)(2008-11#2)(2008-5#2)(2008-9#1)
number of cellular##2##3##(1993-8#1)(2008-11#1)
number of channels and##2##4##(2008-9#2)
number of channels##6##3##(2007-12#1)(2008-7#1)(2008-9#4)
number of children##3##3##(1990-6#1)(2009-7#1)(2010-6#1)
number of chromosomes##3##3##(2008-12#2)(2008-8#1)
number of citations##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
number of claims an employee submitted##2##6##(1994-2#2)
number of claims an employee##3##5##(1994-2#3)
number of claims##4##3##(1994-2#4)
number of clinical##5##3##(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
number of colonies per leaf##2##5##(2008-10#2)
number of colonies##3##3##(2008-10#3)
number of commercial##2##3##(2008-10#1)(2010-4#1)
number of commercially available##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
number of components and##2##4##(2008-10#2)
number of components##4##3##(2008-10#3)(2008-4#1)
number of compounds##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
number of conidia and appressoria##3##5##(2008-10#3)
number of conidia per##2##4##(2008-10#2)
number of conidia##13##3##(2008-10#13)
number of continuous rainy days in April and May##3##9##(2008-10#3)
number of corpora lutea in each ovary##2##7##(1992-3#2)
number of correct responses##2##4##(1991-2#1)(1993-3#1)
number of correctly##2##3##(1992-9#1)(2013-1#1)
number of countries##2##3##(2007-12#1)(2008-11#1)
number of cryptic species##2##4##(2008-10#1)(2012-3#1)
number of data##2##3##(1995-5#1)(2008-10#1)
number of days##6##3##(2008-10#5)(2008-11#1)
number of deaths from breast cancer##2##6##(1997-7#2)
number of deaths##6##3##(1991-9#1)(1997-7#3)(2008-7#1)(2011-3#1)
number of degenerative##2##3##(2008-10#1)(2008-8#1)
number of different strategies##2##4##(2008-11#1)(2008-9#1)
number of different##24##3##(1991-5#1)(1992-12#1)(1994-2#1)(1995-5#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-4#1)(2008-9#2)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
number of disease##2##3##(2008-10#1)(2008-7#1)
number of diseased trees##2##4##(2008-10#2)
number of diseases per##2##4##(2008-10#2)
number of diseases##9##3##(1994-2#1)(2006-6#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)
number of drugs have been##2##5##(2008-8#1)(2009-12#1)
number of drugs##4##3##(2008-11#1)(2008-8#1)(2009-12#1)(2012-3#1)
number of eggs##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
number of elastin fibers##2##4##(2008-5#2)
number of elderly patients##3##4##(1994-3#2)(2011-2#1)
number of elderly##4##3##(1994-3#2)(2011-2#1)(2012-3#1)
number of electrons involved in the electrode reduction##2##8##(2008-10#2)
number of electrons##3##3##(2008-10#3)
number of elements##3##3##(2008-10#2)(2011-2#1)
number of embryos in each uterine horn##2##7##(1992-3#2)
number of embryos##4##3##(1992-3#2)(2008-12#2)
number of experimental##3##3##(1995-6#1)(2008-10#1)(2012-12#1)
number of experiments##5##3##(2008-10#3)(2008-5#2)
number of factors##21##3##(1994-3#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
number of false positives and negatives##2##6##(2008-10#2)
number of false##4##3##(1997-2#2)(2008-10#2)
number of features##2##3##(1995-2#1)(2012-3#1)
number of female##4##3##(1993-9#1)(2008-10#1)(2008-12#2)
number of flowers##3##3##(2008-12#1)(2008-9#1)(2009-5#1)
number of foci##3##3##(2008-10#3)
number of food##2##3##(1990-8#1)(2010-6#1)
number of foods##2##3##(2008-4#2)
number of fungal##2##3##(2008-10#2)
number of gene##2##3##(1993-3#1)(2012-3#1)
number of genes in##2##4##(1996-12#1)(2008-6#1)
number of genes that##3##4##(2008-11#1)(2008-4#1)(2011-1#1)
number of genes##14##3##(1996-12#3)(1996-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-8#1)(2011-1#1)
number of genotypes observed in a sample##2##7##(2008-10#2)
number of genotypes observed##3##4##(2008-10#3)
number of genotypes##5##3##(2008-10#5)
number of groups##3##3##(2008-11#1)(2009-1#1)(2012-2#1)
number of habitat patches##2##4##(2008-8#2)
number of hepatic##3##3##(1994-11#1)(2011-2#2)
number of hospitals##3##3##(1993-3#1)(1994-2#1)(2008-11#1)
number of hours##3##3##(2008-10#3)
number of human##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
number of important##7##3##(1992-9#1)(2008-10#3)(2008-8#1)(2009-6#1)(2012-2#1)
number of index subjects##4##4##(1996-3#4)
number of individuals introduced##2##4##(2008-8#2)
number of individuals with##2##4##(2008-1#1)(2013-8#1)
number of individuals##12##3##(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#4)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
number of induced abortions##2##4##(2013-1#2)
number of industrial##2##3##(1996-1#1)(2011-2#1)
number of infected plants##3##4##(2008-10#3)
number of infected##7##3##(2008-10#7)
number of infection##2##3##(2008-10#2)
number of infective second-stage juveniles##2##5##(2008-10#2)
number of injections##2##3##(1997-5#1)(2011-2#1)
number of interfering##2##3##(2008-10#2)
number of invasive##2##3##(2008-11#1)(2012-3#1)
number of ions##2##3##(2008-10#1)(2010-7#1)
number of irradiation##2##3##(2008-10#2)
number of items in##2##4##(2012-2#2)
number of its##2##3##(1990-2#1)(2010-1#1)
number of key##4##3##(2007-12#1)(2008-10#1)(2008-8#2)
number of laser##2##3##(2008-10#1)(2008-3#1)
number of leaves##4##3##(2008-10#4)
number of lesions per##3##4##(2008-10#3)
number of lesions##9##3##(2008-10#8)(2013-1#1)
number of levels##2##3##(1995-5#1)(2008-11#1)
number of live births##2##4##(1991-3#2)
number of live##3##3##(1991-3#2)(2008-11#1)
number of major##2##3##(1994-11#1)(2008-10#1)
number of male##2##3##(1993-9#1)(2008-12#1)
number of mates##2##3##(2008-8#2)
number of meals##3##3##(1994-6#1)(2008-4#2)
number of medical##2##3##(1990-12#1)(1991-12#1)
number of metabolic##3##3##(2008-10#2)(2009-8#1)
number of metal ions on the determination of##5##8##(2008-10#5)
number of metal ions##7##4##(2008-10#7)
number of methods##2##3##(2008-10#1)(2010-11#1)
number of migrants##3##3##(2008-10#2)(2008-8#1)
number of molecular##2##3##(2008-10#1)(2008-11#1)
number of multiple nucleoli##2##4##(2007-12#2)
number of multiple##3##3##(2007-12#2)(2008-9#1)
number of neurons in the##2##5##(1990-5#1)(2008-10#1)
number of new##8##3##(1990-6#2)(1997-6#1)(2008-10#3)(2008-11#2)
number of notified cases##2##4##(2012-12#1)(2013-8#1)
number of nucleotide substitutions##2##4##(2008-6#1)(2008-8#1)
number of nucleotide##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
number of observations##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
number of offspring##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
number of older persons in##2##5##(1997-2#1)(2010-10#1)
number of older##3##3##(1997-2#1)(2010-10#1)(2010-11#1)
number of olfactory##2##3##(2007-12#1)(2012-2#1)
number of ommatidia per eye##3##5##(2007-12#3)
number of oospores per leaflet##2##5##(2008-10#2)
number of oospores produced##2##4##(2008-10#2)
number of oospores##5##3##(2008-10#5)
number of other##15##3##(1990-11#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-4#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
number of panicles##2##3##(2008-12#1)(2008-8#1)
number of papers##5##3##(2008-10#5)
number of parameters##5##3##(1991-3#1)(1995-9#1)(2008-10#1)(2008-2#2)
number of participants##3##3##(2010-11#1)(2010-7#1)(2012-3#1)
number of particle##2##3##(1992-3#1)(2008-8#1)
number of patches##6##3##(2008-8#6)
number of patients suffering from##2##5##(1993-11#1)(2011-3#1)
number of patients treated##2##4##(1994-5#1)(1995-2#1)
number of patients was##2##4##(1994-12#1)(2011-2#1)
number of patients with##6##4##(1993-1#1)(1996-3#1)(2008-7#1)(2011-1#2)(2011-2#1)
number of patients##32##3##(1991-11#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#3)(2010-12#2)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
number of pecks##2##3##(2008-6#2)
number of people with##3##4##(2008-6#1)(2009-10#1)(2013-8#1)
number of people##6##3##(1992-2#1)(1994-2#1)(1995-12#1)(2008-6#1)(2009-10#1)(2013-8#1)
number of perfused##2##3##(1997-2#2)
number of plant species##2##4##(2008-10#1)(2009-8#1)
number of plant##3##3##(2008-10#2)(2009-8#1)
number of plants##3##3##(2008-10#3)
number of polymorphic loci##2##4##(2008-10#1)(2008-9#1)
number of polymorphisms##2##3##(2008-10#2)
number of pores##2##3##(2008-10#2)
number of positive##2##3##(1990-8#2)
number of possible##7##3##(1991-3#1)(1995-12#1)(1995-3#1)(1997-6#1)(2008-10#2)(2008-9#1)
number of potential mates##3##4##(2008-8#3)
number of potential##6##3##(1994-6#1)(1996-3#1)(2008-11#1)(2008-8#3)
number of pregnancies and##2##4##(2011-1#1)(2011-2#1)
number of pregnancies on bone mineral density##2##7##(2011-2#2)
number of pregnancies##6##3##(2011-1#1)(2011-2#5)
number of previous##5##3##(1991-2#2)(2008-1#1)(2008-8#1)(2012-2#1)
number of problems##3##3##(1995-12#1)(2008-11#2)
number of procedures##3##3##(1993-12#1)(2008-10#1)(2009-5#1)
number of proliferating##2##3##(2008-11#1)(2008-9#1)
number of propagules##4##3##(2008-10#3)(2008-8#1)
number of protein##3##3##(1990-8#1)(2008-12#1)(2010-10#1)
number of proteins##3##3##(2008-11#2)(2010-12#1)
number of protocols##2##3##(2008-10#1)(2010-10#1)
number of publications##2##3##(1995-2#1)(2013-1#1)
number of purine units within the##2##6##(2008-10#2)
number of pustules per##2##4##(2008-10#2)
number of pustules##3##3##(2008-10#3)
number of races##2##3##(2008-10#2)
number of recently##2##3##(1994-12#1)(2008-11#1)
number of regulatory agencies##2##4##(2008-10#2)
number of regulatory##3##3##(2008-10#2)(2010-10#1)
number of reports##4##3##(2008-11#2)(2008-7#1)(2011-2#1)
number of samples in a##2##5##(2008-11#1)(2010-11#1)
number of samples##18##3##(2008-10#13)(2008-11#3)(2008-9#1)(2010-11#1)
number of sampling##3##3##(2008-10#2)(2008-8#1)
number of sclerotia##6##3##(2008-10#6)
number of screening##2##3##(2012-12#1)(2013-1#1)
number of seemingly##2##3##(1993-3#1)(2011-2#1)
number of sessions##5##3##(2009-9#1)(2010-8#1)(2013-8#3)
number of single cells decreases##2##5##(2008-7#2)
number of single cells##5##4##(2008-7#5)
number of single##7##3##(1993-12#1)(1994-3#1)(2008-7#5)
number of sites##3##3##(2008-10#2)(2012-5#1)
number of small amplitude oscillations##2##5##(2008-10#2)
number of small##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
number of smokers##2##3##(2008-10#1)(2010-7#1)
number of sources##3##3##(1993-12#1)(2008-12#1)(2010-11#1)
number of species in##4##4##(2008-10#1)(2008-8#3)
number of species of##3##4##(1993-2#1)(2008-10#2)
number of species##9##3##(1993-2#2)(2008-10#3)(2008-8#4)
number of specific##2##3##(1992-9#1)(2008-11#1)
number of sporangia produced##2##4##(2008-10#2)
number of sporangia##4##3##(2008-10#4)
number of spores per##2##4##(2008-10#2)
number of staff who##2##4##(2008-11#2)
number of standard##2##3##(2008-10#2)
number of steps in##2##4##(2008-10#2)
number of steps##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
number of stipes##2##3##(2008-10#2)
number of strains##3##3##(1993-9#1)(2008-10#2)
number of striga##2##3##(2008-10#2)
number of studies have shown##2##5##(1992-2#1)(2008-11#1)
number of studies have##5##4##(1992-2#1)(2008-11#2)(2008-12#1)(2008-9#1)
number of studies that##2##4##(2008-7#1)(2009-10#1)
number of studies##14##3##(1992-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
number of study##2##3##(1993-12#1)(2008-12#1)
number of subjects in##2##4##(1995-5#1)(1995-9#1)
number of subjects##8##3##(1995-5#1)(1995-9#3)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
number of such##2##3##(2008-11#2)
number of symptoms##3##3##(2008-7#1)(2009-9#2)
number of system##2##3##(2008-10#2)
number of tandem##2##3##(1993-12#1)(2008-11#1)
number of targets##2##3##(2008-11#1)(2009-8#1)
number of tests##4##3##(1990-9#1)(1996-11#1)(2008-10#2)
number of the##17##3##(1992-2#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
number of theoretical plates was##2##5##(2008-10#2)
number of theoretical plates##3##4##(2008-10#3)
number of these##7##3##(1991-3#1)(1997-8#1)(2008-10#3)(2011-2#1)(2013-8#1)
number of times##4##3##(1996-2#1)(1996-3#1)(1997-1#1)(2010-6#1)
number of total##2##3##(1997-3#1)(2008-8#1)
number of traits##3##3##(2008-8#2)(2012-3#1)
number of trees##4##3##(2008-10#4)
number of trials##7##3##(1990-11#1)(1993-3#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-8#2)
number of unprotected##2##3##(2013-1#2)
number of variables##4##3##(2008-10#3)(2008-9#1)
number of viable##5##3##(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
number of virulence##3##3##(2008-10#3)
number of women##4##3##(1993-6#2)(2008-11#1)(2012-2#1)
number of working##2##3##(2008-10#2)
number of##1752##2##(1990-11#5)(1990-12#10)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#6)(1990-8#8)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#4)(1991-2#14)(1991-3#16)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#10)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#6)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#11)(1993-1#5)(1993-11#4)(1993-12#14)(1993-2#4)(1993-3#11)(1993-6#7)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#8)(1994-2#9)(1994-3#7)(1994-5#7)(1994-6#6)(1994-8#4)(1994-9#6)(1995-11#3)(1995-12#14)(1995-2#7)(1995-3#5)(1995-5#12)(1995-6#3)(1995-8#7)(1995-9#8)(1996-1#2)(1996-11#4)(1996-12#7)(1996-2#13)(1996-3#16)(1996-6#3)(1997-1#5)(1997-2#17)(1997-3#7)(1997-4#4)(1997-5#2)(1997-6#10)(1997-7#5)(1997-8#3)(1997-9#2)(2006-6#1)(2007-11#3)(2007-12#20)(2008-1#8)(2008-10#510)(2008-11#126)(2008-12#53)(2008-2#8)(2008-3#18)(2008-4#22)(2008-5#40)(2008-6#16)(2008-7#47)(2008-8#70)(2008-9#62)(2009-1#1)(2009-10#12)(2009-11#1)(2009-12#4)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#10)(2009-9#5)(2010-1#10)(2010-10#13)(2010-11#11)(2010-12#15)(2010-4#2)(2010-5#4)(2010-6#7)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#11)(2011-2#57)(2011-3#5)(2012-12#12)(2012-2#27)(2012-3#34)(2012-4#3)(2012-5#1)(2012-9#1)(2013-1#41)(2013-8#21)
number on##2##2##(2008-7#1)(2010-8#1)
number or##3##2##(1990-12#1)(2011-2#1)(2012-3#1)
number over##2##2##(1997-6#1)(2012-2#1)
number per##2##2##(1993-11#1)(2008-10#1)
number sequences##2##2##(2013-8#2)
number that##2##2##(1996-2#1)(2008-10#1)
number to##2##2##(2012-12#1)(2012-3#1)
number two##2##2##(2007-8#2)
number was##3##2##(1992-12#1)(2008-10#1)(2008-12#1)
number within##2##2##(2008-10#1)(2008-11#1)
number##2055##1##(1990-11#5)(1990-12#12)(1990-2#3)(1990-3#1)(1990-5#6)(1990-6#6)(1990-8#8)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#14)(1991-3#16)(1991-5#6)(1991-6#8)(1991-7#3)(1991-8#10)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#6)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#3)(1992-9#12)(1993-1#5)(1993-11#5)(1993-12#19)(1993-2#4)(1993-3#13)(1993-5#1)(1993-6#7)(1993-8#4)(1993-9#5)(1994-1#1)(1994-11#4)(1994-12#8)(1994-2#10)(1994-3#7)(1994-5#7)(1994-6#8)(1994-8#4)(1994-9#6)(1995-11#4)(1995-12#16)(1995-2#8)(1995-3#7)(1995-5#14)(1995-6#3)(1995-8#10)(1995-9#8)(1996-1#2)(1996-11#4)(1996-12#7)(1996-2#14)(1996-3#17)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#19)(1997-3#7)(1997-4#4)(1997-5#2)(1997-6#14)(1997-7#5)(1997-8#5)(1997-9#2)(2006-6#1)(2007-11#3)(2007-12#20)(2007-8#4)(2008-1#8)(2008-10#580)(2008-11#161)(2008-12#67)(2008-2#9)(2008-3#32)(2008-4#23)(2008-5#48)(2008-6#18)(2008-7#60)(2008-8#81)(2008-9#71)(2009-1#1)(2009-10#13)(2009-11#1)(2009-12#5)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#5)(2009-7#9)(2009-8#10)(2009-9#5)(2010-1#11)(2010-10#17)(2010-11#12)(2010-12#17)(2010-4#2)(2010-5#4)(2010-6#7)(2010-7#5)(2010-8#12)(2010-9#3)(2011-1#12)(2011-2#64)(2011-3#7)(2012-12#14)(2012-2#32)(2012-3#46)(2012-4#3)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#44)(2013-7#2)(2013-8#31)
number)##2##1##(2008-10#1)(2008-11#1)
number-average molecular weight##2##3##(1993-6#1)(2008-12#1)
numbered##3##1##(1992-12#1)(2008-10#1)(2012-2#1)
numbers and##20##2##(1993-9#1)(1994-6#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-9#1)(2012-2#1)(2012-5#1)(2013-1#2)
numbers are##2##2##(2008-3#1)(2013-1#1)
numbers as##2##2##(1991-12#1)(1991-3#1)
numbers between##2##2##(1996-12#1)(2008-10#1)
numbers for##2##2##(2008-10#2)
numbers in the##6##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
numbers in##15##2##(1990-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(2008-10#4)(2008-11#1)(2008-6#1)(2011-2#2)(2013-1#2)
numbers may##2##2##(2008-12#1)(2008-5#1)
numbers of C##3##3##(2008-10#2)(2008-5#1)
numbers of L##2##3##(1996-12#1)(2013-8#1)
numbers of T cells and##2##5##(2008-10#1)(2011-2#1)
numbers of T cells##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
numbers of animals##2##3##(1992-12#1)(2012-2#1)
numbers of ascospores were##3##4##(2008-10#3)
numbers of ascospores##4##3##(2008-10#4)
numbers of cells##3##3##(2008-11#2)(2008-9#1)
numbers of conidia##5##3##(2008-10#5)
numbers of layers of##3##4##(2008-12#3)
numbers of oospores##2##3##(2008-10#2)
numbers of patients##6##3##(1995-12#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-7#1)
numbers of resident##2##3##(2008-10#1)(2008-5#1)
numbers of samples##4##3##(2008-10#3)(2008-9#1)
numbers of shoots)##2##3##(2013-1#2)
numbers of species##2##3##(2008-10#1)(2008-9#1)
numbers of the##5##3##(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
numbers of these##2##3##(2008-11#1)(2013-1#1)
numbers of total##2##3##(2008-10#1)(2013-1#1)
numbers of##178##2##(1990-11#1)(1990-12#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-1#1)(1995-12#6)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#5)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#59)(2008-11#9)(2008-12#6)(2008-3#1)(2008-4#5)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#12)(2009-10#1)(2009-6#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#7)(2012-2#3)(2013-1#9)(2013-8#2)
numbers or##2##2##(1991-7#1)(2008-10#1)
numbers than##3##2##(2008-10#2)(2008-8#1)
numbers vary##3##2##(2008-12#2)(2008-8#1)
numbers was##2##2##(2008-10#1)(2008-11#1)
numbers were##6##2##(1996-12#1)(2008-10#3)(2008-11#1)(2013-8#1)
numbers##309##1##(1990-11#1)(1990-12#2)(1991-12#5)(1991-3#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#2)(1994-9#2)(1995-1#1)(1995-12#8)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#7)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#99)(2008-11#20)(2008-12#11)(2008-3#4)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#15)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#14)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#17)(2013-8#9)
numbers)##2##1##(1995-3#1)(2008-10#1)
numbness and##2##2##(1990-9#1)(2012-3#1)
numbness in##2##2##(2008-12#1)(2012-3#1)
numbness##6##1##(1990-9#1)(1991-6#1)(2008-12#1)(2012-3#2)(2013-8#1)
numeric pain rating scale##2##4##(2008-12#2)
numeric pain rating##3##3##(2008-12#3)
numeric##8##1##(1995-12#1)(1997-2#1)(2008-12#3)(2008-7#1)(2012-2#1)(2012-3#1)
numerical analysis of the##2##4##(2008-10#1)(2008-3#1)
numerical analysis of##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
numerical analysis##7##2##(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#3)
numerical aperture is##2##3##(2007-12#1)(2013-8#1)
numerical aperture##6##2##(2007-12#2)(2008-3#2)(2009-12#1)(2013-8#1)
numerical calculation##2##2##(2008-3#2)
numerical calculations##2##2##(2008-10#1)(2008-2#1)
numerical chromosomal abnormalities##4##3##(2010-1#1)(2012-3#3)
numerical derivative##2##2##(2008-3#2)
numerical filtering##3##2##(2008-3#3)
numerical image reconstruction##2##3##(2008-3#2)
numerical integration of the##2##4##(2007-11#1)(2008-9#1)
numerical integration##6##2##(1991-5#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-9#1)
numerical magnitude##2##2##(2013-8#2)
numerical method##2##2##(2008-3#2)
numerical methods##3##2##(2008-10#2)(2008-3#1)
numerical model##5##2##(1990-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
numerical results concerning##2##3##(2008-2#1)(2008-3#1)
numerical results obtained##2##3##(2008-10#1)(2008-3#1)
numerical results##12##2##(2008-10#1)(2008-2#5)(2008-3#5)(2013-8#1)
numerical simulation and##3##3##(2008-3#3)
numerical simulation of##2##3##(2007-12#1)(2009-8#1)
numerical simulation##7##2##(2007-12#2)(2008-3#4)(2009-8#1)
numerical simulations for##2##3##(2008-10#1)(2013-8#1)
numerical simulations with##2##3##(2008-10#1)(2008-11#1)
numerical simulations##11##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2009-5#1)(2013-8#2)
numerical solution##7##2##(1992-9#2)(2008-10#1)(2008-3#1)(2008-9#2)(2009-10#1)
numerical study##2##2##(2008-3#1)(2013-8#1)
numerical techniques##2##2##(2008-6#1)(2008-8#1)
numerical values##2##2##(2008-10#1)(2008-3#1)
numerical##129##1##(1990-11#1)(1991-2#1)(1991-5#1)(1992-9#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(2007-11#2)(2007-12#6)(2008-10#19)(2008-11#2)(2008-2#9)(2008-3#42)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-3#3)(2013-8#14)
numerically and##2##2##(2007-12#1)(2008-4#1)
numerically##19##1##(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
numerous and##4##2##(1993-12#1)(1994-2#1)(1995-1#1)(2008-11#1)
numerous applications##3##2##(2009-10#1)(2010-7#1)(2012-2#1)
numerous aspects of##2##3##(1995-2#1)(2007-12#1)
numerous biological processes##2##3##(2008-10#2)
numerous biological##3##2##(1993-2#1)(2008-10#2)
numerous cells##2##2##(2008-10#1)(2008-5#1)
numerous changes in##2##3##(2011-2#1)(2012-3#1)
numerous changes##3##2##(1995-12#1)(2011-2#1)(2012-3#1)
numerous chemical##2##2##(2008-3#1)(2010-7#1)
numerous experimental##2##2##(2008-10#1)(2008-11#1)
numerous in##2##2##(2008-10#2)
numerous mitochondria##2##2##(2007-12#1)(2008-7#1)
numerous molecular##3##2##(2008-8#1)(2009-6#1)(2011-2#1)
numerous ornamental##2##2##(2008-10#2)
numerous other##8##2##(1991-2#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-2#1)
numerous pathways##2##2##(2010-10#1)(2011-1#1)
numerous proteins##2##2##(1993-6#1)(2011-2#1)
numerous short##2##2##(1995-12#1)(2007-12#1)
numerous small##2##2##(2008-10#1)(2008-7#1)
numerous studies have##2##3##(2008-1#1)(2008-10#1)
numerous studies##6##2##(1997-8#1)(2008-1#1)(2008-10#1)(2010-1#1)(2011-2#2)
numerous types of##2##3##(2011-2#1)(2013-1#1)
numerous vascular##2##2##(2008-7#1)(2010-6#1)
numerous ways##3##2##(2008-10#1)(2008-8#1)(2010-11#1)
numerous##210##1##(1990-11#2)(1991-12#1)(1991-2#6)(1991-5#2)(1991-7#2)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2007-12#6)(2008-1#1)(2008-10#57)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#3)(2009-12#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#11)(2011-8#1)(2011-9#1)(2012-2#9)(2012-3#4)(2013-1#6)(2013-8#7)
nummularis##2##1##(2011-2#2)
nuptial##2##1##(2008-5#1)(2008-8#1)
nurse academics##2##2##(2008-11#1)(2008-12#1)
nurse and by##2##3##(2008-11#1)(2010-7#1)
nurse and##5##2##(1994-1#1)(2008-11#2)(2010-7#2)
nurse assistants##3##2##(2008-11#1)(2010-11#2)
nurse education and##4##3##(2008-11#2)(2008-12#2)
nurse education in##3##3##(2008-11#2)(2008-12#1)
nurse education to##2##3##(2008-12#2)
nurse education##47##2##(2008-11#32)(2008-12#14)(2013-8#1)
nurse educationalists##2##2##(2008-11#2)
nurse educator##5##2##(2008-11#4)(2008-12#1)
nurse educators and##2##3##(2008-11#1)(2008-12#1)
nurse educators are##3##3##(2008-11#1)(2008-12#2)
nurse educators can##2##3##(2008-12#2)
nurse educators who##2##3##(2008-11#1)(2008-12#1)
nurse educators##23##2##(2008-11#13)(2008-12#10)
nurse educators'##2##2##(2008-11#2)
nurse employee##2##2##(2008-11#2)
nurse examinations##2##2##(2008-11#2)
nurse for##2##2##(1992-3#1)(2008-12#1)
nurse in##4##2##(1996-11#1)(2008-11#2)(2008-7#1)
nurse is##2##2##(1997-5#1)(2008-12#1)
nurse lecturer##2##2##(2008-11#2)
nurse lecturers##7##2##(2008-11#7)
nurse managers##3##2##(1990-12#1)(1997-2#2)
nurse personnel##2##2##(2008-11#2)
nurse practitioner in##3##3##(1993-2#1)(2009-9#1)(2010-10#1)
nurse practitioner##6##2##(1993-2#1)(2008-11#1)(2008-12#2)(2009-9#1)(2010-10#1)
nurse practitioners##10##2##(1991-1#2)(1997-1#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)
nurse researchers##2##2##(1994-3#1)(2008-11#1)
nurse teachers and##2##3##(2008-11#2)
nurse teachers##4##2##(2008-11#4)
nurse to##4##2##(2008-11#2)(2013-8#2)
nurse##218##1##(1990-12#1)(1991-1#2)(1991-2#1)(1992-3#1)(1993-2#2)(1994-1#1)(1994-3#2)(1996-11#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(2008-11#117)(2008-12#40)(2008-3#1)(2008-6#3)(2008-7#1)(2009-6#1)(2009-9#3)(2010-10#4)(2010-11#4)(2010-2#2)(2010-4#3)(2010-7#4)(2010-8#2)(2011-1#2)(2011-2#2)(2013-1#4)(2013-8#6)
nurse'##2##1##(2008-11#2)
nurse's support##2##2##(1995-1#2)
nurse's##16##1##(1990-2#1)(1991-1#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-1#2)(2008-11#2)(2008-12#2)(2010-10#3)(2012-3#2)
nurse-managed secondary prevention program on lifestyle and risk factors##2##9##(2010-7#2)
nurseries and##2##2##(2008-10#2)
nurseries##17##1##(1995-1#1)(2008-10#16)
nursery houses##2##2##(1996-12#2)
nursery in##3##2##(2008-10#2)(2012-3#1)
nursery stock##2##2##(2008-10#2)
nursery##26##1##(1991-12#1)(1993-3#2)(1995-1#2)(1996-12#2)(2008-10#18)(2012-3#1)
nurses about##2##2##(1997-4#1)(2010-10#1)
nurses and medical students##2##4##(2008-11#2)
nurses and midwives##2##3##(2008-11#2)
nurses and occupational therapists##2##4##(2008-11#2)
nurses and other##2##3##(1997-2#1)(2008-11#1)
nurses and the##2##3##(2008-11#1)(2008-12#1)
nurses and their##3##3##(2008-11#3)
nurses and##40##2##(1993-2#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#14)(2008-12#7)(2008-7#1)(2010-9#4)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
nurses are##8##2##(2008-11#2)(2008-12#2)(2010-5#1)(2010-8#2)(2013-1#1)
nurses as##5##2##(2008-11#2)(2012-3#1)(2013-1#2)
nurses at a##2##3##(2008-11#2)
nurses at##6##2##(1997-8#1)(2008-11#3)(2013-1#2)
nurses can##7##2##(2008-11#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-8#1)
nurses do not##2##3##(2008-12#1)(2013-8#1)
nurses employed##2##2##(2008-9#1)(2010-10#1)
nurses felt##2##2##(2008-11#1)(2013-1#1)
nurses for##2##2##(1990-2#1)(2008-11#1)
nurses from##4##2##(1990-2#1)(2008-11#1)(2010-10#1)(2010-8#1)
nurses has##3##2##(2008-11#2)(2008-12#1)
nurses have been##2##3##(2008-11#1)(2010-3#1)
nurses have##4##2##(2008-11#1)(2010-3#2)(2012-12#1)
nurses in a##2##3##(2011-2#1)(2012-3#1)
nurses in aged-care##2##3##(2010-10#2)
nurses in the UK##2##4##(2008-11#2)
nurses in the##7##3##(2008-10#1)(2008-11#3)(2008-12#1)(2010-4#1)(2011-1#1)
nurses in##32##2##(1991-2#1)(1992-12#1)(1992-3#2)(1996-2#1)(2008-10#1)(2008-11#8)(2008-12#3)(2008-7#4)(2010-10#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)
nurses is that##2##3##(2008-11#2)
nurses is##3##2##(1996-2#1)(2008-11#2)
nurses learn##2##2##(2008-11#2)
nurses must##3##2##(2008-12#1)(2010-6#1)(2013-8#1)
nurses need to##3##3##(2008-11#3)
nurses of##2##2##(1990-2#1)(2008-11#1)
nurses on the##3##3##(1990-2#1)(1991-2#1)(2008-11#1)
nurses on##7##2##(1990-2#1)(1991-2#1)(2008-11#1)(2008-12#4)
nurses participated##4##2##(2008-11#1)(2008-7#1)(2010-7#1)(2010-8#1)
nurses provide##2##2##(2008-11#1)(2008-7#1)
nurses responded##2##2##(1990-2#1)(2010-11#1)
nurses support##2##2##(2010-5#2)
nurses that##3##2##(2008-11#2)(2011-1#1)
nurses to be##2##3##(2008-1#1)(2008-12#1)
nurses to develop##3##3##(2008-11#2)(2010-7#1)
nurses to initiate thrombolytic therapy for patients with an acute myocardial infarction - is there a##2##16##(2008-11#2)
nurses to initiate thrombolytic therapy##3##5##(2008-11#3)
nurses to the##3##3##(1993-2#1)(2008-11#1)(2008-7#1)
nurses to use##2##3##(2008-11#1)(2010-11#1)
nurses to work##3##3##(2008-11#2)(2008-12#1)
nurses to##32##2##(1993-2#1)(2008-1#1)(2008-11#19)(2008-12#4)(2008-7#1)(2010-11#1)(2010-7#1)(2012-3#2)(2013-8#2)
nurses was##2##2##(1991-2#1)(2010-10#1)
nurses were##11##2##(1991-2#2)(1992-2#1)(2008-11#3)(2008-12#1)(2008-7#1)(2010-11#2)(2010-3#1)
nurses who are##4##3##(1996-2#1)(2008-11#1)(2008-12#2)
nurses who care for##2##4##(2008-11#1)(2012-3#1)
nurses who provide##2##3##(2008-9#1)(2009-11#1)
nurses who were involved in a##2##6##(2008-11#1)(2010-11#1)
nurses who##24##2##(1996-2#2)(2008-1#2)(2008-11#7)(2008-12#4)(2008-9#1)(2009-11#1)(2010-11#2)(2010-3#1)(2012-3#3)(2013-8#1)
nurses will##2##2##(2008-11#2)
nurses with##7##2##(2008-11#4)(2008-3#1)(2010-4#1)(2013-1#1)
nurses within the##2##3##(2008-11#1)(2008-12#1)
nurses working in##3##3##(2008-11#1)(2010-9#1)(2013-8#1)
nurses working##4##2##(2008-11#2)(2010-9#1)(2013-8#1)
nurses##420##1##(1990-12#1)(1990-2#11)(1991-2#8)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-2#4)(1993-3#3)(1994-12#1)(1994-3#1)(1995-3#1)(1996-2#8)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2008-1#4)(2008-10#2)(2008-11#147)(2008-12#57)(2008-3#3)(2008-6#1)(2008-7#15)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#2)(2009-6#4)(2009-9#1)(2010-10#10)(2010-11#9)(2010-3#9)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#5)(2010-8#9)(2010-9#7)(2011-1#6)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#16)(2013-1#27)(2013-8#11)
nurses' ability to##3##3##(2008-11#2)(2008-7#1)
nurses' decisions to adopt##2##4##(2010-11#2)
nurses' decisions##3##2##(2010-11#2)(2012-3#1)
nurses' experiences##5##2##(2008-11#1)(2010-7#2)(2010-8#1)(2013-8#1)
nurses' perception##2##2##(2010-11#1)(2011-1#1)
nurses' perceptions of##2##3##(2008-11#1)(2008-12#1)
nurses' perceptions regarding the implementation of a best practice guideline##2##10##(2010-10#2)
nurses' perceptions##4##2##(2008-11#1)(2008-12#1)(2010-10#2)
nurses' perspectives toward providing spiritual care##3##6##(2011-1#3)
nurses' practices##2##2##(2012-3#2)
nurses'##49##1##(1992-2#2)(1992-3#1)(1996-2#3)(2008-11#11)(2008-12#3)(2008-7#1)(2010-10#4)(2010-11#6)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#5)(2012-3#3)(2013-1#3)(2013-8#1)
nurses)##2##1##(2009-12#2)
nurses?##2##1##(2008-11#1)(2008-12#1)
nurses]##3##1##(1990-2#1)(1991-2#1)(2012-3#1)
nursing (adult) students##2##3##(2008-12#2)
nursing -##2##2##(2008-12#2)
nursing actions##3##2##(2008-11#1)(2010-10#1)(2012-3#1)
nursing activities##6##2##(1991-2#6)
nursing administration##2##2##(1990-12#1)(1990-2#1)
nursing advocacy##4##2##(2009-12#4)
nursing and health care##2##4##(2008-11#1)(2008-12#1)
nursing and health##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
nursing and medical##5##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
nursing and medicine##2##3##(2008-11#2)
nursing and midwifery##4##3##(2008-11#3)(2008-12#1)
nursing and occupational therapy##2##4##(2008-11#2)
nursing and social work programs across Canada##2##7##(2012-12#2)
nursing and social work programs##3##5##(2012-12#3)
nursing and weaned piglets##2##4##(1996-12#2)
nursing and##36##2##(1990-12#1)(1992-12#1)(1994-2#1)(1996-12#2)(2008-10#1)(2008-11#15)(2008-12#7)(2008-7#1)(2010-10#2)(2012-12#3)(2013-1#2)
nursing are##6##2##(2008-11#2)(2008-12#3)(2010-8#1)
nursing as a##2##3##(2008-11#1)(2012-3#1)
nursing assessments##2##2##(2008-12#2)
nursing care and##2##3##(1991-3#1)(2008-12#1)
nursing care during##3##3##(2012-3#1)(2013-1#2)
nursing care in##4##3##(1990-2#1)(1991-2#1)(2008-12#1)(2012-3#1)
nursing care of older adults##3##5##(2008-11#3)
nursing care of##7##3##(2008-11#4)(2012-3#1)(2013-1#2)
nursing care##39##2##(1990-2#2)(1991-2#3)(1991-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(2008-11#7)(2008-12#4)(2010-10#1)(2010-9#1)(2012-3#8)(2013-1#8)(2013-8#1)
nursing community##2##2##(2008-11#1)(2013-1#1)
nursing course##6##2##(2008-11#4)(2008-12#2)
nursing courses##3##2##(2008-11#3)
nursing coverage##3##2##(2010-7#3)
nursing curricula##7##2##(2008-11#4)(2008-12#3)
nursing curriculum##16##2##(2008-11#10)(2008-12#6)
nursing degree##2##2##(2008-11#2)
nursing development##2##2##(1997-4#1)(2008-12#1)
nursing diagnoses in##3##3##(2012-3#1)(2013-1#2)
nursing diagnoses were##2##3##(2012-3#2)
nursing diagnoses##12##2##(2012-3#4)(2013-1#8)
nursing diagnosis##11##2##(1990-2#9)(2013-1#2)
nursing education and##4##3##(2008-11#3)(2008-12#1)
nursing education is##2##3##(2008-11#1)(2008-12#1)
nursing education program and##2##4##(2008-11#1)(2008-12#1)
nursing education programme##2##3##(2008-11#2)
nursing education##43##2##(1990-2#1)(1991-2#1)(2008-11#18)(2008-12#22)(2012-3#1)
nursing educators##4##2##(2008-11#2)(2008-12#2)
nursing facilities##4##2##(1991-2#1)(1992-2#1)(2008-5#1)(2012-3#1)
nursing facility##10##2##(1991-1#2)(1994-12#1)(1994-2#2)(1995-3#2)(1996-3#2)(2008-5#1)
nursing faculty members##2##3##(2008-11#1)(2008-12#1)
nursing faculty regarding student assignment to a patient with AIDS##2##10##(2008-11#2)
nursing faculty##9##2##(2008-11#6)(2008-12#3)
nursing has##2##2##(1996-2#1)(2008-11#1)
nursing home admission##2##3##(1997-2#2)
nursing home care##9##3##(1991-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-3#1)(2008-11#1)(2009-3#1)
nursing home costs##3##3##(1991-1#1)(1994-2#1)(1995-2#1)
nursing home in##2##3##(2008-12#1)(2010-10#1)
nursing home patients##5##3##(1994-12#2)(1994-2#1)(2008-7#2)
nursing home quality##4##3##(1996-2#1)(2008-11#3)
nursing home residents##6##3##(1991-3#1)(1995-2#2)(1996-2#1)(2010-10#2)
nursing home staff##4##3##(1997-1#1)(2010-10#3)
nursing home##78##2##(1991-1#3)(1991-2#1)(1991-3#3)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-12#4)(1994-2#11)(1995-2#8)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#4)(2008-11#8)(2008-12#5)(2008-7#4)(2009-3#2)(2010-10#10)(2010-11#1)(2011-2#1)
nursing homes and their##2##4##(1994-12#1)(2008-11#1)
nursing homes and##5##3##(1991-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-11#1)
nursing homes in##5##3##(2008-12#1)(2010-10#3)(2010-11#1)
nursing homes##46##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#5)(1994-12#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-2#5)(1996-1#1)(1996-2#4)(1997-1#1)(1997-2#1)(2008-1#1)(2008-11#4)(2008-12#1)(2009-3#2)(2010-10#7)(2010-11#2)(2010-8#1)
nursing in##5##2##(1991-2#1)(2008-12#2)(2008-3#1)(2012-3#1)
nursing intervention in##2##3##(1990-12#1)(2010-7#1)
nursing intervention##4##2##(1990-12#2)(1992-2#1)(2010-7#1)
nursing interventions for##3##3##(2010-4#1)(2013-1#2)
nursing interventions##10##2##(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2013-1#6)
nursing is a##2##3##(2008-11#1)(2008-12#1)
nursing is##5##2##(2008-11#4)(2008-12#1)
nursing knowledge##5##2##(2008-11#1)(2008-12#4)
nursing literature##7##2##(1994-3#2)(2008-11#2)(2008-12#1)(2013-1#2)
nursing outcomes and##4##3##(2013-1#4)
nursing personnel##2##2##(1991-2#2)
nursing practice and##4##3##(2008-11#2)(2008-12#2)
nursing practice##30##2##(2008-11#17)(2008-12#7)(2010-10#2)(2013-1#4)
nursing practitioners##2##2##(2008-11#1)(2008-12#1)
nursing program##4##2##(2008-11#4)
nursing programme##2##2##(2008-11#2)
nursing programmes##4##2##(2008-11#3)(2008-12#1)
nursing research##7##2##(2008-12#3)(2010-9#2)(2013-1#2)
nursing school##2##2##(2008-12#1)(2012-3#1)
nursing service##2##2##(2008-1#2)
nursing shortage##3##2##(1991-2#1)(1993-3#1)(2008-12#1)
nursing staff members'##2##3##(2010-10#2)
nursing staff were##2##3##(2008-12#1)(2010-10#1)
nursing staff##13##2##(1991-2#1)(1993-3#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#6)(2010-11#1)
nursing student##6##2##(2008-11#4)(2008-12#2)
nursing students and##5##3##(2008-11#2)(2008-12#3)
nursing students at##2##3##(2008-11#1)(2008-12#1)
nursing students can##2##3##(2008-11#2)
nursing students in the##2##4##(2008-11#2)
nursing students in##3##3##(2008-11#2)(2008-12#1)
nursing students to##5##3##(2008-11#2)(2008-12#2)(2013-8#1)
nursing students who##3##3##(2008-11#3)
nursing students##72##2##(2008-11#45)(2008-12#24)(2010-10#1)(2010-3#1)(2013-8#1)
nursing students' experiences##2##3##(2008-11#1)(2008-12#1)
nursing students'##12##2##(2008-11#10)(2008-12#2)
nursing support##3##2##(2010-7#3)
nursing survey results##2##3##(2013-1#2)
nursing theory and practice##2##4##(2008-11#2)
nursing to##4##2##(1990-12#1)(2008-12#2)(2013-1#1)
nursing was##3##2##(1994-12#1)(2008-11#2)
nursing with##2##2##(2008-11#1)(2008-12#1)
nursing##762##1##(1990-12#8)(1990-2#20)(1991-1#7)(1991-12#1)(1991-2#23)(1991-3#5)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#6)(1993-12#2)(1993-2#1)(1993-3#4)(1994-1#2)(1994-12#9)(1994-2#17)(1994-3#5)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#17)(1995-3#3)(1996-1#2)(1996-12#3)(1996-2#12)(1996-3#5)(1996-6#1)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(2008-1#4)(2008-10#2)(2008-11#245)(2008-12#155)(2008-3#1)(2008-5#2)(2008-7#9)(2009-12#4)(2009-3#4)(2009-6#1)(2010-10#35)(2010-11#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#12)(2010-8#2)(2010-9#4)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#27)(2013-1#58)(2013-8#2)
nurture##5##1##(1993-12#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)
nut proteins##2##2##(2008-10#2)
nut##9##1##(2008-10#8)(2010-1#1)
nutraceuticals##2##1##(2008-10#1)(2008-11#1)
nutrient acquisition##2##2##(2008-8#1)(2009-8#1)
nutrient activation##2##2##(2008-10#2)
nutrient agar##2##2##(1993-12#1)(2008-10#1)
nutrient and##6##2##(2008-11#3)(2008-7#1)(2008-9#1)(2009-6#1)
nutrient availability##7##2##(2008-10#5)(2008-8#1)(2013-8#1)
nutrient concentration##2##2##(2008-11#2)
nutrient consumption##4##2##(2008-11#1)(2008-7#3)
nutrient content##3##2##(2008-11#1)(2008-12#2)
nutrient cycling##2##2##(2008-7#1)(2008-8#1)
nutrient depletion##6##2##(2008-7#6)
nutrient deprivation##4##2##(2008-5#1)(2008-7#2)(2013-1#1)
nutrient feeding##2##2##(2008-11#1)(2008-7#1)
nutrient intake in##2##3##(1994-12#2)
nutrient intake of##2##3##(2010-6#1)(2013-1#1)
nutrient intake##9##2##(1994-12#4)(2010-6#3)(2012-2#1)(2013-1#1)
nutrient intakes were##2##3##(2010-6#1)(2013-1#1)
nutrient intakes##4##2##(2010-6#2)(2011-2#1)(2013-1#1)
nutrient levels favored##2##3##(2008-10#2)
nutrient levels##3##2##(2008-10#2)(2008-11#1)
nutrient media##7##2##(2008-10#2)(2008-11#3)(2013-1#2)
nutrient removal##2##2##(2008-12#2)
nutrient solution and##2##3##(2008-10#2)
nutrient solution containing##2##3##(2008-10#1)(2008-12#1)
nutrient solution##12##2##(2008-10#10)(2008-12#1)(2008-8#1)
nutrient source##3##2##(2008-7#2)(2008-9#1)
nutrient supply to##2##3##(2008-9#1)(2013-8#1)
nutrient supply##6##2##(2008-11#2)(2008-9#2)(2013-8#2)
nutrient uptake by##2##3##(2008-10#1)(2008-12#1)
nutrient uptake##6##2##(2008-10#2)(2008-12#4)
nutrient##145##1##(1993-12#1)(1994-12#4)(1995-11#1)(2008-10#40)(2008-11#20)(2008-12#10)(2008-5#3)(2008-7#21)(2008-8#15)(2008-9#5)(2009-12#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-6#5)(2011-2#1)(2012-2#4)(2013-1#5)(2013-8#4)
nutrient-limited##2##1##(2008-11#1)(2008-7#1)
nutrient-poor##2##1##(2008-10#1)(2008-9#1)
nutrients and##11##2##(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
nutrients are##2##2##(2008-11#1)(2012-3#1)
nutrients from##2##2##(2008-10#1)(2008-8#1)
nutrients in the##2##3##(2008-10#1)(2008-9#1)
nutrients in##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)
nutrients or##2##2##(2008-11#1)(2013-8#1)
nutrients that##2##2##(1994-8#1)(2011-2#1)
nutrients to##4##2##(2008-11#1)(2008-7#1)(2008-9#2)
nutrients##65##1##(1991-2#1)(1993-12#1)(1994-8#3)(2008-10#16)(2008-11#18)(2008-7#5)(2008-8#6)(2008-9#4)(2009-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
nutrigenomics##4##1##(2008-10#4)
nutrition (TPN)##5##2##(1992-9#2)(1994-6#1)(2008-10#1)(2009-9#1)
nutrition and hydration##3##3##(1990-11#2)(1991-12#1)
nutrition and##17##2##(1990-11#2)(1991-12#1)(1991-6#2)(1996-8#2)(1997-1#1)(2008-10#3)(2008-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
nutrition assessment##2##2##(1992-12#2)
nutrition education##2##2##(1991-2#2)
nutrition for##4##2##(1991-2#1)(1997-4#1)(2008-10#1)(2011-2#1)
nutrition habits##2##2##(1991-2#1)(2011-2#1)
nutrition in Norway##2##3##(1991-6#2)
nutrition in##6##2##(1991-6#2)(2008-7#1)(2009-5#1)(2012-2#2)
nutrition intervention##2##2##(1995-9#1)(1997-1#1)
nutrition is##2##2##(1991-2#1)(1991-6#1)
nutrition of##2##2##(2008-5#2)
nutrition screen##2##2##(1992-12#2)
nutrition status and##2##3##(2011-2#2)
nutrition status##4##2##(2011-2#3)(2013-1#1)
nutrition##107##1##(1990-11#2)(1991-12#1)(1991-2#6)(1991-3#1)(1991-6#7)(1992-12#9)(1992-3#1)(1992-9#3)(1993-12#2)(1994-6#2)(1995-3#1)(1995-9#1)(1996-3#1)(1996-8#2)(1997-1#2)(1997-4#2)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#13)(2012-12#6)(2012-2#8)(2012-8#1)(2012-9#1)(2013-1#3)(2013-8#1)
nutritional and##4##2##(2008-3#1)(2010-12#1)(2010-6#1)(2013-8#1)
nutritional control##3##2##(2008-11#1)(2008-7#1)(2010-10#1)
nutritional deficiencies##2##2##(2008-10#2)
nutritional education##2##2##(2011-2#2)
nutritional factors##2##2##(2008-11#1)(2013-7#1)
nutritional groups##2##2##(2008-11#2)
nutritional indices##2##2##(1993-12#1)(2013-8#1)
nutritional intake##3##2##(1991-2#1)(2010-9#2)
nutritional intervention##2##2##(1993-12#1)(2011-2#1)
nutritional parameters##2##2##(2011-2#2)
nutritional properties##2##2##(2008-7#1)(2011-2#1)
nutritional requirements##2##2##(2010-6#1)(2012-12#1)
nutritional screening##2##2##(2012-12#2)
nutritional status in##3##3##(1993-12#1)(1997-8#1)(2011-1#1)
nutritional status of beef patties##2##5##(2010-4#2)
nutritional status of##6##3##(2008-10#1)(2008-7#1)(2010-4#2)(2010-6#1)(2011-1#1)
nutritional status##14##2##(1990-3#1)(1993-12#1)(1994-6#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#2)(2010-6#1)(2011-1#3)
nutritional supplement##6##2##(2008-10#2)(2013-8#4)
nutritional support##4##2##(1993-9#1)(2009-9#1)(2011-3#1)(2012-12#1)
nutritional value and##2##3##(2008-10#1)(2010-11#1)
nutritional value of the##3##4##(1994-3#1)(2010-11#1)(2011-2#1)
nutritional value of##4##3##(1994-3#1)(2008-10#1)(2010-11#1)(2011-2#1)
nutritional value##9##2##(1994-3#1)(2008-10#4)(2008-5#1)(2010-11#2)(2011-2#1)
nutritional##99##1##(1990-3#1)(1991-2#1)(1991-6#2)(1992-10#1)(1992-12#1)(1993-12#4)(1993-9#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#12)(2011-3#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#6)
nutritionally##6##1##(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2012-2#1)
nutritionists##4##1##(1991-2#4)
nutritive##9##1##(2007-12#1)(2008-10#5)(2008-9#1)(2010-7#2)
nuts were##2##2##(1994-3#1)(2008-10#1)
nuts##7##1##(1994-3#1)(2008-10#3)(2010-7#1)(2011-2#1)(2012-2#1)
nws1##4##1##(2008-10#4)
nygamai##3##1##(2008-10#3)
nylon membrane substrate##2##3##(2008-11#2)
nylon membrane##4##2##(1995-6#1)(2008-10#1)(2008-11#2)
nylon membranes##2##2##(2008-10#1)(2008-11#1)
nylon##12##1##(1990-2#2)(1995-6#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-9#1)(2013-1#1)
nymph##2##1##(2008-8#2)
nymphal##2##1##(2008-12#1)(2008-6#1)
nymphs and##3##2##(2008-8#1)(2013-8#2)
nymphs##11##1##(2008-10#4)(2008-8#2)(2008-9#2)(2013-8#3)
nystagmus##7##1##(1995-8#1)(1997-8#1)(2008-7#4)(2010-9#1)
nystatin##3##1##(2008-5#3)
o and##2##2##(2008-10#1)(2008-7#1)
o##31##1##(1990-6#1)(1990-9#1)(1991-5#1)(1992-5#1)(1994-11#1)(1997-3#1)(2008-10#14)(2008-11#1)(2008-7#4)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)
o') tri(phenylmethyl)tin##3##2##(2008-10#3)
o-##5##1##(2008-10#5)
o-NPOE and##2##2##(2008-10#2)
o-NPOE##11##1##(2008-10#11)
o-catechol##3##1##(2008-10#3)
o-cresolphthalein##2##1##(2008-10#2)
o-dianisidine##5##1##(2008-10#5)
o-dimethyldithiophosphoric acid (DMDTPA)##2##3##(2008-10#2)
o-nitroaniline and p-nitroaniline##2##3##(2008-10#2)
o-nitrophenyl octyl ether##3##3##(2008-10#3)
o-nitrophenyloctyl ether (o-NPOE) as solvent mediator and##2##7##(2008-10#2)
o-nitrophenyloctyl ether (o-NPOE) as##3##4##(2008-10#3)
o-nitrophenyloctyl ether (o-NPOE)##4##3##(2008-10#4)
o-nitrophenyloctyl ether##6##2##(2008-10#6)
o-phenanthroline##4##1##(2008-10#4)
o-phenylenediamine##12##1##(2008-10#12)
o-phtalaldehyde##2##1##(2008-10#2)
o-phthalaldialdehyde and##2##2##(2008-10#2)
o-phthaldialdehyde##2##1##(2008-10#1)(2008-11#1)
o-quinone was##2##2##(2008-10#2)
o-quinone##4##1##(2008-10#4)
o-tolidine##6##1##(2008-10#6)
o-xylene##2##1##(2008-10#2)
o/w and w/o emulsions##2##4##(2008-5#2)
o/w emulsion and##2##3##(2008-5#2)
o/w emulsion##5##2##(2008-5#5)
o/w##10##1##(2008-5#10)
o/w/o##2##1##(2008-5#2)
oFSHbeta##2##1##(1995-8#2)
oGDP##2##1##(1991-5#2)
oICH and##2##2##(2012-3#2)
oICH##8##1##(2012-3#8)
oPRL##2##1##(1995-11#2)
oak (Quercus##2##2##(2008-10#2)
oak bark##3##2##(2008-10#3)
oak death##7##2##(2008-10#7)
oak leaves##2##2##(2012-9#2)
oak species##9##2##(2012-5#2)(2012-6#4)(2012-7#1)(2012-9#2)
oak trees##2##2##(2008-10#1)(2012-9#1)
oak##44##1##(2008-10#24)(2008-5#1)(2012-5#5)(2012-6#4)(2012-7#1)(2012-9#9)
oaks in##2##2##(2008-10#1)(2012-9#1)
oaks##5##1##(2008-10#1)(2012-7#2)(2012-9#2)
oat (Avena sativa L##2##4##(2008-10#2)
oat (Avena##3##2##(2008-10#3)
oat and##5##2##(2008-10#4)(2011-2#1)
oat cell##2##2##(1990-5#2)
oat cells##2##2##(1990-5#1)(2008-10#1)
oat products##2##2##(1991-6#1)(2011-2#1)
oat##39##1##(1990-5#3)(1991-6#1)(2008-10#29)(2008-9#2)(2011-1#1)(2011-2#3)
oatmeal agar##2##2##(2008-10#2)
oats on##2##2##(1991-6#1)(2008-10#1)
oats##11##1##(1991-6#2)(2008-10#9)
obese (fa/fa) and lean (Fa/Fa) Zucker rats##2##7##(1996-12#2)
obese (fa/fa)##4##2##(1996-12#4)
obese and non-obese##2##3##(2012-2#1)(2013-7#1)
obese and nonobese patients##2##4##(2011-2#2)
obese and##8##2##(1996-12#1)(2008-10#2)(2011-2#2)(2012-2#2)(2013-7#1)
obese animals##3##2##(2012-3#3)
obese children and adolescents##2##4##(2011-1#2)
obese children##7##2##(2008-12#1)(2010-8#2)(2011-1#3)(2012-3#1)
obese group##3##2##(2011-1#1)(2012-2#2)
obese individuals with PHA##2##4##(2013-1#2)
obese individuals##9##2##(1996-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
obese male##2##2##(1996-12#1)(2013-1#1)
obese males##2##2##(2012-2#1)(2013-1#1)
obese or##2##2##(1996-12#1)(2008-3#1)
obese participants##2##2##(2013-8#2)
obese patients##12##2##(1993-3#1)(2010-10#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-5#2)
obese patients)##2##2##(2011-2#2)
obese patients]##2##2##(1993-11#1)(1993-5#1)
obese people##2##2##(1993-3#1)(2010-10#1)
obese rats##5##2##(1994-11#2)(1996-12#3)
obese subjects and##3##3##(2008-10#2)(2008-3#1)
obese subjects##5##2##(1992-12#1)(2008-10#2)(2008-3#2)
obese women##2##2##(2008-4#1)(2013-1#1)
obese young women with Down syndrome##2##6##(2013-1#2)
obese young##3##2##(2013-1#3)
obese##104##1##(1992-12#1)(1993-11#1)(1993-3#2)(1993-5#1)(1994-11#2)(1996-12#14)(1996-6#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#5)(2008-4#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-8#3)(2011-1#6)(2011-2#16)(2012-12#2)(2012-2#9)(2012-3#6)(2012-5#2)(2013-1#12)(2013-7#1)(2013-8#4)
obesity among##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
obesity and cholesterol##2##3##(2009-7#2)
obesity and diabetes##2##3##(2008-1#1)(2008-11#1)
obesity and insulin resistance##3##4##(2010-7#1)(2011-1#2)
obesity and the metabolic syndrome##3##5##(2008-10#1)(2008-3#2)
obesity and the##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
obesity and##28##2##(1994-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#5)(2008-4#1)(2008-7#1)(2009-7#2)(2010-12#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#2)
obesity did not##2##3##(2008-12#1)(2011-1#1)
obesity epidemic##6##2##(2008-10#1)(2012-2#4)(2013-1#1)
obesity has been##2##3##(2008-3#1)(2010-5#1)
obesity has##3##2##(2008-3#1)(2010-5#1)(2010-6#1)
obesity in rats##5##3##(2011-2#4)(2013-1#1)
obesity in the##2##3##(1993-11#1)(2011-2#1)
obesity in##14##2##(1993-11#1)(2008-1#4)(2011-2#6)(2012-2#1)(2013-1#2)
obesity is a##2##3##(2008-10#1)(2012-2#1)
obesity is##8##2##(2008-10#1)(2011-1#2)(2011-2#2)(2012-2#3)
obesity measures##2##2##(2013-1#2)
obesity models##2##2##(2008-4#1)(2010-11#1)
obesity on##6##2##(2008-10#1)(2011-1#1)(2011-2#3)(2012-3#1)
obesity prevention programs##3##3##(2012-2#1)(2013-1#2)
obesity prevention##5##2##(2011-2#1)(2012-2#2)(2013-1#2)
obesity that##2##2##(2008-10#1)(2012-2#1)
obesity were##5##2##(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#2)
obesity with##2##2##(2012-12#1)(2012-2#1)
obesity##186##1##(1991-3#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-6#1)(1996-12#2)(2008-1#12)(2008-10#14)(2008-11#8)(2008-12#5)(2008-3#11)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#15)(2011-2#22)(2012-12#4)(2012-2#23)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#6)
obesity-related insulin resistance##2##3##(2010-11#2)
obesity-related##4##1##(2010-11#2)(2010-6#1)(2011-1#1)
obesogenic##3##1##(2008-10#2)(2013-1#1)
obey##6##1##(1990-8#1)(2008-10#4)(2011-2#1)
obeyed Beer's law##2##3##(2008-10#2)
obeyed between##2##2##(2008-10#2)
obeyed for##4##2##(2008-10#4)
obeyed in a concentration##3##4##(2008-10#3)
obeyed in a##5##3##(2008-10#5)
obeyed in the range 0##3##5##(2008-10#3)
obeyed in the range##8##4##(2008-10#8)
obeyed in the##11##3##(2008-10#11)
obeyed in##16##2##(2008-10#16)
obeyed over the concentration range of##4##6##(2008-10#4)
obeyed over the concentration range##5##5##(2008-10#5)
obeyed over the range from##3##5##(2008-10#3)
obeyed over the range of 0##3##6##(2008-10#3)
obeyed over the range##10##4##(2008-10#10)
obeyed over the##16##3##(2008-10#16)
obeyed up to##2##3##(2008-10#2)
obeyed##46##1##(2008-10#45)(2008-9#1)
obeys Beer's law from 0##3##5##(2008-10#3)
obeys Beer's law in the range of 0##2##8##(2008-10#2)
obeys Beer's law in the range##4##6##(2008-10#4)
obeys Beer's law in the##5##5##(2008-10#5)
obeys Beer's law##10##3##(2008-10#10)
obeys Beer's##11##2##(2008-10#11)
obeys a##3##2##(2008-10#2)(2009-8#1)
obeys the##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
obeys##23##1##(1993-2#1)(2008-10#18)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)
object and##2##2##(2008-11#1)(2009-5#1)
object are##3##2##(2008-11#2)(2008-6#1)
object for##2##2##(1995-5#1)(2009-8#1)
object in##5##2##(2008-11#2)(2008-3#2)(2008-5#1)
object is##4##2##(1996-2#1)(2008-3#2)(2009-10#1)
object knowledge##2##2##(2009-12#2)
object of##14##2##(1990-12#1)(1992-12#2)(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
object recall##2##2##(2008-7#2)
object recognition##8##2##(1993-3#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-6#3)(2009-12#1)
object shape##2##2##(2008-3#2)
object size##2##2##(2008-7#2)
object to track a moving target##2##6##(2008-11#2)
object to##5##2##(1990-2#1)(2008-11#2)(2008-3#1)(2011-2#1)
object##105##1##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#2)(1993-11#1)(1993-3#1)(1993-6#1)(1995-5#1)(1996-2#7)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#26)(2008-5#1)(2008-6#8)(2008-7#5)(2008-9#1)(2009-10#3)(2009-12#4)(2009-5#2)(2009-8#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
object-directed hand movements##4##3##(2008-11#4)
object-oriented##3##1##(1996-2#1)(2008-10#1)(2008-12#1)
objection##2##1##(2008-11#2)
objections to the##2##3##(1995-5#1)(2010-4#1)
objections to##4##2##(1995-5#1)(1996-2#1)(2008-11#1)(2010-4#1)
objections##5##1##(1995-5#1)(1996-2#1)(2008-11#1)(2010-4#1)(2013-8#1)
objective and##11##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#4)(2011-2#1)(2013-1#1)
objective assessment of##2##3##(2008-5#1)(2008-8#1)
objective clinical##2##2##(1990-3#1)(2008-10#1)
objective criteria##5##2##(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#1)
objective data to##3##3##(1994-1#1)(2008-10#1)(2010-7#1)
objective data##4##2##(1994-1#1)(2008-10#1)(2010-7#1)(2013-1#1)
objective detection of##2##3##(1990-12#1)(2008-10#1)
objective evidence##2##2##(2008-6#1)(2013-8#1)
objective function##2##2##(2008-3#1)(2010-8#1)
objective in the##2##3##(1992-2#1)(2008-7#1)
objective is to##12##3##(1994-1#1)(1995-12#2)(2008-10#3)(2008-5#1)(2009-6#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
objective is##14##2##(1993-2#1)(1994-1#1)(1995-12#2)(2008-10#4)(2008-5#1)(2009-6#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
objective measures of##2##3##(1992-12#1)(1994-3#1)
objective measures##6##2##(1992-12#1)(1994-3#1)(2008-3#1)(2008-9#3)
objective method for##2##3##(2011-2#1)(2012-2#1)
objective method##3##2##(2010-8#1)(2011-2#1)(2012-2#1)
objective of the present study was to##5##7##(2008-10#2)(2008-5#1)(2011-2#2)
objective of the present study was##6##6##(2008-10#2)(2008-5#1)(2011-2#2)(2012-2#1)
objective of the present##8##4##(2008-10#2)(2008-5#2)(2011-2#2)(2012-2#1)(2013-1#1)
objective of the program##2##4##(1993-12#1)(2008-11#1)
objective of the study was to##2##6##(1990-2#1)(2011-2#1)
objective of the##16##3##(1990-2#1)(1993-12#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
objective of this paper is to##4##6##(1992-3#1)(1993-1#1)(2009-10#1)(2011-1#1)
objective of this research was to##5##6##(2008-10#3)(2008-5#1)(2010-4#1)
objective of this study is to assess the##2##8##(2008-5#1)(2012-3#1)
objective of this study is to##4##6##(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
objective of this study was to analyze the##2##8##(2008-10#1)(2012-3#1)
objective of this study was to determine the##8##8##(1991-8#1)(2008-1#1)(2008-10#3)(2009-5#1)(2011-2#1)(2013-8#1)
objective of this study was to determine##12##7##(1991-8#1)(1994-11#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-5#1)(2011-2#1)(2013-8#2)
objective of this study was to develop##3##7##(2008-10#1)(2008-5#1)(2012-2#1)
objective of this study was to investigate the effects##2##9##(2008-10#1)(2008-3#1)
objective of this study was to investigate the##11##8##(1994-12#1)(2008-10#5)(2008-3#1)(2008-7#3)(2011-2#1)
objective of this study was to investigate##14##7##(1994-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#3)(2011-2#1)(2013-1#1)
objective of this study was to use##2##7##(2008-10#2)
objective of this study was to##63##6##(1991-8#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#2)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#2)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
objective of this study was##64##5##(1991-8#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#2)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#2)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
objective of this study##70##4##(1991-2#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#2)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#2)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
objective of this work is to##3##6##(2008-7#1)(2009-6#1)(2011-2#1)
objective of this work is##4##5##(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)
objective of this work##11##4##(1993-12#1)(1995-12#1)(2008-10#2)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
objective of this##98##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#2)(1997-8#2)(2008-1#3)(2008-10#21)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#4)
objective of##126##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#2)(1997-5#1)(1997-8#3)(2008-1#3)(2008-10#26)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#4)
objective physical health##2##3##(2011-2#2)
objective response##2##2##(1992-12#1)(1992-2#1)
objective structured clinical examination (OSCE) in the assessment of mental health nursing##2##12##(2008-11#2)
objective structured clinical examination (OSCE)##3##5##(2008-11#3)
objective than##2##2##(2008-9#1)(2011-2#1)
objective to##2##2##(2008-10#1)(2012-2#1)
objective tumor##2##2##(1991-6#1)(1992-12#1)
objective was achieved##2##3##(2008-10#1)(2008-5#1)
objective was to characterize##2##4##(2008-10#1)(2010-4#1)
objective was to determine how##2##5##(1991-2#1)(2008-10#1)
objective was to determine if the##2##6##(2008-10#1)(2008-11#1)
objective was to determine if##3##5##(1995-3#1)(2008-10#1)(2008-11#1)
objective was to determine the##2##5##(2008-10#1)(2008-5#1)
objective was to determine##8##4##(1991-2#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-5#1)
objective was to evaluate##2##4##(1992-2#1)(2012-2#1)
objective was to identify##2##4##(2008-10#1)(2013-1#1)
objective was to study##3##4##(2008-2#1)(2008-7#1)(2011-2#1)
objective was to##34##3##(1991-2#1)(1992-2#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-1#1)(1997-3#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
objective was##36##2##(1991-2#1)(1992-2#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-1#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
objective with##2##2##(2007-12#2)
objective##295##1##(1990-12#3)(1990-2#1)(1990-3#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#4)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#1)(1996-1#2)(1996-12#1)(1997-2#3)(1997-3#3)(1997-5#1)(1997-8#3)(2007-12#2)(2008-1#3)(2008-10#53)(2008-11#18)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#20)(2008-6#1)(2008-7#15)(2008-8#5)(2008-9#9)(2009-10#4)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#2)(2011-2#19)(2011-3#2)(2012-12#2)(2012-2#11)(2012-3#6)(2013-1#17)(2013-8#6)
objectively defined##2##2##(1994-2#1)(2013-1#1)
objectively##10##1##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-1#1)(2010-7#1)(2012-3#1)(2013-1#1)
objectives and##3##2##(1991-2#1)(1992-2#1)(1995-3#1)
objectives are met##2##3##(1992-1#1)(2013-1#1)
objectives are##5##2##(1992-1#2)(2008-7#1)(2008-9#1)(2013-1#1)
objectives for##4##2##(1995-2#1)(1995-3#1)(1996-1#1)(2011-1#1)
objectives in##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
objectives of our##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
objectives of the##3##3##(2008-10#2)(2008-12#1)
objectives of this study were to determine the##2##8##(2008-10#1)(2008-11#1)
objectives of this study were to##14##6##(2008-10#6)(2008-11#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
objectives of this study##15##4##(2008-10#7)(2008-11#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
objectives of this##24##3##(1997-1#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)
objectives of##34##2##(1994-12#1)(1997-1#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)
objectives were to determine##2##4##(2008-10#1)(2011-2#1)
objectives were to##8##3##(2008-10#5)(2011-2#1)(2013-1#2)
objectives were##9##2##(2008-10#5)(2008-7#1)(2011-2#1)(2013-1#2)
objectives##100##1##(1991-12#1)(1991-2#2)(1992-1#2)(1992-2#2)(1992-3#1)(1993-3#1)(1994-12#2)(1994-2#2)(1995-12#2)(1995-2#2)(1995-3#4)(1996-1#1)(1996-2#4)(1996-3#2)(1997-1#1)(1997-3#3)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#7)(2008-12#2)(2008-6#1)(2008-7#6)(2008-9#1)(2009-8#1)(2010-10#4)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#6)(2013-8#1)
objectivity##2##1##(2008-10#1)(2012-12#1)
objects and##5##2##(1996-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-5#1)
objects are##3##2##(2008-2#1)(2008-6#1)(2011-2#1)
objects as##2##2##(1990-3#1)(2007-12#1)
objects by##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
objects in a##3##3##(1993-6#1)(2008-3#2)
objects in##12##2##(1992-3#1)(1993-6#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-12#1)(2010-12#1)
objects of##6##2##(1996-1#1)(1996-2#1)(2008-12#1)(2010-1#2)(2010-10#1)
objects that are##2##3##(2008-3#1)(2008-6#1)
objects that##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
objects were##4##2##(1993-6#1)(2007-12#2)(2008-9#1)
objects##116##1##(1990-3#1)(1991-2#1)(1991-9#1)(1992-3#2)(1993-6#4)(1995-2#1)(1996-1#1)(1996-2#5)(1997-8#2)(2007-11#1)(2007-12#3)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#32)(2008-5#1)(2008-6#10)(2008-7#2)(2008-9#4)(2009-10#3)(2009-12#2)(2009-8#3)(2010-1#2)(2010-10#2)(2010-12#1)(2010-5#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)
oblast##2##1##(2013-1#2)
obligate biotrophic##5##2##(2008-10#1)(2010-3#3)(2012-2#1)
obligate brood parasitism##2##3##(2008-8#2)
obligate brood##3##2##(2008-8#2)(2010-8#1)
obligate heterozygotes##2##2##(1990-8#2)
obligate intracellular##4##2##(2008-9#2)(2009-8#1)(2012-3#1)
obligate parasite##3##2##(2008-10#2)(2011-2#1)
obligate plant##2##2##(2008-10#2)
obligate##24##1##(1990-8#2)(2008-10#8)(2008-11#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-3#3)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
obligated to##3##2##(1992-1#2)(1996-5#1)
obligately##4##1##(2008-10#2)(2011-2#2)
obligation of##2##2##(1990-2#1)(1993-6#1)
obligation to##5##2##(1992-3#1)(1995-12#1)(1995-6#1)(2008-12#1)(2008-7#1)
obligation##12##1##(1990-2#1)(1992-3#1)(1993-6#1)(1994-12#2)(1995-12#1)(1995-6#1)(2008-11#2)(2008-12#1)(2008-7#1)(2013-1#1)
obligations of##2##2##(1991-2#1)(1996-2#1)
obligations to##2##2##(1994-1#1)(2008-11#1)
obligations under##2##2##(1991-2#1)(1993-3#1)
obligations##10##1##(1991-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1996-2#1)(1997-4#1)(2008-11#1)(2009-6#1)(2013-8#1)
obligatoriness of moral actions##2##4##(2013-8#2)
obligatory##8##1##(1993-11#1)(1995-1#1)(1996-5#1)(1997-8#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
oblique effect##2##2##(1990-11#2)
oblique projection##2##2##(2008-10#2)
oblique reference##2##2##(1990-11#2)
oblique##23##1##(1990-11#5)(2008-10#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-9#3)(2011-2#1)(2012-2#1)(2013-1#5)
obliquely##3##1##(2008-5#1)(2008-7#1)(2011-2#1)
obliquity##3##1##(2009-9#1)(2012-2#1)(2013-1#1)
obliterans (Buerger's disease)##3##3##(1996-8#2)(1997-8#1)
obliterans##9##1##(1996-8#3)(1997-8#2)(2011-3#3)(2012-2#1)
obliterate the##2##2##(1990-5#1)(2008-7#1)
obliterated##3##1##(2008-7#2)(2008-9#1)
obliteration in##2##2##(1997-6#1)(2012-3#1)
obliteration of the##2##3##(2008-7#2)
obliteration of##4##2##(2008-7#3)(2009-9#1)
obliteration rate##4##2##(2008-7#4)
obliteration was##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
obliteration##24##1##(1997-6#1)(2008-7#16)(2009-9#1)(2011-2#1)(2012-3#5)
obliterative##3##1##(1997-8#1)(2008-11#1)(2011-3#1)
oblivion##2##1##(1991-8#1)(2011-2#1)
obscura##2##1##(2010-8#2)
obscure gastrointestinal bleeding##2##3##(2011-2#2)
obscure the##2##2##(1993-2#1)(2012-3#1)
obscure##21##1##(1993-2#1)(1993-3#1)(1993-9#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)
obscured by##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
obscured##6##1##(1993-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-3#1)
obscurus##4##1##(1991-12#1)(2011-2#3)
observable in##4##2##(1993-12#1)(1995-3#1)(2008-5#2)
observable##18##1##(1991-2#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2012-2#1)
observables##2##1##(1993-5#1)(2008-10#1)
observation allows##2##2##(2008-10#1)(2012-3#1)
observation and analysis of the more common features of##2##9##(2008-12#2)
observation and execution of both##2##5##(2008-11#2)
observation and execution of##3##4##(2008-11#3)
observation and##15##2##(1991-1#1)(1992-4#1)(2006-5#1)(2006-6#1)(2008-11#4)(2008-12#2)(2008-5#1)(2011-2#2)(2013-8#2)
observation in##3##2##(1996-6#1)(2010-1#1)(2012-12#1)
observation is##2##2##(1993-6#1)(2008-7#1)
observation notes##2##2##(2012-2#1)(2013-1#1)
observation of a##4##3##(1990-3#1)(1991-12#1)(1997-2#1)(2013-1#1)
observation of the##6##3##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
observation of thin layers and##2##5##(2008-10#2)
observation of##58##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-3#1)(1995-5#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-11#2)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-7#1)
observation on the##2##3##(2008-10#2)
observation on##3##2##(2008-10#3)
observation period##14##2##(1992-5#1)(1993-3#1)(1996-3#1)(1997-3#1)(1997-4#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
observation showed that the##2##4##(2008-10#1)(2008-8#1)
observation that the##5##3##(1991-9#1)(1995-9#1)(2008-11#1)(2008-6#1)(2009-9#1)
observation that##21##2##(1991-9#1)(1992-4#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-9#1)(1997-3#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#2)(2012-3#2)(2013-8#1)
observation time##3##2##(1993-11#1)(1997-3#1)(2008-3#1)
observation##214##1##(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-8#2)(2006-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#23)(2008-12#5)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#8)
observation]##2##1##(2013-8#2)
observational and##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
observational noise##3##2##(2009-8#3)
observational or##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
observational studies have##2##3##(2008-9#1)(2011-2#1)
observational studies##10##2##(1995-2#1)(2008-11#2)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#3)(2013-1#1)
observational study in##3##3##(1990-9#1)(2008-11#1)(2011-2#1)
observational study of##4##3##(2011-2#4)
observational study##23##2##(1990-9#1)(1991-3#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#6)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
observational##63##1##(1990-9#2)(1991-3#1)(1991-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-8#1)(2008-10#3)(2008-11#9)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-8#4)(2010-10#1)(2010-4#1)(2011-2#10)(2012-12#3)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#9)(2013-8#1)
observations about##2##2##(1997-2#1)(2008-9#1)
observations also##2##2##(2008-10#1)(2010-4#1)
observations and recommendations##3##3##(2013-1#3)
observations and##15##2##(1991-1#1)(1991-2#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2013-1#3)
observations are made##2##3##(1990-3#1)(1991-2#1)
observations are##14##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-12#1)(1995-11#2)(2006-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
observations at four##2##3##(2008-10#1)(2008-11#1)
observations at##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2012-6#1)
observations can##2##2##(2008-8#1)(2011-2#1)
observations demonstrate##3##2##(1996-12#1)(1997-6#1)(2008-10#1)
observations for##5##2##(2008-10#2)(2008-3#1)(2010-8#1)(2010-9#1)
observations from the##2##3##(1996-12#1)(2011-2#1)
observations from##7##2##(1996-12#1)(1997-3#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
observations have been published##2##4##(1994-8#1)(2010-12#1)
observations have##4##2##(1994-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
observations in##4##2##(2008-10#3)(2008-8#1)
observations indicated that the##2##4##(2008-10#1)(2008-11#1)
observations indicated that##4##3##(2008-10#3)(2008-11#1)
observations into##3##2##(1995-12#1)(2010-11#1)(2010-12#1)
observations is##2##2##(1997-6#1)(2008-3#1)
observations made##2##2##(1995-8#1)(2008-10#1)
observations of the##2##3##(2008-3#1)(2010-10#1)
observations of##32##2##(1991-5#1)(1993-12#1)(1994-2#1)(1996-12#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2010-10#1)(2010-8#1)(2012-2#2)(2012-3#1)
observations on the##9##3##(1990-2#1)(1992-5#1)(1994-12#1)(1996-2#1)(1996-3#1)(2008-11#3)(2008-9#1)
observations on##16##2##(1990-2#1)(1992-5#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#2)(2012-7#1)
observations raise the##2##3##(2008-5#1)(2010-4#1)
observations reveal that the##2##4##(2008-10#1)(2009-7#1)
observations revealed that##2##3##(2008-10#2)
observations showed that the##3##4##(2008-10#1)(2008-7#2)
observations showed that##4##3##(1994-2#1)(2008-10#1)(2008-7#2)
observations showed##6##2##(1994-2#1)(2008-10#2)(2008-7#2)(2008-8#1)
observations suggest that the##4##4##(1994-5#1)(1995-2#1)(2008-10#1)(2012-2#1)
observations suggest that##21##3##(1991-5#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
observations suggest##26##2##(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-7#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
observations suggested that##2##3##(2008-10#1)(2008-7#1)
observations suggested##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
observations support the##2##3##(2008-10#2)
observations support##3##2##(1995-8#1)(2008-10#2)
observations that##8##2##(1991-12#1)(1992-6#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
observations were made##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
observations were##7##2##(2008-10#4)(2008-11#1)(2010-12#1)(2010-8#1)
observations with##5##2##(1991-12#1)(1997-2#1)(2008-3#1)(2009-8#1)(2011-10#1)
observations##294##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#2)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#4)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#2)(1996-12#4)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-8#4)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#62)(2008-11#20)(2008-12#3)(2008-2#2)(2008-3#22)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#9)(2008-9#5)(2009-10#4)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#2)(2010-12#4)(2010-4#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-10#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#2)(2012-6#1)(2012-7#1)(2013-1#8)(2013-8#3)
observe and##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2010-6#1)
observe that the##2##3##(2008-11#1)(2008-7#1)
observe that##5##2##(1997-2#1)(2008-11#2)(2008-7#1)(2009-8#1)
observe the##28##2##(1994-8#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#1)
observe variations in the##2##4##(2008-11#1)(2008-3#1)
observe##67##1##(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
observed (P = 0##2##4##(2013-1#2)
observed (P##3##2##(1994-12#1)(2013-1#2)
observed 1##2##2##(2008-10#1)(2008-11#1)
observed 2##2##2##(1996-2#1)(2012-3#1)
observed 7 to##2##3##(2008-10#1)(2011-2#1)
observed a significant##2##3##(2008-11#1)(2012-3#1)
observed a##22##2##(1990-3#1)(1990-8#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-3#1)(2013-8#1)
observed across##5##2##(1996-2#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-8#1)
observed adaptive##2##2##(2008-7#1)(2011-1#1)
observed after##31##2##(1990-2#1)(1991-6#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
observed against##2##2##(2008-10#1)(2008-11#1)
observed along the##2##3##(2008-12#1)(2008-2#1)
observed along##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
observed among isolates##7##3##(2008-10#6)(2012-2#1)
observed among the##2##3##(2008-10#1)(2010-1#1)
observed among these##2##3##(2008-10#1)(2008-8#1)
observed among##26##2##(1992-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-8#1)(2010-1#1)(2012-2#1)(2013-1#2)
observed an increase in##2##4##(1992-6#1)(2008-3#1)
observed an##5##2##(1992-6#1)(1996-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
observed and it##2##3##(1993-2#1)(2008-10#1)
observed and predicted##2##3##(2008-10#1)(2008-8#1)
observed and the##6##3##(1994-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
observed and##36##2##(1991-3#1)(1991-5#1)(1992-9#1)(1993-2#1)(1994-3#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#4)(2010-8#1)(2013-8#1)
observed are##2##2##(2008-10#1)(2008-3#1)
observed around##2##2##(2008-10#2)
observed as early as##2##4##(1994-12#1)(2013-1#1)
observed as the##3##3##(2008-10#2)(2009-4#1)
observed as well##2##3##(2008-10#2)
observed as##10##2##(1991-2#1)(1994-12#1)(2008-10#5)(2008-11#1)(2009-4#1)(2013-1#1)
observed at -0##2##3##(2008-10#2)
observed at 0##2##3##(1994-2#1)(2008-10#1)
observed at both##2##3##(1995-6#1)(2008-10#1)
observed at concentrations##2##3##(2008-10#1)(2008-11#1)
observed at doses##2##3##(1995-2#1)(2008-10#1)
observed at high salt concentrations##2##5##(1990-5#1)(2008-10#1)
observed at high##4##3##(1990-5#1)(2008-10#1)(2008-12#1)(2013-1#1)
observed at higher##3##3##(2008-10#2)(2008-5#1)
observed at pH##2##3##(2008-10#2)
observed at the end of the##3##6##(2008-8#1)(2011-1#1)(2013-1#1)
observed at the end of##4##5##(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
observed at the##23##3##(1990-12#1)(1993-3#1)(1993-8#1)(1997-6#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
observed at##96##2##(1990-12#1)(1990-5#2)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#2)(2008-10#42)(2008-11#8)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)
observed because of##2##3##(1997-2#1)(2008-12#1)
observed because##4##2##(1997-2#1)(2008-10#2)(2008-12#1)
observed before##2##2##(1995-6#1)(2008-10#1)
observed behavioral##2##2##(2007-12#1)(2008-8#1)
observed between the different##2##4##(1994-2#1)(2008-10#1)
observed between the results obtained##2##5##(2008-10#2)
observed between the two groups##3##5##(1990-2#1)(2008-10#1)(2011-2#1)
observed between the two methods##2##5##(2008-10#2)
observed between the two##7##4##(1990-2#1)(1993-1#1)(2008-10#3)(2008-5#1)(2011-2#1)
observed between the##36##3##(1990-2#1)(1992-4#1)(1993-1#1)(1994-2#1)(1994-6#1)(1995-8#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-5#1)(2008-7#3)(2009-2#1)(2010-4#2)(2011-2#3)(2013-1#1)
observed between##91##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#2)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#37)(2008-11#4)(2008-12#1)(2008-5#6)(2008-7#4)(2008-8#2)(2009-2#1)(2010-4#2)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#3)
observed both##2##2##(2008-10#1)(2008-5#1)
observed by both##2##3##(2008-11#1)(2008-4#1)
observed by electron microscopy##2##4##(2008-10#1)(2008-5#1)
observed by means of##2##4##(1994-5#1)(2012-12#1)
observed by optical##2##3##(2008-10#2)
observed by the##3##3##(1992-6#1)(1993-8#1)(2008-10#1)
observed by##37##2##(1992-6#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-1#1)(2008-10#12)(2008-11#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2010-1#1)(2010-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
observed changes in##3##3##(1991-2#1)(2008-8#1)(2012-2#1)
observed changes##5##2##(1991-2#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
observed clinical##2##2##(2008-12#1)(2008-5#1)
observed data##6##2##(2008-10#4)(2008-8#2)
observed depending on the##2##4##(1993-8#1)(2008-10#1)
observed difference in##2##3##(1993-3#1)(2013-1#1)
observed differences between##3##3##(1995-3#1)(2007-12#1)(2009-11#1)
observed differences in##2##3##(1992-2#1)(2008-9#1)
observed differences##6##2##(1991-3#1)(1992-2#1)(1995-3#1)(2007-12#1)(2008-9#1)(2009-11#1)
observed disease##5##2##(2008-10#5)
observed distinct##2##2##(2008-10#1)(2013-1#1)
observed droplet##2##2##(1995-3#1)(2008-3#1)
observed due to the##2##4##(2008-10#1)(2009-5#1)
observed due to##3##3##(2008-10#2)(2009-5#1)
observed due##4##2##(2008-10#3)(2009-5#1)
observed during the first##2##4##(1993-12#1)(2012-3#1)
observed during the interaction##2##4##(1993-8#1)(2008-10#1)
observed during the##21##3##(1993-12#1)(1993-8#2)(1994-5#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
observed during this period##2##4##(2008-10#1)(2011-2#1)
observed during##42##2##(1990-9#1)(1991-8#1)(1993-12#1)(1993-8#4)(1994-3#1)(1994-5#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-7#1)
observed effect##3##2##(1995-9#1)(2008-3#1)(2008-8#1)
observed effects##3##2##(2008-10#2)(2008-11#1)
observed either##2##2##(1991-5#1)(2008-8#1)
observed experimentally##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
observed following##4##2##(1993-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
observed for 2##2##3##(2008-11#2)
observed for all the##3##4##(1990-6#1)(2008-10#2)
observed for all##5##3##(1990-6#1)(2008-10#4)
observed for both analytes##2##4##(2008-10#2)
observed for both##5##3##(2008-10#5)
observed for many##2##3##(2008-5#1)(2012-3#1)
observed for the control##2##4##(2008-10#1)(2009-1#1)
observed for the##31##3##(1991-1#1)(1992-12#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-2#1)(1996-5#1)(2008-10#12)(2008-11#4)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#3)(2013-1#1)
observed for##144##2##(1990-3#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-2#1)(1994-5#1)(1996-2#1)(1996-5#2)(1997-3#2)(1997-9#1)(2008-10#72)(2008-11#12)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
observed frequencies##2##2##(2008-10#2)
observed from all##2##3##(2008-10#1)(2008-12#1)
observed from the##6##3##(1991-9#1)(2008-10#3)(2011-2#1)(2012-3#1)
observed from##27##2##(1990-6#1)(1991-9#1)(1995-12#1)(2008-10#19)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)
observed high##2##2##(2008-10#1)(2008-8#1)
observed higher##2##2##(1992-8#1)(2011-1#1)
observed if the##2##3##(1996-12#1)(2008-10#1)
observed if##4##2##(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)
observed in 22%##2##3##(1995-11#1)(2010-11#1)
observed in a limited##2##4##(2008-10#2)
observed in a##21##3##(1990-3#1)(1990-5#1)(1991-8#1)(1994-6#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
observed in all##12##3##(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
observed in any##4##3##(1993-12#1)(1995-3#1)(1996-12#1)(2008-10#1)
observed in both groups##2##4##(1993-12#1)(1997-3#1)
observed in both##12##3##(1992-12#1)(1993-12#1)(1993-8#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
observed in cases##2##3##(1990-8#1)(1995-12#1)
observed in cells##4##3##(1990-8#1)(1995-6#1)(1995-8#2)
observed in certain##2##3##(1993-6#1)(1997-8#1)
observed in children##3##3##(1995-8#1)(2008-8#1)(2012-3#1)
observed in commercial##2##3##(2008-10#2)
observed in control##3##3##(1994-6#1)(2008-10#1)(2009-12#1)
observed in each##3##3##(2008-10#3)
observed in either##2##3##(2008-7#1)(2008-9#1)
observed in epidermal cells##2##4##(2008-10#2)
observed in four##3##3##(1994-12#1)(2008-5#1)(2008-8#1)
observed in human##4##3##(1993-6#1)(1994-12#1)(1994-3#1)(2011-2#1)
observed in humans##2##3##(1996-12#1)(2008-11#1)
observed in leaf##3##3##(2008-10#3)
observed in liver##2##3##(1993-11#1)(2011-3#1)
observed in male and female mice##2##6##(1995-11#1)(2008-9#1)
observed in male and female##3##5##(1995-11#1)(2008-9#2)
observed in male##4##3##(1995-11#1)(1995-8#1)(2008-9#2)
observed in many##6##3##(1994-12#1)(1995-2#1)(2008-10#1)(2008-8#2)(2013-8#1)
observed in most of the##2##5##(2008-10#1)(2008-6#1)
observed in most##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
observed in normal##2##3##(1992-12#1)(1997-7#1)
observed in older##2##3##(2012-12#1)(2013-1#1)
observed in only##4##3##(1990-2#1)(1990-9#1)(1993-12#1)(2008-10#1)
observed in organic##2##3##(2008-10#1)(2008-3#1)
observed in other##8##3##(1994-5#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-4#1)
observed in our##4##3##(1990-12#1)(1996-1#1)(2007-11#1)(2008-12#1)
observed in patients with##6##4##(1990-12#1)(1993-2#1)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#1)
observed in patients##7##3##(1990-12#1)(1993-2#1)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#2)
observed in plants##2##3##(2008-10#2)
observed in response to##4##4##(1992-8#1)(2008-10#3)
observed in severe##2##3##(2008-7#1)(2009-5#1)
observed in some cases##2##4##(2008-10#2)
observed in some##6##3##(1994-5#1)(2008-10#3)(2008-3#1)(2009-7#1)
observed in subjects##3##3##(1992-2#1)(1992-3#1)(1995-5#1)
observed in the CHX##2##4##(2013-1#2)
observed in the absence of##4##5##(1990-5#1)(2008-10#1)(2008-11#2)
observed in the absence##5##4##(1990-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
observed in the area##2##4##(1996-2#1)(2009-12#1)
observed in the control##4##4##(1994-5#1)(2008-10#2)(2010-12#1)
observed in the culture##2##4##(2008-11#1)(2010-10#1)
observed in the field and##2##5##(2008-10#2)
observed in the field##7##4##(2008-10#5)(2008-7#1)(2008-8#1)
observed in the nucleus accumbens##2##5##(1994-8#2)
observed in the periphery##2##4##(2007-12#1)(2012-3#1)
observed in the presence of##9##5##(1992-8#1)(1995-12#1)(2008-10#6)(2009-10#1)
observed in the present study##2##5##(1990-6#1)(2008-11#1)
observed in the range##3##4##(2008-10#3)
observed in the subjects##2##4##(2008-5#1)(2008-7#1)
observed in the tubular##2##4##(2011-2#1)(2013-7#1)
observed in the##195##3##(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#3)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#5)(1996-2#4)(1996-5#3)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#3)(2008-10#64)(2008-11#11)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
observed in these cells##2##4##(1996-12#1)(2008-11#1)
observed in these experiments##2##4##(1994-3#1)(2008-10#1)
observed in these##7##3##(1994-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
observed in this case##2##4##(2008-10#1)(2009-3#1)
observed in this study##3##4##(1993-12#1)(1997-8#1)(2008-10#1)
observed in this##10##3##(1992-3#1)(1993-12#1)(1995-2#1)(1997-8#1)(2008-10#3)(2008-7#1)(2009-3#1)(2013-7#1)
observed in those##2##3##(2008-10#1)(2013-1#1)
observed in tomato##4##3##(2008-10#4)
observed in treatments with##3##4##(2008-10#3)
observed in two##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
observed in various##5##3##(1990-5#1)(1992-2#1)(1997-8#1)(2008-10#1)(2008-8#1)
observed in vitro##6##3##(1992-8#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-12#1)(2010-11#1)
observed in vivo##2##3##(1996-2#1)(2008-7#1)
observed in##688##2##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#3)(1990-5#6)(1990-6#3)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#4)(1992-10#1)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#4)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#2)(1993-6#4)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#7)(1994-6#3)(1994-8#6)(1995-1#1)(1995-11#9)(1995-12#6)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#9)(1996-1#1)(1996-12#20)(1996-2#5)(1996-3#3)(1996-5#4)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#7)(1997-9#2)(2007-11#1)(2007-12#5)(2008-10#207)(2008-11#36)(2008-12#11)(2008-2#4)(2008-3#8)(2008-5#18)(2008-6#6)(2008-7#21)(2008-8#17)(2008-9#10)(2009-10#1)(2009-11#3)(2009-12#6)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#6)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#6)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#14)(2011-3#3)(2011-9#1)(2012-12#4)(2012-2#7)(2012-3#8)(2012-5#1)(2012-7#1)(2013-1#20)(2013-7#3)(2013-8#9)
observed incidence##4##2##(2008-10#4)
observed increase in##3##3##(1997-1#1)(2009-8#1)(2013-8#1)
observed interactions##2##2##(2012-4#1)(2013-8#1)
observed is##5##2##(1992-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
observed less##2##2##(2008-10#1)(2011-2#1)
observed levels of##2##3##(2008-9#1)(2009-8#1)
observed may##2##2##(1993-2#1)(2008-11#1)
observed more frequently in the##2##5##(2008-12#1)(2011-2#1)
observed more frequently##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
observed more##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
observed near the##2##3##(2008-11#1)(2013-1#1)
observed no##2##2##(1996-6#1)(2008-7#1)
observed on both##3##3##(1990-8#1)(2008-10#1)(2008-5#1)
observed on day##2##3##(1994-2#1)(2006-6#1)
observed on foliage##3##3##(2008-10#3)
observed on leaves of##2##4##(2008-10#2)
observed on leaves##3##3##(2008-10#3)
observed on the##17##3##(1991-6#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#2)(2012-2#1)
observed on##61##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-2#2)(1996-12#1)(1997-9#1)(2006-6#1)(2008-10#30)(2008-11#3)(2008-12#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
observed once##3##2##(2008-10#1)(2011-2#1)(2012-6#1)
observed only at##5##3##(1994-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
observed only in##7##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)
observed only when##2##3##(2008-10#2)
observed only##21##2##(1993-8#1)(1994-3#1)(1996-12#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#3)(2008-9#1)(2013-1#1)(2013-8#1)
observed over a##2##3##(1990-8#1)(2008-10#1)
observed over the concentration range##2##5##(2008-10#2)
observed over the##3##3##(2008-10#3)
observed over time##2##3##(1990-12#1)(2008-10#1)
observed over##9##2##(1990-12#1)(1990-8#1)(2008-10#6)(2013-8#1)
observed patterns of##4##3##(2008-10#1)(2008-8#2)(2009-7#1)
observed patterns##7##2##(2008-10#1)(2008-2#1)(2008-8#3)(2009-7#1)(2009-8#1)
observed regardless##3##2##(2008-11#2)(2008-9#1)
observed relative to##2##3##(2007-11#1)(2008-10#1)
observed relative##3##2##(2007-11#1)(2008-10#2)
observed respectively##2##2##(2010-7#1)(2012-3#1)
observed response##2##2##(2008-10#1)(2009-8#1)
observed seroprevalence##3##2##(2011-2#3)
observed signal##2##2##(1997-2#1)(2008-3#1)
observed significantly##2##2##(2008-11#1)(2008-9#1)
observed that Hg(II)##2##3##(2008-10#2)
observed that cells##2##3##(1992-8#1)(2010-10#1)
observed that in##3##3##(2008-10#2)(2008-11#1)
observed that some##2##3##(2008-10#1)(2012-3#1)
observed that the rate##2##4##(2008-10#1)(2009-4#1)
observed that the##26##3##(1991-5#1)(1993-9#1)(1996-12#1)(2007-12#1)(2008-10#14)(2008-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
observed that these##2##3##(1997-7#1)(2008-10#1)
observed that with##2##3##(1994-8#1)(2008-10#1)
observed that##89##2##(1990-2#1)(1990-5#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#31)(2008-11#9)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
observed the##10##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
observed therapy (DOT) to##2##4##(1996-3#2)
observed therapy (DOT)##7##3##(1996-11#1)(1996-3#6)
observed therapy##18##2##(1996-11#1)(1996-3#17)
observed through##2##2##(2008-10#1)(2010-8#1)
observed to be an##2##4##(2008-10#1)(2012-12#1)
observed to be##16##3##(1991-5#1)(1992-3#1)(1993-12#1)(1993-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
observed to penetrate##2##3##(2008-10#1)(2013-1#1)
observed to recover##2##3##(2008-10#1)(2008-5#1)
observed to##44##2##(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-8#3)(2007-12#1)(2008-10#15)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)
observed under the##2##3##(1993-6#1)(2009-7#1)
observed under this condition##2##4##(2008-10#1)(2011-2#1)
observed under##12##2##(1991-11#1)(1992-3#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-7#1)(2011-2#1)
observed until##2##2##(1997-2#1)(2008-9#1)
observed up to 1##2##4##(2008-10#1)(2013-8#1)
observed up to##8##3##(2008-10#5)(2010-12#1)(2011-2#1)(2013-8#1)
observed upon##5##2##(1990-11#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
observed using##10##2##(1993-6#1)(1994-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
observed values of##3##3##(2008-10#3)
observed values##6##2##(2008-10#5)(2008-8#1)
observed variations in##2##3##(2008-10#2)
observed variations##3##2##(2008-10#2)(2009-7#1)
observed versus##2##2##(2008-10#2)
observed was##5##2##(1992-12#1)(1996-12#1)(1997-7#1)(2009-2#1)(2013-1#1)
observed weak##2##2##(2008-11#1)(2008-3#1)
observed were##8##2##(1991-2#1)(2008-10#4)(2009-8#1)(2010-1#1)(2011-3#1)
observed when a##2##3##(1994-5#1)(2008-10#1)
observed when the##14##3##(1991-5#1)(1991-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)
observed when##54##2##(1990-10#1)(1990-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#1)(1994-5#1)(1996-5#1)(2008-10#19)(2008-11#11)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-2#1)
observed where##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
observed which##4##2##(1997-2#1)(1997-8#1)(2008-10#1)(2012-2#1)
observed with a##8##3##(1990-5#1)(1992-6#1)(2007-12#1)(2008-10#4)(2008-3#1)
observed with increasing##3##3##(2008-10#3)
observed with the##18##3##(1990-2#1)(1992-3#1)(1993-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2012-3#1)
observed with these two##2##4##(1990-5#1)(2008-10#1)
observed with##89##2##(1990-2#1)(1990-5#3)(1991-1#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-8#3)(1994-3#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-4#1)(1997-8#1)(1997-9#2)(2007-12#1)(2008-10#33)(2008-11#3)(2008-3#3)(2008-5#6)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
observed within the##4##3##(1991-12#1)(2008-10#3)
observed within##17##2##(1991-12#2)(1994-11#1)(1995-11#1)(1996-12#1)(2008-10#10)(2008-8#1)(2012-12#1)
observed without treatment##2##3##(1990-11#1)(2008-7#1)
observed without##5##2##(1990-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
observed##2567##1##(1990-10#2)(1990-11#5)(1990-12#7)(1990-2#10)(1990-3#7)(1990-5#22)(1990-6#10)(1990-8#11)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#16)(1991-2#12)(1991-3#4)(1991-5#16)(1991-6#7)(1991-7#2)(1991-8#10)(1991-9#3)(1992-10#4)(1992-12#14)(1992-2#8)(1992-3#9)(1992-4#4)(1992-5#3)(1992-6#14)(1992-8#8)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#17)(1993-2#10)(1993-3#13)(1993-6#11)(1993-8#27)(1993-9#2)(1994-1#1)(1994-11#13)(1994-12#10)(1994-2#10)(1994-3#9)(1994-5#19)(1994-6#7)(1994-8#9)(1995-1#1)(1995-11#13)(1995-12#18)(1995-2#14)(1995-3#6)(1995-5#4)(1995-6#15)(1995-8#15)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#30)(1996-2#18)(1996-3#27)(1996-5#13)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#16)(1997-3#17)(1997-4#4)(1997-5#2)(1997-6#7)(1997-7#10)(1997-8#13)(1997-9#6)(2006-6#1)(2007-11#4)(2007-12#14)(2007-8#3)(2008-1#3)(2008-10#899)(2008-11#163)(2008-12#44)(2008-2#17)(2008-3#40)(2008-4#4)(2008-5#78)(2008-6#9)(2008-7#73)(2008-8#66)(2008-9#50)(2009-1#4)(2009-10#5)(2009-11#6)(2009-12#11)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#11)(2009-8#21)(2009-9#4)(2010-1#11)(2010-10#4)(2010-11#9)(2010-12#14)(2010-2#1)(2010-3#1)(2010-4#12)(2010-5#10)(2010-6#10)(2010-7#4)(2010-8#10)(2010-9#1)(2011-1#13)(2011-2#65)(2011-3#10)(2011-7#1)(2011-9#1)(2012-12#13)(2012-2#31)(2012-3#35)(2012-4#2)(2012-5#3)(2012-6#1)(2012-7#1)(2013-1#69)(2013-7#7)(2013-8#32)
observer variation##2##2##(1990-2#1)(1993-1#1)
observer##14##1##(1990-2#1)(1993-1#1)(1994-3#1)(1997-8#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-11#2)(2010-8#1)(2011-2#3)(2012-2#1)
observers##14##1##(1993-12#1)(1997-8#2)(2008-10#1)(2008-11#3)(2008-5#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-7#1)(2010-8#1)
observes##3##1##(1994-12#1)(1995-12#1)(2008-3#1)
observing others##2##2##(2008-11#1)(2013-8#1)
observing the##6##2##(2008-10#1)(2008-11#2)(2008-5#2)(2013-8#1)
observing##25##1##(1993-9#1)(1994-3#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2010-10#1)(2011-2#1)(2013-8#4)
observé##2##1##(2013-1#2)
obsessive-compulsive disorder##4##2##(2008-11#1)(2011-2#2)(2012-12#1)
obsessive-compulsive##5##1##(2008-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
obsolescence##2##1##(1994-1#1)(2011-2#1)
obstacle to##8##2##(1994-12#1)(1996-3#1)(2008-11#3)(2008-12#1)(2009-10#1)(2012-2#1)
obstacle##14##1##(1991-1#1)(1994-12#1)(1996-3#1)(2008-10#2)(2008-11#4)(2008-12#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
obstacles and##3##2##(1996-3#1)(2008-11#1)(2012-12#1)
obstacles to the##2##3##(1996-2#1)(2010-10#1)
obstacles to##10##2##(1994-2#1)(1995-1#1)(1996-2#1)(1996-5#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)
obstacles##22##1##(1991-3#1)(1992-1#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#2)(1996-3#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
obstetric and##3##2##(1990-3#2)(1992-1#1)
obstetric brachial plexus##2##3##(2010-9#1)(2013-1#1)
obstetric care##4##2##(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
obstetric##18##1##(1990-3#2)(1992-1#1)(1994-1#1)(1996-2#1)(1996-6#1)(2009-7#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
obstetrical care##2##2##(1992-2#1)(1994-1#1)
obstetrical population##3##2##(2007-12#3)
obstetrical services##2##2##(1994-1#1)(1996-2#1)
obstetrical##13##1##(1992-2#1)(1994-1#2)(1994-3#1)(1995-1#1)(1996-2#2)(2007-12#4)(2011-2#1)(2012-2#1)
obstetricians##3##1##(1990-3#1)(2013-1#1)(2013-8#1)
obstetrics and gynaecology##2##3##(2010-8#2)
obstetrics and##6##2##(1990-3#1)(1993-12#1)(2010-8#2)(2012-3#1)(2013-1#1)
obstetrics##9##1##(1990-3#3)(1993-12#1)(1994-12#1)(2010-8#2)(2012-3#1)(2013-1#1)
obstructed##9##1##(1991-3#1)(1992-9#2)(1996-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
obstructing##4##1##(2008-10#3)(2010-10#1)
obstruction and##14##2##(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
obstruction are##2##2##(2012-2#1)(2012-3#1)
obstruction due to##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
obstruction in the##2##3##(2011-2#2)
obstruction in##8##2##(1992-5#1)(1997-8#1)(2008-10#2)(2010-1#1)(2011-2#2)(2013-1#1)
obstruction of the##5##3##(1990-8#1)(1997-8#1)(2008-1#1)(2008-10#1)(2012-12#1)
obstruction of##7##2##(1990-8#1)(1992-4#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2012-12#1)
obstruction or##2##2##(2008-10#2)
obstruction secondary to a##2##4##(2008-12#1)(2009-8#1)
obstruction secondary to##4##3##(1996-8#1)(2008-10#1)(2008-12#1)(2009-8#1)
obstruction who##2##2##(2013-1#2)
obstruction##123##1##(1990-5#1)(1990-6#1)(1990-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-1#4)(1995-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-8#10)(2008-1#3)(2008-10#25)(2008-11#3)(2008-12#8)(2008-7#8)(2009-8#6)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#11)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#13)(2013-8#2)
obstructions in two horses and a donkey##2##7##(1990-3#2)
obstructions##5##1##(1990-3#3)(2008-12#1)(2009-1#1)
obstructive hydrocephalus##2##2##(2008-7#2)
obstructive jaundice##3##2##(1991-3#1)(2008-12#1)(2013-1#1)
obstructive lung disease##3##3##(1995-2#1)(1997-4#1)(2008-7#1)
obstructive lung##6##2##(1995-2#2)(1997-4#1)(2008-1#2)(2008-7#1)
obstructive pulmonary disease (COPD)##15##4##(1992-3#1)(1995-12#1)(1996-1#2)(2008-1#1)(2010-10#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-8#2)
obstructive pulmonary disease and##3##4##(2009-1#1)(2011-2#2)
obstructive pulmonary disease in##2##4##(1992-1#1)(1995-12#1)
obstructive pulmonary disease##29##3##(1992-1#1)(1992-3#1)(1995-12#2)(1996-1#2)(2007-12#1)(2008-1#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#2)
obstructive pulmonary##34##2##(1992-1#1)(1992-3#1)(1993-11#1)(1995-12#2)(1996-1#2)(2007-12#1)(2008-1#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#3)
obstructive sleep apnea##2##3##(2009-9#1)(2013-1#1)
obstructive uropathy##4##2##(2008-10#4)
obstructive##64##1##(1991-3#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-2#1)(1995-12#2)(1995-2#2)(1996-1#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#7)(2008-12#1)(2008-7#4)(2009-1#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
obtain a##58##2##(1991-2#1)(1991-3#3)(1991-5#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-12#2)(2007-8#1)(2008-10#23)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
obtain an##17##2##(1991-2#1)(1992-5#1)(1994-5#1)(1996-12#1)(1997-3#1)(2008-10#7)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#2)
obtain better##6##2##(2008-10#4)(2008-7#1)(2012-3#1)
obtain feedback##5##2##(1995-12#1)(2013-1#4)
obtain high##6##2##(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
obtain information from##2##3##(2008-11#1)(2012-12#1)
obtain information##6##2##(1991-1#1)(1997-3#1)(2006-6#1)(2008-11#1)(2008-7#1)(2012-12#1)
obtain more##4##2##(1993-12#1)(1996-11#1)(1997-8#1)(2010-1#1)
obtain qualitative##2##2##(2008-10#1)(2013-1#1)
obtain quantitative##4##2##(2008-10#4)
obtain reliable##4##2##(1992-9#1)(2008-10#2)(2010-12#1)
obtain some of the##2##4##(1994-12#1)(2008-10#1)
obtain some##4##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-5#1)
obtain the best##3##3##(2008-10#2)(2013-8#1)
obtain the full-length##2##3##(1996-2#1)(2008-10#1)
obtain the##64##2##(1993-8#2)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
obtain##350##1##(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#4)(1991-5#2)(1992-12#4)(1992-2#1)(1992-5#1)(1992-9#2)(1993-12#3)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#2)(1994-8#1)(1995-12#3)(1995-5#2)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#132)(2008-11#24)(2008-12#3)(2008-2#6)(2008-3#12)(2008-4#6)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#14)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#12)(2013-8#4)
obtainable##8##1##(1992-3#1)(1997-2#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)
obtained (0##2##2##(2008-10#2)
obtained a complete##2##3##(1990-6#1)(2008-7#1)
obtained a detection limit of##2##5##(2008-10#2)
obtained a##15##2##(1990-6#1)(1994-11#1)(1994-6#2)(1997-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)
obtained about##3##2##(1992-5#1)(1994-5#1)(2008-10#1)
obtained above##2##2##(2008-10#2)
obtained according to the##2##4##(2008-10#2)
obtained according to##3##3##(2008-10#2)(2011-2#1)
obtained after a##2##3##(2008-10#2)
obtained after analyzing##2##3##(2008-10#2)
obtained after digestion##3##3##(2008-10#3)
obtained after##31##2##(1990-2#1)(1990-6#1)(1991-2#1)(1992-12#1)(1995-6#1)(1997-3#1)(2008-10#19)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)
obtained agree##3##2##(2008-10#3)
obtained allowed to##2##3##(2008-10#2)
obtained among the##2##3##(1996-12#1)(2008-10#1)
obtained and compared for the##2##5##(2008-10#2)
obtained and compared##3##3##(2008-10#3)
obtained and discussed##2##3##(2008-10#2)
obtained and the calculated standard rate constant (k(s)) is##2##9##(2008-10#2)
obtained and the##8##3##(2008-10#8)
obtained and used##2##3##(2008-2#1)(2008-4#1)
obtained and##27##2##(1994-11#1)(1997-3#1)(2008-10#18)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)
obtained are compared with##2##4##(2008-10#1)(2008-3#1)
obtained are compared##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
obtained are discussed##2##3##(2008-10#2)
obtained are in good agreement with the certified values##2##9##(2008-10#2)
obtained are in good agreement with##3##6##(2008-10#3)
obtained are in##5##3##(2008-10#5)
obtained are reported##2##3##(2008-10#2)
obtained are##18##2##(2008-10#16)(2008-11#1)(2008-3#1)
obtained as a function of##2##5##(2007-12#1)(2008-10#1)
obtained as a##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
obtained as##12##2##(1991-5#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2012-2#1)
obtained at 0##2##3##(2008-10#1)(2008-11#1)
obtained at 30##2##3##(1993-6#1)(2008-10#1)
obtained at a sampling rate of##2##6##(2008-10#2)
obtained at a##10##3##(1993-3#1)(2008-10#5)(2008-3#2)(2008-6#1)(2009-11#1)
obtained at pH 4##2##4##(2008-12#1)(2009-7#1)
obtained at the signal##2##4##(2008-10#2)
obtained at the##15##3##(1991-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-12#1)(2011-1#1)(2013-1#1)
obtained at##62##2##(1991-12#1)(1991-5#1)(1993-3#2)(1993-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#30)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
obtained before##3##2##(1995-2#1)(2008-11#1)(2009-10#1)
obtained between the##13##3##(1993-2#1)(2008-10#12)
obtained between##23##2##(1993-2#2)(2008-10#21)
obtained biosensor##2##2##(2008-10#2)
obtained both from##2##3##(2008-10#2)
obtained both##6##2##(1991-2#1)(1994-12#1)(2008-10#4)
obtained but##2##2##(2008-11#1)(2008-5#1)
obtained by Fourier##2##3##(2008-10#2)
obtained by HPLC##5##3##(2008-10#5)
obtained by ICP-AES##4##3##(2008-10#4)
obtained by PCR##2##3##(1993-9#1)(2008-9#1)
obtained by Soxhlet##2##3##(2008-10#2)
obtained by X-ray fluorescence##2##4##(2008-10#1)(2013-8#1)
obtained by a reference method##3##5##(2008-10#3)
obtained by a##23##3##(1991-2#1)(1993-12#1)(1995-9#1)(1996-8#1)(2008-10#18)(2010-9#1)
obtained by acid##2##3##(2008-10#1)(2008-5#1)
obtained by adding##2##3##(2008-10#1)(2011-2#1)
obtained by all##2##3##(2008-10#2)
obtained by an##8##3##(2008-10#6)(2008-8#1)(2013-1#1)
obtained by analyzing##2##3##(2008-10#1)(2010-11#1)
obtained by applying the##3##4##(2008-10#3)
obtained by applying##7##3##(2008-10#6)(2008-5#1)
obtained by atomic absorption spectrometry##2##5##(2008-10#2)
obtained by atomic absorption##4##4##(2008-10#4)
obtained by atomic##5##3##(2008-10#5)
obtained by both methods##3##4##(2008-10#3)
obtained by both##9##3##(2008-10#9)
obtained by combining##2##3##(2008-10#1)(2008-11#1)
obtained by comparing the##2##4##(2008-10#2)
obtained by continuous addition of a reagent##2##7##(2008-10#2)
obtained by conventional##6##3##(2008-10#5)(2008-5#1)
obtained by difference##2##3##(2008-10#1)(2008-2#1)
obtained by differential##3##3##(1993-8#1)(2008-10#1)(2008-2#1)
obtained by digestion of##2##4##(1992-6#1)(2008-10#1)
obtained by direct##2##3##(2008-10#1)(2008-5#1)
obtained by either##2##3##(2008-10#2)
obtained by electropolymerization of##2##4##(2008-10#2)
obtained by gas chromatography##3##4##(2008-10#3)
obtained by graphite furnace atomic absorption spectrometry##2##7##(2008-10#2)
obtained by inductively coupled plasma##3##5##(2008-10#3)
obtained by manual##2##3##(2008-10#2)
obtained by means of the##2##5##(2008-10#1)(2008-3#1)
obtained by means of##8##4##(1993-3#1)(2008-10#5)(2008-3#2)
obtained by measuring##2##3##(2008-10#2)
obtained by other methods##2##4##(2008-10#2)
obtained by other##5##3##(1991-9#1)(2008-10#3)(2008-5#1)
obtained by reaction between##2##4##(2008-10#2)
obtained by several##2##3##(2008-4#1)(2008-5#1)
obtained by supercritical carbon dioxide##2##5##(2008-10#2)
obtained by the FIA##2##4##(2008-10#2)
obtained by the HPLC##2##4##(2008-10#2)
obtained by the application of##3##5##(2008-10#3)
obtained by the developed##3##4##(2008-10#3)
obtained by the present method##3##5##(1995-3#1)(2008-10#2)
obtained by the present##5##4##(1995-3#1)(2008-10#4)
obtained by the proposed method##10##5##(2008-10#10)
obtained by the proposed##14##4##(2008-10#14)
obtained by the reference##4##4##(2008-10#4)
obtained by the standard addition method##2##6##(2008-10#2)
obtained by the standard##4##4##(2008-10#4)
obtained by the two##4##4##(2008-10#4)
obtained by the##117##3##(1991-12#1)(1995-12#1)(1995-3#1)(2008-10#103)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-12#1)
obtained by thermal cracking of waste polymers##2##7##(2008-10#2)
obtained by thermal##4##3##(2008-10#4)
obtained by these two resins##2##5##(2008-10#2)
obtained by this method agreed##3##5##(2008-10#3)
obtained by this method are##2##5##(1992-4#1)(2008-10#1)
obtained by this method were in##2##6##(2008-10#1)(2008-5#1)
obtained by this method were##5##5##(2008-10#4)(2008-5#1)
obtained by this method##11##4##(1990-2#1)(1992-4#1)(2008-10#8)(2008-5#1)
obtained by this procedure##2##4##(2008-10#2)
obtained by this##20##3##(1990-2#1)(1992-4#1)(2008-10#15)(2008-2#1)(2008-5#1)(2013-1#1)
obtained by two##2##3##(1993-11#1)(2008-10#1)
obtained by use of a##2##5##(2008-3#2)
obtained by use of the##3##5##(2008-2#1)(2008-3#2)
obtained by use of##8##4##(2007-12#1)(2008-2#1)(2008-3#6)
obtained by using a##9##4##(2008-10#8)(2011-1#1)
obtained by using the##11##4##(1995-12#1)(2008-10#9)(2010-7#1)
obtained by using##41##3##(1995-12#1)(2008-10#33)(2008-8#4)(2008-9#1)(2010-7#1)(2011-1#1)
obtained by##518##2##(1990-2#2)(1990-5#2)(1990-9#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-9#1)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#384)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#3)(2008-5#12)(2008-7#3)(2008-8#9)(2008-9#6)(2009-1#1)(2009-11#2)(2009-5#1)(2009-7#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#2)
obtained can be##2##3##(2008-10#2)
obtained can##3##2##(2008-10#2)(2011-2#1)
obtained compare well##2##3##(2008-10#2)
obtained compared to##2##3##(2008-10#1)(2008-8#1)
obtained compared##6##2##(2008-10#5)(2008-8#1)
obtained could##2##2##(2008-10#1)(2008-11#1)
obtained data##5##2##(1990-5#1)(2008-10#1)(2008-12#1)(2008-5#2)
obtained demonstrated that##2##3##(1996-12#1)(2008-5#1)
obtained directly by##2##3##(1993-3#1)(2008-8#1)
obtained directly##4##2##(1993-3#1)(2008-10#2)(2008-8#1)
obtained due to##2##3##(2008-10#2)
obtained during two##3##3##(2008-3#2)(2008-5#1)
obtained during##14##2##(1994-11#1)(1994-3#1)(1996-2#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2011-2#2)(2013-1#1)
obtained either##2##2##(1990-5#1)(2013-1#1)
obtained employing##3##2##(2008-10#3)
obtained evidence##3##2##(1990-5#1)(2008-10#1)(2012-3#1)
obtained experimental##2##2##(1997-2#1)(2011-2#1)
obtained experimentally##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
obtained for As##2##3##(2008-10#2)
obtained for Cu##2##3##(2008-10#2)
obtained for a##7##3##(2008-10#7)
obtained for all elements##3##4##(2008-10#1)(2011-2#2)
obtained for all the compounds##2##5##(2008-10#1)(2008-7#1)
obtained for all the##6##4##(2008-10#5)(2008-7#1)
obtained for all##13##3##(2008-10#10)(2008-7#1)(2011-2#2)
obtained for an##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
obtained for both the##2##4##(2008-10#1)(2008-3#1)
obtained for both##9##3##(2008-10#8)(2008-3#1)
obtained for commercial##3##3##(2008-10#3)
obtained for determination of##2##4##(2008-10#2)
obtained for different amounts of cadmium##2##6##(2008-10#2)
obtained for different##4##3##(2008-10#3)(2008-3#1)
obtained for each##12##3##(2008-10#9)(2010-8#1)(2012-2#1)(2013-1#1)
obtained for five##2##3##(2008-10#2)
obtained for most##3##3##(2008-10#3)
obtained for nine##3##3##(2008-10#3)
obtained for several##2##3##(2008-10#1)(2008-3#1)
obtained for simultaneous##2##3##(2008-10#2)
obtained for the determination of##10##5##(2008-10#10)
obtained for the enzyme##2##4##(1993-8#1)(1994-11#1)
obtained for the membrane##2##4##(2008-10#2)
obtained for the same##2##4##(2008-10#2)
obtained for the##60##3##(1991-5#1)(1993-8#2)(1994-11#1)(1995-11#1)(2008-10#52)(2008-11#1)(2008-3#1)(2010-12#1)
obtained for these##5##3##(2008-10#5)
obtained for untreated##3##3##(1995-8#2)(2008-5#1)
obtained for vanadium##2##3##(2008-10#2)
obtained for##272##2##(1990-2#1)(1991-1#1)(1991-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-12#3)(2008-10#225)(2008-11#6)(2008-12#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)
obtained four##2##2##(2008-10#1)(2008-9#1)
obtained free##2##2##(2008-10#2)
obtained from 0##5##3##(2008-10#5)
obtained from 10##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
obtained from 12##2##3##(2008-5#1)(2010-4#1)
obtained from 46##2##3##(1990-2#1)(1997-3#1)
obtained from 49##2##3##(2008-1#1)(2008-10#1)
obtained from a Nd##2##4##(2008-2#2)
obtained from a commercial##2##4##(2008-10#2)
obtained from a human##2##4##(1994-11#1)(1994-8#1)
obtained from a previous##2##4##(1991-2#2)
obtained from a single##2##4##(2008-10#2)
obtained from a synthetic phage display##2##6##(2008-10#2)
obtained from a##34##3##(1991-2#2)(1992-3#1)(1993-2#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-1#2)(2008-10#14)(2008-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
obtained from an##4##3##(1992-12#1)(1993-6#1)(1997-8#1)(2008-10#1)
obtained from both methods##2##4##(2008-10#2)
obtained from both##7##3##(2008-10#5)(2008-11#1)(2012-2#1)
obtained from bovine##2##3##(2008-11#1)(2013-1#1)
obtained from different places##2##4##(2008-10#2)
obtained from different##6##3##(2008-10#5)(2008-11#1)
obtained from diseased leaves##2##4##(2008-10#2)
obtained from diseased##4##3##(2008-10#4)
obtained from experiments##2##3##(2008-10#2)
obtained from in vivo##3##4##(2008-10#2)(2008-11#1)
obtained from in##4##3##(2008-10#3)(2008-11#1)
obtained from normal##2##3##(1997-1#1)(1997-7#1)
obtained from other hosts##2##4##(2008-10#2)
obtained from other##7##3##(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)
obtained from patients##2##3##(1995-12#1)(2009-11#1)
obtained from plant##2##3##(2008-10#2)
obtained from samples##2##3##(2008-10#2)
obtained from soil samples fortified at##2##6##(2008-10#2)
obtained from soil##3##3##(2008-10#3)
obtained from soils##2##3##(2008-10#2)
obtained from standard##2##3##(2008-11#1)(2008-9#1)
obtained from the Spanish market##2##5##(2008-10#2)
obtained from the analysis of##2##5##(2008-10#2)
obtained from the experimental##2##4##(2008-10#2)
obtained from the in##2##4##(2008-11#1)(2008-5#1)
obtained from the reaction##2##4##(1990-5#1)(2008-10#1)
obtained from the##89##3##(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-10#42)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
obtained from these##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
obtained from this##4##3##(2008-10#3)(2008-2#1)
obtained from two##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
obtained from using the##2##4##(2008-10#2)
obtained from various##2##3##(1992-3#1)(2008-10#1)
obtained from##417##2##(1990-2#2)(1990-5#1)(1990-8#5)(1991-2#4)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#6)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#2)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#208)(2008-11#23)(2008-12#9)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#11)(2008-6#5)(2008-7#7)(2008-8#2)(2008-9#8)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#9)(2013-8#3)
obtained have##3##2##(1993-8#1)(2008-10#2)
obtained here##3##2##(2008-10#2)(2008-11#1)
obtained highly##2##2##(2008-10#1)(2011-2#1)
obtained if the##2##3##(2008-10#2)
obtained if##4##2##(2008-10#3)(2008-11#1)
obtained in a classical##2##4##(2008-11#2)
obtained in a##14##3##(1992-5#1)(1993-2#1)(1993-3#1)(2008-10#5)(2008-11#3)(2008-3#2)(2013-1#1)
obtained in all cases##2##4##(2009-3#1)(2011-2#1)
obtained in all##5##3##(1993-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)
obtained in an##2##3##(2008-10#1)(2011-2#1)
obtained in aqueous solution##2##4##(1990-5#1)(2008-10#1)
obtained in excellent##2##3##(2008-5#1)(2011-1#1)
obtained in only 0##2##4##(2008-10#2)
obtained in our##2##3##(1993-8#1)(1994-2#1)
obtained in several##2##3##(1990-5#1)(2008-10#1)
obtained in the absence of##2##5##(2008-10#2)
obtained in the analysis of##5##5##(2008-10#5)
obtained in the concentration range##5##5##(2008-10#5)
obtained in the concentration##6##4##(2008-10#6)
obtained in the determination of##4##5##(2008-10#4)
obtained in the presence of##3##5##(1997-2#1)(2008-10#2)
obtained in the range 0##2##5##(2008-10#2)
obtained in the range of##4##5##(2008-10#3)(2008-12#1)
obtained in the range##10##4##(2008-10#9)(2008-12#1)
obtained in the same conditions##2##5##(2008-10#2)
obtained in the same##3##4##(2008-10#3)
obtained in the##73##3##(1992-9#1)(1993-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#51)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)
obtained in this study##5##4##(2006-6#1)(2008-10#3)(2008-11#1)
obtained in this work##4##4##(2008-10#4)
obtained in this##17##3##(1990-3#1)(2006-6#1)(2008-10#11)(2008-11#2)(2008-5#1)(2011-2#1)
obtained in vitro with##2##4##(1995-2#1)(2008-5#1)
obtained in vitro##3##3##(1995-2#1)(1996-12#1)(2008-5#1)
obtained in water##2##3##(1992-12#1)(2008-10#1)
obtained in##219##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1991-6#2)(1991-8#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#114)(2008-11#19)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#15)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#2)(2009-3#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
obtained indicate that the##4##4##(2008-10#3)(2008-5#1)
obtained indicate that##7##3##(2008-10#5)(2008-5#2)
obtained indicate##11##2##(1995-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)
obtained indicated##4##2##(2008-10#4)
obtained is##5##2##(1992-9#1)(2008-10#3)(2008-5#1)
obtained more##2##2##(2008-10#1)(2008-3#1)
obtained on days##3##3##(1990-11#1)(1995-12#2)
obtained on the##6##3##(2008-10#5)(2008-8#1)
obtained on##30##2##(1990-11#1)(1991-9#1)(1993-8#1)(1994-3#1)(1995-12#2)(1997-2#1)(2007-12#1)(2008-10#13)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2011-3#1)
obtained only if##2##3##(2008-10#2)
obtained only##6##2##(1991-6#2)(2008-10#3)(2009-3#1)
obtained over a##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)
obtained over the concentration##2##4##(2008-10#2)
obtained over the range##4##4##(2008-10#4)
obtained over the##10##3##(2008-10#10)
obtained over##17##2##(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-4#1)
obtained previously##4##2##(1992-3#1)(1992-9#1)(2008-10#1)(2008-3#1)
obtained proved##2##2##(2008-10#2)
obtained provided##2##2##(2008-10#2)
obtained ranged from##2##3##(2008-10#1)(2008-11#1)
obtained results were##10##3##(2008-10#9)(2008-12#1)
obtained results##42##2##(2007-12#1)(2008-10#34)(2008-12#1)(2008-3#1)(2008-5#2)(2010-8#2)(2013-1#1)
obtained revealed##3##2##(2008-10#3)
obtained show that##6##3##(2008-10#5)(2008-5#1)
obtained show##8##2##(2008-10#6)(2008-5#2)
obtained showed better##2##3##(2008-10#2)
obtained showed that##4##3##(1993-3#1)(2008-10#2)(2008-5#1)
obtained showed##9##2##(1993-3#1)(2008-10#7)(2008-5#1)
obtained simultaneously from##2##3##(1991-12#1)(1996-2#1)
obtained simultaneously##3##2##(1991-12#1)(1996-2#1)(2008-9#1)
obtained solution##2##2##(2008-10#2)
obtained suggest##3##2##(2008-10#1)(2008-11#2)
obtained that##3##2##(1996-8#1)(2008-10#1)(2008-5#1)
obtained the##4##2##(1993-8#1)(2008-10#2)(2008-9#1)
obtained through a##5##3##(1994-12#1)(2008-10#1)(2008-12#2)(2008-9#1)
obtained through the##8##3##(2008-10#4)(2008-11#1)(2010-8#1)(2013-1#2)
obtained through##28##2##(1994-12#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-5#1)(2008-9#4)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
obtained to date##2##3##(1991-2#1)(2008-7#1)
obtained to determine##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
obtained to##12##2##(1991-2#1)(1994-2#1)(1994-3#1)(1996-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)
obtained together with##2##3##(2008-10#2)
obtained two##2##2##(1995-6#1)(1997-7#1)
obtained under the optimized##2##4##(2008-10#2)
obtained under the same##2##4##(2008-10#2)
obtained under the##8##3##(2008-10#8)
obtained under##14##2##(2008-10#13)(2011-2#1)
obtained up to##3##3##(2008-10#3)
obtained upon sonication were##2##4##(2008-10#2)
obtained upon##4##2##(2008-10#3)(2009-6#1)
obtained using Mg2+##2##3##(1995-6#2)
obtained using a##20##3##(1994-5#1)(1994-8#1)(2008-10#15)(2008-5#2)(2009-10#1)
obtained using an##2##3##(1992-3#1)(2008-10#1)
obtained using atomic absorption spectrometry##3##5##(2008-10#3)
obtained using chemical##2##3##(2008-10#2)
obtained using only##2##3##(2008-10#2)
obtained using solid-phase##2##3##(2008-10#1)(2013-8#1)
obtained using the standard##2##4##(2008-10#2)
obtained using the##28##3##(2006-6#1)(2008-10#23)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
obtained using##111##2##(1990-5#1)(1992-3#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#2)(1997-3#1)(2006-6#1)(2008-10#84)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
obtained via##4##2##(2008-10#3)(2008-6#1)
obtained was##19##2##(1990-8#1)(1991-5#1)(1992-12#1)(1995-2#1)(2008-10#13)(2008-11#2)
obtained were 0##2##3##(2008-10#2)
obtained were compared with the##4##5##(2008-10#3)(2008-5#1)
obtained were compared with##7##4##(2008-10#6)(2008-5#1)
obtained were compared##8##3##(2008-10#7)(2008-5#1)
obtained were in good agreement with the certified values##2##9##(2008-10#2)
obtained were in##6##3##(2008-10#6)
obtained were##47##2##(2008-10#40)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2010-6#1)
obtained when the##12##3##(1995-6#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#1)
obtained when using the##2##4##(2008-10#1)(2008-12#1)
obtained when##31##2##(1995-6#1)(2007-12#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2013-8#1)
obtained which##4##2##(2008-10#2)(2008-9#1)(2012-12#1)
obtained with a##41##3##(1994-6#1)(1997-8#1)(2007-12#1)(2008-10#26)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#3)(2011-2#1)
obtained with an##4##3##(1993-5#1)(1996-5#1)(2007-12#1)(2008-11#1)
obtained with and without##2##4##(2008-10#1)(2012-2#1)
obtained with both##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
obtained with conventional##3##3##(2008-10#3)
obtained with detection##2##3##(2008-10#2)
obtained with different##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
obtained with individual##2##3##(2008-10#1)(2013-1#1)
obtained with natural##2##3##(2008-10#2)
obtained with no##2##3##(1996-5#1)(2008-10#1)
obtained with other##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
obtained with probes##2##3##(1996-12#1)(2008-10#1)
obtained with strain##2##3##(2008-10#2)
obtained with the classical##2##4##(2008-10#2)
obtained with the conventional##2##4##(2008-10#2)
obtained with the two##3##4##(2008-10#2)(2008-5#1)
obtained with the use of##4##5##(2008-10#2)(2008-7#1)(2013-1#1)
obtained with the##62##3##(1990-12#1)(1995-8#1)(1997-3#1)(2006-6#1)(2008-10#45)(2008-11#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
obtained with these##3##3##(2008-10#2)(2008-11#1)
obtained with this##8##3##(1996-5#1)(1997-2#1)(2008-10#6)
obtained with those##2##3##(2008-10#2)
obtained with three##2##3##(2008-10#1)(2008-2#1)
obtained with##242##2##(1990-12#1)(1990-8#2)(1991-6#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#3)(2008-10#156)(2008-11#22)(2008-12#1)(2008-2#5)(2008-3#14)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
obtained within a##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
obtained within##9##2##(1992-12#1)(2008-10#7)(2008-4#1)
obtained without the##2##3##(2008-10#1)(2008-9#1)
obtained without##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)
obtained##2942##1##(1990-11#1)(1990-12#4)(1990-2#7)(1990-3#2)(1990-5#9)(1990-6#4)(1990-8#8)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#9)(1991-3#3)(1991-5#7)(1991-6#5)(1991-8#2)(1991-9#3)(1992-12#10)(1992-2#3)(1992-3#10)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#6)(1993-3#11)(1993-5#1)(1993-6#5)(1993-8#8)(1993-9#1)(1994-1#1)(1994-11#11)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#5)(1995-11#7)(1995-12#10)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#11)(1995-8#4)(1995-9#2)(1996-12#11)(1996-2#5)(1996-3#3)(1996-5#13)(1996-6#2)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#8)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#11)(2006-6#3)(2007-11#8)(2007-12#15)(2007-8#3)(2008-1#7)(2008-10#1868)(2008-11#124)(2008-12#27)(2008-2#37)(2008-3#89)(2008-4#13)(2008-5#80)(2008-6#9)(2008-7#37)(2008-8#40)(2008-9#36)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#3)(2009-3#7)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#4)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#12)(2010-5#3)(2010-6#6)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#8)(2011-10#1)(2011-2#43)(2011-3#5)(2012-12#8)(2012-2#18)(2012-3#13)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#35)(2013-7#2)(2013-8#17)
obtaining a full-length##2##3##(2008-10#1)(2008-9#1)
obtaining a##21##2##(1994-12#1)(1995-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
obtaining accurate##4##2##(2008-10#2)(2010-7#1)(2013-1#1)
obtaining adequate##2##2##(2008-10#1)(2008-9#1)
obtaining an##5##2##(2008-10#2)(2008-12#1)(2008-7#1)(2012-5#1)
obtaining fresh##2##2##(2008-10#2)
obtaining information##2##2##(2008-10#1)(2010-10#1)
obtaining large numbers of##2##4##(2008-4#2)
obtaining new##2##2##(2008-10#1)(2011-3#1)
obtaining positive##3##2##(1992-12#1)(2010-6#2)
obtaining quantitative##2##2##(2008-3#1)(2008-4#1)
obtaining the analytical##2##3##(2008-10#2)
obtaining the necessary##2##3##(1996-12#1)(2011-2#1)
obtaining the##15##2##(1994-12#1)(1996-12#2)(2008-10#5)(2008-3#1)(2008-4#1)(2011-2#2)(2012-2#2)(2012-3#1)
obtaining useful##2##2##(1990-12#1)(2008-12#1)
obtaining##119##1##(1990-12#2)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-2#1)(2006-6#1)(2008-10#43)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#4)(2010-7#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#3)(2013-8#1)
obtains##2##1##(1996-3#1)(2009-11#1)
obtusifolia##6##1##(2008-10#6)
obtusifoliol##4##1##(1992-3#4)
obviate##3##1##(1991-11#1)(1991-3#1)(1997-8#1)
obviates the need for##4##4##(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
obviates the need to##2##4##(1997-4#1)(2008-9#1)
obviates the need##6##3##(1996-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
obviates the##7##2##(1996-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)
obvious changes in##2##3##(2008-9#2)
obvious changes##4##2##(2008-10#1)(2008-9#3)
obvious difference in##2##3##(1995-3#1)(2008-9#1)
obvious difference##5##2##(1995-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
obvious external##2##2##(2008-7#1)(2008-9#1)
obvious symptoms##2##2##(2008-10#2)
obvious when##2##2##(2008-10#1)(2008-11#1)
obvious##64##1##(1990-12#1)(1991-11#1)(1992-5#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-1#1)(1997-3#1)(2008-10#16)(2008-11#6)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#7)(2009-1#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
obviously inhibited##2##2##(1994-12#1)(2010-1#1)
obviously##37##1##(1991-9#1)(1992-3#1)(1992-6#1)(1994-12#1)(1996-3#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#7)(2010-1#1)(2010-5#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
occasion of##4##2##(1997-2#1)(2008-11#1)(2011-1#1)(2013-1#1)
occasion##12##1##(1991-6#1)(1993-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-1#1)(2013-1#1)
occasional##22##1##(1990-12#2)(1993-11#1)(1994-3#2)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
occasionally in##2##2##(1996-5#1)(2008-10#1)
occasionally observed##2##2##(1995-12#1)(2008-10#1)
occasionally the##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
occasionally##47##1##(1991-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-1#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#1)
occasions in##2##2##(1993-12#1)(2008-12#1)
occasions with##3##2##(1993-1#1)(1997-4#1)(2006-6#1)
occasions##19##1##(1990-2#1)(1993-1#1)(1993-12#1)(1996-5#1)(1997-4#2)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2013-1#2)
occidentalis and##4##2##(2008-10#2)(2008-8#2)
occidentalis##19##1##(2008-10#14)(2008-8#5)
occidentalis) was##2##2##(2008-10#2)
occidentalis)##3##1##(2008-10#2)(2009-8#1)
occipital bone##2##2##(2008-7#1)(2011-2#1)
occipital condyle##5##2##(2008-7#1)(2013-1#4)
occipital condyles##3##2##(2013-1#3)
occipital craniotomy##2##2##(2008-7#1)(2011-2#1)
occipital lobes##2##2##(1990-8#1)(2008-7#1)
occipital##33##1##(1990-8#1)(1991-12#2)(1994-3#2)(1996-12#2)(1996-2#1)(1996-9#2)(2008-7#9)(2010-6#2)(2010-7#1)(2011-2#3)(2013-1#7)(2013-8#1)
occipitocervical fusion##3##2##(2008-12#1)(2012-3#2)
occipitocervical##5##1##(2008-12#1)(2012-3#4)
occiput to C2##3##3##(2012-3#3)
occlude##3##1##(1997-3#1)(2008-7#2)
occluded with wax##2##3##(2008-10#2)
occluded##21##1##(1991-3#2)(1991-6#1)(1995-2#1)(1996-9#2)(1997-3#3)(1997-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2013-1#4)
occluding##3##1##(2008-10#2)(2010-2#1)
occlusal splint##2##2##(2010-6#2)
occlusal splints##2##2##(2010-6#2)
occlusal##9##1##(1993-1#1)(2009-7#1)(2010-6#4)(2013-1#3)
occlusion and the##5##3##(1996-6#1)(2008-11#1)(2010-9#1)(2011-2#2)
occlusion and##12##2##(1990-8#1)(1992-6#1)(1992-9#1)(1996-6#1)(2008-11#1)(2010-9#1)(2011-2#5)(2013-1#1)
occlusion following##2##2##(2008-7#1)(2013-1#1)
occlusion in##10##2##(1990-5#1)(1997-3#5)(2008-7#2)(2010-3#1)(2011-2#1)
occlusion is##2##2##(1991-12#1)(2011-2#1)
occlusion of a##4##3##(1997-6#1)(1997-8#1)(2008-12#1)(2008-7#1)
occlusion of the internal carotid artery##2##6##(2008-7#2)
occlusion of the left##2##4##(2010-12#1)(2010-3#1)
occlusion of the middle##2##4##(2008-12#1)(2008-4#1)
occlusion of the subclavian artery##2##5##(2008-7#2)
occlusion of the##21##3##(1991-8#1)(1996-6#1)(1996-9#1)(1997-3#1)(2008-12#2)(2008-4#1)(2008-7#7)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#3)
occlusion of##35##2##(1991-8#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#5)(2008-4#2)(2008-7#10)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#2)(2013-1#2)(2013-8#3)
occlusion rate##2##2##(1997-3#1)(2011-2#1)
occlusion was##2##2##(1991-3#1)(1997-6#1)
occlusion were##2##2##(1991-12#1)(2013-1#1)
occlusion with##2##2##(1997-3#1)(2008-11#1)
occlusion without##3##2##(1997-8#1)(2010-6#2)
occlusion##125##1##(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1996-12#1)(1996-6#3)(1996-9#2)(1997-2#1)(1997-3#10)(1997-6#3)(1997-8#8)(2008-10#3)(2008-11#6)(2008-12#6)(2008-4#3)(2008-5#2)(2008-7#14)(2008-8#1)(2009-1#1)(2010-1#2)(2010-12#1)(2010-3#2)(2010-6#2)(2010-9#5)(2011-2#14)(2011-3#2)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#4)
occlusions and##2##2##(2008-12#1)(2011-2#1)
occlusions of the##2##3##(2008-12#1)(2011-2#1)
occlusions of##4##2##(2008-12#1)(2011-2#3)
occlusions were##2##2##(1997-8#1)(2011-2#1)
occlusions with##2##2##(2008-12#1)(2011-2#1)
occlusions##19##1##(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-7#1)(2011-2#10)(2011-3#1)
occlusive disease##2##2##(1996-8#1)(2008-11#1)
occlusive phase##2##2##(1991-6#1)(1997-8#1)
occlusive vascular disease##4##3##(1992-9#4)
occlusive vascular##5##2##(1992-9#4)(1995-2#1)
occlusive##17##1##(1991-2#3)(1991-6#1)(1992-9#4)(1995-2#1)(1996-8#2)(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
occult blood##8##2##(1991-3#1)(1993-6#1)(1994-2#1)(1997-8#1)(2009-1#1)(2009-12#1)(2010-8#1)(2012-12#1)
occult fecal blood##2##3##(1993-3#2)
occult papillary thyroid carcinoma##2##4##(1990-6#2)
occult papillary##3##2##(1990-6#3)
occult sciences##2##2##(2008-11#2)
occult##29##1##(1990-6#5)(1991-3#1)(1991-6#1)(1993-3#2)(1993-6#1)(1994-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2009-1#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
occultation##3##1##(2008-3#3)
occupancy rates##2##2##(1992-12#1)(1996-3#1)
occupancy surveys##2##2##(2008-8#2)
occupancy##26##1##(1992-12#1)(1993-8#2)(1996-3#1)(2008-11#2)(2008-2#1)(2008-8#12)(2008-9#6)(2011-1#1)
occupant##2##1##(1991-12#1)(2013-1#1)
occupants##5##1##(1991-12#2)(2008-9#2)(2010-5#1)
occupation and##2##2##(1991-12#1)(2008-12#1)
occupation##11##1##(1991-12#1)(1993-3#1)(1995-12#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#2)
occupational and environmental intoxication##2##4##(2009-12#2)
occupational and environmental##6##3##(1991-12#1)(2008-10#1)(2009-12#3)(2010-1#1)
occupational and##10##2##(1991-12#2)(1996-6#1)(2008-10#3)(2009-12#3)(2010-1#1)
occupational asthma##5##2##(1990-3#1)(1997-1#1)(2008-10#3)
occupational discourses##2##2##(2010-9#2)
occupational diseases##3##2##(1990-3#1)(2009-12#2)
occupational exposure in##2##3##(2009-12#1)(2012-2#1)
occupational exposure to solvents##2##4##(1990-2#1)(1990-8#1)
occupational exposure to##6##3##(1990-2#1)(1990-8#1)(1997-5#1)(2008-10#1)(2013-1#2)
occupational exposure##13##2##(1990-2#1)(1990-8#1)(1991-12#2)(1997-5#1)(2008-10#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
occupational health service##4##3##(1995-2#3)(2009-12#1)
occupational health services##2##3##(1990-6#1)(1991-3#1)
occupational health##15##2##(1990-6#1)(1991-3#3)(1995-2#3)(2008-11#3)(2009-11#1)(2009-12#2)(2009-3#1)(2011-1#1)
occupational injury##4##2##(1994-3#2)(2008-11#2)
occupational medicine]##3##2##(1990-3#2)(1997-8#1)
occupational noise##2##2##(2011-2#2)
occupational status##3##2##(1995-3#2)(2010-1#1)
occupational therapist##3##2##(2008-4#1)(2010-9#1)(2012-2#1)
occupational therapists##7##2##(2008-11#2)(2008-4#2)(2012-2#1)(2013-8#2)
occupational therapy and occupational science##2##5##(2010-9#2)
occupational therapy##12##2##(2008-11#2)(2008-12#1)(2010-9#7)(2013-8#2)
occupational##125##1##(1990-2#1)(1990-3#6)(1990-6#1)(1990-8#1)(1991-12#6)(1991-3#4)(1992-5#1)(1993-3#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-12#1)(1995-2#3)(1995-3#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#15)(2008-12#1)(2008-3#2)(2008-4#3)(2009-11#1)(2009-12#12)(2009-3#1)(2010-1#2)(2010-11#2)(2010-9#13)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#10)
occupationally exposed to##2##3##(1991-12#2)
occupationally exposed##4##2##(1991-12#3)(2013-8#1)
occupationally##7##1##(1991-12#3)(2008-10#2)(2010-11#1)(2013-8#1)
occupationally-relevant doses of TCE##2##4##(2008-10#2)
occupations and##2##2##(1991-12#1)(1993-3#1)
occupations##9##1##(1991-1#2)(1991-12#1)(1993-1#1)(1993-3#1)(1994-3#2)(1995-12#1)(2011-2#1)
occupied by the cells##2##4##(2008-11#2)
occupied by the##5##3##(1994-12#1)(1995-11#1)(2008-10#1)(2008-11#2)
occupied by##10##2##(1994-12#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-8#1)
occupied the##2##2##(2008-10#1)(2008-7#1)
occupied##21##1##(1994-12#1)(1995-11#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-8#1)
occupies a##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
occupies##5##1##(1996-6#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
occupy the##3##2##(2008-1#1)(2008-6#1)(2008-8#1)
occupy##12##1##(1994-2#1)(2008-1#2)(2008-11#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)
occupying the##2##2##(2011-2#1)(2013-1#1)
occupying##8##1##(1991-3#1)(2008-11#2)(2011-2#2)(2013-1#3)
occur after##9##2##(1991-3#1)(1991-9#1)(1994-8#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2010-1#1)(2013-8#1)
occur and the##2##3##(1992-6#1)(2008-8#1)
occur and##9##2##(1992-6#1)(1995-2#1)(1997-2#1)(2008-10#4)(2008-8#1)(2011-2#1)
occur as a consequence of##2##5##(2008-11#1)(2011-2#1)
occur as a result of##3##5##(2007-12#1)(2008-9#1)(2013-1#1)
occur as a##7##3##(1995-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
occur as##18##2##(1994-2#1)(1994-3#1)(1995-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
occur at the##5##3##(1996-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
occur at##18##2##(1995-11#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-2#2)
occur because of##2##3##(2008-10#1)(2011-2#1)
occur because##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
occur between##6##2##(1991-5#1)(1994-9#1)(2008-10#3)(2012-2#1)
occur by##6##2##(1994-2#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
occur commonly in##2##3##(2008-9#1)(2010-1#1)
occur during a##2##3##(1997-8#1)(2008-7#1)
occur during the##6##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
occur during##22##2##(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
occur early##2##2##(2008-2#1)(2011-2#1)
occur either as a##2##4##(1996-11#1)(2008-9#1)
occur either##4##2##(1996-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
occur even##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
occur exclusively in##2##3##(2008-10#1)(2008-9#1)
occur following##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
occur for the most##2##4##(1997-8#1)(2007-12#1)
occur for##7##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-7#1)(2013-8#1)
occur frequently##2##2##(2008-10#2)
occur from##3##2##(1991-12#1)(2008-9#1)(2010-1#1)
occur if the##2##3##(2008-8#2)
occur if##5##2##(1994-2#1)(2008-10#1)(2008-7#1)(2008-8#2)
occur in a##8##3##(1991-3#1)(1997-2#1)(2008-10#3)(2009-10#1)(2009-8#1)(2011-2#1)
occur in any##3##3##(1995-2#1)(2008-12#1)(2013-1#1)
occur in childhood##2##3##(1990-6#1)(2008-7#1)
occur in early##2##3##(2008-7#1)(2010-12#1)
occur in four##2##3##(2008-6#1)(2012-3#1)
occur in isolation##2##3##(2010-10#1)(2011-2#1)
occur in less than##2##4##(1996-11#1)(2011-2#1)
occur in many##2##3##(1994-12#1)(2008-8#1)
occur in patients##3##3##(1990-9#1)(1997-8#1)(2013-1#1)
occur in relation to##2##4##(2008-7#1)(2013-1#1)
occur in the absence of##4##5##(1995-6#1)(2008-10#1)(2008-9#1)(2010-4#1)
occur in the##34##3##(1991-12#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(2007-12#2)(2008-10#9)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-7#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#3)
occur in##127##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#4)(2008-10#17)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
occur independent of##2##3##(1995-6#1)(2008-10#1)
occur most commonly##2##3##(1991-2#1)(2008-8#1)
occur most##3##2##(1991-2#1)(1996-6#1)(2008-8#1)
occur not only in##2##4##(1994-11#1)(2008-11#1)
occur on the##4##3##(2008-10#2)(2008-5#2)
occur on##8##2##(2008-10#5)(2008-5#2)(2009-4#1)
occur only##6##2##(1996-11#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-4#1)(2011-2#1)
occur over##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
occur primarily in the##2##4##(1997-8#1)(2011-2#1)
occur primarily##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
occur simultaneously##2##2##(2008-7#1)(2008-9#1)
occur sporadically##2##2##(2008-1#1)(2012-3#1)
occur through the##2##3##(1994-8#1)(2008-10#1)
occur through##7##2##(1992-9#1)(1994-8#1)(1995-6#1)(2008-10#3)(2013-1#1)
occur throughout the##4##3##(2008-10#3)(2008-8#1)
occur to##4##2##(2008-11#1)(2009-10#2)(2011-3#1)
occur together##2##2##(1991-12#1)(2008-10#1)
occur via##6##2##(1990-5#1)(1994-3#1)(2008-11#1)(2013-1#2)(2013-7#1)
occur when one of the##2##5##(2008-3#1)(2008-5#1)
occur when the##2##3##(1996-11#1)(2008-8#1)
occur when##10##2##(1996-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-8#1)(2012-3#1)
occur while##3##2##(2009-5#1)(2012-2#1)(2013-8#1)
occur with##16##2##(1990-11#2)(1991-8#1)(1993-6#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#3)(2011-2#2)(2012-3#1)
occur within the##2##3##(1996-12#1)(2009-12#1)
occur within##7##2##(1996-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-7#1)(2013-1#2)
occur without##2##2##(2008-10#1)(2008-11#1)
occur##439##1##(1990-11#5)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-11#4)(1996-12#3)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#6)(2007-12#12)(2007-8#1)(2008-1#3)(2008-10#87)(2008-11#20)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#13)(2008-6#1)(2008-7#21)(2008-8#30)(2008-9#17)(2009-1#1)(2009-10#5)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#25)(2011-3#1)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#8)
occured##2##1##(1996-9#1)(2008-7#1)
occurence##2##1##(2007-8#1)(2013-1#1)
occuring##2##1##(2008-10#1)(2008-11#1)
occurred after surgery##2##3##(2008-7#1)(2012-12#1)
occurred after the##3##3##(1991-6#1)(2011-2#1)(2013-8#1)
occurred after##17##2##(1991-6#1)(1993-2#1)(1995-11#2)(1997-8#2)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
occurred among##7##2##(1991-12#3)(1991-8#1)(2008-10#2)(2013-1#1)
occurred and##4##2##(1991-1#1)(1991-6#1)(1994-3#1)(2008-10#1)
occurred as a result of the##2##6##(2008-3#1)(2010-11#1)
occurred as a##4##3##(2008-3#1)(2010-11#1)(2012-12#1)(2012-3#1)
occurred as of##2##3##(1992-9#1)(2008-12#1)
occurred as the##3##3##(1997-8#1)(2008-10#2)
occurred as##14##2##(1992-9#1)(1993-12#1)(1994-3#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2010-11#1)(2012-12#1)(2012-3#1)
occurred at 0##2##3##(2008-10#2)
occurred at 30 degrees C##2##5##(2008-10#2)
occurred at a rate##2##4##(1991-9#1)(2008-10#1)
occurred at a##9##3##(1991-9#1)(1995-11#1)(2008-10#3)(2008-11#2)(2009-8#1)(2013-1#1)
occurred at high##2##3##(2010-8#1)(2012-2#1)
occurred at temperatures ranging from 5 to##2##7##(2008-10#2)
occurred at temperatures ranging from##3##5##(2008-10#3)
occurred at the##11##3##(1990-3#1)(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#3)(2013-1#1)
occurred at##49##2##(1990-3#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-5#1)(2008-10#24)(2008-11#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)
occurred before##6##2##(1991-6#1)(2008-10#3)(2008-8#1)(2013-1#1)
occurred between 12##2##3##(1997-3#1)(2008-10#1)
occurred between the##3##3##(2008-10#3)
occurred between these##2##3##(2008-10#2)
occurred between##19##2##(1990-3#1)(1994-11#1)(1996-12#1)(1997-3#3)(2008-10#12)(2013-8#1)
occurred by the##2##3##(1994-3#1)(2008-10#1)
occurred by##6##2##(1994-3#1)(2008-10#3)(2010-5#1)(2011-2#1)
occurred despite##2##2##(1990-5#1)(1994-8#1)
occurred during the##8##3##(1991-12#1)(1997-3#1)(2008-10#2)(2008-9#2)(2009-5#1)(2013-8#1)
occurred during##21##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1994-3#1)(1994-6#1)(1997-3#1)(2008-10#5)(2008-9#2)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
occurred earlier##5##2##(1990-2#1)(1996-12#1)(2008-10#2)(2010-6#1)
occurred even though##2##3##(1994-11#1)(2008-10#1)
occurred even when the##2##4##(2008-10#1)(2008-6#1)
occurred even##4##2##(1994-11#1)(2008-10#2)(2008-6#1)
occurred exclusively##3##2##(1993-8#1)(2008-10#2)
occurred following##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
occurred for##5##2##(1990-2#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
occurred frequently##4##2##(1996-6#1)(2008-10#2)(2011-2#1)
occurred from##3##2##(1991-3#1)(1994-3#1)(2008-10#1)
occurred in a##10##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1992-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
occurred in all three##2##4##(1996-6#1)(2008-12#1)
occurred in all##5##3##(1995-8#1)(1996-6#1)(2008-10#1)(2008-12#1)(2009-10#1)
occurred in less than##2##4##(1997-4#1)(2013-1#1)
occurred in only two##2##4##(1996-9#1)(2008-10#1)
occurred in only##3##3##(1996-9#1)(2008-10#1)(2009-8#1)
occurred in resistant##3##3##(1994-8#1)(2008-10#2)
occurred in response to##3##4##(1990-10#1)(2008-10#2)
occurred in snap bean##2##4##(2008-10#2)
occurred in the##47##3##(1990-9#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-12#1)(2011-2#1)(2012-2#1)
occurred in this series##2##4##(1992-2#1)(2009-3#1)
occurred in two patients##2##4##(1996-9#1)(2011-2#1)
occurred in two##4##3##(1996-9#1)(2008-10#1)(2011-2#2)
occurred in##169##2##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-6#1)(1994-11#2)(1994-3#3)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#4)(1996-1#3)(1996-11#4)(1996-6#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-10#53)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#11)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
occurred later##2##2##(2008-10#1)(2008-11#1)
occurred mainly##2##2##(1992-5#1)(2008-10#1)
occurred more rapidly##2##3##(2008-10#1)(2008-9#1)
occurred more than##2##3##(2008-12#1)(2009-8#1)
occurred more##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)
occurred on the##5##3##(1995-11#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#1)
occurred on##12##2##(1990-11#1)(1993-12#1)(1995-11#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2010-5#1)(2013-1#1)
occurred only at##2##3##(2008-10#1)(2008-9#1)
occurred only in the##3##4##(1995-11#1)(2008-9#2)
occurred only in##7##3##(1990-12#1)(1995-11#1)(2008-10#3)(2008-9#2)
occurred only##12##2##(1990-12#1)(1991-12#1)(1995-11#1)(2008-10#6)(2008-9#3)
occurred over##3##2##(2008-10#3)
occurred primarily in##2##3##(2008-9#2)
occurred primarily##3##2##(2008-10#1)(2008-9#2)
occurred rapidly##3##2##(1994-3#1)(1995-8#1)(2010-11#1)
occurred regularly##2##2##(2008-10#1)(2008-9#1)
occurred relatively##2##2##(1993-6#1)(2008-10#1)
occurred specifically##2##2##(1995-6#1)(2008-9#1)
occurred spontaneously##2##2##(1995-2#1)(1996-1#1)
occurred through##3##2##(2008-10#2)(2008-8#1)
occurred to##2##2##(1994-3#1)(1996-5#1)
occurred under##2##2##(2008-10#2)
occurred when the##8##3##(1991-12#1)(1992-10#1)(2008-10#4)(2010-11#2)
occurred when##21##2##(1991-12#1)(1991-3#1)(1992-10#1)(1994-8#1)(2008-10#11)(2008-9#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-3#1)
occurred with a significantly increased incidence in##2##7##(2008-9#2)
occurred with a##3##3##(2008-10#1)(2008-9#2)
occurred with the##3##3##(2008-10#1)(2008-12#1)(2009-7#1)
occurred with##20##2##(1993-8#1)(1993-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-9#3)(2009-5#1)(2009-7#1)(2012-2#1)
occurred within 0##2##3##(1990-2#2)
occurred within 24##2##3##(2008-10#2)
occurred within the##3##3##(1992-1#1)(2008-10#2)
occurred within##20##2##(1990-2#2)(1990-6#1)(1992-1#1)(1994-8#1)(1995-9#1)(2008-10#12)(2008-12#1)(2012-3#1)
occurred without##3##2##(1991-5#1)(2008-10#1)(2013-8#1)
occurred##587##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#4)(1991-8#3)(1991-9#1)(1992-1#4)(1992-10#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#4)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#6)(1994-2#1)(1994-3#10)(1994-6#2)(1994-8#5)(1994-9#2)(1995-11#5)(1995-2#2)(1995-6#3)(1995-8#6)(1995-9#1)(1996-1#4)(1996-11#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#3)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#219)(2008-11#23)(2008-12#9)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#11)(2008-9#32)(2009-10#3)(2009-11#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#21)(2011-3#3)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#19)(2013-8#6)
occurrence among##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
occurrence and levels##2##3##(2008-10#2)
occurrence and the##3##3##(2008-10#1)(2008-8#1)(2009-10#1)
occurrence and##21##2##(1992-9#1)(1996-11#1)(2008-10#9)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#2)
occurrence as##2##2##(1993-11#1)(2007-8#1)
occurrence during##2##2##(2008-10#1)(2010-5#1)
occurrence in the##2##3##(2008-10#2)
occurrence in##16##2##(1990-6#1)(1994-12#1)(2008-10#4)(2008-11#3)(2008-9#1)(2009-1#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-2#1)
occurrence is##2##2##(1991-3#1)(2008-5#1)
occurrence of P##2##3##(2008-10#2)
occurrence of a##2##3##(1990-8#1)(1994-9#1)
occurrence of aggressive behaviours##2##4##(2011-2#2)
occurrence of both##2##3##(2008-10#2)
occurrence of empty##2##3##(2008-10#2)
occurrence of hexaploid loach Misgurnus anguillicaudatus##2##6##(2010-8#2)
occurrence of major##2##3##(2008-9#1)(2010-12#1)
occurrence of oospores##2##3##(2008-10#2)
occurrence of several##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
occurrence of such##2##3##(1994-9#1)(2008-9#1)
occurrence of the##15##3##(1991-11#1)(1996-12#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
occurrence of two##3##3##(1992-6#1)(2008-8#1)(2013-1#1)
occurrence of urinary##2##3##(2008-10#1)(2012-12#1)
occurrence of##169##2##(1990-12#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1992-12#3)(1992-6#1)(1993-12#1)(1993-8#1)(1994-9#2)(1995-2#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#49)(2008-11#15)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-2#11)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#7)(2013-8#2)
occurrence time and##2##3##(2011-2#2)
occurrence with##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
occurrence##246##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-12#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-2#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#70)(2008-11#21)(2008-12#5)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#5)(2009-1#2)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2011-2#23)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#10)(2013-8#3)
occurrences of##4##2##(1990-11#1)(2007-12#1)(2008-11#1)(2012-3#1)
occurrences##18##1##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1997-6#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#1)
occurring after initial##2##3##(2008-10#1)(2008-7#1)
occurring after##12##2##(1994-5#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
occurring among##2##2##(1992-9#1)(2009-5#1)
occurring as##5##2##(2008-10#2)(2009-11#1)(2010-12#1)(2013-8#1)
occurring at a##2##3##(1997-3#1)(2008-10#1)
occurring at the##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
occurring at##14##2##(1991-3#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2011-2#1)
occurring disease##2##2##(2008-10#1)(2011-2#1)
occurring during a##2##3##(2008-10#1)(2008-11#1)
occurring during the##4##3##(1995-2#1)(2008-10#1)(2008-4#1)(2009-11#1)
occurring during##12##2##(1994-3#1)(1995-2#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-8#1)
occurring from##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
occurring in 0##2##3##(2010-6#1)(2012-2#1)
occurring in a##6##3##(1990-6#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-8#2)
occurring in an##2##3##(2009-9#1)(2011-2#1)
occurring in both##2##3##(2008-10#2)
occurring in the course of##2##5##(2008-7#1)(2010-12#1)
occurring in the same##2##4##(2008-11#1)(2008-7#1)
occurring in the##21##3##(1992-6#1)(1993-12#1)(1995-1#1)(1995-6#1)(1996-9#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#2)(2010-12#1)(2012-3#1)
occurring in these##2##3##(2008-1#1)(2008-7#1)
occurring in##75##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-6#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
occurring on the##3##3##(1990-12#1)(2008-10#2)
occurring on##10##2##(1990-12#1)(2008-10#7)(2008-9#1)(2010-3#1)
occurring populations of##2##3##(2008-10#2)
occurring populations##3##2##(2008-10#2)(2013-1#1)
occurring throughout##2##2##(2008-11#1)(2011-2#1)
occurring with the##2##3##(2008-11#1)(2009-11#1)
occurring with##3##2##(2008-11#1)(2009-11#1)(2010-12#1)
occurring within the##3##3##(1994-3#1)(2007-12#1)(2008-4#1)
occurring within##4##2##(1994-3#1)(2007-12#1)(2008-4#1)(2012-12#1)
occurring##244##1##(1990-11#2)(1990-12#3)(1990-6#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#76)(2008-11#17)(2008-12#5)(2008-3#3)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#6)(2009-1#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#6)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#2)
occurs across##2##2##(1993-8#1)(1994-5#1)
occurs after the##2##3##(2010-1#1)(2010-6#1)
occurs after##11##2##(1992-6#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-1#1)(2010-6#2)(2011-1#1)
occurs along##2##2##(2008-12#1)(2008-3#1)
occurs and the##2##3##(1995-2#1)(2008-10#1)
occurs and##4##2##(1995-2#1)(1996-8#1)(2008-10#1)(2008-4#1)
occurs as a##2##3##(1992-6#1)(1992-9#1)
occurs as the##2##3##(2007-12#1)(2009-8#1)
occurs as##7##2##(1992-6#1)(1992-9#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-8#1)
occurs at a##4##3##(1993-2#1)(1993-8#1)(2008-10#1)(2008-3#1)
occurs at the level of##2##5##(2008-9#1)(2010-7#1)
occurs at the##9##3##(1990-10#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)
occurs at##28##2##(1990-10#1)(1990-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
occurs because##2##2##(2008-8#1)(2012-3#1)
occurs between##5##2##(1992-9#1)(2008-10#3)(2010-5#1)
occurs by##6##2##(1991-5#1)(1993-8#1)(1994-6#1)(2008-10#3)
occurs commonly in##2##3##(2008-8#1)(2009-9#1)
occurs continuously##2##2##(2008-9#1)(2011-2#1)
occurs during the##4##3##(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
occurs during##10##2##(1994-6#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
occurs for##2##2##(1996-12#1)(2008-2#1)
occurs frequently##2##2##(1991-12#1)(2008-3#1)
occurs from##2##2##(1997-1#1)(2008-10#1)
occurs in a##9##3##(1994-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-10#3)(2008-7#1)(2009-8#1)
occurs in some##4##3##(1994-11#1)(1995-6#1)(2007-12#1)(2008-10#1)
occurs in the##23##3##(1993-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
occurs in this##2##3##(2008-10#1)(2008-5#1)
occurs in two##2##3##(1995-5#1)(2008-10#1)
occurs in##96##2##(1990-2#1)(1991-2#1)(1993-12#1)(1993-2#1)(1994-11#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#4)(2008-3#2)(2008-5#4)(2008-7#6)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#3)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)
occurs independently of##3##3##(2008-9#1)(2009-9#1)(2012-2#1)
occurs inside##2##2##(2008-8#2)
occurs mainly through##2##3##(2008-4#1)(2011-2#1)
occurs mainly##5##2##(1991-5#1)(1992-12#1)(1995-12#1)(2008-4#1)(2011-2#1)
occurs more##2##2##(2011-2#1)(2012-7#1)
occurs most commonly in##2##4##(1993-6#1)(2009-3#1)
occurs most##3##2##(1993-6#1)(2009-3#1)(2013-1#1)
occurs naturally##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
occurs on##6##2##(2007-8#1)(2008-10#3)(2010-6#1)(2012-2#1)
occurs only in##2##3##(2008-7#2)
occurs only##6##2##(1990-12#1)(1994-9#1)(2008-7#3)(2012-2#1)
occurs primarily in the##2##4##(1992-10#1)(2008-11#1)
occurs primarily in##3##3##(1992-10#1)(2008-11#2)
occurs primarily##6##2##(1991-12#1)(1992-10#1)(1994-12#1)(2008-11#3)
occurs prior to##2##3##(2008-10#1)(2008-9#1)
occurs shortly after##2##3##(1995-2#1)(2010-12#1)
occurs through a##2##3##(1994-8#1)(1995-6#1)
occurs through the##4##3##(1995-6#1)(2008-10#2)(2011-2#1)
occurs through##10##2##(1994-8#1)(1995-6#3)(2008-10#4)(2008-8#1)(2011-2#1)
occurs to##2##2##(2008-10#1)(2008-3#1)
occurs under##2##2##(1996-5#1)(2013-8#1)
occurs via##3##2##(1992-10#1)(1995-2#1)(1995-8#1)
occurs when proliferation ceases while cells##2##6##(2008-11#2)
occurs when##14##2##(1990-5#1)(1991-3#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2009-10#1)(2011-2#1)(2013-1#1)
occurs with##6##2##(1994-11#1)(1996-5#1)(2008-10#2)(2008-9#1)(2010-8#1)
occurs within the##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
occurs within##7##2##(1993-2#1)(1993-9#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-9#1)
occurs without##3##2##(1994-8#1)(1996-2#1)(2008-8#1)
occurs##375##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1992-10#2)(1992-12#3)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#7)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#3)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#7)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#8)(1996-8#2)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#89)(2008-11#21)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#16)(2008-8#15)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#14)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#10)(2012-7#2)(2013-1#12)(2013-7#2)(2013-8#3)
ocean and##3##2##(2008-2#1)(2008-3#2)
ocean color##4##2##(2008-3#4)
ocean optics##2##2##(2008-3#2)
ocean water##5##2##(2008-3#5)
ocean##37##1##(1990-8#3)(2008-10#5)(2008-2#2)(2008-3#18)(2008-8#2)(2008-9#4)(2012-2#2)(2013-1#1)
ocean-color##2##1##(2008-2#2)
oceanic##7##1##(2008-10#1)(2008-2#1)(2008-3#5)
oceanographic lidar##3##2##(2008-2#3)
oceanographic##4##1##(2008-2#3)(2008-8#1)
oceans##4##1##(2008-10#2)(2008-2#1)(2012-2#1)
ocellata##6##1##(2010-8#6)
ocellatus##4##1##(2008-5#4)
ocelli##3##1##(2008-9#3)
oceurrence of##2##2##(2013-8#2)
ochnaflavone##5##1##(1994-11#4)(2008-11#1)
ochratoxin A (OTA)##2##3##(2008-10#2)
ochratoxin A##4##2##(2008-10#4)
ochre##11##1##(2008-10#6)(2008-5#2)(2008-9#3)
octadecenedioic acid##4##2##(2008-5#4)
octadecyl and diol##2##3##(1997-2#2)
octadecyl silica membrane disks modified with##4##6##(2008-10#4)
octadecyl silica membrane disks modified##9##5##(2008-10#9)
octadecyl silica##12##2##(2008-10#12)
octadecyl##18##1##(1997-2#2)(2008-10#16)
octadecyl-bonded silica membrane##2##3##(2008-10#2)
octadecyl-bonded silica##3##2##(2008-10#3)
octadecylsilica##2##1##(2008-10#2)
octahedral##2##1##(2008-10#1)(2011-2#1)
octahydro-1##3##1##(2008-10#3)
octamer##7##1##(1991-10#2)(1992-3#1)(1992-8#1)(2008-8#3)
octameric##4##1##(1991-10#2)(1992-3#1)(1992-8#1)
octan-1-ol##3##1##(2008-10#3)
octane##3##1##(1990-5#2)(2008-10#1)
octanol##10##1##(1991-5#7)(2008-10#3)
octanol-water distribution##2##2##(2008-10#2)
octanol/water partition coefficient##2##3##(2008-10#1)(2008-5#1)
octanol/water partition##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
octanol/water##4##1##(1991-5#1)(1996-2#1)(2008-10#1)(2008-5#1)
octapeptide##7##1##(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-8#3)
octaurelia##2##1##(2008-12#2)
octogenarians##3##1##(1995-3#1)(1997-7#1)(2011-2#1)
octopamine and##2##2##(1994-2#1)(2008-7#1)
octopamine##7##1##(1994-2#3)(2008-7#4)
octopirox in##2##2##(2008-5#2)
octopole collision cell ICP-MS##4##4##(2008-10#4)
octopole collision cell##6##3##(2008-10#6)
octopole reaction##2##2##(2008-10#2)
octopole##8##1##(2008-10#8)
octreotide##6##1##(1995-8#2)(1997-4#4)
octy##2##1##(2008-10#2)
octyl dimethyl PABA##2##3##(2008-5#2)
octyl ether (NPOE)##4##3##(2008-10#4)
octyl ether (o-NPOE)##2##3##(2008-10#2)
octyl ether##12##2##(2008-10#12)
octyl methoxycinnamate and octyl salicylate##2##5##(2008-5#2)
octyl methoxycinnamate and##3##3##(2008-5#3)
octyl methoxycinnamate##6##2##(2008-5#6)
octyl##25##1##(1994-5#1)(2008-10#13)(2008-5#11)
octylmethoxycinnamate##2##1##(2008-5#2)
octylphenoxypolyethoxyethanol##2##1##(2008-10#2)
octylphenyl-N-N- diisobutylcarbamoylmethylphosphine oxide##2##3##(2008-10#2)
ocular diseases##3##2##(2008-8#1)(2010-10#2)
ocular dominance columns in##3##4##(2008-11#3)
ocular dominance columns##4##3##(2008-11#4)
ocular dominance plasticity##3##3##(2012-2#3)
ocular dominance##10##2##(2008-11#5)(2012-2#5)
ocular inflammation##2##2##(2010-1#1)(2011-2#1)
ocular##39##1##(1990-3#1)(1994-2#1)(2007-11#1)(2008-11#5)(2008-12#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-5#1)(2011-2#4)(2011-3#5)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#2)(2013-8#1)
oculomotor##4##1##(1996-3#1)(2008-6#1)(2011-2#2)
oculopalpebral signs##2##2##(2013-1#2)
odd##2##1##(2008-10#1)(2011-2#1)
odds for##3##2##(1995-2#1)(2010-7#1)(2012-3#1)
odds of CP##2##3##(2011-2#2)
odds of a positive discography##3##5##(2012-12#3)
odds of a##5##3##(2010-7#2)(2012-12#3)
odds of##15##2##(2008-11#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#2)
odds ratio (OR)##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
odds ratio for##4##3##(1991-11#1)(1997-8#1)(2008-12#1)(2012-3#1)
odds ratio of##4##3##(2008-11#1)(2008-3#1)(2012-3#2)
odds ratio##19##2##(1990-8#1)(1991-11#2)(1991-8#2)(1994-9#2)(1997-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-11#1)(2011-2#2)(2012-3#4)(2013-1#1)
odds ratios (OR)##2##3##(2011-2#1)(2013-1#1)
odds ratios##5##2##(2008-11#1)(2011-2#2)(2013-1#2)
odds##49##1##(1990-8#1)(1991-11#2)(1991-8#2)(1993-5#1)(1994-9#2)(1995-2#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2009-4#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#3)(2011-2#9)(2012-12#3)(2012-3#7)(2013-1#6)
odontogenic cyst##5##2##(2007-12#1)(2013-1#4)
odontogenic cysts##3##2##(2013-1#3)
odontogenic tumor##6##2##(2007-12#3)(2013-1#3)
odontogenic tumors##4##2##(2007-12#2)(2013-1#2)
odontogenic##23##1##(1997-3#1)(2007-12#8)(2013-1#14)
odontoid##4##1##(2011-2#3)(2013-1#1)
odontology##4##1##(1993-2#1)(2008-10#2)(2008-12#1)
odontoma##5##1##(2007-12#1)(2013-1#4)
odontomas in##2##2##(2013-1#2)
odontomas##3##1##(2013-1#3)
odontostomatologic##2##1##(1990-3#2)
odor chemicals##6##2##(2008-10#6)
odor signature chemicals##2##3##(2008-10#2)
odor signature##3##2##(2008-10#3)
odor##24##1##(1990-8#1)(1994-8#1)(2008-10#12)(2008-5#5)(2009-8#5)
odor-binding##2##1##(2008-5#2)
odorant##3##1##(2008-10#1)(2008-7#1)(2012-2#1)
odorants##2##1##(2012-2#1)(2013-1#1)
odorless##2##1##(2008-5#2)
odorous##2##1##(1994-8#1)(2008-5#1)
odors##7##1##(1990-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2009-6#1)(2013-1#2)
odour detection##3##2##(2008-7#3)
odour evaluation##2##2##(2008-5#2)
odour perception##8##2##(2008-7#8)
odour production##2##2##(1997-4#1)(2008-5#1)
odour##36##1##(1990-5#3)(1993-3#1)(1997-4#3)(2008-10#8)(2008-5#9)(2008-7#11)(2009-12#1)
odours and##2##2##(2008-10#1)(2010-4#1)
odours##5##1##(2008-10#4)(2010-4#1)
oedema and##3##2##(1994-6#1)(2008-7#1)(2011-2#1)
oedema in##2##2##(2008-7#1)(2011-2#1)
oedema was##3##2##(1996-6#3)
oedema with##2##2##(2011-2#1)(2013-7#1)
oedema##27##1##(1994-6#1)(1995-11#1)(1996-6#5)(2008-5#1)(2008-7#4)(2010-7#3)(2011-2#8)(2011-3#1)(2013-1#2)(2013-7#1)
oedematous##2##1##(2012-2#2)
oerstedii##3##1##(2007-12#3)
oesophageal and gastric events##2##4##(2008-11#2)
oesophageal and gastric##3##3##(2008-11#3)
oesophageal cancer and##2##3##(1990-9#1)(2011-2#1)
oesophageal cancer##7##2##(1990-9#2)(1993-6#1)(2008-1#2)(2011-2#2)
oesophageal or gastric##2##3##(2008-11#2)
oesophageal varices##5##2##(2009-8#3)(2013-1#2)
oesophageal##26##1##(1990-9#2)(1993-6#2)(1996-3#2)(2008-1#3)(2008-11#9)(2009-8#3)(2011-1#1)(2011-2#2)(2013-1#2)
oesophagectomy and##2##2##(2011-2#2)
oesophagitis##5##1##(1993-12#1)(1996-3#1)(2008-11#2)(2009-8#1)
oestrogen##5##1##(1990-11#2)(2009-6#1)(2011-2#1)(2013-8#1)
of $1##2##2##(1994-2#1)(1994-9#1)
of $100##2##2##(1994-2#1)(1997-1#1)
of &gt##37##2##(1994-3#1)(1994-6#1)(1997-5#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)
of &lt##36##2##(1997-5#3)(2008-10#23)(2008-11#2)(2008-3#3)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#2)
of &quot##106##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-8#2)(1992-2#1)(1992-3#3)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#3)(1994-9#1)(1995-12#1)(1995-5#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(2008-1#2)(2008-10#18)(2008-11#4)(2008-12#4)(2008-7#3)(2008-8#10)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-4#2)(2011-2#10)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
of 'Canthatch'##2##2##(2008-10#2)
of 'Oketsu'##2##2##(2008-10#2)
of 'replenishing##3##2##(2013-8#3)
of 'treating different diseases by the same method'##2##8##(2013-8#2)
of 'treating different diseases by the same##3##7##(2013-8#3)
of (-)-dictyostatin##3##2##(2008-8#3)
of (-)-epicatechin in##2##3##(2008-10#2)
of (-)-epicatechin##3##2##(2008-10#3)
of (1##4##2##(2008-10#4)
of (1)##3##2##(1990-11#1)(1993-3#1)(1997-3#1)
of (187)Os in molybdenite by##2##5##(2008-10#2)
of (2##2##2##(2008-10#1)(2008-12#1)
of (234)Th##2##2##(2008-10#2)
of (5##2##2##(2008-10#2)
of (58##2##2##(2008-10#2)
of (7##2##2##(1992-10#1)(2008-10#1)
of (R)-1##2##2##(2008-10#2)
of (i)##3##2##(2008-10#2)(2008-7#1)
of +##2##2##(1990-12#1)(2008-10#1)
of +/-0##7##2##(2008-10#7)
of +/-10%##2##2##(2008-10#2)
of +/-2##3##2##(2008-10#3)
of +0##5##2##(2008-10#5)
of -0##25##2##(1996-2#1)(2008-10#22)(2008-7#2)
of -1##6##2##(1996-2#1)(2008-10#3)(2012-7#1)(2012-9#1)
of -23##2##2##(2008-10#1)(2008-3#1)
of -7##3##2##(2008-10#3)
of 0 to 10##2##4##(2008-5#1)(2008-7#1)
of 0 to##11##3##(2008-10#5)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2013-1#1)
of 0##819##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-7#1)(1992-11#2)(1992-12#2)(1992-8#1)(1993-12#1)(1993-8#4)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#4)(1996-12#2)(1997-3#1)(1997-8#3)(2007-12#5)(2007-8#2)(2008-10#615)(2008-11#37)(2008-12#7)(2008-2#7)(2008-3#11)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#8)(2009-2#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#12)(2013-8#2)
of 0-10##5##2##(2008-10#2)(2008-7#1)(2013-1#2)
of 0-4##2##2##(1991-3#1)(2008-10#1)
of 0-5##2##2##(2008-10#1)(2008-7#1)
of 1 M##3##3##(1997-2#1)(2008-10#2)
of 1 and 0##2##4##(2008-10#2)
of 1 and the##2##4##(2008-10#2)
of 1 and##5##3##(2008-10#4)(2008-12#1)
of 1 cm##2##3##(2009-2#1)(2013-1#1)
of 1 g##2##3##(2008-11#1)(2008-12#1)
of 1 in##4##3##(1995-12#1)(2008-10#2)(2008-11#1)
of 1 m##2##3##(2008-10#1)(2008-3#1)
of 1 mM##2##3##(2008-10#1)(2008-11#1)
of 1 microM##3##3##(1990-5#1)(1991-12#1)(1995-11#1)
of 1 min##3##3##(2008-10#2)(2011-2#1)
of 1 ml min(-1)##3##4##(2008-10#3)
of 1 ml of##2##4##(2008-10#2)
of 1 ml##5##3##(2008-10#5)
of 1 ml/min##2##3##(2008-10#1)(2012-2#1)
of 1 mol l(-1)##3##4##(2008-10#3)
of 1 mol##5##3##(1994-5#1)(2008-10#4)
of 1 muM for##2##4##(2008-10#2)
of 1 muM##5##3##(2008-10#4)(2008-11#1)
of 1 mug l(-1)##3##4##(2008-10#3)
of 1 mug##5##3##(2008-10#5)
of 1 nM##2##3##(1995-11#1)(2008-11#1)
of 1 or##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
of 1 to 4##2##4##(2008-10#1)(2008-6#1)
of 1 to##7##3##(1992-10#1)(1993-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)
of 1 x 10(-3)##2##4##(2008-2#2)
of 1 x##6##3##(1994-5#1)(2008-10#2)(2008-2#2)(2008-3#1)
of 1 year##2##3##(1995-2#1)(2008-10#1)
of 1##558##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#3)(1991-12#1)(1991-3#1)(1991-5#6)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#5)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#3)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#9)(1996-6#6)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#4)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#347)(2008-11#23)(2008-12#4)(2008-2#9)(2008-3#19)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#5)(2009-1#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#7)(2013-8#2)
of 1%##15##2##(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)
of 1-##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
of 1-2##2##2##(2008-11#2)
of 1-20##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
of 1-4##4##2##(1991-2#1)(2008-10#1)(2013-1#2)
of 1-5##3##2##(1990-2#2)(2008-10#1)
of 1-[G'(1)]##2##2##(1996-5#2)
of 1-decylalcohol##2##2##(2008-10#2)
of 1-dopa##2##2##(2008-7#2)
of 1-nitroso-2-naphthol##2##2##(2008-10#2)
of 1-pyrrolidine##2##2##(2008-10#2)
of 10 Hz##2##3##(2008-3#2)
of 10 amino##2##3##(1995-8#1)(2008-8#1)
of 10 and##4##3##(1995-8#1)(2008-10#3)
of 10 days##2##3##(2008-10#1)(2008-5#1)
of 10 degrees C##2##4##(2008-10#2)
of 10 degrees##3##3##(2008-10#2)(2008-3#1)
of 10 m##2##3##(2007-12#1)(2008-3#1)
of 10 mM phosphate##2##4##(2008-10#2)
of 10 mM##6##3##(1995-11#1)(2008-10#3)(2008-11#2)
of 10 mV##3##3##(2008-10#3)
of 10 mg##2##3##(2008-10#2)
of 10 microg##2##3##(2008-10#2)
of 10 micrograms##3##3##(1990-2#1)(1993-6#1)(1996-2#1)
of 10 months##4##3##(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
of 10 muM##3##3##(2008-10#2)(2008-11#1)
of 10 nM##5##3##(1992-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
of 10 ng##2##3##(2008-10#2)
of 10 nm filaments##2##4##(2008-8#2)
of 10 samples##2##3##(2008-10#2)
of 10 to##3##3##(1991-5#1)(2008-10#2)
of 10 was##2##3##(2008-10#2)
of 10 years##2##3##(1996-5#1)(1997-2#1)
of 10 μm##2##3##(2009-12#1)(2011-2#1)
of 10##191##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-8#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#89)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#8)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#8)(2009-12#2)(2010-11#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#6)(2013-8#2)
of 10% of##2##3##(2008-3#1)(2008-9#1)
of 10%##15##2##(1991-5#1)(1993-6#1)(1995-3#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#1)
of 10(-3) M##4##3##(2008-10#4)
of 10(-3)##5##2##(2008-10#5)
of 10(-4) M##2##3##(2008-10#2)
of 10(-4)##3##2##(2008-10#3)
of 10(-5) M##2##3##(2008-10#2)
of 10(-5)##3##2##(2008-10#2)(2011-2#1)
of 10(-6)##2##2##(1994-3#1)(2008-10#1)
of 10(-9) M##3##3##(1990-11#1)(1994-3#1)(2008-10#1)
of 10(-9)##6##2##(1990-11#1)(1994-3#1)(2008-10#2)(2011-2#2)
of 10(2)##4##2##(1995-2#1)(2008-10#2)(2009-6#1)
of 10(4) to##2##3##(1995-2#1)(2008-10#1)
of 10(4)##4##2##(1995-2#1)(2008-10#3)
of 10(6)##3##2##(1996-5#1)(2008-11#2)
of 10(9)##4##2##(1997-1#1)(2008-10#2)(2008-9#1)
of 10-15##2##2##(1996-11#1)(2007-12#1)
of 10-40##2##2##(1994-2#1)(2008-9#1)
of 100 and 200 mg/kg##3##5##(2008-10#1)(2012-2#2)
of 100 and##7##3##(1995-2#1)(1995-8#1)(2008-10#3)(2012-2#2)
of 100 cases]##2##3##(1990-2#1)(2009-5#1)
of 100 ml##6##3##(2008-10#6)
of 100 mug l(-1)##2##4##(2008-10#2)
of 100 nM##3##3##(1994-5#1)(1997-4#1)(2008-11#1)
of 100 ng ml(-1)##4##4##(2008-10#4)
of 100 patients##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
of 100 to##4##3##(2008-10#2)(2008-11#1)(2010-11#1)
of 100##93##2##(1990-2#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-10#45)(2008-11#6)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#2)
of 100%##9##2##(2008-10#7)(2008-5#1)(2012-3#1)
of 100-fold##2##2##(2008-10#1)(2008-11#1)
of 1000 and##2##3##(2008-10#2)
of 1000##9##2##(1994-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-11#1)
of 100mugl(-1)##2##2##(2008-10#2)
of 101##8##2##(1997-3#1)(2008-10#5)(2008-7#1)(2013-8#1)
of 1013##2##2##(1997-8#1)(2013-8#1)
of 102##5##2##(1990-6#1)(2008-10#2)(2008-9#1)(2013-1#1)
of 103##4##2##(1995-11#1)(1996-1#1)(2008-10#1)(2011-1#1)
of 104##4##2##(1994-2#1)(1997-3#1)(2008-11#1)(2011-2#1)
of 105##7##2##(2008-10#2)(2008-3#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
of 1059##2##2##(1995-2#1)(2008-10#1)
of 106##3##2##(1997-8#1)(2008-10#1)(2008-12#1)
of 1064-nm##2##2##(2008-3#2)
of 108 epidemics of##2##4##(2008-10#2)
of 108##7##2##(2008-10#4)(2008-8#2)(2013-1#1)
of 109##3##2##(2008-10#1)(2011-2#2)
of 10mgl(-1)##2##2##(2008-10#2)
of 10min##4##2##(2008-10#4)
of 10nM##2##2##(2008-10#2)
of 10s##2##2##(2008-10#2)
of 11 and##4##3##(1996-5#1)(2008-10#3)
of 11##58##2##(1990-4#1)(1990-8#1)(1991-12#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-9#1)(1997-5#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#3)(2009-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#3)
of 110##11##2##(1991-6#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)
of 111 patients##2##3##(1990-2#1)(2013-1#1)
of 111##3##2##(1990-2#1)(2013-1#2)
of 112##8##2##(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2012-2#1)
of 114##2##2##(1997-7#1)(2008-10#1)
of 115##3##2##(1990-11#1)(1991-1#1)(1996-1#1)
of 116##2##2##(1990-12#1)(2008-10#1)
of 117##5##2##(1995-12#1)(1995-6#2)(2009-12#1)(2012-3#1)
of 118##4##2##(2008-10#1)(2008-12#1)(2010-4#1)(2012-2#1)
of 119##7##2##(1995-6#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-8#1)
of 12 and##2##3##(1990-2#1)(2008-10#1)
of 12 h##2##3##(2008-10#2)
of 12 months##2##3##(2008-7#1)(2013-1#1)
of 12 mug##3##3##(2008-10#2)(2008-11#1)
of 12 patients##4##3##(1997-7#1)(2008-7#1)(2011-2#1)(2011-3#1)
of 12 samples##2##3##(2008-10#2)
of 12 selected##2##3##(1992-1#1)(2008-10#1)
of 12 volunteers##2##3##(2008-11#1)(2012-2#1)
of 12 weeks##2##3##(2008-10#1)(2008-5#1)
of 12##76##2##(1990-2#1)(1991-12#1)(1992-1#1)(1994-12#1)(1994-8#2)(1997-7#1)(2008-10#35)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
of 12-O-tetradecanoylphorbol-13-acetate##4##2##(1992-8#3)(1997-1#1)
of 120##24##2##(1990-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-3#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
of 1200##4##2##(1991-5#1)(1997-2#1)(2008-10#2)
of 121##2##2##(2008-10#1)(2012-2#1)
of 122##2##2##(2011-2#1)(2012-3#1)
of 123##2##2##(2009-7#1)(2013-1#1)
of 123-I MIBG imaging##3##4##(2012-2#3)
of 124##4##2##(1997-8#1)(2011-2#1)(2012-2#1)(2013-3#1)
of 125##6##2##(1991-12#1)(1993-12#1)(1995-1#1)(2008-10#2)(2011-2#1)
of 125I-[Y39]exendin-4##2##2##(1994-8#2)
of 125I-bFGF##2##2##(1991-12#2)
of 125IUdR incorporation##2##3##(1993-11#2)
of 126##6##2##(1990-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
of 127 amino acids##2##4##(1990-5#1)(1991-9#1)
of 127##4##2##(1990-5#1)(1991-9#1)(1995-3#1)(2008-10#1)
of 128##4##2##(1993-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
of 129##3##2##(1995-11#1)(2008-11#1)(2013-1#1)
of 13 and##2##3##(1995-8#1)(2008-9#1)
of 13 studies##2##3##(1993-1#1)(2011-2#1)
of 13##36##2##(1990-2#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#2)(1997-8#1)(2008-10#11)(2008-11#6)(2008-12#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
of 130##8##2##(1992-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
of 131##2##2##(1990-8#1)(2008-10#1)
of 133##3##2##(1997-6#1)(2008-10#1)(2010-4#1)
of 134##2##2##(1996-12#1)(2012-2#1)
of 135##6##2##(1993-11#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
of 139##3##2##(1994-1#1)(2008-10#1)(2012-2#1)
of 13C-labeled##3##2##(1993-3#3)
of 14 days##4##3##(1990-12#1)(1990-9#1)(2008-10#2)
of 14 patients##2##3##(2008-10#1)(2013-1#1)
of 14 species of##2##4##(2008-10#1)(2008-8#1)
of 14 species##4##3##(2008-10#2)(2008-8#2)
of 14##50##2##(1990-12#2)(1990-9#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-10#17)(2008-11#1)(2008-7#2)(2008-8#4)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#4)
of 14-3-3 protein##2##3##(2008-11#2)
of 14-3-3##4##2##(2008-11#3)(2010-12#1)
of 140##2##2##(1991-6#1)(2008-10#1)
of 143##2##2##(2008-10#2)
of 144##3##2##(1997-8#1)(2008-11#1)(2008-7#1)
of 145##2##2##(1990-6#1)(2008-7#1)
of 146##3##2##(1996-12#1)(2008-10#1)(2013-1#1)
of 148##2##2##(1994-8#1)(2008-10#1)
of 149##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
of 14F7##2##2##(2012-3#2)
of 15 and 60 min##2##5##(2008-9#2)
of 15 and##3##3##(2008-10#1)(2008-9#2)
of 15 different##2##3##(1997-4#1)(2008-10#1)
of 15 min##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
of 15 organic phosphonate esters##2##5##(2008-10#2)
of 15 to##3##3##(2008-10#3)
of 15 years##4##3##(1990-8#1)(1992-12#1)(2008-10#1)(2011-2#1)
of 15##87##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#10)(2009-11#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
of 15%##6##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
of 15)##2##2##(1996-3#1)(2008-10#1)
of 15-30##3##2##(1994-8#1)(1995-8#1)(2008-10#1)
of 15-LO##2##2##(2008-5#2)
of 150 cases##2##3##(1990-12#1)(1996-3#1)
of 150##25##2##(1990-12#2)(1993-8#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#9)(2008-5#2)(2008-9#2)(2009-12#2)(2010-12#1)(2010-6#1)
of 1500##5##2##(1994-3#1)(2008-10#3)(2013-1#1)
of 151##2##2##(2008-11#1)(2008-9#1)
of 152##3##2##(2008-10#2)(2008-8#1)
of 153##4##2##(1990-5#1)(1993-8#1)(2008-11#1)(2013-8#1)
of 155##2##2##(1994-3#1)(2008-10#1)
of 156##8##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)
of 158##3##2##(1991-8#1)(2008-10#1)(2008-9#1)
of 159##4##2##(1990-2#1)(2008-10#1)(2010-5#1)(2011-2#1)
of 15C5##2##2##(2008-10#2)
of 15N-labeled##2##2##(1995-2#1)(2008-4#1)
of 16 alpha-OHE1##2##3##(1995-9#2)
of 16 cases##2##3##(1990-5#1)(2008-11#1)
of 16 different##2##3##(1995-6#1)(2008-10#1)
of 16 months##3##3##(1996-3#1)(2008-10#1)(2011-2#1)
of 16 patients##2##3##(2011-2#1)(2013-1#1)
of 16 years##2##3##(1997-8#1)(2011-2#1)
of 16##36##2##(1990-5#1)(1991-2#1)(1992-12#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-9#2)(1996-3#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#5)(2012-2#1)(2013-1#1)
of 16-week Kouk-Sun-Do##2##3##(2010-4#2)
of 160##4##2##(1992-6#1)(2007-12#1)(2008-10#2)
of 161##3##2##(1994-12#1)(1997-7#1)(2008-12#1)
of 163##3##2##(2008-12#1)(2008-3#1)(2010-8#1)
of 164##2##2##(1995-11#1)(2008-7#1)
of 165##6##2##(1990-12#2)(2008-10#2)(2008-5#1)(2010-11#1)
of 168##3##2##(1995-12#1)(2010-2#1)(2012-3#1)
of 16C5 and##3##3##(2008-10#3)
of 16C5##7##2##(2008-10#7)
of 16S rDNA and##2##4##(2008-10#2)
of 16S rDNA##5##3##(2008-10#4)(2008-5#1)
of 16S rRNA gene##5##4##(2008-10#1)(2008-12#1)(2011-2#2)(2012-2#1)
of 16S rRNA##7##3##(2008-10#3)(2008-12#1)(2011-2#2)(2012-2#1)
of 16S##14##2##(2008-10#9)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)
of 17 beta-estradiol##2##3##(1995-11#1)(2008-11#1)
of 17 elements##2##3##(2008-10#2)
of 17 patients##5##3##(1994-1#1)(1997-4#1)(2008-9#1)(2013-1#2)
of 17##29##2##(1991-3#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-11#4)(2008-5#2)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#1)(2013-1#2)
of 17)##2##2##(1992-1#1)(1996-3#1)
of 170##4##2##(1993-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
of 171##3##2##(1995-8#1)(2008-7#1)(2013-1#1)
of 174##2##2##(2008-1#1)(2008-10#1)
of 177##2##2##(1993-2#1)(2010-12#1)
of 179##3##2##(1992-9#1)(1995-2#1)(2011-1#1)
of 17E8##4##2##(1995-2#4)
of 18 and##2##3##(2008-10#1)(2012-2#1)
of 18 months##3##3##(1991-11#1)(1991-8#1)(2008-10#1)
of 18 patients##2##3##(2008-10#1)(2012-3#1)
of 18 years##2##3##(2009-12#1)(2011-2#1)
of 18##52##2##(1990-3#1)(1991-11#1)(1991-3#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-2#4)(2012-3#2)
of 18%##2##2##(1996-12#1)(2008-10#1)
of 18-crown-6##4##2##(2008-10#4)
of 180##3##2##(2008-10#1)(2011-2#2)
of 180s##2##2##(2008-10#2)
of 182##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2009-2#1)
of 183##3##2##(1990-6#2)(2011-2#1)
of 186##2##2##(2008-10#1)(2010-1#1)
of 187##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
of 188##2##2##(1992-2#1)(1994-12#1)
of 19 HCMV-induced TGr##2##4##(1997-3#2)
of 19 patients##8##3##(1995-12#1)(2008-9#1)(2009-3#1)(2011-2#3)(2012-3#2)
of 19##52##2##(1991-11#1)(1991-6#2)(1993-8#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#2)(1997-8#1)(2008-10#16)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
of 190##3##2##(1990-2#1)(1997-8#1)(2010-11#1)
of 194##2##2##(2008-5#1)(2012-12#1)
of 195##2##2##(2008-10#1)(2008-11#1)
of 196##2##2##(2008-11#1)(2013-1#1)
of 197##3##2##(2008-10#1)(2008-7#1)(2009-12#1)
of 1980##2##2##(1991-1#1)(1994-2#1)
of 1982##3##2##(1993-12#1)(1994-3#1)(1995-3#1)
of 1986##3##2##(1991-1#1)(1991-2#1)(1992-2#1)
of 1987##3##2##(1993-2#1)(1994-1#1)(1996-3#1)
of 1988##4##2##(1991-2#1)(1997-4#1)(2008-10#2)
of 1989##6##2##(1990-9#1)(1991-3#1)(1992-1#1)(1992-9#1)(1994-1#1)(1997-2#1)
of 1990 (Public Law 101-508)##2##5##(1991-12#2)
of 1990##8##2##(1991-12#2)(1993-1#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#2)
of 1991##4##2##(1993-1#2)(1993-3#1)(1997-1#1)
of 1992##5##2##(1990-12#1)(1992-8#1)(1995-3#1)(1996-1#1)(1996-3#1)
of 1993 (Public Law 103-66)##2##5##(1994-3#2)
of 1993##5##2##(1994-3#2)(1996-6#1)(2008-10#2)
of 1994##8##2##(1995-12#1)(1996-2#1)(1996-3#1)(1997-6#2)(2008-10#3)
of 1997##4##2##(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)
of 1998##2##2##(2008-10#1)(2008-5#1)
of 1999##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
of 19C6 for##2##3##(2008-10#2)
of 19C6##6##2##(2008-10#6)
of 1H##4##2##(1994-5#1)(1995-2#1)(2008-10#1)(2009-7#1)
of 1a##5##2##(1992-12#1)(1996-5#2)(2008-10#1)(2009-9#1)
of 1ml of##2##3##(2008-10#2)
of 1ml##4##2##(2008-10#4)
of 1x10(-5)##3##2##(2008-10#3)
of 1x10(-6)##3##2##(2008-10#3)
of 1x10(-7)##3##2##(2008-10#3)
of 2 M##2##3##(2008-10#2)
of 2 and 4##2##4##(2008-11#1)(2008-5#1)
of 2 and##6##3##(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
of 2 cases##2##3##(1997-3#1)(2013-1#1)
of 2 cases]##2##3##(1992-5#1)(1993-6#1)
of 2 g##2##3##(2008-10#1)(2011-2#1)
of 2 mg cm(-2)##2##4##(2008-5#2)
of 2 mg##3##3##(2008-10#1)(2008-5#2)
of 2 microM##2##3##(1990-8#1)(2008-10#1)
of 2 ml##3##3##(2008-10#3)
of 2 mol l(-1)##3##4##(2008-10#3)
of 2 or##2##3##(2008-7#1)(2010-12#1)
of 2 to 3##2##4##(2008-10#2)
of 2 to##5##3##(1996-3#1)(2008-10#2)(2008-5#1)(2009-12#1)
of 2 was##2##3##(2008-10#1)(2013-1#1)
of 2 x##4##3##(2008-10#2)(2008-3#2)
of 2 years##8##3##(1997-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
of 2##399##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#2)(1992-12#6)(1992-3#3)(1992-5#1)(1992-6#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#4)(1996-3#2)(1996-5#2)(1996-8#1)(1997-3#4)(1997-4#2)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#256)(2008-11#9)(2008-12#9)(2008-2#1)(2008-3#15)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#1)(2010-1#3)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#5)(2012-2#5)(2012-3#1)(2013-1#10)
of 2%##9##2##(1993-1#2)(1995-3#1)(2008-10#6)
of 2'-hydroxy-4-R-chalcones##2##2##(2008-10#2)
of 2-(1-carboxy-1-hydroxyethyl)-3##2##2##(1993-8#2)
of 2-3##5##2##(1992-1#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-9#1)
of 2-5%##2##2##(1991-2#1)(2008-10#1)
of 2-amino-5##2##2##(2008-10#2)
of 2-butoxyethanol from##2##3##(2008-10#2)
of 2-cephems and 3-cephems##2##4##(2008-11#2)
of 2-ethoxyethanol in##2##3##(2008-5#2)
of 2-ethoxyethanol##4##2##(2008-5#4)
of 2-ethylhexyl-p-methoxycinnamate##2##2##(2008-10#2)
of 2-mercaptoethanol to the##2##4##(1990-8#1)(1994-8#1)
of 2-mercaptoethanol##6##2##(1990-8#1)(1994-8#2)(2008-10#3)
of 2-methyl-4-amino-5-hydroxymethylpyrimidine##2##2##(1990-2#2)
of 2-propanol##6##2##(2008-10#6)
of 2-propanol-water binary mixtures##2##4##(2008-10#2)
of 2-week##2##2##(1996-11#1)(2013-1#1)
of 20 and##5##3##(2008-10#5)
of 20 different##2##3##(2008-10#2)
of 20 genes##2##3##(1996-2#1)(2008-10#1)
of 20 healthy##2##3##(2008-5#1)(2008-7#1)
of 20 mg##3##3##(1990-2#1)(1991-8#1)(2008-10#1)
of 20 muM##3##3##(2008-10#2)(2008-11#1)
of 20 mug##3##3##(2008-10#3)
of 20 ng##3##3##(2008-10#3)
of 20 patients##8##3##(1994-12#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#1)
of 20 samples h(-1)##2##4##(2008-10#2)
of 20 samples per##3##4##(2008-10#3)
of 20 samples##5##3##(2008-10#5)
of 20 to##2##3##(1997-5#1)(2008-10#1)
of 20 years##2##3##(1997-3#1)(1997-8#1)
of 20##126##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#2)(2007-12#2)(2008-10#59)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
of 20%##9##2##(1990-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2012-3#1)(2013-8#1)
of 20-30##2##2##(2008-10#1)(2011-2#1)
of 20-3000 ng ml(-1)##2##4##(2008-10#2)
of 200 mg l(-1)##2##4##(2008-10#2)
of 200 mg##3##3##(2008-10#2)(2008-5#1)
of 200 ms##2##3##(2008-3#1)(2010-9#1)
of 200 muM##3##3##(2008-10#3)
of 200##33##2##(1990-5#1)(1990-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-2#1)(2008-10#15)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
of 2000##10##2##(1993-2#1)(1995-2#1)(2008-10#6)(2008-11#1)(2010-8#1)
of 2000-2006##2##2##(2010-8#1)(2011-2#1)
of 2002##2##2##(2008-10#1)(2008-4#1)
of 2003##2##2##(2008-11#1)(2012-3#1)
of 2004##2##2##(2008-12#1)(2010-8#1)
of 2005##2##2##(2010-10#1)(2010-8#1)
of 2006##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
of 2008##4##2##(2011-1#1)(2011-2#2)(2012-2#1)
of 2009##5##2##(2011-2#1)(2011-9#2)(2012-12#1)(2012-2#1)
of 2010##3##2##(2008-1#1)(2011-2#2)
of 202##2##2##(1997-3#1)(2008-10#1)
of 203##3##2##(1997-2#1)(2008-8#1)(2009-5#1)
of 204##2##2##(1994-12#1)(1997-7#1)
of 206##3##2##(2008-5#2)(2011-2#1)
of 207##2##2##(1990-3#1)(2009-7#1)
of 208##2##2##(1996-1#1)(2008-10#1)
of 21 patients##2##3##(1991-9#1)(2008-7#1)
of 21##28##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-3#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-3#1)
of 210##3##2##(2008-12#1)(2009-5#1)(2012-3#1)
of 2100##2##2##(2007-12#1)(2008-11#1)
of 212##4##2##(1994-3#1)(1996-3#1)(1997-4#1)(1997-7#1)
of 214##3##2##(1993-11#1)(2008-10#1)(2013-8#1)
of 216##2##2##(2008-10#1)(2008-9#1)
of 219##2##2##(2008-10#1)(2013-1#1)
of 22 metallic elements##2##4##(2008-10#2)
of 22##27##2##(1990-11#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-3#1)(1996-2#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of 22%##2##2##(1991-2#1)(2008-7#1)
of 220 patients##2##3##(2012-3#1)(2013-8#1)
of 220##5##2##(2008-10#1)(2008-8#1)(2012-3#1)(2013-8#2)
of 223##2##2##(1994-3#1)(2013-1#1)
of 224##2##2##(1994-1#1)(2008-5#1)
of 225##5##2##(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)
of 226##2##2##(2008-10#1)(2012-2#1)
of 227##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
of 228##3##2##(1993-2#1)(2008-10#1)(2012-3#1)
of 22q11##3##2##(1997-3#2)(2012-12#1)
of 23 and##3##3##(1994-1#1)(2008-10#2)
of 23##30##2##(1990-10#1)(1990-12#1)(1992-9#1)(1994-1#1)(1994-2#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
of 23%##2##2##(1997-4#1)(2010-2#1)
of 230##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
of 233##2##2##(1997-3#1)(2013-1#1)
of 234##3##2##(1994-11#1)(2008-10#1)(2012-2#1)
of 235##2##2##(2008-3#1)(2010-12#1)
of 236##2##2##(2008-8#1)(2011-2#1)
of 237##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
of 238##4##2##(1993-3#1)(1996-2#1)(1997-1#1)(2008-10#1)
of 24 and##2##3##(2008-10#2)
of 24 h##5##3##(1997-2#1)(2008-10#2)(2008-7#1)(2010-11#1)
of 24 kDa##2##3##(2008-10#2)
of 24 patients treated##2##4##(1990-6#1)(2008-7#1)
of 24 patients##5##3##(1990-6#1)(1994-12#1)(2008-7#1)(2009-1#1)(2011-2#1)
of 24 samples per hour##2##5##(2008-10#2)
of 24 samples##3##3##(2008-10#3)
of 24##48##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-9#1)(1997-2#1)(1997-6#1)(2008-10#17)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of 24-h##2##2##(1995-11#1)(2008-10#1)
of 24-hour##2##2##(1996-1#1)(1997-8#1)
of 240##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
of 242##2##2##(2008-10#1)(2013-1#1)
of 245##2##2##(2008-10#1)(2009-7#1)
of 25 and##4##3##(2008-10#3)(2010-1#1)
of 25 cases##2##3##(2010-11#1)(2010-9#1)
of 25 of##2##3##(1994-9#1)(2013-1#1)
of 25 patients who##2##4##(1990-9#1)(1991-6#1)
of 25 patients##3##3##(1990-9#1)(1991-6#1)(2012-3#1)
of 25 samples##2##3##(2008-10#2)
of 25##59##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-1#1)(1994-11#1)(1994-9#1)(1995-2#1)(1997-8#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-9#2)(2012-2#1)(2012-3#3)(2013-1#2)
of 25%##3##2##(1992-2#1)(2008-10#2)
of 25-30##2##2##(2008-11#1)(2012-2#1)
of 25-300##2##2##(2008-10#2)
of 250##17##2##(1994-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-7#3)(2011-2#1)(2012-5#1)
of 255##2##2##(1990-9#1)(2011-2#1)
of 258##3##2##(1992-5#1)(1996-2#1)(1997-2#1)
of 25S rRNA##2##3##(2008-10#1)(2008-8#1)
of 26 in##2##3##(1990-12#1)(2011-2#1)
of 26##23##2##(1990-12#1)(1990-5#1)(1994-6#1)(1995-3#1)(1996-3#1)(2008-10#7)(2008-12#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#2)(2011-1#1)(2011-2#2)(2013-1#1)
of 260##7##2##(1990-8#1)(1996-2#1)(2008-10#3)(2011-1#2)
of 27 kDa and##2##4##(1990-5#1)(2008-10#1)
of 27##23##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-5#1)(2008-10#10)(2010-2#1)(2010-6#1)(2010-8#1)(2013-1#2)
of 272##2##2##(1990-11#1)(2008-10#1)
of 277##2##2##(1990-6#1)(2008-10#1)
of 28 isolates##2##3##(2008-10#2)
of 28##24##2##(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(2008-1#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-7#1)(2010-9#1)(2013-1#3)
of 28%##5##2##(2008-10#2)(2008-3#2)(2008-9#1)
of 280##2##2##(2008-10#1)(2012-3#1)
of 283##2##2##(1993-2#1)(2011-2#1)
of 285##4##2##(1991-12#1)(1997-2#1)(2011-1#1)(2013-1#1)
of 289##2##2##(1992-3#1)(2013-1#1)
of 29 cases##2##3##(1992-12#1)(1996-9#1)
of 29##30##2##(1992-12#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-9#2)(2008-10#15)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-12#1)(2011-2#1)
of 290##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
of 293 cells##5##3##(2008-11#5)
of 293##6##2##(2008-11#6)
of 295##3##2##(2008-10#2)(2013-1#1)
of 29G11##2##2##(1995-2#2)
of 2AID##2##2##(2008-5#2)
of 2D and 3D##2##4##(2010-12#2)
of 2D##6##2##(1994-5#1)(1996-9#1)(2008-3#1)(2010-12#2)(2012-12#1)
of 2M##3##2##(2008-10#3)
of 2b was##2##3##(1996-5#1)(2008-10#1)
of 2ml##2##2##(2008-10#2)
of 2x10(-5)##2##2##(2008-10#2)
of 2x10(-6)##2##2##(2008-10#2)
of 2x10(-9)##2##2##(2008-10#2)
of 3 and 5##2##4##(2008-10#1)(2013-1#1)
of 3 and##5##3##(2008-10#4)(2013-1#1)
of 3 clinical##2##3##(1990-2#1)(2011-2#1)
of 3 h##2##3##(1997-2#1)(2008-10#1)
of 3 min##3##3##(2008-10#3)
of 3 mm##3##3##(1997-8#1)(2008-3#1)(2013-1#1)
of 3 or 5##2##4##(2008-10#1)(2013-1#1)
of 3 or##3##3##(1993-1#1)(2008-10#1)(2013-1#1)
of 3 to 5##2##4##(2008-4#1)(2010-1#1)
of 3 to##3##3##(2008-10#1)(2008-4#1)(2010-1#1)
of 3 weeks##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
of 3 x##4##3##(1994-11#1)(2008-10#1)(2008-12#1)(2009-7#1)
of 3 years##5##3##(1994-9#1)(2008-10#4)
of 3##243##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#5)(1993-11#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2007-12#1)(2008-10#150)(2008-11#5)(2008-12#4)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-1#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#6)(2013-8#1)
of 3%##7##2##(1993-1#1)(2008-10#4)(2010-4#1)(2012-3#1)
of 3'##2##2##(1994-11#1)(2008-8#1)
of 3)##3##2##(2008-10#2)(2012-2#1)
of 3-##2##2##(2008-5#1)(2008-9#1)
of 3-4%##3##2##(1990-6#1)(1996-12#1)(2008-10#1)
of 3-5##2##2##(1995-12#1)(2012-3#1)
of 3-methyl-2-benzothiazolinone hydrazone (MBTH)##2##4##(2008-10#2)
of 3-methyl-2-benzothiazolinone hydrazone with##3##4##(2008-10#3)
of 3-methyl-2-benzothiazolinone hydrazone##5##3##(2008-10#5)
of 3-methylcholanthrene##2##2##(2008-11#2)
of 30 FNABs##2##3##(2011-1#2)
of 30 and##4##3##(1991-8#1)(2008-10#3)
of 30 h(-1)##4##3##(2008-10#4)
of 30 healthy subjects##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
of 30 in##2##3##(1993-9#1)(2009-10#1)
of 30 kDa##2##3##(1995-6#1)(2013-1#1)
of 30 mV per decade##2##5##(2008-10#2)
of 30 min##6##3##(1993-1#1)(1994-8#1)(2008-10#4)
of 30 months##2##3##(1997-8#1)(2009-3#1)
of 30 or more on the##2##6##(1992-1#2)
of 30 patients with##2##4##(2011-2#1)(2013-1#1)
of 30 patients##5##3##(1990-8#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
of 30 samples per h##2##5##(2008-10#2)
of 30 samples per##3##4##(2008-10#3)
of 30 samples##4##3##(2008-10#4)
of 30 to##3##3##(2008-10#1)(2008-11#2)
of 30 years##2##3##(1997-3#1)(2008-7#1)
of 30##95##2##(1990-3#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#3)(1993-1#2)(1993-9#1)(1994-1#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-8#4)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-3#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#4)
of 30%##7##2##(1996-9#1)(2008-10#3)(2008-3#1)(2010-12#1)(2011-2#1)
of 30-40##2##2##(2008-10#1)(2010-4#1)
of 300 patients##2##3##(1993-6#1)(2008-11#1)
of 300##22##2##(1990-9#1)(1991-6#1)(1993-6#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2013-1#1)
of 3000##2##2##(1990-8#1)(2008-9#1)
of 303##2##2##(2008-5#1)(2010-12#1)
of 304##3##2##(1992-9#1)(1997-2#1)(2008-11#1)
of 307##3##2##(2008-10#1)(2008-5#2)
of 30h(-1)##2##2##(2008-10#2)
of 31##11##2##(1990-5#1)(2008-10#7)(2008-3#1)(2008-5#1)(2011-2#1)
of 311##3##2##(2008-11#1)(2008-12#1)(2009-5#1)
of 312##4##2##(2008-10#2)(2010-4#1)(2011-2#1)
of 317##3##2##(1991-7#1)(2012-2#2)
of 32 months##2##3##(2008-1#1)(2011-2#1)
of 32 patients who underwent##2##5##(1996-3#2)
of 32 patients##3##3##(1995-2#1)(1996-3#2)
of 32 years##2##3##(2008-7#1)(2013-1#1)
of 32##24##2##(1991-5#1)(1991-6#1)(1995-2#1)(1996-3#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of 32PO4(3-)##2##2##(1996-2#2)
of 33 patients##2##3##(1991-9#1)(2008-7#1)
of 33##21##2##(1991-9#1)(1995-10#1)(1995-6#1)(2008-1#1)(2008-10#10)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#1)(2012-3#1)
of 330##3##2##(1991-11#2)(2008-10#1)
of 331 patients##2##3##(1990-2#1)(1990-9#1)
of 333##4##2##(1994-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
of 334##2##2##(2008-10#1)(2008-9#1)
of 336##2##2##(1993-12#1)(2010-1#1)
of 339##3##2##(1991-2#1)(2008-10#1)(2009-5#1)
of 34##15##2##(1990-5#1)(2008-10#7)(2008-2#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#2)
of 347##2##2##(1993-12#1)(1997-6#1)
of 35 amino acid##2##4##(1997-4#1)(2008-6#1)
of 35 and##3##3##(1995-6#1)(2008-10#2)
of 35 patients##4##3##(1990-9#1)(1991-3#1)(2008-9#1)(2011-2#1)
of 35##31##2##(1990-9#1)(1991-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#13)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#2)
of 35%##2##2##(2007-12#1)(2008-11#1)
of 350 cases##2##3##(2010-7#2)
of 350##8##2##(1996-12#1)(2008-10#2)(2008-12#1)(2010-7#3)(2013-1#1)
of 355##2##2##(2008-10#1)(2012-2#1)
of 357##2##2##(1995-6#1)(2008-1#1)
of 358##2##2##(1990-11#1)(2008-12#1)
of 359 amino##2##3##(1991-5#1)(1992-3#1)
of 36 patients##3##3##(1995-10#1)(2008-7#1)(2011-2#1)
of 36##29##2##(1990-12#1)(1993-2#1)(1994-2#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-5#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#5)(2012-2#1)
of 36%##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
of 360##8##2##(1990-9#1)(1993-8#1)(1996-2#1)(2008-10#5)
of 363##2##2##(1991-11#1)(1994-11#1)
of 37 degrees C##3##4##(2008-10#2)(2008-11#1)
of 37##19##2##(1990-2#1)(1990-5#1)(1991-5#1)(1993-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2010-6#1)(2012-3#3)(2013-8#1)
of 37%##2##2##(1992-2#1)(2008-10#1)
of 372##2##2##(2010-8#1)(2013-8#1)
of 375##2##2##(1992-3#1)(1997-7#1)
of 38##23##2##(1993-1#1)(1994-1#4)(1994-3#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
of 382##2##2##(1996-6#1)(2008-7#1)
of 386##2##2##(2008-10#2)
of 39 kDa##2##3##(2008-5#2)
of 39##13##2##(1991-6#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2009-8#1)(2012-2#1)(2013-1#1)
of 390##2##2##(2008-10#2)
of 391##2##2##(1996-12#1)(1997-8#1)
of 399##2##2##(2008-5#2)
of 3D interaction position##2##4##(2010-3#2)
of 3D##8##2##(1995-11#1)(2010-3#4)(2010-8#1)(2011-2#1)(2012-3#1)
of 3H-thymidine incorporation##2##3##(1991-6#1)(1995-3#1)
of 3H-thymidine##4##2##(1991-6#1)(1995-3#2)(2008-7#1)
of 3beta-HSD deficiency##3##3##(2008-4#3)
of 4 M##4##3##(2008-10#4)
of 4 and##2##3##(2008-10#1)(2008-11#1)
of 4 cases##2##3##(1990-6#1)(2013-1#1)
of 4 degrees C##2##4##(1996-12#1)(2007-12#1)
of 4 different##2##3##(1991-3#1)(1996-2#1)
of 4 h##3##3##(1996-2#1)(2008-10#2)
of 4 months##2##3##(1995-12#1)(2008-10#1)
of 4 mug l(-1)##2##4##(2008-10#2)
of 4 mug##3##3##(2008-10#3)
of 4 patients##2##3##(1997-7#1)(2008-7#1)
of 4 to 5##2##4##(2008-10#1)(2012-12#1)
of 4 to##6##3##(1996-5#1)(2008-10#3)(2012-12#2)
of 4 weeks##2##3##(2008-10#2)
of 4 years##2##3##(1994-12#1)(2009-8#1)
of 4##181##2##(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-3#4)(1991-5#1)(1991-8#1)(1992-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#93)(2008-11#9)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-5#8)(2010-6#1)(2011-2#5)(2012-12#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#3)
of 4%##3##2##(2008-10#3)
of 4'-chemistry##3##2##(1991-3#3)
of 4-(2-pyridylazo)resorcinol (PAR)##3##3##(2008-10#3)
of 4-4-20##2##2##(1992-6#2)
of 4-6##4##2##(1995-11#1)(2008-11#1)(2008-3#1)(2013-1#1)
of 4-NP##3##2##(2008-10#3)
of 4-amino-2##3##2##(1994-5#3)
of 4-aminophenol##5##2##(2008-10#5)
of 4-nitrophenol##4##2##(2008-10#4)
of 4-week-old##2##2##(1995-12#1)(2008-10#1)
of 40 cases##3##3##(2008-10#2)(2009-4#1)
of 40 h(-1)##3##3##(2008-10#3)
of 40 kDa##2##3##(1993-1#1)(1993-8#1)
of 40 mg##2##3##(2010-12#1)(2011-2#1)
of 40 mul s(-1)##2##4##(2008-10#2)
of 40 patients with##2##4##(1990-2#1)(2013-1#1)
of 40 patients##5##3##(1990-2#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-1#1)
of 40 samples per hour##3##5##(2008-10#3)
of 40 samples##4##3##(2008-10#4)
of 40 to##2##3##(2010-12#1)(2012-3#1)
of 40 years##4##3##(2008-5#2)(2008-9#1)(2013-1#1)
of 40##69##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-8#1)(1995-8#2)(1996-2#3)(1997-8#1)(2008-10#25)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#6)
of 40% of##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
of 40%##7##2##(1991-5#1)(2008-10#3)(2008-3#1)(2010-4#1)(2011-2#1)
of 40)##2##2##(2008-10#1)(2011-2#1)
of 400 and 800##2##4##(2008-10#1)(2008-9#1)
of 400 and##4##3##(2008-10#3)(2008-9#1)
of 400##15##2##(1994-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-9#3)(2013-1#1)
of 408##2##2##(1993-2#1)(2012-2#1)
of 40h(-1)##3##2##(2008-10#3)
of 41##13##2##(1990-8#1)(1991-12#1)(1994-12#1)(1996-11#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
of 410##2##2##(1996-11#1)(2008-10#1)
of 411##2##2##(2008-10#1)(2010-7#1)
of 42##21##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#5)(2013-1#2)
of 42%##2##2##(1993-3#1)(2008-10#1)
of 420##2##2##(1996-2#1)(1997-2#1)
of 421##2##2##(1991-8#1)(2013-1#1)
of 426##2##2##(2008-8#1)(2009-7#1)
of 429##2##2##(1992-3#1)(2012-12#1)
of 43##14##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
of 44##6##2##(1990-5#1)(1995-12#1)(2008-10#3)(2008-12#1)
of 44%##2##2##(2008-10#1)(2008-5#1)
of 440##2##2##(2008-10#1)(2008-11#1)
of 45 samples per##2##4##(2008-10#2)
of 45##32##2##(1990-8#1)(1993-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
of 450##2##2##(1990-5#1)(1997-2#1)
of 46 patients##4##3##(1990-2#1)(1991-3#1)(1992-1#1)(2011-2#1)
of 46##18##2##(1990-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-8#1)(1994-2#1)(1996-9#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
of 460##4##2##(2008-10#3)(2008-3#1)
of 469##3##2##(1993-12#1)(1994-12#1)(2008-10#1)
of 47##9##2##(1991-12#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#5)
of 474##3##2##(1997-4#1)(2008-9#1)(2013-1#1)
of 48 months##3##3##(1992-12#1)(2008-8#1)(2012-12#1)
of 48##16##2##(1991-2#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)
of 48)##2##2##(2008-12#2)
of 480##2##2##(2008-10#1)(2011-2#1)
of 481##2##2##(1991-2#1)(2013-8#1)
of 488##2##2##(2008-12#1)(2008-2#1)
of 49##5##2##(2008-10#2)(2008-11#1)(2012-2#1)(2013-7#1)
of 49%##2##2##(2008-12#1)(2009-5#1)
of 490##3##2##(2008-10#2)(2008-5#1)
of 493##2##2##(1996-6#1)(1996-9#1)
of 497##2##2##(2008-10#1)(2008-7#1)
of 4q32→q35##2##2##(2012-3#2)
of 5 and 10##2##4##(1995-2#1)(2008-10#1)
of 5 and##7##3##(1991-3#1)(1995-2#1)(2007-12#1)(2008-10#2)(2012-12#1)(2013-1#1)
of 5 containing an##2##4##(1996-5#2)
of 5 degrees##3##3##(2008-10#2)(2009-8#1)
of 5 mM##2##3##(1997-1#1)(2008-10#1)
of 5 mg##3##3##(2008-10#2)(2011-2#1)
of 5 min##6##3##(1997-2#1)(2008-10#5)
of 5 mug l(-1)##2##4##(2008-10#2)
of 5 to 20##2##4##(2008-10#1)(2008-5#1)
of 5 to##3##3##(2008-10#2)(2008-5#1)
of 5 with##3##3##(1996-5#3)
of 5 x##8##3##(1994-5#2)(1996-12#1)(2008-10#3)(2008-3#1)(2008-7#1)
of 5 years##4##3##(1992-6#1)(1997-2#1)(1997-3#1)(2008-7#1)
of 5##207##2##(1990-11#5)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#7)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#106)(2008-11#3)(2008-12#2)(2008-3#7)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-1#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
of 5% to##2##3##(2008-8#1)(2010-1#1)
of 5%##16##2##(1993-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2013-1#1)
of 5'##5##2##(1995-2#1)(2008-8#2)(2008-9#2)
of 5'-flanking##2##2##(1991-7#1)(1994-2#1)
of 5-10##2##2##(2008-10#2)
of 5-15%##2##2##(2008-10#1)(2013-1#1)
of 5-2-1-AN##2##2##(2010-8#2)
of 5-FU##3##2##(1993-8#2)(2008-11#1)
of 5-HIAA##2##2##(1992-1#1)(2008-10#1)
of 5-HT and##2##3##(1994-2#1)(2008-7#1)
of 5-HT fibers##2##3##(1996-12#2)
of 5-HT in##2##3##(1990-5#1)(2008-6#1)
of 5-HT transporter##2##3##(2008-7#2)
of 5-HT##19##2##(1990-5#2)(1993-3#2)(1994-2#2)(1996-12#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)
of 5-HT1A##2##2##(1993-3#1)(1994-2#1)
of 5-HT4##2##2##(1996-12#2)
of 5-VOT is##4##3##(2008-10#4)
of 5-VOT##5##2##(2008-10#5)
of 5-alpha-reductase##2##2##(1990-11#1)(2008-5#1)
of 5-azacitidine##2##2##(2011-2#2)
of 5-fluorouracil##2##2##(1992-2#2)
of 5-fluorouridine##2##2##(1993-8#2)
of 5-methyltetrahydrofolate##4##2##(1994-6#4)
of 5-methylthioninhydrin##2##2##(2012-2#2)
of 5-sulfosalicylic acid (SSA)##2##4##(2008-10#2)
of 50 and 60 kDa##2##5##(2008-10#2)
of 50 and##4##3##(1995-6#1)(2008-10#3)
of 50 is##2##3##(2008-10#1)(2008-5#1)
of 50 mV##2##3##(2008-10#2)
of 50 mg##7##3##(1990-11#1)(1991-11#1)(1994-8#1)(2008-10#3)(2008-11#1)
of 50 microg l(-1)##2##4##(2008-10#2)
of 50 mug l(-1) of##2##5##(2008-10#2)
of 50 mug l(-1)##3##4##(2008-10#3)
of 50 ppm##2##3##(2008-11#1)(2008-5#1)
of 50##81##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#2)(1993-3#1)(1993-9#1)(1994-12#3)(1994-8#2)(1995-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#42)(2008-11#3)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
of 50% and##2##3##(1994-5#1)(1995-11#1)
of 50% in##2##3##(1994-6#1)(2008-7#1)
of 50% were##2##3##(2008-3#1)(2013-1#1)
of 50%##12##2##(1990-6#1)(1994-5#2)(1994-6#1)(1995-11#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
of 50-100##3##2##(2008-10#2)(2008-5#1)
of 50-1000##3##2##(2008-10#3)
of 50-150##2##2##(1993-12#1)(2010-6#1)
of 50-60##2##2##(2008-10#2)
of 50-mum##2##2##(2008-10#1)(2008-2#1)
of 500 and##2##3##(1995-8#1)(2008-10#1)
of 500 mg##4##3##(2008-10#3)(2011-2#1)
of 500 nM##2##3##(1991-5#1)(1996-2#1)
of 500 patients##2##3##(1991-3#1)(1995-10#1)
of 500##24##2##(1990-3#1)(1991-3#1)(1991-5#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-2#2)(2008-10#10)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
of 5000##4##2##(1991-12#1)(2008-11#2)(2008-7#1)
of 500ml##2##2##(2008-10#2)
of 501##2##2##(1995-8#1)(2008-10#1)
of 509 disc excisions in 476##2##6##(2008-7#2)
of 509##3##2##(2008-10#1)(2008-7#2)
of 51##12##2##(1990-9#1)(1994-12#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2012-3#1)
of 516##3##2##(1993-1#1)(2008-12#1)(2011-2#1)
of 52 patients##3##3##(1997-5#1)(2008-7#2)
of 52 samples##2##3##(2008-10#2)
of 52##16##2##(1990-12#1)(1993-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-10#7)(2008-7#2)(2010-12#1)(2013-1#1)
of 525##2##2##(2008-10#1)(2011-2#1)
of 528##2##2##(2008-11#1)(2012-3#1)
of 53 patients who had##2##5##(1994-3#1)(2011-2#1)
of 53 patients##3##3##(1994-3#1)(2011-2#2)
of 53##13##2##(1991-8#1)(1993-2#1)(1994-3#1)(1997-8#3)(2008-10#2)(2008-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
of 54 and##2##3##(2008-10#1)(2008-11#1)
of 54##12##2##(1993-2#1)(1996-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-10#1)
of 540##2##2##(2008-10#1)(2009-5#1)
of 543##2##2##(1997-7#1)(2008-10#1)
of 55##14##2##(1990-11#2)(1991-11#1)(1995-3#1)(1996-6#1)(2008-10#6)(2008-3#1)(2008-6#1)(2009-10#1)
of 550##2##2##(1992-1#1)(2008-9#1)
of 56##13##2##(1994-11#1)(1997-8#1)(2008-10#8)(2008-12#1)(2012-3#1)(2013-8#1)
of 57##7##2##(2008-10#4)(2008-7#1)(2012-3#1)(2013-1#1)
of 57%##2##2##(2008-10#1)(2012-3#1)
of 58##10##2##(1990-8#1)(1991-11#1)(1996-12#1)(2008-10#5)(2012-3#1)(2013-1#1)
of 59##16##2##(1990-5#1)(1991-6#1)(1993-9#2)(1996-12#1)(2008-10#7)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#1)
of 595##2##2##(1993-12#1)(2008-10#1)
of 5FU##2##2##(1992-2#2)
of 5alphaR##3##2##(2008-5#3)
of 5mgl(-1)##2##2##(2008-10#2)
of 5mul##2##2##(2008-10#2)
of 5x10(-6)##2##2##(2008-10#2)
of 5x10(-7)##2##2##(2008-10#2)
of 6 M##3##3##(2008-10#3)
of 6 and 8##2##4##(1991-3#1)(2008-10#1)
of 6 and##4##3##(1991-3#1)(2008-10#3)
of 6 cases##2##3##(1990-6#2)
of 6 min##2##3##(1994-3#1)(1997-7#1)
of 6 months##3##3##(2008-10#3)
of 6 nm##2##3##(1990-11#1)(2008-10#1)
of 6 patients##2##3##(1992-3#1)(1997-3#1)
of 6 weeks##3##3##(2008-11#2)(2008-7#1)
of 6##107##2##(1990-11#1)(1990-12#1)(1990-6#3)(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#57)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#2)(2009-5#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
of 6%##2##2##(2008-10#2)
of 6-APA##4##2##(2008-12#4)
of 6-MP##3##2##(2008-10#3)
of 6-hydroxydopamine##2##2##(1993-3#1)(2008-7#1)
of 6-keto-PGF1 alpha##2##3##(1994-5#1)(1995-11#1)
of 6-mercaptopurine##4##2##(2008-10#4)
of 60 Gy##2##3##(2008-7#1)(2011-2#1)
of 60 h(-1) were achieved##2##5##(2008-10#2)
of 60 h(-1)##6##3##(2008-10#6)
of 60 kDa##2##3##(1997-2#2)
of 60 min##2##3##(1994-5#1)(2008-6#1)
of 60 ml##2##3##(2008-10#2)
of 60 s##4##3##(2008-10#3)(2008-7#1)
of 60 samples##2##3##(2008-10#2)
of 60##54##2##(1991-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1997-2#2)(2008-10#29)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#5)(2012-2#1)
of 60% of the##2##4##(2008-10#1)(2008-7#1)
of 60% of##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
of 60%##5##2##(2008-10#2)(2008-7#1)(2010-7#1)(2011-2#1)
of 600##5##2##(1991-6#1)(1996-1#1)(2008-10#2)(2012-3#1)
of 605##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
of 61##5##2##(1990-8#1)(1992-3#1)(2008-10#1)(2009-9#1)(2011-2#1)
of 62##11##2##(1991-8#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2011-3#1)(2012-2#1)(2013-1#2)
of 62%##2##2##(2008-3#1)(2008-5#1)
of 627##2##2##(1996-8#1)(2010-10#1)
of 63##12##2##(1994-1#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of 64##10##2##(1993-1#1)(1993-2#1)(1994-11#2)(1994-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
of 65##14##2##(1990-3#1)(1991-3#1)(1993-2#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
of 65%##3##2##(2008-10#2)(2010-7#1)
of 650##2##2##(2008-10#1)(2008-9#1)
of 66##8##2##(1990-11#1)(1994-6#1)(1997-7#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#2)
of 660##2##2##(2008-8#1)(2012-2#1)
of 67##8##2##(1991-3#1)(1996-9#1)(2008-10#2)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
of 67%##2##2##(2008-7#1)(2009-4#1)
of 68 kDa##3##3##(1994-5#2)(1995-12#1)
of 68 patients##2##3##(1990-2#1)(1991-8#1)
of 68##12##2##(1990-2#2)(1991-8#1)(1991-9#1)(1994-5#2)(1995-12#1)(1996-12#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
of 69##7##2##(1997-1#1)(2008-10#3)(2010-10#1)(2010-8#1)(2011-1#1)
of 696-nm##2##2##(2008-3#2)
of 6ml##2##2##(2008-10#2)
of 7 alpha-methyl-19-nortestosterone##2##3##(1990-11#2)
of 7 and##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
of 7 days##3##3##(2008-12#2)(2008-8#1)
of 7 of##2##3##(2008-10#1)(2009-3#1)
of 7 patients##3##3##(2010-12#2)(2011-2#1)
of 7 to##2##3##(1994-2#1)(2008-10#1)
of 7 was##2##3##(1994-5#1)(2008-10#1)
of 7##85##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-6#1)(1996-2#2)(1997-2#1)(2007-11#1)(2008-10#37)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
of 7%##3##2##(1990-12#1)(2008-1#1)(2008-10#1)
of 70##11##2##(1990-2#1)(1996-3#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-8#1)
of 70%##3##2##(2008-10#2)(2008-7#1)
of 700##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
of 71##5##2##(1990-11#1)(1993-8#1)(2008-10#2)(2008-8#1)
of 71%##2##2##(2008-3#1)(2010-8#1)
of 72##9##2##(1991-2#1)(1994-1#1)(1995-6#1)(1996-8#1)(1997-6#1)(2008-10#3)(2008-8#1)
of 720##2##2##(2008-10#2)
of 73##2##2##(1991-11#1)(2008-10#1)
of 74##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
of 75##16##2##(1991-2#1)(1994-2#1)(1994-9#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
of 75%##2##2##(2008-10#1)(2008-9#1)
of 76 patients##2##3##(1991-8#1)(2011-2#1)
of 76##7##2##(1991-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
of 76%##2##2##(2008-10#1)(2013-1#1)
of 77##8##2##(1990-3#1)(1993-9#1)(1994-11#1)(1995-9#1)(2008-1#1)(2008-10#2)(2011-1#1)
of 78##10##2##(1991-12#1)(1991-3#1)(1995-6#1)(2007-8#1)(2008-10#3)(2009-7#1)(2010-8#1)(2013-1#1)
of 78%##2##2##(1993-2#1)(2008-10#1)
of 79##3##2##(1996-12#1)(2008-10#2)
of 7MENT##2##2##(1990-11#2)
of 8 mg/kg##2##3##(1991-6#1)(1996-2#1)
of 8 months##5##3##(1994-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
of 8 patients##2##3##(2011-2#2)
of 8 to##3##3##(1991-12#1)(2008-10#1)(2010-1#1)
of 8 x##2##3##(2008-10#1)(2008-3#1)
of 8 years##2##3##(1991-11#1)(2009-3#1)
of 8##87##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-6#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(2008-1#2)(2008-10#34)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#3)(2009-4#1)(2009-5#1)(2010-1#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
of 8%##2##2##(1993-11#1)(2008-3#1)
of 8-OH-DPAT##2##2##(1993-3#1)(1994-2#1)
of 8-oxo-7##2##2##(2008-10#2)
of 8-oxoGua and 8-oxodGuo in##2##5##(2008-10#2)
of 8-oxoGua##3##2##(2008-10#3)
of 80 kDa##2##3##(1992-6#1)(1995-8#1)
of 80##19##2##(1992-6#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
of 800##6##2##(1990-8#1)(2008-10#2)(2008-3#2)(2011-7#1)
of 81##9##2##(1991-9#1)(1993-8#1)(1996-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)
of 82##10##2##(1992-7#1)(1995-6#2)(1996-12#2)(1997-8#1)(2008-10#2)(2008-11#1)(2012-3#1)
of 82%##3##2##(1995-2#1)(2008-3#1)(2013-1#1)
of 83##7##2##(2008-10#4)(2008-2#1)(2011-1#1)(2011-2#1)
of 84##9##2##(1990-11#1)(1994-3#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of 85##8##2##(1996-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-5#1)(2012-2#1)
of 85%##3##2##(1993-3#1)(2008-10#1)(2008-8#1)
of 86##6##2##(1991-11#1)(1991-12#1)(2008-10#3)(2008-3#1)
of 87##6##2##(1991-6#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
of 88##4##2##(1996-6#1)(2008-10#1)(2008-12#1)(2010-1#1)
of 88%##2##2##(1992-3#2)
of 89##2##2##(2008-10#2)
of 89%##2##2##(2008-11#1)(2012-12#1)
of 8x10(-9) to##2##3##(2008-10#2)
of 9 and##3##3##(2008-10#2)(2013-1#1)
of 9 months##2##3##(2009-10#1)(2010-8#1)
of 9##51##2##(1990-6#1)(1990-8#1)(1991-6#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#19)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#3)(2013-1#2)
of 90 and##3##3##(1996-12#1)(2008-10#2)
of 90 h(-1) was##2##4##(2008-10#2)
of 90 h(-1)##5##3##(2008-10#5)
of 90 to##2##3##(2008-10#1)(2008-7#1)
of 90##25##2##(1990-8#1)(1996-12#1)(2008-1#1)(2008-10#17)(2008-3#1)(2008-7#3)(2012-3#1)
of 90%##7##2##(1990-2#1)(1993-2#2)(1997-6#1)(2008-10#2)(2008-8#1)
of 91##7##2##(2008-10#4)(2008-8#1)(2012-3#2)
of 92##6##2##(1997-8#1)(2008-10#3)(2008-9#1)(2012-2#1)
of 921##2##2##(2009-7#1)(2013-8#1)
of 93-100%##2##2##(2008-1#1)(2008-10#1)
of 94##6##2##(1997-8#1)(2008-10#3)(2008-8#1)(2010-2#1)
of 95##9##2##(1996-2#1)(1997-8#1)(2008-10#5)(2008-2#1)(2011-2#1)
of 95% of the##2##4##(2008-10#1)(2010-8#1)
of 95%##8##2##(1997-8#1)(2008-10#5)(2010-8#1)(2013-1#1)
of 951##2##2##(1992-10#1)(2009-7#1)
of 96 ppm##2##3##(2008-10#2)
of 96##11##2##(2008-10#8)(2008-3#1)(2010-7#1)(2012-2#1)
of 97##9##2##(1996-6#1)(2008-10#5)(2008-12#1)(2010-6#1)(2012-3#1)
of 98##8##2##(2008-10#5)(2008-12#1)(2008-7#1)(2011-2#1)
of 98%##6##2##(1996-9#1)(2008-10#4)(2011-2#1)
of 99 patients##2##3##(2008-1#1)(2013-1#1)
of 99##15##2##(1991-9#1)(2008-1#1)(2008-10#11)(2012-2#1)(2013-1#1)
of 99%##2##2##(1990-9#1)(2008-10#1)
of A beta##6##3##(1994-11#4)(1996-2#2)
of A##97##2##(1991-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#4)(1994-3#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-4#1)(1997-8#1)(2008-10#65)(2008-12#2)(2008-7#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
of A(549)##2##2##(2008-9#2)
of A-type lamins##2##3##(2011-2#2)
of A1##5##2##(1990-5#1)(2008-10#3)(2008-11#1)
of A2 and##3##3##(1996-2#2)(2008-10#1)
of A2##4##2##(1996-2#2)(2008-10#2)
of A20##3##2##(1992-7#3)
of A23187##2##2##(1992-6#1)(1994-3#1)
of A511##2##2##(2012-2#2)
of A549 specific##2##3##(2008-11#2)
of A549##3##2##(2008-11#3)
of AA and DA##3##4##(2008-10#3)
of AA and##4##3##(1993-3#1)(2008-10#3)
of AA in##7##3##(1992-12#2)(2008-10#5)
of AA was##3##3##(2008-10#3)
of AA##26##2##(1992-12#3)(1993-3#2)(1993-8#1)(1997-2#1)(2008-10#19)
of AAA##2##2##(2010-12#1)(2013-1#1)
of AANAT##2##2##(2008-5#2)
of AAPCC##2##2##(1993-3#2)
of ABA biosynthesis##2##3##(2008-8#1)(2009-6#1)
of ABA in##2##3##(2008-10#1)(2009-6#1)
of ABA##8##2##(2008-10#1)(2008-8#4)(2009-6#3)
of ABTS##2##2##(2008-10#2)
of ACC##5##2##(1991-11#1)(1993-6#1)(2008-10#2)(2013-1#1)
of ACE##2##2##(1993-12#1)(2008-7#1)
of ACL reconstruction##2##3##(2012-2#1)(2013-1#1)
of ACL##3##2##(1997-8#1)(2012-2#1)(2013-1#1)
of ACLSV##4##2##(2008-10#4)
of ACP##3##2##(1991-11#2)(2013-8#1)
of ACS and ACO enzymes##2##5##(2011-2#2)
of ACS##6##2##(2008-10#1)(2008-3#3)(2011-2#2)
of ACT-toxin##2##2##(2008-10#2)
of ACTH and corticosterone##2##4##(1996-12#2)
of ACTH and##3##3##(1996-12#2)(2011-2#1)
of ACTH##6##2##(1995-12#2)(1996-12#2)(2011-1#1)(2011-2#1)
of AChE molecular forms##2##4##(1990-5#2)
of AChR clusters##2##3##(2009-8#2)
of AChR##3##2##(1997-5#1)(2009-8#2)
of AD patients##2##3##(2008-5#1)(2008-7#1)
of AD##10##2##(1994-11#1)(1995-12#2)(1995-8#1)(1997-2#1)(2008-5#2)(2008-7#2)(2009-10#1)
of ADAM22##3##2##(2008-9#3)
of ADAM29##2##2##(2008-8#2)
of ADAMTS13 in##2##3##(2009-7#2)
of ADAMTS13##3##2##(2009-7#3)
of ADBI##4##2##(2008-10#4)
of ADDTP##2##2##(2008-10#2)
of ADE##3##2##(2008-10#2)(2008-8#1)
of ADH-I was##2##3##(2008-11#2)
of ADH-I##5##2##(2008-11#5)
of ADHD##8##2##(2008-2#4)(2008-9#1)(2009-9#1)(2011-2#2)
of ADK##4##2##(2009-8#4)
of ADP and ATP##2##4##(2013-1#2)
of ADP and##5##3##(2006-6#2)(2008-5#1)(2013-1#2)
of ADP##8##2##(1991-9#2)(2006-6#3)(2008-5#1)(2013-1#2)
of ADR cases##2##3##(2011-2#2)
of ADR##9##2##(1990-2#2)(1993-12#1)(1997-7#1)(2011-2#5)
of ADR/AE following##2##3##(2011-2#2)
of ADR/AE##10##2##(2011-2#10)
of ADRs caused by##2##4##(2011-2#2)
of ADRs##5##2##(2011-2#5)
of ADSCs##2##2##(2012-3#2)
of ADT procedure##2##3##(2012-2#2)
of ADT##3##2##(2012-2#3)
of AE6F4 antibody on 14-3-3##2##5##(2008-11#2)
of AE6F4 antibody##3##3##(2008-11#3)
of AF tissue##2##3##(2012-2#2)
of AF##11##2##(1997-2#1)(2010-12#3)(2011-2#1)(2012-12#4)(2012-2#2)
of AFLP data##2##3##(2008-10#2)
of AFLP markers##2##3##(2008-10#2)
of AFLP##8##2##(2008-10#8)
of AFM##3##2##(2008-10#2)(2008-4#1)
of AFP mRNA##3##3##(2008-10#3)
of AFP##6##2##(2008-10#5)(2008-8#1)
of AFP-27##2##2##(2008-11#2)
of AG-1##4##2##(2008-10#4)
of AG-12##4##2##(2008-10#4)
of AG-13##6##2##(2008-10#6)
of AG-2##6##2##(2008-10#6)
of AG-4##2##2##(2008-10#2)
of AG-G##2##2##(2008-10#2)
of AG-MIN##2##2##(2008-10#2)
of AH##2##2##(1993-8#1)(2009-7#1)
of AH109A invasion##3##3##(2008-11#3)
of AH109A##18##2##(2008-11#18)
of AHL-inactivating##2##2##(2008-9#2)
of AHO##3##2##(2010-6#2)(2011-1#1)
of AI##2##2##(2011-1#1)(2013-1#1)
of AI-2##2##2##(2009-6#2)
of AID##5##2##(2011-2#5)
of AIDS and##4##3##(1992-2#1)(1993-9#1)(2008-9#1)(2010-1#1)
of AIDS in##3##3##(1993-3#1)(1997-6#2)
of AIDS incidence data##2##4##(1994-9#2)
of AIDS incidence##3##3##(1992-9#1)(1994-9#2)
of AIDS volunteers is##2##4##(1993-12#1)(1994-3#1)
of AIDS volunteers##3##3##(1993-12#1)(1994-3#2)
of AIDS##47##2##(1990-12#1)(1990-3#3)(1990-6#1)(1991-12#1)(1992-2#1)(1992-9#5)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-3#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#3)(1996-11#1)(1996-2#1)(1996-3#1)(1997-6#9)(2008-10#1)(2008-5#3)(2008-9#2)(2010-1#1)(2011-3#2)
of AIDS-related##2##2##(1997-6#1)(2009-6#1)
of AIDS/HIV##2##2##(1995-1#2)
of AIII##2##2##(1994-2#2)
of AKT##3##2##(2008-10#2)(2013-1#1)
of ALM in situ##2##4##(2010-6#2)
of ALM##4##2##(2010-6#4)
of ALP##2##2##(2008-10#1)(2008-11#1)
of AM##5##2##(2008-10#1)(2008-11#1)(2011-2#3)
of AMD##3##2##(2011-2#3)
of AMD3100##4##2##(2008-7#4)
of AMF##2##2##(2008-8#2)
of AMG 517##3##3##(2010-2#3)
of AMI##2##2##(1992-3#1)(2008-10#1)
of AML##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
of AML1/ETO fusion gene in##2##5##(2008-10#2)
of AMP##2##2##(2008-11#1)(2008-9#1)
of AMPA receptor subunit##2##4##(1993-12#1)(2008-7#1)
of AMPA##4##2##(1993-12#1)(1996-2#1)(2008-7#1)(2008-8#1)
of AMV##2##2##(2008-10#2)
of ANA##2##2##(1991-2#2)
of ANG II##3##3##(1991-5#1)(1994-8#2)
of ANG##5##2##(1991-5#2)(1994-8#3)
of ANN##6##2##(2008-10#5)(2010-8#1)
of ANNs for##2##3##(2008-10#2)
of ANNs##4##2##(2008-10#4)
of ANP and BNP##3##4##(1991-5#2)(2009-5#1)
of ANP##4##2##(1991-5#2)(2009-5#2)
of ANS##2##2##(1991-9#1)(2013-8#1)
of AOM##3##2##(1993-11#2)(2011-2#1)
of AOX protein##2##3##(2008-9#2)
of AOX##4##2##(2008-9#3)(2009-8#1)
of AP##9##2##(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#2)(2013-1#4)
of AP-1 complexes##2##3##(1995-12#1)(1996-2#1)
of AP-1##8##2##(1992-8#1)(1995-12#1)(1996-2#3)(2008-11#1)(2008-9#2)
of APP and APLP2 mRNA##2##5##(1996-12#2)
of APP and APLP2##3##4##(1996-12#3)
of APP in##2##3##(1992-12#1)(1995-12#1)
of APP processing##2##3##(1992-12#1)(1996-12#1)
of APP##15##2##(1992-12#4)(1994-11#1)(1995-12#1)(1996-12#7)(2008-11#2)
of APS##6##2##(2008-10#4)(2009-8#2)
of AR and##2##3##(2011-2#1)(2012-12#1)
of AR mRNA##2##3##(1995-12#2)
of AR root##2##3##(2008-10#2)
of AR##12##2##(1990-11#2)(1995-12#4)(2008-10#3)(2008-8#1)(2011-2#1)(2012-12#1)
of AR-mediated cardiac hypertrophy##3##4##(2010-12#3)
of ARDS##2##2##(1993-2#1)(2009-5#1)
of ARF18##5##2##(2008-10#5)
of ARM and##3##3##(1994-8#3)
of ARM in##3##3##(2011-2#3)
of ARM##12##2##(1994-8#3)(2011-2#9)
of ARMD and##2##3##(2011-2#2)
of ARMD is##3##3##(2011-2#3)
of ARMD##8##2##(2011-2#8)
of ARP1##2##2##(2008-9#2)
of ARS##3##2##(2008-10#3)
of ART in##2##3##(1992-2#1)(2011-2#1)
of AS##3##2##(2008-10#2)(2013-8#1)
of ASA and##3##3##(2008-10#3)
of ASA##5##2##(2008-10#5)
of ASCs in##2##3##(2012-4#2)
of ASCs##3##2##(1997-1#1)(2012-4#2)
of ASD##9##2##(2008-11#1)(2011-2#1)(2012-12#2)(2012-3#5)
of ASP##2##2##(2013-1#2)
of ASPs##3##2##(2013-1#3)
of ASY##3##2##(2008-8#1)(2008-9#2)
of AT##2##2##(1993-8#1)(2008-4#1)
of AT-rich DNA##2##3##(2008-10#1)(2008-12#1)
of ATP and ADP with rubisco activase##3##7##(1991-9#3)
of ATP and##6##3##(1991-9#3)(1993-6#1)(1994-3#1)(2008-11#1)
of ATP hydrolysis##5##3##(1996-6#1)(2013-1#4)
of ATP synthase##2##3##(2008-8#2)
of ATP##37##2##(1991-5#1)(1991-9#5)(1993-6#7)(1993-8#3)(1994-3#2)(1995-11#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#1)(2008-8#3)(2011-2#1)(2013-1#4)
of ATPase##2##2##(2008-7#1)(2008-8#1)
of ATPgammaS##2##2##(1996-2#2)
of AVM##4##2##(1996-6#1)(2008-7#1)(2012-3#2)
of AVMs##4##2##(2008-7#4)
of AVP##2##2##(1990-5#1)(1995-12#1)
of AWR##3##2##(2008-10#3)
of AZT##4##2##(1990-8#1)(1995-6#1)(2008-10#2)
of Aboriginal##3##2##(2008-12#3)
of Acidovorax avenae subsp##2##4##(2008-10#2)
of Actinobacillus##3##2##(1996-12#3)
of Action and##2##3##(2008-10#1)(2008-11#1)
of Action##6##2##(2008-10#1)(2008-11#4)(2010-10#1)
of Acute Coronary##2##3##(2008-3#2)
of Acute##5##2##(2008-12#1)(2008-3#2)(2009-8#1)(2012-12#1)
of Ad-HGF##4##2##(2008-9#4)
of Adderall XR##2##3##(2008-11#2)
of Adult##2##2##(2008-11#1)(2012-2#1)
of Advanced Nursing##6##3##(2008-11#5)(2008-12#1)
of Advanced##7##2##(1990-11#1)(2008-11#5)(2008-12#1)
of Aegle marmelos in##2##4##(2012-2#2)
of Aegle marmelos##6##3##(2012-2#6)
of Aflatoxin##4##2##(2008-10#2)(2013-1#2)
of Africa##3##2##(1994-3#1)(2008-10#1)(2010-5#1)
of African American men##4##4##(2009-5#4)
of African American##9##3##(2008-12#2)(2009-12#1)(2009-5#4)(2009-7#1)(2010-9#1)
of African Americans##2##3##(2010-10#1)(2013-1#1)
of African histoplasmosis##2##3##(2008-5#2)
of African##19##2##(1996-6#1)(2008-10#1)(2008-12#3)(2008-5#2)(2008-8#1)(2009-12#1)(2009-5#4)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#1)(2013-1#1)
of African-American hair##2##3##(2008-5#2)
of African-Americans##2##2##(1994-1#1)(1997-3#1)
of Ag (I)##2##3##(2008-10#2)
of Ag##7##2##(2008-10#6)(2011-2#1)
of Ag(+) and Zn(2+)##2##4##(2008-10#2)
of Ag(+) and##3##3##(2008-10#3)
of Ag(+)##8##2##(2008-10#7)(2010-11#1)
of Ag(I)##9##2##(2008-10#9)
of Agaricus##2##2##(1997-1#1)(2008-10#1)
of Age-Related Macular Degeneration##2##4##(2011-2#2)
of Agricultural##2##2##(2010-10#1)(2011-3#1)
of Agriculture##5##2##(1996-3#1)(2008-10#2)(2012-2#2)
of Agrobacterium##2##2##(2008-10#2)
of Akt##4##2##(2009-9#1)(2010-1#2)(2013-1#1)
of Al from##2##3##(2008-10#2)
of Al in a tungsten coil##2##6##(2008-10#2)
of Al in##7##3##(2008-10#7)
of Al##29##2##(2008-10#28)(2009-8#1)
of Al(III) and Fe(III)##5##4##(2008-10#5)
of Al(III) and##7##3##(2008-10#7)
of Al(III) in##2##3##(2008-10#2)
of Al(III)##11##2##(2008-10#11)
of Al-citrate in##2##3##(2008-10#2)
of Al-citrate##6##2##(2008-10#6)
of AlCl3##2##2##(1993-3#1)(2008-10#1)
of Ala for##2##3##(1992-4#2)
of Alabama##2##2##(1992-12#1)(2010-4#1)
of Alberta##7##2##(1992-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
of Alcohol##2##2##(2010-11#1)(2013-8#1)
of Alfalfa mosaic virus in##3##5##(2008-10#3)
of Alfalfa mosaic virus##6##4##(2008-10#6)
of Alfalfa##7##2##(2008-10#7)
of Allium spp##2##3##(2008-10#2)
of Allium##4##2##(2008-10#4)
of Almond##2##2##(2008-10#2)
of Alternaria alternata##11##3##(2008-10#11)
of Alternaria citri was##2##4##(2008-10#2)
of Alternaria citri##4##3##(2008-10#4)
of Alternaria panax##2##3##(2008-10#2)
of Alternaria spp##6##3##(2008-10#6)
of Alternaria##28##2##(2008-10#27)(2008-5#1)
of Alzheimer disease##2##3##(2010-6#1)(2011-2#1)
of Alzheimer##3##2##(1993-8#1)(2010-6#1)(2011-2#1)
of Alzheimer's dementia##2##3##(1990-11#1)(1996-11#1)
of Alzheimer's disease (AD)##3##4##(1991-1#1)(1996-2#1)(2008-5#1)
of Alzheimer's disease in##2##4##(2008-6#1)(2008-7#1)
of Alzheimer's disease##17##3##(1991-1#1)(1992-12#1)(1992-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#3)(2013-1#2)
of Alzheimer's##24##2##(1990-11#1)(1991-1#1)(1991-8#1)(1992-12#2)(1992-8#1)(1994-11#1)(1996-11#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2011-3#1)(2013-1#2)
of Am(III)##2##2##(2008-10#2)
of AmB is##2##3##(1997-2#2)
of AmB##6##2##(1997-2#6)
of Amberlite XAD-2 resin loaded with##2##6##(2008-10#2)
of Amberlite XAD-2 resin##3##4##(2008-10#3)
of Amberlite XAD-2##4##3##(2008-10#4)
of Amberlite##7##2##(2008-10#7)
of America##6##2##(1992-3#1)(2008-11#1)(2008-3#2)(2008-6#1)(2012-12#1)
of American health care##2##4##(1997-3#1)(2012-3#1)
of American health##3##3##(1993-2#1)(1997-3#1)(2012-3#1)
of American##14##2##(1990-5#1)(1993-2#1)(1994-1#1)(1994-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
of Americans##3##2##(1996-5#1)(2010-8#1)(2011-1#1)
of Amorpha fruticosa LINNE##3##4##(2008-11#3)
of Amphiprion##2##2##(2010-8#2)
of An##4##2##(2012-12#4)
of AnFBV##2##2##(2008-10#2)
of Analysed Samples##2##3##(2008-10#2)
of Anaplasma##2##2##(2008-12#2)
of Angelman's##2##2##(1990-9#2)
of Anisogramma anomala##4##3##(2008-10#4)
of Annex II##2##3##(2008-11#2)
of Annexin32##3##2##(2008-9#3)
of Anopheles##5##2##(2010-1#3)(2012-12#2)
of Antwerp##2##2##(2008-10#2)
of Aphanomyces cochlioides##3##3##(2008-10#3)
of Aphanomyces euteiches from##2##4##(2008-10#2)
of Aphanomyces euteiches##7##3##(2008-10#7)
of Aphanomyces##11##2##(2008-10#11)
of Apis mellifera##2##3##(2008-7#1)(2011-2#1)
of ApoAI##2##2##(1993-12#2)
of Appeals for the Fourth##3##5##(1995-6#2)(1997-6#1)
of Appeals for the##5##4##(1995-6#4)(1997-6#1)
of Appeals##12##2##(1995-12#4)(1995-6#4)(1996-5#3)(1997-6#1)
of Apple Fruit##2##3##(2008-10#2)
of Apple chlorotic leaf spot virus##3##6##(2008-10#3)
of Apple stem pitting virus##2##5##(2008-10#2)
of Apple##13##2##(2008-10#13)
of Applied##4##2##(2008-10#1)(2008-3#2)(2013-1#1)
of Appressoria##2##2##(2008-10#2)
of April##3##2##(1995-11#1)(1995-2#1)(2012-3#1)
of ArCl##2##2##(2008-10#2)
of Arabidopsis plants##2##3##(2008-10#2)
of Arabidopsis thaliana to Bacterial Wilt Caused by Ralstonia solanacearum##2##10##(2008-10#2)
of Arabidopsis thaliana##13##3##(1997-6#1)(1997-8#1)(2008-10#7)(2008-9#2)(2009-10#1)(2012-3#1)
of Arabidopsis##24##2##(1997-6#1)(1997-8#1)(2008-10#11)(2008-9#4)(2009-10#3)(2009-8#3)(2012-3#1)
of Areca catechu L##2##4##(2008-5#2)
of Arg##2##2##(1995-3#1)(2008-11#1)
of Argentina##4##2##(2008-10#3)(2008-11#1)
of Arizona##3##2##(1990-8#1)(1992-2#1)(2008-10#1)
of Arom-IR neurones were##2##4##(1994-2#2)
of Arslantepe##2##2##(2012-9#2)
of Arthrobacter##2##2##(1995-3#1)(2008-10#1)
of Artichoke##2##2##(2008-10#1)(2011-2#1)
of As and Sb##3##4##(2008-10#3)
of As and Se##5##4##(2008-10#5)
of As and##9##3##(2008-10#9)
of As at##4##3##(2008-10#4)
of As in##2##3##(2008-10#2)
of As species##2##3##(2008-10#2)
of As was##4##3##(2008-10#4)
of As##49##2##(2008-10#46)(2013-1#3)
of As(III) and As(V) in##6##5##(2008-10#6)
of As(III) and As(V)##11##4##(2008-10#11)
of As(III) in##6##3##(2008-10#6)
of As(III) is##2##3##(2008-10#2)
of As(III) to As(V)##2##4##(2008-10#2)
of As(III) was##2##3##(2008-10#2)
of As(III)##37##2##(2008-10#37)
of As(V)##5##2##(2008-10#5)
of As51##2##2##(2010-8#2)
of AsA##4##2##(2008-10#3)(2008-11#1)
of AsH(3)##2##2##(2008-10#2)
of Ascochyta##3##2##(2008-10#3)
of Ascospores in##2##3##(2008-10#2)
of Ascospores of Anisogramma anomala##2##5##(2008-10#2)
of Ascospores of##5##3##(2008-10#5)
of Ascospores##8##2##(2008-10#8)
of Asia##2##2##(2008-10#1)(2011-2#1)
of Asparagus racemosus##2##3##(2008-10#1)(2013-1#1)
of Asparagus##3##2##(2008-10#2)(2013-1#1)
of Aspergillus flavus and##2##4##(2008-10#2)
of Aspergillus flavus##5##3##(2008-10#5)
of Aspergillus nidulans##4##3##(1997-4#1)(1997-7#1)(1997-8#1)(2009-8#1)
of Aspergillus niger##6##3##(1997-2#2)(2008-7#3)(2008-9#1)
of Aspergillus##22##2##(1993-12#1)(1997-2#3)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)
of Assessment##2##2##(2008-11#1)(2012-2#1)
of Asturias]##2##2##(1993-3#1)(1995-5#1)
of Asymptomatic##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
of Atlantic cod Gadus morhua##2##5##(2010-8#2)
of Atmospheric##3##2##(2008-10#1)(2008-3#2)
of Atta##2##2##(2008-8#2)
of Attention##2##2##(2008-11#1)(2010-8#1)
of Au##15##2##(1992-11#1)(2008-10#12)(2008-8#1)(2010-7#1)
of Au(III)##7##2##(2008-10#7)
of August##2##2##(2008-10#1)(2008-4#1)
of Augustine's##2##2##(2008-12#2)
of Aurora kinases##2##3##(2013-1#2)
of Aurora##3##2##(2013-1#3)
of Australia and##2##3##(1994-12#1)(1994-9#1)
of Australia##5##2##(1992-2#1)(1994-12#1)(1994-9#1)(2008-10#1)(2010-8#1)
of Australian centenarians##2##3##(2012-12#2)
of Australian##9##2##(2008-10#4)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#2)
of Autism##2##2##(2008-11#1)(2010-7#1)
of Autographa californica nuclear polyhedrosis virus (AcNPV)##2##7##(1994-11#1)(2008-8#1)
of Autographa californica##3##3##(1993-12#1)(1994-11#1)(2008-8#1)
of Avena sativa##2##3##(2008-10#1)(2008-9#1)
of Avirulence##3##2##(2008-10#3)
of AvrPto##2##2##(2009-8#2)
of AxeA##2##2##(2011-1#2)
of Azorubin##2##2##(2008-10#2)
of B cell##6##3##(2008-11#2)(2008-4#4)
of B cells##10##3##(1995-12#1)(1995-6#1)(1997-9#1)(2008-11#3)(2008-4#2)(2008-5#1)(2013-1#1)
of B chromosomes##2##3##(2008-12#2)
of B##118##2##(1990-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-9#1)(2008-1#1)(2008-10#68)(2008-11#6)(2008-12#4)(2008-4#6)(2008-5#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#13)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
of B(2)##2##2##(2008-10#2)
of B(A)P##5##2##(1993-8#5)
of B-GOx##5##2##(2008-10#5)
of B-cell##2##2##(2008-7#1)(2011-2#1)
of B1##2##2##(2008-11#1)(2012-5#1)
of B16 2F2##3##3##(2008-11#3)
of B16##4##2##(2008-11#4)
of B18C6##2##2##(2008-10#2)
of B5##2##2##(1997-8#2)
of BA##4##2##(2008-10#4)
of BABA##3##2##(2008-10#2)(2009-6#1)
of BAC DNA##2##3##(2008-4#2)
of BAC clones##2##3##(2008-8#1)(2012-3#1)
of BAC transgenic mice in neuroscience research##2##7##(2008-4#2)
of BAC transgenic mice##3##4##(2008-4#3)
of BAC##7##2##(2008-4#5)(2008-8#1)(2012-3#1)
of BAK##2##2##(1992-11#2)
of BAT##2##2##(2013-1#2)
of BBWV##2##2##(2008-10#2)
of BC##3##2##(1993-3#2)(2008-10#1)
of BCAs##2##2##(2008-10#2)
of BCF##2##2##(2008-12#2)
of BCG##5##2##(1995-12#1)(2008-10#1)(2011-2#3)
of BCL2##2##2##(2009-8#2)
of BCVA##2##2##(2011-2#2)
of BDNF and##2##3##(1997-2#1)(2011-2#1)
of BDNF mRNA##4##3##(1996-12#1)(1997-2#3)
of BDNF##11##2##(1996-12#1)(1997-2#5)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
of BE##3##2##(2008-10#1)(2010-12#2)
of BEFV##2##2##(2008-10#2)
of BFP and##2##3##(1991-8#2)
of BFP##3##2##(1991-8#3)
of BGQ60##2##2##(1995-6#2)
of BGYMV##2##2##(2008-10#2)
of BHK cells##2##3##(2008-11#2)
of BHK##3##2##(2008-11#3)
of BHK-21##2##2##(2008-11#1)(2008-8#1)
of BHT##2##2##(1994-5#1)(2013-8#1)
of BLM##2##2##(1990-12#2)
of BLPC##2##2##(2010-4#2)
of BM aspirates##2##3##(2008-11#2)
of BMD##3##2##(2008-8#1)(2011-2#2)
of BMI##2##2##(1994-12#1)(2008-10#1)
of BML in##2##3##(1996-11#1)(2012-3#1)
of BML##5##2##(1996-11#1)(2012-3#4)
of BMP-2/4##3##2##(2011-2#3)
of BMP-7##3##2##(2011-2#3)
of BMPR-II##2##2##(2011-2#2)
of BMPs##3##2##(2011-2#3)
of BMV##2##2##(2008-10#2)
of BNR hyphae##2##3##(2008-10#2)
of BNR##5##2##(2008-10#5)
of BNYVV##2##2##(2008-10#2)
of BOC##3##2##(2013-1#3)
of BP##5##2##(2008-10#1)(2008-11#4)
of BPA in##3##3##(2008-10#1)(2009-8#1)(2010-9#1)
of BPA##6##2##(2008-10#3)(2009-8#1)(2010-9#2)
of BPMV##2##2##(2008-10#2)
of BR##3##2##(1993-11#2)(2009-8#1)
of BRCA1##2##2##(2008-10#1)(2011-2#1)
of BRD7##3##2##(2008-9#3)
of BSA##9##2##(1991-5#1)(1995-12#1)(2008-10#6)(2008-3#1)
of BSE##2##2##(2008-11#1)(2011-2#1)
of BTEX##4##2##(2008-10#4)
of BTH##2##2##(2008-10#2)
of BYDV##8##2##(2008-10#8)
of BYDV-RMV##3##2##(2008-10#3)
of BYSV##2##2##(2008-10#2)
of Ba##2##2##(2008-10#2)
of Ba(IO(3))(2)##2##2##(2008-10#2)
of Ba2+##2##2##(1995-11#2)
of BaP##2##2##(2011-1#2)
of Bacillus and Paenibacillus spp##2##5##(2008-10#2)
of Bacillus and##3##3##(2008-10#3)
of Bacillus cereus strain##2##4##(2011-2#2)
of Bacillus cereus##9##3##(1992-3#1)(2008-10#2)(2011-1#1)(2011-2#5)
of Bacillus spp##3##3##(2008-10#3)
of Bacillus subtilis and##2##4##(1995-3#1)(1996-6#1)
of Bacillus subtilis##4##3##(1993-9#1)(1995-3#1)(1996-6#1)(2008-10#1)
of Bacillus thuringiensis##3##3##(1993-12#1)(1995-6#1)(2008-9#1)
of Bacillus##30##2##(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-6#1)(1996-6#1)(2008-10#11)(2008-7#1)(2008-9#1)(2010-1#2)(2011-1#1)(2011-2#8)
of Bacteria##31##2##(2008-10#2)(2011-2#29)
of Bacterial Antagonists##2##3##(2008-10#2)
of Bacterial Blight##2##3##(2008-10#2)
of Bacterial##10##2##(1994-12#1)(2008-10#8)(2011-2#1)
of Bacteroides##2##2##(1997-2#1)(2008-7#1)
of Bad##2##2##(2008-10#2)
of Baltic##2##2##(2008-10#2)
of Banana##4##2##(2008-10#4)
of Bangladesh##4##2##(2008-10#4)
of Barcelona##3##2##(1993-3#1)(1997-5#1)(2008-10#1)
of Barley yellow dwarf virus##5##5##(2008-10#5)
of Barley yellow dwarf##6##4##(2008-10#6)
of Barley##12##2##(2008-10#12)
of Batesian mimicry##2##3##(2012-3#2)
of Baxter Colleague infusion pumps##2##5##(2011-2#2)
of Baxter's##2##2##(1993-3#1)(1994-1#1)
of Bayesian##3##2##(2008-10#2)(2008-11#1)
of BcEST##2##2##(2011-1#2)
of BcOS1p##2##2##(2008-10#2)
of Bcl-2 family##2##3##(2009-12#1)(2011-2#1)
of Bcl-2##10##2##(2008-11#4)(2008-9#3)(2009-12#1)(2010-12#1)(2011-2#1)
of Bcl-xL##3##2##(2008-11#3)
of Be(+2)##3##2##(2008-10#3)
of Be(II)##3##2##(2008-10#3)
of Bean common mosaic necrosis virus##2##6##(2008-10#2)
of Bean golden##2##3##(2008-10#2)
of Bean pod mottle##3##4##(2008-10#3)
of Bean##7##2##(2008-10#7)
of Beet##4##2##(2008-10#4)
of Beijing##2##2##(2008-10#1)(2008-9#1)
of Belgian##2##2##(1994-12#1)(2008-3#1)
of Bell##2##2##(2008-10#2)
of Bemisia tabaci Gennadius##2##4##(2008-12#2)
of Bemisia tabaci##3##3##(2008-10#1)(2008-12#2)
of Benzimidazole##2##2##(2008-10#1)(2012-2#1)
of Bhutan##2##2##(2008-10#2)
of Bi##11##2##(1991-11#1)(2008-10#10)
of Bi(III)##2##2##(2008-10#2)
of BiP##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
of Bifidobacterium##3##2##(2008-11#2)(2011-1#1)
of Billing's##2##2##(2008-10#2)
of Billroth##2##2##(1991-6#1)(2013-1#1)
of Billroth's##2##2##(2013-1#2)
of Binucleate Rhizoctonia##2##3##(2008-10#2)
of Biocontrol##3##2##(2008-10#3)
of Biolog##2##2##(2008-10#2)
of Biological Control##2##3##(2008-10#2)
of Biological##4##2##(2008-10#3)(2011-4#1)
of Bipolaris sorokiniana##5##3##(2008-10#5)
of Bipolaris##6##2##(2008-10#6)
of Black##3##2##(2008-10#2)(2011-2#1)
of Blk##2##2##(1995-6#2)
of Blumeria graminis f##2##4##(2008-10#2)
of BmNPV gp64 promoter##2##4##(2008-11#2)
of BmNPV##4##2##(2008-11#4)
of BoHV-1##2##2##(2011-2#2)
of BoNT in##2##3##(2011-2#2)
of BoNT##5##2##(2008-5#1)(2011-2#4)
of Bombyx mori nucleopolyhedrovirus##3##4##(2008-11#3)
of Bombyx mori##6##3##(2008-11#3)(2008-5#1)(2008-7#2)
of Bonghan##3##2##(2010-7#3)
of Bordetella pertussis##2##3##(2007-12#1)(2008-7#1)
of Borrelia burgdorferi infection##2##4##(2011-2#2)
of Borrelia burgdorferi##9##3##(1990-2#1)(1992-3#1)(1995-5#1)(2008-9#2)(2011-2#4)
of Botryosphaeria dothidea##8##3##(2008-10#8)
of Botryosphaeria##12##2##(2008-10#12)
of Botryotinia fuckeliana##2##3##(2008-10#2)
of Botryotinia##3##2##(2008-10#3)
of Botrytis cinerea and##2##4##(2008-10#1)(2008-5#1)
of Botrytis cinerea conidia##2##4##(2008-10#2)
of Botrytis cinerea in##2##4##(2008-10#2)
of Botrytis cinerea on##7##4##(2008-10#7)
of Botrytis cinerea was##2##4##(2008-10#2)
of Botrytis cinerea##34##3##(2008-10#33)(2008-5#1)
of Botrytis spp##3##3##(2008-10#3)
of Botrytis##39##2##(2008-10#38)(2008-5#1)
of Bowen's disease##3##3##(2007-8#1)(2010-6#2)
of Br polymorphism##3##3##(2006-6#3)
of Br(-)##2##2##(2008-10#2)
of Brain##3##2##(1996-3#1)(1997-3#1)(2012-3#1)
of Brassica napus##3##3##(2008-10#2)(2012-3#1)
of Brassica oleracea##2##3##(2008-10#1)(2012-3#1)
of Brassica spp##2##3##(2008-10#2)
of Brassica##9##2##(2008-10#6)(2011-1#1)(2012-3#2)
of Brazil##7##2##(2008-10#4)(2008-12#1)(2010-7#1)(2012-3#1)
of Brazilian##3##2##(2008-10#3)
of Bremia lactucae on##2##4##(2008-10#2)
of Bremia lactucae##9##3##(2008-10#9)
of Brenneria##2##2##(2008-10#2)
of Brilliant##2##2##(2008-10#2)
of British Columbia##6##3##(1992-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-3#1)(2013-8#1)
of British##9##2##(1992-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-3#1)(2011-1#1)(2013-8#1)
of Brn-3a##2##2##(1995-6#1)(1996-12#1)
of Brown##3##2##(2008-10#2)(2008-7#1)
of Brucella##2##2##(2011-2#2)
of Buenos Aires##3##3##(2008-5#1)(2009-10#2)
of Buerger disease##2##3##(1997-8#2)
of Buerger's disease##3##3##(1996-8#1)(1997-8#1)(2008-10#1)
of Burkitt's lymphoma##4##3##(2008-1#3)(2008-9#1)
of ByT-FAS##2##2##(2008-10#2)
of C levels##2##3##(2008-9#2)
of C##162##2##(1990-2#1)(1990-3#1)(1993-9#2)(1996-1#1)(1996-12#1)(1996-6#2)(2007-12#1)(2008-10#109)(2008-5#9)(2008-7#1)(2008-8#7)(2008-9#2)(2009-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#3)(2012-6#7)(2013-1#2)(2013-8#2)
of C(60) molecules##2##3##(2008-5#2)
of C(60)##4##2##(2008-10#2)(2008-5#2)
of C-ADR compared with##2##4##(2012-12#2)
of C-ADR##4##2##(2012-12#4)
of C-RFa##2##2##(2008-6#2)
of C-reactive protein##2##3##(2008-7#1)(2013-1#1)
of C/EBP##3##2##(1990-5#1)(2008-5#1)(2012-2#1)
of C/H##2##2##(2008-10#2)
of C16##2##2##(2008-8#2)
of C1YVV isolates of strain##2##5##(2008-10#2)
of C1YVV isolates##3##3##(2008-10#3)
of C2##3##2##(2010-9#1)(2012-3#1)(2013-1#1)
of C24##3##2##(2012-3#3)
of C3 were##2##3##(2008-10#2)
of C3##8##2##(1991-2#1)(2008-10#7)
of C5a##3##2##(2008-10#3)
of C6##2##2##(1992-6#1)(1997-8#1)
of C9-1S on##2##3##(2008-10#2)
of C9-1S##4##2##(2008-10#4)
of CA##3##2##(1995-11#1)(2008-10#1)(2011-2#1)
of CA1##2##2##(1995-8#1)(2008-11#1)
of CAA##2##2##(2008-10#2)
of CACY##2##2##(1994-5#2)
of CAD##4##2##(2008-10#2)(2012-2#2)
of CAI##2##2##(2013-1#2)
of CAK##2##2##(1997-1#2)
of CALUX results##2##3##(2008-10#2)
of CALUX##4##2##(2008-10#4)
of CAN##4##2##(2012-2#4)
of CAPD patients##2##3##(2008-10#2)
of CAT##7##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#4)
of CArG##2##2##(1994-11#2)
of CB agonists##3##3##(2009-12#3)
of CB##4##2##(2008-10#1)(2009-12#3)
of CBB bacteria##2##3##(2008-10#2)
of CBF##3##2##(1995-2#1)(2008-7#1)(2012-2#1)
of CBF-B##3##2##(2012-2#3)
of CBS##5##2##(1993-8#3)(2011-2#2)
of CBZ and CBZ-E##2##4##(2008-10#2)
of CBZ##4##2##(2008-10#4)
of CBs##2##2##(2008-10#2)
of CC##6##2##(2008-11#5)(2013-8#1)
of CC-516##5##2##(2008-5#5)
of CCBs##2##2##(2008-11#2)
of CCD##5##2##(2008-3#2)(2011-1#2)(2013-1#1)
of CCK##4##2##(1991-5#1)(1992-8#1)(1993-6#2)
of CCK-8##4##2##(1994-2#4)
of CCMV RNA3##2##3##(2008-10#2)
of CCMV##3##2##(2008-10#3)
of CD spectra##2##3##(2008-4#2)
of CD##13##2##(1990-8#1)(1994-5#2)(2008-10#2)(2008-4#2)(2008-7#2)(2008-8#1)(2012-2#2)(2013-8#1)
of CD-ROM##5##2##(1991-12#2)(1991-3#3)
of CD-causing R##2##3##(2008-10#2)
of CD11a/CD18##2##2##(1996-12#2)
of CD14##2##2##(2008-10#2)
of CD1a+##2##2##(1996-12#2)
of CD25+CD4+ T cells##2##4##(2011-2#2)
of CD25+CD4+ regulatory T cells##2##5##(2011-2#2)
of CD25+CD4+##4##2##(2011-2#4)
of CD34(+) cells##4##3##(2008-8#2)(2008-9#2)
of CD34(+)##6##2##(2008-8#2)(2008-9#4)
of CD34+ cells##2##3##(2011-2#2)
of CD34+##4##2##(2008-7#1)(2008-9#1)(2011-2#2)
of CD38##4##2##(1994-11#3)(2008-9#1)
of CD4##3##2##(1995-2#1)(2008-4#1)(2008-8#1)
of CD4(+) T cells##2##4##(2008-11#1)(2010-1#1)
of CD4(+)##6##2##(2008-11#3)(2008-5#2)(2010-1#1)
of CD4+ T##2##3##(1995-2#1)(2008-11#1)
of CD4+##4##2##(1995-2#1)(1997-8#1)(2008-11#1)(2013-8#1)
of CD40##2##2##(2008-10#1)(2008-9#1)
of CD41##2##2##(2006-6#2)
of CD45(-) CD105(+) cells among##2##5##(2008-11#2)
of CD45RA+CD4+ cells##2##3##(1995-12#2)
of CD5(+)B cells##2##3##(2011-2#2)
of CD8##2##2##(1997-9#1)(2007-11#1)
of CD8+##4##2##(2008-11#2)(2013-8#2)
of CD86 expression##2##3##(2008-10#2)
of CD86##3##2##(2008-10#2)(2008-11#1)
of CD9##2##2##(2009-8#2)
of CDD/ ANP-(99-126)##2##3##(1995-11#2)
of CDD/ANP-(99-126)##2##2##(1995-11#2)
of CDDP##4##2##(1990-6#1)(2013-1#3)
of CDDP-DNA adducts##2##3##(2013-1#2)
of CE for##2##3##(2008-10#2)
of CE with##2##3##(2008-10#2)
of CE##8##2##(2008-10#5)(2008-5#2)(2010-7#1)
of CEA##5##2##(2008-10#1)(2008-11#4)
of CEC and CEP##3##4##(2010-1#3)
of CEF##3##2##(1991-5#3)
of CENP-B box##2##3##(2008-7#2)
of CER3##2##2##(2008-10#2)
of CEUS has##2##3##(2010-12#2)
of CEUS in##2##3##(2010-12#2)
of CEUS##6##2##(2010-12#6)
of CEVd##2##2##(2008-10#2)
of CEf##2##2##(2008-5#2)
of CEs##5##2##(2008-5#5)
of CF##7##2##(1994-2#1)(1997-1#1)(2008-10#1)(2009-8#1)(2012-3#3)
of CFCs##6##2##(1992-3#1)(1996-1#5)
of CFS patients##2##3##(2010-1#2)
of CFS##5##2##(2010-1#5)
of CFTR##2##2##(2011-3#2)
of CFU##3##2##(2008-10#3)
of CGRP in the##3##4##(1992-6#3)
of CGRP in##5##3##(1992-6#5)
of CGRP is##2##3##(1992-6#2)
of CGRP##25##2##(1992-6#20)(1997-3#1)(1997-4#4)
of CH(4)##2##2##(2008-3#1)(2010-7#1)
of CHA0##4##2##(2008-10#4)
of CHCHD1##2##2##(2013-8#2)
of CHD##2##2##(2012-2#2)
of CHINs##2##2##(1997-1#2)
of CHM##2##2##(2008-10#2)
of CHO cell##2##3##(2008-11#1)(2011-2#1)
of CHO cells and##2##4##(2008-11#1)(2011-2#1)
of CHO cells in##3##4##(2008-11#2)(2008-7#1)
of CHO cells##16##3##(1995-2#1)(1997-1#1)(2008-11#11)(2008-7#2)(2011-2#1)
of CHO##22##2##(1995-2#1)(1997-1#1)(2008-11#14)(2008-7#2)(2011-2#2)(2013-8#2)
of CHO-K1 cells##3##3##(1997-1#1)(2008-11#2)
of CHO-K1##4##2##(1997-1#1)(2008-11#3)
of CHT##2##2##(2008-10#2)
of CHX against##2##3##(2011-3#2)
of CHX##4##2##(2011-3#4)
of CI##3##2##(1996-2#1)(2008-8#2)
of CIN##7##2##(1991-2#2)(1994-1#2)(1994-12#1)(1994-2#2)
of CK specific cDNA##2##4##(2008-11#2)
of CK##7##2##(1990-11#1)(1993-6#1)(2008-11#2)(2011-3#3)
of CK-II##2##2##(1993-2#2)
of CKD##3##2##(2009-1#2)(2012-2#1)
of CL development##2##3##(2008-9#2)
of CL intensity##3##3##(2008-10#3)
of CL##12##2##(1991-2#1)(2008-10#6)(2008-5#1)(2008-8#2)(2008-9#2)
of CL-emission##2##2##(2008-10#2)
of CLL cells##2##3##(1995-2#2)
of CLL##5##2##(1995-2#3)(2008-9#2)
of CLP##2##2##(2012-3#2)
of CMF##4##2##(1992-12#1)(2008-11#1)(2009-1#2)
of CMLV##2##2##(2008-10#2)
of CMT1A##2##2##(1997-3#2)
of CMV and##3##3##(2008-10#3)
of CMV isolates##3##3##(2008-10#3)
of CMV was##2##3##(2008-10#2)
of CMV##18##2##(2008-10#17)(2008-8#1)
of CN##2##2##(2008-10#1)(2011-2#1)
of CN(-)##3##2##(2008-10#3)
of CNE-2L2 cell##2##3##(2008-8#2)
of CNG channels in the##2##5##(2009-10#2)
of CNG channels in##4##4##(2009-10#4)
of CNL patients##2##3##(2008-7#2)
of CNL##3##2##(2008-7#3)
of CNS##7##2##(2008-11#1)(2008-7#4)(2012-2#1)(2013-1#1)
of CNTF##4##2##(1990-5#3)(1996-2#1)
of CO exposure##2##3##(1990-5#2)
of CO##14##2##(1990-5#3)(1990-8#1)(1992-3#1)(1995-2#2)(2008-10#3)(2008-3#2)(2008-8#1)(2009-5#1)
of CO(2) in##2##3##(2008-10#1)(2008-3#1)
of CO(2) laser##2##3##(2008-2#1)(2008-3#1)
of CO(2) on##2##3##(2008-10#2)
of CO(2)##17##2##(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#1)(2008-9#1)
of CO(3)(2-)##2##2##(2008-10#2)
of CO2 and HCO3-##2##4##(1993-6#2)
of CO2 and##5##3##(1993-6#2)(1995-8#1)(1996-12#1)(2008-11#1)
of CO2 laser##4##3##(1994-12#1)(1995-2#1)(2008-2#1)(2008-3#1)
of CO2##11##2##(1993-6#3)(1994-12#1)(1995-2#1)(1995-8#1)(1996-12#2)(2008-11#1)(2008-2#1)(2008-3#1)
of CO39##2##2##(2008-10#2)
of COL1A2##2##2##(1992-8#2)
of COOP##2##2##(2008-7#1)(2010-8#1)
of COPD##4##2##(2008-1#1)(2010-5#2)(2011-2#1)
of COX-2##3##2##(2010-12#1)(2011-2#1)(2013-8#1)
of CP compared with full term##2##6##(2011-2#2)
of CP were##2##3##(2008-10#1)(2011-2#1)
of CP##15##2##(1990-12#1)(2008-10#5)(2008-12#1)(2008-7#2)(2011-2#4)(2012-2#1)(2012-3#1)
of CPC in##2##3##(2008-10#2)
of CPC##4##2##(2008-10#4)
of CPPs##2##2##(2011-3#2)
of CPT##2##2##(1994-2#1)(1994-8#1)
of CQI are##2##3##(1993-3#2)
of CQI##5##2##(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)
of CR##4##2##(2008-10#1)(2008-11#1)(2008-7#2)
of CR-EAE##2##2##(2013-7#2)
of CRC##7##2##(2008-10#3)(2009-12#1)(2010-12#3)
of CREB at##2##3##(2008-11#2)
of CREB##7##2##(1996-12#2)(2008-11#5)
of CRF##5##2##(1997-4#2)(2008-1#3)
of CRH##2##2##(2008-11#2)
of CRMP2##3##2##(2013-1#3)
of CRS##2##2##(2011-2#1)(2013-8#1)
of CS to##4##3##(1997-2#1)(2008-10#1)(2013-1#2)
of CS##22##2##(1997-2#1)(2008-10#2)(2011-2#1)(2013-1#18)
of CSCs##3##2##(2011-2#3)
of CSD and##2##3##(2008-10#2)
of CSD##3##2##(2008-10#3)
of CSD-symptomatic trees##3##3##(2008-10#3)
of CSF leak##3##3##(2011-2#1)(2012-3#2)
of CSF##8##2##(1993-1#1)(2008-7#2)(2011-2#2)(2012-3#2)(2013-7#1)
of CSOM##2##2##(2008-9#2)
of CT and MR##2##4##(1997-8#1)(2008-1#1)
of CT and##4##3##(1992-12#1)(1992-6#1)(1997-8#1)(2008-1#1)
of CT findings##3##3##(1990-3#1)(1997-8#1)(2012-2#1)
of CT in##2##3##(2008-1#1)(2008-12#1)
of CT scans##2##3##(2011-2#1)(2013-1#1)
of CT##26##2##(1990-3#1)(1992-12#1)(1992-6#2)(1994-2#1)(1997-8#4)(2008-1#3)(2008-12#1)(2008-7#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-2#6)(2013-1#3)
of CTAB and##3##3##(2008-10#2)(2008-11#1)
of CTAB##6##2##(2008-10#3)(2008-11#3)
of CTC##2##2##(2008-1#1)(2008-10#1)
of CTLs##5##2##(1994-5#1)(2008-11#4)
of CTS##3##2##(2008-9#2)(2010-8#1)
of CTV incidence at the##3##5##(2008-10#3)
of CTV incidence##4##3##(2008-10#4)
of CTV##9##2##(2008-10#9)
of CTV-positive trees##2##3##(2008-10#2)
of CV##5##2##(2008-10#4)(2008-12#1)
of CVD##8##2##(2008-6#1)(2010-12#3)(2011-1#2)(2012-12#1)(2012-2#1)
of CVI##5##2##(2011-2#3)(2011-3#2)
of CWD##2##2##(2008-10#2)
of CWP##5##2##(2008-10#5)
of CYDV##2##2##(2008-10#2)
of CYP1A1##4##2##(1995-11#2)(2008-11#2)
of CYP1B1 protein##2##3##(1995-11#2)
of CYP1B1##3##2##(1995-11#3)
of CYP2E1 in##2##3##(2008-8#2)
of CYP2E1##4##2##(2008-8#4)
of CYP3A and P-glycoprotein on the absorption of buagafuran in##2##10##(2011-3#2)
of CYP3A4##2##2##(1994-5#1)(2008-10#1)
of CYSDV##3##2##(2008-10#3)
of CYVD strains##2##3##(2008-10#2)
of CYVD##3##2##(2008-10#3)
of Ca and Mg##2##4##(2008-10#2)
of Ca##16##2##(1991-5#1)(2008-10#11)(2008-3#1)(2009-6#2)(2012-2#1)
of Ca(2+) and Mg(2+)##4##4##(2008-10#3)(2008-11#1)
of Ca(2+) and##5##3##(2008-10#4)(2008-11#1)
of Ca(2+) with##2##3##(2008-10#2)
of Ca(2+)##18##2##(2008-10#9)(2008-11#3)(2008-8#4)(2008-9#1)(2009-6#1)
of Ca(2+)-ATPase##2##2##(1995-11#1)(2008-8#1)
of Ca(2+)-dependent##3##2##(1992-6#1)(1994-6#1)(2008-10#1)
of Ca2+ and##5##3##(1993-8#1)(1994-11#3)(1996-2#1)
of Ca2+ currents##2##3##(1992-8#1)(1996-2#1)
of Ca2+ influx by##2##4##(1991-1#1)(1992-8#1)
of Ca2+ influx##4##3##(1991-1#2)(1992-8#1)(1994-8#1)
of Ca2+ release##4##3##(1995-6#4)
of Ca2+##36##2##(1990-10#1)(1990-5#2)(1990-8#2)(1991-1#2)(1992-8#2)(1992-9#1)(1993-8#3)(1994-11#4)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#5)(1995-6#4)(1995-8#1)(1996-2#4)(2013-1#1)
of Ca2+/calmodulin-dependent protein kinase II##2##5##(1993-6#2)
of Ca2+/calmodulin-dependent##3##2##(1990-5#1)(1993-6#2)
of CaCO(3) and##2##3##(2008-10#2)
of CaD*##3##2##(1994-5#3)
of CaM and##2##3##(2008-8#1)(2011-3#1)
of CaM in##3##3##(1994-3#1)(2008-8#2)
of CaM kinase II for calmodulin##2##6##(1993-6#2)
of CaM kinase II##4##4##(1993-6#4)
of CaM##15##2##(1993-6#4)(1994-3#1)(1996-12#1)(2008-8#7)(2011-3#2)
of CaMK II##3##3##(1995-8#3)
of CaMKII##2##2##(2009-7#1)(2012-2#1)
of CaMV 35S promoter##3##4##(2008-8#1)(2008-9#2)
of CaMV##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
of CaMV35S##3##2##(2008-9#3)
of CaN##2##2##(2011-3#2)
of CaO##3##2##(2013-1#3)
of CaSR mRNA##5##3##(2008-11#5)
of CaSR##6##2##(2008-11#6)
of Caco-2 cells##5##3##(1994-6#3)(2008-11#2)
of Caco-2##6##2##(1994-6#3)(2008-11#3)
of Calcium##2##2##(2008-10#1)(2008-11#1)
of California and##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
of California##17##2##(1991-12#1)(1992-3#1)(1995-2#2)(2008-10#11)(2008-8#1)(2011-2#1)
of Calla lily chlorotic spot virus##2##6##(2008-10#2)
of Calotropis gigantea##3##3##(2008-12#3)
of Campylobacter jejuni##3##3##(1990-3#1)(1993-9#1)(2010-12#1)
of Campylobacter##11##2##(1990-3#1)(1993-9#2)(2008-10#6)(2010-12#1)(2011-1#1)
of Canada##8##2##(1993-12#1)(1993-9#1)(1994-12#1)(1997-3#1)(2008-11#1)(2008-8#1)(2010-8#1)(2013-8#1)
of Canadian##9##2##(1994-1#1)(1994-12#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-11#4)
of Cancer##7##2##(1992-12#1)(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-11#1)
of Candida albicans to##2##4##(2008-5#1)(2013-1#1)
of Candida albicans##7##3##(2008-5#6)(2013-1#1)
of Candida oleophila##2##3##(2008-10#2)
of Candida saitoana##2##3##(2008-10#2)
of Candida sake (CPA-1)##2##4##(2008-10#2)
of Candida sake##4##3##(2008-10#4)
of Candida spp##2##3##(2008-5#1)(2011-2#1)
of Candida##23##2##(2008-10#8)(2008-5#10)(2011-2#2)(2013-1#3)
of Canola##2##2##(2008-10#2)
of Canton##2##2##(1996-11#2)
of Capsicum##3##2##(1993-11#1)(2008-10#2)
of Captopril in pharmaceutical formulation and reconstituted serum##2##8##(2008-10#2)
of Captopril in##4##3##(2008-10#4)
of Captopril##7##2##(2008-10#7)
of Cardiac Troponin I in##2##5##(2008-12#2)
of Cardiac##5##2##(2008-12#2)(2008-7#1)(2011-2#1)(2012-12#1)
of Cardiology##4##2##(2008-3#1)(2009-6#1)(2010-12#1)(2013-1#1)
of Cardiovascular##2##2##(2011-2#1)(2012-3#1)
of Care and##2##3##(1996-12#1)(2010-12#1)
of Care##4##2##(1996-12#1)(1997-1#1)(2010-12#1)(2010-7#1)
of Case Mix Groups##2##4##(1991-12#1)(1993-12#1)
of Case##3##2##(1991-12#1)(1993-12#1)(2013-8#1)
of Catalyser-21(TM)##2##2##(2008-11#2)
of Caucasian##2##2##(2008-5#2)
of Cauliflower##2##2##(2008-10#2)
of Cavernous##3##2##(2012-3#1)(2013-1#2)
of Cd and Hg##4##4##(1990-5#4)
of Cd and Pb in##3##5##(2008-10#3)
of Cd and Pb##8##4##(2008-10#8)
of Cd and Zn##5##4##(2008-10#5)
of Cd and##18##3##(1990-5#4)(2008-10#14)
of Cd in the##2##4##(1990-5#1)(2008-10#1)
of Cd in##8##3##(1990-5#1)(2008-10#7)
of Cd was##2##3##(2008-10#2)
of Cd##54##2##(1990-5#5)(2008-10#49)
of Cd(2+) and##2##3##(2008-10#2)
of Cd(2+) in##2##3##(2008-10#2)
of Cd(2+) ions##2##3##(2008-10#2)
of Cd(2+)##10##2##(2008-10#10)
of Cd(II) and In(III)##2##4##(2008-10#2)
of Cd(II) and Pb(II)##3##4##(2008-10#3)
of Cd(II) and##6##3##(2008-10#6)
of Cd(II)##22##2##(2008-10#22)
of Cd(II)-8-hydroxyquinoline-5-sulphonic acid complex##2##4##(2008-10#2)
of CdHL##2##2##(2008-10#2)
of CdS and PbS##2##4##(2008-10#2)
of CdS##5##2##(2008-10#3)(2008-8#2)
of CdSe##5##2##(2008-10#5)
of Cdc7##3##2##(2012-3#3)
of Ce##4##2##(2008-10#3)(2010-4#1)
of Ce(3+) and Eu(3+)##2##4##(2008-10#2)
of Ce(3+)##3##2##(2008-10#2)(2010-4#1)
of Ce(III)##3##2##(2008-10#3)
of Ce(III)-EDTA complex##2##3##(2008-10#2)
of Ce(IV)##4##2##(2008-10#4)
of CeA for##3##3##(2008-10#3)
of CeA##4##2##(2008-10#4)
of Cell##2##2##(2008-11#1)(2013-8#1)
of Cellular##2##2##(2008-10#1)(2013-8#1)
of Cellulytic##2##2##(2008-10#2)
of Central Mexico##2##3##(2008-10#2)
of Central Nervous System##2##4##(2011-2#1)(2012-3#1)
of Central##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
of Cephalosporium gramineum##2##3##(2008-10#2)
of Ceratocystis fimbriata##4##3##(2008-10#4)
of Ceratocystis resinifera##2##3##(2008-10#2)
of Ceratocystis##6##2##(2008-10#6)
of Cercospora Leaf##2##3##(2008-10#1)(2012-3#1)
of Cercospora sorghi from##2##4##(2008-10#2)
of Cercospora sorghi##3##3##(2008-10#3)
of Cercospora zeae-maydis##2##3##(2008-10#2)
of Cercospora##11##2##(2008-10#10)(2012-3#1)
of Cervical##2##2##(2012-3#1)(2013-8#1)
of ChMV##2##2##(2008-10#2)
of Change##6##2##(2008-12#2)(2008-4#2)(2008-6#1)(2009-12#1)
of Charles Bonnet##2##3##(2011-2#1)(2013-8#1)
of Charles##3##2##(2010-4#1)(2011-2#1)(2013-8#1)
of Chemistry##3##2##(2008-10#2)(2008-12#1)
of Chicago##3##2##(1990-11#1)(2008-5#1)(2013-1#1)
of Child##2##2##(1997-8#1)(2013-1#1)
of Children's Health##3##3##(1992-3#1)(1994-3#2)
of Children's##4##2##(1992-3#1)(1994-3#2)(2011-2#1)
of Chile##4##2##(2013-1#3)(2013-8#1)
of China were##2##3##(2008-10#1)(2008-9#1)
of China##11##2##(2008-10#4)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
of Chinese cabbage##3##3##(2008-8#3)
of Chinese hamster ovary (CHO) cells##3##6##(2008-10#1)(2008-11#2)
of Chinese hamster ovary (CHO)##4##5##(2008-10#1)(2008-11#3)
of Chinese hamster ovary cells##5##5##(2008-11#4)(2008-7#1)
of Chinese hamster ovary##11##4##(2008-10#1)(2008-11#9)(2008-7#1)
of Chinese hamster##12##3##(1997-7#1)(2008-10#1)(2008-11#9)(2008-7#1)
of Chinese herbal medicine##2##4##(2008-10#1)(2013-8#1)
of Chinese herbal##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
of Chinese##42##2##(1994-12#1)(1997-7#1)(2008-10#6)(2008-11#10)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#3)(2009-5#2)(2011-2#4)(2013-1#2)(2013-8#3)
of Chitinase##2##2##(2008-10#2)
of Chlamydia trachomatis##2##3##(1990-5#1)(2013-1#1)
of Chlamydia##6##2##(1990-5#2)(2008-5#2)(2010-12#1)(2013-1#1)
of ChromID ESBL agar##2##4##(2010-6#2)
of Cichorium endivia##2##3##(2013-1#2)
of Cincinnati##3##2##(1993-1#1)(1994-12#1)(2008-5#1)
of Cistanche species##3##3##(2011-2#3)
of Cistanche##4##2##(2011-2#4)
of Citrus Tristeza Virus##2##4##(2008-10#2)
of Citrus limetta##2##3##(2012-3#2)
of Citrus tristeza virus##3##4##(2008-10#3)
of Citrus##12##2##(2008-10#10)(2012-3#2)
of Ciwujia##2##2##(2011-2#2)
of Cl##3##2##(1996-9#1)(2008-10#2)
of Cl(-)##7##2##(2008-10#5)(2009-8#1)(2012-7#1)
of ClO(3)(-)-ClO(2)(-)##2##2##(2008-10#2)
of Cladosporium tenuissimum##2##3##(2008-10#2)
of Cladosporium##3##2##(2008-10#3)
of Clark##2##2##(1991-7#1)(2008-11#1)
of Class Analogy##2##3##(2008-10#2)
of Class II##2##3##(2008-11#1)(2013-1#1)
of Class Pi##2##3##(1990-2#2)
of Class##7##2##(1990-2#2)(1995-6#1)(2008-10#2)(2008-11#1)(2013-1#1)
of Clavibacter michiganensis subsp##4##4##(2008-10#4)
of Claviceps##2##2##(2008-10#2)
of Cleome##2##2##(2010-2#1)(2013-8#1)
of Clinical Oncology##5##3##(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#1)
of Clinical##25##2##(1991-3#2)(1994-12#8)(1996-2#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#3)
of Clostridium botulinum##3##3##(1992-3#2)(2011-2#1)
of Clostridium perfringens##3##3##(2010-6#1)(2011-2#2)
of Clostridium##7##2##(1992-3#2)(2010-6#1)(2011-2#4)
of CmPGIP##2##2##(2008-10#2)
of CnH##2##2##(1993-6#2)
of Cnidium monnieri fruits in different regions of China##2##9##(2008-10#2)
of Co##11##2##(2008-10#11)
of Co(2+) and Cu(2+)##2##4##(2008-10#2)
of Co(2+)##7##2##(2008-10#6)(2008-3#1)
of Co(II) and Zn(II)##4##4##(2008-10#4)
of Co(II) and##6##3##(2008-10#6)
of Co(II) determination##2##3##(2008-10#2)
of Co(II) was##2##3##(2008-10#2)
of Co(II) with##4##3##(2008-10#4)
of Co(II)##25##2##(2008-10#25)
of Co(III)##3##2##(2008-10#3)
of CoPc-modified##2##2##(2008-10#2)
of CoQ10 in##2##3##(1993-3#2)
of CoQ10##6##2##(1993-3#4)(2013-1#2)
of Cochlospermum##2##2##(2008-12#2)
of Colletotrichum acutatum and##2##4##(2008-10#2)
of Colletotrichum acutatum on Symptomless Strawberry Leaves##2##7##(2008-10#2)
of Colletotrichum acutatum on##3##4##(2008-10#3)
of Colletotrichum acutatum were##2##4##(2008-10#2)
of Colletotrichum acutatum##13##3##(2008-10#13)
of Colletotrichum gloeosporioides##6##3##(2008-10#6)
of Colletotrichum graminicola##2##3##(2008-10#2)
of Colletotrichum lindemuthianum##3##3##(2008-10#3)
of Colletotrichum spp##5##3##(2008-10#5)
of Colletotrichum##33##2##(2008-10#33)
of Colombian##4##2##(2011-2#3)(2013-1#1)
of Colonization##2##2##(2008-10#2)
of Combination##2##2##(2009-6#1)(2013-1#1)
of Commerce##2##2##(1997-2#1)(2008-11#1)
of Common Blight Bacteria (Xanthomonas campestris pv##2##7##(2008-10#2)
of Common##5##2##(1995-12#2)(2008-10#3)
of Community##3##2##(1995-3#1)(1995-6#1)(2009-12#1)
of Con A##2##3##(2008-10#2)
of Conidia of##2##3##(2008-10#2)
of Connecticut##2##2##(1996-9#1)(1997-3#1)
of Control##2##2##(1994-2#1)(2009-10#1)
of Control)##3##2##(1994-2#3)
of Corn##3##2##(2008-10#3)
of Corynebacterium glutamicum##3##3##(2008-7#3)
of Corynebacterium species##2##3##(2008-5#2)
of Corynebacterium##5##2##(2008-5#2)(2008-7#3)
of Cotesia##2##2##(2008-8#1)(2010-4#1)
of Cotton##2##2##(2008-10#2)
of Cougarblight##2##2##(2008-10#2)
of CpG islands##2##3##(1995-12#2)
of CpG##6##2##(1993-2#1)(1995-12#2)(2008-4#3)
of Cr##15##2##(2008-10#14)(2009-12#1)
of Cr(2)O(3) for the standard##2##5##(2008-10#2)
of Cr(2)O(3)##4##2##(2008-10#4)
of Cr(3+)##4##2##(2008-10#4)
of Cr(III) and Cr(VI) in river and reservoir water##2##9##(2008-10#2)
of Cr(III) and Cr(VI) in water samples##2##7##(2008-10#2)
of Cr(III) and Cr(VI) in water##3##6##(2008-10#3)
of Cr(III) and Cr(VI) in##7##5##(2008-10#7)
of Cr(III) and Cr(VI)##12##4##(2008-10#12)
of Cr(III) and##13##3##(2008-10#13)
of Cr(III) ions##5##3##(2008-10#5)
of Cr(III) to Cr(VI)##4##4##(2008-10#4)
of Cr(III) with##3##3##(2008-10#3)
of Cr(III)##40##2##(2008-10#40)
of Cr(III)TTHA##2##2##(2008-10#2)
of Cr(VI) and Cr(III)##4##4##(2008-10#4)
of Cr(VI) and Pb(II)##3##4##(2008-10#3)
of Cr(VI) and##8##3##(2008-10#8)
of Cr(VI) concentrations##2##3##(2008-10#2)
of Cr(VI) in the##2##4##(2008-10#2)
of Cr(VI) in##9##3##(2008-10#9)
of Cr(VI) on##2##3##(2008-10#2)
of Cr(VI) was##5##3##(2008-10#5)
of Cr(VI) with##4##3##(2008-10#4)
of Cr(VI)##48##2##(2008-10#46)(2011-2#2)
of Cr1##2##2##(2008-10#2)
of Cr2##4##2##(2008-10#4)
of CrEL##2##2##(2008-10#2)
of Creutzfeldt-Jakob disease##2##3##(1996-8#1)(2008-5#1)
of Crinipellis perniciosa##2##3##(2008-10#2)
of Croatia##4##2##(2008-10#1)(2011-2#3)
of Croatian scientists##2##3##(2013-1#2)
of Croatian##4##2##(2013-1#4)
of Crohn disease##3##3##(1993-2#1)(1997-8#2)
of Crohn's disease and##2##4##(1990-3#1)(2010-12#1)
of Crohn's disease in##2##4##(2010-12#2)
of Crohn's disease##15##3##(1990-3#2)(1994-6#2)(1997-5#1)(2008-10#1)(2010-12#7)(2012-2#1)(2013-1#1)
of Crohn's##17##2##(1990-3#2)(1994-6#2)(1997-5#1)(2008-10#2)(2010-12#8)(2012-2#1)(2013-1#1)
of Cronartium ribicola##5##3##(2008-10#5)
of Cronbach's##2##2##(2009-12#2)
of CryIA(b)##2##2##(2008-10#2)
of Cryphonectria parasitica##3##3##(2008-10#3)
of Cryphonectria##4##2##(2008-10#4)
of Cryptococcus neoformans var##5##4##(2008-5#5)
of Cryptococcus neoformans##7##3##(2008-5#7)
of Cryptococcus##10##2##(2008-10#1)(2008-5#9)
of Cryptosporidium##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
of CsA##4##2##(1991-9#1)(1994-8#1)(2008-6#2)
of Cu and Pb##2##4##(2008-10#2)
of Cu and Zn##3##4##(2008-10#3)
of Cu and##10##3##(2008-10#9)(2008-12#1)
of Cu in##3##3##(2008-10#3)
of Cu on##3##3##(2008-10#2)(2008-12#1)
of Cu##53##2##(1995-6#2)(1997-8#4)(2008-10#42)(2008-11#2)(2008-12#2)(2012-2#1)
of Cu(2+) in##2##3##(2008-10#1)(2008-12#1)
of Cu(2+) ion##2##3##(2008-10#2)
of Cu(2+) ions##2##3##(2008-10#2)
of Cu(2+) with a##2##4##(2008-10#2)
of Cu(2+) with##5##3##(2008-10#5)
of Cu(2+)##22##2##(2008-10#20)(2008-12#2)
of Cu(II) and Ni(II)##3##4##(2008-10#3)
of Cu(II) and Zn(II)##2##4##(2008-10#2)
of Cu(II) and##10##3##(2008-10#9)(2013-1#1)
of Cu(II) by##2##3##(2008-10#2)
of Cu(II) from##3##3##(2008-10#3)
of Cu(II) in##8##3##(2008-10#8)
of Cu(II) ions##2##3##(2008-10#2)
of Cu(II) was##2##3##(2008-10#2)
of Cu(II) with##10##3##(2008-10#10)
of Cu(II)##57##2##(2008-10#56)(2013-1#1)
of Cu(II)/tetraglycine##2##2##(2008-10#2)
of Cu(II)L(2)##2##2##(2008-10#2)
of Cu-adenine##2##2##(2008-10#2)
of CuLCV-AZ and##2##3##(2008-10#2)
of CuSO(4) induced S2MtEGFP##2##4##(2008-11#2)
of CuSO(4)##4##2##(2008-10#1)(2008-11#3)
of CuSO₄##3##2##(2010-11#3)
of Cucumber mosaic virus (CMV)##3##5##(2008-10#3)
of Cucumber mosaic virus##6##4##(2008-10#6)
of Culex quinquefasciatus##2##3##(2007-12#2)
of Current##2##2##(1997-3#2)
of Cushing's syndrome##3##3##(1990-11#1)(1991-10#1)(2011-2#1)
of Cx43##2##2##(2008-11#2)
of Cys##2##2##(2008-10#1)(2012-2#1)
of Cys/Sec replacement##2##3##(2012-2#2)
of D##46##2##(1993-12#4)(1995-3#2)(2007-12#1)(2008-10#25)(2008-8#1)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#5)
of D-alanine into##3##3##(1995-6#3)
of D-alanine##5##2##(1991-12#1)(1995-6#4)
of D-amphetamine##5##2##(1993-6#5)
of D-dimer##4##2##(2010-3#1)(2011-2#3)
of D-glucosaminic acid##2##3##(2011-2#2)
of D-glucosaminic##3##2##(2011-2#3)
of D1 dopamine receptors##2##4##(1994-2#2)
of D1R- and##2##3##(2013-8#2)
of D29 cells##2##3##(2008-11#2)
of D4T##5##2##(1991-3#2)(2008-7#3)
of DA in##2##3##(1996-12#1)(2008-10#1)
of DA##8##2##(1996-12#3)(1997-2#2)(2008-10#3)
of DA-9601##3##2##(2008-11#3)
of DAB2IP##2##2##(2013-1#2)
of DAPG##2##2##(2008-10#2)
of DAT##2##2##(1996-12#1)(2008-6#1)
of DB exercise##2##3##(2012-2#2)
of DBTC##2##2##(2008-10#2)
of DC##10##2##(2008-10#3)(2008-11#4)(2008-9#1)(2012-2#2)
of DCPC system##2##3##(2013-8#2)
of DCs##4##2##(2008-11#2)(2011-2#1)(2012-2#1)
of DD##2##2##(2008-10#1)(2011-2#1)
of DEET through##2##3##(2008-5#2)
of DEET##4##2##(2008-5#4)
of DEJ##4##2##(2008-5#3)(2010-10#1)
of DES##3##2##(2008-10#3)
of DETA##3##2##(2008-10#3)
of DGPS##2##2##(2009-10#2)
of DHAA##2##2##(1997-2#2)
of DHN1 expression and subcellular distribution in A##2##8##(2008-9#2)
of DHZS##2##2##(2008-10#2)
of DI RNAs##3##3##(2008-10#3)
of DIV##3##2##(2008-10#2)(2011-2#1)
of DKT##4##2##(2011-2#4)
of DKTP##2##2##(2008-10#2)
of DLA-EIAV and EIAV L##2##5##(2008-9#2)
of DLA-EIAV and##3##3##(2008-9#3)
of DLA-EIAV##5##2##(2008-9#5)
of DM##4##2##(2008-5#1)(2012-2#3)
of DMA##8##2##(2008-10#8)
of DME##6##2##(2008-1#2)(2011-7#4)
of DMF##3##2##(2008-10#3)
of DMI##2##2##(2008-10#2)
of DMSO##2##2##(2008-10#2)
of DMT##2##2##(2008-10#2)
of DN##2##2##(2008-1#2)
of DNA adduct formation##3##4##(1993-8#2)(1995-9#1)
of DNA adducts##2##3##(1993-8#1)(2008-10#1)
of DNA and RNA##4##4##(2008-10#1)(2008-4#1)(2008-9#2)
of DNA and proteins##2##4##(1991-6#2)
of DNA and the##2##4##(2008-10#1)(2011-2#1)
of DNA and##13##3##(1991-6#2)(1994-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#2)(2011-2#1)
of DNA are##2##3##(2008-10#1)(2008-12#1)
of DNA as##2##3##(2008-10#1)(2008-11#1)
of DNA at the##2##4##(1995-6#1)(2008-10#1)
of DNA at##4##3##(1995-6#1)(1997-7#1)(2008-10#2)
of DNA bands##2##3##(2008-10#2)
of DNA biosynthesis##2##3##(1990-2#2)
of DNA content and DNA strand breaks##2##7##(2008-9#2)
of DNA content and##6##4##(2008-9#6)
of DNA content##11##3##(2008-9#11)
of DNA damage##8##3##(1994-8#2)(2008-10#1)(2008-4#2)(2008-9#1)(2011-2#1)(2013-1#1)
of DNA double-strand breaks##3##4##(1997-7#1)(2008-9#1)(2011-2#1)
of DNA double-strand##4##3##(1997-7#2)(2008-9#1)(2011-2#1)
of DNA extracted from##3##4##(2008-10#2)(2008-12#1)
of DNA extraction##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
of DNA fingerprints##2##3##(2008-5#2)
of DNA fragmentation##4##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-9#1)
of DNA fragments in##2##4##(2008-10#1)(2008-8#1)
of DNA fragments##7##3##(1993-2#1)(2008-10#4)(2008-4#1)(2008-8#1)
of DNA from##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
of DNA hybridisation##2##3##(2008-10#2)
of DNA hybridization##6##3##(2008-10#5)(2008-4#1)
of DNA in##5##3##(1991-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
of DNA into the##2##4##(1995-5#1)(2008-11#1)
of DNA into##4##3##(1993-9#1)(1995-5#1)(2008-11#2)
of DNA is##2##3##(2008-10#1)(2010-7#1)
of DNA markers##2##3##(2008-10#2)
of DNA methylation##5##3##(1995-12#1)(2008-8#1)(2009-4#1)(2013-8#2)
of DNA molecules##3##3##(2008-10#2)(2008-8#1)
of DNA of##4##3##(2008-10#4)
of DNA on##3##3##(2008-10#2)(2008-11#1)
of DNA oxidative damage##2##4##(2008-10#2)
of DNA ploidy##2##3##(2008-9#2)
of DNA polymerases##2##3##(1992-6#2)
of DNA polymorphism##2##3##(2008-10#2)
of DNA probes##2##3##(2008-10#1)(2008-4#1)
of DNA repair##8##3##(1993-11#1)(1993-8#2)(2008-11#4)(2011-2#1)
of DNA replication##3##3##(1994-11#1)(1994-3#1)(1997-3#1)
of DNA sequence##2##3##(1993-12#1)(2008-10#1)
of DNA sequences that##2##4##(1995-8#1)(2008-10#1)
of DNA sequences##6##3##(1995-8#1)(2008-10#4)(2008-4#1)
of DNA single-strand breaks##2##4##(1994-8#2)
of DNA strand##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
of DNA structure##2##3##(1994-3#1)(2008-4#1)
of DNA synthesis in hepatocytes##2##5##(1993-3#2)
of DNA synthesis##13##3##(1991-2#1)(1991-5#1)(1993-3#2)(1994-5#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-7#3)(2009-3#1)
of DNA topoisomerase II##2##4##(1995-6#1)(2008-11#1)
of DNA using##3##3##(2008-10#3)
of DNA were##2##3##(2008-10#1)(2008-9#1)
of DNA with##3##3##(1990-5#1)(1996-12#1)(2008-10#1)
of DNA##267##2##(1990-2#2)(1990-5#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#3)(1991-8#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#8)(1993-9#2)(1994-11#1)(1994-3#3)(1994-5#4)(1994-8#4)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#5)(2008-10#88)(2008-11#19)(2008-12#6)(2008-2#1)(2008-4#12)(2008-5#4)(2008-7#8)(2008-8#4)(2008-9#26)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
of DNA-A and DNA-B##2##4##(2008-10#2)
of DNA-A##3##2##(2008-10#3)
of DNA-dependent##2##2##(1995-2#1)(2013-1#1)
of DNA-protein##2##2##(1990-5#1)(2008-9#1)
of DO##2##2##(2008-10#2)
of DOM-bound##3##2##(2008-11#3)
of DON##4##2##(2008-10#4)
of DOPT was##2##3##(1997-2#2)
of DOT##2##2##(1996-3#2)
of DPH##3##2##(1991-5#1)(1995-8#1)(2008-9#1)
of DPKSH##3##2##(2008-10#3)
of DPM##4##2##(2008-7#4)
of DPPH radical##2##3##(2008-10#2)
of DR-ILD##3##2##(2011-2#3)
of DRG refinement##2##3##(1992-2#2)
of DRG##5##2##(1992-2#2)(1994-12#2)(1996-12#1)
of DRGs##2##2##(1992-2#1)(1994-12#1)
of DS salt##7##3##(2008-5#7)
of DS##12##2##(1996-2#1)(2008-5#7)(2012-2#4)
of DSB repair and##2##4##(2013-1#2)
of DSB repair##3##3##(2011-2#1)(2013-1#2)
of DSBs##2##2##(1995-8#2)
of DSKNPH##5##2##(2008-10#5)
of DT-diaphorase##3##2##(1995-8#3)
of DTBTA-Eu(3+)-labeled##2##2##(2008-10#2)
of DTPA and BHT##4##4##(2008-5#4)
of Daily Living##8##3##(2008-7#5)(2011-2#2)(2012-2#1)
of Danish##2##2##(1990-6#1)(1997-3#1)
of Data##2##2##(1991-8#1)(1996-8#1)
of Daucus glaber Forssk##2##4##(2008-11#2)
of Deaf##2##2##(2011-2#2)
of Defense##6##2##(1995-6#1)(1996-12#1)(1996-5#2)(2008-10#2)
of Degenerate Primers for##2##4##(2008-10#2)
of Delhi##3##2##(1994-9#3)
of Delta##2##2##(2008-10#2)
of DeltaA'-plants##2##2##(2008-10#2)
of Dental Medicine##2##3##(2013-1#2)
of Dental##4##2##(2008-11#1)(2013-1#3)
of Dermatology##2##2##(2008-5#1)(2008-6#1)
of DiYMV were##2##3##(2008-10#2)
of Diagnostic Accuracy##2##3##(2008-12#2)
of Diagnostic##4##2##(2008-10#1)(2008-12#3)
of Diaporthe phaseolorum and Phomopsis longicolla from##2##7##(2008-10#2)
of Diaporthe phaseolorum and Phomopsis longicolla##3##6##(2008-10#3)
of Diaporthe phaseolorum##4##3##(2008-10#4)
of Didymella rabiei##5##3##(2008-10#5)
of Didymella##6##2##(2008-10#6)
of Diet in Renal Disease##3##5##(1994-3#1)(2011-2#1)(2013-1#1)
of Different Genotypes of##2##4##(2008-10#2)
of Different##3##2##(2008-10#2)(2009-1#1)
of Distinct##2##2##(2008-10#2)
of Diversity in##2##3##(2008-10#2)
of Diversity##5##2##(2008-10#5)
of DnaC##3##2##(1991-12#3)
of Dnl4##2##2##(1997-7#2)
of Doehlert designs##2##3##(2008-10#2)
of Doehlert##4##2##(2008-10#4)
of Dothistroma needle blight##3##4##(2008-10#3)
of Dothistroma##4##2##(2008-10#4)
of Double##2##2##(2008-10#1)(2013-8#1)
of Douglas-fir##2##2##(2008-10#2)
of Dr##5##2##(1993-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
of Drosophila and##2##3##(1990-3#2)
of Drosophila hydei##2##3##(1993-12#2)
of Drosophila melanogaster##11##3##(1993-6#1)(1995-6#1)(1997-8#3)(2007-12#1)(2008-11#2)(2008-9#2)(2010-1#1)
of Drosophila##26##2##(1990-3#2)(1993-12#3)(1993-6#1)(1995-6#3)(1997-7#2)(1997-8#3)(2007-12#1)(2008-11#2)(2008-8#2)(2008-9#4)(2010-1#1)(2012-3#2)
of Drug##2##2##(1991-1#1)(2010-11#1)
of DuP 532##2##3##(1991-5#2)
of Duke's##2##2##(2012-12#1)(2012-2#1)
of Dural##2##2##(1996-9#1)(2012-3#1)
of Dutch##5##2##(1990-6#1)(2008-10#2)(2008-5#1)(2011-2#1)
of E##59##2##(1990-5#2)(1991-12#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#2)(1997-8#1)(2008-10#29)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#5)(2009-12#1)(2010-3#2)(2012-2#2)(2012-3#1)(2013-1#1)
of E-cadherin##3##2##(2013-1#3)
of E1B-19K##2##2##(2008-11#2)
of E2 C16 alpha-hydroxylation##2##4##(1995-9#2)
of E2##10##2##(1995-12#2)(1995-9#4)(2008-10#2)(2008-11#1)(2008-9#1)
of E2F1/DP1 complex##2##3##(2012-2#2)
of E2F4 expression##3##3##(2011-2#3)
of E2F4##5##2##(2011-2#5)
of E3##2##2##(2008-4#1)(2009-10#1)
of EA##6##2##(1995-12#2)(1995-2#1)(2008-10#1)(2008-5#2)
of EAE##2##2##(2011-2#2)
of EAP##2##2##(1995-6#2)
of EB##2##2##(2008-10#2)
of EBL##2##2##(2008-12#2)
of EBV##5##2##(1993-8#1)(2008-2#1)(2008-5#2)(2008-9#1)
of EC##2##2##(1990-12#1)(2008-10#1)
of ECDs##3##2##(2010-1#3)
of ECH in##2##3##(2008-10#2)
of ECH##4##2##(2008-10#4)
of ECL##2##2##(2008-10#2)
of ECM in##3##3##(2009-10#2)(2013-8#1)
of ECM##9##2##(2009-10#2)(2011-2#1)(2012-2#2)(2013-8#4)
of ED##8##2##(1996-12#1)(2008-7#1)(2009-11#1)(2010-9#1)(2011-2#3)(2012-2#1)
of EDO##2##2##(1997-8#2)
of EDRF1##5##2##(2008-8#4)(2008-9#1)
of EDTA and##3##3##(2008-10#3)
of EDTA in##2##3##(2008-10#2)
of EDTA with##2##3##(2008-10#2)
of EDTA##16##2##(1990-5#1)(2008-10#14)(2008-4#1)
of EE##3##2##(2009-11#1)(2013-8#2)
of EEG##3##2##(2008-7#1)(2010-8#2)
of EF-3##4##2##(1996-2#4)
of EG##2##2##(2008-10#2)
of EGF##4##2##(2008-6#3)(2010-5#1)
of EH##2##2##(2008-9#1)(2011-2#1)
of EHMC##2##2##(2008-10#2)
of EIB##2##2##(2010-1#2)
of EIN##2##2##(2011-2#2)
of ELBW teenagers##3##3##(2008-11#3)
of ELISA and##2##3##(1991-12#1)(2008-11#1)
of ELISA##7##2##(1991-1#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-9#1)
of EMG##4##2##(2010-8#1)(2012-12#3)
of EMLA##3##2##(1993-1#3)
of EMS##2##2##(1996-3#1)(2008-9#1)
of ENOX2##4##2##(2009-9#4)
of EOC##2##2##(2010-7#2)
of EP##3##2##(2008-10#3)
of EP-IPV##3##2##(1995-5#3)
of EPO##9##2##(2008-11#7)(2008-4#1)(2008-8#1)
of EPS I##3##3##(2008-10#3)
of EPS in##2##3##(2011-2#2)
of EPS##10##2##(2008-10#3)(2011-2#7)
of ER##4##2##(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
of ERCP in##2##3##(1991-9#1)(2013-1#1)
of ERCP##3##2##(1991-9#1)(2013-1#2)
of ERK activation##2##3##(2013-8#2)
of ERK##8##2##(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#5)
of ERK1-4##2##2##(2010-10#2)
of ERalpha mRNA##2##3##(2008-12#2)
of ERalpha##3##2##(2008-12#3)
of ERα##3##2##(2011-2#3)
of ES cell##4##3##(2008-11#3)(2012-2#1)
of ES cells##3##3##(2008-11#2)(2008-8#1)
of ES##11##2##(2008-11#5)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#3)
of ESAs##2##2##(2010-11#2)
of ESBL##2##2##(2010-6#1)(2012-2#1)
of ESRD##2##2##(1991-3#1)(1996-2#1)
of ESTs##2##2##(2010-10#1)(2010-4#1)
of ET in##3##3##(2008-10#2)(2012-3#1)
of ET##9##2##(2008-10#4)(2008-7#1)(2012-3#3)(2013-1#1)
of ET-1##9##2##(1993-3#5)(1994-8#4)
of ETAAS##3##2##(2008-10#3)
of ETOH##2##2##(1990-5#2)
of EU##3##2##(2008-10#1)(2008-11#2)
of EUS##2##2##(2008-2#1)(2013-1#1)
of EUSES##5##2##(2008-11#5)
of EV71##2##2##(2008-12#1)(2008-8#1)
of EVAR##2##2##(2010-12#2)
of Early##4##2##(1993-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
of Earth's##2##2##(1995-3#1)(2008-12#1)
of East Coast##2##3##(2010-1#2)
of East##5##2##(2008-10#1)(2008-8#1)(2010-1#2)(2010-8#1)
of Echinococcus multilocularis DNA##2##4##(1996-12#2)
of Economic##2##2##(1997-2#1)(2009-10#1)
of Education##6##2##(1991-12#4)(1992-3#1)(2008-11#1)
of Egyptian nursing home residents towards staying in a nursing home##2##11##(2010-10#2)
of Egyptian##3##2##(2008-10#1)(2010-10#2)
of Eh252 or 10##2##4##(2008-10#2)
of Eh252##4##2##(2008-10#4)
of Ehlers-Danlos syndrome##2##3##(2013-8#2)
of Electronic Health Records##2##4##(2010-8#2)
of Electronic Health##3##3##(2010-8#3)
of Embelia ribes##2##3##(2012-2#2)
of Embelia##4##2##(2012-2#4)
of Empathy and##2##3##(2008-11#1)(2013-1#1)
of English##2##2##(2008-11#1)(2013-8#1)
of Enterobacter cloacae##2##3##(2008-9#1)(2011-2#1)
of Enterobacteriaceae##2##2##(1997-5#1)(2008-5#1)
of Enterovirus##3##2##(2008-8#2)(2012-2#1)
of Environmental Factors##2##3##(2008-10#2)
of Environmental##10##2##(1991-12#1)(2008-10#5)(2008-11#2)(2008-9#2)
of Epinephelus coioides##2##3##(2008-12#2)
of Epistylis##3##2##(2008-9#3)
of Epo##3##2##(2008-11#3)
of Epstein-Barr##2##2##(1994-3#1)(2010-6#1)
of Er(3+)##3##2##(2007-11#2)(2008-3#1)
of Ergotamine Tartrate##2##3##(2008-10#2)
of Erwinia amylovora on##2##4##(2008-10#2)
of Erwinia amylovora was##2##4##(2008-10#2)
of Erwinia amylovora##10##3##(2008-10#10)
of Erwinia##13##2##(1990-5#1)(1993-8#1)(2008-10#11)
of Escherichia coli K-12##4##4##(1991-11#1)(1996-12#2)(2008-10#1)
of Escherichia coli K12##3##4##(1990-5#1)(2008-7#2)
of Escherichia coli was##3##4##(1991-5#1)(2008-10#1)(2008-8#1)
of Escherichia coli##46##3##(1990-11#2)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-5#2)(1995-2#1)(1995-6#4)(1996-12#3)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-7#4)(2008-8#2)(2009-6#1)(2012-3#1)
of Escherichia coliform (E##2##4##(2008-10#2)
of Escherichia coliform##3##3##(2008-10#3)
of Escherichia##50##2##(1990-11#2)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-5#2)(1995-2#1)(1995-6#4)(1996-12#3)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-7#4)(2008-8#2)(2009-6#1)(2012-3#1)
of EtOH##3##2##(1996-5#1)(2008-10#2)
of Ethylene Production##2##3##(2008-10#2)
of Eu##4##2##(2008-10#4)
of Eu(III)##2##2##(2008-10#2)
of Eucalyptus##4##2##(2008-10#2)(2008-5#1)(2010-3#1)
of Eucosma notanthes Meyrick##2##4##(2008-10#2)
of Eugenia##3##2##(2008-10#1)(2010-2#2)
of Europe and##2##3##(1997-6#1)(2008-10#1)
of Europe##5##2##(1997-6#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
of European American##2##3##(2008-12#1)(2011-2#1)
of European and##2##3##(2008-10#1)(2008-12#1)
of European species##2##3##(2008-8#2)
of European##22##2##(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#2)(2012-7#1)
of Eutypa lata and Eutypella vitis in##2##7##(2008-10#2)
of Eutypa##8##2##(2008-10#8)
of Experimental##3##2##(2009-8#2)(2012-2#1)
of Expt##2##2##(1992-12#1)(1993-6#1)
of Extracellular##2##2##(2008-10#1)(2013-8#1)
of F##100##2##(2008-10#96)(2008-5#1)(2008-9#1)(2009-8#1)(2013-1#1)
of F(-)##3##2##(2008-10#3)
of F(0) was##2##3##(2008-8#2)
of F(0)##5##2##(2008-8#5)
of F(1)##5##2##(2008-10#4)(2008-9#1)
of F(2)##3##2##(2008-10#3)
of F(3) families##2##3##(2008-10#2)
of F-actin##10##2##(1991-5#1)(1993-8#1)(1994-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2012-2#1)
of F1##3##2##(2008-11#3)
of F1-ATPase##2##2##(1990-2#2)
of F113##2##2##(2008-10#2)
of F3TdR##3##2##(1994-8#3)
of FA##7##2##(2008-10#2)(2008-4#2)(2008-5#1)(2013-1#2)
of FAD##3##2##(1992-1#1)(1996-8#2)
of FAE##2##2##(2011-1#1)(2013-1#1)
of FAs##4##2##(2008-10#3)(2013-1#1)
of FB(1)##3##2##(2008-10#3)
of FBA/NE-ISG was##2##3##(2011-3#2)
of FBA/NE-ISG##3##2##(2011-3#3)
of FBS##2##2##(2008-11#2)
of FDP##4##2##(2008-10#4)
of FFA##2##2##(2008-10#2)
of FFS##2##2##(1993-12#1)(1997-2#1)
of FGD cases##2##3##(2011-1#2)
of FGF receptor##2##3##(1997-1#1)(1997-7#1)
of FGFR##2##2##(1997-1#1)(2013-1#1)
of FHB and GER##3##4##(2008-10#3)
of FHB resistance##2##3##(2008-10#2)
of FHB##9##2##(2008-10#7)(2011-10#2)
of FIA systems##2##3##(2008-10#2)
of FIA##12##2##(2008-10#12)
of FIX protein##3##3##(1995-2#3)
of FL##3##2##(2010-11#3)
of FLIP##4##2##(2009-9#3)(2011-2#1)
of FLLs##2##2##(2010-12#2)
of FM patients##2##3##(2009-11#1)(2010-12#1)
of FMOC##2##2##(2008-10#2)
of FMS##2##2##(2011-2#2)
of FN##8##2##(1994-11#3)(2008-7#3)(2012-2#2)
of FNAB##3##2##(2008-10#2)(2011-1#1)
of FP-IX##3##2##(1994-8#3)
of FPs##2##2##(2008-6#2)
of FRM2##2##2##(1996-3#2)
of FS##2##2##(1991-12#1)(2008-10#1)
of FSH##6##2##(1993-11#3)(1995-11#2)(2012-12#1)
of FT-IR##2##2##(2008-10#2)
of Fallot##4##2##(1997-3#2)(2009-10#1)(2012-3#1)
of Family and##2##3##(1993-5#1)(2013-1#1)
of Family##9##2##(1991-1#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1996-8#1)(1997-8#1)(2012-3#1)(2013-1#1)
of Fasciola eggs##2##3##(1996-12#2)
of Fasciola##5##2##(1996-12#3)(2009-8#1)(2012-2#1)
of Fatty Acids##2##3##(2008-10#1)(2009-8#1)
of Fc receptor-mediated phagocytosis in##2##5##(1993-6#1)(1994-6#1)
of Fc##3##2##(1993-6#1)(1994-6#2)
of Fe and Ni##3##4##(2008-10#3)
of Fe and##7##3##(2008-10#6)(2013-8#1)
of Fe in##2##3##(2008-10#2)
of Fe##27##2##(1996-2#2)(2008-10#21)(2008-12#1)(2010-11#2)(2013-8#1)
of Fe(3+) in##3##3##(2008-10#3)
of Fe(3+) using##2##3##(2008-10#2)
of Fe(3+)##10##2##(2008-10#9)(2010-11#1)
of Fe(II) and Fe(III) with##2##5##(2008-10#2)
of Fe(II) and Fe(III)##10##4##(2008-10#10)
of Fe(II) and total-Fe##2##4##(2008-10#2)
of Fe(II) and##12##3##(2008-10#12)
of Fe(II) to##2##3##(2008-10#2)
of Fe(II) uptake##3##3##(1996-2#3)
of Fe(II)##36##2##(1996-2#5)(2008-10#30)(2008-5#1)
of Fe(III) and Fe(II)##7##4##(2008-10#7)
of Fe(III) and##10##3##(2008-10#10)
of Fe(III) in##5##3##(2008-10#5)
of Fe(III) to Fe(II)##2##4##(2008-10#2)
of Fe(III)##34##2##(2008-10#34)
of FeS at##2##3##(1995-6#2)
of FeS##4##2##(1995-6#3)(2008-10#1)
of FeSO(4)##2##2##(2008-11#2)
of Federal##3##2##(1995-12#1)(1996-3#2)
of Fiber##2##2##(2008-10#1)(2008-3#1)
of Fiji##2##2##(2008-1#2)
of Fis##2##2##(2008-7#2)
of Fitness for Practice##2##4##(2008-11#2)
of Flame x##2##3##(2008-10#2)
of Flavescence dorée phytoplasma##2##4##(2008-10#2)
of Florence##3##2##(1991-6#2)(1992-2#1)
of Florida##4##2##(1992-1#2)(2008-10#2)
of Fo-B2##4##2##(2008-10#4)
of Fo47##4##2##(2008-10#4)
of Forensic##4##2##(1997-8#2)(2008-12#1)(2011-2#1)
of Fos##2##2##(1996-12#2)
of Fos-LI##3##2##(1994-2#3)
of Fos-like##3##2##(1997-2#3)
of Fot1##2##2##(2008-10#2)
of Four##2##2##(2008-10#2)
of Fourier transform infrared spectrometry##2##5##(2008-10#2)
of Fourier transform##3##3##(2008-10#2)(2008-3#1)
of Fourier##4##2##(1993-3#1)(2008-10#2)(2008-3#1)
of Framesearch##2##2##(2008-9#2)
of France##5##2##(2008-10#4)(2010-1#1)
of Frank##2##2##(1996-3#1)(2008-8#1)
of Frankliniella fusca##2##3##(2008-10#2)
of French##2##2##(1997-5#1)(2008-10#1)
of Freund's##2##2##(1996-12#1)(1997-2#1)
of Functioning##4##2##(1991-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
of Fungal##4##2##(2008-10#4)
of Fungi##2##2##(2008-10#2)
of Fungicides##2##2##(2008-10#2)
of Fusarium Wilt in##2##4##(2008-10#2)
of Fusarium Wilt of Chickpea##2##5##(2008-10#2)
of Fusarium Wilt of Tomato by Nonpathogenic Fusarium##3##8##(2008-10#3)
of Fusarium Wilt of##7##4##(2008-10#7)
of Fusarium Wilt##10##3##(2008-10#10)
of Fusarium crown and root rot of##3##7##(2008-10#3)
of Fusarium culmorum##3##3##(2008-10#3)
of Fusarium graminearum##5##3##(2008-10#5)
of Fusarium head blight (FHB)##3##5##(2008-10#3)
of Fusarium head blight##4##4##(2008-10#4)
of Fusarium moniliforme##2##3##(2008-10#2)
of Fusarium oxysporum and##2##4##(2008-10#2)
of Fusarium oxysporum f##32##4##(2008-10#32)
of Fusarium oxysporum##44##3##(2008-10#44)
of Fusarium solani f##5##4##(2008-10#5)
of Fusarium solani##6##3##(2008-10#5)(2008-7#1)
of Fusarium spp##9##3##(2008-10#9)
of Fusarium verticillioides##2##3##(2008-10#2)
of Fusarium were##3##3##(2008-10#3)
of Fusarium wilt epidemics##4##4##(2008-10#4)
of Fusarium wilt in##2##4##(2008-10#2)
of Fusarium wilt of chickpea##2##5##(2008-10#2)
of Fusarium wilt of flax##3##5##(2008-10#3)
of Fusarium wilt of##7##4##(2008-10#7)
of Fusarium wilt##21##3##(2008-10#21)
of Fusarium##124##2##(2008-10#121)(2008-5#2)(2008-7#1)
of G alpha subunits##2##4##(1995-6#2)
of G protein##3##3##(1995-11#1)(2008-9#2)
of G proteins in##2##4##(1993-3#1)(2008-9#1)
of G proteins##4##3##(1993-3#1)(1995-11#1)(1995-6#1)(2008-9#1)
of G##60##2##(1993-3#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-6#3)(1997-7#1)(2008-10#40)(2008-12#1)(2008-5#2)(2008-9#4)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#1)
of G(o alpha)##2##3##(1992-9#2)
of G(o)alpha GDP##2##3##(2008-9#2)
of G(o)alpha##5##2##(2008-9#5)
of G-CSF##2##2##(2008-10#1)(2011-2#1)
of G-LDL##2##2##(1991-5#2)
of G-actin##6##2##(1992-4#5)(2011-2#1)
of G-protein coupled receptors##2##4##(1997-1#1)(2008-11#1)
of G-protein coupled##3##3##(1996-2#1)(1997-1#1)(2008-11#1)
of G-protein##4##2##(1996-2#1)(1997-1#1)(2008-11#1)(2012-2#1)
of G1##4##2##(1991-5#1)(1994-11#1)(2008-10#1)(2008-7#1)
of G3OH can bind##2##4##(1990-9#2)
of G4##2##2##(1991-7#2)
of G418##4##2##(2008-11#4)
of G6PD deficiency in##2##4##(2007-12#1)(2013-8#1)
of G6PD deficiency##3##3##(1991-2#1)(2007-12#1)(2013-8#1)
of GABA##5##2##(1992-12#1)(1992-3#1)(1994-2#1)(2008-7#1)(2008-8#1)
of GABA(A)##2##2##(2008-8#1)(2011-2#1)
of GABA- and##2##3##(1994-2#2)
of GABAA receptors##2##3##(1995-12#2)
of GABAA##3##2##(1995-11#1)(1995-12#2)
of GABAergic##2##2##(1990-5#1)(2011-2#1)
of GAD67##2##2##(1996-12#2)
of GAP##4##2##(2013-1#4)
of GAP-43##6##2##(1994-2#2)(2008-7#1)(2008-9#3)
of GAPDH##3##2##(1994-5#3)
of GB stones##2##3##(2013-8#2)
of GB##4##2##(2008-10#1)(2013-8#3)
of GBM cells##2##3##(2011-2#2)
of GBM##3##2##(2011-2#3)
of GBP for immobilizing the antibody on the sensor chip##2##10##(2008-10#2)
of GBP##4##2##(1992-6#2)(2008-10#2)
of GC neurons##3##3##(2008-11#3)
of GC##9##2##(1997-1#1)(2008-10#4)(2008-11#3)(2009-8#1)
of GC-MS##2##2##(2008-10#1)(2008-5#1)
of GC7##3##2##(1997-1#3)
of GCG in##2##3##(2013-1#2)
of GCP##2##2##(1991-3#2)
of GCs##3##2##(2008-11#3)
of GDH##3##2##(1993-9#1)(2008-4#1)(2008-8#1)
of GDP##3##2##(1993-3#1)(1995-8#1)(2013-8#1)
of GDP/GTP exchange##2##3##(1995-6#1)(2008-9#1)
of GE##2##2##(1990-2#2)
of GEPR##2##2##(1996-12#2)
of GFAP##2##2##(1997-2#1)(1997-3#1)
of GFLV RNA-2 in##2##4##(2008-10#2)
of GFP as a##2##4##(1996-6#1)(2008-4#1)
of GFP fluorescence##2##3##(2008-11#1)(2008-9#1)
of GFP##17##2##(1996-6#3)(2008-10#1)(2008-11#5)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2011-3#1)
of GH and IGF-I##4##4##(2010-5#2)(2012-3#2)
of GH##12##2##(1994-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(2010-5#4)(2012-3#3)(2013-1#1)
of GHD##2##2##(2012-3#2)
of GHR##4##2##(2008-9#2)(2010-5#2)
of GHR1##3##2##(1995-8#2)(2010-5#1)
of GI and GII norovirus##2##5##(2013-8#2)
of GI events##2##3##(2008-11#2)
of GI##6##2##(2008-11#3)(2011-2#1)(2013-8#2)
of GIP##4##2##(1995-11#1)(1997-4#3)
of GIP(1-42)##2##2##(1997-4#2)
of GIS-derived and meteorological predictors##2##5##(2009-7#2)
of GIST##3##2##(2012-12#1)(2012-3#2)
of GLG6##2##2##(1990-12#2)
of GLP-1##2##2##(1995-8#1)(1996-2#1)
of GLS##2##2##(2008-10#2)
of GLUT##2##2##(1994-2#2)
of GLUT4##3##2##(1994-8#2)(2008-11#1)
of GM-CSF##2##2##(2008-8#2)
of GM1##2##2##(1993-3#2)
of GNPs##2##2##(1991-1#2)
of GOX in##2##3##(2008-10#2)
of GOx##2##2##(2008-10#2)
of GP##2##2##(2008-10#1)(2013-1#1)
of GPI##3##2##(1990-8#1)(1995-2#2)
of GPI-anchored##2##2##(2008-11#2)
of GPNMB##3##2##(2009-4#3)
of GR##3##2##(2008-11#1)(2011-2#2)
of GRNX were##2##3##(2011-2#2)
of GRV##3##2##(2008-10#3)
of GSG1##2##2##(1995-9#2)
of GSH depletion##2##3##(2008-7#2)
of GSH in##5##3##(2008-10#4)(2008-7#1)
of GSH##19##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-8#1)(2008-10#10)(2008-7#4)(2013-1#1)
of GSM##3##2##(2008-9#1)(2009-6#2)
of GST P##2##3##(1990-2#2)
of GST##3##2##(1990-2#2)(1995-6#1)
of GTP and##3##3##(1991-5#2)(1997-1#1)
of GTP gamma S##2##4##(1993-8#1)(1995-8#1)
of GTP##7##2##(1991-5#2)(1993-8#1)(1995-6#1)(1995-8#2)(1997-1#1)
of GUS activity of##2##4##(2008-8#2)
of GUS activity##3##3##(2008-8#2)(2008-9#1)
of GUS##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
of GVA##2##2##(2008-10#2)
of Ga(3+)##3##2##(2008-10#3)
of GaAs##2##2##(1996-9#1)(2008-3#1)
of Galen##7##2##(1996-3#2)(1996-6#4)(1996-9#1)
of Garcinia cambogia in##2##4##(2012-2#2)
of Garcinia cambogia##3##3##(2012-2#3)
of Gastroenterology##2##2##(2008-11#1)(2013-1#1)
of Gaucher disease in##2##4##(2008-10#2)
of Gaussian##2##2##(2008-3#2)
of GbCLH##2##2##(2008-11#2)
of Gcr1p##2##2##(1996-3#2)
of Gd and##2##3##(1997-8#1)(2008-10#1)
of Gd##4##2##(1997-8#3)(2008-10#1)
of Gdańsk##3##2##(2008-11#3)
of GeXP were##2##3##(2013-8#2)
of GeXP##3##2##(2013-8#3)
of Gender##2##2##(2011-2#1)(2012-3#1)
of General##6##2##(1991-12#1)(1994-6#2)(2008-10#1)(2011-2#2)
of Genetic##5##2##(1995-9#1)(2008-10#4)
of Geneva##2##2##(1990-11#1)(1996-11#1)
of Genoa syndrome##2##3##(2011-1#2)
of Genomic##2##2##(2008-6#1)(2011-2#1)
of Georgia##2##2##(1990-11#1)(1996-9#1)
of Germany##10##2##(1991-12#1)(1991-2#1)(1992-1#2)(1994-3#1)(1995-1#1)(1996-5#1)(2008-11#2)(2013-1#1)
of Gerumano##2##2##(2012-12#2)
of Gestalt##2##2##(2010-6#2)
of GhTub1 in##2##3##(2008-9#2)
of GhTub1##3##2##(2008-9#3)
of Giardia duodenalis in dairy and beef cattle##2##8##(2012-3#2)
of Giardia##4##2##(2008-8#1)(2012-12#1)(2012-3#2)
of Gibberella zeae##4##3##(2008-10#4)
of Gilbertiodendron##2##2##(2008-8#2)
of Ginkgo biloba##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
of Glioblastoma##2##2##(2012-3#1)(2013-1#1)
of Glomerella##2##2##(2008-10#2)
of Glu-98 was##3##3##(1995-6#3)
of Glu-98##5##2##(1995-6#5)
of GluR-B##2##2##(1993-12#2)
of GluR1##2##2##(2008-7#2)
of Glucolevel##3##2##(2008-10#3)
of GnRH##6##2##(1994-8#1)(1995-11#3)(1996-2#2)
of Go Local##2##3##(2010-5#2)
of God means##2##3##(2013-1#2)
of God##6##2##(2009-10#1)(2013-1#5)
of Goiás##2##2##(2008-10#1)(2011-2#1)
of Golgi##2##2##(1993-9#1)(2008-8#1)
of Gorgan##2##2##(2008-12#2)
of Governmental##5##2##(1996-3#4)(2008-10#1)
of Grade I##2##3##(2011-2#1)(2012-12#1)
of Grade##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
of Gram-negative bacilli##2##3##(2012-2#2)
of Gram-negative##4##2##(1995-2#1)(2007-12#1)(2012-2#2)
of Granada##3##2##(2008-5#3)
of Grape##5##2##(2008-10#5)
of Grapevine fanleaf virus##3##4##(2008-10#3)
of Grapevine leafroll-associated virus-5##2##4##(2008-10#2)
of Grapevine leafroll-associated##3##3##(2008-10#3)
of Grapevine##12##2##(2008-10#12)
of Gray's##2##2##(2008-8#1)(2010-1#1)
of Greater##2##2##(1994-1#1)(1995-12#1)
of Greek##5##2##(2008-11#1)(2010-4#1)(2010-6#1)(2011-2#2)
of Green S##2##3##(1993-8#2)
of Green##8##2##(1993-8#2)(2008-10#6)
of Gremmeniella abietina##4##3##(2008-10#4)
of Groundnut rosette assistor virus##2##5##(2008-10#2)
of Groundnut rosette##3##3##(2008-10#3)
of Group##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
of Gs alpha##2##3##(1994-2#1)(1995-6#1)
of Guillain-Barré syndrome##3##3##(1991-11#1)(2012-3#2)
of Guinea pig##2##3##(2013-1#2)
of Gus mRNA##2##3##(1993-8#2)
of Gus##3##2##(1993-8#2)(1996-5#1)
of H##59##2##(1990-5#1)(1991-8#2)(1993-12#1)(1995-2#1)(1996-12#2)(1997-1#6)(2008-10#26)(2008-11#2)(2008-12#4)(2008-5#4)(2008-7#2)(2008-8#3)(2009-6#1)(2009-8#1)(2010-10#1)(2012-2#1)(2012-8#1)
of H(2)O(2) and##6##3##(2008-10#5)(2013-1#1)
of H(2)O(2) in the##3##4##(2008-10#3)
of H(2)O(2) in##9##3##(2008-10#9)
of H(2)O(2) with##2##3##(2008-10#2)
of H(2)O(2)##42##2##(2008-10#40)(2010-4#1)(2013-1#1)
of H(2)S##2##2##(2008-10#2)
of H(2)SO(4) and##3##3##(2008-10#3)
of H(2)SO(4)##4##2##(2008-10#4)
of H+##2##2##(1995-2#1)(1997-8#1)
of H-H##2##2##(2010-4#2)
of H-point##2##2##(2008-10#2)
of H1(0)##3##2##(1993-6#3)
of H2O##2##2##(2008-3#2)
of H2O2##4##2##(1997-4#1)(2008-10#1)(2008-12#1)(2013-8#1)
of H7 subtype##2##3##(2013-8#2)
of H9 cells##2##3##(1994-11#1)(1997-1#1)
of HA and FA##3##4##(2008-10#3)
of HA and##8##3##(1993-12#1)(2008-10#4)(2009-7#1)(2011-2#1)(2013-8#1)
of HA on##2##3##(2010-8#1)(2013-8#1)
of HA##24##2##(1990-5#1)(1993-12#1)(2008-10#10)(2008-5#1)(2009-7#2)(2010-10#1)(2010-8#1)(2011-2#3)(2013-8#4)
of HAC##2##2##(2008-11#2)
of HAG1##2##2##(2008-8#2)
of HAV##2##2##(2007-12#1)(2009-5#1)
of HAc-NaAc##2##2##(2008-10#2)
of HB-EGF mRNA##3##3##(1997-1#3)
of HB-EGF##4##2##(1997-1#4)
of HBD-2##3##2##(2011-3#3)
of HBV DNA##2##3##(1990-8#1)(2013-1#1)
of HBV and##2##3##(1995-5#1)(2009-8#1)
of HBV##13##2##(1990-8#1)(1995-2#3)(1995-5#1)(2008-10#2)(2009-12#1)(2009-8#2)(2013-1#3)
of HBc##2##2##(2008-8#2)
of HBsAg##6##2##(1995-2#2)(1996-3#1)(2008-10#1)(2013-1#2)
of HC##3##2##(2008-10#2)(2011-3#1)
of HC-Pro##2##2##(2008-10#2)
of HCA##2##2##(2009-8#2)
of HCC is##2##3##(2013-1#1)(2013-7#1)
of HCC##14##2##(1993-2#1)(2008-10#4)(2008-11#5)(2008-8#1)(2010-12#1)(2013-1#1)(2013-7#1)
of HCHO in##2##3##(2008-10#2)
of HCMV##4##2##(1997-3#3)(2008-9#1)
of HCO(3)(-)##2##2##(2008-10#2)
of HCV infection##3##3##(2009-8#1)(2011-2#1)(2013-1#1)
of HCV##12##2##(2008-10#5)(2009-8#1)(2011-2#3)(2013-1#3)
of HCc##2##2##(2008-8#2)
of HCl and##4##3##(2008-10#4)
of HCl##17##2##(1997-1#1)(2008-10#16)
of HD##3##2##(2008-10#3)
of HDC##2##2##(1997-1#2)
of HDL##5##2##(2008-6#4)(2011-2#1)
of HDR##2##2##(2009-2#2)
of HEG##3##2##(2008-10#3)
of HEL117##2##2##(1995-6#2)
of HF and##2##3##(2008-10#2)
of HF##8##2##(2008-10#6)(2013-8#2)
of HFA134a##4##2##(1996-1#3)(1996-2#1)
of HFK cells##2##3##(2008-11#2)
of HFMD##2##2##(2013-8#2)
of HG##4##2##(2008-10#2)(2008-7#2)
of HGF and EGF on##3##5##(1991-12#3)
of HGF and##4##3##(1991-12#3)(2008-11#1)
of HGF was##2##3##(2008-11#1)(2011-2#1)
of HGF##18##2##(1991-12#4)(1993-3#1)(2008-11#9)(2008-8#1)(2008-9#2)(2011-2#1)
of HHE##2##2##(2011-1#2)
of HIC1##2##2##(2009-8#2)
of HIF-1##3##2##(2009-4#1)(2010-7#2)
of HIV LTR-CAT##2##3##(1993-8#2)
of HIV disease##3##3##(1995-6#1)(2011-2#2)
of HIV in##3##3##(1996-11#1)(2008-1#1)(2013-1#1)
of HIV infected and##2##4##(1995-12#2)
of HIV infection among##2##4##(2011-2#2)
of HIV infection by##2##4##(1996-8#1)(2013-8#1)
of HIV infection on##2##4##(1992-9#1)(2013-8#1)
of HIV infection##20##3##(1992-9#2)(1993-11#1)(1993-3#1)(1994-11#1)(1995-12#2)(1995-6#1)(1996-11#3)(1996-5#1)(1996-8#1)(1997-6#1)(2011-2#3)(2013-8#3)
of HIV infections##3##3##(1993-3#1)(1996-9#1)(1997-6#1)
of HIV latency##2##3##(2012-12#2)
of HIV positive##2##3##(2008-5#1)(2013-1#1)
of HIV prevalence##2##3##(1992-9#1)(2011-2#1)
of HIV prevention community planning##3##5##(1997-2#3)
of HIV prevention##4##3##(1996-5#1)(1997-2#3)
of HIV transmission##3##3##(1995-6#1)(1996-5#1)(2009-5#1)
of HIV treatment##3##3##(2008-10#2)(2010-11#1)
of HIV##98##2##(1991-1#1)(1991-2#1)(1991-5#2)(1992-9#3)(1993-11#1)(1993-3#4)(1993-8#3)(1994-11#2)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#1)(1995-5#2)(1995-6#6)(1996-11#6)(1996-3#1)(1996-5#7)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#4)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#2)(2009-5#2)(2010-11#1)(2011-2#7)(2011-3#4)(2012-12#3)(2012-2#4)(2013-1#3)(2013-8#3)
of HIV-1 Infection##2##3##(2008-2#2)
of HIV-1 PR##2##3##(1991-9#1)(2011-3#1)
of HIV-1 Rev##2##3##(1993-8#2)
of HIV-1 by##2##3##(2011-3#2)
of HIV-1 in##3##3##(1992-12#1)(1992-9#2)
of HIV-1 infected##2##3##(1990-2#1)(2011-2#1)
of HIV-1 infection##4##3##(1991-1#1)(2008-11#1)(2008-2#2)
of HIV-1 integrase##2##3##(1992-6#1)(2011-3#1)
of HIV-1 on##2##3##(2008-11#2)
of HIV-1 p24CA##2##3##(1997-3#2)
of HIV-1 production##2##3##(1994-11#2)
of HIV-1 protease##2##3##(1991-9#2)
of HIV-1##53##2##(1990-2#1)(1991-1#1)(1991-9#3)(1992-12#1)(1992-6#1)(1992-9#4)(1993-8#2)(1994-11#3)(1994-5#1)(1996-5#1)(1997-3#5)(2008-11#4)(2008-2#5)(2008-5#1)(2009-8#1)(2011-2#3)(2011-3#12)(2013-1#2)(2013-8#2)
of HIV-infected patients##2##3##(2008-9#1)(2011-2#1)
of HIV-infected##5##2##(1993-3#1)(1996-5#1)(1997-6#1)(2008-9#1)(2011-2#1)
of HIV-positive##4##2##(1990-3#2)(2008-1#1)(2009-8#1)
of HIV/AIDS and##2##3##(2008-10#1)(2012-2#1)
of HIV/AIDS##11##2##(1997-2#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-6#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
of HL-60 cells##7##3##(1993-8#3)(1994-11#1)(2008-11#1)(2008-8#2)
of HL-60##8##2##(1993-8#3)(1994-11#1)(2008-11#2)(2008-8#2)
of HLA antibodies##2##3##(2008-9#2)
of HLA class I and##2##5##(2008-4#1)(2011-2#1)
of HLA class I heavy chain expression##2##7##(1997-9#2)
of HLA class I heavy##4##5##(1997-9#4)
of HLA class I##9##4##(1994-5#1)(1997-9#6)(2008-4#1)(2011-2#1)
of HLA class II genes##2##5##(1997-8#2)
of HLA class##11##3##(1994-5#1)(1997-8#2)(1997-9#6)(2008-4#1)(2011-2#1)
of HLA##23##2##(1994-5#1)(1997-8#4)(1997-9#7)(2008-10#2)(2008-4#1)(2008-9#4)(2011-2#4)
of HLA-B5##2##2##(1997-8#2)
of HM##3##2##(2008-10#1)(2008-9#2)
of HMC-1##3##2##(2011-2#3)
of HMG 2##3##3##(1990-3#3)
of HMG proteins##3##3##(1990-3#2)(2008-8#1)
of HMG##9##2##(1990-3#8)(2008-8#1)
of HMGA2##2##2##(2012-12#2)
of HMO##3##2##(1997-2#1)(2008-11#2)
of HMOs##5##2##(1991-3#3)(1996-3#1)(2008-11#1)
of HMQ##3##2##(2008-10#3)
of HMV-1 cells##3##3##(2008-11#3)
of HN protein##2##3##(2008-9#2)
of HN##4##2##(2008-9#4)
of HNO(3) and##3##3##(2008-10#3)
of HNO(3)##11##2##(2008-10#11)
of HO##5##2##(1995-2#1)(2008-10#1)(2012-2#3)
of HO-1##6##2##(1995-2#1)(2011-2#5)
of HORs##2##2##(2008-7#2)
of HP-beta-CD##2##2##(2008-10#2)
of HPA axis function##2##4##(2013-1#2)
of HPA axis##3##3##(2013-1#3)
of HPLC##15##2##(1990-11#1)(2008-10#14)
of HPTLC##2##2##(2008-10#2)
of HPV##5##2##(1992-10#1)(2011-3#1)(2012-3#2)(2013-1#1)
of HPV-16 infection##3##3##(2011-3#3)
of HPV-16##5##2##(1995-2#2)(2011-3#3)
of HPV-related##2##2##(1994-1#1)(2008-11#1)
of HPg##3##2##(1993-8#3)
of HPlg##2##2##(1993-8#2)
of HR##2##2##(2008-10#2)
of HRP##13##2##(2008-10#13)
of HRP-SjAb##4##2##(2008-10#4)
of HRV##4##2##(2012-2#1)(2013-8#3)
of HRV-positive##2##2##(2013-8#2)
of HS##6##2##(2008-10#6)
of HS-metal##2##2##(2008-10#2)
of HSA##4##2##(1997-6#2)(2008-10#2)
of HSP28##3##2##(1994-8#3)
of HSP70 and##3##3##(1993-8#1)(1994-8#1)(2008-9#1)
of HSP70##6##2##(1993-8#1)(1994-8#2)(2008-10#1)(2008-9#1)(2010-5#1)
of HSV##2##2##(2008-11#2)
of HTLV-1##2##2##(1990-3#1)(2011-2#1)
of HTLV-I##2##2##(1994-11#1)(2008-8#1)
of HUH7-ins##2##2##(2010-11#2)
of HUVEC##6##2##(2008-11#2)(2008-8#1)(2008-9#2)(2010-3#1)
of Haemophilus influenzae type b##2##5##(1990-12#1)(2007-11#1)
of Haemophilus paragallinarum##2##3##(2008-5#2)
of Haemophilus##5##2##(1990-12#2)(2007-11#1)(2008-5#2)
of Hansenula##2##2##(1993-12#1)(1995-9#1)
of Hawaii##4##2##(2008-1#1)(2008-10#3)
of Hb heme Fe(III)/Fe(II) redox couple##2##6##(2008-10#2)
of Hb in##2##3##(2008-10#2)
of Hb##8##2##(1992-11#2)(2008-10#6)
of HbA1c and##2##3##(2011-2#1)(2012-4#1)
of HbA1c##9##2##(1994-6#1)(2011-2#4)(2012-4#1)(2012-5#3)
of Hct in##2##3##(2011-3#2)
of Hct##9##2##(2011-3#9)
of HeLa cell##2##3##(1993-6#1)(2008-8#1)
of HeLa cells##9##3##(1997-1#1)(2008-11#1)(2008-8#6)(2009-4#1)
of HeLa##12##2##(1993-6#1)(1993-8#1)(1997-1#1)(2008-11#1)(2008-8#7)(2009-4#1)
of Head##2##2##(1990-9#1)(2009-4#1)
of Health Administration##2##3##(1992-1#1)(1996-1#1)
of Health Outcomes##2##3##(1994-1#1)(2012-12#1)
of Health Sciences##5##3##(2009-10#1)(2010-1#1)(2010-11#1)(2012-3#2)
of Health Services Management at the##2##6##(1991-2#1)(1996-1#1)
of Health Services Research##4##4##(2012-2#4)
of Health Services##7##3##(1991-2#1)(1994-12#1)(1996-1#1)(2012-2#4)
of Health and Human Services##7##5##(1993-12#2)(1994-1#1)(1996-2#1)(1996-5#1)(2008-7#1)(2012-2#1)
of Health and Human##8##4##(1993-12#2)(1994-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
of Health and##17##3##(1991-2#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
of Health has##3##3##(1997-1#1)(1997-2#1)(2010-8#1)
of Health in##3##3##(1994-1#1)(2008-5#1)(2008-9#1)
of Health of##2##3##(1997-5#1)(2008-10#1)
of Health##104##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#5)(1992-1#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-1#3)(1994-12#3)(1995-12#1)(1995-3#1)(1996-1#2)(1996-2#2)(1996-3#4)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#15)(2008-12#3)(2008-5#4)(2008-7#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-11#1)(2010-8#2)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#3)(2013-8#2)
of Health's##4##2##(2008-11#1)(2010-10#1)(2012-12#2)
of Healthcare##4##2##(1991-1#1)(1994-12#1)(1995-3#1)(2008-11#1)
of Helichrysum##2##2##(2008-11#2)
of Helicobacter pylori infection in##2##5##(1992-5#1)(2011-2#1)
of Helicobacter pylori infection##4##4##(1992-5#1)(1997-1#1)(2011-2#1)(2013-1#1)
of Helicobacter pylori##14##3##(1992-5#2)(1996-12#2)(1997-1#1)(1997-8#2)(2008-12#3)(2009-6#1)(2011-2#2)(2013-1#1)
of Helicobacter##15##2##(1990-2#1)(1992-5#2)(1996-12#2)(1997-1#1)(1997-8#2)(2008-12#3)(2009-6#1)(2011-2#2)(2013-1#1)
of Hematology##5##2##(2008-11#1)(2008-7#1)(2009-4#1)(2010-11#2)
of Hepatitis B##3##3##(2008-10#2)(2008-11#1)
of Hepatitis G virus##2##4##(2008-10#2)
of Hepatitis##5##2##(2008-10#4)(2008-11#1)
of Heterobasidion annosum in##3##4##(2008-10#3)
of Heterobasidion annosum##4##3##(2008-10#4)
of Heterodera glycines##6##3##(2008-10#6)
of Heterodera schachtii##2##3##(2008-10#2)
of Heterodera##8##2##(2008-10#8)
of Hf##5##2##(2008-10#5)
of Hg in##7##3##(2008-10#7)
of Hg species##2##3##(2008-10#2)
of Hg##17##2##(2008-10#16)(2008-7#1)
of Hg(2+)##7##2##(2008-10#7)
of Hg(I)##2##2##(2008-10#2)
of Hg(II) in pharmaceutical preparations##2##5##(2008-10#2)
of Hg(II) in the##2##4##(2008-10#2)
of Hg(II) in##9##3##(2008-10#9)
of Hg(II) ions by##2##4##(2008-10#2)
of Hg(II) ions##3##3##(2008-10#3)
of Hg(II) is##3##3##(2008-10#3)
of Hg(II) was##2##3##(2008-10#2)
of Hg(II) with##2##3##(2008-10#2)
of Hg(II)##26##2##(2008-10#26)
of Hg(II)-SCN##2##2##(2008-10#2)
of Hib vaccine##2##3##(2008-1#2)
of Hib##4##2##(2007-12#1)(2008-1#3)
of High##4##2##(1990-11#1)(2008-7#2)(2013-8#1)
of High-Fivetrade mark cells##2##4##(2008-11#2)
of Higher Education Institutions##2##4##(2008-11#2)
of Hispanics##2##2##(2011-2#2)
of Histoplasma capsulatum##2##3##(2008-5#2)
of Hoechst 33342##3##3##(2008-11#2)(2008-9#1)
of Hoechst##5##2##(2008-11#2)(2008-9#3)
of Hospital##3##2##(1994-2#1)(2008-8#1)(2013-8#1)
of Host##10##2##(2008-10#10)
of Hox##4##2##(1993-12#1)(2008-9#1)(2012-2#2)
of Hsp70 in##2##3##(1991-9#2)
of Hsp70##5##2##(1991-9#5)
of Hsp90##2##2##(1997-4#1)(2010-4#1)
of Human Bone Marrow Mesenchymal Stem Cells##2##7##(2008-11#2)
of Human Bone Marrow Mesenchymal Stem##3##6##(2008-11#3)
of Human##11##2##(1994-12#1)(1995-6#2)(2008-10#1)(2008-11#3)(2008-4#1)(2010-10#1)(2010-11#1)(2012-3#1)
of Humic Cambisol-DOM##2##3##(2008-11#2)
of Hunan##2##2##(2008-9#2)
of Huntington's disease##2##3##(1995-12#1)(2008-5#1)
of Hydrogen cyanide gas##2##4##(2008-10#2)
of Hydrogen##3##2##(2008-10#2)(2008-5#1)
of Hymenolepis##2##2##(2011-2#1)(2012-2#1)
of Hyphantria cunea##2##3##(2008-11#2)
of I and II##2##4##(2008-10#2)
of I and##3##3##(1990-2#1)(2008-10#2)
of I##22##2##(1990-2#1)(1995-6#1)(1996-12#1)(2008-10#12)(2008-11#4)(2008-6#2)(2013-8#1)
of I(-)##4##2##(2008-10#4)
of I184Y##2##2##(1992-1#2)
of IA##3##2##(2011-2#3)
of IAA in##2##3##(2008-10#2)
of IAA##8##2##(2008-10#5)(2008-12#1)(2008-9#2)
of IBD##5##2##(2008-9#1)(2009-12#4)
of IBS##2##2##(2013-1#2)
of IBV##3##2##(2008-5#3)
of IC##2##2##(2008-10#2)
of ICA##3##2##(1994-12#2)(2012-3#1)
of ICAM-1##4##2##(2008-10#1)(2010-1#3)
of ICD-10##3##2##(1997-8#1)(2012-12#2)
of ICD-9##2##2##(1991-12#1)(2012-12#1)
of ICP gradients##2##3##(2008-7#2)
of ICP##4##2##(2008-12#1)(2008-7#3)
of ICP-AES##4##2##(2008-10#4)
of ICP-MS and ICP-OES##2##4##(2008-10#2)
of ICP-MS##6##2##(2008-10#6)
of ICSS##6##2##(1991-2#4)(1996-2#2)
of ID##2##2##(2008-10#1)(2008-12#1)
of IDA##2##2##(2008-10#2)
of IDHR##4##2##(2008-10#4)
of IDO##3##2##(2008-11#3)
of IE##3##2##(2011-2#3)
of IECs##2##2##(2008-11#2)
of IFN##7##2##(1992-2#1)(1993-2#1)(1995-12#1)(2008-5#1)(2009-8#3)
of IFN-alpha##3##2##(1993-2#2)(2009-5#1)
of IFN-beta##4##2##(1995-12#1)(2008-11#3)
of IFN-gamma by##2##3##(1996-12#1)(2008-7#1)
of IFN-gamma with##2##3##(1996-12#1)(2008-7#1)
of IFN-gamma##13##2##(1996-12#3)(2008-11#5)(2008-4#2)(2008-7#2)(2008-8#1)
of IFN-γ##2##2##(2011-2#2)
of IFNgamma##2##2##(2008-10#1)(2008-9#1)
of IGEs##3##2##(2008-8#3)
of IGF-1##4##2##(1994-11#2)(2008-9#2)
of IGF-I and##3##3##(1996-2#1)(2008-11#2)
of IGF-I##16##2##(1996-2#4)(2008-11#6)(2008-6#1)(2010-5#3)(2011-1#1)(2012-3#1)
of IGF-IR##5##2##(2008-8#5)
of IGS##2##2##(2008-10#2)
of IH901##3##2##(2008-11#3)
of IHPM##2##2##(2010-12#2)
of III##2##2##(1993-1#1)(2008-10#1)
of IImtl##2##2##(1991-10#2)
of IL-1 and##2##3##(1994-3#2)
of IL-1 beta precursor##2##4##(1995-2#2)
of IL-1 beta##9##3##(1993-8#1)(1995-2#5)(1996-12#3)
of IL-1 in##2##3##(1990-12#2)
of IL-1##17##2##(1990-12#4)(1993-8#2)(1994-3#2)(1995-2#5)(1996-12#3)(2008-5#1)
of IL-10 in the##2##4##(1996-12#1)(2008-11#1)
of IL-10 in##3##3##(1996-12#2)(2008-11#1)
of IL-10##10##2##(1996-12#4)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2011-3#2)
of IL-12 and##2##3##(2008-11#1)(2011-2#1)
of IL-12 to##2##3##(2008-11#2)
of IL-12##13##2##(2008-11#6)(2008-8#5)(2011-2#2)
of IL-17 and##2##3##(2012-2#2)
of IL-17##3##2##(2007-11#1)(2012-2#2)
of IL-2 and IL-4##2##4##(2008-11#2)
of IL-2##9##2##(1990-12#1)(1992-12#1)(1994-11#1)(1994-5#2)(2008-11#3)(2008-7#1)
of IL-4##6##2##(1996-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-12#2)
of IL-5##2##2##(1995-6#2)
of IL-6 and##2##3##(2008-10#1)(2008-11#1)
of IL-6 production##2##3##(2008-10#2)
of IL-6##8##2##(1990-5#1)(1995-12#1)(1997-7#2)(2008-10#3)(2008-11#1)
of IL-7 gene##2##3##(1995-2#2)
of IL-7##4##2##(1995-2#2)(2008-11#2)
of IL-9##3##2##(2008-4#3)
of IMID##6##2##(2011-2#6)
of IMP dehydrogenase##2##3##(1990-10#1)(1993-8#1)
of IMRT##2##2##(2008-2#1)(2011-2#1)
of IMS##5##2##(2008-10#4)(2010-9#1)
of INF alpha##3##3##(1997-5#3)
of INF1##2##2##(2008-10#2)
of INH##3##2##(2008-10#3)
of IOP##3##2##(2011-2#3)
of IORT##2##2##(2011-2#2)
of IP3 to##3##3##(1993-8#3)
of IP3##6##2##(1993-8#6)
of IPFY##2##2##(2012-2#2)
of IPMC##2##2##(2010-4#2)
of IPTG##2##2##(1993-8#1)(1993-9#1)
of IQ##2##2##(1997-7#1)(2008-10#1)
of IR##4##2##(2008-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
of IRB members and chairs##3##5##(2009-4#3)
of IRB##5##2##(2009-4#5)
of IRBs##2##2##(2009-4#2)
of IRF-8##3##2##(2013-1#3)
of IRS-1 in vitro##3##4##(1995-8#3)
of IRS-1 in##6##3##(1995-8#6)
of IRS-1##10##2##(1992-10#2)(1994-11#2)(1995-8#6)
of IRS-I##8##2##(1997-1#8)
of IS##2##2##(1995-8#1)(2012-3#1)
of ISAV##2##2##(2009-6#2)
of ISDN in##2##3##(2008-10#2)
of ISDN##3##2##(2008-10#3)
of ISEs based on##2##4##(2008-10#2)
of ISEs##4##2##(2008-10#4)
of ISFETs##2##2##(2008-10#2)
of ISGs##2##2##(2010-10#2)
of ISIS##4##2##(2008-10#4)
of ISR by Bacillus spp##2##5##(2008-10#2)
of ISR by##3##3##(2008-10#3)
of ISR##5##2##(2008-10#5)
of ITO-TEOS-BSA-ChOx/HRP##2##2##(2008-10#2)
of ITP##2##2##(2006-6#2)
of ITS##2##2##(2008-10#1)(2008-11#1)
of IUC##2##2##(2013-1#2)
of IV##4##2##(1992-9#1)(1997-6#1)(2011-1#1)(2012-2#1)
of Id1##2##2##(2013-1#2)
of Ig##4##2##(1990-12#2)(2008-10#1)(2008-11#1)
of IgA##2##2##(1993-2#1)(2013-8#1)
of IgE##2##2##(2008-10#1)(2010-5#1)
of IgG##14##2##(1990-12#3)(1991-5#1)(1995-12#1)(2008-10#6)(2008-11#2)(2010-3#1)
of IgG1 and##2##3##(1993-6#1)(1997-8#1)
of IgM##3##2##(1990-12#2)(1993-12#1)
of Imatinib and its main metabolite##2##6##(2008-10#2)
of Imatinib##5##2##(2008-10#5)
of In(III)##3##2##(2008-10#3)
of InBr(-)(4)##2##2##(2008-10#2)
of India##6##2##(2008-11#2)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)
of Individuals##2##2##(2009-3#1)(2012-12#1)
of Infected##3##2##(2008-10#2)(2012-2#1)
of Infection and Colonization of##2##5##(2008-10#2)
of Infection by##2##3##(2008-10#2)
of Infection##9##2##(2008-10#7)(2010-6#2)
of Inh##2##2##(2008-10#2)
of Inner Mongolia##2##3##(2008-9#1)(2013-1#1)
of Institutional Review##2##3##(1997-8#1)(2009-4#1)
of Interceed (TC7)##2##3##(1992-1#2)
of Internal##3##2##(1996-11#1)(2008-10#1)(2012-3#1)
of Internet##2##2##(2008-11#1)(2009-5#1)
of Intracranial##2##2##(1995-11#1)(1996-6#1)
of Inula helenium L##2##4##(2008-10#1)(2008-5#1)
of Inula viscosa##2##3##(2008-10#2)
of Inula##4##2##(2008-10#3)(2008-5#1)
of Ioannina##3##2##(2008-10#3)
of Iran using##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
of Iran##15##2##(2008-10#2)(2008-12#7)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
of Iran)##2##2##(2008-12#2)
of Isfahan##2##2##(2008-12#2)
of Isolates of##3##3##(2008-10#3)
of Isolates##6##2##(2008-10#6)
of Isospora##2##2##(1996-12#2)
of Italian##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
of Italy##6##2##(1990-3#1)(1992-9#1)(1993-2#1)(2008-10#2)(2013-8#1)
of Itch##3##2##(2012-2#3)
of Its##4##2##(2008-10#4)
of J/ psi##2##3##(1992-8#1)(1994-2#1)
of JH##6##2##(2012-2#6)
of JQ1##2##2##(2012-12#2)
of JYG-MMTV##2##2##(1994-12#2)
of January##2##2##(1994-1#1)(2008-5#1)
of Japan##6##2##(2008-10#4)(2008-11#1)(2008-3#1)
of Japanese cedar pollinosis in##2##5##(2012-12#2)
of Japanese cedar pollinosis##3##4##(2012-12#3)
of Japanese cedar##4##3##(2012-12#4)
of Japanese native horses##2##4##(2013-1#2)
of Japanese style acupuncture##2##4##(2008-10#2)
of Japanese##18##2##(1995-12#1)(2008-10#8)(2008-11#1)(2010-2#1)(2012-12#5)(2013-1#2)
of John##2##2##(1990-6#1)(2009-11#1)
of July##3##2##(1991-3#1)(1996-12#1)(2008-10#1)
of June##3##2##(1992-3#1)(1996-5#1)(2008-10#1)
of Justice##3##2##(1995-12#1)(1995-6#1)(1996-3#1)
of K##6##2##(1995-8#1)(1997-7#2)(2008-10#2)(2011-2#1)
of K(+)##4##2##(2008-10#3)(2008-8#1)
of K(f)##3##2##(2008-10#3)
of K+##8##2##(1991-11#1)(1991-7#1)(1994-12#1)(1994-3#2)(2008-11#1)(2008-12#1)(2008-3#1)
of K252a##4##2##(1990-12#2)(1994-11#1)(2008-11#1)
of K562 cells##3##3##(2008-11#2)(2008-9#1)
of K562##4##2##(2008-11#2)(2008-8#1)(2008-9#1)
of KB##3##2##(1991-12#3)
of KBD##2##2##(2011-2#2)
of KC70 in##2##3##(2010-5#2)
of KC70##3##2##(2010-5#3)
of KCl in##2##3##(2008-10#2)
of KCl##7##2##(1990-5#1)(2008-10#3)(2008-11#1)(2008-12#2)
of KD##3##2##(2012-2#3)
of KOH##2##2##(2008-10#2)
of KPF(6)##2##2##(2008-10#2)
of KS##2##2##(2012-3#2)
of KSA##2##2##(2008-7#1)(2013-1#1)
of KSD##2##2##(2010-4#2)
of KT##4##2##(2013-1#4)
of KTP crystals##2##3##(2008-3#2)
of KTP##4##2##(2008-10#1)(2008-3#3)
of KU812 cells treated with both 450 ng ml(-1) IgE and 1##2##12##(2008-11#2)
of KU812 cells treated with##3##5##(2008-11#3)
of KU812 cells##7##3##(1990-5#1)(2008-11#6)
of Karnal##2##2##(2008-10#2)
of Kathmandu##3##2##(2008-11#2)(2012-3#1)
of Kawasaki disease##3##3##(2008-11#1)(2012-2#2)
of Kazakhstan##2##2##(2008-10#1)(2013-1#1)
of Kefir##2##2##(2008-11#2)
of Khon Kaen##2##3##(2011-2#2)
of Kikuchi's disease##2##3##(2011-2#2)
of Km*1##2##2##(1997-8#2)
of Kohonen neural networks##2##4##(2008-10#2)
of Krukenberg tumour##2##3##(2012-2#2)
of Ku##2##2##(1996-2#1)(2013-1#1)
of L##40##2##(1991-10#1)(1994-11#1)(1996-12#4)(1997-6#1)(2007-12#1)(2008-10#17)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#2)(2010-8#2)(2011-2#2)(2012-2#3)(2013-8#2)
of L-680##2##2##(1993-8#2)
of L-PHP##3##2##(2013-7#3)
of L-TGF-beta 1##2##3##(1990-2#2)
of L-arginine or total amino acids##2##6##(1990-12#2)
of L-arginine or##3##3##(1990-12#3)
of L-arginine##11##2##(1990-12#6)(1994-11#1)(1995-11#2)(1997-2#2)
of L-ascorbic acid##2##3##(1993-12#1)(2008-11#1)
of L-carnitine##5##2##(1991-12#2)(2008-10#1)(2009-8#1)(2012-2#1)
of L-chain##2##2##(1995-2#2)
of L-dopa##5##2##(1990-8#1)(2008-10#4)
of L-histidine##8##2##(1995-8#3)(2008-11#5)
of L-leucine##7##2##(1990-2#1)(2008-11#6)
of L-selectin##3##2##(1992-12#3)
of L-tyrosine##2##2##(2008-10#2)
of L1 in##2##3##(1995-2#1)(1996-12#1)
of L1##7##2##(1991-11#1)(1995-2#3)(1996-12#2)(2008-11#1)
of L16C5 and##2##3##(2008-10#2)
of L16C5##4##2##(2008-10#4)
of L3##3##2##(1991-11#2)(2008-10#1)
of LAS##3##2##(2008-10#3)
of LBP##2##2##(2010-3#1)(2012-12#1)
of LBVV##2##2##(2008-10#2)
of LC##2##2##(2008-10#2)
of LCAT##3##2##(1993-6#2)(1993-8#1)
of LChD##2##2##(2008-10#2)
of LD##3##2##(2008-12#2)(2008-7#1)
of LDH was##3##3##(2008-11#3)
of LDH##6##2##(1994-2#1)(2008-11#5)
of LDL and##3##3##(1992-5#1)(2008-10#2)
of LDL by##2##3##(2008-10#1)(2009-8#1)
of LDL particle##2##3##(2011-1#2)
of LDL to##2##3##(1991-12#1)(1991-5#1)
of LDL with##3##3##(1994-8#1)(2008-3#1)(2009-8#1)
of LDL##26##2##(1990-2#1)(1991-12#3)(1991-5#2)(1992-5#2)(1994-8#1)(1995-8#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-9#1)(2009-8#6)(2011-1#2)
of LDR in##2##3##(2008-7#2)
of LDR##5##2##(2008-7#3)(2013-1#2)
of LFLX##2##2##(2008-10#2)
of LH##2##2##(2010-3#1)(2013-8#1)
of LH-RH##2##2##(1993-1#2)
of LHR mRNA##4##3##(2008-8#4)
of LHRH agonists##2##3##(2008-4#2)
of LHRH analogues##2##3##(2008-4#2)
of LHRH##5##2##(2008-4#5)
of LIF to##2##3##(2008-11#2)
of LIF##6##2##(2008-10#1)(2008-11#4)(2008-3#1)
of LIR was##3##3##(2008-9#3)
of LLD##2##2##(2008-11#2)
of LMM##3##2##(2011-2#3)
of LMP2##3##2##(2012-2#3)
of LNA##2##2##(2008-4#2)
of LNK##3##2##(2012-2#3)
of LOOH##2##2##(2008-10#1)(2008-11#1)
of LOV##3##2##(2011-1#3)
of LP##2##2##(2008-12#2)
of LPG##2##2##(2008-10#2)
of LPL##4##2##(1992-3#3)(2008-11#1)
of LPS##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
of LS##3##2##(2008-10#1)(2012-3#2)
of LS-11##3##2##(2008-10#3)
of LSCs##2##2##(2011-2#2)
of LTC##3##2##(1996-2#1)(1997-3#1)(2009-4#1)
of LTP##14##2##(1995-12#2)(1995-2#2)(1997-2#4)(2008-7#6)
of LTs##2##2##(1994-8#2)
of LV##6##2##(2008-10#2)(2011-2#4)
of LVH##2##2##(2009-1#2)
of LXA4 and LXB4##2##4##(1991-5#2)
of LXA4##3##2##(1991-5#3)
of LY##2##2##(2008-10#2)
of La(3+)##2##2##(2008-10#1)(2008-9#1)
of La(III)##3##2##(2008-10#3)
of La3+##2##2##(1996-2#1)(1997-2#1)
of Lactobacilli##3##2##(2008-12#3)
of Lactobacillus acidophilus##2##3##(2008-5#2)
of Lactobacillus strains##2##3##(2008-12#1)(2012-2#1)
of Lactobacillus##7##2##(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#1)
of Lake Nasser##2##3##(2008-10#2)
of Langerhans in##2##3##(1994-8#1)(2008-1#1)
of Langerhans##10##2##(1994-8#1)(1995-8#2)(2008-1#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2012-3#1)
of Langmuir##2##2##(2008-10#2)
of Latent##2##2##(2008-10#2)
of Latin##3##2##(1993-1#1)(2008-12#1)(2010-1#1)
of Latinos##2##2##(2011-2#1)(2013-1#1)
of Layered Learning##2##3##(1995-2#2)
of LeCAS expression##2##3##(2008-10#2)
of LeCAS##3##2##(2008-10#3)
of Leaf##3##2##(2008-10#3)
of Legionella pneumophila##2##3##(2008-12#2)
of Leishmania spp##2##3##(2012-2#2)
of Leishmania##5##2##(2008-11#1)(2012-2#4)
of Lemon verbena##6##3##(2008-12#6)
of Leptosphaeria maculans##4##3##(2008-10#4)
of Lettuce Drop##2##3##(2008-10#2)
of Lettuce##5##2##(2008-10#5)
of Lewis##3##2##(1996-5#2)(2008-11#1)
of Lewisite I##2##3##(2008-11#2)
of Leydig cell cytoplasm##2##4##(1992-12#2)
of Leydig cell##3##3##(1992-12#3)
of Li##3##2##(2008-10#2)(2012-3#1)
of Li(+)##2##2##(2008-10#2)
of LiCF(3)SO(3) and gamma-LiAlO(2) in composite##2##6##(2008-10#2)
of LiCF(3)SO(3)##3##2##(2008-10#3)
of LiNPh(2) to##2##3##(2008-11#2)
of Life##10##2##(1993-3#1)(1994-12#1)(2008-10#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#4)
of Light##5##2##(2008-10#5)
of Lilium##4##2##(1995-6#1)(2008-8#2)(2009-12#1)
of Lineweaver-Burk##2##2##(2008-10#1)(2010-11#1)
of Listeria monocytogenes##4##3##(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
of Listeria##5##2##(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)
of Literature##2##2##(2009-8#1)(2012-3#1)
of Little cherry virus##2##4##(2008-10#2)
of Lmo2##2##2##(2008-9#2)
of London##3##2##(1996-8#2)(2009-10#1)
of Love waves##2##3##(2008-10#2)
of Lowry##3##2##(2008-10#2)(2008-12#1)
of Lp(a)##2##2##(1993-2#1)(2008-6#1)
of Lu(2)O(3)##2##2##(2010-4#2)
of Lung##2##2##(2011-3#1)(2013-8#1)
of LuxS##2##2##(2009-6#2)
of Ly-49+##2##2##(1995-2#2)
of Lyme borreliosis##2##3##(1994-6#1)(2008-10#1)
of Lyme disease in##2##4##(1997-3#1)(2008-11#1)
of Lyme disease##11##3##(1992-3#1)(1997-3#9)(2008-11#1)
of Lyme##14##2##(1992-3#1)(1994-6#1)(1997-3#9)(2008-10#1)(2008-11#1)(2011-2#1)
of Lynch##2##2##(2011-2#1)(2012-3#1)
of Lysholm##2##2##(2013-1#2)
of M##94##2##(1990-5#1)(1995-2#3)(2007-12#1)(2008-10#63)(2008-11#5)(2008-2#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-8#2)(2010-12#1)(2011-2#5)(2013-1#5)
of M79##3##2##(2008-8#3)
of MAE extracts##2##3##(2008-10#2)
of MAP##5##2##(1993-8#2)(1995-8#1)(2008-10#1)(2009-7#1)
of MAPK##6##2##(2008-11#3)(2009-7#1)(2009-8#1)(2013-1#1)
of MAT-1##2##2##(2008-10#2)
of MAb##3##2##(2008-11#3)
of MB and NMB on##2##5##(2008-10#2)
of MB and##3##3##(2008-10#3)
of MB##10##2##(2008-10#10)
of MB-ODNs##2##2##(2008-4#2)
of MBCK I##2##3##(1993-6#2)
of MBP##5##2##(1992-9#2)(1993-3#1)(1993-6#1)(2012-3#1)
of MC##3##2##(2011-2#1)(2012-12#2)
of MCA##3##2##(1995-6#1)(1996-6#1)(2008-10#1)
of MCC##2##2##(2011-2#2)
of MCF-7 cells##3##3##(1993-1#1)(2008-11#2)
of MCF-7##5##2##(1993-1#1)(2008-11#4)
of MCI in PD##2##4##(2008-6#2)
of MCI##3##2##(2008-5#1)(2008-6#2)
of MCL##2##2##(2009-1#1)(2009-8#1)
of MCO##2##2##(2012-2#2)
of MCP##2##2##(2008-10#2)
of MCs##2##2##(2010-5#1)(2012-12#1)
of MD##2##2##(1996-5#1)(2008-10#1)
of MDA##5##2##(1996-2#3)(2008-12#2)
of MDD##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
of MDL##2##2##(1996-2#2)
of MDM2 inhibitors##2##3##(2013-1#2)
of MDM2##7##2##(1994-12#1)(2011-2#1)(2013-1#5)
of MDR TB##2##3##(2011-2#2)
of MDR##8##2##(1990-2#1)(2008-11#4)(2010-2#1)(2011-2#2)
of MDR-associated##2##2##(2008-11#2)
of MDSS2N##2##2##(2008-11#2)
of MEDLINE and##3##3##(1994-3#1)(2013-1#2)
of MEDLINE##5##2##(1991-1#1)(1992-12#1)(1994-3#1)(2013-1#2)
of MEFs##3##2##(2008-2#2)(2010-3#1)
of MEP##2##2##(2008-11#1)(2008-7#1)
of MG##4##2##(2008-10#2)(2008-11#2)
of MHC class I molecules on##2##6##(2008-8#2)
of MHC class I molecules##4##5##(2008-11#1)(2008-8#3)
of MHC class I##8##4##(1995-12#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-8#4)
of MHC class##10##3##(1995-12#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#5)
of MHC##11##2##(1995-12#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#6)
of MHO##2##2##(2013-1#2)
of MI##3##2##(2008-10#1)(2013-8#2)
of MICA/B and ULBP2##2##4##(2013-1#2)
of MKL-4##3##2##(1994-12#3)
of MLC20##5##2##(1994-11#5)
of MLCK##2##2##(1992-6#2)
of MLD##2##2##(1997-3#1)(2008-10#1)
of MLT##2##2##(2013-7#2)
of MM##3##2##(1990-12#1)(2010-12#2)
of MMA##2##2##(2008-10#1)(2010-8#1)
of MMD##2##2##(2008-10#1)(2013-1#1)
of MMP-1##3##2##(2008-5#2)(2012-3#1)
of MMP-2 and##2##3##(2008-9#1)(2009-3#1)
of MMP-2##4##2##(2008-9#2)(2009-3#1)(2013-8#1)
of MO##2##2##(2008-3#1)(2013-8#1)
of MORs##2##2##(2009-7#2)
of MP affinity to RNA##2##5##(1997-3#2)
of MPA##5##2##(1993-1#4)(2008-10#1)
of MPD##4##2##(2012-2#4)
of MPO##4##2##(1992-10#3)(2008-12#1)
of MPTP##4##2##(1990-7#2)(2008-7#2)
of MR imaging##2##3##(1997-8#1)(2012-2#1)
of MR##8##2##(1990-11#2)(1992-3#1)(1997-8#1)(2008-10#1)(2008-9#1)(2012-2#2)
of MRI in the diagnosis##2##5##(1996-11#1)(2011-2#1)
of MRI in the##3##4##(1996-11#1)(2010-12#1)(2011-2#1)
of MRI in##4##3##(1996-11#1)(2010-12#2)(2011-2#1)
of MRI##9##2##(1992-3#1)(1996-11#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-9#1)(2011-2#1)(2013-1#1)
of MRL(+/+) mice##2##3##(2008-10#2)
of MRP##2##2##(2008-11#2)
of MS patients##3##3##(1995-12#1)(2010-12#2)
of MS##13##2##(1995-12#1)(2008-12#1)(2010-12#5)(2011-2#1)(2012-2#1)(2012-3#4)
of MSCs for##2##3##(2008-11#1)(2009-10#1)
of MSOPD##2##2##(2008-10#2)
of MSP##3##2##(2008-8#3)
of MSV resistance##2##3##(2008-10#2)
of MT in##5##3##(2008-10#3)(2008-11#2)
of MT##14##2##(2008-10#6)(2008-11#7)(2013-7#1)
of MTBE##4##2##(2008-12#3)(2009-8#1)
of MTBI##3##2##(1997-2#3)
of MTU##2##2##(2008-10#2)
of MTX treatment##2##3##(1992-8#2)
of MTX##3##2##(1992-8#3)
of MTs##5##2##(2008-11#1)(2009-10#1)(2013-7#3)
of MVP1-4##4##2##(2008-10#4)
of MVT##2##2##(2011-2#2)
of MY##3##2##(2008-10#3)
of MYCN amplified##2##3##(2011-2#2)
of MYCN##4##2##(2011-2#4)
of MaYMFV##2##2##(2008-10#2)
of Macroptilium##2##2##(2008-10#2)
of Madopar##2##2##(2008-7#2)
of Madrid honeys##2##3##(2011-2#2)
of Madrid##6##2##(2008-10#2)(2008-11#2)(2011-2#2)
of Magnaporthe grisea##10##3##(2008-10#10)
of Magnaporthe oryzae##5##3##(2008-10#4)(2012-2#1)
of Magnaporthe##15##2##(2008-10#14)(2012-2#1)
of Maine's##2##2##(1991-1#1)(2008-5#1)
of Maize Streak Virus##2##4##(2008-10#2)
of Maize streak virus##2##4##(2008-10#2)
of Maize##9##2##(2008-10#9)
of Major##2##2##(2008-10#1)(2008-6#1)
of Malaria##2##2##(2012-2#2)
of Malassezia spp##2##3##(2008-5#2)
of Malassezia##3##2##(2008-5#2)(2010-6#1)
of Malathion##4##2##(2008-10#2)(2008-11#2)
of Malaysian##2##2##(2008-10#1)(2008-12#1)
of Malignant##2##2##(2012-3#1)(2013-1#1)
of Mammalian##3##2##(1994-9#1)(2008-11#1)(2012-2#1)
of Mancozeb and##2##3##(2008-10#2)
of Mancozeb##4##2##(2008-10#4)
of Mango##2##2##(2008-10#2)
of Mao-to##3##2##(2010-7#3)
of Marek's disease virus serotype##2##5##(2008-5#2)
of Marfan syndrome##2##3##(2013-1#2)
of Maternal##2##2##(1996-3#1)(2009-10#1)
of Matrigel##2##2##(2008-11#2)
of May##2##2##(2008-10#1)(2008-5#1)
of Mb##2##2##(2008-10#2)
of Mb-PAM films##3##3##(2008-10#3)
of Mdm2SNP309##2##2##(2011-2#2)
of MeBr##3##2##(1995-3#3)
of MeHg##2##2##(2008-10#2)
of Medicaid and##2##3##(1992-2#2)
of Medicaid eligibility##3##3##(1992-2#2)(1994-2#1)
of Medicaid expenditure growth##2##4##(1996-1#2)
of Medicaid expenditures##2##3##(1995-1#1)(1995-2#1)
of Medicaid recipients##2##3##(1994-2#1)(1994-3#1)
of Medicaid##21##2##(1992-2#6)(1993-3#1)(1994-1#1)(1994-2#3)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#3)(1997-2#1)
of Medical Sciences##3##3##(1996-11#1)(2008-10#2)
of Medical electrical equipment##2##4##(2012-3#2)
of Medical##15##2##(1992-1#2)(1992-12#1)(1996-11#2)(2008-10#3)(2008-12#1)(2010-1#1)(2011-2#2)(2012-3#3)
of Medicare and Medicaid##3##4##(1991-2#1)(1991-3#1)(1996-2#1)
of Medicare and##4##3##(1991-2#1)(1991-3#1)(1996-12#1)(1996-2#1)
of Medicare beneficiaries have private supplementary##2##6##(1991-2#1)(1996-3#1)
of Medicare beneficiaries##5##3##(1991-2#1)(1993-1#1)(1994-3#1)(1995-12#1)(1996-3#1)
of Medicare data##2##3##(1992-11#1)(1997-3#1)
of Medicare discharges##2##3##(1993-1#1)(1993-12#1)
of Medicare payment##2##3##(1991-12#1)(1994-12#1)
of Medicare##34##2##(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#2)(1995-12#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#1)(2012-3#1)
of Medicare's RBRVS##3##3##(1994-12#3)
of Medicare's##6##2##(1994-12#3)(1994-2#1)(1996-3#1)(1997-3#1)
of Medicare-covered##2##2##(1994-2#1)(1995-3#1)
of Medicine and##4##3##(1996-9#1)(1997-2#1)(2008-1#1)(2012-3#1)
of Medicine##37##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#4)(1994-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#1)(2008-1#3)(2008-10#3)(2008-5#1)(2009-10#2)(2010-1#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
of Medicine's##2##2##(1995-11#1)(1996-1#1)
of Medicines##2##2##(1997-1#1)(2008-11#1)
of Mediterranean##3##2##(2008-11#1)(2011-2#2)
of Melampsora##2##2##(2008-10#2)
of Meldola's blue##2##3##(2008-10#2)
of Meloidogyne chitwoodi and M##2##5##(2008-10#2)
of Meloidogyne##5##2##(2008-10#5)
of MenACWY-CRM in##2##3##(2013-1#2)
of Mental Disorders##8##3##(2008-7#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#3)(2013-1#1)
of Mental Health##3##3##(1995-2#1)(2010-12#1)(2013-1#1)
of Mental##11##2##(1995-2#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#3)(2013-1#2)
of Mentha pulegium L##2##4##(2008-10#2)
of Mentha##6##2##(2008-10#3)(2013-1#3)
of MetS##2##2##(2010-10#2)
of Mexican##5##2##(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)
of Mexico##5##2##(2008-10#4)(2012-3#1)
of Mg##3##2##(2008-10#3)
of Mg(2+) and##3##3##(2008-10#2)(2008-9#1)
of Mg(2+) and/or vitamin D(2) into pure DPPC liposomes##2##9##(2008-10#2)
of Mg(2+) in##3##3##(2008-10#1)(2013-1#2)
of Mg(2+) with##3##3##(2008-10#3)
of Mg(2+)##20##2##(2008-10#16)(2008-9#2)(2013-1#2)
of Mg2+##5##2##(1990-5#1)(1991-9#1)(1993-6#2)(2008-4#1)
of MgSO(4)##2##2##(2008-10#1)(2008-7#1)
of MhNPR1##2##2##(2011-10#2)
of Mhc genes##2##3##(2008-8#2)
of Mhc##3##2##(2008-8#3)
of MiLV##2##2##(2008-10#2)
of Michel##2##2##(2012-3#1)(2013-1#1)
of Michigan##7##2##(1991-3#1)(1994-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-7#1)(2008-11#1)
of Microsatellite##2##2##(2008-10#1)(2013-8#1)
of Microsomacanthus##2##2##(2011-2#2)
of Microsphaeropsis sp##5##3##(2008-10#5)
of Middle Age##2##3##(2008-10#2)
of Middle##4##2##(2008-10#3)(2008-12#1)
of Mie scattering##2##3##(2008-2#1)(2008-3#1)
of Milan##2##2##(1993-6#1)(2008-10#1)
of Milsana##4##2##(2008-10#4)
of Minas Gerais##2##3##(2010-10#1)(2012-3#1)
of Mississippi Medical Center##2##4##(2009-3#2)
of Mississippi##3##2##(2009-3#3)
of Mitochondrial DNA##2##3##(2008-6#2)
of Mitochondrial##3##2##(2008-5#1)(2008-6#2)
of Mn##9##2##(2008-10#9)
of Mn(II)##8##2##(2008-10#8)
of MnP##3##2##(2008-7#3)
of MnSOD mRNA by irradiation##2##5##(1995-6#2)
of MnSOD mRNA##3##3##(1995-6#3)
of MnSOD##5##2##(1995-6#5)
of Mo and Bi in steels##2##6##(2008-10#2)
of Mo in the##2##4##(2008-10#2)
of Mo in##3##3##(2008-10#3)
of Mo##11##2##(2008-10#11)
of Mo(VI) and##2##3##(2008-10#2)
of Mo(VI) with##2##3##(2008-10#2)
of Mo(VI)##7##2##(2008-10#7)
of Mo17##2##2##(2008-10#2)
of MoAb##2##2##(1993-1#1)(2008-11#1)
of Modena##3##2##(2008-10#2)(2008-11#1)
of Molecular Ecology##3##3##(2013-1#3)
of Molecular##5##2##(2008-10#2)(2013-1#3)
of Monilinia fructicola##5##3##(2008-10#5)
of Monilinia##8##2##(2008-10#8)
of Monte-Carlo##2##2##(2008-10#2)
of Moringa oleifera##2##3##(2008-10#2)
of Motor oils##2##3##(2008-10#2)
of Motor##4##2##(2008-10#3)(2011-8#1)
of Mouse##3##2##(1994-12#1)(2008-11#1)(2008-6#1)
of Moutan Cortex##4##3##(2008-10#4)
of Mr##4##2##(1991-10#2)(1997-9#1)(2008-11#1)
of Mre11##3##2##(2011-2#3)
of Mt##2##2##(2008-3#1)(2008-5#1)
of Mulberry##2##2##(2008-10#2)
of Muscat grapes##2##3##(2008-10#2)
of Mustela##2##2##(2008-6#2)
of MxA mRNA##3##3##(2008-7#3)
of My##3##2##(2008-12#1)(2010-7#2)
of Mycelium of##2##3##(2008-10#2)
of Mycobacterium tuberculosis##12##3##(1995-2#1)(2008-10#1)(2008-7#2)(2008-9#6)(2011-2#1)(2013-1#1)
of Mycobacterium##14##2##(1995-2#1)(2008-10#1)(2008-7#2)(2008-9#7)(2011-2#1)(2012-12#1)(2013-1#1)
of Mycoplasma meleagridis##2##3##(2008-5#2)
of Mycoplasma##5##2##(2008-5#2)(2010-6#1)(2011-2#1)(2013-8#1)
of Mycosphaerella citri##3##3##(2008-10#3)
of Mycosphaerella fijiensis##2##3##(2008-10#2)
of Mycosphaerella graminicola##16##3##(2008-10#15)(2011-10#1)
of Mycosphaerella spp##3##3##(2008-10#3)
of Mycosphaerella##27##2##(2008-10#26)(2011-10#1)
of Myxobacter Sp##2##3##(2009-3#2)
of Müller##2##2##(2008-7#2)
of N and##4##3##(2008-10#3)(2012-5#1)
of N per##2##3##(2008-10#2)
of N sampling units##2##4##(2008-10#2)
of N##48##2##(2008-10#34)(2008-12#5)(2008-2#1)(2008-5#1)(2010-8#1)(2012-3#3)(2012-5#1)(2012-8#1)(2012-9#1)
of N(2)##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
of N)##2##2##(2008-10#2)
of N-acetyl-d-glucosamine and d-glucosamine##2##4##(2008-10#2)
of N-acetylcysteine##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
of N-glycosylation of##2##3##(2013-1#2)
of N-glycosylation##4##2##(1993-6#1)(2013-1#3)
of N-linked oligosaccharide##2##3##(1994-5#1)(2008-7#1)
of N-linked##5##2##(1994-5#2)(2008-11#1)(2008-7#2)
of N-methyl-D-aspartate (NMDA)##3##3##(1996-2#1)(2008-8#1)(2012-2#1)
of N-methyl-D-aspartate##5##2##(1995-12#1)(1996-2#1)(2008-8#1)(2012-2#2)
of N-phenylanthranilic acid in the two-phase systems##2##7##(2008-10#2)
of N-phenylanthranilic acid in the##3##5##(2008-10#3)
of N-phenylanthranilic acid in##4##4##(2008-10#4)
of N-terminal##2##2##(1996-12#1)(2008-8#1)
of N1##3##2##(1990-6#1)(1991-8#1)(2008-8#1)
of N2 and##2##3##(1990-6#1)(1991-8#1)
of N2##3##2##(1990-6#1)(1991-8#1)(2008-3#1)
of N3##2##2##(1990-6#1)(1991-8#1)
of NA##6##2##(2008-10#2)(2008-8#3)(2013-8#1)
of NAA and##2##3##(2008-10#2)
of NAA##6##2##(2008-10#4)(2008-12#1)(2008-8#1)
of NAD(+) and NADH in normal and cancer tissues##2##9##(2008-10#2)
of NAD(+) and NADH in##3##5##(2008-10#3)
of NAD(P)H##3##2##(1996-2#2)(2008-10#1)
of NAD+##7##2##(1990-10#4)(1994-11#2)(2008-10#1)
of NADH and##4##3##(1990-10#1)(2008-10#3)
of NADH oxidation##2##3##(1990-5#1)(2008-10#1)
of NADH##20##2##(1990-10#1)(1990-5#2)(1992-9#1)(2008-10#16)
of NADPH oxidase##8##3##(1990-5#1)(1991-5#1)(1993-6#1)(1993-8#3)(1994-6#1)(2013-8#1)
of NADPH##19##2##(1990-2#1)(1990-5#1)(1991-5#4)(1993-3#1)(1993-6#1)(1993-8#5)(1994-6#1)(2008-7#2)(2009-9#1)(2010-12#1)(2013-8#1)
of NADPH-cytochrome P-450 reductase##2##4##(1993-6#2)
of NADPH-dependent cytosolic##3##3##(1991-5#3)
of NADPH-diaphorase##2##2##(1992-12#1)(1995-12#1)
of NADPH-diaphorase-positive perikarya##2##3##(1992-12#2)
of NADPH-diaphorase-positive##3##2##(1992-12#3)
of NAL in##3##3##(2008-10#3)
of NAL##4##2##(2008-10#4)
of NANC##2##2##(1997-4#2)
of NAS##2##2##(2009-10#2)
of NAT##3##2##(1994-2#2)(2011-2#1)
of NBS with##2##3##(2008-10#2)
of NBS##5##2##(2008-10#5)
of NCX-4016##3##2##(2008-5#3)
of NDELA##2##2##(2008-5#2)
of NDPK##2##2##(1996-2#2)
of NE##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
of NEP1##2##2##(2008-10#2)
of NF-B##3##2##(2010-10#3)
of NF-L##5##2##(2008-8#5)
of NF-M and##3##3##(1997-2#1)(2008-8#2)
of NF-kappa B##2##3##(2008-10#1)(2008-11#1)
of NF-kappa##3##2##(1991-7#1)(2008-10#1)(2008-11#1)
of NF-kappaB activation##2##3##(2008-11#2)
of NF-kappaB in##2##3##(2008-11#1)(2010-3#1)
of NF-kappaB##8##2##(2008-11#4)(2010-3#4)
of NF-κB##2##2##(2011-2#1)(2012-2#1)
of NFκB##5##2##(2010-11#1)(2011-2#4)
of NGF and##2##3##(1991-12#1)(1996-12#1)
of NGF in##4##3##(1996-2#1)(2010-8#3)
of NGF##8##2##(1991-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-11#1)(2010-8#3)
of NGFI-A mRNA##2##3##(1996-12#2)
of NGFI-B mRNA in##3##4##(1996-12#3)
of NGFI-B mRNA##7##3##(1996-12#7)
of NGFI-B##9##2##(1996-12#9)
of NH(3) gas##3##3##(2008-10#3)
of NH(3)##4##2##(2008-10#3)(2012-2#1)
of NH(4)(+)##3##2##(2008-10#3)
of NH(4)H(2)PO(4)##2##2##(2008-10#2)
of NIH 3T3 cells##2##4##(1995-2#2)
of NIH 3T3##3##3##(1992-7#1)(1995-2#2)
of NIR##4##2##(2008-10#4)
of NK cells to##2##4##(2008-8#2)
of NK cells##8##3##(2008-10#4)(2008-8#3)(2013-1#1)
of NK##10##2##(2008-10#4)(2008-8#4)(2012-2#1)(2013-1#1)
of NK433##2##2##(1996-2#2)
of NKG2D##2##2##(2013-1#2)
of NMDA receptors##2##3##(1996-2#1)(1997-2#1)
of NMDA##5##2##(1992-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-8#1)
of NMDAR1##3##2##(1997-2#3)
of NMDAR2B mRNA##2##3##(1996-2#2)
of NMDS##4##2##(1995-5#4)
of NMF##3##2##(2008-10#3)
of NNK by##3##3##(1990-6#2)(1993-11#1)
of NNK##5##2##(1990-6#2)(1993-11#3)
of NO and##2##3##(2008-10#1)(2008-8#1)
of NO at##2##3##(2008-10#1)(2010-6#1)
of NO from##2##3##(1992-3#1)(2008-10#1)
of NO in##8##3##(1992-5#2)(1993-8#1)(2008-10#3)(2008-3#1)(2010-12#1)
of NO is##2##3##(1996-2#1)(2008-10#1)
of NO synthase##6##3##(1992-12#2)(1995-11#2)(1997-2#1)(2008-7#1)
of NO##54##2##(1992-12#2)(1992-3#2)(1992-5#3)(1993-8#1)(1995-11#3)(1996-2#1)(1997-2#1)(2008-10#22)(2008-3#4)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#3)
of NO(2) in the air##2##5##(2008-10#2)
of NO(2) in##3##3##(2008-10#3)
of NO(2)##5##2##(2008-10#4)(2008-11#1)
of NO(2)(-)##2##2##(2008-10#2)
of NOL7##4##2##(2013-1#4)
of NOM##5##2##(2008-10#1)(2008-11#4)
of NOR-1##2##2##(1995-12#2)
of NOS##2##2##(2008-5#2)
of NP test##2##3##(2010-1#2)
of NP##3##2##(2008-10#1)(2010-1#2)
of NPC##5##2##(1990-8#2)(2008-9#1)(2011-2#2)
of NPIK##3##2##(1997-8#3)
of NPSLE is##2##3##(2012-3#2)
of NPY##4##2##(1997-4#4)
of NS##4##2##(2008-10#4)
of NS0 cells##2##3##(2008-11#2)
of NSAIDs##5##2##(2008-10#2)(2008-12#1)(2008-8#2)
of NSCLC##2##2##(2013-1#1)(2013-8#1)
of NSCs##4##2##(2008-11#2)(2009-10#2)
of NSs##2##2##(2008-10#2)
of NT and##2##3##(1996-2#1)(2008-7#1)
of NT##4##2##(1996-2#2)(2008-7#1)(2008-9#1)
of NTO and ANTA in##2##5##(2008-11#2)
of NTO and ANTA##3##4##(2008-11#3)
of NXIIts##3##2##(2008-8#3)
of Na and##2##3##(2008-10#1)(2008-9#1)
of Na##4##2##(1992-8#1)(2008-10#2)(2008-9#1)
of Na(+)##7##2##(2008-10#6)(2012-7#1)
of Na+ channel##2##3##(2008-7#2)
of Na+##3##2##(1993-3#1)(2008-7#2)
of Na+/H+ exchange##2##3##(1992-10#1)(1995-8#1)
of Na+/H+##3##2##(1992-10#1)(1993-3#1)(1995-8#1)
of Na+/K(+)-ATPase##2##2##(1995-6#2)
of Na-K ATPase##2##3##(1995-8#2)
of Na-butyrate##2##2##(2008-11#2)
of NaBH(4)##2##2##(2008-10#2)
of NaBH(4)/KPF(6)##2##2##(2008-10#2)
of NaCl on##3##3##(2008-10#2)(2011-2#1)
of NaCl were##2##3##(2008-10#2)
of NaCl##17##2##(1990-5#1)(2008-10#10)(2008-11#4)(2011-2#1)(2012-7#1)
of NaF##4##2##(1993-3#1)(2008-10#2)(2013-1#1)
of NaOH##2##2##(2008-10#2)
of Nafion##5##2##(2008-10#5)
of Nanta##3##2##(2012-12#3)
of Nariño##2##2##(2012-12#2)
of National##3##2##(1991-2#1)(2008-11#1)(2013-1#1)
of Native Hawaiian well-being##2##4##(2008-1#2)
of Native Hawaiian##3##3##(2008-1#3)
of Natural##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
of Nd##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
of Nei's coefficient of##2##4##(2008-10#2)
of Nei's##3##2##(2008-10#3)
of Neisseria meningitidis##4##3##(1993-12#2)(2008-12#1)(2013-1#1)
of Neisseria##7##2##(1993-12#3)(1993-9#2)(2008-12#1)(2013-1#1)
of Nep1##6##2##(2008-10#6)
of Nepal##5##2##(2008-10#1)(2012-3#4)
of Nepalese##2##2##(2012-3#2)
of Neu5Ac##2##2##(2012-2#2)
of Neu5Gc alpha 2--&gt##2##4##(1994-11#2)
of NeuroD##2##2##(2010-11#2)
of Neurological Surgeons##3##3##(2012-3#2)(2013-1#1)
of Neurology at##2##3##(1997-8#1)(2010-5#1)
of Neurology##5##2##(1997-8#1)(2007-8#1)(2009-11#1)(2010-1#1)(2010-5#1)
of Neurospora crassa##2##3##(1997-4#1)(2012-3#1)
of Neurosurgery##3##2##(1995-11#1)(2013-8#2)
of NeutrAvidin-tagged liposomal nanovesicles as##2##5##(2008-10#2)
of NeutrAvidin-tagged liposomes##3##3##(2008-10#3)
of NeutrAvidin-tagged##5##2##(2008-10#5)
of New World##2##3##(2008-11#1)(2012-2#1)
of New York##4##3##(1991-12#1)(1994-12#1)(2008-10#1)(2013-1#1)
of New Zealand##3##3##(2008-12#1)(2011-1#2)
of New##16##2##(1991-12#1)(1993-1#2)(1994-12#1)(1996-1#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#1)
of Newcastle disease##4##3##(2008-5#4)
of NeyTumorin##2##2##(1997-4#2)
of Ni and##3##3##(2008-10#3)
of Ni in##4##3##(2008-10#4)
of Ni##16##2##(2008-10#16)
of Ni(2+)##3##2##(2008-10#3)
of Ni(II)##8##2##(1993-8#1)(2008-10#7)
of Ni3S2 alone##2##3##(1994-5#2)
of Ni3S2##4##2##(1994-5#4)
of NiHCF##2##2##(2008-10#2)
of NiS in##2##3##(2008-10#2)
of NiS##7##2##(2008-10#7)
of NiTMpyP##4##2##(2008-10#4)
of NiV##3##2##(2008-12#3)
of Nicotiana benthamiana##2##3##(2008-10#2)
of Nicotiana obtusifolia##2##3##(2008-10#2)
of Nicotiana##9##2##(2008-10#8)(2008-11#1)
of NifA central domain##5##4##(2008-9#5)
of NifA##11##2##(2008-9#11)
of Nigeria##4##2##(2008-12#2)(2011-2#1)(2013-1#1)
of Nile blue A##2##4##(2008-10#2)
of Nile##3##2##(2008-10#3)
of Nippostrongylus brasiliensis and Heligmosomoides polygyrus##2##6##(2008-4#2)
of Nitric Oxide##2##3##(2008-8#1)(2010-6#1)
of NleA##2##2##(2011-2#2)
of Nonpathogenic##2##2##(2008-10#2)
of North America##4##3##(2008-10#3)(2008-8#1)
of North American##3##3##(1991-12#1)(2008-10#1)(2010-10#1)
of North##11##2##(1991-12#1)(1995-12#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-10#1)
of Norway##2##2##(1991-2#1)(1996-11#1)
of Norwegian##5##2##(1990-9#1)(1991-11#1)(1991-6#1)(1991-9#1)(1993-2#1)
of Norwegians##2##2##(1991-2#1)(1996-11#1)
of Novel##2##2##(2008-10#2)
of Noxa##2##2##(2010-3#2)
of NuMA##4##2##(2010-5#4)
of Nuclear Magnetic Resonance##2##4##(1992-3#1)(2011-2#1)
of Nuclear Medicine##3##3##(2008-10#1)(2012-2#2)
of Nuclear##9##2##(1992-3#1)(1996-9#1)(2008-10#2)(2011-2#1)(2012-2#3)(2012-3#1)
of Nunavut##2##2##(2008-11#1)(2013-8#1)
of Nurse Education##2##3##(2008-11#1)(2008-12#1)
of Nursing##20##2##(2008-11#12)(2008-12#8)
of O##12##2##(2008-10#9)(2008-8#1)(2010-8#1)(2013-8#1)
of O(2) and N(2)##2##4##(2008-3#2)
of O(2) and##4##3##(2008-10#1)(2008-3#3)
of O(2)##7##2##(2008-10#3)(2008-3#4)
of O-GlcNAc##3##2##(2008-4#3)
of O2##2##2##(1991-3#1)(2008-3#1)
of O6-alkylguanine-DNA alkyltransferase##2##3##(1993-11#1)(2008-5#1)
of OA##2##2##(1992-3#1)(2013-1#1)
of OAB##2##2##(2008-12#2)
of OAV##3##2##(1997-3#3)
of OCD##2##2##(2008-11#1)(2013-1#1)
of OCE##3##2##(2011-2#3)
of OCT in##2##3##(2011-7#2)
of OCT##5##2##(2011-7#5)
of OCT4A##2##2##(2013-1#2)
of ODC activity##3##3##(1995-8#1)(2008-10#2)
of OECs##2##2##(2008-7#2)
of OFL##3##2##(2008-10#3)
of OH radical concentration in combustion environments##2##7##(2008-2#2)
of OH radicals##2##3##(2008-11#2)
of OH##14##2##(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#3)
of OL1 with the##2##4##(1992-4#2)
of OMC##2##2##(2008-5#2)
of OP pesticides##2##3##(2013-1#2)
of OP poisoning##3##3##(2013-1#3)
of OP##9##2##(2010-12#1)(2013-1#8)
of OPCs in##2##3##(2008-7#1)(2012-4#1)
of OPCs##4##2##(2008-7#3)(2012-4#1)
of OPN in the islets##2##5##(2010-11#2)
of OPN##7##2##(2010-11#7)
of OPV##2##2##(1995-5#2)
of OPs##2##2##(2008-10#2)
of ORF##3##2##(2008-10#2)(2008-12#1)
of ORF7##3##2##(2008-10#3)
of ORNs##2##2##(2007-12#2)
of OSCC##4##2##(2010-12#2)(2013-1#2)
of OSR##2##2##(2008-10#2)
of OTA##3##2##(2008-10#1)(2011-2#2)
of OVA and##2##3##(2008-11#2)
of OYDV##2##2##(2008-10#2)
of Obstetrics and Gynecology##3##4##(1991-3#2)(1996-9#1)
of Obstetrics and##4##3##(1991-3#2)(1996-1#1)(1996-9#1)
of October##2##2##(1994-9#1)(2008-10#1)
of Ohio##2##2##(2008-10#2)
of Okazaki fragment synthesis##2##4##(1992-3#2)
of Ontario##4##2##(1993-1#1)(1994-1#1)(1995-3#2)
of Ontogenic##2##2##(2008-10#1)(2008-11#1)
of Ophiostoma##2##2##(2008-10#2)
of Ophthalmology##2##2##(2010-10#1)(2011-2#1)
of Oregon##3##2##(2008-10#3)
of Origin##3##2##(2008-10#3)
of Orobanche##3##2##(2008-10#2)(2011-2#1)
of Orthopaedics and Traumatology##3##4##(2009-4#1)(2013-1#2)
of Oryza sativa L##2##4##(2008-9#2)
of Oryza sativa##4##3##(2008-10#1)(2008-9#2)(2009-10#1)
of Oryza##6##2##(2008-10#1)(2008-8#1)(2008-9#2)(2009-10#2)
of Oslo##5##2##(1990-9#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-6#1)
of Otostegia persica Boiss##2##4##(2008-12#2)
of P##277##2##(1992-6#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#244)(2008-5#6)(2008-7#2)(2008-9#1)(2009-5#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#3)(2012-2#6)(2013-1#1)(2013-8#1)
of P(V)##3##2##(2008-10#3)
of P-450(11 beta)##3##3##(1990-5#3)
of P-450arom##2##2##(1995-8#2)
of P-glycoprotein and##2##3##(2008-11#2)
of P-glycoprotein##6##2##(1992-12#1)(2008-10#2)(2008-11#3)
of P-gp##2##2##(2011-3#2)
of P-selectin##3##2##(2006-6#1)(2008-9#2)
of P1##4##2##(1992-6#2)(1994-11#1)(2008-9#1)
of P450##6##2##(1990-5#1)(1993-8#1)(2008-7#2)(2009-9#2)
of P450c17##2##2##(2008-4#2)
of P89##2##2##(2008-10#2)
of PA##4##2##(2008-10#3)(2008-11#1)
of PAA##3##2##(2008-10#3)
of PACAP##2##2##(1995-11#2)
of PACE##2##2##(1992-1#1)(2008-7#1)
of PAD##2##2##(2008-10#1)(2008-8#1)
of PAF##2##2##(1991-5#2)
of PAH##10##2##(2008-10#6)(2008-11#3)(2010-10#1)
of PAHs from##4##3##(2008-10#4)
of PAHs in##8##3##(2008-10#7)(2008-11#1)
of PAHs was##2##3##(2008-10#2)
of PAHs##22##2##(2008-10#21)(2008-11#1)
of PAI##5##2##(1995-2#5)
of PAM##4##2##(1996-3#1)(2008-9#1)(2012-12#2)
of PAN-treated##2##2##(2009-6#2)
of PAP in##3##3##(2008-10#1)(2008-12#2)
of PAP##5##2##(1990-9#1)(2008-10#1)(2008-12#3)
of PAR during the##2##4##(2008-10#2)
of PAR##8##2##(2008-10#6)(2008-7#2)
of PARAFAC##2##2##(2008-10#2)
of PAV##2##2##(2008-10#2)
of PBDEs##4##2##(2008-10#4)
of PBMCs##2##2##(2008-10#1)(2008-4#1)
of PBN gustatory neurons##2##4##(2009-10#2)
of PBS was##2##3##(2008-8#2)
of PBS##8##2##(2008-10#1)(2008-8#7)
of PC exposure##2##3##(2012-3#2)
of PC##6##2##(2008-10#2)(2008-7#1)(2012-3#2)(2013-1#1)
of PC12 cells##6##3##(2008-11#6)
of PC12##7##2##(2008-11#7)
of PCA##2##2##(2011-1#2)
of PCBs in##2##3##(2008-10#2)
of PCDD/F##2##2##(2008-10#2)
of PCDDs##3##2##(2008-10#3)
of PCDDs/PCDFs and dioxin-like PCBs in food##2##7##(2008-10#2)
of PCFV##4##2##(2008-10#4)
of PCOS##2##2##(2008-4#2)
of PCP in##2##3##(2008-10#2)
of PCP##5##2##(2008-10#4)(2009-3#1)
of PCR primers##2##3##(2008-10#2)
of PCR products##4##3##(1993-6#1)(2008-10#1)(2008-4#2)
of PCR##20##2##(1993-12#2)(1993-6#1)(1996-12#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-4#3)(2008-9#3)
of PCR-amplified##3##2##(2008-10#3)
of PCS##4##2##(2013-1#4)
of PCs in##2##3##(1994-2#1)(2008-10#1)
of PCs##4##2##(1994-2#1)(2008-10#2)(2008-11#1)
of PD and##3##3##(2008-6#1)(2008-7#2)
of PD dementia##2##3##(2008-7#2)
of PD in##2##3##(2008-10#1)(2008-12#1)
of PD patients##3##3##(2008-7#3)
of PD phytoplasma##2##3##(2008-10#2)
of PD therapy##3##3##(2011-2#3)
of PD##36##2##(1997-2#1)(2008-10#4)(2008-12#2)(2008-6#1)(2008-7#20)(2008-8#1)(2010-8#1)(2011-2#6)
of PD-L1##3##2##(2012-3#3)
of PDA##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
of PDGF##2##2##(1995-11#2)
of PDGF-betaRWT##2##2##(1997-7#2)
of PDMCs##2##2##(2008-9#2)
of PE##3##2##(2008-8#1)(2012-2#2)
of PEG from##2##3##(2008-10#2)
of PEG into##3##3##(2008-10#3)
of PEG##10##2##(2008-10#8)(2008-12#1)(2011-2#1)
of PEI##4##2##(2008-10#3)(2008-11#1)
of PET and##2##3##(2012-12#1)(2012-2#1)
of PET radiopharmaceuticals##3##3##(2013-1#3)
of PET##8##2##(1995-2#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-1#3)
of PET/CT##3##2##(2009-2#1)(2009-9#1)(2012-2#1)
of PF-68##2##2##(2011-2#2)
of PFBBr##4##2##(2008-10#4)
of PFC##2##2##(1996-5#1)(2013-8#1)
of PG isozymes##2##3##(2008-10#2)
of PG##14##2##(1990-2#2)(2008-10#4)(2008-11#3)(2008-8#4)(2013-8#1)
of PGC-1alpha##2##2##(2008-1#2)
of PGCs##6##2##(2008-11#6)
of PGE(2) and TXB(2)##2##4##(2008-10#2)
of PGE1##4##2##(1993-12#1)(1994-2#3)
of PGE2 at##4##3##(1997-2#4)
of PGE2##5##2##(1997-1#1)(1997-2#4)
of PGEs and gold##2##4##(2008-10#2)
of PGM##2##2##(2008-10#2)
of PGMs##2##2##(2008-10#2)
of PGN##2##2##(2009-8#2)
of PHR1##2##2##(1996-3#2)
of PHS 70 in##2##4##(2012-3#2)
of PHS##3##2##(2012-3#3)
of PHV##4##2##(2008-10#1)(2008-5#3)
of PI 3-kinase##3##3##(1994-11#3)
of PI 88788##2##3##(2008-10#2)
of PI##7##2##(1990-5#1)(1994-11#3)(2008-10#2)(2013-1#1)
of PI-PLC##2##2##(1995-8#2)
of PI3K##4##2##(1996-2#4)
of PIBs produced##2##3##(2008-11#2)
of PIBs##3##2##(2008-11#3)
of PIH##4##2##(1994-3#3)(2012-2#1)
of PIP3##2##2##(1993-8#2)
of PKA##8##2##(1993-3#1)(1994-8#5)(2008-10#1)(2008-11#1)
of PKC activity##2##3##(1997-2#1)(2008-10#1)
of PKC by##2##3##(1996-12#1)(1997-1#1)
of PKC epsilon##2##3##(1995-2#2)
of PKC in the##3##4##(1994-6#2)(1997-1#1)
of PKC in##4##3##(1994-6#2)(1996-12#1)(1997-1#1)
of PKC to##2##3##(1993-12#1)(1993-8#1)
of PKC was##3##3##(2008-11#1)(2008-8#2)
of PKC##27##2##(1990-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#2)(1997-1#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)
of PKCalpha was##2##3##(2008-9#2)
of PKCalpha##4##2##(2008-9#4)
of PLA2##2##2##(1994-6#2)
of PLC-gamma##3##2##(1992-7#2)(1997-7#1)
of PLD activity##2##3##(1995-8#2)
of PLD##5##2##(1995-8#5)
of PLL##2##2##(1991-5#1)(2008-10#1)
of PLP##2##2##(2009-6#2)
of PLRV##2##2##(2008-10#2)
of PLS and##2##3##(2008-10#2)
of PLS regression##2##3##(2008-10#2)
of PLS##6##2##(2008-10#6)
of PM##6##2##(2008-10#4)(2008-7#2)
of PMA##6##2##(1994-3#1)(1994-8#3)(1995-11#1)(1997-1#1)
of PMCs##2##2##(2013-1#2)
of PME##2##2##(1991-9#1)(2008-8#1)
of PMN##3##2##(1991-2#2)(2008-10#1)
of PMSG##2##2##(2008-5#1)(2008-8#1)
of PMT##2##2##(2013-8#2)
of PN-2/APP in##2##3##(1992-12#2)
of PN-2/APP##3##2##(1992-12#3)
of PNET in a##2##4##(2008-7#2)
of PO in##2##3##(2008-10#1)(2011-10#1)
of PO##3##2##(1993-8#1)(2008-10#1)(2011-10#1)
of POEMS syndrome##2##3##(1992-12#1)(2009-7#1)
of PP##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
of PPAR gamma 2##2##4##(1994-12#2)
of PPAR gamma##3##3##(1994-12#3)
of PPG and its derivatives##2##5##(2008-9#2)
of PPG-1025##2##2##(2008-10#2)
of PPH##3##2##(1997-5#3)
of PPI##3##2##(2008-11#2)(2008-8#1)
of PPR##3##2##(1995-12#1)(2011-2#2)
of PPS##3##2##(1992-1#1)(1992-2#2)
of PPV##4##2##(2008-10#4)
of PPV-M##2##2##(2008-10#2)
of PPa in##2##3##(2008-8#2)
of PPa##3##2##(2008-8#3)
of PQ##5##2##(1995-8#1)(2008-10#4)
of PQC##2##2##(2008-10#2)
of PR proteins##2##3##(2008-10#2)
of PR##5##2##(2008-10#3)(2013-8#2)
of PRL expression in##2##4##(1994-3#2)
of PRL was##2##3##(2008-10#1)(2011-2#1)
of PRL##7##2##(1994-3#3)(2008-10#1)(2011-2#3)
of PRL-R mRNA##2##3##(2011-2#2)
of PRL-R##5##2##(2011-2#5)
of PRO##2##2##(2008-10#2)
of PROM##3##2##(2012-3#3)
of PRSV##2##2##(2008-10#2)
of PRms in##2##3##(2008-10#2)
of PRms##3##2##(2008-10#3)
of PS##4##2##(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#1)
of PSA in##2##3##(2010-12#2)
of PSA promoter##2##3##(2008-9#2)
of PSA##10##2##(1990-9#1)(2008-9#2)(2009-5#1)(2010-12#5)(2011-2#1)
of PSD values of##2##4##(2010-8#2)
of PSII##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-7#1)
of PSP##2##2##(2012-12#2)
of PTFE##3##2##(1990-9#1)(2008-10#2)
of PTH##5##2##(1991-12#2)(1993-12#1)(1994-11#1)(2008-1#1)
of PTHrP in##2##3##(1993-3#2)
of PTHrP##5##2##(1993-3#4)(2013-7#1)
of PTP synthase##3##3##(1997-8#3)
of PTP##5##2##(1994-6#2)(1997-8#3)
of PTPase##3##2##(2008-8#3)
of PTPepsilon##2##2##(2009-6#2)
of PTSD and##2##3##(2008-10#2)
of PTSD##7##2##(1991-2#1)(2008-10#2)(2008-6#2)(2009-11#1)(2010-10#1)
of PUFAs##5##2##(2008-10#3)(2010-6#2)
of PV##6##2##(2008-10#1)(2010-7#1)(2011-2#4)
of PVA in##2##3##(2008-10#2)
of PVA##7##2##(2008-10#7)
of PVC and##2##3##(2008-10#2)
of PVC##6##2##(2008-10#6)
of PVMV##2##2##(2008-10#2)
of PVV##3##2##(2008-10#3)
of PVY##6##2##(2008-10#6)
of PZFX##3##2##(2011-2#3)
of Pacific hake Merluccius productus##2##5##(2010-8#2)
of Pacific##8##2##(2008-1#4)(2008-10#2)(2010-8#2)
of Pacificans##2##2##(2008-1#2)
of Paediatrics##2##2##(2008-11#1)(2012-12#1)
of Paget's disease##2##3##(1991-11#2)
of Pakistan and##2##3##(2012-2#2)
of Pakistan##3##2##(2012-2#3)
of Pantoea agglomerans on##2##4##(2008-10#2)
of Pantoea agglomerans##6##3##(2008-10#6)
of Pantoea##7##2##(2008-10#7)
of Pap smears##2##3##(1990-12#2)
of Paracoccidioides brasiliensis##2##3##(2008-5#2)
of Paris##3##2##(2008-11#1)(2010-1#1)(2012-3#1)
of Parkinson's disease (PD)##3##4##(2008-10#1)(2008-7#2)
of Parkinson's disease and##4##4##(1991-5#2)(1997-2#1)(2008-7#1)
of Parkinson's disease##28##3##(1991-5#2)(1992-3#1)(1997-2#2)(2008-10#2)(2008-12#1)(2008-7#14)(2008-8#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
of Parkinson's##30##2##(1991-5#2)(1992-3#1)(1997-2#2)(2008-10#2)(2008-12#1)(2008-7#15)(2008-8#1)(2009-11#1)(2010-5#2)(2010-8#1)(2011-2#1)(2013-7#1)
of Partial Resistance##2##3##(2008-10#2)
of Partial##3##2##(2008-10#2)(2008-11#1)
of Pathogenic##2##2##(2008-10#2)
of Pathologists##2##2##(1994-12#1)(1994-8#1)
of Pathology##4##2##(1991-9#1)(1994-12#1)(2008-5#1)(2013-8#1)
of Pathotypes##2##2##(2008-10#2)
of Patient Focused##5##3##(1993-12#1)(1994-2#4)
of Patient##6##2##(1993-12#1)(1994-2#4)(2013-8#1)
of Patients with##3##3##(1995-11#1)(2009-10#1)(2012-3#1)
of Patients##4##2##(1995-11#1)(2009-10#1)(2010-8#1)(2012-3#1)
of Pb and Cd##2##4##(2008-10#2)
of Pb and##6##3##(2008-10#6)
of Pb in##3##3##(2008-10#3)
of Pb##26##2##(2008-10#25)(2008-11#1)
of Pb(2+) and Cd(2+)##4##4##(2008-10#4)
of Pb(2+) ions##4##3##(2008-10#4)
of Pb(2+)##14##2##(2008-10#14)
of Pb(II) and Tl(I)##2##4##(2008-10#2)
of Pb(II) and##3##3##(2008-10#3)
of Pb(II) at##3##3##(2008-10#3)
of Pb(II) with##2##3##(2008-10#2)
of Pb(II)##13##2##(2008-10#13)
of Pb2+ on##2##3##(1995-11#2)
of PcMV##7##2##(2008-10#7)
of Pd##6##2##(2008-10#5)(2008-11#1)
of Pd(II) and Pt(IV)##2##4##(2008-10#2)
of Pd(II) with##3##3##(2008-10#3)
of Pd(II)##13##2##(2008-10#13)
of Pd(II)TMPyP##3##2##(2008-10#3)
of Pdx##2##2##(1994-5#2)
of Pea##2##2##(2008-10#2)
of Peach##3##2##(2008-10#3)
of Peanut chlorotic fan-spot virus##2##5##(2008-10#2)
of Peanut##4##2##(2008-10#4)
of Pear##2##2##(2008-10#2)
of Pediatric##6##2##(2008-10#4)(2011-2#1)(2013-1#1)
of Pediatrics##5##2##(1991-6#1)(1996-6#1)(2008-11#1)(2010-8#1)(2013-1#1)
of Peg-Interferon##3##2##(2013-1#3)
of Penicillium digitatum##2##3##(2008-10#2)
of Penicillium oxalicum##3##3##(2008-10#3)
of Penicillium spp##2##3##(2008-10#2)
of Penicillium##11##2##(2008-10#10)(2011-2#1)
of Pennisetum##2##2##(2008-10#2)
of Pennsylvania##2##2##(1990-11#1)(1993-2#1)
of PepMoV through the stem##2##5##(2008-10#2)
of PepMoV##3##2##(2008-10#3)
of Pepper mild mottle virus##2##5##(2008-10#2)
of Pepper##4##2##(2008-10#4)
of Perceived##2##2##(2008-11#1)(2013-8#1)
of Perna##2##2##(2008-10#2)
of Peronospora tabacina with##2##4##(2008-10#2)
of Peronospora tabacina##6##3##(2008-10#6)
of Peronospora##7##2##(2008-10#7)
of Persian version##2##3##(2012-12#1)(2013-8#1)
of Persian##3##2##(2008-12#1)(2012-12#1)(2013-8#1)
of Peruvian##2##2##(2008-10#2)
of Petroselinum crispum##3##3##(2008-12#3)
of PfTrx-2##5##2##(2012-2#5)
of PhTX-343 and spermine##2##4##(1990-7#2)
of PhTX-343 and##3##3##(1990-7#3)
of Phaeosphaeria nodorum##5##3##(2008-10#5)
of Phanerochaete chrysosporium##2##3##(2008-6#1)(2008-7#1)
of Pharmacy##2##2##(1991-3#1)(2010-3#1)
of Phaseolus vulgaris##2##3##(2008-10#1)(2008-11#1)
of Phaseolus##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
of Phe##3##2##(1992-4#1)(2008-9#2)
of Phialophora gregata##2##3##(2008-10#2)
of Phlebotominae sand flies##2##4##(2008-12#2)
of Phlebovirus##2##2##(2013-8#2)
of Phomopsis amygdali##2##3##(2008-10#2)
of Phomopsis leaf blight##3##4##(2008-10#3)
of Phomopsis##6##2##(2008-10#6)
of Photofrin II##2##3##(1993-8#2)
of Physical Activity##2##3##(2012-2#1)(2012-3#1)
of Physical##3##2##(2008-12#1)(2012-2#1)(2012-3#1)
of Physician##2##2##(2009-2#2)
of PhysioDirect##2##2##(2011-2#2)
of Phytophthora capsici in Michigan##3##5##(2008-10#3)
of Phytophthora capsici in##6##4##(2008-10#6)
of Phytophthora capsici##12##3##(2008-10#12)
of Phytophthora cinnamomi in##2##4##(2008-10#2)
of Phytophthora cinnamomi##4##3##(2008-10#4)
of Phytophthora infestans Sporangia##2##4##(2008-10#2)
of Phytophthora infestans from the##2##5##(2008-10#2)
of Phytophthora infestans from##4##4##(2008-10#4)
of Phytophthora infestans in the Toluca Valley##2##7##(2008-10#2)
of Phytophthora infestans in the Toluca##3##6##(2008-10#3)
of Phytophthora infestans in the United States and Canada##2##9##(2008-10#2)
of Phytophthora infestans in the United States##4##7##(2008-10#4)
of Phytophthora infestans in the##7##5##(2008-10#7)
of Phytophthora infestans in##10##4##(2008-10#10)
of Phytophthora infestans on##2##4##(2008-10#2)
of Phytophthora infestans sensu lato##2##5##(2008-10#2)
of Phytophthora infestans to##3##4##(2008-10#3)
of Phytophthora infestans were##2##4##(2008-10#2)
of Phytophthora infestans##48##3##(2008-10#47)(2008-8#1)
of Phytophthora is##2##3##(2008-10#2)
of Phytophthora nicotianae##6##3##(2008-10#6)
of Phytophthora parasitica in##3##4##(2008-10#3)
of Phytophthora parasitica##8##3##(2008-10#8)
of Phytophthora ramorum in##2##4##(2008-10#2)
of Phytophthora ramorum##11##3##(2008-10#11)
of Phytophthora spp##7##3##(2008-10#7)
of Phytophthora##115##2##(2008-10#114)(2008-8#1)
of Pi-ta##4##2##(2008-10#4)
of Pichia anomala##2##3##(2008-10#2)
of Pichia guilermondii and Bacillus mycoides##2##6##(2008-10#2)
of Pichia guilermondii##3##3##(2008-10#3)
of Pichia##6##2##(2008-10#5)(2008-7#1)
of Pierce's Disease##3##3##(2008-10#3)
of Pierce's disease (PD)##2##4##(2008-10#2)
of Pierce's##5##2##(2008-10#5)
of Pimelodus##3##2##(2008-12#3)
of Pineapple##2##2##(2008-10#2)
of Pinus##5##2##(2008-10#4)(2011-10#1)
of Pipizini##2##2##(2008-8#2)
of Plant##11##2##(2008-10#5)(2009-8#1)(2011-2#5)
of Plantago palmata##2##3##(2008-10#2)
of Plasmodiophora brassicae##3##3##(2008-10#3)
of Plasmodium falciparum##7##3##(1991-4#1)(1991-8#1)(1995-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
of Plasmodium##10##2##(1991-4#1)(1991-8#1)(1995-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#3)(2012-2#1)
of Plasmopara halstedii##2##3##(2008-10#2)
of Plasmopara##3##2##(2008-10#3)
of Plum pox virus (PPV)##2##5##(2008-10#2)
of Plum pox virus##4##4##(2008-10#4)
of PmTLP##6##2##(2008-10#6)
of Pneumocystis##2##2##(1991-12#1)(1993-2#1)
of Podosphaera macularis##2##3##(2008-10#2)
of Podosphaera##4##2##(2008-10#4)
of Poland##4##2##(2008-10#1)(2008-12#3)
of Polish intelligentsia##2##3##(2008-12#2)
of Polish##4##2##(2008-12#3)(2013-1#1)
of Polymorphisms in##2##3##(2011-2#1)(2013-8#1)
of Polystoechotes punctatus##2##3##(2007-12#2)
of Ponceau##3##2##(2008-10#3)
of Population##2##2##(2008-10#1)(2013-8#1)
of Populations of##3##3##(2008-10#2)(2008-6#1)
of Populations##4##2##(2008-10#3)(2008-6#1)
of Porphyromonas gingivalis and Bacteroides forsythus in chronic periodontitis##2##9##(2008-12#2)
of Porphyromonas gingivalis##3##3##(2008-12#2)(2008-9#1)
of Porphyromonas##4##2##(2008-12#2)(2008-9#2)
of Portugal##2##2##(2008-10#2)
of Potato virus V##2##4##(2008-10#2)
of Potato virus X##2##4##(2008-10#2)
of Potato virus Y##2##4##(2008-10#2)
of Potato virus##7##3##(2008-10#7)
of Potato##13##2##(2008-10#12)(2011-2#1)
of PrEP##3##2##(2012-2#2)(2013-1#1)
of Pratylenchus##2##2##(2008-10#2)
of Prc-MIH##3##2##(2008-6#3)
of President Reagan's colon cancer episode##2##6##(1991-3#2)
of President##3##2##(1991-3#2)(1995-6#1)
of Prevalence##2##2##(2008-11#1)(2013-1#1)
of Prevention##2##2##(1997-5#1)(2010-6#1)
of Primary##7##2##(1991-9#2)(1994-6#1)(1996-5#2)(2008-10#2)
of Primatone RL##4##3##(2008-7#4)
of Principal##2##2##(2008-10#1)(2008-5#1)
of Pro-Pro-[3H]benzylamide##2##2##(1992-3#2)
of Professor##2##2##(2008-10#1)(2008-12#1)
of Programmed##2##2##(2012-3#2)
of Protein Kinase##2##3##(2008-11#1)(2008-3#1)
of Prune dwarf virus##2##4##(2008-10#2)
of Prune##5##2##(2008-10#5)
of Prunus necrotic ringspot virus (PNRSV)##2##6##(2008-10#2)
of Prunus##5##2##(2008-10#5)
of Prussian-Blue##2##2##(2008-10#2)
of Pseudomonas aeruginosa##8##3##(2008-10#2)(2008-7#2)(2012-2#4)
of Pseudomonas fluorescens B5##5##4##(2008-10#5)
of Pseudomonas fluorescens##13##3##(2008-10#13)
of Pseudomonas putida 06909-rif/nal##8##4##(2008-10#8)
of Pseudomonas putida##9##3##(2008-10#8)(2012-2#1)
of Pseudomonas spp##2##3##(2008-10#2)
of Pseudomonas syringae pv##8##4##(2008-10#8)
of Pseudomonas syringae pvs##2##4##(2008-10#2)
of Pseudomonas syringae##14##3##(2008-10#14)
of Pseudomonas##47##2##(2008-10#40)(2008-7#2)(2012-2#5)
of Pseudothecia##2##2##(2008-10#2)
of Psychiatric##3##2##(2008-12#1)(2009-6#1)(2011-4#1)
of Psychiatry and##2##3##(2008-7#1)(2011-3#1)
of Psychiatry##6##2##(2008-12#1)(2008-7#1)(2011-3#1)(2011-4#3)
of Pt and##2##3##(2008-10#2)
of Pt##7##2##(2008-10#5)(2008-11#2)
of Pten in##2##3##(2011-2#2)
of Pten##3##2##(2011-2#3)
of Pterocarya fraxinifolia##2##3##(2011-1#2)
of Ptr##2##2##(2008-10#2)
of Pu##7##2##(2008-10#7)
of Public Health identified##2##4##(1996-1#1)(2008-10#1)
of Public Health##14##3##(1991-2#2)(1996-1#4)(1996-12#1)(1996-6#1)(2008-10#3)(2008-12#1)(2010-6#1)(2010-8#1)
of Public##16##2##(1991-2#2)(1991-3#1)(1996-1#4)(1996-12#1)(1996-6#1)(2008-10#3)(2008-12#1)(2010-5#1)(2010-6#1)(2010-8#1)
of Puccinia allii##2##3##(2008-10#2)
of Puccinia coronata##2##3##(2008-10#2)
of Puccinia graminis##2##3##(2008-10#2)
of Puccinia recondita f##2##4##(2008-10#2)
of Puccinia striiformis##2##3##(2008-10#2)
of Puccinia triticina from##3##4##(2008-10#3)
of Puccinia triticina##11##3##(2008-10#11)
of Puccinia##23##2##(2008-10#23)
of Puerto##4##2##(1994-2#1)(2012-12#3)
of PurR##3##2##(2008-8#3)
of Purkinje neurons##2##3##(1995-8#2)
of Purkinje##3##2##(1995-8#2)(1997-8#1)
of Pyr and D-Pyr##2##4##(1994-12#2)
of Pyr-ms##2##2##(2008-10#2)
of Pyrenopeziza brassicae##2##3##(2008-10#2)
of Pyrenophora tritici-repentis##4##3##(2008-10#4)
of Pyrenophora##5##2##(2008-10#5)
of Pyricularia grisea from##2##4##(2008-10#2)
of Pyricularia grisea##4##3##(2008-10#4)
of Pyricularia##5##2##(2008-10#5)
of Pythium oligandrum##3##3##(2008-10#3)
of Pythium spp##7##3##(2008-10#7)
of Pythium ultimum var##3##4##(2008-10#3)
of Pythium ultimum##4##3##(2008-10#4)
of Pythium##22##2##(2008-10#22)
of Q were##2##3##(2008-10#2)
of Q##8##2##(2008-10#6)(2012-5#1)(2012-6#1)
of Q8r1-96##2##2##(2008-10#2)
of QAS##2##2##(2008-10#2)
of QCM##2##2##(2008-10#2)
of QSAR##2##2##(2008-10#1)(2012-3#1)
of QTL for##2##3##(2008-10#1)(2012-3#1)
of QTL##7##2##(2008-10#5)(2012-3#2)
of QTLs for##2##3##(2008-9#1)(2009-10#1)
of QTLs##4##2##(2008-10#1)(2008-9#2)(2009-10#1)
of Qc to##2##3##(1993-8#2)
of Qc##3##2##(1993-8#3)
of Qi deficiency##2##3##(2013-1#1)(2013-8#1)
of QoL##6##2##(2008-10#3)(2013-1#3)
of Quality##2##2##(1997-1#1)(1997-2#1)
of Quantitative Trait Loci##2##4##(2008-10#2)
of Quebec##6##2##(1992-1#2)(1996-1#2)(1997-2#1)(2009-10#1)
of Queensland##2##2##(2010-10#1)(2013-8#1)
of Quercus##3##2##(2008-10#1)(2009-12#1)(2012-6#1)
of Québec##2##2##(1996-3#1)(2008-10#1)
of R genes##3##3##(2008-10#3)
of R##66##2##(1995-12#1)(2008-10#62)(2008-5#1)(2008-8#1)(2010-1#1)
of R(1)##2##2##(2008-10#2)
of R-baclofen##3##2##(2008-10#3)
of R-strand##2##2##(2008-7#2)
of R22L##2##2##(2008-8#2)
of R338W##5##2##(1995-8#5)
of RA into##2##3##(2008-5#2)
of RA##18##2##(1990-6#2)(2008-11#4)(2008-5#4)(2008-8#1)(2010-12#2)(2012-2#2)(2013-8#3)
of RAM1##2##2##(1993-9#2)
of RANKL##2##2##(2008-11#2)
of RAPB##2##2##(2008-9#2)
of RAPD and##2##3##(2008-10#2)
of RAPD markers##2##3##(1995-6#1)(2008-10#1)
of RAPD##8##2##(1995-6#1)(2008-10#7)
of RATEC##2##2##(2008-11#2)
of RB protein##5##3##(1993-8#5)
of RB##11##2##(1993-8#5)(2008-10#4)(2013-1#2)
of RBC##2##2##(2008-10#1)(2010-8#1)
of RBCs##2##2##(2008-8#2)
of RBV##2##2##(2013-1#2)
of RC##2##2##(2008-12#1)(2008-8#1)
of RC-160##4##2##(1995-2#4)
of RCC##4##2##(2011-2#1)(2012-3#3)
of RCK7##2##2##(2008-11#2)
of RDV##4##2##(2008-10#4)
of RDX##6##2##(2008-10#2)(2008-7#4)
of REE##3##2##(2008-10#2)(2012-2#1)
of REEs in##2##3##(2008-10#2)
of REEs##6##2##(2008-10#6)
of REV were##2##3##(2008-5#1)(2013-8#1)
of REV##3##2##(2008-5#1)(2013-8#2)
of REp##2##2##(2008-5#2)
of RF power##3##3##(1992-3#3)
of RF##8##2##(1992-3#5)(2008-10#1)(2010-6#1)(2011-2#1)
of RGAs were##2##3##(2008-10#2)
of RGAs##3##2##(2008-10#3)
of RH##5##2##(2008-10#5)
of RLA/Verh rats as compared to##2##6##(1994-2#2)
of RNA 1 and##2##4##(2008-10#2)
of RNA 2##2##3##(2008-10#2)
of RNA and DNA##5##4##(1992-3#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
of RNA and##7##3##(1991-8#1)(1992-3#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
of RNA editing in##2##4##(2012-2#2)
of RNA editing##3##3##(1997-2#1)(2012-2#2)
of RNA polymerase II##3##4##(1994-3#2)(2012-2#1)
of RNA polymerase##7##3##(1994-3#2)(1995-2#1)(2008-9#1)(2012-2#1)(2012-3#2)
of RNA samples##2##3##(2008-4#1)(2008-5#1)
of RNA secondary##2##3##(1991-9#1)(2011-3#1)
of RNA silencing##2##3##(2011-1#1)(2011-2#1)
of RNA synthesis##4##3##(1995-2#2)(1996-2#1)(2008-9#1)
of RNA viruses##2##3##(2008-10#1)(2013-8#1)
of RNA##66##2##(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-3#2)(1995-2#3)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#4)(2008-10#9)(2008-4#12)(2008-5#1)(2008-8#1)(2008-9#6)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-2#3)(2012-3#3)(2013-8#2)
of RNA-dependent RNA polymerases##3##4##(2008-10#3)
of RNA-dependent RNA##4##3##(2008-10#4)
of RNAi##2##2##(2011-1#1)(2013-1#1)
of RNAs##2##2##(2008-10#1)(2008-2#1)
of RO 11-2933##2##3##(1990-2#2)
of ROE##2##2##(2008-5#2)
of ROH##2##2##(2008-10#2)
of ROS and##2##3##(2008-11#1)(2011-2#1)
of ROS production##3##3##(1994-5#1)(2009-3#1)(2010-12#1)
of ROS##17##2##(1994-5#4)(2008-10#2)(2008-11#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-3#1)
of RP genes##3##3##(2009-8#3)
of RP##5##2##(2009-8#3)(2011-2#2)
of RPMI 1788 cells##3##4##(1990-12#3)
of RPMI 1788##4##3##(1990-12#4)
of RQA##2##2##(2008-11#2)
of RS extract##7##3##(2008-11#7)
of RSB##2##2##(2013-1#2)
of RSV##2##2##(1995-6#2)
of RT-PCR##3##2##(2008-10#2)(2008-9#1)
of RTP##2##2##(2008-10#2)
of RWA##2##2##(2008-9#2)
of RXRα##3##2##(2012-12#3)
of Rab##5##2##(1995-8#1)(2011-2#4)
of Rac2##2##2##(1997-7#2)
of Race##2##2##(2008-10#2)
of Race-Specific##3##2##(2008-10#3)
of Radiation Oncology and##2##4##(2008-10#2)
of Radiation Oncology##3##3##(2008-10#3)
of Radiation##4##2##(2008-10#3)(2013-1#1)
of Radiology##13##2##(1991-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(2010-12#2)(2012-2#6)
of Ragusa##2##2##(1991-2#2)
of Ralstonia solanacearum in##2##4##(2008-10#2)
of Ralstonia solanacearum##11##3##(2008-10#11)
of Raman spectroscopy##2##3##(2008-10#2)
of Raman tweezers##2##3##(2009-12#2)
of Raman##6##2##(2008-10#3)(2009-12#2)(2013-8#1)
of Ran##3##2##(1995-2#2)(2011-2#1)
of Random Amplified Polymorphic DNA Markers Linked to##2##8##(2008-10#2)
of Ras##7##2##(1996-2#3)(1997-7#2)(2008-10#1)(2008-5#1)
of RasGRP1##3##2##(2013-8#3)
of Rat##3##2##(2008-11#2)(2009-8#1)
of Rauvolfia tetraphylla L##2##4##(2008-12#2)
of Rb##2##2##(2008-10#1)(2008-8#1)
of Reactive##3##2##(2008-10#2)(2011-2#1)
of Reference##4##2##(2008-10#3)(2011-2#1)
of Relative##3##2##(2008-10#3)
of Renal##2##2##(2008-1#1)(2013-1#1)
of RepK##4##2##(1997-6#4)
of Research##2##2##(2009-4#2)
of Resistance to Sterol Demethylation##2##5##(2008-10#2)
of Resistance to##15##3##(2008-10#15)
of Resistance##18##2##(2008-10#17)(2010-1#1)
of Resource##2##2##(1991-12#1)(1994-12#1)
of Respiratory##2##2##(1997-4#1)(2011-2#1)
of Retzius##2##2##(1997-3#2)
of Rh##4##2##(1996-3#2)(2008-10#2)
of Rheumatology at Hospital for Special Surgery##3##7##(2008-8#3)
of Rheumatology##4##2##(1997-8#1)(2008-8#3)
of Rhexocercosporidium##3##2##(2008-10#3)
of Rhizoctonia blight##2##3##(2008-10#2)
of Rhizoctonia solani Anastomosis Group##3##5##(2008-10#3)
of Rhizoctonia solani Anastomosis##4##4##(2008-10#4)
of Rhizoctonia solani anastomosis group##3##5##(2008-10#3)
of Rhizoctonia solani and##2##4##(2008-10#2)
of Rhizoctonia solani##22##3##(2008-10#22)
of Rhizoctonia spp##3##3##(2008-10#3)
of Rhizoctonia##31##2##(2008-10#31)
of Rhizopus head rot##3##4##(2008-10#3)
of Rho123##3##2##(2008-10#3)
of Rhodamine 6G##2##3##(2007-11#1)(2008-3#1)
of Rhodamine##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
of Rhynchosporium secalis from##2##4##(2008-10#2)
of Rhynchosporium secalis in##2##4##(2008-10#2)
of Rhynchosporium secalis##4##3##(2008-10#4)
of Riberalta##2##2##(2012-12#2)
of Rice Blast##2##3##(2008-10#2)
of Rice##6##2##(2008-10#5)(2013-8#1)
of Ricinus communis##2##3##(1993-11#1)(2008-11#1)
of Riedel's thyroiditis##3##3##(2008-12#3)
of Rio##2##2##(2008-10#1)(2012-3#1)
of Rizaben for##2##3##(2008-5#2)
of Roman age##2##3##(2008-10#2)
of Roman high-avoidance##2##3##(1994-2#2)
of Roman##6##2##(1994-2#2)(2008-10#4)
of Rome##6##2##(1990-8#2)(1992-9#1)(2011-7#1)(2013-1#2)
of Root and##2##3##(2008-10#2)
of Root##3##2##(2008-10#3)
of Rosellinia necatrix##2##3##(2008-10#2)
of Ru##4##2##(2008-10#4)
of Ru(III)##2##2##(2008-10#2)
of Ru(bpy)(3)(2+)##10##2##(2008-10#10)
of Ru-bipy##2##2##(2008-12#2)
of Rubia cordifolia in##2##4##(2012-2#2)
of Rubia cordifolia##5##3##(2012-2#5)
of Rubisco##2##2##(2008-8#2)
of Russian##2##2##(2008-9#1)(2013-8#1)
of S and R captopril using##2##6##(2008-10#2)
of S and##3##3##(2008-10#2)(2008-2#1)
of S strain##2##3##(2008-10#2)
of S##117##2##(1990-2#2)(1991-5#1)(1992-6#3)(1993-9#1)(1995-9#1)(1996-12#4)(1996-6#5)(1996-8#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#63)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-6#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#2)
of S-1##5##2##(1991-5#5)
of S-1(A2)##3##2##(1992-4#3)
of S-adenosylhomocysteine hydrolase##2##3##(1994-8#1)(2011-2#1)
of S1##3##2##(1992-3#1)(1994-5#1)(1997-9#1)
of SA##11##2##(1993-6#1)(2008-10#8)(2008-12#1)(2011-2#1)
of SAA##2##2##(2009-10#2)
of SAH##4##2##(2008-7#1)(2009-7#1)(2012-3#2)
of SAM##2##2##(2008-10#1)(2008-7#1)
of SAMs##2##2##(2008-10#2)
of SAR##2##2##(2008-10#2)
of SB obstruction##2##3##(1997-8#2)
of SBA levels##2##3##(2013-1#2)
of SC lipids##2##3##(2008-5#2)
of SC##4##2##(2008-10#1)(2008-5#3)
of SC115##5##2##(1990-11#5)
of SCAVMs##3##2##(1995-11#2)(1997-6#1)
of SCD in young##2##4##(2012-3#2)
of SCE##3##2##(1990-6#1)(2008-11#2)
of SCH##2##2##(2012-3#2)
of SCMV##3##2##(2008-10#2)(2008-9#1)
of SCN(-)##2##2##(2008-10#2)
of SCSs##2##2##(2008-10#1)(2008-11#1)
of SCr##2##2##(2008-1#2)
of SD##2##2##(2008-10#1)(2008-9#1)
of SDME##2##2##(2008-10#2)
of SDS was##3##3##(1990-11#1)(2012-2#2)
of SDS##14##2##(1990-11#1)(1991-5#1)(2008-10#5)(2008-5#2)(2012-2#5)
of SDS-degrading##2##2##(2012-2#2)
of SDS/OP micellar medium##2##4##(2008-10#2)
of SE##2##2##(2008-10#1)(2009-8#1)
of SE5-OH##2##2##(2010-1#2)
of SEAP##3##2##(2008-11#3)
of SEM##2##2##(2008-10#1)(2008-5#1)
of SEP##2##2##(2008-10#1)(2009-3#1)
of SERS-active##2##2##(2008-10#1)(2008-12#1)
of SFE##3##2##(2008-10#3)
of SFPI##3##2##(2011-3#3)
of SGP##2##2##(2013-1#2)
of SHIP2-SH2##2##2##(2012-2#2)
of SHLI with western##2##4##(2011-2#2)
of SHLI with##3##3##(2011-2#3)
of SHLI##8##2##(2011-2#8)
of SIA for##2##3##(2008-10#2)
of SIDS##3##2##(1991-11#1)(1993-12#1)(2008-1#1)
of SIJ dysfunction##3##3##(2010-1#3)
of SIL##2##2##(2012-12#2)
of SIP##5##2##(1993-6#2)(2011-2#3)
of SIT##5##2##(2011-2#5)
of SIV-PR##2##2##(1991-9#2)
of SIVs##2##2##(2013-8#2)
of SL-selectin##2##2##(1992-12#2)
of SLCO1B1##2##2##(2011-2#2)
of SLE##4##2##(2008-1#1)(2008-10#2)(2013-1#1)
of SLI##2##2##(2008-11#1)(2009-8#1)
of SLIT##3##2##(2011-2#3)
of SMARCAL1##2##2##(2011-2#2)
of SMC##2##2##(1994-11#1)(2008-10#1)
of SMV HC-Pro##2##3##(2008-10#2)
of SMV##11##2##(2008-10#11)
of SNAP-25##4##2##(1995-2#3)(1995-6#1)
of SNB##2##2##(2008-10#2)
of SNPs##3##2##(2008-12#2)(2008-9#1)
of SO(2)##8##2##(2008-10#3)(2008-11#2)(2008-3#3)
of SO(4)(2-)##2##2##(2008-10#2)
of SOD##7##2##(1990-3#1)(1997-8#2)(2008-10#2)(2011-3#2)
of SOM##2##2##(2013-8#2)
of SOP##2##2##(2008-7#2)
of SP##3##2##(1997-3#2)(2008-10#1)
of SP1##2##2##(2010-4#2)
of SPARC##3##2##(2008-1#3)
of SPB##2##2##(2012-12#2)
of SPC##4##2##(1995-2#3)(2008-10#1)
of SPE##3##2##(2008-10#3)
of SPECT in##2##3##(1994-1#2)
of SPFMV##4##2##(2008-10#4)
of SPME with##2##3##(2008-10#2)
of SPME##10##2##(2008-10#8)(2009-8#2)
of SPS##3##2##(2008-12#2)(2011-2#1)
of SR alpha##3##3##(1995-6#3)
of SR##8##2##(1995-6#4)(2008-8#3)(2013-8#1)
of SR141716A##2##2##(1996-2#2)
of SRIF mRNA##2##3##(1997-2#2)
of SRIF##3##2##(1997-2#3)
of SRM##3##2##(2008-10#3)
of SS##5##2##(2007-11#1)(2009-11#2)(2010-5#2)
of SSAT##2##2##(1992-10#2)
of SSE1##2##2##(1993-9#2)
of SSI rates##2##3##(2010-12#2)
of SSR incidence##2##3##(2008-10#2)
of SSR##7##2##(2008-10#5)(2010-7#2)
of ST segment and R wave changes in##2##8##(1996-6#2)
of ST##5##2##(1996-6#3)(2008-12#1)(2012-3#1)
of STATs##3##2##(1996-2#1)(2012-3#2)
of STI##2##2##(2008-12#1)(2011-2#1)
of STL-3##4##2##(2008-11#4)
of STLCV##3##2##(2008-10#3)
of SV2##4##2##(1993-12#4)
of SV40##3##2##(2008-11#2)(2008-4#1)
of SVPC##2##2##(2010-11#2)
of SW catalytic##2##3##(2008-10#2)
of SWNTs##2##2##(2008-7#2)
of SYSV##3##2##(2008-10#3)
of Saccharomyces cerevisiae chromosome VII##3##5##(1995-9#1)(1996-3#1)(1996-6#1)
of Saccharomyces cerevisiae chromosome XIV##2##5##(1996-3#2)
of Saccharomyces cerevisiae chromosome##8##4##(1994-9#2)(1995-12#1)(1995-9#1)(1996-3#3)(1996-6#1)
of Saccharomyces cerevisiae is##2##4##(1996-3#1)(1996-6#1)
of Saccharomyces cerevisiae that##3##4##(1993-12#1)(1995-2#1)(1997-6#1)
of Saccharomyces cerevisiae was##2##4##(1995-9#1)(1996-6#1)
of Saccharomyces cerevisiae##36##3##(1990-2#1)(1992-3#1)(1993-12#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#8)(1996-6#3)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2008-10#2)(2008-7#2)
of Saccharomyces##39##2##(1990-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#8)(1996-6#3)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#2)(2008-10#2)(2008-7#2)(2009-8#1)
of Salmonella SBP##2##3##(2009-8#2)
of Salmonella enterica serovar Typhimurium##2##5##(2008-11#2)
of Salmonella enteritidis##5##3##(1991-11#1)(1993-2#1)(1995-9#2)(2008-10#1)
of Salmonella##16##2##(1990-12#1)(1991-11#1)(1993-2#1)(1995-5#1)(1995-9#2)(2008-10#1)(2008-11#2)(2009-8#2)(2011-2#1)(2013-8#4)
of Sanandaj city##2##3##(2008-12#2)
of Sanandaj##3##2##(2008-12#3)
of Santiago##3##2##(2008-3#1)(2008-5#1)(2013-1#1)
of Sarcandra##2##2##(2008-10#2)
of Saskatchewan##3##2##(1995-12#1)(2008-10#1)(2008-12#1)
of Saudi Arabia were##3##4##(2008-1#2)(2008-10#1)
of Saudi Arabia##6##3##(2008-1#4)(2008-10#1)(2013-1#1)
of Sb in##2##3##(2008-10#2)
of Sb##5##2##(2008-10#5)
of Sb(III) and Bi(III)##4##4##(2008-10#4)
of Sb(III) and Sb(V)##5##4##(2008-10#5)
of Sb(III) and##9##3##(2008-10#9)
of Sb(III) in##5##3##(2008-10#5)
of Sb(III)##18##2##(2008-10#18)
of Sb(V) to Sb(III)##3##4##(2008-10#3)
of Sb(V)##6##2##(2008-10#6)
of ScYLV##2##2##(2008-10#2)
of Schiff base##2##3##(2008-10#2)
of Schiff##3##2##(2008-10#2)(2010-8#1)
of Schistosoma mansoni##5##3##(1993-2#2)(1996-8#1)(1997-6#2)
of Schistosoma##8##2##(1992-2#1)(1993-2#2)(1996-8#1)(1997-6#2)(2008-10#2)
of Schizosaccharomyces pombe##4##3##(1997-2#1)(1997-4#1)(2012-3#2)
of Schönlein-Henoch purpura##2##3##(1997-8#2)
of Schönlein-Henoch##3##2##(1997-8#3)
of Science##4##2##(1994-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
of Scleranthus annuus##2##3##(2008-10#2)
of Sclerotia##2##2##(2008-10#2)
of Sclerotinia homoeocarpa##3##3##(2008-10#3)
of Sclerotinia minor and S##3##5##(2008-10#3)
of Sclerotinia minor##5##3##(2008-10#5)
of Sclerotinia sclerotiorum from##2##4##(2008-10#2)
of Sclerotinia sclerotiorum in##3##4##(2008-10#3)
of Sclerotinia sclerotiorum to##2##4##(2008-10#2)
of Sclerotinia sclerotiorum##12##3##(2008-10#12)
of Sclerotinia stem rot##3##4##(2008-10#3)
of Sclerotinia##24##2##(2008-10#24)
of Sclerotium rolfsii##5##3##(2008-10#5)
of Se (IV)##2##3##(2008-10#2)
of Se compounds##3##3##(2008-10#3)
of Se in##4##3##(2008-10#4)
of Se##26##2##(2008-10#23)(2012-2#3)
of Se(IV) and Se(VI) were##2##5##(2008-10#2)
of Se(IV) and Se(VI)##4##4##(2008-10#4)
of Se(IV) and##5##3##(2008-10#5)
of Se(IV) in##4##3##(2008-10#4)
of Se(IV) on##3##3##(2008-10#3)
of Se(IV)##25##2##(2008-10#25)
of Se(VI) to Se(IV)##5##4##(2008-10#5)
of Se(VI)##10##2##(2008-10#10)
of SecY##2##2##(1991-5#2)
of Seedborne##2##2##(2008-10#2)
of Senecio vulgaris##2##3##(2008-10#2)
of Sepia officinalis##3##3##(2008-7#3)
of Sepia##4##2##(2008-7#4)
of September##2##2##(1995-5#1)(1997-2#1)
of Septoria passerinii##2##3##(2008-10#2)
of Septoria tritici##5##3##(2008-10#5)
of Septoria##9##2##(2008-10#9)
of Ser##4##2##(1991-3#1)(1992-8#1)(1994-11#1)(2008-2#1)
of Ser-132##4##2##(1992-3#4)
of Serratia marcescens Strains##2##4##(2008-10#2)
of Serratia marcescens##3##3##(1996-12#1)(2008-10#2)
of Sertoli cells##2##3##(2009-10#2)
of Setosphaeria turcica##3##3##(2008-10#3)
of Sf-9 cells##2##3##(2008-11#1)(2008-7#1)
of Sharka disease##2##3##(2008-10#2)
of Sharka##3##2##(2008-10#3)
of Shc##5##2##(1995-8#1)(1997-7#3)(2012-2#1)
of Shen deficiency##3##3##(2013-8#3)
of Sherry##2##2##(2008-10#2)
of Shigella##3##2##(2008-10#1)(2008-9#2)
of Shpol'skii solvent##2##3##(2008-10#2)
of Shuanghuanglian injection##2##3##(2011-2#2)
of Si increased##3##3##(2008-10#3)
of Si##7##2##(2008-10#5)(2008-3#1)(2013-8#1)
of Si-sol##2##2##(2008-10#2)
of SiO(2) and##2##3##(2008-10#1)(2008-3#1)
of SiO(2)##4##2##(2008-10#3)(2008-3#1)
of SiO2##2##2##(1992-8#1)(2008-10#1)
of SiOEP##2##2##(2008-10#2)
of SiR-HP##2##2##(1993-8#2)
of Sig-1R##3##2##(2011-2#3)
of SilicoSec##4##2##(2008-12#4)
of Silicon##2##2##(1996-9#1)(2008-10#1)
of Silver dicyano complex##2##4##(2008-10#2)
of Skull Base##2##3##(2011-2#1)(2012-3#1)
of Smad2 conditional gene targeting##2##5##(2008-9#2)
of Smad2##4##2##(2008-9#4)
of Sn##5##2##(2008-10#5)
of Sn(IV)##3##2##(2008-10#3)
of SnO(2)##2##2##(2008-10#2)
of Social Security##3##3##(1995-2#1)(2011-2#2)
of Social##7##2##(1995-2#1)(2008-11#1)(2010-1#1)(2010-3#1)(2011-2#2)(2013-1#1)
of Soil##4##2##(2008-10#4)
of Solanum##3##2##(2008-10#2)(2008-11#1)
of Sorghum bicolor by Colletotrichum sublineolum##2##6##(2008-10#2)
of Sorubim lima##3##3##(2008-7#3)
of South Africa##8##3##(1997-7#1)(2010-11#3)(2010-3#1)(2011-2#1)(2013-8#2)
of South African##3##3##(2008-10#1)(2013-1#2)
of South Australia##2##3##(2008-10#1)(2008-12#1)
of South Carolina##3##3##(1991-2#1)(1991-8#2)
of South##22##2##(1991-2#1)(1991-8#2)(1997-2#1)(1997-7#1)(2008-10#4)(2008-12#2)(2010-11#3)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
of Southern##5##2##(1992-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
of Soxhlet##2##2##(2008-10#2)
of Soybean dwarf virus##2##4##(2008-10#2)
of Soybean mosaic virus (SMV)##2##5##(2008-10#2)
of Soybean mosaic virus##3##4##(2008-10#3)
of Soybean##8##2##(2008-10#8)
of Spain and##2##3##(2008-10#2)
of Spain were##2##3##(1996-12#1)(2008-10#1)
of Spain##12##2##(1996-12#2)(2008-10#8)(2009-10#2)
of Spain)##4##2##(2008-10#2)(2008-5#2)
of Spanish honeys##2##3##(2008-10#2)
of Spanish##8##2##(2008-10#5)(2008-11#1)(2008-5#1)(2009-10#1)
of Special##8##2##(2008-11#8)
of Species##2##2##(2010-5#1)(2012-2#1)
of Spodoptera frugiperda##4##3##(1993-6#1)(1994-11#1)(2008-11#1)(2008-7#1)
of Spontaneous##3##2##(2008-10#1)(2008-2#1)(2010-9#1)
of Sport and Exercise##2##4##(2008-12#1)(2010-6#1)
of Sports Medicine##2##3##(1996-6#1)(2012-3#1)
of Spr3##2##2##(2009-10#2)
of Sr##2##2##(2008-10#2)
of SrSRI##2##2##(2009-8#2)
of Src##11##2##(1995-6#5)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
of St##3##2##(1991-2#1)(1991-3#1)(2011-2#1)
of Stagonospora nodorum##3##3##(2008-10#3)
of Stagonospora##4##2##(2008-10#4)
of Standard##2##2##(2008-10#1)(2008-3#1)
of Staphylococcus aureus##8##3##(1992-6#1)(1996-12#1)(2008-12#3)(2009-6#1)(2011-2#1)(2012-2#1)
of Staphylococcus epidermidis##2##3##(1991-3#1)(1993-9#1)
of Staphylococcus##13##2##(1991-3#1)(1992-6#1)(1993-9#1)(1996-12#1)(1997-5#1)(2008-12#3)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of State##3##2##(1995-12#2)(1997-2#1)
of States##2##2##(1996-9#1)(1997-2#1)
of Stem##2##2##(2008-10#1)(2008-11#1)
of Stewart's Disease of Corn##2##5##(2008-10#2)
of Strawberry##4##2##(2008-10#4)
of Streptococcus pneumoniae##4##3##(1997-7#1)(2007-12#1)(2008-7#1)(2013-8#1)
of Streptococcus pyogenes##4##3##(1996-12#2)(2008-9#2)
of Streptococcus##10##2##(1996-12#2)(1997-7#1)(2007-12#1)(2008-7#1)(2008-9#2)(2012-2#1)(2013-1#1)(2013-8#1)
of Streptomyces ansochromogenes##6##3##(2008-8#4)(2008-9#2)
of Streptomyces coelicolor##2##3##(2008-8#2)
of Streptomyces scabies##2##3##(2008-10#2)
of Streptomyces##16##2##(1992-3#1)(2008-10#2)(2008-11#1)(2008-8#7)(2008-9#2)(2009-6#1)(2012-3#2)
of Striga asiatica##3##3##(2008-10#2)(2009-8#1)
of Striga spp##2##3##(2008-10#2)
of Striga##6##2##(2008-10#5)(2009-8#1)
of Subpopulations of##2##3##(2008-10#1)(2008-11#1)
of Sudarshan Kriya Yoga##2##4##(2012-2#2)
of Sudden##2##2##(2008-10#2)
of Suez##2##2##(2013-1#2)
of Sugar Beet##2##3##(2008-10#2)
of Sugarcane##2##2##(2008-10#2)
of Suicide##2##2##(1992-1#1)(2013-8#1)
of Surgery and##2##3##(1991-9#1)(1992-5#1)
of Surgery##6##2##(1991-9#2)(1992-5#1)(1995-12#1)(2009-4#1)(2012-3#1)
of Susceptible and Resistant##2##4##(2008-10#2)
of Sweet##2##2##(2008-10#2)
of Sweetpotato feathery mottle virus##2##5##(2008-10#2)
of Swiss##6##2##(1994-3#1)(2008-10#2)(2008-12#1)(2010-1#1)(2012-3#1)
of Syk##2##2##(1995-6#1)(2009-6#1)
of Synechocystis sp##8##3##(1995-12#1)(1995-8#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-6#2)
of Synechocystis##9##2##(1995-12#2)(1995-8#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-6#2)
of SyrM##2##2##(2008-8#2)
of Systematic##5##2##(1993-12#1)(2011-2#1)(2013-1#3)
of São Paulo##4##3##(1996-12#1)(2008-10#3)
of T and B cells##2##5##(1997-8#1)(2008-4#1)
of T cell receptor##2##4##(2008-11#1)(2008-4#1)
of T cell##7##3##(1995-5#1)(1996-12#1)(2007-12#1)(2008-11#3)(2008-4#1)
of T cells and##3##4##(2008-10#1)(2009-6#1)(2011-2#1)
of T cells is##2##4##(1995-5#1)(2008-4#1)
of T cells that##3##4##(2008-4#1)(2010-11#1)(2012-2#1)
of T cells to##2##4##(1992-6#1)(2013-1#1)
of T cells##22##3##(1992-6#1)(1993-8#1)(1995-12#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#4)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
of T lymphocytes and macrophages in##2##6##(1997-8#2)
of T lymphocytes and##3##4##(1994-3#1)(1997-8#2)
of T lymphocytes##6##3##(1994-3#2)(1997-8#2)(2008-9#1)(2013-1#1)
of T##112##2##(1991-6#1)(1992-6#1)(1993-8#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-5#3)(1996-12#1)(1997-7#1)(1997-8#3)(2007-12#3)(2008-10#47)(2008-11#6)(2008-12#7)(2008-4#6)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#2)
of T(382)##2##2##(2008-10#2)
of T- and##2##3##(2008-10#1)(2008-8#1)
of T-CD4 T cells##6##4##(2012-12#6)
of T-cell##9##2##(1991-12#3)(1992-12#1)(1995-2#2)(2008-11#1)(2009-8#1)(2013-8#1)
of T-cells##4##2##(2008-10#3)(2008-11#1)
of T1 and##3##3##(1991-6#1)(2008-10#2)
of T1##5##2##(1990-6#1)(1991-6#1)(2008-10#2)(2012-12#1)
of T2##3##2##(1990-6#1)(1993-5#1)(2011-2#1)
of T22##4##2##(2008-10#4)
of T3 in##2##3##(2008-10#2)
of T3##9##2##(1990-6#1)(1993-8#2)(1994-11#3)(2008-10#3)
of T4##7##2##(1990-6#2)(1993-2#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-6#1)
of T7##3##2##(1991-5#2)(1994-5#1)
of TA##7##2##(1997-8#7)
of TAM##4##2##(1997-7#2)(2008-10#2)
of TASK-2##2##2##(2013-8#2)
of TAT##3##2##(1991-3#2)(2010-3#1)
of TB IRIS##3##3##(2010-5#3)
of TB##10##2##(1996-11#1)(2008-1#3)(2010-11#1)(2010-5#5)
of TBE infections##2##3##(1996-11#2)
of TBE##6##2##(1996-11#6)
of TBI patients##2##3##(2008-10#1)(2010-9#1)
of TBI##4##2##(2008-10#2)(2010-9#1)(2013-1#1)
of TBP##4##2##(1993-8#2)(1993-9#2)
of TBTO##5##2##(2008-10#5)
of TBZ##2##2##(2011-10#2)
of TC##4##2##(2008-10#1)(2009-5#2)(2011-2#1)
of TCA in##2##3##(2008-10#2)
of TCA overdose##2##3##(2010-1#2)
of TCA##5##2##(2008-10#2)(2010-1#3)
of TCDD and related HAHs##2##5##(2008-10#2)
of TCDD##11##2##(1992-12#1)(1994-5#3)(2008-10#5)(2008-11#2)
of TCE##7##2##(2008-10#6)(2010-4#1)
of TCMTB##6##2##(2008-10#6)
of TCP##3##2##(2008-10#2)(2009-8#1)
of TCPP with##3##3##(2008-10#3)
of TCPP##9##2##(2008-10#9)
of TCR##2##2##(2008-11#1)(2008-4#1)
of TCRgammadelta(+) IELs##2##3##(2008-11#2)
of TCS##3##2##(2008-10#3)
of TE##3##2##(2008-10#1)(2008-11#2)
of TEA##2##2##(2008-10#2)
of TEMPO##2##2##(2008-8#2)
of TEP##2##2##(2008-10#2)
of TER##5##2##(2008-10#5)
of TEWL##3##2##(2008-5#3)
of TFAR19##3##2##(2008-9#3)
of TFIIB##2##2##(1995-2#2)
of TG##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
of TGF alpha##2##3##(1997-1#1)(1997-4#1)
of TGF beta##2##3##(1992-8#1)(1995-12#1)
of TGF##5##2##(1992-8#1)(1995-12#1)(1997-1#2)(1997-4#1)
of TGF-beta 1 on##2##4##(1990-5#2)
of TGF-beta 1##4##3##(1990-5#4)
of TGF-beta##12##2##(1990-5#4)(1995-2#1)(2008-11#5)(2008-12#1)(2008-8#1)
of TH##6##2##(1995-5#2)(1996-12#2)(2008-11#1)(2013-1#1)
of THBA##2##2##(2008-10#2)
of THP-1 cells##2##3##(1993-6#1)(2008-11#1)
of TI##3##2##(2008-10#3)
of TIEG2-MAO B##2##3##(2009-12#2)
of TIMP-1##2##2##(2008-5#1)(2008-9#1)
of TKA##2##2##(2013-1#2)
of TL1 and TL2 averaged##2##5##(2008-10#2)
of TLC##2##2##(1996-2#2)
of TLS##5##2##(2008-7#5)
of TM-β##2##2##(2010-12#2)
of TMA##4##2##(2008-10#4)
of TMG##3##2##(2008-10#3)
of TMJ##2##2##(2011-2#2)
of TMSG-1##2##2##(2008-9#2)
of TMV##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
of TMV-B##3##2##(2008-8#3)
of TNF##8##2##(1994-5#1)(1995-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
of TNF-alpha##13##2##(1992-8#1)(1995-12#3)(1996-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#5)
of TNP-470##4##2##(1994-12#4)
of TNT in##3##3##(2008-10#2)(2008-11#1)
of TNT##15##2##(2008-10#10)(2008-11#3)(2008-3#1)(2009-3#1)
of TPO cDNA##2##3##(2008-8#2)
of TPO##3##2##(2008-8#3)
of TQM##3##2##(1993-12#1)(1994-1#1)(1995-3#1)
of TRAb##2##2##(2012-3#2)
of TRH was##2##3##(1992-8#1)(2008-10#1)
of TRH##5##2##(1991-6#1)(1992-8#2)(2008-10#1)(2013-7#1)
of TRPV4##2##2##(2011-2#2)
of TS##2##2##(2008-10#1)(2008-7#1)
of TS/pH##2##2##(2008-11#2)
of TSH receptor##2##3##(1991-5#1)(2012-3#1)
of TSH##4##2##(1991-5#2)(2012-12#1)(2012-3#1)
of TSHr##2##2##(1994-11#2)
of TSP##2##2##(2008-10#2)
of TSPO binding##2##3##(2012-2#2)
of TSPO##11##2##(2012-2#11)
of TSWV and INSV##3##4##(2008-10#3)
of TSWV and##4##3##(2008-10#4)
of TSWV from##2##3##(2008-10#2)
of TSWV in the##2##4##(2008-10#2)
of TSWV inoculum##2##3##(2008-10#2)
of TSWV##23##2##(2008-10#23)
of TSWV-infected##2##2##(2008-10#2)
of TTCTOHA##2##2##(2008-10#2)
of TTM##3##2##(2013-1#3)
of TWIST##2##2##(1991-8#2)
of TYLCV##11##2##(2008-10#11)
of TYLCV-Sr##2##2##(2008-10#2)
of TYMV##3##2##(1997-3#1)(2008-10#2)
of Tachypleus amebocyte lysate##2##4##(2008-10#2)
of Taiwan##2##2##(2008-10#1)(2008-7#1)
of Takayasu arteritis (TA)##3##4##(1997-8#3)
of Takayasu arteritis##12##3##(1997-8#12)
of Takayasu##13##2##(1997-8#13)
of Takayasu's arteritis##3##3##(1997-8#3)
of Takotsubo cardiomyopathy##3##3##(2010-5#1)(2010-7#1)(2013-1#1)
of Tamsulosin##2##2##(2008-10#2)
of Tanichthys albonubes##4##3##(2010-5#4)
of Tapesia##2##2##(2008-10#2)
of Taphrina deformans##3##3##(2008-10#3)
of Tartrazine##4##2##(2008-10#4)
of Tat##2##2##(2009-8#1)(2012-12#1)
of TauD##2##2##(2012-12#2)
of Taxus##2##2##(2012-7#2)
of TcPO2##2##2##(2013-1#2)
of Technology##3##2##(1994-8#1)(2008-10#1)(2010-12#1)
of Teflon##3##2##(1990-3#1)(2008-10#2)
of Temperature and Inoculum Density of Fusarium oxysporum f##2##9##(2008-10#2)
of Temperature and Wetness Duration on##2##6##(2008-10#2)
of Temperature and##7##3##(2008-10#6)(2008-3#1)
of Temperature##8##2##(2008-10#7)(2008-3#1)
of Tessier##2##2##(2008-10#2)
of Tetramune##2##2##(1995-5#2)
of Texas##5##2##(1990-11#2)(1996-5#1)(2011-2#2)
of Tf##4##2##(2010-11#3)(2013-7#1)
of Th##6##2##(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#2)
of Th1-type##3##2##(2008-11#3)
of Th2 cytokines##2##3##(1996-12#1)(2011-2#1)
of Th2##4##2##(1996-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
of Th2-type cytokine producing##2##4##(2008-11#2)
of Th2-type cytokine##3##3##(2008-11#3)
of Th2-type##5##2##(2008-11#5)
of Thatcher wheat##2##3##(2008-10#2)
of Thatcher##3##2##(2008-10#3)
of The American Phytopathological Society##2##5##(2008-10#2)
of The##5##2##(2008-10#3)(2010-10#1)(2010-8#1)
of Therapeutic##2##2##(2008-10#1)(2012-12#1)
of Thermobia domestica (Packard)##2##4##(2008-12#2)
of Thielaviopsis basicola##4##3##(2008-10#4)
of Thinopyrum ponticum##2##3##(2008-10#2)
of Thinopyrum##4##2##(2008-10#4)
of Three##7##2##(2008-10#6)(2013-1#1)
of Thurgau##2##2##(1996-11#2)
of Thymus kotschyanus var##2##4##(2008-11#2)
of Thymus##5##2##(2008-11#2)(2008-12#3)
of ThzID1-M3##2##2##(2008-10#2)
of Ti##2##2##(2008-10#2)
of Ti-6Al-4V##3##2##(2009-7#3)
of TiO _ 2##3##4##(2008-5#3)
of TiO(2)##7##2##(2008-10#7)
of Tid1##2##2##(2011-2#2)
of Tilletia controversa and T##2##5##(2008-10#2)
of Tilletia indica##4##3##(2008-10#4)
of Tilletia##8##2##(2008-10#8)
of Time##2##2##(2009-3#2)
of Tiron##2##2##(2008-10#2)
of Title X##2##3##(1991-1#2)
of Tl##3##2##(2008-10#3)
of Tl(I)##2##2##(2008-10#2)
of Tl(III) in##2##3##(2008-10#2)
of Tn4001##2##2##(1993-12#2)
of ToCV##3##2##(2008-10#3)
of ToM##2##2##(2008-12#2)
of Tobacco##3##2##(2008-10#3)
of Tomato Spotted Wilt Virus##2##5##(2008-10#2)
of Tomato Spotted Wilt##3##4##(2008-10#3)
of Tomato by##4##3##(2008-10#4)
of Tomato leaf curl##4##4##(2008-10#4)
of Tomato spotted wilt virus (TSWV)##5##6##(2008-10#5)
of Tomato spotted wilt virus by##2##6##(2008-10#2)
of Tomato spotted wilt virus##10##5##(2008-10#10)
of Tomato spotted wilt##11##4##(2008-10#11)
of Tomato yellow leaf curl virus##5##6##(2008-10#5)
of Tomato##40##2##(2008-10#40)
of Tongan##2##2##(2008-1#2)
of Toremifene upon the##2##4##(1991-3#2)
of Toremifene##4##2##(1991-3#4)
of Toronto##5##2##(1991-1#1)(1991-12#1)(1991-2#2)(2008-11#1)
of Toxoplasma gondii##3##3##(1996-3#1)(2012-2#2)
of TrPs##2##2##(2010-9#2)
of Trace##2##2##(2008-3#1)(2009-8#1)
of Traditional Uighur Medicine##2##4##(2009-5#2)
of Transmissible##2##2##(1997-5#1)(2008-10#1)
of Traumatic##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
of Treatment##3##2##(1991-8#1)(2008-10#1)(2009-9#1)
of Treg##3##2##(2013-8#3)
of Trichoderma and their##2##4##(2008-10#2)
of Trichoderma atroviride##2##3##(2008-10#2)
of Trichoderma harzianum##7##3##(2008-10#7)
of Trichoderma longibrachiatum##2##3##(2008-10#2)
of Trichoderma reesei##2##3##(1993-8#1)(2008-10#1)
of Trichoderma spp##6##3##(2008-10#6)
of Trichoderma virens##2##3##(2008-10#2)
of Trichoderma##30##2##(1993-8#1)(2008-10#28)(2013-8#1)
of Trichophyton simii in a##2##5##(2008-5#2)
of Trichophyton spp##3##3##(2011-2#3)
of Trichophyton##7##2##(2008-5#4)(2011-2#3)
of Trimeresurus##2##2##(1993-3#1)(2008-6#1)
of Triton X-100 and##3##4##(2008-10#3)
of Triton X-100##4##3##(2008-10#4)
of Triton##6##2##(2008-10#6)
of Trolox C##3##3##(2008-11#3)
of Trolox##6##2##(2008-10#3)(2008-11#3)
of Tromsø##3##2##(1992-5#1)(1993-6#2)
of Trp residues##2##3##(1990-5#1)(1995-2#1)
of Trp##6##2##(1990-5#1)(1994-5#1)(1995-2#1)(2008-10#3)
of Tsx##4##2##(1990-11#4)
of Tumor##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
of Turkey##4##2##(1997-5#1)(2008-10#2)(2009-8#1)
of Turkish##3##2##(2010-10#1)(2010-7#1)(2011-1#1)
of Turnip##2##2##(2008-10#2)
of Tween 80##4##3##(2008-10#4)
of Two Distinct##2##3##(2008-10#2)
of Two Thrips Species##2##4##(2008-10#2)
of Two##18##2##(2008-10#14)(2011-2#2)(2013-1#1)(2013-8#1)
of Type 1 diabetes##3##4##(1994-12#2)(2010-10#1)
of Type##5##2##(1994-12#3)(2010-10#1)(2012-3#1)
of Typhula spp##2##3##(2008-10#2)
of Tyr##4##2##(1991-5#1)(1994-5#2)(2008-10#1)
of Tyr83##2##2##(1990-5#2)
of U isotope ratios##2##4##(2008-10#2)
of U isotope##3##3##(2008-10#3)
of U##28##2##(1993-3#1)(1997-2#1)(2008-1#1)(2008-10#19)(2008-12#2)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
of U(VI) and Th(IV)##2##4##(2008-10#2)
of U(VI)##12##2##(2008-10#12)
of U-50##2##2##(1997-2#2)
of U937##2##2##(1990-2#1)(2008-10#1)
of UA##7##2##(1994-8#1)(2008-10#6)
of UC##3##2##(2008-9#1)(2011-2#2)
of UCS##4##2##(2008-11#2)(2011-2#2)
of UHR-OCT##2##2##(2011-7#2)
of UK##4##2##(1996-1#1)(2010-3#1)(2012-3#1)(2013-1#1)
of UO(2)(2+)##2##2##(2008-10#2)
of UOx with##2##3##(2008-10#2)
of UOx##4##2##(2008-10#4)
of UPLC##2##2##(2008-10#2)
of US##11##2##(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#2)(2010-12#4)(2012-2#1)
of US-1 and US-8 isolates##2##5##(2008-10#2)
of US-1##3##2##(2008-10#3)
of US-11##3##2##(2008-10#3)
of US-8 isolates##3##3##(2008-10#3)
of US-8##8##2##(2008-10#8)
of USC atrophy##2##3##(2010-12#2)
of USV##2##2##(2008-4#2)
of UTI##3##2##(1994-3#1)(2008-7#2)
of UTIs caused by##2##4##(2011-2#2)
of UV irradiation##3##3##(2008-10#3)
of UV photobleaching of poled##2##5##(2008-2#2)
of UV photobleaching##3##3##(2008-2#3)
of UV radiation##4##3##(2008-10#1)(2008-3#1)(2011-2#2)
of UV##22##2##(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#2)(2011-2#4)
of UV-B##2##2##(1991-6#1)(2011-2#1)
of UV-Vis spectra##2##3##(2008-10#2)
of UV-Vis##6##2##(2008-10#6)
of UV-absorbing##2##2##(2008-10#1)(2008-5#1)
of UV-induced##2##2##(2008-10#2)
of UV-vis##4##2##(2008-10#3)(2009-3#1)
of UVA protection##4##3##(2008-5#4)
of UVA##5##2##(2008-10#1)(2008-5#4)
of UVA-filter##2##2##(2008-5#2)
of UVB radiation##3##3##(2008-11#3)
of UVB##5##2##(2008-11#3)(2008-5#2)
of UVR##2##2##(2011-2#2)
of Ubx##2##2##(2012-2#2)
of Ulocladium atrum##2##3##(2008-10#2)
of Uncinula necator on##2##4##(2008-10#2)
of Uncinula necator##4##3##(2008-10#4)
of Uromyces appendiculatus##2##3##(2008-10#2)
of Urtica dioica on##2##4##(2008-12#2)
of Ustilago hordei##2##3##(2008-10#2)
of Ustilago nuda##2##3##(2008-10#2)
of Ustilago##9##2##(1996-6#1)(2008-10#8)
of V##66##2##(1990-9#1)(1997-8#2)(2008-10#56)(2008-12#3)(2008-5#1)(2008-9#1)(2012-3#2)
of V(H) and V(L)##2##4##(2008-10#1)(2008-11#1)
of V(IV) and Co(II)##2##4##(2008-10#2)
of V(IV) and V(V)##2##4##(2008-10#2)
of V(IV) and##4##3##(2008-10#4)
of V(IV)##7##2##(2008-10#7)
of V(V) and##6##3##(2008-10#6)
of V(V) by##2##3##(2008-10#2)
of V(V) in##3##3##(2008-10#3)
of V(V)##14##2##(2008-10#14)
of V(c) was##2##3##(2008-10#2)
of V(c)##6##2##(2008-10#6)
of V(v)##3##2##(2008-10#3)
of V1##2##2##(2008-11#2)
of VAP##2##2##(1995-5#1)(2010-7#1)
of VB(2)##4##2##(2008-10#4)
of VC is##2##3##(2009-1#2)
of VC##5##2##(2008-10#1)(2009-1#4)
of VCG1A##2##2##(2008-10#2)
of VCG4##2##2##(2008-10#2)
of VCT##4##2##(2013-1#4)
of VCZ##2##2##(2008-10#2)
of VDR##2##2##(1995-2#2)
of VEGF and##2##3##(2008-1#1)(2008-9#1)
of VEGF expression in##2##4##(2008-9#1)(2010-12#1)
of VEGF expression##5##3##(2008-9#1)(2009-8#3)(2010-12#1)
of VEGF in##2##3##(2008-1#1)(2008-9#1)
of VEGF##13##2##(2008-1#2)(2008-9#4)(2009-8#4)(2010-12#1)(2013-8#2)
of VFAs##2##2##(2008-10#2)
of VGAM##2##2##(1996-3#2)
of VHFs##2##2##(2013-8#2)
of VIP##2##2##(1990-5#1)(1995-11#1)
of VLDL##5##2##(1991-12#5)
of VO(2+)##4##2##(2008-10#4)
of VOCs in##3##3##(2008-10#3)
of VOCs##5##2##(2008-10#4)(2008-11#1)
of VPA##3##2##(2011-1#1)(2011-2#2)
of VR##3##2##(1992-3#1)(2009-11#2)
of VSMC##2##2##(2008-9#2)
of VTE##3##2##(2012-3#3)
of VWA##2##2##(2008-12#2)
of Valencia##3##2##(2008-10#3)
of Vancouver Island##2##3##(2008-10#2)
of Vancouver##3##2##(2008-10#2)(2011-2#1)
of Vater##2##2##(1990-9#1)(2011-2#1)
of Vaud##2##2##(1990-6#1)(1991-6#1)
of Vcyto##3##2##(1991-11#3)
of Vegetative Compatibility##2##3##(2008-10#2)
of Venezuelan spirituous beverages##2##4##(2008-10#2)
of Venezuelan##4##2##(2008-10#3)(2009-10#1)
of Ventolin##2##2##(1994-12#2)
of Venturia inaequalis and##2##4##(2008-10#2)
of Venturia inaequalis##14##3##(2008-10#14)
of Venturia nashicola##3##3##(2008-10#3)
of Venturia##18##2##(2008-10#18)
of Venus##3##2##(1991-5#1)(2008-11#1)(2009-8#1)
of Vero and##2##3##(2008-11#2)
of Vero cell growth##2##4##(2008-11#1)(2008-9#1)
of Vero cells in##2##4##(2008-11#2)
of Vero cells##5##3##(2008-11#3)(2008-9#2)
of Vero##10##2##(2008-11#7)(2008-9#3)
of Verticillium dahliae in##2##4##(2008-10#2)
of Verticillium dahliae##11##3##(2008-10#9)(2008-12#2)
of Verticillium fungicola##2##3##(2008-10#2)
of Verticillium spp##3##3##(2008-10#3)
of Verticillium wilt##6##3##(2008-10#6)
of Verticillium##25##2##(2008-10#22)(2008-12#2)(2008-5#1)
of Veterans Affairs##7##3##(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(2009-11#1)(2011-2#1)(2013-1#1)
of Veterinary Medicine##2##3##(2013-8#2)
of Veterinary##4##2##(1996-12#1)(2013-8#3)
of Vf##2##2##(2008-10#2)
of Vg##3##2##(2008-10#3)
of Viable##2##2##(2008-10#1)(2008-11#1)
of Vibrio cholerae##6##3##(1990-5#1)(2008-9#2)(2009-8#1)(2012-3#2)
of Vibrio##8##2##(1990-5#1)(2008-10#2)(2008-9#2)(2009-8#1)(2012-3#2)
of Vicia faba##3##3##(2008-8#3)
of Victoria blue##2##3##(2008-10#1)(2008-11#1)
of Victoria##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
of Virginia's##2##2##(1997-2#1)(1997-6#1)
of Virulence in##3##3##(2008-10#3)
of Virulence##5##2##(2008-10#5)
of Vit##2##2##(2013-1#2)
of Vitamin C##2##3##(2008-10#1)(2008-5#1)
of Vitamin##9##2##(2008-10#7)(2008-5#1)(2013-1#1)
of Vitis vinifera and##2##4##(2008-10#2)
of Vitis vinifera##5##3##(2008-10#5)
of Vitis##6##2##(2008-10#6)
of Vpr and Vpx##3##4##(1997-3#3)
of W (VI)##4##3##(2008-10#4)
of W##6##2##(2008-10#6)
of W(VI)##4##2##(2008-10#4)
of W370dsRNA##2##2##(2008-10#2)
of WB and PS showed##2##5##(1993-11#2)
of WB##3##2##(1993-11#3)
of WCS358##2##2##(2008-10#2)
of WD leading to different##2##5##(2008-10#2)
of WD##3##2##(2008-10#3)
of WDR neurons##2##3##(1997-2#2)
of WEP##2##2##(2008-11#2)
of WHO##4##2##(1990-12#1)(1993-11#1)(2008-10#1)(2009-10#1)
of WSMV##9##2##(2008-10#9)
of WSMoV##6##2##(2008-10#6)
of WSN virus##2##3##(1990-5#2)
of WT##5##2##(1995-6#2)(2008-10#1)(2008-9#1)(2013-8#1)
of WT1##2##2##(1991-10#2)
of WTEs##2##2##(2012-2#2)
of WTORS##2##2##(2013-1#2)
of WW domain##2##3##(2008-11#2)
of WW##3##2##(2008-11#3)
of WWP##2##2##(2008-10#2)
of Wake Forest University##2##4##(1992-1#1)(2008-11#1)
of Wales##2##2##(1996-1#1)(2008-11#1)
of Washington##8##2##(1995-12#2)(1996-1#1)(1997-6#1)(2008-10#4)
of Waste##2##2##(2008-10#1)(2013-1#1)
of Water##5##2##(2008-10#4)(2008-12#1)
of Watermelon silver mottle virus (WSMoV) was##2##7##(2008-10#2)
of Watermelon silver mottle virus##4##5##(2008-10#4)
of Watermelon##5##2##(2008-10#5)
of Wegener's granulomatosis##4##3##(2008-1#1)(2010-11#3)
of West Bengal##2##3##(2010-10#1)(2011-1#1)
of West##6##2##(2008-12#1)(2008-9#1)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
of Western blotting##5##3##(2008-8#2)(2008-9#3)
of Western##12##2##(1992-1#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#3)(2011-2#1)(2012-2#1)
of Wheat##12##2##(2008-10#12)
of Williams and Beuren syndrome##2##5##(2008-10#2)
of Wilms' tumor##2##3##(2008-10#2)
of Winter Wheat##4##3##(2008-10#4)
of Winter##5##2##(2008-10#5)
of Wistar rats##4##3##(1993-12#1)(1996-3#1)(2008-10#1)(2011-2#1)
of Wistar##6##2##(1993-12#2)(1995-8#1)(1996-3#1)(2008-10#1)(2011-2#1)
of Wolbachia##5##2##(2008-8#3)(2008-9#2)
of World Journal of Gastrointestinal Surgery##2##6##(2010-12#2)
of World Journal of##4##4##(2010-12#4)
of World##7##2##(1995-3#1)(2008-12#1)(2010-12#4)(2011-2#1)
of Wuyujing-7##2##2##(2009-10#2)
of X##67##2##(1990-3#1)(1993-6#3)(1994-8#1)(2008-10#57)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
of X-linked##2##2##(2008-11#2)
of X-ray diffraction and##2##4##(2008-10#1)(2008-11#1)
of X-ray##12##2##(1997-8#1)(2008-10#5)(2008-11#1)(2008-4#2)(2011-2#1)(2013-8#2)
of XBP1 in##4##3##(2011-2#4)
of XBP1##6##2##(2011-2#6)
of XC DFB lasers##2##4##(2008-3#2)
of Xa4##2##2##(2008-10#2)
of Xanthomonas albilineans##3##3##(2008-10#3)
of Xanthomonas axonopodis pv##11##4##(2008-10#11)
of Xanthomonas campestris pv##17##4##(2008-10#17)
of Xanthomonas campestris##18##3##(2008-10#17)(2012-2#1)
of Xanthomonas oryzae pv##9##4##(2008-10#8)(2008-9#1)
of Xanthomonas strains##2##3##(2008-10#2)
of Xanthomonas translucens pv##2##4##(2008-10#2)
of Xanthomonas translucens##4##3##(2008-10#4)
of Xanthomonas##55##2##(2008-10#52)(2008-8#1)(2008-9#1)(2012-2#1)
of Xenopus laevis##6##3##(1993-5#1)(1993-6#1)(1995-12#2)(1997-2#1)(2011-2#1)
of Xenopus##12##2##(1990-7#2)(1993-3#1)(1993-5#1)(1993-6#1)(1995-12#2)(1997-2#1)(2008-5#1)(2008-8#2)(2011-2#1)
of Xmsx-1##4##2##(2008-6#4)
of Xmsx-2B in##2##3##(2008-6#2)
of Xmsx-2B##6##2##(2008-6#6)
of XylS##2##2##(2011-1#2)
of Xylella fastidiosa from Citrus##2##5##(2008-10#2)
of Xylella fastidiosa from##3##4##(2008-10#3)
of Xylella fastidiosa in##2##4##(2008-10#2)
of Xylella fastidiosa##15##3##(2008-10#15)
of Y chromosome##3##3##(2008-8#1)(2008-9#2)
of Y was##3##3##(2008-10#3)
of Y with respect to##2##5##(2008-10#2)
of Y##11##2##(2008-10#6)(2008-7#2)(2008-8#1)(2008-9#2)
of Y-CPApK##3##2##(2008-10#3)
of YAC clones##2##3##(1996-12#2)
of YAC##6##2##(1995-6#1)(1996-12#2)(1997-2#1)(2008-4#2)
of YH439##5##2##(2008-11#5)
of YPA(4)##2##2##(2008-10#2)
of YRRM sequences##2##3##(1993-12#2)
of Yersinia##4##2##(1996-12#2)(2012-2#1)(2013-8#1)
of Yl##2##2##(1995-2#2)
of Young's modulus##2##3##(2009-5#1)(2009-7#1)
of Young's##3##2##(2009-5#1)(2009-7#2)
of Youth##2##2##(2009-9#1)(2011-2#1)
of Yunnan##2##2##(2008-9#2)
of ZAPM##2##2##(2008-7#2)
of ZCFIA##2##2##(2008-10#2)
of ZDV and##2##3##(2008-7#2)
of ZGMMV##2##2##(2008-10#2)
of ZYMV##4##2##(2008-10#4)
of Zea mays##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
of Zingel asper##2##3##(2010-8#2)
of Zn by between 15 and 25%##2##7##(2008-10#2)
of Zn in##4##3##(2008-10#1)(2012-2#2)(2013-8#1)
of Zn##17##2##(1993-12#3)(2008-10#7)(2008-12#1)(2010-11#1)(2012-2#4)(2013-8#1)
of Zn(2+) in##2##3##(2008-10#2)
of Zn(2+)##9##2##(2008-10#9)
of Zn(II) in##2##3##(2008-10#2)
of Zn(II)##8##2##(2008-10#8)
of Zn(ii)-NA##2##2##(2010-11#2)
of ZnSO(4)##2##2##(2008-10#2)
of Zr##8##2##(2008-10#8)
of Zr(IV) and Hf(IV) in##2##5##(2008-10#2)
of Zr(IV) and Hf(IV)##5##4##(2008-10#5)
of Zucchini yellow mosaic virus##4##5##(2008-10#4)
of Zymomonas mobilis##3##3##(2008-7#3)
of [(18)F]-fluorodeoxyglucose incorporation##5##3##(2008-11#5)
of [(18)F]-fluorodeoxyglucose##6##2##(2008-11#6)
of [(3)H]5-HT##2##2##(2008-7#2)
of [111In-DTPA-D-Phe1]-octreotide scintigraphy##2##3##(1997-8#2)
of [125I]D-Trp6-LH-RH and##2##3##(1993-1#2)
of [3H]##2##2##(1991-9#1)(1994-8#1)
of [3H]ACPC##2##2##(1995-11#2)
of [3H]D-aspartate transport##4##3##(1995-11#4)
of [3H]D-aspartate##5##2##(1995-11#5)
of [3H]Ins1##2##2##(1993-6#2)
of [3H]MK-801 was increased##3##4##(1997-2#3)
of [3H]MK-801##4##2##(1997-2#4)
of [3H]PtdInsP2##2##2##(1993-6#2)
of [3H]glycerol into##2##3##(1994-5#2)
of [3H]inositol##2##2##(1997-1#2)
of [3H]prazosin##3##2##(1991-6#3)
of [3H]thymidine##6##2##(1994-3#1)(1995-12#1)(1995-2#3)(1997-1#1)
of [4##5##2##(1996-5#5)
of [Ca(2+)]##2##2##(2008-8#1)(2008-9#1)
of [Ca(2+)](i)##4##2##(2008-9#3)(2012-2#1)
of [Ca++]i##2##2##(1991-5#2)
of [Ca2+]i##8##2##(1991-5#1)(1992-6#1)(1994-6#3)(2011-3#3)
of [Formula##5##2##(2008-11#1)(2008-8#3)(2013-1#1)
of [I] and the reagent blank##2##6##(2008-10#2)
of [I]##3##2##(2008-10#3)
of [Leu]- and [Met]enkephalin##2##4##(1991-3#2)
of a &quot##23##3##(1992-10#1)(1993-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
of a 0##12##3##(1996-8#1)(2008-10#11)
of a 1##21##3##(1990-2#1)(1991-2#1)(1994-2#1)(1997-3#1)(2008-10#12)(2008-3#2)(2009-12#1)(2010-5#1)(2013-1#1)
of a 10##3##3##(2008-10#2)(2011-2#1)
of a 13##2##3##(1991-3#1)(2011-2#1)
of a 150##2##3##(2008-10#2)
of a 160-GHz##2##3##(2007-11#2)
of a 2##2##3##(1996-5#1)(2008-10#1)
of a 20##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of a 23-year-old##2##3##(1990-6#1)(2013-8#1)
of a 26-year-old##2##3##(1994-12#1)(2010-6#1)
of a 27-year-old##2##3##(2008-12#1)(2013-1#1)
of a 3##4##3##(1994-8#1)(2008-10#3)
of a 30-year-old man who had##2##6##(1990-8#1)(2008-11#1)
of a 30-year-old man##3##4##(1990-8#1)(2008-11#2)
of a 32-year-old##4##3##(2008-7#1)(2010-6#1)(2013-1#2)
of a 4-month##2##3##(1993-1#1)(2013-7#1)
of a 4-year##3##3##(1993-12#1)(1994-12#1)(2008-10#1)
of a 40##4##3##(1994-11#1)(1996-6#2)(2008-10#1)
of a 45-year-old##2##3##(2008-11#1)(2010-5#1)
of a 5##3##3##(2008-10#2)(2008-11#1)
of a 5-year-old child##2##4##(2008-10#1)(2013-1#1)
of a 5-year-old##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
of a 57-year-old man with##2##5##(1997-8#1)(2011-2#1)
of a 60 kDa##2##4##(1996-12#2)
of a 65-year-old##2##3##(2008-11#1)(2012-2#1)
of a 73-year-old man##2##4##(2013-1#2)
of a 96-well##2##3##(2008-11#1)(2008-9#1)
of a C5-C6##2##3##(2011-2#2)
of a CD-R##2##3##(2008-10#1)(2008-3#1)
of a CO(2)##2##3##(2008-3#2)
of a Chinese##5##3##(1991-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
of a CpG##2##3##(1991-6#1)(2008-10#1)
of a DNA fragment##2##4##(1993-6#1)(1993-8#1)
of a DNA##9##3##(1990-5#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-4#2)
of a Diploma in##2##4##(2008-11#1)(2013-1#1)
of a Fabry-Perot##3##3##(2008-2#1)(2008-3#2)
of a G##2##3##(1994-3#1)(1995-6#1)
of a GIST##2##3##(2009-7#1)(2012-12#1)
of a Gaussian beam##2##4##(2008-3#2)
of a Gaussian##3##3##(2008-3#3)
of a Gene##3##3##(2008-10#3)
of a Gene-for-Gene Coevolution System##2##5##(2008-10#2)
of a H+ electrochemical potential##2##5##(1997-8#2)
of a Health Goals##2##4##(1991-2#2)
of a Member of the##2##5##(2008-10#2)
of a Nd##7##3##(2007-12#1)(2008-10#1)(2008-3#5)
of a New##6##3##(1996-5#1)(2008-10#4)(2008-11#1)
of a Novel##3##3##(2008-10#3)
of a P##2##3##(2008-10#1)(2008-7#1)
of a PCR##3##3##(2008-10#3)
of a Small##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
of a T##2##3##(2008-10#1)(2008-11#1)
of a V-shaped##2##3##(2007-12#1)(2009-12#1)
of a Worldwide Collection of Puccinia triticina from Durum Wheat##2##10##(2008-10#2)
of a baby##3##3##(1992-2#1)(1996-2#1)(2008-11#1)
of a bacterial##3##3##(1990-11#1)(2008-5#1)(2008-8#1)
of a bacterium##2##3##(2008-8#2)
of a bare##2##3##(2008-10#2)
of a barrier##2##3##(1990-6#1)(2008-10#1)
of a basic##3##3##(1997-2#1)(2008-11#1)(2011-2#1)
of a basilar artery##2##4##(2011-2#2)
of a batch##4##3##(2008-10#1)(2008-11#1)(2008-7#2)
of a better##2##3##(2008-10#1)(2011-2#1)
of a bimodal distribution##2##4##(2008-3#1)(2009-7#1)
of a bimodal##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
of a binary##2##3##(2008-10#2)
of a biocontrol##2##3##(2008-10#2)
of a biologically##2##3##(2008-10#1)(2011-2#1)
of a biomimetic##2##3##(2008-10#1)(2010-5#1)
of a bioprocess##2##3##(2012-2#1)(2013-1#1)
of a biopsy##2##3##(2011-2#1)(2013-1#1)
of a biosensor##5##3##(2008-10#5)
of a biotinylated##2##3##(1992-6#1)(2008-10#1)
of a bird##2##3##(1996-8#2)
of a blood pressure##2##4##(2008-12#1)(2012-3#1)
of a blue##2##3##(2008-10#1)(2008-7#1)
of a bone##3##3##(2008-11#2)(2013-1#1)
of a bovine##2##3##(1995-12#1)(1996-6#1)
of a brain##3##3##(1991-11#1)(2011-2#1)(2011-3#1)
of a breast##5##3##(1993-11#1)(1994-12#1)(1994-9#1)(2012-12#1)(2013-1#1)
of a brief##3##3##(2008-11#1)(2010-9#1)(2013-1#1)
of a broad##2##3##(2008-10#1)(2010-4#1)
of a broader##3##3##(2008-11#1)(2013-1#2)
of a burnout workshop##2##4##(1996-2#2)
of a cDNA coding for##2##5##(1995-2#1)(1996-2#1)
of a cDNA encoding a##2##5##(1997-1#1)(2008-8#1)
of a cDNA encoding the##3##5##(1993-3#2)(2008-5#1)
of a cDNA encoding##9##4##(1993-12#1)(1993-3#2)(1994-11#2)(1997-1#1)(2008-5#1)(2008-8#2)
of a cDNA for##2##4##(1994-11#1)(1995-6#1)
of a cDNA##18##3##(1992-9#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#4)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-5#2)(2008-6#1)(2008-8#2)
of a calibration##4##3##(2008-10#3)(2008-9#1)
of a capillary##10##3##(1997-2#2)(2008-10#7)(2008-2#1)
of a carbohydrate-restricted diet##3##4##(2008-3#3)
of a carbon paste electrode modified##2##6##(2008-10#2)
of a carbon paste electrode##4##5##(2008-10#4)
of a carbon##7##3##(1994-8#1)(2008-10#6)
of a cardiac##2##3##(2008-11#1)(2013-7#1)
of a careful##2##3##(1991-6#1)(1993-11#1)
of a carrier##3##3##(2008-10#2)(2008-11#1)
of a case of##9##4##(1990-3#1)(1991-8#1)(1993-1#1)(1993-3#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-3#1)
of a case study##2##4##(2008-11#1)(2012-2#1)
of a case##30##3##(1990-3#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#5)(2008-5#1)(2008-7#2)(2009-8#2)(2010-10#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)
of a case]##2##3##(1990-9#1)(1991-6#1)
of a catalytic combustion sensor##2##5##(2008-10#2)
of a catalytic##4##3##(2008-10#3)(2010-6#1)
of a cationic surfactant##6##4##(2008-10#6)
of a cationic##7##3##(2008-10#6)(2009-12#1)
of a cavity##2##3##(1996-5#1)(2008-2#1)
of a cell wall##2##4##(2008-10#2)
of a cell##13##3##(1993-8#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
of a cellular##4##3##(1990-12#1)(2008-11#2)(2011-2#1)
of a cellulose binding domain##2##5##(2008-7#2)
of a cerebral##6##3##(1994-8#1)(1997-5#4)(2008-7#1)
of a certain##2##3##(2008-10#1)(2011-2#1)
of a certified##3##3##(2008-10#3)
of a cervical##3##3##(1996-6#1)(2010-8#1)(2013-1#1)
of a change in##2##4##(1991-2#1)(1996-2#1)
of a chelating resin##2##4##(2008-10#2)
of a chemical##4##3##(2008-10#3)(2008-11#1)
of a child with##2##4##(1992-6#1)(2010-7#1)
of a child##8##3##(1992-6#1)(1993-1#1)(1993-2#1)(2008-11#1)(2009-5#2)(2010-7#1)(2011-2#1)
of a child's##3##3##(1992-2#1)(2011-2#1)(2012-3#1)
of a chimeric gene composed of the##2##7##(1994-5#2)
of a chimeric##4##3##(1990-8#1)(1994-5#2)(2008-11#1)
of a cholinergic##2##3##(1994-8#1)(2013-1#1)
of a chromatographic##3##3##(2008-10#2)(2013-1#1)
of a chronic disease##2##4##(1993-11#1)(1994-5#1)
of a chronic##3##3##(1993-11#1)(1994-5#1)(2009-8#1)
of a class of##2##4##(1996-3#1)(2008-10#1)
of a classical##5##3##(1991-12#1)(1993-12#1)(2008-10#1)(2008-9#1)(2010-12#1)
of a clean##2##3##(1997-1#1)(2008-7#1)
of a clear##2##3##(2010-1#1)(2012-3#1)
of a clinical case]##3##4##(1990-3#1)(1993-6#2)
of a clinical trial##5##4##(1992-9#1)(1996-6#2)(2010-6#1)(2010-8#1)
of a clinical##14##3##(1990-3#1)(1990-5#3)(1992-9#1)(1993-6#2)(1996-6#2)(2008-11#1)(2008-12#1)(2010-6#1)(2010-8#1)(2012-12#1)
of a clone##3##3##(1994-11#1)(1996-3#1)(2008-9#1)
of a cloned##4##3##(1997-2#2)(2008-11#1)(2008-8#1)
of a closterovirus associated with##3##5##(2008-10#3)
of a coated##2##3##(2008-10#1)(2008-3#1)
of a coherent##3##3##(2008-3#3)
of a cohort of##2##4##(1995-9#1)(2010-1#1)
of a cold##2##3##(2008-5#1)(2011-2#1)
of a collaborative##4##3##(1994-12#1)(1995-11#1)(2008-11#1)(2008-12#1)
of a collection of##2##4##(2008-10#2)
of a combination of##6##4##(1991-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
of a combination##7##3##(1991-8#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
of a combined##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2013-2#1)
of a commercial##11##3##(1994-8#1)(2008-10#9)(2009-12#1)
of a commercially available##3##4##(2008-10#2)(2008-11#1)
of a common single-mode fiber##2##5##(2008-3#2)
of a common##11##3##(1990-8#1)(1994-2#1)(2008-10#3)(2008-3#2)(2011-2#1)(2012-3#1)(2013-1#2)
of a commonly used##2##4##(2008-10#2)
of a commonly##3##3##(2008-10#3)
of a community engagement##2##4##(2012-2#2)
of a community##6##3##(1991-2#1)(1996-11#1)(2008-9#1)(2010-10#1)(2012-2#2)
of a community-based##4##3##(1992-1#1)(1994-1#1)(2008-11#1)(2012-12#1)
of a compact##6##3##(2008-10#5)(2008-3#1)
of a competitive##2##3##(1991-3#1)(2008-10#1)
of a complete denture##2##4##(2013-1#2)
of a complete##8##3##(1993-6#1)(1995-12#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#2)
of a complex of##3##4##(1995-8#1)(1997-1#1)(2008-10#1)
of a complex##22##3##(1990-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-12#1)
of a complex-coupled##2##3##(2008-3#2)
of a complicated##2##3##(2010-12#1)(2013-8#1)
of a composite##4##3##(2008-10#2)(2008-2#1)(2010-2#1)
of a compound##7##3##(1991-5#1)(2008-10#4)(2008-11#1)(2010-11#1)
of a comprehensive screening program##2##5##(1996-2#1)(2008-10#1)
of a comprehensive##10##3##(1991-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
of a computer search of##2##5##(1995-8#1)(2008-8#1)
of a computer##3##3##(1995-8#1)(2008-11#1)(2008-8#1)
of a computerized##4##3##(1996-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
of a concept##3##3##(1994-3#2)(2008-11#1)
of a conditioned place preference (CPP)##2##6##(1993-6#1)(1994-2#1)
of a conference##6##3##(1992-12#1)(1992-3#1)(1995-12#1)(1996-9#1)(1997-1#1)(2008-11#1)
of a congenital splenic cyst##3##5##(1997-8#3)
of a congenital##5##3##(1997-8#3)(2010-3#1)(2012-3#1)
of a conidial suspension##2##4##(2008-10#2)
of a conserved##3##3##(1995-2#1)(2008-10#1)(2009-8#1)
of a considerable##2##3##(2008-10#1)(2010-10#1)
of a consistent##3##3##(1993-3#1)(2013-1#2)
of a constant##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
of a consumer##2##3##(1996-2#1)(2008-11#1)
of a contact##3##3##(2008-10#1)(2008-3#1)(2009-1#1)
of a continuous##9##3##(1992-9#1)(1994-3#1)(1994-5#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)
of a continuous-wave laser##2##4##(2008-2#1)(2008-3#1)
of a continuous-wave##4##3##(2008-2#1)(2008-3#3)
of a continuum of##2##4##(2008-10#1)(2008-12#1)
of a control##3##3##(1993-2#1)(2008-10#1)(2008-9#1)
of a controlled##2##3##(2011-2#2)
of a conventional##8##3##(1990-12#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-8#1)
of a coordinated##2##3##(1992-1#1)(2008-12#1)
of a core##3##3##(1990-3#1)(2008-10#1)(2008-11#1)
of a correct##4##3##(1991-3#1)(1991-6#1)(2008-3#1)(2013-1#1)
of a correction##2##3##(1997-4#1)(2008-10#1)
of a cosmetic formulation##2##4##(2008-5#2)
of a cosmetic##4##3##(2008-5#4)
of a cost-effective##2##3##(1994-2#1)(2008-10#1)
of a cover crop##2##4##(2008-10#2)
of a crop##2##3##(2008-10#1)(2008-11#1)
of a cross between##3##4##(2008-10#2)(2008-9#1)
of a crosslinked##2##3##(2008-10#1)(2010-6#1)
of a crown##2##3##(2008-10#1)(2009-8#1)
of a crude##2##3##(2008-10#2)
of a customizable##2##3##(2013-1#2)
of a cw laser##3##4##(2008-2#2)(2008-3#1)
of a cw##5##3##(2008-2#3)(2008-3#2)
of a cyclic##2##3##(1992-4#1)(1995-9#1)
of a data collection##2##4##(1993-3#1)(1995-2#1)
of a database##2##3##(2008-10#1)(2008-7#1)
of a dedicated##5##3##(1993-3#1)(1994-1#2)(2008-10#1)(2008-11#1)
of a deep##2##3##(2011-2#1)(2013-1#1)
of a defined##3##3##(1991-1#1)(1995-6#1)(2008-10#1)
of a degree##2##3##(1992-1#1)(2008-10#1)
of a delay##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
of a delayed##2##3##(1993-3#1)(2008-7#1)
of a deletion##2##3##(1993-11#1)(1997-3#1)
of a dental##2##3##(2008-4#1)(2011-2#1)
of a design##2##3##(1992-12#1)(1994-2#1)
of a detailed##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
of a detection system based on##2##6##(2008-10#1)(2008-3#1)
of a diagnosis##2##3##(2008-10#1)(2008-11#1)
of a difference##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
of a different##7##3##(1992-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
of a diode laser##3##4##(2008-10#1)(2008-3#2)
of a diode-pumped##5##3##(2007-12#1)(2008-3#4)
of a disease##6##3##(1996-2#1)(1996-3#1)(2008-10#4)
of a dispersion of##2##4##(1997-2#1)(2008-3#1)
of a dispersion##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
of a disposable##5##3##(2008-10#5)
of a dissolved oxygen##2##4##(2008-10#2)
of a distal##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
of a distinct##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
of a diverse group of##2##5##(2008-10#1)(2008-4#1)
of a diverse range of##4##5##(2008-11#1)(2011-2#2)(2012-2#1)
of a diverse##8##3##(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#2)(2012-2#1)
of a divine##2##3##(2013-1#2)
of a documentation##2##3##(1997-2#2)
of a double##5##3##(1992-12#1)(1992-2#1)(1992-3#1)(2008-7#1)(2011-2#1)
of a double-blind randomized##2##4##(1991-3#1)(1994-6#1)
of a drug##10##3##(1992-9#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-8#1)(2012-3#1)
of a dry##2##3##(2008-10#1)(2008-5#1)
of a dual##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
of a dynamic##7##3##(2008-10#4)(2008-3#1)(2009-8#1)(2011-2#1)
of a factor##2##3##(1996-2#1)(2008-3#1)
of a family of##5##4##(1992-3#1)(1995-8#2)(2008-10#1)(2011-2#1)
of a family##8##3##(1992-3#1)(1994-5#1)(1995-8#2)(1997-8#1)(2008-10#1)(2011-2#2)
of a fast##5##3##(2008-10#3)(2008-3#2)
of a feeding##2##3##(1994-12#1)(2008-11#1)
of a female patient##6##4##(1992-12#1)(2008-1#1)(2010-7#1)(2012-12#2)(2012-3#1)
of a female##11##3##(1992-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#1)(2012-12#2)(2012-3#2)(2013-1#1)
of a few percent##2##4##(1992-6#1)(2008-3#1)
of a few##12##3##(1992-3#1)(1992-6#1)(2008-10#5)(2008-3#3)(2010-6#1)(2012-2#1)
of a fiber ring##2##4##(2008-2#1)(2008-3#1)
of a fiber##6##3##(2008-10#1)(2008-2#2)(2008-3#3)
of a field##4##3##(2007-12#1)(2008-10#2)(2009-8#1)
of a finite##3##3##(2008-3#3)
of a firing##2##3##(2008-11#1)(2008-2#1)
of a fish##2##3##(2008-10#1)(2011-2#1)
of a fixed##4##3##(1991-2#1)(1991-6#1)(1994-9#1)(2008-11#1)
of a flame##3##3##(2008-10#3)
of a flash-lamp-pumped##2##3##(2008-2#2)
of a flat sheet membrane desolvator##2##6##(2008-10#2)
of a flat##5##3##(2008-10#2)(2008-11#1)(2008-3#2)
of a flow cytometer##4##4##(2008-9#4)
of a flow injection (FI)##2##5##(2008-10#2)
of a flow injection analysis (FIA) system##2##7##(2008-10#2)
of a flow injection analysis##3##5##(2008-10#3)
of a flow injection system for the##2##7##(2008-10#2)
of a flow injection##8##4##(2008-10#8)
of a flow##18##3##(2008-10#13)(2008-9#4)(2011-2#1)
of a flow-through type redox electrode detector##2##7##(2008-10#2)
of a flow-through##5##3##(2008-10#5)
of a fluorescent##4##3##(2008-10#3)(2010-4#1)
of a fluorometric-enzymatic method##2##4##(2008-10#2)
of a follow-up of##2##4##(1991-6#1)(1993-6#1)
of a follow-up##4##3##(1990-3#1)(1991-6#1)(1993-11#1)(1993-6#1)
of a foreign body##3##4##(2011-2#2)(2013-1#1)
of a foreign gene##2##4##(2008-10#1)(2008-11#1)
of a foreign##6##3##(2008-10#1)(2008-11#2)(2011-2#2)(2013-1#1)
of a former##2##3##(2008-11#2)
of a founder effect##2##4##(2008-10#2)
of a fourth##2##3##(1993-3#2)
of a fraction of the##2##5##(2008-10#1)(2008-3#1)
of a fragment of##4##4##(1992-12#1)(1996-3#1)(2008-12#1)(2013-8#1)
of a framework##2##3##(1995-2#1)(2008-10#1)
of a frequency-modulated continuous-wave##2##4##(2008-3#2)
of a full##5##3##(1991-5#1)(2008-10#2)(2008-5#1)(2009-11#1)
of a full-length cDNA##2##4##(1991-9#1)(1996-3#1)
of a full-length##6##3##(1991-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-9#1)
of a fully##5##3##(1993-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
of a functional##12##3##(1991-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2013-1#1)
of a fundamental##4##3##(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)
of a fungal##3##3##(1995-3#1)(2008-10#1)(2008-9#1)
of a fusion##2##3##(1994-11#1)(2012-3#1)
of a gas-diffusion##2##3##(2008-10#2)
of a gene encoding##4##4##(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)
of a gene product##2##4##(1995-2#1)(2008-4#1)
of a gene that encodes##2##5##(1993-2#1)(2008-10#1)
of a gene##21##3##(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#3)(1996-3#1)(1997-7#1)(2008-10#2)(2008-4#2)(2008-8#2)(2008-9#1)(2009-8#1)(2012-3#2)(2013-1#1)
of a general##14##3##(1994-3#1)(1995-1#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2012-2#1)
of a generalized##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
of a genetic##5##3##(1996-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
of a giant##7##3##(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#3)
of a given gene##2##4##(1997-9#1)(2011-2#1)
of a given species##2##4##(2008-12#1)(2008-8#1)
of a given##22##3##(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1997-9#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#1)(2013-8#1)
of a glass electrode##2##4##(2008-10#2)
of a glass tube packed with##2##6##(2008-10#2)
of a glass tube##3##4##(2008-10#3)
of a glass##6##3##(2008-10#6)
of a glassy carbon electrode##5##5##(1990-12#1)(2008-10#4)
of a glucose##2##3##(2008-10#2)
of a good##5##3##(1992-2#1)(2008-11#2)(2010-10#1)(2013-1#1)
of a graft##2##3##(2010-3#1)(2011-3#1)
of a granulomatous##2##3##(2011-2#1)(2013-1#1)
of a grass pollen allergic patient##2##6##(2012-2#2)
of a grass##3##3##(2008-8#1)(2012-2#2)
of a great##2##3##(2008-10#1)(2012-3#1)
of a greater##3##3##(1993-12#1)(2008-11#1)(2008-8#1)
of a green##3##3##(1995-9#1)(2008-10#2)
of a group of##9##4##(1996-5#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-1#1)(2012-3#1)
of a group##14##3##(1993-2#1)(1994-3#2)(1995-1#1)(1996-5#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-1#1)(2012-3#1)(2013-1#1)
of a growing number of##2##5##(1995-12#1)(2007-12#1)
of a growing##5##3##(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#2)
of a growth##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
of a guidewire##4##3##(1997-6#1)(2010-12#3)
of a hand-held##3##3##(2008-10#2)(2008-11#1)
of a health care##3##4##(1991-1#1)(1995-1#1)(2013-1#1)
of a health center]##2##4##(1995-5#1)(1996-11#1)
of a health##10##3##(1991-1#1)(1993-3#2)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-11#1)(2008-7#1)(2013-1#1)
of a healthy##5##3##(1995-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
of a heart##2##3##(1993-3#1)(2008-3#1)
of a heavy##3##3##(1996-12#1)(2008-10#2)
of a herbal medicine##2##4##(2008-10#1)(2010-2#1)
of a heterogeneous group of##2##5##(2008-5#1)(2012-3#1)
of a heterogeneous##4##3##(2008-5#1)(2008-8#2)(2012-3#1)
of a heterozygous##2##3##(2008-10#1)(2008-4#1)
of a hexagonal##2##3##(2008-3#2)
of a high concentration of##2##5##(2008-10#1)(2009-12#1)
of a high performance liquid chromatography##3##6##(2008-10#1)(2008-5#2)
of a high performance##4##4##(2008-10#1)(2008-5#2)(2011-2#1)
of a high throughput##2##4##(2008-10#2)
of a high##19##3##(1991-8#1)(1992-6#1)(1995-6#1)(2008-10#8)(2008-12#1)(2008-5#3)(2009-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
of a high-resolution##2##3##(2008-3#2)
of a high-risk##2##3##(1996-3#2)
of a higher##6##3##(2008-10#3)(2008-11#3)
of a highly conserved microsatellite locus##2##6##(2010-8#2)
of a highly conserved##5##4##(1991-12#1)(2008-10#2)(2010-8#2)
of a highly sensitive##3##4##(2008-10#2)(2008-2#1)
of a highly##15##3##(1991-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#2)(2013-1#1)
of a hollow##5##3##(1993-6#1)(1995-10#1)(2008-10#2)(2008-3#1)
of a home##3##3##(1993-11#1)(1996-5#1)(1997-4#1)
of a home-built##2##3##(2008-10#1)(2008-11#1)
of a homogeneous##3##3##(2008-10#3)
of a hospital to##2##4##(1991-2#1)(1991-3#1)
of a hospital##5##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-12#1)
of a hospital-based##3##3##(1990-8#1)(1994-1#2)
of a host##6##3##(1991-2#1)(2008-10#2)(2008-3#1)(2008-8#2)
of a huge##2##3##(1997-8#1)(2008-7#1)
of a human gene##2##4##(1995-12#1)(1995-8#1)
of a human##27##3##(1991-2#1)(1991-5#1)(1991-6#2)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-7#1)(2008-11#4)(2008-5#2)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)
of a hyaluronic acid preparation##3##5##(2013-1#3)
of a hybrid artificial liver##3##5##(2008-11#3)
of a hybrid##6##3##(2008-10#1)(2008-11#3)(2008-3#2)
of a hybridoma cell line##2##5##(2008-11#2)
of a hydrogen##2##3##(1991-3#1)(2008-10#1)
of a joint##3##3##(1994-3#2)(2013-1#1)
of a key##2##3##(1990-5#1)(1993-12#1)
of a kinetically##2##3##(1991-9#1)(2008-10#1)
of a knee##3##3##(2013-1#3)
of a known##8##3##(1991-5#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-7#2)
of a l-lysine biosensor##2##4##(2008-10#2)
of a laboratory##3##3##(1996-12#1)(2008-10#2)
of a lacZ-marked##2##3##(2009-12#2)
of a large amount of##2##5##(2008-10#2)
of a large group of##2##5##(2008-10#1)(2011-2#1)
of a large number of genes##2##6##(1996-12#1)(1996-6#1)
of a large number of##17##5##(1990-12#1)(1996-12#1)(1996-2#1)(1996-6#1)(2008-10#10)(2008-11#2)(2009-8#1)
of a large##54##3##(1990-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(2008-10#20)(2008-11#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
of a large-scale##2##3##(2008-3#1)(2008-7#1)
of a larger##10##3##(1992-1#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-12#1)(2010-10#1)(2010-7#1)(2013-8#1)
of a laser##7##3##(1993-2#1)(2008-3#6)
of a latent##2##3##(1995-6#1)(2009-11#1)
of a lawsuit filed by##2##5##(1995-12#2)
of a leaf##4##3##(2008-10#4)
of a learning##2##3##(2008-11#2)
of a left##2##3##(1991-6#1)(2008-7#1)
of a lesion##2##3##(2008-10#1)(2013-1#1)
of a less##2##3##(2008-10#1)(2008-11#1)
of a lifespan##2##3##(2008-11#1)(2010-3#1)
of a ligand##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
of a light beam##2##4##(2008-3#2)
of a light##3##3##(2008-3#3)
of a limited number of##2##5##(2011-1#1)(2011-2#1)
of a limited##8##3##(1991-1#1)(1992-6#1)(2008-10#2)(2011-1#1)(2011-2#3)
of a limiting##2##3##(1994-11#1)(2008-8#1)
of a line##2##3##(1996-11#1)(2012-12#1)
of a linear##7##3##(2008-11#1)(2008-3#1)(2008-7#2)(2010-2#1)(2010-6#1)(2011-2#1)
of a lipid##2##3##(1994-5#1)(2008-10#1)
of a liquid##3##3##(2008-10#1)(2008-3#2)
of a liquid's##2##3##(2008-3#2)
of a liquid-crystal##2##3##(2008-2#1)(2008-3#1)
of a lithium##2##3##(1996-5#1)(2008-10#1)
of a local##3##3##(2008-10#3)
of a logistic##2##3##(2008-10#2)
of a long period grating##2##5##(2008-10#2)
of a long##7##3##(1995-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
of a low temperature##2##4##(2008-10#2)
of a low##10##3##(2008-10#5)(2008-11#3)(2008-3#1)(2010-4#1)
of a low-cost##3##3##(2008-10#3)
of a low-fat##2##3##(1995-9#1)(1997-1#1)
of a lower##6##3##(1991-2#1)(1995-6#1)(2008-10#2)(2012-2#1)(2013-1#1)
of a magnet##2##3##(1990-12#2)
of a maize##2##3##(1994-6#1)(2008-10#1)
of a major##13##3##(1992-1#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-3#2)(2008-10#2)(2008-4#1)(2008-8#2)(2009-12#1)(2013-1#1)
of a mammalian##2##3##(1997-7#2)
of a man##4##3##(1995-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
of a managed care##2##4##(1994-2#1)(1996-1#1)
of a mandibular first molar with##2##6##(2012-12#2)
of a mandibular##3##3##(1997-5#1)(2012-12#2)
of a manual##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
of a mass disaster##4##4##(1995-11#4)
of a mass##7##3##(1995-11#4)(2008-10#1)(2008-5#1)(2012-2#1)
of a mature##3##3##(2011-3#2)(2013-1#1)
of a maxillary##2##3##(1990-3#1)(2013-1#1)
of a mechanical##2##3##(2008-10#1)(2008-3#1)
of a medical##5##3##(1991-2#1)(1994-12#1)(2008-6#1)(2011-2#2)
of a member of the family##7##6##(2011-2#7)
of a member of the##14##5##(2008-11#1)(2011-2#13)
of a member##15##3##(2008-11#1)(2011-2#14)
of a mercury electrode##2##4##(1990-5#1)(2008-10#1)
of a mercury##3##3##(1990-5#1)(2008-10#2)
of a metabolic##3##3##(2008-10#2)(2008-11#1)
of a metal##3##3##(2008-10#2)(2008-2#1)
of a metal-oxide-semiconductor field-effect##2##4##(2009-5#2)
of a metapopulation##3##3##(2008-8#2)(2008-9#1)
of a method for the##3##5##(2008-10#3)
of a method for##5##4##(2008-10#5)
of a method of##2##4##(2008-3#1)(2012-3#1)
of a method to##2##4##(1997-7#1)(2008-11#1)
of a method##10##3##(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2012-3#1)
of a methylene group to##2##5##(2008-10#2)
of a methylene group##3##4##(2008-10#3)
of a microlens array##2##4##(2007-11#1)(2008-3#1)
of a micropump##2##3##(2008-10#2)
of a microwave##2##3##(2008-10#2)
of a miniature##2##3##(2008-10#1)(2010-7#1)
of a minicolumn##2##3##(2008-10#2)
of a minimal tiling path##2##5##(2012-3#2)
of a minimal##3##3##(1995-2#1)(2012-3#2)
of a minimum##2##3##(1997-8#1)(2008-10#1)
of a mirror##2##3##(2008-2#1)(2008-3#1)
of a mixed##7##3##(1994-12#1)(2008-10#5)(2008-5#1)
of a mixture containing##4##4##(2008-10#4)
of a mixture of##17##4##(1990-12#1)(1990-9#1)(2008-10#14)(2008-8#1)
of a mixture##23##3##(1990-12#1)(1990-9#1)(2008-10#20)(2008-8#1)
of a mock##2##3##(2008-8#1)(2010-7#1)
of a mode-locked##2##3##(2008-3#2)
of a model for##4##4##(1996-6#1)(2008-1#1)(2008-10#1)(2011-2#1)
of a model liquid crystal##2##5##(2008-10#2)
of a model substrate##2##4##(2008-10#1)(2008-4#1)
of a model##23##3##(1992-9#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#6)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#1)
of a modern##4##3##(1994-12#1)(2008-4#1)(2010-5#1)(2011-2#1)
of a modified##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
of a molecular##5##3##(1993-5#1)(2008-10#2)(2009-3#1)(2011-2#1)
of a molecule##2##3##(1991-5#1)(2008-10#1)
of a monoclonal antibody to##2##5##(1992-6#1)(1995-2#1)
of a monoclonal antibody##4##4##(1992-6#1)(1995-2#1)(2008-11#1)(2008-8#1)
of a monoclonal##6##3##(1992-6#1)(1995-2#2)(2008-11#1)(2008-8#1)(2013-8#1)
of a more##13##3##(1991-2#1)(1994-11#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-8#1)
of a mouse cDNA##2##4##(1993-8#1)(1997-7#1)
of a mouse##7##3##(1993-8#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#1)(2012-12#1)
of a moving##4##3##(2008-10#1)(2009-8#2)(2011-2#1)
of a multi-frequency laser##2##4##(2008-10#2)
of a multichannel##2##3##(2008-10#1)(2008-9#1)
of a multidimensional##2##3##(1992-12#1)(1997-1#1)
of a multidisciplinary pain##2##4##(1994-1#1)(2013-1#1)
of a multidisciplinary program to quit##2##6##(2013-8#2)
of a multidisciplinary##10##3##(1994-1#1)(2010-12#4)(2012-3#1)(2013-1#2)(2013-8#2)
of a multigene family##3##4##(1993-6#1)(1994-11#1)(1996-12#1)
of a multigene##4##3##(1993-6#1)(1994-11#1)(1996-12#2)
of a multiple##3##3##(2008-4#1)(2008-5#2)
of a multiple-component##2##3##(1995-6#1)(2008-8#1)
of a multistep##2##3##(2008-10#1)(2011-2#1)
of a multivariate calibration model##2##5##(2008-10#2)
of a multivariate calibration##3##4##(2008-10#3)
of a multivariate##4##3##(2008-10#4)
of a murine hybridoma##3##4##(2008-11#3)
of a murine##10##3##(1993-6#1)(1994-5#1)(1995-6#1)(2008-11#5)(2008-4#1)(2008-9#1)
of a muscular##2##3##(1993-3#1)(2007-12#1)
of a mutant##5##3##(1995-8#1)(1995-9#1)(2008-11#1)(2008-4#1)(2008-8#1)
of a mutated##2##3##(1993-6#1)(1996-5#1)
of a mutation in##2##4##(1991-12#1)(2013-1#1)
of a mutation##4##3##(1991-12#1)(1994-8#1)(1997-7#1)(2013-1#1)
of a narrow##2##3##(2008-10#1)(2008-3#1)
of a nasopharyngeal##2##3##(2008-12#1)(2011-2#1)
of a national##5##3##(1992-2#1)(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#1)
of a natural disaster on##2##5##(1991-2#2)
of a natural##6##3##(1991-2#2)(1997-7#1)(2008-10#1)(2008-5#1)(2009-7#1)
of a naturally occurring##2##4##(2008-6#1)(2011-1#1)
of a near-infrared##5##3##(2008-10#3)(2008-3#2)
of a nearly##2##3##(1995-3#1)(2011-3#1)
of a negative##4##3##(1993-8#1)(2008-10#1)(2009-11#1)(2009-8#1)
of a network##2##3##(2008-10#1)(2011-2#1)
of a neural##2##3##(1993-6#1)(2008-10#1)
of a neutral##5##3##(1994-8#1)(2008-10#3)(2008-9#1)
of a new and##2##4##(2008-10#1)(2009-8#1)
of a new approach##3##4##(1992-1#1)(2008-5#1)(2008-6#1)
of a new class of##3##5##(1991-3#1)(2008-11#1)(2008-5#1)
of a new desensitizing dentifrice containing 8##2##7##(2011-2#2)
of a new era in##2##5##(2008-11#1)(2009-5#1)
of a new era##3##4##(2008-11#1)(2009-5#1)(2011-2#1)
of a new extraction##2##4##(2008-10#2)
of a new gene##2##4##(2008-8#2)
of a new lignin peroxidase##2##5##(1990-12#2)
of a new soya biopeptide##2##5##(2008-5#2)
of a new trial##3##4##(1996-6#3)
of a new type of##9##5##(1992-6#1)(2008-10#5)(2008-8#1)(2012-2#1)(2012-3#1)
of a new type##10##4##(1992-6#1)(2008-10#6)(2008-8#1)(2012-2#1)(2012-3#1)
of a new##119##3##(1990-12#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#3)(1994-1#1)(1994-12#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-4#1)(1997-7#1)(2008-10#43)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#1)(2011-2#8)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#1)
of a newly##5##3##(1994-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
of a nickel##2##3##(2008-10#2)
of a nitrogen##3##3##(2008-10#3)
of a nonlinear##3##3##(2007-12#1)(2008-3#2)
of a normal##2##3##(1995-2#1)(2008-5#1)
of a novel cDNA##2##4##(1995-6#1)(2008-4#1)
of a novel human##2##4##(1996-2#1)(1997-8#1)
of a novel method##2##4##(2008-10#1)(2012-2#1)
of a novel##51##3##(1990-5#2)(1992-6#1)(1993-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-7#1)(1997-8#2)(2008-10#19)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
of a nuclear##3##3##(1994-11#1)(2008-3#1)(2008-9#1)
of a number of different##2##5##(2008-10#1)(2008-11#1)
of a number of possible##2##5##(2008-10#1)(2008-9#1)
of a number of##47##4##(1991-12#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#4)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
of a nursing##5##3##(1992-2#1)(2008-11#1)(2008-7#2)(2012-3#1)
of a pH##3##3##(2008-10#3)
of a pair of##2##4##(2008-10#1)(2008-8#1)
of a panel of##2##4##(2008-11#1)(2010-9#1)
of a paper##2##3##(2008-10#1)(2012-2#1)
of a parasite##2##3##(2008-8#1)(2008-9#1)
of a parent##2##3##(1991-2#1)(2008-11#1)
of a particular Al species##2##5##(2008-10#2)
of a particular##19##3##(1992-1#1)(1993-12#1)(1993-6#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
of a partnership##4##3##(1992-3#1)(1996-3#1)(2008-12#2)
of a pathogen##9##3##(2008-10#7)(2008-8#1)(2008-9#1)
of a pathogenic##2##3##(2008-10#2)
of a pathology##2##3##(1996-6#1)(2011-2#1)
of a patient classification system##2##5##(1994-3#1)(1995-2#1)
of a patient who##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
of a patient with cervicogenic headache##2##6##(2008-12#2)
of a patient with##15##4##(1990-8#1)(1991-11#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-8#1)(2011-2#2)(2012-3#3)(2013-1#2)
of a patient##35##3##(1990-8#1)(1991-11#1)(1993-2#1)(1993-6#3)(1994-12#1)(1994-3#1)(1995-2#2)(1995-9#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#5)
of a patient's##7##3##(1991-12#1)(1993-12#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-7#1)
of a pelvic##2##3##(1991-2#1)(2008-12#1)
of a pepper isolate of potato virus##2##7##(2008-10#2)
of a peptide##8##3##(1991-9#1)(1994-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-6#1)(2012-2#1)
of a permanent##2##3##(2010-1#1)(2011-2#1)
of a person##2##3##(2008-12#1)(2008-2#1)
of a personal##4##3##(1990-2#1)(1993-6#2)(2008-11#1)
of a pharmacodynamic effect##2##4##(2008-5#2)
of a phase II study##2##5##(1994-2#1)(1995-10#1)
of a phase##4##3##(1994-2#1)(1995-10#1)(2008-3#1)(2009-11#1)
of a phenylalanine##2##3##(1992-9#1)(1994-5#1)
of a phylogenetic tree##3##4##(1991-5#1)(2008-8#1)(2009-10#1)
of a physical##2##3##(2008-10#1)(2008-12#1)
of a physician's##2##3##(1994-1#1)(1997-2#1)
of a piezoelectric##5##3##(2007-12#1)(2008-10#2)(2009-5#2)
of a pilot study##2##4##(2008-11#1)(2010-9#1)
of a pilot##6##3##(1993-1#1)(1994-1#1)(1994-3#1)(2008-11#1)(2009-10#1)(2010-9#1)
of a pineal##2##3##(2008-7#2)
of a plan##2##3##(1992-1#1)(2008-11#1)
of a plant##7##3##(1993-2#1)(1995-2#1)(2008-10#4)(2008-8#1)
of a platinum##2##3##(2008-10#2)
of a point-source integrating-cavity absorption meter##2##6##(2008-3#2)
of a polyclonal##2##3##(2008-10#2)
of a polymer##2##3##(2008-2#1)(2008-5#1)
of a polymerase chain##4##4##(1996-12#1)(2008-10#2)(2012-2#1)
of a polyp##2##3##(1993-3#1)(2012-12#1)
of a poor##2##3##(1993-11#2)
of a population of##3##4##(2008-10#2)(2008-11#1)
of a population##17##3##(1992-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#4)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#2)
of a portable##4##3##(1997-4#1)(2008-10#3)
of a portfolio##2##3##(2008-12#2)
of a portion of the##2##5##(2008-10#2)
of a positive##11##3##(1990-6#1)(1991-2#1)(1996-5#1)(1996-6#1)(2007-12#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#1)
of a possible##5##3##(2008-11#1)(2009-8#1)(2011-2#2)(2013-1#1)
of a posterior##6##3##(2008-10#1)(2008-9#2)(2011-2#1)(2012-12#2)
of a potato##2##3##(2008-12#1)(2009-6#1)
of a potential##10##3##(1994-8#1)(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#1)
of a potentiometric##4##3##(2008-10#4)
of a potyvirus##2##3##(2008-10#1)(2008-9#1)
of a power plant##2##4##(2008-10#1)(2010-8#1)
of a power##5##3##(1992-9#1)(2008-10#1)(2008-6#1)(2010-3#1)(2010-8#1)
of a pre-registration##2##3##(2008-11#2)
of a predator##2##3##(2009-8#1)(2012-3#1)
of a pregnancy##2##3##(2012-3#1)(2013-1#1)
of a pregnant##3##3##(1997-4#1)(1997-7#1)(2008-10#1)
of a presumptive##2##3##(1993-8#1)(2008-10#1)
of a preterm infant##2##4##(1994-3#2)
of a previous study##2##4##(2008-9#1)(2011-2#1)
of a previous##4##3##(2008-5#1)(2008-9#1)(2011-2#2)
of a previously unknown##2##4##(1995-2#1)(2012-12#1)
of a previously##10##3##(1991-5#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-8#1)(2012-12#1)
of a primary care##2##4##(1996-11#1)(2008-11#1)
of a primary##7##3##(1995-6#1)(1996-11#1)(2008-10#1)(2008-11#2)(2013-1#2)
of a prior##3##3##(2010-6#2)(2012-3#1)
of a probability##2##3##(2008-3#1)(2011-2#1)
of a procedure for##2##4##(2008-10#1)(2008-5#1)
of a procedure##3##3##(2008-10#2)(2008-5#1)
of a process##4##3##(2008-10#1)(2008-11#2)(2008-6#1)
of a product##5##3##(2008-10#2)(2008-5#2)(2008-7#1)
of a progeny##2##3##(2008-10#2)
of a program for##2##4##(1995-3#1)(2008-12#1)
of a program of preventive activities##2##6##(1993-11#1)(1993-3#1)
of a program of##3##4##(1993-11#1)(1993-3#1)(1996-6#1)
of a program##9##3##(1993-11#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-12#2)(2008-7#1)
of a progressive##2##3##(2008-10#1)(2012-2#1)
of a project##2##3##(2008-10#1)(2009-10#1)
of a promoter##2##3##(1990-12#1)(1993-12#1)
of a prospective payment##2##4##(1994-3#2)
of a prospective##4##3##(1993-9#1)(1994-3#2)(1997-3#1)
of a protective##2##3##(2008-10#1)(2011-1#1)
of a protein that##2##4##(1995-12#1)(2008-8#1)
of a protein##22##3##(1991-2#1)(1991-5#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#2)(2013-8#1)
of a protein-free diet or food restriction on the immune system##2##11##(1993-12#2)
of a protein-free##3##3##(1993-12#2)(2008-11#1)
of a proton##2##3##(1992-10#1)(2008-10#1)
of a prototype##4##3##(1991-9#1)(2008-10#2)(2008-3#1)
of a psychiatric##2##3##(1996-8#1)(2008-4#1)
of a public health##3##4##(1991-3#1)(1997-2#1)(2011-2#1)
of a public##4##3##(1991-3#1)(1997-2#1)(2009-10#1)(2011-2#1)
of a pulsed##5##3##(1995-12#1)(2008-2#2)(2008-3#2)
of a purified##2##3##(1991-5#1)(2011-2#1)
of a putative##4##3##(1993-2#1)(1995-12#1)(1996-6#1)(1997-4#1)
of a quadrat##2##3##(2008-10#1)(2008-8#1)
of a qualitative##2##3##(2008-11#1)(2009-5#1)
of a quality##2##3##(2008-10#1)(2008-4#1)
of a quantitative##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
of a quartz crystal##3##4##(2008-10#2)(2009-5#1)
of a questionnaire##4##3##(1994-6#1)(1997-2#1)(2008-9#1)(2010-1#1)
of a random sample of##3##5##(1991-3#1)(1997-4#1)(2008-7#1)
of a random##5##3##(1991-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-7#1)
of a randomized trial##2##4##(1994-8#1)(1995-12#1)
of a randomized##3##3##(1994-8#1)(1995-12#1)(2009-12#1)
of a randomly##2##3##(2008-3#1)(2012-12#1)
of a range of##11##4##(1994-1#1)(1997-2#1)(2008-10#5)(2008-5#2)(2010-5#1)(2012-8#1)
of a rapid##2##3##(2008-10#1)(2008-4#1)
of a rapidly##3##3##(1994-2#1)(2008-12#1)(2008-3#1)
of a rare case##2##4##(2008-11#1)(2013-1#1)
of a rare##9##3##(1995-11#1)(1996-3#1)(2008-11#2)(2008-8#1)(2010-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
of a rat##6##3##(1991-5#1)(1995-6#1)(2008-11#3)(2008-9#1)
of a rational##2##3##(1995-5#1)(2008-5#1)
of a reagent##3##3##(2008-10#3)
of a real##2##3##(2008-10#2)
of a recent##5##3##(1990-9#1)(1992-3#1)(1995-1#1)(1995-2#1)(2008-10#1)
of a recently discovered##2##4##(1990-3#1)(1995-12#1)
of a recently proposed method for estimating creatinine clearance##2##9##(2008-7#2)
of a recently##6##3##(1990-3#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-7#2)
of a recombinant CHO cell line in##2##7##(2008-11#2)
of a recombinant form of##2##5##(2008-6#1)(2009-3#1)
of a recombinant glycoprotein##2##4##(2008-7#1)(2011-2#1)
of a recombinant therapeutic##2##4##(2008-11#1)(2011-2#1)
of a recombinant##19##3##(1995-11#1)(1997-2#1)(2008-10#1)(2008-11#9)(2008-6#1)(2008-7#2)(2009-3#1)(2010-4#1)(2011-2#2)
of a red##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#2)
of a red-region fluorescent##2##4##(2008-10#2)
of a reducing agent##3##4##(2008-10#3)
of a reduction in##2##4##(1990-5#1)(2008-10#1)
of a region of##2##4##(1990-2#1)(1997-2#1)
of a region##6##3##(1990-2#1)(1991-5#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)
of a regular##3##3##(2008-3#1)(2008-5#1)(2008-6#1)
of a regulatory gene##2##4##(2008-8#2)
of a regulatory##3##3##(2008-8#2)(2011-2#1)
of a related##2##3##(1992-9#1)(2008-8#1)
of a relatively##4##3##(2008-10#1)(2008-9#1)(2009-8#1)(2010-4#1)
of a reliable##2##3##(2008-10#2)
of a reproducible pulsed flow##2##5##(2008-10#2)
of a reproducible##3##3##(2008-10#2)(2008-3#1)
of a research##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
of a resistant cultivar##3##4##(2008-10#3)
of a resistant##4##3##(2008-10#4)
of a resource##2##3##(2008-12#1)(2008-8#1)
of a response##3##3##(1996-5#1)(2008-6#1)(2010-12#1)
of a restriction##2##3##(2008-10#1)(2008-4#1)
of a restructured##2##3##(1994-3#1)(1996-3#1)
of a retrospective##2##3##(1992-12#1)(2009-5#1)
of a reverse##2##3##(2008-10#1)(2008-8#1)
of a reversible immunosensor with##2##5##(2008-7#2)
of a reversible##4##3##(2008-11#1)(2008-7#2)(2011-2#1)
of a rice##7##3##(1996-12#1)(2008-8#2)(2008-9#3)(2009-10#1)
of a robotic##2##3##(2008-10#1)(2010-7#1)
of a robust##4##3##(1992-9#1)(2008-10#2)(2009-9#1)
of a role of##2##4##(1995-12#1)(2008-10#1)
of a routine##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
of a rural town]##2##4##(1993-5#2)
of a sample of##2##4##(2008-10#1)(2008-12#1)
of a sample##13##3##(2008-10#8)(2008-12#2)(2008-3#1)(2010-8#1)(2011-2#1)
of a sampling##6##3##(2008-10#6)
of a saturable##2##3##(1990-8#1)(2008-3#1)
of a scale##2##3##(2013-1#2)
of a scalp##2##3##(2010-6#1)(2013-8#1)
of a scanning##2##3##(2007-12#1)(2008-3#1)
of a school##2##3##(2008-2#1)(2012-2#1)
of a screening tool##2##4##(1992-12#1)(2010-9#1)
of a screening##7##3##(1991-6#1)(1992-12#1)(1995-12#1)(2008-10#1)(2010-9#2)(2011-3#1)
of a search##2##3##(2008-12#1)(2012-3#1)
of a second##16##3##(1990-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-12#2)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
of a secondary##3##3##(1993-8#1)(1996-5#1)(2008-9#1)
of a secreted##3##3##(2008-11#3)
of a section of##2##4##(1992-12#1)(2008-3#1)
of a seed##3##3##(2008-10#1)(2008-8#2)
of a selected##3##3##(2008-10#2)(2008-8#1)
of a selection of##3##4##(2008-10#1)(2008-11#2)
of a selection##5##3##(2008-10#2)(2008-11#2)(2008-8#1)
of a selective##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
of a self##2##3##(2008-10#1)(2008-11#1)
of a self-activating##2##3##(2008-11#2)
of a sensitive##6##3##(1990-2#1)(2008-10#4)(2010-6#1)
of a sequence##2##3##(1996-12#1)(2008-9#1)
of a sequential injection##3##4##(2008-10#3)
of a sequential##5##3##(2008-10#5)
of a series of individual##2##5##(2008-10#2)
of a series of##27##4##(1994-5#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#2)(2012-3#1)
of a serious##2##3##(1991-1#1)(2008-10#1)
of a serum-free##3##3##(2008-11#3)
of a service##2##3##(1993-3#1)(1994-12#1)
of a set of##23##4##(1993-9#1)(1996-2#1)(1996-3#1)(2008-10#13)(2008-11#3)(2008-6#1)(2008-9#2)(2009-10#1)
of a severe strain##2##4##(2008-10#2)
of a severe##4##3##(2008-10#2)(2008-9#1)(2010-1#1)
of a sexually##2##3##(1992-3#1)(2008-10#1)
of a shampoo##3##3##(2008-10#1)(2008-5#2)
of a sharp##2##3##(1992-1#1)(1995-3#1)
of a short##5##3##(1993-2#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-7#1)
of a shortage of##2##4##(1997-6#1)(2008-11#1)
of a signal##5##3##(1991-10#1)(1993-12#1)(2008-10#2)(2008-3#1)
of a significant difference##2##4##(2008-10#1)(2013-1#1)
of a significant##5##3##(1990-5#1)(2008-10#2)(2011-2#1)(2013-1#1)
of a silicon##2##3##(2008-10#1)(2008-3#1)
of a similar##10##3##(1990-6#2)(1994-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
of a simple##13##3##(1990-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)
of a simulated##2##3##(2008-12#1)(2008-3#1)
of a simulation##2##3##(1996-3#1)(2008-10#1)
of a single channel##3##4##(2008-10#1)(2011-3#2)
of a single gene##2##4##(1993-2#1)(2008-10#1)
of a single host##2##4##(2008-10#2)
of a single resistance gene##2##5##(2008-10#2)
of a single##84##3##(1990-11#1)(1990-6#1)(1991-11#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#29)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#6)(2008-6#1)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#2)(2012-3#2)(2013-1#2)(2013-8#1)
of a small amount of##2##5##(2008-10#1)(2008-3#1)
of a small number of##2##5##(1990-5#1)(1997-6#1)
of a small##20##3##(1990-5#2)(1991-12#1)(1997-6#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#3)(2010-10#1)(2010-4#1)(2013-1#1)
of a smooth##2##3##(1992-9#1)(2008-11#1)
of a social##4##3##(2008-11#1)(2008-9#2)(2009-6#1)
of a sodium##2##3##(1990-6#1)(2008-10#1)
of a soft##3##3##(1992-2#1)(2008-10#1)(2011-2#1)
of a soil to##2##4##(2008-10#2)
of a soil##7##3##(2008-10#6)(2008-9#1)
of a solid phase extraction (SPE)##2##6##(2008-10#2)
of a solid##6##3##(2008-10#5)(2012-2#1)
of a solid-phase extraction##2##4##(1997-2#1)(2008-10#1)
of a solid-phase microextraction##2##4##(1997-2#1)(2008-10#1)
of a solid-phase##4##3##(1997-2#2)(2008-10#2)
of a solid-state##2##3##(1992-1#1)(2008-2#1)
of a soluble solid sample##2##5##(2008-10#2)
of a soluble##5##3##(1990-10#1)(2008-10#3)(2008-11#1)
of a solution containing##4##4##(2008-10#4)
of a solution of##3##4##(2008-10#3)
of a solution##9##3##(2008-10#8)(2008-3#1)
of a spacer device must be such that##2##8##(1996-2#2)
of a spatial##6##3##(1993-3#1)(1993-6#1)(1994-8#1)(2008-11#2)(2008-8#1)
of a special##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
of a species##4##3##(2008-10#1)(2008-8#3)
of a specific##22##3##(1994-8#1)(1995-6#1)(1995-9#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of a specimen##2##3##(2009-7#1)(2012-2#1)
of a spectrophotometric method##2##4##(2008-10#2)
of a spectrophotometric##3##3##(2008-10#3)
of a spectrum##2##3##(2008-10#1)(2008-7#1)
of a spherical bioparticle under substrate inhibition##2##7##(2008-7#2)
of a spherical##4##3##(2007-12#1)(2008-3#1)(2008-7#2)
of a spinal##4##3##(2008-7#3)(2013-1#1)
of a spontaneous##2##3##(2011-2#2)
of a stable##7##3##(1993-8#1)(2008-10#4)(2008-4#1)(2010-7#1)
of a standard and##2##4##(2008-10#1)(2008-5#1)
of a standard reference##2##4##(2008-10#2)
of a standard##19##3##(1990-6#1)(1992-1#1)(1994-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
of a standardized##8##3##(1993-2#1)(2008-11#2)(2008-5#2)(2010-1#1)(2013-1#1)(2013-8#1)
of a statewide##3##3##(1995-12#1)(1996-1#1)(2008-9#1)
of a statistical##2##3##(2008-10#2)
of a step##2##3##(1995-12#1)(2008-3#1)
of a sterile##2##3##(2008-10#1)(2012-2#1)
of a strain##3##3##(1993-9#1)(2008-7#1)(2012-2#1)
of a strategy##3##3##(1996-3#1)(2008-1#1)(2008-7#1)
of a strong##5##3##(2008-10#3)(2008-3#1)(2010-4#1)
of a structured##2##3##(2008-11#1)(2011-2#1)
of a study of##5##4##(1992-1#1)(1993-9#1)(2009-4#1)(2009-8#1)(2010-10#1)
of a study##12##3##(1992-1#1)(1993-3#1)(1993-9#1)(1996-1#1)(2008-11#1)(2008-5#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-9#1)
of a subject##2##3##(1991-3#1)(1992-9#1)
of a subset of##5##4##(1997-1#1)(2008-10#2)(2008-4#1)(2009-7#1)
of a subset##6##3##(1997-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-7#1)
of a successful##5##3##(1991-2#1)(1993-3#1)(2008-10#1)(2010-10#1)(2013-7#1)
of a suitable##8##3##(1993-8#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-5#3)(2008-9#1)
of a suite of##2##4##(2008-10#1)(2008-9#1)
of a surface##5##3##(2008-10#2)(2008-3#1)(2008-6#1)(2010-7#1)
of a surfactant##2##3##(2008-10#2)
of a survey##9##3##(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#2)
of a survival##2##3##(1996-12#1)(2008-6#1)
of a susceptible cultivar##2##4##(2008-10#2)
of a susceptible##6##3##(2008-10#6)
of a suspension##2##3##(2008-11#1)(2008-12#1)
of a symptomatic##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of a synthetic##5##3##(1992-7#1)(2008-10#4)
of a system##4##3##(1993-3#1)(1997-7#1)(2008-10#2)
of a systematic literature##2##4##(2008-11#1)(2013-1#1)
of a systematic##8##3##(1992-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#3)
of a systemic##3##3##(1990-6#1)(2009-10#1)(2013-8#1)
of a target##5##3##(2008-11#4)(2008-7#1)
of a teaching##4##3##(1990-2#1)(1996-1#1)(2008-10#1)(2008-12#1)
of a technique##3##3##(1992-12#1)(2008-10#2)
of a temporal##2##3##(2006-6#1)(2007-12#1)
of a ternary##3##3##(1994-5#1)(2008-10#2)
of a test##7##3##(2008-10#2)(2008-11#2)(2008-3#2)(2012-2#1)
of a tetrasaccharide##2##3##(1990-9#1)(1992-12#1)
of a theophylline-selective electrode##2##4##(2008-10#2)
of a theoretical##2##3##(2008-3#1)(2008-5#1)
of a therapeutic##2##3##(1991-9#1)(2008-11#1)
of a thin film##2##4##(2008-10#2)
of a thin##6##3##(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)
of a third##2##3##(2010-6#1)(2013-1#1)
of a thoracic##2##3##(2011-2#2)
of a thorough##2##3##(2008-7#2)
of a thoroughgoing##2##3##(2008-6#1)(2010-2#1)
of a three##2##3##(1994-6#1)(2008-11#1)
of a three-dimensional tissue construct from##2##6##(2013-1#2)
of a three-dimensional##8##3##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#3)(2013-1#2)
of a three-species##2##3##(2008-8#2)
of a threshold##2##3##(2008-10#1)(2010-1#1)
of a tooth##2##3##(2010-10#1)(2013-1#1)
of a total of##9##4##(1992-9#1)(1993-2#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-12#1)(2011-1#1)(2013-8#1)
of a total##13##3##(1992-9#1)(1993-2#1)(1994-3#1)(1996-8#1)(1997-4#1)(2008-10#3)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
of a trace##2##3##(2008-10#1)(2008-3#1)
of a trade-off##2##3##(2008-9#1)(2010-10#1)
of a training program for##2##5##(1991-12#1)(2008-7#1)
of a training##3##3##(1991-12#1)(2008-11#1)(2008-7#1)
of a transcription factor##2##4##(2008-11#2)
of a transformation##2##3##(1996-6#1)(2008-11#1)
of a transgenic##2##3##(2008-10#2)
of a transported##2##3##(1994-11#2)
of a traumatic##3##3##(1994-12#1)(2011-2#1)(2013-8#1)
of a treatment##2##3##(1996-5#2)
of a tree##3##3##(2008-10#3)
of a trial##4##3##(1996-6#2)(2008-10#1)(2008-3#1)
of a tumor##5##3##(1994-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-8#1)
of a tumour##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
of a tunable##3##3##(2008-2#1)(2008-3#2)
of a tungsten##2##3##(2008-10#2)
of a twin##2##3##(1990-6#1)(2011-2#1)
of a two##2##3##(2008-10#1)(2008-7#1)
of a two-dimensional##2##3##(1991-9#1)(2008-2#1)
of a two-step##2##3##(1990-2#1)(2008-9#1)
of a type I##2##4##(2008-2#2)
of a type##7##3##(2008-10#2)(2008-2#2)(2008-4#1)(2011-2#2)
of a typical soft ice cream##2##6##(2011-2#2)
of a typical##9##3##(1996-8#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-2#1)(2011-2#2)
of a tyrosinase##2##3##(2008-10#2)
of a uniform##3##3##(2008-10#2)(2008-2#1)
of a unique##9##3##(1995-11#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of a university hospital##2##4##(2009-1#1)(2010-8#1)
of a university##4##3##(1995-11#1)(2009-1#1)(2010-1#1)(2010-8#1)
of a vaccine##3##3##(1997-7#2)(2011-2#1)
of a variety of compounds##2##5##(2008-10#2)
of a variety of genes##2##5##(1995-12#1)(2008-10#1)
of a variety of##26##4##(1991-9#1)(1993-2#1)(1994-1#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-11#3)(2008-4#1)(2010-11#1)(2012-3#1)(2013-8#3)
of a vascular##4##3##(1990-12#1)(2008-12#1)(2008-7#1)(2009-1#1)
of a vasoconstrictor to a local anesthetic may##2##8##(1993-1#2)
of a vector##2##3##(2008-8#1)(2010-7#1)
of a very##7##3##(1990-11#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)
of a vestibular schwannoma##2##4##(2011-2#2)
of a viral##3##3##(1995-5#1)(2008-9#1)(2010-5#1)
of a virtual##2##3##(2008-10#1)(2008-6#1)
of a virus##5##3##(1997-1#1)(2008-10#3)(2008-5#1)
of a visual##2##3##(1991-2#1)(1996-2#1)
of a voltammetric sensor##2##4##(2008-10#2)
of a wastewater treatment plant (WWTP)##2##6##(2008-10#2)
of a water##6##3##(1991-2#1)(2008-10#5)
of a water-soluble##2##3##(2008-10#1)(2008-7#1)
of a well##2##3##(2008-10#1)(2009-10#1)
of a well-defined##3##3##(1997-3#1)(2008-10#2)
of a whole##2##3##(2008-10#2)
of a wide range of##9##5##(1996-3#1)(2008-10#3)(2008-3#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)
of a wide variety of##8##5##(1996-11#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)
of a wide##21##3##(1991-3#1)(1996-11#1)(1996-3#2)(1997-2#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
of a woman##3##3##(1991-3#1)(2008-4#1)(2012-2#1)
of a work##2##3##(1993-1#1)(1996-3#1)
of a workshop##3##3##(1994-2#1)(2008-10#1)(2008-6#1)
of a worse prognosis##2##4##(1990-8#1)(2011-2#1)
of a yeast##3##3##(1991-5#1)(1995-3#1)(1995-6#1)
of a young male##2##4##(2008-11#1)(2012-2#1)
of a young woman with##2##5##(2010-12#1)(2011-2#1)
of a young woman##4##4##(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
of a young##12##3##(1996-2#2)(1996-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
of a zinc##2##3##(2008-10#1)(2008-5#1)
of a##5467##2##(1990-10#2)(1990-11#9)(1990-12#22)(1990-2#7)(1990-3#11)(1990-4#1)(1990-5#19)(1990-6#15)(1990-7#1)(1990-8#18)(1990-9#7)(1991-1#5)(1991-10#4)(1991-11#10)(1991-12#23)(1991-2#36)(1991-3#18)(1991-5#18)(1991-6#27)(1991-7#1)(1991-8#6)(1991-9#16)(1992-1#16)(1992-10#4)(1992-11#3)(1992-12#19)(1992-2#17)(1992-3#22)(1992-4#3)(1992-5#2)(1992-6#12)(1992-7#2)(1992-8#6)(1992-9#16)(1993-1#15)(1993-11#12)(1993-12#35)(1993-2#32)(1993-3#31)(1993-5#5)(1993-6#32)(1993-8#20)(1993-9#11)(1994-1#19)(1994-11#23)(1994-12#33)(1994-2#21)(1994-3#35)(1994-5#21)(1994-6#8)(1994-8#23)(1994-9#6)(1995-1#15)(1995-10#2)(1995-11#20)(1995-12#29)(1995-2#45)(1995-3#18)(1995-5#11)(1995-6#29)(1995-8#16)(1995-9#17)(1996-1#10)(1996-11#12)(1996-12#23)(1996-2#38)(1996-3#39)(1996-5#20)(1996-6#26)(1996-8#10)(1996-9#8)(1997-1#13)(1997-2#37)(1997-3#22)(1997-4#13)(1997-5#6)(1997-6#14)(1997-7#34)(1997-8#31)(1997-9#1)(2006-6#2)(2007-11#11)(2007-12#40)(2007-8#1)(2008-1#13)(2008-10#1503)(2008-11#371)(2008-12#100)(2008-2#88)(2008-3#292)(2008-4#56)(2008-5#104)(2008-6#30)(2008-7#149)(2008-8#129)(2008-9#130)(2009-1#10)(2009-10#23)(2009-11#7)(2009-12#21)(2009-2#2)(2009-3#9)(2009-4#8)(2009-5#12)(2009-6#15)(2009-7#19)(2009-8#39)(2009-9#6)(2010-1#18)(2010-10#24)(2010-11#12)(2010-12#29)(2010-2#5)(2010-3#10)(2010-4#17)(2010-5#21)(2010-6#26)(2010-7#19)(2010-8#25)(2010-9#9)(2011-1#19)(2011-2#222)(2011-3#12)(2011-6#1)(2011-7#1)(2012-12#50)(2012-2#79)(2012-3#90)(2012-7#1)(2012-8#1)(2013-1#185)(2013-2#1)(2013-7#5)(2013-8#56)
of abdominal aortic aneurysm##3##4##(1992-5#2)(2010-12#1)
of abdominal aortic##5##3##(1992-5#3)(2010-12#2)
of abdominal pain##8##3##(1997-5#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2012-12#1)
of abdominal##25##2##(1991-3#2)(1992-2#1)(1992-5#3)(1996-2#1)(1997-5#2)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-3#1)
of aberrant##3##2##(1995-9#1)(2008-11#1)(2008-3#1)
of ability to##6##3##(1990-2#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
of abiotic##3##2##(2008-10#1)(2009-10#1)(2013-8#1)
of ablation##3##2##(1991-2#1)(2008-10#1)(2010-8#1)
of abnormal cardiac function##2##4##(2011-2#2)
of abnormal joint torque coupling##2##5##(2010-7#2)
of abnormal results##2##3##(2007-11#1)(2013-1#1)
of abnormal ventricular septal motion in##2##6##(2012-2#2)
of abnormal##28##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1994-3#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-7#2)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
of abnormalities in##3##3##(1990-2#1)(1997-8#1)(2011-1#1)
of abnormalities##6##2##(1990-2#1)(1997-8#1)(2008-4#1)(2011-1#1)(2012-2#2)
of aborted##2##2##(2008-10#1)(2008-12#1)
of abortion##5##2##(2008-11#2)(2012-3#2)(2013-8#1)
of abortions##3##2##(1991-3#2)(2008-11#1)
of about 0##11##3##(1996-12#1)(2008-10#9)(2009-5#1)
of about 1##6##3##(1990-12#1)(1993-6#1)(1997-2#1)(1997-5#1)(2008-10#1)(2013-1#1)
of about 10##6##3##(1990-11#1)(2008-10#5)
of about 10%##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
of about 10(7)##2##3##(2008-10#2)
of about 100##5##3##(1991-5#1)(1997-3#1)(2007-12#1)(2008-10#2)
of about 12##2##3##(2008-7#1)(2010-12#1)
of about 2##2##3##(1996-3#1)(2008-10#1)
of about 20##2##3##(2008-10#1)(2008-8#1)
of about 25%##2##3##(1993-8#1)(2008-7#1)
of about 3##2##3##(2008-10#2)
of about 30##4##3##(1990-5#1)(1996-12#1)(2008-10#2)
of about 35##2##3##(1991-5#1)(2012-12#1)
of about 4 x##2##4##(2008-10#1)(2008-11#1)
of about 40% of##2##4##(1996-6#1)(2011-3#1)
of about 40%##3##3##(1996-6#1)(2008-12#1)(2011-3#1)
of about 50##4##3##(2008-10#3)(2009-5#1)
of about 60 samples##2##4##(2008-10#2)
of about a##2##3##(1995-11#1)(2008-11#1)
of about##126##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#2)(1997-5#1)(2007-12#2)(2008-10#61)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
of above##2##2##(2008-10#2)
of absence of##2##3##(1997-3#1)(2013-1#1)
of absolute##7##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-9#1)
of absorbance at##3##3##(2008-10#3)
of absorbance measurements##2##3##(2008-10#2)
of absorbance versus sample loading flow rate##2##7##(2008-10#2)
of absorbance versus##3##3##(2008-10#3)
of absorbance##16##2##(2008-10#14)(2008-12#1)(2010-7#1)
of absorbances##2##2##(2008-10#2)
of absorbing##2##2##(2008-3#1)(2011-2#1)
of absorption and##3##3##(2008-10#2)(2008-2#1)
of absorption of##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
of absorption spectra##3##3##(2008-10#2)(2008-3#1)
of absorption##17##2##(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)
of abstinence##2##2##(2009-5#1)(2013-8#1)
of abundant##3##2##(2008-7#1)(2009-10#1)(2012-12#1)
of abuse##20##2##(1991-1#2)(1995-11#1)(1996-11#1)(1996-5#1)(2008-10#5)(2009-7#1)(2012-12#4)(2012-3#2)(2013-8#3)
of academia##2##2##(2008-1#1)(2012-3#1)
of academic##9##2##(1993-1#1)(1996-1#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)
of acarbose##2##2##(1994-12#2)
of accelerated##4##2##(2008-5#1)(2013-1#3)
of acceleration##2##2##(2008-10#1)(2013-1#1)
of acceptability##3##2##(1994-2#1)(2008-6#1)(2009-11#1)
of acceptable##2##2##(1992-3#1)(2008-7#1)
of acceptance of the disease##2##5##(1993-11#2)
of acceptance##3##2##(1993-11#2)(2010-1#1)
of accepted##2##2##(2006-6#1)(2008-6#1)
of access for##2##3##(2008-11#1)(2011-2#1)
of access site complications##2##4##(2011-2#2)
of access site##3##3##(2011-2#3)
of access to care##3##4##(1995-12#1)(1997-4#1)(2013-8#1)
of access to##6##3##(1995-12#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
of access##17##2##(1994-2#2)(1995-1#1)(1995-12#2)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#3)(2011-2#4)(2012-2#1)(2013-8#1)
of accessions##3##2##(2008-10#3)
of accessory gland secretion##2##4##(2007-12#2)
of accessory##4##2##(2007-12#3)(2008-7#1)
of accidental##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
of accidents##3##2##(1990-6#2)(2011-2#1)
of accommodation##2##2##(1990-3#2)
of accountability##3##2##(1993-12#1)(2008-6#2)
of acculturation##2##2##(2012-2#2)
of accumulated##4##2##(1991-12#1)(2008-10#2)(2008-7#1)
of accumulation##6##2##(2008-10#5)(2008-11#1)
of accuracy and precision##2##4##(2008-10#2)
of accuracy and##4##3##(1990-2#1)(2008-10#3)
of accuracy of##4##3##(1993-5#1)(2008-10#2)(2009-5#1)
of accuracy##22##2##(1990-2#1)(1993-5#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#2)(2009-5#2)(2013-1#1)
of accurate and##2##3##(2008-10#1)(2008-11#1)
of accurate control##2##3##(2008-10#2)
of accurate##8##2##(2008-10#4)(2008-11#2)(2008-9#1)(2010-8#1)
of accurately##3##2##(1993-1#1)(2008-10#2)
of acellular##2##2##(1997-8#1)(2008-5#1)
of acetaldehyde##3##2##(1994-5#2)(2008-2#1)
of acetaminophen##8##2##(2008-10#7)(2008-11#1)
of acetate buffer##3##3##(2008-10#3)
of acetate##15##2##(1997-2#1)(2008-10#9)(2008-6#2)(2008-7#2)(2011-1#1)
of acetazolamide and##2##3##(2008-10#2)
of acetic acid was##2##4##(1991-5#2)
of acetic acid with##2##4##(2008-10#2)
of acetic acid##9##3##(1991-5#2)(1994-8#1)(2008-10#6)
of acetic##11##2##(1991-5#2)(1994-8#1)(2008-10#8)
of acetoin##2##2##(2008-6#1)(2013-1#1)
of acetone and##2##3##(2008-10#1)(2008-9#1)
of acetone##7##2##(2008-10#6)(2008-9#1)
of acetonitrile and##3##3##(2008-10#3)
of acetonitrile##8##2##(2008-10#8)
of acetonitrile-water##3##2##(2008-10#3)
of acetyl##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
of acetylated H3 and H4##2##5##(2011-2#2)
of acetylation##2##2##(2008-10#2)
of acetylcholine (ACh)##2##3##(2008-8#1)(2009-8#1)
of acetylcholine and##2##3##(2008-8#1)(2013-1#1)
of acetylcholine in##5##3##(1994-8#4)(2008-10#1)
of acetylcholine release##2##3##(1992-3#1)(2013-8#1)
of acetylcholine##20##2##(1992-3#2)(1994-8#4)(1995-11#1)(2008-10#5)(2008-8#3)(2009-8#2)(2013-1#2)(2013-8#1)
of acetylcholinesterase##5##2##(1990-5#2)(1992-8#1)(1994-8#1)(2008-10#1)
of acetylene##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of acetylsalicylic acid##6##3##(2008-10#6)
of achievement##5##2##(1994-1#1)(2008-12#2)(2009-12#1)(2013-1#1)
of achieving a target weight##2##5##(2013-1#2)
of achieving a##6##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#2)
of achieving the##3##3##(1990-11#1)(2008-7#1)(2013-1#1)
of achieving##15##2##(1990-11#1)(1990-2#1)(1990-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#3)
of acid and##2##3##(2008-10#2)
of acid dissociation constants based on##2##6##(2008-10#2)
of acid dissociation constants##4##4##(2008-10#4)
of acid invertase##6##3##(2008-9#6)
of acid phosphatase##3##3##(1995-3#1)(2008-11#1)(2008-7#1)
of acid rain##2##3##(2008-10#2)
of acid##43##2##(1992-6#1)(1995-3#1)(1996-5#1)(1997-4#2)(2008-10#30)(2008-11#1)(2008-7#1)(2008-9#6)
of acid-base indicators##2##3##(2008-10#2)
of acid-base##4##2##(2008-10#4)
of acidic##8##2##(1994-5#2)(1997-7#1)(2008-10#4)(2008-5#1)
of acidified##3##2##(2008-10#3)
of acidity constants of some##2##5##(2008-10#2)
of acidity constants of##4##4##(2008-10#4)
of acidity constants##6##3##(2008-10#6)
of acidity##11##2##(2008-10#11)
of acids and bases##2##4##(2008-10#2)
of acids##9##2##(2008-10#8)(2008-5#1)
of acoustic energy##2##3##(1993-5#1)(2009-5#1)
of acoustic wave##2##3##(2008-10#1)(2009-3#1)
of acoustic##7##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2009-5#1)(2011-2#1)
of acousto-optic tunable filters##2##4##(2008-10#2)
of acousto-optic##3##2##(2008-10#3)
of acquired immunodeficiency syndrome (AIDS)##5##5##(1991-9#1)(1995-2#1)(1996-1#1)(1997-3#1)(2011-3#1)
of acquired immunodeficiency syndrome##6##4##(1991-9#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-12#1)(2011-3#1)
of acquired immunodeficiency##7##3##(1991-9#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-12#1)(2011-2#1)(2011-3#1)
of acquired##14##2##(1991-9#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)
of acquiring##7##2##(1994-1#1)(2008-10#1)(2008-5#2)(2010-6#1)(2012-2#1)(2013-1#1)
of acquisition of##2##3##(1994-8#1)(2008-10#1)
of acquisition##6##2##(1994-8#1)(2008-10#3)(2008-5#2)
of acridine orange##4##3##(2008-10#1)(2008-11#1)(2008-9#2)
of acrivastine in##4##3##(2008-10#4)
of acrivastine##5##2##(2008-10#5)
of acromegaly##2##2##(2008-5#1)(2011-2#1)
of acrosome##5##2##(2008-7#2)(2012-2#1)(2013-1#2)
of acrylamide##3##2##(2008-10#2)(2008-2#1)
of acrylic##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
of actin and myosin##2##4##(1991-5#1)(1992-9#1)
of actin and##3##3##(1991-5#1)(1992-9#1)(2008-11#1)
of actin cytoskeleton##2##3##(1997-7#1)(2008-9#1)
of actin dynamics in##2##4##(2008-11#1)(2012-2#1)
of actin dynamics##3##3##(2008-11#1)(2012-2#2)
of actin filament bundles at the##2##6##(2012-2#2)
of actin filament bundles##3##4##(2012-2#3)
of actin filament##4##3##(1996-12#1)(2012-2#3)
of actin filaments##6##3##(1993-8#1)(1993-9#1)(2008-7#1)(2009-9#2)(2012-2#1)
of actin in##2##3##(1993-3#1)(1996-12#1)
of actin##32##2##(1991-5#4)(1992-4#1)(1992-9#1)(1993-3#1)(1993-8#2)(1993-9#1)(1996-12#2)(1997-7#1)(2008-11#4)(2008-7#1)(2008-9#2)(2009-9#2)(2011-2#1)(2012-2#9)
of actin-binding##2##2##(1993-8#1)(2011-2#1)
of actinides and##3##3##(2008-10#3)
of actinomycetes##3##2##(2008-10#2)(2010-12#1)
of actinomycin D##2##3##(1991-5#1)(2008-11#1)
of action and the##2##4##(1991-2#1)(1995-8#1)
of action and##12##3##(1991-2#2)(1993-2#1)(1995-5#1)(1995-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
of action as##3##3##(2011-2#3)
of action by##3##3##(1991-1#1)(2008-10#1)(2012-2#1)
of action for##6##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#2)
of action in##3##3##(1992-12#1)(1996-2#1)(2010-10#1)
of action is unknown##2##4##(1990-12#1)(2009-12#1)
of action of the drugs##2##5##(1997-1#1)(2011-1#1)
of action of the##10##4##(1994-5#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-1#1)
of action of these##2##4##(2008-10#1)(2008-11#1)
of action of this##2##4##(1996-3#1)(1997-2#1)
of action of##46##3##(1991-5#1)(1994-11#1)(1994-5#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-7#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-7#1)(2013-8#1)
of action potential##2##3##(2008-4#1)(2013-8#1)
of action potentials in the##2##5##(1992-12#1)(2009-12#1)
of action potentials##7##3##(1992-12#1)(2008-11#2)(2008-4#1)(2009-12#2)(2009-8#1)
of action studies##2##3##(2011-2#2)
of action than the##3##4##(1991-5#1)(2008-7#2)
of action that##3##3##(1993-1#1)(2008-10#1)(2008-11#1)
of action##157##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#3)(1991-5#2)(1992-12#2)(1992-3#2)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-7#1)(2007-11#1)(2008-10#30)(2008-11#18)(2008-12#1)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#2)(2009-12#4)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-4#1)(2010-6#2)(2010-7#3)(2011-1#1)(2011-2#12)(2011-3#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
of actions##6##2##(1993-2#1)(2008-11#3)(2009-12#1)(2012-2#1)
of activated B cells (NF-κB)##2##5##(2012-3#1)(2013-1#1)
of activated B cells##5##4##(1991-3#2)(1995-6#1)(2012-3#1)(2013-1#1)
of activated T cells##2##4##(2009-6#1)(2010-5#1)
of activated cells##2##3##(2008-10#1)(2008-4#1)
of activated charcoal##2##3##(2008-10#2)
of activated human##2##3##(1995-12#1)(2008-7#1)
of activated macrophages##2##3##(1994-5#2)
of activated##27##2##(1991-3#2)(1991-5#1)(1993-8#1)(1994-5#2)(1995-12#1)(1995-6#4)(2008-10#7)(2008-4#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
of activating##6##2##(1990-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
of activation of the##3##4##(1991-3#1)(1994-3#1)(2008-10#1)
of activation of##7##3##(1991-3#1)(1994-3#1)(1995-2#2)(1996-2#1)(2008-10#1)(2010-10#1)
of activation##18##2##(1991-3#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-8#1)
of activator protein-1##2##3##(1994-6#2)
of activator##3##2##(1994-6#2)(2008-8#1)
of active TrPs##2##3##(2010-9#2)
of active and##3##3##(2008-12#1)(2009-8#1)(2012-2#1)
of active ingredient##4##3##(2008-5#4)
of active ingredients in##3##4##(2008-10#2)(2010-9#1)
of active ingredients'##2##3##(2008-5#2)
of active nanostructures##2##3##(2010-12#2)
of active recombinant##2##3##(2008-11#2)
of active sites##2##3##(2008-10#1)(2008-4#1)
of active##68##2##(1991-2#1)(1991-5#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#13)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#6)(2008-7#3)(2008-8#3)(2009-12#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-7#1)(2010-9#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of actively growing##2##3##(1994-5#1)(2008-10#1)
of actively##5##2##(1993-1#1)(1993-12#1)(1994-5#1)(2008-10#1)(2012-3#1)
of activin A##3##3##(1992-6#1)(1995-8#2)
of activin##4##2##(1992-6#2)(1995-8#2)
of activin-A##2##2##(1994-11#2)
of activities of the##2##4##(1996-2#1)(2012-12#1)
of activities of##5##3##(1994-11#1)(1996-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
of activities##14##2##(1994-11#1)(1996-2#1)(1997-3#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
of activity and##5##3##(1995-3#1)(1997-8#1)(2008-10#3)
of activity between##2##3##(1996-1#1)(2008-10#1)
of activity coefficients##2##3##(2008-10#1)(2008-5#1)
of activity from##2##3##(1997-1#1)(2008-10#1)
of activity in the##2##4##(2008-11#1)(2008-4#1)
of activity in##4##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
of activity of the##3##4##(1993-8#1)(1994-2#2)
of activity of##10##3##(1993-8#1)(1994-2#2)(1995-11#1)(2008-10#2)(2008-7#1)(2013-1#3)
of activity on##2##3##(2008-10#1)(2008-9#1)
of activity##58##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-1#1)(1993-8#1)(1994-2#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-8#1)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#5)
of activity)##2##2##(2008-10#1)(2008-7#1)
of activity-dependent##2##2##(1996-2#1)(1997-7#1)
of actual##4##2##(1991-1#1)(1997-5#1)(2008-10#1)(2008-12#1)
of acupuncture and##2##3##(2008-10#1)(2013-1#1)
of acupuncture practice in##2##4##(2008-10#2)
of acupuncture treatment##2##3##(2010-7#1)(2013-1#1)
of acupuncture##17##2##(1995-12#4)(2008-10#8)(2010-7#2)(2013-1#3)
of acute EtOH administration##2##4##(2008-10#2)
of acute PE##2##3##(2011-2#2)
of acute abdomen##3##3##(2009-8#1)(2012-2#1)(2013-1#1)
of acute and chronic##5##4##(2008-10#1)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)
of acute arterial thrombosis##2##4##(2006-6#1)(2011-2#1)
of acute bacterial pneumonia in##2##5##(1991-3#2)
of acute bacterial##4##3##(1991-3#2)(2008-10#1)(2010-12#1)
of acute care##2##3##(1992-3#1)(1994-3#1)
of acute colonic diverticulitis##2##4##(2009-8#2)
of acute complications##3##3##(1994-6#2)(2013-7#1)
of acute coronary syndrome##2##4##(2008-3#2)
of acute coronary syndromes##6##4##(2008-3#5)(2009-10#1)
of acute coronary##8##3##(2008-3#7)(2009-10#1)
of acute hepatitis##2##3##(1996-3#1)(2010-8#1)
of acute leukemia##2##3##(2008-9#1)(2013-1#1)
of acute myeloid leukemia (AML)##2##5##(2011-2#1)(2012-12#1)
of acute myeloid leukemia##4##4##(1990-8#1)(2009-12#1)(2011-2#1)(2012-12#1)
of acute myocardial infarction (AMI)##2##5##(2008-10#1)(2009-6#1)
of acute myocardial infarction##8##4##(1992-3#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-5#1)(2012-2#1)
of acute myocardial##9##3##(1992-3#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-5#1)(2012-2#1)
of acute or##2##3##(1991-3#1)(1992-9#1)
of acute pain##4##3##(2013-1#4)
of acute pancreatitis is##2##4##(2013-1#2)
of acute pancreatitis##7##3##(1990-3#1)(2009-7#1)(2012-12#1)(2013-1#4)
of acute rejection##3##3##(1991-11#1)(2008-10#1)(2012-2#1)
of acute respiratory##6##3##(1993-5#1)(2008-11#1)(2009-7#1)(2012-12#3)
of acute stress##2##3##(2012-3#1)(2013-8#1)
of acute stroke##3##3##(2007-9#1)(2009-11#1)(2013-8#1)
of acute toxicity##2##3##(2008-12#2)
of acute##165##2##(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-3#3)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-9#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#3)(1994-9#3)(1995-11#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(2006-6#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#5)(2008-12#5)(2008-3#8)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#4)(2010-12#3)(2010-5#1)(2010-8#2)(2011-2#14)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#18)(2013-7#1)(2013-8#5)
of acutely##3##2##(1991-2#2)(1992-9#1)
of acyclovir##4##2##(1991-12#1)(1994-3#1)(1995-6#2)
of acylglycerols##3##2##(2009-8#3)
of adaptation to##7##3##(2008-10#2)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-3#1)
of adaptation##11##2##(1991-4#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-3#1)
of adapted##6##2##(1994-8#1)(2008-10#1)(2008-11#1)(2013-8#3)
of adaptive deme formation in phytophagous##2##6##(2008-9#2)
of adaptive deme formation##3##4##(2008-9#3)
of adaptive mutations##2##3##(2008-9#2)
of adaptive radiation in##2##4##(2008-8#2)
of adaptive radiation##3##3##(2008-8#3)
of adaptive##26##2##(1990-8#1)(1996-12#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#9)(2008-9#5)(2009-3#1)(2009-7#1)(2010-2#1)(2013-8#2)
of adaptively##2##2##(2008-10#1)(2008-8#1)
of add-on devices##2##3##(1996-2#1)(1997-1#1)
of add-on##3##2##(1996-2#1)(1997-1#1)(2009-10#1)
of added##14##2##(1990-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1997-1#1)(2008-10#7)(2008-11#1)(2009-8#1)
of addiction and##2##3##(2013-1#1)(2013-8#1)
of addiction##5##2##(1991-1#1)(2013-1#2)(2013-8#2)
of adding##8##2##(2008-10#6)(2008-11#1)(2010-4#1)
of addition of##3##3##(2008-10#2)(2008-11#1)
of addition##4##2##(2008-10#2)(2008-11#2)
of additional##38##2##(1990-5#1)(1991-11#1)(1991-2#2)(1992-2#1)(1992-3#1)(1994-3#2)(1994-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#4)(2013-1#2)
of additive effects##2##3##(2007-11#1)(2008-9#1)
of additive##3##2##(2007-11#1)(2008-8#1)(2008-9#1)
of additives##3##2##(2008-10#2)(2008-11#1)
of additivity##2##2##(1995-11#1)(2008-10#1)
of addressing##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
of adduct levels##2##3##(2008-12#2)
of adduct##6##2##(2008-10#4)(2008-12#2)
of adducts##2##2##(2008-10#1)(2008-12#1)
of adefovir-resistant##3##2##(2013-1#3)
of adenine nucleotides##3##3##(2008-7#3)
of adenine##9##2##(2008-10#4)(2008-11#2)(2008-7#3)
of adenocarcinoma##4##2##(2008-1#3)(2008-10#1)
of adenomas##3##2##(1992-5#1)(2009-12#1)(2012-3#1)
of adenomatoid odontogenic##2##3##(2013-1#2)
of adenomatous polyps##2##3##(2008-1#1)(2009-12#1)
of adenoregulin##3##2##(1993-3#3)
of adenosine A1 receptors##3##4##(1997-1#3)
of adenosine A1##4##3##(1993-6#1)(1997-1#3)
of adenosine in##2##3##(1996-2#1)(2008-7#1)
of adenosine influx##2##3##(1994-8#2)
of adenosine##25##2##(1990-5#1)(1991-3#1)(1993-6#2)(1994-11#1)(1994-6#2)(1994-8#2)(1995-11#1)(1996-2#6)(1997-1#3)(1997-8#1)(2008-4#2)(2008-7#2)(2009-8#1)
of adenoviral##5##2##(2008-11#5)
of adenovirus##7##2##(1997-8#1)(2008-11#3)(2010-1#1)(2011-2#1)(2012-3#1)
of adenylate cyclase##4##3##(1990-8#1)(1992-6#1)(1993-6#1)(1995-6#1)
of adenylyl cyclase##4##3##(1995-11#2)(1997-1#1)(1997-2#1)
of adequacy##2##2##(1993-1#1)(2011-2#1)
of adequate##14##2##(1993-1#1)(1993-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-3#1)
of adherence to##2##3##(1994-3#1)(2008-10#1)
of adherence##8##2##(1994-3#3)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#2)
of adherent cells##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
of adherent##5##2##(1991-3#1)(2008-10#2)(2008-11#1)(2010-10#1)
of adhesion formation##3##3##(1991-1#1)(1992-1#1)(1992-2#1)
of adhesion molecules##3##3##(2006-6#1)(2008-5#1)(2012-2#1)
of adhesion##12##2##(1991-1#1)(1992-1#2)(1992-2#1)(2006-6#1)(2008-5#2)(2008-7#3)(2008-9#1)(2012-2#1)
of adhesions##2##2##(1994-12#1)(1996-1#1)
of adhesive##2##2##(2008-11#1)(2009-6#1)
of adipic acid##2##3##(2008-10#2)
of adipocyte##2##2##(1994-12#1)(2011-2#1)
of adipocytes##2##2##(2008-11#1)(2011-2#1)
of adipogenesis##2##2##(1994-12#1)(2008-11#1)
of adipogenic##2##2##(2008-4#1)(2012-2#1)
of adipose cells##2##3##(1990-11#1)(2008-10#1)
of adipose tissue##5##3##(2008-11#4)(2011-2#1)
of adipose##8##2##(1990-11#1)(2008-10#1)(2008-11#4)(2010-6#1)(2011-2#1)
of adipose-derived stem cells##2##4##(2009-11#1)(2012-4#1)
of adiposity##6##2##(2012-2#6)
of adjacent chromosomal##2##3##(1991-9#1)(1993-12#1)
of adjacent segment disease##3##4##(2012-12#2)(2012-3#1)
of adjacent##15##2##(1991-9#1)(1993-12#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-8#1)(2010-7#1)(2012-12#3)(2012-3#1)(2013-1#1)
of adjudin##3##2##(2012-2#3)
of adjunctive##5##2##(2008-4#1)(2011-2#2)(2013-1#2)
of adjusting the##2##3##(2008-10#1)(2008-11#1)
of adjusting##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
of adjustment##2##2##(2008-7#1)(2010-1#1)
of adjustments to the number of##2##6##(2008-9#2)
of adjuvant therapy of breast cancer##2##6##(1993-11#1)(1993-2#1)
of adjuvant therapy##3##3##(1993-11#1)(1993-2#1)(2012-3#1)
of adjuvant##9##2##(1992-12#1)(1993-11#2)(1993-2#1)(1993-9#1)(1995-5#1)(2008-10#1)(2012-3#1)(2013-1#1)
of adjuvants##5##2##(1995-5#4)(2012-2#1)
of administering##3##2##(1994-9#1)(1995-5#1)(2010-8#1)
of administration of the##2##4##(1992-9#1)(1997-5#1)
of administration of##7##3##(1992-12#1)(1992-9#1)(1997-5#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
of administration##20##2##(1991-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-6#1)(2010-9#2)(2011-2#3)(2013-1#1)
of administrative##2##2##(1993-2#1)(2013-1#1)
of admission to the##2##4##(1992-3#1)(1994-1#1)
of admission##9##2##(1990-9#1)(1991-12#2)(1991-8#1)(1992-3#1)(1994-1#1)(2009-12#1)(2013-1#2)
of adolescent cannabis##2##3##(2009-7#1)(2013-8#1)
of adolescent girls##3##3##(2008-1#1)(2010-10#1)(2013-1#1)
of adolescent motherhood##2##3##(1995-1#1)(2013-8#1)
of adolescent mothers##3##3##(1995-1#1)(2013-1#2)
of adolescent##24##2##(1992-3#1)(1995-1#2)(2008-1#1)(2008-11#2)(2008-8#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-7#1)(2013-1#8)(2013-8#3)
of adolescents aged##2##3##(1997-6#1)(2009-7#1)
of adolescents and adults##2##4##(1993-1#1)(2008-11#1)
of adolescents and young##2##4##(2008-11#1)(2008-12#1)
of adolescents and##5##3##(1993-1#1)(2008-11#2)(2008-12#1)(2010-1#1)
of adolescents in##3##3##(1993-3#1)(1997-3#1)(1997-8#1)
of adolescents who were##2##4##(2009-7#1)(2012-2#1)
of adolescents who##3##3##(2009-7#1)(2012-2#2)
of adolescents with##2##3##(1993-3#1)(2010-1#1)
of adolescents##23##2##(1990-6#1)(1990-9#1)(1992-3#1)(1993-1#1)(1993-3#2)(1996-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-11#3)(2008-12#1)(2009-7#2)(2010-1#2)(2010-9#1)(2012-2#2)(2013-1#2)
of adolescents'##2##2##(2009-7#1)(2010-5#1)
of adoption of the three practices##2##6##(2010-11#2)
of adoption of##3##3##(2010-11#3)
of adoptive##3##2##(2009-11#1)(2011-2#2)
of adrenal##8##2##(1990-11#1)(1990-12#1)(1991-6#1)(1993-3#2)(2011-2#1)(2012-3#2)
of adriamycin##4##2##(2008-10#4)
of adriblastina##4##2##(2008-10#4)
of adsorbed##5##2##(2008-10#5)
of adsorbent##6##2##(2008-10#6)
of adsorption for##2##3##(2008-10#2)
of adsorption of##4##3##(2008-10#4)
of adsorption##10##2##(2008-10#10)
of adsorptive##3##2##(2008-10#3)
of adult and##2##3##(2008-5#2)
of adult disease##3##3##(2013-1#3)
of adult education##2##3##(1992-2#1)(2008-12#1)
of adult females##2##3##(2008-8#1)(2008-9#1)
of adult males##2##3##(1991-12#1)(2007-12#1)
of adult mice##2##3##(1994-11#1)(2008-9#1)
of adult rat hepatocytes##3##4##(1993-8#2)(1995-8#1)
of adult rat##4##3##(1993-8#2)(1995-8#1)(2008-11#1)
of adult rats##2##3##(1994-2#1)(1997-1#1)
of adult type-II cells##3##4##(1994-3#3)
of adult##77##2##(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-7#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#7)(2009-7#2)(2009-9#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#5)
of adult-plant##2##2##(2008-10#2)
of adults experiencing chronic nonmalignant pain##2##6##(2010-3#2)
of adults with##4##3##(1997-8#1)(2008-11#1)(2010-3#1)(2013-8#1)
of adults##18##2##(1994-8#1)(1995-5#1)(1996-11#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#3)(2010-8#1)(2013-8#1)
of advanced age##2##3##(1994-2#1)(1997-3#1)
of advanced breast##2##3##(1992-5#1)(1994-12#1)
of advanced##35##2##(1990-12#4)(1990-6#1)(1991-9#1)(1992-5#1)(1992-9#1)(1994-12#2)(1994-2#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#2)(2009-10#2)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#2)
of advancement##3##2##(1995-12#1)(2008-12#1)(2011-3#1)
of advances in##2##3##(2008-4#1)(2009-12#1)
of advantages over traditional##2##4##(1993-3#1)(2008-9#1)
of advantages over##7##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)
of advantages##10##2##(1993-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#1)
of adventitial##2##2##(1997-8#2)
of adventitious##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
of adverse drug reactions##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
of adverse drug##5##3##(2008-11#2)(2011-2#2)(2013-8#1)
of adverse effects of##2##4##(2008-5#1)(2010-2#1)
of adverse effects on##2##4##(2007-11#1)(2008-2#1)
of adverse effects##7##3##(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#1)
of adverse events and##2##4##(2011-2#1)(2013-1#1)
of adverse events in##3##4##(2008-11#1)(2008-7#1)(2009-12#1)
of adverse events##7##3##(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
of adverse health effects##2##4##(2008-10#1)(2008-11#1)
of adverse health##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
of adverse oesophageal##2##3##(2008-11#2)
of adverse reaction##2##3##(2013-1#1)(2013-8#1)
of adverse reactions##5##3##(1996-8#1)(1997-7#2)(2008-10#1)(2008-11#1)
of adverse##36##2##(1991-1#1)(1996-8#1)(1997-5#1)(1997-7#2)(2007-11#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#5)(2013-1#3)(2013-8#2)
of advocacy##3##2##(2009-12#3)
of aeration##2##2##(2010-11#2)
of aerial##2##2##(2008-10#1)(2012-2#1)
of aerobic bacteria##2##3##(1991-3#1)(2008-10#1)
of aerobic endospore-forming bacteria##3##4##(2008-10#3)
of aerobic exercise##2##3##(2010-12#1)(2012-3#1)
of aerobic spore-forming bacteria##2##4##(2011-2#2)
of aerobic##15##2##(1991-3#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-1#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of aerosol containment##2##3##(2008-9#2)
of aerosol extinction and##2##4##(2008-3#2)
of aerosol extinction##3##3##(2008-3#3)
of aerosol spectral##2##3##(2008-3#2)
of aerosol to##2##3##(1996-2#1)(1996-3#1)
of aerosol##28##2##(1991-1#1)(1992-3#2)(1995-3#2)(1996-2#2)(1996-3#4)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#9)(2008-9#2)
of aerosol-soot mixtures##2##3##(2008-3#2)
of aerosolized##6##2##(1992-2#1)(1993-2#1)(1995-3#2)(1996-3#1)(2008-10#1)
of aerosols in##2##3##(1992-3#1)(2008-10#1)
of aerosols##7##2##(1992-3#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-2#1)
of aesculin and##3##3##(2008-10#3)
of affected doves##3##3##(2008-5#3)
of affected relatives of##3##4##(1992-9#3)
of affected relatives##4##3##(1992-9#4)
of affected##16##2##(1992-2#1)(1992-9#5)(1997-2#1)(2008-1#1)(2008-4#1)(2008-5#3)(2010-1#1)(2011-2#2)(2012-3#1)
of affective interpersonal bonds##2##4##(2008-1#2)
of affective##10##2##(1991-11#1)(1993-6#1)(1996-12#1)(2008-1#3)(2008-11#2)(2010-6#1)(2013-1#1)
of afferent##2##2##(1996-12#1)(1996-2#1)
of affinity##6##2##(1991-9#1)(1995-11#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#1)
of aflatoxin M1##4##3##(2008-12#2)(2013-1#2)
of aflatoxin contamination in##2##4##(2008-10#2)
of aflatoxin contamination##3##3##(2008-10#3)
of aflatoxin##11##2##(2008-10#7)(2008-12#2)(2013-1#2)
of aflatoxins##3##2##(2008-10#3)
of agar##4##2##(2008-10#2)(2012-2#2)
of agaro-oligosaccharides##2##2##(2008-10#2)
of age and sex##2##4##(2008-7#2)
of age and##16##3##(1991-12#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#2)(2010-9#1)(2012-12#2)(2012-2#1)
of age at first##2##4##(1995-12#1)(2009-5#1)
of age at##6##3##(1995-12#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-2#1)
of age group##4##3##(1997-3#1)(2012-2#1)(2012-3#2)
of age in##4##3##(1997-8#1)(2008-7#1)(2010-6#1)(2012-2#1)
of age is##4##3##(1991-6#1)(1995-8#2)(2008-10#1)
of age of##3##3##(1994-8#2)(2008-5#1)
of age on the##2##4##(1990-3#1)(2008-9#1)
of age on##9##3##(1990-3#1)(1995-8#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#1)
of age or##5##3##(1991-12#1)(1991-3#1)(1992-1#1)(1993-12#1)(2008-7#1)
of age to##2##3##(2008-12#1)(2011-2#1)
of age was##4##3##(1991-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
of age were##6##3##(1995-12#1)(1995-8#1)(1996-1#1)(2008-10#2)(2012-12#1)
of age who##2##3##(2006-5#1)(2011-2#1)
of age with##2##3##(1994-6#1)(2013-1#1)
of age##195##2##(1990-3#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#5)(1991-7#1)(1992-1#2)(1992-6#1)(1993-12#5)(1993-3#1)(1994-1#1)(1994-2#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-8#9)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2006-5#4)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-12#6)(2008-5#5)(2008-7#15)(2008-8#6)(2008-9#8)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-9#1)(2011-1#1)(2011-2#17)(2012-12#7)(2012-2#7)(2012-3#7)(2013-1#9)(2013-8#5)
of age)##5##2##(2008-10#1)(2008-7#2)(2010-10#1)(2012-12#1)
of age-appropriate##2##2##(1992-1#1)(2009-11#1)
of age-related changes in the##2##5##(2008-5#1)(2008-7#1)
of age-related changes in##3##4##(1995-8#1)(2008-5#1)(2008-7#1)
of age-related macular degeneration##3##4##(2010-8#1)(2011-2#2)
of age-related variation in##2##4##(2008-8#2)
of age-related##12##2##(1995-8#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#3)(2010-8#1)(2011-2#2)
of age-specific##3##2##(1991-2#1)(1991-6#1)(2008-10#1)
of age]##2##2##(2012-3#2)
of aged##7##2##(1990-5#1)(1993-12#1)(1995-8#1)(1996-2#1)(2010-10#1)(2010-7#1)(2012-2#1)
of ageing and##3##3##(1995-3#1)(2008-10#2)
of ageing on##2##3##(2008-5#1)(2012-2#1)
of ageing##9##2##(1995-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2012-2#1)
of agencies##2##2##(1995-3#1)(1997-3#1)
of agency##3##2##(1995-6#1)(1997-3#1)(2008-11#1)
of agent##2##2##(2011-2#2)
of agents active in the presynaptic dopaminergic system on the##2##10##(1996-2#2)
of agents of human granulocytic anaplasmosis and monocytic erlychiosis##2##9##(2013-1#2)
of agents of human granulocytic anaplasmosis and monocytic##3##8##(2013-1#3)
of agents of##4##3##(2013-1#4)
of agents that##2##3##(2008-10#1)(2008-11#1)
of agents##17##2##(1995-6#1)(1996-2#2)(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-2#3)(2013-1#4)
of aggrecan mRNA##3##3##(2008-11#3)
of aggrecan##7##2##(1992-1#3)(2008-11#4)
of aggregated virus##2##3##(2011-2#2)
of aggregated##5##2##(1993-11#1)(2011-2#2)(2012-2#1)(2013-7#1)
of aggregates##2##2##(1993-11#1)(2008-11#1)
of aggregation and##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
of aggregation of##8##3##(1994-5#2)(2008-10#6)
of aggregation##25##2##(1990-5#1)(1992-9#1)(1994-5#2)(1997-2#1)(2006-6#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-8#4)
of aggression in##3##3##(2008-11#1)(2008-7#1)(2009-10#1)
of aggression##11##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#3)(2012-3#2)
of aggressive behaviour##3##3##(1993-2#2)(1994-12#1)
of aggressive interactions on##2##4##(2008-8#2)
of aggressive melanoma cells##2##4##(2009-3#2)
of aggressive##16##2##(1993-2#2)(1994-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-10#1)(2009-3#3)(2010-9#1)(2011-2#3)
of aggressiveness of##2##3##(2008-10#1)(2008-2#1)
of aggressiveness on##2##3##(2008-10#2)
of aggressiveness##9##2##(2008-10#8)(2008-2#1)
of aging in##6##3##(2008-7#3)(2008-9#2)(2012-2#1)
of aging is##3##3##(2008-9#3)
of aging mice##2##3##(1993-12#2)
of aging##29##2##(1990-3#2)(1992-12#1)(1992-9#1)(1993-12#3)(2008-10#1)(2008-12#1)(2008-7#7)(2008-9#9)(2011-2#1)(2012-2#3)
of agitation##3##2##(2008-7#1)(2009-6#1)(2010-11#1)
of agonists##6##2##(1993-3#1)(1994-5#2)(1996-2#1)(2008-5#1)(2012-2#1)
of agreement between the##2##4##(2008-5#1)(2011-2#1)
of agreement between##3##3##(2008-5#1)(2010-7#1)(2011-2#1)
of agreement on##2##3##(1993-12#1)(1995-1#1)
of agreement##15##2##(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-1#2)(2010-1#1)(2010-7#1)(2011-2#1)
of agricultural##16##2##(1995-3#1)(2008-10#8)(2008-11#3)(2008-12#1)(2011-2#2)(2013-1#1)
of agriculture##2##2##(2008-11#2)
of agrochemicals##2##2##(2008-10#1)(2010-7#1)
of agrocin 84##2##3##(2008-10#2)
of agronomic##2##2##(2008-10#1)(2012-3#1)
of air drying##3##3##(2008-10#3)
of air particulate matter is##2##5##(2008-10#2)
of air pollutants##2##3##(2008-10#1)(2008-11#1)
of air pollution in##2##4##(2008-11#2)
of air pollution##5##3##(1997-1#2)(2008-11#3)
of air##44##2##(1991-3#3)(1993-6#1)(1993-9#1)(1995-12#1)(1997-1#2)(2008-10#17)(2008-11#6)(2008-2#3)(2008-3#5)(2008-6#2)(2008-7#1)(2010-3#1)(2011-2#1)
of airborne particulate matter##3##4##(2008-10#2)(2009-7#1)
of airborne##22##2##(1994-3#1)(2008-10#16)(2008-11#1)(2008-3#2)(2009-7#1)(2012-7#1)
of aircraft##3##2##(1996-12#1)(2008-3#2)
of airway and##2##3##(1992-3#1)(1997-2#1)
of airway epithelial cells##2##4##(1991-5#1)(2010-5#1)
of airway inflammation##2##3##(2009-1#1)(2010-5#1)
of airway retention##4##3##(1995-12#4)
of airway sensitization potential of##2##5##(2008-10#2)
of airway##20##2##(1991-5#1)(1992-3#1)(1995-12#4)(1996-12#1)(1997-1#3)(1997-2#1)(2008-10#2)(2008-11#1)(2009-1#1)(2010-1#1)(2010-5#3)(2010-7#1)
of airways##2##2##(2008-7#2)
of alachlor##2##2##(1993-12#1)(2008-10#1)
of alanine aminotransferase (ALT)##2##4##(2009-8#1)(2012-3#1)
of alanine aminotransferase##3##3##(2008-12#1)(2009-8#1)(2012-3#1)
of alanine##7##2##(1990-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-3#1)
of alate##2##2##(2008-10#2)
of albedo##2##2##(2008-2#2)
of albinism in##2##3##(2008-6#2)
of albinism##3##2##(2008-6#3)
of albumin and IgG1##2##4##(2008-10#2)
of albumin and##6##3##(2008-10#5)(2011-2#1)
of albumin secretion##3##3##(2008-11#3)
of albumin##22##2##(1990-2#1)(1991-12#1)(1995-2#1)(2008-10#13)(2008-11#4)(2008-5#1)(2011-2#1)
of albumin-globulin ratio##2##3##(2012-2#2)
of alcian blue##2##3##(2008-10#2)
of alcohol abuse##4##3##(1990-2#1)(1997-2#2)(2009-7#1)
of alcohol consumption##4##3##(1992-9#1)(1995-11#2)(2009-7#1)
of alcohol dehydrogenase##3##3##(1992-11#1)(2008-11#1)(2008-5#1)
of alcohol drinking##2##3##(1990-2#1)(2013-8#1)
of alcohol use disorders in humans##2##6##(2012-3#2)
of alcohol use disorders##3##4##(2012-3#3)
of alcohol use##9##3##(2008-11#3)(2008-12#1)(2012-12#1)(2012-3#3)(2013-8#1)
of alcohol##47##2##(1990-2#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-11#2)(1996-12#1)(1997-2#3)(1997-8#2)(2008-10#8)(2008-11#5)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#3)(2012-12#1)(2012-3#3)(2013-8#3)
of alcoholic##10##2##(1990-5#1)(1995-11#1)(2008-10#4)(2009-7#4)
of alcoholism##6##2##(1993-2#1)(1994-5#1)(1994-6#1)(1995-11#3)
of alcohols and##2##3##(2008-10#2)
of alcohols##7##2##(1990-5#2)(2008-10#4)(2009-8#1)
of aldehydes and ketones##2##4##(1996-5#1)(2008-10#1)
of aldehydes##6##2##(1996-5#1)(2008-10#5)
of aldose reductase##2##3##(1996-2#2)
of alendronate sodium in##2##4##(2008-10#2)
of alendronate sodium##6##3##(2008-10#6)
of alendronate##9##2##(2008-10#8)(2008-11#1)
of alexithymia##2##2##(2008-11#2)
of alfalfa##5##2##(2008-10#4)(2008-11#1)
of algae##2##2##(2008-10#2)
of algal##3##2##(2008-10#3)
of alginate##3##2##(2008-10#2)(2008-7#1)
of alginate/poly-L##2##2##(2008-11#2)
of algorithms##2##2##(2008-9#2)
of aligned##3##2##(2008-4#1)(2008-7#2)
of alignment##3##2##(2013-1#3)
of alignments##2##2##(2008-9#1)(2011-3#1)
of aliphatic alcohols##4##3##(1990-5#1)(2008-10#3)
of aliphatic amines##7##3##(2008-10#7)
of aliphatic##16##2##(1990-5#1)(1994-8#1)(2008-10#12)(2008-11#2)
of alizarin##2##2##(2008-10#2)
of alkali and alkaline earth metal ions##2##7##(2008-10#2)
of alkali and alkaline earth metal##3##6##(2008-10#3)
of alkali metal picrates with##3##5##(2008-10#3)
of alkali metal##5##3##(2008-10#4)(2008-2#1)
of alkali##14##2##(2008-10#13)(2008-2#1)
of alkaline aluminate solutions with##2##5##(2008-10#2)
of alkaline phosphatase##13##3##(1991-10#3)(2008-10#8)(2008-11#1)(2013-1#1)
of alkaline##23##2##(1991-10#3)(2008-10#14)(2008-11#3)(2009-7#1)(2012-4#1)(2013-1#1)
of alkaloid salts##2##3##(2008-10#2)
of alkaloid##4##2##(2008-10#2)(2011-3#2)
of alkaloids##3##2##(2008-10#3)
of alkyl sulfatase was##2##4##(2012-2#2)
of alkyl sulfatase##3##3##(2012-2#3)
of alkyl##5##2##(2008-10#1)(2009-8#1)(2012-2#3)
of alkylating##2##2##(2008-11#1)(2010-11#1)
of all ages##7##3##(1992-3#1)(1993-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
of all assays##2##3##(2008-10#2)
of all available data##2##4##(2010-11#1)(2011-2#1)
of all available##4##3##(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#1)
of all brain##2##3##(1993-8#1)(2012-2#1)
of all cancers##3##3##(1990-2#2)(1994-2#1)
of all cases of##4##4##(1990-12#1)(2010-12#1)(2010-6#1)(2011-2#1)
of all cases were##2##4##(2008-7#1)(2012-3#1)
of all cases##8##3##(1990-12#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
of all cells##2##3##(1994-11#1)(2008-8#1)
of all children in##2##4##(1991-8#1)(1994-9#1)
of all compounds##3##3##(2008-10#2)(2010-6#1)
of all deaths##3##3##(1992-6#2)(2008-11#1)
of all defined##2##3##(2012-2#2)
of all demented PD patients)##2##5##(2008-7#2)
of all five##4##3##(2008-10#2)(2009-12#1)(2013-8#1)
of all flow##2##3##(2008-10#1)(2008-4#1)
of all four##7##3##(1993-6#1)(1993-8#1)(1995-6#1)(2008-10#2)(2012-3#2)
of all ganglion neurons##2##4##(2008-7#2)
of all hospital##2##3##(1994-12#1)(2012-2#1)
of all influenza##2##3##(1992-6#2)
of all isolates##4##3##(2008-10#4)
of all kinds##2##3##(1992-2#1)(2012-2#1)
of all known##4##3##(1997-9#2)(2008-10#1)(2011-2#1)
of all large acrocentric autosomes##2##5##(1993-12#2)
of all large##3##3##(1993-12#2)(2012-3#1)
of all lesions##2##3##(1994-1#1)(2008-10#1)
of all lung##2##3##(2009-1#1)(2011-3#1)
of all major##3##3##(1995-11#1)(2008-10#1)(2011-2#1)
of all men##2##3##(2008-1#1)(2008-10#1)
of all methods##2##3##(2008-10#1)(2008-6#1)
of all newly##2##3##(2008-10#1)(2012-2#1)
of all of##2##3##(1997-3#1)(2011-2#1)
of all oral cancer##2##4##(2010-12#1)(2013-1#1)
of all other##6##3##(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)
of all ovarian##2##3##(1990-2#1)(2007-8#1)
of all participants##2##3##(2008-10#1)(2011-2#1)
of all pathogenic##2##3##(2008-10#2)
of all patients with##4##4##(1992-12#1)(1995-5#1)(1997-4#1)(1997-5#1)
of all patients##10##3##(1991-3#1)(1992-12#1)(1995-1#1)(1995-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2011-2#3)
of all phases##2##3##(2008-10#1)(2012-3#1)
of all possible##4##3##(2007-12#1)(2008-12#1)(2008-9#1)(2009-7#1)
of all pregnant women##2##4##(1990-6#1)(1991-11#1)
of all relevant##3##3##(1993-12#1)(2008-8#1)(2013-1#1)
of all samples##3##3##(1991-11#1)(2008-12#1)(2008-4#1)
of all six##3##3##(2008-10#2)(2008-5#1)
of all stages of##2##4##(2008-10#1)(2010-6#1)
of all strains were##2##4##(2008-10#2)
of all test##2##3##(2008-10#1)(2008-5#1)
of all the analytes##2##4##(2008-10#2)
of all the##47##3##(1991-12#1)(1991-8#1)(1993-12#1)(1993-8#1)(1996-3#1)(2008-10#25)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
of all these aspects##2##4##(2008-10#2)
of all these metal ions##2##5##(2008-10#2)
of all these##11##3##(1991-3#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-10#4)(2010-7#1)(2011-2#1)(2013-8#1)
of all three substrates##2##4##(1994-5#1)(2008-11#1)
of all three##18##3##(1990-5#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-7#1)(2011-2#2)(2012-8#1)
of all types of##2##4##(2008-11#1)(2012-2#1)
of all types##4##3##(1994-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
of all variables##2##3##(2008-10#1)(2008-3#1)
of all women##2##3##(1990-6#1)(2011-2#1)
of all##438##2##(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#3)(1990-6#4)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#1)(1991-8#2)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#6)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-6#1)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-9#2)(2007-12#8)(2007-8#1)(2008-1#4)(2008-10#115)(2008-11#20)(2008-12#5)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#15)(2008-8#10)(2008-9#10)(2009-1#2)(2009-10#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#5)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#30)(2011-3#4)(2011-9#1)(2012-2#17)(2012-3#9)(2012-8#1)(2013-1#16)(2013-7#1)(2013-8#8)
of all-cause mortality##3##3##(2008-7#3)
of all-cause##5##2##(2008-7#3)(2009-10#1)(2013-1#1)
of all-trans retinoic acid##3##4##(2008-5#2)(2008-8#1)
of allele frequencies##2##3##(2008-10#2)
of allele##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
of alleles at##2##3##(2008-10#2)
of alleles for##2##3##(2008-10#1)(2009-10#1)
of alleles in##2##3##(2008-10#1)(2012-3#1)
of alleles##15##2##(1994-12#1)(2008-10#9)(2009-10#1)(2012-3#1)(2012-5#1)(2013-8#2)
of allelic##3##2##(2008-2#1)(2008-8#1)(2008-9#1)
of allergen##2##2##(2008-10#2)
of allergen-specific IgE##3##3##(2008-10#3)
of allergen-specific##4##2##(2008-10#4)
of allergic antibody to##2##4##(2008-10#2)
of allergic contact dermatitis##2##4##(2008-5#2)
of allergic diseases##2##3##(1994-6#1)(2012-12#1)
of allergic rhinitis##4##3##(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
of allergic##15##2##(1990-3#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
of allergy##2##2##(2008-10#1)(2012-12#1)
of alliance activities##2##3##(2013-1#2)
of allochthonous inputs on##2##4##(2008-9#2)
of allochthonous inputs##3##3##(2008-9#3)
of allodynia##4##2##(2008-9#2)(2011-2#2)
of allogeneic hematopoietic##2##3##(2008-11#1)(2010-11#1)
of allogeneic##6##2##(1996-9#1)(2008-11#3)(2008-7#1)(2010-11#1)
of allograft##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
of alloplasmic wheat##2##3##(2008-8#2)
of allopurinol in the##2##4##(2008-10#2)
of allopurinol##4##2##(2008-10#4)
of allosteric interaction##2##3##(1995-11#2)
of allosteric##3##2##(1991-10#1)(1995-11#2)
of allowing##2##2##(2008-10#1)(2013-8#1)
of alloy samples##3##3##(2008-10#3)
of alloy##4##2##(2008-10#3)(2013-1#1)
of almond and peach##2##4##(2008-10#2)
of almond##3##2##(2008-10#3)
of almost all ions##2##4##(2008-10#2)
of almost all##3##3##(2008-10#3)
of almost##8##2##(2008-10#4)(2009-8#1)(2010-7#1)(2010-8#1)(2012-3#1)
of alopecia##2##2##(2008-10#1)(2013-8#1)
of alpha 1-adrenoceptor##2##3##(1995-11#2)
of alpha 7##3##3##(1996-12#3)
of alpha Amy3##3##3##(1994-11#3)
of alpha and beta subunits##2##5##(1991-10#1)(1992-9#1)
of alpha and beta##3##4##(1991-10#1)(1992-9#1)(2008-8#1)
of alpha and##6##3##(1991-10#1)(1992-9#1)(1995-6#2)(2008-8#2)
of alpha phase##3##3##(2009-7#3)
of alpha##35##2##(1990-5#1)(1991-10#1)(1991-6#1)(1992-9#1)(1993-6#2)(1994-11#3)(1994-12#1)(1995-11#4)(1995-6#4)(1995-8#1)(1996-12#3)(1996-5#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-7#3)(2010-7#1)(2011-3#2)
of alpha- and beta- myosin heavy chain genes in##2##9##(1992-3#2)
of alpha- and beta- myosin heavy chain##3##7##(1992-3#3)
of alpha- and beta-naphthol##2##4##(2008-10#2)
of alpha- and beta-subunits##2##4##(1991-3#2)
of alpha- and##11##3##(1990-9#1)(1991-3#2)(1992-3#3)(1992-6#1)(1996-2#1)(2008-10#3)
of alpha-##14##2##(1990-9#1)(1991-3#2)(1992-3#3)(1992-6#1)(1996-2#1)(2008-10#6)
of alpha-CD##4##2##(2008-10#4)
of alpha-GP##3##2##(2008-10#3)
of alpha-MSH##2##2##(1995-2#1)(2008-6#1)
of alpha-actinin to actin##3##4##(1993-8#3)
of alpha-actinin##4##2##(1993-8#4)
of alpha-amino##2##2##(1996-5#1)(2009-8#1)
of alpha-amylase gene fromS##2##4##(2008-8#2)
of alpha-amylase gene##4##3##(2008-8#4)
of alpha-amylase##6##2##(2008-10#1)(2008-8#5)
of alpha-bungarotoxin##3##2##(1996-12#3)
of alpha-cyclodextrin##2##2##(1997-2#1)(2008-10#1)
of alpha-helix##2##2##(1995-2#1)(2008-8#1)
of alpha-hydroxy acids in##2##4##(2008-5#2)
of alpha-hydroxy##4##2##(1992-12#1)(2008-5#3)
of alpha-ketoglutarate##4##2##(2007-8#3)(2008-8#1)
of alpha-lactalbumin##3##2##(2008-7#3)
of alpha-naphtholphthalein in polyIBM##2##4##(2008-10#2)
of alpha-naphtholphthalein in##3##3##(2008-10#3)
of alpha-pinene gas##2##3##(2008-3#2)
of alpha-tocopherol##8##2##(1991-12#1)(1992-9#1)(1996-2#2)(2008-10#1)(2009-8#3)
of alpha-toxin##2##2##(2010-6#2)
of alteration of consciousness##3##4##(2013-8#3)
of alteration of##4##3##(2008-5#1)(2013-8#3)
of alteration##5##2##(2008-11#1)(2008-5#1)(2013-8#3)
of alterations found##2##3##(2008-11#1)(2011-2#1)
of alterations in##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
of alterations##7##2##(1992-1#1)(1993-8#1)(2008-10#1)(2008-11#2)(2009-7#1)(2011-2#1)
of altered##10##2##(1992-3#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
of alternant PAHs##2##3##(2008-10#2)
of alternaria##2##2##(2008-10#2)
of alternate##4##2##(1993-12#1)(1994-3#1)(1997-1#1)(2008-8#1)
of alternating layers of##2##4##(2008-10#2)
of alternating##10##2##(1996-2#1)(2008-10#4)(2008-2#2)(2008-7#1)(2008-8#1)(2009-8#1)
of alternative fumigants##2##3##(2008-10#2)
of alternative methods##4##3##(1997-1#1)(1997-7#1)(2008-10#1)(2008-5#1)
of alternative routes for##2##4##(1992-12#1)(2008-10#1)
of alternative##34##2##(1990-8#1)(1992-12#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-1#1)(1996-6#2)(1997-1#1)(1997-7#2)(1997-8#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-6#1)(2011-2#1)(2012-3#1)
of alternatively spliced##2##3##(1994-11#1)(2008-11#1)
of alternatives##2##2##(2008-10#1)(2008-11#1)
of altitude range##2##3##(2008-2#2)
of altruism##6##2##(1995-3#1)(2008-8#4)(2008-9#1)
of altruistic##2##2##(2008-8#1)(2010-12#1)
of alumina aggregates##2##3##(2008-3#2)
of alumina##3##2##(2008-10#1)(2008-3#2)
of aluminium and lead##2##4##(2008-10#2)
of aluminium and manganese in human scalp hair##2##8##(2008-10#2)
of aluminium and##4##3##(2008-10#4)
of aluminium as##2##3##(2008-10#2)
of aluminium chloride with##3##4##(2008-10#3)
of aluminium in##3##3##(2008-10#3)
of aluminium ion##2##3##(2008-10#2)
of aluminium on##2##3##(2008-10#2)
of aluminium##28##2##(2008-10#27)(2008-7#1)
of aluminon##2##2##(2008-10#2)
of aluminum by electrothermal##2##4##(2008-10#2)
of aluminum by##4##3##(2008-10#4)
of aluminum in natural waters with rubeanic acid##2##8##(2008-10#2)
of aluminum in##6##3##(2008-10#6)
of aluminum ions to##2##4##(1994-11#2)
of aluminum tetrasulfophthalocyanines##5##3##(2012-3#5)
of aluminum##26##2##(1994-11#2)(2008-10#18)(2010-4#1)(2012-3#5)
of alveolar type of##2##4##(2010-11#2)
of alveolar type##3##3##(1995-8#1)(2010-11#2)
of alveolar##7##2##(1995-8#1)(1996-2#1)(2008-12#1)(2010-11#2)(2010-7#1)(2011-2#1)
of amantadine for##2##3##(2011-10#1)(2011-2#1)
of amantadine##4##2##(1997-2#1)(2011-10#1)(2011-2#2)
of amaranth grain##4##3##(2008-11#4)
of ambient##5##2##(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
of ambiguous##3##2##(2008-10#2)(2011-3#1)
of amblyopia##2##2##(2013-1#1)(2013-7#1)
of ambroxol##4##2##(2008-10#4)
of ambulatory care##2##3##(1991-3#2)
of ambulatory##7##2##(1991-1#1)(1991-3#2)(1995-2#1)(1996-3#1)(2010-1#1)(2013-8#1)
of amendments##2##2##(2008-10#2)
of amide linkages on acidity##2##5##(2008-10#2)
of amide linkages##3##3##(2008-10#3)
of amide##4##2##(1992-4#1)(2008-10#3)
of amides and aryl chlorides##2##5##(2010-8#2)
of amiloride##4##2##(1991-5#2)(2008-10#2)
of amine##3##2##(1994-11#1)(2008-10#2)
of amines##5##2##(2008-10#5)
of amino acid derivatives##2##4##(2008-10#1)(2008-7#1)
of amino acid sequence##3##4##(1992-7#1)(1993-3#2)
of amino acid sequences of the##2##6##(2008-10#2)
of amino acid sequences of##5##5##(1994-12#1)(1997-8#1)(2008-10#2)(2008-8#1)
of amino acid sequences##7##4##(1994-11#1)(1994-12#1)(1997-8#2)(2008-10#2)(2008-8#1)
of amino acid##22##3##(1990-12#1)(1990-8#1)(1992-7#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)(2010-7#1)(2013-8#1)
of amino acids and peptides##2##5##(2008-10#2)
of amino acids and##4##4##(1990-2#1)(1995-12#1)(2008-10#2)
of amino acids in##4##4##(2008-10#3)(2008-11#1)
of amino acids was##2##4##(2008-10#2)
of amino acids##46##3##(1990-2#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-9#2)(1993-8#2)(1994-6#1)(1995-12#1)(1997-6#1)(2008-10#22)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
of amino compounds in xylem##2##5##(2012-8#2)
of amino compounds in##3##4##(2012-8#3)
of amino groups##2##3##(2008-10#2)
of amino##79##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-3#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-6#1)(1997-8#2)(2008-10#29)(2008-11#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-1#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-8#3)(2013-8#2)
of aminoacylation##4##2##(1997-3#3)(2012-2#1)
of aminomethylbenzoic acid and aminophylline##3##5##(2008-10#3)
of aminomethylbenzoic acid in##2##4##(2008-10#2)
of aminomethylbenzoic acid##5##3##(2008-10#5)
of amiodarone##3##2##(1993-6#1)(1994-8#1)(2008-11#1)
of amitraz##2##2##(2008-10#2)
of amitrole in##2##3##(2008-10#2)
of amitrole with##2##3##(2008-10#2)
of amitrole##6##2##(2008-10#6)
of amlodipine besylate##4##3##(2008-10#4)
of amlodipine##5##2##(2008-10#4)(2012-12#1)
of ammodytin L##2##3##(1995-8#2)
of ammonia and##3##3##(2008-10#2)(2008-11#1)
of ammonia based on##2##4##(2008-10#2)
of ammonia in beers##2##4##(2008-10#2)
of ammonia in natural water##2##5##(2008-10#2)
of ammonia in##6##3##(2008-10#6)
of ammonia to##3##3##(2008-10#3)
of ammonia was##3##3##(2008-11#3)
of ammonia##41##2##(1995-3#2)(2007-12#1)(2008-10#24)(2008-11#8)(2008-3#4)(2008-7#1)(2008-9#1)
of ammonium and nitrate##5##4##(2008-10#5)
of ammonium and##8##3##(2008-10#7)(2008-9#1)
of ammonium assimilation##2##3##(1997-1#2)
of ammonium in Kjeldahl digests##2##5##(2008-10#2)
of ammonium in##4##3##(2008-10#4)
of ammonium ion##3##3##(2008-10#2)(2008-11#1)
of ammonium molybdate##4##3##(2008-10#4)
of ammonium sulfate precipitation and##2##5##(1991-9#1)(2008-8#1)
of ammonium##36##2##(1991-9#1)(1997-1#2)(2008-10#29)(2008-11#2)(2008-8#1)(2008-9#1)
of amniocenteses tests##2##3##(2012-3#2)
of amniocenteses##3##2##(2012-3#3)
of amniotes##2##2##(1996-5#1)(1997-3#1)
of amniotic fluid##3##3##(1990-9#1)(1992-12#1)(1995-8#1)
of amorphous##3##2##(2008-10#2)(2010-7#1)
of amosite fibers##2##3##(1991-12#2)
of amount##2##2##(2008-10#2)
of amoxycillin and clavulanic acid##2##5##(2008-10#2)
of amperometric##12##2##(2008-10#12)
of amperometry##2##2##(2008-10#2)
of amphetamine and##3##3##(1993-6#1)(1994-2#1)(2008-10#1)
of amphetamine in rat's blood and brain##2##7##(2008-10#2)
of amphetamine##8##2##(1993-6#2)(1994-2#1)(2008-10#5)
of amphetamine-induced##2##2##(1993-6#1)(1994-2#1)
of amphibians##4##2##(1996-5#1)(1997-3#3)
of amphotericin B##4##3##(1997-1#1)(2008-5#1)(2011-2#2)
of amphotericin##5##2##(1997-1#1)(2008-5#1)(2011-2#3)
of ampicillin in##2##3##(2008-10#2)
of ampicillin##6##2##(2008-10#5)(2011-2#1)
of amplicons##4##2##(1995-12#1)(2008-10#3)
of amplification##5##2##(1990-6#1)(2008-10#4)
of amplified fragment length##2##4##(2008-10#2)
of amplified genes##3##3##(2008-11#3)
of amplified##14##2##(2007-12#1)(2008-10#8)(2008-11#3)(2008-3#1)(2011-2#1)
of amplifier##2##2##(2007-11#1)(2007-12#1)
of amplifying##2##2##(2008-10#1)(2008-11#1)
of amplitude##2##2##(2007-11#1)(2008-3#1)
of amygdaloid##2##2##(1994-2#1)(2008-10#1)
of amylase activity##3##3##(2008-10#3)
of amylase##5##2##(2008-10#5)
of amyloid precursor protein##2##4##(1995-12#1)(2008-11#1)
of amyloid##9##2##(1994-11#1)(1995-12#1)(2008-11#3)(2008-4#2)(2008-5#1)(2013-7#1)
of amyotrophic lateral sclerosis##3##4##(2008-4#1)(2009-9#1)(2013-1#1)
of amyotrophic##4##2##(2008-4#1)(2009-9#1)(2013-1#2)
of an &quot##3##3##(2008-10#1)(2009-1#1)(2009-4#1)
of an ASP##2##3##(2013-1#2)
of an Arabidopsis##2##3##(2007-12#1)(2008-8#1)
of an Australian##2##3##(1996-1#1)(2008-11#1)
of an E##2##3##(1997-4#1)(2008-10#1)
of an HPLC##3##3##(2008-10#2)(2008-4#1)
of an ICP-MS##2##3##(2008-10#2)
of an Italian##2##3##(2008-10#1)(2008-11#1)
of an LDL particle##2##4##(1996-8#1)(2008-5#1)
of an OCD##3##3##(2013-1#3)
of an RNA##2##3##(1997-6#1)(2008-4#1)
of an SPR sensor chip##2##5##(2008-10#2)
of an abdominal##2##3##(1994-2#1)(2010-7#1)
of an abstract##2##3##(2008-12#1)(2010-4#1)
of an accurate##4##3##(1990-6#1)(1991-11#1)(1995-11#1)(2013-8#1)
of an acidic##3##3##(1994-5#1)(1994-6#1)(2011-2#1)
of an activator##2##3##(1992-8#1)(1994-5#1)
of an active##13##3##(1990-5#1)(1991-12#1)(1991-5#1)(1994-5#1)(1995-6#2)(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#2)
of an actual##2##3##(1991-12#1)(2008-6#1)
of an acute##4##3##(1994-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
of an adaptive##3##3##(2007-11#1)(2008-3#2)
of an additional##6##3##(1990-5#1)(1993-3#1)(1997-3#1)(2008-10#3)
of an adenovirus##2##3##(1992-9#1)(2010-1#1)
of an adequate##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
of an admixture of##3##4##(1997-8#1)(2010-6#1)(2011-2#1)
of an adolescent##2##3##(1992-3#1)(2008-11#1)
of an adult##6##3##(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
of an aerosol##3##3##(1992-3#1)(1996-3#1)(2008-3#1)
of an agent##2##3##(2008-10#1)(2008-5#1)
of an aggressive##2##3##(1991-1#1)(2007-8#1)
of an aging##2##3##(1994-2#1)(2007-12#1)
of an air##4##3##(2008-10#2)(2008-11#1)(2009-10#1)
of an alternate action is##2##5##(2013-1#2)
of an alternate##3##3##(1993-12#1)(2013-1#2)
of an alternative##9##3##(1993-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
of an amperometric biosensor##2##4##(2008-10#2)
of an amperometric glucose biosensor based on##2##7##(2008-10#2)
of an amperometric glucose##3##4##(2008-10#3)
of an amperometric##5##3##(2008-10#5)
of an analysis##2##3##(2008-10#2)
of an analyte##5##3##(2008-10#5)
of an analytical method to##2##5##(1996-12#1)(2008-10#1)
of an analytical method##4##4##(1996-12#1)(2008-10#3)
of an analytical procedure##3##4##(2008-10#3)
of an analytical##10##3##(1996-12#1)(2008-10#9)
of an aneurysm##3##3##(1991-6#1)(2008-7#1)(2011-2#1)
of an angiomyolipoma##3##3##(1992-2#1)(2010-6#2)
of an animal##2##3##(2008-8#1)(2008-9#1)
of an anionic##4##3##(1994-5#1)(2008-10#3)
of an annual##2##3##(2008-8#1)(2008-9#1)
of an antagonist##3##3##(1994-5#1)(2008-10#2)
of an anterior##5##3##(1992-9#2)(1996-3#2)(2008-7#1)
of an antibacterial##2##3##(2008-10#1)(2008-5#1)
of an antibody##3##3##(1993-8#1)(2008-10#1)(2010-6#1)
of an antihypertensive##2##3##(2008-10#1)(2008-8#1)
of an aortic##2##3##(1994-6#1)(2013-1#1)
of an apparent##2##3##(2008-1#1)(2008-11#1)
of an applied##2##3##(2008-10#1)(2008-7#1)
of an approach##2##3##(1996-3#1)(2008-10#1)
of an appropriate##5##3##(1995-2#1)(1997-8#1)(2008-10#3)
of an aqueous sample##2##4##(2008-10#2)
of an aqueous##4##3##(2008-10#2)(2008-7#2)
of an arbitrary##2##3##(2008-3#2)
of an argon##2##3##(2008-2#2)
of an array of##3##4##(2008-10#1)(2008-3#2)
of an artemisinin-type compound##2##4##(2008-10#2)
of an artery##3##3##(2008-9#2)(2009-1#1)
of an article##8##3##(2008-11#6)(2012-2#1)(2012-3#1)
of an artificial culture matrix##2##5##(2011-2#2)
of an artificial##3##3##(2008-10#1)(2011-2#2)
of an aspartate##2##3##(1991-12#1)(1995-8#1)
of an assessment##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
of an association between##5##4##(1997-4#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-1#1)
of an association##6##3##(1990-3#1)(1997-4#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-1#1)
of an asymmetric##4##3##(1992-3#1)(1993-3#1)(2008-10#2)
of an asymptomatic##3##3##(1992-12#1)(1997-3#1)(2008-10#1)
of an atomic absorption##2##4##(2008-10#2)
of an atomic##3##3##(2008-10#3)
of an automated solid-phase##2##4##(2008-10#1)(2012-2#1)
of an automated##5##3##(1990-2#1)(2008-10#3)(2012-2#1)
of an autosomal##2##3##(1990-9#1)(2008-7#1)
of an avian##2##3##(2008-8#1)(2013-8#1)
of an earlier##5##3##(1993-12#1)(1994-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
of an early##2##3##(2007-9#1)(2013-8#1)
of an educational intervention##2##4##(2008-8#2)
of an educational##5##3##(1997-7#1)(2008-12#1)(2008-8#2)(2011-1#1)
of an effective##4##3##(1996-3#1)(1997-6#1)(2012-3#1)(2013-1#1)
of an efficient and##3##4##(1994-3#2)(2008-11#1)
of an efficient##7##3##(1993-9#1)(1994-3#2)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
of an eight-week##2##3##(1990-2#1)(2011-1#1)
of an elderly##4##3##(1994-12#1)(2010-7#1)(2012-12#2)
of an electric##3##3##(2007-11#1)(2008-11#2)
of an electrochemical##4##3##(2008-10#4)
of an electrode##3##3##(2008-10#3)
of an electron##2##3##(2008-10#2)
of an electronic##4##3##(1991-8#1)(2008-10#2)(2009-10#1)
of an elevated blood pressure in the acute phase of a cerebral infarction is##2##14##(1997-5#2)
of an elliptic retarder##2##4##(2008-3#2)
of an emergency##4##3##(1997-2#1)(2008-3#2)(2010-1#1)
of an endogenous EAA##2##4##(1994-11#2)
of an endogenous##4##3##(1990-5#1)(1994-11#2)(1996-12#1)
of an enormous##2##3##(2008-10#1)(2013-1#1)
of an enzyme##6##3##(1992-3#1)(2008-10#4)(2009-5#1)
of an enzyme-linked immunosorbent assay (ELISA) for##2##7##(2008-10#1)(2011-2#1)
of an enzyme-linked immunosorbent assay (ELISA)##3##6##(2008-10#2)(2011-2#1)
of an enzyme-linked immunosorbent assay##4##5##(2008-10#2)(2011-2#2)
of an epidemic##3##3##(1996-11#1)(2008-10#2)
of an epidemiological##2##3##(2008-7#1)(2011-2#1)
of an essential##2##3##(1995-6#1)(2008-8#1)
of an evidence-based##3##3##(2008-8#1)(2013-1#2)
of an exact##2##3##(2008-3#1)(2012-3#1)
of an excess of##5##4##(1991-12#1)(2008-10#4)
of an exogenous##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
of an expanding##2##3##(2008-10#2)
of an experimental##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
of an extended##2##3##(1992-4#1)(1993-3#1)
of an extensive##4##3##(1996-11#1)(1996-3#1)(1997-2#1)(2008-10#1)
of an extract##2##3##(1993-2#1)(2008-10#1)
of an extraction##4##3##(2008-10#4)
of an extradural##2##3##(2008-7#2)
of an iatrogenic##2##3##(1991-6#1)(2008-12#1)
of an imaging##3##3##(2007-12#2)(2008-2#1)
of an immobilised##3##3##(2008-10#3)
of an immobilized##2##3##(1990-5#1)(2008-10#1)
of an important##5##3##(1996-5#1)(2008-10#2)(2008-7#1)(2013-1#1)
of an improved##3##3##(1996-12#1)(2008-10#2)
of an in vitro##8##4##(1990-12#1)(2008-11#2)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
of an in##9##3##(1990-12#1)(2008-11#2)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
of an inactivated##2##3##(2008-5#2)
of an incident##2##3##(2008-2#1)(2008-3#1)
of an increase in the##3##5##(1997-1#1)(2008-9#1)(2011-1#1)
of an increase in##4##4##(1997-1#2)(2008-9#1)(2011-1#1)
of an increase##5##3##(1997-1#2)(2008-9#1)(2010-11#1)(2011-1#1)
of an increased##2##3##(1991-12#1)(2008-5#1)
of an increasing##2##3##(1997-4#1)(2011-2#1)
of an independent##6##3##(1993-12#1)(1993-3#1)(1995-5#1)(2008-10#2)(2008-11#1)
of an indirect##2##3##(1996-12#1)(2008-10#1)
of an individual##15##3##(1990-9#1)(1993-3#1)(2008-10#5)(2008-12#1)(2008-7#2)(2008-8#2)(2011-1#2)(2012-2#1)
of an individual's##4##3##(1995-2#1)(2008-5#1)(2009-10#1)(2013-8#1)
of an inexpensive##2##3##(2008-10#2)
of an infant with##2##4##(2012-2#1)(2012-3#1)
of an infant##6##3##(1991-2#1)(1993-12#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
of an infected##2##3##(2011-3#2)
of an infection of##2##4##(2008-11#1)(2010-12#1)
of an infection##4##3##(2008-11#2)(2010-12#1)(2010-5#1)
of an infectious##4##3##(1990-12#1)(2008-10#3)
of an inflammatory##2##3##(1994-11#1)(1996-3#1)
of an inherent safety approach##2##5##(2009-10#2)
of an inherent##3##3##(2008-11#1)(2009-10#2)
of an inhibitor of##2##4##(2008-10#1)(2011-2#1)
of an initial##5##3##(1994-3#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
of an initiative##2##3##(2008-10#1)(2008-11#1)
of an injection##2##3##(2008-10#1)(2011-2#1)
of an inner##2##3##(2008-10#1)(2011-2#1)
of an innovative education##2##4##(2008-12#1)(2008-6#1)
of an innovative##8##3##(1994-2#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-6#1)(2013-1#1)
of an inorganic##3##3##(2008-10#2)(2010-6#1)
of an instrument##4##3##(1997-1#2)(2009-12#1)(2012-2#1)
of an insulin##2##3##(1996-3#1)(2008-12#1)
of an integrated approach to##2##5##(2008-10#1)(2008-11#1)
of an integrated management##3##4##(2008-10#3)
of an integrated##22##3##(1992-3#1)(1996-3#1)(2007-9#1)(2008-10#11)(2008-11#3)(2008-3#1)(2010-5#1)(2011-1#2)(2013-8#1)
of an interaction##2##3##(2009-7#1)(2011-2#1)
of an interdisciplinary approach in##2##5##(1997-8#1)(2008-4#1)
of an interdisciplinary##3##3##(1997-8#1)(2008-4#1)(2011-2#1)
of an interfood interval##2##4##(2008-5#2)
of an intermediate##2##3##(2008-10#2)
of an internal##2##3##(1993-8#1)(2011-2#1)
of an international##6##3##(1993-1#2)(1994-2#1)(1995-12#1)(1995-9#1)(2008-10#1)
of an intervention##5##3##(1991-2#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#1)
of an intracranial##3##3##(1992-6#1)(2008-7#2)
of an introduced##3##3##(2008-10#2)(2012-3#1)
of an ion associate##2##4##(2008-10#2)
of an ion mobility spectrometer##2##5##(2008-10#2)
of an ion##7##3##(2008-10#7)
of an ion-selective##2##3##(2008-10#2)
of an isolate of##2##4##(2008-10#1)(2008-5#1)
of an isolate##3##3##(2008-10#2)(2008-5#1)
of an isolated##2##3##(2012-3#1)(2013-1#1)
of an iterative##3##3##(1992-9#1)(2008-3#2)
of an mRNA##2##3##(2011-2#1)(2012-3#1)
of an object recognition##2##4##(2008-6#2)
of an object##5##3##(1996-2#2)(2008-3#1)(2008-6#2)
of an oil spill##2##4##(2008-10#1)(2008-11#1)
of an oil##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
of an old##2##3##(2008-10#1)(2008-5#1)
of an on-line preconcentration system for##3##6##(2008-10#3)
of an on-line preconcentration##4##4##(2008-10#4)
of an on-line##10##3##(1997-2#1)(2008-10#9)
of an ongoing##3##3##(1996-6#1)(2008-10#1)(2008-7#1)
of an open reading frame (ORF)##3##6##(1993-12#1)(1996-8#1)(2008-10#1)
of an open reading frame##4##5##(1993-12#1)(1996-8#1)(2008-10#2)
of an open##9##3##(1990-12#1)(1991-8#1)(1993-12#1)(1996-8#1)(2008-10#3)(2008-3#1)(2013-1#1)
of an operation##2##3##(2012-12#1)(2013-1#1)
of an optical biosensor##3##4##(2008-10#3)
of an optical##15##3##(1992-11#1)(2008-10#6)(2008-3#7)(2009-5#1)
of an optically thick##2##4##(2008-3#2)
of an optically##3##3##(2007-12#1)(2008-3#2)
of an optimal##2##3##(2011-3#1)(2013-8#1)
of an oral##2##3##(1991-2#1)(2008-11#1)
of an organic modifier##2##4##(2008-10#2)
of an organic reducing reagent##2##5##(2008-10#2)
of an organic##6##3##(2008-10#5)(2008-5#1)
of an organically modified##2##4##(2008-10#2)
of an organism##2##3##(1995-8#1)(2008-10#1)
of an organization's##2##3##(1993-3#1)(2010-8#1)
of an otherwise##2##3##(1994-9#1)(1997-3#1)
of an outbreak##2##3##(1996-2#1)(2008-12#1)
of an overall##2##3##(1992-2#1)(1996-3#1)
of an oxidative stress##2##4##(2008-10#1)(2010-12#1)
of an ultrasonic##2##3##(2008-10#2)
of an understanding regarding##2##4##(2008-4#1)(2013-1#1)
of an unfavorable##2##3##(2012-3#1)(2013-1#1)
of an unknown##3##3##(2008-10#2)(2008-3#1)
of an unstable##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
of an unusual##2##3##(1990-9#1)(2008-10#1)
of an upper##2##3##(2008-11#1)(2011-2#1)
of an urban##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
of an##1186##2##(1990-10#2)(1990-11#5)(1990-12#6)(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#2)(1990-8#1)(1990-9#5)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#8)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#5)(1993-1#4)(1993-12#10)(1993-2#4)(1993-3#6)(1993-5#1)(1993-6#1)(1993-8#8)(1993-9#2)(1994-1#2)(1994-11#8)(1994-12#3)(1994-2#8)(1994-3#5)(1994-5#9)(1994-6#3)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#3)(1996-1#4)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#10)(1996-5#9)(1996-6#3)(1996-8#2)(1997-1#6)(1997-2#8)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#6)(1997-7#4)(1997-8#4)(2007-11#4)(2007-12#11)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#342)(2008-11#67)(2008-12#24)(2008-2#10)(2008-3#67)(2008-4#14)(2008-5#32)(2008-6#9)(2008-7#26)(2008-8#27)(2008-9#18)(2009-1#3)(2009-10#8)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#4)(2009-8#5)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#6)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#7)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#11)(2011-10#2)(2011-2#45)(2011-3#5)(2012-12#15)(2012-2#19)(2012-3#25)(2013-1#50)(2013-8#11)
of anabolic##3##2##(1991-3#1)(2008-10#1)(2012-2#1)
of anaerobic bacteria##2##3##(2011-1#2)
of anaerobic##6##2##(1997-4#1)(2008-2#1)(2011-1#2)(2012-3#1)(2013-1#1)
of anaesthesia##8##2##(1994-3#1)(1996-6#1)(2010-7#2)(2011-2#4)
of anaesthetic##3##2##(1991-6#1)(2010-7#1)(2011-1#1)
of anal canal##2##3##(2013-1#2)
of analgesia##3##2##(2012-3#3)
of analgesic##2##2##(2008-10#1)(2008-12#1)
of analgesics##3##2##(2008-11#1)(2010-11#1)(2012-3#1)
of analogous##2##2##(1994-5#1)(2008-10#1)
of analogs##2##2##(1990-5#1)(1994-8#1)
of analogues of##2##3##(1994-8#1)(2008-4#1)
of analyses##7##2##(1993-12#1)(2008-10#4)(2008-9#2)
of analysing the##4##3##(2008-10#3)(2008-11#1)
of analysing##7##2##(2008-10#4)(2008-11#2)(2008-12#1)
of analysis and##5##3##(2008-10#5)
of analysis are##2##3##(1994-9#1)(2008-10#1)
of analysis for##3##3##(2008-10#2)(2008-9#1)
of analysis in##2##3##(2008-10#1)(2011-2#1)
of analysis is##6##3##(2008-10#3)(2008-9#2)(2011-2#1)
of analysis of the##3##4##(1995-6#1)(2008-10#1)(2013-8#1)
of analysis of variance##2##4##(2008-10#1)(2008-7#1)
of analysis of##13##3##(1993-2#1)(1995-6#1)(2008-10#7)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
of analysis was##3##3##(2008-10#3)
of analysis##62##2##(1990-2#1)(1991-6#1)(1993-2#1)(1994-9#1)(1995-6#1)(1996-6#1)(2008-10#42)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#5)(2011-2#2)(2012-3#1)(2013-8#2)
of analyte concentrations##3##3##(2008-10#3)
of analyte extraction from##2##4##(2008-10#2)
of analyte extraction##3##3##(2008-10#3)
of analyte ions in##2##4##(2008-10#2)
of analyte ions##4##3##(2008-10#4)
of analyte molecules##2##3##(2008-10#2)
of analyte##29##2##(2008-10#28)(2008-4#1)
of analytes in the##3##4##(2008-10#3)
of analytes in##7##3##(2008-10#6)(2008-4#1)
of analytes is##3##3##(2008-10#3)
of analytes were##3##3##(2008-10#3)
of analytes##34##2##(2008-10#33)(2008-4#1)
of analytical and##7##3##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
of analytical chemistry##4##3##(2008-10#1)(2008-11#1)(2010-7#2)
of analytical information##2##3##(1992-2#1)(2008-10#1)
of analytical methodology##2##3##(2008-10#2)
of analytical methods##5##3##(2008-10#5)
of analytical procedures##3##3##(1992-3#1)(2008-10#2)
of analytical results##2##3##(2008-10#2)
of analytical signals in##2##4##(2007-11#1)(2008-10#1)
of analytical signals##3##3##(2007-11#1)(2008-10#2)
of analytical steps##2##3##(2008-10#2)
of analytical techniques and instruments##2##5##(2008-10#2)
of analytical techniques##4##3##(2008-10#4)
of analytical##66##2##(1992-2#1)(1992-3#1)(1996-3#1)(2007-11#2)(2008-10#49)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)(2010-7#3)(2011-2#1)(2012-2#1)(2013-8#1)
of analyzed##2##2##(2008-10#1)(2013-1#1)
of analyzing the##2##3##(1990-6#1)(1993-2#1)
of analyzing##5##2##(1990-6#1)(1993-2#1)(2008-10#2)(2013-1#1)
of anamorph##3##2##(2008-10#3)
of anaphylaxis##5##2##(1992-6#1)(2010-6#1)(2012-3#1)(2013-1#2)
of anaplastic transformation##2##3##(2008-12#2)
of anaplastic##3##2##(2008-12#3)
of anastomosis group##2##3##(2008-10#2)
of anastomosis##4##2##(1992-9#1)(2008-10#3)
of anatomic##6##2##(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2011-2#1)
of anatomical and##2##3##(2011-2#1)(2013-1#1)
of anatomical##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
of anatomically reduced##2##3##(2013-1#2)
of anatomically##6##2##(1994-3#1)(2009-6#1)(2013-1#4)
of anatomy and##2##3##(2011-2#1)(2013-1#1)
of anatomy##3##2##(2009-9#1)(2011-2#1)(2013-1#1)
of ancestral##5##2##(1997-6#1)(2008-10#2)(2008-12#1)(2008-8#1)
of anchorage-dependent cells##4##3##(2008-11#4)
of anchorage-dependent##6##2##(2008-11#6)
of ancient ceramic##2##3##(2008-10#2)
of ancient##10##2##(1991-5#1)(2008-10#9)
of ancillary##3##2##(1996-1#2)(2008-10#1)
of and risk factors for##2##5##(2009-8#1)(2012-3#1)
of and the##2##3##(1996-2#1)(2011-2#1)
of and##27##2##(1991-2#1)(1991-3#2)(1994-5#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)
of androgen receptor expression##2##4##(1991-5#2)
of androgen receptor##5##3##(1990-11#1)(1991-5#3)(1995-12#1)
of androgen##9##2##(1990-11#2)(1991-5#3)(1993-8#1)(1995-12#2)(2008-6#1)
of androgens in##2##3##(1994-8#1)(2012-3#1)
of androgens to##2##3##(1990-11#1)(2011-1#1)
of androgens##6##2##(1990-11#1)(1994-8#1)(2008-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
of androids##2##2##(2008-11#2)
of anemia in##2##3##(2011-2#1)(2012-12#1)
of anemia was##2##3##(2011-2#2)
of anemia##11##2##(1996-2#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-12#1)
of anergy##2##2##(2008-11#2)
of anesthesia##8##2##(1993-1#1)(2010-8#2)(2012-3#5)
of anesthesia-induced modest hypothermia##2##4##(2008-9#2)
of anesthetic##6##2##(1993-1#1)(2010-8#2)(2012-3#3)
of anesthetics##3##2##(1995-12#3)
of anesthetized##3##2##(1994-11#1)(1997-2#1)(2012-3#1)
of aneuploidy##2##2##(1991-6#1)(2012-3#1)
of aneurysm##4##2##(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of aneurysmal bone##2##3##(2012-12#1)(2013-1#1)
of aneurysmal##3##2##(2011-3#1)(2012-12#1)(2013-1#1)
of aneurysms##3##2##(2010-7#1)(2013-8#2)
of angina##3##2##(1996-3#1)(2008-3#1)(2010-8#1)
of angiogenesis inhibitors##2##3##(1994-12#1)(1997-1#1)
of angiogenesis is##2##3##(2008-1#1)(2013-8#1)
of angiogenesis##7##2##(1994-12#1)(1997-1#1)(2008-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
of angiogenic inhibitors##3##3##(2008-1#3)
of angiogenic##5##2##(2008-1#3)(2009-8#1)(2012-3#1)
of angiographic##5##2##(1991-2#1)(1997-3#2)(2012-3#2)
of angiosperm plant orders##2##4##(2008-10#2)
of angiosperms##2##2##(2008-10#1)(2009-8#1)
of angiotensin II analogues##2##4##(1991-5#2)
of angiotensin II##6##3##(1991-5#3)(1994-8#3)
of angiotensin##8##2##(1991-5#3)(1994-2#1)(1994-8#4)
of angle##2##2##(2008-3#2)
of angry##3##2##(2008-11#2)(2009-4#1)
of angular leaf spot and##2##5##(2008-10#2)
of angular leaf spot##3##4##(2008-10#3)
of angular##8##2##(2008-10#3)(2008-3#2)(2012-2#1)(2013-1#2)
of aniline in##2##3##(2008-10#2)
of aniline##6##2##(2008-10#6)
of animal and human##2##4##(2008-2#1)(2009-7#1)
of animal and plant cells##2##5##(2008-11#1)(2009-8#1)
of animal and plant##3##4##(2008-11#1)(2009-8#1)(2011-2#1)
of animal and##6##3##(2008-11#1)(2008-2#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
of animal behavior##2##3##(2008-11#2)
of animal cell culture##4##4##(2008-11#4)
of animal cell##7##3##(2008-11#6)(2009-8#1)
of animal cells##6##3##(2008-10#1)(2008-11#3)(2008-8#1)(2013-1#1)
of animal feeds##2##3##(2008-10#2)
of animal models of infection for the evaluation of##2##9##(2008-7#2)
of animal models of##3##4##(1992-9#1)(2008-7#2)
of animal models##4##3##(1992-9#1)(1997-7#1)(2008-7#2)
of animal origin and##2##4##(2008-10#1)(2011-1#1)
of animal origin##7##3##(2008-10#1)(2008-11#3)(2009-8#1)(2011-1#1)(2013-8#1)
of animal##60##2##(1992-6#1)(1992-9#1)(1994-2#1)(1997-7#5)(2008-10#9)(2008-11#20)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#3)(2011-1#1)(2011-2#6)(2013-1#1)(2013-8#2)
of animal-derived raw materials##2##4##(2008-11#2)
of animal-derived##4##2##(2008-11#4)
of animals and plants##2##4##(2008-10#1)(2008-8#1)
of animals and##5##3##(1997-7#1)(2007-12#1)(2008-10#2)(2008-8#1)
of animals in##2##3##(1992-12#1)(2008-10#1)
of animals to##3##3##(1991-2#1)(2008-8#2)
of animals was##2##3##(2008-11#1)(2011-2#1)
of animals##30##2##(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#1)(1996-12#2)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
of anion##4##2##(2008-10#3)(2011-2#1)
of anion-exchange##3##2##(1994-8#1)(2008-10#2)
of anionic additive##2##3##(2008-10#2)
of anionic and##3##3##(2008-10#3)
of anionic surfactants##6##3##(2008-10#4)(2008-5#2)
of anionic##21##2##(2008-10#17)(2008-12#2)(2008-5#2)
of anions and cations##3##4##(2008-10#3)
of anions and##4##3##(2008-10#4)
of anions in##2##3##(2008-10#2)
of anions##25##2##(1994-5#1)(2008-10#24)
of anisette samples##2##3##(2008-10#2)
of anisotropic##4##2##(2008-3#3)(2009-7#1)
of ankle fracture##2##3##(2009-1#2)
of ankle fractures##2##3##(2009-1#1)(2013-1#1)
of ankle sprain##2##3##(2011-2#1)(2013-1#1)
of ankle##13##2##(2009-1#3)(2009-7#1)(2011-2#7)(2013-1#2)
of ankylosing spondylitis##2##3##(2008-7#1)(2012-3#1)
of ankylosing##3##2##(1991-8#1)(2008-7#1)(2012-3#1)
of annexin V##2##3##(2006-6#1)(2008-11#1)
of annual clovers##2##3##(2011-2#2)
of annual##8##2##(2008-8#2)(2008-9#1)(2011-2#5)
of anodic##2##2##(2008-10#2)
of anomalies##2##2##(1997-4#1)(2010-6#1)
of another group##2##3##(1990-2#1)(2008-10#1)
of another person##2##3##(2008-11#1)(2008-9#1)
of another##24##2##(1990-2#1)(1991-2#1)(1991-6#1)(1993-2#2)(1993-6#1)(1993-9#1)(1995-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-1#1)
of antagonism between##2##3##(2008-10#2)
of antagonism##3##2##(2008-10#3)
of antagonistic##5##2##(2008-10#4)(2008-8#1)
of antenatal care##2##3##(2008-11#2)
of antenatal##4##2##(1996-8#1)(2008-11#2)(2012-3#1)
of antennal sensilla##2##3##(2007-12#2)
of antennal##3##2##(2007-12#2)(2008-9#1)
of anterior communicating artery##2##4##(2008-7#2)
of anterior##15##2##(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2011-2#3)(2013-1#3)
of anthazoline and naphazoline##2##4##(2008-10#2)
of anthelmintic##2##2##(1997-7#2)
of anthesis##3##2##(2008-10#3)
of anthracene##3##2##(2008-10#3)
of anthracnose##12##2##(2008-10#12)
of anthrax in##2##3##(1990-9#1)(1992-12#1)
of anthrax##5##2##(1990-9#2)(1992-12#1)(2009-10#1)(2011-2#1)
of anthropogenic##6##2##(2008-10#2)(2008-11#2)(2010-8#1)(2013-1#1)
of anthurium##4##2##(2008-10#4)
of anti-HIV natural compounds##2##4##(2011-3#2)
of anti-HIV##5##2##(2011-2#1)(2011-3#4)
of anti-HIV-1 drugs##3##3##(2011-2#2)(2011-3#1)
of anti-IgG##2##2##(2008-10#2)
of anti-Leishmania antibodies##2##3##(1996-12#1)(2012-2#1)
of anti-TNF therapies##2##3##(2011-2#2)
of anti-TNF##3##2##(2011-2#3)
of anti-TNF-alpha##3##2##(2008-10#1)(2010-12#2)
of anti-VEGF##2##2##(2011-2#1)(2013-8#1)
of anti-ageing##2##2##(2008-5#2)
of anti-cancer##2##2##(2008-11#2)
of anti-fibrotic##2##2##(2013-8#2)
of anti-inflammatory##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
of anti-nuclear antibodies##2##3##(1993-3#1)(2008-10#1)
of anti-nuclear##3##2##(1993-3#1)(2008-10#2)
of anti-oxidants##2##2##(2008-11#1)(2008-5#1)
of anti-peptide antisera##2##3##(1990-5#1)(2008-4#1)
of antibacterial agents##2##3##(1997-3#1)(2008-10#1)
of antibacterial##6##2##(1997-3#1)(1997-5#1)(2008-10#2)(2012-2#2)
of antibiotic and##2##3##(2008-9#1)(2010-10#1)
of antibiotic therapy##5##3##(1990-5#1)(1993-11#1)(2007-8#1)(2010-6#1)(2011-2#1)
of antibiotic treatment##2##3##(1995-9#1)(2008-10#1)
of antibiotic use##3##3##(1996-11#2)(2013-1#1)
of antibiotic##22##2##(1990-5#1)(1991-1#1)(1993-11#1)(1995-3#1)(1995-9#1)(1996-11#3)(1996-6#1)(2007-8#1)(2008-10#4)(2008-9#1)(2009-1#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
of antibiotics and##2##3##(2008-10#2)
of antibiotics are##2##3##(2011-2#1)(2013-1#1)
of antibiotics in##4##3##(1996-3#1)(2008-10#1)(2010-6#1)(2011-2#1)
of antibiotics##20##2##(1991-3#1)(1996-11#2)(1996-3#1)(2008-10#5)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
of antibodies against small##2##4##(2008-11#1)(2011-2#1)
of antibodies against the##2##4##(1995-12#1)(2011-2#1)
of antibodies against##11##3##(1993-3#1)(1995-12#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#3)(2012-3#1)
of antibodies and##2##3##(1995-2#1)(2008-10#1)
of antibodies that recognize##3##4##(2008-1#1)(2008-4#2)
of antibodies that##4##3##(2008-1#1)(2008-10#1)(2008-4#2)
of antibodies to##10##3##(1990-12#2)(1990-6#1)(1991-3#2)(1995-12#1)(2008-12#2)(2009-12#1)(2013-1#1)
of antibodies##45##2##(1990-12#4)(1990-6#1)(1991-3#2)(1993-3#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-6#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-4#5)(2008-9#1)(2009-12#1)(2009-3#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
of antibody avidity and##2##4##(1995-5#2)
of antibody for##2##3##(2008-11#1)(2008-9#1)
of antibody production in##2##4##(2008-11#2)
of antibody production was not##2##5##(2008-11#2)
of antibody production##13##3##(2008-10#1)(2008-11#12)
of antibody secretion##2##3##(2008-11#1)(2008-4#1)
of antibody to##3##3##(1991-3#1)(1996-12#1)(1997-2#1)
of antibody##41##2##(1990-5#1)(1991-3#2)(1995-11#1)(1995-5#2)(1996-12#1)(1997-2#1)(2006-6#1)(2008-10#9)(2008-11#16)(2008-4#2)(2008-9#4)(2011-2#1)
of antibody-antigen##2##2##(2008-10#1)(2008-7#1)
of anticancer drug##2##3##(2008-11#1)(2008-8#1)
of anticancer drugs##2##3##(2008-10#1)(2009-12#1)
of anticancer treatment##2##3##(2008-7#1)(2010-11#1)
of anticancer##9##2##(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#2)(2010-11#1)
of anticholinergic##2##2##(1990-3#1)(2008-5#1)
of anticoagulants in acute##3##4##(1993-12#2)(2012-12#1)
of anticoagulants in##4##3##(1993-12#2)(2012-12#2)
of anticoagulants##6##2##(1993-12#2)(2012-12#4)
of anticoagulation in##2##3##(1992-1#1)(1995-11#1)
of anticoagulation##4##2##(1992-1#1)(1995-11#1)(1997-3#1)(2008-5#1)
of anticonvulsant##3##2##(1992-3#1)(2008-5#1)(2010-4#1)
of antidepressant drugs##2##3##(1990-5#1)(2008-10#1)
of antidepressant##3##2##(1990-5#1)(2008-10#1)(2010-4#1)
of antidepressants##4##2##(2008-11#2)(2012-2#1)(2012-3#1)
of antiendomysial##2##2##(2008-10#2)
of antiestrogen##2##2##(2008-11#2)
of antiestrogens##5##2##(2008-10#2)(2008-11#3)
of antifouling agent##3##3##(2008-10#3)
of antifouling##4##2##(2008-10#3)(2008-11#1)
of antifungal compounds##2##3##(2008-10#2)
of antifungal therapy##2##3##(2008-12#1)(2011-2#1)
of antifungal##11##2##(2008-10#7)(2008-12#1)(2011-2#3)
of antigen in the##2##4##(2008-10#2)
of antigen in##4##3##(2008-10#4)
of antigen presentation by##2##4##(1995-5#1)(2008-11#1)
of antigen##26##2##(1990-12#1)(1993-3#1)(1994-3#1)(1995-5#2)(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#4)(2008-11#9)(2008-9#2)(2012-12#1)(2012-2#2)
of antigen-specific T cells##4##4##(2008-11#1)(2008-4#1)(2012-12#1)(2013-8#1)
of antigen-specific human B##2##4##(2008-11#2)
of antigen-specific##9##2##(2008-10#1)(2008-11#4)(2008-4#1)(2012-12#2)(2013-8#1)
of antigenic##5##2##(1995-2#1)(1996-12#1)(2008-5#2)(2012-2#1)
of antigens##5##2##(2008-10#2)(2008-4#1)(2008-9#2)
of antihypertensive drugs##2##3##(1992-11#1)(1996-6#1)
of antihypertensive treatment##2##3##(1997-8#1)(2008-10#1)
of antihypertensive##7##2##(1992-11#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2010-1#2)
of antimicrobial activity##3##3##(1994-11#1)(1994-5#1)(2008-10#1)
of antimicrobial agents have been##2##5##(2008-7#1)(2013-1#1)
of antimicrobial agents##10##3##(2008-11#1)(2008-7#5)(2011-2#1)(2013-1#3)
of antimicrobial compounds##2##3##(2008-11#1)(2009-6#1)
of antimicrobial resistance##3##3##(1996-11#1)(2013-1#1)(2013-8#1)
of antimicrobial therapy##5##3##(2008-10#1)(2008-7#1)(2011-2#3)
of antimicrobial##31##2##(1991-3#1)(1994-11#1)(1994-5#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-7#7)(2009-6#2)(2011-2#5)(2012-3#1)(2013-1#7)(2013-8#1)
of antimony and bismuth##2##4##(2008-10#2)
of antimony and##3##3##(2008-10#3)
of antimony by##5##3##(2008-10#5)
of antimony in##13##3##(2008-10#13)
of antimony##26##2##(2008-10#26)
of antimony(III) and antimony(V)##3##4##(2008-10#3)
of antimony(III) in##3##3##(2008-10#3)
of antimony(III)##7##2##(2008-10#7)
of antioxidant activity##2##3##(2008-10#1)(2013-8#1)
of antioxidant and##2##3##(2008-12#1)(2009-8#1)
of antioxidant enzymes##2##3##(1990-3#1)(2010-5#1)
of antioxidant vitamins##2##3##(1992-9#2)
of antioxidant##17##2##(1990-3#1)(1991-12#1)(1992-9#2)(2008-10#7)(2008-12#1)(2009-8#2)(2010-5#1)(2011-2#1)(2013-8#1)
of antioxidants in##2##3##(2008-10#1)(2010-5#1)
of antioxidants##14##2##(1992-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-8#2)(2010-5#3)(2011-2#1)
of antiperspirant##2##2##(2008-5#2)
of antiperspirants##3##2##(2008-5#3)
of antiplatelet##4##2##(1991-11#1)(2008-8#1)(2011-2#2)
of antipsychotic drugs##2##3##(1992-6#1)(2008-11#1)
of antipsychotic##3##2##(1992-6#1)(2008-11#1)(2008-4#1)
of antiretroviral##5##2##(1990-8#1)(2008-11#2)(2010-11#1)(2011-2#1)
of antisense RNA##2##3##(2008-10#1)(2008-8#1)
of antisense oligonucleotide##4##3##(2008-11#4)
of antisense##10##2##(1994-5#1)(1996-12#1)(2008-10#2)(2008-11#4)(2008-8#1)(2009-10#1)
of antisocial behavior##3##3##(2008-11#2)(2012-12#1)
of antithrombotic##2##2##(2008-9#1)(2013-1#1)
of antitrypsin##2##2##(1993-2#2)
of antituberculous##3##2##(1996-3#1)(2007-8#1)(2009-8#1)
of antitumor##4##2##(1991-8#1)(1994-5#1)(2008-5#2)
of antiviral##5##2##(2011-2#2)(2011-3#1)(2013-1#2)
of ants##2##2##(2008-10#2)
of anxiety and##3##3##(2008-11#1)(2008-4#1)(2009-7#1)
of anxiety disorders##4##3##(1991-2#2)(2009-6#1)(2013-8#1)
of anxiety in##2##3##(2010-12#1)(2012-2#1)
of anxiety symptoms##4##3##(2012-2#4)
of anxiety to##2##3##(2008-4#1)(2013-1#1)
of anxiety##26##2##(1991-2#2)(1993-3#1)(1995-1#1)(2008-11#3)(2008-4#2)(2009-12#1)(2009-6#1)(2009-7#3)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
of anxiolytic drugs##2##3##(1990-11#1)(1993-3#1)
of anxious##2##2##(2009-12#1)(2009-6#1)
of any additional##2##3##(2008-10#1)(2011-2#1)
of any combination##2##3##(2008-10#1)(2013-1#1)
of any effect##2##3##(1991-3#1)(1993-11#1)
of any effort##2##3##(1993-3#1)(1997-3#1)
of any given##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
of any of the##7##4##(1992-5#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)
of any of these##2##4##(2008-10#1)(2012-2#1)
of any of##9##3##(1992-5#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
of any one##4##3##(1991-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
of any other##2##3##(2007-12#1)(2010-7#1)
of any particular##2##3##(2008-4#1)(2013-1#1)
of any##116##2##(1990-5#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-9#1)(1995-3#2)(1996-3#1)(1997-3#2)(1997-8#1)(2007-12#2)(2008-10#26)(2008-11#7)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
of aorta##5##2##(2008-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
of aortic aneurysm##2##3##(1991-8#1)(2009-10#1)
of aortic##12##2##(1991-8#1)(1997-8#2)(2008-12#2)(2008-8#1)(2009-10#2)(2010-12#1)(2012-2#1)(2013-1#1)(2013-3#1)
of aorto-iliac##2##2##(1997-8#1)(2011-2#1)
of aphid##6##2##(1996-12#1)(2008-10#5)
of aphids##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
of apical##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
of apitherapy##2##2##(2008-10#2)
of apo B and##2##4##(1994-11#1)(1995-8#1)
of apo##4##2##(1991-12#1)(1994-11#1)(1995-8#1)(2012-2#1)
of apo(a)##2##2##(1993-2#1)(1996-8#1)
of apolipoprotein B##3##3##(1992-12#1)(1995-2#1)(1997-8#1)
of apolipoprotein E##2##3##(2008-10#1)(2008-7#1)
of apolipoprotein##6##2##(1992-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
of apomorphine##3##2##(1995-2#1)(1997-2#2)
of apoptosis and necrosis##2##4##(2008-11#1)(2013-1#1)
of apoptosis and##9##3##(1995-12#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-9#1)(2013-1#1)
of apoptosis by##2##3##(2008-8#1)(2009-3#1)
of apoptosis in the##6##4##(1995-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
of apoptosis in##12##3##(1994-11#1)(1995-12#1)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
of apoptosis induction##2##3##(2008-12#2)
of apoptosis of##4##3##(1995-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
of apoptosis##68##2##(1993-8#3)(1994-11#1)(1995-12#2)(1995-2#2)(1996-2#1)(2008-10#3)(2008-11#13)(2008-12#5)(2008-5#1)(2008-7#7)(2008-8#6)(2008-9#10)(2009-12#2)(2009-3#1)(2009-9#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
of apoptotic bodies##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
of apoptotic cell death##6##4##(1995-2#1)(1995-6#1)(1995-8#2)(2008-11#1)(2011-2#1)
of apoptotic cell##7##3##(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(2008-11#1)(2011-2#1)
of apoptotic cells##9##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#1)(2010-1#1)(2011-2#1)
of apoptotic##25##2##(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#1)(2011-2#2)(2012-3#1)
of apothecia by##2##3##(2008-10#2)
of apothecia of##2##3##(2008-10#2)
of apothecia##17##2##(2008-10#17)
of apothecial development##2##3##(2008-10#2)
of apothecial##3##2##(2008-10#3)
of apothecium development##2##3##(2008-10#2)
of apothecium##3##2##(2008-10#3)
of apparent##10##2##(1991-5#1)(1991-9#1)(1996-5#1)(2008-10#4)(2008-11#1)(2009-11#1)(2011-2#1)
of appearance of##3##3##(1993-12#1)(1994-8#1)(2009-8#1)
of appearance##5##2##(1992-12#1)(1993-12#1)(1994-8#1)(2008-11#1)(2009-8#1)
of appearing##2##2##(2008-10#1)(2011-7#1)
of appendectomy##3##2##(2008-10#2)(2012-12#1)
of appendiceal Crohn's disease##3##4##(2011-2#3)
of appendiceal masses##2##3##(2008-12#2)
of appendiceal##6##2##(1990-3#1)(2008-12#2)(2011-2#3)
of apple and##4##3##(2008-10#4)
of apple in##5##3##(2008-10#5)
of apple leaves##2##3##(2008-10#2)
of apple replant disease in##2##5##(2008-10#2)
of apple replant disease##5##4##(2008-10#5)
of apple seedlings grown in##3##5##(2008-10#3)
of apple seedlings##4##3##(2008-10#4)
of apple stem grooving capillovirus##2##5##(2008-10#2)
of apple was##2##3##(2008-10#2)
of apple##50##2##(1990-9#2)(1997-2#1)(2008-10#47)
of apples##6##2##(2008-10#6)
of applicability##2##2##(2008-10#1)(2008-9#1)
of application and##2##3##(2008-10#2)
of application in##5##3##(2008-10#1)(2008-9#4)
of application of##6##3##(1995-5#1)(2008-10#4)(2008-7#1)
of application to##2##3##(1996-3#1)(2008-5#1)
of application##29##2##(1991-3#1)(1993-8#1)(1995-5#1)(1996-3#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#5)(2013-1#1)
of applications for##3##3##(1993-6#1)(2008-11#1)(2008-3#1)
of applications in##3##3##(2008-10#2)(2008-9#1)
of applications of##5##3##(1997-7#1)(2008-4#1)(2010-12#1)(2012-2#2)
of applications##26##2##(1993-6#1)(1995-1#1)(1996-1#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#2)(2012-2#3)(2013-1#2)
of applied current##3##3##(2008-10#2)(2009-12#1)
of applied potential##2##3##(2008-10#2)
of applied voltage##2##3##(2008-10#2)
of applied##13##2##(2008-10#8)(2008-5#1)(2009-12#2)(2010-10#1)(2010-8#1)
of applying the##3##3##(2008-10#2)(2008-9#1)
of applying##14##2##(1996-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
of appressoria was##2##3##(2008-10#2)
of appressoria##8##2##(2008-10#8)
of appressorium formation by the##2##5##(2008-10#2)
of appressorium formation by##3##4##(2008-10#3)
of appressorium formation##4##3##(2008-10#4)
of approach##3##2##(1995-11#1)(2008-8#1)(2013-1#1)
of approaches have been proposed##2##5##(2008-10#1)(2012-3#1)
of approaches have been##5##4##(2008-10#2)(2008-11#1)(2010-8#1)(2012-3#1)
of approaches to##3##3##(2008-9#1)(2010-11#1)(2010-7#1)
of approaches##13##2##(1993-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#2)(2010-7#1)(2010-8#1)(2012-3#2)
of appropriate standards##2##3##(2008-4#1)(2008-6#1)
of appropriate##37##2##(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#2)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#1)
of approx##7##2##(1993-12#2)(1993-6#1)(1997-7#2)(2008-5#1)(2011-2#1)
of approximately 0##5##3##(2008-10#1)(2008-11#3)(2008-2#1)
of approximately 1##7##3##(1990-8#1)(1991-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
of approximately 10##5##3##(1991-8#1)(1997-7#1)(2008-5#1)(2009-5#1)(2012-3#1)
of approximately 13##2##3##(2008-7#1)(2008-9#1)
of approximately 15##3##3##(2008-10#2)(2008-3#1)
of approximately 18##3##3##(2008-10#3)
of approximately 2##2##3##(2008-11#1)(2008-3#1)
of approximately 20##4##3##(1997-7#1)(2008-10#1)(2008-2#1)(2008-9#1)
of approximately 200##3##3##(1996-12#1)(2008-10#1)(2009-5#1)
of approximately 23##2##3##(2008-10#1)(2008-11#1)
of approximately 300##2##3##(1991-3#1)(2009-12#1)
of approximately 4##4##3##(1990-5#1)(2008-10#1)(2008-3#1)(2009-7#1)
of approximately 40##4##3##(1992-10#1)(2008-11#2)(2008-8#1)
of approximately 5 x##2##4##(2008-11#1)(2008-3#1)
of approximately 5##7##3##(1993-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
of approximately 50##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
of approximately 6##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
of approximately 60##2##3##(1991-12#1)(2008-10#1)
of approximately 7##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
of approximately 8##5##3##(1991-2#1)(2008-11#1)(2008-3#1)(2008-9#2)
of approximately 80%##2##3##(2008-10#2)
of approximately 90##2##3##(2008-10#2)
of approximately two##2##3##(1991-6#1)(2013-1#1)
of approximately##128##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-7#2)(1997-8#1)(2008-10#41)(2008-11#14)(2008-2#8)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#7)(2009-12#1)(2009-5#3)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of aptamers##5##2##(2008-4#1)(2010-5#2)(2010-7#2)
of aquatic humic substances##3##4##(2008-10#3)
of aquatic humic##6##3##(2008-10#6)
of aquatic##10##2##(1992-5#1)(2008-10#8)(2009-3#1)
of aqueous and##2##3##(2008-10#2)
of aqueous phase##7##3##(2008-10#7)
of aqueous sample solution##2##4##(2008-10#2)
of aqueous sample##4##3##(2008-10#4)
of aqueous solution##3##3##(2008-10#3)
of aqueous solutions of various##2##5##(2008-10#2)
of aqueous solutions of##4##4##(2008-10#4)
of aqueous solutions##8##3##(2008-10#7)(2008-5#1)
of aqueous standards##4##3##(2008-10#4)
of aqueous##49##2##(1995-3#1)(2008-10#41)(2008-12#3)(2008-3#1)(2008-5#2)(2009-5#1)
of arachidonate release from##3##4##(2008-11#3)
of arachidonic acid and##2##4##(1993-8#1)(2013-1#1)
of arachidonic acid##10##3##(1991-12#1)(1992-12#1)(1993-8#1)(1994-5#2)(1997-1#1)(2008-11#2)(2009-8#1)(2013-1#1)
of arachidonic##11##2##(1991-12#1)(1992-12#1)(1993-8#1)(1994-5#3)(1997-1#1)(2008-11#2)(2009-8#1)(2013-1#1)
of arbitrary##4##2##(1992-9#1)(2007-11#1)(2008-6#1)(2009-7#1)
of archaeological bones for reconstruction of paleodiet##2##7##(2008-10#2)
of archaeological##6##2##(2008-10#5)(2012-9#1)
of architectural##2##2##(1991-12#1)(2009-12#1)
of archival##3##2##(1992-1#1)(1994-11#1)(2008-10#1)
of area and temperature##2##4##(2008-9#2)
of area and##3##3##(2008-12#1)(2008-9#2)
of area##7##2##(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#3)
of areas as##2##3##(1991-12#1)(2008-11#1)
of areas##7##2##(1991-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
of arginase##2##2##(1992-5#1)(2013-8#1)
of arginine vasopressin##2##3##(2008-4#1)(2010-1#1)
of arginine##9##2##(1992-9#1)(1995-3#1)(1997-1#1)(2008-11#1)(2008-4#1)(2009-7#2)(2010-1#1)(2013-7#1)
of argon##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
of aristolochic##2##2##(2008-10#2)
of arm##2##2##(1990-11#1)(2013-8#1)
of aroma compounds in##2##4##(2008-10#2)
of aroma compounds##6##3##(2008-10#6)
of aroma##8##2##(2008-10#7)(2008-5#1)
of aromatase mRNA in##4##4##(1993-8#4)
of aromatase##6##2##(1993-8#5)(1994-2#1)
of aromatherapy##3##2##(2008-10#3)
of aromatic amino acids##2##4##(2008-10#2)
of aromatic compounds##4##3##(2008-10#2)(2008-11#1)(2011-1#1)
of aromatic##19##2##(1992-6#1)(1995-8#2)(2008-10#12)(2008-11#2)(2011-1#1)(2012-3#1)
of aromatics##2##2##(2008-10#2)
of around +/-2%##2##3##(2008-10#2)
of around##10##2##(1990-3#1)(1992-6#1)(2008-10#5)(2008-11#2)(2013-8#1)
of around-the-clock##2##2##(2008-11#1)(2013-1#1)
of arrays##2##2##(2008-4#1)(2009-12#1)
of arrhenotokous populations##2##3##(2008-10#2)
of arrhythmogenic##3##2##(1996-3#1)(2008-12#1)(2012-2#1)
of arsenate and##3##3##(2008-10#2)(2008-11#1)
of arsenate##6##2##(2008-10#5)(2008-11#1)
of arsenic (As) in##2##4##(2008-10#2)
of arsenic (As)##4##3##(2008-10#3)(2013-1#1)
of arsenic acid##2##3##(2008-10#2)
of arsenic and antimony in##2##5##(2008-10#2)
of arsenic and selenium##3##4##(2008-10#3)
of arsenic and##8##3##(1995-11#1)(2008-10#7)
of arsenic by##6##3##(2008-10#6)
of arsenic compounds from lichens##2##5##(2008-10#2)
of arsenic compounds in##5##4##(2008-10#5)
of arsenic compounds##7##3##(2008-10#7)
of arsenic in a##2##4##(1995-11#1)(2008-10#1)
of arsenic in aqueous samples##2##5##(2008-10#2)
of arsenic in environmental samples##3##5##(2008-10#3)
of arsenic in environmental##5##4##(2008-10#5)
of arsenic in ground water##2##5##(2008-10#2)
of arsenic in groundwater##2##4##(2008-10#2)
of arsenic in the##2##4##(1995-11#1)(2008-10#1)
of arsenic in##33##3##(1995-11#2)(2008-10#31)
of arsenic species in water samples##2##6##(2008-10#2)
of arsenic species in##6##4##(2008-10#6)
of arsenic species##11##3##(2008-10#11)
of arsenic was##2##3##(2008-10#2)
of arsenic were##3##3##(1995-11#1)(2008-10#2)
of arsenic##120##2##(1995-11#10)(2008-10#107)(2008-8#1)(2010-1#1)(2013-1#1)
of arsenic(III) and arsenic(V) by##2##5##(2008-10#2)
of arsenic(III) and arsenic(V)##4##4##(2008-10#4)
of arsenic(V) in##2##3##(2008-10#2)
of arsenite and arsenate##2##4##(2008-10#2)
of arsenite##10##2##(1994-11#1)(2008-10#9)
of arsenobetaine##3##2##(2008-10#3)
of art##14##2##(1993-2#1)(2008-10#11)(2008-11#1)(2013-1#1)
of artemether##2##2##(1994-8#2)
of artemisinin##3##2##(2008-10#3)
of arterial blood pressure##2##4##(1997-8#1)(2009-5#1)
of arterial hypertension##7##3##(2008-7#2)(2011-2#4)(2012-3#1)
of arterial thrombosis##2##3##(1990-9#1)(2011-2#1)
of arterial##22##2##(1990-11#1)(1990-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-7#2)(2009-1#1)(2009-5#1)(2009-7#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
of arteriosclerotic##2##2##(1991-3#1)(1997-3#1)
of arteriovenous malformation (AVM)##2##4##(2008-7#2)
of arteriovenous malformation##3##3##(2008-7#3)
of arteriovenous malformations (AVMs)##2##4##(2008-7#2)
of arteriovenous malformations##6##3##(2008-7#6)
of arteriovenous##11##2##(1991-11#1)(1996-9#1)(2008-7#9)
of arthritic##2##2##(2008-11#1)(2013-1#1)
of arthritis##6##2##(1991-8#1)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)
of arthrodesis##2##2##(2008-8#1)(2012-3#1)
of arthrogryposis##2##2##(2008-10#1)(2009-5#1)
of arthropod##2##2##(2007-12#1)(2011-2#1)
of arthropods##5##2##(1997-7#1)(2007-12#2)(2008-7#1)(2008-9#1)
of arthroscopic##2##2##(2008-8#1)(2013-1#1)
of arthroscopy##3##2##(2008-9#2)(2013-1#1)
of articles##4##2##(1991-11#1)(1993-12#1)(1996-3#1)(2012-2#1)
of articular surface##2##3##(2011-2#2)
of articular##10##2##(1991-11#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#4)(2013-1#1)
of articulating##2##2##(2008-12#1)(2011-2#1)
of artificial neural network##5##4##(2008-10#5)
of artificial neural networks##7##4##(2008-10#7)
of artificial neural##12##3##(2008-10#12)
of artificial surfaces##2##3##(2008-10#1)(2013-1#1)
of artificial##24##2##(1991-3#1)(1991-9#1)(1995-11#1)(2008-10#15)(2008-8#1)(2010-12#1)(2010-8#1)(2013-1#3)
of artificially inoculated##3##3##(2008-10#2)(2010-4#1)
of artificially##5##2##(2008-10#3)(2008-5#1)(2010-4#1)
of aryl##4##2##(1996-5#1)(2008-12#1)(2008-6#1)(2010-5#1)
of arylamine##2##2##(1991-5#1)(1993-3#1)
of aryldiamines##3##2##(2008-10#3)
of as little as##2##4##(2008-10#1)(2010-4#1)
of as many##5##3##(2008-10#3)(2008-12#1)(2012-2#1)
of as much as##6##4##(2007-11#1)(2007-12#2)(2008-3#2)(2012-2#1)
of as##18##2##(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-3#2)(2008-9#2)(2010-4#1)(2012-2#2)
of asbestos exposure##5##3##(1991-12#3)(2010-12#1)(2010-5#1)
of asbestos fibers##6##3##(1991-12#6)
of asbestos in##2##3##(1991-12#2)
of asbestos##22##2##(1991-12#18)(1992-1#1)(1995-2#1)(2010-12#1)(2010-5#1)
of asbestos-induced pleural fibrosis##2##4##(1991-12#2)
of asbestos-induced##3##2##(1991-12#3)
of asbestos-related pleural##2##3##(1991-12#2)
of asbestos-related##3##2##(1991-12#2)(1995-2#1)
of asbestosis##4##2##(1991-12#4)
of ascending##2##2##(1991-6#1)(2008-11#1)
of asci##4##2##(2008-10#4)
of ascites##2##2##(1991-12#1)(2011-2#1)
of ascitic##2##2##(2008-10#1)(2008-9#1)
of ascocarps on foliage##2##4##(2008-10#2)
of ascocarps##3##2##(2008-10#3)
of ascomycetes##2##2##(2008-10#2)
of ascorbate##12##2##(1990-9#2)(1993-8#1)(2008-10#7)(2008-11#1)(2009-9#1)
of ascorbic acid (AA) and##2##5##(2008-10#2)
of ascorbic acid (AA) in##2##5##(2008-10#2)
of ascorbic acid (AA)##7##4##(2008-10#7)
of ascorbic acid (AsA)##3##4##(2008-10#2)(2008-11#1)
of ascorbic acid and uric acid##3##6##(2008-10#3)
of ascorbic acid and##7##4##(2008-10#6)(2008-5#1)
of ascorbic acid at##2##4##(2008-10#2)
of ascorbic acid in Vitamin C tablets##2##7##(2008-10#2)
of ascorbic acid in##12##4##(1992-12#1)(2008-10#11)
of ascorbic acid on the BZ oscillating chemical system##2##9##(2008-10#2)
of ascorbic acid on the##3##5##(2008-10#3)
of ascorbic acid using##4##4##(2008-10#4)
of ascorbic acid was##6##4##(2008-10#6)
of ascorbic acid with##3##4##(2008-10#3)
of ascorbic acid##92##3##(1992-12#1)(1993-12#1)(2008-10#83)(2008-11#2)(2008-5#3)(2011-2#2)
of ascorbic##94##2##(1992-12#1)(1993-12#1)(2008-10#84)(2008-11#3)(2008-5#3)(2011-2#2)
of ascospore release##6##3##(2008-10#6)
of ascospore##12##2##(2008-10#12)
of ascospores in the##3##4##(2008-10#3)
of ascospores in##4##3##(2008-10#4)
of ascospores of##4##3##(2008-10#4)
of ascospores were##4##3##(2008-10#4)
of ascospores##29##2##(2008-10#29)
of aseptic loosening##2##3##(2009-4#1)(2013-1#1)
of asexual##3##2##(2008-10#3)
of ash##2##2##(2008-10#2)
of asian##2##2##(2008-10#1)(2013-1#1)
of asparagine and glutamine##2##4##(2008-11#2)
of asparagine##3##2##(1997-3#1)(2008-11#2)
of asparagine-linked glycoproteins##2##3##(1992-10#2)
of aspartase##2##2##(1991-5#1)(1992-11#1)
of aspartate aminotransferase##3##3##(1993-2#1)(1997-5#1)(2008-12#1)
of aspartate formation##2##3##(1991-3#2)
of aspartate##9##2##(1991-3#4)(1993-2#1)(1995-6#2)(1997-5#1)(2008-12#1)
of aspartic acid##2##3##(1990-10#1)(1990-12#1)
of aspartic##3##2##(1990-10#1)(1990-12#1)(2008-4#1)
of aspects of##2##3##(2008-11#1)(2008-12#1)
of aspects##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
of aspirin and##2##3##(2008-12#1)(2011-2#1)
of aspirin##9##2##(1990-5#1)(1992-5#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
of assay##3##2##(2008-10#2)(2008-9#1)
of assays in##2##3##(2008-10#1)(2008-4#1)
of assays##4##2##(1995-8#1)(2008-10#2)(2008-4#1)
of assembly##2##2##(2009-11#1)(2011-3#1)
of assessing the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
of assessing##16##2##(1990-8#1)(1994-3#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#2)
of assessment and##3##3##(2008-11#1)(2010-7#1)(2012-2#1)
of assessment are##2##3##(1994-2#1)(2008-11#1)
of assessment of##3##3##(1995-5#1)(2008-9#1)(2009-11#1)
of assessment##25##2##(1991-12#1)(1992-3#1)(1994-2#3)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#9)(2008-9#2)(2009-11#1)(2009-12#1)(2010-11#2)(2010-7#1)(2012-2#1)
of assigning##3##2##(1992-2#1)(1995-6#1)(2008-4#1)
of assisted living in##2##4##(2008-12#2)
of assisted living##4##3##(2008-12#4)
of assisted##6##2##(1996-9#1)(2008-11#1)(2008-12#4)
of associated##8##2##(1995-10#1)(1996-3#1)(1997-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
of association between##5##3##(2008-10#2)(2008-6#1)(2011-2#1)(2013-8#1)
of association constants##2##3##(2008-10#2)
of association of##3##3##(1995-6#1)(2008-10#2)
of association##22##2##(1993-1#1)(1995-6#1)(2008-10#15)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
of associations##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
of astaxanthin##4##2##(2008-10#3)(2013-8#1)
of astemizole##3##2##(2008-10#3)
of asthma and##3##3##(1996-1#1)(1997-1#1)(2011-1#1)
of asthma in##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2010-6#1)
of asthma##28##2##(1992-3#1)(1993-1#2)(1996-1#1)(1996-2#1)(1997-1#3)(1997-5#1)(2008-10#2)(2008-11#4)(2008-7#2)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#2)(2013-1#1)
of astrocyte##2##2##(1990-7#1)(2008-11#1)
of astrocytes is##2##3##(2008-11#1)(2008-12#1)
of astrocytes##11##2##(1994-2#1)(1997-3#1)(2008-11#2)(2008-12#2)(2008-7#4)(2013-7#1)
of astrogliosis##2##2##(2009-8#2)
of asymmetric##7##2##(1993-8#2)(2008-8#2)(2011-2#1)(2012-2#2)
of asymptomatic##10##2##(1990-3#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#2)
of asynchrony##2##2##(1996-2#1)(2008-10#1)
of at least 15##2##4##(1994-3#1)(2008-11#1)
of at least 4##3##4##(1990-12#1)(1997-3#1)(2012-12#1)
of at least 5##2##4##(2008-8#1)(2011-2#1)
of at least 6##2##4##(1990-12#1)(2008-11#1)
of at least five##2##4##(2008-10#1)(2010-8#1)
of at least four##2##4##(1993-9#1)(1995-6#1)
of at least nine##2##4##(1993-8#1)(2008-10#1)
of at least one##10##4##(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
of at least some##3##4##(1990-6#1)(2008-7#1)(2008-8#1)
of at least three##4##4##(1995-2#1)(2008-10#2)(2012-3#1)
of at least two##6##4##(1990-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
of at least##58##3##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#14)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
of at##60##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#15)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
of atherogenesis##2##2##(2008-10#1)(2008-5#1)
of atherogenic lipids##2##3##(2008-9#2)
of atherogenic##3##2##(2008-1#1)(2008-9#2)
of atherosclerosis and##4##3##(1995-8#1)(1997-8#1)(2008-6#1)(2012-2#1)
of atherosclerosis##29##2##(1991-12#1)(1991-9#2)(1993-6#1)(1994-11#1)(1994-5#1)(1995-8#1)(1997-8#3)(2008-1#4)(2008-11#1)(2008-6#5)(2008-9#2)(2010-9#2)(2012-2#2)(2012-3#2)(2013-7#1)
of atherosclerotic changes##2##3##(2011-2#2)
of atherosclerotic lesions##2##3##(2008-6#1)(2010-9#1)
of atherosclerotic plaque##3##3##(2010-9#3)
of atherosclerotic##10##2##(1991-9#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-9#4)(2011-2#2)
of atherothrombotic##2##2##(2011-2#2)
of athletes##3##2##(1993-3#1)(2010-1#1)(2013-1#1)
of athletic##2##2##(2010-1#1)(2010-7#1)
of atmospheric SO(2)##2##3##(2008-3#2)
of atmospheric aerosol##4##3##(2008-10#2)(2008-3#2)
of atmospheric##28##2##(1995-3#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#15)
of atomic absorption spectrometry##3##4##(2008-10#3)
of atomic nitrogen##3##3##(2008-2#3)
of atomic##10##2##(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#2)
of atomization##3##2##(2008-10#3)
of atoms in the##2##4##(1990-12#1)(1997-2#1)
of atoms##3##2##(1990-12#1)(1992-8#1)(1997-2#1)
of atopic dermatitis##4##3##(1991-2#4)
of atopic##7##2##(1991-2#6)(2008-10#1)
of atopy##2##2##(2009-10#1)(2012-3#1)
of atranorin##2##2##(2008-5#2)
of atrazine and simazine in##2##5##(2008-10#2)
of atrazine and simazine##3##4##(2008-10#3)
of atrazine and##4##3##(2008-10#4)
of atrazine at##2##3##(2008-10#2)
of atrazine in##6##3##(2008-10#6)
of atrazine using##2##3##(2008-10#2)
of atrazine##25##2##(2008-10#25)
of atretic follicles##2##3##(2008-11#1)(2008-8#1)
of atrial fibrillation in##2##4##(2012-3#1)(2013-8#1)
of atrial fibrillation##6##3##(2008-7#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
of atrial septal defects##2##4##(1997-8#2)
of atrial septal##3##3##(1997-8#2)(2008-11#1)
of atrial##14##2##(1996-2#2)(1997-8#2)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-12#3)(2012-3#1)(2013-8#1)
of atropine and##3##3##(2008-10#2)(2008-12#1)
of atropine##7##2##(1990-9#1)(1996-12#1)(1997-4#2)(2008-10#2)(2008-12#1)
of attached##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
of attaching##2##2##(2008-4#1)(2008-9#1)
of attachment##4##2##(1990-8#1)(2008-11#3)
of attempts##2##2##(2013-1#2)
of attendance##2##2##(1992-2#1)(2010-2#1)
of attendees##3##2##(1991-3#1)(2008-5#1)(2009-5#1)
of attention and##2##3##(2008-4#1)(2008-7#1)
of attention deficit/hyperactivity disorder##2##4##(1997-8#2)
of attention in##3##3##(2008-12#1)(2010-9#1)(2013-8#1)
of attention##27##2##(1991-3#1)(1994-2#1)(1996-2#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#2)
of attentional##2##2##(2008-11#1)(2013-8#1)
of attenuated total reflectance##2##4##(2008-10#2)
of attenuated total##6##3##(2008-10#5)(2008-5#1)
of attenuation##2##2##(1992-9#1)(2008-11#1)
of attorney##2##2##(1992-1#1)(1994-1#1)
of attraction##2##2##(2008-9#1)(2013-8#1)
of attractive male##2##3##(2008-8#2)
of attractive##4##2##(2008-10#1)(2008-6#1)(2008-8#2)
of atypical antipsychotic agents##2##4##(2008-4#1)(2008-8#1)
of atypical antipsychotics##4##3##(2008-8#3)(2012-3#1)
of atypical##12##2##(1996-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2011-2#1)(2012-2#1)(2012-3#1)
of auditory##7##2##(1996-6#1)(2008-8#1)(2008-9#2)(2011-1#1)(2013-8#2)
of auricular acupuncture##3##3##(2008-11#1)(2010-6#2)
of authentic##6##2##(1990-8#1)(1995-12#1)(2008-10#3)(2008-12#1)
of authentication##2##2##(2008-11#2)
of authors##2##2##(2008-11#1)(2008-7#1)
of autism and##2##3##(2008-11#1)(2012-3#1)
of autism##10##2##(1997-8#1)(2008-11#3)(2010-7#2)(2012-3#4)
of autistic features##2##3##(2008-11#2)
of autoantibodies in##2##3##(2011-2#1)(2013-1#1)
of autoantibodies##5##2##(1996-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
of autochthonous##3##2##(2008-10#2)(2010-4#1)
of autocorrelation##4##2##(2007-11#1)(2008-10#1)(2008-8#2)
of autocrine##3##2##(1990-5#1)(1995-8#1)(2008-11#1)
of autodeposition##2##2##(2008-10#2)
of autogamy##3##2##(2008-12#3)
of autogenous##2##2##(2009-10#1)(2011-3#1)
of autograft and allograft fixation in##2##6##(2009-3#2)
of autograft##3##2##(2009-3#2)(2010-3#1)
of autoimmune disease##4##3##(1993-3#1)(2008-10#3)
of autoimmune diseases##7##3##(1992-5#1)(2008-10#3)(2008-4#1)(2011-2#2)
of autoimmune hepatitis##4##3##(1996-11#3)(2008-10#1)
of autoimmune##27##2##(1992-5#1)(1993-3#2)(1994-12#1)(1996-11#3)(1997-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
of autoimmunity in##2##3##(2008-10#1)(2008-9#1)
of autoimmunity##13##2##(2008-10#6)(2008-8#1)(2008-9#1)(2010-5#2)(2011-2#2)(2013-1#1)
of autologous##4##2##(1990-2#1)(1996-9#1)(2008-11#1)(2012-2#1)
of automated test procedures##2##4##(2008-10#2)
of automated test##3##3##(2008-10#3)
of automated##13##2##(1995-11#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-11#2)(2013-1#1)
of automating##2##2##(2008-10#1)(2008-9#1)
of automation##4##2##(2008-10#4)
of automotive##2##2##(2008-10#1)(2008-11#1)
of autonomic dysfunction##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
of autonomic system##2##3##(2008-12#2)
of autonomic##10##2##(1994-3#1)(1996-6#1)(2008-10#1)(2008-12#2)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#2)
of autonomy and##3##3##(1992-1#1)(2008-11#1)(2009-7#1)
of autonomy##5##2##(1992-1#1)(1995-9#1)(2008-11#1)(2008-12#1)(2009-7#1)
of autophagic##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
of autophagy##2##2##(2012-2#1)(2013-1#1)
of autosomal recessive##2##3##(1996-8#1)(2012-3#1)
of autosomal##3##2##(1996-2#1)(1996-8#1)(2012-3#1)
of auxin##8##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#3)
of auxins##2##2##(2008-10#1)(2008-12#1)
of available data##4##3##(1990-8#1)(2008-11#1)(2008-12#1)(2008-5#1)
of available treatments##2##3##(2008-11#1)(2012-3#1)
of available##25##2##(1990-8#1)(1991-12#1)(1992-1#1)(1992-2#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
of average flow velocity##2##4##(2011-2#2)
of average molecular mass M(a) = 0##2##7##(2008-5#2)
of average weight##2##3##(1995-12#1)(2008-11#1)
of average##14##2##(1995-1#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2011-2#2)(2012-2#1)
of avian##6##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
of aviation##2##2##(2008-10#1)(2012-3#1)
of avidin##6##2##(1993-6#4)(2008-10#1)(2008-12#1)
of avirulence##9##2##(2008-10#9)
of avocado fruit with Cg-M-142##2##5##(2008-10#2)
of avocado##4##2##(2008-10#4)
of avoiding##4##2##(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)
of awareness of##4##3##(1995-8#1)(1996-1#1)(2008-10#1)(2011-2#1)
of awareness##5##2##(1994-1#1)(1995-8#1)(1996-1#1)(2008-10#1)(2011-2#1)
of axial##6##2##(1994-12#1)(2007-12#1)(2008-3#2)(2008-6#1)(2011-2#1)
of axillary##8##2##(1991-8#1)(2008-5#6)(2012-3#1)
of axonal##4##2##(1995-12#1)(1996-5#1)(1997-3#1)(2011-7#1)
of axons##5##2##(1993-12#1)(1995-12#1)(1997-3#1)(2008-11#1)(2008-5#1)
of azathioprine##2##2##(2008-10#2)
of azidothymidine##2##2##(2008-10#2)
of azithromycin##3##2##(2008-10#3)
of azo dyes##2##3##(2008-10#1)(2011-1#1)
of azo##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
of azobenzene##3##2##(1995-6#2)(2008-10#1)
of b##5##2##(2008-10#3)(2010-11#1)(2011-2#1)
of b(5)##5##2##(2008-7#5)
of b(rw)##2##2##(2008-2#2)
of bFGF and##4##3##(1994-11#2)(1995-12#1)(2008-11#1)
of bFGF in the##2##4##(1992-3#1)(1995-12#1)
of bFGF in##3##3##(1992-3#1)(1995-12#1)(2013-8#1)
of bFGF##18##2##(1992-3#2)(1994-11#3)(1995-12#9)(2008-11#3)(2013-8#1)
of babies##2##2##(2008-11#1)(2010-6#1)
of baccalaureate##2##2##(1991-1#2)
of back pain syndrome##2##4##(2007-11#2)
of back pain##3##3##(2007-11#2)(2008-12#1)
of back##4##2##(2007-11#2)(2008-10#1)(2008-12#1)
of background signals##3##3##(2008-3#3)
of background##17##2##(2008-10#8)(2008-2#1)(2008-3#6)(2008-4#1)(2010-3#1)
of backscatter from two##2##4##(2008-3#2)
of backscatter##4##2##(2008-3#4)
of backscattering##2##2##(2008-3#2)
of baclofen##3##2##(1990-5#2)(2008-10#1)
of bacteraemia##2##2##(2008-5#1)(2013-8#1)
of bacteremia##2##2##(1990-2#1)(2010-6#1)
of bacteria and fungi##2##4##(2006-6#1)(2008-5#1)
of bacteria and##5##3##(2006-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
of bacteria in the##2##4##(2008-10#1)(2011-2#1)
of bacteria in##7##3##(2008-10#5)(2008-9#1)(2011-2#1)
of bacteria on##3##3##(2008-10#2)(2008-8#1)
of bacteria pathogenic on potato##2##5##(2008-10#2)
of bacteria to the##2##4##(2006-6#1)(2008-7#1)
of bacteria to##4##3##(2006-6#1)(2008-10#1)(2008-7#1)(2013-8#1)
of bacteria using##2##3##(2008-10#1)(2008-12#1)
of bacteria with##2##3##(2011-2#1)(2013-1#1)
of bacteria within the##2##4##(1996-6#1)(2013-8#1)
of bacteria##65##2##(1990-5#1)(1996-12#1)(1996-6#1)(2006-6#2)(2007-12#1)(2008-10#30)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#9)(2012-3#2)(2013-1#2)(2013-8#2)
of bacterial DNA##2##3##(1995-6#1)(2008-10#1)
of bacterial aggregates##2##3##(2008-10#2)
of bacterial and yeast##2##4##(2008-10#1)(2012-2#1)
of bacterial and##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
of bacterial antagonists##2##3##(2008-10#2)
of bacterial artificial chromosome (BAC)##2##5##(2008-8#1)(2009-10#1)
of bacterial artificial##3##3##(2008-4#1)(2008-8#1)(2009-10#1)
of bacterial bioreporters##2##3##(2011-2#2)
of bacterial blight of onion##3##5##(2008-10#3)
of bacterial blight of##4##4##(2008-10#4)
of bacterial blight##6##3##(2008-10#5)(2008-8#1)
of bacterial cells##4##3##(2008-10#3)(2008-3#1)
of bacterial fatty##2##3##(2008-10#2)
of bacterial growth inhibition##2##4##(2008-5#2)
of bacterial growth##5##3##(1997-8#1)(2008-5#3)(2009-6#1)
of bacterial infection##2##3##(1990-12#1)(2006-5#1)
of bacterial infections in##3##4##(2012-3#2)(2013-1#1)
of bacterial infections##5##3##(1996-12#1)(2012-3#3)(2013-1#1)
of bacterial meningitis##3##3##(1996-3#1)(2008-11#1)(2010-12#1)
of bacterial species##2##3##(2008-10#1)(2009-8#1)
of bacterial speck##3##3##(2008-10#3)
of bacterial spot of##2##4##(2008-10#2)
of bacterial spot on##2##4##(2008-10#2)
of bacterial spot##4##3##(2008-10#4)
of bacterial vaginosis##2##3##(2007-12#1)(2008-10#1)
of bacterial wilt##2##3##(2008-10#2)
of bacterial##95##2##(1990-12#1)(1990-2#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-10#38)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-6#3)(2009-8#4)(2010-12#2)(2011-1#2)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#2)
of bacterially produced##2##3##(2008-10#1)(2008-4#1)
of bacteriophage lambda##2##3##(1993-9#1)(1995-2#1)
of bacteriophage phi X174##2##4##(1991-5#2)
of bacteriophage##11##2##(1991-5#2)(1993-9#1)(1995-2#2)(1996-2#1)(2008-8#3)(2012-2#2)
of bacteriopheophytin##2##2##(2008-9#2)
of bacteriorhodopsin##2##2##(1990-5#1)(1994-5#1)
of bacterivorous##2##2##(2008-10#1)(2008-8#1)
of baicalein##2##2##(2008-10#2)
of baker's yeast##2##3##(2008-10#1)(2011-1#1)
of baker's##3##2##(1990-3#1)(2008-10#1)(2011-1#1)
of balance and##2##3##(2010-11#1)(2013-1#1)
of balance##7##2##(2008-11#2)(2008-7#2)(2010-11#1)(2010-12#1)(2013-1#1)
of balanced##4##2##(2008-11#3)(2008-8#1)
of balloon angioplasty##2##3##(1991-3#1)(2012-3#1)
of banana and##2##3##(2008-10#2)
of banana##10##2##(2008-10#10)
of bananas##2##2##(2008-10#2)
of band patterns##2##3##(2008-12#2)
of band##4##2##(1991-9#1)(2008-12#2)(2013-1#1)
of bandpass##2##2##(2008-10#1)(2008-3#1)
of bands##4##2##(2008-10#4)
of bare##4##2##(1997-7#1)(2008-10#2)(2008-12#1)
of barium iodate##2##3##(2008-10#2)
of barium##6##2##(2008-10#4)(2010-8#1)(2011-2#1)
of barley (Hordeum vulgare L##2##5##(1995-6#1)(2008-10#1)
of barley alpha-amylase##2##3##(2008-8#2)
of barley and##2##3##(2008-10#2)
of barley covered smut##2##4##(2008-10#2)
of barley in##7##3##(2008-10#7)
of barley##34##2##(1992-9#1)(1995-6#2)(2008-10#29)(2008-8#2)
of barrier agents##2##3##(1991-1#2)
of barrier cells##2##3##(2008-7#2)
of barrier##6##2##(1991-1#2)(2008-5#1)(2008-7#2)(2010-10#1)
of barriers to##2##3##(1993-12#1)(1994-1#1)
of barriers##5##2##(1993-12#1)(1994-1#1)(2008-1#1)(2010-11#1)(2010-7#1)
of basal cell carcinoma##2##4##(1997-3#1)(2013-8#1)
of basal##12##2##(1991-7#1)(1993-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
of base##2##2##(1996-6#1)(2008-10#1)
of baseline##7##2##(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#1)
of basement membrane##2##3##(2008-11#2)
of bases##2##2##(1996-6#1)(2008-10#1)
of basic alloys##2##3##(2013-1#2)
of basic fibroblast growth factor (bFGF)##2##6##(1992-3#1)(2008-11#1)
of basic fibroblast growth factor##4##5##(1992-3#2)(1995-12#1)(2008-11#1)
of basic research##2##3##(1992-12#1)(2012-2#1)
of basic##25##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#1)(1995-12#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of basidiomycetes associated with wood decay##2##6##(2008-10#2)
of basolateral membranes##2##3##(1993-3#2)
of basolateral##4##2##(1993-3#2)(1993-6#1)(2008-11#1)
of basonuclin protein##2##3##(2008-9#2)
of basonuclin##4##2##(2008-9#4)
of basophils##2##2##(2008-11#2)
of bat##3##2##(2009-8#1)(2013-1#2)
of batch culture##3##3##(1994-8#1)(2008-11#2)
of batch cultures##3##3##(2008-11#3)
of batch##11##2##(1994-8#1)(2008-10#1)(2008-11#7)(2010-8#1)(2011-2#1)
of bats##5##2##(2009-8#1)(2013-1#4)
of battered##4##2##(1995-5#3)(2009-5#1)
of bcl-2 and bag-1##3##4##(2008-11#3)
of bcl-2 expression on##2##4##(2008-11#1)(2008-7#1)
of bcl-2 expression##3##3##(2008-11#2)(2008-7#1)
of bcl-2 in##2##3##(2008-11#2)
of bcl-2 over-expression##2##3##(2008-11#2)
of bcl-2##15##2##(1993-3#1)(2008-10#1)(2008-11#12)(2008-7#1)
of bead##2##2##(2008-10#1)(2012-2#1)
of beads##8##2##(1997-2#3)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)
of beam##7##2##(2008-3#7)
of bean samples##2##3##(2008-10#2)
of bean##9##2##(2008-10#9)
of becoming##4##2##(1996-2#1)(1997-6#1)(2008-12#1)(2008-4#1)
of bed##2##2##(1990-12#1)(2010-4#1)
of beds##4##2##(1991-6#1)(1993-1#1)(1996-3#1)(1997-4#1)
of bee##2##2##(2007-12#1)(2008-10#1)
of beef patties##3##3##(2010-4#3)
of beef##5##2##(2008-10#1)(2010-4#4)
of beer with##2##3##(2008-10#2)
of beer##11##2##(1991-5#1)(2008-10#9)(2012-2#1)
of beers##3##2##(2008-10#3)
of beet necrotic yellow vein virus##2##6##(2008-10#2)
of beet##4##2##(2008-10#4)
of beetles##2##2##(2008-10#1)(2008-9#1)
of begomovirus##4##2##(2008-10#4)
of begomoviruses in clarified plant extracts##2##6##(2008-10#2)
of begomoviruses##6##2##(2008-10#6)
of behavior change##2##3##(1993-12#1)(2013-1#1)
of behavior generation##2##3##(2008-11#2)
of behavior therapy##2##3##(2013-1#2)
of behavior##21##2##(1993-12#1)(1993-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#6)(2008-8#5)(2012-3#1)(2013-1#3)(2013-8#1)
of behavioral change##2##3##(1991-3#1)(2008-11#1)
of behavioral##19##2##(1991-2#1)(1991-3#2)(1996-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2010-9#1)(2011-2#1)(2013-8#1)
of behaviors##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
of behaviour##3##2##(1994-3#1)(1994-6#1)(1997-5#1)
of behavioural deficits##2##3##(1991-2#1)(1997-2#1)
of behavioural##9##2##(1990-3#1)(1991-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#2)
of being a##10##3##(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
of being an##2##3##(2008-10#1)(2011-2#1)
of being highly##2##3##(2008-10#1)(2008-4#1)
of being in##2##3##(2008-11#1)(2010-10#1)
of being##54##2##(1991-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#5)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of bell##2##2##(2008-10#2)
of below##3##2##(1993-12#1)(2008-10#2)
of benchmark##2##2##(2008-5#1)(2013-1#1)
of bending##2##2##(1991-7#1)(1997-6#1)
of beneficence##2##2##(1991-2#1)(1995-9#1)
of beneficial##4##2##(1996-9#1)(2008-10#2)(2008-7#1)
of beneficiaries##4##2##(1994-12#1)(1997-2#1)(1997-3#2)
of benefit##4##2##(1991-3#1)(1997-5#1)(2007-11#1)(2008-9#1)
of benefits and##2##3##(1992-3#1)(2008-8#1)
of benefits##7##2##(1990-2#1)(1991-3#1)(1992-3#1)(1996-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
of benfluorex##3##2##(1995-11#3)
of benign and malignant##6##4##(2008-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
of benign and##7##3##(2008-11#1)(2008-12#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
of benign##20##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
of bent##2##2##(1997-6#1)(2008-3#1)
of benzene##11##2##(2008-10#9)(2008-3#2)
of benzidine##2##2##(2008-10#2)
of benzo(a)pyrene##2##2##(1993-8#1)(2008-11#1)
of benzo-18-crown-6 (B18C6)##2##3##(2008-10#2)
of benzo[a]pyrene##7##2##(2008-10#6)(2011-1#1)
of benzodiazepine binding##2##3##(1995-11#1)(1995-12#1)
of benzodiazepine receptors by##2##4##(1996-2#2)
of benzodiazepine receptors##4##3##(1996-2#4)
of benzodiazepine##9##2##(1995-11#2)(1995-12#2)(1996-2#4)(2008-10#1)
of benzodiazepines##3##2##(1994-2#1)(1995-12#1)(2008-10#1)
of benzoic acid##3##3##(2008-10#3)
of benzoic acids##2##3##(2008-10#2)
of benzoic##5##2##(2008-10#5)
of benzoyl peroxide##4##3##(2008-10#4)
of benzoyl##6##2##(2008-10#6)
of benzoylurea insecticides##2##3##(2008-10#2)
of benzyl##3##2##(2008-10#2)(2010-2#1)
of benzylpenicillin##2##2##(1992-12#1)(2011-1#1)
of berbamine##2##2##(1995-11#2)
of bermudagrass##4##2##(2008-10#4)
of berries##3##2##(2008-10#3)
of berry##5##2##(2008-10#5)
of beryllium from##3##3##(2008-10#3)
of beryllium in##3##3##(2008-10#3)
of beryllium using##2##3##(2008-10#2)
of beryllium##14##2##(2008-10#14)
of best practice##2##3##(2008-11#1)(2010-10#1)
of best##4##2##(2008-10#1)(2008-11#1)(2010-10#2)
of beta##16##2##(1990-11#1)(1991-10#1)(1991-6#1)(1992-4#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2013-8#1)
of beta(nuc)##2##2##(2009-8#2)
of beta-1##11##2##(2008-10#11)
of beta-APP##3##2##(1993-8#3)
of beta-CD and##3##3##(2008-10#1)(2008-11#2)
of beta-CD##11##2##(2008-10#9)(2008-11#2)
of beta-adrenoceptors##2##2##(1995-11#1)(1997-2#1)
of beta-amylase##2##2##(2008-9#2)
of beta-amyloid precursor protein##3##4##(1992-6#1)(1993-8#2)
of beta-amyloid protein precursor##2##4##(1992-6#2)
of beta-amyloid protein##4##3##(1992-6#2)(2008-8#2)
of beta-amyloid##8##2##(1991-10#1)(1992-6#3)(1993-8#2)(2008-8#2)
of beta-blockers##2##2##(2008-10#1)(2008-3#1)
of beta-carotene##4##2##(1992-9#1)(2008-10#1)(2009-6#2)
of beta-catenin##3##2##(1994-11#1)(2008-11#1)(2009-8#1)
of beta-cell function and insulin sensitivity##3##6##(1994-12#3)
of beta-cell function##4##3##(1994-12#4)
of beta-cell##5##2##(1994-12#5)
of beta-cells##3##2##(1996-2#1)(2008-11#1)(2013-1#1)
of beta-cyclodextrin (beta-CD)##3##3##(2008-10#3)
of beta-cyclodextrin and its##2##4##(2008-10#1)(2008-11#1)
of beta-cyclodextrin and##3##3##(2008-10#2)(2008-11#1)
of beta-cyclodextrin##8##2##(2008-10#7)(2008-11#1)
of beta-endorphin##3##2##(1990-12#3)
of beta-galactosidase by recombinant##2##4##(1997-8#2)
of beta-galactosidase by##3##3##(1997-8#2)(2008-11#1)
of beta-galactosidase##8##2##(1993-12#1)(1993-8#1)(1997-8#2)(2008-11#2)(2008-7#1)(2008-8#1)
of beta-keratins##2##2##(2011-2#2)
of beta-l##2##2##(2008-11#2)
of beta-lactam antibiotics##2##3##(1994-8#1)(2010-6#1)
of beta-lactam##3##2##(1994-8#1)(2008-7#1)(2010-6#1)
of beta-lactoglobulin##2##2##(1997-2#1)(2008-11#1)
of beta-sheet##2##2##(1996-2#1)(2008-10#1)
of beta2m##4##2##(1997-9#4)
of beta3 integrin##3##3##(2009-9#3)
of betablockers##2##2##(2008-10#2)
of better than 0##4##4##(2008-10#3)(2008-3#1)
of better than 1##2##4##(2007-12#1)(2008-10#1)
of better than##12##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#5)(2012-3#1)
of better##16##2##(1992-1#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#5)(2012-3#1)
of betulinic acid##2##3##(2008-10#2)
of between##10##2##(1994-3#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-5#2)(2008-7#3)
of bevacizumab##2##2##(2013-1#1)(2013-8#1)
of bi-##2##2##(1994-5#1)(2013-1#1)
of bi-CoPc##2##2##(2008-10#2)
of bias errors##2##3##(2008-10#2)
of bias in the##3##4##(1996-3#1)(2008-10#2)
of bias##11##2##(1992-9#1)(1995-2#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-8#1)(2012-3#1)
of bicuculline##2##2##(1993-3#1)(2008-7#1)
of bidirectional##3##2##(2008-2#1)(2008-5#1)(2010-8#1)
of bifunctional chelators##2##3##(2012-3#2)
of bifunctional##3##2##(2012-3#3)
of bilateral##14##2##(1990-5#1)(1994-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2012-3#1)(2013-1#5)
of bilayer##3##2##(1993-8#1)(2008-10#1)(2008-8#1)
of bile acids into##2##4##(1992-3#2)
of bile acids##5##3##(1992-3#2)(1993-2#1)(2008-11#1)(2013-1#1)
of bile duct##4##3##(1995-11#1)(2008-2#1)(2010-12#2)
of bile##15##2##(1991-3#1)(1992-3#2)(1993-2#1)(1993-3#3)(1995-11#1)(2008-11#1)(2008-2#1)(2010-12#2)(2012-2#2)(2013-1#1)
of biliary##6##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-3#1)(2010-12#1)(2012-12#1)
of bilingual##2##2##(2010-8#1)(2011-2#1)
of bilirubin##7##2##(2008-10#6)(2008-11#1)
of biliverdin to BSA##2##4##(2008-10#2)
of binary and ternary##3##4##(2008-10#3)
of binary mixtures of##5##4##(2008-10#5)
of binary mixtures##8##3##(2008-10#8)
of binary##17##2##(2008-10#14)(2008-11#1)(2008-3#1)(2013-8#1)
of binding of##3##3##(1993-1#1)(1993-8#1)(1994-11#1)
of binding sites for##2##4##(1990-8#1)(1991-5#1)
of binding sites in##2##4##(1994-3#1)(2008-10#1)
of binding sites##12##3##(1990-12#1)(1990-8#2)(1991-5#1)(1994-3#1)(1995-12#1)(1995-8#1)(2008-10#4)(2008-7#1)
of binding to##5##3##(1993-8#1)(1994-8#1)(2008-10#1)(2008-9#2)
of binding##41##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-5#1)(1993-1#1)(1993-3#1)(1993-8#5)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-10#12)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-8#1)(2010-11#1)(2012-2#1)
of binocular##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
of binucleate Rhizoctonia spp##4##4##(2008-10#4)
of binucleate Rhizoctonia##7##3##(2008-10#7)
of bioaccumulation##3##2##(2008-11#1)(2008-12#2)
of bioactive amines in##2##4##(2008-10#2)
of bioactive compounds from##2##4##(2008-10#2)
of bioactive compounds##3##3##(2008-10#2)(2011-1#1)
of bioactive##14##2##(1995-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-12#1)(2009-7#3)(2011-1#1)(2013-1#2)
of bioanalytical applications##2##3##(2008-10#1)(2010-11#1)
of bioanalytical##4##2##(2008-10#2)(2010-11#2)
of bioartificial liver##2##3##(2008-11#1)(2010-12#1)
of biocatalysis##3##2##(2008-7#1)(2011-1#2)
of biochemical and##2##3##(2008-11#1)(2008-2#1)
of biochemical##15##2##(1990-5#1)(1994-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-10#1)(2012-3#1)
of biochemistry##2##2##(1994-12#2)
of biocide action##2##3##(2008-7#2)
of biocontrol agents for fire blight##2##6##(2008-10#2)
of biocontrol agents##3##3##(2008-10#3)
of biocontrol in##2##3##(2008-10#2)
of biocontrol of##3##3##(2008-10#3)
of biocontrol pseudomonads##2##3##(2008-10#2)
of biocontrol strains##2##3##(2008-10#2)
of biocontrol yeasts##2##3##(2008-10#2)
of biocontrol##19##2##(2008-10#19)
of biodegradable##2##2##(1993-1#1)(2013-1#1)
of biofilm##5##2##(2008-5#1)(2013-8#4)
of biofilms in##2##3##(2008-5#1)(2011-2#1)
of biofilms##3##2##(2008-5#1)(2011-2#2)
of biogenic amine##2##3##(2008-10#1)(2008-7#1)
of biogenic amines in##2##4##(2008-10#1)(2008-7#1)
of biogenic amines##5##3##(2008-10#4)(2008-7#1)
of biogenic##7##2##(2008-10#5)(2008-7#2)
of bioinformatics##5##2##(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2013-8#1)
of biologic##5##2##(1991-3#1)(1997-1#1)(2008-6#2)(2013-1#1)
of biological activities##3##3##(2008-10#1)(2008-5#1)(2011-3#1)
of biological activity of##4##4##(2008-12#2)(2008-7#1)(2011-3#1)
of biological activity##6##3##(1995-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-3#1)
of biological and##6##3##(2008-10#4)(2008-12#1)(2010-11#1)
of biological applications##2##3##(2008-11#2)
of biological control by##2##4##(2008-10#2)
of biological control in##2##4##(2008-10#2)
of biological control of##3##4##(2008-10#3)
of biological control##17##3##(2008-10#17)
of biological macromolecules##2##3##(1997-6#1)(2008-10#1)
of biological markers##2##3##(1991-11#1)(2008-7#1)
of biological materials##4##3##(2008-10#3)(2008-9#1)
of biological membranes##2##3##(1994-5#1)(2008-10#1)
of biological molecules##3##3##(2008-10#2)(2008-4#1)
of biological origin##3##3##(2008-10#2)(2011-2#1)
of biological processes##5##3##(1996-6#1)(1997-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
of biological samples##10##3##(1993-2#1)(2008-10#5)(2008-4#2)(2009-12#2)
of biological significance##2##3##(2008-9#1)(2009-12#1)
of biological systems##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
of biological treatment##2##3##(1992-5#1)(2012-3#1)
of biological##119##2##(1990-5#1)(1991-11#1)(1991-5#1)(1992-12#2)(1992-5#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#47)(2008-11#8)(2008-12#3)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#7)(2009-12#4)(2009-8#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#3)(2012-2#1)(2012-3#2)(2013-1#3)
of biologically active recombinant##2##4##(1990-8#1)(2010-5#1)
of biologically active##9##3##(1990-8#1)(1993-6#3)(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
of biologically derived##2##3##(2008-10#2)
of biologically##14##2##(1990-8#1)(1993-6#3)(1994-5#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-9#2)(2010-5#1)
of biology##8##2##(2008-12#2)(2008-8#2)(2009-6#2)(2010-5#1)(2013-8#1)
of bioluminescence##2##2##(2007-12#1)(2008-10#1)
of bioluminescent##2##2##(2007-12#1)(2008-10#1)
of biomarker studies##2##3##(2010-5#2)
of biomarker##5##2##(2008-11#1)(2010-5#4)
of biomarkers for##2##3##(2011-2#2)
of biomarkers##4##2##(2008-10#1)(2010-5#1)(2011-2#2)
of biomass and ligninolytic enzymes by Pleurotus ostreatus##2##8##(2008-5#2)
of biomass in the##2##4##(2008-7#1)(2008-9#1)
of biomass production##2##3##(2008-10#1)(2008-8#1)
of biomass##12##2##(2008-10#2)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
of biomaterials##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
of biomedical##5##2##(2008-10#2)(2009-12#1)(2009-7#1)(2011-2#1)
of biomolecules and##2##3##(1997-6#1)(2010-7#1)
of biomolecules with##2##3##(1997-6#2)
of biomolecules##9##2##(1997-6#3)(2008-10#1)(2008-12#1)(2008-9#1)(2010-7#2)(2013-1#1)
of biopharmaceuticals in##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of biopharmaceuticals##6##2##(2008-10#2)(2008-11#3)(2011-2#1)
of biopolymer##2##2##(2008-10#2)
of biopolymers##3##2##(2008-10#3)
of bioprocess##2##2##(2008-11#1)(2013-1#1)
of biopsies##2##2##(1990-11#1)(2013-8#1)
of biopsy##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
of bioreactors##2##2##(2008-10#1)(2008-11#1)
of biorecognition##2##2##(2008-10#2)
of biosensor##6##2##(2008-10#6)
of biosensors based on##2##4##(2008-10#2)
of biosensors##8##2##(2008-10#8)
of biosorbent##2##2##(2008-12#2)
of biosorption##2##2##(2008-10#2)
of biosynthetic##3##2##(1993-1#1)(1993-12#1)(2008-7#1)
of biotechnological##2##2##(2008-11#2)
of biotechnology##5##2##(1994-12#1)(2008-11#4)
of biotherapeutic##2##2##(2008-10#2)
of biotherapeutics in clinical##2##4##(2008-10#2)
of biotherapeutics##5##2##(2008-10#5)
of biotic##3##2##(2008-11#1)(2010-10#2)
of biotin to##2##3##(2008-10#2)
of biotin##5##2##(1990-12#1)(1993-6#1)(1995-2#1)(2008-10#2)
of biotinylated ligands##2##3##(2008-10#2)
of biotinylated##6##2##(1994-5#1)(2008-10#4)(2008-11#1)
of biotransformation##3##2##(1994-6#1)(2008-10#2)
of biotrophic##2##2##(2008-10#2)
of bipolar disorder##5##3##(2008-8#1)(2010-6#1)(2010-7#3)
of bipolar##6##2##(1992-12#1)(2008-8#1)(2010-6#1)(2010-7#3)
of bipolarity##2##2##(2009-10#2)
of biporous##2##2##(2008-10#2)
of birch##5##2##(2008-11#3)(2012-5#2)
of birds##11##2##(2008-5#2)(2008-8#3)(2008-9#3)(2010-5#1)(2012-3#2)
of birth and##2##3##(2012-3#1)(2013-1#1)
of birth defects##3##3##(2010-1#1)(2012-12#2)
of birth##17##2##(1990-6#1)(1991-12#1)(1991-2#1)(1994-9#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
of births##5##2##(1990-12#1)(1990-6#1)(1995-12#1)(2008-10#1)(2008-11#1)
of bis(2##2##2##(2008-10#2)
of bismuth in biological##2##4##(2008-10#2)
of bismuth in water samples##2##5##(2008-10#2)
of bismuth in water##3##4##(2008-10#3)
of bismuth in##12##3##(2008-10#12)
of bismuth was investigated##2##4##(2008-10#2)
of bismuth##31##2##(2008-10#31)
of bismuth(III)##4##2##(2008-10#4)
of bisphenol A (BPA) in##2##5##(2008-10#1)(2009-8#1)
of bisphenol A and##2##4##(2008-10#1)(2010-5#1)
of bisphenol A##7##3##(2008-10#4)(2009-8#2)(2010-5#1)
of black carbon##3##3##(2008-3#3)
of black patients##2##3##(1993-9#1)(1995-12#1)
of black tea##6##3##(2008-10#1)(2009-8#5)
of black tooth stains##2##4##(2013-1#2)
of black##23##2##(1993-9#1)(1995-12#1)(2008-10#8)(2008-12#1)(2008-3#3)(2008-5#1)(2009-8#5)(2013-1#3)
of bladder cancer##4##3##(1991-8#1)(2009-4#1)(2013-8#2)
of bladder exstrophy##4##3##(2008-10#4)
of bladder mucosa##2##3##(2008-10#2)
of bladder preservation##2##3##(2008-10#1)(2008-11#1)
of bladder##19##2##(1991-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#2)
of blank##5##2##(2008-10#5)
of blast##3##2##(2008-10#3)
of blastocysts derived in##2##4##(2008-11#2)
of blastocysts was##2##3##(1996-8#1)(2008-9#1)
of blastocysts##5##2##(1996-8#1)(2008-11#3)(2008-9#1)
of bleeding in the##2##4##(1996-11#1)(2008-7#1)
of bleeding##9##2##(1996-11#1)(2008-5#1)(2008-7#3)(2010-7#1)(2013-1#3)
of bleeds##2##2##(2009-3#2)
of blind##3##2##(2009-11#1)(2012-3#2)
of blister##3##2##(2008-10#2)(2008-11#1)
of block##3##2##(2008-3#1)(2011-2#1)(2012-3#1)
of blocks##2##2##(2008-9#1)(2012-3#1)
of blood and blood##2##4##(1993-11#1)(2008-12#1)
of blood and##9##3##(1991-1#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
of blood banks##2##3##(1995-6#1)(2011-2#1)
of blood coagulation##4##3##(1991-9#1)(1992-12#1)(2011-2#1)(2013-1#1)
of blood cultures##2##3##(2007-12#1)(2010-6#1)
of blood donors##2##3##(1990-6#1)(2008-11#1)
of blood flow##6##3##(1997-1#1)(2008-7#1)(2013-1#3)(2013-8#1)
of blood glucose levels##2##4##(2010-11#2)
of blood glucose##5##3##(2010-11#2)(2010-2#1)(2011-1#1)(2012-2#1)
of blood levels##2##3##(1992-9#1)(1993-3#1)
of blood lipids##2##3##(2011-2#1)(2013-8#1)
of blood loss##2##3##(1993-1#1)(1994-3#1)
of blood pressure (BP) and heart rate (HR)##2##8##(2008-11#2)
of blood pressure and##2##4##(1994-6#1)(2012-3#1)
of blood pressure in##3##4##(1997-8#1)(2008-10#1)(2010-7#1)
of blood pressure is##2##4##(1993-11#1)(2008-5#1)
of blood pressure##17##3##(1991-6#1)(1993-11#1)(1993-2#1)(1994-6#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2009-7#1)(2010-7#1)(2012-3#1)
of blood transfusion##2##3##(2008-9#1)(2011-2#1)
of blood vessels is##2##4##(1994-9#1)(2010-1#1)
of blood vessels##9##3##(1994-9#1)(2008-12#1)(2008-6#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
of blood volume and##2##4##(2008-7#1)(2010-7#1)
of blood##109##2##(1990-6#1)(1991-1#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-3#4)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-8#2)(2007-12#1)(2008-1#3)(2008-10#11)(2008-11#7)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-6#3)(2010-7#6)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#3)
of bloom and##2##3##(2008-10#2)
of bloom##6##2##(2008-10#6)
of blossom blight##2##3##(2008-10#2)
of blossom##5##2##(2008-10#5)
of blossoms by##2##3##(2008-10#2)
of blossoms colonized by##2##4##(2008-10#2)
of blossoms##13##2##(2008-10#13)
of blue##5##2##(1991-11#1)(2008-10#3)(2010-1#1)
of blueberry##3##2##(2008-10#3)
of blunt renal##2##3##(1990-9#2)
of blunt##5##2##(1990-9#2)(1991-6#1)(2012-2#2)
of bmDCs##2##2##(2008-10#2)
of board##3##2##(1991-12#1)(1992-3#1)(1994-2#1)
of boards##2##2##(1992-3#1)(1996-1#1)
of bodies##3##2##(1995-11#1)(2008-12#1)(2013-8#1)
of body awareness##2##3##(2009-1#2)
of body composition##2##3##(2012-2#1)(2012-3#1)
of body condition##2##3##(1996-8#1)(2008-9#1)
of body fat##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
of body image##2##3##(2009-5#1)(2010-11#1)
of body size evolution in##2##5##(2012-3#2)
of body size##3##3##(2008-9#1)(2012-3#2)
of body temperature##2##3##(1992-2#1)(2008-7#1)
of body weight##5##3##(1990-9#1)(2008-5#1)(2009-7#1)(2011-3#2)
of body##34##2##(1990-9#1)(1991-5#1)(1992-2#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-3#3)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
of bohemine##2##2##(2008-11#2)
of bolesatine##2##2##(1995-11#2)
of bombesin##2##2##(1994-3#2)
of bombolitin III##2##3##(1994-5#2)
of bonded glucose##2##3##(2008-10#2)
of bonded##3##2##(2008-10#3)
of bone and##2##3##(1990-11#1)(2008-8#1)
of bone density##4##3##(1991-11#3)(1994-12#1)
of bone diameter##2##3##(2013-1#2)
of bone formation##2##3##(1991-5#1)(2008-11#1)
of bone fragments##2##3##(2013-1#2)
of bone in##2##3##(2008-1#1)(2008-7#1)
of bone loss##5##3##(1991-11#1)(2008-7#1)(2010-5#1)(2013-1#2)
of bone marrow##8##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-6#2)(2010-8#1)(2011-2#1)
of bone metabolism##2##3##(1992-6#1)(2007-8#1)
of bone metastases##4##3##(1991-8#2)(2008-1#1)(2011-2#1)
of bone metastasis##3##3##(1994-12#2)(2011-2#1)
of bone mineral density##4##4##(1996-8#2)(2011-2#2)
of bone mineral##5##3##(1994-9#1)(1996-8#2)(2011-2#2)
of bone morphogenetic proteins##2##4##(1991-5#1)(2011-2#1)
of bone morphogenetic##4##3##(1991-5#1)(2011-2#3)
of bone pain##2##3##(1991-11#1)(2008-10#1)
of bone resorption##3##3##(2008-10#1)(2013-1#2)
of bone tissue##2##3##(2007-11#1)(2007-8#1)
of bone tunnel##2##3##(2013-1#2)
of bone turnover##2##3##(1990-2#1)(2011-2#1)
of bone union##2##3##(2007-8#1)(2008-11#1)
of bone##96##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#9)(1991-5#2)(1991-8#2)(1992-6#1)(1994-12#3)(1994-9#1)(1996-3#2)(1996-8#2)(1997-1#1)(2007-11#2)(2007-8#4)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#5)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#5)(2010-8#1)(2011-2#16)(2012-12#1)(2012-3#1)(2013-1#14)
of bone's##2##2##(2013-1#2)
of bones##2##2##(2007-8#1)(2008-10#1)
of border cell and root tip exudates on##2##8##(2008-10#2)
of border cells##3##3##(2008-10#3)
of border##5##2##(2008-10#5)
of borderline statistical significance##3##4##(2008-11#2)(2008-4#1)
of borderline##6##2##(1990-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2011-1#1)
of boreal##2##2##(2008-9#2)
of boric acid as a##2##5##(2008-10#2)
of boron as boric acid in eye lotions##2##8##(2008-10#2)
of boron in water samples##2##5##(2008-10#2)
of boron in##10##3##(2008-10#10)
of boron with##2##3##(2008-10#2)
of boron##24##2##(1990-3#1)(2008-10#23)
of bosentan##3##2##(2009-10#2)(2010-10#1)
of both 25 (OH) and 1##2##6##(2012-3#2)
of both HA and##2##4##(2008-10#1)(2009-7#1)
of both active##2##3##(2008-10#2)
of both adrenal glands##2##4##(2013-1#2)
of both analytes in##5##4##(2008-10#5)
of both analytes##12##3##(2008-10#12)
of both anions##3##3##(2008-10#3)
of both approaches##3##3##(2008-10#2)(2011-2#1)
of both beneficial and harmful##2##5##(2008-10#1)(2013-8#1)
of both biocontrol##2##3##(2008-10#2)
of both cell lines##3##4##(1994-8#1)(1997-1#1)(2008-11#1)
of both cell##4##3##(1994-8#1)(1997-1#1)(2008-11#2)
of both cells##2##3##(1993-8#1)(2008-9#1)
of both compounds##3##3##(2008-10#3)
of both cultivars##2##3##(2008-10#2)
of both drugs##4##3##(2008-10#2)(2008-5#2)
of both enzymes##4##3##(1993-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
of both factors##2##3##(2008-10#1)(2008-7#1)
of both female and male##2##5##(1990-3#1)(1994-2#1)
of both free and##5##4##(1990-12#1)(1991-2#1)(2008-10#1)(2008-7#2)
of both fungi##3##3##(2008-10#3)
of both gene pools##3##4##(2008-10#3)
of both genes##3##3##(1991-6#1)(2008-10#2)
of both genetic and environmental##2##5##(2008-12#1)(2012-2#1)
of both genetic##3##3##(2008-12#1)(2010-10#1)(2012-2#1)
of both genotypes##2##3##(2008-10#2)
of both groups##3##3##(2008-5#2)(2011-2#1)
of both hands and##2##4##(2010-6#1)(2012-3#1)
of both hands##3##3##(1996-8#1)(2010-6#1)(2012-3#1)
of both host##2##3##(2008-10#1)(2008-8#1)
of both in##2##3##(1993-8#1)(2008-5#1)
of both insulin and##2##4##(2008-7#1)(2010-6#1)
of both lesions##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
of both limbs##2##3##(2013-1#1)(2013-8#1)
of both liver##2##3##(1990-5#2)
of both metals in##2##4##(2008-10#2)
of both metals##5##3##(2008-10#5)
of both methods##10##3##(2008-10#7)(2008-3#1)(2011-2#1)(2012-3#1)
of both models##2##3##(2008-10#1)(2008-7#1)
of both normal and##3##4##(1990-12#1)(1997-1#1)(2008-10#1)
of both normal##4##3##(1990-12#1)(1997-1#1)(2008-10#1)(2010-4#1)
of both of##2##3##(2008-8#1)(2013-1#1)
of both organic and##3##4##(2008-10#3)
of both organisms##2##3##(2008-10#1)(2012-2#1)
of both parental species##2##4##(2008-10#1)(2008-8#1)
of both parental##3##3##(2008-10#1)(2008-8#2)
of both pathogens##3##3##(2008-10#3)
of both patients##2##3##(1991-3#1)(2009-12#1)
of both platinum and palladium##2##5##(2008-10#2)
of both populations##2##3##(2008-8#1)(2013-8#1)
of both positive and negative##2##5##(1993-12#1)(1995-8#1)
of both products of##2##4##(1991-3#1)(1993-12#1)
of both protein##2##3##(1993-12#1)(1994-11#1)
of both proteins##4##3##(1995-11#1)(1995-8#1)(2008-10#1)(2009-10#1)
of both sample##2##3##(2008-10#2)
of both scientific##2##3##(2008-10#1)(2012-2#1)
of both sexes##18##3##(1990-11#2)(1993-8#2)(1995-8#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#4)(2008-8#1)(2012-3#1)
of both size and##2##4##(1993-9#1)(2008-10#1)
of both species in##4##4##(2008-10#2)(2008-8#1)(2012-8#1)
of both species were##4##4##(1991-8#1)(2008-10#2)(2010-8#1)
of both species##18##3##(1991-8#1)(1992-3#1)(1994-11#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#2)(2012-8#1)
of both strains and##2##4##(2008-10#1)(2008-11#1)
of both strains##5##3##(2008-10#4)(2008-11#1)
of both subjective and##2##4##(2008-5#1)(2013-1#1)
of both substances##2##3##(2008-10#2)
of both techniques##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
of both temperature and##3##4##(1994-5#1)(2008-10#2)
of both the number of##2##5##(1997-7#1)(2008-10#1)
of both the protein##2##4##(2008-4#1)(2010-1#1)
of both the##71##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-7#2)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-12#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
of both types of##6##4##(1994-8#1)(1997-1#1)(2006-6#1)(2007-12#1)(2008-11#1)(2012-2#1)
of both viruses##6##3##(1995-12#1)(2008-10#5)
of both##622##2##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#5)(1990-8#1)(1991-1#3)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-6#4)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#6)(1993-9#4)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#7)(1995-11#3)(1995-12#1)(1995-5#1)(1995-6#4)(1995-8#3)(1995-9#3)(1996-1#2)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-6#3)(2007-12#7)(2008-1#1)(2008-10#224)(2008-11#33)(2008-12#7)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#20)(2008-6#3)(2008-7#20)(2008-8#17)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#4)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#4)(2010-3#1)(2010-4#1)(2010-6#4)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#19)(2011-7#1)(2012-12#4)(2012-2#11)(2012-3#13)(2012-7#1)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#8)
of botrocetin##2##2##(1993-3#1)(1994-11#1)
of botulinum neurotoxin##4##3##(1994-11#3)(2011-2#1)
of botulinum toxin type A##3##5##(2008-10#2)(2008-8#1)
of botulinum toxin##6##3##(2008-10#2)(2008-8#2)(2012-3#2)
of botulinum##10##2##(1994-11#3)(2008-10#2)(2008-8#2)(2011-2#1)(2012-3#2)
of botulism in##3##3##(1991-3#1)(2007-12#2)
of bound##13##2##(1990-12#1)(1991-11#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)
of boundary##3##2##(1991-3#1)(2008-11#2)
of bovine adrenal##2##3##(1992-6#1)(2009-9#1)
of bovine blastocysts##2##3##(2008-11#2)
of bovine brain##4##3##(1993-8#1)(1994-5#1)(1997-2#1)(2013-7#1)
of bovine hemoglobin##3##3##(1995-3#3)
of bovine herpesvirus 1##2##4##(2011-2#2)
of bovine seminal plasma##2##4##(1990-5#1)(1994-3#1)
of bovine seminal##3##3##(1990-5#2)(1994-3#1)
of bovine serum albumin (BSA)##2##5##(2008-10#2)
of bovine serum albumin##5##4##(1993-8#1)(2008-10#3)(2008-9#1)
of bovine spongiform encephalopathy##2##4##(2011-2#2)
of bovine trypsin##2##3##(1990-12#2)
of bovine##49##2##(1990-12#3)(1990-5#2)(1990-8#3)(1991-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#3)(1995-9#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#4)(2008-11#9)(2008-9#1)(2009-9#1)(2011-2#4)(2012-12#1)(2013-7#1)
of bowel##3##2##(1994-2#1)(1996-6#1)(2012-2#1)
of boys##4##2##(1996-11#2)(2008-10#1)(2013-8#1)
of brain activity##2##3##(2008-11#1)(2009-8#1)
of brain and##3##3##(1994-11#1)(2009-8#1)(2010-12#1)
of brain function##5##3##(1992-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)
of brain injury##4##3##(1992-3#1)(2009-11#1)(2011-2#1)(2011-7#1)
of brain regions##7##3##(1995-12#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-12#1)(2013-8#1)
of brain research##2##3##(2010-9#2)
of brain size##3##3##(2012-3#3)
of brain tissue##2##3##(1990-10#1)(2008-6#1)
of brain tumors##5##3##(1995-2#2)(2008-11#1)(2011-2#2)
of brain tumours##2##3##(2008-7#2)
of brain##80##2##(1990-10#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#3)(1992-3#2)(1994-11#1)(1994-2#4)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#4)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-11#11)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2009-11#2)(2009-5#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-9#2)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-8#2)
of brain-derived neurotrophic factor##2##4##(1997-2#1)(2011-2#1)
of brain-initiated normal and pathological behaviors##2##6##(2009-5#2)
of brainstem##2##2##(1994-2#1)(2008-12#1)
of branched-chain amino acids##2##4##(1993-12#1)(1994-5#1)
of branches##4##2##(2008-10#1)(2008-12#3)
of brassinosteroid##2##2##(2008-9#1)(2009-8#1)
of brazzein##3##2##(2008-9#3)
of bread##2##2##(1990-8#1)(2008-10#1)
of breast and endometrial cancer##2##5##(2008-10#1)(2011-2#1)
of breast and##5##3##(1990-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
of breast cancer and##4##4##(1990-11#1)(1993-11#1)(1994-12#1)(2013-8#1)
of breast cancer are##2##4##(1996-11#1)(2012-3#1)
of breast cancer cells in the brain##2##7##(2012-2#2)
of breast cancer cells##3##4##(2012-2#2)(2013-8#1)
of breast cancer in Nepal##4##5##(2010-8#4)
of breast cancer in##6##4##(1993-1#1)(1997-7#1)(2010-8#4)
of breast cancer patients and##2##5##(1992-2#1)(1994-3#1)
of breast cancer patients##4##4##(1992-2#1)(1993-1#1)(1993-11#1)(1994-3#1)
of breast cancer screening##2##4##(1994-3#1)(1997-1#1)
of breast cancer was##2##4##(1993-1#1)(2012-3#1)
of breast cancer which##3##4##(1990-11#1)(2012-3#1)(2013-7#1)
of breast cancer##62##3##(1990-11#3)(1990-12#2)(1990-8#1)(1991-2#1)(1992-2#3)(1993-1#4)(1993-11#7)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#2)(1996-11#2)(1997-1#2)(1997-7#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-1#1)(2009-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#2)(2012-2#5)(2012-3#5)(2013-7#3)(2013-8#2)
of breast cancers##4##3##(1993-11#2)(1994-12#1)(1997-7#1)
of breast carcinoma##4##3##(1994-12#4)
of breast lesions##2##3##(2012-2#2)
of breast reconstruction##2##3##(1990-9#1)(2013-1#1)
of breast##98##2##(1990-11#4)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#1)(1992-2#3)(1992-9#1)(1993-1#4)(1993-11#10)(1993-2#1)(1993-6#1)(1994-12#6)(1994-2#1)(1994-3#2)(1994-9#2)(1995-6#1)(1996-11#2)(1997-1#2)(1997-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#3)(2009-1#1)(2009-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#5)(2013-1#4)(2013-7#3)(2013-8#2)
of breastfeeding##5##2##(1991-8#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
of breath##9##2##(2007-12#1)(2008-7#3)(2010-10#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
of breeders##2##2##(2008-8#2)
of breeding##6##2##(2008-10#3)(2008-8#3)
of bridge##2##2##(1995-6#1)(2009-10#1)
of bridging##2##2##(2008-3#1)(2011-2#1)
of brief##6##2##(1997-2#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-1#1)
of bright##2##2##(1991-5#1)(2013-1#1)
of brine##2##2##(2008-10#1)(2008-9#1)
of broad##5##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
of broadband##4##2##(2007-11#1)(2008-3#3)
of broccoli##5##2##(2008-10#5)
of broiler chicks##2##3##(2008-12#2)
of bromate##6##2##(2008-10#6)
of bromazepam##4##2##(1990-8#1)(2008-10#3)
of bromhexine##2##2##(2008-10#1)(2009-7#1)
of bromide in seawater##4##4##(2008-10#4)
of bromide in##6##3##(2008-10#6)
of bromide ion in##3##4##(2008-10#3)
of bromide ion##4##3##(2008-10#4)
of bromide ions##3##3##(2008-10#3)
of bromide##21##2##(2008-10#21)
of bromine##2##2##(2008-10#2)
of bromoalcohols##2##2##(2008-10#2)
of bromocriptine on##2##3##(1991-1#1)(2008-7#1)
of bromophenols##2##2##(2008-10#2)
of bromopropylate##2##2##(2008-10#2)
of bronchial##5##2##(1992-9#1)(1995-12#1)(1996-3#1)(2008-1#1)(2012-3#1)
of bronchiectasis##2##2##(2007-8#1)(2011-3#1)
of brooms on##2##3##(2008-10#2)
of brooms##3##2##(2008-10#3)
of brown hare##2##3##(2013-1#2)
of brown rot of##3##4##(2008-10#3)
of brown rot##9##3##(2008-10#9)
of brown stem rot of soybean##2##6##(2008-10#2)
of brown stem rot was##3##5##(2008-10#3)
of brown stem rot##9##4##(2008-10#9)
of brown##24##2##(2008-10#21)(2008-11#1)(2013-1#2)
of buagafuran in##5##3##(2011-3#5)
of buagafuran was##3##3##(2011-3#3)
of buagafuran##8##2##(2011-3#8)
of budding yeast##3##3##(1995-12#1)(1995-2#1)(2008-9#1)
of buffer solution##2##3##(2008-10#2)
of buffer solutions##2##3##(2008-10#1)(2008-5#1)
of buffer##12##2##(2008-10#11)(2008-5#1)
of buffered##2##2##(2008-10#2)
of buffers##3##2##(2008-10#3)
of building an##2##3##(1996-3#1)(2008-10#1)
of building##5##2##(1996-3#1)(1997-3#1)(2008-10#2)(2008-12#1)
of bulk drug##2##3##(2008-10#2)
of bulk liquids##4##3##(2008-11#4)
of bulk water##2##3##(2008-5#2)
of bulk##10##2##(1993-8#1)(2008-10#3)(2008-11#4)(2008-5#2)
of bullfrog##4##2##(1997-7#4)
of bullying##6##2##(2008-11#5)(2009-7#1)
of bundled##2##2##(2009-7#1)(2009-9#1)
of buprenorphine##9##2##(1991-1#3)(2008-11#5)(2008-6#1)
of burden##2##2##(2011-2#1)(2013-8#1)
of burnout##10##2##(1992-1#1)(1995-1#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#2)(2010-2#1)(2010-7#1)
of business##3##2##(1992-11#2)(1995-6#1)
of butane##3##2##(2008-10#1)(2011-2#2)
of butyrate##3##2##(2008-11#3)
of butyric acid##2##3##(2008-11#2)
of butyric##3##2##(1993-8#1)(2008-11#2)
of c-Abl##2##2##(1995-8#2)
of c-FLIP##3##2##(2012-2#3)
of c-FLIP(L)##2##2##(2012-2#2)
of c-Jun##3##2##(1995-2#2)(1996-12#1)
of c-KIT##2##2##(2013-1#2)
of c-Myc in##2##3##(2013-1#2)
of c-Myc##7##2##(1994-9#2)(2008-11#1)(2013-1#4)
of c-fos##5##2##(1994-11#1)(1996-12#2)(1997-2#1)(2008-9#1)
of c-jun AS##2##3##(2008-11#2)
of c-jun gene##2##3##(1995-8#1)(2008-11#1)
of c-jun##6##2##(1995-8#3)(2008-11#3)
of c-myb##2##2##(1990-6#2)
of c-myc gene expression##2##4##(2008-11#1)(2008-8#1)
of c-myc gene##3##3##(2008-11#1)(2008-8#2)
of c-myc##11##2##(1993-1#1)(1993-2#2)(2008-11#5)(2008-8#3)
of cAMP formation##2##3##(1992-4#1)(1995-12#1)
of cAMP in##2##3##(1997-2#1)(2010-1#1)
of cAMP on##2##3##(1994-11#1)(1995-6#1)
of cAMP pathway##3##3##(2008-11#3)
of cAMP##20##2##(1992-4#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-2#6)(2008-10#1)(2008-11#4)(2008-8#2)(2010-1#1)
of cAMP-dependent protein kinase##3##4##(1990-2#1)(1995-2#1)(2008-10#1)
of cAMP-dependent##4##2##(1990-2#1)(1994-8#1)(1995-2#1)(2008-10#1)
of cDNA clones##9##3##(1991-6#1)(1995-8#2)(1996-2#2)(1996-8#1)(1997-2#3)
of cDNA encoding##2##3##(1990-5#1)(1993-2#1)
of cDNA libraries##2##3##(1997-6#1)(2008-11#1)
of cDNA##23##2##(1990-5#1)(1991-6#1)(1991-9#1)(1993-2#1)(1995-8#2)(1996-12#2)(1996-2#2)(1996-8#1)(1997-2#3)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-5#2)
of cDNAs##5##2##(1990-8#1)(1991-6#1)(1991-7#1)(1993-6#1)(2008-11#1)
of cFIX cDNA##2##3##(2008-9#2)
of cGMP##4##2##(1995-2#2)(1995-8#1)(2008-7#1)
of cGMP-binding##2##2##(1995-8#2)
of cLBP##2##2##(2013-1#2)
of cTR##3##2##(1991-6#3)
of cTnI##3##2##(2008-10#1)(2010-12#2)
of ca##16##2##(1993-8#1)(1995-8#1)(1996-5#1)(1996-6#1)(2008-10#9)(2009-3#2)(2010-10#1)
of cabbage##4##2##(1997-8#1)(2008-10#3)
of cachexia##2##2##(2008-10#2)
of cadaver organs##2##3##(1994-1#1)(1995-12#1)
of cadmium (II) and lead (II)##2##6##(2008-10#2)
of cadmium (II)##3##3##(2008-10#3)
of cadmium and copper##3##4##(2008-10#3)
of cadmium and lead in biological##2##6##(2008-10#2)
of cadmium and lead in table salt samples##3##8##(2008-10#3)
of cadmium and lead in table salt##4##7##(2008-10#4)
of cadmium and lead in##9##5##(2008-10#9)
of cadmium and lead##12##4##(2008-10#12)
of cadmium and zinc##4##4##(1994-6#1)(2008-10#3)
of cadmium and##20##3##(1994-6#1)(2008-10#19)
of cadmium at##2##3##(2008-10#2)
of cadmium from##2##3##(2008-10#2)
of cadmium in sewage sludge by differential pulse anodic stripping voltammetry##2##11##(2008-10#2)
of cadmium in the##2##4##(1993-12#1)(2008-10#1)
of cadmium in urine by##2##5##(2008-10#2)
of cadmium in urine specimens by graphite furnace atomic absorption spectrometry##2##11##(2008-10#2)
of cadmium in urine##4##4##(2008-10#4)
of cadmium in water##3##4##(2008-10#3)
of cadmium in##24##3##(1993-12#1)(2008-10#23)
of cadmium was##2##3##(2008-10#2)
of cadmium##85##2##(1990-5#1)(1993-12#1)(1994-6#1)(2008-10#81)(2008-11#1)
of cadmium(II) and##4##3##(1991-5#1)(2008-10#3)
of cadmium(II)##9##2##(1991-5#1)(2008-10#8)
of caffeic acid in##2##4##(2008-11#2)
of caffeic acid##5##3##(2008-10#1)(2008-11#2)(2013-1#2)
of caffeine and nicotine in people with schizophrenia##2##8##(2009-7#2)
of caffeine and nicotine##3##4##(2009-7#3)
of caffeine and##4##3##(2008-10#1)(2009-7#3)
of caffeine in##2##3##(2008-10#2)
of caffeine on Ca2+ fluxes and##2##6##(1995-11#2)
of caffeine on##5##3##(1995-11#5)
of caffeine##20##2##(1990-2#1)(1991-1#1)(1995-11#5)(2008-10#10)(2009-7#3)
of calcaneal intraosseous##2##3##(2010-3#2)
of calcaneal##3##2##(2010-3#3)
of calcaneocuboid##2##2##(2009-10#1)(2012-2#1)
of calcification##2##2##(2012-12#1)(2013-1#1)
of calcineurin##2##2##(1991-9#1)(2008-9#1)
of calcitonin gene-related peptide in the rat##2##7##(1992-6#2)
of calcitonin gene-related peptide in the##4##6##(1992-6#4)
of calcitonin gene-related peptide in##6##5##(1992-6#6)
of calcitonin gene-related peptide##8##4##(1992-6#8)
of calcitonin##13##2##(1990-2#3)(1990-9#1)(1992-6#9)
of calcium and cadmium##2##4##(2008-10#2)
of calcium and magnesium in##4##5##(2008-10#4)
of calcium and magnesium ions##2##5##(2008-10#2)
of calcium and magnesium##10##4##(2008-10#10)
of calcium and##22##3##(1990-8#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-6#1)(1997-8#1)(2008-10#15)(2013-1#1)
of calcium antagonists##4##3##(1990-6#1)(1991-8#2)(2008-7#1)
of calcium carbonate##4##3##(2008-10#3)(2012-12#1)
of calcium channel blockers##4##4##(2008-10#1)(2008-11#3)
of calcium channel##5##3##(2008-10#1)(2008-11#3)(2012-12#1)
of calcium concentration in##2##4##(2008-10#1)(2013-8#1)
of calcium concentrations##2##3##(1993-6#1)(2009-8#1)
of calcium in the##2##4##(1991-2#1)(2008-10#1)
of calcium in##8##3##(1991-2#1)(1993-6#1)(2008-10#5)(2008-8#1)
of calcium ions##5##3##(1995-11#2)(1995-8#2)(2008-10#1)
of calcium is##2##3##(1997-8#2)
of calcium oxalate##6##3##(1991-12#1)(1992-9#3)(2008-10#2)
of calcium oxide##2##3##(2013-1#2)
of calcium removal##2##3##(2008-8#2)
of calcium to##2##3##(1994-3#1)(2011-2#1)
of calcium with##2##3##(2008-10#2)
of calcium##117##2##(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-9#4)(1993-11#1)(1993-6#4)(1994-11#1)(1994-3#1)(1995-11#3)(1995-2#2)(1995-8#2)(1997-5#1)(1997-8#3)(2008-1#1)(2008-10#53)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-8#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#2)
of calcium-based##2##2##(2012-12#2)
of calcium/calmodulin-dependent protein kinase II##3##5##(1995-2#2)(1996-2#1)
of calcium/calmodulin-dependent##4##2##(1995-2#2)(1996-12#1)(1996-2#1)
of calculation##2##2##(2008-10#1)(2008-11#1)
of calculations##2##2##(2008-10#1)(2008-2#1)
of caldesmon##4##2##(1994-5#4)
of calendar instruments##2##3##(2010-1#2)
of calendar##3##2##(2010-1#3)
of calf##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
of calibration and validation##2##4##(2008-10#2)
of calibration curve##2##3##(2008-10#2)
of calibration curves##3##3##(2008-10#2)(2010-11#1)
of calibration##19##2##(2008-10#14)(2008-3#2)(2010-11#1)(2011-2#1)(2013-1#1)
of callose##2##2##(2008-10#2)
of callus and##2##3##(2008-12#2)
of callus##4##2##(2008-10#1)(2008-12#3)
of calmodulin and##2##3##(1995-11#1)(2008-8#1)
of calmodulin in##2##3##(1994-3#1)(2008-8#1)
of calmodulin##11##2##(1993-6#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-2#3)(2008-10#1)(2008-8#3)
of calorimetry##2##2##(2011-1#2)
of calpain I##3##3##(1992-6#3)
of calpain##9##2##(1990-2#3)(1992-12#2)(1992-6#3)(2008-11#1)
of calponin##3##2##(1993-6#3)
of calreticulin##3##2##(1994-11#3)
of calsequestrin##2##2##(1990-2#2)
of calves##6##2##(1996-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
of campylobacteriosis##3##2##(2008-10#1)(2008-7#2)
of cancellous##2##2##(2009-7#1)(2010-3#1)
of cancer and##6##3##(1992-9#1)(1994-5#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)
of cancer as##2##3##(1994-2#1)(2013-7#1)
of cancer biology##2##3##(1992-2#1)(2008-11#1)
of cancer care to##2##4##(2012-3#2)
of cancer care##5##3##(2008-11#1)(2012-3#4)
of cancer cases##2##3##(1995-12#1)(2011-3#1)
of cancer cell lines##2##4##(2008-11#1)(2009-4#1)
of cancer cell##7##3##(2008-11#2)(2008-9#3)(2009-4#1)(2013-8#1)
of cancer cells and of##2##5##(2008-11#1)(2013-8#1)
of cancer cells and##4##4##(1991-6#1)(2008-11#1)(2008-9#1)(2013-8#1)
of cancer cells is##2##4##(2011-2#1)(2013-1#1)
of cancer cells to##3##4##(2008-11#2)(2009-7#1)
of cancer cells##23##3##(1991-6#2)(2008-11#8)(2008-9#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#2)
of cancer control programs##2##4##(2011-3#2)
of cancer control##5##3##(1997-1#3)(2011-3#2)
of cancer deaths in##2##4##(2008-7#1)(2009-12#1)
of cancer deaths##3##3##(1997-1#1)(2008-7#1)(2009-12#1)
of cancer during##3##3##(1994-9#1)(2013-1#2)
of cancer in the##2##4##(1990-6#1)(2013-1#1)
of cancer in##5##3##(1990-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
of cancer is##3##3##(2008-11#1)(2010-6#1)(2013-7#1)
of cancer mortality##4##3##(1990-8#1)(1994-2#1)(2008-7#1)(2009-10#1)
of cancer of the##6##4##(1990-3#1)(1990-9#1)(1996-6#1)(2009-11#1)(2010-12#2)
of cancer pain##7##3##(1997-3#3)(2008-7#1)(2012-2#3)
of cancer patients##6##3##(1992-3#1)(1994-12#1)(2008-10#2)(2008-5#1)(2011-3#1)
of cancer prevention##2##3##(1997-1#1)(2013-1#1)
of cancer treatment##2##3##(2008-11#1)(2008-7#1)
of cancer##184##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-3#1)(1991-6#4)(1992-12#2)(1992-2#2)(1992-3#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-11#2)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#26)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#13)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#5)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#7)(2011-3#7)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#6)
of cancer-causing##2##2##(2011-2#1)(2011-3#1)
of cancer-related##5##2##(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
of cancers in##2##3##(1994-12#1)(1995-11#1)
of cancers##15##2##(1991-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-7#1)(2013-8#1)
of candidate genes##5##3##(1997-8#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
of candidate##8##2##(1997-8#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#2)
of candour##2##2##(2013-8#2)
of canine leukocytes##2##3##(2008-10#2)
of canine rabies##2##3##(2011-2#2)
of canine##14##2##(1994-11#2)(1995-2#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#3)(2012-2#1)(2012-3#1)
of canker##2##2##(2008-10#2)
of cankers was##2##3##(2008-10#2)
of cankers##3##2##(2008-10#3)
of cannabinoid binding sites##2##4##(1996-2#2)
of cannabinoid##3##2##(1996-2#2)(2009-12#1)
of cannabinoids##2##2##(1997-8#1)(2008-11#1)
of cannabis##9##2##(2008-12#3)(2009-7#3)(2013-8#3)
of canola##5##2##(2008-10#5)
of canopy closure##3##3##(2008-10#3)
of canopy##5##2##(2008-10#5)
of cantaloupe fruit##2##3##(2008-10#2)
of cantaloupe##11##2##(2008-10#11)
of capability##3##2##(1990-2#1)(1997-3#1)(2013-1#1)
of capacity and##3##3##(2008-7#1)(2010-8#2)
of capacity##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#2)
of capillary electrophoresis (CE)##3##4##(2008-10#2)(2010-7#1)
of capillary electrophoresis is##2##4##(2008-10#2)
of capillary electrophoresis to##4##4##(2008-10#4)
of capillary electrophoresis##12##3##(2008-10#9)(2008-2#1)(2008-5#1)(2010-7#1)
of capillary waves in##2##4##(2008-3#2)
of capillary waves##3##3##(2008-3#3)
of capillary zone electrophoresis##3##4##(2008-10#3)
of capillary##26##2##(2008-10#20)(2008-2#1)(2008-3#3)(2008-5#1)(2010-7#1)
of capital for##2##3##(1993-1#1)(1994-2#1)
of capital##7##2##(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(2013-8#1)
of capitation##3##2##(1991-2#1)(1997-1#2)
of capped RNA##2##3##(2011-2#2)
of capsaicin on the##2##4##(1992-6#1)(1993-11#1)
of capsaicin on##5##3##(1992-6#1)(1993-11#2)(2008-11#1)(2009-9#1)
of capsaicin##12##2##(1992-6#4)(1993-11#2)(1997-4#2)(2008-11#3)(2009-9#1)
of capsule endoscopy##2##3##(2010-12#1)(2011-2#1)
of captopril##9##2##(1990-11#1)(1993-2#1)(2008-10#5)(2008-7#2)
of capturing##2##2##(2010-9#1)(2011-7#1)
of carbachol and##2##3##(1994-8#1)(1996-12#1)
of carbachol##10##2##(1994-8#6)(1996-12#3)(1997-1#1)
of carbamates##3##2##(2008-10#3)
of carbaryl##6##2##(2008-10#6)
of carbofuran##5##2##(2008-10#5)
of carbohydrate metabolism##2##3##(2008-10#2)
of carbohydrate##9##2##(1993-1#1)(1994-5#1)(1995-8#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-12#1)(2011-1#1)
of carbohydrates##5##2##(1993-1#1)(1995-3#1)(1995-8#1)(2008-10#2)
of carbon dioxide in gaseous samples##2##6##(2008-10#2)
of carbon dioxide in##3##4##(2008-10#3)
of carbon dioxide##13##3##(1992-1#1)(2008-10#10)(2008-11#2)
of carbon electrodes##2##3##(2008-10#1)(2013-1#1)
of carbon fibers for##2##4##(2008-10#2)
of carbon in##4##3##(2008-10#4)
of carbon nanotubes and##2##4##(2008-10#2)
of carbon nanotubes##8##3##(2008-10#5)(2008-7#1)(2010-4#1)(2011-2#1)
of carbon paste electrode modified with##2##6##(2008-10#2)
of carbon paste electrode##3##4##(2008-10#3)
of carbon##47##2##(1992-1#1)(2008-10#33)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
of carbonate in##3##3##(2008-10#3)
of carbonate##9##2##(2008-10#9)
of carbonyl compounds##4##3##(2008-10#4)
of carbonyl##6##2##(1996-5#1)(2008-10#4)(2009-8#1)
of carboxyl groups##2##3##(2008-10#2)
of carboxylic##5##2##(1997-2#1)(2008-10#2)(2010-4#1)(2011-2#1)
of carboxypeptidase M##2##3##(1995-6#2)
of carboxypeptidase##3##2##(1995-6#2)(1995-8#1)
of carcinoembryonic antigen (CEA)##2##4##(2008-10#1)(2008-11#1)
of carcinoembryonic antigen##3##3##(2008-10#2)(2008-11#1)
of carcinogenic##7##2##(1992-6#1)(2008-9#3)(2009-6#1)(2013-1#1)(2013-8#1)
of carcinoid##3##2##(2010-2#1)(2011-2#2)
of carcinoma cells##4##3##(1992-8#1)(2008-11#3)
of carcinoma was##2##3##(1990-11#1)(1993-8#1)
of carcinoma##11##2##(1990-11#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-8#1)(1995-3#1)(1997-8#1)(2008-11#3)(2011-2#1)
of carcinomas##3##2##(1994-12#2)(2012-3#1)
of carcinomatous##2##2##(1991-6#1)(2011-2#1)
of cardiac complications##2##3##(2008-11#1)(2009-5#1)
of cardiac computed tomography##2##4##(2008-12#1)(2013-2#1)
of cardiac contractility##3##3##(2008-9#2)(2010-4#1)
of cardiac function##2##3##(1992-6#1)(2010-6#1)
of cardiac hypertrophy##4##3##(2010-12#1)(2010-4#1)(2010-6#1)(2012-12#1)
of cardiac remodelling##2##3##(2012-3#2)
of cardiac troponin I (cTnI)##2##5##(2008-10#1)(2010-12#1)
of cardiac troponin I##3##4##(2008-10#2)(2010-12#1)
of cardiac troponin##4##3##(2008-10#2)(2008-6#1)(2010-12#1)
of cardiac##45##2##(1990-11#1)(1990-9#1)(1992-6#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-5#1)(2010-12#2)(2010-4#2)(2010-6#4)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-2#1)(2013-8#1)
of cardiomyocytes##2##2##(2008-11#1)(2008-7#1)
of cardiomyopathy##4##2##(1996-8#1)(2010-4#1)(2010-6#1)(2013-8#1)
of cardiopulmonary bypass##2##3##(2011-2#1)(2013-1#1)
of cardiopulmonary##3##2##(1994-9#1)(2011-2#1)(2013-1#1)
of cardiorespiratory##2##2##(2012-2#1)(2013-1#1)
of cardiovascular disease (CVD)##2##4##(2010-12#1)(2013-1#1)
of cardiovascular disease and##2##4##(2007-8#1)(2013-7#1)
of cardiovascular disease guided by total##2##6##(2013-1#2)
of cardiovascular disease in##2##4##(1993-12#1)(2008-7#1)
of cardiovascular disease##16##3##(1992-8#1)(1993-12#1)(1996-11#1)(2007-8#1)(2008-7#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-3#1)(2013-7#1)(2013-8#1)
of cardiovascular diseases in##4##4##(1991-6#2)(2008-11#1)(2009-10#1)
of cardiovascular diseases##9##3##(1991-6#2)(1993-11#1)(1995-2#2)(2008-11#2)(2008-8#1)(2009-10#1)
of cardiovascular risk factors##3##4##(2008-7#2)(2013-3#1)
of cardiovascular risk##6##3##(2008-7#2)(2009-12#1)(2010-9#1)(2013-1#1)(2013-3#1)
of cardiovascular##47##2##(1991-6#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-2#2)(1996-11#1)(2007-8#1)(2008-11#3)(2008-7#4)(2008-8#1)(2009-10#2)(2009-12#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-3#2)(2013-7#2)(2013-8#2)
of care across##2##3##(2010-12#1)(2012-3#1)
of care and##12##3##(1993-2#1)(1994-3#2)(1996-2#2)(1997-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)(2012-3#2)
of care are##4##3##(1997-3#1)(2010-12#2)(2011-1#1)
of care as##3##3##(1995-12#1)(2008-11#1)(2010-12#1)
of care coordination##2##3##(1993-3#1)(1995-3#1)
of care for patients##2##4##(2008-3#1)(2008-6#1)
of care for the##2##4##(1994-12#1)(2008-8#1)
of care for##12##3##(1991-2#1)(1993-1#1)(1993-12#1)(1994-12#2)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)
of care in teaching nursing homes##2##6##(1996-2#2)
of care in the##5##4##(1991-11#1)(2008-11#2)(2013-1#2)
of care in##19##3##(1991-11#1)(1991-3#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-2#4)(1997-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2010-12#1)(2013-1#3)
of care of##4##3##(1990-6#1)(1995-5#1)(2008-1#1)(2012-3#1)
of care provided to##3##4##(1992-1#1)(1996-2#1)(2008-3#1)
of care provided##7##3##(1992-1#2)(1993-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-3#1)
of care related to##3##4##(1995-2#1)(2008-3#2)
of care that are##2##4##(1994-12#1)(2008-7#1)
of care to##3##3##(1994-2#1)(2008-11#1)(2010-10#1)
of care used to deliver##2##5##(2009-10#2)
of care used##3##3##(1991-1#1)(2009-10#2)
of care were##2##3##(1994-12#1)(2009-3#1)
of care with##3##3##(1992-3#1)(1994-12#1)(1994-2#1)
of care##207##2##(1990-6#2)(1991-1#3)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#3)(1992-1#4)(1992-2#3)(1992-3#4)(1992-4#2)(1993-1#6)(1993-12#3)(1993-2#2)(1993-3#7)(1993-6#1)(1994-12#8)(1994-2#5)(1994-3#6)(1995-12#5)(1995-2#4)(1995-3#5)(1995-5#1)(1996-1#4)(1996-2#16)(1996-3#3)(1997-1#4)(1997-2#7)(1997-3#3)(1997-4#1)(1997-8#3)(2008-1#1)(2008-10#3)(2008-11#14)(2008-12#3)(2008-3#8)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2010-10#2)(2010-12#8)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#9)(2013-1#10)(2013-8#1)
of career##2##2##(1991-6#1)(2012-2#1)
of caregivers and##2##3##(2009-5#2)
of caregivers##7##2##(1991-12#1)(1993-11#1)(1994-1#1)(2009-5#2)(2012-3#1)(2013-8#1)
of caregiving##5##2##(1991-12#1)(1996-1#1)(2008-6#1)(2008-7#2)
of caries and periodontal disease##2##5##(1990-3#2)
of caries##3##2##(1990-3#2)(1991-6#1)
of caring for##4##3##(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#1)
of caring##6##2##(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-8#1)(2013-8#1)
of carminic acid##6##3##(2008-10#6)
of carotenogenesis##2##2##(2010-10#2)
of carotenoid biosynthesis##2##3##(1995-2#1)(2009-10#1)
of carotenoid##5##2##(1995-2#1)(2008-8#3)(2009-10#1)
of carotid artery##5##3##(2008-11#1)(2010-10#1)(2011-2#3)
of carotid##11##2##(1990-5#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2011-2#4)
of carp hemoglobin##2##3##(1990-8#2)
of carp##5##2##(1990-8#2)(2008-10#3)
of carpal tunnel syndrome##3##4##(2008-12#1)(2010-8#2)
of carpal##4##2##(2008-12#1)(2010-8#2)(2013-1#1)
of carrier solution##2##3##(2008-10#2)
of carrier##7##2##(1995-5#1)(2008-10#5)(2008-7#1)
of carriers##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
of carrot##3##2##(2008-10#2)(2008-9#1)
of carrying out a##2##4##(1990-9#1)(2008-10#1)
of carrying out##3##3##(1990-9#1)(2008-10#1)(2008-7#1)
of carrying##6##2##(1990-9#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-7#1)
of carthamin at##3##3##(2008-11#3)
of carthamin##4##2##(2008-11#4)
of cartilage and bone##2##4##(1991-5#1)(2007-11#1)
of cartilage##11##2##(1990-11#1)(1990-3#1)(1991-5#1)(1993-2#3)(2007-11#1)(2008-11#2)(2008-7#1)(2009-1#1)
of carvacrol on##2##3##(2008-11#2)
of carvacrol##7##2##(2008-11#7)
of carvedilol##3##2##(2008-10#3)
of case mix and##3##4##(1992-12#2)(1995-2#1)
of case mix##8##3##(1991-12#1)(1992-12#2)(1992-2#1)(1995-2#4)
of case reports##2##3##(2011-2#1)(2013-1#1)
of case studies##3##3##(2008-11#3)
of case##19##2##(1991-12#3)(1991-8#1)(1992-12#2)(1992-2#1)(1993-1#1)(1995-2#4)(2008-11#3)(2008-8#1)(2011-2#1)(2013-1#2)
of case-mix##2##2##(1993-1#1)(1993-2#1)
of casein kinase I##3##4##(1993-6#1)(1994-11#2)
of casein kinase II##2##4##(1990-12#1)(1994-11#1)
of casein kinase##5##3##(1990-12#1)(1993-6#1)(1994-11#3)
of cases and controls##6##4##(1990-8#1)(1992-9#1)(2008-10#1)(2011-2#3)
of cases and##12##3##(1990-8#1)(1992-9#2)(2008-10#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-8#1)
of cases are due to##4##5##(1995-12#1)(2008-11#1)(2010-2#1)(2013-1#1)
of cases are##7##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-2#1)(2013-1#1)
of cases at##2##3##(1990-9#1)(2008-10#1)
of cases but##2##3##(2008-5#1)(2011-2#1)
of cases classified as##2##4##(2011-2#2)
of cases have been##2##4##(2008-7#1)(2013-1#1)
of cases in patients##2##4##(2008-12#1)(2012-3#1)
of cases in the##3##4##(1994-9#1)(1997-6#1)(2010-3#1)
of cases in which##2##4##(2008-9#1)(2013-1#1)
of cases in##9##3##(1994-9#2)(1995-12#1)(1997-6#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
of cases of##15##3##(1990-6#1)(1990-9#1)(1992-9#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
of cases that had a##2##5##(2011-1#2)
of cases that##4##3##(1993-12#1)(2008-6#1)(2011-1#2)
of cases the##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)
of cases were##2##3##(1992-12#1)(1994-3#1)
of cases with##9##3##(1990-12#1)(1990-8#1)(1991-2#1)(1995-2#1)(1997-3#1)(2008-7#1)(2011-2#1)(2013-8#2)
of cases within##2##3##(1993-1#1)(2008-7#1)
of cases##147##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-5#1)(1992-9#6)(1993-1#3)(1993-11#1)(1993-12#3)(1993-3#1)(1994-3#1)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#2)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#3)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#18)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#10)(2013-8#5)
of caspase activation##3##3##(2008-11#3)
of caspase##4##2##(2008-11#3)(2011-2#1)
of caspase-3##5##2##(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2011-3#1)
of caspases##2##2##(2008-11#1)(2008-4#1)
of cassava##4##2##(2008-10#4)
of castration-resistant##2##2##(2011-2#1)(2013-8#1)
of cat##4##2##(1991-10#1)(1991-4#1)(2008-9#2)
of cat-86##3##2##(1991-9#3)
of catalase##4##2##(1990-3#1)(2008-10#2)(2008-7#1)
of catalysis on the##2##4##(2008-10#2)
of catalysis##4##2##(1995-6#1)(2008-10#2)(2008-4#1)
of catalysts##2##2##(2008-10#2)
of catalytic converters##2##3##(2008-10#2)
of catalytic##16##2##(1993-8#1)(1994-5#1)(1995-2#1)(1997-3#1)(2008-10#11)(2011-1#1)
of catastrophic##2##2##(2008-12#1)(2013-1#1)
of catechins##7##2##(2008-10#7)
of catechol##7##2##(2008-10#7)
of catecholamine##6##2##(1997-2#1)(2008-10#3)(2013-1#2)
of catecholaminergic##3##2##(1995-12#1)(1997-2#2)
of catecholamines in the##2##4##(1997-2#2)
of catecholamines in##6##3##(1997-2#2)(2008-10#4)
of catecholamines##8##2##(1997-2#2)(2008-10#6)
of categorization##2##2##(2008-5#1)(2012-2#1)
of cathepsin B##2##3##(1995-6#1)(2009-8#1)
of cathepsin D##3##3##(1994-5#2)(1995-8#1)
of cathepsin G##2##3##(1994-5#2)
of cathepsin##9##2##(1992-9#1)(1994-5#4)(1995-6#2)(1995-8#1)(2009-8#1)
of cathepsins B and D##3##5##(1995-6#2)(1997-1#1)
of catheter##6##2##(1991-3#1)(1994-6#1)(2008-7#1)(2011-2#2)(2013-1#1)
of cathodic electrolyte on the performance of electrochemical hydride generation##2##10##(2008-10#2)
of cathodic##3##2##(2008-10#3)
of cation##3##2##(2008-10#3)
of cationic arsenic##4##3##(2008-10#4)
of cationic polyelectrolytes##4##3##(2008-10#4)
of cationic species##3##3##(2008-10#2)(2009-9#1)
of cationic surfactant##3##3##(2008-10#3)
of cationic surfactants##3##3##(2008-10#3)
of cationic##34##2##(1995-2#2)(1996-12#2)(2008-10#23)(2008-11#2)(2008-5#4)(2009-9#1)
of cations and anions##4##4##(2008-10#4)
of cations and##5##3##(2008-10#5)
of cations with##3##3##(2008-10#3)
of cations##19##2##(1997-1#1)(2008-10#18)
of cats##2##2##(2008-8#1)(2012-3#1)
of cattle herds##2##3##(2011-2#2)
of cattle liver##2##3##(2008-10#2)
of cattle##12##2##(1990-9#1)(1991-8#1)(1996-12#2)(2008-10#4)(2010-4#1)(2011-2#2)(2013-1#1)
of cauliflower##3##2##(2008-10#3)
of causal##2##2##(2008-11#2)
of causes including##2##3##(2008-11#1)(2008-6#1)
of causes##4##2##(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#1)
of causing##12##2##(1993-9#2)(1997-8#1)(2006-6#1)(2008-10#6)(2008-11#1)(2012-12#1)
of caveolin##4##2##(1995-2#2)(1995-6#2)
of caveolin-1##2##2##(2010-1#2)
of cavernous##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
of cavity ringdown spectroscopy##3##4##(2008-3#3)
of cecal volvulus##2##3##(2012-3#2)
of cecropin CMIV##2##3##(2008-8#2)
of cecropin##5##2##(1994-5#3)(2008-8#2)
of cefadroxil monohydrate##2##3##(2008-10#2)
of cefadroxil##8##2##(2008-10#8)
of cefazolin sodium##3##3##(2008-10#3)
of cefazolin##4##2##(2008-10#4)
of cefixime was##2##3##(2008-10#2)
of cefixime##5##2##(2008-10#5)
of cefminox in##3##3##(2008-10#3)
of cefminox##5##2##(2008-10#5)
of ceftazidime##2##2##(2008-10#2)
of ceftibuten##2##2##(1994-8#2)
of celecoxib in##2##3##(2008-10#2)
of celecoxib##3##2##(2008-10#3)
of celiac disease##4##3##(2008-10#1)(2008-12#2)(2011-2#1)
of celiac##5##2##(2008-10#1)(2008-12#2)(2011-2#1)(2013-1#1)
of cell adhesion on##2##4##(2008-11#2)
of cell and##3##3##(2008-11#1)(2008-9#2)
of cell attachment##2##3##(1995-6#2)
of cell concentration##3##3##(2008-11#2)(2008-7#1)
of cell culture##9##3##(1993-12#1)(1997-7#1)(2008-11#6)(2008-8#1)
of cell cultures##5##3##(2008-11#5)
of cell cycle analyses##2##4##(2008-11#1)(2008-9#1)
of cell cycle analysis##3##4##(2008-11#2)(2008-9#1)
of cell cycle arrest##2##4##(2008-11#1)(2009-3#1)
of cell cycle phases##2##4##(2008-11#2)
of cell cycle progression##4##4##(1995-9#1)(1997-7#1)(2008-11#1)(2012-3#1)
of cell cycle##23##3##(1993-3#1)(1995-9#1)(1997-1#1)(1997-7#1)(2008-11#9)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#1)(2012-2#1)(2012-3#2)
of cell damage##2##3##(1992-9#1)(2012-12#1)
of cell death by##2##4##(2008-11#1)(2008-8#1)
of cell death in the##3##5##(1996-12#1)(2008-11#1)(2009-8#1)
of cell death##21##3##(1994-11#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#2)
of cell division##9##3##(1993-8#1)(2008-11#3)(2008-9#3)(2009-5#2)
of cell expansion##2##3##(2009-8#2)
of cell fusion##2##3##(2008-11#1)(2008-8#1)
of cell growth and##3##4##(2008-11#2)(2012-2#1)
of cell growth at##2##4##(2008-11#2)
of cell growth by##2##4##(1995-2#1)(2008-11#1)
of cell growth in a##2##5##(2008-7#2)
of cell growth in##5##4##(2008-11#3)(2008-7#2)
of cell growth##26##3##(1990-5#1)(1991-5#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-11#16)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)
of cell killing##2##3##(1993-8#1)(2008-9#1)
of cell kinetics##2##3##(1993-11#1)(2008-10#1)
of cell line cross-contamination##2##4##(2008-11#2)
of cell lines for##2##4##(2008-11#2)
of cell lines##10##3##(1991-6#1)(1992-8#1)(2008-11#7)(2008-9#1)
of cell membrane##2##3##(1994-5#1)(2011-3#1)
of cell membranes##4##3##(1991-5#1)(2008-10#1)(2008-11#1)(2009-7#1)
of cell metabolism##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
of cell migration##3##3##(2008-11#1)(2008-5#1)(2009-1#1)
of cell morphology##2##3##(2008-11#2)
of cell nuclei##2##3##(2010-8#2)
of cell numbers##2##3##(2008-7#2)
of cell proliferation and##4##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
of cell proliferation by##2##4##(1995-2#1)(2008-9#1)
of cell proliferation of MCF-7 cells##2##6##(2008-11#2)
of cell proliferation of##3##4##(1997-1#1)(2008-11#2)
of cell proliferation##16##3##(1992-3#1)(1995-12#1)(1995-2#2)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-9#3)
of cell properties##2##3##(2008-11#1)(2008-5#1)
of cell shape##4##3##(1994-8#1)(2008-11#2)(2011-2#1)
of cell signaling##2##3##(1991-9#1)(2008-10#1)
of cell sizes##2##3##(2008-10#2)
of cell specific##2##3##(1995-3#1)(2008-11#1)
of cell subsets##2##3##(1994-8#1)(2008-4#1)
of cell surface##11##3##(1994-5#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)
of cell survival##2##3##(2008-10#1)(2012-2#1)
of cell therapy##3##3##(1994-6#3)
of cell type specific factors##2##5##(2008-11#1)(2009-8#1)
of cell type##3##3##(1994-11#1)(2008-11#1)(2009-8#1)
of cell types##8##3##(1995-6#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2012-3#1)
of cell viability in##3##4##(2008-11#3)
of cell viability##6##3##(2008-11#5)(2008-9#1)
of cell wall extracts##3##4##(2008-5#3)
of cell wall##10##3##(2008-10#5)(2008-5#3)(2008-9#1)(2009-12#1)
of cell walls##6##3##(2008-10#6)
of cell##282##2##(1990-12#2)(1990-5#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#5)(1994-11#2)(1994-5#4)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#3)(1997-1#3)(1997-3#1)(1997-7#3)(1997-8#1)(2008-10#31)(2008-11#98)(2008-12#1)(2008-4#5)(2008-5#8)(2008-7#11)(2008-8#5)(2008-9#28)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
of cell-associated##2##2##(1993-6#1)(2008-11#1)
of cell-based therapies##2##3##(2008-10#1)(2008-9#1)
of cell-based##5##2##(2008-10#4)(2008-9#1)
of cell-cell##3##2##(2009-12#1)(2009-7#1)(2010-7#1)
of cell-cycle##2##2##(2008-11#1)(2012-3#1)
of cell-free##5##2##(2008-11#1)(2008-4#2)(2010-11#1)(2011-2#1)
of cell-mediated immunity##3##3##(2008-5#1)(2009-12#2)
of cell-mediated##4##2##(1994-11#1)(2008-5#1)(2009-12#2)
of cell-penetrating peptides##2##3##(2010-10#1)(2011-3#1)
of cell-surface##2##2##(1996-12#1)(2008-4#1)
of cells and cell##2##4##(2008-11#1)(2008-12#1)
of cells and##12##3##(1993-8#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#2)(2012-2#2)
of cells by##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
of cells can be##2##4##(2008-4#1)(2008-9#1)
of cells close to##2##4##(2008-10#1)(2009-12#1)
of cells cultured on##2##4##(2008-5#2)
of cells cultured##3##3##(1994-3#1)(2008-5#2)
of cells expressing##2##3##(1995-2#1)(2008-11#1)
of cells for##7##3##(2008-10#1)(2008-11#3)(2008-9#2)(2013-1#1)
of cells from the##2##4##(2007-12#1)(2008-11#1)
of cells from##6##3##(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-3#1)
of cells grown in##3##4##(2008-11#3)
of cells in the S##4##5##(1994-3#1)(2008-11#2)(2008-9#1)
of cells in the fraction were##2##6##(2008-11#2)
of cells in the##10##4##(1994-3#1)(1997-1#1)(2008-11#6)(2008-7#1)(2008-9#1)
of cells in vitro##2##4##(2008-11#2)
of cells in##23##3##(1993-11#1)(1994-3#1)(1995-2#1)(1997-1#1)(2008-11#12)(2008-7#1)(2008-9#4)(2010-10#1)(2012-2#1)
of cells infected with##2##4##(1993-6#1)(2008-7#1)
of cells into##2##3##(2008-7#1)(2009-8#1)
of cells known##2##3##(2008-12#1)(2010-6#1)
of cells may##2##3##(2007-12#1)(2008-11#1)
of cells of the##2##4##(1997-8#1)(2008-10#1)
of cells of##4##3##(1996-2#1)(1997-8#1)(2008-10#1)(2008-9#1)
of cells on##6##3##(1995-9#2)(2008-10#1)(2008-11#3)
of cells present##2##3##(2008-9#2)
of cells subjected to##2##4##(2008-7#1)(2009-12#1)
of cells that##4##3##(1994-8#1)(2008-10#2)(2008-9#1)
of cells through##3##3##(1995-2#1)(2008-11#2)
of cells to the inhibition of ubiquitin-proteasome pathway##2##8##(2008-9#2)
of cells to the##3##4##(2008-5#1)(2008-9#2)
of cells to##9##3##(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-3#1)
of cells treated with##2##4##(1997-1#1)(2013-8#1)
of cells was##3##3##(2008-11#1)(2009-12#1)(2013-1#1)
of cells with the##2##4##(1995-11#1)(2008-11#1)
of cells with##20##3##(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(2008-11#9)(2008-2#1)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#2)
of cells##205##2##(1990-11#1)(1990-3#1)(1992-6#2)(1992-7#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#6)(1994-11#3)(1994-2#2)(1994-3#2)(1994-8#2)(1995-11#2)(1995-2#4)(1995-6#3)(1995-8#1)(1995-9#3)(1996-12#1)(1996-2#1)(1997-1#4)(1997-3#5)(1997-8#1)(2007-12#3)(2008-10#16)(2008-11#59)(2008-12#3)(2008-2#1)(2008-4#5)(2008-5#6)(2008-7#11)(2008-8#2)(2008-9#23)(2009-12#3)(2009-3#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-6#1)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
of cellular DNA##3##3##(2008-11#1)(2008-9#2)
of cellular aging##2##3##(2008-7#1)(2011-2#1)
of cellular and viral##2##4##(2008-11#1)(2010-1#1)
of cellular and##4##3##(2008-11#2)(2010-1#1)(2012-2#1)
of cellular components##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
of cellular differentiation##3##3##(2008-11#2)(2008-9#1)
of cellular functions##2##3##(2008-11#1)(2009-10#1)
of cellular metabolism##3##3##(2008-11#3)
of cellular morphology##2##3##(1992-2#1)(1996-2#1)
of cellular physiology##2##3##(2008-7#1)(2009-8#1)
of cellular processes##6##3##(2008-4#1)(2008-7#2)(2009-6#1)(2012-2#1)(2012-3#1)
of cellular proliferation##2##3##(1996-2#1)(2008-1#1)
of cellular protein##2##3##(2008-11#1)(2010-12#1)
of cellular proteins##9##3##(1991-5#1)(1992-10#1)(1993-8#1)(1994-5#1)(1996-8#1)(1997-3#1)(2008-11#2)(2008-9#1)
of cellular signal transduction pathways by leptin##2##7##(2012-3#2)
of cellular signal transduction##4##4##(1992-12#1)(2011-3#1)(2012-3#2)
of cellular therapies##2##3##(2013-1#2)
of cellular therapy products##2##4##(2013-1#2)
of cellular##100##2##(1990-12#2)(1990-2#1)(1991-5#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#20)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#8)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#4)(2011-3#2)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)
of cellulase##3##2##(2008-10#2)(2011-2#1)
of cellulases##2##2##(1990-5#1)(2011-2#1)
of cellulite intensity##2##3##(2008-5#2)
of cellulose and##3##3##(2008-10#3)
of cellulose to ethanol##2##4##(2008-6#2)
of cellulose##11##2##(2008-10#7)(2008-11#1)(2008-6#2)(2011-2#1)
of cement materials of variable##2##5##(2008-10#2)
of cement##3##2##(2008-10#3)
of cemented##2##2##(2009-4#1)(2013-1#1)
of census##2##2##(2008-8#2)
of centenarians##3##2##(2008-7#3)
of centers##2##2##(1997-2#1)(2012-2#1)
of central metabolic##2##3##(2008-11#1)(2010-7#1)
of central nervous system (CNS)##2##5##(1997-4#1)(2011-2#1)
of central nervous system##7##4##(1997-4#1)(2008-12#1)(2011-2#3)(2011-7#1)(2013-1#1)
of central retinal##2##3##(2011-2#2)
of central venous##3##3##(2008-7#2)(2011-3#1)
of central##39##2##(1990-2#1)(1991-2#1)(1991-8#1)(1994-11#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of centralized##5##2##(1995-12#2)(1996-1#1)(1997-8#1)(2008-10#1)
of centrin##2##2##(2008-9#2)
of centrin-1##2##2##(2008-9#2)
of cephalopod##2##2##(2008-7#2)
of cephalosporin antibiotics##2##3##(2008-10#2)
of cephalosporins##2##2##(2008-10#1)(2011-1#1)
of ceramide##3##2##(1995-12#1)(2008-5#2)
of cercospora##3##2##(2008-10#3)
of cereal##2##2##(2008-10#2)
of cereals##4##2##(2008-10#4)
of cerebellar##4##2##(1992-6#1)(1997-2#1)(2008-7#2)
of cerebral AVMs##2##3##(2008-7#2)
of cerebral air embolism##2##4##(2008-7#2)
of cerebral arteriovenous malformation##2##4##(2008-7#2)
of cerebral arteriovenous malformations (AVMs)##3##5##(2008-7#3)
of cerebral arteriovenous malformations##5##4##(1997-6#1)(2008-7#4)
of cerebral arteriovenous##7##3##(1997-6#1)(2008-7#6)
of cerebral blood flow##2##4##(1996-6#1)(2008-7#1)
of cerebral infarction##4##3##(1990-3#1)(1997-5#1)(2008-7#2)
of cerebral microbleeds##2##3##(2008-8#2)
of cerebral oxygen##2##3##(1990-5#1)(2008-7#1)
of cerebral##44##2##(1990-12#1)(1990-3#1)(1990-5#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#2)(2008-10#1)(2008-7#17)(2008-8#4)(2009-1#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#5)
of cerebroside##3##2##(1993-8#2)(2008-10#1)
of cerebrospinal fluid (CSF)##6##4##(1990-5#1)(1991-12#1)(1992-3#1)(1993-1#1)(2008-7#1)(2011-2#1)
of cerebrospinal fluid##8##3##(1990-5#1)(1991-12#1)(1992-3#1)(1993-1#1)(2008-7#2)(2011-2#2)
of cerebrovascular##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
of cerium##6##2##(2008-10#6)
of cerium(IV)##2##2##(2008-10#2)
of certain cancers##2##3##(2008-2#1)(2011-1#1)
of certain dyes##2##3##(2008-5#1)(2008-9#1)
of certain types of##2##4##(1992-9#1)(2008-10#1)
of certain##60##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-5#1)(1994-9#1)(1996-11#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#17)(2008-11#8)(2008-2#1)(2008-5#4)(2008-9#4)(2009-12#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
of certainty##3##2##(1995-3#1)(2008-6#1)(2009-8#1)
of certification##4##2##(1993-12#2)(2008-10#1)(2012-12#1)
of certified reference materials and##7##5##(2008-10#7)
of certified reference materials of##2##5##(2008-10#2)
of certified reference materials##16##4##(2008-10#16)
of certified reference##23##3##(2008-10#23)
of certified values##3##3##(2008-10#3)
of certified##30##2##(2008-10#29)(2010-11#1)
of cerulenin##2##2##(1995-6#1)(2009-8#1)
of ceruloplasmin##5##2##(1992-12#1)(2008-10#1)(2012-2#2)(2013-1#1)
of cervical cancer##7##3##(1995-9#1)(2008-11#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#1)
of cervical disc##2##3##(2008-7#1)(2011-2#1)
of cervical intraepithelial neoplasia##6##4##(1991-2#2)(1994-12#2)(2012-3#1)(2013-1#1)
of cervical##37##2##(1990-12#1)(1991-1#1)(1991-2#3)(1992-2#2)(1994-1#1)(1994-12#2)(1995-9#1)(1996-10#1)(1996-3#1)(2008-11#3)(2008-12#4)(2008-7#1)(2010-12#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#3)
of cesium ion##2##3##(2008-10#2)
of cesium##4##2##(2008-10#4)
of cessation##2##2##(2010-8#1)(2011-2#1)
of ceterizine hydrochloride##2##3##(2008-10#2)
of cetyl alcohol##2##3##(2008-5#2)
of cetylpyridinium chloride##6##3##(2008-10#6)
of cetylpyridinium##8##2##(2008-10#8)
of cetyltriethylammonium bromide##3##3##(2008-11#3)
of cetyltrimethylammonium bromide (CTAB)##4##4##(2008-10#4)
of cetyltrimethylammonium bromide##5##3##(2008-10#5)
of cetyltrimethylammonium##6##2##(2008-10#6)
of challenges##4##2##(2008-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
of challenging##2##2##(2008-10#1)(2010-5#1)
of change for##2##3##(1992-12#1)(1996-1#1)
of change in##17##3##(1992-12#1)(1993-1#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#3)(2013-1#1)(2013-8#1)
of change of##3##3##(1990-2#1)(1992-6#1)(2009-7#1)
of change##46##2##(1990-2#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-5#1)(1996-1#2)(1997-1#2)(2008-10#8)(2008-11#7)(2008-12#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-5#1)(2012-2#3)(2013-1#4)(2013-8#1)
of changes in population##2##4##(2008-12#1)(2008-8#1)
of changes in the##8##4##(1992-12#1)(1994-2#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
of changes in##34##3##(1991-1#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
of changes on##2##3##(1995-12#1)(2012-2#1)
of changes to##3##3##(2008-12#1)(2008-8#1)(2013-1#1)
of changes##45##2##(1991-1#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#3)
of changing##11##2##(1996-2#1)(2008-10#1)(2008-11#6)(2008-12#1)(2010-8#1)(2012-12#1)
of channel##2##2##(1997-2#1)(2008-6#1)
of channels##8##2##(1994-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#4)
of chaos##3##2##(2008-11#2)(2008-9#1)
of chaotic##3##2##(2007-11#1)(2007-12#1)(2008-11#1)
of character##2##2##(2008-8#2)
of characterising##2##2##(2008-10#1)(2011-3#1)
of characteristic##8##2##(1996-11#1)(1997-8#1)(2008-10#3)(2008-3#1)(2009-5#1)(2010-2#1)
of characteristics##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
of characterizing##2##2##(2008-10#1)(2008-3#1)
of charge##7##2##(1990-12#1)(1991-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)
of charge-transfer##3##2##(1992-1#1)(2008-10#2)
of charged residues##3##3##(1990-11#1)(1997-9#1)(2011-1#1)
of charged##15##2##(1990-11#1)(1992-8#1)(1992-9#1)(1995-6#1)(1997-2#2)(1997-9#1)(2008-10#3)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)
of charges##6##2##(1990-12#1)(1992-12#1)(1995-12#1)(2008-10#3)
of charity care##6##3##(1992-3#2)(1996-2#3)(2008-11#1)
of charity##8##2##(1992-3#3)(1996-2#4)(2008-11#1)
of cheese##3##2##(2008-10#3)
of chelate##2##2##(2008-10#2)
of chelating resin##2##3##(2008-10#2)
of chelating##8##2##(1994-5#1)(2008-10#7)
of chelation##3##2##(2008-10#3)
of chelerythrine and sanguinarine in##2##5##(2008-10#2)
of chelerythrine and sanguinarine##3##4##(2008-10#3)
of chemical analysis##2##3##(2008-10#2)
of chemical and##6##3##(2008-10#6)
of chemical components##2##3##(2011-3#1)(2012-3#1)
of chemical composition##2##3##(2008-10#1)(2013-1#1)
of chemical control and##2##4##(2008-10#2)
of chemical control##3##3##(2008-10#3)
of chemical modification##3##3##(1992-6#1)(2008-10#2)
of chemical modifier##2##3##(2008-10#2)
of chemical modifiers##3##3##(2008-10#3)
of chemical oxygen demand values##2##5##(2008-10#2)
of chemical oxygen demand##4##4##(2008-10#4)
of chemical reagents##2##3##(2008-10#1)(2008-5#1)
of chemical shifts##3##3##(1994-8#1)(2008-9#1)(2012-2#1)
of chemical species##2##3##(2008-10#1)(2008-3#1)
of chemical synthesis##2##3##(2008-10#1)(2009-5#1)
of chemical##77##2##(1990-8#1)(1991-9#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(2008-10#41)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-9#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-7#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)
of chemically induced##2##3##(1990-6#1)(1995-11#1)
of chemically modified##4##3##(2008-10#4)
of chemically##13##2##(1990-6#1)(1995-11#1)(2008-10#10)(2008-9#1)
of chemicals and contaminated environmental samples##2##6##(2008-11#2)
of chemicals and##3##3##(2008-11#2)(2008-5#1)
of chemicals in the##2##4##(2008-11#1)(2011-2#1)
of chemicals in##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of chemicals##18##2##(2008-10#4)(2008-11#11)(2008-5#2)(2011-2#1)
of chemiluminescence and##2##3##(2008-10#2)
of chemiluminescence##6##2##(2008-10#6)
of chemiluminescent##2##2##(2008-10#1)(2010-11#1)
of chemisorption##2##2##(2008-10#2)
of chemistry##3##2##(2008-10#2)(2008-11#1)
of chemometrics##5##2##(2008-10#5)
of chemotherapeutic agents##5##3##(1990-2#1)(1997-7#1)(2008-11#1)(2012-2#2)
of chemotherapeutic##7##2##(1990-2#1)(1992-2#1)(1997-7#2)(2008-11#1)(2012-2#2)
of chemotherapy and##7##3##(1991-8#2)(2006-6#1)(2008-7#2)(2012-3#1)(2013-1#1)
of chemotherapy in the##2##4##(1990-6#1)(1997-5#1)
of chemotherapy in##4##3##(1990-6#1)(1994-8#1)(1997-5#1)(2008-7#1)
of chemotherapy##25##2##(1990-6#2)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1997-3#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#3)(2012-3#2)(2013-1#4)
of chemotherapy-induced nausea and vomiting##2##5##(2010-12#2)
of chemotherapy-induced##6##2##(2008-11#1)(2008-7#2)(2010-11#1)(2010-12#2)
of chest pain patients in the##2##6##(2008-3#1)(2012-2#1)
of chest pain##8##3##(2008-10#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
of chest##13##2##(1991-2#1)(1995-2#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#4)(2012-2#1)
of chestnut blight##2##3##(2008-10#2)
of chewing lice##2##3##(2011-2#2)
of chewing##3##2##(2010-12#1)(2011-2#2)
of chick##3##2##(1993-6#1)(1996-2#2)
of chicken PTH-(1-88)##2##3##(1991-3#2)
of chicken brain##2##3##(1993-6#2)
of chicken heart apocytochrome c##2##5##(2008-8#2)
of chicken##22##2##(1990-11#1)(1990-9#1)(1991-3#2)(1993-12#1)(1993-2#1)(1993-6#2)(1994-11#1)(1997-9#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#4)(2013-8#1)
of chickens##2##2##(2008-5#1)(2008-8#1)
of chickpea (Cicer##2##3##(2008-10#2)
of chickpea##8##2##(2008-10#8)
of chicks##6##2##(1990-3#1)(1991-3#2)(2008-5#1)(2008-6#1)(2008-8#1)
of chief##2##2##(1993-3#1)(1995-8#1)
of child abuse##4##3##(1992-1#1)(1995-5#1)(2009-9#2)
of child care and protection##2##5##(1995-5#2)
of child development and##2##4##(1996-9#1)(2011-1#1)
of child development##4##3##(1995-1#1)(1996-9#1)(2011-1#2)
of child health##2##3##(1994-6#1)(2012-3#1)
of child sexual##2##3##(1992-1#1)(1995-5#1)
of child well-being##2##3##(2008-11#1)(2010-3#1)
of child##27##2##(1992-1#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#6)(1996-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-10#1)(2009-11#1)(2009-9#2)(2010-3#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-8#1)
of childbearing##4##2##(1990-2#1)(1991-1#1)(2009-10#1)(2013-1#1)
of childhood and##3##3##(1990-12#1)(1995-5#1)(2008-10#1)
of childhood asthma##2##3##(2008-11#2)
of childhood community adversity on young adult##2##7##(2010-7#2)
of childhood community adversity##4##4##(2010-7#4)
of childhood community contexts##2##4##(2010-7#2)
of childhood community##6##3##(2010-7#6)
of childhood obesity##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
of childhood that##2##3##(1997-8#1)(2011-2#1)
of childhood##28##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1995-5#3)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-7#6)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
of children aged##2##3##(2010-11#1)(2010-6#1)
of children and adolescents##8##4##(1991-2#1)(1993-1#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
of children and their families##3##5##(1994-1#1)(2008-11#1)(2010-12#1)
of children and##15##3##(1991-2#1)(1992-2#1)(1993-1#1)(1994-1#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
of children are##2##3##(1997-2#1)(2008-11#1)
of children at risk for##2##5##(1996-12#1)(2009-7#1)
of children at risk##4##4##(1991-12#1)(1996-12#1)(2008-12#1)(2009-7#1)
of children from##2##3##(1990-6#1)(1996-12#1)
of children in a##4##4##(2011-2#2)(2012-3#1)(2013-8#1)
of children in##8##3##(1992-3#1)(1997-1#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
of children is##2##3##(1991-12#1)(1994-8#1)
of children presenting##2##3##(2008-11#2)
of children receiving##2##3##(1996-1#1)(2007-11#1)
of children who receive##2##4##(1994-6#1)(2010-4#1)
of children who##13##3##(1994-2#1)(1994-6#1)(1995-1#1)(1996-12#1)(2008-11#2)(2008-2#2)(2008-9#1)(2009-9#2)(2010-4#1)(2011-1#1)
of children with ADHD##3##4##(1996-6#1)(2008-11#1)(2011-2#1)
of children with AIDS##3##4##(2012-3#3)
of children with chronic##2##4##(1997-2#1)(2011-2#1)
of children with cochlear implants##3##5##(2008-9#3)
of children with diabetes##5##4##(1994-6#1)(1995-2#3)(1995-3#1)
of children with disabilities##4##4##(1994-1#2)(1995-1#1)(1996-1#1)
of children with learning difficulties##2##5##(2008-11#2)
of children with learning disabilities##2##5##(2011-1#2)
of children with learning##4##4##(2008-11#2)(2011-1#2)
of children with severe disabilities##2##5##(1993-3#1)(1996-1#1)
of children with severe##4##4##(1993-3#3)(1996-1#1)
of children with##63##3##(1990-12#1)(1992-2#2)(1993-3#6)(1994-1#2)(1994-3#1)(1994-6#2)(1995-1#3)(1995-2#3)(1995-3#2)(1996-1#2)(1996-11#1)(1996-6#2)(1997-2#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-9#5)(2009-3#1)(2009-5#1)(2010-1#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#2)(2011-5#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
of children##165##2##(1990-12#2)(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#2)(1992-2#4)(1992-3#1)(1993-1#1)(1993-3#6)(1994-1#3)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#1)(1995-1#5)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#3)(1996-1#3)(1996-11#1)(1996-12#5)(1996-6#2)(1997-1#1)(1997-2#2)(1997-4#1)(2007-11#3)(2008-10#7)(2008-11#21)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#1)(2008-9#9)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#3)(2010-7#4)(2010-9#2)(2011-1#5)(2011-2#9)(2011-5#1)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#2)
of children's mental health##2##4##(1993-1#1)(2010-12#1)
of children's reactive control##2##4##(2011-2#2)
of children's##11##2##(1990-2#1)(1991-2#1)(1992-3#1)(1993-1#1)(1995-1#1)(2008-11#2)(2010-12#1)(2010-7#1)(2011-2#2)
of chili powder##2##3##(2008-10#2)
of chill accumulation##2##3##(2012-4#1)(2012-8#1)
of chilling##2##2##(2012-4#1)(2012-8#1)
of chimeric##9##2##(1992-2#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)
of chiral discrimination##2##3##(2008-10#2)
of chiral##10##2##(1992-11#1)(1994-8#3)(2008-10#4)(2009-10#2)
of chitin in the##2##4##(2008-10#2)
of chitin##10##2##(2008-10#9)(2011-2#1)
of chitinase##3##2##(2008-10#3)
of chitinases##2##2##(2008-10#2)
of chitobiase enzyme##2##3##(1992-10#2)
of chitobiase gene expression##2##4##(1992-10#2)
of chitobiase##4##2##(1992-10#4)
of chitosan was##2##3##(2008-10#2)
of chitosan##11##2##(2008-10#6)(2008-5#5)
of chlamydia##2##2##(1990-5#1)(2012-3#1)
of chlamydospores##4##2##(2008-10#3)(2010-3#1)
of chloramphenicol##8##2##(1995-6#1)(2008-10#7)
of chloranilic acid##2##3##(2008-10#2)
of chlorate##4##2##(2008-10#4)
of chloride and##2##3##(2008-10#2)
of chloride in drinking and ground water##2##7##(2008-10#2)
of chloride in##7##3##(2008-10#7)
of chloride ion in aqueous samples##2##6##(2008-10#2)
of chloride ion in##3##4##(2008-10#3)
of chloride ion##5##3##(2008-10#5)
of chloride reactant##2##3##(2008-10#2)
of chloride with##2##3##(1994-5#1)(2008-10#1)
of chloride##34##2##(1994-5#3)(2008-10#30)(2011-3#1)
of chlorides and##2##3##(2008-10#2)
of chlorides##3##2##(2008-10#3)
of chlorinated biphenyls (CBs)##2##4##(2008-10#2)
of chlorinated##6##2##(2008-10#5)(2011-1#1)
of chlorine dioxide in##3##4##(2008-10#3)
of chlorine##8##2##(2008-10#7)(2009-8#1)
of chlorite in drinking##2##4##(2008-10#2)
of chlorite##4##2##(2008-10#4)
of chloro-organic product formation##2##4##(2009-8#2)
of chloro-organic##3##2##(2009-8#3)
of chloroacetic acids (mono-##2##4##(2008-10#2)
of chloroacetic acids##3##3##(2008-10#3)
of chloroaluminum (III) tetrasulphonated naphthalocyanine##2##5##(2008-10#2)
of chlorobenzenes##2##2##(2008-10#2)
of chlorofluorocarbon (CFC) propellants##2##4##(1992-3#2)
of chlorofluorocarbon (CFC)##3##3##(1992-3#2)(1996-1#1)
of chloroform##4##2##(1991-8#1)(2008-10#1)(2008-11#2)
of chlorogenic acid##8##3##(2008-10#4)(2008-11#4)
of chloroguaiacol##2##2##(2008-10#2)
of chlorophenols##2##2##(2008-10#2)
of chlorophenoxyacid herbicides##4##3##(2008-10#4)
of chlorophyll a##3##3##(2008-3#2)(2008-8#1)
of chlorophyll##8##2##(2008-11#1)(2008-12#1)(2008-3#3)(2008-8#2)(2009-10#1)
of chlorophylls a and b##3##5##(2008-10#3)
of chlorophylls and pheopigments##2##4##(2008-10#2)
of chlorophylls##5##2##(2008-10#5)
of chloroplast##3##2##(2008-1#1)(2008-12#1)(2008-8#1)
of chloroplasts##2##2##(2008-10#1)(2009-8#1)
of chloroquine##6##2##(1993-8#2)(2008-10#4)
of chlorosis##3##2##(2008-10#3)
of chlorotic##3##2##(2008-10#3)
of chlorovinylarsines##2##2##(2008-11#2)
of chlorpromazine hydrochloride##3##3##(2008-10#3)
of chlorpromazine##6##2##(2008-10#6)
of chlortetracycline##5##2##(2008-10#5)
of choice and##2##3##(1992-9#1)(2011-2#1)
of choice for patients with##2##5##(2009-12#1)(2010-10#1)
of choice for the##3##4##(1996-2#1)(1997-2#1)(2008-8#1)
of choice for##28##3##(1991-10#1)(1991-9#1)(1992-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
of choice in the##2##4##(1990-2#1)(2011-2#1)
of choice in##14##3##(1990-2#1)(1990-9#1)(1992-12#1)(1994-3#1)(1995-11#1)(1996-1#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2011-3#1)
of choice is##2##3##(1992-9#1)(1994-5#1)
of choice of##2##3##(1992-3#1)(1993-6#1)
of choice to assist##2##4##(2011-7#1)(2012-12#1)
of choice##74##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#6)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#2)(2011-2#5)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
of cholangiocarcinoma##4##2##(2008-2#1)(2009-9#2)(2013-8#1)
of cholecystokinin (CCK)##2##3##(1996-2#1)(2008-7#1)
of cholecystokinin##5##2##(1995-12#1)(1996-2#1)(1997-1#1)(2008-7#2)
of choledocholithiasis##2##2##(1997-8#1)(2009-9#1)
of cholera##5##2##(1992-5#2)(1997-3#1)(2008-10#2)
of cholesterol and##3##3##(1990-8#1)(2008-10#2)
of cholesterol esterification##2##3##(1990-8#1)(1994-8#1)
of cholesterol in egg yolk##2##5##(2008-10#2)
of cholesterol in##4##3##(2008-10#3)(2013-1#1)
of cholesterol metabolism##2##3##(1993-3#1)(1993-6#1)
of cholesterol with##2##3##(2008-10#2)
of cholesterol##30##2##(1990-8#2)(1991-11#1)(1991-5#1)(1991-8#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(2008-10#12)(2012-2#1)(2013-1#1)
of cholic##2##2##(2008-10#2)
of choline acetyltransferase##2##3##(1993-3#1)(1996-2#1)
of choline##5##2##(1993-3#1)(1996-12#1)(1996-2#1)(2008-10#2)
of cholinergic nerve##2##3##(2008-5#1)(2008-8#1)
of cholinergic neurons##2##3##(1997-2#1)(2008-5#1)
of cholinergic transmission##4##3##(2008-8#3)(2013-8#1)
of cholinergic##10##2##(1991-7#1)(1997-2#1)(2008-5#2)(2008-8#4)(2013-8#2)
of cholinesterase##2##2##(2008-10#1)(2011-1#1)
of chondroblastic osteosarcoma##2##3##(2013-1#2)
of chondrocyte##2##2##(1992-1#1)(2008-7#1)
of chondrocytes in##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
of chondrocytes##7##2##(2008-11#4)(2008-7#1)(2011-2#2)
of chondrogenic##2##2##(2008-11#2)
of chorea##3##2##(2011-10#3)
of chromate##2##2##(2008-10#2)
of chromatin##7##2##(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2011-2#1)(2011-9#1)
of chromatographic analysis##2##3##(2008-10#2)
of chromatographic methods##2##3##(2008-10#2)
of chromatographic resolution##2##3##(2008-10#2)
of chromatographic##13##2##(1993-8#1)(2008-10#12)
of chromatography##2##2##(2008-10#1)(2010-7#1)
of chromium (III) converted to chromium (VI)##2##7##(2008-10#2)
of chromium (III)##5##3##(2008-10#5)
of chromium (VI) with##3##4##(2008-10#3)
of chromium (VI)##6##3##(2008-10#6)
of chromium and##4##3##(2008-10#3)(2008-12#1)
of chromium by##2##3##(2008-10#2)
of chromium determination##2##3##(2008-10#2)
of chromium in drinking water samples by##2##7##(2008-10#2)
of chromium in gallium##2##4##(2008-10#2)
of chromium in mineral waters and salinas##2##7##(2008-10#2)
of chromium in##20##3##(2008-10#20)
of chromium is##4##3##(2008-10#4)
of chromium using##2##3##(2008-10#2)
of chromium##70##2##(2008-10#68)(2008-12#1)(2009-12#1)
of chromium(III) in##2##3##(2008-10#2)
of chromium(III)##6##2##(2008-10#6)
of chromium(V) in the##2##4##(2008-10#2)
of chromium(V)##4##2##(2008-10#4)
of chromium(VI) and##4##3##(2008-10#4)
of chromium(VI) by##4##3##(2008-10#4)
of chromium(VI) in##9##3##(2008-10#9)
of chromium(VI) ion##2##3##(2008-10#2)
of chromium(VI) with iron(II)##2##4##(2008-10#2)
of chromium(VI) with##4##3##(2008-10#4)
of chromium(VI)##31##2##(2008-10#31)
of chromogenic##2##2##(1992-12#1)(2008-10#1)
of chromogranin A##3##3##(1993-8#2)(2010-11#1)
of chromogranin##4##2##(1992-12#1)(1993-8#2)(2010-11#1)
of chromophore##5##2##(2008-10#3)(2008-3#2)
of chromosomal integration of transgenes in microinjected##2##7##(1993-6#2)
of chromosomal integration##3##3##(1993-6#2)(1994-2#1)
of chromosomal rearrangements on gene flow##2##6##(2012-3#2)
of chromosomal##15##2##(1990-8#1)(1993-6#2)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#4)
of chromosome 1##3##3##(2008-10#2)(2012-3#1)
of chromosome 11##2##3##(2008-10#1)(2008-11#1)
of chromosome 3##3##3##(1997-2#1)(2009-10#2)
of chromosome 3H##2##3##(2008-10#2)
of chromosome 4##3##3##(2007-12#1)(2009-10#1)(2012-3#1)
of chromosome 5##4##3##(1997-5#1)(1997-6#1)(1997-8#2)
of chromosome 6##5##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
of chromosome II##2##3##(1996-6#1)(2012-3#1)
of chromosome VI were##2##4##(1997-6#2)
of chromosome XIII##2##3##(1995-9#1)(2008-8#1)
of chromosome breakage##3##3##(1997-3#1)(2012-3#2)
of chromosome##74##2##(1993-9#1)(1994-11#2)(1995-6#1)(1995-9#4)(1996-2#1)(1996-3#4)(1996-6#7)(1996-8#2)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2007-12#1)(2008-10#17)(2008-11#1)(2008-4#2)(2008-8#3)(2008-9#2)(2009-10#3)(2010-1#1)(2012-12#1)(2012-3#6)(2013-1#1)(2013-8#1)
of chromosomes in the##2##4##(2008-12#1)(2013-1#1)
of chromosomes in##3##3##(2008-12#1)(2012-3#1)(2013-1#1)
of chromosomes##21##2##(1990-5#1)(1992-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#3)(2013-1#2)
of chromotropic acid##2##3##(2008-10#2)
of chronic HCV##2##3##(2013-1#2)
of chronic TRZ##2##3##(1996-12#2)
of chronic and##2##3##(1991-11#1)(2009-12#1)
of chronic angina pectoris##2##4##(2008-12#2)
of chronic bronchitis##4##3##(1996-11#1)(1997-4#1)(2008-7#2)
of chronic cerebral hypoperfusion##2##4##(2008-7#1)(2009-6#1)
of chronic cerebral##3##3##(2008-7#2)(2009-6#1)
of chronic cocaine##2##3##(1991-1#2)
of chronic conditions##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
of chronic disease##3##3##(1995-3#1)(2010-1#1)(2012-2#1)
of chronic diseases##5##3##(1991-3#1)(1996-6#1)(2008-6#1)(2012-2#1)(2013-7#1)
of chronic fatigue syndrome##2##4##(2009-10#1)(2010-1#1)
of chronic fatigue##4##3##(2008-10#2)(2009-10#1)(2010-1#1)
of chronic headache##2##3##(1996-2#1)(2008-9#1)
of chronic heart failure##2##4##(2008-7#1)(2009-10#1)
of chronic hepatitis B virus (HBV) infection##2##7##(2008-10#1)(2009-8#1)
of chronic hepatitis B##6##4##(1993-2#1)(2008-10#1)(2009-8#4)
of chronic hepatitis C##2##4##(2009-5#1)(2013-7#1)
of chronic hepatitis due to##2##5##(1995-10#1)(2013-1#1)
of chronic hepatitis##11##3##(1993-2#1)(1995-10#1)(2008-10#1)(2009-5#1)(2009-8#5)(2013-1#1)(2013-7#1)
of chronic kidney disease##5##4##(2009-1#2)(2010-10#1)(2011-2#1)(2012-2#1)
of chronic liver disease##3##4##(2009-8#2)(2010-12#1)
of chronic lymphocytic leukemia (CLL)##2##5##(2009-12#1)(2011-2#1)
of chronic myeloid leukemia##3##4##(1990-2#1)(2010-11#2)
of chronic obstructive lung##2##4##(1995-2#1)(2008-1#1)
of chronic obstructive pulmonary disease (COPD)##4##6##(2008-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
of chronic obstructive pulmonary disease##6##5##(2007-12#1)(2008-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
of chronic obstructive##8##3##(1995-2#1)(2007-12#1)(2008-1#2)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
of chronic pain syndrome##2##4##(2008-4#2)
of chronic pain##6##3##(2008-4#5)(2012-3#1)
of chronic pancreatitis##2##3##(2009-7#1)(2011-2#1)
of chronic periodontitis patients and##2##5##(2008-12#2)
of chronic periodontitis##3##3##(2008-12#3)
of chronic renal disease##2##4##(1994-3#1)(2011-2#1)
of chronic renal failure##2##4##(2008-1#2)
of chronic renal insufficiency##2##4##(2011-2#2)
of chronic renal##6##3##(1994-3#1)(2008-1#2)(2011-2#3)
of chronic suppurative##2##3##(1997-1#1)(2008-9#1)
of chronic total occlusions##2##4##(2008-12#2)
of chronic total##3##3##(2008-12#3)
of chronic treatment with##3##4##(1992-3#1)(2010-6#1)(2013-1#1)
of chronic versus acute EtOH##2##5##(2008-10#2)
of chronic##157##2##(1990-2#1)(1991-1#4)(1991-11#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-6#1)(1997-1#2)(1997-4#3)(1997-6#1)(2007-12#1)(2008-1#4)(2008-10#7)(2008-11#4)(2008-12#8)(2008-4#6)(2008-6#1)(2008-7#9)(2008-9#5)(2009-1#2)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#8)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#2)(2010-5#1)(2010-6#2)(2011-2#16)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#2)
of chronically##4##2##(1994-5#1)(1996-12#1)(2008-10#1)(2008-11#1)
of chrysotile asbestos##2##3##(1991-12#2)
of chrysotile##3##2##(1991-12#3)
of chsA gene##2##3##(2008-9#2)
of chylomicrons##4##2##(1995-2#1)(2008-10#3)
of chymosin##2##2##(2008-7#2)
of ciclesonide##2##2##(2008-8#2)
of cigarette smoking##5##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2013-8#1)
of cigarette##9##2##(1991-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2013-1#1)(2013-8#2)
of cigarettes##6##2##(1991-9#2)(1993-2#1)(1994-6#1)(2009-7#1)(2013-1#1)
of ciliary##2##2##(1996-2#1)(2008-7#1)
of cimetidine and ranitidine##2##4##(2008-11#2)
of cimetidine##5##2##(2008-11#5)
of cine computed tomographic##2##4##(2013-1#2)
of ciprofloxacin in human urine and serum samples##2##8##(2008-10#2)
of ciprofloxacin in##5##3##(2007-8#1)(2008-10#4)
of ciprofloxacin##10##2##(2007-8#1)(2008-10#8)(2008-7#1)
of circadian##7##2##(1994-2#1)(1995-2#1)(1997-2#1)(2008-5#2)(2009-7#1)(2009-8#1)
of circular dichroism##2##3##(1992-8#1)(1994-5#1)
of circular##6##2##(1992-8#1)(1994-5#1)(2008-10#1)(2008-3#3)
of circulating immune complexes##2##4##(1990-12#1)(1997-8#1)
of circulating##22##2##(1990-12#1)(1991-12#1)(1991-2#2)(1992-3#1)(1993-2#1)(1995-9#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-8#1)
of circulation##2##2##(2008-10#2)
of circumstances##2##2##(1992-3#1)(2009-8#1)
of cirrhosis##4##2##(1996-11#1)(2009-8#2)(2011-2#1)
of cirrus##2##2##(2008-3#2)
of cis-acting##2##2##(1992-6#1)(2008-7#1)
of cis-platin and carboplatin##2##4##(2008-10#2)
of cis-platin##4##2##(2008-10#4)
of cisapride##4##2##(1990-5#4)
of cisatracurium in##2##3##(2008-10#2)
of cisatracurium##6##2##(2008-10#6)
of cisplatin and##2##3##(1991-2#1)(1993-8#1)
of cisplatin##7##2##(1990-12#1)(1990-6#1)(1991-2#1)(1993-8#2)(2008-10#1)(2013-1#1)
of cisplatin-induced##3##2##(1990-12#2)(1990-6#1)
of citations##6##2##(1996-2#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
of cited##2##2##(2008-10#2)
of cities##3##2##(1990-11#3)
of citrate##9##2##(1992-9#3)(1997-4#1)(2008-10#3)(2008-7#2)
of citric acid was##2##4##(2008-10#2)
of citric acid##7##3##(2008-10#7)
of citric##8##2##(2008-10#8)
of citrinin##4##2##(1993-12#4)
of citrus fruit##5##3##(2008-10#5)
of citrus in##3##3##(2008-10#3)
of citrus samples##3##3##(2008-10#3)
of citrus tristeza virus (CTV)##2##5##(2008-10#2)
of citrus tristeza virus incidence##3##5##(2008-10#3)
of citrus tristeza virus##7##4##(2008-10#7)
of citrus variegated chlorosis##3##4##(2008-10#3)
of citrus##41##2##(2008-10#40)(2013-8#1)
of civil##2##2##(1994-3#1)(2008-11#1)
of civilization##2##2##(1991-6#1)(1995-5#1)
of cladograms##3##2##(2010-3#3)
of claims data##2##3##(1991-1#1)(1993-12#1)
of claims##6##2##(1991-1#1)(1993-12#1)(1994-2#4)
of clamping##2##2##(1992-9#1)(2008-7#1)
of clarified##2##2##(1997-3#1)(2008-10#1)
of clarifying the##2##3##(1994-11#1)(2008-11#1)
of clarithromycin in human plasma##2##5##(2008-10#2)
of clarithromycin in##3##3##(2008-10#3)
of clarithromycin##5##2##(2008-10#5)
of class I MHC##2##4##(1990-5#1)(1994-5#1)
of class I##4##3##(1990-5#1)(1994-5#1)(1995-12#1)(1997-9#1)
of class analogy (SIMCA)##3##4##(2008-10#3)
of class analogy##5##3##(2008-10#5)
of class##16##2##(1990-5#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-9#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-8#1)(2012-2#2)
of classes of##2##3##(2008-10#1)(2008-5#1)
of classes##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
of classic##5##2##(1990-6#1)(1993-2#1)(2008-10#1)(2008-11#1)(2010-11#1)
of classical##9##2##(2008-10#6)(2008-5#1)(2008-7#1)(2012-2#1)
of classification##9##2##(1990-3#1)(1993-1#1)(2008-10#4)(2008-7#1)(2011-2#1)(2013-8#1)
of classifier##2##2##(2008-11#2)
of classroom climate##2##3##(2008-12#2)
of classroom##7##2##(2008-12#7)
of clay##2##2##(2008-10#2)
of clear##4##2##(1990-11#1)(2008-10#2)(2010-10#1)
of clearance##2##2##(1996-2#1)(2011-3#1)
of cleavage##2##2##(1991-3#1)(1993-8#1)
of clenbuterol by capillary electrophoresis##2##5##(2008-10#2)
of clenbuterol##8##2##(2008-10#6)(2010-12#1)(2010-6#1)
of client groups and##2##4##(2013-8#2)
of client##4##2##(1993-1#1)(2010-4#1)(2013-8#2)
of clients##6##2##(1991-1#1)(1993-1#1)(1994-2#1)(1995-3#1)(2008-9#1)(2012-3#1)
of climate change on##2##4##(2008-11#2)
of climate change##4##3##(2008-11#2)(2008-3#1)(2012-8#1)
of climate##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2012-8#1)
of clindamycin##4##2##(2007-11#4)
of clinical and experimental##2##4##(2008-10#1)(2011-1#1)
of clinical and##14##3##(1992-9#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of clinical application of nursing diagnosis##2##6##(1990-2#2)
of clinical applications##3##3##(2008-11#2)(2009-4#1)
of clinical backgrounds##2##3##(2008-11#2)
of clinical biochemistry on##3##4##(1994-12#3)
of clinical biochemistry##4##3##(1994-12#4)
of clinical biochemists##3##3##(1994-12#3)
of clinical care##2##3##(1995-2#1)(2008-12#1)
of clinical data##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
of clinical decision-making##9##3##(2008-11#9)
of clinical evidence##2##3##(2012-2#2)
of clinical laboratory technologist##2##4##(1994-12#2)
of clinical laboratory##5##3##(1994-12#5)
of clinical mastitis##3##3##(1992-2#1)(1996-8#2)
of clinical medicine##3##3##(1993-11#1)(2011-3#2)
of clinical outcome##3##3##(1997-1#1)(2011-2#1)(2012-3#1)
of clinical outcomes##3##3##(1997-1#1)(2009-6#1)(2009-7#1)
of clinical placements##3##3##(2008-11#1)(2008-12#2)
of clinical practice guidelines##2##4##(1993-12#1)(1996-2#1)
of clinical practice##8##3##(1993-12#1)(1996-2#2)(2008-11#3)(2012-12#1)(2012-2#1)
of clinical reasoning##2##3##(2008-11#1)(2008-12#1)
of clinical research##3##3##(2009-10#1)(2009-3#1)(2010-11#1)
of clinical samples##2##3##(2008-10#1)(2008-5#1)
of clinical significance##4##3##(2008-10#1)(2008-11#1)(2013-1#2)
of clinical signs##3##3##(1990-3#1)(1992-5#1)(2008-5#1)
of clinical studies are##2##4##(2013-1#1)(2013-8#1)
of clinical studies##6##3##(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
of clinical subgroups##2##3##(1995-12#1)(2008-12#1)
of clinical supervision##2##3##(2008-11#1)(2008-4#1)
of clinical symptoms##3##3##(1992-3#1)(1997-3#1)(2013-1#1)
of clinical trials of##3##4##(1995-5#1)(2008-8#2)
of clinical trials##18##3##(1992-2#1)(1993-12#2)(1993-9#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-6#2)(2008-10#1)(2008-8#2)(2010-10#1)(2010-11#1)(2012-2#2)(2013-1#1)(2013-7#1)
of clinical##205##2##(1990-2#3)(1990-3#1)(1991-12#1)(1991-3#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-9#2)(1993-11#2)(1993-12#4)(1993-3#1)(1993-9#3)(1994-12#14)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#29)(2008-12#9)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#9)(2011-3#2)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#8)
of clinically relevant##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
of clinically##10##2##(1990-6#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
of clinicians and##2##3##(1992-3#1)(2010-10#1)
of clinicians##5##2##(1992-3#1)(2008-11#2)(2010-10#1)(2012-12#1)
of clonal lineages##2##3##(2008-10#2)
of clonal##7##2##(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)
of clonality##2##2##(2008-10#2)
of clone##3##2##(1997-7#1)(1997-8#1)(2008-9#1)
of cloned##8##2##(1990-5#1)(1993-6#1)(1993-9#1)(2008-10#3)(2008-4#1)(2013-8#1)
of clonidine##2##2##(1997-4#2)
of cloning##4##2##(1995-2#1)(1997-2#2)(2008-11#1)
of clopidogrel bisulphate##3##3##(2008-10#3)
of clopidogrel##5##2##(2008-10#3)(2011-2#2)
of close relationships##2##3##(2012-2#2)
of close##10##2##(1990-11#1)(1990-2#1)(1991-8#1)(1992-9#1)(1997-4#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#2)
of close-proximity fluorophores##2##3##(2009-5#2)
of closed##3##2##(2008-10#2)(2013-1#1)
of closely related##5##3##(1990-12#1)(2008-10#2)(2008-5#1)(2010-4#1)
of closely spaced##2##3##(2007-11#1)(2008-4#1)
of closely##8##2##(1990-12#1)(1991-5#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-4#1)
of closing##2##2##(1993-12#1)(2008-1#1)
of cloud##2##2##(2008-3#2)
of clouds and aerosols##6##4##(2008-3#6)
of clouds and##7##3##(2008-10#1)(2008-3#6)
of clover##4##2##(2008-10#4)
of cluster##8##2##(1992-2#1)(1993-8#1)(2008-10#3)(2008-8#1)(2009-11#1)(2010-11#1)
of clustering##2##2##(2008-10#1)(2008-4#1)
of clusters of##4##3##(1995-6#1)(2008-10#2)(2011-2#1)
of clusters##7##2##(1995-6#1)(2008-10#2)(2008-5#1)(2010-10#2)(2011-2#1)
of cms-T##3##2##(2008-10#3)
of co-existing##3##2##(2008-10#2)(2008-11#1)
of co-infection##2##2##(2011-2#2)
of co-stimulatory molecules##3##3##(2007-11#1)(2008-10#2)
of coagulase-negative staphylococci##3##3##(2008-7#1)(2010-4#2)
of coagulation is##2##3##(1991-9#1)(2013-1#1)
of coagulation##6##2##(1991-9#1)(2008-8#2)(2010-3#2)(2013-1#1)
of coal fly ash and##2##5##(2008-10#2)
of coal samples##3##3##(2008-10#3)
of coal##7##2##(2008-10#7)
of coarse##3##2##(2008-11#1)(2010-6#1)(2012-3#1)
of coastal##2##2##(2008-3#1)(2010-1#1)
of coat protein##3##3##(1997-3#2)(2008-10#1)
of coat##4##2##(1990-9#1)(1997-3#2)(2008-10#1)
of coated##4##2##(1993-9#1)(1997-1#1)(2008-10#1)(2008-11#1)
of coating##3##2##(2008-10#3)
of coatings on##3##3##(2008-10#3)
of coatings##6##2##(2008-10#6)
of cobalamin##2##2##(1992-9#1)(2011-1#1)
of cobalt by##2##3##(2008-10#2)
of cobalt in the presence of##2##6##(2008-10#2)
of cobalt in##16##3##(2008-10#16)
of cobalt with nitroso-R-salt##2##4##(2008-10#2)
of cobalt with##4##3##(2008-10#4)
of cobalt##60##2##(2008-10#58)(2008-12#2)
of cobalt(II) and##4##3##(2008-10#4)
of cobalt(II) with##2##3##(2008-10#2)
of cobalt(II)##16##2##(2008-10#16)
of cocaethylene##5##2##(1996-12#5)
of cocaine addiction##2##3##(1991-1#1)(2008-11#1)
of cocaine in##2##3##(1993-6#1)(2013-8#1)
of cocaine with##2##3##(1991-1#2)
of cocaine##22##2##(1991-1#11)(1991-11#1)(1991-2#1)(1993-6#2)(2008-11#1)(2010-11#2)(2013-8#4)
of cochlear implant electrode arrays##2##5##(2008-9#2)
of cochlear implant use##2##4##(2008-9#2)
of cochlear implant##11##3##(2008-9#11)
of cochlear implantation in##2##4##(2008-9#2)
of cochlear implantation##6##3##(2008-9#5)(2012-2#1)
of cochlear implants##4##3##(2008-9#4)
of cochlear##25##2##(1996-2#1)(2008-9#23)(2012-2#1)
of cocultivation##2##2##(2008-10#2)
of coding##4##2##(1997-3#1)(1997-7#1)(2008-8#1)(2012-12#1)
of codon##2##2##(1993-11#1)(1994-11#1)
of codons##3##2##(1995-12#1)(1997-8#2)
of coefficients##2##2##(1996-3#1)(2010-1#1)
of coeliac##3##2##(1991-12#2)(1992-12#1)
of coenzyme##4##2##(1993-3#1)(1994-8#1)(2008-10#1)(2013-1#1)
of coevolution between##2##3##(2008-10#1)(2008-9#1)
of coevolution##3##2##(2008-10#2)(2008-9#1)
of coexistence##2##2##(2008-8#1)(2010-5#1)
of coexistent##3##2##(1993-1#1)(1993-8#1)(2008-10#1)
of coexisting ions were##2##4##(2008-10#2)
of coexisting##6##2##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)
of cofactors##2##2##(1991-9#1)(2008-2#1)
of coffee##7##2##(2008-10#5)(2008-11#1)(2008-5#1)
of cognition in##2##3##(2008-4#1)(2009-8#1)
of cognition##9##2##(2008-12#2)(2008-4#1)(2009-12#1)(2009-7#2)(2009-8#3)
of cognitive function##2##3##(1993-11#1)(2008-11#1)
of cognitive impairment##2##3##(2008-2#1)(2012-12#1)
of cognitive##15##2##(1993-11#2)(1995-1#1)(1996-11#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
of cognitive-behavioral therapy##2##3##(2009-11#1)(2012-2#1)
of cognitive-behavioral##3##2##(2009-11#1)(2012-2#1)(2013-1#1)
of coherence##3##2##(2007-12#1)(2008-11#1)(2012-3#1)
of coherent Doppler lidar##2##4##(2008-3#2)
of coherent##4##2##(1992-11#1)(1992-8#1)(2008-3#2)
of cohorts##2##2##(2008-10#2)
of coinfected##2##2##(2008-10#1)(2008-7#1)
of colchicine##2##2##(1990-2#1)(1995-2#1)
of cold and##2##3##(1993-8#1)(2012-3#1)
of cold##7##2##(1993-8#1)(1994-12#1)(2008-10#1)(2008-2#2)(2008-9#1)(2012-3#1)
of colds##2##2##(2008-7#2)
of colitic mice##2##3##(2011-3#2)
of colitis##5##2##(1991-8#1)(1992-6#2)(2011-3#1)(2012-2#1)
of collaboration between##4##3##(1991-2#1)(1993-3#1)(1996-12#1)(2008-12#1)
of collaboration##10##2##(1991-2#1)(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2013-1#1)(2013-8#1)
of collagen alpha 1##2##4##(1994-12#2)
of collagen gel##3##3##(1994-11#2)(1994-8#1)
of collagen##27##2##(1992-8#1)(1994-11#2)(1994-12#2)(1994-8#3)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#6)(2008-7#4)(2008-8#2)(2009-7#1)(2012-3#1)(2013-1#1)
of collagenase##2##2##(2008-11#1)(2008-5#1)
of collagens##2##2##(1991-5#1)(2008-5#1)
of colleagues##2##2##(1990-6#1)(1994-12#1)
of collection##4##2##(2008-10#3)(2013-8#1)
of collective##4##2##(2009-8#1)(2010-8#1)(2012-2#2)
of college graduates##2##3##(1995-2#1)(1997-2#1)
of college students##6##3##(2008-5#1)(2009-3#1)(2012-2#1)(2013-8#3)
of college##9##2##(1992-1#1)(1995-2#1)(1997-2#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-8#3)
of colletotrichum species from##2##4##(2008-10#2)
of colletotrichum##3##2##(2008-10#3)
of colloid cysts##2##3##(2008-7#2)
of colloidal##2##2##(1990-6#1)(2008-10#1)
of colon CSCs##2##3##(2011-2#2)
of colon cancer##7##3##(1993-11#1)(1993-12#1)(1995-9#1)(2007-8#2)(2008-12#1)(2008-5#1)
of colon lamina propria dendritic cells from mice with colitis##2##10##(2008-11#2)
of colon tumors in##2##4##(1993-11#2)
of colon tumors##3##3##(1993-11#3)
of colon##17##2##(1993-11#5)(1993-12#1)(1995-9#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#2)
of coloniality##3##2##(2008-9#3)
of colonic##4##2##(1992-9#1)(2008-12#1)(2012-2#1)(2012-3#1)
of colonies##8##2##(1993-8#1)(1995-2#1)(2008-10#5)(2008-5#1)
of colonization and##2##3##(2008-10#2)
of colonization of tomato##2##4##(2008-10#2)
of colonization of##4##3##(2008-10#4)
of colonization##17##2##(2008-10#14)(2008-11#1)(2008-8#2)
of colony form##2##3##(2008-9#1)(2009-8#1)
of colony formation##2##3##(1990-12#1)(2008-11#1)
of colony##12##2##(1990-12#1)(1993-9#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#3)(2009-8#1)
of color and##2##3##(1994-12#1)(1996-5#1)
of color##11##2##(1993-3#1)(1994-12#1)(1996-5#1)(2008-10#3)(2008-6#1)(2009-5#1)(2009-7#3)
of colorectal cancer (CRC)##2##4##(2010-12#1)(2010-6#1)
of colorectal cancer patients##3##4##(1990-6#1)(1997-8#2)
of colorectal cancer##16##3##(1990-6#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-5#1)(1997-8#4)(2008-1#1)(2008-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
of colorectal carcinoma##2##3##(1995-12#1)(2012-12#1)
of colorectal liver metastases##3##4##(2012-3#2)(2013-1#1)
of colorectal##26##2##(1990-6#1)(1992-9#1)(1993-12#2)(1993-3#2)(1994-2#2)(1995-12#1)(1995-5#1)(1997-8#4)(2008-1#1)(2008-10#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
of colored##2##2##(2008-10#2)
of colour##5##2##(1990-12#1)(2008-10#2)(2011-1#1)(2011-2#1)
of coloured##2##2##(2008-10#2)
of column##3##2##(2008-10#2)(2008-3#1)
of columnar##3##2##(1991-2#2)(2008-3#1)
of columns##2##2##(2008-10#1)(2008-4#1)
of coma##5##2##(2008-3#1)(2008-7#4)
of combination chemotherapy##2##3##(1993-2#1)(1993-8#1)
of combination of##2##3##(2011-2#1)(2013-1#1)
of combination therapy in##2##4##(2010-10#2)
of combination therapy##7##3##(2008-10#1)(2010-10#4)(2010-4#1)(2011-2#1)
of combination vaccines##2##3##(1995-5#2)
of combination##16##2##(1993-2#1)(1993-8#1)(1995-5#3)(1997-5#1)(2008-10#1)(2008-6#1)(2010-10#4)(2010-4#1)(2011-2#2)(2013-1#1)
of combinations of##3##3##(1994-5#1)(2011-2#1)(2013-1#1)
of combined species densities##2##4##(2008-8#2)
of combined##25##2##(1991-7#1)(1993-1#1)(1993-8#1)(1993-9#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
of combining the##4##3##(1995-9#1)(2008-10#1)(2009-5#1)(2010-11#1)
of combining##11##2##(1995-9#1)(2008-10#6)(2008-9#1)(2009-5#1)(2010-11#1)(2013-1#1)
of combustible##2##2##(2008-10#2)
of combustion products##2##3##(1996-12#2)
of combustion##4##2##(1996-12#4)
of comfort in##2##3##(1996-9#1)(2010-6#1)
of comfort##3##2##(1996-9#1)(2009-3#1)(2010-6#1)
of comma bacillus##2##3##(2013-1#2)
of commercial samples##2##3##(2008-10#2)
of commercial##30##2##(1995-8#1)(2008-10#23)(2008-5#3)(2010-4#2)(2013-1#1)
of commercially available instruments##2##4##(2008-4#1)(2008-9#1)
of commercially available##20##3##(1993-3#1)(2008-10#8)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#4)(2013-1#1)
of commercially##25##2##(1993-3#1)(2008-10#11)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#4)(2012-2#1)(2013-1#2)
of commitment##2##2##(2008-11#1)(2009-7#1)
of common scab##2##3##(2008-10#2)
of common weeds in##2##4##(2008-12#2)
of common##44##2##(1992-11#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-5#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#2)
of commonly used##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
of commonly##8##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2013-8#1)
of communicating##3##2##(2010-4#1)(2013-1#1)(2013-8#1)
of communication (p##2##3##(2008-9#1)(2010-4#1)
of communication as##2##3##(2008-9#1)(2013-8#1)
of communication between##3##3##(1994-2#1)(2013-1#2)
of communication##23##2##(1992-3#2)(1994-2#1)(1997-3#1)(2008-11#3)(2008-12#1)(2008-9#4)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#3)
of communities##5##2##(1997-3#1)(2008-10#1)(2008-8#3)
of community and##2##3##(1995-3#1)(2010-4#1)
of community based##2##3##(2008-12#2)
of community engagement##2##3##(2012-2#2)
of community health information networks##2##5##(1996-1#2)
of community health##4##3##(1996-1#2)(1996-2#1)(1997-2#1)
of community pharmacists##2##3##(2011-1#1)(2013-1#1)
of community residents in##3##4##(1995-3#3)
of community##36##2##(1991-2#1)(1993-1#1)(1994-3#1)(1995-3#4)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(2008-1#1)(2008-11#1)(2008-12#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-7#2)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
of community-acquired pneumonia in##2##4##(1992-5#1)(2010-5#1)
of community-acquired##4##2##(1992-5#2)(2010-5#1)(2011-2#1)
of community-associated methicillin-resistant Staphylococcus aureus##2##5##(2008-10#1)(2008-11#1)
of community-based##4##2##(1997-3#1)(2008-1#1)(2008-11#1)(2013-1#1)
of comorbid##3##2##(2008-6#1)(2008-8#1)(2013-8#1)
of comorbidities##2##2##(2008-7#1)(2012-12#1)
of compact##6##2##(2008-10#3)(2008-3#1)(2009-7#1)(2011-2#1)
of companies that##2##3##(2008-11#2)
of companies##3##2##(1992-3#1)(2008-11#2)
of comparable size##3##3##(1992-10#1)(2008-10#2)
of comparable##5##2##(1992-10#1)(1994-3#1)(2008-10#2)(2008-11#1)
of comparative##8##2##(1995-5#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)
of comparing the##2##3##(1994-12#1)(2008-10#1)
of comparing##4##2##(1994-12#1)(1994-6#1)(2008-10#1)(2010-4#1)
of comparison##6##2##(1994-1#1)(1994-9#1)(2008-10#2)(2008-3#2)
of compartmental##2##2##(2008-11#1)(2008-5#1)
of compatible##2##2##(2008-10#1)(2012-7#1)
of compensation##8##2##(1991-2#2)(1994-2#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-2#1)
of compensatory homeostasis##2##3##(2012-2#2)
of compensatory interactions##2##3##(1994-8#2)
of compensatory##6##2##(1994-8#2)(2008-10#1)(2012-2#2)(2012-3#1)
of competence in##2##3##(1992-2#1)(2007-12#1)
of competence##6##2##(1991-6#1)(1992-2#1)(2007-12#1)(2008-11#2)(2008-8#1)
of competency##3##2##(1994-1#1)(2008-11#1)(2010-3#1)
of competent##4##2##(2008-11#2)(2008-12#2)
of competing species at a single trophic level##2##8##(2008-9#2)
of competing species##5##3##(2008-8#3)(2008-9#2)
of competing##11##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#2)(2013-1#1)
of competition and##2##3##(2008-8#1)(2009-7#1)
of competition are##2##3##(2008-11#1)(2008-9#1)
of competition between##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
of competition in##2##3##(1995-2#1)(2008-8#1)
of competition##25##2##(1995-2#1)(2008-10#2)(2008-11#3)(2008-8#12)(2008-9#6)(2009-7#1)
of competitive ELISA##2##3##(1990-12#1)(1995-12#1)
of competitive exclusion##2##3##(2008-8#2)
of competitive##13##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-2#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#3)(2012-2#1)
of competitor##2##2##(2008-10#1)(2008-8#1)
of competitors##6##2##(2008-8#4)(2008-9#1)(2009-10#1)
of complaints##2##2##(1990-3#1)(1994-6#1)
of complement##4##2##(1990-8#1)(1993-3#2)(2009-6#1)
of complementarity##2##2##(1994-5#1)(2008-4#1)
of complementary##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
of complete genome sequences##2##4##(2008-4#2)
of complete genome##3##3##(2008-4#2)(2008-9#1)
of complete##21##2##(1991-2#1)(1994-2#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)
of completely##5##2##(1993-9#1)(2008-11#2)(2008-2#1)(2008-5#1)
of completeness of##2##3##(2008-10#1)(2010-8#1)
of completing##2##2##(1991-8#1)(2008-11#1)
of complex carbohydrates in##2##4##(1995-2#1)(2008-5#1)
of complex carbohydrates##3##3##(1995-2#1)(1997-2#1)(2008-5#1)
of complex formation equilibria##2##4##(2008-10#2)
of complex formation of##2##4##(2008-10#2)
of complex formation##6##3##(2008-10#6)
of complex microbial communities##2##4##(2011-2#2)
of complex or##2##3##(2008-10#1)(2009-12#1)
of complex pathotypes##2##3##(2008-10#2)
of complex samples##3##3##(2008-10#3)
of complex species##3##3##(2008-10#3)
of complex training##2##3##(2009-1#2)
of complex traits##5##3##(1994-9#2)(2010-7#1)(2012-3#2)
of complex##78##2##(1990-2#1)(1992-11#1)(1992-4#1)(1993-9#1)(1994-9#3)(1995-2#1)(1997-2#2)(1997-3#1)(2007-11#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#2)(2009-12#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#4)(2011-7#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
of complexation of##2##3##(2008-10#2)
of complexation##6##2##(2008-10#6)
of complexed##2##2##(2008-10#2)
of complexes between##2##3##(2008-10#2)
of complexes formed by##2##4##(2008-10#2)
of complexes formed##4##3##(1995-8#1)(2008-10#3)
of complexes with##2##3##(2008-10#2)
of complexes##16##2##(1990-2#1)(1995-8#1)(2008-10#14)
of complexing agent##3##3##(2008-10#3)
of complexing agent)##2##3##(2008-10#2)
of complexing##7##2##(2008-10#6)(2008-5#1)
of complexity##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
of compliance##3##2##(1993-3#1)(1994-5#1)(2008-10#1)
of complicated##8##2##(1993-12#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-12#2)(2012-2#2)
of complication##3##2##(1990-5#1)(2009-8#1)(2013-1#1)
of complications and##4##3##(2011-2#1)(2011-3#1)(2013-1#2)
of complications in the##2##4##(1991-9#1)(1992-12#1)
of complications in##7##3##(1990-11#1)(1990-9#1)(1991-9#1)(1992-12#1)(1995-12#1)(1996-6#1)(2010-12#1)
of complications such as##5##4##(1996-9#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-3#1)
of complications that##2##3##(2008-7#1)(2013-1#1)
of complications was##5##3##(1991-8#1)(1992-12#2)(2008-9#1)(2010-3#1)
of complications##46##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-12#3)(1992-9#1)(1993-11#1)(1995-12#2)(1996-11#1)(1996-6#2)(1996-9#1)(1997-8#1)(2007-11#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-1#9)
of component##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
of components in the##2##4##(2008-10#2)
of components in##3##3##(2008-10#3)
of components of the##2##4##(2008-10#2)
of components of##4##3##(2008-10#4)
of components##14##2##(1997-3#1)(2008-10#10)(2008-4#1)(2008-8#1)(2013-1#1)
of composite##9##2##(1991-6#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)
of composition##5##2##(1992-12#1)(2008-10#4)
of compost##4##2##(2008-10#3)(2008-11#1)
of compost-amended##2##2##(2008-10#2)
of compost-mediated induced resistance##2##4##(2008-10#2)
of compound##12##2##(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
of compounds and##2##3##(2008-10#1)(2010-5#1)
of compounds are##4##3##(2008-10#4)
of compounds as##2##3##(1993-8#1)(1994-8#1)
of compounds for##2##3##(1991-1#1)(2008-10#1)
of compounds in##2##3##(2008-10#2)
of compounds is##2##3##(2008-10#1)(2008-6#1)
of compounds that inhibit##2##4##(2008-10#2)
of compounds that##8##3##(2008-10#5)(2009-4#1)(2011-2#2)
of compounds was##2##3##(2008-10#2)
of compounds were##2##3##(2009-4#1)(2012-2#1)
of compounds which##2##3##(2008-10#2)
of compounds with##4##3##(2008-10#1)(2008-5#1)(2011-1#1)(2011-3#1)
of compounds##55##2##(1991-1#1)(1991-5#1)(1993-8#2)(1994-3#1)(1994-8#1)(1996-5#1)(2008-10#31)(2008-11#4)(2008-5#1)(2008-6#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)
of comprehension##4##2##(1997-3#2)(2009-4#1)(2010-7#1)
of comprehensive care##2##3##(1994-2#1)(2008-11#1)
of comprehensive##13##2##(1992-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2011-7#1)(2013-1#1)
of compression##4##2##(2008-10#1)(2008-12#1)(2013-8#2)
of compressive##2##2##(2008-7#1)(2011-3#1)
of compromised##2##2##(2008-9#2)
of compulsory##3##2##(1994-1#2)(1994-2#1)
of computational##2##2##(2008-11#1)(2011-2#1)
of computed tomography and##2##4##(1990-12#1)(2011-2#1)
of computed tomography in##2##4##(2008-12#1)(2012-2#1)
of computed tomography##8##3##(1990-12#1)(1997-4#1)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#2)(2012-2#1)
of computed##10##2##(1990-12#1)(1990-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of computer simulation##4##3##(2008-3#2)(2008-4#2)
of computer software##3##3##(2008-9#2)(2012-2#1)
of computer vision##2##3##(2012-3#2)
of computer##21##2##(1993-1#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#3)(2008-9#2)(2009-5#1)(2012-2#1)(2012-3#2)
of computer-based##2##2##(2008-10#1)(2008-12#1)
of computerized##6##2##(1995-3#1)(2008-11#2)(2008-8#1)(2010-10#1)(2013-1#1)
of computers##5##2##(1996-2#1)(2008-10#1)(2008-12#1)(2009-9#1)(2012-2#1)
of computing##4##2##(1995-9#1)(2008-3#2)(2011-3#1)
of concanavalin A (Con A)##3##5##(1994-11#1)(2008-10#2)
of concanavalin##4##2##(1994-11#1)(2008-10#3)
of concealed##3##2##(2008-10#3)
of concentrated HCl##3##3##(2008-10#3)
of concentrated HNO(3)##2##3##(2008-10#2)
of concentrated hydrochloric acid##2##4##(2008-10#2)
of concentrated##13##2##(2008-10#11)(2008-11#1)(2008-7#1)
of concentration and a detection limit of##2##7##(2008-10#2)
of concentration and##6##3##(2008-10#5)(2010-5#1)
of concentration of##9##3##(2008-10#6)(2013-1#2)(2013-8#1)
of concentration was##3##3##(2008-10#3)
of concentration##34##2##(1991-8#1)(2008-10#23)(2008-3#2)(2008-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2013-1#2)(2013-8#2)
of concentrations of##5##3##(1996-12#1)(2008-10#3)(2008-12#1)
of concentrations##16##2##(1994-11#1)(1996-12#1)(2008-10#12)(2008-12#1)(2008-5#1)
of concept##5##2##(1996-6#1)(2008-12#1)(2010-10#1)(2011-9#1)(2013-1#1)
of concepts##6##2##(1995-3#1)(1996-3#1)(2008-10#2)(2009-6#1)(2012-3#1)
of conceptual##2##2##(1996-3#1)(2010-10#1)
of concern for##2##3##(2008-9#1)(2013-8#1)
of concern in the##3##4##(2008-10#1)(2008-6#1)(2011-2#1)
of concern in##5##3##(2008-10#2)(2008-6#1)(2010-6#1)(2011-2#1)
of concern is##2##3##(2007-12#1)(2011-2#1)
of concern to the##2##4##(2008-10#1)(2008-11#1)
of concern##19##2##(1993-3#1)(1994-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-2#3)(2013-8#1)
of concerns##3##2##(1991-3#1)(1993-3#1)(2008-7#1)
of conclusions about##2##3##(2008-10#1)(2009-12#1)
of concomitant##8##2##(1993-9#1)(2008-10#4)(2009-9#1)(2012-12#1)(2013-1#1)
of concomitants##2##2##(2008-10#2)
of concordant##2##2##(2011-2#2)
of concrete##2##2##(2008-11#1)(2013-1#1)
of concurrency##2##2##(2011-2#2)
of concurrent sexual partnerships##2##4##(2011-2#2)
of concurrent##11##2##(1990-6#1)(1992-5#1)(1997-5#1)(2008-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of concussion##2##2##(2010-1#1)(2013-1#1)
of condensation##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
of condensed##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
of condition-dependent##2##2##(2008-8#2)
of conditional stability constants of##2##5##(2008-10#2)
of conditional stability constants##4##4##(2008-10#4)
of conditional##7##2##(2008-10#6)(2008-11#1)
of conditioned fear##2##3##(1997-7#2)
of conditioned medium##3##3##(2008-11#3)
of conditioned##5##2##(1997-7#2)(2008-11#3)
of conditions for##3##3##(2008-10#2)(2008-6#1)
of conditions##25##2##(1990-10#1)(1990-2#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-7#1)(2011-2#1)(2013-1#2)
of condom##2##2##(2008-1#1)(2008-10#1)
of condoms##2##2##(1990-6#1)(2009-5#1)
of conductance##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
of conducting polymer##2##3##(2008-10#2)
of conducting polymers##2##3##(1990-8#1)(2008-10#1)
of conducting##11##2##(1990-8#1)(1997-3#1)(2008-10#5)(2009-11#1)(2010-11#1)(2010-5#1)(2012-2#1)
of confectionery sunflower##2##3##(2008-10#2)
of confidence intervals for##2##4##(1994-9#1)(2008-10#1)
of confidence intervals##5##3##(1994-9#2)(1995-5#1)(2008-10#2)
of confidence##21##2##(1994-9#2)(1995-5#1)(2008-10#15)(2008-12#1)(2008-9#1)(2009-7#1)
of confidentiality##5##2##(1990-2#1)(1995-12#1)(1995-9#1)(2007-12#1)(2008-8#1)
of configuration at C-2##2##4##(1996-5#2)
of configuration at##3##3##(1996-5#3)
of confirmatory##2##2##(2009-3#1)(2013-1#1)
of conflict and##2##3##(2008-8#1)(2010-1#1)
of conflict between##2##3##(1993-12#1)(2008-8#1)
of conflict##4##2##(1993-12#1)(2008-8#2)(2010-1#1)
of confluent##2##2##(1991-5#1)(2008-10#1)
of conformation of##2##3##(1990-5#1)(2008-10#1)
of conformational##3##2##(1991-9#1)(2008-5#1)(2012-2#1)
of confounding##3##2##(1991-8#1)(1992-9#1)(1996-12#1)
of congenital anomalies##3##3##(1997-3#2)(2008-11#1)
of congenital heart disease##4##4##(1993-12#1)(2008-10#1)(2010-6#1)(2013-8#1)
of congenital heart##6##3##(1993-12#1)(1997-8#2)(2008-10#1)(2010-6#1)(2013-8#1)
of congenital hypothyroidism##2##3##(2008-4#1)(2011-1#1)
of congenital malformations##3##3##(2008-7#1)(2013-1#2)
of congenital toxoplasmosis##3##3##(1990-9#3)
of congenital##34##2##(1990-9#6)(1992-5#1)(1993-12#1)(1994-1#1)(1994-9#1)(1997-3#2)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
of congestive heart failure##4##4##(2008-11#1)(2008-3#1)(2012-3#2)
of congestive##5##2##(1996-3#1)(2008-11#1)(2008-3#1)(2012-3#2)
of conidia and##8##3##(2008-10#7)(2010-3#1)
of conidia from##4##3##(2008-10#4)
of conidia germinated##2##3##(2008-10#2)
of conidia in##3##3##(2008-10#3)
of conidia of##4##3##(2008-10#4)
of conidia on##2##3##(2008-10#2)
of conidia or##2##3##(2008-10#2)
of conidia produced in PV plus##2##6##(2008-10#2)
of conidia produced##3##3##(2008-10#3)
of conidia was##2##3##(2008-10#1)(2008-5#1)
of conidia##58##2##(2008-10#56)(2008-5#1)(2010-3#1)
of conidial germination##2##3##(2008-10#2)
of conidial##4##2##(2008-10#4)
of conifers##2##2##(2008-10#1)(2010-10#1)
of conjugate##3##2##(2006-6#1)(2007-11#1)(2008-8#1)
of conjugated dienes##4##3##(1992-3#2)(2009-8#2)
of conjugated##10##2##(1990-12#1)(1992-3#2)(2008-10#2)(2008-11#3)(2009-8#2)
of conjunctival##2##2##(1995-11#2)
of connecting##2##2##(2010-3#1)(2012-12#1)
of connection data##2##3##(1995-5#2)
of connections between##3##3##(1995-5#2)(2009-8#1)
of connections##4##2##(1995-5#2)(1997-3#1)(2009-8#1)
of connective tissue##7##3##(1997-4#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-3#2)(2013-1#1)
of connective##8##2##(1997-4#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-3#2)(2013-1#2)
of conscientious##2##2##(2011-2#2)
of conscious##5##2##(1995-2#1)(1995-8#1)(1995-9#1)(2008-11#1)(2012-3#1)
of consciousness and##4##3##(1997-3#1)(2008-11#1)(2010-6#1)(2012-2#1)
of consciousness is##3##3##(2008-11#3)
of consciousness##22##2##(1992-6#2)(1997-3#1)(2008-11#7)(2008-7#1)(2010-6#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#3)
of consecutive##7##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)
of consensus##8##2##(1995-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
of conservation##7##2##(1991-12#1)(1991-6#1)(1993-11#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-9#1)
of conservative treatment##4##3##(2008-10#1)(2009-5#1)(2013-1#2)
of conservative##8##2##(1992-3#1)(1993-12#1)(1997-6#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#2)
of conserved##3##2##(1993-12#1)(2008-9#1)(2013-1#1)
of considerable importance##3##3##(2008-11#1)(2008-7#1)(2009-10#1)
of considerable##8##2##(2008-10#3)(2008-11#1)(2008-7#2)(2009-10#1)(2011-2#1)
of considering##8##2##(1995-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-8#2)(2011-2#1)(2012-12#1)
of consistency lots##3##3##(1995-5#3)
of consistent##3##2##(1990-8#1)(2010-9#1)(2012-3#1)
of consolidation##3##2##(2008-10#3)
of conspecific sperm precedence##2##4##(2008-8#2)
of conspecific##6##2##(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#1)
of constant##13##2##(1990-11#4)(1996-3#1)(2008-10#6)(2008-11#1)(2008-8#1)
of constituents##2##2##(2008-10#1)(2013-1#1)
of constitutive and##3##3##(1994-8#1)(1995-9#1)(2008-8#1)
of constitutive##8##2##(1994-11#1)(1994-8#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)
of constitutively##2##2##(2013-1#2)
of constrained##2##2##(2008-10#1)(2012-2#1)
of constraints on##2##3##(2008-8#1)(2008-9#1)
of constraints##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
of constructing##2##2##(1996-3#1)(2008-8#1)
of consultation##2##2##(1993-5#1)(2013-1#1)
of consumed##3##2##(2008-10#2)(2010-8#1)
of consumer complaints##2##3##(1993-3#1)(1997-3#1)
of consumer empowerment and involvement##2##5##(1997-3#2)
of consumer information##2##3##(1997-3#2)
of consumer##19##2##(1991-3#1)(1993-1#1)(1993-3#1)(1994-3#2)(1995-2#1)(1996-2#2)(1997-3#5)(2008-9#2)(2010-10#2)(2011-1#2)
of consumer/survivor##2##2##(1997-3#2)
of consumers##5##2##(2008-12#1)(2008-5#1)(2008-8#1)(2010-7#1)(2013-1#1)
of consumption##2##2##(2008-7#1)(2011-2#1)
of contact between the##2##4##(2008-11#1)(2012-2#1)
of contact with##2##3##(1992-5#1)(2008-11#1)
of contact##15##2##(1992-5#1)(1995-11#1)(2008-10#8)(2008-11#3)(2012-2#1)(2013-1#1)
of contacts##4##2##(1992-12#1)(1994-6#3)
of contagion and##2##3##(2008-10#1)(2013-8#1)
of containment##2##2##(2011-2#1)(2013-1#1)
of contaminant elements##2##3##(2008-10#2)
of contaminant##5##2##(2008-10#4)(2008-7#1)
of contaminants##7##2##(2008-10#2)(2008-11#3)(2008-9#1)(2011-2#1)
of contaminated soil##2##3##(2008-10#2)
of contaminated##8##2##(2008-10#3)(2008-11#2)(2008-3#1)(2011-1#1)(2012-3#1)
of contaminating##4##2##(1993-8#1)(1995-6#1)(1997-3#1)(2008-5#1)
of contamination and##2##3##(2008-10#2)
of contamination##19##2##(1994-3#1)(2008-10#14)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
of contemporary##7##2##(1994-12#1)(1995-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#1)(2012-12#1)
of content##3##2##(1994-2#1)(2008-10#1)(2010-11#1)
of contents##3##2##(1992-12#1)(2008-12#1)(2009-4#1)
of contexts##2##2##(1991-1#1)(2013-8#1)
of contextual##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
of contiguous##3##2##(1997-9#1)(2008-10#1)(2009-10#1)
of continued##2##2##(2008-3#1)(2008-9#1)
of continuing education##2##3##(1997-5#1)(2008-11#1)
of continuing##8##2##(1993-8#1)(1994-1#1)(1996-1#1)(1997-5#1)(2008-10#1)(2008-11#2)(2013-1#1)
of continuity and##2##3##(1993-1#1)(2012-3#1)
of continuity##4##2##(1991-6#1)(1993-1#2)(2012-3#1)
of continuous flow##4##3##(2008-10#3)(2010-6#1)
of continuous improvement##2##3##(1994-1#1)(1994-2#1)
of continuous quality improvement##4##4##(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)
of continuous##43##2##(1991-3#1)(1993-11#1)(1994-1#2)(1994-12#1)(1994-2#3)(1995-12#1)(1995-2#1)(1997-1#1)(2007-11#2)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-4#1)
of continuous-wave##2##2##(2008-3#2)
of continuously##2##2##(1995-2#1)(1995-6#1)
of contraceptive##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
of contract learning##2##3##(2008-11#2)
of contract##3##2##(1992-1#1)(2008-11#2)
of contracting AIDS##2##3##(1992-12#1)(1995-12#1)
of contracting##3##2##(1992-12#1)(1992-2#1)(1995-12#1)
of contralateral##5##2##(1990-8#2)(1994-2#1)(2008-8#1)(2008-9#1)
of contrast enhancement##3##3##(2012-2#2)(2013-1#1)
of contrast media##2##3##(1992-3#1)(2008-12#1)
of contrast medium##3##3##(1992-12#1)(1996-9#1)(2011-2#1)
of contrast##16##2##(1992-12#1)(1992-3#1)(1993-3#1)(1996-9#1)(2008-10#2)(2008-12#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of contrast-enhanced MR mammography##3##4##(1997-8#3)
of contrast-enhanced US##2##3##(2010-12#1)(2012-2#1)
of contrast-enhanced##7##2##(1997-8#3)(2010-12#2)(2012-2#2)
of contributions##2##2##(2008-3#2)
of control and##6##3##(1993-8#1)(1996-2#2)(1997-7#1)(2008-10#1)(2008-11#1)
of control cells##5##3##(2008-11#5)
of control for##4##3##(2008-10#3)(2009-7#1)
of control group##2##3##(2008-10#1)(2012-3#1)
of control in##2##3##(1992-3#1)(2008-10#1)
of control of##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
of control strategies##2##3##(2008-10#1)(2008-11#1)
of control values##3##3##(1990-5#1)(1994-3#1)(1997-2#1)
of control##86##2##(1990-5#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-3#1)(1995-11#1)(1995-3#2)(1996-1#3)(1996-2#4)(1997-2#2)(1997-7#3)(2008-1#1)(2008-10#15)(2008-11#17)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
of control)##4##2##(1993-8#1)(1994-12#1)(1996-12#1)(2008-11#1)
of controlled##7##2##(1991-10#1)(1992-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-10#1)
of controlling##6##2##(1994-6#1)(2008-10#1)(2008-5#1)(2010-1#2)(2012-2#1)
of controls##16##2##(1990-11#1)(1990-8#2)(1994-3#1)(1996-11#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
of controversy##2##2##(1994-9#1)(2008-10#1)
of conventional emission##2##3##(2008-10#2)
of conventional radiography##2##3##(2011-2#1)(2013-1#1)
of conventional##34##2##(1992-3#1)(1994-3#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#2)(2010-10#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
of convergence##2##2##(2008-8#1)(2009-10#1)
of convergent evolution##4##3##(2008-9#1)(2009-6#1)(2011-2#2)
of convergent##5##2##(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)
of conversion of Se(VI)##2##4##(2008-10#2)
of conversion of##4##3##(1990-10#1)(2008-10#3)
of conversion##8##2##(1990-10#1)(1996-11#1)(2008-10#4)(2013-1#2)
of converting##3##2##(1994-11#1)(1996-1#1)(2010-1#1)
of convincing##2##2##(1991-3#1)(1994-1#1)
of cooked##3##2##(2008-10#2)(2010-4#1)
of cooling##3##2##(2008-3#2)(2008-5#1)
of cooperation##13##2##(2008-8#8)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
of cooperative##8##2##(1991-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)
of coordinate expression##2##3##(1997-7#2)
of coordinated##2##2##(2009-6#1)(2012-2#1)
of copies##2##2##(1991-2#1)(2012-12#1)
of coping skills training##2##4##(2013-1#2)
of coping##6##2##(1997-8#1)(2008-1#1)(2008-11#1)(2010-4#1)(2013-1#2)
of copolymers##2##2##(2009-10#1)(2013-1#1)
of copper (Cu) and##2##4##(2010-5#1)(2013-8#1)
of copper and iron in##4##5##(2008-10#4)
of copper and iron##11##4##(2008-10#11)
of copper and lead##3##4##(2008-10#3)
of copper and mercury ions##3##5##(2008-10#3)
of copper and zinc##2##4##(2008-10#2)
of copper and##28##3##(2008-10#28)
of copper are##2##3##(1992-12#1)(2008-10#1)
of copper at##5##3##(2008-10#5)
of copper by##9##3##(2008-10#9)
of copper deficiency##2##3##(2012-2#2)
of copper determination in##2##4##(2008-10#2)
of copper from##2##3##(2008-10#2)
of copper in alloys##2##4##(2008-10#2)
of copper in natural##3##4##(2008-10#3)
of copper in the##4##4##(2008-10#4)
of copper in water samples##5##5##(2008-10#5)
of copper in##31##3##(2008-10#31)
of copper ions##4##3##(2008-10#4)
of copper is##4##3##(2008-10#4)
of copper metabolism##2##3##(1992-12#1)(2008-12#1)
of copper on##3##3##(2008-10#2)(2008-12#1)
of copper oxide##2##3##(2008-10#1)(2008-2#1)
of copper was##5##3##(2008-10#5)
of copper were##2##3##(2008-10#2)
of copper with##4##3##(2008-10#4)
of copper##171##2##(1990-8#1)(1992-12#2)(2008-10#156)(2008-12#4)(2008-2#2)(2010-5#1)(2012-2#4)(2013-8#1)
of copper(II) and##7##3##(2008-10#7)
of copper(II) at##2##3##(2008-10#2)
of copper(II) based on its catalytic##2##6##(2008-10#2)
of copper(II) based on its##3##5##(2008-10#3)
of copper(II) based on##4##4##(2008-10#4)
of copper(II) by##4##3##(2008-10#4)
of copper(II) in##7##3##(2008-10#7)
of copper(II) ions##5##3##(2008-10#5)
of copper(II) with##4##3##(2008-10#4)
of copper(II)##58##2##(2008-10#58)
of copper-resistant##2##2##(2008-10#2)
of copulation##2##2##(2007-12#1)(2008-11#1)
of copy number##2##3##(2008-9#1)(2012-3#1)
of coral##4##2##(2008-3#1)(2012-2#2)(2013-1#1)
of coral-reef fishes##2##3##(2010-8#2)
of cord blood cells##2##4##(2008-11#2)
of cord blood##5##3##(2008-11#5)
of core##5##2##(1993-1#1)(1994-12#1)(2008-11#1)(2008-12#1)(2010-11#1)
of corn (Zea mays)##2##4##(2008-10#2)
of corn from##2##3##(2008-10#2)
of corn##15##2##(2008-10#14)(2011-2#1)
of cornea##2##2##(2011-3#1)(2012-3#1)
of corneal##5##2##(2010-10#1)(2011-2#3)(2013-1#1)
of corneocytes##3##2##(2008-5#3)
of coronary artery disease##10##4##(1992-9#1)(2008-11#1)(2008-12#2)(2009-10#1)(2010-2#2)(2010-9#1)(2012-2#1)(2013-8#1)
of coronary artery stenosis##2##4##(2011-2#2)
of coronary artery##18##3##(1992-9#1)(1997-8#1)(2008-11#3)(2008-12#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
of coronary heart disease in##2##5##(1996-8#2)
of coronary heart disease##9##4##(1991-2#1)(1991-8#1)(1996-8#2)(2008-12#3)(2008-8#1)(2012-2#1)
of coronary heart##10##3##(1991-2#1)(1991-8#1)(1996-8#2)(2008-12#3)(2008-8#1)(2012-2#1)(2013-1#1)
of coronary##41##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-9#1)(1996-8#2)(1997-8#1)(2008-11#6)(2008-12#7)(2008-7#1)(2008-8#2)(2009-10#1)(2010-2#2)(2010-9#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of corpora##3##2##(1992-3#2)(1995-11#1)
of corpus##2##2##(1995-11#1)(2008-10#1)
of corpuscularism##2##2##(2008-12#2)
of correct answers##2##3##(2008-12#1)(2013-8#1)
of correct classification for##2##4##(2008-10#2)
of correct classification##3##3##(2008-10#3)
of correct diagnosis##2##3##(1990-9#1)(2010-5#1)
of correct responses##3##3##(1991-2#1)(1993-3#1)(2013-8#1)
of correct##22##2##(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#2)(1993-3#1)(1995-2#1)(2008-10#5)(2008-12#2)(2008-9#4)(2010-5#1)(2011-1#1)(2013-8#2)
of correction##3##2##(2008-10#1)(2008-7#1)(2010-11#1)
of correctly identified##2##3##(2008-10#1)(2013-1#1)
of correctly##4##2##(1992-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
of correlated##2##2##(1996-6#1)(2008-8#1)
of correlation between##5##3##(1991-12#1)(2008-10#3)(2008-3#1)
of correlation coefficient##4##3##(2008-10#4)
of correlation with##2##3##(1994-8#1)(2013-8#1)
of correlation##18##2##(1991-12#1)(1994-8#1)(1996-3#1)(2008-10#12)(2008-3#1)(2013-8#2)
of correlations##3##2##(2008-10#2)(2008-5#1)
of corresponding##6##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
of cortex##5##2##(1996-12#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
of cortexin##2##2##(2010-4#2)
of cortical and hippocampal 5-HT1A##2##5##(1994-2#2)
of cortical and subcortical##2##4##(2008-11#2)
of cortical and##4##3##(1994-2#2)(2008-11#2)
of cortical cell walls##2##4##(2008-10#2)
of cortical cells##4##3##(1990-8#1)(2008-10#2)(2008-11#1)
of cortical##32##2##(1990-8#2)(1994-2#2)(1994-3#1)(2008-10#5)(2008-11#12)(2008-7#3)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
of corticosteroid##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
of corticosteroids##7##2##(1992-3#1)(1997-5#2)(1997-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
of corticosterone##6##2##(1990-11#2)(1997-2#2)(2008-10#1)(2008-8#1)
of corticotropin-releasing##2##2##(1990-5#1)(2008-4#1)
of cortisol##4##2##(1990-12#1)(1990-5#1)(1991-6#1)(2008-6#1)
of cosmetic products##6##3##(2008-5#6)
of cosmetic##10##2##(2008-10#1)(2008-5#9)
of cosmetics##6##2##(2008-5#6)
of cost and##7##3##(1992-11#1)(1993-3#1)(1994-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
of cost containment on##2##4##(1991-3#1)(1992-1#1)
of cost containment##4##3##(1991-3#2)(1992-1#1)(1995-3#1)
of cost##17##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-11#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
of cost-effective##3##2##(1994-2#1)(2008-11#1)(2009-8#1)
of cost-effectiveness##4##2##(1992-1#1)(1997-8#1)(2008-2#1)(2009-8#1)
of costimulatory molecules on##2##4##(2008-11#2)
of costimulatory molecules##4##3##(2007-12#1)(2008-10#1)(2008-11#2)
of costs and benefits of##2##5##(2008-12#1)(2009-4#1)
of costs and##4##3##(1992-5#1)(2008-10#1)(2008-12#1)(2009-4#1)
of costs##8##2##(1992-5#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-4#1)
of cotrimoxazole and trimethoprim##2##4##(2008-11#2)
of cotrimoxazole##6##2##(2008-11#6)
of cotton wilt disease##2##4##(2008-12#2)
of cotton##14##2##(2008-10#9)(2008-12#3)(2008-8#1)(2008-9#1)
of cottonball##2##2##(2008-10#2)
of cottonseed##3##2##(2008-10#3)
of cotyledon##5##2##(2008-8#1)(2008-9#4)
of cotyledons##3##2##(2008-10#2)(2009-8#1)
of coughing##3##2##(1991-11#1)(1993-6#1)(2008-12#1)
of coumarin##4##2##(2008-10#2)(2008-11#2)
of coumarins##2##2##(1990-6#1)(2008-10#1)
of coumestrol to##3##3##(1995-11#3)
of coumestrol##4##2##(1995-11#4)
of counseling##3##2##(2008-6#2)(2012-3#1)
of counterion species##2##3##(1997-2#2)
of countries##6##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
of couple therapy##2##3##(2012-2#2)
of couple##3##2##(2012-2#3)
of coupled##4##2##(2008-10#1)(2008-9#1)(2009-8#2)
of couples who##2##3##(2012-2#2)
of couples##4##2##(2012-2#4)
of coupling between##2##3##(1995-11#1)(2011-1#1)
of coupling##9##2##(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)
of course and##2##3##(2008-12#1)(2013-1#1)
of course##12##2##(1994-1#2)(1997-4#1)(2008-12#3)(2008-5#1)(2009-10#2)(2013-1#3)
of courses##5##2##(1990-12#1)(1994-12#1)(1996-1#1)(2008-11#1)(2011-2#1)
of covalent##4##2##(1994-5#2)(2008-10#2)
of covalently##3##2##(1995-6#1)(2008-10#2)
of covariance##7##2##(1992-9#1)(1997-7#1)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of covariates##2##2##(2009-12#1)(2011-2#1)
of covariation##2##2##(2008-10#2)
of cover crop##2##3##(2008-10#2)
of coverage##3##2##(1995-1#1)(1996-12#1)(2012-2#1)
of cow milk##4##3##(2008-10#4)
of cows##2##2##(1992-12#1)(2013-1#1)
of coxsackievirus B1##2##3##(2013-8#2)
of cpe-positive C##3##3##(2011-2#3)
of crack##3##2##(2008-1#2)(2009-7#1)
of cranberry##4##2##(2008-10#3)(2011-1#1)
of cranial nerve##2##3##(1996-12#1)(2008-7#1)
of cranial nerves##2##3##(1993-9#1)(1996-12#1)
of cranial##6##2##(1993-9#1)(1994-9#1)(1996-12#2)(2008-7#1)(2011-2#1)
of craniofacial##2##2##(2010-6#1)(2011-2#1)
of craniopharyngioma##3##2##(1995-5#1)(2008-7#1)(2011-2#1)
of cream##3##2##(2008-5#3)
of creams##4##2##(2008-5#4)
of creatine and##3##3##(2008-10#3)
of creatine kinase##4##3##(1992-3#1)(1993-3#1)(1995-8#2)
of creatine##7##2##(1992-3#1)(1993-3#1)(1995-8#2)(2008-10#3)
of creating##7##2##(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-3#2)(2009-7#1)
of creatinine in##3##3##(1991-12#1)(2008-10#2)
of creatinine##12##2##(1991-12#2)(1995-3#1)(2008-10#7)(2011-2#1)(2013-1#1)
of creative##3##2##(1993-2#1)(2007-8#1)(2012-3#1)
of creativity##2##2##(1995-1#2)
of creeping bentgrass (Agrostis stolonifera)##2##5##(2008-10#2)
of creeping bentgrass##5##3##(2008-10#5)
of creeping##6##2##(2008-10#6)
of crime##5##2##(1991-1#1)(1992-2#1)(2008-10#1)(2009-7#1)(2010-7#1)
of criminal##2##2##(1992-1#1)(2008-10#1)
of crises##2##2##(2008-10#1)(2013-1#1)
of criteria for##5##3##(1993-12#1)(1993-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
of criteria##8##2##(1993-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
of critical importance##5##3##(1990-6#1)(1991-1#1)(2008-10#1)(2009-3#1)(2013-8#1)
of critical thinking##7##3##(2008-11#6)(2008-12#1)
of critical##30##2##(1990-11#1)(1990-6#1)(1991-1#1)(1993-3#1)(1993-9#1)(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#10)(2008-12#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-3#1)(2013-8#1)
of critically##3##2##(2008-12#1)(2011-3#1)(2012-2#1)
of criticism##4##2##(1990-11#1)(2008-11#2)(2009-11#1)
of crop protection##3##3##(2008-10#3)
of crop##14##2##(2008-10#8)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
of crops##5##2##(2008-10#5)
of cross protection##2##3##(2008-10#2)
of cross##6##2##(2008-10#4)(2008-8#1)(2013-8#1)
of cross-cultural##2##2##(2008-1#1)(2013-8#1)
of cross-flow filtration##2##3##(2008-10#2)
of cross-linked##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
of cross-protection##3##2##(2008-8#3)
of cross-reactive##2##2##(2008-11#1)(2011-2#1)
of cross-resistance##2##2##(2008-5#1)(2013-1#1)
of crosses between resistant##2##4##(2008-10#2)
of crosses between##4##3##(2008-10#4)
of crosses##9##2##(2008-10#8)(2012-3#1)
of crossing##2##2##(1995-6#1)(2008-10#1)
of crown and root rot disease of tomato##2##8##(2008-10#2)
of crown and root rot##3##5##(2008-10#3)
of crown ether##2##3##(2008-10#2)
of crown ethers##2##3##(2008-10#2)
of crown gall of tomato##2##5##(2008-10#2)
of crown gall##3##3##(2008-10#3)
of crown rust resistance in##3##5##(2008-10#3)
of crown rust resistance##4##4##(2008-10#4)
of crown rust##5##3##(2008-10#5)
of crown##17##2##(2008-10#16)(2013-1#1)
of crucial importance in##3##4##(2008-10#2)(2008-9#1)
of cruciferous##2##2##(2008-10#2)
of crucifers##2##2##(2008-10#2)
of crude oil##2##3##(2008-10#2)
of crude##6##2##(2008-10#4)(2008-12#1)(2008-4#1)
of cry1Ab gene in transgenic rice##2##6##(2008-9#2)
of cryIVB##2##2##(1993-12#2)
of cryopreserved##2##2##(1996-3#1)(2008-11#1)
of cryptic##4##2##(2008-10#1)(2009-6#1)(2010-4#1)(2012-3#1)
of cryptococcal meningitis in##2##4##(2011-2#2)
of cryptococcosis in##2##3##(2008-5#2)
of cryptogenic##2##2##(2008-7#1)(2009-10#1)
of cryptolepis sanguinolenta##3##3##(2011-2#3)
of crystal violet solution##3##4##(2008-10#3)
of crystal violet##5##3##(2008-10#5)
of crystal##6##2##(2008-10#5)(2008-3#1)
of crystalline##2##2##(2008-10#1)(2008-5#1)
of ctDNA##2##2##(2008-10#2)
of cubic##2##2##(1991-5#1)(2008-3#1)
of cucumber leaves##2##3##(2008-10#2)
of cucumber mosaic cucumovirus##2##4##(2008-10#2)
of cucumber mosaic virus (CMV)##2##5##(2008-10#2)
of cucumber mosaic virus##4##4##(2008-10#4)
of cucumber mosaic##6##3##(2008-10#6)
of cucumber##21##2##(2008-10#21)
of cucurbit-infecting##2##2##(2008-10#2)
of cucurbits##6##2##(2008-10#5)(2013-8#1)
of culinary practice##2##3##(2012-2#2)
of culinary##3##2##(1994-3#1)(2012-2#2)
of cultivar and##2##3##(2008-10#2)
of cultivar##9##2##(2008-10#9)
of cultivars##8##2##(2008-10#7)(2012-4#1)
of cultivated##4##2##(2008-10#3)(2009-10#1)
of cultivation and##2##3##(2008-11#1)(2010-7#1)
of cultivation##10##2##(2008-10#1)(2008-11#6)(2008-7#1)(2010-7#1)(2011-2#1)
of culturable bacteria##3##3##(2008-10#3)
of culturable##5##2##(2008-10#4)(2008-7#1)
of cultural diversity in##2##4##(2008-11#2)
of cultural diversity##3##3##(1997-2#1)(2008-11#2)
of cultural heritage##2##3##(2008-10#2)
of cultural##10##2##(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2009-10#1)(2010-4#1)
of culturally appropriate##2##3##(2008-6#1)(2010-9#1)
of culturally##5##2##(1997-2#1)(2008-1#1)(2008-6#1)(2010-9#1)(2012-3#1)
of culture and##2##3##(2008-11#1)(2011-2#1)
of culture conditions for##2##4##(2008-11#2)
of culture conditions##3##3##(2008-11#3)
of culture media##2##3##(2008-11#1)(2008-9#1)
of culture medium##2##3##(1996-12#1)(2008-11#1)
of culture##40##2##(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#22)(2008-8#2)(2008-9#3)(2009-12#1)(2011-2#1)(2013-1#1)
of culture-negative endocarditis##2##3##(1993-2#1)(1996-11#1)
of culture-negative##4##2##(1993-12#1)(1993-2#1)(1996-11#1)(2011-2#1)
of cultured cells##10##3##(1992-12#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-11#4)(2011-2#1)
of cultured hippocampal neurons##3##4##(1996-12#1)(1997-7#2)
of cultured human##3##3##(1990-2#1)(1994-3#1)(2008-11#1)
of cultured##24##2##(1990-2#1)(1991-5#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-3#2)(1996-12#1)(1997-7#2)(2008-10#3)(2008-11#9)(2008-9#1)(2011-2#1)
of cultures##8##2##(1997-8#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)
of culturing##3##2##(1992-8#1)(2008-11#2)
of cumulative##5##2##(1992-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
of cumulus cells##2##3##(2008-9#1)(2013-1#1)
of cupric##2##2##(2008-10#1)(2013-1#1)
of curcumin on##3##3##(2008-11#2)(2011-2#1)
of curcumin##8##2##(2008-11#4)(2011-2#3)(2012-3#1)
of current and##2##3##(1994-12#1)(2009-10#1)
of current interest##2##3##(1997-2#1)(2008-7#1)
of current knowledge##2##3##(1996-3#1)(2012-2#1)
of current methods##2##3##(2008-11#1)(2008-12#1)
of current practice##2##3##(2008-7#1)(2008-8#1)
of current through##2##3##(2008-9#2)
of current##61##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
of currently available##3##3##(2011-2#1)(2011-3#1)(2012-3#1)
of currently used##2##3##(2008-5#1)(2008-9#1)
of currently##7##2##(1997-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
of curricular##2##2##(1996-2#1)(2009-8#1)
of curriculum##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
of customer##2##2##(1994-3#1)(1995-1#1)
of customers'##2##2##(1992-1#1)(1993-12#1)
of cut##2##2##(2008-9#2)
of cutaneous haemangiomas in chickens##2##5##(2008-5#2)
of cutaneous melanomas##2##3##(2009-4#2)
of cutaneous metastases##2##3##(2010-6#1)(2013-8#1)
of cutaneous##30##2##(1993-9#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#10)(2008-7#1)(2008-9#1)(2009-4#2)(2010-11#1)(2010-6#5)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of cuticle##4##2##(2008-10#3)(2009-8#1)
of cuticular caps##2##3##(2007-12#2)
of cuticular hydrocarbons that##2##4##(2008-9#1)(2013-8#1)
of cuticular hydrocarbons##4##3##(2008-9#1)(2012-3#2)(2013-8#1)
of cuticular##7##2##(2007-12#3)(2008-9#1)(2012-3#2)(2013-8#1)
of cuts in##2##3##(2008-11#1)(2013-8#1)
of cv##15##2##(2008-10#15)
of cvs##6##2##(2008-10#6)
of cyanide ion##2##3##(2008-10#2)
of cyanide using##2##3##(2008-10#2)
of cyanide##19##2##(2008-10#19)
of cyanobacterial##2##2##(2008-11#1)(2010-5#1)
of cyanthiwigin U to##2##4##(2009-12#2)
of cyanthiwigin##3##2##(2009-12#3)
of cyclamate##3##2##(2008-10#3)
of cyclamen##2##2##(2008-10#2)
of cyclandelate##3##2##(1994-8#3)
of cycle##2##2##(2008-10#2)
of cycles##4##2##(1991-8#2)(1992-2#1)(2008-11#1)
of cyclic AMP production##2##4##(1995-11#2)
of cyclic AMP##10##3##(1993-6#1)(1994-2#2)(1994-6#2)(1995-11#2)(1996-12#1)(1997-2#1)(2008-10#1)
of cyclic strain##2##3##(1994-11#2)
of cyclic succession##2##3##(2008-9#2)
of cyclic voltammetric##3##3##(2008-10#3)
of cyclic##26##2##(1993-6#1)(1993-8#1)(1994-11#4)(1994-2#2)(1994-6#2)(1995-11#2)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)
of cyclin D1##2##3##(2010-1#2)
of cyclin D2##5##3##(1997-8#5)
of cyclin##12##2##(1994-11#3)(1997-7#1)(1997-8#5)(2008-9#1)(2010-1#2)
of cyclin-dependent##2##2##(1997-7#1)(2012-2#1)
of cycling cells##2##3##(2008-11#2)
of cycling##3##2##(2008-11#2)(2013-8#1)
of cycloaddition##2##2##(1996-5#2)
of cyclodextrins##5##2##(2008-10#5)
of cycloheximide##6##2##(1992-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2011-3#1)
of cyclohexyl moieties##2##3##(1995-11#2)
of cyclohexylamine##2##2##(2008-10#2)
of cyclooxygenase-2##4##2##(1997-1#2)(2008-10#2)
of cyclopropane derivatives##2##3##(2008-10#2)
of cyclosporin##2##2##(2008-10#1)(2008-6#1)
of cyclosporine A##4##3##(2008-10#3)(2011-3#1)
of cylindrical multicellular aggregate (cylindroid)##2##5##(2008-11#2)
of cylindrical##4##2##(1992-12#1)(2008-11#2)(2011-2#1)
of cypermethrin and deltamethrin##3##4##(2008-10#3)
of cyst##4##2##(1996-3#2)(1997-8#1)(2008-12#1)
of cystadenocarcinoma##2##2##(1990-6#2)
of cysteine and##6##3##(2008-10#5)(2009-8#1)
of cysteine in human serum##2##5##(2008-10#2)
of cysteine in human##3##4##(2008-10#3)
of cysteine in##4##3##(2008-10#4)
of cysteine on##3##3##(2008-10#3)
of cysteine residues##2##3##(1993-6#1)(1993-9#1)
of cysteine##43##2##(1991-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-10#34)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)
of cystic fibrosis##7##3##(1990-4#1)(1991-2#2)(1991-8#1)(1997-1#1)(1997-8#1)(2011-3#1)
of cystic##11##2##(1990-4#1)(1991-2#2)(1991-8#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-3#1)(2012-2#1)
of cystine##7##2##(1990-5#2)(2008-10#2)(2008-11#3)
of cystosarcoma##3##2##(2008-10#1)(2011-3#2)
of cysts##5##2##(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
of cytochrome P-450##5##3##(1991-5#1)(1992-3#1)(1995-8#1)(2008-5#1)(2008-8#1)
of cytochrome P-450cam##2##3##(1994-5#2)
of cytochrome P450##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
of cytochrome b558##2##3##(1993-8#2)
of cytochrome c oxidase##4##4##(1997-7#3)(2010-4#1)
of cytochrome c##7##3##(1997-7#3)(2008-10#2)(2010-4#1)(2011-2#1)
of cytochrome oxidase##5##3##(1990-5#1)(1993-2#1)(1995-6#2)(2008-7#1)
of cytochrome##31##2##(1990-5#2)(1991-5#1)(1992-3#1)(1993-2#1)(1993-8#2)(1994-5#4)(1995-6#2)(1995-8#1)(1997-2#2)(1997-7#3)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-4#1)(2011-2#1)
of cytogenetic##2##2##(2008-9#1)(2013-8#1)
of cytoglobin##4##2##(2010-11#4)
of cytokine genes##2##3##(2008-4#1)(2008-9#1)
of cytokine production##4##3##(1991-2#1)(1996-12#1)(2008-4#2)
of cytokine receptors##2##3##(1996-2#1)(2008-9#1)
of cytokine##19##2##(1991-2#1)(1996-12#3)(1996-2#2)(2008-10#1)(2008-4#6)(2008-9#3)(2009-3#1)(2013-1#1)(2013-8#1)
of cytokines and##6##3##(1993-11#1)(1997-8#1)(2008-11#2)(2009-10#1)(2010-11#1)
of cytokines to##3##3##(1996-12#1)(1996-2#1)(2008-11#1)
of cytokines##15##2##(1993-11#1)(1993-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-11#4)(2008-4#2)(2008-7#1)(2009-10#1)(2010-11#1)
of cytokinesis##4##2##(2008-11#2)(2009-10#2)
of cytological##2##2##(2009-10#1)(2011-10#1)
of cytoplasm##3##2##(2008-10#3)
of cytoplasmic##13##2##(1991-11#4)(1991-5#1)(1992-10#1)(1993-2#1)(1994-11#1)(1997-7#1)(2008-12#1)(2008-4#1)(2008-9#2)
of cytosine##2##2##(1997-2#2)
of cytoskeletal##5##2##(1993-6#1)(2008-11#2)(2008-7#1)(2009-8#1)
of cytosol##2##2##(1990-5#1)(1993-8#1)
of cytosolic Ca2+##5##3##(1991-5#1)(1995-11#1)(1996-2#3)
of cytosolic phospholipase A2##2##4##(1995-11#2)
of cytosolic proteins##2##3##(1992-12#2)
of cytosolic##21##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#4)(1992-12#2)(1994-8#1)(1995-11#3)(1996-2#3)(2008-11#2)(2008-7#1)(2009-9#1)(2010-5#1)
of cytostatic##2##2##(1991-8#2)
of cytotoxic drugs##3##3##(1991-8#1)(2009-12#1)(2013-1#1)
of cytotoxic##9##2##(1990-12#1)(1991-8#1)(1993-1#1)(1995-6#1)(1997-5#1)(2008-10#1)(2009-12#1)(2013-1#2)
of cytotoxicity in##2##3##(1995-8#1)(2008-11#1)
of cytotoxicity of##4##3##(2008-11#2)(2009-12#2)
of cytotoxicity##9##2##(1994-3#1)(1995-8#1)(2008-10#1)(2008-11#3)(2009-12#2)(2011-1#1)
of d##3##2##(2008-10#3)
of d-gluconic-delta-lactone acid##2##3##(2008-10#2)
of d-glucosamine##2##2##(2008-10#2)
of d-lactic acid##2##3##(2008-10#2)
of d-penicillamine##2##2##(2008-10#2)
of d-sorbitol##2##2##(2008-5#2)
of d-tagatose and d-sorbitol##3##4##(2008-5#3)
of d-tagatose to##2##3##(2008-5#2)
of d-tagatose##7##2##(2008-5#7)
of dAMP##2##2##(2008-8#2)
of dQTL##3##2##(2008-10#3)
of dahlia##2##2##(2008-10#1)(2008-12#1)
of daidzein##6##2##(2008-10#4)(2010-1#2)
of daily and##3##3##(2008-10#1)(2008-11#2)
of daily life##3##3##(2009-9#1)(2011-2#1)(2012-2#1)
of daily living and##3##4##(1991-12#1)(1995-2#1)(2011-2#1)
of daily living##14##3##(1991-12#1)(1992-12#1)(1993-3#1)(1995-2#2)(2008-7#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
of daily pain##2##3##(2008-7#2)
of daily smoking##2##3##(1991-11#1)(1991-6#1)
of daily##35##2##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(1995-2#2)(2008-10#6)(2008-11#3)(2008-7#4)(2009-9#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
of dairy food consumption on body weight##2##7##(2012-2#2)
of dairy##8##2##(1996-12#1)(1996-8#1)(2008-10#1)(2011-2#1)(2012-2#2)(2013-1#2)
of damage in##2##3##(2008-3#1)(2011-2#1)
of damage##13##2##(2008-10#5)(2008-3#3)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
of damaged##7##2##(1993-3#1)(1995-2#2)(2008-8#1)(2011-2#2)(2012-3#1)
of damaging agents##2##3##(2008-7#2)
of damaging##4##2##(2008-7#2)(2011-2#2)
of damping-off caused by Pythium##2##5##(2008-10#2)
of damping-off##6##2##(2008-10#6)
of danger##3##2##(2008-11#1)(2012-12#2)
of dansyl chloride##2##3##(2008-10#2)
of dansyl##5##2##(1994-5#1)(2008-10#4)
of dark green##2##3##(2013-8#2)
of dark##5##2##(2008-10#2)(2008-9#1)(2013-8#2)
of data analysis##7##3##(2008-10#1)(2008-11#2)(2008-3#2)(2008-9#1)(2009-7#1)
of data and##4##3##(1995-12#1)(2008-10#3)
of data are##3##3##(1994-2#1)(2008-10#1)(2010-7#1)
of data by##4##3##(2008-10#3)(2009-10#1)
of data collection in##2##4##(2008-11#1)(2009-10#1)
of data collection##10##3##(1992-1#1)(1993-12#1)(1993-3#1)(1995-2#1)(1997-3#1)(2008-11#3)(2008-7#1)(2009-10#1)
of data for##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
of data found##2##3##(1990-9#1)(2008-10#1)
of data from a##3##4##(1991-8#1)(2008-3#1)(2010-11#1)
of data from the##7##4##(1994-2#1)(1994-6#2)(1995-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of data from##24##3##(1990-9#1)(1991-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#2)(1995-12#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of data has been##2##4##(1995-12#1)(2009-3#1)
of data has##4##3##(1995-12#1)(2009-3#2)(2011-3#1)
of data have also##2##4##(2008-1#2)
of data have##3##3##(2008-1#2)(2012-3#1)
of data in##5##3##(1997-5#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
of data indicates that the##2##5##(2008-10#1)(2008-7#1)
of data is##4##3##(1995-5#1)(2008-10#1)(2008-5#1)(2009-9#1)
of data mining##3##3##(2008-9#2)(2010-8#1)
of data obtained##2##3##(1994-5#1)(2008-10#1)
of data of##2##3##(2008-1#1)(2012-12#1)
of data on the##3##4##(1993-9#1)(1995-2#1)(2008-10#1)
of data on##11##3##(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#2)
of data sets##3##3##(2008-10#2)(2010-7#1)
of data standards##2##3##(2008-7#1)(2010-8#1)
of data that##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
of data was used to##2##5##(2008-11#1)(2011-1#1)
of data was##5##3##(1991-2#1)(2008-11#1)(2011-1#1)(2013-1#2)
of data##176##2##(1990-9#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#2)(1994-5#1)(1994-6#2)(1995-12#7)(1995-2#2)(1995-5#3)(1996-2#2)(1996-6#1)(1997-2#1)(1997-3#4)(1997-5#1)(2008-1#6)(2008-10#34)(2008-11#18)(2008-12#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#8)(2009-10#3)(2009-3#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#5)(2011-3#3)(2011-8#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
of database##3##2##(1992-3#1)(2008-11#1)(2008-4#1)
of databases##3##2##(1993-2#1)(2008-12#1)(2012-12#1)
of date##2##2##(2008-10#1)(2011-2#1)
of daunomycin##5##2##(1990-2#2)(2008-10#2)(2008-7#1)
of day care##2##3##(1994-3#1)(2010-3#1)
of day##12##2##(1990-5#1)(1992-3#1)(1994-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#2)(2010-3#1)(2010-7#1)(2012-5#1)
of days##12##2##(2008-10#9)(2008-11#1)(2008-5#1)(2009-12#1)
of db/db##2##2##(2012-3#2)
of ddGuo##2##2##(1990-10#2)
of de Broglie##2##3##(2008-5#2)
of de novo purine synthesis##2##5##(1993-12#2)
of de novo##4##3##(1993-12#2)(1993-2#1)(1995-6#1)
of de##8##2##(1993-12#2)(1993-2#1)(1995-6#1)(2008-10#1)(2008-5#2)(2013-8#1)
of deactivation##2##2##(1990-6#1)(1997-2#1)
of dead cells##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
of dead##11##2##(1991-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
of deaf##2##2##(2011-2#2)
of deafness##3##2##(2008-9#3)
of dealing with the problem##2##5##(1992-1#1)(1994-6#1)
of dealing with##4##3##(1992-1#1)(1992-2#1)(1994-6#1)(2010-1#1)
of death and disability##2##4##(1995-11#1)(2010-9#1)
of death and##6##3##(1994-2#1)(1995-11#1)(1995-2#2)(2008-10#1)(2010-9#1)
of death during the##2##4##(2008-7#1)(2013-1#1)
of death from cardiovascular##2##4##(2008-11#1)(2011-2#1)
of death from##4##3##(1995-12#1)(2008-11#2)(2011-2#1)
of death in Western countries##2##5##(2012-2#1)(2012-3#1)
of death in Western##3##4##(2012-2#1)(2012-3#1)(2013-8#1)
of death in patients with##2##5##(1993-9#1)(1996-11#1)
of death in the##3##4##(2008-7#1)(2010-10#1)(2011-3#1)
of death in##16##3##(1993-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of death of##3##3##(1990-6#1)(2011-2#1)(2011-3#1)
of death was##4##3##(1991-2#1)(1995-11#2)(2008-11#1)
of death were##5##3##(1991-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
of death##76##2##(1990-11#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#4)(1997-1#1)(1997-3#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-5#1)(2008-7#4)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#8)(2011-3#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
of deaths and##2##3##(1997-7#1)(2010-8#1)
of deaths due to##2##4##(1992-6#1)(2008-9#1)
of deaths in##5##3##(1991-3#1)(1991-9#1)(1997-2#1)(2011-3#1)(2012-2#1)
of deaths##19##2##(1991-3#1)(1991-9#1)(1992-6#2)(1997-2#1)(1997-7#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)
of debate in##2##3##(2008-11#1)(2008-7#1)
of debate##5##2##(1997-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)
of debris##7##2##(2008-10#5)(2008-9#1)(2012-3#1)
of decanol to##2##3##(2008-10#2)
of decanol##3##2##(2008-10#3)
of decapods##2##2##(2007-12#2)
of decay##2##2##(1991-2#1)(2008-10#1)
of decentralization##2##2##(2012-12#2)
of deciduous##2##2##(2012-9#1)(2013-8#1)
of decision making##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
of decision##4##2##(1995-2#1)(2008-10#1)(2008-6#1)(2008-9#1)
of decision-making##3##2##(2008-11#1)(2008-9#1)(2010-11#1)
of decline##2##2##(1993-3#1)(2010-8#1)
of declining##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
of decomposition##2##2##(2008-10#1)(2008-11#1)
of decrease in##2##3##(1994-11#1)(1994-3#1)
of decrease##5##2##(1994-11#1)(1994-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
of decreased##9##2##(1991-11#1)(1991-7#1)(1995-2#1)(2008-11#2)(2008-7#1)(2011-2#2)(2012-3#1)
of decreasing##6##2##(2008-10#2)(2008-11#1)(2012-3#2)(2013-8#1)
of deep breathing##4##3##(2012-2#4)
of deep mycoses##2##3##(2008-5#2)
of deep##15##2##(1991-9#1)(2007-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#4)
of defeated##2##2##(2008-10#2)
of defective RNAs##2##3##(2008-10#2)
of defective##7##2##(1990-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2012-3#1)
of defects in##2##3##(2008-10#1)(2012-3#1)
of defects##8##2##(2008-10#2)(2008-4#1)(2009-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
of defense against##5##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-7#1)
of defense compounds##2##3##(2008-10#2)
of defense genes##2##3##(2008-10#2)
of defense mechanisms##2##3##(2008-10#2)
of defense response##3##3##(2008-10#3)
of defense responses##2##3##(2008-10#1)(2008-9#1)
of defense##21##2##(1993-12#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#1)
of defense-related##5##2##(2008-10#4)(2009-8#1)
of deficient##2##2##(1997-7#1)(2009-10#1)
of deficits##2##2##(1992-3#1)(2009-7#1)
of defined mixtures of two different polyamines##2##7##(2008-12#2)
of defined##7##2##(1996-3#1)(2008-11#1)(2008-12#2)(2010-5#1)(2010-8#1)(2012-3#1)
of defining##3##2##(1995-2#1)(1995-9#1)(2013-1#1)
of definitive##3##2##(1991-3#1)(2008-7#1)(2012-12#1)
of defoliation##2##2##(2008-10#2)
of deformation##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
of degenerate##3##2##(2008-10#2)(2008-5#1)
of degenerative changes in synaptic terminals and axons##2##8##(1997-3#2)
of degenerative changes##4##3##(1997-3#4)
of degenerative hepatic##2##3##(2008-10#2)
of degenerative##13##2##(1991-11#1)(1997-3#4)(2007-11#1)(2008-10#3)(2008-8#1)(2012-3#2)(2013-8#1)
of degradation of##6##3##(2008-10#3)(2008-8#1)(2012-2#1)(2013-1#1)
of degradation##16##2##(1994-5#1)(2008-10#8)(2008-11#2)(2008-8#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
of degraded##2##2##(2008-10#1)(2008-12#1)
of degree hours##2##3##(2008-10#2)
of degree of##2##3##(1997-8#1)(2008-10#1)
of degree##4##2##(1997-8#1)(2008-10#3)
of degree-days##2##2##(2008-10#2)
of dehydration##2##2##(2007-12#1)(2012-12#1)
of dehydroascorbate##2##2##(2009-9#2)
of dehydroascorbic acid##2##3##(2008-10#2)
of delay##3##2##(1991-8#1)(1995-2#1)(2013-8#1)
of delayed alternation##2##3##(1994-8#2)
of delayed##15##2##(1994-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#2)(2013-1#2)(2013-8#2)
of deleterious mutations##2##3##(1997-7#1)(2008-8#1)
of deleterious##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
of deletion##4##2##(1993-2#1)(1994-11#1)(1994-8#1)(2008-8#1)
of delinquent or depressed##2##4##(2009-7#2)
of delinquent##4##2##(1990-12#2)(2009-7#2)
of delipidated LH/hCG##2##3##(1995-8#2)
of delipidated##4##2##(1995-8#4)
of delirium in##3##3##(2010-10#1)(2012-12#1)(2013-1#1)
of delirium##8##2##(2010-10#2)(2011-2#1)(2012-12#1)(2013-1#4)
of delivering##2##2##(2008-5#1)(2012-2#1)
of delivery##12##2##(1993-11#1)(1997-1#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#2)
of delta and##2##3##(2008-8#2)
of delta##6##2##(1990-5#1)(1991-12#1)(1993-8#1)(1995-2#1)(2008-8#2)
of deltamethrin on##2##3##(2008-10#2)
of deltamethrin##5##2##(2008-10#5)
of demand for##2##3##(1992-2#1)(2008-12#1)
of demand##3##2##(1992-2#1)(2008-12#1)(2013-8#1)
of demented##4##2##(2008-7#4)
of dementia and regional brain syndromes in##2##7##(2008-7#2)
of dementia and##3##3##(2008-7#3)
of dementia in##4##3##(1995-12#1)(2008-7#3)
of dementia on##2##3##(2008-1#1)(2008-7#1)
of dementia##28##2##(1990-11#1)(1991-8#1)(1995-12#1)(1996-11#4)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#13)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of dementia-specific##2##2##(1993-2#2)
of demethylation##2##2##(2008-10#1)(2008-9#1)
of demographic and##2##3##(2008-9#1)(2011-2#1)
of demographic##7##2##(1996-3#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
of denatured##3##2##(2008-10#3)
of dendrimers##2##2##(1996-5#2)
of dendrites##3##2##(1994-2#2)(2008-10#1)
of dendritic cells (DC)##2##4##(2008-10#1)(2008-11#1)
of dendritic cells##7##3##(2008-10#1)(2008-11#2)(2008-9#3)(2011-2#1)
of dendritic spines##2##3##(1995-8#1)(2008-11#1)
of dendritic##14##2##(1994-2#1)(1995-8#1)(2008-10#2)(2008-11#4)(2008-9#3)(2009-8#1)(2011-2#1)(2012-2#1)
of denervated##2##2##(1997-3#1)(2007-8#1)
of dengue virus##2##3##(2011-2#1)(2013-8#1)
of dengue##7##2##(2011-2#4)(2011-3#1)(2012-12#1)(2013-8#1)
of densely##2##2##(2008-7#1)(2012-2#1)
of density dependence##5##3##(2008-8#4)(2008-9#1)
of density##9##2##(2007-12#1)(2008-10#2)(2008-8#5)(2008-9#1)
of density-independent mortality##2##3##(2008-8#2)
of dental caries##5##3##(1991-6#1)(2008-7#3)(2013-7#1)
of dental education##3##3##(1993-1#1)(2008-8#1)(2013-1#1)
of dental implants##5##3##(2009-7#1)(2011-7#1)(2012-12#1)(2013-1#2)
of dental patients##2##3##(2008-1#1)(2008-5#1)
of dental##28##2##(1991-6#1)(1993-1#3)(1995-9#1)(1996-3#1)(2008-1#3)(2008-10#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-7#2)(2011-2#1)(2011-7#1)(2012-12#2)(2013-1#4)(2013-7#1)
of dentigerous cysts##2##3##(2013-1#2)
of dentin hypersensitivity##4##3##(2011-2#4)
of dentin##5##2##(2011-2#4)(2013-1#1)
of dentistry##6##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1995-6#1)(2013-8#1)
of dentists##4##2##(1994-12#1)(1997-2#1)(2008-11#1)(2013-1#1)
of denture##4##2##(2013-1#4)
of deoxyhypusine##3##2##(1994-3#1)(1997-1#2)
of dependence##3##2##(1991-6#1)(2008-10#1)(2012-6#1)
of dependency##2##2##(1997-4#1)(2008-6#1)
of dependent##3##2##(1994-3#1)(2008-7#1)(2010-5#1)
of deployment##2##2##(2008-10#2)
of deposition##6##2##(2008-10#3)(2008-11#3)
of depressed##5##2##(1991-2#1)(1993-2#1)(2008-7#3)
of depression and hostility##2##4##(2008-4#2)
of depression and##9##3##(2008-11#1)(2008-12#2)(2008-4#2)(2010-4#1)(2010-7#2)(2012-2#1)
of depression in##3##3##(2008-4#1)(2008-7#1)(2012-3#1)
of depression model rats##2##4##(2013-1#2)
of depression or##2##3##(2008-12#1)(2010-7#1)
of depression were##2##3##(1991-1#1)(2008-12#1)
of depression with and without dementia in##2##7##(2008-7#2)
of depression##49##2##(1991-1#1)(1992-1#1)(1997-7#2)(2007-12#3)(2008-11#1)(2008-12#5)(2008-4#8)(2008-6#4)(2008-7#7)(2008-8#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-7#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
of depressive symptoms was found##2##5##(2010-10#1)(2013-1#1)
of depressive symptoms##8##3##(2007-12#1)(2008-7#1)(2010-10#3)(2013-1#3)
of depressive##11##2##(2007-12#1)(2008-7#1)(2010-10#3)(2010-12#1)(2010-5#1)(2013-1#3)(2013-8#1)
of deprivation##2##2##(1991-1#1)(1991-6#1)
of deprotonation##2##2##(1990-5#1)(2008-10#1)
of derivative spectrophotometry##3##3##(2008-10#3)
of derivative##5##2##(2008-10#5)
of derivatives##2##2##(2008-10#2)
of derivatized##2##2##(2008-10#2)
of derived##3##2##(2008-4#1)(2012-3#2)
of deriving##2##2##(2008-11#1)(2008-3#1)
of dermal##2##2##(1993-3#1)(1996-6#1)
of dermaseptin b and##2##4##(1994-5#2)
of dermaseptin b##3##3##(1994-5#3)
of dermatofibrosarcoma##2##2##(1992-2#2)
of dermatology##2##2##(2008-5#1)(2012-3#1)
of dermatoses##3##2##(2011-2#3)
of desacetyl-alpha-MSH##2##2##(2008-6#2)
of descending aorta##3##3##(2012-2#1)(2012-3#2)
of descending##4##2##(2008-12#1)(2012-2#1)(2012-3#2)
of descriptive##3##2##(1991-2#1)(2008-12#1)(2012-2#1)
of desferrioxamine##3##2##(1993-2#1)(2008-10#2)
of design of##2##3##(1990-8#1)(2007-11#1)
of design##3##2##(1990-8#1)(2007-11#1)(2008-7#1)
of designated##2##2##(2008-11#2)
of designing##7##2##(1992-3#1)(1994-12#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-8#2)
of desired##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
of desmetryne##2##2##(2008-10#2)
of desmoid##3##2##(1997-8#2)(2009-12#1)
of desmoids##3##2##(1997-8#3)
of desorption of##2##3##(2008-10#1)(2010-4#1)
of desquamation##4##2##(2008-5#4)
of destruction##2##2##(1997-5#1)(2011-2#1)
of detached##3##2##(2008-10#3)
of detail##3##2##(2008-11#1)(2008-6#2)
of detailed##8##2##(1994-2#1)(1996-3#1)(2008-11#2)(2009-6#1)(2011-3#1)(2013-1#2)
of detainees in police custody##2##5##(2010-1#2)
of detainees##3##2##(2010-1#3)
of detectability##2##2##(2008-10#1)(2008-5#1)
of detectable populations##4##3##(2008-10#4)
of detectable##10##2##(1993-12#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#5)
of detected##3##2##(2012-3#3)
of detecting multiple##2##3##(2008-10#2)
of detecting the##2##3##(2008-10#1)(2008-2#1)
of detecting##26##2##(1993-3#1)(1994-11#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#13)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)
of detection (1##2##3##(2008-10#2)
of detection (3sigma) for##2##4##(2008-10#2)
of detection (3sigma)##12##3##(2008-10#12)
of detection (LD)##2##3##(2008-10#2)
of detection (LOD) and quantitation (LOQ)##2##6##(2008-10#2)
of detection (LOD) and##7##4##(2008-10#7)
of detection (LOD) for##9##4##(2008-10#8)(2010-5#1)
of detection (LOD) ranged from##2##5##(2008-10#2)
of detection (LOD) ranged##3##4##(2008-10#3)
of detection (LOD) were##2##4##(2008-10#2)
of detection (LOD)##49##3##(2008-10#48)(2010-5#1)
of detection (LODs) were##2##4##(2008-10#2)
of detection (LODs)##6##3##(2008-10#6)
of detection (S/N=3)##4##3##(2008-10#4)
of detection achieved##4##3##(2008-10#4)
of detection and quantification of##3##5##(2008-10#3)
of detection and quantification##5##4##(2008-10#5)
of detection and quantitation were##2##5##(2008-10#2)
of detection and quantitation##3##4##(2008-10#3)
of detection and##24##3##(1997-2#1)(2008-10#22)(2012-2#1)
of detection as 1##2##4##(2008-10#2)
of detection at the##4##4##(2008-10#4)
of detection at##6##3##(2008-10#5)(2008-3#1)
of detection between##3##3##(2008-10#3)
of detection by##2##3##(1993-8#1)(2008-10#1)
of detection for a##2##4##(2008-10#2)
of detection for each type of##2##6##(2008-10#2)
of detection for the##4##4##(2008-10#3)(2010-11#1)
of detection for##34##3##(2008-10#33)(2010-11#1)
of detection in##9##3##(2008-10#8)(2012-8#1)
of detection is##19##3##(2008-10#18)(2013-1#1)
of detection obtained##2##3##(2008-10#2)
of detection of 0##11##4##(2008-10#11)
of detection of a##2##4##(2007-12#1)(2011-2#1)
of detection of the##17##4##(2008-10#17)
of detection of##67##3##(2007-12#1)(2008-10#61)(2008-5#1)(2009-6#1)(2011-2#2)(2013-1#1)
of detection than##2##3##(2008-10#2)
of detection values##3##3##(2008-10#2)(2011-2#1)
of detection was##37##3##(1997-2#1)(2008-10#36)
of detection were##19##3##(2008-10#19)
of detection with##2##3##(2008-10#2)
of detection##408##2##(1993-8#1)(1996-8#1)(1997-2#3)(2007-12#1)(2008-10#383)(2008-3#2)(2008-5#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-8#1)(2013-1#2)
of detection)##3##2##(2008-10#3)
of detections (LODs)##2##3##(2008-10#2)
of detections##5##2##(2008-10#5)
of detergents##3##2##(1992-7#1)(2008-4#1)(2008-5#1)
of deterioration##2##2##(2008-10#2)
of determination (R##3##3##(2008-10#3)
of determination (r(2))##2##3##(2008-10#2)
of determination by the proposed method##2##6##(2008-10#2)
of determination for##8##3##(2008-10#7)(2008-11#1)
of determination is##2##3##(2008-10#2)
of determination of the##2##4##(2008-10#2)
of determination of##12##3##(2008-10#9)(2008-5#1)(2009-8#2)
of determination##45##2##(2008-10#40)(2008-11#1)(2008-5#1)(2009-8#2)(2011-2#1)
of determined##2##2##(1994-5#1)(2008-10#1)
of determining an##2##3##(1992-12#1)(2011-2#1)
of determining the##6##3##(1996-11#1)(2008-10#3)(2009-8#1)(2011-2#1)
of determining##23##2##(1992-12#1)(1994-1#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#2)
of deuterium##7##2##(1991-3#1)(1992-4#1)(1992-6#2)(2008-10#2)(2008-3#1)
of developed##3##2##(2008-10#1)(2008-12#1)(2009-3#1)
of developing a new##2##4##(1990-12#1)(1996-5#1)
of developing a##8##3##(1990-12#1)(1991-3#1)(1996-5#1)(2008-10#2)(2008-5#1)(2011-8#1)(2013-1#1)
of developing and##2##3##(1993-3#1)(2008-11#1)
of developing endometrial##2##3##(2008-10#1)(2011-2#1)
of developing mild cognitive impairment##2##5##(2009-10#2)
of developing the disease##3##4##(1992-9#2)(1996-6#1)
of developing the##6##3##(1992-9#2)(1996-6#1)(2008-11#1)(2008-12#1)(2008-4#1)
of developing##79##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-9#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#6)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-7#2)(2010-10#2)(2011-2#3)(2011-8#1)(2012-12#1)(2012-3#6)(2013-1#1)(2013-8#1)
of development and##4##3##(1992-12#1)(1995-9#1)(2008-8#1)(2011-2#1)
of development of both the##2##5##(2008-10#2)
of development of##10##3##(1996-8#1)(2008-10#3)(2008-9#1)(2012-3#4)(2013-8#1)
of development##47##2##(1990-5#1)(1991-1#1)(1991-7#1)(1992-12#3)(1994-12#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-8#2)(1997-7#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
of developmental events##2##3##(1995-11#1)(2008-9#1)
of developmental sequences##2##3##(2008-9#2)
of developmental thresholds##2##3##(2008-8#2)
of developmental##24##2##(1994-1#2)(1995-11#1)(1995-2#1)(1997-8#1)(2008-11#3)(2008-8#6)(2008-9#4)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
of developments in##3##3##(1992-1#1)(2008-12#1)(2010-1#1)
of developments##4##2##(1992-1#1)(2008-10#1)(2008-12#1)(2010-1#1)
of device##6##2##(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2010-6#1)
of devices##3##2##(2008-9#1)(2012-12#1)(2012-2#1)
of dew##2##2##(2008-10#2)
of dexamethasone on##2##3##(1994-3#1)(2010-12#1)
of dexamethasone##9##2##(1993-3#1)(1994-3#3)(2008-11#4)(2010-12#1)
of dexrazoxane##3##2##(2008-11#3)
of diabetes and##10##3##(1994-6#1)(1995-2#1)(2008-1#1)(2010-10#2)(2010-9#2)(2012-3#1)(2012-5#1)(2013-8#1)
of diabetes in##5##3##(1994-12#1)(2008-1#1)(2008-11#1)(2010-10#1)(2012-2#1)
of diabetes is##2##3##(2008-10#1)(2012-2#1)
of diabetes mellitus##12##3##(1994-6#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#2)(2011-3#1)(2013-1#2)
of diabetes on the##4##4##(2008-1#1)(2008-11#1)(2011-2#2)
of diabetes on##6##3##(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#2)
of diabetes##64##2##(1992-11#1)(1993-2#2)(1994-12#4)(1994-6#3)(1995-2#1)(1995-5#1)(1996-11#2)(1996-2#1)(1997-4#1)(2008-1#6)(2008-10#7)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#7)(2010-12#1)(2010-9#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2012-5#2)(2013-1#3)(2013-7#3)(2013-8#1)
of diabetic complications##2##3##(1996-2#1)(2008-1#1)
of diabetic macular edema##2##4##(2011-7#2)
of diabetic nephropathy##3##3##(1997-8#2)(2013-1#1)
of diabetic patients##4##3##(1993-11#1)(2012-2#2)(2012-3#1)
of diabetic peripheral##2##3##(2007-7#1)(2008-9#1)
of diabetic##29##2##(1993-11#1)(1994-12#2)(1995-9#1)(1996-2#1)(1997-8#3)(2007-7#1)(2008-1#3)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#2)(2011-7#2)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
of diacetyl##2##2##(2008-6#2)
of diacylglycerol and##2##3##(1991-3#1)(2008-11#1)
of diacylglycerol##9##2##(1990-5#2)(1991-3#1)(1994-5#4)(1997-2#1)(2008-11#1)
of diagnosed##2##2##(2008-5#1)(2012-12#1)
of diagnoses and##2##3##(1994-9#1)(2012-12#1)
of diagnoses##3##2##(1994-9#1)(2008-11#1)(2012-12#1)
of diagnosing##3##2##(1993-2#1)(2008-7#1)(2010-7#1)
of diagnosis and treatment##3##4##(2008-12#1)(2011-2#1)(2012-12#1)
of diagnosis and##14##3##(1990-3#1)(1991-11#1)(1992-5#1)(1993-1#1)(1993-6#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#2)
of diagnosis of##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
of diagnosis##37##2##(1990-3#1)(1990-6#1)(1991-11#1)(1992-3#1)(1992-5#2)(1993-1#2)(1993-6#1)(1994-12#2)(1994-9#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#1)(2010-10#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-12#5)
of diagnosis-related groups##4##3##(1991-12#1)(1991-3#1)(1994-12#2)
of diagnosis-related##5##2##(1991-12#1)(1991-3#1)(1992-2#1)(1994-12#2)
of diagnostic accuracy##4##3##(1995-11#1)(2008-12#1)(2013-1#2)
of diagnostic and##2##3##(2008-11#1)(2013-1#1)
of diagnostic assays##2##3##(2008-10#2)
of diagnostic methods##2##3##(1990-9#1)(1994-9#1)
of diagnostic tests##2##3##(1993-3#1)(2011-2#1)
of diagnostic##30##2##(1990-3#2)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
of dialysis patients##2##3##(2008-1#1)(2008-10#1)
of dialysis##10##2##(1993-6#1)(1995-12#1)(2008-1#1)(2008-10#4)(2008-12#2)(2011-2#1)
of diameter##3##2##(2008-10#1)(2008-5#2)
of diaphragm##3##2##(2008-7#1)(2010-5#1)(2012-3#1)
of diarrhea##7##2##(1990-2#1)(1991-3#1)(1991-8#2)(1992-12#1)(2007-12#1)(2008-10#1)
of diastolic##2##2##(2013-1#2)
of diazacrown##2##2##(2008-10#2)
of diazepam and prazepam in##2##5##(2008-10#2)
of diazinon##3##2##(2008-10#3)
of dibenzo-18-crown-6##4##2##(2008-10#4)
of dibutyryl##2##2##(1993-8#1)(1995-8#1)
of dichlobenil and its metabolites##2##5##(2008-10#2)
of dichloroacetic acid in##3##4##(2008-10#1)(2008-9#2)
of dichloroacetic acid##5##3##(2008-10#2)(2008-9#3)
of dichloromethane and##2##3##(2008-10#2)
of dichloromethane##3##2##(2008-10#3)
of dichlorvos##5##2##(2008-10#5)
of diclofenac in pharmaceutical preparations by diffuse reflectance##2##8##(2008-10#2)
of diclofenac in pharmaceutical preparations##3##5##(2008-10#3)
of diclofenac in the presence of##2##6##(2008-10#2)
of diclofenac in##6##3##(2008-10#6)
of diclofenac##8##2##(1991-3#1)(2008-10#7)
of dielectric##6##2##(2008-10#1)(2008-3#4)(2013-8#1)
of diesel##3##2##(2008-10#1)(2008-11#2)
of diet and##4##3##(1990-8#1)(2008-10#1)(2009-5#1)(2012-2#1)
of diet##9##2##(1990-8#3)(1996-12#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
of dietary boron##2##3##(1990-3#2)
of dietary intake##2##3##(1991-2#1)(2009-5#1)
of dietary phytoestrogens##3##3##(2008-10#3)
of dietary protein restriction##2##4##(1994-3#2)
of dietary restriction on serum antioxidant##2##6##(2008-7#2)
of dietary supplementation##2##3##(1991-6#1)(2013-1#1)
of dietary##40##2##(1990-3#2)(1991-2#1)(1991-6#2)(1992-9#1)(1993-11#3)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#3)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-2#4)(2013-1#3)(2013-8#1)
of diethylenetriamine##3##2##(2008-10#3)
of diethylstilbestrol##2##2##(2008-10#2)
of diferric transferrin##2##3##(1994-3#2)
of difference##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
of differences between##6##3##(2008-10#1)(2008-3#2)(2008-9#1)(2010-1#1)(2012-12#1)
of differences in the##4##4##(1995-11#1)(2008-1#1)(2008-10#2)
of differences in their##2##4##(2008-10#1)(2010-8#1)
of differences in##19##3##(1991-11#1)(1993-3#1)(1995-11#1)(2008-1#1)(2008-10#8)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
of differences##29##2##(1991-11#1)(1993-3#1)(1994-2#1)(1995-11#1)(2008-1#1)(2008-10#10)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)
of different age##3##3##(2011-2#1)(2013-1#2)
of different ages##8##3##(1991-9#1)(1995-6#1)(1997-9#1)(2008-1#1)(2008-10#2)(2008-5#2)
of different amounts of##2##4##(1997-7#1)(2008-10#1)
of different analytical methods##2##4##(2008-10#2)
of different analytical##3##3##(2008-10#2)(2008-11#1)
of different and##2##3##(2008-4#2)
of different aspects of the##2##5##(1996-2#1)(2008-10#1)
of different buffer media##2##4##(2008-10#2)
of different calibration##2##3##(2008-10#2)
of different cell lines##2##4##(2008-11#2)
of different cell types##2##4##(2008-11#1)(2009-8#1)
of different cell##4##3##(2008-11#3)(2009-8#1)
of different cells##2##3##(2008-11#1)(2013-8#1)
of different chemical forms##2##4##(2008-10#2)
of different chemical##3##3##(2008-10#3)
of different classes of##2##4##(2008-10#2)
of different classes##3##3##(2008-10#3)
of different combinations of##3##4##(2008-10#1)(2008-11#1)(2012-4#1)
of different commercial##2##3##(2008-10#2)
of different concentrations of##4##4##(1997-8#1)(2008-12#1)(2012-2#1)(2012-3#1)
of different concentrations##5##3##(1997-8#1)(2008-12#1)(2008-8#1)(2012-2#1)(2012-3#1)
of different culture##2##3##(1996-12#1)(2008-11#1)
of different cytokines##2##3##(2006-6#1)(2008-10#1)
of different days of meat spoilage##2##6##(2008-10#2)
of different experimental##2##3##(2008-10#1)(2012-3#1)
of different factors##4##3##(2008-10#4)
of different families##2##3##(2008-10#2)
of different focus of attention##2##5##(2013-1#2)
of different food##2##3##(2008-10#2)
of different forms##3##3##(2008-10#2)(2013-1#1)
of different frequencies##4##3##(1996-12#3)(2008-8#1)
of different growing media on the growth and development of Dahlia (Dahlia pinnata)##2##13##(2008-12#2)
of different host##2##3##(2008-9#2)
of different immunosuppressive drugs##2##4##(2008-9#2)
of different intensities##2##3##(1996-2#1)(2008-8#1)
of different kinds of##6##4##(1991-11#1)(1996-6#1)(2008-10#2)(2008-11#1)(2010-4#1)
of different levels of feed added black seed (Nigella sativa L##2##11##(2008-12#2)
of different levels##3##3##(2008-12#2)(2010-8#1)
of different lipid##4##3##(2008-10#1)(2008-11#2)(2009-8#1)
of different load application devices on fracture resistance##2##8##(2013-1#2)
of different mating##2##3##(2008-10#2)
of different matrix##2##3##(2008-10#2)
of different methods##4##3##(2008-10#1)(2009-8#1)(2012-12#1)(2012-3#1)
of different modes##2##3##(2008-3#2)
of different molecular descriptors##2##4##(2008-10#2)
of different molecular##7##3##(1992-9#1)(2008-10#5)(2011-2#1)
of different origin including##2##4##(2008-10#2)
of different origin##8##3##(2008-10#5)(2008-11#2)(2011-2#1)
of different origins##5##3##(2008-10#4)(2008-3#1)
of different parameters on##2##4##(2008-10#2)
of different parameters such as##2##5##(2008-10#2)
of different parameters##9##3##(2008-10#9)
of different percentages of##3##4##(2008-10#3)
of different phases##3##3##(2008-3#1)(2008-8#1)(2012-2#1)
of different polarity##4##3##(2008-10#4)
of different possible##2##3##(1995-5#1)(2013-8#1)
of different processing##2##3##(1995-5#1)(2008-5#1)
of different regions##2##3##(1993-12#1)(2011-1#1)
of different sample##3##3##(2008-10#3)
of different samples##2##3##(2008-10#1)(2011-3#1)
of different sets of##2##4##(2008-2#1)(2008-9#1)
of different sizes and##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
of different sizes##14##3##(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#3)(2012-2#1)
of different skill levels##2##4##(2011-2#2)
of different skill##3##3##(1997-2#1)(2011-2#2)
of different species of##2##4##(2008-7#1)(2008-8#1)
of different species##6##3##(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)
of different strains of##2##4##(2008-12#1)(2012-2#1)
of different strategies##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
of different studies##2##3##(2008-10#1)(2008-9#1)
of different substrates##2##3##(1991-5#1)(2010-3#1)
of different surface##2##3##(1994-5#1)(2008-10#1)
of different techniques##2##3##(2008-10#1)(2012-2#1)
of different tissue##2##3##(2008-8#1)(2009-9#1)
of different type##2##3##(2008-10#2)
of different types of##17##4##(1992-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
of different types##26##3##(1992-1#1)(1994-2#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of different values##2##3##(1992-3#1)(2009-7#1)
of different variables##4##3##(2008-10#4)
of different varieties##2##3##(2008-10#2)
of different##509##2##(1990-2#2)(1991-11#1)(1991-12#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#1)(1995-12#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-6#2)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#4)(1997-9#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-10#230)(2008-11#28)(2008-12#17)(2008-2#2)(2008-3#14)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#20)(2008-9#16)(2009-10#2)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#14)(2011-3#2)(2011-4#1)(2012-12#4)(2012-2#12)(2012-3#9)(2012-4#1)(2012-8#2)(2012-9#1)(2013-1#20)(2013-8#6)
of differential absorption lidar##2##4##(2008-2#1)(2008-3#1)
of differential absorption##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of differential diagnosis##6##3##(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2012-12#1)(2012-3#1)
of differential staining##2##3##(1997-8#1)(2008-9#1)
of differential##28##2##(1993-8#1)(1995-12#1)(1997-8#1)(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#2)(2012-12#1)(2012-3#2)(2013-8#1)
of differentially##3##2##(2008-10#2)(2009-6#1)
of differentiated##7##2##(1995-11#3)(2008-11#2)(2013-1#2)
of differentiating##8##2##(2008-10#3)(2008-11#1)(2008-9#2)(2012-2#1)(2013-1#1)
of differentiation and##4##3##(1993-3#1)(2008-11#1)(2009-12#1)(2011-2#1)
of differentiation factors##2##3##(2008-11#1)(2011-2#1)
of differentiation of##3##3##(1993-3#1)(1997-6#1)(2008-10#1)
of differentiation##25##2##(1991-2#1)(1993-3#2)(1994-11#1)(1997-6#1)(2008-10#3)(2008-11#9)(2008-4#1)(2008-9#2)(2009-12#1)(2011-2#4)
of differing##10##2##(1991-12#1)(1993-9#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2010-1#1)
of difficult##2##2##(2011-2#1)(2013-8#1)
of difficulties in##3##3##(2008-7#3)
of difficulty in identifying those##2##5##(2008-10#1)(2008-3#1)
of difficulty in##3##3##(2008-10#1)(2008-3#1)(2011-7#1)
of difficulty of##2##3##(1992-3#1)(2008-11#1)
of difficulty##6##2##(1992-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-7#1)
of diffraction efficiency##2##3##(2008-2#1)(2008-3#1)
of diffraction##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
of diffractive optical elements##4##4##(2008-3#4)
of diffractive optical##5##3##(2008-3#5)
of diffractive optics##2##3##(2008-3#2)
of diffractive##9##2##(2008-2#1)(2008-3#8)
of diffuse malignant mesothelioma##6##4##(1991-12#6)
of diffuse scattering##2##3##(2008-3#2)
of diffuse##18##2##(1991-12#6)(1994-6#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-3#1)
of diffusible##3##2##(2008-10#3)
of diffusion##14##2##(1990-6#1)(1991-5#1)(1993-12#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-3#1)(2013-8#1)
of diffusive##3##2##(2008-10#2)(2008-8#1)
of digested sample##3##3##(2008-10#3)
of digested##6##2##(2008-10#6)
of digestion##5##2##(2008-10#5)
of digestive##4##2##(1991-11#1)(1991-3#1)(1993-11#1)(2007-12#1)
of digital##7##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-3#1)(2010-8#1)
of digoxin##2##2##(2009-10#2)
of dihydroberberine derivatives##2##3##(2008-11#2)
of dihydroetorphine##4##2##(1995-11#4)
of diisopropylcarbodiimide##3##2##(2008-9#3)
of dilated cardiomyopathy##2##3##(2012-2#2)
of dilated##3##2##(1990-6#1)(2012-2#2)
of dilute##4##2##(2008-10#4)
of diluted##4##2##(2008-10#4)
of dilution##6##2##(2008-10#4)(2008-11#1)(2008-6#1)
of dimensional approaches##2##3##(2008-8#2)
of dimensional##3##2##(1990-9#1)(2008-8#2)
of dimensionality##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
of dimer##2##2##(2008-10#1)(2008-8#1)
of dimeric##2##2##(1996-2#1)(2008-10#1)
of dimers##2##2##(2008-11#1)(2008-9#1)
of dimethyl##6##2##(1996-5#1)(2008-10#3)(2008-7#1)(2011-2#1)
of dimethylarsinate (DMA)##2##3##(2008-10#2)
of dimethyltin chloride##5##3##(2008-10#5)
of diminished##2##2##(2008-11#1)(2008-7#1)
of dinucleotide occurrences##2##3##(1997-6#2)
of dinucleotide##3##2##(1997-6#3)
of dioxin in##2##3##(2008-10#2)
of dioxin##4##2##(2008-10#4)
of dioxin-like compounds##2##3##(2008-10#2)
of dioxin-like##4##2##(2008-10#4)
of dioxins and##2##3##(2008-10#2)
of dioxins in##6##3##(2008-10#6)
of dioxins##13##2##(2008-10#12)(2008-11#1)
of dioxygen##4##2##(2008-10#4)
of diphenhydramine##5##2##(2008-10#5)
of diphtheria##4##2##(1995-3#2)(1995-5#1)(2007-11#1)
of diploid##3##2##(1990-3#1)(2008-11#1)(2009-12#1)
of dipyridamole##3##2##(2008-10#3)
of direct and indirect##2##4##(2008-10#1)(2008-9#1)
of direct and##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
of direct gene transfer##2##4##(1994-5#2)
of direct##37##2##(1992-6#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-8#2)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
of direct-detection Doppler lidar##2##4##(2008-3#2)
of directing##2##2##(1992-3#1)(2013-1#1)
of direction##2##2##(1994-8#1)(2008-8#1)
of directional effects##2##3##(2008-3#2)
of directional##5##2##(2008-10#1)(2008-3#3)(2008-8#1)
of directions##2##2##(1997-3#1)(2011-2#1)
of directly##7##2##(1995-8#2)(2007-12#1)(2008-10#2)(2012-2#1)(2013-8#1)
of directors##4##2##(1994-12#1)(1995-6#1)(1996-1#1)(1996-3#1)
of dirithromycin##3##2##(2008-10#3)
of disability##15##2##(1991-11#1)(1991-3#1)(1992-2#1)(1994-1#2)(1995-2#1)(1996-1#2)(2008-12#1)(2008-7#2)(2009-11#1)(2009-6#1)(2010-3#1)(2013-1#1)
of disabled##6##2##(1991-1#1)(1991-12#1)(1992-3#1)(1994-1#2)(2008-8#1)
of disagreement##2##2##(2011-2#1)(2013-1#1)
of disc##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
of discharge and##2##3##(1990-11#1)(2008-11#1)
of discharge##7##2##(1990-11#1)(2008-11#3)(2009-11#1)(2012-12#2)
of discharged##3##2##(1995-2#1)(2008-11#1)(2012-12#1)
of discharges##4##2##(1990-12#2)(1992-12#1)(1992-2#1)
of disciplines##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
of disclosure##4##2##(1991-3#1)(1995-9#1)(2008-10#1)(2008-12#1)
of discolored##3##2##(2008-10#3)
of discontinuous##2##2##(2007-12#1)(2010-4#1)
of discourse##3##2##(2008-12#1)(2012-3#2)
of discovery##4##2##(1995-12#1)(2011-3#1)(2012-2#2)
of discrete##13##2##(1994-2#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#2)(2013-8#1)
of discriminant analysis##3##3##(2008-10#3)
of discriminant##4##2##(1991-2#1)(2008-10#3)
of discriminating between##2##3##(1994-5#1)(2008-10#1)
of discriminating##3##2##(1994-5#1)(2008-10#1)(2008-9#1)
of discrimination and##2##3##(2008-11#1)(2009-3#1)
of discrimination##3##2##(2008-11#1)(2008-12#1)(2009-3#1)
of discussion and##2##3##(1996-1#1)(2008-11#1)
of discussion on##2##3##(1996-2#1)(2008-8#1)
of discussion##7##2##(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-11#1)
of disease across##2##3##(2008-10#2)
of disease activity##2##3##(1997-8#2)
of disease and##12##3##(1992-12#1)(2008-10#7)(2008-12#1)(2008-6#1)(2009-10#1)(2013-1#1)
of disease as##2##3##(1991-8#1)(2008-10#1)
of disease at##4##3##(1990-12#1)(1993-11#2)(2009-1#1)
of disease caused by the##2##5##(2008-10#2)
of disease caused by##3##4##(2008-10#2)(2011-2#1)
of disease control##9##3##(2008-10#9)
of disease development##7##3##(2008-10#7)
of disease during##2##3##(1994-8#1)(2008-10#1)
of disease extension##2##3##(1992-9#1)(2008-1#1)
of disease for##2##3##(2008-10#1)(2008-7#1)
of disease in##10##3##(2008-10#8)(2008-12#1)(2012-12#1)
of disease incidence and severity##2##5##(2008-10#2)
of disease incidence and##4##4##(2008-10#4)
of disease incidence data##5##4##(2008-10#5)
of disease incidence was##2##4##(2008-10#2)
of disease incidence##22##3##(1994-9#1)(1997-3#1)(2008-10#20)
of disease increase##4##3##(2008-10#4)
of disease intensity##3##3##(2008-10#3)
of disease is##3##3##(2008-10#2)(2013-1#1)
of disease management##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
of disease on##2##3##(2008-10#2)
of disease outbreaks##2##3##(1996-12#1)(2008-10#1)
of disease processes##3##3##(2008-2#1)(2008-7#1)(2010-2#1)
of disease progress##4##3##(2008-10#4)
of disease progression##6##3##(2008-10#2)(2009-6#1)(2010-10#1)(2011-7#1)(2013-8#1)
of disease recurrence##5##3##(2012-2#2)(2013-1#3)
of disease resistance in##2##4##(2008-10#2)
of disease resistance##5##3##(2008-10#5)
of disease severity at##2##4##(2008-10#2)
of disease severity##16##3##(2008-10#13)(2008-11#1)(2008-7#1)(2009-4#1)
of disease spread##3##3##(2008-10#3)
of disease suppression##5##3##(2008-10#5)
of disease symptoms##3##3##(2008-10#2)(2008-7#1)
of disease was##7##3##(1992-12#1)(2008-10#5)(2008-7#1)
of disease were##3##3##(1992-2#1)(2008-10#2)
of disease with##2##3##(2008-10#1)(2009-12#1)
of disease##279##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#2)(1991-12#2)(1991-8#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#2)(1993-11#2)(1994-8#2)(1994-9#3)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#3)(2008-1#1)(2008-10#170)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-7#2)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#11)(2013-8#4)
of disease&quot##2##2##(2008-10#1)(2013-1#1)
of disease)##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
of disease-free##2##2##(2008-10#1)(2010-3#1)
of disease-suppressive##2##2##(2008-10#2)
of diseased individuals##2##3##(2008-10#2)
of diseased plants in##2##4##(2008-10#2)
of diseased plants##8##3##(2008-10#8)
of diseased spikelets##4##3##(2008-10#4)
of diseased##29##2##(2008-10#29)
of diseases caused by##3##4##(1995-2#1)(2008-10#1)(2008-5#1)
of diseases diagnosed##2##3##(1994-2#2)
of diseases in humans##3##4##(2011-1#1)(2011-2#1)(2012-3#1)
of diseases in##4##3##(2006-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
of diseases that##2##3##(2012-2#1)(2012-3#1)
of diseases##42##2##(1991-11#1)(1991-6#2)(1992-11#1)(1992-9#1)(1994-2#2)(1995-2#1)(1995-9#1)(2006-6#1)(2008-10#7)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#8)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
of disgust##2##2##(2012-2#2)
of disinfection by-products##2##3##(2008-9#2)
of disinhibition##3##2##(2010-3#3)
of disintegrated##2##2##(2008-10#1)(2008-7#1)
of disk##2##2##(2008-12#1)(2008-8#1)
of dislocation##5##2##(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
of disorders characterized by##2##4##(2008-7#1)(2010-10#1)
of disorders##8##2##(1990-11#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-7#1)(2012-2#2)
of disparities in##2##3##(2008-11#1)(2013-1#1)
of dispensing##2##2##(2010-3#1)(2013-8#1)
of dispersal ability##2##3##(2008-9#2)
of dispersal and##4##3##(2008-8#3)(2008-9#1)
of dispersal of##2##3##(2008-10#2)
of dispersal that##2##3##(2008-10#1)(2008-8#1)
of dispersal##25##2##(2008-10#7)(2008-8#11)(2008-9#5)(2013-1#2)
of dispersed##5##2##(2008-10#4)(2008-7#1)
of dispersion is##2##3##(2007-11#1)(2008-10#1)
of dispersion of the##2##4##(2008-10#1)(2008-2#1)
of dispersion of##3##3##(2008-10#2)(2008-2#1)
of dispersion##13##2##(2007-11#1)(2008-10#10)(2008-2#2)
of displaced##6##2##(1991-9#1)(1994-9#2)(2013-1#3)
of displacement curves of##2##4##(1993-1#2)
of displacement##5##2##(1993-1#2)(2008-11#1)(2008-3#1)(2008-7#1)
of disposable##3##2##(1994-2#1)(2008-10#2)
of disruptions##2##2##(1993-9#1)(2011-2#1)
of dissatisfaction with##2##3##(1996-3#1)(2008-11#1)
of dissecting##2##2##(2008-10#1)(2013-1#1)
of disseminated cryptococcosis##2##3##(2008-5#2)
of disseminated##6##2##(1993-9#1)(1997-3#1)(2008-5#3)(2008-9#1)
of dissemination##4##2##(2008-10#1)(2008-11#1)(2010-10#1)(2013-1#1)
of dissipative##2##2##(2010-7#1)(2012-2#1)
of dissociated##4##2##(2008-10#3)(2009-9#1)
of dissociation##4##2##(1995-11#1)(2008-10#3)
of dissolution tests##2##3##(2008-10#2)
of dissolution##8##2##(2008-10#7)(2012-2#1)
of dissolved humic##2##3##(2008-10#2)
of dissolved organic matter##3##4##(2008-10#3)
of dissolved organic##6##3##(2008-10#6)
of dissolved oxygen (DO)##2##4##(2008-10#1)(2008-11#1)
of dissolved oxygen and##2##4##(2008-10#1)(2008-7#1)
of dissolved oxygen in##3##4##(2008-10#3)
of dissolved oxygen##10##3##(2008-10#8)(2008-11#1)(2008-7#1)
of dissolved##39##2##(2008-10#34)(2008-11#3)(2008-7#1)(2011-2#1)
of distal##17##2##(1991-12#1)(1993-1#1)(1994-5#1)(1996-9#1)(1997-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-11#1)(2012-12#2)(2012-3#1)(2013-8#2)
of distance##7##2##(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)(2011-3#1)(2012-3#1)
of distant metastases##3##3##(1991-8#1)(2010-3#1)(2011-2#1)
of distant##4##2##(1991-8#1)(1995-11#1)(2010-3#1)(2011-2#1)
of distilled drinks##2##3##(2008-10#2)
of distilled water and##2##4##(2008-10#1)(2012-3#1)
of distilled water##5##3##(2008-10#4)(2012-3#1)
of distilled##8##2##(2008-10#6)(2012-3#2)
of distinct primary##2##3##(2008-10#1)(2011-2#1)
of distinct##19##2##(1990-8#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#5)(2009-10#1)(2009-12#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of distinguishing these##2##3##(2008-11#1)(2012-2#1)
of distinguishing##5##2##(1991-12#1)(2008-11#2)(2010-10#1)(2012-2#1)
of distraction##3##2##(2009-3#2)(2011-2#1)
of distress##4##2##(1995-2#1)(2013-8#3)
of distributed##6##2##(2007-12#1)(2008-3#2)(2008-8#1)(2010-8#1)(2012-2#1)
of distribution of##4##3##(1995-6#1)(2008-10#2)(2008-5#1)
of distribution##18##2##(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-10#11)(2008-5#1)(2009-10#1)(2012-2#1)
of distributions##2##2##(2008-10#1)(2008-3#1)
of disturbance and##2##3##(2008-9#2)
of disturbance on##2##3##(2008-9#2)
of disturbance##6##2##(2008-8#1)(2008-9#5)
of disturbed##2##2##(2008-11#1)(2013-1#1)
of disulfides on##2##3##(2008-10#2)
of dithiocarbamate##3##2##(2008-10#3)
of dithiothreitol##2##2##(1992-3#2)
of diuretics in##3##3##(2008-10#3)
of diuretics##7##2##(1992-11#1)(1994-12#1)(2008-10#4)(2010-10#1)
of diurnal##2##2##(2007-12#1)(2008-11#1)
of diuron##2##2##(2008-10#2)
of divalent cation##3##3##(1990-2#3)
of divalent cations##2##3##(1994-6#1)(2008-10#1)
of divalent metal cations##2##4##(2008-10#2)
of divalent metal##3##3##(2008-10#3)
of divalent transition metal beta-diketonates##2##5##(2008-10#2)
of divalent transition metals##2##4##(2008-10#2)
of divalent transition##4##3##(2008-10#4)
of divalent##16##2##(1990-2#3)(1994-6#1)(2006-6#1)(2008-10#10)(2010-11#1)
of divergence##2##2##(2008-10#1)(2008-8#1)
of divergent##3##2##(1997-9#1)(2008-6#1)(2012-2#1)
of diverse ions on the determination of##2##7##(2008-10#2)
of diverse ions on the##4##5##(2008-10#4)
of diverse ions##5##3##(2008-10#5)
of diverse##17##2##(1990-5#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
of diversification##2##2##(2008-10#1)(2012-3#1)
of diversity and##4##3##(2008-10#1)(2011-1#1)(2012-3#2)
of diversity for aggressiveness##2##4##(2008-10#2)
of diversity in this##2##4##(2008-10#2)
of diversity in##3##3##(2008-10#2)(2008-11#1)
of diversity within##3##3##(2008-10#3)
of diversity##28##2##(1994-12#1)(1995-12#1)(2008-10#20)(2008-11#1)(2008-8#2)(2011-1#1)(2012-3#2)
of dividing cells##3##3##(1995-2#1)(2008-9#1)(2009-8#1)
of division##2##2##(2008-11#1)(2008-8#1)
of divorce##3##2##(2011-2#3)
of dizocilpine maleate##2##3##(1996-12#2)
of docetaxel##2##2##(2008-10#2)
of docked granules##3##3##(1997-7#3)
of docking##3##2##(1997-7#1)(2008-11#1)(2012-2#1)
of doctors and##2##3##(2008-12#1)(2008-8#1)
of doctors##13##2##(1990-3#1)(1990-6#1)(1991-2#3)(1993-6#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-8#1)(2012-2#1)
of documented##3##2##(1990-3#1)(1995-12#1)(1997-3#1)
of dodecyl sulfate##3##3##(2008-10#3)
of dodecyl##5##2##(2008-10#5)
of dog bites##2##3##(2013-8#2)
of dog##6##2##(1990-6#1)(1991-6#2)(2008-9#1)(2013-8#2)
of dogs##6##2##(1992-5#1)(2008-10#1)(2008-5#2)(2012-3#2)
of doing##8##2##(1990-2#1)(1991-3#1)(1994-3#1)(1995-5#1)(2008-11#1)(2012-2#1)(2013-1#2)
of doll therapy##4##3##(2013-8#4)
of dollar spot resistance in##2##5##(2008-10#2)
of dollar spot##5##3##(2008-10#5)
of dollars##2##2##(2008-11#1)(2008-7#1)
of domain II-less Aux/IAA##2##4##(2009-8#2)
of domain##4##2##(2008-3#1)(2009-8#2)(2011-2#1)
of domains##2##2##(2011-2#2)
of domestic homicide##3##3##(2011-2#3)
of domestic violence##3##3##(1995-12#1)(2012-12#1)(2013-1#1)
of domestic##12##2##(1995-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
of dominance##3##2##(2008-10#3)
of dominant##8##2##(1990-5#1)(1991-9#1)(1992-1#1)(1994-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-8#1)
of domino##2##2##(2009-10#2)
of domperidone from wastewater##2##4##(2008-10#2)
of domperidone in##2##3##(2008-10#2)
of domperidone##4##2##(2008-10#4)
of donated##2##2##(1992-1#1)(1992-3#1)
of donations##2##2##(1991-12#1)(1991-2#1)
of donor and acceptor##2##4##(2008-10#2)
of donor cells##4##3##(2008-11#1)(2008-9#3)
of donor site##2##3##(2012-3#1)(2013-1#1)
of donor##20##2##(2008-10#3)(2008-11#4)(2008-8#1)(2008-9#5)(2010-10#1)(2010-12#2)(2012-3#3)(2013-1#1)
of dopamine (DA)##7##3##(1996-12#2)(1997-2#1)(2008-10#4)
of dopamine and ascorbic acid##2##5##(2008-10#2)
of dopamine and its##3##4##(1997-3#1)(2008-10#1)(2008-7#1)
of dopamine and##10##3##(1990-8#1)(1991-1#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-7#1)
of dopamine at##3##3##(2008-10#3)
of dopamine by##2##3##(2008-10#2)
of dopamine hydrochloride##2##3##(2008-10#2)
of dopamine in the presence of ascorbic acid##2##8##(2008-10#2)
of dopamine in the##4##4##(2008-10#4)
of dopamine in##9##3##(2008-10#9)
of dopamine is obtained##2##4##(2008-10#2)
of dopamine is##3##3##(2008-10#3)
of dopamine on the##2##4##(2008-10#2)
of dopamine on##3##3##(2008-10#3)
of dopamine sensing##4##3##(2008-10#4)
of dopamine##64##2##(1990-7#1)(1990-8#2)(1991-1#1)(1992-3#1)(1993-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#3)(1997-2#2)(1997-3#3)(1997-4#1)(2008-10#40)(2008-11#1)(2008-7#3)
of dopaminergic neurons##2##3##(1990-7#1)(1997-3#1)
of dopaminergic##11##2##(1990-7#1)(1993-1#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-7#2)(2009-11#1)(2010-12#1)(2013-7#1)(2013-8#1)
of doping##2##2##(2010-11#2)
of dormancy##2##2##(2012-8#2)
of dormant##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
of dorsal horn group II##2##5##(1997-3#2)
of dorsal lips##3##3##(2011-2#3)
of dorsal root##2##3##(2008-5#1)(2008-7#1)
of dorsal##11##2##(1997-3#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#3)
of dose optimization points##2##4##(2009-2#2)
of dose##4##2##(1992-3#1)(2008-10#1)(2009-2#2)
of dose/response##2##2##(1993-8#1)(2008-10#1)
of dosed males and females##2##5##(2008-9#2)
of dosed males##3##3##(2008-9#3)
of dosed##4##2##(2008-9#4)
of doses##2##2##(1992-3#1)(2008-10#1)
of dosing##2##2##(2008-10#1)(2008-11#1)
of dots##3##2##(1995-3#1)(2008-10#2)
of double##13##2##(1990-8#1)(1993-8#2)(1997-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#3)(2012-3#1)
of double-stranded DNA##6##3##(2008-10#5)(2008-9#1)
of double-stranded RNA##2##3##(2008-10#1)(2008-8#1)
of double-stranded cDNA##2##3##(2008-2#2)
of double-stranded##12##2##(2008-10#7)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)
of downstream##3##2##(2009-3#1)(2010-4#1)(2013-7#1)
of downy mildew of##2##4##(2008-10#2)
of downy mildew##10##3##(2008-10#10)
of doxorubicin and Victoria Blue BO##2##6##(2008-11#2)
of doxorubicin and##3##3##(2008-11#2)(2013-1#1)
of doxorubicin##14##2##(1990-2#1)(2008-10#4)(2008-11#7)(2011-2#1)(2013-1#1)
of doxorubicin-induced##2##2##(2011-2#2)
of doxycycline hydrochloride and chlortetracycline hydrochloride##2##6##(2008-10#2)
of doxycycline hydrochloride##4##3##(2008-10#4)
of doxycycline or chlortetracycline in pharmaceutical formulations##2##7##(2008-10#2)
of doxycycline##8##2##(2008-10#7)(2011-2#1)
of dreams##2##2##(2008-12#2)
of drebrin E##3##3##(2012-2#3)
of dried##3##2##(1994-6#1)(2008-10#1)(2012-2#1)
of drinking water##4##3##(1992-2#1)(1992-5#1)(2009-7#1)(2013-1#1)
of drinking##8##2##(1990-2#1)(1992-2#1)(1992-5#1)(2008-12#1)(2009-7#1)(2010-7#2)(2013-1#1)
of drop##4##2##(2008-10#3)(2008-3#1)
of drop-based analytical measurements##2##4##(2008-10#2)
of droplet##7##2##(1995-3#2)(2008-3#5)
of droplets and##2##3##(2008-3#1)(2008-9#1)
of droplets##3##2##(2008-3#2)(2008-9#1)
of dropped fruit##2##3##(2008-10#2)
of drought and##2##3##(2012-6#1)(2012-9#1)
of drought##4##2##(2008-12#1)(2012-6#1)(2012-9#2)
of drug absorption##2##3##(1994-2#1)(2008-10#1)
of drug abuse treatment##2##4##(1991-1#1)(2008-6#1)
of drug abuse##5##3##(1991-1#2)(2008-1#1)(2008-6#1)(2009-7#1)
of drug administration##3##3##(1994-9#1)(2008-11#1)(2013-1#1)
of drug and##2##3##(2008-12#1)(2008-4#1)
of drug delivery##4##3##(1996-2#1)(1997-1#2)(2010-6#1)
of drug development##2##3##(1991-3#1)(2008-10#1)
of drug epidemics##2##3##(2013-8#2)
of drug exposure##2##3##(1996-12#1)(2012-2#1)
of drug in##4##3##(1996-2#1)(2008-10#3)
of drug resistance and##2##4##(1992-2#1)(2009-8#1)
of drug resistance in##2##4##(2008-11#1)(2012-3#1)
of drug resistance##13##3##(1990-2#1)(1992-2#2)(1997-7#2)(2008-10#1)(2008-11#5)(2009-8#1)(2012-3#1)
of drug resistant##3##3##(2008-11#1)(2010-7#1)(2011-2#1)
of drug safety##2##3##(2008-11#2)
of drug to##3##3##(1996-2#1)(1997-1#1)(2009-8#1)
of drug treatment##2##3##(1990-11#1)(2009-11#1)
of drug use##5##3##(2008-1#1)(2008-11#1)(2013-8#3)
of drug##118##2##(1990-11#1)(1990-2#3)(1991-1#4)(1991-3#1)(1992-2#3)(1992-3#4)(1993-12#2)(1993-3#2)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#4)(1997-1#6)(1997-2#3)(1997-3#1)(1997-7#2)(2008-1#2)(2008-10#13)(2008-11#20)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#3)(2009-7#1)(2009-8#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#7)
of drug-eluting stents in##2##4##(2008-11#1)(2008-12#1)
of drug-eluting stents##7##3##(2008-11#5)(2008-12#1)(2011-2#1)
of drug-induced##5##2##(1991-1#1)(2008-10#3)(2011-2#1)
of drug-resistant bacteria##2##3##(2012-2#2)
of drug-resistant##5##2##(2008-10#1)(2011-3#1)(2012-2#2)(2013-1#1)
of drugs and##8##3##(1992-3#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-8#1)
of drugs by##3##3##(1992-3#1)(1996-3#1)(2008-10#1)
of drugs for##2##3##(2011-2#1)(2012-3#1)
of drugs have##3##3##(2008-8#1)(2009-12#1)(2011-2#1)
of drugs in##6##3##(1991-3#1)(1996-6#1)(2008-10#2)(2009-12#1)(2013-8#1)
of drugs may##2##3##(1990-11#1)(1997-2#1)
of drugs of abuse##2##4##(1991-1#1)(2008-10#1)
of drugs of##4##3##(1991-1#2)(2008-10#2)
of drugs should be##2##4##(1996-6#1)(2012-3#1)
of drugs that##2##3##(2008-8#1)(2011-1#1)
of drugs to##3##3##(1995-12#1)(2008-10#1)(2008-9#1)
of drugs used##3##3##(1997-1#1)(2008-8#2)
of drugs##75##2##(1990-11#1)(1990-2#3)(1991-1#3)(1991-3#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-11#1)(1994-2#1)(1995-1#2)(1995-12#1)(1996-3#1)(1996-6#5)(1997-1#1)(1997-2#2)(1997-3#1)(2006-6#1)(2008-10#15)(2008-11#6)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#5)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#3)(2012-2#2)(2012-3#3)(2013-8#1)
of dry and##2##3##(2008-10#1)(2008-5#1)
of dry mass##2##3##(2008-10#1)(2008-12#1)
of dry matter production before and after heading##2##8##(2008-9#2)
of dry matter##4##3##(2008-10#2)(2008-9#2)
of dry soil##2##3##(2008-10#2)
of dry##27##2##(1995-3#1)(1996-3#1)(1997-2#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-9#2)(2012-3#1)
of drying oils##2##3##(2008-10#2)
of drying temperature##2##3##(2011-2#2)
of drying##4##2##(2008-10#2)(2011-2#2)
of dsDNA##6##2##(2008-10#6)
of dsRNA##6##2##(2008-10#4)(2008-9#1)(2013-1#1)
of dual##4##2##(1993-2#1)(2009-8#1)(2013-1#1)(2013-8#1)
of duloxetine##3##2##(2008-10#2)(2011-2#1)
of duodenal##2##2##(1992-11#1)(2009-12#1)
of duplicated##2##2##(1993-3#1)(2008-10#1)
of durability of##3##3##(2007-11#1)(2008-10#2)
of durability##6##2##(2007-11#1)(2008-10#5)
of dural arteriovenous malformations of the cranium##2##7##(2008-7#2)
of dural arteriovenous##5##3##(1996-9#3)(2008-7#2)
of dural sinus thrombosis##2##4##(2008-7#2)
of dural##9##2##(1996-9#3)(1997-3#1)(2008-7#4)(2011-2#1)
of duration of##6##3##(1990-11#1)(1992-9#1)(2008-10#1)(2010-8#1)(2011-2#1)(2011-3#1)
of duration##9##2##(1990-11#1)(1992-9#1)(2008-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
of durum wheat##4##3##(2008-10#3)(2013-8#1)
of durum##5##2##(2008-10#4)(2013-8#1)
of dust##3##2##(1992-12#1)(2008-11#2)
of dwarf mistletoe##2##3##(2008-10#2)
of dwarf##3##2##(2008-10#2)(2008-9#1)
of dyad##2##2##(1990-11#1)(2010-4#1)
of dye##12##2##(2008-10#8)(2008-3#1)(2010-4#2)(2011-2#1)
of dye-induced##2##2##(2008-10#2)
of dyes##7##2##(2008-10#5)(2008-3#1)(2008-4#1)
of dying well##2##3##(2010-8#2)
of dying##12##2##(1993-6#1)(1994-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-8#2)(2012-12#1)(2013-1#1)
of dynamic extraction##2##3##(2008-10#2)
of dynamic high-pressure micro-fluidization##2##4##(2013-8#2)
of dynamic##16##2##(2008-10#3)(2008-11#3)(2008-3#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
of dysfunction##4##2##(2008-12#2)(2010-9#2)
of dysfunctional##2##2##(1994-12#1)(2009-9#1)
of dysfunctions##2##2##(1990-2#1)(2010-9#1)
of dyslexia##4##2##(2008-11#2)(2008-12#1)(2012-2#1)
of dyslexics##2##2##(2008-11#2)
of dyspepsia##2##2##(1995-10#2)
of dysphagia##5##2##(1992-9#1)(1993-6#2)(2008-1#1)(2011-2#1)
of dysplasia and epidermoid cancer of cervix##2##7##(2013-1#2)
of dysplasia and##3##3##(1993-8#1)(2013-1#2)
of dysplasia##6##2##(1990-6#1)(1993-8#3)(2013-1#2)
of dysplastic lesions##3##3##(1993-8#3)
of dysplastic##4##2##(1993-8#3)(2013-1#1)
of dyspnea and##2##3##(2008-10#1)(2010-1#1)
of dyspnea was##2##3##(1990-12#1)(2008-10#1)
of dyspnea##11##2##(1990-12#2)(2008-10#7)(2010-1#1)(2012-3#1)
of dysprosium from##2##3##(2008-10#2)
of dysprosium##5##2##(2008-10#5)
of dystonia##2##2##(2008-7#2)
of dystrophin##4##2##(1993-3#2)(1995-12#1)(2011-2#1)
of dysuria##2##2##(2008-10#2)
of e##2##2##(2008-10#1)(2008-8#1)
of eIF2α##3##2##(2012-2#3)
of eIF4E in##2##3##(1997-7#2)
of eIF4E##3##2##(1997-7#3)
of each approach##4##3##(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
of each cell##3##3##(1995-12#2)(2008-11#1)
of each characteristic##2##3##(2008-5#2)
of each component##5##3##(2008-10#2)(2008-3#1)(2008-5#2)
of each compound##5##3##(2008-10#5)
of each country##2##3##(1994-1#1)(2011-2#1)
of each cycle##2##3##(2008-11#1)(2013-1#1)
of each element##4##3##(2008-10#3)(2013-8#1)
of each enzyme##2##3##(2008-10#2)
of each experiment##3##3##(1994-3#2)(2008-10#1)
of each group##2##3##(2008-10#1)(2009-8#1)
of each individual##6##3##(1995-9#1)(1997-3#1)(2008-10#3)(2008-11#1)
of each isolate##5##3##(2008-10#4)(2011-2#1)
of each measurement##2##3##(2008-10#1)(2008-3#1)
of each metal##4##3##(2008-10#4)
of each method##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of each of the four##2##5##(1995-12#1)(2008-10#1)
of each of the methods##2##5##(2008-10#2)
of each of the##15##4##(1994-5#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#9)(2008-11#1)(2011-1#1)
of each of these##9##4##(1993-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-2#1)
of each of##33##3##(1993-1#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#2)(1997-3#1)(2008-10#16)(2008-11#2)(2008-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
of each other and##2##4##(2008-10#1)(2008-8#1)
of each other##5##3##(1993-8#1)(2008-10#3)(2008-8#1)
of each pair##2##3##(1994-5#2)
of each pathogen##2##3##(2008-10#1)(2013-8#1)
of each patient##4##3##(1995-2#1)(2008-5#1)(2011-3#1)(2013-1#1)
of each peptide was##2##4##(2008-8#2)
of each peptide##3##3##(1996-12#1)(2008-8#2)
of each primer set##2##4##(2008-10#2)
of each protein##5##3##(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
of each sample was##2##4##(2008-10#2)
of each sample##7##3##(2008-10#7)
of each single compound##2##4##(2008-10#1)(2008-5#1)
of each species##6##3##(2008-10#4)(2008-12#1)(2008-8#1)
of each strain##2##3##(2008-10#2)
of each technique are##2##4##(2008-10#2)
of each technique##4##3##(2008-10#3)(2010-7#1)
of each transporter##2##3##(2008-7#2)
of each treatment##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
of each type of##2##4##(2008-10#1)(2008-3#1)
of each variable##2##3##(1992-1#1)(2013-1#1)
of each virus##3##3##(2008-10#3)
of each vitamin##3##3##(2008-10#1)(2008-5#2)
of each was##2##3##(2008-10#1)(2008-5#1)
of each##335##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#5)(1994-6#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#4)(1996-3#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#144)(2008-11#15)(2008-12#4)(2008-3#12)(2008-4#2)(2008-5#14)(2008-6#3)(2008-7#4)(2008-8#11)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-2#8)(2012-3#5)(2013-1#11)(2013-8#5)
of ear##2##2##(2008-10#2)
of earlier findings##2##3##(1992-12#1)(1994-11#1)
of earlier studies##2##3##(1996-12#1)(2008-5#1)
of earlier##10##2##(1992-12#1)(1992-5#1)(1994-11#1)(1996-12#1)(1997-7#1)(2008-2#1)(2008-5#2)(2011-2#2)
of early Late Triassic age##2##5##(1990-8#2)
of early and##2##3##(1991-3#1)(2008-12#1)
of early breast cancer##3##4##(1992-2#1)(1993-11#1)(1993-9#1)
of early detection##2##3##(1990-8#1)(1991-3#1)
of early development##2##3##(2008-11#1)(2008-4#1)
of early diagnosis and treatment##2##5##(2013-1#2)
of early diagnosis and##3##4##(2013-1#2)(2013-7#1)
of early diagnosis##6##3##(1990-6#1)(2008-11#1)(2013-1#3)(2013-7#1)
of early flowering##2##3##(1997-8#1)(2008-10#1)
of early gene##2##3##(1991-5#1)(1993-9#1)
of early intervention and the##2##5##(2008-11#1)(2008-9#1)
of early intervention##6##3##(1992-12#1)(1994-1#1)(1995-1#1)(1997-2#1)(2008-11#1)(2008-9#1)
of early leaf spot##2##4##(2008-10#2)
of early onset##3##3##(1996-2#1)(2011-2#2)
of early treatment##3##3##(1996-11#1)(2008-9#2)
of early##103##2##(1990-6#1)(1990-8#4)(1990-9#2)(1991-12#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-9#2)(1994-1#1)(1994-2#1)(1995-1#1)(1995-8#2)(1996-11#1)(1996-2#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#12)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#2)
of early-onset##3##2##(1995-8#1)(2008-3#1)(2012-3#1)
of ease##2##2##(2008-10#1)(2009-5#1)
of easily##3##2##(2008-10#3)
of eastern filbert blight##3##4##(2008-10#3)
of eastern##8##2##(2008-10#6)(2008-8#1)(2010-3#1)
of easy##2##2##(1994-1#1)(2008-7#1)
of eating disorder##2##3##(2012-2#2)
of eating disorders##4##3##(2010-11#3)(2012-2#1)
of eating##10##2##(1993-6#1)(2010-11#4)(2012-2#4)(2013-1#1)
of eberconazole##2##2##(2008-5#2)
of eccrine sweat##2##3##(2008-5#2)
of ecdysteroid secretion by##2##4##(1995-11#2)
of ecdysteroid secretion##3##3##(1995-11#3)
of ecdysteroid##4##2##(1995-11#3)(2008-9#1)
of ecdysteroids in##2##3##(2008-9#2)
of ecdysteroids##4##2##(2008-9#3)(2012-2#1)
of echicetin##3##2##(1994-11#3)
of echocardiography##2##2##(2011-2#1)(2012-2#1)
of ecological communities##2##3##(2008-8#1)(2008-9#1)
of ecological constraints##5##3##(2008-8#5)
of ecological##19##2##(2008-10#2)(2008-11#2)(2008-8#9)(2008-9#4)(2012-2#2)
of economic importance##2##3##(2008-12#1)(2011-2#1)
of economic##10##2##(1991-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-1#2)(2011-2#2)
of economically##2##2##(2008-10#2)
of economies##2##2##(1994-3#1)(1996-1#1)
of ectopic pregnancy##3##3##(1994-3#1)(2011-2#1)(2012-12#1)
of ectopic##10##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
of edema##4##2##(1992-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
of edentulous patients##2##3##(2010-5#1)(2011-7#1)
of edentulous##3##2##(2010-5#1)(2011-7#1)(2013-1#1)
of edges##2##2##(2009-3#1)(2011-2#1)
of edible##7##2##(2008-10#5)(2008-12#1)(2010-7#1)
of education and the##3##4##(1991-2#1)(1993-3#1)(2013-1#1)
of education and##9##3##(1991-2#1)(1993-2#1)(1993-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2010-8#1)(2013-1#1)
of education has##2##3##(2008-11#1)(2008-12#1)
of education in managed care##2##5##(1997-3#2)
of education in##5##3##(1997-3#2)(2008-11#2)(2011-2#1)
of education on##3##3##(1990-3#1)(1991-1#1)(2008-11#1)
of education was##2##3##(2008-7#1)(2009-11#1)
of education##40##2##(1990-3#1)(1991-1#1)(1991-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-3#2)(1996-1#2)(1997-3#2)(2008-1#1)(2008-11#9)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
of educational processes##2##3##(1992-2#1)(2008-12#1)
of educational##16##2##(1992-2#1)(2008-1#1)(2008-11#5)(2008-12#5)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
of effect of##3##3##(2008-11#2)(2008-8#1)
of effect##8##2##(1993-1#1)(1993-3#1)(2008-11#3)(2008-8#1)(2011-2#1)(2013-1#1)
of effective##32##2##(1992-12#1)(1994-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
of effectiveness of##2##3##(2008-10#1)(2013-1#1)
of effectiveness##5##2##(1991-2#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
of effector mechanisms##2##3##(2008-10#2)
of effector##6##2##(1990-12#2)(2008-10#2)(2009-8#1)(2010-5#1)
of effects of##5##3##(1991-12#1)(2008-10#2)(2012-2#1)(2013-1#1)
of effects on##4##3##(2008-11#2)(2012-2#1)(2013-1#1)
of effects was##2##3##(2009-1#1)(2010-4#1)
of effects##18##2##(1991-12#1)(2008-10#4)(2008-11#4)(2008-4#1)(2009-1#1)(2010-1#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#2)
of efferent##2##2##(1995-3#1)(1997-3#1)
of efficacy and safety##2##4##(1990-9#1)(2011-1#1)
of efficacy and##3##3##(1990-9#1)(1996-12#1)(2011-1#1)
of efficacy##18##2##(1990-9#2)(1993-11#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
of efficiency over##2##3##(2008-10#2)
of efficiency##5##2##(2008-10#3)(2008-6#1)(2008-8#1)
of efficient sampling##2##3##(2008-10#2)
of efficient##12##2##(1992-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-2#1)
of efficiently##4##2##(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
of effluent##4##2##(2008-10#3)(2008-12#1)
of effort##5##2##(1995-1#1)(2008-12#1)(2008-8#2)(2013-8#1)
of efforts to##5##3##(1991-2#1)(1994-2#1)(1996-3#1)(2008-11#1)(2010-4#1)
of efforts##7##2##(1991-2#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
of egg contents and##2##4##(1991-11#1)(2008-8#1)
of egg drop syndrome virus##2##5##(2008-8#2)
of egg production##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
of egg size##3##3##(1991-5#2)(2010-8#1)
of egg##17##2##(1991-11#1)(1991-5#2)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#4)(2008-9#2)(2010-8#1)(2013-1#1)
of eggs in##2##3##(1996-12#1)(2008-10#1)
of eggs##14##2##(1996-12#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#4)(2010-8#3)(2013-1#1)
of eicosapentaenoic##2##2##(2008-11#1)(2011-2#1)
of eigenmodes##2##2##(1992-8#1)(2008-2#1)
of eight animals were protected better than 80% by##2##9##(1995-5#2)
of eight animals were protected better than##3##7##(1995-5#3)
of eight cases##2##3##(2008-5#1)(2009-4#1)
of eight patients with##3##4##(2008-7#1)(2010-1#1)(2011-2#1)
of eight patients##4##3##(2008-7#1)(2010-1#2)(2011-2#1)
of eight triazines##2##3##(2008-10#2)
of eight##61##2##(1992-7#1)(1994-5#2)(1995-1#1)(1995-5#3)(1995-6#1)(1996-12#1)(1997-1#1)(2008-10#31)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#3)(2011-2#1)(2012-2#2)(2012-3#2)
of eighteen##2##2##(1997-3#1)(2012-3#1)
of either high##2##3##(2008-10#1)(2008-9#1)
of either of the##2##4##(1991-12#1)(1997-7#1)
of either of##3##3##(1991-12#1)(1996-2#1)(1997-7#1)
of either species##4##3##(2008-10#4)
of either the##11##3##(1990-11#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-11#2)(1995-6#1)(2008-10#2)(2008-11#2)
of either type##2##3##(1990-12#1)(2008-10#1)
of either##103##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#30)(2008-11#10)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-12#2)(2010-7#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of elastase activity##2##3##(2008-5#1)(2008-7#1)
of elastase##7##2##(1992-12#2)(2008-5#4)(2008-7#1)
of elastic##4##2##(2008-3#1)(2008-5#1)(2010-10#1)(2013-1#1)
of elasticity modulus##3##3##(2008-10#3)
of elastin##7##2##(1990-8#1)(2008-5#3)(2008-7#2)(2009-7#1)
of elastofibroma##3##2##(1991-6#1)(2009-4#2)
of elbow##3##2##(2011-2#3)
of elderly men##2##3##(2011-2#2)
of elderly patients##5##3##(1994-3#2)(2008-7#1)(2008-8#1)(2011-2#1)
of elderly people##2##3##(1992-1#1)(2012-3#1)
of elderly residents##2##3##(2008-11#1)(2010-10#1)
of elderly##25##2##(1992-1#1)(1992-3#1)(1993-1#2)(1994-1#2)(1994-3#2)(1996-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#6)(2012-3#2)(2013-1#1)
of election##2##2##(1990-3#1)(2008-10#1)
of electric##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
of electrical activity##6##3##(1994-3#1)(1996-2#3)(2009-5#1)(2010-6#1)
of electrical stimulation of the##2##5##(1996-2#1)(2008-9#1)
of electrical stimulation##5##3##(1994-2#1)(1996-2#1)(2008-9#2)(2009-10#1)
of electrical##15##2##(1990-9#1)(1994-2#1)(1994-3#2)(1996-2#4)(2008-12#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-6#1)
of electrically stimulated##2##3##(1995-3#1)(2009-9#1)
of electrically##5##2##(1995-3#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-7#1)
of electroactive##4##2##(2008-10#3)(2008-4#1)
of electroacupuncture combined##2##3##(2013-1#1)(2013-8#1)
of electrocatalytic##2##2##(2010-6#2)
of electrochemical hydride generation##4##4##(2008-10#4)
of electrochemical sensors##2##3##(2008-10#2)
of electrochemical techniques##2##3##(2008-10#2)
of electrochemical##19##2##(2008-10#19)
of electrochemically##3##2##(2008-10#3)
of electrochemiluminescent##2##2##(2008-10#2)
of electrochemistry##3##2##(2008-10#2)(2009-9#1)
of electrode is##2##3##(2008-10#2)
of electrode polishing##2##3##(2008-10#2)
of electrode surface##2##3##(2008-10#2)
of electrode##14##2##(2008-10#12)(2009-7#1)(2010-7#1)
of electrodes##11##2##(2008-10#7)(2008-11#2)(2008-9#1)(2010-7#1)
of electrodialysis##2##2##(2008-10#2)
of electrogenerated##3##2##(2008-10#3)
of electroinactive##2##2##(2008-10#2)
of electrolyte leakage##2##3##(2008-10#2)
of electrolyte solution##3##3##(2008-10#3)
of electrolyte##12##2##(2008-10#12)
of electrolytes on the retention behavior of some benzenesulfonates in electrochemically modulated liquid chromatography##2##14##(2008-10#2)
of electrolytes##13##2##(2008-10#11)(2008-12#1)(2012-2#1)
of electromagnetic theory##2##3##(2008-3#2)
of electromagnetic##7##2##(1992-3#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#1)
of electron transfer##2##3##(1997-7#1)(2008-10#1)
of electron transport##2##3##(1990-5#1)(1995-3#1)
of electron##13##2##(1990-5#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-7#1)(2011-2#1)
of electron-dense##2##2##(1992-2#1)(2008-10#1)
of electronic health##2##3##(2010-8#2)
of electronic##11##2##(1995-2#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-8#3)(2011-2#1)(2012-12#1)
of electrons transferred##3##3##(2008-10#3)
of electrons##7##2##(1991-5#1)(2008-10#5)(2009-11#1)
of electroosmotic##3##2##(2008-10#3)
of electrophilic##2##2##(1996-5#1)(2008-4#1)
of electrophoretic##2##2##(2008-10#2)
of electroporation##2##2##(2008-11#2)
of electrospray ionization##2##3##(2010-6#1)(2010-7#1)
of electrospray##4##2##(2008-10#2)(2010-6#1)(2010-7#1)
of electrospun##3##2##(2009-12#1)(2009-7#2)
of electrostatic interactions in##2##4##(1996-5#1)(2008-4#1)
of electrostatic interactions##4##3##(1996-5#1)(2008-10#1)(2008-4#2)
of electrostatic##6##2##(1994-8#1)(1996-5#1)(2008-10#1)(2008-4#3)
of element##2##2##(2008-10#2)
of elemental composition of##2##4##(2008-10#2)
of elemental composition##3##3##(2008-10#3)
of elemental concentrations##2##3##(2008-10#2)
of elemental##13##2##(2008-10#13)
of elements in##7##3##(2008-10#4)(2008-11#1)(2008-8#1)(2009-8#1)
of elements of##2##3##(1990-11#1)(2010-8#1)
of elements were##2##3##(1994-3#1)(2008-10#1)
of elements##25##2##(1990-11#1)(1991-6#1)(1994-3#1)(2008-10#13)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
of elevated blood pressure##2##4##(2008-5#2)
of elevated concentrations of##2##4##(2008-11#1)(2008-7#1)
of elevated levels of##3##4##(1994-2#1)(1995-2#1)(2008-11#1)
of elevated##16##2##(1991-12#1)(1992-12#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
of eleven##6##2##(2008-10#3)(2008-12#1)(2008-5#1)(2013-1#1)
of elicited##2##2##(2008-10#1)(2011-10#1)
of elicitin production##2##3##(2008-10#2)
of elimination##3##2##(1996-1#1)(2008-10#1)(2008-12#1)
of ellagic acid##4##3##(2008-10#2)(2008-5#2)
of elongated particles##2##3##(1991-12#2)
of elongated##5##2##(1991-12#2)(2008-10#1)(2008-12#1)(2008-5#1)
of elongating##3##2##(2009-10#1)(2012-2#2)
of elongation factor 3##2##4##(1996-2#2)
of elongation##4##2##(1994-11#1)(1996-2#2)(2008-10#1)
of eluate##3##2##(1990-2#1)(2008-10#2)
of eluent and##3##3##(2008-10#3)
of eluent##15##2##(2008-10#15)
of elution##7##2##(2008-10#7)
of embarrassment##2##2##(1996-5#1)(2013-8#1)
of embolization of##2##3##(2008-7#2)
of embolization##3##2##(1997-8#1)(2008-7#2)
of embryo##4##2##(1992-5#1)(1996-8#1)(2008-9#1)(2011-2#1)
of embryogenesis and##2##3##(2007-12#1)(2009-12#1)
of embryogenesis##6##2##(2007-12#2)(2009-12#1)(2009-7#1)(2009-8#1)(2013-1#1)
of embryonic acid tolerance and##2##5##(2012-3#2)
of embryonic and##2##3##(2009-3#1)(2013-1#1)
of embryonic stem cells##4##4##(2008-11#3)(2008-9#1)
of embryonic stem##6##3##(2008-11#4)(2008-9#1)(2010-7#1)
of embryonic##21##2##(1990-5#1)(1993-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-11#6)(2008-7#1)(2008-9#2)(2009-3#1)(2010-7#1)(2012-3#3)(2013-1#1)
of embryos##15##2##(1991-3#1)(1992-3#2)(1996-8#1)(1997-8#1)(2008-11#3)(2008-12#2)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)
of emergence##4##2##(2008-10#1)(2008-12#2)(2011-2#1)
of emergency nurses##2##3##(2008-11#2)
of emergency##16##2##(1991-6#1)(1993-12#1)(1995-12#1)(1997-5#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#2)(2009-4#2)(2010-11#1)(2010-8#1)
of emergent##4##2##(2008-1#1)(2009-9#1)(2012-12#1)(2013-8#1)
of emerging##6##2##(1996-1#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-8#1)
of emission##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
of emissions##5##2##(2008-10#4)(2008-3#1)
of emitted##2##2##(1994-8#1)(2008-11#1)
of emotion and##2##3##(2008-4#1)(2011-2#1)
of emotion##8##2##(2008-11#5)(2008-4#1)(2009-4#1)(2011-2#1)
of emotional exhaustion##2##3##(2008-11#1)(2010-7#1)
of emotional##17##2##(1992-3#1)(1995-1#1)(2008-10#1)(2008-11#8)(2008-4#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-7#1)(2013-1#1)
of emotions##2##2##(1994-2#1)(1997-2#1)
of empirical findings##2##3##(2008-11#1)(2013-8#1)
of empirical work##2##3##(2008-11#1)(2008-8#1)
of empirical##6##2##(1996-3#1)(2008-11#2)(2008-8#1)(2008-9#1)(2013-8#1)
of empirically##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
of employee##3##2##(1995-1#1)(1995-6#1)(2012-12#1)
of employees##6##2##(1994-1#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-11#1)(2012-3#1)
of employer-sponsored health insurance##2##4##(2008-11#2)
of employing the##2##3##(2008-10#2)
of employing##7##2##(1991-2#1)(2008-10#6)
of employment as##2##3##(1991-12#1)(2008-10#1)
of employment##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
of emulsifier##2##2##(2008-10#2)
of enamel and dentin##2##4##(1991-2#1)(2012-12#1)
of enamel##6##2##(1991-2#1)(2009-7#1)(2010-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
of enantiomeric##3##2##(2008-10#3)
of enantiomers of##3##3##(2008-10#3)
of enantiomers##5##2##(2008-10#5)
of enantioselective##2##2##(2008-10#2)
of encapsulated##2##2##(2008-11#1)(2008-5#1)
of encapsulating peritoneal sclerosis##3##4##(2011-2#3)
of encapsulation##2##2##(2008-10#1)(2008-5#1)
of encephalitis##3##2##(2008-7#1)(2011-2#2)
of encoding##2##2##(2008-10#1)(2013-8#1)
of encounter##2##2##(1997-2#1)(2008-8#1)
of encountering##2##2##(2008-1#1)(2010-10#1)
of encounters with##2##3##(2008-11#1)(2008-8#1)
of encounters##4##2##(2008-11#1)(2008-8#3)
of encouraging##2##2##(1993-11#1)(2010-5#1)
of end stage renal disease (ESRD)##2##6##(1991-3#1)(2012-2#1)
of end stage renal disease##3##5##(1991-3#1)(2012-2#1)(2013-1#1)
of end users##2##3##(1992-12#1)(2009-6#1)
of end##6##2##(1991-3#1)(1992-12#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
of end-stage##7##2##(2007-11#1)(2008-1#1)(2010-6#1)(2011-2#1)(2011-3#2)(2013-1#1)
of endo-PG##2##2##(2008-10#2)
of endobiliary stent##2##3##(2008-12#2)
of endocarditis##3##2##(1997-5#1)(2011-2#2)
of endocrine##6##2##(1990-11#1)(1992-12#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
of endogenous ROS in##2##4##(2008-11#2)
of endogenous ROS##4##3##(2008-11#3)(2009-8#1)
of endogenous and exogenous##2##4##(1992-5#1)(2008-10#1)
of endogenous opioid##2##3##(2008-10#1)(2008-11#1)
of endogenous##50##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#5)(1996-2#1)(1997-1#2)(2008-1#1)(2008-10#6)(2008-11#9)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-11#2)(2011-2#2)(2012-3#1)
of endogenously##2##2##(1992-6#1)(2013-8#1)
of endometrial carcinoma##3##3##(1995-3#1)(2011-2#2)
of endometrial##13##2##(1994-12#1)(1995-3#3)(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
of endometriosis##7##2##(1992-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(2010-12#2)
of endopolygalacturonase##2##2##(2008-10#2)
of endos(00003)/+##2##2##(2012-3#2)
of endoscopic##11##2##(1994-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-12#1)(2013-1#1)
of endoscopy##2##2##(1997-8#1)(2012-2#1)
of endosepsis in##2##3##(2008-10#2)
of endosepsis##3##2##(2008-10#3)
of endosulfan##2##2##(2008-12#2)
of endothelial cells to##3##4##(1993-3#1)(2008-11#1)(2010-1#1)
of endothelial cells##12##3##(1993-3#3)(1993-6#1)(1996-12#1)(2008-11#2)(2008-9#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#1)
of endothelial##20##2##(1993-3#3)(1993-6#2)(1996-12#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)
of endothelin##3##2##(1992-3#1)(1993-3#1)(1997-4#1)
of endothelin-1 on##4##3##(1992-3#4)
of endothelin-1##8##2##(1991-5#1)(1992-3#6)(1993-3#1)
of endovascular and##2##3##(2008-7#1)(2011-3#1)
of endovascular treatment##2##3##(1996-6#1)(1997-6#1)
of endovascular##12##2##(1996-6#1)(1996-9#2)(1997-4#1)(1997-6#1)(2008-10#1)(2008-7#1)(2010-12#2)(2011-3#1)(2012-2#2)
of energetic##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
of energy and##3##3##(1994-12#1)(2008-10#1)(2012-2#1)
of energy as##6##3##(1996-12#2)(2008-1#2)(2008-4#2)
of energy coding##3##3##(2008-11#3)
of energy delivered by##2##4##(2008-10#1)(2013-1#1)
of energy delivered##4##3##(2008-10#1)(2008-9#1)(2013-1#2)
of energy homeostasis##3##3##(2008-10#1)(2008-4#2)
of energy intake as##2##4##(1997-8#2)
of energy metabolism##2##3##(2008-1#1)(2008-7#1)
of energy transfer##4##3##(2008-10#3)(2008-7#1)
of energy##57##2##(1994-12#1)(1994-2#1)(1996-12#2)(1997-6#1)(1997-8#2)(2008-1#3)(2008-10#10)(2008-11#3)(2008-3#1)(2008-4#5)(2008-7#5)(2008-8#5)(2008-9#5)(2009-8#1)(2010-6#2)(2012-2#3)(2013-1#7)
of engaging##2##2##(2009-5#1)(2010-9#1)
of engineered##2##2##(2008-10#1)(2008-11#1)
of engineering##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
of engraftment##2##2##(2010-11#1)(2013-1#1)
of engrailed expression##2##3##(2007-12#2)
of engrailed##3##2##(1993-2#1)(2007-12#2)
of enhanced##13##2##(1991-10#1)(1993-1#1)(1994-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2013-1#1)
of enhancing the##3##3##(1995-5#1)(2008-10#2)
of enhancing##6##2##(1995-5#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
of enlarged similarity##2##3##(1996-6#2)
of enlarged##5##2##(1996-6#2)(2008-10#2)(2009-10#1)
of enlargement##2##2##(2011-2#1)(2012-12#1)
of enriched (137)Ba##2##3##(2010-8#2)
of enriched##4##2##(2008-10#2)(2010-8#2)
of enrichment factor##2##3##(2008-10#2)
of enrichment##7##2##(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
of enrofloxacin against Riemerella anatipestifer##2##5##(2008-5#2)
of enrollment##4##2##(1991-1#1)(1991-12#2)(1991-3#1)
of ensuring##3##2##(1991-3#1)(2011-1#1)(2012-3#1)
of entactin##3##2##(1995-6#3)
of enteric##4##2##(1994-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
of enterovirus 71##3##3##(2008-12#2)(2013-8#1)
of enthalpy and##2##3##(1990-8#1)(2008-10#1)
of entire##5##2##(1992-6#1)(2008-10#1)(2009-10#1)(2009-7#1)(2010-8#1)
of entomology##3##2##(2010-1#3)
of entomopathogenic##3##2##(2008-5#1)(2008-8#2)
of entrapment by estoppel##2##4##(1994-3#2)
of entrepreneurs##2##2##(1996-2#2)
of entry of##2##3##(2008-5#1)(2008-7#1)
of entry##11##2##(1997-1#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#1)
of environment on##2##3##(2008-10#1)(2010-1#1)
of environment##4##2##(2008-10#2)(2010-1#1)(2010-6#1)
of environmental analysis##2##3##(2008-10#2)
of environmental and genetic factors##2##5##(2008-9#1)(2009-8#1)
of environmental and genetic##3##4##(2008-9#1)(2009-8#1)(2010-4#1)
of environmental and industrial exposure to heavy metals##2##8##(2008-10#2)
of environmental and##9##3##(2008-10#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)
of environmental conditions##4##3##(2008-10#4)
of environmental data##2##3##(2008-10#1)(2008-8#1)
of environmental factors##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
of environmental health services##2##4##(1997-2#2)
of environmental health##3##3##(1997-2#2)(2008-1#1)
of environmental noise##6##3##(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#2)
of environmental pollutants##5##3##(2008-10#5)
of environmental problems##2##3##(2008-10#1)(2008-11#1)
of environmental samples##4##3##(2008-10#3)(2012-12#1)
of environmental stewardship and##2##4##(2009-8#2)
of environmental stressors##2##3##(2009-8#1)(2010-4#1)
of environmental tobacco smoke##2##4##(1996-3#2)
of environmental variables##2##3##(2008-11#1)(2008-5#1)
of environmental variation##2##3##(2008-8#1)(2012-3#1)
of environmental##97##2##(1991-1#1)(1991-12#1)(1994-3#2)(1995-11#1)(1996-1#1)(1996-3#2)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#37)(2008-11#5)(2008-5#2)(2008-7#2)(2008-8#13)(2008-9#4)(2009-12#2)(2009-8#6)(2009-9#1)(2010-4#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
of environmentally##5##2##(2008-10#2)(2008-11#1)(2008-8#2)
of environments that##2##3##(2008-8#1)(2008-9#1)
of environments##6##2##(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#2)
of enzymatic activity##2##3##(2008-11#1)(2008-7#1)
of enzymatic hydrolysis##4##3##(2008-10#1)(2008-5#2)(2013-1#1)
of enzymatic oxidation##2##3##(2008-10#2)
of enzymatic reactions##2##3##(1990-5#1)(2008-4#1)
of enzymatic##21##2##(1990-5#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2013-1#1)
of enzymatically active##3##3##(1992-12#1)(2008-4#2)
of enzymatically generated##3##3##(2008-10#3)
of enzymatically##7##2##(1992-12#1)(2008-10#4)(2008-4#2)
of enzyme activities##2##3##(2008-5#1)(2008-7#1)
of enzyme activity##9##3##(1991-5#1)(1992-6#1)(1995-6#2)(1997-6#2)(2011-1#1)(2011-2#1)(2013-1#1)
of enzyme kinetic##2##3##(2008-10#1)(2011-1#1)
of enzyme molecules##2##3##(2011-2#1)(2012-2#1)
of enzyme##46##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#2)(1992-6#2)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#2)(1997-2#1)(1997-6#2)(2008-10#15)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
of enzyme-catalyzed reaction##2##3##(2008-10#2)
of enzyme-catalyzed##3##2##(2008-10#2)(2008-7#1)
of enzymes in##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
of enzymes that##3##3##(2008-1#1)(2008-4#1)(2009-10#1)
of enzymes##23##2##(1995-3#2)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of eosinophil##2##2##(1994-11#1)(1995-6#1)
of eosinophilic##2##2##(2010-12#1)(2011-2#1)
of eosinophils##5##2##(1992-3#1)(1995-6#1)(2008-10#1)(2008-5#1)(2010-6#1)
of eperisone-HCl##2##2##(1996-2#2)
of ephedrine derivatives##2##3##(2008-10#2)
of ephedrine in ephedra callus##2##5##(2008-10#2)
of ephedrine in##3##3##(2008-10#3)
of ephedrine##6##2##(2008-10#6)
of epicatechin##4##2##(2008-10#4)
of epichlorohydrin in##2##3##(2008-10#2)
of epichlorohydrin##3##2##(2008-10#3)
of epidemic onset##3##3##(2008-10#3)
of epidemic##9##2##(1992-9#1)(2008-10#5)(2009-9#1)(2010-10#1)(2010-4#1)
of epidemics in##3##3##(1995-5#1)(2008-10#2)
of epidemics##11##2##(1995-5#1)(2008-10#8)(2013-1#2)
of epidemiologic##2##2##(2011-1#1)(2012-12#1)
of epidemiological##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2011-3#1)(2012-12#1)
of epidemiology##3##2##(1994-2#1)(2008-11#1)(2012-3#1)
of epidermal and cortical##2##4##(2008-10#1)(2008-12#1)
of epidermal and##3##3##(2008-10#2)(2008-12#1)
of epidermal cell##2##3##(2008-10#2)
of epidermal cells##4##3##(2008-10#2)(2008-7#2)
of epidermal glands in neotenic reproductives of##2##7##(2007-12#2)
of epidermal growth factor##2##4##(1994-8#1)(1995-11#1)
of epidermal hyperkeratosis##2##3##(2008-9#2)
of epidermal##21##2##(1992-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(2007-12#2)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#3)
of epidural##3##2##(1996-3#1)(2009-5#1)(2011-2#1)
of epigenetic changes##2##3##(2009-4#2)
of epigenetic##6##2##(2008-11#1)(2009-12#1)(2009-4#3)(2011-9#1)
of epilepsy patients and##2##4##(2009-9#1)(2010-8#1)
of epilepsy patients##3##3##(2009-9#1)(2010-8#2)
of epilepsy##11##2##(1990-3#1)(1992-9#1)(1994-2#2)(1997-8#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-8#2)(2011-1#1)
of epileptic seizures##2##3##(2008-5#1)(2010-8#1)
of epileptic##4##2##(2008-5#1)(2009-8#1)(2010-8#2)
of epinephrine in##3##3##(1990-5#1)(2008-10#2)
of epinephrine with##2##3##(1990-5#1)(2008-10#1)
of epinephrine##11##2##(1990-5#2)(2008-10#9)
of epiphytotics##2##2##(2008-10#2)
of epirubicin##3##2##(1991-6#2)(1993-2#1)
of episodic##3##2##(2008-1#1)(2008-9#2)
of epistasis##2##2##(2008-10#1)(2008-8#1)
of epithelial cells##5##3##(1991-11#1)(1991-8#1)(1993-11#1)(1995-2#1)(2008-7#1)
of epithelial origin##2##3##(1995-6#1)(2013-1#1)
of epithelial ovarian##3##3##(1994-12#1)(2009-5#1)(2011-1#1)
of epithelial proliferation##2##3##(1993-3#1)(1994-3#1)
of epithelial##24##2##(1991-11#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
of epithelial-myoepithelial carcinoma##2##3##(1991-6#2)
of equal##9##2##(1992-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)
of equations##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#2)
of equilibrated##2##2##(2008-10#1)(2008-5#1)
of equilibria##6##2##(2008-10#5)(2008-9#1)
of equilibrium between the##3##4##(1995-3#1)(2008-10#2)
of equilibrium concentrations of##2##4##(2008-10#2)
of equilibrium constants##2##3##(2008-10#2)
of equilibrium##15##2##(1995-3#1)(2008-10#12)(2009-5#1)(2013-8#1)
of equipment suitable for##2##4##(1996-3#2)
of equipment##7##2##(1996-3#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
of equivalence##4##2##(2008-10#3)(2008-3#1)
of equivalent##11##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-12#1)(2013-1#1)
of eradicating##2##2##(2008-10#1)(2012-2#1)
of eradication therapy##2##3##(1996-11#1)(2013-1#1)
of ergonomic problems##2##3##(2008-11#2)
of ergot##4##2##(1996-2#1)(2008-10#3)
of error in##3##3##(2008-10#2)(2008-3#1)
of error##13##2##(2007-11#1)(2008-10#8)(2008-3#2)(2008-6#1)(2009-8#1)
of errors in##2##3##(1996-2#1)(2008-3#1)
of errors on the##2##4##(2008-2#2)
of errors##13##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2012-12#1)(2013-1#1)
of erythrocyte##10##2##(1990-2#1)(1992-11#1)(1993-6#1)(1995-8#3)(1997-8#1)(2008-8#2)(2013-8#1)
of erythrocytes##2##2##(1990-2#1)(2012-12#1)
of erythroid differentiation##2##3##(1993-8#2)
of erythroid##7##2##(1993-8#2)(2008-11#1)(2008-9#4)
of erythromycin##2##2##(2008-7#2)
of erythropoietin##4##2##(1990-9#1)(1995-1#1)(2008-11#2)
of esca##3##2##(2008-10#3)
of escalating##2##2##(1993-9#1)(1995-2#1)
of escalation events##2##3##(2009-10#2)
of escape##4##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)
of escitalopram and##2##3##(2012-3#2)
of escitalopram##4##2##(2012-3#4)
of esophageal cancer##4##3##(2010-12#1)(2010-6#2)(2013-1#1)
of esophageal carcinoma##2##3##(1992-8#1)(1993-8#1)
of esophageal stents##2##3##(2013-1#2)
of esophageal##15##2##(1990-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1997-8#1)(2010-12#2)(2010-6#3)(2013-1#3)(2013-8#1)
of essential amino acids##2##4##(2010-4#2)
of essential and##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
of essential hypertension##3##3##(1993-2#1)(2008-7#1)(2011-2#1)
of essential oil##2##3##(2012-2#1)(2012-3#1)
of essential oils##5##3##(2008-10#3)(2008-12#1)(2013-1#1)
of essential##31##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
of established##4##2##(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
of establishing new##2##3##(2008-12#1)(2008-8#1)
of establishing the##2##3##(2008-12#1)(2013-1#1)
of establishing##10##2##(1993-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
of ester synthesis##2##3##(2011-1#2)
of ester##6##2##(1995-2#1)(2008-10#1)(2010-4#1)(2011-1#3)
of esters##2##2##(1995-6#1)(2011-1#1)
of estimated##6##2##(1991-7#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
of estimates of##2##3##(2008-10#1)(2008-6#1)
of estimates##3##2##(1992-9#1)(2008-10#1)(2008-6#1)
of estimating the frequency of recombination in##2##7##(2008-10#2)
of estimating the##5##3##(1995-9#1)(2008-10#3)(2011-2#1)
of estimating##6##2##(1995-9#1)(2008-10#3)(2011-2#1)(2013-8#1)
of estimation##3##2##(1997-3#1)(2008-10#1)(2013-1#1)
of estradiol (E2)##2##3##(1993-1#1)(1995-12#1)
of estradiol##5##2##(1993-1#1)(1995-12#1)(2008-11#2)(2012-3#1)
of estradiol-17 beta##2##3##(1992-9#1)(1994-3#1)
of estriol##2##2##(2008-10#2)
of estrogen and##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
of estrogen in##5##3##(1995-9#1)(2008-10#1)(2008-7#2)(2010-6#1)
of estrogen on##6##3##(2008-11#3)(2008-6#1)(2008-7#2)
of estrogen receptor alpha##2##4##(2008-12#2)
of estrogen receptor##11##3##(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(2008-11#4)(2008-12#2)(2010-5#1)
of estrogen receptors##3##3##(2008-11#3)
of estrogen##38##2##(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-11#13)(2008-12#3)(2008-6#3)(2008-7#5)(2010-5#1)(2010-6#1)(2011-1#2)(2013-1#1)
of estrogenic##2##2##(2008-10#2)
of estrogenicity##3##2##(2008-10#3)
of estrogens in the##2##4##(2008-12#1)(2012-2#1)
of estrogens in##6##3##(1995-12#1)(2008-10#2)(2008-12#2)(2012-2#1)
of estrogens##11##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2012-2#2)(2012-3#1)
of estrone##2##2##(1995-8#1)(2008-10#1)
of estrus##4##2##(2013-1#4)
of etching##2##2##(2008-2#1)(2013-1#1)
of ethanol absorption##3##3##(2008-11#3)
of ethanol and##8##3##(2008-10#6)(2008-5#1)(2012-2#1)
of ethanol in the organic phase##2##6##(2008-10#2)
of ethanol in the##3##4##(1997-2#1)(2008-10#2)
of ethanol in##10##3##(1990-5#1)(1997-2#1)(2008-10#8)
of ethanol on##3##3##(1992-6#1)(1992-7#1)(2009-7#1)
of ethanol with##4##3##(1992-6#1)(1993-8#1)(2008-10#2)
of ethanol##54##2##(1990-5#1)(1991-1#1)(1991-5#1)(1992-6#3)(1992-7#2)(1993-8#1)(1994-5#1)(1996-2#2)(1997-2#2)(2008-10#27)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
of ethanol's##4##2##(1997-2#3)(2009-7#1)
of ethanol-induced motor impairment##4##4##(1997-2#4)
of ethanol-induced motor incoordination##3##4##(1997-2#3)
of ethanol-induced motor##7##3##(1997-2#7)
of ethanolic extract of##4##4##(2008-10#2)(2008-12#2)
of ethanolic extract##5##3##(2008-10#3)(2008-12#2)
of ethical##5##2##(1991-3#1)(2008-12#3)(2009-4#1)
of ethidium bromide##2##3##(1990-2#1)(2008-10#1)
of ethinylestradiol##2##2##(2008-10#2)
of ethirimol##2##2##(2008-10#2)
of ethnicity##2##2##(2009-7#1)(2010-1#1)
of ethyl acetate##5##3##(2008-10#4)(2012-2#1)
of ethyl alcohol##3##3##(1990-5#1)(2008-10#2)
of ethyl##15##2##(1990-5#1)(1993-1#2)(1996-5#1)(2008-10#8)(2011-1#1)(2012-2#1)(2012-3#1)
of ethylarsine dichloride##2##3##(2008-11#2)
of ethylene production##2##3##(2008-10#2)
of ethylene##9##2##(2008-10#7)(2008-2#1)(2008-3#1)
of etiologic##2##2##(1995-5#1)(2008-11#1)
of etiology##4##2##(1991-2#1)(1991-6#1)(2010-7#1)(2013-1#1)
of etodolac##4##2##(2008-10#4)
of eucalyptus wood residue##2##4##(2009-3#2)
of eucalyptus##3##2##(2008-10#1)(2009-3#2)
of eukaryotes are##2##3##(2009-6#2)
of eukaryotes##6##2##(1995-8#1)(1997-7#1)(2008-11#1)(2009-6#2)(2010-8#1)
of eukaryotic cells##7##3##(1993-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2013-8#1)
of eukaryotic nucleus##2##3##(2008-8#2)
of eukaryotic##23##2##(1990-7#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-8#1)
of europium (III)##5##3##(2008-10#5)
of europium##11##2##(2008-10#11)
of europium(III)##2##2##(2008-10#2)
of euthanasia##3##2##(1991-8#1)(2009-7#1)(2012-12#1)
of evaluating and##3##3##(2007-11#1)(2008-6#1)(2008-9#1)
of evaluating the##5##3##(1994-2#1)(2008-10#2)(2008-11#1)(2012-3#1)
of evaluating##11##2##(1994-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
of evaluation##5##2##(1992-1#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
of even order##2##3##(2008-8#1)(2013-1#1)
of even##8##2##(1991-3#1)(1992-3#1)(1997-1#1)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
of event##6##2##(1992-9#1)(1993-3#1)(1997-3#1)(2008-11#1)(2012-2#2)
of events and##2##3##(2008-11#1)(2009-9#1)
of events during##2##3##(1995-2#1)(2012-3#1)
of events leading to the##2##5##(1991-5#1)(1996-9#1)
of events leading to##3##4##(1991-5#1)(1996-9#1)(2008-12#1)
of events leading##4##3##(1990-9#1)(1991-5#1)(1996-9#1)(2008-12#1)
of events was##2##3##(2008-10#1)(2013-8#1)
of events##25##2##(1990-9#1)(1991-5#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-8#1)(1995-2#1)(1996-9#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2009-6#2)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
of eventual##2##2##(2011-2#2)
of every##13##2##(1991-6#1)(1993-11#2)(1993-8#1)(1995-12#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#2)(2013-1#1)
of everyday##2##2##(2009-7#1)(2011-2#1)
of evidence as##2##3##(2008-11#1)(2008-8#1)
of evidence based practice##3##4##(2008-11#3)
of evidence for a##2##4##(1991-12#1)(1993-8#1)
of evidence for##5##3##(1991-12#1)(1993-8#1)(1994-3#1)(2010-10#1)(2012-12#1)
of evidence in the##2##4##(1993-12#1)(2010-12#1)
of evidence indicate that##5##4##(1996-6#1)(2008-7#2)(2009-7#1)(2011-2#1)
of evidence is##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
of evidence on##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
of evidence suggesting that##2##4##(2008-10#1)(2008-12#1)
of evidence##58##2##(1990-9#1)(1991-12#1)(1992-3#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-2#1)(1996-6#2)(2008-10#4)(2008-11#8)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-10#1)(2011-2#3)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
of evidence-based policies##3##3##(2008-11#3)
of evidence-based practice##3##3##(2008-11#2)(2008-12#1)
of evidence-based##15##2##(2008-10#1)(2008-11#6)(2008-12#1)(2009-3#2)(2010-10#2)(2010-11#2)(2010-12#1)
of evoked##2##2##(1996-2#1)(2009-6#1)
of evolution and##3##3##(1990-3#1)(2008-9#1)(2011-2#1)
of evolution is##2##3##(1997-6#2)
of evolution of##4##3##(2008-8#3)(2008-9#1)
of evolution##24##2##(1990-3#1)(1991-3#1)(1994-11#1)(1997-6#3)(2008-5#1)(2008-8#7)(2008-9#3)(2009-8#2)(2010-5#2)(2011-2#2)(2012-3#1)
of evolutionarily##3##2##(1994-6#1)(2008-11#1)(2008-8#1)
of evolutionary biology##2##3##(2008-8#1)(2009-6#1)
of evolutionary change##3##3##(2008-8#1)(2010-4#1)(2012-3#1)
of evolutionary games##2##3##(2013-8#2)
of evolutionary strategies##2##3##(1997-6#2)
of evolutionary##18##2##(1997-6#4)(2008-4#1)(2008-8#4)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-8#2)
of evolved##3##2##(2008-10#2)(2012-3#1)
of ex vivo##2##3##(2008-4#1)(2008-5#1)
of exacerbations and##2##3##(2008-7#1)(2011-2#1)
of exacerbations##6##2##(2008-5#1)(2008-7#1)(2011-2#4)
of examination and##2##3##(1997-8#1)(2012-3#1)
of examination##4##2##(1991-12#2)(1997-8#1)(2012-3#1)
of examinations##3##2##(1991-7#1)(1992-5#1)(2013-1#1)
of examined##2##2##(2008-10#1)(2011-2#1)
of examining##8##2##(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#1)
of examples##2##2##(2012-2#1)(2012-3#1)
of excellence##3##2##(1992-1#1)(1992-3#1)(2013-1#1)
of excellent##5##2##(1993-3#1)(2008-10#2)(2008-4#1)(2010-6#1)
of excess demand are##2##4##(1995-2#1)(2008-11#1)
of excess demand##3##3##(1995-2#2)(2008-11#1)
of excess of##5##3##(1991-6#1)(2008-10#4)
of excess##24##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1994-11#1)(1995-11#1)(1995-2#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
of excessive mastocytes##2##3##(1991-11#2)
of excessive##7##2##(1991-11#2)(1992-5#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#1)
of exchange##2##2##(2008-10#2)
of excipients##3##2##(2012-2#3)
of excised##3##2##(2008-10#2)(2008-5#1)
of excitability in##2##3##(1991-2#1)(2011-2#1)
of excitable##2##2##(2009-9#1)(2012-3#1)
of excitation and emission##6##4##(2008-10#6)
of excitation##7##2##(2008-10#7)
of excitatory##5##2##(1997-2#2)(1997-4#2)(2008-11#1)
of exclusive##3##2##(2008-8#1)(2010-11#1)(2010-6#1)
of excretion##2##2##(2008-10#1)(2008-6#1)
of executive##7##2##(1994-12#1)(1995-12#1)(2009-10#1)(2013-8#4)
of exercise programs for OA##2##5##(2013-1#2)
of exercise programs##4##3##(2013-1#4)
of exercise training##4##3##(2009-10#1)(2013-1#3)
of exercise##35##2##(1990-3#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-1#3)(2011-2#2)(2012-2#1)(2013-1#14)(2013-8#2)
of exercise-induced##4##2##(2008-5#2)(2010-1#1)(2010-6#1)
of exhaled##2##2##(2008-10#1)(2010-5#1)
of existence##2##2##(2007-8#1)(2013-8#1)
of existing##26##2##(1992-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-11#1)(2010-5#2)(2011-2#1)(2012-3#2)
of exocytosis##3##2##(1992-6#2)(2012-2#1)
of exogenous double-stranded RNA##2##4##(2008-9#2)
of exogenous growth factors##2##4##(2008-11#2)
of exogenous##29##2##(1990-11#1)(1990-8#1)(1992-9#1)(1994-12#1)(1997-7#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#8)(2010-12#1)(2010-8#1)(2011-10#1)(2012-3#3)(2013-7#1)
of exogenously supplied##2##3##(2008-10#1)(2008-11#1)
of exoglc1 was##2##3##(2008-10#2)
of exoglycosidases##3##2##(1993-12#1)(2009-8#2)
of exon##4##2##(1993-6#1)(1997-3#1)(1997-7#1)(2008-10#1)
of exons##6##2##(1991-5#1)(1991-6#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-9#1)
of exotic species##3##3##(2010-3#3)
of exotic##6##2##(2008-10#1)(2008-8#1)(2010-3#3)(2012-2#1)
of expander-implant##2##2##(2013-1#2)
of expanding##4##2##(1996-1#1)(2008-10#1)(2013-1#2)
of expectations and##2##3##(2008-9#1)(2013-1#1)
of expectations##3##2##(1995-1#1)(2008-9#1)(2013-1#1)
of expected##4##2##(1992-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
of expenditure##3##2##(1991-2#1)(2008-9#2)
of expenditures##6##2##(1990-11#1)(1991-12#1)(1992-12#1)(1995-12#1)(1995-2#1)(1997-3#1)
of expensive##3##2##(1992-12#1)(1993-11#1)(2008-10#1)
of experience and##2##3##(1994-3#1)(2008-1#1)
of experience in##4##3##(1991-9#1)(1993-12#1)(2008-9#1)(2010-12#1)
of experience##19##2##(1991-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
of experienced##5##2##(1991-6#1)(2008-11#1)(2010-12#1)(2012-2#2)
of experiences##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
of experiential##4##2##(1996-1#2)(2008-11#2)
of experiment##6##2##(2007-8#1)(2008-10#4)(2008-8#1)
of experimental and##2##3##(2008-10#1)(2012-12#1)
of experimental animals##3##3##(2008-4#1)(2010-7#1)(2013-1#1)
of experimental conditions##5##3##(2008-10#4)(2008-4#1)
of experimental data##10##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2013-8#1)
of experimental design and##2##4##(2008-10#1)(2008-8#1)
of experimental design##3##3##(2008-10#2)(2008-8#1)
of experimental designs##2##3##(2008-7#1)(2012-12#1)
of experimental factors##2##3##(2008-10#1)(2011-2#1)
of experimental parameters##8##3##(1997-2#1)(2008-10#7)
of experimental variables##2##3##(2008-10#2)
of experimental##67##2##(1991-12#1)(1991-2#1)(1993-3#1)(1994-9#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#27)(2008-11#4)(2008-12#2)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
of experimentally induced##2##3##(2009-11#1)(2012-3#1)
of experimentally##8##2##(1995-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-7#2)(2012-3#1)
of experiments was##2##3##(1993-8#1)(2008-8#1)
of experiments were##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
of experiments##32##2##(1992-6#1)(1993-3#2)(1993-8#2)(1994-12#1)(1996-2#1)(2008-10#9)(2008-11#4)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-8#1)
of expert##4##2##(1993-12#1)(1995-2#1)(2008-11#1)(2008-5#1)
of expertise##5##2##(1990-11#1)(1992-1#1)(1996-2#1)(2008-11#1)(2011-2#1)
of experts##2##2##(2011-10#2)
of explanatory variables##2##3##(2008-4#1)(2010-1#1)
of explants##2##2##(2008-12#1)(2008-8#1)
of explicit##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
of exploitation##3##2##(1995-5#3)
of exploration##2##2##(1991-6#1)(1993-6#1)
of exploratory##2##2##(1993-6#1)(2008-10#1)
of explosion##2##2##(2009-10#2)
of explosive compounds##2##3##(2008-10#2)
of explosive##7##2##(2008-10#6)(2009-10#1)
of explosives and##2##3##(2008-10#2)
of explosives##15##2##(2008-10#15)
of exponential growth##4##3##(2008-11#1)(2008-7#2)(2009-12#1)
of exponential##5##2##(2008-11#2)(2008-7#2)(2009-12#1)
of exposed groups was similar to that of control groups##2##10##(2008-9#2)
of exposed individuals##2##3##(1991-12#2)
of exposed males##2##3##(2008-9#2)
of exposed##7##2##(1991-12#2)(2008-9#4)(2011-2#1)
of exposure and##3##3##(1995-2#1)(2008-10#2)
of exposure compared##2##3##(1995-3#1)(2008-5#1)
of exposure in##2##3##(1991-12#1)(2008-7#1)
of exposure of the##2##4##(2008-11#1)(2008-8#1)
of exposure of##3##3##(1996-2#1)(2008-11#1)(2008-8#1)
of exposure on##2##3##(2008-10#1)(2012-4#1)
of exposure to a##2##4##(2008-11#1)(2012-12#1)
of exposure to asbestos##2##4##(1991-12#2)
of exposure to the##2##4##(2008-4#1)(2013-1#1)
of exposure to##27##3##(1991-12#2)(1993-1#1)(1994-3#1)(1996-12#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
of exposure##64##2##(1991-12#4)(1993-1#1)(1994-3#1)(1995-2#1)(1995-3#4)(1996-12#1)(1996-2#2)(1996-3#2)(2008-10#18)(2008-11#5)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#3)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2012-5#1)(2013-1#1)
of exposures##3##2##(1991-12#1)(1996-12#1)(2008-10#1)
of expressed sequence tags (ESTs)##4##5##(1995-8#1)(1997-6#1)(2010-4#1)(2013-8#1)
of expressed sequence tags##5##4##(1995-8#1)(1997-6#1)(2010-4#2)(2013-8#1)
of expressed##9##2##(1995-2#1)(1995-8#1)(1997-6#1)(2008-2#1)(2008-8#1)(2010-4#2)(2012-3#1)(2013-8#1)
of expressing##7##2##(1993-9#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
of expression for##2##3##(2008-10#1)(2011-1#1)
of expression in##4##3##(1993-6#1)(1997-1#1)(1997-6#1)(1997-7#1)
of expression of the reporter gene##2##6##(2008-11#1)(2011-1#1)
of expression of the##14##4##(1993-3#1)(1994-11#1)(1995-8#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#1)
of expression of##26##3##(1993-3#1)(1994-11#1)(1994-2#1)(1995-8#2)(1995-9#1)(1996-12#1)(2008-10#3)(2008-11#6)(2008-7#1)(2008-9#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2012-2#1)
of expression vectors##2##3##(1991-6#1)(1993-2#1)
of expression##65##2##(1990-8#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-12#4)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-11#8)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#4)(2012-2#2)(2012-3#1)(2013-8#1)
of expressive##3##2##(2008-11#1)(2008-12#1)(2009-8#1)
of extant##2##2##(2007-12#1)(2008-4#1)
of extended colostrum feeding on##2##5##(2012-2#2)
of extended extinction##2##3##(2008-5#2)
of extended##11##2##(1990-8#1)(2008-10#3)(2008-5#2)(2010-11#1)(2012-2#3)(2013-1#1)
of extended-MDR##2##2##(2008-11#2)
of extension##4##2##(1995-12#1)(1997-2#2)(2008-11#1)
of extensive##11##2##(1994-5#1)(1997-3#1)(2008-10#2)(2008-11#3)(2009-12#1)(2010-6#1)(2012-3#1)(2013-7#1)
of extensor muscle afferents##2##4##(1997-2#2)
of extensor muscle##3##3##(1997-2#3)
of extensor##5##2##(1997-2#3)(2010-3#1)(2012-2#1)
of exterior##2##2##(1993-2#2)
of external and internal##2##4##(2008-4#1)(2010-8#1)
of external fixation##2##3##(2008-8#2)
of external##30##2##(1990-5#1)(1991-11#1)(1993-3#1)(1996-6#2)(1996-8#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)
of extinction error##2##3##(2008-3#2)
of extinction of##2##3##(2008-9#1)(2009-8#1)
of extinction##13##2##(1991-5#1)(2008-3#3)(2008-5#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
of extra-hepatic##2##2##(1992-9#1)(2008-10#1)
of extracellular Ca2+##4##3##(1991-5#1)(1991-6#1)(1994-6#1)(1996-12#1)
of extracellular K+##2##3##(1994-2#1)(1997-1#1)
of extracellular calcium##4##3##(1990-5#1)(1994-11#1)(1994-3#2)
of extracellular matrix (ECM)##3##4##(2009-10#1)(2009-12#1)(2013-8#1)
of extracellular matrix genes##2##4##(1990-5#1)(1992-8#1)
of extracellular matrix##8##3##(1990-5#1)(1992-8#1)(1994-12#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-8#1)
of extracellular purines##2##3##(2013-8#2)
of extracellular signal-regulated kinase##2##4##(2010-12#1)(2011-2#1)
of extracellular signals##3##3##(1994-11#1)(1995-2#1)(2009-8#1)
of extracellular##52##2##(1990-5#2)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#7)(2008-11#4)(2008-4#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#1)(2010-12#2)(2011-2#4)(2013-8#4)
of extrachromosomal##2##2##(2007-12#1)(2008-10#1)
of extracorporeal##2##2##(1997-6#1)(2008-11#1)
of extracranial##4##2##(1992-5#1)(2008-7#2)(2012-3#1)
of extract from##3##3##(1996-12#1)(2008-10#2)
of extract of Apocynum venetum##2##5##(2011-3#2)
of extract were added to##2##5##(2008-10#1)(2008-12#1)
of extract##9##2##(1996-12#1)(2008-10#3)(2008-12#3)(2011-3#2)
of extractable arsenic in##2##4##(2008-10#2)
of extractable##6##2##(2008-10#5)(2008-11#1)
of extractant##2##2##(2008-10#2)
of extractants##3##2##(2008-10#3)
of extracted##7##2##(1991-3#1)(2008-10#6)
of extracting##2##2##(2008-10#2)
of extraction and##3##3##(2008-10#3)
of extraction are##2##3##(2008-10#2)
of extraction of##4##3##(2008-10#3)(2012-2#1)
of extraction was##2##3##(2008-10#2)
of extraction##37##2##(2008-10#35)(2012-2#1)(2013-8#1)
of extracts from##5##3##(1990-12#1)(2008-10#3)(2012-3#1)
of extracts of##2##3##(1993-6#1)(2008-10#1)
of extracts##14##2##(1990-12#1)(1993-6#1)(2008-10#10)(2010-2#1)(2012-3#1)
of extradural anterior clinoidectomy via the trans-SOF approach##2##8##(2011-2#2)
of extrathoracic##2##2##(2008-11#1)(2008-7#1)
of extreme outgroups##2##3##(2008-11#2)
of extreme##9##2##(2008-10#3)(2008-11#3)(2010-1#1)(2011-2#1)(2013-1#1)
of extremely low##3##3##(1991-6#1)(2008-10#1)(2011-2#1)
of extremely short##2##3##(2008-2#2)
of extremely##7##2##(1991-6#1)(2008-10#1)(2008-2#2)(2008-8#1)(2011-2#1)(2013-1#1)
of extrinsic phospholipid##3##3##(2008-9#3)
of extrinsic##7##2##(2008-9#4)(2010-12#1)(2010-3#1)(2011-2#1)
of exudative##3##2##(2010-9#1)(2013-1#1)(2013-8#1)
of eye##7##2##(1990-11#1)(1993-11#1)(2008-6#1)(2010-10#1)(2011-2#1)(2011-7#1)(2013-8#1)
of eyes##2##2##(2010-10#1)(2011-2#1)
of eyespot##3##2##(2008-10#2)(2008-9#1)
of fMRI##2##2##(2008-11#2)
of fabricating##2##2##(2008-10#1)(2013-1#1)
of fabrication errors and##2##4##(2008-3#2)
of fabrication errors##3##3##(2008-2#1)(2008-3#2)
of fabrication##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
of fac-Re(CO)(3)(dpknph)Cl##12##2##(2008-10#12)
of face##3##2##(2008-11#2)(2009-10#1)
of faces and##2##3##(2009-10#1)(2009-8#1)
of faces##7##2##(1991-11#1)(2008-11#1)(2009-10#3)(2009-8#1)(2013-8#1)
of facial cellulitis##2##3##(2013-1#2)
of facial expression##2##3##(2008-11#2)
of facial expressions##5##3##(2008-11#4)(2009-8#1)
of facial##21##2##(1993-1#1)(1997-2#1)(2008-11#6)(2008-12#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
of facilitating##3##2##(1991-1#1)(2008-12#1)(2009-9#1)
of facilitators##2##2##(2010-10#2)
of facilities##5##2##(1992-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(2010-8#1)
of facility##5##2##(1992-2#3)(1994-1#1)(2008-2#1)
of factor 2##2##3##(1995-2#2)
of factor H##2##3##(2009-6#2)
of factor IX##2##3##(1995-2#1)(2008-9#1)
of factor VIII##2##3##(2011-2#2)
of factor XI by##2##4##(1991-9#2)
of factor XIII##4##3##(2008-11#4)
of factor b##2##3##(1993-12#2)
of factor##22##2##(1991-9#2)(1993-12#2)(1994-5#2)(1995-2#3)(2008-10#2)(2008-11#5)(2008-8#1)(2008-9#1)(2009-6#2)(2011-2#2)
of factorial##3##2##(2008-10#2)(2008-5#1)
of factors and##2##3##(2008-10#2)
of factors associated with##2##4##(1996-3#1)(2012-2#1)
of factors by##2##3##(1991-2#1)(2008-4#1)
of factors including##2##3##(2008-11#1)(2013-8#1)
of factors influencing##4##3##(1994-3#1)(1997-1#1)(2008-7#1)(2009-5#1)
of factors that influence the##3##5##(1993-11#1)(1995-9#1)(2008-9#1)
of factors that##9##3##(1993-11#1)(1993-3#1)(1995-2#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-2#1)
of factors##60##2##(1990-12#1)(1991-2#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-8#2)
of faculty##7##2##(1993-2#1)(1996-1#1)(2008-11#3)(2008-12#1)(2013-1#1)
of failed##2##2##(2010-5#1)(2010-7#1)
of failure and##3##3##(2008-11#1)(2009-4#1)(2011-2#1)
of failure of##3##3##(2008-11#1)(2009-10#1)(2012-12#1)
of failure##14##2##(1991-2#1)(1994-12#1)(1996-3#2)(2008-11#2)(2009-10#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-12#2)(2012-3#2)
of fairness##2##2##(1992-2#1)(1994-3#1)
of faith development##2##3##(2008-12#1)(2011-1#1)
of faith##4##2##(2008-12#2)(2009-11#1)(2011-1#1)
of falciparum malaria##2##3##(2011-2#1)(2012-3#1)
of fall##2##2##(2008-10#1)(2010-11#1)
of falls##2##2##(2008-7#2)
of false negative results##2##4##(1997-2#1)(2008-10#1)
of false positives##3##3##(2008-10#2)(2011-2#1)
of false##8##2##(1997-2#2)(1997-4#1)(2008-10#3)(2008-11#1)(2011-2#1)
of false-negatives##5##2##(2010-10#1)(2012-12#4)
of false-positives##2##2##(2010-10#1)(2012-12#1)
of familial parkinsonism##2##3##(2008-7#2)
of familial##12##2##(1992-9#2)(1995-8#1)(2008-10#1)(2008-4#1)(2008-7#3)(2009-12#1)(2010-4#1)(2010-7#1)(2012-3#1)
of familiarity##2##2##(2008-8#1)(2011-2#1)
of families##7##2##(1993-2#1)(1994-1#1)(1995-1#1)(1995-5#1)(1996-2#1)(2011-2#1)(2012-12#1)
of family and##2##3##(2010-8#1)(2013-1#1)
of family connectedness##3##3##(2010-10#3)
of family dinners##5##3##(2013-1#5)
of family functioning##2##3##(2013-1#2)
of family members##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
of family planning clinics##2##4##(1991-1#1)(1994-8#1)
of family planning##6##3##(1991-1#3)(1994-8#3)
of family support##2##3##(1995-1#1)(2008-7#1)
of family##57##2##(1991-1#4)(1991-12#1)(1991-8#2)(1992-1#1)(1993-11#1)(1994-1#1)(1994-8#3)(1995-1#2)(1996-3#1)(1996-6#1)(1997-4#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#3)(2009-12#1)(2010-10#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#9)
of family-centered pediatric care##2##4##(2010-9#2)
of family-centered##4##2##(1994-3#2)(2010-9#2)
of famotidine were##2##3##(2008-10#2)
of famotidine##4##2##(2008-10#4)
of farm##3##2##(1990-3#1)(2008-10#1)(2008-11#1)
of farms##2##2##(2008-10#1)(2010-1#1)
of fascia##4##2##(1991-2#1)(2009-9#2)(2013-1#1)
of fascial##5##2##(1991-2#2)(1992-1#1)(2008-9#1)(2009-9#1)
of fasciolosis##2##2##(2008-12#2)
of fast analysis##2##3##(2008-10#1)(2010-9#1)
of fast and##2##3##(2008-10#1)(2012-2#1)
of fast##10##2##(2007-12#2)(2008-10#4)(2008-3#1)(2010-9#1)(2012-2#2)
of fast-twitch##2##2##(1996-2#2)
of fasting and refeeding on##2##5##(2008-7#2)
of fasting##6##2##(1991-7#2)(1992-9#1)(2008-7#3)
of fat and##2##3##(2008-10#1)(2012-2#1)
of fat grafting##3##3##(2013-1#3)
of fat injection##3##3##(2011-2#1)(2013-1#2)
of fat necrosis##3##3##(2013-1#3)
of fat##21##2##(1995-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#8)
of fatigue##4##2##(2009-7#1)(2010-8#2)(2013-1#1)
of fatty acid methyl esters##3##5##(2008-10#3)
of fatty acid synthesis##3##4##(1992-4#1)(1992-8#1)(1995-6#1)
of fatty acid##16##3##(1992-4#3)(1992-6#1)(1992-8#1)(1993-3#1)(1995-6#2)(1996-6#1)(2008-10#4)(2008-6#1)(2008-7#1)(2010-4#1)
of fatty acids from##4##4##(2008-10#2)(2008-6#1)(2009-8#1)
of fatty acids in##2##4##(2012-2#1)(2012-3#1)
of fatty acids##16##3##(1992-8#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#2)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of fatty liver deposition##2##4##(2012-2#2)
of fatty tissue##2##3##(1993-3#1)(2008-1#1)
of fatty##38##2##(1992-4#3)(1992-6#1)(1992-8#2)(1993-3#2)(1994-8#1)(1995-6#2)(1996-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-8#2)(2010-12#1)(2010-4#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
of fear of##2##3##(1996-6#2)
of fear##7##2##(1996-6#2)(2008-11#2)(2009-8#1)(2010-2#1)(2010-9#1)
of feather##2##2##(2008-5#1)(2008-9#1)
of feature##2##2##(2013-8#2)
of features##7##2##(1995-2#1)(2008-6#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
of febrile##5##2##(1993-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
of fecal##4##2##(1995-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
of feces in a loop of sigmoid colon##2##8##(2008-12#2)
of feces##4##2##(2008-10#2)(2008-12#2)
of federal and state##3##4##(1996-1#2)(2008-10#1)
of federal##8##2##(1992-3#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2011-9#1)
of feed rate on##2##4##(2008-11#2)
of feed##12##2##(2008-10#5)(2008-11#3)(2008-12#3)(2008-5#1)
of feedback##7##2##(1996-12#1)(2009-10#3)(2011-2#1)(2013-8#2)
of feeding and##2##3##(2008-8#2)
of feeding difficulties and##2##4##(2010-9#2)
of feeding difficulties##3##3##(2010-9#3)
of feeding##22##2##(1993-6#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-8#1)(2010-5#1)(2010-9#3)(2012-12#1)
of feline immunodeficiency virus##2##4##(1997-3#2)
of feline##6##2##(1997-3#2)(2008-11#3)(2013-8#1)
of female and male##3##4##(1990-3#1)(2008-12#1)(2010-4#1)
of female breast##2##3##(1990-12#1)(1992-2#1)
of female managers##2##3##(2012-3#2)
of female migration to##2##4##(2011-2#2)
of female rats##4##3##(1990-11#1)(1995-8#2)(2013-1#1)
of female sexual##2##3##(1993-9#1)(2009-10#1)
of female##45##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-8#2)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#4)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-3#3)(2013-1#2)
of female-searching males##2##3##(2008-6#2)
of female-searching##3##2##(2008-6#3)
of females and##2##3##(2008-9#1)(2013-8#1)
of females in the##2##4##(2008-9#2)
of females with##2##3##(1991-5#1)(2012-2#1)
of females##27##2##(1990-6#1)(1991-5#1)(1994-6#3)(2007-12#3)(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#9)(2009-8#1)(2012-2#2)(2013-8#1)
of feminine##2##2##(2009-10#2)
of femoral neck fractures##2##4##(1991-9#2)
of femoral neck##3##3##(1991-9#2)(2011-2#1)
of femtosecond optical##2##3##(2007-11#1)(2008-3#1)
of femtosecond##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
of ferbam in##2##3##(2008-10#2)
of ferbam##6##2##(2008-10#6)
of fermentation and##2##3##(2008-7#2)
of fermentation##8##2##(2008-10#2)(2008-11#1)(2008-7#4)(2012-3#1)
of fermented##2##2##(2010-4#1)(2011-1#1)
of fermenting##2##2##(2008-10#1)(2012-3#1)
of ferric##3##2##(2008-10#2)(2008-11#1)
of ferriprotoporphyrin IX##2##3##(1993-8#2)
of ferritin in##3##3##(1993-11#1)(2008-10#2)
of ferritin##10##2##(1990-5#3)(1993-11#1)(2008-10#4)(2013-8#2)
of ferrous##5##2##(1992-8#1)(2008-10#1)(2008-11#2)(2008-5#1)
of fertility##2##2##(2008-8#1)(2009-10#1)
of fertilization##4##2##(1994-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
of fertilized eggs##2##3##(2008-11#1)(2010-8#1)
of fertilizer##2##2##(1996-12#1)(2008-12#1)
of ferulic acid by##2##4##(1994-5#1)(2008-10#1)
of ferulic acid##11##3##(1994-5#5)(2008-10#5)(2008-5#1)
of fetal alcohol syndrome (fas)##2##5##(2008-11#2)
of fetal alcohol##3##3##(2008-11#3)
of fetal##23##2##(1990-11#2)(1990-6#1)(1992-6#1)(1994-3#2)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#5)(2008-7#1)(2008-9#1)(2010-11#2)(2012-2#1)(2012-3#2)(2013-1#1)
of fever##15##2##(1994-12#1)(1994-3#3)(1997-4#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-3#2)
of feverfew##2##2##(2008-10#2)
of few##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
of few-tillering##2##2##(2008-9#2)
of fewer##3##2##(1991-3#1)(2008-10#1)(2010-10#1)
of fiber##9##2##(1991-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-12#1)(2009-7#1)(2013-8#1)
of fibers##3##2##(1991-1#1)(2008-10#1)(2010-4#1)
of fibre##4##2##(2008-10#1)(2009-7#2)(2010-4#1)
of fibrils##4##2##(1994-5#1)(2008-5#1)(2008-7#2)
of fibrin##4##2##(1992-3#1)(1995-3#1)(2010-6#1)(2011-2#1)
of fibrinogen##12##2##(1993-8#3)(1994-5#2)(1995-2#3)(2006-6#1)(2008-10#3)
of fibroblast##4##2##(1997-1#1)(2008-11#1)(2008-5#1)(2012-3#1)
of fibroblasts with##2##3##(1994-5#1)(1995-3#1)
of fibroblasts##5##2##(1994-5#1)(1995-3#2)(2008-5#1)(2012-3#1)
of fibromyalgia##2##2##(2009-11#1)(2013-1#1)
of fibronectin##4##2##(1992-3#1)(1994-11#1)(2008-11#1)(2012-2#1)
of fibrotic##2##2##(2008-1#1)(2008-5#1)
of fibrous tissue##3##3##(2008-10#1)(2008-9#1)(2010-5#1)
of fibrous tremolite##2##3##(1991-12#2)
of fibrous##9##2##(1991-12#2)(2008-10#2)(2008-11#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
of field and##4##3##(2008-10#3)(2008-12#1)
of field data##3##3##(2008-10#2)(2008-8#1)
of field experiments##3##3##(2008-10#1)(2008-12#2)
of field incidence##2##3##(2008-10#2)
of field populations of##4##4##(2008-10#4)
of field populations##5##3##(2008-10#5)
of field soil##2##3##(2008-10#2)
of field##43##2##(1994-3#1)(1996-1#1)(2008-10#28)(2008-12#3)(2008-3#5)(2008-8#1)(2010-9#1)(2011-8#1)(2012-12#1)(2012-8#1)
of field-grown##4##2##(2008-10#4)
of fields in##2##3##(2008-10#1)(2008-3#1)
of fields that is sprayed##2##5##(2008-10#2)
of fields##7##2##(1990-11#1)(2008-10#3)(2008-3#1)(2010-1#1)(2011-8#1)
of fifteen isolates identified as##2##5##(2008-10#2)
of fifteen##5##2##(1994-2#1)(2008-10#2)(2009-8#1)(2012-2#1)
of fifty##2##2##(1996-3#1)(2008-5#1)
of fig##2##2##(2008-10#2)
of fights##2##2##(2008-9#2)
of filament##3##2##(1993-8#1)(2008-8#1)(2009-10#1)
of filamentous actin##2##3##(2008-9#1)(2011-2#1)
of filamentous fungi##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
of filamentous material##2##3##(2008-10#2)
of filamentous##11##2##(1993-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
of filling##2##2##(1993-1#1)(2013-1#1)
of film thickness##2##3##(2008-10#2)
of film##6##2##(2008-10#5)(2008-5#1)
of films##4##2##(2008-10#1)(2008-12#3)
of filter paper##2##3##(2008-10#2)
of filter radiometers##2##3##(2008-2#2)
of filter##7##2##(1993-3#1)(2008-10#3)(2008-2#2)(2010-8#1)
of filters##2##2##(1993-3#1)(2008-10#1)
of fimbrial##2##2##(1996-6#1)(2008-10#1)
of final##11##2##(1995-5#1)(1996-5#1)(2008-10#3)(2008-11#3)(2008-9#1)(2010-4#1)(2012-2#1)
of financial and##2##3##(1995-12#1)(1997-3#1)
of financial##10##2##(1994-1#1)(1995-12#1)(1995-2#1)(1996-3#2)(1997-3#1)(2008-11#3)(2011-2#1)
of financing##4##2##(1992-1#1)(1994-2#1)(1996-3#1)(2008-11#1)
of finasteride##3##2##(2008-5#2)(2012-3#1)
of finding##5##2##(1996-1#1)(2008-10#1)(2008-12#1)(2011-2#2)
of findings are##2##3##(1992-12#1)(1995-3#1)
of findings by##3##3##(1990-2#1)(1996-2#1)(2011-2#1)
of findings##11##2##(1990-2#1)(1990-6#1)(1992-12#1)(1992-3#1)(1995-3#1)(1996-2#1)(2008-11#2)(2009-7#1)(2010-5#1)(2011-2#1)
of fine needle aspiration##2##4##(1990-6#1)(1991-3#1)
of fine needle##3##3##(1990-6#1)(1991-3#1)(1997-2#1)
of fine##9##2##(1990-6#1)(1991-3#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-4#1)
of fine-needle##2##2##(2008-9#1)(2011-1#1)
of finger##4##2##(2013-1#1)(2013-8#3)
of fingers in##2##3##(2013-8#2)
of fingers##3##2##(2011-1#1)(2013-8#2)
of finished##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
of finite##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
of finite-length##2##2##(2008-10#1)(2008-2#1)
of fire blight by##2##4##(2008-10#2)
of fire blight##16##3##(2008-10#16)
of fire##19##2##(1994-12#1)(1996-12#1)(2008-10#17)
of firing##2##2##(2008-8#1)(2009-10#1)
of first year##2##3##(2008-12#1)(2013-1#1)
of first##27##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-8#1)(1994-3#1)(1995-12#1)(2008-10#4)(2008-12#3)(2008-3#1)(2008-7#2)(2009-7#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#3)
of first- and second-order comparator##2##5##(2008-5#2)
of first-line##2##2##(1996-11#1)(1997-2#1)
of first-order##2##2##(1992-3#1)(2008-3#1)
of fiscal##2##2##(1995-3#1)(1997-2#1)
of fish feces##2##3##(2008-10#2)
of fish feed##2##3##(2008-10#2)
of fish freshness##5##3##(2008-10#5)
of fish in the water##2##5##(2008-2#2)
of fish spoilage##2##3##(2008-10#2)
of fish##34##2##(2008-10#15)(2008-11#4)(2008-12#2)(2008-2#2)(2008-7#1)(2008-8#1)(2010-1#2)(2010-8#3)(2011-2#3)(2012-3#1)
of fishes##3##2##(2010-8#2)(2012-2#1)
of fission##2##2##(2008-10#1)(2009-6#1)
of fit##7##2##(1995-9#1)(2009-10#6)
of fitness##6##2##(2008-8#3)(2008-9#2)(2013-1#1)
of fitting##2##2##(2008-10#1)(2008-11#1)
of five cases##5##3##(1991-8#1)(2008-10#1)(2008-7#1)(2009-12#2)
of five different variables##3##4##(2008-10#3)
of five different##5##3##(1991-1#1)(2008-10#4)
of five exons##2##3##(1991-6#1)(1997-7#1)
of five species of##3##4##(2007-12#1)(2008-10#1)(2010-8#1)
of five species##4##3##(2007-12#1)(2008-10#2)(2010-8#1)
of five teacher actions to encourage children's##2##7##(2008-4#2)
of five##113##2##(1991-1#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#47)(2008-11#10)(2008-12#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#2)(2009-3#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#1)
of fixation##7##2##(1991-9#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#3)
of fixed cells##2##3##(2008-9#2)
of fixed##7##2##(1990-5#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-9#3)
of flabby##2##2##(2013-1#2)
of flag shoots as primary inoculum##2##6##(2008-10#2)
of flag##3##2##(2008-10#2)(2008-9#1)
of flame##2##2##(2008-10#2)
of flanking##2##2##(2008-10#2)
of flavonoid##7##2##(1993-8#1)(2008-10#4)(2008-11#1)(2008-9#1)
of flavonoids in##5##3##(2008-10#5)
of flavonoids##16##2##(2008-10#8)(2008-11#5)(2008-5#1)(2012-12#1)(2013-8#1)
of flaxseed flour##3##3##(2010-4#3)
of fleroxacin##3##2##(2008-10#3)
of flexible##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
of flexicurity##2##2##(2012-2#2)
of flexion of the##2##4##(2008-9#1)(2009-1#1)
of flexion##4##2##(2008-9#1)(2009-1#1)(2012-3#1)(2013-1#1)
of flexor##2##2##(2009-11#1)(2010-5#1)
of flies##3##2##(1995-6#1)(2008-9#2)
of flight##10##2##(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#3)
of floaters##2##2##(2008-10#1)(2008-8#1)
of flooding##3##2##(2012-5#2)(2013-8#1)
of floral integration##5##3##(2009-8#5)
of floral tissues##2##3##(2009-8#1)(2011-10#1)
of floral##10##2##(1997-8#1)(2008-8#1)(2009-8#7)(2011-10#1)
of flow analysis##2##3##(2008-10#2)
of flow cytometers##2##3##(2008-9#2)
of flow cytometry for##2##4##(2008-9#2)
of flow cytometry##14##3##(1993-1#1)(2008-4#2)(2008-9#11)
of flow injection (FI)##2##4##(2008-10#2)
of flow injection analysis (FIA)##4##5##(2008-10#4)
of flow injection analysis##8##4##(2008-10#8)
of flow injection##14##3##(2008-10#14)
of flow rate and##4##4##(2008-10#3)(2010-4#1)
of flow rate##10##3##(1997-2#1)(2008-10#7)(2008-7#1)(2010-4#1)
of flow rates of##4##4##(1996-2#1)(2008-10#3)
of flow rates##6##3##(1996-2#1)(2008-10#4)(2010-4#1)
of flow techniques##2##3##(2008-10#2)
of flow##60##2##(1993-1#2)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#33)(2008-4#2)(2008-7#2)(2008-9#14)(2010-4#2)(2012-2#1)
of flow-injection analysis##2##3##(2008-10#2)
of flow-injection##3##2##(2008-10#3)
of flower and##2##3##(2008-10#2)
of flower development##2##3##(1997-8#1)(2008-8#1)
of flower extracts##2##3##(2008-10#2)
of flower infection and##2##4##(2008-10#2)
of flower infection##4##3##(2008-10#4)
of flower##17##2##(1997-8#2)(2008-10#10)(2008-12#2)(2008-8#3)
of flowering plants##2##3##(2010-5#2)
of flowering##6##2##(2008-12#1)(2008-8#2)(2009-8#1)(2010-5#2)
of flowers and##2##3##(2008-9#1)(2009-5#1)
of flowers per##2##3##(2008-12#1)(2009-5#1)
of flowers##8##2##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#2)(2009-5#2)
of flowing##5##2##(1993-12#1)(2008-10#4)
of flows##2##2##(2008-11#1)(2008-3#1)
of fluctuating##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
of fluctuations##2##2##(2008-3#1)(2008-8#1)
of fluence-limiting defects##2##3##(2008-3#2)
of flufenamic##2##2##(2008-10#2)
of fluid transport systems##2##4##(1990-8#2)
of fluid##12##2##(1990-8#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-2#2)(2013-7#1)
of fluids##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2013-1#1)
of flunarizine##2##2##(2008-10#2)
of fluo-3##2##2##(1990-2#1)(1991-5#1)
of fluorescein##8##2##(2008-10#2)(2008-12#5)(2008-3#1)
of fluorescence and##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)
of fluorescence changes##2##3##(1994-5#2)
of fluorescence correlation spectroscopy##2##4##(1997-6#2)
of fluorescence enhancement##2##3##(1991-3#1)(2008-10#1)
of fluorescence intensity##5##3##(2008-10#3)(2008-3#2)
of fluorescence is##4##3##(2008-10#4)
of fluorescence microscopy##3##3##(1994-5#1)(2008-11#1)(2008-9#1)
of fluorescence of the##2##4##(1990-2#1)(2008-10#1)
of fluorescence of##5##3##(1990-2#1)(2008-10#3)(2008-3#1)
of fluorescence signal##2##3##(2008-10#1)(2008-9#1)
of fluorescence signals##2##3##(1994-5#1)(2008-10#1)
of fluorescence was##2##3##(2008-10#2)
of fluorescence##61##2##(1990-2#1)(1991-3#1)(1991-5#1)(1994-5#4)(1995-8#1)(1997-6#2)(2008-10#32)(2008-11#4)(2008-3#6)(2008-4#1)(2008-9#6)(2010-12#2)
of fluorescent Pseudomonas spp##2##4##(2008-10#2)
of fluorescent probes in tissue-like##2##5##(2010-12#2)
of fluorescent probes in##3##4##(2008-9#1)(2010-12#2)
of fluorescent probes##5##3##(2008-9#3)(2010-12#2)
of fluorescent pseudomonads##3##3##(2008-10#3)
of fluorescent##21##2##(1991-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-12#2)(2010-4#1)(2012-3#1)
of fluorescently labeled##2##3##(2008-10#1)(2008-4#1)
of fluorescently##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
of fluorescing corals##2##3##(2008-3#2)
of fluoride and##2##3##(2008-10#1)(2008-12#1)
of fluoride in##7##3##(2008-10#6)(2013-1#1)
of fluoride ion##7##3##(2008-10#7)
of fluoride ions##4##3##(2008-10#4)
of fluoride on##3##3##(2008-10#2)(2013-1#1)
of fluoride with##3##3##(2008-10#3)
of fluoride##38##2##(1991-11#1)(2008-10#28)(2008-12#3)(2013-1#6)
of fluorine##4##2##(1991-6#1)(2008-10#3)
of fluorochromes##2##2##(2008-9#2)
of fluorophore##2##2##(2008-10#1)(2008-12#1)
of fluorophores##8##2##(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)
of fluoroquinolone##2##2##(2008-10#1)(2012-3#1)
of fluoroquinolones in##2##3##(2008-10#2)
of fluoroquinolones##3##2##(2008-10#3)
of fluorosis##2##2##(1991-11#2)
of fluoxetine in##3##3##(2008-10#3)
of fluoxetine##7##2##(2008-10#6)(2008-4#1)
of fluphenazine##3##2##(2008-10#3)
of flurbiprofen##6##2##(2008-10#2)(2011-2#2)(2011-3#2)
of flux##2##2##(1991-3#1)(1993-2#1)
of fluxes##2##2##(2008-10#1)(2008-7#1)
of fly ash samples##2##4##(2008-10#2)
of fly ash##6##3##(2008-10#6)
of fly##8##2##(2008-10#6)(2008-12#1)(2010-10#1)
of foam##2##2##(1990-8#1)(2009-7#1)
of focal liver lesions##6##4##(2010-12#6)
of focal##10##2##(1997-8#1)(2008-10#2)(2008-7#1)(2010-12#6)
of focus group##3##3##(1997-3#1)(2009-5#1)(2012-2#1)
of focus##8##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-2#1)
of focused ultrasound##2##3##(2008-10#2)
of focused##3##2##(2008-10#3)
of foetal haemoglobin##2##3##(2009-3#2)
of foetal ovarian##2##3##(2008-11#2)
of foetal##6##2##(1991-9#2)(2008-11#2)(2009-3#2)
of folate in##2##3##(1994-6#2)
of folate##6##2##(1992-10#1)(1992-9#1)(1994-6#2)(2011-2#2)
of folding##4##2##(1994-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
of foliar diseases##2##3##(2008-10#2)
of foliar##8##2##(2008-10#7)(2008-8#1)
of folinic acid##3##3##(1992-2#1)(2008-10#2)
of follicle##3##2##(1993-11#1)(2008-7#2)
of follicles##2##2##(2008-8#1)(2012-3#1)
of follicular atresia##4##3##(2008-7#3)(2008-8#1)
of follicular##6##2##(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)
of follow up##8##3##(2008-10#1)(2010-3#1)(2012-2#1)(2013-1#5)
of follow-up was##4##3##(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
of follow-up##26##2##(1990-2#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
of following##4##2##(1993-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
of food additives##2##3##(2008-11#2)
of food and##6##3##(1991-2#1)(1993-12#2)(2008-10#2)(2010-7#1)
of food consumed##3##3##(2008-9#1)(2010-8#1)(2013-1#1)
of food consumption##2##3##(1994-6#1)(2008-7#1)
of food intake##3##3##(1996-2#1)(2008-9#1)(2010-8#1)
of food on##2##3##(1997-1#1)(2008-11#1)
of food packaging##3##3##(1994-3#2)(2010-7#1)
of food products##6##3##(2008-10#2)(2010-7#3)(2011-2#1)
of food ration and##2##4##(2010-8#2)
of food ration##3##3##(2010-8#3)
of food resources##3##3##(2008-8#3)
of food restriction##2##3##(1990-3#2)
of food safety##2##3##(2007-12#1)(2008-10#1)
of food samples##3##3##(2008-10#3)
of food spoilage##2##3##(2011-2#2)
of food web##2##3##(2008-8#1)(2008-9#1)
of food##81##2##(1990-3#2)(1990-8#1)(1991-12#1)(1991-2#1)(1993-12#2)(1993-6#5)(1994-2#1)(1994-3#3)(1994-6#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#2)(2007-12#2)(2008-10#12)(2008-11#7)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#9)(2009-4#1)(2010-6#3)(2010-7#5)(2010-8#5)(2011-2#4)(2012-2#3)(2013-1#1)
of foodborne disease is##2##4##(2007-12#2)
of foodborne disease##5##3##(2007-12#5)
of foodborne illness##3##3##(2007-12#2)(2011-2#1)
of foodborne##11##2##(2007-12#9)(2011-2#2)
of foods and beverages##2##4##(2008-10#1)(2012-12#1)
of foods and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
of foods##16##2##(1994-3#2)(1997-2#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-4#2)(2011-2#3)(2012-12#1)
of foodstuffs##2##2##(2008-10#1)(2011-2#1)
of foot and hand massage##2##5##(2010-7#2)
of foot and##4##3##(2010-3#1)(2010-7#2)(2011-2#1)
of foot##12##2##(2010-10#2)(2010-3#2)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
of foragers##3##2##(2008-8#1)(2008-9#2)
of foraging##9##2##(2008-8#5)(2008-9#4)
of force##7##2##(1992-8#1)(1995-5#2)(1995-6#2)(2007-12#1)(2012-2#1)
of foreign body##2##3##(2012-12#1)(2013-1#1)
of foreign genes##6##3##(1995-5#1)(1997-8#1)(2008-11#2)(2008-8#2)
of foreign ions and##2##4##(2008-10#2)
of foreign ions on the##2##5##(2008-10#2)
of foreign ions on##3##4##(2008-10#3)
of foreign ions##14##3##(2008-10#14)
of foreign##32##2##(1995-5#2)(1997-7#1)(1997-8#1)(2008-10#17)(2008-11#5)(2008-8#4)(2012-12#1)(2013-1#1)
of forensic##9##2##(2008-10#1)(2008-12#5)(2010-7#1)(2011-2#2)
of forest pathology##2##3##(2008-10#2)
of forest trees##2##3##(2008-12#1)(2010-4#1)
of forest##13##2##(1995-3#2)(2008-10#7)(2008-12#1)(2008-9#1)(2009-8#1)(2010-4#1)
of forests##3##2##(2008-10#3)
of form and##2##3##(2010-6#1)(2010-8#1)
of form##3##2##(2009-5#1)(2010-6#1)(2010-8#1)
of formal##6##2##(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#1)
of formaldehyde in air##4##4##(2008-10#4)
of formaldehyde in anaerobic##2##4##(2008-7#2)
of formaldehyde in shiitake mushroom##2##5##(2008-10#2)
of formaldehyde in the##4##4##(2008-10#3)(2008-7#1)
of formaldehyde in##17##3##(2008-10#14)(2008-7#3)
of formaldehyde##25##2##(2008-10#19)(2008-7#6)
of formally incorporating##2##3##(1996-6#2)
of formally##3##2##(1996-6#2)(2008-11#1)
of formation constants of complexes##3##5##(2008-10#3)
of formation constants of##4##4##(2008-10#4)
of formation constants##5##3##(2008-10#5)
of formation of the##3##4##(1991-5#1)(1993-9#1)(2008-10#1)
of formation of##5##3##(1991-5#1)(1993-6#1)(1993-9#1)(2008-10#2)
of formation##12##2##(1991-5#1)(1993-6#1)(1993-9#1)(2008-10#8)(2008-11#1)
of former##3##2##(1996-3#1)(2008-1#1)(2008-8#1)
of forming an##2##3##(1992-8#1)(2008-11#1)
of forming##10##2##(1992-8#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#2)(2011-2#1)
of forms##3##2##(1991-3#1)(1997-3#1)(2008-6#1)
of formulating##2##2##(2008-10#1)(2011-2#1)
of formulation##4##2##(2008-10#3)(2008-5#1)
of formulations##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
of fortified medium##2##3##(2008-11#2)
of forward head posture##2##4##(2010-9#2)
of forward##3##2##(2007-12#1)(2010-9#2)
of fosfomycin##2##2##(2008-10#2)
of fossil##3##2##(2008-10#2)(2008-8#1)
of fossilized##2##2##(1995-3#2)
of fouling##4##2##(2008-10#1)(2008-11#2)(2010-8#1)
of four anti-dandruff agents##3##4##(2008-5#3)
of four birth cohorts##2##4##(2008-7#2)
of four cases##4##3##(1990-12#1)(1991-12#2)(2011-2#1)
of four different##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
of four groups##4##3##(1992-1#1)(2008-12#1)(2011-2#2)
of four impurities for a stavudine synthesis control##2##8##(2008-10#2)
of four isolates of##2##4##(2008-10#2)
of four isolates##3##3##(2008-10#3)
of four key##3##3##(1997-3#1)(2008-11#2)
of four major##6##3##(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)
of four mammalian cell lines##2##5##(2008-11#2)
of four months##3##3##(1993-2#1)(1997-5#1)(2011-2#1)
of four novel##2##3##(1991-5#1)(2008-10#1)
of four of##5##3##(1994-5#1)(1997-3#1)(2008-10#2)(2008-11#1)
of four pairs of##2##4##(2008-10#1)(2008-12#1)
of four patients with##4##4##(2008-12#2)(2009-8#1)(2013-8#1)
of four patients##6##3##(2008-12#2)(2008-7#1)(2009-8#1)(2010-12#1)(2013-8#1)
of four treatments##2##3##(2008-12#1)(2012-9#1)
of four types of##2##4##(2008-10#1)(2009-8#1)
of four variables##2##3##(2008-10#1)(2011-2#1)
of four volunteers##2##3##(2008-10#2)
of four##174##2##(1990-12#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-2#2)(1993-6#2)(1994-5#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#75)(2008-11#9)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#10)(2008-7#4)(2008-8#3)(2008-9#5)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#10)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#1)
of fox##2##2##(1994-8#1)(1996-12#1)
of fraction##4##2##(1992-12#2)(2008-11#2)
of fractions##4##2##(1990-5#1)(1993-8#1)(2008-10#1)(2011-2#1)
of fracture and##2##3##(2008-11#1)(2013-1#1)
of fracture line##2##3##(2011-2#1)(2013-1#1)
of fracture##15##2##(2007-8#1)(2008-11#4)(2008-5#1)(2009-11#1)(2010-12#1)(2011-2#5)(2013-1#2)
of fractures##10##2##(1991-11#1)(1991-8#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-3#1)(2010-10#2)(2011-2#1)
of fragile sites in cancer development##2##6##(2011-2#2)
of fragile##4##2##(2008-5#1)(2011-2#3)
of fragment##4##2##(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
of fragmentation##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
of fragmented##6##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#1)
of fragments of##3##3##(2008-10#2)(2013-1#1)
of fragments##5##2##(2008-10#3)(2008-2#1)(2013-1#1)
of fragrance materials##2##3##(2008-5#2)
of fragrance##4##2##(2008-5#4)
of free 2##2##3##(2008-10#2)
of free NO and of##2##5##(2008-10#2)
of free Os##2##3##(2008-10#2)
of free TNT##3##3##(2008-10#3)
of free amino##2##3##(2008-5#2)
of free and conjugated##2##4##(1993-2#1)(2008-10#1)
of free and total##2##4##(2008-10#1)(2008-5#1)
of free and##9##3##(1991-12#1)(1993-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)
of free available##2##3##(2008-10#2)
of free chlorine##3##3##(2008-10#3)
of free fatty acids and##2##5##(2008-10#1)(2008-5#1)
of free fatty acids from##2##5##(1994-8#1)(2008-10#1)
of free fatty acids##5##4##(1994-8#1)(1997-2#1)(2008-10#2)(2008-5#1)
of free glucose##2##3##(2008-10#1)(2008-11#1)
of free moisture##2##3##(2008-10#2)
of free radical##2##3##(1996-2#1)(2008-10#1)
of free radicals that##2##4##(2007-8#1)(2009-8#1)
of free radicals##9##3##(1993-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-8#1)(2013-8#1)
of free sugars##2##3##(2008-10#2)
of free zinc ions##2##4##(2013-7#2)
of free##91##2##(1990-2#1)(1990-8#1)(1991-12#3)(1992-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-10#51)(2008-11#4)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#3)(2013-8#2)
of free-living##2##2##(2008-10#1)(2011-2#1)
of freedom##9##2##(1990-8#1)(1992-8#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
of freely##2##2##(1997-2#1)(2008-11#1)
of freestanding##2##2##(1991-1#1)(2008-11#1)
of freeze-dried##3##2##(2008-10#3)
of freezing temperatures##2##3##(2008-10#2)
of freezing##3##2##(2008-10#2)(2008-8#1)
of frequencies##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
of frequency of##2##3##(1994-5#1)(2011-2#1)
of frequency##9##2##(1990-8#1)(1991-2#1)(1994-5#1)(2008-10#4)(2008-3#1)(2011-2#1)
of frequent cannabis use##2##4##(2009-7#2)
of frequent##6##2##(2009-7#3)(2009-8#1)(2012-12#1)(2013-1#1)
of fresh and##2##3##(2008-10#1)(2012-5#1)
of fresh cells##2##3##(1994-6#2)
of fresh ginseng##2##3##(2012-3#2)
of fresh##33##2##(1990-12#1)(1990-2#1)(1991-2#1)(1994-6#2)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2011-2#2)(2012-2#3)(2012-3#5)(2012-5#1)(2012-7#1)(2013-8#1)
of freshly isolated##2##3##(1997-1#1)(2008-11#1)
of freshwater##7##2##(2007-12#1)(2008-10#3)(2008-11#1)(2010-8#2)
of friction##3##2##(2008-5#1)(2010-4#1)(2012-2#1)
of friends and##3##3##(2009-7#3)
of friends##7##2##(2009-7#7)
of front##2##2##(1996-1#1)(2008-11#1)
of front-line##3##2##(2009-3#2)(2010-1#1)
of frontal sinus##2##3##(2013-1#2)
of frontal##6##2##(1996-6#1)(1997-8#1)(2011-2#1)(2013-1#3)
of frozen-thawed##4##2##(1996-8#3)(2012-3#1)
of fructose##2##2##(1996-2#1)(2008-9#1)
of fructose-1##2##2##(2008-9#1)(2010-12#1)
of fruit and##2##3##(1997-1#1)(2008-10#1)
of fruit brown rot##3##4##(2008-10#3)
of fruit flies was##2##4##(2013-8#2)
of fruit flies##4##3##(2013-8#4)
of fruit##38##2##(1997-1#1)(2008-10#30)(2008-9#2)(2010-1#1)(2013-8#4)
of fruiting bodies##2##3##(2008-10#2)
of fruits##7##2##(1994-2#1)(2008-10#3)(2008-12#1)(2010-8#1)(2013-1#1)
of frying fats##2##3##(2008-10#2)
of ftz##2##2##(1993-9#2)
of fucose##2##2##(1990-8#1)(2008-11#1)
of fucosylated##2##2##(2008-11#1)(2008-5#1)
of fuel##2##2##(2008-10#1)(2010-12#1)
of full length##2##3##(2008-11#2)
of full##9##2##(1991-1#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-3#1)
of full-length cDNA clones of##2##5##(2008-10#2)
of full-length cDNA##7##3##(1997-2#4)(2008-10#2)(2008-8#1)
of full-length##12##2##(1993-6#1)(1995-2#1)(1995-6#1)(1997-2#4)(2008-10#4)(2008-8#1)
of full-thickness##2##2##(2011-2#1)(2013-8#1)
of fully##6##2##(1992-6#1)(1994-5#1)(1995-3#1)(1996-12#1)(2008-10#1)(2012-2#1)
of fulminant##4##2##(2011-2#2)(2013-1#2)
of fulvic and humic acids##3##5##(2008-10#3)
of fulvic##5##2##(2008-10#5)
of fumigants##2##2##(2008-10#2)
of fumonisin##6##2##(2008-10#5)(2013-1#1)
of function and quality of life##3##6##(2009-12#1)(2011-2#1)(2013-8#1)
of function and quality of##4##5##(2009-12#2)(2011-2#1)(2013-8#1)
of function and##6##3##(2008-10#1)(2009-12#2)(2011-2#1)(2013-8#2)
of function in##2##3##(1997-8#1)(2008-11#1)
of function of##3##3##(2011-2#1)(2011-3#1)(2013-8#1)
of function##31##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#3)(1994-5#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-12#3)(2009-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-8#3)
of function'##2##2##(2008-11#2)
of functional MRI##2##3##(2009-9#2)
of functional and##2##3##(2008-11#1)(2012-2#1)
of functional domains##2##3##(1990-5#1)(1997-3#1)
of functional genomics##2##3##(2008-5#1)(2009-10#1)
of functional glutamate transporters in the developing##2##7##(2008-7#2)
of functional groups##5##3##(1994-9#1)(2008-10#4)
of functional human##2##3##(2012-2#2)
of functional importance##2##3##(2008-9#1)(2010-5#1)
of functional interactions between##2##4##(1993-6#1)(2008-4#1)
of functional neuroimaging##2##3##(2008-11#1)(2009-9#1)
of functional recovery##2##3##(2008-8#1)(2013-1#1)
of functional regions##2##3##(1992-12#1)(2008-11#1)
of functional##65##2##(1990-5#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(2008-1#2)(2008-10#9)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-9#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#7)(2013-1#4)(2013-8#1)
of functionalized nano-HgS##2##3##(2008-10#2)
of functionalized##7##2##(2008-10#7)
of functionally##8##2##(1990-5#1)(1993-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2011-2#2)(2013-8#1)
of functioning##11##2##(1990-11#1)(1991-6#1)(1993-2#1)(1997-8#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)
of functions##7##2##(1992-1#1)(1995-9#1)(1997-6#1)(2008-11#3)(2012-2#1)
of fundamental and##3##3##(1995-12#1)(2008-3#2)
of fundamental importance in##2##4##(1990-2#1)(2008-10#1)
of fundamental importance##5##3##(1990-2#1)(2008-10#2)(2010-7#1)(2010-9#1)
of fundamental interest##2##3##(2008-3#1)(2008-8#1)
of fundamental##20##2##(1990-2#1)(1995-12#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)
of funding for##3##3##(1993-2#1)(2008-11#1)(2011-2#1)
of funding from##3##3##(1992-1#1)(1995-3#1)(1997-3#1)
of funding##16##2##(1991-1#1)(1992-1#1)(1993-2#2)(1994-2#1)(1995-12#1)(1995-3#3)(1997-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#1)
of funds##3##2##(1991-2#1)(1993-12#1)(1997-2#1)
of fungal DNA##3##3##(2008-10#2)(2011-2#1)
of fungal biomass##3##3##(2008-10#3)
of fungal colonization##4##3##(2008-10#3)(2008-12#1)
of fungal development##2##3##(2008-10#1)(2009-8#1)
of fungal growth in##2##4##(2008-10#2)
of fungal growth##5##3##(2008-10#5)
of fungal hyphae##2##3##(2008-10#2)
of fungal infection##2##3##(2008-10#1)(2008-5#1)
of fungal infections##3##3##(2008-5#1)(2011-2#2)
of fungal laccase##2##3##(2008-10#2)
of fungal spore adhesion##2##4##(2008-10#2)
of fungal##52##2##(1993-2#1)(2008-10#36)(2008-12#1)(2008-5#2)(2008-8#1)(2009-6#3)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#5)
of fungemia##3##2##(2008-5#3)
of fungi and##3##3##(2008-10#1)(2009-8#2)
of fungi in##2##3##(2008-10#2)
of fungi##18##2##(1997-2#1)(2008-10#10)(2008-5#2)(2009-8#3)(2010-10#1)(2011-1#1)
of fungicidal protection##2##3##(2008-10#2)
of fungicide resistance##4##3##(2008-10#4)
of fungicide##11##2##(2008-10#11)
of fungicide-resistant##2##2##(2008-10#2)
of fungicides in##3##3##(2008-10#3)
of fungicides##15##2##(2008-10#15)
of fungus##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
of furosemide##9##2##(1993-2#1)(1994-8#1)(1997-4#1)(2008-10#3)(2012-2#3)
of further##13##2##(1991-3#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)
of fusarium head blight##2##4##(2008-10#2)
of fusarium wilt of##3##4##(2008-10#3)
of fusarium wilt##4##3##(2008-10#4)
of fusarium##11##2##(2008-10#10)(2008-7#1)
of fused C2-C3 was##2##4##(2013-1#2)
of fused##5##2##(1993-12#1)(2007-12#1)(2013-1#3)
of fusion proteins##3##3##(1995-2#1)(1996-6#1)(2008-4#1)
of fusion##10##2##(1995-12#1)(1995-2#1)(1996-6#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)(2012-3#3)
of future cardiovascular##2##3##(2008-11#1)(2009-12#1)
of future development##2##3##(2008-10#1)(2011-7#1)
of future##32##2##(1992-3#1)(1993-3#1)(1994-2#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2010-6#1)(2011-2#2)(2011-7#1)(2012-2#2)(2013-1#1)(2013-8#2)
of fuzzy logic##2##3##(2011-2#2)
of fuzzy##3##2##(2011-2#3)
of g-KGM##2##2##(2011-2#2)
of g-SA##2##2##(2011-2#2)
of gabapentin (100 mg/kg)##2##4##(2011-2#2)
of gabapentin##4##2##(2011-2#2)(2011-3#2)
of gadolinium##3##2##(1997-8#1)(2008-10#1)(2012-3#1)
of gain##2##2##(2007-11#1)(2008-3#1)
of gains##3##2##(2009-10#1)(2009-11#1)(2012-3#1)
of gait##6##2##(2010-3#1)(2013-1#5)
of galactosamine##3##2##(2008-10#3)
of galactose##2##2##(1994-5#1)(2008-5#1)
of galanin##4##2##(1994-8#3)(1996-12#1)
of gallbladder cancer##3##3##(2010-12#3)
of gallbladder##9##2##(1990-12#1)(1991-8#1)(1992-9#1)(2008-11#1)(2008-12#1)(2010-12#3)(2012-3#1)
of gallium (III)##3##3##(2008-10#3)
of gallium and##2##3##(2008-10#2)
of gallium by##3##3##(2008-10#3)
of gallium was##2##3##(2008-10#2)
of gallium##15##2##(1993-11#1)(2008-10#14)
of gallium(III) with 2-methyl-8-quinolinol##2##4##(2008-10#2)
of gallium(III) with HMO(4)Q##2##4##(2008-10#2)
of gallium(III) with##4##3##(2008-10#4)
of gallium(III)##6##2##(2008-10#6)
of gallstone##3##2##(1990-9#1)(2008-12#2)
of galvanic##3##2##(2008-10#2)(2012-3#1)
of gametic disequilibrium##3##3##(2008-10#3)
of gametic##4##2##(2008-10#3)(2010-5#1)
of gamma##7##2##(1990-12#1)(1995-11#1)(2008-8#3)(2012-12#1)(2012-3#1)
of gamma-aminobutyric acid##3##3##(1990-5#1)(2008-8#1)(2008-9#1)
of gamma-globulin##2##2##(2008-10#2)
of gamma/delta T##2##3##(1993-8#2)
of gap junctions##4##3##(1994-3#1)(2008-7#2)(2012-2#1)
of gap##5##2##(1994-3#1)(2008-11#1)(2008-7#2)(2012-2#1)
of garenoxacin in##4##3##(2008-10#4)
of garenoxacin##7##2##(2008-10#5)(2011-2#2)
of garlic oil on##2##4##(2008-9#2)
of garlic##3##2##(2008-9#3)
of gas chromatographic##2##3##(2008-10#2)
of gas chromatography (GC)##2##4##(2008-10#2)
of gas chromatography##3##3##(2008-10#3)
of gas exchange##2##3##(1997-1#1)(2008-10#1)
of gas leaks##2##3##(2008-10#1)(2008-3#1)
of gas phase##3##3##(2008-10#2)(2008-11#1)
of gas##32##2##(1995-3#2)(1996-12#1)(1997-1#1)(2008-10#15)(2008-11#1)(2008-3#3)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#2)
of gaseous pollutants##2##3##(2008-10#1)(2008-3#1)
of gaseous##8##2##(2008-10#7)(2008-3#1)
of gases##6##2##(1997-1#1)(2008-10#2)(2008-3#1)(2012-2#2)
of gastric acid secretion##3##4##(1992-6#1)(1993-12#1)(1997-1#1)
of gastric and##2##3##(1992-5#1)(1995-2#1)
of gastric cancer cell##2##4##(2008-11#2)
of gastric cancer##16##3##(1992-12#1)(1992-9#1)(1997-1#1)(2008-11#3)(2008-12#6)(2011-2#4)
of gastric carcinoma##3##3##(1992-9#1)(1994-12#1)(2010-12#1)
of gastric emptying##2##3##(1997-4#1)(2012-2#1)
of gastric function##3##3##(1992-6#3)
of gastric juice##2##3##(2008-10#2)
of gastric neuroendocrine##2##3##(1997-1#2)
of gastric wall##2##3##(1992-9#2)
of gastric##54##2##(1992-12#1)(1992-5#1)(1992-6#6)(1992-9#6)(1993-12#1)(1994-12#1)(1995-2#1)(1997-1#5)(1997-4#1)(2008-10#2)(2008-11#3)(2008-12#9)(2008-9#1)(2009-8#2)(2010-12#1)(2010-7#2)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)
of gastrin##4##2##(1994-8#2)(1997-1#1)(2011-2#1)
of gastritis##4##2##(1997-1#3)(2010-12#1)
of gastroduodenal##2##2##(1990-5#1)(2008-12#1)
of gastroenteritis##2##2##(1996-2#1)(2012-12#1)
of gastroenterology##2##2##(1990-2#1)(2013-1#1)
of gastroesophageal reflux##4##3##(1992-11#1)(1992-3#2)(2013-1#1)
of gastroesophageal##5##2##(1992-11#1)(1992-3#2)(2008-11#1)(2013-1#1)
of gastrointestinal (GI)##2##3##(1991-2#1)(2011-2#1)
of gastrointestinal bleeding##4##3##(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
of gastrointestinal cancer in##2##4##(1990-9#2)
of gastrointestinal disorders##2##3##(1991-3#1)(2008-11#1)
of gastrointestinal nematodes in##2##4##(1996-11#1)(1996-12#1)
of gastrointestinal nematodes##3##3##(1996-11#1)(1996-12#2)
of gastrointestinal stromal##2##3##(2008-10#1)(2013-1#1)
of gastrointestinal##24##2##(1990-6#1)(1990-9#2)(1991-2#1)(1991-3#1)(1995-10#1)(1996-11#1)(1996-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
of gastroparesis##3##2##(2012-2#3)
of gdh##2##2##(1993-9#2)
of gel filtration##3##3##(2008-10#1)(2008-8#2)
of gel##11##2##(1995-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#2)
of gellike material##2##3##(2008-11#2)
of gellike##3##2##(2008-11#3)
of gemcitabine##2##2##(2008-10#1)(2013-1#1)
of geminate recombination##2##3##(1990-8#2)
of geminivirus##2##2##(2008-10#2)
of geminiviruses in##2##3##(2008-10#2)
of gender and its##2##4##(2009-10#2)
of gender and##4##3##(2009-10#2)(2009-7#1)(2013-1#1)
of gender differences in##4##4##(2008-12#2)(2008-4#1)(2008-7#1)
of gender differences##5##3##(2008-12#2)(2008-4#1)(2008-7#1)(2011-1#1)
of gender on the association of adiposity with cardiovascular reactivity##2##10##(2012-2#2)
of gender##17##2##(2008-10#1)(2008-11#1)(2008-12#4)(2008-4#1)(2008-7#1)(2009-10#3)(2009-7#1)(2010-1#1)(2011-1#1)(2012-2#2)(2013-1#1)
of gene 32##2##3##(1997-3#2)
of gene action##2##3##(2008-10#1)(2009-10#1)
of gene amplification##4##3##(1991-6#2)(1994-12#1)(2008-11#1)
of gene and##2##3##(2007-12#1)(2008-10#1)
of gene diversity was distributed among##2##6##(2008-10#2)
of gene diversity was distributed within##3##6##(2008-10#3)
of gene diversity was distributed##5##5##(2008-10#5)
of gene diversity##8##3##(2008-10#7)(2012-5#1)
of gene expression and##5##4##(2008-4#2)(2008-9#2)(2009-8#1)
of gene expression at##2##4##(2008-11#1)(2008-4#1)
of gene expression by##2##4##(1994-8#1)(2008-7#1)
of gene expression in the##2##5##(2012-2#1)(2013-7#1)
of gene expression in##11##4##(1993-12#1)(1997-3#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
of gene expression of##2##4##(2008-2#1)(2008-9#1)
of gene expression##53##3##(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#6)(2008-2#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#6)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
of gene families##2##3##(2009-6#1)(2011-2#1)
of gene flow between##2##4##(2008-10#2)
of gene flow##7##3##(2008-10#5)(2008-8#1)(2008-9#1)
of gene function##2##3##(1997-8#1)(2010-5#1)
of gene fusions##2##3##(1991-6#1)(2008-9#1)
of gene interaction##2##3##(2008-10#1)(2011-3#1)
of gene models##2##3##(2009-10#2)
of gene products##2##3##(1995-9#1)(2008-9#1)
of gene regulation##3##3##(2008-7#2)(2012-3#1)
of gene therapy for##2##4##(2008-8#1)(2008-9#1)
of gene therapy##8##3##(1994-5#1)(2007-11#1)(2008-11#2)(2008-8#2)(2008-9#1)(2010-10#1)
of gene transcription and##2##4##(1994-11#1)(1996-3#1)
of gene transfer and expression##2##5##(2008-11#1)(2008-9#1)
of gene transfer and##3##4##(2008-11#2)(2008-9#1)
of gene transfer##5##3##(1994-11#1)(2008-10#1)(2008-11#2)(2008-9#1)
of gene##144##2##(1991-6#4)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#3)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#30)(2008-11#11)(2008-2#1)(2008-4#7)(2008-7#5)(2008-8#10)(2008-9#14)(2009-10#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#4)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#6)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
of gene-modified##2##2##(1994-5#1)(2012-10#1)
of general and##4##3##(1990-12#1)(1990-6#1)(1997-3#1)(2010-8#1)
of general cognitive##3##3##(2010-1#2)(2010-5#1)
of general health##4##3##(1992-3#2)(2008-11#1)(2010-1#1)
of general manager##2##3##(1990-12#2)
of general practice##2##3##(1990-3#1)(1997-4#1)
of general practitioners in the##2##5##(1997-4#1)(2008-11#1)
of general practitioners##4##3##(1993-3#1)(1997-4#1)(1997-5#1)(2008-11#1)
of general validity##2##3##(2007-11#1)(2008-11#1)
of general##57##2##(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-9#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#4)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#3)
of generalized##7##2##(2008-12#1)(2008-2#1)(2009-8#1)(2010-6#1)(2012-3#2)(2013-1#1)
of generated##3##2##(2008-10#3)
of generating##11##2##(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-10#1)
of generation##2##2##(2008-10#2)
of generic medicines##4##3##(2011-1#4)
of generic##11##2##(1996-2#1)(2008-10#1)(2008-11#2)(2010-4#1)(2011-1#5)(2011-3#1)
of genes active in##2##4##(1996-2#1)(1997-8#1)
of genes and##4##3##(1995-6#1)(1996-12#1)(2008-4#1)(2008-8#1)
of genes are##3##3##(1997-7#1)(2008-9#1)(2009-8#1)
of genes associated with##3##4##(2008-10#2)(2010-11#1)
of genes coding##2##3##(1997-8#1)(2008-12#1)
of genes encoding glycolytic enzymes##2##5##(1996-3#2)
of genes encoding##10##3##(1996-12#2)(1996-3#2)(2008-11#1)(2008-4#1)(2008-8#2)(2012-2#1)(2012-3#1)
of genes for resistance to##2##5##(2008-10#2)
of genes for##5##3##(1996-12#2)(2008-10#3)
of genes from##2##3##(1993-9#1)(2008-7#1)
of genes implicated in prostate carcinogenesis##2##6##(2008-6#2)
of genes in the##2##4##(1995-8#1)(2008-6#1)
of genes in various##2##4##(2008-10#1)(2011-3#1)
of genes in##11##3##(1990-5#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2011-3#1)(2012-3#1)
of genes including##2##3##(2008-10#1)(2013-1#1)
of genes involved in##6##4##(1995-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
of genes involved##7##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)
of genes of##3##3##(2011-1#1)(2011-2#1)(2013-8#1)
of genes related to##3##4##(2008-9#1)(2010-11#1)(2010-5#1)
of genes that are##2##4##(1993-9#1)(2011-1#1)
of genes that encode##2##4##(2008-4#1)(2012-3#1)
of genes that##9##3##(1993-9#1)(1994-5#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#3)
of genes to##3##3##(2008-4#1)(2008-7#1)(2010-11#1)
of genes under##2##3##(2008-10#1)(2008-7#1)
of genes whose##2##3##(1992-12#1)(2008-4#1)
of genes with##2##3##(2008-8#1)(2009-8#1)
of genes##121##2##(1990-5#1)(1992-12#1)(1993-9#3)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#3)(1996-12#7)(1996-2#1)(1996-3#3)(1996-6#2)(1997-6#1)(1997-7#3)(1997-8#2)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#4)(2009-8#3)(2010-1#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-10#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#2)(2013-8#2)
of genetic algorithms##2##3##(1994-2#1)(2008-10#1)
of genetic alterations##2##3##(2008-11#1)(2011-2#1)
of genetic and phenotypic##2##4##(2008-10#1)(2010-12#1)
of genetic and##7##3##(2008-10#4)(2008-4#1)(2010-12#1)(2011-2#1)
of genetic differentiation among##5##4##(2008-10#5)
of genetic differentiation were##3##4##(2008-10#3)
of genetic differentiation##16##3##(2008-10#14)(2012-3#1)(2012-5#1)
of genetic diversity##14##3##(2008-10#10)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
of genetic engineering##2##3##(2008-8#1)(2011-2#1)
of genetic information##4##3##(1993-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
of genetic origin##2##3##(1990-2#1)(2013-1#1)
of genetic polymorphism##3##3##(2006-6#1)(2008-9#1)(2012-3#1)
of genetic profiles for##2##4##(2008-11#1)(2010-7#1)
of genetic recombination##2##3##(2008-10#2)
of genetic resistance##2##3##(2008-10#2)
of genetic structure##2##3##(2008-10#1)(2008-8#1)
of genetic testing in##2##4##(2010-7#1)(2011-2#1)
of genetic testing##5##3##(1995-9#1)(2010-7#1)(2011-2#2)(2012-3#1)
of genetic variability##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
of genetic variation among##2##4##(2008-10#2)
of genetic variation in##2##4##(2008-10#2)
of genetic variation##16##3##(2008-10#10)(2008-8#1)(2008-9#3)(2010-4#1)(2012-2#1)
of genetic##134##2##(1990-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-8#1)(2006-6#1)(2008-10#55)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#5)(2008-8#12)(2008-9#11)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#8)(2011-3#2)(2012-2#2)(2012-3#7)(2012-5#1)(2013-1#3)(2013-8#1)
of genetically engineered herpes simplex viruses##2##6##(1995-2#2)
of genetically engineered##4##3##(1995-2#2)(2008-11#1)(2011-1#1)
of genetically##11##2##(1995-2#2)(1996-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
of genetics##4##2##(1996-8#1)(2008-4#1)(2008-7#1)(2010-1#1)
of genistein##10##2##(1997-7#3)(2008-11#1)(2010-3#2)(2012-2#4)
of genital##9##2##(1994-2#1)(1996-1#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#3)
of genome size##2##3##(1997-2#1)(2008-8#1)
of genome##12##2##(1993-12#1)(1997-2#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#5)(2011-2#1)(2013-1#1)
of genome-wide##4##2##(2011-2#3)(2012-3#1)
of genomes##4##2##(1997-2#1)(2009-6#1)(2010-5#1)(2012-3#1)
of genomic DNA and##4##4##(1992-3#1)(1993-12#1)(1997-7#1)(2008-4#1)
of genomic DNA from##2##4##(1996-6#1)(2008-10#1)
of genomic DNA of##3##4##(1993-12#1)(2008-10#1)(2008-9#1)
of genomic DNA##18##3##(1992-3#1)(1993-12#2)(1993-2#1)(1993-9#1)(1996-6#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-9#1)
of genomic and##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
of genomic sequence##3##3##(2008-11#1)(2010-7#1)(2012-2#1)
of genomic sequences##2##3##(2008-9#1)(2009-10#1)
of genomic tools##2##3##(2008-11#1)(2010-10#1)
of genomic##39##2##(1990-8#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-9#1)(1996-6#1)(1997-6#1)(1997-7#2)(2008-10#9)(2008-11#4)(2008-4#4)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
of genomics##6##2##(2008-10#1)(2008-11#1)(2010-10#1)(2010-4#1)(2010-5#1)(2013-8#1)
of genotype resistance and##2##4##(2008-10#2)
of genotype resistance##4##3##(2008-10#4)
of genotype##9##2##(2008-10#8)(2008-8#1)
of genotypes that##2##3##(2008-10#2)
of genotypes within##2##3##(2008-10#2)
of genotypes##19##2##(2008-10#14)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-12#1)
of genotypic diversity##8##3##(2008-10#8)
of genotypic##12##2##(2008-10#11)(2011-2#1)
of gentamicin##2##2##(2008-10#2)
of gentamycin##5##2##(2008-10#5)
of genuine##6##2##(1994-3#2)(1997-3#1)(2008-10#1)(2009-8#1)(2011-1#1)
of genus##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
of geographic##6##2##(1994-6#1)(2008-10#4)(2008-8#1)
of geological samples##3##3##(2008-10#3)
of geological##5##2##(2008-10#4)(2008-12#1)
of geometric##2##2##(2008-3#1)(2013-1#1)
of geometrical optics##2##3##(2008-2#1)(2008-3#1)
of geometrical parameters of transpedicular##2##5##(2007-11#2)
of geometrical##6##2##(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#1)(2009-3#1)
of geriatric##3##2##(1990-11#1)(1991-1#1)(1992-1#1)
of germ cell development##3##4##(2009-10#1)(2012-2#2)
of germ cell##6##3##(2008-12#2)(2009-10#1)(2012-2#3)
of germ cells##2##3##(2008-7#1)(2009-10#1)
of germ line p53 mutations##2##5##(1990-12#1)(1994-12#1)
of germ line##3##3##(1990-12#1)(1994-12#1)(2008-11#1)
of germ tubes##4##3##(2008-10#4)
of germ##16##2##(1990-12#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#2)(2012-2#3)
of germanium by##3##3##(2008-10#3)
of germanium in botanical samples##2##5##(2008-10#2)
of germanium in##3##3##(2008-10#3)
of germanium##7##2##(2008-10#7)
of germinal##2##2##(2008-10#1)(2008-9#1)
of germinated conidia##4##3##(2008-10#4)
of germinated##7##2##(2008-10#6)(2008-5#1)
of germinating seeds##2##3##(2008-10#1)(2008-7#1)
of germinating##4##2##(2008-10#3)(2008-7#1)
of germination and##3##3##(2008-10#2)(2011-2#1)
of germination in##2##3##(2008-10#2)
of germination of sclerotia##2##4##(2008-10#2)
of germination of##4##3##(2008-10#3)(2008-5#1)
of germination was##2##3##(2008-10#2)
of germination##16##2##(2008-10#12)(2008-5#1)(2011-2#3)
of germline##3##2##(1996-12#1)(2008-9#1)(2011-2#1)
of gestation and##2##3##(1993-12#2)
of gestation with##2##3##(2013-1#2)
of gestation##22##2##(1990-11#1)(1990-5#1)(1993-12#6)(1996-11#2)(1997-3#1)(2008-10#1)(2008-11#3)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#4)
of gestational age##2##3##(2008-11#2)
of gestational diabetes##3##3##(1992-12#1)(1996-11#2)
of gestational stress on##2##4##(2008-11#2)
of gestational stress##4##3##(2008-11#4)
of gestational##10##2##(1992-12#1)(1996-11#2)(2008-11#6)(2013-1#1)
of gestodene##3##2##(2011-3#3)
of getting##5##2##(1991-1#1)(1993-1#1)(2008-10#1)(2009-9#1)(2010-4#1)
of ghrelin##3##2##(2011-1#1)(2012-3#1)(2013-8#1)
of giant##14##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#5)(2009-3#1)(2010-5#1)(2012-3#1)(2013-1#2)
of gifts##2##2##(1997-4#1)(2008-12#1)
of gingival##3##2##(2008-5#1)(2013-1#2)
of ginseng leaves##2##3##(2008-10#2)
of ginseng##10##2##(2008-10#7)(2008-11#1)(2012-3#2)
of girls##5##2##(1990-2#1)(1996-11#1)(2008-10#2)(2009-10#1)
of given##3##2##(2008-10#2)(2008-3#1)
of giving##2##2##(1995-2#1)(2009-10#1)
of glaA gene##2##3##(2008-9#2)
of glaA##3##2##(2008-8#1)(2008-9#2)
of glands in##2##3##(1997-1#1)(2007-12#1)
of glands##4##2##(1995-11#1)(1997-1#1)(2007-12#2)
of glass and##2##3##(2008-10#2)
of glass electrodes##3##3##(2008-10#3)
of glass fibers##2##3##(2009-7#2)
of glass samples##2##3##(2008-10#2)
of glass##26##2##(1995-3#1)(2008-10#23)(2009-7#2)
of glass-ionomer##2##2##(2009-7#1)(2013-1#1)
of glasses##4##2##(1995-3#2)(2008-10#2)
of glassy carbon##3##3##(2008-10#3)
of glassy##4##2##(1995-3#1)(2008-10#3)
of glaucoma##5##2##(1990-11#1)(2009-9#1)(2011-2#2)(2011-7#1)
of glia##2##2##(2008-7#2)
of glial cells##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
of glial##5##2##(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
of glioblastoma multiforme##3##3##(2011-2#2)(2011-3#1)
of glioblastoma##5##2##(2011-2#2)(2011-3#2)(2012-3#1)
of glioma##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
of global budgets##2##3##(1994-1#2)
of global climate change##2##4##(2008-10#1)(2008-11#1)
of global postural reeducation in the treatment of temporomandibular disorder##2##10##(2013-1#2)
of global##21##2##(1993-1#1)(1994-1#2)(1995-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#2)(2013-3#1)(2013-8#1)
of globin##2##2##(2008-8#1)(2008-9#1)
of glomerular##5##2##(1993-2#1)(1996-6#2)(2011-2#1)(2012-2#1)
of gloves##4##2##(1996-11#1)(2012-2#3)
of glucagon at##2##3##(1994-8#1)(1996-2#1)
of glucagon secretion##2##3##(1994-11#2)
of glucagon##9##2##(1992-9#1)(1994-11#2)(1994-8#1)(1995-6#2)(1996-2#2)(2012-2#1)
of glucagon-induced##2##2##(1994-8#1)(1996-2#1)
of glucocorticoid receptor##2##3##(1990-11#1)(1996-12#1)
of glucocorticoid receptors##2##3##(1991-12#1)(2009-6#1)
of glucocorticoid##5##2##(1990-11#1)(1991-12#1)(1995-12#1)(1996-12#1)(2009-6#1)
of glucocorticoids in##2##3##(2008-11#1)(2008-8#1)
of glucocorticoids##4##2##(1996-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
of gluconeogenesis in##2##3##(1991-3#1)(1994-8#1)
of gluconeogenesis##4##2##(1991-3#2)(1994-8#1)(1995-8#1)
of gluconic acid##3##3##(2008-10#3)
of glucose and ethanol##4##4##(2008-10#4)
of glucose and glutamine metabolism in hybridoma##2##7##(2008-11#2)
of glucose and glutamine metabolism##3##5##(2008-11#3)
of glucose and glutamine##6##4##(2008-11#6)
of glucose and##22##3##(1991-2#1)(1994-8#1)(1995-8#1)(2008-10#9)(2008-11#7)(2008-7#1)(2010-10#1)(2010-7#1)
of glucose by the##2##4##(2008-10#2)
of glucose by##4##3##(1992-6#1)(2008-10#3)
of glucose concentration##4##3##(1992-12#2)(2008-10#1)(2009-8#1)
of glucose for##2##3##(1995-8#1)(2008-10#1)
of glucose in the range##2##5##(2008-10#2)
of glucose in the##8##4##(1991-10#1)(1994-8#1)(2008-10#6)
of glucose in##20##3##(1991-10#1)(1994-8#1)(1995-8#1)(2008-10#16)(2008-11#1)
of glucose metabolism in##2##4##(1993-11#1)(2013-8#1)
of glucose metabolism##4##3##(1991-12#1)(1993-11#1)(1996-2#1)(2013-8#1)
of glucose oxidase (GOx)##2##4##(2008-10#2)
of glucose oxidase and##2##4##(2008-10#2)
of glucose oxidase##11##3##(2008-10#11)
of glucose starvation##2##3##(2008-11#2)
of glucose to##6##3##(1991-7#1)(1995-8#4)(2008-10#1)
of glucose transport##3##3##(1994-11#2)(2008-7#1)
of glucose transporter##3##3##(1993-8#1)(2008-11#2)
of glucose uptake by##2##4##(1991-7#1)(2008-10#1)
of glucose uptake##3##3##(1991-7#1)(2008-10#1)(2008-11#1)
of glucose utilization in##2##4##(1994-8#2)
of glucose utilization##3##3##(1994-8#3)
of glucose was##5##3##(2008-10#5)
of glucose with##3##3##(1994-12#1)(2008-10#2)
of glucose##142##2##(1990-5#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#4)(1992-12#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-8#6)(1995-11#1)(1995-8#9)(1996-2#1)(1997-6#1)(2008-10#66)(2008-11#21)(2008-12#2)(2008-7#7)(2009-10#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
of glucose-6-phosphatase##2##2##(1994-11#2)
of glucose-6-phosphate dehydrogenase and##2##4##(1991-5#1)(2008-11#1)
of glucose-6-phosphate dehydrogenase##5##3##(1991-5#2)(1995-6#1)(2007-12#1)(2008-11#1)
of glucose-6-phosphate##7##2##(1991-5#2)(1995-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
of glucosinolate##2##2##(2008-10#2)
of glucuronidation##3##2##(2008-11#3)
of glutamate dehydrogenase##3##3##(1995-11#1)(2008-4#2)
of glutamate in##2##3##(1994-2#1)(2008-11#1)
of glutamate receptor##2##3##(1994-11#1)(2008-7#1)
of glutamate receptors##2##3##(1994-8#1)(1997-2#1)
of glutamate##21##2##(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#4)(2008-8#1)(2011-2#1)
of glutamic acid by##2##4##(2008-10#2)
of glutamic acid on the oscillating##2##6##(2008-10#2)
of glutamic acid##8##3##(2008-10#6)(2011-2#1)(2013-8#1)
of glutamic##9##2##(2008-10#6)(2008-11#1)(2011-2#1)(2013-8#1)
of glutaminase##2##2##(2008-11#2)
of glutamine and serine##2##4##(2008-11#2)
of glutamine and##3##3##(2008-11#3)
of glutamine in##2##3##(1995-3#1)(2008-11#1)
of glutamine synthetase##5##3##(1996-12#4)(1997-1#1)
of glutamine##25##2##(1993-8#2)(1995-3#1)(1996-12#4)(1997-1#1)(2008-11#16)(2013-8#1)
of glutaraldehyde##5##2##(2008-10#5)
of glutathione (GSH)##4##3##(1990-2#1)(2008-10#2)(2008-7#1)
of glutathione S-transferase##2##3##(1992-6#1)(1995-6#1)
of glutathione and glutathione disulfide in human plasma and tobacco leaves##2##11##(2008-10#2)
of glutathione and##3##3##(2008-10#2)(2012-2#1)
of glutathione in##2##3##(2008-10#2)
of glutathione##23##2##(1990-2#3)(1992-1#2)(1992-12#1)(1992-6#1)(1993-3#1)(1995-6#1)(2008-10#8)(2008-11#1)(2008-7#2)(2009-7#1)(2012-2#2)
of glutinous##3##2##(2008-10#3)
of glycaemic control##3##3##(1992-9#3)
of glycemic##3##2##(2008-10#1)(2008-3#1)(2012-5#1)
of glycerin##2##2##(2008-5#2)
of glycerol or##2##3##(2008-10#1)(2008-7#1)
of glycerol##6##2##(2008-10#3)(2008-11#2)(2008-7#1)
of glycine and GABA##2##4##(1997-2#2)
of glycine and##4##3##(1997-2#3)(2008-10#1)
of glycine##10##2##(1995-11#1)(1996-2#1)(1997-1#1)(1997-2#3)(2008-10#4)
of glycogen##7##2##(1990-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2012-2#3)
of glycolate##2##2##(1997-7#1)(2008-8#1)
of glycolysis##4##2##(1997-6#2)(2008-11#1)(2010-7#1)
of glycolytic##4##2##(1996-6#3)(2008-11#1)
of glycoprotein##2##2##(1996-2#1)(2008-1#1)
of glycoproteins with##2##3##(2008-1#1)(2008-7#1)
of glycoproteins##6##2##(1990-5#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)
of glycosylation##6##2##(1993-1#1)(2008-11#4)(2011-2#1)
of glyoxalase I##2##3##(1991-12#1)(1991-5#1)
of glyphosate was##2##3##(2008-10#1)(2010-1#1)
of glyphosate##5##2##(2008-10#2)(2010-1#3)
of goat and sheep##2##4##(2008-12#1)(2010-4#1)
of goat##9##2##(1995-6#1)(2008-10#1)(2008-12#1)(2010-4#6)
of goblet cells##2##3##(1994-11#1)(2008-5#1)
of goblet##3##2##(1994-11#2)(2008-5#1)
of gold at##2##3##(1994-5#2)
of gold by##2##3##(2008-10#2)
of gold nanoparticles##2##3##(2008-10#1)(2008-11#1)
of gold were studied##2##4##(1994-5#1)(2008-10#1)
of gold##26##2##(1994-5#7)(2008-10#15)(2008-11#1)(2008-9#1)(2013-1#2)
of goldfilled##2##2##(2008-10#2)
of goldfish##2##2##(1994-11#1)(2011-2#1)
of gonadal##5##2##(2008-11#2)(2008-4#1)(2008-7#1)(2010-8#1)
of gonococcal##2##2##(1993-12#1)(1995-12#1)
of gonorrhoea##2##2##(1990-3#2)
of good quality##4##3##(2008-10#1)(2008-11#2)(2010-4#1)
of good##17##2##(1993-1#1)(1994-1#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#2)(2010-4#1)(2012-12#1)(2012-3#3)
of goods and##2##3##(1991-2#1)(2008-11#1)
of goods##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
of gossypol was##2##3##(2008-8#2)
of gossypol were##2##3##(1990-11#2)
of gossypol##6##2##(1990-11#4)(2008-8#2)
of gout##2##2##(1991-8#1)(2011-2#1)
of governance##2##2##(1996-1#2)
of government in##2##3##(1996-3#1)(2012-2#1)
of government##14##2##(1991-2#1)(1992-1#2)(1992-2#1)(1994-1#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#3)(2008-11#1)(2012-2#1)
of grade IV##2##3##(2008-12#2)
of grade##5##2##(2008-12#4)(2013-1#1)
of gradient-enriched##2##2##(1997-3#2)
of gradual##2##2##(2008-11#1)(2010-8#1)
of graduate medical education##2##4##(1991-8#2)
of graduate##6##2##(1991-1#1)(1991-8#3)(1996-1#1)(1996-3#1)
of graduates##3##2##(1991-2#1)(1991-8#1)(1996-1#1)
of graft##6##2##(1994-5#1)(1997-8#1)(2008-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
of grafts in the##2##4##(1990-5#1)(1991-2#1)
of grafts in##3##3##(1990-5#1)(1991-2#1)(2011-3#1)
of grain##10##2##(2008-10#6)(2008-8#1)(2008-9#2)(2013-1#1)
of gram##2##2##(1991-2#1)(2008-12#1)
of gram-negative##3##2##(2008-10#1)(2010-6#1)(2011-3#1)
of granisetron##3##2##(2010-12#2)(2010-7#1)
of granite##2##2##(2008-1#1)(2008-10#1)
of granular##4##2##(1995-3#1)(2008-10#2)(2008-7#1)
of granulated##2##2##(2008-11#1)(2010-1#1)
of granule##2##2##(1994-8#2)
of granules##2##2##(1990-5#1)(2010-11#1)
of granulocyte colony-stimulating factor in##2##5##(2008-11#2)
of granulocyte colony-stimulating factor##3##4##(1994-12#1)(2008-11#2)
of granulocytes##2##2##(2011-2#1)(2013-1#1)
of granulocytic anaplasmosis##2##3##(2008-12#1)(2013-1#1)
of granulomatous##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
of granulosa##2##2##(1995-12#2)
of grape black rot##3##4##(2008-10#3)
of grape##11##2##(2008-10#11)
of grapefruit##2##2##(2008-10#2)
of grapes##7##2##(2008-10#6)(2013-1#1)
of grapevine downy mildew##2##4##(2008-10#2)
of grapevine leaves by##2##4##(2008-10#2)
of grapevine##10##2##(2008-10#10)
of grapevines##2##2##(2008-10#2)
of graphite##2##2##(2008-10#2)
of grasses and##3##3##(2008-10#1)(2008-8#2)
of grasses##4##2##(2008-10#2)(2008-8#2)
of grating##4##2##(2008-3#1)(2013-8#3)
of gratings written##2##3##(2007-12#2)
of gratitude##2##2##(2008-12#2)
of gravity##3##2##(2008-11#1)(2008-2#1)(2010-10#1)
of gray leaf spot of maize##2##6##(2008-10#2)
of gray leaf spot of perennial ryegrass turf##2##8##(2008-10#2)
of gray leaf spot of##5##5##(2008-10#5)
of gray leaf spot##7##4##(2008-10#7)
of gray mold##3##3##(1997-4#1)(2008-10#2)
of gray##11##2##(1997-4#1)(2008-10#9)(2008-3#1)
of grazing##2##2##(1996-12#2)
of great concern##2##3##(2008-10#2)
of great importance for##3##4##(1991-2#1)(2011-2#1)(2013-1#1)
of great importance in##4##4##(1997-1#1)(2008-10#1)(2011-1#1)(2013-1#1)
of great importance to##2##4##(2008-9#1)(2009-1#1)
of great importance##18##3##(1990-11#1)(1991-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#2)(2013-1#2)
of great interest for##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
of great interest in the##2##5##(2008-10#2)
of great interest##9##3##(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
of great practical importance##2##4##(2008-8#1)(2010-7#1)
of great practical##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)
of great value##3##3##(1991-6#1)(1996-11#1)(2009-8#1)
of great##53##2##(1990-11#1)(1991-2#1)(1991-6#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#4)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#3)
of greater than##4##3##(1995-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
of greater thickness##2##3##(2008-10#1)(2008-3#1)
of greater##22##2##(1991-12#1)(1993-2#1)(1993-3#1)(1995-6#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#3)(2009-11#1)(2011-2#1)(2012-2#1)
of greatest##3##2##(2008-10#1)(2008-2#1)(2010-7#1)
of greatly##2##2##(1991-12#1)(1994-8#1)
of green and black tea##2##5##(2009-8#2)
of green and##3##3##(2008-10#1)(2009-8#2)
of green fluorescent protein##7##4##(2008-10#1)(2008-11#2)(2008-7#4)
of green mold##2##3##(2008-10#2)
of green tea##2##3##(2008-11#1)(2009-8#1)
of green##23##2##(1993-8#1)(2008-10#8)(2008-11#5)(2008-7#4)(2008-9#1)(2009-8#3)(2010-6#1)
of green-yellow colour##2##3##(2011-2#2)
of greenhouse##4##2##(2008-10#3)(2008-12#1)
of greenhouse-grown##3##2##(2008-10#3)
of grey cast iron##4##4##(2008-10#4)
of grip force control##3##4##(2013-1#3)
of grip##6##2##(2008-9#3)(2013-1#3)
of gross saponins of Tribulus terrestris##2##6##(2011-3#2)
of gross##11##2##(1991-12#1)(1991-2#1)(1992-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2011-3#2)
of ground squirrel##2##3##(2008-8#2)
of ground##10##2##(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#2)(2010-4#2)(2013-1#1)
of groundnut rosette disease##2##4##(2008-10#2)
of groundnut rosette##3##3##(2008-10#3)
of groundnut##7##2##(2008-10#7)
of groundwater##3##2##(2008-10#1)(2013-1#2)
of group 1 were##2##4##(2008-10#1)(2008-9#1)
of group 1##4##3##(1991-3#1)(2008-10#2)(2008-9#1)
of group 2##4##3##(1991-3#1)(2008-10#2)(2008-9#1)
of group A##2##3##(1993-12#1)(2009-9#1)
of group C##2##3##(2010-7#1)(2012-2#1)
of group I isolates##2##4##(2008-10#2)
of group I##5##3##(1995-6#1)(1996-12#2)(2008-10#2)
of group II isolates##2##4##(2008-10#2)
of group II##5##3##(2008-10#5)
of group III##4##3##(2008-10#3)(2008-8#1)
of group size##2##3##(2008-8#2)
of group##38##2##(1991-3#2)(1993-12#2)(1994-9#1)(1995-6#1)(1996-12#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
of groups I and II##4##5##(2008-10#4)
of groups I##5##3##(2008-10#5)
of groups in##2##3##(1994-9#1)(2009-1#1)
of groups of##3##3##(1995-2#1)(2008-10#2)
of groups##20##2##(1991-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(2008-10#9)(2008-11#1)(2009-1#1)(2009-12#3)(2012-2#1)
of growing concern##2##3##(2007-12#1)(2008-8#1)
of growing importance##2##3##(2008-10#1)(2008-11#1)
of growing##14##2##(1992-11#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#1)
of growth and##16##3##(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
of growth arrest##3##3##(1997-3#1)(2008-11#1)(2009-5#1)
of growth by##2##3##(1994-8#1)(2008-8#1)
of growth during##2##3##(2008-7#1)(2009-8#1)
of growth factor##2##3##(1990-12#2)
of growth factors##10##3##(1990-12#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#2)(2008-4#1)(2008-6#1)(2013-8#1)
of growth hormone (GH)##2##4##(2010-5#1)(2013-1#1)
of growth hormone and prolactin##2##5##(1993-2#2)
of growth hormone in##3##4##(2012-3#1)(2013-1#1)(2013-7#1)
of growth hormone receptor (GHR)##2##5##(2008-9#1)(2010-5#1)
of growth hormone receptor##4##4##(1993-2#1)(2008-9#2)(2010-5#1)
of growth hormone##12##3##(1993-2#4)(2008-9#2)(2010-5#2)(2012-3#1)(2013-1#2)(2013-7#1)
of growth in##3##3##(1992-2#1)(2008-10#1)(2013-7#1)
of growth of##8##3##(1995-11#1)(1995-9#1)(1996-3#1)(1997-1#1)(2008-10#2)(2011-2#1)(2012-2#1)
of growth or##2##3##(2008-10#1)(2010-8#1)
of growth rate##3##3##(2007-11#2)(2008-11#1)
of growth rates##2##3##(2008-8#2)
of growth temperature##2##3##(2011-2#2)
of growth under##2##3##(1993-9#1)(2008-10#1)
of growth were##3##3##(2008-11#3)
of growth##109##2##(1990-12#3)(1991-1#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-2#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-8#5)(1995-11#3)(1995-2#2)(1995-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-11#4)(2008-1#1)(2008-10#13)(2008-11#13)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
of growth-arrest genes##2##3##(1992-12#2)
of guanethidine##2##2##(1995-12#1)(1997-4#1)
of guanidine hydrochloride with the##2##5##(1993-3#2)
of guanidine hydrochloride with##3##4##(1993-3#3)
of guanidine hydrochloride##4##3##(1993-3#4)
of guanidine##5##2##(1992-6#1)(1993-3#4)
of guanine and##2##3##(1994-8#1)(2008-11#1)
of guanine bases##2##3##(1990-5#2)
of guanine in the presence of##2##6##(2008-10#2)
of guanine in##3##3##(2008-10#3)
of guanine##15##2##(1990-5#2)(1991-5#1)(1994-8#2)(2008-10#9)(2008-11#1)
of guanosine##5##2##(1995-8#1)(2008-4#1)(2009-12#3)
of guest##2##2##(2008-10#1)(2010-12#1)
of guidance and##2##3##(2008-11#1)(2008-12#1)
of guide##2##2##(2011-2#2)
of guideline development##2##3##(2008-7#1)(2008-8#1)
of guiding##4##2##(2008-11#2)(2008-9#1)(2011-2#1)
of guinea pig spermatozoa##2##4##(2008-8#2)
of guinea pig##8##3##(1991-5#1)(1992-3#1)(1992-6#1)(1994-11#1)(2008-8#3)(2013-1#1)
of guppies from##2##3##(2008-8#1)(2012-3#1)
of gustatory##3##2##(2008-11#1)(2008-2#1)(2009-10#1)
of gynecologic malignancy##2##3##(1991-3#1)(2013-8#1)
of gynecologic##5##2##(1991-3#1)(1992-3#1)(1993-3#1)(2012-3#1)(2013-8#1)
of gynecological##2##2##(2010-11#1)(2011-1#1)
of gypsum application on##2##4##(2008-12#2)
of gypsum##4##2##(2008-12#4)
of h-TR beta 1##2##4##(1993-8#2)
of hBD-2 mRNA##2##3##(2008-11#2)
of hCaT1##2##2##(2008-11#2)
of hESC##5##2##(2008-11#2)(2008-9#3)
of hEp##3##2##(1993-12#2)(1993-6#1)
of hFGF-10##2##2##(2011-3#2)
of hFIX##3##2##(2008-8#2)(2008-9#1)
of hFSH-beta##2##2##(1990-4#2)
of hIL-6 and##2##3##(2008-8#2)
of hIL-6##7##2##(2008-11#4)(2008-8#3)
of hIL-6R (V106-P322)##3##3##(2008-8#3)
of hIL-6R with##2##3##(2008-8#2)
of hIL-6R##5##2##(2008-8#5)
of hMSCs in the presence of FGF-2##2##7##(2008-11#2)
of hMSCs##8##2##(2008-11#5)(2010-8#3)
of hMss4##2##2##(1995-8#2)
of hSIM2##2##2##(1996-6#2)
of hTERT transcription##2##3##(2008-11#2)
of hTERT##4##2##(2008-11#4)
of hTERT-immortalized cells##2##3##(2008-11#2)
of hTR##2##2##(1991-6#2)
of habitat in the##2##4##(2008-8#1)(2008-9#1)
of habitat patches##5##3##(2008-8#3)(2008-9#2)
of habitat saturation##2##3##(2008-8#2)
of habitat selection##2##3##(2008-8#2)
of habitat##22##2##(2008-8#17)(2008-9#4)(2010-8#1)
of habitats##2##2##(2008-8#1)(2012-2#1)
of habituation to##2##3##(1994-3#1)(2008-11#1)
of habituation##3##2##(1994-3#1)(1997-2#1)(2008-11#1)
of haemoglobin##3##2##(1994-8#1)(2013-1#2)
of haemolysis##2##2##(1994-8#1)(2008-10#1)
of haemorrhage##5##2##(1992-6#1)(1996-6#2)(1996-9#1)(2008-7#1)
of haemorrhagic enteritis##2##3##(2011-2#2)
of hagfishes##2##2##(2012-2#2)
of hair and##2##3##(2008-10#1)(2008-5#1)
of hair in##2##3##(2008-5#2)
of hair loss##5##3##(2008-5#4)(2010-6#1)
of hair shampoo##4##3##(2008-5#4)
of hair was##2##3##(2012-3#2)
of hair##33##2##(1990-8#2)(2008-10#1)(2008-5#22)(2008-9#2)(2010-6#1)(2011-2#2)(2012-3#3)
of hairpin##3##2##(1991-5#1)(1993-12#1)(2011-1#1)
of hairs##3##2##(2008-5#1)(2011-2#2)
of half##5##2##(1990-6#1)(2008-10#3)(2013-8#1)
of halide##4##2##(1994-5#1)(2008-10#3)
of halides##2##2##(2008-10#2)
of hallucinogenic plants in plant mixtures##2##6##(2008-12#2)
of hallux valgus deformity with primary medial collateral ligamentous insufficiency##2##10##(2012-2#2)
of hallux valgus deformity##3##4##(2012-2#3)
of halo nevi##3##3##(2011-2#3)
of halo##4##2##(2011-2#3)(2012-2#1)
of haloacetic acids##2##3##(2008-10#1)(2008-9#1)
of haloacetic##3##2##(2008-10#2)(2008-9#1)
of halogenated##9##2##(1993-12#1)(2008-10#4)(2008-11#3)(2008-9#1)
of haloperidol##2##2##(1996-12#1)(2008-10#1)
of hamster##2##2##(1994-8#1)(2008-11#1)
of hand containment/massage##2##3##(2008-10#2)
of hand hygiene##2##3##(2008-12#1)(2012-3#1)
of hand##16##2##(1991-6#1)(1992-3#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of handling##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
of haploid##2##2##(1994-11#1)(2008-10#1)
of hapten and bovine serum albumin##2##6##(2008-11#2)
of hapten##5##2##(2008-11#5)
of hard and soft##2##4##(1991-2#1)(2008-10#1)
of hard boundaries and an##2##5##(2008-8#2)
of hard##10##2##(1991-2#1)(1997-2#1)(2008-10#4)(2008-8#3)(2011-2#1)
of hares##3##2##(2013-1#3)
of harmane##2##2##(2008-10#2)
of harmful effects##2##3##(2008-11#1)(2008-7#1)
of harmful##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
of harpin##3##2##(2008-10#1)(2008-8#2)
of harsh##2##2##(2008-9#1)(2009-7#1)
of harvested##2##2##(2008-10#2)
of hatching##2##2##(2008-5#1)(2008-8#1)
of haustoria##2##2##(2008-10#2)
of having a baby with congenital anomalies##2##7##(2008-11#2)
of having a mentor during their first practice placement##2##9##(2008-11#2)
of having a usual source of##2##6##(1995-12#1)(2008-10#1)
of having a##17##3##(1990-9#1)(1995-12#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#3)(2012-3#1)
of having more than one##2##5##(1992-9#1)(1997-2#1)
of having##33##2##(1990-9#1)(1992-2#1)(1992-9#1)(1994-2#1)(1995-12#2)(1996-1#1)(1997-2#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#1)(2010-12#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
of hazardous chemicals##2##3##(2008-9#1)(2010-7#1)
of hazardous materials##2##3##(2008-10#1)(2009-10#1)
of hazardous##9##2##(1996-5#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)
of hazards##2##2##(1995-5#1)(2008-11#1)
of hazmat##2##2##(2009-10#2)
of hcp##2##2##(1990-12#1)(1995-3#1)
of head and neck cancer patients##3##6##(2008-5#3)
of head and neck cancer##7##5##(2007-11#1)(2008-5#4)(2013-1#2)
of head and neck cancers##2##5##(2008-5#1)(2010-4#1)
of head and neck tumors##2##5##(2009-11#1)(2011-2#1)
of head and neck##16##4##(1990-12#1)(2007-11#1)(2008-1#1)(2008-5#5)(2009-11#1)(2010-4#1)(2011-2#2)(2013-1#3)(2013-8#1)
of head concussions##2##3##(2010-1#2)
of head injury##3##3##(2010-8#1)(2012-3#1)(2013-1#1)
of head##28##2##(1990-12#1)(1990-5#1)(1992-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#5)(2009-11#1)(2010-1#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
of head-down tilt##2##3##(1993-1#2)
of headache##10##2##(1994-6#1)(1994-9#1)(1996-9#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2013-1#1)
of headaches##4##2##(2008-4#3)(2008-6#1)
of headspace##4##2##(2008-10#3)(2011-2#1)
of healing##2##2##(2008-11#1)(2011-2#1)
of health administration education##2##4##(1993-2#1)(1996-3#1)
of health administration##7##3##(1993-2#5)(1996-1#1)(1996-3#1)
of health and disease##3##4##(1992-5#1)(1993-11#1)(2010-10#1)
of health and social##2##4##(1992-3#1)(2008-1#1)
of health and##9##3##(1991-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-2#1)
of health care costs##6##4##(1992-2#1)(1994-12#1)(1994-2#2)(1995-1#1)(1996-3#1)
of health care delivery##3##4##(1991-2#1)(1993-2#1)(1993-3#1)
of health care expenditures##3##4##(1992-1#1)(1993-3#1)(1995-3#1)
of health care in##5##4##(1993-2#1)(1995-11#1)(1995-2#1)(1997-4#1)(2008-1#1)
of health care information##4##4##(1992-12#1)(1993-1#1)(1996-2#1)(2008-11#1)
of health care is##2##4##(1992-1#1)(2008-11#1)
of health care organizations##2##4##(1991-3#1)(1997-2#1)
of health care providers##6##4##(1991-2#1)(1993-12#1)(1994-12#1)(1996-9#1)(2008-11#2)
of health care quality##4##4##(1994-1#2)(1994-12#1)(1996-1#1)
of health care reform##11##4##(1993-12#2)(1994-1#1)(1994-2#1)(1995-12#2)(1996-3#2)(1997-3#1)(2010-5#1)(2010-8#1)
of health care resources##3##4##(2008-1#1)(2011-2#1)(2012-3#1)
of health care services##11##4##(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#3)(1994-3#1)(1996-2#1)(1997-1#1)
of health care spending##3##4##(1993-3#1)(1994-1#1)(1995-2#1)
of health care system##2##4##(1995-2#1)(2009-4#1)
of health care to##2##4##(1995-12#1)(1997-3#1)
of health care workers##3##4##(2008-11#1)(2010-11#2)
of health care##124##3##(1990-2#1)(1991-2#4)(1991-3#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#9)(1993-2#4)(1993-3#5)(1994-1#7)(1994-12#7)(1994-2#6)(1994-3#6)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#1)(1996-1#1)(1996-2#5)(1996-3#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#8)(2008-12#1)(2008-4#2)(2008-7#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-8#1)
of health education##4##3##(1997-6#1)(2008-11#1)(2010-12#1)(2013-1#1)
of health expenditures##2##3##(1991-2#1)(1995-3#1)
of health insurance coverage##2##4##(1991-2#1)(1993-3#1)
of health insurance for##2##4##(1992-3#1)(2011-2#1)
of health insurance##8##3##(1991-2#1)(1992-3#2)(1993-3#1)(2008-11#2)(2008-7#1)(2011-2#1)
of health literacy##2##3##(2009-8#2)
of health maintenance organization##2##4##(1996-2#1)(1996-3#1)
of health maintenance##4##3##(1991-3#1)(1994-2#1)(1996-2#1)(1996-3#1)
of health of##2##3##(1992-3#1)(2011-2#1)
of health plan##2##3##(1995-2#1)(1997-3#1)
of health problems##3##3##(1992-3#1)(1997-1#1)(2008-10#1)
of health professionals to##2##4##(2008-11#1)(2008-12#1)
of health professionals##8##3##(1993-12#1)(1994-12#1)(1994-3#1)(2008-11#4)(2008-12#1)
of health promotion in##2##4##(2008-11#1)(2013-8#1)
of health promotion##5##3##(1993-11#1)(2008-11#2)(2009-6#1)(2013-8#1)
of health providers##2##3##(1997-2#1)(2011-2#1)
of health reform##4##3##(1994-1#1)(1996-1#1)(1996-3#2)
of health service##4##3##(1991-2#1)(1993-2#1)(1997-2#1)(2008-7#1)
of health services administration##3##4##(1994-2#1)(1996-1#1)(1997-3#1)
of health services##20##3##(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-2#3)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(2008-11#1)(2008-12#1)(2009-3#1)
of health spending##4##3##(1991-2#1)(1992-12#1)(1996-2#1)(1997-3#1)
of health status and##2##4##(1996-2#1)(1997-1#1)
of health status##4##3##(1996-2#1)(1997-1#2)(2008-7#1)
of health systems##2##3##(1991-3#1)(2013-8#1)
of health##278##2##(1990-12#1)(1990-2#2)(1991-2#10)(1991-3#4)(1991-6#1)(1992-1#4)(1992-12#3)(1992-2#3)(1992-3#7)(1992-5#1)(1993-1#2)(1993-11#5)(1993-12#13)(1993-2#12)(1993-3#7)(1993-6#1)(1994-1#8)(1994-12#9)(1994-2#10)(1994-3#7)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#3)(1996-1#4)(1996-2#9)(1996-3#8)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#9)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-1#8)(2008-10#9)(2008-11#21)(2008-12#5)(2008-4#3)(2008-7#6)(2008-8#3)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-10#5)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#3)
of health-related##2##2##(1997-3#1)(2008-1#1)
of health-risk behaviors##2##3##(2010-5#1)(2010-7#1)
of healthcare in##2##3##(2008-10#1)(2013-1#1)
of healthcare professionals##2##3##(1991-1#1)(2008-11#1)
of healthcare resources##2##3##(2012-2#2)
of healthcare services##3##3##(1994-3#1)(2008-1#1)(2012-2#1)
of healthcare systems##2##3##(2009-3#1)(2012-2#1)
of healthcare##30##2##(1991-1#1)(1992-12#1)(1992-8#1)(1994-3#1)(1995-1#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-3#1)(2009-8#2)(2010-1#1)(2010-4#1)(2012-2#4)(2013-1#9)
of healthy and diseased##2##4##(2008-10#2)
of healthy and##5##3##(2008-10#3)(2008-11#2)
of healthy children##3##3##(1995-2#2)(2008-12#1)
of healthy controls##2##3##(1990-2#1)(1991-12#1)
of healthy individuals##7##3##(2008-10#2)(2008-7#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#1)
of healthy lifestyle##2##3##(2008-12#1)(2013-1#1)
of healthy subjects and##2##4##(2008-12#1)(2010-12#1)
of healthy subjects##4##3##(2008-12#1)(2010-12#1)(2013-1#1)(2013-8#1)
of healthy##58##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1993-2#1)(1995-2#2)(1996-2#1)(1997-4#1)(2006-6#1)(2008-10#18)(2008-11#7)(2008-12#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
of hearing and##2##3##(1990-12#1)(2011-2#1)
of hearing loss##3##3##(1996-6#1)(2008-9#2)
of hearing##20##2##(1990-12#3)(1994-9#2)(1996-6#1)(2008-9#4)(2011-2#9)(2012-2#1)
of heart and##2##3##(2008-8#1)(2011-2#1)
of heart disease and##2##4##(2008-10#1)(2008-12#1)
of heart disease##6##3##(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)
of heart failure##15##3##(1994-6#1)(2008-3#1)(2008-7#3)(2009-10#3)(2010-6#4)(2012-2#1)(2013-1#2)
of heart##31##2##(1994-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-10#3)(2010-12#1)(2010-6#4)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#4)
of heat and##3##3##(1992-2#2)(1996-12#1)
of heat on##2##3##(2008-3#1)(2013-8#1)
of heat shock protein##2##4##(1994-8#1)(2008-7#1)
of heat shock##3##3##(1994-8#2)(2008-7#1)
of heat##24##2##(1990-10#1)(1990-12#1)(1992-2#2)(1992-3#4)(1994-5#1)(1994-8#2)(1996-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of heat-shock##2##2##(1993-6#1)(2008-7#1)
of heating and##3##3##(1990-9#1)(2008-10#2)
of heating in##2##3##(1994-5#1)(2008-10#1)
of heating##7##2##(1990-9#1)(1994-5#1)(2008-10#5)
of heavy metal ions from aqueous##2##6##(2008-10#2)
of heavy metal ions from##3##5##(1994-6#1)(2008-10#2)
of heavy metal ions in##2##5##(2008-10#2)
of heavy metal ions onto##2##5##(2008-10#2)
of heavy metal ions##17##4##(1994-6#1)(2008-10#16)
of heavy metal##24##3##(1993-12#1)(1994-6#1)(2008-10#20)(2013-1#2)
of heavy metals from##2##4##(2008-10#2)
of heavy metals in different tissues of##2##7##(2008-12#2)
of heavy metals in different##3##5##(2008-11#1)(2008-12#2)
of heavy metals in the##2##5##(2008-10#1)(2011-2#1)
of heavy metals in##12##4##(2008-10#8)(2008-11#1)(2008-12#2)(2011-2#1)
of heavy metals with##2##4##(2008-10#1)(2008-11#1)
of heavy metals##29##3##(1994-6#1)(2008-10#22)(2008-11#2)(2008-12#3)(2011-2#1)
of heavy##59##2##(1993-12#1)(1994-6#2)(1997-1#1)(1997-9#1)(2008-10#43)(2008-11#2)(2008-12#3)(2008-4#1)(2011-2#3)(2013-1#2)
of hedgehog##2##2##(1993-2#2)
of height##2##2##(2008-8#1)(2011-2#1)
of helminth##2##2##(1997-7#1)(2007-12#1)
of helminthes##2##2##(2011-2#2)
of help for##2##3##(1992-5#1)(2008-4#1)
of help##4##2##(1992-5#1)(1996-3#1)(2008-10#1)(2008-4#1)
of helper virus##2##3##(1990-5#1)(2008-10#1)
of helper##5##2##(1990-5#1)(1992-3#1)(1997-3#1)(2008-10#2)
of helping##4##2##(1991-12#1)(1993-1#1)(2008-12#1)(2008-8#1)
of hematocrit##2##2##(2008-3#1)(2013-1#1)
of hematological malignancies##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
of hematology##2##2##(2008-10#1)(2011-2#1)
of hematopoiesis##2##2##(2008-10#1)(2008-8#1)
of hematopoietic cells##5##3##(1996-2#1)(1997-7#1)(2008-11#2)(2008-7#1)
of hematopoietic progenitor cells##2##4##(2008-11#2)
of hematopoietic progenitors##4##3##(2008-11#2)(2010-8#1)(2011-2#1)
of hematopoietic stem cells from##2##5##(2008-10#1)(2008-9#1)
of hematopoietic stem cells##6##4##(2008-10#3)(2008-9#3)
of hematopoietic stem##7##3##(2008-10#3)(2008-9#3)(2012-12#1)
of hematopoietic##23##2##(1993-8#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#7)(2008-7#1)(2008-9#4)(2010-8#2)(2011-2#1)(2012-12#1)
of hematoporphyrin##2##2##(2008-8#1)(2008-9#1)
of heme and##2##3##(2008-9#2)
of heme polymerase##2##3##(1993-8#2)
of heme##9##2##(1993-8#3)(1994-5#2)(2008-9#3)(2010-12#1)
of heme-protein##2##2##(2008-10#2)
of hemerythrin##2##2##(1991-10#1)(1992-8#1)
of hemi-fusion in##2##3##(1991-5#2)
of hemin##8##2##(1994-5#2)(2008-10#5)(2008-8#1)
of hemocytes##6##2##(2008-5#4)(2008-7#1)(2010-4#1)
of hemodialysis (HD)##2##3##(2008-1#1)(2011-2#1)
of hemodialysis facilities##2##3##(1991-12#2)
of hemodialysis##9##2##(1991-12#2)(2008-1#3)(2011-2#2)(2013-1#2)
of hemodynamic and##2##3##(1993-9#1)(2012-12#1)
of hemodynamic##7##2##(1990-8#1)(1993-9#1)(1997-5#1)(2007-8#1)(2009-1#1)(2012-12#1)(2012-3#1)
of hemoglobin A1c##2##3##(2012-5#2)
of hemoglobin in##4##3##(2008-10#3)(2008-9#1)
of hemoglobin using##2##3##(2008-10#2)
of hemoglobin##22##2##(1990-8#4)(1990-9#1)(1993-8#1)(2008-1#1)(2008-10#9)(2008-9#1)(2009-3#2)(2010-11#1)(2012-5#2)
of hemolymph##2##2##(1997-8#2)
of hemolysis##2##2##(2013-1#2)
of hemopoietic##2##2##(1993-3#1)(1994-5#1)
of hemorrhage##3##2##(2008-7#1)(2009-8#1)(2012-3#1)
of hemorrhagic##5##2##(1991-6#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
of hemostasis##5##2##(2008-10#1)(2008-9#1)(2013-1#3)
of heparan sulfate in##2##4##(1995-12#2)
of heparan##3##2##(1995-12#2)(1996-8#1)
of heparin in##3##3##(1992-10#2)(2008-10#1)
of heparin to##2##3##(1992-10#1)(2008-11#1)
of heparin##18##2##(1992-10#4)(1996-6#1)(1997-1#2)(2008-10#6)(2008-11#3)(2008-4#1)(2011-2#1)
of heparin-induced extracorporeal lipoprotein apheresis##2##5##(2011-2#2)
of hepatic glucagon##2##3##(1994-11#2)
of hepatic glucose production##4##4##(1991-7#1)(1993-8#2)(2008-1#1)
of hepatic glucose##5##3##(1991-7#2)(1993-8#2)(2008-1#1)
of hepatic##39##2##(1990-5#2)(1991-11#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-2#1)(1993-12#3)(1993-8#2)(1994-11#2)(1994-8#2)(1995-6#1)(1996-2#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#2)(2013-1#2)
of hepatitis A##3##3##(2007-12#2)(2008-7#1)
of hepatitis B virus (HBV)##2##5##(1990-8#1)(2009-8#1)
of hepatitis B virus surface antigen Pre-S1##2##7##(2008-8#2)
of hepatitis B virus surface antigen##3##6##(2008-8#3)
of hepatitis B virus##12##4##(1990-8#2)(1994-8#2)(1996-3#2)(2008-8#4)(2009-8#1)(2013-1#1)
of hepatitis B##17##3##(1990-8#2)(1994-8#2)(1995-3#1)(1996-3#4)(2008-8#4)(2009-8#1)(2013-1#1)(2013-7#2)
of hepatitis C virus (HCV)##5##5##(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#2)
of hepatitis C virus##9##4##(2008-1#1)(2008-10#4)(2008-8#1)(2011-2#1)(2013-1#2)
of hepatitis C##11##3##(2008-1#1)(2008-10#4)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#2)
of hepatitis##35##2##(1990-8#2)(1994-11#1)(1994-8#2)(1995-3#1)(1996-3#5)(2007-12#2)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#5)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#3)(2013-7#2)
of hepatoblastoma##3##2##(2011-1#3)
of hepatocarcinoma##2##2##(2010-1#1)(2013-1#1)
of hepatocellular carcinoma (HCC)##3##4##(2008-10#1)(2010-12#1)(2013-7#1)
of hepatocellular carcinoma in a##2##5##(1993-2#1)(2011-2#1)
of hepatocellular carcinoma##10##3##(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-7#2)(2011-2#1)(2013-7#1)
of hepatocellular##12##2##(1993-2#2)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-7#1)
of hepatocyte cytoplasmic vacuolization were increased in males##2##8##(2008-9#2)
of hepatocyte cytoplasmic vacuolization##3##4##(2008-9#3)
of hepatocyte growth factor##3##4##(2008-11#3)
of hepatocyte##10##2##(1996-2#1)(2008-11#5)(2008-9#4)
of hepatocytes and##3##3##(1993-3#1)(2008-11#2)
of hepatocytes in##2##3##(1994-8#1)(2008-11#1)
of hepatocytes##15##2##(1990-5#1)(1993-3#1)(1994-11#1)(1994-8#2)(1996-2#1)(2008-11#7)(2008-6#1)(2012-2#1)
of hepatoma cell invasion##2##4##(2008-11#2)
of hepatoma cells##6##3##(2008-11#6)
of hepatoma##9##2##(2008-11#8)(2013-8#1)
of her left##2##3##(1996-8#1)(2008-12#1)
of her right##4##3##(1991-12#1)(2008-12#1)(2008-5#1)(2010-3#1)
of her symptoms##3##3##(2008-7#2)(2013-1#1)
of her##23##2##(1991-12#2)(1991-3#1)(1992-9#1)(1995-6#1)(1996-8#1)(1997-3#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
of her-2/neu##2##2##(2008-10#1)(2008-11#1)
of herb##2##2##(2008-10#2)
of herbal products##2##3##(2008-10#1)(2013-1#1)
of herbal shampoos##2##3##(2008-5#2)
of herbal##9##2##(2008-10#2)(2008-5#2)(2009-12#2)(2013-1#2)(2013-7#1)
of herbicide##2##2##(2008-10#1)(2008-11#1)
of herbicides##6##2##(1996-3#2)(2008-10#4)
of herbivore-induced##2##2##(1990-11#1)(2008-9#1)
of herbivores##4##2##(2008-8#2)(2008-9#2)
of herbivorous##2##2##(2008-8#2)
of herbivory##5##2##(2008-8#2)(2008-9#3)
of hereditary breast##2##3##(1995-12#1)(2011-2#1)
of hereditary cancer##2##3##(2011-2#2)
of hereditary##14##2##(1995-12#1)(1996-11#1)(1997-7#3)(2009-12#1)(2010-11#1)(2010-6#1)(2011-2#5)(2012-3#1)
of heritability##3##2##(1997-7#1)(2008-10#1)(2009-4#1)
of hermaphroditism in animals##2##4##(2008-8#2)
of hermaphroditism##3##2##(2008-8#3)
of hernia is##2##3##(1990-5#1)(2008-12#1)
of hernia##5##2##(1990-5#1)(2008-12#2)(2010-8#1)(2012-12#1)
of herniation##4##2##(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)
of heroin##2##2##(1996-11#1)(2008-11#1)
of herpes simplex virus DNA polymerase##2##6##(1995-2#2)
of herpes simplex##3##3##(1994-11#1)(1995-2#2)
of herpes##4##2##(1994-11#1)(1995-2#2)(2008-5#1)
of heterochromatin##3##2##(2008-12#3)
of heterocyclic amines##2##3##(1997-2#1)(2008-10#1)
of heterogeneity of the##2##4##(2008-10#2)
of heterogeneity of##3##3##(2008-10#3)
of heterogeneity##12##2##(1994-8#1)(1996-3#1)(2008-10#10)
of heterogeneous##6##2##(2008-10#3)(2008-8#3)
of heterologous protein##2##3##(2008-11#1)(2008-7#1)
of heterologous##9##2##(1994-6#1)(1995-5#2)(1996-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#1)
of heteroplasmy##2##2##(2013-8#2)
of heterosis in rice##2##4##(2008-8#2)
of heterosis##3##2##(2008-8#2)(2009-10#1)
of heterotopic ossification##4##3##(1994-8#2)(2012-12#2)
of heterotopic##5##2##(1994-8#2)(1997-8#1)(2012-12#2)
of heterotrimeric G proteins##2##4##(1995-6#1)(1995-8#1)
of heterozygosity##6##2##(1993-11#1)(1995-12#1)(1997-2#1)(1997-5#1)(2012-3#2)
of heterozygotes##4##2##(1995-2#1)(2008-10#2)(2008-6#1)
of heterozygous##3##2##(1995-2#1)(2013-1#2)
of hexacyanoferrate(III)##3##2##(2008-10#3)
of hexagonal##2##2##(1991-5#1)(2008-3#1)
of hexane##2##2##(2008-10#1)(2008-11#1)
of hexaploid##3##2##(2008-10#1)(2010-8#2)
of hexavalent chromium##8##3##(2008-10#5)(2008-12#2)(2011-2#1)
of hexavalent##9##2##(2008-10#6)(2008-12#2)(2011-2#1)
of hfNSCs in##2##3##(2009-10#2)
of hidden##3##2##(1995-5#1)(2008-10#1)(2012-3#1)
of hierarchical##4##2##(1997-2#1)(2008-10#1)(2008-4#1)(2009-5#1)
of high affinity##7##3##(1990-11#1)(1992-6#1)(1993-6#1)(1995-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
of high amounts of##2##4##(1991-5#1)(1994-11#1)
of high and low##2##4##(2008-10#1)(2011-2#1)
of high and##3##3##(2008-10#2)(2011-2#1)
of high blood pressure##2##4##(1993-2#1)(1994-6#1)
of high cell density##2##4##(2008-11#2)
of high cell##3##3##(2008-11#3)
of high concentration of##2##4##(2008-10#1)(2008-5#1)
of high concentration##3##3##(2008-10#2)(2008-5#1)
of high concentrations of##7##4##(1990-12#1)(2008-10#3)(2008-11#2)(2008-3#1)
of high cost##2##3##(2008-10#1)(2008-11#1)
of high density##4##3##(1990-5#1)(1991-10#1)(1993-2#1)(2008-10#1)
of high dose##2##3##(1996-8#1)(2008-11#1)
of high doses of##3##4##(1992-9#1)(1997-3#1)(2008-10#1)
of high frequency ventilation##2##4##(1994-6#2)
of high frequency##3##3##(1994-6#2)(2011-2#1)
of high glucose##2##3##(1992-6#1)(2012-5#1)
of high level##2##3##(2008-11#1)(2012-3#1)
of high levels of##8##4##(1992-9#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-8#1)
of high molecular weight##7##4##(1990-12#1)(1991-9#1)(1996-12#1)(2008-10#2)(2010-11#2)
of high performance liquid chromatography (HPLC)##3##6##(2008-10#3)
of high priority##2##3##(2008-10#1)(2012-3#1)
of high purity arsenic through##2##5##(2008-10#2)
of high purity##7##3##(2008-10#6)(2008-11#1)
of high quality##4##3##(1995-1#1)(2008-10#1)(2008-11#1)(2013-7#1)
of high relative humidity##3##4##(2008-10#3)
of high risk##2##3##(1994-3#1)(1995-1#1)
of high sensitivity##3##3##(2008-10#3)
of high temperature##3##3##(2008-10#3)
of high##166##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-2#3)(1993-5#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#59)(2008-11#17)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#3)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#2)
of high-dose##4##2##(1990-12#1)(1993-9#1)(1996-6#1)(2008-7#1)
of high-energy##5##2##(1993-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
of high-flow priapism in##2##4##(2008-10#2)
of high-grade##5##2##(2008-10#2)(2011-2#1)(2013-1#2)
of high-level##2##2##(2008-10#1)(2008-11#1)
of high-molecular-weight polycyclic aromatic##2##4##(2011-1#2)
of high-molecular-weight##3##2##(2008-4#1)(2011-1#2)
of high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
of high-performance liquid chromatography##4##4##(1997-2#1)(2008-10#3)
of high-performance liquid##5##3##(1997-2#1)(2008-10#4)
of high-performance##9##2##(1997-2#1)(2008-10#6)(2008-7#1)(2010-12#1)
of high-power##2##2##(2008-2#1)(2008-3#1)
of high-quality##6##2##(1993-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-9#1)
of high-resolution##5##2##(1991-6#1)(2008-3#2)(2009-9#1)(2011-2#1)
of high-risk infants##3##3##(2008-11#3)
of high-risk##7##2##(1993-3#2)(2008-11#3)(2011-2#1)(2013-1#1)
of high-throughput##5##2##(2008-11#1)(2008-7#1)(2009-4#2)(2012-3#1)
of higher education for##2##4##(2008-12#2)
of higher levels of##5##4##(1993-11#1)(2008-11#2)(2008-8#1)(2009-11#1)
of higher plant##2##3##(1994-12#1)(2008-11#1)
of higher##40##2##(1992-12#2)(1993-11#1)(1993-3#2)(1994-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#3)(2012-5#2)
of higher-order##6##2##(2007-12#2)(2008-11#2)(2008-3#2)
of highest##5##2##(2008-10#2)(2008-9#1)(2009-10#1)(2012-2#1)
of highly active##4##3##(2008-1#1)(2008-10#1)(2009-7#1)(2011-2#1)
of highly conserved##2##3##(1995-6#1)(2010-7#1)
of highly differentiated##2##3##(2008-11#1)(2013-1#1)
of highly efficient##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of highly heterogeneous##2##3##(2008-10#1)(2008-6#1)
of highly resistant##2##3##(2008-10#1)(2013-1#1)
of highly sensitive##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
of highly##47##2##(1991-2#1)(1991-5#1)(1993-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#2)(2010-7#2)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#2)
of hind##2##2##(1997-2#1)(2010-12#1)
of hindfoot##2##2##(2012-2#1)(2012-3#1)
of hip arthroplasty##2##3##(2012-2#1)(2013-1#1)
of hip##9##2##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#3)
of hippocampal 5-HT1A##2##3##(1994-2#2)
of hippocampal##12##2##(1991-2#1)(1993-12#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(2008-11#1)(2013-8#1)
of hippocampus##4##2##(1990-11#1)(1994-2#1)(2008-12#2)
of his head##2##3##(2011-2#1)(2013-8#1)
of his life##2##3##(2008-11#1)(2012-3#1)
of his neurological##2##3##(2008-7#1)(2011-2#1)
of his symptoms##2##3##(2010-1#1)(2011-2#1)
of his##48##2##(1991-6#1)(1993-11#3)(1993-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-6#1)(1996-9#2)(1997-5#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-12#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#2)(2010-1#4)(2010-5#1)(2010-6#1)(2011-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
of his/her##2##2##(1992-12#1)(2012-3#1)
of histamine in##2##3##(1995-12#1)(2008-10#1)
of histamine##11##2##(1994-6#1)(1995-12#2)(1997-1#1)(2008-10#4)(2008-12#3)
of histamine-induced##2##2##(1994-8#1)(2008-5#1)
of histidine and its metabolites##2##5##(2008-10#2)
of histidine in##2##3##(1995-3#1)(2008-10#1)
of histidine##13##2##(1994-11#1)(1994-5#2)(1995-3#1)(1997-1#1)(2008-10#7)(2008-8#1)
of histiocytic##2##2##(1991-3#1)(2012-12#1)
of histologic verification##2##3##(1991-2#2)
of histologic##5##2##(1991-2#2)(1994-12#1)(2009-3#1)(2011-2#1)
of histological##9##2##(1991-6#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-4#1)(2011-2#2)
of histologically##3##2##(1994-1#2)(1997-8#1)
of histone H2AX##2##3##(2008-9#2)
of histone modifications##2##3##(2009-8#1)(2011-2#1)
of histone##8##2##(1997-2#1)(2008-10#2)(2008-9#2)(2009-8#1)(2011-2#1)(2013-8#1)
of histopathological##2##2##(2012-3#2)
of historic##5##2##(2008-10#2)(2008-2#3)
of historical##5##2##(2008-10#3)(2008-12#1)(2008-3#1)
of history##6##2##(2008-12#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
of hit compounds##2##3##(2013-1#2)
of hnRNP##2##2##(2008-8#2)
of holistic##8##2##(2008-11#5)(2008-12#1)(2009-11#1)(2009-8#1)
of hollow##2##2##(2008-11#1)(2008-3#1)
of homatropine methylbromide##2##3##(2008-10#2)
of home care##7##3##(1991-3#3)(1992-2#1)(1995-2#2)(2012-2#1)
of home health care##4##4##(1995-3#4)
of home health services##4##4##(1995-3#4)
of home health##11##3##(1994-2#1)(1995-3#10)
of home##30##2##(1991-1#1)(1991-2#1)(1991-3#3)(1992-2#1)(1994-2#1)(1995-12#1)(1995-2#3)(1995-3#10)(1997-4#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of home-based##2##2##(2007-12#1)(2008-10#1)
of homeostasis system##2##3##(2013-1#2)
of homeostasis##4##2##(1993-6#1)(2012-2#1)(2013-1#2)
of homocysteine##8##2##(2008-10#6)(2008-8#1)(2011-2#1)
of homogeneity in##2##3##(2011-2#1)(2012-3#1)
of homogeneity##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
of homogeneous##4##2##(1992-10#1)(1994-5#1)(2008-10#1)(2012-12#1)
of homologous blood##2##3##(1990-2#1)(1992-3#1)
of homologous##14##2##(1990-2#1)(1992-3#1)(1992-6#2)(1993-2#1)(1994-5#2)(2008-10#4)(2008-11#1)(2008-12#1)(2010-8#1)
of homology in##2##3##(1994-11#1)(2008-4#1)
of homology to##4##3##(1992-8#1)(1993-12#1)(1993-2#1)(2008-10#1)
of homology with##2##3##(1996-12#1)(2008-9#1)
of homology##16##2##(1990-7#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
of honey and##2##3##(2008-10#2)
of honey with##3##3##(2008-10#2)(2011-2#1)
of honey##7##2##(2008-10#5)(2011-2#2)
of honeybee behaviour##2##3##(2008-7#2)
of honeybees##2##2##(2008-10#1)(2008-7#1)
of honokiol and magnolol in##3##5##(2008-10#3)
of honokiol and magnolol##4##4##(2008-10#4)
of hop powdery mildew##3##4##(2008-10#3)
of hop stunt viroid##2##4##(2008-10#2)
of hop##5##2##(2008-10#5)
of hope and expectancy##2##4##(2008-11#2)
of hope##5##2##(1997-5#1)(2008-11#2)(2010-10#2)
of horizontal transmission##2##3##(2012-3#2)
of horizontal##7##2##(2008-3#3)(2008-7#1)(2009-6#1)(2012-3#2)
of hormesis in##4##3##(2008-7#4)
of hormetic##2##2##(2008-7#2)
of hormonal##6##2##(1990-6#1)(1991-3#1)(1995-11#1)(2008-10#1)(2008-6#1)(2012-2#1)
of hormone and##2##3##(1995-11#1)(2009-10#1)
of hormone replacement therapy##2##4##(2010-12#1)(2012-3#1)
of hormone therapy##2##3##(2008-11#2)
of hormone##15##2##(1990-11#1)(1993-2#1)(1995-11#1)(1996-12#1)(1997-7#2)(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
of hormone-dependent##2##2##(1993-1#1)(2008-10#1)
of hormone-related##3##2##(1990-6#1)(1995-9#1)(2009-8#1)
of hormones and##3##3##(1993-12#1)(2008-4#1)(2013-7#1)
of hormones in##2##3##(2008-8#1)(2010-5#1)
of hormones##11##2##(1993-12#1)(1997-2#1)(1997-4#1)(2008-4#1)(2008-8#3)(2009-8#1)(2010-5#1)(2013-7#2)
of horse chestnut##2##3##(2008-5#2)
of horse##6##2##(1990-8#1)(1994-5#2)(2008-10#1)(2008-5#2)
of horseradish peroxidase (HRP) and##2##5##(2008-10#2)
of horseradish peroxidase (HRP)##7##4##(2008-10#7)
of horseradish peroxidase##12##3##(1994-5#1)(1997-2#1)(2008-10#10)
of horses##2##2##(2012-3#1)(2013-1#1)
of hospital and##3##3##(1991-12#1)(2008-11#1)(2011-2#1)
of hospital care and##2##4##(1994-2#1)(2008-8#1)
of hospital care##9##3##(1991-3#4)(1992-3#1)(1994-2#2)(1994-3#1)(2008-8#1)
of hospital governing boards##2##4##(1991-1#1)(1991-12#1)
of hospital outpatient##2##3##(1991-2#1)(1992-12#1)
of hospital security##3##3##(1991-12#1)(1993-2#1)(1996-12#1)
of hospital services in##2##4##(1991-2#1)(1993-2#1)
of hospital services##3##3##(1991-1#1)(1991-2#1)(1993-2#1)
of hospital stay##11##3##(1991-12#3)(1992-12#1)(1992-2#1)(1996-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
of hospital##61##2##(1990-11#1)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#6)(1992-12#2)(1992-2#2)(1992-3#3)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#3)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
of hospital-acquired##2##2##(2008-10#1)(2013-1#1)
of hospital-based##2##2##(1991-1#1)(1991-3#1)
of hospitalisation##2##2##(1994-5#1)(2008-11#1)
of hospitalization and##5##3##(1992-2#1)(1995-2#2)(2008-10#1)(2008-11#1)
of hospitalization for##2##3##(1995-12#1)(2008-11#1)
of hospitalization##20##2##(1991-2#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-2#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2011-2#3)(2013-1#3)
of hospitalizations and##3##3##(1995-1#1)(2008-11#1)(2012-3#1)
of hospitalizations for##2##3##(1995-12#1)(2008-11#1)
of hospitalizations##5##2##(1995-1#1)(1995-12#1)(2008-11#2)(2012-3#1)
of hospitalized children##3##3##(1991-2#1)(2013-1#2)
of hospitals serving##2##3##(1991-6#1)(1992-2#1)
of hospitals to##2##3##(1992-2#1)(1996-3#1)
of hospitals##22##2##(1990-9#1)(1991-2#1)(1991-6#1)(1992-12#3)(1992-2#2)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-2#1)(2008-11#2)(2008-3#1)
of host DNA##2##3##(2008-10#2)
of host and parasite##2##4##(2008-8#2)
of host and pathogen##2##4##(2008-10#2)
of host and##4##3##(2008-10#2)(2008-8#2)
of host cell##2##3##(2008-10#2)
of host cytoplasm##2##3##(2008-10#2)
of host defense##2##3##(2008-10#2)
of host diversity on##4##4##(2008-10#4)
of host diversity##6##3##(2008-10#6)
of host functions##2##3##(2008-9#1)(2013-1#1)
of host genotype in##2##4##(2008-10#2)
of host genotype##4##3##(2008-10#4)
of host genotypes on##2##4##(2008-10#2)
of host genotypes##4##3##(2008-10#4)
of host phenology##2##3##(2008-10#2)
of host plant infection by##2##5##(2008-10#2)
of host plant##5##3##(2008-10#5)
of host plants with##2##4##(2008-10#2)
of host plants##12##3##(2007-12#2)(2008-10#9)(2009-8#1)
of host range##2##3##(2008-10#1)(2008-11#1)
of host resistance and##3##4##(2008-10#2)(2008-8#1)
of host resistance##11##3##(2008-10#7)(2008-8#3)(2009-10#1)
of host specialization##3##3##(2008-10#2)(2008-9#1)
of host species##4##3##(2008-10#3)(2008-8#1)
of host tissue##3##3##(2008-10#3)
of host traits##2##3##(2008-8#1)(2012-3#1)
of host##112##2##(1995-9#1)(2007-12#2)(2008-10#85)(2008-11#3)(2008-8#8)(2008-9#5)(2009-10#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of host-diversity effects##3##3##(2008-10#3)
of host-parasite associations##2##3##(2008-8#1)(2012-3#1)
of host-parasite##5##2##(2008-10#1)(2008-8#3)(2012-3#1)
of host-pathogen interactions##3##3##(2008-10#1)(2008-9#2)
of host-specific virulence in##2##4##(2008-10#2)
of host-specific##4##2##(2008-10#3)(2009-8#1)
of hosts and##2##3##(2008-9#1)(2013-1#1)
of hosts##6##2##(1996-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
of hot##3##2##(1992-6#1)(2009-5#1)(2011-2#1)
of hot-carrier luminescence from##2##4##(2007-12#2)
of hourly##2##2##(2008-11#1)(2008-3#1)
of hours of continuous##2##4##(2008-10#2)
of hours##8##2##(1990-3#2)(1997-5#2)(2008-10#4)
of household labor##2##3##(2011-2#2)
of household##5##2##(2008-12#1)(2011-2#4)
of how stress##2##3##(2009-8#1)(2012-2#1)
of how the##20##3##(1990-9#1)(1992-10#1)(1993-1#1)(1997-3#1)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-3#1)(2012-3#1)(2013-1#2)
of how these##8##3##(1995-9#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
of how they##2##3##(2008-11#1)(2008-9#1)
of how this##2##3##(2008-11#1)(2008-9#1)
of how to##9##3##(1994-2#1)(1994-3#1)(1996-6#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#1)(2012-3#1)
of how##88##2##(1990-11#1)(1990-5#1)(1990-9#1)(1992-10#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#15)(2008-12#2)(2008-2#1)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#9)(2009-10#1)(2009-12#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#3)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
of huge##3##2##(2008-11#1)(2008-7#1)(2013-7#1)
of hull##2##2##(2008-8#2)
of human B cell##2##4##(2008-11#1)(2008-8#1)
of human B##3##3##(1992-8#1)(2008-11#1)(2008-8#1)
of human Cu##2##3##(1997-8#2)
of human DNA##4##3##(1996-6#1)(1997-7#1)(2008-12#1)(2008-5#1)
of human IgG##2##3##(1996-12#1)(2008-10#1)
of human NK##2##3##(2008-4#1)(2008-8#1)
of human P-glycoprotein##2##3##(2013-1#2)
of human Schwann cells##2##4##(1995-2#2)
of human T cell##5##4##(1995-12#2)(2008-11#3)
of human T##6##3##(1995-12#2)(2008-11#4)
of human T-lymphocytes##2##3##(2008-11#2)
of human adenovirus##5##3##(2013-8#5)
of human aging##3##3##(2008-11#1)(2009-8#2)
of human and animal##2##4##(2008-12#1)(2009-7#1)
of human and mouse##2##4##(2008-4#1)(2013-1#1)
of human and murine##6##4##(1990-12#1)(1992-2#2)(1993-8#1)(1994-11#1)(2013-1#1)
of human and##16##3##(1990-12#1)(1992-2#2)(1993-8#2)(1994-11#1)(1995-12#1)(1997-6#1)(2008-12#2)(2008-4#1)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#2)
of human antibody in CHO cells##2##6##(2008-11#2)
of human atherosclerosis##2##3##(1997-8#1)(2010-9#1)
of human beings##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
of human beta 1 thyroid hormone receptor##2##7##(1993-8#2)
of human blood##5##3##(1993-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
of human bone marrow mesenchymal stem cells (MSCs)##2##8##(2008-11#2)
of human bone marrow mesenchymal stem cells##3##7##(2008-11#3)
of human bone marrow##4##4##(2008-11#3)(2008-9#1)
of human brain##6##3##(1991-5#1)(1997-2#2)(2008-10#1)(2008-7#1)(2009-8#1)
of human breast cancer##7##4##(1993-1#1)(1993-11#1)(1994-12#1)(1994-8#1)(2008-11#2)(2012-3#1)
of human breast##10##3##(1993-1#1)(1993-11#2)(1994-12#1)(1994-8#1)(1996-10#1)(2008-11#2)(2011-2#1)(2012-3#1)
of human cancer cells##2##4##(2008-11#2)
of human cancer##4##3##(2008-11#4)
of human cancers##6##3##(1997-7#1)(2008-11#1)(2008-8#1)(2013-1#3)
of human cell lines##2##4##(2008-11#2)
of human cell##4##3##(1995-8#1)(1996-2#1)(2008-11#2)
of human cells##5##3##(1993-3#1)(1995-6#1)(1997-3#2)(2008-11#1)
of human chondrocytes##2##3##(2008-11#2)
of human chromosome 7##2##4##(1996-6#2)
of human chromosome##4##3##(1996-2#1)(1996-6#2)(1997-8#1)
of human colon##2##3##(1994-8#1)(2008-11#1)
of human cytomegalovirus (HCMV)##3##4##(1993-8#1)(1996-12#1)(1997-3#1)
of human cytomegalovirus##4##3##(1993-8#2)(1996-12#1)(1997-3#1)
of human cytosolic purine 5'-nucleotidase##2##5##(1994-11#2)
of human dihydrolipoamide dehydrogenase##2##4##(1995-6#2)
of human disease##4##3##(1994-5#1)(2008-11#1)(2008-4#1)(2008-9#1)
of human diseases##2##3##(2009-8#1)(2011-2#1)
of human embryonic stem cells##3##5##(2008-11#2)(2008-9#1)
of human embryonic stem##4##4##(2008-11#2)(2008-9#2)
of human enterovirus 71##2##4##(2013-8#2)
of human erythrocyte membranes##2##4##(2008-8#1)(2009-8#1)
of human erythrocyte##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
of human erythrocytes##3##3##(1991-5#1)(1995-6#2)
of human exposure##2##3##(1992-3#1)(2013-1#1)
of human factor IX mutant##2##5##(2008-9#2)
of human fetal##6##3##(1992-5#1)(2008-11#1)(2008-9#2)(2009-10#2)
of human fibroblast##2##3##(2008-12#1)(2008-5#1)
of human fibroblasts##3##3##(1990-5#1)(1994-3#1)(2013-1#1)
of human fibrosarcoma##2##3##(2008-11#1)(2011-2#1)
of human foetal liver Zn-metallothioneins##2##5##(2008-10#2)
of human hair and##2##4##(2008-10#2)
of human hair##9##3##(2008-10#2)(2008-5#7)
of human health##2##3##(1991-2#1)(2011-2#1)
of human hematopoietic progenitor##2##4##(2008-11#2)
of human hematopoietic##6##3##(2008-11#6)
of human hepatocellular##2##3##(2011-2#2)
of human hepatoma##4##3##(1995-2#1)(2008-11#1)(2008-8#2)
of human immunodeficiency virus (HIV) infection##2##6##(1996-9#1)(2008-2#1)
of human immunodeficiency virus type 1##4##6##(1992-6#1)(1997-3#1)(2008-11#1)(2008-2#1)
of human immunodeficiency virus##14##4##(1991-3#1)(1991-5#1)(1992-6#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-9#1)(1997-3#1)(2008-11#1)(2008-2#2)(2009-8#1)(2013-1#2)
of human immunodeficiency##16##3##(1991-3#1)(1991-5#1)(1992-6#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-9#1)(1997-3#1)(2008-11#2)(2008-2#2)(2008-9#1)(2009-8#1)(2013-1#2)
of human interleukin-6##2##3##(2008-8#2)
of human intestinal##2##3##(1990-2#1)(2011-2#1)
of human language##2##3##(2010-5#2)
of human liver UDP-glucuronosyltransferase cDNA##2##5##(2008-11#2)
of human liver##6##3##(1990-5#1)(1994-8#1)(2008-11#3)(2008-9#1)
of human lung cancer##2##4##(1990-5#1)(2008-8#1)
of human lung##4##3##(1990-5#1)(1996-2#1)(2008-8#1)(2008-9#1)
of human malignancies##2##3##(2008-11#1)(2011-2#1)
of human malignant##2##3##(1995-2#1)(2008-4#1)
of human melanoma##2##3##(2008-11#2)
of human mesenchymal stem cells##2##5##(2008-11#1)(2010-8#1)
of human mitochondrial tRNA(Leu(UUR))##2##4##(2008-8#2)
of human monoclonal antibody##4##4##(2008-11#4)
of human monoclonal##6##3##(2008-11#6)
of human nebulin##2##3##(2008-6#2)
of human neutrophils##3##3##(1992-12#1)(1993-6#1)(2008-1#1)
of human or##2##3##(2008-11#1)(2008-4#1)
of human osteoblasts##2##3##(1993-3#1)(2008-11#1)
of human papillomavirus (HPV) infection##2##5##(1992-3#1)(2011-2#1)
of human papillomavirus##4##3##(1992-3#1)(1995-2#1)(2011-2#1)(2013-8#1)
of human parathyroid##3##3##(1991-6#2)(2008-11#1)
of human peripheral blood lymphocytes (PBL)##2##6##(1995-12#1)(2008-11#1)
of human peripheral blood lymphocytes##5##5##(1995-12#2)(2008-11#2)(2008-9#1)
of human peripheral blood mononuclear cells##2##6##(2008-11#1)(2008-9#1)
of human peripheral blood##9##4##(1994-11#1)(1995-12#2)(2008-11#3)(2008-9#3)
of human perturbations##2##3##(2008-10#2)
of human placental##3##3##(1990-12#1)(1991-5#1)(1994-3#1)
of human plasma##3##3##(1990-12#1)(2008-10#2)
of human preadipocytes##2##3##(2008-5#2)
of human presence##2##3##(2008-11#1)(2008-8#1)
of human prostate cancer##2##4##(2008-4#1)(2011-2#1)
of human recombinant##4##3##(1994-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
of human resources##4##3##(1994-1#1)(2008-10#1)(2008-11#1)(2010-8#1)
of human retroviral replication##2##4##(1995-2#2)
of human retroviral##3##3##(1995-2#3)
of human rhinovirus##2##3##(2013-8#2)
of human rights##3##3##(1991-3#1)(1995-11#2)
of human serum albumin (HSA)##4##5##(2008-10#4)
of human serum albumin##5##4##(2008-10#5)
of human serum and urine##2##5##(2008-10#2)
of human serum##7##3##(2008-10#7)
of human skeletal muscle##2##4##(2008-11#1)(2008-6#1)
of human skin##10##3##(1995-3#1)(2008-10#1)(2008-5#7)(2008-6#1)
of human spaceflight##2##3##(2012-3#2)
of human telomerase##4##3##(2008-11#3)(2008-9#1)
of human topoisomerase II beta in##2##6##(1995-6#2)
of human transforming growth factor##3##5##(1990-8#1)(2008-8#2)
of human tumor##4##3##(2008-11#1)(2008-8#2)(2008-9#1)
of human tumors##2##3##(2008-10#1)(2008-11#1)
of human umbilical vein endothelial cells (HUVEC)##2##7##(1994-8#1)(2008-9#1)
of human umbilical vein endothelial cells##3##6##(1991-5#1)(1994-8#1)(2008-9#1)
of human umbilical##5##3##(1991-5#1)(1994-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
of human urine and##2##4##(2008-10#2)
of human vascular endothelial growth##2##5##(1997-7#1)(2008-8#1)
of human##559##2##(1990-12#7)(1990-2#4)(1990-3#2)(1990-5#5)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#5)(1991-6#4)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#3)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#6)(1993-6#3)(1993-8#13)(1993-9#1)(1994-1#1)(1994-11#12)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#8)(1995-11#3)(1995-12#10)(1995-2#13)(1995-3#2)(1995-6#10)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#6)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#4)(1997-6#3)(1997-7#6)(1997-8#5)(1997-9#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#91)(2008-12#10)(2008-2#2)(2008-3#1)(2008-4#12)(2008-5#27)(2008-6#4)(2008-7#7)(2008-8#27)(2008-9#33)(2009-10#3)(2009-4#1)(2009-7#11)(2009-8#6)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-2#21)(2011-3#1)(2012-2#6)(2012-3#9)(2013-1#20)(2013-7#1)(2013-8#13)
of humanangiopoietin-1##2##2##(2008-8#2)
of humans and animals##3##4##(2008-11#1)(2008-5#1)(2011-2#1)
of humans and##6##3##(1992-11#1)(2008-11#1)(2008-5#1)(2011-2#3)
of humans to##3##3##(1992-3#1)(1994-5#1)(2011-2#1)
of humans with##3##3##(1994-3#1)(2008-5#1)(2012-2#1)
of humans##16##2##(1992-11#1)(1992-3#1)(1994-3#1)(1994-5#1)(1997-5#2)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#4)(2012-2#2)
of humic acid##6##3##(2008-10#6)
of humic acids (HA)##3##4##(2008-10#3)
of humic acids##9##3##(2008-10#9)
of humic compounds present in the##2##6##(2008-10#2)
of humic compounds##4##3##(2008-10#4)
of humic substances (HS)##2##4##(2008-10#2)
of humic substances##5##3##(2008-10#5)
of humic##30##2##(2008-10#30)
of humidity on the##2##4##(2008-10#2)
of humidity on##3##3##(2008-10#3)
of humidity were##2##3##(2008-10#2)
of humidity##6##2##(2008-10#6)
of hummingbird##2##2##(2008-8#1)(2008-9#1)
of humoral immune response##2##4##(1997-8#1)(2012-2#1)
of humoral immune##3##3##(1997-8#1)(2008-10#1)(2012-2#1)
of humoral immunity##2##3##(1993-12#1)(1995-12#1)
of humoral##7##2##(1993-12#2)(1993-3#1)(1995-12#1)(1997-8#1)(2008-10#1)(2012-2#1)
of hundreds of##4##3##(2008-10#2)(2008-7#1)(2013-8#1)
of husbandry parameters on the##3##5##(2008-11#3)
of hyaline##2##2##(1991-8#1)(2013-8#1)
of hyaluronan in##2##3##(1993-6#1)(2011-1#1)
of hyaluronan##5##2##(1993-6#2)(2011-1#3)
of hyaluronic acid##6##3##(2008-10#2)(2010-10#1)(2012-2#1)(2013-1#2)
of hybrid and parental##2##4##(2008-12#2)
of hybrid and##3##3##(2008-12#2)(2008-8#1)
of hybrid##15##2##(1995-5#2)(2008-10#3)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-2#2)(2012-3#1)
of hybridization between the##2##4##(2008-10#1)(2012-3#1)
of hybridization in##2##3##(2008-8#1)(2012-3#1)
of hybridization##8##2##(1996-12#1)(2008-10#2)(2008-8#1)(2012-3#4)
of hybridoma cells##7##3##(2008-11#7)
of hybridoma culture##2##3##(1990-12#1)(2008-11#1)
of hybridoma##13##2##(1990-12#1)(2008-11#12)
of hybridomas##3##2##(2008-11#3)
of hybrids##8##2##(1996-6#1)(2008-10#5)(2008-9#2)
of hydatid cyst##3##3##(2008-12#2)(2010-11#1)
of hydatid disease##2##3##(2008-7#1)(2013-1#1)
of hydatid##7##2##(1991-8#1)(2008-12#3)(2008-7#1)(2010-11#1)(2013-1#1)
of hydatidosis##2##2##(2010-12#1)(2011-2#1)
of hydration##7##2##(1991-11#1)(2008-10#2)(2008-5#3)(2008-7#1)
of hydraulic##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
of hydrazine and phenylhydrazine in##2##5##(2008-10#2)
of hydrazine and phenylhydrazine##4##4##(2008-10#4)
of hydrazine and##7##3##(2008-10#7)
of hydrazine at##3##3##(2008-10#3)
of hydrazine by##2##3##(2008-10#2)
of hydrazine in##7##3##(2008-10#6)(2010-5#1)
of hydrazine with##2##3##(2008-10#2)
of hydrazine##32##2##(1996-5#1)(2008-10#28)(2008-11#1)(2010-5#2)
of hydride##2##2##(2008-10#2)
of hydrocarbon##2##2##(2008-11#1)(2012-2#1)
of hydrocarbons from##2##3##(2008-10#2)
of hydrocarbons in##2##3##(2008-10#1)(2008-11#1)
of hydrocarbons##9##2##(2008-10#8)(2008-11#1)
of hydrocephalus##2##2##(2008-7#2)
of hydrochloric acid##6##3##(2008-10#6)
of hydrochloric##8##2##(2008-10#8)
of hydrochlorothiazide in##3##3##(2008-10#2)(2011-3#1)
of hydrochlorothiazide##7##2##(2008-10#5)(2011-3#2)
of hydrocortisone##2##2##(2011-3#1)(2012-3#1)
of hydrofluoric acid##2##3##(2008-10#2)
of hydrofluoric##3##2##(2008-10#3)
of hydrogel##3##2##(2008-10#1)(2008-5#1)(2009-12#1)
of hydrogen bond##2##3##(2008-8#1)(2012-3#1)
of hydrogen bonds##2##3##(2008-10#2)
of hydrogen gas on the plasma##2##6##(2008-10#2)
of hydrogen gas##3##3##(2008-10#3)
of hydrogen ion##4##3##(1993-12#1)(2008-10#3)
of hydrogen ions##4##3##(2008-10#4)
of hydrogen peroxide (H(2)O(2))##3##4##(2008-10#3)
of hydrogen peroxide and##7##4##(2008-10#7)
of hydrogen peroxide at##3##4##(2008-10#3)
of hydrogen peroxide in rainwater##4##5##(2008-10#4)
of hydrogen peroxide in snow##2##5##(2008-10#2)
of hydrogen peroxide in the##3##5##(2008-10#3)
of hydrogen peroxide in##14##4##(2008-10#14)
of hydrogen peroxide using##2##4##(2008-10#2)
of hydrogen peroxide with##2##4##(2008-10#2)
of hydrogen peroxide##63##3##(2008-10#62)(2008-5#1)
of hydrogen sulfide##3##3##(2008-10#2)(2013-8#1)
of hydrogen was##2##3##(2008-10#2)
of hydrogen##98##2##(1991-6#1)(1992-12#1)(1993-12#1)(2008-10#86)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
of hydrolysis of##5##3##(1990-5#1)(1992-7#1)(1994-11#1)(1994-5#1)(2008-11#1)
of hydrolysis were##2##3##(2008-10#1)(2008-5#1)
of hydrolysis##13##2##(1990-5#1)(1992-7#1)(1994-11#1)(1994-5#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
of hydrolytic enzymes that##2##4##(1992-3#1)(2012-2#1)
of hydrolyzed##2##2##(2008-11#1)(2010-4#1)
of hydronephrosis##2##2##(2008-10#2)
of hydrophilic compounds##2##3##(2008-10#1)(2008-7#1)
of hydrophilic##5##2##(1997-1#1)(2008-10#2)(2008-7#1)(2008-9#1)
of hydrophobic interaction##2##3##(2008-10#2)
of hydrophobic##11##2##(1992-12#1)(1994-5#1)(1995-6#1)(2008-10#5)(2008-8#1)(2009-9#1)(2012-2#1)
of hydrophobicity##4##2##(1991-5#1)(1993-3#1)(2008-5#2)
of hydroquinone in##6##3##(2008-10#6)
of hydroquinone##17##2##(2008-10#15)(2008-5#1)(2008-6#1)
of hydroxide##4##2##(2008-10#4)
of hydroxyapatite##4##2##(2008-12#1)(2009-7#3)
of hydroxyl groups##2##3##(2008-10#2)
of hydroxyl radical with##2##4##(2008-9#2)
of hydroxyl radical##5##3##(2008-10#3)(2008-9#2)
of hydroxyl radicals##2##3##(2008-10#1)(2008-4#1)
of hydroxyl##12##2##(2008-10#9)(2008-4#1)(2008-9#2)
of hydroxylamine hydrochloride##2##3##(2008-10#2)
of hydroxyurea##2##2##(1994-11#2)
of hypaphorine##2##2##(2008-10#2)
of hyperandrogenism##3##2##(2008-4#3)
of hypercalcemia##2##2##(1991-12#1)(2008-1#1)
of hypercholesterolemia]##2##2##(1991-3#1)(1996-2#1)
of hyperfine##2##2##(1991-9#1)(1993-8#1)
of hyperglycemia##5##2##(1991-7#1)(1994-6#1)(2008-1#1)(2008-11#1)(2010-10#1)
of hyperglycemic##2##2##(1994-2#1)(2010-11#1)
of hyperkinetic##2##2##(1990-9#1)(1991-8#1)
of hyperosmotic##2##2##(2008-11#2)
of hyperplasia##2##2##(2006-6#1)(2011-2#1)
of hypersensitivity reactions##2##3##(2008-8#2)
of hypersensitivity##3##2##(2008-11#1)(2008-8#2)
of hypertension and its##2##4##(2008-11#1)(2010-4#1)
of hypertension and##9##3##(1994-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#3)(2010-4#1)(2011-2#1)
of hypertension in an urban##2##5##(2008-11#2)
of hypertension in patients##2##4##(1993-8#1)(2010-4#1)
of hypertension in##16##3##(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-5#1)(2008-11#7)(2008-7#1)(2009-8#1)(2010-4#1)
of hypertension is##2##3##(2008-11#2)
of hypertension on##2##3##(2008-7#1)(2010-4#1)
of hypertension was##4##3##(1990-11#1)(1994-12#1)(2008-11#1)(2008-7#1)
of hypertension##70##2##(1990-11#2)(1990-6#1)(1991-5#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1996-6#2)(1997-2#1)(1997-5#1)(1997-8#2)(2008-10#1)(2008-11#21)(2008-5#1)(2008-7#9)(2008-8#1)(2009-1#3)(2009-3#1)(2009-8#1)(2009-9#1)(2010-4#6)(2011-2#2)
of hypertensive##7##2##(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
of hypertrophic scarring in##2##4##(1991-2#2)
of hypertrophic##5##2##(1991-2#2)(1997-7#1)(2009-4#1)(2011-2#1)
of hyphae of##2##3##(2008-10#2)
of hyphae##9##2##(2008-10#8)(2008-5#1)
of hyphal growth##2##3##(2008-10#2)
of hyphal##6##2##(2008-10#6)
of hypnosis##4##2##(2009-9#4)
of hypobaric hypoxia##2##3##(1996-12#2)
of hypocalcemia and hypophosphatemia in malignancy##2##6##(1991-8#2)
of hypocalcemia##4##2##(1991-8#2)(2011-2#2)
of hypochlorite and##2##3##(2008-10#2)
of hypochlorite##7##2##(2008-10#7)
of hypoglycemia##5##2##(1990-5#1)(1997-2#1)(1997-4#1)(2010-2#1)(2011-1#1)
of hyponatremia and##2##3##(2009-11#1)(2011-2#1)
of hyponatremia##3##2##(1990-9#1)(2009-11#1)(2011-2#1)
of hypospadia##2##2##(2013-1#2)
of hypotension##3##2##(2009-12#1)(2011-2#1)(2012-3#1)
of hypothalamic##4##2##(1991-11#1)(1991-9#1)(1994-2#1)(1996-12#1)
of hypotheses##4##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
of hypothesized##2##2##(2008-12#1)(2008-8#1)
of hypothetical##3##2##(1997-3#1)(2008-10#2)
of hypothyroidism##5##2##(1996-8#1)(2008-6#1)(2011-1#1)(2011-2#2)
of hypovirulence##6##2##(2008-10#4)(2008-9#2)
of hypoxia##4##2##(1994-2#2)(1996-12#1)(2008-1#1)
of hypoxic##2##2##(2010-8#2)
of hysterectomy and##2##3##(1995-12#1)(2010-12#1)
of hysterectomy##5##2##(1994-2#1)(1995-1#1)(1995-12#1)(2010-12#1)(2012-3#1)
of i##9##2##(1993-8#1)(1995-5#2)(1996-2#1)(1997-4#2)(2008-1#2)(2008-7#1)
of iNOS and##2##3##(2008-9#1)(2011-2#1)
of iNOS gene##2##3##(2011-2#2)
of iNOS##8##2##(1996-12#3)(2008-9#1)(2011-1#1)(2011-2#3)
of iatrogenic##4##2##(2008-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
of ibandronic acid##3##3##(2011-2#3)
of ibogaine##3##2##(1997-2#3)
of ibotenic acid##2##3##(1993-3#1)(1993-6#1)
of ibuprofen in pharmaceutical preparations##2##5##(2008-10#2)
of ibuprofen in##5##3##(2008-10#5)
of ibuprofen##7##2##(1991-3#1)(2008-10#6)
of ice##6##2##(2008-10#2)(2008-3#4)
of ice-like water##2##3##(2008-5#2)
of ice-like##3##2##(2008-5#3)
of iconic##2##2##(2010-5#2)
of ideas##5##2##(1995-5#1)(1996-1#1)(2008-11#2)(2008-8#1)
of identical sequence##2##3##(1995-8#1)(1997-7#1)
of identical##10##2##(1990-4#1)(1993-12#1)(1995-8#1)(1996-3#1)(1997-7#1)(1997-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
of identification and##5##3##(2008-10#3)(2009-10#1)(2009-8#1)
of identification##8##2##(1994-9#1)(2008-10#4)(2008-5#1)(2009-10#1)(2009-8#1)
of identified##5##2##(1997-3#1)(1997-6#1)(2007-12#2)(2008-11#1)
of identifying##10##2##(1995-8#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
of identity##3##2##(1996-2#1)(2008-12#1)(2008-8#1)
of idiopathic##9##2##(1990-9#1)(1992-2#1)(1997-8#2)(2008-10#1)(2008-12#1)(2010-10#2)(2013-1#1)
of ifenprodil##2##2##(1996-2#2)
of ileal##5##2##(1990-3#2)(1991-9#1)(1992-8#2)
of ileum##5##2##(2008-10#2)(2008-12#3)
of illicit drugs##2##3##(2008-10#1)(2013-8#1)
of illicit##7##2##(1991-12#1)(2008-10#5)(2013-8#1)
of illness and##4##3##(1993-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
of illness##22##2##(1991-9#1)(1993-12#3)(1993-2#1)(1994-12#2)(1994-9#1)(1995-2#1)(2008-11#1)(2008-6#2)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
of illnesses##3##2##(2008-7#1)(2010-2#1)(2011-2#1)
of illumination##2##2##(2008-3#1)(2008-9#1)
of illustration##7##2##(2008-10#2)(2008-11#1)(2010-8#4)
of iloprost##3##2##(2011-2#3)
of image##4##2##(1997-8#1)(2008-4#1)(2008-6#2)
of image-guided surgery##2##3##(2009-12#2)
of imagery)##2##2##(2013-8#2)
of images and##2##3##(2008-6#2)
of images##10##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2012-2#1)(2013-1#2)
of imagination##2##2##(2008-5#1)(2011-2#1)
of imaging and##3##3##(1997-6#1)(2008-3#1)(2009-11#1)
of imaging systems##2##3##(2007-12#1)(2012-2#1)
of imaging##23##2##(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#6)(2013-8#1)
of imazalil##2##2##(2008-10#2)
of imidazole derivatives##3##3##(2008-10#3)
of imidazole##10##2##(1994-5#4)(2008-10#6)
of imipramine##6##2##(1990-5#4)(1994-2#1)(2008-10#1)
of immature##9##2##(1990-11#1)(1997-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)
of immediate##10##2##(2008-10#3)(2008-11#1)(2009-10#1)(2010-1#1)(2010-12#1)(2013-1#3)
of immediate-early genes##2##3##(1996-12#1)(1997-3#1)
of immediately loaded##3##3##(2011-7#1)(2013-1#2)
of immigrants##3##2##(1997-2#1)(1997-8#1)(2008-9#1)
of immobilisation##2##2##(2008-10#2)
of immobilised##2##2##(2008-10#2)
of immobilization##6##2##(1997-2#1)(2008-10#4)(2013-7#1)
of immobilized DNA##2##3##(2008-10#2)
of immobilized human plasminogen##2##4##(1993-8#2)
of immobilized human##3##3##(1993-8#3)
of immobilized nanometer TiO(2) for##2##5##(2008-10#2)
of immobilized##25##2##(1993-8#3)(1994-11#1)(1995-3#2)(2008-10#17)(2008-11#1)(2008-12#1)
of immortalised##2##2##(2008-11#2)
of immortalized##2##2##(2008-11#2)
of immune cell##2##3##(2008-10#1)(2008-9#1)
of immune cells in##2##4##(2008-9#1)(2012-3#1)
of immune cells##9##3##(1991-2#1)(1992-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-3#2)
of immune complexes##2##3##(1991-2#1)(2008-10#1)
of immune defense##2##3##(2008-8#2)
of immune function##3##3##(1995-12#1)(2008-10#2)
of immune functions##2##3##(1993-12#1)(1994-11#1)
of immune privilege in the##2##5##(2010-1#2)
of immune privilege##4##3##(2010-1#4)
of immune response##4##3##(1992-9#1)(1997-8#1)(2009-3#1)(2013-8#1)
of immune responses to##2##4##(2008-10#1)(2011-2#1)
of immune responses##4##3##(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)
of immune system##3##3##(2009-1#1)(2013-1#1)(2013-7#1)
of immune tolerance##2##3##(2012-3#1)(2013-1#1)
of immune##55##2##(1991-2#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-8#2)(2008-10#9)(2008-11#3)(2008-4#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-8#1)(2010-1#4)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#2)
of immune-mediated inflammatory diseases (IMID)##2##5##(2011-2#2)
of immune-mediated inflammatory diseases##6##4##(2011-2#6)
of immune-mediated inflammatory##7##3##(2008-10#1)(2011-2#6)
of immunity##4##2##(2007-11#1)(2008-7#2)(2012-3#1)
of immunization with##2##3##(1995-5#1)(2011-2#1)
of immunization##7##2##(1995-5#2)(1996-12#2)(2008-10#2)(2011-2#1)
of immunizations##4##2##(1995-5#2)(1996-12#2)
of immunized animals##2##3##(1995-2#1)(2011-2#1)
of immunized##3##2##(1995-2#1)(2008-4#1)(2011-2#1)
of immunizing##3##2##(1996-1#1)(1996-12#2)
of immunodeficiency##2##2##(2008-10#1)(2012-12#1)
of immunogenicity##7##2##(1995-5#2)(2008-10#4)(2013-8#1)
of immunoglobulin G##2##3##(2008-1#1)(2008-7#1)
of immunoglobulin##8##2##(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
of immunoglobulins and##2##3##(1995-12#1)(2008-11#1)
of immunoglobulins##3##2##(1990-12#1)(1995-12#1)(2008-11#1)
of immunohistochemical##4##2##(1997-8#1)(2008-5#1)(2008-8#1)(2013-1#1)
of immunohistochemistry##5##2##(1991-8#1)(2008-12#2)(2008-7#1)(2009-8#1)
of immunologic##3##2##(1995-5#2)(1997-8#1)
of immunological and##2##3##(1996-2#1)(1997-7#1)
of immunological##5##2##(1994-3#1)(1996-11#1)(1996-2#1)(1997-7#1)(2013-1#1)
of immunologically##2##2##(2008-4#1)(2012-3#1)
of immunoreactive##5##2##(1991-5#1)(1995-11#1)(1997-2#2)(2007-12#1)
of immunoreactivity##4##2##(1990-5#1)(1993-3#1)(1994-12#1)(1997-2#1)
of immunostaining##3##2##(1995-12#2)(1997-3#1)
of immunosuppressants##2##2##(2010-10#1)(2010-12#1)
of immunosuppression on the##2##4##(2008-5#2)
of immunosuppression##8##2##(2008-10#5)(2008-5#3)
of immunosuppressive drugs##2##3##(2008-10#1)(2011-3#1)
of immunosuppressive therapy##2##3##(1994-5#1)(2011-2#1)
of immunosuppressive##8##2##(1994-5#2)(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
of immunotherapy##3##2##(1991-6#1)(1994-12#1)(2008-11#1)
of immunotoxicity##4##2##(2008-10#4)
of immunotoxicology##2##2##(2008-10#2)
of impact##5##2##(1995-3#1)(2008-7#1)(2010-8#1)(2012-2#2)
of impacted##5##2##(1990-2#1)(1991-3#1)(2010-12#1)(2013-1#2)
of impacts##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
of impaired glucose tolerance##2##4##(1995-12#1)(2012-3#1)
of impaired##6##2##(1991-7#1)(1992-12#1)(1993-11#1)(1995-12#1)(2012-3#1)(2013-1#1)
of impairment and##2##3##(1991-1#1)(1991-12#1)
of impairment##9##2##(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1995-3#1)(2010-7#1)(2011-1#1)(2013-8#1)
of imperfect##2##2##(2008-3#1)(2012-3#1)
of impingement##2##2##(2011-2#2)
of implant users##2##3##(2008-9#2)
of implant##6##2##(2008-9#4)(2011-2#1)(2012-2#1)
of implantable##5##2##(2008-11#1)(2008-12#2)(2012-3#2)
of implantation##8##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#3)(2010-6#1)(2012-3#1)
of implanted children##2##3##(2008-9#2)
of implanted##7##2##(1992-3#1)(2008-3#1)(2008-8#1)(2008-9#3)(2012-3#1)
of implantees##2##2##(2008-9#2)
of implants in##3##3##(2008-11#1)(2010-5#1)(2013-1#1)
of implants##5##2##(1996-3#1)(2008-11#1)(2010-5#1)(2013-1#2)
of implementation of##3##3##(2008-1#1)(2013-1#2)
of implementation##7##2##(1997-2#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
of implementing a##4##3##(1992-2#1)(1996-3#1)(2008-11#1)(2008-12#1)
of implementing the##2##3##(1997-3#1)(2008-12#1)
of implementing##13##2##(1992-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(2008-11#2)(2008-12#3)(2008-3#1)(2011-2#1)(2013-1#1)
of import##3##2##(1995-2#1)(2008-1#1)(2008-8#1)
of importance for##4##3##(1991-9#1)(2008-11#1)(2008-5#1)(2008-9#1)
of importance from##2##3##(1994-1#1)(2008-10#1)
of importance in the##5##4##(1990-11#1)(1992-9#1)(1997-8#1)(2008-5#1)(2010-12#1)
of importance in##9##3##(1990-11#1)(1992-9#1)(1995-8#1)(1997-8#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)
of importance##23##2##(1990-11#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-1#1)(1994-8#1)(1995-8#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-10#2)(2010-12#1)(2011-2#2)
of important crops##2##3##(2008-10#2)
of important##20##2##(1991-1#1)(1992-9#1)(1994-3#1)(1995-5#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-8#2)(2012-2#1)
of imported##2##2##(2011-2#1)(2013-8#1)
of improper##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
of improved##16##2##(1994-5#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-4#1)
of improvement in##2##3##(1995-3#1)(2008-9#1)
of improvement##8##2##(1991-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
of improvements in##4##3##(1997-3#1)(2008-11#2)(2010-10#1)
of improvements##5##2##(1997-3#1)(2008-11#2)(2008-4#1)(2010-10#1)
of improving patient##2##3##(2010-3#1)(2010-8#1)
of improving the##5##3##(2008-10#2)(2008-11#1)(2008-7#2)
of improving##14##2##(1994-2#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2013-1#1)
of impurities in##2##3##(2008-10#2)
of impurities##9##2##(2008-10#6)(2008-11#1)(2013-8#2)
of in situ hybridization##3##4##(1995-2#1)(1997-2#1)(2010-1#1)
of in situ##20##3##(1990-12#1)(1995-2#1)(1997-2#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-2#2)
of in utero##2##3##(1991-1#1)(2008-8#1)
of in vitro development##2##4##(1996-2#1)(2009-12#1)
of in vitro systems##2##4##(2008-1#1)(2008-10#1)
of in vitro##23##3##(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#2)
of in vivo##20##3##(1995-12#1)(1995-6#2)(1996-12#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-9#2)(2012-3#1)(2013-1#1)
of in##72##2##(1990-12#1)(1991-1#1)(1991-2#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#3)(2009-9#1)(2010-1#1)(2010-5#1)(2010-9#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
of in-home##2##2##(1991-2#1)(1995-3#1)
of in-house##2##2##(2008-10#2)
of in-phase##3##2##(1997-8#2)(2009-3#1)
of in-stent##3##2##(2008-12#1)(2011-2#2)
of inactivated##3##2##(1992-9#1)(1994-5#1)(1996-12#1)
of inadequate##6##2##(1992-9#1)(1993-3#2)(2008-1#1)(2008-10#1)(2011-10#1)
of inaperisone hydrochloride (inaperisone)##2##4##(1992-3#2)
of inaperisone##4##2##(1992-3#4)
of inappropriate##2##2##(2011-2#1)(2012-12#1)
of inattention##2##2##(2008-2#1)(2008-8#1)
of inbred##2##2##(1994-8#1)(2008-8#1)
of inbreds##2##2##(2008-10#2)
of inbreeding depression##2##3##(2008-8#2)
of inbreeding##9##2##(2008-12#1)(2008-8#2)(2008-9#3)(2012-3#3)
of incarcerated##2##2##(2008-11#1)(2009-11#1)
of incarceration of##2##3##(2008-12#2)
of incentives##2##2##(1993-3#1)(1996-12#1)
of incidence and severity##2##4##(2008-10#2)
of incidence and##5##3##(1992-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
of incidence of##4##3##(1990-11#1)(1990-12#1)(2008-10#2)
of incidence##27##2##(1990-11#1)(1990-12#1)(1991-2#2)(1991-3#1)(1992-12#2)(2008-10#13)(2008-2#1)(2008-3#4)(2008-8#1)(2010-7#1)
of incident##6##2##(2008-2#2)(2008-3#2)(2008-7#1)(2010-12#1)
of incidental##2##2##(2009-8#1)(2013-1#1)
of included##3##2##(2008-10#1)(2011-2#2)
of including a##2##3##(1992-2#1)(2008-8#1)
of including##6##2##(1992-2#1)(2008-1#1)(2008-10#2)(2008-8#2)
of inclusion bodies in##2##4##(2008-10#1)(2009-3#1)
of inclusion complexes##2##3##(2008-10#2)
of inclusion##8##2##(1994-9#1)(1996-3#1)(2008-10#3)(2009-3#1)(2012-3#2)
of inclusions##3##2##(2008-10#3)
of incoherent##2##2##(2008-2#1)(2008-3#1)
of income##3##2##(1994-1#1)(2012-12#1)(2013-1#1)
of incompatibility##2##2##(2008-10#1)(2008-11#1)
of incomplete resistance##4##3##(2008-10#4)
of incomplete##8##2##(1990-9#1)(1996-12#3)(2008-10#4)
of incompletely occluded aneurysms##2##4##(2013-1#2)
of incompletely occluded##3##3##(2013-1#3)
of incorporated##3##2##(1991-12#1)(2008-10#2)
of incorporating the##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
of increase in mortality rate##2##5##(2008-9#2)
of increase in##6##3##(1993-12#1)(1993-3#1)(2008-11#1)(2008-9#2)(2012-2#1)
of increase of##3##3##(2008-10#2)(2008-8#1)
of increase##14##2##(1993-12#1)(1993-3#3)(1993-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
of increased intracranial pressure##3##4##(2008-1#1)(2008-12#1)(2008-7#1)
of increased metabolic##2##3##(2008-11#1)(2010-12#1)
of increased##40##2##(1991-1#1)(1991-12#1)(1992-10#1)(1992-5#1)(1992-6#1)(1994-1#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-8#1)
of increases in##3##3##(1994-8#1)(2008-10#1)(2013-8#1)
of increasing concern##2##3##(1996-3#1)(2012-12#1)
of increasing interest##2##3##(2008-11#1)(2008-9#1)
of increasing the##7##3##(1990-2#1)(1991-1#1)(1991-2#1)(2008-10#3)(2008-8#1)
of increasing##40##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1996-3#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-8#1)(2013-7#1)
of increasingly##3##2##(2008-1#1)(2008-11#2)
of incremental##2##2##(2010-12#1)(2011-2#1)
of incubation and##2##3##(2008-11#1)(2008-7#1)
of incubation of##3##3##(1990-5#1)(1997-2#1)(2008-11#1)
of incubation temperature##3##3##(2008-10#1)(2011-2#2)
of incubation time##6##3##(1992-12#1)(2008-10#1)(2008-12#1)(2008-5#3)
of incubation##37##2##(1990-12#2)(1990-5#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-2#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-5#5)(2008-7#2)(2011-1#2)(2011-2#2)(2012-2#1)
of indentation##2##2##(2008-10#1)(2009-7#1)
of independence##3##2##(1991-2#1)(1996-2#1)(2008-10#1)
of independent walking##2##3##(1993-12#2)
of independent##11##2##(1993-12#2)(1993-9#1)(1994-3#1)(1996-6#2)(1997-2#1)(2008-10#3)(2008-5#1)
of indeterminate##3##2##(1994-6#1)(2008-1#1)(2010-12#1)
of index##7##2##(1992-9#2)(1996-3#4)(2008-8#1)
of indications##4##2##(1990-9#1)(1996-3#1)(1997-4#1)(2008-7#1)
of indicator##6##2##(1990-12#1)(1991-2#1)(2008-10#2)(2008-9#1)(2012-2#1)
of indicators of##2##3##(1996-2#1)(2011-2#1)
of indicators##12##2##(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(2007-12#1)(2008-11#3)(2008-8#1)(2011-2#1)
of indices##2##2##(1995-2#1)(2008-11#1)
of indigenous##10##2##(2008-10#5)(2008-11#2)(2009-6#1)(2010-1#1)(2013-1#1)
of indigent##2##2##(1996-3#1)(2008-11#1)
of indigo carmine##2##3##(2008-10#2)
of indirect##5##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
of indium in high purity antimony by electrothermal atomic absorption##2##10##(2008-10#2)
of indium in##4##3##(2008-10#4)
of indium##9##2##(1995-3#1)(2008-10#8)
of individual and##2##3##(2008-10#1)(2009-11#1)
of individual cells##6##3##(2008-1#1)(2008-11#3)(2008-2#1)(2008-5#1)
of individual chemical##2##3##(1995-6#1)(2008-10#1)
of individual components##2##3##(2008-10#2)
of individual compounds##2##3##(2008-10#2)
of individual isolates##2##3##(2008-10#1)(2011-2#1)
of individual negotiator##2##3##(1992-2#2)
of individual patients##4##3##(1997-5#1)(2008-11#1)(2008-2#1)(2010-12#1)
of individual plants##3##3##(2008-10#3)
of individual species##3##3##(2008-10#1)(2009-8#1)(2012-3#1)
of individual volunteers##2##3##(1993-12#1)(1994-3#1)
of individual##129##2##(1991-2#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-2#3)(1993-12#2)(1993-8#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#2)(2008-1#2)(2008-10#41)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
of individuals and##6##3##(1993-3#1)(1997-3#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-8#1)
of individuals from##2##3##(1994-1#1)(2008-12#1)
of individuals in##3##3##(1991-2#1)(1994-12#1)(2008-9#1)
of individuals that##2##3##(2008-8#2)
of individuals who##3##3##(2008-8#1)(2012-3#1)(2013-1#1)
of individuals with##14##3##(1992-1#1)(1994-12#1)(1994-2#1)(1997-1#1)(1997-3#2)(2008-1#1)(2008-12#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of individuals within##2##3##(2008-10#1)(2008-8#1)
of individuals##63##2##(1991-2#2)(1992-1#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1996-3#2)(1997-1#1)(1997-3#3)(2008-1#2)(2008-10#6)(2008-12#4)(2008-5#1)(2008-8#13)(2008-9#2)(2009-10#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
of individuals'##2##2##(2008-9#1)(2009-12#1)
of indole-3-acetic##2##2##(2008-10#2)
of indomethacin##8##2##(1994-8#2)(2008-10#5)(2012-2#1)
of indoor air##3##3##(1994-9#1)(2008-10#1)(2010-5#1)
of indoor and outdoor##2##4##(2008-10#1)(2010-5#1)
of indoor pollution##2##3##(2008-10#2)
of indoor##8##2##(1994-9#2)(2008-10#4)(2010-5#2)
of induced abortions##3##3##(2013-1#3)
of induced resistance is##2##4##(2008-10#2)
of induced resistance##7##3##(2008-10#7)
of induced systemic resistance##3##4##(2008-10#3)
of induced##26##2##(1991-3#2)(1994-2#1)(1995-11#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2013-1#3)
of inducer##2##2##(2008-7#1)(2012-2#1)
of inducible nitric oxide synthase##3##5##(1996-12#2)(2010-12#1)
of inducible##8##2##(1994-11#1)(1994-8#2)(1996-12#3)(2009-8#1)(2010-12#1)
of inducing a##4##3##(1990-9#1)(2008-10#2)(2008-8#1)
of inducing##12##2##(1990-9#1)(1991-12#1)(1994-11#1)(1995-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
of induction chemotherapy##2##3##(1990-6#1)(2008-10#1)
of induction of##6##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-8#1)
of induction##18##2##(1990-6#1)(1994-8#1)(1995-2#2)(2008-10#5)(2008-11#4)(2008-7#1)(2008-8#2)(2011-2#2)
of inductive##3##2##(1994-12#1)(2008-11#1)(2011-1#1)
of inductively coupled plasma atomic##2##5##(2008-10#2)
of inductively coupled plasma mass spectrometry##2##6##(2008-10#2)
of inductively coupled plasma##5##4##(2008-10#5)
of industrial fermentation##2##3##(2012-3#2)
of industrial products##2##3##(2011-2#1)(2012-3#1)
of industrial##17##2##(1994-3#1)(1996-1#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-3#3)
of industrialized##2##2##(2008-10#1)(2012-2#1)
of industry##2##2##(1996-2#1)(2008-10#1)
of indwelling##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
of inelastic##2##2##(2008-2#2)
of inequality##2##2##(2011-2#2)
of inert##2##2##(2008-10#2)
of inertial##2##2##(1991-9#1)(2010-8#1)
of infancy##9##2##(1995-8#1)(2008-10#4)(2010-6#1)(2011-2#1)(2013-8#2)
of infant health##3##3##(1993-3#1)(1994-3#2)
of infant massage##2##3##(2008-10#2)
of infant mortality##2##3##(1997-6#1)(2012-3#1)
of infant##12##2##(1990-12#1)(1992-2#1)(1993-3#1)(1994-3#2)(1995-3#1)(1997-6#1)(2008-10#2)(2008-4#1)(2012-3#2)
of infantile##3##2##(1994-8#1)(1996-6#1)(2008-7#1)
of infants and children##2##4##(1995-6#1)(2008-11#1)
of infants and##4##3##(1991-12#1)(1992-12#1)(1995-6#1)(2008-11#1)
of infants with##2##3##(1994-6#2)
of infants##14##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-6#4)(1995-6#1)(2007-12#1)(2008-11#1)(2010-4#2)
of infarction##4##2##(1990-9#1)(1993-11#2)(2008-7#1)
of infected and##4##3##(1994-9#1)(2008-10#2)(2008-9#1)
of infected cells##9##3##(1990-7#1)(1997-3#2)(2008-10#1)(2008-11#2)(2009-7#1)(2011-2#1)(2013-1#1)
of infected fruit in##3##4##(2008-10#3)
of infected fruit##6##3##(2008-10#6)
of infected leaf##2##3##(2008-10#2)
of infected leaves##4##3##(2008-10#4)
of infected mice##3##3##(1996-12#1)(2008-4#1)(2012-2#1)
of infected plant##3##3##(2008-10#3)
of infected plants in##2##4##(2008-10#2)
of infected plants##9##3##(2008-10#9)
of infected pollen##2##3##(2008-10#2)
of infected potato##4##3##(2008-10#4)
of infected tissue##3##3##(2008-10#2)(2008-9#1)
of infected##86##2##(1990-7#1)(1994-9#2)(1996-11#1)(1996-12#2)(1997-3#2)(2008-10#57)(2008-11#5)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-7#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)
of infecting##7##2##(1991-11#1)(1995-2#1)(2008-10#4)(2011-3#1)
of infection (MOI)##4##3##(2008-11#4)
of infection and for##2##4##(2011-1#1)(2012-12#1)
of infection and precancerous lesions##3##5##(2011-3#3)
of infection and##17##3##(1991-8#1)(2007-11#1)(2008-10#8)(2008-11#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-12#1)
of infection by##9##3##(2008-10#8)(2009-8#1)
of infection courts##2##3##(2008-10#2)
of infection for##7##3##(2008-10#3)(2008-7#2)(2008-8#1)(2013-1#1)
of infection hyphae from##2##4##(2008-10#1)(2012-2#1)
of infection in both##2##4##(2008-10#2)
of infection in the##5##4##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
of infection in##23##3##(1994-6#1)(1994-9#1)(1996-8#1)(2008-10#13)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
of infection is the##3##4##(1991-3#1)(2007-12#1)(2008-10#1)
of infection is##4##3##(1991-3#1)(2007-12#1)(2008-10#2)
of infection of##6##3##(2008-10#5)(2008-11#1)
of infection on##2##3##(2008-7#1)(2010-5#1)
of infection or##2##3##(2008-10#1)(2011-2#1)
of infection through##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
of infection was##4##3##(2008-10#3)(2009-6#1)
of infection were##7##3##(2008-10#5)(2008-7#1)(2012-12#1)
of infection with an##2##4##(2008-11#1)(2011-2#1)
of infection with##7##3##(1996-6#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2011-2#1)
of infection##180##2##(1990-3#1)(1991-3#1)(1991-8#1)(1992-9#2)(1994-6#2)(1994-9#1)(1995-12#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#83)(2008-11#12)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#8)(2008-8#6)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-5#2)(2010-6#3)(2011-1#1)(2011-10#1)(2011-2#12)(2011-3#4)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#2)
of infection)##2##2##(2011-3#2)
of infections of##3##3##(1991-8#1)(2010-12#2)
of infections##17##2##(1990-12#1)(1991-8#1)(1994-6#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-3#1)
of infectious bronchitis virus (IBV)##3##5##(2008-5#3)
of infectious bronchitis virus##7##4##(1996-11#1)(2008-5#6)
of infectious complications##2##3##(1991-12#1)(2011-2#1)
of infectious diseases and##2##4##(2012-3#1)(2013-8#1)
of infectious diseases##11##3##(1994-6#2)(1996-11#1)(2008-10#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
of infectious salmon anaemia virus (ISAV)##2##6##(2009-6#2)
of infectious##40##2##(1990-2#1)(1991-12#1)(1991-3#1)(1994-6#2)(1996-11#2)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-5#8)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#3)(2010-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
of infective endocarditis##2##3##(2006-6#1)(2011-2#1)
of infective insects##2##3##(2008-10#2)
of infective##8##2##(2006-6#1)(2008-10#4)(2011-2#3)
of inferior competitors##2##3##(2008-8#2)
of inferior##3##2##(2008-8#2)(2008-9#1)
of infertile##4##2##(2008-12#4)
of infertility##3##2##(1991-12#1)(1991-3#1)(1994-12#1)
of infestation for##2##3##(2011-2#2)
of infestation##8##2##(1996-12#1)(2008-10#3)(2008-12#1)(2011-2#2)(2012-12#1)
of infested##4##2##(2008-10#3)(2008-12#1)
of inflammation and##3##3##(2008-10#1)(2010-1#1)(2013-1#1)
of inflammation##18##2##(1990-2#1)(1991-2#1)(1993-2#3)(1997-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of inflammatory bowel disease##3##4##(2008-11#1)(2008-4#1)(2010-12#1)
of inflammatory bowel##4##3##(1997-3#1)(2008-11#1)(2008-4#1)(2010-12#1)
of inflammatory cells##4##3##(1992-5#1)(1997-8#1)(2008-10#1)(2009-10#1)
of inflammatory conditions##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
of inflammatory diseases##6##3##(2008-10#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
of inflammatory mediators and##2##4##(2008-12#1)(2013-1#1)
of inflammatory mediators##4##3##(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
of inflammatory responses##2##3##(2008-10#1)(2012-3#1)
of inflammatory##45##2##(1990-6#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-9#1)(1994-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
of infliximab therapy##3##3##(2010-12#2)(2012-3#1)
of infliximab##5##2##(2010-12#3)(2012-3#2)
of inflow##2##2##(1997-3#1)(2008-7#1)
of influence of##3##3##(2008-10#2)(2008-8#1)
of influence##15##2##(2008-10#7)(2008-12#1)(2008-8#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of influential##4##2##(2008-10#4)
of influenza A virus##3##4##(2011-2#2)(2013-8#1)
of influenza A viruses##2##4##(2013-1#1)(2013-8#1)
of influenza A##8##3##(1992-6#1)(2008-9#1)(2011-2#3)(2013-1#1)(2013-8#2)
of influenza A(H3N2) viruses##2##4##(2013-8#2)
of influenza A(H3N2)##4##3##(1994-9#1)(2013-8#3)
of influenza B##2##3##(2011-2#2)
of influenza virus##6##3##(1990-5#2)(2008-5#1)(2012-3#1)(2013-8#2)
of influenza viruses in humans##2##5##(2011-2#2)
of influenza viruses in##3##4##(2011-2#2)(2013-8#1)
of influenza##31##2##(1990-5#2)(1991-8#1)(1992-6#1)(1994-9#2)(2008-5#1)(2008-9#1)(2011-2#9)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#8)
of informal##2##2##(1992-1#1)(2009-5#1)
of informants##2##2##(1994-1#1)(2011-2#1)
of information about the##3##4##(1996-2#1)(2011-2#2)
of information about##10##3##(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)
of information and##4##3##(1994-1#1)(1994-12#1)(2008-10#1)(2011-2#1)
of information available to##2##4##(1997-3#1)(2008-11#1)
of information between##2##3##(2008-11#1)(2008-5#1)
of information concerning##5##3##(1991-2#3)(2008-6#1)(2013-8#1)
of information for##2##3##(1997-3#1)(2012-3#1)
of information from##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
of information in consumer##2##4##(1997-3#2)
of information in the##2##4##(1992-2#1)(2013-1#1)
of information in##10##3##(1992-2#2)(1993-2#1)(1993-6#1)(1995-1#1)(1995-2#1)(1997-3#2)(2010-8#1)(2013-1#1)
of information is##4##3##(1993-3#1)(1994-3#1)(2008-10#2)
of information on the##2##4##(2008-3#1)(2012-2#1)
of information on##8##3##(1991-11#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2010-11#1)(2012-2#2)
of information provided by the##2##5##(1992-12#1)(2008-10#1)
of information provided by##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
of information technologies##2##3##(2010-8#1)(2013-1#1)
of information technology in##3##4##(1993-2#1)(2008-10#2)
of information technology##7##3##(1993-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
of information that##5##3##(1992-9#1)(1995-12#1)(2008-12#1)(2008-7#1)(2010-10#1)
of information to##3##3##(1990-2#1)(2010-11#1)(2011-10#1)
of information was##2##3##(2008-10#1)(2011-1#1)
of information##117##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#3)(1992-12#1)(1992-2#3)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#3)(1995-1#2)(1995-12#3)(1995-2#3)(1995-5#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#4)(1997-3#8)(1997-6#1)(2008-1#1)(2008-10#9)(2008-11#11)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-10#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
of informational##2##2##(1997-3#1)(2008-4#1)
of informed consent##5##3##(1993-2#1)(1996-11#1)(1997-6#1)(2008-8#1)(2009-4#1)
of infrared spectroscopy##2##3##(2008-10#2)
of infrared##6##2##(2008-10#5)(2008-3#1)
of infusion##3##2##(2008-7#1)(2010-7#1)(2011-2#1)
of ingredients##3##2##(2008-5#3)
of inguinal hernia in children##2##5##(2008-12#2)
of inguinal hernia##4##3##(2008-12#3)(2012-12#1)
of inhalation flow rate on the##2##6##(1997-2#2)
of inhalation flow rate##4##4##(1994-2#1)(1997-2#3)
of inhalation##6##2##(1994-2#1)(1997-2#4)(2008-10#1)
of inhaled cocaine##2##3##(2013-8#2)
of inhaled particles##2##3##(1992-3#1)(1997-1#1)
of inhaled##20##2##(1991-12#1)(1992-3#1)(1993-8#3)(1994-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#3)(2007-11#3)(2008-10#1)(2008-12#1)(2010-5#1)(2013-8#2)
of inherent##6##2##(1991-2#1)(2008-10#3)(2008-2#1)(2013-1#1)
of inherently##3##2##(2008-10#2)(2008-2#1)
of inheritance##7##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
of inherited##3##2##(1990-5#1)(1991-11#1)(2010-12#1)
of inhibin subunits##2##3##(2008-8#2)
of inhibiting the##2##3##(2008-10#1)(2008-11#1)
of inhibiting##4##2##(1994-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
of inhibition in##2##3##(2008-7#2)
of inhibition of the##2##4##(1995-11#1)(2008-10#1)
of inhibition of ubiquitin-proteasome pathway on human##2##7##(2008-9#2)
of inhibition of##10##3##(1991-9#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-9#2)
of inhibition##25##2##(1991-9#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#2)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#2)(2010-1#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
of inhibitor and##2##3##(1992-12#1)(1993-8#1)
of inhibitor##5##2##(1992-12#2)(1993-8#1)(2008-5#1)(2011-3#1)
of inhibitors from##3##3##(2008-10#1)(2011-1#2)
of inhibitors of##3##3##(1991-5#1)(1993-8#1)(2009-8#1)
of inhibitors##8##2##(1991-5#1)(1993-8#1)(2008-10#1)(2009-8#1)(2011-1#2)(2011-3#1)(2013-1#1)
of inhibitory postsynaptic##2##3##(1995-2#1)(2011-2#1)
of inhibitory##8##2##(1995-2#1)(1997-2#1)(2008-10#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
of initial conditions##2##3##(2008-10#1)(2013-8#1)
of initial dose in##2##4##(1994-12#1)(2010-6#1)
of initial epidemic conditions##2##4##(2008-10#2)
of initial inocula##2##3##(2008-10#2)
of initial##29##2##(1992-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
of initiating##5##2##(2008-10#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
of initiation##6##2##(1993-11#1)(1994-3#1)(1994-8#1)(1997-7#1)(2008-10#1)(2013-8#1)
of injected##4##2##(1993-11#1)(2008-10#2)(2013-1#1)
of injecting the##2##3##(1995-2#1)(2010-8#1)
of injecting##4##2##(1995-2#2)(2010-8#2)
of injection of##2##3##(2008-10#1)(2010-7#1)
of injection##13##2##(1992-6#1)(1993-1#1)(1994-6#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2010-7#1)(2013-8#1)
of injections in##2##3##(1996-3#1)(1997-5#1)
of injections##3##2##(1996-3#1)(1997-5#1)(2011-2#1)
of injured cells##2##3##(2008-10#2)
of injured##8##2##(1990-9#1)(2008-10#3)(2008-11#1)(2010-1#1)(2011-2#1)(2013-8#1)
of injuries and##3##3##(1996-6#1)(2010-8#1)(2012-2#1)
of injuries##9##2##(1990-6#1)(1991-12#1)(1996-6#1)(1997-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
of injury and##4##3##(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
of injury in##2##3##(1995-11#1)(2012-2#1)
of injury##28##2##(1990-6#1)(1992-9#1)(1993-2#1)(1995-11#2)(1996-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2010-1#2)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
of inks##2##2##(2008-10#2)
of innate immunity##2##3##(2008-10#1)(2009-3#1)
of innate##5##2##(2008-10#1)(2008-4#1)(2009-3#1)(2009-4#1)(2013-8#1)
of inner##4##2##(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
of innervation##2##2##(1992-6#1)(1994-12#1)
of innovation##3##2##(1994-12#1)(2010-5#1)(2011-1#1)
of innovations##5##2##(2008-11#1)(2010-10#2)(2013-8#2)
of innovative##3##2##(1991-12#1)(2010-12#1)(2013-1#1)
of inocula##2##2##(2008-10#2)
of inoculated leaves##4##3##(2008-10#4)
of inoculated plants##4##3##(2008-10#4)
of inoculated##15##2##(2008-10#14)(2008-12#1)
of inoculation##19##2##(2008-10#17)(2008-11#1)(2008-5#1)
of inoculum and##3##3##(2008-10#3)
of inoculum density##5##3##(2008-10#5)
of inoculum for##8##3##(2008-10#8)
of inoculum in##4##3##(2008-10#4)
of inoculum of##2##3##(2008-10#2)
of inoculum sources##2##3##(2008-10#2)
of inoculum was##3##3##(2008-10#3)
of inoculum##54##2##(2008-10#53)(2008-11#1)
of inorganic As(III)##2##3##(2008-10#2)
of inorganic and alkylmercury##2##4##(2008-10#2)
of inorganic and methyl mercury in##2##6##(2008-10#2)
of inorganic and organic mercury##2##5##(2008-10#2)
of inorganic and organic##7##4##(2008-10#6)(2011-2#1)
of inorganic and##11##3##(2008-10#10)(2011-2#1)
of inorganic arsenic in##3##4##(2008-10#3)
of inorganic arsenic species in##2##5##(2008-10#2)
of inorganic arsenic species##4##4##(2008-10#4)
of inorganic arsenic using##2##4##(2008-10#2)
of inorganic arsenic##17##3##(1995-11#1)(2008-10#16)
of inorganic cations##3##3##(2008-10#3)
of inorganic ions##2##3##(2008-10#2)
of inorganic mercury##2##3##(2008-10#2)
of inorganic nickel compounds in##2##5##(2008-10#2)
of inorganic oxyanions of As##2##5##(2008-10#2)
of inorganic phosphate##2##3##(2008-10#1)(2010-8#1)
of inorganic salts##5##3##(1991-9#1)(1994-5#1)(2008-10#2)(2008-11#1)
of inorganic selenium##2##3##(2008-10#2)
of inorganic##74##2##(1991-9#1)(1994-5#1)(1995-11#2)(1995-3#1)(2008-10#64)(2008-11#2)(2008-6#1)(2010-8#1)(2011-2#1)
of inosine##7##2##(2008-10#7)
of inositol 1##5##3##(1990-8#1)(1993-8#2)(1995-11#1)(2008-8#1)
of inositol phosphates##5##3##(1991-5#1)(1993-6#4)
of inositol trisphosphate##7##3##(1990-8#3)(1991-12#1)(1993-3#2)(1993-6#1)
of inositol##22##2##(1990-8#5)(1991-12#1)(1991-5#1)(1993-3#2)(1993-6#5)(1993-8#3)(1995-11#1)(1997-1#2)(2008-11#1)(2008-8#1)
of inpatient care##3##3##(1992-1#1)(1992-2#1)(1993-12#1)
of inpatient hospital##2##3##(1992-2#1)(1994-3#1)
of inpatient psychiatric treatment##2##4##(1991-2#1)(1992-2#1)
of inpatient psychiatric##3##3##(1991-2#2)(1992-2#1)
of inpatient##14##2##(1991-1#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#3)(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-2#1)
of inpatients with##2##3##(2008-11#1)(2013-8#1)
of input##7##2##(1991-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#1)
of inputs##3##2##(2008-11#1)(2009-8#1)(2013-8#1)
of inquiry##2##2##(2008-12#2)
of insect cell##2##3##(2008-11#2)
of insect cells##5##3##(1993-6#1)(2008-11#4)
of insect pheromones##2##3##(2008-10#2)
of insect##19##2##(1993-6#1)(1995-6#1)(2008-10#5)(2008-11#6)(2008-8#3)(2008-9#2)(2010-4#1)
of insecticide##3##2##(1997-7#1)(2008-9#1)(2012-12#1)
of insecticides##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2012-12#1)
of insects##9##2##(1995-11#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#3)(2012-3#1)
of insensitivity in##2##3##(2008-10#2)
of insensitivity##4##2##(2008-10#4)
of insertion and##2##3##(2008-10#1)(2010-7#1)
of insertion of##2##3##(1991-10#1)(2010-7#1)
of insertion##12##2##(1991-10#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-7#6)
of insight and##2##3##(2008-7#1)(2013-8#1)
of insight##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
of insoluble##8##2##(1993-8#1)(1994-11#2)(2008-10#2)(2008-6#1)(2011-2#2)
of insolubles in##2##3##(2008-10#2)
of insomnia##2##2##(1994-6#1)(2013-1#1)
of inspiration##3##2##(1996-2#1)(2008-12#1)(2012-3#1)
of instability##2##2##(1995-2#1)(2009-1#1)
of instantaneous##2##2##(2008-10#1)(2013-1#1)
of institutional##5##2##(1991-1#2)(1991-2#1)(1991-6#1)(1993-1#1)
of institutionalized##3##2##(1991-6#1)(1994-12#1)(1997-3#1)
of institutions##6##2##(1993-12#2)(1993-2#1)(1995-12#1)(2008-12#1)(2009-4#1)
of instruction##8##2##(1993-12#2)(1994-6#1)(1997-5#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
of instrument##3##2##(2008-10#1)(2008-3#2)
of instrumental and##5##3##(2008-10#4)(2008-5#1)
of instrumental##14##2##(2008-10#8)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)
of instrumentation##3##2##(2008-10#2)(2010-11#1)
of instruments##2##2##(2008-3#1)(2010-4#1)
of insufficient##4##2##(1997-8#1)(2010-5#1)(2010-7#1)(2011-2#1)
of insulin action##2##3##(1993-8#1)(1994-8#1)
of insulin and IGF-1 receptors##2##5##(1994-11#2)
of insulin and IGF-1##4##4##(1994-11#3)(2008-9#1)
of insulin and glucagon##2##4##(1994-11#1)(2008-3#1)
of insulin and##8##3##(1994-11#4)(1994-6#1)(2008-11#1)(2008-3#1)(2008-9#1)
of insulin on the##2##4##(1991-7#1)(1996-2#1)
of insulin receptor##5##3##(1992-10#1)(1994-11#1)(1994-12#1)(1997-1#1)(2008-3#1)
of insulin resistance and##3##4##(2010-12#2)(2011-1#1)
of insulin resistance in##3##4##(2008-1#2)(2012-5#1)
of insulin resistance##17##3##(2008-1#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#3)(2011-1#4)(2012-5#2)(2013-7#1)
of insulin secretion in##2##4##(1995-8#1)(2013-1#1)
of insulin secretion##6##3##(1994-11#1)(1995-8#1)(1997-4#1)(2008-11#1)(2010-10#1)(2013-1#1)
of insulin##78##2##(1991-2#1)(1991-7#1)(1992-10#1)(1992-6#1)(1993-8#1)(1994-11#8)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-1#5)(2008-10#1)(2008-11#7)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#9)(2009-9#2)(2010-10#5)(2010-11#2)(2010-12#3)(2011-1#4)(2012-2#1)(2012-4#1)(2012-5#2)(2013-1#1)(2013-7#2)(2013-8#1)
of insulin-like growth factor 1##2##5##(2008-9#2)
of insulin-like growth##4##3##(1994-6#1)(2008-9#2)(2010-5#1)
of insulin-responsive glucose transporter (GLUT4)##2##5##(1994-11#2)
of insulin-stimulated##2##2##(1992-6#1)(1994-11#1)
of insulinoma##2##2##(1997-5#1)(2008-2#1)
of insurance contract##3##3##(1992-1#3)
of insurance##10##2##(1991-3#1)(1992-1#4)(1993-2#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-5#1)
of intact BAC DNA for##2##5##(2008-4#2)
of intact cells##2##3##(1994-8#1)(1996-6#1)
of intact chromogranin A##2##4##(1993-8#2)
of intact type VI collagen microfibrils##2##6##(1993-3#2)
of intact##26##2##(1993-3#2)(1993-8#2)(1994-8#1)(1996-12#2)(1996-6#1)(1997-2#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-5#1)(2008-9#2)(2010-4#1)(2010-5#2)(2012-12#1)
of integral##4##2##(2008-10#1)(2008-3#1)(2009-7#1)(2010-7#1)
of integrated delivery systems##2##4##(1996-1#1)(1996-3#1)
of integrated health care##2##4##(1994-1#1)(1996-1#1)
of integrated pest management##3##4##(1997-7#1)(2008-10#1)(2008-9#1)
of integrated##15##2##(1994-1#1)(1996-1#2)(1996-3#3)(1997-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#1)(2012-3#2)
of integrating##8##2##(2008-10#1)(2008-11#2)(2008-12#2)(2010-7#1)(2011-1#1)(2012-3#1)
of integration##6##2##(1997-3#1)(2008-10#3)(2008-3#2)
of integrative approaches to couple therapy##2##6##(2012-2#2)
of integrative##4##2##(1997-6#1)(2012-2#3)
of integrin clusters in##2##4##(2010-10#2)
of integrin clusters##4##3##(2010-10#4)
of integrin##8##2##(1995-6#1)(2009-7#1)(2010-10#5)(2010-6#1)
of integrity of##2##3##(2008-10#2)
of integrity##3##2##(2008-10#2)(2008-9#1)
of intense research##3##3##(2008-5#1)(2008-9#1)(2010-7#1)
of intense##10##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-7#1)
of intensely##4##2##(1990-11#1)(1997-2#1)(1997-3#1)(2008-3#1)
of intensity##10##2##(1992-9#1)(1995-12#2)(2007-11#2)(2008-10#1)(2008-3#2)(2008-9#1)(2013-8#1)
of intensive care##3##3##(1990-11#1)(1990-2#1)(1995-1#1)
of intensive##16##2##(1990-11#1)(1990-2#1)(1995-1#1)(2008-10#5)(2008-12#1)(2011-2#4)(2012-2#2)(2013-8#1)
of intent##2##2##(1996-3#1)(2008-4#1)
of intentional##4##2##(2008-11#1)(2009-10#1)(2009-12#1)(2010-2#1)
of inter##2##2##(2008-10#1)(2012-3#1)
of interacting phenotypes##4##3##(2008-8#4)
of interacting with the##3##4##(1994-11#1)(1995-5#1)(2013-1#1)
of interacting with##4##3##(1994-11#1)(1995-5#1)(2008-11#1)(2013-1#1)
of interacting##11##2##(1994-11#1)(1995-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#4)(2013-1#1)(2013-8#1)
of interaction among##2##3##(2008-11#1)(2010-6#1)
of interaction and##2##3##(2009-12#1)(2012-3#1)
of interaction between the##2##4##(1997-2#1)(2008-10#1)
of interaction between##6##3##(1990-11#1)(1990-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-9#1)
of interaction of##4##3##(2008-10#3)(2009-8#1)
of interaction with##2##3##(1990-4#1)(2008-11#1)
of interaction##25##2##(1990-11#1)(1990-2#2)(1990-4#1)(1995-11#1)(1997-1#1)(1997-2#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
of interactions between the##2##4##(2008-11#1)(2012-2#1)
of interactions between##9##3##(1992-6#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
of interactions that##2##3##(2008-9#1)(2009-7#1)
of interactions with##4##3##(2008-10#2)(2009-12#1)(2013-1#1)
of interactions##21##2##(1992-6#1)(1992-9#1)(1993-8#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
of intercellular##5##2##(2008-10#2)(2008-11#1)(2010-1#1)(2013-8#1)
of interchangeability##2##2##(1990-2#1)(2013-1#1)
of interest and##7##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-3#1)
of interest are discussed##2##4##(2008-11#1)(2013-8#1)
of interest are##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
of interest as##2##3##(2008-11#1)(2011-2#1)
of interest can be##3##4##(1996-6#1)(2008-4#1)(2008-7#1)
of interest for the##4##4##(2008-10#1)(2008-9#1)(2009-12#1)(2013-8#1)
of interest for##13##3##(1991-5#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2011-2#2)(2013-8#1)
of interest in the##7##4##(1992-9#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
of interest in##19##3##(1991-6#1)(1992-9#1)(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-1#3)
of interest is the##2##4##(2008-9#2)
of interest is##10##3##(2008-10#2)(2008-11#1)(2008-4#4)(2008-9#2)(2012-2#1)
of interest on##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
of interest to##13##3##(1990-2#1)(1993-11#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
of interest was##2##3##(2008-10#1)(2008-8#1)
of interest were##2##3##(2008-10#1)(2008-9#1)
of interest##186##2##(1990-2#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-6#3)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#31)(2008-11#21)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#16)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#12)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-5#3)(2010-6#1)(2011-1#26)(2011-2#10)(2011-3#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
of interested##3##2##(1993-1#1)(2008-10#1)(2008-11#1)
of interests##3##2##(1992-1#1)(2008-12#1)(2010-2#1)
of interfacial##3##2##(1990-8#1)(2008-10#1)(2012-2#1)
of interference by##2##3##(2008-10#1)(2008-2#1)
of interference##14##2##(1990-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
of interferences from##3##3##(2008-10#3)
of interferences in##2##3##(2008-10#2)
of interferences was##3##3##(2008-10#3)
of interferences##23##2##(2008-10#23)
of interferent##2##2##(2008-10#2)
of interferents##4##2##(2008-10#4)
of interfering ions on##2##4##(2008-10#2)
of interfering ions##11##3##(2008-10#11)
of interfering substances##2##3##(2008-10#2)
of interfering##23##2##(1997-2#2)(2008-10#20)(2013-1#1)
of interferogram##2##2##(2013-8#2)
of interferon (IFN)-gamma##3##3##(1994-8#1)(1996-12#1)(2008-11#1)
of interferon alpha##2##3##(1997-5#1)(2009-10#1)
of interferon##11##2##(1991-8#1)(1993-2#1)(1994-8#1)(1996-12#1)(1997-5#1)(2008-11#2)(2008-7#1)(2009-10#1)(2012-3#2)
of interferon-alpha##2##2##(1993-2#1)(1997-5#1)
of interferon-beta##8##2##(2008-11#8)
of interferon-gamma (IFN-gamma)##2##3##(2008-11#1)(2008-7#1)
of interferon-gamma##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
of interlaboratory##2##2##(2008-10#2)
of interleukin 7 (IL-7)##2##4##(2008-11#2)
of interleukin 7##3##3##(2008-11#3)
of interleukin##6##2##(1994-5#1)(2008-11#4)(2008-12#1)
of interleukin-1##5##2##(1990-10#2)(1994-6#2)(1995-6#1)
of interleukin-2##2##2##(1990-5#1)(1994-6#1)
of interleukin-6 (IL-6)##2##3##(2008-11#1)(2012-3#1)
of interleukin-6##3##2##(1995-12#1)(2008-11#1)(2012-3#1)
of intermediate grade##2##3##(1990-3#1)(2008-5#1)
of intermediate##16##2##(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1994-6#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2012-2#1)
of intermediates##6##2##(1990-5#2)(1991-6#1)(2008-10#2)(2011-1#1)
of intermittent##7##2##(1997-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
of intermolecular##3##2##(1993-8#1)(2008-10#2)
of internal carotid##2##3##(1996-9#1)(2013-1#1)
of internal organs##2##3##(2010-7#1)(2012-3#1)
of internal standard##5##3##(2008-10#5)
of internal standards##2##3##(2008-10#2)
of internal transcribed spacer (ITS)##2##5##(2008-10#2)
of internal transcribed##3##3##(2008-10#3)
of internal##44##2##(1990-3#1)(1990-5#1)(1990-9#1)(1994-11#1)(1994-3#2)(1996-1#1)(1996-2#1)(1996-9#1)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-4#1)(2010-7#1)(2012-3#4)(2013-1#2)
of internally##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
of international##11##2##(1991-8#1)(1993-2#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-9#2)(2012-2#1)
of interneurons##3##2##(1990-5#1)(1997-3#2)
of interobserver variability##2##3##(1991-12#1)(2009-11#1)
of interpartner conflict##2##3##(2009-9#2)
of interpersonal##3##2##(2008-11#1)(2012-3#2)
of interphase##2##2##(1990-3#1)(1997-3#1)
of interpretation of##2##3##(1994-12#1)(2008-11#1)
of interpretation##5##2##(1991-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2009-12#1)
of interpreting##2##2##(2008-11#1)(2009-6#1)
of interprofessional collaboration##2##3##(2008-12#1)(2013-1#1)
of interprofessional##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
of interrogation##2##2##(2011-2#2)
of interruption of##2##3##(1995-2#1)(2008-10#1)
of intersex##3##2##(2008-10#3)
of interspecies##2##2##(1993-8#1)(2013-1#1)
of interspecific competition##3##3##(2008-8#3)
of interspecific hybridization was##2##4##(2008-9#2)
of interspecific hybridization##5##3##(2008-10#1)(2008-9#4)
of interspecific##12##2##(2008-10#2)(2008-6#1)(2008-8#3)(2008-9#6)
of interstitial lung##2##3##(1991-12#1)(2012-12#1)
of interstitial##7##2##(1991-12#1)(1991-8#1)(1992-1#1)(1996-12#2)(2012-12#2)
of intertrochanteric nonunion##2##3##(2009-3#2)
of intervention in##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
of intervention##24##2##(1991-12#1)(1991-6#1)(1992-9#1)(1994-1#1)(1995-1#1)(1996-1#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
of interventional##4##2##(1995-11#1)(1997-3#1)(2012-3#1)(2013-8#1)
of interventions are##2##3##(2008-11#1)(2011-2#1)
of interventions for##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
of interventions##11##2##(1990-6#1)(1993-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#2)(2013-1#1)
of interview data##2##3##(2013-1#2)
of interview##3##2##(2011-8#1)(2013-1#2)
of interviews with##2##3##(1994-2#1)(1996-3#1)
of intestinal and##2##3##(1990-2#1)(1994-11#1)
of intestinal bacteria##2##3##(2008-11#1)(2008-8#1)
of intestinal obstruction##7##3##(1990-5#1)(2008-12#3)(2009-8#1)(2013-1#2)
of intestinal occlusion##2##3##(1990-3#1)(1990-5#1)
of intestinal parasitosis among##2##4##(2012-3#2)
of intestinal##39##2##(1990-2#5)(1990-3#1)(1990-5#2)(1991-12#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-8#3)(1996-12#1)(1997-1#1)(1997-7#1)(2008-11#3)(2008-12#4)(2008-8#1)(2009-1#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-3#3)(2013-1#3)
of intestine##3##2##(1993-2#1)(2008-5#1)(2012-3#1)
of intimal##2##2##(1997-8#1)(2006-6#1)
of intimate partner violence##3##4##(2008-12#1)(2012-12#2)
of intoxication##2##2##(2008-10#1)(2010-1#1)
of intra-abdominal##3##2##(1996-8#1)(2011-2#1)(2013-8#1)
of intra-arterial##2##2##(1997-3#1)(1997-5#1)
of intra-articular##2##2##(2013-1#2)
of intra-operative##2##2##(2008-9#1)(2013-1#1)
of intraaortic##2##2##(2008-3#1)(2008-8#1)
of intracellular Ca(2+)##4##3##(2008-11#1)(2008-8#1)(2009-8#2)
of intracellular Ca2+##8##3##(1990-2#1)(1991-6#2)(1994-11#1)(1994-6#2)(1996-2#1)(2008-9#1)
of intracellular MIF in##4##4##(2009-6#4)
of intracellular MIF##5##3##(2009-6#5)
of intracellular ROS##2##3##(2008-11#2)
of intracellular amino##2##3##(1990-12#2)
of intracellular calcium##6##3##(1990-8#1)(1994-8#1)(1995-8#1)(2008-8#2)(2008-9#1)
of intracellular flux analysis##2##4##(2008-7#2)
of intracellular flux##4##3##(2008-7#4)
of intracellular free##2##3##(1994-6#1)(2008-9#1)
of intracellular pH##3##3##(1990-2#1)(2008-9#1)(2010-8#1)
of intracellular proteins##2##3##(2008-11#1)(2008-8#1)
of intracellular reactive oxygen species (ROS)##2##6##(2008-9#1)(2009-8#1)
of intracellular signaling pathways##3##4##(2008-11#1)(2008-7#1)(2009-12#1)
of intracellular signaling##4##3##(1994-12#1)(2008-11#1)(2008-7#1)(2009-12#1)
of intracellular##87##2##(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#3)(1991-11#1)(1991-6#2)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#3)(1994-8#1)(1995-2#1)(1995-8#3)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#15)(2008-4#2)(2008-5#1)(2008-7#11)(2008-8#4)(2008-9#10)(2009-12#1)(2009-6#5)(2009-8#3)(2009-9#1)(2010-8#1)(2013-1#1)
of intracerebral hemorrhage##2##3##(2007-9#1)(2012-3#1)
of intracerebral##4##2##(2007-9#1)(2008-12#1)(2008-8#1)(2012-3#1)
of intracranial aneurysms##4##3##(1997-3#1)(2008-7#1)(2009-9#1)(2011-2#1)
of intracranial haemorrhage##3##3##(1992-6#1)(2008-7#1)(2011-2#1)
of intracranial##17##2##(1992-6#1)(1994-8#2)(1996-2#1)(1997-3#1)(1997-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)
of intractable##3##2##(2011-2#2)(2012-12#1)
of intradural spinal##2##3##(2011-2#1)(2012-3#1)
of intradural##4##2##(2009-5#1)(2011-2#1)(2012-3#2)
of intraguild predation and stage structure##2##6##(2008-8#2)
of intrahepatic##2##2##(1990-3#1)(2010-12#1)
of intramolecular##2##2##(1994-11#1)(2008-10#1)
of intramuscular##2##2##(2008-8#1)(2010-5#1)
of intraoperative##8##2##(1990-3#1)(1992-2#1)(1994-3#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
of intraspecific variation##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
of intraspecific##5##2##(2008-10#2)(2008-8#2)(2012-2#1)
of intrauterine devices##2##3##(1993-12#2)
of intrauterine##6##2##(1991-2#1)(1993-12#2)(2010-8#1)(2013-1#2)
of intravascular##4##2##(1993-2#1)(1994-5#1)(1996-6#1)(2008-11#1)
of intravenous digital subtraction angiography##2##5##(1993-8#2)
of intravenous##14##2##(1993-1#1)(1993-6#1)(1993-8#2)(1996-11#2)(1997-2#1)(2008-12#1)(2009-12#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
of intravenously##2##2##(1993-11#1)(2010-8#1)
of intravitreal Ranibizumab##2##3##(2013-1#2)
of intravitreal##4##2##(2010-9#1)(2011-2#1)(2013-1#2)
of intrinsic##11##2##(1990-5#1)(1992-12#1)(1992-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
of introduced##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
of introducing a##2##3##(2008-11#1)(2008-3#1)
of introducing the##2##3##(2008-10#1)(2008-11#1)
of introducing##10##2##(2008-10#1)(2008-11#3)(2008-3#2)(2008-8#2)(2013-1#1)(2013-8#1)
of introduction of##2##3##(2008-10#1)(2011-2#1)
of introduction##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
of introspection##2##2##(1993-2#1)(2012-3#1)
of inulin##2##2##(1992-1#1)(2008-10#1)
of invading##2##2##(1990-2#1)(2008-10#1)
of invasion of##2##3##(1995-12#1)(2013-8#1)
of invasion##7##2##(1995-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#1)(2013-8#1)
of invasive bladder cancer##2##4##(2013-8#2)
of invasive carcinoma##2##3##(1990-6#1)(1994-2#1)
of invasive cervical resorption##2##4##(2013-1#2)
of invasive##21##2##(1990-6#1)(1994-2#2)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
of invasiveness##2##2##(1990-6#1)(2008-8#1)
of inverse##3##2##(1996-3#1)(2008-11#1)(2009-8#1)
of invertase##2##2##(2008-10#2)
of invertebrates##3##2##(1990-5#1)(2008-7#1)(2009-6#1)
of investigated##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
of investigating the##2##3##(1991-2#1)(2013-8#1)
of investigating##4##2##(1991-2#1)(2008-11#1)(2012-3#1)(2013-8#1)
of investigation and##2##3##(1992-12#1)(1993-11#1)
of investigation in the##2##4##(1992-1#1)(2009-6#1)
of investigation in##4##3##(1991-3#1)(1992-1#1)(2008-3#1)(2009-6#1)
of investigation of##2##3##(2008-10#1)(2008-11#1)
of investigation##18##2##(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2012-7#1)(2013-1#2)
of investigations##6##2##(2008-10#3)(2008-11#1)(2010-10#1)(2012-12#1)
of involved##2##2##(1993-3#1)(2008-10#1)
of involvement of the##3##4##(1997-8#2)(2013-1#1)
of involvement of##5##3##(1995-2#1)(1997-8#2)(2008-7#1)(2013-1#1)
of involvement##10##2##(1990-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-8#3)(2008-7#1)(2013-1#2)
of involving service users##2##4##(2008-12#2)
of involving##4##2##(1997-7#1)(2008-12#3)
of iodate in##2##3##(2008-10#2)
of iodate##7##2##(2008-10#7)
of iodide by##3##3##(2008-10#3)
of iodide in##5##3##(2008-10#5)
of iodide ion##4##3##(2008-10#4)
of iodide on##2##3##(2008-10#2)
of iodide oxidation##2##3##(2008-10#2)
of iodide was##2##3##(2008-10#2)
of iodide##26##2##(2008-10#26)
of iodine and bromine with two new macrocycle diamides##2##9##(2008-10#2)
of iodine in##2##3##(2008-10#1)(2012-3#1)
of iodine supplementation##2##3##(2012-3#2)
of iodine using##2##3##(2008-10#2)
of iodine##18##2##(1997-8#1)(2008-10#13)(2012-3#3)(2013-1#1)
of ion associates of##3##4##(2008-10#3)
of ion associates##6##3##(2008-10#6)
of ion association of##2##4##(2008-10#2)
of ion association##5##3##(2008-10#5)
of ion channel##5##3##(1992-6#2)(1995-8#2)(2012-3#1)
of ion exchange equilibrium constants##3##5##(2008-10#3)
of ion exchange##5##3##(2008-10#5)
of ion mobility spectrometry##3##4##(2008-10#3)
of ion pairs##4##3##(2008-10#4)
of ion selective electrodes##3##4##(2008-10#2)(2008-6#1)
of ion##45##2##(1992-6#2)(1995-8#2)(2007-12#1)(2008-10#35)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
of ion-exchange##2##2##(2008-10#2)
of ion-exchanger##2##2##(2008-10#2)
of ion-pair flow injection with piezoelectric detection##2##7##(2008-10#2)
of ion-pair##4##2##(2008-10#4)
of ion-selective electrode##2##3##(2008-10#2)
of ion-selective electrodes (ISEs)##3##4##(2008-10#3)
of ion-selective electrodes##6##3##(2008-10#6)
of ion-selective##8##2##(2008-10#8)
of ionene##2##2##(2008-10#2)
of ionic species##2##3##(2008-10#2)
of ionic strength##5##3##(2008-10#5)
of ionic##13##2##(2008-10#11)(2008-5#1)(2010-7#1)
of ionizing radiation##5##3##(1997-8#1)(2008-7#3)(2013-1#1)
of ionizing##7##2##(1997-8#1)(2008-11#1)(2008-7#4)(2013-1#1)
of ionophore##4##2##(2008-10#4)
of ions in the##2##4##(2008-10#2)
of ions in##3##3##(2008-10#3)
of ions##18##2##(2008-10#14)(2008-8#1)(2010-7#1)(2012-2#2)
of iprodione##4##2##(2008-10#4)
of iran##3##2##(2012-2#2)(2013-1#1)
of iridium oxide##2##3##(2008-10#2)
of iridium##10##2##(2008-10#10)
of iridophores in##3##3##(2008-5#3)
of iris##2##2##(2008-10#1)(2008-8#1)
of iron (II)##3##3##(2008-10#2)(2009-9#1)
of iron and copper##2##4##(2008-10#2)
of iron and manganese##2##4##(2008-10#2)
of iron and nickel##3##4##(2008-10#3)
of iron and ruthenium##2##4##(2008-10#2)
of iron and zinc in the human hair with##2##9##(2008-10#2)
of iron and zinc in##3##5##(2008-10#3)
of iron and zinc##5##4##(2008-10#5)
of iron and##26##3##(1996-2#1)(2008-10#22)(2008-8#1)(2011-2#1)(2013-8#1)
of iron as##3##3##(2008-10#3)
of iron by##4##3##(2008-10#4)
of iron containing##2##3##(2008-11#2)
of iron content in##2##4##(2008-10#2)
of iron depletion##2##3##(2009-8#2)
of iron from##4##3##(2008-10#3)(2008-5#1)
of iron in milk##2##4##(2008-10#2)
of iron in natural##2##4##(2008-10#2)
of iron in tap and##2##5##(2008-10#2)
of iron in the##6##4##(1993-2#1)(2008-10#5)
of iron in water samples##3##5##(2008-10#3)
of iron in##29##3##(1993-2#1)(2008-10#27)(2012-2#1)
of iron metabolism##2##3##(1993-11#1)(2013-8#1)
of iron on##2##3##(2008-10#2)
of iron was##2##3##(2008-10#2)
of iron##128##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-8#1)(1995-3#1)(1996-2#3)(2008-1#1)(2008-10#94)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#3)(2009-9#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
of iron(II) and##3##3##(2008-10#3)
of iron(II) tris-(1##3##3##(2008-10#3)
of iron(II)##9##2##(2008-10#9)
of iron(III) and copper(II) and of iron(III) and palladium(II)##3##9##(2008-10#3)
of iron(III) and iron(II) in##2##5##(2008-10#2)
of iron(III) and iron(II)##3##4##(2008-10#3)
of iron(III) and titanium(IV)##3##4##(2008-10#3)
of iron(III) and total iron by sequential injection analysis##2##9##(2008-10#2)
of iron(III) and total iron##3##5##(2008-10#3)
of iron(III) and##15##3##(2008-10#15)
of iron(III)##29##2##(2008-10#29)
of irradiated##6##2##(2008-10#4)(2008-7#1)(2008-8#1)
of irradiation##8##2##(2008-10#5)(2008-3#1)(2008-9#2)
of irrational beliefs##3##3##(2010-5#3)
of irrationality##3##2##(2010-5#3)
of irregular##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
of irrelevant##2##2##(2009-8#1)(2013-8#1)
of irresponsible##2##2##(1996-2#1)(1997-6#1)
of irreversible##3##2##(2008-6#1)(2010-12#1)(2012-2#1)
of irrigation water##2##3##(2008-10#2)
of irrigation##5##2##(2008-10#5)
of irritable bowel##2##3##(2013-1#2)
of irritation##3##2##(2008-10#1)(2008-5#2)
of ischaemic stroke##3##3##(2008-8#3)
of ischaemic##4##2##(1995-12#1)(2008-8#3)
of ischemia##3##2##(1994-2#1)(1994-3#1)(2008-12#1)
of ischemic colitis##2##3##(2013-1#2)
of ischemic heart disease (IHD)##2##5##(2008-3#1)(2012-3#1)
of ischemic heart disease##9##4##(2008-10#2)(2008-3#1)(2010-12#2)(2010-6#2)(2012-3#2)
of ischemic heart##10##3##(2008-10#2)(2008-3#1)(2010-12#2)(2010-6#2)(2012-3#3)
of ischemic stroke##4##3##(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of ischemic##23##2##(1991-3#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#2)(2011-2#3)(2012-3#4)(2013-1#3)
of island##2##2##(2008-8#1)(2011-2#1)
of islet##2##2##(1992-6#1)(2008-1#1)
of islets##5##2##(1995-8#1)(2008-4#1)(2010-11#3)
of isoforms##2##2##(1993-3#1)(2008-10#1)
of isofraxidin and fumaric acid in##2##6##(2008-10#2)
of isolate EN-4##2##3##(2008-10#2)
of isolate##9##2##(2008-10#7)(2008-9#1)(2011-2#1)
of isolated cells##2##3##(2008-11#2)
of isolated outer##2##3##(1990-5#1)(2009-9#1)
of isolated pancreatic##2##3##(2010-1#1)(2013-1#1)
of isolated##34##2##(1990-12#1)(1990-5#1)(1993-8#1)(1995-3#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#2)
of isolates as##2##3##(2008-10#2)
of isolates belonging to group I##2##6##(2008-10#2)
of isolates belonging to##4##4##(2008-10#4)
of isolates from each##3##4##(2008-10#3)
of isolates from the##2##4##(2008-10#2)
of isolates from##13##3##(2008-10#13)
of isolates in##3##3##(2008-10#3)
of isolates of the pathogen##2##5##(2008-10#2)
of isolates of the##6##4##(2008-10#5)(2013-8#1)
of isolates of##14##3##(2008-10#11)(2012-2#1)(2013-1#1)(2013-8#1)
of isolates sampled from##2##4##(2008-10#2)
of isolates that##2##3##(2008-10#2)
of isolates were##6##3##(2008-10#5)(2008-5#1)
of isolates within##2##3##(2008-10#2)
of isolates##87##2##(2008-10#78)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
of isolation and purification##2##4##(2008-10#2)
of isolation and##3##3##(2008-10#3)
of isolation of##6##3##(2008-10#3)(2008-12#1)(2009-12#1)(2012-2#1)
of isolation##15##2##(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)(2012-2#1)
of isomeric##6##2##(1992-12#2)(1996-5#1)(2008-10#3)
of isoniazid tablets##2##3##(2008-10#2)
of isoniazid##9##2##(2008-10#8)(2008-11#1)
of isoproterenol##4##2##(2008-10#3)(2011-2#1)
of isosorbide dinitrate##2##3##(1996-9#1)(2008-10#1)
of isotopic##3##2##(2008-10#3)
of isotopomer models is##2##4##(2008-7#2)
of isotopomer##3##2##(2008-7#3)
of isotropic##3##2##(2008-2#1)(2008-3#2)
of isozymes##2##2##(2008-10#2)
of issues and##2##3##(1995-3#1)(2010-4#1)
of issues related to##3##4##(1997-2#1)(2008-10#1)(2013-1#1)
of issues that##4##3##(1991-3#1)(2008-11#1)(2008-12#1)(2008-4#1)
of issues##15##2##(1991-3#1)(1992-11#1)(1994-12#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2010-4#1)(2010-6#1)(2013-1#2)
of it##18##2##(1991-5#1)(1994-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(2008-10#6)(2008-11#2)(2009-12#1)(2009-6#1)(2011-2#1)(2012-3#2)
of item##6##2##(2008-12#1)(2012-2#5)
of item-writing##2##2##(2008-12#2)
of items with##2##3##(2010-11#1)(2010-2#1)
of items##9##2##(1993-12#1)(2008-7#1)(2010-1#1)(2010-11#2)(2010-2#1)(2011-2#1)(2012-2#2)
of its 1-(2-pyridylazo)-2-naphthol##2##3##(2008-10#2)
of its DNA##2##3##(2008-11#1)(2011-2#1)
of its ability to##6##4##(1993-6#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)
of its activity##3##3##(1991-5#1)(1995-6#1)(2010-6#1)
of its behavior##2##3##(2008-8#1)(2009-5#1)
of its cell##2##3##(1990-8#1)(2008-11#1)
of its clinical##3##3##(2008-8#1)(2009-8#1)(2010-1#1)
of its components##2##3##(1990-11#1)(2009-12#1)
of its concentration##4##3##(2008-10#4)
of its critical surface tension##2##5##(2008-5#2)
of its development##2##3##(2006-6#1)(2008-12#1)
of its effect on##3##4##(1994-3#1)(1995-2#1)(2008-10#1)
of its effectiveness in##2##4##(1993-1#1)(2008-11#1)
of its effects on##2##4##(2008-12#1)(2012-12#1)
of its electrochemical##2##3##(2008-10#2)
of its ethyl xanthate complex onto naphthalene##2##7##(2008-10#2)
of its expression##2##3##(2008-8#2)
of its formation##2##3##(2008-10#1)(2011-2#1)
of its function##3##3##(1992-9#1)(1995-2#1)(2009-8#1)
of its genome##2##3##(2008-10#1)(2012-3#1)
of its high##8##3##(1991-2#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
of its host plant##2##4##(2009-8#2)
of its host##4##3##(2009-8#2)(2011-1#1)(2011-2#1)
of its initial##3##3##(1993-6#1)(2008-10#1)(2012-2#1)
of its interaction##2##3##(2008-8#1)(2010-4#1)
of its isolated##3##3##(1993-8#1)(2011-2#2)
of its kind in##2##4##(1996-3#1)(2012-2#1)
of its kind##6##3##(1996-3#1)(1996-5#1)(2008-12#1)(2008-7#1)(2009-7#1)(2012-2#1)
of its length##2##3##(1990-5#1)(2013-1#1)
of its mRNA##3##3##(1994-11#1)(1995-2#1)(2008-9#1)
of its major##2##3##(2008-11#1)(2011-3#1)
of its manufacture##2##3##(2008-10#1)(2008-3#1)
of its many##2##3##(1992-3#1)(2008-5#1)
of its mechanism##2##3##(2008-11#1)(2013-8#1)
of its original##2##3##(2008-10#1)(2008-11#1)
of its own##5##3##(1991-5#2)(1994-12#1)(1995-2#1)(2008-10#1)
of its oxidation##3##3##(2008-10#2)(2011-1#1)
of its parents are##2##4##(2008-10#1)(2008-12#1)
of its possible##2##3##(1991-3#1)(1994-6#1)
of its potential to##2##4##(2008-10#1)(2012-2#1)
of its potential##7##3##(1996-2#1)(2008-10#2)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
of its properties##3##3##(2008-10#1)(2008-5#1)(2010-1#1)
of its rarity##4##3##(2008-12#1)(2010-11#1)(2010-7#1)(2012-3#1)
of its receptors##2##3##(2008-8#2)
of its role in##3##4##(1991-12#1)(2011-2#1)(2013-1#1)
of its role##4##3##(1991-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
of its specific##4##3##(1996-3#1)(2008-10#2)(2013-7#1)
of its structural##2##3##(2008-7#1)(2009-12#1)
of its total##2##3##(2008-10#2)
of its use##5##3##(1993-3#1)(2008-11#2)(2008-9#1)(2013-8#1)
of its vector##2##3##(2008-10#2)
of its##435##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#6)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#6)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#3)(1992-9#3)(1993-1#2)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#7)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#6)(2006-6#1)(2007-11#1)(2008-10#103)(2008-11#27)(2008-12#13)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#19)(2008-6#2)(2008-7#5)(2008-8#15)(2008-9#10)(2009-1#2)(2009-10#1)(2009-12#4)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#26)(2011-3#1)(2012-12#1)(2012-2#8)(2012-3#11)(2013-1#13)(2013-7#1)(2013-8#8)
of jasmonic acid##2##3##(2008-10#1)(2009-8#1)
of jejunal##5##2##(1990-5#1)(1990-9#1)(1991-12#2)(2013-1#1)
of job insecurity##2##3##(2009-10#2)
of job satisfaction##3##3##(1994-5#1)(2008-11#1)(2008-7#1)
of job strain##3##3##(2008-10#3)
of job##13##2##(1993-3#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#2)(2012-2#1)
of jogging on mental well-being and seasonal mood##2##8##(1991-8#2)
of jogging##4##2##(1991-8#4)
of joint attention##2##3##(2008-11#1)(2010-10#1)
of joint ventures##4##3##(1993-1#1)(2008-11#3)
of joint##14##2##(1992-2#1)(1992-8#1)(1993-1#2)(1995-2#1)(2008-11#4)(2008-12#2)(2009-7#1)(2010-10#1)(2012-3#1)
of judgment##2##2##(1993-2#1)(2008-11#1)
of junD was##2##3##(1996-12#2)
of junD##3##2##(1996-12#3)
of just one##2##3##(2008-7#1)(2010-7#1)
of just##4##2##(1992-6#1)(2008-7#1)(2010-7#1)(2011-2#1)
of juvenile hormone##2##3##(2008-8#1)(2008-9#1)
of juvenile lemon sharks Negaprion brevirostris##2##6##(2010-8#2)
of juvenile rainbow trout##2##4##(2010-8#2)
of juvenile walleye pollock Theragra chalcogramma##2##6##(2010-8#2)
of juvenile##20##2##(1992-6#2)(1994-8#1)(2008-8#5)(2008-9#2)(2010-12#1)(2010-8#7)(2011-2#1)(2013-1#1)
of juveniles##5##2##(2008-10#3)(2008-9#2)
of kainate##2##2##(1994-2#1)(1995-11#1)
of kanamycin resistance##3##3##(2008-10#3)
of karyotype##2##2##(2008-11#1)(2008-12#1)
of keratin##6##2##(1991-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
of keratinocyte differentiation##3##3##(1994-3#1)(2008-11#1)(2008-5#1)
of keratinocyte##4##2##(1994-3#2)(2008-11#1)(2008-5#1)
of keratosis##2##2##(2011-2#2)
of kernel##4##2##(2008-10#4)
of kernels infected##2##3##(2008-10#2)
of kernels##4##2##(2008-10#4)
of kerosene##3##2##(2008-10#1)(2008-11#2)
of ketones##2##2##(2008-12#1)(2010-7#1)
of ketoprofen##3##2##(2008-10#2)(2012-3#1)
of ketorolac was##2##3##(2008-10#2)
of ketorolac##5##2##(2008-10#5)
of key articles were searched##4##5##(2012-12#4)
of key articles##6##3##(2012-12#6)
of key components##2##3##(1996-2#1)(2008-5#1)
of key enzymes##2##3##(2008-10#1)(2008-11#1)
of key importance##2##3##(1994-8#2)
of key stakeholders##2##3##(1991-1#1)(1991-3#1)
of key##43##2##(1991-1#1)(1991-3#2)(1994-3#1)(1994-8#3)(1995-3#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#3)(2009-12#1)(2010-8#1)(2011-2#2)(2012-12#6)(2012-2#1)(2013-1#3)(2013-7#1)
of kidney in##3##3##(1997-8#1)(2008-12#2)
of kidney stones##2##3##(2008-12#1)(2013-8#1)
of kidney##19##2##(1990-2#1)(1991-8#1)(1993-2#1)(1994-5#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-12#5)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#2)
of kidneys##3##2##(1997-8#1)(2011-3#1)(2012-3#1)
of killing##3##2##(1993-12#1)(1995-2#1)(2008-11#1)
of kilometers##3##2##(1991-8#1)(2008-10#1)(2008-9#1)
of kin selection##2##3##(2008-8#1)(2010-4#1)
of kin##3##2##(1993-6#1)(2008-8#1)(2010-4#1)
of kinase##3##2##(1992-9#1)(1993-8#1)(2008-5#1)
of kinematic focusing was##2##4##(2008-10#2)
of kinematic focusing##3##3##(2008-10#3)
of kinematic##4##2##(1993-3#1)(2008-10#3)
of kinetic parameters##2##3##(1995-12#1)(2008-7#1)
of kinetic##7##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
of kinetically-hindered##2##2##(2008-10#2)
of knee OA##2##3##(1992-3#2)
of knee evaluation##2##3##(2013-1#2)
of knee##7##2##(1992-3#2)(2009-3#1)(2009-4#1)(2013-1#3)
of knees##2##2##(2008-5#1)(2012-2#1)
of knowing##2##2##(2008-1#1)(2008-12#1)
of knowledge about the##2##4##(1996-11#1)(2008-11#1)
of knowledge about##5##3##(1994-2#1)(1996-11#1)(2008-11#1)(2008-5#1)(2013-8#1)
of knowledge and skills##2##4##(2009-6#1)(2011-2#1)
of knowledge and##6##3##(1995-2#1)(2008-11#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
of knowledge from the##2##4##(1994-6#1)(2008-11#1)
of knowledge in the##2##4##(2013-1#2)
of knowledge in##5##3##(2008-10#1)(2008-9#1)(2010-6#1)(2013-1#2)
of knowledge of the##2##4##(2008-10#1)(2008-8#1)
of knowledge of##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
of knowledge on the##3##4##(1990-8#1)(2008-10#1)(2008-11#1)
of knowledge on##5##3##(1990-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
of knowledge regarding the##2##4##(2008-12#1)(2012-3#1)
of knowledge##61##2##(1990-8#1)(1991-3#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-11#13)(2008-12#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
of known amounts of##2##4##(2008-10#2)
of known and##2##3##(2011-2#1)(2012-3#1)
of known composition##2##3##(2008-10#1)(2008-3#1)
of known concentration##2##3##(2008-10#2)
of known or##3##3##(1994-9#1)(2008-1#1)(2008-10#1)
of known##44##2##(1991-12#1)(1991-5#1)(1992-1#1)(1993-3#1)(1993-8#2)(1994-9#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
of kojic acid##2##3##(2008-5#2)
of kolkata##2##2##(2009-10#2)
of l-ascorbic acid in##3##4##(2008-10#3)
of l-ascorbic acid##14##3##(2008-10#14)
of l-carnitine##4##2##(2008-10#4)
of l-carnosine##2##2##(2011-1#2)
of l-cysteine and glutathione##3##4##(2008-10#3)
of l-cysteine and##7##3##(2008-10#7)
of l-cysteine##18##2##(2008-10#18)
of l-cystine##2##2##(2008-10#2)
of l-glutamate##5##2##(2008-10#5)
of l-histidine##3##2##(2008-10#3)
of l-malic acid with alkaline metals##2##6##(2008-10#2)
of l-phenylalanine##3##2##(2008-10#3)
of l-tyrosine##4##2##(2008-10#4)
of lab##2##2##(1994-8#1)(2010-8#1)
of label##4##2##(1990-12#1)(2008-7#2)(2008-8#1)
of labeled polypeptides##2##3##(1994-11#2)
of labeled##15##2##(1994-11#2)(1997-1#7)(1997-3#1)(2008-10#2)(2008-4#2)(2011-2#1)
of labeling was##2##3##(1994-5#1)(1997-2#1)
of labeling##5##2##(1994-5#1)(1995-11#1)(1997-2#1)(2008-7#1)(2013-1#1)
of labels##3##2##(1992-3#1)(1994-3#1)(2008-10#1)
of labile Cu(2+) in fresh waters##2##6##(2008-10#2)
of labile##5##2##(2008-10#5)
of labor in##4##3##(2008-12#1)(2008-8#3)
of labor##13##2##(1994-2#2)(1996-1#1)(2008-11#2)(2008-12#1)(2008-8#6)(2013-1#1)
of laboratories##8##2##(1993-6#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)
of laboratory animals##2##3##(2008-10#1)(2008-4#1)
of laboratory experiments##2##3##(2008-10#1)(2008-8#1)
of laboratory investigations##2##3##(2008-11#1)(2008-7#1)
of laboratory medicine##4##3##(1994-12#4)
of laboratory strains##2##3##(2012-3#2)
of laboratory testing##2##3##(1994-12#1)(2008-10#1)
of laboratory tests##3##3##(1991-2#1)(1994-12#1)(1997-3#1)
of laboratory##38##2##(1990-9#1)(1991-2#1)(1992-12#1)(1993-2#1)(1994-12#8)(1996-12#1)(1996-6#1)(1997-3#2)(2008-10#6)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
of labour##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
of lacZ expression##2##3##(1995-6#1)(1997-8#1)
of lacZ##5##2##(1993-12#2)(1995-6#1)(1997-8#1)(2009-12#1)
of laccase and 0##2##4##(2008-5#2)
of laccase##4##2##(2008-10#2)(2008-5#2)
of lack of##3##3##(1995-11#1)(2009-12#1)(2011-2#1)
of lactate accumulation##2##3##(2008-10#1)(2008-11#1)
of lactate and##2##3##(2008-11#1)(2012-3#1)
of lactate dehydrogenase##3##3##(1995-11#3)
of lactate in whole##2##4##(2008-10#2)
of lactate##13##2##(1994-11#1)(1995-11#3)(2008-10#4)(2008-11#4)(2012-3#1)
of lactic acid bacteria##5##4##(2008-11#5)
of lactic acid##10##3##(2008-10#4)(2008-11#5)(2008-7#1)
of lactic##12##2##(1990-5#1)(2008-10#4)(2008-11#5)(2008-5#1)(2008-7#1)
of lactobacillus##2##2##(2008-12#1)(2012-2#1)
of lactose and##2##3##(2008-10#1)(2008-11#1)
of lactose##3##2##(2008-10#2)(2008-11#1)
of lag##5##2##(2008-11#1)(2011-2#4)
of lambda DNA##2##3##(1994-11#2)
of lambda plasmid##3##3##(1994-11#3)
of lambda##9##2##(1992-2#1)(1992-6#1)(1994-11#5)(1995-8#1)(1996-6#1)
of lambda-DNA##3##2##(2008-8#3)
of lambdaN gene expression##2##4##(2008-8#1)(2008-9#1)
of lambdaN gene##10##3##(2008-8#8)(2008-9#2)
of lambdaN##11##2##(2008-8#9)(2008-9#2)
of lambs##2##2##(1996-12#1)(2008-10#1)
of lamellae in the##2##4##(2008-7#2)
of lamellae##5##2##(2008-7#5)
of lamina##2##2##(1997-3#1)(2008-11#1)
of laminin 332##3##3##(2013-8#3)
of laminin-5##2##2##(2008-11#1)(2008-5#1)
of laminitis##2##2##(1997-5#2)
of lamivudine##2##2##(2009-8#2)
of land plants##2##3##(2009-6#2)
of land##4##2##(2008-10#1)(2008-12#1)(2009-6#2)
of landscape structure##2##3##(2008-8#1)(2013-1#1)
of landscape##3##2##(2008-8#1)(2013-1#2)
of language and##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
of language##12##2##(1994-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-5#1)(2011-1#3)(2012-3#1)(2013-8#2)
of lanosterol 14##2##3##(1991-5#1)(1992-3#1)
of lanosterol##3##2##(1991-5#1)(1992-3#2)
of lansoprazole in daily practice##2##5##(2008-11#2)
of lansoprazole##4##2##(2008-11#4)
of lanthanide##5##2##(2008-10#5)
of lanthanides in##2##3##(2008-10#2)
of lanthanides##12##2##(2008-10#12)
of lanthanoids(III)##3##2##(2008-10#3)
of lanthanum##6##2##(1997-2#1)(2008-10#3)(2008-7#1)(2008-9#1)
of laparoscopic and##2##3##(2010-12#1)(2011-1#1)
of laparoscopic cholecystectomy##2##3##(2008-12#1)(2012-3#1)
of laparoscopic surgery##4##3##(1993-12#1)(2013-1#3)
of laparoscopic##21##2##(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#2)(2008-10#2)(2008-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
of laparoscopically assisted vaginal hysterectomy##3##5##(1993-12#1)(1994-2#2)
of laparoscopy##5##2##(1993-3#2)(1996-1#1)(1996-3#2)
of laparotomy##2##2##(1990-2#1)(1996-1#1)
of large amount of##3##4##(2008-10#3)
of large amounts of##6##4##(2008-10#4)(2008-11#1)(2008-5#1)
of large and small##3##4##(1995-12#1)(1997-8#1)(2010-11#1)
of large and##6##3##(1995-12#1)(1995-6#1)(1997-8#1)(2008-7#1)(2010-11#1)(2011-2#1)
of large blood vessels##2##4##(2011-2#2)
of large bowel cancer##3##4##(1991-6#3)
of large bowel##5##3##(1991-6#4)(2012-3#1)
of large cell##2##3##(2008-11#1)(2009-8#1)
of large ensembles of##2##4##(2009-8#2)
of large insert##2##3##(2008-4#2)
of large numbers of##5##4##(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)
of large particles##2##3##(2008-10#1)(2008-3#1)
of large quantities of protein##2##5##(2008-11#2)
of large quantities of##5##4##(1996-5#1)(1997-3#1)(2008-11#3)
of large sample##3##3##(1995-9#1)(2008-10#1)(2012-2#1)
of large vessels##2##3##(1997-8#1)(2010-9#1)
of large volumes of##2##4##(2008-10#1)(2009-7#1)
of large##103##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-6#4)(1992-3#3)(1992-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#2)(2008-10#20)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
of large-scale##7##2##(1990-3#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#3)
of larger size##2##3##(2008-10#1)(2012-3#1)
of larger##12##2##(1995-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
of larvae##13##2##(2008-12#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-8#3)(2012-2#1)(2013-1#1)(2013-8#1)
of larval inhibition##2##3##(1996-12#2)
of larval##17##2##(1996-12#2)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-8#4)(2012-3#1)
of laryngeal carcinoma##3##3##(1997-8#2)(2011-2#1)
of laryngeal lesion##2##3##(1990-6#1)(2012-3#1)
of laryngeal##13##2##(1990-6#2)(1991-12#1)(1992-9#1)(1997-8#3)(2011-2#2)(2012-3#3)(2013-1#1)
of larynx was##2##3##(2010-7#2)
of larynx##5##2##(2010-7#4)(2013-1#1)
of laser ablation##3##3##(2008-10#3)
of laser activation##2##3##(2012-3#2)
of laser beams##2##3##(2008-2#1)(2008-3#1)
of laser light##3##3##(1994-3#1)(2008-3#2)
of laser pulses##2##3##(2007-11#1)(2008-10#1)
of laser##39##2##(1991-1#1)(1991-3#1)(1991-9#1)(1994-2#1)(1994-3#1)(2007-11#1)(2008-10#12)(2008-12#1)(2008-2#4)(2008-3#13)(2010-1#1)(2012-3#2)
of laser-assisted##2##2##(2008-10#1)(2012-3#1)
of laser-induced##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
of lasers by##2##3##(2008-3#2)
of lasers in dentistry##2##4##(1993-3#2)
of lasers##8##2##(1993-3#3)(2008-3#4)(2008-9#1)
of last##5##2##(1992-6#1)(1996-5#1)(1997-2#1)(2008-8#1)(2008-9#1)
of late blight##7##3##(2008-10#6)(2008-8#1)
of late effects##2##3##(2010-11#2)
of late gene##2##3##(1997-3#2)
of late presentation for HIV care in Northern Greece during the##2##11##(2013-1#2)
of late##30##2##(1993-3#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#3)(2010-7#1)(2012-2#1)(2013-1#3)(2013-8#1)
of late-arising##3##2##(2008-9#3)
of latent infection and##2##4##(2008-10#2)
of latent infection were##2##4##(2008-10#2)
of latent infection##13##3##(2008-10#13)
of latent period##2##3##(2008-10#2)
of latent##22##2##(1991-3#1)(2008-10#17)(2008-5#1)(2012-2#2)(2012-3#1)
of later##5##2##(1991-12#1)(1995-1#1)(2008-12#1)(2012-2#1)(2013-1#1)
of lateral##14##2##(1991-2#1)(1993-3#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
of laterality##3##2##(1994-8#3)
of lateralization##2##2##(1994-8#2)
of latex particles##4##3##(1990-12#1)(2008-10#2)(2010-6#1)
of latex##6##2##(1990-12#1)(2008-10#3)(2008-9#1)(2010-6#1)
of lawsuits##2##2##(1992-2#1)(2008-11#1)
of layered##2##2##(2008-10#1)(2009-7#1)
of layers of##4##3##(2008-12#4)
of layers##6##2##(2008-10#1)(2008-12#4)(2008-3#1)
of leaching##3##2##(2008-10#2)(2008-11#1)
of lead (II) and mercury (II)##2##6##(2008-10#2)
of lead (Pb)##3##3##(2008-10#3)
of lead and cadmium in##2##5##(2008-10#2)
of lead and cadmium##3##4##(2008-10#3)
of lead and copper##4##4##(2008-10#4)
of lead and mercury in##2##5##(2008-10#2)
of lead and tin##3##4##(2008-10#3)
of lead and##16##3##(2008-10#16)
of lead by##5##3##(2008-10#5)
of lead concentration##2##3##(2008-10#2)
of lead from##3##3##(2008-10#1)(2011-2#2)
of lead in blood##2##4##(2008-10#2)
of lead in dialysis concentrates##2##5##(2008-10#2)
of lead in human saliva##3##5##(2008-10#3)
of lead in saliva##2##4##(2008-10#2)
of lead in the presence of##2##6##(2008-10#2)
of lead in the##4##4##(2008-10#4)
of lead in water samples##3##5##(2008-10#3)
of lead in water##4##4##(2008-10#4)
of lead in wine samples##2##5##(2008-10#2)
of lead in##52##3##(1992-12#1)(2008-10#51)
of lead ions##2##3##(2008-10#2)
of lead is##2##3##(2008-10#2)
of lead onto the##2##4##(2008-10#2)
of lead salts##2##3##(2008-10#2)
of lead using##2##3##(2008-10#2)
of lead was##3##3##(2008-10#2)(2011-2#1)
of lead were##3##3##(2008-10#3)
of lead with##6##3##(2008-10#6)
of lead##135##2##(1992-12#1)(2008-10#129)(2008-11#1)(2011-2#4)
of lead(II) from##3##3##(2008-10#3)
of lead(II) in##3##3##(2008-10#3)
of lead(II) with##4##3##(2008-10#4)
of lead(II)##21##2##(2008-10#21)
of lead-acid batteries##2##3##(2008-10#2)
of leader##3##2##(1991-9#1)(1993-1#1)(2008-8#1)
of leadership in##4##3##(1993-12#1)(1996-3#3)
of leadership##12##2##(1991-2#1)(1991-3#1)(1992-2#2)(1992-5#1)(1993-12#1)(1994-1#1)(1996-3#4)(2008-6#1)
of leading##2##2##(1994-3#1)(2008-3#1)
of leaf area##4##3##(2008-10#4)
of leaf blast##3##3##(2008-10#3)
of leaf blight##2##3##(2008-10#2)
of leaf blotch##2##3##(2008-10#2)
of leaf colonization##3##3##(2008-10#3)
of leaf hairs##2##3##(2008-10#2)
of leaf infection##2##3##(2008-10#2)
of leaf nitrogen##2##3##(2008-10#1)(2012-5#1)
of leaf rust resistance gene##2##5##(2008-10#2)
of leaf rust resistance genes##3##5##(2008-10#3)
of leaf rust resistance##6##4##(2008-10#6)
of leaf rust##8##3##(2008-10#8)
of leaf samples##2##3##(2008-10#1)(2008-12#1)
of leaf spot##6##3##(2008-10#6)
of leaf spots##2##3##(2008-10#2)
of leaf tissue##2##3##(2008-10#2)
of leaf wetness and temperature##2##5##(2008-10#2)
of leaf wetness and##3##4##(2008-10#3)
of leaf wetness was##3##4##(2008-10#3)
of leaf wetness##12##3##(2008-10#12)
of leaf##75##2##(2008-10#65)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-10#1)(2012-5#2)
of leaflets with##2##3##(2008-10#2)
of leaflets##7##2##(2008-10#7)
of leakage current##3##3##(2012-3#3)
of lean##5##2##(2008-3#1)(2012-2#3)(2013-8#1)
of learner-centered development##2##3##(1992-12#2)
of learners##4##2##(2008-11#3)(2013-1#1)
of learning activities##2##3##(2008-12#1)(2010-8#1)
of learning and memory in##2##5##(2008-9#1)(2009-8#1)
of learning and memory##4##4##(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
of learning and##5##3##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
of learning contracts##3##3##(2008-11#3)
of learning disability##2##3##(2008-11#2)
of learning in##2##3##(2008-11#2)
of learning resources##3##3##(2008-11#3)
of learning##45##2##(1991-2#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#24)(2008-12#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
of least##2##2##(2008-10#1)(2008-8#1)
of leather##2##2##(2008-10#2)
of leaves and##4##3##(2008-10#3)(2008-12#1)
of leaves from##2##3##(2008-10#2)
of leaves of##5##3##(2008-10#3)(2011-3#1)(2012-2#1)
of leaves with##3##3##(2008-10#3)
of leaves##34##2##(2008-10#27)(2008-12#2)(2008-5#1)(2011-3#1)(2012-2#2)(2012-9#1)
of leaving##3##2##(1993-8#1)(2008-3#1)(2009-12#1)
of lecturer##2##2##(2008-11#2)
of lectures##3##2##(1993-11#1)(1994-12#1)(2012-2#1)
of leek rust##2##3##(2008-10#2)
of leek##4##2##(2008-10#4)
of left cardiac##2##3##(1993-3#1)(2008-9#1)
of left renal##2##3##(2008-11#1)(2010-11#1)
of left ventricular dysfunction##2##4##(2008-3#1)(2009-1#1)
of left ventricular systolic##2##4##(2008-11#1)(2010-11#1)
of left ventricular##17##3##(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#1)(2009-1#3)(2010-11#1)(2011-2#2)(2012-2#3)(2012-3#1)
of left##41##2##(1993-3#1)(1997-3#2)(2008-10#2)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#3)(2010-11#2)(2010-12#2)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
of leg and back pain disorders##2##6##(2008-12#2)
of leg##4##2##(2008-12#2)(2009-1#1)(2013-8#1)
of legal##4##2##(1991-2#1)(1994-6#1)(1996-11#2)
of legislation##2##2##(1991-3#1)(1994-1#1)
of legs##2##2##(2008-5#1)(2009-10#1)
of legume##2##2##(2008-10#2)
of leiomyoma of the##2##4##(2012-2#1)(2013-7#1)
of leishmania##2##2##(2009-5#1)(2012-2#1)
of leishmaniasis##2##2##(2008-10#1)(2013-1#1)
of length of##3##3##(1993-12#1)(2008-10#1)(2012-3#1)
of length##5##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
of lens##2##2##(2010-8#1)(2010-9#1)
of leptin in##2##3##(2008-4#1)(2008-9#1)
of leptin##5##2##(2008-10#1)(2008-4#3)(2008-9#1)
of lesbian and gay parents##2##5##(2012-2#2)
of lesbian and gay##3##4##(1992-1#1)(2012-2#2)
of lesbian and##4##3##(1992-1#1)(2008-12#1)(2012-2#2)
of lesbian##5##2##(1992-1#1)(2008-12#2)(2012-2#2)
of lesion density##3##3##(2008-10#3)
of lesion##12##2##(1996-9#2)(2008-10#6)(2008-6#1)(2008-8#2)(2012-2#1)
of lesions and##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
of lesions caused by##3##4##(2008-10#3)
of lesions##28##2##(1991-2#1)(1994-1#1)(1994-6#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
of less than 0##9##4##(1995-1#1)(2008-10#6)(2008-2#1)(2008-3#1)
of less than 1##6##4##(2008-10#4)(2008-3#2)
of less than 10##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
of less than 10%##2##4##(1996-12#1)(2008-10#1)
of less than 2 cm##2##5##(1990-9#1)(1997-4#1)
of less than 2##6##4##(1990-9#1)(1997-4#1)(2008-10#3)(2013-1#1)
of less than 2%##4##4##(2008-10#2)(2008-3#2)
of less than 20##2##4##(1994-3#1)(2008-2#1)
of less than 3##2##4##(2008-10#1)(2008-2#1)
of less than 5% for both migration##2##7##(2008-10#2)
of less than 5% for##3##5##(2008-10#3)
of less than 6##2##4##(1992-6#1)(2008-10#1)
of less than##60##3##(1990-5#1)(1990-9#1)(1991-1#1)(1992-6#1)(1994-3#1)(1995-1#1)(1996-12#1)(1997-4#2)(1997-8#1)(2008-10#31)(2008-11#2)(2008-2#3)(2008-3#8)(2008-5#4)(2008-8#1)(2013-1#1)
of less##66##2##(1990-5#1)(1990-9#1)(1991-1#1)(1992-6#1)(1994-3#1)(1995-1#1)(1996-12#1)(1997-4#2)(1997-8#1)(2008-10#33)(2008-11#4)(2008-2#3)(2008-3#8)(2008-5#4)(2008-7#2)(2008-8#1)(2013-1#1)
of less-thans##2##2##(2008-10#2)
of let-7##2##2##(2012-12#2)
of lethal##2##2##(2008-11#1)(2012-3#1)
of lethality##2##2##(1996-12#2)
of letters##2##2##(1990-8#1)(2008-11#1)
of lettuce downy mildew##3##4##(2008-10#3)
of lettuce drop##4##3##(2008-10#4)
of lettuce##15##2##(2008-10#15)
of leucine##3##2##(1994-11#1)(2008-11#2)
of leukaemia##3##2##(1993-2#1)(2009-3#1)(2013-1#1)
of leukemia##10##2##(1992-3#1)(1992-7#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#2)(2011-2#2)
of leukemic##4##2##(2008-11#1)(2008-9#1)(2010-6#2)
of leukocyte##2##2##(1991-5#1)(2008-9#1)
of leukocyte-platelet aggregates##2##3##(2008-9#2)
of leukocytes and##2##3##(2008-10#1)(2008-5#1)
of leukocytes to endothelium##2##4##(1992-12#1)(1995-2#1)
of leukocytes##10##2##(1992-12#1)(1993-6#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2010-8#1)
of leukotriene##3##2##(1991-5#1)(2008-1#1)(2008-11#1)
of leukotrienes##2##2##(1994-8#1)(2008-1#1)
of levamisole##2##2##(2008-1#2)
of level observed with cognate beta2m)##2##6##(1997-9#2)
of level##4##2##(1997-9#2)(2008-10#1)(2008-6#1)
of levels##4##2##(1995-5#1)(2008-11#2)(2008-3#1)
of levodopa in the##2##4##(2008-7#2)
of levodopa##5##2##(2008-10#2)(2008-7#3)
of levofloxacin in##4##3##(2008-10#4)
of levofloxacin##7##2##(2008-10#5)(2011-1#1)(2011-2#1)
of levonorgestrel##4##2##(2008-10#4)
of lexical##3##2##(1991-2#3)
of liability##2##2##(1993-2#1)(1996-3#1)
of libraries##2##2##(1995-2#1)(1997-2#1)
of lichen planus##3##3##(1990-5#1)(1991-2#1)(2009-6#1)
of lichen##4##2##(1990-5#1)(1991-2#1)(2009-6#1)(2011-2#1)
of lidar##3##2##(2008-2#2)(2008-3#1)
of lidocaine##9##2##(1990-9#4)(2008-10#1)(2008-9#4)
of life (QoL)##4##3##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
of life and death##3##4##(1993-11#2)(2011-9#1)
of life and the##2##4##(1996-9#1)(2013-8#1)
of life and##26##3##(1992-1#1)(1993-11#2)(1993-12#1)(1994-9#1)(1995-2#1)(1996-9#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#2)(2011-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of life decisions##4##3##(2012-12#4)
of life for##7##3##(1994-5#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-12#2)(2012-3#1)
of life history##5##3##(2008-8#4)(2010-8#1)
of life in the##4##4##(1993-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
of life in##28##3##(1990-2#1)(1992-11#1)(1993-6#1)(2008-10#1)(2008-12#3)(2008-7#3)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#6)(2012-3#1)(2013-1#4)(2013-8#2)
of life is##5##3##(1995-1#1)(1996-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
of life of##12##3##(1990-12#1)(1993-11#1)(1996-2#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-8#1)
of life span##3##3##(1995-6#1)(2008-9#1)(2010-8#1)
of life table##2##3##(1995-3#2)
of life with##4##3##(1995-3#1)(2008-10#1)(2009-6#1)(2011-1#1)
of life##253##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1991-2#3)(1991-3#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-12#5)(1993-6#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-11#3)(1996-2#4)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-5#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#10)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#17)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#3)(2010-1#2)(2010-10#7)(2010-11#6)(2010-12#6)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#25)(2011-3#3)(2011-7#1)(2011-9#1)(2012-12#11)(2012-2#5)(2012-3#12)(2013-1#16)(2013-7#2)(2013-8#9)
of life'##3##2##(1995-3#1)(1996-2#1)(2010-10#1)
of life-history variation##2##3##(2008-8#2)
of life-history##9##2##(2008-8#7)(2008-9#1)(2010-8#1)
of life-long learning##2##3##(2008-11#2)
of life-sustaining treatment##2##3##(1991-2#1)(2010-4#1)
of life-threatening##5##2##(1994-6#1)(2008-11#1)(2010-11#1)(2011-2#2)
of lifestyle##3##2##(1993-2#1)(2008-6#1)(2011-2#1)
of lifetime sex partners##2##4##(2008-12#2)
of ligand binding##6##3##(1990-8#2)(1993-8#2)(1995-11#1)(1995-2#1)
of ligand structure##2##3##(2008-10#2)
of ligand##19##2##(1990-8#2)(1992-6#1)(1993-8#2)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#11)
of ligands for##2##3##(1994-6#1)(2008-10#1)
of ligands in##2##3##(2008-10#1)(2009-3#1)
of ligands##14##2##(1994-6#1)(1995-11#1)(1995-6#1)(2008-10#8)(2008-4#1)(2009-3#1)(2012-2#1)
of ligated##2##2##(2008-4#1)(2008-9#1)
of light and heavy##2##4##(1993-8#1)(2008-10#1)
of light and##10##3##(1992-2#1)(1993-8#1)(2008-10#4)(2008-3#2)(2009-8#2)
of light at##2##3##(2008-10#1)(2008-9#1)
of light by##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
of light chain##2##3##(2008-11#1)(2013-8#1)
of light chains##3##3##(1993-9#2)(2011-2#1)
of light delivery##2##3##(2008-7#2)
of light from##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of light in##2##3##(2008-2#1)(2013-7#1)
of light intensity##2##3##(2008-8#1)(2008-9#1)
of light leaf spot##3##4##(2008-10#3)
of light propagation##2##3##(2008-3#2)
of light scattering from##2##4##(2008-3#2)
of light scattering##7##3##(2008-10#2)(2008-3#5)
of light through a##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
of light through##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
of light##98##2##(1991-2#3)(1992-2#1)(1992-8#1)(1993-3#2)(1993-8#2)(1993-9#2)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#31)(2008-11#4)(2008-2#6)(2008-3#24)(2008-7#5)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#4)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of light-induced##4##2##(1994-2#2)(2008-2#1)(2008-3#1)
of lignin and##2##3##(2008-10#1)(2013-8#1)
of lignin monomers##2##3##(2008-11#2)
of lignin peroxidase##2##3##(2008-6#2)
of lignin##13##2##(2008-10#4)(2008-11#2)(2008-6#2)(2009-8#2)(2009-9#1)(2011-1#1)(2013-8#1)
of likely##3##2##(1996-3#1)(1997-6#1)(1997-7#1)
of limb##9##2##(1992-9#1)(1994-11#2)(1994-8#1)(2007-12#1)(2009-3#1)(2010-5#1)(2011-3#2)
of limbs##3##2##(1990-9#1)(2008-9#1)(2010-12#1)
of limit of detection##2##4##(2008-10#2)
of limit##3##2##(1995-5#1)(2008-10#2)
of limitation##2##2##(1996-5#1)(2008-10#1)
of limitations##5##2##(1996-5#2)(2008-11#2)(2011-2#1)
of limited resection##2##3##(1994-12#2)
of limited use##2##3##(2008-10#2)
of limited##13##2##(1990-2#1)(1991-12#1)(1994-12#2)(1997-2#1)(2008-10#4)(2008-5#1)(2009-1#1)(2011-2#1)(2012-2#1)
of limiting the##2##3##(2008-8#1)(2012-3#1)
of limiting##6##2##(1997-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
of limits of detection##2##4##(2008-10#2)
of limonene##3##2##(2008-5#3)
of lin-12##2##2##(1994-12#2)
of line 30-4##2##3##(2008-10#2)
of line##7##2##(2008-10#4)(2008-3#1)(2009-12#1)(2013-8#1)
of lineage##2##2##(2008-10#1)(2011-2#1)
of lineage-specific##2##2##(2008-9#1)(2011-2#1)
of linear alkylbenzene sulfonates##3##4##(2008-10#3)
of linear range##2##3##(2008-10#2)
of linear regression##4##3##(2008-10#4)
of linear response##3##3##(2008-10#3)
of linear##33##2##(1990-5#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#4)(2008-8#3)(2010-6#2)(2013-1#1)
of linearity of##2##3##(2008-10#2)
of linearity##14##2##(1996-2#1)(2008-10#11)(2009-8#1)(2012-2#1)
of linezolid in the presence of##3##6##(2008-10#3)
of linezolid##4##2##(2008-10#4)
of link nurses##2##3##(2008-11#2)
of linkage disequilibrium##4##3##(2008-10#2)(2010-5#1)(2012-3#1)
of linkage##7##2##(1992-10#1)(1994-12#1)(2008-10#2)(2008-11#1)(2010-5#1)(2012-3#1)
of linkages##2##2##(1997-2#1)(2008-12#1)
of linked##3##2##(1991-3#1)(2008-10#2)
of linoleic acid##4##3##(2008-11#2)(2008-12#1)(2009-6#1)
of linoleic##5##2##(2008-11#2)(2008-12#1)(2009-6#2)
of lipase activity##6##3##(2008-10#1)(2010-10#5)
of lipases##2##2##(1995-3#1)(2008-7#1)
of lipid A##3##3##(1990-5#2)(2011-2#1)
of lipid components##2##3##(1992-12#1)(1997-6#1)
of lipid lowering drugs##2##4##(2008-11#2)
of lipid lowering##3##3##(2008-11#2)(2008-4#1)
of lipid metabolism##2##3##(2008-9#1)(2013-1#1)
of lipid peroxidation##8##3##(1991-5#1)(1992-3#2)(1993-2#3)(1996-2#1)(2009-8#1)
of lipid peroxides in##3##4##(1990-5#2)(2013-1#1)
of lipid##31##2##(1990-5#4)(1991-5#1)(1992-12#1)(1992-3#2)(1993-2#3)(1994-5#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#3)(2008-9#2)(2009-8#2)(2011-2#2)(2013-1#3)
of lipids and proteins##2##4##(2008-7#1)(2009-8#1)
of lipids and##6##3##(1991-11#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-7#1)(2009-8#1)
of lipids with##2##3##(1995-2#1)(2012-12#1)
of lipids##18##2##(1990-2#1)(1991-11#1)(1994-12#1)(1995-2#2)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-8#1)(2012-12#1)(2013-1#2)
of lipofuscin in the##2##4##(1995-3#1)(2011-2#1)
of lipofuscin in##3##3##(1995-3#2)(2011-2#1)
of lipofuscin##4##2##(1995-3#3)(2011-2#1)
of lipoid##2##2##(2008-5#1)(2011-2#1)
of lipoma##3##2##(1990-12#1)(1990-3#1)(2013-1#1)
of lipoperoxidation##3##2##(2008-10#2)(2008-11#1)
of lipophilic##8##2##(2008-10#5)(2008-5#3)
of lipopolysaccharide (LPS)##4##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
of lipopolysaccharide##10##2##(1995-12#1)(1996-12#5)(1997-2#1)(2008-10#1)(2008-11#2)
of lipopolysaccharide-induced prostaglandin H synthase-2##2##5##(1993-3#2)
of lipoprotein (a)##2##3##(1991-12#1)(2011-2#1)
of lipoprotein lipase##4##3##(1991-12#1)(2008-11#1)(2008-3#1)(2013-1#1)
of lipoprotein metabolism in##2##4##(2008-6#2)
of lipoprotein##11##2##(1990-8#2)(1991-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2011-2#1)(2013-1#1)
of liposomal##3##2##(1995-5#2)(2008-8#1)
of liposome##2##2##(2008-10#2)
of liposomes and##4##3##(1997-1#2)(2008-10#1)(2008-8#1)
of liposomes##13##2##(1990-2#1)(1997-1#2)(2008-10#8)(2008-8#2)
of lipoxins##2##2##(1991-5#2)
of lipoxygenase##3##2##(2008-11#2)(2011-10#1)
of lipstick##3##2##(2008-5#3)
of liquid L-dopa/carbidopa in##2##4##(2008-7#2)
of liquid L-dopa/carbidopa##3##3##(2008-7#3)
of liquid nitrogen##2##3##(1995-11#1)(2008-8#1)
of liquid##25##2##(1995-11#1)(1995-3#1)(1996-3#1)(2008-10#15)(2008-3#1)(2008-7#3)(2008-8#2)(2010-7#1)
of liquid-liquid extraction##2##3##(2008-10#2)
of liquids##4##2##(1994-2#1)(2008-10#1)(2008-3#2)
of list length##3##3##(1993-3#1)(2008-6#2)
of listeriolysin O by##3##4##(1996-12#3)
of listeriolysin O##5##3##(1996-12#5)
of literature and##3##3##(2008-11#1)(2010-7#1)(2011-2#1)
of literature is##3##3##(2007-12#1)(2010-11#1)(2010-8#1)
of literature on the##2##4##(1992-8#1)(2008-8#1)
of literature on##5##3##(1992-8#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
of literature##43##2##(1992-5#1)(1992-8#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-7#1)(2008-8#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
of lithiasis##3##2##(1990-5#1)(1991-3#1)(1997-8#1)
of lithium ions##2##3##(2008-10#2)
of lithium traces##2##3##(2008-10#2)
of lithium##15##2##(1996-12#1)(1996-5#2)(2008-10#11)(2009-8#1)
of little value##2##3##(1991-2#1)(2008-5#1)
of little##5##2##(1991-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
of live attenuated##2##3##(2008-11#1)(2010-8#1)
of live cells##4##3##(2008-11#2)(2008-9#1)(2009-6#1)
of live##23##2##(1991-3#2)(1994-2#1)(1995-6#1)(1996-9#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-5#1)(2008-9#1)(2009-6#3)(2010-4#1)(2010-8#3)
of liver and kidney##2##4##(1990-12#1)(2008-9#1)
of liver and##4##3##(1990-12#1)(1990-2#1)(1995-9#1)(2008-9#1)
of liver cell##2##3##(2008-11#1)(2009-8#1)
of liver damage##2##3##(2009-8#2)
of liver disease##4##3##(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
of liver fibrosis and##2##4##(2013-1#1)(2013-8#1)
of liver fibrosis##5##3##(2013-1#3)(2013-8#2)
of liver fluke infection##2##4##(2008-12#2)
of liver functions##2##3##(2008-11#2)
of liver in##2##3##(2010-11#1)(2012-3#1)
of liver metastases##2##3##(2010-12#2)
of liver specific functions##2##4##(2008-11#2)
of liver tumors##2##3##(1990-6#1)(2008-10#1)
of liver##59##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-12#2)(1992-5#1)(1992-6#2)(1993-12#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#4)(2008-9#1)(2009-8#7)(2010-11#2)(2010-12#5)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
of livestock production##2##3##(2011-2#2)
of livestock##9##2##(1990-3#1)(1997-7#1)(2010-1#1)(2011-2#6)
of living cells and##2##4##(2008-11#1)(2009-7#1)
of living cells##6##3##(1992-5#2)(2008-10#2)(2008-11#1)(2009-7#1)
of living organisms##3##3##(1992-11#1)(2009-8#1)(2010-11#1)
of living with##3##3##(2008-12#1)(2008-2#1)(2010-10#1)
of living##24##2##(1992-11#1)(1992-5#2)(1993-1#1)(1993-11#1)(1994-11#1)(1994-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#1)
of lizards##3##2##(1991-5#1)(2008-7#1)(2011-2#1)
of load##3##2##(2012-2#1)(2013-1#2)
of load-bearing bone##2##3##(2009-7#2)
of loaded##3##2##(2008-10#3)
of loading and##2##3##(2008-10#2)
of loading##3##2##(2008-10#3)
of lobar##2##2##(2008-2#1)(2012-2#1)
of lobule VII##3##3##(1994-2#3)
of local adaptation##2##3##(2012-7#2)
of local and systemic##3##4##(1991-8#1)(1995-5#1)(2011-2#1)
of local and##10##3##(1991-8#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-12#2)(2008-8#2)(2011-2#1)(2013-8#1)
of local anesthetic##3##3##(1995-3#1)(2012-3#1)(2013-1#1)
of local environmental##2##3##(2008-10#1)(2010-6#1)
of local habitats##2##3##(2008-8#2)
of local populations##2##3##(2008-10#1)(2010-1#1)
of local recurrence and##2##4##(2008-11#1)(2010-3#1)
of local recurrence##6##3##(1993-11#1)(2008-11#1)(2010-3#2)(2011-2#1)(2013-1#1)
of local relapses##2##3##(1990-3#2)
of local##90##2##(1990-3#2)(1990-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-1#2)(1993-11#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-1#4)(2008-10#12)(2008-11#4)(2008-12#6)(2008-3#2)(2008-7#2)(2008-8#10)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#2)(2013-1#6)(2013-8#1)
of localization##2##2##(1991-11#1)(2008-10#1)
of localized folate##2##3##(1992-9#2)
of localized##12##2##(1990-12#1)(1991-9#1)(1992-9#2)(1995-2#1)(2008-10#2)(2008-9#1)(2010-6#1)(2011-2#2)(2013-1#1)
of locally advanced breast cancer##4##5##(1991-8#3)(1993-11#1)
of locally advanced head and neck cancer##2##7##(1990-6#1)(1993-9#1)
of locally advanced##12##3##(1990-12#1)(1990-6#2)(1991-8#3)(1992-3#2)(1993-11#1)(1993-9#1)(1997-7#1)(2008-10#1)
of locally##18##2##(1990-12#1)(1990-6#2)(1991-8#3)(1992-3#2)(1993-11#1)(1993-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#1)
of location shift##2##3##(1996-3#2)
of location##6##2##(1996-3#2)(1996-5#1)(2008-11#1)(2008-7#1)(2009-5#1)
of locations##3##2##(1995-12#1)(2008-10#1)(2008-5#1)
of loci##5##2##(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
of loco-regional##2##2##(1990-12#1)(1990-3#1)
of locomotion##2##2##(1993-3#1)(2008-9#1)
of locomotor##6##2##(1992-12#1)(1993-3#1)(1994-3#1)(1997-2#2)(2010-8#1)
of locoregional##3##2##(1993-11#1)(1996-10#1)(2012-2#1)
of locus of control and social support##2##7##(1996-2#2)
of locus##3##2##(1996-2#2)(2008-10#1)
of log 5##2##3##(2008-10#1)(2008-5#1)
of log##4##2##(1991-9#2)(2008-10#1)(2008-5#1)
of logistic regression##2##3##(2008-11#1)(2009-5#1)
of logistic##3##2##(1992-9#1)(2008-11#1)(2009-5#1)
of logistical problems##2##3##(1993-2#1)(2008-11#1)
of long bone##2##3##(2010-6#1)(2013-1#1)
of long bones##2##3##(2007-8#1)(2009-1#1)
of long chain acyl-ACP##2##4##(1995-6#2)
of long chain fatty##2##4##(1993-8#1)(2008-10#1)
of long chain##6##3##(1993-8#1)(1995-6#3)(2008-10#1)(2009-6#1)
of long duration##2##3##(1991-2#1)(2013-1#1)
of long standing##2##3##(1997-1#1)(2012-2#1)
of long term##8##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#2)
of long##38##2##(1991-12#1)(1991-2#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-6#3)(1996-6#2)(1997-1#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-7#1)(2012-2#1)(2013-1#5)
of long-chain fatty acids##3##4##(1990-5#1)(2008-4#1)(2008-5#1)
of long-chain##5##2##(1990-5#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
of long-distance##3##2##(2008-10#3)
of long-lived##3##2##(1995-12#1)(2012-2#1)(2012-5#1)
of long-period##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
of long-term administration of##2##4##(2008-10#1)(2009-8#1)
of long-term care##8##3##(1992-3#4)(1993-12#1)(1994-2#1)(1995-3#2)
of long-term depression##2##3##(1997-7#1)(2012-2#1)
of long-term monitoring##2##3##(2008-3#1)(2008-9#1)
of long-term outcome##2##3##(1992-12#1)(2008-11#1)
of long-term outcomes##2##3##(2008-9#1)(2009-8#1)
of long-term potentiation (LTP) in the##2##6##(1990-5#1)(2008-7#1)
of long-term potentiation (LTP)##4##4##(1990-5#1)(1995-12#2)(2008-7#1)
of long-term potentiation in the##4##5##(1990-5#1)(1995-12#2)(2008-7#1)
of long-term potentiation##8##3##(1990-5#2)(1995-12#4)(2008-7#2)
of long-term##54##2##(1990-3#1)(1990-5#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#4)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#4)(1995-3#2)(1996-12#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#3)(2010-11#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)
of longer duration##2##3##(2008-11#1)(2008-5#1)
of longer pulse duration##2##4##(2009-8#2)
of longer##12##2##(1994-8#1)(1996-8#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#2)(2012-3#1)
of longevity##2##2##(1992-11#1)(2008-7#1)
of longitudinal##2##2##(1992-3#1)(2008-10#1)
of loop##2##2##(1992-3#1)(1992-4#1)
of loosely##2##2##(2008-10#1)(2012-3#1)
of lopinavir and ritonavir in human##2##6##(2011-3#2)
of lorazepam##3##2##(2008-10#3)
of losing##4##2##(1992-5#1)(1995-12#1)(1996-11#1)(2008-10#1)
of loss of consciousness##2##4##(1992-6#1)(2008-11#1)
of loss of##8##3##(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-3#1)(2008-11#1)(2008-5#1)(2012-3#1)
of loss##14##2##(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2012-3#1)
of losses in##2##3##(2008-10#1)(2008-3#1)
of losses##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
of lost##3##2##(1991-2#1)(2008-11#1)(2010-10#1)
of low LET radiation##6##4##(2008-7#6)
of low abundance##2##3##(1997-2#1)(2008-4#1)
of low amounts of##2##4##(2008-10#2)
of low and high##3##4##(1995-11#1)(2008-10#1)(2011-2#1)
of low back pain##8##4##(1993-6#1)(2008-12#2)(2009-4#2)(2010-1#1)(2010-9#2)
of low back##9##3##(1993-6#1)(2008-12#3)(2009-4#2)(2010-1#1)(2010-9#2)
of low birth weight##5##4##(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#1)(2008-11#1)
of low concentration##2##3##(2008-10#2)
of low concentrations of##5##4##(1992-7#1)(2008-10#3)(2008-7#1)
of low concentrations##7##3##(1992-7#1)(2008-10#5)(2008-7#1)
of low density lipoprotein (LDL)##3##5##(1991-5#1)(1992-5#1)(1995-8#1)
of low density lipoproteins (LDL)##2##5##(1991-5#1)(1993-6#1)
of low density lipoproteins by##2##5##(1991-11#1)(1991-5#1)
of low density lipoproteins##5##4##(1991-11#2)(1991-5#2)(1993-6#1)
of low density##10##3##(1991-11#3)(1991-5#3)(1992-5#1)(1993-6#1)(1995-8#1)(2008-9#1)
of low dose exposures##2##4##(2008-7#2)
of low dose##5##3##(2007-11#1)(2008-11#1)(2008-7#3)
of low doses of##6##4##(1990-5#1)(1993-1#1)(2008-11#1)(2008-7#1)(2013-1#2)
of low income##2##3##(1994-12#1)(1995-12#1)
of low ionic strength##3##4##(1993-3#1)(1994-5#1)(2011-2#1)
of low level##2##3##(2008-10#1)(2008-11#1)
of low levels of##6##4##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#2)
of low levels##7##3##(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#2)
of low molecular weight organic acids in soil solution##2##9##(2008-10#2)
of low molecular weight##8##4##(2008-10#4)(2008-7#1)(2009-9#1)(2010-11#1)(2011-2#1)
of low molecular##9##3##(2008-10#5)(2008-7#1)(2009-9#1)(2010-11#1)(2011-2#1)
of low pH##4##3##(1990-5#1)(1994-8#3)
of low redox potential##3##4##(2008-10#3)
of low solubility##2##3##(1997-1#1)(2008-10#1)
of low temperature##3##3##(2008-10#1)(2010-12#1)(2012-4#1)
of low viscosity##3##3##(2008-8#2)(2009-7#1)
of low vitamin B12##2##4##(1990-3#1)(2010-1#1)
of low##168##2##(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#5)(1991-12#1)(1991-5#3)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-5#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#4)(1995-11#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-2#2)(1997-5#1)(2007-11#1)(2008-10#48)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#3)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-9#2)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#2)(2012-4#1)(2013-1#4)(2013-8#1)
of low-carbohydrate##2##2##(2008-3#2)
of low-energy##2##2##(1993-8#1)(1994-5#1)
of low-frequency##3##2##(1992-9#1)(2008-3#2)
of low-grade##3##2##(1990-12#1)(2008-7#1)(2012-12#1)
of low-income##3##2##(2013-1#3)
of lower extremity##3##3##(2008-8#1)(2009-3#1)(2012-2#1)
of lower jaw##2##3##(1993-12#1)(2013-1#1)
of lower than##2##3##(1996-2#1)(2008-10#1)
of lower urinary tract##3##4##(2011-2#1)(2012-12#1)(2013-8#1)
of lower##33##2##(1990-11#1)(1990-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1996-2#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of lowering##2##2##(2008-10#1)(2008-5#1)
of luciferase##6##2##(2008-10#2)(2008-11#3)(2008-9#1)
of lucigenin##3##2##(2008-10#3)
of lumbar disc##2##3##(2008-12#2)
of lumbar spine##2##3##(2012-12#1)(2013-1#1)
of lumbar##10##2##(1993-1#1)(2007-11#1)(2008-12#2)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#3)
of luminescence##2##2##(2008-10#2)
of luminescent##3##2##(2008-10#3)
of luminol with hydrogen peroxide catalyzed by##3##7##(2008-10#3)
of luminol with hydrogen peroxide in##2##6##(2008-10#2)
of luminol with hydrogen peroxide##6##5##(2008-10#6)
of luminol with##10##3##(2008-10#10)
of luminol##18##2##(2008-10#18)
of luminol-hydrogen##2##2##(2008-10#2)
of lung adenocarcinoma##4##3##(2008-9#3)(2013-8#1)
of lung cancer and##2##4##(1991-12#1)(1992-6#1)
of lung cancer in##2##4##(1991-2#1)(2008-12#1)
of lung cancer##18##3##(1991-12#1)(1991-2#1)(1992-6#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-3#2)(2013-1#1)(2013-8#1)
of lung carcinoma##3##3##(1994-12#1)(2008-1#1)(2008-9#1)
of lung cavities##2##3##(2010-8#2)
of lung disease##2##3##(2008-10#1)(2012-3#1)
of lung function##2##3##(1991-2#1)(1992-6#1)
of lung transplantation##4##3##(1993-2#1)(2011-3#3)
of lung##60##2##(1991-12#2)(1991-2#2)(1992-6#2)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-9#1)(1997-2#2)(1997-3#1)(2008-1#3)(2008-10#4)(2008-11#6)(2008-12#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2011-3#7)(2012-3#2)(2013-1#3)(2013-8#2)
of lupane triterpenes on##3##4##(2008-11#3)
of lupane triterpenes##4##3##(2008-11#4)
of lupin##2##2##(2008-10#2)
of lupus##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
of lymph node metastasis in##2##5##(2011-2#2)
of lymph node metastasis##4##4##(2009-12#1)(2011-2#2)(2013-1#1)
of lymph node##5##3##(1990-9#1)(2009-12#1)(2011-2#2)(2013-1#1)
of lymph##6##2##(1990-9#1)(1992-2#1)(2009-12#1)(2011-2#2)(2013-1#1)
of lymphatic##3##2##(1997-7#1)(2008-11#1)(2012-3#1)
of lymphocyte##7##2##(1990-12#1)(1993-12#1)(1993-8#1)(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
of lymphocytes and##3##3##(1992-12#1)(2008-12#1)(2011-2#1)
of lymphocytes in the elderly##2##5##(1995-8#2)
of lymphocytes in##3##3##(1995-8#2)(2008-11#1)
of lymphocytes##22##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-12#1)(1995-8#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#4)(2011-2#2)
of lymphoid tissues##2##3##(2008-10#2)
of lymphoid##6##2##(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#2)
of lymphoma##3##2##(1992-12#1)(2009-1#2)
of lyophilized cells##2##3##(2008-10#2)
of lyophilized##3##2##(2008-10#2)(2008-7#1)
of lysed##2##2##(2008-11#2)
of lysine and##2##3##(2008-10#1)(2012-2#1)
of lysine residues##2##3##(1992-6#1)(1995-6#1)
of lysine##10##2##(1991-5#1)(1992-6#1)(1995-6#2)(2008-10#3)(2008-11#1)(2012-2#2)
of lysis##2##2##(2008-10#1)(2008-8#1)
of lysosomal##7##2##(1991-7#1)(1993-8#1)(1994-11#1)(1995-6#2)(2006-6#1)(2010-8#1)
of lysozyme from##2##3##(2008-10#2)
of lysozyme##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#1)
of lytic##4##2##(1994-5#1)(2008-10#2)(2013-1#1)
of m##3##2##(1994-5#1)(2013-8#2)
of m-aminophenol##2##2##(2008-10#2)
of m-nisoldipine##2##2##(2011-3#2)
of mAMSA and CPT##2##4##(1994-8#2)
of mAb##2##2##(2008-11#2)
of mAbs##2##2##(1996-12#1)(2008-11#1)
of mES cells##2##3##(2008-11#2)
of mGluRs in##2##3##(1995-12#2)
of mMOR##3##2##(1995-6#3)
of mPGES-1 in the##3##4##(2012-2#3)
of mPGES-1 in##4##3##(2012-2#4)
of mPGES-1##5##2##(2012-2#5)
of mRNA and##3##3##(1993-6#1)(1995-6#1)(2009-12#1)
of mRNA expression##2##3##(1996-2#1)(2008-4#1)
of mRNA for##5##3##(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-4#1)
of mRNA from##3##3##(1993-9#1)(1995-2#1)(2008-7#1)
of mRNA level##2##3##(2008-4#1)(2009-8#1)
of mRNA of the##2##4##(1995-12#1)(1997-8#1)
of mRNA of##3##3##(1995-12#1)(1997-8#1)(2008-8#1)
of mRNA were##2##3##(1995-11#1)(2008-12#1)
of mRNA##40##2##(1990-5#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-2#2)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#2)(2013-8#1)
of mRNAs encoding the##2##4##(1994-2#1)(1995-2#1)
of mRNAs encoding##5##3##(1994-2#1)(1995-2#1)(2008-11#2)(2011-2#1)
of mRNAs for##5##3##(1995-2#1)(1996-12#1)(2008-8#3)
of mRNAs##16##2##(1994-2#1)(1995-2#2)(1996-12#3)(1997-2#1)(2008-11#3)(2008-8#3)(2011-2#1)(2012-2#1)(2013-1#1)
of mSERT gene expression##2##4##(1996-12#2)
of mSERT##3##2##(1996-12#3)
of mTERT##2##2##(2008-11#2)
of mTOR##4##2##(2009-7#2)(2013-1#2)
of macaques##4##2##(1994-2#1)(1997-3#2)(2008-4#1)
of macerated##2##2##(1995-9#1)(2008-10#1)
of macro##2##2##(2008-10#2)
of macro- and##2##3##(2008-10#1)(2008-12#1)
of macrocycle##4##2##(2008-10#4)
of macrocycles##2##2##(2008-10#2)
of macromolecular##3##2##(1991-11#1)(2008-10#1)(2008-4#1)
of macromolecules##8##2##(1997-6#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
of macronutrients##3##2##(2008-10#1)(2008-3#2)
of macroparasites##2##2##(2008-9#2)
of macrophage##3##2##(1991-6#1)(2008-11#1)(2008-12#1)
of macrophages and##4##3##(1991-5#1)(1995-6#1)(2008-10#2)
of macrophages##14##2##(1990-12#1)(1991-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2013-1#2)
of macroporous##2##2##(2008-11#2)
of macroscopic haematuria##2##3##(1995-5#2)
of macroscopic##4##2##(1995-5#2)(2008-10#1)(2012-2#1)
of macular degeneration##5##3##(2011-2#5)
of macular##9##2##(2011-2#7)(2013-1#2)
of magnesium and##3##3##(1994-5#1)(2008-10#2)
of magnesium in##6##3##(2008-10#6)
of magnesium ions on##2##4##(2008-10#2)
of magnesium ions##3##3##(2008-10#2)(2008-4#1)
of magnesium were##2##3##(2008-10#2)
of magnesium##29##2##(1994-5#2)(1997-3#1)(1997-8#1)(2008-10#21)(2008-4#1)(2008-6#2)(2008-7#1)
of magnetic beads##3##3##(2008-10#2)(2010-11#1)
of magnetic field##3##3##(2008-10#2)(2008-8#1)
of magnetic resonance imaging##6##4##(2008-7#2)(2010-12#2)(2012-2#1)(2012-3#1)
of magnetic resonance##12##3##(1992-3#1)(1993-5#1)(1996-11#1)(2008-12#1)(2008-7#3)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
of magnetic##22##2##(1992-3#1)(1993-5#1)(1996-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2010-11#1)(2010-12#2)(2011-2#1)(2012-2#2)(2012-3#1)
of magnitude and a##2##4##(2008-10#2)
of magnitude and##6##3##(2008-10#5)(2013-8#1)
of magnitude for##2##3##(1991-5#1)(2008-10#1)
of magnitude from##2##3##(2008-10#1)(2008-3#1)
of magnitude greater##2##3##(1995-6#1)(2008-2#1)
of magnitude higher than that##3##5##(1992-8#1)(2008-10#2)
of magnitude higher than those##2##5##(1991-5#1)(2008-10#1)
of magnitude higher than##7##4##(1991-5#1)(1992-8#1)(2007-11#1)(2008-10#4)
of magnitude larger than##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
of magnitude lower than##2##4##(2008-10#2)
of magnitude lower##3##3##(2008-10#3)
of magnitude more##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
of magnitude over##2##3##(2008-10#1)(2008-3#1)
of magnitude relative to##2##4##(1994-5#1)(2008-10#1)
of magnitude than##2##3##(2008-10#2)
of magnitude when##3##3##(2008-10#3)
of magnitude##105##2##(1990-11#2)(1991-2#1)(1991-5#3)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#3)(1995-3#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#59)(2008-11#5)(2008-2#2)(2008-3#11)(2008-7#2)(2008-9#2)(2010-4#1)(2010-8#2)(2012-2#1)(2013-8#3)
of magnolol##2##2##(2011-2#2)
of main and##2##3##(2008-10#1)(2011-1#1)
of main##7##2##(1994-2#1)(1995-12#1)(2008-10#2)(2008-7#1)(2011-1#1)(2013-1#1)
of mainly##2##2##(2008-10#1)(2008-9#1)
of maintained##2##2##(2008-10#1)(2009-8#1)
of maintaining a##2##3##(1992-3#1)(2008-10#1)
of maintaining##10##2##(1992-3#1)(1993-3#1)(1994-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)
of maintenance##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
of maize amylose##2##3##(2013-8#2)
of maize genotypes##2##3##(2008-10#2)
of maize in##2##3##(2008-10#1)(2012-2#1)
of maize streak virus (MSV)##2##5##(2008-10#2)
of maize streak##3##3##(2008-10#3)
of maize##49##2##(1991-10#1)(2008-10#34)(2008-12#4)(2008-8#2)(2008-9#4)(2012-2#1)(2013-8#3)
of major adverse cardiac events##2##5##(2008-11#1)(2010-12#1)
of major and minor elements of##2##6##(2008-10#2)
of major and minor##3##4##(1990-9#1)(2008-10#2)
of major complications##3##3##(2008-9#1)(2010-3#1)(2011-2#1)
of major components of##2##4##(2011-3#2)
of major genes##2##3##(2008-10#2)
of major histocompatibility##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
of major importance for the##2##5##(1991-2#1)(2008-11#1)
of major importance in##4##4##(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
of major importance##10##3##(1991-2#1)(1997-6#1)(2008-11#2)(2008-5#2)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)
of major resistance genes##2##4##(2008-10#2)
of major##65##2##(1990-6#1)(1990-9#2)(1991-2#1)(1992-3#1)(1994-1#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#22)(2008-11#7)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
of making the##3##3##(2008-8#2)(2011-2#1)
of making##7##2##(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#2)
of malaria cases##2##3##(2012-12#2)
of malaria diagnosis##3##3##(2012-12#3)
of malaria in the##2##4##(2012-12#2)
of malaria in##7##3##(1990-3#1)(2012-12#6)
of malaria##23##2##(1990-12#1)(1990-3#1)(1993-8#3)(2009-6#1)(2011-2#1)(2012-12#15)(2012-2#1)
of malarial##2##2##(2012-3#1)(2013-1#1)
of malate##2##2##(1991-3#1)(2008-10#1)
of malathion##2##2##(2008-10#1)(2013-1#1)
of male and female##7##4##(2008-12#2)(2008-8#1)(2008-9#2)(2012-2#1)(2012-3#1)
of male breast cancer##4##4##(1990-2#1)(1997-7#2)(2011-2#1)
of male fitness##2##3##(2008-9#2)
of male infertility##2##3##(2008-12#1)(2009-10#1)
of male killing##2##3##(2008-8#2)
of male rats##6##3##(1991-10#1)(1992-12#1)(1994-8#1)(1995-2#1)(2008-11#2)
of male sex pheromone##2##4##(2007-12#2)
of male sex##3##3##(2007-12#2)(2008-12#1)
of male sexual##3##3##(1994-2#1)(2012-3#2)
of male##69##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1992-12#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-6#1)(1997-7#2)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#5)(2008-6#4)(2008-8#9)(2008-9#6)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#5)(2012-2#1)(2012-3#6)(2013-1#3)
of maleic hydrazide##4##3##(2008-10#4)
of males and females##3##4##(2008-5#1)(2008-8#1)(2008-9#1)
of males and##9##3##(1994-6#3)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)
of males##30##2##(1990-2#1)(1990-6#1)(1991-6#1)(1993-8#1)(1994-6#4)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#7)(2008-9#5)(2012-2#1)
of malformations##2##2##(2008-10#1)(2012-3#1)
of malignancies##7##2##(1990-6#1)(1994-5#1)(1997-4#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
of malignancy##21##2##(1990-2#4)(1990-6#2)(1991-2#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#2)(1995-6#1)(1997-2#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
of malignant and##2##3##(1995-12#1)(2010-11#1)
of malignant cells##6##3##(1990-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#2)
of malignant lymphoma##2##3##(2008-10#1)(2009-8#1)
of malignant melanoma in##2##4##(2011-2#2)
of malignant melanoma##4##3##(2011-2#4)
of malignant mesothelioma##5##3##(1991-12#2)(1991-2#1)(2010-1#1)(2010-12#1)
of malignant plasma##2##3##(2012-12#2)
of malignant pleural mesothelioma##4##4##(1992-12#2)(1995-2#1)(1997-5#1)
of malignant pleural##5##3##(1991-6#1)(1992-12#2)(1995-2#1)(1997-5#1)
of malignant transformation##9##3##(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-1#2)
of malignant tumors##3##3##(2010-1#1)(2011-2#2)
of malignant tumors]##2##3##(1993-2#1)(2013-1#1)
of malignant##67##2##(1990-11#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-6#2)(1993-9#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#2)(1997-5#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#3)(2010-1#4)(2010-11#1)(2010-12#1)(2011-2#13)(2011-3#1)(2012-12#3)(2012-3#2)(2013-1#5)(2013-8#1)
of malnutrition and##2##3##(2010-9#1)(2012-12#1)
of malnutrition##6##2##(2010-9#1)(2011-2#2)(2012-12#3)
of malondialdehyde##4##2##(1993-2#1)(2008-12#1)(2009-8#1)(2013-1#1)
of malonyl-CoA in the##2##4##(1995-6#2)
of malonyl-CoA##4##2##(1995-6#4)
of malpractice##2##2##(1995-1#1)(1997-2#1)
of maltol##4##2##(2008-10#4)
of mammalian cell culture##2##4##(2008-11#2)
of mammalian cell cultures##3##4##(2008-11#3)
of mammalian cell##5##3##(2008-11#5)
of mammalian cells by##3##4##(2008-11#1)(2010-10#1)(2011-2#1)
of mammalian cells##16##3##(1997-1#1)(2008-11#12)(2010-10#1)(2011-2#2)
of mammalian##43##2##(1990-5#2)(1993-6#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#22)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-10#1)(2011-2#2)
of mammals and##2##3##(2008-4#1)(2009-10#1)
of mammals##5##2##(2008-4#1)(2009-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
of mammary gland##2##3##(2008-9#1)(2013-1#1)
of mammary preneoplasia##2##3##(1995-9#2)
of mammary##10##2##(1991-11#1)(1992-2#1)(1992-9#1)(1993-11#2)(1995-9#2)(1997-7#1)(2008-9#1)(2013-1#1)
of man##2##2##(1991-6#1)(1995-2#1)
of man-made##2##2##(1991-6#1)(2008-11#1)
of managed care and##3##4##(1996-1#1)(1997-1#1)(2008-11#1)
of managed care options##2##4##(1991-3#1)(1997-3#1)
of managed care organizations (MCOs)##2##5##(1996-2#1)(1997-2#1)
of managed care plans##3##4##(1995-12#1)(1996-12#1)(1997-2#1)
of managed care programs##3##4##(1995-12#1)(1995-2#1)(2008-11#1)
of managed care##25##3##(1991-3#1)(1992-2#1)(1992-3#2)(1995-12#2)(1995-2#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#1)(2008-11#3)
of managed##30##2##(1991-3#2)(1992-2#1)(1992-3#2)(1995-12#2)(1995-2#2)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#5)(1997-3#1)(2008-10#1)(2008-11#3)(2012-9#1)
of management development##4##3##(1994-1#2)(1996-3#2)
of management of##4##3##(1993-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
of management practices##2##3##(1993-1#1)(2008-10#1)
of management that##2##3##(1992-12#1)(1993-3#1)
of management##35##2##(1990-6#1)(1990-8#1)(1991-2#1)(1992-1#2)(1992-12#1)(1993-1#2)(1993-3#1)(1994-1#4)(1994-3#1)(1996-1#2)(1996-3#3)(2008-10#5)(2008-3#1)(2010-6#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
of managerial##2##2##(1994-1#1)(2009-8#1)
of managers about the##2##4##(2012-3#2)
of managers##5##2##(1996-3#1)(1997-1#1)(2012-3#3)
of managing##6##2##(1994-3#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
of mandatory##3##2##(1994-12#1)(1997-3#1)(2009-11#1)
of manganese (II)##4##3##(2008-10#4)
of manganese in urine##2##4##(2008-10#2)
of manganese in##10##3##(2008-10#10)
of manganese oxide##3##3##(2008-10#3)
of manganese peroxidase were obtained in##2##6##(2008-5#2)
of manganese peroxidase##4##3##(2008-5#2)(2008-7#2)
of manganese was##2##3##(2008-10#2)
of manganese##46##2##(1990-2#1)(2008-10#40)(2008-5#2)(2008-7#2)(2013-1#1)
of manganese(II) was##3##3##(2008-10#3)
of manganese(II)##13##2##(2008-10#13)
of manganese(IV)##4##2##(2008-10#4)
of mango##4##2##(2008-10#4)
of mania and##2##3##(1995-5#1)(2009-8#1)
of manipulation##7##2##(1993-1#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)
of manipulations##3##2##(2008-2#1)(2010-7#1)(2011-2#1)
of manipulative therapy##2##3##(2008-12#2)
of mannitol has##2##3##(2008-10#2)
of mannitol was##2##3##(2008-10#1)(2011-2#1)
of mannitol##9##2##(2008-10#4)(2008-7#1)(2008-8#2)(2011-2#1)(2012-7#1)
of manual##7##2##(1991-3#1)(1993-12#1)(2008-11#1)(2008-12#1)(2010-8#1)(2010-9#1)(2012-3#1)
of manufactory##2##2##(2008-10#2)
of manufacturing##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
of many cell types##3##4##(1993-6#1)(2008-11#2)
of many cellular##2##3##(2008-5#1)(2009-4#1)
of many common##2##3##(1990-8#1)(2008-10#1)
of many congenital anomalies##2##4##(2008-11#2)
of many diseases##5##3##(2008-10#2)(2008-5#1)(2011-3#1)(2013-1#1)
of many economically important plants##2##5##(2008-10#2)
of many factors##2##3##(2008-5#1)(2011-2#1)
of many foods##2##3##(2008-10#1)(2012-2#1)
of many forms of##2##4##(1990-9#1)(2008-8#1)
of many genes##4##3##(1997-2#1)(2008-9#1)(2010-4#1)(2012-3#1)
of many health care organizations##2##5##(1994-12#1)(1996-1#1)
of many human##2##3##(2009-8#1)(2011-2#1)
of many of the##4##4##(1991-7#1)(2008-10#2)(2013-8#1)
of many of these##5##4##(1994-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-7#1)
of many of##10##3##(1991-7#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
of many other##3##3##(2008-10#2)(2010-4#1)
of many researchers##2##3##(2008-10#1)(2013-1#1)
of many such##2##3##(1991-12#1)(2008-9#1)
of many tissue types##2##4##(1993-6#1)(2008-11#1)
of many##139##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#3)(1993-6#2)(1994-12#2)(1994-3#2)(1994-9#1)(1995-2#1)(1995-5#2)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#4)(2008-10#34)(2008-11#8)(2008-12#1)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#11)(2008-9#6)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#6)(2011-3#3)(2011-7#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#2)
of map##2##2##(1996-2#1)(1997-8#1)
of marble industry effluent on##2##5##(2008-12#2)
of marginal##2##2##(2008-10#1)(2011-3#1)
of marijuana##2##2##(2013-8#2)
of marijuana-only##2##2##(2013-8#2)
of marine algae from##2##4##(2008-11#2)
of marine mammals##2##3##(2008-10#2)
of marine##18##2##(2008-10#5)(2008-11#3)(2008-3#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
of marked##6##2##(1991-1#1)(1997-6#1)(2008-10#2)(2008-11#2)
of marker##2##2##(2008-10#2)
of markers in##2##3##(2008-10#2)
of markers was##2##3##(2008-10#1)(2008-9#1)
of markers##7##2##(2008-10#4)(2008-9#1)(2010-12#1)(2013-1#1)
of market entry##2##3##(1991-3#1)(2008-11#1)
of market##5##2##(1991-3#1)(1994-2#1)(1996-3#1)(2008-11#1)(2009-9#1)
of marketed##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
of marking##2##2##(2008-11#1)(2010-8#1)
of marks##3##2##(2008-9#2)(2013-8#1)
of marriage##2##2##(2008-11#2)
of married##2##2##(1994-6#1)(1996-9#1)
of masking##4##2##(2008-10#3)(2012-2#1)
of maspin##3##2##(1995-6#3)
of mass production##2##3##(2008-10#1)(2008-12#1)
of mass spectra##2##3##(2008-10#1)(2011-2#1)
of mass spectrometry##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
of mass##25##2##(1991-3#1)(1992-3#1)(1994-5#1)(2008-10#10)(2008-12#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-7#1)(2011-2#3)(2013-1#2)(2013-8#1)
of massage therapy##2##3##(2008-11#1)(2010-6#1)
of massage##7##2##(2008-10#1)(2008-11#1)(2008-12#2)(2009-3#1)(2010-6#1)(2011-2#1)
of massive##5##2##(1990-3#1)(1992-5#2)(1996-3#1)(2007-12#1)
of mast cells##3##3##(2008-9#1)(2009-6#1)(2011-2#1)
of mast seeding##2##3##(2008-8#2)
of mast##7##2##(2008-8#2)(2008-9#2)(2009-6#2)(2011-2#1)
of mastectomy##2##2##(2012-3#2)
of masticatory##2##2##(1996-2#1)(2013-1#1)
of mastocytes##3##2##(1991-11#3)
of matched##2##2##(1991-7#1)(1997-8#1)
of matching##3##2##(1993-9#1)(1995-1#1)(2007-12#1)
of mate recognition##2##3##(2008-9#2)
of mate##3##2##(2008-8#1)(2008-9#2)
of material deposited in the##2##5##(1994-2#1)(1995-12#1)
of material flow systems##2##4##(2008-11#2)
of material##24##2##(1990-5#1)(1992-2#1)(1994-2#1)(1995-12#1)(2008-10#8)(2008-11#2)(2008-3#3)(2009-3#1)(2009-7#2)(2010-11#2)(2010-2#1)(2012-2#1)
of materials used in##2##4##(2008-10#2)
of materials used##3##3##(2008-10#2)(2013-1#1)
of materials##13##2##(1990-8#1)(1992-1#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2012-3#1)(2013-1#1)
of maternal acculturation##2##3##(2009-7#2)
of maternal and##3##3##(1995-2#1)(2008-9#1)(2013-8#1)
of maternal behavior##2##3##(1990-12#1)(2011-2#1)
of maternal diabetes##2##3##(1996-11#2)
of maternal serum##2##3##(1990-9#1)(1992-9#1)
of maternal##28##2##(1990-12#1)(1990-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-7#4)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
of maternally inherited##2##3##(1993-1#1)(2008-9#1)
of maternally##3##2##(1993-1#1)(1997-3#1)(2008-9#1)
of mates for##2##3##(2008-8#1)(2008-9#1)
of mates##6##2##(2008-8#4)(2008-9#2)
of mathematical##5##2##(2008-11#3)(2008-12#2)
of mathematics##2##2##(2008-12#1)(2013-8#1)
of mating and##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
of mating between relatives##2##4##(2012-3#2)
of mating partners##2##3##(2008-8#2)
of mating type genes##2##4##(2008-10#2)
of mating type##5##3##(2008-10#5)
of mating types##5##3##(2008-10#5)
of mating##24##2##(1991-5#1)(2008-10#12)(2008-8#5)(2008-9#2)(2009-6#1)(2012-3#3)
of mating-type##2##2##(2008-10#1)(2012-3#1)
of matings##3##2##(2008-10#2)(2008-8#1)
of matrices##6##2##(2008-10#3)(2008-11#3)
of matrine in rat plasma##2##5##(2008-10#2)
of matrine in##3##3##(2008-10#3)
of matrine##5##2##(2008-10#5)
of matrix can##2##3##(2008-10#1)(2008-9#1)
of matrix effects##5##3##(2008-10#5)
of matrix elements##6##3##(2008-10#6)
of matrix interferences##2##3##(2008-10#2)
of matrix metalloproteinase##2##3##(1997-2#1)(2008-9#1)
of matrix metalloproteinases and their inhibitors##2##6##(2008-1#1)(2008-9#1)
of matrix##37##2##(1997-2#1)(2008-1#1)(2008-10#27)(2008-8#2)(2008-9#3)(2010-6#1)(2012-2#1)(2012-3#1)
of matter##3##2##(1997-6#1)(2008-10#2)
of maturation of##4##3##(2008-10#3)(2008-5#1)
of maturation##7##2##(2007-12#1)(2008-10#3)(2008-5#2)(2012-2#1)
of mature adipocytes##2##3##(2008-11#1)(2010-6#1)
of mature pseudothecia##2##3##(2008-10#2)
of mature teratoma##2##3##(2008-7#2)
of mature##34##2##(1990-12#1)(1991-11#1)(1991-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-1#1)(2010-6#1)(2010-8#2)(2011-3#1)(2012-3#1)(2013-7#1)(2013-8#1)
of matured##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
of maturity##5##2##(1994-3#1)(2008-10#2)(2008-11#1)(2010-8#1)
of maxillary sensilla styloconica##2##4##(2008-8#2)
of maxillary##8##2##(2008-5#1)(2008-8#2)(2011-7#1)(2013-1#4)
of maximum oxygen uptake##2##4##(2013-8#2)
of maximum##29##2##(1993-3#1)(1993-8#1)(1994-8#1)(2008-10#13)(2008-11#5)(2008-6#1)(2008-7#1)(2008-9#2)(2010-6#1)(2013-1#1)(2013-8#2)
of mdx##2##2##(1995-12#2)
of mealybug wilt of pineapple##2##5##(2008-10#2)
of mealybug##3##2##(2008-10#3)
of mean##17##2##(1992-9#1)(2008-10#8)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2012-5#1)(2013-1#1)
of meaning##3##2##(1995-1#1)(2008-12#1)(2012-3#1)
of meaningful##2##2##(2008-12#1)(2008-8#1)
of means of##2##3##(1994-12#1)(2008-11#1)
of measles and##2##3##(2012-12#2)
of measles##5##2##(1995-3#1)(1995-5#2)(2012-12#2)
of measles-specific##2##2##(2008-12#2)
of measured##7##2##(2008-10#2)(2008-12#1)(2008-3#2)(2011-1#1)(2013-1#1)
of measurement and##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
of measurement data##2##3##(2008-11#2)
of measurement error and temporal variability##2##6##(1992-9#2)
of measurement error##3##3##(1992-9#2)(2008-3#1)
of measurement##37##2##(1992-9#2)(1993-3#1)(1996-2#1)(1997-2#1)(2008-10#11)(2008-11#3)(2008-3#8)(2008-4#2)(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#5)
of measurements and##2##3##(2008-10#1)(2008-11#1)
of measurements in##3##3##(1996-3#1)(2007-12#1)(2008-10#1)
of measurements of##3##3##(2008-2#2)(2008-3#1)
of measurements was##2##3##(2008-10#2)
of measurements##26##2##(1996-3#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#3)(2009-11#1)(2011-2#1)
of measures##6##2##(1992-1#1)(2007-12#1)(2008-10#2)(2008-12#1)(2012-2#1)
of measuring##14##2##(1990-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-9#1)(2009-7#1)(2012-2#1)
of meat and bone meal##2##5##(2008-10#2)
of meat and##4##3##(2008-10#4)
of meat from##2##3##(2010-4#2)
of meat products##2##3##(2008-10#2)
of meat##17##2##(2008-10#10)(2010-4#7)
of mebendazole##3##2##(2008-10#3)
of mechanical forces##2##3##(2009-8#1)(2013-8#1)
of mechanical properties##2##3##(2012-2#1)(2013-8#1)
of mechanical##17##2##(1994-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
of mechanically##3##2##(2007-12#1)(2008-10#2)
of mechanisms by which##2##4##(2008-6#1)(2008-9#1)
of mechanisms of##2##3##(2008-10#1)(2012-2#1)
of mechanisms##12##2##(1997-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
of mechanistic##2##2##(2009-8#1)(2013-1#1)
of mechanotherapy##3##2##(2008-12#3)
of medaka##2##2##(2009-7#2)
of media and regulatory##2##4##(2008-11#2)
of media and##3##3##(2008-11#3)
of media for##2##3##(1995-12#1)(2008-12#1)
of media##20##2##(1992-12#1)(1993-8#1)(1995-12#1)(1996-11#1)(2008-10#3)(2008-11#8)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)
of medial##7##2##(1996-12#1)(2008-11#2)(2008-8#1)(2012-2#1)(2013-1#2)
of median##3##2##(1992-5#2)(2007-8#1)
of mediastinal##4##2##(1991-8#1)(1997-8#1)(2009-8#1)(2010-7#1)
of mediating##4##2##(2008-10#3)(2010-1#1)
of medical and surgical##3##4##(1993-12#1)(2008-9#1)(2010-6#1)
of medical and##9##3##(1991-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-6#1)(2008-9#1)(2009-6#1)(2010-6#1)(2012-3#1)
of medical care##6##3##(1991-12#2)(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
of medical devices##3##3##(2008-11#2)(2010-6#1)
of medical education and##2##4##(2008-11#1)(2010-11#1)
of medical education##6##3##(1994-12#1)(2008-11#3)(2010-11#2)
of medical emergencies in India##2##5##(1995-12#1)(2009-4#1)
of medical emergencies##4##3##(1995-12#1)(2008-1#2)(2009-4#1)
of medical entomology and##2##4##(2010-1#2)
of medical entomology in##3##4##(2010-1#3)
of medical entomology##9##3##(2010-1#9)
of medical graduates##4##3##(1992-1#1)(1994-12#2)(2009-10#1)
of medical imaging##2##3##(1996-1#1)(2009-10#1)
of medical malpractice##2##3##(1997-1#1)(2012-3#1)
of medical necessity##2##3##(2011-2#2)
of medical personnel##2##3##(1992-3#1)(1994-6#1)
of medical procedures##4##3##(1992-2#1)(1995-12#1)(2008-4#1)(2011-2#1)
of medical professionals##2##3##(1995-6#1)(1996-9#1)
of medical records and##4##4##(1994-3#2)(2013-1#1)(2013-8#1)
of medical records##5##3##(1992-5#1)(1994-3#2)(2013-1#1)(2013-8#1)
of medical schools##2##3##(2009-6#1)(2011-2#1)
of medical services##6##3##(1993-3#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)
of medical staff##3##3##(1992-1#1)(1993-12#1)(2008-12#1)
of medical students##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
of medical treatment##2##3##(1997-5#1)(2011-2#1)
of medical##133##2##(1990-12#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#8)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#4)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2008-1#3)(2008-10#2)(2008-11#9)(2008-12#2)(2008-4#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#2)(2010-1#11)(2010-11#2)(2010-6#2)(2011-1#1)(2011-2#13)(2012-2#2)(2012-3#8)(2013-1#5)(2013-7#2)(2013-8#2)
of medication errors##5##3##(2011-1#5)
of medication in##2##3##(2008-6#1)(2011-1#1)
of medication##20##2##(1992-3#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#6)(2012-12#4)(2012-3#1)
of medications##6##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
of medicinal plants##4##3##(2008-11#2)(2010-6#1)(2012-2#1)
of medicinal##6##2##(2008-11#3)(2010-6#1)(2012-2#1)(2012-3#1)
of medicine and##2##3##(1992-3#1)(2010-1#1)
of medicine are##2##3##(1997-5#1)(2013-1#1)
of medicine in##5##3##(2008-10#2)(2009-10#1)(2009-5#1)(2012-12#1)
of medicine##32##2##(1991-1#1)(1992-2#1)(1992-3#1)(1993-11#3)(1993-3#1)(1993-6#2)(1994-12#1)(1995-1#1)(1995-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#2)
of medicines##12##2##(1992-2#1)(2008-11#5)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#2)
of medigap##4##2##(1991-2#1)(1992-2#2)(1997-3#1)
of medium and##2##3##(2008-11#1)(2009-12#1)
of medium##20##2##(1993-12#1)(1996-2#1)(2008-10#2)(2008-11#12)(2008-12#2)(2008-3#1)(2009-12#1)
of medulloblastoma##3##2##(1993-9#1)(2008-7#1)(2009-1#1)
of meeting##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
of mefenacet##4##2##(2008-10#4)
of mefenamic acid##4##3##(2012-2#4)
of mefenamic##5##2##(2012-2#5)
of mefenoxam sensitivity was##2##4##(2008-10#2)
of mefenoxam##3##2##(2008-10#3)
of megacolon##2##2##(1993-6#1)(1994-12#1)
of meiosis##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
of meiosis-specific##3##2##(1995-8#1)(2011-2#1)(2012-3#1)
of meiotic telomeres##2##3##(2011-2#2)
of meiotic##3##2##(2007-12#1)(2011-2#2)
of melanin##2##2##(2008-5#1)(2008-9#1)
of melanocytes##4##2##(1997-7#1)(2008-5#2)(2011-2#1)
of melanoma cells to##3##4##(2009-4#2)(2012-3#1)
of melanoma cells##5##3##(2008-8#1)(2009-4#2)(2012-3#2)
of melanoma##16##2##(1992-2#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2011-2#7)(2012-3#2)
of melatonin and its derivatives##2##5##(2008-10#2)
of melatonin and its##3##4##(2008-10#3)
of melatonin and##4##3##(2008-10#3)(2011-2#1)
of melatonin in the##2##4##(1995-11#1)(2008-11#1)
of melatonin in##6##3##(1995-11#2)(1996-2#1)(2008-10#1)(2008-11#2)
of melatonin on##3##3##(1990-5#1)(1996-2#1)(2010-12#1)
of melatonin receptors##2##3##(1995-12#1)(2013-7#1)
of melatonin##23##2##(1990-5#1)(1995-11#2)(1995-12#1)(1996-2#3)(2008-10#6)(2008-11#3)(2008-5#1)(2010-12#1)(2011-2#2)(2013-7#3)
of melittin##3##2##(2008-10#3)
of melon##4##2##(2008-10#4)
of melphalan##2##2##(2011-3#2)
of members and chairs##2##4##(2009-4#2)
of members and##3##3##(1996-3#1)(2009-4#2)
of members of the Association for##2##6##(1994-3#2)
of members of the family##2##5##(2008-10#1)(2008-6#1)
of members of the##9##4##(1994-3#2)(1996-2#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
of members##18##2##(1994-3#3)(1995-1#1)(1995-2#1)(1996-2#2)(1996-3#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-9#1)(2009-4#2)(2011-2#1)(2012-2#1)
of membrane and##2##3##(1993-8#1)(2008-10#1)
of membrane composition and##2##4##(2008-10#2)
of membrane composition##4##3##(2008-10#4)
of membrane damage##2##3##(2009-6#2)
of membrane fluidity##2##3##(1991-5#1)(1996-12#1)
of membrane lipid biophysical properties##2##5##(2008-9#2)
of membrane lipid biophysical##3##4##(2008-9#3)
of membrane lipid##4##3##(2008-9#4)
of membrane lipids##3##3##(1991-5#1)(2008-8#2)
of membrane potential##4##3##(1990-8#1)(1997-1#1)(2008-10#1)(2008-9#1)
of membrane protein##3##3##(1990-2#1)(2008-10#1)(2011-1#1)
of membrane proteins and##2##4##(2008-8#2)
of membrane proteins##15##3##(1990-5#2)(1992-11#1)(1992-12#1)(1993-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#3)(2011-1#2)
of membrane##67##2##(1990-2#1)(1990-5#2)(1990-8#1)(1991-5#3)(1992-11#2)(1992-12#1)(1993-8#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#6)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#5)
of membranes##10##2##(1992-7#1)(2008-10#5)(2008-8#1)(2009-6#1)(2012-3#1)(2013-1#1)
of memory##10##2##(1996-2#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-10#3)(2013-1#1)
of men and women##4##4##(1995-12#1)(1996-6#1)(2011-2#1)(2013-8#1)
of men and##7##3##(1995-12#1)(1996-6#1)(1997-8#1)(2008-1#1)(2011-2#2)(2013-8#1)
of men undergoing##2##3##(2010-10#2)
of men##19##2##(1995-12#1)(1996-6#1)(1997-8#2)(2008-1#2)(2008-10#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-10#4)(2011-2#3)(2013-8#2)
of meningeal##3##2##(2008-7#2)(2009-11#1)
of meningioma##2##2##(2010-11#1)(2011-2#1)
of meningitis in##2##3##(1993-12#1)(2013-7#1)
of meningitis##12##2##(1993-12#2)(2008-12#1)(2008-7#2)(2008-9#3)(2009-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
of meniscal##2##2##(1993-11#2)
of mental and##2##3##(1993-12#1)(2008-12#1)
of mental health and##3##4##(1996-12#1)(2013-8#2)
of mental health issues in##2##5##(2008-12#2)
of mental health nursing##4##4##(2008-11#2)(2008-12#1)(2009-6#1)
of mental health professionals##4##4##(1994-1#3)(2008-11#1)
of mental health services##7##4##(1994-1#2)(1996-12#1)(1996-3#2)(2008-11#1)(2013-1#1)
of mental health##31##3##(1992-1#1)(1993-2#1)(1994-1#7)(1995-1#1)(1996-12#2)(1996-3#2)(1997-5#1)(2008-11#5)(2008-12#3)(2009-6#1)(2010-5#1)(2012-2#1)(2013-1#3)(2013-8#2)
of mental illness##9##3##(1993-5#1)(2008-12#4)(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
of mental##51##2##(1991-8#1)(1992-1#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#7)(1995-1#1)(1995-2#1)(1996-12#2)(1996-3#2)(1997-5#1)(2008-11#6)(2008-12#8)(2008-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#5)
of mentally ill##4##3##(1990-2#1)(1992-3#1)(1996-9#1)(2009-7#1)
of meperidine##2##2##(2011-2#2)
of mequitazine and the IS##2##5##(2008-10#2)
of mequitazine##4##2##(2008-10#4)
of merchant##2##2##(1991-12#1)(2008-11#1)
of mercuric chloride##2##3##(2008-7#2)
of mercury and##3##3##(2008-10#3)
of mercury by##4##3##(2008-10#4)
of mercury film##2##3##(2008-10#2)
of mercury from##6##3##(2008-10#6)
of mercury in agroindustrial samples by##2##6##(2008-10#2)
of mercury in the##2##4##(2008-10#2)
of mercury in##16##3##(2008-10#16)
of mercury ions##2##3##(2008-10#2)
of mercury species##5##3##(2008-10#5)
of mercury with##3##3##(2008-10#3)
of mercury##71##2##(1992-11#1)(2008-10#70)
of mercury(II) and lead(II) in##2##5##(2008-10#2)
of mercury(II) and lead(II)##3##4##(2008-10#3)
of mercury(II) and##4##3##(2008-10#4)
of mercury(II) by##5##3##(2008-10#5)
of mercury(II) in##2##3##(2008-10#2)
of mercury(II) ions##2##3##(2008-10#2)
of mercury(II) with##2##3##(2008-10#2)
of mercury(II)##24##2##(2008-10#24)
of mercy##2##2##(1993-5#1)(2008-6#1)
of merit and##3##3##(2008-10#3)
of merit such as limit of detection##2##7##(2008-10#2)
of merit##27##2##(2008-10#25)(2008-3#1)(2011-2#1)
of merits in##2##3##(2008-10#2)
of merits##4##2##(2008-10#4)
of mesalazine##2##2##(2010-11#2)
of mesangial cells##3##3##(1993-8#1)(1995-11#1)(2011-2#1)
of mesangial##4##2##(1993-8#1)(1995-11#1)(1996-6#1)(2011-2#1)
of mesenchymal stem cells##5##4##(2008-9#3)(2010-12#1)(2010-8#1)
of mesenchymal stem##6##3##(2008-11#1)(2008-9#3)(2010-12#1)(2010-8#1)
of mesenchymal##11##2##(1994-5#1)(2008-11#4)(2008-9#3)(2010-12#1)(2010-8#1)(2011-2#1)
of mesolimbic##2##2##(1991-1#1)(1993-6#1)
of mesoporous##2##2##(2008-10#1)(2010-4#1)
of mesothelioma##7##2##(1991-12#6)(1997-5#1)
of messages##2##2##(2009-6#1)(2010-11#1)
of meta-analysis and the##2##4##(1996-6#1)(2010-11#1)
of meta-analysis##6##2##(1996-6#3)(1996-8#1)(2008-10#1)(2010-11#1)
of metabolic and hormonal##2##4##(1994-12#1)(2013-7#1)
of metabolic and##3##3##(1994-12#1)(2008-10#1)(2013-7#1)
of metabolic functions##2##3##(2008-10#2)
of metabolic origin##2##3##(2007-8#1)(2011-2#1)
of metabolic pathways##7##3##(2008-11#1)(2008-3#1)(2008-7#3)(2009-8#1)(2010-7#1)
of metabolic reactions##2##3##(2008-7#2)
of metabolic syndrome in##2##4##(2008-3#1)(2012-2#1)
of metabolic syndrome##13##3##(2008-1#1)(2008-11#1)(2008-3#7)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
of metabolic##40##2##(1992-12#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-3#9)(2008-7#6)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-4#1)(2012-5#1)(2013-1#1)(2013-7#1)
of metabolically##2##2##(1992-9#1)(2008-11#1)
of metabolism##5##2##(1994-8#1)(1995-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
of metabolites##9##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#2)(2012-3#1)
of metacentric chromosomes##2##3##(2008-12#2)
of metal cations##3##3##(2008-10#3)
of metal complexes##2##3##(2008-10#2)
of metal content##3##3##(2008-10#2)(2010-11#1)
of metal distributions in##2##4##(2010-11#2)
of metal ion solution##2##4##(2008-10#2)
of metal ion##15##3##(1994-11#1)(2008-10#13)(2010-11#1)
of metal ions Cu(II) and##2##5##(2008-10#2)
of metal ions and##5##4##(2008-10#5)
of metal ions by##3##4##(2008-10#3)
of metal ions from##4##4##(2008-10#4)
of metal ions in the##3##5##(2008-10#3)
of metal ions in##12##4##(1997-7#1)(2008-10#11)
of metal ions is##2##4##(2008-10#2)
of metal ions to##2##4##(2008-10#2)
of metal ions using##4##4##(2008-10#4)
of metal ions was##2##4##(2008-10#2)
of metal ions were##3##4##(2008-10#3)
of metal ions with##3##4##(2008-10#3)
of metal ions##75##3##(1994-6#1)(1997-7#1)(2008-10#73)
of metal species##2##3##(2008-10#2)
of metal to##2##3##(2008-10#1)(2008-11#1)
of metal##145##2##(1994-11#1)(1994-6#1)(1997-7#1)(2008-10#128)(2008-11#2)(2010-11#8)(2010-5#2)(2013-8#2)
of metal-binding##2##2##(2008-10#1)(2010-11#1)
of metallic ions##2##3##(2008-10#2)
of metallic silver##2##3##(2008-10#1)(2011-2#1)
of metallic##10##2##(2008-10#8)(2011-2#1)(2012-12#1)
of metalloproteases##3##2##(2006-6#1)(2008-4#1)(2008-7#1)
of metalloproteinase##7##2##(1990-8#2)(1992-6#2)(2008-5#1)(2008-9#1)(2010-1#1)
of metalloproteins##4##2##(2008-10#1)(2010-11#3)
of metallothionein (MT)##3##3##(2008-10#3)
of metallothionein by##4##3##(1991-5#4)
of metallothionein isoforms##3##3##(2008-10#3)
of metallothionein proteins##2##3##(2008-10#2)
of metallothionein##23##2##(1990-5#3)(1991-5#4)(1992-6#1)(1993-12#1)(2008-10#13)(2008-11#1)
of metallothioneins by##2##3##(2008-10#2)
of metallothioneins##6##2##(1990-5#1)(2008-10#5)
of metals and anions##2##4##(2008-10#2)
of metals and##5##3##(2008-10#5)
of metals at##2##3##(2008-10#2)
of metals from sediment##2##4##(2008-10#2)
of metals from##7##3##(2008-10#7)
of metals in lubricating##2##4##(2008-10#2)
of metals in solution##2##4##(2008-10#2)
of metals in used lubricating oils##2##6##(2008-10#2)
of metals in##19##3##(2008-10#17)(2010-11#2)
of metals was##2##3##(2008-10#2)
of metals with##2##3##(2008-10#2)
of metals##55##2##(1994-6#1)(2008-10#50)(2008-12#1)(2010-11#2)(2013-1#1)
of metaphase chromosomes##2##3##(1990-3#1)(2008-9#1)
of metaphase##3##2##(1990-3#1)(1997-3#1)(2008-9#1)
of metaphorical##2##2##(2012-2#2)
of metapopulations##4##2##(2008-8#4)
of metastases##8##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-11#1)(1994-12#1)(2009-10#1)
of metastasis to lung##2##4##(2008-8#2)
of metastasis##9##2##(1990-6#1)(1994-12#1)(1994-8#1)(2008-8#2)(2010-3#2)(2012-3#2)
of metastatic bone disease##2##4##(2012-3#2)
of metastatic disease to the##2##5##(1990-12#1)(2008-1#1)
of metastatic disease##4##3##(1990-12#1)(2008-1#2)(2012-2#1)
of metastatic renal cell carcinoma##2##5##(1990-2#1)(1994-12#1)
of metastatic spread##4##3##(1991-2#1)(1994-12#1)(2008-1#1)(2009-9#1)
of metastatic##22##2##(1990-12#1)(1990-2#3)(1991-2#1)(1991-7#1)(1992-2#1)(1993-9#1)(1994-12#2)(1994-5#1)(1996-11#1)(2008-1#3)(2009-3#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
of metatarsus adductus##2##3##(2012-2#2)
of metered dose inhalers##2##4##(1992-2#2)
of metered dose##3##3##(1992-2#2)(1992-3#1)
of metformin in##3##3##(1995-8#2)(2008-10#1)
of metformin##12##2##(1994-8#3)(1995-8#2)(2008-10#2)(2011-2#3)(2012-2#2)
of methamidophos##3##2##(2008-10#3)
of methamphetamine and prescription drug use##2##6##(2013-1#2)
of methamphetamine##7##2##(1991-1#3)(2008-10#1)(2013-1#2)(2013-8#1)
of methane monooxygenase##2##3##(1991-12#2)
of methane##12##2##(1991-12#2)(2007-12#1)(2008-10#5)(2008-3#4)
of methanol and ethanol##2##4##(2008-10#2)
of methanol and##5##3##(2008-10#5)
of methanol extract of Aegle marmelos##3##6##(2012-2#3)
of methanol extract of##4##4##(2012-2#3)(2012-3#1)
of methanol in##2##3##(2008-10#2)
of methanol##39##2##(1996-5#2)(2008-10#29)(2008-2#2)(2008-7#2)(2012-2#3)(2012-3#1)
of methanol-water##4##2##(2008-10#4)
of methanol/water##2##2##(2008-10#1)(2008-5#1)
of methaqualone##4##2##(2008-10#4)
of methicillin-resistant Staphylococcus aureus (MRSA)##3##5##(2007-12#1)(2008-10#1)(2011-2#1)
of methicillin-resistant Staphylococcus aureus##4##4##(2007-12#1)(2008-10#1)(2010-6#1)(2011-2#1)
of methionine##5##2##(1992-6#1)(2008-10#2)(2008-11#2)
of method and##2##3##(2008-10#1)(2008-7#1)
of method##10##2##(2008-10#7)(2008-11#1)(2008-7#1)(2012-3#1)
of methodological##4##2##(1992-1#1)(1992-3#1)(1995-5#1)(1997-1#1)
of methodologies for##2##3##(2008-10#1)(2013-1#1)
of methodologies to determine##2##4##(2008-10#1)(2013-8#1)
of methodologies##6##2##(1992-9#1)(1995-5#1)(2008-10#2)(2013-1#1)(2013-8#1)
of methodology##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
of methods and##2##3##(2008-10#1)(2013-1#1)
of methods for the determination of##2##6##(2008-10#1)(2008-11#1)
of methods for##7##3##(1995-9#1)(2008-10#3)(2008-11#1)(2008-4#2)
of methods is##2##3##(2008-10#1)(2013-1#1)
of methods to##3##3##(1993-3#1)(2008-10#1)(2008-9#1)
of methods##27##2##(1993-3#1)(1995-9#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-4#2)(2008-9#3)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
of methotrexate (Mtx)##2##3##(2008-10#2)
of methotrexate##12##2##(1992-12#1)(1995-8#3)(2008-10#4)(2008-11#4)
of methoxy##2##2##(2008-10#1)(2008-11#1)
of methyl 3-O-beta-D-glucopyranosyl-beta-D-glucopyranoside (methyl beta-D-laminarabioside)##2##5##(1992-12#2)
of methyl bromide##3##3##(2008-10#3)
of methyl ester##2##3##(2008-10#2)
of methyl esters##2##3##(2008-10#1)(2009-8#1)
of methyl orange##4##3##(2008-10#3)(2009-11#1)
of methyl tert-butyl ether##2##4##(2008-12#2)
of methyl yellow##2##3##(2008-10#2)
of methyl##32##2##(1992-12#4)(1994-5#1)(1996-5#2)(2008-10#18)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)
of methyl-β-cyclodextrin##4##2##(2011-2#4)
of methylamine##2##2##(2008-10#1)(2008-11#1)
of methylamphetamine and related compounds##2##5##(2008-10#2)
of methylamphetamine##3##2##(2008-10#3)
of methylation##4##2##(1994-5#1)(2008-10#1)(2009-12#1)(2011-2#1)
of methyldopa##2##2##(2008-10#2)
of methylene blue (MB) with##2##5##(2008-10#2)
of methylene blue (MB)##8##4##(2008-10#8)
of methylene blue and##2##4##(2008-10#2)
of methylene blue##13##3##(2008-10#12)(2012-2#1)
of methylene##16##2##(2008-10#15)(2012-2#1)
of methylglyoxal##3##2##(2008-11#3)
of methylmercury and inorganic mercury##2##5##(2008-10#2)
of methylmercury##5##2##(2008-10#5)
of methylphenidate hydrochloride##2##3##(1995-11#2)
of methylphenidate##7##2##(1995-11#4)(2008-9#1)(2012-2#2)
of metoclopramide##15##2##(2008-10#12)(2012-12#3)
of metronidazole##9##2##(2008-10#9)
of miR-218##2##2##(2011-2#2)
of miRNA##3##2##(2011-2#3)
of miRNAs##6##2##(2008-11#3)(2011-2#3)
of mice and##2##3##(1995-12#1)(2008-10#1)
of mice in##2##3##(1995-5#1)(2008-11#1)
of mice that##2##3##(1993-12#1)(2011-2#1)
of mice were##2##3##(1994-3#1)(2008-10#1)
of mice with##11##3##(1995-5#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-6#2)(2010-12#1)(2011-2#2)(2011-3#1)
of mice##47##2##(1993-12#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#2)(1997-2#3)(1997-8#2)(2008-10#5)(2008-11#5)(2008-12#4)(2008-4#1)(2008-7#3)(2008-9#2)(2009-6#2)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
of micellar##5##2##(2008-10#5)
of micro##6##2##(2008-10#5)(2012-3#1)
of micro-optics##2##2##(2008-3#2)
of microRNA##2##2##(2010-4#1)(2010-7#1)
of microRNA-218##2##2##(2011-2#2)
of microRNAs (miRNAs)##2##3##(2008-10#1)(2011-2#1)
of microRNAs##4##2##(2008-10#1)(2010-7#2)(2011-2#1)
of microarray analysis##2##3##(2008-11#1)(2009-10#1)
of microarray experiments##2##3##(2008-4#1)(2009-10#1)
of microarray##12##2##(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#2)(2009-10#3)(2010-1#1)(2012-3#1)
of microarrays for##2##3##(2007-12#1)(2010-4#1)
of microarrays##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
of microbes##5##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#2)
of microbial activity##2##3##(2008-10#2)
of microbial contamination##2##3##(2008-5#1)(2012-2#1)
of microbial extracellular glycolipids##2##4##(2008-11#2)
of microbial pathogens##2##3##(2008-10#2)
of microbial##21##2##(2008-10#9)(2008-11#3)(2008-5#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#1)
of microbially##2##2##(2008-10#2)
of microbiology and##2##3##(1992-12#1)(2008-10#1)
of microbiology##5##2##(1992-12#1)(2008-10#1)(2008-9#2)(2013-1#1)
of microbodies##3##2##(2008-10#3)
of microcapsule##2##2##(2008-11#2)
of microcarrier##3##2##(2008-11#3)
of microcephaly##2##2##(1997-3#2)
of microchannel structure##2##3##(2008-10#2)
of microchannel##3##2##(2008-10#3)
of microcracks##2##2##(2009-7#2)
of microcrystals##2##2##(2008-10#2)
of microcystin-LR in surface water##2##5##(2008-10#2)
of microcystins##5##2##(2008-10#4)(2010-5#1)
of microelements##2##2##(2008-10#2)
of microfibrillar-associated protein 4##2##4##(2012-2#2)
of microfilament##2##2##(1993-8#1)(2009-10#1)
of microfluidic##4##2##(2008-10#4)
of microglia in denervated neuropil##3##5##(1997-3#3)
of micrometer-sized polymer##2##3##(2008-10#1)(2008-3#1)
of micromolar##2##2##(2008-10#1)(2008-11#1)
of micron sized##2##3##(2008-10#2)
of micron##3##2##(2008-10#3)
of micronucleated erythrocytes in male and female##2##7##(2008-9#2)
of micronucleated erythrocytes##3##3##(2008-9#3)
of micronuclei##2##2##(1993-8#1)(2008-9#1)
of micronutrients in##2##3##(2008-10#1)(2013-8#1)
of micronutrients##6##2##(2008-10#2)(2010-6#1)(2013-8#3)
of microorganism##2##2##(2006-6#1)(2008-10#1)
of microorganisms in##3##3##(2011-1#1)(2011-2#2)
of microorganisms##19##2##(2008-10#5)(2008-11#3)(2008-7#2)(2008-9#1)(2011-1#2)(2011-2#3)(2012-2#3)
of micropropagated cranberry plants##2##4##(2008-10#2)
of micropropagated##4##2##(2008-10#3)(2009-8#1)
of microsatellite##5##2##(2008-10#2)(2008-9#1)(2010-7#1)(2013-8#1)
of microsatellites##4##2##(1994-11#1)(1997-6#1)(2010-7#1)(2012-3#1)
of microsclerotia of V##2##4##(2008-10#2)
of microsclerotia##9##2##(2008-10#9)
of microscopic##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
of microscopy##3##2##(2008-11#1)(2008-4#2)
of microsomal##7##2##(1992-6#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(2012-2#1)
of microspheres##2##2##(2008-10#1)(2012-3#1)
of microteaching##5##2##(2008-11#5)
of microtubule##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
of microtubules in the##2##4##(2008-1#1)(2008-7#1)
of microtubules##10##2##(1995-2#1)(2007-12#2)(2008-1#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#1)(2012-2#1)
of microvascular decompression##2##3##(2012-3#1)(2013-1#1)
of microvascular##3##2##(2009-10#1)(2012-3#1)(2013-1#1)
of microvilli##2##2##(2008-6#1)(2009-8#1)
of microwave digestion##4##3##(2008-10#4)
of microwave energy##2##3##(2008-10#2)
of microwave##10##2##(2008-10#10)
of microwave-assisted extraction##4##3##(2008-10#4)
of microwave-assisted##5##2##(2008-10#5)
of microwaves##3##2##(2008-10#3)
of middle ear effusion and serum##2##6##(2008-10#2)
of middle##6##2##(1995-2#1)(2008-10#2)(2011-2#2)(2012-12#1)
of middle-aged##2##2##(2008-7#2)
of midgut##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
of midline neuropils in##2##4##(2007-12#2)
of midline##4##2##(2007-12#2)(2008-7#1)(2011-2#1)
of midsagittal##2##2##(1995-5#2)
of midwives##2##2##(1990-6#1)(2008-12#1)
of migraine attacks##2##3##(2008-9#2)
of migraine pathophysiology##2##3##(2008-9#2)
of migraine##16##2##(2008-5#1)(2008-6#1)(2008-9#13)(2009-9#1)
of migrants##5##2##(1997-8#1)(2008-10#2)(2008-8#1)(2010-8#1)
of migrating##2##2##(2008-8#1)(2012-3#1)
of migration of##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
of migration times and peak areas##2##6##(2008-10#2)
of migration times and##4##4##(2008-10#4)
of migration times##6##3##(2008-10#6)
of migration##18##2##(2008-1#1)(2008-10#9)(2008-12#1)(2008-8#3)(2010-8#2)(2011-2#1)(2013-1#1)
of migratory##8##2##(1995-3#2)(2008-8#1)(2009-9#1)(2010-8#2)(2011-2#2)
of mild cognitive impairment##3##4##(2008-2#1)(2009-10#1)(2011-2#1)
of mild to##2##3##(2008-5#1)(2008-7#1)
of mild##19##2##(1993-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-10#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
of mildewed##2##2##(2008-10#2)
of military##2##2##(1996-12#1)(2011-2#1)
of milk##13##2##(2008-10#8)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)
of milligrams##3##2##(2008-10#2)(2008-11#1)
of millions of##3##3##(1991-2#1)(2008-10#1)(2013-8#1)
of millions##4##2##(1991-2#1)(2008-10#2)(2013-8#1)
of mimicry evolution##2##3##(2012-3#2)
of mimicry##3##2##(2012-3#3)
of mimosine##4##2##(2008-10#4)
of mind and##2##3##(2008-11#2)
of mind##6##2##(2008-11#3)(2008-12#2)(2013-8#1)
of mindfulness##2##2##(2012-2#1)(2013-1#1)
of mindfulness-based##3##2##(2013-1#3)
of mineral acids##2##3##(2008-10#2)
of mineral feed additives based on##2##6##(2008-10#2)
of mineral##17##2##(1991-12#1)(2008-10#9)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#2)
of mineralization##4##2##(2008-10#3)(2008-12#1)
of mini-white##2##2##(2012-3#2)
of miniature##3##2##(1996-2#1)(2008-10#2)
of minimal##7##2##(1995-2#1)(2008-10#1)(2008-11#2)(2010-7#1)(2011-2#1)(2012-3#1)
of minimally invasive##5##3##(2008-11#1)(2009-12#1)(2012-12#3)
of minimizing##2##2##(2008-10#1)(2013-1#1)
of minimum##2##2##(2009-6#1)(2013-1#1)
of minocycline##2##2##(1997-8#1)(2008-7#1)
of minor effect##2##3##(2008-10#2)
of minor groove##3##3##(1996-3#1)(2008-4#2)
of minor salivary##3##3##(1990-6#1)(2013-1#2)
of minor veins##2##3##(2008-10#2)
of minor##28##2##(1990-6#1)(1992-6#2)(1993-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-4#2)(2009-3#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of minorities##3##2##(1991-8#1)(1994-12#1)(1997-2#1)
of minority health care##2##4##(1997-2#2)
of minority##6##2##(1994-12#1)(1997-2#3)(2011-2#2)
of minors##2##2##(1996-1#1)(2008-10#1)
of minute##4##2##(1990-8#1)(1997-6#1)(2008-11#1)(2012-3#1)
of mirror##6##2##(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)
of misclassification##2##2##(2008-10#1)(2011-2#1)
of misidentification##2##2##(2008-10#1)(2008-11#1)
of misleading##3##2##(2008-11#2)(2012-2#1)
of mismatched grating pairs##2##4##(2008-2#2)
of mismatched##4##2##(2008-2#2)(2010-11#2)
of mismatches##3##2##(1995-12#3)
of misoprostol##4##2##(1995-8#4)
of missed##2##2##(1996-12#1)(2008-8#1)
of missing data##4##3##(1994-9#1)(1995-12#1)(2012-2#2)
of missing##7##2##(1993-8#1)(1994-9#1)(1995-12#1)(2008-11#1)(2012-2#2)(2013-1#1)
of mitochondria and##2##3##(2008-12#1)(2013-1#1)
of mitochondria from##2##3##(1994-5#1)(2008-10#1)
of mitochondria##12##2##(1994-5#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-6#1)(2013-1#1)
of mitochondrial DNA##9##3##(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#2)(2009-8#1)(2013-8#1)
of mitochondrial dysfunction##2##3##(2007-8#2)
of mitochondrial function##4##3##(1994-5#1)(1997-1#1)(2008-7#1)(2013-1#1)
of mitochondrial matrix##2##3##(1990-2#2)
of mitochondrial membrane potential##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
of mitochondrial membrane##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
of mitochondrial permeability transition##3##4##(2008-11#2)(2010-12#1)
of mitochondrial respiration##3##3##(1990-5#2)(2008-7#1)
of mitochondrial##40##2##(1990-2#2)(1990-3#1)(1990-5#2)(1993-2#1)(1993-3#1)(1994-5#1)(1995-6#2)(1997-1#1)(1997-2#2)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
of mitogen-activated protein kinase##3##4##(1993-8#1)(1995-6#1)(2012-3#1)
of mitomycin C (MMC)##2##4##(1997-7#1)(2008-11#1)
of mitomycin C##3##3##(1997-7#2)(2008-11#1)
of mitosis##4##2##(1992-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
of mitotic chromosomes##2##3##(2008-12#1)(2008-4#1)
of mitotic##7##2##(1990-8#1)(1993-12#1)(1995-9#2)(2008-12#1)(2008-4#2)
of mitoxantrone##2##2##(1991-6#2)
of mitral##2##2##(2011-2#1)(2013-1#1)
of mivacurium in##2##3##(2008-10#2)
of mixed infections##2##3##(2008-10#2)
of mixed##32##2##(1990-2#1)(1991-11#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
of mixes##3##2##(2008-10#2)(2011-2#1)
of mixing##7##2##(1997-2#1)(2008-10#3)(2008-7#2)(2008-8#1)
of mixture design on##2##4##(2008-10#2)
of mixture##5##2##(2008-10#5)
of mixtures in##3##3##(2008-10#3)
of mixtures of three##2##4##(2008-10#2)
of mixtures of##13##3##(1990-12#1)(1993-8#1)(2008-10#10)(2008-6#1)
of mixtures with##2##3##(2008-10#2)
of mixtures##26##2##(1990-12#1)(1993-8#1)(2008-10#22)(2008-12#1)(2008-6#1)
of mobile phase variables##4##4##(2008-10#4)
of mobile phase##12##3##(2008-10#12)
of mobile##21##2##(2008-10#15)(2008-12#1)(2008-8#1)(2009-10#2)(2012-12#1)(2012-3#1)
of mobility##2##2##(2008-10#1)(2008-7#1)
of mobilizations##2##2##(2012-2#2)
of model parameters##3##3##(2009-4#1)(2013-1#1)(2013-8#1)
of model##29##2##(1990-12#1)(1991-5#1)(1992-9#1)(1994-9#1)(1995-11#1)(1997-2#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#3)
of modeling##7##2##(1990-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-1#1)
of modelling##2##2##(2008-10#1)(2008-12#1)
of models used##2##3##(2008-10#1)(2012-2#1)
of models##16##2##(1990-5#1)(1994-5#1)(1995-5#1)(2008-10#5)(2008-4#1)(2008-8#3)(2010-1#1)(2012-2#1)(2013-8#2)
of moderate or severe##2##4##(1990-3#1)(2010-11#1)
of moderate or##3##3##(1990-3#1)(2010-11#2)
of moderate##8##2##(1990-3#1)(1991-5#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-11#2)
of moderately##4##2##(2008-10#3)(2011-2#1)
of modern##19##2##(1990-6#2)(1994-5#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-3#1)(2012-9#1)(2013-1#1)
of modes##5##2##(2007-11#1)(2008-3#2)(2011-2#2)
of modest##2##2##(2008-9#1)(2012-3#1)
of modification##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
of modified electrodes##3##3##(2008-10#3)
of modified proteins##2##3##(2008-10#1)(2009-5#1)
of modified##25##2##(1990-11#1)(1991-5#1)(1993-8#1)(1995-3#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-8#1)(2009-5#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
of modifier and##2##3##(2008-10#2)
of modifier##6##2##(2008-10#6)
of modifiers##3##2##(2008-10#2)(2012-3#1)
of modifying##2##2##(2008-4#2)
of modulation##4##2##(1994-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
of module##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
of moist##2##2##(2008-10#2)
of moisture in##4##3##(2008-10#3)(2008-5#1)
of moisture occurrence##2##3##(2008-10#2)
of moisture on##2##3##(2008-10#2)
of moisture periods##2##3##(2008-10#2)
of moisture##15##2##(1996-2#1)(2008-10#13)(2008-5#1)
of molar##2##2##(2008-10#2)
of molds##2##2##(2008-3#1)(2008-7#1)
of molecular MRI##2##3##(2010-9#2)
of molecular biology in veterinary parasitology##2##6##(1997-7#2)
of molecular biology in##3##4##(1997-7#2)(2011-2#1)
of molecular biology to##2##4##(1995-9#1)(1997-7#1)
of molecular biology##12##3##(1995-9#1)(1997-7#5)(2008-11#1)(2008-9#1)(2011-2#3)(2012-12#1)
of molecular data##2##3##(2008-10#2)
of molecular evolution##5##3##(1997-6#3)(2008-11#1)(2010-4#1)
of molecular genetic##2##3##(2008-9#1)(2011-2#1)
of molecular interactions##2##3##(2008-9#1)(2010-10#1)
of molecular markers for##3##4##(1997-8#1)(2008-10#2)
of molecular markers##10##3##(1997-7#1)(1997-8#1)(2008-10#6)(2010-10#1)(2011-2#1)
of molecular mechanisms##2##3##(2009-6#1)(2012-2#1)
of molecular oxygen##2##3##(2008-10#1)(2008-3#1)
of molecular recognition##2##3##(2008-10#1)(2009-3#1)
of molecular self-assembly##2##3##(2013-8#2)
of molecular species##2##3##(2008-11#1)(2008-3#1)
of molecular techniques##2##3##(2011-2#1)(2012-2#1)
of molecular variance (AMOVA) revealed##2##5##(2008-10#2)
of molecular variance revealed that##2##5##(2008-10#2)
of molecular variance##13##3##(2008-10#13)
of molecular variation##2##3##(2008-10#2)
of molecular weight##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)
of molecular weights##2##3##(2008-10#1)(2009-10#1)
of molecular##120##2##(1990-5#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-6#1)(1995-9#1)(1997-6#3)(1997-7#6)(1997-8#2)(2008-10#45)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2010-10#4)(2010-4#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
of molecularly imprinted##2##3##(2008-10#2)
of molecules in the##2##4##(2008-3#1)(2008-5#1)
of molecules in##3##3##(1997-6#1)(2008-3#1)(2008-5#1)
of molecules of##3##3##(1993-8#1)(1995-8#1)(2008-11#1)
of molecules or##2##3##(2008-7#1)(2010-7#1)
of molecules that##2##3##(2008-7#1)(2010-11#1)
of molecules##17##2##(1991-5#1)(1993-8#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#1)
of molybdate##5##2##(1990-11#2)(2008-10#3)
of molybdenum and tungsten##2##4##(2008-10#2)
of molybdenum and##5##3##(2008-10#5)
of molybdenum by##2##3##(2008-10#2)
of molybdenum determination was##2##4##(2008-10#2)
of molybdenum in seawater##2##4##(2008-10#2)
of molybdenum in##12##3##(2008-10#12)
of molybdenum was##2##3##(2008-10#2)
of molybdenum with##3##3##(2008-10#3)
of molybdenum##37##2##(2008-10#37)
of molybdenum(VI)##6##2##(2008-10#6)
of molybdenyl##2##2##(2008-10#2)
of molybdophosphate##2##2##(2008-10#2)
of monitoring and##2##3##(1997-2#1)(2008-10#1)
of monitoring of qualitative content of##2##6##(2013-1#2)
of monitoring of##3##3##(2008-10#1)(2013-1#2)
of monitoring the##3##3##(2008-10#2)(2008-11#1)
of monitoring##20##2##(1997-2#1)(2008-10#12)(2008-11#1)(2009-6#1)(2012-3#3)(2013-1#2)
of monkey##2##2##(1997-2#2)
of mono- and sesquiterpenes in##2##5##(2008-10#2)
of mono- and##6##3##(2008-10#6)
of mono-##8##2##(2008-10#7)(2008-11#1)
of monobromobenzoic acids##2##3##(2008-10#2)
of monoclonal antibodies (mAb)##2##4##(2008-4#1)(2011-2#1)
of monoclonal antibodies against##5##4##(1995-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
of monoclonal antibodies##27##3##(1990-12#1)(1990-6#1)(1991-2#1)(1993-1#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#8)(2008-4#2)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#1)
of monoclonal antibody against##3##4##(2008-11#3)
of monoclonal antibody production##2##4##(2008-11#2)
of monoclonal antibody##15##3##(1992-6#1)(2008-10#2)(2008-11#11)(2008-8#1)
of monoclonal##46##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#19)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-8#1)(2011-2#1)
of monocytes and##2##3##(1997-8#1)(2008-10#1)
of monocytes##6##2##(1994-3#1)(1995-6#1)(1997-8#1)(2006-6#1)(2008-10#1)(2013-1#1)
of monocytic##2##2##(1997-7#1)(2013-1#1)
of monolithic##4##2##(2008-10#2)(2008-3#1)(2009-7#1)
of monomer##3##2##(2008-10#2)(2008-12#1)
of monomeric##5##2##(2008-10#1)(2008-5#1)(2008-7#2)(2010-4#1)
of monomers##2##2##(2008-10#1)(2008-2#1)
of mononuclear cells from##2##4##(1992-3#1)(2008-9#1)
of mononuclear cells##6##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)
of mononuclear##7##2##(1992-3#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-10#1)
of mononucleosis syndrome##2##3##(2011-2#2)
of monoterpene hydrocarbons##3##3##(2008-11#3)
of monoterpenes##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
of monovalent##3##2##(2008-10#3)
of monozygotic##4##2##(2008-7#3)(2010-8#1)
of montelukast in##2##3##(2008-1#2)
of monthly##2##2##(2012-12#1)(2013-1#1)
of months##2##2##(1991-8#1)(1997-2#1)
of mood and##3##3##(2008-5#1)(2010-10#1)(2013-8#1)
of mood disorders##5##3##(2008-4#1)(2008-7#3)(2013-8#1)
of mood##15##2##(1991-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-10#1)(2012-2#1)(2013-8#5)
of moral##8##2##(1991-2#2)(2008-11#3)(2012-2#1)(2013-8#2)
of morality##4##2##(1991-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
of morbid##2##2##(1993-3#1)(1994-12#1)
of morbidity after##2##3##(2012-3#1)(2013-1#1)
of morbidity and mortality in the##2##6##(2008-12#1)(2011-2#1)
of morbidity and mortality in##7##5##(1993-3#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-8#2)(2011-2#1)
of morbidity and mortality##14##4##(1993-3#1)(1993-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-2#2)
of morbidity in##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
of morbidity##24##2##(1991-2#1)(1993-3#1)(1993-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#2)(2009-8#2)(2009-9#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
of more and more##2##4##(2008-10#1)(2009-10#1)
of more complex##3##3##(1993-11#1)(2008-6#1)(2011-2#1)
of more effective##3##3##(1993-12#1)(2009-12#1)(2013-1#1)
of more frequent##2##3##(2008-9#1)(2011-2#1)
of more general##2##3##(1993-11#1)(2008-10#1)
of more potent##2##3##(1994-5#1)(2012-2#1)
of more severe##2##3##(2011-2#1)(2012-2#1)
of more species##2##3##(2008-10#2)
of more than 1##3##4##(1993-6#1)(1997-4#1)(2008-10#1)
of more than 100##4##4##(1996-3#1)(2008-10#1)(2010-7#1)(2011-2#1)
of more than 150##2##4##(2008-11#1)(2011-2#1)
of more than 20##2##4##(2008-7#1)(2009-9#1)
of more than 30##3##4##(1996-11#1)(2008-10#2)
of more than 40##2##4##(2007-12#1)(2008-10#1)
of more than 40% in##2##5##(2008-11#1)(2008-8#1)
of more than 5##2##4##(2008-7#1)(2008-8#1)
of more than 50##2##4##(1993-2#1)(2008-10#1)
of more than 50% of##2##5##(1990-12#1)(2008-5#1)
of more than 90%##2##4##(1997-1#1)(2008-10#1)
of more than one##6##4##(2008-10#5)(2008-7#1)
of more than##58##3##(1990-12#3)(1993-2#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#2)(2007-12#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
of more##112##2##(1990-12#3)(1991-3#1)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#29)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#7)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
of morin-Al(3+) complex##2##3##(2008-10#2)
of morphine and beta-endorphin##3##4##(1992-3#3)
of morphine and##5##3##(1992-3#3)(1995-6#1)(2008-10#1)
of morphine in the##2##4##(1995-12#1)(1997-2#1)
of morphine in tolerant rats##2##5##(1996-2#2)
of morphine in##9##3##(1991-1#2)(1995-12#1)(1996-2#2)(1997-2#2)(2008-10#2)
of morphine is presented##2##4##(1995-11#1)(2008-10#1)
of morphine on##4##3##(1994-2#1)(1996-2#1)(2008-10#1)(2008-12#1)
of morphine sulfate##2##3##(1996-2#2)
of morphine were##3##3##(1995-11#2)(2008-12#1)
of morphine##43##2##(1991-1#3)(1992-3#3)(1994-2#1)(1995-11#3)(1995-12#1)(1995-6#1)(1996-2#12)(1997-2#3)(2008-10#9)(2008-11#1)(2008-12#6)
of morphogenesis##2##2##(1993-12#1)(1996-3#1)
of morphogenetic##2##2##(1994-9#1)(2009-8#1)
of morphologic##5##2##(1990-8#1)(1992-12#1)(2008-10#1)(2010-9#1)(2011-2#1)
of morphological and##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
of morphological##10##2##(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
of morphologically normal##2##3##(2011-2#2)
of morphologically##7##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#3)
of morphology##2##2##(2008-10#1)(2009-12#1)
of morphotype##6##2##(2008-10#6)
of mortality and##2##3##(2008-7#1)(2009-10#1)
of mortality by##2##3##(2008-1#1)(2012-12#1)
of mortality during##2##3##(2008-10#1)(2013-1#1)
of mortality in##8##3##(2010-7#1)(2011-2#5)(2013-1#2)
of mortality rate##3##3##(1995-3#1)(1995-8#1)(2008-8#1)
of mortality when##2##3##(2008-7#1)(2008-8#1)
of mortality##42##2##(1991-3#1)(1992-1#1)(1992-3#1)(1995-3#2)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
of mosaic symptoms##2##3##(2008-10#2)
of most interfering substances##2##4##(2008-10#2)
of most of the##12##4##(1993-8#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-1#1)(2008-10#5)(2008-4#1)(2009-7#1)
of most of##14##3##(1993-8#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-1#1)(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
of most##66##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
of mother and##2##3##(1990-12#1)(1994-6#1)
of mother##6##2##(1990-12#1)(1990-9#1)(1994-6#1)(2008-10#2)(2008-11#1)
of mothers of children with##4##5##(1996-1#2)(2008-9#1)(2010-1#1)
of mothers##16##2##(1990-9#1)(1993-3#1)(1996-1#2)(2008-4#1)(2008-9#2)(2009-11#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
of mothers' confidence to care for children assisted with tracheostomy##2##10##(2012-2#2)
of mothers'##3##2##(2009-7#1)(2012-2#2)
of motifs##2##2##(2010-7#2)
of motile##2##2##(2008-10#1)(2012-2#1)
of motility##2##2##(2008-7#1)(2009-6#1)
of motion and proprioception##2##4##(2010-12#2)
of motion and##4##3##(2008-8#1)(2009-1#1)(2010-12#2)
of motion in##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
of motion##41##2##(2008-10#1)(2008-11#2)(2008-12#10)(2008-7#1)(2008-8#1)(2008-9#4)(2009-1#2)(2009-7#1)(2010-12#3)(2010-7#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#6)
of motivation##2##2##(1993-6#2)
of motivational beliefs##2##3##(2010-1#2)
of motivational readiness for physical activity##3##6##(2008-4#3)
of motivational##8##2##(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2010-1#2)
of motor complications##4##3##(2008-7#1)(2010-12#3)
of motor function##2##3##(2013-1#1)(2013-8#1)
of motor neurone##2##3##(1996-5#2)
of motor neurons##2##3##(1990-5#2)
of motor units##2##3##(2013-1#1)(2013-8#1)
of motor##22##2##(1990-5#2)(1996-5#2)(2008-10#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-1#1)(2010-12#3)(2011-2#1)(2011-8#1)(2013-1#3)(2013-8#3)
of moulds##2##2##(2008-5#2)
of mountain##2##2##(2013-1#1)(2013-8#1)
of mouse ES##2##3##(2008-9#1)(2012-2#1)
of mouse IgG protein##2##4##(2008-10#2)
of mouse IgG##3##3##(2008-10#3)
of mouse TGF-beta receptor genes##2##5##(1997-2#2)
of mouse and human##2##4##(1997-7#1)(2008-4#1)
of mouse bone marrow##2##4##(2008-11#1)(2008-9#1)
of mouse calpastatin##2##3##(2008-11#2)
of mouse embryonic fibroblasts##2##4##(2008-2#2)
of mouse liver##3##3##(2008-10#2)(2008-9#1)
of mouse melanoma##2##3##(2008-11#2)
of mouse neurons##2##3##(1994-2#1)(2012-2#1)
of mouse thymic##2##3##(2008-8#2)
of mouse tissues##2##3##(1991-6#1)(2008-11#1)
of mouse##58##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#3)(1997-7#2)(2008-10#6)(2008-11#13)(2008-2#3)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#5)(2009-6#1)(2012-2#3)
of mouse-human hybridomas##2##3##(2008-11#2)
of mouth##3##2##(1997-2#1)(2008-5#1)(2013-1#1)
of mouth-opening##2##2##(2008-5#2)
of movement of##3##3##(1991-5#2)(2008-10#1)
of movement##16##2##(1990-5#2)(1991-5#2)(1993-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#2)(2010-6#2)
of moving objects##2##3##(2008-3#1)(2011-2#1)
of moving##12##2##(1993-5#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
of mrr##3##2##(2008-11#3)
of mtDNA##7##2##(1994-11#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)
of mtRNA(Leu(M)) was##2##3##(2008-8#2)
of mu and delta opioid receptors in##2##7##(2009-7#2)
of mu and delta##3##4##(2009-7#3)
of mu and##4##3##(2008-10#1)(2009-7#3)
of mu##6##2##(1996-2#1)(2008-10#1)(2009-7#4)
of mu-opioid receptors##3##3##(1996-2#1)(1997-2#2)
of mu-opioid##4##2##(1996-2#2)(1997-2#2)
of much debate##2##3##(2008-11#1)(2013-7#1)
of much less##2##3##(2009-6#2)
of much##13##2##(1990-5#1)(1995-5#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-6#2)(2013-1#2)(2013-7#1)
of mucinous ovarian cystomas of intestinal##2##6##(1990-2#2)
of mucormycosis##5##2##(2010-10#1)(2011-2#4)
of mucosa-associated lymphoid tissue##4##4##(2009-5#1)(2009-8#3)
of mucosal##6##2##(1991-8#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
of mug l(-1)##3##3##(2008-10#3)
of mug##4##2##(2008-10#4)
of mulberry anthracnose##2##3##(2008-10#2)
of mulberry##3##2##(2008-10#3)
of mulch##2##2##(2008-10#2)
of multi-component##2##2##(2008-10#2)
of multicellular##3##2##(2008-10#1)(2009-6#1)(2011-2#1)
of multicistronic expression##2##3##(2008-11#2)
of multicommutation##3##2##(2008-10#3)
of multicomponent##6##2##(2008-10#4)(2008-11#1)(2009-10#1)
of multicopper oxidases##2##3##(2008-10#1)(2012-2#1)
of multidimensional##4##2##(1995-5#1)(2008-10#2)(2012-3#1)
of multidisciplinary##5##2##(1996-1#2)(2008-12#1)(2012-3#1)(2013-1#1)
of multidrug resistance##3##3##(1990-2#1)(2008-11#2)
of multidrug resistant##6##3##(1996-3#1)(2008-11#2)(2009-5#1)(2012-2#1)(2013-8#1)
of multidrug##10##2##(1990-2#1)(1991-8#1)(1996-3#1)(2008-11#4)(2009-5#1)(2012-2#1)(2013-8#1)
of multidrug-resistant##3##2##(1996-3#1)(2010-6#1)(2011-2#1)
of multielemental analysis in##2##4##(2008-10#2)
of multielemental analysis##3##3##(2008-10#3)
of multifocal##2##2##(1997-1#1)(2009-9#1)
of multifunctional##2##2##(2008-5#2)
of multigene metabolic engineering##2##4##(2008-11#2)
of multilayer##3##2##(2008-10#3)
of multilayered##2##2##(2008-12#2)
of multilevel##3##2##(2011-2#1)(2012-12#2)
of multilocus correlation##7##3##(2008-10#7)
of multilocus structure of populations##2##5##(2008-10#2)
of multilocus##16##2##(2008-10#14)(2008-9#1)(2012-3#1)
of multimedia##2##2##(2010-7#1)(2013-8#1)
of multimode##2##2##(2008-2#1)(2008-3#1)
of multiorgan##2##2##(1997-3#1)(2008-12#1)
of multiple burials of sclerotia##2##5##(2008-10#2)
of multiple cell##2##3##(2008-8#1)(2012-2#1)
of multiple defense##2##3##(2008-10#2)
of multiple gene##2##3##(1997-7#1)(2012-3#1)
of multiple genes##2##3##(2008-11#1)(2008-9#1)
of multiple genetic and##2##4##(2008-7#1)(2009-6#1)
of multiple genetic##3##3##(2008-7#1)(2009-6#1)(2012-3#1)
of multiple hydatid cysts##2##4##(2008-7#2)
of multiple lesions##2##3##(2011-2#1)(2013-1#1)
of multiple myeloma##3##3##(1991-12#1)(2010-12#1)(2012-12#1)
of multiple populations##2##3##(2008-9#1)(2012-2#1)
of multiple sclerosis##6##3##(1994-9#1)(1995-12#1)(2008-8#1)(2010-2#1)(2012-3#2)
of multiple##128##2##(1990-2#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-6#1)(1993-1#2)(1993-12#1)(1994-12#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-6#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-7#1)(2007-12#3)(2007-8#1)(2008-10#24)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#8)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-2#5)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#4)(2013-8#2)
of multiplex PCR products##3##4##(2008-10#2)(2008-9#1)
of multiplex PCR##4##3##(2008-10#3)(2008-9#1)
of multiplexed##2##2##(2008-11#1)(2008-9#1)
of multiplication and##2##3##(2008-10#2)
of multiprofessional##2##2##(1997-8#1)(2012-3#1)
of multiresistant##2##2##(2012-3#2)
of multistep##2##2##(2008-10#1)(2010-10#1)
of multivariate analysis##2##3##(2008-10#2)
of multivariate data##3##3##(2008-10#2)(2008-6#1)
of multivariate##16##2##(2008-10#13)(2008-3#1)(2008-6#1)(2008-8#1)
of multiwall carbon nanotubes##3##4##(2008-10#3)
of multiwalled carbon nanotubes##2##4##(2008-10#1)(2009-3#1)
of mung bean seedlings##2##4##(2008-9#2)
of mung bean##3##3##(2008-10#1)(2008-9#2)
of mural##2##2##(1992-9#1)(2008-7#1)
of murexide##3##2##(2008-10#3)
of murine Smad5##2##3##(2008-8#2)
of murine and human##4##4##(1992-2#1)(1995-2#1)(2008-4#1)(2010-6#1)
of murine erythroid##2##3##(2008-8#2)
of murine hybridoma##2##3##(2008-11#2)
of murine##31##2##(1992-2#1)(1992-3#2)(1993-3#3)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#6)(2008-9#2)(2010-12#1)(2010-6#1)(2013-1#1)
of muscarinic##2##2##(1995-11#1)(1996-12#1)
of muscle cells##2##3##(1994-3#1)(2008-10#1)
of muscle fibers##2##3##(1995-12#1)(2011-2#1)
of muscle tone##4##3##(1995-2#4)
of muscle weakness##2##3##(1997-8#1)(2012-3#1)
of muscle##35##2##(1990-8#1)(1991-5#1)(1992-4#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#4)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2009-3#2)(2010-4#1)(2010-8#2)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of muscles##5##2##(1990-5#2)(1994-5#1)(2008-9#1)(2010-9#1)
of muscular##5##2##(1997-3#1)(2012-2#2)(2013-1#2)
of musculoskeletal##5##2##(2008-12#3)(2012-2#1)(2013-1#1)
of mushroom##4##2##(2008-10#2)(2008-5#1)(2010-11#1)
of music after cochlear implantation##2##5##(2008-9#2)
of music on##3##3##(1991-12#2)(2008-9#1)
of music therapists##2##3##(1991-12#2)
of music therapy and other##2##5##(1993-2#2)
of music##13##2##(1991-12#4)(1993-2#2)(2008-9#6)(2013-8#1)
of musical experience##2##3##(2008-11#2)
of musical instruments##2##3##(2008-9#2)
of musical##5##2##(2008-11#3)(2008-9#2)
of muskmelon##2##2##(2008-10#2)
of mussel##2##2##(2008-10#2)
of mussels##3##2##(2008-10#2)(2008-9#1)
of mutagenesis##2##2##(2011-1#1)(2013-8#1)
of mutagenic process##3##3##(2008-10#3)
of mutagenic##4##2##(2008-10#4)
of mutant p53 in##2##4##(1991-2#1)(2009-4#1)
of mutant p53##5##3##(1990-12#1)(1991-2#1)(1991-5#1)(2009-4#2)
of mutant##21##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-4#2)(2011-2#1)
of mutants of##2##3##(1995-9#1)(2008-8#1)
of mutants##10##2##(1995-9#1)(1996-3#1)(2008-10#3)(2008-8#3)(2008-9#1)(2012-3#1)
of mutated##6##2##(1992-6#1)(1997-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
of mutating##2##2##(1997-7#1)(2010-5#1)
of mutation##10##2##(1990-8#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
of mutations in##5##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)
of mutations##13##2##(1995-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-9#2)(2010-4#2)
of mutual aid##2##3##(1996-3#2)
of mutual respect and##2##4##(1991-3#1)(2008-12#1)
of mutual##8##2##(1991-3#1)(1992-2#1)(1996-3#2)(1996-6#1)(2008-11#1)(2008-12#1)(2013-1#1)
of mutualism##2##2##(2008-8#2)
of mutually##2##2##(2007-12#1)(2008-9#1)
of my##2##2##(2008-12#1)(2008-7#1)
of mycelia##3##2##(2008-10#3)
of mycelial growth##2##3##(2008-10#2)
of mycelial##4##2##(2008-10#4)
of mycelium in##2##3##(2008-10#2)
of mycelium##8##2##(1994-8#1)(2008-10#7)
of mycobacterial infections##2##3##(2011-2#1)(2013-1#1)
of mycobacterial##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
of mycolic acids##2##3##(2008-9#2)
of mycoparasitism##2##2##(2008-10#2)
of mycoplasma contamination in cell cultures##2##6##(2008-11#2)
of mycoplasma contamination##3##3##(2008-11#3)
of mycoplasmas##3##2##(2008-11#3)
of mycosis fungoides##2##3##(2010-6#2)
of mycosis##3##2##(2008-5#1)(2010-6#2)
of mycotoxin##2##2##(2008-10#2)
of mycotoxins##4##2##(2008-10#1)(2010-7#3)
of myelin in the##2##4##(2009-6#2)
of myelin##5##2##(2008-7#1)(2009-6#3)(2010-12#1)
of myelinating cells##2##3##(2008-7#2)
of myelinating##3##2##(2008-7#3)
of myelination##3##2##(2008-5#2)(2008-7#1)
of myelodysplastic syndromes##2##3##(2010-1#1)(2010-11#1)
of myeloid progenitor cells##2##4##(1994-5#1)(1997-7#1)
of myeloma cells##2##3##(2011-2#1)(2013-1#1)
of myoblasts##4##2##(1997-1#1)(2008-11#2)(2008-4#1)
of myocardial infarction (MI)##2##4##(2008-10#1)(2009-5#1)
of myocardial infarction##11##3##(1991-3#2)(1991-6#2)(1995-2#1)(1996-8#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2013-8#1)
of myocardial ischemia##2##3##(2008-10#2)
of myocardial perfusion##2##3##(2009-10#1)(2013-8#1)
of myocardial stunning##3##3##(1991-3#3)
of myocardial viability##3##3##(1992-5#1)(2009-10#1)(2012-2#1)
of myocardial##33##2##(1990-11#1)(1991-3#7)(1991-6#2)(1992-5#2)(1993-12#1)(1995-2#1)(1996-8#1)(1997-3#1)(2008-10#3)(2008-7#1)(2009-10#3)(2009-5#2)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
of myocarditis##2##2##(2010-7#1)(2012-3#1)
of myofascial trigger##2##3##(2008-12#1)(2013-1#1)
of myofascial##4##2##(2008-12#2)(2009-1#1)(2013-1#1)
of myogenic factors##2##3##(1995-6#2)
of myogenic##7##2##(1995-6#2)(1995-8#4)(2008-11#1)
of myointima##2##2##(2006-6#2)
of myometrial##4##2##(1993-1#1)(1994-3#2)(2011-2#1)
of myosin##8##2##(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#2)(1993-9#1)(1994-5#1)(2008-11#1)
of myositis##2##2##(2012-2#1)(2013-1#1)
of myristic##4##2##(2008-10#4)
of n##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)
of n-3 PUFAs on CVD##2##5##(2013-1#2)
of n-3 PUFAs on##3##4##(2013-1#3)
of n-3 PUFAs##7##3##(2013-1#7)
of n-3##10##2##(2013-1#9)(2013-8#1)
of n-butylamine##2##2##(2008-10#2)
of nNOS##2##2##(1996-12#2)
of nafion##3##2##(2008-10#3)
of naive##4##2##(1994-11#1)(1994-2#1)(1995-12#1)(2008-11#1)
of nalbuphine and fentanyl as intravenous##2##6##(1993-1#2)
of nalidixic acid##5##3##(2008-10#4)(2012-2#1)
of nanocrystalline Ce(1-x)Ln(x)O(2-x/2-delta) (Ln = Yb##2##6##(2010-4#2)
of nanogram quantities of iron(II) tris-(1##2##6##(2008-10#2)
of nanogram quantities##3##3##(2008-10#3)
of nanogram##7##2##(2008-10#7)
of nanomaterials##6##2##(2010-12#1)(2010-7#5)
of nanometers##2##2##(2008-10#2)
of nanoparticle##2##2##(2008-10#1)(2008-11#1)
of nanoparticles##4##2##(2008-10#2)(2008-7#2)
of nanoscale##2##2##(2010-7#2)
of nanosensors##3##2##(2008-10#3)
of nanosized##2##2##(2008-10#2)
of nanostructures##2##2##(2010-7#1)(2011-2#1)
of nanotechnology patent applications##2##4##(2010-12#2)
of nanotechnology##8##2##(2008-10#2)(2008-7#1)(2010-12#5)
of nanowires##4##2##(2008-7#1)(2009-11#2)(2012-2#1)
of naphthalene##4##2##(2008-10#2)(2008-11#2)
of naphthol##2##2##(2008-10#2)
of naproxen##13##2##(2008-10#11)(2008-11#2)
of narratives##2##2##(2008-12#1)(2011-2#1)
of narrow##2##2##(2006-6#1)(2007-12#1)
of nasal##4##2##(1993-2#1)(2008-10#1)(2011-2#2)
of nasally inhaled##2##3##(2013-1#2)
of nascent##5##2##(1994-11#1)(1994-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
of nasopharyngeal carcinoma##2##3##(1991-8#1)(1993-9#1)
of national health##2##3##(1991-2#1)(2008-11#1)
of national##14##2##(1990-6#1)(1991-2#1)(1993-3#1)(1997-3#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-1#1)
of native and denatured##3##4##(1990-5#1)(2008-10#2)
of native and##5##3##(1990-5#2)(2008-10#2)(2008-4#1)
of native arteries##2##3##(2011-2#2)
of native enzyme##5##3##(1993-8#1)(1995-6#4)
of native glucagon##2##3##(2008-8#1)(2011-2#1)
of native populations##2##3##(2008-10#2)
of native##36##2##(1990-5#2)(1992-8#2)(1993-8#2)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#4)(2008-10#10)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-7#1)(2010-11#1)(2011-2#3)
of natriuretic peptide##2##3##(2009-5#2)
of natriuretic peptides##4##3##(2009-5#4)
of natriuretic##6##2##(2009-5#6)
of natural and synthetic##2##4##(2008-10#1)(2008-11#1)
of natural and##7##3##(1992-11#1)(1992-8#1)(2008-10#2)(2008-11#2)(2012-3#1)
of natural enemies##4##3##(2008-8#3)(2008-9#1)
of natural fluids##2##3##(2008-10#2)
of natural human##2##3##(2007-11#1)(2008-11#1)
of natural humic##2##3##(2008-10#2)
of natural infections##2##3##(2008-10#1)(2008-5#1)
of natural killer (NK)##2##4##(2008-9#1)(2013-1#1)
of natural killer cells##2##4##(1995-2#1)(1996-12#1)
of natural killer##5##3##(1995-2#1)(1996-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
of natural organic matter (NOM)##3##5##(1992-5#1)(2008-10#1)(2008-11#1)
of natural organic matter##5##4##(1992-5#1)(2008-10#3)(2008-11#1)
of natural polymers##3##3##(2008-10#2)(2008-5#1)
of natural populations and##2##4##(2008-10#2)
of natural populations of##4##4##(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
of natural populations##7##3##(2008-10#3)(2008-9#2)(2012-12#1)(2012-3#1)
of natural product##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
of natural products and##2##4##(2009-10#1)(2009-2#1)
of natural products##3##3##(2008-10#1)(2009-10#1)(2009-2#1)
of natural resistance##2##3##(2008-10#2)
of natural samples##2##3##(2008-10#1)(2011-2#1)
of natural selection in##2##4##(2010-4#1)(2012-3#1)
of natural selection##7##3##(2008-8#1)(2010-4#2)(2010-5#1)(2012-3#3)
of natural shampoos##2##3##(2008-5#2)
of natural water##6##3##(2008-10#6)
of natural waters and##2##4##(2008-10#2)
of natural waters##5##3##(2008-10#5)
of natural##124##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-9#1)(2007-11#1)(2008-1#1)(2008-10#49)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
of naturally infected##4##3##(2008-10#4)
of naturally occurring large presecretory proteins##2##6##(1994-11#2)
of naturally occurring##8##3##(1992-11#1)(1994-11#2)(2008-10#4)(2008-8#1)
of naturally##15##2##(1992-11#1)(1994-11#2)(2008-10#8)(2008-11#1)(2008-8#2)(2009-10#1)
of nature##12##2##(2008-11#1)(2008-12#7)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)
of nausea and vomiting##2##4##(1990-12#1)(2008-7#1)
of ncRNAs##2##2##(2012-3#2)
of near-field##2##2##(2008-2#1)(2008-3#1)
of near-infrared spectroscopy##2##3##(2008-10#2)
of near-infrared##6##2##(2008-10#4)(2008-3#2)
of nearby##2##2##(2008-10#1)(2009-10#1)
of nearly##8##2##(1995-3#1)(1996-1#1)(2008-10#4)(2008-3#1)(2011-3#1)
of nebulization##2##2##(1993-2#1)(1996-3#1)
of nebulized insulin was##2##4##(1996-3#2)
of nebulized insulin##3##3##(1996-3#3)
of nebulized##5##2##(1993-2#1)(1996-1#1)(1996-3#3)
of nebulizers##2##2##(1995-3#1)(1997-1#1)
of necessary##3##2##(1995-12#1)(2008-1#1)(2008-10#1)
of neck##5##2##(2008-7#1)(2009-4#1)(2010-12#1)(2010-9#1)(2013-1#1)
of necrosis and##4##3##(1994-6#1)(2008-10#2)(2011-2#1)
of necrosis##15##2##(1991-2#1)(1991-3#1)(1994-6#1)(2008-10#7)(2008-3#1)(2011-2#3)(2012-3#1)
of necrotic leaf tissue##2##4##(2008-10#2)
of necrotic lesions##3##3##(2008-10#3)
of necrotic##10##2##(2008-10#8)(2011-2#2)
of necrotizing##3##2##(2008-10#1)(2009-1#1)(2011-2#1)
of need##4##2##(1990-9#1)(2008-11#1)(2008-9#1)(2011-2#1)
of needle pain##3##3##(2008-11#3)
of needle##4##2##(2008-10#1)(2008-11#3)
of needles##3##2##(1992-9#1)(2013-1#2)
of needs##2##2##(1997-3#1)(2008-10#1)
of negative affect##2##3##(2009-11#2)
of negative affectivity##2##3##(2010-6#2)
of negative emotions##2##3##(2008-11#1)(2010-11#1)
of negative phototropism##3##3##(2008-9#3)
of negative##21##2##(1992-2#1)(1993-1#1)(1993-2#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#5)(2009-11#3)(2009-12#1)(2010-10#1)(2010-11#1)(2010-6#2)
of negatively charged Al-citrate##2##4##(2008-10#2)
of negatively charged##4##3##(1995-8#1)(2008-10#3)
of negatively##5##2##(1990-5#1)(1995-8#1)(2008-10#3)
of negligence##2##2##(1995-12#1)(2008-10#1)
of neighborhood##2##2##(2008-11#1)(2009-7#1)
of neighbors##2##2##(2008-8#1)(2008-9#1)
of nematode##3##2##(2008-10#3)
of nematode-trapping fungi was##2##4##(2008-10#2)
of nematode-trapping fungi##4##3##(2008-10#4)
of nematodes that had fed on##2##6##(2008-10#2)
of nematodes that##4##3##(2008-10#4)
of nematodes##10##2##(2008-10#9)(2008-12#1)
of neoadjuvant therapy##3##3##(2010-12#2)(2013-8#1)
of neoadjuvant##6##2##(2010-12#2)(2011-3#1)(2012-3#1)(2013-8#2)
of neocortical##8##2##(1992-12#2)(1994-3#1)(2008-11#4)(2010-7#1)
of neocuproine##2##2##(2008-10#2)
of neonatal and##2##3##(2010-12#1)(2011-2#1)
of neonatal follow-up##2##3##(2008-11#2)
of neonatal intensive care units##2##5##(1991-2#1)(2008-11#1)
of neonatal intensive care##5##4##(1991-2#1)(2008-11#4)
of neonatal sepsis##2##3##(2008-5#1)(2009-12#1)
of neonatal##20##2##(1991-2#1)(1993-12#1)(1995-12#1)(1996-12#1)(2008-11#8)(2008-5#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)
of neonate##3##2##(2008-5#1)(2011-3#1)(2012-3#1)
of neonates and##2##3##(1994-6#1)(2008-11#1)
of neonates##6##2##(1991-1#1)(1994-6#1)(1996-6#1)(2008-11#3)
of neoplasia##4##2##(1990-9#2)(2008-12#1)(2010-12#1)
of neoplasms##4##2##(1995-11#1)(2008-9#2)(2011-2#1)
of neoplastic cells##2##3##(2010-3#1)(2011-2#1)
of neoplastic diseases##2##3##(1990-12#1)(2008-11#1)
of neoplastic##5##2##(1990-12#1)(2008-11#1)(2010-12#1)(2010-3#1)(2011-2#1)
of neopterin##4##2##(1990-2#1)(1992-12#1)(2008-10#1)(2009-12#1)
of neostigmine##4##2##(2008-10#4)
of neovascular##3##2##(2011-7#3)
of nephrolithiasis##5##2##(2008-10#1)(2008-12#2)(2011-2#1)(2012-12#1)
of nephropathy##2##2##(2008-9#2)
of nephrosis##2##2##(1996-6#1)(2009-6#1)
of nerve cells##3##3##(1995-8#1)(2008-11#1)(2008-7#1)
of nerve growth factor (NGF)##3##5##(1991-12#1)(1996-12#1)(2008-11#1)
of nerve growth factor##6##4##(1991-12#1)(1996-12#2)(2008-11#3)
of nerve##24##2##(1991-12#1)(1992-3#1)(1995-8#1)(1996-12#3)(2008-11#4)(2008-12#1)(2008-7#2)(2008-9#4)(2009-5#1)(2011-2#2)(2012-2#4)
of nerves##2##2##(2009-5#1)(2011-2#1)
of nested##2##2##(2008-7#1)(2011-2#1)
of net##6##2##(1991-10#1)(1992-3#1)(2008-10#3)(2008-7#1)
of network##4##2##(1990-5#1)(2008-9#1)(2010-1#1)(2011-2#1)
of networks##4##2##(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
of neural codes##2##3##(2008-11#2)
of neural development##2##3##(1995-2#1)(2010-1#1)
of neural dynamics##2##3##(2008-11#1)(2013-8#1)
of neural network##3##3##(2008-10#3)
of neural networks##3##3##(2008-10#3)
of neural stem cells##6##4##(1994-11#3)(2008-10#1)(2008-11#2)
of neural tissue##2##3##(1991-2#1)(2008-11#1)
of neural##45##2##(1990-5#1)(1990-8#1)(1991-2#2)(1993-12#1)(1994-11#3)(1994-12#1)(1994-8#2)(1995-2#1)(1996-12#1)(2008-10#8)(2008-11#11)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2010-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of neurite outgrowth##3##3##(1990-8#1)(1995-6#2)
of neurite##4##2##(1990-8#1)(1995-6#2)(2008-11#1)
of neuritic plaques##2##3##(1992-12#1)(1996-2#1)
of neuroanatomical connection data##3##4##(1995-5#3)
of neuroanatomical##4##2##(1995-5#3)(2008-4#1)
of neuroblastoma##2##2##(1990-8#1)(1993-3#1)
of neurodegeneration##2##2##(2008-7#1)(2013-8#1)
of neurodegenerative diseases##2##3##(2008-11#2)
of neurodegenerative##6##2##(1994-11#1)(2008-11#3)(2013-1#2)
of neuroendocrine##4##2##(2008-1#1)(2008-11#1)(2012-3#2)
of neurofibrillary tangles##3##3##(1991-1#2)(2008-7#1)
of neurofibromatosis##3##2##(2011-2#2)(2012-3#1)
of neurofilament proteins##2##3##(1995-12#1)(1996-12#1)
of neurofilament##5##2##(1995-12#1)(1996-12#4)
of neurogenesis##5##2##(2008-11#1)(2008-7#2)(2008-9#1)(2012-2#1)
of neuroinflammatory##2##2##(2012-2#1)(2013-1#1)
of neuroleptic##2##2##(1992-12#1)(2012-3#1)
of neurologic deficits##2##3##(2008-7#1)(2011-2#1)
of neurologic##6##2##(1992-12#1)(1997-3#1)(2008-7#2)(2011-2#1)(2012-3#1)
of neurological deficit##2##3##(1996-3#1)(2011-2#1)
of neurological##10##2##(1991-11#1)(1991-9#1)(1996-3#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
of neuromediators##4##2##(2008-10#4)
of neuromuscular blockade##2##3##(1993-1#1)(2010-7#1)
of neuromuscular junction##2##3##(2012-3#2)
of neuromuscular##7##2##(1993-1#1)(2008-12#1)(2010-7#1)(2012-3#4)
of neuron specific enolase##2##4##(1990-2#2)
of neuron##5##2##(1990-2#2)(1994-2#1)(1997-3#1)(2008-10#1)
of neuron-specific enolase##2##3##(2011-2#2)
of neuronal activity##2##3##(1991-6#1)(2008-4#1)
of neuronal cells##2##3##(1995-12#1)(2009-10#1)
of neuronal function##2##3##(1997-3#1)(2008-7#1)
of neuronal migration##2##3##(1995-5#1)(2008-11#1)
of neuronal nicotinic acetylcholine receptors##3##5##(1995-11#3)
of neuronal somata##3##3##(1995-12#3)
of neuronal##36##2##(1990-5#1)(1991-12#1)(1991-6#1)(1994-11#2)(1995-11#4)(1995-12#5)(1995-2#1)(1995-5#1)(1995-8#1)(1997-3#1)(2008-1#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#1)(2013-1#2)
of neurones##4##2##(1995-12#2)(1995-8#1)(2008-11#1)
of neurons and##6##3##(1993-12#1)(1997-2#1)(2008-4#1)(2008-5#1)(2008-7#2)
of neurons in the##10##4##(1990-5#1)(1991-2#1)(1993-3#1)(1994-2#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-2#1)
of neurons in##11##3##(1990-5#1)(1991-2#1)(1993-3#1)(1994-2#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-10#1)(2012-2#1)
of neurons with##2##3##(1996-12#1)(1997-3#1)
of neurons##50##2##(1990-5#2)(1991-12#1)(1991-2#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-8#1)(1996-12#2)(1996-2#2)(1997-2#1)(1997-3#3)(2007-12#1)(2008-10#1)(2008-11#9)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#5)(2012-2#1)(2013-1#1)(2013-8#1)
of neuropathic pain##7##3##(1997-3#1)(2008-12#1)(2008-9#4)(2010-7#1)
of neuropathic##8##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-9#4)(2010-7#1)
of neuropeptide Y##2##3##(1997-4#2)
of neuropeptides##3##2##(1997-4#1)(2008-10#1)(2009-12#1)
of neuropsychiatric disease##2##3##(2008-4#2)
of neuropsychiatric##3##2##(2008-12#1)(2008-4#2)
of neuropsychological functioning and decline over time in dementia##2##9##(2008-7#2)
of neuropsychological##6##2##(1991-1#1)(1991-2#1)(2008-11#1)(2008-7#3)
of neuroreceptor imaging##2##3##(2011-1#2)
of neurosecretory cells which stained with##2##6##(2008-5#2)
of neurosecretory cells##3##3##(2008-5#3)
of neurosecretory##5##2##(1990-5#2)(2008-5#3)
of neurosurgical complications##3##3##(2012-3#3)
of neurosurgical##4##2##(2008-11#1)(2012-3#3)
of neurotensin##3##2##(1995-2#1)(1996-2#2)
of neuroticism##2##2##(2008-11#2)
of neurotransmitter release##3##3##(1995-2#1)(2008-5#1)(2008-7#1)
of neurotransmitter##5##2##(1993-8#1)(1995-2#1)(2008-2#1)(2008-5#1)(2008-7#1)
of neurotrophic##2##2##(2008-11#1)(2013-1#1)
of neurotrophin##2##2##(1996-12#2)
of neurotrophins##4##2##(1996-12#2)(2008-7#2)
of neutral and##2##3##(2008-10#1)(2013-1#1)
of neutral endopeptidase##2##3##(1990-5#2)
of neutral red##3##3##(2008-10#2)(2008-11#1)
of neutral##24##2##(1990-5#2)(1992-11#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-6#1)(2009-8#1)(2013-1#3)
of neutralizing antibody##3##3##(1995-5#3)
of neutralizing##6##2##(1995-5#3)(2008-10#3)
of neutrophil elastase##2##3##(1994-5#2)
of neutrophil granules##2##3##(1990-5#2)
of neutrophil##13##2##(1990-5#2)(1991-12#1)(1991-5#1)(1993-3#1)(1994-5#2)(1994-8#1)(2008-11#5)
of neutrophils and##2##3##(1991-2#1)(2012-2#1)
of neutrophils##6##2##(1990-12#1)(1991-2#1)(1994-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
of nevirapine##3##2##(2008-10#3)
of new and##7##3##(1995-3#1)(1996-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)
of new anti-HIV-1 drugs##2##4##(2011-3#2)
of new cases of##2##4##(2012-2#1)(2013-1#1)
of new cases##4##3##(1997-6#1)(2008-10#1)(2012-2#1)(2013-1#1)
of new chemical##2##3##(2008-10#1)(2010-7#1)
of new compounds##5##3##(1991-1#2)(2008-10#1)(2008-11#1)(2012-3#1)
of new cosmetic##3##3##(2008-5#2)(2011-1#1)
of new diethyl 1##2##4##(2012-3#2)
of new drug##2##3##(2008-10#1)(2013-1#1)
of new drugs##3##3##(1993-1#1)(2011-2#2)
of new fluorescent##2##3##(2008-10#2)
of new food##2##3##(2008-4#1)(2011-2#1)
of new genes##2##3##(2008-10#1)(2009-10#1)
of new materials##2##3##(2010-7#1)(2013-1#1)
of new methods##3##3##(1997-1#1)(1997-8#1)(2008-10#1)
of new molecules##2##3##(2010-11#1)(2011-3#1)
of new niches##2##3##(2008-10#1)(2012-12#1)
of new proteins##2##3##(1997-6#1)(2008-10#1)
of new species##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
of new substances##2##3##(2008-10#1)(2011-3#1)
of new systems##2##3##(2008-11#1)(2011-2#1)
of new targets##2##3##(2008-11#1)(2009-12#1)
of new technologies in##2##4##(1992-2#1)(2008-11#1)
of new technologies##6##3##(1992-2#1)(2008-10#1)(2008-11#2)(2013-1#2)
of new therapeutic##2##3##(1996-11#1)(2008-6#1)
of new treatment##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
of new types of##2##4##(2008-10#1)(2013-8#1)
of new##232##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-11#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#53)(2008-11#21)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#6)(2011-1#3)(2011-10#1)(2011-2#13)(2011-3#5)(2012-12#2)(2012-2#4)(2012-3#8)(2012-4#1)(2013-1#6)(2013-8#4)
of newborn cells##2##3##(2008-11#1)(2012-2#1)
of newborn infants##4##3##(1994-6#2)(1995-2#1)(2012-12#1)
of newborn##14##2##(1990-11#1)(1990-5#1)(1993-2#1)(1994-3#1)(1994-6#3)(1995-2#1)(1995-9#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
of newborns##5##2##(1992-11#1)(1994-6#1)(2008-8#1)(2009-8#1)(2012-3#1)
of newer##5##2##(1991-1#3)(2010-6#1)(2011-2#1)
of newly diagnosed##3##3##(1991-2#1)(2008-11#1)(2013-1#1)
of newly eclosed##2##3##(2008-8#2)
of newly synthesized##6##3##(1996-2#1)(1997-1#1)(2008-10#3)(2008-4#1)
of newly##23##2##(1991-2#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2011-2#2)(2013-1#1)
of ng ml(-1)##3##3##(2008-10#3)
of nia##2##2##(1993-6#2)
of nickel and##8##3##(1994-5#1)(2008-10#7)
of nickel by##2##3##(2008-10#2)
of nickel in natural waters##2##5##(2008-10#2)
of nickel in natural##4##4##(2008-10#4)
of nickel in some natural food samples##2##7##(2008-10#2)
of nickel in table salt and baking soda##2##8##(2008-10#2)
of nickel in the##2##4##(2008-10#2)
of nickel in##22##3##(2008-10#22)
of nickel ion##2##3##(2008-10#2)
of nickel with a##2##4##(2008-10#2)
of nickel within##2##3##(2008-10#2)
of nickel##54##2##(1994-5#1)(2008-10#53)
of nickel(II) in##3##3##(2008-10#3)
of nickel(II)##7##2##(2008-10#7)
of nicotinamide adenine dinucleotide phosphate##2##5##(2011-2#2)
of nicotinamide adenine dinucleotide##3##4##(2008-10#1)(2011-2#2)
of nicotine was##2##3##(1996-2#1)(2008-8#1)
of nicotine##15##2##(1996-2#4)(2008-10#2)(2008-8#1)(2010-8#2)(2011-2#4)(2013-1#1)(2013-8#1)
of nicotinic acetylcholine receptor##2##4##(2008-8#2)
of nicotinic acetylcholine##3##3##(1995-11#1)(2008-8#2)
of nicotinic##4##2##(1995-11#1)(2008-8#3)
of nifedipine##2##2##(1991-11#1)(2012-12#1)
of nigral##2##2##(2008-7#2)
of nigrostriatal DAergic neurons##3##4##(2013-7#3)
of nigrostriatal##4##2##(1996-12#1)(2013-7#3)
of nile blue sulphate##2##4##(2008-10#2)
of nine isolates##2##3##(1997-8#1)(2008-10#1)
of nine species of##2##4##(2008-10#1)(2008-11#1)
of nine species##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
of nine##40##2##(1991-1#1)(1992-2#1)(1996-3#1)(1997-2#2)(1997-8#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)
of nineteen##2##2##(2008-12#1)(2011-2#1)
of niobium##2##2##(2008-10#2)
of niobium(V) oxide as a##2##5##(2008-10#2)
of nitrate and chlorate in swimming pool water##2##8##(2008-10#2)
of nitrate and chlorate in##3##5##(2008-10#3)
of nitrate and nitrite##3##4##(2008-10#3)
of nitrate and##11##3##(2008-10#10)(2008-11#1)
of nitrate in##9##3##(2008-10#9)
of nitrate ions##2##3##(2008-10#2)
of nitrate##39##2##(2008-10#35)(2008-11#4)
of nitric acid and##2##4##(2008-10#2)
of nitric acid at##2##4##(2008-10#2)
of nitric acid solution##2##4##(2008-10#2)
of nitric acid##9##3##(2008-10#9)
of nitric and##2##3##(2008-10#2)
of nitric oxide (NO) in##2##5##(2008-10#2)
of nitric oxide (NO)##8##4##(1992-12#1)(1995-11#1)(1995-2#1)(2008-10#5)
of nitric oxide and##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
of nitric oxide in##3##4##(2008-10#2)(2011-1#1)
of nitric oxide on the##2##5##(1993-3#1)(2010-12#1)
of nitric oxide on##3##4##(1993-3#2)(2010-12#1)
of nitric oxide synthase##2##4##(1996-12#1)(2008-5#1)
of nitric oxide using polymer modified electrodes##2##7##(2008-10#2)
of nitric oxide using##3##4##(2008-10#3)
of nitric oxide with##2##4##(2008-10#1)(2008-3#1)
of nitric oxide##42##3##(1992-12#1)(1992-3#1)(1993-3#3)(1995-11#3)(1995-2#1)(1996-12#2)(1997-4#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)
of nitric##55##2##(1992-12#1)(1992-3#1)(1993-3#3)(1995-11#3)(1995-2#1)(1996-12#2)(1997-4#1)(2008-10#31)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)
of nitrite and nitrate in##8##5##(2008-10#8)
of nitrite and nitrate using##2##5##(2008-10#2)
of nitrite and nitrate##17##4##(2008-10#17)
of nitrite and##22##3##(2008-10#22)
of nitrite based on its##3##5##(2008-10#3)
of nitrite by##4##3##(2008-10#4)
of nitrite in the##4##4##(2008-10#4)
of nitrite in##16##3##(2008-10#16)
of nitrite ion using##3##4##(2008-10#3)
of nitrite ion##11##3##(2008-10#11)
of nitrite on the##2##4##(2008-10#2)
of nitrite using##3##3##(2008-10#3)
of nitrite was##2##3##(2008-10#2)
of nitrite##92##2##(1997-4#1)(2008-10#90)(2008-11#1)
of nitrite-nitrogen was##2##3##(2008-10#2)
of nitrite-nitrogen##3##2##(2008-10#3)
of nitro-organic explosives##2##3##(2008-10#2)
of nitroaniline isomers##4##3##(2008-10#4)
of nitroaniline##6##2##(2008-10#6)
of nitroaromatic##5##2##(2008-10#5)
of nitrobenzene##2##2##(2008-10#1)(2008-11#1)
of nitrocompounds##3##2##(1995-8#3)
of nitrofurantoin and its toxic metabolite##2##6##(2008-10#2)
of nitrofurantoin##3##2##(2008-10#3)
of nitrogen and methane##2##4##(2008-2#2)
of nitrogen and##4##3##(2008-10#2)(2008-2#2)
of nitrogen dioxide using##2##4##(2008-10#2)
of nitrogen dioxide##7##3##(2008-10#6)(2008-11#1)
of nitrogen##29##2##(2008-10#21)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
of nitrous acid##2##3##(2008-10#2)
of nitrous oxide##5##3##(1991-6#2)(2008-11#1)(2008-8#1)(2009-12#1)
of nitrous##7##2##(1991-6#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)
of no##24##2##(1990-11#1)(1995-5#1)(1995-9#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-9#1)(2010-1#2)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
of noble metals##2##3##(2008-10#2)
of noble##4##2##(2008-10#4)
of nociceptive##4##2##(2008-9#1)(2009-11#1)(2009-12#1)(2010-9#1)
of nocturnal##2##2##(2007-12#1)(2008-10#1)
of nodal##8##2##(1990-12#2)(2008-7#2)(2012-3#2)(2013-1#2)
of node##2##2##(2008-10#1)(2008-8#1)
of nodes##6##2##(2008-10#5)(2012-2#1)
of noise and##2##3##(2008-9#1)(2013-8#1)
of noise in##2##3##(2008-3#1)(2010-10#1)
of noise on the##2##4##(2008-3#2)
of noise on##3##3##(2008-3#2)(2011-2#1)
of noise##22##2##(2008-10#2)(2008-3#9)(2008-4#1)(2008-9#6)(2010-10#2)(2011-2#1)(2013-8#1)
of non##8##2##(1990-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
of non-CFC MDIs##2##3##(1996-1#2)
of non-Hodgkin's##3##2##(2008-1#1)(2008-12#1)(2009-8#1)
of non-attendance##2##2##(1992-2#2)
of non-blood contacting pneumatic ventricle assistance##2##6##(2012-3#2)
of non-coding RNA##2##3##(2011-2#2)
of non-coding##3##2##(1997-6#1)(2011-2#2)
of non-covalent##2##2##(2008-10#1)(2008-9#1)
of non-extractable residues##3##3##(2008-11#3)
of non-fucosylated##2##2##(2008-11#2)
of non-insulin-dependent diabetes##2##3##(1994-12#1)(2008-10#1)
of non-invasive##5##2##(1993-3#1)(1996-3#1)(2012-2#1)(2013-1#2)
of non-ionic surfactant##2##3##(2008-10#2)
of non-ionic surfactants (NS)##2##4##(2008-10#2)
of non-ionic surfactants##5##3##(2008-10#5)
of non-ionic##8##2##(2008-10#8)
of non-metallic inclusions##2##3##(2008-10#2)
of non-metallic##3##2##(2008-10#3)
of non-pharmacological##2##2##(2010-12#1)(2012-3#1)
of non-polar##2##2##(2008-10#2)
of non-polarized infrared##2##3##(2008-10#2)
of non-random##3##2##(1995-12#1)(2009-10#1)(2012-5#1)
of non-small cell lung##3##4##(1997-5#1)(2013-1#1)(2013-8#1)
of non-small##4##2##(1997-5#1)(2013-1#2)(2013-8#1)
of non-smoking##2##2##(1991-11#2)
of non-spatial##2##2##(1993-3#1)(1995-5#1)
of non-specific##7##2##(1996-3#1)(2008-10#6)
of nonadherence##2##2##(1994-3#1)(2008-4#1)
of nonagenarians##2##2##(2008-10#1)(2008-7#1)
of nonaqueous##3##2##(2008-10#3)
of noncoding##2##2##(1995-2#1)(2008-9#1)
of nonexercised controls##2##3##(2008-10#2)
of nonhomologous DNA##3##3##(1993-2#1)(2008-10#2)
of nonindigenous##2##2##(2008-10#1)(2008-8#1)
of noninoculated##2##2##(2008-10#2)
of noninvasive imaging##2##3##(2008-12#1)(2010-9#1)
of noninvasive##6##2##(1991-3#1)(2008-12#2)(2009-1#1)(2010-9#1)(2013-8#1)
of nonionic surfactant##2##3##(2008-10#2)
of nonionic##4##2##(2008-10#4)
of nonlinear interactions##2##3##(2008-8#1)(2010-11#1)
of nonlinear optical##3##3##(2007-12#1)(2008-2#2)
of nonlinear##13##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-8#1)(2009-8#2)(2010-11#1)(2012-2#1)(2013-1#1)
of nonpalpable##2##2##(1997-8#2)
of nonparametric##2##2##(1991-12#1)(2008-10#1)
of nonpathogenic Fusarium oxysporum##3##4##(2008-10#3)
of nonpathogenic Fusarium##4##3##(2008-10#4)
of nonpathogenic##7##2##(2008-10#7)
of nonpolyadenylated RNA##3##3##(2008-9#3)
of nonprofit##4##2##(1991-12#1)(1994-12#1)(2008-11#2)
of nonprofits##2##2##(1995-3#2)
of nonresonant##2##2##(2008-3#2)
of nonselective##2##2##(2008-9#1)(2009-10#1)
of nonspecific binding##2##3##(2008-10#1)(2008-7#1)
of nonspecific##5##2##(2008-10#3)(2008-7#1)(2012-12#1)
of nontransformed##3##2##(2008-10#3)
of nontuberculous mycobacterial disease##3##4##(2007-12#3)
of nontuberculous##4##2##(2007-12#3)(2011-2#1)
of nonviable cells##2##3##(2008-4#1)(2008-9#1)
of nonviable##3##2##(2008-4#1)(2008-9#1)(2010-6#1)
of noradrenaline and adrenaline##2##4##(1994-2#1)(2008-10#1)
of noradrenaline and dopamine##3##4##(2008-10#3)
of noradrenaline and##5##3##(1994-2#1)(2008-10#4)
of norcantharidin##2##2##(2011-3#2)
of norepinephrine (NE)##2##3##(1993-3#1)(2008-10#1)
of norepinephrine##7##2##(1990-12#1)(1990-5#2)(1993-3#1)(2008-10#2)(2013-8#1)
of normal and abnormal##2##4##(2010-8#2)
of normal and pathological##3##4##(2009-5#1)(2010-8#1)(2013-1#1)
of normal and##14##3##(1991-11#2)(1992-3#1)(1994-5#1)(1995-6#1)(1996-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)(2010-8#3)(2013-1#1)
of normal anterior cruciate ligament (ACL) and##2##7##(1997-8#2)
of normal atlas and##2##4##(2013-1#2)
of normal breast##2##3##(1990-12#1)(2011-2#1)
of normal cell##3##3##(2008-11#2)(2008-5#1)
of normal donors##2##3##(1990-12#2)
of normal human keratinocytes##2##4##(2008-5#2)
of normal human skin##2##4##(2008-5#2)
of normal human##8##3##(1991-3#1)(1992-10#1)(1995-2#1)(2008-11#1)(2008-5#4)
of normal liver##2##3##(1990-2#2)
of normal mammalian cells##2##4##(1990-5#1)(2008-11#1)
of normal mice##2##3##(1995-12#1)(1997-3#1)
of normal platelets##3##3##(1990-5#1)(2006-6#2)
of normal rat pituitary cells##2##5##(1992-6#2)
of normal rat##3##3##(1992-6#3)
of normal serum##2##3##(1990-2#1)(2012-3#1)
of normal skin##2##3##(2008-5#2)
of normal sleep##2##3##(2008-7#2)
of normal subjects##2##3##(1994-12#1)(2006-6#1)
of normal##119##2##(1990-12#4)(1990-2#5)(1990-5#4)(1991-11#4)(1991-3#1)(1992-10#1)(1992-3#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-2#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#1)(1997-3#2)(1997-5#1)(1997-8#3)(2006-6#3)(2008-1#1)(2008-10#9)(2008-11#10)(2008-12#2)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#6)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
of normalization##2##2##(2008-7#1)(2010-7#1)
of normally distributed##4##3##(1995-12#1)(1995-5#1)(2008-10#2)
of normally##7##2##(1995-12#1)(1995-5#1)(2008-10#3)(2008-8#1)(2008-9#1)
of normotensive##2##2##(1994-2#1)(2012-12#1)
of norovirus in##2##3##(2013-8#2)
of norovirus##3##2##(2013-8#3)
of north##4##2##(2008-11#1)(2008-12#1)(2010-1#1)(2012-12#1)
of northern Italy##3##3##(1993-2#2)(2012-7#1)
of northern##6##2##(1993-2#2)(2007-12#1)(2008-10#1)(2008-8#1)(2012-7#1)
of noscapine##4##2##(2008-11#4)
of nose##3##2##(1990-9#2)(2008-7#1)
of nosocomial##2##2##(2008-5#1)(2010-8#1)
of not##7##2##(1991-2#1)(1991-6#1)(2008-10#2)(2008-11#1)(2009-1#1)(2012-2#1)
of note##2##2##(1990-12#1)(2009-4#1)
of notifiable diseases##2##3##(1997-3#2)
of novalgin##4##2##(2008-10#4)
of novel and##2##3##(2008-5#1)(2013-8#1)
of novel arylpiperazines##2##3##(1992-3#2)
of novel genes##3##3##(2008-10#2)(2008-11#1)
of novel##69##2##(1992-3#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)(2008-10#15)(2008-11#6)(2008-5#2)(2008-8#4)(2008-9#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#3)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#3)(2011-7#1)(2011-9#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
of nuclear DNA content##4##4##(1991-6#1)(1994-3#1)(2008-11#1)(2008-9#1)
of nuclear DNA##8##3##(1991-6#1)(1992-8#1)(1994-3#1)(1994-5#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
of nuclear Overhauser effects and##2##5##(1992-4#1)(1994-5#1)
of nuclear Overhauser##3##3##(1992-4#1)(1993-8#1)(1994-5#1)
of nuclear and cytoplasmic##2##4##(2008-2#1)(2011-2#1)
of nuclear fast red##2##4##(2008-10#2)
of nuclear genes##3##3##(1991-2#1)(2008-8#1)(2011-2#1)
of nuclear matrix##4##3##(1990-5#2)(2008-8#2)
of nuclear medicine##2##3##(2012-2#2)
of nuclear membrane dynamics##2##4##(2011-2#2)
of nuclear proteins##2##3##(1997-2#2)
of nuclear rDNA##2##3##(2008-10#2)
of nuclear receptor ligands##3##4##(2008-9#3)
of nuclear receptor##4##3##(2008-9#3)(2011-2#1)
of nuclear ribosomal##2##3##(2008-12#1)(2010-3#1)
of nuclear structure##2##3##(1993-8#1)(1995-2#1)
of nuclear transcription factors##2##4##(1995-8#1)(2009-6#1)
of nuclear##64##2##(1990-5#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-8#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-8#1)(1997-2#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#7)(2008-9#8)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)
of nuclear-coded subunits of##2##4##(1990-2#2)
of nuclei with##2##3##(2008-7#2)
of nuclei##9##2##(1990-7#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#1)
of nucleic acid sequences##3##4##(1996-6#1)(2008-10#1)(2008-9#1)
of nucleic acid structure##4##4##(2008-4#4)
of nucleic acid##21##3##(1992-8#1)(1996-6#2)(2008-10#6)(2008-4#7)(2008-9#3)(2011-2#1)(2012-2#1)
of nucleic acids by##3##4##(2008-10#3)
of nucleic acids in##3##4##(2008-10#3)
of nucleic acids is##2##4##(2008-4#1)(2008-9#1)
of nucleic acids was##2##4##(2008-10#2)
of nucleic acids##28##3##(1996-6#1)(1997-6#2)(2008-10#19)(2008-4#4)(2008-9#2)
of nucleic##51##2##(1992-8#1)(1996-6#3)(1997-6#2)(2008-10#26)(2008-4#11)(2008-8#1)(2008-9#5)(2011-2#1)(2012-2#1)
of nucleocytoplasmic transport##2##3##(2011-2#2)
of nucleocytoplasmic##3##2##(2008-9#1)(2011-2#2)
of nucleolar skeleton##3##3##(2008-8#3)
of nucleolar##6##2##(2007-12#1)(2008-8#4)(2011-2#1)
of nucleolus##4##2##(2008-12#1)(2008-8#3)
of nucleophagy##2##2##(2011-2#2)
of nucleoplasmic##2##2##(2008-8#2)
of nucleoporins##2##2##(2011-2#2)
of nucleoside 2-deoxyribosyltransferase##2##3##(1995-6#2)
of nucleoside##5##2##(1994-8#1)(1995-6#2)(1997-7#1)(2008-4#1)
of nucleosides and bases##2##4##(2008-10#2)
of nucleosides##4##2##(1992-3#1)(2008-10#2)(2008-4#1)
of nucleosomes##3##2##(2008-8#3)
of nucleotide sequence##2##3##(2008-10#1)(2008-8#1)
of nucleotide sequences##4##3##(2008-10#2)(2008-4#1)(2008-6#1)
of nucleotide substitution in the##2##5##(1991-2#1)(2008-6#1)
of nucleotide substitution##4##3##(1991-2#1)(2008-4#2)(2008-6#1)
of nucleotide##20##2##(1991-2#1)(1991-5#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-6#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)
of nucleotides##8##2##(1991-7#1)(1992-8#1)(1997-2#1)(2008-11#4)(2008-4#1)
of nucleus basalis lesions##2##4##(1990-5#2)
of nucleus##5##2##(1990-5#2)(2008-8#3)
of nude mice##2##3##(2008-8#2)
of nude##3##2##(2008-8#2)(2008-9#1)
of null##2##2##(1996-3#1)(2009-8#1)
of number of trials##2##4##(2008-5#1)(2013-8#1)
of number of##8##3##(2008-10#3)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
of number##9##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
of numerical##5##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-8#2)
of numerous##32##2##(1991-5#1)(1992-12#1)(1992-5#1)(1993-2#2)(1994-11#1)(1995-2#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2012-2#2)(2012-3#2)
of nurse education and##2##4##(2008-12#2)
of nurse education##7##3##(2008-11#4)(2008-12#3)
of nurse lecturers##2##3##(2008-11#2)
of nurse##13##2##(2008-11#9)(2008-12#3)(2010-10#1)
of nurses and##2##3##(2008-11#2)
of nurses in##5##3##(1991-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2012-3#1)
of nurses to##4##3##(2008-11#2)(2012-3#2)
of nurses who##3##3##(2010-11#2)(2012-3#1)
of nurses##37##2##(1990-2#1)(1991-2#2)(2008-11#12)(2008-12#5)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#2)(2010-11#4)(2010-3#2)(2010-4#1)(2012-3#5)
of nurses&quot##2##2##(1990-2#2)
of nurses'##5##2##(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)(2011-1#1)
of nursing activities##3##3##(1991-2#3)
of nursing advocacy##3##3##(2009-12#3)
of nursing and midwifery##2##4##(2008-11#1)(2008-12#1)
of nursing and##8##3##(2008-11#5)(2008-12#2)(2010-10#1)
of nursing care in##2##4##(1990-2#1)(2012-3#1)
of nursing care of##2##4##(2008-11#1)(2012-3#1)
of nursing care##12##3##(1990-2#1)(1991-3#1)(1994-3#1)(2008-11#2)(2008-12#1)(2012-3#4)(2013-1#2)
of nursing diagnosis are##2##4##(1990-2#2)
of nursing diagnosis##4##3##(1990-2#4)
of nursing education##3##3##(2008-11#2)(2008-12#1)
of nursing faculty##3##3##(2008-11#3)
of nursing home care##3##4##(1993-2#1)(1995-2#1)(2009-3#1)
of nursing home residents##2##4##(1991-3#1)(1996-2#1)
of nursing home##18##3##(1991-3#3)(1993-2#1)(1994-12#3)(1994-2#3)(1995-2#2)(1996-2#2)(1997-2#1)(2008-11#2)(2009-3#1)
of nursing homes##3##3##(1991-1#1)(1997-1#1)(2008-12#1)
of nursing in##2##3##(2008-12#1)(2012-3#1)
of nursing knowledge##3##3##(2008-11#1)(2008-12#2)
of nursing must##2##3##(2008-11#2)
of nursing practice##5##3##(2008-11#4)(2008-12#1)
of nursing research##2##3##(2008-12#1)(2010-9#1)
of nursing staff##2##3##(2010-10#2)
of nursing students##5##3##(2008-11#2)(2008-12#3)
of nursing to##3##3##(1990-12#1)(2008-12#2)
of nursing##122##2##(1990-12#3)(1990-2#9)(1991-1#1)(1991-2#4)(1991-3#4)(1993-2#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-9#1)(1995-2#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-11#37)(2008-12#27)(2008-7#1)(2009-12#3)(2009-3#1)(2010-10#3)(2010-8#1)(2010-9#1)(2012-3#5)(2013-1#4)
of nutrient##13##2##(2008-10#3)(2008-11#3)(2008-7#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
of nutrients in##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
of nutrients to##2##3##(2008-11#1)(2008-9#1)
of nutrients##16##2##(2008-10#1)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#3)(2012-2#1)(2013-8#2)
of nutrition and##2##3##(1996-8#2)
of nutrition in children##2##4##(2012-2#2)
of nutrition##8##2##(1996-8#2)(2008-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
of nutritional status##2##3##(2011-1#2)
of nutritional##7##2##(1991-2#1)(1991-6#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)
of o-##2##2##(2008-10#2)
of o-catechol##2##2##(2008-10#2)
of o-phenylenediamine##2##2##(2008-10#2)
of oak##4##2##(2008-10#2)(2012-5#1)(2012-9#1)
of oat##4##2##(1990-5#1)(2008-10#2)(2008-9#1)
of oats##3##2##(1991-6#1)(2008-10#2)
of obese children##2##3##(2010-8#2)
of obese##6##2##(1996-12#2)(2010-8#2)(2011-1#1)(2011-2#1)
of obesity and##10##3##(2008-10#1)(2008-11#1)(2008-3#3)(2009-7#1)(2010-12#1)(2011-1#2)(2012-12#1)
of obesity has##2##3##(2010-5#1)(2010-6#1)
of obesity in##7##3##(1993-11#1)(2008-1#3)(2011-2#2)(2012-2#1)
of obesity is##2##3##(2011-1#1)(2011-2#1)
of obesity on the psychometric##2##5##(2011-2#2)
of obesity on the##3##4##(2011-2#3)
of obesity on##4##3##(2011-2#3)(2012-3#1)
of obesity##48##2##(1993-11#1)(1996-12#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#3)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
of object##2##2##(1993-3#1)(2008-3#1)
of objective criteria##2##3##(2008-10#2)
of objective##5##2##(2008-10#2)(2008-11#2)(2011-1#1)
of objectively##2##2##(1994-2#1)(2008-5#1)
of objectives##2##2##(1991-2#1)(1995-3#1)
of objects in a##2##4##(1993-6#1)(2008-3#1)
of objects in##3##3##(1993-6#1)(2008-3#2)
of objects##13##2##(1990-3#1)(1993-6#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2009-10#1)(2009-8#1)(2010-5#1)
of obligate##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
of obscure##3##2##(2009-8#1)(2012-12#1)(2012-2#1)
of observation in##2##3##(2010-1#1)(2012-12#1)
of observation##9##2##(1990-8#1)(1992-3#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-12#1)(2012-3#1)
of observational##2##2##(2008-11#1)(2008-12#1)
of observations in##2##3##(2008-10#1)(2008-8#1)
of observations that##2##3##(1992-6#1)(1997-1#1)
of observations with##2##3##(2008-3#1)(2009-8#1)
of observations##11##2##(1992-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2012-3#1)
of observed##11##2##(1992-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-11#1)(2013-1#2)(2013-8#1)
of observing##3##2##(2008-10#1)(2010-10#1)(2013-8#1)
of obsessive-compulsive disorder in##2##4##(2008-11#1)(2012-12#1)
of obsessive-compulsive##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
of obstructed##2##2##(1991-3#1)(2010-5#1)
of obstruction##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
of obstructive##5##2##(1991-3#1)(1997-8#1)(2008-10#2)(2013-1#1)
of obtaining a##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
of obtaining##14##2##(1990-12#1)(1994-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-11#1)(2010-6#1)
of obtusifoliol##3##2##(1992-3#3)
of obvious##2##2##(2008-11#1)(2013-1#1)
of occipital condyles##2##3##(2013-1#2)
of occipital##4##2##(2008-7#1)(2013-1#3)
of occlusal##3##2##(2009-7#1)(2010-6#2)
of occlusion##2##2##(1997-3#1)(2012-3#1)
of occlusive vascular disease##2##4##(1992-9#2)
of occlusive vascular##3##3##(1992-9#2)(1995-2#1)
of occult blood in##2##4##(1993-6#1)(2009-1#1)
of occult papillary##2##3##(1990-6#2)
of occult##8##2##(1990-6#4)(1993-3#1)(1993-6#1)(2008-5#1)(2009-1#1)
of occupational asthma##3##3##(2008-10#3)
of occupational exposure##2##3##(2011-2#1)(2012-2#1)
of occupational injury and ill-health##2##5##(2008-11#2)
of occupational##19##2##(1990-3#2)(2008-10#4)(2008-11#5)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#5)
of occurrence of##5##3##(2008-10#1)(2008-11#1)(2009-8#2)(2012-3#1)
of occurrence##13##2##(1994-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2009-10#1)(2009-8#2)(2011-2#2)(2012-3#1)
of occurring##2##2##(2008-10#2)
of ocean color##2##3##(2008-3#2)
of ocean##3##2##(2008-3#3)
of oceanic waters##3##3##(2008-3#3)
of oceanic##4##2##(2008-3#4)
of octadecenedioic acid##2##3##(2008-5#2)
of octopamine##3##2##(1994-2#3)
of octreotide##2##2##(1995-8#1)(1997-4#1)
of octyl methoxycinnamate##2##3##(2008-5#2)
of octyl##3##2##(2008-5#3)
of odds ratio##2##3##(1997-8#1)(2012-3#1)
of oesophageal varices##3##3##(2009-8#2)(2013-1#1)
of oesophageal##7##2##(2008-1#1)(2008-11#3)(2009-8#2)(2013-1#1)
of oestrogen##2##2##(1990-11#1)(2011-2#1)
of of##3##2##(1992-1#1)(1996-6#1)(2011-2#1)
of off standard pods##2##4##(2008-12#2)
of offenders##4##2##(2008-11#1)(2008-6#1)(2011-2#1)(2012-3#1)
of official##2##2##(2008-10#1)(2011-2#1)
of offspring##9##2##(2008-8#4)(2008-9#4)(2011-2#1)
of ofloxacin in##4##3##(2008-10#4)
of ofloxacin##8##2##(1990-2#1)(2008-10#7)
of oil for##2##3##(2008-10#1)(2009-3#1)
of oil##21##2##(2008-10#16)(2008-5#2)(2009-10#2)(2009-3#1)
of oils and solidifying agents##2##5##(2008-5#2)
of oils##6##2##(1997-2#1)(2008-10#3)(2008-5#2)
of oilseed rape##3##3##(2008-10#3)
of oilseed##4##2##(2008-10#4)
of okadaic acid##3##3##(1992-8#2)(1993-8#1)
of old and##2##3##(2008-12#1)(2011-2#1)
of old people##2##3##(1990-11#1)(2008-7#1)
of old people's##2##3##(2010-6#2)
of old##15##2##(1990-11#2)(1995-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#3)(2008-8#1)(2010-6#2)(2011-2#1)
of older adults in##2##4##(2008-5#1)(2012-12#1)
of older adults##7##3##(2008-11#3)(2008-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
of older mothers##2##3##(1997-3#1)(2010-2#1)
of older patients with cancer##2##5##(2010-11#2)
of older patients with##3##4##(2010-10#1)(2010-11#2)
of older people##15##3##(1995-3#1)(2008-1#1)(2008-7#1)(2010-10#12)
of older persons##3##3##(1997-2#1)(2010-10#2)
of older##44##2##(1994-2#1)(1995-3#2)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-5#1)(2008-7#1)(2009-11#2)(2009-3#1)(2010-10#15)(2010-11#3)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#1)
of oleic##2##2##(1994-8#1)(2008-7#1)
of olfactory ensheathing cells##2##4##(2008-7#2)
of olfactory interneurons in##2##4##(1990-5#2)
of olfactory##8##2##(1990-5#2)(2007-12#3)(2008-7#2)(2012-2#1)
of oligodeoxynucleotides##2##2##(2008-10#1)(2008-4#1)
of oligonucleotide##5##2##(2008-10#3)(2008-4#2)
of oligonucleotides##5##2##(1994-11#1)(2008-10#3)(2008-4#1)
of oligopyrrole##2##2##(2008-10#2)
of oligosaccharides obtained by##2##4##(1990-9#2)
of oligosaccharides##6##2##(1990-9#2)(1993-8#1)(2008-10#2)(2012-2#1)
of olmesartan medoxomil##2##3##(2008-11#2)
of omental cakes is##2##4##(2012-2#2)
of omental cakes##3##3##(2012-2#3)
of omethoate##2##2##(2008-10#2)
of ommatidia##4##2##(2007-12#4)
of omnivory##4##2##(2008-8#1)(2008-9#3)
of omphalocele with##2##3##(1997-3#1)(2010-8#1)
of on-line instrumentation##2##3##(2008-10#2)
of on-line sample##3##3##(2008-10#3)
of on-line##13##2##(2008-10#13)
of onco-antigens in serum##2##4##(2013-1#2)
of oncogene##2##2##(1996-12#1)(2008-11#1)
of oncogenes##8##2##(1990-8#1)(2008-11#6)(2009-4#1)
of oncogenic##2##2##(1996-1#1)(2008-5#1)
of oncolytic viruses##2##3##(2013-1#1)(2013-8#1)
of one and##3##3##(1996-6#1)(2008-10#1)(2010-11#1)
of one another##4##3##(2008-10#4)
of one case]##7##3##(2013-1#3)(2013-8#4)
of one class of##2##4##(1993-12#1)(2008-10#1)
of one electron##2##3##(2008-10#2)
of one gene##2##3##(1992-6#1)(2008-10#1)
of one group##2##3##(2008-10#2)
of one lung##2##3##(2008-10#1)(2011-2#1)
of one of the two##2##5##(1997-2#1)(2012-12#1)
of one of the##25##4##(1991-5#1)(1992-12#1)(1993-6#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-8#2)(2009-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
of one of these##5##4##(1992-10#1)(1992-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
of one of##33##3##(1991-5#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-6#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
of one or more of the##2##6##(1996-2#1)(2008-11#1)
of one or more##12##4##(1992-12#1)(1994-6#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)
of one or the other##2##5##(2008-7#1)(2009-12#1)
of one or two##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
of one or##22##3##(1992-12#1)(1994-6#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
of one pair of##2##4##(2008-12#1)(2010-7#1)
of one sample##2##3##(2008-10#1)(2008-3#1)
of one species##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
of one such##2##3##(2008-4#1)(2008-9#1)
of one type of##3##4##(2007-12#1)(2008-10#1)(2013-8#1)
of one type##4##3##(2007-12#1)(2008-10#2)(2013-8#1)
of one year##5##3##(1990-12#1)(1994-6#1)(1996-8#1)(2008-3#1)(2012-3#1)
of one##176##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1994-2#1)(1994-6#3)(1995-10#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#62)(2008-11#9)(2008-12#4)(2008-3#3)(2008-4#6)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#6)(2013-8#6)
of one's own##3##3##(2009-4#2)(2010-10#1)
of one's##8##2##(1994-6#1)(1996-5#1)(2008-7#1)(2009-4#2)(2010-10#1)(2010-2#1)(2010-6#1)
of ongoing research##2##3##(1992-1#1)(2010-5#1)
of ongoing##10##2##(1992-1#1)(1997-1#1)(1997-5#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-6#1)
of onion yellows phytoplasma##3##4##(2008-10#3)
of onion##13##2##(2008-10#13)
of onium salt##4##3##(2008-10#4)
of online resources##2##3##(1994-12#1)(2008-11#1)
of online##10##2##(1991-2#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-4#1)(2011-1#2)
of only 0##2##3##(2008-10#1)(2008-8#1)
of only 1##2##3##(2008-10#2)
of only a single##2##4##(2008-10#1)(2008-3#1)
of only a##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
of only one##3##3##(2008-10#3)
of only##31##2##(1990-2#1)(1990-3#1)(1995-12#1)(2008-10#17)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-1#1)
of onset and##2##3##(2008-10#1)(2008-7#1)
of onset of the##2##4##(1990-5#1)(2008-1#1)
of onset of##5##3##(1990-5#1)(2008-1#1)(2008-5#1)(2010-10#1)(2012-12#1)
of onset##16##2##(1990-5#1)(1993-12#1)(1994-12#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#1)
of ontogenic resistance to##2##4##(2008-10#2)
of ontogenic resistance##4##3##(2008-10#4)
of ontogenic##5##2##(2008-10#4)(2008-11#1)
of oocysts##4##2##(1996-12#3)(2007-12#1)
of oocyte tPA##2##3##(2008-8#2)
of oocyte##3##2##(2008-12#1)(2008-8#2)
of oocytes##9##2##(1995-12#1)(2008-12#3)(2008-7#1)(2008-9#1)(2013-1#3)
of oogonia##2##2##(2008-10#2)
of oospores in the##2##4##(2008-10#2)
of oospores in##5##3##(2008-10#5)
of oospores of##2##3##(2008-10#2)
of oospores##22##2##(2008-10#22)
of opaque microstructures in optically diffuse media##2##7##(2008-3#2)
of opaque##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
of open reading frame##2##4##(2008-10#1)(2008-8#1)
of open reading frames##2##4##(1992-3#1)(1996-6#1)
of open reading##4##3##(1992-3#1)(1996-6#1)(2008-10#1)(2008-8#1)
of open tubular##2##3##(2008-10#2)
of open##17##2##(1992-3#1)(1995-12#1)(1996-6#1)(2008-10#6)(2008-4#1)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
of opening##2##2##(2008-10#1)(2008-12#1)
of openness##2##2##(2008-12#1)(2013-8#1)
of operating conditions##3##3##(2008-3#1)(2008-7#1)(2010-4#1)
of operating##6##2##(2008-10#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)
of operation and##5##3##(1992-9#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
of operation of##2##3##(1990-3#1)(2008-11#1)
of operation##20##2##(1990-3#3)(1991-11#1)(1992-9#1)(1993-2#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#1)(2013-1#1)
of operationally##2##2##(1991-2#1)(2008-3#1)
of operations##4##2##(1992-9#1)(2008-10#1)(2008-9#1)(2010-8#1)
of operative##5##2##(1990-6#1)(1993-3#1)(2008-11#1)(2010-12#1)(2013-1#1)
of ophthalmic segment##2##3##(2012-3#2)
of ophthalmic##5##2##(2008-10#1)(2012-3#3)(2013-8#1)
of ophthalmology##3##2##(1995-9#1)(2011-7#2)
of opiate##2##2##(1991-1#1)(1995-12#1)
of opinion##3##2##(1990-9#1)(1991-12#1)(2008-11#1)
of opioid dependence##2##3##(2008-6#2)
of opioid receptor##2##3##(2008-11#1)(2009-7#1)
of opioid receptors and##2##4##(2008-11#1)(2009-7#1)
of opioid receptors in the##2##5##(2008-11#2)
of opioid receptors in##4##4##(2008-11#3)(2009-7#1)
of opioid receptors##7##3##(1995-11#1)(2008-11#4)(2009-7#2)
of opioid##19##2##(1991-1#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-11#6)(2008-6#2)(2009-7#4)(2013-1#1)
of opioids and##2##3##(1997-5#1)(2011-2#1)
of opioids in##4##3##(2011-2#4)
of opioids##8##2##(1997-5#1)(2009-7#1)(2011-2#5)(2012-3#1)
of opium poppy##2##3##(2008-10#2)
of opportunistic##4##2##(2008-5#1)(2011-2#1)(2013-1#2)
of opportunities that##2##3##(1993-1#1)(2008-11#1)
of opportunity for##3##3##(2008-3#1)(2010-7#1)(2013-1#1)
of opportunity##7##2##(2008-10#2)(2008-11#1)(2008-3#2)(2010-7#1)(2013-1#1)
of opposite##2##2##(1995-6#1)(2008-10#1)
of opsonisation##2##2##(1996-12#2)
of optic nerve##2##3##(2008-5#1)(2010-5#1)
of optic##4##2##(2008-5#1)(2008-9#1)(2010-5#1)(2011-7#1)
of optical components##3##3##(2008-2#2)(2008-3#1)
of optical fibers##2##3##(2008-10#1)(2008-3#1)
of optical filters##2##3##(2008-11#1)(2008-6#1)
of optical##43##2##(1990-8#1)(1991-2#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#17)(2008-4#1)(2008-6#1)(2008-9#1)(2009-7#2)(2010-11#1)(2011-2#1)(2011-7#2)
of optically active##2##3##(1996-5#1)(2008-7#1)
of optically thick##2##3##(2008-3#2)
of optically##9##2##(1994-2#1)(1996-5#1)(2007-11#2)(2008-10#1)(2008-3#3)(2008-7#1)
of optimal##12##2##(1992-3#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#2)(2013-8#1)
of optimality##3##2##(2008-8#1)(2008-9#1)(2010-1#1)
of optimised##2##2##(2008-10#2)
of optimization##3##2##(2008-10#3)
of optimized##3##2##(2008-10#1)(2008-11#1)(2009-2#1)
of optimizing##2##2##(2009-10#1)(2010-4#1)
of optimum##3##2##(1992-12#1)(1997-2#1)(2008-8#1)
of options and##2##3##(1992-1#1)(1994-1#1)
of options for##2##3##(1991-2#1)(2008-11#1)
of options##4##2##(1991-2#1)(1992-1#1)(1994-1#1)(2008-11#1)
of optode##2##2##(2008-10#2)
of or##3##2##(1995-9#1)(2009-12#1)(2013-7#1)
of oral agents##2##3##(2010-5#1)(2010-6#1)
of oral and##3##3##(1991-12#1)(2007-11#1)(2010-10#1)
of oral anticoagulation##2##3##(1995-5#1)(1997-5#1)
of oral cancer##3##3##(1992-9#1)(2013-1#2)
of oral cavity##4##3##(2010-12#1)(2011-7#1)(2013-1#2)
of oral contraceptives##5##3##(1990-6#1)(1991-2#1)(1991-8#1)(2008-11#2)
of oral diseases##3##3##(1991-6#1)(2008-1#2)
of oral granisetron##3##3##(2010-12#3)
of oral health##4##3##(1991-6#1)(2008-1#1)(2008-5#1)(2012-3#1)
of oral hypoglycemics##2##3##(1991-12#2)
of oral language and phonological awareness on##2##7##(2008-12#2)
of oral reading fluency##2##4##(2008-12#2)
of oral tolerance##4##3##(2008-11#4)
of oral##74##2##(1990-2#1)(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-9#1)(1995-3#1)(1995-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-11#10)(2008-12#5)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#2)(2013-1#8)
of orally administered##2##3##(1995-5#1)(2008-11#1)
of orbit##3##2##(2010-11#2)(2013-1#1)
of orbital##2##2##(2010-11#1)(2013-7#1)
of orchard##3##2##(2008-10#3)
of order##10##2##(2008-11#2)(2008-5#5)(2008-8#1)(2011-2#1)(2013-1#1)
of ordered##3##2##(1992-8#1)(2008-5#1)(2010-4#1)
of ordinal##5##2##(2008-10#4)(2008-9#1)
of ordinary##3##2##(1994-6#1)(2007-12#1)(2008-10#1)
of organ function##2##3##(1992-3#1)(2013-1#1)
of organ##12##2##(1992-3#1)(1994-6#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-3#1)(2013-1#2)
of organelles##10##2##(2008-11#1)(2008-4#5)(2008-7#1)(2009-10#1)(2009-8#1)(2012-3#1)
of organic acids##5##3##(2008-10#4)(2008-7#1)
of organic ammonium##2##3##(2008-10#2)
of organic and inorganic##3##4##(2008-10#3)
of organic and##4##3##(2008-10#4)
of organic carbon##4##3##(2008-10#4)
of organic compounds by##3##4##(2008-10#3)
of organic compounds from##2##4##(2008-10#2)
of organic compounds##14##3##(2008-10#14)
of organic contaminants in##2##4##(2008-10#2)
of organic dyes##2##3##(2008-10#2)
of organic ligands##3##3##(2008-10#3)
of organic matter##6##3##(2008-10#2)(2008-11#3)(2008-12#1)
of organic molecules##2##3##(2008-10#2)
of organic phase##2##3##(2008-10#2)
of organic silicon##2##3##(2008-10#2)
of organic small molecules##2##4##(2008-10#2)
of organic solvent and##4##4##(2008-10#4)
of organic solvent##11##3##(2008-10#11)
of organic solvents in##2##4##(2008-10#2)
of organic solvents##10##3##(2008-10#8)(2011-2#1)(2012-2#1)
of organic##105##2##(1991-7#1)(1995-11#1)(2008-10#87)(2008-11#9)(2008-12#2)(2008-7#2)(2011-2#1)(2012-2#2)
of organisms in##2##3##(2008-8#1)(2009-8#1)
of organisms to##4##3##(2008-10#1)(2008-8#2)(2012-2#1)
of organisms##19##2##(1995-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#2)
of organization##5##2##(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#2)
of organizational##10##2##(1990-11#1)(1992-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(2008-11#1)(2008-7#1)(2010-10#1)
of organizations##2##2##(1991-3#1)(1994-3#1)
of organized##8##2##(1990-6#3)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
of organochlorine pesticides##3##3##(2008-10#3)
of organochlorine##4##2##(2008-10#4)
of organogenesis##3##2##(2008-7#1)(2008-9#2)
of organomercurials##3##2##(2008-10#3)
of organometallic##3##2##(2008-10#1)(2009-9#1)(2012-3#1)
of organophosphonate##2##2##(2008-10#2)
of organophosphorous pesticides in##2##4##(2008-10#1)(2013-1#1)
of organophosphorous pesticides##3##3##(2008-10#2)(2013-1#1)
of organophosphorous##6##2##(1994-5#1)(2008-10#2)(2010-5#2)(2013-1#1)
of organophosphorus and carbamate pesticides##2##5##(2008-10#2)
of organophosphorus pesticides in water##5##5##(2008-10#5)
of organophosphorus pesticides##11##3##(2008-10#11)
of organophosphorus##16##2##(2008-10#16)
of organotin compounds##3##3##(2008-10#3)
of organotin in##2##3##(2008-10#2)
of organotin##6##2##(2008-10#6)
of organotins##3##2##(2008-10#3)
of organs##5##2##(1991-2#1)(1993-2#2)(2011-3#1)(2013-8#1)
of oriLyt##4##2##(1997-3#4)
of oriental lacquer films##2##4##(2008-10#2)
of orientation and##2##3##(2008-10#1)(2008-8#1)
of orientation selectivity##2##3##(2008-11#1)(2008-8#1)
of orientation tuning##2##3##(2008-11#2)
of orientation##9##2##(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#4)
of origin and##3##3##(2008-10#2)(2012-12#1)
of origin in##2##3##(2008-10#1)(2008-11#1)
of origin of the##2##4##(2008-10#2)
of origin of##8##3##(2008-10#5)(2010-11#1)(2012-2#1)(2013-1#1)
of origin##41##2##(1994-2#1)(2008-10#29)(2008-11#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
of original##5##2##(1991-12#1)(1991-2#1)(1993-3#1)(2009-8#1)(2011-3#1)
of ornamental plants##2##3##(2008-10#2)
of ornithine decarboxylase activity##2##4##(1992-9#1)(2008-10#1)
of ornithine##3##2##(1992-9#1)(2008-10#1)(2009-8#1)
of orofacial clefts##5##3##(2009-10#5)
of orofacial##7##2##(2008-5#1)(2009-10#5)(2013-1#1)
of oropharyngeal##5##2##(1996-2#3)(2008-8#2)
of orthogonal films##2##3##(2009-11#2)
of orthogonal##5##2##(1990-5#1)(2007-12#1)(2008-11#1)(2009-11#2)
of orthopaedic##3##2##(2007-11#2)(2008-12#1)
of orthopedic##2##2##(2009-3#1)(2010-6#1)
of orthophosphate and total phosphates##2##5##(2008-10#2)
of orthophosphate and total##4##4##(2008-10#4)
of orthophosphate in##4##3##(2008-10#4)
of orthophosphate##10##2##(2008-10#10)
of orthotopic##2##2##(1991-11#1)(2008-5#1)
of oscillation##2##2##(1994-6#1)(2008-11#1)
of osmium tetroxide##2##3##(2008-10#1)(2008-7#1)
of osmium##7##2##(2008-10#6)(2008-7#1)
of osmolarity##3##2##(1991-11#1)(2008-11#2)
of osmotic##7##2##(2008-11#7)
of osmotin##2##2##(2008-10#1)(2008-8#1)
of osseous##2##2##(2008-1#1)(2013-1#1)
of osteoarthritis##3##2##(2012-3#1)(2013-1#2)
of osteoblast metabolism##2##3##(2008-11#2)
of osteoblast##3##2##(2008-11#3)
of osteoblastic MC3T3-E1 cells##2##4##(1997-1#2)
of osteoblastic cells##2##3##(2008-11#2)
of osteoblastic##4##2##(1997-1#2)(2008-11#2)
of osteoblasts##4##2##(1990-11#1)(1997-1#1)(2008-11#1)(2013-1#1)
of osteocalcin##2##2##(1993-3#1)(2008-11#1)
of osteoclast##2##2##(2011-2#2)
of osteoclastic##2##2##(1993-6#1)(2008-11#1)
of osteoclasts##2##2##(1991-11#1)(2012-3#1)
of osteogenic##7##2##(2008-11#5)(2011-2#2)
of osteomyelitis defects##3##3##(2010-6#3)
of osteomyelitis##16##2##(2009-6#1)(2010-6#15)
of osteopenia and##2##3##(2007-8#2)
of osteopontin##2##2##(2009-7#1)(2010-11#1)
of osteoporosis and##2##3##(1996-6#1)(2012-12#1)
of osteoporosis in##7##3##(1996-6#1)(2008-7#4)(2010-3#2)
of osteoporosis is##2##3##(2008-7#1)(2010-3#1)
of osteoporosis##21##2##(1990-11#1)(1991-11#3)(1996-11#1)(1996-6#3)(1997-8#1)(2008-11#1)(2008-7#5)(2008-8#1)(2010-3#4)(2012-12#1)
of osteoporotic bone##2##3##(1992-6#1)(2011-2#1)
of osteoporotic##5##2##(1991-11#1)(1992-6#1)(2008-11#1)(2011-2#1)(2013-1#1)
of osteoprotegerin (OPG) on##2##4##(2008-12#2)
of osteoprotegerin (OPG)##3##3##(2008-12#2)(2013-1#1)
of other amino##2##3##(2008-10#2)
of other authors##2##3##(2008-5#1)(2013-8#1)
of other bacterial##2##3##(2008-5#1)(2009-6#1)
of other begomoviruses##2##3##(2008-10#2)
of other cancers##3##3##(2009-12#1)(2011-2#1)(2011-3#1)
of other cations##5##3##(2008-10#5)
of other cell types##2##4##(2008-11#1)(2008-7#1)
of other cell##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
of other closteroviruses##3##3##(2008-10#3)
of other common##2##3##(2008-10#2)
of other components##2##3##(2008-10#1)(2008-8#1)
of other contaminants##2##3##(2008-10#2)
of other cytokines##3##3##(1996-2#1)(2008-4#2)
of other drugs##2##3##(1991-1#1)(2008-10#1)
of other enzymes##2##3##(1992-4#1)(2011-1#1)
of other fungi##2##3##(2008-10#2)
of other groups##2##3##(1995-12#1)(2012-3#1)
of other ions in the##2##5##(2008-10#2)
of other ions in##3##4##(2008-10#3)
of other ions##7##3##(2008-10#7)
of other males##2##3##(2008-8#1)(2009-6#1)
of other mammals##2##3##(1992-12#1)(1995-6#1)
of other metal ions##7##4##(2008-10#7)
of other metal##8##3##(2008-10#8)
of other metals##2##3##(2008-10#2)
of other natural##2##3##(2008-8#1)(2013-1#1)
of other neurons##2##3##(1997-3#1)(2008-11#1)
of other organisms##2##3##(1993-9#1)(1995-12#1)
of other plants##2##3##(2008-10#1)(2008-8#1)
of other potential##2##3##(2011-2#1)(2013-7#1)
of other proteins##3##3##(1997-6#1)(2008-10#1)(2008-12#1)
of other recombinant##2##3##(2008-11#1)(2008-4#1)
of other sites##3##3##(1991-12#1)(1992-12#1)(2010-11#1)
of other species##7##3##(1993-6#1)(1997-3#1)(2008-10#3)(2008-2#1)(2011-2#1)
of other studies##2##3##(1994-2#1)(2008-11#1)
of other subjects##2##3##(2008-10#2)
of other substances##4##3##(2008-10#4)
of other##314##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-10#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#122)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#3)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#12)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#2)
of others is##2##3##(2008-10#1)(2008-11#1)
of others##16##2##(1991-2#1)(1994-1#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-11#5)(2008-9#2)(2009-6#1)(2009-9#1)(2011-1#1)
of otherwise##2##2##(1997-1#1)(2008-9#1)
of otitis media##3##3##(1991-3#2)(2008-9#1)
of otolith calcium carbonate##2##4##(2008-10#2)
of our approach is that##2##5##(2008-8#1)(2009-8#1)
of our approach##8##3##(2008-10#1)(2008-6#1)(2008-8#2)(2009-8#2)(2010-8#1)(2012-2#1)
of our case##2##3##(1991-3#1)(2013-1#1)
of our combined experience##2##4##(1991-12#1)(2008-8#1)
of our current##3##3##(2008-4#1)(2013-8#2)
of our data with##2##4##(2008-10#1)(2008-12#1)
of our data##3##3##(1995-12#1)(2008-10#1)(2008-12#1)
of our experience##2##3##(2008-7#1)(2011-2#1)
of our findings##7##3##(1990-6#1)(1996-11#1)(2008-3#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
of our health##2##3##(1995-3#1)(1997-2#1)
of our hospital##2##3##(2013-1#2)
of our investigation##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
of our investigations##2##3##(2008-10#1)(2008-11#1)
of our knowledge about##3##4##(1997-8#1)(2008-7#1)(2010-5#1)
of our knowledge##19##3##(1994-12#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of our method##3##3##(1991-2#1)(2008-3#2)
of our model##5##3##(1993-8#1)(2008-6#1)(2008-8#2)(2013-1#1)
of our own##3##3##(2008-12#1)(2008-7#1)(2013-8#1)
of our patient##2##3##(2010-7#1)(2013-1#1)
of our patients with##2##4##(1996-3#1)(2008-8#1)
of our patients##10##3##(1990-6#1)(1991-3#1)(1996-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#2)(2013-8#1)
of our previous##4##3##(1992-12#1)(1994-8#1)(1997-2#1)(2008-10#1)
of our profession##3##3##(1993-12#1)(1994-12#1)(2012-2#1)
of our recent##2##3##(2011-2#1)(2012-12#1)
of our research##2##3##(2008-12#1)(2013-1#1)
of our results##3##3##(1994-5#1)(1997-8#1)(2008-7#1)
of our sample##2##3##(2008-11#1)(2011-2#1)
of our study is##5##4##(2008-11#2)(2009-6#1)(2011-2#1)(2011-7#1)
of our study was to evaluate the##4##7##(1991-3#1)(1997-8#1)(2011-2#1)(2012-3#1)
of our study was to evaluate##5##6##(1991-3#1)(1997-8#2)(2011-2#1)(2012-3#1)
of our study was to examine##2##6##(2011-1#1)(2012-3#1)
of our study was to##17##5##(1991-3#1)(1997-8#2)(2008-10#1)(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#2)(2012-6#1)(2013-1#3)
of our study was##18##4##(1990-5#1)(1991-3#1)(1997-8#2)(2008-10#1)(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#2)(2012-6#1)(2013-1#3)
of our study were##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
of our study##41##3##(1990-5#1)(1991-3#2)(1992-12#1)(1997-8#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-3#3)(2012-6#1)(2013-1#5)
of our treatment##2##3##(1990-9#1)(2009-6#1)
of our work##2##3##(2008-5#1)(2012-2#1)
of our##236##2##(1990-5#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#5)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-8#6)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#17)(2008-12#6)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#10)(2008-8#12)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#5)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#14)(2011-7#1)(2012-12#3)(2012-2#10)(2012-3#5)(2012-6#1)(2013-1#21)(2013-7#1)(2013-8#4)
of outbreaks##2##2##(1997-3#1)(2012-2#1)
of outcome measures##4##3##(1996-3#1)(2008-11#2)(2008-12#1)
of outcome##21##2##(1992-9#2)(1993-1#1)(1993-11#1)(1996-2#1)(1996-3#1)(2008-11#3)(2008-12#1)(2008-9#1)(2009-11#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#1)
of outcomes research in##2##4##(2008-8#1)(2008-9#1)
of outcomes research##3##3##(1994-12#1)(2008-8#1)(2008-9#1)
of outcomes##7##2##(1993-3#1)(1994-12#1)(1996-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)
of outcrossing##2##2##(2008-10#2)
of outdoor aeroallergens##2##3##(2008-5#2)
of outdoor##3##2##(2008-5#3)
of outer##3##2##(1994-11#1)(1996-12#1)(2008-11#1)
of outgrowth##2##2##(2011-2#2)
of outlier data##3##3##(2008-10#3)
of outlier##7##2##(1993-9#1)(2008-10#5)(2009-8#1)
of outliers##4##2##(1991-12#1)(2008-10#3)
of outpatient chemotherapy##2##3##(2010-2#2)
of outpatient##11##2##(1992-1#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-6#1)(2010-2#2)(2012-2#1)
of outpatients##2##2##(1993-11#1)(2011-2#1)
of output##6##2##(1992-2#1)(1993-3#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-4#1)
of ovarian cancer##9##3##(1990-12#1)(1991-6#1)(1994-6#1)(1994-9#1)(2008-1#1)(2013-8#4)
of ovarian carcinoma##4##3##(1991-8#1)(2010-7#1)(2013-1#2)
of ovarian##28##2##(1990-12#1)(1991-6#1)(1991-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-1#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#4)(2010-7#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#4)
of ovary##3##2##(2008-10#1)(2013-1#2)
of over 100##2##3##(1996-8#1)(2008-10#1)
of over 30##2##3##(1993-2#1)(2011-2#1)
of over##23##2##(1992-2#1)(1992-3#1)(1993-2#1)(1996-8#2)(1997-5#1)(2008-10#6)(2008-11#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#1)
of over-expression##2##2##(2008-11#2)
of overactive bladder##2##3##(2008-12#1)(2011-1#1)
of overall complications and##2##4##(2013-1#2)
of overall success##2##3##(2012-12#2)
of overall##9##2##(1992-3#1)(1996-3#1)(1997-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
of overcoming##5##2##(1995-3#1)(2008-10#1)(2008-11#2)(2013-8#1)
of overdominance##2##2##(2008-10#2)
of overexpression of##2##3##(2008-11#1)(2011-2#1)
of overexpression##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
of overlap##2##2##(1994-3#1)(2010-4#1)
of overlapping genes in bacteriophage T4##2##6##(1997-7#2)
of overlapping peaks##3##3##(2008-10#3)
of overlapping##10##2##(1993-8#1)(1997-7#2)(2008-10#6)(2011-2#1)
of overload##2##2##(1990-9#1)(2012-3#1)
of overt##2##2##(2009-1#1)(2011-2#1)
of overtraining##2##2##(1993-2#2)
of overweight and obesity among##2##5##(2011-1#1)(2011-2#1)
of overweight and obesity##5##4##(2011-1#1)(2011-2#1)(2012-2#3)
of overweight and##6##3##(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#3)
of overweight##9##2##(2008-10#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
of overwintering##3##2##(2008-10#2)(2008-8#1)
of ovine##3##2##(1996-12#1)(1997-3#1)(2010-12#1)
of oviposition##2##2##(2007-12#1)(2009-6#1)
of own##2##2##(1993-12#1)(1996-6#1)
of ownership of##2##3##(1993-2#1)(2008-10#1)
of ownership##3##2##(1993-2#1)(2008-10#1)(2008-12#1)
of oxalate##14##2##(2008-10#11)(2012-2#3)
of oxalic acid in urine##2##5##(2008-10#2)
of oxalic acid##6##3##(2008-10#3)(2012-2#1)(2013-1#2)
of oxidant##3##2##(2008-10#3)
of oxidase##2##2##(2008-10#2)
of oxidation agent##2##3##(2008-10#2)
of oxidation is##2##3##(2008-10#2)
of oxidation of##7##3##(1990-5#1)(2008-10#5)(2008-12#1)
of oxidation products##2##3##(2008-10#2)
of oxidation##17##2##(1990-5#1)(2008-10#14)(2008-11#1)(2008-12#1)
of oxidative modification of##2##4##(2008-10#1)(2009-8#1)
of oxidative phosphorylation##3##3##(2008-7#2)(2013-8#1)
of oxidative stress and##2##4##(2008-10#1)(2008-9#1)
of oxidative stress in##3##4##(2008-11#2)(2010-12#1)
of oxidative stress##14##3##(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-5#1)
of oxidative##29##2##(1994-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-7#4)(2008-9#2)(2009-6#1)(2009-8#3)(2010-12#1)(2010-5#1)(2011-2#2)(2012-5#1)(2013-8#1)
of oxidizable##7##2##(2008-10#7)
of oxidized##12##2##(1992-9#1)(1993-9#1)(1994-5#3)(1994-8#1)(1996-2#2)(2008-10#2)(2008-11#1)(2010-12#1)
of oxolinic acid##2##3##(2008-10#2)
of oxychlorine species##4##3##(2008-10#4)
of oxygen and##6##3##(1995-12#1)(2007-8#1)(2008-10#3)(2008-11#1)
of oxygen consumption##5##3##(1997-1#1)(2008-10#1)(2008-5#1)(2010-11#2)
of oxygen deprivation##2##3##(1992-3#1)(2008-10#1)
of oxygen in##3##3##(2008-10#2)(2008-3#1)
of oxygen partial pressure on##2##5##(2008-11#2)
of oxygen radicals##2##3##(1993-8#1)(1994-11#1)
of oxygen to##2##3##(1995-2#1)(2008-3#1)
of oxygen uptake and carbon dioxide production rates##2##8##(2008-11#2)
of oxygen uptake and carbon dioxide##5##6##(2008-11#5)
of oxygen uptake reserve##5##4##(2013-8#5)
of oxygen uptake##14##3##(2008-11#6)(2008-12#1)(2013-8#7)
of oxygen##69##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-1#2)(1993-8#2)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#2)(2007-8#1)(2008-10#23)(2008-11#9)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-11#2)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#7)
of oxygen-17##3##2##(1990-5#3)
of oxygen-derived free radicals##2##4##(2008-10#1)(2010-10#1)
of oxygenation##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
of oxytetracycline and metronidazole##2##4##(1996-6#2)
of oxytetracycline##3##2##(1996-6#2)(2008-10#1)
of oxytocin##3##2##(1996-11#1)(1997-4#2)
of ozonation##2##2##(2008-10#2)
of ozone as##2##3##(2008-10#2)
of ozone in##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
of ozone##14##2##(1991-5#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)
of p##6##2##(1996-2#1)(2008-10#4)(2008-11#1)
of p-phenylenediamine##2##2##(2008-10#2)
of p130Cas##2##2##(2011-1#2)
of p150Glued##2##2##(1995-2#2)
of p16INK4a##2##2##(1997-7#2)
of p21##2##2##(1997-7#2)
of p33CDK2##2##2##(1997-1#2)
of p38##2##2##(2008-7#1)(2011-2#1)
of p53 and NF-B##2##4##(2010-10#2)
of p53 and##6##3##(1993-8#1)(2008-9#1)(2010-10#2)(2011-2#1)(2013-1#1)
of p53 in##4##3##(1997-7#1)(2008-9#2)(2011-2#1)
of p53 or##2##3##(1994-12#1)(2010-10#1)
of p53 protein##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
of p53##43##2##(1991-5#2)(1993-8#1)(1994-12#5)(1994-5#1)(1994-9#1)(1995-9#1)(1997-7#3)(2008-10#5)(2008-5#4)(2008-7#1)(2008-9#4)(2009-4#1)(2009-8#1)(2010-10#4)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)
of p53-mediated##2##2##(1994-12#1)(1997-7#1)
of p65##4##2##(1995-6#4)
of p75##2##2##(1995-8#2)
of pH 2##7##3##(2008-10#7)
of pH 3##3##3##(2008-10#3)
of pH 4##4##3##(1990-5#1)(2008-10#2)(2012-9#1)
of pH 5##4##3##(2008-10#4)
of pH 7##4##3##(2008-10#4)
of pH and of##2##4##(2008-10#2)
of pH and temperature##3##4##(2008-10#2)(2008-5#1)
of pH and##17##3##(1996-12#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
of pH from##4##3##(2008-10#4)
of pH has##2##3##(2008-10#2)
of pH in##8##3##(2008-10#6)(2008-8#1)(2010-8#1)
of pH of the##3##4##(2008-10#3)
of pH of##6##3##(2008-10#6)
of pH on the##4##4##(2008-10#3)(2008-5#1)
of pH on##8##3##(1991-5#2)(2008-10#5)(2008-5#1)
of pH##138##2##(1990-5#2)(1991-5#3)(1991-9#1)(1995-2#1)(1996-12#1)(2008-10#117)(2008-11#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2012-9#1)(2013-1#1)
of pK##2##2##(1991-9#1)(2008-9#1)
of pK(a) values##2##3##(2008-10#2)
of pK(a)##3##2##(2008-10#3)
of pMLZ-4##2##2##(1993-2#2)
of pOCs into##2##3##(2008-11#2)
of pOCs##4##2##(2008-11#4)
of pRB##2##2##(2008-11#1)(2013-1#1)
of pRNA##2##2##(2010-5#2)
of packed##2##2##(1993-8#1)(2008-10#1)
of paediatric cochlear implantation##3##4##(2008-9#3)
of paediatric cochlear##4##3##(2008-9#4)
of paediatric urology##3##3##(2008-10#3)
of paediatric##20##2##(2008-10#5)(2008-11#9)(2008-7#1)(2008-9#4)(2011-2#1)
of pain and##14##3##(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-9#2)(2011-2#1)(2013-1#2)
of pain assessment##2##3##(2008-11#2)
of pain associated with##3##4##(1992-2#1)(1993-2#1)(2010-1#1)
of pain behaviour by##2##4##(2008-11#2)
of pain experienced##2##3##(2010-11#1)(2011-2#1)
of pain for##2##3##(2008-9#1)(2013-1#1)
of pain in childhood##2##4##(2008-11#2)
of pain in the##4##4##(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)
of pain in##12##3##(1991-11#2)(1997-8#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2012-2#1)
of pain is##2##3##(2008-11#1)(2008-9#1)
of pain management##2##3##(2009-12#1)(2010-11#1)
of pain on##2##3##(1990-9#2)
of pain relief##3##3##(1990-6#1)(2008-9#1)(2010-10#1)
of pain was##2##3##(2008-7#1)(2013-1#1)
of pain were##2##3##(1993-2#1)(2010-3#1)
of pain##91##2##(1990-6#1)(1990-9#2)(1991-11#3)(1991-2#1)(1991-3#1)(1992-2#2)(1993-2#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#14)(2008-12#7)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#10)(2009-1#1)(2009-12#3)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)
of painful##5##2##(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#2)
of paired##2##2##(2008-11#1)(2010-8#1)
of pairs of##2##3##(2008-10#2)
of pale eggs##2##3##(2008-8#2)
of palladium and##3##3##(2008-10#2)(2008-11#1)
of palladium by##2##3##(2008-10#2)
of palladium matrix modification##2##4##(1991-12#2)
of palladium with##2##3##(2008-10#2)
of palladium##21##2##(1991-12#3)(2008-10#17)(2008-11#1)
of palladium(II) and##3##3##(2008-10#3)
of palladium(II) in##2##3##(2008-10#2)
of palladium(II) with##5##3##(2008-10#5)
of palladium(II)##16##2##(2008-10#16)
of palliative care##3##3##(2010-10#1)(2011-2#1)(2012-3#1)
of palliative medicine##2##3##(2012-3#2)
of palliative radiotherapy##2##3##(2008-10#2)
of palliative##10##2##(1990-11#1)(1993-6#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#3)
of palmitic##2##2##(1994-8#1)(2010-12#1)
of palmitoyl-CoA##2##2##(1990-5#2)
of pancreas##10##2##(2010-12#1)(2012-2#1)(2012-3#7)(2013-1#1)
of pancreatic OPN##2##3##(2010-11#2)
of pancreatic beta-cells##2##3##(1996-2#1)(2012-3#1)
of pancreatic cancer cells##2##4##(2013-1#2)
of pancreatic cancer##7##3##(1990-9#1)(1994-3#1)(2009-5#1)(2013-1#4)
of pancreatic cancer]##3##3##(1990-11#1)(1990-9#2)
of pancreatic carcinoma##2##3##(1994-6#1)(2008-1#1)
of pancreatic cells##2##3##(2008-9#1)(2010-11#1)
of pancreatic endocrine##2##3##(1992-7#1)(2011-2#1)
of pancreatic islet##3##3##(2008-2#2)(2010-12#1)
of pancreatic neoplasms##2##3##(2012-2#2)
of pancreatic secretion##2##3##(1992-8#1)(2008-7#1)
of pancreatic##44##2##(1990-11#1)(1990-9#3)(1991-3#2)(1992-7#1)(1992-8#2)(1993-6#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(2008-1#2)(2008-2#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#4)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)
of pancreatitis##2##2##(1990-3#1)(2012-12#1)
of pandemic spread##4##3##(2008-10#4)
of pandemic##8##2##(2008-10#4)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
of panicle and shoot blight of pistachio##2##7##(2008-10#2)
of panicle and shoot blight##3##5##(2008-10#3)
of panicle blast##4##3##(2008-10#4)
of panicle##7##2##(2008-10#7)
of panthenol##2##2##(2008-5#2)
of papaverine##4##2##(2008-10#4)
of paper disc##2##3##(1994-11#2)
of paper##6##2##(1994-11#2)(2008-9#2)(2012-2#1)(2013-1#1)
of papers##16##2##(2008-10#13)(2009-10#1)(2010-5#1)(2010-7#1)
of papillae and##2##3##(1991-3#1)(2008-10#1)
of papillae##5##2##(1991-3#1)(2008-10#4)
of papillary calculi##2##3##(1995-8#2)
of para-Cl-phenylazo-R-acid##3##2##(2008-10#3)
of para-substituted##2##2##(1994-5#1)(2008-10#1)
of paracetamol and##2##3##(2008-10#2)
of paracetamol in pharmaceutical formulations##3##5##(2008-10#3)
of paracetamol in##10##3##(2008-10#10)
of paracetamol##20##2##(2007-8#1)(2008-10#19)
of paraffin-embedded##2##2##(1994-12#1)(2008-10#1)
of paraganglioma##2##2##(2011-2#1)(2012-2#1)
of parallel##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
of paralytic##2##2##(1990-5#1)(1997-8#1)
of parameter values##6##3##(2008-10#2)(2008-8#2)(2008-9#1)(2010-2#1)
of parameter##10##2##(2008-10#4)(2008-11#1)(2008-8#3)(2008-9#1)(2010-2#1)
of parameters that##2##3##(2008-3#1)(2009-8#1)
of parameters##28##2##(1991-3#1)(1995-9#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-11#1)(2013-8#1)
of paramount importance##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
of paramount##5##2##(1994-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#1)
of paranasal aspergilloma##2##3##(2008-5#2)
of paraneoplastic##2##2##(1996-11#1)(2013-7#1)
of paraoxon##6##2##(2008-10#6)
of paraquat in human##2##4##(2008-10#2)
of paraquat in##6##3##(2008-10#6)
of paraquat##13##2##(2008-10#13)
of parasite virulence##6##3##(2008-8#6)
of parasite##13##2##(2008-8#9)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)
of parasites and##2##3##(1997-7#2)
of parasites in##3##3##(1997-7#1)(2008-8#1)(2012-2#1)
of parasites##16##2##(1992-2#1)(1997-7#6)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#2)
of parasitic##5##2##(2007-12#1)(2009-6#1)(2010-1#1)(2010-8#1)(2013-8#1)
of parasitism in##3##3##(2008-8#3)
of parasitism##9##2##(2008-10#2)(2008-8#7)
of parasitized##2##2##(1992-6#1)(2012-12#1)
of parasitology##2##2##(2010-1#2)
of parathyroid hormone (PTH)##3##4##(1994-11#1)(2011-1#1)(2012-12#1)
of parathyroid hormone##5##3##(1993-12#1)(1994-11#1)(2008-10#1)(2011-1#1)(2012-12#1)
of parathyroid##8##2##(1993-12#1)(1993-3#1)(1994-11#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)
of parenchyma cells##2##3##(2008-10#1)(2012-5#1)
of parent drug##2##3##(2010-11#2)
of parent##8##2##(1995-1#1)(1995-11#1)(2008-10#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-2#1)
of parent-adolescent##2##2##(2009-7#1)(2013-1#1)
of parental care in##2##4##(2008-4#1)(2008-8#1)
of parental care##3##3##(2008-4#1)(2008-8#2)
of parental investment##4##3##(2008-8#1)(2008-9#3)
of parental##14##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#3)(2010-1#1)(2012-2#1)(2012-3#1)
of parenting##4##2##(1995-2#1)(2009-9#2)(2010-1#1)
of parents and peers##2##4##(1990-2#2)
of parents and##5##3##(1990-2#2)(2008-10#1)(2008-9#1)(2011-2#1)
of parents of children with##2##5##(1992-2#1)(1993-3#1)
of parents of##3##3##(1992-2#1)(1993-3#1)(1994-3#1)
of parents##18##2##(1990-2#2)(1992-2#3)(1993-3#1)(1994-3#2)(2008-10#2)(2008-11#2)(2008-9#2)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
of parents'##3##2##(1994-3#1)(2010-1#2)
of parents/guardians##2##2##(2010-9#2)
of parkinsonian##3##2##(1993-11#1)(2008-12#1)(2008-7#1)
of parkinsonism and##3##3##(1997-2#2)(2008-7#1)
of parkinsonism##6##2##(1997-2#2)(2008-7#4)
of parsley plastocyanin##2##3##(1994-5#2)
of part of the##2##4##(1995-2#1)(2008-10#1)
of part of##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
of partial hospitalization##3##3##(1991-1#2)(1992-1#1)
of partial least squares (PLS)##2##5##(2008-10#2)
of partial least squares##3##4##(2008-10#3)
of partial resistance in##4##4##(2008-10#4)
of partial resistance to##2##4##(2008-10#2)
of partial resistance were##2##4##(2008-10#2)
of partial resistance##13##3##(2008-10#13)
of partial##36##2##(1990-5#1)(1991-1#2)(1991-5#1)(1992-1#1)(1993-6#1)(1996-2#1)(2008-10#19)(2008-11#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
of partially polarized beams##2##4##(2008-3#2)
of partially purified##3##3##(1990-11#2)(1995-11#1)
of partially resistant##3##3##(2008-10#3)
of partially##16##2##(1990-11#2)(1992-12#1)(1995-11#1)(1995-3#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-8#1)
of participant##4##2##(2008-10#1)(2009-11#1)(2009-4#1)(2012-2#1)
of participants was##2##3##(2012-3#1)(2013-1#1)
of participants##22##2##(1995-1#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-7#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
of participating##3##2##(1995-12#2)(2013-1#1)
of participation in##4##3##(1990-2#1)(1996-2#1)(2008-11#1)(2011-2#1)
of participation##10##2##(1990-2#1)(1992-1#1)(1994-12#1)(1995-2#2)(1996-2#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
of particle capture##3##3##(2008-9#3)
of particle matter##2##3##(2008-3#2)
of particle size and##3##4##(2008-10#2)(2008-2#1)
of particle size##12##3##(1992-3#2)(2008-10#8)(2008-2#1)(2008-5#1)
of particle##25##2##(1992-3#3)(1993-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#3)(2012-3#1)
of particle-size distribution##2##3##(2008-3#2)
of particles and##2##3##(1996-12#1)(2008-10#1)
of particles in the##3##4##(1991-12#1)(2008-10#2)
of particles in##4##3##(1991-12#1)(2008-10#2)(2008-3#1)
of particles of##2##3##(1997-3#1)(2011-2#1)
of particles that are##2##4##(1990-6#1)(2008-3#1)
of particles##22##2##(1990-6#1)(1991-12#1)(1993-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-3#4)(2008-5#1)(2011-2#2)(2012-2#1)
of particular concern##7##3##(1991-3#1)(1996-1#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
of particular elements##2##3##(2008-10#2)
of particular importance in##2##4##(1993-3#1)(2013-1#1)
of particular importance##4##3##(1993-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
of particular interest because##3##4##(1990-12#1)(1996-12#1)(2008-10#1)
of particular interest for##2##4##(2008-9#2)
of particular interest##14##3##(1990-12#1)(1991-12#1)(1993-12#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)(2009-7#1)
of particular relevance in##2##4##(2008-11#1)(2013-8#1)
of particular relevance##3##3##(1994-8#1)(2008-11#1)(2013-8#1)
of particular##46##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#2)(2008-9#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
of particulate matter##2##3##(2008-10#2)
of particulate##4##2##(1997-1#1)(2008-10#2)(2008-9#1)
of partition coefficients##5##3##(2008-10#5)
of partition##6##2##(2008-10#5)(2011-2#1)
of partitioning##2##2##(1990-5#2)
of partnership##5##2##(1992-1#3)(1995-12#1)(2008-9#1)
of parts in##2##3##(2008-3#2)
of parts per##3##3##(2008-10#1)(2008-3#2)
of parts##5##2##(2008-10#1)(2008-3#4)
of passage##2##2##(1997-3#1)(2008-12#1)
of passive##6##2##(1990-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
of past##10##2##(1990-3#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-9#3)(2013-1#1)
of pasture and##2##3##(2010-4#2)
of patch occupancy are##2##4##(2008-8#1)(2008-9#1)
of patch occupancy##5##3##(2008-8#3)(2008-9#2)
of patch##6##2##(2008-10#1)(2008-8#3)(2008-9#2)
of patches##9##2##(2008-10#1)(2008-8#6)(2008-9#2)
of patent##3##2##(2010-12#1)(2011-3#1)(2012-2#1)
of patented##2##2##(2010-7#1)(2012-2#1)
of paternal care##2##3##(2008-8#2)
of paternal inheritance##2##3##(2008-8#2)
of paternal##5##2##(2008-8#4)(2008-9#1)
of paternally derived deletions##2##4##(1997-3#2)
of paternity##6##2##(2007-12#1)(2008-12#1)(2008-8#3)(2008-9#1)
of pathogen DNA in##2##4##(2008-10#2)
of pathogen DNA##7##3##(2008-10#7)
of pathogen colonization##3##3##(2008-10#2)(2009-12#1)
of pathogen growth##3##3##(2008-10#3)
of pathogen inoculum##2##3##(2008-10#2)
of pathogen##36##2##(2008-10#34)(2008-9#1)(2009-12#1)
of pathogen-derived resistance##2##3##(2008-10#2)
of pathogenesis and##4##3##(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
of pathogenesis##7##2##(1997-8#1)(2008-10#2)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
of pathogenesis-related (PR) genes##2##4##(2008-10#2)
of pathogenesis-related (PR)##3##3##(2008-10#3)
of pathogenesis-related genes##3##3##(2008-10#1)(2011-10#2)
of pathogenesis-related##8##2##(2008-10#6)(2011-10#2)
of pathogenic and nonpathogenic##2##4##(2008-10#2)
of pathogenic and##4##3##(2008-10#3)(2008-9#1)
of pathogenic fungi##2##3##(2008-10#2)
of pathogenic isolates from##2##4##(2008-10#2)
of pathogenic microorganisms##3##3##(1994-11#1)(1994-5#1)(2008-9#1)
of pathogenic##19##2##(1994-11#1)(1994-5#1)(2008-10#12)(2008-9#3)(2009-6#1)(2011-2#1)
of pathogenicity##7##2##(2008-10#6)(2008-12#1)
of pathogens and their##2##4##(1994-3#1)(2011-2#1)
of pathogens and##5##3##(1994-3#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
of pathogens in##3##3##(1996-8#1)(2008-10#2)
of pathogens that##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
of pathogens to##2##3##(2008-10#2)
of pathogens##26##2##(1994-3#1)(1996-8#1)(2008-10#17)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)
of pathologic##7##2##(1990-6#1)(1990-8#1)(1994-8#1)(2008-11#1)(2009-3#2)(2011-2#1)
of pathological changes##3##3##(1990-11#1)(1991-6#1)(2013-1#1)
of pathological gambling##2##3##(2008-11#1)(2013-8#1)
of pathological##11##2##(1990-11#1)(1990-5#1)(1991-6#1)(1993-3#1)(1995-5#1)(1997-4#1)(2008-11#1)(2009-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
of pathologies##2##2##(2012-2#1)(2012-3#1)
of pathology##8##2##(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-9#1)(2012-3#1)(2013-1#1)
of pathophysiology and##2##3##(2013-1#2)
of pathway##3##2##(2009-6#1)(2010-11#2)
of pathways in##2##3##(2009-10#1)(2010-11#1)
of pathways##11##2##(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
of patient and##3##3##(2008-10#1)(2008-8#1)(2010-2#1)
of patient care##9##3##(1991-12#1)(1993-3#2)(1997-1#1)(2008-11#3)(2009-8#1)(2012-12#1)
of patient compliance##2##3##(1993-11#1)(1996-3#1)
of patient data##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
of patient factors##2##3##(2008-10#1)(2008-11#1)
of patient focused restructuring##2##4##(1993-12#2)
of patient focused##3##3##(1993-12#2)(1994-2#1)
of patient information##3##3##(1993-3#1)(2010-8#1)(2012-3#1)
of patient outcomes##3##3##(2010-10#1)(2013-1#2)
of patient satisfaction and##2##4##(1996-1#1)(1997-1#1)
of patient satisfaction##9##3##(1994-12#1)(1995-12#1)(1996-1#2)(1996-3#2)(1997-1#1)(2008-10#1)(2013-1#1)
of patient with##2##3##(2012-3#1)(2013-1#1)
of patient##74##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#3)(1993-3#4)(1994-12#1)(1994-2#2)(1994-3#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#5)(1997-1#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)
of patient's##4##2##(1991-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
of patient-based##3##2##(1994-3#3)
of patient-reported##2##2##(1995-2#1)(2013-1#1)
of patients admitted to the##2##5##(2011-2#1)(2012-3#1)
of patients admitted##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
of patients affected with##2##4##(1992-2#1)(1993-6#1)
of patients and volunteers##2##4##(1992-3#2)
of patients and##11##3##(1991-3#1)(1992-3#2)(1993-6#1)(2008-10#1)(2008-7#2)(2010-10#1)(2010-3#1)(2011-2#2)
of patients and/or##2##3##(2008-11#2)
of patients are##3##3##(1995-11#1)(2008-10#2)
of patients at high risk of##2##6##(1993-1#1)(2008-7#1)
of patients at risk of##3##5##(1992-12#1)(2008-8#1)(2010-5#1)
of patients at risk##4##4##(1992-12#1)(2008-8#1)(2010-5#1)(2012-2#1)
of patients at##9##3##(1992-12#2)(1993-1#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#2)
of patients before##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
of patients entering##2##3##(1994-5#1)(1996-6#1)
of patients experienced##3##3##(2008-10#1)(2009-11#1)(2013-1#1)
of patients for##4##3##(1994-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
of patients from##3##3##(2008-5#1)(2008-8#1)(2012-12#1)
of patients had a successful result##2##6##(2009-3#2)
of patients had a##3##4##(1992-9#1)(2009-3#2)
of patients had at least##2##5##(1994-2#1)(2012-3#1)
of patients had##15##3##(1990-2#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(2008-11#2)(2009-3#2)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
of patients have to##2##4##(1996-2#1)(2010-12#1)
of patients have##5##3##(1990-6#1)(1996-2#1)(2008-12#1)(2010-12#1)(2012-3#1)
of patients hospitalized for##2##4##(2008-7#1)(2012-12#1)
of patients hospitalized##4##3##(2007-8#1)(2008-7#1)(2012-12#2)
of patients in a##2##4##(1994-12#1)(1995-3#1)
of patients in the control group reported that they would make that choice##2##13##(2010-4#2)
of patients in the intervention group reported that they would choose to##2##12##(2010-4#2)
of patients in the##10##4##(1992-12#2)(2010-4#4)(2010-6#1)(2011-2#2)(2012-3#1)
of patients in whom##2##4##(2008-7#1)(2010-12#1)
of patients in##25##3##(1992-12#2)(1992-3#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-11#5)(2008-7#2)(2009-8#1)(2010-12#1)(2010-4#4)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
of patients is##4##3##(1992-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
of patients over the age of##2##6##(2011-2#2)
of patients over##3##3##(2011-2#3)
of patients presented##2##3##(2011-2#1)(2013-1#1)
of patients presenting with##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
of patients presenting##4##3##(1995-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
of patients prior##2##3##(2009-8#1)(2011-2#1)
of patients receiving##2##3##(2011-2#1)(2013-8#1)
of patients requiring##2##3##(1995-2#1)(2011-2#1)
of patients suffering from##6##4##(1991-11#1)(1993-11#1)(1997-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
of patients that##3##3##(1995-12#1)(2007-8#1)(2008-12#1)
of patients to##4##3##(1991-11#1)(1994-6#1)(2008-7#1)(2010-1#1)
of patients treated by##2##4##(1992-9#1)(2008-10#1)
of patients treated with##4##4##(1995-2#1)(2011-2#1)(2013-1#2)
of patients treated##10##3##(1991-9#1)(1992-9#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#3)
of patients under##3##3##(1990-5#1)(2008-10#1)(2013-1#1)
of patients undergoing spinal##2##4##(2012-12#1)(2012-3#1)
of patients undergoing##6##3##(1992-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
of patients underwent##2##3##(1990-5#1)(1992-2#1)
of patients was##3##3##(1994-12#1)(1994-8#1)(2011-2#1)
of patients were##12##3##(1990-2#1)(1991-3#1)(1992-2#1)(1994-2#1)(1995-11#2)(1995-12#1)(2007-8#1)(2008-11#2)(2008-7#1)(2012-3#1)
of patients who are at##2##5##(1994-12#1)(2008-7#1)
of patients who are##3##4##(1994-12#1)(2008-7#1)(2013-1#1)
of patients who died##2##4##(1991-8#1)(2008-7#1)
of patients who had##6##4##(1992-3#1)(1993-11#1)(1994-3#1)(2008-9#1)(2010-7#1)(2011-2#1)
of patients who have undergone##2##5##(1990-9#1)(2010-6#1)
of patients who have##3##4##(1990-9#1)(2010-6#1)(2013-8#1)
of patients who underwent##4##4##(2007-8#1)(2010-11#1)(2012-3#1)(2013-1#1)
of patients who##28##3##(1990-9#1)(1991-8#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-7#5)(2008-9#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
of patients whose##4##3##(2011-2#2)(2012-3#1)(2013-8#1)
of patients with AIDS and##2##5##(1996-11#1)(2011-2#1)
of patients with COPD##2##4##(2009-1#1)(2011-2#1)
of patients with Graves'##2##4##(1994-11#1)(2008-7#1)
of patients with Parkinson##2##4##(2013-8#2)
of patients with SAH##2##4##(1995-11#1)(2008-7#1)
of patients with a neuromuscular disorder in this group had a successful result##2##13##(2009-3#2)
of patients with a##8##4##(1990-3#1)(1991-8#1)(1996-1#1)(2008-9#3)(2009-3#2)
of patients with acute coronary##3##5##(2008-3#2)(2013-8#1)
of patients with acute##5##4##(1992-9#1)(2008-3#2)(2012-12#1)(2013-8#1)
of patients with advanced breast##2##5##(1991-6#1)(2011-2#1)
of patients with advanced##4##4##(1991-6#1)(2008-1#1)(2008-7#1)(2011-2#1)
of patients with asthma##3##4##(1993-1#1)(1996-2#1)(2012-2#1)
of patients with benign##2##4##(1992-5#1)(1995-3#1)
of patients with breast cancer##2##5##(1990-8#1)(1993-1#1)
of patients with cancer of the##3##6##(1990-9#1)(1991-2#1)(1991-8#1)
of patients with cancer##7##4##(1990-9#1)(1991-2#1)(1991-8#1)(1996-11#1)(2008-2#1)(2008-7#2)
of patients with cardiovascular##3##4##(2010-4#1)(2011-2#1)(2013-1#1)
of patients with chest pain##2##5##(2008-3#1)(2012-2#1)
of patients with chronic pain##3##5##(2008-4#1)(2008-9#1)(2012-3#1)
of patients with chronic##10##4##(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of patients with complicated##2##4##(1991-6#1)(2012-12#1)
of patients with coronary artery##2##5##(1990-3#1)(2008-1#1)
of patients with coronary##4##4##(1990-3#1)(1993-3#1)(1995-3#1)(2008-1#1)
of patients with diabetes mellitus##2##5##(2008-1#1)(2013-1#1)
of patients with different##3##4##(1991-2#1)(1997-2#1)(2012-3#1)
of patients with epilepsy##2##4##(1997-8#1)(2011-2#1)
of patients with idiopathic##2##4##(1991-5#1)(2013-1#1)
of patients with malignant##2##4##(1990-6#1)(1997-2#1)
of patients with muscular##2##4##(2012-2#1)(2012-3#1)
of patients with normal##2##4##(2008-10#1)(2009-5#1)
of patients with ovarian##2##4##(1994-2#1)(1996-10#1)
of patients with primary##3##4##(1992-9#1)(1997-3#1)(2013-1#1)
of patients with schizophrenia##2##4##(1995-5#1)(2012-3#1)
of patients with severe sepsis##3##5##(2009-6#3)
of patients with severe##6##4##(1992-1#1)(1992-3#1)(1993-1#1)(2009-6#3)
of patients with suspected##5##4##(1990-6#1)(2010-10#1)(2011-1#1)(2012-2#2)
of patients with this##3##4##(2008-7#1)(2011-2#2)
of patients with type 2 diabetes##2##6##(2010-10#1)(2012-12#1)
of patients with type##3##4##(1996-11#1)(2010-10#1)(2012-12#1)
of patients with##238##3##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#4)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#4)(1991-8#3)(1992-1#2)(1992-12#2)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#6)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#2)(1996-10#1)(1996-11#6)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#6)(2008-1#6)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#6)(2009-1#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#19)(2011-7#1)(2012-12#7)(2012-2#11)(2012-3#19)(2013-1#18)(2013-8#4)
of patients without##2##3##(1990-3#1)(2008-10#1)
of patients##593##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#7)(1990-5#4)(1990-6#4)(1990-8#1)(1990-9#3)(1991-11#6)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#5)(1991-8#6)(1991-9#1)(1992-1#2)(1992-12#6)(1992-2#7)(1992-3#13)(1992-4#1)(1992-5#3)(1992-8#1)(1992-9#4)(1993-1#7)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#6)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#7)(1995-12#3)(1995-2#6)(1995-3#3)(1995-5#1)(1996-1#4)(1996-10#1)(1996-11#7)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#23)(2008-11#25)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#33)(2008-8#3)(2008-9#9)(2009-1#2)(2009-11#1)(2009-12#2)(2009-3#6)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#13)(2010-3#1)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#3)(2011-1#8)(2011-2#65)(2011-3#2)(2011-7#2)(2012-12#12)(2012-2#14)(2012-3#37)(2013-1#46)(2013-8#10)
of patients'##13##2##(1992-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
of pattern formation in##2##4##(2007-12#1)(2009-8#1)
of pattern recognition##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
of pattern##7##2##(2007-12#1)(2008-10#1)(2008-11#3)(2009-8#1)(2010-8#1)
of patterns of##3##3##(2008-3#2)(2008-8#1)
of patterns##5##2##(2008-10#1)(2008-3#2)(2008-8#2)
of patulin and##2##3##(2008-10#2)
of payment for outpatient##2##4##(1995-2#1)(1997-1#1)
of payment for##3##3##(1995-1#1)(1995-2#1)(1997-1#1)
of payment reform##2##3##(1994-1#1)(1997-1#1)
of payment##7##2##(1992-12#1)(1994-1#1)(1995-1#1)(1995-2#1)(1997-1#3)
of pazufloxacin mesilate##2##3##(2011-2#2)
of pea##8##2##(1993-8#1)(2008-10#5)(2008-8#1)(2009-8#1)
of peach fruit##3##3##(2008-10#3)
of peach##13##2##(2008-10#13)
of peak area##2##3##(2008-10#2)
of peak current is##2##4##(2008-10#2)
of peak current was##2##4##(2008-10#2)
of peak current##6##3##(2008-10#6)
of peak experiences##3##3##(2013-8#3)
of peak height##3##3##(2008-10#3)
of peak potential##2##3##(2008-10#2)
of peak##26##2##(2008-10#18)(2008-2#1)(2010-3#1)(2013-1#1)(2013-8#5)
of peaks##3##2##(2008-10#3)
of peanut (Arachis hypogaea)##3##4##(2008-10#3)
of peanut##5##2##(2008-10#5)
of pear and apple##4##4##(2008-10#4)
of pear##11##2##(2008-10#11)
of pearl millet##2##3##(2008-10#2)
of peat##4##2##(2008-10#3)(2008-8#1)
of peatlands##2##2##(2008-8#2)
of pecks##3##2##(2008-6#3)
of pectolytic enzymes##2##3##(1997-2#1)(2008-10#1)
of pectolytic##3##2##(1997-2#2)(2008-10#1)
of pectoralis minor##3##3##(2010-9#1)(2013-1#2)
of pedal edema##3##3##(2010-2#3)
of pedal##7##2##(1997-8#2)(2010-2#3)(2011-3#2)
of pediatric abdominal surgical emergencies in##2##6##(2011-2#2)
of pediatric hospitals##2##3##(1994-1#1)(2008-11#1)
of pediatric renal length##2##4##(2008-10#2)
of pediatric renal##3##3##(1991-2#1)(2008-10#2)
of pediatric##29##2##(1991-2#1)(1992-5#1)(1994-1#4)(1997-8#1)(2008-10#3)(2008-11#2)(2009-10#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
of peer##4##2##(1991-1#2)(2008-12#1)(2013-1#1)
of peled##2##2##(2008-12#2)
of pellet##5##2##(2008-10#4)(2008-7#1)
of pellets##8##2##(2008-10#1)(2008-7#7)
of pelvic endometriosis##3##3##(1992-1#1)(1995-2#1)(2013-1#1)
of pelvic##13##2##(1991-1#1)(1992-1#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-3#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
of pelvic-peritoneal tuberculosis##3##3##(2008-10#3)
of pendimethalin residue (0##2##4##(2011-1#2)
of pendimethalin##7##2##(2008-11#1)(2011-1#6)
of penetrating##3##2##(2008-10#1)(2009-10#1)(2010-10#1)
of penetration of##3##3##(2008-10#3)
of penetration##10##2##(2008-10#8)(2008-3#1)(2013-1#1)
of penicillamine##2##2##(2008-10#2)
of penicillin G##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
of penicillin##11##2##(1992-12#1)(1994-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
of penoscrotal hypospadia##2##3##(2013-1#2)
of penoscrotal##3##2##(2008-10#1)(2013-1#2)
of pentachlorophenol in##2##3##(2008-10#2)
of pentachlorophenol##3##2##(2008-10#2)(2009-3#1)
of pentamidine##4##2##(1993-2#4)
of pentavalent antimony##2##3##(2008-10#2)
of pentoxifylline##2##2##(2008-10#2)
of pentoxyverine##3##2##(2008-10#3)
of people are##2##3##(2008-10#1)(2008-11#1)
of people in the##3##4##(1995-6#1)(2011-2#1)(2013-8#1)
of people who##5##3##(1991-8#1)(1995-1#1)(2008-11#1)(2013-1#2)
of people with AIDS and##2##5##(1995-6#2)
of people with disabilities##2##4##(1996-1#2)
of people with##13##3##(1995-6#2)(1996-1#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2012-3#2)(2013-1#1)(2013-8#1)
of people##35##2##(1991-8#1)(1992-2#1)(1992-3#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-6#3)(1996-1#3)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
of pepper##7##2##(2008-10#7)
of pepsinogen secretion##2##3##(1995-8#1)(1997-1#1)
of peptic ulcer disease##2##4##(1997-1#2)
of peptic##3##2##(1997-1#3)
of peptidase##2##2##(1991-3#1)(2008-5#1)
of peptide##12##2##(1990-8#1)(1991-12#1)(1993-8#1)(1995-12#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-4#3)
of peptides and proteins##3##4##(1995-2#1)(1997-4#1)(2008-11#1)
of peptides and##4##3##(1995-2#1)(1997-4#1)(2008-11#1)(2008-4#1)
of peptides or##2##3##(1995-2#2)
of peptides under 1 kDa in size##2##7##(2008-11#2)
of peptides##29##2##(1990-5#1)(1992-12#1)(1992-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#3)(1995-6#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-4#4)(2008-5#1)(2008-9#3)(2011-2#1)
of per capita##2##3##(1997-3#1)(2009-4#1)
of per##4##2##(1993-12#1)(1997-3#1)(2009-4#1)(2012-3#1)
of perceived exertion (RPE)##3##4##(2013-1#1)(2013-8#2)
of perceived exertion##5##3##(2013-1#1)(2013-8#4)
of perceived norms##2##3##(2011-1#1)(2013-1#1)
of perceived support##2##3##(2010-1#1)(2010-2#1)
of perceived##24##2##(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-1#2)(2010-10#1)(2010-2#2)(2010-3#2)(2010-6#1)(2011-1#1)(2013-1#4)(2013-8#4)
of percent##4##2##(1993-2#1)(2008-10#3)
of percentage##5##2##(1991-2#1)(1996-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of perception and##2##3##(1994-12#1)(2012-2#1)
of perception##5##2##(1991-2#2)(1994-12#1)(2011-2#1)(2012-2#1)
of perceptions and##2##3##(2012-2#1)(2013-1#1)
of perceptions##6##2##(2008-11#1)(2012-2#1)(2013-1#4)
of perceptual##3##2##(2008-11#2)(2008-9#1)
of perchlorate in##6##3##(2008-10#6)
of perchlorate##15##2##(2008-10#15)
of percutaneous coronary intervention (PCI)##2##5##(2008-11#1)(2013-8#1)
of percutaneous coronary##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
of percutaneous##8##2##(1996-3#1)(2008-11#2)(2008-12#1)(2010-12#1)(2011-2#2)(2013-8#1)
of perennial ryegrass turf##3##4##(2008-10#3)
of perennial ryegrass##8##3##(2008-10#8)
of perennial##11##2##(2008-10#9)(2008-8#1)(2008-9#1)
of perforated##2##2##(1993-6#2)
of perforators##2##2##(2011-3#1)(2013-1#1)
of perforin##2##2##(1993-3#2)
of performance and##3##3##(1995-2#1)(1996-3#1)(2008-10#1)
of performance##19##2##(1994-12#1)(1994-2#2)(1994-3#2)(1995-12#1)(1995-2#2)(1996-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#1)(2011-2#1)
of performing the##2##3##(1992-6#1)(2010-8#1)
of performing##12##2##(1991-3#1)(1992-6#1)(2008-10#5)(2008-11#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
of perfumes##2##2##(2008-5#2)
of perfusion##5##2##(1993-3#1)(2008-11#2)(2010-12#1)(2011-3#1)
of pergolide##3##2##(2008-7#3)
of peri-implantitis##3##2##(2013-1#3)
of periapical##2##2##(2011-2#1)(2013-1#1)
of perinatal##7##2##(1991-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
of periodate and iodate##4##4##(2008-10#4)
of periodate with 1-(3##2##4##(2008-10#2)
of periodate##10##2##(2008-10#10)
of periodic##3##2##(2008-10#2)(2013-8#1)
of periodically poled##2##3##(2007-12#1)(2008-3#1)
of periodontal disease##2##3##(1997-4#1)(2008-9#1)
of periodontal##6##2##(1995-8#1)(1997-4#1)(2008-1#1)(2008-9#1)(2013-1#2)
of perioperative risk##2##3##(2009-5#1)(2011-2#1)
of perioperative##4##2##(2009-5#3)(2011-2#1)
of peripheral blood dilution##2##4##(2008-11#2)
of peripheral blood gene expression##2##5##(2008-10#2)
of peripheral blood lymphocytes##3##4##(1994-6#1)(1995-12#1)(2008-9#1)
of peripheral blood##14##3##(1994-6#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#3)(2011-2#1)(2013-1#1)(2013-7#1)
of peripheral nerve##3##3##(1995-12#1)(2008-11#1)(2011-2#1)
of peripheral neuropathy occurrence in HIV-1 infected patients##2##8##(2008-11#2)
of peripheral neuropathy occurrence in HIV-1 infected##3##7##(2008-11#3)
of peripheral neuropathy##5##3##(1996-2#1)(2008-11#4)
of peripheral##41##2##(1991-6#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#7)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
of peristaltic##2##2##(2008-10#1)(2008-7#1)
of peritoneal dialysis fluid by##2##5##(2008-5#2)
of peritoneal dialysis##5##3##(2008-10#1)(2008-5#2)(2011-2#2)
of peritoneal##11##2##(1993-6#2)(2008-10#2)(2008-12#1)(2008-5#2)(2011-2#4)
of peritonitis##4##2##(2008-12#2)(2011-2#2)
of permanent and##2##3##(2010-6#1)(2011-2#1)
of permanent tooth germs##2##4##(2009-3#2)
of permanent##9##2##(2008-10#2)(2008-4#1)(2009-3#2)(2010-6#1)(2011-2#2)(2013-1#1)
of permanganate##4##2##(2008-10#4)
of peroxidase##5##2##(2008-10#5)
of peroxidases##2##2##(2008-10#2)
of peroxide value in##2##4##(2008-10#2)
of peroxide##6##2##(1990-5#1)(2008-10#5)
of peroxisome##3##2##(1993-9#1)(1995-9#1)(2010-10#1)
of peroxisomes and mitochondria##3##4##(2009-10#3)
of peroxisomes##4##2##(1993-9#1)(2009-10#3)
of peroxynitrite in##2##3##(2008-10#2)
of peroxynitrite on##2##3##(2008-10#2)
of peroxynitrite##11##2##(2008-10#11)
of perphenazine in##4##3##(2008-10#4)
of perphenazine using##2##3##(2008-10#2)
of perphenazine##12##2##(2008-10#12)
of persistence with##2##3##(2009-6#2)
of persistence##6##2##(1995-5#1)(2008-11#1)(2008-5#1)(2009-6#2)(2012-3#1)
of persistent TD##2##3##(2010-12#2)
of persistent##24##2##(1990-5#1)(1992-10#1)(1992-6#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
of personal and professional##2##4##(1994-3#1)(2011-2#1)
of personal and##3##3##(1994-3#1)(2011-2#1)(2011-3#1)
of personal care products##2##4##(2008-5#2)
of personal cleansing##3##3##(2008-5#3)
of personal protective##2##3##(2009-12#1)(2010-4#1)
of personal reflection##2##3##(2008-11#1)(2008-12#1)
of personal##28##2##(1990-3#2)(1994-3#2)(1994-6#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#5)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-4#2)(2011-2#1)(2011-3#1)(2012-3#1)
of personality##5##2##(1991-1#1)(2009-5#1)(2011-2#2)(2013-1#1)
of personalized medicine and##2##4##(2010-10#2)
of personnel##5##2##(1993-3#1)(1993-6#1)(1994-2#1)(2008-10#2)
of persons of##2##3##(1994-2#1)(2008-10#1)
of persons who##2##3##(2011-2#1)(2012-3#1)
of persons with disabilities##2##4##(1997-2#1)(2009-6#1)
of persons with##7##3##(1992-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-7#1)(2009-6#1)
of persons##19##2##(1991-11#1)(1992-3#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
of perspective##3##2##(1996-2#1)(2008-11#1)(2008-12#1)
of perspectives##2##2##(2008-11#1)(2013-8#1)
of persuasion##2##2##(2010-1#2)
of perturbation of##2##3##(2008-10#1)(2011-2#1)
of pertussis vaccines##3##3##(1995-5#3)
of pertussis##5##2##(1991-1#1)(1995-5#4)
of pest##3##2##(2008-10#3)
of pesticide##14##2##(1995-6#1)(1996-3#1)(2008-10#10)(2011-2#2)
of pesticides in##7##3##(2008-10#6)(2008-11#1)
of pesticides was##2##3##(2008-10#2)
of pesticides##20##2##(2008-10#17)(2008-11#3)
of pests##6##2##(2008-10#6)
of petroleum##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
of petrous bone##2##3##(2011-2#2)
of petrous##5##2##(2011-2#5)
of phage antibodies##2##3##(2008-10#1)(2008-4#1)
of phage display##2##3##(2008-4#1)(2009-6#1)
of phage therapy##4##3##(2012-2#4)
of phage##17##2##(1992-4#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-4#3)(2008-9#1)(2009-6#1)(2012-2#6)(2013-1#1)
of phagocytosis by##2##3##(1993-6#1)(2008-9#1)
of phagocytosis##9##2##(1990-12#1)(1993-6#4)(1994-6#3)(2008-9#1)
of pharaonis hR in##2##4##(1994-5#2)
of pharaonis hR##3##3##(1994-5#3)
of pharmaceutical formulations##5##3##(2008-10#5)
of pharmaceutical interest##3##3##(2008-10#3)
of pharmaceutical preparations##3##3##(2008-10#3)
of pharmaceutical products##2##3##(1995-1#1)(2008-10#1)
of pharmaceutical residues in##2##4##(2008-10#2)
of pharmaceutical residues##4##3##(2008-10#4)
of pharmaceutical##28##2##(1995-1#2)(1995-11#1)(2008-10#23)(2008-6#1)(2010-3#1)
of pharmaceuticals containing##2##3##(2008-10#2)
of pharmaceuticals##16##2##(1993-12#1)(1996-3#1)(2008-10#13)(2012-2#1)
of pharmacists##3##2##(2011-1#3)
of pharmacoepidemiology##2##2##(2008-11#2)
of pharmacogenomics##2##2##(2010-8#1)(2013-8#1)
of pharmacokinetic##2##2##(2008-10#1)(2009-7#1)
of pharmacologic##4##2##(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
of pharmacological and##2##3##(2008-11#1)(2009-7#1)
of pharmacological##9##2##(1995-2#1)(2008-10#1)(2008-11#2)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
of pharmacologically active catechins in##2##5##(2008-10#2)
of pharmacologically##3##2##(1993-8#1)(2008-10#2)
of pharmacology##4##2##(2008-11#2)(2008-12#2)
of pharmacotherapy##4##2##(2008-4#1)(2008-6#1)(2013-1#2)
of pharmacovigilance##4##2##(2008-11#4)
of phase I##2##3##(1995-12#1)(2011-2#1)
of phase levels of a Talbot array illuminator##2##8##(2008-3#2)
of phase levels of a##3##5##(2008-3#3)
of phase levels##4##3##(2008-3#4)
of phase objects##2##3##(2008-3#2)
of phase##19##2##(1991-9#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#8)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)
of phase-separated##2##2##(1994-5#1)(2008-10#1)
of phase-shifting interferometry##2##3##(2008-3#2)
of phase-shifting##3##2##(2007-11#1)(2008-3#2)
of phases##4##2##(1992-1#1)(2008-10#2)(2012-2#1)
of phasic##4##2##(1997-4#1)(2011-2#3)
of phenanthrene##5##2##(1994-5#2)(2008-11#3)
of phenazopyridine hydrochloride##2##3##(2008-10#2)
of phencyclidine (PCP)##2##3##(1991-1#2)
of phenethyl alcohol##3##3##(2008-5#3)
of phenobarbital and phenytoin##2##4##(2008-10#2)
of phenobarbital##3##2##(2008-10#3)
of phenol and catechol##2##4##(2008-10#2)
of phenol and##6##3##(2008-10#4)(2008-3#1)(2008-8#1)
of phenol in transformer##2##4##(2008-10#2)
of phenol in##5##3##(2008-10#5)
of phenol is##2##3##(2008-10#2)
of phenol##27##2##(2008-10#24)(2008-3#1)(2008-8#2)
of phenolic acids was##2##4##(2008-10#2)
of phenolic acids##3##3##(2008-10#3)
of phenolic antioxidants##3##3##(2008-10#3)
of phenolic compounds and##3##4##(2008-10#3)
of phenolic compounds as natural antioxidants##2##6##(2008-10#2)
of phenolic compounds by##2##4##(2008-10#2)
of phenolic compounds in##3##4##(2008-10#3)
of phenolic compounds##22##3##(2008-10#19)(2008-11#1)(2011-1#1)(2011-2#1)
of phenolic##37##2##(2008-10#29)(2008-11#1)(2008-5#3)(2008-9#1)(2011-1#1)(2011-2#2)
of phenolics##4##2##(2008-10#3)(2011-2#1)
of phenols and polyphenols##3##4##(2008-10#3)
of phenols and##5##3##(2008-10#5)
of phenols by##2##3##(2008-10#2)
of phenols from##2##3##(2008-10#2)
of phenols##21##2##(1994-5#2)(2008-10#19)
of phenomena##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
of phenophases##2##2##(2012-6#2)
of phenothiazine derivatives##7##3##(2008-10#7)
of phenothiazines in##2##3##(2008-10#2)
of phenothiazines##3##2##(2008-10#3)
of phenotype##5##2##(2008-10#2)(2008-11#2)(2008-8#1)
of phenotypes##5##2##(1994-2#1)(2008-10#3)(2008-9#1)
of phenotypic and genotypic##2##4##(2008-10#2)
of phenotypic plasticity##2##3##(2008-8#1)(2008-9#1)
of phenotypic selection##2##3##(2008-8#2)
of phenotypic specialization##2##3##(2008-8#1)(2008-9#1)
of phenotypic variance##4##3##(2008-10#2)(2008-8#2)
of phenotypic##19##2##(2008-10#6)(2008-8#10)(2008-9#2)(2009-5#1)
of phenoxyl free##2##3##(2008-10#2)
of phenoxyl radicals##2##3##(2008-10#2)
of phenoxyl##4##2##(2008-10#4)
of phenylalanine##3##2##(2008-10#3)
of phenylephrine on##2##3##(1991-3#1)(2012-3#1)
of phenylephrine##8##2##(1991-3#1)(1994-3#1)(2008-10#5)(2012-3#1)
of phenylmercury##4##2##(2008-10#4)
of phenylpropanolamine and methoxamine##2##4##(2008-10#2)
of phenylurea##2##2##(2008-10#2)
of phenytoin in##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
of phenytoin on the##2##4##(2008-11#2)
of phenytoin were##3##3##(1994-2#2)(2008-11#1)
of phenytoin##17##2##(1994-2#4)(2008-10#3)(2008-11#8)(2008-7#2)
of pheochromocytoma##2##2##(2009-1#2)
of pheophytin##2##2##(2008-8#1)(2008-9#1)
of phi X174##2##3##(1991-5#2)
of phi##3##2##(1991-5#2)(2008-3#1)
of phlD##2##2##(2008-10#2)
of phlD(+)##2##2##(2008-10#2)
of phlD+ pseudomonads in##2##4##(2008-10#2)
of phloem cells##3##3##(2008-10#2)(2008-11#1)
of phloem##6##2##(2008-10#4)(2008-11#2)
of phomopsis leaf blight of strawberry##2##6##(2008-10#2)
of phonological awareness and semantic intervention on word-learning##2##8##(2011-1#2)
of phonological awareness and##4##4##(2008-12#2)(2011-1#2)
of phonological awareness##5##3##(2008-12#3)(2011-1#2)
of phonological##6##2##(2008-11#1)(2008-12#3)(2011-1#2)
of phonon##2##2##(2008-2#2)
of phorbol ester##4##3##(1992-8#1)(1995-6#1)(1995-8#1)(2008-11#1)
of phorbol esters##3##3##(1992-12#1)(1994-11#1)(2010-12#1)
of phorbol##9##2##(1992-12#1)(1992-8#1)(1994-11#1)(1994-8#2)(1995-6#1)(1995-8#1)(2008-11#1)(2010-12#1)
of phosphatases##2##2##(1992-8#1)(2008-7#1)
of phosphate and silicate using molybdenum blue##2##7##(2008-10#2)
of phosphate and silicate##3##4##(2008-10#3)
of phosphate and##7##3##(2008-10#6)(2012-12#1)
of phosphate buffer##2##3##(2008-10#2)
of phosphate esters##2##3##(1993-8#1)(1994-11#1)
of phosphate in hydroponic nutrient solutions##2##6##(2008-10#2)
of phosphate in hydroponic nutrient##3##5##(2008-10#3)
of phosphate in marine waters##2##5##(2008-10#2)
of phosphate in natural water##2##5##(2008-10#2)
of phosphate in##10##3##(2008-10#10)
of phosphate ion in##2##4##(2008-10#2)
of phosphate ion##3##3##(2008-10#3)
of phosphate to the##2##4##(2008-10#2)
of phosphate##48##2##(1993-8#1)(1994-11#2)(1995-8#1)(2008-10#41)(2008-7#1)(2010-8#1)(2012-12#1)
of phosphates##3##2##(1993-6#1)(2008-10#2)
of phosphatidic acid##5##3##(1990-8#1)(1991-5#1)(1994-3#3)
of phosphatidylcholine (PC)##4##3##(1991-5#1)(1993-8#1)(2008-10#1)(2008-8#1)
of phosphatidylcholine in##3##3##(2008-10#3)
of phosphatidylcholine##9##2##(1991-5#1)(1993-8#1)(2008-10#6)(2008-8#1)
of phosphatidylethanolamine##2##2##(2012-2#2)
of phosphatidylglycerol##2##2##(2008-8#2)
of phosphatidylinositol 3-kinase (PI 3-kinase)##2##5##(1995-8#1)(2008-11#1)
of phosphatidylinositol 3-kinase##5##3##(1995-6#1)(1995-8#1)(2008-11#1)(2008-3#2)
of phosphatidylinositol 4-phosphate##2##3##(1993-8#1)(1997-8#1)
of phosphatidylinositol##16##2##(1990-8#1)(1993-8#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-8#2)(2008-11#3)(2008-3#2)(2013-1#1)
of phosphatidylserine##4##2##(1990-5#1)(1993-8#1)(1995-2#1)(2008-11#1)
of phosphite##2##2##(2008-10#2)
of phosphoinositide##5##2##(1995-8#1)(1996-2#3)(1997-1#1)
of phospholipase A(2)##4##3##(2008-11#3)(2011-2#1)
of phospholipase A2 by##2##4##(1994-11#2)
of phospholipase A2##10##3##(1990-5#1)(1994-11#2)(1994-5#4)(1996-2#2)(2013-8#1)
of phospholipase C and protein kinase C##2##7##(2008-11#2)
of phospholipase C and##3##4##(2008-11#3)
of phospholipase C##9##3##(1990-8#1)(1993-6#1)(1994-11#1)(1997-1#1)(2008-10#1)(2008-11#3)(2012-2#1)
of phospholipase D in##2##4##(1993-3#1)(1995-8#1)
of phospholipase D##6##3##(1993-3#3)(1995-8#2)(1997-2#1)
of phospholipase activity##2##3##(1995-8#2)
of phospholipase##31##2##(1990-5#1)(1990-8#1)(1993-3#3)(1993-6#1)(1994-11#3)(1994-5#4)(1995-8#4)(1996-2#2)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#6)(2011-2#1)(2012-2#1)(2013-8#1)
of phospholipid##11##2##(1992-11#1)(1993-8#3)(1994-5#2)(1995-6#2)(2008-11#1)(2008-7#1)(2008-9#1)
of phospholipids on the reconstitution##2##5##(1995-8#2)
of phospholipids on the##3##4##(1995-8#3)
of phospholipids##13##2##(1990-5#1)(1994-5#1)(1995-8#3)(2008-10#3)(2008-11#3)(2008-5#1)(2009-8#1)
of phosphopeptides##4##2##(1996-2#2)(2010-7#2)
of phosphoproteins##2##2##(1995-6#1)(2010-9#1)
of phosphorescence##2##2##(2008-10#2)
of phosphoric acid##4##3##(2008-10#4)
of phosphorothioate##2##2##(1995-12#1)(2008-4#1)
of phosphorus and##2##3##(2008-12#2)
of phosphorus in soil and sediment##3##6##(2008-10#3)
of phosphorus in##7##3##(2008-10#6)(2008-11#1)
of phosphorus species##5##3##(2008-10#5)
of phosphorus##33##2##(2008-10#27)(2008-11#1)(2008-12#3)(2011-10#2)
of phosphorylase kinase##3##3##(1990-8#3)
of phosphorylated##7##2##(1993-8#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#3)
of phosphorylation of##3##3##(1993-8#1)(1995-12#1)(2011-2#1)
of phosphorylation##10##2##(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-12#1)(1995-6#1)(2008-11#1)(2008-8#1)(2011-2#1)
of photoacoustic##4##2##(1994-11#1)(2008-10#1)(2011-7#2)
of photoaging##2##2##(1991-6#1)(2011-2#1)
of photocatalytic##2##2##(2008-10#2)
of photochemical##2##2##(2008-10#1)(2008-5#1)
of photochemically induced fluorescence##2##4##(2008-10#2)
of photodegradation##5##2##(2008-10#5)
of photodynamic therapy (PDT) in##2##5##(2009-4#1)(2012-3#1)
of photodynamic therapy##5##3##(2008-8#1)(2009-4#2)(2012-3#2)
of photon##3##2##(2008-3#2)(2010-10#1)
of photons##2##2##(2008-2#1)(2008-4#1)
of photopolymer##2##2##(2007-12#2)
of photoreceptor outer##2##3##(2008-7#2)
of photoreceptor##5##2##(1996-2#1)(2008-7#3)(2012-3#1)
of photoreceptors##4##2##(1991-10#1)(1996-2#2)(2008-7#1)
of photorefractive##2##2##(2008-3#2)
of photosensitization##2##2##(1991-5#1)(2008-8#1)
of photosynthesis##5##2##(1996-12#1)(2008-10#1)(2008-9#1)(2009-10#1)(2012-7#1)
of photosynthetic bacteria##2##3##(2008-8#2)
of photosynthetic electron transport to photorespiration##2##6##(2008-8#2)
of photosynthetic##7##2##(1997-4#1)(2008-10#1)(2008-8#4)(2008-9#1)
of photosynthetically active radiation##2##4##(2008-10#2)
of photosystem II##2##3##(1997-4#1)(2008-11#1)
of phototype##2##2##(2008-5#2)
of phthalate##2##2##(2008-10#2)
of phthalates##2##2##(2008-10#2)
of phycoerythrin##2##2##(2008-8#2)
of phycoerythrobilins on##2##3##(2008-8#2)
of phyllodes tumour##2##3##(2011-2#2)
of phylogenetic relationships##2##3##(2008-5#1)(2008-8#1)
of phylogenetic##12##2##(1991-5#1)(2008-10#3)(2008-5#1)(2008-8#3)(2011-2#4)
of phylogenetically##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
of phylogenies##2##2##(2010-5#1)(2012-3#1)
of physical abuse##2##3##(2010-7#1)(2012-3#1)
of physical activity in##2##4##(2012-12#1)(2013-1#1)
of physical activity##18##3##(2008-11#1)(2008-12#1)(2008-4#1)(2010-11#5)(2010-8#1)(2012-12#2)(2013-1#7)
of physical and biological##2##4##(1994-5#1)(2008-10#1)
of physical and chemical##4##4##(2008-10#3)(2013-8#1)
of physical and##10##3##(1991-2#1)(1994-5#1)(2008-10#4)(2009-11#1)(2010-6#1)(2011-2#1)(2013-8#1)
of physical barriers##2##3##(2008-10#2)
of physical evidence##2##3##(2008-10#2)
of physical examination##2##3##(2008-8#1)(2010-8#1)
of physical exercise##2##3##(1993-6#1)(2010-12#1)
of physical medicine##2##3##(2008-12#2)
of physical properties##2##3##(2008-5#1)(2011-2#1)
of physical restraints##2##3##(2010-10#2)
of physical therapy##3##3##(1993-3#1)(2008-12#2)
of physical training on##2##4##(2013-8#2)
of physical##76##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-6#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-12#8)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#2)(2010-11#7)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#7)(2013-8#3)
of physician leaders##2##3##(1994-1#1)(2008-11#1)
of physician payment reform##2##4##(1994-1#2)
of physician##22##2##(1991-12#1)(1992-12#1)(1993-3#1)(1994-1#5)(1995-12#3)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-11#1)(2013-1#5)
of physicians and hospitals##2##4##(1992-11#1)(1997-5#1)
of physicians and nurses to##2##5##(1993-2#1)(2008-11#1)
of physicians and##9##3##(1991-2#1)(1991-3#1)(1992-11#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-1#1)(1997-5#1)(2008-11#1)
of physicians to##3##3##(1994-1#2)(1995-1#1)
of physicians##36##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#3)(1994-1#3)(1994-2#1)(1994-3#6)(1995-1#3)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-11#1)(2009-3#1)(2010-1#2)(2012-2#1)(2012-3#1)
of physicians'##4##2##(1991-2#1)(1995-12#1)(1995-2#1)(2011-1#1)
of physicochemical##2##2##(2008-10#1)(2013-1#1)
of physiologic##2##2##(2010-7#1)(2012-3#1)
of physiological and##4##3##(1991-2#1)(1992-6#1)(2008-4#1)(2011-2#1)
of physiological functions##3##3##(2008-5#1)(2011-2#2)
of physiological##26##2##(1990-11#1)(1991-2#2)(1992-6#1)(1993-1#1)(1996-2#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#3)(2008-9#1)(2009-8#1)(2011-2#5)(2013-7#1)
of physiologically##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
of physiology##3##2##(2009-11#1)(2012-2#1)(2013-8#1)
of physiotherapists##3##2##(1993-1#1)(1994-3#1)(2009-7#1)
of physiotherapy##2##2##(1992-2#1)(1993-3#1)
of phytoalexins##2##2##(2008-10#2)
of phytochrome action##2##3##(1990-5#2)
of phytoestrogens##2##2##(2008-10#2)
of phytohormones##3##2##(2008-10#3)
of phytopathogenic##2##2##(2008-10#2)
of phytophthora##2##2##(2008-10#2)
of phytoplankton blooms##2##3##(2008-3#1)(2008-8#1)
of phytoplankton##9##2##(2008-10#2)(2008-3#1)(2008-8#5)(2013-8#1)
of phytoplasma in the##2##4##(2008-10#2)
of phytoplasma in##6##3##(2008-10#6)
of phytoplasma##14##2##(2008-10#14)
of phytoplasmas in the##2##4##(2008-10#2)
of phytoplasmas were##2##3##(2008-10#2)
of phytoplasmas##13##2##(2008-10#13)
of pi##2##2##(2008-3#1)(2008-8#1)
of picrate anions##2##3##(2008-10#2)
of picric acid##4##3##(2008-10#4)
of piezoelectric immunosensors for##2##4##(2008-10#2)
of piezoelectric quartz crystal (PQC)##2##5##(2008-10#2)
of piezoelectric quartz crystal##4##4##(2008-10#4)
of piezoelectric quartz##5##3##(1990-8#1)(2008-10#4)
of piezoelectric##7##2##(1990-8#1)(2008-10#6)
of pig##3##2##(2006-6#1)(2008-12#1)(2013-1#1)
of pigeon herpes virus (PHV)##2##5##(2008-5#2)
of piglets from##2##3##(1996-8#1)(2013-1#1)
of pigment substitution on the electrochemical properties of Rhodobacter sphaeroides 601 reaction centers##2##13##(2008-8#2)
of pigment substitution##4##3##(2008-8#4)
of pigment##7##2##(2008-10#1)(2008-5#1)(2008-8#4)(2013-1#1)
of pigmentation##2##2##(2008-10#1)(2008-8#1)
of pigmented and wooden surfaces##2##5##(2008-10#2)
of pigmented surfaces##2##3##(2008-10#2)
of pigmented##8##2##(2008-10#4)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
of pigments and##2##3##(2008-10#2)
of pigments##6##2##(2008-10#4)(2008-3#1)(2008-8#1)
of pigs in##2##3##(2011-2#1)(2013-8#1)
of pigs##3##2##(2011-2#1)(2013-8#2)
of pilE##2##2##(1993-12#2)
of pindolol##4##2##(2008-10#4)
of pine##2##2##(2008-10#2)
of pineapple##4##2##(2008-10#4)
of piperidine##2##2##(1993-8#1)(2008-11#1)
of piroxicam (PX) in##2##4##(2008-10#2)
of piroxicam##6##2##(1990-9#1)(2008-10#5)
of pistachio in##2##3##(2008-10#2)
of pistachio##7##2##(2008-10#7)
of pitfalls##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
of pituitary apoplexy##2##3##(2011-2#2)
of pituitary##8##2##(1996-11#1)(2009-1#1)(2011-2#5)(2013-8#1)
of pityriasis versicolor##2##3##(2008-5#2)
of pivotal##2##2##(1997-8#1)(2011-2#1)
of place##5##2##(1994-3#1)(2008-11#3)(2013-1#1)
of placebo##3##2##(2008-10#1)(2008-12#1)(2010-9#1)
of placental##2##2##(1996-11#1)(2008-11#1)
of placing##3##2##(1992-12#1)(1993-6#1)(2013-1#1)
of plain radiography##2##3##(2010-6#1)(2011-2#1)
of plan##3##2##(1994-2#1)(1997-3#2)
of planar##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)
of planned##2##2##(2010-6#1)(2012-2#1)
of planning and##3##3##(1991-1#1)(1994-6#1)(2009-11#1)
of planning##9##2##(1991-1#1)(1993-1#1)(1994-2#1)(1994-6#1)(1996-3#1)(1997-3#1)(2008-11#2)(2009-11#1)
of plant age##3##3##(2008-10#3)
of plant and animal##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
of plant and##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2011-10#1)
of plant biology##2##3##(2007-12#1)(2008-9#1)
of plant cell##2##3##(2009-10#1)(2009-8#1)
of plant cells##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2009-8#2)
of plant chromosomes##2##3##(2008-9#2)
of plant defense reactions##2##4##(2008-10#2)
of plant defense##5##3##(2008-10#4)(2008-8#1)
of plant development##4##3##(2008-10#3)(2009-8#1)
of plant disease epidemics##3##4##(2008-10#3)
of plant disease##5##3##(2008-10#5)
of plant diseases##4##3##(2008-10#4)
of plant growth regulators##2##4##(2008-10#1)(2008-12#1)
of plant growth##7##3##(2008-10#4)(2008-12#1)(2011-2#1)(2013-8#1)
of plant growth-promoting rhizobacteria##3##4##(2008-10#3)
of plant keratin intermediate##2##4##(2008-8#2)
of plant materials##2##3##(2008-10#2)
of plant origin##3##3##(1994-5#1)(2008-10#1)(2012-2#1)
of plant pathogen##2##3##(2008-10#2)
of plant pathogens by##2##4##(2008-10#2)
of plant pathogens##16##3##(2008-10#16)
of plant protection products##3##4##(2008-11#3)
of plant responses to##2##4##(2008-10#1)(2009-8#1)
of plant roots##3##3##(2008-10#2)(2009-8#1)
of plant samples##3##3##(2008-10#2)(2008-9#1)
of plant species##6##3##(2008-10#3)(2008-8#2)(2009-8#1)
of plant tissue##3##3##(2008-10#2)(2008-9#1)
of plant viruses by##2##4##(2008-10#2)
of plant viruses##10##3##(2008-10#9)(2008-9#1)
of plant water##2##3##(2008-10#1)(2009-8#1)
of plant##159##2##(1994-5#1)(1995-2#1)(1997-8#1)(2007-12#3)(2008-10#88)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#13)(2008-9#13)(2009-10#2)(2009-6#3)(2009-8#13)(2011-1#1)(2011-10#2)(2011-2#3)(2012-2#3)(2012-3#1)(2012-6#1)(2013-8#1)
of plant-associated microbes##2##3##(2008-10#2)
of plant-derived##2##2##(2008-10#1)(2012-12#1)
of plant-herbivore##2##2##(2008-8#1)(2008-9#1)
of plant-parasitic nematodes##2##3##(2008-10#2)
of plant-virus##2##2##(2008-10#2)
of plantar##2##2##(2008-7#1)(2012-2#1)
of planting##4##2##(2008-10#4)
of plants and##4##3##(2008-10#3)(2008-9#1)
of plants in the##4##4##(2008-10#3)(2010-7#1)
of plants in##6##3##(2008-10#4)(2008-12#1)(2010-7#1)
of plants inoculated##2##3##(2008-10#2)
of plants to##11##3##(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#1)(2009-8#2)(2011-2#1)(2012-5#1)
of plants were##2##3##(2008-10#1)(2008-12#1)
of plants with##5##3##(2008-10#5)
of plants within##2##3##(2008-10#2)
of plants##70##2##(2008-10#50)(2008-11#3)(2008-12#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#4)(2010-7#2)(2011-2#1)(2012-5#1)
of plaque##7##2##(2008-6#1)(2008-7#2)(2010-9#4)
of plaques and##2##3##(1991-1#1)(2012-2#1)
of plaques##6##2##(1990-5#1)(1991-1#1)(1991-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
of plasma cells##2##3##(2008-9#2)
of plasma homocysteine##2##3##(1991-12#1)(1992-9#1)
of plasma membrane##10##3##(1990-5#2)(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-9#1)
of plasma membranes##4##3##(1991-5#1)(2008-10#1)(2008-11#2)
of plasma##53##2##(1990-12#1)(1990-5#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-2#3)(1996-11#1)(1997-8#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-3#2)(2008-7#3)(2008-9#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)
of plasma-derived##2##2##(2010-11#1)(2012-12#1)
of plasmid DNA##14##3##(1997-8#2)(2008-10#4)(2008-11#4)(2008-4#1)(2008-8#2)(2011-2#1)
of plasmid delivery##2##3##(2008-11#1)(2012-2#1)
of plasmid##19##2##(1997-8#2)(2008-10#4)(2008-11#8)(2008-4#1)(2008-8#2)(2011-2#1)(2012-2#1)
of plasmids##7##2##(1993-2#1)(1993-9#1)(1994-11#1)(1997-3#1)(1997-7#1)(2008-11#1)(2011-2#1)
of plasminogen activator##2##3##(1994-3#1)(1997-1#1)
of plasminogen activators##2##3##(1992-6#2)
of plasminogen##6##2##(1992-6#2)(1994-3#1)(1995-6#1)(1997-1#1)(2010-3#1)
of plastic surgery##2##3##(2013-1#2)
of plastic##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
of plasticity##7##2##(2008-8#6)(2009-3#1)
of plasticizer and##2##3##(2008-10#2)
of plasticizer##4##2##(2008-10#4)
of plasticizers##4##2##(2008-10#3)(2008-5#1)
of platelet activation##2##3##(1990-5#1)(1994-3#1)
of platelet aggregation and##2##4##(1990-8#1)(1992-4#1)
of platelet aggregation in##2##4##(2006-6#1)(2008-5#1)
of platelet aggregation##5##3##(1990-8#1)(1992-4#1)(2006-6#2)(2008-5#1)
of platelet##25##2##(1990-5#1)(1990-8#1)(1992-12#2)(1992-4#2)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(2006-6#4)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#4)
of platelet-derived growth factor##2##4##(1995-11#1)(2008-11#1)
of platelet-derived growth##3##3##(1995-11#2)(2008-11#1)
of platelet-leukocyte##2##2##(2006-6#2)
of platelets by##3##3##(1992-12#1)(2006-6#1)(2008-9#1)
of platelets in##5##3##(1991-12#1)(2006-6#1)(2008-1#1)(2008-8#2)
of platelets##21##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-12#2)(1992-6#1)(2006-6#6)(2008-1#1)(2008-11#1)(2008-8#3)(2008-9#3)(2011-2#1)
of platform##2##2##(2008-10#1)(2012-12#1)
of platinum and palladium##6##4##(2008-10#6)
of platinum and ruthenium##3##4##(2008-10#3)
of platinum and##11##3##(2008-10#11)
of platinum group elements##2##4##(2008-10#1)(2008-11#1)
of platinum group metals##5##4##(2008-10#5)
of platinum group##8##3##(2008-10#7)(2008-11#1)
of platinum with a##2##4##(2008-10#2)
of platinum with##3##3##(2008-10#3)
of platinum##42##2##(1993-8#1)(2008-10#39)(2008-11#2)
of platinum(II) with##4##3##(2008-10#4)
of platinum(II)##7##2##(2008-10#7)
of platinum(IV)##5##2##(2008-10#5)
of play##2##2##(2008-12#1)(2013-8#1)
of pleomorphic##3##2##(1991-12#1)(2008-7#1)(2010-12#1)
of pleural##3##2##(1997-4#1)(1997-5#1)(2008-1#1)
of plots##6##2##(2008-10#4)(2008-8#2)
of plum##2##2##(2008-10#2)
of plutonium##2##2##(2008-10#2)
of pneumatic##2##2##(2008-10#2)
of pneumatosis intestinalis##3##3##(2012-2#3)
of pneumatosis##4##2##(2012-2#4)
of pneumococcal##4##2##(1990-9#1)(2007-12#1)(2008-10#1)(2011-2#1)
of podophyllotoxin##4##2##(2008-11#4)
of podoplanin##2##2##(2013-1#2)
of poikilothermic##3##2##(2008-7#2)(2008-9#1)
of point mutations in##2##4##(2008-10#1)(2008-7#1)
of point mutations##3##3##(1991-5#1)(2008-10#1)(2008-7#1)
of point##4##2##(1991-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
of points##7##2##(1997-6#1)(2008-11#3)(2008-9#1)(2009-11#1)(2009-8#1)
of polar and nonpolar##2##4##(2008-10#1)(2013-8#1)
of polar and##4##3##(2008-10#2)(2012-3#1)(2013-8#1)
of polar##6##2##(2008-10#4)(2012-3#1)(2013-8#1)
of polarity##3##2##(1997-2#1)(2008-10#1)(2009-8#1)
of polarization and##3##3##(2008-10#1)(2008-3#2)
of polarization##18##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#10)
of polarized light##2##3##(2008-3#2)
of polarized##4##2##(2008-3#4)
of polarizing##2##2##(1993-12#2)
of polarographic##2##2##(2008-10#2)
of poled polymer##2##3##(2008-2#1)(2008-3#1)
of poled##3##2##(2008-2#2)(2008-3#1)
of policies and##2##3##(2008-11#1)(2010-7#1)
of policies##6##2##(1995-1#1)(1996-1#1)(2008-11#1)(2010-7#1)(2012-2#2)
of policy##8##2##(1995-3#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-6#1)(2010-10#2)(2012-3#1)
of policy-relevant##2##2##(1995-1#1)(2008-11#1)
of poliomyelitis##3##2##(1994-8#1)(1994-9#1)(1995-5#1)
of poliovirus##2##2##(1993-6#1)(1995-5#1)
of political##3##2##(1996-1#1)(2008-10#1)(2011-2#1)
of pollen grains##2##3##(2008-10#2)
of pollen limitation##2##3##(2008-8#1)(2008-9#1)
of pollen transfer##2##3##(2008-8#2)
of pollen##16##2##(2008-10#6)(2008-8#6)(2008-9#1)(2009-12#1)(2011-2#1)(2012-7#1)
of pollination##2##2##(2008-10#1)(2009-6#1)
of pollutant##2##2##(2008-11#2)
of pollutants in a##2##4##(2008-10#2)
of pollutants in##3##3##(2008-10#3)
of pollutants##11##2##(1991-3#1)(1994-3#1)(2008-10#9)
of pollution##7##2##(1990-8#1)(2008-10#4)(2008-11#2)
of poly##3##2##(2008-10#1)(2009-10#1)(2011-2#1)
of poly(ethylene##3##2##(2008-10#3)
of poly(sodium##2##2##(2008-10#2)
of poly(vinyl##2##2##(2008-10#2)
of poly-L-lysine##3##2##(2008-10#1)(2008-11#2)
of polyadenylated##2##2##(2010-4#2)
of polyamine##2##2##(1992-9#1)(2013-8#1)
of polyamines and##2##3##(2008-10#2)
of polyamines##6##2##(2008-10#6)
of polyaniline##4##2##(2008-10#4)
of polyanions##4##2##(2008-10#4)
of polyaromatic hydrocarbons##3##3##(2008-10#3)
of polyaromatic##4##2##(2008-10#4)
of polyarteritis##2##2##(1990-9#1)(1997-8#1)
of polyatomic##2##2##(2008-10#2)
of polybrominated diphenyl ethers (PBDEs)##2##5##(2008-10#2)
of polybrominated diphenyl ethers##5##4##(2008-10#5)
of polybrominated##6##2##(2008-10#6)
of polychlorinated biphenyls in##2##4##(2008-10#2)
of polychlorinated biphenyls##3##3##(2008-10#3)
of polychlorinated##4##2##(2008-10#4)
of polycyclic aromatic compounds##2##4##(2008-10#2)
of polycyclic aromatic hydrocarbons (PAHs) from##2##6##(2008-10#2)
of polycyclic aromatic hydrocarbons (PAHs) in airborne particulate matter##2##9##(2008-10#2)
of polycyclic aromatic hydrocarbons (PAHs) in##6##6##(2008-10#6)
of polycyclic aromatic hydrocarbons (PAHs)##12##5##(2008-10#12)
of polycyclic aromatic hydrocarbons and##3##5##(2008-10#2)(2008-11#1)
of polycyclic aromatic hydrocarbons by##3##5##(2008-10#3)
of polycyclic aromatic hydrocarbons from##2##5##(2008-10#2)
of polycyclic aromatic hydrocarbons in water samples##3##7##(2008-10#3)
of polycyclic aromatic hydrocarbons in water##4##6##(2008-10#4)
of polycyclic aromatic hydrocarbons in##8##5##(2008-10#8)
of polycyclic aromatic hydrocarbons using##2##5##(2008-10#2)
of polycyclic aromatic hydrocarbons##33##4##(2008-10#32)(2008-11#1)
of polycyclic aromatic##36##3##(2008-10#35)(2008-11#1)
of polycystic ovary syndrome (PCOS)##3##5##(2008-4#3)
of polyethylene glycol (PEG)##2##4##(2008-10#2)
of polyethylene glycol##3##3##(1992-11#1)(2008-10#2)
of polyethylene##5##2##(1992-11#1)(2008-10#3)(2008-11#1)
of polyethyleneglycol (PEG)##2##3##(2008-10#1)(2008-12#1)
of polyethyleneglycol##3##2##(1994-11#1)(2008-10#1)(2008-12#1)
of polyethyleneimine (PEI)##2##3##(2008-10#2)
of polyethyleneimine##3##2##(2008-10#3)
of polygalacturonase##2##2##(1997-2#1)(2008-10#1)
of polygenic##2##2##(2008-7#1)(2013-1#1)
of polyhydric phenols##2##3##(2008-10#2)
of polyhydroxy phenols##2##3##(2008-10#2)
of polymer brush-modified##2##3##(2010-7#2)
of polymer film##3##3##(2008-10#3)
of polymer modified electrode##2##4##(2008-10#2)
of polymer##23##2##(2008-10#15)(2008-5#1)(2009-5#1)(2010-4#2)(2010-7#3)(2013-1#1)
of polymerase chain reaction (PCR)##3##5##(1991-1#1)(1995-12#1)(2008-10#1)
of polymerase chain reaction##7##4##(1991-1#1)(1995-12#1)(1996-11#1)(2008-10#2)(2010-6#1)(2013-1#1)
of polymeric galactoglucomannans##2##3##(2013-1#2)
of polymeric resin##2##3##(2008-10#2)
of polymeric##13##2##(1995-3#1)(2008-10#5)(2008-3#2)(2008-5#1)(2009-4#1)(2010-4#1)(2013-1#2)
of polymerization##6##2##(1990-6#1)(2008-10#2)(2008-2#1)(2013-1#2)
of polymers##7##2##(1995-3#1)(2008-10#3)(2009-7#1)(2010-10#1)(2011-1#1)
of polymorphic N-acetyltransferase##2##3##(1993-3#1)(1995-9#1)
of polymorphic loci##3##3##(2008-10#2)(2008-9#1)
of polymorphic##10##2##(1993-3#1)(1995-9#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
of polymorphisms##5##2##(1997-9#1)(2008-10#2)(2010-11#1)(2011-2#1)
of polymorphonuclear leukocytes##2##3##(2008-12#1)(2010-1#1)
of polymorphonuclear##5##2##(1990-12#2)(1991-11#1)(2008-12#1)(2010-1#1)
of polymyalgia rheumatica##2##3##(1994-9#1)(2008-7#1)
of polymyxins on the##2##4##(2008-10#2)
of polynuclear aromatic hydrocarbons (PAHs)##2##5##(2008-10#2)
of polynuclear aromatic hydrocarbons##3##4##(2008-10#3)
of polynucleated PAM##2##3##(1993-8#2)
of polyoxometalates##3##2##(2008-10#3)
of polypeptide##3##2##(1991-10#1)(1996-2#1)(2008-4#1)
of polypeptides##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
of polyphenol oxidase##4##3##(2008-10#4)
of polyphenol##5##2##(2008-10#4)(2009-12#1)
of polyphenols in##4##3##(2008-10#2)(2009-12#1)(2009-3#1)
of polyphenols##10##2##(2008-10#3)(2008-7#1)(2009-12#3)(2009-3#2)(2009-8#1)
of polyphosphates##2##2##(2008-10#2)
of polypropylene fiber liquid filtration membrane particles##2##7##(2012-3#2)
of polypropylene##3##2##(2012-3#3)
of polysaccharide##3##2##(2009-3#1)(2012-3#1)(2013-8#1)
of polysaccharides in##2##3##(2008-10#1)(2011-2#1)
of polysaccharides##4##2##(1996-12#1)(2008-10#1)(2011-2#2)
of polyspermy##2##2##(2008-8#2)
of polystyrene latex spheres##2##4##(2008-3#2)
of polystyrene##5##2##(2008-10#2)(2008-3#3)
of polyunsaturated fatty acids (PUFAs) in##2##6##(2008-10#1)(2010-4#1)
of polyunsaturated fatty acids##4##4##(1991-12#1)(2008-10#2)(2010-4#1)
of polyvinyl alcohol##3##3##(2008-10#3)
of polyvinyl##4##2##(2008-10#3)(2008-5#1)
of pooled##2##2##(2008-10#1)(2009-11#1)
of pools##2##2##(1995-6#1)(2008-11#1)
of poor outcome##2##3##(2011-2#1)(2012-3#1)
of poor##12##2##(1995-2#1)(1995-9#1)(1996-11#1)(2008-10#6)(2008-12#1)(2011-2#1)(2012-3#1)
of poorer##2##2##(1992-2#1)(2008-5#1)
of poorly##3##2##(1994-12#1)(2012-2#1)(2012-3#1)
of poplar##2##2##(2008-10#2)
of popliteal lymph##2##3##(2008-11#1)(2008-5#1)
of popliteal##4##2##(1991-3#2)(2008-11#1)(2008-5#1)
of popular##3##2##(1993-1#1)(1995-2#1)(2009-10#1)
of population data##2##3##(2008-10#1)(2008-12#1)
of population decline##2##3##(1995-3#1)(2008-10#1)
of population differentiation##2##3##(2008-10#2)
of population dynamics##2##3##(2008-10#1)(2010-8#1)
of population fluctuations##2##3##(2008-8#2)
of population growth rate##2##4##(2008-8#1)(2010-8#1)
of population growth##3##3##(1991-3#1)(2008-8#1)(2010-8#1)
of population regulation##3##3##(2008-8#3)
of population screening##2##3##(1990-6#1)(1996-8#1)
of population structure##4##3##(2008-10#3)(2008-9#1)
of population##45##2##(1990-6#1)(1991-3#2)(1995-12#1)(1995-3#1)(1996-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#12)(2008-9#5)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#1)
of population-based##2##2##(1991-6#1)(1995-12#1)
of populations from##4##3##(2008-10#3)(2008-9#1)
of populations of Phytophthora##2##4##(2008-10#2)
of populations of##11##3##(2008-10#7)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
of populations##36##2##(1995-12#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-6#2)(2008-8#5)(2008-9#5)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of porcine coronary artery##3##4##(1990-8#1)(2008-11#2)
of porcine coronary##4##3##(1990-8#1)(1997-8#1)(2008-11#2)
of porcine embryos##2##3##(1996-8#2)
of porcine pancreatic alpha-amylase##4##4##(1990-9#2)(1992-12#2)
of porcine pancreatic elastase##2##4##(1991-3#2)
of porcine pancreatic##6##3##(1990-9#2)(1991-3#2)(1992-12#2)
of porcine##33##2##(1990-8#1)(1990-9#2)(1991-3#2)(1992-12#3)(1992-6#1)(1994-11#1)(1995-12#2)(1995-8#2)(1996-12#1)(1996-8#2)(1997-8#1)(2008-11#6)(2008-5#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#5)
of porins##2##2##(1997-8#1)(2008-10#1)
of pork##2##2##(1990-8#1)(2008-10#1)
of porogens##2##2##(2008-10#2)
of porosity##2##2##(2009-7#2)
of porous silicon##3##3##(2008-10#2)(2008-3#1)
of porous##11##2##(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2009-7#1)(2010-7#1)
of porphyrin fluorescence##2##3##(1991-5#2)
of porphyrin to##2##3##(2008-10#2)
of porphyrin##7##2##(1991-5#2)(1996-5#1)(2008-10#3)(2008-9#1)
of porphyrins##2##2##(1991-5#1)(2008-10#1)
of portal hypertension##3##3##(2009-9#2)(2013-1#1)
of portals##4##2##(2008-10#4)
of portfolio development##2##3##(2008-11#2)
of portfolio##3##2##(2008-11#3)
of portfolios##4##2##(2008-11#4)
of position##2##2##(1996-12#1)(2008-12#1)
of positional##2##2##(1995-5#1)(2008-10#1)
of positive and negative##2##4##(1993-12#1)(2010-9#1)
of positive cases##3##3##(1990-6#1)(2012-12#1)(2013-8#1)
of positive clones##2##3##(1990-8#1)(2008-8#1)
of positive samples##2##3##(1996-12#1)(2011-2#1)
of positive##37##2##(1990-6#1)(1990-8#2)(1992-9#1)(1993-12#2)(1996-12#2)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#2)(2013-1#1)(2013-8#1)
of positively charged##4##3##(2008-10#2)(2008-8#1)(2011-1#1)
of positron emission##2##3##(1992-11#1)(2012-12#1)
of possible inhibitory##2##3##(1994-5#1)(2008-7#1)
of possible sources of##2##4##(1995-3#1)(2008-10#1)
of possible##36##2##(1991-2#1)(1991-3#2)(1992-5#1)(1994-5#1)(1995-12#2)(1995-3#1)(1997-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
of post##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
of post-prandial lipoprotein##2##3##(2008-6#2)
of post-prandial##3##2##(2008-6#3)
of post-surgical##2##2##(1991-1#1)(2007-8#1)
of post-translational modifications##3##3##(2008-11#1)(2009-5#1)(2010-9#1)
of post-translational##6##2##(2008-11#1)(2008-4#1)(2009-5#2)(2009-7#1)(2010-9#1)
of post-translationally modified##2##3##(2009-7#1)(2011-1#1)
of post-transplant##2##2##(2007-11#2)
of post-traumatic stress disorder##2##4##(2008-6#2)
of post-traumatic##4##2##(1997-3#1)(2008-6#2)(2008-7#1)
of post-treatment##2##2##(1992-9#1)(2013-1#1)
of postactivation potentiation##2##3##(2009-1#2)
of posterior pituitary##2##3##(1997-8#2)
of posterior##11##2##(1997-8#2)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
of posteromedial tibial plateau##2##4##(2013-1#2)
of postgraduate##3##2##(1992-1#1)(1994-12#1)(2013-1#1)
of postharvest decay##2##3##(2008-10#2)
of postharvest pathogens##2##3##(2008-10#2)
of postharvest##10##2##(2008-10#10)
of postmenopausal##3##2##(1992-12#1)(1994-12#1)(2010-7#1)
of postnatal##3##2##(1992-12#1)(1995-6#1)(2013-1#1)
of postoperative complications##2##3##(2011-3#1)(2012-3#1)
of postoperative respiratory##2##3##(2009-5#1)(2012-3#1)
of postoperative##25##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#5)(2008-8#1)(2009-2#1)(2009-3#2)(2009-5#1)(2010-4#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#3)
of postprandial##2##2##(1997-4#1)(2008-12#1)
of poststroke##2##2##(2009-11#1)(2013-1#1)
of postsynaptic##3##2##(1990-9#1)(2008-11#2)
of posttranscriptional##2##2##(2008-10#1)(2013-1#1)
of potassium bromide##2##3##(2008-10#2)
of potassium channels##2##3##(1992-6#2)
of potassium ferricyanide##4##3##(2008-10#3)(2009-9#1)
of potassium iodide##2##3##(2008-10#2)
of potassium ion##2##3##(2008-10#2)
of potassium phosphate##3##3##(2008-10#2)(2008-7#1)
of potassium##36##2##(1992-6#2)(1992-9#1)(1995-11#1)(1997-8#1)(2008-10#27)(2008-2#1)(2008-7#1)(2008-9#1)(2009-9#1)
of potato (cv##2##3##(2008-10#2)
of potato and tomato##4##4##(2008-10#4)
of potato and##5##3##(2008-10#5)
of potato cultivars##3##3##(2008-10#3)
of potato cvs##2##3##(2008-10#2)
of potato cyst##2##3##(2008-10#2)
of potato late blight##5##4##(2008-10#5)
of potato stem rot##2##4##(2008-10#2)
of potato virus y##2##4##(2008-10#2)
of potato virus##4##3##(1997-3#1)(2008-10#3)
of potato##48##2##(1993-12#2)(1997-3#1)(2008-10#45)
of potatoes##3##2##(2008-10#2)(2008-9#1)
of potent##5##2##(1995-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
of potential adverse##2##3##(2008-10#1)(2011-2#1)
of potential and##3##3##(2008-10#1)(2008-11#2)
of potential interfering ions on the determination of##2##8##(2008-10#2)
of potential interfering ions##4##4##(2008-10#4)
of potential interfering##5##3##(2008-10#5)
of potential markers##2##3##(2008-10#1)(2010-12#1)
of potential mates##5##3##(2008-8#5)
of potential pathogen##3##3##(2008-10#3)
of potential pathogens##2##3##(1994-6#1)(2007-12#1)
of potential use as an##2##5##(1993-12#1)(1996-5#1)
of potential use##3##3##(1993-12#1)(1996-5#1)(2010-4#1)
of potential##89##2##(1991-1#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-6#1)(1995-5#1)(1996-3#2)(1996-5#1)(1996-6#2)(2007-12#1)(2008-10#34)(2008-11#7)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#5)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#1)
of potentially##14##2##(1994-5#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
of potentiation##2##2##(1993-6#1)(1995-12#1)
of potentiometric titration##3##3##(2008-10#3)
of potentiometric titrations##2##3##(2008-10#2)
of potentiometric##13##2##(2008-10#13)
of potted apple trees##2##4##(2008-10#2)
of potted##3##2##(2008-10#3)
of potting mix##2##3##(2008-10#2)
of potting##3##2##(2008-10#3)
of potyvirus##3##2##(2008-10#3)
of potyviruses##2##2##(2008-10#2)
of poultry##2##2##(1990-8#1)(2008-5#1)
of poverty##8##2##(2008-11#8)
of powder##2##2##(2008-10#2)
of powdered##2##2##(2008-10#1)(2008-11#1)
of powdery mildew on##4##4##(2008-10#4)
of powdery mildew##12##3##(2008-10#12)
of powdery##13##2##(2008-10#13)
of power at##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
of power in##2##3##(1997-2#1)(2010-5#1)
of power of##2##3##(2008-10#1)(2008-3#1)
of power##21##2##(1994-9#1)(1997-2#1)(1997-3#2)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#4)(2010-5#1)(2012-12#1)(2013-8#1)
of powerful##3##2##(2008-10#1)(2008-5#1)(2009-4#1)
of pp185##2##2##(1992-10#2)
of pp60c-src##2##2##(1990-12#2)
of ppb##2##2##(2008-10#2)
of prC4##2##2##(1997-8#2)
of practical and##2##3##(2008-11#1)(2008-4#1)
of practical importance##2##3##(1995-11#1)(2013-1#1)
of practical nursing skills##2##4##(2008-11#2)
of practical samples##2##3##(2008-10#2)
of practical##17##2##(1995-11#1)(2008-10#6)(2008-11#4)(2008-3#2)(2008-4#1)(2008-9#1)(2013-1#2)
of practice in healthcare##2##4##(2008-12#1)(2011-2#1)
of practice in##6##3##(2008-1#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
of practice learning##3##3##(2008-11#3)
of practice##30##2##(1990-6#1)(1993-12#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#13)(2008-12#6)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
of practice-based teaching##3##3##(2008-11#3)
of practices##3##2##(1996-3#1)(2012-2#1)(2013-1#1)
of practicing##3##2##(1993-12#1)(1996-1#1)(2010-11#1)
of practitioners##5##2##(1991-3#1)(1992-1#1)(1993-11#1)(1997-4#1)(2012-12#1)
of prairie##2##2##(2008-9#2)
of praseodymium##6##2##(2008-10#6)
of pre- and##3##3##(1993-3#1)(2008-10#1)(2012-3#1)
of pre-column##2##2##(2008-10#2)
of pre-end stage renal disease##2##5##(2008-1#2)
of pre-end stage renal##3##4##(2008-1#3)
of pre-existing β-cells##3##3##(2010-11#3)
of pre-existing##4##2##(1996-3#1)(2010-11#3)
of pre-operative##3##2##(1995-12#1)(1997-6#1)(2008-12#1)
of pre-registration nursing##4##3##(2008-11#4)
of pre-registration##6##2##(2008-11#6)
of pre-settlement##2##2##(2010-8#2)
of pre-tRNA(fMet)##2##2##(1995-6#2)
of pre-treatment##2##2##(2008-10#1)(2013-1#1)
of preactivated##2##2##(2008-10#2)
of precancerous lesions##2##3##(2011-2#1)(2011-3#1)
of preceptorship##2##2##(2008-11#2)
of precious##3##2##(2008-10#3)
of precipitation and##2##3##(2008-10#1)(2008-3#1)
of precipitation##10##2##(2008-10#9)(2008-3#1)
of precise##6##2##(2008-10#2)(2009-8#1)(2010-5#1)(2010-7#1)(2012-3#1)
of precisely##2##2##(2008-10#1)(2008-9#1)
of precision##8##2##(2008-10#7)(2008-11#1)
of preclinical##2##2##(2010-10#1)(2012-3#1)
of preconcentration time##5##3##(2008-10#5)
of preconcentration##12##2##(2008-10#12)
of precordial pain##2##3##(2008-10#1)(2008-7#1)
of precursor##3##2##(1990-5#1)(1991-2#1)(2008-11#1)
of precursors##7##2##(1991-6#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-1#1)
of predation and##2##3##(2008-9#2)
of predation on the##2##4##(2008-8#1)(2008-9#1)
of predation on##4##3##(2008-8#3)(2008-9#1)
of predation##9##2##(2008-8#6)(2008-9#3)
of predator-prey interactions##2##3##(2008-8#1)(2008-9#1)
of predator-prey##3##2##(2008-8#2)(2008-9#1)
of predators and prey##2##4##(2008-8#2)
of predators in##2##3##(2008-8#2)
of predators that##2##3##(2008-8#2)
of predators##11##2##(2008-8#10)(2012-3#1)
of predictable##3##2##(1994-3#1)(2008-11#2)
of predicted##5##2##(2008-10#2)(2011-2#1)(2011-3#1)(2013-8#1)
of predicting##5##2##(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)
of prediction (RSEP)##3##3##(2008-10#3)
of prediction##21##2##(2008-10#20)(2012-2#1)
of predictions##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2009-7#1)
of predictive validity##2##3##(1994-2#1)(2010-7#1)
of predictive##8##2##(1994-2#1)(2008-10#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#2)
of predictors of##2##3##(1995-12#1)(2008-12#1)
of predictors##5##2##(1995-12#2)(2008-12#1)(2011-2#2)
of predisposing##2##2##(2010-1#1)(2012-12#1)
of predominantly##2##2##(2008-7#1)(2012-3#1)
of preeclampsia and##3##3##(1996-11#1)(2008-11#2)
of preeclampsia##5##2##(1996-11#1)(2008-11#3)(2012-2#1)
of preemergence damping-off##2##3##(2008-10#2)
of preexisting conditions##2##3##(1994-2#1)(2008-7#1)
of preexisting##5##2##(1994-2#1)(1996-11#1)(2008-10#2)(2008-7#1)
of preference and performance##2##4##(2008-8#2)
of preference and##3##3##(2008-8#3)
of preformed DAPs##2##3##(2010-5#2)
of preformed antifungal##2##3##(2008-10#2)
of preformed##6##2##(1995-2#1)(2008-10#3)(2010-5#2)
of prefrontal##3##2##(1997-2#1)(2008-11#2)
of pregnancies##10##2##(1991-3#1)(2011-1#1)(2011-2#5)(2013-1#3)
of pregnancy and##8##3##(1995-12#2)(1995-8#1)(2008-9#1)(2012-3#3)(2013-8#1)
of pregnancy in##2##3##(1995-3#1)(2012-3#1)
of pregnancy or##2##3##(2008-12#1)(2012-3#1)
of pregnancy was##2##3##(1993-3#1)(2012-3#1)
of pregnancy were##2##3##(1995-12#2)
of pregnancy##51##2##(1990-6#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#2)(1993-3#1)(1994-3#3)(1995-12#6)(1995-3#1)(1995-8#4)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-9#2)(2009-1#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#12)(2013-8#1)
of pregnancy-associated cancer##2##3##(2013-1#2)
of pregnancy-associated##4##2##(2008-10#1)(2013-1#3)
of pregnancy-induced hypertension##3##3##(1994-3#1)(2010-10#1)(2012-2#1)
of pregnant and lactating##3##4##(1990-11#2)(2011-2#1)
of pregnant and##4##3##(1990-11#2)(2010-6#1)(2011-2#1)
of pregnant women in##3##4##(1997-6#1)(2007-12#1)(2010-6#1)
of pregnant women##8##3##(1993-3#1)(1996-11#3)(1997-6#1)(2007-12#1)(2010-6#1)(2012-2#1)
of pregnant##17##2##(1990-11#2)(1993-3#1)(1996-11#3)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#1)
of pregnenolone sulfate##2##3##(1996-2#2)
of pregnenolone##4##2##(1990-11#1)(1996-2#3)
of preliminary##4##2##(1997-2#1)(2008-10#3)
of prelingually##2##2##(2008-9#2)
of preload##2##2##(2011-2#2)
of premating##2##2##(2008-8#1)(2012-3#1)
of premature adrenarche##2##3##(2008-4#2)
of premature infants##6##3##(1990-11#1)(1994-3#1)(2007-11#1)(2008-11#1)(2011-2#1)(2012-12#1)
of premature##18##2##(1990-11#2)(1991-12#1)(1991-6#1)(1992-6#1)(1992-9#1)(1994-3#2)(1995-1#1)(2007-11#1)(2008-11#2)(2008-4#2)(2009-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
of prematurity##4##2##(1991-9#1)(1994-3#1)(2008-11#1)(2012-12#1)
of premenopausal##2##2##(1994-12#1)(1994-2#1)
of premixed##2##2##(2008-10#1)(2008-3#1)
of prenatal alcohol##2##3##(2008-11#2)
of prenatal care and##2##4##(1992-2#1)(1993-3#1)
of prenatal care##8##3##(1992-2#2)(1993-3#2)(1995-12#1)(1995-2#1)(2008-10#2)
of prenatal contraceptive counseling and##2##5##(2013-1#2)
of prenatal contraceptive counseling##3##4##(2013-1#3)
of prenatal development##2##3##(2012-3#2)
of prenatal##19##2##(1992-2#2)(1993-3#2)(1995-12#1)(1995-2#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#4)(2012-3#2)(2013-1#3)
of prenatally##3##2##(2008-10#2)(2008-4#1)
of prenylated flavonoids##2##3##(2011-2#2)
of prenylated##3##2##(2008-5#1)(2011-2#2)
of prenyltransferases##2##2##(2008-8#1)(2011-2#1)
of preoperative chemotherapy##2##3##(2012-3#2)
of preoperative feeding##2##3##(2011-2#2)
of preoperative##12##2##(1990-11#1)(1993-12#1)(1995-1#1)(1996-1#1)(2008-7#1)(2011-2#3)(2011-7#1)(2012-3#3)
of prepaid##2##2##(1994-2#1)(1997-1#1)
of preparation and##2##3##(2008-10#1)(2008-11#1)
of preparation##10##2##(1991-12#1)(1994-5#1)(2008-10#5)(2008-11#1)(2008-12#2)
of preparations of##2##3##(1991-5#1)(2013-1#1)
of preparations##3##2##(1991-5#1)(2008-5#1)(2013-1#1)
of prepared##3##2##(2008-10#2)(2012-3#1)
of preparing a##2##3##(2008-10#2)
of preparing##8##2##(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-4#1)
of prepenetration##2##2##(2008-10#2)
of preschool##2##2##(2009-9#1)(2011-2#1)
of prescribing##4##2##(2008-11#3)(2013-1#1)
of prescription drug##3##3##(1995-1#3)
of prescription drugs##5##3##(1995-1#1)(2008-11#2)(2013-1#1)(2013-8#1)
of prescription##12##2##(1991-1#1)(1995-1#5)(2008-11#3)(2011-2#1)(2013-1#1)(2013-8#1)
of prescriptions##6##2##(1991-12#1)(1994-9#1)(2008-11#1)(2009-9#2)(2013-1#1)
of presence of##3##3##(2008-10#3)
of present study##2##3##(2008-12#1)(2012-2#1)
of present##8##2##(1991-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#2)
of presentation and##3##3##(1991-8#1)(1995-10#1)(2008-7#1)
of presentation of##2##3##(2010-3#1)(2012-3#1)
of presentation##19##2##(1991-8#2)(1995-10#1)(1997-8#2)(2008-12#3)(2008-7#1)(2008-9#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#3)
of presentations##46##2##(2008-11#45)(2008-7#1)
of presenting##2##2##(1991-6#1)(2009-8#1)
of preserved##2##2##(2008-10#1)(2008-11#1)
of preserving##3##2##(1996-3#1)(2011-2#1)(2012-2#1)
of pressure (COP)##2##3##(2010-12#1)(2010-9#1)
of pressure and##3##3##(1991-3#1)(2008-3#2)
of pressure ulcer##2##3##(2012-3#2)
of pressure##23##2##(1991-3#1)(2008-10#10)(2008-11#1)(2008-3#4)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#2)
of pressurized##3##2##(1992-3#1)(2008-10#2)
of presumed##3##2##(1992-3#1)(1996-12#1)(2012-3#1)
of presynaptic function##2##3##(1995-11#1)(1997-7#1)
of presynaptic##3##2##(1995-11#1)(1997-7#1)(2008-11#1)
of pretectal neurons##2##3##(2008-8#2)
of preterm birth##2##3##(2011-2#2)
of preterm delivery##3##3##(1994-3#1)(1996-11#1)(2012-3#1)
of preterm infants##3##3##(1990-3#1)(1991-1#1)(2007-11#1)
of preterm##11##2##(1990-11#1)(1990-3#1)(1991-1#1)(1993-3#1)(1994-3#1)(1996-11#1)(2007-11#1)(2010-11#1)(2011-2#2)(2012-3#1)
of pretreatment##4##2##(1990-11#1)(2008-10#2)(2011-2#1)
of prevalence of##3##3##(2008-10#2)(2008-3#1)
of prevalent##2##2##(2011-2#1)(2013-1#1)
of preventing##6##2##(1992-3#1)(1993-2#1)(1996-3#1)(1997-3#1)(2008-10#2)
of prevention and##3##3##(2008-9#1)(2010-12#2)
of prevention programs##2##3##(1993-3#1)(1997-2#1)
of prevention##13##2##(1992-5#1)(1993-1#1)(1993-3#1)(1994-9#1)(1995-5#1)(1997-2#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#2)(2013-8#1)
of preventive activities##3##3##(1993-11#1)(1993-3#1)(1997-3#1)
of preventive services##2##3##(1995-12#1)(1995-2#1)
of preventive##14##2##(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-3#1)(2012-12#1)(2013-1#1)
of previous blood transfusions##2##4##(1991-3#1)(2008-1#1)
of previous research##3##3##(2008-9#1)(2012-2#2)
of previous studies##7##3##(1990-12#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
of previous trials##2##3##(1996-6#1)(2013-8#1)
of previous##46##2##(1990-12#2)(1991-12#1)(1991-2#2)(1991-3#1)(1993-2#1)(1994-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
of previously known##2##3##(2008-10#1)(2008-9#1)
of previously published##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
of previously##16##2##(1993-11#1)(1994-2#1)(1994-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-8#1)
of prey##7##2##(2008-8#4)(2008-9#1)(2010-8#2)
of price##2##2##(1993-12#1)(1995-1#1)
of pricing##2##2##(1995-1#1)(2008-12#1)
of primary As species in##2##5##(2008-10#2)
of primary afferents##2##3##(1992-6#1)(1997-3#1)
of primary aliphatic short-chain monoamines##2##5##(2008-10#2)
of primary amino groups##2##4##(2008-10#1)(2008-5#1)
of primary and interfering##2##4##(2008-10#2)
of primary and recurrent##2##4##(1991-6#2)
of primary and secondary infection##5##5##(2008-10#5)
of primary and secondary##10##4##(1995-2#1)(2008-10#5)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
of primary and##17##3##(1991-6#2)(1992-11#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-10#7)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
of primary care##12##3##(1991-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-1#2)(1997-3#1)(2009-9#1)(2011-2#2)(2013-1#1)
of primary care]##2##3##(1994-6#1)(1997-5#1)
of primary cultures of##2##4##(1994-3#1)(1995-11#1)
of primary health care##3##4##(1994-3#1)(1996-12#1)(1996-6#1)
of primary health##4##3##(1991-9#1)(1994-3#1)(1996-12#1)(1996-6#1)
of primary human cells##2##4##(2008-11#2)
of primary human##3##3##(2008-11#3)
of primary hyperparathyroidism##3##3##(1990-2#1)(2008-12#2)
of primary inoculum##11##3##(2008-10#11)
of primary open angle##2##4##(2011-2#1)(2012-2#1)
of primary porcine hepatocytes##3##4##(2008-11#3)
of primary prevention##6##3##(1995-3#1)(1996-12#1)(1996-3#1)(2007-8#1)(2011-2#1)(2013-1#1)
of primary rat hepatocytes##2##4##(2008-11#2)
of primary##167##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-5#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#17)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#4)
of primate##2##2##(2008-9#2)
of prime##4##2##(1996-2#1)(2008-10#1)(2008-9#2)
of primers and probe##2##4##(2008-10#2)
of primers that##2##3##(1993-12#1)(2008-10#1)
of primers##14##2##(1993-12#1)(1995-8#1)(2008-10#10)(2008-5#1)(2008-8#1)
of primordial germ cells##2##4##(2008-11#1)(2010-5#1)
of primordial##3##2##(2008-11#1)(2008-9#1)(2010-5#1)
of principal component analysis and##2##5##(2008-10#1)(2013-8#1)
of principal component analysis##3##4##(2008-10#2)(2013-8#1)
of principal component##5##3##(2008-10#3)(2008-11#1)(2013-8#1)
of principal components##2##3##(2008-10#1)(2010-7#1)
of principal##8##2##(2008-10#5)(2008-11#1)(2010-7#1)(2013-8#1)
of principle##3##2##(1997-5#1)(2008-10#1)(2010-4#1)
of principles of##2##3##(1993-12#1)(1997-7#1)
of principles##3##2##(1993-12#1)(1997-7#1)(2008-9#1)
of prion protein##2##3##(2008-11#1)(2008-5#1)
of prion##4##2##(2008-11#3)(2008-5#1)
of prior##12##2##(1990-11#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-12#1)(1996-6#1)(2008-10#2)(2008-9#1)(2010-12#1)(2013-1#2)
of pristinamycin##2##2##(2010-2#2)
of privacy##3##2##(1995-12#1)(1996-5#1)(1997-5#1)
of private and public##2##4##(1996-1#1)(1997-3#1)
of private insurance##2##3##(1992-2#1)(1994-1#1)
of private sector##2##3##(1994-2#1)(1996-12#1)
of private##9##2##(1992-2#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-3#1)
of prmt5 in##2##3##(2009-7#2)
of prmt5##3##2##(2009-7#3)
of pro- and anti-inflammatory##2##4##(2008-10#1)(2013-7#1)
of pro- and##4##3##(2008-10#1)(2009-12#2)(2013-7#1)
of pro-inflammatory##3##2##(2008-11#1)(2009-12#1)(2012-2#1)
of proalbumin##2##2##(1990-8#1)(1993-2#1)
of probability##4##2##(1997-3#1)(2008-10#2)(2012-3#1)
of probe##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)
of probes and##2##3##(2008-10#1)(2012-3#1)
of probes##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
of probing##2##2##(1994-5#1)(2008-10#1)
of probiotic##9##2##(2009-11#1)(2009-12#1)(2010-10#1)(2011-2#4)(2013-1#2)
of probiotics in health and disease##3##6##(2013-7#3)
of probiotics in##6##3##(2008-10#1)(2009-11#1)(2009-12#1)(2013-7#3)
of probiotics is##2##3##(2011-2#1)(2013-7#1)
of probiotics##13##2##(2008-10#2)(2009-11#1)(2009-12#1)(2011-2#3)(2012-2#1)(2013-7#5)
of problem behaviors were##2##4##(2008-12#2)
of problem behaviors##3##3##(2008-12#3)
of problem##7##2##(1995-5#1)(2008-11#1)(2008-12#5)
of problem-based learning##3##3##(1995-2#1)(2008-11#1)(2008-12#1)
of problems##15##2##(1990-11#1)(1991-1#1)(1992-2#1)(1994-6#1)(1995-12#2)(1996-9#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#2)(2013-1#2)
of procaine hydrochloride##7##3##(2008-10#7)
of procalcitonin in##2##3##(2008-5#2)
of procalcitonin##3##2##(2008-5#3)
of procathepsin L##4##3##(1995-6#4)
of procedural##2##2##(1993-2#1)(2008-12#1)
of procedure##7##2##(1996-3#1)(2008-10#4)(2008-7#1)(2013-1#1)
of procedures for##3##3##(1995-2#1)(2008-10#1)(2010-3#1)
of procedures performed##3##3##(1995-2#1)(2011-2#1)(2013-1#1)
of procedures that##3##3##(2008-10#1)(2008-4#2)
of procedures to##2##3##(2008-10#1)(2008-12#1)
of procedures##16##2##(1993-12#1)(1994-3#1)(1995-2#2)(2008-10#4)(2008-12#1)(2008-4#3)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
of process##10##2##(1993-12#1)(1996-2#1)(2008-11#2)(2008-12#2)(2010-10#1)(2013-1#1)(2013-8#2)
of processes##6##2##(1994-3#1)(2008-11#2)(2008-3#1)(2008-7#1)(2013-8#1)
of processing##16##2##(1994-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-7#1)
of produced##5##2##(2008-10#3)(2008-11#2)
of producing a##3##3##(1994-5#1)(2008-11#1)(2008-12#1)
of producing##17##2##(1990-11#1)(1990-5#1)(1993-3#1)(1993-9#1)(1994-5#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
of product##18##2##(1992-3#1)(2008-10#4)(2008-11#3)(2008-5#5)(2008-7#2)(2011-2#1)(2012-2#2)
of production and##2##3##(2008-10#1)(2008-11#1)
of production of the##3##4##(1990-11#1)(2008-10#1)(2008-7#1)
of production of##6##3##(1990-11#1)(2008-10#3)(2008-7#1)(2009-9#1)
of production##19##2##(1990-11#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
of productivity##9##2##(2008-11#4)(2008-8#2)(2008-9#3)
of products and##3##3##(1991-12#1)(1996-12#1)(2012-2#1)
of products of##2##3##(2007-12#1)(2010-7#1)
of products##23##2##(1991-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-12#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-5#4)(2009-5#1)(2010-7#1)(2012-2#1)
of professional confidence##4##3##(2008-11#2)(2008-12#2)
of professional practice##3##3##(2008-11#2)(2008-12#1)
of professional relationships##2##3##(2008-7#2)
of professional##27##2##(1991-2#2)(1993-2#1)(1993-6#1)(1995-1#1)(1996-3#3)(2008-10#1)(2008-11#9)(2008-12#5)(2008-7#2)(2013-1#1)(2013-8#1)
of professionalism##4##2##(1993-3#1)(2008-12#1)(2013-1#2)
of professionals##7##2##(1993-2#1)(1993-6#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2012-2#1)
of professor##2##2##(2011-2#1)(2013-8#1)
of profound deafness##2##3##(2008-9#2)
of profound hearing loss##2##4##(2008-9#2)
of profound##5##2##(2008-9#5)
of profoundly##2##2##(2008-9#2)
of progenitor cells##8##3##(2008-11#5)(2008-9#2)(2010-11#1)
of progenitor##9##2##(2008-11#6)(2008-9#2)(2010-11#1)
of progeny budded virus##2##4##(1997-3#2)
of progeny of##2##3##(2008-10#2)
of progeny##9##2##(1994-11#1)(1997-3#2)(2008-10#4)(2008-8#1)(2013-8#1)
of progesterone receptor##3##3##(1993-11#1)(2008-11#2)
of progesterone##7##2##(1990-11#1)(1993-11#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-8#1)
of prognosis##5##2##(1990-12#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-3#1)
of prognostic factors##2##3##(1992-9#1)(1994-12#1)
of prognostic value##2##3##(1990-8#1)(2011-2#1)
of prognostic##8##2##(1990-12#1)(1990-8#1)(1992-9#1)(1994-12#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
of prognostically##2##2##(1995-5#1)(2012-3#1)
of program##7##2##(1992-3#1)(1994-3#2)(1995-3#1)(1997-1#1)(2010-11#1)(2013-1#1)
of programmed cell death##4##4##(1994-9#1)(2008-8#1)(2009-8#1)(2011-2#1)
of programmed##5##2##(1994-9#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)
of programming##2##2##(2008-9#2)
of programs for##2##3##(1991-2#1)(1995-3#1)
of programs in##2##3##(1996-3#1)(2008-1#1)
of programs##10##2##(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-9#1)
of progress in the##2##4##(1996-3#1)(2008-10#1)
of progress in##3##3##(1994-3#1)(1996-3#1)(2008-10#1)
of progress monitoring##3##3##(2011-2#3)
of progress##11##2##(1990-9#1)(1994-3#1)(1996-3#1)(2008-10#3)(2009-5#1)(2011-2#3)(2012-2#1)
of progression of##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
of progression to##2##3##(2008-9#1)(2011-3#1)
of progression##6##2##(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
of progressive##11##2##(1991-3#1)(1992-12#1)(1997-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-7#1)(2012-3#2)(2013-1#2)
of prohibited substances##2##3##(2010-11#1)(2010-7#1)
of proinflammatory cytokines##7##3##(2007-11#2)(2008-11#4)(2009-8#1)
of proinflammatory##11##2##(2007-11#2)(2008-10#1)(2008-11#4)(2009-8#2)(2010-1#1)(2013-7#1)
of projection##3##2##(1991-5#1)(2008-3#2)
of projects##3##2##(1995-8#1)(1997-8#1)(2008-10#1)
of prokaryotic##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
of prolactin##6##2##(1994-11#1)(1994-3#1)(1994-6#1)(2008-11#1)(2008-12#2)
of proliferating##5##2##(2008-11#1)(2008-7#1)(2008-9#2)(2013-1#1)
of proliferation and##6##3##(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#2)
of proliferation of##3##3##(1991-3#1)(1994-3#1)(2013-8#1)
of proliferation##15##2##(1990-8#1)(1991-3#2)(1993-11#1)(1994-3#1)(2008-10#1)(2008-11#3)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of proliferative##2##2##(1995-12#1)(2008-11#1)
of proline in##3##3##(2008-10#3)
of proline##7##2##(1990-9#1)(2008-10#3)(2008-5#1)(2011-1#1)(2012-7#1)
of prolonged##6##2##(1995-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
of promethazine hydrochloride using##2##4##(2008-10#2)
of promethazine hydrochloride##4##3##(2008-10#4)
of promethazine-HCl##3##2##(2008-10#3)
of prominent##2##2##(2008-7#1)(2010-8#1)
of promising##5##2##(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
of promoter##8##2##(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2012-2#1)
of promoters##2##2##(1995-2#1)(2008-7#1)
of promoting##3##2##(2010-10#2)(2011-2#1)
of propagation of##3##3##(2008-10#1)(2008-5#2)
of propagation##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
of propagule size##2##3##(2008-8#2)
of propagule##5##2##(2008-10#1)(2008-8#2)(2008-9#2)
of propagules in##3##3##(2008-10#3)
of propagules##7##2##(2008-10#6)(2008-8#1)
of propellants##4##2##(1992-3#1)(1996-1#2)(2008-10#1)
of proper##9##2##(1993-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2011-2#4)
of properties##3##2##(1993-1#1)(2008-10#1)(2009-10#1)
of prophylactic##6##2##(1993-3#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-1#1)(2013-1#1)
of prophylaxis and##3##3##(1992-12#1)(2013-1#2)
of prophylaxis##5##2##(1992-12#1)(2011-2#1)(2013-1#3)
of propiconazole##3##2##(2008-10#3)
of propionic acid methyl##2##4##(2008-7#2)
of propiverine and##3##3##(2008-10#3)
of propolis##7##2##(2008-10#3)(2008-11#4)
of proposed##5##2##(1995-2#1)(2008-10#3)(2008-11#1)
of propranolol and##5##3##(1994-5#2)(2008-10#3)
of propranolol##11##2##(1994-5#2)(2008-10#5)(2008-7#1)(2009-8#3)
of prosodic##3##2##(2009-10#1)(2010-9#2)
of prosody##5##2##(2010-9#5)
of prospective payment##4##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)
of prospective studies have##2##4##(1997-6#1)(2012-3#1)
of prospective##12##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1995-2#1)(1997-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
of prostacyclin##5##2##(1991-5#2)(1992-6#1)(1995-11#1)(2008-11#1)
of prostaglandin E2 (PGE2)##2##4##(1997-2#1)(2007-11#1)
of prostaglandin E2 synthesis by##2##5##(1997-1#2)
of prostaglandin E2##6##3##(1996-2#1)(1997-1#2)(1997-2#2)(2007-11#1)
of prostaglandin H synthase##3##4##(1994-5#3)
of prostaglandin H synthase-2##3##4##(1993-3#3)
of prostaglandin H##7##3##(1993-3#3)(1994-5#4)
of prostaglandin##16##2##(1992-3#1)(1993-3#3)(1994-5#4)(1996-11#1)(1996-2#1)(1997-1#3)(1997-2#2)(2007-11#1)
of prostaglandins##5##2##(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#2)
of prostate cancer in##4##4##(1994-12#1)(1995-9#1)(2010-1#1)(2011-2#1)
of prostate cancer##27##3##(1991-8#1)(1994-12#1)(1995-9#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-5#2)(2010-1#1)(2010-12#3)(2011-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
of prostate gland##2##3##(2008-7#1)(2012-3#1)
of prostate##39##2##(1991-8#1)(1994-12#3)(1995-8#1)(1995-9#2)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-12#2)(2009-5#2)(2010-1#2)(2010-12#3)(2011-2#7)(2012-3#3)(2013-1#1)(2013-8#2)
of prostate-specific antigen##2##3##(2008-9#2)
of prostatic cancer##2##3##(1990-9#1)(1991-7#1)
of prostatic##9##2##(1990-9#1)(1991-2#4)(1991-7#1)(2008-10#2)(2008-11#1)
of prostatitis syndrome##2##3##(2008-10#2)
of prostatitis##3##2##(2008-10#3)
of prostheses##3##2##(2009-1#1)(2011-2#1)(2013-1#1)
of prosthetic##2##2##(2008-2#1)(2013-1#1)
of protease##5##2##(1992-12#1)(1992-6#2)(2008-10#1)(2011-2#1)
of proteases##4##2##(1990-11#1)(2008-11#1)(2008-4#2)
of proteasome##2##2##(2008-4#1)(2013-8#1)
of protected amine-functionalised polymer beads##2##5##(2008-10#2)
of protected##6##2##(1997-4#1)(2008-10#3)(2008-4#2)
of protecting##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
of protection against##5##3##(1995-12#1)(1995-5#2)(2008-10#1)(2008-7#1)
of protection from##2##3##(1991-2#1)(2008-11#1)
of protection##21##2##(1991-2#1)(1995-12#1)(1995-5#5)(1996-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2012-2#2)
of protective immunity##3##3##(2011-2#3)
of protective##5##2##(1992-11#1)(2008-12#1)(2011-2#3)
of protein A in##2##4##(1990-12#2)
of protein A##6##3##(1990-12#4)(2008-10#1)(2008-11#1)
of protein C##2##3##(2008-1#1)(2008-12#1)
of protein G##2##3##(2008-10#2)
of protein and to##2##4##(2008-10#1)(2013-8#1)
of protein and##7##3##(1992-8#1)(1993-8#1)(2008-10#3)(2011-2#1)(2013-8#1)
of protein based on##2##4##(2008-10#2)
of protein based##3##3##(2008-10#2)(2008-5#1)
of protein by##3##3##(1994-5#1)(2008-10#2)
of protein coding##2##3##(2008-4#1)(2010-7#1)
of protein concentration##2##3##(2008-10#1)(2008-4#1)
of protein disulfide isomerase##3##4##(1993-6#2)(2013-1#1)
of protein domain evolution##2##4##(2011-2#2)
of protein engineering##2##3##(1994-8#1)(2011-2#1)
of protein expression##7##3##(2008-11#4)(2008-4#2)(2008-7#1)
of protein extracts##3##3##(2008-10#2)(2008-4#1)
of protein folding##2##3##(1991-6#2)
of protein function##2##3##(2008-9#1)(2011-2#1)
of protein in##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
of protein interactions##2##3##(2008-4#2)
of protein isolates##2##3##(2011-2#2)
of protein kinase A##3##4##(1993-8#1)(1996-12#1)(2012-2#1)
of protein kinase C (PKC)##8##5##(1992-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-8#1)(2013-8#1)
of protein kinase C activation##2##5##(1992-8#1)(2008-11#1)
of protein kinase C activity##3##5##(1990-5#1)(1990-8#1)(1993-8#1)
of protein kinase C and##3##5##(1994-6#1)(1995-11#1)(2008-11#1)
of protein kinase C by##3##5##(1990-12#1)(1993-8#1)(2008-8#1)
of protein kinase C in the##2##6##(1997-1#2)
of protein kinase C in##5##5##(1992-8#1)(1997-1#2)(2008-11#2)
of protein kinase C with##2##5##(1994-5#1)(1995-2#1)
of protein kinase C##50##4##(1990-12#2)(1990-5#5)(1990-8#2)(1992-12#1)(1992-8#2)(1993-12#1)(1993-6#2)(1993-8#6)(1994-5#6)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-7#1)(2008-11#8)(2008-8#2)(2008-9#1)(2013-8#1)
of protein kinase inhibitors##2##4##(1990-8#1)(1994-11#1)
of protein kinase##58##3##(1990-12#2)(1990-5#5)(1990-8#3)(1992-12#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#7)(1994-11#1)(1994-5#6)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-12#2)(1997-1#2)(1997-7#1)(1997-8#1)(2008-11#9)(2008-8#2)(2008-9#1)(2012-2#1)(2013-8#1)
of protein kinases in the##2##5##(2008-11#1)(2012-3#1)
of protein kinases in##3##4##(1997-1#1)(2008-11#1)(2012-3#1)
of protein kinases##6##3##(1994-11#1)(1994-6#1)(1996-2#1)(1997-1#1)(2008-11#1)(2012-3#1)
of protein per##3##3##(2008-10#2)(2010-7#1)
of protein phosphatase##5##3##(1993-8#1)(1994-11#1)(1995-8#2)(2008-4#1)
of protein sequence##2##3##(2008-9#2)
of protein serine/threonine##2##3##(1994-11#1)(1995-8#1)
of protein structure##2##3##(1991-3#1)(2012-3#1)
of protein structures by##2##4##(1994-8#2)
of protein structures##3##3##(1994-8#2)(2009-5#1)
of protein synthesis##9##3##(1991-2#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-7#1)(2009-5#1)
of protein tyrosine kinase (PTK)##2##5##(1994-6#1)(2008-8#1)
of protein tyrosine phosphatase##2##4##(1994-6#1)(2008-8#1)
of protein tyrosine##6##3##(1994-6#2)(1996-2#2)(2008-8#2)
of protein##218##2##(1990-12#8)(1990-5#7)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-8#4)(1993-12#2)(1993-2#1)(1993-6#6)(1993-8#9)(1994-11#5)(1994-5#10)(1994-6#5)(1994-8#4)(1995-11#3)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#5)(1996-12#3)(1996-2#5)(1997-1#3)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#31)(2008-11#24)(2008-12#2)(2008-2#1)(2008-4#11)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#6)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
of protein)##2##2##(1996-2#1)(2010-11#1)
of protein-bound##2##2##(1991-12#1)(2008-7#1)
of protein-protein interaction##2##3##(2008-11#1)(2008-4#1)
of protein-protein interactions##4##3##(2008-11#1)(2008-4#2)(2010-10#1)
of protein-protein##8##2##(1992-9#1)(2008-11#2)(2008-4#4)(2010-10#1)
of proteinaceous binding media##3##4##(2008-10#3)
of proteinaceous glues##2##3##(2008-10#2)
of proteinaceous##6##2##(2008-10#6)
of proteinases##3##2##(1994-5#1)(1995-6#1)(2008-11#1)
of proteins after##2##3##(2008-11#1)(2010-3#1)
of proteins and peptides##2##4##(1997-2#1)(2008-10#1)
of proteins and##12##3##(1992-11#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
of proteins are##4##3##(1997-6#1)(2008-1#1)(2010-12#1)(2013-1#1)
of proteins based on the##2##5##(2008-10#2)
of proteins based on##3##4##(2008-10#2)(2011-3#1)
of proteins by##6##3##(1997-2#2)(2008-10#2)(2008-8#1)(2012-2#1)
of proteins from##5##3##(1991-12#1)(1993-2#1)(2008-4#1)(2008-9#1)(2010-4#1)
of proteins has been##2##4##(1997-6#1)(2008-10#1)
of proteins has##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
of proteins in the##5##4##(1996-1#1)(1997-3#1)(2008-10#3)
of proteins in##21##3##(1991-5#1)(1994-9#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#8)(2008-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)
of proteins including##2##3##(2008-11#1)(2010-12#1)
of proteins involved in##2##4##(2008-4#1)(2011-1#1)
of proteins that have##2##4##(2009-7#1)(2011-2#1)
of proteins that##7##3##(1990-11#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#2)
of proteins to specific##2##4##(2009-5#1)(2012-7#1)
of proteins to##4##3##(2008-11#1)(2008-7#1)(2009-5#1)(2012-7#1)
of proteins using##2##3##(2008-10#1)(2008-11#1)
of proteins was##2##3##(2008-10#2)
of proteins were##3##3##(2008-10#3)
of proteins with some heteropoly compounds##2##6##(2008-10#2)
of proteins with##11##3##(1992-6#1)(1997-2#1)(2008-10#7)(2009-9#1)(2011-2#1)
of proteins within##2##3##(2008-1#1)(2008-4#1)
of proteins##166##2##(1990-11#1)(1990-5#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#8)(1997-3#1)(1997-6#3)(2008-1#4)(2008-10#44)(2008-11#9)(2008-2#3)(2008-4#16)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#9)(2011-3#2)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#3)
of proteoglycans##3##2##(1990-2#2)(2007-11#1)
of proteolipid##2##2##(2009-6#2)
of proteolytic enzymes##2##3##(2010-3#1)(2013-1#1)
of proteolytic##7##2##(1990-11#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
of proteomes##3##2##(2008-4#2)(2008-9#1)
of proteomic##2##2##(2008-10#1)(2008-11#1)
of proto-oncogene induction##2##3##(1991-5#1)(1996-12#1)
of protocol##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
of protocols for##3##3##(2008-4#2)(2008-9#1)
of protocols##7##2##(2008-10#1)(2008-4#2)(2008-9#3)(2010-10#1)
of proton pump inhibitors##3##4##(2012-2#3)
of proton pump##4##3##(2009-11#1)(2012-2#3)
of proton##7##2##(1993-8#1)(2008-10#2)(2009-11#1)(2012-2#3)
of protonated##10##2##(2008-10#10)
of protonation constants##2##3##(2008-10#2)
of protonation##7##2##(1997-7#1)(2008-10#6)
of protons##2##2##(2008-10#2)
of protoplasts##3##2##(2008-8#1)(2008-9#2)
of prototypical##2##2##(2008-10#1)(2009-11#1)
of protozoa##2##2##(2008-12#1)(2012-12#1)
of prourokinase##3##2##(2008-11#3)
of provider##3##2##(1991-3#1)(1997-1#1)(2013-1#1)
of providers##6##2##(1992-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1997-3#1)(2011-2#1)
of providing a##3##3##(1996-3#1)(2008-2#1)(2009-7#1)
of providing care to##2##4##(2008-6#1)(2010-4#1)
of providing more##2##3##(2010-10#1)(2012-3#1)
of providing##31##2##(1991-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#2)
of provision##2##2##(1995-12#1)(2012-3#1)
of proximal##9##2##(1993-1#1)(1994-5#1)(1995-11#1)(2008-10#2)(2008-9#2)(2009-4#1)(2010-12#1)
of prune##3##2##(2008-10#3)
of pseudoaneurysm##2##2##(1991-3#1)(2008-12#1)
of pseudoarthrosis##2##2##(2009-3#2)
of pseudodipeptides##2##2##(2008-5#2)
of pseudoephedrine##4##2##(2008-10#4)
of pseudosclerotia##7##2##(2008-10#7)
of pseudothecia and ascospores##2##4##(2008-10#2)
of pseudothecia and##4##3##(2008-10#4)
of pseudothecia on##2##3##(2008-10#2)
of pseudothecia was##3##3##(2008-10#3)
of pseudothecia##15##2##(2008-10#15)
of pseudothecial##2##2##(2008-10#2)
of pseudouridine##3##2##(1992-3#2)(1993-8#1)
of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2##2##14##(2008-10#2)
of psilocin and psilocybin##3##4##(2008-10#3)
of psilocybin users##5##3##(2013-8#5)
of psilocybin##8##2##(2013-8#8)
of psittacine##2##2##(2008-5#2)
of psoriasis in##2##3##(1997-8#1)(2008-6#1)
of psoriasis##10##2##(1993-11#1)(1997-8#2)(2007-11#2)(2008-6#5)
of psychiatric comorbidity##2##3##(2008-6#1)(2013-1#1)
of psychiatric diseases##2##3##(1996-12#1)(2013-1#1)
of psychiatric disorders##3##3##(2012-2#1)(2013-1#2)
of psychiatric morbidity##2##3##(1993-5#1)(2012-3#1)
of psychiatric symptoms##2##3##(2013-8#2)
of psychiatric treatment##2##3##(1993-2#1)(2010-11#1)
of psychiatric##25##2##(1991-1#1)(1991-2#2)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-6#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
of psychiatry##2##2##(1993-1#1)(1996-1#1)
of psychoactive drugs##2##3##(1994-2#1)(2008-1#1)
of psychological##8##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2011-2#1)
of psychometric##2##2##(2009-12#1)(2013-8#1)
of psychopathology##3##2##(2012-5#1)(2013-8#2)
of psychopharmacologic##2##2##(2008-4#2)
of psychophysical##2##2##(2008-9#1)(2011-2#1)
of psychosis##7##2##(1992-12#1)(1993-1#1)(2008-11#1)(2011-1#3)(2011-2#1)
of psychosocial##4##2##(1992-3#1)(2008-11#1)(2009-6#1)(2013-8#1)
of psychosocially focused##2##3##(2010-11#2)
of psychotherapeutic##3##2##(2009-10#1)(2013-1#2)
of psychotherapy##3##2##(2008-4#1)(2013-1#2)
of psychotic##2##2##(2008-4#1)(2011-2#1)
of psychotropic drugs##2##3##(1996-9#1)(2009-3#1)
of psychotropic##4##2##(1996-9#2)(2009-3#1)(2012-3#1)
of psychrotrophic bacteria##2##3##(2011-2#2)
of pthN##2##2##(2008-10#2)
of puberty##4##2##(2008-11#1)(2008-4#2)(2009-6#1)
of public and##2##3##(1996-3#1)(2011-2#1)
of public health and a##2##5##(1994-1#1)(1997-3#1)
of public health and##6##4##(1994-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-6#1)(2012-3#1)
of public health importance##4##4##(1997-3#1)(2008-7#1)(2010-1#1)(2011-2#1)
of public health in an##2##5##(1996-3#1)(1997-3#1)
of public health is##2##4##(1996-3#1)(2013-1#1)
of public health nurses and high-priority families in northern##2##9##(2010-9#2)
of public health nurses and high-priority families in##3##8##(2010-9#3)
of public health nurses##5##4##(1995-3#1)(1996-2#1)(2010-9#3)
of public health practice##4##4##(1996-2#1)(1996-3#1)(1997-3#2)
of public health surveillance##4##4##(1997-3#3)(2008-7#1)
of public health to##2##4##(1997-2#1)(2008-7#1)
of public health##71##3##(1990-11#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-1#2)(1995-12#10)(1995-3#1)(1996-1#7)(1996-12#1)(1996-2#6)(1996-3#8)(1997-1#1)(1997-2#5)(1997-3#11)(2008-10#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-7#1)(2010-9#3)(2011-2#2)(2012-3#1)(2013-1#1)
of public involvement##2##3##(2008-7#2)
of public##99##2##(1990-11#1)(1991-12#2)(1991-3#3)(1992-1#1)(1993-2#2)(1993-3#2)(1994-1#2)(1994-2#4)(1995-12#10)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#7)(1996-12#1)(1996-2#6)(1996-3#11)(1997-1#1)(1997-2#7)(1997-3#11)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-5#1)(2010-7#1)(2010-9#3)(2011-2#4)(2012-3#1)(2013-1#2)
of publication##2##2##(2008-3#1)(2013-1#1)
of publications##6##2##(1992-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2013-1#1)
of published data##3##3##(1995-1#1)(2008-10#1)(2013-1#1)
of published studies##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
of published##16##2##(1992-1#1)(1995-1#1)(1995-3#1)(2008-10#5)(2008-8#1)(2008-9#3)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
of pulmonary and##2##3##(1997-1#1)(2013-1#1)
of pulmonary arterial hypertension##2##4##(2010-10#2)
of pulmonary arterial##5##3##(2008-10#1)(2010-10#2)(2011-2#1)(2012-2#1)
of pulmonary arteries##3##3##(2008-1#2)(2012-3#1)
of pulmonary disease in##2##4##(1997-3#1)(2007-12#1)
of pulmonary disease##3##3##(1997-3#1)(2007-12#1)(2011-2#1)
of pulmonary embolism##4##3##(1991-11#3)(2010-10#1)
of pulmonary function##4##3##(1991-12#1)(2011-2#1)(2011-3#1)(2012-3#1)
of pulmonary hyalinizing granuloma##2##4##(2008-10#2)
of pulmonary hypertension##4##3##(2010-10#2)(2012-2#2)
of pulmonary tuberculosis##2##3##(1995-2#1)(1997-3#1)
of pulmonary vessels##2##3##(2008-1#1)(2012-3#1)
of pulmonary##58##2##(1990-3#1)(1991-11#3)(1991-12#1)(1992-12#1)(1994-8#1)(1995-2#2)(1996-12#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-10#6)(2010-12#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#2)
of pulp##2##2##(2008-10#1)(2008-6#1)
of pulse##2##2##(1993-1#1)(2007-11#1)
of pulsed##6##2##(1992-3#1)(2008-10#2)(2008-3#1)(2012-2#2)
of pumice##3##2##(2008-10#2)(2008-7#1)
of pump##5##2##(2008-10#1)(2008-3#4)
of punishment##2##2##(2008-8#2)
of pups##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
of purR##2##2##(2008-8#1)(2008-9#1)
of pure DNA##2##3##(1990-5#1)(2008-10#1)
of pure and##2##3##(2008-2#1)(2011-2#1)
of pure chlorophenols##3##3##(2008-10#3)
of pure extraction resin##2##4##(2008-10#2)
of pure methyl##2##3##(2008-10#1)(2009-8#1)
of pure water##3##3##(2008-10#1)(2008-2#2)
of pure##33##2##(1990-5#1)(1997-5#1)(2008-10#15)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#2)(2013-1#2)
of purification##5##2##(2008-10#1)(2008-11#2)(2008-4#1)(2012-2#1)
of purified MT##2##3##(2008-10#2)
of purified##29##2##(1990-5#1)(1991-12#2)(1992-6#1)(1993-12#2)(1993-8#3)(1995-6#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#1)
of purine receptors##2##3##(2013-1#2)
of purine ribonucleosides##2##3##(2008-4#2)
of purine units##3##3##(2008-10#3)
of purine##11##2##(1994-11#1)(2008-10#4)(2008-4#2)(2008-9#2)(2013-1#2)
of purity of##2##3##(2008-10#2)
of purpose##2##2##(1991-12#1)(1993-12#1)
of purpurogallin##3##2##(2008-10#3)
of pustules##4##2##(2008-10#4)
of putative virus-resistant##2##3##(2008-10#2)
of putative##18##2##(1995-6#1)(1995-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2009-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of putrescine##5##2##(2008-10#2)(2011-2#2)(2012-2#1)
of pycnidia##4##2##(2008-10#4)
of pyelonephritis##3##2##(2011-2#2)(2013-1#1)
of pyramidal neurons##2##3##(1991-2#1)(2008-11#1)
of pyramidal##4##2##(1991-2#1)(1995-3#1)(1995-8#1)(2008-11#1)
of pyrantel pamoate##2##3##(2008-10#2)
of pyrene and##2##3##(2008-10#2)
of pyrene##4##2##(2008-10#3)(2009-11#1)
of pyridine nucleotide##2##3##(1992-1#1)(1994-3#1)
of pyridine##6##2##(1992-1#1)(1994-3#1)(2008-10#4)
of pyridinium chloride##2##3##(2008-10#2)
of pyridinium##3##2##(1995-8#1)(2008-10#2)
of pyridoxine hydrochloride##5##3##(2008-10#5)
of pyridoxine##6##2##(2008-10#5)(2013-1#1)
of pyrocatechol##2##2##(2008-10#2)
of pyrogallol compounds##4##3##(2008-10#4)
of pyrogallol##9##2##(2008-10#9)
of pyrolysis and atomization temperatures##3##5##(2008-10#3)
of pyrolysis and atomization##4##4##(2008-10#4)
of pyrolysis##7##2##(2008-10#6)(2010-3#1)
of pyrrole##4##2##(2008-10#4)
of pyruvate in##3##3##(2008-10#3)
of pyruvate kinase from##2##4##(1990-5#2)
of pyruvate kinase##6##3##(1990-5#3)(1991-3#1)(1995-12#1)(2008-7#1)
of pyruvate##13##2##(1990-5#3)(1991-3#1)(1995-12#1)(2008-10#7)(2008-7#1)
of qi##2##2##(2008-10#2)
of quadrat size##3##3##(2008-10#3)
of quadrat##5##2##(2008-10#5)
of quadriceps muscle##2##3##(2013-1#2)
of quail##2##2##(1993-6#1)(2008-6#1)
of qualia##2##2##(2012-2#2)
of qualified nurses##2##3##(2008-11#1)(2008-12#1)
of qualified##4##2##(2008-11#2)(2008-12#1)(2012-3#1)
of qualitative content##3##3##(2009-6#1)(2013-1#2)
of qualitative research and##2##4##(1997-3#1)(2012-3#1)
of qualitative research##4##3##(1997-3#2)(2008-11#1)(2012-3#1)
of qualitative##12##2##(1992-9#1)(1994-9#1)(1997-3#2)(2008-10#2)(2008-11#1)(2009-6#1)(2012-3#2)(2013-1#2)
of quality and##2##3##(1992-2#1)(1995-12#1)
of quality assurance##5##3##(1992-5#1)(1993-3#1)(2008-4#1)(2008-5#1)(2010-12#1)
of quality care##2##3##(1992-3#1)(1997-3#1)
of quality control in##2##4##(2008-9#2)
of quality control##6##3##(1994-6#1)(2008-9#4)(2011-3#1)
of quality criteria##2##3##(1995-2#1)(2008-11#1)
of quality for##2##3##(1996-2#1)(2008-10#1)
of quality in the##2##4##(1994-12#1)(2008-10#1)
of quality in##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
of quality of care##5##4##(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2013-1#1)
of quality of life##6##4##(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of quality of##12##3##(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of quality##63##2##(1991-2#1)(1991-3#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-12#2)(1994-2#3)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#4)(1997-1#3)(1997-2#1)(1997-3#6)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#5)
of quantification (10sigma)##2##3##(2008-10#2)
of quantification (LOQ)##6##3##(2008-10#6)
of quantification and##3##3##(2008-10#3)
of quantification for the##2##4##(2008-10#1)(2012-2#1)
of quantification of##4##3##(1994-1#1)(2008-10#2)(2008-5#1)
of quantification was##3##3##(2008-10#2)(2008-5#1)
of quantification were##6##3##(2008-10#5)(2011-3#1)
of quantification##42##2##(1994-1#1)(2008-10#36)(2008-5#3)(2011-3#1)(2012-2#1)
of quantifying##4##2##(2008-10#3)(2011-2#1)
of quantitation for##2##3##(2008-10#2)
of quantitation of##4##3##(2008-10#3)(2012-12#1)
of quantitation##19##2##(2008-10#18)(2012-12#1)
of quantitative host resistance##2##4##(2008-10#2)
of quantitative resistance##3##3##(2008-10#1)(2009-10#1)(2011-10#1)
of quantitative trait Loci for fusarium head blight resistance in##2##10##(2008-10#2)
of quantitative trait Loci for##3##5##(2008-10#3)
of quantitative trait loci (QTL)##4##5##(2008-10#3)(2012-3#1)
of quantitative trait loci##6##4##(2008-10#4)(2009-10#1)(2012-3#1)
of quantitative trait##10##3##(2008-10#7)(2009-10#1)(2012-3#2)
of quantitative##32##2##(2008-10#21)(2008-8#2)(2008-9#2)(2009-10#2)(2010-11#1)(2011-10#1)(2011-2#1)(2012-3#2)
of quantum##6##2##(1993-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-3#1)
of quarantine##2##2##(2008-10#2)
of quartz crystal microbalance (QCM)##2##5##(2008-10#2)
of quartz crystal microbalance##3##4##(2008-10#3)
of quartz crystal##5##3##(2008-10#3)(2013-8#2)
of quartz from##2##3##(2013-8#2)
of quartz##11##2##(2008-10#6)(2013-8#5)
of quaternary ammonium##2##3##(2008-10#2)
of quaternary##3##2##(2008-10#3)
of quenching##2##2##(2008-10#1)(2008-9#1)
of quercetin##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
of questionable##5##2##(1995-11#1)(2008-1#1)(2008-7#1)(2011-2#2)
of questions##9##2##(1993-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-4#1)
of quick##3##2##(1991-3#1)(2008-9#2)
of quickly##2##2##(2008-10#1)(2011-3#1)
of quiescent##7##2##(1993-12#2)(1997-3#2)(2008-10#3)
of quinine in##2##3##(2008-10#2)
of quinine##7##2##(2008-10#7)
of quinolones##2##2##(2008-10#2)
of quinone##2##2##(1991-5#1)(1993-8#1)
of quinones##5##2##(1993-8#2)(2008-10#1)(2009-9#2)
of quite different##2##3##(2008-10#1)(2011-2#1)
of quite##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
of quorum-quenching enzymes##2##3##(2008-9#2)
of r##3##2##(2008-10#3)
of r(2)=0##4##2##(2008-10#4)
of r(g)##2##2##(2008-10#2)
of r-HuEPO##2##2##(2008-1#2)
of r-[K4HPg]##2##2##(1993-8#2)
of rAAV##4##2##(2008-8#1)(2008-9#3)
of rCBF##2##2##(1995-5#2)
of rDNA from##2##3##(2008-10#2)
of rDNA##14##2##(2007-12#2)(2008-10#9)(2010-8#2)(2012-2#1)
of rFurin##3##2##(2008-11#3)
of rHuEPO##3##2##(1995-1#3)
of rIL-2##3##2##(1990-12#2)(1991-8#1)
of rNG-hCGalpha with native hCGbeta##2##5##(1995-8#2)
of rNG-hCGalpha with##4##3##(1995-8#4)
of rNG-hCGalpha##6##2##(1995-8#6)
of rNT-3##2##2##(2008-8#2)
of rPEA##2##2##(2008-10#2)
of rPlg##4##2##(1995-6#4)
of rRNA gene##3##3##(2008-8#3)
of rRNA##6##2##(2008-8#5)(2010-4#1)
of rTNF-alpha##2##2##(1994-8#2)
of rabbit muscle##2##3##(1992-4#1)(1994-5#1)
of rabbit##17##2##(1991-5#3)(1992-4#1)(1992-6#1)(1993-2#2)(1994-11#2)(1994-5#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-9#2)
of rabbits with##5##3##(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#2)
of rabbits##10##2##(1993-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-9#1)(2009-7#1)(2013-1#1)
of rabeprazole##2##2##(2008-10#2)
of rac p21s is##2##4##(1993-8#2)
of rac p21s##5##3##(1993-8#5)
of rac##6##2##(1993-8#5)(1996-2#1)
of race 1 and race 2##2##6##(2008-10#2)
of race 1 isolates##2##4##(2008-10#2)
of race 1##6##3##(2008-10#6)
of race##17##2##(2008-10#12)(2008-11#2)(2008-8#1)(2010-9#1)(2011-2#1)
of race-change mutants and##2##4##(2008-10#2)
of race-change mutants##4##3##(2008-10#4)
of race-specific##2##2##(2008-10#2)
of racemic##2##2##(1992-12#1)(1996-5#1)
of races 1##3##3##(2008-10#3)
of races 2##3##3##(2008-10#3)
of races 4 and##2##4##(2008-10#2)
of races in##2##3##(2008-10#2)
of races##17##2##(2008-10#17)
of rachis##4##2##(2008-10#4)
of radial basis function neural networks##2##6##(2008-10#2)
of radial##10##2##(1995-5#1)(2008-10#4)(2008-7#1)(2010-11#1)(2011-2#2)(2012-2#1)
of radiation at##2##3##(2007-12#1)(2008-3#1)
of radiation can##3##3##(2008-7#3)
of radiation on##2##3##(1993-9#1)(2008-7#1)
of radiation therapy##4##3##(1994-12#1)(1997-5#1)(2008-1#1)(2008-7#1)
of radiation##38##2##(1993-9#2)(1994-12#1)(1996-6#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#14)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#6)
of radiation-induced##4##2##(1995-12#1)(2008-7#1)(2011-2#2)
of radical##5##2##(1990-9#1)(1996-5#1)(2007-11#1)(2008-10#1)(2011-2#1)
of radicular pain##2##3##(2012-2#2)
of radicular##3##2##(1997-3#1)(2012-2#2)
of radioactive##6##2##(1990-6#1)(1991-9#1)(2008-10#3)(2012-12#1)
of radioactivity##12##2##(1990-12#1)(1991-12#1)(1992-2#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-7#1)
of radiofrequency ablation##2##3##(2008-11#1)(2011-2#1)
of radiofrequency##6##2##(2008-10#1)(2008-11#1)(2009-3#1)(2010-3#1)(2011-2#2)
of radiographic##7##2##(1991-12#2)(1997-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
of radioiodinated##2##2##(1994-8#1)(1995-6#1)
of radiolabel##2##2##(1991-12#1)(1993-6#1)
of radiolabeled##5##2##(1993-11#1)(1995-11#1)(2008-10#1)(2008-4#2)
of radiolabelled##4##2##(1990-11#1)(1990-12#1)(2008-11#1)(2008-7#1)
of radiological##5##2##(1991-11#1)(1991-12#1)(2010-9#1)(2011-1#1)(2013-1#1)
of radiologists##2##2##(1992-1#1)(2012-2#1)
of radiology practices##2##3##(1993-3#2)
of radiology##14##2##(1991-1#1)(1991-2#1)(1992-1#1)(1993-1#2)(1993-3#3)(1995-1#1)(1995-2#1)(1996-2#1)(2009-9#2)(2012-2#1)
of radiosurgery##4##2##(1995-12#1)(2008-7#2)(2011-2#1)
of radiotherapy in##2##3##(1994-8#1)(2008-10#1)
of radiotherapy##10##2##(1990-12#1)(1993-9#1)(1994-8#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-7#2)(2009-1#1)
of radish##9##2##(2008-10#9)
of radius##3##2##(2008-4#1)(2010-11#2)
of rain##6##2##(2008-10#5)(2008-3#1)
of rainbow##3##2##(1997-9#1)(2008-11#1)(2008-3#1)
of rainbows##2##2##(2008-3#2)
of raindrops##2##2##(2008-3#2)
of rainfall##2##2##(2008-10#2)
of rainwater##3##2##(2008-10#3)
of raised ICP##7##3##(1996-9#1)(2008-7#2)(2010-5#4)
of raised##11##2##(1994-3#1)(1996-9#1)(2008-7#2)(2010-5#5)(2012-3#1)(2013-1#1)
of ramipril##2##2##(2010-12#2)
of random amplified polymorphic DNA (RAPD)##2##6##(2008-10#2)
of random amplified polymorphic DNA##4##5##(2008-10#4)
of random##21##2##(1990-12#1)(1995-8#1)(1996-3#1)(2008-10#13)(2008-3#2)(2008-4#1)(2008-8#2)
of randomized controlled trials##2##4##(2008-11#1)(2013-1#1)
of randomized trials##2##3##(1993-12#1)(2012-3#1)
of randomized##5##2##(1993-12#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
of randomly selected##2##3##(2008-10#2)
of randomly##6##2##(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-3#1)
of range of motion##2##4##(2008-9#1)(2010-12#1)
of range##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
of ranitidine##3##2##(1992-11#1)(1992-8#1)(2008-11#1)
of rapamycin##6##2##(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#3)
of rapeseed proteins##2##3##(2008-11#2)
of rapeseed##3##2##(2008-10#1)(2008-11#2)
of rapid and##2##3##(2008-10#2)
of rapid diagnostic##2##3##(2011-2#1)(2013-1#1)
of rapid##28##2##(1990-6#1)(1993-2#1)(1995-6#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-8#1)(2011-2#3)(2013-1#3)
of rapidity##2##2##(2008-10#2)
of rapidly##4##2##(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
of rare earth elements##5##4##(2008-10#5)
of rare earth impurities in high purity##2##7##(2008-10#2)
of rare earth impurities##3##4##(2008-10#3)
of rare earth##10##3##(2008-10#10)
of rare earths##4##3##(2008-10#4)
of rare side##2##3##(1991-3#2)
of rare##26##2##(1991-3#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-7#1)
of ras-rBHK-IgG##2##2##(2008-11#2)
of rat adrenal nerve cells##2##5##(2008-11#2)
of rat and mouse##3##4##(1991-6#1)(1991-8#2)
of rat and##7##3##(1991-6#1)(1991-8#2)(1992-3#1)(1995-6#1)(1996-2#1)(2008-11#1)
of rat brain##6##3##(1990-5#1)(1991-5#1)(1993-3#1)(1995-11#1)(2008-10#2)
of rat hepatocytes##4##3##(1990-5#1)(1994-8#1)(2008-11#2)
of rat hippocampal##3##3##(1995-12#1)(1995-6#1)(2008-7#1)
of rat hippocampus##2##3##(1995-12#1)(1997-2#1)
of rat intestinal##2##3##(1991-12#1)(1992-9#1)
of rat liver S-adenosylhomocysteinase##2##4##(1990-10#2)
of rat liver##15##3##(1990-10#2)(1990-3#1)(1990-5#1)(1990-8#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-8#2)(1995-12#1)(2008-10#2)(2008-8#1)(2009-8#1)
of rat lung##2##3##(1995-2#2)
of rat primary hepatocytes##2##4##(2008-11#2)
of rat renal##2##3##(1995-11#1)(2008-8#1)
of rat skeletal muscle##3##4##(1991-5#1)(1993-3#1)(2008-9#1)
of rat##121##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#5)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#2)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#5)(1993-5#1)(1994-11#4)(1994-2#2)(1994-5#1)(1994-8#4)(1995-11#5)(1995-12#6)(1995-2#3)(1995-6#3)(1995-8#1)(1996-12#4)(1996-2#1)(1997-2#3)(2008-10#7)(2008-11#18)(2008-7#3)(2008-8#3)(2008-9#5)(2009-8#1)(2010-12#4)(2011-3#6)(2013-8#2)
of rate equations##2##3##(2008-2#1)(2008-9#1)
of rate isomorphy##4##3##(2008-8#4)
of rate##8##2##(2008-10#1)(2008-2#2)(2008-8#4)(2008-9#1)
of rate-limiting##2##2##(2008-7#1)(2010-12#1)
of rates of##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
of rates##5##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
of rational##2##2##(1992-9#1)(1995-5#1)
of ratios##2##2##(2008-10#2)
of rats (n =##2##4##(1993-6#1)(1997-8#1)
of rats bearing##3##3##(1993-8#3)
of rats by##3##3##(1993-12#1)(2008-10#1)(2013-1#1)
of rats fed vitamin##2##4##(1993-12#1)(1994-5#1)
of rats fed##3##3##(1993-12#1)(1994-5#1)(2013-1#1)
of rats from##3##3##(1991-5#1)(1993-3#1)(2008-10#1)
of rats received##3##3##(1993-3#1)(2008-5#1)(2008-6#1)
of rats treated with##3##4##(1994-5#1)(2008-10#2)
of rats treated##4##3##(1994-5#1)(1997-2#1)(2008-10#2)
of rats were##2##3##(1990-5#1)(1993-8#1)
of rats with##10##3##(1990-12#1)(1993-3#2)(1996-2#1)(1997-1#1)(2009-6#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
of rats##73##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#2)(1993-8#7)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-6#1)(2009-8#1)(2011-2#3)(2011-3#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
of raw and cooked beef patties##2##6##(2010-4#2)
of raw and##4##3##(2008-12#1)(2010-4#3)
of raw data measurements##2##4##(2008-10#2)
of raw material##2##3##(2011-2#2)
of raw materials used##2##4##(2008-10#2)
of raw materials##5##3##(2008-10#4)(2008-5#1)
of raw##18##2##(2008-10#8)(2008-12#1)(2008-5#1)(2010-4#6)(2011-2#2)
of ray##3##2##(2008-2#1)(2008-3#2)
of re-bleeding and##3##3##(2013-1#3)
of reaching the recommended levels of HbA1c##2##7##(2011-2#2)
of reaching the##3##3##(1997-2#1)(2011-2#2)
of reaching##5##2##(1991-2#1)(1997-2#1)(2011-1#1)(2011-2#2)
of reacquisition##2##2##(2008-5#2)
of reaction between##4##3##(2008-10#4)
of reaction conditions##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
of reaction norms##2##3##(2008-8#2)
of reaction of##2##3##(1994-5#1)(2008-10#1)
of reaction products##2##3##(1992-6#1)(2008-4#1)
of reaction time##2##3##(2008-10#2)
of reaction was##3##3##(2008-10#3)
of reaction##33##2##(1991-5#1)(1991-9#1)(1992-6#1)(1994-5#1)(1996-5#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-12#1)(2010-6#1)(2011-2#1)
of reaction-diffusion equations##2##3##(2013-8#2)
of reaction-diffusion##3##2##(2008-9#1)(2013-8#2)
of reactions##10##2##(1994-6#1)(1994-8#1)(2008-10#6)(2008-7#1)(2008-9#1)
of reactive oxygen and##2##4##(2009-8#1)(2011-2#1)
of reactive oxygen species (ROS)##8##5##(1994-5#1)(2008-11#1)(2009-8#2)(2010-5#1)(2011-2#3)
of reactive oxygen species by##3##5##(2008-10#1)(2009-3#1)(2010-1#1)
of reactive oxygen species##19##4##(1992-12#1)(1994-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
of reactive oxygen##24##3##(1992-12#1)(1993-6#1)(1994-5#2)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-3#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
of reactive species by##2##4##(2008-10#1)(2008-11#1)
of reactive species is##2##4##(2008-10#1)(2008-11#1)
of reactive species##4##3##(2008-10#2)(2008-11#2)
of reactive##38##2##(1991-1#1)(1992-12#1)(1993-6#1)(1994-5#2)(1995-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-8#1)(2009-3#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-8#1)
of readily available##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
of reading##11##2##(1993-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-12#3)(2009-4#1)(2010-7#1)
of readmission##2##2##(2011-2#2)
of reagent##19##2##(1990-12#1)(1990-2#1)(2008-10#16)(2012-2#1)
of reagents and##8##3##(2008-10#5)(2008-5#1)(2008-9#2)
of reagents to##2##3##(2008-10#2)
of reagents used##2##3##(1992-3#1)(2008-9#1)
of reagents##23##2##(1992-3#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-9#4)(2009-8#1)(2013-1#2)
of real sample analysis##3##4##(2008-10#3)
of real sample##6##3##(2008-10#6)
of real samples##13##3##(1997-2#1)(2008-10#12)
of real water samples##2##4##(2008-10#2)
of real world##2##3##(2008-10#2)
of real##32##2##(1997-2#1)(2008-10#26)(2008-11#1)(2008-2#1)(2008-8#1)(2010-7#1)(2013-1#1)
of real-time##4##2##(1996-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
of real-world##3##2##(1995-11#1)(2008-10#1)(2008-3#1)
of realistic##3##2##(2008-10#1)(2008-11#2)
of reality##2##2##(1995-2#1)(2008-12#1)
of reasons and##2##3##(2007-11#1)(2008-12#1)
of reasons##6##2##(1993-6#1)(1995-12#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
of rebleeding##2##2##(1997-3#1)(2008-7#1)
of recA-like genes##2##3##(1995-6#2)
of recA-like##3##2##(1995-6#3)
of recall##2##2##(1994-8#1)(2010-1#1)
of recent developments in##2##4##(2008-10#1)(2008-11#1)
of recent literature##2##3##(1996-1#1)(2009-8#1)
of recent publications##2##3##(1993-3#1)(2011-2#1)
of recent studies##6##3##(1993-6#1)(2008-10#2)(2009-8#1)(2011-2#2)
of recent trends in population redistribution##2##6##(2011-2#2)
of recent##38##2##(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-1#1)(1996-1#1)(1996-11#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-7#1)(2009-8#3)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of recently developed##2##3##(2008-11#1)(2011-2#1)
of recently##8##2##(1994-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2011-2#1)
of receptive field##2##3##(2008-11#1)(2008-8#1)
of receptor molecules##2##3##(1996-12#2)
of receptor##17##2##(1991-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#3)(2007-11#1)(2007-12#1)(2008-8#3)(2009-8#2)(2011-1#1)
of receptors##13##2##(1990-11#1)(1993-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2009-1#1)(2013-1#1)
of recipient##5##2##(1997-5#1)(2008-11#3)(2010-11#1)
of reciprocal altruism##2##3##(2012-3#2)
of reciprocal##5##2##(2009-7#1)(2012-2#1)(2012-3#3)
of reciprocity##2##2##(2010-9#1)(2012-3#1)
of recognition memory##2##3##(1993-3#1)(2008-6#1)
of recognition of##2##3##(1991-11#1)(2012-3#1)
of recognition##5##2##(1991-11#1)(1993-3#1)(1997-1#1)(2008-6#1)(2012-3#1)
of recognizing##6##2##(1993-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-11#1)
of recombinant CHO##3##3##(2008-11#3)
of recombinant Chinese hamster ovary##2##5##(2008-11#2)
of recombinant DNA##2##3##(1991-9#1)(2011-2#1)
of recombinant Escherichia coli##2##4##(2008-7#2)
of recombinant IGF-I##2##3##(2008-11#1)(2008-5#1)
of recombinant adeno-associated virus##2##4##(1993-2#1)(2008-8#1)
of recombinant antibodies##2##3##(2008-10#1)(2013-8#1)
of recombinant antibody##3##3##(2008-11#3)
of recombinant chicken##2##3##(1991-3#1)(2008-11#1)
of recombinant human coagulation factor##2##5##(2008-11#1)(2008-8#1)
of recombinant human erythropoietin##2##4##(2008-11#2)
of recombinant human glucagon was##3##5##(2008-8#3)
of recombinant human keratinocyte growth factor##2##6##(1994-11#1)(2008-7#1)
of recombinant human protein C##2##5##(2008-12#2)
of recombinant human##28##3##(1990-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-6#3)(1996-11#1)(2008-11#7)(2008-12#2)(2008-7#4)(2008-8#4)(2011-2#1)
of recombinant inbred (RI) lines##2##5##(2008-10#2)
of recombinant inbred##5##3##(2008-10#5)
of recombinant mammalian cell lines##2##5##(2008-11#2)
of recombinant mammalian##3##3##(2008-11#3)
of recombinant protein in##2##4##(2008-11#2)
of recombinant protein is##2##4##(1993-2#1)(2008-11#1)
of recombinant protein##21##3##(1993-2#1)(1994-11#1)(2008-11#16)(2008-4#1)(2011-2#2)
of recombinant proteins for##3##4##(2008-11#3)
of recombinant proteins in the##2##5##(2008-11#2)
of recombinant proteins in##5##4##(2008-11#5)
of recombinant proteins produced##2##4##(2008-4#1)(2011-2#1)
of recombinant proteins##24##3##(1994-11#1)(2008-11#20)(2008-4#1)(2011-2#2)
of recombinant rat##5##3##(2008-11#4)(2008-8#1)
of recombinant wild-type##2##3##(1992-9#1)(1995-6#1)
of recombinant zebrafish##2##3##(2010-5#2)
of recombinant##183##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-9#3)(1992-10#1)(1992-9#2)(1993-2#2)(1993-6#2)(1993-8#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#4)(1996-11#1)(1997-7#3)(1997-8#1)(2008-1#2)(2008-10#13)(2008-11#84)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#12)(2008-8#9)(2008-9#1)(2009-7#1)(2010-5#3)(2010-6#2)(2011-2#10)(2011-3#2)(2012-3#2)(2013-8#2)
of recombinants##2##2##(1995-9#1)(2008-10#1)
of recombination and##6##3##(2008-10#4)(2009-10#1)(2013-8#1)
of recombination in##4##3##(1993-12#2)(2008-10#2)
of recombination##16##2##(1993-12#2)(2008-10#10)(2008-12#1)(2008-8#1)(2009-10#1)(2013-8#1)
of recombined single chain insulin and##2##6##(2008-9#2)
of recombined single chain insulin##4##5##(2008-9#4)
of recommendations for##3##3##(1993-12#1)(1996-6#1)(2008-9#1)
of recommendations##7##2##(1993-12#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-9#1)(2012-3#1)
of recommended##2##2##(1994-12#1)(2012-2#1)
of reconstituted##3##2##(2008-8#3)
of reconstructed epidermis##3##3##(2008-5#3)
of reconstructed##7##2##(2007-12#1)(2008-5#5)(2008-9#1)
of reconstructing##3##2##(2008-4#1)(2011-3#1)(2011-7#1)
of reconstruction of the##4##4##(1990-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
of reconstruction of##5##3##(1990-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
of reconstruction##11##2##(1990-3#1)(1990-9#1)(1996-3#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
of reconstructive##4##2##(1993-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
of recordable##2##2##(2008-10#1)(2008-3#1)
of recorded signals is##2##4##(2008-3#1)(2011-1#1)
of recorded##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
of recording##8##2##(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2011-1#1)
of records of##2##3##(2011-1#1)(2012-3#1)
of records##4##2##(1994-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
of recovered##5##2##(1993-3#1)(2008-10#2)(2008-7#1)(2012-2#1)
of recoveries##4##2##(2008-10#4)
of recovery for##2##3##(2008-10#1)(2008-5#1)
of recovery of the##2##4##(2008-10#1)(2008-7#1)
of recovery of##9##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
of recovery was##5##3##(1991-2#1)(2008-10#2)(2008-12#1)(2012-3#1)
of recovery were not##2##4##(1994-8#1)(2012-3#1)
of recovery##34##2##(1991-2#2)(1994-5#1)(1994-8#1)(1995-6#2)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#3)(2008-8#1)(2010-5#1)(2012-3#3)
of recruitment and##2##3##(1991-6#1)(2008-12#1)
of recruitment##4##2##(1990-2#1)(1991-6#1)(2008-12#1)(2013-1#1)
of rectal cancer##2##3##(2009-12#1)(2013-8#1)
of rectal mucosal prolapse and hemorrhoidal prolapse##2##7##(2013-1#2)
of rectal mucosal prolapse##5##4##(2013-1#5)
of rectal neoplasia##2##3##(2009-12#2)
of rectal##15##2##(1990-3#1)(1990-5#1)(2009-11#1)(2009-12#4)(2013-1#6)(2013-8#2)
of rectum##7##2##(1990-3#1)(2008-12#3)(2012-12#1)(2012-3#1)(2013-8#1)
of rectus femoris muscle##2##4##(2008-12#1)(2011-2#1)
of recurrence and##5##3##(2008-2#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
of recurrence##23##2##(1991-9#1)(1992-1#1)(1993-1#1)(1994-2#1)(1994-8#1)(1996-11#1)(2008-2#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
of recurrences for##2##3##(1994-1#1)(2008-10#1)
of recurrences##6##2##(1992-5#1)(1994-1#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-7#1)
of recurrent disease##2##3##(1994-5#1)(2012-3#1)
of recurrent infection##2##3##(2008-8#1)(2011-2#1)
of recurrent vertigo##3##3##(2012-3#3)
of recurrent##27##2##(1992-5#1)(1993-1#2)(1994-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-8#3)(2009-12#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#7)(2013-1#1)(2013-8#1)
of red beds and##3##4##(2013-8#3)
of red beds##5##3##(2013-8#5)
of red blood cells##2##4##(1992-11#1)(2008-9#1)
of red blood##3##3##(1992-11#1)(2008-9#1)(2013-1#1)
of red light##2##3##(1990-5#2)
of red wine##3##3##(2008-10#2)(2008-7#1)
of red##22##2##(1990-5#2)(1992-11#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#5)
of redisplacement##3##2##(1991-9#1)(2011-2#2)
of redox mediator##2##3##(2008-10#2)
of redox##7##2##(1992-6#1)(2008-10#4)(2008-12#1)(2009-9#1)
of reduced glutathione (GSH) in##2##5##(2008-10#2)
of reduced glutathione##4##3##(1990-12#1)(2008-10#3)
of reduced hemodynamic load##2##4##(2012-3#2)
of reduced phosphorus##2##3##(2008-10#2)
of reduced sulfur compounds (RSC)##2##5##(2008-10#2)
of reduced sulfur compounds##4##4##(2008-10#4)
of reduced##40##2##(1990-12#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#14)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-8#1)
of reducing the##2##3##(2008-10#1)(2008-11#1)
of reducing##19##2##(1992-9#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-11#2)(1995-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#2)(2013-1#1)
of reduction in##3##3##(1996-2#1)(2008-10#1)(2009-7#1)
of reduction of the##2##4##(2008-10#1)(2009-8#1)
of reduction of##5##3##(2008-10#4)(2009-8#1)
of reduction##13##2##(1991-9#1)(1996-2#1)(2008-10#9)(2009-7#1)(2009-8#1)
of reductive##5##2##(2008-10#3)(2008-11#1)(2011-1#1)
of redundancy##2##2##(2011-2#1)(2011-3#1)
of refeeding##2##2##(2008-3#1)(2008-7#1)
of reference compounds##2##3##(2008-10#1)(2008-5#1)
of reference for the##2##4##(1990-12#1)(2011-2#1)
of reference materials##4##3##(2008-10#4)
of reference values##2##3##(2008-10#1)(2008-11#1)
of reference##26##2##(1990-12#1)(1990-2#1)(1992-2#2)(1994-8#1)(1996-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#2)
of references##3##2##(2008-4#1)(2008-9#1)(2013-8#1)
of referral of##2##3##(1990-12#1)(1992-12#1)
of referral##4##2##(1990-12#1)(1992-12#1)(2008-1#1)(2008-11#1)
of referrals##4##2##(1994-2#1)(1997-8#1)(2008-12#1)(2010-4#1)
of reflectance##9##2##(1991-2#1)(2008-10#5)(2008-3#2)(2008-8#1)
of reflection and reflective practice##3##5##(2008-11#3)
of reflection and##5##3##(2008-11#5)
of reflection as a##2##4##(2008-12#2)
of reflection as##3##3##(2008-11#1)(2008-12#2)
of reflection in##3##3##(2008-11#2)(2008-12#1)
of reflection##19##2##(2008-11#15)(2008-12#4)
of reflective practice##2##3##(1997-4#1)(2008-11#1)
of reflective##9##2##(1997-4#1)(2008-11#4)(2008-12#3)(2008-3#1)
of reflux disease##2##3##(2011-2#2)
of refluxing ureters##2##3##(2008-10#2)
of refluxing##3##2##(2008-10#3)
of reform##2##2##(1994-12#1)(1996-2#1)
of reforms##3##2##(1993-2#1)(1997-1#1)(2008-1#1)
of refraction##13##2##(1991-9#1)(2008-2#1)(2008-3#11)
of refractive index##3##3##(2007-11#2)(2008-10#1)
of refractive turbulence on ground-based verification of##2##7##(2008-3#2)
of refractive##7##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2009-9#1)
of refractory##4##2##(1991-2#1)(2008-10#1)(2011-2#2)
of refugees and asylum-seekers who##2##5##(1995-11#2)
of refugees##3##2##(1990-6#1)(1995-11#2)
of refusers##2##2##(1991-6#2)
of regenerated##4##2##(1995-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
of regenerating##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
of regeneration of the##2##4##(1995-12#1)(2008-10#1)
of regeneration of##4##3##(1995-12#1)(2008-10#2)(2013-8#1)
of regeneration##7##2##(1995-12#1)(2008-10#2)(2012-2#1)(2013-8#3)
of regenerative medicine##3##3##(2008-11#2)(2013-1#1)
of regional anesthesia##3##3##(2008-8#1)(2012-2#1)(2012-3#1)
of regional##19##2##(1990-9#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-3#1)
of regions of##2##3##(2009-7#1)(2011-2#1)
of regions##4##2##(1991-6#1)(2008-2#1)(2009-7#1)(2011-2#1)
of registered nurses in##2##4##(2008-11#1)(2012-3#1)
of registered nurses##4##3##(1991-2#1)(2008-11#2)(2012-3#1)
of registered##7##2##(1991-2#1)(1996-3#1)(2008-11#3)(2012-12#1)(2012-3#1)
of registration##2##2##(1993-12#1)(2008-11#1)
of regression models##2##3##(1991-1#1)(1992-9#1)
of regression##7##2##(1991-1#2)(1992-9#1)(2008-10#3)(2013-8#1)
of regular##10##2##(1993-3#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-3#1)(2008-5#1)(2011-2#3)(2013-8#1)
of regulated##2##2##(1992-12#1)(2008-10#1)
of regulating##5##2##(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#2)
of regulation of##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)
of regulation##9##2##(1994-6#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-7#1)
of regulatory genes##2##3##(1994-11#1)(2008-10#1)
of regulatory networks##2##3##(2008-11#1)(2010-10#1)
of regulatory proteins##3##3##(2008-4#1)(2009-3#1)(2013-7#1)
of regulatory##17##2##(1990-9#1)(1994-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#3)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-7#1)
of rehabilitation##7##2##(1993-6#1)(2008-11#1)(2010-10#2)(2010-9#1)(2013-1#2)
of reinforcement##5##2##(1993-6#2)(2008-5#1)(2009-7#1)(2010-10#1)
of rejection##2##2##(1997-5#1)(2010-8#1)
of relapse##8##2##(1990-11#1)(1992-12#1)(1993-1#1)(1997-8#2)(2009-11#1)(2009-9#1)(2013-1#1)
of relapses##2##2##(2012-3#1)(2013-8#1)
of relapsing##2##2##(1991-2#1)(2010-12#1)
of related##15##2##(1990-5#1)(1992-4#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
of relatedness and##2##3##(2009-10#1)(2010-4#1)
of relatedness##5##2##(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)
of relating##4##2##(1993-1#1)(1993-2#1)(2008-10#1)(2013-8#1)
of relations between##2##3##(2008-10#1)(2010-6#1)
of relations##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
of relationship and##2##3##(2008-11#1)(2008-6#1)
of relationship satisfaction##2##3##(2008-6#1)(2012-2#1)
of relationship##9##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#2)(2012-2#3)
of relationships among##2##3##(1992-3#1)(1997-2#1)
of relationships between##4##3##(1991-2#1)(1992-3#1)(2008-10#2)
of relationships with##2##3##(1995-2#1)(2009-7#1)
of relationships##13##2##(1991-2#1)(1992-3#2)(1995-2#1)(1997-2#1)(2008-10#2)(2008-8#1)(2009-7#2)(2010-1#1)(2013-1#2)
of relative humidity##3##3##(2008-10#3)
of relative potency##2##3##(1995-12#1)(2008-5#1)
of relative standard deviation (R##4##5##(2008-10#4)
of relative standard deviation##6##4##(2008-10#6)
of relative##29##2##(1991-2#1)(1995-12#1)(2008-10#17)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#1)(2012-9#1)
of relatively hydrophilic chemicals##2##4##(2008-11#2)
of relatively large##6##3##(1997-2#1)(1997-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
of relatively##12##2##(1997-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
of relaxation##2##2##(2008-11#1)(2012-3#1)
of relaxed selective constraint##2##4##(2011-2#2)
of release of##2##3##(1992-3#1)(2008-10#1)
of release##5##2##(1992-3#1)(1996-2#1)(2008-10#2)(2008-5#1)
of released alpha-tocopherol##2##3##(2009-8#2)
of released##5##2##(1992-6#1)(2008-10#1)(2009-8#3)
of releasing##2##2##(1992-9#1)(2008-8#1)
of relevance for##2##3##(2008-12#1)(2008-3#1)
of relevance to the##3##4##(1992-12#1)(2011-2#1)(2013-1#1)
of relevance##6##2##(1991-1#1)(1992-12#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
of relevant and##2##3##(2008-10#1)(2008-7#1)
of relevant articles for##2##4##(1994-3#1)(2013-8#1)
of relevant##13##2##(1994-3#1)(1995-2#1)(2008-10#5)(2008-11#2)(2008-7#3)(2013-8#1)
of reliability and##2##3##(2008-1#1)(2012-2#1)
of reliability##6##2##(1993-12#1)(1995-2#1)(1997-4#1)(2008-1#1)(2009-12#1)(2012-2#1)
of reliable##4##2##(2008-10#1)(2008-9#1)(2010-11#1)(2013-8#1)
of reliably##4##2##(1991-3#1)(2008-10#2)(2012-2#1)
of religion##3##2##(2008-12#2)(2009-6#1)
of religiosity##4##2##(2009-11#2)(2011-1#2)
of religious##2##2##(2010-10#2)
of relying on##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
of remaining##5##2##(1992-9#1)(1996-12#1)(2008-7#2)(2011-2#1)
of remarkable##3##2##(2008-1#1)(2008-12#1)(2008-7#1)
of remifentanil for reducing##2##4##(2011-2#2)
of remifentanil on arterial oxygenation during one-lung ventilation##2##8##(2011-2#2)
of remifentanil on##3##3##(2011-2#3)
of remifentanil##6##2##(2011-2#6)
of remission in##2##3##(2010-12#1)(2012-3#1)
of remission##5##2##(1992-2#1)(1994-6#1)(2008-8#1)(2010-12#1)(2012-3#1)
of remote sensing of##2##4##(2008-2#1)(2008-3#1)
of remote##5##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-8#1)
of removal of##3##3##(1993-12#1)(1994-8#1)(2008-10#1)
of removing##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
of renal arteries##2##3##(1993-8#1)(2008-12#1)
of renal artery##2##3##(1994-9#1)(2008-12#1)
of renal cell carcinoma in##2##5##(1990-8#2)
of renal cell carcinoma##5##4##(1990-8#2)(2010-8#1)(2011-2#1)(2012-3#1)
of renal cell##6##3##(1990-8#2)(2010-8#1)(2011-2#1)(2012-3#2)
of renal disease##2##3##(2008-1#1)(2009-6#1)
of renal diseases##2##3##(1997-5#1)(2013-1#1)
of renal failure##2##3##(1995-12#1)(2008-1#1)
of renal function##2##3##(2008-1#1)(2011-2#1)
of renal impairment##2##3##(2013-1#2)
of renal injuries##2##3##(1990-9#1)(2012-2#1)
of renal stones##2##3##(2008-10#1)(2011-2#1)
of renal transplant##2##3##(2010-7#2)
of renal transplantation##2##3##(1994-5#1)(2008-1#1)
of renal##57##2##(1990-2#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-5#1)(1992-3#1)(1992-5#2)(1993-8#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1996-6#1)(1997-5#1)(2008-1#4)(2008-10#8)(2008-12#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#5)
of rendering##2##2##(1996-9#1)(2008-4#1)
of reoperation with##2##3##(2012-3#2)
of repair##5##2##(2011-1#1)(2011-2#3)(2012-3#1)
of repeat##5##2##(1990-3#1)(1993-11#1)(1995-11#1)(2008-11#1)(2008-8#1)
of repeatability at the##2##4##(2008-10#2)
of repeatability##5##2##(2008-10#4)(2012-12#1)
of repeated measures##3##3##(1992-9#2)(1994-9#1)
of repeated##20##2##(1992-9#2)(1993-6#2)(1994-9#1)(1995-5#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#3)
of reperfusion##4##2##(1994-3#1)(1996-12#2)(2008-10#1)
of repetitive self-injury##2##3##(2008-11#2)
of repetitive##13##2##(1990-11#1)(1991-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
of replacement##2##2##(1997-1#1)(2008-10#1)
of replacing##3##2##(2008-10#1)(2008-11#2)
of replant##2##2##(2008-10#2)
of replicate##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
of replication of##2##3##(1991-12#1)(1994-11#1)
of replication stress##2##3##(2011-2#1)(2012-3#1)
of replication##12##2##(1991-12#1)(1993-12#1)(1994-11#1)(1995-12#1)(1997-6#1)(1997-8#1)(2008-10#3)(2011-2#2)(2012-3#1)
of reportable##3##2##(1997-3#2)(2010-11#1)
of reported cases##2##3##(1991-2#1)(2013-1#1)
of reported##14##2##(1991-2#1)(1993-2#1)(1995-12#1)(2008-10#2)(2008-11#4)(2010-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
of reporter gene expression##3##4##(1995-2#1)(2008-11#1)(2008-8#1)
of reporter genes##2##3##(2008-10#1)(2008-8#1)
of reporter##9##2##(1995-2#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#2)(2012-2#1)
of reporting##2##2##(2008-10#1)(2013-1#1)
of reports of##3##3##(2008-7#1)(2009-6#1)(2012-3#1)
of reports that##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
of reports##16##2##(1995-2#1)(1996-8#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of representative isolates##2##3##(2008-10#1)(2011-2#1)
of representative##8##2##(2008-10#5)(2008-8#1)(2011-2#1)(2012-3#1)
of representing##2##2##(2009-7#1)(2013-8#1)
of repressor and##2##3##(1991-5#1)(2012-3#1)
of repressor##3##2##(1991-5#1)(1992-4#1)(2012-3#1)
of reproducibility##2##2##(2008-10#1)(2008-5#1)
of reproducible##2##2##(2008-10#2)
of reproducing##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
of reproduction in##3##3##(1997-7#1)(2008-8#2)
of reproduction##15##2##(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#6)(2008-9#6)
of reproductive effort##6##3##(2008-8#5)(2008-9#1)
of reproductive health##2##3##(2008-1#2)
of reproductive isolation##4##3##(2008-8#4)
of reproductive output##3##3##(2008-8#3)
of reproductive skew##4##3##(2008-8#3)(2008-9#1)
of reproductive structure##2##3##(2011-2#2)
of reproductive##35##2##(1992-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#16)(2008-9#4)(2009-5#1)(2009-6#2)(2010-8#2)(2011-1#2)(2011-2#3)
of requiring##2##2##(1996-1#1)(2013-1#1)
of research and practice##5##4##(2010-10#5)
of research and##7##3##(2008-11#1)(2010-10#5)(2012-2#1)
of research are##4##3##(1997-8#1)(2008-2#1)(2008-5#1)(2012-12#1)
of research areas##2##3##(1993-2#1)(2009-10#1)
of research evidence to##2##4##(2008-11#1)(2008-12#1)
of research evidence##3##3##(2008-11#2)(2008-12#1)
of research has been conducted##2##5##(2010-12#1)(2011-2#1)
of research has been##3##4##(2010-12#1)(2011-2#1)(2013-1#1)
of research has demonstrated##2##4##(1990-11#1)(2008-7#1)
of research has##7##3##(1990-11#1)(1997-1#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
of research in the past##2##5##(2009-1#1)(2010-10#1)
of research in the##4##4##(2008-11#1)(2009-1#1)(2010-10#1)(2012-2#1)
of research in##12##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-1#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-7#1)(2012-2#1)(2013-8#1)
of research into##4##3##(2010-10#1)(2011-2#1)(2013-1#2)
of research is##3##3##(1997-1#1)(2008-11#2)
of research on the##2##4##(2008-9#1)(2013-8#1)
of research on##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
of research participation##2##3##(2009-4#2)
of research that##11##3##(2008-10#1)(2008-11#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
of research to##2##3##(2008-11#2)
of research uptake##3##3##(2010-10#3)
of research##116##2##(1990-11#1)(1992-12#1)(1993-1#1)(1993-2#2)(1994-9#1)(1997-1#5)(1997-8#1)(2008-10#5)(2008-11#17)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#3)(2009-4#7)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#10)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#5)(2013-8#3)
of researchers##5##2##(2008-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#1)
of resected##2##2##(2013-1#2)
of resection##4##2##(1994-12#1)(2008-9#2)(2011-2#1)
of reserpine in the##2##4##(2008-10#1)(2008-12#1)
of reserpine in##4##3##(2008-10#2)(2008-12#2)
of reserpine##9##2##(2008-10#5)(2008-12#4)
of reserves##2##2##(2008-10#1)(2008-8#1)
of residence in##2##3##(2010-12#2)
of residence##7##2##(1991-1#1)(1994-3#1)(1994-6#1)(1997-2#1)(2010-12#2)(2012-12#1)
of residency##3##2##(1994-12#1)(1994-3#1)(2010-8#1)
of resident bacteria##2##3##(2008-5#2)
of resident##14##2##(1991-3#1)(1997-1#1)(2008-10#4)(2008-12#2)(2008-5#3)(2008-9#1)(2010-10#1)(2010-8#1)
of residents in##2##3##(1992-2#1)(1996-9#1)
of residents##14##2##(1991-3#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#2)(1995-2#1)(1996-9#1)(1997-1#2)(2011-2#3)
of residual acetic acid##2##4##(2008-10#2)
of residual chlorine##2##3##(2008-10#2)
of residual##27##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-9#2)(1993-1#1)(1995-11#1)(2008-10#10)(2008-3#1)(2008-9#2)(2009-7#2)(2011-2#5)
of residue##4##2##(2008-10#3)(2008-11#1)
of residues at positions##2##4##(1994-3#1)(1994-5#1)
of residues##7##2##(1992-12#1)(1994-3#1)(1994-5#3)(1995-2#1)(2008-10#1)
of resin composites##2##3##(2010-10#1)(2013-1#1)
of resin##7##2##(2008-10#5)(2010-10#1)(2013-1#1)
of resistance against##3##3##(2008-10#2)(2008-8#1)
of resistance and##7##3##(1995-6#1)(2008-10#6)
of resistance conferred by##2##4##(2008-10#2)
of resistance development##2##3##(2008-10#2)
of resistance displayed by the source plant##2##7##(2008-10#2)
of resistance elicitors##4##3##(2008-10#4)
of resistance genes##8##3##(2008-10#8)
of resistance in a##2##4##(2008-10#1)(2008-11#1)
of resistance in the##2##4##(2008-10#2)
of resistance in##13##3##(1995-6#1)(2008-10#10)(2008-11#1)(2011-10#1)
of resistance into commercial##2##4##(2008-10#2)
of resistance into##3##3##(2008-10#3)
of resistance is##2##3##(2008-10#2)
of resistance loci##3##3##(2008-10#3)
of resistance responses##2##3##(2008-10#1)(2009-6#1)
of resistance to Aspergillus ear rot and aflatoxin production##2##9##(2008-10#2)
of resistance to Aspergillus ear rot and aflatoxin##3##8##(2008-10#3)
of resistance to FHB##2##4##(2008-10#2)
of resistance to Sclerotinia##2##4##(2008-10#2)
of resistance to aflatoxin production##2##5##(2008-10#2)
of resistance to alkylating agents##2##5##(2008-11#2)
of resistance to fumonisin production and accumulation in grain##2##9##(2008-10#2)
of resistance to fumonisin##3##4##(2008-10#3)
of resistance to the##2##4##(2008-10#2)
of resistance to therapy##2##4##(1995-2#1)(2012-3#1)
of resistance to##64##3##(1993-12#1)(1993-8#1)(1995-2#1)(1997-5#1)(2008-10#49)(2008-11#4)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)
of resistance was##7##3##(2008-10#7)
of resistance were##5##3##(2008-10#4)(2013-8#1)
of resistance##185##2##(1993-12#1)(1993-8#2)(1994-8#1)(1995-2#1)(1995-6#2)(1997-5#1)(2008-10#146)(2008-11#8)(2008-12#1)(2008-5#1)(2008-8#5)(2008-9#3)(2009-6#1)(2009-8#1)(2010-11#1)(2011-10#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
of resistance-associated##2##2##(2008-11#2)
of resistant and susceptible##3##4##(2008-10#3)
of resistant cultivars##7##3##(2008-10#7)
of resistant genotypes##2##3##(2008-10#2)
of resistant host##2##3##(2008-10#1)(2008-8#1)
of resistant hypertension##2##3##(2010-6#2)
of resistant isolates##5##3##(2008-10#5)
of resistant plants##2##3##(2008-10#2)
of resistant strains##2##3##(2008-10#2)
of resistant##41##2##(1996-3#1)(2008-10#31)(2008-8#3)(2010-11#1)(2010-6#2)(2011-2#1)(2013-1#2)
of resolution and##3##3##(1991-7#1)(1993-9#1)(2008-3#1)
of resolution##10##2##(1991-7#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-7#1)
of resolving##2##2##(2008-10#1)(2008-3#1)
of resonance##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
of resonant##2##2##(2008-10#1)(2008-11#1)
of resonator-originated and external beam shaping##2##6##(2008-2#2)
of resource availability##4##3##(2008-8#3)(2008-9#1)
of resource capture##3##3##(2008-8#1)(2008-9#2)
of resource competition##3##3##(2008-8#2)(2008-9#1)
of resource sharing##2##3##(1995-2#1)(2011-2#1)
of resource supply##2##3##(2008-8#2)
of resource use##2##3##(1993-12#1)(2008-9#1)
of resource##30##2##(1993-12#1)(1995-2#1)(2008-12#1)(2008-8#19)(2008-9#7)(2011-2#1)
of resources and##5##3##(1997-3#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-12#1)
of resources to##3##3##(1990-12#1)(2008-9#2)
of resources used##2##3##(1997-4#1)(2008-8#1)
of resources##28##2##(1990-12#1)(1990-9#1)(1991-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#5)(2008-9#4)(2010-12#1)(2010-7#1)(2012-2#2)
of respective##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
of respirable size##2##3##(1991-12#1)(1996-1#1)
of respirable##3##2##(1991-12#2)(1996-1#1)
of respiration is##2##3##(2008-7#2)
of respiration##5##2##(2008-7#4)(2009-8#1)
of respiratory disease##2##3##(1997-1#1)(2009-10#1)
of respiratory diseases##2##3##(1996-3#2)
of respiratory distress##2##3##(2008-5#1)(2008-7#1)
of respiratory epithelium and##2##4##(2012-3#2)
of respiratory failure##2##3##(1991-6#1)(2009-5#1)
of respiratory muscles and##2##4##(1991-6#1)(2012-3#1)
of respiratory##29##2##(1990-11#1)(1990-9#1)(1991-6#2)(1992-6#1)(1993-12#1)(1996-3#4)(1996-5#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)
of respondents reported##2##3##(1990-6#1)(2010-8#1)
of respondents reporting##2##3##(1993-9#1)(1996-3#1)
of respondents were##2##3##(2008-9#1)(2009-10#1)
of respondents##15##2##(1990-6#1)(1991-12#1)(1992-1#1)(1993-12#1)(1993-9#1)(1996-3#1)(2007-12#1)(2008-11#2)(2008-9#1)(2009-10#2)(2010-8#1)(2012-2#2)
of responders##5##2##(1990-12#1)(1990-2#1)(1990-6#1)(2009-6#1)(2010-12#1)
of responding to the##3##4##(2008-10#1)(2008-5#2)
of responding##9##2##(1993-6#1)(2008-10#1)(2008-5#7)
of response to neoadjuvant##2##4##(1993-11#1)(2010-7#1)
of response to##12##3##(1993-11#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#1)
of response was##5##3##(1990-6#1)(1991-6#1)(1992-2#1)(1994-8#1)(1997-1#1)
of response##44##2##(1990-6#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#2)(1993-6#2)(1994-8#1)(1995-12#1)(1997-1#1)(2008-10#9)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#3)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
of responses in##2##3##(1995-8#1)(2008-11#1)
of responses increased significantly from##2##5##(2008-12#2)
of responses that##3##3##(2008-11#1)(2008-6#1)(2012-3#1)
of responses to##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
of responses##22##2##(1995-8#1)(2008-10#7)(2008-11#7)(2008-12#3)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
of responsibilities##2##2##(1995-12#1)(2012-3#1)
of responsibility##4##2##(1995-12#1)(1996-1#1)(1997-2#1)(2008-11#1)
of responsiveness##2##2##(1991-1#1)(1995-12#1)
of rest##2##2##(2009-1#1)(2013-1#1)
of restenosis after##2##3##(1991-5#1)(2008-7#1)
of restenosis##10##2##(1991-5#1)(1992-9#3)(1994-9#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
of resting##6##2##(1992-6#1)(2006-6#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)
of restraint##3##2##(1997-2#2)(2008-7#1)
of restricted##2##2##(2008-9#1)(2012-3#1)
of restriction enzyme##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
of restriction sites##2##3##(1996-2#1)(2008-11#1)
of restriction##9##2##(1993-12#1)(1993-9#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
of restrictive##3##2##(1990-9#1)(1991-12#2)
of resulting##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-7#1)
of results and##2##3##(1991-8#1)(2012-2#1)
of results can##2##3##(2008-9#1)(2013-1#1)
of results from##4##3##(1990-9#1)(1995-3#1)(2008-10#1)(2008-2#1)
of results in the##2##4##(2008-10#1)(2008-12#1)
of results in##3##3##(2008-1#1)(2008-10#1)(2008-12#1)
of results obtained by##3##4##(2008-10#2)(2008-11#1)
of results obtained##8##3##(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)
of results##41##2##(1990-2#1)(1990-9#2)(1991-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2012-2#1)(2013-1#3)
of resuscitation##2##2##(2008-11#1)(2010-8#1)
of resveratrol##6##2##(2008-10#5)(2012-4#1)
of retained##2##2##(2008-12#2)
of retention and elution##3##4##(2008-10#3)
of retention of##2##3##(2008-10#1)(2008-11#1)
of retention##16##2##(1990-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2009-9#1)(2013-1#2)
of reticular##2##2##(1990-9#1)(2013-1#1)
of reticulated platelets##4##3##(2006-6#3)(2008-9#1)
of reticulocytes in##2##3##(2008-9#2)
of reticulocytes turning into##2##4##(2008-9#2)
of reticulocytes##6##2##(1993-2#1)(1996-2#1)(2008-9#4)
of retina##2##2##(2010-1#1)(2011-2#1)
of retinal ganglion cells##2##4##(2008-7#1)(2011-2#1)
of retinal pathology##2##3##(2011-7#2)
of retinal##10##2##(1994-6#1)(1995-9#1)(2008-7#1)(2009-10#1)(2011-2#2)(2011-7#2)(2011-9#1)(2013-1#1)
of retinoblastoma##2##2##(1997-7#1)(2011-2#1)
of retinoic acid (RA)##2##4##(1990-6#1)(1995-9#1)
of retinoic acid in##2##4##(1990-6#1)(2007-11#1)
of retinoic acid on##3##4##(1993-3#1)(1994-11#1)(2008-11#1)
of retinoic acid##8##3##(1990-6#2)(1993-3#1)(1994-11#2)(1995-9#1)(2007-11#1)(2008-11#1)
of retinoic##9##2##(1990-6#2)(1993-3#1)(1994-11#2)(1995-9#1)(1997-7#1)(2007-11#1)(2008-11#1)
of retinoid##4##2##(1995-8#1)(2007-11#2)(2008-5#1)
of retinoids##2##2##(1994-6#1)(2007-11#1)
of retinol deficiency and curcumin##2##5##(1994-8#2)
of retinol##12##2##(1994-8#2)(2008-5#8)(2009-6#2)
of retinopathy##2##2##(1995-9#2)
of retinula##2##2##(2007-12#2)
of retired workers##2##3##(1993-1#2)
of retrieval of##2##3##(1993-12#1)(2008-3#1)
of retroperitoneal lesions##2##3##(2011-2#2)
of retroperitoneal##6##2##(1990-5#1)(1994-6#1)(1996-6#1)(2011-2#2)(2013-1#1)
of retrospective study##2##3##(2008-11#1)(2012-3#1)
of retrospective##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
of retroviral vector##2##3##(2008-11#2)
of retroviral##6##2##(2008-11#3)(2008-4#3)
of retroviruses##3##2##(2008-11#3)
of returning##4##2##(2007-11#1)(2008-8#3)
of reverse oblique##2##3##(2013-1#2)
of reverse##6##2##(1995-12#1)(1996-12#1)(2008-10#1)(2013-1#3)
of reverse-correlation##3##2##(2013-8#3)
of reversed micelles as##2##4##(2008-10#2)
of reversed micelles##4##3##(1990-5#1)(1995-3#1)(2008-10#2)
of reversed##6##2##(1990-5#3)(1995-3#1)(2008-10#2)
of reversed-phase high-performance liquid chromatography##2##5##(1997-2#1)(2008-10#1)
of reversed-phase##3##2##(1996-12#1)(1997-2#1)(2008-10#1)
of reversibility##5##2##(1992-10#1)(1992-5#1)(2008-10#3)
of reversible##3##2##(1990-9#1)(1997-2#1)(2008-10#1)
of revertants##2##2##(1995-5#1)(2008-9#1)
of reviewed##2##2##(2008-10#1)(2008-11#1)
of revision THA in##2##4##(2013-1#2)
of revision THA##3##3##(2013-1#3)
of revision##6##2##(2012-12#1)(2012-3#1)(2013-1#4)
of reward and##3##3##(1994-8#1)(2008-7#1)(2013-8#1)
of reward##9##2##(1992-12#2)(1994-8#1)(1996-3#1)(1996-5#1)(2008-7#1)(2009-7#1)(2013-8#2)
of rhAT III##2##3##(2008-7#2)
of rhP2##2##2##(1995-12#2)
of rhPC##2##2##(2008-12#2)
of rhabdomyolysis##2##2##(2011-2#2)
of rheumatic diseases##2##3##(1991-8#1)(1993-3#1)
of rheumatic fever##2##3##(1996-12#2)
of rheumatic##5##2##(1991-8#1)(1993-3#1)(1994-2#1)(1996-12#2)
of rheumatoid arthritis and##2##4##(2009-1#1)(2013-1#1)
of rheumatoid arthritis##9##3##(1991-8#1)(1996-9#1)(2007-11#1)(2009-1#1)(2010-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
of rheumatoid##10##2##(1991-8#1)(1996-9#1)(2007-11#1)(2008-4#1)(2009-1#1)(2010-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
of rheumatology##2##2##(1991-11#1)(2012-2#1)
of rhizoctonia##2##2##(2008-10#2)
of rhizomania in##2##3##(2008-10#2)
of rhizomania##6##2##(2008-10#6)
of rhizosphere##2##2##(2008-10#2)
of rho##4##2##(1992-3#1)(2008-10#3)
of rhodamine 6G##2##3##(2008-10#2)
of rhodamine B##2##3##(2008-10#1)(2008-12#1)
of rhodamine##7##2##(2008-10#6)(2008-12#1)
of rhodium by##2##3##(2008-10#2)
of rhodium in different##2##4##(2008-10#2)
of rhodium in##4##3##(2008-10#4)
of rhodium##21##2##(2008-10#21)
of rhodium(III) has been##2##4##(2008-10#2)
of rhodium(III) in##3##3##(2008-10#3)
of rhodium(III)##9##2##(2008-10#9)
of ribavirin##4##2##(1990-10#1)(2008-10#3)
of riboflavin in beer by capillary##2##6##(2008-10#2)
of riboflavin in##6##3##(2008-10#5)(2008-9#1)
of riboflavin##11##2##(1992-9#1)(2008-10#6)(2008-9#2)(2012-2#1)(2012-3#1)
of ribonuclease##2##2##(1992-4#1)(2008-7#1)
of ribonucleosides##3##2##(1997-2#1)(2008-4#2)
of ribonucleotide reductase##2##3##(1992-10#2)
of ribosomal DNA##8##3##(2008-10#7)(2008-9#1)
of ribosomal RNA##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
of ribosomal frameshifting##3##3##(1995-9#3)
of ribosomal protein genes##2##4##(2008-11#1)(2009-8#1)
of ribosomal protein##4##3##(2008-11#2)(2008-8#1)(2009-8#1)
of ribosomal##20##2##(1993-12#1)(1995-9#3)(2008-10#8)(2008-11#2)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)
of rice (Oryza sativa##2##4##(2008-10#1)(2009-10#1)
of rice and wheat##2##4##(2008-10#1)(2008-11#1)
of rice and##8##3##(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#3)(2013-8#1)
of rice blast##5##3##(2008-10#5)
of rice chromosomes 4 and 7##2##6##(1997-2#2)
of rice chromosomes##5##3##(1996-12#2)(1997-2#2)(2008-8#1)
of rice dwarf##2##3##(2008-10#1)(2008-8#1)
of rice growth##2##3##(2008-10#1)(2008-9#1)
of rice paper##4##3##(2008-10#4)
of rice root##6##3##(2008-9#6)
of rice to##3##3##(2008-10#3)
of rice##78##2##(1995-6#1)(1996-12#2)(1997-2#2)(2008-10#32)(2008-11#2)(2008-12#1)(2008-8#10)(2008-9#12)(2009-10#10)(2012-2#3)(2013-1#1)(2013-8#2)
of ricin and abrin##2##4##(1994-5#2)
of ricin##3##2##(1993-11#1)(1994-5#2)
of right##8##2##(1995-1#1)(2008-12#1)(2008-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
of right-sided facial##2##3##(2011-2#2)
of rigorous##2##2##(2008-11#1)(2009-4#1)
of rinderpest in##2##3##(1990-3#1)(2011-2#1)
of rinderpest##3##2##(1990-3#1)(2011-2#2)
of ring##6##2##(1993-1#1)(1994-11#1)(1994-5#1)(2008-10#3)
of rise##2##2##(1994-2#1)(1994-3#1)
of rising##3##2##(1993-1#1)(1993-3#1)(2008-11#1)
of risk analysis##2##3##(2008-11#1)(2009-7#1)
of risk and##2##3##(1997-3#1)(2008-6#1)
of risk assessment##2##3##(2011-2#1)(2013-1#1)
of risk assessments##2##3##(2008-10#1)(2011-2#1)
of risk factors and##2##4##(1993-3#1)(2011-2#1)
of risk factors for chronic disease as health status adjusters##2##10##(1993-3#2)
of risk factors for coronary heart disease##2##7##(2008-12#2)
of risk factors for##9##4##(1993-3#2)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#2)
of risk factors which##2##4##(1993-9#1)(2008-11#1)
of risk factors##25##3##(1992-12#1)(1992-9#2)(1993-2#1)(1993-3#3)(1993-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)(2009-7#1)(2011-2#3)(2012-3#2)(2013-1#4)
of risk for##2##3##(1991-8#1)(2012-2#1)
of risk management##2##3##(1994-2#1)(2009-4#1)
of risk to##2##3##(1991-12#1)(2012-3#1)
of risk tolerance##2##3##(2011-2#2)
of risk##69##2##(1991-12#1)(1991-6#1)(1991-8#2)(1992-12#4)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#3)(2009-7#2)(2010-12#2)(2010-7#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)
of risks##4##2##(1996-3#1)(2008-10#1)(2013-1#2)
of risky##2##2##(2009-7#1)(2013-8#1)
of ritodrine hydrochloride##4##3##(2008-10#4)
of ritual##2##2##(1991-8#1)(2009-10#1)
of rituximab##2##2##(2008-7#1)(2013-1#1)
of rivalry##2##2##(1992-3#1)(2008-11#1)
of rivanol##4##2##(2008-10#4)
of rivastigmine##3##2##(2011-2#3)
of river water and##2##4##(2008-10#2)
of river water##3##3##(2008-10#3)
of river##6##2##(2008-10#6)
of road traffic##4##3##(2008-10#1)(2010-11#3)
of roadside soils##2##3##(2008-10#2)
of roadside##4##2##(2008-10#3)(2013-1#1)
of robotics##2##2##(2008-10#1)(2010-7#1)
of robust##11##2##(1993-3#1)(2008-10#3)(2008-11#2)(2008-7#2)(2010-10#1)(2010-6#1)(2011-2#1)
of rock##2##2##(2008-10#1)(2013-8#1)
of rocks##2##2##(2008-10#1)(2008-3#1)
of rocuronium##2##2##(2011-2#2)
of rod##2##2##(1993-8#1)(2008-8#1)
of rodent##5##2##(1990-5#1)(1990-8#1)(2008-11#2)(2008-4#1)
of rodents##3##2##(1994-3#1)(1995-2#1)(2012-2#1)
of role conflict and##2##4##(1990-2#2)
of role conflict##3##3##(1990-2#3)
of role modelling##4##3##(2008-12#4)
of role##10##2##(1990-2#3)(2008-12#4)(2009-11#2)(2009-7#1)
of roles##3##2##(2008-11#1)(2010-11#1)(2013-1#1)
of rolling circle plasmid pKYM##2##5##(1997-6#2)
of rolling-stock##2##2##(1991-12#2)
of roman age##2##3##(2008-10#2)
of roman##3##2##(2008-10#3)
of root and##2##3##(2008-10#2)
of root bark of##2##4##(2008-10#1)(2008-12#1)
of root colonization by##2##4##(2008-10#2)
of root colonization##3##3##(2008-10#3)
of root disease##2##3##(2008-10#2)
of root infection##2##3##(2008-10#2)
of root pathogens##2##3##(2008-10#2)
of root rot##4##3##(2008-10#4)
of root samples##2##3##(2008-10#2)
of root surface biomodification##2##4##(2013-1#2)
of root##43##2##(2008-10#34)(2008-12#1)(2008-9#1)(2009-8#2)(2012-3#1)(2013-1#4)
of root-knot nematodes##2##3##(2008-10#2)
of root-knot##3##2##(2008-10#3)
of roots from##2##3##(2008-10#2)
of roots was##2##3##(2008-10#2)
of roots##13##2##(2008-10#12)(2008-9#1)
of rosiglitazone##2##2##(2008-11#1)(2010-7#1)
of rosmarinic acid##2##3##(2013-1#2)
of rotating constant magnetic field##2##5##(2008-8#2)
of rotation##3##2##(2008-11#3)
of rotational##3##2##(1991-5#1)(2011-2#1)(2013-8#1)
of rough endoplasmic reticulum##2##4##(2008-7#2)
of rough##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
of roughly##3##2##(2008-10#2)(2008-7#1)
of round##3##2##(1991-3#1)(2008-5#1)(2008-6#1)
of routine wrist radiography##2##4##(2008-9#2)
of routine##22##2##(1990-6#1)(1991-11#1)(1991-12#1)(1994-1#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-9#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)
of rtN236T##3##2##(2013-1#3)
of rubidate##5##2##(2008-10#5)
of rubidium in##2##3##(2008-10#2)
of rubidium##4##2##(2008-10#3)(2008-3#1)
of rubisco##2##2##(1991-9#2)
of rules##3##2##(1996-3#1)(1997-8#1)(2008-10#1)
of ruminants##3##2##(1997-7#2)(2013-1#1)
of running buffer##2##3##(2008-10#2)
of rupintrivir##2##2##(2008-10#2)
of rupture of the##2##4##(1996-1#1)(2012-2#1)
of rupture of##4##3##(1991-6#1)(1996-1#1)(2011-2#1)(2012-2#1)
of rupture##8##2##(1991-6#1)(1994-1#1)(1996-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of ruptured##4##2##(1997-3#1)(2008-7#1)(2010-5#2)
of rural##11##2##(1991-1#1)(1992-12#3)(1993-12#1)(1994-2#1)(1996-3#2)(1997-2#1)(2008-12#1)(2011-2#1)
of rust on leaves##2##4##(2008-10#2)
of rust on##3##3##(2008-10#3)
of rust##20##2##(2008-10#20)
of rusts##2##2##(2008-10#2)
of ruthenium and##3##3##(2008-10#3)
of ruthenium##12##2##(2008-10#11)(2010-7#1)
of ruthenium(II)##2##2##(2008-10#2)
of rutin and##2##3##(2008-10#1)(2008-9#1)
of rutin in##4##3##(2008-10#4)
of rutin##13##2##(2008-10#12)(2008-9#1)
of s##2##2##(2008-10#1)(2008-11#1)
of sIL-1R I##2##3##(2008-10#2)
of sIL-1R##4##2##(1995-2#2)(2008-10#2)
of sacroiliac joints in##2##4##(2011-2#2)
of safe sex##2##3##(1997-6#2)
of safe##8##2##(1995-1#1)(1997-6#2)(2008-12#2)(2010-10#1)(2011-2#2)
of safety data##2##3##(2008-11#2)
of safety##13##2##(1994-3#1)(1995-5#1)(1996-3#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-2#1)
of saikosaponin c##3##3##(2008-11#3)
of salbutamol in pharmaceutical products##2##5##(2008-10#2)
of salbutamol in pharmaceutical##3##4##(2008-10#3)
of salbutamol in##5##3##(2008-10#4)(2008-11#1)
of salbutamol with 4-aminoantipyrine##2##4##(2008-10#2)
of salbutamol##18##2##(1996-1#3)(1996-2#2)(2008-10#11)(2008-11#2)
of salicylate in##3##3##(2008-10#3)
of salicylic acid (SA)##2##4##(2008-10#2)
of salicylic acid and its derivatives##2##6##(1993-11#2)
of salicylic acid and its##3##5##(1993-11#3)
of salicylic acid in##3##4##(2008-10#3)
of salicylic acid##15##3##(1993-11#3)(2008-10#12)
of salicylic##16##2##(1993-11#3)(2008-10#13)
of saline (0##2##3##(1997-4#1)(2011-2#1)
of saline##7##2##(1994-11#1)(1994-2#1)(1994-8#1)(1997-4#2)(2008-10#1)(2011-2#1)
of saliva##2##2##(2009-6#2)
of salivary##8##2##(1990-6#1)(1991-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#2)(2013-1#1)
of salmeterol##2##2##(1996-2#2)
of salt and##2##3##(1997-8#1)(2008-8#1)
of salt stress##2##3##(2008-11#1)(2009-8#1)
of salt##12##2##(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)
of salts##5##2##(2008-10#4)(2009-8#1)
of salvianolic##2##2##(2008-10#2)
of samarium##3##2##(2008-10#3)
of sample and eluent##3##4##(2008-10#3)
of sample and reagent##3##4##(2008-10#3)
of sample and reagents##5##4##(2008-10#4)(2010-7#1)
of sample and##20##3##(2008-10#19)(2010-7#1)
of sample and/or standard solution containing##2##6##(2008-10#2)
of sample handling##2##3##(2008-10#2)
of sample is##4##3##(2008-10#4)
of sample matrix##5##3##(2008-10#5)
of sample or standard##2##4##(2008-10#2)
of sample or##3##3##(2008-10#3)
of sample preparation and##3##4##(2008-10#1)(2008-5#1)(2010-7#1)
of sample preparation methods##2##4##(2008-10#2)
of sample preparation##11##3##(2008-10#7)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)
of sample pretreatment##2##3##(2008-10#2)
of sample processing##2##3##(2008-10#1)(2008-11#1)
of sample solution and eluent##3##5##(2008-10#3)
of sample solution and##5##4##(2008-10#5)
of sample solution gave a##2##5##(2008-10#2)
of sample solution is##3##4##(2008-10#3)
of sample solution were##2##4##(2008-10#2)
of sample solution##22##3##(2008-10#22)
of sample solutions##2##3##(2008-10#2)
of sample to##3##3##(2008-10#3)
of sample treatment##2##3##(2008-10#2)
of sample types##3##3##(2008-10#2)(2008-3#1)
of sample volume##4##3##(2008-10#4)
of sample volume)##4##3##(2008-10#4)
of sample was used and the L(D) was approximately##2##9##(2008-10#2)
of sample was##4##3##(2008-10#4)
of sample with a##2##4##(2008-10#2)
of sample with##4##3##(2008-10#4)
of sample##153##2##(1994-3#1)(1994-9#2)(2008-10#137)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#3)(2009-10#1)(2010-7#2)(2010-8#1)
of sample)##2##2##(2008-10#2)
of samples and reagents##2##4##(2008-10#2)
of samples and the##2##4##(2008-10#2)
of samples and##8##3##(2008-10#8)
of samples are##2##3##(2008-10#2)
of samples by##3##3##(1996-12#1)(2008-10#2)
of samples could be##2##4##(2008-10#2)
of samples for##2##3##(2008-10#1)(2008-9#1)
of samples from##4##3##(2008-10#2)(2008-12#1)(2008-4#1)
of samples have##2##3##(2008-10#1)(2009-4#1)
of samples in a##3##4##(2008-10#1)(2008-11#1)(2010-11#1)
of samples in##5##3##(2008-10#3)(2008-11#1)(2010-11#1)
of samples is##3##3##(2008-10#3)
of samples of##5##3##(2008-10#3)(2008-4#1)(2008-7#1)
of samples was##7##3##(2008-10#7)
of samples were##4##3##(2008-10#3)(2008-12#1)
of samples with##11##3##(2008-10#6)(2008-11#2)(2008-4#1)(2013-1#2)
of samples##128##2##(1992-12#1)(1992-3#1)(1996-12#1)(2008-10#95)(2008-11#5)(2008-12#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#5)(2009-4#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
of sampling techniques##2##3##(2008-10#2)
of sampling units##4##3##(2008-10#4)
of sampling##32##2##(1992-12#1)(2008-10#26)(2008-11#1)(2008-5#2)(2008-8#1)(2010-7#1)
of samplings##2##2##(2008-10#2)
of sanA##2##2##(2008-9#2)
of sand flies##3##3##(2008-12#1)(2013-1#2)
of sand fly##2##3##(2008-12#1)(2012-2#1)
of sand##5##2##(2008-12#2)(2012-2#1)(2013-1#2)
of saplings##2##2##(2008-9#1)(2012-9#1)
of saponins##2##2##(2010-2#1)(2013-8#1)
of sapstain##3##2##(2008-10#3)
of sarcoidosis##2##2##(2008-1#1)(2012-3#1)
of satRNA##2##2##(2008-10#2)
of satRNAs##2##2##(2008-10#2)
of satellite DNA##2##3##(2008-10#1)(2010-8#1)
of satellite cells##2##3##(1993-3#1)(2008-7#1)
of satellite##8##2##(1993-3#1)(2008-10#5)(2008-7#1)(2010-8#1)
of satisfaction with the##3##4##(1993-12#1)(2008-11#1)(2013-8#1)
of satisfaction##7##2##(1992-1#1)(1993-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
of saturated##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
of saturating##2##2##(1995-11#1)(2008-3#1)
of saturation and##2##3##(1995-12#1)(2008-3#1)
of saturation in##2##3##(2008-3#1)(2010-10#1)
of saturation##10##2##(1990-8#1)(1995-12#1)(2008-3#5)(2010-10#1)(2011-1#1)(2012-2#1)
of savings##2##2##(1991-1#1)(1995-2#1)
of saw##2##2##(2008-12#1)(2008-8#1)
of sawdust##2##2##(2008-9#1)(2013-1#1)
of scab##8##2##(2008-10#8)
of scabies##4##2##(1996-12#1)(2010-2#1)(2010-6#2)
of scaffold##2##2##(2010-9#1)(2012-2#1)
of scale##12##2##(1991-2#1)(1992-2#1)(1994-3#1)(1996-1#1)(1997-1#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-2#1)
of scaling##3##2##(1993-5#1)(2008-11#1)(2008-8#1)
of scandium(III) and yttrium(III)##3##4##(2008-10#3)
of scanning electron##2##3##(2008-10#1)(2008-6#1)
of scanning##8##2##(1997-2#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)
of scar##2##2##(1997-3#1)(2008-9#1)
of scarring##2##2##(1991-12#1)(2013-1#1)
of scattered light##2##3##(2008-10#1)(2008-3#1)
of scattered radiation##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of scattered##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
of scatterers##2##2##(2008-3#2)
of scattering and absorption##2##4##(2008-3#2)
of scattering and##5##3##(2008-3#5)
of scattering##14##2##(2008-2#1)(2008-3#12)(2010-7#1)
of scavenger##4##2##(1993-6#1)(1993-8#3)
of scenarios##2##2##(2008-10#1)(2009-10#1)
of schizophrenia and##4##3##(2008-4#1)(2008-8#2)(2011-1#1)
of schizophrenia is##2##3##(1990-11#1)(1993-9#1)
of schizophrenia##14##2##(1990-11#1)(1993-9#1)(1995-12#1)(1995-5#1)(2008-4#1)(2008-8#3)(2009-12#1)(2009-7#1)(2010-1#2)(2011-1#2)
of scholarly##2##2##(2010-4#1)(2012-12#1)
of school engagement##2##3##(2009-7#2)
of school readiness##2##3##(2008-11#1)(2008-12#1)
of school##14##2##(1991-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-7#3)(2010-1#3)(2012-2#1)(2013-1#1)
of school-based##2##2##(1995-12#1)(2009-7#1)
of science and##3##3##(1994-12#1)(2008-11#1)(2009-4#1)
of science##12##2##(1994-12#1)(2008-10#1)(2008-11#2)(2009-3#1)(2009-4#1)(2009-6#2)(2011-2#1)(2012-2#2)(2013-1#1)
of scientific discovery##2##3##(2012-2#2)
of scientific information##2##3##(2008-10#1)(2010-5#1)
of scientific interest##2##3##(2008-10#1)(2012-2#1)
of scientific knowledge##3##3##(2010-1#1)(2011-2#2)
of scientific##22##2##(1992-12#1)(1993-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)
of scientists##6##2##(2008-11#1)(2008-9#1)(2009-11#1)(2012-2#2)(2013-8#1)
of scintigraphic##3##2##(2011-2#1)(2013-1#2)
of scirtids##2##2##(2008-12#2)
of scleroderma##2##2##(1992-8#1)(1993-9#1)
of sclerotia and the##2##4##(2008-10#2)
of sclerotia and##4##3##(2008-10#4)
of sclerotia in##3##3##(2008-10#3)
of sclerotia produced##2##3##(2008-10#2)
of sclerotia##30##2##(2008-10#30)
of sclerotial size##2##3##(2008-10#2)
of sclerotial##5##2##(2008-10#5)
of sclerotinia stem rot of##2##5##(2008-10#2)
of scopolamine and its##2##4##(2008-10#2)
of scopolamine##5##2##(1994-8#1)(2008-10#4)
of score##3##2##(2013-1#3)
of scores##4##2##(2008-10#2)(2011-1#2)
of screen-detected cancer cases##2##4##(1995-12#2)
of screen-detected##3##2##(1991-6#1)(1995-12#2)
of screen-printed##2##2##(2008-10#2)
of screening and##5##3##(2008-10#1)(2008-11#1)(2009-4#1)(2012-3#2)
of screening for prostatic cancer##2##5##(1991-7#2)
of screening for##8##3##(1990-6#2)(1991-7#2)(1993-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
of screening methods##2##3##(2008-10#1)(2008-12#1)
of screening tests##2##3##(2008-11#2)
of screening##32##2##(1990-2#1)(1990-6#2)(1991-7#2)(1992-5#1)(1993-3#1)(1995-12#2)(2008-10#5)(2008-11#7)(2008-12#1)(2008-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
of screw##3##2##(2007-11#1)(2008-8#1)(2009-3#1)
of screws##2##2##(2007-11#1)(2012-12#1)
of sea water##4##3##(2008-10#4)
of sea##7##2##(1994-11#1)(2008-10#4)(2008-7#1)(2012-2#1)
of searching##4##2##(1994-3#1)(2008-11#1)(2008-8#2)
of seasonal##4##2##(2008-12#1)(2009-8#1)(2012-12#1)(2012-3#1)
of seatbelts##2##2##(1997-6#1)(2008-10#1)
of seawater samples##3##3##(2008-10#3)
of seawater##15##2##(2008-10#13)(2008-3#2)
of seborrheic keratosis##2##3##(2007-8#1)(2011-2#1)
of second generation##2##3##(1990-2#1)(1997-3#1)
of second group##2##3##(2012-3#2)
of second messengers##3##3##(1991-3#1)(2009-8#1)(2013-1#1)
of second##13##2##(1990-2#1)(1991-3#1)(1993-1#1)(1993-3#1)(1997-3#1)(2008-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2012-3#2)(2013-1#1)
of second-generation##2##2##(2010-12#1)(2011-2#1)
of second-harmonic##3##2##(2007-11#1)(2007-12#2)
of second-order##2##2##(1997-7#1)(2007-11#1)
of secondary conidia##3##3##(2008-10#3)
of secondary hyperparathyroidism##2##3##(1991-11#1)(1991-8#1)
of secondary inoculum##2##3##(2008-10#2)
of secondary prevention##2##3##(1993-3#1)(2011-3#1)
of secondary products##2##3##(2008-10#1)(2008-11#1)
of secondary sporidia##2##3##(2008-10#2)
of secondary structure##3##3##(1990-4#1)(1990-5#1)(2011-2#1)
of secondary##50##2##(1990-12#2)(1990-4#1)(1990-5#2)(1991-11#1)(1991-3#1)(1991-8#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-3#1)(1996-5#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-6#1)(2008-9#1)(2009-7#2)(2010-3#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of seconds at##2##3##(1994-5#1)(2008-10#1)
of secreted##6##2##(1994-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-6#1)
of secretion of##2##3##(2008-11#2)
of secretion##4##2##(1991-5#1)(2008-11#3)
of secretions##2##2##(1997-1#2)
of secretory proteins##2##3##(1991-5#1)(1994-8#1)
of secretory vesicles##2##3##(2008-11#2)
of secretory##9##2##(1991-5#1)(1994-8#1)(2007-12#1)(2008-11#3)(2008-7#2)(2010-11#1)
of security##2##2##(1991-3#1)(1992-12#1)
of sediment samples##2##3##(2008-10#2)
of sediment##4##2##(2008-10#4)
of sediments##3##2##(2008-10#3)
of seed coat##2##3##(2013-8#2)
of seed extract##3##3##(2012-2#3)
of seed infection##5##3##(2008-10#5)
of seed meal##2##3##(2008-10#2)
of seed plant##2##3##(2008-8#2)
of seed##27##2##(2008-10#16)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2012-2#3)(2013-8#3)
of seed-transmitted endophytes##2##3##(2008-8#2)
of seed-transmitted##3##2##(2008-10#1)(2008-8#2)
of seedborne##4##2##(2008-10#4)
of seeding##3##2##(2008-10#1)(2011-2#2)
of seedling##4##2##(2008-10#3)(2008-12#1)
of seedlings##8##2##(2008-10#8)
of seeds of##2##3##(2008-10#1)(2008-8#1)
of seeds or##2##3##(2008-10#1)(2008-9#1)
of seeds##10##2##(2008-10#3)(2008-8#3)(2008-9#3)(2011-2#1)
of seeking##2##2##(2010-10#1)(2012-12#1)
of segment##2##2##(2008-10#1)(2011-2#1)
of segments##3##2##(1992-5#1)(2008-10#2)
of segregating##2##2##(2008-10#2)
of segregation##4##2##(2008-10#3)(2011-2#1)
of seizure activity##2##3##(1990-5#1)(1997-3#1)
of seizure##6##2##(1990-5#1)(1997-3#2)(2008-8#1)(2009-8#1)(2013-1#1)
of seizures in##2##3##(2008-11#1)(2008-8#1)
of seizures##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#2)
of select metals##2##3##(2008-10#2)
of select##6##2##(2008-10#3)(2008-11#1)(2010-10#1)(2013-1#1)
of selected PCBs##2##3##(2008-11#2)
of selected clinical##2##3##(2012-3#1)(2013-1#1)
of selected##52##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-11#1)(1994-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#2)
of selecting##4##2##(2008-10#2)(2009-1#1)(2010-8#1)
of selection and##6##3##(2008-4#1)(2008-8#4)(2012-3#1)
of selection for resistance##3##4##(2008-10#3)
of selection for##5##3##(1997-4#1)(2008-10#3)(2008-8#1)
of selection in##2##3##(1995-2#1)(2012-3#1)
of selection of##2##3##(2008-10#1)(2011-3#1)
of selection on##6##3##(2008-8#4)(2008-9#2)
of selection##49##2##(1995-2#2)(1997-4#1)(2008-10#10)(2008-11#1)(2008-4#3)(2008-8#21)(2008-9#4)(2009-8#1)(2010-4#2)(2011-3#1)(2012-3#3)
of selective and nonselective media##2##5##(2008-12#2)
of selective and nonselective##3##4##(2008-10#1)(2008-12#2)
of selective brain cooling on the expression of##2##8##(2010-1#2)
of selective serotonin reuptake inhibitors##4##5##(1997-8#3)(2008-11#1)
of selective##26##2##(1991-2#1)(1991-3#1)(1992-12#1)(1995-11#1)(1997-8#3)(2008-10#8)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-7#2)(2010-1#2)(2011-2#2)
of selectively##2##2##(1997-6#1)(2008-10#1)
of selectivity and##3##3##(2008-10#2)(2008-5#1)
of selectivity coefficients of##2##4##(2008-10#2)
of selectivity coefficients##4##3##(2008-10#4)
of selectivity for##2##3##(2008-10#2)
of selectivity##15##2##(1997-1#1)(2008-10#12)(2008-5#1)(2008-7#1)
of selenite (Se(IV))##2##3##(2008-10#2)
of selenite##10##2##(1993-12#2)(2008-10#8)
of selenium (IV) in##2##4##(2008-10#2)
of selenium (IV)##4##3##(2008-10#4)
of selenium and##2##3##(2008-10#2)
of selenium by##2##3##(2008-10#2)
of selenium in the##3##4##(2008-10#2)(2012-2#1)
of selenium in water and##2##5##(2008-10#2)
of selenium in water##3##4##(2008-10#3)
of selenium in##18##3##(2008-10#17)(2012-2#1)
of selenium is##5##3##(2008-10#5)
of selenium species##3##3##(2008-10#3)
of selenium##53##2##(2008-10#47)(2008-6#2)(2010-11#1)(2012-2#2)(2013-1#1)
of selenium(IV) and molybdenum(VI)##2##4##(2008-10#2)
of selenium(IV) and##6##3##(2008-10#6)
of selenium(IV)##9##2##(2008-10#9)
of selenium-containing##2##2##(2008-10#1)(2008-8#1)
of selenoamino acids in##2##4##(2008-10#2)
of selenoamino acids##3##3##(2008-10#3)
of selenoprotein mRNA##2##3##(2012-2#2)
of selenoprotein##4##2##(2012-2#4)
of selenospecies##3##2##(2008-10#3)
of self and others##2##4##(2008-11#1)(2008-12#1)
of self and##5##3##(2008-11#3)(2008-12#1)(2008-9#1)
of self monitoring##3##3##(2008-10#3)
of self##18##2##(1993-12#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-9#1)(2010-6#1)(2010-8#2)(2013-8#1)
of self-assembled##3##2##(1995-3#1)(2008-10#1)(2009-11#1)
of self-care##2##2##(2008-12#1)(2010-2#1)
of self-control##3##2##(2008-12#3)
of self-defense##2##2##(2008-10#2)
of self-directed work teams##3##4##(1993-12#3)
of self-directed##4##2##(1993-12#3)(1996-2#1)
of self-fertilization##3##2##(2008-8#1)(2008-9#2)
of self-help groups in##2##4##(1996-3#1)(2008-4#1)
of self-help groups##4##3##(1996-3#2)(2008-4#2)
of self-help##7##2##(1994-1#1)(1996-3#4)(2008-4#2)
of self-monitoring##2##2##(2008-11#2)
of self-organization in##2##3##(2008-8#1)(2008-9#1)
of self-organization##3##2##(2008-8#1)(2008-9#2)
of self-pumped phase conjugation##2##4##(2008-2#2)
of self-pumped phase##3##3##(2008-2#3)
of self-reference##2##2##(2008-9#2)
of self-renewal##5##2##(2008-11#1)(2009-12#1)(2013-1#3)
of self-reported health##2##3##(1993-1#1)(2008-10#1)
of self-reported##5##2##(1993-1#1)(2008-10#1)(2009-7#1)(2012-3#1)(2013-1#1)
of selfing##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
of selfishness##5##2##(2008-9#4)(2010-2#1)
of semen##3##2##(2008-12#2)(2010-12#1)
of semi-structured interviews with##2##4##(2008-12#1)(2009-10#1)
of semi-structured interviews##3##3##(2008-12#1)(2009-10#1)(2009-12#1)
of semi-structured##4##2##(2008-12#1)(2009-10#1)(2009-12#1)(2013-1#1)
of semicarbazide and hydrazine##4##4##(2008-10#4)
of semicarbazide##6##2##(2008-10#6)
of seminal gamma-GTP##2##3##(1995-11#2)
of seminal##8##2##(1990-5#1)(1994-3#1)(1995-11#3)(1997-8#1)(2008-11#1)(2011-2#1)
of semiselective##2##2##(2008-10#2)
of semisolid##2##2##(2008-10#1)(2008-5#1)
of semisynthetic penicillins##2##3##(2008-10#2)
of semisynthetic##3##2##(1993-8#1)(2008-10#2)
of senescence in##3##3##(1997-7#1)(2011-2#1)(2012-3#1)
of senescence##9##2##(1997-7#1)(2008-7#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-3#2)
of senescent##2##2##(1997-7#1)(2008-5#1)
of senior##7##2##(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#2)(2008-11#1)(2008-12#1)
of sense and antisenseabp transgenic tobacco##2##6##(2008-8#2)
of sense of##2##3##(2008-7#1)(2013-1#1)
of sense##4##2##(2008-7#1)(2008-8#2)(2013-1#1)
of sensilla basiconica##2##3##(2007-12#2)
of sensilla##3##2##(2007-12#3)
of sensing molecules##2##3##(2008-10#1)(2013-8#1)
of sensing##7##2##(2008-10#4)(2008-3#1)(2010-6#1)(2013-8#1)
of sensitive detection of##2##4##(2008-10#1)(2012-2#1)
of sensitive##6##2##(2008-10#3)(2008-5#1)(2008-9#1)(2012-2#1)
of sensitivities##3##2##(2008-10#3)
of sensitivity and reproducibility##2##4##(2008-10#1)(2008-4#1)
of sensitivity and selectivity##4##4##(2008-10#4)
of sensitivity and specificity##2##4##(1993-3#1)(2011-2#1)
of sensitivity and##11##3##(1993-3#1)(1997-3#1)(2008-10#6)(2008-4#2)(2011-2#1)
of sensitivity for##4##3##(1996-8#1)(2008-10#3)
of sensitivity in##2##3##(2008-10#1)(2008-3#1)
of sensitivity of the##3##4##(1997-1#1)(2008-10#1)(2010-10#1)
of sensitivity of##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2010-10#1)
of sensitivity to##10##3##(1990-12#1)(1990-5#1)(2008-10#6)(2008-5#1)(2013-1#1)
of sensitivity##51##2##(1990-12#1)(1990-5#1)(1993-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-10#33)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
of sensitization##5##2##(1993-6#1)(1993-8#1)(2008-10#3)
of sensitizing##2##2##(2008-10#1)(2008-11#1)
of sensor##11##2##(2008-10#10)(2012-3#1)
of sensorimotor reflexes##2##3##(1992-12#2)
of sensors and##2##3##(2008-10#2)
of sensors are##2##3##(2008-10#2)
of sensors##11##2##(2008-10#11)
of sensory nerves##2##3##(1992-6#2)
of sensory processing##2##3##(2009-12#1)(2013-8#1)
of sensory stimuli##2##3##(2013-1#2)
of sensory##18##2##(1992-6#2)(1995-2#1)(2008-10#2)(2008-11#2)(2009-12#3)(2009-8#2)(2011-2#1)(2013-1#3)(2013-8#2)
of sentence##2##2##(2008-9#1)(2011-1#1)
of sentinel##3##2##(2008-9#1)(2010-7#1)(2011-2#1)
of separate##10##2##(1990-7#1)(1992-1#1)(1994-1#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-6#1)(2008-8#1)
of separating##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)
of separation and##2##3##(2008-10#2)
of separation of##3##3##(2008-10#2)(2008-12#1)
of separation##12##2##(2008-10#11)(2008-12#1)
of sepsis management are##2##4##(2011-2#2)
of sepsis management##3##3##(2011-2#3)
of sepsis##14##2##(1991-3#2)(2008-8#1)(2009-6#1)(2010-7#1)(2011-2#7)(2012-3#1)(2013-8#1)
of septic arthritis##2##3##(2010-12#1)(2013-8#1)
of septic shock##4##3##(1996-3#1)(2011-2#3)
of septic##8##2##(1996-3#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#3)(2013-8#1)
of sequence analysis##2##3##(1995-8#1)(2008-2#1)
of sequence divergence##3##3##(2008-10#3)
of sequence information##2##3##(1995-8#1)(2008-4#1)
of sequence variants##7##3##(2008-10#5)(2008-4#2)
of sequence##39##2##(1991-6#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#3)(1995-11#2)(1995-6#1)(1995-8#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#2)(2008-10#11)(2008-2#1)(2008-4#4)(2008-9#1)(2012-2#1)(2012-3#1)
of sequence-specific##2##2##(2008-4#2)
of sequenced##3##2##(1997-6#1)(2008-7#1)(2009-6#1)
of sequences and##2##3##(2008-10#1)(2011-2#1)
of sequences from##2##3##(1996-12#1)(2008-10#1)
of sequences of the##2##4##(2008-10#2)
of sequences of##3##3##(2008-10#3)
of sequences##14##2##(1996-12#1)(2008-1#1)(2008-10#7)(2008-4#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
of sequencing targets##2##3##(2008-10#2)
of sequential injection analysis##5##4##(2008-10#5)
of sequential injection systems##2##4##(2008-10#2)
of sequential injection with##2##4##(2008-10#2)
of sequential injection##10##3##(2008-10#10)
of sequential##21##2##(1990-11#1)(1990-6#1)(1991-9#1)(1994-9#1)(1996-11#1)(2008-10#16)
of sequestering##2##2##(2008-10#1)(2008-11#1)
of sera##2##2##(2008-10#1)(2008-11#1)
of serial##8##2##(1990-5#1)(2008-10#3)(2008-8#2)(2010-1#1)(2013-1#1)
of sericin##3##2##(2008-11#3)
of serine and##3##3##(2008-10#2)(2008-4#1)
of serine proteases##4##3##(1995-2#1)(2008-4#2)(2008-9#1)
of serine proteinases##4##3##(1991-5#1)(1993-3#1)(2012-3#2)
of serine##22##2##(1991-5#1)(1993-3#1)(1994-11#2)(1994-5#3)(1995-2#1)(1997-1#2)(1997-7#1)(2008-10#5)(2008-4#3)(2008-9#1)(2012-3#2)
of serine-143##2##2##(1994-5#2)
of serine/threonine kinases##2##3##(1993-3#1)(1995-2#1)
of serine/threonine##3##2##(1993-3#1)(1995-2#1)(2009-9#1)
of serious adverse##2##3##(2008-8#1)(2013-8#1)
of serious complications##2##3##(2008-11#1)(2011-2#1)
of serious hypoglycemia##2##3##(1994-6#2)
of serious side effects##4##4##(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
of serious##20##2##(1994-6#2)(1994-8#1)(1994-9#2)(1995-5#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#1)(2011-2#4)(2012-2#1)(2013-8#1)
of serogroup##3##2##(2008-10#2)(2011-2#1)
of serological and##2##3##(1995-12#1)(2008-10#1)
of serological##4##2##(1995-12#1)(1996-12#1)(2008-10#1)(2011-2#1)
of seropositive dogs##2##3##(2011-2#2)
of seropositive##3##2##(2011-2#2)(2012-3#1)
of serotonergic##5##2##(1993-3#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
of serotonin (5-HT)##4##3##(1992-1#1)(1993-3#1)(2008-6#1)(2008-8#1)
of serotonin transport##2##3##(1996-12#2)
of serotonin##11##2##(1992-1#1)(1993-3#2)(1996-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#3)
of serotypes 1##2##3##(1996-12#2)
of serotypes##3##2##(1996-12#3)
of serous##2##2##(1992-2#1)(2008-12#1)
of serrated polyps##2##3##(2009-12#2)
of serrated##3##2##(2009-12#3)
of serum albumin in the##2##5##(2008-7#2)
of serum albumin##6##3##(1995-12#2)(2008-10#1)(2008-7#2)(2011-2#1)
of serum and##7##3##(1990-2#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-11#3)
of serum antibody to##2##4##(1991-12#1)(1995-5#1)
of serum cholesterol was##2##4##(1991-6#1)(2008-10#1)
of serum cholesterol##3##3##(1991-6#2)(2008-10#1)
of serum creatinine##2##3##(1990-12#1)(1994-12#1)
of serum free thyroxine##2##4##(2008-6#1)(2012-3#1)
of serum in##5##3##(1991-5#1)(1992-3#1)(2008-11#3)
of serum magnesium##2##3##(2011-2#2)
of serum proteins##4##3##(1991-12#1)(1996-6#1)(1997-5#1)(2013-8#1)
of serum sickness##2##3##(1997-8#2)
of serum sodium concentration##2##4##(2010-1#2)
of serum was##2##3##(1995-12#1)(2008-10#1)
of serum were##2##3##(2008-7#2)
of serum##96##2##(1990-12#2)(1990-2#3)(1990-6#1)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#2)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-5#3)(1996-2#4)(1996-6#2)(1997-5#1)(1997-8#2)(2008-10#9)(2008-11#19)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-1#5)(2010-12#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#2)
of serum-derived##2##2##(1990-7#1)(2008-11#1)
of serum-free media##2##3##(2008-11#2)
of serum-free produced##2##3##(2008-11#2)
of serum-free##5##2##(2008-11#5)
of service delivery##2##3##(1994-2#2)
of service providers##2##3##(1993-1#1)(1995-1#1)
of service user##2##3##(2008-12#2)
of service users and##2##4##(2008-11#1)(2009-6#1)
of service users##5##3##(2008-11#1)(2008-12#2)(2009-6#2)
of service##24##2##(1993-1#2)(1994-1#2)(1994-2#3)(1995-1#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(2008-11#1)(2008-12#4)(2009-6#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of services and##4##3##(1991-2#1)(1993-2#1)(1993-3#1)(2012-2#1)
of services for##2##3##(1991-3#1)(1995-3#1)
of services is##2##3##(1991-2#1)(1992-12#1)
of services provided##3##3##(1992-12#1)(1992-2#1)(1995-3#1)
of services to##4##3##(1997-8#1)(2008-11#1)(2009-6#1)(2011-1#1)
of services were##2##3##(1996-1#1)(2012-2#1)
of services##46##2##(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#2)(1992-12#2)(1992-2#3)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#1)(1995-3#3)(1996-1#3)(1996-2#3)(1996-3#2)(1997-1#2)(1997-2#2)(1997-8#2)(2008-11#1)(2009-6#2)(2011-1#2)(2012-12#1)(2012-2#3)
of sesquiterpene##2##2##(2008-8#2)
of sesquiterpenes##2##2##(2011-10#1)(2013-8#1)
of setting##2##2##(2008-11#1)(2008-9#1)
of settings and##2##3##(1994-2#1)(2008-11#1)
of settings##5##2##(1994-2#1)(1996-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
of settlement##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
of seven EST clones##2##4##(2008-10#2)
of seven cases##2##3##(1991-2#1)(1991-6#1)
of seven different##2##3##(2008-10#1)(2008-5#1)
of seven field trials##2##4##(2008-10#2)
of seven populations from##2##4##(2008-10#1)(2008-8#1)
of seven replicates##4##3##(2008-10#4)
of seven##60##2##(1991-2#1)(1991-6#1)(1991-9#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#34)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2010-10#1)(2012-2#3)(2013-8#1)
of several analytes##2##3##(2008-10#2)
of several attachment##2##3##(2012-5#2)
of several clinical##2##3##(1994-12#1)(1996-3#1)
of several components of##2##4##(2008-10#1)(2012-3#1)
of several components##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
of several compounds##3##3##(1995-8#1)(2008-10#2)
of several different##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
of several enzymes##2##3##(2008-10#1)(2008-7#1)
of several experimental##3##3##(2008-10#3)
of several factors##2##3##(2008-10#1)(2009-5#1)
of several genes##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of several human##4##3##(1990-5#1)(1997-8#1)(2008-11#1)(2008-8#1)
of several hundred##5##3##(1993-12#1)(1997-6#1)(2008-10#3)
of several important factors##4##4##(2008-10#4)
of several important##5##3##(2008-10#4)(2008-11#1)
of several ions##2##3##(2008-10#2)
of several kinds of##2##4##(2008-11#1)(2008-8#1)
of several known##2##3##(2008-10#1)(2013-1#1)
of several mammalian##2##3##(2008-10#1)(2008-11#1)
of several mechanisms##2##3##(2008-10#1)(2008-8#1)
of several metals##2##3##(2008-10#2)
of several mixtures##2##3##(2008-10#2)
of several of the##2##4##(2012-2#1)(2012-3#1)
of several of##4##3##(2008-10#1)(2012-2#2)(2012-3#1)
of several organs##3##3##(2008-10#1)(2010-10#1)(2010-11#1)
of several parameters##2##3##(2008-10#2)
of several protein##2##3##(1994-5#1)(2008-11#1)
of several recent##2##3##(2008-3#1)(2008-8#1)
of several surfactants##2##3##(1996-1#1)(2008-10#1)
of several techniques##2##3##(1992-12#1)(2008-4#1)
of several types of##2##4##(2008-11#1)(2009-10#1)
of several variables##4##3##(2008-10#4)
of several##273##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1997-3#3)(1997-6#1)(1997-8#2)(2007-12#2)(2008-10#131)(2008-11#21)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#3)(2008-7#4)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-2#4)(2012-3#5)(2012-5#2)(2013-1#4)(2013-8#1)
of severe and##2##3##(1996-11#1)(2012-12#1)
of severe disease##2##3##(2006-6#1)(2011-2#1)
of severe human##2##3##(2008-4#1)(2008-8#1)
of severe pulmonary##2##3##(2008-11#2)
of severe##54##2##(1990-12#2)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1994-6#1)(1995-5#1)(1996-11#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#6)(2012-12#2)(2012-3#5)(2013-1#5)(2013-8#3)
of severely##2##2##(1995-1#1)(2008-10#1)
of severity of##2##3##(1994-12#1)(2008-7#1)
of severity##9##2##(1994-1#1)(1994-12#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)
of sewage sludge##2##3##(2008-11#1)(2008-12#1)
of sex allocation##2##3##(2008-8#1)(2008-9#1)
of sex chromosome evolution##3##4##(2010-5#3)
of sex chromosome##5##3##(2008-12#1)(2010-5#3)(2012-3#1)
of sex differences in##3##4##(2008-4#1)(2008-8#1)(2008-9#1)
of sex hormones##2##3##(2008-7#1)(2010-6#1)
of sex in##2##3##(1997-7#1)(2008-10#1)
of sex pheromone##3##3##(2008-10#3)
of sex steroids##3##3##(1990-11#1)(1995-12#1)(2009-6#1)
of sex##41##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1993-2#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-7#3)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-7#1)(2010-5#3)(2010-6#1)(2012-3#5)(2013-1#1)
of sex-linked##2##2##(2012-3#2)
of sexting##3##2##(2013-1#3)
of sexual abuse##10##3##(1996-11#2)(2009-9#4)(2010-10#3)(2010-4#1)
of sexual and##3##3##(2008-9#1)(2012-12#1)(2012-3#1)
of sexual assault##3##3##(2008-12#2)(2009-5#1)
of sexual behavior##4##3##(1992-12#1)(2008-4#1)(2011-2#2)
of sexual dimorphism in##2##4##(2008-8#1)(2012-3#1)
of sexual dimorphism##4##3##(2008-8#3)(2012-3#1)
of sexual minority##2##3##(2008-12#2)
of sexual recombination##4##3##(2008-10#4)
of sexual reproduction of##2##4##(2008-10#2)
of sexual reproduction##10##3##(2008-10#4)(2008-9#2)(2009-5#1)(2012-3#3)
of sexual risk##2##3##(2008-4#1)(2011-2#1)
of sexual selection in##2##4##(1995-2#1)(2008-8#1)
of sexual selection on males##2##5##(2008-8#2)
of sexual selection on##3##4##(2008-8#3)
of sexual selection##16##3##(1995-2#2)(2008-8#10)(2008-9#2)(2012-3#2)
of sexual##86##2##(1990-9#1)(1992-12#1)(1992-9#1)(1993-9#1)(1995-2#2)(1996-11#2)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#10)(2008-12#6)(2008-4#2)(2008-7#3)(2008-8#17)(2008-9#10)(2009-5#2)(2009-9#4)(2010-10#3)(2010-4#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#9)(2013-1#1)
of sexuality##3##2##(1996-9#1)(1997-7#2)
of sexually abused##2##3##(1990-11#1)(2010-10#1)
of sexually selected traits##3##4##(2008-9#1)(2012-3#2)
of sexually transmitted diseases##2##4##(1996-6#1)(2009-12#1)
of sexually transmitted infections##2##4##(2011-2#1)(2013-8#1)
of sexually transmitted##7##3##(1995-11#1)(1996-6#1)(2008-4#1)(2009-12#1)(2011-2#2)(2013-8#1)
of sexually##17##2##(1990-11#1)(1995-11#1)(1996-6#1)(1996-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2010-10#1)(2011-2#3)(2012-3#2)(2013-8#1)
of sgcD##2##2##(2008-9#2)
of sham##2##2##(1995-11#1)(2013-1#1)
of shampoo##2##2##(2008-10#1)(2008-5#1)
of shapes##4##2##(2008-6#2)(2009-10#1)(2009-8#1)
of shared##4##2##(1994-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
of sharp##2##2##(2008-3#2)
of shaving on axillary##2##4##(2008-5#2)
of shaving##4##2##(2008-5#4)
of shear stress##2##3##(2008-11#1)(2010-1#1)
of shear##3##2##(1997-6#1)(2008-11#1)(2010-1#1)
of sheath blight##3##3##(2008-10#3)
of sheath##4##2##(2008-10#4)
of shedding of revertant virus##2##5##(1995-5#2)
of shedding##4##2##(1995-5#2)(2013-8#2)
of sheep and goats##2##4##(2008-12#1)(2011-2#1)
of sheep liver##2##3##(2008-5#2)
of sheep##15##2##(1991-8#1)(1996-12#2)(1997-5#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
of shell##3##2##(2010-4#1)(2011-2#2)
of shift of tumor position##2##5##(2009-11#2)
of shift work on##2##4##(2010-7#2)
of shift work##3##3##(2010-7#3)
of shift##5##2##(2009-11#2)(2010-7#3)
of shiga toxin##3##3##(2008-8#3)
of shock waves##2##3##(1994-5#2)
of shock##4##2##(1992-5#1)(1994-5#2)(2011-2#1)
of shoot##3##2##(2008-10#1)(2013-1#2)
of shoots and roots##2##4##(2008-10#2)
of shoots and##3##3##(2008-10#3)
of shoots##8##2##(2008-10#7)(2008-12#1)
of short DNA##2##3##(2008-10#1)(2008-11#1)
of short protein coding regions##2##5##(1996-12#2)
of short stature##4##3##(2011-1#1)(2012-2#1)(2013-1#2)
of short##35##2##(1990-6#1)(1991-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#3)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
of short- and##2##3##(1995-8#1)(2008-10#1)
of short-chain##3##2##(1991-5#1)(1995-6#1)(2008-5#1)
of short-distance##2##2##(2008-10#1)(2011-2#1)
of short-stay hospital##2##3##(1991-1#1)(1991-3#1)
of short-term##15##2##(1992-9#2)(1994-11#1)(1995-12#3)(2008-1#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-7#1)
of shortening##2##2##(1993-9#1)(2012-12#1)
of shorter##4##2##(1995-2#1)(2008-10#1)(2008-7#2)
of shoulder function##3##3##(2008-9#3)
of shoulder muscles##2##3##(2012-2#2)
of shoulder##10##2##(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#4)(2010-7#1)(2012-2#2)
of showing##2##2##(2008-10#1)(2013-8#1)
of sialic acid on the viscosity of canine tracheal mucin##2##10##(1994-11#2)
of sialic acid##3##3##(1994-11#2)(2008-11#1)
of sialic##4##2##(1994-11#2)(2008-11#2)
of sibling##5##2##(2008-10#5)
of siblings about##2##3##(2010-9#2)
of siblings##4##2##(2008-8#1)(2010-9#2)(2013-1#1)
of siboglinids##2##2##(2009-8#2)
of sibutramine and citalopram##3##4##(2012-3#3)
of sickle##2##2##(1992-9#1)(2013-1#1)
of side effects##8##3##(1991-6#1)(1993-2#2)(1997-1#1)(1997-3#1)(1997-8#1)(2011-2#1)(2013-1#1)
of side population cells##2##4##(2010-6#2)
of side##12##2##(1991-6#1)(1993-2#2)(1997-1#1)(1997-3#1)(1997-8#1)(2008-11#1)(2010-6#2)(2011-2#1)(2013-1#1)(2013-8#1)
of siderophore##2##2##(2013-1#2)
of sieve##2##2##(2008-10#1)(2008-11#1)
of sigmoid colon##3##3##(2008-12#2)(2012-12#1)
of sigmoid##5##2##(2008-12#2)(2009-1#1)(2010-12#1)(2012-12#1)
of signal generation##2##3##(2008-11#1)(2009-8#1)
of signal peptides##3##3##(1994-11#1)(1997-6#1)(2008-10#1)
of signal transduction and##2##4##(2008-11#2)
of signal transduction##5##3##(1995-2#1)(2008-11#2)(2008-9#1)(2011-3#1)
of signal##29##2##(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-9#2)(2009-11#3)(2009-8#2)(2010-7#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#2)
of signal-to-noise##2##2##(2008-10#2)
of signaling molecules##2##3##(2009-12#1)(2013-8#1)
of signaling pathways##3##3##(1994-12#1)(2011-2#2)
of signaling##13##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#3)(2009-12#1)(2011-2#4)(2013-8#1)
of signalling##4##2##(1996-2#1)(2008-1#1)(2009-7#1)(2011-2#1)
of signals from##2##3##(1995-2#1)(2008-8#1)
of signals##6##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-8#1)
of signature chemicals##2##3##(2008-10#2)
of signature##3##2##(2008-10#2)(2013-1#1)
of significance for##2##3##(1990-11#1)(2010-9#1)
of significance to##2##3##(1992-2#1)(2008-8#1)
of significance##8##2##(1990-11#1)(1992-2#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-8#1)(2010-6#1)(2010-9#1)
of significant CAD##2##3##(2012-2#2)
of significant amounts of##3##4##(1993-11#1)(1996-5#1)(2008-7#1)
of significant differences##2##3##(2010-1#1)(2013-1#1)
of significant importance##2##3##(1994-9#1)(2008-10#1)
of significant potential##2##3##(1995-2#1)(2010-6#1)
of significant##48##2##(1990-5#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-10#15)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-1#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
of significantly##5##2##(1992-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
of signs and symptoms##3##4##(2008-7#1)(2008-9#1)(2012-3#1)
of signs of##3##3##(2009-8#1)(2013-1#2)
of signs##6##2##(2008-7#1)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#2)
of sildenafil citrate##4##3##(2008-10#4)
of silent##5##2##(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2012-3#1)
of silica fume produced by zircon desilication##2##7##(2008-10#2)
of silica gel and##2##4##(2008-10#2)
of silica gel##11##3##(2008-10#11)
of silica in##2##3##(2008-10#2)
of silica modified with##2##4##(2008-10#2)
of silica nanospheres##2##3##(2008-10#2)
of silica surface##2##3##(2008-10#2)
of silica##35##2##(1997-2#1)(2008-10#30)(2009-7#2)(2010-7#2)
of silica-ERT phase##4##3##(2008-10#4)
of silica-ERT##5##2##(2008-10#5)
of silicate based##2##3##(2008-10#2)
of silicate##5##2##(2008-10#5)
of silicon (Si)##3##3##(2008-10#3)
of silicon by##2##3##(2008-10#2)
of silicon in##5##3##(2008-10#5)
of silicon##23##2##(2008-10#17)(2008-3#2)(2008-9#1)(2010-3#2)(2011-2#1)
of siliquae##2##2##(2013-8#2)
of silk##3##2##(2007-12#1)(2008-7#1)(2008-9#1)
of silkworm hemolymph on the expression of##2##7##(1997-8#2)
of silkworm##3##2##(1997-8#2)(2012-2#1)
of silkwormAttacus ricini##2##3##(2008-8#2)
of silver in##7##3##(2008-10#7)
of silver ions onto##4##4##(2008-10#4)
of silver ions##8##3##(2008-10#8)
of silver nanoparticles##2##3##(2011-2#2)
of silver picrate##2##3##(2008-10#2)
of silver was##3##3##(2008-10#3)
of silver were##2##3##(2008-10#2)
of silver##45##2##(2008-10#38)(2008-3#1)(2008-7#1)(2011-2#4)(2013-1#1)
of silver(I)##8##2##(2008-10#8)
of simian virus 40##2##4##(1997-7#1)(2008-11#1)
of simian##3##2##(1997-7#1)(2008-11#1)(2012-12#1)
of similar cases##2##3##(2008-12#1)(2012-12#1)
of similar mass##2##3##(2008-8#1)(2008-9#1)
of similar size and##2##4##(1996-3#1)(2008-10#1)
of similar size##4##3##(1993-12#1)(1996-2#1)(1996-3#1)(2008-10#1)
of similar structure##5##3##(2008-10#4)(2012-3#1)
of similar##42##2##(1991-12#1)(1991-3#1)(1991-6#1)(1993-12#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
of similarity between##2##3##(1993-2#1)(2008-10#1)
of similarity to##2##3##(1995-12#1)(2008-10#1)
of similarity##17##2##(1993-2#2)(1993-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-10#7)(2008-4#1)(2008-8#1)(2012-2#1)
of simple bromophenols in##2##4##(2008-10#2)
of simple cells##4##3##(1996-2#1)(2008-11#1)(2008-8#2)
of simple##41##2##(1992-12#1)(1992-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-7#1)(2006-5#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-8#5)(2008-9#2)(2009-7#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
of simple-cell receptive##2##3##(2008-8#2)
of simplicity and##2##3##(2008-10#2)
of simplicity##7##2##(2008-10#7)
of simplified##2##2##(1994-3#1)(1995-6#1)
of simulated microgravity on nitric oxide##2##6##(2008-9#2)
of simulated microgravity on##3##4##(2008-9#3)
of simulated microgravity##4##3##(2008-9#4)
of simulated##13##2##(1990-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#4)(2010-2#1)(2012-5#1)
of simulating##2##2##(1994-3#1)(2008-11#1)
of simulation in##2##3##(2008-10#1)(2008-11#1)
of simulation##7##2##(2008-10#2)(2008-11#2)(2008-3#2)(2013-8#1)
of simulation-based##2##2##(2012-2#1)(2013-8#1)
of simulations##5##2##(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)
of simultaneous determination of##3##4##(2008-10#3)
of simultaneous measurements##2##3##(2008-3#2)
of simultaneous##24##2##(1994-9#1)(1995-5#2)(1996-3#1)(2008-10#9)(2008-3#4)(2008-6#2)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)
of simultaneously##3##2##(2008-10#2)(2012-2#1)
of single and##5##3##(1993-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
of single cells##8##3##(2008-7#6)(2008-9#1)(2009-12#1)
of single gene##2##3##(2008-8#1)(2012-3#1)
of single mandibular molars##2##4##(2013-1#2)
of single nucleotide polymorphisms##3##4##(2008-10#2)(2009-8#1)
of single or##2##3##(2008-9#1)(2011-1#1)
of single strand##2##3##(1993-12#1)(2008-8#1)
of single versus multiple##3##4##(2008-10#3)
of single##71##2##(1991-5#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-9#1)(1996-8#1)(1997-7#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-12#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
of single-cell suspensions of##2##4##(2008-4#1)(2008-9#1)
of single-chain variable##2##3##(2008-10#2)
of single-chain##5##2##(2008-10#3)(2008-4#2)
of single-copy##2##2##(2008-10#1)(2008-9#1)
of single-electron reduction##2##3##(1995-8#2)
of single-electron##3##2##(1995-8#2)(1996-5#1)
of single-mode##2##2##(2008-2#1)(2008-3#1)
of single-shot##4##2##(2008-3#4)
of single-spore##2##2##(2008-10#2)
of single-stranded DNA##2##3##(2008-10#1)(2008-9#1)
of single-stranded##5##2##(1992-8#1)(2008-10#3)(2008-9#1)
of singlet oxygen##4##3##(2008-10#1)(2008-5#2)(2010-4#1)
of singly##2##2##(2008-2#1)(2009-12#1)
of singular##4##2##(1990-8#1)(2008-10#1)(2009-7#1)(2013-1#1)
of sinoatrial blocks##2##3##(1996-3#2)
of sinonasal symptoms##2##3##(2011-2#2)
of sinus rhythm##3##3##(2008-7#1)(2010-12#2)
of sinusoidal##2##2##(1995-2#1)(2008-8#1)
of sirolimus##2##2##(2008-11#1)(2013-1#1)
of site##5##2##(1991-6#1)(2008-10#2)(2008-7#1)(2013-1#1)
of site-directed##3##2##(1993-8#1)(1995-2#1)(2008-11#1)
of site-specific recombinases##2##3##(2008-11#2)
of site-specific##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
of sites for##3##3##(1991-5#1)(1991-6#1)(1992-3#1)
of sites##10##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#1)(1994-12#1)(2008-10#3)(2008-11#1)(2012-5#1)
of situational##2##2##(2008-12#1)(2009-7#1)
of situations##4##2##(1996-3#1)(2008-11#1)(2008-4#1)(2008-9#1)
of six and##2##3##(1996-12#1)(2008-10#1)
of six chicken respiratory##2##4##(2013-8#2)
of six months##3##3##(1990-12#1)(1997-4#1)(2013-8#1)
of six phenols and related compounds##2##6##(2008-10#2)
of six prisms##2##3##(2008-3#2)
of six pyrethroids##2##3##(2008-10#2)
of six samples##3##3##(2008-10#3)
of six vineyards##2##3##(2008-10#2)
of six##91##2##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#39)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
of size 1##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
of size and shape##2##4##(2008-5#1)(2010-7#1)
of size and##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)(2013-8#1)
of size exclusion chromatography##2##4##(2008-10#2)
of size inequality##2##3##(2008-8#2)
of size variation##2##3##(2008-8#2)
of size##27##2##(1991-11#1)(1993-2#1)(1996-12#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-8#8)(2008-9#1)(2010-7#1)(2011-2#4)(2013-8#1)
of size-abundance relationships among free-living animals##2##6##(2008-9#2)
of size-exclusion chromatography##2##3##(2008-10#1)(2008-4#1)
of skeletal and##2##3##(2010-7#1)(2012-3#1)
of skeletal muscle##5##3##(1993-12#2)(2008-1#1)(2011-2#1)(2012-12#1)
of skeletal##18##2##(1990-11#1)(1993-12#3)(1995-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of skew##4##2##(2008-8#4)
of skill##3##2##(1994-2#1)(2008-11#1)(2011-2#1)
of skilled##2##2##(1992-2#1)(2010-1#1)
of skills##7##2##(1990-12#1)(1996-3#1)(2007-12#1)(2008-11#2)(2011-2#1)(2012-12#1)
of skin cancer is##2##4##(2011-2#2)
of skin cancer##4##3##(1991-6#1)(1994-5#1)(2011-2#2)
of skin cancers##2##3##(2011-2#2)
of skin colour##2##3##(2008-5#2)
of skin dryness##2##3##(2008-5#2)
of skin fibroblasts##3##3##(2008-5#2)(2008-7#1)
of skin hydration in##2##4##(2008-5#2)
of skin hydration##3##3##(2008-10#1)(2008-5#2)
of skin improvement##2##3##(2008-5#2)
of skin in##2##3##(1995-11#1)(1996-12#1)
of skin irritation##2##3##(2008-10#1)(2008-5#1)
of skin lesions##2##3##(2010-6#1)(2012-3#1)
of skin markers##2##3##(2013-1#2)
of skin melanoma in##2##4##(1994-12#1)(2011-2#1)
of skin metastases in##2##4##(1991-6#2)
of skin physiology##2##3##(2008-5#2)
of skin sensitization##2##3##(2008-5#2)
of skin tone##2##3##(2008-11#2)
of skin##88##2##(1991-6#3)(1991-8#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-5#47)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-6#2)(2010-7#1)(2011-2#8)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
of skull##3##2##(2012-12#1)(2012-3#1)(2013-7#1)
of slash and##2##3##(2008-10#1)(2010-7#1)
of sleep EEG##2##3##(2009-8#1)(2010-8#1)
of sleep and##2##3##(2009-8#1)(2013-1#1)
of sleep stages##2##3##(2010-8#2)
of sleep##14##2##(1990-5#1)(1994-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#4)(2010-8#3)(2013-1#2)
of sliding##2##2##(2011-2#2)
of slight##2##2##(1996-6#1)(2008-11#1)
of slightly##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
of slope##2##2##(2008-10#1)(2008-3#1)
of slow##7##2##(1991-3#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2012-2#1)
of sludge##5##2##(2008-11#1)(2008-12#4)
of slurries##2##2##(2008-10#2)
of slurry##4##2##(2008-10#4)
of small (&lt##3##3##(2008-7#1)(2010-12#1)(2012-3#1)
of small GTP-binding proteins##3##4##(1992-3#1)(1994-6#1)(1997-1#1)
of small amounts of##8##4##(1990-5#1)(1993-6#1)(2008-10#5)(2008-8#1)
of small animals##2##3##(2010-12#1)(2010-7#1)
of small bowel obstruction##2##4##(2008-12#2)
of small bowel##10##3##(1991-12#1)(1995-12#1)(1996-8#1)(1997-8#1)(2008-12#3)(2010-12#1)(2012-12#1)(2012-3#1)
of small cell lung cancer##2##5##(2009-1#2)
of small cell##4##3##(1992-12#1)(1997-4#1)(2009-1#2)
of small intestinal##4##3##(1996-6#1)(2008-5#1)(2013-1#2)
of small intestine##2##3##(1995-12#1)(2012-2#1)
of small molecule##3##3##(2008-10#1)(2010-3#1)(2013-8#1)
of small molecules##4##3##(2010-7#1)(2011-2#3)
of small phosphorus-containing compounds by capillary electrophoresis##2##7##(2008-10#2)
of small quantities of##2##4##(2008-10#2)
of small to##2##3##(1990-8#1)(2008-10#1)
of small##102##2##(1990-5#3)(1990-8#1)(1991-12#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#2)(1993-6#1)(1994-6#1)(1995-12#3)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#24)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#3)(2009-11#4)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
of small-diameter##3##2##(1991-2#2)(2008-10#1)
of small-scale##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
of smaller##11##2##(1995-3#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#2)
of smells##2##2##(2012-2#2)
of smoke##3##2##(1996-12#3)
of smokers in##2##3##(2008-10#1)(2013-1#1)
of smokers##9##2##(1992-9#1)(1996-9#1)(2007-12#1)(2008-10#2)(2010-7#1)(2011-2#1)(2013-1#2)
of smoking among women##2##4##(1991-11#2)
of smoking among##4##3##(1991-11#3)(2009-7#1)
of smoking and##3##3##(1992-6#1)(2013-1#2)
of smoking cessation##3##3##(1995-3#1)(2008-11#1)(2013-1#1)
of smoking habits##2##3##(1990-2#1)(1996-3#1)
of smoking was##2##3##(1996-3#1)(2011-2#1)
of smoking were##4##3##(1996-3#1)(2010-11#1)(2010-2#2)
of smoking##32##2##(1990-2#1)(1990-6#2)(1991-1#1)(1991-11#5)(1991-12#1)(1992-6#1)(1994-6#2)(1995-3#1)(1996-3#3)(1997-6#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-11#2)(2010-2#3)(2011-2#1)(2013-1#4)
of smooth muscle##9##3##(1992-9#2)(1993-6#1)(1994-6#1)(1996-1#1)(2008-10#2)(2008-11#1)(2012-2#1)
of smooth##10##2##(1992-9#2)(1993-6#1)(1994-6#1)(1996-1#1)(2008-10#2)(2008-11#1)(2012-2#2)
of smoothing##2##2##(2008-10#2)
of snails##4##2##(2008-12#4)
of snake##2##2##(2008-12#1)(2008-7#1)
of snow molds##2##3##(2008-10#2)
of so-called##4##2##(1991-3#1)(1992-3#1)(1995-5#1)(2010-1#1)
of social and##2##3##(1991-1#1)(2010-6#1)
of social behavior##3##3##(2008-11#1)(2008-8#1)(2010-3#1)
of social cognition##3##3##(2008-11#3)
of social dominance##3##3##(2008-11#1)(2008-8#1)(2010-1#1)
of social evolution##3##3##(2008-8#1)(2012-3#2)
of social interaction##4##3##(1996-11#1)(2008-11#1)(2008-4#1)(2011-2#1)
of social interactions##4##3##(2008-12#1)(2008-8#2)(2012-3#1)
of social medicine]##2##3##(1996-11#2)
of social phobia##8##3##(2008-4#5)(2010-2#3)
of social selection##2##3##(2008-8#1)(2012-3#1)
of social support and##3##4##(1992-3#1)(2009-7#2)
of social support from##3##4##(2009-7#3)
of social support##17##3##(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#4)(1996-3#1)(2009-10#1)(2009-5#2)(2009-7#6)
of social##88##2##(1991-1#2)(1992-1#1)(1992-2#1)(1992-3#4)(1994-3#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-11#4)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-11#12)(2008-12#5)(2008-4#6)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#3)(2009-5#2)(2009-6#1)(2009-7#6)(2010-1#3)(2010-10#1)(2010-2#3)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#4)(2013-1#2)
of sociality in##2##3##(2008-8#2)
of sociality##5##2##(2008-8#5)
of socially##2##2##(2009-6#1)(2009-7#1)
of society##6##2##(1991-3#1)(1992-3#1)(1995-5#2)(2008-1#1)(2008-11#1)
of socio-economic and behavioural factors on childhood malnutrition in Yemen##2##10##(2010-6#2)
of socio-economic##3##2##(2010-11#1)(2010-6#2)
of sociobiology##2##2##(2010-4#2)
of socioeconomic##5##2##(2008-12#2)(2009-10#1)(2012-12#1)(2013-7#1)
of sodium and potassium##4##4##(2008-10#4)
of sodium and##5##3##(2008-10#4)(2013-8#1)
of sodium bromate in##2##4##(2008-9#2)
of sodium bromate##3##3##(2008-9#3)
of sodium channel##4##3##(1996-12#2)(2008-7#2)
of sodium chloride in##2##4##(2008-10#1)(2011-2#1)
of sodium chloride##10##3##(1994-5#1)(1996-3#1)(2008-10#5)(2008-12#2)(2011-2#1)
of sodium dodecyl sulfate (SDS)##3##5##(1990-11#1)(2008-10#2)
of sodium dodecyl sulfate##5##4##(1990-11#1)(1996-12#1)(2008-10#3)
of sodium dodecyl sulphate (SDS) and##2##6##(2008-10#2)
of sodium dodecyl sulphate##3##4##(2008-10#3)
of sodium dodecyl##8##3##(1990-11#1)(1996-12#1)(2008-10#6)
of sodium dodecylsulfate (SDS)##2##4##(2008-10#2)
of sodium dodecylsulfate##3##3##(2008-10#3)
of sodium fluoride##2##3##(2008-12#1)(2013-1#1)
of sodium hydroxide##3##3##(2008-10#3)
of sodium in##3##3##(2008-10#3)
of sodium ion##4##3##(2008-10#4)
of sodium metabisulfite in##2##4##(2008-10#2)
of sodium sulfate##2##3##(2008-10#1)(2008-9#1)
of sodium##105##2##(1990-11#1)(1992-11#1)(1992-12#2)(1992-3#1)(1994-5#2)(1995-8#1)(1996-12#4)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#69)(2008-11#3)(2008-12#4)(2008-5#1)(2008-7#3)(2008-9#5)(2011-2#3)(2013-1#1)(2013-8#1)
of soft tissue and non-thrust joint manipulation##2##7##(2008-12#2)
of soft tissue##8##3##(1992-1#1)(1996-11#1)(2008-12#4)(2008-7#1)(2012-2#1)
of soft tissues##4##3##(2008-12#1)(2010-4#1)(2010-9#1)(2012-2#1)
of soft##17##2##(1992-1#1)(1996-11#1)(2008-10#3)(2008-12#5)(2008-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-2#2)
of soft-tissue##2##2##(2008-9#1)(2013-1#1)
of software for##2##3##(1992-9#1)(2008-10#1)
of software##5##2##(1992-9#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
of soil and##10##3##(2008-10#7)(2008-11#1)(2008-9#1)(2013-1#1)
of soil fertility##2##3##(2008-11#1)(2010-7#1)
of soil in##4##3##(2008-10#4)
of soil microbial##2##3##(2008-10#2)
of soil moisture and##2##4##(2008-10#1)(2008-9#1)
of soil organic matter##3##4##(2008-10#2)(2013-8#1)
of soil organic phosphorus##3##4##(2008-10#3)
of soil organic##6##3##(2008-10#5)(2013-8#1)
of soil samples##4##3##(2008-10#2)(2008-11#2)
of soil to##2##3##(2008-10#2)
of soil were##3##3##(2008-10#3)
of soil with##5##3##(2008-10#4)(2008-12#1)
of soil##96##2##(2008-10#76)(2008-11#11)(2008-12#1)(2008-9#2)(2010-3#1)(2010-7#1)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
of soil)##9##2##(2008-10#9)
of soilborne pathogens##7##3##(2008-10#7)
of soilborne plant pathogens##4##4##(2008-10#4)
of soilborne plant##5##3##(2008-10#5)
of soilborne##17##2##(2008-10#17)
of soils and sediments##2##4##(2008-10#2)
of soils and##4##3##(2008-10#4)
of soils by##2##3##(2008-10#1)(2008-12#1)
of soils in##2##3##(2008-10#2)
of soils with##2##3##(2008-10#2)
of soils##19##2##(2008-10#18)(2008-12#1)
of sol-gel##4##2##(2008-10#3)(2010-7#1)
of solanaceous##2##2##(2008-10#1)(2008-6#1)
of solar radiation on##2##4##(2010-1#2)
of solar radiation##7##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#3)(2011-2#1)
of solar##15##2##(2008-10#4)(2008-11#1)(2008-3#4)(2008-8#1)(2010-1#3)(2011-2#2)
of solid phase extraction##2##4##(2008-10#2)
of solid phase##5##3##(2008-10#5)
of solid samples##3##3##(2008-10#3)
of solid substrate##2##3##(1997-2#1)(2008-7#1)
of solid tumors##4##3##(2008-11#1)(2010-7#1)(2011-2#1)(2013-1#1)
of solid tumours##2##3##(2008-11#1)(2009-4#1)
of solid waste##2##3##(2008-12#2)
of solid##40##2##(1991-5#1)(1992-3#1)(1997-2#3)(2008-10#23)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
of solid-phase extraction##5##3##(2008-10#5)
of solid-phase microextraction##3##3##(2008-10#3)
of solid-phase##8##2##(2008-10#8)
of solid-state##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
of solids##4##2##(1994-12#1)(2008-10#3)
of solitary##8##2##(1991-3#2)(1992-12#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-6#1)(2012-3#1)
of solubility##6##2##(1991-12#1)(2008-10#4)(2012-2#1)
of solubilized##2##2##(1992-3#1)(2008-11#1)
of soluble and##2##3##(1996-1#1)(2008-10#1)
of soluble fulvic##2##3##(2008-10#2)
of soluble phosphates in##2##4##(2008-10#2)
of soluble##29##2##(1990-12#1)(1990-5#1)(1990-9#1)(1996-1#1)(2006-6#1)(2008-10#16)(2008-11#2)(2008-8#1)(2009-3#1)(2009-6#2)(2012-2#1)(2013-8#1)
of solute##2##2##(2008-10#2)
of solutes##5##2##(2008-10#2)(2008-7#2)(2011-2#1)
of solution pH on the##2##5##(2008-10#1)(2008-5#1)
of solution pH##6##3##(2008-10#5)(2008-5#1)
of solution##21##2##(1993-12#1)(1995-3#1)(2008-10#17)(2008-5#1)(2011-2#1)
of solutions and the##2##4##(2008-10#2)
of solutions and##3##3##(2008-10#3)
of solutions containing##2##3##(2008-10#2)
of solutions is##2##3##(1997-5#1)(2008-2#1)
of solutions with##3##3##(2008-10#3)
of solutions##18##2##(1994-2#1)(1997-5#1)(2008-10#13)(2008-12#1)(2008-2#1)(2013-8#1)
of solvation##6##2##(2008-10#3)(2008-4#1)(2009-9#1)(2010-7#1)
of solvent and##4##3##(2008-10#4)
of solvent composition##3##3##(2008-10#3)
of solvent on the##2##4##(2008-10#2)
of solvent##26##2##(1992-4#1)(2008-10#20)(2008-5#1)(2008-7#2)(2013-1#2)
of solvents##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
of solving##2##2##(2008-10#2)
of somatic alterations##2##3##(2008-9#2)
of somatic cells##2##3##(2008-9#1)(2010-7#1)
of somatic##11##2##(1994-5#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-7#1)
of somatosensory##2##2##(2008-5#1)(2010-7#1)
of somatostatin##8##2##(1995-8#1)(1997-4#4)(1997-8#2)(2012-3#1)
of somatotropes##2##2##(1992-6#2)
of some active##2##3##(2008-10#2)
of some amino acids##2##4##(2008-10#2)
of some amino##3##3##(1997-2#1)(2008-10#2)
of some analytical##2##3##(2008-10#2)
of some anions##3##3##(2008-10#3)
of some aromatic##3##3##(2008-10#3)
of some biological##3##3##(2008-10#3)
of some biologically##2##3##(2008-12#1)(2013-8#1)
of some catechol derivatives##2##4##(2008-10#2)
of some components##2##3##(1994-3#1)(1996-12#1)
of some diseases##2##3##(1993-2#1)(2008-11#1)
of some functional##2##3##(2008-10#1)(2008-5#1)
of some heavy##2##3##(2008-10#2)
of some important##2##3##(2008-10#1)(2012-2#1)
of some instrumental factors##2##4##(2008-10#2)
of some instrumental##3##3##(2008-10#3)
of some isolates##2##3##(2008-10#2)
of some matrix##2##3##(2008-10#2)
of some metal ions##5##4##(2008-10#5)
of some metal-4-(2-pyridylazo) resorcinol##2##4##(2008-10#2)
of some metals##4##3##(2008-10#4)
of some new##2##3##(2008-10#2)
of some novel##2##3##(1996-5#1)(2012-2#1)
of some of the compounds##2##5##(1994-8#1)(2008-10#1)
of some of the most##2##5##(2008-11#1)(2011-2#1)
of some of the##27##4##(1992-12#1)(1993-1#1)(1993-2#1)(1994-8#1)(1996-2#2)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#2)(2009-1#1)(2009-12#1)(2011-2#3)(2012-2#2)
of some of these##5##4##(2008-10#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
of some of##36##3##(1991-12#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#3)(2009-1#1)(2009-12#1)(2009-9#1)(2011-2#3)(2012-2#2)(2013-8#1)
of some organic and biological molecules##2##6##(2008-10#2)
of some organic##6##3##(1990-9#1)(2008-10#5)
of some patients##2##3##(2008-12#1)(2012-3#1)
of some pharmaceutical##2##3##(2008-10#2)
of some recently synthesized##2##4##(2008-10#2)
of some samples##2##3##(2008-10#2)
of some transition metals##2##4##(2008-10#2)
of some transition##3##3##(2008-10#3)
of some trivalent metal##2##4##(2008-10#2)
of some##288##2##(1990-6#1)(1990-9#1)(1991-12#3)(1991-2#3)(1992-12#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-7#1)(1997-9#1)(2007-8#1)(2008-1#2)(2008-10#157)(2008-11#8)(2008-12#4)(2008-3#3)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
of somites##3##2##(1994-12#3)
of song sparrows (Melospiza melodia)##3##5##(2008-8#1)(2008-9#2)
of song##6##2##(2008-8#3)(2008-9#3)
of sonication##3##2##(2008-10#3)
of sonography##2##2##(1991-3#1)(1997-8#1)
of soot##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
of sophisticated##2##2##(2008-10#1)(2010-7#1)
of sorbent##7##2##(2008-10#7)
of sorbic##2##2##(2011-2#2)
of sorbinil on##3##3##(1994-8#3)
of sorbitol##2##2##(2008-8#1)(2012-7#1)
of sorghum anthracnose##3##3##(2008-10#3)
of sorghum##10##2##(2008-10#7)(2008-9#3)
of sorption of##3##3##(2008-10#3)
of sorption##14##2##(2008-10#12)(2010-4#2)
of sound##10##2##(1996-6#1)(2008-11#1)(2008-3#5)(2010-8#1)(2011-1#1)(2013-8#1)
of sounds##3##2##(2008-11#1)(2010-8#1)(2011-1#1)
of sour orange##4##3##(2008-10#4)
of source##10##2##(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)(2009-2#1)(2011-2#1)
of source-sink dynamics##2##3##(2008-8#2)
of sources of##2##3##(2008-10#1)(2008-12#1)
of sources##9##2##(1993-12#1)(1995-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)
of southern##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2010-1#1)
of sowing date##4##3##(2008-10#4)
of sowing distances on edible pod yields and yield components of three vegetable cowpea cultivars (Vigna unguiculata L##2##18##(2008-12#2)
of sowing##8##2##(2008-10#6)(2008-12#2)
of soy##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
of soybean (Glycine max)##3##4##(2008-10#3)
of soybean fungal diseases in##2##5##(2008-10#2)
of soybean mosaic virus##3##4##(2008-10#2)(2008-8#1)
of soybean oil ethanolysis##2##4##(2008-10#2)
of soybean rust##3##3##(2008-10#3)
of soybean sclerotinia stem rot##2##5##(2008-10#2)
of soybean seedlings##3##3##(2008-10#2)(2008-8#1)
of soybean##37##2##(2008-10#33)(2008-6#1)(2008-8#2)(2009-10#1)
of soybeans##5##2##(2008-10#5)
of space in##2##3##(2009-10#1)(2013-8#1)
of space##9##2##(2008-10#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-9#1)(2013-8#1)
of spaceborne##3##2##(2008-3#3)
of sparkling wines##3##3##(2008-10#3)
of sparkling##4##2##(2008-10#4)
of spasmodic##2##2##(1996-2#2)
of spatial aggregation and##2##4##(2008-10#1)(2008-8#1)
of spatial aggregation##4##3##(2008-10#2)(2008-8#2)
of spatial and temporal##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)
of spatial association##2##3##(2008-10#2)
of spatial correlation##2##3##(2008-10#2)
of spatial delayed alternation##2##4##(1991-2#1)(1994-8#1)
of spatial heterogeneity##3##3##(2008-10#2)(2008-8#1)
of spatial hole burning##2##4##(2008-3#2)
of spatial learning##2##3##(1991-7#1)(2012-2#1)
of spatial organization##2##3##(1991-2#1)(1995-6#1)
of spatial patterns##3##3##(2008-10#1)(2008-8#2)
of spatial proximity##2##3##(2008-7#2)
of spatial resolution##3##3##(1995-11#1)(2008-8#1)(2013-8#1)
of spatial##57##2##(1991-2#4)(1991-7#1)(1994-8#1)(1995-11#1)(1995-6#1)(2008-10#22)(2008-11#4)(2008-3#6)(2008-7#2)(2008-8#8)(2008-9#1)(2009-11#1)(2010-4#1)(2012-2#1)(2013-8#3)
of spatially correlated extinctions##2##4##(2008-8#2)
of spatially referenced##3##3##(2008-10#3)
of spatially##8##2##(2008-10#3)(2008-5#1)(2008-8#2)(2010-10#1)(2013-8#1)
of spatiotemporal##2##2##(2008-10#1)(2008-11#1)
of spawning##3##2##(2010-8#3)
of spawnings##2##2##(2010-8#2)
of special importance in##2##4##(2008-10#1)(2013-8#1)
of special interest##8##3##(1990-9#1)(1996-3#1)(2011-2#6)
of special##24##2##(1990-9#1)(1991-12#1)(1991-6#2)(1994-3#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#6)(2013-1#1)(2013-8#1)
of specialist##8##2##(1993-12#1)(1993-6#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
of specialization##6##2##(1993-2#1)(2008-8#4)(2008-9#1)
of specialized metabolites##2##3##(2011-2#2)
of specialized training##2##3##(1994-12#1)(1996-11#1)
of specialized##14##2##(1991-2#1)(1991-3#1)(1994-12#1)(1996-1#1)(1996-11#1)(2008-11#2)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#3)
of specialty and##2##3##(1993-6#2)
of specialty##7##2##(1991-2#1)(1991-6#3)(1993-6#2)(1996-3#1)
of speciation##5##2##(2008-10#4)(2013-1#1)
of species and##2##3##(1993-2#1)(2008-8#1)
of species diversity##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
of species from the##2##4##(2008-8#1)(2012-3#1)
of species from##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
of species has##2##3##(2008-10#1)(2008-8#1)
of species in##6##3##(2008-10#2)(2008-8#4)
of species that are##2##4##(2008-6#1)(2008-9#1)
of species with##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
of species within##2##3##(2008-8#1)(2010-10#1)
of species##61##2##(1993-2#2)(1996-2#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#14)(2008-9#9)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
of species-specific##2##2##(2008-10#2)
of specific cell##2##3##(2008-11#1)(2008-4#1)
of specific gene##4##3##(1995-11#2)(2008-10#1)(2008-8#1)
of specific growth##3##3##(2008-11#2)(2008-9#1)
of specific markers for##2##4##(2008-9#2)
of specific molecular##2##3##(2008-11#1)(2008-4#1)
of specific primers##3##3##(2008-10#2)(2013-8#1)
of specific proteins##3##3##(2008-10#2)(2008-4#1)
of specific##131##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#3)(1992-1#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-1#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#1)(1996-3#1)(1997-2#2)(1997-3#1)(2006-6#1)(2008-10#24)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#11)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#9)(2009-1#1)(2009-12#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#1)
of specifically##7##2##(1995-11#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-11#1)
of specificity and##2##3##(1992-6#1)(2008-10#1)
of specificity##8##2##(1992-6#1)(1996-3#1)(2008-10#3)(2008-8#1)(2009-11#1)(2010-6#1)
of specified##2##2##(1995-2#1)(2008-10#1)
of specimens of##2##3##(2008-10#1)(2010-1#1)
of specimens##8##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)
of spectra##7##2##(1997-2#1)(2008-10#5)(2008-8#1)
of spectral data##5##3##(2008-10#4)(2008-11#1)
of spectral extinction##2##3##(2008-3#2)
of spectral##17##2##(2008-10#11)(2008-11#2)(2008-3#3)(2008-5#1)
of spectral-domain OCT##4##3##(2011-7#4)
of spectrophotometric data##3##3##(2008-10#3)
of spectrophotometric method##2##3##(2008-10#2)
of spectrophotometric##5##2##(2008-10#5)
of spectroscopic##5##2##(1994-8#1)(2008-10#3)(2008-3#1)
of spectrum##2##2##(2008-3#1)(2013-8#1)
of speech and##3##3##(2008-9#1)(2011-1#2)
of speech perception##2##3##(2008-11#1)(2008-9#1)
of speech##16##2##(2008-11#1)(2008-9#4)(2009-10#1)(2011-1#10)
of speed##4##2##(2008-10#3)(2008-4#1)
of spending##2##2##(1991-2#2)
of spent##2##2##(2008-10#1)(2008-11#1)
of sperm cells##2##3##(2008-12#2)
of sperm competition in##2##4##(2008-8#1)(2009-6#1)
of sperm storage##3##3##(2007-12#3)
of sperm##17##2##(1994-5#2)(1995-2#1)(1996-9#1)(2007-12#4)(2008-12#3)(2008-8#3)(2009-6#1)(2011-2#1)(2012-2#1)
of spermatids##2##2##(2008-7#2)
of spermatocytes##2##2##(2009-10#1)(2012-2#1)
of spermatogenesis and##2##3##(2008-8#1)(2012-2#1)
of spermatogenesis are##2##3##(2009-10#1)(2012-2#1)
of spermatogenesis##14##2##(1992-12#1)(2008-8#1)(2009-10#4)(2010-5#1)(2012-2#7)
of spermatogenic##2##2##(2012-2#2)
of spermatozoa of the##2##4##(2008-7#2)
of spermatozoa##6##2##(2008-6#1)(2008-7#2)(2010-5#1)(2012-2#1)(2013-1#1)
of spermidine/spermine N1-acetyltransferase##2##3##(1991-9#1)(1992-10#1)
of spermine##2##2##(1990-7#1)(1996-2#1)
of spermiogenesis##5##2##(2007-12#1)(2008-7#3)(2012-2#1)
of spheres deposited on a##2##5##(2008-3#2)
of spheres##5##2##(2008-3#5)
of spherical monodisperse magnetite particles##2##5##(1992-12#2)
of spherical##10##2##(1992-12#2)(1996-1#1)(2008-10#3)(2008-3#4)
of spider##3##2##(2007-12#1)(2008-7#1)(2012-3#1)
of spike##5##2##(2008-10#4)(2008-11#1)
of spiked samples and##3##4##(2008-10#3)
of spiked samples were found##2##5##(2008-10#2)
of spiked samples were##4##4##(2008-10#4)
of spiked samples##9##3##(2008-10#9)
of spiked tap##2##3##(2008-10#2)
of spiked water samples##3##4##(2008-10#3)
of spiked##21##2##(1997-2#1)(2008-10#20)
of spikes##5##2##(2008-10#2)(2008-11#1)(2009-8#2)
of spiking##3##2##(2008-11#2)(2009-8#1)
of spilled##2##2##(2008-10#1)(2012-2#1)
of spin##3##2##(1994-5#1)(2008-8#1)(2010-7#1)
of spin-labeled##2##2##(1994-5#2)
of spinach##9##2##(1990-5#1)(1994-11#1)(2008-10#3)(2008-9#4)
of spinal anesthesia##5##3##(2012-3#5)
of spinal arteriovenous malformations##2##4##(2008-7#2)
of spinal cord compression##2##4##(1991-9#1)(1992-12#1)
of spinal cord##7##3##(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1997-6#1)(2008-4#1)
of spinal##24##2##(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1995-12#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-7#4)(2009-5#2)(2011-2#1)(2012-2#1)(2012-3#6)(2013-1#1)
of spindle cell##2##3##(1990-12#1)(1991-8#1)
of spindle cells and##2##4##(2012-12#1)(2012-2#1)
of spindle##4##2##(1990-12#1)(1991-8#1)(2012-12#1)(2012-2#1)
of spine curve##4##3##(2007-8#4)
of spines##3##2##(2008-11#3)
of spinfilter rotation velocity##2##4##(2008-11#2)
of spirituality##6##2##(2008-11#1)(2008-12#3)(2010-11#2)
of spironolactone##3##2##(2008-10#3)
of spiroplasma##2##2##(2008-10#2)
of spiroplasmas##3##2##(2008-10#3)
of splash##2##2##(2008-10#2)
of spleen cells##2##3##(1996-12#1)(2008-11#1)
of spleen##6##2##(1992-2#1)(1996-12#1)(2008-11#2)(2008-5#1)(2008-9#1)
of splenectomy##2##2##(2012-12#1)(2012-2#1)
of splenic rupture##2##3##(1992-2#1)(2011-2#1)
of splenic##12##2##(1992-2#2)(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#4)(2011-2#1)(2012-3#2)
of splenocytes##4##2##(1991-1#1)(1995-12#1)(2008-10#2)
of splenomegaly##2##2##(2007-12#1)(2012-2#1)
of splicing##6##2##(1991-5#1)(1993-8#1)(2008-8#2)(2010-12#2)
of spline wavelet least square##2##5##(2008-10#2)
of spline wavelet##3##3##(2008-10#3)
of split rice spikelet##2##4##(2008-8#2)
of split##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2012-3#1)
of spoken##2##2##(2008-11#1)(2008-9#1)
of spondylolysis##2##2##(1996-6#2)
of spontaneous PC##2##3##(2008-7#2)
of spontaneous activity##4##3##(2008-11#1)(2013-1#1)(2013-8#2)
of spontaneous and##2##3##(2008-11#1)(2008-7#1)
of spontaneous bacterial peritonitis##2##4##(2009-8#1)(2011-2#1)
of spontaneous intraventricular haemorrhage##3##4##(2008-7#3)
of spontaneous splenic rupture##2##4##(1992-2#2)
of spontaneous##42##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1992-2#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-6#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-7#8)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
of sporadic##6##2##(2007-12#1)(2008-4#1)(2008-7#2)(2009-12#1)(2011-2#1)
of sporangia and zoospores in##2##5##(2008-10#2)
of sporangia and zoospores of##2##5##(2008-10#2)
of sporangia and zoospores##6##4##(2008-10#6)
of sporangia of##2##3##(2008-10#2)
of sporangia##18##2##(2008-10#18)
of sporangiophores##2##2##(2008-10#2)
of spore deposition##4##3##(2008-10#4)
of spore dispersal##2##3##(2008-10#2)
of spore germination and outgrowth##2##5##(2011-2#2)
of spore germination##3##3##(2011-2#3)
of spore##16##2##(2008-10#12)(2011-2#4)
of spore-forming bacteria##3##3##(2011-2#3)
of spores from a##2##4##(2008-10#2)
of spores from##4##3##(2008-10#4)
of spores in water##2##4##(2008-10#2)
of spores of Bacillus cereus##2##5##(2011-2#2)
of spores of##5##3##(2008-10#2)(2008-5#1)(2011-2#2)
of spores##31##2##(2008-10#20)(2008-5#1)(2009-8#1)(2010-10#2)(2010-5#1)(2011-2#6)
of sports and##2##3##(2009-7#1)(2013-1#1)
of sports##4##2##(1993-3#1)(1996-6#1)(2009-7#1)(2013-1#1)
of sports-related injuries##2##3##(2013-1#2)
of sporulating##4##2##(2008-10#4)
of sporulation by light##2##4##(2008-10#2)
of sporulation##12##2##(1990-12#1)(1995-9#1)(2008-10#8)(2011-2#2)
of spot blotch##2##3##(2008-10#2)
of spot##3##2##(2008-10#3)
of spots##2##2##(2010-12#1)(2012-2#1)
of spray and point inoculation##2##5##(2008-10#2)
of spray##3##2##(2008-10#3)
of spread of the##3##4##(2008-10#2)(2011-2#1)
of spread of##5##3##(2008-10#4)(2011-2#1)
of spread##15##2##(1996-10#1)(2008-10#11)(2008-7#1)(2011-2#2)
of spreading##4##2##(1990-12#1)(1990-2#1)(2008-10#1)(2009-10#1)
of spring##3##2##(1996-12#1)(2008-12#1)(2013-1#1)
of spruce##4##2##(2008-10#2)(2013-1#2)
of sputum##3##2##(1991-11#1)(1997-1#1)(2013-8#1)
of squalene##2##2##(2008-10#1)(2008-5#1)
of squamous cell carcinoma##3##4##(1991-6#1)(1993-8#1)(2013-8#1)
of squamous cell##8##3##(1991-6#1)(1993-8#1)(1997-3#1)(2008-1#1)(2008-9#2)(2012-2#1)(2013-8#1)
of squamous##10##2##(1991-2#1)(1991-6#1)(1993-8#1)(1997-3#1)(2008-1#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
of square wave voltammetry##3##4##(2008-10#3)
of square wave##4##3##(2008-10#4)
of square##5##2##(2008-10#5)
of srebf1a##2##2##(2012-2#2)
of ssDNA##3##2##(1991-5#2)(2008-10#1)
of stability constants for##3##4##(2008-10#3)
of stability constants of##7##4##(2008-10#7)
of stability constants##16##3##(2008-10#16)
of stability in##2##3##(1996-6#1)(2008-5#1)
of stability of##2##3##(2008-11#2)
of stability##30##2##(1996-6#1)(2008-10#21)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)
of stabilized##3##2##(2008-10#2)(2010-4#1)
of stabilizing##4##2##(2008-2#1)(2008-8#2)(2012-3#1)
of stable and##2##3##(2008-10#1)(2008-11#1)
of stable isotope##2##3##(2008-6#1)(2010-8#1)
of stable##22##2##(1993-12#1)(1995-2#1)(2008-10#6)(2008-11#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-3#1)
of stably##3##2##(2008-11#2)(2008-8#1)
of stachyose in Chinese artichoke##3##5##(2008-10#3)
of stachyose in##4##3##(2008-10#4)
of stachyose##5##2##(2008-10#5)
of staff and##2##3##(1993-2#1)(2008-11#1)
of staff development##3##3##(1994-1#2)(2008-9#1)
of staff who##3##3##(2008-11#3)
of staff##16##2##(1991-12#2)(1993-2#1)(1994-1#2)(1995-1#1)(2008-11#5)(2008-12#2)(2008-9#1)(2010-10#1)(2011-2#1)
of stage II##3##3##(1993-11#1)(2009-10#2)
of stage at diagnosis##2##4##(1990-12#1)(2012-3#1)
of stage##10##2##(1990-12#1)(1990-6#1)(1993-11#1)(1994-8#1)(2008-4#1)(2008-8#2)(2009-10#2)(2012-3#1)
of staining with##2##3##(1994-2#2)
of staining##6##2##(1990-5#1)(1994-2#2)(1995-12#1)(2008-5#1)(2008-7#1)
of stakeholders##5##2##(1995-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2013-1#1)
of stalk##2##2##(2008-8#2)
of staminate##2##2##(2012-3#2)
of stand-by therapy##2##3##(1993-8#2)
of standard drink##2##3##(2009-7#2)
of standard reference materials##6##4##(2008-10#6)
of standard reference##7##3##(2008-10#7)
of standard samples##2##3##(2008-10#2)
of standard solutions##3##3##(2008-10#3)
of standard##52##2##(2008-10#37)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#3)(2010-10#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
of standardised##2##2##(2008-11#1)(2008-12#1)
of standardization##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
of standardized##9##2##(1991-11#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#2)
of standardizing##2##2##(2008-10#1)(2008-9#1)
of standards and##2##3##(1994-12#1)(2008-10#1)
of standards##10##2##(1994-12#1)(2008-10#7)(2013-1#2)
of standing##2##2##(2007-12#1)(2013-1#1)
of starch##8##2##(2008-10#5)(2008-8#1)(2008-9#1)(2009-10#1)
of starting##5##2##(1991-9#1)(1993-8#1)(2008-10#3)
of startle##3##2##(1996-5#1)(2008-11#2)
of state and federal##2##4##(1995-2#1)(1997-3#1)
of state and##3##3##(1995-2#1)(1996-3#1)(1997-3#1)
of state##22##2##(1990-12#1)(1993-1#1)(1994-12#1)(1995-12#1)(1995-2#2)(1996-3#2)(1996-9#2)(1997-1#1)(1997-3#2)(2008-11#4)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
of states in##2##3##(1995-3#1)(1997-3#1)
of states##6##2##(1991-9#1)(1995-3#1)(1997-1#1)(1997-3#2)(2008-12#1)
of static and dynamic##2##4##(1994-3#1)(2008-3#1)
of static and##3##3##(1994-3#1)(2008-3#1)(2009-1#1)
of static extraction and 5##2##5##(2008-10#2)
of static##9##2##(1994-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-1#1)(2011-2#1)
of statins and##2##3##(2008-12#1)(2009-6#1)
of statins##7##2##(2008-12#1)(2009-6#3)(2010-2#1)(2013-1#2)
of stationary phase##4##3##(2008-10#3)(2008-11#1)
of stationary##6##2##(2008-10#3)(2008-11#2)(2009-8#1)
of statistical analysis##2##3##(1997-8#1)(2008-9#1)
of statistical and##2##3##(1993-12#1)(2007-12#1)
of statistical data##2##3##(1995-1#1)(2008-10#1)
of statistical geometry##2##3##(1997-6#2)
of statistical methods##3##3##(1997-1#1)(2008-3#1)(2008-5#1)
of statistical process control##2##4##(1995-2#1)(2008-10#1)
of statistical tools##2##3##(1993-3#1)(2008-10#1)
of statistical##31##2##(1991-2#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2013-1#1)(2013-8#1)
of statistics##2##2##(1992-2#1)(2008-10#1)
of status##4##2##(2008-12#3)(2008-8#1)
of statutory##3##2##(1996-3#1)(1996-8#1)(2008-11#1)
of stay among the##2##4##(1992-2#1)(2012-3#1)
of stay and##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
of stay of##3##3##(1991-1#1)(1992-12#1)(2013-1#1)
of stay##50##2##(1991-1#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#3)(1993-12#7)(1993-2#2)(1993-3#1)(1994-12#2)(1994-3#4)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-2#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#2)
of steady state##3##3##(1996-3#1)(2008-10#1)(2008-7#1)
of steady-state##2##2##(1994-5#1)(2008-10#1)
of stem and##2##3##(2008-10#2)
of stem canker##3##3##(2008-10#3)
of stem cell##10##3##(2008-10#1)(2008-11#4)(2008-5#1)(2009-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
of stem cells for##2##4##(2008-11#2)
of stem cells into##2##4##(2008-11#2)
of stem cells to the##2##5##(2008-10#1)(2008-11#1)
of stem cells will be##2##5##(2008-11#1)(2010-12#1)
of stem cells##21##3##(2008-10#2)(2008-11#12)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
of stem diameter##2##3##(2008-10#2)
of stem infection##2##3##(2008-10#2)
of stem rot##2##3##(2008-10#2)
of stem rust resistance in##3##5##(2008-10#3)
of stem rust resistance##4##4##(2008-10#4)
of stem rust##8##3##(2008-10#8)
of stem##57##2##(2008-10#28)(2008-11#16)(2008-5#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
of stems##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
of stenophagy in spiders##2##4##(2012-3#2)
of stenophagy were##2##3##(2012-3#2)
of stenophagy##4##2##(2012-3#4)
of stenosis##5##2##(1993-8#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of stent wires##2##3##(2010-12#2)
of stent##6##2##(1990-8#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-12#2)
of step##2##2##(2008-7#1)(2012-2#1)
of steps##6##2##(1992-3#1)(1993-3#1)(2008-10#2)(2012-3#1)(2013-1#1)
of stepwise##3##2##(2008-10#2)(2008-11#1)
of stereodefined PS-oligos##2##3##(2008-4#2)
of steric##2##2##(2008-10#2)
of sterile##9##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
of sterility##3##2##(2008-10#1)(2008-11#2)
of sterilization##6##2##(1991-3#3)(1995-1#2)(1996-3#1)
of steroid 5 alpha-reductase##3##4##(1990-11#2)(1995-9#1)
of steroid##13##2##(1990-11#2)(1991-12#1)(1993-2#1)(1995-9#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
of steroidogenesis##3##2##(1991-3#1)(2012-2#2)
of steroids on##2##3##(2008-7#1)(2012-2#1)
of steroids##13##2##(1990-11#1)(1992-3#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-7#2)(2012-2#3)(2013-1#1)
of sterol synthesis##2##3##(1992-3#1)(1993-6#1)
of sterol##5##2##(1990-12#1)(1991-5#1)(1992-3#2)(1993-6#1)
of sterols##3##2##(1992-3#1)(2008-10#2)
of stethoscopes used by medical students in Nigeria##2##8##(2009-6#2)
of stewardship in health policy##2##5##(2012-2#2)
of stewardship in health##3##4##(2012-2#3)
of stewardship##4##2##(2012-2#4)
of stifle##2##2##(2012-3#2)
of stimulants##2##2##(2008-10#2)
of stimulated Raman scattering##2##4##(2008-2#1)(2008-3#1)
of stimulated scattering##2##3##(2008-3#2)
of stimulated##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
of stimulating##2##2##(1997-2#1)(2008-11#1)
of stimulation rate##2##3##(2008-9#2)
of stimulation##19##2##(1990-8#1)(1992-12#2)(1992-8#1)(1993-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#4)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
of stimulator##2##2##(2012-3#2)
of stimulatory##2##2##(1996-2#1)(2008-11#1)
of stimuli##9##2##(1993-3#1)(1997-7#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#2)
of stimulus##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
of stimulus--reward##2##2##(1993-6#2)
of stirring##3##2##(2008-10#3)
of stochastic##6##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-8#2)(2011-2#1)
of stocking rate on##2##4##(1996-12#2)
of stocking rate##3##3##(1996-12#3)
of stoichiometric##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
of stoichiometry and##3##3##(1994-5#1)(2008-10#2)
of stolon regression##2##3##(2009-8#2)
of stolon##3##2##(2009-8#3)
of stomach cancer in##2##4##(1992-12#1)(2012-12#1)
of stomach cancer##4##3##(1990-9#1)(1992-12#1)(2012-12#2)
of stomach##7##2##(1990-9#1)(1992-12#1)(1992-9#1)(1996-12#1)(2012-12#2)(2013-1#1)
of stomatopods##2##2##(2007-12#2)
of stone##4##2##(1991-12#1)(2008-10#2)(2012-12#1)
of storage at##7##3##(2008-10#6)(2008-12#1)
of storage in##6##3##(2008-10#3)(2008-5#1)(2009-7#1)(2010-8#1)
of storage##33##2##(1992-3#1)(1994-3#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#2)(2013-1#2)
of stored##6##2##(1992-10#1)(1996-2#1)(2008-10#3)(2008-6#1)
of stories##2##2##(2008-11#1)(2012-2#1)
of storing##2##2##(1996-12#1)(2008-3#1)
of strain 1505##2##3##(2008-10#2)
of strain 50##2##3##(2008-5#2)
of strain 70T01##2##3##(2008-10#2)
of strain A506##4##3##(2008-10#4)
of strain Q8r1-96##2##3##(2008-10#2)
of strain##34##2##(1996-12#1)(2008-10#29)(2008-5#2)(2009-7#1)(2012-3#1)
of strain-specific##4##2##(1996-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
of strains into##3##3##(2008-10#3)
of strains of##3##3##(2008-10#3)
of strains that##2##3##(1992-12#1)(2008-10#1)
of strains were##2##3##(2008-10#2)
of strains with##2##3##(2008-10#2)
of strains##30##2##(1992-12#1)(1993-9#1)(2008-10#20)(2008-5#2)(2008-9#3)(2011-2#1)(2012-3#2)
of strains)##2##2##(2008-10#2)
of strangles##2##2##(2013-8#2)
of strategic##3##2##(1991-8#1)(1997-1#1)(1997-3#1)
of strategies for##6##3##(1994-3#1)(2008-7#1)(2011-2#1)(2013-1#3)
of strategies that##2##3##(2010-11#1)(2013-8#1)
of strategies to##4##3##(1996-9#1)(2008-11#3)
of strategies##18##2##(1994-3#1)(1996-9#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
of stratospheric##4##2##(1991-5#1)(2008-3#3)
of stratum corneum##10##3##(2008-5#10)
of strawberry and##2##3##(2008-10#2)
of strawberry leaf blight##2##4##(2008-10#2)
of strawberry leaflets##2##3##(2008-10#2)
of strawberry leaves##3##3##(2008-10#3)
of strawberry plants##2##3##(2008-10#2)
of strawberry production##2##3##(2008-10#2)
of strawberry##23##2##(2008-10#23)
of streams##2##2##(2008-10#1)(2009-8#1)
of street##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
of streptavidin##2##2##(2008-10#1)(2008-9#1)
of streptokinase from##2##3##(2012-2#2)
of streptokinase##10##2##(1994-12#1)(1994-6#1)(2012-2#8)
of streptomycin sulfate##4##3##(2008-10#4)
of streptozotocin##3##2##(2008-10#2)(2011-3#1)
of stress and##2##3##(2008-10#1)(2010-7#1)
of stress in##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
of stress on distress##2##4##(2012-3#2)
of stress on##6##3##(1997-4#1)(2008-6#1)(2012-3#4)
of stress proteins##2##3##(1992-5#1)(2008-11#1)
of stress response##2##3##(2011-2#1)(2012-2#1)
of stress##44##2##(1991-12#2)(1992-3#1)(1992-5#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#3)(2009-8#2)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#6)(2013-1#1)(2013-7#1)
of stressor effects##2##3##(2008-11#2)
of striatal dopamine##3##3##(1995-2#2)(2008-7#1)
of striatal##9##2##(1990-7#2)(1991-6#1)(1995-2#2)(1996-2#1)(1997-2#1)(2008-5#1)(2008-7#1)
of striga##3##2##(2008-10#3)
of strip##2##2##(2008-10#2)
of stripping potentiometry##2##3##(2008-10#2)
of stripping##5##2##(2008-10#5)
of stroke and##2##3##(2008-8#1)(2010-10#1)
of stroke in##2##3##(2008-8#1)(2009-7#1)
of stroke or##2##3##(2007-7#1)(2011-2#1)
of stroke symptoms##2##3##(2010-10#2)
of stroke##25##2##(1996-11#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-8#9)(2008-9#2)(2009-11#1)(2009-7#1)(2010-10#3)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of stromal cells##2##3##(1995-12#1)(2010-3#1)
of stromal##3##2##(1995-12#1)(2008-11#1)(2010-3#1)
of strong##17##2##(1992-1#1)(1995-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-12#1)(2012-2#1)
of strongly reducing species of V##2##6##(2008-10#2)
of strongly##6##2##(2008-10#4)(2008-3#1)(2011-1#1)
of strontium ion##3##3##(2008-10#3)
of strontium or lanthanum##3##4##(2008-10#3)
of strontium##10##2##(2008-10#10)
of structural and##4##3##(1991-6#1)(2008-10#2)(2012-3#1)
of structural features##2##3##(2008-10#2)
of structural genes##2##3##(1990-5#1)(2008-9#1)
of structural information##2##3##(2008-8#1)(2012-2#1)
of structural similarity##2##3##(1990-4#1)(1992-6#1)
of structural##39##2##(1990-4#3)(1990-5#1)(1991-3#1)(1991-6#1)(1992-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-7#1)(2010-11#1)(2010-4#1)(2011-3#3)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
of structurally##5##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
of structure and##2##3##(2007-12#2)
of structure to##2##3##(1996-2#1)(2008-5#1)
of structure##7##2##(1996-2#1)(2007-12#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)
of structure-selective ligand binding##2##4##(2008-4#2)
of structured student tutorial support##2##5##(2008-11#2)
of structured##6##2##(2008-10#1)(2008-11#3)(2009-11#1)(2010-3#1)
of structures and##4##3##(2008-12#2)(2008-4#1)(2011-7#1)
of structures with##2##3##(1994-5#1)(2013-1#1)
of structures##11##2##(1994-5#1)(1997-6#1)(2008-10#2)(2008-12#2)(2008-4#2)(2008-8#1)(2011-7#1)(2013-1#1)
of student nurses##7##3##(2008-11#5)(2010-3#1)(2013-8#1)
of student##17##2##(2008-11#11)(2008-12#3)(2010-3#1)(2010-9#1)(2013-8#1)
of students and##5##3##(1997-5#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
of students had##2##3##(1991-9#1)(2008-11#1)
of students in##2##3##(2008-12#1)(2012-2#1)
of students to##2##3##(2008-11#2)
of students undertaking##2##3##(2008-11#2)
of students who had##2##4##(2008-11#1)(2013-1#1)
of students who##3##3##(2008-11#2)(2013-1#1)
of students with##2##3##(2008-12#1)(2012-2#1)
of students##41##2##(1991-9#1)(1992-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-11#19)(2008-12#7)(2010-9#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
of students' clinical##2##3##(2008-12#2)
of students' competence##2##3##(1993-1#1)(2008-12#1)
of students'##11##2##(1993-1#1)(2008-10#1)(2008-11#2)(2008-12#6)(2012-3#1)
of studies have reported##2##4##(2008-9#1)(2013-8#1)
of studies have shown that##2##5##(2008-11#1)(2012-2#1)
of studies have shown##3##4##(1992-2#1)(2008-11#1)(2012-2#1)
of studies have##8##3##(1992-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
of studies of##4##3##(1990-8#1)(1996-12#1)(2008-3#1)(2011-2#1)
of studies on the##3##4##(2008-10#1)(2008-12#1)(2011-3#1)
of studies on##6##3##(1992-3#1)(2008-10#2)(2008-12#2)(2011-3#1)
of studies that##4##3##(2008-7#1)(2009-10#1)(2010-12#1)(2013-8#1)
of studies which##2##3##(1997-1#1)(2008-11#1)
of studies##50##2##(1990-8#1)(1992-2#1)(1992-3#1)(1993-2#1)(1996-12#1)(1997-1#1)(2008-10#7)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
of study and##2##3##(2008-11#1)(2013-8#1)
of study is in##2##4##(1990-6#1)(2012-2#1)
of study is to##2##4##(2012-3#2)
of study is##4##3##(1990-6#1)(2012-2#1)(2012-3#2)
of study on##2##3##(2008-11#1)(2010-10#1)
of study patients##2##3##(1993-12#1)(2010-12#1)
of study that##2##3##(1997-7#1)(2008-12#1)
of study##41##2##(1990-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#7)(2008-12#4)(2008-9#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#3)
of study-specific##2##2##(1995-12#1)(2008-10#1)
of studying the##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
of studying##6##2##(1993-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#2)
of stunting and##2##3##(2008-10#1)(2010-6#1)
of stunting##4##2##(2008-10#1)(2010-6#2)(2011-1#1)
of stylet##2##2##(2008-10#2)
of styrene and##3##3##(2008-10#2)(2008-11#1)
of styrene##6##2##(2008-10#4)(2008-11#1)(2008-12#1)
of subacute##3##2##(1991-11#1)(1991-9#1)(2010-9#1)
of subcellular##2##2##(1995-6#1)(2009-6#1)
of subclinical atherosclerosis##3##3##(2008-11#3)
of subclinical cryptosporidiosis##2##3##(1996-12#2)
of subclinical##6##2##(1996-12#2)(2008-11#3)(2008-2#1)
of subcortical##2##2##(2008-2#1)(2008-7#1)
of subcutaneous fat##6##3##(1996-3#1)(2012-2#5)
of subcutaneous lipomatous soft-tissue##2##4##(2012-2#2)
of subcutaneous##15##2##(1991-6#3)(1996-3#1)(2009-12#1)(2010-6#1)(2012-2#7)(2012-3#1)(2013-1#1)
of subgraphs##2##2##(2010-10#2)
of subgroup##6##2##(2008-10#4)(2008-12#1)(2008-9#1)
of subgroups##2##2##(1996-2#1)(2008-5#1)
of subject##2##2##(1993-11#1)(2008-10#1)
of subjective and objective##2##4##(1992-9#1)(2008-3#1)
of subjective##5##2##(1992-9#1)(2008-3#1)(2008-9#1)(2013-1#2)
of subjects from##2##3##(2008-12#1)(2011-2#1)
of subjects on the##2##4##(1991-6#1)(2008-7#1)
of subjects on##3##3##(1991-6#1)(2008-7#1)(2011-2#1)
of subjects were##4##3##(2008-11#1)(2008-7#2)(2010-1#1)
of subjects who##2##3##(2008-11#1)(2013-8#1)
of subjects with##9##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2012-2#2)(2013-8#1)
of subjects##43##2##(1990-9#1)(1991-2#1)(1991-6#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-9#3)(1997-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-5#3)(2008-7#4)(2008-9#1)(2009-1#1)(2010-1#2)(2010-12#1)(2011-2#3)(2012-2#4)(2013-8#2)
of submicron##2##2##(2008-10#1)(2008-11#1)
of submucosal hematoma of the esophagus##2##6##(2011-2#2)
of submucosal##4##2##(1990-5#1)(2008-12#1)(2011-2#2)
of subordinate##3##2##(1992-1#2)(2008-8#1)
of subpopulation##2##2##(2008-10#1)(2008-12#1)
of subsequent##13##2##(1993-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#3)(2012-3#1)
of subsets of##2##3##(1997-8#1)(2008-3#1)
of subsets##4##2##(1997-8#1)(2008-3#1)(2008-9#2)
of substance P##5##3##(1994-8#5)
of substance abuse##4##3##(2008-6#1)(2009-5#1)(2010-11#1)(2013-8#1)
of substance##12##2##(1991-1#1)(1994-8#5)(2008-6#2)(2009-5#1)(2009-7#1)(2010-11#1)(2013-8#1)
of substances in a##2##4##(2008-11#1)(2013-8#1)
of substances in##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
of substances##9##2##(2007-12#1)(2008-10#3)(2008-11#3)(2013-8#2)
of substantial##4##2##(1991-1#1)(1991-12#1)(1993-2#1)(2012-2#1)
of substituents##3##2##(1991-5#1)(2009-10#2)
of substituted##5##2##(2008-10#3)(2008-12#1)(2008-4#1)
of substitution of##3##3##(2008-8#1)(2011-2#2)
of substitution##10##2##(1992-3#2)(2008-10#4)(2008-4#1)(2008-8#1)(2011-2#2)
of substrate and##4##3##(1991-3#1)(2008-10#1)(2008-3#1)(2010-3#1)
of substrate dissolution##2##3##(2008-7#2)
of substrate in##2##3##(1995-2#1)(2008-7#1)
of substrate proteins##2##3##(2009-6#1)(2009-7#1)
of substrate##30##2##(1991-3#1)(1992-3#2)(1995-2#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#8)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
of substrates and inhibitors##2##4##(1994-8#2)
of substrates##12##2##(1992-11#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
of subsystems##2##2##(2008-10#1)(2008-11#1)
of subtelomeric DNA##2##3##(1991-7#1)(1997-6#1)
of subtelomeric##3##2##(1991-7#1)(1997-6#2)
of subtilisin##3##2##(1992-11#2)(1992-4#1)
of subtle##2##2##(2008-7#1)(2013-1#1)
of subunit##4##2##(1990-10#1)(1990-2#1)(1991-3#2)
of subunits of##2##3##(1992-6#1)(2011-2#1)
of subunits##5##2##(1991-10#1)(1991-3#1)(1991-7#1)(1992-6#1)(2011-2#1)
of success##10##2##(1991-2#1)(1994-12#1)(1994-2#1)(1996-3#1)(2008-11#2)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
of successes and##2##3##(1994-12#1)(1994-3#1)
of successful service redeployment##2##4##(1993-1#2)
of successful##26##2##(1991-2#1)(1991-4#1)(1993-1#2)(1996-11#1)(1996-3#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#3)(2010-10#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-7#1)
of successfully##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
of successive##7##2##(2008-10#4)(2008-11#1)(2008-9#1)(2013-1#1)
of such a method##2##4##(2008-10#2)
of such a program##2##4##(1992-12#1)(1992-3#1)
of such a system##2##4##(1992-2#1)(2008-2#1)
of such a##42##3##(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-2#1)(2007-12#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#3)
of such activities##2##3##(1991-12#1)(2008-11#1)
of such an assessment##2##4##(2008-11#2)
of such an##13##3##(1990-6#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#1)(2009-12#1)(2010-1#1)
of such background signals##2##4##(2008-3#2)
of such cases##6##3##(2008-11#2)(2008-12#1)(2011-2#1)(2013-1#2)
of such data##5##3##(1991-12#2)(2011-3#1)(2012-2#1)(2013-1#1)
of such disasters##2##3##(1991-2#1)(1993-1#1)
of such elements##2##3##(2008-10#1)(2008-3#1)
of such factors as##2##4##(2008-11#1)(2008-8#1)
of such findings##2##3##(1992-12#1)(1995-11#1)
of such injuries##3##3##(1990-2#1)(1990-9#1)(1993-3#1)
of such interactions##2##3##(2008-10#1)(2010-10#1)
of such lesions is##2##4##(2008-11#1)(2012-3#1)
of such lesions##4##3##(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
of such methods##2##3##(1992-6#1)(2008-11#1)
of such patients with##2##4##(2008-7#1)(2011-2#1)
of such patients##6##3##(1997-8#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)
of such programs##4##3##(1992-1#1)(1995-3#1)(2012-12#2)
of such sensors##2##3##(2008-10#2)
of such studies##5##3##(1994-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
of such system##2##3##(2008-5#1)(2013-8#1)
of such systems##6##3##(1996-1#1)(1997-6#2)(2008-11#1)(2009-8#1)(2013-8#1)
of such techniques##2##3##(2008-10#2)
of such trials##2##3##(1994-9#1)(2013-7#1)
of such##263##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#2)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-9#3)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#49)(2008-11#34)(2008-12#7)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#7)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2011-2#9)(2011-3#2)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#11)
of sucrose in##5##3##(2008-10#4)(2011-2#1)
of sucrose##15##2##(1993-6#2)(1995-3#1)(2008-10#9)(2010-12#1)(2011-2#2)
of sudden cardiac##2##3##(2010-1#1)(2012-3#1)
of sudden death syndrome##3##4##(2008-10#3)
of sudden death##5##3##(2008-10#3)(2008-12#1)(2013-8#1)
of sudden infant death##5##4##(1991-11#2)(1991-9#2)(1996-9#1)
of sudden##19##2##(1991-11#3)(1991-9#2)(1993-8#1)(1996-9#1)(2008-10#6)(2008-12#1)(2008-5#1)(2010-1#1)(2010-11#1)(2012-3#1)(2013-8#1)
of sufficient quality##2##3##(2008-10#1)(2008-3#1)
of sufficient##13##2##(1995-2#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-9#2)(2012-2#1)
of sugar beet##11##3##(2008-10#5)(2008-12#5)(2012-3#1)
of sugar##17##2##(1997-2#1)(2008-10#8)(2008-12#5)(2008-8#1)(2012-2#1)(2012-3#1)
of sugarcane (Saccharum##2##3##(2008-10#2)
of sugarcane##12##2##(2008-10#11)(2011-2#1)
of sugars and##4##3##(2008-10#3)(2008-6#1)
of sugars##9##2##(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-3#1)
of suicidal ideation##2##3##(1992-1#1)(2010-6#1)
of suicidal##8##2##(1992-1#2)(1992-5#1)(2008-6#1)(2010-6#3)(2010-7#1)
of suicide in Abitibi-Temiscamingue##2##4##(1996-1#2)
of suicide in older##2##4##(2009-5#2)
of suicide in##7##3##(1996-1#2)(2009-5#3)(2010-6#1)(2011-2#1)
of suicide##14##2##(1990-8#1)(1996-1#2)(2009-5#5)(2010-6#2)(2010-9#1)(2011-2#2)(2012-3#1)
of suitable##9##2##(1994-2#1)(2008-10#5)(2008-4#1)(2011-3#1)(2013-1#1)
of suitably protected##2##3##(1992-12#1)(2008-4#1)
of suitably##4##2##(1992-12#1)(2008-3#1)(2008-4#1)(2010-6#1)
of sulfaguanidine##3##2##(2008-10#3)
of sulfate and##2##3##(2008-10#2)
of sulfate ion##4##3##(2008-10#4)
of sulfate##12##2##(1992-10#1)(2008-10#8)(2008-3#1)(2009-8#2)
of sulfated glycosaminoglycans##4##3##(1993-12#3)(1995-2#1)
of sulfathiazole in##2##3##(2008-10#2)
of sulfide##22##2##(2008-10#21)(2008-11#1)
of sulfides##2##2##(2008-10#1)(2008-6#1)
of sulfisoxazole was##2##3##(2008-12#2)
of sulfisoxazole##5##2##(2008-12#5)
of sulfite ion##2##3##(2008-10#2)
of sulfite ions##2##3##(2008-10#2)
of sulfite##20##2##(1993-8#2)(2008-10#18)
of sulfonamide##5##2##(2008-10#2)(2009-3#2)(2009-8#1)
of sulfonamides and quinolones on##2##5##(2008-10#2)
of sulfonamides##9##2##(2008-10#9)
of sulfonylurea##3##2##(1992-3#1)(1994-8#1)(2008-10#1)
of sulfonylureas##2##2##(1991-12#1)(1992-3#1)
of sulfosalicylic acid##2##3##(2008-10#2)
of sulfur and##2##3##(2008-10#1)(2008-9#1)
of sulfur dioxide in##3##4##(2008-10#3)
of sulfur dioxide##4##3##(2008-10#4)
of sulfur##19##2##(2008-10#16)(2008-5#1)(2008-9#1)(2011-2#1)
of sulfuric acid##4##3##(2008-10#4)
of sulfuric##5##2##(2008-10#5)
of sulphamethoxazole##2##2##(2008-10#2)
of sulphate##7##2##(2008-10#7)
of sulphated##2##2##(1993-6#1)(1994-8#1)
of sulphide at##2##3##(2008-10#2)
of sulphide##8##2##(2008-10#8)
of sulphur compounds##2##3##(2008-10#2)
of sulphur dioxide##2##3##(2008-10#2)
of sulphur in##5##3##(2008-10#5)
of sulphur##12##2##(2008-10#11)(2008-11#1)
of sulphuric acid##3##3##(2008-10#3)
of summation##3##2##(2008-10#3)
of summer##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
of sun care products##2##4##(2008-5#2)
of sun exposure in##2##4##(2011-2#2)
of sun exposure##3##3##(2011-2#3)
of sun protection factors##3##4##(2008-5#3)
of sun reactive skin##2##4##(1991-6#1)(2008-5#1)
of sun##11##2##(1991-6#1)(2008-3#1)(2008-5#6)(2011-2#3)
of sunflower (Helianthus##2##3##(2008-10#2)
of sunflower##9##2##(2008-10#9)
of sunlight intensity##2##3##(2008-6#1)(2008-8#1)
of sunlight is##2##3##(2008-10#1)(2011-2#1)
of sunlight##13##2##(2008-10#3)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#6)
of sunscreen lotions##2##3##(2008-5#2)
of sunscreen products##2##3##(2008-5#2)
of sunscreen##12##2##(2008-10#1)(2008-5#10)(2008-8#1)
of sunscreening agents##2##3##(2008-5#2)
of sunscreens##9##2##(1991-6#2)(2008-5#7)
of sunset yellow##2##3##(2008-10#2)
of supercritical CO(2)##2##3##(2008-10#2)
of supercritical carbon dioxide##3##4##(2008-10#1)(2010-4#2)
of supercritical fluid extraction##2##4##(2008-10#1)(2012-3#1)
of supercritical fluid##3##3##(2008-10#2)(2012-3#1)
of supercritical##10##2##(2008-10#6)(2010-4#2)(2012-2#1)(2012-3#1)
of superficial mycosis##2##3##(2008-5#2)
of superficial##10##2##(1993-11#1)(2008-5#5)(2008-7#1)(2009-9#1)(2011-3#1)(2012-3#1)
of superheated water##2##3##(2008-10#2)
of superior##5##2##(1997-3#1)(2008-8#2)(2008-9#1)(2013-1#1)
of superior-posterior radiograms##2##3##(2007-8#2)
of supernatant##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
of superoxide (O(2)##2##3##(2008-10#2)
of superoxide anion and hydrogen peroxide##2##6##(1994-8#1)(2008-10#1)
of superoxide anion##7##3##(1993-6#3)(1994-8#1)(1995-6#1)(2008-10#2)
of superoxide dismutase (SOD)##3##4##(2008-10#2)(2011-2#1)
of superoxide dismutase##7##3##(1990-3#2)(2008-10#3)(2011-2#1)(2013-1#1)
of superoxide generation##2##3##(1993-6#1)(1994-11#1)
of superoxide##20##2##(1990-3#2)(1993-6#4)(1994-11#1)(1994-8#1)(1995-6#2)(2008-10#7)(2009-9#1)(2011-2#1)(2013-1#1)
of supplemental vitamin E##2##4##(1992-9#2)
of supplementation of##2##3##(2008-11#1)(2008-7#1)
of supplementation##3##2##(2008-11#2)(2008-7#1)
of supplements##2##2##(2008-11#1)(2013-7#1)
of support for##2##3##(2008-1#1)(2008-11#1)
of support services##2##3##(1993-1#2)
of support to##3##3##(1995-1#1)(1997-2#1)(2009-9#1)
of support##21##2##(1992-3#1)(1993-1#2)(1994-3#2)(1995-1#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-3#1)
of supporting electrolyte##3##3##(2008-10#3)
of supporting##11##2##(1994-5#1)(1996-3#1)(2008-10#5)(2008-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
of supportive care##2##3##(1991-8#1)(2008-7#1)
of supportive##6##2##(1991-8#1)(2008-7#4)(2009-1#1)
of suppressing##4##2##(2008-11#2)(2008-3#1)(2013-1#1)
of suppression of##4##3##(2008-1#1)(2008-3#1)(2008-8#1)(2013-7#1)
of suppression##7##2##(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2013-7#1)
of suppressive##2##2##(2008-10#1)(2008-8#1)
of suppressiveness##3##2##(2008-10#3)
of supracondylar##3##2##(2010-11#1)(2013-1#2)
of suprathreshold##3##2##(2008-9#2)(2011-2#1)
of surface active##2##3##(2008-10#2)
of surface and##4##3##(1990-12#2)(2008-10#1)(2008-9#1)
of surface charge##3##3##(1994-5#1)(1997-2#1)(2013-1#1)
of surface plasmon resonance (SPR)##2##5##(2008-10#1)(2008-9#1)
of surface plasmon resonance##3##4##(1992-11#1)(2008-10#1)(2008-9#1)
of surface water##6##3##(2008-10#2)(2008-11#1)(2008-8#3)
of surface##51##2##(1990-12#2)(1990-5#1)(1992-11#1)(1993-12#1)(1994-5#3)(1997-2#2)(2007-12#1)(2008-10#21)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-7#1)(2010-6#1)(2012-2#2)(2013-1#2)
of surface-enhanced Raman##2##3##(2008-10#2)
of surface-patterned nanostructures##2##3##(2008-10#2)
of surface-plasmon polaritons##2##3##(2008-3#2)
of surface-plasmon##3##2##(2008-3#3)
of surfaces is##2##3##(2008-10#1)(2008-3#1)
of surfaces##9##2##(2008-10#3)(2008-3#5)(2008-4#1)
of surfactant concentration##2##3##(2008-10#2)
of surfactant micelles##2##3##(2008-10#2)
of surfactant##21##2##(1990-11#1)(1994-5#4)(2008-10#13)(2008-5#1)(2010-11#1)(2011-2#1)
of surfactants in##2##3##(2008-10#2)
of surfactants##16##2##(2008-10#11)(2008-5#4)(2008-7#1)
of surgeonfish##3##2##(2008-5#3)
of surgery and##6##3##(1993-1#1)(1993-6#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
of surgery for##5##3##(1990-9#1)(1991-3#1)(1994-12#1)(2010-7#1)(2012-3#1)
of surgery is##2##3##(2011-2#2)
of surgery were##2##3##(1993-12#1)(2011-2#1)
of surgery##47##2##(1990-2#1)(1990-9#2)(1991-1#2)(1991-3#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-1#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-5#2)(2010-12#1)(2010-6#1)(2010-7#2)(2011-2#5)(2012-2#2)(2012-3#9)(2013-1#3)
of surgical and##3##3##(1990-12#1)(2008-9#1)(2013-1#1)
of surgical approach##3##3##(2011-2#1)(2011-3#1)(2013-1#1)
of surgical approaches##2##3##(1991-3#1)(2008-7#1)
of surgical complications##2##3##(1993-3#1)(2008-9#1)
of surgical intervention##4##3##(2008-7#1)(2009-12#1)(2012-12#1)(2013-1#1)
of surgical resection##5##3##(1990-9#1)(2008-2#1)(2008-7#2)(2013-8#1)
of surgical site infection##2##4##(2010-12#1)(2012-3#1)
of surgical site infections##2##4##(2009-3#1)(2012-3#1)
of surgical site##6##3##(2009-3#1)(2010-12#1)(2012-3#3)(2013-1#1)
of surgical techniques##2##3##(1994-5#1)(2009-10#1)
of surgical therapy##2##3##(1990-5#1)(2011-3#1)
of surgical treatment of##2##4##(1990-5#1)(2008-8#1)
of surgical treatment##10##3##(1990-5#1)(1990-9#2)(1993-3#1)(1994-12#1)(2008-10#1)(2008-8#2)(2011-2#1)(2013-1#1)
of surgical##62##2##(1990-12#1)(1990-5#3)(1990-9#3)(1991-3#1)(1992-5#1)(1993-3#2)(1994-12#2)(1994-5#1)(1995-3#2)(1996-10#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#4)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#1)
of surgically treated##2##3##(2008-7#1)(2011-2#1)
of surgically##6##2##(1996-1#1)(1997-8#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
of surprise and##2##3##(1990-11#2)
of surrogates##2##2##(1995-5#1)(2008-10#1)
of surrounding##5##2##(2008-10#2)(2008-5#1)(2009-6#1)(2011-2#1)
of surveillance and##4##3##(1997-2#1)(2008-7#1)(2009-12#1)(2009-8#1)
of surveillance##9##2##(1993-2#1)(1997-2#1)(1997-3#2)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
of survey##2##2##(1997-3#1)(2009-4#1)
of surveys##2##2##(1991-3#1)(1993-1#1)
of survival and##2##3##(1994-6#1)(1996-3#1)
of survival curves##2##3##(1995-1#1)(1995-3#1)
of survival was##2##3##(1991-6#1)(2008-7#1)
of survival##29##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-4#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-8#1)
of survivin##5##2##(2010-1#1)(2011-2#4)
of surviving##8##2##(2008-10#3)(2008-8#1)(2008-9#2)(2010-4#1)(2012-3#1)
of survivors of##3##3##(2008-11#3)
of survivors##7##2##(1990-11#1)(2008-11#3)(2008-5#2)(2011-3#1)
of susceptibility##11##2##(2007-12#1)(2008-10#6)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
of susceptible and resistant cultivars##2##5##(2008-10#2)
of susceptible and resistant##5##4##(2008-10#5)
of susceptible and##7##3##(2008-10#7)
of susceptible crops##4##3##(2008-10#4)
of susceptible cultivars##2##3##(2008-10#2)
of susceptible host tissue##2##4##(2008-10#2)
of susceptible host##3##3##(2008-10#3)
of susceptible plants##2##3##(2008-10#2)
of susceptible potato##2##3##(2008-10#2)
of susceptible##36##2##(1994-3#1)(1996-12#1)(1997-1#1)(2008-10#31)(2011-2#2)
of suspected breast cancer local recurrences##2##6##(1990-6#2)
of suspected##9##2##(1990-12#1)(1990-6#3)(1992-3#1)(2008-10#2)(2009-3#1)(2011-1#1)
of suspended solids##2##3##(2008-10#1)(2010-5#1)
of suspended##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)
of suspension cells##3##3##(2008-11#3)
of suspension##8##2##(2008-10#1)(2008-11#5)(2008-7#1)(2008-8#1)
of suspicion is required to##2##5##(1995-10#1)(2010-1#1)
of suspicion##10##2##(1992-5#1)(1995-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#3)(2013-8#1)
of suspicious##2##2##(1990-6#1)(2008-10#1)
of sustainability##2##2##(1997-7#2)
of sustained and transient##2##4##(2008-9#2)
of sustained##10##2##(1990-3#1)(1992-8#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-11#1)(2008-9#2)(2010-4#1)(2012-4#1)
of swainsonine##3##2##(2008-11#3)
of swallows and martins##2##4##(2008-8#2)
of swarming in##2##3##(2009-6#2)
of sweat##3##2##(1992-3#1)(2008-10#1)(2008-5#1)
of sweet cherry##2##3##(2008-10#2)
of sweet orange##4##3##(2008-10#4)
of sweet potato feathery mottle potyvirus##2##6##(2008-10#2)
of sweet##11##2##(2008-10#10)(2008-2#1)
of swimmers##2##2##(1996-8#1)(2009-1#1)
of swimming##2##2##(1990-11#1)(2013-8#1)
of symbiotic##2##2##(2007-12#1)(2008-11#1)
of symmetric##2##2##(1993-8#1)(2008-8#1)
of symmetrical##2##2##(2008-10#1)(2008-9#1)
of symmetry##4##2##(1996-5#1)(2008-3#1)(2008-6#1)(2008-7#1)
of sympathetic##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
of sympathy##3##2##(2012-2#3)
of sympatry##2##2##(2008-10#2)
of symptom development##2##3##(2008-10#2)
of symptom severity##3##3##(2008-10#3)
of symptom##12##2##(2008-10#9)(2008-7#1)(2008-9#1)(2009-9#1)
of symptomatic plants##2##3##(2008-10#2)
of symptomatic trees##3##3##(2008-10#3)
of symptomatic##19##2##(1993-12#1)(1996-3#1)(2008-10#8)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-3#2)(2013-1#1)
of symptomatology##4##2##(1990-9#1)(1994-6#1)(1996-9#2)
of symptomless##3##2##(2008-10#3)
of symptoms and the##3##4##(2011-2#1)(2012-12#1)(2013-1#1)
of symptoms and##12##3##(1991-6#1)(1992-5#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-12#4)(2013-1#1)
of symptoms by##2##3##(2008-5#1)(2008-7#1)
of symptoms in##7##3##(1990-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-12#1)
of symptoms induced##2##3##(2008-10#2)
of symptoms of##2##3##(2008-10#1)(2008-7#1)
of symptoms on##3##3##(2008-10#3)
of symptoms was##7##3##(1997-8#1)(2008-10#1)(2008-7#3)(2012-12#1)(2013-1#1)
of symptoms##81##2##(1990-12#1)(1990-2#1)(1990-6#4)(1991-12#1)(1991-6#2)(1991-8#2)(1992-5#1)(1993-11#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#11)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-4#1)(2011-10#1)(2011-2#6)(2012-12#7)(2013-1#6)(2013-8#1)
of synaptic activity##2##3##(1996-12#1)(2013-8#1)
of synaptic connections##2##3##(1997-2#1)(2008-11#1)
of synaptic homeostasis##4##3##(2009-9#4)
of synaptic plasticity##6##3##(1993-12#1)(2008-4#3)(2009-9#1)(2012-2#1)
of synaptic strength##2##3##(1995-2#1)(2008-11#1)
of synaptic transmission in the##2##5##(1993-12#1)(2008-5#1)
of synaptic transmission in##3##4##(1993-12#1)(1995-2#1)(2008-5#1)
of synaptic transmission##7##3##(1993-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(2008-5#2)(2009-9#1)
of synaptic vesicles##3##3##(1993-12#1)(1997-7#2)
of synaptic##34##2##(1990-9#1)(1993-12#3)(1994-8#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#4)(2008-11#3)(2008-4#3)(2008-5#2)(2009-9#7)(2012-2#1)(2013-8#2)
of synchronized##2##2##(1994-5#1)(2013-1#1)
of synchronous fluorescence spectroscopy##2##4##(2008-10#2)
of synchronous luminescence##2##3##(2008-10#2)
of synchronous##11##2##(1991-6#1)(1993-8#1)(1996-2#1)(1997-2#1)(2008-10#6)(2009-1#1)
of synchrony##3##2##(2008-11#3)
of synchrotron radiation##2##3##(2008-10#2)
of syngeneic##2##2##(1990-12#1)(2013-1#1)
of synovial membrane##2##3##(2013-1#2)
of synovial##7##2##(1992-3#2)(2010-10#1)(2013-1#4)
of synthesis of##2##3##(2008-5#1)(2009-8#1)
of synthesis##6##2##(1990-12#1)(1993-9#1)(1994-8#1)(2008-10#1)(2008-5#1)(2009-8#1)
of synthetic and##3##3##(2008-10#3)
of synthetic mixtures of##2##4##(2008-10#2)
of synthetic mixtures##4##3##(2008-10#4)
of synthetic peptides##7##3##(1992-6#1)(2008-10#1)(2008-4#5)
of synthetic playing surfaces##2##4##(2013-1#2)
of synthetic##56##2##(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#24)(2008-11#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
of syphilis##5##2##(1995-2#1)(1997-5#1)(2008-10#1)(2011-2#2)
of syringaldazine##2##2##(2008-10#2)
of system is##2##3##(2007-11#1)(2013-8#1)
of system##8##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)(2013-8#2)
of systematic##9##2##(1991-12#1)(1994-6#1)(2008-10#2)(2008-11#2)(2008-3#2)(2011-2#1)
of systemic acquired resistance##3##4##(2008-10#3)
of systemic acquired##4##3##(2008-10#4)
of systemic autoimmune diseases##2##4##(2008-10#1)(2012-3#1)
of systemic autoimmune##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
of systemic disease##3##3##(2008-10#2)(2009-8#1)
of systemic infection##2##3##(2008-10#1)(2008-11#1)
of systemic infections##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
of systemic lupus erythematosus (SLE)##2##5##(2008-1#1)(2011-2#1)
of systemic lupus erythematosus##5##4##(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of systemic resistance##9##3##(2008-10#9)
of systemic##60##2##(1991-2#1)(1992-9#1)(1993-11#1)(1994-2#2)(1994-9#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#4)
of systems##9##2##(1996-12#1)(2008-10#1)(2008-7#2)(2009-10#2)(2010-12#1)(2012-3#2)
of systolic##3##2##(2008-10#1)(2010-11#1)(2011-1#1)
of t-PA##3##2##(2008-11#3)
of t-PA/PAI-1 complexes by monocytes##2##5##(1995-8#2)
of t-PA/PAI-1 complexes##3##3##(1995-8#3)
of tNOX##2##2##(2009-9#2)
of tPA in the##2##4##(2008-8#1)(2010-3#1)
of tPA##5##2##(2008-11#2)(2008-8#2)(2010-3#1)
of tRNA genes and##2##4##(2008-9#2)
of tRNA genes##3##3##(1995-8#1)(2008-9#2)
of tRNA##4##2##(1995-8#1)(2008-8#1)(2008-9#2)
of tRNA(Gly)1##2##2##(1997-7#2)
of tRNA(fMet)##2##2##(1995-6#2)
of tachykinin NK1 and NK2 receptor antagonists##2##7##(1997-4#2)
of tachykinin receptors##2##3##(2008-8#2)
of tachykinin##4##2##(1997-4#2)(2008-8#2)
of tacrine##2##2##(2011-3#1)(2012-3#1)
of tactile##3##2##(2008-5#1)(2009-8#2)
of tagged##2##2##(2010-8#2)
of tagitinin C in##2##4##(2008-10#2)
of tagitinin C##3##3##(2008-10#3)
of tai chi##2##3##(2008-10#2)
of tail markings##3##3##(2008-9#3)
of tail##6##2##(1993-3#1)(2008-6#1)(2008-9#4)
of tailoring##3##2##(1993-12#1)(2008-10#1)(2013-8#1)
of take-all epidemics on winter wheat yield formation##2##8##(2008-10#2)
of take-all epidemics##3##3##(2008-10#3)
of take-all on##2##3##(2008-10#2)
of take-all##9##2##(2008-10#9)
of taking##6##2##(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
of tall fescue##2##3##(2008-10#2)
of tamoxifen##3##2##(1997-7#1)(2008-10#2)
of tan spot and##3##4##(2008-10#3)
of tan spot of wheat##3##5##(2008-10#3)
of tan spot##12##3##(2008-10#12)
of tandem##5##2##(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
of tangential##2##2##(2008-11#1)(2008-7#1)
of tankships on the marine environment##2##6##(2008-11#2)
of tannic acid##4##3##(2008-10#4)
of tanshinones##3##2##(2008-10#3)
of tantalum##2##2##(2008-10#2)
of tap and mineral##2##4##(2008-10#2)
of tap water##2##3##(2008-10#2)
of tap##4##2##(2008-10#4)
of tape##2##2##(1991-12#1)(2008-10#1)
of tapwater##2##2##(2008-10#2)
of tarabine PFS and adriblastina##3##5##(2008-10#3)
of target DNA##4##3##(2008-10#3)(2013-1#1)
of target analytes##2##3##(2008-10#2)
of target and##2##3##(1990-12#1)(2008-10#1)
of target attainment##2##3##(2011-2#2)
of target cells##6##3##(1990-5#1)(2008-10#1)(2008-11#2)(2010-8#1)(2012-2#1)
of target mRNA##4##3##(1996-12#1)(2008-4#3)
of target mRNAs##2##3##(2011-2#1)(2013-1#1)
of target receptor##2##3##(2008-8#2)
of target##41##2##(1990-12#1)(1990-5#1)(1996-12#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-4#4)(2008-8#2)(2008-9#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#4)
of targeted##13##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#2)(2011-3#3)(2012-2#1)
of targeting##4##2##(1995-12#1)(2008-11#1)(2009-3#1)(2010-9#1)
of targets and##2##3##(2008-11#1)(2013-1#1)
of targets in##3##3##(2008-10#1)(2009-8#1)(2010-12#1)
of targets##9##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
of tartaric acid released##3##4##(2008-5#3)
of tartaric acid##9##3##(2008-10#3)(2008-5#6)
of tartaric##11##2##(2008-10#5)(2008-5#6)
of tartrazine##2##2##(2008-10#2)
of task##4##2##(1991-1#1)(2008-11#2)(2011-2#1)
of tasks##2##2##(1996-2#1)(2008-11#1)
of taste##5##2##(1991-3#1)(2008-10#1)(2008-5#1)(2008-7#2)
of tau protein##3##3##(1995-12#1)(2011-2#2)
of tau with##3##3##(1993-6#2)(1995-12#1)
of tau##11##2##(1992-3#1)(1993-6#2)(1995-12#4)(2008-3#1)(2011-2#3)
of taurine in##4##3##(1992-9#1)(2008-10#3)
of taurine##9##2##(1992-9#1)(2008-10#7)(2008-5#1)
of taxa##2##2##(2008-8#1)(2010-3#1)
of taxane therapy##2##3##(2008-9#2)
of taxonomic##2##2##(2008-8#1)(2008-9#1)
of te##2##2##(2008-11#2)
of tea##4##2##(2008-10#2)(2008-11#1)(2012-12#1)
of teacher##3##2##(2008-12#2)(2009-7#1)
of teachers##4##2##(2008-10#2)(2008-12#1)(2011-2#1)
of teaching and assessing##2##4##(2008-11#2)
of teaching and learning##2##4##(1996-1#1)(2008-12#1)
of teaching and##5##3##(1996-1#1)(2008-11#2)(2008-12#1)(2013-1#1)
of teaching##14##2##(1992-12#2)(1992-2#1)(1993-12#1)(1994-12#1)(1996-1#1)(2008-11#2)(2008-12#3)(2013-1#2)(2013-8#1)
of team##2##2##(1993-12#1)(1994-12#1)
of teamwork##2##2##(1996-1#1)(2013-1#1)
of tear##2##2##(2011-7#1)(2013-8#1)
of teas##2##2##(2008-11#2)
of tebuconazole##4##2##(2008-10#4)
of technical grade##2##3##(2008-10#2)
of technical oils in supercritical##2##5##(2008-10#2)
of technical##16##2##(1991-1#1)(1991-12#1)(1992-1#3)(1996-1#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-5#1)
of technique##2##2##(2009-3#1)(2011-2#1)
of techniques for##3##3##(2008-10#2)(2008-11#1)
of techniques such as##2##4##(2010-7#1)(2012-2#1)
of techniques that##3##3##(1994-1#1)(2008-9#1)(2009-12#1)
of techniques##20##2##(1991-3#1)(1994-1#1)(1995-5#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-2#1)
of technological##3##2##(2010-12#1)(2013-8#2)
of technologies##5##2##(1995-5#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-3#1)
of technology##13##2##(1992-1#1)(1992-12#1)(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-12#3)
of teeth##4##2##(1991-2#1)(1991-6#1)(2008-5#1)(2013-1#1)
of teicoplanin##4##2##(2008-10#4)
of telemedicine##6##2##(1996-3#4)(2008-11#1)(2013-1#1)
of teleost##2##2##(1995-12#1)(1997-9#1)
of teleosts##2##2##(1995-2#1)(2010-5#1)
of teliospore germination##2##3##(2008-10#2)
of teliospores##4##2##(2008-10#4)
of tellurium in##4##3##(2008-10#4)
of tellurium(IV)##3##2##(2008-10#3)
of telomerase activity and telomere##2##5##(2008-11#2)
of telomerase activity##3##3##(2008-11#3)
of telomerase and##2##3##(2008-11#2)
of telomerase##8##2##(2008-11#6)(2008-9#2)
of telomere biology##2##3##(2008-11#1)(2012-3#1)
of telomere##5##2##(2008-11#2)(2012-3#2)(2013-1#1)
of telomeres and##4##3##(2008-11#2)(2011-2#1)(2012-3#1)
of telomeres##8##2##(2008-11#5)(2011-2#2)(2012-3#1)
of telomeric DNA##4##3##(1990-5#4)
of temperate##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
of temperature (5 to##2##4##(2008-10#2)
of temperature and duration of##3##5##(2008-10#3)
of temperature and leaf wetness duration on##2##7##(2008-10#2)
of temperature and moisture##2##4##(2008-10#2)
of temperature and pH##2##4##(2008-10#1)(2008-5#1)
of temperature and##23##3##(1996-12#1)(2008-10#14)(2008-3#4)(2008-5#1)(2008-9#1)(2009-5#1)(2012-4#1)
of temperature on the##7##4##(1991-11#1)(1991-5#1)(2008-10#4)(2011-2#1)
of temperature on##17##3##(1991-11#1)(1991-5#1)(2008-10#12)(2008-11#1)(2009-8#1)(2011-2#1)
of temperature sensitive##2##3##(2008-10#1)(2011-2#1)
of temperature was##2##3##(2008-10#1)(2010-4#1)
of temperature##82##2##(1991-11#1)(1991-5#1)(1996-12#1)(1996-2#1)(2008-10#50)(2008-11#6)(2008-3#7)(2008-5#2)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-4#2)(2011-2#2)(2012-4#1)(2013-8#2)
of temperatures and##2##3##(2008-10#2)
of temperatures of##2##3##(2008-10#1)(2008-8#1)
of temperatures##15##2##(2008-10#8)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2012-8#1)
of template##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)
of temporal bone##5##3##(2008-9#2)(2011-2#3)
of temporal prediction##2##3##(2009-7#1)(2013-8#1)
of temporal##22##2##(1993-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-7#2)(2009-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
of temporary##3##2##(1993-5#1)(2011-2#1)(2013-1#1)
of temporomandibular##3##2##(1995-10#1)(2013-1#2)
of ten lambs##2##3##(1996-12#2)
of ten##20##2##(1991-2#1)(1991-3#1)(1991-5#1)(1993-12#1)(1996-12#3)(1996-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of tendon##2##2##(1997-5#1)(2013-1#1)
of tension##3##2##(1995-3#1)(2008-7#1)(2009-3#1)
of terahertz##3##2##(2008-2#1)(2012-12#2)
of terazosin##3##2##(2008-10#3)
of terbinafine##8##2##(2008-10#4)(2008-5#4)
of terbium(III)##2##2##(2008-10#1)(2008-4#1)
of term##2##2##(2007-11#1)(2008-11#1)
of terminal differentiation##2##3##(1990-5#1)(1991-5#1)
of terminal##10##2##(1990-5#1)(1991-5#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
of terminally differentiated##2##3##(1995-2#1)(2009-10#1)
of terminally##4##2##(1994-12#1)(1995-2#1)(2008-7#1)(2009-10#1)
of terminology and##2##3##(1995-1#1)(2008-4#1)
of terminology##4##2##(1995-1#1)(2008-4#1)(2013-1#2)
of terms and analytic methods##2##5##(1996-2#2)
of terms##5##2##(1995-3#1)(1996-2#3)(2011-2#1)
of ternary and multicomponent complexes##2##5##(2008-10#2)
of ternary mixtures of##3##4##(2008-10#3)
of ternary mixtures##6##3##(2008-10#6)
of ternary##12##2##(2008-10#12)
of terpenes in water##2##4##(2008-10#2)
of terpenes##4##2##(2008-10#4)
of terpenoid##2##2##(1990-11#1)(2008-10#1)
of terrestrial##5##2##(1991-6#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-3#1)
of territory##3##2##(2008-8#3)
of tert-butyl##3##2##(2008-12#2)(2009-8#1)
of tertiary##2##2##(2008-4#2)
of test samples##2##3##(2008-10#1)(2008-2#1)
of test solution##2##3##(2008-10#1)(2012-2#1)
of test solutions##2##3##(2008-10#2)
of test takers##2##3##(2009-12#2)
of test##24##2##(1995-12#1)(1996-8#1)(1997-5#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2012-2#2)(2012-3#1)
of tested compounds##3##3##(2008-10#2)(2008-5#1)
of tested##7##2##(2008-10#4)(2008-5#1)(2009-8#1)(2013-1#1)
of testes##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-7#1)
of testicular torsion##3##3##(2008-10#3)
of testicular tumours##2##3##(2011-2#2)
of testicular##13##2##(2008-10#6)(2008-12#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-3#2)
of testing for##3##3##(2008-4#1)(2009-11#1)(2012-3#1)
of testing is##2##3##(1995-9#1)(2009-12#1)
of testing##16##2##(1993-6#1)(1995-9#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2012-2#1)(2012-3#2)
of testis##3##2##(1994-11#1)(2009-7#1)(2010-11#1)
of testosterone (T)##2##3##(1996-2#1)(2008-3#1)
of testosterone in aqueous##2##4##(2008-10#2)
of testosterone in##5##3##(1995-2#1)(2008-10#2)(2008-5#1)(2012-2#1)
of testosterone##29##2##(1990-11#1)(1990-2#2)(1991-5#1)(1992-12#2)(1993-8#3)(1994-2#1)(1994-6#1)(1995-2#4)(1996-2#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#2)(2012-2#3)
of tests and##2##3##(1990-9#1)(2008-10#1)
of tests to##2##3##(2008-10#1)(2008-11#1)
of tests used for##2##4##(2008-7#1)(2008-9#1)
of tests##20##2##(1990-9#3)(1996-11#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#1)
of tetanus toxin##4##3##(1995-2#1)(2008-10#3)
of tethered##2##2##(2008-11#1)(2008-7#1)
of tetrabromoindate(III)##2##2##(2008-10#2)
of tetrabutylammonium bromide##4##3##(2008-10#4)
of tetrabutylammonium##7##2##(2008-10#7)
of tetracarboxylate-18-crown-6##2##2##(2008-10#2)
of tetracycline antibiotics##3##3##(2008-10#3)
of tetracycline##11##2##(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#1)
of tetracyclines in##2##3##(2008-10#2)
of tetracyclines##5##2##(2008-10#5)
of tetrahydrofuran##3##2##(2008-10#3)
of tetramerization##2##2##(1993-8#2)
of tetramethylpyrazine##4##2##(1991-6#4)
of tetraphenylporphyrin##2##2##(2008-10#2)
of texture at##2##3##(2013-8#2)
of texture##5##2##(2008-10#1)(2008-5#2)(2013-8#2)
of thalassemia##2##2##(2008-10#2)
of thallium in##5##3##(1991-12#1)(1994-5#2)(2008-10#2)
of thallium##14##2##(1991-12#3)(1994-5#3)(2008-10#8)
of thallium(I)##4##2##(2008-10#4)
of that approach##2##3##(1997-2#1)(2008-10#1)
of that care##2##3##(1991-3#1)(1994-2#1)
of that for##2##3##(1990-9#1)(2008-6#1)
of that in the control##2##5##(1994-12#1)(2008-9#1)
of that in##5##3##(1994-12#1)(2008-11#1)(2008-9#2)(2012-3#1)
of that observed in##3##4##(1996-12#1)(2008-10#1)(2008-8#1)
of that observed##4##3##(1996-12#1)(1997-9#1)(2008-10#1)(2008-8#1)
of that obtained##3##3##(2008-10#2)(2008-11#1)
of that of insulin##2##4##(2008-9#2)
of that of##12##3##(1990-11#1)(1993-8#1)(1997-2#1)(2008-10#3)(2008-8#2)(2008-9#3)(2010-11#1)
of that period##2##3##(2008-12#2)
of that process##2##3##(2007-12#1)(2008-3#1)
of that value##3##3##(2008-10#3)
of that##91##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-9#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-2#2)(1997-9#1)(2007-12#1)(2008-10#17)(2008-11#5)(2008-12#5)(2008-3#2)(2008-5#4)(2008-6#2)(2008-8#5)(2008-9#7)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#5)(2012-3#3)(2013-7#1)
of thaxtomin##2##2##(2008-10#2)
of the &quot##32##3##(1990-12#1)(1990-5#2)(1991-12#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-5#2)(1996-9#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2013-1#3)(2013-8#1)
of the 'natural##2##3##(1994-12#1)(2010-2#1)
of the 0##4##3##(2008-10#3)(2008-11#1)
of the 1##19##3##(1993-1#1)(1994-11#1)(1996-5#3)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2012-2#1)(2013-1#1)
of the 10##11##3##(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2011-2#1)
of the 100##2##3##(1994-11#1)(2008-9#1)
of the 11 patients##3##4##(1996-9#1)(1997-7#1)(2008-10#1)
of the 11##13##3##(1995-8#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#2)(2010-4#1)(2012-12#1)
of the 12 patients##2##4##(1997-7#1)(1997-8#1)
of the 12##10##3##(1997-7#1)(1997-8#2)(2008-10#4)(2008-5#1)(2008-9#1)(2009-10#1)
of the 13##4##3##(1991-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
of the 14##6##3##(1991-2#1)(1991-6#1)(1996-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
of the 15##8##3##(1992-1#1)(1993-3#1)(1995-3#1)(2008-10#2)(2008-9#1)(2010-8#1)(2012-3#1)
of the 16 participating##2##4##(2008-11#1)(2013-1#1)
of the 16##8##3##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2012-2#1)(2013-1#1)
of the 16S rDNA gene##2##5##(2008-12#2)
of the 16S rRNA##3##4##(2008-10#2)(2009-6#1)
of the 16S##6##3##(2008-10#3)(2008-12#2)(2009-6#1)
of the 16S-23S rDNA##2##4##(2008-10#2)
of the 16th century]##2##4##(2008-11#2)
of the 17 compounds##2##4##(2008-10#1)(2008-11#1)
of the 17##8##3##(1990-2#1)(2008-1#1)(2008-10#5)(2008-11#1)
of the 175R protein##2##4##(1993-2#2)
of the 18##7##3##(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#2)(2009-8#1)
of the 18th##4##3##(1993-11#2)(2008-1#1)(2011-2#1)
of the 19##3##3##(2008-10#2)(2010-11#1)
of the 1980s##3##3##(1991-3#1)(1993-3#1)(2011-2#1)
of the 1990s##5##3##(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1997-6#1)
of the 1993##2##3##(1994-1#1)(1994-3#1)
of the 1997##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
of the 19th century##3##4##(1991-6#1)(1994-5#1)(2008-12#1)
of the 2##12##3##(1990-12#1)(1993-9#1)(1994-5#1)(1997-3#1)(2008-10#5)(2009-2#1)(2009-8#1)(2012-12#1)
of the 20##5##3##(2008-10#3)(2011-2#2)
of the 2002##2##3##(2008-10#1)(2011-2#1)
of the 2004##2##3##(2008-10#1)(2011-2#1)
of the 20S proteasome##3##4##(2008-4#2)(2008-5#1)
of the 20S##4##3##(2008-4#2)(2008-5#2)
of the 20th century##7##4##(1994-12#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-10#1)(2011-7#1)
of the 20th##8##3##(1994-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-10#1)(2011-7#1)
of the 21##4##3##(1991-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
of the 21st century##4##4##(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
of the 22##3##3##(1997-8#1)(2008-3#1)(2008-7#1)
of the 22q11##3##3##(1997-3#2)(2012-12#1)
of the 23##3##3##(1994-12#1)(2008-8#1)(2013-8#1)
of the 24##6##3##(1993-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-3#1)
of the 24-hydroxylase##2##3##(1994-11#2)
of the 24-kDa oleosin##2##4##(2009-10#2)
of the 25##8##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)(2009-5#1)
of the 26##2##3##(1996-11#1)(2011-2#1)
of the 287 were related to##2##6##(2013-1#2)
of the 28S##2##3##(2008-10#1)(2010-4#1)
of the 29##2##3##(1991-12#1)(2008-10#1)
of the 296##2##3##(2008-10#2)
of the 3##11##3##(1990-11#2)(1996-2#1)(1997-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the 3'##11##3##(1993-12#1)(1993-3#1)(1993-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#4)
of the 3'-terminal##2##3##(2008-10#2)
of the 3-D##2##3##(2008-8#1)(2011-2#1)
of the 30##6##3##(1995-6#1)(2007-11#1)(2008-10#2)(2012-2#2)
of the 32##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
of the 32-##2##3##(1995-6#1)(2008-10#1)
of the 33##3##3##(1997-5#1)(2008-9#1)(2011-2#1)
of the 34##7##3##(1993-3#1)(1996-3#1)(2008-7#1)(2009-7#4)
of the 36##2##3##(1990-2#1)(1997-5#1)
of the 37 degrees C-grown##2##5##(2008-5#2)
of the 37##4##3##(1993-3#1)(2008-5#2)(2010-8#1)
of the 38##3##3##(1996-3#1)(2008-12#1)(2011-2#1)
of the 3D##2##3##(2008-3#1)(2012-2#1)
of the 3rd##2##3##(1994-2#1)(1995-11#1)
of the 4##7##3##(1990-12#1)(1991-2#1)(1992-3#1)(1993-3#1)(2008-10#1)(2010-5#1)(2011-1#1)
of the 43##2##3##(1996-3#1)(2009-7#1)
of the 45##6##3##(1993-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)
of the 46##3##3##(1991-3#1)(1991-6#1)(1997-3#1)
of the 5##9##3##(1991-8#1)(1996-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
of the 5' region of the##2##6##(1995-2#1)(2008-8#1)
of the 5'##7##3##(1993-2#1)(1993-3#1)(1995-2#1)(2008-10#3)(2008-8#1)
of the 5'-flanking region##3##4##(1994-11#1)(1997-8#1)(2010-5#1)
of the 5'-flanking##4##3##(1994-11#1)(1995-6#1)(1997-8#1)(2010-5#1)
of the 5-HT1A receptor##2##4##(1993-3#1)(1994-2#1)
of the 5-HT2C receptor##2##4##(1996-12#2)
of the 5-amino##2##3##(1993-1#2)
of the 50%##3##3##(2009-8#1)(2012-2#2)
of the 54##2##3##(2008-10#2)
of the 56##2##3##(1990-3#1)(2010-9#1)
of the 57##2##3##(1990-8#1)(2008-10#1)
of the 58K##2##3##(1997-3#1)(2008-8#1)
of the 5th##2##3##(2011-2#1)(2013-1#1)
of the 6##2##3##(2008-10#1)(2008-12#1)
of the 67 K protein##3##5##(1995-12#3)
of the 69##2##3##(1990-8#1)(2008-10#1)
of the 6th##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
of the 7##7##3##(1990-3#1)(1991-3#1)(2008-10#1)(2008-5#1)(2012-12#2)(2013-1#1)
of the 793/B serotype##3##4##(2008-5#3)
of the 8th##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
of the 90##2##3##(2008-10#2)
of the 9th##2##3##(1991-9#1)(2008-8#1)
of the A##8##3##(1995-2#1)(1997-8#1)(2008-10#5)(2012-3#1)
of the A(549)/DDP cells##2##4##(2008-9#2)
of the A(section)E((R))##2##3##(2008-9#2)
of the A2 segment##3##4##(1996-3#3)
of the A2##6##3##(1996-3#3)(2008-10#2)(2008-12#1)
of the A6 mAb##2##4##(1994-5#2)
of the AAC##2##3##(2008-10#2)
of the ABL##3##3##(2008-2#3)
of the ACL##2##3##(2013-1#2)
of the ACS##2##3##(2008-5#2)
of the ADA##2##3##(1995-6#1)(1996-1#1)
of the ADR##2##3##(2008-10#1)(2011-2#1)
of the AF4Q initiative##2##4##(2013-1#2)
of the AFC##4##3##(2011-2#4)
of the AFLP markers##2##4##(2008-10#2)
of the AFLP##5##3##(2008-10#5)
of the AIDS epidemic##7##4##(1990-12#2)(1990-3#1)(1994-9#1)(1995-1#1)(1996-5#1)(2008-5#1)
of the AIDS##9##3##(1990-12#2)(1990-3#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-1#1)(1996-5#1)(2008-5#1)
of the AML##2##3##(2008-10#2)
of the ASA##2##3##(1997-6#2)
of the AT1 receptor##2##4##(1994-8#2)
of the ATP##2##3##(1993-8#2)
of the AVM by##2##4##(2008-7#2)
of the AVM##5##3##(2008-7#5)
of the Ac##2##3##(2012-3#2)
of the Acceptability E-scale##2##4##(2010-10#2)
of the Achatina##2##3##(1991-5#2)
of the Achilles##2##3##(2009-10#1)(2011-2#1)
of the Adh gene##2##4##(1997-8#2)
of the Age of Enlightenment##3##5##(2008-12#3)
of the Ah##2##3##(1992-12#1)(1993-12#1)
of the Al##2##3##(2008-10#2)
of the Alu##2##3##(1991-5#1)(1997-2#1)
of the Alzheimer amyloid##2##4##(1993-8#1)(1994-11#1)
of the Alzheimer##5##3##(1992-12#1)(1993-8#1)(1994-11#1)(1996-11#1)(2008-7#1)
of the Amazon##2##3##(2010-7#2)
of the American College of Physicians##2##6##(1993-12#2)
of the American Heart Association##3##5##(1996-6#1)(2009-5#1)(2012-12#1)
of the American Medical Association##2##5##(1991-8#2)
of the American Society for##2##5##(1997-7#1)(2011-2#1)
of the American Society of##4##5##(2008-7#3)(2008-8#1)
of the American Society##6##4##(1997-7#1)(2008-7#3)(2008-8#1)(2011-2#1)
of the American##25##3##(1991-8#2)(1993-12#2)(1994-12#1)(1995-6#1)(1996-6#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
of the Americans with Disabilities Act##4##6##(1992-12#1)(1993-3#1)(1994-2#1)(1995-6#1)
of the Americans##5##3##(1992-12#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-6#1)
of the Antarctic##3##3##(1991-5#1)(2013-8#2)
of the Anterior##2##3##(2008-12#1)(2013-1#1)
of the Apple##2##3##(2008-10#2)
of the Arabidopsis thaliana##3##4##(1997-6#1)(1997-8#1)(2008-10#1)
of the Arabidopsis##7##3##(1995-2#2)(1997-6#1)(1997-8#1)(2008-10#2)(2012-3#1)
of the ArsA protein##2##4##(1994-5#2)
of the Asian##2##3##(2008-10#1)(2013-1#1)
of the Aspergillus##2##3##(2008-10#2)
of the Association for the Care of Children's Health##2##9##(1992-3#1)(1994-3#1)
of the Association for##3##4##(1992-3#1)(1994-3#2)
of the Association of##3##4##(2009-11#1)(2010-3#1)(2012-12#1)
of the Association##8##3##(1992-3#1)(1994-3#2)(2008-10#1)(2009-11#1)(2010-3#1)(2011-4#1)(2012-12#1)
of the Australian##3##3##(1994-12#1)(2008-5#1)(2012-12#1)
of the Autographa californica##2##4##(1993-12#1)(1997-3#1)
of the B chromosome number##2##5##(2008-12#2)
of the B##14##3##(1990-11#1)(1990-2#1)(1994-11#1)(1994-5#1)(1997-8#1)(2008-10#3)(2008-12#3)(2008-4#1)(2011-2#2)
of the BBA##4##3##(2008-11#4)
of the BBWV-K##2##3##(2008-10#2)
of the BTB##4##3##(2009-10#3)(2012-2#1)
of the Bacillus cereus group##2##5##(2011-2#2)
of the Bacillus subtilis##5##4##(1993-12#1)(1995-12#1)(1996-8#2)(1997-7#1)
of the Bacillus##9##3##(1993-12#1)(1995-12#1)(1996-8#2)(1997-7#1)(2008-10#2)(2011-2#2)
of the Baltic Sea##3##4##(2008-11#2)(2010-8#1)
of the Barley##2##3##(2008-10#2)
of the Basque##2##3##(2008-10#2)
of the Bcl-2 family of##2##5##(2008-11#1)(2009-12#1)
of the Bcl-2 family##5##4##(2008-11#2)(2009-12#1)(2011-2#2)
of the Bcl-2##6##3##(2008-11#3)(2009-12#1)(2011-2#2)
of the Bean##2##3##(2008-10#2)
of the Biocontrol Agent Pseudomonas##2##5##(2008-10#2)
of the Biocontrol##5##3##(2008-10#5)
of the Blue##2##3##(1994-12#1)(1997-6#1)
of the BmNPV##2##3##(1997-3#2)
of the Brassaia strains##2##4##(2008-10#2)
of the Breast##3##3##(1994-12#1)(1997-1#1)(1997-7#1)
of the Bright/ARID##2##3##(2009-7#2)
of the British##2##3##(1992-1#1)(2008-10#1)
of the Brugada syndrome##3##4##(2008-12#3)
of the Button##2##3##(2008-5#2)
of the C##11##3##(1994-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-1#1)
of the C-terminal##9##3##(1993-8#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-7#2)
of the C-terminus##2##3##(1997-3#1)(2011-2#1)
of the C1 screw##2##4##(2012-12#2)
of the C103S mutant of the N-terminal domain of DsbD from Neisseria##2##12##(2009-7#2)
of the CA3##2##3##(1990-5#1)(2008-11#1)
of the CALUX (DX##2##4##(2008-10#2)
of the CALUX bioassay for##2##5##(2008-10#2)
of the CALUX##7##3##(2008-10#7)
of the CBS##3##3##(1993-8#3)
of the CC##2##3##(2008-10#1)(2013-1#1)
of the CCAAT transcription##2##4##(1993-2#2)
of the CD _ 2##2##5##(2008-5#2)
of the CD##6##3##(1994-5#1)(2008-10#3)(2008-5#2)
of the CDC##2##3##(1996-1#1)(2012-12#1)
of the CE##4##3##(1997-2#1)(2008-10#1)(2008-5#2)
of the CEA##2##3##(1990-5#1)(1994-5#1)
of the CFH and Worland strains##2##6##(2008-10#2)
of the CFH##4##3##(2008-10#4)
of the CH(2) symmetric##2##4##(2008-10#2)
of the CH(2)##7##3##(1997-2#1)(2008-10#5)(2008-5#1)
of the CIP##2##3##(2008-10#2)
of the CL reaction##2##4##(2008-10#2)
of the CL##5##3##(2008-10#5)
of the CNS##15##3##(1990-3#1)(1991-2#1)(1995-12#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#4)(2010-12#1)(2011-2#1)(2013-1#1)
of the CNTs##2##3##(2011-2#2)
of the CO 2 laser##2##5##(1991-3#1)(1992-3#1)
of the CO 2##3##4##(1991-3#1)(1992-3#2)
of the CO##4##3##(1991-3#1)(1992-3#2)(1992-6#1)
of the CO(2)##2##3##(2008-10#1)(2012-3#1)
of the CO-diffusion capacity##2##4##(1992-6#2)
of the COXI##2##3##(1993-2#1)(1995-6#1)
of the CP gene##6##4##(2008-10#6)
of the CP genes##3##4##(2008-10#3)
of the CP##14##3##(2008-10#14)
of the CPTQ##3##3##(2008-12#3)
of the CRF##2##3##(2008-4#2)
of the CTL##2##3##(2008-8#2)
of the CTV##3##3##(2008-10#3)
of the Ca(2+)-dependent##2##3##(1994-6#1)(2008-8#1)
of the Ca2+##2##3##(1990-2#1)(1996-2#1)
of the CaM-BP68##2##3##(1994-5#2)
of the Caenorhabditis elegans##2##4##(1993-12#1)(1995-6#1)
of the California##4##3##(2008-10#2)(2010-8#2)
of the Canadian##8##3##(1993-9#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-1#1)
of the Caribbean##2##3##(2007-12#2)
of the Catholic University of Chile##2##6##(2013-1#2)
of the Catholic##3##3##(1990-6#1)(2013-1#2)
of the Cd and Pb##2##5##(2008-10#2)
of the Centers for Disease Control and Prevention's##2##8##(1997-2#1)(2008-11#1)
of the Centers for Disease Control and##3##7##(1996-1#1)(1997-2#1)(2008-11#1)
of the Cervical##2##3##(2008-12#2)
of the Children's##2##3##(1994-3#1)(2008-11#1)
of the Chinese##2##3##(1997-7#1)(2008-8#1)
of the Citrus##2##3##(2008-10#2)
of the Clarion##2##3##(2008-9#2)
of the Clearinghouse##5##3##(1994-1#3)(1996-3#2)
of the Clinical##5##3##(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#1)(2008-12#1)
of the Cognitive##2##3##(1991-1#1)(2008-12#1)
of the Colorado potato beetle##2##5##(2008-10#2)
of the Colorado##3##3##(2008-10#3)
of the Common##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
of the Council##2##3##(1991-8#1)(1995-6#1)
of the Cr##2##3##(2008-10#1)(2008-2#1)
of the Cr(VI)##3##3##(2008-10#3)
of the Cr2 gene##2##4##(2008-10#2)
of the D##2##3##(2007-12#1)(2008-10#1)
of the D-loop##2##3##(2008-5#1)(2008-8#1)
of the DDR##2##3##(2011-2#2)
of the DNA double##2##4##(1996-2#1)(2008-10#1)
of the DNA fragments##2##4##(2008-10#2)
of the DNA hybridization##2##4##(2008-10#2)
of the DNA##24##3##(1991-9#1)(1992-3#1)(1993-8#1)(1994-3#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-8#1)(2013-1#1)
of the DNB and##2##4##(1993-3#2)
of the DNB##3##3##(1993-3#3)
of the DPH probe##2##4##(1990-2#1)(2008-9#1)
of the DPH2##4##3##(1993-9#4)
of the DRG##2##3##(1992-2#1)(1994-12#1)
of the DRR206 promoter##2##4##(2008-10#2)
of the DRUJ##2##3##(2008-9#2)
of the DSES##2##3##(2009-11#2)
of the Department of Health##3##5##(1991-2#1)(1992-1#1)(1997-3#1)
of the Department of##11##4##(1991-2#1)(1991-6#1)(1992-1#1)(1997-3#1)(2008-10#5)(2008-11#1)(2012-2#1)
of the Department##13##3##(1991-2#1)(1991-6#1)(1992-1#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2012-2#1)
of the Diagnostic and Statistical Manual of Mental Disorders##2##9##(2011-2#2)
of the Diagnostic##3##3##(2008-11#1)(2011-2#2)
of the Diskus has##2##4##(1996-2#2)
of the Drosophila suppressor of forked##2##6##(1995-6#2)
of the Drosophila##13##3##(1993-12#1)(1993-6#1)(1994-12#2)(1995-6#3)(1997-3#1)(1997-8#1)(2008-9#3)(2012-3#1)
of the Dutch##3##3##(1997-8#1)(2009-8#1)(2013-8#1)
of the E##7##3##(1990-11#1)(1992-9#2)(1993-12#1)(1995-11#1)(1997-7#1)(2008-4#1)
of the EBV##3##3##(1997-3#1)(2008-5#1)(2008-8#1)
of the ECG##2##3##(1991-3#1)(1992-6#1)
of the ED##2##3##(1997-8#1)(2009-6#1)
of the EDTA##4##3##(2008-10#3)(2008-11#1)
of the EEG##2##3##(2009-8#1)(2010-8#1)
of the EGF receptor##2##4##(1993-8#2)
of the ELISA##3##3##(1990-2#1)(1995-2#1)(2011-2#1)
of the EMG##2##3##(2008-9#1)(2013-1#1)
of the ENS##2##3##(2008-8#2)
of the EP##2##3##(1994-12#1)(2008-10#1)
of the EPO##2##3##(2008-11#2)
of the ER##8##3##(1993-6#1)(2008-11#3)(2009-8#2)(2011-2#2)
of the ERG##2##3##(2009-12#2)
of the ERK##2##3##(2009-8#1)(2010-10#1)
of the ESPU##2##3##(2008-10#2)
of the ETAAS instrument##2##4##(2008-10#2)
of the EU##3##3##(2008-10#3)
of the Earth##3##3##(2008-12#1)(2008-3#2)
of the Ebro river basin##2##5##(2008-10#2)
of the Ecuadorian A2##2##4##(2008-10#2)
of the Edge Hill##2##4##(2009-10#2)
of the Effects of##3##4##(2008-10#3)
of the Egyptian##2##3##(2008-10#2)
of the Ehrlich##2##3##(1990-5#1)(2012-3#1)
of the English##2##3##(2008-11#1)(2011-2#1)
of the Escherichia coli##16##4##(1990-7#1)(1991-10#1)(1991-7#1)(1992-3#1)(1992-9#1)(1995-2#2)(1995-6#1)(1996-12#4)(1996-6#3)(2013-1#1)
of the Eu(III)##3##3##(2008-10#3)
of the European Society of##2##5##(2008-7#1)(2012-2#1)
of the European##14##3##(1990-2#1)(1997-6#1)(2008-10#7)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the F##5##3##(1992-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
of the F(1)##6##3##(2008-10#6)
of the F(3)##3##3##(2008-10#3)
of the F-actin##2##3##(1993-8#1)(2008-10#1)
of the F3##2##3##(2008-12#2)
of the FAS##2##3##(2009-8#1)(2009-9#1)
of the FHL tendon##2##4##(2009-10#2)
of the FI##3##3##(2008-10#3)
of the FIA##2##3##(1995-3#1)(2008-10#1)
of the FMOC##2##3##(2008-10#2)
of the Family##2##3##(1997-6#1)(2008-10#1)
of the Fd##2##3##(1993-6#2)
of the Fe(3+)##2##3##(2008-10#1)(2008-9#1)
of the Federal##2##3##(1995-1#1)(2012-3#1)
of the Fiji##2##3##(2008-1#2)
of the First##2##3##(2011-2#1)(2013-1#1)
of the Food##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
of the Fourier##2##3##(2008-3#2)
of the French##5##3##(1990-8#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-3#1)
of the Functional Movement Screen##2##5##(2011-2#2)
of the Fusarium graminearum##2##4##(2008-10#2)
of the Fusarium oxysporum##2##4##(2008-10#2)
of the Fusarium##4##3##(2008-10#4)
of the G##3##3##(1993-1#1)(1994-12#1)(2008-11#1)
of the GABA##2##3##(1992-3#1)(1996-12#1)
of the GAP-43##3##3##(1994-2#2)(2008-7#1)
of the GB virus##2##4##(2008-10#2)
of the GBC##2##3##(2010-12#2)
of the GC##3##3##(1993-3#1)(2008-10#2)
of the GFAP##2##3##(1997-2#1)(2011-2#1)
of the GM3 was##2##4##(1990-5#2)
of the GP's##2##3##(1997-4#2)
of the GST##2##3##(1990-2#1)(1994-2#1)
of the Gaussian##3##3##(2008-10#1)(2008-3#2)
of the Gene Ontology project##2##5##(2008-9#2)
of the General Health Questionnaire (GHQ 20)##2##7##(2008-1#2)
of the Genomic##30##3##(2011-2#30)
of the Genus##4##3##(2008-10#3)(2010-2#1)
of the German Health##2##4##(2009-7#1)(2012-2#1)
of the German##5##3##(1997-8#1)(2009-7#2)(2012-2#2)
of the Glu-50--&gt##2##3##(1995-6#2)
of the Golgi complex##3##4##(2008-7#3)
of the Golgi##5##3##(2008-11#1)(2008-7#3)(2012-2#1)
of the Green's function##2##4##(2008-3#2)
of the Gus##2##3##(1993-8#2)
of the H##5##3##(2008-10#4)(2008-11#1)
of the H-Wave(R) device##3##4##(2010-1#3)
of the H-point standard##2##4##(2008-10#2)
of the H-point##3##3##(2008-10#3)
of the HA##4##3##(2008-10#2)(2010-8#1)(2011-2#1)
of the HDC##2##3##(1997-1#2)
of the HIV epidemic in##2##5##(1990-12#1)(1995-1#1)
of the HIV epidemic##6##4##(1990-12#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)
of the HIV##10##3##(1990-12#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-6#1)(2008-4#2)
of the HMG##2##3##(1993-2#1)(2008-8#1)
of the HPA axis##3##4##(1994-2#2)(1995-12#1)
of the HPLC method##2##4##(2008-10#2)
of the HPSAM##2##3##(2008-10#2)
of the HR##2##3##(2008-11#1)(2013-8#1)
of the HRP-rotating biosensor##2##4##(2008-10#2)
of the Haemophilus influenzae##2##4##(2008-11#1)(2008-7#1)
of the Hall technique##3##4##(2013-1#3)
of the Harvard##2##3##(1990-11#1)(2010-5#1)
of the Health Care Financing Administration##2##6##(1991-1#1)(1997-2#1)
of the Health Care Financing##6##5##(1991-1#1)(1994-12#1)(1996-2#2)(1997-2#1)(1997-3#1)
of the Health Care##7##4##(1991-1#2)(1994-12#1)(1996-2#2)(1997-2#1)(1997-3#1)
of the Health##9##3##(1991-1#2)(1994-12#1)(1995-1#1)(1996-2#2)(1997-2#1)(1997-3#1)(2008-10#1)
of the Hg##2##3##(2008-10#2)
of the HiRIS##2##3##(2008-10#2)
of the Hibiscus rosa-sinensys##2##4##(2008-10#2)
of the Human Genome##2##4##(1994-9#1)(2008-4#1)
of the Human##4##3##(1994-9#1)(2008-11#1)(2008-4#2)
of the IAC##2##3##(2008-10#2)
of the IC##2##3##(2008-10#2)
of the ICA##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
of the ICU environment##2##4##(1992-2#2)
of the ICU##4##3##(1992-2#4)
of the IL-6##3##3##(1990-5#1)(1996-2#2)
of the ILS##2##3##(2008-10#1)(2008-3#1)
of the INM##2##3##(2011-2#2)
of the IP3-sensitive Ca2+ store##2##5##(1993-8#2)
of the IR##4##3##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
of the ISE##2##3##(2008-10#2)
of the ISEs##4##3##(2008-10#4)
of the ISFET##2##3##(2008-10#2)
of the ITS and##2##4##(2008-10#1)(2010-3#1)
of the ITS region##5##4##(2008-10#4)(2010-3#1)
of the ITS##12##3##(2008-10#10)(2010-3#2)
of the IVC##5##3##(2011-2#3)(2013-1#2)
of the IgG##4##3##(1990-12#2)(2008-1#1)(2008-11#1)
of the Impact of##3##4##(2008-1#1)(2008-10#1)(2010-2#1)
of the Implementation of##2##4##(2008-10#1)(2008-12#1)
of the Implementation##3##3##(1996-1#1)(2008-10#1)(2008-12#1)
of the Indian##3##3##(1994-8#1)(1997-8#1)(2008-10#1)
of the Institut##2##3##(1992-9#1)(2008-11#1)
of the Institute##2##3##(1990-2#1)(2010-1#1)
of the Interaction Between##2##4##(2008-10#2)
of the Internal##2##3##(2008-10#2)
of the International##14##3##(1990-11#2)(1991-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
of the Internet and##2##4##(1994-3#1)(2008-11#1)
of the Internet##4##3##(1994-3#1)(1996-2#1)(2008-11#1)(2009-5#1)
of the Israeli##2##3##(2008-10#1)(2013-1#1)
of the Italian NEO-PI-R##2##4##(2008-11#2)
of the Italian Society##2##4##(2011-2#2)
of the Italian##13##3##(1990-3#1)(1991-8#1)(1992-9#1)(1993-11#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-11#1)(2011-2#3)
of the Jackson Hole Group##2##5##(1994-1#2)
of the Japanese Society of##2##5##(1994-12#1)(2010-1#1)
of the Japanese##6##3##(1994-12#1)(1995-2#1)(2008-6#2)(2010-1#1)(2011-3#1)
of the Journal of##6##4##(2008-10#3)(2008-3#1)(2009-10#1)(2009-8#1)
of the Journal##9##3##(1997-1#1)(2008-10#4)(2008-3#1)(2009-10#1)(2009-8#1)(2011-4#1)
of the KDR##3##3##(1994-11#3)
of the Kjeldahl method##2##4##(2008-10#2)
of the L##6##3##(1992-8#1)(2008-10#4)(2011-2#1)
of the L1##2##3##(1991-11#1)(1997-2#1)
of the L3##2##3##(1991-11#1)(1992-8#1)
of the LDL receptor##2##4##(1995-6#1)(2008-6#1)
of the LE model##4##4##(2008-10#4)
of the LG##2##3##(2008-10#2)
of the LPL##2##3##(1994-11#2)
of the Lambda##2##3##(1994-2#1)(2008-10#1)
of the Langmuir##3##3##(1994-5#1)(2008-10#2)
of the LiF##2##3##(2008-3#2)
of the Literature##5##3##(1997-3#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the London##2##3##(2008-11#1)(2012-2#1)
of the M RNA##2##4##(2008-10#2)
of the M##8##3##(1993-12#1)(1997-3#2)(2008-10#3)(2008-3#1)(2009-6#1)
of the M1##2##3##(1992-10#1)(2013-8#1)
of the M2(D)##2##3##(2008-8#2)
of the MADS##2##3##(1997-8#2)
of the MAPK##4##3##(1995-2#1)(2009-8#3)
of the MCF-7##2##3##(1994-12#1)(2008-11#1)
of the MDCK and the dog##2##6##(1995-11#2)
of the MDCK##3##3##(1995-11#2)(2008-11#1)
of the MDM2 gene##2##4##(1994-12#2)
of the MDM2##3##3##(1994-12#3)
of the MED-EL##2##3##(2008-9#2)
of the MFS##3##3##(1994-1#2)(2011-1#1)
of the MHC class I##2##5##(2008-4#2)
of the MHC##4##3##(1995-5#1)(1997-9#1)(2008-4#2)
of the MLL##2##3##(2011-3#2)
of the MP##2##3##(2008-9#2)
of the MRP encoded protein P190##2##6##(2008-11#2)
of the MRP##3##3##(2008-11#3)
of the MRP/GS-X pump##2##4##(2008-11#2)
of the MS##2##3##(2008-10#1)(2012-3#1)
of the MT isoforms##2##4##(2008-10#2)
of the MT##3##3##(2008-10#3)
of the Maslach Burnout Inventory##2##5##(2008-10#1)(2008-11#1)
of the Medicaid##3##3##(1991-3#1)(1994-2#1)(1997-2#1)
of the Medical##2##3##(2007-8#1)(2013-1#1)
of the Medicare and Medicaid##2##5##(1991-12#1)(1996-3#1)
of the Medicare fee schedule##3##5##(1993-3#1)(1994-1#2)
of the Medicare hospice benefit##2##5##(1991-3#1)(1994-12#1)
of the Medicare population##2##4##(1993-12#1)(1995-12#1)
of the Medicare program##2##4##(1991-1#1)(1995-2#1)
of the Medicare prospective payment system##3##6##(1991-3#1)(1992-1#1)(1993-12#1)
of the Medicare##22##3##(1991-1#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-12#2)(1993-3#2)(1994-1#3)(1994-12#3)(1994-3#1)(1995-12#2)(1995-2#2)(1996-3#1)
of the Mediterranean##4##3##(2008-10#2)(2010-1#1)(2011-2#1)
of the Mexican##2##3##(1993-6#1)(2008-10#1)
of the Mid Staffordshire##2##4##(2013-8#2)
of the Ministry of##3##4##(1991-3#1)(2008-10#1)(2013-1#1)
of the Multidimensional 10 Commandments Questionnaire (M10CQ)##2##7##(2008-12#2)
of the Multidimensional##3##3##(2008-12#2)(2012-2#1)
of the N gene##2##4##(2008-10#2)
of the N##5##3##(2008-10#5)
of the N-linked##3##3##(1993-8#1)(2008-11#1)(2008-7#1)
of the N-methyl-D-aspartate##2##3##(1995-12#1)(1997-2#1)
of the N-terminal domain of##6##5##(2006-6#1)(2008-9#1)(2009-7#3)(2011-1#1)
of the N-terminal domain##7##4##(2006-6#1)(2008-4#1)(2008-9#1)(2009-7#3)(2011-1#1)
of the N-terminal region##2##4##(1996-3#1)(2009-7#1)
of the N-terminal##18##3##(1990-12#1)(1991-10#1)(1996-3#1)(2006-6#2)(2008-10#3)(2008-4#1)(2008-9#1)(2009-7#6)(2011-1#1)(2011-2#1)
of the NAC##2##3##(1996-5#2)
of the NAc##3##3##(2008-7#3)
of the NC strip##2##4##(2008-10#2)
of the NILs##6##3##(2008-10#6)
of the NMDA receptor##4##4##(1996-2#3)(2008-7#1)
of the NMDA/R1 receptor subunit##2##5##(1995-12#2)
of the NMR##2##3##(1994-5#1)(2008-10#1)
of the NPC##8##3##(2011-2#8)
of the Na+##2##3##(1992-12#1)(1997-8#1)
of the Nafion/MV##2##3##(2008-10#2)
of the Nation's##4##3##(1992-12#1)(1993-3#1)(1995-3#1)(2008-6#1)
of the National Cancer Institute##4##5##(1991-3#1)(1993-6#1)(2008-10#1)(2012-3#1)
of the National Health Service##2##5##(2008-12#1)(2011-2#1)
of the National Health##3##4##(1997-3#1)(2008-12#1)(2011-2#1)
of the National Institute of Obstetrics and Gynecology on the##2##10##(1991-3#2)
of the National Institute of##3##5##(1991-3#2)(2008-7#1)
of the National##22##3##(1991-12#1)(1991-3#3)(1992-3#1)(1993-6#1)(1994-2#1)(1995-6#1)(1997-3#2)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
of the Nd##2##3##(2008-10#2)
of the Netherlands##4##3##(1991-8#2)(1996-3#1)(2008-10#1)
of the New York##4##4##(1991-12#1)(1992-8#1)(1994-12#1)(2008-8#1)
of the New##6##3##(1991-12#1)(1992-8#1)(1994-1#1)(1994-12#1)(2008-11#1)(2008-8#1)
of the Nordic##2##3##(2008-10#1)(2011-4#1)
of the North American##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
of the North##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)
of the Norwegian##5##3##(1990-6#1)(1994-6#1)(1996-6#1)(2010-6#1)(2011-2#1)
of the O##2##3##(1997-4#1)(2008-10#1)
of the OECD##2##3##(2011-1#2)
of the OPO##2##3##(2007-12#1)(2008-3#1)
of the OPV##2##3##(1994-9#2)
of the Omnibus##2##3##(1991-1#1)(1997-3#1)
of the Order##2##3##(2008-3#1)(2010-1#1)
of the Organization for Economic Cooperation and Development##2##8##(1993-2#1)(1994-1#1)
of the Orinoco Oil Belt##2##5##(2008-10#2)
of the Ox IgG1 Fab##2##5##(1993-6#2)
of the Ox IgG3##2##4##(1993-6#2)
of the Ox##4##3##(1993-6#4)
of the P##7##3##(1993-9#1)(2008-10#6)
of the P-glycoprotein##4##3##(1992-12#1)(2008-11#3)
of the P2##2##3##(1990-11#1)(1995-8#1)
of the P450##2##3##(2009-9#2)
of the PA method##2##4##(2012-2#2)
of the PACE##3##3##(1992-1#1)(2008-7#2)
of the PAH##2##3##(2008-10#1)(2010-10#1)
of the PAHs##2##3##(2008-10#2)
of the PAI##2##3##(2008-10#2)
of the PANI film##2##4##(2008-10#2)
of the PAP##2##3##(2008-11#2)
of the PB films##2##4##(2008-10#2)
of the PB layer##3##4##(2008-10#3)
of the PB##6##3##(2008-10#6)
of the PCR products##3##4##(2008-10#3)
of the PCR##4##3##(2008-10#4)
of the PD catheter##2##4##(2011-2#2)
of the PD##4##3##(2008-7#2)(2011-2#2)
of the PDA##4##3##(2008-10#1)(2008-12#2)(2012-12#1)
of the PDGF-betaR##2##3##(1997-7#2)
of the PEG hydrogel group compared with 66##2##8##(2012-3#2)
of the PG##2##3##(1990-2#2)
of the PGs##2##3##(1990-2#2)
of the POA neurons##2##4##(2008-8#2)
of the PPTg##2##3##(1994-2#2)
of the PQ(35) transition##2##4##(2008-3#2)
of the PR and##2##4##(2008-10#1)(2010-1#1)
of the PVY 1-2 HC##2##5##(2008-10#2)
of the PVY##3##3##(2008-10#3)
of the Pacific salmon##2##4##(1995-11#2)
of the Pacific##5##3##(1995-11#2)(2008-1#1)(2008-9#1)(2012-12#1)
of the Pap smear##2##4##(1992-3#2)
of the Pap##3##3##(1991-6#1)(1992-3#2)
of the Paramecium aurelia##4##4##(2008-12#4)
of the Petrous##2##3##(2011-2#2)
of the Phytophthora genus-specific##2##4##(2008-10#2)
of the Phytophthora sp-h isolates##2##5##(2008-10#2)
of the Phytophthora##5##3##(2008-10#5)
of the Pinewood Nematode##2##4##(2008-10#2)
of the Pm-AMP1##2##3##(2008-10#2)
of the Polyscias strains##2##4##(2008-10#2)
of the Postharvest##2##3##(2008-10#2)
of the Primary##2##3##(1996-2#1)(2008-10#1)
of the Prussian Blue##2##4##(2008-10#2)
of the Public Health##2##4##(1996-2#1)(2012-12#1)
of the Pythium##2##3##(2008-10#2)
of the QCM with LB##2##5##(2008-10#2)
of the QCM##4##3##(2008-10#4)
of the QD##2##3##(2008-7#2)
of the QIs##2##3##(1996-2#2)
of the QRS duration##2##4##(2008-10#1)(2010-1#1)
of the QTL##3##3##(2008-10#3)
of the Qinghai-Tibet Plateau##2##4##(2008-9#2)
of the Quality Assurance##2##4##(1997-2#1)(2008-11#1)
of the QuickVue##2##3##(2011-2#2)
of the R##3##3##(1993-6#1)(2008-10#1)(2010-10#1)
of the R-D-LSI##2##3##(2012-2#2)
of the RAND##2##3##(2008-10#2)
of the RBC##2##3##(1995-2#1)(2013-1#1)
of the RGD sequence##3##4##(1995-6#3)
of the RGD##4##3##(1995-6#3)(2008-7#1)
of the RGD-BBN##2##3##(2010-6#2)
of the RI##2##3##(2008-10#2)
of the RN##3##3##(2008-12#3)
of the RNA 4##2##4##(2008-10#2)
of the RNA polymerase##4##4##(1995-6#2)(1997-2#1)(2008-10#1)
of the RNA secondary##2##4##(1991-9#1)(2008-4#1)
of the RNA##17##3##(1991-9#1)(1993-12#1)(1993-3#1)(1995-6#2)(1997-2#1)(2008-10#6)(2008-4#3)(2008-7#1)(2009-7#1)
of the RTP emission##2##4##(2008-10#2)
of the RTP##4##3##(2008-10#4)
of the Raman##5##3##(1991-5#1)(2008-10#3)(2008-2#1)
of the Raman-scattering coefficients##2##4##(2008-2#2)
of the Raman-scattering##3##3##(2008-2#3)
of the Regional##2##3##(2008-10#2)
of the Rep##3##3##(2008-10#3)
of the Republic of##2##4##(2008-10#1)(2011-2#1)
of the Review##3##3##(1997-2#1)(1997-3#2)
of the Role of##3##4##(2008-10#3)
of the Royal College of Physicians of London##2##8##(1996-8#2)
of the Royal College of##3##5##(1994-12#1)(1996-8#2)
of the Royal##4##3##(1992-1#1)(1994-12#1)(1996-8#2)
of the RyR1s##4##3##(2008-9#4)
of the S RNA##2##4##(2008-10#2)
of the S##8##3##(1993-1#1)(1993-2#1)(1997-7#1)(2008-10#4)(2008-8#1)
of the S-phase fraction##2##4##(1993-1#1)(1993-11#1)
of the SAM##2##3##(2008-10#2)
of the SAR##2##3##(2008-8#2)
of the SC##5##3##(2008-5#5)
of the SI##2##3##(2007-12#1)(2008-10#1)
of the SIA system##3##4##(2008-10#3)
of the SPE##2##3##(1997-2#1)(2011-2#1)
of the SPR##4##3##(2008-10#4)
of the SS##2##3##(2008-10#1)(2009-11#1)
of the SSCT##4##3##(2008-9#4)
of the STARD##2##3##(2008-12#2)
of the Saccharomyces cerevisiae##2##4##(1993-9#1)(1997-8#1)
of the Saccharomyces##3##3##(1993-9#1)(1997-8#1)(2012-3#1)
of the Salmonella typhimurium##3##4##(1991-12#1)(1996-6#1)(2011-1#1)
of the Schiff base##4##4##(1994-5#2)(2008-10#2)
of the Schlieren effect##2##4##(2008-10#2)
of the School of##2##4##(1992-1#1)(2008-10#1)
of the Se-enriched##2##3##(2008-10#1)(2010-11#1)
of the SeaWiFS##2##3##(2008-2#1)(2008-3#1)
of the Self-Help Clearinghouse##2##4##(1994-1#2)
of the Sialis-type##2##3##(2008-12#2)
of the Sonoran Desert##2##4##(2008-10#2)
of the South##3##3##(2008-1#1)(2011-2#2)
of the Soviet Union##2##4##(2008-12#2)
of the Soybean##2##3##(2008-10#2)
of the Spanish##4##3##(1993-5#1)(2008-10#3)
of the Src##2##3##(1995-6#1)(2011-2#1)
of the Staphylococcus aureus##2##4##(1996-12#1)(1996-6#1)
of the State of##4##4##(1991-8#2)(1997-3#1)(2010-10#1)
of the State##8##3##(1991-8#2)(1995-12#1)(1997-3#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
of the States have##2##4##(1994-3#2)
of the States##4##3##(1994-3#2)(1995-1#1)(1997-2#1)
of the Streptococcus##2##3##(2011-1#1)(2011-2#1)
of the Stroke Belt Consortium##2##5##(2007-9#2)
of the Stroke##3##3##(2007-9#2)(2012-12#1)
of the Strong##2##3##(1996-9#1)(2012-3#1)
of the Swiss##2##3##(1991-2#1)(2008-3#1)
of the Syphilis Study at Tuskegee##2##6##(2013-1#2)
of the Syrian hamster##2##4##(1990-7#1)(1996-8#1)
of the T##7##3##(1991-3#1)(1992-8#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-8#1)
of the T-DNA##2##3##(2008-10#2)
of the T3##2##3##(1995-8#1)(2008-10#1)
of the T4##2##3##(1990-5#1)(1997-3#1)
of the T7 RNA polymerase##2##5##(1990-11#1)(2008-8#1)
of the TEMPO+ behind-the-ear speech processor##2##6##(2008-9#2)
of the TEMPO+##3##3##(2008-9#3)
of the TM##5##3##(2009-7#5)
of the TMJ##2##3##(2011-2#1)(2012-3#1)
of the TNF##2##3##(2008-8#1)(2009-3#1)
of the TQM process##2##4##(1993-3#1)(1994-1#1)
of the TSI##4##3##(2012-3#4)
of the TSPO##2##3##(2012-2#2)
of the TSPO-targeted probe##2##4##(2012-2#2)
of the TUNEL##2##3##(2008-11#1)(2010-1#1)
of the Technical##2##3##(2008-11#1)(2008-12#1)
of the Third##3##3##(2011-2#3)
of the Thirteenth Amendment##2##4##(2011-2#2)
of the Ti##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
of the Toyota##2##3##(2012-2#1)(2013-8#1)
of the Translocator Protein##2##4##(2012-2#2)
of the Tutotest##3##3##(2008-10#3)
of the TxtA##2##3##(2008-10#2)
of the Ty1##2##3##(1995-9#2)
of the U##10##3##(1990-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-2#1)(1996-3#2)(2008-10#1)(2012-3#1)(2013-1#1)
of the U-G units##2##4##(1997-3#2)
of the UK##5##3##(2008-11#2)(2008-12#2)(2011-2#1)
of the US##11##3##(1990-9#1)(1994-8#1)(1995-6#1)(1997-2#2)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the US-1 genotype##2##4##(2008-10#2)
of the US-1##3##3##(2008-10#3)
of the US-7##2##3##(2008-10#2)
of the US-8 genotype##2##4##(2008-10#2)
of the US-8##6##3##(2008-10#6)
of the USP##2##3##(2008-10#2)
of the USPHS Syphilis Study at Tuskegee##2##7##(2013-1#2)
of the UV##7##3##(2008-10#4)(2008-5#2)(2011-2#1)
of the UVA/UVB ratio##2##4##(2008-5#2)
of the Unified##2##3##(2008-7#1)(2012-3#1)
of the United States Department of Agriculture's##2##7##(2008-3#2)
of the United States and Canada##3##6##(2008-10#3)
of the United States and##5##5##(2008-10#5)
of the United States in##2##5##(1993-2#1)(2008-10#1)
of the United States##35##4##(1991-12#1)(1991-8#1)(1993-2#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-8#1)
of the United##37##3##(1991-12#1)(1991-8#1)(1993-2#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-3#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-8#1)
of the University Hospital of##2##5##(1996-11#1)(2011-2#1)
of the University Hospital##3##4##(1996-11#1)(2011-2#2)
of the University of##11##4##(1990-9#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-3#1)(1997-6#1)(2008-10#2)(2009-10#1)(2012-2#1)(2013-1#1)
of the University##14##3##(1990-9#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-3#1)(1996-11#1)(1997-6#1)(2008-10#2)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
of the V##2##3##(2008-10#2)
of the VSF##2##3##(2008-3#2)
of the WNN model##2##4##(2008-10#2)
of the WSMV##2##3##(2008-10#2)
of the WWTP##2##3##(2008-10#2)
of the Water Framework Directive##3##5##(2008-10#3)
of the Weibull##2##3##(2008-10#1)(2010-4#1)
of the West Indies##4##4##(2011-2#4)
of the World Health Organization##3##5##(1990-11#1)(2008-11#1)(2013-1#1)
of the World Health##4##4##(1990-11#1)(2008-11#1)(2012-12#1)(2013-1#1)
of the World##8##3##(1990-11#1)(1997-5#1)(1997-8#1)(2008-11#1)(2011-2#1)(2012-12#2)(2013-1#1)
of the X##5##3##(1993-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
of the X-ray##3##3##(2013-8#3)
of the Xanthomonas avr/pth##3##4##(2008-10#3)
of the Xanthomonas##4##3##(2008-10#4)
of the Xenopus laevis##3##4##(1993-12#1)(1993-6#2)
of the Xenopus vitellogenin A2 gene##2##6##(1992-6#2)
of the Xenopus##7##3##(1992-6#2)(1993-12#1)(1993-6#3)(1997-7#1)
of the Y##2##3##(2012-3#1)(2013-8#1)
of the Yb##3##3##(2008-2#1)(2008-3#2)
of the Zn##2##3##(2008-10#2)
of the aa sequence##2##4##(1990-5#1)(1993-2#1)
of the aa##3##3##(1990-5#1)(1993-12#1)(1993-2#1)
of the abdomen showed##2##4##(2011-2#1)(2013-8#1)
of the abdomen##7##3##(1991-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
of the abdominal wall##3##4##(1991-12#1)(1996-3#1)(2012-12#1)
of the abdominal##6##3##(1991-12#1)(1993-6#1)(1996-3#1)(1997-8#1)(2011-3#1)(2012-12#1)
of the abducens nerve##2##4##(2012-3#2)
of the abilities##2##3##(2010-2#2)
of the ability of the##4##5##(1997-7#1)(2008-3#1)(2008-5#1)(2010-10#1)
of the ability of##9##4##(1994-8#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-10#1)
of the ability to##4##4##(1995-2#1)(2008-12#1)(2010-12#1)(2012-3#1)
of the ability##14##3##(1994-8#1)(1994-9#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-10#1)(2010-12#1)(2012-3#1)
of the abnormal##3##3##(1990-5#1)(2008-7#2)
of the above mentioned parameters##2##5##(1990-9#1)(2008-10#1)
of the above mentioned##7##4##(1990-9#1)(2008-10#5)(2011-2#1)
of the above species##2##4##(2008-10#2)
of the above three##2##4##(2008-10#1)(2008-5#1)
of the above two##2##4##(1995-11#1)(2008-4#1)
of the above##30##3##(1990-9#2)(1994-5#1)(1995-11#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#2)(2013-8#1)
of the absence of##4##4##(1992-1#1)(1997-8#1)(2008-11#1)(2009-8#1)
of the absolute##2##3##(2008-10#1)(2010-1#1)
of the absorbance of the##3##5##(2008-10#3)
of the absorbance of##5##4##(2008-10#5)
of the absorbance##12##3##(2008-10#11)(2008-8#1)
of the absorption coefficient##3##4##(2008-3#3)
of the absorption##10##3##(2008-10#4)(2008-11#1)(2008-3#4)(2008-6#1)
of the abundant##3##3##(1990-5#1)(2008-10#1)(2012-2#1)
of the academic##2##3##(2008-11#2)
of the acceptor##5##3##(1995-6#1)(1996-5#1)(2008-10#3)
of the accessible##2##3##(1997-6#1)(2008-11#1)
of the accessions were##2##4##(2008-10#2)
of the accessions##3##3##(2008-10#3)
of the accessory glands##2##4##(2008-7#2)
of the accessory##7##3##(2007-12#1)(2008-10#1)(2008-7#3)(2012-2#1)(2013-1#1)
of the accumulation of##2##4##(2008-10#1)(2008-8#1)
of the accuracy of the##2##5##(2008-10#2)
of the accuracy of##5##4##(2007-12#1)(2008-10#3)(2012-3#1)
of the acetate##2##3##(1997-2#1)(2008-10#1)
of the acid##10##3##(2008-10#9)(2008-7#1)
of the acid-base##3##3##(2008-10#3)
of the acidic##3##3##(2006-6#1)(2008-10#2)
of the acidity##4##3##(2008-10#4)
of the acids##2##3##(2008-10#2)
of the acorn barnacle Megabalanus rosa##4##6##(1990-5#4)
of the acoustic##2##3##(2009-3#1)(2009-5#1)
of the acquired##4##3##(1990-6#1)(2008-10#1)(2010-3#1)(2013-1#1)
of the acrosome and##2##4##(2008-7#2)
of the acrosome reaction##3##4##(2008-8#3)
of the acrosome##5##3##(2008-7#2)(2008-8#3)
of the act##2##3##(1994-1#1)(2009-10#1)
of the actin cytoskeleton##3##4##(2008-11#2)(2008-9#1)
of the actin##9##3##(1992-3#1)(2008-10#1)(2008-11#5)(2008-9#1)(2009-7#1)
of the action of##3##4##(1997-2#1)(2008-10#1)(2008-7#1)
of the action##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
of the activated##4##3##(1996-2#1)(1997-7#1)(2008-10#2)
of the activation motif##2##4##(1997-3#2)
of the activation of##3##4##(1996-2#1)(2008-10#1)(2009-6#1)
of the activation##8##3##(1996-2#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)
of the active ingredient##3##4##(2008-5#3)
of the active material##2##4##(2008-3#1)(2008-5#1)
of the active principle##2##4##(2008-10#2)
of the active site of##2##5##(1990-2#1)(1991-5#1)
of the active site##7##4##(1990-2#1)(1991-5#1)(1992-4#2)(1992-6#1)(1995-6#1)(2010-11#1)
of the active##33##3##(1990-2#1)(1991-5#1)(1991-9#1)(1992-4#2)(1992-6#4)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-6#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#5)(2008-8#2)(2010-11#1)(2010-9#1)
of the active-site##2##3##(1994-5#1)(1995-6#1)
of the activities of the##3##5##(1995-5#1)(2012-12#1)(2013-1#1)
of the activities of##4##4##(1995-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
of the activities##6##3##(1995-5#1)(2008-10#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#1)
of the activity coefficients##4##4##(2008-10#4)
of the activity of the##2##5##(1995-2#1)(2008-10#1)
of the activity of##13##4##(1990-11#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
of the activity##22##3##(1990-11#1)(1990-2#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-3#1)
of the actual##8##3##(1991-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-3#1)
of the acute##5##3##(1996-3#1)(1997-2#1)(2008-9#1)(2010-12#1)(2010-5#1)
of the acutely compensated state##2##5##(1991-2#2)
of the acutely lethal##2##4##(1997-3#2)
of the acutely##4##3##(1991-2#2)(1997-3#2)
of the adaptive immune##2##4##(2008-10#1)(2013-8#1)
of the adaptive##6##3##(1997-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-8#1)
of the added##5##3##(1994-5#1)(2008-10#2)(2011-2#2)
of the addition of the##2##5##(1995-1#1)(1997-1#1)
of the addition of##7##4##(1993-12#1)(1995-1#1)(1997-1#1)(2008-10#3)(2010-11#1)
of the additional##3##3##(1992-5#1)(2008-10#2)
of the adenomatous##2##3##(2008-1#1)(2008-10#1)
of the adenovirus##2##3##(1993-2#1)(2008-11#1)
of the adequacy of##3##4##(1995-1#1)(1996-3#2)
of the adherent##3##3##(2008-10#1)(2008-11#2)
of the adhesion##3##3##(1992-1#1)(2008-10#1)(2013-8#1)
of the adhesive##3##3##(2008-5#2)(2008-9#1)
of the admixtures##2##3##(2008-10#2)
of the adolescent##2##3##(1993-3#1)(2008-11#1)
of the adolescents##2##3##(1990-2#1)(2010-11#1)
of the adrenal cortex##4##4##(1990-11#1)(1990-5#2)(2008-4#1)
of the adrenal gland##5##4##(1991-6#1)(2008-12#1)(2011-2#2)(2013-1#1)
of the adrenal##11##3##(1990-11#1)(1990-5#2)(1991-6#1)(1996-12#1)(2008-12#1)(2008-4#1)(2011-2#3)(2013-1#1)
of the adsorbed species##2##4##(2008-10#2)
of the adsorbed##9##3##(2008-10#8)(2011-2#1)
of the adsorbent##3##3##(2008-10#3)
of the adsorption of##2##4##(2008-10#2)
of the adsorption##8##3##(1997-2#1)(2008-10#7)
of the adult population##5##4##(1996-6#1)(1997-2#1)(2008-11#1)(2008-8#2)
of the adult rat##2##4##(2008-11#1)(2012-2#1)
of the adult##16##3##(1995-2#1)(1996-12#2)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)(2012-3#2)
of the adults##3##3##(2008-12#1)(2008-9#1)(2012-12#1)
of the advances##2##3##(2008-11#1)(2013-1#1)
of the advantages of##3##4##(1991-2#1)(2008-8#1)(2010-12#1)
of the advantages##5##3##(1991-2#1)(1993-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
of the adventitia##3##3##(1991-8#1)(1997-8#2)
of the adverse effects of##2##5##(2008-10#1)(2012-12#1)
of the adverse##8##3##(1992-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
of the aerodynamic##2##3##(1992-3#1)(2008-11#1)
of the aerosol##12##3##(1992-3#2)(1994-12#1)(1995-3#1)(2008-10#3)(2008-2#1)(2008-3#4)
of the aetiology and##2##4##(1997-1#1)(2008-12#1)
of the aetiology of##2##4##(2008-10#1)(2010-1#1)
of the aetiology##4##3##(1997-1#1)(2008-10#1)(2008-12#1)(2010-1#1)
of the affected##7##3##(1991-3#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
of the affinity##5##3##(1993-1#1)(1995-11#1)(1997-4#1)(2008-10#2)
of the aforementioned##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
of the age##2##3##(2008-10#1)(2012-3#1)
of the aged##4##3##(1994-2#1)(1995-8#1)(1996-2#2)
of the agent##2##3##(2008-10#1)(2008-5#1)
of the agents##5##3##(1990-6#1)(1994-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
of the aggrecan gene##2##4##(1992-1#2)
of the aggrecan##4##3##(1992-1#4)
of the aggregated##2##3##(2008-10#1)(2009-10#1)
of the aggressive##2##3##(2008-10#2)
of the aging##2##3##(2008-10#1)(2008-7#1)
of the air##4##3##(2008-10#3)(2008-11#1)
of the airway circulation##3##4##(1996-1#1)(1997-1#2)
of the airway##4##3##(1996-1#2)(1997-1#2)
of the airways##2##3##(1997-2#1)(2009-1#1)
of the alcohol##9##3##(1992-7#1)(1994-11#1)(1994-6#1)(1997-8#1)(2008-10#4)(2011-1#1)
of the alcoholic##2##3##(2008-10#2)
of the alcohols with##2##4##(1996-5#1)(2008-10#1)
of the algae##3##3##(2008-10#3)
of the alginate##2##3##(2008-11#1)(2008-7#1)
of the algorithm##2##3##(2008-6#2)
of the aliphatic##2##3##(1994-8#1)(1996-5#1)
of the alkali##2##3##(2008-10#2)
of the alkyl##3##3##(2008-10#1)(2008-5#2)
of the allele##2##3##(1993-3#1)(2012-2#1)
of the allelic##2##3##(2008-10#1)(2008-8#1)
of the allosteric interaction of semi-rigid verapamil analogues with##2##9##(1995-11#2)
of the allosteric##3##3##(1995-11#2)(2008-4#1)
of the alloy##2##3##(2009-7#2)
of the almond##2##3##(2008-10#1)(2008-11#1)
of the alpha 1 (I)##2##5##(1991-5#2)
of the alpha 1##3##4##(1991-5#2)(1996-2#1)
of the alpha 4 beta 2##2##6##(1995-11#2)
of the alpha subunit of##2##5##(1995-2#1)(2012-2#1)
of the alpha subunit##4##4##(1995-2#1)(1995-8#1)(2008-11#1)(2012-2#1)
of the alpha##12##3##(1991-5#3)(1992-2#1)(1994-11#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-2#1)(2008-11#1)(2012-2#1)
of the alpha-subunit##4##3##(1991-3#3)(1995-6#1)
of the alpha-subunits##2##3##(1995-6#2)
of the alterations##3##3##(1992-12#1)(1992-5#1)(2008-7#1)
of the altered enzyme##2##4##(1992-1#2)
of the altered mineral metabolism##2##5##(2009-1#2)
of the altered##6##3##(1992-1#2)(2009-1#2)(2013-1#1)(2013-8#1)
of the alternative##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
of the alveolar epithelium##2##4##(1995-8#2)
of the alveolar##4##3##(1992-12#1)(1995-8#2)(2010-12#1)
of the american##7##3##(2008-10#4)(2008-3#1)(2008-8#1)(2011-2#1)
of the amide##2##3##(2008-10#1)(2008-12#1)
of the amine group##2##4##(2008-10#2)
of the amine groups##2##4##(2008-10#2)
of the amine##6##3##(2008-10#6)
of the amino acid sequence of the##3##7##(1990-5#1)(1993-8#1)(2008-10#1)
of the amino acid sequence of##4##6##(1990-5#1)(1993-12#1)(1993-8#1)(2008-10#1)
of the amino acid##15##4##(1990-5#1)(1993-12#1)(1993-8#1)(1995-8#1)(1997-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)
of the amino acids##6##4##(1994-12#1)(2008-10#2)(2008-11#2)(2011-1#1)
of the amino group##2##4##(1992-3#1)(2008-10#1)
of the amino##25##3##(1990-5#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-9#1)(2008-10#7)(2008-11#5)(2008-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)
of the amniotic##2##3##(2008-10#1)(2008-9#1)
of the amorphous content of##2##5##(2008-10#2)
of the amorphous##4##3##(2008-10#3)(2010-8#1)
of the amount of##13##4##(1992-12#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2009-8#1)
of the amount##16##3##(1990-3#1)(1992-12#1)(1996-3#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2009-8#1)
of the amounts of##3##4##(2008-10#3)
of the amperometric response##2##4##(2008-10#2)
of the amperometric##4##3##(2008-10#4)
of the amphiphilic##2##3##(1994-11#1)(1994-5#1)
of the amplicons##2##3##(2008-10#2)
of the amplified fragments##2##4##(2008-10#1)(2012-2#1)
of the amplified gene##2##4##(2008-11#2)
of the amplified products##2##4##(2008-10#2)
of the amplified##10##3##(1996-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2011-2#1)(2012-2#1)
of the amplitude##2##3##(1997-4#1)(2008-3#1)
of the amygdala##10##3##(1991-10#2)(1993-6#3)(1996-12#1)(1996-5#1)(2008-11#3)
of the amyloid##2##3##(1992-12#1)(2008-5#1)
of the anal##2##3##(2013-1#2)
of the analysed##2##3##(2008-10#2)
of the analyser##2##3##(2008-10#2)
of the analysis of the##3##5##(1993-12#1)(2008-10#2)
of the analysis of##8##4##(1993-12#1)(2008-10#5)(2008-7#1)(2013-1#1)
of the analysis##28##3##(1990-6#1)(1993-12#1)(1994-9#1)(1995-12#1)(1996-12#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#4)(2012-2#1)(2013-1#1)
of the analyte and##3##4##(2008-10#3)
of the analyte by##3##4##(2008-10#2)(2009-8#1)
of the analyte from the##2##5##(2008-10#2)
of the analyte in the##5##5##(2008-10#5)
of the analyte in##7##4##(2008-10#7)
of the analyte pulse##2##4##(2008-10#2)
of the analyte solution##4##4##(2008-10#4)
of the analyte was##3##4##(2008-10#3)
of the analyte with##3##4##(2008-10#3)
of the analyte##57##3##(2008-10#54)(2008-7#1)(2009-8#1)(2012-12#1)
of the analytes can be##2##5##(2008-10#2)
of the analytes from##2##4##(2008-10#2)
of the analytes in##4##4##(2008-10#4)
of the analytes on the##2##5##(2008-10#2)
of the analytes on##5##4##(2008-10#5)
of the analytes retained on##2##5##(2008-10#2)
of the analytes retained##3##4##(2008-10#3)
of the analytes was##2##4##(2008-10#2)
of the analytes were investigated##2##5##(2008-10#2)
of the analytes were##6##4##(2008-10#6)
of the analytes with the##2##5##(2008-10#2)
of the analytes##45##3##(1997-2#1)(2008-10#44)
of the analytical characteristics##2##4##(2008-10#2)
of the analytical performances##2##4##(2008-10#2)
of the analytical procedure##5##4##(2008-10#5)
of the analytical properties##2##4##(2008-10#2)
of the analytical results##2##4##(2008-10#2)
of the analytical signal##2##4##(2008-10#2)
of the analytical signals##2##4##(2008-10#2)
of the analytical system##2##4##(2008-10#2)
of the analytical##35##3##(2008-10#34)(2008-3#1)
of the analyzed##4##3##(2008-10#3)(2012-2#1)
of the anatomical##4##3##(1995-2#1)(2009-10#1)(2011-2#2)
of the anatomy##2##3##(2010-6#1)(2013-1#1)
of the ancestral##2##3##(2008-8#1)(2013-1#1)
of the aneurysm##7##3##(1997-3#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
of the aneurysmal sac##2##4##(1997-3#2)
of the angiotensin##3##3##(1994-2#2)(1994-8#1)
of the angiotensin-converting enzyme##2##4##(2008-12#1)(2008-7#1)
of the angle##2##3##(2008-3#2)
of the angular##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
of the animal models##2##4##(2008-7#1)(2010-6#1)
of the animal##10##3##(1990-2#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-11#2)(2010-6#1)
of the animals##10##3##(1991-2#1)(1994-5#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#2)
of the anion exchanger##2##4##(2008-10#2)
of the anion##4##3##(1994-5#1)(2008-10#2)(2008-11#1)
of the anionic##5##3##(1990-5#1)(2008-10#4)
of the anions##3##3##(2008-10#2)(2010-4#1)
of the ankle joint##4##4##(2009-7#2)(2010-5#1)(2012-2#1)
of the ankle##11##3##(2008-12#1)(2009-7#2)(2010-5#1)(2012-2#5)(2012-3#1)(2013-1#1)
of the annual##3##3##(1992-2#1)(2008-9#1)(2012-5#1)
of the annulus##3##3##(1996-6#3)
of the ant##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
of the antagonist in##2##4##(2008-10#2)
of the antagonist##10##3##(1995-11#1)(1996-2#1)(2008-10#8)
of the antagonistic##2##3##(2008-10#2)
of the anterior abdominal wall##3##5##(1991-1#2)(2012-12#1)
of the anterior cerebral artery##2##5##(1997-3#1)(2008-7#1)
of the anterior cruciate ligament##2##5##(2009-1#1)(2013-1#1)
of the anterior horn##2##4##(1990-9#1)(2008-7#1)
of the anterior segment##2##4##(2010-9#1)(2011-7#1)
of the anterior##27##3##(1990-9#2)(1991-1#2)(1992-9#1)(1994-3#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#1)(2013-1#2)
of the anti-HIV agent 2'##2##5##(1990-10#1)(1991-3#1)
of the anti-inflammatory drug##2##4##(2008-10#2)
of the anti-oncogenic##2##3##(1997-7#2)
of the antibiotic 2##2##4##(2008-10#2)
of the antibiotic##7##3##(1990-2#1)(1992-12#2)(1997-2#1)(2008-10#3)
of the antibiotics##2##3##(1991-1#1)(2008-10#1)
of the antibodies##5##3##(2008-10#5)
of the antibody##11##3##(1995-5#1)(2008-10#2)(2008-11#2)(2008-7#4)(2008-8#2)
of the anticancer##2##3##(2008-10#1)(2008-11#1)
of the anticipated##2##3##(2008-10#1)(2008-3#1)
of the anticoagulant effect##2##4##(2008-10#2)
of the antidepressant##3##3##(2008-10#2)(2008-6#1)
of the antifouling biocides##2##4##(2008-11#2)
of the antifouling##3##3##(2008-10#1)(2008-11#2)
of the antifungal##3##3##(2008-10#3)
of the antigen by##2##4##(1990-12#2)
of the antigen##6##3##(1990-12#3)(2008-11#2)(2008-8#1)
of the antigen-antibody##3##3##(2008-10#3)
of the antigens##3##3##(1990-12#2)(1995-5#1)
of the antimicrobial##4##3##(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
of the antimony##2##3##(2008-10#2)
of the antioxidant activity of##3##5##(2008-10#3)
of the antioxidant capacity of##3##5##(2008-10#3)
of the antioxidant##9##3##(2008-10#8)(2010-5#1)
of the antioxidants##6##3##(1992-9#1)(1993-2#1)(2008-10#2)(2008-5#2)
of the antisera##2##3##(2008-5#1)(2010-6#1)
of the antiviral##2##3##(1990-10#1)(1994-6#1)
of the aorta##6##3##(1996-11#1)(1997-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2013-3#1)
of the aortic valve##2##4##(1997-5#1)(2012-2#1)
of the aortic##5##3##(1991-9#1)(1997-5#1)(2009-7#1)(2010-7#1)(2012-2#1)
of the aphid Schizaphis graminum##2##5##(1996-12#1)(2008-10#1)
of the aphid##9##3##(1996-12#3)(2007-12#1)(2008-10#5)
of the apical cell##2##4##(2007-12#1)(2009-8#1)
of the apical##7##3##(2007-12#1)(2009-8#1)(2012-2#2)(2013-1#3)
of the apo B gene##2##5##(1997-8#2)
of the apo##3##3##(1991-12#1)(1997-8#2)
of the apo-E##2##3##(2008-10#2)
of the apolipoprotein B gene##2##5##(1995-2#1)(1997-8#1)
of the apoptosis##2##3##(2008-10#1)(2008-11#1)
of the apoptotic##3##3##(1995-12#1)(2009-3#1)(2010-1#1)
of the apparatus##3##3##(1997-6#1)(2008-3#2)
of the apparent diffusion coefficient##2##5##(2008-10#1)(2010-12#1)
of the apparent##10##3##(1991-9#1)(1996-12#1)(2008-10#6)(2008-3#1)(2010-12#1)
of the appendicular##2##3##(1991-11#1)(2011-2#1)
of the appendix##2##3##(1997-8#1)(2008-12#1)
of the apple snail##2##4##(2008-11#2)
of the apple##6##3##(2008-10#4)(2008-11#2)
of the applicable##2##3##(1992-12#1)(2008-11#1)
of the application of the##4##5##(1990-9#1)(1992-9#1)(2008-10#1)(2008-3#1)
of the application of these##2##5##(2008-10#1)(2012-2#1)
of the application of##17##4##(1990-9#1)(1992-9#1)(1995-5#1)(1996-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)
of the application##20##3##(1990-9#1)(1992-9#1)(1995-5#1)(1996-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#2)
of the applied current##3##4##(2008-10#3)
of the applied treatment##2##4##(2008-10#2)
of the applied##11##3##(1995-3#2)(2008-10#9)
of the appressoria##2##3##(2008-10#2)
of the approach is##2##4##(1996-5#1)(2008-10#1)
of the approach to##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
of the approach##9##3##(1996-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)
of the approaches##2##3##(2008-11#1)(2008-8#1)
of the appropriate##8##3##(1991-3#1)(1996-5#1)(2008-10#4)(2008-9#1)(2011-2#1)
of the approximation##2##3##(1996-3#1)(2013-1#1)
of the aquatic HS##2##4##(2008-10#2)
of the aquatic environment##2##4##(2008-10#1)(2008-11#1)
of the aquatic##5##3##(2008-10#3)(2008-11#1)(2010-6#1)
of the aqueous phase##6##4##(2008-10#6)
of the aqueous##13##3##(2008-10#11)(2008-11#1)(2008-12#1)
of the arcjet##2##3##(2008-2#2)
of the area under the##2##5##(2008-10#2)
of the area##7##3##(1991-8#1)(1997-3#1)(2008-10#5)
of the areas##2##3##(2008-12#1)(2010-9#1)
of the arm##4##3##(1994-5#1)(2008-5#1)(2008-9#1)(2011-2#1)
of the aromatic##3##3##(2008-10#2)(2010-4#1)
of the array of##2##4##(1991-3#1)(2011-2#1)
of the array##6##3##(1991-3#1)(2008-10#1)(2009-10#1)(2011-2#2)(2012-3#1)
of the arsenic species was performed by##2##7##(2008-10#2)
of the arsenic species##3##4##(2008-10#3)
of the arsenic##5##3##(2008-10#5)
of the art and##3##4##(1993-3#1)(2008-11#1)(2010-11#1)
of the art##17##3##(1993-3#2)(1994-8#1)(1995-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#2)
of the arterial wall##2##4##(2009-1#1)(2011-2#1)
of the arterial##6##3##(1993-1#1)(1995-8#1)(1997-8#1)(2006-6#1)(2009-1#1)(2011-2#1)
of the arteriovenous##2##3##(1993-6#1)(2011-3#1)
of the artery##2##3##(2008-4#1)(2008-9#1)
of the article##4##3##(1993-6#1)(2009-4#2)(2009-5#1)
of the articles##3##3##(1997-1#1)(1997-3#1)(2012-2#1)
of the artificial##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of the ascending aorta##5##4##(1997-5#4)(1997-8#1)
of the ascospore##3##3##(2008-10#3)
of the assay are##2##4##(2008-10#1)(2008-9#1)
of the assay extends from##2##5##(2008-11#2)
of the assay was##4##4##(1992-6#1)(2008-10#3)
of the assay##22##3##(1991-5#1)(1992-6#1)(1997-2#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-9#1)(2013-8#1)
of the assays##3##3##(2008-10#3)
of the assembled##2##3##(1996-6#1)(2008-10#1)
of the assessment and##2##4##(1992-12#1)(2009-5#1)
of the assessment of##2##4##(1996-12#1)(2008-11#1)
of the assessment##6##3##(1992-12#1)(1996-12#1)(2008-11#1)(2009-5#1)(2012-2#1)(2013-1#1)
of the assigned##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
of the associated##5##3##(1997-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
of the association between##3##4##(2008-10#1)(2009-7#1)(2010-1#1)
of the association of##3##4##(2008-7#1)(2009-7#1)(2013-1#1)
of the association##11##3##(2008-10#5)(2008-7#1)(2009-7#2)(2010-1#1)(2011-2#1)(2013-1#1)
of the assumptions##4##3##(1994-9#1)(2008-3#1)(2008-9#1)(2012-2#1)
of the astrocyte##2##3##(1990-7#1)(2008-11#1)
of the atherosclerotic plaque##2##4##(2010-9#1)(2011-2#1)
of the atmosphere##7##3##(2008-2#1)(2008-3#6)
of the atmospheric##8##3##(1996-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2013-8#1)
of the atomic##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)
of the atrial septal##2##4##(2008-11#2)
of the atrial##3##3##(1990-9#1)(2008-11#2)
of the attention is##2##4##(2008-10#1)(2011-2#1)
of the attenuated##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
of the atypical##3##3##(2008-11#1)(2008-7#1)(2009-8#1)
of the audit tool##2##4##(2008-11#2)
of the audit##4##3##(1993-1#2)(2008-11#2)
of the auditory cortex##3##4##(2010-7#3)
of the auditory nerve##2##4##(2008-8#1)(2008-9#1)
of the auditory##8##3##(1991-1#1)(2008-8#1)(2008-9#2)(2010-5#1)(2010-7#3)
of the author##2##3##(2008-12#1)(2012-2#1)
of the authors##7##3##(1994-2#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-8#1)(2011-2#1)
of the autocorrelation function##2##4##(2008-3#1)(2008-8#1)
of the autocorrelation##3##3##(2008-3#1)(2008-8#1)(2013-1#1)
of the autologous##2##3##(2008-11#1)(2012-12#1)
of the automated system##2##4##(2008-10#2)
of the automated##7##3##(2008-10#7)
of the automatic##2##3##(2008-10#2)
of the autonomic nervous system (ANS)##2##6##(2009-11#1)(2013-8#1)
of the autonomic nervous system##3##5##(2009-11#1)(2013-1#1)(2013-8#1)
of the autonomic nervous##4##4##(2009-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
of the autonomic##5##3##(2009-11#1)(2010-5#1)(2013-1#1)(2013-8#2)
of the autophagy##2##3##(2013-1#2)
of the autosampler in the##2##5##(2008-10#2)
of the autumnal##2##3##(2008-11#1)(2010-8#1)
of the availability##2##3##(1993-8#1)(2008-10#1)
of the available data##3##4##(1991-12#1)(1996-1#1)(2010-8#1)
of the available evidence##2##4##(1992-2#1)(1993-12#1)
of the available treatments##2##4##(2008-7#1)(2011-2#1)
of the available##17##3##(1991-12#1)(1991-5#1)(1992-2#1)(1993-12#1)(1996-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-8#2)(2011-2#2)(2013-8#1)
of the average##8##3##(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-3#1)
of the axilla##3##3##(2008-5#3)
of the axillary microflora##2##4##(2008-5#2)
of the axillary##4##3##(2008-5#3)(2013-1#1)
of the axon##2##3##(2012-2#2)
of the azobenzene##3##3##(2008-10#3)
of the baboon and##2##4##(1993-6#1)(2008-9#1)
of the baby##4##3##(1994-3#1)(2008-1#1)(2008-11#1)(2012-3#1)
of the back##2##3##(1997-3#1)(2008-5#1)
of the background signals##3##4##(2008-3#3)
of the background##7##3##(2008-10#4)(2008-3#3)
of the baclofen##2##3##(2008-10#1)(2011-2#1)
of the bacteria to##2##4##(2008-11#1)(2011-2#1)
of the bacteria##12##3##(1995-2#1)(1996-12#3)(2006-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
of the bacterial chloramphenicol acetyltransferase##2##5##(1993-3#1)(1993-8#1)
of the bacterial community##2##4##(2008-10#1)(2010-6#1)
of the bacterial populations##2##4##(2008-10#2)
of the bacterial spot pathogen##2##5##(2008-10#2)
of the bacterial##20##3##(1991-12#1)(1993-3#1)(1993-8#1)(2008-10#11)(2008-11#1)(2008-5#1)(2010-6#2)(2011-2#1)(2012-2#1)
of the bacterially expressed##2##4##(1994-11#1)(1994-5#1)
of the bacteriophage##3##3##(1990-5#1)(1991-5#1)(2008-8#1)
of the bacterium##10##3##(1996-12#1)(2008-10#5)(2008-7#2)(2008-8#1)(2009-8#1)
of the baculovirus##3##3##(1997-3#3)
of the balloon##2##3##(1997-6#1)(2008-7#1)
of the bands in##2##4##(2008-10#1)(2008-9#1)
of the bare##3##3##(2008-10#3)
of the barium##2##3##(2008-10#2)
of the barley##5##3##(2008-10#4)(2008-9#1)
of the barrier function in a reconstituted human epidermis##2##9##(2008-5#2)
of the barrier##5##3##(2008-10#2)(2008-5#3)
of the barriers to##2##4##(1993-12#1)(1997-2#1)
of the barriers##3##3##(1993-12#1)(1997-2#1)(2008-11#1)
of the basal ganglia##4##4##(1996-12#2)(1997-3#1)(2013-8#1)
of the basal medium##2##4##(2008-11#2)
of the basal nuclear complex##2##5##(1996-12#2)
of the basal##16##3##(1991-9#1)(1995-2#1)(1996-12#4)(1997-3#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-9#1)(2010-4#1)(2013-8#1)
of the base of tongue that required reconstructive surgery##2##9##(2013-1#2)
of the base of tongue##4##5##(2013-1#4)
of the base##9##3##(1991-5#1)(2008-10#4)(2013-1#4)
of the baseline##4##3##(2008-10#2)(2008-11#1)(2009-5#1)
of the basic##16##3##(1994-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#4)(2008-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2013-1#1)
of the basilar artery##4##4##(1997-6#1)(2011-2#1)(2013-8#2)
of the basolateral amygdala##3##4##(1990-5#1)(1993-6#2)
of the basolateral##4##3##(1990-5#2)(1993-6#2)
of the batch##4##3##(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
of the battered##3##3##(1995-5#3)
of the bcl-2##4##3##(1993-3#1)(2008-11#3)
of the beads##2##3##(2008-10#1)(2008-11#1)
of the beam##11##3##(2008-10#1)(2008-3#10)
of the bean##2##3##(2008-10#1)(2008-8#1)
of the beginning of##2##4##(1993-12#1)(2008-10#1)
of the behavior of##5##4##(2008-10#2)(2008-9#1)(2009-5#1)(2011-2#1)
of the behavior##6##3##(2008-10#3)(2008-9#1)(2009-5#1)(2011-2#1)
of the behaviour##2##3##(2008-10#2)
of the benefit##3##3##(1994-2#1)(1995-11#1)(1995-3#1)
of the benefits and costs##2##5##(1995-3#1)(2009-4#1)
of the benefits and##3##4##(1995-3#1)(1997-3#1)(2009-4#1)
of the benefits of##2##4##(1990-11#1)(1996-3#1)
of the benefits##5##3##(1990-11#1)(1995-3#1)(1996-3#1)(1997-3#1)(2009-4#1)
of the benign##2##3##(2010-12#1)(2011-2#1)
of the bent##3##3##(1993-8#1)(2008-3#2)
of the bentonite##2##3##(2008-10#2)
of the benzodiazepine##3##3##(1994-2#1)(1995-11#2)
of the best characterized##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
of the best##15##3##(1991-6#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
of the beta subunit of##2##5##(1994-11#1)(1995-2#1)
of the beta subunit##6##4##(1992-9#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#2)
of the beta##12##3##(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(2008-10#1)(2008-11#1)
of the beta-binomial distribution##5##4##(2008-10#5)
of the beta-binomial##9##3##(2008-10#9)
of the beta-chain of bovine hemoglobin##2##6##(1995-3#2)
of the beta-chain##3##3##(1993-8#1)(1995-3#2)
of the beta-subunit of##2##4##(1993-8#1)(1996-12#1)
of the beta-tubulin gene##2##4##(2008-10#2)
of the beta-tubulin##4##3##(2008-10#3)(2010-3#1)
of the bias##3##3##(1996-3#1)(2008-10#1)(2013-8#1)
of the biggest##4##3##(1991-2#2)(2008-3#1)(2012-2#1)
of the bilateral##3##3##(1997-6#1)(2008-7#1)(2011-3#1)
of the bilaterian##2##3##(2010-4#2)
of the bilayer##3##3##(2008-10#3)
of the bile##5##3##(1991-3#2)(2008-11#2)(2013-1#1)
of the biliary tract in geriatric##2##6##(1992-9#2)
of the biliary tract##7##4##(1990-5#1)(1990-8#1)(1992-9#5)
of the biliary##9##3##(1990-5#1)(1990-8#1)(1991-6#1)(1992-9#5)(2012-12#1)
of the binary power law##3##5##(2008-10#3)
of the binary##8##3##(2008-10#8)
of the binding characteristics of##2##5##(1991-9#1)(1994-5#1)
of the binding of##5##4##(1995-6#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-7#1)
of the binding sites##2##4##(1994-5#1)(2008-10#1)
of the binding##16##3##(1991-9#1)(1993-1#1)(1994-2#1)(1994-5#3)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)
of the binomial distribution##2##4##(2008-10#2)
of the bioactive glass##2##4##(2009-7#2)
of the bioactive##4##3##(2009-7#2)(2011-1#1)(2012-2#1)
of the biocatalyst##2##3##(2008-7#1)(2011-2#1)
of the biochemical and##2##4##(1994-8#1)(2012-2#1)
of the biochemical##5##3##(1994-8#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#1)
of the biocontrol agent##2##4##(2008-10#2)
of the biocontrol agents##2##4##(2008-10#2)
of the biocontrol fungus Trichoderma harzianum ThzID1##2##7##(2008-10#2)
of the biocontrol isolates##2##4##(2008-10#2)
of the biocontrol##10##3##(2008-10#10)
of the bioelectrode is##2##4##(2008-10#2)
of the bioelectrode##3##3##(2008-10#3)
of the biofilm##3##3##(2008-7#1)(2009-4#1)(2013-1#1)
of the biological activities of the GPIs##2##7##(2013-8#2)
of the biological activity##2##4##(2008-8#1)(2009-3#1)
of the biological control##2##4##(2008-10#2)
of the biological##23##3##(1991-2#1)(1992-12#1)(1994-8#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
of the biology of##5##4##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
of the biology##6##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
of the biomass dry weight##2##5##(2008-7#2)
of the biomass##4##3##(2008-7#3)(2008-8#1)
of the biopsies##2##3##(1994-1#1)(2008-11#1)
of the bioreactor##3##3##(2008-11#1)(2008-7#2)
of the biosensor for##2##4##(2008-10#2)
of the biosensor in the##3##5##(2008-10#3)
of the biosensor was##2##4##(2008-10#2)
of the biosensor##22##3##(2008-10#22)
of the biosensors was evaluated##2##5##(2008-10#2)
of the biosensors##5##3##(2008-10#5)
of the biosynthesis of##2##4##(2012-2#1)(2013-8#1)
of the bladder and##2##4##(2008-10#1)(2011-2#1)
of the bladder is a rare##2##6##(1992-12#1)(2010-12#1)
of the bladder##20##3##(1992-12#2)(1993-2#1)(1994-3#2)(2008-10#10)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
of the blank signal##3##4##(2008-10#3)
of the blank signal)##2##4##(2008-10#2)
of the blank##13##3##(2008-10#13)
of the blank) and##2##4##(2008-10#2)
of the blank)##3##3##(2008-10#3)
of the blood pressure##4##4##(1992-2#1)(1997-5#1)(2008-5#1)(2008-7#1)
of the blood##19##3##(1990-11#1)(1990-12#1)(1990-6#1)(1992-2#1)(1992-3#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2011-3#1)
of the blood-brain barrier in##2##5##(1990-5#1)(1994-5#1)
of the blood-brain barrier##6##4##(1990-5#2)(1992-3#2)(1994-5#1)(2013-1#1)
of the bloom##2##3##(2008-8#2)
of the blue color##3##4##(2008-10#3)
of the blue complex##2##4##(2008-10#2)
of the blue##9##3##(1992-11#1)(1994-11#1)(2008-10#6)(2008-5#1)
of the board##2##3##(1995-12#1)(1995-6#1)
of the board's role##2##4##(1995-12#1)(2008-11#1)
of the body and##2##4##(2008-10#2)
of the body were##2##4##(1992-3#1)(2008-5#1)
of the body##17##3##(1992-3#2)(1993-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-5#5)(2010-6#1)(2010-7#1)(2013-1#3)
of the bolus##2##3##(1995-12#1)(2008-10#1)
of the bone and##3##4##(2008-10#1)(2010-6#2)
of the bone marrow##2##4##(2008-11#1)(2010-8#1)
of the bone union##3##4##(2007-8#3)
of the bone##19##3##(1991-11#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-12#1)
of the borderline##2##3##(1990-2#1)(1992-1#1)
of the both##2##3##(2008-10#1)(2013-1#1)
of the bound##6##3##(1990-10#1)(1990-12#2)(1994-5#1)(2008-7#1)(2008-8#1)
of the boundary##3##3##(2008-12#1)(2008-3#1)(2013-1#1)
of the bovine##5##3##(1991-6#1)(1992-10#1)(1994-8#2)(1996-3#1)
of the bowel wall##2##4##(2012-2#2)
of the boy##3##3##(1995-5#2)(2012-2#1)
of the boys and##3##4##(1991-9#3)
of the brachial##3##3##(2009-1#3)
of the brain and##5##4##(1990-11#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-8#1)
of the brain are##4##4##(1995-5#1)(1997-6#1)(2008-11#1)(2010-12#1)
of the brain as##2##4##(2009-12#1)(2009-6#1)
of the brain had##2##4##(1991-6#1)(2008-7#1)
of the brain has##2##4##(2007-12#1)(2008-11#1)
of the brain of##2##4##(1996-5#1)(2008-7#1)
of the brain stem##2##4##(2008-7#2)
of the brain that##3##4##(1996-12#1)(2008-4#1)(2009-5#1)
of the brain##58##3##(1990-11#1)(1990-8#1)(1991-1#1)(1991-6#1)(1993-3#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#4)(1996-5#1)(1997-6#1)(2007-12#2)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#12)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
of the brains of##2##4##(2008-11#1)(2011-2#1)
of the branch##3##3##(2008-3#2)(2008-9#1)
of the branched##2##3##(1996-5#1)(1997-2#1)
of the branchial heart complex of Sepia officinalis L##2##9##(2008-7#2)
of the branchial heart##4##4##(2008-7#4)
of the breast and##4##4##(1994-12#1)(1994-2#1)(2008-11#1)(2010-7#1)
of the breast in##2##4##(1990-11#1)(1994-12#1)
of the breast with##2##4##(1994-6#1)(2012-3#1)
of the breast##27##3##(1990-11#1)(1990-6#1)(1991-8#1)(1992-2#3)(1992-5#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-6#2)(1997-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-1#1)(2009-2#1)(2010-7#1)(2012-2#1)(2012-3#3)
of the breeding##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
of the bright##2##3##(2008-3#2)
of the broad##2##3##(1997-3#1)(2008-8#1)
of the bronchial vasculature##2##4##(1997-1#2)
of the bronchial##8##3##(1991-12#1)(1994-9#1)(1995-12#1)(1997-1#4)(2008-1#1)
of the bronchiolar stem##2##4##(2013-1#2)
of the brown##3##3##(2008-10#2)(2013-1#1)
of the buccal##2##3##(1992-9#1)(2011-2#1)
of the budding yeast##2##4##(1997-7#1)(2008-9#1)
of the budding##3##3##(1996-6#1)(1997-7#1)(2008-9#1)
of the buffer solution##2##4##(2008-10#2)
of the buffer##12##3##(1991-5#1)(2008-10#10)(2008-3#1)
of the building##2##3##(1992-2#1)(2010-7#1)
of the bulk material##2##4##(2010-4#1)(2012-2#1)
of the bulk solvent##2##4##(2008-10#2)
of the bulk##9##3##(2008-10#6)(2008-3#1)(2010-4#1)(2012-2#1)
of the burden of disease##2##5##(2012-12#2)
of the burden of##4##4##(2008-8#1)(2012-12#3)
of the burden##5##3##(2008-8#1)(2011-2#1)(2012-12#3)
of the c-Ki-ras gene##2##4##(1992-8#2)
of the c-Ki-ras##3##3##(1992-8#3)
of the c-myc gene##2##4##(1993-2#2)
of the c-myc##3##3##(1993-2#2)(2008-11#1)
of the cAMP##2##3##(1994-8#1)(2008-11#1)
of the cDNA clones##2##4##(1993-6#1)(1996-2#1)
of the cDNA for##2##4##(1995-2#1)(1996-12#1)
of the cDNA sequence##2##4##(1992-10#1)(2008-4#1)
of the cDNA##16##3##(1991-5#1)(1992-10#1)(1992-8#1)(1993-2#2)(1993-6#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)
of the cDNAs##3##3##(1994-11#1)(1995-8#2)
of the cabbage looper moth##2##5##(1990-8#2)
of the cabbage##3##3##(1990-8#2)(2008-8#1)
of the cadmium##3##3##(2008-10#3)
of the calcitonin/alpha-CGRP##2##3##(1992-6#2)
of the calcium##6##3##(1991-5#1)(1991-8#1)(1995-11#1)(1996-5#1)(2008-10#2)
of the calculated##2##3##(2008-3#1)(2012-12#1)
of the calculation##2##3##(1992-12#1)(2008-2#1)
of the calf uterine androgen receptor##2##6##(1990-11#2)
of the calf##5##3##(1990-11#2)(1991-6#1)(2008-10#1)(2011-2#1)
of the calibration curve was##2##5##(2008-10#2)
of the calibration curve##7##4##(2008-10#7)
of the calibration curves##5##4##(2008-10#4)(2009-8#1)
of the calibration graph is##5##5##(2008-10#5)
of the calibration graph##7##4##(2008-10#7)
of the calibration graphs##2##4##(2008-10#2)
of the calibration matrix##2##4##(2008-10#2)
of the calibration models##2##4##(2008-10#2)
of the calibration##41##3##(1995-9#1)(2008-10#39)(2009-8#1)
of the calibrator##3##3##(2008-10#3)
of the cancer##6##3##(1990-8#1)(2008-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#1)
of the candidate genes##3##4##(2008-8#1)(2011-2#1)(2012-3#1)
of the candidate##5##3##(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
of the canopy##3##3##(2008-10#2)(2008-9#1)
of the cap structure##4##4##(1997-2#2)(2008-10#2)
of the cap##5##3##(1995-6#1)(1997-2#2)(2008-10#2)
of the capabilities of##2##4##(2008-10#1)(2011-1#1)
of the capillary##6##3##(2008-10#4)(2008-3#2)
of the capsid##3##3##(1991-5#1)(2008-10#2)
of the carbohydrates##2##3##(2008-3#1)(2008-9#1)
of the carbon##4##3##(1995-9#1)(2008-10#2)(2011-2#1)
of the carbonyl##2##3##(1996-5#1)(2008-10#1)
of the carboxylic##4##3##(1991-9#1)(2008-10#3)
of the carcases##2##3##(1997-5#2)
of the carcinogenic##3##3##(1990-5#2)(2008-10#1)
of the cardiac##10##3##(1992-3#1)(1996-6#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-3#1)
of the cardiovascular##3##3##(2008-1#1)(2008-10#2)
of the care plan##3##4##(1993-3#1)(2013-1#2)
of the care##8##3##(1993-12#1)(1993-3#1)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
of the caregiving##2##3##(1992-3#1)(2008-7#1)
of the carotid artery##3##4##(1993-3#1)(2008-7#1)(2011-2#1)
of the carotid##6##3##(1993-3#1)(2008-7#2)(2010-6#1)(2011-2#2)
of the carp##2##3##(2008-5#2)
of the carpal##2##3##(2008-9#1)(2013-1#1)
of the carrier solution##4##4##(2008-10#4)
of the carrier##10##3##(1991-5#2)(2008-10#6)(2008-7#2)
of the cartilage##2##3##(1990-3#1)(2009-1#1)
of the cascade##2##3##(1992-2#1)(1994-6#1)
of the case##9##3##(1990-9#1)(1993-2#1)(1996-1#1)(1996-3#1)(2008-11#1)(2009-12#1)(2010-5#1)(2013-1#2)
of the cases and##3##4##(1993-2#1)(2008-11#1)(2008-5#1)
of the cases the##2##4##(1991-9#1)(2013-1#1)
of the cases was##2##4##(1991-8#1)(2008-10#1)
of the cases were reported##2##5##(1995-12#1)(1997-8#1)
of the cases##61##3##(1990-12#3)(1990-9#2)(1991-2#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-12#1)(1992-5#2)(1992-9#1)(1993-2#2)(1994-1#1)(1995-11#1)(1995-12#2)(1996-3#2)(1996-6#1)(1997-6#1)(1997-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#1)
of the catalyst##4##3##(2008-10#4)
of the catalytic domain of Cex##2##6##(1992-11#2)
of the catalytic domain##3##4##(1992-11#2)(1995-8#1)
of the catalytic hydrogen signal##2##5##(2008-10#2)
of the catalytic reaction##3##4##(2008-10#3)
of the catalytic subunit of##2##5##(1995-11#1)(1995-8#1)
of the catalytic subunit##4##4##(1995-11#1)(1995-2#2)(1995-8#1)
of the catalytic##23##3##(1992-11#2)(1992-3#2)(1992-6#1)(1993-8#2)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#2)(1997-7#1)(2008-10#8)(2008-11#1)
of the cataract##2##3##(2010-8#2)
of the catechol##2##3##(2008-10#2)
of the catheter##8##3##(1996-3#1)(1997-3#1)(2008-5#1)(2011-2#5)
of the cationic surfactant##2##4##(2008-10#1)(2008-8#1)
of the cationic##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
of the cations##5##3##(2008-10#5)
of the cats were##2##4##(2012-3#1)(2013-8#1)
of the cats##5##3##(2008-8#1)(2012-3#3)(2013-8#1)
of the caudal##5##3##(1990-5#1)(1990-9#1)(1997-8#1)(2008-10#1)(2012-3#1)
of the causal agent##3##4##(2008-10#3)
of the causal organism##2##4##(2008-10#2)
of the causal##9##3##(2008-10#8)(2010-5#1)
of the cause of##2##4##(1990-9#1)(1991-7#1)
of the cause##6##3##(1990-9#1)(1991-11#1)(1991-7#1)(2011-1#1)(2011-2#2)
of the causes of##4##4##(1995-5#1)(2008-3#1)(2012-12#1)(2013-1#1)
of the causes##6##3##(1991-6#1)(1995-5#1)(1996-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
of the cavernous sinus##2##4##(1990-12#1)(1993-9#1)
of the cavity and the##2##5##(2008-10#1)(2008-2#1)
of the cavity in##2##4##(1996-5#1)(2008-3#1)
of the cavity##10##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#6)
of the cecum##2##3##(2008-12#2)
of the cell and##2##4##(2008-6#1)(2008-9#1)
of the cell culture##3##4##(1996-2#1)(2008-11#1)(2012-2#1)
of the cell cycle by##2##5##(1994-3#1)(1997-1#1)
of the cell cycle in##2##5##(2008-11#1)(2008-4#1)
of the cell cycle##22##4##(1994-3#3)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#11)(2008-4#1)(2008-7#1)(2008-9#2)(2013-1#1)
of the cell line to##2##5##(2008-11#2)
of the cell line##8##4##(1990-5#1)(2008-11#7)
of the cell lines##6##4##(1992-8#1)(2008-11#4)(2008-8#1)
of the cell membrane##4##4##(1991-5#1)(1997-3#1)(2009-7#1)(2009-9#1)
of the cell population##4##4##(2008-11#2)(2008-7#1)(2013-1#1)
of the cell size##4##4##(1995-9#3)(2008-7#1)
of the cell surface##5##4##(1995-2#1)(2007-12#1)(2008-10#1)(2009-9#2)
of the cell suspension##2##4##(2008-11#2)
of the cell volume##2##4##(2008-11#1)(2008-7#1)
of the cell wall##3##4##(2008-10#3)
of the cell##112##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-3#3)(1994-8#1)(1995-2#1)(1995-9#4)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#2)(2007-12#2)(2008-10#9)(2008-11#43)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
of the cells and was##3##5##(2008-10#1)(2008-11#2)
of the cells and##9##4##(1990-8#1)(1995-12#1)(2008-10#3)(2008-11#4)
of the cells at##4##4##(2008-11#4)
of the cells co-cultured with the##2##6##(2009-7#2)
of the cells grown##2##4##(2008-11#1)(2008-5#1)
of the cells in##5##4##(1995-9#1)(2008-11#4)
of the cells to##4##4##(1990-5#1)(1992-8#1)(2008-11#2)
of the cells was##5##4##(2008-10#1)(2008-11#3)(2013-1#1)
of the cells were##3##4##(1991-5#1)(1994-8#1)(2008-11#1)
of the cells with##6##4##(1995-12#1)(1997-1#4)(2008-11#1)
of the cells##79##3##(1990-5#1)(1990-8#2)(1991-5#2)(1991-6#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#3)(1995-12#2)(1995-9#1)(1996-2#1)(1997-1#4)(1997-7#1)(2008-10#7)(2008-11#35)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-7#2)(2009-8#1)(2011-3#1)(2013-1#1)
of the cells'##2##3##(2012-2#1)(2013-8#1)
of the cellular##18##3##(1994-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-7#2)(2009-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
of the central beta-noradrenergic##2##4##(1997-2#2)
of the central cell##4##4##(2008-11#1)(2008-9#3)
of the central metabolism##2##4##(2008-7#2)
of the central nervous system (CNS)##4##6##(1991-2#1)(1996-12#1)(2011-2#1)(2013-8#1)
of the central nervous system by##2##6##(2008-7#1)(2011-2#1)
of the central nervous system##23##5##(1990-8#1)(1991-2#2)(1993-9#1)(1995-5#1)(1996-12#2)(2007-12#1)(2008-11#1)(2008-7#5)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-8#1)
of the central##44##3##(1990-8#1)(1991-2#2)(1992-3#1)(1993-12#1)(1993-9#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-7#7)(2008-8#1)(2008-9#4)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
of the centrosome protein##2##4##(2008-9#2)
of the century##5##3##(1992-2#1)(1994-9#1)(1997-3#1)(1997-6#1)(2008-10#1)
of the ceramide##2##3##(1994-5#1)(2008-5#1)
of the cerebellar##4##3##(1997-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the cerebellum##3##3##(1991-1#1)(1992-6#1)(2013-1#1)
of the cerebral cortex##2##4##(2008-11#1)(2011-2#1)
of the cerebral##7##3##(1992-12#1)(1994-2#1)(1997-5#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
of the cerebrospinal fluid##2##4##(2008-7#1)(2011-2#1)
of the certified reference##2##4##(2008-10#2)
of the certified values##2##4##(2008-10#2)
of the certified##6##3##(2008-10#6)
of the cervical cancer##2##4##(2011-3#1)(2012-3#1)
of the cervical spine are##2##5##(1997-4#1)(2011-2#1)
of the cervical spine revealed##2##5##(2009-3#2)
of the cervical spine##15##4##(1997-4#1)(2009-3#3)(2010-12#3)(2011-2#4)(2012-12#2)(2013-1#2)
of the cervical##20##3##(1990-6#1)(1991-2#1)(1997-4#1)(2009-3#3)(2010-12#3)(2011-2#5)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
of the cervix in##2##4##(1991-3#1)(1996-6#1)
of the cervix##9##3##(1990-8#3)(1991-3#1)(1992-2#1)(1994-1#1)(1996-6#1)(2008-11#1)(2012-3#1)
of the chain of##3##4##(1994-2#1)(2008-12#1)(2010-8#1)
of the challenges and##3##4##(1996-2#1)(2010-5#1)(2010-6#1)
of the challenges of##2##4##(2008-11#1)(2011-1#1)
of the challenges##7##3##(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-5#1)(2010-6#1)(2011-1#1)
of the change in the##2##5##(1990-5#1)(1997-2#1)
of the change in##5##4##(1990-5#1)(1997-2#1)(2008-10#3)
of the change of##3##4##(2008-10#2)(2008-8#1)
of the change##10##3##(1990-5#1)(1996-1#1)(1997-2#1)(2008-10#6)(2008-8#1)
of the changes in##4##4##(1994-1#1)(2008-11#1)(2010-10#1)(2010-9#1)
of the changes of##2##4##(2008-5#1)(2008-8#1)
of the changes##14##3##(1994-1#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-9#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-9#1)
of the channels##2##3##(1995-2#1)(2008-10#1)
of the characteristic features of##2##5##(2008-5#1)(2010-7#1)
of the characteristic features##3##4##(2008-11#1)(2008-5#1)(2010-7#1)
of the characteristic##13##3##(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#2)(2010-7#1)(2011-2#2)(2012-2#1)
of the characteristics of the##2##5##(2008-10#1)(2011-2#1)
of the characteristics of##6##4##(1992-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)
of the characteristics##7##3##(1992-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)
of the characterization of##2##4##(1995-6#1)(2008-11#1)
of the characterization##3##3##(1995-6#1)(2008-11#1)(2008-3#1)
of the charge is##2##4##(2007-11#2)
of the charge##6##3##(1997-6#1)(2007-11#2)(2008-10#3)
of the chelate is 1##3##5##(2008-10#3)
of the chelate##6##3##(2008-10#6)
of the chelating resin##2##4##(2008-10#2)
of the chelating##6##3##(2008-10#6)
of the chemical alternatives##2##4##(2008-10#2)
of the chemical composition##2##4##(2008-11#1)(2010-4#1)
of the chemical species##3##4##(2008-10#2)(2008-3#1)
of the chemical##27##3##(1993-12#1)(1995-11#2)(2008-10#17)(2008-11#3)(2008-3#1)(2008-5#1)(2010-4#1)(2010-7#1)
of the chemicals##2##3##(1996-12#1)(2011-1#1)
of the chemiluminescence##4##3##(2008-10#4)
of the chemokine##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
of the chemometric##2##3##(2008-10#2)
of the chest revealed a##2##5##(1991-9#1)(2008-7#1)
of the chest##3##3##(1991-9#1)(2007-8#1)(2008-7#1)
of the chestnut blight fungus##2##5##(2008-10#2)
of the chicken beta##2##4##(1991-5#2)
of the chicken##13##3##(1991-5#3)(1991-6#2)(1993-12#1)(1993-2#1)(1997-7#1)(1997-9#1)(2008-12#1)(2008-5#3)
of the chickpea cultivar##3##4##(2008-10#3)
of the child and##2##4##(1995-5#1)(2008-11#1)
of the child##18##3##(1992-12#1)(1994-6#1)(1995-5#6)(1996-2#1)(1997-2#1)(2008-11#2)(2010-9#3)(2011-2#1)(2012-2#1)(2012-3#1)
of the child's##4##3##(1992-1#2)(2010-6#1)(2011-2#1)
of the children and##3##4##(1991-2#1)(2008-11#1)(2012-12#1)
of the children are##2##4##(1990-6#1)(2008-9#1)
of the children were##3##4##(1990-12#1)(1996-1#1)(2012-12#1)
of the children with##4##4##(1996-1#1)(2008-11#2)(2012-2#1)
of the children##31##3##(1990-12#4)(1990-6#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-2#1)(1994-12#1)(1995-5#1)(1996-1#2)(1996-9#1)(2008-11#3)(2008-12#1)(2008-9#5)(2010-4#1)(2010-9#1)(2012-12#3)(2012-2#1)(2013-1#1)
of the chiral##4##3##(1997-2#1)(2008-10#3)
of the chloride ion##2##4##(2008-10#2)
of the chloride##3##3##(2008-10#3)
of the chloroplast signal recognition particle##2##6##(2009-7#2)
of the chloroplast##3##3##(2008-12#1)(2009-7#2)
of the choice of##2##4##(1991-3#1)(2008-8#1)
of the choice##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
of the cholesterol content##2##4##(2008-10#1)(2008-6#1)
of the cholesterol##4##3##(1994-8#1)(2008-10#2)(2008-6#1)
of the choroid##2##3##(1996-12#1)(2013-1#1)
of the chromatographic##5##3##(2008-10#5)
of the chromium##4##3##(2008-10#4)
of the chromophore in##2##4##(2008-10#1)(2008-8#1)
of the chromophore##6##3##(1994-5#1)(1996-5#1)(2008-10#2)(2008-8#1)(2009-9#1)
of the chromophores##2##3##(1996-5#1)(2009-9#1)
of the chromosomal##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
of the chromosome##10##3##(1990-8#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-3#1)(2013-8#1)
of the chromosomes##2##3##(2008-11#1)(2008-12#1)
of the chronic##3##3##(1997-2#1)(2007-8#1)(2008-4#1)
of the ciliary##2##3##(1992-8#1)(2011-2#1)
of the cilium##2##3##(2008-7#1)(2013-1#1)
of the circadian##3##3##(1993-6#1)(2008-11#1)(2009-8#1)
of the circle##2##3##(2008-7#1)(2008-8#1)
of the circuit and##2##4##(2008-11#1)(2010-9#1)
of the circuit##3##3##(2008-11#2)(2010-9#1)
of the cited##2##3##(2008-10#2)
of the citrate##2##3##(1992-9#1)(2012-5#1)
of the city of##5##4##(2008-10#1)(2008-5#3)(2013-1#1)
of the city##11##3##(1990-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#4)(2013-1#1)
of the class I##2##4##(1991-2#1)(1995-12#1)
of the class of##2##4##(1994-5#1)(2008-9#1)
of the class##7##3##(1991-2#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
of the classic##4##3##(1994-5#1)(2008-10#2)(2010-7#1)
of the classical##8##3##(1991-12#1)(1991-8#1)(1996-3#1)(2008-10#2)(2009-5#1)(2012-2#1)(2012-3#1)
of the classification##3##3##(1991-12#1)(1991-9#1)(2010-6#1)
of the claw##2##3##(2011-2#2)
of the cleavage##2##3##(1995-6#2)
of the cleaved##3##3##(1994-8#1)(1997-7#1)(2008-10#1)
of the clinical and pathological##2##5##(1991-12#1)(2011-2#1)
of the clinical and##4##4##(1991-12#1)(1997-3#1)(2011-2#2)
of the clinical features##2##4##(2008-5#1)(2008-7#1)
of the clinical records##2##4##(1992-9#1)(1993-11#1)
of the clinical trial##2##4##(1992-9#1)(2008-7#1)
of the clinical##37##3##(1990-3#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-12#2)(1997-3#2)(1997-5#1)(1997-6#3)(1997-8#1)(2008-11#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#3)(2012-3#1)
of the clinically##2##3##(1997-2#1)(2008-5#1)
of the clinician-trainer program##2##4##(2008-11#2)
of the clonal##4##3##(1994-11#1)(2008-10#3)
of the cloned fragments##2##4##(2008-10#2)
of the cloned##11##3##(1991-9#1)(1992-3#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)
of the clones##4##3##(1997-2#2)(1997-8#1)(2008-11#1)
of the close##4##3##(1990-11#1)(1991-6#1)(2008-11#1)(2013-1#1)
of the cloud##2##3##(2008-10#1)(2008-3#1)
of the cluster##2##3##(1996-6#1)(2013-1#1)
of the clusters##2##3##(1995-6#1)(2008-10#1)
of the coat protein (CP) and##2##6##(2008-10#2)
of the coat protein (CP) gene was##2##7##(2008-10#1)(2008-8#1)
of the coat protein (CP) gene##3##6##(2008-10#2)(2008-8#1)
of the coat protein (CP)##5##5##(2008-10#4)(2008-8#1)
of the coat protein gene##2##5##(2008-10#2)
of the coat protein##10##4##(2008-10#9)(2008-8#1)
of the coat##11##3##(2008-10#10)(2008-8#1)
of the coated##2##3##(2008-10#2)
of the coating##4##3##(2008-10#2)(2008-3#1)(2009-7#1)
of the coatings##2##3##(2008-3#1)(2010-4#1)
of the cobalt complex##2##4##(2008-10#2)
of the cochlea and the cochlear implant##2##7##(2012-2#2)
of the cochlea and the##3##5##(2012-2#3)
of the cochlea and##4##4##(2008-9#1)(2012-2#3)
of the cochlea##5##3##(2008-9#2)(2012-2#3)
of the cochlear##2##3##(2008-9#1)(2012-2#1)
of the coding region for##2##5##(1990-7#2)
of the coding region of##4##5##(1993-2#1)(1995-12#1)(2008-4#1)(2008-8#1)
of the coding region##7##4##(1990-7#2)(1993-2#1)(1993-6#1)(1995-12#1)(2008-4#1)(2008-8#1)
of the coding regions##2##4##(1991-9#1)(2008-10#1)
of the coding##13##3##(1990-7#2)(1991-9#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-2#2)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
of the coenzyme##2##3##(2008-10#1)(2013-8#1)
of the coevolution##2##3##(2008-8#2)
of the cognate##2##3##(2008-9#2)
of the cognitive##3##3##(2008-2#1)(2008-9#1)(2009-10#1)
of the coherent##2##3##(2008-10#1)(2008-2#1)
of the coiled##2##3##(1992-9#1)(2008-2#1)
of the cold##2##3##(2008-11#1)(2011-2#1)
of the collaborative##2##3##(2008-10#1)(2013-1#1)
of the collagen##5##3##(1992-6#2)(2008-7#1)(2009-7#1)(2013-1#1)
of the collateral##2##3##(1991-2#1)(1997-3#1)
of the collected data##2##4##(2008-10#1)(2008-11#1)
of the collected##3##3##(2008-10#2)(2008-11#1)
of the collecting##2##3##(2008-2#1)(2011-2#1)
of the collection##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
of the collector##2##3##(2008-10#2)
of the colon is##2##4##(1990-9#1)(2010-12#1)
of the colon##11##3##(1990-11#1)(1990-3#2)(1990-9#1)(1991-6#1)(1994-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2009-1#1)(2010-12#1)
of the colonies##2##3##(2008-10#1)(2008-11#1)
of the colonization process##2##4##(2008-10#1)(2008-8#1)
of the colonization##3##3##(2008-10#1)(2008-8#2)
of the colony##4##3##(2008-10#3)(2008-6#1)
of the color of the##2##5##(2008-10#2)
of the color##5##3##(2008-10#4)(2008-3#1)
of the colored##2##3##(2008-10#2)
of the coloured complex##2##4##(2008-10#2)
of the coloured##5##3##(2008-10#5)
of the colposcopy directed##2##4##(2008-11#2)
of the column##4##3##(2008-10#4)
of the columns##4##3##(2008-10#4)
of the combination of##5##4##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)
of the combination##8##3##(1995-5#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)
of the combined method of##2##5##(2008-10#1)(2013-1#1)
of the combined use of##2##5##(1997-7#1)(2008-7#1)
of the combined##9##3##(1992-9#1)(1993-6#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
of the commercial##5##3##(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the commercially available##2##4##(2008-10#2)
of the common bean (Phaseolus vulgaris)##2##6##(2008-10#2)
of the common bean##4##4##(2008-10#4)
of the common bile duct##5##5##(1990-5#2)(1990-9#1)(1996-11#1)(2009-9#1)
of the common carotid artery##2##5##(2008-7#2)
of the common##34##3##(1990-5#2)(1990-9#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#2)(2009-1#1)(2009-9#1)(2010-7#1)(2010-8#1)(2013-1#1)
of the communication##2##3##(2008-11#1)(2008-3#1)
of the community##15##3##(1992-1#1)(1993-2#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-6#1)(2013-1#2)
of the comparison##4##3##(1996-3#1)(2008-10#1)(2008-2#2)
of the competition##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
of the competitive interaction##2##4##(2008-10#2)
of the competitive##5##3##(2008-10#5)
of the complement system##2##4##(1991-2#1)(2008-10#1)
of the complement##4##3##(1991-2#1)(1993-11#1)(2008-10#1)(2008-12#1)
of the complementary target##2##4##(2008-10#2)
of the complementary##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
of the complete ITS##2##4##(2008-10#2)
of the complete##17##3##(1991-11#1)(1993-3#1)(1993-8#1)(1996-8#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#2)
of the completed##3##3##(1992-3#2)(2012-12#1)
of the complex and##2##4##(2010-6#1)(2011-2#1)
of the complex are##5##4##(1995-2#1)(2008-10#3)(2009-10#1)
of the complex formation##2##4##(2008-10#2)
of the complex formed##2##4##(1994-5#1)(2008-10#1)
of the complex has been##2##5##(2008-10#2)
of the complex in##2##4##(2008-10#2)
of the complex is 1##2##5##(2008-10#2)
of the complex is##8##4##(2008-10#8)
of the complex of##4##4##(1993-8#2)(2008-10#1)(2008-11#1)
of the complex species##3##4##(2008-10#3)
of the complex was##6##4##(1990-5#1)(2008-10#5)
of the complex with##2##4##(2008-10#2)
of the complex##81##3##(1990-5#1)(1990-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-9#1)(2008-10#53)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-6#2)(2011-2#3)(2013-8#2)
of the complexation reaction##2##4##(2008-10#2)
of the complexation##5##3##(2008-10#5)
of the complexed##2##3##(2008-10#2)
of the complexes of##4##4##(2008-10#4)
of the complexes##21##3##(1990-2#1)(1994-5#1)(2008-10#18)(2010-7#1)
of the complexing agent was##2##5##(2008-10#2)
of the complexing agent##5##4##(2008-10#5)
of the complexity of the##5##5##(1995-5#1)(2008-10#2)(2008-12#1)(2010-12#1)
of the complexity of##6##4##(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)
of the complications##3##3##(1994-6#1)(1996-12#1)(2010-1#1)
of the component proteins##2##4##(1992-12#1)(1992-9#1)
of the component##7##3##(1991-12#1)(1992-12#1)(1992-9#1)(2008-10#3)(2013-8#1)
of the components and##2##4##(2008-10#2)
of the components is##2##4##(1992-9#1)(2008-10#1)
of the components of the##6##5##(1991-12#1)(2008-10#4)(2009-10#1)
of the components of##11##4##(1991-12#1)(1995-5#1)(1996-2#1)(2008-10#6)(2008-11#1)(2009-10#1)
of the components##22##3##(1991-12#1)(1992-9#1)(1995-5#1)(1996-2#1)(2008-10#15)(2008-11#1)(2008-3#1)(2009-10#1)
of the composite materials##2##4##(2008-10#1)(2009-7#1)
of the composite##6##3##(2008-10#4)(2009-7#2)
of the composition of sialoliths##2##5##(2008-10#2)
of the composition of the##5##5##(2008-10#5)
of the composition of##10##4##(2008-10#10)
of the composition##13##3##(1990-5#1)(2008-10#12)
of the compost mix##2##4##(2008-10#2)
of the compost water extract##2##5##(2008-10#2)
of the compost##5##3##(2008-10#5)
of the compound in##2##4##(2008-10#2)
of the compound to##2##4##(2008-10#2)
of the compound##13##3##(1990-5#1)(1992-9#1)(1993-1#1)(2008-10#8)(2009-6#1)(2011-3#1)
of the compounds at##2##4##(2008-10#1)(2011-3#1)
of the compounds most frequently##2##5##(2008-10#2)
of the compounds present##2##4##(2008-10#2)
of the compounds was##2##4##(2008-10#2)
of the compounds were##3##4##(2008-10#2)(2008-5#1)
of the compounds##32##3##(1991-3#1)(1992-3#1)(1992-8#1)(1994-8#1)(1996-5#1)(2008-10#21)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-3#1)(2012-12#1)
of the compression##2##3##(2008-9#1)(2013-8#1)
of the computational##2##3##(1992-9#1)(2008-3#1)
of the computer##3##3##(1991-9#1)(2008-10#1)(2010-5#1)
of the concentrate was##2##4##(2008-10#1)(2012-2#1)
of the concentrated##4##3##(2008-10#4)
of the concentration of##22##4##(2008-10#18)(2008-11#2)(2008-3#1)(2008-4#1)
of the concentration range##2##4##(2008-10#2)
of the concentration##27##3##(2008-10#23)(2008-11#2)(2008-3#1)(2008-4#1)
of the concentrations of##3##4##(1994-11#1)(2008-10#2)
of the concentrations##5##3##(1994-11#1)(2008-10#4)
of the concept of##6##4##(1993-1#1)(1995-5#1)(2008-12#2)(2008-3#1)(2009-12#1)
of the concept##11##3##(1993-1#1)(1995-5#1)(2008-10#2)(2008-12#2)(2008-3#1)(2009-1#1)(2009-12#1)(2009-5#1)(2012-3#1)
of the conclusions##2##3##(2008-10#1)(2010-6#1)
of the condensed tannin##2##4##(2008-10#2)
of the condition##9##3##(1990-3#1)(1990-9#1)(1992-5#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#2)
of the conditional##2##3##(2008-10#2)
of the conditions for##2##4##(2008-10#2)
of the conditions of##2##4##(2008-10#1)(2013-1#1)
of the conditions##5##3##(2008-10#3)(2008-12#1)(2013-1#1)
of the conducting airways##2##4##(1991-12#1)(2013-1#1)
of the conducting##4##3##(1991-12#1)(2008-10#1)(2013-1#2)
of the conference##5##3##(1993-12#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
of the conically sculpted##2##4##(1995-2#2)
of the conidia##4##3##(2008-10#4)
of the conjugate##3##3##(1994-11#1)(2008-10#2)
of the conjugated##2##3##(1991-5#1)(1992-3#1)
of the connecting peptide##3##4##(2008-9#3)
of the connective##2##3##(1990-2#1)(2012-2#1)
of the consensus values##2##4##(2008-10#2)
of the consensus##7##3##(1994-5#1)(2008-10#5)(2011-2#1)
of the conserved##5##3##(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-6#1)
of the constituent##2##3##(2008-10#1)(2012-2#1)
of the constituents##3##3##(2008-10#1)(2008-11#1)(2011-3#1)
of the constitutional##2##3##(1996-9#1)(2011-2#1)
of the constitutive##2##3##(1995-11#1)(2009-3#1)
of the construct##2##3##(2008-10#1)(2013-1#1)
of the construction of##2##4##(2008-10#1)(2008-3#1)
of the construction##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
of the consultant##2##3##(1996-2#1)(2012-3#1)
of the consumer##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the consumers##2##3##(2008-8#1)(2010-8#1)
of the consumption##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
of the contact surface##2##4##(2008-10#2)
of the contact##7##3##(1993-1#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2013-1#1)
of the contemporary##2##3##(1996-1#1)(2011-2#1)
of the content of##3##4##(2008-10#2)(2011-3#1)
of the context##2##3##(2008-7#1)(2009-6#1)
of the continent##2##3##(2008-10#1)(2008-12#1)
of the continuous##6##3##(1993-3#1)(2008-10#3)(2008-11#1)(2008-8#1)
of the contract##2##3##(1993-12#1)(1996-12#1)
of the contralateral##6##3##(1990-9#1)(1993-3#2)(1994-2#1)(1996-12#1)(2008-9#1)
of the contrast##2##3##(2008-6#2)
of the contribution of##7##4##(1993-1#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-1#1)
of the contribution##8##3##(1991-12#1)(1993-1#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-1#1)
of the control group (P &lt##2##6##(1994-3#1)(2012-3#1)
of the control group##5##4##(1994-3#1)(2008-8#1)(2011-2#2)(2012-3#1)
of the control groups in both studies##2##7##(2008-9#2)
of the control groups##6##4##(2008-9#6)
of the control knees and##2##5##(2008-8#2)
of the control level##2##4##(1994-12#2)
of the control##35##3##(1991-5#1)(1992-6#1)(1993-12#1)(1994-12#2)(1994-3#2)(1994-8#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#4)(2008-9#8)(2010-3#1)(2011-2#3)(2012-3#1)
of the controls for##2##4##(2008-10#1)(2008-9#1)
of the controls##6##3##(1996-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)
of the convective##2##3##(2008-3#2)
of the conventional method##3##4##(2008-12#2)(2008-8#1)
of the conventional##18##3##(2007-12#2)(2008-10#6)(2008-12#2)(2008-3#2)(2008-8#2)(2009-3#1)(2010-4#1)(2010-8#1)(2013-1#1)
of the conversion of##4##4##(1995-3#1)(2008-10#1)(2008-8#1)(2010-5#1)
of the coordinate##2##3##(2008-10#1)(2010-7#1)
of the copolymer##2##3##(2008-10#1)(2008-11#1)
of the copper oxide##2##4##(2008-10#2)
of the copper##3##3##(2008-10#3)
of the copper(II)##2##3##(2008-10#2)
of the coracoid##2##3##(2013-1#2)
of the core##6##3##(1991-9#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
of the cornea##4##3##(2008-11#1)(2011-2#1)(2011-7#1)(2013-1#1)
of the corneocyte##2##3##(2008-5#2)
of the coronary arteries in##2##5##(2012-3#2)
of the coronary arteries##4##4##(2012-3#4)
of the coronary artery##2##4##(2008-12#1)(2013-2#1)
of the coronary##6##3##(2008-12#1)(2012-3#4)(2013-2#1)
of the corpora cavernosa##2##4##(2008-10#2)
of the corpus callosum##2##4##(1996-2#1)(2011-2#1)
of the corpus##5##3##(1995-11#1)(1995-12#1)(1996-2#1)(2011-2#1)(2013-1#1)
of the correct##3##3##(2008-11#1)(2008-2#1)(2012-3#1)
of the correlation between##2##4##(1995-9#1)(2008-10#1)
of the correlation coefficients##2##4##(2008-10#2)
of the correlation##6##3##(1995-9#1)(2008-10#5)
of the corresponding gene##4##4##(1993-2#1)(1995-8#1)(1997-6#1)(2011-1#1)
of the corresponding genes##4##4##(1995-8#1)(1996-2#1)(2008-10#1)(2009-8#1)
of the corresponding proteins##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
of the corresponding##44##3##(1990-11#1)(1990-5#2)(1991-12#1)(1991-6#1)(1993-2#1)(1993-8#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#2)(2009-8#2)(2010-6#1)(2011-1#2)(2011-2#2)
of the cortex##7##3##(1990-12#1)(1990-9#1)(1996-12#1)(2008-11#1)(2010-7#3)
of the cortical##4##3##(2008-5#1)(2010-7#3)
of the cos##2##3##(1990-11#1)(1996-2#1)
of the cost of##6##4##(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
of the cost##8##3##(1995-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-2#1)
of the costs and##2##4##(1993-12#1)(2010-9#1)
of the costs##3##3##(1993-12#1)(2008-7#1)(2010-9#1)
of the counter ion##2##4##(2008-10#2)
of the counterpart##2##3##(1993-8#1)(1994-11#1)
of the country##7##3##(1993-12#1)(1994-6#1)(1996-1#1)(2008-10#3)(2009-10#1)
of the coupled##3##3##(2008-10#3)
of the couples##2##3##(1996-9#2)
of the coupling##2##3##(1995-11#1)(2008-10#1)
of the course of pregnancy and labor##2##7##(2012-3#2)
of the course##13##3##(2008-11#8)(2008-12#2)(2012-3#2)(2013-8#1)
of the coverage##2##3##(1993-9#1)(2008-10#1)
of the cox I and II##2##6##(2008-10#2)
of the craniofacial skeleton##4##4##(2010-6#4)
of the craniofacial##5##3##(2008-9#1)(2010-6#4)
of the cranium##6##3##(1996-9#2)(2008-7#2)(2010-6#1)(2013-8#1)
of the creams##2##3##(2008-5#2)
of the creation of##2##4##(2008-10#1)(2008-11#1)
of the criterion##2##3##(2008-10#1)(2010-2#1)
of the critical steps##2##4##(2008-8#1)(2008-9#1)
of the critical##7##3##(2008-11#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
of the crop##3##3##(2008-10#2)(2008-8#1)
of the cropping##2##3##(2008-10#2)
of the cross##4##3##(2008-10#3)(2008-3#1)
of the crown##4##3##(2008-10#3)(2013-1#1)
of the crude extract##2##4##(2008-10#1)(2008-12#1)
of the crude##7##3##(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2013-1#1)
of the cryopreservation##2##3##(1996-8#2)
of the crystal structure of##2##5##(1994-3#1)(2012-2#1)
of the crystal##8##3##(1994-3#1)(2008-2#5)(2008-3#1)(2012-2#1)
of the crystalline##6##3##(1993-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
of the cultivars##4##3##(2008-10#4)
of the cultivation of##3##4##(2008-11#3)
of the culturable##2##3##(2008-10#2)
of the cultural##3##3##(2008-10#2)(2012-3#1)
of the culture and##2##4##(2008-11#1)(2008-7#1)
of the culture medium##2##4##(1995-3#1)(2008-11#1)
of the culture under no CO(2) supply was##2##8##(2008-11#2)
of the culture under##4##4##(2008-11#4)
of the culture##17##3##(1995-3#1)(2008-11#12)(2008-7#3)(2008-8#1)
of the cultured##2##3##(2008-11#2)
of the cultures##8##3##(2008-10#2)(2008-11#6)
of the current knowledge on the##2##6##(2009-4#1)(2011-7#1)
of the current knowledge on##3##5##(2008-11#1)(2009-4#1)(2011-7#1)
of the current literature##5##4##(1997-8#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-2#1)
of the current methods##2##4##(1997-7#1)(2008-11#1)
of the current paper##2##4##(1997-3#1)(2010-10#1)
of the current research##3##4##(2008-7#1)(2010-12#1)(2012-2#1)
of the current state of##3##5##(2008-10#1)(2011-2#1)(2012-2#1)
of the current study##2##4##(2008-10#1)(2011-2#1)
of the current##54##3##(1994-1#1)(1996-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#8)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#5)(2011-7#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
of the currently##4##3##(2008-1#1)(2008-11#1)(2012-2#2)
of the curriculum##5##3##(1994-1#2)(1994-12#1)(2008-11#1)(2008-12#1)
of the curvature##2##3##(2008-3#1)(2008-9#1)
of the curve##2##3##(2008-10#2)
of the curves for##3##4##(2008-10#1)(2008-7#2)
of the curves##7##3##(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)
of the cutaneous##4##3##(1990-9#1)(2008-5#2)(2009-1#1)
of the cuticle##2##3##(1993-12#1)(2008-10#1)
of the cuticular hydrocarbons##2##4##(2008-9#2)
of the cuticular##4##3##(2007-12#1)(2008-5#1)(2008-9#2)
of the cw##3##3##(2008-2#1)(2008-3#2)
of the cyanide##2##3##(1993-8#1)(2008-10#1)
of the cycle##2##3##(1990-12#1)(2008-10#1)
of the cyclic AMP##2##4##(1993-6#1)(1997-2#1)
of the cyclic##3##3##(1993-6#1)(1996-12#1)(1997-2#1)
of the cyclin-dependent kinase inhibitor##2##5##(2008-11#2)
of the cyclo-oxygenase##2##3##(1995-11#1)(1995-6#1)
of the cyclodextrin##2##3##(2008-10#2)
of the cyclooxygenase##2##3##(1994-5#2)
of the cylinder##4##3##(2008-3#2)(2009-2#2)
of the cyst and##2##4##(1991-8#1)(2008-10#1)
of the cyst was##2##4##(1997-8#1)(2008-7#1)
of the cyst##7##3##(1990-6#1)(1991-8#3)(1997-8#1)(2008-10#1)(2008-7#1)
of the cystic duct##5##4##(1992-9#3)(2008-12#2)
of the cystic##8##3##(1992-9#3)(2008-10#1)(2008-12#2)(2008-5#1)(2009-3#1)
of the cysts##3##3##(1995-12#1)(2012-2#1)(2012-3#1)
of the cytobrush##2##3##(1992-1#2)
of the cytochrome oxidase##3##4##(1995-6#2)(2008-11#1)
of the cytochrome##11##3##(1992-3#1)(1994-5#3)(1995-6#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#2)
of the cytokine receptor superfamily##2##5##(1996-2#2)
of the cytokine##3##3##(1996-2#3)
of the cytokines##2##3##(1994-6#1)(2008-11#1)
of the cytological##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
of the cytomegalovirus##2##3##(1995-12#1)(2008-11#1)
of the cytoplasm##2##3##(1991-11#1)(2012-7#1)
of the cytoskeletal##2##3##(1997-2#1)(2008-11#1)
of the cytosol fraction##2##4##(1990-11#1)(2008-10#1)
of the cytosol##4##3##(1990-11#1)(1990-5#2)(2008-10#1)
of the cytosolic##4##3##(1990-5#1)(1994-11#2)(1994-2#1)
of the cytostatic genes##2##4##(2008-7#2)
of the cytostatic##3##3##(2008-7#3)
of the cytotoxic##5##3##(1990-12#2)(1993-1#1)(2008-11#1)(2010-12#1)
of the daily##2##3##(1996-12#1)(2011-2#1)
of the damages##2##3##(1995-6#1)(2009-8#1)
of the dansyl##4##3##(1994-5#2)(2008-10#2)
of the dark##2##3##(1994-2#1)(2008-3#1)
of the data and##3##4##(1995-11#1)(2009-5#1)(2011-3#1)
of the data from the##2##5##(2008-10#2)
of the data have been##2##5##(1994-6#1)(2008-10#1)
of the data in##2##4##(2008-10#1)(2008-11#1)
of the data indicated##2##4##(2008-10#2)
of the data is##2##4##(2008-3#1)(2008-6#1)
of the data of##3##4##(1997-8#1)(2008-10#1)(2012-3#1)
of the data on##2##4##(2008-11#1)(2008-3#1)
of the data set##3##4##(1997-6#1)(2008-10#2)
of the data sets at the##2##6##(2008-10#2)
of the data sets using##2##5##(2008-10#2)
of the data sets##5##4##(2008-10#5)
of the data to##3##4##(2008-10#2)(2008-11#1)
of the data was##3##4##(1995-8#1)(2008-10#1)(2008-11#1)
of the data with##2##4##(2008-10#1)(2009-6#1)
of the data##63##3##(1991-2#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-8#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-8#2)(2009-5#1)(2009-6#1)(2010-10#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
of the database##5##3##(1991-3#1)(1992-12#1)(1994-12#1)(2010-5#2)
of the day##6##3##(1991-9#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-2#1)
of the days##2##3##(2008-11#1)(2008-9#1)
of the de novo##2##4##(1997-3#1)(2008-4#1)
of the de##4##3##(1997-3#1)(2008-10#2)(2008-4#1)
of the dead##2##3##(1991-11#1)(2011-2#1)
of the death##3##3##(1991-12#1)(2009-3#1)(2013-1#1)
of the deaths##2##3##(2012-12#1)(2012-3#1)
of the debate##2##3##(1997-1#1)(2008-8#1)
of the decaying tissue##2##4##(2008-10#2)
of the decision##2##3##(2008-10#2)
of the decrease in##5##4##(1991-3#1)(2006-6#1)(2008-10#2)(2009-7#1)
of the decrease##6##3##(1991-3#1)(1995-2#1)(2006-6#1)(2008-10#2)(2009-7#1)
of the decreased##2##3##(2008-10#1)(2008-8#1)
of the decreasing##2##3##(2008-10#1)(2012-3#1)
of the deduced amino acid sequence##2##6##(1993-9#1)(2008-8#1)
of the deduced amino acid sequences##3##6##(2008-10#2)(2008-9#1)
of the deduced amino acid##5##5##(1993-9#1)(2008-10#2)(2008-8#1)(2008-9#1)
of the deduced##11##3##(1991-6#1)(1992-8#1)(1993-6#2)(1993-9#1)(2008-10#4)(2008-8#1)(2008-9#1)
of the deep##2##3##(2008-9#2)
of the defect##5##3##(1991-2#1)(1997-3#1)(2008-3#1)(2008-7#1)(2011-2#1)
of the defective##2##3##(1995-9#1)(2008-11#1)
of the defense##6##3##(1992-12#1)(1995-6#1)(2008-10#1)(2008-9#3)
of the defensive##2##3##(2007-12#2)
of the deficiency##4##3##(1993-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the defined##2##3##(2008-10#1)(2008-11#1)
of the definitions##2##3##(1991-2#1)(1993-2#1)
of the deformation##2##3##(2008-10#1)(2009-7#1)
of the degradation products of##2##5##(2008-10#2)
of the degradation products##6##4##(2008-10#6)
of the degradation##9##3##(2008-10#8)(2008-11#1)
of the degree of##15##4##(1991-5#1)(1992-1#1)(1993-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the degree##16##3##(1991-5#1)(1992-1#1)(1993-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the delay between##2##4##(1991-2#1)(2008-12#1)
of the delay of##2##4##(2008-10#1)(2012-12#1)
of the delay##5##3##(1991-2#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-8#1)
of the deleted##2##3##(1997-3#1)(2008-10#1)
of the deletion##2##3##(1994-11#1)(1996-12#1)
of the delivered##3##3##(1997-8#1)(2008-11#1)(2008-3#1)
of the demands##2##3##(1992-3#1)(2008-11#1)
of the dementia##2##3##(1996-11#1)(2008-7#1)
of the demographic##4##3##(1995-12#1)(2008-6#1)(2008-9#2)
of the denatured##2##3##(1990-5#1)(2009-9#1)
of the dendritic tree##2##4##(1994-2#2)
of the dendritic##4##3##(1994-2#3)(2013-1#1)
of the density of##5##4##(1996-2#1)(2008-10#2)(2008-8#2)
of the density##10##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2013-8#1)
of the density-dependent##2##3##(2008-7#1)(2008-9#1)
of the dental##6##3##(1990-2#1)(2008-1#1)(2008-10#2)(2013-1#2)
of the dentate##2##3##(1991-7#1)(1994-8#1)
of the denture##2##3##(2013-1#2)
of the department of##2##4##(2008-10#1)(2013-8#1)
of the department##5##3##(2008-10#1)(2008-12#3)(2013-8#1)
of the departmental portfolio##2##4##(2008-12#2)
of the departments and municipalities##2##5##(2012-12#2)
of the departments of##2##4##(1997-3#1)(2012-12#1)
of the departments##5##3##(1990-9#1)(1997-3#1)(2012-12#3)
of the dependence of##2##4##(2008-2#1)(2008-7#1)
of the deposited##3##3##(2008-10#1)(2008-3#2)
of the deposition##3##3##(1994-12#1)(2008-10#2)
of the derivatives##9##3##(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2011-2#1)
of the derivatized##3##3##(2008-10#2)(2008-7#1)
of the derived##2##3##(2008-3#1)(2010-8#1)
of the dermal##3##3##(1992-12#1)(2011-2#1)(2012-3#1)
of the described##4##3##(1990-9#2)(2008-10#2)
of the design and##2##4##(2008-3#1)(2012-3#1)
of the design of##2##4##(2008-2#1)(2008-3#1)
of the design##7##3##(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#1)
of the designed##3##3##(2008-10#2)(2011-2#1)
of the designs##2##3##(1994-9#1)(2009-7#1)
of the desired products##2##4##(2008-4#1)(2009-12#1)
of the desired##9##3##(1992-6#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-2#1)
of the detailed##2##3##(1995-5#1)(2008-7#1)
of the detected##4##3##(1994-1#1)(2008-10#3)
of the detection limit of##3##5##(2008-10#3)
of the detection limit##4##4##(2008-10#4)
of the detection limits##2##4##(2008-10#2)
of the detection of##2##4##(1996-3#1)(2008-10#1)
of the detection##10##3##(1996-3#1)(2008-10#9)
of the detector##2##3##(2008-10#1)(2008-3#1)
of the determinants##2##3##(1992-2#1)(2008-10#1)
of the determination is##2##4##(2008-10#2)
of the determination of##14##4##(1992-5#1)(2008-10#13)
of the determination was 1##3##5##(2008-10#3)
of the determination was##8##4##(2008-10#8)
of the determination##27##3##(1992-5#1)(2008-10#26)
of the determinations##5##3##(2008-10#5)
of the determined##4##3##(1996-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
of the deutocerebrum##2##3##(2007-12#2)
of the developed method for##4##5##(2008-10#4)
of the developed method is##2##5##(2008-10#2)
of the developed method was##6##5##(2008-10#6)
of the developed method##27##4##(2008-10#27)
of the developed procedure##3##4##(2008-10#3)
of the developed system##2##4##(2008-10#1)(2010-8#1)
of the developed technique##2##4##(2008-10#2)
of the developed##48##3##(2008-10#44)(2009-3#1)(2010-8#2)(2011-1#1)
of the developing##9##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-9#1)(2012-2#1)(2013-1#2)
of the development and##2##4##(2008-10#1)(2008-11#1)
of the development of a new##2##6##(1997-4#1)(2008-5#1)
of the development of a##5##5##(1992-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
of the development of the##2##5##(1996-12#1)(2008-10#1)
of the development of##21##4##(1992-1#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-6#1)(1996-12#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
of the development##26##3##(1992-1#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-6#1)(1996-12#1)(1997-4#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
of the developmental##4##3##(1993-12#2)(2008-7#1)(2009-12#1)
of the developments in##2##4##(2008-10#1)(2008-12#1)
of the deviance##2##3##(1994-9#1)(1996-3#1)
of the device in the##2##5##(2008-11#1)(2008-2#1)
of the device in##3##4##(2008-11#1)(2008-2#1)(2010-6#1)
of the device##20##3##(2007-11#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-9#3)(2009-10#1)(2010-6#2)(2010-7#2)(2012-3#1)(2013-1#1)
of the devices##3##3##(1993-12#1)(2008-9#1)(2010-12#1)
of the diabetic##2##3##(1990-3#1)(2011-2#1)
of the diagnosis##4##3##(1991-12#1)(2011-2#3)
of the diagnostic##9##3##(1990-9#1)(1992-9#1)(1993-1#1)(1994-1#1)(1996-3#1)(1997-8#1)(2008-10#1)(2009-11#1)(2011-2#1)
of the dialysis##2##3##(1996-12#1)(2008-5#1)
of the diameter##2##3##(2008-2#1)(2011-1#1)
of the diaphragm is##2##4##(2010-5#2)
of the diaphragm##4##3##(1991-3#1)(2009-6#1)(2010-5#2)
of the diastolic##3##3##(1996-6#2)(2008-8#1)
of the diazonium##2##3##(2008-10#2)
of the difference between the##2##5##(2008-5#1)(2008-7#1)
of the difference##4##3##(1990-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
of the differences between##3##4##(1994-8#1)(1997-6#1)(2008-10#1)
of the differences in##3##4##(2008-10#2)(2013-8#1)
of the differences##9##3##(1994-8#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
of the different approaches##2##4##(2008-10#2)
of the different classes##2##4##(2008-10#1)(2012-12#1)
of the different imaging techniques##2##5##(2011-2#1)(2012-2#1)
of the different mechanisms##2##4##(1993-3#1)(2008-8#1)
of the different species##2##4##(2008-10#2)
of the different types of##2##5##(2008-10#1)(2012-2#1)
of the different##64##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-1#2)(2008-1#1)(2008-10#28)(2008-11#5)(2008-5#1)(2008-8#2)(2009-1#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-9#1)(2013-8#1)
of the differential group delay##3##5##(2007-11#1)(2007-12#2)
of the differential pulse##3##4##(2008-10#3)
of the differential##15##3##(1990-5#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-3#2)(2008-7#1)
of the differentially expressed proteins##2##5##(2011-3#2)
of the differentiated##2##3##(1995-3#1)(2008-9#1)
of the differentiation##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
of the difficulties##4##3##(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)
of the difficulty of##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
of the difficulty##4##3##(1992-12#1)(2008-10#1)(2008-11#2)
of the diffraction##4##3##(1992-4#1)(1992-9#1)(2008-2#1)(2008-3#1)
of the diffuse##2##3##(2007-12#1)(2008-3#1)
of the diffusion##3##3##(1990-12#1)(2008-5#1)(2008-7#1)
of the digestion##2##3##(2008-10#2)
of the digestive tract##5##4##(1990-8#2)(2011-2#3)
of the digestive##7##3##(1990-8#2)(2007-12#1)(2011-2#3)(2013-1#1)
of the dimer##5##3##(1991-7#1)(2008-10#2)(2008-8#2)
of the dimeric##2##3##(1990-5#1)(2008-10#1)
of the dimerization equilibrium##2##4##(2008-10#2)
of the dimerization##3##3##(2008-10#3)
of the diode##4##3##(2008-10#1)(2008-3#3)
of the dipole particles##2##4##(1992-12#2)
of the dipole##3##3##(1992-12#2)(2010-8#1)
of the direct##8##3##(1994-2#1)(2008-10#6)(2008-3#1)
of the direction of##2##4##(2008-3#2)
of the direction##5##3##(1992-2#1)(1993-12#1)(2008-11#1)(2008-3#2)
of the disc##3##3##(1994-11#1)(1996-6#1)(2011-2#1)
of the discolored region##2##4##(1995-11#2)
of the discolored##3##3##(1995-11#3)
of the discovery##3##3##(1995-12#1)(1997-1#1)(2009-12#1)
of the discrepancy##2##3##(2008-2#1)(2008-8#1)
of the discussion##2##3##(2008-10#1)(2008-11#1)
of the disease and its##3##5##(1991-2#1)(2008-5#1)(2012-12#1)
of the disease and the##3##5##(2007-8#1)(2008-10#2)
of the disease and##19##4##(1990-3#1)(1990-9#1)(1991-2#1)(1995-9#1)(1997-8#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)
of the disease are##3##4##(2008-11#1)(2008-5#1)(2013-1#1)
of the disease as##4##4##(1993-11#1)(2008-11#3)
of the disease but##2##4##(2008-10#1)(2008-7#1)
of the disease cycle##3##4##(2008-10#3)
of the disease from##2##4##(2008-10#1)(2008-8#1)
of the disease gene##2##4##(1993-1#1)(1997-8#1)
of the disease has##2##4##(1997-6#1)(2008-10#1)
of the disease in the##4##5##(1990-9#1)(1994-9#1)(2008-10#2)
of the disease in##16##4##(1990-9#1)(1991-12#1)(1991-8#1)(1992-9#1)(1994-9#1)(1995-2#1)(2008-10#8)(2011-2#1)(2012-3#1)
of the disease is##8##4##(1991-11#1)(1991-2#1)(1991-8#1)(1996-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-8#1)
of the disease may##2##4##(2008-7#1)(2011-2#1)
of the disease or##2##4##(1994-12#1)(2012-2#1)
of the disease progress curve##2##5##(2008-10#2)
of the disease should##2##4##(2008-10#1)(2013-1#1)
of the disease status of##2##5##(1992-3#1)(2008-10#1)
of the disease to##2##4##(2008-10#1)(2011-2#1)
of the disease was##6##4##(1991-8#1)(1997-5#1)(2008-10#3)(2011-2#1)
of the disease were##2##4##(2008-10#1)(2008-5#1)
of the disease with##3##4##(1997-8#1)(2008-10#1)(2008-7#1)
of the disease##204##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#4)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#4)(1995-2#2)(1995-9#1)(1996-3#1)(1996-6#2)(1997-5#1)(1997-6#2)(1997-8#6)(2006-6#1)(2007-8#3)(2008-1#1)(2008-10#51)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#9)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#18)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#9)(2013-8#2)
of the diseased##6##3##(1994-11#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
of the diseases##6##3##(1993-11#1)(1997-1#1)(2008-10#4)
of the dishes##2##3##(1995-8#1)(2008-11#1)
of the disorder and##3##4##(2008-7#2)(2008-9#1)
of the disorder##11##3##(1995-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-7#4)(2008-9#1)(2010-1#1)(2013-8#1)
of the displaced##2##3##(1991-9#1)(2012-12#1)
of the displacement##2##3##(2008-7#1)(2010-7#1)
of the display##4##3##(2008-3#3)(2013-8#1)
of the dissociation constants of##2##5##(1993-8#1)(2008-10#1)
of the dissociation constants##3##4##(1992-3#1)(1993-8#1)(2008-10#1)
of the dissociation##5##3##(1992-3#1)(1993-8#1)(2008-10#3)
of the dissolved organic carbon##2##5##(2008-10#2)
of the dissolved##7##3##(2008-10#7)
of the distal radius##4##4##(2008-9#3)(2013-1#1)
of the distal##21##3##(1993-6#1)(1993-8#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#5)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
of the distinctions between##2##4##(2008-11#1)(2008-12#1)
of the distribution of##13##4##(1992-2#1)(2008-10#6)(2008-11#1)(2008-8#3)(2008-9#1)(2010-10#1)
of the distribution ratio##2##4##(2008-10#2)
of the distribution##20##3##(1992-2#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#3)(2008-9#1)(2010-10#1)
of the distributions##3##3##(1996-3#1)(2008-10#1)(2008-2#1)
of the district##2##3##(1993-3#1)(1997-6#1)
of the disulfide bonds##2##4##(1990-5#1)(1993-8#1)
of the disulphide##2##3##(2008-10#2)
of the diversity of##4##4##(1990-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
of the dnaA region of the##2##6##(1996-12#2)
of the doctor-patient relationship in##2##5##(2011-2#2)
of the doctors##3##3##(1991-6#1)(1995-6#1)(1996-8#1)
of the dog##2##3##(1991-3#1)(1995-11#1)
of the dogs##4##3##(1992-5#2)(2012-3#2)
of the domain##2##3##(2008-11#1)(2008-2#1)
of the domains##2##3##(1994-5#1)(2008-11#1)
of the domestic##2##3##(2007-12#1)(2008-12#1)
of the dominant##7##3##(1990-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
of the donor##5##3##(1993-12#1)(1994-6#1)(2010-10#1)(2011-2#2)
of the dopamine uptake system##2##5##(1995-11#2)
of the dopamine##5##3##(1995-11#3)(1995-2#1)(2008-7#1)
of the dorsal and##2##4##(1991-12#1)(1996-12#1)
of the dorsal horn##6##4##(1995-12#2)(1996-12#1)(1997-3#3)
of the dorsal nucleus of the lateral lemniscus##2##8##(1997-3#2)
of the dorsal nucleus of##3##5##(1991-7#1)(1997-3#2)
of the dorsal##18##3##(1991-12#1)(1991-7#1)(1995-12#2)(1996-12#2)(1996-2#1)(1997-3#5)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
of the dorsalis pedis artery##2##5##(2010-7#2)
of the dorsolateral##2##3##(2007-12#2)
of the dose##3##3##(1995-3#1)(2008-7#2)
of the dose-response curve##2##4##(1994-11#1)(1997-1#1)
of the dose-response##3##3##(1994-11#1)(1997-1#1)(2008-7#1)
of the double##3##3##(1991-5#1)(2008-11#1)(2008-9#1)
of the double-edge##2##3##(2008-3#2)
of the downstream##5##3##(1995-2#1)(1997-3#1)(2008-9#1)(2010-5#1)(2012-2#1)
of the draft##2##3##(2008-9#2)
of the drawn##2##3##(2009-10#2)
of the droplet##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
of the droplets##2##3##(1996-3#1)(2008-10#1)
of the dropping mercury electrode##2##5##(2008-10#2)
of the drug and##2##4##(1993-6#1)(2008-10#1)
of the drug at##3##4##(1991-10#1)(2008-10#2)
of the drug by##2##4##(2008-7#1)(2010-8#1)
of the drug in human serum##2##6##(2008-10#2)
of the drug in human##3##5##(2008-10#3)
of the drug in the##2##5##(1990-11#1)(2008-10#1)
of the drug in##14##4##(1990-11#1)(2008-10#13)
of the drug molecule##2##4##(2008-10#2)
of the drug on##3##4##(1994-8#1)(1996-3#1)(2008-8#1)
of the drug to##2##4##(2008-10#1)(2008-11#1)
of the drug was##2##4##(2008-1#1)(2008-10#1)
of the drug were observed at##2##6##(2008-10#1)(2008-11#1)
of the drug were observed##3##5##(1990-9#1)(2008-10#1)(2008-11#1)
of the drug were##4##4##(1990-9#1)(1997-2#1)(2008-10#1)(2008-11#1)
of the drug with##2##4##(2008-10#2)
of the drug##69##3##(1990-11#3)(1990-2#1)(1990-9#1)(1991-10#1)(1991-3#4)(1992-6#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-4#1)(2008-1#1)(2008-10#36)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-2#2)
of the drugs for##2##4##(2008-10#1)(2012-12#1)
of the drugs in urine##2##5##(2008-10#2)
of the drugs in##7##4##(2008-10#7)
of the drugs studied##2##4##(2008-10#2)
of the drugs##32##3##(1992-3#1)(1993-11#1)(1997-1#1)(2008-10#20)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
of the drying##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
of the dsRNA##2##3##(2008-10#2)
of the dsRNAs##2##3##(2008-10#2)
of the dual##4##3##(2008-11#1)(2011-2#1)(2013-1#2)
of the dura##4##3##(2008-7#1)(2009-8#2)(2011-2#1)
of the durability of resistance##4##5##(2008-10#4)
of the dural##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
of the duration of##3##4##(2008-10#1)(2011-2#1)(2011-3#1)
of the dust samples##2##4##(2010-5#2)
of the dye are at##2##5##(2008-10#2)
of the dye molecules##2##4##(1991-5#1)(2010-4#1)
of the dye were##2##4##(2008-10#2)
of the dye##22##3##(1991-5#2)(2008-10#14)(2008-3#1)(2008-9#2)(2010-4#3)
of the dyes##5##3##(1990-6#1)(2008-10#3)(2008-5#1)
of the dying##5##3##(1991-12#1)(1991-2#1)(1997-6#1)(2010-10#1)(2010-8#1)
of the dynactin complex##2##4##(1995-2#2)
of the dynamic range of the##2##6##(2007-11#1)(2013-8#1)
of the dynamic##4##3##(2007-11#1)(2008-10#1)(2009-7#1)(2013-8#1)
of the dynamics of the##4##5##(2008-10#2)(2008-11#1)(2008-3#1)
of the dynamics of##9##4##(1993-5#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
of the dynamics##10##3##(1993-5#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)
of the dystrophin gene##2##4##(1997-3#2)
of the ear##2##3##(2008-1#1)(2008-7#1)
of the earliest##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
of the early embryonic##2##4##(2007-12#1)(2008-11#1)
of the early phases##2##4##(1991-8#1)(2008-11#1)
of the early stages of##2##5##(2008-4#1)(2013-8#1)
of the early##20##3##(1991-6#1)(1991-8#1)(1994-12#1)(2007-12#2)(2008-10#1)(2008-11#5)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#2)(2010-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
of the ears##2##3##(1991-3#1)(2008-8#1)
of the earthquake##2##3##(2013-1#1)(2013-8#1)
of the earthworm##2##3##(2008-5#1)(2008-9#1)
of the ease of##2##4##(2008-10#1)(2012-2#1)
of the ecology of##6##4##(2008-10#4)(2008-8#1)(2008-9#1)
of the ecology##7##3##(2008-10#4)(2008-8#1)(2008-9#2)
of the economic##3##3##(1993-12#1)(1995-11#1)(2008-11#1)
of the economically##2##3##(2010-3#1)(2013-8#1)
of the education and training programme on##2##7##(2008-12#2)
of the education##4##3##(2008-12#3)(2011-2#1)
of the educational##5##3##(1992-1#1)(2008-11#2)(2010-9#1)(2011-1#1)
of the efe gene##2##4##(2008-10#2)
of the efe##3##3##(2008-10#3)
of the effect of a##3##5##(2008-10#1)(2008-3#1)(2011-2#1)
of the effect of the##2##5##(2008-2#1)(2008-8#1)
of the effect of##43##4##(1991-2#1)(1991-6#1)(1992-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-1#3)
of the effect##47##3##(1991-2#1)(1991-6#1)(1992-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-1#3)
of the effective size of a##2##6##(2007-12#1)(2008-8#1)
of the effective##6##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)
of the effectiveness of##8##4##(1995-3#1)(1996-1#1)(2008-1#1)(2008-10#1)(2011-3#1)(2012-2#1)(2013-1#2)
of the effects of the##3##5##(1996-3#1)(2008-10#2)
of the effects of these##2##5##(2009-12#2)
of the effects of##47##4##(1990-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-8#1)(2008-10#14)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
of the effects##53##3##(1990-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#17)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
of the efficacy and##2##4##(1994-8#1)(2008-5#1)
of the efficacy of##4##4##(1993-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
of the efficacy##6##3##(1993-2#1)(1994-8#1)(2008-10#1)(2008-5#2)(2012-2#1)
of the efficiency and##2##4##(1997-1#1)(2013-1#1)
of the efficiency of##2##4##(2008-3#1)(2008-8#1)
of the efficiency##4##3##(1997-1#1)(2008-3#1)(2008-8#1)(2013-1#1)
of the effluent##2##3##(2008-10#2)
of the egg##5##3##(2008-11#1)(2008-12#3)(2008-8#1)
of the eggs##3##3##(1995-2#1)(2008-10#1)(2010-8#1)
of the egl1 gene##2##4##(2008-10#2)
of the eight patients##2##4##(1994-9#1)(2011-2#1)
of the eight##14##3##(1994-9#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
of the ejaculatory duct##2##4##(2008-7#2)
of the ejaculatory ducts##3##4##(1997-8#3)
of the ejaculatory##5##3##(1997-8#3)(2008-7#2)
of the elastic##2##3##(2008-10#1)(2009-7#1)
of the elderly in##2##4##(1995-5#1)(2009-5#1)
of the elderly population##4##4##(2008-7#1)(2010-10#1)(2011-2#1)(2011-7#1)
of the elderly##13##3##(1991-3#1)(1992-3#1)(1993-1#1)(1994-1#1)(1995-5#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-10#1)(2011-2#1)(2011-7#1)(2013-1#1)
of the electric field##2##4##(2008-10#1)(2008-3#1)
of the electrical##2##3##(2008-10#1)(2012-12#1)
of the electroactive##4##3##(2008-10#4)
of the electrochemical behavior of##2##5##(2008-10#2)
of the electrochemical##7##3##(2008-10#7)
of the electrochemically accumulated ahODN-Cu(I) complex##2##6##(2008-10#2)
of the electrochemically accumulated##3##4##(2008-10#3)
of the electrochemically##4##3##(2008-10#4)
of the electrode and##4##4##(2008-10#3)(2008-9#1)
of the electrode array##3##4##(2008-10#1)(2008-9#2)
of the electrode by##2##4##(2008-10#2)
of the electrode can be##2##5##(2008-10#2)
of the electrode can##3##4##(2008-10#3)
of the electrode double##2##4##(2008-10#2)
of the electrode prepared##2##4##(2008-10#2)
of the electrode response##3##4##(2008-10#3)
of the electrode surface##4##4##(2008-10#4)
of the electrode was 3##2##5##(2008-10#2)
of the electrode was about##2##5##(2008-10#2)
of the electrode was discussed##2##5##(2008-10#2)
of the electrode was##14##4##(2008-10#14)
of the electrode##75##3##(2008-10#69)(2008-9#6)
of the electrodes and##2##4##(2008-10#2)
of the electrodes was##3##4##(2008-10#3)
of the electrodes##21##3##(2008-10#20)(2010-7#1)
of the electrolyte##3##3##(2008-10#3)
of the electrolytic##2##3##(2008-10#2)
of the electromagnetic field in##2##5##(2007-12#1)(2008-3#1)
of the electromagnetic field##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of the electromagnetic fields##2##4##(2008-2#2)
of the electromagnetic##6##3##(2007-12#1)(2008-2#3)(2008-3#1)(2012-12#1)
of the electronic##4##3##(2008-10#3)(2010-7#1)
of the electropolymerization##2##3##(2008-10#2)
of the element##7##3##(1990-3#1)(2008-10#4)(2008-3#1)(2009-6#1)
of the elements and the##2##5##(2008-10#1)(2013-1#1)
of the elements and##3##4##(2008-10#2)(2013-1#1)
of the elements in the##2##5##(2008-10#2)
of the elements in##3##4##(2008-10#3)
of the elements were##3##4##(2008-10#3)
of the elements##22##3##(2008-10#21)(2013-1#1)
of the elevated##2##3##(1997-5#1)(2008-4#1)
of the elevation of##2##4##(2008-11#1)(2010-11#1)
of the elevation##3##3##(2008-11#1)(2008-3#1)(2010-11#1)
of the elimination##2##3##(1994-2#1)(2012-12#1)
of the eluates##2##3##(2008-10#2)
of the eluent##4##3##(2008-10#4)
of the eluted metals##2##4##(2008-10#2)
of the embryo##5##3##(1993-12#1)(1994-9#1)(2007-12#2)(2008-6#1)
of the embryonic##2##3##(2007-12#1)(2012-12#1)
of the emergence##2##3##(2008-10#1)(2008-11#1)
of the emergency##3##3##(1994-5#1)(2008-3#2)
of the emergent##2##3##(2010-1#1)(2011-2#1)
of the emerging trends in the##2##6##(1997-2#1)(2008-12#1)
of the emerging##5##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
of the emission of##3##4##(2007-12#1)(2008-10#2)
of the emission##8##3##(1990-5#1)(2007-12#1)(2008-10#5)(2008-11#1)
of the emulsions##3##3##(2008-10#1)(2008-5#2)
of the enantiomeric composition of##2##5##(2008-10#2)
of the enantiomeric##3##3##(2008-10#3)
of the enantiomers of##2##4##(2008-10#1)(2008-11#1)
of the enantiomers##5##3##(2008-10#4)(2008-11#1)
of the enclosure##2##3##(2008-9#1)(2013-8#1)
of the encounters##3##3##(1991-6#3)
of the end of##4##4##(1992-9#1)(2008-6#1)(2011-1#1)(2012-7#1)
of the end point##2##4##(2008-10#2)
of the end##7##3##(1992-12#1)(1992-9#1)(2008-10#2)(2008-6#1)(2011-1#1)(2012-7#1)
of the endemic##4##3##(1996-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
of the endocrine##2##3##(1991-7#1)(2010-11#1)
of the endogenous##11##3##(1992-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
of the endometrium is##2##4##(2011-2#1)(2012-3#1)
of the endometrium##8##3##(1993-9#1)(1995-3#1)(2011-2#4)(2012-3#2)
of the endoplasmic reticulum##6##4##(1993-8#1)(1996-3#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
of the endosymbiont of the aphid##2##6##(1996-12#2)
of the endosymbiont##3##3##(1996-12#3)
of the endothelial##2##3##(1993-8#1)(2008-7#1)
of the endothelium and##2##4##(1995-2#1)(2008-10#1)
of the endothelium##3##3##(1992-11#1)(1995-2#1)(2008-10#1)
of the energetic##2##3##(2008-3#2)
of the energy from##3##4##(2008-3#3)
of the energy##10##3##(1993-5#1)(1994-2#1)(1997-6#1)(2008-3#5)(2008-9#1)(2013-1#1)
of the enhanced##4##3##(2008-10#3)(2008-11#1)
of the enhancement##5##3##(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
of the enrichment##3##3##(2008-10#3)
of the enthalpy##2##3##(1990-8#1)(2008-10#1)
of the entire ITS region##2##5##(2008-10#2)
of the entire genome and##3##5##(1996-6#2)(2011-2#1)
of the entire genome##5##4##(1996-6#3)(1996-8#1)(2011-2#1)
of the entire sequence##3##4##(1993-8#1)(1995-9#1)(2013-8#1)
of the entire##32##3##(1991-11#1)(1991-6#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
of the entorhinal cortex##6##4##(1994-8#1)(1997-3#1)(2008-11#4)
of the entry inhibitors##2##4##(2011-2#2)
of the environment##17##3##(1994-3#2)(1994-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)
of the environmental##7##3##(2008-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)
of the enzymatic activity of##2##5##(2008-10#1)(2008-11#1)
of the enzymatic activity##3##4##(2008-10#2)(2008-11#1)
of the enzymatic hydrolysis##3##4##(2008-10#3)
of the enzymatic##15##3##(1993-12#1)(2008-10#11)(2008-11#1)(2008-6#2)
of the enzymatically##2##3##(1994-6#1)(2008-10#1)
of the enzyme activity was##3##5##(2008-10#3)
of the enzyme activity##8##4##(1990-5#1)(1997-6#1)(2008-10#5)(2008-8#1)
of the enzyme and the##2##5##(2008-10#2)
of the enzyme and##5##4##(1992-6#1)(2008-10#4)
of the enzyme at##2##4##(1993-8#1)(2008-10#1)
of the enzyme by##5##4##(1993-9#1)(1994-11#1)(1997-8#1)(2008-7#1)(2009-7#1)
of the enzyme electrode##3##4##(2008-10#3)
of the enzyme for##2##4##(1990-5#1)(1993-3#1)
of the enzyme from##3##4##(1995-8#1)(1997-2#1)(2008-11#1)
of the enzyme glucose oxidase##2##5##(2008-10#2)
of the enzyme heme oxygenase##2##5##(1994-5#1)(1995-2#1)
of the enzyme in the##4##5##(1990-5#1)(2008-10#3)
of the enzyme in##7##4##(1990-11#1)(1990-5#1)(1996-2#1)(2008-10#4)
of the enzyme is##2##4##(1992-4#1)(1993-8#1)
of the enzyme on##2##4##(1995-6#1)(2008-10#1)
of the enzyme reaction##3##4##(2008-10#3)
of the enzyme to the##2##5##(1992-12#1)(1995-8#1)
of the enzyme to##3##4##(1992-12#1)(1995-8#1)(2008-10#1)
of the enzyme with##3##4##(1993-6#1)(1995-6#1)(2008-10#1)
of the enzyme##119##3##(1990-11#2)(1990-5#8)(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#2)(1994-5#2)(1994-8#2)(1995-11#1)(1995-2#2)(1995-6#5)(1995-8#4)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#3)(1997-8#1)(2008-10#41)(2008-11#4)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the enzyme-catalyzed reaction##4##4##(2008-10#4)
of the enzymes##8##3##(1990-5#1)(1991-5#1)(1994-11#1)(1997-6#3)(2008-5#1)(2011-1#1)
of the epidemic in##2##4##(1990-12#1)(1995-6#1)
of the epidemic##17##3##(1990-12#2)(1995-6#1)(1996-5#1)(2008-10#13)
of the epidemics##3##3##(2008-10#3)
of the epidemiology and##2##4##(2008-10#1)(2008-4#1)
of the epidemiology##4##3##(2008-10#3)(2008-4#1)
of the epidermal growth factor receptor##2##6##(1993-8#1)(1995-6#1)
of the epidermal growth factor##3##5##(1993-8#1)(1995-6#1)(2011-2#1)
of the epidermal##5##3##(1993-8#1)(1995-6#1)(2008-5#1)(2008-7#1)(2011-2#1)
of the epidermis##9##3##(1994-5#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-5#3)(2010-6#1)
of the epilepsy##2##3##(1997-8#1)(2010-8#1)
of the epileptic##2##3##(2008-11#1)(2009-8#1)
of the epithelial cycle##3##4##(2009-10#2)(2012-2#1)
of the epithelial##4##3##(2009-10#2)(2012-2#1)(2013-1#1)
of the epithelium##6##3##(1991-5#1)(1997-1#1)(2008-5#1)(2008-7#1)(2011-2#2)
of the epitopes##2##3##(2006-6#1)(2008-10#1)
of the equation##2##3##(2008-10#1)(2008-3#1)
of the equations##2##3##(2008-10#1)(2008-11#1)
of the equilibrium constant##2##4##(1997-2#1)(2008-10#1)
of the equilibrium distribution of the##2##6##(2008-10#2)
of the equilibrium##9##3##(1997-2#1)(2008-10#6)(2008-9#2)
of the equipment##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
of the equivalence point##2##4##(2008-10#2)
of the equivalent##2##3##(1995-12#1)(2012-3#1)
of the error##6##3##(1995-3#1)(2008-10#2)(2008-3#2)(2012-2#1)
of the errors##3##3##(2008-10#1)(2008-3#2)
of the esophagus##10##3##(1992-6#1)(1992-9#1)(1993-8#2)(2008-12#1)(2011-2#5)
of the esophagus]##2##3##(1992-9#1)(1996-3#1)
of the essential amino##2##4##(2008-5#1)(2012-2#1)
of the essential oil of the fruits##2##7##(2008-11#1)(2008-12#1)
of the essential oil of the##3##6##(2008-11#2)(2008-12#1)
of the essential oil of##4##5##(2008-11#3)(2008-12#1)
of the essential oil##5##4##(2008-11#3)(2008-12#2)
of the essential oils##4##4##(2008-10#1)(2008-11#2)(2008-12#1)
of the essential role of##2##5##(1995-12#1)(2013-8#1)
of the essential##16##3##(1995-12#1)(1997-3#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-5#1)(2012-2#1)(2013-8#1)
of the established##2##3##(2008-10#1)(2010-5#1)
of the establishment of##2##4##(1997-7#1)(2009-10#1)
of the estimated value##2##4##(2008-10#2)
of the estimated##6##3##(1992-3#1)(1993-3#1)(2008-10#4)
of the estrogen##2##3##(1990-5#1)(2008-10#1)
of the etalon##2##3##(2008-2#2)
of the etched##2##3##(2008-10#2)
of the etching##3##3##(2008-10#2)(2008-3#1)
of the ethanol##4##3##(2008-10#3)(2011-3#1)
of the ethnic##2##3##(2008-1#1)(2008-9#1)
of the etiology of##2##4##(1997-2#1)(2013-1#1)
of the eukaryotic nucleus##2##4##(2008-8#2)
of the eukaryotic##7##3##(1993-9#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)
of the evaluated##2##3##(2013-1#2)
of the evaluation##6##3##(2008-11#2)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
of the event##2##3##(2008-11#1)(2010-2#1)
of the event-related##2##3##(2008-11#2)
of the events##4##3##(1996-11#1)(2008-11#1)(2008-4#1)(2009-10#1)
of the evidence is##2##4##(1992-5#1)(2008-8#1)
of the evidence to support##2##5##(2008-11#1)(2008-8#1)
of the evidence##12##3##(1992-5#1)(1993-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-7#1)(2013-1#1)
of the evidence-based##2##3##(2008-12#1)(2013-1#1)
of the evolution of##13##4##(1991-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-5#1)
of the evolution##14##3##(1991-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-5#1)
of the evolutionary##5##3##(2008-10#1)(2008-8#2)(2010-4#1)(2010-7#1)
of the exact##5##3##(1996-3#2)(2008-10#1)(2008-11#1)(2008-3#1)
of the examination##3##3##(1990-3#2)(2013-8#1)
of the examined##4##3##(2008-10#4)
of the excellent##2##3##(2008-10#1)(2008-5#1)
of the excess##2##3##(2008-10#2)
of the exchange##3##3##(1992-4#1)(2008-10#1)(2008-11#1)
of the exchanger##2##3##(2008-10#2)
of the excitation beam##2##4##(2008-3#2)
of the excitation##4##3##(2008-10#1)(2008-3#3)
of the excited transitions##2##4##(2008-3#2)
of the excited##3##3##(2008-3#3)
of the exercise##4##3##(2008-11#1)(2008-12#1)(2010-7#1)(2013-8#1)
of the existence and##2##4##(2007-12#1)(2009-10#1)
of the existence of##10##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
of the existence##12##3##(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2010-5#1)(2013-1#1)(2013-8#1)
of the existing##12##3##(1992-3#1)(1993-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-2#1)
of the exogenous##4##3##(1990-10#1)(2008-11#1)(2008-8#1)(2010-10#1)
of the exon 8##2##4##(1993-8#2)
of the exon##7##3##(1991-5#1)(1992-8#1)(1993-8#3)(1995-6#1)(1997-8#1)
of the expected##9##3##(1990-6#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-12#1)(2008-10#2)(2008-5#1)(2010-5#1)
of the experience of##2##4##(1995-1#1)(2012-3#1)
of the experience##4##3##(1995-1#1)(1995-2#1)(2008-12#1)(2012-3#1)
of the experiences of##5##4##(1992-2#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
of the experiment##8##3##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
of the experimental and theoretical##2##5##(2008-2#1)(2008-3#1)
of the experimental and##3##4##(2008-2#1)(2008-3#2)
of the experimental conditions##7##4##(2008-10#7)
of the experimental data##2##4##(2008-10#2)
of the experimental design##2##4##(2008-10#1)(2011-1#1)
of the experimental results##2##4##(2008-5#1)(2008-7#1)
of the experimental variables##2##4##(2008-10#2)
of the experimental##35##3##(1995-6#1)(2008-10#22)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)
of the experimentally##2##3##(1997-6#1)(2008-10#1)
of the experiments##5##3##(2008-11#1)(2008-6#1)(2008-7#3)
of the expert##3##3##(2008-10#2)(2010-8#1)
of the exponential phase##3##4##(2008-11#3)
of the exponential##4##3##(1996-1#1)(2008-11#3)
of the exposed##5##3##(2008-10#1)(2009-1#1)(2011-2#2)(2013-1#1)
of the exposure##4##3##(1991-12#1)(2008-10#1)(2008-8#1)(2009-11#1)
of the expressed enzyme##2##4##(1991-5#1)(1993-8#1)
of the expressed protein##3##4##(1995-11#1)(2008-11#1)(2008-4#1)
of the expressed##8##3##(1991-5#2)(1993-8#1)(1995-11#2)(2008-10#1)(2008-11#1)(2008-4#1)
of the expression of the##2##5##(1995-12#1)(2008-11#1)
of the expression of##14##4##(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-12#2)(2008-10#2)(2008-11#2)(2008-9#2)(2011-2#1)(2012-2#1)
of the expression plasmids##2##4##(2008-9#2)
of the expression vector##3##4##(1997-8#2)(2008-4#1)
of the expression##23##3##(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-12#2)(1996-8#1)(1997-8#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#4)(2011-2#1)(2012-2#1)
of the expressions##2##3##(2008-11#1)(2011-2#1)
of the extended boundary condition method##3##6##(2008-3#3)
of the extended##6##3##(1993-12#1)(1993-6#1)(2008-3#3)(2008-5#1)
of the extent of the##2##5##(1994-9#1)(2010-6#1)
of the extent of##9##4##(1991-12#1)(1993-2#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-6#1)
of the extent to which##2##5##(1994-12#1)(2010-9#1)
of the extent##12##3##(1991-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2010-6#1)(2010-9#1)
of the external carotid artery##6##5##(1997-3#2)(1997-6#4)
of the external carotid##8##4##(1996-9#1)(1997-3#2)(1997-6#4)(2013-1#1)
of the external iliac##2##4##(2011-2#2)
of the external mirror##2##4##(2008-3#2)
of the external##20##3##(1990-3#1)(1994-2#1)(1996-9#1)(1997-3#2)(1997-6#4)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#2)(2013-1#1)
of the extinction spectrum##2##4##(2008-3#1)(2009-12#1)
of the extinction##3##3##(2008-3#1)(2008-8#1)(2009-12#1)
of the extracellular domain##2##4##(1995-11#1)(2008-11#1)
of the extracellular matrix##6##4##(1990-5#1)(2008-1#1)(2008-9#2)(2009-8#1)(2013-8#1)
of the extracellular protease##2##4##(2008-10#2)
of the extracellular##17##3##(1990-2#1)(1990-5#1)(1993-12#1)(1993-6#1)(1995-11#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#2)(2009-8#2)(2013-8#1)
of the extracranial##3##3##(1992-5#1)(2008-7#2)
of the extract and##5##4##(2008-10#4)(2008-11#1)
of the extract in##2##4##(2008-10#1)(2008-5#1)
of the extract##12##3##(2008-10#8)(2008-11#3)(2008-5#1)
of the extracted complexes##3##4##(2008-10#3)
of the extracted species is##2##5##(2008-10#2)
of the extracted species##6##4##(2008-10#6)
of the extracted##15##3##(2008-10#14)(2008-8#1)
of the extracting solvent##2##4##(2008-10#2)
of the extracting##4##3##(2008-10#4)
of the extraction of##3##4##(2008-10#3)
of the extraction procedures##2##4##(2008-10#2)
of the extraction process##4##4##(2008-10#4)
of the extraction vessel##2##4##(2008-10#2)
of the extraction##31##3##(2008-10#31)
of the extracts of##2##4##(2008-10#1)(2008-5#1)
of the extracts were##2##4##(2008-10#2)
of the extracts##8##3##(2008-10#4)(2008-11#2)(2008-5#1)(2013-1#1)
of the extremely##4##3##(2008-10#1)(2009-3#1)(2011-2#1)(2011-3#1)
of the eye is##2##4##(2007-12#1)(2008-11#1)
of the eye##7##3##(2007-12#1)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)(2011-7#2)
of the eyes##2##3##(2012-12#1)(2013-8#1)
of the eyespot##4##3##(2008-10#1)(2009-10#1)(2012-3#2)
of the fabella##2##3##(2011-2#2)
of the fabricated##3##3##(2008-10#3)
of the face and neck##2##5##(1996-11#1)(2010-6#1)
of the face and##3##4##(1996-11#1)(2010-1#1)(2010-6#1)
of the face with##2##4##(2010-1#1)(2012-3#1)
of the face##17##3##(1996-11#1)(2008-5#2)(2009-8#1)(2010-1#6)(2010-6#1)(2012-2#1)(2012-3#4)(2013-1#1)
of the facet joint##3##4##(1996-9#1)(2011-2#2)
of the facet joints##2##4##(1996-9#2)
of the facet##5##3##(1996-9#3)(2011-2#2)
of the facial nerve##5##4##(2008-12#1)(2008-9#2)(2011-2#1)(2012-3#1)
of the facial skin##3##4##(2008-5#3)
of the facial##9##3##(2008-12#1)(2008-5#3)(2008-9#2)(2011-2#2)(2012-3#1)
of the fact that the##3##5##(2008-10#1)(2008-11#1)(2010-5#1)
of the fact that##14##4##(1991-2#1)(1995-5#1)(1996-3#1)(1997-5#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)
of the factor(s)##2##3##(1992-12#2)
of the factors driving the##2##5##(1991-3#1)(2008-8#1)
of the factors that influence the##3##6##(1995-2#1)(2008-10#2)
of the factors that##6##4##(1995-2#1)(1997-1#1)(2008-10#2)(2008-4#1)(2009-8#1)
of the factors##21##3##(1991-3#1)(1995-12#1)(1995-2#1)(1997-1#2)(1997-8#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2012-3#1)(2013-8#1)
of the faculty##3##3##(1992-1#1)(1993-2#1)(2009-10#1)
of the failure##2##3##(1997-3#1)(2008-11#1)
of the fallopian tube##4##4##(1992-1#2)(1992-12#1)(1993-2#1)
of the families##2##3##(2012-3#1)(2013-8#1)
of the family Araceae##2##4##(2008-10#2)
of the family Brachyspiraceae##3##4##(2011-2#3)
of the family Geodermatophilaceae##2##4##(2011-2#2)
of the family Luteoviridae##2##4##(2008-10#2)
of the family Potyviridae##5##4##(2008-10#5)
of the family Synergistaceae##2##4##(2011-2#2)
of the family environment##2##4##(2008-7#1)(2012-3#1)
of the family physician##2##4##(1995-11#1)(1997-4#1)
of the family##72##3##(1990-12#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-4#3)(1997-8#2)(2008-10#21)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#24)(2012-12#1)(2012-3#2)
of the far-field##3##3##(2008-3#3)
of the fast##2##3##(1991-12#1)(2008-10#1)
of the fat pads##2##4##(2008-11#2)
of the fat##4##3##(1997-3#1)(2008-11#2)(2012-2#1)
of the fatigue##2##3##(2013-8#2)
of the fatty acids##2##4##(2008-10#1)(2011-1#1)
of the fatty##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
of the feasibility of##2##4##(2008-10#1)(2008-5#1)
of the features##5##3##(2008-11#1)(2008-3#1)(2009-12#1)(2012-2#1)(2013-8#1)
of the fecal##2##3##(2008-10#1)(2012-3#1)
of the fee##2##3##(1993-3#1)(1994-1#1)
of the feed##3##3##(2008-10#2)(2008-7#1)
of the feeding apparatus##4##4##(2010-8#4)
of the feeding##8##3##(2008-7#3)(2008-9#1)(2010-8#4)
of the feeds##2##3##(2008-10#2)
of the feet##8##3##(1994-12#1)(1997-8#1)(2008-10#1)(2010-9#1)(2012-3#1)(2013-1#3)
of the female##14##3##(1990-11#1)(1992-3#1)(1994-2#1)(1995-8#1)(1995-9#1)(2007-12#1)(2008-11#2)(2008-8#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-3#1)
of the females##3##3##(1993-11#1)(1994-2#1)(2008-7#1)
of the femoral neck##4##4##(2009-3#3)(2013-1#1)
of the femoral##11##3##(1992-3#1)(1992-6#1)(2008-3#1)(2009-3#3)(2013-1#5)
of the femur##5##3##(1991-11#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
of the fenestrated##2##3##(2010-12#1)(2013-8#1)
of the fermentation##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
of the ferric##2##3##(2008-10#1)(2011-2#1)
of the ferritin##2##3##(1990-5#1)(2008-1#1)
of the fertility##2##3##(2009-10#1)(2009-12#1)
of the fetuses##2##3##(2008-11#1)(2012-3#1)
of the few##4##3##(1994-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
of the fiber was##3##4##(1992-1#1)(2008-10#2)
of the fiber##12##3##(1992-1#3)(2008-10#5)(2008-3#4)
of the fiber's##2##3##(2007-11#1)(2008-3#1)
of the fiber-optic##2##3##(2008-10#2)
of the fibers##4##3##(1991-12#1)(2008-10#2)(2012-3#1)
of the fibre##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
of the fibrous##2##3##(2008-10#1)(2008-11#1)
of the field experiment##3##4##(2008-10#3)
of the field isolates##2##4##(2008-10#2)
of the field of##4##4##(1992-1#1)(2008-4#2)(2010-12#1)
of the field##22##3##(1992-1#1)(1994-3#2)(1995-12#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-4#2)(2008-9#1)(2010-12#1)(2013-1#1)
of the fields in##2##4##(2008-10#2)
of the fields##5##3##(2008-10#5)
of the fifth##4##3##(1997-8#1)(2008-10#2)(2012-12#1)
of the fight##2##3##(2008-7#1)(2011-2#1)
of the film is##3##4##(2008-10#3)
of the film thickness##3##4##(2008-10#3)
of the film##21##3##(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
of the films was##2##4##(2008-10#2)
of the films##11##3##(2008-10#8)(2008-11#2)(2009-11#1)
of the filter##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
of the final product##3##4##(2008-5#1)(2012-2#2)
of the final products##2##4##(2008-4#1)(2011-2#1)
of the final##19##3##(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
of the findings on##2##4##(2008-11#1)(2008-12#1)
of the findings##12##3##(1990-11#1)(1991-6#1)(1993-3#1)(1994-3#1)(1997-1#1)(2008-11#1)(2008-12#2)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
of the fine##2##3##(2007-12#1)(2008-11#1)
of the fire ant Solenopsis saevissima##2##6##(2007-12#2)
of the fire##4##3##(1996-12#2)(2007-12#2)
of the firm##2##3##(1993-3#1)(1997-1#1)
of the first and second##5##5##(1990-8#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-2#1)
of the first and##7##4##(1990-8#1)(2008-10#3)(2008-8#1)(2009-7#1)(2011-2#1)
of the first international classifications of mental health and developmental disorders of infancy and early##2##15##(2013-8#2)
of the first metatarsal##3##4##(2008-12#3)
of the first part of##2##5##(2010-12#1)(2013-8#1)
of the first semester in##2##5##(2008-10#1)(2012-3#1)
of the first stage##2##4##(2008-10#1)(2013-8#1)
of the first symptomatic fruit##2##5##(2008-10#2)
of the first three##2##4##(1992-4#1)(2008-3#1)
of the first two##4##4##(2008-10#2)(2008-12#1)(2009-7#1)
of the first year of##2##5##(1995-1#1)(2008-12#1)
of the first year##5##4##(1991-6#1)(1995-1#1)(1996-12#1)(2008-12#1)(2011-1#1)
of the first##105##3##(1990-2#1)(1990-3#1)(1990-8#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#3)(1997-3#1)(1997-8#1)(2007-11#2)(2008-10#21)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-8#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#4)
of the first-derivative##2##3##(2008-10#2)
of the fistula##7##3##(1996-9#2)(1997-3#2)(2011-3#1)(2012-12#1)(2013-1#1)
of the fistulas##2##3##(1993-2#1)(2008-7#1)
of the fitness##3##3##(2008-10#1)(2008-9#2)
of the five Taiwan##3##4##(2008-10#3)
of the five isolates##2##4##(2008-10#2)
of the five##25##3##(1991-2#1)(1991-6#1)(1995-11#1)(1995-5#1)(1996-8#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-8#2)(2011-2#1)
of the flagella##2##3##(2007-12#1)(2008-10#1)
of the flagellum##3##3##(2008-7#3)
of the flame##4##3##(2008-10#4)
of the flanking##2##3##(2008-10#1)(2008-9#1)
of the flavin##2##3##(1992-1#2)
of the fleece##2##3##(1997-5#2)
of the flotation##2##3##(2008-10#2)
of the flow cell##5##4##(2008-10#5)
of the flow cytometric##2##4##(1990-12#1)(2008-9#1)
of the flow injection##5##4##(2008-10#5)
of the flow rates##2##4##(2008-10#2)
of the flow system##4##4##(2008-10#4)
of the flow##27##3##(1990-12#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#2)(2013-1#1)(2013-8#1)
of the flow-injection##2##3##(2008-10#2)
of the flowing##3##3##(2008-10#2)(2011-2#1)
of the fluorescence intensity of the##3##6##(1990-12#1)(2008-10#2)
of the fluorescence intensity of##5##5##(1990-12#1)(2008-10#4)
of the fluorescence intensity##7##4##(1990-12#1)(2008-10#5)(2008-3#1)
of the fluorescence of the##2##5##(2008-10#2)
of the fluorescence of##5##4##(1990-5#1)(2008-10#4)
of the fluorescence resonance energy##2##5##(2008-10#1)(2008-9#1)
of the fluorescence##31##3##(1990-12#1)(1990-5#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)
of the fluorescent pseudomonad community##2##5##(2008-10#2)
of the fluorescent pseudomonad##3##4##(2008-10#3)
of the fluorescent##12##3##(1991-11#1)(1994-5#1)(2008-10#8)(2008-11#1)(2008-9#1)
of the fluoride##2##3##(2008-10#2)
of the fly ash##2##4##(2008-10#2)
of the fly##3##3##(2008-10#2)(2008-11#1)
of the focal##4##3##(2008-3#1)(2008-8#2)(2010-12#1)
of the focus##3##3##(2010-8#1)(2012-3#2)
of the foetus##4##3##(1991-9#2)(1996-11#1)(2009-8#1)
of the fold##2##3##(2009-9#2)
of the folded##3##3##(1991-6#1)(2009-7#1)(2009-9#1)
of the follicle cells##3##4##(2008-6#3)
of the follicle##7##3##(1990-8#1)(2008-12#1)(2008-5#1)(2008-6#3)(2011-2#1)
of the follicular##3##3##(2008-12#2)(2012-3#1)
of the follow-up period##3##4##(2008-7#3)
of the follow-up##4##3##(2008-7#3)(2008-8#1)
of the following parameters##2##4##(2008-10#1)(2008-8#1)
of the following##30##3##(1990-2#1)(1991-2#2)(1992-2#1)(1992-5#1)(1995-6#1)(1997-2#1)(2008-10#12)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#3)
of the food canal of nematodes that##2##7##(2008-10#2)
of the food canal of##3##5##(2008-10#3)
of the food chain##2##4##(2008-9#2)
of the food##10##3##(2007-12#1)(2008-10#4)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
of the foot and ankle##5##5##(2008-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
of the foot and##6##4##(2008-12#1)(2011-2#2)(2012-2#2)(2012-3#1)
of the foot##16##3##(2008-12#3)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#4)
of the foramen magnum##2##4##(1996-9#2)
of the foramen##3##3##(1996-9#2)(2012-12#1)
of the forearm##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
of the foreign##6##3##(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
of the forelimbs##3##3##(1993-3#1)(1996-6#1)(2012-3#1)
of the form##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
of the forma specialis##2##4##(2008-10#2)
of the formal potential##2##4##(2008-10#2)
of the formation and##3##4##(2008-10#3)
of the formation of the##3##5##(2008-10#1)(2011-2#1)(2012-5#1)
of the formation of##12##4##(1991-5#1)(1992-3#1)(1994-11#1)(2007-12#1)(2008-10#6)(2011-2#1)(2012-5#1)
of the formation##16##3##(1991-5#1)(1992-3#1)(1994-11#1)(2007-12#1)(2008-10#10)(2011-2#1)(2012-5#1)
of the formed complexes##2##4##(2008-10#2)
of the formed##15##3##(2008-10#14)(2011-2#1)
of the former##11##3##(1992-12#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
of the forms##2##3##(1991-6#1)(2012-3#1)
of the formula##2##3##(2008-5#2)
of the formulation##4##3##(2008-10#1)(2008-5#2)(2011-3#1)
of the four domains##2##4##(1992-4#2)
of the four##48##3##(1992-3#2)(1992-4#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#1)(1996-2#1)(1997-7#1)(2008-10#26)(2008-5#3)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)
of the fourth and fifth##3##5##(1997-3#2)(2008-10#1)
of the fourth and##4##4##(1997-3#2)(2008-10#1)(2012-9#1)
of the fourth##11##3##(1992-12#2)(1995-6#1)(1997-3#2)(2008-10#1)(2008-7#1)(2008-8#1)(2012-9#1)(2013-1#2)
of the fraction of##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
of the fraction##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the fractional##2##3##(1993-5#1)(2008-3#1)
of the fractions##2##3##(2008-11#2)
of the fracture##6##3##(2007-11#1)(2007-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
of the fragment##2##3##(1997-2#1)(2008-10#1)
of the fragments could##2##4##(1995-11#1)(2008-9#1)
of the fragments##5##3##(1992-3#1)(1992-6#1)(1995-11#1)(2008-10#1)(2008-9#1)
of the fragrance##6##3##(2008-5#6)
of the framework##2##3##(2009-1#1)(2013-1#1)
of the free and##2##4##(2008-10#2)
of the free##16##3##(1990-5#1)(1994-3#1)(1994-5#1)(2007-12#1)(2008-10#9)(2010-10#1)(2010-6#1)(2012-2#1)
of the frequency##7##3##(2007-12#1)(2008-10#4)(2008-3#2)
of the freshwater bryozoan Cristatella mucedo##2##6##(2011-2#2)
of the freshwater##5##3##(2008-12#1)(2008-7#1)(2011-2#3)
of the fringe##2##3##(2008-3#2)
of the front##2##3##(2008-3#1)(2012-12#1)
of the fruit fly##2##4##(2008-9#2)
of the fruit##9##3##(2008-10#5)(2008-11#1)(2008-9#3)
of the fucoidan extracts on##2##5##(2008-11#2)
of the full##5##3##(1991-1#1)(1997-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
of the full-length cDNA##2##4##(1997-7#2)
of the full-length##5##3##(1991-5#1)(1992-6#1)(1997-7#2)(2008-10#1)
of the fully##2##3##(2011-2#2)
of the fume##4##3##(2008-10#4)
of the function of##2##4##(2009-8#1)(2013-8#1)
of the function##3##3##(2008-6#1)(2009-8#1)(2013-8#1)
of the functional domains##2##4##(1990-7#1)(1993-12#1)
of the functional form##2##4##(2008-7#1)(2012-2#1)
of the functional##17##3##(1990-7#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of the functionally##2##3##(1990-7#1)(2009-10#1)
of the fundamental equilibrium constants##2##5##(2008-10#2)
of the fundamental##11##3##(1992-3#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#1)(2013-8#1)
of the fungal community isolated from##2##6##(2008-10#2)
of the fungal community##3##4##(2008-10#3)
of the fungal pathogen##3##4##(2008-10#3)
of the fungal##19##3##(2008-10#18)(2008-8#1)
of the fungi##8##3##(2008-10#6)(2008-5#1)(2008-8#1)
of the fungicide applications##2##4##(2008-10#2)
of the fungicide##8##3##(2008-10#8)
of the fungicides##3##3##(2008-10#2)(2008-5#1)
of the fungus Leptolegnia chapmanii (Oomycetes##2##6##(2008-5#2)
of the fungus and##2##4##(2008-10#2)
of the fungus in the##3##5##(2008-10#3)
of the fungus in##6##4##(2008-10#6)
of the fungus to##3##4##(2008-10#3)
of the fungus was##3##4##(2008-10#3)
of the fungus##44##3##(2008-10#41)(2008-5#3)
of the fusiform rust##2##4##(2008-10#2)
of the fusion##4##3##(1994-8#1)(1997-7#1)(2008-8#1)(2013-1#1)
of the future##10##3##(1992-11#1)(1993-2#2)(1994-2#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)
of the gain##2##3##(2007-11#1)(2008-3#1)
of the gait performance##2##4##(2012-12#1)(2013-1#1)
of the gait##3##3##(2012-12#1)(2013-1#2)
of the gallbladder is##2##4##(1991-6#1)(2011-2#1)
of the gallbladder##10##3##(1991-12#3)(1991-6#2)(1991-8#1)(1992-9#1)(2011-2#2)(2012-3#1)
of the gaps##2##3##(1997-1#1)(2012-12#1)
of the gas in the##2##5##(2008-10#2)
of the gas##8##3##(1997-1#1)(2008-10#3)(2008-3#2)(2009-9#1)(2012-2#1)
of the gaseous##2##3##(2008-10#2)
of the gastric##9##3##(1990-9#2)(1997-1#3)(1997-4#2)(2009-8#1)(2011-2#1)
of the gastrocnemius##2##3##(1995-2#1)(2012-2#1)
of the gastrointestinal tract is##2##5##(1990-11#1)(2009-1#1)
of the gastrointestinal tract##11##4##(1990-11#1)(1990-8#1)(2009-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
of the gastrointestinal##14##3##(1990-11#1)(1990-8#1)(1996-3#1)(1997-8#1)(2008-5#1)(2009-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
of the gate##2##3##(1995-1#1)(2012-2#1)
of the gaze shift##2##4##(2008-11#2)
of the gcs gene##2##4##(1997-7#2)
of the gel##11##3##(1990-11#1)(1993-8#1)(1996-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)
of the gene and##3##4##(1994-11#1)(1996-2#1)(1996-8#1)
of the gene coding for the##2##6##(1992-3#1)(1993-8#1)
of the gene coding for##3##5##(1992-3#1)(1993-8#1)(1996-8#1)
of the gene encoding the##7##5##(1993-2#1)(1993-3#1)(1993-9#1)(1996-12#1)(1996-8#1)(2008-5#1)(2008-9#1)
of the gene encoding##15##4##(1990-5#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
of the gene expression##2##4##(1991-5#1)(1997-6#1)
of the gene for##2##4##(1994-11#1)(2010-4#1)
of the gene in##2##4##(1997-1#1)(2008-10#1)
of the gene was##3##4##(1997-8#1)(2008-8#2)
of the gene##56##3##(1990-5#2)(1991-5#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#5)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#3)(1997-1#1)(1997-6#2)(1997-7#2)(1997-8#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2010-10#1)(2010-4#2)(2013-1#1)
of the genera Sphaerochaeta##2##4##(2013-8#2)
of the genera##6##3##(2008-10#2)(2008-5#1)(2011-2#1)(2013-8#2)
of the general health##2##4##(2008-10#1)(2013-1#1)
of the general population##9##4##(1991-2#3)(1993-1#1)(1997-3#1)(2008-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
of the general practitioner##2##4##(1993-11#1)(1995-11#1)
of the general practitioners##3##4##(1993-2#1)(1997-4#2)
of the general##24##3##(1991-2#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-3#1)(1997-4#2)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
of the generalized##3##3##(1991-9#1)(1995-9#1)(2008-3#1)
of the generated##6##3##(1995-3#1)(2007-12#1)(2008-10#4)
of the genes are##2##4##(1993-6#1)(2008-10#1)
of the genes encoding the##4##5##(1991-6#1)(1992-9#1)(1996-2#1)(2008-7#1)
of the genes encoding##7##4##(1991-6#1)(1992-9#1)(1993-12#1)(1996-2#1)(1997-7#1)(2008-7#1)(2010-7#1)
of the genes involved in##2##5##(2008-10#1)(2008-9#1)
of the genes were##2##4##(2008-10#1)(2009-10#1)
of the genes##43##3##(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-6#2)(1996-2#1)(1997-2#1)(1997-6#2)(1997-7#3)(1997-8#3)(2008-10#7)(2008-11#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-7#2)(2013-8#1)
of the genetic basis of##3##5##(2008-10#1)(2008-8#1)(2012-3#1)
of the genetic code##2##4##(1994-5#1)(1997-6#1)
of the genetic dissection of complex##2##6##(1994-9#2)
of the genetic diversity##5##4##(1995-2#1)(2008-10#3)(2010-7#1)
of the genetic map##2##4##(2008-10#1)(2012-3#1)
of the genetic structure of##4##5##(2008-10#2)(2008-8#1)(2011-2#1)
of the genetic variation for##2##5##(2008-10#2)
of the genetic variation##3##4##(2008-10#3)
of the genetic##35##3##(1994-5#1)(1994-9#2)(1995-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#17)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#2)
of the genetically##2##3##(2008-10#2)
of the genetics of##2##4##(2008-10#1)(2008-8#1)
of the genetics##3##3##(2008-10#1)(2008-8#1)(2009-3#1)
of the geniculate##2##3##(2011-2#2)
of the genitalia##3##3##(1997-3#1)(2008-10#2)
of the genome by##2##4##(1995-6#1)(2012-3#1)
of the genome of the##6##5##(1995-12#1)(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)
of the genome of##11##4##(1992-6#1)(1995-12#1)(1995-8#2)(1996-6#2)(1997-3#1)(2008-10#3)(2010-8#1)
of the genome was##3##4##(1996-6#1)(2008-10#2)
of the genome##45##3##(1992-6#1)(1993-12#1)(1995-12#1)(1995-6#1)(1995-8#3)(1996-6#7)(1997-3#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-4#2)(2008-9#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)
of the genomes of##5##4##(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)
of the genomic regions##2##4##(1996-12#1)(2008-10#1)
of the genomic##9##3##(1990-8#1)(1991-6#1)(1992-6#1)(1993-12#1)(1996-12#1)(2008-10#3)(2008-8#1)
of the genotypes##6##3##(2008-10#6)
of the genotyping primers##2##4##(2008-9#2)
of the genus Aminobacterium##2##4##(2011-2#2)
of the genus Arcanobacterium##2##4##(2011-2#2)
of the genus Arcobacter##2##4##(2011-2#2)
of the genus Astyanax##2##4##(2010-8#2)
of the genus Cellulomonas##3##4##(2011-2#3)
of the genus Closterovirus##2##4##(2008-10#2)
of the genus Haloterrigena##2##4##(2011-2#2)
of the genus Meiothermus and only the third genome sequence to be published from a member of the family Thermaceae##2##20##(2011-2#2)
of the genus Meiothermus##3##4##(2011-2#3)
of the genus Microsomacanthus Lopez-Neyra##2##5##(2011-2#2)
of the genus Microsomacanthus##4##4##(2011-2#4)
of the genus Olsenella##2##4##(2011-2#2)
of the genus Sinularia##3##4##(2010-2#3)
of the genus Sulfurospirillum##2##4##(2011-2#2)
of the genus Thermobispora##2##4##(2011-2#2)
of the genus Tobamovirus##2##4##(2008-10#2)
of the genus Tospovirus##2##4##(2008-10#2)
of the genus Trichovirus##4##4##(2008-10#4)
of the genus Tymovirus##2##4##(2008-10#2)
of the genus##101##3##(1997-2#1)(2008-10#36)(2008-11#1)(2008-5#4)(2008-6#5)(2008-9#1)(2010-1#1)(2010-2#3)(2010-4#1)(2010-8#3)(2011-2#43)(2013-1#1)(2013-8#1)
of the geographic##4##3##(1991-3#2)(2008-10#2)
of the geometrical##2##3##(2007-11#1)(2008-3#1)
of the geometrical-optics##2##3##(2008-3#2)
of the geriatric##2##3##(2010-1#1)(2011-2#1)
of the germ tubes##2##4##(2008-7#2)
of the germ##6##3##(2008-10#1)(2008-7#3)(2009-10#1)(2010-3#1)
of the germinal vesicle##2##4##(2007-12#1)(2008-7#1)
of the germline##3##3##(1992-10#1)(2010-5#1)(2012-3#1)
of the ginbuna##2##3##(2008-5#2)
of the girls##2##3##(1991-9#1)(2013-1#1)
of the girls)##2##3##(1991-9#2)
of the given##2##3##(2008-10#1)(2010-12#1)
of the gland and##2##4##(2007-12#2)
of the gland opening##3##4##(2007-12#3)
of the gland##8##3##(2007-12#6)(2008-7#1)(2011-2#1)
of the glass electrode##3##4##(2008-10#3)
of the glass##12##3##(1995-3#1)(2008-10#10)(2010-4#1)
of the glassy##2##3##(1995-3#1)(2008-10#1)
of the glial##2##3##(1997-2#1)(2009-8#1)
of the global##9##3##(1990-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2011-2#2)(2012-3#1)
of the glomerulonephritis##2##3##(1993-2#2)
of the gloves##4##3##(1995-6#2)(2012-2#2)
of the glucagon receptor##2##4##(1995-11#2)
of the glucagon##3##3##(1995-11#2)(2011-2#1)
of the glucocorticoid receptor##4##4##(1991-12#1)(1996-12#3)
of the glucose sensing##2##4##(2008-11#2)
of the glucose##8##3##(1994-12#1)(1994-2#1)(2008-10#4)(2008-11#2)
of the glutamate dehydrogenase##2##4##(2008-11#1)(2008-8#1)
of the glutamate##5##3##(1995-11#1)(2008-11#1)(2008-7#2)(2008-8#1)
of the glutinous##2##3##(2008-10#2)
of the glycine cleavage##2##4##(1992-10#1)(1997-1#1)
of the glycoprotein##3##3##(1993-6#1)(1994-8#1)(2008-7#1)
of the goals##3##3##(1994-3#1)(2008-10#1)(2012-3#1)
of the gold##3##3##(2008-10#3)
of the gonadal steroid environment##2##5##(2008-11#2)
of the gonadal steroid##3##4##(2008-11#3)
of the gradient##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
of the graft##2##3##(1996-3#1)(2011-3#1)
of the grafted##2##3##(2008-10#2)
of the grafts##2##3##(2008-10#1)(2008-11#1)
of the grant##4##3##(1992-12#1)(1995-6#2)(1996-2#1)
of the granules were##2##4##(2008-10#2)
of the granules##3##3##(2008-10#2)(2008-5#1)
of the graphite##6##3##(2008-10#6)
of the grasshopper##5##3##(2007-12#4)(2008-9#1)
of the grating and##2##4##(2008-3#2)
of the grating##13##3##(2008-2#2)(2008-3#11)
of the gratings##2##3##(2008-3#2)
of the gravity##2##3##(2008-10#1)(2009-8#1)
of the grazing season##2##4##(1991-8#1)(1996-12#1)
of the great vessels##2##4##(1990-11#1)(1996-11#1)
of the great##9##3##(1990-11#1)(1996-11#1)(1997-3#1)(2008-10#2)(2008-9#1)(2009-10#1)(2010-6#1)(2012-3#1)
of the greater prairie chicken##2##5##(2008-9#2)
of the greater##3##3##(2008-10#1)(2008-9#2)
of the greatest##4##3##(1996-1#1)(2008-10#2)(2011-2#1)
of the green toad##2##4##(2008-12#2)
of the green##5##3##(2008-11#1)(2008-12#2)(2009-9#1)(2012-3#1)
of the greenhouse effect##2##4##(1991-6#2)
of the greenhouse##3##3##(1991-6#2)(2008-10#1)
of the groE##2##3##(1996-12#1)(2008-10#1)
of the groove##2##3##(2008-3#1)(2008-8#1)
of the ground squirrel##3##4##(1990-5#1)(2008-8#2)
of the group and##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
of the group in##2##4##(2008-11#1)(2008-9#1)
of the group##21##3##(1993-1#1)(1995-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#4)(2011-1#2)(2011-2#2)(2013-1#1)
of the groups##7##3##(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-2#1)
of the growing season##3##4##(2008-10#2)(2012-5#1)
of the growing##7##3##(1991-2#1)(1993-3#1)(2008-10#3)(2012-5#1)(2013-1#1)
of the growth factor##5##4##(1997-1#1)(1997-7#2)(2008-8#1)(2009-8#1)
of the growth kinetics##2##4##(2008-11#1)(2008-7#1)
of the growth medium##4##4##(1991-11#2)(1996-6#1)(2008-11#1)
of the growth of##3##4##(1993-3#1)(1994-3#1)(2008-8#1)
of the growth phase##3##4##(2008-11#3)
of the growth rate##3##4##(2008-11#3)
of the growth substrate##2##4##(2008-7#2)
of the growth##33##3##(1991-11#2)(1993-3#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-7#2)(2008-10#2)(2008-11#10)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
of the gsa-1 gene##2##4##(1997-7#2)
of the guanine##3##3##(1991-5#1)(2008-10#2)
of the guest##4##3##(2008-10#4)
of the guests##2##3##(2008-10#1)(2010-4#1)
of the guided light##2##4##(2008-10#2)
of the guided##3##3##(2008-10#3)
of the guideline##2##3##(2008-10#2)
of the guidelines##4##3##(1990-6#2)(2012-12#1)(2012-2#1)
of the guinea pig extraocular muscles##3##6##(1997-3#3)
of the guinea-pig##3##3##(1990-5#1)(1997-4#2)
of the gut##7##3##(2010-5#1)(2011-2#6)
of the hIL-6##2##3##(2008-11#2)
of the hTERT mRNA and##2##5##(2008-11#2)
of the hTERT##4##3##(2008-11#4)
of the habitat##3##3##(2008-10#2)(2008-8#1)
of the haematoma##2##3##(1997-3#1)(2008-7#1)
of the hair##6##3##(2008-5#6)
of the hairy##2##3##(1990-9#1)(2008-7#1)
of the half##2##3##(2008-10#1)(2008-11#1)
of the hallmarks of##2##4##(2008-10#1)(2011-2#1)
of the hamster##2##3##(1996-8#1)(2008-9#1)
of the hand and##3##4##(2010-9#1)(2012-2#1)(2013-1#1)
of the hand##7##3##(2008-9#4)(2010-9#1)(2012-2#1)(2013-1#1)
of the hands##3##3##(1997-3#1)(2011-2#1)(2012-3#1)
of the hard palate##3##4##(1991-11#2)(2013-1#1)
of the hard##5##3##(1991-11#3)(2008-10#1)(2013-1#1)
of the head and neck##6##5##(1990-6#2)(2007-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the head and##8##4##(1990-6#2)(2007-11#1)(2007-12#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the head of##2##4##(1990-9#1)(2007-12#1)
of the head##16##3##(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1994-6#1)(2007-11#1)(2007-12#2)(2008-8#2)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
of the headspace##2##3##(2008-10#1)(2011-2#1)
of the health and##3##4##(1992-3#1)(1997-4#1)(2010-9#1)
of the health care delivery system##2##6##(1993-12#1)(1995-2#1)
of the health care industry##2##5##(1991-1#1)(1993-12#1)
of the health care system in##2##6##(1992-12#1)(1992-2#1)
of the health care system##6##5##(1992-12#1)(1992-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1996-2#1)
of the health care##17##4##(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#2)(1997-8#2)(2008-11#2)(2011-1#1)
of the health sector##2##4##(1992-1#1)(2013-8#1)
of the health system##3##4##(1996-3#1)(1997-3#1)(2008-1#1)
of the health##35##3##(1990-11#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#3)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#3)(2008-1#3)(2008-11#2)(2008-12#2)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the healthcare##2##3##(1992-11#1)(2013-8#1)
of the healthy##8##3##(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#2)(2012-3#2)
of the hearing##3##3##(2008-9#3)
of the heart with##2##4##(2008-7#1)(2009-1#1)
of the heart##17##3##(1991-6#1)(1993-12#3)(1993-6#1)(1996-2#1)(2006-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)
of the heat shock protein 70##2##6##(1995-11#1)(2008-10#1)
of the heat shock protein##3##5##(1995-11#1)(2008-10#1)(2008-7#1)
of the heat shock##7##4##(1992-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-7#2)
of the heat##9##3##(1992-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-7#2)(2010-3#1)
of the heavy chain of##2##5##(1990-5#1)(1995-2#1)
of the heavy chain##4##4##(1990-5#1)(1993-6#1)(1995-2#1)(1997-9#1)
of the heavy metal##2##4##(2008-10#2)
of the heavy##9##3##(1990-5#1)(1993-6#1)(1994-5#1)(1995-2#1)(1997-9#1)(2008-10#3)(2008-12#1)
of the helical##2##3##(1995-6#1)(2008-10#1)
of the helix##3##3##(1994-5#3)
of the helper virus##2##4##(2008-10#2)
of the helper##3##3##(2008-10#3)
of the hematoma##2##3##(2008-7#1)(2012-12#1)
of the heme##4##3##(1993-8#1)(1994-5#3)
of the hemorrhagic##2##3##(2008-7#1)(2010-6#1)
of the hepatic##3##3##(1993-2#1)(2009-9#1)(2012-12#1)
of the hepatitis C##2##4##(1994-11#1)(2008-10#1)
of the hepatitis##3##3##(1994-11#2)(2008-10#1)
of the hepatocyte##5##3##(1996-11#1)(2008-11#2)(2008-9#2)
of the hepatocytes##2##3##(1993-3#1)(2008-11#1)
of the hepatoma##2##3##(2008-11#2)
of the herbicide desmetryne##2##4##(2008-10#2)
of the herbicide##10##3##(2008-10#9)(2010-1#1)
of the herbicides from##2##4##(2008-10#1)(2008-11#1)
of the herbs##2##3##(2008-10#1)(2013-1#1)
of the heterodimeric##2##3##(1993-8#1)(2011-2#1)
of the heterogeneity of##2##4##(2011-2#1)(2012-12#1)
of the heterogeneity##4##3##(1994-5#1)(2011-2#2)(2012-12#1)
of the heterogeneous##2##3##(2008-4#1)(2011-2#1)
of the heterologous##2##3##(2008-10#1)(2008-11#1)
of the hexagonal column##3##4##(2008-3#3)
of the hexapeptide##2##3##(2008-5#2)
of the hierarchical##2##3##(1992-5#1)(2008-11#1)
of the high affinity##2##4##(1994-11#1)(2008-11#1)
of the high##27##3##(1990-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(1996-6#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-7#1)(2010-1#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the high-affinity##2##3##(1995-2#1)(2009-7#1)
of the higher##8##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
of the highest##7##3##(2008-10#1)(2008-11#3)(2008-5#1)(2010-10#1)(2011-2#1)
of the highly##6##3##(1993-12#1)(1994-1#1)(1995-12#1)(2008-10#2)(2008-11#1)
of the hip and##2##4##(1995-5#1)(2013-1#1)
of the hip joint##3##4##(1997-6#2)(2008-8#1)
of the hip##8##3##(1991-11#1)(1995-5#1)(1997-6#2)(2008-8#1)(2013-1#2)(2013-7#1)
of the hippocampal lesioned##2##4##(1990-11#2)
of the hippocampal##6##3##(1990-11#2)(1995-3#1)(2008-11#2)(2013-8#1)
of the hippocampus##9##3##(1990-11#1)(1993-6#2)(1996-12#2)(1997-3#1)(2008-11#2)(2008-7#1)
of the historical##2##3##(2008-10#1)(2013-1#1)
of the history and##2##4##(2008-5#1)(2010-1#1)
of the history of##7##4##(1993-11#1)(1994-12#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2010-6#1)
of the history##9##3##(1993-11#1)(1994-12#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-6#1)
of the home in##2##4##(2007-12#2)
of the home##7##3##(1995-12#1)(1995-3#1)(2007-12#4)(2011-2#1)
of the homologs##3##3##(2008-10#2)(2011-2#1)
of the homozygous##2##3##(1996-12#1)(2008-10#1)
of the honey bee##2##4##(2008-6#1)(2013-1#1)
of the honey##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
of the horizontal##2##3##(2007-12#1)(2008-5#1)
of the hormetic##2##3##(2008-7#2)
of the hormone in##2##4##(1990-2#1)(2010-5#1)
of the hormone##5##3##(1990-2#1)(1991-3#1)(1995-12#1)(2010-5#1)(2013-8#1)
of the hormones##2##3##(1995-11#1)(2009-8#1)
of the hospital##14##3##(1991-1#1)(1991-3#1)(1992-2#1)(1992-5#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-5#1)(2008-11#1)(2010-8#1)(2012-3#1)
of the host by##2##4##(2008-10#2)
of the host cell wall##2##5##(2008-10#2)
of the host cell##5##4##(2008-10#3)(2008-11#2)
of the host defense system##2##5##(1992-10#1)(2013-1#1)
of the host plant by##2##5##(2008-10#2)
of the host plant##5##4##(2007-12#1)(2008-10#4)
of the host population##5##4##(1994-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
of the host species##3##4##(2008-10#1)(2008-8#2)
of the host tissue##2##4##(2008-10#2)
of the host tissues##2##4##(2008-10#2)
of the host##66##3##(1992-10#1)(1994-2#1)(1994-5#1)(1996-3#2)(2007-12#1)(2008-10#36)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#7)(2008-9#1)(2009-8#3)(2010-1#1)(2011-2#5)(2013-1#1)(2013-8#1)
of the hot##2##3##(2009-5#1)(2011-2#1)
of the human ER gene##2##5##(1993-6#2)
of the human GABAA receptor##2##5##(1995-11#2)
of the human NGF##2##4##(1990-8#2)
of the human and##2##4##(1997-6#1)(2010-5#1)
of the human beta-like globin##3##5##(2008-8#3)
of the human body##2##4##(2012-3#1)(2013-1#1)
of the human brain##2##4##(1992-3#1)(1994-2#1)
of the human c-erbA alpha gene##2##6##(1993-3#2)
of the human chromosome##2##4##(1996-8#1)(1997-8#1)
of the human endogenous retrovirus-like sequence##2##6##(1996-12#2)
of the human estrogen receptor gene##2##6##(1992-3#2)
of the human gene##2##4##(1991-7#1)(1997-7#1)
of the human immunodeficiency virus##2##5##(1993-12#1)(1997-7#1)
of the human insulin##2##4##(1997-8#1)(2008-11#1)
of the human left ventricle##2##5##(2013-1#2)
of the human lung##2##4##(1992-12#1)(2008-11#1)
of the human platelet##3##4##(1992-8#1)(2006-6#2)
of the human psoas major muscle##2##6##(2011-2#2)
of the human thyrotropin##2##4##(1991-5#1)(1995-12#1)
of the human type I insulin-like growth factor receptor##2##9##(1991-7#2)
of the human type##3##4##(1991-7#2)(1994-11#1)
of the human##113##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#4)(1992-10#1)(1992-12#3)(1992-3#3)(1992-8#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-8#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#4)(1996-8#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#6)(1997-8#2)(1997-9#1)(2006-6#3)(2008-10#1)(2008-11#12)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#3)(2009-10#1)(2010-10#1)(2010-5#1)(2011-2#6)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
of the humoral response##2##4##(1991-12#1)(2008-10#1)
of the humoral##3##3##(1991-12#1)(1996-9#1)(2008-10#1)
of the hybrid method##3##4##(2008-3#3)
of the hybrid##5##3##(2008-3#3)(2008-9#2)
of the hybrids##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
of the hydatid##2##3##(1991-8#1)(2010-12#1)
of the hydration process in 3CaO##2##6##(2008-10#2)
of the hydration process##3##4##(2008-10#3)
of the hydration##4##3##(2008-10#3)(2008-7#1)
of the hydrocarbon##2##3##(1992-9#1)(2008-10#1)
of the hydrolysis of##2##4##(1993-8#2)
of the hydrolysis##4##3##(1993-8#2)(2008-10#2)
of the hydrolytic##2##3##(1995-2#1)(2008-10#1)
of the hydrophobic##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
of the hydroxide residue with##3##5##(2008-10#3)
of the hydroxyl##3##3##(2008-10#2)(2008-8#1)
of the hyperparasite##3##3##(2008-10#1)(2008-9#2)
of the hypersensitive response (HR)##3##5##(2008-10#3)
of the hypersensitive response##4##4##(2008-10#4)
of the hypodermis##2##3##(2008-10#1)(2008-5#1)
of the hypothalamic-pituitary-adrenal axis and##2##5##(2008-4#1)(2013-8#1)
of the hypothalamic-pituitary-adrenal axis##3##4##(1997-2#1)(2008-4#1)(2013-8#1)
of the hypothalamic-pituitary-adrenal##4##3##(1997-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
of the hypothalamo-pituitary-adrenal##2##3##(1994-2#2)
of the hypothalamus##7##3##(1994-2#4)(1996-12#2)(1996-2#1)
of the hypotheses##2##3##(2008-9#2)
of the hypothesis##5##3##(1994-9#1)(1995-5#1)(2008-11#1)(2008-9#1)(2013-1#1)
of the hypovirulent##2##3##(2008-10#2)
of the identified##9##3##(1993-6#1)(2008-10#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
of the ileocecal valve##2##4##(1994-5#1)(2010-12#1)
of the iliac##2##3##(1991-11#1)(2008-12#1)
of the illness##5##3##(1996-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
of the illumination##2##3##(2008-3#2)
of the image##5##3##(2008-10#2)(2008-3#2)(2010-8#1)
of the images##2##3##(1995-11#1)(2012-2#1)
of the imaging##2##3##(2008-3#1)(2008-7#1)
of the imidazole##2##3##(2008-10#2)
of the immature##2##3##(1994-3#1)(2008-7#1)
of the immediate##2##3##(1993-8#1)(2008-7#1)
of the immobilization##2##3##(2008-10#2)
of the immobilized##14##3##(1990-12#1)(2008-10#9)(2008-12#1)(2008-7#3)
of the immune response##7##4##(1993-12#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#2)
of the immune system and##4##5##(1990-9#1)(1995-12#1)(1996-11#1)(2012-3#1)
of the immune system for##2##5##(1993-3#1)(2008-10#1)
of the immune system in##3##5##(2011-2#1)(2012-3#1)(2013-1#1)
of the immune system##21##4##(1990-9#1)(1993-3#1)(1995-12#1)(1996-11#1)(2008-10#4)(2008-4#3)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
of the immune##29##3##(1990-9#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)
of the immunization##3##3##(1995-5#1)(2008-9#1)(2013-1#1)
of the immunoassay##2##3##(2008-10#2)
of the immunogenicity of##2##4##(1995-5#1)(2008-8#1)
of the immunoglobulin superfamily##2##4##(2008-7#1)(2009-6#1)
of the immunoglobulin##6##3##(1996-12#1)(1996-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)
of the immunological##3##3##(2008-10#2)(2008-9#1)
of the immunoreaction##2##3##(1994-2#1)(2008-10#1)
of the immunosensing device##2##4##(2008-10#2)
of the immunosensor##6##3##(2008-10#5)(2008-7#1)
of the impact and##2##4##(2011-2#1)(2012-3#1)
of the impact of the##4##5##(1991-2#1)(1995-6#1)(2008-10#1)(2008-12#1)
of the impact of##13##4##(1991-2#1)(1993-6#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#2)(2013-8#1)
of the impact##16##3##(1991-2#1)(1993-6#1)(1995-12#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
of the impedance##2##3##(2008-10#2)
of the implant##3##3##(2008-9#2)(2011-2#1)
of the implanted##3##3##(1995-11#1)(2008-9#2)
of the implementation of the##2##5##(1991-1#1)(2008-2#1)
of the implementation of##4##4##(1991-1#1)(2008-2#1)(2008-7#1)(2012-2#1)
of the implementation##6##3##(1991-1#1)(1994-3#1)(1997-2#1)(2008-2#1)(2008-7#1)(2012-2#1)
of the implemented##2##3##(2011-3#1)(2012-12#1)
of the importance of this##3##5##(1990-5#1)(2008-10#2)
of the importance of##16##4##(1990-2#1)(1990-5#1)(1991-12#1)(1995-1#1)(2008-10#2)(2008-11#3)(2009-7#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
of the importance##17##3##(1990-2#1)(1990-5#1)(1991-12#1)(1995-1#1)(2008-10#2)(2008-11#4)(2009-7#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
of the important factors##2##4##(2008-8#1)(2008-9#1)
of the important##21##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-3#2)(1995-5#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)
of the imported##2##3##(2008-10#2)
of the imprinted polymer##3##4##(2008-10#3)
of the imprinted##5##3##(2008-10#5)
of the impurities##2##3##(2010-2#2)
of the in situ##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
of the in vitro##5##4##(1991-3#1)(2008-5#3)(2009-6#1)
of the in vivo##4##4##(2008-5#2)(2008-7#1)(2009-12#1)
of the in##13##3##(1991-3#1)(2008-10#2)(2008-3#1)(2008-5#6)(2008-7#1)(2009-12#1)(2009-6#1)
of the inactive##4##3##(1990-3#1)(1993-6#1)(1994-12#1)(2013-1#1)
of the inadequate##2##3##(1992-12#1)(2008-10#1)
of the incidence of##9##4##(1990-3#1)(1997-5#1)(2008-10#5)(2008-7#1)(2009-8#1)
of the incidence##13##3##(1990-3#1)(1997-5#1)(2008-10#6)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)
of the incident beam##2##4##(2008-3#2)
of the incident laser beam##2##5##(2008-3#2)
of the incident##8##3##(2007-12#1)(2008-3#7)
of the inclusion complex##5##4##(2008-10#5)
of the inclusion complexes##2##4##(2008-10#2)
of the inclusion##14##3##(2008-10#14)
of the inclusions##2##3##(2008-10#2)
of the incorporation of##2##4##(2008-11#1)(2008-5#1)
of the increase in##3##4##(2008-10#3)
of the increase of##2##4##(2008-10#1)(2008-9#1)
of the increase##7##3##(2008-10#6)(2008-9#1)
of the increased##4##3##(1990-6#1)(1994-11#1)(2008-10#2)
of the increasing number of##2##5##(2008-8#1)(2011-2#1)
of the increasing prevalence of##2##5##(2010-5#1)(2012-3#1)
of the increasing##8##3##(1990-11#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-2#2)(2012-3#1)
of the incubation##5##3##(1990-12#1)(1991-2#1)(2008-10#2)(2011-2#1)
of the independent variable##2##4##(2008-11#2)
of the independent##5##3##(1993-8#1)(2008-10#1)(2008-11#3)
of the index of##2##4##(1991-9#1)(2008-10#1)
of the index##7##3##(1991-9#1)(1996-1#1)(2008-10#1)(2008-3#2)(2011-2#2)
of the indicator##7##3##(1990-12#1)(1990-2#1)(2008-10#3)(2008-9#2)
of the indices of##2##4##(2008-11#1)(2013-8#1)
of the indigenous##2##3##(2008-10#2)
of the indirect##2##3##(2008-10#1)(2008-8#1)
of the individual components of##2##5##(2008-10#1)(2008-12#1)
of the individual components##4##4##(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)
of the individual species##2##4##(2008-10#2)
of the individual##44##3##(1990-5#1)(1994-2#1)(1995-2#1)(1995-5#2)(1997-9#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-7#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
of the individuals##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
of the induced##6##3##(1991-7#1)(2008-10#1)(2008-12#2)(2009-10#1)(2012-2#1)
of the inducible isoform##2##4##(1995-11#2)
of the inducible##3##3##(1995-11#2)(1995-6#1)
of the induction of##6##4##(1995-11#1)(2008-10#2)(2008-11#1)(2011-2#2)
of the induction##9##3##(1990-6#1)(1995-11#1)(2008-10#4)(2008-11#1)(2011-2#2)
of the industrial##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
of the industry##5##3##(1992-3#1)(2008-10#1)(2008-11#3)
of the infant##2##3##(2009-12#1)(2010-9#1)
of the infant's##2##3##(1993-3#1)(2009-11#1)
of the infants were##2##4##(1991-11#1)(1994-6#1)
of the infants##4##3##(1991-11#1)(1994-6#2)(2008-10#1)
of the infected##9##3##(1990-6#1)(1990-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
of the infection in##2##4##(2008-7#1)(2008-9#1)
of the infection process##2##4##(2008-10#2)
of the infection##22##3##(1991-6#1)(1992-6#1)(1994-5#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#4)(2012-12#1)
of the infectious##7##3##(1995-5#1)(2007-12#1)(2008-10#2)(2010-6#1)(2011-2#1)(2012-3#1)
of the inferior competitor##2##4##(2008-8#2)
of the inferior vena##2##4##(2009-5#1)(2013-1#1)
of the inferior##5##3##(1990-9#1)(2008-8#2)(2009-5#1)(2013-1#1)
of the inflammatory process##3##4##(1992-6#1)(1993-1#1)(2009-5#1)
of the inflammatory##5##3##(1992-6#1)(1993-1#1)(1997-8#1)(2008-10#1)(2009-5#1)
of the inflorescence##2##3##(2008-10#2)
of the influence of##8##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
of the information available##2##4##(2008-4#1)(2011-2#1)
of the information##9##3##(1995-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
of the infusion##2##3##(1997-3#1)(2008-7#1)
of the ingested##2##3##(2008-11#1)(2008-7#1)
of the inhaled##3##3##(1992-3#1)(2007-11#1)(2013-1#1)
of the inherent##2##3##(2008-11#1)(2008-7#1)
of the inhibition of##3##4##(1995-11#1)(1996-2#1)(2008-10#1)
of the inhibition period and##3##5##(1991-12#3)
of the inhibition period##4##4##(1991-12#4)
of the inhibition##10##3##(1991-12#4)(1995-11#1)(1996-2#1)(2008-10#4)
of the inhibitor##5##3##(1991-3#1)(1994-11#2)(2009-12#1)(2013-1#1)
of the inhibitors##3##3##(1993-8#1)(1995-11#1)(1995-12#1)
of the inhibitory effect##2##4##(1992-12#1)(2008-10#1)
of the inhibitory##11##3##(1992-12#1)(1994-8#1)(1996-2#2)(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
of the initial and##2##4##(1993-11#1)(2008-10#1)
of the initial inoculum##2##4##(2008-10#2)
of the initial##40##3##(1990-12#2)(1990-5#1)(1991-12#1)(1991-3#1)(1993-11#1)(1995-11#1)(1995-3#1)(1996-5#1)(2007-12#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-9#1)(2009-6#2)(2009-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
of the initiative##3##3##(1994-12#1)(2008-11#1)(2012-2#1)
of the injected dose##2##4##(1993-11#1)(2013-1#1)
of the injected sample##2##4##(2008-10#2)
of the injected##7##3##(1991-12#1)(1993-11#1)(1993-6#1)(2008-10#3)(2013-1#1)
of the injection##6##3##(1993-3#1)(1997-5#2)(2008-10#2)(2008-12#1)
of the injured##3##3##(1990-6#1)(1997-3#2)
of the injury##2##3##(2009-8#1)(2013-8#1)
of the innate##2##3##(2008-10#1)(2013-8#1)
of the inner core##3##4##(1995-3#2)(2008-8#1)
of the inner ear##2##4##(1994-9#1)(2008-9#1)
of the inner##14##3##(1991-5#1)(1994-9#1)(1995-3#2)(1997-2#1)(2008-10#3)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#1)
of the inoculated stalk pieces##2##5##(2008-10#2)
of the inoculated##9##3##(2008-10#7)(2008-5#2)
of the inoculum##5##3##(1991-11#1)(2008-10#3)(2008-5#1)
of the inpatient##2##3##(1992-3#1)(2010-12#1)
of the input spike trains##2##5##(2008-11#2)
of the input##4##3##(1992-6#1)(2008-11#2)(2008-2#1)
of the insect##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
of the inserted gene(s)##2##4##(1997-8#2)
of the inserted genes##2##4##(1997-8#2)
of the inserted##5##3##(1997-8#4)(2008-10#1)
of the insertion##4##3##(2008-12#1)(2009-7#3)
of the instability##2##3##(2011-7#1)(2012-3#1)
of the instantaneous##2##3##(1990-11#1)(2010-8#1)
of the instrument is##2##4##(2008-10#1)(2008-3#1)
of the instrument##16##3##(1993-3#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#4)(2009-12#1)(2012-2#1)
of the instrument's##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
of the instrumental##6##3##(1991-3#1)(2008-10#3)(2008-3#2)
of the instruments##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
of the insulin receptor##3##4##(1993-8#1)(1994-12#1)(2008-4#1)
of the insulin##6##3##(1993-8#1)(1994-12#1)(1996-3#1)(2008-4#2)(2010-11#1)
of the intact##6##3##(1992-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(2008-10#1)(2013-8#1)
of the integrase##2##3##(1992-6#1)(1997-3#1)
of the integrated##2##3##(1997-2#1)(2008-10#1)
of the integration of##3##4##(2008-10#1)(2009-12#1)(2012-3#1)
of the integration##4##3##(2008-10#1)(2008-3#1)(2009-12#1)(2012-3#1)
of the integrity of the##2##5##(2008-10#1)(2011-2#1)
of the intellectual##2##3##(2011-2#2)
of the intelligentsia in##2##4##(2008-12#2)
of the intensity of the##2##5##(2008-10#2)
of the intensity of##9##4##(1992-1#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-4#1)
of the intensity##13##3##(1992-1#1)(1997-2#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)
of the inter atrial septum##2##5##(2012-3#2)
of the interacting##3##3##(2008-11#2)(2009-12#1)
of the interaction between the##2##5##(2008-10#1)(2008-7#1)
of the interaction between##8##4##(2008-10#7)(2008-7#1)
of the interaction of the##2##5##(1994-5#1)(2008-2#1)
of the interaction of##10##4##(1994-5#1)(1995-6#1)(1996-12#1)(2008-10#6)(2008-2#1)
of the interaction##27##3##(1994-3#1)(1994-5#1)(1995-6#1)(1996-12#1)(2008-10#19)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
of the interactions between##2##4##(2008-10#1)(2008-5#1)
of the interactions of##2##4##(1991-9#1)(1997-2#1)
of the interactions##7##3##(1991-9#1)(1997-2#1)(2008-10#3)(2008-5#1)(2011-2#1)
of the intercept##3##3##(2008-10#3)
of the interdependence between##2##4##(2009-8#2)
of the interface of##2##4##(2008-10#1)(2008-8#1)
of the interface##4##3##(2008-10#3)(2008-8#1)
of the interfacial##2##3##(2008-10#2)
of the interference##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
of the interferences##2##3##(2008-10#2)
of the interfering cations##2##4##(2008-10#2)
of the interfering##3##3##(2008-10#3)
of the interferometer##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of the intergenic spacer (IGS)##2##5##(2008-10#2)
of the intergenic spacer##3##4##(2008-10#3)
of the intergenic##4##3##(2008-10#4)
of the interhyoid muscle##4##4##(2011-2#4)
of the interhyoid##5##3##(2011-2#5)
of the interior##3##3##(1992-3#1)(1994-11#1)(2008-3#1)
of the interleukin-2 receptor##2##4##(1990-5#1)(1991-9#1)
of the intermediate##7##3##(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#2)(2010-10#1)
of the internal carotid artery##5##5##(2008-7#3)(2011-2#1)(2012-3#1)
of the internal field##2##4##(2008-2#1)(2008-3#1)
of the internal transcribed spacer (ITS) region of the##2##9##(2008-10#2)
of the internal transcribed spacer (ITS) region of##5##8##(2008-10#5)
of the internal transcribed spacer (ITS) region##7##7##(2008-10#7)
of the internal transcribed spacer (ITS) regions of##2##8##(2008-10#2)
of the internal transcribed spacer (ITS) regions##3##7##(2008-10#3)
of the internal transcribed spacer (ITS)##11##6##(2008-10#11)
of the internal transcribed spacer 1##2##6##(2008-10#2)
of the internal transcribed spacer of the##2##7##(2008-10#2)
of the internal transcribed spacer region##4##6##(2008-10#4)
of the internal transcribed spacer##22##5##(2008-10#22)
of the internal##46##3##(1990-3#1)(1990-9#1)(1992-12#2)(1992-3#1)(1993-5#1)(1996-9#1)(2008-10#28)(2008-2#1)(2008-3#1)(2008-7#4)(2010-5#1)(2011-2#2)(2012-3#2)
of the international##5##3##(1991-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
of the interpretation##2##3##(1995-11#1)(1997-8#1)
of the intervention##9##3##(1995-1#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-8#3)(2010-10#1)(2013-1#1)
of the interventions were##2##4##(2012-2#2)
of the interventions##6##3##(1995-3#1)(1996-2#1)(2012-2#3)(2013-1#1)
of the interview transcripts##3##4##(1993-3#1)(2009-5#1)(2013-1#1)
of the interview##6##3##(1990-6#1)(1993-3#1)(1997-1#1)(2009-5#1)(2010-8#1)(2013-1#1)
of the intestinal##6##3##(1992-12#1)(1996-3#1)(2008-10#1)(2009-12#1)(2010-5#1)(2011-1#1)
of the intimal hyperplasia in##2##5##(2006-6#2)
of the intracavity##3##3##(2008-10#1)(2008-3#2)
of the intracellular##11##3##(1992-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-12#1)(2008-11#2)(2008-4#2)(2008-7#1)
of the intracranial##2##3##(2007-9#1)(2011-2#1)
of the intramuscular fat##2##4##(2010-4#2)
of the intramuscular##3##3##(2010-4#2)(2013-1#1)
of the intravesical##2##3##(2008-10#2)
of the intrinsic##8##3##(1991-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
of the introduced##5##3##(2008-10#4)(2008-8#1)
of the introduction of a##2##5##(2008-11#2)
of the introduction of new##2##5##(1995-5#1)(2008-10#1)
of the introduction of##6##4##(1995-5#1)(2008-10#2)(2008-11#3)
of the introduction##7##3##(1995-5#1)(2008-10#2)(2008-11#3)(2008-12#1)
of the intron##3##3##(1991-5#1)(1992-10#1)(1993-12#1)
of the invading##2##3##(2008-10#2)
of the inverse##2##3##(2008-3#2)
of the inverted##3##3##(1990-2#1)(2008-3#1)(2008-5#1)
of the investigated compounds in##2##5##(2008-10#2)
of the investigated compounds##3##4##(2008-10#3)
of the investigated drugs##4##4##(2008-10#3)(2008-11#1)
of the investigated##18##3##(1990-11#1)(1995-3#1)(2008-10#14)(2008-11#1)(2008-3#1)
of the investigation of##2##4##(2008-10#1)(2008-11#1)
of the investigation##7##3##(1993-3#1)(2008-10#4)(2008-11#1)(2009-10#1)
of the involved##6##3##(1992-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
of the involvement of##4##4##(2007-12#1)(2008-10#2)(2011-1#1)
of the iodate##2##3##(2008-10#2)
of the ion associate##3##4##(2008-10#3)
of the ion association##4##4##(2008-10#4)
of the ion exchanger##4##4##(2008-10#4)
of the ion pair##2##4##(2008-10#2)
of the ion transport##2##4##(1997-1#2)
of the ion##20##3##(1990-12#1)(1997-1#2)(2008-10#17)
of the ion-pair formed between##2##5##(2008-10#2)
of the ion-pair##4##3##(2008-10#4)
of the ionic fraction of heavy metals##2##7##(2008-10#2)
of the ionic strength##4##4##(1997-2#1)(2008-10#3)
of the ionic##13##3##(1997-2#1)(2008-10#11)(2010-7#1)
of the ipsilateral##2##3##(1993-3#1)(1996-12#1)
of the iron chalcogenide glass##2##5##(2008-10#2)
of the iron##5##3##(1992-8#1)(2008-10#3)(2011-2#1)
of the irradiated LDH##2##4##(2011-2#2)
of the irradiated##4##3##(1993-2#1)(2008-9#1)(2011-2#2)
of the irrigation methods##2##4##(2008-10#2)
of the irrigation##5##3##(2008-10#5)
of the ischemic##2##3##(2008-10#1)(2009-10#1)
of the islet##3##3##(1992-6#1)(1995-8#1)(2010-11#1)
of the isocoumarin ring##2##4##(1991-3#2)
of the isolate##6##3##(2008-10#5)(2008-7#1)
of the isolated mature##2##4##(2008-11#2)
of the isolated##18##3##(1990-2#1)(1991-3#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-5#2)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#5)(2009-10#1)
of the isolates belonged to##2##5##(2008-10#2)
of the isolates in the##2##5##(2008-10#1)(2008-5#1)
of the isolates in##4##4##(2008-10#3)(2008-5#1)
of the isolates were resistant##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
of the isolates were##11##4##(2008-10#7)(2008-5#1)(2008-7#2)(2011-2#1)
of the isolates##45##3##(1996-12#1)(2008-10#32)(2008-12#2)(2008-5#2)(2008-7#3)(2011-2#4)(2012-3#1)
of the isolation##2##3##(2008-10#1)(2008-5#1)
of the isomers##2##3##(2008-10#2)
of the issue##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
of the issues involved in##2##5##(1991-12#1)(1993-2#1)
of the issues involved##3##4##(1991-12#1)(1993-2#1)(2008-9#1)
of the issues surrounding##2##4##(2008-10#1)(2013-8#1)
of the issues that##3##4##(2008-10#1)(2008-4#2)
of the issues##14##3##(1991-12#1)(1993-2#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-6#1)(2008-9#1)(2013-8#1)
of the items##4##3##(1990-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
of the jaw##5##3##(1997-3#1)(2010-9#1)(2011-2#2)(2012-12#1)
of the jaws##7##3##(2008-1#2)(2012-12#3)(2013-1#2)
of the job##2##3##(1991-2#1)(1992-1#1)
of the joint##6##3##(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the journal##5##3##(1991-2#1)(1992-2#1)(1996-2#1)(2013-1#2)
of the karyosome##3##3##(2008-7#3)
of the keratin##2##3##(1991-12#1)(2009-10#1)
of the keratinocytes##2##3##(1993-11#1)(1995-11#1)
of the key##24##3##(1995-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#2)(2010-10#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of the kidney##11##3##(1994-5#1)(2008-10#4)(2008-11#1)(2010-1#1)(2011-2#2)(2013-1#2)
of the kinase##6##3##(1990-12#1)(1990-5#1)(1993-6#1)(1993-8#1)(1995-6#1)(2013-8#1)
of the kind of##2##4##(2008-7#1)(2009-10#1)
of the kind##3##3##(2008-10#1)(2008-7#1)(2009-10#1)
of the kinetic constants##2##4##(1991-3#1)(2008-10#1)
of the kinetic##8##3##(1990-5#1)(1991-3#1)(1992-12#1)(1995-12#1)(2008-10#3)(2008-6#1)
of the kinetics of##3##4##(1990-8#1)(1994-5#1)(2008-10#1)
of the knee in##2##4##(2008-8#1)(2012-3#1)
of the knee joint##2##4##(1997-8#1)(2007-8#1)
of the knee##17##3##(1993-3#1)(1997-8#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#4)
of the knowledge and##2##4##(1991-1#1)(2012-12#1)
of the knowledge##4##3##(1991-1#1)(2012-12#1)(2012-3#2)
of the known##5##3##(1995-2#1)(2008-10#2)(2008-3#1)(2012-2#1)
of the label##2##3##(1991-5#1)(2008-11#1)
of the labeled##2##3##(1994-2#1)(2008-10#1)
of the labelled claim##2##4##(1996-2#2)
of the labelled##4##3##(1996-2#2)(2008-10#2)
of the laboratories##2##3##(2008-10#2)
of the laboratory##5##3##(1994-2#1)(2008-10#4)
of the labrum is##2##4##(2007-12#2)
of the labrum##5##3##(2007-12#5)
of the lac##3##3##(1990-5#1)(1995-2#1)(2008-10#1)
of the lacZ##2##3##(1997-7#1)(2009-12#1)
of the lack of##6##4##(1997-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
of the lacquer films##2##4##(2008-10#2)
of the lacrimal##2##3##(1995-9#1)(2011-2#1)
of the lactate##2##3##(1990-8#1)(2008-10#1)
of the lag period##2##4##(2008-10#2)
of the lag time between##2##5##(2008-10#2)
of the lag##6##3##(2008-10#4)(2008-5#1)(2011-2#1)
of the laminin fragments##2##4##(1997-1#2)
of the laminin##3##3##(1997-1#2)(2013-8#1)
of the lamprey##4##3##(1993-3#1)(1997-3#3)
of the lanthanide##2##3##(2008-10#1)(2008-4#1)
of the lanthanides##2##3##(2008-10#2)
of the large intestine##3##4##(1990-11#1)(1991-6#1)(2011-2#1)
of the large subunit##2##4##(2008-10#1)(2010-4#1)
of the large##19##3##(1990-11#1)(1990-3#1)(1991-6#1)(1991-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)
of the larger##3##3##(1990-11#1)(1993-12#1)(1994-1#1)
of the largest##8##3##(1991-2#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-5#1)
of the larvae##3##3##(1997-8#1)(2008-10#1)(2010-8#1)
of the larynx##2##3##(2008-11#1)(2013-8#1)
of the laser and##2##4##(2008-3#2)
of the laser as##2##4##(1991-1#1)(2008-3#1)
of the laser beam##7##4##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#4)
of the laser performance##2##4##(2008-2#1)(2008-3#1)
of the laser power##2##4##(1992-12#1)(2008-3#1)
of the laser temporal pulse##2##5##(2008-10#2)
of the laser was##2##4##(2008-3#1)(2012-3#1)
of the laser##40##3##(1991-1#1)(1992-12#1)(1993-3#2)(2008-10#5)(2008-2#7)(2008-3#21)(2008-9#1)(2012-3#2)
of the laser's##2##3##(2008-3#2)
of the last##6##3##(1991-11#1)(1993-2#1)(1997-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
of the late blight pathogen Phytophthora infestans##2##7##(2008-10#2)
of the late blight pathogen##4##5##(2008-10#4)
of the late##7##3##(2008-10#4)(2008-11#1)(2008-6#1)(2011-2#1)
of the latent##3##3##(2008-10#1)(2009-4#1)(2010-11#1)
of the later##2##3##(1992-5#1)(2008-7#1)
of the lateral hypothalamus##2##4##(1996-2#1)(2009-10#1)
of the lateral nucleus of the amygdala##2##7##(1993-6#2)
of the lateral ventricle##2##4##(2008-7#2)
of the lateral##24##3##(1991-8#1)(1993-6#2)(1996-2#1)(1997-3#6)(1997-8#2)(2007-12#1)(2008-10#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-2#3)(2012-2#1)(2013-1#1)
of the latest##3##3##(1992-9#1)(2008-8#1)(2009-10#1)
of the latex films##2##4##(2008-10#2)
of the latex##5##3##(2008-10#4)(2008-5#1)
of the latissimus dorsi##2##4##(1990-9#1)(2013-1#1)
of the latter and##2##4##(2008-8#1)(2009-8#1)
of the latter in##2##4##(1991-11#1)(2008-10#1)
of the latter species##2##4##(2008-10#1)(2011-2#1)
of the latter##20##3##(1990-8#1)(1991-11#1)(1992-12#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)
of the law and##2##4##(1994-1#1)(1997-8#1)
of the law##5##3##(1993-6#1)(1994-1#1)(1995-5#1)(1996-3#1)(1997-8#1)
of the lead complex##2##4##(2008-10#2)
of the lead##6##3##(2008-10#4)(2008-11#1)(2011-2#1)
of the leading##7##3##(2007-12#1)(2008-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
of the leaf rust##2##4##(2008-10#2)
of the leaf##8##3##(2008-10#8)
of the leaf-drop symptom##2##4##(2008-10#2)
of the learning##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
of the least##5##3##(1992-2#1)(2008-10#2)(2008-6#1)(2013-1#1)
of the leaves of##2##4##(1992-2#1)(2008-10#1)
of the leaves##5##3##(1992-2#1)(2008-10#2)(2008-11#2)
of the leaving group##4##4##(1993-8#4)
of the lectin##4##3##(1990-5#1)(1995-11#1)(2008-10#2)
of the lecturer in##2##4##(2008-11#2)
of the lecturer practitioner##6##4##(2008-11#4)(2008-12#2)
of the lecturer##9##3##(2008-11#7)(2008-12#2)
of the left and right##2##5##(1991-2#1)(2011-2#1)
of the left atrial##2##4##(2008-11#1)(2010-12#1)
of the left atrium##2##4##(2008-7#1)(2013-1#1)
of the left breast##2##4##(2011-2#1)(2012-3#1)
of the left cardiac sympathetic nerve##2##6##(2008-9#2)
of the left cervical##2##4##(1991-3#1)(2013-8#1)
of the left eye##2##4##(2011-2#1)(2013-8#1)
of the left kidney and##3##5##(2011-2#1)(2013-1#2)
of the left lower lobe##2##5##(1991-3#1)(2007-8#1)
of the left superior##2##4##(1996-2#1)(2011-2#1)
of the left ventricle##7##4##(1997-8#1)(2010-5#1)(2013-1#5)
of the left ventricular##3##4##(1990-9#1)(2008-10#1)(2010-8#1)
of the left##55##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1993-3#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-8#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
of the leg##3##3##(2007-12#1)(2008-12#1)(2008-5#1)
of the legal##3##3##(1994-1#1)(1996-3#1)(2008-11#1)
of the legs##3##3##(2008-5#2)(2013-8#1)
of the length of the##2##5##(1992-9#1)(2009-10#1)
of the length##3##3##(1992-9#1)(2008-10#1)(2009-10#1)
of the lens##2##3##(2011-2#1)(2012-2#1)
of the lenslet##2##3##(2008-3#2)
of the lesion and##4##4##(1990-3#1)(1997-6#1)(2008-7#1)(2009-1#1)
of the lesion on##2##4##(1996-3#1)(2012-12#1)
of the lesion revealed##2##4##(1993-3#1)(2010-6#1)
of the lesion were##2##4##(1996-3#1)(2012-3#1)
of the lesion##26##3##(1990-3#1)(1991-3#1)(1993-3#1)(1994-6#1)(1995-11#2)(1996-3#3)(1997-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-7#3)(2009-1#1)(2010-10#1)(2010-5#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-3#1)
of the lesions and##2##4##(2008-10#1)(2008-8#1)
of the lesions in##2##4##(2008-11#1)(2008-7#1)
of the lesions##17##3##(1991-11#1)(1991-2#1)(1995-11#1)(1996-1#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#1)
of the less##3##3##(1990-5#1)(1993-6#1)(1996-5#1)
of the lessons learned##2##4##(1995-12#1)(2009-10#1)
of the lessons##3##3##(1995-12#1)(2008-12#1)(2009-10#1)
of the level of##8##4##(1991-11#1)(1993-5#1)(2008-10#2)(2008-11#1)(2013-1#2)(2013-8#1)
of the level##11##3##(1991-11#1)(1993-5#1)(1997-2#1)(2008-10#3)(2008-11#2)(2013-1#2)(2013-8#1)
of the levels of##10##4##(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
of the lichen##3##3##(2008-11#2)(2008-5#1)
of the lidar ratio##3##4##(2008-2#3)
of the lidar##4##3##(2008-2#3)(2008-3#1)
of the life cycle of##2##5##(1997-7#1)(2008-10#1)
of the life cycle##5##4##(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)
of the life##13##3##(1990-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-10#1)(2012-2#1)(2012-3#1)
of the ligament-to-bone attachment##2##4##(2009-7#2)
of the ligament-to-bone##3##3##(2009-7#3)
of the ligand as##2##4##(2008-10#2)
of the ligand##11##3##(1996-12#1)(2008-10#10)
of the ligand-binding domain of the##2##6##(1991-12#2)
of the ligand-binding domain##4##4##(1991-12#2)(2008-8#2)
of the ligand-binding##5##3##(1991-12#2)(2008-4#1)(2008-8#2)
of the light absorption##2##4##(2008-3#2)
of the light chain##2##4##(1994-11#2)
of the light source##2##4##(2008-3#1)(2008-5#1)
of the light##17##3##(1994-11#2)(1997-6#1)(2008-10#4)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#3)
of the likelihood ratio##2##4##(2008-10#2)
of the likelihood##4##3##(2008-10#3)(2008-12#1)
of the likely##2##3##(1996-1#1)(2010-4#1)
of the limb bud##2##4##(1993-12#1)(1995-8#1)
of the limb##5##3##(1993-12#1)(1995-8#2)(2011-3#1)(2012-3#1)
of the limbic system##3##4##(1992-12#3)
of the limitations and##3##4##(1993-11#1)(2008-10#1)(2008-7#1)
of the limitations of the##2##5##(1992-3#1)(2008-11#1)
of the limitations of##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
of the limitations##8##3##(1992-3#1)(1993-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
of the limited##2##3##(1996-11#1)(2008-10#1)
of the line##6##3##(1995-8#2)(2008-3#4)
of the lineages##3##3##(2008-10#2)(2008-9#1)
of the linear##11##3##(2008-10#6)(2008-3#3)(2008-8#1)(2013-1#1)
of the linearly polarized##2##4##(2007-12#1)(2008-2#1)
of the linearly##3##3##(2007-12#1)(2008-2#1)(2009-7#1)
of the lines##4##3##(2008-10#3)(2008-8#1)
of the linewidth of##2##4##(2008-2#2)
of the linker##2##3##(2009-6#1)(2010-5#1)
of the lipid bilayer##3##4##(1991-5#1)(1992-9#1)(2008-9#1)
of the lipid##15##3##(1991-5#1)(1992-9#1)(1994-11#1)(1994-5#2)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)
of the lipid-stimulated##2##3##(1992-9#2)
of the lipids##4##3##(1991-5#1)(2008-10#1)(2008-9#1)(2012-12#1)
of the lipophilic surfactant##2##4##(2008-5#2)
of the lipophilic##5##3##(2008-10#2)(2008-5#3)
of the liposomes##2##3##(1991-5#1)(1994-11#1)
of the liquid crystalline##2##4##(1992-9#1)(2008-7#1)
of the liquid##12##3##(1992-9#1)(1995-3#1)(2008-10#4)(2008-3#3)(2008-7#1)(2010-4#1)(2010-8#1)
of the literature and##9##4##(1990-3#1)(1991-1#1)(1991-3#1)(1993-11#1)(1993-3#1)(2006-5#1)(2008-10#1)(2012-3#1)(2013-1#1)
of the literature as##2##4##(1996-12#1)(2009-7#1)
of the literature from##2##4##(2008-10#2)
of the literature is based on##2##6##(1995-9#1)(2008-11#1)
of the literature is##5##4##(1991-3#1)(1995-9#1)(2008-1#1)(2008-11#1)(2010-12#1)
of the literature on the##6##5##(1992-1#1)(1993-11#1)(1996-12#1)(2008-11#1)(2009-6#1)(2013-1#1)
of the literature on##14##4##(1992-1#1)(1993-11#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-8#1)(2012-2#2)(2013-1#1)
of the literature related to##2##5##(2008-12#1)(2009-1#1)
of the literature showed##3##4##(2008-7#1)(2011-2#2)
of the literature##128##3##(1990-3#2)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-1#2)(1992-12#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(2006-5#1)(2008-1#1)(2008-10#13)(2008-11#11)(2008-12#8)(2008-5#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#9)(2011-3#1)(2012-2#6)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#1)
of the lithium##2##3##(2008-10#2)
of the lived experience##2##4##(2008-11#2)
of the liver and##3##4##(1995-11#1)(2009-8#1)(2012-2#1)
of the liver in##3##4##(1990-11#1)(1991-12#1)(1992-2#1)
of the liver to##2##4##(1995-8#1)(2008-5#1)
of the liver was##2##4##(1993-6#1)(2011-1#1)
of the liver with##3##4##(2009-1#1)(2010-12#1)(2013-1#1)
of the liver##37##3##(1990-11#3)(1990-2#1)(1990-5#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-2#2)(1993-6#2)(1995-11#1)(1995-8#1)(1997-7#1)(1997-8#2)(2008-11#1)(2008-5#1)(2009-1#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#6)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
of the living##3##3##(2008-10#2)(2008-9#1)
of the lizard Anolis carolinensis##2##5##(2011-2#2)
of the loaded resin##2##4##(2008-10#2)
of the local and##2##4##(1997-3#1)(2008-12#1)
of the local##16##3##(1991-3#1)(1993-1#1)(1997-3#1)(2006-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#1)
of the location of the##3##5##(2008-11#1)(2008-5#1)(2009-7#1)
of the location of##6##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)
of the location##7##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)
of the locust##3##3##(2007-12#3)
of the logarithm of##2##4##(2008-10#2)
of the long arm of##4##5##(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
of the long arm##5##4##(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)
of the long bones##2##4##(2008-12#1)(2010-6#1)
of the long##12##3##(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#2)(2010-6#1)
of the long-term##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
of the longest##3##3##(1993-12#1)(2008-7#1)(2012-3#1)
of the loop##6##3##(1995-1#2)(2008-11#2)(2008-4#1)(2008-7#1)
of the loss of##5##4##(1992-2#1)(1997-7#2)(2008-9#1)(2009-8#1)
of the low##21##3##(1992-12#1)(1995-8#2)(1996-9#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#4)(2011-1#1)(2012-3#1)(2013-8#1)
of the lower extremities##5##4##(1995-8#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
of the lower leg with##2##5##(2012-12#2)
of the lower leg##5##4##(1994-6#1)(1997-8#2)(2012-12#2)
of the lower limbs is##2##5##(1990-3#1)(2008-8#1)
of the lower limbs##6##4##(1990-3#1)(1991-11#1)(2007-8#1)(2008-8#2)(2009-3#1)
of the lower lip##3##4##(1991-8#2)(2013-1#1)
of the lower##35##3##(1990-3#1)(1991-11#1)(1991-8#2)(1992-6#1)(1994-1#2)(1994-6#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-8#3)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
of the lowest##5##3##(1991-6#1)(2008-10#2)(2008-12#1)(2008-6#1)
of the lucigenin##2##3##(2008-10#2)
of the lumbar spine##4##4##(1991-11#2)(2012-2#1)(2012-3#1)
of the lumbar##6##3##(1991-11#2)(1996-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
of the lumen##2##3##(1996-3#1)(2008-10#1)
of the lung and##2##4##(1996-3#1)(1997-1#1)
of the lung in##2##4##(2008-2#1)(2010-7#1)
of the lung tissue##2##4##(1991-12#1)(1996-3#1)
of the lung##26##3##(1990-3#1)(1991-12#3)(1991-2#1)(1992-12#2)(1994-12#2)(1996-3#2)(1997-1#3)(1997-2#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-1#1)(2010-10#1)(2010-7#1)(2010-8#1)(2013-1#3)
of the lungs and##2##4##(1996-3#1)(2011-2#1)
of the lungs##6##3##(1996-3#1)(1997-1#2)(2008-5#1)(2011-2#1)(2012-3#1)
of the luteal##2##3##(1990-8#1)(1992-9#1)
of the lymph node##2##4##(1990-5#1)(1990-6#1)
of the lymph##3##3##(1990-5#1)(1990-6#1)(1996-3#1)
of the lymphatic##2##3##(1990-3#1)(2013-1#1)
of the lymphoid##6##3##(1992-12#2)(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)
of the lysosomal enzymes##2##4##(1991-12#1)(2012-3#1)
of the lysosomal system##3##4##(1992-12#1)(2008-7#2)
of the lysosomal##9##3##(1991-12#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-5#1)(1997-7#1)(2008-7#2)(2012-3#1)
of the mAb##2##3##(2008-11#2)
of the mRNA for##3##4##(1992-6#1)(1996-12#1)(2008-11#1)
of the mRNA has##2##4##(1993-2#1)(1993-8#1)
of the mRNA##11##3##(1992-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-11#1)(1996-12#1)(2008-11#1)(2008-9#2)(2013-1#1)
of the macrophage##2##3##(1991-5#1)(1994-6#1)
of the macrophages##2##3##(1992-12#1)(1995-5#1)
of the magnetic beads##3##4##(2008-10#3)
of the magnetic field##2##4##(2008-10#1)(2008-8#1)
of the magnetic##8##3##(1993-5#1)(2008-10#5)(2008-8#1)(2012-2#1)
of the magnitude##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
of the main chain and##3##5##(2008-9#2)(2009-7#1)
of the main constituents of##2##5##(2008-11#2)
of the main constituents##3##4##(2008-11#3)
of the main factors##2##4##(1994-12#1)(2008-10#1)
of the main objectives in##2##5##(2008-11#1)(2011-2#1)
of the main##58##3##(1990-5#1)(1990-9#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#9)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#3)(2013-8#1)
of the major NORs##2##4##(1993-12#2)
of the major components##2##4##(2008-10#1)(2008-5#1)
of the major exoglucanase##2##4##(1997-1#2)
of the major histocompatibility complex (MHC)##2##6##(1990-5#1)(2008-1#1)
of the major obstacles##3##4##(1996-5#1)(2008-12#1)(2008-4#1)
of the major##70##3##(1990-5#1)(1992-1#1)(1993-12#2)(1994-11#2)(1994-12#1)(1995-2#1)(1995-6#3)(1996-5#1)(1997-1#2)(1997-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#2)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
of the majority of##2##4##(1991-3#1)(1997-2#1)
of the malaria##4##3##(2012-12#4)
of the male accessory glands##2##5##(2007-12#1)(2008-7#1)
of the male accessory##3##4##(1991-5#1)(2007-12#1)(2008-7#1)
of the male rats##2##4##(1990-11#1)(1994-2#1)
of the male urogenital##2##4##(1994-11#1)(2013-1#1)
of the male##18##3##(1990-11#1)(1991-5#1)(1992-2#2)(1992-3#2)(1994-11#1)(1994-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the males##2##3##(1993-11#1)(1994-2#1)
of the malformation##2##3##(1990-9#2)
of the malignant polyp##2##4##(2009-12#2)
of the malignant##8##3##(1990-5#1)(1996-6#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-3#1)
of the mammalian brain##3##4##(1995-6#1)(2008-11#2)
of the mammalian##17##3##(1990-7#1)(1991-6#1)(1994-2#1)(1995-2#1)(1995-6#2)(2008-11#4)(2008-9#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
of the management of##6##4##(2008-1#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#2)
of the management##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#2)
of the mandible##4##3##(1997-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
of the manifold##2##3##(2008-10#2)
of the mannitol permease##4##4##(1991-10#4)
of the manual##4##3##(1991-3#1)(2008-10#2)(2010-10#1)
of the manufacturing##3##3##(1995-5#2)(2008-10#1)
of the many##9##3##(1992-2#1)(1994-12#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)
of the marginal##2##3##(1995-9#1)(2008-7#1)
of the marine##3##3##(2008-10#1)(2008-6#1)(2010-8#1)
of the marked strain##2##4##(2008-10#2)
of the marked##4##3##(2008-10#3)(2008-5#1)
of the marker genes##2##4##(2008-10#1)(2008-8#1)
of the marker##4##3##(2008-10#3)(2008-8#1)
of the markers##3##3##(2008-10#2)(2008-9#1)
of the market##7##3##(1991-12#1)(1994-3#2)(1995-1#1)(1997-5#1)(2008-10#1)(2010-5#1)
of the marks##2##3##(1996-3#1)(2008-11#1)
of the masking effect##2##4##(2008-10#1)(2008-5#1)
of the masking##4##3##(2008-10#3)(2008-5#1)
of the mass and##2##4##(2010-11#1)(2011-2#1)
of the mass of##2##4##(1992-2#1)(2008-10#1)
of the mass##16##3##(1990-12#1)(1991-5#1)(1992-2#1)(2008-10#5)(2008-12#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the masseter muscle in##3##5##(2010-6#1)(2013-1#2)
of the masseter muscle##4##4##(1996-2#1)(2010-6#1)(2013-1#2)
of the masticatory##2##3##(1990-9#1)(2010-9#1)
of the mastoid process##4##4##(2008-7#3)(2008-9#1)
of the matched cord##2##4##(2010-11#2)
of the mate recognition system##3##5##(2008-8#1)(2008-9#2)
of the material for##2##4##(2008-10#1)(2008-7#1)
of the material##11##3##(1995-8#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-5#1)(2012-3#1)
of the materials was##2##4##(2008-5#1)(2009-3#1)
of the materials##10##3##(1990-9#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#1)
of the maternal##6##3##(1994-11#1)(1996-11#1)(2007-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
of the mathematical##2##3##(2008-10#1)(2009-8#1)
of the mating##3##3##(1996-2#1)(2008-10#2)
of the matrices##2##3##(2008-10#2)
of the matrix is##2##4##(2008-10#2)
of the matrix##24##3##(1990-8#1)(1992-1#1)(1994-12#1)(1994-8#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-8#3)(2012-2#1)
of the mats##2##3##(1990-11#1)(2011-2#1)
of the matter##3##3##(1994-3#1)(2008-10#1)(2010-7#1)
of the mature##5##3##(1991-9#1)(1993-2#1)(1995-2#1)(2007-12#1)(2008-10#1)
of the maxillary sinus##2##4##(1993-1#1)(2011-7#1)
of the maxillary stylets##2##4##(2007-12#2)
of the maxillary##4##3##(1993-1#1)(2007-12#2)(2011-7#1)
of the maximal power##2##4##(2008-3#1)(2011-2#1)
of the maximal##5##3##(1990-12#1)(1991-5#1)(1994-11#1)(2008-3#1)(2011-2#1)
of the maximum possible##2##4##(2008-10#2)
of the maximum##12##3##(1993-3#1)(2008-10#9)(2008-5#1)(2010-5#1)
of the mean value##2##4##(2008-10#2)
of the mean##16##3##(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-3#1)(2012-2#1)(2013-1#1)
of the meaning of##2##4##(1993-1#1)(2008-11#1)
of the measure##3##3##(1990-2#1)(2008-1#1)(2008-11#1)
of the measured shape##2##4##(2008-6#2)
of the measured##12##3##(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-6#2)
of the measurement and##2##4##(2008-10#2)
of the measurement of##2##4##(2008-10#1)(2008-3#1)
of the measurement##14##3##(1997-6#1)(2008-10#8)(2008-11#1)(2008-3#3)(2009-11#1)
of the measurements at##2##4##(2008-10#1)(2008-3#1)
of the measurements made##2##4##(1996-1#1)(2008-10#1)
of the measurements was##2##4##(2008-10#2)
of the measurements##11##3##(1996-1#1)(2008-10#7)(2008-3#3)
of the measures##2##3##(1990-2#1)(2008-10#1)
of the measuring##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
of the meat##4##3##(2008-10#1)(2010-4#3)
of the mecA gene##3##4##(2008-10#2)(2011-2#1)
of the mechanism and##3##4##(2008-10#2)(2010-12#1)
of the mechanism of action of##2##6##(1991-5#1)(2008-11#1)
of the mechanism of action##3##5##(1991-5#1)(2008-11#1)(2008-5#1)
of the mechanism of the##2##5##(2008-10#1)(2008-11#1)
of the mechanism of##8##4##(1991-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)
of the mechanism##14##3##(1991-5#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)
of the mechanisms and##2##4##(1997-7#1)(2008-10#1)
of the mechanisms of##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
of the mechanisms underlying the##4##5##(1993-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
of the mechanisms##20##3##(1992-9#1)(1993-8#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
of the media##6##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
of the medial prefrontal cortex##3##5##(1994-8#1)(1996-2#1)(1997-2#1)
of the medial prefrontal##4##4##(1991-2#1)(1994-8#1)(1996-2#1)(1997-2#1)
of the medial##17##3##(1990-9#1)(1991-10#1)(1991-2#1)(1994-8#1)(1996-12#1)(1996-2#3)(1997-2#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the median domain##2##4##(2007-12#2)
of the median nerve##4##4##(2008-9#4)
of the median##6##3##(2007-12#2)(2008-9#4)
of the mediastinum is##2##4##(1991-8#2)
of the medical and##2##4##(1997-3#1)(2010-11#1)
of the medical records##2##4##(2008-9#1)(2011-2#1)
of the medical staff##2##4##(1997-1#1)(2012-2#1)
of the medical##20##3##(1991-3#1)(1992-12#1)(1995-11#3)(1997-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of the medication##2##3##(1997-2#1)(2008-7#1)
of the medium and the##2##5##(2008-10#2)
of the medium and##3##4##(2008-10#2)(2008-11#1)
of the medium perfusion rate##2##5##(2008-11#2)
of the medium##18##3##(1991-5#1)(2008-10#7)(2008-11#7)(2008-3#2)(2008-7#1)
of the meeting##3##3##(1994-9#1)(2008-11#1)(2008-5#1)
of the members of the##2##5##(1997-6#1)(2008-10#1)
of the members of##4##4##(1997-6#1)(2008-10#2)(2008-9#1)
of the membrane anchor##2##4##(1994-8#2)
of the membrane and##3##4##(2008-10#2)(2008-9#1)
of the membrane disks modified by 5 mg of the##2##10##(2008-10#2)
of the membrane disks modified by##4##6##(2008-10#4)
of the membrane disks modified##5##5##(2008-10#5)
of the membrane in##2##4##(2009-9#1)(2012-2#1)
of the membrane was##3##4##(2008-10#2)(2011-2#1)
of the membrane##47##3##(1990-12#1)(1991-5#1)(1993-8#2)(1994-5#1)(1994-8#3)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#24)(2008-9#3)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
of the membrane-bound##2##3##(1990-5#1)(1995-6#1)
of the membranes with##3##4##(1992-7#1)(1993-3#1)(1995-11#1)
of the membranes##8##3##(1992-7#1)(1993-3#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
of the men##3##3##(1991-12#2)(2011-2#1)
of the mental##3##3##(1992-1#1)(2012-3#2)
of the mentally ill##3##4##(1992-3#1)(1995-2#1)(1996-1#1)
of the mentioned##2##3##(2010-6#1)(2011-2#1)
of the mercury film##2##4##(2008-10#2)
of the mercury##4##3##(2008-10#4)
of the merits of##2##4##(1993-2#1)(2008-11#1)
of the mesencephalic locomotor region##2##5##(1994-2#1)(1997-2#1)
of the mesenchymal##2##3##(1990-5#1)(2008-11#1)
of the mesenteron##2##3##(2008-7#2)
of the mesopontine complex##2##4##(1996-12#2)
of the message##2##3##(1993-3#1)(2010-8#1)
of the metabolic inhibitor tissue homogenate##2##6##(2010-8#2)
of the metabolic syndrome and##2##5##(2008-3#1)(2008-7#1)
of the metabolic syndrome as##2##5##(2008-1#2)
of the metabolic syndrome in a clinical##2##7##(2008-3#2)
of the metabolic syndrome in##3##5##(2008-10#1)(2008-3#2)
of the metabolic syndrome that##2##5##(2008-1#1)(2008-6#1)
of the metabolic syndrome##17##4##(2008-1#7)(2008-10#1)(2008-11#1)(2008-3#4)(2008-6#2)(2008-7#1)(2010-5#1)
of the metabolic##26##3##(1994-2#1)(1996-11#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-3#5)(2008-6#4)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#2)(2012-12#1)
of the metabolism of##4##4##(1992-11#1)(1993-6#1)(2008-10#1)(2008-7#1)
of the metabolism##5##3##(1992-11#1)(1993-6#1)(2008-10#1)(2008-7#2)
of the metabolites were##2##4##(2008-10#1)(2008-11#1)
of the metabolites##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-3#2)
of the metal cluster##3##4##(1994-5#3)
of the metal ion to##3##5##(1997-4#1)(2008-10#2)
of the metal ion##5##4##(1997-4#1)(2008-10#4)
of the metal ions in##2##5##(2008-10#2)
of the metal ions##15##4##(2008-10#14)(2010-11#1)
of the metal species##2##4##(2008-10#2)
of the metal##48##3##(1994-5#5)(1997-4#1)(2008-10#40)(2010-11#2)
of the metallic##3##3##(2008-10#3)
of the metals and##2##4##(2008-10#1)(2010-11#1)
of the metals##9##3##(2008-10#7)(2008-12#1)(2010-11#1)
of the metastatic##2##3##(1997-7#1)(2009-3#1)
of the methanol##2##3##(1997-7#1)(2008-7#1)
of the method and##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
of the method are all satisfactory##2##6##(2008-10#2)
of the method are##9##4##(1994-9#1)(1995-12#1)(2008-10#7)
of the method by##3##4##(2008-10#2)(2008-11#1)
of the method developed##2##4##(2008-10#1)(2008-5#1)
of the method for the determination of##2##7##(2008-10#2)
of the method for the##5##5##(2008-10#5)
of the method for##16##4##(2008-10#15)(2008-3#1)
of the method has been##7##5##(2008-10#7)
of the method have been##2##5##(2008-10#2)
of the method in##2##4##(2008-10#2)
of the method is 0##8##5##(2008-10#8)
of the method is demonstrated by##2##6##(2008-10#2)
of the method is evaluated##2##5##(2008-10#2)
of the method is##33##4##(1990-9#1)(1996-5#1)(2008-10#28)(2008-11#1)(2008-3#2)
of the method of##4##4##(1993-8#1)(2008-10#2)(2008-12#1)
of the method to real samples##3##6##(2008-10#3)
of the method to real##4##5##(2008-10#4)
of the method to the analysis of##3##7##(2008-10#3)
of the method to the determination of##2##7##(2008-10#2)
of the method to the##7##5##(2008-10#7)
of the method to##21##4##(1990-12#1)(1996-3#1)(1997-6#1)(2008-10#16)(2008-3#1)(2009-7#1)
of the method using##2##4##(2008-10#1)(2010-7#1)
of the method varied##2##4##(2008-10#2)
of the method was 0##3##5##(2008-10#3)
of the method was 12##2##5##(2008-10#2)
of the method was checked by##2##6##(2008-10#2)
of the method was checked##3##5##(2008-10#3)
of the method was confirmed by##2##6##(2008-10#2)
of the method was demonstrated by the##4##7##(2008-10#4)
of the method was demonstrated by##7##6##(2008-10#7)
of the method was demonstrated##8##5##(2008-10#8)
of the method was estimated##4##5##(2008-10#4)
of the method was evaluated##3##5##(2008-10#3)
of the method was tested by##2##6##(2008-10#2)
of the method was tested##7##5##(2008-10#6)(2010-4#1)
of the method was##55##4##(1995-11#1)(2008-10#53)(2010-4#1)
of the method were##6##4##(2008-10#5)(2008-5#1)
of the method##246##3##(1990-12#1)(1990-9#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-10#212)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#2)(2009-12#1)(2009-7#1)(2010-4#1)(2010-7#2)(2011-1#1)
of the methodology##9##3##(2008-10#5)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
of the methods and##2##4##(2008-10#1)(2008-4#1)
of the methods in##2##4##(2008-10#2)
of the methods to##2##4##(2008-10#2)
of the methods was##5##4##(2008-10#5)
of the methods were##3##4##(2008-10#3)
of the methods##24##3##(2007-11#1)(2008-10#20)(2008-11#1)(2008-4#1)(2013-8#1)
of the methylated HA##2##4##(2008-10#2)
of the methylene group##2##4##(1997-1#2)
of the mice developed##2##4##(1995-12#1)(2013-1#1)
of the mice##6##3##(1995-12#1)(1995-9#2)(2008-7#1)(2012-2#1)(2013-1#1)
of the micellar system##4##4##(1990-5#4)
of the micellar##5##3##(1990-5#4)(2008-10#1)
of the microbe##2##3##(2008-10#1)(2011-2#1)
of the microbial complex##2##4##(2008-10#2)
of the microbial##6##3##(2008-10#5)(2008-11#1)
of the microbiota##2##3##(2011-2#2)
of the microcirculation##2##3##(2010-7#2)
of the microenvironment##2##3##(2009-10#1)(2009-4#1)
of the microflora##2##3##(2008-10#1)(2008-5#1)
of the microfluidic##3##3##(2008-10#3)
of the microorganisms##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
of the microplot trials was##2##5##(2008-10#2)
of the microscope##2##3##(2009-12#1)(2010-1#1)
of the microscopic##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
of the microsensor##2##3##(2008-10#2)
of the microsomal##2##3##(1992-6#1)(1993-3#1)
of the microstructure##3##3##(2008-3#1)(2009-7#2)
of the microvilli##2##3##(2008-7#2)
of the middle cerebral artery##6##5##(2008-12#1)(2008-4#1)(2008-7#4)
of the middle ear##2##4##(1991-3#1)(1995-5#1)
of the middle meningeal artery##2##5##(2008-12#2)
of the middle##16##3##(1991-3#1)(1995-5#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-7#5)(2008-9#1)(2009-3#1)(2011-2#1)
of the midgut##6##3##(1997-3#1)(2007-12#2)(2008-10#1)(2008-7#2)
of the migraine attack##2##4##(2008-9#2)
of the migration time and peak area##2##7##(2008-10#2)
of the migration time and##3##5##(2008-10#3)
of the migration time##4##4##(2008-10#4)
of the milk##3##3##(2008-10#2)(2012-2#1)
of the mind##2##3##(2009-10#1)(2012-2#1)
of the mineral##3##3##(2008-10#2)(2008-5#1)
of the mineralogical##2##3##(2008-10#2)
of the minimal##2##3##(1991-11#1)(1995-2#1)
of the minimum##5##3##(1993-1#1)(1996-3#1)(2008-10#2)(2008-3#1)
of the minor NORs##2##4##(1993-12#2)
of the minor##4##3##(1993-12#2)(1995-6#1)(2008-10#1)
of the mirror##2##3##(2008-11#1)(2008-3#1)
of the mitochondria##2##3##(2008-10#1)(2008-7#1)
of the mitochondrial DNA##4##4##(1994-11#4)
of the mitochondrial gene##2##4##(1993-2#1)(2008-6#1)
of the mitochondrial##18##3##(1990-5#1)(1991-6#1)(1993-2#2)(1994-11#4)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-6#2)(2012-2#3)(2013-8#1)
of the mitogen-activated protein kinase##2##5##(1995-2#1)(2008-11#1)
of the mitogen-activated protein##3##4##(1995-2#1)(2008-11#1)(2010-10#1)
of the mitogen-activated##4##3##(1995-2#1)(2008-11#1)(2008-7#1)(2010-10#1)
of the mitogenic##2##3##(1990-12#1)(1997-1#1)
of the mitotic spindle##2##4##(2008-8#1)(2008-9#1)
of the mitral valve##5##4##(2010-12#1)(2013-1#4)
of the mitral##6##3##(2008-10#1)(2010-12#1)(2013-1#4)
of the mixed##14##3##(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2013-1#1)
of the mixture##15##3##(1997-8#1)(2008-10#12)(2008-2#1)(2008-5#1)
of the mixtures in##2##4##(2008-10#2)
of the mixtures were##2##4##(1993-8#1)(2008-10#1)
of the mixtures##7##3##(1993-8#1)(2008-10#6)
of the mobile phase was##2##5##(2008-10#2)
of the mobile phase##12##4##(2008-10#12)
of the mobile##16##3##(2008-10#15)(2012-12#1)
of the modal##3##3##(2008-2#1)(2008-3#2)
of the model and##2##4##(2008-10#2)
of the model for##2##4##(1992-1#1)(1994-5#1)
of the model in##2##4##(2008-11#1)(2008-7#1)
of the model is##4##4##(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
of the model showed##2##4##(1992-9#1)(2008-10#1)
of the model to##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
of the model using##2##4##(2008-10#1)(2008-9#1)
of the model##64##3##(1990-12#1)(1990-8#1)(1992-1#1)(1992-3#3)(1992-9#1)(1993-1#1)(1994-5#1)(1995-9#1)(1996-2#1)(2008-10#16)(2008-11#10)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#7)(2009-10#1)(2009-4#1)(2010-5#1)(2013-8#1)
of the modeling##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
of the models in##2##4##(2008-11#1)(2008-8#1)
of the models##8##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-8#1)
of the modern##7##3##(1991-5#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-11#1)
of the modified Einthoven triangle##2##5##(2010-8#2)
of the modified electrode was##2##5##(2008-10#2)
of the modified electrode were##2##5##(2008-10#2)
of the modified electrode##6##4##(2008-10#6)
of the modified enzyme##2##4##(2008-10#2)
of the modified silica gel##2##5##(2008-10#2)
of the modified silica##3##4##(2008-10#3)
of the modified triangular interferometer##2##5##(2008-3#2)
of the modified##34##3##(1990-9#1)(1991-5#1)(2008-10#23)(2008-2#1)(2008-3#3)(2008-8#2)(2010-3#1)(2010-8#2)
of the modifier##2##3##(2008-10#2)
of the modifiers##2##3##(2008-10#2)
of the moiré fringes##2##4##(2008-3#2)
of the moisture##2##3##(2008-10#2)
of the molecular basis of##3##5##(2008-11#1)(2011-2#2)
of the molecular events##2##4##(2008-10#1)(2010-12#1)
of the molecular masses of##2##5##(1990-12#1)(1993-8#1)
of the molecular mechanisms##3##4##(2008-11#1)(2010-5#1)(2011-3#1)
of the molecular##37##3##(1990-12#1)(1993-12#1)(1993-8#2)(1994-11#2)(1994-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2009-3#2)(2009-7#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#5)(2011-3#1)(2013-1#2)
of the molecule##22##3##(1990-5#1)(1991-5#1)(1993-1#1)(1993-8#2)(1994-11#1)(1997-8#1)(1997-9#1)(2008-10#5)(2008-11#4)(2008-4#3)(2008-5#1)(2008-8#1)
of the molecules and##2##4##(1992-9#1)(2009-9#1)
of the molecules in##2##4##(1992-9#1)(2008-8#1)
of the molecules that##2##4##(2008-8#1)(2013-8#1)
of the molecules##14##3##(1992-9#3)(1994-8#1)(2008-10#4)(2008-8#2)(2009-5#1)(2009-9#1)(2012-2#1)(2013-8#1)
of the molybdenum blue##2##4##(2008-10#2)
of the molybdenum##4##3##(2008-10#4)
of the monitoring##3##3##(1997-2#1)(2007-8#1)(2008-10#1)
of the monoamine neurotransmitters in the##2##6##(2008-10#2)
of the monoamine##3##3##(1994-8#1)(2008-10#2)
of the monoclonal##2##3##(2008-11#2)
of the monolayer in the##2##5##(2008-10#2)
of the monolayer##6##3##(2008-10#4)(2008-11#2)
of the monomer 13##2##4##(1992-12#2)
of the monomer and##2##4##(2008-10#2)
of the monomer##9##3##(1992-12#3)(1992-4#1)(2008-10#4)(2008-8#1)
of the monomeric##6##3##(1991-7#1)(1994-11#1)(1997-4#1)(2008-10#3)
of the monomers##2##3##(2008-10#1)(2008-8#1)
of the more common##6##4##(2008-12#2)(2008-2#1)(2008-9#1)(2009-9#1)(2012-2#1)
of the more##18##3##(1992-6#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
of the mortality##2##3##(1997-7#1)(2010-7#1)
of the mosquito##2##3##(2011-2#2)
of the most abundant##4##4##(2008-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
of the most appropriate##2##4##(2011-2#1)(2012-12#1)
of the most common##41##4##(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1994-5#1)(1997-7#1)(1997-8#2)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#5)
of the most commonly used##4##5##(2008-11#1)(2008-9#2)(2012-2#1)
of the most exciting##2##4##(2008-9#1)(2010-7#1)
of the most frequent##5##4##(1993-2#1)(2011-2#1)(2013-1#3)
of the most frequently##2##4##(2011-3#1)(2013-1#1)
of the most important and##3##5##(2008-4#1)(2010-10#1)(2010-7#1)
of the most important functions##2##5##(2008-10#1)(2008-11#1)
of the most important gluconeogenic##2##5##(1994-8#2)
of the most important##44##4##(1990-12#2)(1993-6#1)(1994-1#1)(1994-8#2)(1997-2#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#2)(2010-7#3)(2010-9#1)(2011-10#1)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
of the most often##3##4##(2008-10#2)(2009-8#1)
of the most popular##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
of the most potent##3##4##(1992-9#1)(2008-10#1)(2010-8#1)
of the most prevalent##3##4##(2008-10#1)(2009-5#1)(2013-1#1)
of the most primitive##4##4##(1994-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
of the most prominent##2##4##(1995-8#1)(2008-10#1)
of the most recent##6##4##(1991-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
of the most recently##2##4##(2008-11#1)(2011-2#1)
of the most representative##2##4##(2008-5#1)(2010-1#1)
of the most salient##2##4##(1994-1#1)(2008-10#1)
of the most suitable##2##4##(2008-10#2)
of the most##224##3##(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#55)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#1)(2011-10#2)(2011-2#11)(2011-3#4)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#2)
of the mother and##2##4##(1997-8#1)(2010-10#1)
of the mother##9##3##(1990-6#1)(1991-9#1)(1995-6#1)(1997-8#1)(2008-8#1)(2009-6#1)(2010-10#1)(2011-1#1)(2012-2#1)
of the mothers##9##3##(1990-6#1)(1991-1#1)(1991-11#1)(1993-12#1)(2008-10#1)(2009-10#1)(2011-1#3)
of the motifs##2##3##(2008-8#1)(2008-9#1)
of the motivational##2##3##(1996-5#1)(2010-10#1)
of the motor evoked potential##2##5##(2008-7#2)
of the motor##8##3##(1992-6#1)(1994-2#1)(2008-4#1)(2008-7#3)(2010-1#1)(2010-7#1)
of the mouse##30##3##(1991-6#2)(1992-3#1)(1993-12#1)(1993-3#4)(1993-6#2)(1994-12#2)(1994-5#1)(1995-2#1)(1995-6#3)(1996-12#3)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2013-8#1)
of the mouth in##2##4##(2008-11#1)(2013-1#1)
of the mouth##8##3##(1990-8#1)(2008-11#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
of the mouthparts##2##3##(2007-12#2)
of the movement##4##3##(2008-12#2)(2008-7#2)
of the movements##2##3##(2008-11#1)(2012-3#1)
of the moving##3##3##(2008-3#2)(2011-2#1)
of the mtDNA##2##3##(1994-11#1)(2008-12#1)
of the mu receptor##2##4##(1995-6#2)
of the mucosal##2##3##(2008-11#2)
of the multidisciplinary##3##3##(2010-11#1)(2013-1#2)
of the multidrug resistance##2##4##(2008-11#2)
of the multidrug##3##3##(2008-11#3)
of the multifarious##3##3##(2008-12#1)(2013-1#2)
of the multilayer##2##3##(2008-10#1)(2008-3#1)
of the multiple##6##3##(1990-5#1)(1993-6#1)(2008-10#2)(2008-9#1)(2010-1#1)
of the multivariate##2##3##(2008-10#2)
of the municipalities##4##3##(1991-6#1)(1992-2#1)(2012-12#2)
of the municipality##3##3##(2012-12#2)(2012-3#1)
of the murine##7##3##(1991-6#1)(1992-6#1)(1993-6#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-11#1)
of the muscle##5##3##(1991-2#1)(2008-7#3)(2013-1#1)
of the muscles##2##3##(2008-12#1)(2011-2#1)
of the mutant LPL##2##4##(1992-3#2)
of the mutant enzyme##2##4##(1995-6#1)(1997-7#1)
of the mutant##13##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#2)(1994-5#1)(1995-6#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
of the mutants##9##3##(1995-2#1)(1995-6#1)(2008-10#2)(2008-9#3)(2011-1#1)(2012-3#1)
of the mutated##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
of the mutation in##3##4##(1993-8#1)(1993-9#1)(1994-11#1)
of the mutation##9##3##(1990-2#1)(1991-7#1)(1993-8#3)(1993-9#1)(1994-11#1)(1997-3#2)
of the mutations on##2##4##(1991-10#1)(1995-6#1)
of the mutations##5##3##(1991-10#1)(1991-5#1)(1995-6#1)(2011-1#1)(2012-3#1)
of the mutual##2##3##(2008-10#1)(2008-9#1)
of the mycelium##5##3##(2008-10#4)(2008-7#1)
of the mycoparasite##3##3##(2008-10#3)
of the mycorrhizosphere##2##3##(2008-10#2)
of the mycotoxin##2##3##(2008-10#2)
of the myelin##2##3##(1996-12#1)(2008-7#1)
of the myocardium##4##3##(1990-9#2)(1992-5#1)(2011-2#1)
of the myocytic calcium channel blocker diltiazem##2##7##(2008-7#2)
of the myofibroma##2##3##(2010-6#2)
of the myosin##2##3##(1990-5#1)(1992-4#1)
of the nail##3##3##(2008-9#1)(2010-5#1)(2013-1#1)
of the name##3##3##(2008-10#3)
of the nanoclusters##2##3##(2008-10#2)
of the nanoelectrodes##2##3##(2008-10#2)
of the nanofilter##2##3##(2008-10#2)
of the nanoparticles##2##3##(2008-10#2)
of the nasal##7##3##(1990-6#1)(1990-9#1)(1993-8#1)(1993-9#1)(1996-5#1)(2008-11#1)(2009-1#1)
of the nasopharyngeal##2##3##(1995-10#1)(2008-10#1)
of the nation##3##3##(1991-8#1)(2008-11#1)(2011-2#1)
of the nation's##3##3##(1995-6#1)(1997-6#1)(2008-11#1)
of the national average##2##4##(1992-12#1)(2008-10#1)
of the national economy##2##4##(1994-2#1)(2010-1#1)
of the national##9##3##(1992-1#1)(1992-12#1)(1994-2#1)(1995-2#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-12#2)
of the native and reconstituted##2##5##(1992-8#1)(1993-8#1)
of the native enzyme##3##4##(1990-5#1)(1994-11#1)(2008-10#1)
of the native##19##3##(1990-11#1)(1990-5#1)(1991-10#1)(1992-8#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-8#2)(2011-2#1)
of the natural history of this##2##6##(1990-12#1)(2008-7#1)
of the natural history of##4##5##(1990-12#1)(1996-6#1)(2008-7#1)(2009-8#1)
of the natural history##5##4##(1990-12#1)(1996-6#1)(1996-9#1)(2008-7#1)(2009-8#1)
of the natural##30##3##(1990-12#1)(1991-3#1)(1992-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2008-10#8)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-1#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
of the naturally occurring##2##4##(2008-10#1)(2008-5#1)
of the naturally##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
of the nature and##3##4##(1993-1#1)(1994-1#1)(2008-10#1)
of the nature of the##7##5##(2008-10#6)(2009-4#1)
of the nature of##13##4##(1993-2#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)
of the nature##17##3##(1993-1#1)(1993-2#1)(1994-1#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)
of the near-infrared##2##3##(2008-10#1)(2008-2#1)
of the nebulizer##5##3##(1994-12#2)(1995-12#1)(1995-3#1)(1996-3#1)
of the nebulizers##2##3##(1995-3#2)
of the neck##10##3##(1991-11#1)(1997-3#1)(2008-7#2)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)
of the necrotic##4##3##(2008-10#1)(2009-1#1)(2011-2#2)
of the need for##5##4##(1993-12#1)(1996-1#1)(2008-11#1)(2008-12#1)(2009-5#1)
of the need to##5##4##(1992-1#1)(1995-1#1)(2008-11#1)(2009-8#1)(2011-2#1)
of the need##10##3##(1992-1#1)(1993-12#1)(1995-1#1)(1996-1#1)(2008-11#2)(2008-12#1)(2009-5#1)(2009-8#1)(2011-2#1)
of the needle##2##3##(1992-12#1)(2012-2#1)
of the negative binomial distribution##2##5##(2008-10#2)
of the negative##6##3##(2008-1#1)(2008-10#3)(2008-9#1)(2010-7#1)
of the nematode Caenorhabditis elegans##2##5##(1995-3#1)(1996-6#1)
of the nematode population##3##4##(2008-10#3)
of the nematode##11##3##(1995-3#1)(1996-6#1)(2008-10#9)
of the nematodes##5##3##(2008-10#4)(2008-8#1)
of the neocortex##3##3##(2008-11#2)(2010-7#1)
of the neomycin resistance##2##4##(2008-11#2)
of the neonate##2##3##(2012-12#1)(2012-3#1)
of the neonates##2##3##(2011-1#2)
of the neoplasm##4##3##(1990-3#1)(1991-2#1)(1993-6#1)(1997-8#1)
of the neoplastic cells##2##4##(1992-2#1)(1997-1#1)
of the neoplastic##3##3##(1992-2#1)(1997-1#1)(2013-1#1)
of the nerve##4##3##(2008-9#2)(2011-2#1)(2012-2#1)
of the nervous system##12##4##(1992-9#1)(1994-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
of the nervous##13##3##(1992-9#1)(1994-11#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
of the net##3##3##(1994-9#1)(2008-10#2)
of the network##2##3##(2008-11#1)(2010-10#1)
of the network's##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
of the networks##4##3##(2008-11#2)(2010-10#1)(2010-4#1)
of the neural network##3##4##(2008-10#2)(2009-5#1)
of the neural precursor cells##2##5##(2008-11#2)
of the neural##12##3##(2007-8#1)(2008-10#2)(2008-11#5)(2008-7#1)(2009-5#1)(2009-9#1)(2010-8#1)
of the neurites##3##3##(2008-11#3)
of the neurochemical##2##3##(2008-7#1)(2013-1#1)
of the neurohypophyseal##3##3##(1997-8#3)
of the neurologic##2##3##(2008-7#1)(2012-3#1)
of the neurological##8##3##(1991-11#1)(1991-6#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-12#1)(2008-7#1)
of the neuronal##5##3##(1990-5#1)(1997-2#1)(2007-8#1)(2009-10#1)(2009-8#1)
of the neurons##5##3##(1994-2#1)(2008-11#2)(2008-8#1)(2009-8#1)
of the neurotoxin##4##3##(1990-5#1)(1994-11#3)
of the neurotransmitter##2##3##(2008-10#1)(2008-5#1)
of the neutral##4##3##(2008-10#3)(2009-7#1)
of the neutrophil##3##3##(1992-8#1)(1993-6#1)(2008-10#1)
of the new Medicare##2##4##(1992-1#2)
of the new algorithm is##2##5##(2008-10#1)(2008-3#1)
of the new compounds showed##2##5##(2008-11#1)(2012-2#1)
of the new compounds##3##4##(1992-3#1)(2008-11#1)(2012-2#1)
of the new host##2##4##(2008-8#2)
of the new method##4##4##(2008-10#3)(2008-3#1)
of the new modified alumina sorbent for##2##7##(2008-10#2)
of the new##73##3##(1991-12#2)(1991-3#1)(1992-1#3)(1992-3#2)(1992-6#1)(1992-9#1)(1993-9#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-8#1)(2008-10#24)(2008-11#8)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#2)
of the newborn##5##3##(1994-2#1)(1995-12#1)(2012-2#2)(2013-1#1)
of the newly developed##3##4##(2008-10#2)(2010-11#1)
of the newly formed##2##4##(2008-10#1)(2008-9#1)
of the newly##15##3##(1993-6#1)(1996-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)
of the next generation##3##4##(1991-6#1)(2008-11#2)
of the next##6##3##(1991-6#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-9#1)
of the next-generation##2##3##(2008-10#1)(2008-3#1)
of the nickel##3##3##(2008-10#3)
of the nidus in##2##4##(1996-3#1)(2008-7#1)
of the nidus##9##3##(1991-2#1)(1996-3#1)(2008-7#7)
of the nine##7##3##(1996-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-3#1)
of the nineteenth century##5##4##(1991-12#1)(2010-1#2)(2011-2#2)
of the nipple##2##3##(1997-5#1)(2011-2#1)
of the nitrate##2##3##(1993-6#1)(2008-10#1)
of the nitrogen fixation##2##4##(2008-9#2)
of the nitrogen##4##3##(1995-11#1)(2008-9#3)
of the nitrosamino##2##3##(1996-5#2)
of the noble scallop##2##4##(2013-8#2)
of the noble##3##3##(2008-10#1)(2013-8#2)
of the nociceptive##2##3##(1997-2#1)(2009-12#1)
of the non##4##3##(2007-8#1)(2008-10#2)(2008-7#1)
of the non-ionic surfactant##2##4##(2008-10#2)
of the nonionic surfactant##2##4##(2008-10#1)(2011-2#1)
of the nonlinear##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
of the nonparametric##2##3##(2008-10#1)(2009-10#1)
of the nonstructural##3##3##(2008-10#3)
of the normal appendix##2##4##(1997-8#2)
of the normal controls##5##4##(2008-10#3)(2008-7#2)
of the normal rat##2##4##(2008-7#1)(2008-9#1)
of the normal##24##3##(1991-5#1)(1992-12#1)(1994-12#1)(1995-5#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-7#3)(2008-9#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
of the normalized##2##3##(1993-2#1)(2008-10#1)
of the north-western zone of the Bogota Savanna##2##8##(2012-12#2)
of the north-western zone of the Bogota##3##7##(2012-12#3)
of the northern##2##3##(1990-11#1)(2008-9#1)
of the nose##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
of the novel##11##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2011-2#2)
of the nt##2##3##(1991-6#1)(1993-6#1)
of the nuclear envelope##3##4##(1995-2#1)(2011-2#2)
of the nuclear membrane##2##4##(2008-9#1)(2011-2#1)
of the nuclear ribosomal DNA##4##5##(2008-10#4)
of the nuclear ribosomal##9##4##(2008-10#9)
of the nuclear##25##3##(1991-2#1)(1993-8#1)(1995-2#2)(2008-10#12)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#5)
of the nucleic acid##2##4##(2008-10#1)(2008-4#1)
of the nucleotide and##2##4##(1990-7#1)(2008-10#1)
of the nucleotide sequence of the##3##6##(1994-12#1)(1995-8#1)(2008-10#1)
of the nucleotide sequence of##6##5##(1990-11#1)(1990-2#1)(1994-12#1)(1995-8#1)(2008-10#2)
of the nucleotide sequences##2##4##(2008-10#2)
of the nucleotide##11##3##(1990-11#1)(1990-2#1)(1990-7#1)(1994-12#1)(1995-8#1)(2008-10#5)(2008-5#1)
of the nucleus accumbens and its##2##6##(1993-6#1)(2008-7#1)
of the nucleus accumbens and##3##5##(1993-6#1)(1994-2#1)(2008-7#1)
of the nucleus accumbens##10##4##(1993-6#4)(1994-2#1)(1994-3#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-7#1)
of the nucleus in##2##4##(2008-9#1)(2011-2#1)
of the nucleus##21##3##(1993-3#1)(1993-6#4)(1994-2#1)(1994-3#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-7#5)(2008-9#1)(2011-2#5)
of the number and##3##4##(1993-3#1)(2013-1#2)
of the number of##36##4##(1990-6#1)(1991-2#1)(1991-3#1)(1993-3#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
of the number##42##3##(1990-6#1)(1991-2#1)(1991-3#1)(1993-3#2)(1996-11#1)(1996-12#1)(1996-3#2)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#3)(2010-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
of the numerical##3##3##(2008-10#1)(2012-3#2)
of the nurse##7##3##(2008-11#4)(2008-12#1)(2008-6#2)
of the nurses##5##3##(1990-2#2)(2008-7#1)(2012-3#1)(2013-1#1)
of the nursing##7##3##(1993-3#1)(1994-3#1)(1994-5#1)(2008-11#1)(2008-12#2)(2012-3#1)
of the nutrient##2##3##(2008-10#1)(2008-7#1)
of the oak##2##3##(2008-5#1)(2012-6#1)
of the obese##4##3##(1996-12#1)(2008-10#1)(2013-1#2)
of the object##9##3##(1993-6#1)(1996-2#1)(2008-11#4)(2008-7#1)(2011-2#2)
of the objects in##2##4##(2008-3#1)(2009-12#1)
of the objects##4##3##(2008-3#3)(2009-12#1)
of the observation of##2##4##(2008-11#1)(2008-3#1)
of the observation period##2##4##(1993-3#1)(2008-6#1)
of the observation##4##3##(1993-3#1)(2008-11#1)(2008-3#1)(2008-6#1)
of the observations##3##3##(2008-10#2)(2008-3#1)
of the observed HIV-positive population size##3##6##(2008-1#3)
of the observed patterns of##2##5##(2008-8#2)
of the observed patterns##3##4##(2008-8#3)
of the observed##22##3##(1992-6#1)(1993-12#1)(2007-11#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#4)(2010-1#1)
of the obtained results##3##4##(2008-10#3)
of the obtained##10##3##(1996-8#1)(2008-10#6)(2008-5#1)(2010-12#1)(2010-4#1)
of the occipital##3##3##(1990-8#1)(2008-7#2)
of the occluded##2##3##(1997-8#1)(2008-12#1)
of the occlusion and the##2##5##(1996-6#1)(2010-9#1)
of the occupational##2##3##(1996-3#1)(2008-11#1)
of the occurrence of##4##4##(1996-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
of the occurrence##5##3##(1996-3#1)(2008-10#2)(2008-11#1)(2012-3#1)
of the odds##2##3##(2010-12#1)(2012-3#1)
of the odontoid process##2##4##(2011-2#2)
of the oesophagus##7##3##(1990-12#1)(1990-9#1)(1993-6#1)(2008-1#3)(2008-11#1)
of the offending drug##3##4##(2008-7#2)(2008-8#1)
of the official##2##3##(1993-5#1)(2008-10#1)
of the offspring##2##3##(2008-10#1)(2008-4#1)
of the oil##4##3##(2008-10#1)(2008-5#2)(2011-2#1)
of the old##3##3##(2008-7#2)(2008-8#1)
of the older##5##3##(2008-6#1)(2010-10#4)
of the oldest##4##3##(2008-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
of the oleosin##2##3##(2009-10#2)
of the olfactory bulb##5##4##(2009-12#5)
of the olfactory organ##2##4##(2007-12#2)
of the olfactory##10##3##(2007-12#3)(2008-7#1)(2009-12#6)
of the oligomeric##2##3##(1995-2#1)(1997-8#1)
of the oligonucleotide##4##3##(2008-10#3)(2012-3#1)
of the oligosaccharide##2##3##(1990-9#1)(2008-7#1)
of the oligosaccharides##5##3##(1990-9#1)(1991-12#1)(1992-10#1)(2008-10#1)(2008-11#1)
of the on-line##4##3##(2008-10#4)
of the oncology##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
of the ongoing##3##3##(1991-1#1)(1991-6#1)(1996-3#1)
of the only##3##3##(1993-6#1)(1996-11#1)(2008-10#1)
of the onset of##6##4##(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
of the onset##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
of the oocyte##4##3##(2007-12#1)(2008-12#1)(2008-7#1)(2013-1#1)
of the open reading frame of##2##6##(1992-6#2)
of the open reading frame##5##5##(1992-6#2)(1992-8#1)(1993-8#1)(1995-8#1)
of the open reading frames##2##5##(1996-3#2)
of the open reading##7##4##(1992-6#2)(1992-8#1)(1993-8#1)(1995-8#1)(1996-3#2)
of the open##8##3##(1992-6#2)(1992-8#1)(1993-8#1)(1995-8#1)(1996-3#2)(2008-10#1)
of the operated patients##2##4##(2011-2#1)(2013-1#1)
of the operating##3##3##(1991-1#1)(2008-10#2)
of the operation##4##3##(1991-3#1)(1995-6#1)(1996-3#1)(2008-10#1)
of the opposite##3##3##(2008-9#1)(2009-10#1)(2013-8#1)
of the optic nerve##4##4##(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
of the optic##5##3##(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#1)
of the optical properties of##2##5##(2008-10#1)(2008-3#1)
of the optical spectrum##2##4##(2008-3#1)(2011-2#1)
of the optical##22##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#11)(2011-2#1)(2013-8#3)
of the optimal##8##3##(1996-3#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-8#1)
of the optimisation##2##3##(2008-10#2)
of the optimised BCR SEP##2##5##(2008-10#2)
of the optimization##2##3##(2008-10#2)
of the optimized procedure##2##4##(2008-10#2)
of the optimized##5##3##(1993-8#1)(2008-10#4)
of the optimum##4##3##(2008-10#3)(2008-9#1)
of the options##3##3##(2008-10#1)(2009-5#1)(2012-2#1)
of the optode membrane##3##4##(2008-10#3)
of the optode##5##3##(2008-10#5)
of the oral and maxillofacial##2##5##(2008-7#2)
of the oral and##3##4##(2008-7#2)(2013-1#1)
of the oral cavity##2##4##(1991-6#1)(1995-9#1)
of the oral##6##3##(1991-6#1)(1995-9#1)(2008-11#1)(2008-7#2)(2013-1#1)
of the orbit and frontal sinus##2##6##(2011-2#2)
of the orbit##5##3##(2008-9#1)(2011-2#3)(2012-3#1)
of the orchard##6##3##(2008-10#6)
of the orchards##2##3##(2008-10#2)
of the order Acipenseriformes##2##4##(2008-8#2)
of the order in the##3##5##(2008-10#2)(2008-5#1)
of the order of several##2##5##(1997-6#1)(2008-3#1)
of the order of##20##4##(1996-3#1)(1997-6#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-3#7)
of the order##30##3##(1990-12#1)(1996-3#1)(1997-6#1)(2007-12#4)(2008-10#11)(2008-2#1)(2008-3#7)(2008-5#1)(2008-8#2)(2011-2#1)
of the ordinary##2##3##(2008-12#1)(2008-7#1)
of the organ##3##3##(1990-11#1)(2008-5#2)
of the organelle##2##3##(2008-10#1)(2011-2#1)
of the organic carbon##2##4##(2008-10#2)
of the organic crystal DAST##2##5##(2007-12#2)
of the organic phase##3##4##(2008-10#3)
of the organic solvent##2##4##(2008-10#2)
of the organic##21##3##(2007-12#2)(2008-10#16)(2008-11#1)(2008-5#1)(2013-8#1)
of the organism and##2##4##(2011-2#1)(2013-8#1)
of the organism##20##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#7)(2013-8#1)
of the organization and##2##4##(1993-12#1)(2012-2#1)
of the organization of the##2##5##(1995-5#2)
of the organization of##3##4##(1995-11#1)(1995-5#2)
of the organization##9##3##(1993-1#1)(1993-12#2)(1994-2#2)(1995-11#1)(1995-5#2)(2012-2#1)
of the organizational##2##3##(1992-12#1)(2008-11#1)
of the orientation of the##4##5##(2007-11#2)(2007-12#1)(2008-3#1)
of the orientation##7##3##(1990-11#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
of the origin and##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
of the origin of##5##4##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
of the origin##9##3##(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#2)
of the original data##2##4##(2008-10#2)
of the original hybrid linear analysis (HLA) method##2##8##(2008-10#2)
of the original tumor##2##4##(1990-2#1)(2011-2#1)
of the original##34##3##(1990-2#1)(1992-11#2)(1993-8#1)(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2011-2#3)(2011-3#1)(2012-3#1)
of the orthorhombic crystal form##2##5##(1993-8#1)(2008-8#1)
of the oscillation period##2##4##(2008-10#1)(2010-10#1)
of the oscillations is equal to the##2##7##(2008-3#2)
of the oscillator##2##3##(1990-8#1)(2007-12#1)
of the osseous##2##3##(2010-5#1)(2011-2#1)
of the ossified cochlea##2##4##(2008-9#2)
of the other components of##2##5##(2010-7#1)(2012-3#1)
of the other components##3##4##(2008-10#1)(2010-7#1)(2012-3#1)
of the other hospitals##2##4##(1992-2#2)
of the other species##2##4##(2008-10#1)(2010-3#1)
of the other three##2##4##(2008-10#1)(2009-10#1)
of the other two groups##2##5##(2008-10#2)
of the other two##5##4##(1993-11#1)(1993-6#1)(2008-10#3)
of the other##53##3##(1990-5#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-5#2)(1997-2#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-9#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#2)
of the otolith##2##3##(2008-7#2)
of the outcome##6##3##(1994-3#1)(1996-5#1)(1997-7#1)(2008-8#1)(2008-9#1)(2009-11#1)
of the outer layer##2##4##(2008-10#1)(2008-7#1)
of the outer membrane in##2##5##(1997-8#1)(2008-5#1)
of the outer membrane##3##4##(1997-8#2)(2008-5#1)
of the outer membrane)##2##4##(1997-8#2)
of the outer##15##3##(1994-11#1)(1997-8#4)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2010-1#1)(2011-2#1)(2012-2#1)
of the output pulse peak power and##2##7##(2008-3#2)
of the output signal##2##4##(2008-10#2)
of the output##11##3##(1993-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2013-1#1)
of the outward##2##3##(1997-2#1)(2008-3#1)
of the ovarian follicles##2##4##(2008-12#2)
of the ovarian surface##2##4##(2011-2#2)
of the ovarian##12##3##(1992-3#2)(1996-1#2)(2007-12#1)(2008-12#2)(2008-4#1)(2011-2#2)(2012-3#2)
of the ovary in##2##4##(2007-12#1)(2008-12#1)
of the ovary is##2##4##(2013-1#1)(2013-8#1)
of the ovary##17##3##(1990-2#1)(1992-3#1)(1993-2#1)(1995-12#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-12#1)(2009-7#1)(2010-12#1)(2013-1#3)(2013-8#3)
of the overall fluorescence)##2##4##(1991-5#2)
of the overall##28##3##(1991-5#3)(1991-8#1)(1995-9#1)(1996-8#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)
of the overexpressed##3##3##(1994-5#2)(2009-8#1)
of the overlapping ORFs 3 and 4##2##7##(2008-10#2)
of the overlapping##9##3##(1996-12#1)(1996-8#1)(2008-10#6)(2008-3#1)
of the overweight##2##3##(2008-10#2)
of the ovipositor##2##3##(2007-12#2)
of the oxidant##7##3##(1995-8#1)(2008-10#6)
of the oxidase##2##3##(1993-8#1)(2008-10#1)
of the oxidation of##3##4##(2008-10#3)
of the oxidation reaction of##2##5##(2008-10#2)
of the oxidation reaction##3##4##(2008-10#3)
of the oxidation state of##2##5##(2008-10#2)
of the oxidation##15##3##(2008-10#14)(2012-3#1)
of the oxidative##2##3##(2008-10#2)
of the oxidized##6##3##(2008-10#3)(2008-11#1)(2009-7#2)
of the oxidizing##2##3##(2008-10#2)
of the ozone##2##3##(1991-6#1)(2008-11#1)
of the p53 gene##2##4##(1993-11#1)(2008-10#1)
of the p53##7##3##(1993-11#1)(1994-12#2)(1994-5#1)(1997-7#1)(2008-10#1)(2010-3#1)
of the pH and##2##4##(2008-10#2)
of the pH##10##3##(2008-10#10)
of the pK(a)##3##3##(2008-10#3)
of the pain##8##3##(1991-11#1)(1992-2#2)(1996-3#1)(2008-11#2)(2008-12#1)(2008-4#1)
of the paired t-test##2##4##(2008-10#2)
of the palate##2##3##(1991-2#1)(2009-1#1)
of the palladium##2##3##(2008-10#2)
of the palmar##3##3##(2008-9#1)(2011-2#2)
of the pancreas in##2##4##(1992-5#1)(2013-1#1)
of the pancreas is##4##4##(1990-3#1)(1991-3#1)(2013-1#2)
of the pancreas##30##3##(1990-3#2)(1990-9#7)(1991-3#2)(1992-5#2)(1992-9#1)(1997-5#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#9)
of the pancreatic##5##3##(1990-9#1)(2008-7#1)(2009-7#2)(2010-12#1)
of the pandemic##2##3##(2008-10#1)(2011-2#1)
of the paper##10##3##(1991-2#1)(2008-12#3)(2009-6#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the papers##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
of the papillary##2##3##(1990-9#1)(2008-5#1)
of the parameter##4##3##(2008-10#2)(2008-11#2)
of the parameters affecting the##2##5##(2008-10#2)
of the parameters in the##2##5##(1995-9#1)(2008-7#1)
of the parameters of##2##4##(2008-10#1)(2008-3#1)
of the parameters that affect the##2##6##(2008-10#1)(2008-11#1)
of the parameters that affect##3##5##(1992-3#1)(2008-10#1)(2008-11#1)
of the parameters that##7##4##(1992-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-7#1)
of the parameters##18##3##(1992-3#1)(1995-9#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2012-3#1)
of the parametric##3##3##(2008-3#1)(2009-10#2)
of the paranasal sinuses##3##4##(1991-6#1)(2008-11#1)(2011-2#1)
of the parasite##7##3##(1997-6#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
of the parasites##2##3##(1996-12#1)(2008-5#1)
of the parasitic##4##3##(1990-11#1)(2008-8#1)(2009-8#1)(2012-2#1)
of the parathyroid##2##3##(1990-9#1)(2008-5#1)
of the parent compound##2##4##(1995-6#1)(2008-11#1)
of the parent drug and the##2##6##(2008-10#1)(2011-3#1)
of the parent drug##4##4##(2008-10#3)(2011-3#1)
of the parent##11##3##(1995-6#1)(2008-10#7)(2008-11#1)(2009-12#1)(2011-3#1)
of the parent-child relationship##2##4##(1995-5#1)(1996-9#1)
of the parental##10##3##(1990-8#1)(1993-1#1)(1994-8#1)(1995-1#1)(1995-12#1)(2008-10#2)(2008-8#1)(2010-4#1)(2012-3#1)
of the parents is a##2##5##(1990-6#1)(2013-1#1)
of the parents##7##3##(1990-6#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
of the parietal cell##2##4##(1997-1#2)
of the parietal##4##3##(1995-6#1)(1997-1#2)(1997-6#1)
of the parotid gland##3##4##(1991-6#2)(2009-3#1)
of the partial least##2##4##(2008-10#2)
of the partial least-squares algorithm##2##5##(2008-10#2)
of the partial##7##3##(1993-12#1)(2008-10#5)(2011-2#1)
of the partially##3##3##(1993-8#1)(1996-3#1)(2008-10#1)
of the participants had##2##4##(1994-12#1)(2008-10#1)
of the participants##16##3##(1991-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of the participating##4##3##(1994-3#1)(2008-11#1)(2008-12#2)
of the particle size##3##4##(2008-10#2)(2008-3#1)
of the particle##10##3##(1994-11#1)(2008-10#2)(2008-3#6)(2009-5#1)
of the particles in##2##4##(2008-10#2)
of the particles##8##3##(1993-8#1)(1996-11#1)(2008-10#4)(2008-3#1)(2008-5#1)
of the particular##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
of the particulate##3##3##(2008-3#3)
of the partition coefficient of##2##5##(2008-10#2)
of the partition coefficient##3##4##(2008-10#3)
of the partition##4##3##(2008-10#4)
of the passage of##2##4##(2008-10#1)(2011-2#1)
of the past##14##3##(1993-12#1)(1993-3#1)(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#4)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
of the patch##4##3##(1994-11#1)(2008-5#2)(2008-8#1)
of the patch-clamp technique##2##4##(1993-3#1)(1995-2#1)
of the patellar tendon##3##4##(2009-4#1)(2013-1#2)
of the patellar##4##3##(1997-8#1)(2009-4#1)(2013-1#2)
of the path##2##3##(2008-11#1)(2008-7#1)
of the pathogen and the##6##5##(2008-10#6)
of the pathogen and##11##4##(2008-10#10)(2008-9#1)
of the pathogen at the##2##5##(2008-10#2)
of the pathogen between##2##4##(2008-10#2)
of the pathogen by##2##4##(2008-10#2)
of the pathogen collected##2##4##(2008-10#2)
of the pathogen did not##2##5##(2008-10#2)
of the pathogen has##2##4##(2008-10#2)
of the pathogen in the##4##5##(2008-10#4)
of the pathogen in##13##4##(2008-10#12)(2008-5#1)
of the pathogen on the##2##5##(2008-10#2)
of the pathogen on##5##4##(2008-10#5)
of the pathogen population##4##4##(2008-10#4)
of the pathogen to##3##4##(2008-10#3)
of the pathogen was##7##4##(2008-10#7)
of the pathogen were##6##4##(2008-10#6)
of the pathogen##128##3##(2008-10#122)(2008-5#1)(2008-9#3)(2011-2#1)(2012-2#1)
of the pathogen's##2##3##(2008-10#2)
of the pathogenesis of##6##4##(1990-9#1)(1995-12#1)(1997-1#1)(2008-7#1)(2010-5#1)(2013-1#1)
of the pathogenesis-related##2##3##(2008-10#2)
of the pathogenic##5##3##(2008-10#4)(2012-3#1)
of the pathogens##6##3##(2008-10#6)
of the pathological##2##3##(2008-5#1)(2013-8#1)
of the pathology##5##3##(1992-12#1)(2008-10#1)(2010-3#1)(2013-1#2)
of the pathophysiology of##6##4##(1996-2#1)(2008-12#1)(2008-6#1)(2011-2#2)(2013-8#1)
of the pathophysiology##9##3##(1994-6#1)(1996-2#1)(2008-12#1)(2008-6#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of the pathway##5##3##(1990-7#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)
of the pathways##2##3##(1996-2#1)(2009-8#1)
of the patient and##5##4##(1990-6#1)(1994-12#1)(2012-2#1)(2013-1#2)
of the patient experience##2##4##(2009-8#1)(2012-3#1)
of the patient for##2##4##(1990-2#1)(1992-3#1)
of the patient in the##2##5##(2011-2#1)(2013-8#1)
of the patient in##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
of the patient is##2##4##(1990-3#1)(1995-2#1)
of the patient to##2##4##(1992-3#1)(2011-1#1)
of the patient with##3##4##(1997-4#1)(2008-10#1)(2008-9#1)
of the patient##59##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#3)(1993-11#1)(1994-11#2)(1994-12#1)(1995-12#2)(1995-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
of the patient's##17##3##(1990-11#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#3)
of the patients and##3##4##(1992-2#1)(2008-10#1)(2010-8#1)
of the patients died##3##4##(1996-6#1)(2008-11#1)(2011-3#1)
of the patients had a##3##5##(1993-2#1)(2008-1#1)(2010-6#1)
of the patients had##14##4##(1990-12#1)(1990-2#1)(1991-2#2)(1993-12#1)(1993-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-8#1)
of the patients in the##3##5##(1994-3#1)(1997-5#2)
of the patients in##4##4##(1994-3#1)(1997-5#2)(2011-1#1)
of the patients must be##2##5##(1997-8#1)(2012-3#1)
of the patients reported side effects##2##6##(1991-3#1)(1993-2#1)
of the patients to##2##4##(1995-11#1)(2008-10#1)
of the patients was##11##4##(1991-8#1)(1993-2#1)(1997-8#1)(2008-1#2)(2008-11#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-3#1)
of the patients were on##2##5##(2008-1#1)(2012-5#1)
of the patients were##10##4##(1990-6#1)(1990-9#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-3#2)(2012-5#1)
of the patients who##5##4##(1990-12#1)(1996-11#1)(1997-3#1)(2008-11#1)(2012-3#1)
of the patients with Lbs##2##5##(2008-7#2)
of the patients with##9##4##(1992-11#1)(1992-5#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-1#1)
of the patients##141##3##(1990-11#1)(1990-12#5)(1990-2#2)(1990-6#1)(1990-9#5)(1991-12#1)(1991-2#4)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-5#2)(1992-6#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1994-3#2)(1994-9#4)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#4)(2007-11#1)(2007-12#1)(2008-1#16)(2008-10#4)(2008-11#9)(2008-7#7)(2008-8#3)(2008-9#1)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#7)(2011-3#3)(2012-12#2)(2012-3#7)(2012-5#1)(2013-1#2)(2013-8#1)
of the pattern##5##3##(1990-12#1)(2008-3#1)(2009-8#1)(2011-2#2)
of the pea##3##3##(2008-10#2)(2009-8#1)
of the peak corresponds to##2##5##(2008-10#2)
of the peak current##3##4##(2008-10#3)
of the peak height##2##4##(2008-10#2)
of the peak##15##3##(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)
of the peaks are##2##4##(2008-10#2)
of the peaks##7##3##(2008-10#7)
of the pecten##2##3##(2008-5#2)
of the pectins##2##3##(2008-10#2)
of the pectoralis##2##3##(2009-1#1)(2010-9#1)
of the pedunculopontine tegmental nucleus##2##5##(1994-2#2)
of the pelvic##5##3##(1990-5#2)(1992-3#1)(1994-3#1)(2008-7#1)
of the pelvis##6##3##(1991-12#1)(1992-12#2)(2011-2#3)
of the penicillin##2##3##(2008-10#1)(2011-1#1)
of the penis in a##2##5##(2008-10#2)
of the penis##8##3##(1990-12#2)(1991-8#1)(2008-10#3)(2013-1#1)(2013-8#1)
of the people##6##3##(1994-8#1)(2008-1#1)(2008-10#1)(2010-12#2)(2010-8#1)
of the peptide in the##3##5##(1992-6#2)(2008-6#1)
of the peptide was##2##4##(1991-5#1)(1993-8#1)
of the peptide##23##3##(1990-5#1)(1991-5#1)(1992-4#1)(1992-6#3)(1993-8#2)(1994-5#2)(1995-2#1)(1996-12#2)(1997-4#2)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)
of the peptides##6##3##(1990-5#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-6#1)(2009-10#1)
of the peptone##3##3##(2008-7#3)
of the perceived##4##3##(1994-1#1)(1996-2#1)(2008-6#1)(2009-7#1)
of the percentage of diseased##2##5##(2008-10#2)
of the percentage of##7##4##(1991-5#1)(2008-10#6)
of the percentage##8##3##(1991-5#1)(2008-10#6)(2010-1#1)
of the perchlorate##2##3##(2008-10#2)
of the performance of the##3##5##(2008-5#1)(2008-9#1)(2009-8#1)
of the performance of##12##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-8#1)
of the performance##13##3##(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-8#1)
of the perfusion rate##2##4##(2008-11#2)
of the perfusion system##2##4##(2008-11#1)(2012-2#1)
of the perfusion##4##3##(2008-11#3)(2012-2#1)
of the peri-implant##3##3##(2013-1#3)
of the perikaryon##3##3##(2008-7#3)
of the perinuclear##3##3##(2008-7#3)
of the period##4##3##(1996-3#1)(2008-12#1)(2008-3#1)(2008-5#1)
of the peripheral nervous system##2##5##(1995-12#1)(1996-2#1)
of the peripheral##4##3##(1995-12#1)(1996-2#1)(2008-5#1)(2008-9#1)
of the perisomatic space##3##4##(1994-2#3)
of the peritoneal##2##3##(2011-2#2)
of the peritrophic membrane##3##4##(2007-12#1)(2008-7#2)
of the permanent##2##3##(1992-2#1)(2013-1#1)
of the permanganates##2##3##(2008-10#2)
of the permeant##2##3##(1991-5#1)(2008-5#1)
of the persimmon bark borer##2##5##(2008-10#2)
of the persimmon##3##3##(2008-10#3)
of the persistent##2##3##(2008-11#1)(2008-8#1)
of the person##4##3##(1994-1#1)(1994-2#1)(2008-10#1)(2010-6#1)
of the pertinent##3##3##(1996-6#1)(2010-12#1)(2012-2#1)
of the perturbation of##2##4##(1997-6#1)(2008-10#1)
of the perturbation##4##3##(1997-6#1)(2008-10#1)(2008-3#2)
of the pest##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
of the pesticide##10##3##(2008-10#10)
of the pesticides##5##3##(2008-10#3)(2008-11#2)
of the petrous##3##3##(2008-7#1)(2011-2#2)
of the phage##4##3##(2008-10#3)(2008-8#1)
of the pharmaceutical industry##2##4##(1991-3#1)(2008-11#1)
of the pharmaceutical##4##3##(1991-3#2)(2008-11#2)
of the pharmacists##2##3##(2011-1#2)
of the pharmacokinetic##2##3##(1991-2#1)(2008-10#1)
of the pharynx##2##3##(1997-7#1)(2011-2#1)
of the phase##13##3##(1995-12#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)
of the phenolic##3##3##(1990-5#1)(2008-10#2)
of the phenomena of##2##4##(2008-5#1)(2010-10#1)
of the phenomena##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)
of the phenomenon##4##3##(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)
of the phenotypes##2##3##(1991-9#1)(1997-8#1)
of the phenotypic variance##8##4##(2008-10#8)
of the phenotypic variation for resistance##2##6##(2008-10#2)
of the phenotypic variation for##4##5##(2008-10#4)
of the phenotypic variation in##2##5##(2008-10#2)
of the phenotypic variation##11##4##(2008-10#11)
of the phenotypic##24##3##(2008-10#22)(2008-8#1)(2012-3#1)
of the phloem##3##3##(2008-10#2)(2008-11#1)
of the phosphatase 2A catalytic subunit##3##6##(1992-9#3)
of the phosphate##3##3##(1994-11#1)(2008-10#2)
of the phospholipids##2##3##(1993-8#1)(2008-10#1)
of the phosphomolybdenum blue##2##4##(2008-10#2)
of the phosphonate##2##3##(2008-10#2)
of the phosphorescence emission##3##4##(2008-10#3)
of the phosphorylated##3##3##(1994-11#1)(1997-1#1)(2008-8#1)
of the phosphorylation##2##3##(1995-12#1)(1995-6#1)
of the photoacoustic##2##3##(2008-3#1)(2011-7#1)
of the photonic##3##3##(2007-12#2)(2008-3#1)
of the photoreceptive system##2##4##(2008-5#2)
of the photosensitizers##2##3##(1993-11#1)(2008-11#1)
of the photosynthetic apparatus##3##4##(2008-10#2)(2012-6#1)
of the phyllosilicate##2##3##(2008-6#2)
of the phylum Spirochaetes##2##4##(2013-8#2)
of the phylum##4##3##(2011-2#1)(2013-8#3)
of the physical and chemical environment##2##6##(2008-10#1)(2008-8#1)
of the physical and chemical##3##5##(2008-10#2)(2008-8#1)
of the physical properties of##2##5##(2008-5#2)
of the physical##20##3##(1990-9#1)(1992-2#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
of the physicians##5##3##(1993-11#1)(1997-3#2)(2008-1#2)
of the physicians'##3##3##(1995-2#2)(1996-1#1)
of the physicochemical##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
of the physiological##17##3##(1990-11#1)(1995-11#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-12#1)(2010-10#1)(2012-2#2)(2013-1#1)
of the phytopathogenic##2##3##(1997-4#1)(2008-10#1)
of the picture##2##3##(1993-12#1)(2008-7#1)
of the piezoelectric quartz crystal##2##5##(2008-10#2)
of the piezoelectric##5##3##(2008-10#4)(2009-5#1)
of the pigments##4##3##(2008-10#4)
of the pineal hormone melatonin##2##5##(1990-2#2)
of the pineal##6##3##(1990-2#2)(1994-2#1)(1995-12#1)(2012-2#1)(2013-7#1)
of the pink##2##3##(2008-10#1)(2010-10#1)
of the pioneers##2##3##(1993-6#1)(2012-2#1)
of the pituitary gland##5##4##(1996-11#1)(1996-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the pituitary##7##3##(1994-5#1)(1996-11#1)(1996-2#1)(1997-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the placenta##2##3##(1995-12#1)(2012-12#1)
of the planar##2##3##(2008-10#2)
of the planarian##3##3##(2008-5#3)
of the plant and##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
of the plant species##2##4##(2008-10#1)(2008-8#1)
of the plant##34##3##(2007-12#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#3)(2010-10#1)(2011-1#1)(2012-2#1)
of the plant-pathogenic##2##3##(2008-10#2)
of the plants##12##3##(1995-2#1)(2008-10#10)(2008-8#1)
of the plasma membrane of##2##5##(1990-12#1)(2008-11#1)
of the plasma membrane##9##4##(1990-12#1)(1995-2#2)(2008-10#2)(2008-11#2)(2009-8#1)(2009-9#1)
of the plasma##11##3##(1990-12#1)(1995-2#2)(2008-10#3)(2008-11#2)(2008-2#1)(2009-8#1)(2009-9#1)
of the plasmalemma##3##3##(2007-12#1)(2008-10#2)
of the plasmid##4##3##(1996-6#1)(1997-2#1)(2008-10#2)
of the plastic##2##3##(2007-12#1)(2008-11#1)
of the plasticizer admixtures##2##4##(2008-10#2)
of the plasticizer##4##3##(2008-10#4)
of the plasticizers##2##3##(2008-10#2)
of the plateau##3##3##(1994-6#1)(2008-9#1)(2013-1#1)
of the platelet##2##3##(2006-6#1)(2008-5#1)
of the platform##3##3##(2008-10#2)(2009-9#1)
of the platinum group elements##3##5##(2008-10#2)(2008-11#1)
of the platinum##5##3##(2008-10#4)(2008-11#1)
of the plot##4##3##(2008-10#4)
of the plots##2##3##(2008-10#2)
of the plume##2##3##(2008-2#1)(2008-3#1)
of the points##2##3##(2008-6#1)(2009-2#1)
of the polar##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
of the polarization##4##3##(2008-3#3)(2008-9#1)
of the polarographic##2##3##(2008-10#2)
of the pollen tube##2##4##(2008-11#1)(2009-8#1)
of the pollen##5##3##(2008-10#1)(2008-11#1)(2009-8#1)(2012-7#2)
of the pollutants##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of the poly(sodium 4-styrenesulfonate) coatings##2##5##(2008-10#2)
of the poly(sodium##3##3##(2008-10#3)
of the polyadenylation##2##3##(1994-11#1)(2010-4#1)
of the polyamine site of##2##5##(1996-2#2)
of the polyamine##3##3##(1990-7#1)(1996-2#2)
of the polycystic ovary syndrome##4##5##(2008-3#1)(2008-4#3)
of the polymer and##2##4##(1995-6#1)(2008-10#1)
of the polymer matrix##3##4##(2008-3#1)(2008-7#1)(2010-4#1)
of the polymer##15##3##(1995-6#2)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#2)
of the polymerase chain reaction##2##5##(1992-6#1)(2008-10#1)
of the polymerase##5##3##(1992-6#1)(1993-12#1)(1994-12#1)(2008-10#1)(2012-12#1)
of the polymeric matrix##2##4##(2008-10#2)
of the polymeric##6##3##(2008-10#5)(2008-5#1)
of the polymers##4##3##(1994-11#1)(2008-10#2)(2013-1#1)
of the polymorphic##2##3##(1995-6#1)(2008-10#1)
of the polypeptide##3##3##(1992-9#1)(1993-8#1)(2008-8#1)
of the polypyrrole##2##3##(2008-10#2)
of the polyurethane##2##3##(2008-10#1)(2009-7#1)
of the popliteal##2##3##(1991-3#2)
of the population and##2##4##(1992-1#1)(1996-3#1)
of the population being##2##4##(2008-7#1)(2008-9#1)
of the population densities##2##4##(2008-10#2)
of the population dynamics of##2##5##(2008-10#1)(2008-9#1)
of the population has##2##4##(1997-5#1)(1997-8#1)
of the population in the##3##5##(2008-5#1)(2008-6#2)
of the population in##4##4##(2008-11#1)(2008-5#1)(2008-6#2)
of the population is##4##4##(1994-9#1)(2010-1#1)(2010-7#1)(2012-12#1)
of the population of##4##4##(1994-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
of the population that##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
of the population to##2##4##(1997-2#1)(2008-9#1)
of the population were##3##4##(2012-12#3)
of the population##70##3##(1991-3#1)(1992-1#2)(1993-2#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2008-10#21)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#6)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-8#2)
of the populations of##2##4##(2008-10#1)(2008-8#1)
of the populations##14##3##(1996-3#1)(2008-1#1)(2008-10#7)(2008-7#1)(2008-8#2)(2008-9#2)
of the porcine##4##3##(1991-6#1)(2008-5#1)(2012-2#2)
of the porphyrin##2##3##(1991-5#1)(2008-10#1)
of the portal vein##2##4##(1995-2#1)(2009-9#1)
of the portal##3##3##(1993-3#1)(1995-2#1)(2009-9#1)
of the positioning of the##2##5##(2008-9#2)
of the positive##11##3##(1992-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)(2011-3#1)
of the positively charged##2##4##(1997-8#1)(2008-10#1)
of the possibility of##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
of the possibility##6##3##(2008-11#1)(2008-12#1)(2011-2#2)(2013-1#2)
of the possible role of##3##5##(1995-9#2)(2011-3#1)
of the possible##15##3##(1992-12#1)(1992-6#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-9#2)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)
of the post-lead-time survival##2##4##(1995-12#2)
of the posterior lobe##2##4##(1997-8#1)(2012-3#1)
of the posterior pituitary##2##4##(1997-8#1)(2008-4#1)
of the posterior##17##3##(1991-2#1)(1996-2#1)(1997-6#1)(1997-8#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
of the postsynaptic neuron##2##4##(1997-7#1)(2009-8#1)
of the postsynaptic##6##3##(1996-12#1)(1997-2#2)(1997-7#1)(2008-11#1)(2009-8#1)
of the postulated##2##3##(1990-7#1)(2008-11#1)
of the potassium##4##3##(1995-8#1)(2008-10#3)
of the potato##9##3##(2008-10#9)
of the potent##4##3##(1991-3#1)(1991-5#1)(1992-10#1)(1993-8#1)
of the potential benefits##2##4##(1994-3#1)(2008-11#1)
of the potential buffer##2##4##(2008-10#2)
of the potential for##5##4##(1996-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the potential genes##2##4##(1997-6#1)(1997-8#1)
of the potential of##3##4##(1996-3#1)(2008-10#2)
of the potential##39##3##(1991-7#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-6#1)(1997-8#1)(2008-10#15)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the potentially##2##3##(2008-10#1)(2013-1#1)
of the potentiometric titration##2##4##(2008-10#2)
of the potentiometric##3##3##(2008-10#3)
of the powder pharmaceutical samples of sulfaguanidine##2##7##(2008-10#2)
of the powder##4##3##(2008-10#3)(2008-5#1)
of the power##4##3##(2008-10#1)(2008-3#1)(2009-5#1)(2010-8#1)
of the practical##3##3##(1992-3#1)(2008-11#1)(2012-2#1)
of the practice##6##3##(1994-12#1)(1995-1#1)(2008-11#3)(2010-1#1)
of the practitioners##2##3##(2008-1#2)
of the pre- and##2##4##(1991-1#1)(2010-8#1)
of the preceding##2##3##(1996-6#1)(2008-10#1)
of the precipitate##4##3##(2008-10#4)
of the precipitated##3##3##(2008-7#1)(2013-1#2)
of the precise##2##3##(2008-10#1)(2012-2#1)
of the precision##2##3##(2008-10#2)
of the precursor of##4##4##(1990-8#1)(1991-7#1)(1993-3#1)(1997-1#1)
of the precursor##8##3##(1990-8#1)(1991-7#2)(1992-6#1)(1993-3#2)(1995-8#1)(1997-1#1)
of the predator##3##3##(2008-8#2)(2008-9#1)
of the predicted amino acid sequence##2##6##(1995-8#1)(2008-10#1)
of the predicted polypeptide##2##4##(1990-5#1)(1995-6#1)
of the predicted##20##3##(1990-5#2)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-3#1)(2011-1#1)(2011-3#1)(2013-8#2)
of the prediction##2##3##(2008-11#2)
of the predictions of##2##4##(1992-3#1)(2008-10#1)
of the predictions##4##3##(1992-3#1)(2008-10#1)(2008-9#1)(2010-8#1)
of the predictors of##2##4##(2008-11#1)(2009-11#1)
of the predictors##4##3##(1995-12#1)(2008-11#2)(2009-11#1)
of the predominant##3##3##(2008-10#2)(2013-1#1)
of the prefrontal##2##3##(1994-8#1)(2008-11#1)
of the pregnant##5##3##(1997-4#1)(2008-8#3)(2009-10#1)
of the preliminary##2##3##(2008-7#1)(2013-1#1)
of the preparation of##2##4##(2008-10#2)
of the preparation##5##3##(1992-5#1)(2008-10#3)(2008-11#1)
of the preparations##3##3##(2008-10#1)(2008-5#2)
of the prepared##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
of the preprohormone##2##3##(2008-4#2)
of the prescription##2##3##(1995-11#1)(2008-11#1)
of the presence and##2##4##(2008-10#2)
of the presence of an##2##5##(1991-11#1)(1993-8#1)
of the presence of the##5##5##(2008-10#2)(2008-11#1)(2008-3#1)(2010-3#1)
of the presence of##30##4##(1991-11#1)(1991-2#1)(1992-2#1)(1993-8#2)(1996-12#1)(2008-10#17)(2008-11#3)(2008-3#1)(2008-5#2)(2010-3#1)
of the presence or absence of##4##6##(1990-5#1)(1993-3#1)(2008-10#1)(2008-8#1)
of the presence##37##3##(1990-5#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-3#1)(1993-8#2)(1996-12#1)(2008-10#21)(2008-11#3)(2008-3#1)(2008-5#2)(2008-8#1)(2010-3#1)
of the presenilin##2##3##(1996-2#2)
of the present case##2##4##(1997-7#1)(2008-7#1)
of the present investigations##2##4##(2008-6#1)(2008-7#1)
of the present method##5##4##(2008-10#5)
of the present procedure##2##4##(2008-10#2)
of the present research##2##4##(2008-12#1)(2013-8#1)
of the present results##3##4##(1991-5#1)(1995-12#1)(2008-11#1)
of the present review is to##2##6##(2008-10#1)(2010-1#1)
of the present review##4##4##(2008-10#1)(2008-11#1)(2010-1#1)(2011-1#1)
of the present study is to assess the##2##8##(2008-11#1)(2012-3#1)
of the present study is to assess##3##7##(2008-11#1)(2011-2#1)(2012-3#1)
of the present study is to investigate the##2##8##(2008-10#1)(2008-5#1)
of the present study is to##9##6##(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#2)(2012-3#1)(2013-1#1)
of the present study is##10##5##(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
of the present study suggest that##2##6##(2011-2#1)(2012-5#1)
of the present study was to determine##4##7##(2008-10#2)(2008-12#1)(2011-1#1)
of the present study was to develop##2##7##(2008-10#1)(2008-11#1)
of the present study was to evaluate##9##7##(1993-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-3#1)(2013-1#3)
of the present study was to examine the##5##8##(1992-2#1)(2010-6#1)(2011-2#2)(2013-8#1)
of the present study was to examine##7##7##(1992-2#1)(2010-10#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
of the present study was to investigate the##6##8##(2008-12#1)(2009-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
of the present study was to investigate##9##7##(2008-10#1)(2008-11#1)(2008-12#1)(2009-1#1)(2010-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
of the present study was to##49##6##(1990-8#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-5#4)(2008-7#1)(2009-1#1)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
of the present study was##51##5##(1990-8#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-5#4)(2008-7#1)(2009-1#1)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#2)
of the present study were to##2##6##(2008-10#1)(2012-2#1)
of the present study were##3##5##(2008-10#2)(2012-2#1)
of the present study##83##4##(1990-8#1)(1992-2#1)(1993-1#1)(1993-6#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#2)(1997-3#1)(2008-10#14)(2008-11#3)(2008-12#6)(2008-5#8)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#9)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#2)(2013-1#10)(2013-8#2)
of the present work is##4##5##(1997-2#1)(2008-10#2)(2009-12#1)
of the present work was to evaluate the##3##8##(1993-11#1)(2008-5#1)(2012-2#1)
of the present work was to##8##6##(1992-12#1)(1993-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
of the present work##13##4##(1992-12#1)(1993-11#1)(1997-2#1)(2008-10#4)(2008-5#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
of the present##135##3##(1990-12#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-6#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2008-10#28)(2008-11#8)(2008-12#7)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#2)(2009-12#3)(2010-1#1)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#10)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#4)(2012-5#2)(2013-1#12)(2013-8#5)
of the presentation##2##3##(2008-10#1)(2011-2#1)
of the presented model##2##4##(2008-10#1)(2008-8#1)
of the presented##3##3##(2008-10#2)(2008-8#1)
of the pressure##4##3##(2008-10#4)
of the presynaptic neuron##2##4##(1997-7#2)
of the prevailing##2##3##(2008-5#1)(2008-8#1)
of the prevalence of##4##4##(1994-6#1)(1994-9#1)(1996-1#1)(2010-1#1)
of the prevalence##5##3##(1994-6#1)(1994-9#1)(1996-1#1)(2008-4#1)(2010-1#1)
of the preventive effect of##2##5##(2008-5#1)(2009-8#1)
of the preventive##4##3##(1993-9#1)(1996-2#1)(2008-5#1)(2009-8#1)
of the previous##7##3##(1990-2#1)(1990-5#2)(2008-10#2)(2010-11#1)(2012-2#1)
of the previously described##2##4##(2008-10#2)
of the previously published##2##4##(1993-8#1)(2010-2#1)
of the previously##7##3##(1993-8#1)(1996-6#1)(2008-10#3)(2010-2#1)(2013-1#1)
of the prey##4##3##(2008-8#2)(2008-9#2)
of the primary and recurrent##2##5##(1991-6#2)
of the primary and##3##4##(1991-6#2)(2010-12#1)
of the primary electron donor is##2##6##(2008-8#2)
of the primary inoculum##2##4##(2008-10#2)
of the primary lesion##2##4##(1992-2#1)(2008-10#1)
of the primary outcomes##2##4##(2008-7#1)(2010-1#1)
of the primary tumor##5##4##(1990-6#1)(1991-3#1)(2008-1#1)(2012-3#1)(2013-1#1)
of the primary tumour##2##4##(1991-6#1)(2011-3#1)
of the primary##61##3##(1990-5#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-6#4)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-5#4)(1997-3#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2010-1#1)(2010-12#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
of the primate##3##3##(1995-11#1)(1995-5#2)
of the primers##4##3##(2008-10#4)
of the principal##6##3##(1992-3#1)(2008-3#3)(2011-2#1)(2011-3#1)
of the principle of##4##4##(1992-1#1)(2008-11#1)(2008-12#1)(2008-2#1)
of the principle##6##3##(1992-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-3#1)
of the principles and##2##4##(1993-12#1)(1997-3#1)
of the principles of##3##4##(1997-3#1)(2008-10#1)(2008-9#1)
of the principles##7##3##(1993-12#1)(1995-1#1)(1997-3#2)(2008-10#1)(2008-9#1)(2010-8#1)
of the probability of developing the disease in the##2##9##(1992-9#2)
of the probability of##4##4##(1992-9#2)(2009-10#1)(2012-3#1)
of the probe##10##3##(1995-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-4#1)
of the probes##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
of the probiotic##4##3##(2011-2#2)(2013-1#2)
of the problem and##2##4##(2008-10#1)(2012-12#1)
of the problem is##2##4##(2008-5#1)(2011-2#1)
of the problem of##2##4##(1996-6#1)(1997-7#1)
of the problem under##2##4##(2008-3#1)(2013-8#1)
of the problem##21##3##(1991-6#1)(1995-12#1)(1996-6#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#2)
of the problems of##2##4##(1991-3#1)(2008-11#1)
of the problems##9##3##(1990-9#1)(1991-3#1)(1992-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2009-5#1)(2011-1#1)
of the procedure for##2##4##(2008-10#2)
of the procedure is illustrated##3##5##(2008-10#2)(2010-5#1)
of the procedure is##5##4##(1996-12#1)(2008-10#3)(2010-5#1)
of the procedure was##7##4##(2008-10#7)
of the procedure were##3##4##(2008-10#3)
of the procedure##36##3##(1993-6#1)(1994-6#1)(1995-12#1)(1996-12#1)(2006-6#1)(2008-10#22)(2008-11#2)(2008-7#1)(2008-9#1)(2010-5#2)(2011-2#2)(2012-2#1)
of the procedures##5##3##(1996-6#1)(2008-10#3)(2008-4#1)
of the process and##2##4##(2008-1#1)(2008-12#1)
of the process of##5##4##(2008-11#2)(2008-12#1)(2008-4#1)(2012-3#1)
of the process##32##3##(1990-6#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-1#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#2)(2008-4#2)(2008-7#4)(2010-2#1)(2012-3#1)
of the processed##2##3##(2008-10#1)(2013-1#1)
of the processes of##3##4##(2008-10#2)(2012-3#1)
of the processes##8##3##(1996-12#1)(2008-10#3)(2008-11#2)(2012-3#1)(2013-8#1)
of the processing of##2##4##(1990-8#1)(1993-6#1)
of the processing##5##3##(1990-8#1)(1991-2#1)(1993-6#1)(2008-11#1)(2013-8#1)
of the produced##7##3##(2008-10#2)(2008-11#3)(2008-7#1)(2012-2#1)
of the producer##3##3##(2008-11#3)
of the product and##2##4##(1995-5#1)(2008-5#1)
of the product of##3##4##(2008-10#3)
of the product##26##3##(1994-3#1)(1995-5#1)(2008-10#14)(2008-11#2)(2008-5#5)(2008-7#1)(2010-10#1)(2012-2#1)
of the production of##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
of the production process##3##4##(2008-11#1)(2012-2#2)
of the production##7##3##(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#3)
of the productivity##2##3##(2008-11#2)
of the products of##5##4##(1992-12#1)(1994-8#1)(1996-12#2)(2008-10#1)
of the products##15##3##(1991-3#1)(1992-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-5#1)(2008-10#5)(2008-5#2)
of the profession##10##3##(1991-2#1)(1993-1#2)(1996-1#1)(2008-11#1)(2008-12#2)(2012-3#3)
of the professional##4##3##(1991-3#1)(1992-3#1)(1996-3#1)(2012-2#1)
of the profile##5##3##(1996-1#1)(2008-10#2)(2008-3#1)(2010-5#1)
of the progeny##2##3##(2008-10#2)
of the prognosis##3##3##(1996-11#1)(2008-7#1)(2010-8#1)
of the program##22##3##(1991-12#3)(1991-2#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-7#1)(2012-12#1)(2013-1#3)
of the programme is##2##4##(2008-11#1)(2008-12#1)
of the programme##7##3##(2008-10#1)(2008-11#3)(2008-12#1)(2010-1#1)(2011-2#1)
of the programs##5##3##(1992-1#1)(1996-1#1)(1997-2#1)(2008-6#1)(2008-9#1)
of the progression of##2##4##(2008-7#1)(2011-2#1)
of the project##8##3##(1995-2#1)(1996-1#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-5#1)
of the prolapse##2##3##(2013-1#2)
of the proliferation of##3##4##(1992-2#1)(2008-11#1)(2008-6#1)
of the proliferation##4##3##(1992-2#1)(2008-11#1)(2008-6#1)(2011-2#1)
of the proliferative lymphocytes##2##4##(2008-9#2)
of the proliferative##4##3##(1992-3#1)(2008-9#2)(2011-2#1)
of the prolonged##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
of the prominent##2##3##(1991-8#1)(2008-5#1)
of the promoter for##2##4##(1995-2#1)(1995-6#1)
of the promoter region of##2##5##(1993-2#1)(1993-3#1)
of the promoter region##3##4##(1993-2#1)(1993-3#1)(2011-1#1)
of the promoter regions##2##4##(1997-2#1)(2012-3#1)
of the promoter##14##3##(1993-2#1)(1993-3#1)(1995-2#2)(1995-6#2)(1997-2#1)(2008-11#1)(2008-8#2)(2008-9#1)(2011-1#2)(2012-3#1)
of the properties of##8##4##(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)
of the properties##9##3##(1993-8#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)
of the proportion of##5##4##(1992-12#1)(1996-3#1)(2008-10#3)
of the proposal##3##3##(1992-2#3)
of the proposed diet##2##4##(2008-3#2)
of the proposed method and##2##5##(2008-10#2)
of the proposed method are##4##5##(2008-10#3)(2008-3#1)
of the proposed method for determining##2##6##(2008-10#2)
of the proposed method for##9##5##(2008-10#9)
of the proposed method is##13##5##(2008-10#13)
of the proposed method was checked##3##6##(2008-10#3)
of the proposed method was evaluated by analyzing##2##8##(2008-10#2)
of the proposed method was evaluated by##4##7##(2008-10#4)
of the proposed method was##17##5##(2008-10#17)
of the proposed method##63##4##(2008-10#62)(2008-3#1)
of the proposed methodology has been##2##6##(2008-10#2)
of the proposed methodology was##2##5##(2008-10#2)
of the proposed methodology##5##4##(2008-10#5)
of the proposed methods##5##4##(2008-10#3)(2008-3#1)(2010-11#1)
of the proposed model##4##4##(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
of the proposed models##2##4##(2008-10#1)(2009-8#1)
of the proposed procedure for##2##5##(2008-10#2)
of the proposed procedure is##2##5##(2008-10#2)
of the proposed procedure##9##4##(2008-10#9)
of the proposed sensor##4##4##(2008-10#4)
of the proposed system was##2##5##(2008-10#2)
of the proposed system##6##4##(2008-10#5)(2008-3#1)
of the proposed technique was##3##5##(2008-10#3)
of the proposed technique##5##4##(2008-10#5)
of the proposed##144##3##(1990-6#1)(1992-9#1)(1993-3#1)(1995-2#1)(1996-8#1)(2008-10#119)(2008-2#1)(2008-3#7)(2008-6#2)(2009-10#1)(2009-8#2)(2010-11#2)(2012-2#3)(2013-1#2)
of the prospective payment system##4##5##(1991-1#1)(1991-2#2)(1992-12#1)
of the prospective payment##5##4##(1991-1#2)(1991-2#2)(1992-12#1)
of the prostate gland##2##4##(2008-12#1)(2008-7#1)
of the prostate##10##3##(1990-9#1)(1991-8#2)(1994-12#1)(1995-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
of the prosthesis##5##3##(1997-6#1)(2009-1#1)(2011-2#1)(2011-7#1)(2013-1#1)
of the protease##4##3##(1991-9#1)(1992-6#1)(2008-10#1)(2008-4#1)
of the protection against##2##4##(2008-10#1)(2008-11#1)
of the protection##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
of the protective##2##3##(1997-7#1)(2008-8#1)
of the protein and##4##4##(1994-5#1)(2008-11#1)(2008-9#1)(2009-3#1)
of the protein as determined by##2##6##(1990-5#1)(1993-3#1)
of the protein complex##3##4##(1997-7#1)(2008-5#1)(2011-2#1)
of the protein fraction##2##4##(1994-11#1)(2011-2#1)
of the protein is##3##4##(1992-6#1)(1993-12#1)(1994-8#1)
of the protein kinase C (PKC)##2##6##(1990-5#1)(1992-9#1)
of the protein kinase##4##4##(1990-5#1)(1992-9#1)(1995-2#1)(1997-2#1)
of the protein structure##2##4##(1997-6#1)(2008-4#1)
of the protein##86##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#7)(1994-8#4)(1995-2#3)(1995-6#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#11)(2008-11#5)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#8)(2009-3#4)(2009-8#1)(2010-11#2)(2010-3#1)(2011-1#1)(2011-2#2)(2013-8#1)
of the protein-coding##2##3##(1997-2#1)(2011-2#1)
of the proteinase##2##3##(1990-2#1)(2008-11#1)
of the proteins in the##3##5##(1990-12#1)(1995-6#1)(2008-10#1)
of the proteins in##4##4##(1990-12#1)(1995-6#1)(1997-6#1)(2008-10#1)
of the proteins##18##3##(1990-12#1)(1991-2#2)(1995-6#1)(1997-6#1)(2008-10#6)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#2)
of the proteolytic##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
of the proto-oncogene##2##3##(1997-7#1)(2011-2#1)
of the protocol##4##3##(1991-6#1)(1997-2#1)(2009-2#1)(2012-3#1)
of the proton##3##3##(1990-2#1)(2008-10#1)(2008-11#1)
of the protonated##3##3##(1995-6#1)(2008-10#2)
of the protonation##3##3##(2008-10#2)(2009-9#1)
of the prototype##2##3##(2008-10#1)(2008-3#1)
of the provider's##2##3##(2008-11#1)(2013-8#1)
of the provisions##2##3##(1991-3#1)(1993-1#1)
of the proximal femur##2##4##(2009-3#1)(2013-1#1)
of the proximal##14##3##(1994-5#2)(1996-5#1)(2007-12#3)(2008-11#2)(2009-1#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
of the psoas##2##3##(1991-3#1)(1996-6#1)
of the psychiatric##4##3##(1993-2#1)(1993-6#1)(2008-4#1)(2009-10#1)
of the psychological##3##3##(1996-9#1)(2008-5#1)(2012-5#1)
of the public and##4##4##(1995-5#1)(1996-12#1)(1996-2#2)
of the public health##4##4##(1995-12#1)(1997-2#1)(2008-10#1)(2012-12#1)
of the public##12##3##(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-6#1)(2012-12#1)
of the pulmonary artery##3##4##(2010-10#3)
of the pulmonary##8##3##(1991-3#1)(2008-10#2)(2008-5#1)(2010-10#3)(2013-8#1)
of the pulse##4##3##(1993-1#1)(2007-11#2)(2007-12#1)
of the pulsed##2##3##(1991-3#1)(2008-3#1)
of the pump beam was##2##5##(2008-2#1)(2008-3#1)
of the pump beam##3##4##(2008-2#1)(2008-3#2)
of the pump##9##3##(1992-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)
of the pure analyte##2##4##(2008-10#2)
of the pure##9##3##(2008-10#7)(2008-12#1)(2009-3#1)
of the purified enzyme##2##4##(1990-11#1)(1992-9#1)
of the purified protein##3##4##(1992-3#1)(1992-8#1)(2008-10#1)
of the purified##17##3##(1990-11#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(2008-10#5)(2008-8#1)(2012-2#1)
of the purine##2##3##(2008-10#2)
of the purity of##2##4##(1992-11#1)(2008-10#1)
of the purple color##2##4##(2008-10#2)
of the purple##3##3##(2008-10#3)
of the putative##12##3##(1992-6#1)(1993-12#2)(1993-2#2)(1994-5#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-9#1)
of the pyridine##2##3##(1992-1#1)(1993-8#1)
of the pyrolysis##2##3##(2008-10#1)(2008-3#1)
of the pyruvate##2##3##(1993-8#1)(2008-10#1)
of the quadrat##3##3##(2008-10#3)
of the quadriceps muscle##2##4##(2008-4#1)(2012-3#1)
of the quadriceps##3##3##(2008-4#1)(2012-3#1)(2013-1#1)
of the qualitative##3##3##(1997-3#1)(2008-12#1)(2012-3#1)
of the quality of care##3##5##(1993-3#1)(1995-2#1)(2010-12#1)
of the quality of prenatal##2##5##(1993-3#1)(1996-6#1)
of the quality of##11##4##(1993-3#2)(1995-2#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-12#1)
of the quality##18##3##(1991-2#1)(1993-3#2)(1994-2#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2012-12#2)
of the quantitative##5##3##(1990-9#1)(2008-10#2)(2008-5#1)(2009-10#1)
of the quantities of##2##4##(2008-10#2)
of the quantity of##3##4##(1992-3#1)(2008-10#2)
of the quenching effect##2##4##(2008-10#2)
of the quenching##5##3##(2008-10#4)(2008-2#1)
of the questionnaire##2##3##(2008-11#1)(2013-1#1)
of the questions##4##3##(1990-2#1)(2008-12#1)(2013-1#2)
of the rDNA##6##3##(2008-10#6)
of the rRNA##3##3##(2008-10#1)(2010-4#2)
of the rabbit##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
of the radial artery##4##4##(2008-7#1)(2011-2#2)(2013-1#1)
of the radial##8##3##(2008-7#1)(2011-2#4)(2012-2#2)(2013-1#1)
of the radiation##6##3##(2008-10#2)(2008-2#2)(2009-11#1)(2010-7#1)
of the radiative##2##3##(2008-3#2)
of the radical##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)
of the radicals##2##3##(2008-10#2)
of the radiological##3##3##(2007-8#1)(2011-2#1)(2012-3#1)
of the radiology department##2##4##(1996-1#1)(2012-2#1)
of the radius##2##3##(1991-11#1)(2008-3#1)
of the rainbow trout egg envelope##2##6##(1994-5#2)
of the rainbow trout##3##4##(1994-5#2)(2008-5#1)
of the range of##7##4##(2008-3#1)(2008-8#5)(2008-9#1)
of the range##8##3##(2008-10#1)(2008-3#1)(2008-8#5)(2008-9#1)
of the rapid##6##3##(1993-8#1)(1994-9#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-7#1)
of the rapidly growing##2##4##(2011-2#1)(2013-1#1)
of the rapidly##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
of the rare earth elements##2##5##(2008-10#2)
of the rare earth##3##4##(2008-10#3)
of the rare earths##4##4##(2008-10#4)
of the rare##16##3##(1997-5#1)(2008-10#9)(2008-3#1)(2009-3#1)(2010-5#1)(2012-12#1)(2012-2#2)
of the ras##2##3##(1992-8#1)(1994-6#1)
of the rat at##2##4##(1994-2#1)(2008-8#1)
of the rat bladder##2##4##(1990-5#2)
of the rat brain##4##4##(1992-10#1)(1993-8#1)(1994-8#1)(2008-10#1)
of the rat gene##3##4##(1991-7#1)(1993-8#1)(1994-11#1)
of the rat in##2##4##(1995-12#1)(2008-7#1)
of the rat is##2##4##(1992-3#1)(1994-8#1)
of the rat kidney##2##4##(1992-6#1)(1995-12#1)
of the rat liver##2##4##(1990-5#1)(2008-10#1)
of the rat neuronal cell##4##5##(1993-6#1)(2008-11#3)
of the rat stomach##2##4##(1997-4#2)
of the rat trachea##2##4##(2008-9#2)
of the rat vibrissal##2##4##(2011-2#2)
of the rat##69##3##(1990-5#6)(1991-12#1)(1991-4#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#6)(1994-11#1)(1994-2#3)(1994-8#4)(1995-12#5)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-4#2)(2008-10#2)(2008-11#6)(2008-7#2)(2008-8#2)(2008-9#4)(2011-2#3)(2013-8#1)
of the rate of##12##4##(1991-5#1)(1992-3#1)(1993-12#1)(1994-8#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-7#2)(2013-7#1)
of the rate##19##3##(1990-8#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-12#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-7#1)
of the ratio between the##2##5##(2008-10#1)(2008-11#1)
of the ratio between##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
of the ratio of the##2##5##(2008-10#1)(2008-3#1)
of the ratio of##3##4##(2008-10#1)(2008-3#2)
of the ratio spectra##3##4##(2008-10#3)
of the ratio##13##3##(1992-12#1)(2008-10#7)(2008-11#1)(2008-3#3)(2012-3#1)
of the rats##5##3##(1993-8#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-8#1)
of the raw materials##2##4##(2008-10#2)
of the raw##5##3##(2008-10#4)(2010-4#1)
of the rbcS##2##3##(1993-12#2)
of the reactant##2##3##(2013-8#2)
of the reaction between##6##4##(2008-10#6)
of the reaction by##2##4##(2008-10#1)(2008-9#1)
of the reaction is##5##4##(1996-5#1)(2008-10#3)(2009-10#1)
of the reaction medium##2##4##(2008-10#2)
of the reaction of##6##4##(2008-10#6)
of the reaction products##2##4##(1996-12#1)(2008-10#1)
of the reaction system##2##4##(2008-10#1)(2011-1#1)
of the reaction was##3##4##(1996-2#1)(2008-10#1)(2008-8#1)
of the reaction were##2##4##(1997-2#1)(2008-10#1)
of the reaction with##2##4##(2008-10#2)
of the reaction##59##3##(1993-3#1)(1993-6#1)(1993-8#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-2#1)(2008-10#43)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-1#1)
of the reactions##4##3##(2008-10#3)(2013-8#1)
of the reactive##4##3##(2008-10#2)(2009-8#1)(2011-2#1)
of the reactor##4##3##(2008-10#2)(2008-11#2)
of the reagent and##3##4##(2008-10#3)
of the reagent solution in##2##5##(2008-10#2)
of the reagent##13##3##(2008-10#13)
of the reagents##5##3##(2008-10#4)(2010-3#1)
of the real##8##3##(1992-12#1)(1997-7#1)(2008-10#5)(2008-3#1)
of the reality##2##3##(2008-11#1)(2012-3#1)
of the rearing##2##3##(1990-3#1)(1991-2#1)
of the reasons for the##3##5##(1996-2#1)(2008-8#1)(2013-1#1)
of the reasons for##6##4##(1996-2#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-1#1)
of the reasons##9##3##(1991-9#1)(1996-2#1)(2008-10#2)(2008-8#1)(2010-12#1)(2012-2#2)(2013-1#1)
of the recent past and measures taken##2##7##(1991-3#2)
of the recent##13##3##(1991-3#2)(1994-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the recently described##2##4##(2008-10#1)(2008-6#1)
of the recently proposed##2##4##(2008-10#1)(2008-7#1)
of the recently##8##3##(1991-2#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
of the receptor and##3##4##(1995-6#1)(1995-8#1)(2008-4#1)
of the receptor to##2##4##(2008-10#1)(2008-4#1)
of the receptor##25##3##(1990-11#2)(1991-5#1)(1992-3#1)(1992-4#1)(1994-12#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#2)(1997-2#1)(2006-6#1)(2008-10#2)(2008-4#2)(2009-6#1)(2013-1#1)
of the receptors for##2##4##(1993-8#1)(2008-10#1)
of the receptors of##2##4##(1993-2#1)(2009-8#1)
of the receptors##5##3##(1993-2#1)(1993-8#1)(1995-11#1)(2008-10#1)(2009-8#1)
of the recipient##2##3##(2008-10#1)(2008-9#1)
of the recognition##3##3##(1995-6#1)(1995-8#1)(2008-11#1)
of the recognized##2##3##(1990-12#1)(2008-10#1)
of the recombinant E##2##4##(2008-7#1)(2011-1#1)
of the recombinant human##5##4##(1990-5#2)(1990-8#1)(1994-5#2)
of the recombinant protein was##2##5##(2008-11#1)(2008-8#1)
of the recombinant protein##6##4##(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)
of the recombinant##25##3##(1990-11#1)(1990-5#2)(1990-8#1)(1991-9#1)(1994-5#2)(2008-10#2)(2008-11#7)(2008-7#2)(2008-8#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)
of the recombinase activating gene 1##2##6##(1994-11#2)
of the recommended##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
of the reconstituted InsP(3) receptor##2##5##(2008-8#2)
of the reconstituted##3##3##(1995-2#1)(2008-8#2)
of the reconstructed image##2##4##(2007-11#2)
of the reconstructed##8##3##(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)
of the record##2##3##(1997-3#1)(2008-4#1)
of the recorded##4##3##(1994-9#1)(2008-10#3)
of the recording of##2##4##(1995-12#2)
of the recording##4##3##(1991-12#1)(1995-12#2)(2007-12#1)
of the recovered##4##3##(1993-8#1)(1995-6#1)(2008-10#2)
of the recovery##6##3##(1990-5#1)(1991-2#1)(2008-10#2)(2012-3#1)(2013-1#1)
of the rectum and##2##4##(2007-8#1)(2012-12#1)
of the rectum##7##3##(2007-12#1)(2007-8#1)(2012-12#3)(2013-8#2)
of the rectus femoris##2##4##(2008-12#1)(2011-2#1)
of the recurrent##3##3##(1991-6#1)(2008-9#2)
of the red blood cell##2##5##(1997-6#1)(2011-2#1)
of the red cell membrane##2##5##(1997-6#1)(2008-11#1)
of the red##8##3##(1997-5#1)(1997-6#2)(2008-11#1)(2008-12#1)(2008-3#2)(2011-2#1)
of the redox##8##3##(1992-8#1)(2008-10#6)(2009-8#1)
of the reduced##6##3##(1992-6#1)(1994-5#1)(1996-2#1)(2008-10#2)(2011-2#1)
of the reducing##2##3##(1992-12#1)(2008-10#1)
of the reductase was##3##4##(1996-3#2)(2008-11#1)
of the reduction of##5##4##(1996-6#1)(2008-10#3)(2008-11#1)
of the reduction product##2##4##(2008-10#2)
of the reduction##13##3##(1996-6#1)(2008-10#8)(2008-11#2)(2008-8#2)
of the reference##12##3##(2008-10#7)(2008-3#2)(2008-5#2)(2011-2#1)
of the reflected##3##3##(2008-3#3)
of the reflection##2##3##(2008-2#1)(2008-3#1)
of the refractive##5##3##(2008-2#1)(2008-3#4)
of the refractive-index##3##3##(2008-3#3)
of the regenerated gratings##2##4##(2013-8#2)
of the region of##2##4##(1995-6#1)(2010-6#1)
of the region##12##3##(1995-6#1)(1996-1#1)(1996-12#2)(1997-8#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)(2013-1#2)
of the regional##3##3##(1997-6#1)(2009-1#1)(2011-2#1)
of the regions##4##3##(1996-8#1)(1997-8#1)(2008-10#2)
of the regression analysis between observed and estimated SSR##2##9##(2008-10#2)
of the regression coefficients##2##4##(2008-10#2)
of the regression line##2##4##(2008-10#2)
of the regression models##2##4##(1990-2#1)(2010-11#1)
of the regression##11##3##(1990-2#1)(2008-10#9)(2010-11#1)
of the regulation of##5##4##(1991-9#1)(2008-10#1)(2008-11#3)
of the regulatory##8##3##(1993-8#2)(1994-8#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-7#1)(2010-11#1)
of the rehabilitation##4##3##(2008-9#1)(2010-10#1)(2013-1#2)
of the related##4##3##(1996-12#1)(1996-5#1)(2008-12#1)(2013-8#1)
of the relation between##3##4##(1993-11#1)(2008-7#1)(2010-1#1)
of the relation##4##3##(1993-11#1)(1996-2#1)(2008-7#1)(2010-1#1)
of the relations##3##3##(2010-2#2)(2010-8#1)
of the relationship between structure and function in the brain##2##10##(2009-5#2)
of the relationship between structure and##3##6##(2009-5#2)(2012-2#1)
of the relationship between the##2##5##(2008-10#1)(2012-5#1)
of the relationship between##22##4##(1992-1#1)(1992-9#1)(1994-5#1)(1995-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-7#1)(2011-10#1)(2012-2#2)(2012-5#1)
of the relationship of melancholia and the mother##2##8##(2008-12#2)
of the relationship of##4##4##(2008-10#1)(2008-12#2)(2010-10#1)
of the relationship##28##3##(1992-1#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-3#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-7#1)(2011-10#1)(2012-2#2)(2012-5#1)
of the relationships between##3##4##(1996-2#1)(2008-10#1)(2008-9#1)
of the relationships##4##3##(1993-12#1)(1996-2#1)(2008-10#1)(2008-9#1)
of the relative abundance of##2##5##(1994-11#1)(2008-8#1)
of the relative importance of##2##5##(1992-2#1)(2008-8#1)
of the relative##19##3##(1992-2#1)(1994-11#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#2)(2012-2#1)
of the relatively high##2##4##(1994-1#1)(1997-8#1)
of the relatively##6##3##(1992-3#1)(1994-1#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-6#1)
of the release of##2##4##(2008-10#1)(2008-12#1)
of the release##5##3##(2008-10#4)(2008-12#1)
of the relevant##7##3##(1993-2#1)(2008-10#2)(2008-11#1)(2010-11#1)(2012-2#1)(2013-1#1)
of the reliability##2##3##(1993-11#1)(2008-10#1)
of the remaining nidus##2##4##(2008-7#2)
of the remaining##25##3##(1990-6#1)(1991-11#1)(1992-9#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#2)(2009-8#1)(2011-2#2)(2013-1#1)
of the remarkable##2##3##(2008-11#1)(2010-10#1)
of the renal##7##3##(1991-12#1)(1996-6#1)(2008-6#1)(2011-2#2)(2011-3#1)(2013-8#1)
of the rep gene##2##4##(2008-10#2)
of the repeatability of measurements##2##5##(1996-3#1)(2008-10#1)
of the replicase##2##3##(2008-10#1)(2008-9#1)
of the replication##3##3##(1992-3#1)(1993-9#1)(2011-3#1)
of the report##2##3##(2008-11#1)(2011-2#1)
of the reported cases##3##4##(1994-9#1)(2008-1#1)(2009-3#1)
of the reported##7##3##(1994-9#1)(1997-1#1)(2008-1#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
of the reporter gene##5##4##(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#1)
of the reporter##7##3##(2008-10#1)(2008-11#4)(2008-9#1)(2011-1#1)
of the reporting forms##2##4##(2012-12#2)
of the reporting##4##3##(1994-2#1)(2012-12#3)
of the reports##2##3##(2008-11#2)
of the representation##2##3##(2009-10#1)(2012-3#1)
of the reproductive##5##3##(1993-2#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)
of the required##3##3##(1994-12#1)(1995-6#1)(2012-2#1)
of the requirements for##2##4##(2010-12#1)(2013-1#1)
of the requirements of##2##4##(1996-1#1)(2008-7#1)
of the requirements##5##3##(1993-11#1)(1996-1#1)(2008-7#1)(2010-12#1)(2013-1#1)
of the research on##2##4##(2009-7#1)(2013-1#1)
of the research was to##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
of the research was##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
of the research were##2##4##(2008-10#2)
of the research##23##3##(1990-11#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#2)(2009-4#2)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#3)
of the researcher's##2##3##(1997-1#1)(2008-4#1)
of the researchers##2##3##(2010-9#1)(2011-2#1)
of the resected specimen showed##2##5##(2008-10#1)(2011-2#1)
of the resected##3##3##(1997-3#1)(2008-10#1)(2011-2#1)
of the resident##2##3##(2008-10#1)(2008-4#1)
of the residual##2##3##(2008-10#1)(2010-12#1)
of the residuals##3##3##(1995-9#1)(2008-10#2)
of the residue##3##3##(2008-10#3)
of the resin and the##2##5##(2008-10#1)(2010-4#1)
of the resin for the##2##5##(2008-10#2)
of the resin for##5##4##(2008-10#5)
of the resin material##2##4##(2008-10#2)
of the resin##18##3##(2008-10#17)(2010-4#1)
of the resin-phase##2##3##(2008-10#2)
of the resins##3##3##(2008-10#2)(2008-5#1)
of the resistance gene##2##4##(2008-10#2)
of the resistance genes##3##4##(2008-10#3)
of the resistance##13##3##(2008-10#12)(2012-3#1)
of the resistant genotype##2##4##(2008-10#2)
of the resistant lines##2##4##(2008-10#2)
of the resistant##13##3##(2008-10#12)(2008-11#1)
of the resonance##2##3##(1990-8#1)(2008-10#1)
of the resonant##2##3##(2008-10#1)(2008-3#1)
of the resources##2##3##(1994-3#1)(2008-8#1)
of the respective##13##3##(1990-12#1)(1992-9#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
of the respiratory burst##2##4##(1993-6#1)(1994-6#1)
of the respiratory chain##2##4##(1995-11#2)
of the respiratory system##4##4##(1996-3#1)(2008-5#2)(2010-7#1)
of the respiratory tract##3##4##(1994-12#2)(2008-10#1)
of the respiratory##14##3##(1991-6#1)(1993-6#1)(1994-12#2)(1994-6#1)(1995-11#2)(1996-3#1)(1996-5#1)(1997-5#1)(2008-10#1)(2008-5#2)(2010-7#1)
of the respondents had##2##4##(2013-1#1)(2013-8#1)
of the respondents##10##3##(1994-1#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#2)(2013-1#2)(2013-8#1)
of the responders##3##3##(1997-8#2)(2011-2#1)
of the response in##2##4##(1994-8#1)(1997-3#1)
of the response of M##2##5##(2008-10#2)
of the response of##10##4##(1997-8#1)(2008-10#7)(2008-11#1)(2013-7#1)
of the response to##3##4##(1990-11#1)(1995-11#1)(2008-1#1)
of the response##30##3##(1990-11#1)(1990-5#1)(1992-6#1)(1994-8#2)(1995-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
of the responses of the##2##5##(1997-2#1)(2008-10#1)
of the responses of##3##4##(1997-2#1)(2008-10#1)(2009-8#1)
of the responses##7##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)
of the resting##3##3##(1992-6#1)(1994-3#1)(2013-8#1)
of the resultant##6##3##(1994-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
of the resulting modified##2##4##(2008-10#2)
of the resulting##32##3##(1992-12#1)(1993-8#1)(1995-2#1)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
of the results and##3##4##(1996-5#1)(2008-4#1)(2011-2#1)
of the results for##3##4##(2008-10#2)(2009-7#1)
of the results is##4##4##(1991-12#1)(2008-11#1)(2008-4#1)(2011-7#1)
of the results obtained by the##2##6##(2008-10#2)
of the results obtained by##3##5##(2008-10#3)
of the results obtained for##2##5##(2008-10#2)
of the results obtained##8##4##(1991-3#1)(1992-6#1)(1993-8#1)(2008-10#5)
of the results of the##4##5##(1991-3#1)(1993-1#1)(2008-4#1)(2011-2#1)
of the results of##12##4##(1991-3#1)(1991-9#1)(1993-1#1)(1995-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
of the results to##2##4##(1994-2#1)(2008-4#1)
of the results was##3##4##(2008-10#3)
of the results were##2##4##(2008-10#2)
of the results##58##3##(1991-12#2)(1991-3#2)(1991-9#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-6#1)(2008-10#25)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#2)(2011-3#1)(2011-7#1)(2013-1#3)
of the retained##3##3##(1991-3#1)(2008-10#1)(2009-12#1)
of the retention##4##3##(2008-10#4)
of the retina##3##3##(2011-2#2)(2011-7#1)
of the retinal##3##3##(2008-3#1)(2010-10#1)(2011-7#1)
of the retrieval##2##3##(2008-11#1)(2008-3#1)
of the retrieved##4##3##(2008-3#3)(2008-8#1)
of the review##6##3##(1992-1#2)(1994-8#1)(2008-10#1)(2008-11#2)
of the revised##2##3##(1992-1#1)(2010-5#1)
of the reward##2##3##(1993-6#1)(2010-10#1)
of the rhythm to##2##4##(1994-2#1)(2008-5#1)
of the rhythm##3##3##(1994-2#1)(2008-5#2)
of the ribosomal DNA##3##4##(2008-10#3)
of the ribosomal genes##2##4##(2008-10#2)
of the ribosomal##8##3##(2008-10#8)
of the ribozyme in##2##4##(1993-9#1)(2008-9#1)
of the ribozyme##6##3##(1993-9#3)(1994-11#2)(2008-9#1)
of the rice blast fungus##3##5##(2008-10#3)
of the rice##9##3##(2008-10#4)(2008-8#1)(2008-9#4)
of the right breast##2##4##(1994-12#1)(2008-10#1)
of the right eye##2##4##(2012-2#1)(2013-7#1)
of the right hemisphere##3##4##(1996-2#3)
of the right middle cerebral artery##3##6##(1996-3#1)(2008-7#2)
of the right middle##4##4##(1996-3#2)(2008-7#2)
of the right pulmonary artery##3##5##(1997-5#1)(2008-11#1)(2010-10#1)
of the right ventricle in##2##5##(2008-11#1)(2009-10#1)
of the right ventricle##4##4##(2008-11#1)(2009-10#1)(2010-10#1)(2012-3#1)
of the right##37##3##(1991-11#1)(1991-6#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-2#3)(1996-3#2)(1997-5#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-12#5)(2008-7#4)(2009-10#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-2#1)(2013-7#1)(2013-8#1)
of the risk factors for##2##5##(2008-10#1)(2010-10#1)
of the risk factors##3##4##(1993-2#1)(2008-10#1)(2010-10#1)
of the risk of##10##4##(1994-2#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the risk##21##3##(1992-11#1)(1992-3#1)(1993-2#1)(1994-2#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
of the risks##4##3##(2008-4#1)(2010-10#1)(2010-12#2)
of the robust##2##3##(2008-10#2)
of the rock##2##3##(2008-10#2)
of the rodenticides warfarin##2##4##(2008-10#2)
of the role of##25##4##(1990-9#1)(1992-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1997-5#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
of the role##32##3##(1990-9#1)(1992-1#1)(1992-10#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
of the romance##2##3##(2012-2#2)
of the root bark of##2##5##(2008-10#1)(2008-11#1)
of the root cap##2##4##(2008-10#1)(2009-8#1)
of the root system##3##4##(2008-10#3)
of the root##18##3##(2008-10#13)(2008-11#1)(2009-8#2)(2012-3#1)(2013-1#1)
of the root-knot nematode Meloidogyne javanica##2##6##(2008-10#2)
of the root-knot nematode Meloidogyne##3##5##(2008-10#3)
of the roots of##3##4##(2008-10#1)(2010-6#1)(2013-1#1)
of the roots##7##3##(1995-9#1)(2008-10#3)(2008-9#1)(2010-6#1)(2013-1#1)
of the rosy bitterling##2##4##(2008-5#2)
of the rough endoplasmic reticulum##2##5##(2008-7#2)
of the routine investigations##2##4##(2008-9#1)(2010-6#1)
of the routine##4##3##(1993-2#1)(1994-6#1)(2008-9#1)(2010-6#1)
of the ryanodine sensitive ion channel##2##6##(1994-8#2)
of the ryanodine##3##3##(1994-8#3)
of the sac##3##3##(1995-11#2)(2007-12#1)
of the saccharide##2##3##(1991-7#1)(2008-10#1)
of the sacroiliac##2##3##(2011-2#2)
of the safety of##2##4##(1990-11#1)(1995-5#1)
of the safety##4##3##(1990-11#1)(1995-5#1)(2011-1#1)(2011-2#1)
of the said##2##3##(2008-10#2)
of the saline##2##3##(2008-10#1)(2013-8#1)
of the salivary##4##3##(2008-4#2)(2009-3#2)
of the salt##2##3##(2008-10#1)(2008-4#1)
of the same age group##2##5##(1990-2#1)(2011-2#1)
of the same age##6##4##(1990-2#1)(1991-11#1)(1991-9#1)(1996-6#1)(2008-7#1)(2011-2#1)
of the same brand##2##4##(2008-10#1)(2013-1#1)
of the same family##5##4##(1997-4#1)(2008-10#2)(2008-5#1)(2012-12#1)
of the same length##2##4##(2008-9#1)(2011-2#1)
of the same magnitude##2##4##(1993-2#1)(2008-10#1)
of the same or##2##4##(2008-10#1)(2008-8#1)
of the same order##2##4##(1991-2#1)(1991-5#1)
of the same population##2##4##(2008-10#2)
of the same sample##2##4##(2008-10#2)
of the same size##5##4##(1997-2#1)(2008-10#2)(2008-11#1)(2009-1#1)
of the same species##6##4##(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2012-2#1)
of the same type##2##4##(2008-11#1)(2008-9#1)
of the same##122##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-2#1)(1996-1#1)(1996-2#2)(1996-6#2)(1997-2#2)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#45)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#2)(2013-1#2)
of the sample and of##2##5##(2008-10#2)
of the sample and##9##4##(1997-2#1)(2008-10#7)(2009-8#1)
of the sample in##5##4##(2008-10#4)(2008-9#1)
of the sample introduction##2##4##(2008-10#2)
of the sample is##4##4##(1995-12#1)(2008-10#3)
of the sample matrix##3##4##(2008-10#3)
of the sample plug##2##4##(2008-10#2)
of the sample solution on##2##5##(2008-10#2)
of the sample solution was##2##5##(2008-10#2)
of the sample solution##11##4##(2008-10#11)
of the sample to##3##4##(2008-10#3)
of the sample treated##2##4##(2008-9#1)(2013-1#1)
of the sample was##3##4##(2008-10#2)(2013-8#1)
of the sample with##2##4##(2008-10#2)
of the sample zone##2##4##(2008-10#2)
of the sample##96##3##(1990-12#1)(1991-2#1)(1992-2#1)(1993-1#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-10#81)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-8#1)(2013-1#1)(2013-8#1)
of the sample)##2##3##(2008-10#1)(2012-3#1)
of the samples and##5##4##(2008-10#4)(2008-11#1)
of the samples are##2##4##(2008-10#2)
of the samples by##2##4##(2008-10#2)
of the samples did not##2##5##(2008-10#1)(2008-11#1)
of the samples have##2##4##(2008-10#2)
of the samples in MeOH##2##5##(2008-10#2)
of the samples in##6##4##(2008-10#6)
of the samples is##2##4##(2008-10#2)
of the samples of##2##4##(2008-10#2)
of the samples studied##2##4##(1996-12#1)(2008-10#1)
of the samples was##3##4##(2008-10#3)
of the samples were##4##4##(2008-10#3)(2008-12#1)
of the samples with##3##4##(2008-10#3)
of the samples##71##3##(1990-12#1)(1995-11#1)(1996-12#1)(2008-10#52)(2008-11#5)(2008-12#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-2#1)
of the sampling##6##3##(2008-10#3)(2008-11#1)(2008-3#2)
of the satellite##2##3##(2008-3#2)
of the saturated##2##3##(2008-11#1)(2008-3#1)
of the scaffold##2##3##(2009-7#2)
of the scale parameter##2##4##(1996-3#2)
of the scale##6##3##(1996-3#2)(2008-11#1)(2008-9#2)(2009-10#1)
of the scalp##3##3##(2008-5#1)(2008-9#2)
of the scandium-alizarin red S complex onto a carbon paste electrode##2##11##(2008-10#2)
of the scapular##2##3##(2010-9#1)(2012-3#1)
of the scattered##2##3##(2008-3#1)(2009-11#1)
of the scattering##4##3##(2008-2#1)(2008-3#3)
of the scheme is##2##4##(2008-2#1)(2008-3#1)
of the scheme##4##3##(1991-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
of the school##4##3##(1990-6#1)(1991-12#1)(2008-12#1)(2010-1#1)
of the science##5##3##(1997-1#1)(2008-10#1)(2009-5#2)(2010-9#1)
of the scientific##6##3##(1996-6#1)(2008-10#2)(2008-3#1)(2009-10#1)(2012-2#1)
of the score and##2##4##(2008-10#1)(2012-3#1)
of the scores##2##3##(2008-11#2)
of the screening##8##3##(1990-2#2)(1992-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#1)
of the screws##3##3##(1991-9#1)(2007-11#1)(2008-10#1)
of the scute##2##3##(2008-7#2)
of the sea##2##3##(2008-11#1)(2008-2#1)
of the search##2##3##(2008-6#1)(2012-3#1)
of the season##6##3##(2008-10#3)(2008-8#3)
of the seasonal ascospore release occurred##2##6##(2008-10#2)
of the second and third##3##5##(1993-12#1)(2008-5#1)(2013-1#1)
of the second one##2##4##(2008-10#1)(2009-8#1)
of the second order##2##4##(2008-10#1)(2008-11#1)
of the second##36##3##(1990-8#1)(1991-8#1)(1992-3#1)(1993-12#2)(1993-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-8#1)(2011-2#2)(2013-1#2)
of the second-order advantage##2##4##(2008-10#2)
of the second-order##3##3##(1993-8#1)(2008-10#2)
of the secondary##8##3##(1991-3#1)(1995-11#1)(2006-6#1)(2007-12#1)(2008-10#2)(2012-12#1)(2012-2#1)
of the secreted##2##3##(1997-1#1)(2008-11#1)
of the secretion##2##3##(2006-6#1)(2008-11#1)
of the secretory##6##3##(1991-5#1)(2007-12#2)(2008-11#1)(2008-7#2)
of the sections##2##3##(2008-4#1)(2009-1#1)
of the sector##2##3##(1995-3#1)(2008-10#1)
of the security##4##3##(1993-12#1)(1994-12#1)(1994-2#1)(2010-8#1)
of the sediment##2##3##(1996-12#1)(2008-10#1)
of the seed lots##2##4##(2008-10#2)
of the seed oils##2##4##(2008-11#2)
of the seed##12##3##(2008-10#5)(2008-11#3)(2008-2#2)(2009-10#1)(2013-8#1)
of the seedlings##2##3##(2008-10#1)(2011-10#1)
of the segment##2##3##(2007-12#1)(2008-10#1)
of the seizure##2##3##(2008-7#1)(2010-12#1)
of the selected##11##3##(2008-10#4)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
of the selection##4##3##(1997-1#1)(2008-10#2)(2008-11#1)
of the selective##5##3##(1994-5#1)(2008-10#2)(2008-3#1)(2012-3#1)
of the selenium##4##3##(2008-10#4)
of the self##3##3##(2008-11#2)(2012-2#1)
of the self-assembled##2##3##(2008-10#2)
of the sellar region##5##4##(2012-3#5)
of the seminal vesicle##4##4##(2008-11#2)(2011-2#2)
of the seminal##6##3##(1997-8#1)(2008-11#2)(2008-9#1)(2011-2#2)
of the seminiferous epithelial cycle##2##5##(2009-10#2)
of the seminiferous epithelium##4##4##(2009-10#4)
of the seminiferous##8##3##(2008-7#1)(2009-10#6)(2012-2#1)
of the sense##2##3##(1994-11#1)(2008-7#1)
of the sensing film##3##4##(2008-10#3)
of the sensing##9##3##(2008-10#7)(2011-1#1)(2013-8#1)
of the sensitive##3##3##(2008-10#2)(2008-11#1)
of the sensitivity of the##4##5##(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#1)
of the sensitivity of##6##4##(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-3#1)
of the sensitivity##8##3##(1993-8#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-6#1)
of the sensor for##3##4##(2008-10#3)
of the sensor is 6##2##5##(2008-10#2)
of the sensor is about##2##5##(2008-10#2)
of the sensor is##8##4##(2008-10#8)
of the sensor response##3##4##(2008-10#3)
of the sensor was evaluated##2##5##(2008-10#2)
of the sensor was##9##4##(2008-10#9)
of the sensor were##3##4##(2008-10#3)
of the sensor##58##3##(2008-10#57)(2008-3#1)
of the sensors##3##3##(2008-10#3)
of the sensory##7##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
of the separate##2##3##(1995-5#1)(2008-10#1)
of the separated analytes##2##4##(2008-10#2)
of the separated##3##3##(2008-10#3)
of the separation channel##2##4##(2008-10#2)
of the separation of##2##4##(2008-10#2)
of the separation##9##3##(2008-10#9)
of the septum##2##3##(1994-8#1)(1997-3#1)
of the sequence of events##2##5##(2008-11#1)(2012-3#1)
of the sequence of##5##4##(2008-10#1)(2008-11#2)(2009-10#1)(2012-3#1)
of the sequence revealed that##2##5##(1990-2#1)(1996-12#1)
of the sequence revealed##3##4##(1990-2#1)(1996-12#1)(1996-3#1)
of the sequence##18##3##(1990-2#1)(1991-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#1)(2009-10#1)(2012-3#1)
of the sequenced##4##3##(1995-8#1)(1997-6#1)(1997-8#1)(2008-8#1)
of the sequences of##3##4##(1995-11#1)(1997-8#1)(2010-4#1)
of the sequences##11##3##(1991-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#2)(2010-4#1)
of the sequencing##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
of the sequential injection##2##4##(2008-10#2)
of the sequential##4##3##(2008-10#3)(2008-11#1)
of the series of##2##4##(1994-8#1)(2011-2#1)
of the series##5##3##(1994-8#1)(2008-10#2)(2011-2#2)
of the serine##3##3##(1993-3#1)(1997-1#1)(2009-10#1)
of the serious##3##3##(2009-6#2)(2012-12#1)
of the serotonin transporter##2##4##(2012-3#2)
of the serum triglyceride##2##4##(1991-12#2)
of the serum##14##3##(1991-12#2)(1991-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
of the service##4##3##(1992-12#1)(1992-2#1)(1995-2#1)(2011-2#1)
of the session##2##3##(1991-12#1)(2008-6#1)
of the set of##4##4##(2008-10#2)(2008-5#1)(2008-8#1)
of the set##8##3##(1992-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2013-1#1)
of the settlement##2##3##(1995-12#1)(2008-9#1)
of the seven##14##3##(1996-6#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
of the several##2##3##(2008-10#1)(2012-3#1)
of the severe##2##3##(2008-10#1)(2008-11#1)
of the severity of##2##4##(2009-5#1)(2010-8#1)
of the severity##3##3##(2009-5#1)(2009-8#1)(2010-8#1)
of the sex pheromone##2##4##(2008-10#2)
of the sex##3##3##(1990-2#1)(2008-10#2)
of the sexual##7##3##(1992-9#1)(1993-3#1)(1996-3#1)(2008-10#3)(2008-12#1)
of the sexually##2##3##(1992-3#1)(1995-5#1)
of the shampoo##2##3##(2008-10#1)(2008-5#1)
of the shape##2##3##(1993-3#1)(1995-9#1)
of the sheath##4##3##(2007-12#1)(2008-10#3)
of the sheep##2##3##(1996-12#1)(2008-10#1)
of the shift##2##3##(2007-12#1)(2011-2#1)
of the shoot##2##3##(2008-10#1)(2008-8#1)
of the short##4##3##(2008-7#1)(2009-10#1)(2009-6#1)(2012-3#1)
of the shoulder##10##3##(1990-12#1)(1997-5#2)(1997-6#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
of the side chain of##2##5##(1992-1#1)(2008-10#1)
of the side chain##3##4##(1992-1#1)(2008-10#1)(2008-9#1)
of the side chains##2##4##(1993-12#1)(2008-10#1)
of the side##8##3##(1992-1#1)(1993-12#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)
of the sigmoid colon##3##4##(1991-6#1)(2010-12#1)(2011-2#1)
of the signal sequence##4##4##(1991-6#2)(2008-11#2)
of the signal transducers and activators of transcription##2##8##(1996-2#1)(2011-2#1)
of the signal was##2##4##(2008-10#1)(2008-3#1)
of the signal##24##3##(1991-6#2)(1995-12#1)(1995-6#1)(1996-2#2)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#5)(2008-6#1)(2009-4#1)(2009-8#1)(2011-2#1)
of the signal-to-noise##2##3##(2008-10#1)(2008-3#1)
of the signals##2##3##(1994-6#1)(2008-10#1)
of the significance of the##2##5##(2008-7#1)(2012-3#1)
of the significance of##3##4##(1991-12#1)(2008-7#1)(2012-3#1)
of the significant##5##3##(1992-2#1)(2008-10#3)(2008-12#1)
of the silica gel##2##4##(2008-10#2)
of the silica##9##3##(2008-10#9)
of the silicon##3##3##(2008-10#2)(2008-8#1)
of the silkmoth##2##3##(2008-6#1)(2008-7#1)
of the silkworm##4##3##(1995-11#2)(2008-11#1)(2008-9#1)
of the silver##3##3##(2008-10#2)(2008-3#1)
of the simian immunodeficiency virus##2##5##(1992-6#1)(1997-3#1)
of the simian##3##3##(1992-6#1)(1997-3#1)(2008-9#1)
of the simple##3##3##(1990-5#1)(2008-10#1)(2008-8#1)
of the simplest##4##3##(2008-10#2)(2008-8#1)(2009-8#1)
of the simulation##2##3##(2008-10#1)(2008-3#1)
of the single##7##3##(1993-6#1)(1995-6#1)(1996-12#1)(2008-8#1)(2009-5#2)(2013-1#1)
of the single-frequency##2##3##(2008-2#2)
of the sinus of Valsalva and of the ascending aorta##3##10##(1997-5#3)
of the sinus##5##3##(1996-9#1)(1997-5#3)(2008-5#1)
of the site of##5##4##(1994-5#2)(1997-7#1)(2008-10#1)(2008-11#1)
of the site##10##3##(1994-5#2)(1995-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2013-1#1)
of the situation##4##3##(1993-1#1)(2008-7#1)(2009-8#1)(2010-7#1)
of the six##18##3##(1990-5#1)(1991-6#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#2)(2010-6#1)(2011-3#1)(2013-8#1)
of the size and##2##4##(2008-8#1)(2013-1#1)
of the size distribution##2##4##(2008-10#1)(2008-11#1)
of the size of the##3##5##(1997-2#1)(2008-10#1)(2009-10#1)
of the size of##4##4##(1993-8#1)(1997-2#1)(2008-10#1)(2009-10#1)
of the size##9##3##(1993-8#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2013-1#1)
of the skeletal muscle##2##4##(1992-3#1)(1993-8#1)
of the skill##3##3##(2007-12#1)(2008-11#2)
of the skin and##5##4##(1991-11#1)(2008-1#1)(2008-5#3)
of the skin before and after##2##6##(2008-10#2)
of the skin or##2##4##(2008-10#1)(2008-5#1)
of the skin over##2##4##(2008-10#1)(2008-5#1)
of the skin surface and##2##5##(2008-5#2)
of the skin surface##5##4##(2008-5#5)
of the skin##68##3##(1990-6#2)(1991-11#1)(1991-8#1)(1993-3#1)(1995-11#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#40)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#2)(2010-6#1)(2011-2#4)(2012-3#1)(2013-8#1)
of the skin's##2##3##(2008-5#2)
of the skull base##3##4##(2008-7#2)(2011-2#1)
of the skull##7##3##(1994-2#1)(2008-7#2)(2008-9#1)(2011-2#2)(2013-1#1)
of the sky##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of the slab is##2##4##(1995-6#2)
of the slab##3##3##(1995-6#3)
of the sleeve##2##3##(2008-11#2)
of the slope##2##3##(2008-10#2)
of the small bowel##8##4##(1990-11#2)(2009-1#1)(2010-12#2)(2011-2#3)
of the small intestine and##2##5##(2010-12#1)(2011-2#1)
of the small intestine##6##4##(1990-11#1)(1992-5#1)(1995-12#1)(2010-11#1)(2010-12#1)(2011-2#1)
of the small##26##3##(1990-11#3)(1990-2#1)(1992-5#2)(1994-11#1)(1995-11#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-1#2)(2010-11#1)(2010-12#3)(2011-2#4)
of the smaller##2##3##(1990-11#1)(2012-2#1)
of the smallest##2##3##(2008-5#1)(2011-2#1)
of the smokers##2##3##(1990-6#1)(1993-2#1)
of the smoking##2##3##(1996-3#1)(2013-1#1)
of the so-called##6##3##(2007-12#1)(2008-10#3)(2008-11#2)
of the social##9##3##(1993-11#1)(1995-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#2)
of the society##2##3##(2008-10#1)(2012-2#1)
of the sodium##5##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
of the soft tissues##3##4##(2009-4#1)(2012-2#1)(2013-1#1)
of the soft##7##3##(1991-3#1)(2008-10#2)(2009-4#1)(2012-2#1)(2013-1#2)
of the soil microbial community##2##5##(2008-10#2)
of the soil##10##3##(2008-10#9)(2008-11#1)
of the soils##2##3##(2008-10#2)
of the sol-gel##3##3##(2008-10#3)
of the solid content of the porous material##2##8##(2008-3#2)
of the solid phase##2##4##(1990-12#1)(2008-10#1)
of the solid solution##2##4##(2007-11#1)(2008-10#1)
of the solid##14##3##(1990-12#1)(2007-11#1)(2008-10#9)(2008-2#1)(2008-3#2)
of the solubility of##2##4##(2008-10#1)(2008-5#1)
of the solubility##5##3##(2008-10#4)(2008-5#1)
of the soluble##8##3##(1990-2#1)(1992-6#1)(1994-6#1)(1996-2#1)(1996-8#1)(2008-11#2)(2008-9#1)
of the solute and the##2##5##(2008-10#2)
of the solute in the##2##5##(2008-10#2)
of the solute##8##3##(2008-10#7)(2008-3#1)
of the solutes##3##3##(2008-10#3)
of the solution and##2##4##(2008-10#2)
of the solution from the##2##5##(2008-10#2)
of the solution was##3##4##(2008-10#2)(2013-1#1)
of the solution##29##3##(1990-5#1)(1995-3#1)(1996-3#1)(2008-10#22)(2008-9#1)(2009-10#1)(2009-9#1)(2013-1#1)
of the solutions##9##3##(1991-1#1)(1997-4#1)(2008-10#6)(2008-5#1)
of the solvation##2##3##(2010-7#1)(2011-3#1)
of the solvent and the##2##5##(2008-10#2)
of the solvent systems##2##4##(2008-10#2)
of the solvent##16##3##(2008-10#13)(2008-3#1)(2008-7#1)(2013-1#1)
of the solvents##2##3##(2008-10#2)
of the somatic##2##3##(2007-12#1)(2008-7#1)
of the somatosensory##2##3##(1994-3#1)(2008-5#1)
of the sorbed##2##3##(2008-10#2)
of the sorbent##5##3##(2008-10#5)
of the sorghum##2##3##(2008-10#2)
of the sorption of##2##4##(2008-10#2)
of the sorption##4##3##(2008-10#4)
of the sound##2##3##(2008-2#1)(2013-8#1)
of the source population##2##4##(2008-10#2)
of the source##10##3##(2007-11#1)(2008-10#6)(2008-3#3)
of the sources##2##3##(1990-11#1)(2008-10#1)
of the southern red tabira bitterling Acheilognathus tabira jordani##2##9##(2010-8#2)
of the southern##5##3##(2008-10#1)(2008-8#1)(2010-8#2)(2011-2#1)
of the soybean fields in##2##5##(2008-10#2)
of the soybean##3##3##(2008-10#3)
of the spacer##4##3##(1995-8#1)(2008-10#2)(2008-3#1)
of the spatial##14##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#2)(2009-10#2)
of the spatially varying##2##4##(2008-3#1)(2013-1#1)
of the spatially##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
of the special##4##3##(1993-3#1)(1996-3#1)(2008-4#1)(2008-8#1)
of the specialist##2##3##(1993-5#1)(2008-7#1)
of the specialized##2##3##(1992-6#1)(1995-6#1)
of the species are##3##4##(2008-11#1)(2008-8#1)(2010-8#1)
of the species in the##2##5##(2008-10#2)
of the species in##4##4##(2008-10#3)(2012-5#1)
of the species was##2##4##(2008-10#1)(2011-2#1)
of the species##37##3##(1995-6#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#2)(2012-5#1)
of the specific microbe##2##4##(2011-2#2)
of the specific##27##3##(1993-8#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#2)(2012-2#1)
of the specimen##3##3##(2009-7#1)(2012-12#1)(2013-8#1)
of the specimens##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
of the speckle##3##3##(2007-12#1)(2008-3#2)
of the spectra of##2##4##(2008-10#1)(2008-8#1)
of the spectral##7##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-8#1)
of the spectrometer##6##3##(2008-10#6)
of the spectrophotometric##2##3##(2008-10#2)
of the spectroscopic##2##3##(2008-10#2)
of the spectrum of##2##4##(2008-11#1)(2012-2#1)
of the spectrum##11##3##(2008-10#3)(2008-11#1)(2008-2#1)(2011-2#3)(2012-2#1)(2013-8#2)
of the specular peak perpendicular to the principal plane##2##9##(2008-3#2)
of the sperm##6##3##(1994-8#2)(2008-7#1)(2008-8#2)(2012-2#1)
of the spermatozoa##3##3##(2008-7#1)(2008-8#2)
of the sphenoid sinus##3##4##(2008-7#2)(2012-3#1)
of the sphenoid##4##3##(2008-7#3)(2012-3#1)
of the spike##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
of the spiked amount##2##4##(2008-10#2)
of the spiked mercury(II)##2##4##(2008-10#2)
of the spiked##14##3##(2008-10#14)
of the spin##2##3##(1993-8#1)(2009-5#1)
of the spinach##2##3##(2008-10#2)
of the spinal arteriovenous malformation (AVM)##2##6##(2008-7#1)(2013-1#1)
of the spinal cord and the##2##6##(1992-12#1)(2008-7#1)
of the spinal cord##7##4##(1991-6#1)(1992-12#1)(1996-12#1)(1996-9#1)(2008-7#1)(2011-2#1)(2012-3#1)
of the spinal##16##3##(1991-6#1)(1992-12#2)(1996-12#1)(1996-9#1)(2007-11#1)(2008-7#4)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
of the spindle cell##2##4##(2008-10#1)(2011-2#1)
of the spindle##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
of the spine and##3##4##(1991-11#1)(2008-8#1)(2010-1#1)
of the spine##13##3##(1991-11#1)(1996-6#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-3#1)(2011-2#2)
of the spleen and##2##4##(1990-3#1)(2012-3#1)
of the spleen##6##3##(1990-3#1)(1992-5#1)(1994-9#1)(2008-9#1)(2012-2#1)(2012-3#1)
of the splenic##3##3##(1993-12#2)(2011-2#1)
of the splenocolic##2##3##(1990-3#2)
of the spliceosome by##2##4##(2008-2#2)
of the spontaneous##2##3##(1990-3#1)(2008-11#1)
of the spore##2##3##(2008-10#2)
of the spores were##2##4##(2008-10#2)
of the spores##6##3##(2008-10#5)(2011-2#1)
of the sporocysts##2##3##(1996-12#2)
of the spot##2##3##(2008-10#2)
of the spread of##2##4##(1996-3#1)(2008-10#1)
of the square wave##3##4##(2008-10#3)
of the square##4##3##(2008-10#4)
of the stability constant##3##4##(2008-10#3)
of the stability constants for##2##5##(2008-10#2)
of the stability constants of##2##5##(2008-10#2)
of the stability constants##4##4##(2008-10#4)
of the stability of the##2##5##(2008-10#2)
of the stability of##6##4##(2008-10#3)(2008-5#1)(2008-8#1)(2009-12#1)
of the stability##14##3##(2008-10#11)(2008-5#1)(2008-8#1)(2009-12#1)
of the stable##4##3##(1995-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
of the staff and##2##4##(1996-3#1)(2008-12#1)
of the staff##4##3##(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#1)
of the stage of##2##4##(1996-8#1)(2012-3#1)
of the staining##2##3##(2008-9#2)
of the standard additions method in flame atomic absorption spectrometry##2##10##(2008-10#2)
of the standard additions method##5##5##(2008-10#5)
of the standard##25##3##(1995-9#1)(1996-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-11#1)(2012-3#1)(2013-1#1)
of the standards##2##3##(1996-3#1)(2008-10#1)
of the starch##2##3##(2008-8#1)(2009-8#1)
of the starting##5##3##(1991-5#1)(2008-10#2)(2008-4#1)(2008-5#1)
of the startle##2##3##(2008-11#2)
of the state of the##2##5##(2008-10#1)(2008-7#1)
of the state of##5##4##(1991-2#1)(1993-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
of the state##12##3##(1990-12#1)(1991-2#1)(1993-2#1)(1996-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
of the state's##2##3##(1991-8#1)(1992-8#1)
of the static##3##3##(1993-9#1)(2008-6#1)(2013-8#1)
of the stationary phase and##2##5##(2008-10#1)(2008-7#1)
of the stationary phase##9##4##(2008-10#6)(2008-7#2)(2011-2#1)
of the stationary##10##3##(2008-10#6)(2008-3#1)(2008-7#2)(2011-2#1)
of the statistic##2##3##(2008-10#2)
of the statistical##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
of the status of the##2##5##(1995-3#1)(2009-12#1)
of the statutory##2##3##(1992-12#1)(2008-10#1)
of the stay##2##3##(1992-12#2)
of the steady-state##2##3##(1993-6#1)(2008-10#1)
of the stem cell##4##4##(1992-12#1)(1994-11#1)(2008-11#1)(2012-2#1)
of the stem to##2##4##(2008-10#2)
of the stem##15##3##(1992-12#1)(1992-3#2)(1994-11#1)(2008-10#4)(2008-11#3)(2009-4#1)(2009-6#1)(2012-2#1)(2013-1#1)
of the steps##2##3##(1995-9#1)(2010-1#1)
of the steroid binding##2##4##(1990-12#1)(1991-12#1)
of the steroid##9##3##(1990-11#2)(1990-12#1)(1991-12#1)(2008-10#1)(2008-11#3)(2008-4#1)
of the sterols##2##3##(1997-2#2)
of the stigma##2##3##(2008-10#2)
of the stimulation##2##3##(2008-5#1)(2010-10#1)
of the stimuli##3##3##(1993-3#1)(2008-9#1)(2013-8#1)
of the stimulus##2##3##(1996-2#1)(2008-11#1)
of the stoichiometric##2##3##(2008-10#2)
of the stomach with##2##4##(1991-8#1)(1992-6#1)
of the stomach##17##3##(1990-9#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-9#1)(1997-1#2)(2008-12#2)(2008-5#1)(2009-5#1)(2010-6#1)(2012-3#1)
of the storage##2##3##(2008-10#1)(2008-11#1)
of the straight line##2##4##(2008-10#2)
of the straight##4##3##(1996-6#1)(2008-10#3)
of the strain##4##3##(2008-10#1)(2008-8#2)(2011-2#1)
of the strains produced##2##4##(2008-10#2)
of the strains that##2##4##(2008-10#2)
of the strains were##5##4##(2008-10#3)(2008-12#1)(2011-2#1)
of the strains##24##3##(1991-3#1)(1996-12#1)(1997-9#1)(2008-10#16)(2008-12#1)(2008-5#1)(2010-4#2)(2011-2#1)
of the strategies##3##3##(1991-12#1)(1997-7#1)(2008-10#1)
of the strategy##4##3##(1992-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the stratum corneum (SC)##3##5##(2008-10#1)(2008-5#2)
of the stratum corneum lipids##3##5##(2008-5#3)
of the stratum corneum of##2##5##(2008-5#2)
of the stratum corneum##26##4##(2008-10#1)(2008-5#25)
of the strawberry##2##3##(2008-10#2)
of the stream##2##3##(1995-3#1)(2009-8#1)
of the streams##3##3##(2008-10#3)
of the stress##8##3##(1994-2#1)(1995-1#1)(2008-11#3)(2008-4#1)(2009-7#1)(2010-11#1)
of the stress-induced##2##3##(1994-2#2)
of the stress-responsive##2##3##(1996-2#1)(2009-10#1)
of the stressful##2##3##(2008-11#1)(2012-3#1)
of the stressor##3##3##(2008-11#2)(2008-4#1)
of the stressosome##2##3##(2009-8#2)
of the striatum##3##3##(1997-3#2)(2013-8#1)
of the stroke##2##3##(2010-12#1)(2011-1#1)
of the strong##5##3##(2008-10#3)(2008-11#1)(2013-1#1)
of the strongly##2##3##(2008-10#1)(2009-5#1)
of the structural##8##3##(1991-6#1)(2008-10#4)(2008-3#1)(2008-8#2)
of the structurally##2##3##(1993-2#1)(2008-10#1)
of the structure and##3##4##(1992-12#1)(2008-10#1)(2008-5#1)
of the structure of the##4##5##(1994-11#1)(1996-12#1)(2010-4#1)(2010-8#1)
of the structure of##7##4##(1990-9#1)(1991-6#1)(1992-9#1)(1994-11#1)(1996-12#1)(2010-4#1)(2010-8#1)
of the structure##13##3##(1990-9#1)(1991-6#2)(1992-12#1)(1992-9#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-7#1)(2010-8#1)
of the structure-activity relationships##2##4##(1991-3#1)(2008-11#1)
of the structures##2##3##(2008-11#1)(2008-8#1)
of the student##4##3##(2008-11#3)(2008-12#1)
of the students and##2##4##(2008-11#1)(2013-8#1)
of the students had##2##4##(2008-11#1)(2013-1#1)
of the students##8##3##(1991-9#1)(2008-11#3)(2013-1#1)(2013-8#3)
of the students' perceptions##2##4##(2009-7#1)(2012-3#1)
of the students'##3##3##(2008-11#1)(2009-7#1)(2012-3#1)
of the studied cases##3##4##(1993-2#1)(2008-11#1)(2011-2#1)
of the studied drug##2##4##(2008-10#2)
of the studied drugs##4##4##(2008-10#4)
of the studied dyes##2##4##(2008-10#2)
of the studied##25##3##(1993-2#1)(1994-2#1)(2008-10#19)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
of the studies##14##3##(1992-3#1)(1994-6#1)(1995-2#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#3)
of the study and##4##4##(1992-5#1)(2008-12#1)(2009-11#1)(2011-2#1)
of the study in##2##4##(2008-5#1)(2010-9#1)
of the study indicate that##2##5##(1996-1#1)(2008-12#1)
of the study is to examine##2##6##(2010-9#1)(2011-1#1)
of the study is to##10##5##(1993-3#1)(1997-3#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-3#3)(2013-1#1)
of the study is##12##4##(1993-3#1)(1997-3#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-3#2)(2012-3#3)(2013-1#1)(2013-8#1)
of the study of##2##4##(2008-10#1)(2008-3#1)
of the study participants##3##4##(2008-12#1)(2010-7#1)(2013-1#1)
of the study period##2##4##(2008-11#1)(2008-9#1)
of the study population##3##4##(2008-1#1)(2008-10#1)(2008-11#1)
of the study showed that##4##5##(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the study was the##2##5##(2007-11#1)(2008-5#1)
of the study was to analyze##2##6##(2008-12#1)(2012-3#1)
of the study was to assess the##3##7##(2008-5#1)(2008-7#1)(2012-3#1)
of the study was to assess##4##6##(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
of the study was to compare the##4##7##(1997-8#1)(2011-2#1)(2013-1#2)
of the study was to compare##7##6##(1990-2#1)(1997-8#1)(2008-11#1)(2011-2#1)(2013-1#3)
of the study was to determine the##2##7##(2008-12#1)(2013-8#1)
of the study was to determine##6##6##(1990-8#1)(1994-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-8#1)
of the study was to evaluate##4##6##(2008-12#1)(2010-10#1)(2010-11#1)(2013-1#1)
of the study was to examine##3##6##(2008-11#2)(2009-5#1)
of the study was to identify##2##6##(2010-1#1)(2013-1#1)
of the study was to investigate##3##6##(2008-5#1)(2008-9#1)(2009-6#1)
of the study was to##45##5##(1990-2#2)(1990-8#1)(1993-1#1)(1993-2#1)(1994-12#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-11#5)(2008-12#4)(2008-5#4)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
of the study was##49##4##(1990-2#2)(1990-8#1)(1993-1#1)(1993-2#1)(1994-12#1)(1996-6#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-11#5)(2008-12#4)(2008-5#5)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#6)(2013-8#1)
of the study were##6##4##(1991-1#1)(1992-12#1)(2008-10#1)(2010-1#1)(2012-3#2)
of the study##140##3##(1990-2#3)(1990-8#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#14)(2008-12#8)(2008-3#1)(2008-5#10)(2008-7#5)(2008-9#5)(2009-11#1)(2009-5#1)(2009-6#1)(2010-1#4)(2010-10#2)(2010-11#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-2#2)(2012-3#10)(2013-1#10)(2013-8#3)
of the subarachnoid##2##3##(2008-7#2)
of the subclavian artery##3##4##(1993-3#1)(2008-7#2)
of the subclavian##4##3##(1993-3#1)(2008-7#3)
of the subepithelial##2##3##(2009-8#1)(2013-1#1)
of the subject##5##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)
of the subject's##2##3##(2008-11#1)(2013-8#1)
of the subjects were##2##4##(1991-2#1)(2008-12#1)
of the subjects##10##3##(1991-2#3)(2008-12#2)(2008-5#1)(2008-7#2)(2010-9#1)(2013-8#1)
of the subsequent##4##3##(1995-12#1)(1997-2#1)(2008-10#2)
of the substance##2##3##(1990-6#1)(2008-5#1)
of the substances##5##3##(1994-12#1)(2008-10#2)(2010-8#1)(2013-1#1)
of the substantia nigra pars compacta##2##6##(1996-12#2)
of the substantia nigra##5##4##(1990-5#1)(1996-12#4)
of the substrate and##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
of the substrate between##2##4##(1990-5#2)
of the substrate in##3##4##(1990-5#1)(1994-5#1)(2008-10#1)
of the substrate##29##3##(1990-5#3)(1992-3#2)(1992-6#1)(1993-3#1)(1993-8#1)(1994-5#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-10#1)(2012-2#1)(2013-8#1)
of the substrates##7##3##(1991-3#1)(1994-5#3)(2008-10#3)
of the subtelomeric##2##3##(1997-6#1)(2009-10#1)
of the subunits##4##3##(1992-3#2)(2008-9#2)
of the success of##2##4##(1994-9#1)(2008-11#1)
of the success##3##3##(1994-9#1)(2008-11#1)(2012-3#1)
of the sucrose##2##3##(2008-10#2)
of the sugar beet##2##4##(2008-10#1)(2008-12#1)
of the sugar##5##3##(1992-6#1)(2008-10#2)(2008-11#1)(2008-12#1)
of the sugars##2##3##(2008-10#2)
of the suicidal##3##3##(2010-6#3)
of the sun##5##3##(1991-6#1)(1994-3#2)(2011-2#2)
of the sunlight##2##3##(2008-5#1)(2011-2#1)
of the super##2##3##(1991-12#1)(2008-10#1)
of the superficial##2##3##(2011-2#1)(2013-8#1)
of the superior mesenteric artery##4##5##(2013-1#4)
of the superior##9##3##(1991-6#1)(1996-2#1)(1997-3#1)(2008-12#1)(2011-2#1)(2013-1#4)
of the supernatant##2##3##(2008-10#2)
of the support##3##3##(1990-2#1)(2008-11#1)(2010-6#1)
of the supporting electrolyte##4##4##(2008-10#4)
of the supporting##6##3##(2008-10#6)
of the surface components##2##4##(1991-12#2)
of the surface is##2##4##(2008-10#1)(2008-5#1)
of the surface of the##3##5##(2008-10#1)(2008-4#1)(2008-5#1)
of the surface of##4##4##(2008-10#1)(2008-4#2)(2008-5#1)
of the surface with##2##4##(2008-10#1)(2008-5#1)
of the surface##31##3##(1990-12#1)(1991-12#2)(1994-6#1)(1996-12#1)(1997-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2011-2#1)(2012-2#1)
of the surfactant##8##3##(1997-1#1)(2008-10#5)(2008-5#2)
of the surfactants and##2##4##(2008-10#2)
of the surfactants##6##3##(2008-10#3)(2008-5#3)
of the surgery##3##3##(1990-9#1)(2008-7#1)(2012-12#1)
of the surgical specimen revealed##2##5##(2011-2#1)(2013-1#1)
of the surgical treatment of##2##5##(1990-3#1)(1990-9#1)
of the surgical treatment##3##4##(1990-3#1)(1990-9#1)(1992-9#1)
of the surgical##12##3##(1990-3#1)(1990-9#1)(1992-3#1)(1992-9#2)(1996-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#2)
of the surgically##2##3##(1990-6#1)(1992-9#1)
of the surrounding##4##3##(1993-1#1)(2011-2#1)(2013-1#2)
of the surveillance##2##3##(1996-11#1)(2011-2#1)
of the survey were##2##4##(1991-12#1)(2008-10#1)
of the survey##11##3##(1991-12#1)(1991-2#1)(2008-10#5)(2008-11#1)(2012-2#1)(2013-1#2)
of the survival curve##3##4##(1995-3#3)
of the survival##5##3##(1995-3#3)(2008-1#1)(2008-11#1)
of the susceptible potato##2##4##(2008-10#2)
of the susceptible##6##3##(2008-10#6)
of the suspended##2##3##(2008-3#1)(2009-7#1)
of the suspension##2##3##(2008-10#2)
of the swollen##2##3##(2008-5#1)(2009-5#1)
of the symmetric##2##3##(2008-10#2)
of the sympathetic nervous system##2##5##(1997-2#1)(2012-2#1)
of the sympathetic nervous##3##4##(1997-2#1)(2008-5#1)(2012-2#1)
of the sympathetic##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
of the symphysis pubis##2##4##(1994-3#1)(2012-12#1)
of the symptom##4##3##(1991-11#1)(2011-2#3)
of the symptoms and##2##4##(2008-7#1)(2010-3#1)
of the symptoms##13##3##(1995-3#1)(1997-8#1)(2008-10#5)(2008-7#1)(2009-11#2)(2010-12#1)(2010-3#1)(2012-3#1)
of the syndrome##6##3##(1995-5#1)(1997-3#1)(2008-1#1)(2008-8#1)(2012-12#1)(2012-2#1)
of the synergid##2##3##(2008-11#1)(2009-8#1)
of the synthesis##3##3##(1991-10#1)(2008-10#1)(2008-4#1)
of the synthesized compounds##2##4##(2012-2#1)(2012-3#1)
of the synthesized##11##3##(2008-1#1)(2008-10#3)(2008-6#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#2)
of the synthetic glucocorticoid##2##4##(1991-5#1)(1995-8#1)
of the synthetic##8##3##(1991-5#1)(1992-6#1)(1995-8#1)(1996-5#1)(2008-10#2)(2010-1#1)(2012-3#1)
of the syrB gene##3##4##(2008-10#3)
of the system and the##3##5##(1996-1#1)(2008-10#1)(2012-3#1)
of the system and to##2##5##(2008-10#1)(2008-3#1)
of the system and##7##4##(1996-1#1)(2008-10#3)(2008-3#2)(2012-3#1)
of the system as##2##4##(1991-2#1)(2008-10#1)
of the system can##2##4##(2008-10#2)
of the system for##2##4##(2008-11#1)(2008-7#1)
of the system have##2##4##(2008-10#1)(2008-3#1)
of the system is##11##4##(2008-10#7)(2008-11#2)(2008-2#1)(2008-8#1)
of the system of##2##4##(1996-2#1)(2012-3#1)
of the system to##4##4##(1992-12#1)(1997-3#1)(2008-10#1)(2008-11#1)
of the system was ascertained by analyzing a set of##2##10##(2008-10#2)
of the system was##15##4##(1997-1#1)(2008-10#13)(2013-8#1)
of the system were optimized##3##5##(2008-10#3)
of the system were##8##4##(1992-12#1)(2008-10#6)(2008-12#1)
of the system with##3##4##(2008-10#2)(2008-3#1)
of the system without##2##4##(2008-10#2)
of the system##106##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-1#1)(1995-11#1)(1996-1#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#59)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#4)(2013-8#1)
of the system's##3##3##(1991-12#1)(2008-10#1)(2013-1#1)
of the systemic##2##3##(2008-10#1)(2010-11#1)
of the systems##6##3##(1991-1#1)(2008-10#3)(2008-11#1)(2008-8#1)
of the tablets##2##3##(2008-10#2)
of the tactile##2##3##(2008-5#2)
of the tagged gene##2##4##(1997-8#2)
of the tagged##3##3##(1997-8#3)
of the tail##2##3##(2008-5#1)(2009-7#1)
of the talus##4##3##(2008-12#1)(2009-1#1)(2009-5#1)(2012-2#1)
of the target area##2##4##(1994-8#1)(2008-10#1)
of the target cell##2##4##(2008-11#2)
of the target compounds##4##4##(2008-10#4)
of the target population##2##4##(1997-1#1)(2008-10#1)
of the target species##2##4##(1997-7#1)(2008-10#1)
of the target##32##3##(1990-12#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-10#16)(2008-11#4)(2008-3#2)(2009-11#3)(2009-7#1)(2011-1#1)(2012-12#1)
of the targeted##3##3##(1995-6#1)(2008-10#1)(2010-12#1)
of the targets##2##3##(1991-5#1)(2008-11#1)
of the task##5##3##(1991-2#1)(2008-10#2)(2013-8#2)
of the taxa##2##3##(2008-10#1)(2010-3#1)
of the teaching##2##3##(2008-12#2)
of the team##6##3##(1991-2#1)(1992-2#1)(1996-1#1)(1996-3#1)(2009-6#1)(2010-11#1)
of the technique and##4##4##(2008-10#2)(2008-4#1)(2010-7#1)
of the technique are##4##4##(1995-11#1)(2008-10#1)(2008-3#1)(2009-1#1)
of the technique in##2##4##(2008-2#1)(2013-8#1)
of the technique is##5##4##(2007-11#1)(2008-10#1)(2008-3#3)
of the technique was##2##4##(2008-10#2)
of the technique##31##3##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-8#1)
of the techniques and##2##4##(2008-11#1)(2008-4#1)
of the techniques that##2##4##(1995-5#1)(2008-9#1)
of the techniques##9##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)
of the technology##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
of the teeth##2##3##(1995-9#1)(2011-2#1)
of the teleomorph##2##3##(2008-10#2)
of the telescope##3##3##(1991-2#1)(2008-3#2)
of the temperature and pH##2##5##(2008-10#2)
of the temperature distribution##2##4##(2008-3#1)(2008-7#1)
of the temperature##12##3##(1995-2#1)(1997-2#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-7#1)
of the template##2##3##(2008-10#1)(2008-8#1)
of the temporal bone##3##4##(2008-9#1)(2011-2#2)
of the temporal lobe##3##4##(2008-4#1)(2011-2#2)
of the temporal##14##3##(1994-3#1)(1994-9#1)(2007-12#1)(2008-2#3)(2008-4#1)(2008-9#1)(2009-8#2)(2011-2#4)
of the temporo-mandibular joint##3##4##(2011-2#3)
of the ten##2##3##(1995-12#1)(1996-2#1)
of the tennis serve##2##4##(2011-2#2)
of the terminal CN groups##2##5##(2008-10#2)
of the terminal##8##3##(1990-9#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-11#1)
of the ternary complex##3##4##(1993-8#1)(2008-10#2)
of the ternary##6##3##(1993-8#1)(2008-10#5)
of the terpenoids##2##3##(1990-11#1)(2008-10#1)
of the terrestrial##3##3##(1990-5#1)(2008-3#1)(2008-6#1)
of the test sample##2##4##(2008-10#1)(2008-9#1)
of the test specimen##2##4##(2008-10#2)
of the test with##2##4##(1992-9#1)(1996-3#1)
of the test##32##3##(1990-6#1)(1992-9#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-5#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-12#1)(2011-2#1)
of the tested substances##2##4##(2008-10#1)(2008-5#1)
of the tested##17##3##(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#1)
of the testing##4##3##(1990-11#1)(1996-6#1)(2008-5#1)(2008-7#1)
of the testis is a rare##2##6##(2007-8#1)(2011-2#1)
of the testis##7##3##(1994-11#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
of the tests##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
of the tetracycline##2##3##(2008-10#2)
of the tetrapeptide Pro-D-Phe-Pro-Gly in##2##5##(1991-5#2)
of the tetrapyrrole##2##3##(2011-1#2)
of the text##2##3##(2008-10#2)
of the the##2##3##(1990-5#1)(2008-7#1)
of the theoretical##7##3##(1991-12#1)(1993-3#1)(2008-12#1)(2008-3#3)(2008-5#1)
of the theory##6##3##(2008-10#1)(2008-8#3)(2011-2#1)(2013-8#1)
of the theory-practice gap##2##4##(2008-11#2)
of the therapeutic##7##3##(1990-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the thermal lens was##2##5##(2008-2#2)
of the thermal lens##6##4##(2008-2#2)(2008-3#4)
of the thermal##14##3##(2008-10#1)(2008-2#3)(2008-3#7)(2011-1#1)(2011-2#1)(2012-6#1)
of the thermodynamic##7##3##(1993-8#1)(2008-10#5)(2008-4#1)
of the theta##2##3##(2008-11#2)
of the thickness of##2##4##(1991-5#1)(2008-10#1)
of the thigh##4##3##(1991-6#1)(1997-3#1)(2008-12#1)(2013-1#1)
of the thin##3##3##(1991-5#1)(2008-5#1)(2008-6#1)
of the thiocyanato-complexes##2##3##(2008-10#2)
of the thiol##2##3##(2008-10#1)(2008-11#1)
of the third ventricle##5##4##(2008-7#5)
of the third##16##3##(1990-3#2)(1990-8#1)(1992-12#2)(1995-3#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-3#1)(2008-7#5)(2013-1#1)
of the thirteen bisquinolines had##2##5##(1992-6#2)
of the thirteen##3##3##(1992-6#2)(1994-2#1)
of the thoracic aorta##2##4##(2008-10#1)(2008-12#1)
of the thoracic##5##3##(1990-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
of the thorax##2##3##(1991-12#1)(2010-9#1)
of the thought##2##3##(2011-2#2)
of the three arsenic species##2##5##(2008-10#2)
of the three components##2##4##(2008-10#1)(2013-1#1)
of the three compounds##2##4##(2008-10#1)(2011-2#1)
of the three different##2##4##(2008-10#1)(2008-7#1)
of the three dyes##2##4##(2008-10#2)
of the three groups##4##4##(2008-10#3)(2008-12#1)
of the three loop##2##4##(1997-1#2)
of the three main##5##4##(1994-5#1)(2008-10#2)(2012-2#1)(2012-3#1)
of the three major##3##4##(1995-11#1)(2009-10#1)(2012-2#1)
of the three metals##2##4##(2008-10#2)
of the three methods##2##4##(2008-10#2)
of the three species##4##4##(2011-3#2)(2012-8#1)(2012-9#1)
of the three test emulsions##2##5##(2008-5#2)
of the three types of##3##5##(1995-11#1)(2009-7#2)
of the three##122##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-6#1)(2008-10#53)(2008-11#5)(2008-12#7)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-7#3)(2010-11#3)(2010-12#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-2#2)(2012-3#1)(2012-8#1)(2012-9#1)(2013-1#1)(2013-8#2)
of the three-way##2##3##(2008-10#2)
of the thumb##3##3##(2008-9#3)
of the thymic##2##3##(1991-8#1)(2013-7#1)
of the thymidine##2##3##(1993-11#1)(2008-4#1)
of the thymus##5##3##(1997-5#1)(1997-7#2)(1997-9#1)(2008-10#1)
of the thyroid gland##6##4##(1990-3#1)(1997-2#1)(2008-7#1)(2011-1#1)(2013-1#2)
of the thyroid in##2##4##(2008-6#1)(2011-1#1)
of the thyroid##14##3##(1990-3#1)(1995-12#1)(1996-11#1)(1997-2#1)(2008-6#1)(2008-7#1)(2009-3#3)(2011-1#2)(2012-12#1)(2013-1#2)
of the tibia##2##3##(2009-3#1)(2011-2#1)
of the tibial##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
of the tick##5##3##(1994-6#1)(2008-10#1)(2008-12#1)(2010-1#1)(2013-8#1)
of the tick-borne pathogen##2##4##(2013-8#2)
of the time and##2##4##(1992-12#1)(2008-10#1)
of the time axis##2##4##(1995-9#1)(2008-8#1)
of the time course of##2##5##(1995-12#1)(2008-10#1)
of the time course##3##4##(1995-12#2)(2008-10#1)
of the time necessary##2##4##(2008-10#2)
of the time of##2##4##(2008-10#2)
of the time##30##3##(1991-3#1)(1992-12#2)(1995-12#2)(1995-9#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#1)(2013-1#1)
of the timing of##3##4##(2008-10#2)(2010-12#1)
of the tip of the##2##5##(1991-3#1)(2010-8#1)
of the tip of##3##4##(1991-3#1)(2008-10#1)(2010-8#1)
of the tip##5##3##(1991-3#1)(2007-12#1)(2008-10#2)(2010-8#1)
of the tissue##11##3##(1991-3#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
of the tissues##6##3##(1994-5#1)(2008-10#2)(2008-12#1)(2013-1#2)
of the title compounds##2##4##(1997-4#1)(2012-3#1)
of the title##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
of the titrant##12##3##(2008-10#12)
of the titration and##2##4##(2008-10#2)
of the titration curve##2##4##(2008-10#2)
of the titration##9##3##(2008-10#9)
of the tobacco##3##3##(1992-2#1)(2008-10#1)(2008-7#1)
of the tongue##2##3##(1997-4#1)(2013-1#1)
of the tonoplast##2##3##(2008-10#1)(2008-11#1)
of the tool##5##3##(2008-11#3)(2008-12#1)(2008-9#1)
of the tools##4##3##(1997-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
of the tooth##3##3##(1991-2#1)(1996-2#1)(2008-7#1)
of the top of##2##4##(2008-3#2)
of the top##7##3##(2008-10#2)(2008-3#2)(2008-9#2)(2013-1#1)
of the topics##2##3##(2008-11#1)(2008-5#1)
of the tospoviruses##2##3##(2008-10#2)
of the total amount of##4##5##(2008-10#4)
of the total concentration of##2##5##(2008-10#2)
of the total culture##2##4##(2008-11#2)
of the total disease that##2##5##(2008-10#2)
of the total gene##2##4##(2008-10#1)(2010-1#1)
of the total genetic variation was distributed##2##7##(2008-10#2)
of the total genetic variation##4##5##(2008-10#4)
of the total genetic##6##4##(2008-10#6)
of the total number of##2##5##(1997-3#1)(2011-2#1)
of the total of##2##4##(1991-8#1)(2013-1#1)
of the total phenotypic variation for resistance in##2##8##(2008-10#2)
of the total phenotypic variation##3##5##(2008-10#3)
of the total phenotypic##5##4##(2008-10#5)
of the total population##3##4##(2008-10#2)(2008-8#1)
of the total proteins in the##2##6##(2008-8#2)
of the total proteins in##3##5##(2008-8#3)
of the total soluble protein##2##5##(1994-5#1)(2008-9#1)
of the total variance and##3##5##(2008-10#2)(2008-5#1)
of the total variance in the##2##6##(2008-10#1)(2008-8#1)
of the total variance##13##4##(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)
of the total variation##3##4##(2008-10#2)(2008-8#1)
of the total##119##3##(1990-2#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-6#2)(1993-2#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#65)(2008-11#6)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#2)(2013-1#2)
of the total)##4##3##(2008-10#4)
of the toxic##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
of the toxicity of##2##4##(1994-5#1)(1996-12#1)
of the toxicity##4##3##(1994-5#1)(1996-12#1)(2008-10#1)(2008-7#1)
of the toxin##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
of the toxins##3##3##(1990-5#1)(1993-12#1)(2008-10#1)
of the trace metals##2##4##(2008-10#1)(2008-5#1)
of the trace##6##3##(2008-10#5)(2008-5#1)
of the tracheal walls##2##4##(2007-12#2)
of the tracheal##5##3##(1996-3#1)(1997-1#1)(2007-12#3)
of the tracheobronchial circulation in##2##5##(1996-1#1)(1997-1#1)
of the tracked##2##3##(2008-6#1)(2009-12#1)
of the traditional##8##3##(1991-2#1)(1992-1#1)(1994-2#1)(1995-1#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-1#1)
of the training##10##3##(1991-2#1)(1991-3#2)(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2013-8#1)
of the trait##2##3##(2012-3#2)
of the trans isomer##2##4##(1991-5#2)
of the trans##4##3##(1990-9#1)(1991-5#2)(2008-10#1)
of the transcript##5##3##(1991-5#2)(1993-12#1)(1996-12#1)(1997-7#1)
of the transcription bubble##2##4##(1995-2#2)
of the transcription factor##6##4##(1992-8#1)(1993-9#1)(1994-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
of the transcription factors##2##4##(1997-7#2)
of the transcription##11##3##(1992-8#1)(1993-9#1)(1994-11#1)(1995-2#2)(1997-7#2)(2008-10#1)(2008-11#1)(2009-6#1)(2011-1#1)
of the transcriptional##5##3##(1992-3#1)(1995-6#1)(2008-9#2)(2013-1#1)
of the transcriptome##2##3##(2012-2#1)(2013-8#1)
of the transcripts##2##3##(1996-8#1)(1997-2#1)
of the transfected##2##3##(1994-6#1)(2008-11#1)
of the transfecting##2##3##(1997-7#1)(2008-11#1)
of the transfer of##2##4##(2008-10#2)
of the transfer##3##3##(1993-12#1)(2008-10#2)
of the transformants##5##3##(1990-8#1)(1997-8#1)(2008-10#2)(2008-8#1)
of the transformation zone##3##4##(1994-12#1)(1994-2#2)
of the transformation##4##3##(1994-12#1)(1994-2#2)(2008-10#1)
of the transformations##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
of the transformed cell##2##4##(1993-6#1)(2008-11#1)
of the transformed##6##3##(1993-6#1)(1995-6#1)(2008-10#2)(2008-11#2)
of the transforming growth factor##2##5##(2008-11#1)(2011-2#1)
of the transforming##3##3##(1993-2#1)(2008-11#1)(2011-2#1)
of the transgene in##2##4##(1995-2#1)(2008-10#1)
of the transgene##13##3##(1993-6#1)(1995-2#1)(2008-10#8)(2008-8#2)(2012-3#1)
of the transgenes##2##3##(2008-11#1)(2011-1#1)
of the transgenic lines##2##4##(2008-10#2)
of the transient##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
of the transition state##3##4##(1990-5#2)(2008-4#1)
of the transition##8##3##(1990-5#2)(2008-10#1)(2008-3#3)(2008-4#1)(2009-7#1)
of the translation initiation##2##4##(1997-2#1)(1997-6#1)
of the translation##3##3##(1997-2#1)(1997-6#1)(2008-11#1)
of the translational##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
of the translocation##2##3##(1991-5#1)(2012-2#1)
of the transmission of##2##4##(2008-3#1)(2011-3#1)
of the transmission##5##3##(2008-10#2)(2008-3#2)(2011-3#1)
of the transmittance##2##3##(2008-2#1)(2008-3#1)
of the transmitted##4##3##(2008-10#1)(2008-3#3)
of the transplantation##2##3##(1995-9#1)(1996-9#1)
of the transplanted##3##3##(2008-10#1)(2008-9#1)(2010-11#1)
of the transport##6##3##(1991-5#1)(1995-8#1)(2008-10#2)(2008-7#2)
of the transverse sinus##2##4##(2008-7#2)
of the transverse##3##3##(2008-7#2)(2012-2#1)
of the traumatic event##2##4##(2008-10#1)(2008-6#1)
of the treated embryos##2##4##(2008-11#1)(2008-12#1)
of the treated##6##3##(1994-12#1)(2008-11#2)(2008-12#1)(2009-7#1)(2013-8#1)
of the treatment groups##4##4##(1991-2#1)(1994-12#3)
of the treatment of renal##2##5##(1992-5#1)(2008-10#1)
of the treatment of##8##4##(1992-1#1)(1992-5#1)(1994-2#1)(1996-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
of the treatment was##2##4##(1992-3#1)(2012-3#1)
of the treatment##40##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-5#2)(1994-12#3)(1994-2#2)(1994-9#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of the treatments##3##3##(2008-10#1)(2011-1#1)(2012-5#1)
of the tree canopy##2##4##(2008-10#2)
of the tree##3##3##(2008-10#3)
of the trees in a##2##5##(2008-10#2)
of the trial##12##3##(1991-3#3)(1994-9#1)(2008-10#4)(2008-8#1)(2009-4#2)(2009-8#1)
of the trials##4##3##(1997-1#1)(2008-10#3)
of the triangle##2##3##(2008-6#1)(2011-2#1)
of the tricyclic##2##3##(1996-5#2)
of the trigeminal ganglion##2##4##(1997-3#1)(2008-7#1)
of the trigeminal nerve##5##4##(1990-12#1)(2011-2#4)
of the trigeminal##8##3##(1990-12#1)(1997-3#1)(2008-7#1)(2008-9#1)(2011-2#4)
of the tropical##4##3##(2008-10#3)(2008-11#1)
of the true##6##3##(1990-6#1)(1992-3#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
of the truncated##2##3##(1993-6#2)
of the tryptic##2##3##(1997-2#1)(2008-10#1)
of the tsx gene##2##4##(1990-11#2)
of the tube##5##3##(1994-9#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)
of the tuber##2##3##(2008-10#2)
of the tubule##2##3##(2007-12#1)(2008-7#1)
of the tumor and##4##4##(1993-11#1)(2008-11#1)(2011-1#1)(2013-8#1)
of the tumor position##3##4##(2009-11#3)
of the tumor suppressor##2##4##(2008-7#1)(2013-1#1)
of the tumor was##2##4##(2010-6#1)(2011-2#1)
of the tumor##37##3##(1990-2#1)(1990-6#1)(1991-12#3)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#1)(1994-6#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#3)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
of the tumors##2##3##(1990-12#1)(1991-12#1)
of the tumour was##3##4##(2008-7#2)(2012-12#1)
of the tumour##15##3##(1991-6#1)(1993-8#1)(2008-10#1)(2008-7#9)(2011-2#1)(2012-12#2)
of the tumours were##2##4##(1990-12#2)
of the tumours##3##3##(1990-12#2)(2008-10#1)
of the tunica##2##3##(2008-10#1)(2009-10#1)
of the twelve##2##3##(2008-8#1)(2011-3#1)
of the twentieth century##2##4##(2010-1#1)(2011-2#1)
of the twentieth##3##3##(2010-1#2)(2011-2#1)
of the twenty-first century##3##4##(1994-2#1)(1997-1#1)(2008-12#1)
of the two analytes##3##4##(2008-10#3)
of the two cell lines##3##5##(2008-11#1)(2008-9#2)
of the two compounds##2##4##(2008-10#2)
of the two constituents##2##4##(2008-10#2)
of the two diseases##5##4##(2008-10#5)
of the two drugs##4##4##(1990-9#1)(2008-10#1)(2008-11#1)(2012-2#1)
of the two epitopes##2##4##(1995-2#1)(2008-8#1)
of the two forms of##3##5##(1991-12#1)(2008-10#1)(2010-5#1)
of the two genes##3##4##(1991-9#1)(1993-6#1)(2008-9#1)
of the two groups##5##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
of the two isolates##2##4##(2008-10#2)
of the two kinds of macrocycle stationary phases##2##8##(2008-10#2)
of the two kinds of##3##5##(2008-10#2)(2008-8#1)
of the two lasers##2##4##(2008-3#2)
of the two main components of##2##6##(1993-8#1)(2008-1#1)
of the two main##3##4##(1993-8#1)(2008-1#1)(2008-10#1)
of the two major##4##4##(1995-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
of the two metals##2##4##(2008-10#2)
of the two methods##3##4##(2008-10#3)
of the two pathogens##2##4##(2008-10#1)(2010-4#1)
of the two phases##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
of the two procedures##2##4##(2008-10#2)
of the two resistance##2##4##(2008-10#2)
of the two species##7##4##(2008-10#4)(2008-8#1)(2008-9#1)(2012-5#1)
of the two study groups##2##5##(1991-11#1)(2010-4#1)
of the two substrates##3##4##(1994-5#2)(2008-7#1)
of the two subunits##3##4##(1991-10#1)(1991-12#1)(1993-8#1)
of the two types of##2##5##(1991-12#1)(2008-5#1)
of the two viruses##2##4##(2008-10#1)(2008-9#1)
of the two##206##3##(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-6#1)(1991-9#2)(1992-3#3)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#2)(1994-5#4)(1994-8#2)(1995-12#3)(1995-2#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#4)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#83)(2008-11#11)(2008-12#2)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#12)(2008-9#9)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-5#2)(2012-6#1)(2013-1#1)(2013-8#3)
of the two-component##2##3##(1996-12#2)
of the two-dimensional##3##3##(2008-10#1)(2008-3#2)
of the two-node model##2##4##(1992-3#2)
of the two-winged Cloeodes##2##4##(2013-8#2)
of the type II##3##4##(1995-2#2)(2008-4#1)
of the type and##5##4##(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
of the type of##12##4##(1992-9#1)(1993-1#1)(1995-11#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-5#1)(2009-7#1)(2010-11#1)(2011-2#1)
of the type##27##3##(1992-9#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2009-7#1)(2010-11#1)(2011-2#2)
of the types of##5##4##(1992-12#1)(1993-1#1)(1997-2#1)(2008-6#1)(2008-8#1)
of the types##6##3##(1992-12#1)(1993-1#1)(1997-2#1)(2008-5#1)(2008-6#1)(2008-8#1)
of the typical##8##3##(1993-2#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2012-2#1)
of the ubiquitous##2##3##(2008-10#1)(2011-2#1)
of the ulna##3##3##(2011-2#2)(2013-1#1)
of the ulnar nerve##5##4##(2008-12#1)(2008-9#4)
of the ulnar##6##3##(2008-12#1)(2008-9#5)
of the ultrasonic separation##2##4##(2008-11#2)
of the ultrasonic##5##3##(2008-10#2)(2008-11#3)
of the ultrasound##2##3##(1996-11#1)(2008-5#1)
of the uncertainty associated with the##2##6##(2008-10#2)
of the uncertainty##3##3##(2008-10#3)
of the uncomplexed##2##3##(2008-10#2)
of the undergraduate##2##3##(1991-6#1)(2013-1#1)
of the underlying disease##2##4##(2011-2#1)(2011-3#1)
of the underlying##21##3##(1994-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#3)(2010-11#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
of the unicellular cyanobacterium##5##4##(1995-6#1)(1995-8#1)(1996-6#3)
of the uniformity##2##3##(2008-12#1)(2008-3#1)
of the uninsured##2##3##(1992-2#1)(1994-2#1)
of the unique##6##3##(1991-1#1)(1996-1#1)(2008-11#1)(2008-12#1)(2010-4#1)(2012-3#1)
of the unit is##3##4##(2008-11#1)(2008-4#2)
of the unit##8##3##(1992-9#1)(1995-12#1)(2008-11#1)(2008-4#3)(2008-7#1)(2010-8#1)
of the universal##2##3##(2008-8#1)(2011-2#1)
of the universe##2##3##(1995-6#1)(1996-12#1)
of the unknown##6##3##(2008-10#3)(2011-2#2)(2012-3#1)
of the unquantified##2##3##(2008-4#2)
of the unstable##2##3##(2008-3#2)
of the unstirred layers##2##4##(1991-5#2)
of the unstirred##7##3##(1991-5#7)
of the untreated##3##3##(2008-10#1)(2013-7#2)
of the unusual##5##3##(1992-9#1)(1994-3#1)(2008-10#1)(2008-7#1)(2013-8#1)
of the upcoming##3##3##(2008-11#2)(2008-3#1)
of the upper airways##3##4##(1991-6#1)(1996-6#1)(1997-4#1)
of the upper limb##2##4##(2009-1#2)
of the upper trapezius##2##4##(2010-9#2)
of the upper##29##3##(1990-6#1)(1991-6#1)(1991-9#1)(1993-2#1)(1996-6#1)(1997-4#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-9#2)(2009-1#2)(2009-5#1)(2010-12#1)(2010-6#2)(2010-9#3)(2011-2#3)(2013-1#2)
of the upstream##3##3##(1990-8#1)(1991-6#1)(1993-9#1)
of the uptake and##2##4##(2008-10#1)(2008-9#1)
of the urea##3##3##(1995-6#1)(2008-10#2)
of the ureter##6##3##(1997-3#1)(1997-4#1)(2008-10#1)(2013-7#3)
of the urethra and##2##4##(2008-10#2)
of the urethra##4##3##(2008-10#4)
of the urethral##3##3##(1992-1#1)(1996-11#1)(2013-1#1)
of the uridine##2##3##(1993-8#1)(1995-8#1)
of the urinary bladder##8##4##(1992-12#1)(1993-2#2)(2008-10#1)(2011-2#3)(2012-12#1)
of the urinary tract##4##4##(1990-11#2)(2008-10#1)(2011-2#1)
of the urinary##12##3##(1990-11#2)(1992-12#1)(1993-2#2)(2008-10#2)(2011-2#4)(2012-12#1)
of the urine##2##3##(1995-3#1)(2008-10#1)
of the urogenital tract##3##4##(1995-5#1)(1997-2#1)(1997-6#1)
of the use of a##2##5##(2008-10#1)(2008-7#1)
of the use of different##3##5##(2008-10#3)
of the use of heteropoly anions##2##6##(2008-10#2)
of the use of the##5##5##(2008-10#4)(2008-11#1)
of the use of##43##4##(1991-3#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1995-3#1)(1995-5#2)(1996-6#1)(1997-3#2)(2008-10#15)(2008-11#6)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the use##44##3##(1991-3#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1995-3#1)(1995-5#2)(1996-6#1)(1997-3#2)(2008-10#15)(2008-11#6)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the used##2##3##(2008-10#1)(2008-11#1)
of the users##4##3##(1991-1#1)(1995-2#1)(2008-11#1)(2012-2#1)
of the usual abdominal##2##4##(1994-2#1)(1997-3#1)
of the usual##6##3##(1994-2#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2012-3#1)
of the uterine cervix##4##4##(1990-6#1)(2008-11#1)(2009-11#2)
of the uterine##9##3##(1990-6#1)(1991-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-11#1)(2009-11#2)
of the uterus and##2##4##(2012-2#1)(2012-3#1)
of the uterus##5##3##(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the utility of##3##4##(2008-10#1)(2008-9#2)
of the vaccinated animals##2##4##(1995-9#2)
of the vaccine##7##3##(1990-9#1)(1995-5#1)(1996-12#1)(2008-11#2)(2011-2#1)(2013-1#1)
of the vacuolar##2##3##(1994-6#1)(2008-11#1)
of the vacuum disc##2##4##(2012-2#2)
of the vagina##2##3##(1990-2#1)(1994-1#1)
of the vaginal##5##3##(1991-12#1)(1991-3#1)(1992-12#1)(1996-9#1)(2008-10#1)
of the validation##5##3##(1997-2#1)(2008-10#3)(2008-3#1)
of the validity of##2##4##(1991-2#1)(2007-12#1)
of the value of the##2##5##(2008-3#2)
of the value of##3##4##(1997-7#1)(2008-3#2)
of the value##5##3##(1997-7#1)(2008-10#2)(2008-3#2)
of the values of##2##4##(1994-12#1)(2008-12#1)
of the values##3##3##(1994-12#1)(2008-12#1)(2008-6#1)
of the valve##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
of the van der Waals##2##5##(1995-3#1)(2013-1#1)
of the vapor##2##3##(2008-10#2)
of the variability between##2##4##(2008-10#2)
of the variability was##2##4##(2008-10#1)(2008-7#1)
of the variability##11##3##(2008-10#10)(2008-7#1)
of the variable##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
of the variables affecting##2##4##(2008-10#2)
of the variables and##2##4##(2008-10#2)
of the variables##14##3##(1994-3#1)(2008-10#9)(2008-11#1)(2011-2#3)
of the variance in the##6##5##(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2012-3#1)
of the variance in##14##4##(1994-3#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-9#2)(2009-12#3)(2010-2#1)(2012-3#2)(2013-8#1)
of the variance of##2##4##(2008-10#2)
of the variance##24##3##(1993-12#1)(1994-3#1)(1995-3#1)(2008-10#8)(2008-4#1)(2008-9#2)(2009-12#3)(2010-2#1)(2010-5#1)(2012-3#3)(2013-1#1)(2013-8#1)
of the variant enzymes##2##4##(2011-2#2)
of the variant##4##3##(1990-8#1)(2008-7#1)(2011-2#2)
of the variation for resistance in##2##6##(2008-10#2)
of the variation for resistance##3##5##(2008-10#3)
of the variation in##14##4##(1993-3#1)(2008-10#7)(2008-2#1)(2008-7#1)(2008-8#3)(2012-3#1)
of the variation was##2##4##(2008-10#1)(2013-8#1)
of the variation##23##3##(1993-3#1)(2008-10#15)(2008-2#1)(2008-7#1)(2008-8#3)(2012-3#1)(2013-8#1)
of the variations in the##2##5##(1993-2#1)(2013-8#1)
of the variety##3##3##(2008-5#2)(2010-6#1)
of the various protocols##2##4##(2008-9#1)(2013-8#1)
of the various types of##2##5##(1992-12#1)(2008-10#1)
of the various##44##3##(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-11#1)(1993-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
of the vas deferens##6##4##(1994-8#1)(1997-8#1)(2008-10#4)
of the vas##7##3##(1994-8#2)(1997-8#1)(2008-10#4)
of the vascular##12##3##(1992-12#2)(1996-11#1)(1997-1#1)(1997-6#1)(2008-10#4)(2009-1#1)(2011-2#1)(2012-2#1)
of the vector##3##3##(2008-11#1)(2008-6#1)(2010-1#1)
of the vectors##3##3##(1993-12#1)(2008-10#1)(2012-12#1)
of the vehicle control groups##3##5##(2008-9#3)
of the vehicle control##4##4##(2008-9#4)
of the vehicle##7##3##(2008-5#1)(2008-9#6)
of the vehicles on the##2##5##(2008-5#2)
of the vena cava##2##4##(1992-9#1)(2010-4#1)
of the venous##2##3##(2011-2#1)(2011-3#1)
of the ventilator##3##3##(1995-12#1)(2011-1#1)(2011-2#1)
of the ventral##7##3##(1993-6#2)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#1)
of the ventricular##2##3##(1990-9#1)(2010-12#1)
of the vertebral artery##3##4##(1991-8#1)(1993-3#1)(2008-7#1)
of the vertebral body and##2##5##(2007-11#1)(2007-8#1)
of the vertebral venous##2##4##(2011-2#2)
of the vertebral##11##3##(1991-8#2)(1993-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-7#2)(2011-2#3)
of the vertebrate##2##3##(1997-7#1)(2008-9#1)
of the vertical##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
of the very complex##3##4##(1992-5#1)(2008-10#1)(2011-1#1)
of the very##6##3##(1992-10#1)(1992-5#1)(2008-10#3)(2011-1#1)
of the vesicles##3##3##(2008-10#1)(2008-5#2)
of the vessel##4##3##(1991-8#1)(1993-8#1)(2009-10#1)(2010-4#1)
of the vestibular##2##3##(1991-2#1)(1995-8#1)
of the viable cell density##2##5##(2008-11#2)
of the viable cell##4##4##(2008-11#4)
of the vibrissal FSC##2##4##(2011-2#2)
of the victims##3##3##(1991-2#1)(1995-11#1)(1996-11#1)
of the viral RNA##3##4##(2008-10#3)
of the viral S RNA##2##5##(2008-10#2)
of the viral genome##3##4##(2008-10#2)(2008-11#1)
of the viral##24##3##(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#2)(1997-3#1)(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-3#1)
of the virulence factors of##2##5##(2008-10#1)(2008-9#1)
of the virulence##8##3##(2008-10#6)(2008-9#1)(2009-8#1)
of the virulent##4##3##(2008-10#4)
of the virus and##4##4##(1996-11#1)(2008-10#2)(2008-5#1)
of the virus as##2##4##(1990-2#1)(2008-11#1)
of the virus by##3##4##(2008-10#3)
of the virus from##3##4##(2008-10#3)
of the virus in##6##4##(2008-10#6)
of the virus life cycle##2##5##(2008-10#1)(2013-1#1)
of the virus to##2##4##(2008-10#2)
of the virus was##2##4##(2008-10#2)
of the virus##55##3##(1990-2#1)(1993-3#1)(1996-11#1)(2008-1#1)(2008-10#38)(2008-11#3)(2008-5#4)(2008-9#1)(2010-1#1)(2011-3#1)(2013-1#3)
of the viruses was##2##4##(2008-10#2)
of the viruses##7##3##(2008-10#5)(2011-2#2)
of the visible##3##3##(1992-1#1)(1994-5#1)(2008-3#1)
of the visual cortex##2##4##(2011-2#2)
of the visual input in##4##5##(1991-2#4)
of the visual input##5##4##(1991-2#5)
of the visual system##3##4##(1995-5#2)(2008-10#1)
of the visual##17##3##(1991-2#5)(1995-5#2)(1995-8#1)(1996-2#1)(2008-10#1)(2009-10#1)(2011-2#4)(2012-3#1)(2013-8#1)
of the vital##2##3##(1997-3#1)(2012-3#1)
of the vitamin##7##3##(1991-12#1)(1992-9#1)(1994-6#1)(2008-1#1)(2008-10#2)(2013-1#1)
of the vocabulary##2##3##(2011-2#2)
of the voice##2##3##(2008-9#1)(2011-1#1)
of the volatile##4##3##(2008-10#3)(2009-8#1)
of the voltammetric##6##3##(2008-10#6)
of the volume##2##3##(2008-3#2)
of the volumes##2##3##(2008-10#1)(2009-2#1)
of the volunteer##2##3##(1993-12#1)(1994-3#1)
of the vulnerable plaque##3##4##(2012-2#3)
of the vulva##5##3##(1992-3#4)(1994-1#1)
of the w##2##3##(1991-5#2)
of the waiting##2##3##(1991-11#2)
of the waiver##3##3##(1992-2#2)(1997-2#1)
of the wall##3##3##(2008-11#1)(2008-3#1)(2009-1#1)
of the walls##2##3##(2007-12#2)
of the war##2##3##(2008-10#1)(2008-6#1)
of the waste##2##3##(2008-10#2)
of the water column##3##4##(2008-3#1)(2008-8#1)(2012-2#1)
of the water sample##3##4##(2008-10#3)
of the water samples##2##4##(2008-10#2)
of the water##26##3##(1990-9#1)(1991-5#2)(1993-2#1)(1994-3#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#2)(2012-2#1)(2012-5#1)(2013-1#1)
of the water-vapor mixing ratio##2##5##(2008-3#2)
of the waveguide##3##3##(1992-3#1)(2007-12#1)(2008-10#1)
of the wavelength range##2##4##(2008-10#1)(2008-3#1)
of the wavelength##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
of the wax matrix##6##4##(2008-5#6)
of the way##3##3##(1990-11#1)(1992-12#1)(2008-11#1)
of the weak##2##3##(2008-10#2)
of the weakest##2##3##(2008-5#1)(2012-3#1)
of the weapon##2##3##(1995-11#1)(2008-10#1)
of the weight of##2##4##(1996-8#1)(2009-12#1)
of the weight##4##3##(1996-8#2)(2008-11#1)(2009-12#1)
of the well##3##3##(2008-11#3)
of the well-known##3##3##(2008-10#1)(2008-3#2)
of the wet##2##3##(2008-10#1)(2010-8#1)
of the wetting##4##3##(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#1)
of the wheat##4##3##(2008-10#4)
of the white matter##5##4##(1996-11#2)(2008-11#1)(2010-12#2)
of the white pine blister rust##2##6##(2008-10#2)
of the white pine##3##4##(2008-10#3)
of the white##13##3##(1996-11#2)(1997-5#1)(2008-10#4)(2008-11#1)(2009-9#1)(2010-12#2)(2010-5#1)(2012-12#1)
of the whitefly##2##3##(2008-10#2)
of the whole analytical procedure##2##5##(2008-10#2)
of the whole body##3##4##(1992-3#1)(2008-10#1)(2008-7#1)
of the whole cortical##2##4##(1995-5#1)(2008-7#1)
of the whole procedure##2##4##(2008-10#1)(2011-2#1)
of the whole##29##3##(1992-3#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-5#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
of the wide variety of##2##5##(2008-11#1)(2008-9#1)
of the wide##4##3##(1997-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
of the widely used##6##4##(1994-1#1)(2008-10#3)(2008-11#1)(2008-9#1)
of the widely##8##3##(1994-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-9#1)
of the widespread##3##3##(1993-3#1)(2008-10#2)
of the wild type and##2##5##(2008-10#1)(2008-8#1)
of the wild type##13##4##(1990-5#1)(1992-6#1)(1993-3#2)(1993-8#1)(1997-8#1)(2008-10#2)(2008-8#3)(2010-10#1)(2013-8#1)
of the wild##15##3##(1990-5#1)(1992-6#1)(1993-3#2)(1993-8#1)(1997-8#1)(2008-10#3)(2008-8#4)(2010-10#1)(2013-8#1)
of the wild-type enzyme##5##4##(1990-10#2)(1994-5#1)(1995-12#1)(1995-6#1)
of the wild-type level of##2##5##(1995-2#2)
of the wild-type strain on##2##5##(2008-10#2)
of the wild-type strain##4##4##(2008-10#4)
of the wild-type##20##3##(1990-10#2)(1991-10#1)(1991-12#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-3#1)(2008-10#8)(2009-10#1)
of the wine##3##3##(2008-10#3)
of the wings##2##3##(1990-9#1)(2013-8#1)
of the wireless##2##3##(2010-2#1)(2010-8#1)
of the women had##3##4##(1990-8#1)(1995-8#1)(2008-11#1)
of the women in##2##4##(2008-11#1)(2009-11#1)
of the women were##2##4##(1996-6#1)(2008-11#1)
of the women##13##3##(1990-8#1)(1995-8#1)(1996-1#1)(1996-6#2)(2008-11#3)(2009-11#1)(2009-4#1)(2010-3#1)(2011-1#2)
of the women's##3##3##(1994-3#2)(1995-8#1)
of the wood##5##3##(2008-10#1)(2009-8#1)(2013-8#3)
of the word##3##3##(1995-5#2)(2008-5#1)
of the work##8##3##(1995-2#1)(1996-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)
of the worker##3##3##(2008-6#3)
of the workforce reported exposure to a coworker who approved of##2##11##(2012-12#2)
of the workforce reported exposure to a coworker who used or was impaired by##2##14##(2012-12#2)
of the workforce reported exposure to a coworker who##4##9##(2012-12#4)
of the workforce reported that they could easily##2##8##(2012-12#2)
of the workforce reported##6##4##(2012-12#6)
of the working electrode##4##4##(2008-10#4)
of the working##9##3##(1991-3#1)(1993-2#1)(2008-10#6)(2008-4#1)
of the workplace##2##3##(2008-9#2)
of the workshop on##2##4##(1992-1#1)(2008-10#1)
of the workshop was##2##4##(2008-10#1)(2013-8#1)
of the workshop##4##3##(1992-1#1)(2008-10#2)(2013-8#1)
of the workshops##3##3##(2008-12#3)
of the world and##3##4##(2010-10#1)(2010-5#1)(2012-2#1)
of the world##45##3##(1990-2#1)(1991-6#1)(1994-1#2)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#4)(2008-5#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
of the world's population##2##4##(2008-5#1)(2009-10#1)
of the world's##6##3##(1990-2#1)(1993-3#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-12#1)
of the wound##3##3##(1990-2#1)(2008-10#2)
of the wrist##5##3##(2008-9#4)(2011-2#1)
of the writing##3##3##(1991-1#1)(2008-3#1)(2010-10#1)
of the written##2##3##(2008-11#1)(2009-9#1)
of the x-ray##2##3##(2008-3#1)(2010-1#1)
of the xylem vessels##2##4##(2007-12#1)(2008-10#1)
of the xylem##3##3##(2007-12#1)(2008-10#2)
of the year##12##3##(1990-12#1)(1997-4#1)(2008-10#2)(2008-12#2)(2008-3#3)(2008-5#1)(2010-8#1)(2013-1#1)
of the yeast Candida oleophila##2##5##(2008-10#2)
of the yeast cell##2##4##(1991-5#1)(1993-8#1)
of the yeast##24##3##(1990-2#1)(1991-5#1)(1991-6#1)(1993-8#3)(1993-9#2)(1995-6#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-7#1)(1997-8#3)(2008-10#5)(2008-5#2)
of the young people##2##4##(1995-8#2)
of the young##3##3##(1995-8#2)(2008-7#1)
of the zinc##5##3##(2008-10#4)(2009-12#1)
of the##31657##2##(1990-10#10)(1990-11#106)(1990-12#110)(1990-2#90)(1990-3#55)(1990-5#190)(1990-6#66)(1990-7#15)(1990-8#72)(1990-9#105)(1991-1#51)(1991-10#19)(1991-11#70)(1991-12#144)(1991-2#138)(1991-3#142)(1991-4#4)(1991-5#130)(1991-6#134)(1991-7#24)(1991-8#65)(1991-9#71)(1992-1#97)(1992-10#20)(1992-11#21)(1992-12#166)(1992-2#100)(1992-3#162)(1992-4#21)(1992-5#43)(1992-6#112)(1992-7#3)(1992-8#49)(1992-9#115)(1993-1#70)(1993-11#53)(1993-12#177)(1993-2#126)(1993-3#153)(1993-5#15)(1993-6#152)(1993-8#208)(1993-9#55)(1994-1#60)(1994-11#142)(1994-12#128)(1994-2#134)(1994-3#109)(1994-5#182)(1994-6#65)(1994-8#126)(1994-9#55)(1995-1#36)(1995-10#1)(1995-11#158)(1995-12#162)(1995-2#179)(1995-3#83)(1995-5#95)(1995-6#211)(1995-8#107)(1995-9#53)(1996-1#65)(1996-11#49)(1996-12#220)(1996-2#170)(1996-3#170)(1996-5#117)(1996-6#122)(1996-8#44)(1996-9#49)(1997-1#121)(1997-2#198)(1997-3#211)(1997-4#71)(1997-5#65)(1997-6#118)(1997-7#139)(1997-8#227)(1997-9#23)(2006-5#1)(2006-6#34)(2007-11#63)(2007-12#264)(2007-8#33)(2007-9#5)(2008-1#128)(2008-10#9869)(2008-11#1831)(2008-12#529)(2008-2#205)(2008-3#948)(2008-4#254)(2008-5#829)(2008-6#177)(2008-7#890)(2008-8#683)(2008-9#790)(2009-1#56)(2009-10#188)(2009-11#48)(2009-12#100)(2009-2#9)(2009-3#64)(2009-4#36)(2009-5#80)(2009-6#68)(2009-7#166)(2009-8#212)(2009-9#50)(2010-1#109)(2010-10#108)(2010-11#90)(2010-12#138)(2010-2#26)(2010-3#51)(2010-4#97)(2010-5#98)(2010-6#92)(2010-7#103)(2010-8#150)(2010-9#48)(2011-1#137)(2011-10#11)(2011-2#1312)(2011-3#94)(2011-4#5)(2011-7#21)(2011-8#1)(2012-12#226)(2012-2#479)(2012-3#472)(2012-4#2)(2012-5#15)(2012-6#6)(2012-7#6)(2012-8#3)(2012-9#5)(2013-1#762)(2013-2#2)(2013-3#1)(2013-7#29)(2013-8#354)
of theanine##4##2##(2008-11#4)
of their C-terminal##2##3##(1993-8#1)(2010-7#1)
of their ability to##4##4##(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)
of their accuracy##2##3##(2008-10#1)(2011-7#1)
of their actions##2##3##(2008-11#1)(2013-7#1)
of their activity##2##3##(1997-8#1)(2008-10#1)
of their biological##2##3##(2009-3#1)(2011-1#1)
of their chemical properties##3##4##(2008-10#2)(2008-11#1)
of their children##4##3##(1995-1#1)(2011-1#1)(2012-3#2)
of their clinical##5##3##(1997-6#1)(2008-10#1)(2008-12#2)(2008-7#1)
of their complexes with##3##4##(2008-10#3)
of their components##2##3##(2008-10#2)
of their corresponding##2##3##(1992-8#1)(2009-10#1)
of their course##2##3##(2008-11#2)
of their customers'##2##3##(1992-1#2)
of their daily##3##3##(1993-3#1)(2008-11#1)(2012-2#1)
of their degree of##2##4##(2008-9#1)(2013-1#1)
of their detection##3##3##(2008-10#2)(2008-11#1)
of their development##3##3##(1992-6#1)(2009-10#1)(2009-8#1)
of their different##3##3##(2008-10#2)(2008-9#1)
of their distribution##2##3##(1990-5#1)(2008-10#1)
of their effect on##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
of their effectiveness##2##3##(1993-3#1)(1994-2#1)
of their effects on##2##4##(2008-10#1)(2008-8#1)
of their effects##3##3##(2008-10#2)(2008-8#1)
of their efforts##4##3##(1991-8#1)(2008-1#1)(2008-10#1)(2010-10#1)
of their experiences##2##3##(2008-11#1)(2009-12#1)
of their expression##5##3##(1994-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
of their family##2##3##(1995-1#1)(2008-11#1)
of their genetic##3##3##(1992-10#1)(2008-10#1)(2008-12#1)
of their geographical##2##3##(2008-8#1)(2009-6#1)
of their growth kinetics##2##4##(2008-11#2)
of their growth##3##3##(2008-11#2)(2012-2#1)
of their health care##2##4##(1994-1#1)(2008-10#1)
of their health##4##3##(1994-1#1)(2008-10#1)(2010-9#2)
of their hosts##4##3##(2008-8#1)(2012-2#2)(2013-1#1)
of their identity##2##3##(2008-10#1)(2008-11#1)
of their illness##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
of their impact on##2##4##(1992-12#1)(2008-10#1)
of their in##2##3##(2008-8#1)(2009-12#1)
of their individual##3##3##(1995-6#1)(2008-7#1)(2009-8#1)
of their initial##2##3##(1994-2#1)(2010-8#1)
of their interaction with##2##4##(2008-12#1)(2011-2#1)
of their interaction##4##3##(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
of their involvement##2##3##(1995-3#1)(2011-2#1)
of their knowledge##3##3##(2008-11#1)(2011-3#1)(2013-8#1)
of their learning##2##3##(2008-11#1)(2012-3#1)
of their lives##7##3##(1994-9#1)(1997-8#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
of their main##2##3##(2008-10#2)
of their mechanisms of action##3##5##(1995-5#1)(2012-3#1)(2013-1#1)
of their molecular##5##3##(1990-12#1)(1992-6#1)(1995-6#1)(1996-2#1)(2008-4#1)
of their more##3##3##(2013-1#3)
of their new##3##3##(1992-1#1)(2008-11#1)(2010-4#1)
of their occupation##2##3##(2008-11#1)(2009-12#1)
of their overall##4##3##(1991-2#1)(1993-2#1)(2011-1#1)(2012-4#1)
of their own##15##3##(1990-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)
of their parents##2##3##(2008-10#1)(2008-8#1)
of their patients##4##3##(1990-9#1)(1992-1#1)(1992-12#1)(2013-8#1)
of their performance##2##3##(2008-11#1)(2008-7#1)
of their personal##2##3##(1990-5#1)(1996-1#1)
of their potential##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
of their production##3##3##(1995-5#1)(2008-10#1)(2012-2#1)
of their proliferative##2##3##(2008-5#1)(2008-7#1)
of their relative##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
of their resistance##2##3##(1993-2#1)(2008-10#1)
of their respective##6##3##(1990-5#1)(1992-1#1)(1994-1#1)(1996-3#1)(2008-10#1)(2008-9#1)
of their responsiveness to these##2##5##(1990-7#1)(1995-12#1)
of their retention##3##3##(2008-10#3)
of their role##4##3##(1993-6#1)(2008-11#1)(2010-1#1)(2010-11#1)
of their solutions##2##3##(2008-10#1)(2008-9#1)
of their stability##2##3##(2008-10#1)(2012-3#1)
of their students##2##3##(2008-11#1)(2008-12#1)
of their surgery##2##3##(1995-1#1)(2012-3#1)
of their time##2##3##(2008-11#1)(2010-8#1)
of their total FTEs as##2##5##(1996-3#2)
of their total##5##3##(1996-3#3)(1997-2#1)(2008-10#1)
of their training##2##3##(2008-11#2)
of their understanding of##2##4##(2008-12#2)
of their understanding##3##3##(2008-12#2)(2009-12#1)
of their use in##2##4##(1991-12#1)(2008-10#1)
of their use##8##3##(1991-12#2)(1992-3#1)(2008-10#1)(2008-11#3)(2013-8#1)
of their work##3##3##(1991-12#1)(1994-12#1)(2012-2#1)
of their##606##2##(1990-12#2)(1990-5#6)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#6)(1992-10#1)(1992-12#6)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#3)(1993-2#4)(1993-3#3)(1993-6#1)(1993-8#3)(1994-1#5)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#6)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#8)(1996-12#4)(1996-2#4)(1996-3#11)(1996-5#2)(1996-6#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-6#3)(1997-8#3)(2006-5#2)(2007-12#4)(2008-1#3)(2008-10#110)(2008-11#61)(2008-12#14)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#15)(2008-6#2)(2008-7#16)(2008-8#19)(2008-9#21)(2009-10#6)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#8)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#11)(2011-2#20)(2011-3#1)(2011-7#2)(2012-12#4)(2012-2#14)(2012-3#13)(2012-4#2)(2012-5#1)(2013-1#20)(2013-7#2)(2013-8#10)
of them admitted to##2##4##(2008-7#1)(2012-3#1)
of them and##2##3##(1994-8#1)(2013-8#1)
of them are##12##3##(1990-6#1)(1991-5#1)(1995-12#1)(1996-9#1)(2008-10#3)(2008-5#1)(2008-9#2)(2010-8#1)(2012-12#1)
of them being##6##3##(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#2)(2013-1#1)
of them contained##4##3##(1993-8#1)(1995-12#1)(2008-10#2)
of them died##2##3##(1995-2#1)(2011-2#1)
of them exhibit significant similarity to known proteins##2##8##(1996-8#1)(1997-7#1)
of them had a##4##4##(1990-3#1)(1991-11#1)(2008-7#1)(2011-2#1)
of them had##16##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
of them has##2##3##(2008-10#1)(2011-2#1)
of them have been##2##4##(1990-3#1)(1997-8#1)
of them have##5##3##(1990-3#1)(1997-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
of them in##3##3##(1993-6#1)(2008-10#2)
of them is##4##3##(1996-11#1)(2008-10#3)
of them may be##2##4##(1995-8#1)(2011-1#1)
of them may##3##3##(1995-8#1)(2011-1#1)(2013-1#1)
of them presented with##2##4##(1991-8#1)(2008-7#1)
of them presented##3##3##(1991-8#1)(2008-7#1)(2011-2#1)
of them showed##3##3##(1992-12#1)(1995-12#1)(2008-5#1)
of them the##2##3##(1994-3#1)(2008-10#1)
of them was##5##3##(1995-6#1)(2008-10#2)(2008-9#1)(2012-3#1)
of them were identified as##2##5##(2008-10#1)(2008-5#1)
of them were##20##3##(1990-3#1)(1993-2#1)(1995-12#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of them with##2##3##(1991-8#1)(2008-10#1)
of them##209##2##(1990-11#1)(1990-3#3)(1990-6#3)(1991-11#1)(1991-2#2)(1991-5#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#5)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#49)(2008-11#7)(2008-12#1)(2008-4#2)(2008-5#8)(2008-7#12)(2008-8#1)(2008-9#12)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#11)(2012-12#6)(2012-2#1)(2012-3#8)(2012-4#1)(2013-1#9)(2013-7#2)(2013-8#2)
of themes##2##2##(2008-11#1)(2010-10#1)
of themselves##3##2##(1995-3#1)(2008-12#1)(2012-2#1)
of theophylline in tea and drug formulation##2##7##(2008-10#2)
of theophylline##3##2##(2008-10#3)
of theoretical##13##2##(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
of theories##2##2##(2008-9#1)(2013-8#1)
of theory and##2##3##(1993-3#1)(2012-3#1)
of theory to practice##3##4##(2008-11#3)
of theory##10##2##(1993-3#1)(2008-11#5)(2008-12#2)(2008-9#1)(2012-3#1)
of therapeutic aerosols##2##3##(1995-3#1)(1996-2#1)
of therapeutic antibodies##3##3##(2008-11#3)
of therapeutic communication##2##3##(2008-11#2)
of therapeutic efficacy##2##3##(2009-12#1)(2009-8#1)
of therapeutic failure##2##3##(2008-10#1)(2012-2#1)
of therapeutic methods##2##3##(1990-6#1)(2013-1#1)
of therapeutic proteins##4##3##(2008-10#1)(2008-11#2)(2013-8#1)
of therapeutic vaccines##2##3##(2007-12#1)(2008-4#1)
of therapeutic value##2##3##(1993-2#1)(2009-8#1)
of therapeutic##48##2##(1990-6#1)(1993-2#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-12#2)(2009-6#1)(2009-8#2)(2010-6#1)(2011-2#1)(2011-9#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
of therapy and##6##3##(2008-10#1)(2009-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
of therapy for##8##3##(1992-2#2)(2008-11#1)(2008-7#1)(2010-12#3)(2012-2#1)
of therapy in the##3##4##(2008-10#2)(2009-6#1)
of therapy in##4##3##(2008-10#2)(2009-6#1)(2009-9#1)
of therapy progress feedback##2##4##(2012-2#2)
of therapy progress##4##3##(2012-2#4)
of therapy with##3##3##(1996-3#1)(2013-1#2)
of therapy##78##2##(1990-12#3)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-2#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#3)(2010-6#5)(2011-1#1)(2011-2#1)(2012-2#9)(2012-3#2)(2013-1#7)(2013-8#1)
of thermal annealing##2##3##(2008-2#2)
of thermal decomposition products##2##4##(2008-10#2)
of thermal decomposition##4##3##(2008-10#4)
of thermal effects in a diode-end-pumped##2##6##(2008-2#2)
of thermal hyperalgesia##4##3##(1995-12#4)
of thermal inactivation##2##3##(2008-10#2)
of thermal injury on##3##4##(2008-9#3)
of thermal injury##4##3##(1995-1#1)(2008-9#3)
of thermal lens spectrometry##3##4##(2008-10#3)
of thermal lensing##6##3##(2008-10#2)(2008-3#4)
of thermal##45##2##(1992-3#1)(1995-1#1)(1995-12#4)(2008-10#18)(2008-2#5)(2008-3#9)(2008-9#3)(2009-3#1)(2009-5#1)(2011-2#1)(2013-8#1)
of thermally induced birefringence##2##4##(2008-2#1)(2008-3#1)
of thermally induced##3##3##(1994-5#1)(2008-2#1)(2008-3#1)
of thermally##4##2##(1994-5#1)(2008-2#1)(2008-3#1)(2009-5#1)
of thermodynamic##4##2##(2008-10#3)(2008-3#1)
of thermodynamics##2##2##(1993-12#1)(2008-3#1)
of thermogenesis##2##2##(2013-1#2)
of thermolysin##3##2##(1994-5#3)
of thermostable##2##2##(2008-10#1)(2008-7#1)
of these 2##3##3##(1992-2#1)(1997-2#1)(2009-1#1)
of these 3##2##3##(1990-6#1)(1991-3#1)
of these ORFs##3##3##(1991-9#1)(1995-9#1)(2008-10#1)
of these advantages##2##3##(1994-3#1)(2012-2#1)
of these agents##13##3##(1993-8#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
of these alterations##2##3##(2008-2#1)(2010-12#1)
of these amino acids##3##4##(1995-6#1)(2008-10#2)
of these analyses##5##3##(1994-1#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-11#1)
of these analytes##2##3##(2008-10#2)
of these and##5##3##(1993-6#1)(1995-11#1)(1996-2#1)(2008-10#1)(2010-1#1)
of these animals##4##3##(1996-12#2)(2008-10#1)(2008-9#1)
of these annulenes##2##3##(1996-5#2)
of these antibiotics##3##3##(2008-10#2)(2008-11#1)
of these antibodies##3##3##(1991-5#1)(1996-11#2)
of these approaches##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#2)(2013-1#1)
of these are##6##3##(1996-3#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-12#1)(2012-2#1)
of these areas##3##3##(1994-8#1)(1997-2#1)(2008-12#1)
of these aspects##2##3##(2008-10#1)(2008-11#1)
of these assays are##2##4##(2008-10#1)(2008-12#1)
of these assays##8##3##(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#1)
of these attitudes##2##3##(1996-2#1)(2010-10#1)
of these bacteria##8##3##(2008-10#7)(2011-2#1)
of these bands##2##3##(2008-10#2)
of these behaviors##2##3##(1993-6#1)(2008-4#1)
of these benzamides##2##3##(1990-5#1)(2008-10#1)
of these biosensors##2##3##(2008-10#2)
of these cDNAs##2##3##(1993-12#2)
of these cancers##2##3##(2008-11#1)(2013-1#1)
of these cases are##4##4##(1991-8#1)(2010-1#1)(2013-1#2)
of these cases##21##3##(1991-12#2)(1991-8#1)(1993-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
of these categories and##2##4##(2008-11#1)(2008-12#1)
of these categories##3##3##(1995-6#1)(2008-11#1)(2008-12#1)
of these cell bioassay systems##2##5##(2008-10#2)
of these cell lines##6##4##(1992-8#1)(1993-3#1)(1995-6#1)(2008-11#2)(2008-4#1)
of these cell##9##3##(1991-5#1)(1992-8#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-4#1)
of these cells are##2##4##(2008-4#1)(2008-9#1)
of these cells in a##2##5##(2008-11#1)(2010-1#1)
of these cells in the##2##5##(1992-9#1)(1996-12#1)
of these cells in##4##4##(1992-9#1)(1996-12#1)(2008-11#1)(2010-1#1)
of these cells were##4##4##(1992-6#1)(1993-3#1)(2008-8#1)(2008-9#1)
of these cells##32##3##(1992-12#1)(1992-6#1)(1992-9#2)(1993-3#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-1#1)(2013-1#1)
of these changes##5##3##(1991-2#1)(1992-2#1)(1995-1#1)(2008-6#1)(2008-8#1)
of these channels##2##3##(1994-11#2)
of these characteristic##2##3##(2010-10#1)(2012-12#1)
of these characteristics##2##3##(2008-11#1)(2008-3#1)
of these chemicals in##2##4##(1993-3#1)(2008-10#1)
of these chemicals##7##3##(1993-3#1)(2008-10#5)(2008-11#1)
of these children were##2##4##(1990-12#1)(1996-1#1)
of these children##6##3##(1990-12#1)(1994-6#1)(1996-1#1)(2008-2#1)(2010-2#1)(2011-2#1)
of these chromosomes##2##3##(1996-12#1)(2008-7#1)
of these clinical##4##3##(1994-12#1)(2010-6#1)(2013-7#2)
of these clones were##2##4##(1991-12#1)(2008-11#1)
of these clones##4##3##(1991-12#1)(1997-8#2)(2008-11#1)
of these complexes in##3##4##(1992-9#1)(2008-10#1)(2008-11#1)
of these complexes##10##3##(1992-9#2)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-11#1)
of these components in##2##4##(1994-5#1)(1997-3#1)
of these components##10##3##(1994-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2009-8#1)(2010-1#1)(2011-2#1)
of these compounds and##2##4##(2008-10#1)(2009-8#1)
of these compounds are##4##4##(2008-10#4)
of these compounds has##2##4##(2008-10#1)(2008-11#1)
of these compounds in natural##2##5##(2008-10#2)
of these compounds in the##2##5##(2008-10#1)(2010-5#1)
of these compounds in##15##4##(1994-2#1)(2008-10#11)(2008-5#2)(2010-5#1)
of these compounds on the##2##5##(2008-10#2)
of these compounds on##3##4##(1990-11#1)(2008-10#2)
of these compounds was##7##4##(2008-10#4)(2008-11#2)(2012-2#1)
of these compounds were##6##4##(1990-11#1)(1993-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
of these compounds with##2##4##(1991-5#1)(2008-10#1)
of these compounds##64##3##(1990-11#2)(1990-7#1)(1991-5#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(2008-10#42)(2008-11#6)(2008-5#2)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
of these conditions##8##3##(2008-3#1)(2008-5#1)(2008-8#2)(2010-10#1)(2012-2#1)(2012-3#1)(2012-7#1)
of these constructs##2##3##(2008-11#1)(2008-12#1)
of these control##3##3##(2008-10#2)(2013-8#1)
of these criteria##4##3##(1993-8#1)(1997-8#1)(2010-12#1)(2010-2#1)
of these data##8##3##(1995-9#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
of these deletants##2##3##(2008-8#2)
of these descriptors##2##3##(2008-10#2)
of these developments##3##3##(1991-2#1)(1993-1#1)(2008-10#1)
of these devices##6##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#2)(2010-7#1)
of these diabetic##2##3##(2008-1#1)(2008-10#1)
of these differences in##3##4##(1993-12#1)(2008-8#2)
of these differences##9##3##(1991-12#1)(1993-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)
of these diseases are##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
of these diseases##9##3##(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-8#1)
of these disorders##6##3##(1992-1#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-3#1)
of these drugs in##3##4##(1991-8#1)(2007-11#1)(2008-10#1)
of these drugs on##2##4##(2008-10#1)(2013-1#1)
of these drugs##26##3##(1991-1#1)(1991-8#1)(1992-12#1)(1996-11#1)(1997-1#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#2)
of these effects##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)
of these electrodes to##2##4##(2008-10#2)
of these electrodes##6##3##(2008-10#6)
of these elements from##2##4##(2008-10#2)
of these elements in##3##4##(2008-10#2)(2009-6#1)
of these elements##17##3##(1993-6#1)(2008-10#10)(2008-3#1)(2008-7#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
of these entities##2##3##(1996-3#1)(2010-7#1)
of these enzymes##10##3##(1994-8#2)(2008-10#6)(2008-11#1)(2008-6#1)
of these events##4##3##(2008-10#2)(2008-9#2)
of these experiments##5##3##(1995-6#1)(2008-10#4)
of these factors are##4##4##(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)
of these factors in##2##4##(2011-2#1)(2013-8#1)
of these factors is##2##4##(2008-10#1)(2009-10#1)
of these factors on##2##4##(2008-10#2)
of these factors##17##3##(1991-11#1)(1993-1#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#2)(2013-8#1)
of these features##4##3##(1991-12#1)(1994-6#1)(2007-12#1)(2008-3#1)
of these findings are discussed##4##5##(1991-2#1)(1994-2#1)(2009-7#1)(2010-9#1)
of these findings are##5##4##(1991-2#1)(1994-2#1)(2008-5#1)(2009-7#1)(2010-9#1)
of these findings for the##3##5##(1991-5#1)(2008-10#1)(2009-11#1)
of these findings for##7##4##(1991-5#1)(2008-10#2)(2009-11#1)(2009-4#1)(2009-7#1)(2012-2#1)
of these findings in##3##4##(1996-3#1)(2008-10#1)(2011-2#1)
of these findings##26##3##(1991-2#1)(1991-5#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2009-11#2)(2009-4#1)(2009-7#3)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
of these five##4##3##(1993-8#1)(2008-10#2)(2013-1#1)
of these formae speciales##2##4##(2008-10#2)
of these forms##3##3##(1990-2#1)(2008-3#1)(2008-9#1)
of these four##5##3##(2008-10#4)(2008-9#1)
of these fractures##2##3##(2013-1#2)
of these functions##3##3##(1995-6#1)(1997-1#1)(2013-1#1)
of these fungi##3##3##(2008-10#2)(2013-1#1)
of these genes are##2##4##(2011-2#1)(2013-8#1)
of these genes in##7##4##(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#2)
of these genes to##2##4##(2008-10#2)
of these genes were##5##4##(2008-10#3)(2008-8#1)(2013-8#1)
of these genes##42##3##(1992-9#1)(1993-12#3)(1993-9#1)(1994-9#1)(1995-12#3)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#10)(2008-11#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-8#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#3)
of these genomic##2##3##(1997-3#1)(2008-11#1)
of these groups is##2##4##(2008-10#2)
of these groups##5##3##(1991-12#1)(2008-10#3)(2008-11#1)
of these guidelines##2##3##(2008-10#1)(2008-11#1)
of these had developed AIDS and##3##6##(1996-11#3)
of these had##5##3##(1996-11#4)(2008-5#1)
of these have been##4##4##(1994-9#1)(2008-7#1)(2008-9#1)(2009-8#1)
of these have##6##3##(1994-9#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)
of these health##2##3##(1996-12#1)(2008-4#1)
of these herbicides in##4##4##(2008-10#4)
of these herbicides##6##3##(1996-3#1)(2008-10#5)
of these highly##2##3##(2008-5#2)
of these hormones##2##3##(1996-12#1)(2008-1#1)
of these hospitals##2##3##(1992-12#1)(1992-2#1)
of these human##2##3##(1990-5#1)(1994-5#1)
of these hypotheses##2##3##(2008-9#2)
of these immunological##2##3##(2007-11#1)(2013-7#1)
of these in##3##3##(1994-8#1)(2008-5#1)(2013-1#1)
of these individuals##7##3##(1991-11#1)(1995-3#1)(1997-8#1)(2008-11#3)(2010-11#1)
of these infections##6##3##(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#3)
of these initial##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
of these injuries##3##3##(1990-6#1)(1994-3#2)
of these instruments##2##3##(2008-10#1)(2011-2#1)
of these interactions is##2##4##(2008-10#1)(2011-2#1)
of these interactions##4##3##(2008-10#3)(2011-2#1)
of these interventions in##2##4##(2008-10#1)(2008-2#1)
of these interventions##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#3)
of these ions##11##3##(2008-10#11)
of these islands##2##3##(1990-5#1)(2008-8#1)
of these isolates was##3##4##(2008-10#3)
of these isolates were determined##2##5##(2008-10#2)
of these isolates were##4##4##(2008-10#3)(2013-8#1)
of these isolates##20##3##(1995-12#1)(2008-10#18)(2013-8#1)
of these issues is##2##4##(2007-12#1)(2011-1#1)
of these issues##7##3##(1990-6#1)(1991-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2010-5#1)(2011-1#1)
of these items##2##3##(1996-3#1)(2008-7#1)
of these large##2##3##(1992-2#1)(2012-3#1)
of these lasers##2##3##(2008-3#2)
of these latter##2##3##(2008-10#1)(2008-7#1)
of these lesions is##2##4##(2008-7#1)(2012-2#1)
of these lesions##9##3##(1992-2#1)(1994-6#1)(1995-2#1)(1996-9#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#2)
of these limitations##2##3##(2008-5#1)(2008-9#1)
of these lineages##2##3##(2008-10#2)
of these lines##2##3##(2008-10#2)
of these lipids##2##3##(1993-8#1)(2008-10#1)
of these loci##3##3##(2008-10#1)(2009-10#1)(2013-8#1)
of these markers##4##3##(1991-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
of these materials##6##3##(2008-10#2)(2008-3#1)(2009-7#1)(2010-7#1)(2012-2#1)
of these measurements##3##3##(2008-3#2)(2008-9#1)
of these measures##4##3##(1990-2#1)(1992-9#1)(2008-9#1)(2011-2#1)
of these mechanisms in##2##4##(2011-2#2)
of these mechanisms##9##3##(1993-9#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#3)
of these media##2##3##(2012-2#2)
of these membranes to##2##4##(1991-5#1)(2009-8#1)
of these membranes##3##3##(1991-5#1)(1992-7#1)(2009-8#1)
of these metabolites##4##3##(1991-5#1)(1994-8#1)(2008-10#1)(2008-11#1)
of these metal ions were##2##5##(2008-10#2)
of these metal ions##13##4##(2008-10#13)
of these metals in the##2##5##(2008-10#1)(2011-1#1)
of these metals in##6##4##(2008-10#4)(2011-1#2)
of these metals was##2##4##(2008-10#2)
of these metals##11##3##(2008-10#9)(2011-1#2)
of these methods are##2##4##(2008-10#1)(2008-9#1)
of these methods to##3##4##(1994-9#1)(2008-10#1)(2008-8#1)
of these methods##17##3##(1992-1#1)(1994-9#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#1)
of these microbes##2##3##(2008-10#1)(2011-2#1)
of these mixtures##2##3##(1993-8#1)(2008-10#1)
of these models to##2##4##(2008-8#1)(2012-4#1)
of these models##10##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-9#1)(2012-2#1)(2012-4#1)
of these modified##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
of these molecules in##2##4##(1991-2#1)(2008-5#1)
of these molecules with##2##4##(2008-10#1)(2009-10#1)
of these molecules##15##3##(1991-2#1)(1991-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2009-10#1)(2013-8#1)
of these mutants##6##3##(1995-2#1)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
of these mutations on##2##4##(2008-11#2)
of these mutations##8##3##(1993-3#1)(1995-6#1)(1997-8#1)(2008-11#2)(2008-7#1)(2009-4#1)(2012-3#1)
of these natural##2##3##(1992-3#1)(2008-11#1)
of these neoplasms##3##3##(1990-5#1)(2012-2#1)(2013-1#1)
of these neurons##5##3##(1994-2#1)(1996-12#1)(2008-11#3)
of these new##7##3##(1997-4#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-7#1)(2011-3#1)
of these nine##2##3##(1996-3#1)(2008-10#1)
of these novel##6##3##(1997-8#1)(2008-10#2)(2008-4#1)(2012-3#1)(2013-1#1)
of these nucleosides##2##3##(1992-3#2)
of these observations##4##3##(1996-2#1)(2008-10#1)(2010-9#1)(2011-2#1)
of these oligosaccharides##2##3##(2008-12#1)(2012-2#1)
of these options##3##3##(1997-7#1)(2008-1#1)(2008-10#1)
of these organisms in the##2##5##(2011-2#2)
of these organisms##5##3##(2008-11#1)(2008-9#1)(2011-2#2)(2012-2#1)
of these organizations##2##3##(1994-12#1)(1996-3#1)
of these parameters in##2##4##(2007-8#1)(2008-10#1)
of these parameters on the##2##5##(2008-10#1)(2011-2#1)
of these parameters on##4##4##(2008-10#3)(2011-2#1)
of these parameters##9##3##(2007-8#1)(2008-10#6)(2008-5#1)(2011-2#1)
of these parasites##2##3##(2012-2#1)(2013-8#1)
of these pathogens are##2##4##(2008-10#2)
of these pathogens##8##3##(1995-5#1)(2007-12#1)(2008-10#6)
of these pathways is##2##4##(1995-12#1)(2012-3#1)
of these pathways##4##3##(1995-12#1)(1996-2#1)(2008-4#1)(2012-3#1)
of these patients and##2##4##(1991-6#1)(2011-2#1)
of these patients are##3##4##(1990-9#1)(1997-8#1)(2013-1#1)
of these patients as##2##4##(2008-7#1)(2012-3#1)
of these patients had##4##4##(1990-12#1)(1995-2#1)(2011-2#1)(2012-3#1)
of these patients is##2##4##(1990-9#1)(2009-12#1)
of these patients were##3##4##(1991-2#1)(1994-9#1)(2008-9#1)
of these patients##51##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#2)(1991-2#3)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-2#2)(1997-4#1)(1997-8#3)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#3)
of these patterns##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
of these peaks##4##3##(1990-5#2)(2008-10#1)(2008-9#1)
of these peptides to##2##4##(1994-11#1)(2008-10#1)
of these peptides##8##3##(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(2008-10#1)(2009-6#1)(2011-2#1)
of these persons##3##3##(1994-2#1)(2012-2#2)
of these pesticides##4##3##(2008-10#4)
of these plants##5##3##(2008-10#4)(2009-8#1)
of these plasmids##2##3##(2008-5#2)
of these policies##2##3##(1993-3#1)(1997-7#1)
of these polymers##2##3##(2008-10#1)(2008-11#1)
of these polymorphic##2##3##(2008-9#1)(2013-8#1)
of these populations are##2##4##(2008-10#1)(2008-8#1)
of these populations changed##2##4##(2008-10#2)
of these populations##10##3##(2008-1#1)(2008-10#6)(2008-8#1)(2012-3#1)(2012-7#1)
of these probes##2##3##(2008-10#1)(2008-9#1)
of these problems##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
of these procedures##6##3##(1993-12#1)(1994-12#1)(2008-10#1)(2008-9#1)(2009-9#1)(2012-2#1)
of these processes may##2##4##(2008-11#1)(2008-5#1)
of these processes##10##3##(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)
of these products is##2##4##(2008-10#2)
of these products##10##3##(1997-3#1)(2008-10#7)(2008-11#2)
of these programs##7##3##(2008-10#1)(2011-3#2)(2013-1#4)
of these properties##3##3##(1994-8#1)(2008-7#1)(2011-2#1)
of these protein##2##3##(2008-10#1)(2008-11#1)
of these proteins are##2##4##(1993-2#1)(2008-7#1)
of these proteins in##3##4##(1995-2#2)(2008-11#1)
of these proteins is##2##4##(2008-11#1)(2008-7#1)
of these proteins##21##3##(1990-11#1)(1993-2#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#2)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
of these providers##2##3##(1997-1#1)(1997-2#1)
of these pumps##3##3##(2011-2#3)
of these putative##2##3##(2008-10#1)(2008-11#1)
of these rare##3##3##(2010-1#1)(2010-12#1)(2011-2#1)
of these reactions##6##3##(1995-6#1)(2008-10#4)(2008-7#1)
of these reagents##2##3##(2008-10#1)(2008-4#1)
of these receptors##5##3##(1993-2#2)(1995-12#1)(1996-12#1)(2008-10#1)
of these reference##2##3##(2008-10#2)
of these regions##6##3##(1991-10#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(2010-5#1)
of these regulatory##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
of these relationships##4##3##(2008-10#1)(2008-8#1)(2009-8#1)(2010-2#1)
of these repeats##2##3##(1992-10#1)(2008-10#1)
of these reports##2##3##(2013-1#1)(2013-8#1)
of these residues##2##3##(1992-4#1)(1993-8#1)
of these results and##2##4##(2008-10#1)(2009-8#1)
of these results are discussed##2##5##(1991-12#1)(2008-11#1)
of these results for##4##4##(1994-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
of these results in##2##4##(2008-10#1)(2013-8#1)
of these results##27##3##(1991-12#1)(1993-1#1)(1994-1#1)(1994-5#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
of these risk##2##3##(2010-6#1)(2012-2#1)
of these roles##2##3##(2008-12#1)(2011-1#1)
of these same##3##3##(1994-2#1)(1995-1#1)(2008-10#1)
of these samples##9##3##(1994-8#1)(2008-10#5)(2008-11#1)(2010-4#1)(2013-1#1)
of these seaweeds revealed##2##4##(2008-11#2)
of these sensors##4##3##(2008-10#4)
of these sequences##5##3##(1993-6#1)(2008-10#4)
of these services##5##3##(1994-1#3)(1995-2#1)(1997-8#1)
of these sets##2##3##(2008-3#1)(2010-9#1)
of these signaling##2##3##(2008-9#1)(2009-9#1)
of these sites##2##3##(1996-3#1)(2012-2#1)
of these sources##2##3##(2008-1#1)(2008-10#1)
of these species in##3##4##(2008-10#1)(2008-5#1)(2010-8#1)
of these species##14##3##(2007-12#1)(2008-10#10)(2008-5#1)(2010-8#1)(2012-2#1)
of these specific##3##3##(1994-2#1)(2008-11#1)(2010-8#1)
of these spectra##2##3##(2008-10#2)
of these stages##2##3##(2008-10#1)(2013-8#1)
of these steps##2##3##(2008-9#1)(2011-2#1)
of these steroids##2##3##(1990-11#1)(2012-3#1)
of these strains was##2##4##(2008-10#2)
of these strains were##2##4##(2008-10#2)
of these strains##11##3##(1993-12#1)(2008-10#8)(2008-8#1)(2009-6#1)
of these strategies##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2011-1#1)
of these structures in##2##4##(2009-12#1)(2011-2#1)
of these structures##9##3##(1990-12#1)(2007-12#2)(2008-10#2)(2008-4#1)(2009-12#1)(2011-2#2)
of these students##2##3##(2008-11#1)(2013-8#1)
of these studies##16##3##(1991-9#1)(1993-11#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2013-1#1)
of these subjects##2##3##(1995-5#1)(2008-10#1)
of these sublines##2##3##(2008-11#2)
of these substances##6##3##(1991-9#1)(1994-3#1)(1994-8#1)(2008-10#2)(2009-7#1)
of these substrates##2##3##(1996-5#1)(2008-11#1)
of these sunscreens##2##3##(2008-5#2)
of these surfaces##2##3##(2008-2#1)(2013-1#1)
of these symmetries##2##3##(2008-3#1)(2010-8#1)
of these syndromes##3##3##(1996-6#1)(2009-12#2)
of these synthetic##2##3##(1993-8#1)(2008-6#1)
of these systems are compared##2##5##(2008-3#1)(2011-2#1)
of these systems in##3##4##(1994-1#1)(2008-3#1)(2008-8#1)
of these systems is##2##4##(2008-11#1)(2011-7#1)
of these systems##17##3##(1994-1#1)(1994-2#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#1)(2011-7#1)
of these techniques are##2##4##(1991-9#1)(2008-3#1)
of these techniques in the##2##5##(2008-11#1)(2012-2#1)
of these techniques in##3##4##(2008-11#1)(2012-2#1)(2012-3#1)
of these techniques is##2##4##(2008-10#1)(2010-11#1)
of these techniques##16##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-9#1)(2012-2#1)(2012-3#2)
of these technologies##3##3##(2008-11#1)(2010-1#1)(2010-7#1)
of these tests##4##3##(2008-10#1)(2008-12#1)(2008-5#2)
of these therapies##2##3##(2008-10#1)(2008-7#1)
of these three compounds##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
of these three##20##3##(1995-11#1)(1996-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2012-2#2)
of these tissues to##2##4##(2008-6#1)(2013-1#1)
of these tissues##4##3##(1990-11#1)(2008-6#1)(2009-7#1)(2013-1#1)
of these tools##2##3##(2008-10#1)(2008-12#1)
of these transcription##2##3##(2008-9#1)(2011-2#1)
of these transcripts##2##3##(2008-10#1)(2008-8#1)
of these transgenic##2##3##(2008-10#2)
of these transporters##3##3##(2008-7#3)
of these treatments##2##3##(2008-10#1)(2010-1#1)
of these tumors and##3##4##(1992-5#1)(1993-6#1)(2013-8#1)
of these tumors##10##3##(1991-8#1)(1992-5#1)(1993-6#1)(1995-2#1)(1997-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
of these two genera##3##4##(2008-10#3)
of these two genes##3##4##(1991-5#1)(1991-9#1)(1994-11#1)
of these two isolates##2##4##(2008-10#2)
of these two types of##3##5##(1995-2#1)(2009-10#1)(2012-3#1)
of these two##52##3##(1991-5#2)(1991-9#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-9#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-8#2)(2010-10#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
of these type##2##3##(1991-3#1)(2008-10#1)
of these uncertainties##2##3##(2008-10#1)(2009-11#1)
of these unique##2##3##(1997-2#1)(2012-2#1)
of these values##5##3##(2008-10#2)(2008-3#2)(2008-5#1)
of these variables in##2##4##(1994-8#1)(1996-12#1)
of these variables##8##3##(1994-8#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-1#1)
of these variants##2##3##(1995-6#2)
of these variations##2##3##(1993-1#1)(2013-1#1)
of these various##2##3##(2008-10#1)(2011-2#1)
of these vectors##2##3##(1993-12#1)(1993-2#1)
of these viruses##9##3##(1995-2#1)(2008-10#7)(2013-8#1)
of these were treated##2##4##(1997-3#1)(1997-4#1)
of these were##12##3##(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-9#2)
of these women##2##3##(1991-9#1)(2009-9#1)
of these yeasts##2##3##(2008-5#1)(2013-1#1)
of these##2022##2##(1990-11#6)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#8)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#14)(1991-2#11)(1991-3#8)(1991-5#9)(1991-6#5)(1991-8#3)(1991-9#6)(1992-1#5)(1992-10#1)(1992-12#9)(1992-2#7)(1992-3#8)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#8)(1993-1#6)(1993-11#2)(1993-12#16)(1993-2#8)(1993-3#5)(1993-6#9)(1993-8#14)(1993-9#4)(1994-1#7)(1994-11#11)(1994-12#8)(1994-2#15)(1994-3#10)(1994-5#9)(1994-6#6)(1994-8#11)(1994-9#7)(1995-1#3)(1995-11#7)(1995-12#9)(1995-2#20)(1995-3#7)(1995-5#5)(1995-6#18)(1995-8#3)(1995-9#4)(1996-1#6)(1996-11#9)(1996-12#16)(1996-2#12)(1996-3#13)(1996-5#6)(1996-6#6)(1996-9#1)(1997-1#5)(1997-2#15)(1997-3#10)(1997-4#5)(1997-6#2)(1997-7#6)(1997-8#19)(1997-9#2)(2006-6#2)(2007-11#3)(2007-12#15)(2007-8#1)(2008-1#15)(2008-10#585)(2008-11#143)(2008-12#23)(2008-2#11)(2008-3#39)(2008-4#28)(2008-5#45)(2008-6#11)(2008-7#51)(2008-8#42)(2008-9#60)(2009-1#1)(2009-10#18)(2009-11#8)(2009-12#14)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#8)(2009-8#19)(2009-9#8)(2010-1#11)(2010-10#8)(2010-11#8)(2010-12#8)(2010-2#6)(2010-3#4)(2010-4#4)(2010-5#8)(2010-6#7)(2010-7#9)(2010-8#8)(2010-9#7)(2011-1#17)(2011-10#1)(2011-2#82)(2011-3#6)(2011-7#1)(2012-12#4)(2012-2#49)(2012-3#25)(2012-4#1)(2012-7#3)(2013-1#52)(2013-7#3)(2013-8#29)
of theses##2##2##(2012-3#1)(2013-1#1)
of theta phase precession in##2##5##(2008-11#2)
of theta##3##2##(2008-11#2)(2008-8#1)
of thiamine and benfotiamine##2##4##(2012-4#2)
of thiamine with##2##3##(2008-10#2)
of thiamine##12##2##(2008-10#10)(2012-4#2)
of thick##3##2##(1997-3#1)(2008-10#2)
of thienorphine metabolism##2##3##(2011-3#2)
of thienorphine##9##2##(2011-3#9)
of thigh##2##2##(2008-5#2)
of thin Al2O3 films##2##4##(2008-3#2)
of thin##17##2##(2008-10#10)(2008-11#1)(2008-3#4)(2008-7#1)(2010-11#1)
of thin-film##3##2##(2008-10#2)(2008-3#1)
of things##3##2##(1995-2#1)(2012-3#2)
of thinking about##2##3##(2010-5#1)(2013-8#1)
of thinking##6##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-5#1)(2013-8#1)
of thiobarbituric acid##3##3##(1992-3#2)(2008-11#1)
of thiocyanate in##3##3##(2008-10#3)
of thiocyanate##11##2##(2008-10#11)
of thiocyanato-complexes##2##2##(2008-10#2)
of thiocytosine##2##2##(2008-10#2)
of thiol##5##2##(1992-3#1)(1994-8#1)(2008-10#3)
of thiolic proteins##2##3##(2008-10#2)
of thiols at##2##3##(2008-10#2)
of thiols in##2##3##(2008-10#2)
of thiols##7##2##(2008-10#6)(2009-9#1)
of thiorphan##2##2##(1996-2#2)
of thiosulfate##3##2##(2008-10#3)
of thiourea B13 analogues was##2##5##(2011-2#2)
of thiourea##7##2##(2008-10#5)(2011-2#2)
of third##4##2##(1993-1#1)(1996-11#1)(2008-12#1)(2013-1#1)
of third-order##2##2##(2007-11#1)(2008-2#1)
of thirteen##4##2##(1997-2#1)(2008-7#1)(2012-3#1)(2013-1#1)
of this &quot##4##3##(1997-3#1)(2008-10#1)(2012-2#1)(2013-8#1)
of this RNA##2##3##(1990-5#1)(2008-10#1)
of this actual##2##3##(1997-2#1)(2012-12#1)
of this age##3##3##(2008-11#1)(2008-12#1)(2010-8#1)
of this analysis is##2##4##(1995-12#1)(2008-12#1)
of this analysis##9##3##(1995-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2011-2#1)
of this analyte##2##3##(2008-10#2)
of this and##2##3##(2008-10#1)(2011-2#1)
of this apparently##2##3##(1997-1#1)(2008-10#1)
of this approach are##2##4##(2008-10#1)(2010-11#1)
of this approach for##2##4##(1994-5#1)(2010-8#1)
of this approach in##2##4##(2008-5#1)(2010-5#1)
of this approach is##6##4##(1992-3#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-7#1)(2012-3#1)
of this approach that##2##4##(2008-5#1)(2012-12#1)
of this approach was##4##4##(2008-10#4)
of this approach we##2##4##(2008-3#2)
of this approach##32##3##(1992-3#1)(1994-5#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)
of this are discussed##2##4##(2008-10#1)(2008-7#1)
of this area##4##3##(2008-10#3)(2008-9#1)
of this arrangement##2##3##(1996-2#1)(2008-11#1)
of this article is to describe a##2##7##(2008-12#1)(2011-2#1)
of this article is to describe the##3##7##(1994-1#1)(2008-12#1)(2008-5#1)
of this article is to describe##5##6##(1994-1#1)(2008-12#2)(2008-5#1)(2011-2#1)
of this article is to present a##2##7##(1993-12#1)(2013-1#1)
of this article is to present##5##6##(1993-12#1)(1997-8#1)(2012-3#1)(2013-1#2)
of this article is to provide a##4##7##(1997-3#1)(2010-11#1)(2011-1#1)(2012-2#1)
of this article is to provide##7##6##(1997-3#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
of this article is to report##2##6##(2008-11#1)(2013-1#1)
of this article is to##39##5##(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
of this article is##42##4##(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
of this article was to review##2##6##(2011-7#1)(2012-2#1)
of this article was to##3##5##(2010-11#1)(2011-7#1)(2012-2#1)
of this article##77##3##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#5)(2011-7#1)(2012-2#12)(2012-3#4)(2013-1#7)(2013-8#1)
of this assay##7##3##(1991-12#1)(1992-12#1)(1995-11#1)(2008-10#4)
of this assessment##2##3##(2008-11#1)(2011-3#1)
of this association##4##3##(1991-12#1)(2008-10#2)(2013-1#1)
of this bacterial##2##3##(2008-10#2)
of this bacterium##2##3##(1993-8#1)(2008-9#1)
of this cancer##3##3##(2010-12#2)(2012-2#1)
of this case is that##2##5##(2008-1#1)(2010-6#1)
of this case report is to##2##6##(2008-8#1)(2010-9#1)
of this case report##5##4##(2008-1#1)(2008-8#1)(2010-9#1)(2012-12#1)(2013-8#1)
of this case study##4##4##(1991-1#1)(1992-3#1)(1993-1#1)(2010-5#1)
of this case##17##3##(1990-6#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-1#1)(2008-1#2)(2008-12#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
of this cell line##3##4##(1990-5#1)(2008-11#2)
of this cell##5##3##(1990-5#1)(1991-2#1)(1993-6#1)(2008-11#2)
of this chromosome##2##3##(1997-6#1)(2008-10#1)
of this class of compounds##2##5##(1993-8#2)
of this class of##5##4##(1991-12#1)(1993-8#2)(2008-10#1)(2012-3#1)
of this class##6##3##(1991-12#1)(1993-8#2)(2008-10#2)(2012-3#1)
of this clone##5##3##(1990-2#1)(1992-3#1)(1993-6#1)(1994-8#1)(1995-2#1)
of this collaborative##2##3##(2008-11#1)(2008-12#1)
of this combination##2##3##(1997-3#1)(2008-12#1)
of this complex##9##3##(1990-5#1)(1992-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-8#1)
of this complexity##2##3##(2008-4#1)(2008-5#1)
of this complication##7##3##(1991-3#1)(1997-3#1)(2008-7#2)(2013-1#3)
of this compound##7##3##(1993-1#1)(2008-10#6)
of this concept##2##3##(1992-12#1)(2008-10#1)
of this condition and##3##4##(2010-12#1)(2010-5#1)(2011-2#1)
of this condition is##4##4##(2009-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
of this condition##22##3##(1991-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#3)(2011-2#4)(2012-2#1)(2013-1#3)
of this decline##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
of this derivative##2##3##(1997-2#1)(2008-10#1)
of this detection##2##3##(2008-10#2)
of this detector##2##3##(2008-10#2)
of this device##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
of this diagnosis##3##3##(2013-1#3)
of this discussion##2##3##(2008-10#1)(2010-3#1)
of this disease are##2##4##(1997-8#1)(2008-10#1)
of this disease is##3##4##(2008-7#1)(2010-5#1)(2011-2#1)
of this disease was##2##4##(2008-10#2)
of this disease##52##3##(1990-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-8#3)(2008-1#1)(2008-10#18)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#1)
of this disorder is##2##4##(2008-8#1)(2011-2#1)
of this disorder##9##3##(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-2#3)(2013-1#1)
of this distinction##2##3##(2008-11#2)
of this domain##2##3##(1991-10#1)(1991-3#1)
of this drug in##4##4##(1991-12#1)(2008-10#2)(2008-11#1)
of this drug with##2##4##(2008-10#1)(2012-12#1)
of this drug##14##3##(1991-12#1)(1997-2#3)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2010-2#1)(2012-12#1)
of this dsRNA##4##3##(2008-10#4)
of this effect in##2##4##(1990-6#1)(2008-9#1)
of this effect is##3##4##(1991-9#1)(1997-2#1)(2009-8#1)
of this effect##11##3##(1990-3#1)(1990-6#1)(1991-9#1)(1994-3#1)(1995-8#2)(1997-2#1)(2008-10#2)(2008-9#1)(2009-8#1)
of this electrode was##3##4##(2008-10#3)
of this electrode##9##3##(2008-10#9)
of this element in##3##4##(2008-10#3)
of this element##10##3##(2008-10#9)(2009-9#1)
of this enhancement##2##3##(1995-12#1)(2009-7#1)
of this entity##2##3##(2011-2#1)(2012-3#1)
of this enzyme during##2##4##(2008-10#1)(2008-7#1)
of this enzyme##18##3##(1990-5#1)(1991-5#1)(1992-10#2)(1992-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-1#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
of this experience##2##3##(2008-11#2)
of this experiment##2##3##(2008-10#1)(2008-3#1)
of this extract##2##3##(2008-11#1)(2008-5#1)
of this family##7##3##(1993-6#1)(1996-2#1)(2008-10#2)(2009-9#1)(2011-2#2)
of this feature##2##3##(1996-9#1)(2010-5#1)
of this finding##2##3##(1990-12#1)(2009-3#1)
of this form of##3##4##(1990-5#1)(1994-6#1)(2008-10#1)
of this functional group##2##4##(2008-10#2)
of this fungus##5##3##(2008-10#4)(2008-5#1)
of this gene contains##2##4##(1993-12#1)(2008-11#1)
of this gene in##2##4##(1997-7#1)(2008-10#1)
of this gene is##3##4##(1993-2#1)(1995-6#1)(2008-10#1)
of this gene was##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
of this gene with##2##4##(1997-3#1)(2008-10#1)
of this gene##20##3##(1993-12#1)(1993-2#2)(1993-8#1)(1995-6#1)(1997-3#1)(1997-7#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2009-8#1)
of this genetic##2##3##(1996-12#1)(2013-1#1)
of this genotype##2##3##(2008-10#2)
of this genus##2##3##(2008-10#2)
of this group##7##3##(1993-1#1)(1994-1#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-9#2)
of this highly##3##3##(1991-1#1)(2008-9#1)(2011-2#1)
of this hormone##2##3##(1991-6#1)(1993-6#1)
of this hypothesis##3##3##(1990-11#1)(2008-5#1)(2008-7#1)
of this important##5##3##(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
of this in##2##3##(2008-5#1)(2011-2#1)
of this increase##3##3##(1990-8#1)(1991-3#1)(1991-8#1)
of this increased##2##3##(1994-11#1)(2008-10#1)
of this index##2##3##(2008-10#1)(2008-12#1)
of this information##6##3##(2008-11#3)(2008-4#1)(2008-9#1)(2013-1#1)
of this initiative##2##3##(1991-12#1)(2013-8#1)
of this instrument##2##3##(2008-11#1)(2010-11#1)
of this integrated##2##3##(2008-10#1)(2008-2#1)
of this interaction in##2##4##(2008-9#1)(2012-2#1)
of this interaction##3##3##(1995-2#1)(2008-9#1)(2012-2#1)
of this intervention##2##3##(2008-11#1)(2010-4#1)
of this investigation was to##4##5##(2006-6#1)(2008-10#1)(2009-3#1)(2013-8#1)
of this investigation##7##3##(1990-6#1)(2006-6#1)(2008-10#3)(2009-3#1)(2013-8#1)
of this ion##3##3##(1994-8#1)(2008-10#2)
of this is a##2##4##(1990-11#1)(2012-2#1)
of this is##6##3##(1990-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
of this kind are##2##4##(1995-5#1)(2009-8#1)
of this kind of##9##4##(1990-6#1)(1993-3#1)(2008-10#4)(2008-12#1)(2008-8#1)(2011-1#1)
of this kind##16##3##(1990-6#1)(1993-3#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-3#1)
of this knowledge##3##3##(1991-2#1)(1995-5#1)(2011-2#1)
of this lesion is##2##4##(1991-6#2)
of this lesion##9##3##(1990-9#1)(1991-6#2)(1994-8#1)(2008-7#2)(2011-2#2)(2013-1#1)
of this line##2##3##(1991-5#1)(2008-10#1)
of this lineage##3##3##(1995-2#1)(2008-10#2)
of this literature##3##3##(1995-3#1)(2008-10#1)(2009-5#1)
of this locus##2##3##(1997-3#1)(2008-10#1)
of this magnitude##4##3##(1993-12#1)(1993-9#1)(2008-10#1)(2013-1#1)
of this manuscript##2##3##(2010-7#1)(2011-2#1)
of this material##7##3##(1990-9#1)(1991-12#1)(1995-12#1)(2008-10#3)(2008-3#1)
of this matrix##3##3##(2008-10#3)
of this meeting##2##3##(2008-5#1)(2009-4#1)
of this membrane##3##3##(1990-8#1)(2008-10#2)
of this metal##3##3##(2008-10#3)
of this method are##4##4##(2008-10#4)
of this method for the##3##5##(1994-5#1)(2008-10#1)(2008-12#1)
of this method for##6##4##(1994-5#1)(2008-10#4)(2008-12#1)
of this method include##3##4##(1994-8#1)(2008-10#1)(2012-3#1)
of this method is demonstrated by##2##6##(2007-11#1)(2008-10#1)
of this method is that##3##5##(2008-10#3)
of this method is##15##4##(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#10)(2010-11#1)
of this method of##2##4##(2008-11#1)(2008-3#1)
of this method to##4##4##(1995-5#1)(2008-10#2)(2008-3#1)
of this method was demonstrated by##3##6##(2008-10#3)
of this method was tested##2##5##(2008-10#2)
of this method was##16##4##(1990-2#1)(2008-10#13)(2008-11#1)(2008-8#1)
of this method with##2##4##(2008-10#2)
of this method##66##3##(1990-2#1)(1991-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#45)(2008-11#3)(2008-12#1)(2008-3#3)(2008-8#1)(2010-11#1)(2012-3#1)
of this methodology##8##3##(2008-10#5)(2008-12#1)(2009-8#1)(2011-2#1)
of this model is##3##4##(2008-10#1)(2008-4#1)(2011-3#1)
of this model to##2##4##(2008-10#1)(2011-2#1)
of this model##16##3##(1992-4#1)(1993-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#2)(2010-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
of this module is##2##4##(2008-11#1)(2008-12#1)
of this module##3##3##(2008-11#2)(2008-12#1)
of this molecular##2##3##(2008-10#2)
of this molecule##2##3##(2008-5#1)(2012-12#1)
of this motif##2##3##(1991-7#1)(1992-4#1)
of this new method##3##4##(2008-10#2)(2010-9#1)
of this new##19##3##(1991-12#1)(1995-1#1)(1995-6#1)(1996-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-9#1)
of this newly developed method was##4##6##(2008-10#4)
of this newly##6##3##(2008-10#6)
of this novel approach##2##4##(2008-8#1)(2008-9#1)
of this novel##10##3##(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
of this observation##5##3##(1991-11#1)(1991-6#1)(1993-6#1)(2008-3#1)(2011-2#1)
of this optode##2##3##(2008-10#2)
of this organelle##3##3##(2008-11#2)(2008-9#1)
of this organism##18##3##(1996-8#1)(2008-10#1)(2009-9#1)(2011-1#1)(2011-2#14)
of this organization##2##3##(1991-2#1)(2008-11#1)
of this paper are to##2##5##(2008-3#1)(2013-8#1)
of this paper is the##2##5##(2008-10#2)
of this paper is to describe the##4##7##(1992-1#1)(2008-11#2)(2008-5#1)
of this paper is to describe##5##6##(1992-1#1)(2008-11#2)(2008-5#1)(2010-11#1)
of this paper is to discuss the##2##7##(2008-11#1)(2009-10#1)
of this paper is to discuss##3##6##(2008-11#1)(2009-10#1)(2012-3#1)
of this paper is to present##4##6##(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
of this paper is to provide##2##6##(1992-3#1)(1996-3#1)
of this paper is to report on##2##7##(2008-11#2)
of this paper is to report##3##6##(2008-11#2)(2013-1#1)
of this paper is to##33##5##(1992-1#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-5#1)(2009-10#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#3)
of this paper is##37##4##(1992-1#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-10#3)(2008-11#9)(2008-12#2)(2008-5#1)(2009-10#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#3)
of this paper was to##5##5##(1992-2#1)(2008-11#1)(2009-8#2)(2011-2#1)
of this paper##49##3##(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-5#1)(1996-3#1)(1997-4#1)(2008-10#4)(2008-11#11)(2008-12#2)(2008-3#1)(2008-5#1)(2009-10#3)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
of this parameter##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
of this particular##2##3##(1990-11#1)(2008-11#1)
of this pathogen in##2##4##(2008-10#1)(2008-9#1)
of this pathogen##13##3##(2008-10#12)(2008-9#1)
of this pathology##6##3##(1991-3#1)(1991-6#1)(2007-8#1)(2013-1#3)
of this pathway##7##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#1)
of this patient##5##3##(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
of this peptide fragment##2##4##(1992-6#1)(2008-10#1)
of this peptide##6##3##(1992-4#1)(1992-6#1)(1995-11#1)(1997-8#1)(2008-10#2)
of this phase##2##3##(2008-10#1)(2008-5#1)
of this phenomenon##8##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#1)(2013-1#1)
of this phylum##2##3##(2008-10#1)(2013-8#1)
of this pictorial essay is to##4##6##(1997-8#1)(2012-2#3)
of this pictorial review is to##2##6##(2012-2#2)
of this pictorial##6##3##(1997-8#1)(2012-2#5)
of this pilot study was to##6##6##(2008-11#1)(2008-12#4)(2011-2#1)
of this pilot study##8##4##(2008-11#1)(2008-12#5)(2008-7#1)(2011-2#1)
of this pilot##9##3##(1996-1#1)(2008-11#1)(2008-12#5)(2008-7#1)(2011-2#1)
of this plant and##2##4##(2008-11#1)(2011-10#1)
of this plant##4##3##(2008-11#2)(2011-1#1)(2011-10#1)
of this plasmid##2##3##(1993-9#1)(2008-10#1)
of this population is##2##4##(1994-2#1)(2009-5#1)
of this population##11##3##(1991-6#1)(1994-2#1)(1994-3#1)(1996-1#1)(2008-10#2)(2008-9#2)(2009-11#1)(2009-5#1)(2011-2#1)
of this possible complication##2##4##(2008-12#1)(2012-3#1)
of this possible##5##3##(1990-11#1)(2008-12#2)(2012-3#1)(2012-5#1)
of this powerful##2##3##(1996-2#1)(2011-1#1)
of this prediction##2##3##(2007-12#1)(2013-8#1)
of this preliminary##2##3##(2008-12#1)(2013-1#1)
of this preparation##3##3##(1990-12#1)(2008-11#1)(2008-7#1)
of this problem##4##3##(1995-5#1)(1997-7#1)(2008-11#1)(2011-2#1)
of this procedure is##2##4##(2008-10#2)
of this procedure##7##3##(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#2)
of this process is##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
of this process were##2##4##(1991-3#1)(2008-10#1)
of this process##15##3##(1991-3#1)(1991-6#1)(1993-8#2)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#1)(2011-2#1)
of this product##3##3##(2008-10#2)(2008-5#1)
of this program##4##3##(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)
of this programme##3##3##(1990-11#1)(2008-11#2)
of this project is##2##4##(2008-11#1)(2010-7#1)
of this project was to##2##5##(1991-9#1)(1994-3#1)
of this project was##3##4##(1991-9#1)(1994-3#1)(1997-4#1)
of this project##5##3##(1991-9#1)(1994-3#1)(1997-4#1)(2008-11#1)(2010-7#1)
of this prospective##4##3##(1997-3#2)(2010-5#1)(2011-2#1)
of this protection##2##3##(2008-10#1)(2011-2#1)
of this protein in##2##4##(1990-5#1)(1993-1#1)
of this protein##14##3##(1990-5#1)(1991-12#1)(1992-12#1)(1993-1#2)(1993-12#2)(1994-3#1)(2008-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2013-1#1)
of this qualitative study was to explore##3##7##(2008-12#1)(2009-9#1)(2010-10#1)
of this qualitative##4##3##(2008-12#1)(2009-9#1)(2010-10#2)
of this questionnaire##2##3##(2013-1#1)(2013-8#1)
of this randomized##2##3##(2009-12#1)(2011-2#1)
of this rare condition##2##4##(2008-10#1)(2012-3#1)
of this rare##11##3##(1994-2#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
of this reaction##11##3##(1994-8#1)(1995-6#1)(2008-10#7)(2009-10#2)
of this receptor gene##3##4##(1991-5#3)
of this receptor##6##3##(1991-5#3)(1994-8#2)(2008-5#1)
of this reduction##2##3##(1991-6#1)(2008-10#1)
of this regimen##2##3##(1990-12#1)(2008-10#1)
of this region in##2##4##(1990-6#1)(1994-2#1)
of this region##15##3##(1990-6#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-3#1)
of this regulatory##3##3##(1991-2#1)(1995-8#1)(1997-9#1)
of this relationship are##2##4##(1995-3#1)(2008-10#1)
of this relationship##5##3##(1995-3#1)(2008-10#2)(2008-6#1)(2012-2#1)
of this report is to##5##5##(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
of this report##12##3##(1991-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-3#3)
of this research is to##2##5##(1994-8#1)(2008-3#1)
of this research is##3##4##(1994-8#1)(2008-10#1)(2008-3#1)
of this research was to evaluate##2##6##(2008-10#1)(2011-2#1)
of this research was to##14##5##(1994-3#1)(2008-10#5)(2008-12#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of this research was##16##4##(1994-3#1)(2008-10#6)(2008-12#1)(2008-5#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of this research were##5##4##(2008-1#1)(2008-10#4)
of this research##30##3##(1991-2#1)(1992-1#1)(1994-3#1)(1994-8#1)(1997-1#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-5#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of this resistance##3##3##(2008-10#2)(2012-3#1)
of this response##3##3##(1993-12#1)(2008-12#1)(2010-1#1)
of this result and the##2##5##(1995-9#1)(2008-9#1)
of this result##5##3##(1992-3#1)(1995-9#1)(2008-8#1)(2008-9#2)
of this retrospective study##3##4##(2011-2#2)(2012-3#1)
of this retrospective##5##3##(2011-2#3)(2012-2#1)(2012-3#1)
of this review is to discuss the##2##7##(2008-8#1)(2013-1#1)
of this review is to illustrate the##2##7##(2012-2#2)
of this review is to##15##5##(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#2)(2010-5#1)(2011-3#2)(2012-2#2)(2013-1#2)
of this review is##20##4##(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-8#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-3#2)(2012-2#2)(2013-1#2)
of this review was to investigate the##2##7##(2009-11#1)(2013-1#1)
of this review was to##5##5##(1996-6#1)(2009-11#1)(2010-6#1)(2013-1#2)
of this review##40##3##(1990-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#3)(2013-1#7)
of this risk##2##3##(1997-4#1)(2011-2#1)
of this role##3##3##(1993-3#1)(2008-12#1)(2009-8#1)
of this sample##2##3##(1997-2#1)(2008-10#1)
of this sensor##6##3##(2008-10#6)
of this sensory##2##3##(2009-12#1)(2011-2#1)
of this sequence##3##3##(1996-12#1)(1997-9#1)(2008-10#1)
of this series##5##3##(1996-9#1)(2008-10#1)(2008-11#2)(2012-12#1)
of this simple##2##3##(2008-10#1)(2008-5#1)
of this small##2##3##(2008-11#2)
of this solution##4##3##(2008-10#3)(2008-9#1)
of this species are not##2##5##(2008-8#1)(2013-1#1)
of this species are##3##4##(2008-8#2)(2013-1#1)
of this species is##2##4##(2008-12#2)
of this species##18##3##(1996-6#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-5#1)(2008-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
of this spectrum##2##3##(1994-5#1)(2008-4#1)
of this structure##2##3##(1991-5#1)(1993-6#1)
of this study and##3##4##(2008-5#1)(2008-8#1)(2013-1#1)
of this study are to##2##5##(2008-6#1)(2010-8#1)
of this study are##11##4##(1993-1#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-1#1)
of this study has##2##4##(2008-5#1)(2009-7#1)
of this study have##2##4##(2008-10#2)
of this study indicate that##11##5##(1990-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2008-10#3)(2009-7#1)(2011-2#1)
of this study is that##3##5##(1997-8#1)(2008-3#1)(2013-1#1)
of this study is the##2##5##(2007-8#1)(2008-10#1)
of this study is to assess the##3##7##(2008-11#1)(2008-5#1)(2012-3#1)
of this study is to assess##4##6##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
of this study is to describe the##2##7##(2010-7#1)(2011-2#1)
of this study is to describe##3##6##(2008-11#1)(2010-7#1)(2011-2#1)
of this study is to determine##2##6##(2011-2#2)
of this study is to develop##3##6##(2008-10#1)(2010-8#1)(2013-8#1)
of this study is to evaluate the##4##7##(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
of this study is to evaluate##7##6##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#2)(2013-1#2)
of this study is to identify##4##6##(2008-12#1)(2012-3#1)(2013-8#2)
of this study is to investigate##3##6##(2010-12#1)(2010-8#1)(2011-3#1)
of this study is to##42##5##(1992-2#1)(1996-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#4)
of this study is##49##4##(1992-2#1)(1996-1#1)(1997-8#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#4)(2011-2#8)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#4)
of this study revealed that##2##5##(1997-8#1)(2008-5#1)
of this study should be##2##5##(1995-5#1)(2010-4#1)
of this study show that##2##5##(2008-10#1)(2013-1#1)
of this study suggest that##15##5##(1994-12#1)(1994-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2013-1#1)
of this study suggested##3##4##(1992-2#1)(2009-5#1)(2011-3#1)
of this study was to analyze the##5##7##(2008-10#1)(2008-9#1)(2011-2#2)(2012-3#1)
of this study was to analyze##6##6##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)(2012-3#1)
of this study was to apply##2##6##(2008-10#1)(2008-5#1)
of this study was to assess the##9##7##(1992-12#1)(2008-12#1)(2008-5#3)(2008-7#2)(2009-2#1)(2013-8#1)
of this study was to assess##14##6##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#3)(2009-2#1)(2010-6#1)(2012-2#1)(2013-8#1)
of this study was to characterize##2##6##(2008-11#2)
of this study was to compare the##5##7##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)
of this study was to compare##10##6##(1994-12#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#1)
of this study was to describe the##4##7##(2009-3#1)(2010-5#1)(2013-1#2)
of this study was to describe##6##6##(2008-12#1)(2009-3#1)(2010-5#1)(2011-7#1)(2013-1#2)
of this study was to determine the effect of##3##9##(1991-8#1)(2008-10#1)(2011-2#1)
of this study was to determine the effects of##4##9##(2008-10#1)(2008-5#1)(2010-4#1)(2010-6#1)
of this study was to determine the relationship between##2##9##(2008-10#1)(2008-12#1)
of this study was to determine the##34##7##(1991-11#1)(1991-8#1)(1994-5#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-5#3)(2008-9#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-3#1)(2013-8#2)
of this study was to determine whether there are##2##9##(2008-7#1)(2010-7#1)
of this study was to determine whether##10##7##(1994-11#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-3#2)
of this study was to determine which##2##7##(2012-2#1)(2013-1#1)
of this study was to determine##51##6##(1991-11#1)(1991-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-3#1)(2013-8#3)
of this study was to develop a##3##7##(2008-5#2)(2012-4#1)
of this study was to develop an##5##7##(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
of this study was to develop and##2##7##(2008-10#1)(2010-9#1)
of this study was to develop##13##6##(2008-10#3)(2008-11#3)(2008-5#3)(2010-9#1)(2011-2#1)(2012-2#1)(2012-4#1)
of this study was to establish##2##6##(2008-11#1)(2013-1#1)
of this study was to evaluate a##2##7##(2008-10#1)(2013-8#1)
of this study was to evaluate the effect of##2##9##(2008-1#1)(2012-2#1)
of this study was to evaluate the prevalence of##2##9##(2008-12#1)(2012-3#1)
of this study was to evaluate the use of##2##9##(1990-11#1)(2013-1#1)
of this study was to evaluate the##25##7##(1990-11#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#7)
of this study was to evaluate whether##2##7##(2008-11#1)(2013-1#1)
of this study was to evaluate##38##6##(1990-11#1)(1997-8#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
of this study was to examine the possible##2##8##(1996-2#1)(2011-2#1)
of this study was to examine the##15##7##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
of this study was to examine##17##6##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
of this study was to further##2##6##(1992-12#1)(2008-11#1)
of this study was to identify the##3##7##(2008-1#1)(2008-12#1)(2010-10#1)
of this study was to identify##9##6##(1990-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2010-10#1)(2010-11#1)(2011-2#1)
of this study was to investigate how##3##7##(1996-6#1)(1997-8#1)(2008-9#1)
of this study was to investigate the effect of##3##9##(2008-7#1)(2011-1#1)(2012-2#1)
of this study was to investigate the effects of##3##9##(2008-10#1)(2008-5#1)(2012-2#1)
of this study was to investigate the effects##4##8##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
of this study was to investigate the relationship between##2##9##(2009-7#1)(2013-1#1)
of this study was to investigate the##27##7##(1994-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)
of this study was to investigate whether##2##7##(2011-2#1)(2013-1#1)
of this study was to investigate##37##6##(1993-2#1)(1994-12#1)(1996-6#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#4)
of this study was to perform##2##6##(2009-8#1)(2011-2#1)
of this study was to present##3##6##(1994-2#1)(2008-10#2)
of this study was to quantify the##2##7##(2008-10#1)(2009-5#1)
of this study was to report##2##6##(2008-9#2)
of this study was to test##3##6##(1993-12#1)(2008-11#1)(2012-3#1)
of this study was to use##5##6##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
of this study was to verify##3##6##(1996-3#1)(2008-7#1)(2010-9#1)
of this study was to##266##5##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-8#6)(2007-8#1)(2008-1#3)(2008-10#34)(2008-11#19)(2008-12#15)(2008-3#1)(2008-4#1)(2008-5#18)(2008-7#12)(2008-8#2)(2008-9#15)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#23)(2011-7#1)(2012-12#2)(2012-2#10)(2012-3#7)(2012-4#1)(2013-1#21)(2013-3#1)(2013-8#7)
of this study was##272##4##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-8#6)(2007-8#1)(2008-1#3)(2008-10#35)(2008-11#20)(2008-12#15)(2008-3#1)(2008-4#1)(2008-5#18)(2008-7#12)(2008-8#2)(2008-9#15)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#23)(2011-7#1)(2012-12#2)(2012-2#10)(2012-3#7)(2012-4#1)(2013-1#22)(2013-3#1)(2013-8#7)
of this study were to characterize##2##6##(2008-10#1)(2013-1#1)
of this study were to describe##2##6##(2009-5#1)(2013-1#1)
of this study were to determine the##4##7##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
of this study were to determine##5##6##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
of this study were to evaluate##3##6##(2008-10#1)(2008-12#1)(2009-8#1)
of this study were to identify##3##6##(2008-10#1)(2008-11#1)(2013-1#1)
of this study were to##26##5##(2008-10#6)(2008-11#3)(2008-12#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2013-1#5)
of this study were##33##4##(1991-2#1)(1993-12#1)(2008-10#8)(2008-11#6)(2008-12#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2013-1#5)
of this study##454##3##(1990-11#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-5#1)(1994-8#2)(1995-1#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#3)(1997-8#8)(2007-8#2)(2008-1#3)(2008-10#76)(2008-11#39)(2008-12#20)(2008-3#5)(2008-4#1)(2008-5#24)(2008-6#1)(2008-7#16)(2008-8#4)(2008-9#16)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#4)(2011-2#35)(2011-3#2)(2011-7#1)(2012-12#3)(2012-2#10)(2012-3#9)(2012-4#1)(2013-1#40)(2013-3#1)(2013-8#11)
of this subject##2##3##(2008-10#1)(2008-11#1)
of this subset##2##3##(2008-9#1)(2010-12#1)
of this substance##2##3##(2008-11#2)
of this survey##3##3##(1991-12#1)(1996-3#1)(2008-12#1)
of this syndrome is##2##4##(2008-12#2)
of this syndrome##7##3##(1997-3#1)(2008-1#1)(2008-12#2)(2012-2#1)(2013-1#2)
of this synthetic##2##3##(1995-2#1)(2008-10#1)
of this system is##2##4##(1997-3#1)(2008-10#1)
of this system##15##3##(1993-12#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#1)(2009-9#1)
of this systematic##2##3##(2010-12#1)(2013-8#1)
of this technique as a##2##5##(2008-10#2)
of this technique for##2##4##(2008-10#1)(2013-1#1)
of this technique in the##2##5##(2008-2#1)(2013-1#1)
of this technique in##5##4##(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#2)
of this technique is##2##4##(2008-10#1)(2011-2#1)
of this technique to##2##4##(1993-3#1)(2008-2#1)
of this technique##23##3##(1992-2#1)(1993-3#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#2)(2013-1#4)
of this technology to##2##4##(2008-10#1)(2013-8#1)
of this technology##8##3##(2008-10#2)(2008-6#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
of this test##7##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
of this therapy##4##3##(1993-11#1)(2010-6#1)(2012-2#1)(2013-8#1)
of this tool##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
of this trade-off##3##3##(2008-8#3)
of this transcription factor##3##4##(1990-5#1)(2009-8#2)
of this treatment in##2##4##(1994-12#1)(2008-11#1)
of this treatment##9##3##(1992-1#1)(1994-12#1)(1995-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-12#1)(2012-3#1)
of this tumor##5##3##(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
of this type is##2##4##(1990-5#1)(2008-10#1)
of this type of intervention##2##5##(1994-1#1)(2012-2#1)
of this type of##20##4##(1993-1#1)(1994-1#1)(1994-6#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)
of this type##29##3##(1990-5#1)(1991-11#1)(1992-1#1)(1993-1#1)(1994-1#1)(1994-5#1)(1994-6#1)(1997-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)
of this uncommon##4##3##(2008-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
of this understanding##2##3##(2008-12#2)
of this unique##4##3##(1997-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
of this unit is to##4##5##(2008-4#1)(2008-9#3)
of this unit is##7##4##(2008-4#3)(2008-9#4)
of this unit##8##3##(2008-4#4)(2008-9#4)
of this unusual neoplasm##2##4##(2008-10#1)(2009-3#1)
of this variation##2##3##(2008-10#1)(2011-3#1)
of this variety##3##3##(1996-3#1)(2008-5#2)
of this work has##2##4##(2008-10#1)(2012-3#1)
of this work is the##4##5##(2008-10#3)(2008-4#1)
of this work is to##10##5##(2008-10#5)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
of this work is##16##4##(2008-10#9)(2008-4#1)(2008-7#2)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
of this work was to develop##2##6##(1997-2#1)(2012-2#1)
of this work was to evaluate the##4##7##(1997-8#1)(2008-10#1)(2008-5#2)
of this work was to evaluate##5##6##(1997-8#1)(2008-10#1)(2008-5#2)(2013-8#1)
of this work was to##24##5##(1993-12#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#6)(2009-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
of this work was##25##4##(1993-12#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#6)(2009-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
of this work##55##3##(1992-4#1)(1993-12#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#7)(2008-7#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of this##2366##2##(1990-11#9)(1990-12#4)(1990-2#5)(1990-3#2)(1990-5#10)(1990-6#7)(1990-8#3)(1990-9#4)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#16)(1991-2#10)(1991-3#11)(1991-5#6)(1991-6#12)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#7)(1992-10#4)(1992-12#9)(1992-2#7)(1992-3#11)(1992-4#5)(1992-5#5)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#9)(1993-11#1)(1993-12#16)(1993-2#9)(1993-3#11)(1993-6#8)(1993-8#16)(1993-9#5)(1994-1#6)(1994-11#8)(1994-12#8)(1994-2#7)(1994-3#9)(1994-5#12)(1994-6#4)(1994-8#15)(1994-9#1)(1995-1#5)(1995-11#7)(1995-12#7)(1995-2#15)(1995-3#5)(1995-5#7)(1995-6#10)(1995-8#8)(1995-9#5)(1996-1#7)(1996-11#4)(1996-12#10)(1996-2#10)(1996-3#9)(1996-5#1)(1996-6#5)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#13)(1997-3#17)(1997-4#6)(1997-6#3)(1997-7#4)(1997-8#21)(1997-9#3)(2006-6#4)(2007-11#4)(2007-12#7)(2007-8#4)(2008-1#13)(2008-10#571)(2008-11#163)(2008-12#87)(2008-2#11)(2008-3#39)(2008-4#20)(2008-5#77)(2008-6#13)(2008-7#54)(2008-8#38)(2008-9#59)(2009-1#1)(2009-10#16)(2009-11#4)(2009-12#8)(2009-2#2)(2009-3#9)(2009-4#5)(2009-5#14)(2009-6#8)(2009-7#13)(2009-8#26)(2009-9#12)(2010-1#6)(2010-10#9)(2010-11#14)(2010-12#15)(2010-2#4)(2010-3#4)(2010-4#9)(2010-5#18)(2010-6#10)(2010-7#12)(2010-8#18)(2010-9#8)(2011-1#16)(2011-10#1)(2011-2#143)(2011-3#11)(2011-7#4)(2012-12#17)(2012-2#58)(2012-3#42)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#113)(2013-3#1)(2013-7#2)(2013-8#30)
of thoracic aorta##2##3##(2008-10#1)(2009-8#1)
of thoracic##7##2##(1991-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-9#1)
of thoracolumbar##2##2##(2008-8#1)(2010-8#1)
of thorium and##4##3##(2008-10#4)
of thorium##13##2##(2008-10#13)
of thorium(IV)##4##2##(2008-10#4)
of those children##2##3##(1993-3#1)(2010-11#1)
of those from##2##3##(2008-10#2)
of those in##2##3##(2010-10#1)(2011-2#1)
of those not##2##3##(1990-6#1)(1993-1#1)
of those on##3##3##(1996-3#1)(2008-11#2)
of those problems##3##3##(1997-1#1)(2013-1#2)
of those released from##2##4##(2008-11#2)
of those surveyed##2##3##(1997-3#1)(2008-1#1)
of those that##2##3##(2009-10#1)(2011-2#1)
of those treated##2##3##(1992-9#1)(2008-5#1)
of those who are##2##4##(1992-2#1)(1994-1#1)
of those who were##2##4##(1997-8#1)(2012-2#1)
of those who##14##3##(1990-6#1)(1991-3#1)(1992-1#2)(1992-2#1)(1994-1#1)(1994-3#3)(1997-8#1)(2008-11#1)(2010-10#1)(2010-4#1)(2012-2#1)
of those with##9##3##(1990-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1996-3#1)(2008-7#1)(2009-11#1)(2010-1#1)
of those##133##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#3)(1991-10#1)(1991-12#1)(1991-3#2)(1991-8#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-12#1)(1994-3#5)(1995-11#1)(1995-2#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#18)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#3)
of thought##4##2##(1997-2#1)(2008-11#1)(2010-1#1)(2012-3#1)
of thousands of##6##3##(2008-10#1)(2008-7#1)(2009-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
of threatened##2##2##(1991-9#1)(1993-6#1)
of three bacterial##2##3##(2008-10#1)(2011-1#1)
of three cases##7##3##(1991-12#1)(1991-6#1)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#2)
of three chemical##2##3##(2008-10#1)(2008-5#1)
of three clinical##2##3##(2008-10#1)(2008-6#1)
of three dental##2##3##(2012-2#1)(2013-1#1)
of three different##15##3##(1996-12#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
of three distinct##3##3##(2008-10#1)(2008-11#1)(2009-4#1)
of three dyes##2##3##(2008-10#2)
of three flavonoids##2##3##(2008-10#2)
of three hours##2##3##(1996-6#1)(2011-1#1)
of three isolates##3##3##(2008-10#2)(2008-12#1)
of three key##2##3##(1995-2#1)(2008-11#1)
of three large##3##3##(1994-9#1)(1995-12#1)(2011-2#1)
of three layers##6##3##(2008-10#4)(2010-8#2)
of three major##3##3##(1991-9#1)(1997-8#1)(2008-10#1)
of three members##2##3##(1993-12#1)(2009-6#1)
of three months and##2##4##(1991-11#1)(2008-11#1)
of three new##2##3##(2008-10#2)
of three of the##3##4##(1990-6#1)(1994-5#1)(2008-5#1)
of three patients##3##3##(1990-9#1)(2008-11#2)
of three selected##2##3##(1993-11#1)(2008-10#1)
of three species of##3##4##(2007-12#2)(2008-10#1)
of three species##5##3##(2007-12#2)(2008-10#2)(2011-2#1)
of three strains of##3##4##(1994-2#1)(2008-10#1)(2008-11#1)
of three to##2##3##(2008-5#1)(2009-8#1)
of three types of##2##4##(2008-11#1)(2008-3#1)
of three whitefly-borne closteroviruses##2##4##(2008-10#2)
of three years##2##3##(1991-6#1)(1993-9#1)
of three##300##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#3)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#4)(2008-10#129)(2008-11#21)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-2#4)(2012-3#2)(2012-5#2)(2013-1#10)(2013-8#1)
of three-dimensional objects##2##3##(1996-2#1)(2008-3#1)
of three-dimensional##8##2##(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-9#1)(2012-2#1)
of three-way data##2##3##(2008-10#2)
of three-way##8##2##(2008-10#8)
of threedimensional##2##2##(1995-11#1)(2013-1#1)
of threshold##4##2##(2008-3#2)(2008-8#1)(2008-9#1)
of thrips##3##2##(2008-10#3)
of thrombin##3##2##(1992-4#1)(1994-5#1)(2008-4#1)
of thrombo-embolic##2##2##(1997-6#2)
of thrombocytes in##2##3##(2013-1#2)
of thrombocytes##4##2##(2013-1#4)
of thrombocytopenia##4##2##(1990-10#1)(2008-8#2)(2013-1#1)
of thromboembolic diseases##2##3##(1992-9#1)(2010-3#1)
of thromboembolic events##2##3##(1994-3#1)(2008-10#1)
of thromboembolic##6##2##(1992-9#1)(1994-3#1)(1997-6#1)(2008-10#1)(2010-3#1)(2012-2#1)
of thrombolytic therapy##2##3##(2008-7#1)(2009-11#1)
of thrombopoiesis##2##2##(2006-6#2)
of thrombosis of##2##3##(1996-6#1)(1997-3#1)
of thrombosis##8##2##(1996-6#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-7#3)(2011-2#1)
of thrombotic##2##2##(2011-2#2)
of thromboxane A2##2##3##(1990-8#1)(1991-5#1)
of thromboxane##6##2##(1990-12#1)(1990-8#1)(1991-5#2)(1993-3#2)
of thrombus formation##2##3##(2006-6#1)(2008-11#1)
of thrombus##4##2##(2006-6#1)(2008-11#2)(2008-9#1)
of thumb##5##2##(2008-8#3)(2008-9#1)(2009-10#1)
of thylakoid##3##2##(2008-8#2)(2009-10#1)
of thymic##3##2##(2008-10#1)(2008-8#1)(2013-7#1)
of thymidine##2##2##(1991-5#1)(2008-9#1)
of thymocyte##3##2##(2008-10#3)
of thymocytes by##2##3##(1990-5#1)(2008-8#1)
of thymocytes in##2##3##(2008-10#1)(2008-8#1)
of thymocytes is##2##3##(2008-8#2)
of thymocytes##11##2##(1990-5#2)(2008-10#1)(2008-8#7)(2013-7#1)
of thymol##2##2##(1997-2#1)(2008-10#1)
of thymus and##2##3##(1995-12#1)(2008-5#1)
of thymus##6##2##(1995-12#3)(2008-5#2)(2008-8#1)
of thyroid carcinoma##2##3##(2012-3#1)(2013-1#1)
of thyroid dysfunction##2##3##(1991-8#1)(2008-6#1)
of thyroid function in##3##4##(2008-11#1)(2008-4#2)
of thyroid function##8##3##(2008-11#1)(2008-4#3)(2008-6#3)(2013-1#1)
of thyroid gland##3##3##(2008-12#1)(2008-9#2)
of thyroid hormone##3##3##(1995-2#2)(2013-7#1)
of thyroid hormones and##2##4##(1995-8#1)(2011-2#1)
of thyroid hormones were##2##4##(1990-3#1)(2012-2#1)
of thyroid hormones##7##3##(1990-3#1)(1995-8#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)
of thyroid##42##2##(1990-3#2)(1991-6#1)(1991-8#1)(1992-6#1)(1995-12#1)(1995-2#2)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-6#6)(2008-7#4)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
of thyrotropin receptor##2##3##(1994-11#2)
of thyrotropin##4##2##(1994-11#3)(2011-1#1)
of thyrotropin-releasing hormone##2##3##(1992-8#1)(2013-7#1)
of thyroxine (T4)##2##3##(2008-6#1)(2008-7#1)
of thyroxine##3##2##(1997-5#1)(2008-6#1)(2008-7#1)
of tibial shaft##2##3##(2010-11#2)
of tibial##5##2##(2008-8#1)(2010-11#2)(2011-2#1)(2012-3#1)
of ticks##2##2##(1997-7#1)(2010-1#1)
of tight##3##2##(1995-6#1)(2011-2#1)(2012-2#1)
of tightly##3##2##(1990-10#1)(1991-5#1)(1994-5#1)
of tillage practices##3##3##(2008-10#3)
of tillage##4##2##(2008-10#4)
of tillers##2##2##(2008-10#2)
of time and##9##3##(2008-10#5)(2008-11#1)(2008-8#1)(2010-8#1)(2012-2#1)
of time by a##2##4##(2008-10#1)(2008-11#1)
of time by##3##3##(2008-10#1)(2008-11#2)
of time can be##2##4##(2008-11#1)(2008-6#1)
of time for##3##3##(2008-10#1)(2008-11#2)
of time in the##2##4##(1996-3#1)(1997-2#1)
of time in##4##3##(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)
of time of##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
of time or##2##3##(1997-8#1)(2008-10#1)
of time series##2##3##(2008-8#2)
of time the##2##3##(1994-11#1)(2008-8#1)
of time to##9##3##(1995-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
of time##124##2##(1990-11#1)(1990-8#2)(1991-6#1)(1991-8#1)(1992-3#2)(1993-11#1)(1993-3#1)(1994-11#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#22)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#3)
of time-dependent##2##2##(1993-8#1)(2008-8#1)
of time-resolved##2##2##(2008-10#2)
of times##10##2##(1991-6#2)(1996-2#1)(1996-3#1)(1997-1#1)(2008-11#2)(2008-12#1)(2010-6#1)(2011-2#1)
of timing##3##2##(2008-10#2)(2011-1#1)
of tin and##3##3##(2008-10#3)
of tin in##7##3##(2008-10#7)
of tin oxide thin##2##4##(2008-10#2)
of tin oxide##4##3##(2008-10#4)
of tin##22##2##(2008-10#22)
of tin(IV)##3##2##(2008-10#3)
of tinea capitis##2##3##(2008-5#2)
of tinea##5##2##(2008-5#4)(2012-3#1)
of tinnitus##3##2##(1996-6#2)(2010-7#1)
of tip##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
of tissue at the##2##4##(1992-12#1)(2008-11#1)
of tissue culture##4##3##(2008-12#1)(2008-4#3)
of tissue differentiation##2##3##(2008-2#1)(2010-3#1)
of tissue homeostasis##3##3##(2008-5#1)(2009-3#1)(2010-3#1)
of tissue storage##2##3##(2010-8#2)
of tissue##68##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-12#2)(1993-1#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#1)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
of tissue-type plasminogen activator##2##4##(1995-8#1)(1997-1#1)
of tissue-type plasminogen##3##3##(1995-8#2)(1997-1#1)
of tissues##11##2##(1992-9#1)(1993-3#1)(1994-11#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-4#1)(2010-8#1)
of titanium dioxide##2##3##(2008-10#2)
of titanium phosphate##2##3##(2008-10#2)
of titanium##16##2##(2008-10#11)(2009-7#4)(2013-1#1)
of titanium(IV)##2##2##(2008-10#2)
of titrant##3##2##(2008-10#3)
of titration##3##2##(2008-10#3)
of titrations##2##2##(1996-12#1)(2008-10#1)
of tobacco cells##4##3##(2009-6#4)
of tobacco in##2##3##(2008-10#2)
of tobacco mosaic virus##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
of tobacco protoplasts or leaf##2##5##(2008-10#2)
of tobacco thrips##3##3##(2008-10#3)
of tobacco use##2##3##(1994-3#1)(1997-1#1)
of tobacco##41##2##(1990-8#1)(1992-6#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#20)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#4)(2009-7#2)(2012-2#1)(2013-1#4)
of tocopherol acetate into SLN leads to an##2##8##(2008-5#2)
of tocopherol##4##2##(2008-10#1)(2008-5#3)
of tocopherols##2##2##(1992-9#1)(2008-5#1)
of today##3##2##(1996-3#1)(2008-10#1)(2013-7#1)
of today's##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
of tolerance to##4##3##(1992-3#1)(1996-2#1)(2008-10#1)(2009-7#1)
of tolerance##12##2##(1992-3#1)(1996-2#3)(2008-10#5)(2008-3#1)(2008-4#1)(2009-7#1)
of toluene##7##2##(2008-10#6)(2008-7#1)
of toluidine##2##2##(2008-10#2)
of tomato and##4##3##(2008-10#4)
of tomato by##3##3##(2008-10#3)
of tomato caused by##2##4##(2008-10#2)
of tomato have##2##3##(2008-10#2)
of tomato in##2##3##(2008-10#2)
of tomato leaves##2##3##(2008-10#2)
of tomato mottle##2##3##(2008-10#2)
of tomato plants##6##3##(2008-10#6)
of tomato spotted wilt virus##2##5##(2008-10#2)
of tomato spotted wilt##3##4##(2008-10#3)
of tomato under##3##3##(2008-10#3)
of tomato yellow leaf curl##2##5##(2008-10#2)
of tomato##59##2##(1992-8#1)(2008-10#57)(2008-8#1)
of tongue##6##2##(1995-8#1)(2013-1#5)
of too##2##2##(2008-10#2)
of tools##4##2##(1995-2#1)(2008-3#1)(2012-3#1)(2013-8#1)
of tooth##6##2##(1991-2#1)(2008-5#1)(2011-2#1)(2013-1#3)
of toothpaste##2##2##(2008-5#1)(2011-2#1)
of top##2##2##(1994-12#1)(2012-12#1)
of topical##5##2##(1996-2#1)(2007-11#1)(2008-5#2)(2010-3#1)
of topically applied##4##3##(2008-5#4)
of topographical##2##2##(2008-11#1)(2013-1#1)
of topoisomerase I##6##3##(1990-7#1)(1993-8#2)(1994-8#1)(2008-11#2)
of topoisomerase##8##2##(1990-7#1)(1993-8#4)(1994-8#1)(2008-11#2)
of torture##4##2##(1990-6#1)(1995-11#3)
of tospoviruses##4##2##(2008-10#4)
of total APP##3##3##(1996-12#3)
of total As##3##3##(2008-10#3)
of total Cr##2##3##(2008-10#2)
of total DNA##2##3##(2008-10#2)
of total RNA from##2##4##(1993-2#1)(2009-12#1)
of total RNA##5##3##(1993-2#1)(1994-11#1)(2008-4#1)(2009-12#2)
of total and dissolved##2##4##(2008-10#2)
of total and protein-bound homocysteine in##2##6##(2008-10#2)
of total and##6##3##(1995-3#1)(2008-10#5)
of total ankle##2##3##(2009-7#2)
of total antioxidant capacity in green tea##2##7##(2008-10#2)
of total antioxidant capacity##3##4##(2008-10#3)
of total arsenic##7##3##(1995-11#1)(2008-10#6)
of total bacteria and##2##4##(2008-10#2)
of total bilirubin##4##3##(2008-10#2)(2013-1#2)
of total body##2##3##(2007-11#1)(2008-10#1)
of total cell protein##2##4##(2008-11#2)
of total cell##3##3##(2008-11#2)(2009-3#1)
of total cells##3##3##(2008-10#1)(2008-7#2)
of total cellular##3##3##(1990-5#1)(1994-8#1)(2008-4#1)
of total cholesterol##4##3##(1991-11#1)(1994-12#1)(1996-11#1)(2013-1#1)
of total chromium in##4##4##(2008-10#4)
of total chromium##5##3##(2008-10#5)
of total culturable##2##3##(2008-10#2)
of total developmental time spent in a particular##2##8##(2008-8#2)
of total dissolved##3##3##(2008-10#3)
of total flavones from##2##4##(2012-3#1)(2013-8#1)
of total fluorine in##3##4##(2008-10#3)
of total gaseous selenium in##2##5##(2008-10#2)
of total genomic DNA##2##4##(2008-10#2)
of total glycoalkaloids content in##2##5##(2008-10#2)
of total glycoalkaloids content##4##4##(2008-10#4)
of total hip arthroplasty (THA)##2##5##(2013-1#2)
of total hip arthroplasty##3##4##(2008-8#1)(2013-1#2)
of total hip##4##3##(2008-8#1)(2009-3#1)(2013-1#2)
of total homocysteine##2##3##(2008-8#2)
of total hospital##2##3##(1992-2#1)(1993-1#1)
of total inorganic arsenic##2##4##(2008-10#2)
of total inorganic##5##3##(2008-10#5)
of total lipids)##2##3##(2008-11#2)
of total mercury in##4##4##(2008-10#4)
of total mercury##11##3##(2008-10#11)
of total nitrogen##2##3##(2008-10#2)
of total nucleated cells##2##4##(2008-11#1)(2008-8#1)
of total phosphorus in soya food##2##6##(2008-10#2)
of total phosphorus in##3##4##(2008-10#3)
of total phosphorus##5##3##(2008-10#5)
of total polar parts##2##4##(2008-10#2)
of total protein in human serum samples##2##7##(2008-10#2)
of total protein in human serum##3##6##(2008-10#3)
of total protein##8##3##(1992-6#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-3#1)
of total proteins##4##3##(2008-10#4)
of total quality management##3##4##(1993-3#1)(1994-1#2)
of total sialic acids##2##4##(2008-11#2)
of total soluble phenolic compounds##2##5##(2008-10#2)
of total soluble##4##3##(1993-9#1)(2008-10#2)(2011-2#1)
of total thallium##2##3##(2008-10#2)
of total##252##2##(1990-12#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-3#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#136)(2008-11#11)(2008-4#3)(2008-7#5)(2008-8#11)(2008-9#3)(2009-12#2)(2009-3#3)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#2)
of town##2##2##(1994-12#1)(2011-2#1)
of toxic and##2##3##(2008-10#1)(2008-8#1)
of toxic chemicals##2##3##(2008-11#1)(2011-1#1)
of toxic effects##3##3##(1992-3#1)(1996-3#1)(2008-10#1)
of toxic species##2##3##(2008-10#2)
of toxic substances##4##3##(2008-10#2)(2008-11#2)
of toxic##34##2##(1992-3#1)(1994-11#1)(1996-12#1)(1996-3#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
of toxicant##2##2##(2008-10#1)(2008-9#1)
of toxicants##7##2##(2008-10#4)(2008-11#2)(2012-2#1)
of toxicity##10##2##(1991-1#1)(1991-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-12#1)(2012-7#1)
of toxin production##2##3##(2008-10#1)(2011-2#1)
of toxin##7##2##(2008-10#6)(2011-2#1)
of toxins and##2##3##(2008-10#1)(2012-12#1)
of toxins##6##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-12#1)
of trace Cd and Pb in environmental and biological samples##2##10##(2008-10#2)
of trace Cd and Pb##3##5##(2008-10#3)
of trace Cd##4##3##(2008-10#4)
of trace amount of##22##4##(2008-10#22)
of trace amount##23##3##(2008-10#23)
of trace amounts of NADH##2##5##(2008-10#2)
of trace amounts of beryllium##3##5##(2008-10#3)
of trace amounts of bromide##3##5##(2008-10#3)
of trace amounts of copper in##2##6##(2008-10#2)
of trace amounts of copper##5##5##(2008-10#5)
of trace amounts of formaldehyde in air##3##7##(2008-10#3)
of trace amounts of germanium by##2##6##(2008-10#2)
of trace amounts of##86##4##(2008-10#86)
of trace and##5##3##(2008-10#5)
of trace cadmium##2##3##(2008-10#2)
of trace chromium(VI)##2##3##(2008-10#2)
of trace cobalt##4##3##(2008-10#4)
of trace constituents##2##3##(2008-10#2)
of trace copper##3##3##(2008-10#3)
of trace element##3##3##(2008-10#1)(2011-2#2)
of trace elements in solid##2##5##(2008-10#2)
of trace elements in##16##4##(2008-10#15)(2011-2#1)
of trace elements is##2##4##(2008-10#2)
of trace elements were##2##4##(2008-10#2)
of trace elements##33##3##(2008-10#31)(2010-11#1)(2011-2#1)
of trace gases##3##3##(2008-3#3)
of trace heavy metals in##2##5##(2008-10#2)
of trace heavy metals##4##4##(2008-10#4)
of trace impurities in##2##4##(2008-10#2)
of trace iron in beer##2##5##(2008-10#2)
of trace lead##6##3##(2008-10#6)
of trace levels of##19##4##(2008-10#19)
of trace manganese##7##3##(2008-10#7)
of trace mercury##7##3##(2008-10#7)
of trace metal ions in##2##5##(2008-10#2)
of trace metal ions##5##4##(2008-10#5)
of trace metal##8##3##(2008-10#8)
of trace metals by##5##4##(2008-10#5)
of trace metals in water##2##5##(2008-10#2)
of trace metals in##16##4##(2008-10#16)
of trace metals using a##2##5##(2008-10#2)
of trace metals##34##3##(2008-10#33)(2012-2#1)
of trace vanadium##3##3##(2008-10#3)
of trace water in##3##4##(2008-10#3)
of trace##343##2##(2008-10#333)(2008-11#1)(2008-3#4)(2010-11#1)(2011-2#3)(2012-2#1)
of tracer##3##2##(1993-11#1)(1994-12#1)(1996-12#1)
of tracers##2##2##(2008-10#1)(2010-7#1)
of traces of Ni in##2##5##(2008-10#2)
of traces of Ni##3##4##(2008-10#3)
of traces of cobalt##2##4##(2008-10#2)
of traces of gold##2##4##(2008-10#2)
of traces of silver ions onto polyurethane foam##2##8##(2008-10#2)
of traces of##23##3##(2008-10#23)
of traces##25##2##(2008-10#25)
of traction induced##2##3##(2008-9#2)
of trade##2##2##(2007-12#1)(2008-12#1)
of traditional Chinese medicine injections##3##5##(2011-2#2)(2011-3#1)
of traditional Chinese medicine##5##4##(2011-2#3)(2011-3#1)(2013-1#1)
of traditional Chinese##8##3##(1997-2#1)(2011-2#4)(2011-3#1)(2013-1#2)
of traditional medicine##2##3##(1992-5#1)(2008-1#1)
of traditional practices##2##3##(1997-7#2)
of traditional##35##2##(1992-5#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#2)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#3)
of traffic##5##2##(1992-2#1)(1995-12#1)(2008-11#2)(2011-2#1)
of trained##3##2##(1993-11#1)(2011-2#2)
of trainees##2##2##(1994-12#1)(2010-8#1)
of training and##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
of training for##3##3##(1991-3#1)(1994-3#1)(1997-2#1)
of training of##2##3##(1994-3#1)(1996-12#1)
of training set##2##3##(2008-10#2)
of training##32##2##(1991-3#2)(1992-12#1)(1992-2#1)(1993-2#3)(1993-3#1)(1994-12#1)(1994-3#3)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2009-1#1)(2009-10#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
of trait##3##2##(2008-11#2)(2012-3#1)
of traits that##3##3##(2008-11#1)(2008-8#2)
of traits##11##2##(2008-11#1)(2008-8#7)(2010-5#1)(2012-3#2)
of trajectories##2##2##(2008-11#1)(2011-2#1)
of tranilast##3##2##(1995-11#1)(2008-5#2)
of trans-beta-carotene in rat and beef livers##2##7##(2008-10#2)
of trans-beta-carotene in##3##3##(2008-10#3)
of trans-beta-carotene##4##2##(2008-10#4)
of trans-tamoxifen##2##2##(2008-11#2)
of transactions##2##2##(2008-11#1)(2012-3#1)
of transaldolase and phosphoglycerate mutase I##2##6##(2010-12#2)
of transaminases##3##2##(1992-5#1)(1996-11#1)(2012-12#1)
of transcranial##4##2##(1996-2#1)(1996-3#1)(1996-6#1)(2011-2#1)
of transcript##5##2##(2008-10#3)(2008-11#1)(2009-8#1)
of transcription (STAT)##4##3##(2011-2#2)(2012-3#2)
of transcription complexes##2##3##(1995-2#1)(1995-6#1)
of transcription factor##3##3##(1996-2#1)(2008-9#2)
of transcription factors and##2##4##(2009-10#1)(2009-8#1)
of transcription factors binding##2##4##(2008-7#1)(2008-9#1)
of transcription factors##11##3##(1991-5#1)(1992-12#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#2)(2011-1#1)(2012-2#1)
of transcription initiation##2##3##(1997-7#1)(1997-8#1)
of transcription of the##4##4##(1992-1#1)(1997-2#1)(1997-7#2)
of transcription of##8##3##(1992-1#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#2)(2008-11#1)(2008-9#1)
of transcription##49##2##(1991-10#1)(1991-5#2)(1992-1#1)(1992-12#1)(1993-6#1)(1993-9#2)(1994-2#1)(1995-2#1)(1995-6#4)(1996-2#3)(1997-2#1)(1997-7#3)(1997-8#1)(2008-10#1)(2008-11#5)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)
of transcriptional activation of##2##4##(1992-8#1)(1994-11#1)
of transcriptional activation##3##3##(1992-8#1)(1994-11#1)(2008-9#1)
of transcriptional changes##2##3##(2010-11#1)(2012-2#1)
of transcriptional control##2##3##(2008-7#1)(2012-2#1)
of transcriptional regulation##4##3##(1992-8#1)(2008-11#1)(2008-9#1)(2012-3#1)
of transcriptional##22##2##(1991-7#1)(1992-8#2)(1993-8#1)(1994-11#1)(1995-6#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2012-2#3)(2012-3#2)
of transcripts from##2##3##(1992-6#1)(2008-10#1)
of transcripts in##2##3##(1996-12#1)(2011-2#1)
of transcripts##16##2##(1992-6#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-2#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
of transdermal granisetron in##2##4##(2010-12#2)
of transdermal granisetron##3##3##(2010-12#3)
of transdermal##4##2##(2008-8#1)(2010-12#3)
of transduction##4##2##(1996-2#1)(2008-11#1)(2008-8#1)(2010-10#1)
of transfected##6##2##(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#2)(2008-9#1)
of transfection##4##2##(1992-6#1)(2008-11#3)
of transfer function coefficients##2##4##(2011-2#2)
of transfer of learning##2##4##(2008-11#2)
of transfer of##3##3##(2008-10#1)(2008-11#2)
of transfer to##2##3##(2011-2#2)
of transfer##12##2##(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#2)(2011-2#5)(2013-1#1)
of transferrin##2##2##(2008-10#1)(2013-7#1)
of transferring##2##2##(1996-11#1)(2009-10#1)
of transformants##7##2##(1990-5#1)(2008-10#5)(2011-1#1)
of transformation zone##2##3##(2012-3#2)
of transformation##7##2##(1994-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2012-3#2)
of transformed cells##2##3##(2008-10#1)(2011-2#1)
of transformed phenotype##2##3##(1995-9#1)(2008-11#1)
of transformed##10##2##(1995-2#1)(1995-9#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#2)
of transformer oil##2##3##(2008-10#2)
of transformer##3##2##(2008-10#3)
of transforming growth factor beta (TGF-beta)##2##6##(2008-11#1)(2008-12#1)
of transforming growth factor beta##4##5##(1995-2#1)(2008-11#2)(2008-12#1)
of transforming growth##6##3##(1990-2#2)(1995-2#1)(2008-11#2)(2008-12#1)
of transforming##8##2##(1990-2#2)(1990-5#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#1)
of transfused##3##2##(1991-8#2)(2011-2#1)
of transfusion##5##2##(1990-3#1)(1996-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
of transgene expression##2##3##(1997-1#1)(1997-8#1)
of transgene##5##2##(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
of transgenes##5##2##(1993-6#2)(2008-11#1)(2008-9#2)
of transgenesis in N##2##4##(2012-3#2)
of transgenic animals##3##3##(1993-12#1)(1993-6#1)(1995-2#1)
of transgenic lines##2##3##(2008-10#2)
of transgenic livestock##2##3##(2008-11#2)
of transgenic mice##5##3##(1997-7#1)(2008-11#1)(2008-4#3)
of transgenic plants containing the##2##5##(2008-9#2)
of transgenic plants containing##3##4##(2008-9#3)
of transgenic plants##7##3##(2008-8#3)(2008-9#4)
of transgenic rabbits##3##3##(2008-11#1)(2008-12#2)
of transgenic tomato##3##3##(2008-10#3)
of transgenic##33##2##(1993-12#1)(1993-6#1)(1995-2#1)(1997-7#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-4#3)(2008-8#6)(2008-9#5)(2010-5#1)
of transient gene expression in##2##5##(2008-11#2)
of transient##11##2##(1990-5#1)(1992-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2013-1#1)
of transition metal ions##2##4##(2008-10#1)(2010-11#1)
of transition metal##4##3##(2008-10#3)(2010-11#1)
of transition metals in human hair##2##6##(2008-10#2)
of transition metals in##4##4##(2008-10#2)(2008-5#1)(2010-11#1)
of transition metals##6##3##(2008-10#3)(2008-5#1)(2010-11#1)(2011-1#1)
of transition##11##2##(2008-10#7)(2008-5#1)(2010-11#2)(2011-1#1)
of transitions##2##2##(2008-9#1)(2009-10#1)
of translated##2##2##(2008-10#1)(2010-1#1)
of translating##2##2##(2008-4#1)(2009-10#1)
of translation elongation factor##3##4##(2008-10#2)(2008-8#1)
of translation initiation sites##2##4##(1997-6#2)
of translation##12##2##(1995-12#1)(1995-6#1)(1997-6#2)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)
of translational research in##2##4##(2010-10#2)
of translational##4##2##(1995-9#1)(2008-8#1)(2010-10#2)
of translocation##2##2##(1991-12#1)(2008-8#1)
of transmembrane proteins##5##3##(1994-12#1)(2008-4#1)(2008-9#1)(2009-8#2)
of transmembrane signaling##2##3##(1991-12#1)(2008-9#1)
of transmembrane##10##2##(1991-12#1)(1993-12#1)(1994-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#2)(2010-10#1)
of transmission among##3##3##(2012-2#1)(2013-8#2)
of transmission electron microscopy (TEM)##2##5##(2008-10#1)(2008-5#1)
of transmission of infection##2##4##(2010-5#2)
of transmission of##5##3##(1993-3#1)(1996-11#1)(2008-10#1)(2010-5#2)
of transmission##28##2##(1993-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1997-2#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-9#2)(2010-5#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#2)
of transmitted K65R and other tenofovir resistance mutations across##2##9##(2013-1#2)
of transmitted##3##2##(2013-1#3)
of transmitting the##2##3##(2008-10#2)
of transmitting##3##2##(1992-9#1)(2008-10#2)
of transparent##4##2##(1994-3#1)(2008-10#2)(2008-11#1)
of transpedicular screw##3##3##(2007-11#3)
of transpedicular screws##2##3##(2007-11#2)
of transpedicular spine##2##3##(2007-11#2)
of transpedicular##7##2##(2007-11#7)
of transplant##6##2##(1995-12#1)(2008-10#1)(2008-9#1)(2011-2#2)(2011-3#1)
of transplantation##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
of transplanted bone marrow cells##2##5##(2010-11#2)
of transplanted##4##2##(2008-10#1)(2010-10#1)(2010-11#2)
of transplants##2##2##(2008-10#1)(2009-3#1)
of transport of##2##3##(1994-6#1)(2010-8#1)
of transport proteins##2##3##(2008-11#1)(2011-2#1)
of transport was##2##3##(1995-11#1)(2008-10#1)
of transport##15##2##(1994-6#1)(1995-11#1)(2007-9#1)(2008-10#8)(2008-11#1)(2010-8#1)(2011-2#2)
of transposable elements and##2##4##(2009-10#1)(2009-6#1)
of transposable elements in plants##2##5##(2009-6#2)
of transposable elements in##3##4##(2009-6#2)(2010-5#1)
of transposable elements##10##3##(2008-10#2)(2009-10#3)(2009-6#4)(2010-5#1)
of transposable##11##2##(1995-12#1)(2008-10#2)(2009-10#3)(2009-6#4)(2010-5#1)
of transposon##3##2##(1996-12#1)(2008-10#1)(2010-5#1)
of transracial##2##2##(2008-5#2)
of transradial approach for##2##4##(2011-2#2)
of transradial approach##3##3##(2011-2#3)
of transradial##7##2##(2011-2#7)
of transrectal sonography##2##3##(2011-2#2)
of transrectal##3##2##(1997-8#1)(2011-2#2)
of transthyretin in##2##3##(1991-2#2)
of transthyretin##3##2##(1991-2#3)
of transverse myelitis##2##3##(2012-3#2)
of transverse##5##2##(2007-12#1)(2008-7#1)(2012-3#2)(2013-1#1)
of trapping##4##2##(2008-10#3)(2010-4#1)
of trastuzumab##5##2##(2012-12#2)(2013-1#3)
of trauma##8##2##(2008-12#1)(2008-9#1)(2009-4#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
of trauma-focused research on##2##4##(2009-4#2)
of trauma-focused research##3##3##(2009-4#3)
of trauma-related##2##2##(2012-2#2)
of traumatic brain injury##2##4##(1990-12#2)
of traumatic brain##3##3##(1990-12#3)
of traumatic##10##2##(1990-12#3)(2008-1#1)(2008-12#2)(2009-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
of travelers who##2##3##(1996-8#1)(2008-10#1)
of travelers##4##2##(1996-8#1)(2008-10#2)(2010-12#1)
of treadmill running on##2##4##(2008-12#2)
of treadmill running##3##3##(2008-12#2)(2013-1#1)
of treadmill##4##2##(2008-12#2)(2010-12#1)(2013-1#1)
of treated and##2##3##(1995-6#1)(2008-10#1)
of treated hypertensives##2##3##(2008-10#2)
of treated plants##3##3##(2008-10#3)
of treated##14##2##(1991-2#1)(1993-12#1)(1994-6#1)(1995-6#1)(2008-10#8)(2008-6#1)(2011-2#1)
of treating a##2##3##(1995-6#1)(2012-12#1)
of treating the##3##3##(1992-5#1)(2013-1#2)
of treating##18##2##(1991-2#1)(1992-5#1)(1995-6#2)(1996-11#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
of treatment and the##2##4##(1991-6#1)(2012-12#1)
of treatment and##13##3##(1991-6#1)(1992-3#1)(1992-9#1)(1996-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of treatment effects##6##3##(1996-6#1)(2008-11#1)(2009-8#1)(2009-9#2)(2012-6#1)
of treatment for chronic##2##4##(2008-10#1)(2013-1#1)
of treatment for##15##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-3#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#1)(2012-3#1)(2013-1#2)
of treatment in patients with##2##5##(1994-12#1)(2008-10#1)
of treatment in##7##3##(1994-12#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-6#1)(2013-1#1)
of treatment is the##2##4##(1997-2#1)(2013-1#1)
of treatment is##8##3##(1993-3#1)(1993-6#1)(1995-2#1)(1997-2#1)(2008-6#1)(2013-1#3)
of treatment modalities##5##3##(1992-3#1)(1996-1#1)(2008-7#1)(2011-2#2)
of treatment of##15##3##(1990-2#1)(1993-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-12#2)(2012-3#1)(2013-1#3)
of treatment on the##2##4##(1992-9#1)(2008-11#1)
of treatment on##4##3##(1992-9#1)(2008-11#1)(2008-7#1)(2013-1#1)
of treatment options##2##3##(1993-1#1)(2009-3#1)
of treatment protocols##2##3##(1995-8#1)(2012-12#1)
of treatment response##2##3##(2010-12#1)(2011-2#1)
of treatment was##3##3##(1991-8#1)(2008-6#1)(2009-11#1)
of treatment were##7##3##(1996-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-3#1)
of treatment will##2##3##(2008-12#1)(2008-5#1)
of treatment with##10##3##(1990-11#1)(1992-2#1)(1993-11#1)(1995-12#1)(1995-8#2)(1996-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
of treatment##242##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-6#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-3#2)(1991-6#2)(1991-8#3)(1992-1#2)(1992-2#1)(1992-3#5)(1992-5#1)(1992-9#4)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#3)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#4)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#11)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#8)(2008-7#13)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#8)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#8)(2012-2#6)(2012-3#10)(2012-6#1)(2013-1#20)(2013-8#6)
of treatments to##2##3##(1995-12#1)(2009-8#1)
of treatments was##2##3##(2008-10#2)
of treatments##15##2##(1990-2#2)(1995-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-3#1)
of tree species##2##3##(2009-8#1)(2012-6#1)
of tree##11##2##(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2012-6#1)
of trees in##2##3##(2008-10#2)
of trees to##3##3##(2008-10#2)(2012-8#1)
of trees##14##2##(2008-10#11)(2010-4#1)(2011-10#1)(2012-8#1)
of trehalose##5##2##(1993-8#1)(2008-10#2)(2013-1#2)
of tremendous##5##2##(2008-11#1)(2008-4#3)(2008-9#1)
of tremolite##6##2##(1991-12#6)
of trends in##3##3##(1991-2#1)(1993-1#1)(2008-1#1)
of trends##5##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(2008-1#1)
of triacylglycerols##2##2##(2008-11#1)(2008-5#1)
of trial##3##2##(1993-12#1)(1993-3#1)(2008-5#1)
of trials in##2##3##(1994-2#2)
of trials##12##2##(1990-11#1)(1993-12#1)(1993-3#1)(1994-2#2)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2013-8#2)
of triamcinolone##3##2##(1996-3#1)(2010-12#1)(2011-2#1)
of triazine##2##2##(2008-10#2)
of triazines from soils##2##4##(2008-10#2)
of triazines##3##2##(2008-10#3)
of trichinosis##2##2##(2008-10#2)
of trichloroacetic acid (TCA)##2##4##(2008-10#2)
of trichloroacetic acid##3##3##(2008-10#3)
of trichloroethylene (TCE)##3##3##(2008-10#2)(2010-4#1)
of trichloroethylene##7##2##(2008-10#6)(2010-4#1)
of tricyclic antidepressant##2##3##(2008-10#1)(2010-1#1)
of tricyclic antidepressants##4##3##(1991-11#2)(2008-10#1)(2012-2#1)
of tricyclic##7##2##(1990-11#1)(1991-11#2)(2008-10#2)(2010-1#1)(2012-2#1)
of triethanolamine (TEA)##2##3##(2008-10#2)
of triethanolamine##3##2##(2008-10#3)
of triethylamine##3##2##(2008-10#1)(2008-7#2)
of trifluoroethanol##3##2##(1995-2#2)(2009-8#1)
of triflupromazine##2##2##(2008-10#2)
of trifluridine##2##2##(1994-8#2)
of trifoliate orange##4##3##(2008-10#4)
of trigeminal##2##2##(1990-9#1)(2011-2#1)
of trigger##4##2##(2008-12#1)(2009-7#1)(2009-8#1)(2010-9#1)
of triggers##2##2##(2008-10#1)(2008-11#1)
of triglyceride-rich lipoproteins##4##3##(1995-6#4)
of triglyceride-rich##5##2##(1995-6#4)(2008-6#1)
of triglycerides##4##2##(1992-3#1)(1997-8#1)(2008-12#1)(2008-8#1)
of trihalomethanes (THMs)##2##3##(2008-10#2)
of trihalomethanes in##3##3##(2008-10#3)
of trihalomethanes##7##2##(2008-10#7)
of trimellitic##2##2##(2008-10#2)
of trimeperidine##2##2##(2012-3#2)
of trimethylamine in##2##3##(2008-10#2)
of trimethylamine##3##2##(2008-10#3)
of trimethylphosphine binding to##2##4##(1990-8#2)
of trinitrophenol##2##2##(2008-10#2)
of trinitrotoluene (TNT)##2##3##(2008-10#2)
of trinitrotoluene##3##2##(2008-10#3)
of triploid crucian carp##2##4##(2010-5#2)
of triploid##3##2##(2009-12#1)(2010-5#2)
of tripropylamine##2##2##(2008-10#1)(2010-7#1)
of tris(2##3##2##(2008-10#3)
of tris-(2##2##2##(2008-10#2)
of trisomy 21##2##3##(1997-4#1)(2012-3#1)
of trisomy##6##2##(1997-4#1)(2012-3#5)
of triterpenic derivatives##2##3##(2008-5#2)
of tritiated##2##2##(2008-11#1)(2008-9#1)
of tritrophic food chains##2##4##(2008-9#2)
of trivalent##9##2##(2008-10#9)
of trkB##3##2##(1996-12#3)
of trophic cascades##4##3##(2008-8#4)
of trophic##9##2##(1990-3#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2012-3#1)
of tropical diseases##3##3##(2011-2#2)(2012-2#1)
of tropical medicine##2##3##(2010-1#2)
of tropical##19##2##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#4)(2009-8#1)(2010-1#2)(2010-7#1)(2011-2#3)(2012-2#2)
of tropomyosin##3##2##(1992-9#3)
of trouble##2##2##(2008-10#1)(2008-6#1)
of trout##2##2##(1992-6#1)(2008-11#1)
of troutCYP1A gene##2##3##(2008-11#2)
of true##11##2##(1990-5#1)(1991-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-6#1)(2013-1#2)
of truly##2##2##(2008-10#1)(2008-5#1)
of truncated and##2##3##(2008-11#1)(2008-8#1)
of truncated##8##2##(1991-10#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
of trunk strength and stability##2##5##(2008-12#2)
of trunk##3##2##(2008-12#2)(2013-1#1)
of trust##2##2##(1997-3#1)(2008-11#1)
of trypan##2##2##(2008-10#1)(2008-11#1)
of trypanozoon infection##5##3##(2011-2#5)
of trypsin##3##2##(1997-2#2)(2008-11#1)
of tryptic##2##2##(1995-6#1)(2008-10#1)
of tryptophan residues##2##3##(1992-6#1)(1995-2#1)
of tryptophan##11##2##(1992-6#2)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#3)
of tsetse flies##2##3##(2013-8#2)
of tubal pregnancy##2##3##(1994-3#2)
of tubal sterility##2##3##(1994-12#2)
of tubal##5##2##(1991-12#1)(1994-12#2)(1994-3#2)
of tube##2##2##(2009-8#1)(2012-2#1)
of tuber-borne sclerotia##2##3##(2008-10#2)
of tuber-borne##3##2##(2008-10#3)
of tubercular##4##2##(1997-8#2)(2010-8#1)(2012-12#1)
of tuberculosis in##7##3##(1996-3#1)(2008-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
of tuberculosis infection##4##3##(1990-6#2)(2008-10#1)(2010-11#1)
of tuberculosis##33##2##(1990-6#3)(1993-11#1)(1995-10#1)(1996-3#5)(2008-1#2)(2008-10#2)(2008-12#1)(2008-7#2)(2010-11#1)(2011-2#7)(2012-3#4)(2013-1#3)(2013-8#1)
of tuberculous meningitis##3##3##(2011-2#2)(2013-7#1)
of tuberculous spinal cord compression##2##5##(2008-7#2)
of tuberculous##7##2##(1990-6#1)(2008-7#2)(2011-2#3)(2013-7#1)
of tuberous##2##2##(2008-11#1)(2010-6#1)
of tubers##2##2##(2008-10#2)
of tubing##4##2##(1997-3#3)(2008-10#1)
of tubular degeneration##2##3##(2008-5#1)(2008-9#1)
of tubular##5##2##(1992-9#1)(1993-2#1)(2008-5#1)(2008-6#1)(2008-9#1)
of tubules##3##2##(2007-12#1)(2008-7#2)
of tubulin##3##2##(1993-6#1)(1993-8#1)(2010-7#1)
of tumor and##3##3##(1990-2#1)(1993-11#1)(2009-3#1)
of tumor cell##4##3##(1997-7#1)(2008-11#1)(2008-8#1)(2009-3#1)
of tumor cells in##2##4##(2008-11#1)(2009-3#1)
of tumor cells to##2##4##(2008-11#1)(2009-9#1)
of tumor cells##19##3##(1992-3#1)(1994-5#2)(1997-2#1)(2008-11#6)(2008-4#2)(2008-5#1)(2008-9#2)(2009-3#1)(2009-9#1)(2011-2#1)(2012-3#1)
of tumor growth and##2##4##(2009-3#1)(2012-2#1)
of tumor growth##7##3##(1993-1#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
of tumor invasion##3##3##(2008-11#2)(2013-8#1)
of tumor lysis syndrome in adults with hematologic malignancies##2##9##(2008-7#2)
of tumor necrosis factor alpha##2##5##(1992-7#1)(2011-2#1)
of tumor necrosis factor##4##4##(1992-7#1)(1994-8#1)(2011-2#2)
of tumor necrosis factor-alpha (TNF-alpha)##4##5##(1995-9#1)(2008-10#2)(2008-9#1)
of tumor necrosis factor-alpha and##2##5##(1995-10#1)(2008-5#1)
of tumor necrosis factor-alpha##6##4##(1995-10#1)(1995-9#1)(2008-10#2)(2008-5#1)(2008-9#1)
of tumor necrosis##11##3##(1992-7#1)(1994-8#1)(1995-10#1)(1995-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)
of tumor progression##5##3##(1991-2#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-3#1)
of tumor regression##2##3##(1992-12#1)(1994-5#1)
of tumor stage##2##3##(1990-12#1)(2008-1#1)
of tumor suppressor genes##2##4##(1990-12#1)(2011-2#1)
of tumor suppressor##3##3##(1990-12#1)(1995-6#1)(2011-2#1)
of tumor##91##2##(1990-12#3)(1990-2#2)(1990-6#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-11#3)(1993-8#1)(1993-9#1)(1994-5#3)(1994-8#1)(1995-10#1)(1995-6#1)(1995-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#11)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#2)(2009-12#2)(2009-3#5)(2009-6#2)(2009-9#1)(2010-11#1)(2011-2#10)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#5)
of tumor-bearing mice##3##3##(1994-3#1)(2008-9#2)
of tumor-bearing##4##2##(1990-2#1)(1994-3#1)(2008-9#2)
of tumor-immune##3##2##(2013-8#3)
of tumorigenesis induced by##2##4##(2008-11#2)
of tumorigenesis##4##2##(1995-10#1)(1995-9#1)(2008-11#2)
of tumorigenic##3##2##(1995-9#1)(1997-1#1)(2009-3#1)
of tumors and##3##3##(2008-9#1)(2009-3#1)(2010-12#1)
of tumors in##2##3##(2011-2#1)(2012-2#1)
of tumors to##2##3##(2013-7#2)
of tumors with##2##3##(1990-2#1)(2010-12#1)
of tumors##31##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1991-12#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#2)
of tumour hypoxia and the##2##5##(2009-4#1)(2011-2#1)
of tumour hypoxia and##3##4##(2009-4#1)(2011-2#2)
of tumour hypoxia##4##3##(2009-4#2)(2011-2#2)
of tumour spread##3##3##(2008-1#1)(2012-2#2)
of tumour##18##2##(1990-11#1)(1993-3#1)(1993-8#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#3)(2011-2#4)(2012-2#2)
of tumours##4##2##(1997-2#1)(2008-2#1)(2009-8#1)(2011-2#1)
of tuna ferrocytochrome c##2##4##(1994-5#2)
of tuna##3##2##(1994-5#2)(2011-2#1)
of tunable##2##2##(2008-3#2)
of tungsten in##4##3##(2008-10#4)
of tungsten##11##2##(2008-10#11)
of tunicamycin##4##2##(1993-6#1)(1994-8#1)(2008-11#1)(2013-1#1)
of tunnel length##2##3##(2013-1#2)
of tunnel##4##2##(2011-2#2)(2013-1#2)
of tunneling##2##2##(1992-11#1)(2008-3#1)
of turbot##2##2##(2010-5#1)(2010-8#1)
of turbulence##2##2##(2008-12#1)(2008-3#1)
of turbulent##2##2##(2008-3#1)(2008-8#1)
of turnip mosaic virus##2##4##(2008-10#2)
of turnip##3##2##(1997-3#1)(2008-10#2)
of turnover##2##2##(1996-2#1)(2007-12#1)
of twelve##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
of twenty##3##2##(1991-3#1)(2008-10#1)(2008-12#1)
of twenty-five##3##2##(1990-3#1)(1993-2#1)(2008-7#1)
of twin births##3##3##(1990-6#3)
of twin##6##2##(1990-6#3)(1991-3#1)(2010-8#2)
of twins##2##2##(1997-7#1)(2008-7#1)
of two active##3##3##(1997-7#1)(2008-10#2)
of two alternative##3##3##(2008-3#1)(2008-8#2)
of two calibration##2##3##(2008-10#2)
of two cases and review of the##2##7##(1992-12#1)(2012-3#1)
of two cases and##3##4##(1992-12#1)(2011-2#1)(2012-3#1)
of two cases of##2##4##(2008-10#1)(2011-2#1)
of two cases##13##3##(1992-12#1)(1994-6#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
of two closely##2##3##(2008-10#1)(2008-8#1)
of two clusters of##3##4##(1994-5#1)(2008-10#2)
of two cohorts of##2##4##(2008-11#1)(2013-1#1)
of two commercial##5##3##(2008-10#4)(2008-3#1)
of two common##2##3##(2008-10#2)
of two complementary##2##3##(1992-6#1)(1995-5#1)
of two components##2##3##(2008-10#1)(2008-8#1)
of two consecutive##2##3##(2008-10#2)
of two coupled##2##3##(2009-8#1)(2013-8#1)
of two day##2##3##(2008-11#1)(2008-12#1)
of two different extraction methods##2##5##(2008-10#2)
of two different polyamines##3##4##(2008-12#3)
of two different subunits##2##4##(1991-10#2)
of two different##38##3##(1990-11#1)(1990-12#1)(1991-10#2)(1992-9#1)(1993-1#2)(1994-11#2)(1995-2#1)(1995-8#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#2)(2008-8#1)(2009-1#1)(2009-3#1)(2010-5#1)(2010-7#1)(2012-2#2)(2012-3#1)
of two distinct##5##3##(2008-10#3)(2008-11#1)(2010-6#1)
of two fluoquinolones##2##3##(2008-10#2)
of two genes##3##3##(1991-6#1)(2008-10#2)
of two genotypes of##2##4##(2008-10#2)
of two groups of##2##4##(1996-8#1)(2008-10#1)
of two groups##6##3##(1990-12#1)(1992-2#1)(1996-8#1)(2008-10#3)
of two highly##2##3##(2008-10#1)(2008-11#1)
of two identical##2##3##(1997-2#1)(2007-11#1)
of two immiscible##2##3##(1993-8#1)(2008-10#1)
of two interacting##2##3##(2009-8#1)(2011-2#1)
of two interspecific##2##3##(2008-10#2)
of two isoforms of##2##4##(1994-8#1)(1995-2#1)
of two isolates##5##3##(2008-10#5)
of two isomers##2##3##(2008-10#2)
of two kinds of##2##4##(2008-11#1)(2008-8#1)
of two ligands##2##3##(2008-10#2)
of two main##3##3##(2008-11#2)(2008-12#1)
of two major##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
of two metal##2##3##(2008-10#2)
of two methods##2##3##(1997-2#1)(2008-10#1)
of two molecular##2##3##(2008-11#1)(2008-4#1)
of two monoclonal antibodies##3##4##(1990-12#1)(1992-2#1)(1994-5#1)
of two new##6##3##(1992-2#1)(1993-6#1)(2008-10#3)(2008-11#1)
of two nonidentical subunits##2##4##(1992-9#1)(2008-8#1)
of two novel##6##3##(1993-6#1)(1993-8#1)(2008-10#1)(2008-9#2)(2011-2#1)
of two of the##4##4##(1995-6#1)(2008-10#2)(2008-8#1)
of two of##5##3##(1995-6#1)(2008-10#3)(2008-8#1)
of two or more##4##4##(1993-2#1)(2008-10#1)(2008-3#1)(2010-1#1)
of two or##5##3##(1993-2#1)(2008-10#2)(2008-3#1)(2010-1#1)
of two orchid viruses##3##4##(2008-10#3)
of two orders of magnitude##3##5##(2008-10#3)
of two patients who##2##4##(1997-8#1)(2012-12#1)
of two patients with##3##4##(1996-9#1)(2008-10#1)(2010-7#1)
of two patients##6##3##(1996-9#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-12#1)
of two phases##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of two populations##2##3##(2008-12#1)(2008-4#1)
of two proteins##2##3##(1993-12#1)(2010-12#1)
of two representative##2##3##(2008-10#2)
of two sensory##2##3##(1993-12#1)(2008-7#1)
of two separate##5##3##(1992-1#1)(1992-6#1)(2008-10#1)(2008-9#1)(2009-3#1)
of two sets of##2##4##(1996-2#1)(2008-3#1)
of two spatial##2##3##(2008-10#1)(2008-8#1)
of two species of##8##4##(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#1)
of two species##11##3##(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-8#1)(2013-1#1)
of two strains of##3##4##(2008-10#2)(2013-8#1)
of two subgroups##2##3##(2008-10#1)(2008-5#1)
of two tandem##2##3##(1991-9#1)(2008-9#1)
of two treatment##2##3##(2008-5#1)(2012-2#1)
of two treatments##2##3##(1995-9#1)(2008-9#1)
of two types of##6##4##(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-11#1)
of two types##7##3##(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
of two viruses that##2##4##(2008-10#2)
of two viruses##3##3##(1995-2#1)(2008-10#2)
of two weeks##3##3##(1990-9#1)(1996-1#1)(2008-8#1)
of two years##3##3##(1991-12#1)(1995-5#1)(2012-3#1)
of two##617##2##(1990-11#1)(1990-12#7)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#3)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#6)(1992-9#3)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#5)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#2)(1994-11#9)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#8)(1994-6#1)(1994-8#5)(1994-9#3)(1995-12#1)(1995-2#6)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-2#3)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#4)(1997-6#2)(1997-7#4)(1997-8#3)(2006-6#2)(2007-11#2)(2007-12#7)(2008-1#2)(2008-10#219)(2008-11#36)(2008-12#17)(2008-2#6)(2008-3#20)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#10)(2008-8#25)(2008-9#19)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#6)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#5)
of two-dimensional##6##2##(1990-11#1)(1994-5#1)(2008-3#4)
of two-photon##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
of two-stage##4##2##(2008-10#3)(2008-8#1)
of two-way##2##2##(2008-10#1)(2010-8#1)
of tymoviruses##2##2##(2008-10#2)
of type 1 diabetes##3##4##(2008-10#1)(2010-5#1)(2011-1#1)
of type 1##8##3##(1993-6#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-4#1)
of type 2 diabetes and##2##5##(2008-1#1)(2008-11#1)
of type 2 diabetes##9##4##(1994-12#1)(1996-11#1)(2008-1#3)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
of type 2##10##3##(1994-12#1)(1996-11#1)(2008-1#3)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
of type A##2##3##(1994-2#1)(2013-1#1)
of type I collagen##5##4##(1997-1#2)(2008-1#1)(2008-9#2)
of type I error##3##4##(2008-10#3)
of type I##12##3##(1995-12#1)(1997-1#2)(1997-4#1)(2008-1#1)(2008-10#3)(2008-8#1)(2008-9#3)
of type II##9##3##(1994-5#3)(1996-11#1)(1996-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)
of type IV collagenase##3##4##(2008-11#1)(2008-8#2)
of type IV##4##3##(2008-11#1)(2008-8#2)(2011-3#1)
of type VII collagen##3##4##(1992-3#3)
of type VIII collagen##2##4##(1990-8#2)
of type of##4##3##(1994-3#1)(2008-10#1)(2008-9#1)(2012-3#1)
of type##63##2##(1990-8#2)(1992-3#3)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1995-12#1)(1996-11#2)(1996-12#1)(1997-1#2)(1997-4#1)(2008-1#4)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#2)
of types of##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
of types##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
of typical imaging features##2##4##(2012-3#1)(2013-8#1)
of typical##21##2##(1994-1#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of tyrosinase##7##2##(1995-2#1)(2008-10#4)(2008-5#2)
of tyrosine kinases##3##3##(1993-8#1)(1995-6#1)(2013-1#1)
of tyrosine phosphorylation and##2##4##(1994-6#2)
of tyrosine phosphorylation##4##3##(1994-6#2)(1996-2#2)
of tyrosine residues of##3##4##(2008-1#1)(2008-7#1)(2008-8#1)
of tyrosine residues##5##3##(1997-9#1)(2008-1#1)(2008-7#1)(2008-8#2)
of tyrosine##17##2##(1993-8#1)(1994-6#2)(1995-2#1)(1995-6#1)(1996-2#2)(1997-9#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
of tyrosyl##2##2##(1997-7#1)(2008-8#1)
of ubiquitin##2##2##(2008-4#1)(2008-9#1)
of ulcer##2##2##(1996-11#1)(2008-12#1)
of ulcerative##4##2##(1992-3#2)(2008-12#2)
of ultra trace amounts of##8##5##(2008-10#8)
of ultra trace##14##3##(2008-10#14)
of ultra##15##2##(2008-10#14)(2010-4#1)
of ultra-micro amounts of sulfur in igneous##2##7##(2008-10#2)
of ultra-trace elements##2##3##(2008-10#2)
of ultra-trace##12##2##(2008-10#12)
of ultrabrief pulse width##2##4##(2012-12#2)
of ultrafiltration for##2##3##(2008-10#2)
of ultrafiltration##9##2##(2008-10#7)(2008-7#1)(2012-3#1)
of ultrasmooth nanostructured diamond films##2##5##(2008-10#2)
of ultrasonic and thermo-chemical pre-treatments on##2##6##(2013-1#2)
of ultrasonic##8##2##(1993-2#2)(2008-10#4)(2013-1#2)
of ultrasonography and##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
of ultrasonography##6##2##(1991-6#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#2)
of ultrasound in##3##3##(1994-6#1)(2011-2#1)(2012-2#1)
of ultrasound##13##2##(1992-12#1)(1994-6#1)(2008-10#4)(2008-11#1)(2008-5#2)(2011-2#2)(2012-2#2)
of ultrasound-assisted extraction##3##3##(2008-10#3)
of ultrasound-assisted##4##2##(2008-10#4)
of ultrasound-guided##3##2##(2008-8#1)(2012-2#2)
of ultrasounds##2##2##(2008-10#1)(2008-5#1)
of ultrathin##3##2##(2008-10#2)(2008-12#1)
of ultratrace amounts of##2##4##(2008-10#2)
of ultratrace##3##2##(2008-10#3)
of ultraviolet (UV)##2##3##(1991-6#1)(2008-5#1)
of ultraviolet##5##2##(1991-6#1)(2008-11#1)(2008-5#2)(2011-2#1)
of umbilical cord##3##3##(2008-11#1)(2009-8#1)(2012-12#1)
of umbilical##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#1)
of unbalanced##2##2##(2008-9#1)(2011-2#1)
of uncalibrated##2##2##(2008-10#2)
of uncapped##2##2##(2008-10#2)
of uncertainty associated with the##2##5##(2008-10#1)(2009-11#1)
of uncertainty in##4##3##(2008-10#3)(2008-7#1)
of uncertainty##17##2##(1992-12#1)(1993-12#1)(2008-10#7)(2008-11#1)(2008-7#2)(2009-11#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
of unconsciousness##2##2##(2012-12#1)(2012-3#1)
of uncontrolled##3##2##(2008-10#2)(2013-1#1)
of undefined##3##2##(2008-10#3)
of under##3##2##(2008-10#2)(2010-12#1)
of undergoing##2##2##(1996-5#1)(2008-11#1)
of undergraduate education##2##3##(2010-3#2)
of undergraduate nursing##2##3##(2008-11#1)(2008-12#1)
of undergraduate##11##2##(1993-2#1)(2008-11#2)(2008-12#6)(2010-3#2)
of underivatized amino acids in##3##5##(2008-10#3)
of underivatized amino acids##5##4##(2008-10#5)
of underlying mechanisms##2##3##(2008-11#1)(2008-9#1)
of underlying##8##2##(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
of underreporting##3##2##(1991-6#1)(1997-3#2)
of understanding the##3##3##(1990-5#1)(2011-2#1)(2013-8#1)
of understanding##15##2##(1990-5#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2009-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
of undertaking##3##2##(2008-11#3)
of underweight##2##2##(2010-7#1)(2011-1#1)
of undesirable##2##2##(2008-10#1)(2010-4#1)
of undifferentiated cells##2##3##(2008-11#1)(2009-8#1)
of undifferentiated##4##2##(2008-11#3)(2009-8#1)
of undigested##3##2##(2008-10#2)(2008-12#1)
of unenhanced##2##2##(1995-6#2)
of unequal##2##2##(1992-12#1)(2008-8#1)
of unexpected and##2##3##(1994-3#1)(1996-6#1)
of unexpected##6##2##(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)
of unfed larvae and adult mites of Platytrombidium fasciatum (C##2##10##(2007-12#2)
of unfilled##2##2##(1991-2#1)(1993-6#1)
of unfixed##2##2##(2008-4#2)
of unfolding##2##2##(1991-6#1)(2008-4#1)
of unhealthy weight##4##3##(2008-11#1)(2012-2#3)
of unhealthy##6##2##(2008-11#2)(2011-2#1)(2012-2#3)
of unidentified cadavers##2##3##(2008-12#2)
of unidentified human genes##5##4##(1995-8#2)(1996-2#3)
of unidentified##8##2##(1995-8#2)(1996-2#3)(2008-12#2)(2011-2#1)
of uniform cells##2##3##(1991-8#1)(2009-12#1)
of uniform##6##2##(1991-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)
of unilateral##7##2##(1997-2#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#2)
of uninfected##4##2##(1996-12#1)(2008-10#2)(2008-7#1)
of uninoculated##2##2##(2008-10#2)
of uninsured##3##2##(1997-2#1)(2013-1#2)
of unintended##2##2##(1992-12#1)(2008-10#1)
of unique##10##2##(1997-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2010-5#1)(2012-3#1)
of units##7##2##(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
of univalent metal##3##3##(2008-10#3)
of universal cholesterol screening##2##4##(2013-1#2)
of universal health##2##3##(1991-2#1)(1996-2#1)
of universal##10##2##(1991-2#1)(1994-2#1)(1996-2#1)(1997-5#1)(2008-8#1)(2009-10#1)(2010-11#1)(2013-1#3)
of universe##2##2##(2013-1#2)
of university programs in health administration##2##6##(1994-1#1)(1996-3#1)
of university##4##2##(1994-1#1)(1996-3#1)(2008-11#1)(2010-1#1)
of unknown aetiology##2##3##(1996-3#1)(2010-3#1)
of unknown cause##5##3##(1990-6#1)(1994-9#1)(2008-5#1)(2008-7#2)
of unknown composition##3##3##(1992-12#1)(2008-10#2)
of unknown etiology that##2##4##(2008-10#1)(2010-11#1)
of unknown etiology##10##3##(1991-2#1)(1995-6#1)(1997-8#1)(2008-10#3)(2010-11#2)(2011-2#1)(2012-3#1)
of unknown function##10##3##(1992-9#1)(1994-6#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-9#2)(2009-10#1)
of unknown origin##6##3##(1990-2#1)(1996-11#1)(1996-6#1)(2008-1#1)(2012-3#1)(2013-1#1)
of unknown##46##2##(1990-2#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-3#2)(1996-6#2)(1997-8#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
of unlabeled##3##2##(1991-12#2)(2008-9#1)
of unlabelled##3##2##(1990-12#1)(1994-8#1)(1997-1#1)
of unmet##3##2##(1993-2#1)(2012-12#1)(2013-1#1)
of unmodified##3##2##(2008-10#2)(2008-4#1)
of unnatural##3##2##(2008-4#2)(2008-7#1)
of unnecessary##6##2##(2008-10#2)(2011-2#2)(2013-1#2)
of unoriented##3##2##(1991-9#1)(2010-4#2)
of unprotected##4##2##(2008-1#1)(2008-12#1)(2013-1#2)
of unrecognized##2##2##(2008-10#1)(2009-6#1)
of unrelated fungi##2##3##(2008-10#2)
of unrelated##6##2##(1994-12#1)(1997-3#1)(2008-10#3)(2008-8#1)
of unruptured##3##2##(1995-11#1)(2008-7#1)(2009-7#1)
of unsaturated##3##2##(1994-3#1)(1996-3#1)(2010-4#1)
of unsaturation##4##2##(1995-11#2)(2008-10#1)(2010-4#1)
of unstable angina##2##3##(2008-3#1)(2010-12#1)
of unstable##5##2##(2008-10#1)(2008-3#2)(2008-5#1)(2010-12#1)
of unstirred##2##2##(2008-10#1)(2008-11#1)
of untreated##3##2##(1997-4#1)(2008-11#1)(2008-5#1)
of unusual##4##2##(2008-10#2)(2008-7#1)(2010-1#1)
of unvaccinated##2##2##(1994-9#1)(2009-5#1)
of unwanted immunogenicity##4##3##(2008-10#4)
of unwanted##9##2##(1991-3#1)(2008-10#6)(2008-9#2)
of up to 10 mg/kg/day##2##5##(1992-11#2)
of up to 10##3##4##(1992-11#2)(2008-5#1)
of up to 2##2##4##(2008-10#2)
of up to 30##4##4##(1997-1#1)(2008-10#2)(2010-8#1)
of up to 6##2##4##(1990-10#1)(2008-10#1)
of up to three##2##4##(2008-10#1)(2008-11#1)
of up to##46##3##(1990-10#2)(1991-5#1)(1992-11#2)(1993-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#17)(2008-11#5)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)
of upland##2##2##(2008-10#1)(2008-9#1)
of upper gastrointestinal##2##3##(1991-8#1)(2012-2#1)
of upper respiratory symptoms##2##4##(2009-4#1)(2013-8#1)
of upper respiratory##3##3##(2009-4#1)(2013-8#2)
of upper##11##2##(1991-8#1)(1995-10#1)(1996-3#1)(2008-11#1)(2008-12#2)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#2)
of upstream##4##2##(1992-3#1)(1997-7#1)(2010-8#1)(2012-2#1)
of uptake and##2##3##(2008-10#2)
of uptake##9##2##(1991-5#1)(2008-10#6)(2008-5#1)(2013-8#1)
of uranium (VI)##3##3##(2008-10#3)
of uranium and##3##3##(2008-10#3)
of uranium at##2##3##(2008-10#2)
of uranium by##3##3##(2008-10#3)
of uranium from##5##3##(2008-10#5)
of uranium in##7##3##(2008-10#7)
of uranium isotopes##2##3##(2008-10#2)
of uranium##37##2##(2008-10#35)(2010-5#1)(2013-1#1)
of uranium(VI) and thorium(IV)##2##4##(2008-10#2)
of uranium(VI) and##3##3##(2008-10#3)
of uranium(VI)##11##2##(2008-10#11)
of uranyl ion from aqueous##2##5##(2008-10#2)
of uranyl ion##4##3##(2008-10#4)
of uranyl##9##2##(2008-10#9)
of urate and##2##3##(1993-2#1)(2008-10#1)
of urate oxidase crystal growth##2##5##(2008-10#2)
of urate oxidase##3##3##(2008-10#3)
of urate##6##2##(1993-2#1)(2008-10#5)
of urban and rural##2##4##(1992-12#2)
of urban##12##2##(1992-12#4)(2008-10#1)(2008-11#2)(2008-3#2)(2009-8#1)(2013-8#2)
of urban-rural differences in##2##4##(1992-12#1)(2008-11#1)
of urea (1##2##3##(2008-10#2)
of urea and##2##3##(2008-10#2)
of urea by##2##3##(1995-3#1)(2008-10#1)
of urea in alcoholic beverages##2##5##(2008-10#2)
of urea in##4##3##(2008-10#4)
of urea##24##2##(1995-3#1)(1995-6#1)(2008-10#22)
of urease##4##2##(2008-10#4)
of urediniospores##3##2##(2008-10#3)
of uremic##2##2##(2008-5#1)(2013-1#1)
of ureteral##6##2##(1990-11#1)(1991-11#1)(1997-4#1)(2008-10#1)(2009-1#1)(2013-1#1)
of ureteric##3##2##(1991-9#1)(1997-3#2)
of ureters with##2##3##(2008-10#2)
of urethral diverticulum##2##3##(2008-10#2)
of urethral##3##2##(2008-10#3)
of urgency##2##2##(2008-11#1)(2008-7#1)
of uric acid (UA)##3##4##(2008-10#3)
of uric acid and##4##4##(2008-10#3)(2009-6#1)
of uric acid in human urine##2##6##(1997-2#1)(2008-10#1)
of uric acid in##8##4##(1997-2#1)(2008-10#7)
of uric acid is##2##4##(2008-10#2)
of uric acid##25##3##(1997-2#1)(2008-10#21)(2008-5#2)(2009-6#1)
of uric##26##2##(1997-2#1)(2008-10#22)(2008-5#2)(2009-6#1)
of uridine diphosphate##2##3##(1995-8#2)
of uridine##3##2##(1993-8#1)(1995-8#2)
of urinary 8OHdG##2##3##(2008-10#2)
of urinary bladder diverticulum##3##4##(2011-2#3)
of urinary dolichols##2##3##(1991-12#2)
of urinary incontinence##2##3##(1996-2#1)(2008-10#1)
of urinary neopterin and serum##2##5##(2008-10#2)
of urinary nucleosides##2##3##(1997-2#2)
of urinary pseudouridine and 1-methyladenosine##2##5##(1992-3#2)
of urinary tract infection##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
of urinary tract infections##2##4##(1993-2#1)(2011-2#1)
of urinary tract##9##3##(1992-12#1)(1992-6#1)(1993-2#1)(2008-10#2)(2011-2#2)(2012-3#1)(2013-1#1)
of urinary##47##2##(1990-8#1)(1991-12#2)(1992-12#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#4)(2008-10#14)(2009-6#5)(2010-5#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of urine from##2##3##(1993-2#1)(2012-3#1)
of urine sample##2##3##(2008-10#2)
of urine samples##3##3##(1990-2#1)(2008-10#2)
of urine were##2##3##(2008-10#2)
of urine##23##2##(1990-2#1)(1991-12#1)(1992-9#1)(1993-2#1)(2008-10#13)(2010-11#1)(2011-2#2)(2012-3#2)(2013-8#1)
of urogenital##3##2##(1991-11#1)(1994-11#1)(1997-6#1)
of us##10##2##(1994-1#2)(1994-2#4)(1995-2#1)(2008-10#1)(2008-2#1)(2010-8#1)
of use for##3##3##(1996-9#1)(2008-11#1)(2010-8#1)
of use in##4##3##(1997-1#1)(2008-11#1)(2008-3#1)(2012-3#1)
of use of the##2##4##(1994-2#1)(2012-3#1)
of use of##12##3##(1990-8#1)(1991-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-3#1)(2013-1#4)
of use##36##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#1)(2009-6#1)(2010-6#1)(2010-8#1)(2012-2#2)(2012-3#2)(2013-1#6)
of used##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
of useful##4##2##(1996-12#1)(2008-11#1)(2010-12#1)(2012-12#1)
of users of##2##3##(1991-1#1)(2012-3#1)
of users##9##2##(1991-1#4)(2008-11#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
of using PBL in a##2##5##(2008-12#2)
of using a##15##3##(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
of using an##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
of using both##2##3##(2008-10#2)
of using it##2##3##(2012-3#1)(2013-8#1)
of using laser##2##3##(2008-10#2)
of using the##17##3##(1992-3#1)(1992-5#1)(1995-1#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2013-1#2)
of using them##2##3##(1995-6#1)(2011-2#1)
of using this technique for##2##5##(2008-10#2)
of using this##6##3##(2008-10#4)(2008-11#2)
of using##127##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-11#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#34)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
of usual##3##2##(1991-12#1)(2008-10#1)(2009-7#1)
of uterine cervical##2##3##(1994-8#1)(2012-12#1)
of uterine epithelial cells is##2##5##(2008-6#2)
of uterine epithelial cells##5##4##(2008-6#5)
of uterine##17##2##(1993-11#1)(1994-3#1)(1994-8#1)(1996-1#1)(2008-6#5)(2008-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
of uterus##2##2##(2008-11#1)(2012-3#1)
of utilization and##2##3##(1991-3#1)(1995-12#1)
of utilization management##3##3##(1995-2#1)(1997-2#2)
of utilization review##2##3##(1991-3#2)
of utilization##11##2##(1991-3#3)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#2)(2012-12#1)(2012-2#1)
of utilizing##4##2##(2008-10#2)(2010-6#1)(2013-8#1)
of utmost importance##7##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
of utmost##8##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-2#1)
of uveal##2##2##(1991-6#1)(2013-8#1)
of v##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
of vacant sites##2##3##(2008-10#2)
of vacant##6##2##(1991-11#1)(2008-10#4)(2008-9#1)
of vaccinated##2##2##(1995-5#1)(2008-5#1)
of vaccination on##2##3##(1996-3#2)
of vaccination##7##2##(1990-2#1)(1996-3#3)(2008-5#1)(2011-2#1)(2013-1#1)
of vaccinations in##2##3##(1997-3#1)(2007-11#1)
of vaccine safety##2##3##(1995-5#2)
of vaccine##10##2##(1995-5#5)(2008-11#3)(2011-2#2)
of vaccines##7##2##(1993-3#1)(1995-5#3)(2008-11#1)(2008-5#1)(2013-8#1)
of vacuma##2##2##(2008-10#2)
of vacuolar ATPase##2##3##(1995-6#2)
of vacuoles##2##2##(2007-12#1)(2008-7#1)
of vacuum##2##2##(2008-10#2)
of vaginal cylinders##2##3##(2009-2#2)
of vaginal##8##2##(1992-1#1)(1993-1#1)(1995-12#1)(2008-10#1)(2009-2#2)(2012-3#1)(2013-1#1)
of valaciclovir##2##2##(1995-6#2)
of validation##3##2##(2008-10#2)(2010-10#1)
of validity of the##2##4##(2008-11#1)(2008-2#1)
of validity of##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
of validity##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
of valproic##2##2##(2011-1#1)(2013-1#1)
of value in##6##3##(1992-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-9#2)
of value to##5##3##(1992-1#1)(1997-4#1)(2008-11#1)(2008-12#1)(2010-8#1)
of value##14##2##(1992-1#2)(1993-2#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#2)(2010-8#1)
of values for##2##3##(2008-3#1)(2010-2#1)
of values##13##2##(1990-2#1)(1992-2#1)(2008-10#3)(2008-3#2)(2008-7#2)(2010-2#1)(2012-2#1)(2013-1#2)
of valve##2##2##(2008-10#1)(2013-1#1)
of van der Waals##3##4##(2008-10#2)(2009-11#1)
of vanadate##2##2##(1997-1#1)(2008-10#1)
of vanadium (V)##2##3##(2008-10#1)(2011-2#1)
of vanadium and##5##3##(2008-10#5)
of vanadium by##3##3##(2008-10#3)
of vanadium from##2##3##(2008-10#2)
of vanadium in a##2##4##(2008-10#2)
of vanadium in parenteral##2##4##(2008-10#2)
of vanadium in soil##2##4##(2008-10#2)
of vanadium in the range##2##5##(2008-10#2)
of vanadium in the##4##4##(2008-10#4)
of vanadium in water##2##4##(2008-10#2)
of vanadium in##26##3##(2008-10#26)
of vanadium species##2##3##(2008-10#2)
of vanadium##60##2##(1990-5#4)(2008-10#55)(2011-2#1)
of vanadium(IV) and total vanadium##3##5##(2008-10#3)
of vanadium(IV)##4##2##(2008-10#4)
of vanadium(V) and##2##3##(2008-10#2)
of vanadium(V) with##3##3##(2008-10#3)
of vanadium(V)##10##2##(2008-10#10)
of vancomycin and its##2##4##(2008-10#2)
of vancomycin and##4##3##(2008-10#3)(2011-2#1)
of vancomycin##7##2##(2008-10#6)(2011-2#1)
of vanillin and PHB##2##4##(2008-10#2)
of vanillin and##4##3##(2008-10#4)
of vanillin##6##2##(2008-10#6)
of vapor##3##2##(2008-10#2)(2008-3#1)
of vapors##3##2##(2008-10#2)(2008-3#1)
of variability in the##3##4##(2008-10#3)
of variability in##11##3##(2008-10#4)(2008-8#1)(2009-11#1)(2009-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
of variability##26##2##(1990-2#1)(1991-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
of variable length##3##3##(2008-10#3)
of variable##22##2##(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
of variables and##2##3##(1995-9#1)(2008-10#1)
of variables in##2##3##(2008-10#1)(2008-4#1)
of variables was##3##3##(1992-2#1)(2008-10#2)
of variables##25##2##(1992-2#1)(1994-3#1)(1995-9#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#2)(2011-2#1)(2012-12#1)
of variance (ANOVA) was##2##4##(1994-2#1)(2008-10#1)
of variance (ANOVA)##11##3##(1994-2#1)(1995-2#1)(2008-10#6)(2009-2#1)(2012-2#1)(2013-1#1)
of variance and##3##3##(2008-10#1)(2013-1#2)
of variance in##6##3##(1995-2#1)(2008-11#1)(2008-12#2)(2010-5#1)(2013-8#1)
of variance revealed##2##3##(2009-11#1)(2012-3#1)
of variance showed that the##2##5##(1993-2#1)(2013-1#1)
of variance showed that##3##4##(1993-2#2)(2013-1#1)
of variance##51##2##(1990-2#1)(1991-2#1)(1992-2#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-2#2)(1996-3#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
of variances##2##2##(2008-10#2)
of variant##3##2##(1991-12#1)(2011-2#1)(2012-2#1)
of variants##2##2##(1991-12#1)(2010-5#1)
of variation and##2##3##(2010-5#1)(2012-3#1)
of variation between##2##3##(2008-10#1)(2009-8#1)
of variation for##6##3##(1990-2#1)(2008-10#4)(2008-5#1)
of variation in the##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
of variation in##14##3##(1990-9#1)(2008-10#4)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
of variation is##3##3##(1992-3#1)(1994-9#1)(1996-3#1)
of variation less than##3##4##(2008-10#3)
of variation of 1##2##4##(2008-10#2)
of variation of 5##2##4##(2008-10#2)
of variation of the##3##4##(2008-10#3)
of variation of##12##3##(1996-3#1)(2008-10#11)
of variation ranged from##2##4##(1990-11#1)(2008-10#1)
of variation was##2##3##(2008-10#2)
of variation were estimated##2##4##(2008-10#2)
of variation were##9##3##(2008-10#9)
of variation##88##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-9#1)(1996-3#4)(2008-10#47)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#1)
of variation)##2##2##(1991-5#1)(2008-8#1)
of variations of##2##3##(2008-12#1)(2012-3#1)
of variations##11##2##(2008-10#3)(2008-12#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-1#1)(2012-3#1)(2013-8#1)
of varicella##3##2##(2008-12#2)(2008-7#1)
of varices##3##2##(2009-8#1)(2009-9#2)
of varicose veins##2##3##(2011-3#2)
of varicose##3##2##(1997-3#1)(2011-3#2)
of varied##4##2##(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#1)
of various aspects##2##3##(2008-11#1)(2008-5#1)
of various base metals##2##4##(2008-10#2)
of various biomolecules##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
of various carbohydrates##2##3##(2008-10#2)
of various cations and anions##2##5##(2008-10#2)
of various cations##3##3##(2008-10#3)
of various cell lines##2##4##(1993-3#1)(2008-11#1)
of various cell types##3##4##(1994-11#1)(2010-7#1)(2012-3#1)
of various cell##6##3##(1992-10#1)(1993-3#1)(1994-11#1)(2008-11#1)(2010-7#1)(2012-3#1)
of various chemical modifiers##2##4##(2008-10#2)
of various components##2##3##(2008-10#2)
of various compositions##2##3##(2008-10#2)
of various compounds##3##3##(2008-10#3)
of various concentrations of##2##4##(1996-5#1)(2008-12#1)
of various diseases##4##3##(2008-10#3)(2008-7#1)
of various factors on##2##4##(2008-10#1)(2013-8#1)
of various factors to##2##4##(2008-11#1)(2009-4#1)
of various factors##5##3##(2008-10#2)(2008-11#1)(2009-4#1)(2013-8#1)
of various foreign##3##3##(2008-10#3)
of various forms of##2##4##(2008-5#1)(2013-8#1)
of various health##2##3##(1996-1#1)(2013-7#1)
of various ions##3##3##(2008-10#3)
of various metal ions##2##4##(2008-10#2)
of various metal##3##3##(2008-10#3)
of various organic##3##3##(2008-10#2)(2009-8#1)
of various organs##2##3##(1997-8#1)(2008-10#1)
of various origin##2##3##(2009-4#2)
of various parameters on##2##4##(2008-10#1)(2013-1#1)
of various parameters##8##3##(2008-10#6)(2008-5#1)(2013-1#1)
of various recombinant##2##3##(1994-8#1)(2008-11#1)
of various scattering media (aerosols##2##5##(2008-3#2)
of various size##2##3##(1993-9#1)(2008-1#1)
of various sizes and##2##4##(1997-3#1)(2013-1#1)
of various sizes##5##3##(1995-1#1)(1997-3#1)(2008-10#2)(2013-1#1)
of various solvents##2##3##(2008-10#2)
of various species##2##3##(1991-12#1)(2008-8#1)
of various techniques of spinal anesthesia in day##2##8##(2012-3#2)
of various tissues##3##3##(1993-12#1)(1997-2#1)(2012-2#1)
of various types of##8##4##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
of various types##11##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2013-8#1)
of various##268##2##(1990-8#1)(1991-12#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-3#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#5)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#4)(2008-1#2)(2008-10#99)(2008-11#24)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#9)(2008-7#9)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#5)
of varying composition##2##3##(1995-5#1)(2008-10#1)
of varying lengths##2##3##(1995-6#1)(2008-11#1)
of varying severity##2##3##(1995-12#1)(2012-2#1)
of varying the##4##3##(1991-1#1)(2008-3#1)(2010-6#1)(2012-2#1)
of varying##40##2##(1990-9#1)(1991-1#1)(1991-6#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-8#1)
of vascular and##2##3##(2011-2#1)(2013-1#1)
of vascular bundle implantation##2##4##(2009-3#2)
of vascular calcification##2##3##(2009-1#1)(2012-12#1)
of vascular complications##2##3##(2011-2#2)
of vascular corrosion casts##3##4##(2011-2#3)
of vascular dementia##2##3##(1996-11#1)(2008-7#1)
of vascular endothelial cells##4##4##(1996-12#3)(1997-1#1)
of vascular endothelial growth factor##3##5##(2008-9#3)
of vascular endothelial##8##3##(1996-12#4)(1997-1#1)(2008-9#3)
of vascular function##2##3##(1993-6#1)(2013-8#1)
of vascular injury##4##3##(1992-12#2)(1994-5#1)(2013-1#1)
of vascular pericytes##2##3##(1993-3#2)
of vascular plants##3##3##(2008-9#2)(2009-8#1)
of vascular smooth muscle cells##4##5##(1990-12#1)(1992-8#1)(1994-11#1)(2008-1#1)
of vascular smooth muscle##8##4##(1990-12#1)(1990-8#2)(1992-8#1)(1994-11#2)(2008-1#1)(2010-12#1)
of vascular tissues##2##3##(1993-8#1)(2008-9#1)
of vascular wall##2##3##(2006-6#1)(2009-7#1)
of vascular##76##2##(1990-12#1)(1990-8#2)(1991-3#1)(1992-12#3)(1992-8#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#4)(1996-9#1)(1997-1#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#4)(2008-9#6)(2009-1#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
of vasculitis and##2##3##(2010-6#1)(2011-2#1)
of vasculitis##3##2##(1997-8#1)(2010-6#1)(2011-2#1)
of vasoactive intestinal peptide##2##4##(1994-3#2)
of vasoactive intestinal##3##3##(1990-5#1)(1994-3#2)
of vasoactive##4##2##(1990-5#1)(1994-3#2)(1994-9#1)
of vasopressin##3##2##(1994-2#1)(1997-4#2)
of vasopressors##2##2##(2012-3#1)(2013-1#1)
of vasospasm##7##2##(1991-3#1)(1997-3#1)(2008-3#2)(2008-7#1)(2012-3#2)
of vast##2##2##(2008-9#1)(2013-1#1)
of vector and##2##3##(1994-8#1)(2008-10#1)
of vector control##2##3##(2010-1#2)
of vector transmission##2##3##(2008-10#2)
of vector##12##2##(1994-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2010-1#2)
of vector-borne##2##2##(2008-8#1)(2010-1#1)
of vectors carrying##3##3##(2008-10#1)(2008-11#2)
of vectors##8##2##(1995-5#1)(2008-10#1)(2008-11#6)
of vegetable##2##2##(2008-10#2)
of vegetables##4##2##(2008-10#3)(2011-2#1)
of vegetation heterogeneity##2##3##(2008-8#2)
of vegetation##8##2##(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#2)
of vegetative compatibility groups##2##4##(2008-10#2)
of vegetative compatibility##3##3##(2008-10#3)
of vegetative##8##2##(2008-10#5)(2008-11#1)(2008-12#1)(2009-10#1)
of vehicle##4##2##(1994-8#1)(2008-9#3)
of vein formation##2##3##(2009-6#2)
of vein##4##2##(2009-6#3)(2011-3#1)
of velocity##2##2##(2008-3#2)
of venous and arterial##2##4##(2008-10#1)(2011-3#1)
of venous leg##2##3##(1990-6#1)(1997-3#1)
of venous thromboembolism in##2##4##(2010-11#2)
of venous thromboembolism##7##3##(1996-11#2)(2010-11#3)(2010-7#1)(2013-1#1)
of venous thrombosis##2##3##(1997-3#1)(2010-11#1)
of venous##22##2##(1990-3#2)(1990-6#1)(1996-11#2)(1996-3#1)(1997-3#2)(2008-10#1)(2008-9#1)(2010-11#4)(2010-6#1)(2010-7#3)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
of ventilation##5##2##(1994-6#1)(1996-12#1)(1997-1#1)(2008-5#1)(2010-7#1)
of ventilator-assisted children##4##3##(2010-7#4)
of ventral##2##2##(1993-6#1)(2008-5#1)
of ventricular assist devices##2##4##(2010-6#2)
of ventricular##13##2##(1990-9#1)(1993-1#2)(1994-12#1)(1994-8#1)(2008-7#3)(2009-10#2)(2010-1#1)(2010-6#2)
of verapamil##3##2##(1991-8#1)(1994-8#1)(1995-11#1)
of verbal descriptors of dyspnea##2##5##(2008-10#2)
of verbal##4##2##(2008-10#3)(2008-9#1)
of verbascoside##2##2##(2008-8#2)
of vertebral artery##3##3##(1991-8#1)(2008-12#1)(2013-1#1)
of vertebral body##5##3##(2007-8#5)
of vertebral fractures##2##3##(2008-11#2)
of vertebral##11##2##(1991-8#1)(2007-8#5)(2008-11#2)(2008-12#1)(2008-8#1)(2013-1#1)
of vertebrate##12##2##(1994-11#1)(1996-12#1)(1996-2#1)(1997-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
of vertebrates##5##2##(1993-2#1)(1995-11#1)(2008-7#2)(2010-5#1)
of vertebrobasilar##2##2##(1993-3#1)(2011-2#1)
of vertical##4##2##(2008-3#1)(2008-7#1)(2011-3#2)
of very early##2##3##(2008-11#1)(2009-11#1)
of very high##3##3##(2006-5#1)(2008-10#2)
of very late##2##3##(1997-3#1)(2008-11#1)
of very low density##2##4##(1991-12#1)(2008-10#1)
of very low levels of##2##5##(1990-12#1)(2008-10#1)
of very low##14##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-10#2)(2010-7#1)
of very small##4##3##(1990-3#1)(1991-12#1)(2008-10#2)
of very##43##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#2)(1993-3#1)(1993-6#1)(1997-3#1)(2006-5#1)(2008-10#16)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-10#2)(2010-7#1)(2011-2#3)
of vesicle##5##2##(1997-2#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
of vesicles##8##2##(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
of vesicoureteral reflux##4##3##(2008-10#4)
of vesicular##3##2##(1993-6#1)(1994-3#1)(2008-10#1)
of vessel wall##2##3##(2009-10#1)(2013-1#1)
of vessel##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#1)
of vessels##9##2##(1990-8#2)(2008-10#3)(2008-11#1)(2009-7#1)(2012-3#1)(2013-8#1)
of vestibular##3##2##(1991-2#1)(1995-8#1)(2012-3#1)
of veterinary##4##2##(1997-7#2)(2008-10#2)
of viability and##2##3##(2008-11#2)
of viability of##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
of viability##11##2##(1995-2#1)(2008-11#7)(2008-9#2)(2012-3#1)
of viable cell concentration##2##4##(2008-11#1)(2008-7#1)
of viable cell##4##3##(2008-11#3)(2008-7#1)
of viable cells in##3##4##(2008-11#3)
of viable cells##8##3##(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#2)
of viable sclerotia##2##3##(2008-10#2)
of viable spores##2##3##(2008-10#1)(2011-2#1)
of viable##29##2##(1993-3#1)(1996-12#1)(2008-10#8)(2008-11#8)(2008-4#1)(2008-7#2)(2008-9#6)(2011-2#1)(2012-2#1)
of victimization##2##2##(2008-10#1)(2008-12#1)
of videoconferencing##3##2##(2008-11#3)
of videotaped##2##2##(1993-2#1)(2008-8#1)
of videotapes##2##2##(1993-12#1)(1993-2#1)
of view and##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
of view of##12##3##(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-12#1)(2013-8#1)
of view##65##2##(1990-11#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-2#1)(1994-2#3)(1994-3#1)(1995-11#1)(1996-1#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-7#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#4)
of views##2##2##(1994-1#1)(2008-12#1)
of vigabatrin in##2##3##(1992-3#2)
of vigor##2##2##(2008-10#1)(2008-9#1)
of vimentin##2##2##(2008-8#1)(2012-2#1)
of vines infected##3##3##(2008-10#3)
of vines##6##2##(2008-10#6)
of vinorelbine##2##2##(1994-8#2)
of vinyl aziridines and aziridinylen-ynes##2##5##(2009-12#2)
of vinyl##5##2##(2008-10#1)(2008-5#1)(2009-12#2)(2009-5#1)
of violating the##2##3##(2008-7#2)
of violence##14##2##(1991-12#3)(1996-6#1)(2008-11#4)(2009-5#2)(2012-12#1)(2013-1#3)
of violent incidents##2##3##(1993-12#1)(2012-3#1)
of violent##3##2##(1993-12#1)(2008-11#1)(2012-3#1)
of viral DNA replication##2##4##(1995-6#1)(1997-3#1)
of viral DNA##4##3##(1993-8#1)(1995-6#1)(1997-3#1)(2011-2#1)
of viral RNA##6##3##(1997-3#1)(2008-10#3)(2008-9#2)
of viral RNAs##2##3##(1997-3#1)(2008-9#1)
of viral and##2##3##(2008-11#2)
of viral coat protein##2##4##(2008-10#2)
of viral contamination##2##3##(1990-2#1)(2008-11#1)
of viral infection and##3##4##(2008-11#1)(2008-9#2)
of viral infection##5##3##(2008-11#2)(2008-9#2)(2011-2#1)
of viral infections##2##3##(2008-11#1)(2013-1#1)
of viral miRNAs##3##3##(2013-1#3)
of viral populations##2##3##(2008-10#1)(2012-2#1)
of viral quasispecies##4##3##(2013-8#4)
of viral replication##2##3##(2008-5#1)(2011-3#1)
of viral vectors##2##3##(2008-11#2)
of viral##66##2##(1990-2#1)(1990-5#1)(1993-8#1)(1994-1#2)(1994-11#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-3#3)(2008-10#13)(2008-11#12)(2008-5#1)(2008-8#1)(2008-9#6)(2011-2#6)(2011-3#2)(2012-2#1)(2013-1#6)(2013-8#5)
of virion sense##2##3##(2008-9#2)
of virion##3##2##(2008-10#1)(2008-9#2)
of virosomes##2##2##(1990-2#2)
of virtually##2##2##(1996-12#1)(2011-2#1)
of virulence among##3##3##(2008-10#2)(2008-11#1)
of virulence and##2##3##(2008-10#2)
of virulence by##2##3##(2008-10#1)(2009-8#1)
of virulence factors##2##3##(2008-10#1)(2009-8#1)
of virulence in the##2##4##(2008-10#2)
of virulence in##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
of virulence is##2##3##(2008-10#2)
of virulence were##2##3##(2008-10#2)
of virulence##36##2##(2008-10#26)(2008-11#2)(2008-8#4)(2009-8#3)(2013-1#1)
of virulent and non-virulent##2##4##(2008-5#2)
of virulent##5##2##(1996-12#1)(2008-10#1)(2008-5#2)(2008-9#1)
of viruliferous aphids##2##3##(2008-10#2)
of viruliferous nematodes##2##3##(2008-10#2)
of viruliferous##5##2##(2008-10#5)
of virus accumulation##4##3##(2008-10#4)
of virus and##4##3##(2008-10#3)(2008-5#1)
of virus in##5##3##(1995-5#2)(2008-10#3)
of virus particle##2##3##(1997-3#1)(2011-2#1)
of virus particles##3##3##(1997-3#1)(2008-10#2)
of virus structure##2##3##(2008-10#2)
of virus was##2##3##(2008-10#1)(2012-3#1)
of virus##47##2##(1990-11#1)(1995-5#2)(1997-3#2)(2008-10#31)(2008-11#3)(2008-12#1)(2008-5#3)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
of virus-infected cells##2##3##(1997-3#1)(2008-11#1)
of virus-infected##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
of virus-virus interactions##2##3##(1997-3#1)(2008-10#1)
of viruses is##2##3##(1995-2#1)(2012-2#1)
of viruses##12##2##(1994-11#1)(1994-9#1)(1995-2#1)(1995-9#1)(2008-10#2)(2008-11#3)(2008-9#1)(2012-2#1)(2013-1#1)
of visceral larva migrans##2##4##(2012-2#2)
of visceral##7##2##(1991-12#1)(1996-6#1)(1997-8#1)(2008-11#1)(2012-2#3)
of viscosity##3##2##(2008-10#1)(2009-10#1)(2011-2#1)
of visible##11##2##(1993-12#1)(1994-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-9#1)
of vision##12##2##(1993-12#1)(1994-8#1)(1994-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#2)
of visits to##2##3##(1990-9#1)(2008-7#1)
of visits##4##2##(1990-9#1)(1995-3#1)(2008-11#1)(2008-7#1)
of visual attention##2##3##(2008-11#1)(2010-5#1)
of visual function##4##3##(2011-7#1)(2013-1#3)
of visual hallucinations##2##3##(2011-2#1)(2013-8#1)
of visual stimuli##2##3##(2008-4#1)(2008-8#1)
of visual symptoms##2##3##(2008-10#2)
of visual##32##2##(1991-11#1)(1995-5#1)(1996-2#2)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-5#1)(2010-9#1)(2011-2#5)(2011-7#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
of visualization##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
of visualizing##2##2##(2008-10#1)(2012-2#1)
of visually##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
of vital##9##2##(1993-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)
of vitamin A acetate for##3##5##(2008-11#3)
of vitamin A acetate##5##4##(2008-11#5)
of vitamin A and##2##4##(1993-3#1)(2011-2#1)
of vitamin A deficiency##3##4##(1991-8#3)
of vitamin A##12##3##(1991-8#3)(1992-9#1)(1993-3#1)(2008-11#5)(2009-8#1)(2011-2#1)
of vitamin B(2)##2##3##(2008-10#2)
of vitamin B12 on##2##4##(1993-12#1)(2010-1#1)
of vitamin B12##7##3##(1993-12#4)(2010-1#3)
of vitamin B6##2##3##(2013-1#2)
of vitamin C in##3##4##(2008-10#3)
of vitamin C##10##3##(1992-9#2)(2008-10#6)(2008-5#1)(2012-2#1)
of vitamin D and##3##4##(2008-10#1)(2010-10#1)(2012-3#1)
of vitamin D deficiency##2##4##(2012-2#1)(2012-3#1)
of vitamin D##21##3##(1991-11#1)(1992-1#3)(1994-3#2)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#4)(2010-10#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#1)
of vitamin D(2)##5##3##(2008-10#5)
of vitamin D(3)##3##3##(2008-10#2)(2012-12#1)
of vitamin E in##2##4##(1992-9#2)
of vitamin E##8##3##(1990-8#1)(1992-9#4)(1994-5#2)(2010-12#1)
of vitamin K(1)##3##3##(2008-10#3)
of vitamin and##2##3##(2008-10#1)(2008-11#1)
of vitamin pills##3##3##(1996-8#1)(2008-10#2)
of vitamin##84##2##(1990-8#1)(1991-11#1)(1991-8#3)(1992-1#3)(1992-9#9)(1993-12#4)(1993-3#1)(1994-3#2)(1994-5#2)(1995-2#1)(1995-8#1)(1996-8#1)(2008-1#1)(2008-10#27)(2008-11#6)(2008-5#1)(2008-8#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
of vitamins and amino acids##2##5##(2008-11#2)
of vitamins##11##2##(1992-9#3)(2008-10#3)(2008-11#2)(2009-8#1)(2010-1#1)(2013-1#1)
of vitellin##2##2##(2007-12#1)(2008-6#1)
of vitellogenesis the##2##3##(2007-12#2)
of vitellogenesis##4##2##(2007-12#2)(2008-12#1)(2008-7#1)
of vitellogenin##2##2##(2008-6#1)(2010-4#1)
of vitiligo##2##2##(2009-1#1)(2013-1#1)
of vitreous##3##2##(2008-5#3)
of vivax malaria##2##3##(2012-12#2)
of vocabulary and##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
of vocabulary##4##2##(2008-12#1)(2008-9#1)(2011-2#2)
of vocational##2##2##(1992-3#1)(1996-8#1)
of voice##3##2##(2008-11#1)(2011-1#1)(2013-8#1)
of voiding##2##2##(2008-10#1)(2012-3#1)
of volar##2##2##(2008-9#2)
of volatile and semivolatile pollutants in##2##6##(2008-10#2)
of volatile and semivolatile##3##4##(2008-10#3)
of volatile and##5##3##(2008-10#4)(2009-8#1)
of volatile chloro-organic compounds in##2##5##(2008-10#2)
of volatile compounds from##2##4##(2008-10#1)(2009-8#1)
of volatile compounds##6##3##(2008-10#4)(2009-8#1)(2011-10#1)
of volatile elements##2##3##(2008-10#2)
of volatile oils##3##3##(2008-11#3)
of volatile organic compounds (VOCs)##3##5##(2008-10#3)
of volatile organic compounds in##2##5##(2008-10#1)(2008-11#1)
of volatile organic compounds##9##4##(2008-10#7)(2008-11#1)(2008-3#1)
of volatile organic##11##3##(2008-10#9)(2008-11#1)(2008-3#1)
of volatile##44##2##(1992-3#1)(1997-4#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#2)(2011-1#1)(2011-10#1)(2013-8#1)
of volatiles from##2##3##(2008-10#1)(2013-8#1)
of volatiles##6##2##(2008-10#4)(2009-8#1)(2013-8#1)
of voltage##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
of voltage-dependent calcium channels##2##4##(1996-2#1)(2008-8#1)
of voltage-dependent##4##2##(1993-3#1)(1996-2#1)(2008-8#1)(2009-8#1)
of voltage-gated calcium channels##2##4##(2008-12#1)(2008-9#1)
of voltage-gated##4##2##(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)
of voltammetric##6##2##(2008-10#6)
of voltammetry##2##2##(2008-10#2)
of volume##6##2##(2008-11#3)(2008-6#1)(2008-7#1)(2013-1#1)
of volumetric apparatus##2##3##(2008-10#2)
of volumetric##7##2##(1996-2#1)(2008-10#5)(2011-7#1)
of voluntary organizations##2##3##(1996-2#2)
of voluntary##5##2##(1996-2#2)(2008-1#1)(2008-11#1)(2013-1#1)
of volunteer management##2##3##(1994-3#2)
of volunteer work##2##3##(1994-2#1)(1995-2#1)
of volunteer##12##2##(1992-12#1)(1993-12#1)(1994-2#1)(1994-3#8)(1995-2#1)
of volunteers##11##2##(1992-3#1)(1993-12#1)(1994-2#2)(1994-3#5)(2008-10#1)(2008-5#1)
of vomiting##3##2##(2007-12#1)(2008-12#1)(2012-3#1)
of von##5##2##(1992-9#2)(1994-11#2)(2012-3#1)
of vulnerability##2##2##(1990-5#1)(2009-4#1)
of vulnerable##4##2##(1995-2#1)(2008-10#1)(2010-9#1)(2011-2#1)
of w-3##2##2##(2008-9#2)
of wage##2##2##(1992-1#1)(1994-12#1)
of waist circumference##2##3##(1996-8#1)(2011-2#1)
of waist##3##2##(1996-8#1)(2011-2#2)
of waiting list data##2##4##(1991-11#1)(1993-2#1)
of waiting list##4##3##(1991-11#3)(1993-2#1)
of waiting lists##2##3##(1991-11#1)(1993-2#1)
of waiting##10##2##(1991-11#6)(1993-2#2)(1996-1#1)(1997-4#1)
of walking##5##2##(1993-12#2)(1995-2#1)(2010-10#1)(2013-8#1)
of wall appositions##2##3##(2008-10#2)
of wall##4##2##(2008-10#4)
of warm##2##2##(2008-8#1)(2009-9#1)
of washed##2##2##(2008-10#1)(2008-8#1)
of waste analysis##2##3##(2008-10#2)
of waste polymers##3##3##(2008-10#3)
of waste##15##2##(2008-10#13)(2008-12#1)(2011-2#1)
of wastewater##2##2##(2008-10#1)(2008-12#1)
of water and wastewater##2##4##(2008-10#2)
of water and##10##3##(1990-5#1)(1997-1#1)(1997-2#1)(2008-10#7)
of water for the##2##4##(2008-10#1)(2008-7#1)
of water for##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
of water have been##3##4##(1992-9#1)(2008-10#1)(2012-5#1)
of water in the##3##4##(2008-10#3)
of water in##9##3##(1992-9#1)(2008-10#6)(2008-7#1)(2008-8#1)
of water is##2##3##(2008-10#2)
of water molecules##3##3##(2008-10#2)(2010-12#1)
of water sample in the presence of 1% non-ionic surfactant##2##10##(2008-10#2)
of water sample##4##3##(2008-10#4)
of water samples and##2##4##(2008-10#2)
of water samples##12##3##(2008-10#11)(2008-11#1)
of water stress##3##3##(2008-12#2)(2009-8#1)
of water treatment##2##3##(2008-10#1)(2013-1#1)
of water vapor in air##2##5##(2008-3#2)
of water vapor in##3##4##(2008-3#3)
of water vapor##4##3##(2008-3#4)
of water##124##2##(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#3)(1994-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#75)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-8#2)(2010-12#1)(2011-2#3)(2012-5#1)(2012-7#1)(2013-1#1)
of water-soluble organic##2##3##(2008-10#2)
of water-soluble vitamins excreted in##2##5##(2008-10#2)
of water-soluble vitamins##5##3##(2008-10#5)
of water-soluble##14##2##(1991-5#1)(2008-10#11)(2008-11#1)(2008-5#1)
of watermelon seedlings##2##3##(2008-10#2)
of watermelon##6##2##(2008-10#6)
of waters##6##2##(2008-10#5)(2008-3#1)
of wavelength##6##2##(2008-10#3)(2008-3#3)
of wavelengths##9##2##(2008-10#3)(2008-2#1)(2008-3#4)(2011-2#1)
of wavelet##2##2##(2008-10#2)
of wax and oil##3##4##(2008-5#3)
of wax##6##2##(2008-5#5)(2011-2#1)
of ways to##3##3##(1994-1#1)(2009-4#1)(2013-1#1)
of ways##15##2##(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-4#1)(2012-3#1)(2013-1#1)
of weak acids in##3##4##(2008-10#3)
of weak acids##6##3##(2008-10#5)(2008-9#1)
of weak##11##2##(2008-10#9)(2008-3#1)(2008-9#1)
of weakly##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
of weakness##2##2##(2008-12#1)(2010-8#1)
of weaning##3##2##(1995-12#1)(2013-1#2)
of wear metals in##3##4##(2008-10#3)
of wear##9##2##(2008-10#3)(2008-8#5)(2012-12#1)
of weasel##2##2##(1994-8#2)
of weather variables##2##3##(2008-10#2)
of weather##5##2##(2008-10#4)(2008-8#1)
of weathered##2##2##(2008-10#1)(2008-11#1)
of weeds and##2##3##(2008-10#1)(2008-12#1)
of weeds##5##2##(2008-10#4)(2008-12#1)
of weeks##3##2##(1991-2#1)(1991-3#1)(2008-7#1)
of weight and##2##3##(1990-9#1)(2012-2#1)
of weight loss##2##3##(2008-3#1)(2013-8#1)
of weight was##2##3##(1993-3#1)(1996-8#1)
of weight##11##2##(1990-9#1)(1991-11#1)(1991-2#2)(1993-3#1)(1996-8#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
of welfare##2##2##(1994-3#1)(1996-2#1)
of well characterized##2##3##(1992-6#1)(2008-11#1)
of well trained##2##3##(1993-11#1)(1994-8#1)
of well##8##2##(1992-6#1)(1993-11#1)(1994-8#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-3#1)
of well-being##7##2##(1995-2#1)(1996-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-3#1)
of well-child care##2##3##(1996-1#1)(2010-8#1)
of well-defined redox peaks##2##4##(2008-10#2)
of well-defined redox##4##3##(2008-10#4)
of well-defined##10##2##(2008-10#7)(2008-12#1)(2009-8#1)(2011-2#1)
of well-differentiated##2##2##(2009-10#1)(2012-3#1)
of wells##2##2##(2008-10#2)
of western white pine##4##4##(2008-10#4)
of western##7##2##(2008-10#7)
of wet##7##2##(2008-10#5)(2008-4#1)(2008-5#1)
of wetness or##2##3##(2008-10#2)
of wetness was##2##3##(2008-10#2)
of wetness##12##2##(2008-10#12)
of wetting and drying##3##4##(2008-10#3)
of wetting##6##2##(2008-10#6)
of wh-questions in##2##3##(2011-1#2)
of wh-questions##4##2##(2011-1#4)
of what constitutes a##2##4##(1992-9#1)(2010-10#1)
of what constitutes##3##3##(1992-9#1)(2010-10#1)(2013-1#1)
of what is##7##3##(1992-12#1)(1997-2#1)(2008-11#3)(2008-9#1)(2009-3#1)
of what the##2##3##(1991-3#1)(2008-11#1)
of what we##3##3##(1991-12#1)(2008-4#1)(2008-9#1)
of what##35##2##(1990-2#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-12#1)(1992-9#1)(1994-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-10#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of wheat (Triticum aestivum)##3##4##(2008-10#2)(2008-11#1)
of wheat (Triticum##4##3##(2008-10#3)(2008-11#1)
of wheat and barley##4##4##(2008-10#4)
of wheat and wild oats##2##5##(2008-10#2)
of wheat and##10##3##(2008-10#9)(2008-11#1)
of wheat are##2##3##(2008-10#2)
of wheat bugs##4##3##(2013-8#4)
of wheat germ agglutinin##2##4##(1991-12#1)(2008-7#1)
of wheat in##5##3##(2008-10#5)
of wheat is caused by the##2##6##(2008-10#2)
of wheat is caused by##4##5##(2008-10#4)
of wheat is##5##3##(2008-10#5)
of wheat that##3##3##(2008-10#3)
of wheat to##3##3##(2008-10#2)(2010-6#1)
of wheat worldwide##2##3##(2008-10#1)(2011-10#1)
of wheat##110##2##(1991-12#1)(1992-12#1)(2008-10#95)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-6#1)(2011-10#1)(2013-8#4)
of wheelchair##4##2##(2013-1#4)
of when##2##2##(1997-8#1)(2008-4#1)
of where##3##2##(1996-1#1)(2008-12#1)(2011-2#1)
of whether a##2##3##(1991-3#1)(2008-3#1)
of whether an##2##3##(2008-5#1)(2011-2#1)
of whether the##14##3##(1994-6#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-7#1)(2012-3#1)
of whether to##2##3##(1996-2#1)(2008-9#1)
of whether##43##2##(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-2#2)(1997-2#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of whey proteins##4##3##(2008-10#1)(2008-7#3)
of whey##6##2##(2008-10#2)(2008-7#4)
of which 4##2##3##(2008-9#2)
of which a##2##3##(1993-8#1)(2013-8#1)
of which also controlled resistance to isolate MG96-36##2##8##(2008-10#2)
of which also##5##3##(2008-10#3)(2008-7#1)(2013-8#1)
of which are highly##2##4##(2008-10#1)(2010-12#1)
of which are in the##2##5##(2008-10#1)(2008-11#1)
of which are in##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
of which are used##2##4##(2007-12#1)(2010-7#1)
of which are##37##3##(1991-1#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#3)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)
of which belonged to##2##4##(2008-5#1)(2012-3#1)
of which can be prevented##2##5##(2008-7#1)(2013-1#1)
of which can be##6##4##(1993-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2013-1#1)
of which can##7##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2013-1#1)
of which contain##3##3##(1994-9#1)(2008-10#2)
of which contains##2##3##(2008-10#1)(2008-11#1)
of which correspond to##4##4##(1995-9#3)(1996-3#1)
of which encode proteins##2##4##(1993-12#1)(1996-3#1)
of which encode##3##3##(1993-12#1)(1996-2#1)(1996-3#1)
of which had##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
of which has the##2##4##(2008-11#1)(2008-3#1)
of which has##3##3##(1997-2#1)(2008-11#1)(2008-3#1)
of which have been##4##4##(1992-5#1)(1993-11#1)(1996-6#1)(2008-10#1)
of which have##10##3##(1992-5#1)(1992-6#1)(1993-11#1)(1996-12#1)(1996-6#1)(2008-10#2)(2008-11#1)(2011-10#1)(2011-2#1)
of which in the##2##4##(2008-10#2)
of which in##3##3##(2008-10#2)(2011-3#1)
of which is not##2##4##(1992-4#1)(2008-10#1)
of which is the##2##4##(1991-9#1)(1997-1#1)
of which is##34##3##(1990-11#1)(1990-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#1)(1997-1#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-7#1)(2013-1#1)
of which may##2##3##(1990-5#1)(2010-8#1)
of which occurs##2##3##(1993-2#1)(1995-6#1)
of which only four##2##4##(2010-1#1)(2011-1#1)
of which only##4##3##(2008-10#1)(2009-6#1)(2010-1#1)(2011-1#1)
of which remains##2##3##(1997-7#1)(2008-7#1)
of which serves as a##2##5##(2008-10#2)
of which showed##4##3##(1990-11#1)(1993-12#1)(1994-12#1)(2011-2#1)
of which the##13##3##(1992-2#1)(1994-12#1)(1996-6#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#2)(2011-2#1)(2011-3#1)
of which they##2##3##(1997-5#1)(2013-1#1)
of which was greater##2##4##(1991-12#1)(2008-10#1)
of which was##11##3##(1991-12#1)(1991-5#1)(1997-7#1)(2008-10#5)(2008-3#1)(2009-10#1)(2011-2#1)
of which we##2##3##(1995-8#1)(2010-12#1)
of which were##28##3##(1990-5#1)(1991-3#1)(1994-12#2)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
of which##324##2##(1990-11#2)(1990-5#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#4)(1994-12#5)(1994-2#1)(1994-5#1)(1994-8#4)(1994-9#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#3)(1995-9#3)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#72)(2008-11#23)(2008-12#7)(2008-3#5)(2008-4#4)(2008-5#11)(2008-7#9)(2008-8#11)(2008-9#8)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#12)(2011-3#4)(2012-2#8)(2012-3#5)(2013-1#7)(2013-8#6)
of white fir trees##2##4##(2008-10#2)
of white matter##2##3##(2010-12#2)
of white pine blister rust##4##5##(2008-10#4)
of white wines##2##3##(2008-10#2)
of white##22##2##(1991-11#1)(2008-10#15)(2008-9#1)(2009-7#1)(2010-12#2)(2010-8#1)(2013-1#1)
of whole blood##2##3##(1990-2#1)(2008-4#1)
of whole cells##2##3##(2008-10#1)(2008-9#1)
of whole plasma##2##3##(2008-10#1)(2008-3#1)
of whole##25##2##(1990-2#1)(1994-8#1)(1995-12#1)(2008-10#7)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-7#1)(2013-1#1)(2013-8#2)
of whole-body##3##2##(2012-2#1)(2013-8#2)
of whole-genome##2##2##(2008-7#1)(2012-3#1)
of whom are##2##3##(1990-6#1)(2009-5#1)
of whom had##4##3##(1991-11#1)(1991-6#1)(2008-9#1)(2009-5#1)
of whom have##2##3##(1997-2#1)(2013-1#1)
of whom underwent##2##3##(2008-11#1)(2011-2#1)
of whom were##8##3##(1990-5#1)(1993-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
of whom##37##2##(1990-5#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-6#1)(1993-2#1)(1994-2#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-6#3)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#2)(2008-9#2)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
of whooping cough##2##3##(1997-8#1)(2008-8#1)
of why the##2##3##(1992-9#1)(2008-11#1)
of why##5##2##(1992-9#1)(1993-1#1)(2008-11#2)(2008-8#1)
of wide##7##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-3#1)
of wider##2##2##(2008-9#1)(2012-2#1)
of widespread##7##2##(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
of wigs##3##2##(2012-3#3)
of wild type##8##3##(1997-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)
of wild##23##2##(1995-2#1)(1995-9#1)(1997-3#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of wild-type CN##2##3##(2008-9#2)
of wild-type TRbeta1##2##3##(1995-8#2)
of wild-type and mutant##3##4##(1991-6#1)(1992-4#1)(2008-7#1)
of wild-type##29##2##(1991-5#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-3#1)(1997-3#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-10#2)(2011-2#1)(2012-3#1)
of wildlife##4##2##(1990-3#1)(2008-12#1)(2008-9#1)(2013-1#1)
of wilt symptoms##2##3##(2008-10#2)
of wilt##5##2##(2008-10#5)
of wilting##2##2##(2008-10#2)
of wind speed##2##3##(2008-3#2)
of wind-dispersed ascospores##2##3##(2008-10#2)
of wine samples##2##3##(2008-10#2)
of wine yeast##2##3##(2012-3#2)
of wine##14##2##(2008-10#11)(2008-7#1)(2012-3#2)
of wines and##2##3##(2008-10#2)
of wines##6##2##(2008-10#6)
of winter barley##4##3##(2008-10#2)(2008-11#2)
of winter wheat (Triticum aestivum)##2##5##(2008-10#1)(2008-12#1)
of winter wheat##5##3##(2008-10#4)(2008-12#1)
of winter##12##2##(2008-10#7)(2008-11#2)(2008-12#1)(2010-8#1)(2012-4#1)
of wireless##2##2##(2008-10#1)(2010-8#1)
of witches'-broom##2##2##(2008-10#2)
of withdrawal##4##2##(1992-3#1)(2010-11#1)(2011-2#2)
of within-field##3##2##(2008-10#3)
of women aged##6##3##(1990-12#1)(1990-6#1)(1990-8#1)(1992-1#1)(1996-6#1)(2008-5#1)
of women and children in##2##5##(1990-2#1)(2009-9#1)
of women and children##3##4##(1990-2#2)(2009-9#1)
of women and men aged 40-42##2##6##(1991-6#2)
of women and##9##3##(1990-2#2)(1991-6#3)(1995-6#1)(1997-8#1)(2009-9#1)(2012-3#1)
of women had##2##3##(1990-6#1)(2011-2#1)
of women in the##3##4##(1993-6#2)(1996-9#1)
of women in##10##3##(1992-12#1)(1993-6#4)(1996-9#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
of women reporting cervical##2##4##(1990-12#2)
of women treated##2##3##(1992-3#1)(1994-12#1)
of women undergoing##2##3##(1995-12#1)(2008-4#1)
of women who##5##3##(1992-2#1)(2009-9#1)(2011-2#3)
of women with breast##2##4##(2008-10#1)(2012-2#1)
of women with##7##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#2)
of women##78##2##(1990-12#3)(1990-2#4)(1990-6#3)(1990-8#2)(1991-3#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1993-6#7)(1994-12#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-8#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-9#2)(2011-2#6)(2012-2#2)(2012-3#7)(2013-1#2)(2013-8#1)
of women's health##3##3##(1994-3#2)(1997-4#1)
of women's##10##2##(1994-3#2)(1996-1#1)(1997-4#2)(2008-11#1)(2008-5#1)(2009-5#1)(2011-3#1)(2013-8#1)
of wood that##2##3##(2012-12#1)(2013-1#1)
of wood##7##2##(2008-10#4)(2012-12#1)(2013-1#2)
of wood-rotting##2##2##(2008-10#2)
of wooden##2##2##(2008-10#2)
of woody plants##3##3##(2008-10#2)(2008-9#1)
of woody##5##2##(2008-10#3)(2008-9#1)(2012-6#1)
of wool##2##2##(2008-10#1)(2008-5#1)
of word##6##2##(2008-11#5)(2013-8#1)
of words##7##2##(1990-8#2)(1991-2#1)(1996-2#1)(2010-7#1)(2012-3#1)(2013-8#1)
of work and##2##3##(1993-3#1)(2008-11#1)
of work of adhesion##2##4##(2008-7#2)
of work of##3##3##(2008-11#1)(2008-7#2)
of work##23##2##(1991-1#1)(1993-12#1)(1993-3#3)(1996-1#1)(1996-3#1)(1996-8#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#1)
of worker##3##2##(2008-8#2)(2013-1#1)
of workers##8##2##(2007-12#1)(2008-6#1)(2008-8#2)(2009-12#3)(2012-3#1)
of working electrode##4##3##(2008-10#4)
of working in a##2##4##(2008-11#2)
of working life##4##3##(1992-3#1)(2008-11#2)(2008-9#1)
of working memory##3##3##(1993-3#1)(2008-8#1)(2012-3#1)
of working##27##2##(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1997-1#1)(2008-10#11)(2008-11#5)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
of workplace violence##3##3##(1996-12#1)(2008-7#2)
of workplace##7##2##(1996-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-12#1)
of world##2##2##(1991-6#1)(2008-5#1)
of worldwide##2##2##(1994-3#1)(2011-2#1)
of worsening##2##2##(2008-10#1)(2008-7#1)
of worship##2##2##(2010-10#2)
of wound dressing##3##3##(2011-2#3)
of wound healing##2##3##(1990-9#1)(1995-3#1)
of wound##12##2##(1990-3#2)(1990-9#1)(1995-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#4)
of wounded##3##2##(2008-10#3)
of wounds##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
of wrinkles##2##2##(1991-6#1)(2011-2#1)
of wrist pain##3##3##(2008-9#2)(2012-3#1)
of writing an abstract##2##4##(2008-12#1)(2011-2#1)
of writing##5##2##(2008-12#2)(2009-4#1)(2011-2#2)
of written##4##2##(1995-2#1)(2008-8#1)(2009-9#1)(2013-8#1)
of wt-p53##2##2##(1993-11#2)
of x rays in##2##4##(2008-3#2)
of x rays##3##3##(2008-3#3)
of x-rays##3##2##(2013-1#3)
of xanthogranulomatous##2##2##(1991-8#1)(2013-1#1)
of xenobiotics in the##4##4##(1990-6#1)(2008-10#1)(2008-11#2)
of xenobiotics##8##2##(1990-6#1)(2008-10#2)(2008-11#4)(2008-7#1)
of xenogeneic##4##2##(2011-2#2)(2012-3#1)(2013-7#1)
of xerotic##2##2##(2008-5#2)
of xinfeng capsule on##2##4##(2013-1#1)(2013-8#1)
of xylem and phloem##2##4##(2008-10#1)(2012-8#1)
of xylem parenchyma cells##2##4##(2008-10#1)(2008-11#1)
of xylem##6##2##(2008-10#4)(2008-11#1)(2012-8#1)
of xylenol orange##2##3##(2008-10#2)
of yak meat##2##3##(2010-4#2)
of yak##3##2##(2010-4#3)
of year##6##2##(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)
of years##8##2##(1992-1#1)(1993-3#1)(1996-11#1)(1996-9#1)(2008-9#1)(2009-1#1)(2011-2#2)
of yeast cells##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
of yeast chromosome XIV##2##4##(1995-9#1)(1996-3#1)
of yeast chromosome##3##3##(1995-9#1)(1996-3#1)(1996-6#1)
of yeast extract##2##3##(2008-10#1)(2008-7#1)
of yeast strains##2##3##(1992-10#1)(2008-10#1)
of yeast##46##2##(1991-2#1)(1991-5#1)(1992-10#1)(1992-3#2)(1993-9#2)(1994-6#1)(1995-2#1)(1995-6#4)(1995-9#5)(1996-3#2)(1996-6#2)(1997-8#2)(2008-10#8)(2008-11#3)(2008-5#1)(2008-7#3)(2008-8#2)(2011-1#2)(2011-2#1)(2012-3#2)
of yellow gene##3##3##(2008-8#3)
of yellow oleander##2##3##(2008-12#2)
of yellow##9##2##(2008-10#4)(2008-12#2)(2008-8#3)
of yield losses##2##3##(2008-10#2)
of yield strength##2##3##(2009-11#1)(2009-7#1)
of yield##7##2##(2008-10#5)(2009-11#1)(2009-7#1)
of yielding##2##2##(2009-7#1)(2010-4#1)
of yolk##2##2##(2008-6#1)(2010-5#1)
of young adults##9##3##(1991-1#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
of young and old##2##4##(1990-3#1)(2008-7#1)
of young and##5##3##(1990-3#1)(1990-5#1)(1997-9#1)(2008-7#1)(2012-2#1)
of young children##6##3##(1994-3#1)(1995-2#1)(1996-3#1)(2008-9#2)(2009-9#1)
of young individuals##2##3##(1993-1#1)(2008-9#1)
of young people##3##3##(2008-11#1)(2012-2#2)
of young pigs##2##3##(2013-1#1)(2013-8#1)
of young women##2##3##(2009-10#1)(2010-9#1)
of young##49##2##(1990-3#2)(1990-5#2)(1991-1#1)(1993-1#2)(1993-2#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-2#2)(1997-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#6)(2012-3#1)(2012-9#1)(2013-1#3)(2013-8#2)
of younger patients##2##3##(1997-7#1)(2008-11#1)
of younger##3##2##(1997-7#1)(2008-11#1)(2008-7#1)
of your Patient Focused##2##4##(1994-1#1)(1994-2#1)
of your staff##2##3##(1991-3#1)(1997-2#1)
of your##14##2##(1991-1#1)(1991-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#2)(1995-2#1)(1997-2#1)(2011-2#1)
of youth with##2##3##(1992-3#1)(2010-11#1)
of youth##8##2##(1990-12#1)(1992-3#1)(2008-11#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-9#1)(2012-12#1)
of youth's##2##2##(2009-7#2)
of ytterbium-doped##2##2##(2007-12#1)(2008-3#1)
of yttrium from heavy lanthanide by##2##6##(2008-10#2)
of yttrium##4##2##(2008-10#4)
of zebrafish##6##2##(2008-11#2)(2008-4#1)(2008-9#2)(2012-3#1)
of zero##2##2##(2008-12#1)(2008-3#1)
of zinc compounds by##2##4##(2008-10#2)
of zinc compounds##3##3##(2008-10#3)
of zinc from##4##3##(2008-10#4)
of zinc in plant##2##4##(2008-10#2)
of zinc in##13##3##(2008-10#12)(2013-8#1)
of zinc ions##2##3##(2008-10#1)(2008-11#1)
of zinc is##3##3##(2008-10#2)(2013-7#1)
of zinc pyrithione##2##3##(2008-10#1)(2008-5#1)
of zinc traces##4##3##(2008-10#4)
of zinc using##2##3##(2008-10#2)
of zinc##71##2##(1990-5#4)(1992-3#1)(1994-5#4)(2008-10#57)(2008-11#1)(2008-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
of zinc(II)##5##2##(2008-10#5)
of zirconium and hafnium##2##4##(2008-10#2)
of zirconium and##3##3##(2008-10#3)
of zirconium##14##2##(1990-5#3)(2008-10#11)
of zirconium(IV) iodovanadate##2##3##(2008-10#2)
of zirconium(IV)##6##2##(2008-10#6)
of zone-circulating flow injection analysis##2##5##(2008-10#2)
of zoonotic parasites##2##3##(2011-2#2)
of zoonotic##4##2##(2008-12#1)(2011-2#3)
of zoosporangia and##2##3##(2008-10#2)
of zoosporangia##4##2##(2008-10#4)
of zoospores##3##2##(2008-10#3)
of zygomycosis##2##2##(2008-5#2)
of ~1##2##2##(2008-3#2)
of ~20##2##2##(2008-3#1)(2010-4#1)
of ~50##2##2##(2008-3#2)
of β-catenin##3##2##(2013-1#3)
of β-cell##2##2##(2010-11#1)(2013-7#1)
of β-lactam##3##2##(2011-1#1)(2013-1#2)
of β-peptides##2##2##(2011-1#2)
of ∼30##2##2##(2011-2#2)
of##166577##1##(1990-10#48)(1990-11#434)(1990-12#551)(1990-2#473)(1990-3#278)(1990-4#12)(1990-5#761)(1990-6#358)(1990-7#44)(1990-8#377)(1990-9#367)(1991-1#315)(1991-10#72)(1991-11#336)(1991-12#739)(1991-2#677)(1991-3#660)(1991-4#12)(1991-5#561)(1991-6#540)(1991-7#92)(1991-8#304)(1991-9#297)(1992-1#374)(1992-10#101)(1992-11#113)(1992-12#679)(1992-2#432)(1992-3#764)(1992-4#91)(1992-5#184)(1992-6#459)(1992-7#36)(1992-8#194)(1992-9#485)(1993-1#420)(1993-11#318)(1993-12#805)(1993-2#596)(1993-3#765)(1993-5#60)(1993-6#637)(1993-8#877)(1993-9#260)(1994-1#312)(1994-11#675)(1994-12#709)(1994-2#679)(1994-3#689)(1994-5#798)(1994-6#358)(1994-8#708)(1994-9#264)(1995-1#220)(1995-10#28)(1995-11#629)(1995-12#887)(1995-2#1004)(1995-3#441)(1995-5#435)(1995-6#842)(1995-8#582)(1995-9#235)(1996-1#375)(1996-10#8)(1996-11#307)(1996-12#1052)(1996-2#970)(1996-3#792)(1996-5#487)(1996-6#468)(1996-8#171)(1996-9#200)(1997-1#622)(1997-2#1022)(1997-3#921)(1997-4#322)(1997-5#248)(1997-6#398)(1997-7#601)(1997-8#895)(1997-9#82)(2006-5#12)(2006-6#139)(2007-11#272)(2007-12#899)(2007-7#2)(2007-8#160)(2007-9#18)(2008-1#737)(2008-10#53947)(2008-11#10849)(2008-12#3243)(2008-2#814)(2008-3#3273)(2008-4#1564)(2008-5#3554)(2008-6#847)(2008-7#4130)(2008-8#4347)(2008-9#4497)(2009-1#226)(2009-10#833)(2009-11#279)(2009-12#558)(2009-2#46)(2009-3#362)(2009-4#252)(2009-5#372)(2009-6#492)(2009-7#759)(2009-8#1251)(2009-9#356)(2010-1#621)(2010-10#665)(2010-11#648)(2010-12#908)(2010-2#160)(2010-3#301)(2010-4#537)(2010-5#536)(2010-6#592)(2010-7#685)(2010-8#801)(2010-9#287)(2011-1#828)(2011-10#68)(2011-2#6700)(2011-3#628)(2011-4#13)(2011-5#3)(2011-6#2)(2011-7#110)(2011-8#8)(2011-9#14)(2012-10#1)(2012-12#1163)(2012-2#3046)(2012-3#2962)(2012-4#39)(2012-5#80)(2012-6#32)(2012-7#43)(2012-8#31)(2012-9#31)(2013-1#5015)(2013-2#4)(2013-3#8)(2013-7#238)(2013-8#2285)
of)##3##1##(1990-8#1)(2008-10#2)
of1 approximately 15 were##2##4##(2008-11#2)
of1##5##1##(2008-11#4)(2013-8#1)
ofA##4##1##(2008-7#1)(2008-8#3)
ofAFM1 in##2##2##(2008-12#2)
ofAFM1##3##1##(2008-12#3)
ofAplysia##2##1##(2008-7#2)
ofBacillus##2##1##(2008-8#2)
ofE6##2##1##(2008-8#2)
ofEurycoma longifolia Jack##2##3##(2008-11#2)
ofGanoderma lucidum##2##2##(2008-11#2)
ofGossypium##3##1##(2008-8#3)
ofLentinula edodes and##2##3##(2008-11#2)
ofLycium chinense##2##2##(2008-11#2)
ofNfbp6##2##1##(2008-8#2)
ofPTSD was##2##2##(2013-8#2)
ofRhizobium meliloti##2##2##(2008-8#2)
ofS##2##1##(2008-11#1)(2008-9#1)
ofSalvia miltiorrhiza##2##2##(2008-11#2)
ofXa4##2##1##(2008-8#2)
ofa##8##1##(2008-11#3)(2009-8#2)(2013-8#3)
ofasyip gene##2##2##(2008-8#2)
ofcell##2##1##(2008-11#1)(2008-9#1)
ofcells in the##2##3##(2008-11#2)
ofcells in##3##2##(2008-11#3)
ofcells##5##1##(2008-11#5)
off a##3##2##(1992-11#1)(1993-9#1)(2008-3#1)
off and##2##2##(2008-2#1)(2008-6#1)
off from the##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
off from##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
off in##2##2##(2008-10#1)(2010-4#1)
off of##4##2##(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)
off or##2##2##(1997-7#2)
off the##15##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-3#2)
off to##2##2##(1994-3#1)(2008-10#1)
off##81##1##(1991-9#2)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-7#2)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#3)(2009-11#1)(2009-8#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
off&quot##2##1##(1990-8#1)(2008-7#1)
off-axis##7##1##(2007-12#1)(2008-3#6)
off-label##5##1##(2008-11#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)
off-line and##2##2##(2008-10#1)(2008-11#1)
off-line by##2##2##(2008-10#1)(2008-7#1)
off-line sample##2##2##(2008-10#2)
off-line with##2##2##(2008-10#2)
off-line##31##1##(2008-10#20)(2008-11#6)(2008-3#1)(2008-7#3)(2011-1#1)
offenders in domestic homicide cases were##2##6##(2011-2#2)
offenders in##3##2##(2008-11#1)(2011-2#2)
offenders##14##1##(2008-11#3)(2008-6#2)(2010-6#1)(2011-2#7)(2012-3#1)
offending##6##1##(2008-7#3)(2008-8#1)(2009-8#2)
offense##3##1##(1996-5#1)(2008-9#1)(2011-2#1)
offenses##4##1##(1992-9#1)(1996-5#3)
offensive from##2##2##(1992-12#2)
offensive##12##1##(1992-12#6)(1993-2#1)(1995-6#1)(1997-4#1)(2008-11#1)(2008-9#1)(2012-3#1)
offer a means##2##3##(2008-10#1)(2008-11#1)
offer a safe##2##3##(1992-2#1)(2011-2#1)
offer a##32##2##(1991-1#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#2)(1997-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2011-2#4)(2011-7#1)(2012-2#2)
offer an##9##2##(1994-9#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-2#1)
offer as a##2##3##(1996-5#1)(2012-12#1)
offer coverage to##2##3##(1995-6#1)(1996-3#1)
offer formal##2##2##(1992-12#1)(1994-12#1)
offer good##2##2##(1997-8#1)(2008-2#1)
offer great##2##2##(2008-10#1)(2012-12#1)
offer in##2##2##(2008-11#1)(2008-12#1)
offer insight into##3##3##(2009-11#1)(2009-7#1)(2011-1#1)
offer insights##2##2##(2013-1#2)
offer new##5##2##(1997-2#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
offer no##2##2##(1992-3#1)(2008-10#1)
offer opportunities##2##2##(1993-2#1)(2013-1#1)
offer potential##3##2##(1991-12#1)(2008-10#1)(2009-10#1)
offer protection against the##2##4##(2008-12#1)(2013-1#1)
offer protection against##3##3##(1993-11#1)(2008-12#1)(2013-1#1)
offer protection##4##2##(1993-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
offer several##2##2##(2008-10#1)(2008-11#1)
offer some##3##2##(1994-9#1)(2008-10#1)(2011-3#1)
offer the advantage of##2##4##(2008-10#1)(2008-9#1)
offer the best##3##3##(1994-6#1)(2008-10#1)(2012-12#1)
offer the possibility of##3##4##(2008-10#2)(2008-7#1)
offer the possibility##4##3##(1996-6#1)(2008-10#2)(2008-7#1)
offer the##16##2##(1994-6#1)(1996-6#1)(2008-10#6)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2012-12#1)(2013-1#1)
offer valuable##2##2##(2008-10#1)(2010-7#1)
offer##160##1##(1991-1#1)(1991-12#1)(1991-3#3)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1994-12#2)(1994-3#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#4)(1996-12#1)(1996-3#4)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#26)(2008-11#17)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#9)(2013-7#1)
offered a##9##2##(1995-8#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-5#1)(2012-2#1)
offered an##2##2##(2008-12#1)(2008-2#1)
offered and##2##2##(2008-11#1)(2010-9#1)
offered as##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
offered at##4##2##(1994-12#1)(1996-1#1)(2008-11#1)(2013-1#1)
offered by the##5##3##(1990-3#1)(2008-10#3)(2013-1#1)
offered by##23##2##(1990-3#1)(1990-9#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-10#1)(2013-1#3)
offered high##2##2##(2012-12#2)
offered in##3##2##(2008-12#1)(2008-8#1)(2013-1#1)
offered the##4##2##(1991-2#1)(2008-10#2)(2008-4#1)
offered through##2##2##(2008-8#1)(2013-1#1)
offered to the##2##3##(1991-2#1)(2008-11#1)
offered to##9##2##(1991-2#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-8#1)(2012-12#1)
offered##115##1##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-6#1)(1992-12#2)(1992-9#1)(1993-12#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-1#4)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#24)(2008-11#12)(2008-12#9)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#7)
offering a##9##2##(1992-1#1)(1992-2#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#3)(2013-8#1)
offering recommendations for##2##3##(2008-11#1)(2012-2#1)
offering the possibility##2##3##(1996-11#1)(2008-5#1)
offering the##8##2##(1991-1#1)(1995-1#1)(1996-11#1)(2008-10#3)(2008-5#1)(2010-12#1)
offering##42##1##(1991-1#1)(1992-1#1)(1992-2#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#6)(2013-8#1)
offerings##7##1##(1992-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#3)
offers a brief##2##3##(2008-11#1)(2012-12#1)
offers a detailed##2##3##(1996-6#1)(2008-4#1)
offers a highly##2##3##(2008-10#1)(2008-11#1)
offers a low-cost##2##3##(2008-11#1)(2010-5#1)
offers a more##3##3##(2008-10#1)(2010-7#1)(2012-12#1)
offers a new##2##3##(1994-6#1)(2012-2#1)
offers a novel##2##3##(2008-10#1)(2013-1#1)
offers a number of advantages over##2##6##(2007-11#1)(2008-4#1)
offers a number of advantages##3##5##(2007-11#1)(2008-11#1)(2008-4#1)
offers a potential##2##3##(2008-10#2)
offers a unique##3##3##(2008-11#1)(2008-4#1)(2009-6#1)
offers a valuable##2##3##(2008-3#1)(2012-2#1)
offers a##60##2##(1990-8#1)(1991-3#1)(1992-12#1)(1992-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-6#1)(2007-11#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
offers advantages##2##2##(2008-10#2)
offers an acceptable alternative##2##4##(1994-12#1)(2011-2#1)
offers an alternative to biopsy##2##5##(2012-2#2)
offers an alternative to##3##4##(2008-11#1)(2012-2#2)
offers an alternative##4##3##(2008-11#1)(2010-12#1)(2012-2#2)
offers an explanation for##2##4##(2008-9#1)(2010-12#1)
offers an ideal##2##3##(2008-10#1)(2008-8#1)
offers an overview of##3##4##(1993-11#1)(1996-12#1)(2008-4#1)
offers an##22##2##(1993-11#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
offers better##2##2##(1992-9#1)(2008-10#1)
offers distinct##2##2##(1993-3#1)(2008-10#1)
offers good##2##2##(2008-10#1)(2012-12#1)
offers great sensitivity##2##3##(2008-10#1)(2008-3#1)
offers high##3##2##(2008-10#3)
offers improved##2##2##(2008-10#1)(2008-3#1)
offers many advantages over##2##4##(2008-10#1)(2012-2#1)
offers many##4##2##(1996-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
offers novel##2##2##(2008-9#1)(2013-1#1)
offers possible##2##2##(1992-3#1)(1993-1#1)
offers recommendations##2##2##(1996-1#1)(2011-2#1)
offers several##3##2##(2008-10#3)
offers significant##2##2##(2008-10#1)(2008-5#1)
offers some##8##2##(1991-2#1)(1992-12#1)(1992-8#1)(1993-1#1)(2008-10#3)(2008-9#1)
offers the advantage of##3##4##(2007-11#1)(2008-10#2)
offers the advantage##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
offers the advantages of##3##4##(2008-10#2)(2010-7#1)
offers the best##3##3##(1991-2#1)(1996-3#1)(2008-9#1)
offers the opportunity for##2##4##(2010-11#1)(2012-2#1)
offers the potential##3##3##(2008-10#2)(2008-11#1)
offers the unique##2##3##(2007-12#1)(2011-7#1)
offers the##28##2##(1990-5#1)(1991-2#1)(1991-3#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-7#1)(2008-9#2)(2010-11#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-2#1)
offers us##2##2##(1995-12#1)(2012-2#1)
offers##202##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#2)(1992-11#1)(1992-12#3)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-6#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#57)(2008-11#17)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#4)(2010-9#2)(2011-2#6)(2011-7#1)(2012-12#5)(2012-2#11)(2012-3#2)(2013-1#2)(2013-8#1)
office and##2##2##(1991-2#1)(2010-7#1)
office building##2##2##(1997-3#1)(2008-5#1)
office paper&gt##2##2##(2008-10#2)
office was##3##2##(1995-12#1)(2008-1#2)
office##43##1##(1990-11#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-1#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-8#1)(1995-12#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
office-based surgical safety##2##3##(2013-1#2)
office-based surgical##3##2##(2013-1#3)
office-based##8##1##(1994-2#1)(2008-11#1)(2008-4#1)(2013-1#5)
officer##15##1##(1991-1#2)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#2)(1993-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#3)
officers and##2##2##(1993-3#1)(2013-8#1)
officers in##2##2##(1990-3#1)(1992-12#1)
officers##28##1##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#3)(1992-12#2)(1992-2#2)(1993-2#2)(1993-3#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-8#2)(2008-10#5)(2008-3#1)(2008-7#1)(2013-8#1)
offices of the##2##3##(2009-4#1)(2010-12#1)
offices##12##1##(1996-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#5)(2013-1#1)
official and reported methods##2##4##(2008-10#2)
official method of the##3##4##(2008-10#3)
official method of##4##3##(2008-10#4)
official method##14##2##(2008-10#14)
official methods for##2##3##(2008-10#2)
official methods##8##2##(2008-10#6)(2008-11#1)(2008-5#1)
official statistics##2##2##(1990-6#1)(1991-9#1)
official##54##1##(1990-6#1)(1991-3#1)(1991-9#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-5#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-5#3)(2009-10#4)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
officially accepted##2##2##(1996-3#1)(2008-5#1)
officially##7##1##(1990-3#1)(1993-6#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-8#1)(2008-5#1)
officials and##4##2##(1995-12#1)(1996-1#2)(2009-10#1)
officials as##2##2##(1994-3#1)(2008-10#1)
officials come to##2##3##(1995-6#2)
officials##29##1##(1990-2#1)(1994-2#1)(1994-3#1)(1995-12#4)(1995-6#5)(1996-1#3)(1996-3#1)(1996-5#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-5#2)(2011-2#3)
officinalis##8##1##(2008-10#2)(2008-12#1)(2008-7#3)(2011-2#1)(2013-1#1)
officinalis)##3##1##(2008-10#2)(2008-5#1)
offline##6##1##(1991-2#1)(2007-12#1)(2008-9#1)(2010-7#1)(2010-8#1)(2013-8#1)
offset by##7##2##(1992-12#1)(1993-12#1)(1993-3#1)(1995-1#1)(2008-8#1)(2013-1#1)(2013-8#1)
offset in##2##2##(1994-9#1)(2011-2#1)
offset to the##2##3##(1994-12#1)(2008-6#1)
offset##24##1##(1992-12#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-6#1)(2008-8#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
offsets the##2##2##(1992-12#1)(2013-1#1)
offsets##5##1##(1992-12#1)(2008-3#2)(2011-2#1)(2013-1#1)
offsetting##2##1##(1993-12#1)(2008-3#1)
offshore platforms##2##2##(1990-11#2)
offshore##10##1##(1990-11#2)(2008-10#2)(2008-9#1)(2009-10#3)(2010-8#1)(2011-2#1)
offspring and##4##2##(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
offspring fitness##2##2##(2008-8#2)
offspring fitness/propagule size##2##3##(2008-8#2)
offspring is##2##2##(2008-8#1)(2008-9#1)
offspring of the##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
offspring of##11##2##(2008-10#3)(2008-7#2)(2008-8#3)(2010-4#1)(2012-2#2)
offspring retention##3##2##(2008-8#3)
offspring survival##7##2##(2008-8#6)(2008-9#1)
offspring were produced##2##3##(2008-10#1)(2008-9#1)
offspring were##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
offspring##100##1##(1991-1#1)(1993-3#1)(1995-12#1)(1997-7#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#40)(2008-9#21)(2009-8#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
offspring)##4##1##(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
ofglaA##3##1##(2008-8#3)
ofglutamine##2##1##(2008-11#2)
ofglycosylation##2##1##(2008-11#2)
ofin vitro##2##2##(2008-11#1)(2008-8#1)
ofinterest in##2##2##(2008-11#1)(2013-8#1)
ofinterest##3##1##(2008-11#1)(2013-8#2)
ofloxacin (OFLO) and##2##3##(2008-10#2)
ofloxacin and##2##2##(2008-7#1)(2012-3#1)
ofloxacin in##5##2##(2008-10#5)
ofloxacin is##2##2##(1990-2#1)(2008-10#1)
ofloxacin##32##1##(1990-2#2)(2008-10#25)(2008-7#2)(2012-3#3)
ofsuch##2##1##(2008-11#1)(2013-8#1)
ofsufficient##2##1##(2008-11#1)(2013-8#1)
often a##11##2##(1993-11#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
often accompany##2##2##(1994-5#1)(2012-12#1)
often affected##2##2##(2008-5#1)(2010-11#1)
often and##2##2##(2008-9#1)(2013-1#1)
often appear##2##2##(2008-9#1)(2010-10#1)
often applied##2##2##(2008-11#1)(2008-5#1)
often are##8##2##(1990-6#1)(1993-2#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
often arise##2##2##(2008-5#1)(2008-7#1)
often as a##2##3##(1990-5#1)(2009-12#1)
often as##6##2##(1990-5#1)(1994-3#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
often associated with a##2##4##(2008-11#1)(2013-1#1)
often associated with the##2##4##(2012-12#1)(2012-3#1)
often associated with##28##3##(1990-5#1)(1993-11#1)(1997-2#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#4)
often assumed to be##2##4##(1997-7#1)(2008-9#1)
often assumed##3##2##(1997-7#1)(2008-11#1)(2008-9#1)
often at high##2##3##(2008-10#1)(2011-2#1)
often at the##3##3##(1990-11#1)(2012-2#1)(2012-3#1)
often at##7##2##(1990-11#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
often based on##7##3##(1990-6#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#2)(2012-2#1)
often be##11##2##(1991-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-9#1)(2013-1#2)
often becomes##2##2##(1996-2#1)(2008-1#1)
often been##8##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
often cannot be##2##3##(1992-3#1)(2011-2#1)
often causes##3##2##(1991-3#1)(2008-10#1)(2012-12#1)
often causing##2##2##(2008-10#1)(2010-12#1)
often clustered##2##2##(2008-10#1)(2009-5#1)
often considered##4##2##(1996-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
often contains##2##2##(2008-4#1)(2008-5#1)
often contaminated with##2##3##(1991-12#1)(2012-2#1)
often correlated with##2##3##(1996-2#1)(2008-11#1)
often diagnosed##3##2##(1993-3#1)(1997-8#1)(2011-2#1)
often discussed##2##2##(1993-12#1)(1997-3#1)
often do not##3##3##(1991-12#1)(2008-3#1)(2012-2#1)
often does not##2##3##(2008-8#1)(2010-12#1)
often does##3##2##(1992-11#1)(2008-8#1)(2010-12#1)
often employed##2##2##(2008-3#1)(2010-6#1)
often encounter patients##2##3##(2009-7#1)(2013-1#1)
often encountered in##3##3##(1993-8#1)(2008-3#2)
often encountered##5##2##(1993-3#1)(1993-8#1)(2008-10#1)(2008-3#2)
often evaluate##2##2##(1994-12#1)(2008-9#1)
often exceeded##2##2##(2008-10#1)(2012-3#1)
often exhibit##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
often experience##2##2##(1993-12#1)(2010-8#1)
often fail##2##2##(1991-12#1)(2011-2#1)
often feel##2##2##(1997-5#1)(2008-1#1)
often found in##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
often found##8##2##(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)
often given##2##2##(1997-2#1)(2013-1#1)
often had##4##2##(1991-11#1)(1994-12#1)(2008-10#1)(2011-2#1)
often hampered by##4##3##(1990-12#1)(1992-9#1)(2008-10#1)(2011-3#1)
often has been##2##3##(2008-10#2)
often have a##3##3##(2010-1#1)(2010-4#1)(2012-12#1)
often have##13##2##(1991-12#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-4#2)(2010-7#1)(2012-12#1)
often in the##5##3##(1991-6#1)(1996-11#1)(2009-12#1)(2011-1#1)(2013-1#1)
often in##12##2##(1991-6#1)(1992-3#1)(1994-11#1)(1996-11#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
often involve##6##2##(1992-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)
often involved in##3##3##(1997-8#1)(2008-1#1)(2010-12#1)
often involved##5##2##(1997-8#1)(2008-1#1)(2008-7#1)(2010-1#1)(2010-12#1)
often involves the##2##3##(2008-4#1)(2008-5#1)
often involves##7##2##(1997-1#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-6#1)(2013-1#1)
often is##7##2##(2008-10#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
often isolated##2##2##(2008-10#1)(2008-5#1)
often lead to##2##3##(2008-5#1)(2010-6#1)
often lead##3##2##(2008-5#1)(2009-6#1)(2010-6#1)
often leads to##5##3##(1996-11#1)(2006-6#1)(2008-9#1)(2012-3#2)
often leads##6##2##(1996-11#1)(2006-6#1)(2008-9#1)(2012-2#1)(2012-3#2)
often led to##2##3##(2008-10#1)(2012-12#1)
often limited by##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
often limited##8##2##(1994-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)(2011-7#1)
often linked to##2##3##(1996-6#1)(2012-2#1)
often linked##3##2##(1996-6#1)(2009-7#1)(2012-2#1)
often made##3##2##(1993-12#1)(1997-2#1)(2010-3#1)
often makes it##2##3##(2008-11#1)(2008-12#1)
often makes##3##2##(1991-2#1)(2008-11#1)(2008-12#1)
often misdiagnosed##2##2##(2009-9#1)(2010-10#1)
often missed by##2##3##(1996-2#1)(2011-2#1)
often more##2##2##(2008-5#1)(2010-10#1)
often must##2##2##(2008-11#1)(2011-2#1)
often need to##2##3##(1992-1#1)(2012-2#1)
often need##3##2##(1992-1#1)(2011-2#1)(2012-2#1)
often needed##2##2##(2008-4#1)(2008-8#1)
often not##10##2##(1990-3#1)(1991-1#1)(1993-11#1)(1994-3#1)(2008-11#3)(2008-7#1)(2010-8#1)(2011-1#1)
often noted##2##2##(1993-9#1)(2008-10#1)
often obscured##2##2##(1993-9#1)(2012-3#1)
often observed##5##2##(1993-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)
often occur as##2##3##(2008-8#2)
often occur in##3##3##(1994-3#1)(2008-7#1)(2011-2#1)
often occur##7##2##(1994-3#1)(2008-10#2)(2008-7#1)(2008-8#2)(2011-2#1)
often occurred##2##2##(1993-12#1)(1996-1#1)
often occurs##4##2##(2008-11#1)(2008-8#1)(2011-2#2)
often on the##2##3##(1992-1#1)(2008-9#1)
often overlap##2##2##(2008-8#1)(2012-3#1)
often overlooked##6##2##(2008-8#1)(2008-9#1)(2010-4#1)(2011-3#1)(2012-5#1)(2013-8#1)
often performed##2##2##(1990-12#1)(2010-12#1)
often preferred##2##2##(2011-2#1)(2013-1#1)
often present at##2##3##(1997-2#1)(2008-10#1)
often present in the##2##4##(2007-12#1)(2008-1#1)
often present in##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
often present with a##2##4##(2008-10#1)(2010-9#1)
often present with##3##3##(2008-10#1)(2008-11#1)(2010-9#1)
often present##13##2##(1991-8#1)(1992-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2009-10#1)(2010-9#1)
often presents##3##2##(2008-10#1)(2008-12#1)(2009-10#1)
often produced##2##2##(2008-12#1)(2008-9#1)
often provides##2##2##(2008-10#1)(2009-8#1)
often reached##2##2##(1990-12#1)(2008-3#1)
often reduced##2##2##(2008-7#1)(2008-9#1)
often referred to as##3##4##(2010-10#1)(2010-12#1)(2013-7#1)
often referred##4##2##(2008-10#1)(2010-10#1)(2010-12#1)(2013-7#1)
often related to##5##3##(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
often report##2##2##(1994-12#1)(2008-10#1)
often reported##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2010-2#1)
often require##5##2##(2008-11#1)(2011-3#1)(2012-2#2)(2013-8#1)
often required##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
often requires##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
often resistant to##2##3##(2008-7#1)(2013-1#1)
often result in##2##3##(2008-12#1)(2012-2#1)
often results from##2##3##(2008-10#1)(2008-2#1)
often results##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
often reveal##2##2##(1995-2#1)(2011-2#1)
often seen as##2##3##(2008-10#1)(2008-11#1)
often seen in##5##3##(1992-5#1)(1997-8#1)(2008-7#1)(2010-7#1)(2012-12#1)
often seen##10##2##(1992-5#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-7#1)(2012-12#1)
often selected##2##2##(2008-10#1)(2008-12#1)
often show##3##2##(1997-3#1)(2009-8#1)(2010-12#1)
often start##2##2##(1990-2#1)(2008-11#1)
often suffer##2##2##(2008-1#1)(2008-11#1)
often suggested##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
often than not##2##3##(2008-1#1)(2008-10#1)
often than##10##2##(1990-8#1)(1994-12#1)(1994-3#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-11#1)
often the case##3##3##(2008-4#1)(2009-11#1)(2011-2#1)
often the first##3##3##(1993-2#1)(2011-2#1)(2013-1#1)
often the primary##2##3##(2008-3#1)(2012-2#1)
often the##16##2##(1992-9#1)(1993-2#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#1)
often thought to##2##3##(2008-9#1)(2009-8#1)
often to##4##2##(1997-4#1)(2008-11#2)(2008-3#1)
often unavailable##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
often unclear##2##2##(2009-5#1)(2009-6#1)
often underestimated##2##2##(2010-5#1)(2013-8#1)
often undergo##2##2##(2012-2#2)
often unique##2##2##(1994-8#1)(2010-7#1)
often unknown##3##2##(1996-2#1)(2008-11#1)(2012-3#1)
often use##2##2##(1996-3#1)(2009-4#1)
often used as a##3##4##(1996-3#1)(2008-10#1)(2013-1#1)
often used as the##2##4##(2008-10#1)(2010-12#1)
often used as##6##3##(1992-3#1)(1996-3#1)(2008-10#2)(2010-12#1)(2013-1#1)
often used for##2##3##(2008-10#1)(2008-9#1)
often used in##7##3##(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)(2010-10#1)
often used to##10##3##(1993-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
often used##36##2##(1992-3#1)(1993-2#1)(1995-11#1)(1996-3#1)(1997-6#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
often very##2##2##(2008-9#1)(2012-2#1)
often was##2##2##(2008-10#2)
often were##6##2##(2008-10#6)
often with##5##2##(1992-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2013-1#1)
often##810##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#3)(1991-6#3)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#7)(1992-5#2)(1992-8#1)(1992-9#6)(1993-11#3)(1993-12#9)(1993-2#6)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#7)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#9)(1996-3#3)(1996-6#4)(1996-8#1)(1997-1#3)(1997-2#6)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#9)(2006-6#1)(2007-12#5)(2008-1#9)(2008-10#118)(2008-11#52)(2008-12#17)(2008-2#2)(2008-3#9)(2008-4#13)(2008-5#21)(2008-6#6)(2008-7#22)(2008-8#39)(2008-9#41)(2009-10#3)(2009-11#4)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#5)(2009-7#5)(2009-8#10)(2009-9#5)(2010-1#7)(2010-10#8)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#7)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#58)(2011-3#4)(2011-7#4)(2012-12#10)(2012-2#28)(2012-3#17)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#42)(2013-7#1)(2013-8#9)
often)##2##1##(2011-2#2)
often-cited##2##1##(2008-9#1)(2012-2#1)
oftener##3##1##(2013-1#3)
ofthe DMN and its##2##4##(2013-8#2)
ofthe DMN##3##2##(2013-8#3)
ofthe artery##2##2##(2013-8#2)
ofthe disease##2##2##(2013-8#2)
ofthe##38##1##(2008-11#17)(2008-9#2)(2009-8#1)(2013-8#18)
ohio##2##1##(2008-10#1)(2012-2#1)
oil adulteration##2##2##(2008-10#2)
oil and grease (FOG)##2##4##(2013-1#2)
oil and##22##2##(2008-10#16)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#3)
oil as##3##2##(2008-10#2)(2008-5#1)
oil biodiesel##2##2##(2009-3#2)
oil bodies##7##2##(2009-10#6)(2011-2#1)
oil body##2##2##(2009-10#2)
oil by##4##2##(2008-10#4)
oil coated fiber##2##3##(2008-10#2)
oil concentration##3##2##(2008-10#3)
oil content and##2##3##(2008-5#1)(2012-2#1)
oil droplet size##2##3##(2008-7#2)
oil droplets##4##2##(2008-3#1)(2008-5#3)
oil extracted from the##3##4##(2008-5#3)
oil extracted##4##2##(2008-10#1)(2008-5#3)
oil for##5##2##(2008-10#1)(2008-5#2)(2009-3#1)(2013-1#1)
oil from##4##2##(2008-10#1)(2008-12#1)(2009-3#1)(2013-8#1)
oil has##2##2##(2008-10#1)(2008-12#1)
oil in the##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
oil in water&quot##2##3##(2008-10#2)
oil in##13##2##(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2012-3#1)(2013-8#1)
oil industry##2##2##(2008-10#1)(2013-1#1)
oil into##3##2##(2008-10#3)
oil is##2##2##(2008-10#1)(2013-1#1)
oil lamps found in##2##4##(2008-10#2)
oil lamps##4##2##(2008-10#4)
oil medium##3##2##(2008-10#1)(2009-5#2)
oil mixtures##3##2##(2008-10#2)(2008-3#1)
oil of the##9##3##(2008-11#7)(2008-12#2)
oil of##19##2##(2008-11#17)(2008-12#2)
oil on##6##2##(2008-10#2)(2008-11#1)(2008-9#2)(2009-5#1)
oil palm biosolid extract##3##4##(2011-2#3)
oil palm shell##2##3##(2013-1#2)
oil palm##7##2##(2008-10#2)(2011-2#3)(2013-1#2)
oil phase##5##2##(2008-5#5)
oil polyurethane composite##3##3##(2008-10#3)
oil refinery##3##2##(2008-10#2)(2011-2#1)
oil sample##3##2##(2008-10#3)
oil samples in##2##3##(2008-10#2)
oil samples varied in all cases between 1##2##8##(2008-10#2)
oil samples was##2##3##(2008-10#2)
oil samples##17##2##(2008-10#15)(2011-2#2)
oil showed##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
oil spill##3##2##(2008-10#2)(2008-11#1)
oil was found to##2##4##(2008-11#1)(2009-3#1)
oil was used##2##3##(2008-10#1)(2008-11#1)
oil was##8##2##(2008-10#3)(2008-11#2)(2008-12#1)(2009-3#2)
oil were##2##2##(2008-10#2)
oil with##2##2##(2008-10#2)
oil##342##1##(1990-8#1)(1992-9#1)(1994-6#1)(1995-11#1)(1995-5#1)(2008-10#174)(2008-11#32)(2008-12#9)(2008-3#6)(2008-5#36)(2008-7#2)(2008-9#5)(2009-10#11)(2009-3#11)(2009-5#3)(2009-8#4)(2010-1#3)(2011-2#15)(2012-2#7)(2012-3#1)(2013-1#16)(2013-8#2)
oil)##11##1##(1991-6#1)(1994-5#1)(2008-10#8)(2010-7#1)
oil-in-water (o/w)##2##2##(2008-11#1)(2008-5#1)
oil-in-water emulsion##2##2##(2008-10#1)(2008-11#1)
oil-in-water##8##1##(2008-10#2)(2008-11#3)(2008-5#3)
oils also##2##2##(2008-10#1)(2008-12#1)
oils and their main components##2##5##(2008-10#1)(2008-11#1)
oils and their##4##3##(2008-10#3)(2008-11#1)
oils and##18##2##(2008-10#13)(2008-11#1)(2008-5#2)(2009-3#1)(2012-2#1)
oils as##2##2##(2009-3#2)
oils by##9##2##(2008-10#8)(2008-5#1)
oils extracted from##2##3##(2008-10#1)(2013-1#1)
oils from##5##2##(2008-10#4)(2008-12#1)
oils has##2##2##(2008-10#2)
oils have##2##2##(2008-11#1)(2009-3#1)
oils in##5##2##(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)
oils is##3##2##(2008-10#3)
oils of##8##2##(2008-10#2)(2008-11#3)(2008-12#2)(2012-2#1)
oils the##2##2##(2008-10#1)(2008-5#1)
oils used##2##2##(2008-10#2)
oils using##2##2##(2008-10#2)
oils were prepared##2##3##(2008-10#2)
oils were tested##2##3##(2008-10#1)(2008-11#1)
oils were##11##2##(2008-10#4)(2008-11#3)(2008-12#3)(2012-2#1)
oils without titration##3##3##(2008-10#3)
oils##144##1##(1991-6#1)(1997-2#1)(2008-10#88)(2008-11#20)(2008-12#9)(2008-5#11)(2008-6#1)(2009-3#4)(2010-1#1)(2011-2#2)(2012-2#3)(2013-1#3)
oilseed poppy##2##2##(2008-10#2)
oilseed rape##8##2##(2008-10#8)
oilseed##12##1##(2008-10#12)
oilseeds##4##1##(2008-10#3)(2010-7#1)
oily paste extracts##2##3##(2008-10#2)
oily phase##2##2##(2008-5#2)
oily##5##1##(2008-10#2)(2008-5#3)
ointment bases##2##2##(2008-5#2)
ointment prepared from ethanolic extract of Lemon verbena##2##8##(2008-12#2)
ointment##8##1##(1993-11#1)(1997-2#1)(2008-10#1)(2008-12#2)(2008-5#2)(2011-2#1)
okadaic acid (IC50 =##2##4##(1995-8#2)
okadaic acid (OA)##2##3##(1993-8#1)(1994-11#1)
okadaic acid##19##2##(1991-5#3)(1992-8#4)(1993-8#4)(1994-11#3)(1995-11#1)(1995-8#3)(2008-4#1)
okadaic##20##1##(1991-5#3)(1992-8#4)(1992-9#1)(1993-8#4)(1994-11#3)(1995-11#1)(1995-8#3)(2008-4#1)
olanzapine##3##1##(2010-2#3)
old WAG/Rij rats##2##3##(1990-2#2)
old age is##3##3##(1990-11#2)(2013-7#1)
old age##20##2##(1990-11#4)(1990-3#2)(1995-8#1)(1996-3#1)(2008-7#7)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
old and young larvae##2##4##(2008-12#2)
old and young##5##3##(2008-12#2)(2009-10#2)(2009-8#1)
old and##13##2##(2008-10#1)(2008-12#2)(2008-7#2)(2009-10#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
old animals##2##2##(1993-12#1)(2008-7#1)
old boy##5##2##(1991-11#1)(1996-6#2)(2010-8#1)(2012-3#1)
old but##2##2##(1990-3#2)
old child who##2##3##(2010-5#1)(2013-1#1)
old child##3##2##(1995-11#1)(2010-5#1)(2013-1#1)
old children##2##2##(2009-11#1)(2013-1#1)
old cuticle##3##2##(2008-7#3)
old female patient##3##3##(2008-11#1)(2010-11#1)(2011-2#1)
old female presented##2##3##(2012-3#1)(2013-1#1)
old female who presented with##2##5##(2009-7#1)(2011-2#1)
old female with##3##3##(2009-8#1)(2011-2#1)(2012-2#1)
old female##15##2##(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)
old had##2##2##(1990-6#1)(2013-8#1)
old lacquer-ware##2##2##(2008-10#2)
old male##11##2##(1995-12#1)(2008-7#4)(2011-2#2)(2012-3#1)(2013-1#3)
old man developed##2##3##(1990-9#1)(1993-8#1)
old man who presented##2##4##(1991-11#1)(2011-2#1)
old man who##3##3##(1991-11#1)(2009-1#1)(2011-2#1)
old man with##3##3##(1997-6#1)(2009-8#1)(2010-2#1)
old man##15##2##(1990-9#1)(1991-11#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1997-6#1)(2009-1#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#2)
old mice##4##2##(2012-2#1)(2013-7#3)
old ones##4##2##(2007-12#1)(2008-7#2)(2008-8#1)
old patient with##3##3##(1994-5#1)(2008-10#1)(2012-2#1)
old patient##7##2##(1994-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
old problem##2##2##(1990-3#1)(1993-8#1)
old questions##2##2##(2008-11#1)(2012-2#1)
old rat##2##2##(1994-8#1)(1996-12#1)
old rats##13##2##(1994-8#1)(2008-7#12)
old subjects##2##2##(1996-2#1)(1996-8#1)
old who##2##2##(2008-7#1)(2010-10#1)
old woman and##2##3##(1990-2#1)(2009-1#1)
old woman who##4##3##(1997-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
old woman with##2##3##(1990-12#1)(1991-6#1)
old woman##16##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-6#1)(1991-8#1)(1993-6#1)(1994-8#1)(1997-6#2)(2008-5#1)(2009-1#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-8#1)
old##325##1##(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#11)(1990-6#6)(1990-9#2)(1991-1#3)(1991-11#4)(1991-2#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#28)(2008-11#7)(2008-12#12)(2008-5#5)(2008-7#49)(2008-8#8)(2008-9#7)(2009-1#2)(2009-10#2)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#6)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#22)(2012-12#6)(2012-2#9)(2012-3#12)(2012-5#1)(2013-1#16)(2013-7#6)(2013-8#5)
old&quot##2##1##(2008-10#1)(2012-2#1)
old) and##6##2##(1993-12#1)(2008-10#1)(2008-7#2)(2010-12#1)(2013-8#1)
old)##28##1##(1993-12#4)(1996-8#1)(2008-10#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
older Maori##4##2##(2008-1#4)
older Māori##2##2##(2012-12#2)
older New##2##2##(2012-12#2)
older adolescents##3##2##(2010-1#2)(2013-1#1)
older adult##5##2##(1996-2#1)(2008-10#1)(2010-10#1)(2013-1#2)
older adults in##5##3##(2008-12#1)(2008-4#1)(2008-5#1)(2012-12#2)
older adults living##2##3##(2008-5#2)
older adults with##7##3##(1992-1#1)(2010-11#4)(2012-3#1)(2013-1#1)
older adults##42##2##(1991-12#1)(1992-1#4)(1997-3#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-4#3)(2008-5#3)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#6)(2010-7#2)(2012-12#3)(2012-3#1)(2013-1#5)(2013-8#1)
older age groups##4##3##(2008-5#1)(2008-9#1)(2009-7#1)(2013-1#1)
older age##10##2##(1993-12#1)(1996-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
older ages##4##2##(1992-6#2)(2009-7#2)
older and##4##2##(1994-12#1)(2008-10#1)(2009-8#2)
older at##2##2##(2010-11#2)
older athletes##4##2##(2013-1#4)
older berries##3##2##(2008-10#3)
older child##2##2##(2008-2#1)(2008-9#1)
older children and adolescents##2##4##(1995-12#2)
older children and##4##3##(1995-12#2)(1996-2#1)(2008-10#1)
older children##12##2##(1993-3#1)(1994-12#1)(1995-12#2)(1995-2#1)(1996-2#2)(2008-10#2)(2008-9#1)(2009-3#1)(2013-1#1)
older control##4##2##(2008-10#4)
older dogs##3##2##(1996-12#1)(2012-3#2)
older donors##2##2##(2011-2#2)
older formulations##2##2##(2008-2#1)(2008-4#1)
older individuals with##2##3##(2007-12#1)(2008-7#1)
older individuals##3##2##(2007-12#1)(2008-7#1)(2009-8#1)
older men and women##2##4##(1995-3#1)(2009-11#1)
older men and##3##3##(1995-3#1)(2009-11#1)(2009-5#1)
older men##6##2##(1995-3#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-5#2)
older mothers##4##2##(1997-3#2)(2010-2#2)
older ones##2##2##(1991-2#1)(1992-8#1)
older patients with cancer##3##4##(2010-11#3)
older patients with##6##3##(1991-1#1)(2010-10#1)(2010-11#4)
older patients##17##2##(1991-1#2)(1995-5#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#2)(2010-11#4)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
older people and##4##3##(1997-3#1)(2010-10#2)(2013-1#1)
older people as well as##2##5##(2010-10#2)
older people as##3##3##(2010-10#3)
older people in their own##2##5##(2010-10#2)
older people in##8##3##(1991-2#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#4)
older people to##2##3##(2010-10#2)
older people with##2##3##(1991-1#1)(2013-8#1)
older people##48##2##(1991-1#1)(1991-2#1)(1994-12#1)(1995-3#1)(1997-3#2)(2008-1#1)(2008-6#1)(2008-7#3)(2009-3#2)(2010-10#31)(2012-12#2)(2013-1#1)(2013-8#1)
older people's dignity##2##3##(2010-10#2)
older people's lived experiences##2##4##(2010-10#2)
older people's##5##2##(2010-10#5)
older persons in##3##3##(1997-2#1)(2010-10#2)
older persons##7##2##(1994-2#1)(1997-2#1)(2010-10#4)(2011-2#1)
older population##2##2##(2011-2#1)(2012-12#1)
older subjects##4##2##(1995-5#1)(1996-2#1)(2008-7#2)
older taxa have older##2##4##(2008-11#2)
older than 60 years##3##4##(2011-2#2)(2012-3#1)
older than 65 years##7##4##(2008-7#1)(2009-1#1)(2011-2#5)
older than##28##2##(1990-12#1)(1993-8#1)(1994-6#3)(2008-10#4)(2008-7#3)(2009-1#1)(2009-8#2)(2011-2#10)(2012-2#1)(2012-3#1)(2013-8#1)
older women##14##2##(1994-2#1)(1996-8#1)(2008-7#1)(2009-10#1)(2010-10#4)(2011-2#4)(2012-12#2)
older workers##3##2##(2008-6#3)
older##352##1##(1990-12#1)(1990-3#2)(1990-9#1)(1991-1#6)(1991-11#3)(1991-12#3)(1991-2#2)(1992-1#4)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-12#2)(1996-2#5)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-8#1)(2007-12#1)(2008-1#7)(2008-10#23)(2008-11#14)(2008-12#5)(2008-2#2)(2008-4#9)(2008-5#6)(2008-6#4)(2008-7#13)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#4)(2009-3#4)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#7)(2010-1#5)(2010-10#60)(2010-11#13)(2010-12#1)(2010-2#3)(2010-7#3)(2010-8#1)(2011-2#24)(2012-12#15)(2012-2#8)(2012-3#6)(2013-1#19)(2013-8#6)
older)##2##1##(1993-2#1)(2009-7#1)
olderthan##2##1##(2009-8#2)
oldest age##3##2##(2008-7#1)(2012-3#2)
oldest##21##1##(1990-3#1)(1994-9#1)(1996-2#1)(1996-6#1)(2008-10#3)(2008-7#3)(2010-7#2)(2011-2#3)(2012-2#2)(2012-3#3)(2013-8#1)
oleaginous yeast Cryptococcus curvatus##2##4##(1996-6#2)
oleander leaf##2##2##(2008-10#2)
oleander##6##1##(2008-10#4)(2008-12#2)
oleanolic acid##2##2##(2008-5#1)(2012-2#1)
oleate##2##1##(1992-3#1)(2008-10#1)
olefins##2##1##(2008-10#1)(2011-2#1)
oleic (C18##2##2##(2008-10#1)(2008-11#1)
oleic acid##10##2##(1990-5#2)(1993-9#4)(1996-6#1)(2008-11#1)(2008-7#1)(2010-4#1)
oleic and##2##2##(1994-8#1)(2008-11#1)
oleic##17##1##(1990-5#2)(1993-9#4)(1994-8#2)(1996-6#1)(2008-10#3)(2008-11#3)(2008-7#1)(2010-4#1)
oleophila##10##1##(2008-10#10)
oleosin knockdown shows##2##3##(2009-10#2)
oleosin knockdown##4##2##(2009-10#4)
oleosin##10##1##(2009-10#8)(2011-2#2)
oleracea##11##1##(2008-10#7)(2008-8#1)(2012-3#3)
oleracea)##4##1##(2008-10#4)
olfaction##4##1##(1993-3#1)(2008-9#2)(2012-2#1)
olfactive character##2##2##(2008-5#2)
olfactometer##2##1##(2009-8#1)(2013-8#1)
olfactory bulb (OB)##2##3##(2012-2#1)(2013-1#1)
olfactory bulb and##6##3##(2008-11#1)(2009-12#2)(2013-1#3)
olfactory bulb##25##2##(1993-3#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-6#2)(2008-7#5)(2009-12#7)(2012-2#2)(2013-1#5)
olfactory bulbs##3##2##(1993-3#1)(1994-2#1)(2008-7#1)
olfactory conditioning##2##2##(1994-8#2)
olfactory ensheathing cells##3##3##(2008-7#3)
olfactory learning in##2##3##(2009-8#1)(2012-2#1)
olfactory learning##7##2##(2009-8#3)(2012-2#4)
olfactory lobe##2##2##(2007-12#2)
olfactory notes##2##2##(2012-2#2)
olfactory receptor neurons##2##3##(2007-12#1)(2009-12#1)
olfactory receptor##3##2##(2007-12#1)(2009-12#2)
olfactory sensilla##2##2##(2007-12#1)(2008-7#1)
olfactory sensory units##3##3##(2007-12#3)
olfactory system##5##2##(1990-5#1)(2007-12#1)(2008-7#1)(2009-12#1)(2012-2#1)
olfactory systems##3##2##(2007-12#1)(2008-7#1)(2009-10#1)
olfactory tract transection##2##3##(2013-1#2)
olfactory tract##4##2##(2008-6#1)(2013-1#3)
olfactory tubercle##2##2##(1993-6#1)(1996-12#1)
olfactory##81##1##(1990-5#3)(1993-3#5)(1993-6#1)(1994-2#1)(1994-8#3)(1996-12#2)(1997-3#1)(2007-12#14)(2008-11#2)(2008-6#3)(2008-7#13)(2009-10#1)(2009-12#10)(2009-8#3)(2012-2#11)(2013-1#8)
oligandrin treatment##2##2##(2008-10#2)
oligandrin##6##1##(2008-10#6)
oligandrum and##4##2##(2008-10#4)
oligandrum isolates##2##2##(2008-10#2)
oligandrum or oligandrin were##2##4##(2008-10#2)
oligandrum or##3##2##(2008-10#3)
oligandrum was##3##2##(2008-10#3)
oligandrum##29##1##(2008-10#29)
oligo##2##1##(2008-10#1)(2008-9#1)
oligo-gene##2##1##(2007-12#2)
oligoadenylates##2##1##(1994-11#2)
oligoclonal##4##1##(1997-8#1)(2008-11#2)(2011-2#1)
oligodendrocyte##12##1##(1995-12#1)(1996-12#6)(2008-7#4)(2012-2#1)
oligodendrocytes and##2##2##(2008-11#1)(2008-7#1)
oligodendrocytes##11##1##(1996-12#2)(2008-11#3)(2008-7#4)(2009-6#2)
oligodendrogliomas##2##1##(1991-8#1)(2008-11#1)
oligodeoxynucleotide##4##1##(1995-12#1)(2008-11#2)(2011-2#1)
oligodeoxynucleotides (ODNs)##3##2##(1996-12#1)(2008-10#2)
oligodeoxynucleotides##20##1##(1992-6#3)(1995-11#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-4#5)(2011-2#1)
oligodeoxyribonucleotide##5##1##(1993-12#2)(1997-7#1)(2008-4#2)
oligodeoxyribonucleotides##5##1##(1990-5#1)(1993-2#1)(1993-6#1)(2008-4#2)
oligomer structure##2##2##(1994-11#1)(2008-9#1)
oligomer##13##1##(1991-5#1)(1992-6#1)(1993-8#1)(1994-11#2)(1995-6#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)
oligomeric stilbenes##2##2##(2008-10#2)
oligomeric##6##1##(1990-12#1)(1995-2#1)(1997-8#1)(2008-10#3)
oligomerization of the##2##3##(1991-5#1)(1994-11#1)
oligomerization##7##1##(1991-5#1)(1993-8#1)(1994-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
oligomers of##2##2##(1991-5#1)(2008-10#1)
oligomers##17##1##(1991-5#1)(1994-11#2)(2008-10#8)(2008-11#4)(2013-1#1)(2013-8#1)
oligonucleotide and##3##2##(1992-6#1)(2008-4#1)(2009-12#1)
oligonucleotide designed to##2##3##(2008-10#2)
oligonucleotide in##2##2##(1997-8#1)(2008-11#1)
oligonucleotide microarray##2##2##(2011-2#1)(2012-3#1)
oligonucleotide primers for##2##3##(2008-10#2)
oligonucleotide primers##11##2##(2008-10#7)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
oligonucleotide probe##7##2##(1993-3#1)(1996-2#1)(1997-8#2)(2008-10#2)(2008-9#1)
oligonucleotide probes##9##2##(1996-12#1)(1997-2#1)(2008-10#5)(2008-4#1)(2008-9#1)
oligonucleotide synthesis##3##2##(1997-7#1)(2008-4#2)
oligonucleotide to GABAA receptor gamma 2 subunit##2##7##(1995-11#1)(1995-12#1)
oligonucleotide##83##1##(1992-6#1)(1993-1#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-11#3)(1995-12#3)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#4)(2008-10#36)(2008-11#6)(2008-4#6)(2008-5#1)(2008-9#4)(2009-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
oligonucleotides and##2##2##(2008-10#1)(2008-4#1)
oligonucleotides as##2##2##(1991-5#1)(2008-11#1)
oligonucleotides derived from##2##3##(1994-11#1)(2008-10#1)
oligonucleotides designed##3##2##(1993-8#1)(1996-8#1)(2008-10#1)
oligonucleotides on crosslinked poly(vinyl alcohol)##2##5##(2008-10#2)
oligonucleotides on##3##2##(2008-10#3)
oligonucleotides or##2##2##(2008-10#1)(2011-2#1)
oligonucleotides that##2##2##(2007-12#1)(2008-10#1)
oligonucleotides was##2##2##(2008-10#1)(2008-11#1)
oligonucleotides were##3##2##(1993-8#1)(2008-10#2)
oligonucleotides with##4##2##(2008-10#2)(2008-4#2)
oligonucleotides##55##1##(1991-3#2)(1991-5#1)(1993-6#1)(1993-8#4)(1994-11#2)(1995-12#1)(1995-6#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#26)(2008-11#2)(2008-4#11)(2011-2#1)
oligopeptide substrates##5##2##(1991-9#5)
oligopeptide##10##1##(1991-9#5)(1996-6#2)(2008-8#3)
oligopeptides##3##1##(1992-12#1)(1994-11#1)(2008-10#1)
oligoribonucleotide##3##1##(2008-4#3)
oligosaccharide chains##3##2##(1993-12#1)(1994-5#1)(2008-11#1)
oligosaccharide distribution##2##2##(2008-7#2)
oligosaccharide preparation##2##2##(2008-12#2)
oligosaccharide##27##1##(1990-9#1)(1991-12#1)(1992-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-7#8)(2009-8#1)(2012-2#1)
oligosaccharides and##2##2##(1991-12#1)(2010-11#1)
oligosaccharides are##4##2##(1995-6#1)(2008-11#1)(2012-2#2)
oligosaccharides in##3##2##(1991-12#1)(1995-2#1)(2012-2#1)
oligosaccharides obtained##3##2##(1990-9#2)(1992-12#1)
oligosaccharides on##2##2##(1992-10#2)
oligosaccharides was##2##2##(2008-10#1)(2008-12#1)
oligosaccharides with##2##2##(1991-9#1)(2008-10#1)
oligosaccharides##54##1##(1990-12#1)(1990-9#3)(1991-12#4)(1991-9#1)(1992-10#7)(1992-12#2)(1993-1#1)(1993-8#1)(1994-5#4)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-11#1)(2012-2#7)
oligospora##2##1##(2008-10#2)
oligotrophic##4##1##(2008-10#4)
olivacea##3##1##(2008-8#3)
olivaceus##5##1##(2008-6#2)(2010-8#3)
olivary##5##1##(1994-2#1)(1997-3#4)
olive leaf samples##2##3##(2008-10#2)
olive oil and##2##3##(2012-2#1)(2013-1#1)
olive oil production##2##3##(2008-10#2)
olive oil was##2##3##(2008-10#2)
olive oil##22##2##(1995-11#1)(2008-10#14)(2008-5#2)(2009-3#1)(2012-2#1)(2013-1#3)
olive trees##4##2##(2008-10#4)
olive##40##1##(1990-9#1)(1994-5#1)(1995-11#1)(2008-10#29)(2008-5#2)(2009-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
olivine##3##1##(2008-10#3)
olivo-cerebellar##2##1##(1994-2#2)
olmesartan medoxomil##3##2##(2008-11#3)
oman##3##1##(2008-10#1)(2012-12#1)(2012-2#1)
omasum##2##1##(2011-2#2)
omega =##2##2##(1990-5#1)(2008-9#1)
omega##6##1##(1990-5#1)(1990-8#1)(1991-5#1)(1995-2#1)(2008-9#2)
omega(1)##2##1##(2010-7#2)
omega(2)##2##1##(2010-7#2)
omega-3 ethyl ester concentrate##6##4##(2008-3#6)
omega-3 polyunsaturated fatty acids##2##4##(2013-1#2)
omega-3 polyunsaturated##3##2##(2010-1#1)(2013-1#2)
omega-3##10##1##(2008-3#6)(2010-1#2)(2013-1#2)
omental cakes##4##2##(2012-2#4)
omental##5##1##(1990-2#1)(2012-2#4)
omentectomy##2##1##(2013-1#1)(2013-8#1)
omeprazole##7##1##(1996-11#1)(2008-11#2)(2012-2#3)(2012-3#1)
omics&quot##2##1##(2012-3#1)(2013-8#1)
omission of##5##2##(1995-11#1)(2008-1#1)(2008-11#1)(2009-11#1)(2009-8#1)
omission##8##1##(1994-12#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-8#1)(2013-8#1)
omissions of##2##2##(2013-8#2)
omissions##5##1##(2009-8#1)(2013-8#4)
omitted from the##2##3##(1993-2#1)(2008-11#1)
omitted from##3##2##(1993-2#1)(1997-7#1)(2008-11#1)
omitted##10##1##(1990-8#1)(1991-3#1)(1993-1#2)(1993-2#1)(1997-7#1)(2008-10#3)(2008-11#1)
ommata##2##1##(1993-12#2)
ommatidia##5##1##(2007-12#5)
omnivory##6##1##(2008-8#1)(2008-9#5)
omphalocele with##3##2##(1997-3#1)(2008-10#1)(2010-8#1)
omphalocele##9##1##(1990-9#1)(1997-3#3)(2008-10#3)(2010-8#2)
on &quot##28##2##(1990-12#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-5#2)(1994-2#1)(1996-9#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
on 'Harbin'##2##2##(2008-10#2)
on 'Picra'##2##2##(2008-10#2)
on 'Seri 82'##2##3##(2008-10#2)
on 'Sumner'##2##2##(2008-10#2)
on (1)##3##2##(1994-12#1)(2008-4#1)(2012-2#1)
on 1 January 1991##2##4##(1992-9#1)(1997-8#1)
on 1##15##2##(1992-9#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2012-12#1)(2012-3#3)
on 1-year-old##2##2##(2008-10#2)
on 10 plants##2##3##(2008-10#2)
on 10##13##2##(1993-1#1)(1994-3#1)(2008-10#6)(2008-12#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)
on 100##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
on 12##2##2##(2008-10#2)
on 14##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
on 14-3-3##3##2##(2008-11#2)(2010-12#1)
on 15##3##2##(2008-12#1)(2008-5#1)(2009-4#1)
on 16##4##2##(2007-8#1)(2008-11#1)(2008-5#1)(2013-1#1)
on 17##2##2##(2008-10#1)(2008-5#1)
on 19##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
on 2##10##2##(1991-6#1)(1992-12#1)(1996-11#1)(1997-2#2)(2008-10#3)(2008-11#1)(2009-5#1)
on 22##3##2##(2008-10#2)(2008-7#1)
on 24##3##2##(2008-11#1)(2008-5#1)(2010-9#1)
on 25##2##2##(2008-10#1)(2012-3#1)
on 26##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
on 28##2##2##(2009-10#1)(2011-2#1)
on 3##6##2##(1992-2#1)(1995-12#1)(1996-11#1)(2008-10#2)(2011-1#1)
on 30##5##2##(1993-3#1)(1996-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
on 34##3##2##(1991-12#1)(2008-10#1)(2008-12#1)
on 4##3##2##(2008-11#1)(2009-7#1)(2010-1#1)
on 40##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
on 42##2##2##(1990-2#1)(2008-10#1)
on 5##6##2##(1996-5#1)(2008-10#3)(2008-11#1)(2013-1#1)
on 5-HT##2##2##(1996-12#1)(2008-8#1)
on 50##2##2##(2008-10#1)(2008-5#1)
on 6##2##2##(1990-12#1)(2008-10#1)
on 7##4##2##(1992-9#1)(1993-1#1)(2008-10#1)(2008-6#1)
on 7A of##2##3##(2008-10#2)
on 80##2##2##(2008-10#1)(2009-6#1)
on 9##3##2##(2008-10#1)(2008-9#1)(2009-1#1)
on AC##2##2##(2008-10#2)
on ACL reconstructed knees##2##4##(2013-1#2)
on AChE##2##2##(2008-10#1)(2008-11#1)
on APC##2##2##(1997-2#2)
on Adult##2##2##(2008-10#2)
on Aerosols##2##2##(1995-3#1)(1996-2#1)
on Aging##3##2##(1994-2#1)(1995-3#1)(2010-5#1)
on Alfalfa##2##2##(2008-10#2)
on Alzheimer's disease##2##3##(2008-5#1)(2011-3#1)
on Alzheimer's##3##2##(1992-12#1)(2008-5#1)(2011-3#1)
on Amberlite XAD-16##2##3##(2008-10#2)
on Amberlite XAD-4 resin##2##4##(2008-10#2)
on Amberlite XAD-4##4##3##(2008-10#4)
on Amberlite##11##2##(2008-10#11)
on American##2##2##(1994-12#1)(2008-10#1)
on Apple##2##2##(2008-10#2)
on Arabidopsis##3##2##(2008-10#2)(2009-8#1)
on Asian##2##2##(2008-10#2)
on Aspergillus fumigatus immobilized Diaion HP-2MG##2##6##(2008-10#2)
on BMCTV-infected##2##2##(2008-10#2)
on BMI##2##2##(2012-2#1)(2012-3#1)
on BP##2##2##(2010-7#2)
on Blanquilla pears##2##3##(2008-10#2)
on Brassica##2##2##(2008-10#2)
on C##4##2##(2008-10#3)(2013-8#1)
on C(18) bonded##2##3##(2008-10#2)
on C(18)##5##2##(2008-10#5)
on C18##2##2##(1992-12#1)(2008-10#1)
on CABS can##2##3##(2008-10#2)
on CABS was##2##3##(2008-10#2)
on CABS were##2##3##(2008-10#2)
on CABS##8##2##(2008-10#8)
on CD-ROM##3##2##(1991-1#3)
on CHO##3##2##(2008-11#2)(2011-2#1)
on CI 13227##3##3##(2008-10#3)
on CI##5##2##(2008-10#4)(2008-8#1)
on CNS##2##2##(1990-9#1)(2008-12#1)
on CT scan##2##3##(2009-9#1)(2010-12#1)
on CT##10##2##(1997-8#3)(2009-2#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
on CVP##2##2##(2008-10#2)
on Ca2+##6##2##(1990-8#1)(1991-6#1)(1995-11#2)(1996-2#2)
on Caco-2 cells##2##3##(2008-11#1)(2011-2#1)
on Cancer##2##2##(2009-4#1)(2012-2#1)
on Chiclayo##2##2##(2013-1#2)
on Chinese##6##2##(1995-11#1)(2008-10#2)(2009-7#1)(2011-2#2)
on Chromosome##2##2##(2008-10#2)
on Clinton plan##2##3##(1994-2#2)
on Conidial Germination##2##3##(2008-10#2)
on DCT domain for biomedical##2##5##(2010-8#2)
on DCT domain##3##3##(2010-8#3)
on DCs##2##2##(2008-10#1)(2008-11#1)
on DI##2##2##(2008-10#2)
on DIV21##2##2##(2008-11#2)
on DNA extracted from##2##4##(2008-10#2)
on DNA synthesis and cell##2##5##(1993-8#1)(1995-11#1)
on DNA synthesis##3##3##(1993-8#2)(1995-11#1)
on DNA##19##2##(1993-8#2)(1994-5#1)(1995-11#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-4#1)(2008-8#1)(2008-9#2)(2010-5#1)
on DSKNPH in##3##3##(2008-10#3)
on Day 14##2##3##(2008-10#1)(2008-9#1)
on Day 21##2##3##(2008-9#2)
on Day 7##2##3##(2008-10#1)(2008-11#1)
on Day##8##2##(2008-10#2)(2008-11#2)(2008-9#4)
on Days##2##2##(2008-10#1)(2011-2#1)
on December##4##2##(2010-1#1)(2010-12#3)
on Development of Fusarium Wilt##2##5##(2008-10#2)
on Development of##3##3##(2008-10#3)
on Development##4##2##(2008-10#3)(2008-5#1)
on Dowex-50WX8##2##2##(2008-10#2)
on Earth##3##2##(2008-10#2)(2008-12#1)
on Erikson's##2##2##(2008-12#2)
on Escherichia coli##2##3##(2011-3#1)(2012-2#1)
on Eucalyptus##3##2##(2008-10#1)(2010-3#2)
on F##2##2##(2008-10#2)
on February 25##2##3##(1992-3#1)(1997-2#1)
on February##4##2##(1992-3#1)(1997-2#2)(2013-8#1)
on Fru 2##2##3##(1994-3#2)
on Fusarium head blight##3##4##(2008-10#3)
on Fusarium##5##2##(2008-10#5)
on G-actin##2##2##(1992-4#2)
on GC electrode##2##3##(2008-10#2)
on Germination##2##2##(2008-10#2)
on Google##2##2##(2010-8#1)(2013-1#1)
on Growth##2##2##(2008-10#2)
on H##3##2##(2008-10#2)(2008-11#1)
on HIV##3##2##(1995-2#1)(2008-1#1)(2013-8#1)
on HIV-1##6##2##(2011-3#6)
on HIV-1(IIIB)##2##2##(2011-3#2)
on HIV/AIDS##5##2##(1995-12#2)(1995-6#2)(2011-2#1)
on HLA##2##2##(1997-9#1)(2011-2#1)
on HPLC##3##2##(2008-10#1)(2009-8#1)(2012-3#1)
on HRCT##2##2##(2012-2#2)
on HRP##3##2##(2008-10#2)(2012-4#1)
on HaCat##2##2##(2011-3#2)
on Health##4##2##(1991-2#1)(1994-12#1)(1995-6#1)(1997-8#1)
on Heartland##2##2##(2008-10#2)
on High##2##2##(1997-2#1)(2008-7#1)
on Human##4##2##(1996-5#1)(2008-1#1)(2008-4#1)(2010-2#1)
on Hybrid##2##2##(2008-10#1)(2013-8#1)
on IFN##3##2##(1993-2#1)(2008-11#1)(2009-8#1)
on IL-6 production##2##3##(2008-10#2)
on IL-6##3##2##(2008-10#2)(2008-4#1)
on IR##2##2##(2013-1#1)(2013-8#1)
on ITS##3##2##(2008-10#3)
on IgG-Sepharose and nickel##2##4##(1996-12#2)
on Infection of##3##3##(2008-10#3)
on Infection##5##2##(2008-10#5)
on January##2##2##(1994-1#1)(2008-10#1)
on Japanese##2##2##(2010-8#1)(2013-1#1)
on Jeffrey pine in Lake Tahoe##2##6##(2008-10#2)
on Jeffrey pine##3##3##(2008-10#3)
on July##2##2##(1991-12#1)(2009-5#1)
on L##3##2##(2008-10#2)(2009-8#1)
on L-6 cells from rat skeletal muscle##2##7##(1995-8#2)
on LAT cell##3##3##(1990-6#3)
on LATVs##2##2##(2013-1#2)
on LDL##4##2##(1992-9#1)(1993-6#2)(2011-1#1)
on LG10##2##2##(2008-10#2)
on LG7##3##2##(2008-10#3)
on LGs 3##2##3##(2008-10#2)
on LPS-induced cytokine production and##2##5##(2008-10#2)
on LPS-induced cytokine production##3##4##(2008-10#3)
on Langmuir-Blodgett##2##2##(2008-10#1)(2008-11#1)
on Leaves##2##2##(2008-10#2)
on Lettuce##5##2##(2008-10#5)
on Lr26##3##2##(2008-10#3)
on Lyme disease##2##3##(1991-3#1)(2008-11#1)
on Lyme##3##2##(1991-3#1)(2008-11#2)
on M##3##2##(2008-10#2)(2011-2#1)
on MAPK##2##2##(1995-6#2)
on MIN and##2##3##(2008-10#2)
on MIN##5##2##(2008-10#5)
on MMP-1 and TIMP-1##2##4##(2008-5#2)
on MR images##4##3##(1997-8#4)
on MR imaging##3##3##(1997-8#3)
on MR mammography and the##2##5##(1997-8#2)
on MR##10##2##(1997-8#10)
on MRI##11##2##(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2012-12#2)(2012-2#4)(2013-1#1)
on MS medium containing sucrose##3##5##(2013-1#3)
on MS medium##4##3##(2008-12#1)(2013-1#3)
on MS##5##2##(2008-12#1)(2011-2#1)(2013-1#3)
on MSV-infected##2##2##(2008-10#2)
on MTSC4##2##2##(2008-8#2)
on March##3##2##(1996-3#1)(1997-2#1)(2010-6#1)
on Mars##3##2##(1995-3#1)(2008-10#1)(2008-4#1)
on Matrigel##2##2##(2008-11#1)(2012-5#1)
on May 14##2##3##(1996-5#2)
on May##9##2##(1995-6#1)(1996-5#5)(1997-2#1)(2010-10#1)(2013-8#1)
on Medicare##4##2##(1992-1#1)(1992-2#1)(1994-1#1)(1994-2#1)
on Medicare/Medicaid issues in health care##2##6##(2008-11#2)
on N##8##2##(2008-10#6)(2008-12#1)(2008-8#1)
on New##2##2##(2008-10#1)(2008-11#1)
on Norway spruce seedlings##2##4##(2008-10#2)
on Norway spruce##3##3##(2008-10#3)
on November##2##2##(2008-10#1)(2010-12#1)
on ODS##2##2##(2008-10#2)
on October##4##2##(1991-1#1)(1994-9#1)(2009-5#1)(2012-12#1)
on P##3##2##(2008-10#3)
on P1##2##2##(1996-2#1)(2013-8#1)
on PCs##2##2##(1994-2#1)(2008-9#1)
on PD##3##2##(2011-2#3)
on PDA##3##2##(2008-10#3)
on PKC##4##2##(1991-5#1)(1993-8#1)(2008-8#2)
on PMET##2##2##(2009-9#2)
on PPV-infected peach##2##3##(2008-10#2)
on Peach##2##2##(2008-10#2)
on Physical##2##2##(2010-1#1)(2011-2#1)
on Population##4##2##(1994-9#2)(2008-10#1)(2008-11#1)
on Populus##2##2##(2008-10#2)
on Pseudomonas##2##2##(2008-10#2)
on Pythium root rot##2##4##(2008-10#2)
on R##3##2##(2008-10#3)
on RAPD##6##2##(2008-10#6)
on RL##3##2##(2008-10#3)
on RNA##5##2##(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
on RTXd35##3##2##(2013-8#3)
on S##6##2##(1991-5#1)(2008-10#4)(2010-12#1)
on SAH-hydrolase activity##2##3##(1994-8#2)
on SAPC##2##2##(1997-2#2)
on SDS-PAGE##5##2##(1991-5#1)(1993-6#1)(1995-8#1)(2008-8#1)(2009-9#1)
on SDS-polyacrylamide##3##2##(1991-5#1)(1994-5#1)(2008-11#1)
on SPE##2##2##(2008-10#2)
on SSR##3##2##(2008-10#3)
on Sabouraud's##2##2##(2008-5#1)(2009-11#1)
on Saccharomyces cerevisiae immobilized sepiolite##2##5##(2008-10#2)
on Saccharomyces cerevisiae immobilized##3##4##(2008-10#3)
on Saccharomyces cerevisiae##5##3##(1996-3#1)(2008-10#3)(2011-2#1)
on Sephadex##6##2##(1990-11#1)(1990-2#1)(1995-6#1)(2008-10#3)
on September##2##2##(2010-12#1)(2011-2#1)
on Ser-139##2##2##(2008-9#2)
on Sf9##2##2##(2008-11#2)
on Spore##2##2##(2008-10#2)
on Sporulation of##3##3##(2008-10#3)
on St##3##2##(2008-10#2)(2008-11#1)
on State##2##2##(1994-2#1)(2008-1#1)
on Stellaria media##2##3##(2008-10#2)
on Stroke##3##2##(2007-9#1)(2008-8#2)
on Sw 72469-6##3##3##(2008-10#3)
on T##6##2##(1991-6#1)(1994-3#1)(1996-12#1)(1997-8#2)(2012-3#1)
on T-cell proliferation##2##3##(1990-5#1)(2008-11#1)
on T-cell##4##2##(1990-5#1)(1993-12#1)(1993-9#1)(2008-11#1)
on T1-weighted images##3##3##(1991-11#1)(2008-7#2)
on T1-weighted##6##2##(1991-11#1)(2008-7#2)(2012-2#2)(2012-3#1)
on T2- and##2##3##(2008-10#1)(2009-11#1)
on T2-WI##3##2##(1997-8#3)
on T2-weighted##3##2##(1991-11#1)(2009-11#1)(2012-3#1)
on TSPO##2##2##(2012-2#2)
on TSWV-infected plants##4##3##(2008-10#4)
on Teflon##2##2##(2008-10#1)(2008-5#1)
on The##2##2##(1996-1#1)(2008-7#1)
on Ti##3##2##(2008-3#3)
on Tobacco##3##2##(2008-10#3)
on Tomato and Potato in##2##5##(2008-10#2)
on U##2##2##(1992-1#1)(2008-11#1)
on VRCs and##2##3##(2008-11#2)
on Verticillium dahliae##2##3##(2008-10#2)
on Verticillium wilt##2##3##(2008-10#2)
on Verticillium##4##2##(2008-10#4)
on Western blots##3##3##(1995-12#2)(1995-6#1)
on Western##5##2##(1993-12#1)(1995-12#2)(1995-6#1)(2010-9#1)
on Wheat Seedlings##2##3##(2008-10#2)
on Wheat##5##2##(2008-10#5)
on Winter Wheat##2##3##(2008-10#2)
on Winter##4##2##(2008-10#4)
on X-ray##3##2##(1991-12#1)(2008-9#1)(2013-8#1)
on [Ca2+]c##2##2##(1991-12#1)(1995-8#1)
on a &quot##2##3##(1990-9#1)(1995-2#1)
on a 1##3##3##(1991-5#1)(2008-5#1)(2010-12#1)
on a Brassica##2##3##(2008-10#2)
on a C(18) column and##2##5##(2008-10#1)(2012-2#1)
on a C(18) column##5##4##(2008-10#4)(2012-2#1)
on a C(18)##8##3##(2008-10#7)(2012-2#1)
on a FR5 schedule of reinforcement##2##6##(1993-6#2)
on a FR5 schedule##3##4##(1993-6#3)
on a broad range of##2##5##(2008-10#2)
on a case##4##3##(1991-12#1)(2007-9#1)(2008-10#1)(2013-1#1)
on a case-by-case basis##2##4##(2008-10#1)(2011-1#1)
on a cell##2##3##(1995-11#1)(2008-9#1)
on a chelating resin##2##4##(2008-10#2)
on a child##2##3##(2008-9#1)(2009-12#1)
on a chip##4##3##(2008-10#4)
on a circular##2##3##(2008-3#1)(2009-7#1)
on a column of##2##4##(2008-10#1)(2008-4#1)
on a column##5##3##(2008-10#4)(2008-4#1)
on a combination of the##2##5##(2007-12#1)(2008-10#1)
on a combination of##11##4##(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-11#1)(2009-6#1)(2011-2#2)(2013-1#1)
on a common##2##3##(2008-10#1)(2013-8#1)
on a comparative##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
on a comprehensive##2##3##(1995-5#1)(2012-3#1)
on a computer##2##3##(2008-10#1)(2011-2#1)
on a consecutive series of##4##5##(1990-8#1)(1991-8#1)(2012-5#1)(2013-1#1)
on a consecutive##5##3##(1990-12#1)(1990-8#1)(1991-8#1)(2012-5#1)(2013-1#1)
on a continuous##5##3##(1990-2#1)(2008-10#4)
on a continuum of##2##4##(1992-1#1)(2008-12#1)
on a continuum##3##3##(1992-1#1)(2008-12#1)(2008-4#1)
on a conventional##2##3##(1993-9#1)(2008-10#1)
on a daily basis##2##4##(1991-12#1)(2008-7#1)
on a daily##3##3##(1991-12#1)(2008-7#1)(2011-9#1)
on a discontinuous##2##3##(1996-2#1)(2008-10#1)
on a disease##3##3##(1993-3#1)(2008-10#1)(2013-8#1)
on a dry##2##3##(2008-10#1)(2008-7#1)
on a few selected##2##4##(2010-10#1)(2011-2#1)
on a filter##2##3##(2008-10#2)
on a flow cytometer##3##4##(2006-6#1)(2008-9#2)
on a flow##6##3##(2006-6#1)(2008-10#3)(2008-9#2)
on a flow-through##2##3##(2008-10#2)
on a gas##2##3##(2008-10#2)
on a genetic algorithm##2##4##(2008-3#1)(2008-8#1)
on a genome-wide##2##3##(2011-2#1)(2012-3#1)
on a given##7##3##(1992-9#1)(1996-2#1)(2008-10#3)(2008-8#1)(2012-3#1)
on a glass##5##3##(2008-10#3)(2008-3#1)(2008-9#1)
on a glassy carbon disc electrode##2##6##(2008-10#2)
on a glassy carbon electrode (GCE)##3##6##(2008-10#3)
on a glassy carbon electrode and##2##6##(2008-10#2)
on a glassy carbon electrode surface##2##6##(2008-10#2)
on a glassy carbon electrode was##2##6##(2008-10#2)
on a glassy carbon electrode##19##5##(2008-10#19)
on a glassy carbon##22##4##(2008-10#22)
on a global scale##2##4##(2008-3#1)(2008-9#1)
on a global##5##3##(2008-3#1)(2008-6#1)(2008-9#1)(2012-12#1)(2013-1#1)
on a gold electrode##4##4##(2008-10#4)
on a gold##10##3##(2008-10#10)
on a graphical##2##3##(2008-6#1)(2011-2#1)
on a group of##2##4##(1996-9#1)(2009-3#1)
on a hanging mercury drop electrode (HMDE)##3##7##(2008-10#3)
on a hanging mercury drop electrode##7##6##(2008-10#7)
on a high##2##3##(1993-6#1)(2011-2#1)
on a highly##2##3##(2008-10#2)
on a host##2##3##(2008-10#2)
on a hot plate##2##4##(2008-10#2)
on a large scale##5##4##(1994-6#1)(2008-10#3)(2009-12#1)
on a large set of##2##5##(2008-2#1)(2009-10#1)
on a large##11##3##(1994-3#1)(1994-6#1)(2008-10#4)(2008-2#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-12#1)
on a larger##2##3##(1992-5#1)(2008-11#1)
on a likelihood##3##3##(2008-10#1)(2008-12#1)(2008-6#1)
on a lipophilic##2##3##(2008-10#2)
on a macroporous##3##3##(2008-10#3)
on a medical##2##3##(1994-3#1)(2008-3#1)
on a melamine-formaldehyde resin##2##4##(2008-10#2)
on a microcolumn packed with##3##5##(2008-10#3)
on a microcolumn##4##3##(2008-10#4)
on a mini-column packed with##2##5##(2008-10#2)
on a minicolumn##2##3##(2008-10#2)
on a minimal medium##2##4##(2008-10#2)
on a modified##2##3##(2008-10#2)
on a molecular level##2##4##(2010-9#2)
on a molecular##4##3##(2008-10#2)(2010-9#2)
on a monthly basis##2##4##(2008-12#1)(2011-2#1)
on a mouse##2##3##(2008-11#2)
on a national scale##2##4##(1997-1#1)(2008-10#1)
on a national##3##3##(1994-2#1)(1997-1#1)(2008-10#1)
on a new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##2##8##(2008-10#2)
on a new##11##3##(1991-3#1)(1995-9#1)(1996-2#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)
on a newly##2##3##(2008-10#2)
on a novel##4##3##(2008-10#3)(2008-11#1)
on a number of##8##4##(1992-12#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-12#1)(2010-1#1)(2013-1#1)
on a packed##2##3##(2008-10#2)
on a par with##3##4##(1993-1#1)(2008-11#1)(2012-2#1)
on a patient with##3##4##(1996-3#1)(2008-7#1)(2011-3#1)
on a patient##5##3##(1996-3#1)(1997-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
on a patient's##2##3##(1994-12#1)(2008-7#1)
on a per##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
on a piezoelectric transducer##2##4##(2008-10#1)(2008-3#1)
on a piezoelectric##3##3##(2008-10#2)(2008-3#1)
on a planar##3##3##(2008-10#2)(2008-3#1)
on a plane##2##3##(2008-2#1)(2008-3#1)
on a plant##2##3##(2008-10#2)
on a plasticized##2##3##(2008-10#2)
on a platinum (Pt) electrode##2##5##(2008-10#2)
on a platinum electrode##2##4##(2008-10#2)
on a platinum##5##3##(2008-10#5)
on a polycarbonate chip##2##4##(2008-10#2)
on a polydimethylsiloxane##2##3##(2008-10#2)
on a polymeric##2##3##(2008-10#2)
on a polystyrene##2##3##(2008-11#2)
on a population basis##2##4##(1995-12#1)(2008-9#1)
on a positive##2##3##(1991-4#1)(2010-10#1)
on a previous##3##3##(1990-5#1)(2008-10#1)(2010-10#1)
on a qualitative##2##3##(2008-1#1)(2013-8#1)
on a quartz##3##3##(2008-10#3)
on a random sample##2##4##(2008-7#1)(2010-6#1)
on a range of##3##4##(1995-1#1)(2008-10#1)(2008-12#1)
on a rare##3##3##(2010-6#1)(2012-3#1)(2013-1#1)
on a reference material##2##4##(2008-10#2)
on a reference##3##3##(2008-10#2)(2008-9#1)
on a regional level##3##4##(1994-2#1)(2008-10#2)
on a regional##6##3##(1993-12#1)(1994-2#1)(1995-5#1)(2008-10#3)
on a regular basis##4##4##(1997-8#1)(2008-1#1)(2008-7#1)(2008-8#1)
on a regular##7##3##(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)
on a representative##2##3##(2008-10#1)(2012-2#1)
on a retrospective##2##3##(1990-9#1)(1993-6#1)
on a reversed-phase C18##2##4##(2008-10#2)
on a reversed-phase##4##3##(2008-10#4)
on a review of##3##4##(1993-6#1)(1997-2#1)(2008-12#1)
on a review##4##3##(1993-6#1)(1995-12#1)(1997-2#1)(2008-12#1)
on a rotating##5##3##(1990-12#1)(2008-10#4)
on a sample of##7##4##(1990-8#1)(1994-6#1)(2008-10#2)(2010-11#1)(2010-5#1)(2013-1#1)
on a scale from 0 to##2##6##(1995-8#1)(2008-9#1)
on a scale of 0-10##3##5##(2008-7#1)(2013-1#2)
on a scale of##5##4##(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#2)
on a scale##8##3##(1995-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#2)
on a screen-printed##2##3##(2008-10#2)
on a selective medium##3##4##(2008-10#3)
on a series of##6##4##(1992-12#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
on a set of##6##4##(1996-3#1)(2008-10#5)
on a sheep##2##3##(2011-2#2)
on a silica##4##3##(2008-10#4)
on a silver##2##3##(2008-10#1)(2008-3#1)
on a similar##2##3##(2008-10#1)(2010-10#1)
on a simple##8##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)
on a single##17##3##(1992-1#1)(1994-9#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-3#1)(2012-3#1)
on a small##5##3##(2008-10#4)(2010-7#1)
on a solid phase##2##4##(2008-10#1)(2008-11#1)
on a solid support##4##4##(2008-10#2)(2008-4#1)(2009-12#1)
on a solid##6##3##(2008-10#3)(2008-11#1)(2008-4#1)(2009-12#1)
on a soluble##2##3##(2008-10#1)(2008-7#1)
on a specific##6##3##(1991-2#1)(1994-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-9#1)
on a standard##3##3##(2008-10#2)(2013-1#1)
on a stratified##2##3##(1995-9#1)(1997-3#1)
on a strong##2##3##(2008-10#2)
on a subsequent##2##3##(2008-10#2)
on a subset of the##2##5##(2008-10#1)(2011-2#1)
on a subset of##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
on a sufficient##2##3##(2008-10#2)
on a surface##2##3##(2008-10#1)(2008-7#1)
on a susceptible##5##3##(2008-10#5)
on a test of##2##4##(1993-3#1)(2010-7#1)
on a test##3##3##(1993-3#1)(2008-3#1)(2010-7#1)
on a treadmill##4##3##(2008-10#1)(2013-1#2)(2013-8#1)
on a tungsten wire##2##4##(2008-10#2)
on a two##2##3##(1990-3#1)(2008-10#1)
on a variety of##8##4##(1994-2#1)(1996-2#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#1)(2013-8#2)
on a very##2##3##(1990-2#1)(2008-5#1)
on a victim's##2##3##(2008-10#1)(2008-11#1)
on a visual##3##3##(1991-2#2)(2009-3#1)
on a voluntary##2##3##(1990-6#1)(1994-3#1)
on a water##2##3##(2008-10#1)(2008-9#1)
on a wide range of##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
on a wide##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
on a worldwide##3##3##(2008-10#3)
on a##1073##2##(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#5)(1990-9#2)(1991-1#1)(1991-12#5)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#5)(1993-12#3)(1993-2#1)(1993-3#9)(1993-6#7)(1993-9#3)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#5)(1994-6#6)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#7)(1995-2#7)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#5)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#8)(1997-3#7)(1997-5#3)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#481)(2008-11#49)(2008-12#18)(2008-2#9)(2008-3#53)(2008-4#16)(2008-5#10)(2008-6#11)(2008-7#25)(2008-8#20)(2008-9#23)(2009-10#3)(2009-11#3)(2009-12#5)(2009-3#5)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#6)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#2)(2011-2#29)(2011-3#4)(2011-9#1)(2012-12#3)(2012-2#8)(2012-3#10)(2012-4#1)(2012-5#1)(2013-1#22)(2013-8#12)
on abdominal##5##2##(1995-3#1)(2007-12#2)(2008-12#1)(2008-8#1)
on abortion##6##2##(1990-3#1)(1996-5#1)(2008-11#3)(2010-12#1)
on about##2##2##(1990-12#1)(2008-8#1)
on absorbance##2##2##(2008-10#2)
on absorption##4##2##(2008-10#3)(2008-3#1)
on academic##4##2##(1996-3#1)(1997-1#1)(2009-4#1)(2009-7#1)
on access to##5##3##(1992-2#1)(1994-1#1)(1995-12#2)(1996-3#1)
on access##7##2##(1992-2#1)(1994-1#2)(1995-12#2)(1996-3#1)(1997-2#1)
on account of##5##3##(1990-12#2)(1991-9#1)(1992-5#1)(2011-2#1)
on accumulation of##2##3##(1997-1#1)(2008-12#1)
on accumulation##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
on accuracy##3##2##(2008-10#3)
on acid and pepsin secretion##2##5##(1997-1#2)
on acid##6##2##(1997-1#3)(2008-10#3)
on acid-base##2##2##(2008-10#2)
on acidic##2##2##(2008-10#1)(2012-6#1)
on acidified##2##2##(2008-10#2)
on acquisition##3##2##(1993-3#1)(2012-2#2)
on actin##2##2##(1992-4#1)(1994-5#1)
on activated carbon (AC) as##2##5##(2008-10#2)
on activated carbon and##2##4##(2008-10#2)
on activated carbon##16##3##(2008-10#16)
on activated##18##2##(2008-10#17)(2008-5#1)
on activation##2##2##(1997-2#1)(2010-3#1)
on active range of##2##4##(2008-12#2)
on active##5##2##(2008-12#2)(2008-3#1)(2008-8#1)(2010-7#1)
on activities of daily##2##4##(2011-2#1)(2012-2#1)
on activity and##2##3##(2008-8#1)(2010-12#1)
on activity of##2##3##(1992-11#1)(2008-10#1)
on activity##8##2##(1990-6#1)(1992-11#1)(2008-10#1)(2008-8#4)(2010-12#1)
on actual##4##2##(2008-11#1)(2008-3#2)(2011-3#1)
on acute##7##2##(1996-3#1)(2006-6#1)(2010-10#1)(2010-12#1)(2010-7#2)(2013-1#1)
on adaptive##3##2##(2008-9#2)(2010-2#1)
on added##2##2##(1991-6#1)(2008-3#1)
on adequate##2##2##(1990-6#1)(2010-6#1)
on adjacent##4##2##(1997-7#1)(2008-10#2)(2011-3#1)
on admission and##2##3##(1992-1#1)(2008-7#1)
on admission to##2##3##(1994-2#1)(2008-3#1)
on admission##13##2##(1992-1#1)(1992-12#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#4)(2011-2#2)
on adolescent##3##2##(2010-1#1)(2010-7#1)(2013-1#1)
on adsorption##2##2##(2008-10#2)
on adult fecundity##2##3##(2008-11#2)
on adult##8##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-8#1)(2012-2#1)(2012-3#1)
on adult-born##3##2##(2012-2#3)
on adults##4##2##(2008-9#1)(2012-2#1)(2013-1#2)
on adverse##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
on aerosol##2##2##(1997-1#1)(2008-11#1)
on affect regulation##2##3##(2013-1#2)
on agar media##2##3##(2008-10#2)
on agar##8##2##(1993-8#1)(2008-10#6)(2012-2#1)
on agarose##2##2##(1991-5#1)(2008-10#1)
on age and##2##3##(2008-11#1)(2008-5#1)
on age at##2##3##(2008-8#2)
on age##8##2##(1992-2#1)(1994-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2011-3#1)
on ageing##2##2##(2008-10#1)(2010-10#1)
on agency##2##2##(1995-3#1)(1997-3#1)
on aging processes##2##3##(2008-10#1)(2013-7#1)
on aging##4##2##(2008-10#1)(2009-5#1)(2013-1#1)(2013-7#1)
on air##2##2##(1995-3#1)(2008-10#1)
on alcohol##2##2##(2008-11#1)(2010-1#1)
on alfalfa and##2##3##(2008-10#2)
on alfalfa##3##2##(2008-10#3)
on alkane##2##2##(1991-9#2)
on all of these##2##4##(2008-11#1)(2009-11#1)
on all of##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
on all the##3##3##(1992-2#1)(1993-12#1)(2008-9#1)
on all##44##2##(1992-2#1)(1993-12#1)(1995-12#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#1)(2013-8#2)
on alpha##3##2##(1995-11#1)(2008-10#1)(2008-8#1)
on alterations in##2##3##(2008-5#2)
on alumina##4##2##(2008-10#4)
on amino acid sequence##2##4##(1991-5#1)(2008-10#1)
on aminopropyl-glass##2##2##(2008-10#2)
on ammonium##3##2##(2008-10#3)
on amperometric##2##2##(2008-10#2)
on amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
on amplified fragment length polymorphism##4##5##(2008-10#4)
on an active##2##3##(2008-11#2)
on an anion##2##3##(2008-10#2)
on an anion-exchange column##4##4##(2008-10#4)
on an anion-exchange resin loaded with 1##2##7##(2008-10#2)
on an anion-exchange resin##6##4##(2008-10#6)
on an anion-exchange##10##3##(2008-10#10)
on an appropriate##2##3##(2008-10#1)(2008-9#1)
on an average##6##3##(2008-8#4)(2010-6#1)(2012-2#1)
on an efficient##2##3##(2008-2#1)(2008-3#1)
on an electrode##2##3##(2008-10#2)
on an enzyme##2##3##(1994-8#1)(1995-3#1)
on an evaluation of##4##4##(1993-12#1)(1994-1#1)(2008-10#1)(2008-12#1)
on an evaluation##5##3##(1993-12#1)(1994-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
on an evolutionarily##2##3##(1997-1#1)(2010-1#1)
on an in vitro##2##4##(2008-10#1)(2008-5#1)
on an individual##4##3##(1995-2#1)(2008-10#2)(2013-8#1)
on an industrial scale##2##4##(2008-5#1)(2008-7#1)
on an inpatient##2##3##(1994-9#1)(1995-2#1)
on an integrated##2##3##(2008-10#2)
on an intermediate##2##3##(1990-5#1)(2008-10#1)
on an ion##2##3##(2008-10#2)
on an optical##3##3##(2007-12#1)(2008-10#2)
on an out-patient##2##3##(2008-5#1)(2008-9#1)
on an outpatient basis and##2##5##(1993-6#1)(1994-2#1)
on an outpatient basis##5##4##(1993-6#1)(1994-2#1)(1996-3#1)(2008-11#1)(2013-1#1)
on an outpatient##6##3##(1993-2#1)(1993-6#1)(1994-2#1)(1996-3#1)(2008-11#1)(2013-1#1)
on an##199##2##(1990-3#2)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-2#4)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#4)(1994-3#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#75)(2008-11#10)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#3)(2009-1#1)(2009-11#1)(2009-3#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
on analysis of##6##3##(2008-10#6)
on analysis##8##2##(2008-10#6)(2008-11#1)(2009-10#1)
on analytes##2##2##(2008-10#2)
on analytical##4##2##(2008-10#4)
on analyzing the##2##3##(2011-2#2)
on analyzing##3##2##(2008-8#1)(2011-2#2)
on anatomical##3##2##(2008-11#1)(2009-12#1)(2011-2#1)
on and off##2##3##(2008-2#1)(2008-8#1)
on and##13##2##(1992-6#1)(1993-3#1)(1994-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2013-1#1)
on angiogenesis##2##2##(2008-11#1)(2013-1#1)
on animal##6##2##(1992-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#1)
on animals##4##2##(1994-6#2)(2010-4#1)(2011-2#1)
on annual##2##2##(1997-1#1)(2008-10#1)
on another##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
on antibiotic##2##2##(1996-11#1)(2010-8#1)
on antibody production##3##3##(1993-12#1)(2008-11#2)
on antibody##4##2##(1993-12#1)(2008-11#3)
on antigen##2##2##(1993-3#1)(2008-11#1)
on antiretroviral therapy##3##3##(2009-7#1)(2009-8#1)(2011-2#1)
on antiretroviral##4##2##(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)
on anxiety##4##2##(1991-2#1)(2008-12#1)(2009-12#1)(2012-2#1)
on any of the##6##4##(1991-3#1)(1993-1#1)(1993-3#1)(2008-10#1)(2008-12#1)(2012-2#1)
on any of##8##3##(1991-3#1)(1993-1#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
on any##17##2##(1991-3#1)(1993-1#1)(1993-3#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-2#1)(2013-1#1)
on apoptosis induction##2##3##(2008-8#1)(2009-3#1)
on apoptosis of pancreatic##2##4##(2010-12#1)(2012-3#1)
on apoptosis##7##2##(2008-10#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-12#1)(2012-3#1)
on apoptotic##3##2##(2008-11#2)(2008-8#1)
on apple##9##2##(2008-10#9)
on apples##6##2##(2008-10#6)
on applying##3##2##(2008-10#1)(2008-5#1)(2010-11#1)
on appressorium formation of##2##4##(2008-10#2)
on approaches that##2##3##(2008-9#1)(2010-7#1)
on appropriate##5##2##(1991-3#1)(1995-5#1)(2008-5#1)(2008-7#1)(2013-1#1)
on apricot and##2##3##(2008-10#2)
on aqueous##2##2##(2008-10#2)
on arachidonic acid metabolism##2##4##(1994-8#2)
on arachidonic acid##3##3##(1994-8#2)(2008-11#1)
on armaments##2##2##(1990-2#2)
on arrays##4##2##(2008-10#2)(2008-3#1)(2009-12#1)
on arterial##4##2##(2011-2#2)(2012-12#1)(2013-8#1)
on artificial##2##2##(2007-8#1)(2008-5#1)
on ascospore release##3##3##(2008-10#3)
on ascospore##5##2##(2008-10#5)
on aspects of##5##3##(1993-1#1)(1995-1#1)(1996-1#1)(2009-6#1)(2011-2#1)
on assessment##3##2##(1994-2#1)(2013-1#2)
on assessments##2##2##(2008-10#1)(2012-3#1)
on assisting##2##2##(2010-9#1)(2012-2#1)
on asthma##6##2##(2008-10#2)(2010-9#1)(2012-12#2)(2013-1#1)
on asymptomatic##2##2##(2008-10#1)(2009-5#1)
on at least##4##3##(1993-1#1)(1994-12#1)(2008-10#1)(2011-2#1)
on atmospheric##3##2##(2008-11#2)(2011-2#1)
on attachment##3##2##(2007-12#1)(2008-10#2)
on attitudes##2##2##(2008-11#1)(2010-10#1)
on auditory##2##2##(2008-9#1)(2010-12#1)
on automated coagulation analysers##2##4##(2008-10#2)
on automated##4##2##(2008-10#2)(2008-9#1)(2010-2#1)
on available##5##2##(1996-12#1)(2008-11#1)(2009-8#1)(2011-2#1)(2011-3#1)
on average 0##2##3##(2008-7#1)(2012-2#1)
on average in##2##3##(1996-2#1)(2008-10#1)
on average##55##2##(1991-2#1)(1991-7#1)(1992-12#1)(1992-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-11#2)(1996-2#1)(1996-3#3)(1997-2#1)(1997-4#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#6)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
on average)##6##2##(1995-11#1)(1997-2#3)(2011-2#2)
on axial##2##2##(1991-11#1)(2012-2#1)
on axillary skin##2##3##(2008-5#2)
on axillary##4##2##(2008-5#3)(2009-8#1)
on bacterial##8##2##(1993-8#1)(2008-10#2)(2008-5#1)(2008-8#2)(2010-1#1)(2013-1#1)
on baculovirus##2##2##(2013-8#2)
on baker's yeast##3##3##(2010-7#3)
on banana##3##2##(2008-10#3)
on band##3##2##(1997-8#1)(2008-10#1)(2008-3#1)
on bare##4##2##(2008-10#3)(2008-7#1)
on barley and##2##3##(2008-10#2)
on barley##8##2##(2008-10#8)
on basal##5##2##(1992-7#1)(1994-3#1)(1995-12#1)(2008-11#1)(2012-3#1)
on basic##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-5#1)
on basidiomycete sources of##2##4##(2013-1#2)
on basis of##2##3##(1996-2#1)(2008-10#1)
on beam##2##2##(2008-3#2)
on bean leaf##2##3##(2008-10#2)
on bean##9##2##(2008-10#7)(2008-8#2)
on beans##2##2##(2008-10#2)
on behalf of the##3##4##(1991-2#1)(1995-6#1)(2013-8#1)
on behalf of##8##3##(1991-2#1)(1992-1#1)(1995-6#3)(2010-10#1)(2013-7#1)(2013-8#1)
on behavior of##2##3##(2008-10#1)(2011-2#1)
on behavior##5##2##(2008-10#2)(2009-6#1)(2011-2#1)(2012-2#1)
on behavioral##2##2##(2008-11#2)
on behaviour##2##2##(2008-12#1)(2010-2#1)
on beta-glucans##2##2##(1991-5#2)
on bile##2##2##(1993-3#1)(2012-2#1)
on binding of##4##3##(1993-6#1)(1997-4#1)(2008-10#1)(2009-7#1)
on binding##5##2##(1993-6#1)(1997-1#1)(1997-4#1)(2008-10#1)(2009-7#1)
on biochemical##3##2##(1994-12#1)(2009-8#1)(2012-3#1)
on biocontrol##2##2##(2008-10#2)
on biologic##2##2##(2013-1#1)(2013-7#1)
on biological agents##3##3##(1992-12#3)
on biological control of##5##4##(2008-10#5)
on biological mechanisms##2##3##(2009-5#1)(2013-1#1)
on biological##15##2##(1992-12#3)(2008-10#5)(2008-11#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
on biomedical##2##2##(2009-11#1)(2012-12#1)
on biopsy##2##2##(2007-8#1)(2010-12#1)
on birth##3##2##(1991-6#1)(1997-6#1)(2012-12#1)
on black##5##2##(1996-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
on bladder##2##2##(1992-3#1)(2008-10#1)
on blood flow##2##3##(2008-12#2)
on blood pressure and##4##4##(1991-6#1)(1997-8#1)(2008-7#1)(2012-12#1)
on blood pressure##12##3##(1991-6#2)(1993-2#1)(1997-8#1)(2008-10#1)(2008-7#2)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#1)
on blood##26##2##(1991-6#2)(1992-9#1)(1993-2#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#2)(2009-1#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
on blossoms##5##2##(2008-10#5)
on board##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
on body balance##3##3##(2008-12#2)(2010-9#1)
on body mass index (BMI)##2##5##(2012-2#1)(2013-1#1)
on body mass##3##3##(2008-8#1)(2012-2#1)(2013-1#1)
on body weight##3##3##(2008-5#1)(2012-2#2)
on body##13##2##(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2010-10#1)(2010-9#1)(2012-2#3)(2013-1#2)
on bone mineral density (BMD)##2##5##(2011-2#2)
on bone mineral density##4##4##(2008-11#1)(2011-2#3)
on bone tunnel surface##2##4##(2013-1#2)
on bone##16##2##(1991-11#2)(1993-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#3)(2013-1#2)
on both a##2##3##(1995-3#1)(2008-7#1)
on both columns##2##3##(2008-10#2)
on both crops##3##3##(2008-10#3)
on both cultivars##4##3##(2008-10#4)
on both general##2##3##(1991-2#1)(2012-2#1)
on both host##2##3##(2008-10#1)(2008-8#1)
on both hosts##3##3##(2008-10#3)
on both sides of the##5##5##(1990-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
on both sides##9##3##(1990-2#1)(2008-10#5)(2008-7#1)(2009-1#1)(2011-2#1)
on both surfaces##2##3##(2007-12#1)(2010-10#1)
on both the relative##2##4##(1995-5#1)(2008-8#1)
on both the##21##3##(1990-8#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)
on both##129##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1993-8#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#56)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
on bovine adrenal##2##3##(1994-5#1)(1994-8#1)
on bovine##5##2##(1994-5#1)(1994-8#1)(1995-11#1)(1997-8#1)(2008-10#1)
on brain##12##2##(1994-2#1)(1994-8#2)(1995-11#1)(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
on breast cancer##3##3##(1990-6#1)(2008-5#1)(2013-1#1)
on breast##5##2##(1990-6#2)(2008-11#1)(2008-5#1)(2013-1#1)
on breastfeeding##2##2##(2008-11#1)(2012-2#1)
on breath hydrogen excretion##2##4##(1996-6#2)
on breeding##2##2##(2008-8#1)(2008-9#1)
on broader##2##2##(1993-6#1)(1997-2#1)
on bud break were##2##4##(2012-4#2)
on bud break##3##3##(2012-4#3)
on building materials##2##3##(2008-10#2)
on building##3##2##(2008-10#3)
on bulk metals##2##3##(2008-7#2)
on bulk##4##2##(2007-12#1)(2008-7#2)(2013-8#1)
on by the##2##3##(1991-3#1)(1996-8#1)
on by##5##2##(1990-11#1)(1991-3#1)(1996-3#1)(1996-8#1)(2010-5#1)
on cadaver##2##2##(2007-11#1)(2008-3#1)
on cadmium##4##2##(1993-12#3)(2008-10#1)
on calcareous##2##2##(2012-6#1)(2012-9#1)
on calculated##2##2##(2008-10#1)(2008-9#1)
on calibration##4##2##(2008-10#2)(2008-12#1)(2010-11#1)
on call in##2##3##(2008-8#2)
on cancer cells##3##3##(2008-11#1)(2009-12#1)(2013-8#1)
on cancer research##2##3##(1990-2#1)(2009-4#1)
on cancer##10##2##(1990-2#1)(1992-9#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-1#1)(2011-2#1)(2013-8#1)
on canine rabies##2##3##(2011-2#2)
on cannabis##2##2##(2008-1#1)(2008-12#1)
on cantaloupe##2##2##(2008-10#2)
on capacity##2##2##(2008-10#1)(2008-12#1)
on capsules extended##3##3##(1997-3#3)
on capsules##4##2##(1997-3#4)
on carbachol-stimulated##2##2##(1997-1#2)
on carbon nanotubes##2##3##(2008-7#1)(2011-2#1)
on carbon paste##2##3##(2008-10#2)
on carbon##11##2##(2008-10#9)(2008-7#1)(2011-2#1)
on cardiac##10##2##(1991-6#1)(1992-3#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
on cardiocytes impaired by##2##4##(2011-3#2)
on cardiovascular morbidity and mortality##2##5##(2008-7#2)
on cardiovascular system##2##3##(2013-1#2)
on cardiovascular##10##2##(2008-7#2)(2010-1#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
on care##2##2##(1992-1#1)(2010-9#1)
on caring##2##2##(1992-3#1)(2012-3#1)
on carnation##4##2##(2008-10#4)
on carrot##3##2##(2008-10#3)
on case##3##2##(1997-2#1)(1997-3#2)
on cassava##2##2##(2008-10#2)
on catheter##2##2##(2010-9#1)(2011-2#1)
on cauliflower##5##2##(2008-10#5)
on cell culture##2##3##(2008-11#2)
on cell cycle progression##3##4##(1994-11#1)(1996-3#1)(2008-9#1)
on cell cycle##5##3##(1994-11#1)(1996-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
on cell growth and##5##4##(1996-2#1)(2008-11#2)(2011-2#2)
on cell growth of##2##4##(2008-11#2)
on cell growth##15##3##(1994-11#1)(1995-2#1)(1996-2#1)(2008-11#10)(2011-2#2)
on cell proliferation were studied in human breast cancer cells##2##10##(2008-11#2)
on cell proliferation were##4##4##(2008-11#4)
on cell proliferation##8##3##(1990-11#1)(1995-11#1)(1995-2#1)(2008-11#5)
on cell surface##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
on cell surfaces##2##3##(1995-5#1)(2008-8#1)
on cell survival##2##3##(1994-2#1)(2008-11#1)
on cell viability and##2##4##(2008-5#1)(2008-7#1)
on cell viability##3##3##(2008-5#1)(2008-7#1)(2009-6#1)
on cell##57##2##(1990-11#1)(1992-12#1)(1994-11#2)(1994-2#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#27)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#3)(2013-7#1)
on cells##7##2##(1990-8#1)(1992-12#1)(1992-9#1)(1995-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
on cellular radiation##2##3##(2008-9#2)
on cellular##21##2##(1991-12#1)(1992-5#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#2)(2011-2#3)(2013-7#2)
on cellulose via##2##3##(2008-10#2)
on cellulose##7##2##(1991-12#1)(2008-10#5)(2008-5#1)
on central##2##2##(2011-2#1)(2011-3#1)
on cerebellar##2##2##(1995-5#1)(2012-2#1)
on cerebral##4##2##(1990-5#1)(1991-1#1)(1994-2#1)(2008-7#1)
on certain##5##2##(1994-8#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
on cervical##3##2##(1992-10#1)(2008-12#1)(2012-12#1)
on changes in the##2##4##(1996-12#1)(1997-6#1)
on changes in##3##3##(1994-11#1)(1996-12#1)(1997-6#1)
on changes##4##2##(1994-11#1)(1996-12#1)(1997-6#1)(2008-10#1)
on characteristics of##2##3##(2009-12#1)(2009-7#1)
on characteristics##3##2##(2008-11#1)(2009-12#1)(2009-7#1)
on chemical constituents of##4##4##(2012-3#2)(2013-8#2)
on chemical##9##2##(1994-5#1)(2008-10#3)(2012-3#3)(2013-8#2)
on chemically modified##7##3##(2008-10#7)
on chemically##8##2##(1995-9#1)(2008-10#7)
on chemiluminescence##3##2##(2008-10#3)
on chemotherapy##2##2##(2010-11#1)(2012-3#1)
on chest X-ray##3##3##(1991-12#3)
on chest##4##2##(1991-12#3)(2013-7#1)
on chicken##3##2##(2008-12#1)(2008-8#1)(2011-1#1)
on child health##2##3##(1995-1#1)(2008-11#1)
on child##5##2##(1995-1#1)(2008-11#2)(2009-9#1)(2012-2#1)
on childhood##4##2##(1995-12#1)(2008-11#1)(2010-6#2)
on children and##4##3##(2008-11#3)(2012-3#1)
on children##8##2##(1995-3#1)(1995-5#1)(2007-11#1)(2008-11#3)(2009-12#1)(2012-3#1)
on children's##6##2##(2008-11#2)(2008-12#1)(2009-10#1)(2009-4#1)(2010-1#1)
on chip##3##2##(2008-7#1)(2009-10#1)(2010-11#1)
on chiral##2##2##(2008-10#2)
on chitosan##4##2##(2008-10#4)
on choice of##2##3##(1995-1#1)(2008-10#1)
on chromatin##2##2##(1990-2#1)(2009-12#1)
on chromosome 1##6##3##(1995-8#3)(2008-10#2)(2009-10#1)
on chromosome 11##5##3##(2008-10#2)(2008-8#3)
on chromosome 11q13##2##3##(1997-8#2)
on chromosome 12##4##3##(1996-12#1)(2008-10#3)
on chromosome 1AS##2##3##(2008-10#2)
on chromosome 1H##2##3##(2008-10#2)
on chromosome 2##3##3##(1993-2#1)(2008-10#1)(2008-9#1)
on chromosome 2(2H)##2##3##(2008-10#2)
on chromosome 3##5##3##(2008-10#1)(2008-8#2)(2008-9#1)(2012-3#1)
on chromosome 4##5##3##(1997-2#1)(2008-10#1)(2008-9#2)(2009-10#1)
on chromosome 5 explained##2##4##(2008-10#2)
on chromosome 5##6##3##(1993-2#1)(1997-6#1)(1997-8#1)(2008-10#3)
on chromosome 5(1H)##2##3##(2008-10#2)
on chromosome 5BL##2##3##(2008-10#2)
on chromosome 7(5H) at a distance of##2##7##(2008-10#2)
on chromosome 7(5H)##3##3##(2008-10#3)
on chromosome 7A##2##3##(2008-10#2)
on chromosome 8##4##3##(1993-2#1)(2008-8#1)(2008-9#2)
on chromosome II and##2##4##(1993-12#1)(1996-6#1)
on chromosome IV##4##3##(1996-6#2)(1997-8#1)(2012-3#1)
on chromosome IX##2##3##(1996-3#2)
on chromosome arm##3##3##(2008-10#1)(2012-3#2)
on chromosome##110##2##(1991-10#1)(1993-11#2)(1993-12#2)(1993-2#3)(1994-9#2)(1995-8#5)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#4)(1997-2#3)(1997-6#4)(1997-7#1)(1997-8#4)(2008-10#41)(2008-11#1)(2008-7#2)(2008-8#6)(2008-9#8)(2009-10#3)(2011-2#3)(2012-3#9)
on chromosomes 1##6##3##(1996-12#1)(2008-10#2)(2008-8#2)(2008-9#1)
on chromosomes 10 and 12##2##5##(1996-12#2)
on chromosomes 10 and##3##4##(1996-12#3)
on chromosomes 10##4##3##(1996-12#3)(2008-10#1)
on chromosomes 1AS##2##3##(2008-10#2)
on chromosomes 2##2##3##(2008-10#2)
on chromosomes 3##3##3##(2008-10#2)(2008-8#1)
on chromosomes##20##2##(1996-12#4)(2008-10#12)(2008-8#3)(2008-9#1)
on chronic##6##2##(1991-8#1)(1994-1#1)(1997-1#1)(2008-1#1)(2009-8#1)(2013-1#1)
on citrus##7##2##(2008-10#7)
on clinical and##2##3##(2010-10#1)(2010-5#1)
on clinical grounds##2##3##(2008-7#1)(2008-8#1)
on clinical outcomes##2##3##(1994-1#1)(2011-2#1)
on clinical practice##4##3##(2008-11#4)
on clinical##37##2##(1991-3#2)(1992-12#1)(1993-3#1)(1994-1#2)(1995-5#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#5)
on cloning efficiency##2##3##(2008-9#2)
on cloudy days##2##3##(2008-10#2)
on coagulation time##2##3##(2008-9#2)
on coagulation##3##2##(2008-10#1)(2008-9#2)
on coarse spatial scales##2##4##(2008-8#2)
on coarse##3##2##(2008-8#3)
on cocaine##2##2##(1991-1#2)
on coffee leaves##2##3##(2008-10#2)
on cognition##2##2##(2009-8#1)(2011-2#1)
on cognitive##6##2##(2008-11#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-1#1)
on cold##2##2##(2008-10#2)
on collagen gel was##2##4##(1994-8#2)
on collagen gel##4##3##(1994-8#4)
on collagen##13##2##(1994-8#7)(2008-11#3)(2008-5#3)
on collagen-coated##2##2##(2008-11#2)
on collecting information on##2##4##(1996-2#1)(2008-10#1)
on colour##2##2##(1990-12#1)(2008-5#1)
on combination##2##2##(2011-2#1)(2013-1#1)
on combustion products##2##3##(1996-12#2)
on combustion##3##2##(1996-12#2)(2008-11#1)
on commercial##4##2##(2008-10#4)
on common bean##4##3##(2008-10#4)
on common##7##2##(2008-10#6)(2008-11#1)
on community##5##2##(1995-3#1)(1996-1#1)(2008-10#1)(2010-10#1)(2013-1#1)
on comorbid##2##2##(2012-2#2)
on competition for##2##3##(2008-8#1)(2008-9#1)
on competition##4##2##(1991-1#1)(2008-8#1)(2008-9#2)
on competitive##2##2##(1995-9#1)(2008-10#1)
on complementary##3##2##(2008-10#2)(2012-3#1)
on complete##2##2##(2008-10#1)(2011-2#1)
on completion of##2##3##(2009-12#1)(2012-3#1)
on complex##2##2##(2008-7#1)(2009-12#1)
on complexation of##2##3##(2008-10#2)
on complexation##5##2##(2008-10#5)
on components##2##2##(2008-10#1)(2008-12#1)
on computed tomography (CT)##4##4##(2009-3#1)(2011-2#1)(2012-2#2)
on computed tomography##5##3##(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
on computer##2##2##(1992-12#1)(2012-3#1)
on concave##2##2##(2007-8#2)
on conditional##3##2##(1995-9#1)(2008-5#1)(2012-2#1)
on conformation and##2##3##(2008-8#2)
on conformational##2##2##(2008-10#1)(2013-8#1)
on conidia germination##2##3##(2008-10#2)
on conidia##3##2##(2008-10#3)
on conidial germination and appressorium formation##2##6##(2008-10#2)
on conidial##4##2##(2008-10#4)
on constitutive##2##2##(2006-6#2)
on construction of##2##3##(2008-10#1)(2008-11#1)
on consumer##2##2##(1997-3#1)(2013-8#1)
on contemporary##2##2##(2008-12#1)(2009-8#1)
on continuous##11##2##(1997-8#1)(2008-10#8)(2008-11#1)(2009-12#1)
on control##3##2##(1993-8#1)(2008-10#2)
on controlled pore glass##7##4##(2008-10#7)
on controlled##9##2##(2008-10#9)
on controlled-pore##2##2##(2008-10#2)
on conventional##2##2##(2008-10#1)(2009-10#1)
on corn and##2##3##(2008-10#2)
on corn meal agar##2##4##(2008-10#1)(2008-5#1)
on corn##8##2##(2008-10#7)(2008-5#1)
on cornmeal agar##2##3##(2008-10#2)
on coronary artery bypass graft##2##5##(1992-11#1)(2008-12#1)
on coronary artery##3##3##(1992-11#1)(2008-12#1)(2010-2#1)
on correct##4##2##(2007-12#1)(2008-10#2)(2010-12#1)
on cortical##5##2##(1997-2#1)(2008-11#2)(2009-7#1)(2010-9#1)
on cost##3##2##(1996-3#1)(2009-8#1)(2011-2#1)
on costs of##2##3##(1991-1#1)(2008-10#1)
on costs##3##2##(1991-1#2)(2008-10#1)
on coulometric titration##2##3##(2008-10#2)
on creating##2##2##(1995-1#1)(2008-12#1)
on criteria##3##2##(1990-3#1)(1997-5#1)(2011-2#1)
on critical##5##2##(1993-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
on crosslinked##3##2##(2008-10#3)
on cucumber##9##2##(2008-10#7)(2008-12#1)(2013-8#1)
on cultivars##2##2##(2008-10#2)
on cultivated##3##2##(2008-10#2)(2012-3#1)
on cultural##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
on culture media##2##3##(2008-10#2)
on cultured##4##2##(1995-12#1)(1997-1#1)(2008-5#1)(2012-2#1)
on current data##2##3##(2009-8#1)(2013-8#1)
on current##14##2##(1992-6#1)(1995-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
on currently available##2##3##(2008-10#1)(2008-11#1)
on cv##8##2##(2008-10#8)
on cvs##2##2##(2008-10#2)
on cyclic AMP##3##3##(1995-11#1)(1995-12#1)(1997-4#1)
on cyclic##6##2##(1995-11#2)(1995-12#1)(1997-4#1)(2008-10#1)(2010-4#1)
on cytokine and##2##3##(2008-10#1)(2008-11#1)
on cytokine secretion##2##3##(2008-10#1)(2008-11#1)
on cytokine##5##2##(2008-10#3)(2008-11#2)
on cytological##3##2##(1993-11#1)(1997-2#1)(2008-10#1)
on cytosolic phospholipase A2 activation in rabbit platelets##2##8##(1995-11#2)
on cytosolic##3##2##(1990-5#1)(1995-11#2)
on d##2##2##(2008-8#2)
on daily##3##2##(1997-1#1)(2012-2#1)(2013-8#1)
on damping-off##2##2##(2008-10#2)
on data collected##4##3##(1994-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
on data from a sample of##2##6##(1997-4#1)(2008-12#1)
on data from the##4##4##(1990-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
on data from##13##3##(1990-11#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
on data obtained from##2##4##(2008-10#1)(2008-11#1)
on data obtained##3##3##(2008-10#1)(2008-11#2)
on data##32##2##(1990-11#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
on day 0##2##3##(2008-10#2)
on day 1##8##3##(1991-8#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
on day 14##2##3##(2006-6#1)(2008-8#1)
on day 2##3##3##(1994-8#1)(2008-3#1)(2010-7#1)
on day 20 of##2##4##(1993-12#1)(2011-1#1)
on day 20##4##3##(1993-12#1)(1995-12#2)(2011-1#1)
on day 3##8##3##(1994-2#3)(1994-8#1)(2008-11#1)(2008-9#2)(2010-10#1)
on day 4 of##2##4##(2008-10#1)(2008-9#1)
on day 4##6##3##(1994-5#2)(1995-11#1)(1996-2#1)(2008-10#1)(2008-9#1)
on day 5##3##3##(1994-2#2)(2013-1#1)
on day 6##2##3##(2010-7#1)(2012-12#1)
on day 7##4##3##(1994-5#1)(1995-12#1)(2008-11#1)(2008-9#1)
on day 8##3##3##(1993-12#1)(2008-12#1)(2008-8#1)
on day of##2##3##(2008-3#1)(2012-2#1)
on day##65##2##(1990-2#1)(1990-5#2)(1991-8#1)(1993-12#3)(1994-2#6)(1994-5#3)(1994-8#2)(1995-11#1)(1995-12#7)(1996-2#1)(1997-3#1)(2006-6#3)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-8#3)(2008-9#6)(2009-6#1)(2010-10#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
on days 0##3##3##(1995-12#2)(2008-10#1)
on days 1##3##3##(2008-10#2)(2009-12#1)
on days 20##2##3##(1993-12#2)
on days 4##2##3##(1994-5#1)(2010-7#1)
on days 5##2##3##(1993-12#2)
on days 7##2##3##(2006-6#1)(2011-2#1)
on days##24##2##(1990-11#1)(1993-12#6)(1994-5#1)(1995-12#3)(2006-6#1)(2008-10#8)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)
on dead##2##2##(2008-10#2)
on decaying cephalopod beaks##2##4##(2011-2#2)
on decentralization##3##2##(1992-5#1)(2008-1#1)(2012-3#1)
on decreasing##2##2##(2008-11#1)(2012-2#1)
on defined##2##2##(1995-11#1)(2008-11#1)
on delayed##2##2##(1993-3#1)(2008-5#1)
on demand for##3##3##(2008-10#1)(2008-12#2)
on demand##5##2##(1991-12#1)(2008-10#1)(2008-12#2)(2008-7#1)
on demographic##2##2##(2008-8#1)(2009-10#1)
on dendritic##2##2##(2008-10#1)(2008-11#1)
on dental##2##2##(1991-2#1)(2013-1#1)
on depression##6##2##(1995-1#1)(1995-2#1)(1995-3#1)(2008-4#1)(2010-2#2)
on derivatization##3##2##(2008-10#3)
on design of##2##3##(2008-11#2)
on detached leaflets##2##3##(2008-10#2)
on detached##4##2##(2008-10#4)
on detailed##2##2##(1997-3#1)(2008-11#1)
on detection##3##2##(2008-10#2)(2010-7#1)
on determination of##5##3##(2008-10#5)
on developing##4##2##(2007-12#1)(2008-11#1)(2010-4#1)(2011-2#1)
on development of##10##3##(1995-5#1)(2008-10#4)(2008-11#1)(2010-7#2)(2011-2#2)
on development##12##2##(1995-5#1)(2008-10#4)(2008-11#1)(2010-7#2)(2011-2#3)(2012-2#1)
on diabetes control in type 2 diabetic patients##2##8##(2011-2#2)
on diabetes control##3##3##(2011-2#3)
on diabetes##9##2##(1994-12#1)(2008-1#3)(2008-3#1)(2011-2#3)(2012-5#1)
on diagnosis and##4##3##(1995-1#2)(2008-12#1)(2013-1#1)
on diagnosis##6##2##(1995-1#2)(2008-12#1)(2009-5#1)(2010-6#1)(2013-1#1)
on diagnostic##6##2##(1997-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
on dialysis##8##2##(1996-2#1)(2008-1#4)(2008-10#1)(2011-2#2)
on diet##2##2##(1990-8#1)(2008-9#1)
on dietary protein and weight reduction##2##6##(2008-3#2)
on dietary##6##2##(1991-12#1)(2008-3#2)(2010-6#1)(2012-2#1)(2013-1#1)
on differences in the##2##4##(2008-10#1)(2008-12#1)
on differences in##4##3##(1993-2#1)(2008-10#1)(2008-12#1)(2008-3#1)
on differences##5##2##(1993-2#1)(2008-10#2)(2008-12#1)(2008-3#1)
on different days of the estrous cycle##2##7##(1993-11#2)
on different days##4##3##(1990-12#1)(1993-11#2)(2008-1#1)
on different host##3##3##(2008-10#2)(2008-9#1)
on different##49##2##(1990-12#1)(1990-5#1)(1993-11#2)(1993-6#1)(1994-6#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
on differential hosts##2##3##(2008-10#2)
on differential##8##2##(1991-6#1)(1993-11#1)(2008-10#4)(2008-12#1)(2011-2#1)
on diffusion##3##2##(1997-6#1)(2008-10#1)(2012-12#1)
on direct determination##3##3##(2008-10#3)
on direct observation of##2##4##(1990-8#1)(2008-8#1)
on direct##9##2##(1990-8#1)(1994-1#2)(2008-10#5)(2008-8#1)
on direction##2##2##(2008-8#1)(2013-1#1)
on disability pensions##2##3##(1993-6#2)
on disability##3##2##(1993-6#2)(2008-7#1)
on discharge##2##2##(1991-3#1)(1995-3#1)
on discrete##2##2##(1996-12#1)(2008-9#1)
on disease control in##2##4##(2008-10#1)(2008-7#1)
on disease development##3##3##(2008-10#3)
on disease incidence##5##3##(2008-10#5)
on disease progression in##2##4##(2008-10#2)
on disease progression##4##3##(2008-10#4)
on disease severity in the##2##5##(2008-10#2)
on disease severity##5##3##(2008-10#5)
on disease suppressiveness of soils##2##5##(2008-10#2)
on disease##37##2##(1990-11#1)(1993-12#1)(2008-10#29)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
on diseased##2##2##(2008-10#2)
on diseases##3##2##(1995-9#1)(2008-10#1)(2010-8#1)
on distal##3##2##(1994-8#1)(2008-10#1)(2008-2#1)
on distinct##5##2##(2008-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
on distribution##4##2##(1994-5#1)(2008-10#3)
on divalent##2##2##(1991-5#1)(1993-8#1)
on dopamine biosynthesis##2##3##(2008-11#2)
on dopamine##8##2##(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#3)(2009-7#1)
on dormancy progression in apricot##2##5##(2012-8#2)
on drought##2##2##(2012-8#1)(2012-9#1)
on drug concentration##2##3##(1996-3#2)
on drug##8##2##(1996-3#3)(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
on dry##2##2##(2008-10#2)
on dual##3##2##(2008-10#2)(2011-3#1)
on dye##2##2##(2008-3#1)(2008-9#1)
on dynamic##3##2##(2009-10#1)(2010-10#1)(2011-3#1)
on each explant##3##3##(2008-12#3)
on each host##2##3##(2008-10#1)(2008-9#1)
on each individual##3##3##(1990-5#1)(1994-9#1)(2013-8#1)
on each of the##3##4##(1991-2#1)(1992-2#1)(2011-1#1)
on each of##4##3##(1991-2#1)(1992-2#1)(1995-9#1)(2011-1#1)
on each trial##2##3##(2008-5#2)
on each##42##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-5#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-8#1)(2013-1#3)(2013-8#1)
on early diagnosis##2##3##(1991-2#1)(2009-1#1)
on early##11##2##(1991-2#1)(1991-3#1)(1994-1#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-1#1)(2012-2#2)
on ecological and##2##3##(1997-7#1)(2010-12#1)
on ecological communities##2##3##(2008-9#1)(2013-1#1)
on ecological##5##2##(1997-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
on edible##3##2##(2008-12#2)(2010-7#1)
on educational##2##2##(1992-1#1)(2008-11#1)
on effect of##2##3##(1994-6#1)(2008-10#1)
on effective##3##2##(1995-2#1)(2006-6#1)(2011-2#1)
on effects##2##2##(2011-2#1)(2013-8#1)
on efficacy of##2##3##(1995-10#1)(2013-1#1)
on efficacy##3##2##(1995-10#1)(2008-5#1)(2013-1#1)
on efficient##2##2##(1992-12#1)(1994-2#1)
on egg size##2##3##(1991-5#1)(2008-8#1)
on egg##3##2##(1991-5#1)(2008-8#1)(2010-8#1)
on eicosanoid##2##2##(1991-5#2)
on eight different##2##3##(2008-10#1)(2012-2#1)
on eight##5##2##(2008-10#4)(2012-2#1)
on either side of the##3##5##(1996-1#1)(2008-10#1)(2008-9#1)
on either side of##4##4##(1991-5#1)(1996-1#1)(2008-10#1)(2008-9#1)
on either##17##2##(1990-12#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-3#1)(2012-9#1)
on elastic##2##2##(2008-3#1)(2010-8#1)
on electric hot plate##2##4##(2008-10#2)
on electrical##3##2##(2008-10#1)(2009-3#1)(2013-8#1)
on electrochemical##5##2##(2008-10#5)
on electrode##3##2##(2008-10#3)
on electrodeposited##2##2##(2008-10#2)
on electrodes##3##2##(2008-10#3)
on electrostatic interaction##3##3##(2008-10#3)
on electrostatic interactions##2##3##(2008-10#2)
on electrostatic##6##2##(2008-10#6)
on embryonic day 15##2##4##(1993-3#1)(1996-12#1)
on embryonic##3##2##(1993-3#1)(1994-3#1)(1996-12#1)
on emergency##2##2##(2009-4#1)(2012-3#1)
on empirical##6##2##(1992-1#1)(1992-12#1)(1993-12#1)(2010-12#1)(2010-9#1)(2013-1#1)
on endogenous##3##2##(1996-2#1)(2012-3#1)(2013-7#1)
on endothelial##2##2##(2010-6#1)(2011-2#1)
on energetic##2##2##(2008-3#1)(2008-9#1)
on enhancement of##2##3##(2008-11#1)(2012-2#1)
on environmental and##3##3##(1990-9#1)(2008-10#1)(2008-8#1)
on environmental conditions##2##3##(2008-10#2)
on environmental surfaces##2##3##(2007-12#2)
on environmental##8##2##(1990-9#1)(2007-12#2)(2008-10#3)(2008-4#1)(2008-8#1)
on enzymatic##2##2##(2008-10#1)(2010-12#1)
on enzyme##6##2##(1991-3#1)(2008-10#4)(2008-5#1)
on epidemics of potato late blight in##2##7##(2008-10#2)
on epidemics of##3##3##(2008-10#3)
on epidemiological##2##2##(1997-8#1)(2013-1#1)
on episodic memory functioning in##2##5##(2008-7#2)
on epithelial cells##2##3##(1997-1#1)(2008-12#1)
on equilibrium##2##2##(1995-8#1)(2008-10#1)
on established##2##2##(2008-9#1)(2009-6#1)
on estimates of##2##3##(1992-9#1)(1994-11#1)
on estimating##2##2##(1996-6#1)(2008-8#1)
on estradiol##2##2##(2008-11#1)(2008-12#1)
on estrogen##2##2##(1995-12#1)(2008-10#1)
on estrus##2##2##(1993-11#1)(2008-8#1)
on ethanol##2##2##(2008-10#1)(2009-12#1)
on ethanol-induced motor incoordination##2##4##(1997-2#2)
on ethylene##2##2##(2008-10#1)(2008-3#1)
on every dimension##2##3##(2008-10#1)(2010-7#1)
on every##4##2##(1994-1#1)(2008-10#1)(2008-11#1)(2010-7#1)
on evidence##6##2##(1993-12#1)(2008-11#1)(2008-12#1)(2010-12#2)(2010-5#1)
on evolutionary##2##2##(2010-4#1)(2010-7#1)
on examination##2##2##(1993-12#1)(2008-10#1)
on excised##6##2##(2008-10#2)(2008-12#2)(2008-5#2)
on exercise##3##2##(2008-12#1)(2009-10#1)(2011-3#1)
on existing##4##2##(1990-2#1)(1992-12#1)(1996-12#1)(2011-9#1)
on experience##4##2##(1993-3#1)(2008-10#1)(2011-3#2)
on experiences##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
on experimental models##2##3##(1994-12#1)(2008-11#1)
on experimental##8##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#1)
on experimentally##3##2##(2008-10#2)(2008-12#1)
on exposure time##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
on exposure to##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
on exposure##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
on expression and##3##3##(1990-2#1)(2012-2#2)
on expression of##7##3##(1995-6#1)(1995-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
on expression##10##2##(1990-2#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
on external##6##2##(1995-11#1)(2007-12#1)(2008-10#3)(2013-1#1)
on extinction##3##2##(2008-8#2)(2008-9#1)
on extracellular##2##2##(1990-5#1)(2008-6#1)
on extraction efficiency##3##3##(2008-10#3)
on extraction time##2##3##(2008-10#2)
on extraction##12##2##(2008-10#11)(2012-3#1)
on face##2##2##(2013-1#2)
on factors that##4##3##(2006-6#2)(2008-10#1)(2008-9#1)
on factors##6##2##(2006-6#2)(2008-10#3)(2008-9#1)
on families##2##2##(2008-10#1)(2009-9#1)
on farms##2##2##(1991-8#1)(2012-3#1)
on fasting##2##2##(2010-10#2)
on feedback##2##2##(2008-12#1)(2008-6#1)
on female##7##2##(2008-8#2)(2008-9#1)(2009-5#1)(2012-12#1)(2012-3#2)
on females##2##2##(2008-12#1)(2008-8#1)
on femurs of##2##3##(2013-1#2)
on fertility##4##2##(1990-2#1)(1991-8#1)(1997-6#1)(2011-2#1)
on ferulic acid##2##3##(2008-10#1)(2013-8#1)
on fetal##4##2##(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
on fibroblast proliferation##2##3##(2010-3#2)
on fibroblast##6##2##(1995-3#1)(2008-7#1)(2010-3#3)(2013-1#1)
on fibronectin##8##2##(2008-11#6)(2011-2#1)(2012-2#1)
on field##5##2##(2008-10#3)(2008-9#1)(2013-1#1)
on field-grown##2##2##(2008-10#2)
on filter paper##6##3##(2008-10#5)(2012-2#1)
on filter##8##2##(2008-10#7)(2012-2#1)
on filters##5##2##(2008-10#3)(2008-9#2)
on final##2##2##(2008-5#1)(2008-8#1)
on financial##2##2##(1992-12#1)(1996-2#1)
on first##4##2##(1994-11#1)(2008-10#2)(2011-10#1)
on fish##4##2##(2010-5#2)(2010-8#1)(2011-2#1)
on fishes##3##2##(2010-8#3)
on fitness##4##2##(2008-10#1)(2012-3#3)
on fitting##2##2##(2008-10#1)(2009-7#1)
on five different##2##3##(2008-10#2)
on five##15##2##(1990-9#1)(1997-1#1)(1997-5#1)(2008-10#7)(2009-8#1)(2010-10#1)(2010-9#1)(2013-1#1)(2013-8#1)
on fixed##4##2##(1990-5#1)(2008-11#1)(2010-8#1)(2013-8#1)
on flax roots##2##3##(2008-10#2)
on flax##3##2##(2008-10#3)
on flocculation##2##2##(2008-7#2)
on flow injection##3##3##(2008-10#3)
on flow rate##2##3##(1996-2#1)(2008-10#1)
on flow##7##2##(1996-2#1)(2008-10#5)(2008-9#1)
on flower petals##3##3##(2008-10#3)
on flower##4##2##(2008-10#4)
on flowers##2##2##(2008-10#2)
on fluorescence##9##2##(2008-10#9)
on fluorescent##2##2##(2008-10#1)(2013-1#1)
on focal##2##2##(2008-7#1)(2011-2#1)
on foliage until##2##3##(2008-10#2)
on foliage##10##2##(2008-10#10)
on foliar##2##2##(2008-10#1)(2011-10#1)
on follow-up MR##3##3##(1996-6#3)
on follow-up##8##2##(1996-6#3)(2008-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
on food##4##2##(1996-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
on foot##3##2##(2010-3#1)(2013-1#2)
on for##5##2##(1991-8#1)(1992-1#1)(1992-12#2)(2007-8#1)
on formation of##6##3##(1993-8#1)(1994-3#1)(2008-10#3)(2009-8#1)
on formation##7##2##(1993-8#1)(1994-3#1)(2008-10#3)(2008-7#1)(2009-8#1)
on four different##2##3##(2008-10#2)
on four##7##2##(1993-2#1)(1993-3#1)(2008-1#1)(2008-10#3)(2012-7#1)
on fracture##4##2##(2008-11#1)(2011-2#1)(2013-1#2)
on friction##2##2##(1990-6#1)(2010-10#1)
on from the##2##3##(2008-11#2)
on fruit of##2##3##(2008-10#2)
on fruit##9##2##(2008-10#9)
on fruits and##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
on fruits##5##2##(2007-12#1)(2008-10#3)(2008-9#1)
on fully##2##2##(2008-10#2)
on functional##5##2##(1991-2#1)(1993-1#1)(2008-10#1)(2009-9#1)(2010-4#1)
on functionalized##3##2##(2008-10#3)
on fungal growth##3##3##(2008-10#3)
on fungal##6##2##(2008-10#5)(2008-7#1)
on fungicide-amended medium##2##3##(2008-10#2)
on fungicide-amended##3##2##(2008-10#3)
on further##4##2##(1991-3#1)(1992-12#1)(1994-11#1)(2008-3#1)
on fusarium head blight and##2##5##(2008-10#2)
on future##3##2##(1991-6#1)(1992-1#1)(2008-11#1)
on g-KGM##2##2##(2011-2#2)
on gait##3##2##(2013-1#3)
on garlic and chives##2##4##(2008-10#2)
on garlic and##3##3##(2008-10#3)
on gas##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
on gastric adenocarcinoma##2##3##(2008-12#1)(2008-9#1)
on gastric##6##2##(1992-6#1)(1996-12#1)(1997-1#1)(1997-4#1)(2008-12#1)(2008-9#1)
on gastrointestinal##2##2##(1996-12#1)(2012-3#1)
on gel##3##2##(1993-8#1)(2008-10#1)(2008-8#1)
on gender and##2##3##(2011-1#1)(2012-2#1)
on gender##4##2##(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
on gene expression##7##3##(1996-12#2)(2008-10#3)(2011-1#1)(2013-1#1)
on gene##14##2##(1993-6#2)(1996-12#2)(2008-10#3)(2008-8#2)(2010-10#1)(2011-1#1)(2012-3#2)(2013-1#1)
on general##5##2##(1990-3#1)(1993-12#1)(1996-6#1)(2008-10#2)
on generation of##2##3##(1993-6#1)(2008-10#1)
on genes##2##2##(2010-12#1)(2011-2#1)
on genetic and##2##3##(2008-9#1)(2013-1#1)
on genetic distances##2##3##(2008-10#1)(2013-1#1)
on genetic##13##2##(1997-6#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
on genome##3##2##(1997-7#1)(2011-2#1)(2012-3#1)
on genomic##7##2##(1993-12#1)(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-7#1)
on genotypes##2##2##(2008-10#1)(2010-4#1)
on geranium seedlings##3##3##(2008-10#3)
on geranium##6##2##(2008-10#5)(2008-5#1)
on germination and seedling growth of Vigna radiata##2##8##(2008-12#2)
on germination and seedling growth of##3##6##(2008-12#3)
on germination and##4##3##(2008-12#3)(2011-2#1)
on germination of##2##3##(2008-10#1)(2011-2#1)
on germination##7##2##(2008-10#2)(2008-12#3)(2011-2#2)
on giant unilamellar vesicles##2##4##(2012-2#2)
on ginseng##3##2##(2008-10#3)
on glass fiber filters##2##4##(2008-10#2)
on glass surfaces##2##3##(2008-10#2)
on glass##11##2##(2008-10#11)
on glassy carbon (GC) electrode##2##5##(2008-10#2)
on glassy carbon (GC) electrodes##2##5##(2008-10#2)
on glassy carbon (GC)##4##4##(2008-10#4)
on glassy carbon and##2##4##(2008-10#2)
on glassy carbon electrode (GCE)##2##5##(2008-10#2)
on glassy carbon electrode##6##4##(2008-10#6)
on glassy carbon electrodes##3##4##(2008-10#2)(2013-1#1)
on glassy carbon##17##3##(2008-10#16)(2013-1#1)
on global##2##2##(2008-8#1)(2012-2#1)
on glucocorticoid##2##2##(1995-12#1)(2008-8#1)
on glucose and##2##3##(1994-12#1)(1994-8#1)
on glucose##10##2##(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(2008-10#3)(2008-3#1)(2008-7#2)
on gold nanoparticles##2##3##(2008-10#1)(2008-11#1)
on gold surfaces##2##3##(2008-10#2)
on gold##9##2##(2008-10#8)(2008-11#1)
on golf courses in##2##4##(2008-10#2)
on grape berries##2##3##(2008-10#2)
on grape##5##2##(2008-10#5)
on grapefruit##3##2##(2008-10#3)
on grapevine leaf##2##3##(2008-10#2)
on grapevine##4##2##(2008-10#4)
on green##2##2##(2008-10#1)(2011-2#1)
on grooming##2##2##(1994-8#1)(1996-2#1)
on gross##3##2##(2008-5#2)(2010-6#1)
on ground##2##2##(1997-7#1)(2008-8#1)
on group##2##2##(2008-8#2)
on growth and##3##3##(1993-12#1)(2011-2#2)
on growth hormone##2##3##(2007-11#1)(2010-5#1)
on growth of##9##3##(1990-11#1)(1993-12#1)(1995-2#1)(2008-10#3)(2008-12#1)(2010-8#1)(2011-2#1)
on growth rate##4##3##(2007-11#3)(2008-11#1)
on growth##28##2##(1990-11#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(2007-11#5)(2008-10#3)(2008-11#4)(2008-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)
on hair##6##2##(2008-5#6)
on hand##2##2##(2007-12#1)(2013-1#1)
on head##2##2##(2008-11#1)(2013-1#1)
on health care reform and##2##5##(1993-12#1)(1994-12#1)
on health care reform##5##4##(1993-12#2)(1994-12#2)(1995-2#1)
on health care##15##3##(1990-11#1)(1991-12#1)(1992-2#1)(1993-12#2)(1994-12#3)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#1)
on health economics##2##3##(1997-8#1)(2008-6#1)
on health promotion##3##3##(2008-1#1)(2008-12#2)
on health##40##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-12#4)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#2)(2013-1#1)
on health-related quality of life##2##5##(2008-7#1)(2009-5#1)
on health-related##4##2##(2008-7#1)(2009-5#1)(2011-2#2)
on healthcare##3##2##(1992-12#1)(1993-12#1)(1997-3#1)
on healthy plants##2##3##(2008-10#2)
on healthy##9##2##(2008-10#7)(2008-5#1)(2010-12#1)
on heart rate and##2##4##(2010-5#1)(2013-1#1)
on heart rate variability##2##4##(2008-12#1)(2010-12#1)
on heart rate##6##3##(2008-12#1)(2010-12#1)(2010-5#3)(2013-1#1)
on heart##9##2##(1997-1#1)(2008-12#1)(2010-12#1)(2010-5#3)(2013-1#3)
on heating##2##2##(1991-5#1)(2008-3#1)
on hematopoietic##2##2##(2008-11#2)
on hemodynamic##3##2##(1996-2#1)(2012-3#1)(2013-8#1)
on hepatic##9##2##(1992-10#1)(1993-8#1)(1994-11#2)(1994-8#1)(1997-4#1)(2013-1#3)
on hepatoma##2##2##(2008-11#2)
on her face##3##3##(2012-3#1)(2013-1#2)
on her##5##2##(1995-12#1)(1996-11#1)(2012-3#1)(2013-1#2)
on herbivore##3##2##(2008-8#3)
on herbivores##2##2##(2008-9#2)
on high resolution##2##3##(2008-10#1)(2012-2#1)
on high##6##2##(1991-1#1)(1995-11#1)(2008-10#3)(2012-2#1)
on high-performance liquid chromatography##2##4##(2008-10#2)
on high-resolution##5##2##(1991-12#1)(2008-3#1)(2011-2#1)(2012-2#2)
on higher##3##2##(1992-1#1)(1992-2#1)(2013-8#1)
on highly##5##2##(2008-10#2)(2008-3#2)(2010-11#1)
on his behavioral state##2##4##(2009-8#2)
on his or her##2##4##(2008-11#1)(2010-2#1)
on his right##4##3##(1991-6#1)(2011-2#1)(2012-3#2)
on his##19##2##(1991-6#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-3#2)
on histologic examination##2##3##(1991-6#1)(2010-6#1)
on histologic##3##2##(1991-6#1)(1997-8#1)(2010-6#1)
on histological##5##2##(2007-12#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-8#1)
on histology##5##2##(1990-6#1)(1997-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
on histopathological##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
on historical##2##2##(2008-10#1)(2010-6#1)
on holding##2##2##(1995-3#1)(2009-5#1)
on home##3##2##(1991-12#1)(1994-2#1)(1995-3#1)
on homeownership##2##2##(2011-2#2)
on hospital admission##2##3##(1994-12#1)(2007-8#1)
on hospital profitability##2##3##(2008-11#2)
on hospital##14##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1994-12#1)(1995-3#1)(2007-8#1)(2008-11#5)
on hospitals##3##2##(1993-1#1)(2008-11#2)
on host growth and yield##2##5##(2008-10#2)
on host##16##2##(1997-7#1)(2008-10#8)(2008-8#4)(2008-9#2)(2013-1#1)
on host-diversity effects##2##3##(2008-10#2)
on how and##2##3##(1994-12#1)(2008-9#1)
on how nonprofit##2##3##(1991-12#1)(2008-11#1)
on how the##5##3##(1995-6#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-11#1)
on how these##2##3##(1993-3#1)(2013-8#1)
on how they##2##3##(1991-3#1)(2008-11#1)
on how to avoid##2##4##(1995-2#1)(2013-1#1)
on how to deal with##2##5##(2008-11#1)(2012-3#1)
on how to use##3##4##(1990-2#2)(1996-6#1)
on how to##25##3##(1990-2#2)(1995-2#1)(1996-1#1)(1996-6#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
on how we##2##3##(1997-3#1)(2008-12#1)
on how##76##2##(1990-2#2)(1991-12#2)(1991-3#1)(1993-3#2)(1994-12#1)(1995-2#2)(1995-6#2)(1996-1#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-11#9)(2008-12#4)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-2#3)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#4)
on human arterial##2##3##(1995-8#1)(2010-7#1)
on human breast cancer##2##4##(1994-12#1)(1997-7#1)
on human chromosome##8##3##(1990-5#1)(1995-8#2)(1996-8#1)(1997-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
on human health##7##3##(2008-10#5)(2010-4#1)(2011-2#1)
on human intestinal cell line Caco-2##2##6##(2008-11#2)
on human melanocytes##3##3##(1995-2#3)
on human periodontal ligament##2##4##(2013-1#2)
on human peripheral##2##3##(1990-8#1)(2008-11#1)
on human skin##7##3##(1995-3#1)(2008-5#6)
on human subjects##2##3##(1995-2#1)(2008-5#1)
on human##70##2##(1990-5#1)(1990-8#1)(1992-6#2)(1993-1#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-2#4)(1995-3#1)(1995-8#4)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#9)(2008-4#1)(2008-5#10)(2008-7#2)(2008-8#4)(2008-9#3)(2010-4#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
on humans##4##2##(1992-12#1)(1996-12#1)(2010-4#1)(2012-12#1)
on hybrid##3##2##(1996-12#1)(2008-10#1)(2012-3#1)
on hybridization##2##2##(2008-10#2)
on hybridoma cells##2##3##(2008-11#2)
on hybridoma##5##2##(2008-11#5)
on hydrogen peroxide##3##3##(2008-10#3)
on hydrothermal##2##2##(2008-10#2)
on hydroxychloroquine##2##2##(2013-1#2)
on hydroxyl-terminated SAMs##2##3##(2008-10#2)
on hydroxyl-terminated##3##2##(2008-10#3)
on hyphal##3##2##(2008-10#3)
on hypoxia##2##2##(2008-10#1)(2010-11#1)
on identifying##2##2##(1995-3#1)(2013-8#1)
on imaging##3##2##(2008-2#1)(2009-9#1)(2013-1#1)
on immature fruit##2##3##(2008-10#2)
on immature##4##2##(2008-10#4)
on immobilized##7##2##(2008-10#6)(2011-2#1)
on immune function is##2##4##(2008-9#2)
on immune function##4##3##(1995-8#1)(2008-9#2)(2010-12#1)
on immune response in##2##4##(2008-7#1)(2008-8#1)
on immune response##3##3##(1992-9#1)(2008-7#1)(2008-8#1)
on immune##12##2##(1992-9#2)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)
on immunity##2##2##(2008-7#1)(2008-8#1)
on immunization##4##2##(1995-5#1)(1996-12#1)(2008-11#2)
on immunoblots##4##2##(1990-5#1)(1991-9#1)(1995-6#2)
on important##2##2##(2008-11#1)(2009-3#1)
on improving the##3##3##(1993-3#1)(1996-2#1)(2010-7#1)
on improving##11##2##(1991-1#1)(1991-6#1)(1993-3#1)(1996-2#1)(1996-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2013-8#1)
on in the##4##3##(1994-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
on in vitro translocation of a model protein into Vibrio alginolyticus inside-out membrane vesicles##2##14##(1997-8#2)
on in vitro##10##3##(1995-8#1)(1996-2#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)
on in##19##2##(1994-1#1)(1995-8#1)(1996-2#1)(1997-8#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
on incidence and##2##3##(2008-10#2)
on incidence at##2##3##(2008-10#2)
on incidence##8##2##(1994-9#1)(2008-10#6)(2009-12#1)
on inclusion##3##2##(2008-10#2)(2012-12#1)
on increasing##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
on incubation period##2##3##(2008-10#2)
on incubation##4##2##(1990-11#1)(1992-12#1)(2008-10#2)
on independent component analysis##3##4##(2008-10#2)(2009-11#1)
on independent##6##2##(2008-10#2)(2008-8#2)(2009-11#1)(2010-8#1)
on indicators of##2##3##(2008-11#1)(2012-12#1)
on indices of##2##3##(1992-3#1)(2008-4#1)
on indium tin oxide##2##4##(2008-10#1)(2008-12#1)
on individual ADL items##2##4##(2011-2#2)
on individual##16##2##(1991-12#1)(1991-2#1)(1993-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)
on individuals##3##2##(1997-8#1)(2008-11#1)(2009-10#1)
on induced##2##2##(2008-11#1)(2008-7#1)
on induction of##2##3##(1993-12#1)(2008-10#1)
on infant##3##2##(1990-12#1)(1995-2#1)(2010-6#1)
on infected plants##4##3##(2008-10#4)
on infected source plants##2##4##(2008-10#2)
on infected##15##2##(2008-10#15)
on infection efficiency##3##3##(2008-10#3)
on infection of##3##3##(2008-10#3)
on infection##15##2##(1995-6#1)(2008-10#11)(2010-10#2)(2011-2#1)
on infested potato seed tubers##2##5##(2008-10#2)
on infested##3##2##(2008-10#3)
on information##10##2##(1990-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-8#1)(2011-2#1)
on infrared##2##2##(2008-10#1)(2013-1#1)
on inhaled##2##2##(1991-12#1)(2008-11#1)
on inhibitory##3##2##(1996-12#1)(2008-5#1)(2012-2#1)
on initial##4##2##(1995-11#1)(2008-10#1)(2008-11#2)
on initiation of##2##3##(2008-10#2)
on inoculated plants##2##3##(2008-10#2)
on inoculated seedlings##2##3##(2008-10#2)
on inoculated trees and##2##4##(2008-10#2)
on inoculated##10##2##(2008-10#10)
on inpatient##2##2##(1992-1#1)(2009-6#1)
on insect abundances##4##3##(2008-8#4)
on insect diversity##2##3##(2008-8#2)
on insect##9##2##(2008-8#8)(2012-2#1)
on insertion##2##2##(1991-10#1)(2008-10#1)
on insulin binding##3##3##(1995-11#1)(1997-1#2)
on insulin secretion##2##3##(1994-8#1)(1995-8#1)
on insulin##6##2##(1994-8#1)(1995-11#1)(1995-8#1)(1997-1#2)(2010-12#1)
on intact##3##2##(2008-10#1)(2008-5#2)
on integrated##4##2##(1996-1#1)(2007-12#1)(2008-10#2)
on integration##2##2##(2008-10#1)(2009-6#1)
on interaction##2##2##(2008-10#2)
on interactions##3##2##(2006-6#2)(2010-11#1)
on interdisciplinary##2##2##(2010-1#1)(2012-3#1)
on internal carotid##2##3##(2011-3#1)(2012-3#1)
on internal##4##2##(1997-3#1)(2008-11#1)(2011-3#1)(2012-3#1)
on international##4##2##(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
on interviews with##3##3##(1995-12#1)(2010-10#1)(2013-1#1)
on intestinal##2##2##(1990-3#1)(1992-6#1)
on intracellular##5##2##(1995-11#2)(1996-2#1)(2008-7#1)(2010-8#1)
on intracranial pressure (ICP)##2##4##(1993-1#1)(2008-7#1)
on intracranial pressure##3##3##(1993-1#2)(2008-7#1)
on intraoperative##2##2##(2008-7#1)(2010-7#1)
on invasion##3##2##(2008-11#3)
on invasive##2##2##(1990-12#1)(1997-3#1)
on investigating##2##2##(1994-9#1)(2008-10#1)
on ion exchange columns by##2##5##(2008-10#2)
on ion exchange##3##3##(2008-10#3)
on ion transport##2##3##(2008-12#1)(2010-7#1)
on ion##12##2##(1990-5#1)(2008-10#8)(2008-12#1)(2010-7#2)
on ionic strength##5##3##(2008-10#5)
on irradiation with##2##3##(2008-3#1)(2008-5#1)
on irradiation##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
on isolated##2##2##(2008-12#1)(2008-9#1)
on issues of##2##3##(1992-2#1)(1997-1#1)
on issues##8##2##(1991-2#1)(1992-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(2008-12#1)(2009-11#1)(2012-2#1)
on it##7##2##(1993-6#1)(1993-8#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#1)
on items##2##2##(2008-11#1)(2012-2#1)
on its biological##2##3##(2008-10#1)(2008-8#1)
on its own##9##3##(1990-12#1)(1990-5#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)
on its role in##2##4##(2011-1#1)(2011-2#1)
on its surface##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2009-7#1)
on its##117##2##(1990-12#1)(1990-5#2)(1991-11#1)(1991-2#2)(1991-3#1)(1993-12#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#57)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-8#7)(2008-9#4)(2009-10#3)(2009-7#1)(2010-1#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#2)
on juvenile growth and##2##4##(2008-11#2)
on juvenile survival and growth##2##5##(2008-11#2)
on juvenile##5##2##(2008-11#4)(2013-1#1)
on key##4##2##(1994-3#1)(2008-1#1)(2010-10#1)(2012-12#1)
on kidneys of streptozotocin-induced diabetic##2##5##(2011-3#2)
on kinetic##2##2##(1995-12#1)(2008-10#1)
on knowledge##8##2##(1990-6#1)(1990-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#2)
on labor##2##2##(2011-2#1)(2013-1#1)
on laboratory##6##2##(1995-1#1)(2008-10#3)(2008-9#1)(2011-3#1)
on language##2##2##(2012-2#1)(2013-8#1)
on large spatial scales##2##4##(2008-9#1)(2013-1#1)
on large##10##2##(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2011-3#1)(2013-1#1)
on larvae of##2##3##(2008-5#1)(2013-8#1)
on laser##5##2##(2008-10#2)(2008-3#2)(2009-5#1)
on late blight##2##3##(2008-10#2)
on late##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
on lateral##3##2##(1993-6#1)(2008-8#1)(2012-12#1)
on leaf disks##2##3##(2008-10#2)
on leaf surfaces##2##3##(2008-10#2)
on leaf##13##2##(2008-10#11)(2012-5#2)
on learning abilities##2##3##(1994-8#2)
on learning and memory##3##4##(1993-3#1)(2008-5#1)(2013-8#1)
on learning resources##2##3##(2008-11#2)
on learning##9##2##(1993-3#1)(1994-8#2)(1996-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2013-8#1)
on leaves and stems##3##4##(2008-10#3)
on leaves and##11##3##(2008-10#11)
on leaves of cvs##2##4##(2008-10#2)
on leaves of##5##3##(2008-10#5)
on leaves##36##2##(2008-10#35)(2010-3#1)
on left##2##2##(2008-7#1)(2012-2#1)
on legal##3##2##(1991-1#1)(1991-9#1)(2012-12#1)
on length of stay##4##4##(1993-12#1)(1993-2#2)(2012-2#1)
on lesbian##2##2##(2008-12#2)
on lesion##8##2##(1994-2#1)(1995-12#1)(2008-10#5)(2012-3#1)
on lettuce##10##2##(2008-10#10)
on leukocytes##3##2##(2006-6#2)(2008-5#1)
on levels of##3##3##(1994-2#1)(1994-3#1)(2008-8#1)
on liability issues##2##3##(1991-1#1)(2008-6#1)
on liability##3##2##(1991-1#1)(1996-5#1)(2008-6#1)
on lichen##2##2##(2008-10#2)
on life##7##2##(1990-3#1)(1995-1#3)(2008-7#1)(2010-1#1)(2010-5#1)
on life-history traits##2##3##(2008-8#1)(2008-9#1)
on life-history##3##2##(2008-8#2)(2008-9#1)
on ligand##3##2##(2008-10#3)
on light##7##2##(2007-12#1)(2008-10#3)(2008-3#2)(2012-3#1)
on limitations##2##2##(1995-2#1)(2009-11#1)
on limited##2##2##(2008-10#1)(2010-5#1)
on limiting##2##2##(2008-4#1)(2011-2#1)
on line preconcentration and##2##4##(2008-10#2)
on line preconcentration##3##3##(2008-10#3)
on line##13##2##(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
on linkage group##5##3##(2008-10#4)(2013-8#1)
on linkage##9##2##(1994-2#1)(2008-10#7)(2013-8#1)
on lipid levels##2##3##(1991-6#1)(2013-1#1)
on lipid##8##2##(1991-6#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-4#2)(2013-1#1)
on liposome coated silica chromatography##2##5##(2008-10#2)
on liposomes trapping Tb/citrate complex##2##5##(2008-10#2)
on liquid##4##2##(2008-10#2)(2008-9#1)(2009-8#1)
on liquid-liquid extraction##3##3##(2008-10#3)
on listener perceptions of##3##4##(2011-1#3)
on liver##4##2##(1993-11#1)(2008-10#1)(2009-8#1)(2011-2#1)
on living##3##2##(2008-10#3)
on local##13##2##(1990-3#1)(1991-2#1)(1993-11#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#1)(2013-1#1)
on location##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
on long##2##2##(2008-10#2)
on long-term effects##2##3##(2009-7#1)(2010-11#1)
on long-term##10##2##(1991-12#1)(1994-12#1)(1995-8#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-11#1)(2013-8#2)
on longevity and aging##3##4##(2008-7#3)
on longevity##5##2##(2008-11#2)(2008-7#3)
on low density lipoprotein metabolism in##2##6##(1993-6#1)(1994-8#1)
on low molecular weight heparin hemodialysis##2##6##(2013-1#2)
on low##10##2##(1993-6#1)(1994-8#1)(2008-10#2)(2008-12#2)(2009-5#1)(2013-1#3)
on low-density lipoprotein##2##3##(1994-11#1)(2011-1#1)
on lower##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-9#1)
on lymphocytes##4##2##(1995-5#1)(1995-8#2)(2013-8#1)
on macrocyclic##4##2##(2008-10#4)
on magnetic beads##2##3##(2008-10#2)
on magnetic resonance imaging (MRI)##2##5##(1995-5#1)(2012-3#1)
on magnetic resonance imaging of##2##5##(2012-2#1)(2013-1#1)
on magnetic resonance imaging##8##4##(1995-5#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
on magnetic##11##2##(1995-5#1)(2008-10#2)(2009-11#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
on maintaining a##2##3##(1993-3#1)(2010-7#1)
on maintaining##5##2##(1993-3#1)(1996-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
on maize leaves##3##3##(2008-10#3)
on maize##8##2##(2008-10#7)(2008-8#1)
on major##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
on making##4##2##(1995-1#1)(1997-6#1)(2008-11#1)(2010-7#1)
on malaria##3##2##(2010-5#1)(2012-12#1)(2013-8#1)
on male##8##2##(1995-6#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-8#1)
on males##3##2##(2008-8#3)
on mammalian##4##2##(1994-5#1)(2008-10#1)(2008-8#1)(2009-6#1)
on mammary epithelial##2##3##(1994-11#2)
on mammary##3##2##(1994-11#2)(1995-9#1)
on managed care##2##3##(1994-3#1)(1997-2#1)
on management##6##2##(1994-1#2)(1995-1#1)(2008-10#2)(2008-11#1)
on managerial##2##2##(1997-2#1)(2012-3#1)
on manganese##3##2##(2008-10#3)
on manual##2##2##(2008-9#1)(2013-1#1)
on many factors##2##3##(1993-2#1)(2013-8#1)
on many host##2##3##(2008-10#2)
on many of the##2##4##(2008-10#1)(2008-6#1)
on many##12##2##(1993-2#1)(1995-6#1)(2008-10#7)(2008-6#1)(2013-8#2)
on marble##4##2##(2008-10#4)
on mass##6##2##(1990-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
on masticatory muscle reflexes##2##4##(1996-2#2)
on material##5##2##(1997-6#1)(2007-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
on maternal behavior in##2##4##(1990-12#1)(2008-11#1)
on maternal##9##2##(1990-12#1)(1991-12#1)(1992-12#1)(1993-3#1)(2008-11#1)(2008-8#2)(2009-9#1)(2011-2#1)
on mating##2##2##(2008-10#1)(2008-8#1)
on mature##6##2##(2008-10#5)(2008-11#1)
on maximal##3##2##(2008-10#2)(2008-9#1)
on maximum##4##2##(1996-3#1)(2008-10#2)(2008-12#1)
on mean##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)
on measurement of##3##3##(1991-12#1)(2010-5#2)
on measurement##6##2##(1991-12#1)(2008-10#2)(2010-5#2)(2012-2#1)
on measurements of the##2##4##(1991-11#1)(2008-10#1)
on measurements##3##2##(1991-11#1)(2008-10#1)(2008-3#1)
on measures of##5##3##(1991-3#1)(1994-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
on measuring##5##2##(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
on mechanical##2##2##(2008-3#1)(2009-7#1)
on mechanisms##5##2##(1994-1#1)(1995-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
on media##3##2##(2008-10#3)
on mediated##2##2##(1991-3#1)(2008-10#1)
on medical treatment##2##3##(1995-12#1)(2008-11#1)
on medical##16##2##(1991-12#1)(1991-2#3)(1993-12#1)(1993-2#1)(1993-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-11#1)(2009-3#1)(2012-12#2)
on medication##2##2##(2008-11#1)(2010-4#1)
on medicine and##3##3##(1994-5#1)(2008-11#1)(2008-7#1)
on medium containing##2##3##(1997-7#1)(2013-1#1)
on medium##5##2##(1997-7#1)(2008-7#2)(2013-1#2)
on melanogenesis##3##2##(2008-5#3)
on melanoma cells##2##3##(2008-11#1)(2009-10#1)
on melanoma skin cancer##2##4##(2012-3#2)
on melanoma##5##2##(2008-11#1)(2008-9#1)(2009-10#1)(2012-3#2)
on melt inclusions in Martian##2##5##(2008-10#2)
on membrane fluidity and##2##4##(1995-11#2)
on membrane##5##2##(1994-3#1)(1995-11#2)(2006-6#1)(2009-8#1)
on membranes prepared##2##3##(2008-11#2)
on membranes##3##2##(1994-11#1)(2008-11#2)
on memory##4##2##(2008-12#2)(2009-6#1)(2009-8#1)
on mental health##7##3##(2008-12#1)(2009-10#2)(2010-2#1)(2012-3#2)(2013-1#1)
on mental##10##2##(1991-8#2)(1993-11#1)(2008-12#1)(2009-10#2)(2010-2#1)(2012-3#2)(2013-1#1)
on mercury electrodes##2##3##(2008-10#2)
on mercury##4##2##(2008-10#4)
on mesoporous##2##2##(2008-10#2)
on metabolism##3##2##(1991-6#1)(1992-11#1)(2008-11#1)
on metal ion##2##3##(2008-10#2)
on metal##7##2##(2008-10#7)
on metallic##3##2##(2008-10#2)(2008-7#1)
on metaphase chromosomes##2##3##(1993-12#1)(2011-2#1)
on metapopulation survival##2##3##(2008-8#2)
on metapopulation##3##2##(2008-8#3)
on methane##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
on methanol##2##2##(1995-9#2)
on microbial##3##2##(2008-10#3)
on microcarrier##2##2##(2008-11#1)(2008-9#1)
on microcarriers in bioreactors##2##4##(2008-11#2)
on microcarriers in##4##3##(2008-11#4)
on microcarriers##9##2##(2008-11#9)
on microcrystalline naphthalene in the pH range of##2##8##(2008-10#2)
on microcrystalline naphthalene in the pH range##4##7##(2008-10#4)
on microcrystalline naphthalene or by##2##5##(2008-10#2)
on microcrystalline naphthalene##9##3##(2008-10#9)
on microcrystalline##10##2##(2008-10#10)
on microfluidic##2##2##(2008-10#2)
on microscope##2##2##(2008-10#1)(2008-9#1)
on mid-term memory and swim speed in the##2##8##(2008-12#2)
on mid-term##3##2##(2008-12#2)(2011-2#1)
on migration##3##2##(1994-8#1)(2008-10#1)(2008-8#1)
on mineralisation##2##2##(2007-8#2)
on minimal##2##2##(2008-10#2)
on mitochondrial##5##2##(1991-2#1)(2008-10#2)(2013-8#2)
on mixing##3##2##(2007-11#1)(2008-10#2)
on mixture##2##2##(2008-10#1)(2008-12#1)
on mixtures of##2##3##(2008-10#1)(2008-7#1)
on mixtures##3##2##(2008-10#1)(2008-7#2)
on model solutions##2##3##(2008-10#2)
on model##7##2##(2008-10#4)(2008-4#1)(2013-1#1)(2013-8#1)
on models##2##2##(2008-10#1)(2008-8#1)
on modern##4##2##(2008-10#3)(2011-3#1)
on modified##5##2##(2008-10#1)(2008-11#1)(2008-8#2)(2013-8#1)
on molecular##12##2##(1997-3#2)(1997-7#1)(2008-10#5)(2008-8#2)(2010-12#1)(2010-3#1)
on monitoring the##2##3##(2008-10#2)
on monitoring##3##2##(2008-10#2)(2009-7#1)
on monoclonal antibody##2##3##(2008-11#2)
on monocytes##2##2##(1995-6#1)(1996-12#1)
on mononuclear##2##2##(2008-10#1)(2013-7#1)
on mood and##2##3##(2008-12#1)(2009-10#1)
on mood##3##2##(1991-8#1)(2008-12#1)(2009-10#1)
on moral##2##2##(2008-11#2)
on more than##4##3##(1992-3#1)(2008-9#1)(2010-7#1)(2012-2#1)
on more##7##2##(1990-11#1)(1992-3#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#2)
on morning##3##2##(1996-1#1)(1996-2#1)(2011-2#1)
on morphine##2##2##(1996-2#1)(1997-2#1)
on morphological##2##2##(2008-10#1)(2008-8#1)
on morphology was##2##3##(1996-6#1)(2008-8#1)
on morphology##6##2##(1996-6#1)(2007-8#1)(2008-10#2)(2008-8#1)(2012-3#1)
on morphometric##2##2##(2008-12#1)(2008-7#1)
on mortality and##2##3##(1992-12#1)(2010-11#1)
on mortality##9##2##(1991-3#1)(1992-12#1)(1992-2#1)(1995-3#1)(1996-3#1)(2010-11#1)(2010-2#2)(2011-2#1)
on most##2##2##(2008-9#1)(2012-12#1)
on motoneurones##2##2##(1997-2#2)
on motor##2##2##(2008-7#1)(2012-3#1)
on mouse##5##2##(1993-9#1)(1995-2#2)(2008-5#1)(2008-8#1)
on mucosal##2##2##(1997-1#1)(2013-1#1)
on mucus transport##2##3##(1996-1#2)
on mulberry leaves##3##3##(2008-10#3)
on mulberry##4##2##(2008-10#4)
on multidisciplinary##2##2##(1994-1#1)(2011-3#1)
on multiple##7##2##(1996-3#1)(2008-10#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-3#1)
on multivariate##2##2##(2008-10#1)(2011-2#1)
on murine##2##2##(1993-3#1)(2008-11#1)
on muscarinic receptors##2##3##(1995-11#2)
on muscarinic##3##2##(1995-11#2)(1996-2#1)
on muscle##3##2##(1995-2#1)(2008-11#1)(2009-1#1)
on mutations##2##2##(2008-7#1)(2008-8#1)
on mutual##2##2##(1996-3#1)(2008-10#1)
on mycelial growth of R##2##5##(2008-10#2)
on mycelial growth##4##3##(2008-10#4)
on mycelial##5##2##(2008-10#5)
on myocardial##6##2##(1991-2#1)(1995-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
on nanosized##3##2##(2008-10#3)
on naphthalene##2##2##(2008-10#2)
on national##2##2##(1994-12#1)(2008-11#1)
on native##4##2##(1994-8#1)(1995-3#1)(2008-10#1)(2010-3#1)
on natural killer cell activity##2##5##(2007-11#1)(2008-10#1)
on natural##12##2##(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-8#3)
on near-isogenic##2##2##(2008-10#2)
on necrosis##2##2##(1993-2#1)(2008-10#1)
on necrotic##4##2##(2008-10#4)
on neonatal rat##2##3##(2008-10#1)(2010-12#1)
on neonatal##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
on neural##2##2##(2008-11#1)(2008-7#1)
on neurological##2##2##(2010-9#1)(2013-1#1)
on neuronal##3##2##(1993-3#1)(1996-12#2)
on neurons##2##2##(1996-12#1)(2008-7#1)
on neutrophil##6##2##(1993-3#1)(1993-8#1)(1994-8#2)(1996-11#1)(2008-10#1)
on new##9##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#1)(2013-8#1)
on newly##3##2##(1994-9#1)(1996-1#1)(2008-10#1)
on nickel##3##2##(1994-5#1)(2008-10#2)
on nine##2##2##(2008-10#2)
on nitrogen##5##2##(1995-11#1)(1996-5#2)(2013-8#2)
on nonpreferred resources##2##3##(2008-9#2)
on normal and##2##3##(2006-6#1)(2008-11#1)
on normal##10##2##(1990-12#1)(1993-12#1)(1994-2#2)(2006-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-8#1)
on novel hosts##2##3##(2008-8#2)
on novel##6##2##(2008-10#2)(2008-8#3)(2010-11#1)
on nuclear and##2##3##(2008-10#2)
on nuclear##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
on nucleotide##2##2##(2008-10#1)(2008-11#1)
on number of##2##3##(2008-10#1)(2013-8#1)
on numerous##3##2##(2008-10#2)(2011-2#1)
on nurses'##4##2##(2008-11#1)(2010-10#1)(2011-1#1)(2013-1#1)
on nursing practice##2##3##(2008-11#2)
on nursing students'##2##3##(2008-11#2)
on nursing##15##2##(1990-2#1)(1991-2#1)(1994-2#2)(1995-2#1)(2008-11#4)(2008-12#1)(2012-3#3)(2013-1#2)
on nutrient intake##2##3##(1994-12#1)(2012-2#1)
on nutrient##4##2##(1994-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
on nutritional##2##2##(2011-2#1)(2013-1#1)
on nylon filters##2##3##(2008-2#1)(2008-9#1)
on nylon##4##2##(2008-10#2)(2008-2#1)(2008-9#1)
on nymphs##2##2##(2013-8#2)
on oat and##2##3##(2008-10#2)
on objects##2##2##(2007-12#1)(2008-6#1)
on observation of##3##3##(1997-8#1)(2008-11#1)(2008-3#1)
on observations##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
on observed##3##2##(1994-12#1)(2008-10#2)
on occasions##2##2##(1990-2#1)(1997-4#1)
on octadecyl silica##3##3##(2008-10#3)
on older##5##2##(1995-12#1)(2008-10#2)(2010-1#1)(2012-2#1)
on olfactory##2##2##(1994-8#1)(2012-2#1)
on on-line##2##2##(2008-10#2)
on one hand##2##3##(2008-7#1)(2012-2#1)
on one of the##2##4##(2008-4#1)(2008-7#1)
on one of##3##3##(1993-6#1)(2008-4#1)(2008-7#1)
on one or both##2##4##(2008-10#1)(2012-2#1)
on one or##3##3##(2008-10#2)(2012-2#1)
on one side and##3##4##(2008-10#1)(2012-2#2)
on one side##7##3##(1993-3#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-2#2)
on one##34##2##(1991-2#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-1#1)(1997-5#1)(2008-10#8)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-2#1)(2011-2#2)(2012-2#4)(2013-1#2)
on online end-user##2##3##(1991-3#2)
on only one##3##3##(1991-5#1)(2008-10#1)(2011-1#1)
on only##6##2##(1991-5#1)(2008-10#3)(2008-11#1)(2011-1#1)
on opium poppy##2##3##(2008-10#2)
on optical##5##2##(2008-11#1)(2008-3#2)(2009-7#1)(2012-2#1)
on optimal##6##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
on optimization of##2##3##(2008-10#1)(2013-1#1)
on optimizing##2##2##(2012-2#1)(2013-1#1)
on or##6##2##(1990-2#1)(1991-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)
on oral##6##2##(1996-11#1)(2008-1#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
on orbit##2##2##(2008-3#1)(2012-3#1)
on organic hydroperoxides##2##3##(2008-10#2)
on organic matter##2##3##(2008-11#2)
on organic##8##2##(1994-5#1)(1995-9#1)(2008-10#4)(2008-11#2)
on organisms##2##2##(2008-10#1)(2008-8#1)
on other host##2##3##(2008-10#2)
on other hosts##4##3##(2008-10#4)
on other susceptible##2##3##(2008-10#2)
on other##41##2##(1991-4#1)(1991-9#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-8#1)
on our experience with##2##4##(1996-8#1)(2008-7#1)
on our experience##3##3##(1996-8#1)(2008-7#1)(2011-2#1)
on our findings##2##3##(2008-8#1)(2009-6#1)
on our##32##2##(1990-12#1)(1991-12#1)(1993-12#1)(1993-3#1)(1996-11#1)(1996-8#2)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-7#1)(2011-2#2)(2011-3#1)(2013-8#1)
on outcome##2##2##(2011-1#1)(2012-3#1)
on outcomes##3##2##(1995-2#1)(2010-3#1)(2011-1#1)
on oxidative stress##2##3##(2008-10#1)(2008-11#1)
on oxidative##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
on oxygen##2##2##(2008-10#1)(2010-4#1)
on p##14##2##(2008-10#1)(2008-11#3)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
on p-tert-butyl-calix[8]arene-bonded silica gel stationary phase by HPLC##2##8##(2008-10#2)
on p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##3##6##(2008-10#3)
on pH and##2##3##(2008-10#2)
on pH##9##2##(2008-10#8)(2008-11#1)
on pain intensity##2##3##(2009-12#2)
on pain##6##2##(1996-2#1)(2008-10#1)(2008-12#1)(2009-12#2)(2010-1#1)
on paired##2##2##(2008-11#1)(2008-7#1)
on pancreatic##2##2##(2013-1#2)
on paper substrates##2##3##(2012-2#2)
on paper##3##2##(2008-10#1)(2012-2#2)
on parameters of##2##3##(2008-3#1)(2013-1#1)
on parameters##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
on parental##3##2##(1994-8#1)(2010-5#1)(2010-9#1)
on parents and##2##3##(1990-2#1)(2012-3#1)
on partial##3##2##(2008-10#2)(2013-8#1)
on partially##2##2##(2007-11#1)(2008-10#1)
on particle##6##2##(1991-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
on particular##2##2##(2008-10#2)
on passive##2##2##(1992-6#1)(2010-8#1)
on past##5##2##(1991-1#1)(1997-2#1)(2008-7#1)(2012-3#2)
on patch##4##2##(1997-2#1)(2008-8#1)(2008-9#2)
on pathogen evolution##2##3##(2008-10#2)
on pathogen populations##2##3##(2008-10#2)
on pathogen##6##2##(2008-10#6)
on pathogenicity##2##2##(2008-10#2)
on patient and##3##3##(1992-3#1)(2008-11#2)
on patient attitudes##2##3##(2011-2#2)
on patient management##3##3##(1996-2#1)(1997-5#1)(2008-1#1)
on patient outcomes##3##3##(1994-3#1)(2013-1#2)
on patient##21##2##(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-2#2)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-1#2)
on patient's##4##2##(1992-2#1)(2008-7#1)(2009-1#1)(2011-2#1)
on patients and##3##3##(2008-1#1)(2008-11#1)(2009-6#1)
on patients with##5##3##(1997-8#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
on patients##13##2##(1994-12#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
on patients'##4##2##(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
on patterns of##2##3##(2008-8#1)(2008-9#1)
on patterns##3##2##(2008-8#2)(2008-9#1)
on pea##4##2##(2008-10#4)
on peach##2##2##(2008-10#2)
on pear leaves##2##3##(2008-10#2)
on pear##13##2##(2008-10#13)
on pectin##3##2##(2008-10#3)
on pediatric##3##2##(1993-12#1)(2011-1#2)
on pension plans##2##3##(1993-3#2)
on penultimate leaf was##2##4##(2008-10#2)
on pepper##2##2##(2008-10#2)
on peptide##2##2##(2008-10#2)
on percent##4##2##(2008-10#3)(2008-5#1)
on performance##6##2##(1993-12#1)(1993-3#1)(1995-12#1)(2011-1#1)(2013-8#2)
on perinatal outcome##2##3##(2012-3#2)
on perinatal##3##2##(2012-3#3)
on peripheral blood##2##3##(1990-5#1)(2011-2#1)
on peripheral##3##2##(1990-5#1)(2008-8#1)(2011-2#1)
on periphery of##2##3##(2009-2#1)(2010-7#1)
on periphery##3##2##(2009-2#2)(2010-7#1)
on peritoneal dialysis##2##3##(2008-5#1)(2011-2#1)
on peritoneal inflammation in##2##4##(2008-12#2)
on peritoneal##5##2##(2008-12#2)(2008-5#1)(2011-2#2)
on permanent##2##2##(2008-3#1)(2012-3#1)
on personal##7##2##(1992-1#1)(1994-12#1)(1996-2#1)(2008-10#1)(2009-7#1)(2010-5#1)(2010-8#1)
on petioles##2##2##(2008-10#2)
on phage##2##2##(1995-2#1)(2008-10#1)
on pharmaceutical##5##2##(2008-10#3)(2009-3#2)
on pharmacy##2##2##(2008-6#1)(2010-3#1)
on phase##2##2##(2008-10#1)(2013-8#1)
on phenotypic##2##2##(2008-8#1)(2010-4#1)
on phospholipase##2##2##(1994-3#1)(2008-11#1)
on photochemical##2##2##(2008-10#1)(2008-11#1)
on photosynthesis##2##2##(2008-10#2)
on phylogenetic##2##2##(2008-10#2)
on physical and##2##3##(2009-3#1)(2010-6#1)
on physical examination##3##3##(2006-5#1)(2008-12#1)(2013-8#1)
on physical##18##2##(1997-7#1)(2006-5#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2012-2#3)(2013-8#3)
on physician##5##2##(1991-9#1)(1992-12#1)(1994-1#1)(1996-12#1)(1997-3#1)
on physicians and##2##3##(1992-3#1)(2008-6#1)
on physicians##3##2##(1992-3#1)(1995-2#1)(2008-6#1)
on physicians'##2##2##(1992-12#1)(2009-3#1)
on physiological##3##2##(1990-9#1)(1996-12#1)(2008-10#1)
on pistachio##2##2##(2008-10#2)
on placebo##2##2##(1991-3#1)(2008-5#1)
on placement##4##2##(2008-11#3)(2008-12#1)
on plain radiographs##2##3##(2008-9#1)(2010-5#1)
on plain##3##2##(2008-9#1)(2010-5#1)(2012-2#1)
on plant biomass##2##3##(2008-8#2)
on plant growth##6##3##(2008-10#4)(2008-7#1)(2012-7#1)
on plant surfaces##2##3##(2008-10#1)(2009-8#1)
on plant##27##2##(2008-10#14)(2008-11#2)(2008-7#1)(2008-8#5)(2009-8#1)(2011-2#1)(2012-5#1)(2012-6#1)(2012-7#1)
on plants grown in##3##4##(2008-10#3)
on plants in the##2##4##(2008-10#2)
on plants in##3##3##(2008-10#3)
on plants infected with##2##4##(2008-10#2)
on plants inoculated with##2##4##(2008-10#2)
on plants of##4##3##(2008-10#4)
on plants##29##2##(1997-3#1)(2008-10#25)(2008-8#1)(2008-9#1)(2011-2#1)
on plasma lipid##2##3##(2008-7#1)(2012-2#1)
on plasma##9##2##(1993-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on plastic and##3##3##(2008-11#3)
on plastic dishes##2##3##(2008-11#2)
on plastic##10##2##(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#1)
on platelet##8##2##(1990-10#1)(1992-4#1)(1994-8#2)(2006-6#2)(2008-7#1)(2008-8#1)
on platinum##3##2##(2008-10#3)
on pods##5##2##(2008-10#5)
on point##5##2##(2011-2#5)
on policies##2##2##(1995-3#1)(2012-2#1)
on policy##2##2##(1996-3#1)(2009-11#1)
on political##2##2##(1996-1#1)(2008-1#1)
on polyacrylamide##2##2##(2008-10#1)(2009-6#1)
on polymer film##2##3##(2008-10#2)
on poor##2##2##(1992-2#1)(2008-10#1)
on population dynamics of##2##4##(2008-10#2)
on population dynamics##4##3##(1994-8#1)(2008-10#2)(2008-8#1)
on population growth and##2##4##(2008-11#2)
on population##13##2##(1994-8#1)(2008-10#2)(2008-11#2)(2008-8#6)(2008-9#1)(2012-2#1)
on populations##4##2##(1990-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
on porous##6##2##(2008-10#4)(2008-11#2)
on positive##3##2##(1990-11#1)(1993-6#1)(2008-11#1)
on possible mechanisms##3##3##(2008-10#2)(2009-8#1)
on possible##6##2##(2008-10#2)(2008-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
on post-infection##2##2##(2008-10#1)(2008-11#1)
on post-mortem##2##2##(2008-7#1)(2013-1#1)
on posterior gills of the mangrove crab Ucides cordatus##2##9##(2008-7#2)
on postinfection##2##2##(2008-10#2)
on postnatal day##2##3##(1996-12#1)(2012-12#1)
on postnatal##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
on postoperative##5##2##(1992-8#1)(1994-3#1)(1997-3#1)(2008-8#1)(2011-2#1)
on postsurgical adhesion formation##2##4##(1995-12#2)
on potato and tomato##3##4##(2008-10#3)
on potato and##4##3##(2008-10#4)
on potato based ready-to-eat food products##2##6##(2011-2#2)
on potato dextrose agar (PDA)##2##5##(2008-10#2)
on potato dextrose agar##9##4##(2008-10#9)
on potato##25##2##(2008-10#23)(2011-2#2)
on potential##7##2##(1994-3#1)(1995-2#1)(2008-10#2)(2008-5#1)(2010-3#1)(2013-1#1)
on powdery mildew##2##3##(2008-10#2)
on power##2##2##(1996-3#1)(2011-2#1)
on practice##6##2##(1996-2#1)(2008-11#5)
on predictions of##2##3##(2008-8#1)(2013-8#1)
on pregnancy##4##2##(1991-3#1)(2008-10#1)(2013-1#2)
on preliminary##2##2##(1995-3#1)(2008-12#1)
on preoperative##2##2##(2008-12#1)(2011-2#1)
on prescribing patterns##2##3##(2008-11#2)
on prescribing##4##2##(2008-11#4)
on prescription##3##2##(1990-2#2)(2008-11#1)
on presence of##2##3##(2008-10#2)
on present##2##2##(1996-12#1)(2008-12#1)
on pressure##2##2##(1990-9#2)
on prevention of##2##3##(2008-7#1)(2011-2#1)
on prevention##3##2##(1997-5#1)(2008-7#1)(2011-2#1)
on preventive measures##2##3##(2008-10#1)(2010-1#1)
on preventive##4##2##(1995-2#1)(1996-2#1)(2008-10#1)(2010-1#1)
on previous##5##2##(1994-3#1)(2008-7#2)(2008-8#1)(2011-2#1)
on previously##7##2##(1990-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
on prey fitness##2##3##(2008-8#2)
on prey##3##2##(2008-8#3)
on prg##2##2##(2008-10#2)
on primary prevention##2##3##(1996-12#1)(2008-11#1)
on primary##13##2##(1992-1#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2013-8#1)
on prior experience##2##3##(2010-8#2)
on private##3##2##(1993-1#1)(1995-3#1)(1996-12#1)
on problem##2##2##(2008-12#1)(2010-10#1)
on problems of##3##3##(1990-3#1)(2007-8#1)(2009-12#1)
on problems##4##2##(1990-3#1)(2007-8#1)(2009-12#1)(2011-2#1)
on processes##2##2##(1993-6#1)(2008-7#1)
on product##4##2##(1992-1#1)(2008-5#1)(2008-7#2)
on production of##2##3##(2008-11#2)
on production##3##2##(2008-10#1)(2008-11#2)
on productivity in##2##3##(2008-7#1)(2008-8#1)
on productivity##4##2##(1991-2#1)(1992-3#1)(2008-7#1)(2008-8#1)
on prognosis##4##2##(1990-8#1)(1991-8#1)(2010-11#1)(2012-3#1)
on program##3##2##(1993-3#1)(2009-8#1)(2013-1#1)
on progression of##2##3##(2008-1#1)(2013-1#1)
on proliferation and apoptosis##2##4##(2011-2#2)
on proliferation and##4##3##(2006-6#1)(2008-11#1)(2011-2#2)
on proliferation of##4##3##(1995-3#1)(2010-12#2)(2011-3#1)
on proliferation##10##2##(1995-3#1)(2006-6#1)(2008-11#2)(2010-12#2)(2011-2#2)(2011-3#1)(2013-8#1)
on prolonged##2##2##(2008-5#1)(2013-1#1)
on promoting cell growth##2##4##(2008-11#2)
on promoting##6##2##(1994-3#2)(2008-11#4)
on properties##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
on protective##2##2##(2008-12#1)(2010-12#1)
on protein kinase C and##2##5##(1994-5#1)(2008-11#1)
on protein kinase C##4##4##(1990-8#1)(1991-5#1)(1994-5#1)(2008-11#1)
on protein synthesis in##3##4##(2008-11#3)
on protein synthesis##12##3##(1990-11#1)(1995-12#1)(2008-11#10)
on protein##25##2##(1990-11#1)(1990-8#1)(1991-5#1)(1994-5#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#12)(2008-3#1)(2008-4#2)(2008-7#1)(2013-8#1)
on proteins##6##2##(1993-3#1)(2008-10#2)(2008-4#3)
on providing##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
on psychiatric##4##2##(1991-1#1)(1991-3#1)(2012-3#1)(2013-8#1)
on psychological##6##2##(1992-1#1)(1993-12#1)(1996-3#1)(1997-1#1)(2008-4#1)(2012-3#1)
on public health##7##3##(1995-12#1)(1995-2#1)(1996-3#2)(2008-10#2)(2008-11#1)
on public##9##2##(1992-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#2)(2008-10#2)(2008-11#1)
on pulmonary function##4##3##(1991-12#1)(1997-1#1)(2011-2#1)(2013-1#1)
on pulmonary##7##2##(1991-12#1)(1996-3#1)(1997-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
on pump##2##2##(2008-2#1)(2008-3#1)
on purified##2##2##(2008-10#1)(2009-6#1)
on pyrolytic graphite (PG) electrodes were##2##6##(2008-10#2)
on pyrolytic graphite (PG) electrodes##3##5##(2008-10#3)
on pyrolytic graphite (PG)##4##4##(2008-10#4)
on pythium##2##2##(2008-10#2)
on quadrat##3##2##(2008-10#3)
on quality and##2##3##(1995-2#1)(2012-2#1)
on quality of life and##2##5##(2008-7#1)(2012-3#1)
on quality of life##8##4##(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#4)
on quality of##9##3##(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#5)
on quality##14##2##(1993-12#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
on quantitative##7##2##(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-3#1)
on quartz##3##2##(2008-10#3)
on questions##2##2##(1992-1#1)(2008-11#1)
on radiation##4##2##(1996-11#1)(1997-8#1)(2008-9#1)(2012-2#1)
on radiographic##2##2##(2008-3#1)(2012-12#1)
on radiographs##3##2##(1992-5#1)(2011-2#1)(2013-1#1)
on radiology##3##2##(1991-2#1)(2012-2#2)
on random##3##2##(1997-9#1)(2008-10#2)
on rapid##2##2##(2008-10#2)
on rare##2##2##(2008-10#2)
on rat##10##2##(1990-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#3)(2012-3#1)
on rates of##2##3##(2008-10#1)(2008-9#1)
on rats##2##2##(1994-8#1)(2009-11#1)
on raw##2##2##(2008-10#1)(2008-8#1)
on reaction with##3##3##(2008-10#3)
on reading##6##2##(2008-11#1)(2008-12#2)(2008-5#1)(2010-12#1)(2013-8#1)
on real samples##5##3##(2008-10#5)
on real##8##2##(2008-10#7)(2013-1#1)
on recent developments##2##3##(1996-3#1)(2011-2#1)
on recent findings##2##3##(1991-3#1)(2011-2#1)
on recent##17##2##(1991-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#3)(2009-7#1)(2010-5#1)(2011-2#3)
on recently dead chestnut wood##2##5##(2008-10#2)
on recently##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
on recognition##2##2##(1997-7#1)(2008-6#1)
on recombinant protein expression##2##4##(2008-11#1)(2008-7#1)
on recombinant protein##3##3##(2008-11#2)(2008-7#1)
on recombinant##5##2##(1992-10#1)(1995-11#1)(2008-11#2)(2008-7#1)
on recovery from##3##3##(1991-2#1)(2010-7#1)(2012-2#1)
on recovery##7##2##(1991-2#2)(2008-10#2)(2010-7#1)(2012-2#1)(2012-3#1)
on red##3##2##(2008-10#3)
on reducing##6##2##(2008-10#2)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
on reduction of##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
on regional##2##2##(1991-10#1)(1992-12#1)
on regular##2##2##(2008-11#2)
on regulation##2##2##(1991-12#1)(2010-10#1)
on regulatory##2##2##(1995-5#1)(2008-8#1)
on relationships##3##2##(2008-11#1)(2010-9#1)(2013-1#1)
on relative abundance##2##3##(2012-6#2)
on relative##3##2##(2008-4#1)(2012-6#2)
on relatively##3##2##(1995-3#1)(2008-10#2)
on relevant##3##2##(1996-3#1)(2010-8#1)(2012-2#1)
on renal function##2##3##(2011-2#1)(2011-3#1)
on renal gluconeogenesis is##2##4##(1994-8#2)
on renal##7##2##(1994-8#2)(2008-1#2)(2008-12#1)(2011-2#1)(2011-3#1)
on reproductive health##4##3##(2008-1#2)(2008-11#2)
on reproductive performance##2##3##(1996-1#1)(2010-8#1)
on reproductive##7##2##(1996-1#1)(2008-1#2)(2008-11#2)(2008-8#1)(2010-8#1)
on research##7##2##(1994-9#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2009-7#1)(2013-1#1)
on residual##2##2##(2009-8#1)(2013-1#1)
on residues##3##2##(2008-10#3)
on resistance to##4##3##(2008-10#3)(2008-8#1)
on resistance##7##2##(2008-10#4)(2008-8#2)(2013-1#1)
on resistant##5##2##(2008-10#5)
on resolution##3##2##(2008-10#2)(2012-3#1)
on resonance##3##2##(2008-10#3)
on resource allocation##2##3##(2008-11#1)(2008-8#1)
on resource##6##2##(2008-11#1)(2008-8#3)(2008-9#1)(2010-8#1)
on respiration##2##2##(2008-12#1)(2009-5#1)
on respiratory##2##2##(1990-2#1)(1991-6#1)
on responding with conditioned reinforcement##2##5##(1993-6#2)
on response##5##2##(1993-6#1)(2008-10#2)(2010-1#1)(2010-12#1)
on responses to##2##3##(1992-12#1)(1996-3#1)
on resting##2##2##(2008-9#1)(2013-8#1)
on restructuring##2##2##(1992-12#1)(1993-2#1)
on results from##3##3##(1991-6#1)(2008-10#1)(2010-10#1)
on results obtained##4##3##(2008-10#1)(2009-8#1)(2011-2#2)
on results of##5##3##(2008-10#1)(2008-7#1)(2010-10#1)(2012-2#2)
on results##13##2##(1991-6#1)(2008-10#4)(2008-7#1)(2009-8#1)(2010-10#2)(2011-2#2)(2012-2#2)
on retention and selectivity of##2##5##(2008-10#2)
on retention and##3##3##(2008-10#2)(2012-2#1)
on retention##7##2##(2008-10#6)(2012-2#1)
on retrievals##2##2##(2008-3#2)
on retrospective studies##2##3##(2008-7#1)(2012-3#1)
on retrospective##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
on reversed-phase##2##2##(1990-5#1)(2008-5#1)
on reward-related brain function##2##4##(2013-8#2)
on reward-related##3##2##(1993-6#1)(2013-8#2)
on rhizosphere colonization##2##3##(2008-10#2)
on rhizosphere##3##2##(2008-10#3)
on rice (Oryza##2##3##(1996-12#1)(2008-10#1)
on rice line##2##3##(2008-10#2)
on rice plants##2##3##(2008-10#1)(2013-8#1)
on rice##11##2##(1996-12#1)(2008-10#7)(2008-12#1)(2008-8#1)(2013-8#1)
on risk factors##3##3##(1996-3#1)(1997-1#1)(2009-10#1)
on risk of cancer##2##4##(1994-2#1)(2008-11#1)
on risk of##3##3##(1994-2#1)(1997-8#1)(2008-11#1)
on risk##8##2##(1994-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-11#1)(2009-10#2)
on room air##2##3##(2010-7#2)
on root##3##2##(2008-10#3)
on roots of wheat grown in##2##6##(2008-10#2)
on roots of wheat##4##4##(2008-10#4)
on roots of##7##3##(2008-10#7)
on roots##12##2##(2008-10#12)
on rough lemon##2##3##(2008-10#2)
on routine##2##2##(2008-7#1)(2011-2#1)
on rural##2##2##(1991-1#1)(1994-2#1)
on rye##3##2##(2008-10#3)
on safe##3##2##(1996-6#1)(1997-6#1)(2013-1#1)
on safety##4##2##(1993-3#1)(2008-11#3)
on sample##6##2##(2008-10#4)(2009-9#1)(2010-2#1)
on samples##7##2##(2008-10#5)(2008-5#1)(2013-1#1)
on sampling##3##2##(2008-10#2)(2012-3#1)
on school outcomes##2##3##(2009-7#1)(2012-2#1)
on school##3##2##(2009-7#1)(2012-2#2)
on scientific##2##2##(1994-6#1)(2008-7#1)
on sclerotia viability and##2##4##(2008-10#2)
on screen-printed carbon##2##3##(2008-10#2)
on screening##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
on second##4##2##(2008-10#3)(2008-12#1)
on secondary##2##2##(1991-3#1)(2008-4#1)
on sections from##2##3##(1990-12#1)(2008-7#1)
on seed germination##3##3##(2008-12#2)(2008-7#1)
on seed##4##2##(2008-10#1)(2008-12#2)(2008-7#1)
on seedling##4##2##(2008-10#4)
on seedlings of##3##3##(2008-10#2)(2008-8#1)
on seedlings##6##2##(2008-10#5)(2008-8#1)
on segments of##2##3##(2008-10#2)
on seizure##3##2##(1997-3#3)
on selected##9##2##(1991-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#1)
on selection of the##3##4##(2008-10#1)(2008-9#1)(2012-3#1)
on selection of##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
on selection##5##2##(2008-10#3)(2008-9#1)(2012-3#1)
on selective media##3##3##(2008-10#3)
on selective##7##2##(2008-10#7)
on selectivity##4##2##(2008-10#4)
on self-assembled monolayers##2##3##(2008-10#2)
on self-assembled##6##2##(2008-10#6)
on self-reported##3##2##(1991-6#1)(2008-4#1)(2009-11#1)
on semiconductors##2##2##(2008-3#1)(2012-2#1)
on sensing##3##2##(2008-10#2)(2008-11#1)
on sensitive##2##2##(2008-10#2)
on sensitivity##5##2##(1997-7#1)(2008-10#4)
on sensitizing potency##2##3##(2008-5#2)
on sensitizing##3##2##(2008-5#3)
on sensor##3##2##(2008-10#3)
on separate##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
on separation##8##2##(2008-10#8)
on sequence##9##2##(1997-8#1)(2008-10#6)(2008-6#1)(2011-2#1)
on sequences##5##2##(1992-4#1)(2008-10#3)(2011-2#1)
on sequential##6##2##(2008-10#3)(2008-2#1)(2008-7#1)(2010-7#1)
on serial##4##2##(1990-12#1)(1996-6#1)(1997-2#1)(2013-8#1)
on serum adiponectin levels in children with vitamin##2##8##(2011-1#2)
on serum lipid##2##3##(2008-10#1)(2008-3#1)
on serum##15##2##(1992-11#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
on seven##8##2##(1996-3#1)(2008-10#3)(2008-12#2)(2008-9#1)(2010-10#1)
on several aspects of##2##4##(1997-1#1)(2008-11#1)
on several components##2##3##(2008-10#1)(2010-6#1)
on several types of##2##4##(2008-10#1)(2010-1#1)
on several##26##2##(1991-12#1)(1995-8#1)(1996-3#1)(1997-1#2)(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#2)(2009-3#1)(2010-1#1)(2010-6#1)(2011-2#2)
on severe##2##2##(2008-10#1)(2010-2#1)
on severity##5##2##(2008-10#3)(2011-3#1)(2013-1#1)
on sex differences in##3##4##(2008-8#2)(2008-9#1)
on sex##7##2##(1991-12#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-3#2)
on sexual behaviour##2##3##(1996-6#1)(2008-11#1)
on sexual selection##2##3##(2008-8#2)
on sexual##6##2##(1996-5#1)(1996-6#1)(2008-11#1)(2008-8#2)(2012-2#1)
on shape##2##2##(2008-6#2)
on ships##2##2##(2008-10#1)(2008-11#1)
on shoots##2##2##(2008-10#2)
on short##3##2##(2008-3#1)(2008-4#1)(2008-7#1)
on short-term##2##2##(1996-2#1)(2008-8#1)
on sialylation of##2##3##(2008-7#2)
on signal##6##2##(2008-10#2)(2008-8#1)(2010-9#2)(2011-2#1)
on signals of##4##3##(2008-10#1)(2008-8#3)
on significant##3##2##(1991-8#1)(2008-10#1)(2008-6#1)
on silencing##2##2##(2010-1#1)(2011-1#1)
on silica gel and##3##4##(2008-10#2)(2013-8#1)
on silica gel##18##3##(2008-10#16)(2008-11#1)(2013-8#1)
on silica is##2##3##(2008-10#2)
on silica surface were##2##4##(2008-10#2)
on silica surface##3##3##(2008-10#3)
on silica##32##2##(1996-5#1)(2008-10#29)(2008-11#1)(2013-8#1)
on silicon##5##2##(2008-10#5)
on silk fibroin##2##3##(2008-11#2)
on silver##4##2##(2008-10#2)(2008-8#1)(2010-5#1)
on similar##3##2##(2008-10#1)(2008-9#2)
on simple##7##2##(1990-9#1)(1995-12#1)(2008-10#2)(2008-8#2)(2010-10#1)
on simultaneous##3##2##(2008-10#3)
on single##6##2##(1990-8#1)(2008-10#2)(2008-11#1)(2009-12#2)
on site##7##2##(2008-10#5)(2008-11#2)
on six##6##2##(1993-12#1)(1994-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2010-9#1)
on size##6##2##(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)
on skeletal##2##2##(2013-1#2)
on skin barrier##2##3##(2008-5#2)
on skin##17##2##(1992-8#1)(1997-3#3)(2008-5#9)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
on sleep##2##2##(1990-5#1)(2010-7#1)
on small##11##2##(1993-12#1)(1994-6#1)(2008-10#3)(2008-11#3)(2008-3#1)(2011-2#1)(2013-1#1)
on smoking##6##2##(1991-12#1)(1992-6#1)(1996-3#1)(2008-10#2)(2009-7#1)
on smooth muscle##2##3##(1991-5#1)(1991-8#1)
on social support and##2##4##(1992-3#1)(2010-3#1)
on social support in##2##4##(1992-3#2)
on social support##4##3##(1992-3#3)(2010-3#1)
on social##11##2##(1992-3#3)(2008-12#2)(2008-8#2)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
on sodium##3##2##(1992-12#1)(1997-4#2)
on soft##4##2##(2008-10#2)(2008-8#1)(2012-2#1)
on soil pH##2##3##(2008-12#1)(2012-6#1)
on soil texture##2##3##(2008-10#2)
on soil##15##2##(2008-10#9)(2008-12#1)(2008-9#2)(2010-8#1)(2012-6#1)(2012-9#1)
on solid phase##6##3##(2008-10#6)
on solid samples##2##3##(2008-10#2)
on solid sorbents##2##3##(2008-10#2)
on solid substrates##2##3##(2008-10#1)(2009-6#1)
on solid surfaces##2##3##(2008-4#1)(2009-11#1)
on solid##16##2##(1997-2#1)(2008-10#12)(2008-4#1)(2009-11#1)(2009-6#1)
on solid-phase extraction##4##3##(2008-10#4)
on solid-phase##8##2##(1992-6#1)(2008-10#7)
on solution##5##2##(2008-10#4)(2008-9#1)
on solutions containing##3##3##(2008-10#3)
on somatic##4##2##(1992-2#1)(1997-2#1)(2008-12#1)(2010-5#1)
on some aspects of##3##4##(2008-12#1)(2009-10#1)(2011-1#1)
on some biochemical##2##3##(2008-12#2)
on some of the##3##4##(1992-12#1)(1994-2#1)(2008-12#1)
on some physiological and##2##4##(2008-7#1)(2012-2#1)
on some recent##2##3##(1997-3#1)(2011-2#1)
on some##29##2##(1992-12#1)(1994-2#1)(1997-3#1)(2006-6#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
on sorghum##2##2##(2008-10#2)
on sorption##2##2##(2008-10#2)
on source plants##4##3##(2008-10#4)
on source##5##2##(2008-10#4)(2013-8#1)
on soybean##11##2##(2008-10#10)(2008-8#1)
on space##3##2##(2008-8#3)
on spatial learning##3##3##(1991-7#1)(1994-8#1)(2012-2#1)
on spatial statistics##2##3##(2008-10#1)(2008-8#1)
on spatial##8##2##(1991-7#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2012-2#1)
on species richness##3##3##(2008-8#3)
on species##7##2##(2008-8#5)(2008-9#1)(2012-9#1)
on specific##17##2##(1993-2#1)(1995-9#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2009-4#1)(2010-9#2)(2011-1#1)(2013-1#1)(2013-8#2)
on specimens##2##2##(2008-10#2)
on spectrophotometric##5##2##(2008-10#5)
on speech perception##2##3##(2008-9#2)
on speech##3##2##(2008-2#1)(2008-9#2)
on sperm parameters##2##3##(2008-12#2)
on sperm##3##2##(2008-12#2)(2013-8#1)
on spermidine and##2##3##(2009-6#2)
on spiked##5##2##(2008-10#5)
on spinal##2##2##(2010-3#1)(2011-2#1)
on splenic##2##2##(2008-10#2)
on spore release of Bremia lactucae##2##6##(2008-10#2)
on spore release##4##3##(2008-10#4)
on spore##12##2##(2008-10#10)(2011-2#2)
on sport##2##2##(2009-1#1)(2013-1#1)
on sports##2##2##(1993-3#1)(2009-7#1)
on sporulation of Bremia lactucae##2##5##(2008-10#2)
on sporulation##3##2##(2008-10#3)
on spread of##2##3##(2008-10#2)
on spread##4##2##(2008-10#4)
on spring##2##2##(1990-8#1)(2008-10#1)
on stability and##2##3##(2008-10#1)(2013-8#1)
on stability##5##2##(2008-10#2)(2008-9#2)(2013-8#1)
on stable##2##2##(1996-12#1)(2008-8#1)
on staff##3##2##(1994-3#1)(2008-10#1)(2010-5#1)
on stainless##2##2##(2011-2#2)
on standard##9##2##(1991-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2011-1#1)
on standing##2##2##(2008-10#1)(2010-10#1)
on state##2##2##(1997-1#1)(2011-9#1)
on statin therapy##2##3##(2008-3#1)(2010-12#1)
on stationary phases of different polarity##2##6##(2008-10#2)
on statistical##6##2##(2008-10#3)(2008-11#2)(2008-3#1)
on stem##2##2##(2008-10#1)(2008-11#1)
on stems##2##2##(2008-10#2)
on steroid##2##2##(2008-10#1)(2008-7#1)
on steroids and##2##3##(1995-10#1)(2013-1#1)
on steroids##3##2##(1995-10#2)(2013-1#1)
on stomatal guard##2##3##(2008-10#2)
on stomatal##3##2##(2008-10#2)(2008-8#1)
on strategic management##3##3##(1992-12#1)(1993-12#2)
on strategic##4##2##(1992-12#1)(1993-12#2)(1993-2#1)
on strategies##2##2##(1993-3#1)(1995-12#1)
on stratospheric##2##2##(2008-10#1)(2008-3#1)
on strawberry and##2##3##(2008-10#2)
on strawberry leaves##3##3##(2008-10#3)
on strawberry##12##2##(2008-10#12)
on stripe rust##2##3##(2008-10#2)
on stripping##2##2##(2008-10#2)
on structural##2##2##(2008-10#1)(2010-2#1)
on student##2##2##(2008-11#2)
on studies of the##2##4##(2008-7#1)(2009-7#1)
on studies of##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2009-7#1)
on studies with##2##3##(2008-7#1)(2012-12#1)
on studies##9##2##(2008-10#2)(2008-11#2)(2008-7#2)(2009-7#1)(2012-12#2)
on study##3##2##(1993-1#1)(2008-10#1)(2011-2#1)
on subjective##2##2##(1991-1#1)(2008-12#1)
on subsequent##4##2##(1993-1#1)(1994-8#1)(2008-10#1)(2008-9#1)
on substance##3##2##(1994-3#1)(1994-8#1)(2008-4#1)
on such interactions##2##3##(2008-10#2)
on such##9##2##(2008-10#4)(2008-11#1)(2008-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
on sugar beet##2##3##(2008-10#2)
on suicide##3##2##(1996-1#2)(2013-8#1)
on sun-exposed areas##2##3##(2010-6#2)
on sun-exposed##3##2##(2010-6#2)(2011-2#1)
on sunny days##4##3##(2008-10#4)
on supercritical##3##2##(2008-10#2)(2010-10#1)
on superoxide##2##2##(1990-5#1)(1996-2#1)
on supply##2##2##(1992-1#1)(2009-8#1)
on support##2##2##(1996-3#2)
on suppression of##3##3##(2008-10#3)
on surface##7##2##(2008-10#6)(2008-7#1)
on surfaces of##3##3##(2008-10#2)(2013-8#1)
on surfaces##10##2##(1990-8#1)(1997-3#1)(2008-10#3)(2008-7#1)(2009-4#1)(2012-5#1)(2013-8#2)
on surfactant##3##2##(1997-1#1)(2008-10#1)(2012-2#1)
on surgery##2##2##(1997-3#1)(2008-11#1)
on surgical##3##2##(1993-6#1)(2008-11#1)(2010-7#1)
on surveillance##2##2##(1996-1#1)(2011-2#1)
on survival of##6##3##(2008-10#5)(2008-7#1)
on survival##19##2##(1990-12#1)(1995-2#2)(2008-10#8)(2008-2#1)(2008-7#2)(2008-8#2)(2009-10#1)(2011-2#1)(2013-1#1)
on survivors of##2##3##(1995-11#1)(2008-11#1)
on susceptibility##2##2##(2008-10#2)
on susceptible cultivars##2##3##(2008-10#2)
on susceptible##11##2##(2008-10#10)(2008-9#1)
on suspended carriers##2##3##(2008-7#2)
on suspended##3##2##(2008-10#1)(2008-7#2)
on sustained##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
on symptom expression##2##3##(2008-10#2)
on symptomless strawberry##2##3##(2008-10#2)
on symptomless##3##2##(2008-10#3)
on symptoms of##2##3##(2008-10#1)(2013-1#1)
on symptoms##4##2##(2008-10#3)(2013-1#1)
on synthetic samples prepared with the##2##6##(2008-10#2)
on synthetic samples prepared##4##4##(2008-10#4)
on synthetic samples##5##3##(2008-10#5)
on synthetic##8##2##(1990-6#1)(2008-10#6)(2008-3#1)
on system##2##2##(1990-11#1)(2008-9#1)
on systemic##3##2##(1992-5#1)(2008-12#1)(2009-8#1)
on systems##2##2##(2013-8#2)
on tNOX##2##2##(2009-9#2)
on tall fescue##4##3##(2008-10#4)
on target cells##3##3##(1990-8#1)(1993-3#1)(2008-12#1)
on target##8##2##(1990-8#1)(1992-6#1)(1993-3#2)(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)
on targets##2##2##(2009-8#1)(2013-1#1)
on teaching clinical chemistry##2##4##(1994-12#2)
on teaching##8##2##(1994-12#3)(1995-2#1)(2008-10#1)(2008-11#2)(2011-2#1)
on teicoplanin##4##2##(2008-10#4)
on temperature in the##2##4##(2008-10#2)
on temperature##12##2##(1993-1#1)(1996-2#4)(2008-10#6)(2008-3#1)
on temporal##2##2##(1993-1#1)(2008-8#1)
on ten##2##2##(2009-10#2)
on testing##2##2##(2008-10#1)(2013-8#1)
on that of##2##3##(2008-10#1)(2011-2#1)
on that##9##2##(2008-10#7)(2008-7#1)(2011-2#1)
on the &quot##3##3##(1993-9#1)(1995-6#1)(2008-10#1)
on the 11##2##3##(2008-10#2)
on the 3'##3##3##(1993-12#1)(1993-6#1)(2008-9#1)
on the 30th##2##3##(2008-12#1)(2012-3#1)
on the 4##2##3##(2008-10#1)(2013-1#1)
on the 4th##2##3##(2008-10#1)(2010-12#1)
on the 5' end of the##2##6##(2008-10#1)(2008-9#1)
on the 5'##5##3##(1993-12#1)(1993-2#1)(1993-6#1)(2008-10#1)(2008-9#1)
on the Au surface##2##4##(2008-10#2)
on the CALUX##2##3##(2008-10#2)
on the CL reaction between luminol##2##6##(2008-10#2)
on the CL reaction of##4##5##(2008-10#4)
on the CL reaction##6##4##(2008-10#6)
on the CL##9##3##(2008-10#9)
on the CR lever##2##4##(1993-6#2)
on the Collins test##2##4##(1994-8#2)
on the DNA##6##3##(1993-8#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)
on the DOF##4##3##(2010-8#4)
on the Development of##2##4##(2008-10#2)
on the GCE##2##3##(2008-10#1)(2013-1#1)
on the Global##2##3##(2008-12#1)(2008-3#1)
on the Internet##10##3##(1995-12#1)(1996-2#1)(1996-8#1)(2008-11#3)(2009-5#2)(2010-12#1)(2011-1#1)
on the Iowa##2##3##(2008-10#1)(2013-1#1)
on the LB films##3##4##(2008-11#3)
on the LB membranes##4##4##(2008-11#4)
on the LB##7##3##(2008-11#7)
on the LPP test##2##4##(1994-8#2)
on the MIMS response##2##4##(2008-10#2)
on the MMP-1##2##3##(2008-5#1)(2012-3#1)
on the MX line##2##4##(2008-10#2)
on the Medical Ward##2##4##(1992-12#2)
on the Medicare##3##3##(1995-12#1)(1995-2#1)(1997-3#1)
on the Mini Mental State##2##5##(2008-7#1)(2011-2#1)
on the N-terminal##4##3##(1991-10#1)(1993-9#1)(2008-6#1)(2012-2#1)
on the National##3##3##(1994-12#1)(1995-11#1)(1996-11#1)
on the P##2##3##(2008-10#1)(2010-8#1)
on the Pt##2##3##(2008-10#1)(2008-11#1)
on the RA molecule##2##4##(2008-11#2)
on the RRE##4##3##(1993-8#4)
on the SAMs##2##3##(2008-10#2)
on the SPQ-B##2##3##(2008-1#2)
on the SPR sensor##2##4##(2008-10#1)(2008-4#1)
on the SPR##3##3##(2008-10#2)(2008-4#1)
on the TSST-1 molecule##2##4##(1993-3#2)
on the Web##2##3##(2008-10#1)(2008-4#1)
on the ability of a##3##5##(1995-2#1)(1995-5#1)(2013-8#1)
on the ability of the##4##5##(1997-8#1)(2008-10#2)(2008-11#1)
on the ability of##15##4##(1990-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-4#3)(2013-8#1)
on the ability to##5##4##(2008-10#1)(2008-11#2)(2008-6#1)(2010-4#1)
on the ability##20##3##(1990-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-4#3)(2008-6#1)(2010-4#1)(2013-8#1)
on the above##5##3##(1997-8#1)(2008-10#3)(2013-1#1)
on the absorbance##4##3##(2008-10#4)
on the absorption of buagafuran in lumen##2##7##(2011-3#2)
on the absorption of buagafuran in##3##6##(2011-3#3)
on the absorption spectra of the complexes of##2##8##(2008-10#2)
on the absorption spectra of##3##5##(2008-10#3)
on the absorption##9##3##(2008-10#4)(2008-11#1)(2011-3#4)
on the academic performance##3##4##(2013-8#3)
on the academic##4##3##(2008-12#1)(2013-8#3)
on the accumulation##3##3##(1994-6#1)(2008-10#2)
on the accuracy and##2##4##(2008-10#2)
on the accuracy of the##3##5##(2008-10#1)(2008-3#1)(2010-12#1)
on the accuracy of##4##4##(1993-9#1)(2008-10#1)(2008-3#1)(2010-12#1)
on the accuracy##8##3##(1993-9#1)(2008-10#5)(2008-3#1)(2010-12#1)
on the acquisition of##2##4##(2008-5#1)(2008-8#1)
on the action pattern of porcine pancreatic alpha-amylase##2##8##(1990-9#2)
on the action##5##3##(1990-9#2)(1997-2#1)(2008-4#2)
on the activation of##2##4##(1997-4#1)(2012-3#1)
on the activation##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
on the active##4##3##(1990-5#1)(1991-6#1)(2008-10#1)(2008-8#1)
on the activities of##2##4##(1994-8#1)(2008-10#1)
on the activity of the##5##5##(1994-6#1)(1995-6#1)(2008-10#1)(2010-9#1)(2013-1#1)
on the activity of##15##4##(1990-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2010-9#1)(2013-1#1)
on the activity##17##3##(1990-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-5#1)(2010-12#1)(2010-9#1)(2013-1#1)
on the actual##6##3##(1993-12#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
on the adhesion##2##3##(2008-11#1)(2012-5#1)
on the adoption of##2##4##(1997-7#1)(2011-2#1)
on the adrenal##2##3##(2011-1#1)(2011-2#1)
on the adsorption of##6##4##(2008-10#6)
on the adsorption##9##3##(2008-10#8)(2011-2#1)
on the advantages##2##3##(1996-11#1)(2012-2#1)
on the affinity of##2##4##(1994-5#2)
on the age##2##3##(2008-9#1)(2009-7#1)
on the aggregation of##2##4##(2008-10#2)
on the alpha##2##3##(1994-5#1)(1995-11#1)
on the amount of##12##4##(1993-8#1)(1996-6#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-9#1)(2009-7#1)
on the amount##14##3##(1993-8#1)(1996-6#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-9#1)(2009-7#1)
on the amperometric##3##3##(2008-10#3)
on the analysis of##11##4##(1994-2#1)(2008-10#7)(2008-12#1)(2010-10#1)(2010-9#1)
on the analysis##13##3##(1994-2#1)(2008-10#8)(2008-12#1)(2010-10#1)(2010-12#1)(2010-9#1)
on the analyte##3##3##(2008-10#3)
on the analytical performance of the##2##6##(2008-10#2)
on the analytical signal##4##4##(2008-10#4)
on the analytical##12##3##(2008-10#11)(2011-2#1)
on the analyzed##2##3##(2008-10#1)(2009-10#1)
on the angular##2##3##(2008-2#1)(2008-3#1)
on the anterior##3##3##(1996-9#1)(2008-10#1)(2008-12#1)
on the appearance of##2##4##(2008-11#1)(2008-5#1)
on the application of a##2##5##(2008-10#2)
on the application of##14##4##(1993-11#1)(2008-10#7)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
on the application##15##3##(1993-11#1)(2008-10#8)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
on the applied##6##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
on the approach to##2##4##(1993-6#1)(2008-10#1)
on the appropriate##2##3##(2008-10#1)(2013-1#1)
on the aqueous##2##3##(2008-10#2)
on the area of##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
on the assessment and management of foot ulcers for people with diabetes##2##12##(2010-10#2)
on the assessment of##4##4##(2008-10#1)(2008-11#1)(2009-1#1)(2010-5#1)
on the assessment##6##3##(2008-10#1)(2008-11#1)(2009-1#1)(2010-10#2)(2010-5#1)
on the association of##4##4##(2010-12#1)(2012-12#1)(2012-2#2)
on the association##5##3##(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#2)
on the assumption that##6##4##(2008-10#2)(2008-11#1)(2008-3#2)(2009-7#1)
on the assumption##8##3##(2008-10#4)(2008-11#1)(2008-3#2)(2009-7#1)
on the atmospheric##2##3##(2008-10#1)(2008-3#1)
on the availability of##8##4##(1990-12#1)(1991-1#1)(1993-11#1)(1994-12#1)(2008-10#1)(2008-9#2)(2009-3#1)
on the available##5##3##(2008-10#1)(2008-11#2)(2008-12#1)(2012-2#1)
on the average##6##3##(2008-10#4)(2011-2#1)(2012-3#1)
on the back of a##2##5##(2008-11#2)
on the back##6##3##(2008-11#2)(2008-5#2)(2011-2#2)
on the bacterial##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
on the bare##2##3##(2008-10#2)
on the basal##3##3##(1995-2#1)(2008-12#1)(2008-5#1)
on the base of##2##4##(2008-10#1)(2008-11#1)
on the base##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
on the bases of##2##4##(1995-2#1)(2008-10#1)
on the basis of a##13##5##(1990-2#1)(1991-3#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
on the basis of an##3##5##(1994-6#1)(2008-10#1)(2010-11#1)
on the basis of host reactions##2##6##(2008-10#2)
on the basis of its##4##5##(1992-12#1)(2008-10#2)(2008-3#1)
on the basis of sclerotial morphology##2##6##(2008-10#2)
on the basis of the response of the##2##8##(2008-10#2)
on the basis of the##31##5##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1992-12#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-3#1)(1997-2#1)(2008-10#14)(2008-11#2)(2008-3#2)(2009-4#1)(2009-6#1)
on the basis of their##15##5##(1993-12#1)(1993-8#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#1)
on the basis of these##6##5##(2008-10#3)(2008-5#1)(2009-11#1)(2013-1#1)
on the basis of two##2##5##(1990-12#1)(2008-10#1)
on the basis of##179##4##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#2)(1992-7#1)(1993-12#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#3)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#58)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#1)
on the basis##180##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#2)(1992-7#1)(1993-12#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#3)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#58)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#1)
on the battery##2##3##(1996-5#1)(2008-10#1)
on the beads##3##3##(1995-6#1)(2008-10#2)
on the behavior of##2##4##(2008-10#1)(2009-12#1)
on the behavior##3##3##(2008-10#1)(2009-12#1)(2009-8#1)
on the behaviour of the##2##5##(2008-10#1)(2008-5#1)
on the benefits##2##3##(1995-12#1)(1995-6#1)
on the best##3##3##(1996-2#1)(2008-11#1)(2008-9#1)
on the beta##2##3##(1997-1#1)(2010-5#1)
on the binding of##7##4##(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#3)(2008-3#1)
on the binding##12##3##(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#3)(1995-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)
on the biochemical##3##3##(1991-9#1)(1993-8#2)
on the biodiversity##2##3##(2008-8#1)(2012-2#1)
on the biological control##2##4##(2008-10#1)(2008-8#1)
on the biological##7##3##(1991-12#1)(1997-7#1)(2008-10#3)(2008-7#1)(2008-8#1)
on the biology and##2##4##(2008-12#1)(2008-6#1)
on the biology of##2##4##(2008-10#1)(2008-12#1)
on the biology##4##3##(2008-10#1)(2008-12#2)(2008-6#1)
on the biomass of##2##4##(2008-10#1)(2008-8#1)
on the biomass##5##3##(2008-10#4)(2008-8#1)
on the biosensor##4##3##(2008-10#4)
on the blood##4##3##(1996-11#1)(1997-1#1)(2008-10#1)(2008-7#1)
on the body##2##3##(2008-6#1)(2008-8#1)
on the bottom of the##2##5##(2008-10#1)(2012-4#1)
on the bottom of##3##4##(2008-10#1)(2008-9#1)(2012-4#1)
on the bottom##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-4#1)
on the brain##3##3##(2008-11#1)(2013-8#2)
on the buccal##2##3##(1991-2#1)(2012-3#1)
on the calculation##4##3##(2008-10#4)
on the carbon##3##3##(2008-10#3)
on the carcinogenicity of asbestos fibers##2##6##(1991-12#2)
on the cardiovascular system##2##4##(2008-7#2)
on the care of##2##4##(2008-1#1)(2010-8#1)
on the carrier##2##3##(2008-10#1)(2008-7#1)
on the cartridge##2##3##(2008-10#2)
on the case##2##3##(2008-6#1)(2008-9#1)
on the cast films##3##4##(2008-11#3)
on the cast membranes made of##2##6##(2008-11#2)
on the cast membranes was##2##5##(2008-11#2)
on the cast membranes##4##4##(2008-11#4)
on the cast##8##3##(2008-11#8)
on the category##2##3##(1996-2#1)(2008-9#1)
on the cation##3##3##(2008-10#3)
on the causes of##3##4##(2008-10#2)(2012-12#1)
on the cell surface of##2##5##(2008-10#1)(2008-11#1)
on the cell surface##8##4##(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#3)(2009-9#1)(2011-2#1)
on the cell##22##3##(1993-8#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-11#11)(2008-3#1)(2008-9#2)(2009-9#1)(2011-2#1)
on the cellular##5##3##(1994-8#1)(2008-11#1)(2009-12#2)(2011-1#1)
on the cellulose tris(3##2##4##(2008-10#2)
on the central nervous system##2##5##(1990-9#1)(1996-12#1)
on the central nervous##3##4##(1990-9#1)(1995-12#1)(1996-12#1)
on the central##4##3##(1990-9#1)(1995-12#1)(1996-12#1)(2008-10#1)
on the cesium##2##3##(2008-3#2)
on the challenges##2##3##(1996-2#1)(2008-10#1)
on the changes in##4##4##(1990-8#1)(2008-10#2)(2008-6#1)
on the changes##6##3##(1990-8#1)(1996-2#1)(2008-10#2)(2008-6#1)(2008-8#1)
on the characterisation of##2##4##(1995-3#1)(2008-10#1)
on the characteristic##2##3##(2008-3#1)(2011-2#1)
on the characteristics of the##6##5##(1997-7#1)(2008-10#3)(2011-2#1)(2012-2#1)
on the characteristics of##8##4##(1994-2#1)(1997-7#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-2#1)
on the characteristics##9##3##(1994-2#1)(1997-7#1)(2008-10#4)(2008-3#1)(2011-2#1)(2012-2#1)
on the characterization of the##2##5##(1994-5#1)(1996-2#1)
on the characterization of##3##4##(1994-5#1)(1996-2#1)(2008-8#1)
on the charge##3##3##(2008-10#3)
on the cheek##5##3##(2008-5#5)
on the chemical##15##3##(1994-5#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)(2013-8#3)
on the chemiluminescence (CL) reaction between##2##6##(2008-10#2)
on the chemiluminescence (CL) reaction##3##5##(2008-10#3)
on the chemiluminescence emission##2##4##(2008-10#2)
on the chemiluminescence generated##2##4##(2008-10#2)
on the chemiluminescence##13##3##(2008-10#13)
on the chemiluminescent reaction of##2##5##(2008-10#2)
on the chemistry of groundwater samples##2##6##(2013-1#2)
on the chest wall##3##4##(1991-12#1)(2010-6#1)(2013-1#1)
on the chest##4##3##(1991-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
on the child##2##3##(1995-5#1)(2008-11#1)
on the chip##2##3##(2008-10#2)
on the chiral##2##3##(2008-10#2)
on the chromatogram##3##3##(2008-10#3)
on the chromatographic behavior of##2##5##(2008-10#2)
on the chromatographic##5##3##(2008-10#5)
on the chromosomal##2##3##(2008-11#1)(2008-12#1)
on the classical##2##3##(2008-11#1)(2009-9#1)
on the classification##2##3##(2008-10#1)(2011-2#1)
on the clinical##9##3##(1990-2#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-6#1)
on the cloud##2##3##(2008-10#1)(2008-3#1)
on the collection##2##3##(1996-3#1)(2008-12#1)
on the color##4##3##(2008-10#3)(2009-8#1)
on the column was##2##4##(2008-10#2)
on the column##10##3##(2008-10#10)
on the combination of##4##4##(2008-10#3)(2008-9#1)
on the combined##5##3##(2008-10#5)
on the comparative##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
on the comparison of the##2##5##(1990-8#1)(2008-10#1)
on the comparison of##3##4##(1990-8#1)(2008-10#2)
on the comparison##4##3##(1990-8#1)(1996-3#1)(2008-10#2)
on the competitive intensity between the competing pairs##2##8##(2008-8#2)
on the competitive##6##3##(2008-10#4)(2008-8#2)
on the complex formation of##2##5##(2008-10#2)
on the complex formation##3##4##(2008-10#3)
on the complex##9##3##(2008-10#8)(2008-3#1)
on the complexation of##2##4##(2008-10#2)
on the complexation reaction##3##4##(2008-10#3)
on the complexation##8##3##(2008-10#8)
on the composition of##4##4##(1997-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
on the composition##5##3##(1997-7#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
on the computer##2##3##(1995-2#1)(2008-11#1)
on the concentration and lipophilicity of##2##6##(2008-10#2)
on the concentration and##5##4##(2008-10#5)
on the concentration of##11##4##(1992-12#1)(1997-4#1)(2008-10#8)(2012-2#1)
on the concentration##17##3##(1992-12#1)(1997-4#1)(2008-10#14)(2012-2#1)
on the concentrations of##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
on the concept of##7##4##(1997-6#1)(2008-10#3)(2008-3#1)(2012-2#1)(2013-1#1)
on the concept##9##3##(1997-6#1)(2008-10#3)(2008-3#2)(2012-2#2)(2013-1#1)
on the condition of the##2##5##(1991-3#1)(2008-6#1)
on the condition of##3##4##(1991-3#1)(2008-6#1)(2008-9#1)
on the condition##4##3##(1991-3#1)(2008-10#1)(2008-6#1)(2008-9#1)
on the conditions##2##3##(1996-2#1)(1996-8#1)
on the conformation of the##3##5##(1994-5#1)(2008-10#1)(2008-8#1)
on the conformation of##5##4##(1994-5#1)(1996-2#1)(2008-10#1)(2008-8#2)
on the conformation##7##3##(1994-5#1)(1996-2#1)(2008-10#1)(2008-8#2)(2009-3#2)
on the conformational##2##3##(1995-6#1)(2008-10#1)
on the construction of##3##4##(2008-11#1)(2008-4#1)(2013-8#1)
on the construction##4##3##(2008-11#1)(2008-4#1)(2009-8#1)(2013-8#1)
on the consumption of##2##4##(1994-5#1)(2008-10#1)
on the continuous##3##3##(1997-7#1)(2008-10#2)
on the continuum##2##3##(1991-1#1)(2008-10#1)
on the contrary##7##3##(1991-2#1)(1991-3#1)(1994-11#1)(1997-1#1)(1997-8#1)(2008-10#1)(2009-10#1)
on the contribution of##4##4##(1993-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
on the control of##5##4##(1993-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
on the control##7##3##(1993-6#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-2#1)(2013-1#1)
on the convex##2##3##(2008-10#1)(2012-2#1)
on the copper wire##2##4##(2008-10#2)
on the corneal graft##3##4##(2011-2#3)
on the corneal##4##3##(2011-2#4)
on the coronary##2##3##(2012-2#1)(2012-3#1)
on the correct##2##3##(2008-7#1)(2008-9#1)
on the correlation between##2##4##(1997-6#1)(2008-10#1)
on the cost of##2##4##(1996-1#1)(2008-9#1)
on the cost##3##3##(1992-2#1)(1996-1#1)(2008-9#1)
on the critical##4##3##(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#1)
on the cultural##2##3##(2008-5#1)(2010-1#1)
on the culture##4##3##(2008-10#1)(2008-11#2)(2009-6#1)
on the cultured##2##3##(1993-3#1)(2008-11#1)
on the current knowledge of##2##5##(2008-10#1)(2011-1#1)
on the current state##2##4##(2011-2#1)(2013-1#1)
on the current##13##3##(1994-1#1)(2008-10#2)(2008-11#3)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
on the cytosolic##2##3##(1992-6#1)(1994-6#1)
on the data##9##3##(1991-5#1)(2008-10#5)(2008-11#1)(2008-3#2)
on the day of##8##4##(1996-1#2)(2008-10#3)(2008-5#1)(2010-6#1)(2012-2#1)
on the day##10##3##(1994-6#1)(1996-1#2)(2008-10#3)(2008-5#1)(2010-6#2)(2012-2#1)
on the decision to##2##4##(1997-1#1)(2008-9#1)
on the decision##5##3##(1995-9#1)(1997-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
on the deep##2##3##(2008-10#1)(2011-2#1)
on the definition of##2##4##(2011-2#1)(2012-2#1)
on the deflection##2##3##(2008-10#1)(2008-3#1)
on the degree of the##3##5##(2008-10#3)
on the degree of##18##4##(1991-2#1)(1991-3#1)(1993-11#1)(1993-6#1)(1995-8#1)(2008-10#6)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)
on the degree to which##2##5##(2008-8#1)(2008-9#1)
on the degree##20##3##(1991-2#1)(1991-3#1)(1993-11#1)(1993-6#1)(1995-8#1)(2008-10#6)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)
on the densities##2##3##(1994-2#1)(2008-10#1)
on the derivatization reaction##3##4##(2008-10#3)
on the derivatization##5##3##(2008-10#5)
on the design and##2##4##(1992-2#1)(1996-2#1)
on the design##6##3##(1992-2#1)(1996-2#1)(2008-12#1)(2010-8#1)(2012-2#2)
on the detection and##2##4##(1990-6#1)(2008-4#1)
on the detection of##12##4##(1992-6#1)(2008-10#9)(2008-8#1)(2009-3#1)
on the detection##16##3##(1990-6#1)(1992-6#1)(2008-10#11)(2008-4#1)(2008-8#1)(2009-3#1)
on the determination of bismuth##2##5##(2008-10#2)
on the determination of these##2##5##(2008-10#2)
on the determination of##44##4##(1991-12#1)(2008-10#43)
on the determination##46##3##(1991-12#1)(2008-10#45)
on the development of an##3##5##(2008-11#2)(2012-2#1)
on the development of cognition##2##5##(2009-7#2)
on the development of humoral##2##5##(1993-12#2)
on the development of new##2##5##(2008-5#1)(2010-7#1)
on the development of novel##2##5##(2008-10#1)(2011-2#1)
on the development of the##8##5##(1995-12#2)(1996-12#1)(2008-10#3)(2008-12#1)(2010-1#1)
on the development of##51##4##(1990-12#1)(1990-5#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(2008-10#14)(2008-11#5)(2008-12#4)(2008-5#2)(2008-9#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
on the development##53##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#15)(2008-11#5)(2008-12#4)(2008-5#2)(2008-9#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
on the diagnosis and##2##4##(1995-9#1)(2010-12#1)
on the diagnosis##3##3##(1995-9#1)(2008-10#1)(2010-12#1)
on the diagnostic##6##3##(1990-2#1)(2008-11#1)(2008-12#2)(2008-5#1)(2012-2#1)
on the difference in##3##4##(2008-10#3)
on the difference##6##3##(2008-10#6)
on the differences in##2##4##(2008-4#1)(2008-9#1)
on the differences##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
on the different##9##3##(1991-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
on the differential##7##3##(1991-11#1)(2008-10#4)(2008-9#1)(2010-7#1)
on the differentiation##2##3##(2008-11#1)(2010-12#1)
on the diffusion##2##3##(2008-10#2)
on the direct##9##3##(2008-10#8)(2008-8#1)
on the disease##3##3##(2008-10#3)
on the dispersion of##2##4##(2008-10#2)
on the dissociation constants##2##4##(2008-10#2)
on the dissociation##3##3##(2008-10#3)
on the dissolution##2##3##(2008-10#2)
on the distal##8##3##(1996-8#1)(2007-12#4)(2008-8#1)(2012-3#1)(2013-1#1)
on the distribution and##2##4##(1994-5#1)(2008-11#1)
on the distribution of##7##4##(2008-10#2)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#2)
on the distribution##12##3##(1991-5#1)(1994-5#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#2)
on the diversity##4##3##(1992-8#1)(2008-10#1)(2008-6#1)(2012-3#1)
on the doctors'##2##3##(1993-11#1)(2011-2#1)
on the donor##2##3##(2008-10#1)(2008-11#1)
on the dorsal side of the##2##6##(2008-5#1)(2008-7#1)
on the dorsal side of##3##5##(2008-5#1)(2008-7#1)(2011-2#1)
on the dorsal side##4##4##(2008-5#2)(2008-7#1)(2011-2#1)
on the dorsal##5##3##(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)
on the dorsum of##2##4##(2010-3#1)(2012-3#1)
on the drug for##2##4##(2008-8#1)(2012-3#1)
on the drug or##2##4##(1992-9#1)(2008-10#1)
on the drug##7##3##(1992-3#1)(1992-9#1)(1996-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
on the dual##2##3##(2008-10#2)
on the duration of##2##4##(2008-11#2)
on the dynamic##2##3##(2008-10#1)(2008-7#1)
on the dynamics of##3##4##(1995-9#1)(2008-10#1)(2008-9#1)
on the dynamics##4##3##(1995-9#1)(2008-10#1)(2008-9#1)(2013-8#1)
on the early##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)
on the ease of##2##4##(2008-10#1)(2012-3#1)
on the ecological##5##3##(2008-11#2)(2008-8#1)(2012-3#2)
on the economic##2##3##(1995-5#1)(2009-10#1)
on the effect of different##2##5##(2008-10#1)(2012-8#1)
on the effect of the##2##5##(2008-11#1)(2011-2#1)
on the effect of##22##4##(1990-12#1)(1991-2#1)(1992-9#1)(1995-9#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-9#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-3#2)(2012-8#1)
on the effect that##2##4##(2008-10#1)(2008-8#1)
on the effect##24##3##(1990-12#1)(1991-2#1)(1992-9#1)(1995-9#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-3#2)(2012-8#1)
on the effective##3##3##(1992-9#1)(2008-10#2)
on the effectiveness of the##2##5##(2008-10#1)(2013-1#1)
on the effectiveness of##8##4##(1992-12#1)(2008-10#1)(2011-2#1)(2012-2#2)(2013-1#3)
on the effector##2##3##(1995-2#1)(2011-2#1)
on the effects of the##2##5##(2012-12#1)(2013-1#1)
on the effects of##23##4##(1991-2#2)(1992-12#1)(1993-11#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-11#5)(2008-5#3)(2008-7#1)(2009-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
on the effects##26##3##(1991-2#2)(1992-12#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-3#1)(2008-10#5)(2008-11#5)(2008-5#3)(2008-7#1)(2009-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
on the efficacy of##5##4##(1993-5#1)(1996-3#1)(2008-11#1)(2013-1#1)(2013-8#1)
on the efficacy##7##3##(1993-5#1)(1996-3#1)(2008-11#1)(2008-5#1)(2013-1#2)(2013-8#1)
on the efficiency of##6##4##(1992-12#1)(2008-10#3)(2008-12#1)(2009-10#1)
on the efficiency##7##3##(1992-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-10#1)
on the eighth##2##3##(2011-2#2)
on the electrochemical##5##3##(2008-10#2)(2008-8#2)(2010-6#1)
on the electrode and##2##4##(1990-5#1)(2008-10#1)
on the electrode response##2##4##(2008-10#2)
on the electrode surface and##2##5##(2008-10#2)
on the electrode surface via##2##5##(2008-10#2)
on the electrode surface##21##4##(2008-10#21)
on the electrode##38##3##(1990-5#1)(2008-10#37)
on the electronic##2##3##(2008-10#2)
on the electrostatic##2##3##(2008-10#1)(2013-1#1)
on the elevated##2##3##(2011-2#1)(2013-1#1)
on the emission of rubidium##2##5##(2008-10#2)
on the emission of##3##4##(2008-10#3)
on the emission##4##3##(2008-10#4)
on the end##2##3##(2008-10#1)(2008-12#1)
on the endocrine##2##3##(1991-3#1)(2008-11#1)
on the endoplasmic reticulum membrane##2##5##(1995-6#2)
on the endoplasmic reticulum##3##4##(1995-6#2)(2008-11#1)
on the energy metabolism##2##4##(2008-11#2)
on the energy##4##3##(2008-10#1)(2008-11#2)(2009-8#1)
on the enhanced##2##3##(1992-9#1)(2008-10#1)
on the enhancing effect of##2##5##(2008-10#2)
on the enhancing effect##3##4##(2008-10#3)
on the enrichment##2##3##(2011-2#2)
on the entire##2##3##(1996-12#1)(1997-3#1)
on the environment##5##3##(1991-6#1)(2008-10#4)
on the enzymatic##3##3##(2008-10#2)(2008-12#1)
on the enzyme activity##2##4##(1990-5#1)(1993-3#1)
on the enzyme##6##3##(1990-5#1)(1993-3#1)(1994-8#1)(2008-10#2)(2008-7#1)
on the epidemiology of the##2##5##(2008-10#1)(2008-9#1)
on the epidemiology of##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
on the epidemiology##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
on the epidermis##2##3##(2008-5#2)
on the equilibrium##3##3##(2008-10#3)
on the establishment of##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
on the estimation of##3##4##(1992-9#1)(2008-10#1)(2008-12#1)
on the etiology and##2##4##(2009-9#1)(2013-8#1)
on the etiology##4##3##(1996-11#1)(2008-1#1)(2009-9#1)(2013-8#1)
on the evaluation of##4##4##(2008-10#3)(2008-5#1)
on the evaluation##5##3##(1996-2#1)(2008-10#3)(2008-5#1)
on the evidence##4##3##(1993-12#1)(2010-1#1)(2011-2#1)(2013-1#1)
on the evolution of the##5##5##(1997-9#1)(2007-12#1)(2008-10#2)(2008-8#1)
on the evolution of##15##4##(1991-5#1)(1995-5#1)(1997-9#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-8#3)(2008-9#1)(2012-3#2)
on the evolutionary##4##3##(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
on the exact##2##3##(2008-9#2)
on the excess##2##3##(1995-2#1)(2008-10#1)
on the exchange##2##3##(2008-10#1)(2008-11#1)
on the excitation##2##3##(2008-10#1)(2008-3#1)
on the excretion##2##3##(1990-5#1)(1994-5#1)
on the existence of##2##4##(1994-2#1)(2008-10#1)
on the existence##3##3##(1994-2#1)(2008-10#1)(2008-8#1)
on the existing##3##3##(1992-1#1)(2012-3#1)(2013-1#1)
on the expected##3##3##(1993-1#1)(2008-10#1)(2011-2#1)
on the experience of##5##4##(1992-3#1)(2008-12#2)(2008-7#1)(2012-12#1)
on the experience##6##3##(1992-3#1)(1995-12#1)(2008-12#2)(2008-7#1)(2012-12#1)
on the experiences##2##3##(2008-10#1)(2008-12#1)
on the experimental results##2##4##(2008-10#1)(2008-8#1)
on the experimental##10##3##(1990-8#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
on the exposure of##2##4##(1993-8#1)(2008-8#1)
on the expression and##3##4##(1990-2#1)(2007-12#1)(2013-8#1)
on the expression level##2##4##(2008-10#1)(2010-5#1)
on the expression of the aggrecan##2##6##(1992-1#2)
on the expression of the##4##5##(1992-1#2)(1994-11#1)(1997-3#1)
on the expression of##28##4##(1990-3#1)(1990-5#1)(1992-1#2)(1992-3#1)(1994-11#1)(1996-12#2)(1997-3#1)(1997-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-1#2)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
on the expression##34##3##(1990-2#1)(1990-3#1)(1990-5#1)(1992-1#2)(1992-3#1)(1994-11#1)(1996-12#2)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#2)
on the extent of##2##4##(1997-8#1)(2008-8#1)
on the extent##3##3##(1993-8#1)(1997-8#1)(2008-8#1)
on the external surface##3##4##(2008-10#3)
on the external##6##3##(1996-9#2)(2008-10#4)
on the extraction and##2##4##(2008-10#2)
on the extraction efficiency of##2##5##(2008-10#2)
on the extraction of the##2##5##(2008-10#2)
on the extraction of##7##4##(2008-10#7)
on the extraction##19##3##(2008-10#19)
on the extraction-ability and -selectivity##2##5##(2008-10#2)
on the face and##2##4##(2010-6#1)(2011-2#1)
on the face##5##3##(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#2)
on the fact that the##4##5##(2008-10#4)
on the fact that##9##4##(1993-9#1)(2008-10#8)
on the factors that##3##4##(1991-2#1)(1995-12#1)(2013-1#1)
on the factors##6##3##(1991-2#1)(1992-2#1)(1995-12#1)(1996-3#1)(2009-6#1)(2013-1#1)
on the family##2##3##(2008-10#1)(2008-11#1)
on the features##2##3##(2009-7#1)(2010-8#1)
on the fibre##2##3##(2008-10#2)
on the film and##2##4##(2008-10#2)
on the filter were##2##4##(2008-10#2)
on the filter##5##3##(2008-10#5)
on the final height##2##4##(2007-11#2)
on the final##5##3##(2007-11#3)(2008-5#1)(2010-12#1)
on the findings of##3##4##(1996-3#1)(2008-7#1)(2012-2#1)
on the findings##8##3##(1991-12#1)(1996-3#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
on the first day of##2##5##(1990-12#1)(1993-12#1)
on the first day##5##4##(1990-12#3)(1993-12#1)(2008-5#1)
on the first upper true leaves at 14##2##8##(2008-10#2)
on the first##14##3##(1990-12#3)(1993-12#1)(1993-3#1)(1994-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
on the floor##2##3##(1996-5#1)(2008-11#1)
on the flow rate##3##4##(2008-10#3)
on the flow##4##3##(2008-10#4)
on the fluorescence enhancement of##3##5##(2008-10#3)
on the fluorescence of##2##4##(2008-10#1)(2008-9#1)
on the fluorescence##17##3##(1996-2#1)(2008-10#15)(2008-9#1)
on the fluorescent##2##3##(2008-10#2)
on the folding##2##3##(1991-6#1)(1992-6#1)
on the following##7##3##(2008-10#3)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#1)
on the forehead##4##3##(2008-5#3)(2010-6#1)
on the formation and##2##4##(2008-10#2)
on the formation of an##3##5##(2008-10#3)
on the formation of the complex##2##6##(2008-10#2)
on the formation of the##8##5##(1991-3#1)(2008-10#6)(2011-2#1)
on the formation of##35##4##(1991-3#1)(1992-5#1)(2008-10#32)(2011-2#1)
on the formation##39##3##(1991-3#1)(1992-5#1)(2008-10#36)(2011-2#1)
on the formulation##3##3##(1995-12#1)(2008-5#2)
on the found##2##3##(2008-10#2)
on the four##2##3##(1993-2#1)(1997-8#1)
on the fraction of##4##4##(1994-5#1)(2008-10#2)(2011-3#1)
on the frequency of##4##4##(1990-8#1)(1997-1#1)(1997-3#1)(2008-5#1)
on the frequency##5##3##(1990-8#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-5#1)
on the front##2##3##(2008-10#1)(2008-3#1)
on the fruit fly##2##4##(2010-5#1)(2013-8#1)
on the fruit##3##3##(2008-10#1)(2010-5#1)(2013-8#1)
on the full##2##3##(2007-11#1)(2012-2#1)
on the function and##2##4##(1994-5#1)(2008-11#1)
on the function of##6##4##(1994-5#1)(1996-2#1)(2008-11#2)(2008-4#1)(2008-9#1)
on the function##8##3##(1994-5#2)(1996-2#1)(2008-11#3)(2008-4#1)(2008-9#1)
on the functional##4##3##(2008-10#1)(2008-8#1)(2009-12#1)(2009-9#1)
on the functions##2##3##(2007-12#1)(2008-9#1)
on the future of##2##4##(1997-2#1)(2008-11#1)
on the future##3##3##(1997-2#1)(2008-11#1)(2013-1#1)
on the gel##2##3##(1993-8#1)(2008-10#1)
on the gene expression##2##4##(1992-6#1)(1993-9#1)
on the gene##3##3##(1992-6#1)(1993-9#1)(1996-6#1)
on the general##5##3##(1993-12#1)(1993-2#1)(2008-5#1)(2008-7#1)(2012-3#1)
on the generation of##4##4##(1991-5#1)(1996-2#1)(2008-4#2)
on the generic##2##3##(1996-3#1)(2008-6#1)
on the genes##2##3##(2008-8#1)(2011-2#1)
on the genetic map of##3##5##(1996-12#2)(2008-10#1)
on the genetic map##5##4##(1992-4#1)(1996-12#2)(1996-6#1)(2008-10#1)
on the genetic structure of##3##5##(2008-8#1)(2012-3#1)(2013-8#1)
on the genetic##17##3##(1992-4#1)(1995-12#1)(1996-12#2)(1996-6#1)(2008-10#5)(2008-12#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-8#1)
on the genetics and##2##4##(2008-10#1)(2008-8#1)
on the genetics of resistance in##2##6##(2008-10#1)(2011-10#1)
on the genetics of##3##4##(2008-10#2)(2011-10#1)
on the genetics##5##3##(2008-10#3)(2008-8#1)(2011-10#1)
on the genome of Synechocystis sp##4##6##(1996-8#1)(1997-2#1)(1997-6#2)
on the genome of##5##4##(1995-6#1)(1996-8#1)(1997-2#1)(1997-6#2)
on the genome##8##3##(1995-6#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-6#2)
on the genomic##3##3##(1997-3#1)(2008-10#1)(2013-8#1)
on the geometric##2##3##(2008-10#1)(2008-8#1)
on the gingiva##3##3##(1993-1#2)(2012-12#1)
on the glass##2##3##(2008-10#2)
on the glassy carbon electrode (GCE)##2##6##(2008-10#2)
on the glassy carbon electrode##3##5##(2008-10#3)
on the glassy carbon##4##4##(2008-10#4)
on the glucose##4##3##(2008-10#3)(2012-12#1)
on the gold electrode surface##2##5##(2008-10#2)
on the gold electrode##3##4##(2008-10#3)
on the gold##4##3##(2008-10#4)
on the government's##2##3##(1996-5#1)(2008-11#1)
on the graphite electrode surface##2##5##(2008-10#2)
on the graphite##4##3##(2008-10#4)
on the grating length##2##4##(2007-12#1)(2008-3#1)
on the grating##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
on the ground##6##3##(1990-8#1)(2008-10#3)(2008-9#1)(2009-6#1)
on the grounds that it##2##5##(1995-12#1)(1997-4#1)
on the grounds that##4##4##(1991-12#1)(1995-12#1)(1997-4#1)(2011-2#1)
on the group##3##3##(2008-2#1)(2009-10#1)(2013-8#1)
on the grove floor##3##4##(2008-10#3)
on the growth and metabolism of##2##6##(2008-11#2)
on the growth and##8##4##(1994-8#1)(2008-11#4)(2008-12#2)(2008-9#1)
on the growth of human##2##5##(1994-8#1)(2008-11#1)
on the growth of##22##4##(1990-11#1)(1991-5#1)(1993-3#1)(1994-8#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-7#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
on the growth rate of the##2##6##(2008-10#1)(2008-7#1)
on the growth rate of##3##5##(2008-10#1)(2008-12#1)(2008-7#1)
on the growth rate##4##4##(2008-10#2)(2008-12#1)(2008-7#1)
on the growth##36##3##(1990-11#1)(1991-5#1)(1993-3#1)(1994-8#2)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#7)(2008-11#9)(2008-12#5)(2008-7#2)(2008-9#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
on the hair##3##3##(2008-5#2)(2008-8#1)
on the hands of##2##4##(2007-12#1)(2008-10#1)
on the hands##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
on the hanging mercury drop electrode##2##6##(2008-10#2)
on the head##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
on the health care##7##4##(1991-12#1)(1993-2#1)(1993-3#1)(1997-3#2)(2013-1#2)
on the health of##2##4##(2008-11#1)(2012-12#1)
on the health##14##3##(1991-12#1)(1991-3#2)(1992-3#1)(1993-2#1)(1993-3#1)(1994-6#1)(1997-3#2)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
on the healthy##3##3##(2009-6#1)(2012-3#1)(2013-7#1)
on the heart##2##3##(2008-7#1)(2009-12#1)
on the heat tolerance of##2##5##(2010-4#2)
on the heterogeneity of the test##2##6##(2008-10#2)
on the hexagonal column##2##4##(2008-3#2)
on the high##4##3##(1993-6#1)(1996-12#1)(2008-10#1)(2008-9#1)
on the higher##2##3##(2008-10#2)
on the history##2##3##(2012-12#1)(2012-3#1)
on the hospital##2##3##(1992-3#1)(1993-3#1)
on the host cell##2##4##(2008-11#1)(2010-1#1)
on the host from which##2##5##(2008-10#2)
on the host##13##3##(2008-10#9)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)
on the human erythrocyte membrane##2##5##(1990-12#1)(2008-11#1)
on the human##9##3##(1990-12#1)(1992-6#1)(2008-10#2)(2008-11#2)(2008-5#2)(2012-3#1)
on the humoral immune##2##4##(2008-11#2)
on the hybrid##2##3##(2008-10#2)
on the hydrolysis of##2##4##(1994-5#2)
on the hypothesis that##4##4##(2008-11#1)(2009-8#1)(2010-8#1)(2013-1#1)
on the idea##2##3##(2009-5#1)(2012-2#1)
on the identification of##4##4##(1991-12#1)(1996-12#1)(2010-10#1)(2013-8#1)
on the immobilization of##3##4##(2008-10#3)
on the immobilization##4##3##(2008-10#4)
on the immobilized##2##3##(2008-10#2)
on the immune response##2##4##(1992-9#1)(1993-8#1)
on the immune system and##2##5##(1990-11#1)(2013-1#1)
on the immune system of##2##5##(1993-12#1)(2008-10#1)
on the immune system were evaluated##2##6##(2008-10#2)
on the immune system were##3##5##(1993-12#1)(2008-10#2)
on the immune system##11##4##(1990-11#1)(1993-12#3)(1995-12#1)(2008-10#5)(2013-1#1)
on the immune##16##3##(1990-11#1)(1992-9#1)(1993-12#3)(1993-8#1)(1995-12#2)(1995-5#1)(2008-10#5)(2008-5#1)(2013-1#1)
on the impact of the##2##5##(1994-1#2)
on the impact of##6##4##(1994-1#2)(2008-11#3)(2012-2#1)
on the implementation strategies adopted for the instruments##2##8##(2013-1#2)
on the implementation##3##3##(1995-3#1)(2013-1#2)
on the implications of##3##4##(1994-1#1)(2008-10#1)(2008-7#1)
on the importance of the##3##5##(1991-3#1)(1996-3#1)(2010-12#1)
on the importance of##11##4##(1990-3#2)(1991-3#1)(1992-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
on the importance##12##3##(1990-3#2)(1991-3#1)(1992-12#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
on the improvement##2##3##(2010-11#1)(2010-6#1)
on the in vitro##7##4##(1990-2#1)(1993-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
on the incidence and##2##4##(2008-10#2)
on the incidence of##6##4##(1990-3#1)(1990-9#1)(1991-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
on the incidence##8##3##(1990-3#1)(1990-9#1)(1991-3#1)(2008-10#3)(2008-7#1)(2012-12#1)
on the incorporation of##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
on the increase of##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
on the increase##6##3##(1995-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2012-2#1)
on the incubation##2##3##(1992-9#1)(2008-10#1)
on the individual##2##3##(1995-2#1)(2008-11#1)
on the induction of##2##4##(1993-11#1)(2008-4#1)
on the induction##3##3##(1993-11#1)(2008-10#1)(2008-4#1)
on the infection of##2##4##(2008-10#1)(2008-8#1)
on the infection##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
on the inflammatory##3##3##(1994-5#1)(2008-3#1)(2008-7#1)
on the influence of##6##4##(2008-10#3)(2008-11#1)(2011-2#1)(2013-1#1)
on the information##6##3##(1991-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1996-2#1)(2008-12#1)
on the inhibition of##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
on the inhibition##6##3##(1997-8#1)(2008-10#4)(2008-11#1)
on the inhibitory##4##3##(1992-6#1)(1995-11#1)(2008-10#2)
on the initial##4##3##(1992-6#1)(1996-6#1)(2008-10#1)(2011-2#1)
on the injection##5##3##(2008-10#3)(2008-12#1)(2010-1#1)
on the injury rate##2##4##(2008-11#2)
on the innate##2##3##(2008-10#1)(2013-1#1)
on the inner surface of the##2##6##(2008-10#2)
on the inner##5##3##(2008-10#5)
on the inside##2##3##(2008-10#2)
on the insulin##2##3##(2008-11#1)(2008-9#1)
on the intact side##2##4##(1996-2#2)
on the intact##4##3##(1990-2#1)(1996-2#2)(2008-10#1)
on the integrated platform of##3##5##(2008-10#3)
on the integration of##4##4##(1995-1#1)(2008-10#3)
on the integrity of##3##4##(1990-5#2)(2008-2#1)
on the intelligentsia##2##3##(2008-12#2)
on the intensity##2##3##(2008-10#1)(2008-9#1)
on the interaction between the##2##5##(2008-10#1)(2010-7#1)
on the interaction between##7##4##(2008-1#1)(2008-10#5)(2010-7#1)
on the interaction of##12##4##(1994-8#1)(2008-10#9)(2008-11#1)(2008-9#1)
on the interaction##20##3##(1994-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-9#1)(2010-7#1)
on the interactions between##3##4##(2008-11#1)(2008-8#2)
on the interactions##4##3##(2008-11#1)(2008-8#2)(2010-4#1)
on the internal##2##3##(1990-2#1)(2008-10#1)
on the international##2##3##(1991-11#1)(2010-12#1)
on the interpretation of the##2##5##(2008-7#1)(2009-6#1)
on the interpretation of##4##4##(1994-3#1)(2008-12#1)(2008-7#1)(2009-6#1)
on the interpretation##5##3##(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)
on the interval of the##2##5##(2008-5#2)
on the intestinal##3##3##(2008-11#3)
on the intracellular nucleotide##2##4##(2008-11#2)
on the intracellular##4##3##(1995-8#1)(2008-11#3)
on the invasion of##3##4##(2008-11#3)
on the invasion##5##3##(2008-10#1)(2008-11#4)
on the inversion##2##3##(2008-3#2)
on the ion##3##3##(2008-10#3)
on the ion-pairing principle using##2##5##(2008-10#2)
on the ionization of##2##4##(2008-10#2)
on the island of##3##4##(1995-6#1)(2008-10#1)(2011-2#1)
on the island##4##3##(1995-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
on the isolate##2##3##(2008-10#1)(2011-2#1)
on the isolated gamma subunit is at##2##7##(2008-8#2)
on the isomer##2##3##(2008-5#1)(2009-9#1)
on the isothermal characteristics of##2##5##(1997-2#2)
on the isothermal##3##3##(1997-2#3)
on the issue of##4##4##(1992-2#1)(2008-9#1)(2009-10#2)
on the issue##6##3##(1992-2#1)(1994-1#2)(2008-9#1)(2009-10#2)
on the issues of##2##4##(1991-3#1)(1993-2#1)
on the issues##3##3##(1991-3#1)(1993-2#1)(2012-3#1)
on the job in##2##4##(1993-2#2)
on the job##6##3##(1993-2#3)(1994-2#1)(1994-3#1)(1996-2#1)
on the joint##2##3##(1994-3#1)(2012-3#1)
on the key##4##3##(1991-7#1)(1992-9#1)(2008-11#1)(2010-12#1)
on the kind of##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
on the kinetic##3##3##(1993-8#1)(1996-2#1)(2008-10#1)
on the kinetics of##3##4##(2008-10#2)(2008-8#1)
on the kinetics##5##3##(1995-12#1)(2008-10#2)(2008-7#1)(2008-8#1)
on the knowledge##4##3##(2008-10#2)(2008-5#1)(2012-3#1)
on the labeling pattern of the##2##6##(2008-7#2)
on the lack of##4##4##(1993-12#1)(2008-10#1)(2008-9#1)(2009-8#1)
on the large##2##3##(2008-10#1)(2009-8#1)
on the laser##2##3##(2007-12#1)(2008-3#1)
on the late control##2##4##(2013-1#2)
on the late##3##3##(2008-9#1)(2013-1#2)
on the latest##2##3##(2008-9#1)(2012-2#1)
on the latter##2##3##(2008-10#2)
on the leaf surface##2##4##(2008-10#2)
on the leaf##8##3##(2008-10#8)
on the leaves of##2##4##(2008-10#1)(2011-3#1)
on the leaves##4##3##(2008-10#3)(2011-3#1)
on the left arm of chromosome##6##6##(1993-9#1)(1995-9#2)(1996-3#2)(1996-6#1)
on the left arm of##8##5##(1993-9#1)(1995-9#3)(1996-3#2)(1996-6#2)
on the left arm##9##4##(1993-9#1)(1995-11#1)(1995-9#3)(1996-3#2)(1996-6#2)
on the left eye##4##4##(2011-2#4)
on the left main stem##2##5##(1990-9#2)
on the left side of the##2##6##(1993-6#1)(2010-12#1)
on the left side##5##4##(1993-6#1)(2008-10#2)(2008-7#1)(2010-12#1)
on the left thumb##2##4##(2010-6#2)
on the left##29##3##(1990-9#2)(1993-6#1)(1993-9#1)(1995-11#1)(1995-9#3)(1996-3#2)(1996-6#2)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-6#4)(2011-2#4)(2012-3#2)(2013-1#2)
on the legs##2##3##(1997-5#1)(2012-3#1)
on the length of##2##4##(1996-12#1)(2008-10#1)
on the length##4##3##(1996-12#1)(2008-10#1)(2008-9#1)(2009-3#1)
on the level of membrane fatty acid composition##2##8##(2011-1#2)
on the level of##16##4##(1991-12#1)(1994-2#1)(1995-1#1)(2008-10#6)(2008-11#2)(2011-1#2)(2011-2#1)(2013-1#2)
on the level##17##3##(1991-12#1)(1994-2#1)(1995-1#1)(2008-10#6)(2008-11#3)(2011-1#2)(2011-2#1)(2013-1#2)
on the levels of NADPH-dependent cytosolic 3##2##7##(1991-5#2)
on the levels of##6##4##(1991-5#2)(1992-8#1)(1994-2#1)(2008-10#2)
on the life##5##3##(1995-12#1)(2008-11#2)(2008-9#1)(2010-10#1)
on the light##2##3##(2008-10#1)(2012-2#1)
on the likelihood of##2##4##(1995-12#1)(2010-10#1)
on the limits##2##3##(2008-10#1)(2008-2#1)
on the line##3##3##(2008-2#1)(2008-3#2)
on the linear relationship between the changes in the##2##9##(2008-10#2)
on the linear relationship between the##3##6##(2008-10#3)
on the link between##4##4##(2008-11#2)(2010-1#2)
on the linkage map##7##4##(1996-12#4)(1996-6#2)(2008-8#1)
on the lipid metabolism##2##4##(1992-11#1)(2008-11#1)
on the lipid##5##3##(1991-5#1)(1992-11#1)(2008-11#1)(2008-5#1)(2009-8#1)
on the liposome surface##2##4##(2008-10#2)
on the liquid-liquid extraction of##2##5##(2008-10#2)
on the loading##2##3##(2008-10#1)(2009-7#1)
on the local##5##3##(1995-12#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
on the localization##2##3##(2008-9#1)(2012-3#1)
on the location##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
on the locations of##2##4##(2008-10#1)(2008-11#1)
on the locomotor rhythm##2##4##(2008-5#1)(2008-6#1)
on the locomotor##3##3##(2008-5#2)(2008-6#1)
on the long arm of chromosome##4##6##(2008-10#3)(2012-12#1)
on the long arm of wheat##2##6##(2008-10#2)
on the long arm of##7##5##(2008-10#6)(2012-12#1)
on the long##8##3##(1997-8#1)(2008-10#6)(2012-12#1)
on the long-term##3##3##(1995-11#1)(2008-8#1)(2012-12#1)
on the low##2##3##(2008-7#1)(2009-8#1)
on the lower bole##2##4##(2008-10#2)
on the lower rim##2##4##(1996-5#2)
on the lower##5##3##(1996-5#2)(2008-10#2)(2011-2#1)
on the lumbosacral area##2##4##(2010-6#2)
on the magnetic beads##2##4##(2008-10#2)
on the magnetic##3##3##(2008-10#3)
on the magnitude of##4##4##(1994-5#1)(2008-10#2)(2008-8#1)
on the magnitude##5##3##(1994-5#1)(2008-10#2)(2008-8#2)
on the main##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
on the major##6##3##(1991-12#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-7#1)
on the management of##6##4##(2008-3#2)(2009-8#2)(2011-2#2)
on the manner##2##3##(1992-1#1)(2008-10#1)
on the mapping of##2##4##(2008-10#1)(2008-11#1)
on the marine environment##3##4##(2008-11#3)
on the marker##2##3##(2008-10#2)
on the market for##4##4##(1990-6#1)(1992-3#2)(1994-2#1)
on the market##12##3##(1990-6#1)(1991-2#1)(1992-3#2)(1994-2#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2009-6#1)
on the mature##4##3##(1995-12#1)(2006-6#1)(2008-9#2)
on the mean##3##3##(2008-10#2)(2008-5#1)
on the meaning of##3##4##(1993-2#1)(1994-9#1)(2011-3#1)
on the measured##2##3##(2008-10#1)(2008-3#1)
on the measurement of the##6##5##(2008-10#6)
on the measurement of##14##4##(2008-10#11)(2008-3#1)(2008-9#2)
on the measurement##16##3##(2008-10#12)(2008-3#1)(2008-9#2)(2012-3#1)
on the measurements of##3##4##(2008-10#2)(2008-3#1)
on the mechanical properties of##4##5##(2008-10#1)(2009-7#2)(2011-2#1)
on the mechanical properties##7##4##(2008-10#1)(2009-11#1)(2009-7#3)(2011-2#1)(2012-2#1)
on the mechanical##10##3##(2008-10#1)(2009-11#1)(2009-7#4)(2010-12#1)(2011-2#2)(2012-2#1)
on the mechanism of action of##2##6##(1997-2#1)(2008-10#1)
on the mechanism of action##3##5##(1997-2#1)(2008-10#1)(2010-11#1)
on the mechanism of##9##4##(1990-11#1)(1990-2#1)(1997-2#1)(2008-10#4)(2010-10#1)(2010-11#1)
on the mechanism##11##3##(1990-11#1)(1990-2#1)(1997-2#1)(2008-10#5)(2009-9#1)(2010-10#1)(2010-11#1)
on the mechanisms of##5##4##(2008-10#2)(2008-12#1)(2008-8#1)(2013-1#1)
on the mechanisms##8##3##(1993-6#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-1#1)(2013-1#1)
on the medial##3##3##(2007-12#1)(2008-5#1)(2008-9#1)
on the median##2##3##(2008-10#1)(2013-8#1)
on the medical##5##3##(1994-2#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)
on the medium##3##3##(2008-10#2)(2008-8#1)
on the membrane##9##3##(1995-2#1)(1997-1#1)(2008-10#5)(2008-8#1)(2008-9#1)
on the mercury electrode##3##4##(2008-10#3)
on the mercury##6##3##(2008-10#6)
on the metabolism of##4##4##(1993-6#1)(2008-11#2)(2011-2#1)
on the metal ion##2##4##(2008-10#2)
on the metal##7##3##(1994-5#1)(2008-10#5)(2010-11#1)
on the metallic##2##3##(2008-10#1)(2008-3#1)
on the method##3##3##(2008-10#3)
on the microbiology of##2##4##(1997-5#1)(2012-2#1)
on the microcarrier##2##3##(2008-11#1)(2008-9#1)
on the microchip##2##3##(2008-10#2)
on the microelectrode##2##3##(2008-10#2)
on the microshear bond strength of##3##6##(2013-1#3)
on the microstructure of##2##4##(2008-5#2)
on the migration of##3##4##(2008-1#1)(2008-10#1)(2010-7#1)
on the migration##4##3##(2008-1#1)(2008-10#2)(2010-7#1)
on the mixed##2##3##(2008-10#2)
on the model##6##3##(1996-12#1)(2008-10#2)(2008-7#2)(2011-2#1)
on the modified electrode##3##4##(2008-10#3)
on the modified##6##3##(2008-10#6)
on the modulation##2##3##(2008-3#1)(2009-8#1)
on the molar absorptivity##2##4##(2008-10#2)
on the molar##3##3##(2008-10#3)
on the molecular mechanisms of##2##5##(2010-12#1)(2011-2#1)
on the molecular##11##3##(2006-6#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#2)(2011-3#1)
on the monitoring of##2##4##(2008-10#2)
on the morphological##2##3##(2008-5#2)
on the morphology##3##3##(2008-10#3)
on the mortality of##2##4##(2008-1#1)(2008-10#1)
on the mortality##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
on the most##4##3##(1996-1#1)(2008-10#1)(2008-11#1)(2011-1#1)
on the nasolabial fold and chin##2##6##(2008-5#2)
on the nasolabial fold##3##4##(2008-5#3)
on the national##2##3##(1995-1#1)(2008-1#1)
on the native fluorescence##2##4##(2008-10#2)
on the native##3##3##(2008-10#2)(2011-3#1)
on the natural history of##2##5##(1991-6#1)(2011-3#1)
on the natural history##3##4##(1991-6#1)(2009-8#1)(2011-3#1)
on the natural##5##3##(1991-6#1)(1992-9#1)(2008-10#1)(2009-8#1)(2011-3#1)
on the nature and##4##4##(2008-10#2)(2008-5#1)(2010-11#1)
on the nature of the##7##5##(1994-11#1)(1994-5#1)(2008-10#4)(2008-8#1)
on the nature of##13##4##(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2009-9#1)
on the nature##17##3##(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)
on the neck##4##3##(1992-12#1)(1997-6#1)(2008-7#1)(2010-12#1)
on the need##2##3##(2008-5#1)(2012-3#1)
on the needs of##4##4##(1993-1#2)(1993-12#1)(2010-6#1)
on the needs##5##3##(1991-6#1)(1993-1#2)(1993-12#1)(2010-6#1)
on the neural##2##3##(2008-9#1)(2013-1#1)
on the new##8##3##(1992-1#1)(2008-10#6)(2008-8#1)
on the newer##2##3##(2012-2#1)(2013-1#1)
on the night side of##2##5##(1991-5#2)
on the normal##3##3##(1993-11#1)(2008-9#1)(2012-3#1)
on the nose##3##3##(2008-5#3)
on the nucleotide##3##3##(1993-12#1)(2008-10#2)
on the number and##3##4##(1994-6#2)(2008-10#1)
on the number of people##2##5##(1994-2#1)(1995-12#1)
on the number of##14##4##(1991-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)
on the number##19##3##(1991-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#1)
on the numbers##2##3##(2008-8#1)(2008-9#1)
on the numerical##2##3##(2008-3#1)(2008-6#1)
on the observation##3##3##(1994-3#1)(2008-10#1)(2008-6#1)
on the observed##4##3##(1994-5#1)(1995-12#1)(2008-10#1)(2009-7#1)
on the obtained##4##3##(2008-10#3)(2013-8#1)
on the occasion of##2##4##(2008-11#1)(2013-1#1)
on the occipital scalp##2##4##(2010-6#2)
on the occurrence of##4##4##(2008-10#1)(2008-12#1)(2011-2#2)
on the occurrence##5##3##(2008-10#2)(2008-12#1)(2011-2#2)
on the one hand and##4##5##(1991-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
on the one hand##15##4##(1991-2#1)(1991-3#1)(1991-6#1)(1994-1#1)(1994-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#1)
on the one##16##3##(1991-2#1)(1991-3#1)(1991-6#1)(1994-1#1)(1994-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#1)
on the ongoing##2##3##(1994-12#1)(2011-1#1)
on the operating##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
on the opposite##2##3##(2008-11#1)(2012-4#1)
on the optical##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
on the optimal##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
on the oral##3##3##(1993-1#1)(2011-2#1)(2011-7#1)
on the orange-spotted grouper##2##4##(2010-5#2)
on the orchard floor##4##4##(2008-10#4)
on the orchard##5##3##(2008-10#5)
on the order of 1##2##5##(2008-8#1)(2009-7#1)
on the order of##7##4##(1992-2#1)(1996-5#1)(2008-10#2)(2008-8#1)(2009-12#1)(2009-7#1)
on the order##8##3##(1992-2#1)(1996-5#1)(2008-10#3)(2008-8#1)(2009-12#1)(2009-7#1)
on the organization##2##3##(1994-5#1)(1995-12#1)
on the orientation##2##3##(2008-10#1)(2008-3#1)
on the origin and##2##4##(2012-3#2)
on the origin of##4##4##(2008-10#2)(2010-1#1)(2011-2#1)
on the origin##6##3##(2008-10#2)(2010-1#1)(2011-2#1)(2012-3#2)
on the original##5##3##(1990-3#1)(2008-10#2)(2011-2#1)(2013-8#1)
on the oscillating##3##3##(2008-10#3)
on the other hand##29##4##(1991-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-2#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
on the other side##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
on the other##43##3##(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#4)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-8#3)
on the outcome of##5##4##(1997-4#1)(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
on the outcome##7##3##(1997-4#1)(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#2)(2013-1#1)
on the outcomes##2##3##(2008-4#1)(2013-1#1)
on the outer coast##2##4##(1990-11#2)
on the outer##5##3##(1990-11#2)(1995-2#1)(2007-12#1)(2008-10#1)
on the outermost##2##3##(2008-10#1)(2008-5#1)
on the outside of the##3##5##(2008-10#1)(2012-2#2)
on the overall##8##3##(1991-2#1)(1994-12#1)(1996-3#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)
on the oxidation of N##2##5##(2008-10#2)
on the oxidation of methylene blue (MB)##2##7##(2008-10#2)
on the oxidation of##39##4##(2008-10#39)
on the oxidation reaction of##5##5##(2008-10#5)
on the oxidation##46##3##(2008-10#46)
on the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone##2##7##(2008-10#2)
on the oxidative coupling of##4##5##(2008-10#4)
on the oxidative coupling##5##4##(2008-10#5)
on the pH and##2##4##(2008-10#2)
on the pH of the##3##5##(1991-5#1)(2008-10#2)
on the pH##10##3##(1991-5#1)(1993-8#1)(2008-10#8)
on the pKa of the leaving group##2##7##(1993-8#2)
on the pad##3##3##(2008-5#3)
on the parameters of the##4##5##(1993-3#1)(2008-10#2)(2011-2#1)
on the parameters of##5##4##(1993-3#1)(2008-10#2)(2011-2#1)(2013-8#1)
on the parameters##6##3##(1993-3#1)(1995-9#1)(2008-10#2)(2011-2#1)(2013-8#1)
on the parietal##2##3##(1992-6#1)(2008-10#1)
on the part of the##5##5##(1990-11#1)(1995-2#1)(1995-5#1)(2008-12#1)(2008-9#1)
on the part of##12##4##(1990-11#1)(1992-1#1)(1994-1#1)(1995-2#1)(1995-5#2)(1996-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
on the particle##3##3##(1992-2#1)(1997-2#1)(2008-10#1)
on the particles##3##3##(1997-2#1)(2008-10#2)
on the partitioning##2##3##(2008-10#2)
on the passage##2##3##(1995-2#1)(2008-9#1)
on the path to##2##4##(1996-3#1)(2011-2#1)
on the pathogen in##2##4##(2008-10#2)
on the pathogen##5##3##(2008-10#4)(2008-9#1)
on the pathogenesis of##6##4##(1996-11#1)(2006-6#1)(2008-5#2)(2008-9#1)(2009-8#1)
on the pathogenicity##2##3##(2008-10#1)(2008-11#1)
on the pathology and##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
on the pathophysiology of##2##4##(2008-4#1)(2010-12#1)
on the pathophysiology##4##3##(2008-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
on the patient##4##3##(1994-2#1)(2010-2#1)(2012-2#1)(2013-1#1)
on the patient's##2##3##(2008-10#1)(2010-7#1)
on the patients##2##3##(1990-2#1)(2011-2#1)
on the patients'##3##3##(1991-2#1)(2009-1#1)(2011-2#1)
on the pattern of##2##4##(2008-7#1)(2008-8#1)
on the pattern##3##3##(1991-8#1)(2008-7#1)(2008-8#1)
on the patterns##2##3##(2008-2#1)(2012-2#1)
on the peak##4##3##(2008-10#4)
on the percent##3##3##(2008-10#3)
on the percentage of##4##4##(2008-10#4)
on the perception##2##3##(1991-2#1)(2013-8#1)
on the performance of a##3##5##(2008-3#3)
on the performance of the##3##5##(1991-2#1)(1992-2#1)(2008-10#1)
on the performance of##14##4##(1991-2#1)(1992-2#1)(1996-5#1)(2008-10#6)(2008-12#1)(2008-3#4)
on the performance##15##3##(1991-2#1)(1992-2#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#4)
on the performances of the##2##5##(2008-10#2)
on the periodontal##2##3##(1996-2#1)(2008-1#1)
on the peripheral##2##3##(2011-2#1)(2012-3#1)
on the periphery##2##3##(2007-12#1)(2008-12#1)
on the peroxidase##2##3##(2008-10#2)
on the personal##2##3##(2008-11#1)(2009-7#1)
on the pharmacokinetics of YH439 and its metabolites in rats##2##10##(2008-11#2)
on the phenomenology of##2##4##(2008-11#1)(2010-6#1)
on the phenomenon##2##3##(2008-10#1)(2008-9#1)
on the phenotype##2##3##(1995-8#1)(2008-6#1)
on the phenotypes##2##3##(2008-4#1)(2008-8#1)
on the phosphatase activity##2##4##(1997-2#1)(2008-9#1)
on the phosphate##2##3##(2008-10#1)(2010-10#1)
on the photochemical##2##3##(2008-10#1)(2008-11#1)
on the photosynthetic##2##3##(2008-10#2)
on the physical characteristics of the##2##6##(1990-9#1)(1996-3#1)
on the physical characteristics of##3##5##(1990-9#1)(1996-3#1)(2008-7#1)
on the physical map of##3##5##(1995-6#1)(1997-6#1)(1997-8#1)
on the physical map##4##4##(1995-6#1)(1997-6#1)(1997-8#1)(1997-9#1)
on the physical properties of the##2##6##(2008-5#1)(2013-1#1)
on the physical##15##3##(1990-9#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
on the plant surface##2##4##(2008-10#1)(2009-8#1)
on the plant##7##3##(2008-10#4)(2008-8#1)(2009-8#2)
on the plasma concentration of##2##5##(2013-8#2)
on the plasma membrane##3##4##(1994-3#1)(2008-8#2)
on the plasma##9##3##(1992-9#1)(1994-3#1)(2008-10#2)(2008-8#2)(2012-2#1)(2013-8#2)
on the plate##2##3##(2008-10#2)
on the plates##2##3##(2008-10#1)(2008-11#1)
on the polar##2##3##(1994-5#1)(2008-11#1)
on the polarization##3##3##(2008-3#3)
on the polymer surface##2##4##(2008-10#1)(2008-5#1)
on the polymer##3##3##(2008-10#2)(2008-5#1)
on the polymerase##3##3##(1993-8#1)(2008-10#2)
on the population dynamics##2##4##(2008-8#1)(2013-8#1)
on the population##11##3##(1991-6#1)(2008-10#4)(2008-8#2)(2008-9#1)(2013-1#2)(2013-8#1)
on the possibilities##2##3##(2008-11#1)(2008-6#1)
on the possible##4##3##(1993-2#1)(2007-12#1)(2008-11#1)(2012-2#1)
on the posterior##4##3##(1991-6#1)(1993-1#1)(2010-5#1)(2013-1#1)
on the potential response of the##2##6##(2008-10#2)
on the potential response of##3##5##(2008-10#3)
on the potential##14##3##(1990-5#1)(2008-10#7)(2008-11#3)(2011-3#1)(2013-7#1)(2013-8#1)
on the potentiometric selectivity##2##4##(2008-10#2)
on the power##2##3##(2008-11#1)(2008-8#1)
on the practical implications of using##2##6##(2008-11#1)(2008-4#1)
on the practical##3##3##(2008-11#2)(2008-4#1)
on the practice of##2##4##(2008-11#2)
on the practice##3##3##(2008-11#3)
on the precipitation##3##3##(2008-10#2)(2008-7#1)
on the precision##3##3##(2008-10#3)
on the preconcentration of##2##4##(2008-10#2)
on the preconcentration##4##3##(2008-10#4)
on the prediction##2##3##(2008-10#2)
on the premise that##5##4##(1992-3#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#1)
on the presence and##2##4##(1997-8#1)(2008-10#1)
on the presence in##2##4##(1990-5#1)(1993-8#1)
on the presence of extracellular Ca2+##2##6##(1991-5#1)(1994-6#1)
on the presence of##22##4##(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)
on the presence or absence of##6##6##(2008-10#3)(2008-12#1)(2008-8#1)(2010-7#1)
on the presence##32##3##(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1997-3#1)(1997-8#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-7#1)(2013-1#1)
on the prevalence of##8##4##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#1)
on the prevalence##9##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#1)
on the prevention and##2##4##(2010-5#1)(2013-1#1)
on the prevention##3##3##(2010-5#1)(2013-1#1)(2013-8#1)
on the prey##2##3##(2008-9#1)(2012-3#1)
on the primary##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
on the principal##2##3##(2008-10#1)(2010-11#1)
on the principles of##3##4##(1991-2#1)(2008-10#1)(2013-1#1)
on the probability of##2##4##(1993-8#1)(2011-2#1)
on the problem of##2##4##(1994-2#1)(1995-5#1)
on the procedure##2##3##(1996-8#1)(2008-10#1)
on the process of##7##4##(1991-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-6#1)
on the process##8##3##(1991-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-6#1)
on the processes##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
on the production and##3##4##(2008-10#2)(2012-3#1)
on the production of recombinant##2##5##(2008-11#2)
on the production of##10##4##(1994-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2011-2#2)
on the production##13##3##(1994-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2011-2#2)(2012-3#1)
on the progression of##2##4##(1994-3#1)(2008-7#1)
on the proliferation and invasion of hepatoma cells in culture##2##10##(2008-11#2)
on the proliferation and invasion of##5##6##(2008-11#5)
on the proliferation and##7##4##(1995-2#1)(2008-11#5)(2011-2#1)
on the proliferation of human##3##5##(1994-3#1)(2008-11#1)(2008-8#1)
on the proliferation of the##2##5##(2008-11#2)
on the proliferation of three human breast cancer cell lines that differed in their estrogen receptor contents##2##17##(2008-11#2)
on the proliferation of##16##4##(1990-12#2)(1994-11#1)(1994-3#2)(2008-11#6)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-8#1)
on the proliferation##23##3##(1990-12#2)(1994-11#1)(1994-3#2)(1995-2#1)(2008-11#11)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#2)(2013-8#1)
on the promotion of##2##4##(2010-10#1)(2012-12#1)
on the propagation##2##3##(2008-2#1)(2008-3#1)
on the properties of the##2##5##(2008-3#1)(2009-5#1)
on the properties of##5##4##(1991-4#1)(1991-5#1)(1995-6#1)(2008-3#1)(2009-5#1)
on the proportion of##4##4##(2008-10#3)(2012-2#1)
on the proportion##5##3##(2008-10#4)(2012-2#1)
on the protection##2##3##(1990-2#1)(1997-1#1)
on the protein expression of##2##5##(2008-12#1)(2013-8#1)
on the protein kinase##2##4##(1995-8#1)(1997-2#1)
on the protein##9##3##(1994-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-8#1)
on the protonation##2##3##(2008-10#2)
on the provision of##2##4##(1996-5#1)(2008-11#1)
on the proximal##2##3##(1994-5#1)(2013-8#1)
on the psychological##2##3##(2008-11#1)(2008-5#1)
on the psychophysiological responses to imagined exercise##2##7##(1992-12#2)
on the public health##3##4##(1991-3#1)(1995-12#1)(2013-1#1)
on the qualitative##2##3##(2008-10#1)(2011-2#1)
on the quality of life and##2##6##(1992-1#1)(2011-2#1)
on the quality of life##5##5##(1992-1#1)(2009-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
on the quality of the##6##5##(2007-11#1)(2008-10#2)(2012-3#1)(2013-1#1)(2013-8#1)
on the quality of##17##4##(1991-11#1)(1992-1#1)(1994-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
on the quality##19##3##(1991-11#1)(1992-1#1)(1992-2#1)(1994-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
on the quenching##3##3##(2008-10#3)
on the question of##4##4##(1990-2#1)(1991-3#1)(2008-12#1)(2008-7#1)
on the range of##2##4##(2008-10#1)(2009-1#1)
on the rapid##5##3##(2008-10#4)(2008-7#1)
on the rate of transport##2##5##(2008-10#2)
on the rate of##14##4##(1992-2#1)(1995-3#2)(2008-10#8)(2008-11#1)(2009-8#2)
on the rate##16##3##(1992-2#1)(1995-3#2)(2008-10#9)(2008-11#1)(2009-8#2)(2010-8#1)
on the ratio of##4##4##(2008-10#3)(2008-5#1)
on the rationale##2##3##(2008-11#1)(2011-2#1)
on the raw##2##3##(2010-8#1)(2012-2#1)
on the reaction conditions##2##4##(1992-12#1)(2008-10#1)
on the reaction of##25##4##(1994-5#1)(2008-10#24)
on the reaction rate##3##4##(2008-10#2)(2008-7#1)
on the reaction with##3##4##(2008-10#2)(2008-5#1)
on the reaction##55##3##(1992-12#1)(1994-5#1)(1996-5#2)(2008-10#46)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)
on the reactions of the##2##5##(2008-10#2)
on the recent##7##3##(1994-12#1)(1994-6#1)(2008-10#1)(2011-2#1)(2012-2#2)(2012-3#1)
on the recombinant protein production##2##5##(2008-11#2)
on the recovery of the analyte##3##6##(2008-10#3)
on the recovery of the##6##5##(2008-10#6)
on the recovery of##15##4##(2008-10#14)(2012-3#1)
on the recovery##16##3##(2008-10#15)(2012-3#1)
on the red##2##3##(1994-5#1)(2008-11#1)
on the redox reaction between##4##5##(2008-10#4)
on the redox reaction of##2##5##(2008-10#2)
on the redox reaction##6##4##(2008-10#6)
on the redox##7##3##(2008-10#7)
on the reduction of##10##4##(2008-10#10)
on the reduction##12##3##(2008-10#11)(2008-3#1)
on the region of##2##4##(2008-5#1)(2012-3#1)
on the regression##3##3##(1992-9#1)(2008-10#2)
on the regulation of##4##4##(1996-2#1)(2009-5#1)(2009-9#1)(2011-2#1)
on the relation between##3##4##(1990-8#1)(1991-6#1)(2008-3#1)
on the relationship between burnout##2##5##(1997-1#1)(2008-11#1)
on the relationship between the##2##5##(2008-1#1)(2008-12#1)
on the relationship between##13##4##(1991-2#1)(1991-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)
on the relationship##17##3##(1991-2#1)(1991-3#1)(1991-6#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
on the relative##9##3##(1991-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)
on the release of##7##4##(1990-12#1)(1991-5#1)(1995-11#2)(1996-2#1)(1997-4#1)(2006-6#1)
on the release##10##3##(1990-12#1)(1991-5#1)(1995-11#2)(1996-2#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-5#2)
on the relevance of##2##4##(1993-3#1)(2008-10#1)
on the reliability of##2##4##(2008-10#2)
on the reliability##3##3##(1992-3#1)(2008-10#2)
on the removal of##2##4##(2008-10#1)(2011-2#1)
on the replication of Bombyx mori nucleopolyhedrovirus##2##7##(2008-11#2)
on the replication of##3##4##(1995-2#1)(2008-11#2)
on the replication##4##3##(1995-2#1)(2008-11#2)(2013-1#1)
on the reproductive##2##3##(2008-10#1)(2008-11#1)
on the required##2##3##(2008-11#1)(2010-8#1)
on the research##4##3##(2008-11#1)(2009-5#1)(2010-12#1)(2010-8#1)
on the resin##6##3##(2008-10#6)
on the resolution were##3##4##(2008-10#3)
on the respiratory activity of##2##5##(2008-10#1)(2008-5#1)
on the respiratory##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
on the response of the##2##5##(2008-10#1)(2008-7#1)
on the response of##7##4##(2008-10#5)(2008-7#1)(2009-10#1)
on the response properties of the##2##6##(2008-10#2)
on the response##14##3##(2008-10#12)(2008-7#1)(2009-10#1)
on the responses of##6##4##(1990-7#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#1)
on the restorative role of##2##5##(2008-12#2)
on the results of a##2##5##(1992-3#1)(2009-10#1)
on the results of the##3##5##(1995-12#1)(2008-10#2)
on the results of this##4##5##(2008-10#3)(2011-2#1)
on the results of##19##4##(1992-3#1)(1993-2#1)(1995-1#1)(1995-12#1)(2008-10#9)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
on the results##28##3##(1992-3#1)(1993-2#1)(1995-1#1)(1995-12#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
on the retention and enantioselectivity##2##5##(2008-10#2)
on the retention behavior##3##4##(2008-10#3)
on the retention of the##2##5##(2008-10#2)
on the retention of##6##4##(1994-1#1)(2008-10#4)(2008-11#1)
on the retention##13##3##(1992-6#1)(1994-1#1)(2008-10#9)(2008-11#2)
on the rheological##3##3##(2008-5#2)(2011-2#1)
on the rheology##2##3##(2008-5#2)
on the right and##2##4##(2011-2#2)
on the right arm of chromosome XI##2##7##(1996-6#2)
on the right arm of chromosome##4##6##(1995-9#1)(1996-6#3)
on the right arm##5##4##(1995-9#1)(1996-6#4)
on the right side##6##4##(2008-10#1)(2008-7#1)(2010-4#1)(2010-7#2)(2013-7#1)
on the right##27##3##(1995-9#1)(1996-3#2)(1996-6#4)(2008-10#2)(2008-7#1)(2010-4#1)(2010-6#3)(2010-7#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
on the rise##4##3##(1993-5#1)(1995-12#1)(2008-11#1)(2010-8#1)
on the risk for##3##4##(2008-10#1)(2009-10#1)(2009-8#1)
on the risk of##4##4##(1991-8#1)(1994-3#1)(1996-3#1)(2011-3#1)
on the risk##8##3##(1991-8#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2009-10#1)(2009-8#1)(2011-3#1)
on the road##2##3##(2008-8#1)(2009-12#1)
on the rod##2##3##(1997-2#2)
on the role of the##3##5##(2008-10#2)(2013-1#1)
on the role of##22##4##(1990-6#1)(1991-1#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
on the role##26##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
on the roles of##2##4##(1994-1#1)(2011-2#1)
on the roles##3##3##(1994-1#1)(2008-12#1)(2011-2#1)
on the roof of##2##4##(2008-5#1)(2010-5#1)
on the root and##2##4##(2008-10#2)
on the root surface##2##4##(2008-10#2)
on the root##5##3##(2008-10#5)
on the roots##2##3##(2008-10#1)(2012-6#1)
on the safety and security of##2##6##(1992-2#1)(1996-12#1)
on the safety##5##3##(1992-2#1)(1993-12#1)(1994-6#1)(1996-12#1)(2008-10#1)
on the same day##2##4##(2010-12#1)(2011-2#1)
on the same filament##2##4##(2008-10#2)
on the same host##3##4##(2008-10#3)
on the same individual##2##4##(1996-3#1)(2008-10#1)
on the same leaf##2##4##(2008-10#2)
on the same level##2##4##(1990-12#1)(1991-11#1)
on the same patient##2##4##(1996-3#2)
on the same side as the##2##6##(2011-2#1)(2013-1#1)
on the same side##4##4##(2008-10#1)(2011-2#2)(2013-1#1)
on the same##59##3##(1990-12#2)(1990-2#2)(1991-11#1)(1993-12#1)(1994-8#1)(1996-3#3)(1997-3#1)(2008-10#28)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#3)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)
on the sample##9##3##(1994-9#1)(2008-10#8)
on the sampling##3##3##(2008-10#2)(2011-2#1)
on the scale##3##3##(1992-1#1)(2008-10#2)
on the scalp##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
on the scientific##2##3##(2008-10#1)(2013-1#1)
on the search for new##2##5##(2008-1#1)(2008-10#1)
on the season##2##3##(2008-10#1)(2011-2#1)
on the second day##2##4##(2011-1#1)(2012-12#1)
on the second##10##3##(1993-6#1)(1996-3#1)(2008-10#3)(2008-11#2)(2010-6#1)(2011-1#1)(2012-12#1)
on the secondary effect of##2##5##(1990-8#1)(2008-9#1)
on the secondary##5##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
on the secretion of##2##4##(1990-5#1)(2011-2#1)
on the secretion##4##3##(1990-5#1)(1995-8#1)(2008-7#1)(2011-2#1)
on the selected##3##3##(1991-12#1)(2008-10#1)(2010-7#1)
on the selection of##5##4##(1995-9#1)(2008-10#1)(2010-4#1)(2011-2#2)
on the selective##4##3##(1990-12#1)(2008-10#3)
on the selectivity of ISEs##2##5##(2008-10#2)
on the selectivity##7##3##(2008-10#7)
on the sensitivity of the##3##5##(2008-10#3)
on the sensitivity of##5##4##(2008-10#4)(2011-2#1)
on the sensitivity##6##3##(2008-10#5)(2011-2#1)
on the sensitizing effect of##3##5##(2008-10#3)
on the sensor chip##4##4##(2008-10#4)
on the sensor response##2##4##(2008-10#2)
on the sensor surface##3##4##(2008-10#3)
on the sensor##11##3##(2008-10#11)
on the separation and##3##4##(2008-10#3)
on the separation of the##2##5##(2008-10#2)
on the separation of##8##4##(2008-10#8)
on the separation##11##3##(2008-10#11)
on the sequence analysis of##2##5##(2008-10#1)(2008-8#1)
on the sequence##8##3##(2008-10#5)(2008-4#1)(2008-8#1)(2010-4#1)
on the sequential injection##3##4##(2008-10#3)
on the sequential##5##3##(2008-10#4)(2008-12#1)
on the serum##5##3##(1990-3#1)(2008-1#1)(2010-2#1)(2010-6#1)(2013-1#1)
on the services##2##3##(1991-3#1)(1993-12#1)
on the severity of##4##4##(1997-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
on the sex##2##3##(1997-6#1)(2013-1#1)
on the sexual##2##3##(2008-11#1)(2010-12#1)
on the shape of the dose response##2##7##(2008-7#2)
on the shape of the##3##5##(2008-11#1)(2008-7#2)
on the shelf are##2##4##(2010-8#2)
on the shelf##3##3##(2010-8#3)
on the shooting hand##2##4##(1995-11#2)
on the short arm of barley chromosome##2##7##(2008-10#2)
on the short arm of chromosome 6##2##7##(2008-10#1)(2008-4#1)
on the short arm of chromosome##6##6##(2008-10#4)(2008-4#1)(2012-3#1)
on the short arm of##11##5##(1996-2#1)(2008-10#8)(2008-4#1)(2012-3#1)
on the short arm##12##4##(1996-2#1)(2008-10#9)(2008-4#1)(2012-3#1)
on the shoulder##3##3##(2008-12#1)(2009-1#2)
on the sign##2##3##(2008-8#1)(2009-7#1)
on the signal##5##3##(2008-10#4)(2008-2#1)
on the significance of##3##4##(1991-2#1)(2008-7#1)(2013-8#1)
on the silica surface##2##4##(2008-10#2)
on the silica##3##3##(2008-10#3)
on the silicon##2##3##(2008-10#2)
on the simultaneous##6##3##(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
on the single##3##3##(2008-10#2)(2008-2#1)
on the site##2##3##(1994-3#1)(2008-5#1)
on the size and shape of##2##6##(1995-5#1)(2013-8#1)
on the size and the##2##5##(2008-10#1)(2008-3#1)
on the size and##4##4##(1995-5#1)(2008-10#1)(2008-3#1)(2013-8#1)
on the size of the##6##5##(1996-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-8#1)
on the size of##9##4##(1996-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#1)
on the size##14##3##(1995-5#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
on the skeleton##2##3##(1996-5#1)(2012-3#1)
on the skills and##2##4##(2008-11#1)(2008-12#1)
on the skills##3##3##(2008-11#1)(2008-12#2)
on the skin and##4##4##(2008-5#3)(2012-2#1)
on the skin surface##3##4##(2008-5#3)
on the skin##21##3##(1991-6#1)(2008-12#1)(2008-5#17)(2011-3#1)(2012-2#1)
on the slope##2##3##(1995-3#1)(2008-10#1)
on the social##4##3##(2008-11#1)(2008-12#1)(2009-9#1)(2013-8#1)
on the sodium##2##3##(1991-12#1)(2008-10#1)
on the soil surface##7##4##(2008-10#6)(2008-11#1)
on the soil##12##3##(2008-10#10)(2008-11#1)(2008-12#1)
on the solid phase extraction of##3##6##(2008-10#3)
on the solid phase##7##4##(1991-5#1)(2008-10#6)
on the solid support of glass slides##2##7##(2008-10#2)
on the solid support##4##4##(2008-10#4)
on the solid##15##3##(1991-5#1)(2008-10#14)
on the solubility of##2##4##(2008-10#2)
on the solubility##6##3##(2008-10#4)(2013-1#2)
on the sorbent##4##3##(2008-10#4)
on the sorption of##6##4##(2008-10#6)
on the sorption##9##3##(2008-10#9)
on the sound##2##3##(2008-2#1)(2008-8#1)
on the space##2##3##(2008-8#1)(2008-9#1)
on the spatial##9##3##(2008-10#3)(2008-8#4)(2011-2#1)(2013-8#1)
on the specific##9##3##(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-11#1)(2013-1#1)
on the specimen##2##3##(1991-6#1)(2009-7#1)
on the spectrophotometric determination of##2##5##(2008-10#2)
on the spectroscopic##3##3##(2008-10#3)
on the speed of##2##4##(1994-8#1)(2009-7#1)
on the sporulation##4##3##(2008-10#4)
on the spread##2##3##(1994-6#1)(2008-10#1)
on the stability and##2##4##(2008-3#1)(2008-5#1)
on the stability of##7##4##(1992-1#1)(1996-5#1)(2008-10#3)(2008-8#1)(2008-9#1)
on the stability##9##3##(1992-1#1)(1996-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
on the stage of##4##4##(1993-2#1)(2008-10#2)(2008-7#1)
on the standard deviation##2##4##(2008-10#1)(2008-3#1)
on the standard##4##3##(1991-11#1)(2008-10#2)(2008-3#1)
on the state of##4##4##(1990-2#1)(1994-5#1)(1994-9#1)(2008-3#1)
on the stationary phase was##2##5##(2008-10#2)
on the stationary phase##5##4##(2008-10#5)
on the status of##2##4##(1993-3#1)(1994-1#1)
on the stem##3##3##(2008-10#3)
on the stoichiometry of##2##4##(2008-10#1)(2008-7#1)
on the strains##2##3##(2008-10#2)
on the strength of the expression vector##2##7##(1997-8#2)
on the strength of the##3##5##(1997-8#2)(2008-11#1)
on the strength of##4##4##(1997-1#1)(1997-8#2)(2008-11#1)
on the strength##5##3##(1994-8#1)(1997-1#1)(1997-8#2)(2008-11#1)
on the strengths and##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
on the strengths of##2##4##(2008-8#1)(2012-2#1)
on the strengths##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
on the striatal##2##3##(1996-2#1)(2008-7#1)
on the strong##2##3##(2008-10#2)
on the structural dynamics of##2##5##(2008-10#2)
on the structure of maize##2##5##(2013-8#2)
on the structure of##8##4##(1992-4#1)(1992-6#1)(2008-10#2)(2008-9#1)(2013-1#1)(2013-8#2)
on the structure##10##3##(1992-11#1)(1992-4#1)(1992-6#1)(2008-10#2)(2008-9#2)(2013-1#1)(2013-8#2)
on the structures##2##3##(2008-10#1)(2008-3#1)
on the students'##4##3##(2008-11#2)(2008-12#1)(2009-8#1)
on the studied##2##3##(2008-10#2)
on the study of##4##4##(2008-10#2)(2008-12#1)(2010-8#1)
on the subject##8##3##(1994-1#1)(1996-11#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-1#1)(2012-2#1)
on the subjects##2##3##(2008-7#1)(2012-3#1)
on the subsequent##4##3##(1994-8#1)(2008-10#3)
on the substrate##4##3##(1991-9#1)(1994-5#1)(2008-10#1)(2008-5#1)
on the subunit##2##3##(1991-10#1)(2008-8#1)
on the success of##2##4##(2008-8#1)(2013-8#1)
on the support##3##3##(1997-6#1)(2008-11#1)(2008-7#1)
on the supramolecular system##2##4##(2008-10#2)
on the supramolecular##4##3##(2008-10#4)
on the surface and##3##4##(2006-6#1)(2008-9#1)(2009-3#1)
on the surface of a glassy carbon electrode by##2##9##(2008-10#2)
on the surface of a glassy carbon electrode##3##8##(1990-12#1)(2008-10#2)
on the surface of a##12##5##(1990-12#1)(2008-10#9)(2008-8#1)(2008-9#1)
on the surface of bacteriophage##2##5##(1995-2#1)(2008-8#1)
on the surface of electrode##2##5##(2008-10#2)
on the surface of infected##2##5##(2008-10#2)
on the surface of silica gel##2##6##(2008-10#2)
on the surface of the electrode##4##6##(2008-10#4)
on the surface of the filamentous bacteriophage##2##7##(2008-10#1)(2008-8#1)
on the surface of the host##2##6##(2008-10#2)
on the surface of the membrane##2##6##(2008-10#2)
on the surface of the sample##2##6##(2008-10#2)
on the surface of the##44##5##(1990-8#1)(1992-11#1)(1992-6#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-12#1)(2012-2#1)
on the surface of##104##4##(1990-12#1)(1990-2#1)(1990-8#1)(1992-11#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#1)(1995-2#2)(1995-6#2)(2008-10#65)(2008-11#10)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
on the surface was##2##4##(2008-10#2)
on the surface##129##3##(1990-12#1)(1990-2#1)(1990-8#1)(1992-11#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-5#2)(1997-6#1)(2006-6#1)(2008-10#74)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
on the surfaces of the##2##5##(2008-10#2)
on the surfaces of##4##4##(2008-10#3)(2010-7#1)
on the surfaces##7##3##(2008-10#6)(2010-7#1)
on the surgical treatment of##2##5##(2008-10#1)(2008-9#1)
on the surgical treatment##3##4##(2008-10#1)(2008-9#1)(2010-7#1)
on the surgical##4##3##(2008-10#1)(2008-9#1)(2010-12#1)(2010-7#1)
on the survival and##2##4##(2009-10#1)(2010-8#1)
on the survival of patients with##2##6##(2008-11#1)(2008-2#1)
on the survival of the##2##5##(2008-10#1)(2013-1#1)
on the survival of##9##4##(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
on the survival##11##3##(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)(2013-1#1)
on the susceptibility of##2##4##(1994-5#1)(2011-2#1)
on the susceptible cultivar##2##4##(2008-10#2)
on the susceptible##7##3##(2008-10#7)
on the synthesis of##2##4##(1991-5#1)(1993-3#1)
on the synthesis##3##3##(1991-5#1)(1993-3#1)(2008-11#1)
on the synthetic##2##3##(1991-6#1)(2010-2#1)
on the system##3##3##(2008-10#3)
on the target##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
on the techniques for##2##4##(2008-2#1)(2008-9#1)
on the telomeric##2##3##(1994-11#1)(2008-12#1)
on the temperature##6##3##(1994-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-5#1)
on the template##2##3##(2008-9#1)(2012-3#1)
on the temporal and##2##4##(1990-8#1)(2008-10#1)
on the temporal dynamics of##2##5##(2008-10#2)
on the temporal##8##3##(1990-5#1)(1990-8#1)(2008-10#4)(2009-1#1)(2012-2#1)
on the terminal##2##3##(2008-11#1)(2012-3#1)
on the test##2##3##(1992-1#1)(1993-6#1)
on the testosterone displacement equilibrium from its##2##7##(2008-10#2)
on the theory of##4##4##(2008-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
on the theory##5##3##(2008-10#1)(2008-11#1)(2012-3#2)(2013-8#1)
on the thickness##2##3##(2008-3#1)(2009-5#1)
on the third postoperative day##4##5##(1993-1#1)(2010-6#3)
on the third##5##3##(1993-1#1)(1995-6#1)(2010-6#3)
on the three##2##3##(1993-2#1)(2008-10#1)
on the threshold current##2##4##(2008-3#2)
on the thyroid##3##3##(1990-6#1)(2008-7#1)(2013-1#1)
on the time##8##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-8#2)(2011-2#2)
on the timing of##5##4##(1992-12#1)(1997-2#2)(2008-10#1)(2009-5#1)
on the timing##6##3##(1990-5#1)(1992-12#1)(1997-2#2)(2008-10#1)(2009-5#1)
on the tongue##4##3##(1993-1#3)(2013-1#1)
on the top##3##3##(2008-10#2)(2008-11#1)
on the topics##3##3##(1995-2#1)(2011-2#1)(2012-3#1)
on the total##7##3##(2008-10#5)(2011-3#1)(2012-2#1)
on the toxicity of##2##4##(1996-12#1)(2011-2#1)
on the toxicology##2##3##(2008-9#1)(2013-1#1)
on the traditional##2##3##(2008-10#1)(2009-5#1)
on the trait##3##3##(2008-8#3)
on the transcription##2##3##(1994-11#1)(2008-11#1)
on the transducer##2##3##(2008-10#2)
on the transients##2##3##(2008-2#1)(2008-3#1)
on the transmission of##2##4##(2008-10#1)(2008-3#1)
on the transmission##3##3##(2008-10#2)(2008-3#1)
on the transport of Hct##3##5##(2011-3#3)
on the transport of hydrochlorothiazide##2##5##(2011-3#2)
on the transport of##6##4##(2009-10#1)(2011-3#5)
on the treatment of a##2##5##(1991-2#1)(1992-6#1)
on the treatment of##9##4##(1991-2#1)(1992-1#1)(1992-6#1)(1993-3#1)(1993-9#1)(1997-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
on the treatment##10##3##(1991-2#1)(1992-1#1)(1992-6#1)(1993-3#1)(1993-9#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
on the trunk##2##3##(2008-5#1)(2010-6#1)
on the tumor##3##3##(2008-11#1)(2010-6#1)(2013-8#1)
on the two surfaces##2##4##(2008-12#1)(2010-10#1)
on the two##12##3##(1994-5#2)(1994-8#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)
on the type of##18##4##(1995-5#1)(1997-2#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)
on the type##19##3##(1995-5#1)(1997-2#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
on the types of##3##4##(1991-10#1)(1992-1#1)(2011-2#1)
on the ultrastructure of##2##4##(2008-10#1)(2008-7#1)
on the umbilicus##2##3##(2010-6#2)
on the underlying##7##3##(1993-12#1)(1993-3#1)(1995-9#1)(1996-3#1)(2008-10#1)(2010-10#1)(2010-7#1)
on the understanding of##3##4##(2008-10#2)(2012-3#1)
on the unit##2##3##(1990-9#1)(2010-2#1)
on the upper##5##3##(1995-12#1)(2008-1#1)(2008-10#2)(2008-9#1)
on the uptake of##3##4##(1991-9#1)(1994-8#1)(2008-10#1)
on the use of a##6##5##(2008-10#4)(2008-11#1)(2008-3#1)
on the use of animal##2##5##(2008-7#1)(2013-1#1)
on the use of the##11##5##(1992-12#1)(2008-10#7)(2008-11#1)(2008-4#2)
on the use of these##2##5##(1997-4#1)(2008-9#1)
on the use of two##2##5##(1990-12#1)(1991-3#1)
on the use of##86##4##(1990-12#2)(1991-3#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#44)(2008-11#7)(2008-3#4)(2008-4#3)(2008-7#1)(2008-9#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
on the uses of##2##4##(1991-12#1)(2010-5#1)
on the utilisation of##2##4##(2008-10#2)
on the utilization of##4##4##(1996-2#1)(2008-10#2)(2008-4#1)
on the vaccine##2##3##(1995-5#2)
on the value of##5##4##(1990-5#1)(1990-6#1)(1996-2#1)(2008-11#1)(2008-12#1)
on the variance##2##3##(2008-10#1)(2008-8#1)
on the various##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
on the velocity of##2##4##(2008-11#1)(2009-8#1)
on the ventral side of the##2##6##(2007-12#1)(2008-5#1)
on the ventral##4##3##(2007-12#1)(2008-5#2)(2008-9#1)
on the verge of##2##4##(1997-6#1)(2008-11#1)
on the vertex of##2##4##(2008-9#1)(2013-8#1)
on the vertex##3##3##(2008-5#1)(2008-9#1)(2013-8#1)
on the vessel##4##3##(1990-8#1)(2008-6#1)(2009-10#1)(2009-8#1)
on the viability and##2##4##(1990-6#1)(2008-7#1)
on the viability of##6##4##(2008-10#3)(2008-7#2)(2009-12#1)
on the viability##9##3##(1990-6#1)(2008-10#3)(2008-7#3)(2008-8#1)(2009-12#1)
on the video##2##3##(1992-12#1)(2013-1#1)
on the viral complementary strand##3##5##(2008-10#3)
on the viral##6##3##(2008-10#4)(2009-8#1)(2012-2#1)
on the virus##2##3##(1997-1#1)(2008-10#1)
on the visual system##2##4##(2008-8#1)(2009-12#1)
on the voltammetric response##2##4##(2008-10#2)
on the voltammetric##4##3##(2008-10#4)
on the waiting##2##3##(1991-11#1)(2008-9#1)
on the wall##2##3##(1990-9#1)(2008-11#1)
on the walls of the##2##5##(2008-10#2)
on the walls of##5##4##(2008-10#5)
on the water##2##3##(2008-10#1)(2008-7#1)
on the wavelength##3##3##(2008-3#3)
on the wheat##2##3##(2008-10#2)
on the whole##2##3##(1994-9#1)(2008-10#1)
on the width##2##3##(2008-10#1)(2008-9#1)
on the work of##2##4##(2008-11#2)
on the work##3##3##(1997-8#1)(2008-11#2)
on the working electrode##3##4##(2008-10#3)
on the world##2##3##(2008-11#2)
on the year##2##3##(2008-10#2)
on the yield of##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
on the yield##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)
on the zinc##2##3##(2008-10#2)
on the##6647##2##(1990-10#1)(1990-11#12)(1990-12#23)(1990-2#23)(1990-3#11)(1990-5#26)(1990-6#8)(1990-7#3)(1990-8#13)(1990-9#14)(1991-1#10)(1991-10#3)(1991-11#9)(1991-12#24)(1991-2#28)(1991-3#27)(1991-4#1)(1991-5#24)(1991-6#27)(1991-7#2)(1991-8#3)(1991-9#7)(1992-1#17)(1992-11#5)(1992-12#28)(1992-2#15)(1992-3#14)(1992-4#4)(1992-5#6)(1992-6#20)(1992-7#1)(1992-8#5)(1992-9#13)(1993-1#18)(1993-11#11)(1993-12#31)(1993-2#24)(1993-3#26)(1993-5#3)(1993-6#17)(1993-8#39)(1993-9#12)(1994-1#20)(1994-11#18)(1994-12#24)(1994-2#27)(1994-3#19)(1994-5#52)(1994-6#18)(1994-8#23)(1994-9#10)(1995-1#6)(1995-11#22)(1995-12#38)(1995-2#38)(1995-3#11)(1995-5#17)(1995-6#24)(1995-8#14)(1995-9#14)(1996-1#10)(1996-11#7)(1996-12#34)(1996-2#43)(1996-3#36)(1996-5#26)(1996-6#23)(1996-8#9)(1996-9#7)(1997-1#20)(1997-2#34)(1997-3#18)(1997-4#12)(1997-5#11)(1997-6#19)(1997-7#13)(1997-8#24)(1997-9#2)(2006-6#7)(2007-11#12)(2007-12#26)(2007-8#1)(2008-1#27)(2008-10#2536)(2008-11#435)(2008-12#127)(2008-2#42)(2008-3#169)(2008-4#47)(2008-5#195)(2008-6#41)(2008-7#119)(2008-8#165)(2008-9#156)(2009-1#8)(2009-10#34)(2009-11#7)(2009-12#16)(2009-2#4)(2009-3#13)(2009-4#9)(2009-5#14)(2009-6#16)(2009-7#27)(2009-8#44)(2009-9#12)(2010-1#20)(2010-10#22)(2010-11#15)(2010-12#35)(2010-2#7)(2010-3#8)(2010-4#22)(2010-5#21)(2010-6#38)(2010-7#26)(2010-8#33)(2010-9#11)(2011-1#21)(2011-10#2)(2011-2#192)(2011-3#30)(2011-7#4)(2012-12#33)(2012-2#94)(2012-3#91)(2012-4#2)(2012-5#3)(2012-6#1)(2012-8#1)(2012-9#2)(2013-1#161)(2013-7#4)(2013-8#88)
on their ability to##2##4##(2011-1#1)(2013-1#1)
on their activity##2##3##(1994-6#1)(2008-10#1)
on their behalf##2##3##(2009-5#2)
on their capability to##2##4##(2008-10#1)(2008-11#1)
on their different##3##3##(2008-10#2)(2009-5#1)
on their efficacy and##2##4##(2008-5#1)(2012-2#1)
on their experience##2##3##(1990-5#1)(1995-1#1)
on their first##4##3##(1991-2#1)(2008-12#3)
on their high##2##3##(2008-1#1)(2008-11#1)
on their host of origin##2##5##(2008-10#2)
on their host##3##3##(2008-10#2)(2013-1#1)
on their medication##2##3##(2008-11#2)
on their own##13##3##(1993-3#2)(1996-3#1)(1997-3#1)(2008-11#4)(2008-5#1)(2008-6#1)(2009-12#1)(2010-3#1)(2012-3#1)
on their physico-chemical properties##2##4##(2008-5#2)
on their response to##2##4##(1990-11#1)(2013-8#1)
on their response##3##3##(1990-11#1)(2009-12#1)(2013-8#1)
on their school##2##3##(2008-11#1)(2009-7#1)
on their##188##2##(1990-11#1)(1990-5#1)(1991-2#5)(1991-5#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#2)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#45)(2008-11#27)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-2#7)(2012-3#2)(2013-1#7)(2013-8#3)
on them##5##2##(2008-10#2)(2008-7#1)(2010-9#1)(2013-8#1)
on themselves##2##2##(2008-11#2)
on theoretical##5##2##(1996-3#1)(1997-1#1)(2008-10#2)(2010-12#1)
on therapeutic##3##2##(1991-7#1)(2008-11#2)
on therapy##4##2##(1996-11#1)(2008-1#1)(2011-2#1)(2011-3#1)
on thermal lens##2##3##(2008-10#1)(2008-3#1)
on thermal##5##2##(1995-12#1)(1996-12#1)(2008-10#2)(2008-3#1)
on these and##2##3##(1992-9#1)(1996-3#1)
on these cells##6##3##(1990-2#2)(2008-11#1)(2008-8#1)(2009-12#1)(2013-1#1)
on these issues##3##3##(1993-3#1)(2008-11#1)(2009-12#1)
on these leaves##2##3##(2008-10#2)
on these media##2##3##(2008-10#1)(2010-6#1)
on these observations##4##3##(1993-3#1)(1995-5#1)(2008-7#1)(2009-12#1)
on these parameters##2##3##(1991-5#1)(2008-10#1)
on these results##17##3##(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)
on these seven##2##3##(2008-10#2)
on these studies##2##3##(2010-3#1)(2011-2#1)
on these two##4##3##(1993-2#1)(2008-10#1)(2010-11#1)(2011-2#1)
on these##121##2##(1990-2#2)(1990-8#1)(1991-3#1)(1991-5#2)(1992-10#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#3)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#41)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#4)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
on thesurface of##2##3##(2008-11#2)
on thin##4##2##(2008-10#4)
on thin-layer##4##2##(2008-10#4)
on this cell##2##3##(2008-11#1)(2011-2#1)
on this chromosome##2##3##(1995-12#1)(2008-10#1)
on this concept##3##3##(2008-7#1)(2008-8#1)(2009-5#1)
on this effect##2##3##(1995-2#1)(2008-10#1)
on this electrode##2##3##(2008-10#2)
on this enzyme##2##3##(2008-7#2)
on this issue##3##3##(1991-3#1)(2008-11#2)
on this method##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
on this newly##2##3##(2008-10#1)(2008-7#1)
on this problem##4##3##(1992-8#1)(2008-5#1)(2008-8#1)(2008-9#1)
on this process##2##3##(2008-10#1)(2008-11#1)
on this species##2##3##(2008-10#1)(2008-12#1)
on this subject##4##3##(1992-1#1)(2008-5#3)
on this task##4##3##(1993-3#2)(1994-3#2)
on this topic##8##3##(1993-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
on this type of##3##4##(1990-2#1)(1992-3#1)(2011-3#1)
on this##139##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#5)(1993-6#2)(1994-2#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-2#1)(1997-8#3)(2008-10#46)(2008-11#14)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
on those##10##2##(1992-3#1)(1993-12#1)(1994-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
on three##31##2##(1993-1#1)(1996-11#1)(1996-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#3)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#2)(2012-6#1)(2013-8#1)
on three-dimensional##2##2##(1994-8#1)(2013-1#1)
on thyroid##5##2##(1991-8#1)(2008-7#3)(2013-1#1)
on time##5##2##(1993-2#1)(2008-10#2)(2008-8#1)(2010-8#1)
on timing##2##2##(2009-7#1)(2012-3#1)
on tissue##7##2##(1992-10#1)(1992-12#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
on titanium##5##2##(2008-10#4)(2009-7#1)
on to a hanging mercury drop electrode##2##7##(2008-10#2)
on to a##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
on to the##6##3##(2008-10#4)(2009-1#1)(2012-3#1)
on to##27##2##(1990-8#1)(1993-12#1)(1994-3#1)(1996-12#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#2)(2009-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
on tobacco and##4##3##(2008-10#4)
on tobacco##10##2##(1996-1#1)(2008-10#8)(2008-7#1)
on toluene##5##2##(2008-10#1)(2008-7#4)
on tomato and potato##2##4##(2008-10#2)
on tomato and##4##3##(2008-10#4)
on tomato plants grown in##2##5##(2008-10#2)
on tomato plants##3##3##(2008-10#3)
on tomato roots##2##3##(2008-10#2)
on tomato than##2##3##(2008-8#2)
on tomato##19##2##(2008-10#16)(2008-8#3)
on top of the##2##4##(2008-10#2)
on top of##6##3##(2008-10#5)(2008-3#1)
on topics##3##2##(1993-1#1)(1994-3#1)(1997-2#1)
on total##11##2##(1990-8#1)(1992-8#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#3)(2011-2#1)(2013-1#1)
on traditional Chinese medicine##2##4##(2013-1#2)
on traditional##7##2##(1991-3#1)(2008-10#2)(2011-1#1)(2011-7#1)(2013-1#2)
on transcription of the##2##4##(1995-2#1)(1995-6#1)
on transcription##7##2##(1992-3#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(2008-10#1)(2012-12#1)
on transcriptional activation##2##3##(1994-11#1)(2009-8#1)
on transcriptional##4##2##(1994-11#1)(2008-8#1)(2009-8#2)
on transient##3##2##(1992-9#1)(1996-6#1)(2010-12#1)
on transmission##3##2##(1991-10#1)(2008-3#1)(2008-5#1)
on transport##3##2##(1997-7#1)(2008-11#1)(2011-2#1)
on treated##4##2##(1996-12#1)(2008-10#2)(2008-5#1)
on treatment of##3##3##(1997-8#1)(2008-10#1)(2008-6#1)
on treatment##12##2##(1993-3#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#2)
on tree##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
on trees and##2##3##(2008-10#2)
on trees##3##2##(2008-10#3)
on trends in##2##3##(1991-3#2)
on trends##3##2##(1991-3#2)(1996-3#1)
on trial##2##2##(1994-3#1)(1995-8#1)
on trials##3##2##(1994-3#1)(2009-4#1)(2013-1#1)
on tryptophan##2##2##(2008-10#1)(2009-10#1)
on tubal##2##2##(1994-12#1)(1996-3#1)
on tumor cells##3##3##(2008-4#1)(2010-11#1)(2013-8#1)
on tumor growth##4##3##(1994-6#2)(2008-9#1)(2013-7#1)
on tumor##13##2##(1990-8#1)(1992-2#1)(1994-12#1)(1994-6#2)(1995-2#1)(2008-11#1)(2008-4#1)(2008-9#2)(2010-11#1)(2013-7#1)(2013-8#1)
on two approaches##2##3##(2008-11#1)(2008-4#1)
on two closely related##2##4##(2008-8#1)(2012-3#1)
on two different##3##3##(1990-11#1)(2008-11#1)(2008-9#1)
on two new##4##3##(1993-12#1)(2008-10#1)(2008-11#1)(2010-7#1)
on two occasions##3##3##(1997-4#1)(2008-12#1)(2008-9#1)
on two##68##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(2008-10#17)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#2)(2012-6#1)(2012-9#1)(2013-1#1)(2013-8#1)
on two-dimensional##2##2##(1997-2#1)(2007-12#1)
on type of##2##3##(2008-10#1)(2008-8#1)
on type##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
on tyrosinase##2##2##(2008-10#1)(2008-5#1)
on tyrosine residues in##2##4##(1993-6#1)(1995-8#1)
on tyrosine residues##4##3##(1993-6#1)(1995-6#1)(1995-8#1)(1996-2#1)
on tyrosine##6##2##(1992-7#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-2#2)
on ultrasonic extraction##2##3##(2008-10#1)(2013-8#1)
on ultrasound##11##2##(1994-6#1)(2008-10#3)(2011-2#3)(2012-2#3)(2012-3#1)
on undergraduate##3##2##(2008-11#2)(2013-1#1)
on underlying mechanisms##2##3##(2008-11#2)
on underlying##3##2##(1994-9#1)(2008-11#2)
on understanding the mechanisms##2##4##(2009-8#1)(2011-1#1)
on understanding##3##2##(2008-10#1)(2009-8#1)(2011-1#1)
on uniform##2##2##(2008-10#1)(2009-4#1)
on university##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
on untreated##6##2##(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
on upper##2##2##(2008-10#1)(2008-8#1)
on urban##2##2##(1992-12#1)(2008-11#1)
on uredinial##2##2##(2008-10#2)
on urediniospore germination##2##3##(2008-10#2)
on urinary##2##2##(1992-8#1)(2008-12#1)
on use of##5##3##(1995-12#1)(1996-3#1)(2008-11#1)(2008-3#2)
on use##8##2##(1995-1#1)(1995-12#1)(1996-3#1)(2008-11#2)(2008-3#2)(2012-12#1)
on user##2##2##(2011-2#2)
on using the##2##3##(1992-12#1)(2008-9#1)
on using##11##2##(1992-1#1)(1992-12#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-9#2)(2013-1#1)
on uterine epithelial cells##2##4##(2008-6#2)
on utilization and##2##3##(2012-12#2)
on utilization##6##2##(1994-3#1)(1997-4#1)(2012-12#3)(2013-8#1)
on value##3##2##(1994-2#1)(1995-1#1)(2007-11#1)
on variables##3##2##(1993-1#1)(1994-2#1)(2008-3#1)
on various##22##2##(1990-2#1)(1990-8#1)(1991-2#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
on vascular##5##2##(1994-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
on vasopressin##2##2##(1994-2#2)
on vegetative##2##2##(2008-10#1)(2012-8#1)
on viability##3##2##(1990-6#1)(2008-11#2)
on viable cell##2##3##(2008-11#2)
on violence##2##2##(2008-11#1)(2013-1#1)
on viral##4##2##(2008-11#1)(2008-6#1)(2008-9#1)(2013-8#1)
on virulence##4##2##(2008-10#4)
on virus accumulation##2##3##(2008-10#2)
on virus##7##2##(2007-12#1)(2008-10#5)(2008-11#1)
on virus-infected plants##2##3##(2008-10#2)
on viscosity##2##2##(2008-5#2)
on visual cues##3##3##(1991-2#1)(2008-8#1)(2008-9#1)
on visual field##2##3##(2011-2#2)
on visual##15##2##(1991-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#2)(2013-8#1)
on vitamin##3##2##(1992-9#2)(2008-10#1)
on volatile##2##2##(2008-5#1)(2011-10#1)
on voltage-dependent gating of a cloned mammalian neuronal##2##8##(1997-2#2)
on waiting lists##2##3##(1991-11#1)(2011-3#1)
on waiting##4##2##(1991-11#1)(2011-3#3)
on water agar##4##3##(2008-10#4)
on water toxicity##2##3##(2008-10#2)
on water##12##2##(1991-5#1)(2008-10#8)(2008-3#1)(2008-8#1)(2012-2#1)
on wavelength##3##2##(2008-2#1)(2008-3#2)
on weekdays##2##2##(2010-6#2)
on weight##2##2##(1991-2#1)(2011-2#1)
on welfare##2##2##(1994-3#2)
on what constitutes##2##3##(1995-2#1)(2010-10#1)
on what is##2##3##(2010-10#1)(2013-1#1)
on what the##2##3##(2008-10#1)(2008-8#1)
on what##16##2##(1991-2#1)(1993-12#1)(1995-2#1)(1996-2#2)(2008-10#2)(2008-12#1)(2008-8#2)(2009-7#1)(2010-10#4)(2013-1#1)
on wheat chromosome##2##3##(2008-10#2)
on wheat yield##2##3##(2008-12#1)(2008-8#1)
on wheat##35##2##(1993-8#1)(2008-10#31)(2008-12#1)(2008-8#1)(2011-1#1)
on when##2##2##(2010-8#1)(2011-2#1)
on whether the##4##3##(1991-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
on whether##15##2##(1991-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
on which a##2##3##(2008-11#1)(2008-3#1)
on which the##5##3##(2008-10#4)(2008-11#1)
on which to base##3##4##(1997-1#1)(2008-11#1)(2008-7#1)
on which to##5##3##(1997-1#1)(2008-11#2)(2008-7#1)(2011-8#1)
on which viruliferous##2##3##(2008-10#2)
on which##37##2##(1990-11#1)(1992-12#1)(1993-12#1)(1994-3#1)(1997-1#2)(2008-10#11)(2008-11#6)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#2)(2011-2#1)(2011-8#1)(2013-8#1)
on white fir at Teakettle##2##5##(2008-10#2)
on white fir in Lake Tahoe##2##6##(2008-10#2)
on white fir in##3##4##(2008-10#3)
on white fir##6##3##(2008-10#6)
on whole body sweat rate and##2##6##(2008-5#2)
on whole plants##2##3##(2008-10#2)
on whole##6##2##(2008-10#2)(2008-5#2)(2010-1#2)
on why##2##2##(2008-11#1)(2008-8#1)
on wild##4##2##(2008-10#3)(2013-8#1)
on wild-type##2##2##(1990-12#1)(1991-5#1)
on winter wheat##5##3##(2008-10#5)
on winter##6##2##(2008-10#6)
on women##2##2##(1992-2#1)(1994-12#1)
on women's##3##2##(1994-3#1)(2008-11#1)(2010-11#1)
on wood##2##2##(2012-5#1)(2013-1#1)
on work##5##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
on wounded apples##2##3##(2008-10#2)
on wounded##3##2##(2008-10#3)
on yeast##3##2##(1993-2#1)(1995-9#1)(2010-7#1)
on yield were##2##3##(2008-10#2)
on yield##6##2##(2008-10#5)(2009-7#1)
on young adult outcomes##2##4##(2010-7#2)
on young adult##6##3##(2010-7#6)
on young##11##2##(1993-12#2)(2008-7#1)(2010-7#7)(2012-3#1)
on α-glucosidase activity in##2##4##(2010-11#2)
on##19958##1##(1990-10#4)(1990-11#35)(1990-12#51)(1990-2#62)(1990-3#31)(1990-5#58)(1990-6#35)(1990-7#4)(1990-8#48)(1990-9#35)(1991-1#44)(1991-10#7)(1991-11#23)(1991-12#81)(1991-2#81)(1991-3#73)(1991-4#3)(1991-5#60)(1991-6#57)(1991-7#8)(1991-8#26)(1991-9#26)(1992-1#44)(1992-10#10)(1992-11#13)(1992-12#86)(1992-2#43)(1992-3#61)(1992-4#13)(1992-5#15)(1992-6#39)(1992-7#3)(1992-8#17)(1992-9#35)(1993-1#56)(1993-11#30)(1993-12#112)(1993-2#64)(1993-3#102)(1993-5#10)(1993-6#63)(1993-8#65)(1993-9#24)(1994-1#51)(1994-11#50)(1994-12#76)(1994-2#95)(1994-3#84)(1994-5#82)(1994-6#46)(1994-8#100)(1994-9#31)(1995-1#32)(1995-10#4)(1995-11#77)(1995-12#128)(1995-2#123)(1995-3#53)(1995-5#41)(1995-6#76)(1995-8#51)(1995-9#38)(1996-1#43)(1996-11#23)(1996-12#124)(1996-2#128)(1996-3#108)(1996-5#55)(1996-6#51)(1996-8#16)(1996-9#17)(1997-1#71)(1997-2#125)(1997-3#84)(1997-4#30)(1997-5#22)(1997-6#38)(1997-7#44)(1997-8#95)(1997-9#5)(2006-5#1)(2006-6#36)(2007-11#36)(2007-12#78)(2007-8#23)(2007-9#2)(2008-1#87)(2008-10#7161)(2008-11#1249)(2008-12#401)(2008-2#89)(2008-3#404)(2008-4#147)(2008-5#460)(2008-6#104)(2008-7#416)(2008-8#615)(2008-9#482)(2009-1#26)(2009-10#90)(2009-11#38)(2009-12#73)(2009-2#10)(2009-3#41)(2009-4#35)(2009-5#51)(2009-6#56)(2009-7#83)(2009-8#125)(2009-9#41)(2010-1#66)(2010-10#88)(2010-11#69)(2010-12#108)(2010-2#30)(2010-3#44)(2010-4#62)(2010-5#61)(2010-6#79)(2010-7#93)(2010-8#98)(2010-9#50)(2011-1#89)(2011-10#7)(2011-2#643)(2011-3#102)(2011-4#1)(2011-7#8)(2011-8#1)(2011-9#3)(2012-12#114)(2012-2#353)(2012-3#318)(2012-4#9)(2012-5#16)(2012-6#13)(2012-7#4)(2012-8#6)(2012-9#8)(2013-1#557)(2013-7#23)(2013-8#301)
on&quot##7##1##(1990-8#1)(2008-7#6)
on)##2##1##(1995-8#1)(2008-10#1)
on-##2##1##(2008-11#1)(2012-12#1)
on-axis##3##1##(2008-3#3)
on-bipolar cell##4##2##(1993-8#4)
on-board##4##1##(2008-10#3)(2008-11#1)
on-campus##2##1##(2008-11#2)
on-chip capillary electrophoresis##2##3##(2008-10#2)
on-chip separation##2##2##(2008-10#2)
on-chip##10##1##(2008-10#9)(2009-12#1)
on-column##7##1##(2008-10#7)
on-farm measures##2##2##(2011-2#2)
on-farm##4##1##(2008-12#2)(2011-2#2)
on-going##6##1##(1995-2#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2013-1#1)
on-line adsorption preconcentration##2##3##(2008-10#2)
on-line analysis of##2##3##(2008-10#2)
on-line and off-line##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
on-line and##5##2##(2008-10#2)(2008-11#2)(2008-3#1)
on-line atomic absorption##2##3##(2008-10#2)
on-line atomic##3##2##(2008-10#3)
on-line automated##4##2##(2008-10#4)
on-line by flame atomic absorption spectrometry##2##6##(2008-10#2)
on-line by##5##2##(2008-10#4)(2008-11#1)
on-line column enrichment##2##3##(2008-10#2)
on-line column preconcentration##2##3##(2008-10#2)
on-line column##7##2##(1992-11#1)(2008-10#6)
on-line concentration##2##2##(2008-10#2)
on-line coupled continuous flow liquid membrane extraction##2##7##(2008-10#2)
on-line coupled##4##2##(2008-10#4)
on-line coupling of##3##3##(1997-2#1)(2008-10#2)
on-line coupling##4##2##(1997-2#1)(2008-10#3)
on-line derivatization##7##2##(2008-10#7)
on-line detection of##2##3##(2008-10#1)(2010-11#1)
on-line detection##8##2##(2008-10#6)(2008-11#1)(2010-11#1)
on-line determination of##9##3##(2008-10#9)
on-line determination##11##2##(2008-10#11)
on-line dilution of the##2##4##(2008-10#2)
on-line dilution##7##2##(2008-10#7)
on-line electrogenerated##5##2##(2008-10#5)
on-line extraction##2##2##(2008-10#2)
on-line flow injection##4##3##(2008-10#4)
on-line flow##6##2##(2008-10#5)(2008-11#1)
on-line flow-injection microwave-assisted mineralization and##2##5##(2008-10#2)
on-line formed##2##2##(2008-10#2)
on-line hydrolysis##3##2##(2008-10#3)
on-line in the##2##3##(2008-10#2)
on-line in##5##2##(2008-10#4)(2008-7#1)
on-line instrumentation##3##2##(2008-10#3)
on-line into##2##2##(2008-10#2)
on-line liquid-liquid extraction##3##3##(2008-10#3)
on-line liquid-liquid##5##2##(2008-10#5)
on-line measurement of##2##3##(2008-10#1)(2008-11#1)
on-line measurements##3##2##(2008-10#3)
on-line method was##2##3##(2008-10#2)
on-line method##5##2##(2008-10#5)
on-line microdialysis sampling##2##3##(2008-10#2)
on-line microdialysis##3##2##(2008-10#3)
on-line mixing and##2##3##(2008-10#2)
on-line mixing##3##2##(2008-10#3)
on-line monitoring of##5##3##(2008-10#3)(2008-11#1)(2008-7#1)
on-line monitoring##9##2##(2008-10#6)(2008-11#1)(2008-7#2)
on-line multiplexed sorption preconcentration##2##4##(2008-10#2)
on-line of##2##2##(2008-10#2)
on-line oxidation##3##2##(2008-10#3)
on-line precipitation##4##2##(2008-10#4)
on-line preconcentration and##8##3##(2008-10#8)
on-line preconcentration of cobalt##2##4##(2008-10#2)
on-line preconcentration of##6##3##(2008-10#6)
on-line preconcentration system for zinc determination in##2##7##(2008-10#2)
on-line preconcentration system for##7##4##(2008-10#7)
on-line preconcentration system##10##3##(2008-10#10)
on-line preconcentration with a##2##4##(2008-10#2)
on-line preconcentration with##4##3##(2008-10#4)
on-line preconcentration##32##2##(2008-10#32)
on-line preconcentration/separation and determination##2##4##(2008-10#2)
on-line reaction##3##2##(2008-10#3)
on-line retention of##2##3##(2008-10#2)
on-line sample cleanup##2##3##(2008-10#2)
on-line sample concentration##2##3##(2008-10#2)
on-line sample pretreatment##4##3##(2008-10#4)
on-line sample##13##2##(2008-10#12)(2010-7#1)
on-line separation and##3##3##(2008-10#3)
on-line separation##6##2##(2008-10#6)
on-line sequential injection##3##3##(2008-10#3)
on-line sequential##4##2##(2008-10#4)
on-line solid phase extraction##2##4##(2008-10#2)
on-line solid phase##3##3##(2008-10#3)
on-line solid-phase extraction##4##3##(1997-2#1)(2008-10#3)
on-line sorbent##2##2##(2008-10#2)
on-line sorption##2##2##(2008-10#2)
on-line spectrophotometric##2##2##(2008-10#2)
on-line standard addition##4##3##(2008-10#4)
on-line system for##3##3##(2008-10#3)
on-line system with##3##3##(2008-10#3)
on-line system##11##2##(2008-10#11)
on-line to an##2##3##(2008-10#2)
on-line to##5##2##(2008-10#5)
on-line wavelet transform##5##3##(2008-10#5)
on-line with the##3##3##(2008-10#3)
on-line with##14##2##(2008-10#14)
on-line##409##1##(1991-2#1)(1992-11#2)(1995-12#1)(1996-2#1)(1997-2#3)(2008-10#371)(2008-11#16)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#6)(2010-11#1)(2010-7#2)
on-off##4##1##(1995-6#1)(2008-11#1)(2013-8#2)
on-site##19##1##(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2010-1#1)(2012-2#3)
on-the-job training##2##2##(1993-2#1)(1996-3#1)
on-treatment HBsAg##2##2##(2013-1#2)
on-treatment##6##1##(2009-8#3)(2011-2#1)(2013-1#2)
once a day##5##3##(1990-5#1)(2008-10#1)(2008-11#1)(2008-5#2)
once a week for##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
once a week##9##3##(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)
once a year##2##3##(1990-8#1)(1996-12#1)
once a##21##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-9#1)(1994-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)
once again##7##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
once and##2##2##(2008-10#1)(2008-4#1)
once daily##4##2##(1991-11#1)(2007-11#2)(2008-10#1)
once during##2##2##(2008-12#1)(2011-2#1)
once each##2##2##(2008-10#1)(2011-2#1)
once in every##2##3##(1995-2#1)(2010-8#1)
once in the##5##3##(1990-11#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-12#1)
once in##7##2##(1990-11#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-8#1)
once infected##2##2##(1995-2#1)(2008-10#1)
once it##3##2##(1993-3#1)(2008-10#1)(2008-7#1)
once more##2##2##(1991-11#1)(2008-10#1)
once or twice##2##3##(2012-6#1)(2013-1#1)
once per day##2##3##(2008-5#1)(2008-7#1)
once per week##2##3##(1991-12#1)(2008-12#1)
once per year##2##3##(1997-3#2)
once per##7##2##(1991-12#1)(1997-3#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
once the##12##2##(1992-3#1)(1992-9#1)(1997-6#1)(2007-9#1)(2008-10#6)(2008-5#1)(2013-1#1)
once they##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
once##130##1##(1990-11#2)(1990-5#2)(1990-8#2)(1991-11#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-2#4)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-9#1)(2008-10#30)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#3)(2013-7#1)
once-daily##4##1##(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
onco-antigens##4##1##(2013-1#4)
oncogene activated##2##2##(2008-11#2)
oncogene and##2##2##(1995-8#1)(2008-11#1)
oncogene expression in##2##3##(1992-3#1)(1995-8#1)
oncogene product##3##2##(1990-12#1)(1991-9#1)(1995-2#1)
oncogene products##2##2##(2008-11#1)(2008-4#1)
oncogene transfection##3##2##(2008-11#3)
oncogene##35##1##(1990-12#1)(1990-6#2)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#3)(1994-9#1)(1995-2#1)(1995-8#2)(1996-12#1)(1997-7#1)(2008-11#13)(2008-4#1)(2008-9#1)(2011-2#2)(2011-3#1)
oncogene-transfected##2##1##(1995-9#1)(2008-11#1)
oncogenes such as##2##3##(2008-11#2)
oncogenes##29##1##(1990-12#1)(1990-8#3)(1995-2#3)(1997-7#3)(2008-11#13)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#3)
oncogenesis##3##1##(1992-9#1)(2008-9#1)(2013-1#1)
oncogenic potential##2##2##(1995-2#1)(1996-1#1)
oncogenic##14##1##(1991-12#2)(1991-6#1)(1994-1#2)(1995-2#2)(1996-1#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
oncologic##8##1##(1991-3#1)(1997-8#1)(2008-1#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-1#2)
oncological treatment##2##2##(2008-5#1)(2012-3#1)
oncological##11##1##(1991-12#1)(1993-11#1)(2008-5#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-3#3)(2013-1#1)
oncologist and##2##2##(2008-10#1)(2013-1#1)
oncologist##8##1##(2008-10#3)(2008-11#1)(2009-11#2)(2013-1#1)(2013-8#1)
oncologists and##6##2##(1991-2#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
oncologists##11##1##(1991-2#1)(2008-10#2)(2008-11#1)(2009-2#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
oncology and##7##2##(1993-2#1)(1995-10#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-3#1)
oncology centers##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
oncology research##2##2##(2010-5#2)
oncology team##2##2##(2008-7#1)(2010-3#1)
oncology##51##1##(1991-2#1)(1991-8#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-5#3)(2010-7#1)(2011-2#5)(2011-3#2)(2012-2#3)(2012-3#3)(2013-1#2)
oncolytic activity##3##2##(2013-1#3)
oncolytic viruses and a##2##4##(1995-2#1)(2013-8#1)
oncolytic viruses##9##2##(1995-2#1)(2007-11#1)(2013-1#2)(2013-8#5)
oncolytic##15##1##(1995-2#2)(2007-11#1)(2013-1#7)(2013-8#5)
oncomiR##2##1##(2011-2#2)
oncophora##3##1##(1996-12#3)
oncoprotein##4##1##(2008-11#1)(2011-2#1)(2012-2#2)
oncoproteins##2##1##(2008-11#1)(2011-2#1)
oncostatin M##6##2##(1994-11#5)(1996-2#1)
one DNA fingerprint##3##3##(2008-10#3)
one DNA##4##2##(2008-10#4)
one MCG##2##2##(2008-10#2)
one QTL affected##2##3##(2008-10#2)
one QTL for##2##3##(2008-8#2)
one QTL##4##2##(2008-10#2)(2008-8#2)
one RAPD##2##2##(2008-10#2)
one School of##2##3##(2008-11#1)(2008-12#1)
one State##2##2##(1991-2#1)(1997-2#1)
one a##3##2##(1997-3#1)(2008-10#2)
one additional##5##2##(2008-10#3)(2008-12#1)(2010-12#1)
one affected##2##2##(1995-11#1)(2008-7#1)
one after##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
one alternative##2##2##(2008-10#1)(2008-9#1)
one analyte##2##2##(2008-10#2)
one and a half years##2##5##(2008-10#1)(2008-12#1)
one and a half##6##4##(1993-2#1)(1996-6#1)(2008-10#2)(2008-12#1)(2010-6#1)
one and a##9##3##(1992-6#1)(1993-2#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-6#1)
one and four##3##3##(1997-8#1)(2008-12#1)(2010-3#1)
one and the##2##3##(1995-6#1)(2008-10#1)
one and two##4##3##(1997-6#1)(2008-10#2)(2010-10#1)
one and##28##2##(1992-6#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-6#1)
one another and##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
one another in##5##3##(1993-12#1)(1997-7#1)(2008-10#2)(2008-11#1)
one another##32##2##(1990-11#1)(1991-3#1)(1992-9#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-3#2)
one another's##3##2##(1996-1#1)(2008-11#1)(2013-8#1)
one application##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
one approach to##2##3##(1993-3#1)(2008-11#1)
one approach##4##2##(1993-3#1)(1996-1#1)(2008-10#1)(2008-11#1)
one are##2##2##(2008-11#1)(2008-4#1)
one area##3##2##(1995-12#1)(2008-11#1)(2008-9#1)
one as##4##2##(2008-10#1)(2008-5#1)(2009-3#1)(2009-5#1)
one aspect of the##2##4##(1994-1#1)(2008-12#1)
one aspect of##3##3##(1994-1#1)(2008-12#1)(2013-1#1)
one aspect##4##2##(1993-2#1)(1994-1#1)(2008-12#1)(2013-1#1)
one at a time##4##4##(2008-10#2)(2008-7#1)(2013-1#1)
one at##12##2##(1991-9#1)(1994-11#1)(1995-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
one band##4##2##(1997-2#1)(2008-10#3)
one base##2##2##(2008-10#2)
one based on##2##3##(1993-11#1)(2008-10#1)
one because##2##2##(1991-3#1)(2013-1#1)
one before##2##2##(1990-12#1)(2008-1#1)
one being##5##2##(1991-9#1)(1995-8#1)(2008-7#2)(2010-2#1)
one bite##2##2##(1996-11#1)(2008-4#1)
one by one##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
one by##7##2##(1994-11#1)(2008-10#2)(2008-4#2)(2008-8#1)(2011-2#1)
one cDNA clone##3##3##(2008-8#3)
one cDNA##5##2##(1993-6#1)(2008-8#4)
one can be##2##3##(2008-3#1)(2009-8#1)
one can obtain##2##3##(2008-2#1)(2008-3#1)
one can predict the##2##4##(2008-10#1)(2008-11#1)
one can##25##2##(1991-3#1)(1992-9#1)(1994-9#1)(1995-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-1#1)
one cannot##3##2##(1991-12#1)(1995-9#1)(1997-3#1)
one case each of##3##4##(1996-11#1)(2008-5#1)(2008-9#1)
one case of acute##2##4##(2008-5#1)(2012-12#1)
one case of##11##3##(1997-3#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#2)
one case##42##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#2)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-9#3)(2009-1#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#2)
one cell##5##2##(1997-3#2)(2007-12#1)(2008-11#2)
one change##2##2##(1993-8#1)(2012-3#1)
one child##2##2##(2008-9#2)
one chromosome##2##2##(2008-10#1)(2008-12#1)
one class of##4##3##(1990-8#1)(1993-1#1)(1993-12#1)(2008-10#1)
one class##7##2##(1990-8#1)(1993-1#2)(1993-12#1)(2008-10#1)(2008-11#2)
one climatic area##2##3##(2008-10#2)
one climatic##3##2##(2008-10#2)(2013-1#1)
one cluster##3##2##(2008-10#2)(2008-6#1)
one common##2##2##(1991-5#1)(1993-12#1)
one community##2##2##(2009-2#1)(2011-2#1)
one compartment##2##2##(2008-11#1)(2011-2#1)
one complete##4##2##(2008-8#2)(2008-9#1)(2009-10#1)
one component of the##2##4##(1992-9#1)(2008-11#1)
one component of this##2##4##(1993-9#1)(2008-10#1)
one component of##5##3##(1992-9#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
one component##7##2##(1992-9#1)(1993-9#1)(2008-10#3)(2008-11#1)(2008-12#1)
one consisting of##3##3##(2008-10#2)(2008-7#1)
one contained the##2##3##(2008-10#2)
one control and##2##3##(2011-2#1)(2013-1#1)
one control##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
one copy of the##2##4##(2008-8#1)(2012-3#1)
one copy of##4##3##(2008-8#1)(2008-9#1)(2012-3#2)
one could##2##2##(2008-10#1)(2008-11#1)
one cultivar##4##2##(2008-10#4)
one cycle of##3##3##(2008-10#2)(2008-11#1)
one day in##2##3##(1997-7#1)(2008-5#1)
one day##11##2##(1991-3#1)(1993-2#1)(1997-7#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
one death##3##2##(1991-3#1)(1997-8#1)(2008-7#1)
one died##2##2##(1997-3#1)(2012-12#1)
one dimension##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
one direction##2##2##(1995-5#1)(2008-10#1)
one disease##2##2##(1994-2#1)(2010-1#1)
one dominant##4##2##(2008-10#2)(2009-11#1)(2009-6#1)
one dose##2##2##(2007-12#1)(2008-7#1)
one drop of##3##3##(1993-3#2)(2008-10#1)
one drug##2##2##(1991-1#1)(2012-3#1)
one each from##2##3##(2008-10#2)
one each##3##2##(1995-12#1)(2008-10#2)
one electron##3##2##(2008-10#2)(2009-9#1)
one element##2##2##(2008-10#1)(2008-11#1)
one encoding##2##2##(1991-9#1)(2008-11#1)
one end##6##2##(2008-10#4)(2008-3#1)(2008-7#1)
one enzyme##4##2##(1992-6#1)(2008-10#1)(2008-7#1)(2010-3#1)
one establishment every##2##3##(2008-10#2)
one example of##2##3##(2008-4#1)(2008-9#1)
one experiment##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)
one explanation for the##2##4##(1991-12#1)(2011-1#1)
one eye##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
one facility##6##2##(1991-3#2)(1996-11#1)(2008-11#1)(2013-1#2)
one factor##2##2##(2008-10#1)(2008-9#1)
one faculty##2##2##(1993-2#1)(2008-12#1)
one family##2##2##(1991-12#1)(2008-10#1)
one fetus##2##2##(1993-12#1)(2012-3#1)
one fiber##2##2##(2008-10#1)(2008-3#1)
one field##7##2##(2008-10#7)
one fifth of##3##3##(1990-11#1)(2008-8#1)(2012-3#1)
one focuses##3##2##(2008-2#1)(2008-8#2)
one for 1##2##3##(2008-10#1)(2008-9#1)
one for amplification##2##3##(2008-10#1)(2008-3#1)
one for the##4##3##(2008-10#3)(2008-11#1)
one for##27##2##(1993-8#1)(1994-8#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#5)(2009-3#2)(2010-1#1)(2011-2#1)(2013-8#1)
one form of##4##3##(1993-6#1)(2008-10#3)
one format##3##2##(2008-10#1)(2008-4#1)(2010-10#1)
one found solely in##2##4##(2008-10#2)
one found##3##2##(2008-10#2)(2008-2#1)
one fraction##2##2##(1992-11#1)(2008-10#1)
one from chrysanthemum and##2##4##(2008-10#2)
one from the##3##3##(2008-10#2)(2011-2#1)
one from##14##2##(1992-12#1)(2008-10#10)(2008-5#1)(2011-2#2)
one fungicide##2##2##(2008-10#1)(2008-7#1)
one gene##9##2##(1990-8#1)(1992-6#1)(1993-3#1)(1994-9#1)(2008-10#2)(2009-5#2)(2013-8#1)
one genotype##6##2##(2008-10#5)(2013-8#1)
one given##2##2##(2008-10#2)
one group and##2##3##(2008-10#1)(2011-2#1)
one group of##4##3##(1990-2#1)(1994-8#1)(2008-10#1)(2008-9#1)
one group##15##2##(1990-2#1)(1994-8#1)(2008-10#9)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
one had the##2##3##(2008-9#1)(2013-1#1)
one had##7##2##(1991-12#1)(1997-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
one half of the##4##4##(1993-12#1)(2007-12#1)(2008-9#2)
one half of##7##3##(1992-12#1)(1993-12#1)(1997-2#1)(2007-12#1)(2008-9#2)(2011-2#1)
one half##8##2##(1991-6#1)(1992-12#1)(1993-12#1)(1997-2#1)(2007-12#1)(2008-9#2)(2011-2#1)
one hand and##5##3##(1991-6#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
one hand##26##2##(1991-2#1)(1991-3#1)(1991-6#1)(1994-1#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
one haplotype##2##2##(2008-10#2)
one has the##2##3##(1990-6#1)(2008-10#1)
one has##11##2##(1990-6#1)(1995-6#1)(1995-9#1)(2008-10#7)(2013-8#1)
one health care##2##3##(1992-2#1)(1995-2#1)
one health##3##2##(1992-2#1)(1995-2#1)(2008-7#1)
one hospital##4##2##(1991-9#1)(1993-3#1)(1994-12#1)(1994-2#1)
one host species##2##3##(2008-10#1)(2008-9#1)
one host##5##2##(2008-10#3)(2008-9#2)
one hour after##2##3##(1994-8#2)
one hour##10##2##(1992-2#1)(1992-6#1)(1994-8#2)(2008-11#2)(2008-12#1)(2010-11#1)(2010-8#1)(2012-3#1)
one hundred##3##2##(1995-10#1)(2008-11#1)(2008-7#1)
one hybridization##2##2##(1997-3#1)(2008-10#1)
one hypothesis##2##2##(2008-10#1)(2008-8#1)
one implant##2##2##(2013-1#2)
one in a##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
one in each##2##3##(1996-2#1)(2008-10#1)
one in terms of##2##4##(1991-3#1)(2010-10#1)
one in the##3##3##(2008-12#1)(2010-8#1)(2011-2#1)
one in which##5##3##(1991-9#1)(1995-8#1)(2008-8#1)(2009-7#1)(2012-12#1)
one in##28##2##(1991-3#1)(1991-9#1)(1993-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
one individual##5##2##(1991-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)
one instance##3##2##(1996-12#1)(2008-10#1)(2009-1#1)
one is a##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
one is of##2##3##(2007-8#1)(2008-1#1)
one is that##2##3##(2008-11#1)(2008-6#1)
one is the##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
one is##23##2##(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)
one isolate from##2##3##(2008-10#2)
one isolate of##6##3##(2008-10#6)
one isolate##15##2##(2008-10#13)(2008-5#1)(2012-2#1)
one kidney##2##2##(2008-10#1)(2011-2#1)
one large open reading frame##2##5##(2008-10#2)
one large##7##2##(2008-10#4)(2008-8#1)(2010-8#1)(2012-3#1)
one layer of##2##3##(2008-10#1)(2011-2#1)
one layer##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
one lesion per leaf was expected following##2##7##(2008-10#2)
one lesion##3##2##(1997-8#1)(2008-10#2)
one library##2##2##(1997-6#1)(2010-4#1)
one line containing the PinII##2##5##(2008-10#2)
one line##3##2##(2008-10#3)
one lineage##3##2##(2008-10#3)
one location##4##2##(2008-10#4)
one locus with##2##3##(1995-5#1)(2008-10#1)
one locus##4##2##(1995-5#1)(2008-10#2)(2008-9#1)
one louse##2##2##(1996-12#2)
one lung##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
one major##12##2##(1990-6#1)(1994-1#1)(1994-12#1)(1995-6#1)(1997-8#1)(2008-10#5)(2008-7#1)(2008-8#1)
one male##2##2##(2008-12#1)(2008-8#1)
one mating type##2##3##(2008-10#2)
one mating##3##2##(2008-10#2)(2008-8#1)
one may##3##2##(1991-5#1)(2008-11#1)(2009-10#1)
one means of##2##3##(2008-11#1)(2008-12#1)
one mechanism##3##2##(1993-6#1)(2008-10#1)(2010-1#1)
one method##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
one might##4##2##(1996-3#1)(1996-9#1)(2008-12#1)(2012-2#1)
one million people##2##3##(2008-10#1)(2008-11#1)
one million##8##2##(1990-3#1)(1992-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2012-3#1)
one molecule of##4##3##(1990-9#2)(1994-5#2)
one molecule##5##2##(1990-9#2)(1994-5#2)(2008-8#1)
one month after the##2##4##(2008-5#1)(2013-8#1)
one month after##6##3##(1991-2#1)(1991-3#1)(1997-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
one month later##2##3##(2008-11#1)(2008-5#1)
one month of##3##3##(2011-1#1)(2012-2#2)
one month##26##2##(1991-2#1)(1991-3#1)(1991-9#1)(1993-6#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-5#3)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
one more##4##2##(1991-3#1)(1996-12#1)(2008-10#1)(2008-5#1)
one muscle group##2##3##(2010-7#2)
one must##8##2##(1994-9#2)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
one needs to##2##3##(2008-10#1)(2008-7#1)
one ochre mutation##2##3##(2008-9#2)
one of a number of##3##5##(2008-11#2)(2012-2#1)
one of a##5##3##(1995-12#1)(1996-1#1)(2008-11#2)(2012-2#1)
one of five##7##3##(1991-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
one of four##10##3##(1992-1#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-9#1)
one of its##5##3##(1994-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
one of our##2##3##(1991-3#1)(2008-11#1)
one of seven##2##3##(1995-12#1)(2008-10#1)
one of several##12##3##(1990-2#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-2#1)
one of six##4##3##(2008-10#2)(2008-12#1)(2009-7#1)
one of the antagonists##2##4##(1995-11#1)(2008-8#1)
one of the authors##2##4##(2008-11#2)
one of the best##5##4##(1991-6#1)(1995-12#1)(2008-10#2)(2008-12#1)
one of the cell##2##4##(2008-10#1)(2008-11#1)
one of the children##2##4##(1994-12#1)(2008-9#1)
one of the common##3##4##(2008-10#1)(2008-4#1)(2013-1#1)
one of the components of the##2##6##(2008-10#2)
one of the components##3##4##(2008-10#3)
one of the compounds##2##4##(1992-3#1)(2008-10#1)
one of the eight##2##4##(2008-10#1)(2010-12#1)
one of the elements##2##4##(2008-10#1)(2013-1#1)
one of the factors in##2##5##(1997-8#1)(2009-5#1)
one of the factors##10##4##(1995-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2013-8#1)
one of the few##2##4##(1994-6#1)(2008-10#1)
one of the first to##2##5##(2008-11#1)(2012-3#1)
one of the first##9##4##(1993-12#1)(1994-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#2)
one of the following##5##4##(1991-2#1)(2008-10#2)(2008-8#1)(2010-2#1)
one of the four##2##4##(1996-2#1)(2012-12#1)
one of the highest in##2##5##(2008-11#1)(2010-10#1)
one of the highest##6##4##(2008-11#3)(2008-5#1)(2010-10#1)(2011-2#1)
one of the important##6##4##(1992-12#1)(1993-3#1)(2008-10#2)(2008-9#1)(2009-8#1)
one of the key enzymes##2##5##(2008-9#2)
one of the key##7##4##(2008-11#2)(2008-8#1)(2008-9#2)(2010-10#1)(2013-1#1)
one of the largest##4##4##(1991-2#1)(1995-6#1)(2008-10#1)(2008-5#1)
one of the leading##6##4##(2007-12#1)(2008-11#1)(2010-8#1)(2011-2#2)(2013-8#1)
one of the main##13##4##(1991-6#1)(1993-12#1)(1994-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
one of the major obstacles to##2##6##(1996-5#1)(2008-12#1)
one of the major##23##4##(1994-12#1)(1995-6#1)(1996-5#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
one of the many##3##4##(2008-11#1)(2008-12#2)
one of the mechanisms responsible for##2##6##(2008-10#1)(2008-11#1)
one of the mechanisms##4##4##(2008-10#2)(2008-11#1)(2009-12#1)
one of the most abundant##2##5##(2010-11#1)(2011-2#1)
one of the most common infectious diseases##2##7##(1997-8#2)
one of the most common##26##5##(1990-8#1)(1990-9#1)(1991-2#1)(1997-7#1)(1997-8#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#5)
one of the most devastating diseases of##2##7##(1997-7#1)(2008-10#1)
one of the most devastating##4##5##(1997-7#1)(2008-10#2)(2012-3#1)
one of the most effective##2##5##(2008-10#1)(2009-11#1)
one of the most fascinating##2##5##(2008-11#1)(2008-12#1)
one of the most important foliar diseases of##2##8##(2008-10#2)
one of the most important##30##5##(1990-12#1)(1993-6#1)(1994-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-10#1)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
one of the most interesting##2##5##(2008-5#1)(2009-8#1)
one of the most potent##2##5##(2008-10#1)(2010-8#1)
one of the most powerful##3##5##(2008-10#2)(2008-7#1)
one of the most rapidly##4##5##(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
one of the most sensitive##3##5##(2008-10#2)(2008-7#1)
one of the most significant##2##5##(2007-11#1)(2013-1#1)
one of the most widely used##3##6##(2008-10#1)(2011-2#1)(2012-2#1)
one of the most widely##8##5##(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
one of the most##134##4##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-5#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#6)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#1)(2011-10#2)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#1)
one of the municipalities##2##4##(1991-6#1)(1992-2#1)
one of the oldest##2##4##(2008-10#1)(2010-7#1)
one of the parents##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
one of the positive##2##4##(2008-8#1)(2011-3#1)
one of the possible##2##4##(2008-9#1)(2012-12#1)
one of the primary##4##4##(1991-1#1)(1993-1#1)(2008-10#1)(2008-11#1)
one of the rare##4##4##(1997-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
one of the rarest##2##4##(1997-7#1)(2010-3#1)
one of the reasons for##3##5##(2008-10#2)(2008-8#1)
one of the seven##2##4##(2008-10#1)(2008-12#1)
one of the three##4##4##(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
one of the two##21##4##(1991-9#1)(1992-3#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
one of the##479##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1997-2#5)(1997-3#3)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#4)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#125)(2008-11#35)(2008-12#15)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#14)(2008-6#2)(2008-7#13)(2008-8#19)(2008-9#18)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-5#3)(2009-6#1)(2009-8#5)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#2)(2011-10#2)(2011-2#19)(2011-3#5)(2012-12#7)(2012-2#5)(2012-3#10)(2013-1#25)(2013-7#1)(2013-8#5)
one of their##2##3##(2011-2#1)(2012-3#1)
one of them was##3##4##(1995-6#1)(2008-10#2)
one of them##17##3##(1991-8#1)(1994-3#1)(1995-6#1)(1997-2#1)(2008-10#10)(2008-7#1)(2008-9#1)(2013-1#1)
one of these genes##2##4##(1992-9#1)(1997-2#1)
one of these##32##3##(1992-10#1)(1992-9#1)(1993-2#1)(1993-8#3)(1994-5#1)(1997-2#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
one of those##2##3##(1992-3#1)(1996-5#1)
one of three##12##3##(1991-1#1)(1996-11#1)(2008-10#4)(2008-4#2)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#1)
one of two different##2##4##(1990-12#1)(2008-10#1)
one of two specific##2##4##(1994-11#1)(2008-5#1)
one of two##26##3##(1990-12#2)(1990-8#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-8#1)(1996-6#1)(1997-3#2)(1997-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
one of which also##2##4##(2008-10#2)
one of which is##6##4##(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#1)(2009-8#2)
one of which was##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
one of which##20##3##(1993-2#1)(1993-3#2)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#2)(2011-2#1)
one of##686##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#4)(1991-3#5)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#3)(1993-3#5)(1993-6#3)(1993-8#4)(1994-1#2)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-5#1)(1995-6#8)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#2)(1997-2#9)(1997-3#6)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#4)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#174)(2008-11#52)(2008-12#20)(2008-2#2)(2008-3#8)(2008-4#7)(2008-5#20)(2008-6#3)(2008-7#19)(2008-8#23)(2008-9#25)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#10)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#6)(2010-8#4)(2010-9#1)(2011-1#3)(2011-10#2)(2011-2#27)(2011-3#5)(2012-12#7)(2012-2#12)(2012-3#12)(2012-9#1)(2013-1#27)(2013-7#2)(2013-8#7)
one on one##2##3##(1991-3#1)(2008-8#1)
one on the##2##3##(1994-8#1)(2008-5#1)
one on##6##2##(1991-3#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
one onion##2##2##(2008-10#2)
one opal mutation##2##3##(2008-9#2)
one or a##3##3##(2008-10#2)(2010-4#1)
one or both of these##3##5##(1991-3#1)(1995-11#1)(2008-10#1)
one or both of##5##4##(1991-3#1)(1993-8#1)(1995-11#1)(2008-10#2)
one or both##15##3##(1991-3#1)(1993-2#1)(1993-8#1)(1995-11#1)(2008-10#6)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-7#1)
one or more R genes##2##5##(2008-10#2)
one or more chronic##2##4##(1993-3#1)(1994-6#1)
one or more of 12##2##5##(2008-10#1)(2008-11#1)
one or more of the##6##5##(1992-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-6#1)
one or more of these##2##5##(2008-1#1)(2011-2#1)
one or more of##11##4##(1992-5#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2009-6#1)(2011-2#1)
one or more##61##3##(1991-7#1)(1991-9#1)(1992-12#2)(1992-5#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-5#3)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#2)(2008-10#19)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#1)(2011-1#2)(2011-2#4)(2013-1#3)(2013-8#2)
one or multiple##2##3##(2011-2#1)(2012-3#1)
one or several##3##3##(1990-5#1)(2008-12#1)(2009-5#1)
one or the other##3##4##(2008-7#1)(2008-9#1)(2009-12#1)
one or two genotypes##2##4##(2008-10#2)
one or two##27##3##(1990-11#1)(1991-2#1)(1991-5#1)(1995-3#1)(1996-12#1)(1996-5#2)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#1)
one or##117##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#3)(1996-12#2)(1996-2#1)(1996-5#2)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#35)(2008-11#8)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
one order of magnitude##5##4##(1991-5#1)(2008-10#4)
one organic##2##2##(2008-7#1)(2010-4#1)
one oscillation period##2##3##(2008-2#2)
one other case of##2##4##(1990-5#1)(2008-12#1)
one other##7##2##(1990-11#1)(1990-5#1)(1991-10#1)(1994-6#1)(2008-10#1)(2008-12#1)(2013-8#1)
one out of##3##3##(1992-5#1)(1995-6#1)(2008-7#1)
one ovary was##2##3##(1992-3#2)
one pair of##4##3##(2008-10#1)(2008-12#1)(2010-7#1)(2012-3#1)
one pair##5##2##(2008-10#2)(2008-12#1)(2010-7#1)(2012-3#1)
one paper##2##2##(2008-11#1)(2012-3#1)
one parameter##2##2##(2008-10#1)(2008-11#1)
one parent##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
one part##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
one particular##3##2##(1991-2#1)(2008-9#1)(2012-2#1)
one pathogen##2##2##(2008-10#2)
one patient died##2##3##(1991-8#1)(2008-7#1)
one patient was found to##2##5##(2008-7#1)(2011-1#1)
one patient with##4##3##(1990-12#1)(1994-12#1)(1996-9#1)(2008-11#1)
one patient##41##2##(1990-12#1)(1991-8#1)(1994-12#1)(1995-11#1)(1996-9#3)(1997-1#1)(1997-6#2)(1997-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-5#4)(2008-7#6)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#1)
one patients##2##2##(2013-8#2)
one per##2##2##(2008-10#2)
one percent##2##2##(1996-3#1)(2013-1#1)
one permanent##2##2##(1997-3#1)(2008-10#1)
one phototype##2##2##(2008-5#2)
one plant species##3##3##(2008-10#2)(2008-8#1)
one plant##6##2##(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
one point##2##2##(2008-5#1)(2008-6#1)
one polypeptide##3##2##(1991-12#1)(1993-2#1)(2008-8#1)
one population##5##2##(2008-10#4)(2008-8#1)
one positive##3##2##(1992-5#1)(1994-12#1)(2008-9#1)
one possible##3##2##(1995-2#1)(2008-3#1)(2011-2#1)
one pot##2##2##(1996-5#1)(2009-10#1)
one presenting##2##2##(2008-11#1)(2008-7#1)
one previously published##2##3##(2008-10#1)(2008-9#1)
one procedure##2##2##(1991-2#1)(2008-10#1)
one produced##2##2##(1997-6#1)(2008-8#1)
one protein of##2##3##(2008-10#1)(2008-4#1)
one protein##7##2##(2008-10#1)(2008-4#1)(2008-9#3)(2010-12#1)(2012-2#1)
one quarter##2##2##(2008-11#1)(2012-12#1)
one race of P##2##4##(2008-10#2)
one race of##4##3##(2008-10#4)
one race##5##2##(2008-10#5)
one reason why##2##3##(2008-10#1)(2008-9#1)
one reason##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
one receptor##2##2##(1990-8#2)
one recessive gene was detected in BBA 809##2##8##(2008-10#2)
one recessive gene was detected in BBA##3##7##(2008-10#3)
one recessive gene was detected in##4##6##(2008-10#4)
one recessive gene##6##3##(2008-10#5)(2008-9#1)
one reference electrode##2##3##(2008-10#2)
one representative##2##2##(2008-10#2)
one residue##2##2##(1991-10#1)(2008-11#1)
one rice##2##2##(2008-10#1)(2009-10#1)
one sample of##3##3##(2008-10#2)(2008-3#1)
one sample was##2##3##(2008-10#2)
one sample##12##2##(2008-10#10)(2008-11#1)(2008-3#1)
one season##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
one segment##2##2##(2008-10#2)
one sequence##3##2##(1997-6#1)(2008-4#1)(2011-2#1)
one serum##2##2##(2008-11#2)
one set of##4##3##(1995-12#1)(2008-10#3)
one should be##3##3##(2008-5#2)(2012-2#1)
one should consider##2##3##(2008-10#1)(2008-7#1)
one should preferably##2##3##(2008-8#2)
one should##7##2##(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)(2012-2#1)
one side and##4##3##(2008-10#1)(2008-5#1)(2012-2#2)
one side of the##4##4##(1991-5#1)(1993-3#1)(1997-4#1)(2008-10#1)
one side of##6##3##(1991-5#1)(1993-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2011-2#1)
one side##15##2##(1991-5#1)(1993-3#2)(1996-8#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#2)(2012-3#1)
one significant##2##2##(2011-2#1)(2013-1#1)
one single##12##2##(1992-11#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
one site##5##2##(1990-11#1)(1992-2#1)(1994-5#1)(2008-10#2)
one small##2##2##(2008-5#1)(2012-12#1)
one species to##3##3##(2008-8#1)(2012-2#2)
one species##15##2##(1993-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#4)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#1)
one specific##3##2##(2008-11#2)(2008-5#1)
one spray##2##2##(2008-10#2)
one standard drink##2##3##(2009-7#2)
one standard##4##2##(2008-10#2)(2009-7#2)
one step closer to##2##4##(2007-9#1)(2008-6#1)
one step##16##2##(1994-12#1)(1996-5#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)
one still##2##2##(2008-3#1)(2012-2#1)
one stone##2##2##(2011-2#1)(2012-3#1)
one strain##8##2##(1996-12#1)(2008-10#6)(2008-11#1)
one strand##2##2##(1997-9#1)(2008-4#1)
one student##2##2##(1992-3#1)(2008-11#1)
one study##10##2##(1991-1#1)(1991-12#1)(1992-3#1)(1995-2#1)(2008-5#1)(2009-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
one subpopulation##2##2##(2008-10#2)
one subunit##3##2##(1991-12#1)(1991-6#1)(2009-7#1)
one such##11##2##(1991-12#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
one system##2##2##(2008-1#1)(2008-10#1)
one tenth of the##2##4##(2008-10#1)(2008-2#1)
one tenth that of##2##4##(2007-12#1)(2010-6#1)
one tenth##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2010-6#1)
one test##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
one that involves##2##3##(2008-11#1)(2008-9#1)
one that is##5##3##(2008-3#3)(2008-9#1)(2009-3#1)
one that##20##2##(1992-9#1)(1995-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-8#2)(2008-9#4)(2009-3#1)(2009-5#1)(2010-1#1)(2012-2#2)
one the##3##2##(1995-2#1)(1996-9#1)(2008-12#1)
one third of the##5##4##(1997-4#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
one third of##10##3##(1997-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
one third##17##2##(1990-9#1)(1997-2#1)(1997-4#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
one time##7##2##(1995-10#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#1)
one to conclude##2##3##(1995-3#1)(2008-10#1)
one to determine the##2##4##(2008-10#1)(2008-9#1)
one to evaluate##2##3##(2008-10#2)
one to four##4##3##(2008-10#3)(2012-12#1)
one to phenotype##2##3##(2008-10#2)
one to six##2##3##(2008-10#2)
one to three##2##3##(2008-10#2)
one to two##3##3##(1992-11#1)(1993-12#1)(2008-11#1)
one to##54##2##(1992-11#1)(1993-12#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
one told##2##2##(2009-10#1)(2011-2#1)
one tool in the##2##4##(2008-10#1)(2010-11#1)
one trait##2##2##(2008-10#1)(2008-8#1)
one treatment##4##2##(1992-5#1)(1995-2#1)(2012-12#2)
one trial##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
one type of##8##3##(1992-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2013-8#1)
one type##9##2##(1992-6#1)(2007-12#1)(2008-10#4)(2008-11#2)(2013-8#1)
one typical##2##2##(1996-12#1)(2011-1#1)
one unique##3##2##(1994-5#1)(2008-4#1)(2008-9#1)
one university in##2##3##(2008-11#1)(2008-12#1)
one university##4##2##(2008-11#2)(2008-12#2)
one ureter##2##2##(1996-3#1)(2008-10#1)
one using##4##2##(2008-10#2)(2008-9#1)(2010-1#1)
one vineyard##2##2##(2008-10#2)
one was associated with##2##4##(2008-10#1)(2008-11#1)
one was##19##2##(1990-3#1)(1990-5#1)(1995-8#1)(2008-10#4)(2008-11#4)(2008-7#3)(2008-9#2)(2011-2#1)(2013-7#1)(2013-8#1)
one way to##2##3##(1994-12#1)(1997-2#1)
one way##5##2##(1994-12#1)(1995-12#1)(1997-2#1)(2010-10#1)(2011-1#1)
one week after##2##3##(1991-2#1)(2013-1#1)
one week##16##2##(1991-2#1)(1992-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-9#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
one well-defined##3##2##(2008-10#3)
one where##3##2##(1997-4#1)(1997-7#1)(2010-10#1)
one which can##2##3##(1991-11#1)(2008-7#1)
one which##7##2##(1990-8#1)(1991-1#1)(1991-11#1)(2008-11#1)(2008-7#2)(2013-1#1)
one who##2##2##(1994-1#1)(1996-2#1)
one with a##5##3##(2008-10#2)(2008-9#2)(2013-1#1)
one with the##4##3##(1990-3#1)(2008-10#2)(2013-8#1)
one with##27##2##(1990-3#1)(1991-11#2)(1991-3#1)(1995-11#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#4)(2012-2#1)(2013-1#1)(2013-8#1)
one without##4##2##(1990-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
one would expect##2##3##(1995-12#1)(2008-11#1)
one year after the##4##4##(1996-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
one year after##9##3##(1991-8#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-1#1)
one year and##2##3##(1990-12#1)(2013-1#1)
one year in##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
one year of age##2##4##(1991-11#1)(1991-6#1)
one year of##5##3##(1991-11#2)(1991-2#1)(1991-6#1)(2012-12#1)
one year old##2##3##(2013-8#2)
one year were##3##3##(2007-12#1)(2008-11#1)(2012-12#1)
one year##66##2##(1990-12#1)(1990-2#1)(1991-11#3)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-3#1)(2008-7#2)(2008-9#3)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#5)(2013-1#2)(2013-8#4)
one##3050##1##(1990-11#8)(1990-12#10)(1990-2#6)(1990-3#8)(1990-5#12)(1990-6#4)(1990-8#11)(1990-9#7)(1991-1#6)(1991-10#2)(1991-11#7)(1991-12#16)(1991-2#14)(1991-3#19)(1991-5#8)(1991-6#12)(1991-7#2)(1991-8#5)(1991-9#11)(1992-1#7)(1992-10#2)(1992-11#3)(1992-12#11)(1992-2#10)(1992-3#10)(1992-4#1)(1992-5#9)(1992-6#8)(1992-7#1)(1992-9#10)(1993-1#4)(1993-11#1)(1993-12#17)(1993-2#14)(1993-3#17)(1993-6#12)(1993-8#12)(1993-9#2)(1994-1#6)(1994-11#9)(1994-12#22)(1994-2#10)(1994-3#7)(1994-5#12)(1994-6#7)(1994-8#10)(1994-9#8)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#17)(1995-2#13)(1995-3#7)(1995-5#8)(1995-6#16)(1995-8#9)(1995-9#7)(1996-1#9)(1996-11#9)(1996-12#19)(1996-2#15)(1996-3#16)(1996-5#11)(1996-6#7)(1996-8#4)(1996-9#8)(1997-1#5)(1997-2#28)(1997-3#25)(1997-4#9)(1997-5#6)(1997-6#16)(1997-7#14)(1997-8#22)(1997-9#2)(2006-6#1)(2007-11#5)(2007-12#23)(2007-8#4)(2007-9#1)(2008-1#14)(2008-10#859)(2008-11#197)(2008-12#70)(2008-2#18)(2008-3#46)(2008-4#32)(2008-5#89)(2008-6#18)(2008-7#102)(2008-8#111)(2008-9#134)(2009-1#5)(2009-10#21)(2009-11#5)(2009-12#8)(2009-2#1)(2009-3#8)(2009-4#3)(2009-5#10)(2009-6#7)(2009-7#7)(2009-8#17)(2009-9#3)(2010-1#10)(2010-10#14)(2010-11#10)(2010-12#12)(2010-2#7)(2010-3#4)(2010-4#12)(2010-5#3)(2010-6#7)(2010-7#15)(2010-8#16)(2010-9#1)(2011-1#17)(2011-10#3)(2011-2#109)(2011-3#8)(2012-12#27)(2012-2#41)(2012-3#47)(2012-9#1)(2013-1#91)(2013-7#5)(2013-8#49)
one's own institution##2##3##(2009-4#2)
one's own##7##2##(2008-10#1)(2008-11#2)(2009-4#3)(2010-10#1)
one's##22##1##(1991-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-5#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-4#3)(2010-10#1)(2010-2#1)(2010-6#1)(2012-2#1)
one)##5##1##(1990-2#1)(1990-8#1)(1992-5#1)(1993-2#1)(1995-11#1)
one- and##3##2##(1995-5#1)(2008-3#1)(2010-4#1)
one-##5##1##(1993-8#1)(1995-5#1)(2008-10#1)(2008-3#1)(2010-4#1)
one-beam##3##1##(2008-3#3)
one-carbon donor##2##2##(1992-10#2)
one-carbon##4##1##(1992-10#2)(2009-12#1)(2011-2#1)
one-channel##3##1##(2008-9#3)
one-day##4##1##(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
one-dimensional wavelet##2##2##(2008-10#2)
one-dimensional##28##1##(1990-11#1)(1993-5#1)(1994-12#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#2)(2008-8#1)(2010-11#1)(2010-12#1)(2013-8#1)
one-electron reduced to the##2##4##(2008-10#2)
one-electron##4##1##(1993-8#1)(1996-5#1)(2008-10#2)
one-fifth of##2##2##(1994-3#1)(1996-11#1)
one-fourth of the##3##3##(1997-1#1)(2008-10#1)(2008-8#1)
one-fourth of##5##2##(1990-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2010-12#1)
one-frequency##2##1##(2008-10#2)
one-half of the##4##3##(1991-1#1)(1994-12#1)(2008-10#1)(2012-2#1)
one-half of##5##2##(1991-1#2)(1994-12#1)(2008-10#1)(2012-2#1)
one-half the##2##2##(1994-11#1)(1995-5#1)
one-half##13##1##(1991-1#2)(1991-12#1)(1992-1#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-1#1)(1995-5#1)(2008-10#1)(2012-2#2)
one-month##2##1##(2008-5#1)(2011-3#1)
one-photon##3##1##(2008-3#3)
one-pot##9##1##(1996-5#2)(2008-10#3)(2008-11#1)(2011-3#1)(2012-2#1)(2012-3#1)
one-quarter of the##2##3##(1996-1#1)(2008-9#1)
one-shot cases##3##2##(1993-1#3)
one-shot sensor##4##2##(2008-10#4)
one-shot##8##1##(1993-1#3)(2008-10#5)
one-step RT-PCR##5##2##(2008-9#1)(2013-8#4)
one-step##21##1##(1990-12#1)(1993-6#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-9#2)(2012-2#1)(2013-1#3)(2013-8#4)
one-tailed##3##1##(1995-9#1)(2012-2#1)(2013-8#1)
one-tenth##2##1##(2008-10#1)(2010-6#1)
one-third of the##8##3##(1995-6#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)
one-third of##15##2##(1994-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#1)(2011-1#1)(2012-2#1)
one-third the##2##2##(1990-8#1)(2011-2#1)
one-third##22##1##(1990-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
one-time##3##1##(1991-2#1)(2008-10#1)(2008-11#1)
one-to-one mappings##2##2##(2010-10#2)
one-to-one relationship##2##2##(1994-2#1)(2008-10#1)
one-to-one##7##1##(1994-2#1)(1996-12#1)(2008-10#3)(2010-10#2)
one-trial passive avoidance##2##3##(2008-6#2)
one-trial##3##1##(2008-6#2)(2008-7#1)
one-tube##2##1##(2008-10#1)(2008-9#1)
one-way ANOVA##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
one-way analysis of variance##2##4##(1993-2#1)(2008-10#1)
one-way##14##1##(1993-2#2)(1997-1#1)(2008-10#4)(2008-11#1)(2010-8#3)(2011-2#1)(2013-1#2)
one-week##3##1##(2008-11#1)(2011-3#2)
one-year survival##2##2##(1995-2#1)(2008-10#1)
one-year##7##1##(1990-2#1)(1991-6#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#2)
one-year-old##3##1##(1991-8#1)(2008-8#1)(2009-8#1)
onerous##2##1##(1994-2#1)(1996-5#1)
ones and##3##2##(2008-10#2)(2013-1#1)
ones by##2##2##(2007-12#1)(2008-10#1)
ones in##4##2##(1992-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
ones may be##2##3##(2008-10#1)(2008-9#1)
ones such as##2##3##(1997-1#1)(2013-8#1)
ones that##8##2##(1990-2#1)(2008-11#5)(2008-8#1)(2008-9#1)
ones used##3##2##(1997-4#1)(2008-10#1)(2010-8#1)
ones were##6##2##(1990-8#1)(1991-2#4)(2013-8#1)
ones with##3##2##(2008-10#2)(2012-3#1)
ones##170##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#3)(2008-10#46)(2008-11#13)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#7)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#7)
ones)##3##1##(1997-5#1)(2008-10#1)(2008-11#1)
ongoing clinical trials##3##3##(2008-5#1)(2010-6#1)(2011-7#1)
ongoing clinical##4##2##(2008-5#1)(2008-6#1)(2010-6#1)(2011-7#1)
ongoing debate on the##2##4##(2009-10#1)(2011-2#1)
ongoing debate on##3##3##(1991-1#1)(2009-10#1)(2011-2#1)
ongoing debate##7##2##(1991-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)
ongoing destruction of the##2##4##(1993-3#1)(1997-5#1)
ongoing destruction##3##2##(1993-3#1)(1997-5#2)
ongoing engagement in##2##3##(2013-1#2)
ongoing evaluation##2##2##(1996-2#1)(2008-12#1)
ongoing feedback to##2##3##(1996-1#1)(2008-3#1)
ongoing quality##2##2##(1993-2#1)(2010-6#1)
ongoing research##6##2##(1992-1#1)(1997-1#1)(2008-11#1)(2010-5#1)(2011-2#1)(2011-3#1)
ongoing trial##2##2##(1996-6#1)(2012-2#1)
ongoing##107##1##(1991-1#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1996-1#2)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#3)(1997-2#2)(1997-5#3)(1997-6#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#9)(2008-12#4)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2009-10#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2011-4#1)(2011-7#1)(2011-8#2)(2012-12#1)(2012-2#4)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#1)
onion cultivars##2##2##(2008-10#2)
onion in##2##2##(2008-10#2)
onion is##2##2##(2008-10#2)
onion plants##3##2##(2008-10#3)
onion strains of Xanthomonas and##2##5##(2008-10#2)
onion yellow##2##2##(2008-10#2)
onion yellows##4##2##(2008-10#4)
onion##39##1##(1993-12#1)(2008-10#38)
onium salt##5##2##(2008-10#5)
onium##6##1##(1994-8#1)(2008-10#5)
onlay##2##1##(1992-4#1)(2008-10#1)
online and##2##2##(2008-12#1)(2009-2#1)
online health communities##6##3##(2011-2#6)
online health##7##2##(2010-4#1)(2011-2#6)
online learning##2##2##(2008-12#2)
online preconcentration and separation##2##4##(2008-10#2)
online preconcentration and##3##3##(2008-10#3)
online preconcentration##4##2##(2008-10#4)
online resources##3##2##(1994-12#1)(2008-11#2)
online system##3##2##(1991-2#1)(1992-12#1)(1995-11#1)
online##94##1##(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1992-1#1)(1992-12#1)(1994-12#1)(1995-11#1)(2007-12#1)(2008-10#15)(2008-11#5)(2008-12#8)(2008-5#1)(2008-9#2)(2009-2#1)(2010-1#2)(2010-11#1)(2010-12#5)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#18)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#1)
only 0##14##2##(1990-10#1)(1990-6#1)(1991-5#1)(1993-8#1)(2008-10#7)(2008-11#2)(2008-8#1)
only 1 case##2##3##(1990-12#1)(2010-6#1)
only 1##20##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-8#1)(1994-12#1)(1995-11#1)(1996-1#1)(2008-10#4)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
only 1%##2##2##(1992-5#1)(2013-1#1)
only 1-2% of##2##3##(1990-6#1)(2013-8#1)
only 10##5##2##(1995-12#2)(2008-10#2)(2008-7#1)
only 10% of the##2##4##(1996-11#1)(2008-10#1)
only 10% of##3##3##(1992-9#1)(1996-11#1)(2008-10#1)
only 10%##6##2##(1992-9#1)(1993-9#1)(1996-11#2)(2008-10#2)
only 10min##2##2##(2008-10#2)
only 10ml##2##2##(2008-10#2)
only 11##4##2##(1990-8#1)(1990-9#1)(2008-10#1)(2008-8#1)
only 12##3##2##(2008-10#2)(2011-1#1)
only 13##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
only 14##3##2##(1990-9#1)(2008-10#1)(2012-2#1)
only 14%##2##2##(1990-6#1)(2008-7#1)
only 15##4##2##(2007-8#1)(2009-3#1)(2013-1#2)
only 15%##2##2##(1993-3#1)(1994-12#1)
only 16##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
only 18##2##2##(1990-6#1)(1992-12#1)
only 18%##3##2##(1990-12#1)(1990-6#1)(2008-10#1)
only 2 patients##3##3##(1990-12#1)(1991-6#1)(2011-2#1)
only 2##18##2##(1990-12#2)(1991-6#1)(1993-6#1)(1994-8#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-9#1)(2011-2#1)
only 2%##5##2##(1990-8#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)
only 20##2##2##(2008-11#1)(2013-1#1)
only 20% of the##2##4##(1992-5#1)(2011-2#1)
only 20% of##5##3##(1991-8#1)(1992-12#1)(1992-5#1)(2008-10#1)(2011-2#1)
only 20%##8##2##(1990-8#1)(1991-8#1)(1992-12#1)(1992-5#1)(1994-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
only 24##2##2##(2008-10#1)(2011-1#1)
only 28%##2##2##(1993-11#1)(1993-3#1)
only 29%##2##2##(2008-1#1)(2008-11#1)
only 3##9##2##(1992-2#1)(1997-7#1)(2008-10#5)(2008-5#1)(2011-2#1)
only 3% of the total##2##5##(2008-10#1)(2013-1#1)
only 3% of the##3##4##(2008-10#2)(2013-1#1)
only 3%##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
only 33%##2##2##(1994-12#1)(2013-7#1)
only 35% of##2##3##(1990-5#1)(2008-11#1)
only 4##11##2##(1990-11#1)(1991-11#1)(1991-2#1)(2008-10#4)(2008-2#1)(2008-7#2)(2010-7#1)
only 4%##3##2##(1992-3#1)(1995-2#1)(2012-12#1)
only 40%##2##2##(1991-5#1)(1995-12#1)
only 5 to##2##3##(1990-6#1)(1996-12#1)
only 5##8##2##(1990-6#1)(1993-8#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)
only 5% of##3##3##(1992-12#1)(2008-10#1)(2011-2#1)
only 5%##4##2##(1992-12#1)(2008-10#1)(2010-8#1)(2011-2#1)
only 5-10%##2##2##(1990-2#1)(2009-8#1)
only 53%##3##2##(1991-6#1)(1993-8#1)(2008-7#1)
only 54%##2##2##(2008-10#1)(2008-7#1)
only 6 of##2##3##(2008-10#1)(2012-2#1)
only 6##5##2##(1993-6#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
only 6% of the##2##4##(1993-8#1)(1994-2#1)
only 6% of##3##3##(1993-8#1)(1994-2#1)(2008-10#1)
only 6%##4##2##(1993-8#1)(1994-2#1)(2008-10#2)
only 60%##2##2##(2008-10#1)(2008-7#1)
only 65%##2##2##(2008-10#2)
only 7##5##2##(1992-4#1)(1996-11#1)(2008-10#3)
only 8 cases##2##3##(2013-1#2)
only 8##7##2##(1996-5#1)(2008-10#1)(2008-11#2)(2009-8#1)(2013-1#2)
only 80##2##2##(2008-10#2)
only 9##4##2##(1996-3#1)(2008-10#2)(2008-7#1)
only B##2##2##(2008-10#2)
only Fe(II)##2##2##(2008-10#2)
only MaYMFV##2##2##(2008-10#2)
only X##2##2##(2008-10#2)
only a few cases of##2##5##(1994-3#1)(2008-12#1)
only a few cases##4##4##(1994-3#1)(1997-8#1)(2008-12#1)(2013-1#1)
only a few of these##2##5##(1990-2#1)(2008-8#1)
only a few of##3##4##(1990-2#1)(1992-3#1)(2008-8#1)
only a few##47##3##(1990-12#1)(1990-2#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-6#2)(2012-2#1)(2012-4#1)(2013-1#6)
only a limited number of##2##5##(2007-12#1)(2008-6#1)
only a limited##7##3##(1990-6#1)(1995-11#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-12#1)
only a minor role in##2##5##(2008-10#1)(2008-9#1)
only a minor##8##3##(2008-10#4)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
only a minority##3##3##(1992-3#1)(2013-1#2)
only a moderate##2##3##(1997-6#1)(2010-6#1)
only a modest##2##3##(1991-12#1)(1994-5#1)
only a partial##3##3##(1995-2#1)(1997-4#1)(2008-10#1)
only a portion of the##2##5##(1992-3#1)(2008-10#1)
only a short##2##3##(1995-5#1)(1997-4#1)
only a single haploid##2##4##(2008-10#1)(2009-12#1)
only a single##16##3##(1990-12#1)(1991-9#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#1)(2013-1#1)
only a slight##4##3##(1991-6#1)(2008-10#2)(2008-12#1)
only a small number##2##4##(2008-11#1)(2008-7#1)
only a small percentage of##3##5##(1991-3#1)(2008-10#1)(2011-2#1)
only a small proportion of the##5##6##(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#1)(2011-2#1)
only a small proportion of##6##5##(1994-8#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2011-2#1)
only a small##25##3##(1990-12#1)(1990-8#1)(1991-3#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-3#1)(1997-1#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#3)(2011-2#2)
only a subset of the##2##5##(2008-8#1)(2012-2#1)
only a very limited##2##4##(2008-10#1)(2008-11#1)
only a very small##2##4##(2008-11#1)(2010-5#1)
only a very##5##3##(2008-10#2)(2008-11#2)(2010-5#1)
only a##166##2##(1990-12#3)(1990-2#2)(1990-6#2)(1990-8#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#3)(2008-10#43)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#5)(2009-12#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-6#4)(2011-2#5)(2012-2#2)(2012-4#1)(2013-1#9)(2013-8#1)
only able to##4##3##(1991-1#1)(2008-8#1)(2011-3#1)(2012-2#1)
only about 1%##2##3##(1996-12#1)(2010-1#1)
only about##16##2##(1990-11#1)(1990-2#1)(1991-12#1)(1993-12#1)(1996-11#1)(1996-12#1)(2008-10#4)(2008-11#1)(2009-11#1)(2010-1#1)(2011-1#1)(2011-3#1)(2013-1#1)
only accounted for 15##2##4##(2013-1#2)
only achieved##2##2##(2008-10#1)(2008-11#1)
only active##3##2##(2008-10#3)
only additive##2##2##(2008-10#1)(2008-11#1)
only affected##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
only after a##2##3##(2008-10#1)(2011-2#1)
only after the##4##3##(1994-3#1)(1995-2#1)(1997-5#1)(2008-10#1)
only after##24##2##(1991-3#1)(1991-6#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-5#2)(2008-10#8)(2008-11#1)(2008-7#2)(2010-3#1)(2011-2#2)(2013-1#1)
only against PMA-induced arachidonate release##2##5##(2008-11#2)
only against##5##2##(2008-11#3)(2008-4#1)(2008-7#1)
only age##4##2##(1991-3#1)(2008-10#1)(2008-7#2)
only amenable##2##2##(2008-9#1)(2010-8#1)
only an##7##2##(1993-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2011-2#1)
only and##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
only apparent##2##2##(1991-12#1)(2008-10#1)
only approximately##9##2##(1997-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
only are##3##2##(1994-1#1)(2008-7#1)(2008-8#1)
only as a##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
only as an##2##3##(1994-12#1)(1995-12#1)
only as##14##2##(1994-12#1)(1995-12#1)(1995-6#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-7#1)(2012-3#1)
only associated with##2##3##(2008-8#1)(2013-1#1)
only at a##2##3##(2008-10#2)
only at concentrations##3##3##(1990-2#1)(1994-8#1)(2008-9#1)
only at higher##2##3##(1994-11#1)(1994-5#1)
only at pH##2##3##(2008-10#2)
only at the higher inoculum density##2##6##(2008-10#2)
only at the##11##3##(1991-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-3#1)
only at##37##2##(1990-2#1)(1991-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#3)(2010-12#1)(2012-3#1)(2013-1#1)
only available##2##2##(2007-8#1)(2008-11#1)
only based on##2##3##(2011-2#1)(2012-3#1)
only be achieved##3##3##(1994-12#1)(1997-7#1)(2008-7#1)
only be applied##3##3##(2008-10#2)(2013-1#1)
only be obtained##3##3##(1995-2#1)(2008-11#1)(2008-9#1)
only be used##4##3##(2008-10#1)(2008-9#1)(2012-2#2)
only be##49##2##(1990-3#2)(1991-11#1)(1992-6#1)(1993-8#2)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#5)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
only because##4##2##(1995-5#1)(1996-9#1)(1997-1#1)(2012-2#1)
only become##3##2##(2008-1#1)(2008-5#1)(2011-3#1)
only been##7##2##(1991-11#1)(1995-8#1)(2008-1#1)(2008-9#1)(2009-7#1)(2010-11#1)(2013-1#1)
only being##2##2##(2008-10#1)(2012-2#1)
only between##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
only by a##3##3##(1991-1#1)(1993-8#1)(2007-12#1)
only by the##14##3##(1990-3#1)(1991-12#1)(1992-4#1)(1993-12#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2009-11#1)(2012-3#1)
only by##50##2##(1990-2#1)(1990-3#3)(1990-5#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#2)(1995-2#2)(1995-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2011-2#3)(2012-2#1)(2012-3#3)
only can be##2##3##(2009-10#1)(2013-1#1)
only can##3##2##(2008-7#1)(2009-10#1)(2013-1#1)
only clinical##2##2##(1993-11#1)(2013-1#1)
only composed of##2##3##(2008-10#1)(2008-11#1)
only data##2##2##(2008-10#1)(2008-2#1)
only detected in the##2##4##(2008-10#2)
only detected in##4##3##(1993-12#1)(2008-10#2)(2008-11#1)
only detected##7##2##(1993-12#1)(2008-10#4)(2008-11#1)(2010-10#1)
only determination of##3##3##(2008-10#2)(2009-8#1)
only did##2##2##(1993-6#1)(1996-1#1)
only differed##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
only difference##2##2##(1996-12#1)(2008-10#1)
only direct##2##2##(2008-4#1)(2009-9#1)
only distantly related to##2##4##(2008-10#2)
only does##2##2##(2008-10#1)(2012-2#1)
only during the##5##3##(1991-12#1)(2008-10#3)(2008-7#1)
only during##9##2##(1990-12#1)(1991-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-8#1)
only emerged##2##2##(2008-10#1)(2010-1#1)
only exception##2##2##(1990-2#1)(2013-1#1)
only expressed in##4##3##(1993-6#1)(1997-7#1)(2008-11#1)(2008-8#1)
only expressed##5##2##(1993-6#1)(1997-7#1)(2008-11#2)(2008-8#1)
only factor significantly associated with##2##5##(2012-2#2)
only factor##3##2##(1991-2#1)(2012-2#2)
only few reports##2##3##(2008-10#2)
only few##11##2##(1991-8#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#2)
only five##4##2##(1990-3#1)(1995-1#1)(2008-10#2)
only for a few##2##4##(1997-4#1)(2008-8#1)
only for the##11##3##(1993-9#1)(1994-2#1)(1996-11#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-10#1)(2012-2#1)
only for##46##2##(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
only found in##5##3##(1993-9#1)(1997-6#1)(2008-10#1)(2008-7#1)(2009-10#1)
only found##7##2##(1993-9#1)(1997-6#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-7#1)
only four##12##2##(1990-5#1)(1991-7#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-3#1)
only free##2##2##(1997-2#1)(2008-10#1)
only from lung##2##3##(1992-6#1)(2008-5#1)
only from the##6##3##(1993-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
only from##22##2##(1992-6#1)(1993-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#1)
only group##3##2##(2008-10#2)(2013-1#1)
only half##2##2##(1992-6#1)(2009-10#1)
only have a##2##3##(2008-11#1)(2011-1#1)
only have##3##2##(2008-11#2)(2011-1#1)
only highly##2##2##(2008-10#1)(2010-5#1)
only if it##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
only if the##12##3##(1996-1#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-6#1)(2008-8#3)(2012-3#1)
only if##32##2##(1991-1#1)(1994-1#1)(1996-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
only improve##3##2##(1995-2#1)(2011-1#1)(2013-1#1)
only in 1##2##3##(1990-6#1)(1994-1#1)
only in a few##2##4##(2008-11#1)(2013-1#1)
only in a##5##3##(1990-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
only in cells##2##3##(1997-7#1)(2008-10#1)
only in human##3##3##(1991-12#1)(2008-9#1)(2010-11#1)
only in rat##2##3##(1991-12#1)(1995-6#1)
only in the case of##3##5##(1993-8#1)(2008-10#1)(2008-11#1)
only in the first##2##4##(2008-10#1)(2008-7#1)
only in the older DS and##2##6##(1991-1#2)
only in the presence of##9##5##(1991-5#1)(1992-7#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-3#1)
only in the triradiate lumen##2##5##(2008-10#2)
only in the##69##3##(1990-12#1)(1991-1#2)(1991-5#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-12#2)(2008-10#15)(2008-11#10)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#2)
only in two##2##3##(1996-12#1)(2008-8#1)
only in young##2##3##(2008-7#2)
only in##174##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-2#2)(1993-3#2)(1993-8#2)(1994-1#1)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2007-12#2)(2008-10#48)(2008-11#17)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#9)(2008-8#3)(2008-9#7)(2009-10#2)(2009-7#1)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#4)(2012-4#1)(2012-8#1)(2013-1#3)(2013-8#1)
only increased##2##2##(2008-10#2)
only increases the##2##3##(2008-10#1)(2009-9#1)
only increases##3##2##(2008-10#1)(2008-12#1)(2009-9#1)
only individual##2##2##(1996-2#1)(2008-6#1)
only induced##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
only inorganic##3##2##(2008-10#2)(2008-6#1)
only into##2##2##(2008-11#1)(2008-9#1)
only involving##2##2##(2008-10#2)
only is the##3##3##(1991-8#1)(2008-10#1)(2008-3#1)
only is##5##2##(1991-8#1)(2008-10#2)(2008-3#1)(2010-5#1)
only isolated##3##2##(1997-2#1)(2008-10#1)(2013-8#1)
only isolates of##2##3##(2008-10#2)
only isolates##5##2##(2008-10#5)
only known##7##2##(1991-5#1)(1996-11#1)(1997-1#1)(2008-10#3)(2012-2#1)
only less##2##2##(2008-10#2)
only light staining##2##3##(1995-8#1)(2008-7#1)
only limited##5##2##(1991-3#1)(2008-10#1)(2008-12#1)(2009-8#1)(2012-3#1)
only little##2##2##(2008-9#1)(2010-12#1)
only local##2##2##(1993-1#1)(2008-8#1)
only low##2##2##(2008-11#1)(2008-7#1)
only marginally##5##2##(1990-5#1)(1995-6#1)(2008-10#2)(2013-8#1)
only medical school##2##3##(2010-5#1)(2013-8#1)
only mild##2##2##(1990-11#1)(2008-7#1)
only minimal changes in##2##4##(2008-8#1)(2013-8#1)
only minimal##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
only minimally##3##2##(2008-3#1)(2012-2#1)(2013-8#1)
only minor##9##2##(1990-2#1)(1993-8#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-4#1)
only moderate##5##2##(1994-5#1)(1995-8#1)(2008-10#2)(2011-1#1)
only moderately##5##2##(1990-8#1)(1994-12#1)(2008-11#1)(2010-4#1)(2011-2#1)
only modest##4##2##(1997-7#1)(2008-10#1)(2009-7#1)(2010-1#1)
only natural##2##2##(1995-11#1)(2008-7#1)
only neurons##2##2##(1994-8#1)(2008-7#1)
only observed if##2##3##(1993-6#1)(2008-11#1)
only observed in##5##3##(1993-6#1)(1994-6#1)(1997-1#1)(2008-10#1)(2012-5#1)
only observed##11##2##(1992-3#1)(1993-6#2)(1994-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2009-7#1)(2012-5#1)
only obvious##2##2##(1991-11#1)(2008-9#1)
only occasional##2##2##(1993-11#1)(2008-12#1)
only occasionally##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
only occur##3##2##(1994-3#1)(2008-7#1)(2010-5#1)
only occurred when##2##3##(2011-2#1)(2012-3#1)
only occurred##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
only of the##4##3##(2008-11#2)(2008-3#2)
only of##12##2##(1993-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-7#1)
only on strawberry##2##3##(2008-10#2)
only on the basis of##2##5##(1997-1#1)(1997-7#1)
only on the##21##3##(1990-2#1)(1991-2#2)(1991-3#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
only on##56##2##(1990-2#1)(1991-2#2)(1991-3#2)(1994-3#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#19)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
only once##5##2##(1990-5#1)(1992-12#1)(1996-2#1)(1997-6#1)(2008-10#1)
only one case of##2##4##(2012-3#2)
only one case##7##3##(1990-9#1)(1991-8#1)(1997-8#1)(2008-10#1)(2008-9#1)(2012-3#2)
only one copy of##2##4##(2008-9#1)(2012-3#1)
only one gene##2##3##(2009-5#2)
only one in##2##3##(1996-11#1)(2011-2#1)
only one instance##2##3##(1996-12#1)(2009-1#1)
only one isolate##2##3##(2008-10#1)(2012-2#1)
only one major##2##3##(1990-6#1)(2008-7#1)
only one mating##2##3##(2008-10#1)(2008-8#1)
only one of several##2##4##(1990-2#1)(2008-11#1)
only one of the populations##2##5##(2008-8#1)(2008-9#1)
only one of the two##2##5##(2008-10#1)(2008-7#1)
only one of the##12##4##(1991-12#1)(1992-5#1)(1994-12#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#1)(2012-3#1)
only one of##18##3##(1990-2#1)(1991-12#1)(1992-5#1)(1994-12#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-3#1)
only one or two##3##4##(2008-10#2)(2012-12#1)
only one or##4##3##(2008-10#3)(2012-12#1)
only one patient##3##3##(2008-1#1)(2008-5#1)(2012-3#1)
only one protein##2##3##(2008-10#1)(2008-9#1)
only one side of the##2##5##(1991-5#1)(1997-4#1)
only one single##2##3##(2008-11#1)(2013-1#1)
only one species##2##3##(2008-8#1)(2011-2#1)
only one specific##2##3##(2008-11#2)
only one standard solution##2##4##(2008-10#2)
only one strain##2##3##(1996-12#1)(2008-11#1)
only one##142##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1995-2#1)(1996-11#1)(1996-12#3)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#39)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#9)(2009-1#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#4)
only over##3##2##(1993-6#1)(2008-10#2)
only part of a##2##4##(2008-11#1)(2008-6#1)
only part of##3##3##(1993-12#1)(2008-11#1)(2008-6#1)
only partial##5##2##(1990-2#1)(1992-7#1)(2008-9#2)(2011-2#1)
only partially explained by##2##4##(1991-8#1)(2008-10#1)
only partially to##2##3##(1994-8#1)(2008-10#1)
only partially##16##2##(1990-5#1)(1991-3#1)(1991-8#1)(1994-6#1)(1994-8#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2013-8#1)
only positive##3##2##(2008-5#1)(2009-5#1)(2011-2#1)
only possible in##2##3##(2008-10#1)(2012-12#1)
only possible##6##2##(1994-12#1)(1996-6#1)(2008-10#2)(2008-6#1)(2012-12#1)
only present in##2##3##(2008-10#1)(2008-5#1)
only present##5##2##(1996-12#1)(2008-10#2)(2008-5#2)
only produced##2##2##(2008-10#2)
only provide##2##2##(1994-2#1)(2008-10#1)
only provided the##2##3##(2008-11#1)(2008-8#1)
only provided##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
only provides##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
only rarely in the##2##4##(2008-10#2)
only rarely##10##2##(1991-6#1)(1991-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
only recently been##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
only recently##12##2##(1992-1#1)(1993-1#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
only reduced##2##2##(2008-10#1)(2011-2#1)
only reported##2##2##(2007-8#1)(2012-2#1)
only requires##2##2##(2008-10#1)(2011-2#1)
only results in##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
only revealed##2##2##(2009-8#1)(2013-1#1)
only sensitive##2##2##(2008-10#1)(2013-1#1)
only serve to##2##3##(2008-11#1)(2012-2#1)
only seven##4##2##(1993-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
only several##2##2##(1996-2#1)(2008-10#1)
only short##2##2##(1993-9#1)(1997-4#1)
only significant##5##2##(1991-11#1)(1993-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
only single genotypic##2##3##(2008-12#2)
only single##5##2##(2008-10#1)(2008-12#2)(2008-8#1)(2012-2#1)
only six##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
only slight##5##2##(1993-8#1)(1997-6#1)(2008-10#2)(2011-1#1)
only slightly##14##2##(1992-1#1)(1993-1#1)(1995-11#2)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-3#1)(2009-10#1)
only small##5##2##(1991-12#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-9#1)
only some of##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
only some##5##2##(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
only species in##2##3##(2008-10#1)(2011-2#1)
only species present in##2##4##(1990-2#1)(2008-10#1)
only species##5##2##(1990-2#1)(2008-10#2)(2010-8#1)(2011-2#1)
only technique##2##2##(2008-11#2)
only the active##2##3##(1992-12#1)(2013-1#1)
only the first##3##3##(1994-3#1)(2008-10#2)
only the latter##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
only the most##3##3##(1992-6#1)(2008-10#2)
only the number of##2##4##(2008-11#1)(2012-4#1)
only the second##6##3##(1993-8#1)(2008-10#1)(2011-2#3)(2012-3#1)
only the third##4##3##(2011-2#4)
only the two##2##3##(1993-12#1)(2008-7#1)
only the##117##2##(1991-12#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#38)(2008-11#8)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#10)(2011-3#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#1)
only this##3##2##(1991-3#1)(1995-2#1)(2008-10#1)
only those##4##2##(1990-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
only three patients##2##3##(1990-9#1)(2011-2#1)
only three##14##2##(1990-11#1)(1990-9#1)(1991-6#1)(2008-10#6)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)
only through the##4##3##(1991-3#1)(1992-3#1)(1994-3#1)(2009-7#1)
only through##6##2##(1991-3#1)(1992-3#1)(1994-3#1)(2008-8#1)(2008-9#1)(2009-7#1)
only to a##2##3##(1991-9#1)(2008-10#1)
only to an##2##3##(1990-8#1)(2008-10#1)
only to be##2##3##(2008-10#1)(2009-7#1)
only to the##10##3##(1991-2#1)(1991-3#1)(1993-6#1)(1994-1#1)(2008-10#4)(2008-5#1)(2009-3#1)
only to##57##2##(1990-5#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2010-3#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-8#1)
only trace##2##2##(2008-10#1)(2008-11#1)
only treatment##6##2##(1991-6#1)(1996-11#1)(2008-10#1)(2010-8#1)(2012-12#1)(2012-3#1)
only two cases have been##2##5##(1990-12#1)(2009-6#1)
only two cases##4##3##(1990-12#1)(1996-5#1)(1996-9#1)(2009-6#1)
only two of these##2##4##(1996-11#1)(1996-3#1)
only two of##6##3##(1996-11#1)(1996-3#1)(2008-10#3)(2008-5#1)
only two patients##2##3##(1993-1#1)(2011-1#1)
only two sites##2##3##(2008-10#2)
only two##37##2##(1990-12#2)(1990-5#1)(1991-6#2)(1993-1#1)(1993-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
only under##5##2##(1990-3#1)(1993-8#1)(1997-8#1)(2008-11#1)(2008-7#1)
only used##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
only variable##3##2##(1990-8#1)(2008-10#1)(2013-1#1)
only very few##2##3##(2008-11#2)
only very##5##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#2)
only via##2##2##(1990-5#1)(2008-11#1)
only visualized##2##2##(2008-10#2)
only was##5##2##(2008-10#3)(2008-11#1)(2010-11#1)
only water##2##2##(2008-10#1)(2009-6#1)
only way to##3##3##(1994-9#1)(1997-5#1)(2008-11#1)
only way##6##2##(1994-9#2)(1997-5#1)(2008-11#1)(2010-6#1)(2010-7#1)
only weak##4##2##(1992-6#1)(2008-10#3)
only weakly##6##2##(1990-8#1)(1993-11#1)(2008-10#2)(2008-3#1)(2009-5#1)
only were excluded##2##3##(1991-2#1)(2012-12#1)
only were##4##2##(1990-5#1)(1991-2#1)(2008-10#1)(2012-12#1)
only when the##6##3##(1992-3#1)(1996-2#1)(2008-10#2)(2008-3#1)(2012-3#1)
only when they##4##3##(1991-12#1)(2008-11#1)(2010-4#1)(2010-6#1)
only when##36##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-11#5)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-4#1)(2010-6#1)(2010-7#1)(2012-3#2)(2013-1#1)
only with the##8##3##(1991-6#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-10#1)(2011-2#1)
only with##25##2##(1991-6#1)(1991-8#1)(1996-11#1)(1997-3#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
only within##4##2##(2008-10#1)(2008-7#1)(2009-7#1)(2010-4#1)
only##2614##1##(1990-10#1)(1990-11#9)(1990-12#18)(1990-2#15)(1990-3#12)(1990-5#15)(1990-6#16)(1990-8#13)(1990-9#8)(1991-1#7)(1991-11#8)(1991-12#19)(1991-2#14)(1991-3#21)(1991-5#9)(1991-6#14)(1991-7#3)(1991-8#7)(1991-9#5)(1992-1#4)(1992-10#1)(1992-12#12)(1992-2#7)(1992-3#13)(1992-4#3)(1992-5#4)(1992-6#7)(1992-7#2)(1992-9#2)(1993-1#7)(1993-11#6)(1993-12#15)(1993-2#6)(1993-3#8)(1993-6#18)(1993-8#21)(1993-9#5)(1994-1#5)(1994-11#6)(1994-12#18)(1994-2#8)(1994-3#12)(1994-5#13)(1994-6#5)(1994-8#10)(1994-9#6)(1995-1#3)(1995-11#11)(1995-12#17)(1995-2#17)(1995-3#2)(1995-5#6)(1995-6#10)(1995-8#9)(1996-1#5)(1996-11#15)(1996-12#22)(1996-2#12)(1996-3#8)(1996-5#9)(1996-6#3)(1996-8#1)(1996-9#4)(1997-1#14)(1997-2#13)(1997-3#20)(1997-4#7)(1997-5#3)(1997-6#10)(1997-7#13)(1997-8#14)(1997-9#1)(2006-6#2)(2007-11#1)(2007-12#16)(2007-8#3)(2008-1#10)(2008-10#739)(2008-11#170)(2008-12#32)(2008-2#9)(2008-3#43)(2008-4#19)(2008-5#63)(2008-6#12)(2008-7#91)(2008-8#89)(2008-9#76)(2009-1#2)(2009-10#10)(2009-11#4)(2009-12#7)(2009-2#1)(2009-3#8)(2009-4#3)(2009-5#6)(2009-6#9)(2009-7#11)(2009-8#19)(2009-9#5)(2010-1#13)(2010-10#5)(2010-11#12)(2010-12#10)(2010-2#1)(2010-3#6)(2010-4#9)(2010-5#10)(2010-6#12)(2010-7#11)(2010-8#11)(2010-9#1)(2011-1#18)(2011-10#1)(2011-2#110)(2011-3#8)(2011-9#1)(2012-12#15)(2012-2#49)(2012-3#50)(2012-4#3)(2012-5#2)(2012-8#1)(2013-1#70)(2013-7#2)(2013-8#36)
only)##9##1##(1997-8#1)(2008-10#3)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
onset and clinical##2##3##(2008-7#1)(2013-8#1)
onset and progression of##3##4##(1993-9#1)(2010-10#1)(2011-2#1)
onset and the##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
onset and##18##2##(1993-9#1)(1994-9#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
onset before##2##2##(1994-9#1)(2011-2#1)
onset in##2##2##(2006-6#1)(2009-8#1)
onset is##4##2##(1996-9#1)(2008-4#1)(2008-7#1)(2012-3#1)
onset of Alzheimer's##2##3##(2008-7#1)(2008-8#1)
onset of DNA synthesis##3##4##(1994-5#1)(2008-7#2)
onset of DNA##4##3##(1994-3#1)(1994-5#1)(2008-7#2)
onset of a##4##3##(1990-9#1)(1995-3#1)(2008-5#1)(2010-6#1)
onset of abdominal pain##2##4##(2008-10#1)(2012-12#1)
onset of action than the##2##5##(2008-7#2)
onset of action##5##3##(1993-1#1)(2008-7#2)(2012-2#2)
onset of any##2##3##(1991-12#1)(2013-7#1)
onset of cancer##2##3##(1992-12#1)(2013-7#1)
onset of coma##3##3##(2008-7#3)
onset of diabetes##3##3##(1994-12#1)(2010-10#2)
onset of disease##4##3##(1997-3#1)(2008-10#2)(2013-1#1)
onset of estrus##3##3##(2013-1#3)
onset of fever##2##3##(2007-12#2)
onset of pseudothecia maturity and seasonal ascospore showers in relation to blackleg##2##12##(2008-10#2)
onset of pseudothecia maturity##5##4##(2008-10#5)
onset of skin##2##3##(1991-6#1)(2008-5#1)
onset of stroke##3##3##(2008-7#1)(2009-11#1)(2010-10#1)
onset of symptoms and##6##4##(2008-10#1)(2008-7#1)(2012-12#4)
onset of symptoms##15##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2012-12#5)(2013-1#1)
onset of the disease in##2##5##(1991-12#1)(2008-10#1)
onset of the disease##3##4##(1991-12#1)(2008-1#1)(2008-10#1)
onset of the##17##3##(1990-3#1)(1990-5#1)(1991-12#1)(1996-11#1)(1996-5#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#3)(2011-2#1)(2013-1#1)
onset of this##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
onset of##180##2##(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#5)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#25)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#9)(2011-7#1)(2012-12#8)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#2)
onset or##4##2##(1993-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
onset than##2##2##(1995-8#1)(2008-11#1)
onset time##4##2##(1990-5#2)(2008-10#1)(2008-5#1)
onset times##2##2##(1992-9#1)(1993-3#1)
onset was delayed##2##3##(2008-10#2)
onset was##7##2##(2007-8#1)(2008-10#4)(2011-1#1)(2012-12#1)
onset##287##1##(1990-12#2)(1990-3#3)(1990-5#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#4)(1997-7#1)(1997-8#1)(2006-6#2)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#52)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#35)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#20)(2011-7#1)(2012-12#10)(2012-2#6)(2012-3#7)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#6)
ont été##4##2##(2013-1#4)
ont##6##1##(2011-2#1)(2013-1#5)
onthe##2##1##(2008-11#2)
onto a glassy carbon electrode##2##5##(2008-10#2)
onto a glassy carbon##3##4##(2008-10#3)
onto a glassy##4##3##(2008-10#4)
onto a minicolumn packed with##2##5##(2008-10#2)
onto a minicolumn##3##3##(2008-10#3)
onto a piece of wood##2##5##(2013-1#2)
onto a solid##2##3##(2008-10#1)(2008-11#1)
onto a##64##2##(1992-11#1)(1995-2#1)(1995-6#1)(2008-10#46)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#2)
onto an aluminum##2##3##(1991-12#1)(2008-10#1)
onto an##8##2##(1991-12#1)(2008-10#5)(2008-3#1)(2008-4#1)
onto glass substrates##2##3##(2008-10#1)(2008-3#1)
onto glass##4##2##(2008-10#2)(2008-3#1)(2009-12#1)
onto glassy carbon electrode##2##4##(2008-10#2)
onto glassy carbon##6##3##(2008-10#6)
onto glycidoxypropyl-modified Fractosil 1000)##3##4##(1997-2#3)
onto gold electrode##2##3##(2008-10#2)
onto gold##3##2##(2008-10#3)
onto loaded silica gel##2##4##(2008-10#2)
onto loaded##3##2##(2008-10#3)
onto microcrystalline naphthalene or##2##4##(2008-10#2)
onto polyurethane foam##5##3##(2008-10#5)
onto polyurethane##6##2##(2008-10#6)
onto silica gel was##3##4##(2008-10#3)
onto silica##4##2##(2008-10#4)
onto silicone tubing##2##3##(2008-10#2)
onto the SC##2##3##(2008-5#2)
onto the cells##2##3##(2008-2#2)
onto the column##2##3##(2008-10#2)
onto the electrode surface##3##4##(2008-10#3)
onto the electrode##4##3##(2008-10#4)
onto the glassy carbon electrode surface##2##6##(2008-10#2)
onto the gold surface##2##4##(2008-10#2)
onto the gold##3##3##(2008-10#3)
onto the hanging mercury drop electrode for##2##7##(2008-10#2)
onto the resin##3##3##(2008-10#3)
onto the surface of a##3##5##(2008-10#3)
onto the surface of the##5##5##(2008-10#3)(2008-5#1)(2009-3#1)
onto the surface of##10##4##(2008-10#8)(2008-5#1)(2009-3#1)
onto the viral capsid##2##4##(1995-2#2)
onto the##96##2##(1990-12#1)(1991-2#1)(1992-3#1)(1994-2#3)(1995-2#2)(1996-8#1)(1997-7#1)(2008-10#58)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-3#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
onto three##2##2##(2008-10#1)(2008-3#1)
onto various##2##2##(1996-5#1)(2008-10#1)
onto##314##1##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#1)(1994-2#3)(1994-3#2)(1995-2#3)(1995-6#2)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#6)(1997-7#1)(2008-10#206)(2008-11#11)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#1)(2009-10#3)(2009-12#1)(2009-3#2)(2009-5#2)(2010-1#1)(2011-2#2)(2011-7#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#3)
ontogenesis##3##1##(1992-12#1)(2008-12#1)(2011-2#1)
ontogenetic##3##1##(2009-6#1)(2010-8#2)
ontogenic resistance is##2##3##(2008-10#2)
ontogenic resistance to##3##3##(2008-10#3)
ontogenic resistance##13##2##(2008-10#13)
ontogenic##17##1##(2008-10#15)(2008-11#1)(2009-8#1)
ontogeny and##5##2##(1991-5#1)(1992-6#1)(2007-12#1)(2008-11#1)(2013-7#1)
ontogeny of##7##2##(1992-12#1)(1993-12#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-8#1)(2012-2#1)
ontogeny was##2##2##(2010-8#2)
ontogeny##19##1##(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1997-9#1)(2007-12#3)(2008-10#1)(2008-11#2)(2009-6#1)(2010-3#1)(2010-8#4)(2012-2#1)(2013-7#1)
ontologies##2##1##(2008-9#1)(2009-10#1)
ontology##4##1##(2008-12#1)(2008-8#1)(2010-5#1)(2011-2#1)
onward##2##1##(2007-12#1)(2008-5#1)
onwards##8##1##(1991-8#1)(1996-12#1)(2008-5#1)(2011-1#1)(2012-12#2)(2012-3#2)
onychomycosis by##2##2##(2008-5#2)
onychomycosis##6##1##(2008-5#6)
oocyst##5##1##(1996-12#3)(2008-5#2)
oocysts of##2##2##(1996-12#1)(2008-5#1)
oocysts were detected##2##3##(1996-12#2)
oocysts##12##1##(1996-12#9)(2007-12#1)(2008-5#2)
oocyte maturation##2##2##(2012-3#1)(2013-1#1)
oocyte nucleus and##3##3##(1994-11#1)(2007-12#2)
oocyte nucleus##7##2##(1994-11#1)(2007-12#6)
oocyte##34##1##(1993-6#1)(1994-11#1)(1994-9#2)(1995-2#1)(2007-12#6)(2008-12#4)(2008-7#2)(2008-8#5)(2010-3#1)(2010-5#1)(2010-8#1)(2012-3#3)(2013-1#6)
oocytes (phase##4##2##(2008-8#4)
oocytes after##3##2##(1994-8#1)(2008-8#1)(2013-1#1)
oocytes and in##2##3##(1994-11#1)(2007-12#1)
oocytes and##7##2##(1994-11#2)(1995-11#1)(2007-12#1)(2008-12#1)(2008-8#1)(2008-9#1)
oocytes at##2##2##(2008-12#1)(2008-9#1)
oocytes by##2##2##(1995-6#1)(2013-1#1)
oocytes expressing the alpha 3 beta##2##6##(1995-11#2)
oocytes expressing the##3##3##(1995-11#3)
oocytes expressing##4##2##(1995-11#4)
oocytes from##2##2##(1995-12#1)(2008-8#1)
oocytes in##3##2##(1990-7#1)(2008-5#1)(2008-7#1)
oocytes injected with##5##3##(1990-7#1)(1993-8#1)(2008-8#3)
oocytes of##6##2##(1997-2#1)(2007-12#1)(2008-7#2)(2008-8#1)(2009-7#1)
oocytes to##2##2##(1990-7#1)(2010-8#1)
oocytes were##4##2##(1990-7#1)(2008-8#2)(2008-9#1)
oocytes with##2##2##(2008-9#2)
oocytes##93##1##(1990-7#4)(1992-3#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-8#5)(1994-9#1)(1995-11#11)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-12#6)(2008-11#1)(2008-12#4)(2008-5#2)(2008-7#3)(2008-8#15)(2008-9#14)(2009-7#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#9)
oocytes)##4##1##(2008-8#4)
oogenesis and spermatogenesis##2##3##(2009-7#1)(2010-5#1)
oogenesis and##3##2##(2008-11#1)(2009-7#1)(2010-5#1)
oogenesis##13##1##(1994-12#1)(2007-12#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-5#2)(2012-3#1)
oogonia##5##1##(2008-10#3)(2010-3#1)(2010-5#1)
oolong and black teas##2##4##(2008-11#2)
oolong and black##3##3##(2008-11#3)
oolong tea##2##2##(2008-10#1)(2008-5#1)
oolong##6##1##(2008-10#1)(2008-11#4)(2008-5#1)
oomycete and fungal##2##3##(2008-10#2)
oomycete pathogens##2##2##(2008-10#2)
oomycete that causes##3##3##(2008-10#3)
oomycete##12##1##(2008-10#12)
oomycetes##11##1##(2008-10#11)
oophorectomized##2##1##(1994-3#2)
oophorectomy##5##1##(1993-12#1)(1993-3#1)(2013-1#3)
ooplasm during##2##2##(2008-7#1)(2008-9#1)
ooplasm##7##1##(1994-9#1)(2008-7#1)(2008-9#5)
oospore formation##4##2##(2008-10#4)
oospore production in##2##3##(2008-10#2)
oospore production##5##2##(2008-10#5)
oospore progeny##2##2##(2008-10#2)
oospore##12##1##(2008-10#12)
oospores exposed to##2##3##(2008-10#2)
oospores in the##5##3##(2008-10#5)
oospores in##15##2##(2008-10#15)
oospores of##4##2##(2008-10#4)
oospores per leaflet##3##3##(2008-10#3)
oospores per##5##2##(2008-10#5)
oospores were formed on media amended with##2##7##(2008-10#2)
oospores were recorded in##2##4##(2008-10#2)
oospores were##11##2##(2008-10#11)
oospores##67##1##(2008-10#66)(2010-3#1)
op/op##4##1##(1991-5#4)
opacification of the##3##3##(1997-8#1)(2011-2#1)(2013-7#1)
opacification##4##1##(1997-8#1)(2008-12#1)(2011-2#1)(2013-7#1)
opacities##5##1##(1991-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
opacity and##2##2##(2011-7#1)(2012-2#1)
opacity with##2##2##(2008-7#1)(2010-10#1)
opacity##10##1##(1993-6#1)(2008-3#3)(2008-7#1)(2010-10#2)(2010-12#1)(2011-7#1)(2012-2#1)
opal##3##1##(2008-9#3)
opaque##15##1##(1990-3#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#1)
open a new##2##3##(2008-10#1)(2008-9#1)
open a##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
open access to##2##3##(2008-9#1)(2013-8#1)
open access##4##2##(1992-2#1)(2008-9#1)(2011-2#1)(2013-8#1)
open and##6##2##(1990-11#1)(1992-9#1)(1997-6#1)(2008-11#1)(2008-7#1)(2010-9#1)
open angle glaucoma##4##3##(2011-2#3)(2012-2#1)
open angle##6##2##(2011-2#5)(2012-2#1)
open biopsy##4##2##(2008-12#2)(2013-8#2)
open chain polyammonium cations##3##4##(2008-10#3)
open chain polyammonium##4##3##(2008-10#4)
open circuit potential##2##3##(2008-10#2)
open circuit##12##2##(2008-10#11)(2010-12#1)
open clinical trial##2##3##(1991-8#1)(1996-1#1)
open conformation##2##2##(1995-6#2)
open discussion##2##2##(2011-2#1)(2012-3#1)
open end##2##2##(2008-8#2)
open field and##2##3##(1994-3#1)(1996-2#1)
open field##9##2##(1990-5#1)(1992-12#2)(1994-3#2)(1996-2#1)(2008-10#1)(2008-11#2)
open focused microwave##2##3##(2008-10#2)
open focused##3##2##(2008-10#3)
open fractures##2##2##(2010-11#1)(2010-12#1)
open heart surgery##2##3##(1990-2#1)(1997-8#1)
open heart##3##2##(1990-2#1)(1997-8#1)(2008-5#1)
open into##2##2##(2008-7#2)
open ocean##3##2##(2008-10#2)(2008-3#1)
open operation##2##2##(1997-8#2)
open or##4##2##(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)
open oral challenge##3##3##(2012-3#3)
open procedure##2##2##(2008-10#1)(2011-2#1)
open prospective##2##2##(1991-2#1)(2009-5#1)
open pyeloplasty##2##2##(2008-10#2)
open questions##5##2##(1997-3#1)(2009-3#1)(2011-2#1)(2013-8#2)
open reading frame (ORF) encoding a##2##6##(1993-12#1)(1997-7#1)
open reading frame (ORF) encoding##3##5##(1993-12#1)(1993-6#1)(1997-7#1)
open reading frame (ORF) of##5##5##(1991-9#1)(1993-12#1)(1995-8#1)(2008-10#1)(2008-9#1)
open reading frame (ORF)##20##4##(1990-11#1)(1991-9#1)(1993-12#4)(1993-6#1)(1994-12#1)(1995-8#1)(1996-8#1)(1997-7#2)(2008-10#4)(2008-8#3)(2008-9#1)
open reading frame coding for a##2##6##(1991-9#1)(1993-12#1)
open reading frame encoding a polypeptide of##2##7##(1990-5#1)(2008-8#1)
open reading frame encoding a##4##5##(1990-5#2)(2008-10#1)(2008-8#1)
open reading frame encoding##10##4##(1990-5#2)(1995-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
open reading frame from##3##4##(1991-5#1)(1995-2#1)(2008-8#1)
open reading frame of the##3##5##(1992-6#1)(1993-12#1)(2008-10#1)
open reading frame of unknown function##2##6##(1992-9#1)(1994-6#1)
open reading frame of##23##4##(1990-5#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#2)(1994-6#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
open reading frame that##3##4##(1992-10#1)(2008-10#1)(2008-9#1)
open reading frame which##2##4##(1990-11#1)(1994-11#1)
open reading frame##89##3##(1990-11#2)(1990-5#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-6#2)(1995-2#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#3)(1997-9#1)(2008-10#19)(2008-5#1)(2008-6#1)(2008-8#9)(2008-9#4)(2012-3#1)(2013-1#1)(2013-8#1)
open reading frames (ORF)##2##4##(1992-3#1)(2008-10#1)
open reading frames (ORFs) and##2##5##(1996-3#1)(2008-10#1)
open reading frames (ORFs) longer##2##5##(1995-9#1)(1996-3#1)
open reading frames (ORFs) of##2##5##(1996-6#1)(2008-10#1)
open reading frames (ORFs) were##2##5##(1995-9#1)(2008-10#1)
open reading frames (ORFs)##23##4##(1995-12#1)(1995-9#3)(1996-3#5)(1996-6#4)(1997-6#1)(2008-10#9)
open reading frames coding for##2##5##(2008-10#2)
open reading frames encoding the##2##5##(2008-10#2)
open reading frames encoding##4##4##(2008-10#3)(2008-9#1)
open reading frames in##2##4##(1996-3#1)(2008-10#1)
open reading frames including##2##4##(1995-9#1)(1996-6#1)
open reading frames of##2##4##(1994-11#1)(2008-10#1)
open reading frames##61##3##(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#2)(1995-12#2)(1995-9#6)(1996-12#2)(1996-3#8)(1996-6#8)(1997-3#2)(1997-6#1)(1997-7#1)(2008-10#22)(2008-8#1)(2008-9#2)
open reading##152##2##(1990-11#2)(1990-5#3)(1991-5#1)(1991-9#3)(1992-10#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#7)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#7)(1994-12#1)(1994-6#2)(1995-12#2)(1995-2#3)(1995-6#3)(1995-8#1)(1995-9#7)(1996-12#3)(1996-3#9)(1996-6#8)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#4)(1997-9#1)(2008-10#42)(2008-5#1)(2008-6#1)(2008-8#10)(2008-9#6)(2012-3#1)(2013-1#1)(2013-8#1)
open reduction internal fixation##3##4##(2008-8#1)(2009-4#1)(2013-1#1)
open reduction##4##2##(2008-12#1)(2008-8#1)(2009-4#1)(2013-1#1)
open repair##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
open source##4##2##(2009-12#2)(2010-8#1)(2013-1#1)
open surgery or##2##3##(1997-4#1)(2008-10#1)
open surgery##11##2##(1994-5#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-12#1)(2011-2#3)
open the possibility##2##3##(2008-10#1)(2012-2#1)
open the##4##2##(1992-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
open to all##2##3##(1994-1#1)(2008-12#1)
open to the##5##3##(1992-9#1)(1997-1#2)(2008-11#1)(2008-3#1)
open to##16##2##(1992-9#1)(1994-1#2)(1994-12#1)(1995-5#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
open trial##2##2##(2008-11#1)(2013-7#1)
open tubular capillary##2##3##(2008-10#2)
open tubular##4##2##(2008-10#4)
open up new##2##3##(2008-10#1)(2008-5#1)
open urban##3##2##(2008-10#1)(2008-11#2)
open vessel##4##2##(2008-10#4)
open##408##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#5)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#5)(1992-8#1)(1992-9#3)(1993-12#7)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#9)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#7)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#10)(1996-6#8)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#5)(1997-9#1)(2008-10#105)(2008-11#14)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#15)(2008-9#11)(2009-10#4)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#7)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#18)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#14)(2013-7#1)(2013-8#13)
open- and##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
open-access##4##1##(2010-12#3)(2012-2#1)
open-angle glaucoma##2##2##(2011-2#2)
open-angle##5##1##(2011-2#5)
open-chain##3##1##(2008-10#1)(2008-11#2)
open-channel##2##1##(2008-10#2)
open-circuit##2##1##(2008-10#2)
open-ended questions##5##2##(2008-11#1)(2008-12#1)(2009-5#1)(2011-1#1)(2013-8#1)
open-ended##11##1##(1993-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
open-heart surgery##2##2##(1995-3#1)(2008-11#1)
open-label##2##1##(2010-11#2)
open-path##3##1##(2008-10#1)(2008-3#2)
open-pollinated##2##1##(2008-10#2)
open-set speech perception##2##3##(2008-9#2)
open-set speech recognition##3##3##(2008-9#3)
open-set speech##6##2##(2008-9#6)
open-set##10##1##(2008-9#10)
open-tubular capillary column##2##3##(2008-10#2)
open/closed FIA##2##2##(2008-10#2)
opened a##2##2##(1991-8#1)(1993-8#1)
opened and##3##2##(1990-12#1)(2008-12#1)(2011-2#1)
opened by the##2##3##(1997-8#1)(2008-10#1)
opened in##3##2##(1996-6#1)(2008-10#1)(2008-8#1)
opened its##2##2##(2008-10#1)(2008-5#1)
opened the##4##2##(2008-11#1)(2008-5#2)(2011-2#1)
opened##31##1##(1990-12#1)(1991-8#1)(1993-8#1)(1994-3#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#3)(2013-1#1)
opening a##2##2##(2008-10#1)(2013-8#1)
opening and##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
opening angle of the##2##4##(2008-10#1)(2008-9#1)
opening in##2##2##(1990-3#1)(1994-5#1)
opening is##2##2##(2008-10#1)(2008-12#1)
opening new##2##2##(2008-10#1)(2010-4#1)
opening of the vas deferens into Müllerian duct cysts##2##9##(2008-10#2)
opening of the vas deferens into##3##6##(2008-10#3)
opening of the##12##3##(1990-5#1)(1995-2#1)(1996-3#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)
opening of##16##2##(1990-5#1)(1995-2#1)(1996-3#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)
opening the##2##2##(1995-3#1)(2008-11#1)
opening up new##2##3##(2009-6#1)(2011-3#1)
opening up##4##2##(1996-3#1)(2008-12#1)(2009-6#1)(2011-3#1)
opening wedge##2##2##(2008-9#1)(2011-2#1)
opening##73##1##(1990-3#1)(1990-5#1)(1991-2#3)(1992-6#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-8#1)(2007-11#1)(2007-12#5)(2008-10#15)(2008-11#4)(2008-12#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-6#1)(2013-1#2)(2013-8#1)
openings##9##1##(1994-3#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-7#2)(2011-2#1)
openly##2##1##(1995-5#1)(2008-1#1)
openness and transparency##2##3##(2013-8#2)
openness##4##1##(2008-12#1)(2013-8#3)
opens a new##2##3##(2008-11#1)(2012-2#1)
opens a##4##2##(2008-10#1)(2008-11#1)(2012-2#2)
opens new avenues##2##3##(2009-6#1)(2012-2#1)
opens new perspectives##2##3##(1993-8#1)(2008-3#1)
opens new##6##2##(1993-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-2#1)
opens the possibility##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
opens the way to##3##4##(1991-1#1)(2010-7#1)(2011-2#1)
opens the way##4##3##(1991-1#1)(2009-8#1)(2010-7#1)(2011-2#1)
opens the##9##2##(1991-1#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#1)
opens up a##2##3##(2010-7#1)(2010-8#1)
opens up new##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
opens up the possibility##2##4##(2008-7#1)(2009-5#1)
opens up##8##2##(1993-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#1)(2010-8#1)
opens##33##1##(1990-9#1)(1991-1#1)(1993-2#1)(1993-8#1)(1994-9#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-2#4)
operability of##2##2##(1990-9#1)(2008-11#1)
operable breast cancer##7##3##(1991-8#2)(1992-12#2)(1993-11#2)(1994-6#1)
operable breast##9##2##(1991-8#2)(1992-12#2)(1993-11#3)(1994-12#1)(1994-6#1)
operable##13##1##(1991-8#2)(1992-12#2)(1993-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1996-11#1)(1997-8#2)
operant responding##2##2##(1993-6#2)
operant##7##1##(1993-6#3)(2008-10#2)(2008-8#2)
operate at##2##2##(2008-10#2)
operate in a##3##3##(1997-1#1)(2010-7#1)(2012-2#1)
operate in the##5##3##(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)
operate in##15##2##(1997-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#3)(2010-4#2)(2010-7#1)(2012-2#2)(2013-8#1)
operate on##3##2##(1997-8#1)(2009-5#1)(2013-1#1)
operate through##3##2##(1994-5#1)(2010-12#1)(2010-9#1)
operate with##2##2##(2008-2#1)(2008-3#1)
operate##65##1##(1990-2#1)(1990-9#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#16)(2008-11#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#4)(2009-5#2)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
operated as##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
operated at a##3##3##(2008-10#2)(2008-3#1)
operated at##10##2##(1991-9#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#2)
operated by##3##2##(1993-11#1)(2008-10#1)(2008-3#1)
operated during the##2##3##(1991-6#1)(1996-11#1)
operated for##6##2##(1990-5#1)(1992-5#1)(1992-9#1)(2008-8#1)(2010-11#1)(2011-2#1)
operated from##2##2##(2008-3#2)
operated in single mode and##2##5##(2008-2#2)
operated in the##7##3##(2008-10#3)(2008-3#1)(2011-3#2)(2012-3#1)
operated in##15##2##(1991-3#2)(2008-10#6)(2008-2#2)(2008-3#1)(2011-1#1)(2011-3#2)(2012-3#1)
operated on a##2##3##(2008-10#2)
operated on and##2##3##(1993-3#1)(2013-1#1)
operated on both##2##3##(2008-10#1)(2010-8#1)
operated on for##4##3##(1991-8#1)(1992-12#2)(2007-8#1)
operated on the##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
operated on using##2##3##(1992-1#1)(2013-1#1)
operated on##20##2##(1990-6#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#2)(1993-2#1)(1993-3#1)(1996-1#1)(2007-8#1)(2008-10#4)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#3)
operated patients##4##2##(1990-3#1)(1992-9#1)(2011-2#1)(2013-1#1)
operated upon for##2##3##(2008-10#1)(2008-7#1)
operated upon##8##2##(1990-11#1)(1990-3#1)(1991-3#1)(1992-5#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
operated with a##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
operated with this##2##3##(1990-9#1)(2013-8#1)
operated with##8##2##(1990-9#2)(1995-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
operated##113##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#4)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#2)(1992-5#2)(1992-9#2)(1993-11#3)(1993-2#2)(1993-3#2)(1994-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#9)(2008-7#4)(2008-8#2)(2009-1#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#3)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#2)
operates as a##2##3##(1993-3#1)(2008-9#1)
operates as##3##2##(1993-3#1)(2008-10#1)(2008-9#1)
operates at##3##2##(1997-2#1)(2008-3#2)
operates in a##4##3##(1995-6#2)(2008-10#1)(2008-3#1)
operates in the##2##3##(1993-12#1)(2008-10#1)
operates in##8##2##(1993-12#1)(1995-6#2)(2008-10#3)(2008-3#1)(2011-2#1)
operates through##2##2##(2008-10#1)(2008-11#1)
operates##27##1##(1992-2#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-6#2)(1997-2#1)(2008-10#7)(2008-11#1)(2008-3#6)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
operating a##2##2##(2008-11#1)(2008-7#1)
operating at ambient##2##3##(2008-10#2)
operating at##13##2##(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#1)(2011-2#2)
operating between##2##2##(1994-5#1)(2008-2#1)
operating characteristic (ROC) analysis##2##4##(2011-1#1)(2012-3#1)
operating characteristic (ROC)##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
operating characteristic curve##2##3##(2008-10#1)(2012-2#1)
operating characteristic##6##2##(2008-10#3)(2011-1#1)(2012-2#1)(2012-3#1)
operating characteristics##2##2##(2008-3#1)(2011-2#1)
operating conditions and##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
operating conditions are##2##3##(1995-12#1)(2008-10#1)
operating conditions for##2##3##(2008-10#1)(2008-2#1)
operating conditions of##2##3##(2008-10#2)
operating conditions##29##2##(1995-12#1)(2008-10#11)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#8)(2010-4#1)(2011-2#2)
operating costs##3##2##(1991-12#1)(1996-2#1)(2008-2#1)
operating fiberoptic hysteroscope##2##3##(1991-2#2)
operating in a##5##3##(2008-10#2)(2008-11#2)(2008-3#1)
operating in the##5##3##(1991-3#1)(2008-10#1)(2008-3#2)(2008-7#1)
operating in##14##2##(1991-12#1)(1991-3#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)
operating mode##6##2##(2008-11#5)(2008-9#1)
operating near 2##3##3##(2008-3#3)
operating near real time##2##4##(2008-3#2)
operating near##6##2##(2008-3#6)
operating on the##2##3##(2008-2#1)(2013-1#1)
operating on##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#3)(2013-1#1)
operating parameters for##2##3##(2008-10#2)
operating parameters of##2##3##(2008-10#1)(2008-9#1)
operating parameters##9##2##(2008-10#7)(2008-7#1)(2008-9#1)
operating performance##2##2##(1991-1#1)(2008-11#1)
operating plants##2##2##(2009-12#2)
operating potential of##2##3##(2008-10#2)
operating potential##4##2##(2008-10#4)
operating pressure##2##2##(2008-7#1)(2009-7#1)
operating procedure for##2##3##(2011-2#2)
operating ratio##3##2##(2008-11#3)
operating revenue##2##2##(1994-2#2)
operating room##13##2##(1991-1#1)(1991-2#1)(1992-12#1)(1996-3#1)(2008-6#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
operating strategy##2##2##(1997-2#1)(2008-11#1)
operating table##2##2##(2011-2#2)
operating temperature range##2##3##(2008-10#2)
operating temperature##3##2##(2008-10#3)
operating the##2##2##(2008-10#1)(2008-11#1)
operating time for##2##3##(1996-3#1)(2008-10#1)
operating time was##3##3##(1991-1#1)(1995-3#1)(1996-1#1)
operating time##5##2##(1991-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-10#1)
operating##189##1##(1991-1#3)(1991-12#3)(1991-2#3)(1991-3#1)(1992-1#1)(1992-12#4)(1992-2#1)(1993-3#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#3)(1996-1#2)(1996-2#1)(1996-3#4)(1997-2#2)(2008-10#52)(2008-11#16)(2008-2#5)(2008-3#22)(2008-5#3)(2008-6#2)(2008-7#15)(2008-9#5)(2009-12#3)(2009-5#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#15)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
operation &quot##2##2##(2008-11#2)
operation and postoperative##2##3##(1990-12#1)(1992-9#1)
operation and the##2##3##(1992-9#1)(2008-10#1)
operation and##19##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-9#2)(1993-2#2)(1994-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)
operation are##2##2##(2008-10#1)(2008-3#1)
operation at##4##2##(1997-2#1)(2008-2#1)(2008-3#1)(2010-4#1)
operation by##4##2##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
operation conditions##3##2##(2008-10#3)
operation due to##4##3##(1991-6#1)(1994-5#1)(2008-7#2)
operation for##14##2##(1990-3#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#4)(2010-6#1)(2011-2#1)
operation gives##2##2##(2008-10#1)(2008-11#1)
operation in the##7##3##(1990-3#1)(2008-11#2)(2008-2#1)(2008-3#3)
operation in##15##2##(1990-3#1)(1995-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2010-10#1)
operation is based on##2##4##(2008-10#2)
operation is##13##2##(1991-3#1)(1993-6#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#1)(2011-2#2)
operation of a diode-pumped##2##4##(2008-3#2)
operation of a##13##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-9#2)
operation of the##13##3##(1990-3#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-12#1)
operation of##44##2##(1990-3#1)(1991-12#1)(1991-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#2)(2007-12#3)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-7#4)(2008-9#2)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
operation on##2##2##(2008-10#1)(2008-6#1)
operation or##3##2##(2008-10#1)(2008-12#1)(2009-5#1)
operation periods##2##2##(2008-10#1)(2008-7#1)
operation potential##2##2##(2008-10#2)
operation that##2##2##(1993-11#1)(2008-3#1)
operation time##5##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
operation to##3##2##(1991-3#1)(2008-10#1)(2013-1#1)
operation was##14##2##(1990-9#1)(1991-6#1)(1996-3#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
operation were##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
operation with a##2##3##(1990-3#1)(2008-3#1)
operation with##4##2##(1990-3#1)(2008-10#2)(2008-3#1)
operation without##2##2##(2008-10#1)(2013-1#1)
operation##344##1##(1990-12#1)(1990-2#2)(1990-3#8)(1990-6#1)(1990-9#6)(1991-11#1)(1991-12#2)(1991-3#7)(1991-6#5)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-2#5)(1993-6#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1997-2#2)(1997-3#4)(1997-5#1)(1997-8#8)(2006-6#2)(2007-11#2)(2007-12#6)(2007-9#1)(2008-10#82)(2008-11#23)(2008-12#7)(2008-2#9)(2008-3#29)(2008-4#3)(2008-6#1)(2008-7#25)(2008-8#1)(2008-9#10)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-2#22)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#11)(2013-8#1)
operation)##2##1##(2008-3#1)(2013-1#1)
operational amplifier##3##2##(2008-10#3)
operational and storage stability##6##4##(2008-10#6)
operational and##10##2##(1994-12#1)(1996-1#1)(2008-10#7)(2012-2#1)
operational characteristics##2##2##(1995-1#1)(2008-10#1)
operational conditions were##2##3##(2008-10#2)
operational conditions##8##2##(2008-10#5)(2008-11#1)(2008-6#1)(2010-4#1)
operational data##2##2##(1997-3#1)(2010-8#1)
operational definition of##3##3##(2008-10#1)(2013-1#2)
operational definition##7##2##(2008-10#1)(2013-1#6)
operational environment##2##2##(1994-12#1)(2012-3#1)
operational issues##4##2##(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)
operational lifetime of 8 weeks##2##5##(2008-10#2)
operational lifetime of##3##3##(2008-10#3)
operational model##2##2##(2008-3#2)
operational pH##2##2##(2008-10#2)
operational parameters had been investigated##2##5##(2008-10#2)
operational parameters have been selected for the drug##2##8##(2008-10#2)
operational parameters have been##3##4##(2008-10#3)
operational parameters##9##2##(2008-10#9)
operational range##2##2##(2008-10#2)
operational stability and##2##3##(2008-10#2)
operational stability of the##3##4##(2008-10#3)
operational stability##8##2##(2008-10#8)
operational##107##1##(1990-5#1)(1991-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-2#2)(1996-1#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-8#1)(2007-11#1)(2008-10#50)(2008-11#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#1)
operationalising##2##1##(2008-12#2)
operationalize##2##1##(1996-1#1)(2011-2#1)
operationalized##2##1##(2009-12#2)
operationally##5##1##(1991-2#1)(2008-10#2)(2008-3#2)
operations and##6##2##(1996-2#1)(1996-3#1)(1997-8#3)(2008-11#1)
operations are##3##2##(1997-1#1)(2008-11#1)(2008-4#1)
operations at##2##2##(2008-10#1)(2008-9#1)
operations for##5##2##(1990-9#2)(1993-3#1)(1997-8#2)
operations have been##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
operations have##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
operations in##9##2##(1990-3#1)(1996-3#1)(1997-8#2)(2008-10#1)(2009-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
operations of the##2##3##(2008-10#1)(2008-3#1)
operations of##5##2##(1992-3#1)(1996-1#1)(2008-10#1)(2008-3#1)(2009-10#1)
operations to##4##2##(1997-1#2)(2008-10#1)(2010-6#1)
operations were##6##2##(1993-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#2)
operations##117##1##(1990-2#1)(1990-3#2)(1990-9#2)(1991-1#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#4)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#4)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#8)(2007-12#1)(2008-10#18)(2008-11#10)(2008-12#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#1)(2010-10#1)(2010-6#2)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
operative and##2##2##(2010-7#1)(2011-2#1)
operative blood loss##3##3##(1993-12#2)(2009-5#1)
operative blood##4##2##(1993-12#2)(2009-5#1)(2010-7#1)
operative conditions##2##2##(2008-10#1)(2012-3#1)
operative field##2##2##(1995-1#1)(2010-12#1)
operative findings##4##2##(1995-3#1)(1997-8#1)(2008-9#2)
operative in##3##2##(1995-2#1)(2008-10#2)
operative intervention##2##2##(1997-8#1)(2010-12#1)
operative laparoscopy during the##2##4##(1993-12#2)
operative laparoscopy for##2##3##(1994-3#1)(1996-3#1)
operative laparoscopy##14##2##(1992-12#1)(1993-12#6)(1993-3#2)(1994-3#1)(1995-2#3)(1996-3#1)
operative management of##2##3##(2011-2#1)(2013-8#1)
operative management##3##2##(2011-2#2)(2013-8#1)
operative mortality##2##2##(2008-11#1)(2008-7#1)
operative procedure##2##2##(1991-3#1)(2008-7#1)
operative time and##3##3##(1994-12#1)(1995-1#1)(2008-10#1)
operative time was##2##3##(1996-1#1)(2008-10#1)
operative time##9##2##(1994-1#1)(1994-12#1)(1995-1#1)(1996-1#1)(2008-10#2)(2008-9#1)(2009-3#1)(2013-1#1)
operative times##3##2##(2012-3#1)(2013-1#2)
operative treatment of##6##3##(1992-2#2)(1994-3#1)(2008-10#1)(2013-1#2)
operative treatment##9##2##(1992-2#2)(1994-3#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
operative##103##1##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-12#1)(1992-2#3)(1993-12#8)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#3)(1995-1#2)(1995-2#5)(1995-3#1)(1996-1#2)(1996-3#1)(1997-8#2)(2007-8#3)(2008-10#12)(2008-11#2)(2008-7#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#3)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#7)(2013-8#1)
operatively##3##1##(2011-2#1)(2013-1#2)
operator intervention##2##2##(2008-10#1)(2008-11#1)
operator to##4##2##(2008-10#2)(2008-11#2)
operator##35##1##(1991-12#1)(1991-2#1)(1992-12#2)(1992-4#4)(1994-3#2)(2008-10#10)(2008-11#5)(2008-3#4)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#2)
operators and##2##2##(2008-11#1)(2011-2#1)
operators have##2##2##(1994-6#1)(2012-2#1)
operators in##4##2##(2008-10#1)(2011-2#2)(2012-2#1)
operators##22##1##(1990-11#1)(1994-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#4)(2012-2#3)
operators'##2##1##(2009-10#1)(2011-2#1)
operculofrontal AVM##2##2##(2008-7#2)
operon and##2##2##(1991-7#1)(2011-1#1)
operon in##2##2##(1993-9#1)(2008-11#1)
operon is##4##2##(1995-6#2)(1997-2#1)(2008-9#1)
operon##23##1##(1990-11#1)(1991-7#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-6#5)(1995-8#1)(1996-12#3)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#2)(2011-2#2)
operons across##2##2##(2008-8#2)
operons encoding##2##2##(2011-1#1)(2011-2#1)
operons##16##1##(1995-12#2)(2008-11#2)(2008-7#1)(2008-8#8)(2011-1#2)(2011-2#1)
ophiuroid##3##1##(2013-8#3)
ophthalmic artery##4##2##(1992-6#1)(1996-9#1)(2012-3#2)
ophthalmic imaging##2##2##(2011-7#2)
ophthalmic segment##3##2##(2012-3#3)
ophthalmic solutions##2##2##(2008-10#2)
ophthalmic##25##1##(1992-6#1)(1995-9#1)(1996-9#2)(1997-3#1)(2008-10#4)(2010-10#1)(2011-2#3)(2011-3#1)(2011-7#2)(2012-12#1)(2012-3#7)(2013-8#1)
ophthalmological##2##1##(2011-2#1)(2012-12#1)
ophthalmologist##5##1##(1993-11#1)(2013-1#3)(2013-7#1)
ophthalmologists##2##1##(1995-9#1)(2010-10#1)
ophthalmology##12##1##(1991-9#1)(1992-5#1)(1995-9#1)(2010-10#3)(2010-8#2)(2011-2#1)(2011-7#2)(2012-3#1)
ophthalmomyiasis##2##1##(2010-10#2)
ophthalmoplegia##5##1##(1990-12#1)(2008-7#3)(2013-7#1)
ophthalmoscopy##4##1##(1994-12#1)(2011-7#3)
opiate dependence##2##2##(1990-8#1)(1991-1#1)
opiate receptors##3##2##(1995-12#1)(1997-4#1)(2013-8#1)
opiate use##2##2##(1991-1#1)(2010-11#1)
opiate withdrawal##2##2##(1991-1#1)(2008-11#1)
opiate##19##1##(1990-8#2)(1991-1#5)(1995-12#3)(1997-4#1)(2008-10#1)(2008-11#2)(2010-11#4)(2013-8#1)
opiate-induced##2##1##(1991-1#1)(2008-9#1)
opiates in##2##2##(1991-1#1)(1995-12#1)
opiates##6##1##(1991-1#1)(1993-3#1)(1994-8#1)(1995-12#2)(1997-4#1)
opinion about##4##2##(1992-2#2)(1997-8#1)(2013-1#1)
opinion and##4##2##(1995-2#2)(1996-6#1)(2011-2#1)
opinion leaders##3##2##(2008-11#1)(2008-6#1)(2010-11#1)
opinion of##10##2##(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(2008-9#1)(2013-1#2)
opinion on##4##2##(1993-2#1)(1997-8#1)(2008-11#1)(2011-2#1)
opinion survey##2##2##(2013-1#2)
opinion that##4##2##(1995-2#1)(1995-5#1)(2011-2#2)
opinion##58##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#3)(2007-12#1)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
opinions about a web-based distance##2##5##(2010-10#2)
opinions about##7##2##(1991-3#1)(2008-11#1)(2009-4#1)(2010-10#3)(2010-12#1)
opinions of the##3##3##(1990-11#1)(1991-2#1)(1996-3#1)
opinions of##6##2##(1990-11#1)(1991-2#1)(1996-3#1)(2008-12#2)(2009-6#1)
opinions regarding the##2##3##(2008-7#1)(2013-8#1)
opinions regarding##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
opinions to##2##2##(2008-5#1)(2013-1#1)
opinions##31##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#3)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
opioid abuse##2##2##(2008-6#1)(2009-7#1)
opioid activity##2##2##(1991-1#1)(1995-3#1)
opioid and##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
opioid dosing##3##2##(2008-7#3)
opioid genes##2##2##(1996-12#2)
opioid peptides##4##2##(1995-3#1)(1996-12#2)(2009-7#1)
opioid pharmacotherapy##3##2##(2008-4#2)(2008-7#1)
opioid potency##2##2##(1995-3#2)
opioid receptor and##2##3##(1992-3#1)(2008-11#1)
opioid receptor cDNA##2##3##(1995-6#2)
opioid receptor homologue##2##3##(1996-12#2)
opioid receptor##17##2##(1992-3#1)(1995-11#1)(1995-6#5)(1996-12#2)(2008-11#6)(2009-7#2)
opioid receptor-like (ORL1)##2##3##(1996-2#2)
opioid receptor-like##3##2##(1996-2#2)(2008-11#1)
opioid receptors in##7##3##(2008-11#3)(2009-7#4)
opioid receptors##15##2##(1995-11#1)(1995-6#1)(1996-2#1)(2008-11#5)(2009-7#7)
opioid system##2##2##(1991-1#1)(2009-7#1)
opioid tolerance##2##2##(2009-7#2)
opioid treatment##3##2##(2008-6#3)
opioid##93##1##(1991-1#5)(1992-12#4)(1992-3#1)(1995-11#2)(1995-3#5)(1995-6#7)(1996-12#8)(1996-2#4)(1997-3#1)(2008-10#1)(2008-11#15)(2008-4#2)(2008-6#9)(2008-7#7)(2008-9#1)(2009-7#14)(2011-2#1)(2013-1#6)
opioids are##2##2##(2008-7#2)
opioids in##6##2##(1991-1#1)(2011-2#4)(2012-3#1)
opioids like##2##2##(2009-7#2)
opioids##27##1##(1991-1#1)(1991-2#1)(1995-12#1)(1997-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-7#3)(2011-2#5)(2012-3#2)(2013-1#4)(2013-8#3)
opium poppy from##2##3##(2008-10#2)
opium poppy##9##2##(2008-10#9)
opium##10##1##(2008-10#10)
opponent's##4##1##(2008-11#4)
opponents##5##1##(1994-1#1)(2008-11#1)(2008-8#1)(2008-9#2)
opportune##2##1##(1992-5#1)(2013-1#1)
opportunist##2##1##(2008-8#2)
opportunistic infection of the##2##4##(2007-12#1)(2008-5#1)
opportunistic infection##6##2##(1993-12#1)(2007-12#1)(2008-1#1)(2008-5#2)(2010-10#1)
opportunistic infections##2##2##(1994-5#1)(2009-7#1)
opportunistic pathogen##2##2##(2008-10#1)(2011-2#1)
opportunistic pathogens##5##2##(1996-6#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
opportunistic screening##2##2##(1991-6#1)(1996-6#1)
opportunistic##27##1##(1991-6#1)(1993-12#1)(1994-5#1)(1995-11#1)(1996-6#2)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#4)(2009-7#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-1#2)
opportunities and##5##2##(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
opportunities for dietitians##2##3##(1993-12#2)
opportunities for postgraduate##2##3##(1993-11#1)(1993-6#1)
opportunities for the development of##2##5##(2008-6#1)(2012-12#1)
opportunities for the##5##3##(1997-3#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
opportunities for##60##2##(1991-12#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#3)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#2)(2008-5#2)(2008-6#2)(2008-8#2)(2009-11#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)
opportunities in##5##2##(1994-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
opportunities of##2##2##(2013-1#2)
opportunities that##5##2##(1993-1#1)(1994-3#1)(2008-11#1)(2008-5#1)(2013-1#1)
opportunities to develop##2##3##(2008-5#1)(2012-2#1)
opportunities to##20##2##(1992-9#1)(1993-2#3)(1993-6#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#4)
opportunities##139##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-6#3)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#10)(1996-2#3)(1996-3#5)(1996-5#1)(1997-1#5)(1997-2#2)(1997-3#3)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#17)(2008-12#5)(2008-5#4)(2008-6#2)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#3)(2011-2#5)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#10)(2013-8#1)
opportunity for career development##2##4##(1994-3#2)
opportunity for sexual selection##4##4##(2008-8#4)
opportunity for the##5##3##(1996-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
opportunity for##41##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#6)(2008-9#1)(2009-4#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
opportunity of##4##2##(1991-2#1)(1995-1#1)(2010-1#1)(2012-3#1)
opportunity that##2##2##(2008-11#2)
opportunity to compare##2##3##(1994-3#1)(1997-8#1)
opportunity to improve##2##3##(2008-10#1)(2011-2#1)
opportunity to study##3##3##(1993-11#1)(2008-11#1)(2009-8#1)
opportunity to use##2##3##(1994-6#1)(2009-9#1)
opportunity to##62##2##(1991-6#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
opportunity##133##1##(1991-2#3)(1991-6#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#4)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#17)(2008-11#17)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#9)(2008-9#3)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#3)
oppose the##2##2##(2008-8#1)(2011-2#1)
oppose##4##1##(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
opposed lateral##3##2##(1990-12#1)(1993-9#2)
opposed to that##2##3##(2008-11#1)(2008-12#1)
opposed to the##8##3##(1990-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#2)
opposed to##31##2##(1990-3#1)(1991-5#1)(1992-3#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#2)(2013-8#1)
opposed##38##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-8#1)(1993-9#2)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#2)(2013-8#1)
opposed-phase images##2##2##(1997-8#2)
opposed-phase imaging##3##2##(1997-8#3)
opposed-phase pulse sequence##3##3##(1997-8#3)
opposed-phase##12##1##(1997-8#12)
opposing the##2##2##(2009-10#1)(2012-2#1)
opposing##17##1##(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-9#1)(2013-8#1)
opposite direction##5##2##(1991-5#1)(1996-2#1)(1997-3#1)(2008-10#1)(2009-7#1)
opposite directions##8##2##(1994-11#1)(1997-3#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
opposite effect##5##2##(1990-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
opposite effects of##2##3##(1993-3#1)(2012-12#1)
opposite effects on##2##3##(1994-11#1)(1996-2#1)
opposite effects##4##2##(1993-3#1)(1994-11#1)(1996-2#1)(2012-12#1)
opposite of##2##2##(2008-8#1)(2008-9#1)
opposite pattern was observed##2##4##(1994-6#1)(2010-8#1)
opposite sex##4##2##(1990-8#1)(2008-7#1)(2008-9#2)
opposite the##5##2##(2008-10#4)(2010-3#1)
opposite to the##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
opposite was##3##2##(1994-3#1)(2008-7#1)(2012-2#1)
opposite##78##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-5#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-2#3)(1997-3#4)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#1)
oppositely charged##3##2##(2008-10#2)(2010-7#1)
opposites##2##1##(2008-12#1)(2009-10#1)
opposition from##2##2##(2008-12#1)(2009-10#1)
opposition to##2##2##(1995-6#1)(2012-2#1)
opposition##9##1##(1995-6#1)(1996-5#1)(2008-11#2)(2008-12#1)(2009-10#1)(2010-6#1)(2012-2#2)
opsonic##2##1##(1993-3#1)(1995-5#1)
opsonized or not with##2##4##(2008-10#2)
opsonized zymosan##2##2##(1991-2#1)(1994-11#1)
opsonized##7##1##(1990-12#1)(1991-2#2)(1994-11#1)(2008-10#3)
opted to##2##2##(2009-3#1)(2013-8#1)
opted##3##1##(2008-7#1)(2009-3#1)(2013-8#1)
optic disc##3##2##(2010-9#1)(2011-2#1)(2013-7#1)
optic flow##4##2##(2008-11#1)(2008-9#3)
optic nerve##17##2##(1997-3#1)(2008-11#2)(2008-5#2)(2008-7#3)(2010-5#2)(2010-8#1)(2011-2#3)(2011-7#1)(2012-3#2)
optic neuritis##6##2##(1992-3#1)(1995-12#2)(2008-1#1)(2011-7#1)(2012-3#1)
optic neuropathy in Graves' eye disease##3##6##(2008-7#3)
optic neuropathy in##4##3##(2008-7#4)
optic neuropathy##6##2##(2008-7#5)(2013-1#1)
optic probe##3##2##(2008-10#3)
optic sensors##5##2##(2008-10#5)
optic tectum##4##2##(1990-5#1)(1997-3#1)(2008-6#2)
optic##86##1##(1990-12#1)(1990-5#1)(1991-2#1)(1992-3#1)(1995-12#2)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#33)(2008-11#3)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#10)(2008-9#3)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#5)(2011-7#2)(2012-3#3)(2013-1#1)(2013-7#1)
optica (NMO)##2##2##(2010-12#1)(2013-8#1)
optica##5##1##(2010-12#1)(2012-3#2)(2013-8#2)
optical CO(2) sensor based on##2##5##(2008-10#2)
optical Kerr##2##2##(2008-2#2)
optical absorption in##2##3##(2008-10#1)(2011-7#1)
optical absorption spectroscopy##5##3##(2008-10#1)(2008-3#4)
optical absorption##10##2##(2008-10#3)(2008-3#5)(2010-4#1)(2011-7#1)
optical alignment##2##2##(2008-10#1)(2008-9#1)
optical amplifier##2##2##(2007-11#1)(2008-3#1)
optical amplifiers##3##2##(2007-11#2)(2008-2#1)
optical and electronic microscopy##2##4##(2008-10#1)(2009-7#1)
optical and scanning electron##2##4##(2008-10#1)(2010-4#1)
optical and##13##2##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#2)(2010-4#1)(2010-7#1)
optical bandwidth##2##2##(2008-3#2)
optical behavior##2##2##(2008-10#1)(2008-3#1)
optical biosensor##6##2##(1995-12#1)(2008-10#5)
optical breakdown##5##2##(2008-2#3)(2008-3#2)
optical cavities##4##2##(2008-3#4)
optical cavity and##2##3##(2008-3#2)
optical cavity##6##2##(2008-2#1)(2008-3#5)
optical characteristics of##2##3##(2008-2#1)(2008-3#1)
optical chemical sensor based on##2##5##(2008-10#2)
optical chemical sensor##6##3##(2008-10#6)
optical chromatography##2##2##(2008-10#2)
optical coherence tomography (OCT)##7##4##(2008-5#1)(2011-7#4)(2013-1#2)
optical coherence tomography (SD-OCT) has##2##5##(2011-7#2)
optical coherence tomography system##2##4##(2007-11#1)(2008-3#1)
optical coherence tomography##23##3##(2007-11#2)(2008-3#2)(2008-5#1)(2009-9#1)(2010-9#1)(2011-7#13)(2013-1#3)
optical communication##2##2##(2007-11#1)(2007-12#1)
optical components##6##2##(2008-2#3)(2008-3#2)(2008-9#1)
optical configuration##3##2##(2008-3#3)
optical constants##3##2##(2008-10#1)(2008-3#2)
optical correlation##2##2##(1994-11#1)(2008-3#1)
optical correlators##2##2##(2008-3#2)
optical coupling##3##2##(2008-2#3)
optical cross##2##2##(2008-3#2)
optical data storage##2##3##(2008-3#2)
optical data##4##2##(2008-2#1)(2008-3#3)
optical density##9##2##(2008-10#3)(2008-5#2)(2008-7#1)(2010-12#1)(2010-3#2)
optical depth##6##2##(2008-2#2)(2008-3#4)
optical design##2##2##(2008-3#1)(2013-8#1)
optical detection of##2##3##(1997-7#1)(2008-3#1)
optical detection##6##2##(1997-7#1)(2008-10#1)(2008-3#4)
optical device##2##2##(2008-10#2)
optical disks##2##2##(2008-3#2)
optical effects##3##2##(1990-8#1)(2008-2#1)(2008-3#1)
optical element##7##2##(2008-3#7)
optical elements##12##2##(2008-3#12)
optical emission spectrometry (ICP-OES)##11##4##(2008-10#11)
optical emission spectrometry##24##3##(2008-10#24)
optical emission spectroscopy##4##3##(2008-10#1)(2010-11#1)(2011-2#2)
optical emission##30##2##(2008-10#26)(2008-3#1)(2010-11#1)(2011-2#2)
optical extinction##2##2##(2008-2#1)(2008-3#1)
optical feedback##4##2##(2008-3#4)
optical fiber and##2##3##(2008-10#1)(2008-3#1)
optical fiber assembly##2##3##(2008-10#2)
optical fiber refractometer based on a path-matching differential interferometer##2##9##(2008-3#2)
optical fiber sensor for##3##4##(2008-10#3)
optical fiber sensor##5##3##(2007-12#1)(2008-10#4)
optical fiber was##2##3##(2008-10#1)(2008-3#1)
optical fiber##32##2##(2007-12#2)(2008-10#18)(2008-2#1)(2008-3#8)(2008-7#1)(2010-4#2)
optical fibers and##2##3##(2008-10#1)(2008-3#1)
optical fibers by##2##3##(2008-2#1)(2008-3#1)
optical fibers##26##2##(1991-1#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#16)(2008-9#1)
optical field##6##2##(2007-12#2)(2008-2#1)(2008-3#2)(2009-5#1)
optical fields##2##2##(1993-5#1)(2008-3#1)
optical filters##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
optical flow cell##2##3##(2008-10#2)
optical fluorescence##2##2##(2008-3#1)(2010-12#1)
optical frequency comb##2##3##(2008-3#2)
optical gating##2##2##(2007-11#2)
optical glass waveguide gratings##2##4##(2008-3#2)
optical glass##3##2##(2008-10#1)(2008-3#2)
optical image##2##2##(2008-11#1)(2010-8#1)
optical images##9##2##(2007-12#2)(2009-5#2)(2010-8#5)
optical imaging of##2##3##(2008-2#1)(2009-5#1)
optical imaging reveals##2##3##(2008-11#2)
optical imaging##7##2##(2008-11#3)(2008-2#1)(2008-3#2)(2009-5#1)
optical interconnects##2##2##(2008-3#2)
optical interferometer##2##2##(2008-2#1)(2008-3#1)
optical isolation of the sampling volume##2##6##(2008-3#2)
optical isomers##2##2##(1992-9#1)(2008-10#1)
optical loss did not significantly change##2##6##(2008-2#2)
optical loss##6##2##(2008-2#6)
optical method##2##2##(2007-11#1)(2009-5#1)
optical microscope##4##2##(2007-12#3)(2008-5#1)
optical microscopy##7##2##(2008-10#5)(2008-5#1)(2009-7#1)
optical multipass cell##2##3##(2008-3#2)
optical one-shot sensor##2##3##(2008-10#2)
optical parameters of##2##3##(2008-3#1)(2013-8#1)
optical parameters that##2##3##(1990-8#1)(2008-3#1)
optical parameters##10##2##(1990-8#3)(1994-3#1)(2008-3#4)(2013-8#2)
optical parametric amplifier##2##3##(2008-2#1)(2008-3#1)
optical parametric generator##3##3##(2007-12#2)(2008-2#1)
optical parametric oscillation##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
optical parametric oscillator (OPO) based on##2##6##(2007-12#1)(2008-3#1)
optical parametric oscillator (OPO) pumped##2##5##(2008-3#2)
optical parametric oscillator (OPO)##8##4##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)
optical parametric oscillator##16##3##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#8)
optical parametric##26##2##(2007-11#3)(2007-12#8)(2008-10#1)(2008-2#4)(2008-3#10)
optical path difference deviation##2##4##(2013-8#2)
optical path difference##7##3##(2008-3#1)(2013-8#6)
optical path length##3##3##(2008-10#2)(2008-3#1)
optical path##19##2##(2008-10#7)(2008-3#4)(2013-8#8)
optical pathlength##3##2##(2008-10#3)
optical pickup##2##2##(2008-3#2)
optical power##2##2##(2007-12#1)(2008-3#1)
optical process##2##2##(2007-12#1)(2010-7#1)
optical properties and##2##3##(2008-3#2)
optical properties of clouds and aerosols##2##6##(2008-3#2)
optical properties of##8##3##(2007-11#1)(2008-10#2)(2008-3#5)
optical properties##18##2##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#10)(2009-11#1)
optical property##2##2##(2008-2#2)
optical pulse##2##2##(2007-12#1)(2008-2#1)
optical pulses##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
optical quality##2##2##(2008-3#2)
optical rectification##3##2##(2007-11#2)(2007-12#1)
optical resolution of##2##3##(2007-12#1)(2009-12#1)
optical resolution##3##2##(2007-12#1)(2009-12#1)(2012-2#1)
optical resonator##3##2##(2008-3#3)
optical response functions##2##3##(2007-12#2)
optical response of##2##3##(1995-6#1)(2008-10#1)
optical response##6##2##(1990-8#2)(1995-6#1)(2007-12#2)(2008-10#1)
optical responses##2##2##(2008-10#2)
optical scanners##3##2##(2008-3#3)
optical scanning holography##2##3##(2008-3#2)
optical sensing##4##2##(2008-10#4)
optical sensor for##5##3##(1996-5#1)(2008-10#3)(2008-3#1)
optical sensor##12##2##(1996-5#1)(2008-10#9)(2008-3#2)
optical sensors for##3##3##(2008-10#3)
optical sensors##5##2##(2008-10#5)
optical signal##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
optical signals##2##2##(2008-3#2)
optical slope efficiency##3##3##(2008-2#3)
optical storage##3##2##(1994-3#2)(2008-3#1)
optical substrate##2##2##(2008-10#1)(2008-3#1)
optical surface##2##2##(2008-10#1)(2008-3#1)
optical switching##3##2##(1995-6#1)(2008-3#2)
optical system that##2##3##(2008-3#2)
optical system##13##2##(2008-10#1)(2008-3#11)(2008-4#1)
optical systems##5##2##(2008-3#4)(2013-8#1)
optical thickness##5##2##(2008-3#5)
optical thicknesses##5##2##(2008-2#2)(2008-3#3)
optical tomography##2##2##(2007-12#1)(2008-3#1)
optical transmission##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
optical trapping##3##2##(2008-10#2)(2008-3#1)
optical tunnel##2##2##(2008-3#2)
optical tweezers##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
optical vortex##4##2##(2007-12#2)(2009-5#2)
optical waveguide spectroscopy##3##3##(2008-10#3)
optical waveguide##16##2##(2008-10#14)(2008-3#2)
optical waveguides were fabricated from fluorinated polyimides##2##7##(2008-2#2)
optical waveguides##9##2##(2007-12#2)(2008-10#2)(2008-2#5)
optical##756##1##(1990-12#1)(1990-8#8)(1991-1#1)(1991-2#1)(1992-11#2)(1992-4#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-7#2)(2007-11#26)(2007-12#39)(2008-10#191)(2008-11#5)(2008-2#74)(2008-3#282)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#2)(2008-9#4)(2009-11#1)(2009-12#2)(2009-5#10)(2009-7#6)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#6)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#1)(2011-2#8)(2011-7#14)(2012-2#8)(2013-1#4)(2013-8#14)
optical-fiber##3##1##(2008-2#1)(2008-3#2)
optical-to-optical efficiency##2##2##(2008-2#1)(2008-3#1)
optically active##6##2##(1996-5#4)(2008-10#1)(2008-7#1)
optically diffuse##3##2##(2008-3#3)
optically pumped##3##2##(1994-2#1)(2007-12#1)(2008-3#1)
optically pure amino##2##3##(1992-11#1)(1995-3#1)
optically pure##6##2##(1992-11#1)(1992-3#1)(1995-3#3)(2008-5#1)
optically sensitive##2##2##(2007-12#2)
optically thick##6##2##(2008-10#2)(2008-3#4)
optically thin##2##2##(2008-3#2)
optically trapped##3##2##(2008-3#2)(2012-2#1)
optically##49##1##(1992-11#1)(1992-3#1)(1994-2#1)(1995-3#3)(1996-5#4)(2007-11#2)(2007-12#6)(2008-10#7)(2008-2#1)(2008-3#17)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-2#1)
optics and micro-optics##2##3##(2008-3#2)
optics and##9##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)
optics approximation##2##2##(2008-2#2)
optics when##2##2##(2008-3#2)
optics##52##1##(1990-8#1)(2008-1#2)(2008-10#5)(2008-2#11)(2008-3#27)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
optima##7##1##(1991-12#1)(2008-10#2)(2008-8#1)(2010-3#1)(2011-2#2)
optimal activity##2##2##(1997-2#1)(2008-5#1)
optimal analytical conditions##3##3##(2008-10#3)
optimal analytical##4##2##(2008-10#4)
optimal approximation##2##2##(2008-6#2)
optimal care can be##2##4##(2008-11#1)(2011-2#1)
optimal care##4##2##(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
optimal concentration of##2##3##(1992-8#1)(1994-11#1)
optimal concentration##4##2##(1992-8#1)(1994-11#1)(2008-8#2)
optimal concentrations of##4##3##(2008-10#2)(2008-11#2)
optimal concentrations##5##2##(1994-8#1)(2008-10#2)(2008-11#2)
optimal condition##2##2##(2008-10#1)(2013-1#1)
optimal conditions for the##6##4##(2008-10#6)
optimal conditions for##16##3##(2008-10#13)(2008-11#2)(2008-7#1)
optimal conditions of##3##3##(2008-10#3)
optimal conditions##73##2##(1991-5#1)(2008-10#63)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-1#1)
optimal control##5##2##(2009-5#4)(2013-8#1)
optimal decision threshold##2##3##(2008-10#2)
optimal decision##5##2##(1991-12#1)(1992-3#1)(2008-10#2)(2012-3#1)
optimal design##2##2##(2008-3#1)(2010-2#1)
optimal dosage and administration of##2##5##(2013-1#2)
optimal dosage and##3##3##(1992-9#1)(2013-1#2)
optimal estimation formalism can be used##2##6##(2008-3#2)
optimal experimental conditions##5##3##(2008-10#5)
optimal for##6##2##(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-7#1)
optimal foraging##5##2##(2008-8#2)(2008-9#3)
optimal growth##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)
optimal harvest time##5##3##(2008-11#4)(2008-7#1)
optimal investment in##3##3##(2008-8#2)(2012-3#1)
optimal level of##5##3##(2008-10#1)(2008-8#3)(2013-1#1)
optimal level##7##2##(1996-3#1)(2008-10#1)(2008-8#3)(2009-7#1)(2013-1#1)
optimal levels##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
optimal management##3##2##(2010-10#1)(2011-2#1)(2011-3#1)
optimal medical therapy##2##3##(2010-6#1)(2011-3#1)
optimal medical##3##2##(2008-8#1)(2010-6#1)(2011-3#1)
optimal medium##5##2##(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
optimal method of##2##3##(2008-1#1)(2013-1#1)
optimal outcome##2##2##(2008-1#1)(2008-7#1)
optimal oxygen##2##2##(1996-3#2)
optimal pH of##3##3##(1993-3#1)(2008-10#2)
optimal pH##7##2##(1990-2#1)(1993-3#1)(2008-10#4)(2009-3#1)
optimal pain management in older adults on acute medical units##2##10##(2010-7#2)
optimal performance##2##2##(1994-12#1)(2009-10#1)
optimal physician inquiry starting time##2##5##(2010-8#2)
optimal postoperative##2##2##(2010-11#1)(2013-1#1)
optimal propagule size is larger##2##5##(2008-8#2)
optimal range##2##2##(1992-9#1)(2008-11#1)
optimal reaction conditions##3##3##(2008-10#2)(2008-8#1)
optimal reaction norms##2##3##(2008-8#2)
optimal reaction##7##2##(2008-10#4)(2008-8#3)
optimal response##2##2##(2008-10#1)(2012-4#1)
optimal results##2##2##(1992-12#1)(2011-2#1)
optimal selection of##2##3##(2008-10#1)(2008-3#1)
optimal separation##2##2##(2008-10#2)
optimal solution##2##2##(2008-2#1)(2009-7#1)
optimal spatial frequency##2##3##(2008-8#2)
optimal surgical##3##2##(1994-12#1)(2008-12#1)(2013-1#1)
optimal temperatures##2##2##(2008-10#2)
optimal therapy for##3##3##(1995-2#1)(2009-8#1)(2011-2#1)
optimal therapy##5##2##(1995-2#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
optimal to achieve##2##3##(1993-1#1)(2008-7#1)
optimal treatment for##2##3##(2008-7#2)
optimal treatment strategy##2##3##(2011-2#1)(2013-1#1)
optimal treatment##12##2##(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-1#1)(2010-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
optimal use of##2##3##(2008-10#1)(2009-2#1)
optimal values for##2##3##(2008-10#1)(2008-7#1)
optimal values##4##2##(2008-10#3)(2008-7#1)
optimal working conditions##2##3##(2008-10#2)
optimal working##3##2##(2008-10#2)(2010-10#1)
optimal##441##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1997-1#1)(1997-2#4)(1997-4#1)(1997-6#1)(2008-1#3)(2008-10#151)(2008-11#32)(2008-12#6)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#9)(2008-6#9)(2008-7#16)(2008-8#32)(2008-9#12)(2009-1#2)(2009-10#3)(2009-2#1)(2009-3#1)(2009-5#4)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#1)(2011-2#12)(2011-3#5)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#12)(2012-4#1)(2013-1#21)(2013-8#10)
optimality model##2##2##(2008-8#2)
optimality models##3##2##(2008-8#2)(2008-9#1)
optimality##10##1##(1996-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2010-1#1)
optimally at##2##2##(2008-10#1)(2011-2#1)
optimally foraging##2##2##(2008-9#2)
optimally in##2##2##(2008-9#1)(2013-8#1)
optimally##22##1##(1991-12#1)(1992-6#1)(1993-11#1)(1994-2#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#3)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
optimisation and validation of##2##4##(2008-10#2)
optimisation and##6##2##(2008-10#5)(2008-11#1)
optimisation is##2##2##(2008-11#1)(2010-11#1)
optimisation of a##2##3##(2008-10#2)
optimisation of an on-line preconcentration##2##5##(2008-10#2)
optimisation of the experimental conditions##2##5##(2008-10#2)
optimisation of the experimental##3##4##(2008-10#3)
optimisation of the variables##2##4##(2008-10#2)
optimisation of the##14##3##(2008-10#12)(2008-11#2)
optimisation of##25##2##(2008-10#21)(2008-11#4)
optimisation process##3##2##(2008-10#3)
optimisation##50##1##(1997-6#1)(2008-10#40)(2008-11#7)(2008-5#1)(2010-11#1)
optimise the##6##2##(2008-10#6)
optimise##16##1##(1990-3#1)(2008-10#10)(2008-11#3)(2008-7#1)(2010-10#1)
optimised and##9##2##(2008-10#9)
optimised by a##2##3##(2008-10#2)
optimised by##11##2##(2008-10#11)
optimised conditions the##3##3##(2008-10#3)
optimised conditions were##2##3##(2008-10#2)
optimised conditions##14##2##(2008-10#14)
optimised for##9##2##(2008-10#9)
optimised in order to##4##4##(2008-10#4)
optimised to##5##2##(2008-10#5)
optimised##101##1##(1995-3#1)(2008-10#99)(2012-2#1)
optimising all##2##2##(2008-10#1)(2010-12#1)
optimising the##2##2##(2008-10#1)(2008-11#1)
optimising##4##1##(2008-10#2)(2008-11#1)(2010-12#1)
optimism bias##4##2##(2010-7#4)
optimism##12##1##(1992-12#1)(1992-5#1)(1995-12#1)(2008-10#1)(2008-12#1)(2010-2#2)(2010-7#4)(2012-2#1)
optimistic##4##1##(1992-12#1)(1994-9#1)(1996-3#1)(2008-12#1)
optimization algorithm##3##2##(2008-3#3)
optimization algorithms##2##2##(2008-10#1)(2008-7#1)
optimization and characterization##2##3##(2008-10#2)
optimization and##12##2##(2008-10#7)(2008-11#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-6#1)
optimization approach##2##2##(2008-10#1)(2008-11#1)
optimization by##3##2##(2008-10#3)
optimization conditions##2##2##(2008-10#1)(2008-9#1)
optimization for the##2##3##(2008-10#1)(2008-6#1)
optimization for##5##2##(2008-10#3)(2008-11#1)(2008-6#1)
optimization in##2##2##(2008-11#2)
optimization is##4##2##(2008-10#2)(2008-4#1)(2013-8#1)
optimization method##3##2##(2008-10#2)(2008-7#1)
optimization models##2##2##(1995-2#1)(2008-8#1)
optimization of a novel##2##4##(2008-10#1)(2012-2#1)
optimization of a##11##3##(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
optimization of an on-line##2##4##(2008-10#2)
optimization of an##3##3##(2008-10#3)
optimization of experimental##3##3##(2008-10#3)
optimization of preconcentration procedure for##2##5##(2008-10#2)
optimization of the experimental conditions##2##5##(2008-10#2)
optimization of the experimental parameters##2##5##(2008-10#2)
optimization of the experimental##4##4##(2008-10#4)
optimization of the extraction##2##4##(2008-10#2)
optimization of the fermentation process##2##5##(2008-10#1)(2011-2#1)
optimization of the method##3##4##(2008-10#2)(2011-1#1)
optimization of the reaction##2##4##(1996-2#1)(2011-1#1)
optimization of the##41##3##(1996-2#1)(2008-10#24)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2013-1#2)
optimization of these##2##3##(2008-10#1)(2008-7#1)
optimization of##111##2##(1996-2#1)(2008-10#68)(2008-11#7)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-1#1)(2011-1#3)(2011-2#4)(2011-3#2)(2012-2#2)(2013-1#2)(2013-8#2)
optimization point##2##2##(2009-2#2)
optimization points for##2##3##(2009-2#2)
optimization points##8##2##(2009-2#8)
optimization problem##2##2##(1992-12#1)(2013-1#1)
optimization procedure##3##2##(2008-10#3)
optimization process##5##2##(2008-10#5)
optimization study##5##2##(2008-10#4)(2011-2#1)
optimization was performed##2##3##(2008-10#2)
optimization was##3##2##(1997-6#1)(2008-10#2)
optimization##246##1##(1992-12#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#3)(2008-10#135)(2008-11#17)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#12)(2008-8#5)(2008-9#3)(2009-1#1)(2009-2#14)(2009-5#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#5)(2011-3#2)(2012-2#4)(2013-1#5)(2013-8#3)
optimizations##4##1##(2008-10#1)(2008-7#1)(2009-2#2)
optimize product quantity##2##3##(2008-10#2)
optimize the##44##2##(1994-2#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#2)
optimize##93##1##(1994-2#1)(1995-2#1)(2008-1#1)(2008-10#40)(2008-11#9)(2008-12#2)(2008-3#9)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
optimized a new##2##3##(2008-10#1)(2008-11#1)
optimized and a##4##3##(2008-10#3)(2008-4#1)
optimized and applied to the determination of##3##7##(2008-10#2)(2009-8#1)
optimized and the##9##3##(2008-10#9)
optimized and##28##2##(2008-10#25)(2008-11#1)(2008-4#1)(2009-8#1)
optimized between##2##2##(2008-10#1)(2010-1#1)
optimized by a##4##3##(2008-10#3)(2008-5#1)
optimized by both static and dynamic methods##4##7##(2008-10#4)
optimized by means of##2##4##(2008-10#2)
optimized by selecting##2##3##(2008-10#1)(2008-7#1)
optimized by the##2##3##(2008-10#2)
optimized by##26##2##(1995-5#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-7#1)
optimized condition##6##2##(2008-10#6)
optimized conditions for##2##3##(2008-10#2)
optimized conditions of##3##3##(2008-10#3)
optimized conditions##50##2##(2008-10#49)(2008-12#1)
optimized dose distributions for vaginal cylinders##2##6##(2009-2#2)
optimized dose distributions##3##3##(2009-2#3)
optimized experimental conditions##4##3##(2008-10#3)(2009-12#1)
optimized extraction##2##2##(2008-10#1)(2008-4#1)
optimized for each##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
optimized for the determination of##4##5##(2008-10#4)
optimized for the##10##3##(2008-10#10)
optimized for##30##2##(2008-10#21)(2008-11#2)(2008-3#3)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
optimized in the##2##3##(2008-10#2)
optimized in##7##2##(2008-10#6)(2011-3#1)
optimized method##4##2##(2008-10#4)
optimized model##2##2##(2008-10#1)(2013-8#1)
optimized on##3##2##(2008-10#3)
optimized operational conditions##2##3##(2008-10#2)
optimized parameters##3##2##(2008-10#3)
optimized procedure was##2##3##(2008-10#2)
optimized procedure##4##2##(2008-10#4)
optimized protocol##2##2##(2008-10#1)(2008-12#1)
optimized reaction##2##2##(2008-10#1)(2013-8#1)
optimized sampling##2##2##(2007-12#1)(2008-10#1)
optimized separation conditions##2##3##(2008-10#2)
optimized system was##2##3##(2008-10#2)
optimized system##4##2##(2008-10#3)(2008-3#1)
optimized the##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
optimized to allow##2##3##(2008-10#1)(2008-4#1)
optimized to maximize the##2##4##(2008-10#2)
optimized to obtain##3##3##(2008-10#3)
optimized to yield a##2##4##(2008-10#2)
optimized to##21##2##(2008-10#14)(2008-3#4)(2008-4#1)(2008-5#1)(2013-8#1)
optimized using a##4##3##(2008-10#3)(2008-7#1)
optimized using the##2##3##(2008-10#2)
optimized using##9##2##(2008-10#8)(2008-7#1)
optimized with respect to the##2##5##(1991-5#1)(2008-10#1)
optimized with respect to##4##4##(1991-5#1)(2008-10#2)(2008-7#1)
optimized with##5##2##(1991-5#1)(2008-10#2)(2008-3#1)(2008-7#1)
optimized##398##1##(1991-5#1)(1993-8#2)(1995-5#1)(1997-2#1)(1997-6#2)(2007-12#1)(2008-10#317)(2008-11#12)(2008-12#2)(2008-3#16)(2008-4#4)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#3)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#6)
optimizes the##3##2##(1997-1#1)(2008-11#1)(2011-2#1)
optimizes##5##1##(1997-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
optimizing standard##2##2##(2009-10#1)(2010-12#1)
optimizing the##17##2##(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2013-1#2)(2013-8#1)
optimizing##43##1##(1993-3#1)(1996-6#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#2)
optimum SFE conditions##2##3##(2008-10#2)
optimum SFE##3##2##(2008-10#3)
optimum amount of##2##3##(1996-9#1)(2008-10#1)
optimum analytical conditions##4##3##(2008-10#4)
optimum analytical##6##2##(2008-10#6)
optimum and##2##2##(2008-10#1)(2008-8#1)
optimum at##7##2##(2006-6#1)(2008-10#6)
optimum concentration of##3##3##(2008-10#2)(2008-8#1)
optimum concentration##6##2##(2008-10#4)(2008-8#1)(2013-1#1)
optimum condition##9##2##(2008-10#9)
optimum conditions established##2##3##(2008-10#2)
optimum conditions for separation##2##4##(2008-10#2)
optimum conditions for the##12##4##(2008-10#12)
optimum conditions for##23##3##(2008-10#20)(2008-11#2)(2008-12#1)
optimum conditions obtained by the##2##5##(2008-10#2)
optimum conditions obtained##3##3##(2008-10#3)
optimum conditions of##3##3##(2008-10#3)
optimum conditions were found to##2##5##(2008-10#2)
optimum conditions were##9##3##(2008-10#9)
optimum conditions##111##2##(2008-10#108)(2008-11#2)(2008-12#1)
optimum dose##2##2##(2008-10#1)(2013-1#1)
optimum experimental conditions for##2##4##(2008-10#2)
optimum experimental conditions were investigated##2##5##(2008-10#2)
optimum experimental conditions were##4##4##(2008-10#4)
optimum experimental conditions##12##3##(2008-10#12)
optimum flow rate of##3##4##(2008-10#3)
optimum flow rate##4##3##(2008-10#4)
optimum for##2##2##(1993-3#1)(2008-10#1)
optimum number of factors##2##4##(2008-10#2)
optimum of##2##2##(1994-5#1)(2008-10#1)
optimum operating conditions##4##3##(2008-10#3)(2008-3#1)
optimum operation##2##2##(2007-12#1)(2008-10#1)
optimum pH and##2##3##(2008-10#2)
optimum pH range was##2##4##(2008-10#2)
optimum pH range##4##3##(2008-10#4)
optimum pH##24##2##(1994-8#1)(1997-2#1)(2008-10#21)(2008-9#1)
optimum performance##3##2##(2008-10#2)(2008-3#1)
optimum polarization orientation of the##2##5##(2008-3#2)
optimum polarization##3##2##(2008-3#3)
optimum procedures##2##2##(2008-10#2)
optimum pyrolysis and atomization temperatures of##3##6##(2008-10#3)
optimum pyrolysis and atomization temperatures##4##5##(2008-10#4)
optimum range##3##2##(2008-10#3)
optimum reaction conditions were##6##4##(2008-10#6)
optimum reaction conditions##11##3##(2008-10#11)
optimum separation conditions##2##3##(2008-10#2)
optimum separation##5##2##(2008-10#5)
optimum temperature for##4##3##(2008-10#3)(2008-11#1)
optimum temperature range##2##3##(2008-10#2)
optimum temperature##13##2##(1997-2#1)(2008-10#10)(2008-11#1)(2012-2#1)
optimum temperatures##3##2##(2008-10#3)
optimum values of##3##3##(2008-10#3)
optimum values##5##2##(2008-10#5)
optimum was##4##2##(1990-5#2)(2008-10#2)
optimum working##5##2##(2008-10#5)
optimum##373##1##(1990-12#1)(1990-5#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(2006-6#2)(2007-12#1)(2008-10#302)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#12)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-5#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
optimum-design method##2##2##(2013-8#2)
option for a##2##3##(2010-12#1)(2011-3#1)
option for many##2##3##(2008-11#1)(2008-6#1)
option for patients with##2##4##(1994-12#1)(2010-11#1)
option for the##5##3##(2008-10#1)(2008-12#1)(2009-10#1)(2013-1#1)(2013-8#1)
option for##31##2##(1993-12#1)(1994-12#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
option in patients##3##3##(2010-12#2)(2011-2#1)
option in the##2##3##(2011-3#1)(2012-3#1)
option in##9##2##(1993-11#1)(2008-10#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
option of##5##2##(1997-3#1)(2008-10#2)(2008-8#1)(2011-3#1)
option to reduce##2##3##(2008-7#1)(2013-8#1)
option to##8##2##(1993-3#1)(1994-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
option##85##1##(1991-1#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1996-1#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#7)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#4)(2012-12#3)(2012-3#5)(2013-1#6)(2013-8#3)
optional##6##1##(1994-1#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-4#1)
optionally##2##1##(2008-10#1)(2010-10#1)
options and##8##2##(1992-1#1)(1994-1#1)(1995-3#1)(1996-3#1)(1996-9#1)(2008-11#2)(2008-12#1)
options are available##2##3##(2008-7#1)(2010-6#1)
options are##7##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)(2013-1#1)
options available to##3##3##(1991-3#1)(2009-5#1)(2011-2#1)
options available##8##2##(1991-3#1)(2008-11#1)(2008-4#2)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)
options for the treatment##2##4##(2007-11#1)(2010-5#1)
options for##36##2##(1991-2#1)(1993-12#1)(1995-1#1)(1995-3#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-3#1)(2013-1#6)
options in##9##2##(1996-1#1)(1997-1#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
options including##2##2##(2008-9#1)(2012-3#1)
options is##3##2##(2008-10#2)(2008-11#1)
options of##2##2##(1992-12#1)(2009-4#1)
options to restore##2##3##(2008-8#1)(2012-2#1)
options to##6##2##(1996-1#1)(2008-8#3)(2011-2#1)(2012-2#1)
options was##2##2##(2008-10#2)
options were##2##2##(1997-4#1)(2013-1#1)
options will##2##2##(2010-11#1)(2012-3#1)
options with##2##2##(2008-10#1)(2008-8#1)
options##144##1##(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-1#3)(1996-12#1)(1996-3#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#5)(2008-10#17)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#14)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#14)(2013-8#2)
optode is##4##2##(2008-10#4)
optode membrane for##3##3##(2008-10#3)
optode membrane##10##2##(2008-10#10)
optode with##2##2##(2008-10#2)
optode##25##1##(2008-10#25)
optodes##4##1##(2008-10#4)
optoelectronic PH##2##2##(2008-3#2)
optoelectronic device##3##2##(2008-3#3)
optoelectronic##12##1##(2008-3#8)(2008-7#2)(2009-5#2)
optomechanical##3##1##(2008-3#1)(2012-2#2)
optosensing method##2##2##(2008-10#2)
optosensing properties of##2##3##(2008-10#2)
optosensing##10##1##(2008-10#10)
optosensor for##3##2##(2008-10#3)
optosensor##7##1##(2008-10#7)
optrode is##2##2##(2008-10#2)
optrode system##2##2##(2008-10#2)
optrode##8##1##(2008-10#8)
opuntiarum##3##1##(2008-10#3)
opératoires##3##1##(2011-2#1)(2013-1#2)
or &gt##6##2##(2008-10#3)(2008-12#1)(2008-7#1)(2013-1#1)
or &lt##2##2##(2009-1#1)(2013-1#1)
or &quot##41##2##(1990-11#1)(1990-9#2)(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-5#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-6#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
or 'Rely'##2##2##(2008-10#2)
or (4)##2##2##(2011-2#1)(2013-1#1)
or (DOMBT##2##2##(2008-10#2)
or (ii)##2##2##(1992-9#1)(1995-6#1)
or (iii)##2##2##(2008-10#1)(2008-11#1)
or -10 kPa##2##3##(2008-10#2)
or -10##3##2##(2008-10#2)(2012-2#1)
or 0##22##2##(1990-6#2)(1992-12#1)(1993-1#1)(1994-5#3)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#9)(2008-5#2)(2011-2#1)
or 1##25##2##(1991-5#1)(1994-2#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-2#1)
or 1%##2##2##(2008-10#1)(2008-5#1)
or 10##12##2##(1993-6#1)(1994-5#2)(1996-5#1)(2008-10#6)(2008-11#1)(2013-8#1)
or 10%##3##2##(1995-11#1)(2008-10#2)
or 10(-5)##2##2##(1994-2#1)(1997-4#1)
or 10(8)##2##2##(1991-11#1)(2008-10#1)
or 100 ng/ml##2##3##(1995-6#1)(2008-12#1)
or 100##7##2##(1995-6#1)(1996-12#3)(2008-10#1)(2008-12#1)(2008-5#1)
or 100%##2##2##(2008-10#2)
or 1000##2##2##(1995-11#1)(2008-3#1)
or 12 weeks##2##3##(2008-10#2)
or 12##4##2##(1996-11#1)(2008-10#2)(2008-9#1)
or 15##4##2##(2008-10#3)(2008-9#1)
or 16##5##2##(2008-10#3)(2008-9#1)(2011-2#1)
or 18##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
or 2##22##2##(1990-11#1)(1992-10#1)(1993-1#1)(1995-11#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-9#3)(2011-2#1)
or 2) and##2##3##(1990-12#1)(2008-10#1)
or 20##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
or 200##3##2##(2008-10#3)
or 24 h##4##3##(1990-12#1)(1996-12#1)(2008-10#1)(2008-7#1)
or 24##9##2##(1990-11#2)(1990-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
or 25 mg##2##3##(2008-10#1)(2011-2#1)
or 25##4##2##(2008-10#3)(2011-2#1)
or 256 mg sodium bromate/kg body weight##2##7##(2008-9#2)
or 27##2##2##(2008-10#1)(2008-9#1)
or 28 days##3##3##(1996-12#1)(2008-10#1)(2010-6#1)
or 28##4##2##(1996-12#1)(2007-12#1)(2008-10#1)(2010-6#1)
or 280##2##2##(2008-10#2)
or 3##15##2##(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(2008-10#5)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
or 30 degrees C at pH##2##6##(2008-10#2)
or 30 degrees C##5##4##(2008-10#5)
or 30 mg/kg##2##3##(1994-2#1)(2008-10#1)
or 30##16##2##(1994-2#1)(1995-12#1)(2008-10#12)(2012-12#1)(2013-1#1)
or 300##2##2##(1992-3#1)(2008-5#1)
or 35##2##2##(2008-10#1)(2012-2#1)
or 36 degrees C##2##4##(2008-10#2)
or 360 sec)##2##3##(2008-5#2)
or 4##13##2##(1993-1#1)(1993-12#1)(1996-3#1)(2008-10#6)(2008-7#1)(2008-9#1)(2011-2#2)
or 4)##3##2##(2008-10#3)
or 41 weeks##4##3##(2008-9#4)
or 42##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
or 48 h##3##3##(2008-10#3)
or 5##12##2##(1990-11#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)(2013-1#1)
or 5'##2##2##(1994-8#1)(2008-10#1)
or 5'-GC##2##2##(2008-11#2)
or 5'-N-ethylcarboxamido-adenosine##2##2##(1995-8#2)
or 50##10##2##(1992-12#1)(1994-12#1)(1995-8#1)(2008-10#6)(2008-5#1)
or 500##3##2##(2008-10#1)(2008-9#2)
or 52##2##2##(1993-6#1)(2008-10#1)
or 6##6##2##(1991-6#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-7#1)
or 7##5##2##(1990-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2012-9#1)
or 70 mg/kg in ethanol##2##5##(2008-9#2)
or 70 mg/kg##3##3##(2008-9#3)
or 70##4##2##(2008-9#4)
or 72 h of##2##4##(1995-11#1)(2008-7#1)
or 8##2##2##(1994-2#1)(2008-10#1)
or 800 mg/L sodium bromate for 27 weeks (equivalent to average daily doses of approximately##2##15##(2008-9#2)
or 800 mg/L sodium bromate for 43 weeks (equivalent to average daily doses of approximately##2##15##(2008-9#2)
or 800 mg/L sodium bromate for##4##6##(2008-9#4)
or 800 mg/L##5##3##(2008-9#5)
or 800##6##2##(2008-9#6)
or 9##4##2##(1990-8#1)(1995-8#1)(2008-10#1)(2008-8#1)
or 96##2##2##(2008-10#1)(2008-11#1)
or 99%##2##2##(2008-10#2)
or = 0##8##3##(1992-11#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-7#3)(2011-2#1)
or = 1##3##3##(1996-11#1)(2011-2#2)
or = 10##2##3##(1997-1#1)(1997-5#1)
or = 20 microM##2##4##(1995-8#2)
or = 20##7##3##(1995-8#4)(1997-1#1)(1997-8#1)(2008-10#1)
or = 30##2##3##(1994-12#1)(2011-2#1)
or = 35 yrs)##2##4##(2012-3#2)
or = 37##2##3##(1994-3#1)(2008-7#1)
or = 4##2##3##(1996-1#1)(2008-5#1)
or = 4g/dl##2##3##(1996-12#2)
or = 8##2##3##(1992-9#1)(2008-7#1)
or =##68##2##(1992-11#1)(1992-12#1)(1992-9#2)(1993-1#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#4)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-5#7)(2011-2#7)(2012-3#2)
or =1##3##2##(2008-10#2)(2011-2#1)
or =10##2##2##(2008-10#1)(2010-3#1)
or =150 ms in the ischaemic group##2##7##(2008-10#2)
or =150 ms##3##3##(2008-10#3)
or =2##2##2##(2008-10#1)(2011-2#1)
or =25 Kg/m2)##2##3##(2008-10#2)
or =25##5##2##(2008-10#3)(2011-2#2)
or =3##2##2##(2008-10#2)
or =4##2##2##(2008-10#1)(2011-2#1)
or =6##3##2##(2008-10#3)
or A23187##3##2##(1991-5#1)(1994-3#1)(2008-11#1)
or ACBP##2##2##(1994-8#2)
or AIDS##6##2##(1992-1#1)(1992-2#1)(1995-6#2)(2008-5#2)
or APLP2 mRNA##2##3##(1996-12#2)
or Asian##2##2##(2008-12#1)(2010-11#1)
or B##5##2##(1993-11#1)(2008-10#3)(2008-9#1)
or BuONa##2##2##(1993-8#2)
or C##9##2##(2008-10#6)(2008-5#1)(2009-8#1)(2013-8#1)
or C-terminal##4##2##(1996-12#1)(1996-6#1)(2008-9#1)(2011-2#1)
or C6##2##2##(1992-6#1)(2012-2#1)
or CHO-CHO##2##2##(2013-1#2)
or CI##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
or CS from the patient perspective is needed##2##8##(2013-1#2)
or CS##3##2##(2008-10#1)(2013-1#2)
or Ca(2+)##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
or Ca2+##2##2##(1990-5#1)(1994-6#1)
or CaCl(2)##2##2##(2008-10#2)
or Crohn's disease##2##3##(1991-8#1)(2009-12#1)
or D##7##2##(1994-2#1)(1995-8#1)(2008-10#1)(2009-8#1)(2010-7#3)
or DNA constituents##2##3##(2008-10#2)
or DNA sequence##2##3##(2008-10#1)(2008-9#1)
or DNA##17##2##(1992-3#1)(1994-8#1)(1996-2#1)(1997-6#2)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#3)(2008-9#1)
or E##4##2##(2008-10#4)
or EGF##2##2##(1990-8#1)(1995-8#1)
or Escherichia coli##2##3##(2008-10#1)(2008-7#1)
or F##4##2##(1997-2#1)(2008-10#3)
or G##7##2##(1990-12#1)(1992-3#2)(1993-9#1)(2008-10#2)(2013-8#1)
or GTP gamma S##2##4##(1991-6#1)(1992-8#1)
or H##2##2##(1995-5#1)(2011-2#1)
or HAP##3##2##(2008-9#3)
or HIV##3##2##(1997-3#1)(2008-12#1)(2009-5#1)
or HLA##2##2##(2008-4#1)(2011-2#1)
or HNO(3)##6##2##(2008-10#6)
or II##5##2##(2008-11#1)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
or III##2##2##(2007-12#1)(2008-9#1)
or IL-10##2##2##(1996-12#2)
or IgM##2##2##(1991-11#1)(1996-12#1)
or LPS##2##2##(1995-12#1)(2008-11#1)
or LS-CMV##2##2##(2008-10#2)
or M##5##2##(2008-10#5)
or MG##2##2##(2007-12#1)(2008-10#1)
or MRP##2##2##(2008-11#2)
or MY(2-)) species are##2##4##(2008-10#2)
or Mg2+##2##2##(1995-6#1)(1997-3#1)
or Middle##2##2##(2008-10#2)
or N##4##2##(1992-3#1)(2008-10#2)(2008-7#1)
or P##8##2##(1995-11#1)(2008-10#4)(2011-3#2)(2012-12#1)
or PB-induced##2##2##(1994-8#2)
or PCR##2##2##(1994-1#1)(2008-4#1)
or PS##2##2##(1993-11#1)(2008-10#1)
or Pt##2##2##(2008-10#1)(2008-11#1)
or Pyricularia grisea##2##3##(2008-10#1)(2008-9#1)
or S##3##2##(2008-10#3)
or SA##2##2##(2008-10#2)
or SigmaFe##2##2##(2008-10#2)
or Sitisi##2##2##(2008-1#2)
or Swingle citrumelo##2##3##(2008-10#2)
or T cell##2##3##(2008-4#1)(2008-5#1)
or T##6##2##(1993-8#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
or T3##2##2##(1993-8#1)(2008-10#1)
or T4##3##2##(1992-5#1)(1997-3#1)(2008-10#1)
or Tris##3##2##(2008-10#3)
or UTR (for##2##3##(2008-10#2)
or UV irradiation##2##3##(2008-5#2)
or UV##3##2##(1994-8#1)(2008-5#2)
or V##3##2##(2008-10#1)(2009-6#1)(2012-3#1)
or W##3##2##(2008-10#2)(2010-5#1)
or a combination of both##2##5##(2010-7#1)(2011-1#1)
or a combination of##10##4##(1992-3#1)(2008-10#1)(2008-3#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)
or a control group##2##4##(2008-12#1)(2009-12#1)
or a control##5##3##(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2012-3#1)
or a conventional##2##3##(2008-10#2)
or a different##2##3##(2008-4#1)(2011-2#1)
or a large##2##3##(2008-9#1)(2013-8#1)
or a mixture of##2##4##(2008-10#1)(2008-7#1)
or a nuclear##2##3##(1995-2#1)(2008-10#1)
or a part of the##2##5##(2008-10#1)(2008-7#1)
or a separate##2##3##(1995-6#1)(1996-3#1)
or a##156##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-6#3)(1995-2#3)(1995-3#1)(1995-6#2)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-5#1)(2007-8#1)(2008-10#44)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#1)(2012-3#3)(2012-9#1)(2013-1#2)(2013-8#5)
or abdominal##5##2##(1990-5#1)(1997-8#1)(2009-8#1)(2010-3#1)(2011-2#1)
or above##4##2##(2008-10#3)(2008-7#1)
or absence of the##10##4##(1991-5#1)(1995-11#1)(1995-8#1)(2008-10#6)(2008-5#1)
or absence of##57##3##(1990-5#1)(1991-11#1)(1991-5#2)(1992-1#1)(1993-3#3)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#26)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#4)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
or absence##60##2##(1990-5#1)(1991-11#1)(1991-5#2)(1992-1#1)(1993-3#3)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#26)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#4)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
or absent##5##2##(1991-11#1)(1993-9#1)(1995-5#1)(2008-12#1)(2013-1#1)
or absorbing##2##2##(2008-3#1)(2011-2#1)
or absorption##2##2##(2008-3#1)(2008-7#1)
or accessory##2##2##(2008-10#1)(2013-1#1)
or accidental##3##2##(1994-3#1)(2008-10#1)(2010-3#1)
or accumulation##2##2##(2008-10#1)(2008-11#1)
or accuracy##2##2##(2008-10#1)(2008-7#1)
or acid digested##2##3##(2008-10#2)
or acid##4##2##(2008-10#3)(2008-9#1)
or acquired##2##2##(1991-6#1)(2008-11#1)
or act##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
or activated##2##2##(1994-11#1)(2008-10#1)
or activation of the##2##4##(2008-10#1)(2012-2#1)
or activation of##4##3##(1997-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
or activation##6##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
or active##3##2##(1991-1#1)(2008-10#1)(2012-3#1)
or activity##3##2##(1993-8#1)(1994-5#1)(2012-2#1)
or actual##2##2##(1996-8#1)(2008-12#1)
or acute##3##2##(1992-9#1)(2010-12#1)(2012-2#1)
or additional##2##2##(2008-10#1)(2008-8#1)
or adipose##2##2##(2009-10#1)(2012-5#1)
or admitted to##2##3##(1995-2#1)(2008-11#1)
or adult##5##2##(1997-3#1)(2008-10#2)(2008-11#1)(2013-7#1)
or adults##2##2##(2008-10#2)
or adverse##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
or aerobic##2##2##(2008-5#1)(2013-1#1)
or affinity##2##2##(2008-4#1)(2008-6#1)
or after a##5##3##(1994-3#1)(1994-8#1)(1997-2#1)(2012-12#2)
or after the##3##3##(1991-3#1)(1994-9#1)(2013-1#1)
or after##35##2##(1990-6#1)(1991-11#1)(1991-3#1)(1992-5#2)(1993-1#1)(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-2#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-12#3)(2013-1#2)(2013-8#1)
or against##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
or age##4##2##(1991-2#1)(2008-8#1)(2011-2#1)(2013-8#1)
or age-related##2##2##(2008-10#1)(2008-6#1)
or aggregate##2##2##(2008-10#2)
or aggregates##3##2##(2008-10#2)(2008-11#1)
or alcohol##5##2##(1992-12#1)(1995-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
or alcoholism##2##2##(1991-12#1)(1993-2#1)
or aldehyde##4##2##(1994-8#1)(2010-7#3)
or alkaline phosphatase##2##3##(2008-10#1)(2008-4#1)
or alkaline##5##2##(2008-10#4)(2008-4#1)
or all of##3##3##(2007-12#1)(2008-10#2)
or all three##2##3##(1992-3#1)(2008-10#1)
or all##10##2##(1990-12#1)(1992-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-9#1)
or all-cause mortality##2##3##(2010-1#1)(2010-2#1)
or allergic##2##2##(2008-7#1)(2010-6#1)
or allograft##2##2##(2008-5#1)(2010-7#1)
or along##2##2##(1995-8#1)(2008-9#1)
or alpha##2##2##(1995-11#1)(2010-7#1)
or altered##3##2##(1992-9#1)(2012-3#1)(2013-1#1)
or alternative##5##2##(1992-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
or alternatively##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
or amino##2##2##(2008-9#1)(2013-1#1)
or ammonia##2##2##(2008-10#1)(2008-11#1)
or among##5##2##(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)
or amperometric##3##2##(2008-10#3)
or amphetamine (1##2##3##(1994-2#2)
or amygdala##5##2##(1993-6#5)
or an adjacent##2##3##(1990-5#1)(1997-7#1)
or an increase in##2##4##(2009-12#1)(2012-3#1)
or an increase##3##3##(2009-12#1)(2012-3#1)(2012-5#1)
or an integrated##2##3##(1996-1#1)(2008-12#1)
or an##36##2##(1990-5#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-1#1)(1994-11#2)(1994-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-12#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-3#2)(2012-5#1)
or angiotensin II##3##3##(1996-2#1)(1996-6#1)(2008-11#1)
or angle##2##2##(2008-3#1)(2011-2#1)
or animal##2##2##(2008-11#2)
or another##6##2##(1991-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
or antibody##2##2##(1994-6#1)(2008-9#1)
or antigen##5##2##(1990-8#1)(2008-11#1)(2011-2#2)(2012-2#1)
or any combination of##2##4##(1991-8#1)(1992-12#1)
or any other##2##3##(2008-10#1)(2008-7#1)
or any##7##2##(1991-8#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
or apoptosis##2##2##(1995-2#1)(2008-11#1)
or apple##3##2##(2008-10#3)
or applied##2##2##(2008-10#2)
or approaches##2##2##(2008-10#1)(2010-12#1)
or approximately##2##2##(1996-3#1)(2008-10#1)
or aqueous##4##2##(2008-10#4)
or are##17##2##(1991-1#3)(1991-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)
or area##3##2##(1994-9#1)(2011-2#1)(2012-2#1)
or artery##2##2##(1996-3#1)(2008-7#1)
or arthrodesis##2##2##(2008-8#1)(2011-2#1)
or artificial##3##2##(2008-10#2)(2008-11#1)
or as a##12##3##(1991-12#1)(1994-9#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)(2011-2#1)(2013-8#1)
or as an##4##3##(1996-11#1)(2008-10#2)(2008-7#1)
or as part of##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
or as##41##2##(1991-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-2#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#2)
or associated with other##2##4##(1993-6#1)(2011-2#1)
or associated with##4##3##(1993-6#1)(2008-5#1)(2008-9#1)(2011-2#1)
or at a##5##3##(1990-9#1)(1993-9#1)(1994-6#1)(1997-2#1)(2008-10#1)
or at least##8##3##(1993-3#1)(1993-6#1)(2008-10#2)(2008-2#1)(2008-7#2)(2012-5#1)
or at risk for##2##4##(2008-11#1)(2012-12#1)
or at the##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
or at worst##2##3##(2008-11#1)(2011-2#1)
or at##39##2##(1990-9#1)(1991-3#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-1#2)
or atomic##3##2##(2008-10#3)
or atopy##2##2##(2010-6#2)
or atrophy##2##2##(2008-10#1)(2012-2#1)
or automatic##2##2##(2008-11#1)(2008-8#1)
or average##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
or avirulent##2##2##(2008-10#2)
or bad##2##2##(1997-4#1)(2008-11#1)
or baseline##2##2##(2010-12#1)(2013-8#1)
or basic##2##2##(1991-12#1)(2008-10#1)
or be##6##2##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#1)
or because they##3##3##(2008-10#1)(2008-4#1)(2010-7#1)
or before##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
or behaviors##2##2##(1996-9#1)(2013-1#1)
or being##5##2##(1991-8#1)(1997-8#1)(2012-12#2)(2012-2#1)
or below the##2##3##(2008-10#1)(2008-3#1)
or below##4##2##(2008-10#3)(2008-3#1)
or benign##5##2##(1990-3#1)(1990-6#1)(1990-8#1)(1992-2#1)(1993-1#1)
or beta##2##2##(2008-11#1)(2008-8#1)
or better than those##2##4##(2008-10#2)
or better than##6##3##(1996-3#1)(2008-10#3)(2008-9#2)
or better##15##2##(1991-3#1)(1996-3#1)(2008-10#7)(2008-11#1)(2008-9#2)(2009-3#1)(2010-7#1)(2013-7#1)
or between the##2##3##(2008-10#1)(2009-10#1)
or between##11##2##(1997-9#1)(2008-10#6)(2009-10#1)(2009-7#1)(2011-1#1)(2012-2#1)
or bilateral##5##2##(1990-5#1)(1993-1#1)(2008-12#1)(2011-2#2)
or biological##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-7#1)
or biopsy##2##2##(2012-2#1)(2013-1#1)
or black##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
or bladder##2##2##(1992-3#1)(2008-10#1)
or block##2##2##(1990-5#1)(2008-12#1)
or blood##4##2##(1997-3#1)(2008-11#1)(2011-3#1)(2013-1#1)
or blue##2##2##(1990-12#1)(2008-11#1)
or bone marrow##2##3##(1990-3#1)(2008-9#1)
or bone##6##2##(1990-3#1)(2008-12#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
or both and##2##3##(2008-10#2)
or both fungicides##2##3##(2008-10#2)
or both in##2##3##(2008-10#2)
or both the##2##3##(2010-8#1)(2013-8#1)
or both##58##2##(1991-2#2)(1991-3#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#24)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
or both?##4##2##(1995-8#1)(2011-2#1)(2013-1#2)
or bound##4##2##(2008-10#4)
or bovine##3##2##(2008-11#2)(2008-7#1)
or brain##3##2##(1993-1#1)(1997-9#1)(2011-2#1)
or breeding##2##2##(2008-8#2)
or bulbous nose##2##3##(1990-9#1)(1997-3#1)
or by a##8##3##(1990-12#1)(2008-10#3)(2008-7#2)(2008-9#1)(2010-4#1)
or by culture##2##3##(2008-11#1)(2008-5#1)
or by increasing##2##3##(1995-12#1)(2008-10#1)
or by manipulating##2##3##(2008-11#1)(2009-12#1)
or by other##2##3##(2008-11#1)(2012-2#1)
or by the##12##3##(1991-8#1)(1992-1#1)(1994-6#1)(1996-3#1)(2008-10#5)(2008-9#1)(2011-2#1)(2012-3#1)
or by treatment with##2##4##(2008-9#1)(2012-2#1)
or by use of##2##4##(2008-10#1)(2008-3#1)
or by##121##2##(1990-10#1)(1990-12#2)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#37)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#8)(2008-7#2)(2008-8#1)(2008-9#6)(2009-12#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
or cadmium##2##2##(2008-10#2)
or calcium ionophore##2##3##(1990-12#1)(2008-11#1)
or calcium##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
or calcium-channel blockers##2##3##(2009-6#2)
or calvaria##2##2##(2008-11#2)
or can be##2##3##(2008-10#2)
or can##3##2##(2008-10#2)(2008-8#1)
or cancer##3##2##(2009-12#1)(2011-2#1)(2012-3#1)
or cannot##2##2##(1993-3#1)(2008-8#1)
or captopril##2##2##(1992-11#1)(1996-2#1)
or carbohydrates##2##2##(1996-12#1)(2008-7#1)
or catalyst##2##2##(2008-10#2)
or cause##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
or cell##9##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2011-2#1)
or cells##5##2##(1993-6#2)(2008-11#1)(2008-7#1)(2013-8#1)
or central nervous##2##3##(2008-9#1)(2011-2#1)
or central##4##2##(1993-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
or cerebral##4##2##(1994-2#1)(1995-5#1)(2008-7#1)(2012-12#1)
or cerebrospinal fluid##2##3##(2008-10#1)(2011-2#1)
or certain##3##2##(1994-1#1)(2012-2#1)(2013-1#1)
or cervical##2##2##(2008-12#1)(2009-2#1)
or cervicitis##2##2##(2011-2#2)
or change##3##2##(1997-1#1)(2008-6#1)(2013-8#1)
or changed##2##2##(2008-11#1)(2012-3#1)
or changes in##2##3##(2008-5#2)
or changing##2##2##(1997-7#1)(2008-9#1)
or chemical##8##2##(1993-8#1)(1994-8#1)(2008-10#1)(2008-5#1)(2009-12#2)(2011-2#1)(2013-8#1)
or chemicals##2##2##(1994-3#1)(2008-11#1)
or child##3##2##(1997-6#1)(2008-11#1)(2010-7#1)
or chlortetracycline##3##2##(2008-10#3)
or cholesterol##2##2##(1991-5#1)(2008-10#1)
or chromatographic##2##2##(2008-10#2)
or chronic##16##2##(1991-3#1)(1993-3#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
or class##2##2##(1995-5#1)(2008-10#1)
or classic##2##2##(2008-8#1)(2010-2#1)
or clear##2##2##(2008-11#1)(2008-5#1)
or clinic##3##2##(2009-5#2)(2011-2#1)
or clinical##9##2##(1994-12#1)(1995-1#1)(1995-11#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-4#1)(2012-12#2)
or clinically##3##2##(2008-7#1)(2011-2#2)
or close to the##3##4##(1996-8#1)(2008-1#1)(2008-3#1)
or close to##4##3##(1992-6#1)(1996-8#1)(2008-1#1)(2008-3#1)
or close##8##2##(1992-6#1)(1995-2#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
or closed circuit anaesthesia##2##4##(2011-2#2)
or closed##3##2##(2008-10#1)(2011-2#2)
or closely linked##2##3##(2008-10#2)
or closely##3##2##(2008-10#2)(2008-4#1)
or coding##2##2##(2011-2#1)(2013-1#1)
or cognitive##2##2##(2008-4#1)(2012-3#1)
or colon##2##2##(2008-1#1)(2009-4#1)
or colonic##2##2##(1990-6#1)(2012-2#1)
or column##2##2##(2008-10#1)(2008-4#1)
or combination of##2##3##(1992-3#1)(2011-2#1)
or combination##4##2##(1992-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
or combinations of##2##3##(2008-5#1)(2013-8#1)
or combined with##3##3##(2007-11#1)(2011-2#2)
or combined##11##2##(1993-8#1)(2007-11#1)(2008-10#2)(2008-9#1)(2011-2#4)(2013-1#2)
or commercial##2##2##(1995-9#1)(2008-10#1)
or common##5##2##(1994-3#1)(2008-10#1)(2012-2#2)(2013-8#1)
or comparison##2##2##(2008-12#1)(2013-8#1)
or complete##9##2##(1990-6#1)(1990-9#1)(1991-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
or completely##4##2##(1991-12#1)(1993-8#1)(2008-7#1)(2012-3#1)
or complex##3##2##(2008-10#2)(2008-11#1)
or complication##2##2##(1995-1#1)(2013-1#1)
or complications##2##2##(1995-8#1)(2008-7#1)
or composition##2##2##(2008-9#1)(2012-3#1)
or computed tomography##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
or concomitant##2##2##(2008-7#1)(2012-2#1)
or content##2##2##(2008-9#1)(2009-7#1)
or continuous##6##2##(1990-3#1)(2008-10#3)(2008-11#1)(2011-1#1)
or control animals in##2##4##(1992-1#2)
or control##13##2##(1992-1#2)(1993-1#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
or conventional##2##2##(2011-2#1)(2012-12#1)
or copper##2##2##(2008-10#1)(2011-2#1)
or cord blood##2##3##(2008-10#1)(2008-4#1)
or cortisol##3##2##(1990-11#1)(2008-6#1)(2013-1#1)
or cost##2##2##(1992-12#2)
or cotton##2##2##(2008-10#1)(2011-2#1)
or could not##2##3##(1994-1#1)(2008-7#1)
or could##4##2##(1991-12#1)(1994-1#1)(2008-10#1)(2008-7#1)
or covalent grafting##2##3##(2008-10#2)
or create##2##2##(1990-2#1)(2008-12#1)
or creation of##2##3##(2008-10#2)
or critical##2##2##(2008-10#1)(2008-5#1)
or cultivars##2##2##(2008-10#2)
or culture##2##2##(2008-10#2)
or cyclic##2##2##(2008-10#1)(2010-4#1)
or cytokine##2##2##(1994-5#1)(1995-2#1)
or cytotoxic##2##2##(1990-12#1)(1995-5#1)
or dairy##2##2##(2013-1#2)
or damaged##4##2##(1992-9#1)(1997-1#1)(2008-10#1)(2008-8#1)
or data##2##2##(1990-11#1)(2011-2#1)
or death in##2##3##(2009-6#1)(2011-2#1)
or death##12##2##(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#3)(2010-1#1)(2011-1#1)(2011-2#2)(2013-8#1)
or decrease in##4##3##(1990-5#1)(1992-8#1)(2008-10#1)(2008-12#1)
or decrease##11##2##(1990-5#1)(1990-9#1)(1991-6#1)(1992-8#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-3#2)
or decreased in##2##3##(1997-7#1)(2008-11#1)
or decreased##11##2##(1991-9#1)(1994-8#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
or decreasing##2##2##(2008-8#1)(2011-2#1)
or deficient##3##2##(1994-5#1)(2008-9#1)(2012-2#1)
or degenerative##2##2##(2009-3#1)(2013-1#1)
or dehydration##2##2##(2008-10#1)(2010-7#1)
or delay##3##2##(2008-5#1)(2010-10#2)
or deleted in##2##3##(1997-7#1)(2011-2#1)
or deleted##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
or deletion of##2##3##(1997-3#2)
or deletion##4##2##(1997-3#2)(2008-10#1)(2008-9#1)
or deliberate##2##2##(1992-3#1)(2008-7#1)
or density##2##2##(1993-6#1)(2008-9#1)
or depressed##3##2##(2008-12#1)(2009-7#2)
or depression##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
or derivatization##2##2##(2008-10#2)
or desiccation##2##2##(2008-10#1)(2008-8#1)
or detection of##2##3##(2008-11#1)(2012-2#1)
or detection##4##2##(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#1)
or determine##2##2##(1996-6#1)(2008-4#1)
or development##3##2##(2008-3#1)(2008-7#2)
or device failures##2##3##(2011-1#1)(2011-2#1)
or device##3##2##(1997-2#1)(2011-1#1)(2011-2#1)
or dew##2##2##(2008-10#2)
or dexamethasone##2##2##(2008-10#2)
or dibutyryl##2##2##(1991-3#1)(1995-11#1)
or did not##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
or different##6##2##(2008-10#3)(2008-12#1)(2008-8#1)(2012-6#1)
or differential##2##2##(2008-3#1)(2008-7#1)
or differentiation##2##2##(1997-7#1)(2010-12#1)
or diffuse##2##2##(2008-10#1)(2008-12#1)
or digoxigenin##2##2##(2008-10#2)
or diluted##3##2##(2008-10#3)
or direct##4##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
or directly##4##2##(2008-10#2)(2008-3#1)(2008-4#1)
or disability##4##2##(1991-11#1)(1992-2#1)(1995-1#1)(2012-3#1)
or disabling conditions##2##3##(1997-2#2)
or disease of##2##3##(2008-7#1)(2008-9#1)
or disease##10##2##(1997-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#2)
or dissection##2##2##(2008-4#1)(2011-2#1)
or distant metastases##3##3##(1990-6#1)(1997-8#1)(2008-2#1)
or distant##4##2##(1990-6#1)(1993-1#1)(1997-8#1)(2008-2#1)
or distilled##2##2##(1994-9#1)(2013-1#1)
or distortion of##2##3##(2008-11#1)(2010-10#1)
or does not##3##3##(1991-2#1)(2008-10#1)(2010-10#1)
or donor##2##2##(1993-6#1)(2008-11#1)
or dorsal caudate-putamen##2##3##(1993-6#2)
or downstream of##2##3##(1992-3#1)(1996-12#1)
or downstream##4##2##(1992-3#1)(1996-12#1)(2008-8#1)(2012-2#1)
or dramatic##2##2##(2008-10#2)
or drug##4##2##(1992-12#1)(2008-11#1)(2009-5#1)(2011-2#1)
or drug-induced##2##2##(1992-2#1)(2008-9#1)
or drugs##3##2##(1992-9#2)(2008-4#1)
or dry##2##2##(2007-11#1)(2008-10#1)
or due to##5##3##(1994-3#1)(2008-10#1)(2011-2#1)(2013-1#2)
or durations of##2##3##(2008-10#1)(2010-6#1)
or during the##2##3##(1992-3#1)(2008-7#1)
or during##12##2##(1990-8#2)(1992-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
or dynamic##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
or dysfunction##2##2##(2008-5#1)(2008-9#1)
or each##2##2##(2008-10#1)(2008-8#1)
or early##5##2##(1992-5#1)(1993-2#1)(1994-2#1)(2008-9#1)(2011-1#1)
or economic##2##2##(1997-1#1)(2012-2#1)
or effect##2##2##(2008-7#1)(2008-9#1)
or egg##3##2##(2008-10#1)(2008-11#2)
or electrical##3##2##(1992-3#1)(1996-6#1)(2008-10#1)
or electrothermal##2##2##(2008-10#2)
or elevated##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
or eliminate the##2##3##(1992-2#1)(2010-7#1)
or eliminate##3##2##(1992-2#1)(1997-7#1)(2010-7#1)
or eliminated##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
or elimination of##2##3##(1992-5#1)(2008-5#1)
or emotional##3##2##(1990-11#1)(2009-6#1)(2012-2#1)
or employment##2##2##(2011-2#1)(2012-12#1)
or endocrine##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
or endovascular##3##2##(1995-11#1)(2008-7#1)(2011-3#1)
or enhance##2##2##(1996-12#1)(2008-10#1)
or enhanced##2##2##(1997-3#1)(2008-11#1)
or enhancing##2##2##(1994-5#1)(2008-11#1)
or environmental##6##2##(1992-12#1)(1993-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
or environments##2##2##(2008-11#1)(2010-4#1)
or enzymatic##4##2##(2008-10#1)(2008-9#2)(2010-7#1)
or enzyme##3##2##(1992-6#1)(2008-10#2)
or epidermal growth factor##2##4##(1993-1#1)(1995-8#1)
or equal to 10##2##4##(1991-8#1)(2012-3#1)
or equal to 5##2##4##(1992-5#1)(2012-3#1)
or equal to##27##3##(1990-11#2)(1990-12#3)(1990-3#1)(1990-6#1)(1991-6#1)(1991-8#4)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(2008-10#3)(2008-5#3)(2008-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
or ester linkage to##2##4##(2008-10#2)
or estimated##2##2##(1997-4#1)(2008-10#1)
or ethanol##2##2##(1993-8#1)(2008-12#1)
or ethyl##2##2##(2008-10#1)(2008-11#1)
or even a##2##3##(2008-10#1)(2012-12#1)
or even harmful##2##3##(2009-11#1)(2013-1#1)
or even in##2##3##(2008-10#1)(2008-11#1)
or even slightly##2##3##(2008-1#1)(2008-10#1)
or even the##2##3##(2008-10#1)(2011-2#1)
or even to##4##3##(1994-3#1)(2008-11#1)(2008-5#1)(2008-8#1)
or even whole##2##3##(2008-11#1)(2009-10#1)
or even years##2##3##(2008-7#1)(2011-2#1)
or even##62##2##(1991-12#1)(1991-8#1)(1994-12#1)(1994-3#2)(1996-1#1)(1996-12#2)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#7)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
or exaggerated##2##2##(1996-11#1)(2008-9#1)
or excessive##2##2##(2008-10#1)(2008-7#1)
or exclusively##2##2##(1997-3#1)(2008-10#1)
or exocytosis##2##2##(2008-10#1)(2009-6#1)
or expensive##2##2##(1992-12#1)(2008-7#1)
or experimental##2##2##(2008-11#1)(2013-1#1)
or exposed to##2##3##(2008-10#2)
or exposure##2##2##(2008-10#1)(2008-9#1)
or external##2##2##(1992-3#1)(2008-7#1)
or extinction##2##2##(1992-12#1)(2008-9#1)
or extracorporeal##2##2##(1991-3#1)(2011-2#1)
or extramedullary##2##2##(2012-12#1)(2012-3#1)
or extrinsic##2##2##(1990-5#1)(2011-2#1)
or factors##2##2##(2009-5#1)(2010-11#1)
or fail##2##2##(2010-11#1)(2011-1#1)
or failed##2##2##(2008-11#1)(2012-2#1)
or failure of##3##3##(2008-10#2)(2011-2#1)
or failure##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
or family##4##2##(2008-7#1)(2009-9#1)(2010-6#1)(2013-1#1)
or fat##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
or feed##2##2##(2008-10#1)(2008-7#1)
or female##13##2##(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#8)
or fetal##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
or fibrillar##2##2##(2007-12#1)(2008-10#1)
or fibroblasts##2##2##(1990-6#1)(1995-12#1)
or field##2##2##(2008-10#1)(2008-8#1)
or find##2##2##(1996-5#1)(2010-12#1)
or first##2##2##(2008-1#1)(2008-6#1)
or five##5##2##(1991-3#1)(1992-3#1)(2008-10#3)
or fixation##2##2##(2013-1#2)
or fixed##2##2##(2008-10#1)(2008-4#1)
or fluorescent##3##2##(1997-3#1)(2008-10#1)(2008-9#1)
or focal##2##2##(2008-7#1)(2012-2#1)
or following##5##2##(1994-5#1)(2008-10#3)(2008-11#1)
or food samples##2##3##(2008-10#1)(2008-11#1)
or food##8##2##(1993-12#2)(1994-3#1)(2008-10#2)(2008-11#1)(2009-7#1)(2012-2#1)
or for a##2##3##(1996-2#1)(2011-2#1)
or for the##4##3##(1996-2#1)(2008-10#3)
or for their##2##3##(1990-6#1)(2008-10#1)
or for those##3##3##(2008-10#3)
or for whom##2##3##(1992-3#1)(2012-3#1)
or for##39##2##(1990-2#1)(1990-5#1)(1990-6#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-2#2)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
or forskolin##2##2##(1995-8#1)(1997-1#1)
or four##6##2##(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)
or free##2##2##(1993-6#1)(2008-3#1)
or frequency of##2##3##(2008-10#1)(2010-12#1)
or frequent##2##2##(1993-3#1)(2008-9#1)
or from a##5##3##(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-11#1)
or from both sources##2##4##(1994-5#2)
or from construction##2##3##(1992-2#1)(1994-3#1)
or from the##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
or from##33##2##(1991-12#1)(1992-12#2)(1992-2#1)(1993-12#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-4#1)(2008-9#2)(2009-11#1)(2011-2#1)
or fructose##2##2##(1992-12#1)(1994-8#1)
or full##2##2##(1991-1#1)(1995-2#1)
or fully##5##2##(1995-9#1)(2008-10#2)(2011-3#1)(2012-12#1)
or function as##2##3##(1992-6#1)(2012-2#1)
or function##6##2##(1991-5#1)(1992-6#1)(1994-11#1)(1997-3#1)(2012-2#1)(2013-1#1)
or functional##6##2##(1990-11#1)(2008-10#1)(2008-4#2)(2013-8#2)
or fused##3##2##(1995-5#1)(1996-12#1)(2008-8#1)
or gain of##2##3##(2008-10#1)(2008-4#1)
or gamma##3##2##(1990-5#1)(1995-11#1)(1997-1#1)
or gas##3##2##(1990-8#1)(2008-11#1)(2010-6#1)
or gastric##4##2##(1990-8#1)(1994-8#1)(2008-11#2)
or gender##2##2##(2008-11#1)(2010-11#1)
or gene##7##2##(2008-10#1)(2008-11#3)(2008-4#1)(2010-12#1)(2012-3#1)
or general anesthesia##2##3##(1993-1#1)(2008-4#1)
or general##7##2##(1991-3#1)(1993-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
or generic##2##2##(2008-5#1)(2013-1#1)
or genes##6##2##(1995-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
or genetic##3##2##(2008-4#1)(2009-10#1)(2009-8#1)
or genetically##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
or genomic DNA##2##3##(1991-7#1)(2008-2#1)
or geographic##2##2##(2008-10#2)
or glucagon##2##2##(1994-11#1)(1997-2#1)
or glucose##4##2##(2008-10#1)(2008-9#1)(2010-11#2)
or glutamine##2##2##(2008-11#2)
or glutathione##2##2##(2008-10#2)
or gold##2##2##(2008-10#2)
or good##4##2##(1991-3#1)(1991-8#1)(1997-6#1)(2012-3#1)
or government##2##2##(1992-3#1)(2010-12#1)
or grade##2##2##(2008-12#1)(2011-2#1)
or grass##3##2##(2008-10#3)
or greater than##10##3##(1990-12#1)(1991-2#1)(1995-12#1)(1997-4#3)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
or greater##29##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-2#1)(1994-3#1)(1994-5#2)(1995-12#1)(1996-1#1)(1997-4#3)(2008-10#8)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#3)(2011-2#1)(2013-1#1)
or green##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
or greenhouse##2##2##(2008-10#2)
or group##3##2##(2008-10#1)(2009-3#1)(2010-4#1)
or groups of##2##3##(1990-5#1)(2011-2#1)
or growth##6##2##(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
or had a##2##3##(2008-11#1)(2011-1#1)
or had to##2##3##(2011-3#1)(2013-1#1)
or had##13##2##(1991-9#1)(1992-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#2)
or hair##3##2##(2008-10#2)(2008-7#1)
or harmful##3##2##(1993-11#1)(2009-11#1)(2011-2#1)
or has##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
or have a##3##3##(2008-10#2)(2008-12#1)
or have evidence of##2##4##(1995-3#1)(2006-5#1)
or have only##2##3##(2010-11#1)(2011-2#1)
or have##12##2##(1995-3#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#1)
or having##3##2##(1991-12#1)(1995-6#1)(2010-8#1)
or hazardous##2##2##(1992-1#1)(2008-10#1)
or head##2##2##(2008-11#2)
or healthy##3##2##(1994-9#1)(1996-2#1)(2008-10#1)
or heart##2##2##(1993-1#1)(1997-2#1)
or heterodimers##2##2##(1996-2#1)(2008-11#1)
or high insertion##2##3##(2013-1#2)
or high##26##2##(1993-1#1)(1994-5#1)(1996-12#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-7#2)(2008-9#1)(2010-11#1)(2010-9#1)(2012-3#1)(2012-9#2)(2013-1#5)
or higher than##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
or higher##19##2##(1990-12#1)(1994-5#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-8#1)(2009-7#1)(2011-1#2)(2013-1#1)
or higher)##2##2##(2008-5#1)(2012-2#1)
or highly resistant to##2##4##(2008-10#1)(2011-2#1)
or highly##3##2##(2008-10#2)(2011-2#1)
or hippocampal##2##2##(1993-3#1)(1995-11#1)
or hippocampus of##2##3##(1996-12#1)(2012-2#1)
or hospital##5##2##(1992-2#1)(2008-11#3)(2009-5#1)
or hospitalization##3##2##(1995-2#1)(2008-11#1)(2012-12#1)
or hospitals##2##2##(2007-9#1)(2009-10#1)
or host##6##2##(1990-11#1)(2008-10#5)
or how##4##2##(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
or human serum##2##3##(1995-12#1)(2008-10#1)
or human##15##2##(1992-3#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-8#1)(2013-1#2)
or humans##2##2##(1991-12#1)(2008-7#1)
or hybrid##2##2##(2008-3#1)(2009-10#1)
or hydrogen peroxide##2##3##(1992-12#1)(2008-10#1)
or hydrophobic interactions##2##3##(1990-5#1)(1996-12#1)
or hydrophobic##5##2##(1990-5#1)(1996-12#1)(2008-10#2)(2013-1#1)
or hydroxyl##2##2##(2008-10#1)(2011-2#1)
or i##3##2##(1992-12#1)(1992-3#1)(1996-12#1)
or i-propanol##2##2##(2008-10#2)
or identify##2##2##(2008-11#1)(2011-1#1)
or if all##2##3##(2008-9#2)
or if it##2##3##(2008-2#1)(2008-4#1)
or if they##2##3##(1992-3#1)(2009-4#1)
or if##13##2##(1991-6#1)(1992-3#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2011-2#1)(2013-8#1)
or ignored##2##2##(1996-12#1)(2008-10#1)
or imaging##2##2##(2008-3#1)(2012-3#1)
or imidazole##2##2##(1992-6#1)(2012-12#1)
or immigration##2##2##(2008-10#2)
or immobilized##3##2##(2008-10#2)(2008-11#1)
or immune##2##2##(1995-5#1)(2011-2#1)
or immunological##2##2##(2008-10#1)(2011-2#1)
or impairment##2##2##(1995-2#1)(2012-12#1)
or impossible to##3##3##(1997-8#1)(2008-11#1)(2008-8#1)
or impossible##4##2##(1996-2#1)(1997-8#1)(2008-11#1)(2008-8#1)
or improved in##3##3##(1994-9#1)(2008-10#1)(2012-3#1)
or improved##5##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
or improvement##2##2##(1996-11#1)(2011-2#1)
or improving the##2##3##(1991-7#1)(2008-10#1)
or improving##3##2##(1991-7#1)(1995-12#1)(2008-10#1)
or impurities##3##2##(2008-10#2)(2012-2#1)
or in a mixture##2##4##(2008-10#2)
or in a##9##3##(1991-3#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-8#1)(2013-1#1)
or in any##2##3##(1996-1#1)(2008-10#1)
or in association with##3##4##(2010-3#1)(2011-2#1)(2013-1#1)
or in association##5##3##(1990-9#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
or in close##2##3##(1996-12#1)(2010-7#1)
or in combination##17##3##(1993-6#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
or in mixtures##2##3##(2008-10#1)(2012-7#1)
or in pairs##2##3##(1997-3#1)(2008-8#1)
or in situ##3##3##(2008-10#2)(2011-2#1)
or in the form of##2##5##(2008-8#1)(2013-1#1)
or in the presence of##7##5##(1990-2#1)(1993-8#2)(1995-8#1)(1996-2#1)(2008-10#2)
or in the##38##3##(1990-2#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-8#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
or in those##5##3##(1993-2#1)(1995-12#1)(1995-5#1)(2008-7#1)(2011-2#1)
or in vitro##7##3##(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-4#2)(2008-9#1)
or in which##2##3##(1994-8#1)(2008-3#1)
or in##167##2##(1990-2#4)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#6)(2009-10#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#1)
or inadequate##2##2##(2010-9#1)(2013-1#1)
or inappropriate##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
or incidence##3##2##(2008-10#2)(2012-3#1)
or incomplete##4##2##(1990-5#1)(1993-1#1)(2008-10#1)(2008-12#1)
or incompletely##2##2##(2008-7#1)(2012-3#1)
or incorrect##2##2##(1991-6#1)(2008-11#1)
or increase##6##2##(1993-1#1)(1993-2#1)(1996-1#1)(1996-11#1)(2008-10#1)(2008-8#1)
or increased##7##2##(1990-11#1)(1990-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2012-3#1)
or increasing##2##2##(2008-10#2)
or independent##4##2##(1993-1#1)(1993-12#1)(2009-3#1)(2012-3#1)
or indirect##5##2##(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)
or indirectly##9##2##(1992-9#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
or individual##6##2##(2008-10#3)(2008-11#2)(2010-8#1)
or induced by##2##3##(1991-8#1)(2010-4#1)
or induced##8##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)
or inducible##2##2##(1993-9#1)(2012-12#1)
or infected##3##2##(1993-1#1)(1996-12#1)(2008-10#1)
or infection##9##2##(1997-3#1)(2008-10#4)(2008-12#1)(2009-8#1)(2010-12#1)(2013-1#1)
or infections##2##2##(1995-9#1)(2008-10#1)
or infectious##2##2##(1997-7#1)(2010-12#1)
or inflammatory response##2##3##(2008-12#1)(2011-2#1)
or inflammatory##7##2##(1993-2#1)(1997-1#1)(2008-10#2)(2008-12#1)(2009-10#1)(2011-2#1)
or infra-red illumination##2##3##(1991-2#2)
or infusion##2##2##(1996-11#1)(2012-2#1)
or inhibit##5##2##(1994-8#1)(1995-6#1)(2008-9#1)(2009-5#1)(2009-8#1)
or inhibitors##2##2##(2008-10#1)(2008-9#1)
or inhibitory##4##2##(1996-2#1)(1997-3#1)(2006-6#1)(2008-7#1)
or injection of##2##3##(1990-5#1)(2008-12#1)
or injection##3##2##(1990-5#1)(2008-11#1)(2008-12#1)
or insertion##2##2##(2008-11#1)(2013-8#1)
or insignificant##2##2##(1992-3#1)(2008-11#1)
or insufficient##2##2##(1990-9#1)(1997-4#1)
or insulin##2##2##(1996-11#1)(2008-11#1)
or intact##2##2##(1997-3#1)(2008-10#1)
or interaction##2##2##(1993-11#1)(2009-3#1)
or interactive##2##2##(2008-9#1)(2013-8#1)
or interfere with##3##3##(1993-6#1)(1995-6#1)(2010-7#1)
or interference with##2##3##(2008-11#1)(2013-7#1)
or intermediate levels of the defense##2##6##(2008-9#2)
or intermediate##5##2##(1991-2#1)(1996-12#1)(2008-9#2)(2010-12#1)
or intermittent##2##2##(2008-11#1)(2012-4#1)
or internal##3##2##(1997-7#1)(2013-8#2)
or into##2##2##(1993-6#1)(2008-3#1)
or intranasal##2##2##(2007-11#2)
or intraoperative##2##2##(1991-3#1)(2011-2#1)
or intraperitoneal##2##2##(1996-12#1)(2012-2#1)
or intrinsic##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
or invasion##2##2##(2008-10#1)(2013-8#1)
or ion chromatography##2##3##(2008-10#2)
or ionomycin##2##2##(1995-8#1)(2008-11#1)
or irreversible##2##2##(1996-3#1)(2011-2#1)
or is##13##2##(1991-2#1)(1991-5#1)(1992-9#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)
or isolated from##2##3##(1994-5#1)(2012-2#1)
or isolated##4##2##(1994-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
or isolates##2##2##(2008-10#1)(2008-9#1)
or isolation##2##2##(2008-10#1)(2008-4#1)
or it can be##2##4##(2008-10#1)(2008-7#1)
or it can##3##3##(1994-3#1)(2008-10#1)(2008-7#1)
or it##6##2##(1994-3#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-2#1)
or its combination with##2##4##(2012-2#1)(2012-7#1)
or its derivatives##3##3##(1990-6#1)(1995-8#1)(2008-5#1)
or its##36##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#2)(2008-10#6)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-10#1)(2012-2#1)(2012-7#1)(2013-8#2)
or just##3##2##(1993-3#1)(1996-12#1)(2008-4#1)
or kidney##2##2##(1991-12#1)(2008-5#1)
or kinetic##2##2##(2008-10#1)(2008-11#1)
or knowledge##3##2##(1994-12#1)(2008-9#1)(2012-2#1)
or known##6##2##(1994-9#1)(1996-6#1)(1997-3#1)(2008-3#1)(2008-9#1)(2010-7#1)
or laboratory##3##2##(1994-12#1)(1994-6#1)(2011-2#1)
or lack of##5##3##(1997-2#1)(2008-10#2)(2008-5#1)(2009-12#1)
or lack thereof##2##3##(2012-2#1)(2012-3#1)
or lack##9##2##(1991-3#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)
or lacking##2##2##(1994-3#1)(2012-2#1)
or laparoscopic##2##2##(1993-3#1)(2009-12#1)
or large##6##2##(1991-2#1)(1994-11#1)(2008-10#2)(2008-4#1)(2008-9#1)
or larger oligosaccharides having##2##4##(1994-5#2)
or larger##13##2##(1992-5#2)(1994-5#2)(1995-9#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
or laser##5##2##(1992-3#2)(2008-10#1)(2008-3#1)(2008-5#1)
or late##4##2##(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
or later##4##2##(1990-12#1)(1995-11#1)(2010-6#1)(2013-1#1)
or lateral##3##2##(1990-3#1)(1991-2#1)(2013-1#1)
or lead cation##2##3##(2008-10#2)
or lead##4##2##(2008-10#3)(2008-9#1)
or leaf##7##2##(2008-10#6)(2012-9#1)
or leaves##3##2##(2008-10#3)
or left##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)
or lesions##2##2##(2008-10#1)(2008-5#1)
or less at birth##2##4##(1991-6#1)(2012-12#1)
or less at##3##3##(1991-6#1)(2008-10#1)(2012-12#1)
or less in##4##3##(1995-8#1)(2008-10#2)(2008-9#1)
or less severe##2##3##(2008-10#1)(2008-12#1)
or less##59##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#2)(1997-3#1)(1997-8#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#4)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
or limit their##2##3##(1991-12#1)(2008-9#1)
or limit##3##2##(1991-12#1)(2008-9#1)(2009-1#1)
or limited##2##2##(2008-10#2)
or linear##2##2##(2008-10#1)(2008-3#1)
or linked##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
or lip##2##2##(1991-6#1)(2012-3#1)
or lipid##2##2##(1992-3#1)(2010-5#1)
or liquid##7##2##(1992-3#2)(2008-10#4)(2008-7#1)
or liver##5##2##(1990-2#1)(1993-12#1)(1996-12#1)(2008-1#1)(2010-12#1)
or living in##2##3##(2008-5#2)
or local##9##2##(1990-9#1)(1993-3#1)(1995-2#1)(1996-1#1)(2008-11#2)(2008-2#1)(2011-9#1)(2013-1#1)
or locations##3##2##(2008-10#3)
or long term##2##3##(1992-3#1)(2008-5#1)
or long-term##4##2##(1992-9#1)(1996-3#1)(2011-2#1)(2012-5#1)
or longer##9##2##(1991-3#1)(1991-5#1)(1993-8#1)(1996-6#1)(1996-9#1)(2006-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
or loss of##4##3##(1991-12#1)(1994-12#1)(1995-11#1)(2008-10#1)
or loss##6##2##(1991-12#1)(1994-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2010-11#1)
or losses##4##2##(2008-10#4)
or lost##2##2##(1994-11#1)(2011-3#1)
or low##21##2##(1993-12#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-7#1)(2010-1#1)(2010-8#1)(2012-7#1)
or low-density##2##2##(1992-9#1)(2008-6#1)
or lower##17##2##(1997-4#1)(2008-10#9)(2008-12#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
or lyophilized##2##2##(1994-6#1)(2008-10#1)
or mRNA##2##2##(2008-9#1)(2009-9#1)
or magnesium##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
or magnetic resonance imaging##3##4##(1997-8#1)(2010-12#1)(2013-1#1)
or magnetic resonance##4##3##(1997-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
or magnetic##5##2##(1997-8#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
or maintain a##2##3##(2008-10#1)(2010-11#1)
or maintain##3##2##(2008-10#1)(2010-11#1)(2010-2#1)
or maintaining##2##2##(2008-12#1)(2008-7#1)
or major##6##2##(1991-2#1)(1995-5#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-5#1)
or malignant##6##2##(1990-2#1)(1991-2#1)(1993-6#1)(1996-3#1)(2008-10#1)(2009-12#1)
or management##2##2##(1997-2#1)(2008-12#1)
or manual##2##2##(2008-11#1)(2010-5#1)
or many##2##2##(2008-9#2)
or markedly##2##2##(1991-2#1)(1993-12#1)
or mass##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
or may be##2##3##(2008-7#2)
or may not##9##3##(1995-5#1)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
or may##14##2##(1993-1#1)(1995-5#1)(2008-10#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
or mean##2##2##(1990-9#1)(1997-2#1)
or mechanical##2##2##(2008-10#1)(2008-4#1)
or mechanism##2##2##(2008-8#1)(2010-11#1)
or media##3##2##(1995-12#1)(2008-11#1)(2009-7#1)
or medial##3##2##(1993-11#1)(1997-2#1)(2011-2#1)
or medical##10##2##(1994-12#1)(1994-3#1)(1997-6#1)(2008-1#1)(2009-4#1)(2009-9#1)(2011-2#3)(2012-3#1)
or melon##2##2##(2008-10#2)
or merge##2##2##(1996-1#1)(2007-12#1)
or metal##3##2##(1992-3#1)(2008-10#1)(2008-9#1)
or metastasis##2##2##(1993-11#1)(2011-2#1)
or metastatic##2##2##(1994-2#1)(2010-7#1)
or metham sodium##2##3##(2008-10#2)
or methanol##2##2##(2008-10#1)(2008-7#1)
or methyl##2##2##(2008-10#2)
or methylamine##2##2##(1995-9#2)
or methylene##3##2##(1993-8#2)(2008-10#1)
or microarray##2##2##(2008-4#1)(2009-12#1)
or microbial##2##2##(1994-3#1)(2011-2#1)
or microscopic##2##2##(2008-10#1)(2011-2#1)
or migration##3##2##(2008-11#1)(2008-8#1)(2009-9#1)
or mild hypothermia##2##3##(1995-11#1)(2011-2#1)
or mild##6##2##(1993-8#1)(1995-11#1)(1997-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
or minimize##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
or minor##2##2##(2008-8#1)(2013-8#1)
or mixed##7##2##(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
or moderate##5##2##(1995-9#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
or moderately##2##2##(2008-10#2)
or modification##2##2##(2008-10#1)(2008-8#1)
or modified##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
or modify##2##2##(2008-10#1)(2008-9#1)
or molecular##2##2##(1993-12#1)(2008-10#1)
or monitoring of##2##3##(2008-10#1)(2012-12#1)
or monitoring##3##2##(2008-10#1)(2010-10#1)(2012-12#1)
or more DNA##2##3##(1997-2#1)(2008-10#1)
or more antibiotics##2##3##(2008-10#1)(2013-8#1)
or more commonly##2##3##(2006-6#1)(2008-7#1)
or more communication related impairments##2##5##(2011-1#2)
or more from##2##3##(1990-11#1)(2008-5#1)
or more hours##2##3##(1991-9#1)(2008-10#1)
or more in##2##3##(1990-8#1)(1992-2#1)
or more of the six##2##5##(1996-2#1)(2010-6#1)
or more of the##8##4##(1992-5#1)(1996-2#1)(2008-10#3)(2008-11#1)(2009-6#1)(2010-6#1)
or more of these##4##4##(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
or more of##15##3##(1992-5#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-6#1)(2010-6#1)(2011-2#1)
or more sensitive##2##3##(2008-10#2)
or more than##2##3##(2008-10#2)
or more to##2##3##(1994-12#1)(2008-10#1)
or more years##4##3##(1991-12#3)(2012-12#1)
or more##167##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-5#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#4)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#51)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#8)(2009-1#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#7)
or more)##2##2##(2008-2#1)(2008-3#1)
or morphine##2##2##(1996-2#1)(1997-2#1)
or morphology##2##2##(1994-5#1)(1995-6#1)
or mortality between##2##3##(1994-2#1)(2012-3#1)
or mortality##4##2##(1993-11#1)(1994-2#1)(2008-8#1)(2012-3#1)
or mouse##3##2##(2008-4#2)(2011-2#1)
or mouth##2##2##(2008-11#1)(2008-6#1)
or movement##2##2##(2008-10#1)(2013-8#1)
or multiple##13##2##(1994-2#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
or murine##2##2##(1994-11#1)(2011-2#1)
or muscle##6##2##(1993-11#1)(1994-11#1)(1996-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
or muscles##2##2##(2009-11#1)(2009-3#1)
or myelodysplastic syndrome##2##3##(2011-2#2)
or myelodysplastic##3##2##(1990-8#1)(2011-2#2)
or natural##5##2##(2008-10#2)(2010-1#2)(2010-7#1)
or near the##6##3##(1993-3#1)(1994-11#1)(1996-8#1)(2008-10#3)
or near##12##2##(1991-3#1)(1993-3#2)(1994-11#2)(1996-8#1)(2008-10#4)(2008-8#1)(2012-2#1)
or near-infrared##2##2##(2008-3#1)(2008-7#1)
or nearly##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
or neck##2##2##(2008-12#1)(2011-2#1)
or necrotic##5##2##(1997-8#1)(2008-10#2)(2008-5#2)
or negative##12##2##(1995-11#1)(1995-12#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-6#1)(2012-2#1)(2013-8#1)
or negatively##4##2##(2008-10#3)(2008-4#1)
or neonatal##5##2##(1994-9#2)(1995-11#1)(2008-11#1)(2008-12#1)
or neoplastic##2##2##(2008-10#1)(2011-2#1)
or nerve##2##2##(1997-3#1)(2008-9#1)
or neutral##9##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-10#1)(2012-2#2)(2012-3#1)
or new##6##2##(1994-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2012-12#1)(2013-1#1)
or newly##2##2##(2008-10#1)(2008-7#1)
or niche##2##2##(2008-8#1)(2009-12#1)
or night blindness##2##3##(1991-8#2)
or nitrate##2##2##(2008-10#2)
or nitrogen##2##2##(1991-6#1)(2008-10#1)
or no change in##2##4##(2008-10#2)
or no damage to##2##4##(2008-10#1)(2009-12#1)
or no damage##3##3##(1994-8#1)(2008-10#1)(2009-12#1)
or no germination occurred##2##4##(2008-10#2)
or no##68##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-5#1)(1995-9#1)(1997-3#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#3)(2009-12#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
or none##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
or none)##2##2##(2008-10#1)(2011-2#1)
or noninoculated##2##2##(2008-10#2)
or nonneoplastic##4##2##(2008-9#3)(2011-2#1)
or normal##3##2##(1994-8#1)(2008-7#1)(2013-8#1)
or not at all##4##4##(1992-10#1)(2008-10#1)(2008-11#1)(2008-6#1)
or not the##7##3##(1994-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-8#1)
or not to pilot##2##4##(1994-3#2)
or not to##11##3##(1991-2#1)(1994-3#3)(1996-1#2)(2008-11#2)(2008-8#1)(2012-3#1)(2013-1#1)
or not was##2##3##(1993-3#1)(2008-8#1)
or not with##6##3##(1990-8#1)(2008-10#4)(2009-3#1)
or not##94##2##(1990-11#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-10#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1997-3#1)(2008-10#27)(2008-11#15)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
or not)##2##2##(2008-5#1)(2012-3#1)
or not?##4##2##(1994-12#1)(2008-11#1)(2010-4#1)(2011-2#1)
or novel##2##2##(1993-6#1)(2011-3#1)
or number of##2##3##(2008-10#2)
or number##3##2##(2008-10#3)
or nutritive properties##2##3##(2010-7#2)
or obese##4##2##(1996-12#1)(2008-10#2)(2012-2#1)
or observed##2##2##(1991-12#1)(1996-2#1)
or obtaining##2##2##(1995-6#1)(2008-10#1)
or occupational##5##2##(1991-12#1)(1996-6#1)(2008-4#3)
or odd-number##2##2##(2008-11#2)
or of the##7##3##(1990-5#1)(1990-8#1)(1992-2#1)(1995-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
or of##21##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-8#1)(1995-11#1)(1995-3#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
or offspring##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
or old##2##2##(2008-7#2)
or older##6##2##(1991-11#1)(1992-5#1)(1993-8#1)(2008-11#1)(2009-5#1)(2011-2#1)
or oligandrin##3##2##(2008-10#3)
or on the##4##3##(1992-12#1)(2007-12#1)(2008-9#2)
or on##28##2##(1992-12#2)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2011-1#1)(2011-3#1)(2013-8#1)
or on-line##3##2##(1992-11#1)(2008-10#2)
or one##7##2##(1994-12#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-4#1)(2013-8#2)
or only##8##2##(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-3#1)
or onto##2##2##(1997-2#1)(2008-10#1)
or oral##2##2##(2010-5#1)(2010-6#1)
or orally##2##2##(2007-11#1)(2013-7#1)
or organic##5##2##(2008-10#5)
or organs##4##2##(2008-11#2)(2009-12#1)(2010-9#1)
or osteoporosis##2##2##(2012-12#1)(2013-1#1)
or other drugs##2##3##(2010-4#1)(2012-3#1)
or other factors##2##3##(2008-12#1)(2011-2#1)
or other health##2##3##(1995-2#1)(2009-5#1)
or other proteins##2##3##(1995-6#1)(2008-8#1)
or other type of##2##4##(2008-11#1)(2008-4#1)
or other##87##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-11#1)(1996-2#2)(1996-6#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-7#3)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#5)(2013-8#1)
or others##2##2##(1991-12#1)(2013-8#1)
or otherwise##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
or out of##2##3##(2008-9#2)
or outcome##2##2##(2008-7#1)(2011-2#1)
or outside the##2##3##(1991-6#1)(1995-8#1)
or outside##4##2##(1991-6#1)(1995-8#1)(2008-8#1)(2012-12#1)
or over##9##2##(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#1)(1994-6#2)(2008-10#1)(2010-12#1)(2011-2#1)
or overexpression##2##2##(2008-9#1)(2011-2#1)
or oxidation##2##2##(2008-10#1)(2013-1#1)
or p53##2##2##(1995-6#1)(2008-9#1)
or p53175P##2##2##(2008-7#2)
or pH##6##2##(1995-2#1)(1996-3#1)(2008-10#4)
or packed##2##2##(2008-11#2)
or pain##4##2##(1990-11#1)(2009-12#1)(2009-3#1)(2010-8#1)
or papillary##2##2##(1993-2#1)(2010-6#1)
or paraffin-embedded##2##2##(1997-3#1)(2008-9#1)
or parasitic##2##2##(2008-8#1)(2013-1#1)
or part of##2##3##(2007-11#1)(2010-5#1)
or partial##9##2##(1991-6#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-5#1)(2010-9#1)
or partially##9##2##(1990-8#1)(1995-2#1)(1996-3#1)(2008-10#3)(2008-7#1)(2012-3#1)(2013-8#1)
or particle##3##2##(1995-8#1)(2008-10#1)(2008-9#1)
or partly##2##2##(1995-8#1)(2008-11#1)
or parts##3##2##(2008-10#2)(2008-12#1)
or passive##3##2##(1995-5#1)(2010-5#1)(2010-8#1)
or past##3##2##(1992-2#1)(2008-11#1)(2010-9#1)
or pathogen##5##2##(2008-10#5)
or pathological##4##2##(1993-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
or pathways##2##2##(2011-2#1)(2012-2#1)
or patient##3##2##(1991-6#1)(1996-1#1)(2011-2#1)
or patients##5##2##(1994-3#1)(1997-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
or peat##2##2##(2008-10#2)
or pelvic##2##2##(1992-2#1)(1994-12#1)
or peptidase##2##2##(1995-6#1)(2008-4#1)
or peptide##3##2##(1995-5#1)(2008-11#1)(2008-9#1)
or peptides##4##2##(1995-5#1)(2008-11#1)(2008-5#2)
or per##3##2##(1993-12#1)(1994-8#2)
or performing##2##2##(1994-1#1)(2008-4#1)
or perfusion bioreactors##2##3##(2008-11#2)
or perfusion##4##2##(2008-11#3)(2010-12#1)
or perhaps##4##2##(1992-12#1)(1994-11#1)(2008-10#1)(2008-9#1)
or peripheral blood##3##3##(2008-11#2)(2008-4#1)
or peripheral##6##2##(2008-11#2)(2008-4#1)(2008-7#1)(2010-7#2)
or peritoneal##2##2##(1990-6#1)(2012-3#1)
or permanent##8##2##(1990-9#1)(1993-9#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
or persistent##2##2##(1992-6#1)(2011-1#1)
or pharmaceutical##4##2##(2008-4#2)(2008-5#2)
or pharmacologic activation##2##3##(1995-6#2)
or phorbol 12-myristate 13-acetate (PMA)##2##5##(1995-2#1)(1995-6#1)
or phorbol##5##2##(1990-5#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)
or phosphate##2##2##(2008-10#2)
or phosphomolybdic acid##2##3##(2008-10#2)
or physical##5##2##(1995-6#2)(1997-7#1)(2008-10#1)(2012-2#1)
or physiological##4##2##(2008-8#3)(2009-9#1)
or placebo for 6 weeks##2##5##(2008-5#1)(2013-1#1)
or placebo for##3##3##(2008-5#2)(2013-1#1)
or placebo in##2##3##(2013-1#2)
or placebo##9##2##(2008-10#1)(2008-5#3)(2012-2#1)(2013-1#4)
or plant##5##2##(2008-10#3)(2008-8#1)(2009-8#1)
or plasma##2##2##(1990-2#1)(1997-3#1)
or plastic##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
or platelet##2##2##(2008-7#1)(2013-1#1)
or political##2##2##(2009-10#1)(2009-6#1)
or poly-aspartic##2##2##(2008-11#2)
or polymer##3##2##(2008-10#2)(2008-12#1)
or poorly##2##2##(2008-10#1)(2008-3#1)
or population##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
or populations##4##2##(2008-10#4)
or possible##3##2##(1996-11#1)(2008-10#1)(2008-7#1)
or possibly##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
or post-translational modifications##2##3##(1994-8#1)(2008-4#1)
or post-translational##4##2##(1994-8#1)(2008-4#1)(2008-5#1)(2012-2#1)
or posterior##2##2##(1990-11#1)(2008-9#1)
or postnatal##2##2##(1996-1#1)(2011-1#1)
or postoperative complications##3##3##(1992-2#1)(2012-12#2)
or potassium##3##2##(2008-10#2)(2008-7#1)
or potential risks##2##3##(2008-11#1)(2013-1#1)
or potential##9##2##(2008-11#2)(2008-4#1)(2009-12#1)(2012-12#1)(2013-1#4)
or prediction##2##2##(1991-6#1)(2008-8#1)
or pregnancy##3##2##(1991-3#2)(1994-12#1)
or premature##3##2##(2008-11#1)(2010-3#1)(2011-1#1)
or presence of##6##3##(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
or present in##2##3##(2008-10#1)(2010-6#1)
or present##3##2##(2008-10#2)(2010-6#1)
or pressure##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
or prevent##3##2##(2006-6#1)(2008-10#1)(2011-2#1)
or prevention of##2##3##(1990-5#1)(2011-2#1)
or prevention##3##2##(1990-5#1)(1996-11#1)(2011-2#1)
or previous##4##2##(1990-6#1)(2008-1#2)(2008-9#1)
or primary care##2##3##(1995-2#1)(2011-2#1)
or prion##2##2##(2008-11#1)(2010-11#1)
or produce##2##2##(2008-10#1)(2008-12#1)
or product##5##2##(1996-12#2)(2008-10#1)(2008-7#1)(2011-2#1)
or production of##2##3##(2008-11#1)(2010-11#1)
or production##4##2##(1993-3#1)(2008-11#2)(2010-11#1)
or professional##3##2##(1992-1#1)(2008-1#1)(2008-11#1)
or prognostic##2##2##(1990-2#1)(1991-8#1)
or programmed cell death##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
or progression of##3##3##(2011-2#2)(2013-1#1)
or progression##4##2##(1991-8#1)(2011-2#2)(2013-1#1)
or prolonged##2##2##(1995-2#1)(2008-10#1)
or proportion of##2##3##(2011-2#1)(2012-3#1)
or protease##2##2##(1995-6#1)(2011-3#1)
or protective##3##2##(1995-5#1)(2008-10#2)
or protein domains##2##3##(1995-2#1)(2008-4#1)
or protein##12##2##(1991-3#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-2#2)(2008-4#2)(2008-9#1)(2011-2#2)(2012-2#1)
or proteins##6##2##(1995-2#2)(1995-9#1)(2008-10#2)(2011-2#1)
or providing##3##2##(1994-3#1)(2008-1#1)(2013-8#1)
or provocative##2##2##(1997-6#1)(2013-1#1)
or proximal##2##2##(2010-12#1)(2012-3#1)
or pulmonary##2##2##(2012-2#1)(2013-1#1)
or pure##2##2##(2008-10#2)
or purple##2##2##(2008-10#1)(2011-2#1)
or putative##2##2##(2008-10#1)(2008-8#1)
or quality of##3##3##(1992-2#1)(1992-3#1)(1997-8#1)
or quality##5##2##(1992-2#1)(1992-3#1)(1995-1#1)(1997-8#1)(2008-9#1)
or quantified##2##2##(2008-9#1)(2011-2#1)
or quantitative##4##2##(2008-10#3)(2012-2#1)
or quartz##3##2##(2008-10#3)
or quasi-RCTs##2##2##(2008-10#2)
or rabbit##3##2##(1992-6#1)(1995-11#1)(1995-6#1)
or radiation##2##2##(2008-7#1)(2013-1#1)
or radiographic outcomes##2##3##(2013-1#2)
or radiographic##3##2##(2011-2#1)(2013-1#2)
or radiotherapy##2##2##(2008-5#1)(2012-3#1)
or random##4##2##(1990-6#1)(1996-3#1)(2008-10#2)
or randomly##2##2##(1997-2#1)(2008-10#1)
or rat##3##2##(1993-8#1)(1995-11#1)(1996-12#1)
or reactivation##2##2##(2008-10#1)(2011-2#1)
or reagents##2##2##(2008-10#1)(2009-6#1)
or reasonably##2##2##(2008-4#1)(2008-7#1)
or recombinant##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
or recombination##2##2##(1992-6#1)(2008-10#1)
or recovery##2##2##(2008-10#1)(2013-8#1)
or recurrent##6##2##(1991-2#1)(1993-6#1)(1997-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
or reduce the##3##3##(1997-2#1)(2008-5#1)(2010-11#1)
or reduce##7##2##(1995-6#1)(1997-2#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-11#1)(2012-2#1)
or reduced##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
or reducing the##2##3##(1992-3#1)(2012-12#1)
or reducing##5##2##(1990-5#2)(1992-3#1)(1996-9#1)(2012-12#1)
or reduction of##2##3##(2008-10#1)(2010-10#1)
or reference##2##2##(2008-10#2)
or reflective##2##2##(2008-11#2)
or regional##6##2##(1990-11#1)(1992-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
or regions##2##2##(2008-10#1)(2008-11#1)
or regulating##2##2##(2010-11#1)(2011-2#1)
or regulation##2##2##(1994-3#1)(2012-2#1)
or related##5##2##(1992-12#1)(2008-10#1)(2009-10#1)(2010-5#1)(2011-2#1)
or relatives##3##2##(1993-11#1)(2008-12#1)(2008-7#1)
or remain at##2##3##(2008-8#2)
or remain##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
or remained##2##2##(2008-10#2)
or removal of##3##3##(2008-10#2)(2008-11#1)
or renal##4##2##(1993-12#1)(2008-12#1)(2009-6#1)(2011-2#1)
or repair the##2##3##(2008-5#2)
or repair##3##2##(1992-9#1)(2008-5#2)
or repeated##4##2##(1990-7#1)(2008-11#1)(2010-1#1)(2012-2#1)
or replace##2##2##(2008-1#1)(2009-9#1)
or replacement##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
or replacing##2##2##(1991-1#1)(2008-11#1)
or reporting##2##2##(2008-9#1)(2011-1#1)
or repression##2##2##(2008-10#1)(2008-9#1)
or reproductive##3##2##(1992-3#2)(2008-9#1)
or research##4##2##(1996-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
or resistance to##2##3##(2008-9#1)(2010-12#1)
or resistance##6##2##(1993-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
or resistant to##5##3##(1992-7#1)(1997-4#1)(2008-10#3)
or resistant##11##2##(1992-7#1)(1996-12#1)(1997-4#1)(2008-10#7)(2010-12#1)
or respiratory##2##2##(2008-10#1)(2010-1#1)
or response##3##2##(1993-1#1)(2012-3#2)
or restricted##2##2##(2008-10#1)(2010-1#1)
or restriction fragment length polymorphism analysis##2##6##(2008-10#2)
or result from##2##3##(2008-9#1)(2013-1#1)
or reticulated##2##2##(2006-6#1)(2008-10#1)
or reverse the##3##3##(1992-9#1)(1994-2#1)(2013-1#1)
or reverse##4##2##(1992-9#1)(1994-2#1)(2008-4#1)(2013-1#1)
or rice##2##2##(2008-10#1)(2008-5#1)
or right##3##2##(1993-11#1)(2008-8#1)(2009-10#1)
or risk factors##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
or risk##9##2##(1991-8#1)(1994-9#1)(1995-12#1)(2008-7#3)(2011-2#2)(2011-3#1)
or roots##2##2##(2008-10#2)
or running##2##2##(2008-10#2)
or rupture##3##2##(2009-10#1)(2012-2#2)
or safety##3##2##(1993-12#1)(1996-3#1)(2008-7#1)
or saline##5##2##(1994-8#2)(2010-6#2)(2012-5#1)
or sample solution was##2##4##(2008-10#2)
or sample##9##2##(2008-10#9)
or scab##2##2##(2008-10#2)
or second##4##2##(1996-2#1)(2008-7#1)(2009-9#1)(2013-1#1)
or secondary to##2##3##(2008-1#1)(2011-2#1)
or secondary##8##2##(1991-2#1)(1995-10#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
or seed##2##2##(2008-10#1)(2008-9#1)
or seizure##3##2##(1990-5#1)(1992-12#2)
or selective determination of##2##4##(2008-10#2)
or selective##5##2##(1990-2#1)(2008-10#4)
or sensitivity##2##2##(2008-10#2)
or separation of##2##3##(2008-10#2)
or separation##4##2##(2008-10#4)
or sepsis##2##2##(1994-6#1)(2008-5#1)
or sequences##2##2##(1991-7#1)(1993-2#1)
or sequential##3##2##(2008-10#2)(2012-3#1)
or serum##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
or serum-free##2##2##(2008-11#2)
or serve as##2##3##(1991-1#1)(2008-9#1)
or serve##3##2##(1991-1#1)(2008-9#1)(2012-2#1)
or setting##2##2##(2008-11#1)(2008-12#1)
or seven##3##2##(1990-5#1)(1996-8#1)(2008-7#1)
or several##6##2##(1990-5#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)
or severe##14##2##(1990-3#1)(1996-11#1)(2008-11#4)(2008-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#4)
or severity of##2##3##(2008-10#1)(2008-8#1)
or severity##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
or sex differentiation##2##3##(2010-5#2)
or sex##6##2##(1991-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#2)
or sexual##3##2##(2008-10#1)(2008-9#2)
or shared##2##2##(2008-10#1)(2008-8#1)
or short##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
or shortly after##2##3##(2008-8#1)(2009-7#1)
or shortly##3##2##(2008-8#1)(2009-7#1)(2010-12#1)
or should##2##2##(1990-11#1)(1991-12#1)
or shoulder##2##2##(1995-3#1)(2011-2#1)
or showed##2##2##(2008-7#1)(2011-1#1)
or sibling##2##2##(1995-2#1)(2012-3#1)
or sign##3##2##(1991-8#2)(2008-9#1)
or significant##2##2##(1996-3#1)(2012-12#1)
or significantly affect##2##3##(1991-1#1)(2008-11#1)
or significantly reduced##2##3##(1990-9#1)(1996-12#1)
or significantly##6##2##(1990-9#1)(1991-1#1)(1996-12#1)(2008-11#1)(2012-12#2)
or silica##2##2##(2008-10#1)(2009-6#1)
or silicon##2##2##(2008-10#1)(2008-4#1)
or similar##7##2##(1991-2#1)(1996-12#2)(1996-6#1)(2008-10#2)(2008-8#1)
or simple##5##2##(1992-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-10#1)
or simply##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
or simultaneous##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
or simultaneously##4##2##(1995-5#1)(2009-8#1)(2012-2#1)(2012-3#1)
or single##5##2##(1994-6#2)(1997-3#1)(2008-10#1)(2010-11#1)
or site##2##2##(1991-6#1)(2008-10#1)
or sites##3##2##(1993-6#1)(2008-10#2)
or size##2##2##(1996-2#1)(2008-5#1)
or skeletal muscle##2##3##(1990-5#1)(1994-11#1)
or skin##5##2##(1997-3#1)(2008-5#2)(2008-9#1)(2011-2#1)
or slightly lower##2##3##(1997-8#1)(2012-12#1)
or slightly##6##2##(1996-6#1)(1997-8#1)(2008-10#2)(2012-12#1)(2013-1#1)
or slow##2##2##(1995-8#1)(2008-5#1)
or small groups##2##3##(2008-12#1)(2008-5#1)
or small##8##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#2)(2013-8#1)
or smaller##4##2##(1991-5#1)(1995-5#1)(2008-10#1)(2013-1#1)
or so##6##2##(1995-12#1)(1997-7#1)(2008-10#2)(2008-8#1)(2011-2#1)
or so-called##3##2##(2008-10#2)(2008-7#1)
or social##4##2##(1990-2#1)(2008-12#1)(2009-7#1)(2013-1#1)
or sodium##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
or soft##2##2##(2013-1#1)(2013-8#1)
or soil##5##2##(2008-10#5)
or solid-liquid extraction##2##3##(2008-10#2)
or soluble##2##2##(2008-10#1)(2012-9#1)
or solvent##2##2##(2008-10#2)
or some other##4##3##(1992-9#1)(2008-4#1)(2009-9#1)(2010-10#1)
or some##10##2##(1991-3#1)(1992-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2013-8#1)
or southern##2##2##(1997-8#1)(2008-10#1)
or spatial##5##2##(1995-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)
or special##3##2##(2008-11#1)(2010-11#2)
or species##3##2##(2008-10#1)(2012-9#2)
or specific##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-1#1)
or spheroids##2##2##(2008-11#2)
or spin##2##2##(2008-10#1)(2008-9#1)
or spinal##2##2##(2007-11#1)(2008-12#1)
or spontaneous##2##2##(1996-9#1)(1997-4#1)
or spore germination##2##3##(2008-10#2)
or spore##3##2##(2008-10#3)
or spread of##2##3##(2008-10#2)
or stabilize##2##2##(1996-2#1)(2011-3#1)
or stable##3##2##(1992-9#1)(1994-8#1)(1995-6#1)
or stage##2##2##(1992-12#1)(2011-2#1)
or standard##3##2##(2008-10#2)(2010-8#1)
or stem##4##2##(2008-10#1)(2011-2#3)
or stiffness##2##2##(2008-5#1)(2008-9#1)
or stimulation of##2##3##(1994-2#1)(2008-11#1)
or stored##2##2##(2008-10#1)(2008-9#1)
or stress##4##2##(2008-11#1)(2009-10#1)(2009-7#1)(2012-2#1)
or strip##2##2##(2008-10#2)
or sudden##2##2##(2008-7#1)(2012-12#1)
or suicide##2##2##(1993-9#1)(2010-6#1)
or superior to##2##3##(1992-1#1)(2008-11#1)
or superior##3##2##(1992-1#1)(1995-5#1)(2008-11#1)
or supplements##2##2##(2008-10#1)(2012-2#1)
or supplied##2##2##(1994-11#1)(1997-3#1)
or support##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
or suppressed##3##2##(1996-2#1)(2009-8#1)(2010-9#1)
or suppression of##2##3##(2008-11#1)(2008-9#1)
or suppression##4##2##(2008-11#1)(2008-9#1)(2012-3#2)
or surface##3##2##(2008-10#2)(2008-5#1)
or surfactant##2##2##(1994-5#1)(2008-5#1)
or surgery##5##2##(1990-12#1)(1992-12#1)(2008-11#1)(2008-7#1)(2013-1#1)
or surgical therapy##2##3##(2010-12#1)(2013-1#1)
or surgical treatment##2##3##(1996-6#1)(2012-3#1)
or surgical##10##2##(1996-6#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
or survival of##2##3##(2008-10#1)(2013-8#1)
or survival##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
or survive##2##2##(2008-10#1)(2008-9#1)
or susceptibility to##2##3##(2008-10#1)(2008-5#1)
or susceptibility##3##2##(2008-10#2)(2008-5#1)
or suspension##3##2##(2008-10#2)(2008-11#1)
or suspensions to##2##3##(1994-2#2)
or suspensions##3##2##(1994-2#2)(2008-10#1)
or swine manure##2##3##(2008-10#2)
or symptom##2##2##(2008-7#1)(2010-1#1)
or symptomatic##5##2##(1990-8#1)(1996-6#2)(2008-10#1)(2012-3#1)
or symptoms##4##2##(1991-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
or synergistic##3##2##(1991-8#1)(2008-10#2)
or synergize with##2##3##(1995-8#1)(2009-12#1)
or synthetic##6##2##(1991-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-3#1)
or systemic##7##2##(2008-1#1)(2008-10#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)
or taking##2##2##(1997-3#1)(2009-7#1)
or target##2##2##(1994-11#1)(2008-9#1)
or technical##2##2##(2010-7#1)(2013-1#1)
or telephone interviews##2##3##(2008-11#2)
or temperature##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
or temporal##4##2##(1996-6#1)(2008-10#1)(2008-9#1)(2009-10#1)
or tertiary##2##2##(2008-10#1)(2008-4#1)
or testing##2##2##(2008-6#1)(2011-8#1)
or testosterone##2##2##(1990-11#1)(2012-2#1)
or that##10##2##(1992-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-12#1)
or the B##2##3##(1994-5#1)(2008-10#1)
or the absence of##2##4##(2008-7#1)(2011-2#1)
or the activity of##2##4##(1994-5#1)(1995-11#1)
or the addition of##2##4##(2008-10#1)(2008-11#1)
or the amount of##2##4##(2008-10#1)(2008-9#1)
or the complete##2##3##(2007-12#1)(2008-10#1)
or the control##2##3##(1992-11#1)(1997-7#1)
or the dose##2##3##(1991-11#1)(2013-1#1)
or the entire##2##3##(2008-10#1)(2009-2#1)
or the equivalent of##2##4##(2008-10#1)(2009-12#1)
or the expression##2##3##(1990-3#1)(2009-6#1)
or the full labeled rate##2##5##(2008-10#2)
or the mixture of##2##4##(2008-10#2)
or the murine##3##3##(1995-11#1)(2008-11#2)
or the number of##4##4##(1991-2#1)(1991-8#1)(2008-10#1)(2013-1#1)
or the occurrence of##2##4##(2008-10#2)
or the other##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)
or the presence of##3##4##(1994-8#1)(2008-10#2)
or the rate##2##3##(2008-10#1)(2008-8#1)
or the ratio between the##2##5##(2008-10#2)
or the ratio##3##3##(1991-12#1)(2008-10#2)
or the right##2##3##(2008-10#1)(2008-7#1)
or the saphenous nerve##2##4##(1997-3#2)
or the skin##2##3##(2008-11#1)(2008-5#1)
or the social##2##3##(1992-3#1)(2008-9#1)
or the specific##2##3##(2008-11#2)
or the spinal##2##3##(1996-5#1)(2008-7#1)
or the total##2##3##(1995-6#1)(2008-3#1)
or the##288##2##(1990-3#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-8#5)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#4)(2006-6#1)(2007-12#2)(2008-10#80)(2008-11#22)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#11)(2008-7#11)(2008-8#12)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-2#8)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#5)(2013-8#2)
or their families##2##3##(1991-2#1)(2013-1#1)
or their##22##2##(1991-12#1)(1991-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
or therapeutic##7##2##(1990-12#1)(1991-9#1)(1994-2#1)(2008-11#1)(2010-6#1)(2011-2#1)(2013-8#1)
or thermal##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
or they##3##2##(1994-2#1)(2010-12#1)(2011-2#1)
or those born##2##3##(2008-11#1)(2011-1#1)
or those who have##2##4##(2008-11#1)(2008-8#1)
or those who##3##3##(1990-8#1)(2008-11#1)(2008-8#1)
or those##11##2##(1990-8#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-8#1)(2011-1#1)(2013-8#1)
or three times##3##3##(1994-1#1)(2008-10#1)(2008-5#1)
or three##14##2##(1990-8#1)(1994-1#1)(1994-11#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)
or through a##2##3##(1990-5#1)(2013-8#1)
or through the##3##3##(2008-10#1)(2008-4#1)(2010-10#1)
or through##13##2##(1990-5#1)(1993-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-6#1)(2013-8#1)
or time##2##2##(2008-10#2)
or tissue##3##2##(1992-9#1)(2008-4#1)(2010-6#1)
or tissues##2##2##(1997-8#1)(2008-10#1)
or to a##8##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
or to evaluate##2##3##(1991-1#1)(1991-7#1)
or to the##8##3##(1990-8#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)(2013-8#1)
or to##78##2##(1990-5#2)(1990-8#1)(1991-1#1)(1991-7#1)(1992-9#1)(1993-6#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#5)(2008-9#4)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
or tolerance##3##2##(1995-12#1)(2008-10#1)(2011-10#1)
or tolerated##2##2##(2008-11#1)(2012-2#1)
or too##4##2##(1993-2#1)(1995-6#1)(2008-8#1)(2009-3#1)
or total##22##2##(1990-12#2)(1990-9#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-6#1)(2010-8#1)(2012-3#1)
or toxic##3##2##(2008-11#1)(2008-7#2)
or toxicity##2##2##(1997-1#1)(2010-11#1)
or trace##3##2##(2008-10#2)(2013-8#1)
or traditional##3##2##(1993-2#1)(2008-10#1)(2008-5#1)
or transforming##2##2##(2011-2#2)
or transient##4##2##(2007-7#1)(2008-11#2)(2011-1#1)
or translational##2##2##(1993-12#1)(2010-10#1)
or trauma##5##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
or treated with##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
or treated##6##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
or treatment of##2##3##(1993-2#1)(2013-1#1)
or treatment##9##2##(1993-11#1)(1993-2#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
or treatments##4##2##(1991-3#1)(1993-12#1)(2008-10#1)(2013-1#1)
or triple##4##2##(1995-11#1)(2008-10#2)(2012-3#1)
or true##2##2##(2008-8#1)(2009-7#1)
or truncated##2##2##(1997-3#1)(1997-7#1)
or tryptophan methyl ester hydrochloride##2##5##(2008-10#2)
or tumor##6##2##(1991-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
or tumour##2##2##(2008-11#1)(2008-2#1)
or tungsten##2##2##(2008-10#2)
or turmeric treated groups##2##4##(1994-8#2)
or turmeric##6##2##(1994-8#6)
or twice-daily##2##2##(2008-5#2)
or two##38##2##(1990-11#1)(1991-2#1)(1991-5#1)(1995-3#1)(1996-12#1)(1996-5#2)(2007-12#2)(2008-10#13)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
or two?##2##2##(1993-9#1)(2008-12#1)
or type 2 diabetes##2##4##(2008-3#2)
or type of##5##3##(1995-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
or type##9##2##(1994-2#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)
or ultrasonic##2##2##(1990-12#1)(1996-2#1)
or unchanged##2##2##(1997-1#1)(2010-7#1)
or under##5##2##(1990-11#1)(1991-2#1)(1992-12#1)(2008-10#2)
or unknown##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
or unsuitable##2##2##(2008-9#1)(2010-12#1)
or untreated##2##2##(1996-12#1)(2008-10#1)
or up to##3##3##(1994-5#1)(2008-10#2)
or upper##2##2##(2008-10#1)(2008-7#1)
or upregulated##2##2##(2008-10#1)(2012-2#1)
or urinary##3##2##(1990-5#1)(2008-7#1)(2012-3#1)
or urine##4##2##(1990-2#2)(1993-12#2)
or use of##6##3##(1993-12#1)(1996-11#1)(2008-10#1)(2008-11#2)(2009-8#1)
or use##9##2##(1993-12#1)(1995-3#1)(1996-11#1)(2008-10#3)(2008-11#2)(2009-8#1)
or used in##2##3##(2008-10#2)
or used##5##2##(1996-3#1)(2008-10#3)(2009-8#1)
or using##6##2##(2008-10#5)(2008-7#1)
or utilized##2##2##(2008-11#1)(2008-8#1)
or vacuum##2##2##(1995-8#1)(2008-3#1)
or variable##2##2##(2008-10#1)(2008-8#1)
or various##2##2##(2008-10#2)
or vasopressin##3##2##(1991-5#1)(1997-4#2)
or vegetables##3##2##(1994-2#1)(2010-8#1)(2012-2#1)
or vehicle##5##2##(1993-6#2)(1994-5#1)(1994-8#1)(1996-12#1)
or very low##2##3##(2008-10#1)(2013-8#1)
or very##12##2##(1990-9#1)(1992-12#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
or via##5##2##(1996-5#1)(2008-10#3)(2008-11#1)
or violated##2##2##(2008-5#1)(2010-10#1)
or viral##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
or virulence of##2##3##(2008-10#2)
or virus##6##2##(2008-10#4)(2008-11#1)(2008-4#1)
or was not##2##3##(1990-6#1)(2008-11#1)
or was##10##2##(1990-5#1)(1990-6#1)(1992-1#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#2)
or water##7##2##(1991-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
or weak##5##2##(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
or were##13##2##(1995-11#1)(1995-8#3)(1996-6#1)(2008-10#4)(2008-6#1)(2008-7#2)(2008-9#1)
or what##2##2##(1990-2#1)(2008-7#1)
or wheat##2##2##(2008-1#1)(2008-10#1)
or when both##2##3##(2008-10#1)(2008-8#1)
or when the##6##3##(1993-2#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
or when there is a##3##5##(2008-10#1)(2008-3#2)
or when##22##2##(1991-1#1)(1991-12#1)(1993-2#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2011-10#2)
or where##3##2##(1990-5#1)(1997-5#1)(2008-4#1)
or whether it##2##3##(2008-11#1)(2009-5#1)
or whether or not##2##4##(1991-6#1)(2008-7#1)
or whether##6##2##(1991-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
or which##2##2##(1996-12#1)(2008-11#1)
or who##6##2##(1992-6#1)(1994-1#2)(2008-11#1)(2008-5#1)(2008-9#1)
or whole##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
or with a##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
or with an##3##3##(2008-3#1)(2011-3#1)(2012-3#1)
or with both##2##3##(2008-10#1)(2008-3#1)
or with other##2##3##(2008-10#1)(2008-11#1)
or with the##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
or with##67##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-5#2)(1993-12#1)(1994-12#2)(1994-5#1)(1996-11#1)(1996-2#1)(1997-2#2)(2007-11#1)(2008-10#29)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)
or within the##2##3##(1994-5#1)(1997-3#1)
or within##7##2##(1994-5#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-6#1)
or without home health##2##4##(1995-3#2)
or without##99##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-12#3)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-11#1)(1996-2#3)(1996-9#2)(1997-3#1)(1997-5#1)(1997-8#2)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-6#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#5)(2013-8#2)
or worse##3##2##(1994-2#3)
or years in the United States##2##6##(1997-2#2)
or yield##2##2##(2008-10#2)
or young##2##2##(2008-10#1)(2008-9#1)
or##10079##1##(1990-10#4)(1990-11#33)(1990-12#40)(1990-2#30)(1990-3#14)(1990-5#59)(1990-6#25)(1990-7#4)(1990-8#32)(1990-9#22)(1991-1#20)(1991-10#2)(1991-11#18)(1991-12#63)(1991-2#58)(1991-3#42)(1991-5#30)(1991-6#35)(1991-7#9)(1991-8#49)(1991-9#17)(1992-1#20)(1992-10#5)(1992-11#9)(1992-12#49)(1992-2#39)(1992-3#58)(1992-4#5)(1992-5#20)(1992-6#20)(1992-7#2)(1992-8#8)(1992-9#40)(1993-1#35)(1993-11#25)(1993-12#51)(1993-2#30)(1993-3#42)(1993-6#57)(1993-8#49)(1993-9#14)(1994-1#21)(1994-11#35)(1994-12#50)(1994-2#54)(1994-3#64)(1994-5#58)(1994-6#32)(1994-8#73)(1994-9#19)(1995-1#16)(1995-10#4)(1995-11#57)(1995-12#49)(1995-2#71)(1995-3#20)(1995-5#48)(1995-6#62)(1995-8#47)(1995-9#21)(1996-1#29)(1996-11#29)(1996-12#96)(1996-2#59)(1996-3#38)(1996-5#29)(1996-6#25)(1996-8#10)(1996-9#13)(1997-1#39)(1997-2#51)(1997-3#83)(1997-4#28)(1997-5#17)(1997-6#15)(1997-7#41)(1997-8#53)(1997-9#2)(2006-5#5)(2006-6#11)(2007-11#18)(2007-12#41)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#46)(2008-10#2616)(2008-11#665)(2008-12#141)(2008-2#38)(2008-3#112)(2008-4#181)(2008-5#246)(2008-6#54)(2008-7#308)(2008-8#285)(2008-9#383)(2009-1#9)(2009-10#43)(2009-11#13)(2009-12#36)(2009-2#3)(2009-3#19)(2009-4#16)(2009-5#31)(2009-6#32)(2009-7#38)(2009-8#61)(2009-9#20)(2010-1#42)(2010-10#35)(2010-11#55)(2010-12#76)(2010-2#8)(2010-3#16)(2010-4#29)(2010-5#39)(2010-6#51)(2010-7#59)(2010-8#38)(2010-9#12)(2011-1#53)(2011-10#7)(2011-2#457)(2011-3#23)(2011-7#2)(2011-8#1)(2011-9#1)(2012-12#86)(2012-2#191)(2012-3#174)(2012-4#5)(2012-5#7)(2012-6#2)(2012-7#4)(2012-9#9)(2013-1#326)(2013-7#15)(2013-8#136)
or/and##5##1##(2008-10#3)(2009-12#1)(2013-8#1)
or= Ea##2##2##(2008-11#2)
or=##6##1##(2008-11#4)(2008-2#1)(2010-6#1)
oral absorption##2##2##(2008-5#1)(2008-9#1)
oral administration of BIM##2##4##(2008-11#2)
oral administration of YH439##2##4##(2008-11#2)
oral administration of a##2##4##(2008-10#1)(2008-11#1)
oral administration of the##2##4##(2008-10#2)
oral administration of##22##3##(1992-9#1)(1996-6#1)(2008-10#6)(2008-11#9)(2009-8#1)(2010-10#1)(2010-11#1)(2013-1#1)(2013-7#1)
oral administration##25##2##(1992-9#1)(1996-2#1)(1996-6#1)(2008-10#6)(2008-11#11)(2009-8#1)(2010-10#1)(2010-11#1)(2013-1#1)(2013-7#1)
oral agents##5##2##(2010-5#1)(2010-6#2)(2011-2#2)
oral and intravenous##4##3##(1991-12#1)(1994-12#1)(2011-2#2)
oral and maxillofacial surgery##6##4##(1993-1#2)(2008-7#4)
oral and maxillofacial##8##3##(1993-1#2)(2008-7#6)
oral and##20##2##(1991-12#1)(1991-2#1)(1993-1#2)(1994-12#1)(2007-11#1)(2008-11#1)(2008-7#6)(2008-9#1)(2010-10#1)(2011-2#3)(2012-12#1)(2013-1#1)
oral anticoagulants##2##2##(1994-3#1)(1996-6#1)
oral anticoagulation therapy##2##3##(2013-1#2)
oral anticoagulation##4##2##(1995-5#1)(1997-5#1)(2013-1#2)
oral bioavailability##3##2##(1997-1#1)(2008-5#1)(2008-8#1)
oral biofilms##2##2##(2008-9#2)
oral cancer##11##2##(1991-6#1)(1992-9#1)(2010-12#2)(2010-2#1)(2013-1#6)
oral candidosis##3##2##(2008-5#2)(2013-1#1)
oral care products##2##3##(1997-4#1)(2008-5#1)
oral care##4##2##(1997-4#1)(2008-5#1)(2008-7#2)
oral cavity of##7##3##(1995-9#1)(2008-12#2)(2008-5#1)(2013-1#3)
oral cavity##27##2##(1990-2#1)(1990-9#1)(1991-6#1)(1994-2#1)(1995-9#1)(1997-4#1)(2008-11#1)(2008-12#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-7#1)(2013-1#8)
oral challenge##4##2##(2008-5#1)(2012-3#3)
oral communication##2##2##(2008-12#1)(2008-9#1)
oral complications##2##2##(2008-11#1)(2008-7#1)
oral contraceptive pill##2##3##(2010-1#1)(2012-3#1)
oral contraceptive##5##2##(1990-6#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
oral contraceptives##10##2##(1990-6#3)(1991-2#1)(1991-8#1)(1996-11#1)(2008-11#2)(2008-8#1)(2009-8#1)
oral corticosteroid use##2##3##(2008-11#2)
oral corticosteroid##5##2##(2008-11#5)
oral corticosteroids##4##2##(2008-11#4)
oral deposition##2##2##(2008-11#1)(2008-8#1)
oral diseases##4##2##(1991-6#2)(2008-1#2)
oral dose of##2##3##(2008-6#1)(2013-1#1)
oral dose##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
oral doses of##2##3##(2007-11#1)(2008-10#1)
oral dosing##2##2##(2008-11#2)
oral exam##2##2##(2011-2#2)
oral examination##2##2##(2008-1#1)(2011-2#1)
oral fludarabine##3##2##(2009-12#3)
oral form##2##2##(2008-11#1)(2012-3#1)
oral function##2##2##(2011-2#2)
oral gavage##3##2##(2008-10#3)
oral glucose tolerance test (OGTT)##2##5##(1994-12#1)(2011-1#1)
oral glucose##5##2##(1994-12#1)(1995-11#1)(2008-1#1)(2010-11#1)(2011-1#1)
oral granisetron##6##2##(2010-12#6)
oral health care providers##2##4##(2012-3#2)
oral health care##3##3##(2012-3#3)
oral health in##2##3##(1991-6#1)(1995-12#1)
oral health of##2##3##(2012-3#1)(2013-1#1)
oral health program##2##3##(2008-5#2)
oral health status and##2##4##(2008-1#2)
oral health status of##2##4##(2008-1#1)(2008-5#1)
oral health status##5##3##(2008-1#3)(2008-5#2)
oral health##28##2##(1991-6#3)(1995-12#4)(2008-1#6)(2008-11#1)(2008-5#5)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)
oral health-related quality of life##2##5##(2011-7#1)(2013-1#1)
oral health-related quality of##3##4##(2011-2#1)(2011-7#1)(2013-1#1)
oral hygiene##2##2##(2013-1#2)
oral hyperkeratosis and##3##3##(2012-3#3)
oral hyperkeratosis##4##2##(2012-3#4)
oral hypoglycemics##4##2##(1991-12#4)
oral ingestion of##2##3##(1995-11#1)(2012-2#1)
oral ingestion##3##2##(1995-11#2)(2012-2#1)
oral intake of##4##3##(2008-11#1)(2012-3#3)
oral intake##5##2##(2008-11#1)(2012-2#1)(2012-3#3)
oral lesions##3##2##(2011-2#1)(2013-8#2)
oral lichen planus##4##3##(2009-6#1)(2013-1#3)
oral magnesium##3##2##(1990-9#3)
oral malodour##3##2##(2008-10#2)(2013-7#1)
oral manifestations##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
oral mucosa##4##2##(1993-1#3)(2013-1#1)
oral opening##2##2##(1991-2#1)(2013-1#1)
oral or##2##2##(2008-9#1)(2010-5#1)
oral pathogens##2##2##(2008-12#2)
oral polio vaccine##2##3##(1994-9#2)
oral poliovirus vaccine##2##3##(1995-3#2)
oral poliovirus##5##2##(1995-3#3)(1995-5#1)(2008-11#1)
oral reading fluency##4##3##(2008-12#4)
oral rehabilitation##2##2##(2011-2#2)
oral route##2##2##(2010-6#1)(2012-2#1)
oral secretions##2##2##(1990-11#2)
oral sex##2##2##(1996-5#2)
oral squamous cell carcinoma##6##4##(2010-12#2)(2013-1#4)
oral squamous##7##2##(1991-2#1)(2010-12#2)(2013-1#4)
oral steroids##2##2##(2010-5#1)(2012-3#1)
oral surgery with##3##3##(1993-1#3)
oral surgery##8##2##(1990-2#1)(1993-1#7)
oral sustained release##4##3##(2008-11#3)(2012-2#1)
oral tolerance induction##2##3##(2008-11#2)
oral tolerance##7##2##(2008-11#7)
oral toxicity##3##2##(2008-5#1)(2011-3#1)(2013-1#1)
oral treatment with##2##3##(1991-3#1)(2013-7#1)
oral treatment##3##2##(1991-3#1)(1993-12#1)(2013-7#1)
oral vaccination##2##2##(1992-5#1)(1995-5#1)
oral vaccine##2##2##(2008-9#1)(2012-3#1)
oral##443##1##(1990-11#2)(1990-2#4)(1990-3#2)(1990-6#4)(1990-8#1)(1990-9#5)(1991-12#5)(1991-2#4)(1991-3#3)(1991-4#1)(1991-6#9)(1991-8#2)(1992-3#1)(1992-5#2)(1992-9#4)(1993-1#13)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#3)(1995-12#4)(1995-3#3)(1995-5#4)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-2#3)(1996-5#3)(1996-6#2)(1997-1#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#4)(2007-12#2)(2008-1#11)(2008-10#16)(2008-11#53)(2008-12#16)(2008-3#1)(2008-5#29)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#4)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#17)(2010-2#1)(2010-5#3)(2010-6#5)(2010-7#3)(2011-1#1)(2011-2#24)(2011-3#1)(2011-7#3)(2012-12#3)(2012-2#10)(2012-3#23)(2013-1#47)(2013-7#4)(2013-8#5)
oral-facial-digital##2##1##(1997-3#2)
oralis##2##1##(2006-6#1)(2012-2#1)
orally administered##8##2##(1990-2#1)(1990-3#1)(1994-8#1)(1995-5#1)(2007-11#1)(2008-11#3)
orally at doses of##2##4##(2008-5#1)(2012-2#1)
orally at##5##2##(1992-12#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
orally given##3##2##(2008-11#2)(2011-2#1)
orally to##4##2##(1991-5#1)(2008-10#1)(2008-12#1)(2012-2#1)
orally##41##1##(1990-2#2)(1990-3#1)(1991-5#1)(1992-12#2)(1993-12#1)(1994-8#1)(1995-5#1)(1996-6#1)(2007-11#1)(2008-10#4)(2008-11#12)(2008-12#3)(2008-5#1)(2008-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
orally) for 7##2##3##(2011-2#2)
orange (AO)##6##2##(2008-10#3)(2008-12#2)(2008-9#1)
orange (Citrus sinensis)##2##3##(2008-10#2)
orange (Citrus##3##2##(2008-10#3)
orange (XO)##3##2##(2008-10#3)
orange and##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
orange for##2##2##(1991-11#1)(2008-10#1)
orange juice##7##2##(2008-10#4)(2010-5#3)
orange than##2##2##(2008-10#2)
orange to##3##2##(2008-10#1)(2012-2#2)
orange with##2##2##(2008-10#2)
orange##90##1##(1990-6#3)(1990-8#1)(1991-11#1)(1995-2#1)(2008-10#63)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-7#2)(2010-5#3)(2012-2#2)
orange)##2##1##(2006-6#1)(2008-10#1)
orange-spotted grouper##4##2##(2010-5#4)
oranges##2##1##(2008-10#1)(2008-12#1)
orbiculare##4##1##(2008-10#4)
orbit and##5##2##(2010-11#1)(2011-2#3)(2013-1#1)
orbit in##2##2##(2008-3#1)(2013-1#1)
orbit##19##1##(2008-11#1)(2008-3#4)(2008-9#1)(2010-10#1)(2010-11#2)(2011-2#4)(2012-3#3)(2013-1#3)
orbital and##2##2##(2008-10#1)(2011-2#1)
orbital decompression for##2##3##(2008-7#2)
orbital decompression##8##2##(2008-7#6)(2013-1#2)
orbital radiotherapy##2##2##(2013-1#2)
orbital rhabdomyosarcoma with##2##3##(2010-11#2)
orbital wall##2##2##(2010-10#1)(2013-1#1)
orbital##40##1##(1991-5#1)(1991-6#1)(1992-2#2)(1993-8#2)(1994-5#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#6)(2010-10#1)(2010-11#3)(2010-5#1)(2011-2#5)(2013-1#11)(2013-7#1)
orbitals##2##1##(2010-7#2)
orbitofrontal##8##1##(2008-11#1)(2008-7#1)(2009-10#5)(2011-2#1)
orbitopterional approach##4##2##(2011-2#4)
orbits##3##1##(1991-6#1)(1992-8#1)(1995-9#1)
orchard and##5##2##(2008-10#5)
orchard block##5##2##(2008-10#5)
orchard blocks##3##2##(2008-10#3)
orchard experiments##3##2##(2008-10#3)
orchard floor##6##2##(2008-10#6)
orchard in##2##2##(2008-10#2)
orchard sites##2##2##(2008-10#2)
orchard soil##5##2##(2008-10#5)
orchard soils were##2##3##(2008-10#2)
orchard soils##10##2##(2008-10#10)
orchard were##2##2##(2008-10#2)
orchard##87##1##(2008-10#87)
orchards and##5##2##(2008-10#4)(2008-12#1)
orchards are##2##2##(2008-10#2)
orchards at##3##2##(2008-10#3)
orchards during##3##2##(2008-10#3)
orchards in California##3##3##(2008-10#3)
orchards in northern##2##3##(2008-10#2)
orchards in the##3##3##(2008-10#3)
orchards in##13##2##(2008-10#13)
orchards located in##2##3##(2008-10#2)
orchards over##3##2##(2008-10#3)
orchards were##3##2##(2008-10#3)
orchards##78##1##(2008-10#77)(2008-12#1)
orchestrate##4##1##(2007-12#1)(2009-5#1)(2011-2#1)(2012-3#1)
orchestrated to##2##2##(2008-10#1)(2008-3#1)
orchestrated##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
orchid viruses##4##2##(2008-10#4)
orchid##10##1##(2008-10#10)
orchiectomized##2##1##(1996-2#2)
orchiectomy##4##1##(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#1)
orchiopexy##2##1##(2008-10#2)
orchitis##5##1##(1997-8#2)(2008-10#1)(2011-2#2)
ord##3##1##(2013-8#3)
order 1##2##2##(2008-10#1)(2008-8#1)
order I##3##2##(2013-8#3)
order and##6##2##(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)
order as a##2##3##(2007-12#1)(2008-3#1)
order entry system##2##3##(2013-1#2)
order entry##6##2##(1995-2#3)(2013-1#3)
order for##8##2##(1996-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-11#1)(2010-9#1)(2012-12#1)(2012-2#1)
order from##2##2##(2008-10#1)(2008-6#1)
order in the##6##3##(2008-10#4)(2008-5#1)(2013-8#1)
order in##12##2##(2008-10#6)(2008-3#2)(2008-5#1)(2012-2#2)(2013-8#1)
order kinetics##5##2##(1990-2#1)(1992-3#1)(2008-10#2)(2008-11#1)
order model##2##2##(2008-10#1)(2008-5#1)
order of a##2##3##(2008-3#2)
order of magnitude change in##2##5##(2008-10#2)
order of magnitude more##2##4##(1992-3#1)(2008-10#1)
order of magnitude##28##3##(1991-2#1)(1991-5#2)(1992-3#1)(1993-8#1)(1995-3#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#4)(2008-9#1)(2013-8#1)
order of potency##5##3##(1993-6#1)(1994-3#2)(1995-12#1)(2009-12#1)
order of relative##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
order of the##20##3##(1991-2#1)(1992-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-10#8)(2008-2#1)(2008-5#3)(2010-1#1)(2011-1#1)
order of their##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
order of##142##2##(1991-2#4)(1991-5#2)(1992-2#1)(1992-3#2)(1992-6#2)(1993-6#1)(1993-8#3)(1994-1#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-6#1)(2007-12#2)(2008-10#57)(2008-11#5)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#8)(2008-8#4)(2008-9#2)(2009-12#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
order on the##2##3##(2008-10#2)
order on##4##2##(2008-10#3)(2008-12#1)
order or##2##2##(1991-5#1)(1994-3#1)
order parameter##3##2##(1990-12#1)(1994-5#1)(2008-9#1)
order parameters##3##2##(1992-9#2)(2008-11#1)
order patterns##3##2##(2008-11#3)
order reaction##3##2##(2008-10#3)
order statistic##2##2##(2008-3#2)
order substrate binding##2##3##(1995-6#2)
order that##6##2##(1990-11#1)(2008-11#2)(2008-12#2)(2008-5#1)
order to achieve a##2##4##(1992-9#1)(2011-2#1)
order to achieve high##3##4##(1990-12#1)(2008-10#2)
order to achieve the##6##4##(2008-10#3)(2008-11#1)(2009-8#1)(2011-2#1)
order to achieve##18##3##(1990-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#2)
order to add##2##3##(2008-12#1)(2009-9#1)
order to address##2##3##(1997-2#1)(2008-11#1)
order to allow the##5##4##(2008-10#4)(2013-1#1)
order to analyze##4##3##(1992-5#1)(1997-7#1)(2008-10#1)(2008-11#1)
order to apply##2##3##(2008-10#1)(2008-4#1)
order to assess the##11##4##(1990-5#1)(1991-11#1)(1991-8#1)(1992-9#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-3#1)
order to assess##19##3##(1990-5#1)(1991-11#1)(1991-8#1)(1992-9#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#4)(2009-3#1)(2011-2#1)
order to attain##2##3##(1997-8#1)(2008-10#1)
order to avoid the##5##4##(2008-10#4)(2008-11#1)
order to avoid##12##3##(1991-12#1)(1992-12#1)(2008-10#7)(2008-11#1)(2011-2#2)
order to be able to##2##5##(1993-12#1)(2008-10#1)
order to be able##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
order to be##11##3##(1993-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-7#1)
order to calculate##2##3##(2008-10#2)
order to characterize the##5##4##(2008-10#3)(2008-11#1)(2008-7#1)
order to characterize##7##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)
order to check##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2012-7#1)
order to clarify the##2##4##(1991-12#1)(1995-8#1)
order to clarify##4##3##(1991-12#1)(1995-8#1)(2008-11#1)(2008-5#1)
order to compare the##3##4##(1994-3#1)(2008-10#2)
order to compare##8##3##(1991-7#1)(1994-3#1)(1994-5#1)(2008-10#4)(2011-2#1)
order to confirm##6##3##(1990-2#1)(1992-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
order to construct a##2##4##(2008-10#1)(2008-11#1)
order to control the##3##4##(2008-10#3)
order to control##5##3##(2008-10#3)(2008-11#1)(2013-8#1)
order to define##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
order to demonstrate the##3##4##(2008-10#3)
order to demonstrate##6##3##(2008-10#5)(2008-12#1)
order to derive a##2##4##(2008-10#2)
order to determine if##2##4##(1990-2#1)(2008-1#1)
order to determine the##23##4##(1990-11#1)(1990-3#1)(1993-3#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-9#1)(2010-8#2)(2013-1#1)
order to determine their##3##4##(2007-12#1)(2008-10#1)(2011-1#1)
order to determine whether##3##4##(1991-3#1)(1994-12#1)(1997-3#1)
order to determine which##3##4##(1994-2#1)(2008-10#1)(2011-2#1)
order to determine##46##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
order to develop a##8##4##(1990-5#1)(2008-10#3)(2008-7#2)(2008-8#1)(2009-7#1)
order to develop##16##3##(1990-5#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#1)
order to differentiate##3##3##(2008-10#3)
order to distinguish between##2##4##(2008-10#2)
order to distinguish##7##3##(1997-3#1)(2008-10#5)(2012-2#1)
order to eliminate the##2##4##(2008-10#1)(2010-11#1)
order to elucidate the role of##2##6##(1992-6#1)(2008-10#1)
order to elucidate the##8##4##(1992-6#1)(1992-8#1)(1993-3#1)(2008-10#3)(2008-5#1)(2011-3#1)
order to enhance the##3##4##(2008-11#1)(2011-1#1)(2011-2#1)
order to enhance##7##3##(2008-11#1)(2008-5#2)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
order to ensure that##2##4##(1997-8#1)(2008-11#1)
order to ensure##10##3##(1997-8#1)(2008-10#6)(2008-11#2)(2009-5#1)
order to establish a##2##4##(2008-11#1)(2008-7#1)
order to establish##14##3##(1991-6#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
order to estimate the##4##4##(2008-10#2)(2008-11#1)(2013-8#1)
order to evaluate the effect of##3##6##(1997-4#1)(2008-10#1)(2008-7#1)
order to evaluate the##20##4##(1990-2#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-6#1)(1997-4#1)(2008-10#11)(2008-7#1)(2011-2#1)(2013-8#1)
order to evaluate##27##3##(1990-2#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-6#1)(1997-4#1)(2008-10#14)(2008-12#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
order to examine the##7##4##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
order to examine##9##3##(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
order to explain the##3##4##(1994-5#1)(2008-10#2)
order to explain##4##3##(1994-5#1)(2008-10#2)(2012-2#1)
order to explore the##3##4##(2008-10#1)(2008-9#1)(2010-10#1)
order to explore##5##3##(2008-10#1)(2008-12#1)(2008-9#1)(2010-10#1)(2012-3#1)
order to facilitate##11##3##(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2009-11#1)(2013-1#1)
order to find out##4##4##(1991-11#1)(2012-3#1)(2013-1#2)
order to find the##3##4##(2008-10#2)(2008-11#1)
order to find##10##3##(1991-11#1)(1997-6#2)(2008-10#3)(2008-11#1)(2012-3#1)(2013-1#2)
order to further##6##3##(1994-1#1)(2008-10#4)(2008-11#1)
order to gain##7##3##(1993-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#2)
order to get a##4##4##(2008-10#3)(2013-8#1)
order to get##10##3##(2008-10#7)(2008-11#1)(2008-7#1)(2013-8#1)
order to give##3##3##(1993-1#1)(2008-11#2)
order to have a##2##4##(2008-10#1)(2008-12#1)
order to have##3##3##(1993-11#1)(2008-10#1)(2008-12#1)
order to help##5##3##(1992-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)
order to identify the##3##4##(2008-10#3)
order to identify##18##3##(1992-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#2)(2010-11#1)(2013-8#1)
order to illustrate the##2##4##(1990-8#1)(2008-10#1)
order to illustrate##3##3##(1990-8#1)(2008-10#2)
order to improve the##18##4##(1991-6#1)(2008-10#12)(2008-11#3)(2012-3#1)(2013-8#1)
order to improve##31##3##(1991-3#1)(1991-6#1)(1993-2#1)(2008-10#17)(2008-11#4)(2009-7#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#2)
order to increase sensitivity##2##4##(2008-10#2)
order to increase the##6##4##(2008-10#3)(2008-11#1)(2008-5#1)(2012-2#1)
order to increase##14##3##(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-7#1)(2012-2#1)
order to investigate the relationship between##4##6##(1994-3#2)(2008-9#1)(2011-2#1)
order to investigate the##13##4##(1993-6#1)(1994-3#2)(1994-8#2)(1996-12#2)(2008-10#2)(2008-8#1)(2008-9#2)(2011-2#1)
order to investigate their##3##4##(1990-12#1)(2008-11#1)(2008-9#1)
order to investigate##23##3##(1990-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#2)(1996-12#2)(2008-10#4)(2008-11#3)(2008-8#1)(2008-9#3)(2011-2#1)(2012-5#1)
order to know the##4##4##(2008-10#2)(2008-11#1)(2013-8#1)
order to learn##3##3##(1996-12#1)(2010-11#1)(2011-2#1)
order to make##13##3##(1991-2#1)(1993-9#1)(1994-1#1)(1997-8#1)(2008-10#4)(2008-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
order to map##2##3##(1991-8#1)(2008-12#1)
order to maximize the##6##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
order to maximize##9##3##(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)
order to mimic##2##3##(2008-10#1)(2009-7#1)
order to minimise the##2##4##(2010-12#1)(2011-2#1)
order to minimize the##3##4##(2008-10#3)
order to minimize##6##3##(1993-8#1)(2008-10#3)(2008-11#1)(2008-7#1)
order to obtain a##9##4##(2008-10#6)(2008-5#1)(2009-12#1)(2012-2#1)
order to obtain an##3##4##(2008-10#2)(2009-7#1)
order to obtain better##3##4##(2008-10#2)(2008-7#1)
order to obtain the##11##4##(2008-10#8)(2008-5#1)(2008-7#1)(2008-9#1)
order to obtain##45##3##(1991-2#1)(2008-10#28)(2008-11#3)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-7#2)(2010-1#1)(2012-2#1)(2013-1#1)
order to optimize the extraction##2##5##(2008-10#2)
order to optimize the##4##4##(2008-10#3)(2008-4#1)
order to optimize##6##3##(2008-10#4)(2008-11#1)(2008-4#1)
order to overcome##7##3##(1990-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-11#1)(2010-6#1)
order to perform the##2##4##(2008-10#2)
order to perform##6##3##(2008-10#5)(2010-11#1)
order to preserve##3##3##(2008-10#1)(2008-6#1)(2010-8#1)
order to prevent the##3##4##(1994-9#1)(1997-6#1)(2008-10#1)
order to prevent this##2##4##(1993-11#1)(2013-1#1)
order to prevent##12##3##(1991-6#1)(1992-3#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-6#1)(2008-10#1)(2010-1#1)(2010-4#1)(2011-3#1)(2013-1#1)
order to probe##2##3##(1994-5#1)(2008-8#1)
order to prove##3##3##(2008-10#2)(2008-5#1)
order to provide a##3##4##(1992-6#1)(2008-11#1)(2011-2#1)
order to provide##14##3##(1990-2#1)(1992-2#1)(1992-6#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2010-5#1)(2011-2#2)
order to raise the##2##4##(2008-8#1)(2011-2#1)
order to raise##3##3##(2008-8#1)(2011-2#2)
order to reduce the risk of##4##6##(1990-2#1)(2008-11#1)(2013-8#2)
order to reduce the##10##4##(1990-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
order to reduce##14##3##(1990-2#1)(1991-6#1)(1992-9#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#2)
order to remove the##4##4##(2008-10#4)
order to remove##6##3##(2008-10#4)(2008-6#1)(2013-1#1)
order to satisfy##2##3##(1994-3#1)(2008-10#1)
order to select##3##3##(2008-10#3)
order to study the##9##4##(1991-6#1)(1993-3#1)(1994-5#1)(1994-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#1)
order to study##14##3##(1991-12#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#1)
order to support##5##3##(2008-11#1)(2008-12#1)(2010-6#1)(2010-8#1)(2012-3#1)
order to target##2##3##(1997-2#1)(2008-7#1)
order to test the##6##4##(1991-5#1)(2008-10#2)(2008-5#1)(2009-9#1)(2012-2#1)
order to test whether##2##4##(2008-10#1)(2008-8#1)
order to test##10##3##(1991-5#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)
order to understand the##9##4##(1994-5#1)(1997-8#1)(2008-10#5)(2008-5#1)(2012-3#1)
order to understand##16##3##(1994-5#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-1#1)
order to use##2##3##(2008-10#1)(2008-11#1)
order to validate the##6##4##(1997-2#1)(2008-10#3)(2010-12#1)(2011-2#1)
order to validate##7##3##(1997-2#1)(2008-10#4)(2010-12#1)(2011-2#1)
order to verify the##4##4##(1997-2#1)(2008-10#2)(2008-9#1)
order to verify##5##3##(1997-2#1)(2008-10#2)(2008-7#1)(2008-9#1)
order to##883##2##(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#5)(1993-8#3)(1993-9#2)(1994-1#4)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#4)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#8)(1996-2#2)(1996-3#1)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#1)(1997-6#4)(1997-7#2)(1997-8#4)(2006-6#1)(2007-12#1)(2008-1#5)(2008-10#339)(2008-11#97)(2008-12#28)(2008-2#1)(2008-4#7)(2008-5#24)(2008-6#4)(2008-7#28)(2008-8#13)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#7)(2009-8#2)(2009-9#2)(2010-1#5)(2010-10#3)(2010-11#7)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#7)(2011-1#3)(2011-2#32)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#9)(2012-3#8)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#18)(2013-7#1)(2013-8#12)
order was##3##2##(1990-11#1)(2008-10#2)
order##1244##1##(1990-11#3)(1990-12#6)(1990-2#7)(1990-3#2)(1990-5#3)(1990-8#2)(1990-9#2)(1991-11#3)(1991-12#5)(1991-2#6)(1991-3#5)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#5)(1992-3#5)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#7)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#4)(1993-6#6)(1993-8#8)(1993-9#2)(1994-1#5)(1994-11#2)(1994-12#6)(1994-2#4)(1994-3#8)(1994-5#8)(1994-6#4)(1994-8#6)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#8)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#6)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#10)(1996-2#3)(1996-3#3)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#1)(1997-6#5)(1997-7#2)(1997-8#5)(2006-6#1)(2007-12#9)(2008-1#5)(2008-10#465)(2008-11#122)(2008-12#32)(2008-2#4)(2008-3#21)(2008-4#10)(2008-5#40)(2008-6#8)(2008-7#30)(2008-8#22)(2008-9#20)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#5)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#8)(2009-8#2)(2009-9#3)(2010-1#6)(2010-10#3)(2010-11#8)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#5)(2011-2#39)(2011-3#2)(2011-7#1)(2012-12#4)(2012-2#18)(2012-3#8)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#24)(2013-7#1)(2013-8#27)
order)##5##1##(1993-12#2)(2008-10#2)(2011-1#1)
order-disorder##2##1##(1992-8#1)(2008-10#1)
order-parameter##2##1##(2008-8#2)
ordered to##2##2##(1995-6#1)(1996-5#1)
ordered##33##1##(1990-11#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-5#5)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)
ordering and electronic coupling in bilayer nanoscale InAs/GaAs quantum dots separated by a thin##2##14##(2009-11#2)
ordering and##3##2##(2009-11#2)(2013-1#1)
ordering in##2##2##(2008-8#1)(2012-2#1)
ordering of the##3##3##(2008-10#1)(2008-6#1)(2010-3#1)
ordering of##8##2##(1992-9#2)(1996-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-3#1)(2013-1#1)
ordering##26##1##(1990-12#1)(1992-6#2)(1992-9#2)(1996-12#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#3)(2009-5#1)(2010-3#1)(2012-2#3)(2013-1#4)
orderly##8##1##(1991-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)
orders and##2##2##(2011-2#2)
orders are##2##2##(1994-3#1)(1995-2#1)
orders can##2##2##(1995-2#1)(2013-1#1)
orders for##2##2##(2008-10#2)
orders in##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
orders of magnitude (i##2##4##(2008-10#2)
orders of magnitude and##4##4##(2008-10#4)
orders of magnitude higher than that of##2##7##(1992-8#1)(2008-10#1)
orders of magnitude higher than##5##5##(1992-8#1)(2007-11#1)(2008-10#3)
orders of magnitude in##3##4##(2008-3#2)(2010-8#1)
orders of magnitude larger than##2##5##(2008-10#1)(2008-7#1)
orders of magnitude lower##2##4##(2008-10#2)
orders of magnitude of##2##4##(2008-10#2)
orders of magnitude smaller than##2##5##(2008-10#1)(2008-2#1)
orders of magnitude when##2##4##(2008-10#2)
orders of magnitude with detection limits##2##6##(2008-10#2)
orders of magnitude with##4##4##(2008-10#4)
orders of magnitude##70##3##(1990-11#1)(1991-5#1)(1992-8#1)(1994-5#3)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#43)(2008-11#2)(2008-2#1)(2008-3#7)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#2)(2012-2#1)
orders of magnitude)##2##3##(2008-10#2)
orders of scattering##2##3##(2008-3#2)
orders of##76##2##(1990-11#1)(1991-5#1)(1992-8#1)(1994-5#3)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#46)(2008-11#2)(2008-2#1)(2008-3#10)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#2)(2012-2#1)
orders were##2##2##(2008-3#1)(2011-2#1)
orders with##2##2##(2007-12#1)(2008-10#1)
orders##117##1##(1990-11#1)(1991-5#1)(1992-3#2)(1992-8#1)(1994-3#1)(1994-5#3)(1995-2#3)(1995-6#1)(2007-11#2)(2007-12#4)(2008-10#58)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-4#1)(2010-8#2)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#2)
ordinal data##6##2##(1995-9#1)(1996-3#1)(2008-10#4)
ordinal logistic##2##2##(2008-4#1)(2011-2#1)
ordinal responses##3##2##(1993-11#1)(1995-9#1)(1996-3#1)
ordinal scale##2##2##(1995-9#1)(2008-10#1)
ordinal##20##1##(1993-11#1)(1995-9#4)(1996-3#2)(1997-8#1)(2008-10#7)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#2)
ordinances##2##1##(1996-1#2)
ordinarily##3##1##(1990-5#1)(1991-12#1)(1996-3#1)
ordinary UV##2##2##(2008-10#2)
ordinary differential equations##3##3##(2008-6#1)(2010-10#1)(2013-8#1)
ordinary least squares regression##2##4##(1993-12#1)(2008-11#1)
ordinary least squares##4##3##(1993-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
ordinary mean estimator and##2##4##(2008-10#2)
ordinary runs##2##2##(2008-10#2)
ordinary serous and##2##3##(2008-7#2)
ordinary serous##3##2##(2008-7#3)
ordinary strain##2##2##(2008-10#2)
ordinary##46##1##(1990-11#1)(1990-6#1)(1991-6#3)(1993-12#2)(1993-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
ore body rock sample##2##4##(2013-8#2)
ore body rock##6##3##(2013-8#6)
ore body rock--&gt##2##3##(2013-8#2)
ore body##8##2##(2013-8#8)
ore samples##8##2##(2008-10#8)
ore##29##1##(2008-10#19)(2013-8#10)
ores and##4##2##(2008-10#4)
ores##14##1##(2008-10#13)(2008-9#1)
orfs##2##1##(1997-7#2)
org##3##1##(2008-10#1)(2008-8#1)(2009-12#1)
org)##7##1##(2008-11#1)(2008-12#3)(2008-7#1)(2011-2#1)(2013-7#1)
org/10##5##1##(2013-8#5)
org/catalog/pubdates##6##1##(2011-2#6)
organ and##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
organ bath##3##2##(1993-8#1)(1997-4#1)(2008-12#1)
organ blood flow##2##3##(1991-2#1)(2008-10#1)
organ culture##5##2##(1993-12#1)(1994-2#1)(1995-8#2)(2008-11#1)
organ cultures##4##2##(1997-3#1)(2008-11#2)(2008-5#1)
organ damage in##2##3##(1992-6#1)(2009-1#1)
organ damage##6##2##(1992-6#1)(1994-6#1)(2009-1#4)
organ donation##5##2##(1991-3#1)(1992-1#1)(1994-5#1)(1996-9#1)(2012-2#1)
organ dysfunction##3##2##(2012-3#1)(2013-1#2)
organ failure##8##2##(1996-3#1)(1997-1#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#2)
organ for##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
organ function##4##2##(1992-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
organ functions##2##2##(2010-1#1)(2013-1#1)
organ growth rates##3##3##(2008-8#3)
organ injury##3##2##(2008-12#2)(2012-3#1)
organ involvement##4##2##(1997-8#1)(2008-5#1)(2010-12#1)(2013-1#1)
organ is##3##2##(1992-3#1)(2008-11#1)(2008-9#1)
organ of the##2##3##(2007-12#1)(2011-1#1)
organ of##9##2##(1990-5#1)(1994-2#1)(2007-12#2)(2008-11#1)(2008-5#1)(2010-10#1)(2011-1#1)(2011-2#1)
organ preservation##2##2##(1997-2#1)(2011-3#1)
organ samples##2##2##(2008-10#1)(2008-5#1)
organ specific##2##2##(2008-8#1)(2009-3#1)
organ systems##6##2##(1990-11#1)(1993-2#1)(2008-1#1)(2008-10#2)(2010-11#1)
organ transplant recipients##4##3##(1997-2#1)(2008-10#1)(2008-6#2)
organ transplant##5##2##(1997-2#1)(2008-10#1)(2008-6#2)(2013-1#1)
organ transplantation##7##2##(1996-11#1)(1996-2#1)(1997-5#2)(1997-8#1)(2009-3#1)(2011-3#1)
organ weights##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
organ##178##1##(1990-11#2)(1990-5#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#3)(1994-2#4)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-8#3)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#12)(2008-11#10)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#12)(2009-1#4)(2009-10#1)(2009-3#2)(2009-5#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#11)
organ-specific##3##1##(2008-10#1)(2008-11#1)(2008-4#1)
organellar##3##1##(2008-8#1)(2010-4#1)(2012-3#1)
organelle##18##1##(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#2)(2011-2#4)(2012-2#1)(2012-3#1)
organelles and##2##2##(2008-4#1)(2008-7#1)
organelles in the##2##3##(2008-11#1)(2009-10#1)
organelles in##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
organelles such as##2##3##(1994-11#1)(2009-8#1)
organelles##43##1##(1993-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(1995-9#1)(2008-10#3)(2008-11#4)(2008-4#7)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#4)(2009-5#2)(2009-8#3)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)
organgenesis and##2##2##(2008-8#1)(2008-9#1)
organgenesis##3##1##(2008-8#2)(2008-9#1)
organic acid anhydrides##2##3##(1995-11#2)
organic acid##6##2##(1995-11#2)(2008-10#3)(2008-7#1)
organic acids and##5##3##(2008-10#5)
organic acids in##6##3##(2008-10#5)(2013-8#1)
organic acids##24##2##(1992-3#2)(2008-10#20)(2008-7#1)(2013-8#1)
organic additives##2##2##(2008-10#2)
organic amendments##6##2##(2008-10#6)
organic amine##4##2##(2008-10#4)
organic amines##3##2##(2008-10#3)
organic and aqueous##3##3##(2008-10#3)
organic and elemental##2##3##(2008-10#2)
organic and inorganic anions##4##4##(2008-10#4)
organic and inorganic##17##3##(2008-10#13)(2008-11#2)(2009-7#1)(2010-4#1)
organic and##27##2##(2008-10#23)(2008-11#2)(2009-7#1)(2010-4#1)
organic anions##4##2##(2008-10#2)(2008-11#2)
organic arsenic##4##2##(2008-10#4)
organic bases##2##2##(2008-10#2)
organic carbon (TOC)##2##3##(2008-10#2)
organic carbon##12##2##(2008-10#12)
organic chemicals##5##2##(2008-10#3)(2008-11#1)(2009-8#1)
organic compounds (VOCs)##5##3##(2008-10#5)
organic compounds and##3##3##(2008-10#3)
organic compounds are##2##3##(2008-10#2)
organic compounds from##4##3##(2008-10#4)
organic compounds in##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
organic compounds##68##2##(2008-10#59)(2008-11#2)(2008-3#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
organic constituents##2##2##(2008-10#2)
organic contaminants in the##2##4##(2008-10#2)
organic contaminants in##4##3##(1994-3#1)(2008-10#3)
organic content and##2##3##(1995-3#1)(2008-12#1)
organic content##4##2##(1995-3#1)(2008-10#2)(2008-12#1)
organic dye##3##2##(2008-10#3)
organic dyes in##3##3##(2008-10#2)(2008-11#1)
organic dyes##8##2##(2008-10#5)(2008-11#1)(2009-10#1)(2010-4#1)
organic geochemistry##2##2##(2008-11#2)
organic group##3##2##(1996-5#1)(2008-10#2)
organic heart##2##2##(1990-3#2)
organic ion##3##2##(1994-5#1)(2008-10#2)
organic ligand##3##2##(2008-10#3)
organic ligands##8##2##(2008-10#8)
organic liquid##3##2##(2008-10#3)
organic material##2##2##(2008-10#1)(2008-9#1)
organic materials##5##2##(1991-7#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
organic matrices##2##2##(2008-10#2)
organic matrix of##2##3##(2008-10#1)(2008-7#1)
organic matrix##5##2##(2008-10#2)(2008-7#2)(2009-7#1)
organic matter (DOM)##4##3##(2008-10#3)(2008-11#1)
organic matter and##3##3##(2008-10#2)(2008-12#1)
organic matter are##2##3##(2008-10#1)(2008-3#1)
organic matter content and##2##4##(2008-10#2)
organic matter content##6##3##(2008-10#6)
organic matter decomposition##2##3##(2008-11#2)
organic matter in##2##3##(2008-11#2)
organic matter on##2##3##(2008-10#1)(2008-11#1)
organic matter were##2##3##(2008-10#2)
organic matter##58##2##(1992-5#2)(2008-10#38)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#1)(2013-8#3)
organic matter)##2##2##(2011-2#1)(2012-2#1)
organic mercury species##2##3##(2008-10#2)
organic mercury##8##2##(2008-10#8)
organic microdrop##2##2##(2008-10#2)
organic modifier and##5##3##(2008-10#5)
organic modifier##12##2##(2008-10#12)
organic moieties##2##2##(1997-2#1)(2008-10#1)
organic molecules##8##2##(1997-6#2)(2008-10#3)(2009-11#2)(2013-8#1)
organic monolayers##2##2##(1992-8#1)(1994-9#1)
organic nitrogen sources##2##3##(1995-9#2)
organic nitrogen##3##2##(1995-9#2)(2008-10#1)
organic peroxides##2##2##(2008-10#2)
organic phase containing##2##3##(2008-10#2)
organic phase in the##2##4##(2008-10#2)
organic phase of##2##3##(2008-10#1)(2013-1#1)
organic phase through##2##3##(2008-7#1)(2010-4#1)
organic phase was##2##3##(2008-10#2)
organic phase with 1##2##4##(2008-10#2)
organic phase with##5##3##(2008-10#5)
organic phase##49##2##(1994-8#1)(2008-10#43)(2008-7#1)(2010-4#3)(2013-1#1)
organic phases##7##2##(2008-10#6)(2010-4#1)
organic phosphates##2##2##(1994-3#1)(2008-10#1)
organic phosphorus##8##2##(2008-10#8)
organic phthalates##2##2##(2008-11#2)
organic pollutants in##2##3##(2008-10#2)
organic pollutants##7##2##(2008-10#5)(2008-11#2)
organic polyanions##2##2##(2008-10#2)
organic polymer##3##2##(2008-10#2)(2008-3#1)
organic silicon sol##4##3##(2008-10#4)
organic silicon##5##2##(2008-10#5)
organic solvent and##7##3##(2008-10#6)(2008-8#1)
organic solvent as##2##3##(2008-10#2)
organic solvent consumption##2##3##(2008-10#2)
organic solvent extraction##2##3##(2008-10#1)(2008-9#1)
organic solvent has been##2##4##(2008-10#1)(2010-11#1)
organic solvent in##2##3##(2008-10#2)
organic solvent is##3##3##(2008-10#3)
organic solvent modifier##2##3##(2008-10#2)
organic solvent was##4##3##(2008-10#4)
organic solvent##63##2##(1990-5#3)(1992-3#2)(2008-10#52)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)
organic solvents as the extractants##2##5##(2008-10#2)
organic solvents as##4##3##(2008-10#4)
organic solvents on##2##3##(2008-10#1)(2011-1#1)
organic solvents to##2##3##(2008-10#2)
organic solvents were##2##3##(2008-10#2)
organic solvents##49##2##(1990-5#1)(1990-8#2)(1994-8#3)(1995-3#1)(2008-10#36)(2008-11#1)(2008-3#1)(2011-1#2)(2011-2#1)(2012-2#1)
organic species##2##2##(2008-10#2)
organic substances##3##2##(2008-10#3)
organic substrate##3##2##(2008-10#3)
organic substrates and##2##3##(2008-10#1)(2009-4#1)
organic substrates##3##2##(2008-10#2)(2009-4#1)
organic sulfur##3##2##(2008-10#2)(2008-6#1)
organic vapors investigated##3##3##(2008-10#3)
organic vapors##5##2##(2008-10#5)
organic xenobiotics in##2##3##(2008-11#2)
organic##694##1##(1990-3#2)(1990-5#4)(1990-8#2)(1990-9#1)(1991-7#1)(1992-2#1)(1992-3#4)(1992-5#3)(1992-6#1)(1992-8#1)(1994-3#2)(1994-5#2)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#3)(1995-9#2)(1996-2#1)(1996-5#2)(1997-2#2)(1997-6#2)(2007-12#2)(2008-10#521)(2008-11#38)(2008-12#6)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#14)(2008-8#1)(2008-9#2)(2009-10#5)(2009-11#3)(2009-4#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#8)(2010-6#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#7)
organic-inorganic hybrid multilayers##2##3##(2008-10#2)
organic-inorganic##3##1##(2008-10#3)
organically managed##2##2##(2008-10#2)
organically modified silicate##2##3##(2008-10#2)
organically modified sol-gel glass##2##4##(2008-10#2)
organically modified##7##2##(2008-10#6)(2008-3#1)
organically##13##1##(1994-8#1)(2008-10#9)(2008-3#1)(2008-8#1)(2008-9#1)
organics in##2##2##(2008-10#1)(2011-1#1)
organics##3##1##(2008-10#2)(2011-1#1)
organisation and##2##2##(1991-6#1)(2008-1#1)
organisation in##3##2##(1991-7#1)(2007-8#1)(2010-10#1)
organisation is##3##2##(2008-6#1)(2009-6#1)(2010-10#1)
organisation of##8##2##(1993-6#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2009-7#2)(2010-10#1)
organisation##29##1##(1991-6#1)(1991-7#1)(1993-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#6)(2008-6#2)(2009-6#1)(2009-7#2)(2010-10#3)
organisational and##3##2##(2008-11#3)
organisational##12##1##(1994-3#1)(2008-11#7)(2008-12#2)(2011-2#2)
organisations and##2##2##(1997-7#1)(2011-2#1)
organisations are##2##2##(2008-1#1)(2013-1#1)
organisations can##2##2##(2008-11#1)(2008-6#1)
organisations##16##1##(1990-12#1)(1997-7#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
organised by the European Commission and Ecoles des Mines d'Alès##2##10##(2008-10#2)
organised by the European##3##4##(2008-10#3)
organised by##4##2##(2008-10#3)(2008-5#1)
organised##8##1##(1993-12#1)(1996-12#1)(2008-10#5)(2008-5#1)
organising##3##1##(1995-2#1)(2008-11#1)(2011-2#1)
organism and##8##2##(1990-8#2)(1995-2#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-8#1)
organism are##5##2##(1991-6#1)(1997-6#1)(2008-10#1)(2010-4#1)(2011-1#1)
organism by##2##2##(2008-7#1)(2011-2#1)
organism in##6##2##(1991-11#1)(1996-8#1)(1997-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
organism is##8##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-6#1)(2011-2#3)
organism of##4##2##(2008-10#3)(2008-5#1)
organism to study##2##3##(2008-11#1)(2013-8#1)
organism to##5##2##(1996-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2013-8#1)
organism was##3##2##(1992-5#1)(1996-8#1)(2008-5#1)
organism with##2##2##(2008-10#2)
organism##151##1##(1990-8#2)(1991-11#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-2#2)(1993-6#1)(1995-2#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-8#2)(1997-1#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#22)(2008-11#5)(2008-12#2)(2008-4#3)(2008-5#5)(2008-7#9)(2008-8#7)(2008-9#7)(2009-3#1)(2009-8#4)(2009-9#3)(2010-11#1)(2010-3#2)(2010-4#3)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#35)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
organism's ability to##2##3##(2008-4#1)(2011-2#1)
organism's##9##1##(1994-8#1)(1995-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)
organismal##2##1##(2010-5#1)(2012-3#1)
organismic##2##1##(1997-2#1)(2008-11#1)
organisms against##2##2##(2008-10#1)(2013-8#1)
organisms and##13##2##(1990-7#1)(1993-12#1)(1994-3#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#1)(2012-2#1)(2012-3#1)
organisms are##3##2##(1993-6#1)(2008-11#2)
organisms by##2##2##(1992-2#1)(2012-2#1)
organisms can be used##2##4##(2008-10#1)(2008-2#1)
organisms can be##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
organisms can##4##2##(1990-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
organisms causing serious infections in the hospital##2##7##(2008-7#2)
organisms causing serious infections in##3##5##(2008-7#3)
organisms exposed##2##2##(2008-11#2)
organisms for##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
organisms has##3##2##(2008-4#1)(2008-9#2)
organisms have##6##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)
organisms in a##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
organisms in the##4##3##(2008-10#2)(2011-2#2)
organisms in##11##2##(1995-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#2)
organisms including##2##2##(2008-9#1)(2012-2#1)
organisms is##2##2##(2008-11#1)(2010-9#1)
organisms may##2##2##(1997-5#1)(2008-9#1)
organisms of##2##2##(2010-6#1)(2011-2#1)
organisms ranging from##2##3##(2008-8#1)(2009-8#1)
organisms such as##2##3##(2008-8#2)
organisms tested##2##2##(1996-12#1)(2013-1#1)
organisms that are##3##3##(2008-10#1)(2008-8#2)
organisms that##8##2##(2008-10#2)(2008-8#5)(2008-9#1)
organisms to be##2##3##(2008-10#1)(2008-11#1)
organisms to##6##2##(2008-10#2)(2008-11#1)(2008-8#2)(2012-2#1)
organisms were##8##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)
organisms with a##2##3##(2008-8#2)
organisms with##6##2##(1997-7#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-2#1)
organisms##226##1##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-2#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-9#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#4)(2007-12#1)(2008-10#42)(2008-11#12)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#7)(2008-7#16)(2008-8#37)(2008-9#13)(2009-10#1)(2009-4#1)(2009-6#2)(2009-8#6)(2010-10#1)(2010-11#3)(2010-3#1)(2010-5#1)(2010-6#2)(2010-9#2)(2011-1#1)(2011-2#17)(2012-2#8)(2012-3#6)(2013-1#3)(2013-8#2)
organization and a##2##3##(1992-2#1)(2008-10#1)
organization and cell##2##3##(2009-5#1)(2013-1#1)
organization and distribution##2##3##(1996-12#1)(2009-8#1)
organization and fee-for-service##2##3##(1991-3#1)(1993-12#1)
organization and the##4##3##(1990-2#1)(1991-12#1)(1994-1#1)(2013-1#1)
organization and##44##2##(1990-2#2)(1991-12#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-2#2)(2013-1#2)(2013-8#1)
organization are##4##2##(1991-6#1)(1994-5#1)(1997-2#1)(2012-3#1)
organization as well as the##2##5##(1993-12#1)(2009-8#1)
organization as well as##3##4##(1993-12#1)(1995-2#1)(2009-8#1)
organization as##5##2##(1993-12#1)(1994-11#1)(1995-2#1)(1996-2#1)(2009-8#1)
organization at##2##2##(2008-12#1)(2008-9#1)
organization between##2##2##(1995-11#1)(2008-8#1)
organization by##3##2##(2008-7#1)(2009-10#1)(2012-2#1)
organization during the##2##3##(2008-11#1)(2011-2#1)
organization during##4##2##(1995-12#1)(2008-11#2)(2011-2#1)
organization for##2##2##(1990-6#1)(1993-12#1)
organization in the##3##3##(1993-12#1)(2008-12#1)(2008-5#1)
organization in##13##2##(1993-12#1)(1994-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
organization into the##2##3##(1997-1#1)(2010-9#1)
organization is to##2##3##(1994-2#1)(2008-7#1)
organization is##12##2##(1991-2#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-1#2)(2008-10#1)(2008-12#2)(2008-7#1)(2009-9#1)
organization may##3##2##(1991-2#1)(1994-1#1)(2008-5#1)
organization might be##2##3##(1992-11#1)(2008-11#1)
organization must be##2##3##(1994-2#1)(1994-3#1)
organization must##4##2##(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)
organization of the primate##2##4##(1995-5#2)
organization of the stratum corneum##2##5##(2008-10#1)(2008-5#1)
organization of the##39##3##(1991-2#2)(1991-6#1)(1992-3#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-5#5)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#1)(2009-8#1)(2010-4#1)(2013-8#2)
organization of their##2##3##(2008-12#1)(2012-2#1)
organization of##95##2##(1991-2#4)(1991-6#1)(1992-1#1)(1992-3#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-5#6)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#9)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#3)(2009-10#4)(2009-4#1)(2009-5#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2012-2#2)(2013-1#1)(2013-8#3)
organization on##2##2##(1995-12#1)(2008-12#1)
organization that##3##2##(1992-8#1)(1996-3#1)(2013-1#1)
organization through##2##2##(1993-12#1)(1997-3#1)
organization to a##2##3##(1997-2#2)
organization to##8##2##(1992-3#1)(1995-3#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-8#1)(2009-8#1)
organization was observed##2##3##(1997-3#1)(2008-11#1)
organization was typical of##2##4##(2008-10#2)
organization was##6##2##(1991-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
organization will##2##2##(1996-3#1)(1997-1#1)
organization with a##2##3##(1996-1#1)(2012-3#1)
organization with##4##2##(1996-1#1)(1997-7#1)(2009-10#1)(2012-3#1)
organization within the##2##3##(1991-2#1)(1991-6#1)
organization within##3##2##(1991-2#1)(1991-6#1)(2008-11#1)
organization##363##1##(1990-12#1)(1990-2#3)(1990-6#1)(1991-12#1)(1991-2#12)(1991-3#3)(1991-6#3)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#6)(1992-5#1)(1992-8#1)(1993-1#4)(1993-12#9)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#2)(1994-1#8)(1994-11#3)(1994-12#10)(1994-2#9)(1994-3#8)(1994-5#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#3)(1995-5#6)(1995-6#2)(1996-1#10)(1996-12#3)(1996-2#7)(1996-3#7)(1996-6#1)(1997-1#6)(1997-2#7)(1997-3#9)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#6)(2008-1#1)(2008-10#23)(2008-11#21)(2008-12#8)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#13)(2008-9#11)(2009-10#10)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-4#2)(2010-5#3)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#3)(2013-1#6)(2013-8#5)
organization's##13##1##(1991-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(2008-11#1)(2008-9#3)(2010-8#1)
organization-wide##3##1##(1993-3#1)(1994-1#1)(2010-8#1)
organizational and market characteristics##2##4##(2008-11#2)
organizational and##11##2##(1991-1#1)(1992-1#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-3#1)(1996-6#1)(2008-11#3)(2009-5#1)
organizational aspects##3##2##(1990-11#1)(1992-12#1)(2007-12#1)
organizational change##3##2##(1996-1#1)(2008-6#1)(2009-11#1)
organizational changes##5##2##(1996-1#1)(2009-10#3)(2012-3#1)
organizational climate##2##2##(1993-2#1)(2008-11#1)
organizational commitment##6##2##(1996-1#6)
organizational development##2##2##(1993-12#1)(1994-12#1)
organizational leadership##2##2##(1994-12#1)(2013-1#1)
organizational model for##2##3##(1994-12#1)(1996-1#1)
organizational needs##2##2##(1993-1#1)(1994-2#1)
organizational objectives##2##2##(1992-2#1)(1994-2#1)
organizational performance##2##2##(1995-12#1)(1995-2#1)
organizational structure##11##2##(1991-1#1)(1991-3#1)(1992-5#2)(1994-2#1)(1996-1#2)(2008-10#1)(2008-11#2)(2013-8#1)
organizational structures and##2##3##(1993-12#1)(1993-3#1)
organizational structures##6##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-3#1)(1995-1#1)(2008-11#1)
organizational##108##1##(1990-11#3)(1991-1#2)(1991-2#1)(1991-3#3)(1991-6#1)(1992-1#2)(1992-12#3)(1992-2#2)(1992-5#3)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#1)(1994-1#3)(1994-12#6)(1994-2#4)(1994-3#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#13)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#3)(2007-12#1)(2008-10#4)(2008-11#15)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-5#1)(2010-10#1)(2010-7#1)(2010-8#2)(2012-3#2)(2013-1#1)(2013-8#1)
organizational-level##2##1##(2013-1#2)
organizationally##2##1##(1996-2#1)(1997-3#1)
organizations and the##2##3##(1991-3#2)
organizations and##16##2##(1990-6#1)(1991-3#2)(1993-3#2)(1994-12#1)(1995-2#2)(1996-1#2)(1996-2#1)(1997-2#1)(2008-11#2)(2008-7#1)(2010-8#1)
organizations are##11##2##(1991-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-1#1)(2008-12#1)(2008-7#1)(2008-9#1)
organizations can##3##2##(1993-12#2)(2008-6#1)
organizations could##2##2##(1995-12#1)(2012-3#1)
organizations have##5##2##(1991-1#1)(1991-3#1)(1993-11#1)(1995-12#1)(2010-8#1)
organizations in the##2##3##(1996-1#1)(2008-12#1)
organizations in##7##2##(1994-12#2)(1995-3#1)(1996-1#1)(1997-2#1)(2008-12#1)(2013-8#1)
organizations involved in##2##3##(2008-11#1)(2012-2#1)
organizations is##4##2##(1991-12#1)(1993-12#2)(1994-12#1)
organizations must##3##2##(1993-12#1)(1997-1#1)(1997-2#1)
organizations of the##2##3##(1996-12#1)(2008-10#1)
organizations should##3##2##(1992-3#1)(1996-1#1)(1997-1#1)
organizations such as the##2##4##(2008-10#1)(2010-1#1)
organizations that are##3##3##(1993-12#1)(1994-1#1)(1996-3#1)
organizations that have##2##3##(1991-3#1)(2009-3#1)
organizations that##8##2##(1991-3#1)(1993-12#1)(1994-1#1)(1996-2#1)(1996-3#1)(2008-9#1)(2009-3#1)(2013-8#1)
organizations to##9##2##(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2013-8#1)
organizations were##5##2##(1995-1#1)(1995-6#1)(1996-3#1)(2008-11#1)(2009-5#1)
organizations within##2##2##(2008-1#1)(2008-6#1)
organizations##217##1##(1990-6#1)(1991-1#3)(1991-12#7)(1991-2#2)(1991-3#13)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1993-1#2)(1993-11#1)(1993-12#15)(1993-2#2)(1993-3#6)(1994-1#7)(1994-12#14)(1994-2#4)(1994-3#3)(1995-1#4)(1995-12#3)(1995-2#5)(1995-3#2)(1995-6#1)(1996-1#10)(1996-12#1)(1996-2#7)(1996-3#11)(1997-1#10)(1997-2#8)(1997-3#6)(1997-5#1)(2008-1#2)(2008-10#3)(2008-11#10)(2008-12#2)(2008-6#5)(2008-7#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#2)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#4)
organizations'##3##1##(1992-1#1)(1992-12#1)(1996-3#1)
organizations?##2##1##(2008-6#1)(2008-7#1)
organize the##7##2##(2008-1#1)(2009-4#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
organize##19##1##(1991-3#1)(1992-1#1)(1994-1#1)(1994-3#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#2)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
organized and##3##2##(1993-12#1)(1997-3#1)(2008-11#1)
organized around##2##2##(1996-1#1)(2008-11#1)
organized as a##3##3##(2007-12#1)(2008-8#1)(2013-1#1)
organized as##6##2##(1993-12#1)(1994-5#1)(2007-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
organized by the##4##3##(2008-10#2)(2013-1#2)
organized by##8##2##(2008-10#2)(2010-5#1)(2011-2#2)(2013-1#3)
organized in a##5##3##(1991-2#1)(1993-11#1)(1994-2#1)(2008-7#1)(2009-12#1)
organized in##16##2##(1991-2#2)(1993-11#1)(1993-2#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#1)
organized into a##4##3##(1993-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
organized into##11##2##(1992-9#1)(1993-12#2)(1996-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
organized similarly to##2##3##(2008-10#2)
organized##96##1##(1990-6#3)(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-12#1)(1995-3#2)(1996-1#2)(1996-3#1)(1997-1#1)(1997-3#2)(2007-12#4)(2008-10#12)(2008-11#8)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
organizer of##2##2##(2011-2#1)(2011-4#1)
organizer regions (NORs)##2##3##(1993-12#1)(2008-12#1)
organizer##7##1##(1993-12#1)(2007-12#1)(2008-12#2)(2011-2#1)(2011-4#1)(2013-1#1)
organizes##2##1##(1994-12#1)(2012-2#1)
organizing and##2##2##(1992-3#1)(2013-1#1)
organizing pneumonia##2##2##(2010-12#2)
organizing region##2##2##(2008-10#1)(2008-12#1)
organizing##20##1##(1992-3#1)(1993-3#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
organocatalytic##2##1##(2011-2#2)
organochlorine compounds##3##2##(2008-10#3)
organochlorine pesticides (OCPs)##2##3##(2008-10#2)
organochlorine pesticides from##2##3##(2008-10#2)
organochlorine pesticides##8##2##(2008-10#8)
organochlorine##14##1##(2008-10#14)
organofunctional##3##1##(2009-7#3)
organofunctionalized##3##1##(2008-10#3)
organogenesis in##2##2##(2008-12#1)(2011-2#1)
organogenesis of##3##2##(2008-12#2)(2011-2#1)
organogenesis##12##1##(1995-8#1)(2008-12#4)(2008-7#2)(2008-9#2)(2011-2#3)
organoleptic##4##1##(2008-10#1)(2008-5#2)(2010-4#1)
organolithium compound##2##2##(1996-5#2)
organolithium##4##1##(1996-5#4)
organomercury##2##1##(2008-10#2)
organometallic##4##1##(2008-10#2)(2009-9#1)(2012-3#1)
organophilic##3##1##(1992-3#1)(2008-10#2)
organophosphate##7##1##(1990-9#1)(1997-5#1)(2008-10#3)(2012-12#1)(2013-8#1)
organophosphates##2##1##(1994-5#2)
organophosphorous hydrolase##2##2##(2008-10#2)
organophosphorous##10##1##(1994-5#1)(2008-10#6)(2010-5#2)(2013-1#1)
organophosphorus pesticide##4##2##(2008-10#4)
organophosphorus pesticides (OPPs)##2##3##(2008-10#2)
organophosphorus pesticides (OPs)##2##3##(2008-10#2)
organophosphorus pesticides such as##2##4##(2008-10#2)
organophosphorus pesticides##15##2##(2008-10#14)(2008-11#1)
organophosphorus##27##1##(2008-10#26)(2008-11#1)
organosilane##2##1##(1997-2#1)(2008-10#1)
organotin complexes##2##2##(2008-10#2)
organotin compounds##5##2##(2008-10#5)
organotin##14##1##(2008-10#14)
organotin(IV) complexes##2##2##(2008-10#2)
organotins in##2##2##(2008-10#2)
organotins##5##1##(2008-10#5)
organotypic cultures##2##2##(2008-11#1)(2008-4#1)
organotypic##7##1##(2008-11#2)(2008-4#2)(2009-9#2)(2013-1#1)
organotypical in vitro model##2##4##(2008-11#2)
organs and brain regions##2##4##(1994-5#2)
organs and in the##2##4##(2008-10#1)(2008-9#1)
organs and in##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
organs and tissues##5##3##(1995-12#1)(1996-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
organs and##15##2##(1993-8#1)(1993-9#1)(1994-5#2)(1995-12#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-9#1)(2012-2#1)(2012-3#4)
organs as well as##2##4##(1992-6#1)(2008-10#1)
organs at##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
organs between##2##2##(2008-5#1)(2008-8#1)
organs for##2##2##(1994-1#1)(2007-11#1)
organs from##3##2##(1993-2#1)(1996-2#1)(1997-4#1)
organs in the##2##3##(2008-10#2)
organs in##4##2##(1991-8#1)(2008-10#2)(2008-9#1)
organs involved in##2##3##(2008-10#1)(2012-2#1)
organs involved##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
organs is##2##2##(2008-10#1)(2012-3#1)
organs of the##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
organs of##14##2##(1991-8#1)(1996-12#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2013-8#1)
organs or systems##2##3##(2008-5#1)(2013-1#1)
organs or##6##2##(2008-10#2)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
organs such as##2##3##(2010-11#1)(2012-12#1)
organs that##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
organs were##5##2##(1993-3#1)(2007-12#1)(2008-11#1)(2008-5#2)
organs##170##1##(1990-11#1)(1990-12#2)(1990-5#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-5#3)(1995-12#2)(1995-2#3)(1996-12#3)(1996-2#3)(1996-3#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#7)(2008-10#29)(2008-11#7)(2008-12#6)(2008-4#1)(2008-5#11)(2008-7#5)(2008-8#8)(2008-9#5)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#2)(2013-7#1)(2013-8#3)
organs]##2##1##(2012-3#2)
ori lambda##4##2##(1994-11#4)
ori##5##1##(1994-11#4)(1996-6#1)
oriLyt replication##3##2##(1997-3#3)
oriLyt##11##1##(1997-3#11)
oriP elements##2##2##(2008-11#2)
oriP##4##1##(2008-11#4)
orient##3##1##(2008-3#1)(2009-8#2)
oriental##6##1##(1997-8#3)(2008-10#2)(2008-6#1)
orientalis##3##1##(2008-5#1)(2008-8#2)
orientated##7##1##(2008-10#1)(2008-5#1)(2011-2#3)(2012-12#1)(2012-2#1)
orientation and angular distribution of##2##5##(2008-10#2)
orientation and chemicals) of the laboratory in which##2##8##(2008-10#2)
orientation and for##2##3##(2008-3#1)(2009-8#1)
orientation and size of##2##4##(1996-2#2)
orientation and##25##2##(1991-6#1)(1992-1#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-8#2)(2009-8#1)(2010-10#1)(2010-3#1)(2013-1#1)
orientation angle of##2##3##(2008-10#2)
orientation angle##6##2##(2008-10#6)
orientation from##2##2##(1995-12#1)(2008-8#1)
orientation groups##2##2##(2010-11#2)
orientation in the##2##3##(1991-2#1)(2008-8#1)
orientation in##5##2##(1990-11#1)(1991-2#1)(2007-12#1)(2008-11#1)(2008-8#1)
orientation index##2##2##(2008-8#1)(2008-9#1)
orientation is##2##2##(1991-2#1)(1993-2#1)
orientation of CaD*##2##3##(1994-5#2)
orientation of the##16##3##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#6)(2009-12#1)(2009-5#1)(2013-8#1)
orientation of##41##2##(1991-10#1)(1993-3#1)(1994-2#2)(1994-5#5)(1997-6#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#7)(2008-7#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2011-3#1)(2013-1#1)(2013-8#1)
orientation on the##3##3##(1992-6#1)(1995-5#1)(2008-10#1)
orientation on##5##2##(1992-6#1)(1995-5#1)(1996-3#1)(2008-10#1)(2011-3#1)
orientation or direction##2##3##(2008-8#2)
orientation or##7##2##(1996-2#2)(2008-11#1)(2008-8#3)(2009-7#1)
orientation program##3##2##(1991-1#1)(1996-1#2)
orientation relative to##2##3##(1991-12#1)(1993-3#1)
orientation selectivity in##2##3##(2008-11#1)(2008-8#1)
orientation selectivity##5##2##(2008-11#1)(2008-8#4)
orientation to##2##2##(1997-3#1)(2012-2#1)
orientation tuning##3##2##(2008-11#3)
orientation was##2##2##(2008-8#1)(2009-7#1)
orientation were##3##2##(2008-10#1)(2009-7#1)(2012-2#1)
orientation with respect to the##2##5##(1990-11#1)(1997-9#1)
orientation with respect to##3##4##(1990-11#1)(1997-9#1)(2008-11#1)
orientation with##4##2##(1990-11#2)(1997-9#1)(2008-11#1)
orientation within##2##2##(1996-3#1)(2008-10#1)
orientation##199##1##(1990-11#5)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#2)(1994-5#5)(1995-12#3)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#3)(1996-5#2)(1997-3#1)(1997-6#2)(1997-9#1)(2007-11#3)(2007-12#7)(2008-10#28)(2008-11#18)(2008-12#1)(2008-2#2)(2008-3#19)(2008-6#2)(2008-7#3)(2008-8#14)(2008-9#8)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#9)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#3)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
orientational##6##1##(1991-5#1)(1992-9#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
orientations of##7##2##(1993-8#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
orientations##29##1##(1990-11#2)(1991-5#1)(1993-12#1)(1993-8#1)(1994-5#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
oriented and##2##2##(2008-10#1)(2010-4#1)
oriented in a##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
oriented in the##4##3##(2008-3#2)(2008-8#1)(2009-7#1)
oriented in##8##2##(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2009-7#1)(2012-2#1)
oriented parallel to the##2##4##(2009-10#1)(2010-4#1)
oriented to##3##2##(1993-2#1)(1995-2#1)(2008-10#1)
oriented toward##4##2##(1990-2#1)(1992-1#1)(2011-2#2)
oriented##62##1##(1990-2#1)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#2)(1995-2#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-2#2)(2008-3#10)(2008-5#3)(2008-6#3)(2008-8#3)(2009-1#1)(2009-10#1)(2009-7#3)(2010-11#1)(2010-4#4)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
orienting themselves on##2##3##(1994-8#2)
orienting##8##1##(1991-2#1)(1992-7#1)(1994-8#2)(2008-11#1)(2011-1#1)(2013-8#2)
orifice##5##1##(1995-11#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-10#1)
orifices##2##1##(1991-6#1)(2008-10#1)
origin (fragment##2##2##(1997-6#2)
origin and distribution of##2##4##(1992-12#1)(1997-1#1)
origin and the##5##3##(1993-6#1)(2008-10#2)(2011-2#1)(2012-3#1)
origin and to##2##3##(1990-3#1)(1992-5#1)
origin and##38##2##(1990-3#2)(1992-12#1)(1992-5#1)(1993-6#1)(1994-5#1)(1995-11#1)(1997-1#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
origin are##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
origin as well as##2##4##(2009-4#1)(2011-2#1)
origin can##2##2##(2008-5#1)(2011-2#1)
origin for modern humans##2##4##(1994-3#2)
origin for the##2##3##(1991-12#1)(2008-10#1)
origin for##9##2##(1991-12#1)(1994-3#2)(1997-3#1)(1997-5#1)(2008-10#3)(2013-1#1)
origin from the##4##3##(1992-2#1)(1997-2#1)(2008-12#1)(2010-12#1)
origin from##6##2##(1992-2#1)(1997-2#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
origin in the##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
origin in##12##2##(1995-2#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#1)
origin is##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
origin of F##2##3##(2008-10#2)
origin of a##3##3##(1992-8#1)(2008-12#1)(2012-2#1)
origin of ovarian cancer##2##4##(2013-8#2)
origin of replication##4##3##(1993-12#1)(2008-10#2)(2011-2#1)
origin of the pathogen##2##4##(2008-10#1)(2012-2#1)
origin of the##35##3##(1990-5#1)(1993-1#1)(1993-3#1)(1994-5#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-6#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
origin of this##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
origin of##102##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-5#2)(1994-8#1)(1997-3#1)(1997-8#2)(2007-12#3)(2008-10#38)(2008-11#6)(2008-12#4)(2008-2#1)(2008-5#2)(2008-7#4)(2008-8#4)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
origin or##4##2##(2008-10#2)(2011-2#2)
origin should##2##2##(1996-11#1)(2008-8#1)
origin that##3##2##(2008-11#2)(2011-2#1)
origin to##3##2##(1992-5#1)(2008-11#1)(2013-1#1)
origin using##2##2##(1994-5#1)(2008-12#1)
origin was##2##2##(1997-6#1)(2010-8#1)
origin were##3##2##(1991-11#1)(2008-10#1)(2008-8#1)
origin with the##2##3##(1992-3#1)(2012-2#1)
origin with##3##2##(1992-3#1)(2008-10#1)(2012-2#1)
origin##369##1##(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#2)(1991-11#3)(1991-12#4)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#3)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#5)(1994-5#5)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-5#1)(1997-6#3)(1997-8#6)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#123)(2008-11#26)(2008-12#9)(2008-2#1)(2008-5#10)(2008-7#7)(2008-8#12)(2008-9#4)(2009-1#2)(2009-10#1)(2009-4#3)(2009-6#3)(2009-7#1)(2009-8#9)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#19)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#6)(2012-9#1)(2013-1#16)(2013-8#7)
original DNA##2##2##(2008-10#1)(2008-8#1)
original ICH Score##2##3##(2012-3#2)
original activity after##2##3##(2008-10#2)
original and##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2011-3#1)
original brand medicines##2##3##(2011-1#2)
original brand##3##2##(2011-1#3)
original data was##3##3##(2008-10#2)(2010-8#1)
original data##11##2##(1995-5#1)(2008-10#9)(2010-8#1)
original host##4##2##(2008-10#3)(2008-8#1)
original level##2##2##(1990-2#1)(2008-11#1)
original material##2##2##(2008-10#1)(2011-2#1)
original substrate##2##2##(2008-5#1)(2011-2#1)
original version##3##2##(2008-1#1)(2012-12#1)(2013-1#1)
original##202##1##(1990-2#4)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#75)(2008-11#15)(2008-12#5)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#5)
originality##3##1##(1997-2#1)(1997-5#1)(2010-7#1)
originally conceived##2##2##(2008-11#1)(2012-2#1)
originally described by##2##3##(2008-4#1)(2012-3#1)
originally described##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2012-3#1)
originally designed for##2##3##(2008-10#2)
originally designed##4##2##(2008-10#4)
originally developed for##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
originally developed##7##2##(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)
originally found in##3##3##(1992-10#1)(1993-8#1)(2008-10#1)
originally identified as##2##3##(1993-6#1)(2008-10#1)
originally identified##3##2##(1993-6#1)(1995-12#1)(2008-10#1)
originally isolated from a##2##4##(2008-10#1)(2011-2#1)
originally isolated from##6##3##(2008-10#2)(2011-2#4)
originally isolated##8##2##(2008-10#4)(2011-2#4)
originally produced##2##2##(2008-11#2)
originally proposed by##2##3##(1990-5#1)(2012-3#1)
originally proposed##3##2##(1990-5#1)(1995-6#1)(2012-3#1)
originally thought to##2##3##(1997-1#1)(2008-4#1)
originally##75##1##(1990-5#1)(1992-10#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-12#2)(1995-6#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#24)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2011-2#6)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
originate from the##6##3##(1997-1#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)
originate from##20##2##(1990-8#1)(1997-1#2)(1997-3#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2011-2#4)(2012-2#1)
originate in the##5##3##(1997-4#1)(2008-10#2)(2008-5#1)(2011-2#1)
originate in##6##2##(1995-3#1)(1997-4#1)(2008-10#2)(2008-5#1)(2011-2#1)
originate##29##1##(1990-11#1)(1990-8#1)(1995-3#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2009-1#1)(2011-2#5)(2012-2#1)
originated at the##3##3##(2008-10#1)(2009-12#1)(2009-7#1)
originated from a##3##3##(1993-11#1)(1993-3#1)(2008-10#1)
originated from the##8##3##(1995-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
originated from##29##2##(1993-11#1)(1993-3#1)(1995-2#1)(2008-10#16)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)
originated in the##5##3##(2007-12#1)(2008-10#2)(2008-4#1)(2011-2#1)
originated in##6##2##(2007-12#1)(2008-10#3)(2008-4#1)(2011-2#1)
originated##47##1##(1993-11#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#2)
originates from a##2##3##(2008-10#1)(2010-6#1)
originates from the##5##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
originates from##9##2##(1996-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)
originates##11##1##(1995-8#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2010-6#1)
originating from a single##2##4##(2007-12#1)(2008-3#1)
originating from a##6##3##(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)
originating from different##3##3##(2008-10#2)(2009-8#1)
originating from the##15##3##(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
originating from##60##2##(1990-8#1)(1993-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#35)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
originating in lateral recess of the fourth ventricle##2##8##(2013-1#2)
originating in the##5##3##(2008-10#2)(2008-7#2)(2010-11#1)
originating in##10##2##(2008-10#4)(2008-7#2)(2010-11#1)(2012-2#1)(2013-1#2)
originating##73##1##(1990-8#1)(1993-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#41)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#3)(2013-8#2)
origination##3##1##(2009-10#3)
origins and##6##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
origins in##3##2##(2008-10#1)(2008-11#2)
origins of the##5##3##(2008-11#2)(2008-9#1)(2009-10#1)(2010-7#1)
origins of##24##2##(1990-7#2)(1993-2#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#2)(2012-2#1)(2013-1#2)(2013-8#2)
origins##71##1##(1990-7#2)(1993-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#22)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#4)(2013-8#3)
orinocense##3##1##(2008-5#3)
orlistat##6##1##(2008-5#6)
orlon fabric##2##2##(2008-10#2)
orlon##3##1##(2008-10#3)
ormosil-modified electrodes##3##2##(2008-10#3)
ornament##2##1##(2008-8#2)
ornamental crops##2##2##(2008-10#2)
ornamental plants##3##2##(2008-10#3)
ornamental##20##1##(2008-10#14)(2008-8#3)(2008-9#3)
ornamentals##3##1##(2008-10#3)
ornamentation in##2##2##(2008-8#1)(2008-9#1)
ornamentation of##2##2##(2008-9#1)(2010-3#1)
ornamentation##7##1##(2008-8#4)(2008-9#2)(2010-3#1)
ornamented males##2##2##(2008-8#2)
ornamented##4##1##(2008-10#1)(2008-8#3)
ornaments##9##1##(2008-8#9)
ornithine decarboxylase (ODC)##3##3##(1993-8#1)(1995-8#1)(2008-10#1)
ornithine decarboxylase activity##4##3##(1992-8#2)(1992-9#1)(2008-10#1)
ornithine decarboxylase and##2##3##(1992-9#1)(1995-8#1)
ornithine decarboxylase##13##2##(1992-8#5)(1992-9#3)(1993-8#1)(1995-8#2)(2008-10#2)
ornithine##16##1##(1990-2#1)(1992-8#5)(1992-9#3)(1993-8#1)(1995-8#2)(2008-10#3)(2009-8#1)
orofacial clefts##6##2##(2009-10#6)
orofacial pain##2##2##(2008-5#1)(2012-3#1)
orofacial##10##1##(2008-5#1)(2009-10#7)(2012-3#1)(2013-1#1)
orogastric##2##1##(2008-5#2)
oropharyngeal adverse events##3##3##(2008-8#3)
oropharyngeal and##3##2##(2008-5#3)
oropharyngeal clearance##4##2##(1996-2#4)
oropharyngeal##21##1##(1996-2#5)(1997-1#1)(2007-11#1)(2008-5#5)(2008-8#4)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
orotic acid##2##2##(2008-10#2)
orphan##3##1##(1995-12#2)(2011-7#1)
orphaned##3##1##(1997-6#2)(2008-11#1)
orphans in##2##2##(1997-6#2)
orphans##5##1##(1990-12#1)(1997-6#3)(2008-11#1)
ortho catechol##2##2##(2008-11#2)
ortho##7##1##(2008-10#3)(2008-11#3)(2010-8#1)
ortho-##2##1##(2008-10#2)
ortho-phosphate##2##1##(2008-10#2)
orthodontic##6##1##(2008-11#1)(2012-12#1)(2013-1#4)
orthodox##5##1##(2008-11#4)(2011-2#1)
orthogonal array design##3##3##(2008-10#3)
orthogonal array##4##2##(2008-10#4)
orthogonal axes##2##2##(2008-3#2)
orthogonal experimental design##3##3##(2008-10#2)(2008-11#1)
orthogonal polarization states##2##3##(2007-11#1)(2008-3#1)
orthogonal signal##2##2##(2008-10#2)
orthogonal to the##2##3##(2008-10#1)(2008-3#1)
orthogonal to##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
orthogonal##36##1##(1990-5#1)(2007-11#2)(2007-12#2)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#5)(2008-6#1)(2009-11#3)(2010-7#1)(2011-2#1)
orthogonality##4##1##(2008-10#1)(2009-3#3)
orthogonally and##2##2##(2008-10#1)(2008-3#1)
orthogonally polarized##4##2##(2008-3#4)
orthogonally##7##1##(2008-10#1)(2008-3#5)(2008-6#1)
orthographic##5##1##(1991-2#2)(2008-12#1)(2008-6#1)(2013-8#1)
orthokeratinized##2##1##(2013-1#2)
ortholoci for##2##2##(2008-10#2)
ortholog of##2##2##(2008-11#1)(2012-3#1)
ortholog##7##1##(2008-11#1)(2008-9#1)(2009-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
orthologous##2##1##(1993-12#1)(2010-10#1)
orthologs##3##1##(2009-10#2)(2013-1#1)
orthologues##2##1##(2008-11#1)(2011-10#1)
orthopaedic braces##2##2##(2007-8#2)
orthopaedic infections##3##2##(2007-11#3)
orthopaedic surgeons##2##2##(2009-3#1)(2013-1#1)
orthopaedic surgery##3##2##(1990-9#1)(2008-11#1)(2011-2#1)
orthopaedic##22##1##(1990-9#2)(1994-3#1)(2007-11#3)(2007-8#3)(2008-11#2)(2008-12#2)(2009-3#2)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-4#1)(2013-1#1)
orthopaedics and traumatology##2##3##(2007-8#2)
orthopaedics##4##1##(2007-8#2)(2008-12#2)
orthopedic appliance##2##2##(2013-1#2)
orthopedic applications##2##2##(2010-3#1)(2012-3#1)
orthopedic patients##3##2##(2010-6#3)
orthopedic surgeon##2##2##(2008-8#1)(2009-3#1)
orthopedic surgeons##4##2##(2008-8#2)(2009-3#1)(2012-2#1)
orthopedic surgery in spinal anesthesia##2##5##(2011-2#2)
orthopedic surgery##3##2##(2010-6#1)(2011-2#2)
orthopedic##27##1##(1994-3#2)(1996-9#1)(2008-12#1)(2008-8#5)(2009-3#2)(2009-6#1)(2010-3#1)(2010-6#4)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#5)
orthopedics##4##1##(1997-6#2)(2012-2#1)(2013-1#1)
orthophosphate and total inorganic phosphates in##3##6##(2008-10#3)
orthophosphate and total##5##3##(2008-10#5)
orthophosphate and##7##2##(2008-10#7)
orthophosphate##31##1##(2008-10#31)
orthophosphoric acid)##2##2##(2008-10#1)(2008-5#1)
orthorhombic crystal form##4##3##(1993-8#1)(2008-8#3)
orthorhombic##8##1##(1992-12#1)(1993-8#1)(2008-10#1)(2008-5#2)(2008-8#3)
orthosis##2##1##(2010-3#2)
orthotopic liver transplantation##4##3##(1991-11#2)(1993-2#1)(2011-2#1)
orthotopic##7##1##(1991-11#2)(1993-2#1)(2008-5#1)(2009-5#1)(2010-6#1)(2011-2#1)
orthovanadate##4##1##(1994-11#1)(1995-2#1)(2008-10#2)
oryzacystatin##2##1##(2008-10#2)
oryzae Strains##2##2##(2008-10#2)
oryzae and##5##2##(2008-10#4)(2009-10#1)
oryzae in Arabidopsis##2##3##(2012-2#2)
oryzae in Nepal##2##3##(2008-10#2)
oryzae in##8##2##(2008-10#4)(2012-2#3)(2013-8#1)
oryzae isolates##2##2##(2008-10#2)
oryzae pv##27##2##(2008-10#25)(2008-9#1)(2009-10#1)
oryzae to##2##2##(2008-10#2)
oryzae##86##1##(2008-10#72)(2008-9#2)(2009-10#2)(2009-6#2)(2012-2#7)(2013-8#1)
oryzae)##2##1##(1990-3#1)(2008-10#1)
oryzae-sativae##3##1##(2008-10#3)
oryzicola##2##1##(2008-10#2)
oryzophilus##6##1##(2013-8#6)
os##7##1##(1991-3#1)(1993-12#1)(2008-10#2)(2008-5#1)(2009-5#1)(2009-8#1)
oscillate between##2##2##(2008-3#1)(2008-9#1)
oscillate##3##1##(1996-6#1)(2008-3#1)(2008-9#1)
oscillated##2##1##(1996-6#1)(2008-10#1)
oscillating chemical reaction##3##3##(2008-10#3)
oscillating chemical system involving the##2##5##(2008-10#2)
oscillating chemical system##4##3##(2008-10#4)
oscillating chemical##7##2##(2008-10#7)
oscillating reaction is##2##3##(2008-10#2)
oscillating reaction##4##2##(2008-10#4)
oscillating system##2##2##(2008-10#2)
oscillating##21##1##(1990-5#1)(2008-10#14)(2008-11#1)(2008-3#2)(2011-2#3)
oscillation amplitude and##2##3##(2008-10#1)(2012-2#1)
oscillation amplitude##7##2##(2008-10#5)(2012-2#2)
oscillation and##2##2##(2008-10#1)(2012-3#1)
oscillation in##7##2##(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
oscillation is##2##2##(2007-12#1)(2008-2#1)
oscillation period##7##2##(2008-10#1)(2008-2#3)(2010-10#3)
oscillation was##2##2##(1995-11#1)(1996-2#1)
oscillation##57##1##(1990-8#1)(1994-6#6)(1995-11#2)(1995-2#1)(1996-2#3)(2007-11#2)(2007-12#5)(2008-10#14)(2008-11#5)(2008-2#4)(2008-3#3)(2008-7#3)(2008-9#1)(2009-7#1)(2010-10#3)(2012-2#2)(2012-3#1)
oscillations and##2##2##(1992-11#1)(2008-11#1)
oscillations are##4##2##(1990-5#1)(2008-10#1)(2010-10#1)(2013-8#1)
oscillations by##2##2##(1990-5#1)(1994-11#1)
oscillations could be##2##3##(1994-11#1)(2013-8#1)
oscillations could##4##2##(1994-11#1)(2011-2#1)(2013-8#2)
oscillations in a##2##3##(1993-5#1)(2008-11#1)
oscillations in the##4##3##(1990-5#1)(1992-8#1)(2008-10#1)(2013-8#1)
oscillations in##20##2##(1990-5#3)(1992-8#1)(1993-5#1)(1994-11#3)(1995-11#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-8#3)
oscillations of the##2##3##(2007-12#1)(2008-3#1)
oscillations of##7##2##(1990-5#1)(1991-5#1)(1994-11#1)(2007-12#1)(2008-3#1)(2010-10#2)
oscillations were##2##2##(1994-6#1)(2011-2#1)
oscillations##75##1##(1990-5#6)(1991-5#4)(1992-11#1)(1992-8#1)(1993-5#1)(1994-11#9)(1994-6#4)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#3)(2007-12#2)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#2)(2009-8#1)(2010-10#5)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#9)
oscillator for##2##2##(2008-3#2)
oscillator is##3##2##(2008-3#3)
oscillator with##5##2##(1990-12#1)(2007-11#1)(2007-12#2)(2008-3#1)
oscillator##37##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(2007-11#5)(2007-12#8)(2008-10#1)(2008-2#2)(2008-3#14)(2009-8#1)(2010-7#2)
oscillators##10##1##(1990-5#1)(1990-8#1)(2007-12#1)(2008-3#4)(2009-8#2)(2010-7#1)
oscillatory activity##2##2##(2013-1#1)(2013-8#1)
oscillatory behavior in##3##3##(2008-7#3)
oscillatory behavior##4##2##(2008-7#4)
oscillatory##27##1##(1995-11#1)(1995-5#1)(1996-3#1)(1997-6#1)(2008-11#5)(2008-12#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-8#2)(2009-9#1)(2013-1#1)(2013-8#4)
osculatum##2##1##(2012-2#2)
osmiophilic material##6##2##(2008-10#6)
osmiophilic##9##1##(1997-2#1)(2008-10#8)
osmium tetroxide##6##2##(1991-7#1)(2008-10#3)(2008-7#2)
osmium##18##1##(1991-7#1)(2008-10#14)(2008-7#2)(2010-7#1)
osmium(IV) in##2##2##(2008-10#2)
osmium(IV)##3##1##(2008-10#3)
osmolalities##3##1##(2008-11#3)
osmolality compensation##2##2##(2008-11#2)
osmolality of##2##2##(2008-11#2)
osmolality##20##1##(2008-11#17)(2013-8#3)
osmolarity and##3##2##(1991-5#1)(2008-11#2)
osmolarity from##2##2##(1991-11#1)(1997-1#1)
osmolarity medium##2##2##(2008-11#2)
osmolarity of##5##2##(1991-11#5)
osmolarity##31##1##(1991-11#15)(1991-5#1)(1994-12#1)(1997-1#1)(2008-11#13)
osmolytes##3##1##(1991-11#2)(2008-11#1)
osmopriming##2##1##(2008-12#2)
osmoregulation##3##1##(2007-12#1)(2008-12#1)(2011-2#1)
osmoregulatory##3##1##(2008-7#3)
osmosensor histidine kinase##2##3##(2008-10#2)
osmotic adjustment##3##2##(2008-11#1)(2012-7#2)
osmotic and fungicide##2##3##(2008-10#2)
osmotic coefficients##3##2##(1991-11#3)
osmotic fragility##2##2##(2008-9#2)
osmotic potential##6##2##(2008-10#1)(2008-9#3)(2009-6#1)(2012-7#1)
osmotic pressure of##2##3##(2008-11#1)(2010-7#1)
osmotic pressure##13##2##(2008-11#11)(2008-12#1)(2010-7#1)
osmotic sensitivity##2##2##(2008-10#2)
osmotic shock##2##2##(2008-11#1)(2008-7#1)
osmotic stimulation of the hypothalamic paraventricular nucleus##2##7##(1994-8#2)
osmotic stimulation of the##3##4##(1994-8#3)
osmotic stress##10##2##(1997-8#1)(2008-10#1)(2008-11#2)(2008-9#3)(2009-8#2)(2013-1#1)
osmotic swelling##3##2##(1990-2#2)(1991-5#1)
osmotic##60##1##(1990-2#2)(1991-11#4)(1991-5#1)(1994-8#3)(1996-12#1)(1997-8#2)(2008-10#7)(2008-11#15)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#8)(2009-6#1)(2009-8#3)(2010-7#1)(2011-2#2)(2012-7#4)(2013-1#1)
osmotically##3##1##(1996-6#1)(2008-10#1)(2008-7#1)
osmotin and thaumatin-like protein##2##4##(2008-10#2)
osmotin promoter##2##2##(2008-8#2)
osmotin##6##1##(2008-10#2)(2008-8#4)
osseous involvement##2##2##(2008-1#1)(2010-6#1)
osseous##14##1##(1991-11#1)(1992-2#2)(2008-1#1)(2008-7#1)(2010-5#2)(2010-6#3)(2011-2#3)(2013-1#1)
ossicle##3##1##(2007-12#1)(2008-12#2)
ossicles are##4##2##(2007-12#4)
ossicles##14##1##(1996-6#1)(2007-12#10)(2008-12#2)(2008-9#1)
ossificans##2##1##(2013-8#2)
ossification of##3##2##(2008-12#1)(2008-9#1)(2012-3#1)
ossification##12##1##(1991-2#1)(1994-8#2)(2008-12#2)(2008-9#3)(2012-12#3)(2012-3#1)
ossifications##2##1##(1991-11#1)(2011-1#1)
ossified cochlea##3##2##(2008-9#3)
ossified##6##1##(2008-9#6)
ossifying##5##1##(2008-10#3)(2013-1#2)
osteoarthritic##4##1##(1992-3#1)(1993-12#1)(2008-11#1)(2009-12#1)
osteoarthritis (OA)##3##2##(1992-3#1)(2013-1#2)
osteoarthritis and##2##2##(2008-9#1)(2011-2#1)
osteoarthritis of the knee##2##4##(2013-1#2)
osteoarthritis##29##1##(1991-11#1)(1992-3#2)(2007-11#1)(2008-10#1)(2008-9#3)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#14)
osteoarthrosis##2##1##(1993-2#1)(2010-10#1)
osteoarticular pain##2##2##(2011-2#2)
osteoarticular##4##1##(2011-2#3)(2012-3#1)
osteoblast and osteoclast activity##2##4##(2011-2#2)
osteoblast metabolism##3##2##(2008-11#3)
osteoblast##13##1##(2008-11#10)(2011-2#2)(2012-3#1)
osteoblast-like cell##2##2##(1993-3#1)(2008-11#1)
osteoblast-like cells by##2##3##(2008-11#2)
osteoblast-like cells##6##2##(1993-3#1)(1994-11#1)(2008-11#4)
osteoblast-like##8##1##(1993-3#2)(1994-11#1)(2008-11#5)
osteoblastic MC3T3-E1 cells##3##3##(1997-1#3)
osteoblastic cells##5##2##(1994-11#1)(2008-11#4)
osteoblastic##18##1##(1990-11#1)(1991-8#2)(1994-11#1)(1997-1#3)(2008-11#9)(2011-1#1)(2013-1#1)
osteoblasts and cementoblasts##2##3##(2008-11#2)
osteoblasts and##5##2##(1997-1#1)(2008-11#3)(2011-1#1)
osteoblasts cultured##2##2##(2008-11#2)
osteoblasts is##2##2##(2008-11#2)
osteoblasts to##3##2##(1993-6#1)(2007-11#1)(2008-11#1)
osteoblasts##32##1##(1990-11#2)(1993-3#2)(1993-6#2)(1997-1#3)(2007-11#1)(2008-11#15)(2008-9#2)(2011-1#1)(2011-2#1)(2012-4#2)(2013-1#1)
osteocalcin and osteopontin##2##3##(2008-11#2)
osteocalcin gene expression##2##3##(1993-3#2)
osteocalcin gene##3##2##(1993-3#3)
osteocalcin##9##1##(1993-3#4)(2008-11#3)(2012-4#2)
osteochondral defects##2##2##(2012-3#1)(2013-1#1)
osteochondral fracture##2##2##(2008-12#1)(2013-1#1)
osteochondral transplantation##2##2##(2011-2#2)
osteochondral##19##1##(2008-12#2)(2009-1#1)(2011-2#8)(2012-3#6)(2013-1#2)
osteochondroma##3##1##(1997-8#1)(2008-8#2)
osteochondromatosis of the##2##3##(2010-5#1)(2010-7#1)
osteochondromatosis##5##1##(2010-5#3)(2010-7#2)
osteoclast activity##3##2##(2011-2#3)
osteoclast apoptosis##4##2##(2008-11#4)
osteoclast differentiation##3##2##(1991-5#1)(2008-11#1)(2011-2#1)
osteoclast formation##3##2##(1991-5#2)(2012-3#1)
osteoclast##18##1##(1991-11#2)(1991-5#4)(2008-11#5)(2011-2#5)(2012-3#1)(2013-1#1)
osteoclast-like##2##1##(2008-11#1)(2013-1#1)
osteoclastic bone resorption##3##3##(1993-6#1)(2008-11#2)
osteoclastic differentiation##2##2##(1991-5#2)
osteoclastic##7##1##(1991-5#2)(1993-6#1)(2008-11#4)
osteoclasts##18##1##(1991-11#1)(1991-5#1)(2008-11#12)(2009-3#1)(2011-2#1)(2012-3#2)
osteodystrophy##6##1##(1990-9#1)(2010-6#2)(2011-1#1)(2011-2#2)
osteogenesis##5##1##(1991-5#1)(2008-11#3)(2009-3#1)
osteogenic and chondrogenic differentiation potentials of hMSCs##2##7##(2008-11#2)
osteogenic and chondrogenic differentiation potentials of##3##6##(2008-11#3)
osteogenic and chondrogenic differentiation##4##4##(2008-11#4)
osteogenic and##5##2##(2008-11#4)(2013-1#1)
osteogenic differentiation##9##2##(2008-11#8)(2012-4#1)
osteogenic medium##4##2##(2008-11#3)(2012-4#1)
osteogenic potential##4##2##(2008-11#4)
osteogenic sarcoma of the##3##4##(1992-2#2)(2011-2#1)
osteogenic sarcoma##5##2##(1992-12#2)(1992-2#2)(2011-2#1)
osteogenic##35##1##(1992-12#3)(1992-2#2)(2008-11#25)(2011-2#2)(2012-4#2)(2013-1#1)
osteoid osteoma of the##2##4##(2008-8#1)(2013-1#1)
osteoid osteoma##5##2##(2008-8#1)(2012-12#1)(2013-1#3)
osteoid osteomas##2##2##(2013-1#2)
osteoid##7##1##(2008-8#1)(2012-12#1)(2013-1#5)
osteolysis##2##1##(2013-1#2)
osteolytic lesion##3##2##(2008-12#2)(2012-12#1)
osteolytic##6##1##(1991-8#1)(1997-5#1)(2008-12#3)(2012-12#1)
osteoma cutis##3##2##(2010-6#3)
osteoma##8##1##(2008-8#1)(2010-6#3)(2012-12#1)(2013-1#3)
osteomyelitis and##2##2##(2010-6#1)(2012-2#1)
osteomyelitis has##2##2##(2010-6#1)(2012-2#1)
osteomyelitis in a##2##3##(1995-9#1)(2013-8#1)
osteomyelitis in##6##2##(1995-9#1)(2008-9#1)(2010-6#2)(2012-2#1)(2013-8#1)
osteomyelitis is##2##2##(2010-6#2)
osteomyelitis of##2##2##(2010-6#2)
osteomyelitis##52##1##(1995-9#1)(2007-11#1)(2008-9#1)(2009-6#1)(2010-6#40)(2012-12#1)(2012-2#4)(2013-8#3)
osteonal cortical bone is##2##4##(2009-7#2)
osteonal cortical bone##3##3##(2009-7#3)
osteonecrosis of the jaws##2##4##(2012-12#2)
osteonecrosis of the##4##3##(2012-12#3)(2012-3#1)
osteonecrosis##6##1##(2012-12#4)(2012-3#1)(2013-1#1)
osteopathic medicine##2##2##(1991-12#1)(1991-8#1)
osteopathic##6##1##(1991-12#3)(1991-8#1)(2008-12#1)(2010-1#1)
osteopathy##2##1##(1991-11#1)(2008-12#1)
osteopenia and osteoporosis##2##3##(2007-8#1)(2011-2#1)
osteopenia and##3##2##(2007-8#2)(2011-2#1)
osteopenia##4##1##(2007-8#2)(2008-8#1)(2011-2#1)
osteopetrosis##2##1##(2008-11#2)
osteophytic##3##1##(2011-2#3)
osteopontin##6##1##(1995-8#1)(2008-11#3)(2009-7#1)(2010-11#1)
osteoporosis and##5##2##(1992-6#1)(1996-6#1)(2008-5#1)(2011-1#1)(2012-12#1)
osteoporosis in the##2##3##(1991-11#1)(1996-6#1)
osteoporosis in##10##2##(1991-11#1)(1996-6#1)(2008-12#1)(2008-7#4)(2010-3#2)(2013-1#1)
osteoporosis is##6##2##(1991-11#1)(2008-7#2)(2010-10#1)(2010-3#2)
osteoporosis than##2##2##(1996-6#2)
osteoporosis with##2##2##(1991-11#1)(1993-11#1)
osteoporosis##66##1##(1990-11#1)(1991-11#11)(1991-12#1)(1992-6#2)(1993-11#1)(1996-11#2)(1996-6#6)(1997-8#1)(2007-8#1)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#1)(2009-12#1)(2010-10#1)(2010-3#6)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2013-1#4)(2013-8#1)
osteoporosis]##4##1##(1991-11#2)(1994-12#1)(1995-11#1)
osteoporotic fractures##3##2##(1991-11#1)(1996-8#2)
osteoporotic vertebral##3##2##(1991-11#2)(2008-12#1)
osteoporotic women##2##2##(2008-11#1)(2012-3#1)
osteoporotic##16##1##(1991-11#5)(1992-6#2)(1996-8#2)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
osteoprotegerin (OPG) gene##2##3##(2013-1#2)
osteoprotegerin (OPG)##4##2##(2008-12#2)(2013-1#2)
osteoprotegerin##5##1##(2008-11#1)(2008-12#2)(2013-1#2)
osteoradionecrosis of the cervical spine##2##5##(2011-2#2)
osteoradionecrosis##4##1##(2011-2#3)(2013-1#1)
osteosarcoma in the##3##3##(2009-3#1)(2013-1#2)
osteosarcoma in##4##2##(2009-3#1)(2013-1#2)(2013-8#1)
osteosarcoma##13##1##(1991-11#2)(1991-3#1)(1992-12#1)(2008-8#1)(2009-3#1)(2013-1#4)(2013-8#3)
osteosclerotic##2##1##(2011-2#2)
osteosynthesis##2##1##(2007-8#1)(2013-1#1)
osteotomied##2##1##(2007-8#2)
osteotomies##6##1##(2008-8#3)(2008-9#1)(2012-2#2)
osteotomy and denervation##2##3##(2007-8#2)
osteotomy and##4##2##(2007-8#3)(2011-2#1)
osteotomy fixed with##5##3##(2008-9#1)(2013-1#4)
osteotomy for##2##2##(2008-9#1)(2012-2#1)
osteotomy in the##2##3##(2008-10#1)(2010-11#1)
osteotomy in##5##2##(2008-10#2)(2010-11#1)(2011-2#1)(2012-3#1)
osteotomy is##3##2##(1997-4#1)(2009-3#1)(2010-11#1)
osteotomy of the##2##3##(2009-3#1)(2011-2#1)
osteotomy was##2##2##(2009-3#1)(2011-2#1)
osteotomy##39##1##(1997-4#2)(1997-6#1)(2007-8#3)(2008-10#2)(2008-9#2)(2009-10#1)(2009-3#6)(2010-11#3)(2011-2#7)(2012-2#3)(2012-3#3)(2013-1#6)
ostertagi##2##1##(1996-12#2)
ostia##2##1##(2011-2#2)
ostial lesions##2##2##(1994-9#2)
ostial##3##1##(1994-9#2)(2008-11#1)
ostium##2##1##(2009-11#1)(2010-12#1)
ostreatus in##3##2##(2008-10#2)(2008-5#1)
ostreatus##11##1##(2008-10#3)(2008-5#2)(2011-1#6)
ostriches##4##1##(1996-8#2)(2008-5#2)
ot##3##1##(1994-12#1)(2008-11#1)(2009-10#1)
other &quot##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
other 15##2##2##(1991-5#1)(2008-9#1)
other 16##2##2##(2008-9#1)(2013-1#1)
other 3##3##2##(1995-12#1)(2010-10#1)(2013-1#1)
other AGs of R##3##4##(2008-10#3)
other AGs##4##2##(2008-10#4)
other Asian##2##2##(2008-10#1)(2010-3#1)
other B##2##2##(2008-10#2)
other DNA##2##2##(2008-10#1)(2008-9#1)
other DNA-binding proteins##2##3##(1991-7#1)(2008-8#1)
other European##2##2##(2008-10#1)(2008-11#1)
other Fusarium##2##2##(2008-10#2)
other Gryllus species##2##3##(2008-9#2)
other Hrs##2##2##(1991-10#2)
other LED##2##2##(2008-10#1)(2008-11#1)
other Meloidogyne##2##2##(2008-10#2)
other New World##2##3##(2008-10#2)
other New##3##2##(2008-1#1)(2008-10#2)
other ORFs##2##2##(1995-9#1)(1996-3#1)
other P##3##2##(2008-10#3)
other P450##2##2##(2009-9#2)
other Pg genes##3##3##(2008-10#3)
other Phytophthora spp##3##3##(2008-10#3)
other Phytophthora##5##2##(2008-10#5)
other QTL##2##2##(2008-10#1)(2013-8#1)
other S##2##2##(1996-3#2)
other SIV strains##2##3##(1997-3#2)
other U##2##2##(2008-10#2)
other V##2##2##(2008-10#2)
other Venturia##2##2##(2008-10#2)
other Western##2##2##(1990-6#1)(2008-10#1)
other X##4##2##(2008-10#4)
other Xanthomonas##2##2##(2008-10#2)
other abdominal##2##2##(2008-10#1)(2012-2#1)
other abnormalities##2##2##(1991-3#1)(1997-3#1)
other actin-binding proteins##2##3##(1993-8#1)(2012-2#1)
other active##3##2##(2008-10#2)(2012-2#1)
other activities##2##2##(2008-9#1)(2013-1#1)
other additional##2##2##(2008-10#1)(2013-1#1)
other advantages##3##2##(2008-10#2)(2011-2#1)
other adverse events##2##3##(2008-8#1)(2012-12#1)
other adverse##5##2##(1997-7#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-12#1)
other age##2##2##(2011-2#1)(2012-3#1)
other agencies##3##2##(1996-2#1)(1996-3#1)(1997-2#1)
other agents##6##2##(1995-12#1)(1996-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)
other alcohols##2##2##(1992-7#1)(2008-10#1)
other alkali##5##2##(2008-10#5)
other amines##2##2##(2008-10#2)
other amino acids and##2##4##(2008-10#2)
other amino acids##6##3##(2008-10#5)(2008-5#1)
other amino##8##2##(1995-6#1)(2008-10#6)(2008-5#1)
other analgesics##2##2##(2011-2#1)(2013-1#1)
other analytes##6##2##(2008-10#5)(2008-12#1)
other analytical parameters##2##3##(2008-10#2)
other and##29##2##(1993-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-6#1)(2008-10#14)(2008-11#3)(2008-5#1)(2008-8#2)(2010-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
other animals in the population##2##5##(2008-8#2)
other animals##6##2##(1993-3#1)(2008-10#1)(2008-8#3)(2010-4#1)
other anions and can be used in##2##7##(2008-10#2)
other anions and##3##3##(2008-10#3)
other anions##7##2##(2008-10#7)
other antagonists##2##2##(2008-10#2)
other antiepileptic drugs##2##3##(2008-7#1)(2008-8#1)
other antigenic##2##2##(1996-11#1)(2012-2#1)
other antigens##3##2##(1995-5#1)(2012-12#1)(2012-2#1)
other applications##6##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-7#1)(2012-2#1)
other approaches##5##2##(2007-11#1)(2008-10#2)(2008-3#2)
other area##2##2##(2008-10#1)(2010-6#1)
other areas of the##3##4##(2008-10#1)(2008-5#1)(2010-11#1)
other areas of##10##3##(1991-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2013-1#1)
other areas##13##2##(1991-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-12#1)(2013-1#1)
other aromatic##2##2##(2008-10#2)
other arsenic species##2##3##(2008-10#2)
other arsenic##3##2##(2008-10#3)
other as##4##2##(1993-8#1)(2008-10#3)
other aspects of##7##3##(1993-2#1)(1996-12#1)(2008-5#1)(2009-10#1)(2010-7#1)(2012-2#1)(2012-3#1)
other aspects##10##2##(1993-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-7#1)(2012-2#1)(2012-3#1)
other atmospheric##2##2##(2008-3#2)
other authors##5##2##(2008-10#2)(2008-5#2)(2013-8#1)
other autoimmune diseases##2##3##(2012-3#1)(2013-8#1)
other available##4##2##(1990-8#1)(2008-10#2)(2011-2#1)
other bacteria##2##2##(2008-10#2)
other bacterial##5##2##(2008-10#2)(2008-5#1)(2009-6#1)(2011-2#1)
other based on##2##3##(1993-11#1)(2009-5#1)
other begomoviruses##5##2##(2008-10#5)
other behavioral##2##2##(2008-8#1)(2009-8#1)
other benefits##3##2##(1991-12#1)(1991-3#1)(2008-8#1)
other biological##5##2##(1992-9#1)(2008-4#1)(2008-5#2)(2008-9#1)
other blinding##2##2##(2008-7#1)(2010-10#1)
other body##5##2##(1992-9#1)(1996-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
other books##2##2##(2008-10#1)(2010-5#1)
other brain##2##2##(2008-4#1)(2009-5#1)
other broods##2##2##(2008-9#2)
other by##7##2##(1992-6#1)(1994-11#1)(1997-7#1)(2008-10#3)(2008-4#1)
other cancers were##3##3##(1991-3#1)(1993-2#1)(2008-7#1)
other cancers##9##2##(1991-3#1)(1993-1#1)(1993-2#1)(2008-11#2)(2008-7#1)(2009-12#1)(2011-2#1)(2011-3#1)
other cardiac##5##2##(2008-12#1)(2008-7#1)(2010-6#1)(2012-2#2)
other cardiovascular risk factors in a hypertensive population##2##8##(2010-4#2)
other cardiovascular risk factors##3##4##(1996-8#1)(2010-4#2)
other cardiovascular##4##2##(1996-8#1)(2008-6#1)(2010-4#2)
other case##4##2##(1990-5#1)(1996-5#1)(2008-12#1)(2008-7#1)
other cases of##2##3##(2008-8#1)(2011-2#1)
other cases##8##2##(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
other catecholamines##2##2##(1997-3#1)(2008-10#1)
other categories of##2##3##(1992-6#1)(1994-1#1)
other cations##13##2##(2008-10#13)
other causes of##2##3##(2008-12#1)(2009-8#1)
other causes##7##2##(1993-6#1)(1997-1#1)(2008-10#2)(2008-12#2)(2009-8#1)
other cell cycle genes##3##4##(2008-10#3)
other cell lineages##2##3##(1995-12#1)(2008-11#1)
other cell lines##2##3##(2008-11#2)
other cell types##7##3##(1995-3#1)(2008-11#3)(2008-7#2)(2012-3#1)
other cell##19##2##(1993-6#1)(1995-12#1)(1995-3#1)(2008-10#3)(2008-11#10)(2008-7#2)(2012-3#1)
other cells of the##2##4##(2008-4#1)(2008-5#1)
other cells##12##2##(1990-9#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
other cellular##4##2##(1996-12#1)(2008-7#2)(2011-2#1)
other central nervous system##2##4##(2009-12#1)(2009-7#1)
other cereals##2##2##(1991-12#1)(2009-10#1)
other challenges##3##2##(1996-3#1)(2008-8#1)(2013-8#1)
other changes##2##2##(2010-12#1)(2011-2#1)
other characteristics of##2##3##(2008-10#1)(2008-8#1)
other characteristics##3##2##(2008-10#2)(2008-8#1)
other charged-surface microcarriers##2##3##(2008-11#2)
other charged-surface##3##2##(2008-11#3)
other chemical##5##2##(2008-10#1)(2008-11#2)(2008-5#2)
other chronic disease##2##3##(1994-6#1)(2010-1#1)
other chronic##6##2##(1994-12#1)(1994-3#1)(1994-6#1)(2010-1#1)(2010-4#1)(2012-3#1)
other class##2##2##(1993-1#1)(2008-8#1)
other classes of##2##3##(2008-10#2)
other clinical##8##2##(1996-1#1)(2008-1#1)(2008-11#1)(2008-5#2)(2010-12#2)(2012-3#1)
other clinically##3##2##(1991-2#1)(2011-2#2)
other closteroviruses##4##2##(2008-10#4)
other coexisting##3##2##(2008-10#2)(2013-1#1)
other cofactors##2##2##(1990-5#1)(2011-2#1)
other combinations of A2 and T2##2##6##(1996-2#2)
other combinations of##3##3##(1996-2#2)(2012-2#1)
other combinations##4##2##(1996-2#2)(2008-12#1)(2012-2#1)
other common##6##2##(2008-10#6)
other commonly used##2##3##(2008-10#1)(2012-3#1)
other commonly##3##2##(2008-10#1)(2012-3#2)
other community##3##2##(1996-1#1)(2008-9#1)(2012-2#1)
other comorbidities##2##2##(2009-6#1)(2011-2#1)
other complex##4##2##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
other complexes##2##2##(1993-8#1)(2008-10#1)
other components of the##6##4##(1991-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
other components of##9##3##(1991-3#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-7#1)(2012-3#1)
other components##15##2##(1991-3#2)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
other compounds##6##2##(1991-5#1)(2008-10#5)
other conditions##9##2##(1991-2#1)(1994-8#1)(1995-8#1)(1997-3#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
other conserved##2##2##(1992-3#1)(2008-9#1)
other considerations##3##2##(1992-12#1)(1993-1#1)(1996-1#1)
other conventional##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
other countries as##2##3##(1990-6#1)(2008-5#1)
other countries in##2##3##(2008-12#1)(2010-8#1)
other countries##22##2##(1990-11#1)(1990-6#1)(1993-1#1)(1993-2#2)(1993-6#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#3)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#1)(2013-8#1)
other crops##3##2##(2008-10#2)(2013-1#1)
other cultivars##3##2##(2008-10#3)
other cultures##2##2##(2008-11#1)(2010-8#1)
other currently##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
other cytokines##10##2##(1991-5#1)(1996-2#2)(2008-4#6)(2008-7#1)
other data were##2##3##(1991-1#1)(2011-2#1)
other data##4##2##(1991-1#1)(1997-2#1)(2010-10#1)(2011-2#1)
other demographic##3##2##(1994-12#1)(2008-11#1)(2008-12#1)
other derivatives##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
other described##2##2##(2008-10#2)
other detection##2##2##(2008-10#1)(2010-6#1)
other developing countries##2##3##(2008-11#1)(2011-2#1)
other developmental##2##2##(2008-11#1)(2009-8#1)
other differences##2##2##(1995-11#1)(2009-5#1)
other dimensions##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
other direct##2##2##(1996-2#1)(2008-10#1)
other directions##2##2##(2008-10#1)(2008-6#1)
other disciplines##4##2##(1994-12#1)(2008-11#1)(2008-12#2)
other disease##3##2##(1997-7#1)(2008-10#2)
other diseases of##2##3##(1995-5#1)(2008-10#1)
other diseases##13##2##(1992-6#2)(1993-8#1)(1994-5#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
other disorders and##2##3##(2010-1#1)(2012-3#1)
other disorders##6##2##(1997-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-3#1)
other dithiocarbamates##2##2##(2008-10#2)
other divalent##2##2##(1990-5#1)(2008-10#1)
other domains##2##2##(2008-8#1)(2011-2#1)
other drug use behaviors##3##4##(1996-1#3)
other drug##4##2##(1996-1#3)(2012-12#1)
other drugs of abuse##2##4##(1991-1#1)(2009-7#1)
other drugs of##3##3##(1991-1#1)(2008-10#1)(2009-7#1)
other drugs##16##2##(1990-2#2)(1991-1#3)(1993-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
other ecological##2##2##(2008-10#2)
other eczema##2##2##(2013-1#2)
other effects##4##2##(1990-12#1)(1990-9#1)(2010-8#1)(2013-7#1)
other eight##3##2##(2008-10#3)
other elements of##2##3##(2008-3#1)(2012-12#1)
other elements##7##2##(2008-10#5)(2008-3#1)(2012-12#1)
other enteric pathogens##2##3##(2008-10#1)(2011-1#1)
other entities##2##2##(1991-3#1)(1993-2#1)
other environmental##8##2##(1991-12#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-5#1)
other enzymes##5##2##(1992-4#1)(1992-8#1)(1995-6#1)(2008-7#1)(2011-1#1)
other eukaryotes##3##2##(1992-8#1)(1996-3#1)(2012-2#1)
other events##2##2##(2008-9#1)(2010-1#1)
other evidence of##2##3##(2008-7#1)(2011-2#1)
other evidence##3##2##(1993-12#1)(2008-7#1)(2011-2#1)
other examinations##2##2##(1990-5#1)(1997-4#1)
other examples are##2##3##(2008-5#1)(2012-2#1)
other experimental##8##2##(1994-8#1)(2008-10#5)(2008-11#1)(2008-3#1)
other experiments##7##2##(2006-6#1)(2008-10#4)(2008-3#1)(2008-9#1)
other extracellular##2##2##(2008-4#1)(2008-7#1)
other extraction##3##2##(2008-10#3)
other factors are##4##3##(1996-3#1)(2008-1#1)(2012-3#1)(2013-1#1)
other factors influencing##2##3##(1995-3#1)(2008-12#1)
other factors may be##2##4##(2012-2#1)(2013-1#1)
other factors that affect the##2##5##(2008-4#1)(2008-6#1)
other factors that##3##3##(1994-12#1)(2008-4#1)(2008-6#1)
other factors##37##2##(1990-3#1)(1991-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-3#2)(1997-3#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#2)
other faculty##2##2##(1993-1#1)(1993-2#1)
other families##2##2##(2008-7#1)(2008-9#1)
other family##3##2##(2009-9#1)(2011-2#1)(2012-12#1)
other feature##2##2##(1992-9#1)(2008-3#1)
other features##4##2##(2008-3#1)(2008-9#1)(2013-1#1)(2013-8#1)
other field##3##2##(1996-1#1)(2008-10#1)(2008-5#1)
other fields of##2##3##(2008-11#1)(2011-3#1)
other fields##5##2##(2008-10#3)(2008-11#1)(2011-3#1)
other findings##3##2##(1996-12#1)(1997-3#1)(2011-2#1)
other fish species##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
other fish##4##2##(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)
other flow##3##2##(2008-10#3)
other for##3##2##(1995-6#1)(2008-11#1)(2008-4#1)
other forearm##2##2##(2008-5#1)(2008-9#1)
other form##3##2##(2008-10#1)(2010-5#1)(2010-6#1)
other forms of##11##3##(1993-12#1)(1997-2#1)(2008-11#2)(2009-1#1)(2009-10#1)(2010-12#2)(2011-2#1)(2012-3#2)
other formulations##2##2##(2008-10#2)
other four##8##2##(1995-9#1)(1996-12#1)(2008-10#6)
other fractions##2##2##(2008-10#1)(2008-11#1)
other from##6##2##(1990-5#1)(1992-6#1)(1996-8#1)(2008-10#3)
other functions##3##2##(1992-9#1)(2008-9#1)(2010-8#1)
other fungal pathogens##2##3##(2008-10#2)
other fungi##11##2##(2008-10#10)(2010-7#1)
other fungicides##2##2##(2008-10#2)
other gases##3##2##(1991-5#1)(1996-12#1)(2008-10#1)
other gene##6##2##(1990-11#1)(1996-12#2)(1996-6#1)(1997-2#1)(2008-10#1)
other genes##9##2##(1992-10#1)(1992-12#1)(1992-7#1)(1996-6#1)(2008-10#3)(2008-11#1)(2009-10#1)
other genetic##6##2##(1994-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)
other genomic##2##2##(1993-8#1)(2008-10#1)
other genotypes (A##2##3##(2008-10#2)
other genotypes##5##2##(2008-10#4)(2008-8#1)
other geographic areas##2##3##(2008-10#1)(2010-8#1)
other governmental##3##2##(1996-1#1)(2008-11#2)
other grape##2##2##(2008-10#2)
other group members##3##3##(2008-9#3)
other group##13##2##(1991-2#2)(1992-12#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-9#3)(2010-8#1)(2011-2#1)(2013-8#1)
other groups of##3##3##(1991-2#1)(1995-12#1)(2008-8#1)
other groups##20##2##(1990-6#1)(1991-2#1)(1993-12#2)(1995-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
other health care professionals##4##4##(2008-11#1)(2009-5#1)(2010-8#1)(2012-12#1)
other health care##10##3##(1993-1#1)(1994-12#1)(1995-2#1)(1996-12#1)(2008-11#3)(2009-5#1)(2010-8#1)(2012-12#1)
other health professionals##2##3##(1994-6#1)(2008-11#1)
other health professions were##2##4##(1991-6#2)
other health professions##3##3##(1991-6#2)(1997-3#1)
other health##25##2##(1991-3#1)(1991-6#2)(1993-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#2)(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#5)(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-6#1)(2010-8#2)(2012-12#1)
other healthcare##3##2##(1997-2#1)(2010-1#1)(2011-2#1)
other heart diseases##2##3##(1990-3#1)(1993-2#1)
other heavy##3##2##(1995-2#1)(2008-10#2)
other hematological##3##2##(1993-3#1)(2008-7#1)(2010-11#1)
other high-risk##2##2##(2008-6#1)(2009-5#1)
other higher##4##2##(1993-6#1)(1994-5#1)(2008-12#1)(2008-3#1)
other highly##2##2##(1997-2#1)(2008-7#1)
other homologous##2##2##(1994-5#1)(1994-8#1)
other hospital##3##2##(1990-2#1)(1990-9#1)(1993-3#1)
other hospitals##6##2##(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#2)(2008-11#1)
other host plants##2##3##(2008-10#2)
other host species##2##3##(2008-10#2)
other host##8##2##(2008-10#8)
other hosts##18##2##(2008-10#18)
other human##2##2##(1993-6#1)(2008-12#1)
other identified##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
other imaging techniques##2##3##(2011-2#1)(2012-2#1)
other imaging##4##2##(1991-2#1)(1992-11#1)(2011-2#1)(2012-2#1)
other important##11##2##(1992-2#1)(1992-3#2)(2008-1#1)(2008-10#3)(2008-7#1)(2010-7#1)(2012-4#1)(2013-8#1)
other in a##4##3##(1991-12#1)(1995-2#1)(2008-10#1)(2012-12#1)
other in the##5##3##(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
other in##21##2##(1991-12#1)(1992-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-5#1)(2012-12#2)
other indigenous##2##2##(2008-10#1)(2013-1#1)
other infection-related##2##2##(2008-7#1)(2009-8#1)
other infections##3##2##(1995-5#1)(2010-5#1)(2013-1#1)
other infectious##2##2##(2008-5#1)(2010-2#1)
other inflammatory##3##2##(2008-9#1)(2010-12#1)(2011-2#1)
other information##3##2##(1996-11#1)(2008-11#1)(2008-4#1)
other ingredients in##2##3##(2008-10#2)
other inocula##2##2##(2008-10#2)
other inorganic anions##2##3##(2008-10#2)
other inorganic##4##2##(2008-10#4)
other insect##2##2##(2007-12#1)(2008-11#1)
other instances##2##2##(2011-2#1)(2013-8#1)
other institutions##4##2##(1991-3#1)(1995-1#1)(1996-1#2)
other interferents##2##2##(2008-10#2)
other interfering##3##2##(2008-10#3)
other investigators##4##2##(1990-3#1)(1994-2#1)(1994-8#1)(2008-8#1)
other ions##10##2##(2008-10#10)
other is a##3##3##(1993-3#1)(2008-3#2)
other is##9##2##(1992-9#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2013-1#1)
other isolates of##2##3##(2008-10#2)
other isolates were##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
other isolates##11##2##(2008-10#8)(2008-7#1)(2008-9#1)(2011-2#1)
other key##3##2##(1994-1#1)(2008-10#1)(2012-2#1)
other kinds of##3##3##(1990-3#1)(1991-3#1)(1993-12#1)
other known##19##2##(1990-8#1)(1991-5#1)(1994-8#1)(1995-2#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-3#1)(2013-8#1)
other laboratories##3##2##(2008-11#2)(2008-2#1)
other leaf rust##2##3##(2008-10#2)
other less##2##2##(2009-12#1)(2012-2#1)
other lifestyle##2##2##(2008-11#1)(2009-5#1)
other living organisms##2##3##(2008-10#1)(2011-2#1)
other living##4##2##(1994-2#1)(2008-10#2)(2011-2#1)
other locations##6##2##(2008-10#3)(2008-5#1)(2010-1#1)(2010-8#1)
other loculoascomycetes##2##2##(2008-10#2)
other luteoviruses##2##2##(2008-10#2)
other major##4##2##(2008-10#1)(2011-10#1)(2011-2#1)(2012-3#1)
other males##3##2##(1993-11#1)(2008-8#1)(2009-6#1)
other malformations##2##2##(2008-10#1)(2011-1#1)
other mammalian##2##2##(1994-12#1)(2008-10#1)
other mammals##6##2##(1992-12#2)(1994-2#1)(1995-6#1)(2011-2#1)(2013-1#1)
other markers of##3##3##(2008-1#1)(2010-5#1)(2012-5#1)
other markers##6##2##(2008-1#1)(2008-10#2)(2010-5#1)(2012-3#1)(2012-5#1)
other materials##6##2##(1990-2#1)(2008-10#3)(2008-9#1)(2013-1#1)
other matrix##3##2##(2008-10#3)
other means of##2##3##(1994-6#1)(1996-3#1)
other measures of##4##3##(1996-12#1)(2008-12#1)(2012-2#1)(2013-1#1)
other measures##5##2##(1996-12#1)(2008-12#1)(2012-2#1)(2013-1#2)
other mechanisms##10##2##(1992-6#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-12#1)
other media##2##2##(2008-10#2)
other medical##9##2##(1991-12#1)(1992-1#1)(1996-3#1)(1997-7#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
other members of the family##2##5##(2008-10#1)(2012-12#1)
other members of the##12##4##(1992-3#1)(2008-10#8)(2008-11#1)(2011-2#1)(2012-12#1)
other members of##13##3##(1992-3#1)(2008-10#9)(2008-11#1)(2011-2#1)(2012-12#1)
other membrane proteins##2##3##(1993-8#1)(1995-12#1)
other membrane##3##2##(1993-8#1)(1995-12#1)(2008-10#1)
other membranes##2##2##(2008-10#2)
other mesenchymal##2##2##(2008-11#1)(2013-1#1)
other metabolic##4##2##(1994-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
other metal cations##3##3##(2008-10#3)
other metal ions##12##3##(2008-10#12)
other metal##19##2##(2008-10#19)
other metallic##3##2##(2008-10#2)(2008-7#1)
other metals##9##2##(2008-10#8)(2010-11#1)
other method##3##2##(2008-10#2)(2008-7#1)
other methods are##3##3##(1992-11#1)(1997-5#1)(2008-11#1)
other methods such as##2##4##(2008-10#1)(2008-11#1)
other methods##24##2##(1991-2#1)(1992-11#1)(1994-12#1)(1995-1#1)(1996-3#1)(1997-5#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-7#1)(2013-8#1)
other microorganisms##3##2##(2008-10#2)(2008-5#1)
other midline##2##2##(1997-3#2)
other minimally invasive approaches##2##4##(2013-1#2)
other minor loci##2##3##(2008-10#1)(2010-5#1)
other minor##5##2##(1993-12#1)(2008-10#2)(2009-12#1)(2010-5#1)
other modalities##2##2##(2008-5#1)(2010-6#1)
other model##2##2##(2008-10#1)(2008-11#1)
other models of##2##3##(2008-4#1)(2008-9#1)
other models##6##2##(2008-10#2)(2008-4#1)(2008-9#1)(2009-6#2)
other modules##2##2##(2008-11#2)
other molecular##3##2##(1990-6#1)(2009-9#1)(2013-8#1)
other molecules##4##2##(1995-2#1)(2008-3#1)(2009-12#1)(2013-1#1)
other more##5##2##(1991-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
other multivariate statistical##2##3##(2008-10#1)(2010-8#1)
other murine##3##2##(1997-1#2)(2011-2#1)
other mutants##2##2##(1995-6#1)(2008-10#1)
other nations##2##2##(1993-2#1)(2008-1#1)
other naturally occurring##2##3##(1990-11#1)(2008-10#1)
other neoplasms##2##2##(1990-12#1)(2012-2#1)
other neurodegenerative diseases##3##3##(2008-5#1)(2010-12#1)(2010-5#1)
other neurodegenerative##5##2##(1994-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-5#1)
other neurological##5##2##(1996-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
other neurons##5##2##(1997-3#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)
other new##3##2##(1994-3#1)(2007-12#1)(2008-11#1)
other not only##2##3##(2008-10#1)(2008-9#1)
other occupational##4##2##(1994-3#2)(2009-12#2)
other of##2##2##(2008-10#2)
other on##2##2##(1997-1#1)(2008-9#1)
other or##3##2##(1992-12#1)(2008-11#1)(2008-6#1)
other organ##2##2##(1995-1#1)(2010-12#1)
other organic solvents##2##3##(1994-8#1)(2008-11#1)
other organic##5##2##(1990-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2009-11#1)
other organisms##16##2##(1990-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-8#2)(2009-10#1)(2012-2#1)
other organizations##3##2##(1994-12#1)(1995-1#1)(2012-2#1)
other organs##6##2##(1994-5#1)(1995-2#1)(2009-8#1)(2012-3#2)(2013-1#1)
other outcomes##3##2##(1995-2#1)(2008-12#1)(2013-8#1)
other outdoor and indoor allergens##2##5##(2013-1#2)
other oxidant##2##2##(2008-10#2)
other pH values##2##3##(2008-11#1)(2008-5#1)
other parameters also##2##3##(2008-9#1)(2013-1#1)
other parameters such as age##2##5##(1990-8#1)(2011-2#1)
other parameters##15##2##(1990-8#1)(1992-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
other part of the##4##4##(1990-11#1)(2008-1#1)(2008-9#1)(2011-2#1)
other parts of the##4##4##(2008-10#2)(2008-7#1)(2010-5#1)
other parts of##7##3##(1996-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-11#1)(2010-5#1)
other patches##2##2##(2008-8#2)
other pathogenic##2##2##(2008-12#1)(2008-9#1)
other pathogens##5##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
other pathological##2##2##(2008-7#1)(2013-1#1)
other pathosystems##2##2##(2008-10#2)
other patient##4##2##(1991-2#1)(1995-12#1)(1996-6#1)(2008-10#1)
other patients##13##2##(1990-12#1)(1990-2#1)(1991-11#1)(1993-1#1)(1993-12#1)(1994-3#1)(1997-8#1)(2008-7#1)(2011-2#3)(2013-1#2)
other people##3##2##(2008-4#1)(2009-5#1)(2009-6#1)
other people's##2##2##(1997-5#1)(2008-11#1)
other peptide##2##2##(2008-10#1)(2011-1#1)
other peptides##2##2##(1995-3#1)(2008-9#1)
other person's##2##2##(1996-6#1)(2008-12#1)
other phenotypes##2##2##(1996-12#1)(2012-3#1)
other physical##5##2##(1992-5#1)(1996-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
other phytopathogenic fungi##4##3##(1997-4#1)(2008-10#3)
other phytopathogenic##7##2##(1997-4#1)(2008-10#6)
other phytoplasmas##2##2##(2008-10#2)
other places##2##2##(2008-10#1)(2009-10#1)
other plant species##6##3##(2008-10#4)(2008-8#1)(2010-3#1)
other plant viruses##2##3##(2008-10#1)(2008-9#1)
other plant##17##2##(2008-10#11)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#1)
other plants##11##2##(2008-10#5)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-8#1)
other plasma##2##2##(1995-2#1)(2008-10#1)
other polycyclic aromatic hydrocarbons##2##4##(2008-10#2)
other popular##2##2##(2008-11#2)
other populations##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)
other possible causes of##2##4##(2008-7#1)(2008-8#1)
other possible mechanisms##2##3##(1992-3#1)(2008-10#1)
other possible##8##2##(1992-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
other potential##9##2##(1995-6#1)(1996-2#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
other potentially##2##2##(1992-3#1)(2013-1#1)
other previous##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
other previously reported##3##3##(1994-8#1)(2008-10#1)(2012-3#1)
other previously##7##2##(1994-8#1)(2008-10#5)(2012-3#1)
other primary##4##2##(1996-12#1)(1997-8#1)(2010-4#1)(2013-8#1)
other problems##2##2##(2007-12#1)(2008-7#1)
other procedures##8##2##(1991-2#1)(1995-1#2)(1995-12#1)(1997-7#1)(2008-10#2)(2008-9#1)
other processes##4##2##(1991-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
other products##3##2##(2008-10#2)(2008-5#1)
other programs##2##2##(1992-2#1)(2008-10#1)
other properties of the##2##4##(1991-5#1)(2012-2#1)
other properties##7##2##(1991-5#1)(1994-8#1)(1997-3#1)(2008-11#2)(2008-5#1)(2012-2#1)
other protein components##2##3##(1991-12#1)(1995-2#1)
other protein##7##2##(1990-8#1)(1991-12#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2010-11#1)
other proteins that##2##3##(1992-3#1)(2008-10#1)
other proteins##16##2##(1992-3#1)(1994-9#1)(1995-6#1)(1996-2#2)(1997-6#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-2#1)
other published##5##2##(1990-9#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
other race##2##2##(2008-10#2)
other rare##4##2##(2008-10#3)(2008-9#1)
other reactions##3##2##(1991-3#1)(1997-7#1)(2008-7#1)
other reasons##5##2##(1991-8#1)(1992-2#1)(1993-1#1)(1994-3#1)(2011-2#1)
other recent##3##2##(1997-3#1)(2011-2#1)(2012-12#1)
other receptors##2##2##(1995-2#1)(2013-7#1)
other recombinant##3##2##(2008-11#2)(2008-4#1)
other regions of the world##2##5##(2008-10#1)(2008-11#1)
other regions of the##4##4##(1993-12#1)(2008-10#1)(2008-11#1)(2009-12#1)
other regions##11##2##(1993-12#1)(1993-6#1)(1997-7#1)(2008-10#4)(2008-11#2)(2009-12#1)(2013-8#1)
other regulatory##2##2##(1991-3#1)(2008-7#1)
other related##8##2##(1991-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#1)
other relatives##2##2##(1997-3#1)(2011-2#1)
other relevant##4##2##(1994-3#1)(2008-10#2)(2008-9#1)
other remains##2##2##(2008-11#1)(2009-7#1)
other reported methods##2##3##(2008-10#1)(2009-10#1)
other reported##12##2##(1990-7#1)(1991-6#1)(1992-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#1)(2013-1#1)(2013-8#1)
other reports##4##2##(1990-3#1)(1991-6#1)(1994-2#1)(2008-7#1)
other representatives of##2##3##(2007-12#1)(2008-12#1)
other research##5##2##(1997-3#1)(2008-11#2)(2010-5#1)(2011-2#1)
other resistance genes##2##3##(2008-10#1)(2008-11#1)
other results##2##2##(1992-6#1)(1995-2#1)
other retroviral integrases##2##3##(1997-3#2)
other risk factors##2##3##(2008-11#1)(2009-6#1)
other risk##3##2##(2008-11#1)(2009-6#1)(2010-12#1)
other risks##2##2##(2008-7#1)(2009-12#1)
other rodents##2##2##(2008-4#1)(2011-2#1)
other screening##2##2##(1992-3#1)(2008-10#1)
other seasonal allergens##3##3##(2011-2#3)
other seed crops##2##3##(2008-10#1)(2013-8#1)
other seed##3##2##(2008-10#2)(2013-8#1)
other selected lanthanides##2##3##(2008-10#2)
other selected##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
other sensors##3##2##(2008-10#2)(2008-3#1)
other services##2##2##(1994-1#1)(2008-1#1)
other several##2##2##(1992-2#1)(2008-10#1)
other sexually transmitted infections##2##4##(2009-5#1)(2011-2#1)
other sexually transmitted##4##3##(1993-9#1)(1997-6#1)(2009-5#1)(2011-2#1)
other side effects##3##3##(2009-7#1)(2010-7#1)(2013-1#1)
other side of the##2##4##(1994-2#1)(2008-10#1)
other side##10##2##(1994-2#1)(2008-10#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
other signaling##2##2##(2008-11#1)(2009-8#1)
other signalling##2##2##(1996-2#1)(2008-9#1)
other signals##2##2##(1997-3#1)(2008-11#1)
other significant##3##2##(1994-5#1)(2011-2#1)(2012-3#1)
other similar##2##2##(1997-3#1)(2008-10#1)
other sisters##2##2##(2011-2#2)
other sites are##2##3##(1995-6#1)(2008-5#1)
other sites##11##2##(1991-12#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-6#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-5#1)(2013-1#1)
other six##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
other skin##2##2##(1991-6#1)(2008-5#1)
other small##4##2##(1990-12#1)(2008-10#2)(2008-8#1)
other social Hymenoptera##2##3##(2008-8#2)
other social##4##2##(2008-10#1)(2008-8#2)(2011-2#1)
other sociodemographic##2##2##(2011-2#1)(2012-12#1)
other soil##2##2##(2008-10#1)(2008-11#1)
other solvents##3##2##(2008-10#2)(2008-7#1)
other sorbent materials##2##3##(2008-10#2)
other sources of##7##3##(1997-2#1)(2008-10#4)(2008-3#1)(2012-2#1)
other sources##10##2##(1990-8#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2012-2#1)
other specialists and##2##3##(2011-2#1)(2011-3#1)
other species and##3##3##(1992-12#1)(1997-9#1)(2008-10#1)
other species are##2##3##(2008-10#1)(2008-4#1)
other species has##2##3##(2008-10#1)(2008-11#1)
other species of Phytophthora##2##4##(2008-10#2)
other species of##15##3##(1993-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-8#1)
other species##60##2##(1991-3#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1997-2#1)(1997-3#2)(1997-9#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#2)
other specific##4##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-8#1)
other stages of##2##3##(2009-10#1)(2009-8#1)
other stages##3##2##(2008-1#1)(2009-10#1)(2009-8#1)
other states##3##2##(1996-12#1)(1997-1#1)(2008-10#1)
other stimuli##3##2##(1990-5#1)(2009-10#2)
other strains by##2##3##(2008-10#2)
other strains of##3##3##(2008-10#2)(2008-7#1)
other strains##15##2##(1995-9#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)
other strategies##2##2##(2008-11#1)(2010-7#1)
other stressors##2##2##(1996-12#1)(2008-11#1)
other structural##2##2##(2008-11#1)(2008-12#1)
other structurally##2##2##(1990-8#1)(1994-5#1)
other structures##2##2##(1994-2#1)(2013-8#1)
other studies##23##2##(1990-5#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-5#1)(1997-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
other subcellular##2##2##(2008-4#1)(2008-9#1)
other subjects##3##2##(2008-10#2)(2008-5#1)
other subsets##2##2##(2008-10#2)
other substances which##2##3##(1996-1#1)(2008-10#1)
other substances##12##2##(1991-3#1)(1996-1#1)(2008-1#1)(2008-10#7)(2008-11#2)
other suggests that##2##3##(1997-8#1)(2009-5#1)
other surgical and##2##3##(1990-6#1)(1994-3#1)
other surgical procedures##2##3##(1991-8#1)(1992-6#1)
other surgical##5##2##(1990-6#1)(1991-8#1)(1992-6#1)(1994-3#1)(2012-3#1)
other symptoms##4##2##(2008-5#1)(2009-1#2)(2011-2#1)
other syndromes##2##2##(2010-1#1)(2011-2#1)
other synthetic##2##2##(1992-12#1)(1995-2#1)
other systemic##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
other systems##5##2##(1996-1#1)(1997-7#1)(2008-10#1)(2008-9#1)(2010-4#1)
other tasks##2##2##(2012-2#1)(2013-1#1)
other taxa in the genus##2##5##(2008-10#2)
other taxa##3##2##(2008-10#3)
other techniques and##2##3##(2008-10#1)(2008-9#1)
other techniques##12##2##(1991-2#1)(2007-11#1)(2008-10#7)(2008-6#1)(2008-9#1)(2011-2#1)
other technologies##2##2##(2008-10#1)(2008-3#1)
other term##2##2##(2008-10#1)(2008-2#1)
other tested##2##2##(1991-3#1)(2008-10#1)
other tests##2##2##(2008-1#1)(2008-5#1)
other than Al(3+)##2##3##(2008-10#2)
other than antibiosis##2##3##(2008-10#2)
other than at##2##3##(1992-9#1)(2013-1#1)
other than the##15##3##(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#1)(1997-8#1)(2008-10#6)(2008-7#1)(2009-8#1)(2013-1#1)
other than their##2##3##(2008-9#1)(2010-8#1)
other than##92##2##(1990-2#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#3)(1996-12#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#28)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#5)(2013-7#1)
other therapeutic##4##2##(1992-9#1)(1996-1#1)(2007-8#1)(2008-11#1)
other things##4##2##(1990-2#1)(1994-2#1)(2008-10#2)
other three##14##2##(1997-6#1)(2008-10#5)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#3)(2012-3#1)(2013-8#1)
other tissue##3##2##(2008-10#1)(2008-4#1)(2010-6#1)
other tissues##9##2##(1991-12#1)(1993-3#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-5#1)
other to##5##2##(1995-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2013-8#1)
other tospoviruses##7##2##(2008-10#7)
other traditional##2##2##(2008-11#1)(2009-5#1)
other transcription factors required for##2##5##(1990-5#1)(2008-9#1)
other transcription factors##5##3##(1990-5#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)
other transition metal##3##3##(2008-10#2)(2008-12#1)
other treatment modalities##3##3##(1991-9#1)(1993-2#1)(2007-11#1)
other treatment##7##2##(1991-9#1)(1992-1#1)(1993-2#1)(1994-5#1)(1996-3#1)(2007-11#1)(2008-10#1)
other treatments##5##2##(2008-10#2)(2008-12#2)(2009-9#1)
other tumor##3##2##(1991-8#1)(1993-11#1)(2012-2#1)
other tumors of##2##3##(1992-9#1)(2011-2#1)
other tumors##6##2##(1991-2#1)(1992-9#1)(1997-8#1)(2008-11#1)(2010-12#1)(2011-2#1)
other twin##2##2##(2010-1#1)(2010-8#1)
other two groups##7##3##(1991-11#1)(2008-10#4)(2011-3#1)(2013-1#1)
other two##39##2##(1991-11#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#2)(1995-3#1)(1995-6#1)(2008-10#23)(2008-7#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
other type of##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
other type##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
other types of##19##3##(1990-11#1)(1990-3#1)(1990-6#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-1#1)(2010-1#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)
other types##21##2##(1990-11#1)(1990-3#1)(1990-6#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#1)(2010-1#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)
other unique##2##2##(1993-8#1)(2008-10#1)
other unknown##2##2##(2012-3#2)
other urinary##2##2##(1990-2#1)(1990-9#1)
other uses##2##2##(2008-4#1)(2010-5#1)
other using##2##2##(2008-10#2)
other vaccines##2##2##(1994-9#1)(1997-7#1)
other variables##11##2##(1991-12#1)(1991-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
other variants##2##2##(1994-12#1)(2008-10#1)
other various##2##2##(2008-10#1)(2008-9#1)
other vascular##3##2##(1991-3#1)(2008-8#1)(2009-8#1)
other vertebrate##2##2##(1993-6#1)(2008-5#1)
other viral##3##2##(1997-8#1)(2008-1#1)(2012-2#1)
other viruses##4##2##(2008-10#4)
other visual##3##2##(1993-11#1)(1993-6#1)(2009-9#1)
other was##7##2##(1991-3#1)(2008-10#3)(2008-5#1)(2013-1#2)
other wavelengths##2##2##(2008-2#1)(2008-3#1)
other with##8##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
other words##9##2##(1994-3#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-8#1)(2008-9#2)(2013-8#1)
other##3838##1##(1990-11#13)(1990-12#12)(1990-2#18)(1990-3#10)(1990-5#15)(1990-6#7)(1990-7#1)(1990-8#8)(1990-9#8)(1991-1#8)(1991-10#6)(1991-11#4)(1991-12#27)(1991-2#20)(1991-3#25)(1991-4#2)(1991-5#12)(1991-6#12)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#6)(1992-10#2)(1992-11#2)(1992-12#20)(1992-2#14)(1992-3#11)(1992-4#3)(1992-5#3)(1992-6#14)(1992-7#2)(1992-8#4)(1992-9#14)(1993-1#12)(1993-11#11)(1993-12#20)(1993-2#21)(1993-3#18)(1993-6#20)(1993-8#18)(1993-9#5)(1994-1#9)(1994-11#7)(1994-12#19)(1994-2#16)(1994-3#18)(1994-5#20)(1994-6#8)(1994-8#14)(1994-9#4)(1995-1#10)(1995-11#6)(1995-12#23)(1995-2#41)(1995-3#7)(1995-5#8)(1995-6#25)(1995-8#16)(1995-9#4)(1996-1#22)(1996-11#4)(1996-12#35)(1996-2#20)(1996-3#23)(1996-5#12)(1996-6#12)(1996-8#3)(1996-9#4)(1997-1#11)(1997-2#20)(1997-3#40)(1997-4#6)(1997-5#6)(1997-6#12)(1997-7#17)(1997-8#16)(1997-9#3)(2006-6#6)(2007-11#5)(2007-12#19)(2007-8#3)(2008-1#23)(2008-10#1146)(2008-11#251)(2008-12#67)(2008-2#15)(2008-3#48)(2008-4#54)(2008-5#98)(2008-6#30)(2008-7#99)(2008-8#111)(2008-9#106)(2009-1#5)(2009-10#29)(2009-11#5)(2009-12#18)(2009-3#4)(2009-5#16)(2009-6#14)(2009-7#9)(2009-8#28)(2009-9#8)(2010-1#15)(2010-10#13)(2010-11#16)(2010-12#29)(2010-2#3)(2010-3#6)(2010-4#13)(2010-5#20)(2010-6#19)(2010-7#15)(2010-8#29)(2010-9#3)(2011-1#13)(2011-10#3)(2011-2#143)(2011-3#7)(2011-7#1)(2011-9#1)(2012-12#19)(2012-2#72)(2012-3#61)(2012-4#1)(2012-5#3)(2013-1#99)(2013-7#5)(2013-8#54)
other's##5##1##(2008-11#2)(2008-8#1)(2009-6#1)(2010-11#1)
other)##3##1##(2008-8#1)(2012-12#1)(2013-1#1)
other-evaluative##2##1##(2013-8#2)
others and##6##2##(1991-8#1)(1994-1#1)(1996-5#1)(1996-9#1)(2009-9#1)(2011-2#1)
others appear##2##2##(1991-3#1)(2009-5#1)
others are##11##2##(1991-3#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-9#1)(2009-9#1)(2013-8#2)
others by##4##2##(2008-11#2)(2008-5#1)(2011-2#1)
others do not##5##3##(2008-1#1)(2008-10#1)(2008-9#2)(2012-3#1)
others had##2##2##(2008-10#1)(2008-12#1)
others has##2##2##(2008-10#1)(2009-8#1)
others have been##2##3##(2008-10#1)(2011-1#1)
others have##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)
others in the##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
others in##10##2##(1992-3#1)(1994-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)
others is##4##2##(2008-10#2)(2008-11#1)(2010-11#1)
others may##2##2##(2008-10#2)
others previously##2##2##(1995-3#1)(1995-9#1)
others should##2##2##(1994-12#1)(1997-8#1)
others to##6##2##(1993-3#1)(1995-1#1)(1995-12#1)(2008-12#1)(2008-8#1)(2009-10#1)
others using##2##2##(1994-3#1)(2008-1#1)
others were##7##2##(1990-11#1)(1990-5#1)(1990-6#1)(1993-1#1)(1995-12#1)(1995-2#1)(1997-6#1)
others when##2##2##(1991-12#1)(2008-7#1)
others who##2##2##(1992-3#1)(2008-9#1)
others will require##2##3##(2008-6#1)(2012-2#1)
others will##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
others with##2##2##(2008-4#1)(2008-9#1)
others##258##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#2)(2007-12#1)(2008-1#3)(2008-10#53)(2008-11#27)(2008-12#8)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#12)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-2#4)(2012-3#6)(2013-1#7)(2013-8#11)
others'##2##1##(1991-2#1)(1997-3#1)
others)##7##1##(1992-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-2#1)
others?##2##1##(2008-9#1)(2013-8#1)
otherwise advantageous##2##2##(2008-4#1)(2008-5#1)
otherwise be##3##2##(1992-3#1)(2008-11#1)(2008-8#1)
otherwise clinically##2##2##(1992-5#1)(2011-2#1)
otherwise have##2##2##(1991-6#2)
otherwise healthy subjects##2##3##(1997-6#1)(2008-11#1)
otherwise healthy##7##2##(1991-8#1)(1994-9#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
otherwise identical##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
otherwise interfere with##2##3##(2008-10#2)
otherwise it##2##2##(2008-10#1)(2008-7#1)
otherwise known##2##2##(2008-8#1)(2008-9#1)
otherwise normal##4##2##(1995-5#1)(1996-9#1)(2007-12#1)(2008-10#1)
otherwise not##3##2##(2009-6#1)(2011-2#1)(2013-1#1)
otherwise specified##3##2##(2012-2#2)(2012-3#1)
otherwise stable##2##2##(2008-11#1)(2013-1#1)
otherwise the##3##2##(1997-2#1)(2008-5#1)(2008-7#1)
otherwise they##3##2##(1991-12#1)(1991-6#1)(2008-11#1)
otherwise unremarkable##2##2##(2008-11#1)(2013-1#1)
otherwise##94##1##(1991-12#1)(1991-6#3)(1991-8#3)(1992-3#2)(1992-5#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#13)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#12)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
otitis externa##5##2##(1991-3#2)(2008-5#2)(2013-7#1)
otitis media in##2##3##(1990-3#1)(1991-3#1)
otitis media##15##2##(1990-3#1)(1991-3#4)(1993-2#1)(2008-11#1)(2008-7#1)(2008-9#6)(2013-1#1)
otitis##28##1##(1990-3#2)(1991-3#6)(1993-2#1)(1994-3#1)(2008-11#1)(2008-5#7)(2008-7#1)(2008-9#6)(2013-1#2)(2013-7#1)
otolaryngologists##4##1##(2008-11#1)(2008-7#2)(2008-9#1)
otolaryngology##3##1##(2008-11#2)(2013-8#1)
otolith calcium##3##2##(2008-10#3)
otolith##9##1##(2008-10#5)(2008-7#4)
otoliths of##3##2##(2008-10#2)(2010-8#1)
otoliths##8##1##(2008-10#4)(2008-7#3)(2010-8#1)
otorhinolaryngological##3##1##(2011-2#2)(2013-1#1)
ou##9##1##(2008-10#1)(2011-2#4)(2013-1#4)
ouabain maximum binding##2##3##(1995-8#2)
ouabain##4##1##(1992-3#1)(1994-3#1)(1995-8#2)
ought to be##6##3##(1992-12#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
ought to##8##2##(1992-12#2)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
ounce of prevention##2##3##(1993-1#1)(2013-8#1)
our County##4##2##(2011-2#4)
our IRB##4##2##(2009-4#4)
our PD##2##2##(2011-2#2)
our ability to understand##2##4##(1995-5#1)(2012-12#1)
our ability to##8##3##(1991-12#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-3#1)(2010-7#1)(2012-12#1)(2012-2#1)
our aim was to##2##4##(2008-11#1)(2013-1#1)
our algorithm##2##2##(2008-6#2)
our ambulatory##2##2##(1997-3#2)
our analysis of the##3##4##(1996-3#1)(2010-4#1)(2012-3#1)
our analysis of##5##3##(1996-3#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-3#1)
our analysis##11##2##(1991-8#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
our analytical##2##2##(2008-10#2)
our approach is##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
our approach to##2##3##(2010-10#1)(2011-2#1)
our approach##14##2##(2008-10#3)(2008-6#2)(2008-8#2)(2009-8#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
our attempts to##2##3##(2010-5#1)(2010-6#1)
our attention##6##2##(1991-3#1)(1997-6#1)(2008-10#3)(2011-3#1)
our bodies?##2##2##(1992-1#2)
our calibration##2##2##(2010-3#2)
our capacity to##2##3##(2008-11#1)(2009-4#1)
our case##15##2##(1990-8#1)(1991-11#1)(1991-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#2)
our centre##3##2##(1995-10#1)(2010-10#1)(2013-1#1)
our clinic##4##2##(2011-1#2)(2011-2#1)(2012-3#1)
our clinical##2##2##(1991-3#1)(2012-2#1)
our collection of##2##3##(1995-9#1)(2008-10#1)
our community##3##2##(1994-12#1)(2008-7#1)(2012-3#1)
our conclusions##4##2##(1996-3#1)(2008-12#1)(2008-6#1)(2008-8#1)
our conditions##2##2##(1991-12#1)(1993-2#1)
our continuing##2##2##(1993-11#1)(1996-2#1)
our country##7##2##(1990-9#1)(1995-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-1#1)(2013-1#1)
our criteria##2##2##(1997-7#1)(2013-1#1)
our current knowledge##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
our current understanding of the##2##5##(2012-2#1)(2013-8#1)
our current understanding of##6##4##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
our current##14##2##(1992-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#3)
our data are##2##3##(2008-7#1)(2008-8#1)
our data indicate that##3##4##(2008-7#1)(2010-4#1)(2012-3#1)
our data suggest that the##2##5##(1992-12#1)(2011-2#1)
our data suggest that##8##4##(1992-12#1)(1994-11#1)(1995-12#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-3#1)
our data we##2##3##(1990-8#1)(2007-12#1)
our data##37##2##(1990-8#1)(1992-12#1)(1994-11#2)(1994-12#1)(1995-11#1)(1995-12#2)(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-3#2)
our decision making and##2##4##(1993-3#1)(2008-7#1)
our department with a##2##4##(2008-12#1)(2011-2#1)
our department##16##2##(1990-9#1)(1991-11#1)(1993-6#1)(1997-4#1)(1997-8#1)(2008-12#2)(2008-9#2)(2011-1#1)(2011-2#3)(2013-1#2)(2013-7#1)
our discussion##3##2##(2010-10#1)(2012-3#1)(2013-1#1)
our earlier##6##2##(1991-6#1)(1993-2#1)(1997-2#1)(2008-10#2)(2013-8#1)
our educational##2##2##(2008-12#1)(2010-9#1)
our efforts to##3##3##(1994-1#2)(1997-9#1)
our efforts##4##2##(1994-1#2)(1997-9#1)(2010-6#1)
our environment##3##2##(1994-3#1)(2008-10#1)(2013-8#1)
our estimates##2##2##(1992-9#1)(2008-8#1)
our everyday##3##2##(2009-8#3)
our experience in the##2##4##(1990-5#1)(2008-10#1)
our experience in##4##3##(1990-5#1)(1993-9#1)(2008-10#1)(2011-2#1)
our experience of a##2##4##(1991-9#1)(1997-3#1)
our experience of##7##3##(1991-9#1)(1995-10#1)(1997-3#2)(2008-10#2)(2010-8#1)
our experience with the##2##4##(1996-8#1)(2008-12#1)
our experience with##10##3##(1995-3#1)(1996-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)
our experience##35##2##(1990-5#1)(1991-3#1)(1991-9#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-8#1)(1997-3#3)(2008-10#5)(2008-11#4)(2008-12#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#6)(2012-3#1)(2013-1#1)
our experience]##2##2##(1990-5#1)(1991-3#1)
our experiences##5##2##(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)(2010-7#1)
our experimental##4##2##(1997-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
our experimentally##2##2##(2008-3#1)(2008-8#1)
our experiments##3##2##(1995-2#1)(2008-3#1)(2008-5#1)
our facility##2##2##(1992-2#1)(1994-12#1)
our finding##2##2##(2008-7#1)(2013-1#1)
our findings in##3##3##(1995-11#1)(1995-12#1)(2008-9#1)
our findings indicate that##2##4##(2008-9#1)(2009-7#1)
our findings provide##2##3##(2011-2#1)(2013-1#1)
our findings with##2##3##(2008-10#1)(2010-12#1)
our findings##33##2##(1990-6#1)(1995-11#1)(1995-12#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-7#1)(2013-1#4)(2013-8#1)
our first##7##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-12#1)(2013-8#1)
our focus##2##2##(1995-1#1)(2011-2#1)
our future##3##2##(2008-11#2)(2008-12#1)
our general##2##2##(2008-8#2)
our goal##4##2##(2008-6#1)(2009-10#1)(2011-2#1)(2012-2#1)
our group and##2##3##(1991-12#1)(2008-10#1)
our group##7##2##(1991-12#1)(1995-5#1)(2008-10#3)(2010-12#1)(2013-1#1)
our growing##2##2##(2008-12#1)(2011-2#1)
our health care system##2##4##(1992-3#1)(1997-2#1)
our health##3##2##(1992-3#1)(1995-3#1)(1997-2#1)
our high##2##2##(1995-6#1)(2008-11#1)
our high-density##2##2##(1996-12#1)(1997-2#1)
our hospital with##5##3##(1993-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
our hospital##30##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-6#1)(1995-1#1)(1997-8#1)(2008-12#1)(2008-7#1)(2010-6#4)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
our hospitals##3##2##(1990-6#1)(1997-8#1)(2011-2#1)
our hypothesis that##2##3##(2008-10#1)(2010-8#1)
our hypothesis##7##2##(1992-3#1)(2008-10#2)(2010-8#1)(2012-5#1)(2012-7#1)(2013-8#1)
our ignorance of##2##3##(2008-9#1)(2011-2#1)
our in##2##2##(2008-10#1)(2013-1#1)
our in-patient##2##2##(2008-3#2)
our initial experience##2##3##(2010-6#1)(2012-12#1)
our initial##4##2##(2008-10#1)(2008-6#1)(2010-6#1)(2012-12#1)
our institution##13##2##(1991-8#1)(1994-1#1)(1996-3#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#2)
our institution's##2##2##(1990-11#1)(2008-8#1)
our interest##2##2##(2010-7#1)(2013-7#1)
our interpretation##2##2##(2008-12#1)(2008-3#1)
our investigation##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#2)(2011-2#1)
our investigations##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
our knowledge about the effects of##2##6##(2009-10#1)(2012-2#1)
our knowledge about the##4##4##(2008-11#1)(2008-7#1)(2009-10#1)(2012-2#1)
our knowledge about##7##3##(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2012-2#1)
our knowledge and##2##3##(2008-3#1)(2010-12#1)
our knowledge of plant##2##4##(2008-9#1)(2009-8#1)
our knowledge of the##2##4##(2011-1#1)(2011-2#1)
our knowledge of##11##3##(1997-1#1)(2008-10#2)(2008-11#2)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
our knowledge this is the first report of##2##8##(2008-9#1)(2012-3#1)
our knowledge this is the first report##3##7##(2008-5#1)(2008-9#1)(2012-3#1)
our knowledge this is the first##5##6##(1997-8#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-3#1)
our knowledge this is the##7##5##(1997-8#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
our knowledge this##9##3##(1997-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
our knowledge##128##2##(1991-3#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-8#4)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#4)(2008-2#5)(2008-3#14)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#3)(2011-1#3)(2011-2#6)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#2)
our knowledge)##2##2##(2008-3#1)(2012-2#1)
our lab##5##2##(2008-10#2)(2008-7#1)(2008-8#2)
our laboratories##5##2##(1997-2#1)(2008-10#3)(2008-4#1)
our laboratory for##2##3##(1996-1#1)(2008-10#1)
our laboratory showed that##2##4##(1993-1#1)(2009-8#1)
our laboratory##27##2##(1991-2#1)(1993-1#2)(1996-1#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)
our lives##2##2##(2011-2#1)(2012-2#1)
our longitudinal##2##2##(2008-7#1)(2011-2#1)
our main##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
our measurement##2##2##(2008-10#1)(2012-2#1)
our medical service##3##3##(2008-3#3)
our medical##6##2##(1997-1#1)(2008-3#3)(2012-12#1)(2012-2#1)
our method is##2##3##(2008-10#1)(2008-7#1)
our method##8##2##(1991-2#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-6#1)(2012-2#1)
our methods##2##2##(2008-10#1)(2008-6#1)
our model and##2##3##(2008-10#1)(2008-6#1)
our model predicts##3##3##(2008-8#3)
our model to##2##3##(1992-3#1)(2008-3#1)
our model##22##2##(1992-3#1)(1992-9#1)(1993-8#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#7)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
our model's##2##2##(2008-8#1)(2013-8#1)
our modeling##2##2##(2008-3#1)(2013-8#1)
our models##4##2##(2008-10#1)(2008-11#1)(2008-8#2)
our molecular##2##2##(2009-6#1)(2011-2#1)
our moral##3##2##(2008-11#3)
our nation's health##2##3##(1997-2#1)(2010-1#1)
our new##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
our newly##2##2##(2008-10#1)(2010-8#1)
our objective##2##2##(2010-4#1)(2012-2#1)
our observation##3##2##(1996-6#1)(2008-10#1)(2011-2#1)
our observations##3##2##(1996-12#1)(2008-10#2)
our ongoing##4##2##(2008-1#1)(2009-6#1)(2011-3#1)(2012-2#1)
our opinion##5##2##(1990-11#1)(1991-6#1)(1996-11#1)(1997-8#1)(2013-8#1)
our optimized##3##2##(2008-11#2)(2008-5#1)
our original##2##2##(2008-10#1)(2009-10#1)
our own##18##2##(1991-11#1)(1991-8#1)(1994-1#1)(1997-1#1)(2008-11#2)(2008-12#4)(2008-7#3)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
our patient##16##2##(1995-8#1)(1996-8#2)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
our patients there##2##3##(2011-2#1)(2013-1#1)
our patients##19##2##(1990-6#1)(1991-12#1)(1991-3#1)(1993-1#1)(1995-10#1)(1996-3#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#3)(2013-1#2)(2013-8#1)
our policy##2##2##(1992-1#1)(2008-7#1)
our predictions##2##2##(1992-3#1)(2008-8#1)
our preliminary study##2##3##(2013-1#2)
our preliminary##4##2##(2008-3#1)(2010-4#1)(2013-1#2)
our present##6##2##(1990-8#1)(1991-5#1)(1995-12#1)(1997-2#1)(2008-2#1)(2011-2#1)
our previous data##2##3##(2008-10#2)
our previous finding##2##3##(1996-12#1)(2008-9#1)
our previous findings of##2##4##(2008-10#2)
our previous findings##6##3##(1993-1#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#2)
our previous report##3##3##(1994-8#1)(1997-8#1)(2008-10#1)
our previous results##2##3##(1990-8#1)(2009-8#1)
our previous study##6##3##(1993-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
our previous work##5##3##(1994-2#1)(1997-2#1)(2008-10#2)(2008-7#1)
our previous##34##2##(1990-5#1)(1990-8#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-8#3)(1995-12#3)(1996-12#2)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-7#1)(2008-9#2)(2009-8#1)
our previously##2##2##(1996-2#1)(2008-8#1)
our procedure##2##2##(1995-12#1)(2010-1#1)
our procedures##2##2##(1992-6#1)(2008-3#1)
our products##2##2##(2008-10#1)(2008-5#1)
our proposed##2##2##(2008-3#1)(2011-1#1)
our prospective##2##2##(1997-8#1)(2011-2#1)
our readers##2##2##(2008-8#2)
our recent studies on the##2##5##(2008-5#1)(2011-2#1)
our recent studies##3##3##(2008-5#1)(2011-2#2)
our recent study##3##3##(2009-8#2)(2011-2#1)
our recent##14##2##(1994-8#1)(2008-5#1)(2009-6#1)(2009-8#7)(2011-2#3)(2012-12#1)
our recently##2##2##(2008-10#1)(2013-1#1)
our recommendations##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
our research##5##2##(2008-10#1)(2008-12#1)(2009-7#1)(2012-2#1)(2013-1#1)
our results and##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
our results are consistent with##3##5##(2008-10#1)(2008-8#1)(2009-12#1)
our results are##7##3##(1993-11#1)(1997-8#1)(2008-10#2)(2008-8#2)(2009-12#1)
our results demonstrate that##3##4##(2008-10#1)(2012-3#1)(2013-8#1)
our results demonstrate##4##3##(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
our results demonstrated that##2##4##(2008-7#1)(2010-1#1)
our results indicate that##3##4##(1995-2#1)(2008-10#1)(2010-7#1)
our results is that##2##4##(1994-5#1)(2008-10#1)
our results show that##4##4##(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
our results show##5##3##(1995-11#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
our results showed that##2##4##(2008-10#1)(2008-9#1)
our results suggest that the##2##5##(2011-2#1)(2013-8#1)
our results suggest that##8##4##(1997-8#1)(2008-10#1)(2008-11#3)(2010-7#1)(2011-2#1)(2013-8#1)
our results suggested that##2##4##(2008-8#2)
our results with those##2##4##(2008-7#2)
our results##59##2##(1990-12#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#13)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#3)
our review##2##2##(1992-5#1)(2008-7#1)
our sample##6##2##(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
our samples##2##2##(2008-10#1)(2008-8#1)
our scoring function##2##3##(2011-3#2)
our search##2##2##(2010-12#1)(2011-2#1)
our second##3##2##(2008-6#1)(2008-8#1)(2012-12#1)
our series##8##2##(1990-12#1)(1990-6#1)(1991-8#1)(1997-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#1)
our society##8##2##(1994-12#1)(1995-11#1)(1995-3#1)(1996-1#1)(1997-2#2)(2008-9#1)(2009-9#1)
our staff##2##2##(1991-12#2)
our state and##2##3##(1995-1#1)(1996-2#1)
our studies of##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
our studies revealed##2##3##(2008-12#1)(2011-2#1)
our studies##7##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
our study for##2##3##(2008-9#1)(2010-12#1)
our study indicates that##2##4##(2008-11#1)(2012-2#1)
our study is the##2##4##(2008-11#1)(2008-3#1)
our study is##6##3##(2008-11#2)(2008-3#1)(2009-6#1)(2011-2#1)(2011-7#1)
our study of##2##3##(1991-6#1)(2009-8#1)
our study population##2##3##(1990-2#1)(2013-1#1)
our study reveals##2##3##(2012-2#1)(2013-1#1)
our study showed that the##2##5##(2011-2#2)
our study was##19##3##(1990-5#1)(1991-3#1)(1997-8#2)(2008-10#1)(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#2)(2012-6#1)(2013-1#3)
our study we wanted to##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
our study we##6##3##(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
our study##87##2##(1990-2#1)(1990-5#1)(1991-3#2)(1991-6#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-6#1)(1997-8#2)(2007-11#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#10)(2011-7#3)(2012-2#2)(2012-3#7)(2012-6#1)(2013-1#11)
our subjects##2##2##(2008-7#2)
our system is a##2##4##(2008-10#1)(2008-9#1)
our system##7##2##(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-3#1)
our technique##3##2##(2008-10#1)(2008-6#2)
our tertiary##2##2##(2011-2#1)(2013-1#1)
our theoretical##3##2##(2008-3#2)(2010-9#1)
our theory##2##2##(2008-11#1)(2008-8#1)
our thinking##2##2##(1994-1#1)(2008-8#1)
our treatment##3##2##(1990-9#1)(2008-10#1)(2009-6#1)
our understanding of how##4##4##(1993-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
our understanding of the ecology of##2##6##(2008-10#2)
our understanding of the pathophysiology##2##5##(2013-7#1)(2013-8#1)
our understanding of the role##2##5##(2008-7#1)(2013-1#1)
our understanding of the##29##4##(1991-3#1)(1996-11#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
our understanding of this##2##4##(2008-5#1)(2012-2#1)
our understanding of##63##3##(1991-3#2)(1993-12#2)(1993-3#1)(1996-11#1)(2008-10#9)(2008-11#8)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#2)
our understanding on the##2##4##(2009-9#1)(2011-2#1)
our understanding on##3##3##(2009-10#1)(2009-9#1)(2011-2#1)
our understanding##67##2##(1991-3#2)(1993-12#2)(1993-3#1)(1996-11#1)(2008-10#9)(2008-11#8)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#2)
our view##2##2##(2008-8#1)(2012-3#1)
our work##7##2##(1993-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
our##1425##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#4)(1990-6#7)(1990-8#4)(1990-9#5)(1991-11#3)(1991-12#12)(1991-2#5)(1991-3#12)(1991-5#1)(1991-6#4)(1991-8#4)(1991-9#1)(1992-1#6)(1992-12#3)(1992-2#3)(1992-3#5)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#7)(1993-11#3)(1993-12#9)(1993-2#4)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#10)(1994-11#3)(1994-12#8)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#2)(1995-1#9)(1995-10#5)(1995-11#5)(1995-12#13)(1995-2#5)(1995-3#4)(1995-5#4)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#5)(1996-2#8)(1996-3#7)(1996-6#2)(1996-8#5)(1997-1#7)(1997-2#12)(1997-3#19)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#16)(1997-9#1)(2007-11#4)(2007-12#9)(2007-9#3)(2008-1#4)(2008-10#190)(2008-11#97)(2008-12#32)(2008-2#8)(2008-3#47)(2008-4#5)(2008-5#24)(2008-6#19)(2008-7#51)(2008-8#62)(2008-9#37)(2009-1#3)(2009-10#6)(2009-11#2)(2009-12#7)(2009-3#4)(2009-4#10)(2009-5#3)(2009-6#9)(2009-7#4)(2009-8#30)(2009-9#2)(2010-1#6)(2010-10#7)(2010-11#5)(2010-12#14)(2010-2#2)(2010-3#6)(2010-4#7)(2010-5#7)(2010-6#15)(2010-7#9)(2010-8#10)(2010-9#2)(2011-1#11)(2011-2#105)(2011-3#5)(2011-7#4)(2012-12#15)(2012-2#44)(2012-3#44)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#82)(2013-7#6)(2013-8#28)
ours##5##1##(1991-12#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
ourselves##4##1##(1990-9#1)(1994-2#1)(2009-6#1)(2010-9#1)
out a study##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
out a##26##2##(1990-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-3#1)(2008-10#6)(2008-11#5)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
out acute myocardial infarction##2##4##(2008-3#2)
out after##2##2##(2008-5#1)(2010-11#1)
out along##2##2##(2007-12#1)(2013-1#1)
out an##6##2##(1996-2#1)(2008-10#1)(2008-6#1)(2010-3#1)(2011-3#1)(2013-1#1)
out and the##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
out and##17##2##(1992-3#1)(1992-9#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
out as a##2##3##(1990-12#1)(1995-6#1)
out as the##2##3##(2008-10#1)(2012-3#1)
out as##9##2##(1990-12#1)(1995-6#1)(2008-10#4)(2008-7#1)(2008-9#1)(2012-3#1)
out at the##6##3##(1996-5#1)(1997-6#1)(2008-10#2)(2009-9#1)(2010-1#1)
out at##29##2##(1996-5#1)(1997-6#1)(2008-10#17)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
out between##3##2##(1990-5#1)(1991-8#1)(2011-2#1)
out by the##16##3##(1990-12#1)(1990-3#1)(1994-12#1)(1994-2#1)(2008-10#9)(2008-7#1)(2009-10#1)(2012-2#1)
out by##103##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-2#2)(1996-12#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#69)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2012-7#1)
out for the##5##3##(1991-2#1)(2008-10#2)(2010-12#1)(2012-3#1)
out for##19##2##(1991-11#1)(1991-2#1)(1991-3#1)(1993-3#1)(2008-10#9)(2008-11#2)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
out four##2##2##(2008-5#1)(2009-1#1)
out from the##5##3##(2007-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
out from##10##2##(1997-1#1)(2007-12#1)(2008-10#4)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
out how##4##2##(1994-6#1)(2008-11#1)(2008-5#1)(2011-2#1)
out if the##3##3##(1992-5#1)(1993-6#1)(2009-11#1)
out in order to##9##4##(1994-5#1)(1994-6#1)(2008-10#6)(2012-3#1)
out in the##32##3##(1990-6#1)(1996-5#1)(1997-1#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#2)(2013-1#1)
out in##144##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-6#2)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#1)(2007-11#1)(2008-10#74)(2008-11#8)(2008-12#2)(2008-2#2)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#5)(2013-1#3)(2013-8#1)
out of 10##6##3##(2008-10#3)(2008-12#2)(2008-7#1)
out of 11##2##3##(1990-8#1)(2008-1#1)
out of 12##3##3##(1997-7#1)(2013-1#2)
out of 13 patients##2##4##(1990-2#1)(1991-11#1)
out of 15##3##3##(1990-6#1)(2008-12#1)(2008-7#1)
out of 18##6##3##(2008-10#4)(2009-8#2)
out of 20)##3##3##(2008-5#3)
out of 21##3##3##(1991-9#1)(2008-6#1)(2011-2#1)
out of 23##2##3##(1990-12#1)(2008-10#1)
out of 24##3##3##(1994-3#1)(2009-8#2)
out of 25##2##3##(1994-11#1)(2008-5#1)
out of 26##3##3##(1990-12#1)(2008-10#1)(2011-1#1)
out of 260##2##3##(2011-1#2)
out of 4##2##3##(1990-6#1)(1997-7#1)
out of 42 (with equipment aids##2##6##(2011-2#2)
out of 46##2##3##(1991-8#1)(2008-10#1)
out of 50##2##3##(1990-12#2)
out of 6##3##3##(1992-3#1)(2009-5#1)(2010-2#1)
out of 68##3##3##(1990-2#1)(2011-2#1)(2012-3#1)
out of 8##2##3##(2010-2#1)(2011-2#1)
out of a number of##2##5##(1995-3#1)(1996-1#1)
out of a##7##3##(1992-6#1)(1995-3#1)(1996-1#1)(1997-4#1)(2008-11#2)(2011-1#1)
out of all##2##3##(2008-11#1)(2009-7#1)
out of control##2##3##(2008-9#1)(2011-2#1)
out of five##5##3##(1991-9#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#1)
out of four##3##3##(1992-4#1)(1992-5#1)(2008-10#1)
out of hours##4##3##(1990-3#2)(1997-5#2)
out of poverty##2##3##(2008-11#2)
out of seven##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
out of six##2##3##(1996-12#2)
out of the 10##2##4##(2008-10#1)(2008-12#1)
out of the 11##2##4##(1995-8#1)(2008-10#1)
out of the eight##2##4##(1996-12#1)(2008-10#1)
out of the three##2##4##(1995-6#1)(2011-2#1)
out of the##51##3##(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
out of these##3##3##(1992-9#1)(2011-1#1)(2013-1#1)
out of three##4##3##(1990-6#1)(1991-12#1)(2008-5#1)(2010-4#1)
out of total##2##3##(2008-10#1)(2010-12#1)
out of##231##2##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#4)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-9#1)(2008-1#3)(2008-10#37)(2008-11#18)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#1)(2009-5#4)(2009-7#3)(2009-8#6)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#10)(2012-2#3)(2012-3#7)(2013-1#11)
out on an##2##3##(1995-2#1)(2008-6#1)
out on##58##2##(1991-6#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2011-2#5)(2013-1#1)
out only##3##2##(2008-10#2)(2008-3#1)
out or##2##2##(1996-12#1)(2012-2#1)
out selective##2##2##(1997-6#1)(2008-7#1)
out simultaneously##2##2##(2008-10#1)(2011-2#1)
out some of the##2##4##(1991-6#1)(2012-12#1)
out some##3##2##(1991-6#1)(1995-2#1)(2012-12#1)
out that the##6##3##(2008-10#3)(2008-11#1)(2011-2#1)(2013-8#1)
out that##16##2##(1992-5#1)(1994-12#1)(1996-5#1)(1996-9#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
out the life##2##3##(1991-8#1)(2010-1#1)
out the##58##2##(1990-2#1)(1991-8#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#2)
out through the##2##3##(1996-12#1)(2008-4#1)
out through##8##2##(1996-1#1)(1996-12#1)(2008-10#2)(2008-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
out to be a very##3##5##(2008-11#1)(2012-2#2)
out to be a##4##4##(1997-6#1)(2008-11#1)(2012-2#2)
out to be##22##3##(1990-3#1)(1990-5#1)(1991-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#3)
out to determine##13##3##(1994-3#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-7#2)(2011-2#2)(2012-5#1)(2013-1#1)
out to establish##2##3##(2009-10#1)(2012-3#1)
out to evaluate##6##3##(1990-11#1)(1990-2#1)(2008-10#1)(2008-12#3)
out to explore##2##3##(2008-7#2)
out to the##2##3##(2011-2#1)(2012-2#1)
out to##99##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#2)(1991-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#6)(2013-8#1)
out using##56##2##(1991-5#1)(1995-8#1)(1996-12#1)(2008-10#39)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-3#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
out what##2##2##(2011-2#1)(2013-8#1)
out which##5##2##(1991-12#1)(2008-10#1)(2011-2#3)
out with##42##2##(1990-5#2)(1990-9#1)(1991-6#1)(1993-2#1)(1993-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#22)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-4#1)(2011-1#1)
out within##5##2##(1990-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)
out##1275##1##(1990-11#6)(1990-12#6)(1990-2#10)(1990-3#9)(1990-5#6)(1990-6#7)(1990-8#1)(1990-9#5)(1991-1#2)(1991-11#5)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#9)(1991-8#7)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#7)(1992-6#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#6)(1993-6#2)(1993-8#4)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#6)(1994-5#3)(1994-6#6)(1994-9#1)(1995-1#1)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#12)(1996-2#5)(1996-3#6)(1996-5#7)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#5)(1997-4#2)(1997-5#3)(1997-6#6)(1997-7#5)(1997-8#2)(1997-9#1)(2006-5#1)(2007-11#4)(2007-12#3)(2008-1#6)(2008-10#476)(2008-11#65)(2008-12#21)(2008-2#7)(2008-3#17)(2008-4#6)(2008-5#46)(2008-6#8)(2008-7#31)(2008-8#10)(2008-9#25)(2009-1#1)(2009-10#9)(2009-11#3)(2009-12#5)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#7)(2009-8#9)(2009-9#3)(2010-1#5)(2010-10#2)(2010-11#7)(2010-12#8)(2010-2#6)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#11)(2011-2#54)(2011-3#4)(2012-12#16)(2012-2#22)(2012-3#33)(2012-5#1)(2012-7#1)(2013-1#40)(2013-8#13)
out&quot##2##1##(1993-2#1)(2008-12#1)
out-migration##3##1##(2011-2#3)
out-of-court##2##1##(1995-12#1)(1995-6#1)
out-of-hours services##3##2##(1997-8#3)
out-of-hours##4##1##(1997-8#3)(2013-1#1)
out-of-plane##3##1##(2008-3#2)(2009-7#1)
out-of-pocket costs##3##2##(1991-2#2)(1994-3#1)
out-of-pocket expenses##2##2##(1995-12#1)(2009-8#1)
out-of-pocket##9##1##(1991-2#2)(1994-3#1)(1995-12#1)(1997-3#1)(2009-8#1)(2013-1#2)(2013-8#1)
out-patient treatment##2##2##(1990-2#1)(1995-11#1)
out-patient##8##1##(1990-2#1)(1991-11#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-11#1)(2008-5#1)(2008-9#1)
out-patients##3##1##(1990-6#1)(1991-6#1)(1993-3#1)
out?##2##1##(1993-2#1)(2008-6#1)
outbreak in##10##2##(1994-5#1)(1996-2#1)(2008-10#1)(2008-12#5)(2008-5#1)(2011-2#1)
outbreak investigation practicum##3##3##(1996-1#3)
outbreak investigation##4##2##(1996-1#4)
outbreak investigations##2##2##(1996-1#2)
outbreak occurred##2##2##(1990-3#1)(2010-5#1)
outbreak of foodborne##2##3##(2007-12#2)
outbreak of##26##2##(1990-9#2)(1991-11#1)(1991-3#1)(1992-5#1)(1993-2#1)(1993-5#1)(1996-2#1)(1997-5#1)(2007-12#4)(2008-10#5)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#2)
outbreak species##4##2##(2008-8#4)
outbreak spread##2##2##(1990-3#1)(2008-12#1)
outbreak##73##1##(1990-3#3)(1990-9#2)(1991-11#1)(1991-3#1)(1992-5#1)(1993-2#1)(1993-5#1)(1994-5#1)(1996-1#6)(1996-2#2)(1997-5#1)(2007-12#5)(2008-10#9)(2008-12#13)(2008-5#4)(2008-7#3)(2008-8#5)(2010-5#1)(2011-2#5)(2011-3#1)(2012-2#2)(2013-1#5)
outbreaks and##6##2##(1997-3#1)(2008-8#1)(2011-2#2)(2013-8#2)
outbreaks in##3##2##(2010-2#1)(2011-2#1)(2012-2#1)
outbreaks of##10##2##(1990-3#1)(1991-3#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-2#1)
outbreaks##37##1##(1990-3#1)(1991-3#1)(1992-6#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-12#3)(2008-10#7)(2008-12#2)(2008-5#2)(2008-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
outbred##4##1##(2008-10#3)(2008-12#1)
outbreeding##4##1##(2008-8#4)
outcome after AVM-ICH##2##3##(2012-3#2)
outcome after laparoscopic##2##3##(2011-1#2)
outcome after##15##2##(1992-3#2)(1993-1#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#2)(2012-3#4)(2013-1#1)
outcome and its##2##3##(2008-11#1)(2009-4#1)
outcome and possible##2##3##(2008-7#1)(2012-3#1)
outcome and the##2##3##(1995-2#1)(2007-8#1)
outcome and##21##2##(1993-9#1)(1995-2#1)(1996-2#2)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-3#1)
outcome assessment##3##2##(1997-1#1)(2008-11#1)(2008-8#1)
outcome at##3##2##(1991-11#1)(1995-11#1)(2008-7#1)
outcome between##3##2##(1990-2#1)(1997-3#1)(2011-2#1)
outcome can be##2##3##(2008-11#1)(2012-12#1)
outcome data##9##2##(1993-3#2)(2008-12#1)(2008-9#1)(2012-3#2)(2013-1#2)(2013-8#1)
outcome following##4##2##(2008-9#2)(2009-10#2)
outcome for patients##2##3##(2008-9#1)(2012-2#1)
outcome for##9##2##(1991-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)
outcome from##3##2##(1992-1#1)(2008-8#1)(2011-2#1)
outcome in a##5##3##(1990-2#1)(1995-11#1)(2009-10#1)(2012-2#1)(2013-8#1)
outcome in patients with##2##4##(2008-7#2)
outcome in patients##3##3##(2008-7#2)(2011-2#1)
outcome in terms of##2##4##(2008-11#1)(2012-3#1)
outcome in the##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)
outcome in these##2##3##(1995-12#1)(2008-7#1)
outcome in women##2##3##(1994-3#1)(2008-10#1)
outcome in##31##2##(1990-2#1)(1991-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-10#2)(2010-1#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
outcome information##2##2##(2008-6#1)(2013-1#1)
outcome is##13##2##(1990-12#1)(1992-2#1)(1993-3#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
outcome measure was##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
outcome measure##8##2##(1993-1#1)(1995-5#1)(2008-7#1)(2011-2#2)(2013-1#3)
outcome measurement##2##2##(1993-12#1)(1997-2#1)
outcome measures included##4##3##(2008-12#1)(2008-3#1)(2011-2#2)
outcome measures were##5##3##(2008-10#1)(2008-8#1)(2011-2#3)
outcome measures##33##2##(1991-2#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-2#7)(2012-2#1)(2013-1#4)
outcome of both##3##3##(1991-3#1)(1996-1#1)(2012-2#1)
outcome of children with##2##4##(2011-5#1)(2013-7#1)
outcome of immediate##2##3##(2013-1#2)
outcome of modified##2##3##(2013-1#2)
outcome of patients##2##3##(2011-2#1)(2012-3#1)
outcome of pediatric##2##3##(2011-2#1)(2012-3#1)
outcome of the##12##3##(2006-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#2)(2013-1#1)
outcome of this##2##3##(2007-8#1)(2012-2#1)
outcome of treatment##3##3##(1991-6#1)(2008-11#2)
outcome of##95##2##(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-11#2)(1994-1#3)(1994-12#1)(1995-9#1)(1996-1#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#6)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#2)(2009-3#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#10)(2011-3#1)(2011-5#1)(2012-2#2)(2012-3#7)(2012-4#1)(2013-1#10)(2013-7#1)(2013-8#2)
outcome questionnaires##3##2##(2008-9#1)(2012-12#2)
outcome research in the field##2##5##(1992-1#1)(1993-1#1)
outcome research##5##2##(1992-1#1)(1993-1#1)(2008-11#2)(2012-2#1)
outcome than##2##2##(1991-8#1)(2008-11#1)
outcome that##3##2##(1996-1#1)(2008-11#1)(2008-8#1)
outcome variable##4##2##(1991-11#1)(1995-12#2)(1996-6#1)
outcome variables##3##2##(1994-3#1)(2008-7#1)(2012-2#1)
outcome was##13##2##(1991-12#1)(1993-2#1)(1997-3#3)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
outcome were##3##2##(1997-3#1)(2007-8#1)(2013-1#1)
outcome with##3##2##(1991-2#1)(2010-8#1)(2013-8#1)
outcome##476##1##(1990-12#2)(1990-2#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#7)(1991-3#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#6)(1992-9#4)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#5)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#7)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#2)(2007-8#6)(2008-1#3)(2008-10#19)(2008-11#38)(2008-12#16)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#29)(2008-8#15)(2008-9#18)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#5)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#47)(2011-3#1)(2011-5#1)(2012-12#10)(2012-2#15)(2012-3#27)(2012-4#1)(2013-1#38)(2013-7#2)(2013-8#8)
outcome-adaptive##2##1##(2011-2#2)
outcome-based##4##1##(1995-3#2)(1996-1#1)(1997-3#1)
outcome?##4##1##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
outcome]##4##1##(1996-3#1)(2008-11#2)(2009-5#1)
outcomes across##2##2##(2009-11#1)(2012-2#1)
outcomes after##5##2##(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
outcomes among patients##2##3##(2009-12#1)(2009-8#1)
outcomes among##5##2##(2009-12#1)(2009-5#1)(2009-8#1)(2013-1#1)(2013-8#1)
outcomes and quality##2##3##(1997-2#1)(1997-3#1)
outcomes and the##2##3##(1994-1#1)(2008-11#1)
outcomes and##22##2##(1992-12#1)(1994-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-10#1)(2012-2#2)(2012-3#2)(2013-1#8)
outcomes are not##2##3##(1995-2#1)(2008-12#1)
outcomes are##14##2##(1993-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
outcomes assessment##2##2##(1994-2#2)
outcomes associated with##6##3##(2008-12#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-2#2)
outcomes at##8##2##(1994-3#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-6#2)(2012-12#1)(2013-1#1)
outcomes between##2##2##(2010-1#1)(2012-3#1)
outcomes by##2##2##(2010-12#1)(2010-8#1)
outcomes can be##2##3##(2008-11#1)(2008-9#1)
outcomes data##3##2##(2008-9#1)(2009-8#1)(2010-1#1)
outcomes following C-ADR##4##3##(2012-12#4)
outcomes following##9##2##(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#2)
outcomes for patients with##6##4##(2008-3#1)(2009-8#1)(2012-12#2)(2012-2#1)(2013-8#1)
outcomes for patients##7##3##(2008-3#1)(2009-8#1)(2012-12#2)(2012-2#1)(2013-8#2)
outcomes for the##4##3##(1994-12#1)(2008-11#1)(2008-6#1)(2010-6#1)
outcomes for##31##2##(1994-12#2)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-1#2)(2008-11#5)(2008-12#2)(2008-3#2)(2008-6#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
outcomes from##4##2##(1992-2#1)(2008-9#1)(2011-2#1)(2012-12#1)
outcomes have##2##2##(2008-12#1)(2012-2#1)
outcomes in a##3##3##(2008-12#2)(2008-9#1)
outcomes in children##2##3##(2008-10#1)(2008-11#1)
outcomes in patients with##5##4##(2008-12#2)(2009-8#1)(2012-12#1)(2013-1#1)
outcomes in patients##7##3##(2008-12#2)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
outcomes in the context of##2##5##(2011-2#1)(2011-7#1)
outcomes in the##6##3##(1992-11#1)(2008-9#1)(2011-2#2)(2011-7#1)(2012-3#1)
outcomes in this##2##3##(1995-11#1)(2013-1#1)
outcomes in##43##2##(1992-11#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#2)(2010-10#2)(2011-2#8)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
outcomes is##2##2##(2008-12#1)(2009-11#1)
outcomes management##5##2##(1992-12#1)(1993-3#1)(1994-3#1)(1997-1#1)(1997-3#1)
outcomes may##2##2##(2012-3#1)(2013-1#1)
outcomes measurement##2##2##(1994-12#1)(1997-3#1)
outcomes monitoring##2##2##(1994-1#1)(1995-2#1)
outcomes of a##4##3##(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
outcomes of care##6##3##(1993-3#2)(1994-2#1)(1996-2#1)(2013-1#2)
outcomes of competition##2##3##(2008-8#2)
outcomes of health care##2##4##(1996-2#1)(2008-4#1)
outcomes of home health care##2##5##(1995-3#2)
outcomes of interspecific competition##2##4##(2008-8#2)
outcomes of the##5##3##(1996-5#1)(2008-11#1)(2008-12#2)(2013-1#1)
outcomes of these##2##3##(2008-9#1)(2010-1#1)
outcomes of this##2##3##(1996-3#1)(2010-5#1)
outcomes of##64##2##(1991-1#1)(1991-12#1)(1993-3#2)(1994-2#1)(1995-1#2)(1995-3#2)(1996-2#2)(1996-3#1)(1996-5#1)(2008-10#2)(2008-11#6)(2008-12#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-7#2)(2010-1#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#10)(2013-8#2)
outcomes on##2##2##(1993-2#1)(2009-7#1)
outcomes or##3##2##(2008-11#1)(2008-8#1)(2010-4#1)
outcomes over time##2##3##(1993-12#1)(2008-12#1)
outcomes over##3##2##(1993-12#1)(2008-12#2)
outcomes relative to##2##3##(1991-12#1)(2012-12#1)
outcomes research##7##2##(1993-12#2)(1994-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
outcomes such as##3##3##(2008-11#1)(2010-7#1)(2013-8#1)
outcomes that##7##2##(1992-12#1)(1996-3#1)(2008-11#2)(2008-8#1)(2010-6#1)(2013-1#1)
outcomes to##4##2##(2012-12#1)(2013-1#3)
outcomes were##11##2##(1995-3#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-7#2)(2009-9#1)(2010-7#1)(2012-3#1)
outcomes while##2##2##(2009-8#1)(2013-1#1)
outcomes with##7##2##(1994-12#1)(2008-12#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)
outcomes##536##1##(1991-1#3)(1991-12#4)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#2)(1993-12#6)(1993-2#2)(1993-3#5)(1994-1#5)(1994-12#7)(1994-2#7)(1994-3#3)(1995-1#3)(1995-11#1)(1995-2#5)(1995-3#8)(1996-2#6)(1996-3#3)(1996-5#1)(1997-1#4)(1997-2#2)(1997-3#4)(1997-7#1)(2007-12#2)(2008-1#3)(2008-10#9)(2008-11#53)(2008-12#30)(2008-3#3)(2008-4#9)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#16)(2008-9#19)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#3)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#9)(2009-8#10)(2009-9#4)(2010-1#5)(2010-10#5)(2010-11#2)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#11)(2010-7#5)(2010-8#1)(2011-1#7)(2011-2#30)(2011-3#1)(2011-7#1)(2012-12#25)(2012-2#21)(2012-3#25)(2013-1#75)(2013-8#13)
outcomes?##2##1##(2008-12#2)
outcrossed##2##1##(2008-8#1)(2008-9#1)
outcrossing in##3##2##(2008-10#3)
outcrossing##12##1##(2008-10#9)(2008-8#1)(2012-3#2)
outdated##5##1##(1994-2#1)(2008-11#1)(2011-2#1)(2012-2#2)
outdoor activities##2##2##(2011-2#1)(2012-3#1)
outdoor air pollutants##3##3##(1996-3#2)(2008-10#1)
outdoor air##10##2##(1996-3#2)(2008-10#7)(2010-5#1)
outdoor concentrations##2##2##(2008-10#1)(2008-11#1)
outdoor exposure##2##2##(2008-10#1)(2008-11#1)
outdoor##45##1##(1994-3#1)(1996-2#1)(1996-3#3)(2008-10#15)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#2)(2009-7#1)(2010-5#5)(2011-2#2)(2012-3#1)(2013-1#3)
outdoors and##4##2##(1991-3#1)(2008-10#1)(2010-5#1)(2012-12#1)
outdoors##11##1##(1991-3#1)(2008-10#4)(2010-5#2)(2011-2#1)(2012-12#3)
outer cell wall##2##3##(2008-10#1)(2011-2#1)
outer cortex##5##2##(2008-10#5)
outer diameter##4##2##(1994-2#1)(2008-8#2)(2012-2#1)
outer dorsal skin layers from##3##5##(2008-11#3)
outer layer of##4##3##(2008-10#2)(2008-12#1)(2008-7#1)
outer layer##9##2##(2008-10#5)(2008-12#2)(2008-5#1)(2008-7#1)
outer layers of##3##3##(2008-11#2)(2009-8#1)
outer layers##4##2##(2008-10#1)(2008-11#2)(2009-8#1)
outer membrane protein (OMP)##2##4##(1995-12#1)(2008-5#1)
outer membrane protein of##2##4##(1995-12#1)(2008-5#1)
outer membrane protein##7##3##(1990-11#1)(1993-12#1)(1995-12#2)(2008-5#3)
outer membrane##25##2##(1990-11#3)(1993-12#1)(1994-11#1)(1995-12#4)(1997-8#4)(2008-10#1)(2008-11#1)(2008-5#5)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
outer membranes##3##2##(1990-5#1)(1991-10#1)(1996-12#1)
outer mitochondrial membrane##3##3##(1994-11#1)(2012-2#2)
outer nuclear membrane##3##3##(2008-9#2)(2011-2#1)
outer nuclear##6##2##(1991-10#1)(2008-9#2)(2010-1#1)(2011-2#2)
outer ring##3##2##(2008-10#3)
outer scale##3##2##(2008-3#3)
outer segment assembly##2##3##(2008-7#2)
outer segment##4##2##(1997-1#1)(2008-7#3)
outer segments##4##2##(1993-8#1)(1997-1#1)(2008-7#2)
outer shell##2##2##(2008-8#2)
outer surface##5##2##(1994-5#1)(1995-5#1)(1997-7#1)(2008-2#1)(2010-10#1)
outer surfaces##2##2##(2007-12#1)(2008-10#1)
outer zone##3##2##(2008-10#1)(2008-7#2)
outer##133##1##(1990-11#5)(1990-2#1)(1990-5#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-11#3)(1994-2#1)(1994-5#1)(1995-12#4)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-7#1)(1997-8#6)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#9)(2008-7#14)(2008-8#5)(2008-9#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#7)(2012-2#6)(2013-8#2)
outer-layer##2##1##(2008-10#2)
outermost##13##1##(1997-8#1)(2008-10#4)(2008-5#8)
outflow obstruction##4##2##(2008-10#3)(2008-7#1)
outflow of##2##2##(1997-3#1)(2008-10#1)
outflow to the##2##3##(1992-6#2)
outflow##16##1##(1992-6#3)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-2#1)
outgoing##2##1##(2008-11#1)(2008-3#1)
outgroup A##3##2##(2008-10#3)
outgroup##12##1##(2007-12#1)(2008-10#6)(2008-11#2)(2008-8#1)(2010-3#1)(2013-8#1)
outgroups##6##1##(2007-12#1)(2008-10#2)(2008-11#3)
outgrowth and##6##2##(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#1)(2011-2#2)
outgrowth in##5##2##(1995-6#2)(2008-11#3)
outgrowth is##2##2##(2011-2#2)
outgrowth of the##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
outgrowth of##12##2##(2008-11#6)(2008-4#1)(2008-8#1)(2011-2#3)(2013-1#1)
outgrowth ofneurites##2##2##(2008-11#2)
outgrowth promoting activity##3##3##(2008-11#3)
outgrowth was##6##2##(2008-11#6)
outgrowth##58##1##(1990-8#1)(1995-2#1)(1995-6#4)(1996-12#1)(1997-3#1)(2008-11#27)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#19)(2013-1#1)
outgrowths were observed##2##3##(2008-11#2)
outgrowths were##3##2##(2008-11#2)(2011-2#1)
outgrowths##8##1##(2008-11#4)(2008-9#1)(2011-2#3)
outlays##3##1##(1992-3#1)(1993-3#1)(1995-1#1)
outlet and the##2##3##(2008-10#2)
outlet obstruction and##2##3##(2008-10#1)(2008-12#1)
outlet obstruction##6##2##(2008-10#2)(2008-12#2)(2011-2#1)(2013-1#1)
outlet of##6##2##(2008-10#5)(2008-11#1)
outlet##22##1##(1996-9#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#2)(2011-2#1)(2011-3#1)(2013-1#2)
outlets##2##1##(2008-10#1)(2011-2#1)
outlier data##4##2##(2008-10#4)
outlier detection##3##2##(2008-10#3)
outlier payments##3##2##(1992-12#3)
outlier##20##1##(1992-12#4)(1993-12#1)(1993-3#2)(1993-9#1)(2008-10#10)(2009-8#2)
outliers##15##1##(1991-12#1)(1992-12#4)(2008-10#10)
outliers)##3##1##(1991-12#1)(2008-10#2)
outline a##7##2##(1994-1#2)(2008-10#1)(2008-11#2)(2008-8#2)
outline how the##2##3##(1992-3#1)(2012-2#1)
outline of the##5##3##(1992-12#1)(1997-8#1)(2008-5#1)(2008-6#1)(2013-1#1)
outline of##9##2##(1992-12#1)(1997-8#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
outline the most##2##3##(2011-2#1)(2012-3#1)
outline the rationale##2##3##(2010-5#1)(2010-6#1)
outline the##17##2##(1993-6#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
outline their##2##2##(1993-2#1)(2012-3#1)
outline##49##1##(1991-3#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-5#1)(1996-1#1)(1997-3#1)(1997-8#2)(2008-10#3)(2008-11#6)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
outlined and##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
outlined as to##2##3##(2008-10#1)(2009-10#1)
outlined as well as##2##4##(1993-3#1)(2011-2#1)
outlined as##5##2##(1993-3#1)(1997-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
outlined by##2##2##(2008-11#2)
outlined here##3##2##(1996-2#1)(2008-11#1)(2012-2#1)
outlined in this article##2##4##(2012-2#1)(2012-3#1)
outlined in this##4##3##(2008-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
outlined in##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
outlined the##3##2##(1990-9#1)(1991-9#1)(1996-12#1)
outlined##60##1##(1990-8#1)(1990-9#2)(1991-12#1)(1991-9#1)(1992-1#2)(1993-3#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#10)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#4)(2012-3#1)
outlines a##5##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-9#2)
outlines how the##2##3##(2008-11#2)
outlines how##4##2##(2008-11#3)(2010-9#1)
outlines some##2##2##(1997-2#1)(2008-11#1)
outlines the development##3##3##(2008-11#1)(2008-12#2)
outlines the##18##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(2008-11#5)(2008-12#2)(2008-4#2)(2008-7#2)
outlines this##2##2##(1994-3#1)(2008-12#1)
outlines##49##1##(1993-11#1)(1993-12#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-1#2)(1997-2#4)(2008-10#1)(2008-11#14)(2008-12#3)(2008-4#5)(2008-7#3)(2008-9#2)(2009-5#1)(2010-9#1)(2012-3#1)
outlining the##4##2##(1992-3#1)(2008-11#1)(2008-4#1)(2012-2#1)
outlining##8##1##(1992-3#1)(1994-3#1)(1997-3#1)(2008-11#2)(2008-4#1)(2008-9#1)(2012-2#1)
outlook for##4##2##(1993-12#1)(1994-2#1)(2008-10#1)(2008-8#1)
outlook of##3##2##(1996-2#1)(1996-5#1)(2013-1#1)
outlook on##2##2##(2008-12#1)(2008-5#1)
outlook##17##1##(1991-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)(2013-1#1)
outpatient and##2##2##(1995-12#1)(1996-3#1)
outpatient care##8##2##(1991-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2011-1#2)
outpatient cases##2##2##(1996-3#1)(2012-12#1)
outpatient chemotherapy##4##2##(2010-2#4)
outpatient clinic##5##2##(1997-4#1)(2008-11#1)(2011-2#1)(2013-1#2)
outpatient clinics##2##2##(1992-12#2)
outpatient department##2##2##(1991-9#1)(1992-12#1)
outpatient drug##3##2##(1995-1#1)(1995-2#2)
outpatient drugs##2##2##(1995-1#2)
outpatient hospital##5##2##(1992-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)
outpatient oral and maxillofacial surgery##2##5##(1993-1#2)
outpatient physiotherapy services##2##3##(2012-2#2)
outpatient prescription drug use##2##4##(1992-1#1)(1995-1#1)
outpatient prescription drug##5##3##(1992-1#2)(1995-1#3)
outpatient procedures##2##2##(1992-12#1)(1996-1#1)
outpatient services##15##2##(1991-2#4)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-2#2)(1995-2#1)(1995-3#2)(1996-1#1)(2010-6#1)
outpatient setting##4##2##(1991-1#1)(1993-12#1)(1995-2#1)(2008-3#1)
outpatient settings##3##2##(1991-12#1)(2008-8#1)(2013-1#1)
outpatient surgery##4##2##(1991-2#1)(1996-3#3)
outpatient surgical care##2##3##(1992-6#1)(1995-2#1)
outpatient treatment##3##2##(1990-11#1)(1990-2#1)(1997-3#1)
outpatient visits##2##2##(1992-2#1)(1995-2#1)
outpatient##127##1##(1990-11#2)(1990-2#1)(1991-1#5)(1991-11#1)(1991-12#1)(1991-2#7)(1991-9#1)(1992-1#4)(1992-12#12)(1992-2#3)(1992-6#1)(1992-7#1)(1993-1#3)(1993-12#2)(1993-2#2)(1993-6#1)(1994-2#6)(1994-3#3)(1995-1#6)(1995-12#6)(1995-2#11)(1995-3#2)(1996-1#2)(1996-11#1)(1996-3#8)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-5#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-2#4)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
outpatients and##2##2##(2008-7#1)(2012-5#1)
outpatients with ovarian dysfunction##2##4##(2011-2#2)
outpatients with##4##2##(2008-4#1)(2008-6#1)(2011-2#2)
outpatients##20##1##(1991-3#1)(1993-11#1)(1993-8#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#6)(2012-3#1)(2012-5#1)
outperformed##2##1##(2008-10#1)(2011-1#1)
outperforms conventional##2##2##(2008-10#1)(2008-5#1)
outperforms the##2##2##(2012-2#1)(2012-3#1)
outperforms##6##1##(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
output and##18##2##(1991-12#1)(1991-6#1)(1995-3#3)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2012-2#3)(2012-3#3)
output at the##2##3##(2008-12#1)(2008-5#1)
output at##5##2##(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)
output beam##3##2##(2008-2#2)(2008-3#1)
output but##2##2##(2008-12#1)(2008-9#1)
output by##2##2##(2008-4#1)(2008-9#1)
output characteristics##2##2##(1994-12#1)(1995-3#1)
output coupler##9##2##(2008-2#7)(2008-3#2)
output couplers##2##2##(2008-3#2)
output energy##2##2##(2008-2#2)
output for##2##2##(1995-2#1)(2008-3#1)
output frequency##2##2##(2007-11#1)(2008-3#1)
output from a##5##3##(2008-11#1)(2008-2#1)(2008-3#3)
output from the##2##3##(1991-7#1)(2008-3#1)
output from##10##2##(1991-7#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#4)
output in the##2##3##(2007-12#1)(2008-4#1)
output in##3##2##(2007-12#1)(2008-12#1)(2008-4#1)
output is##10##2##(1991-2#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-9#3)(2009-8#2)(2012-3#1)
output layers##5##2##(2008-10#5)
output levels##2##2##(1996-2#1)(2009-4#1)
output of a##7##3##(2008-10#2)(2008-2#3)(2008-3#1)(2008-9#1)
output of the##11##3##(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2009-12#1)(2009-8#1)
output of##27##2##(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#6)(2008-3#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-2#1)
output power and##3##3##(2008-2#1)(2008-3#2)
output power by##2##3##(2008-3#2)
output power is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
output power of 1##2##4##(2008-3#2)
output power of a##2##4##(2008-3#2)
output power of##12##3##(2008-2#3)(2008-3#9)
output power with##2##3##(2008-2#1)(2008-3#1)
output power##34##2##(2007-11#1)(2007-12#1)(2008-2#12)(2008-3#20)
output powers##2##2##(2008-2#1)(2008-3#1)
output pressure##3##2##(2008-10#3)
output pulse energies##2##3##(2008-3#2)
output pulse##6##2##(2007-11#1)(2008-3#5)
output rate and##2##3##(2008-11#2)
output rate##3##2##(2008-10#1)(2008-11#2)
output rates were##2##3##(2008-10#2)
output rates##6##2##(1995-3#2)(2008-10#4)
output remains##2##2##(2007-12#1)(2008-3#1)
output signal was##2##3##(2008-10#1)(2008-3#1)
output signal##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
output was##4##2##(1995-12#1)(2007-11#1)(2008-10#1)(2013-1#1)
output##273##1##(1991-12#2)(1991-2#2)(1991-6#3)(1991-7#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-6#3)(1994-12#3)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#8)(1996-2#3)(1996-3#1)(1997-7#1)(2007-11#5)(2007-12#7)(2008-10#41)(2008-11#14)(2008-12#6)(2008-2#43)(2008-3#65)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#8)(2008-9#9)(2009-12#1)(2009-4#1)(2009-8#6)(2010-1#2)(2010-10#2)(2010-8#5)(2011-1#1)(2011-3#1)(2012-2#6)(2012-3#5)(2013-1#3)
output)##2##1##(2008-9#1)(2011-2#1)
outputs and##3##2##(1992-2#1)(1993-1#1)(2008-7#1)
outputs can##2##2##(2008-11#1)(2013-1#1)
outputs of the##3##3##(1997-7#1)(2008-10#1)(2009-8#1)
outputs of##5##2##(1997-7#1)(2008-10#3)(2009-8#1)
outputs processed by##2##3##(2008-10#2)
outputs##35##1##(1992-2#4)(1993-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-8#1)(2011-2#1)(2013-1#2)
outreach##7##1##(1992-2#1)(1994-2#1)(1996-1#1)(1997-2#2)(2010-5#1)(2011-1#1)
outside and##2##2##(2008-10#1)(2008-7#1)
outside of a##2##3##(2008-8#1)(2012-12#1)
outside of the##17##3##(1995-6#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2012-12#1)(2012-2#3)(2013-1#1)
outside of##28##2##(1993-1#1)(1995-6#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#5)(2010-2#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
outside the company##2##3##(2008-11#2)
outside the cyclodextrin##3##3##(2008-10#3)
outside the home and##2##4##(1993-1#1)(2013-8#1)
outside the##53##2##(1991-1#1)(1991-10#1)(1991-6#2)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
outside their##4##2##(1991-12#1)(1997-3#1)(2008-10#1)(2012-3#1)
outside##122##1##(1990-2#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-6#2)(1992-2#1)(1992-9#1)(1993-1#2)(1993-6#1)(1993-9#2)(1994-1#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#2)(2008-10#25)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#9)(2008-9#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
outside-out##2##1##(1995-2#2)
outsourcing##2##1##(2011-2#1)(2012-3#1)
outspoken##2##1##(2010-10#2)
outstanding importance##2##2##(1994-5#1)(2008-11#1)
outstanding properties##2##2##(2008-5#1)(2010-7#1)
outstanding##16##1##(1991-3#1)(1994-5#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
outward current##2##2##(1991-5#1)(1993-3#1)
outward growth of##3##3##(1995-3#1)(2008-10#1)(2009-1#1)
outward rectification##2##2##(1996-2#1)(2011-2#1)
outward##15##1##(1991-5#2)(1993-3#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-1#1)(2010-12#1)(2010-7#1)(2011-2#2)
outwardly##2##1##(2008-10#2)
outweigh the##5##2##(1992-3#1)(1993-8#1)(2008-8#1)(2010-6#1)(2011-2#1)
outweigh##8##1##(1992-3#1)(1993-8#1)(1996-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)
outweighed by the##2##3##(2008-12#1)(2008-9#1)
outweighing##2##1##(2008-10#1)(2008-7#1)
outweighs the##2##2##(1997-8#1)(2008-10#1)
outweighs##3##1##(1997-8#1)(2008-10#1)(2013-1#1)
ovIL4##2##1##(1993-2#2)
ova##2##1##(2008-8#1)(2013-1#1)
oval and##2##2##(2008-12#1)(2008-9#1)
oval##7##1##(1994-2#1)(1997-3#1)(1997-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)
ovalbumin (OVA)-specific##3##2##(2008-11#3)
ovalbumin and##4##2##(1990-5#1)(1995-2#1)(1995-6#1)(2008-10#1)
ovalbumin##22##1##(1990-5#1)(1995-2#2)(1995-6#1)(2008-10#10)(2008-11#8)
ovale##11##1##(1996-3#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-10#1)(2011-2#3)(2012-2#1)
ovarian Mr = 80##4##4##(1990-10#4)
ovarian Mr##5##2##(1990-10#5)
ovarian adenocarcinoma##2##2##(1997-8#1)(2013-1#1)
ovarian and##4##2##(1995-8#1)(1997-8#1)(2008-4#1)(2011-2#1)
ovarian cancer (EOC) is##2##4##(2010-7#1)(2010-8#1)
ovarian cancer cells##3##3##(1990-2#1)(1997-7#2)
ovarian cancer patients##2##3##(1990-2#1)(1996-10#1)
ovarian cancer##33##2##(1990-12#1)(1990-2#2)(1991-3#1)(1991-6#2)(1991-8#2)(1994-12#1)(1994-6#1)(1994-9#1)(1996-10#2)(1997-7#4)(2008-1#1)(2008-10#2)(2008-8#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#8)
ovarian carcinoma are##2##3##(2007-8#1)(2010-7#1)
ovarian carcinoma cells##2##3##(1993-8#2)
ovarian carcinoma##15##2##(1990-12#1)(1990-2#2)(1991-3#1)(1991-8#1)(1993-2#1)(1993-8#2)(2007-8#1)(2010-7#2)(2012-2#1)(2013-1#3)
ovarian cyst##3##2##(1992-3#2)(2013-1#1)
ovarian cystectomy##3##2##(1993-3#1)(1996-3#2)
ovarian cystomas of intestinal type##2##5##(1990-2#2)
ovarian cystomas of intestinal##3##4##(1990-2#3)
ovarian cystomas##4##2##(1990-2#4)
ovarian disease##4##2##(1990-2#1)(2008-4#2)(2010-8#1)
ovarian follicles in##2##3##(2008-12#2)
ovarian follicles##12##2##(1995-12#1)(2008-11#1)(2008-12#8)(2008-9#1)(2010-8#1)
ovarian growth of flightless##2##4##(2008-9#2)
ovarian growth##3##2##(2008-9#3)
ovarian masses##5##2##(1996-1#5)
ovarian response##2##2##(2012-3#2)
ovarian stimulation in##2##3##(2007-7#1)(2012-3#1)
ovarian stimulation##4##2##(2007-7#1)(2012-3#3)
ovarian surgery##5##2##(1992-3#5)
ovarian syndrome##3##2##(2007-7#1)(2010-11#2)
ovarian tissue##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
ovarian tissues##2##2##(2008-10#1)(2008-11#1)
ovarian tumor promoter##2##3##(2007-12#2)
ovarian tumor##6##2##(2007-12#5)(2008-11#1)
ovarian##192##1##(1990-10#7)(1990-11#1)(1990-12#2)(1990-2#13)(1990-8#1)(1991-3#2)(1991-6#2)(1991-8#3)(1992-3#11)(1993-2#1)(1993-3#1)(1993-8#3)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-8#7)(1995-9#1)(1996-1#6)(1996-10#2)(1996-3#2)(1997-7#4)(1997-8#2)(2007-12#5)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#14)(2008-4#11)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#1)(2009-5#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#6)(2012-12#5)(2012-2#2)(2012-3#10)(2013-1#7)(2013-8#12)
ovariectomized##3##1##(1993-1#1)(1994-3#1)(2008-10#1)
ovariectomy##2##1##(1994-12#1)(2008-4#1)
ovaries of##3##2##(2007-12#1)(2008-12#1)(2012-3#1)
ovaries were##3##2##(1992-3#2)(2012-3#1)
ovaries##28##1##(1992-3#3)(1994-2#1)(1995-2#1)(2007-12#2)(2008-10#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
ovariole formation##2##2##(2008-12#2)
ovariole##4##1##(2008-12#2)(2008-7#2)
ovarioles of the##2##3##(2008-12#1)(2008-7#1)
ovarioles of##3##2##(2007-12#1)(2008-12#1)(2008-7#1)
ovarioles##6##1##(2007-12#3)(2008-12#2)(2008-7#1)
ovary (CHO) cell line##3##4##(2008-11#3)
ovary (CHO) cell##5##3##(2008-11#3)(2008-7#2)
ovary (CHO)##30##2##(1991-6#1)(1992-10#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#18)(2008-7#5)
ovary Psi(w)##2##2##(2008-10#2)
ovary and##10##2##(1993-2#1)(2008-10#2)(2008-12#2)(2008-6#3)(2010-5#1)(2012-2#1)
ovary during##3##2##(2008-12#1)(2008-9#2)
ovary of##3##2##(2007-12#1)(2009-7#1)(2010-5#1)
ovary syndrome (PCOS) is##3##4##(2008-4#3)
ovary syndrome (PCOS)##8##3##(2008-4#8)
ovary syndrome##21##2##(2007-7#1)(2008-3#4)(2008-4#12)(2008-5#1)(2012-12#1)(2012-3#2)
ovary was longitudinally bivalved with a scalpel##2##7##(1992-3#2)
ovary was##7##2##(1990-8#1)(1992-3#5)(2010-5#1)
ovary##161##1##(1990-2#1)(1990-8#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-3#8)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-1#1)(1997-8#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#44)(2008-12#4)(2008-3#4)(2008-4#13)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#3)(2009-7#2)(2010-12#2)(2010-5#6)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#4)
ovary-specific##2##1##(1995-2#1)(2008-4#1)
ovatum##3##1##(2010-3#3)
ovatus##3##1##(1997-2#3)
oven at 450W##2##3##(2008-10#2)
oven at##5##2##(2008-10#5)
oven temperature##5##2##(2008-10#5)
oven##29##1##(2008-10#29)
over &quot##2##2##(2008-8#1)(2011-2#1)
over 0##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
over 1##8##2##(1991-1#1)(1996-3#1)(2008-10#5)(2008-11#1)
over 10 years##2##3##(2012-12#1)(2013-1#1)
over 10##10##2##(2008-1#1)(2008-10#5)(2008-6#1)(2010-4#1)(2012-12#1)(2013-1#1)
over 100##7##2##(1996-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)
over 100-fold##4##2##(1994-5#1)(1996-2#1)(2008-10#2)
over 100mg of##2##3##(2008-10#2)
over 12##2##2##(2008-7#1)(2012-2#1)
over 13##2##2##(1991-6#1)(2008-11#1)
over 15 nm##2##3##(2007-12#1)(2008-2#1)
over 15##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
over 150##2##2##(1997-2#1)(2009-8#1)
over 18 h##2##3##(1990-6#1)(1995-11#1)
over 18##5##2##(1990-6#1)(1992-3#1)(1995-11#1)(1997-8#1)(2008-8#1)
over 19##2##2##(2008-10#2)
over 2 months##2##3##(2008-10#2)
over 2 years##9##3##(1996-12#1)(2008-10#6)(2010-10#1)(2010-8#1)
over 2##18##2##(1992-3#1)(1996-12#1)(2008-10#11)(2008-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)
over 20 years##2##3##(2008-10#1)(2013-1#1)
over 20##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
over 20%##3##2##(1992-2#1)(1992-6#1)(2012-3#1)
over 200##6##2##(2008-10#4)(2008-2#1)(2008-4#1)
over 23##2##2##(1991-2#1)(1992-3#1)
over 24 h##4##3##(2008-10#3)(2010-8#1)
over 24 hours##2##3##(1990-11#1)(2008-8#1)
over 24##7##2##(1990-11#1)(2008-10#3)(2008-8#1)(2010-8#1)(2013-8#1)
over 3 years##6##3##(2008-10#5)(2008-12#1)
over 3##15##2##(1991-8#1)(1994-2#1)(1994-3#1)(2008-10#9)(2008-12#1)(2008-7#1)(2013-8#1)
over 30 min##2##3##(2008-10#1)(2008-12#1)
over 30 months##2##3##(2008-10#1)(2008-12#1)
over 30 years##2##3##(2008-10#2)
over 30##9##2##(1993-2#1)(2008-10#4)(2008-12#2)(2009-9#1)(2011-2#1)
over 300##5##2##(1995-12#1)(2008-11#2)(2012-2#2)
over 35 years of age were treated##2##7##(2008-10#2)
over 35 years##4##3##(2008-10#4)
over 35##7##2##(1990-8#2)(2008-10#5)
over 4 months##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
over 4 years##2##3##(1993-12#1)(2008-10#1)
over 4##10##2##(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
over 40 years##2##3##(2008-10#1)(2013-8#1)
over 40##4##2##(1994-2#1)(2008-10#1)(2009-12#1)(2013-8#1)
over 400##4##2##(1992-9#1)(1997-6#1)(2008-1#1)(2009-9#1)
over 5 days##2##3##(2008-10#2)
over 5##8##2##(2008-10#4)(2008-11#2)(2008-5#1)(2012-2#1)
over 50 years##2##3##(2008-10#1)(2013-8#1)
over 50##9##2##(1992-9#1)(2008-10#4)(2008-12#2)(2012-12#1)(2013-8#1)
over 50% of the##3##4##(1993-1#1)(2008-10#2)
over 50% of##6##3##(1993-1#1)(2008-10#3)(2013-1#2)
over 50%##8##2##(1993-1#1)(2008-10#4)(2008-2#1)(2013-1#2)
over 55##2##2##(1997-2#1)(2012-3#1)
over 6 to##2##3##(2008-10#1)(2009-11#1)
over 6##4##2##(2008-10#2)(2009-11#1)(2010-12#1)
over 60 years old##2##4##(2008-7#1)(2012-3#1)
over 60 years##5##3##(2008-7#1)(2011-2#1)(2012-3#3)
over 60##6##2##(1990-6#1)(2008-7#1)(2011-2#1)(2012-3#3)
over 60% of##4##3##(1992-6#1)(1997-6#1)(2008-8#1)(2013-1#1)
over 60%##6##2##(1992-6#1)(1997-6#1)(2008-8#1)(2008-9#1)(2013-1#2)
over 65 years in##2##4##(2011-2#1)(2012-12#1)
over 65 years old were##2##5##(2011-2#1)(2012-12#1)
over 65 years old##3##4##(2011-2#2)(2012-12#1)
over 65 years##7##3##(2008-11#1)(2011-2#4)(2012-12#2)
over 65##8##2##(1992-9#1)(2008-11#1)(2011-2#4)(2012-12#2)
over 70 years##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
over 70##4##2##(1990-6#1)(1996-3#1)(2008-10#1)(2008-11#1)
over 70% of the##2##4##(1995-6#1)(2008-10#1)
over 70% of##3##3##(1995-6#1)(2008-10#2)
over 70%##5##2##(1995-6#1)(2008-10#3)(2010-10#1)
over 8##3##2##(1997-2#2)(2008-10#1)
over 80##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
over 80% of the##2##4##(2008-10#1)(2008-5#1)
over 80%##5##2##(1997-1#1)(2008-10#2)(2008-5#1)(2013-8#1)
over 90 days##2##3##(2008-10#1)(2010-6#1)
over 90##4##2##(1991-7#1)(2008-10#1)(2009-5#1)(2010-6#1)
over 90% of##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
over 90% were##2##3##(2008-10#1)(2008-12#1)
over 90%##10##2##(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
over 96##2##2##(1997-1#1)(2008-10#1)
over 98% of the##2##4##(2008-12#1)(2011-2#1)
over 98%##4##2##(1995-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
over K(+)##4##2##(2008-10#4)
over YUF##2##2##(2008-11#2)
over a 1-year period##3##4##(2008-5#1)(2011-2#1)(2013-8#1)
over a 10-year period##3##4##(1997-6#1)(2008-10#1)(2008-7#1)
over a 2-week period##3##4##(2008-11#1)(2009-11#1)(2010-11#1)
over a 2-year period##3##4##(2008-10#2)(2012-5#1)
over a 2-year##4##3##(1996-12#1)(2008-10#2)(2012-5#1)
over a 20-year period##2##4##(2013-8#2)
over a 3-month period##2##4##(2008-10#2)
over a 3-year period##5##4##(2008-10#4)(2012-2#1)
over a 4-year period##2##4##(2008-10#1)(2008-5#1)
over a 5 year##2##4##(1993-9#1)(2008-10#1)
over a 5-year period##2##4##(2010-1#1)(2011-2#1)
over a 6-month period##2##4##(2008-10#1)(2012-12#1)
over a 6-year period##3##4##(2008-10#2)(2013-1#1)
over a 7-year period##2##4##(1994-1#1)(2011-2#1)
over a broad range of##2##5##(2008-3#1)(2008-8#1)
over a broad##5##3##(1991-5#1)(2008-3#3)(2008-8#1)
over a broader##2##3##(2008-10#2)
over a concentration range of 0##2##6##(2008-10#2)
over a concentration range of##3##5##(2008-10#3)
over a concentration range##5##4##(2008-10#5)
over a decade##5##3##(1995-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
over a duration of upto six years##2##7##(2008-7#2)
over a five-year period##3##4##(1991-12#1)(1992-1#1)(2008-12#1)
over a large number of anions##2##6##(2008-10#2)
over a large number of cations##2##6##(2008-10#2)
over a large number of##5##5##(2008-10#5)
over a large range of values##2##6##(2008-10#1)(2008-3#1)
over a large##13##3##(2008-10#6)(2008-11#1)(2008-3#5)(2008-8#1)
over a linear range of##2##5##(2008-10#2)
over a linear##4##3##(2008-10#3)(2008-9#1)
over a long period of time##2##6##(2008-9#1)(2010-6#1)
over a long period##3##4##(2008-9#1)(2010-6#1)(2010-8#1)
over a number of##2##4##(1991-2#1)(2008-10#1)
over a pH range from 3##2##6##(2008-10#2)
over a pH range of 3##2##6##(2008-10#2)
over a pH range of##5##5##(1991-9#1)(2008-10#3)(2012-2#1)
over a pH range##7##4##(1991-9#1)(2008-10#5)(2012-2#1)
over a pH##8##3##(1991-9#2)(2008-10#5)(2012-2#1)
over a period of 10 months##2##6##(2008-11#1)(2013-8#1)
over a period of 24 h##2##6##(1997-2#1)(2008-10#1)
over a period of 3##2##5##(2008-10#2)
over a period of 4##2##5##(1991-3#1)(2008-10#1)
over a period of 5 years##2##6##(1997-2#1)(2008-7#1)
over a period of 5##3##5##(1997-2#1)(2008-10#1)(2008-7#1)
over a period of 6##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
over a period of four##2##5##(1991-6#1)(2011-2#1)
over a period of one month##2##6##(1993-6#1)(2008-10#1)
over a period of one##3##5##(1993-6#1)(2008-10#1)(2008-3#1)
over a period of three##2##5##(1996-6#1)(2008-11#1)
over a period of time##5##5##(1990-8#1)(2008-11#4)
over a period of two##2##5##(1991-12#1)(2008-8#1)
over a period of##44##4##(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-8#1)(1995-1#1)(1996-6#1)(1997-2#2)(1997-8#2)(2008-10#12)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
over a period##45##3##(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-8#1)(1995-1#1)(1996-6#1)(1997-2#2)(1997-8#2)(2008-10#12)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
over a range of 0##4##5##(1993-12#1)(2008-10#2)(2008-11#1)
over a range of inoculum densities##2##6##(2008-10#2)
over a range of temperatures##4##5##(2008-10#2)(2008-4#1)(2008-8#1)
over a range of##22##4##(1992-3#1)(1993-12#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
over a range##25##3##(1992-3#1)(1993-12#1)(1994-5#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
over a relatively wide range of##2##6##(2008-10#1)(2008-2#1)
over a relatively wide##3##4##(2008-10#2)(2008-2#1)
over a relatively##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
over a short period of time##3##6##(1993-3#1)(1996-3#1)(2008-11#1)
over a short period##5##4##(1993-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2013-8#1)
over a variety of##2##4##(2008-10#2)
over a very wide concentration##2##5##(2008-10#2)
over a very##3##3##(2008-10#2)(2008-3#1)
over a wide concentration range (1##8##6##(2008-10#8)
over a wide concentration range (5##3##6##(2008-10#3)
over a wide concentration range 5##2##6##(2008-10#2)
over a wide concentration range of##2##6##(2008-10#2)
over a wide concentration range##23##5##(1993-8#1)(2008-10#22)
over a wide pH range of##2##6##(2008-10#2)
over a wide pH range##8##5##(1993-8#1)(2008-10#7)
over a wide range of concentrations##2##6##(2008-10#2)
over a wide range of solvent composition (0-60 wt%##2##9##(2008-10#2)
over a wide range of##20##5##(2007-11#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)
over a wide variety of metal ions##3##7##(2008-10#3)
over a wide variety of other anions##2##7##(2008-10#2)
over a wide variety of other cations including alkali##2##9##(2008-10#2)
over a wide variety of other metal ions and could be used in##2##13##(2008-10#2)
over a wide variety of other metal ions##4##8##(2008-10#4)
over a wide variety of other##8##6##(2008-10#8)
over a wide variety of##15##5##(2008-10#15)
over a wide##71##3##(1993-8#3)(2007-11#1)(2007-12#1)(2008-10#58)(2008-11#2)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)
over a##338##2##(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-3#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#160)(2008-11#22)(2008-12#4)(2008-2#3)(2008-3#21)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#8)(2009-11#1)(2009-12#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#7)
over about two orders of magnitude##2##6##(2008-10#2)
over about##3##2##(2008-10#3)
over after##2##2##(2008-10#1)(2008-9#1)
over age##3##2##(1991-3#1)(1994-3#2)
over alkali##6##2##(2008-10#6)
over all loci##2##3##(2008-10#1)(2013-8#1)
over all the##3##3##(1994-3#1)(2008-10#2)
over all##18##2##(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#1)(2012-6#1)(2013-8#1)
over almost##2##2##(2008-10#2)
over an 8-year period##2##4##(2008-10#1)(2012-2#1)
over an entire##2##3##(2008-10#1)(2012-7#1)
over an extended##2##3##(2008-11#1)(2011-2#1)
over an##12##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-7#1)
over and above that##3##4##(2008-12#1)(2008-5#1)(2008-7#1)
over and above the##2##4##(2008-7#1)(2012-2#1)
over and above##7##3##(2008-12#1)(2008-5#2)(2008-7#2)(2009-9#1)(2012-2#1)
over and##10##2##(1991-12#1)(1994-2#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-9#1)(2012-12#1)(2012-2#1)
over approximately##3##2##(1993-6#1)(2008-3#1)(2009-10#1)
over at least##4##3##(2008-10#2)(2011-1#1)(2012-4#1)
over both the##2##3##(2008-3#1)(2008-8#1)
over both years##2##3##(2008-10#2)
over both##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
over control##2##2##(1995-8#1)(2008-12#1)
over conventional spectrophotometry for##2##4##(2008-10#2)
over conventional##12##2##(1994-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2011-2#1)
over current##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
over different##4##2##(1993-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
over entire##2##2##(2008-10#2)
over existing##4##2##(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
over expression of##2##3##(2007-12#1)(2011-3#1)
over expression##3##2##(2007-12#1)(2011-3#1)(2013-1#1)
over extended##2##2##(2008-10#2)
over food##2##2##(2008-1#1)(2009-10#1)
over four##3##2##(1990-2#1)(2008-10#2)
over fungal##2##2##(2008-10#1)(2008-8#1)
over half of##3##3##(1992-2#1)(2011-2#1)(2012-2#1)
over half##4##2##(1992-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
over health care reform##2##4##(1993-12#1)(1994-8#1)
over health care##3##3##(1993-12#1)(1994-8#1)(1997-3#1)
over in##2##2##(1995-9#1)(2008-8#1)
over interfering cations##2##3##(2008-10#2)
over its##3##2##(2008-3#1)(2010-8#1)(2013-1#1)
over land and##2##3##(2008-2#1)(2008-3#1)
over land##4##2##(2008-2#1)(2008-3#3)
over large areas##2##3##(2008-10#1)(2008-7#1)
over large##5##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
over left##4##2##(1995-2#1)(2008-10#3)
over local##2##2##(2008-8#2)
over long distances##6##3##(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#1)
over long periods of time##4##5##(1995-1#1)(2008-10#1)(2008-11#2)
over long periods of##5##4##(1995-1#1)(2008-10#2)(2008-11#2)
over long periods##7##3##(1995-1#1)(2008-10#2)(2008-11#4)
over long##14##2##(1995-1#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-9#1)(2009-3#1)(2011-2#1)
over many years##3##3##(1997-1#1)(1997-4#1)(2008-10#1)
over many##10##2##(1997-1#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)
over more than one##2##4##(2008-11#1)(2011-2#1)
over most of the##2##4##(1992-9#1)(2008-8#1)
over most##3##2##(1992-9#1)(2008-10#1)(2008-8#1)
over much##2##2##(2009-8#1)(2010-1#1)
over multiple##2##2##(2008-12#1)(2008-3#1)
over narrow##2##2##(2008-10#1)(2008-9#1)
over nine##2##2##(2008-10#1)(2008-5#1)
over one##4##2##(2008-10#2)(2008-12#1)(2011-2#1)
over other alkali metal cations##2##5##(2008-10#2)
over other alkali metal##3##4##(2008-10#3)
over other alkali##4##3##(2008-10#4)
over other mono-##2##3##(2008-10#2)
over other##22##2##(1994-12#1)(1995-2#1)(2008-10#14)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-10#1)(2012-2#1)
over pH range##2##3##(1997-2#1)(2008-10#1)
over placebo##2##2##(2008-10#1)(2012-2#1)
over potassium ion##2##3##(2008-10#2)
over previously##2##2##(2008-10#1)(2008-7#1)
over recent years##2##3##(2008-10#1)(2008-11#1)
over relatively##2##2##(1996-2#1)(2013-8#1)
over reproductive##6##2##(2008-11#1)(2008-8#5)
over seven##2##2##(2012-12#1)(2012-3#1)
over several generations##2##3##(2008-10#1)(2008-8#1)
over several weeks##2##3##(2008-10#2)
over several years and##2##4##(2008-10#2)
over several##8##2##(2008-10#6)(2008-8#1)(2010-5#1)
over sex allocation##2##3##(2008-8#2)
over sex##4##2##(2008-8#4)
over short distances##2##3##(2008-10#2)
over short time##2##3##(2012-2#1)(2013-8#1)
over short##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
over six##3##2##(1996-2#1)(2012-3#1)(2013-1#1)
over some##2##2##(2008-10#1)(2008-9#1)
over space and time##3##4##(2008-10#2)(2010-8#1)
over successive spawnings##4##3##(2010-8#4)
over successive years##2##3##(2008-10#2)
over successive##7##2##(2008-10#3)(2010-8#4)
over ten##3##2##(2008-1#1)(2008-5#1)(2013-1#1)
over that of control##4##4##(2008-11#4)
over that of##7##3##(1993-8#1)(2008-10#1)(2008-11#4)(2008-7#1)
over that##12##2##(1993-8#1)(2008-10#4)(2008-11#5)(2008-7#1)(2010-11#1)
over the 0##2##3##(2008-10#1)(2008-3#1)
over the 1##2##3##(2008-10#2)
over the 10-year period##2##4##(1993-2#1)(1997-2#1)
over the 2##3##3##(1996-2#1)(2008-10#2)
over the 24-h##2##3##(2008-10#1)(2008-9#1)
over the 3##2##3##(2008-10#1)(2008-7#1)
over the 5##2##3##(2008-10#1)(2013-8#1)
over the Internet##2##3##(2008-4#2)
over the age of##6##4##(1994-12#2)(1996-3#1)(2011-2#3)
over the concentration range 0##13##5##(2008-10#13)
over the concentration range 1##4##5##(2008-10#4)
over the concentration range 10(-1)-10(-5) mol l(-1)##2##7##(2008-10#2)
over the concentration range 10(-6)-10(-2)##2##5##(2008-10#2)
over the concentration range of 0##4##6##(2008-10#3)(2011-3#1)
over the concentration range of 1##3##6##(2008-10#3)
over the concentration range of 5##2##6##(2008-10#2)
over the concentration range of##17##5##(2008-10#16)(2011-3#1)
over the concentration range##55##4##(2008-10#54)(2011-3#1)
over the concentration ranges of##2##5##(2008-10#2)
over the concentration ranges##4##4##(2008-10#4)
over the concentration##59##3##(2008-10#58)(2011-3#1)
over the conventional##4##3##(1994-1#1)(2008-10#2)(2010-8#1)
over the corresponding##2##3##(1990-11#1)(2010-6#1)
over the course of a##2##5##(2008-11#1)(2008-8#1)
over the course of the##2##5##(2008-10#2)
over the course of treatment##2##5##(2008-12#1)(2012-2#1)
over the course of##14##4##(1994-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2010-10#1)(2012-2#2)(2013-8#1)
over the dose range##2##4##(1993-6#1)(1994-8#1)
over the entire##17##3##(1990-8#1)(1991-5#1)(1992-3#2)(1996-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2013-1#1)
over the first##5##3##(1991-2#1)(1992-1#1)(2007-9#1)(2008-10#1)(2011-2#1)
over the growing season##4##4##(2008-10#4)
over the landscape##2##3##(2008-10#1)(2008-9#1)
over the last 10 years##3##5##(2008-10#2)(2008-11#1)
over the last 10##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
over the last 2 decades##2##5##(2008-9#1)(2012-2#1)
over the last 25 years##2##5##(1996-1#1)(1996-11#1)
over the last 30 years##2##5##(2008-10#2)
over the last 5 years##2##5##(1996-11#1)(2008-10#1)
over the last decade##9##4##(1992-1#1)(1997-7#1)(2008-10#3)(2008-12#1)(2009-12#1)(2010-6#1)(2010-8#1)
over the last few decades##5##5##(1995-1#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)
over the last few##6##4##(1995-1#1)(1997-7#1)(2008-11#2)(2008-4#1)(2008-5#1)
over the last several years##2##5##(1995-2#1)(2010-6#1)
over the last two decades##5##5##(2008-11#1)(2009-12#1)(2011-3#1)(2012-3#1)(2013-8#1)
over the last two##7##4##(1996-12#1)(2008-11#1)(2009-12#1)(2009-5#1)(2011-3#1)(2012-3#1)(2013-8#1)
over the last##45##3##(1990-6#1)(1992-1#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-7#3)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-6#2)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
over the left##2##3##(2012-12#1)(2012-3#1)
over the long term##3##4##(2008-6#1)(2008-8#1)(2008-9#1)
over the medial##2##3##(2010-3#1)(2011-2#1)
over the next 2##2##4##(1994-12#1)(1996-9#1)
over the next 3 days##2##5##(1991-2#1)(2008-10#1)
over the next 3##3##4##(1991-2#1)(1996-2#1)(2008-10#1)
over the next two decades##2##5##(1991-5#1)(2009-3#1)
over the next##12##3##(1991-2#2)(1991-5#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-9#1)(2008-10#2)(2009-3#1)(2012-2#1)(2012-3#1)
over the other two##2##4##(2008-10#2)
over the other##8##3##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
over the pH range##7##4##(2008-10#7)
over the pH##9##3##(2008-10#9)
over the past 10 years##3##5##(1992-3#1)(1993-8#1)(2013-8#1)
over the past 15 years##2##5##(2008-11#1)(2012-2#1)
over the past 20 years##3##5##(2008-10#1)(2010-6#1)(2010-7#1)
over the past 50 years##2##5##(2008-11#1)(2008-7#1)
over the past decade##10##4##(1997-1#1)(2008-10#4)(2008-9#1)(2010-6#1)(2011-2#2)(2013-1#1)
over the past decades##2##4##(2011-2#1)(2013-1#1)
over the past few years##4##5##(1992-9#1)(1995-12#1)(1995-3#1)(2011-2#1)
over the past few##5##4##(1992-9#1)(1995-12#1)(1995-3#1)(2011-2#1)(2013-1#1)
over the past million years##2##5##(1994-3#2)
over the past several years##3##5##(1991-1#1)(1992-2#1)(2008-4#1)
over the past ten years##2##5##(1990-6#1)(1996-3#1)
over the past three decades##3##5##(2008-1#1)(2008-11#1)(2010-8#1)
over the past three##4##4##(2008-1#1)(2008-11#1)(2010-8#1)(2012-3#1)
over the past twenty years##2##5##(1992-1#1)(2013-8#1)
over the past two decades##2##5##(2011-2#2)
over the past two##3##4##(1996-8#1)(2011-2#2)
over the past years##3##4##(1996-3#1)(2008-11#1)(2011-2#1)
over the past##56##3##(1990-6#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-3#2)(1995-12#1)(1995-3#2)(1996-3#2)(1996-8#1)(1997-1#3)(1997-6#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
over the period from##2##4##(2008-10#1)(2012-12#1)
over the period of##2##4##(2008-11#2)
over the period##11##3##(1990-3#1)(1991-6#1)(1996-1#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-12#1)
over the physiological##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
over the potential##3##3##(2008-10#2)(2013-1#1)
over the previous##2##3##(1991-3#1)(2013-1#1)
over the range 0##22##4##(2008-10#21)(2008-5#1)
over the range 1##6##4##(2008-10#6)
over the range 3##2##4##(2008-10#2)
over the range 5##2##4##(2008-10#2)
over the range from##5##4##(2008-10#4)(2008-3#1)
over the range of 0##13##5##(2008-10#13)
over the range of 1##2##5##(2008-10#1)(2008-11#1)
over the range of 2##4##5##(2008-10#4)
over the range of##36##4##(2008-10#34)(2008-11#1)(2008-3#1)
over the range studied##2##4##(2008-10#1)(2008-11#1)
over the range##94##3##(2008-10#89)(2008-11#2)(2008-3#2)(2008-5#1)
over the ranges 0##2##4##(2008-10#2)
over the same##4##3##(1991-8#1)(1995-1#1)(1995-8#1)(2008-10#1)
over the season##2##3##(2008-10#1)(2008-8#1)
over the standard##3##3##(1994-9#1)(2008-3#1)(2008-7#1)
over the study period##3##4##(1992-5#1)(2008-5#1)(2008-8#1)
over the study##4##3##(1992-5#1)(2008-5#1)(2008-8#1)(2011-1#1)
over the surface of##2##4##(2008-10#2)
over the time##4##3##(2008-10#2)(2008-11#1)(2011-1#1)
over the two##3##3##(2008-10#3)
over the whole##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2013-8#1)
over the wide##2##3##(2008-10#2)
over the working range##2##4##(2008-10#2)
over the working##3##3##(2008-10#3)
over the years##13##3##(1991-12#1)(1994-12#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-2#1)(2010-1#1)(2010-5#1)(2012-3#2)(2013-8#2)
over the##623##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#4)(1992-2#2)(1992-3#3)(1992-5#2)(1992-9#1)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-8#2)(1996-1#5)(1996-11#3)(1996-12#1)(1996-2#5)(1996-3#5)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#4)(1997-8#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#279)(2008-11#26)(2008-12#12)(2008-2#5)(2008-3#14)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#10)(2008-8#12)(2008-9#16)(2009-1#1)(2009-10#5)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#2)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#4)(2010-8#6)(2011-1#3)(2011-2#20)(2011-3#3)(2012-12#5)(2012-2#9)(2012-3#9)(2013-1#11)(2013-8#10)
over their##9##2##(1992-1#1)(1995-1#1)(1996-1#1)(2008-5#1)(2008-8#2)(2010-10#1)(2011-1#1)(2013-1#1)
over this##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
over those##3##2##(1994-2#2)(2008-7#1)
over three commercial products##2##4##(2008-10#2)
over three decades##2##3##(2010-12#1)(2011-1#1)
over three orders of magnitude and the##2##7##(2008-10#2)
over three orders of magnitude##6##5##(1991-5#1)(2008-10#5)
over three##16##2##(1991-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-12#1)
over time and##8##3##(1990-12#2)(2008-10#3)(2009-5#1)(2009-7#1)(2010-1#1)
over time by##2##3##(1994-12#1)(2008-10#1)
over time followed a##2##4##(2008-10#2)
over time for##2##3##(2008-10#1)(2010-5#1)
over time from##2##3##(2008-10#1)(2008-9#1)
over time in the##8##4##(1990-12#1)(1997-2#1)(2008-10#4)(2009-7#1)(2012-12#1)
over time in##18##3##(1990-12#1)(1997-2#1)(2008-10#8)(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-12#1)(2012-2#2)
over time scales##2##3##(2008-3#2)
over time was##2##3##(2008-10#2)
over time were##2##3##(2008-10#1)(2012-3#1)
over time when##2##3##(2008-10#2)
over time##168##2##(1990-12#3)(1991-1#1)(1991-2#4)(1992-9#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#3)(1995-9#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#59)(2008-11#6)(2008-12#8)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#9)(2009-5#2)(2009-7#3)(2010-1#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#1)
over traditional##5##2##(1993-3#1)(2008-10#2)(2008-9#2)
over turbid##2##2##(2008-3#2)
over two growing seasons##3##4##(2008-10#3)
over two orders of magnitude##3##5##(2008-10#3)
over two seasons##3##3##(2008-10#3)
over two years##2##3##(1997-2#1)(2013-8#1)
over two##20##2##(1993-11#1)(1997-2#1)(2008-10#14)(2010-8#1)(2012-2#2)(2013-8#1)
over which the method was##2##5##(2008-10#2)
over which the##3##3##(2008-10#2)(2011-2#1)
over which##9##2##(1990-8#1)(2008-10#4)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)
over wide concentration range##2##4##(2008-10#2)
over wide concentration##3##3##(2008-10#3)
over wide##6##2##(2008-10#5)(2010-8#1)
over years or##2##3##(2008-10#1)(2013-1#1)
over years##6##2##(2008-10#4)(2012-2#1)(2013-1#1)
over##2051##1##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#6)(1990-8#9)(1990-9#1)(1991-1#3)(1991-12#6)(1991-2#12)(1991-3#6)(1991-5#7)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#7)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#9)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#7)(1993-1#2)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#7)(1993-5#1)(1993-6#9)(1993-8#6)(1993-9#4)(1994-1#6)(1994-11#3)(1994-12#10)(1994-2#10)(1994-3#13)(1994-5#5)(1994-6#6)(1994-8#4)(1994-9#5)(1995-1#7)(1995-11#2)(1995-12#9)(1995-2#6)(1995-3#7)(1995-6#3)(1995-8#3)(1995-9#3)(1996-1#6)(1996-11#4)(1996-12#3)(1996-2#12)(1996-3#11)(1996-5#5)(1996-6#6)(1996-8#3)(1996-9#1)(1997-1#10)(1997-2#10)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#5)(2007-11#3)(2007-12#14)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#828)(2008-11#107)(2008-12#46)(2008-2#18)(2008-3#65)(2008-4#8)(2008-5#31)(2008-6#10)(2008-7#49)(2008-8#65)(2008-9#57)(2009-1#2)(2009-10#8)(2009-11#2)(2009-12#5)(2009-3#4)(2009-4#3)(2009-5#9)(2009-7#7)(2009-8#12)(2009-9#5)(2010-1#10)(2010-10#8)(2010-11#7)(2010-12#6)(2010-3#6)(2010-4#4)(2010-5#11)(2010-6#12)(2010-7#7)(2010-8#20)(2010-9#1)(2011-1#9)(2011-2#71)(2011-3#7)(2011-9#1)(2012-12#20)(2012-2#42)(2012-3#27)(2012-4#1)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#36)(2013-7#1)(2013-8#27)
over- or##2##2##(2008-8#1)(2008-9#1)
over-##3##1##(2008-8#1)(2008-9#1)(2010-12#1)
over-dominance##4##1##(2008-12#1)(2008-8#3)
over-expressed in a variety of##2##5##(2008-8#1)(2009-3#1)
over-expressed in##5##2##(2008-11#1)(2008-8#1)(2009-3#1)(2010-11#1)(2012-2#1)
over-expressing NSP 5a3a##2##3##(2011-2#2)
over-expression of the##4##3##(1993-2#1)(2008-11#2)(2011-2#1)
over-expression of##14##2##(1993-2#1)(1995-6#1)(1996-12#2)(2007-12#2)(2008-11#6)(2010-12#1)(2011-2#1)
over-expression##19##1##(1993-2#1)(1995-2#1)(1995-6#1)(1996-12#2)(2007-12#2)(2008-11#9)(2008-4#1)(2010-12#1)(2011-2#1)
over-five##2##1##(2008-2#2)
over-represented in##3##2##(2008-12#2)(2010-6#1)
over-represented##4##1##(2008-10#1)(2008-12#2)(2010-6#1)
over-the-counter drugs and beverages##2##4##(2010-9#2)
over-the-counter drugs and food additives in##2##6##(2010-9#2)
over-the-counter drugs and##4##3##(2010-9#4)
over-the-counter##6##1##(1992-11#1)(2008-11#1)(2010-9#4)
overactive##3##1##(2008-12#1)(2008-4#1)(2011-1#1)
overactivity in##2##2##(1993-1#1)(1993-9#1)
overactivity##3##1##(1993-1#1)(1993-9#1)(2008-12#1)
overall agreement##3##2##(1997-2#1)(2008-10#1)(2010-12#1)
overall aim of##3##3##(2008-11#2)(2012-2#1)
overall aim##4##2##(2008-11#2)(2012-2#2)
overall amino acid identity##2##4##(1995-6#1)(1996-3#1)
overall analysis##2##2##(2008-10#1)(2013-8#1)
overall analytical##2##2##(2008-10#2)
overall and##7##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#2)
overall architecture of the##2##4##(2008-8#1)(2011-2#1)
overall architecture##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
overall average##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
overall body##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
overall care of##2##3##(2011-3#1)(2012-3#1)
overall cost##3##2##(1993-12#1)(2012-3#1)(2013-1#1)
overall decrease in##2##3##(1994-12#1)(1997-8#1)
overall diagnostic##2##2##(1996-11#1)(2011-2#1)
overall efficiency of##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
overall estimated##2##2##(1996-3#1)(2008-10#1)
overall extraction equilibrium constants##3##4##(2008-10#3)
overall extraction equilibrium##4##3##(2008-10#4)
overall extraction##8##2##(2008-10#8)
overall features##2##2##(2007-11#1)(2008-3#1)
overall fitness##4##2##(2008-10#1)(2008-9#1)(2009-5#1)(2012-2#1)
overall health and##2##3##(1996-3#1)(2013-1#1)
overall health##9##2##(1996-3#1)(2007-11#1)(2008-7#4)(2010-1#1)(2013-1#1)(2013-8#1)
overall hospital##2##2##(1993-3#1)(2008-11#1)
overall identity##2##2##(1991-9#1)(1996-3#1)
overall improvement##2##2##(1992-6#1)(2008-12#1)
overall incidence##3##2##(1994-12#1)(2012-2#1)(2012-3#1)
overall increase in##2##3##(1993-3#1)(2008-6#1)
overall job satisfaction##2##3##(1991-2#2)
overall length of##2##3##(1994-2#1)(2010-7#1)
overall mean intercept##2##3##(2008-10#2)
overall mean regression slope and intercept##2##6##(2008-10#2)
overall mean##8##2##(2008-10#5)(2008-7#1)(2008-9#2)
overall method##3##2##(2008-10#3)
overall mortality##3##2##(2008-7#2)(2012-3#1)
overall network activity##2##3##(2013-8#2)
overall network##3##2##(2012-3#1)(2013-8#2)
overall objective##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
overall outcome of##2##3##(2008-7#1)(2013-1#1)
overall outcome##4##2##(2008-7#2)(2010-12#1)(2013-1#1)
overall patient##3##2##(1993-12#1)(2011-2#1)(2013-1#1)
overall performance of the##2##4##(2008-10#1)(2008-5#1)
overall performance##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
overall precision##3##2##(1997-2#1)(2008-10#2)
overall prevalence of##6##3##(1990-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
overall process##4##2##(1996-5#1)(2008-10#1)(2008-12#1)(2009-3#1)
overall prognosis##2##2##(2008-12#1)(2008-7#1)
overall psychological##2##2##(2008-4#1)(2012-2#1)
overall public health##2##3##(1995-12#1)(1997-3#1)
overall rate of##5##3##(1991-11#1)(1991-2#1)(1993-11#1)(1994-2#1)(2008-10#1)
overall rate##6##2##(1991-11#1)(1991-2#1)(1993-11#1)(1994-2#1)(1995-6#1)(2008-10#1)
overall rating##2##2##(1992-1#2)
overall reaction##3##2##(2008-10#3)
overall reduction##4##2##(2008-10#3)(2008-3#1)
overall response rate##5##3##(1993-1#1)(2008-10#3)(2012-2#1)
overall response##7##2##(1993-1#1)(1997-1#1)(1997-5#1)(2008-10#3)(2012-2#1)
overall results##7##2##(1994-8#1)(2008-10#5)(2012-2#1)
overall satisfaction##2##2##(1991-3#1)(1996-3#1)
overall scores##2##2##(1995-12#1)(2010-3#1)
overall sensitivity##3##2##(1996-12#1)(1997-8#1)(2008-3#1)
overall sequence##2##2##(1995-12#1)(2008-10#1)
overall similarity of##2##3##(1991-9#1)(2008-9#1)
overall similarity##3##2##(1991-9#1)(2008-10#1)(2008-9#1)
overall stability constants##3##3##(2008-10#3)
overall stability##4##2##(2008-10#3)(2008-8#1)
overall strategy##2##2##(1991-3#1)(1994-3#1)
overall strength of evidence##3##4##(2012-12#3)
overall strength of##4##3##(2008-11#1)(2012-12#3)
overall structure is##2##3##(1993-8#2)
overall structure##5##2##(1991-5#1)(1992-6#1)(1993-8#2)(1997-9#1)
overall success rate##2##3##(2008-10#1)(2008-12#1)
overall success##6##2##(2008-10#1)(2008-12#1)(2012-12#2)(2013-1#2)
overall survival (OS)##5##3##(1991-8#1)(1993-1#1)(2008-10#2)(2011-2#1)
overall survival and disease-free##2##4##(1994-2#1)(2011-2#1)
overall survival of##2##3##(2011-2#1)(2013-8#1)
overall survival was##8##3##(1990-12#1)(1991-8#2)(1992-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
overall survival##29##2##(1990-12#2)(1990-9#1)(1991-2#1)(1991-8#3)(1992-12#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-2#1)(2008-10#3)(2008-11#1)(2010-11#2)(2011-2#5)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#2)
overall system##2##2##(2008-10#1)(2008-3#1)
overall treatment effect##2##3##(1996-3#1)(2013-1#1)
overall treatment##4##2##(1993-2#1)(1996-3#1)(2008-6#1)(2013-1#1)
overall uncertainty##3##2##(2008-10#2)(2011-2#1)
overall understanding of the##2##4##(1997-1#1)(2008-10#1)
overall yield and##2##3##(1996-5#1)(2008-10#1)
overall yield##6##2##(1996-5#4)(2008-10#1)(2008-11#1)
overall##515##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#5)(1991-3#5)(1991-5#5)(1991-6#1)(1991-8#4)(1991-9#2)(1992-1#2)(1992-12#3)(1992-2#4)(1992-3#1)(1992-6#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#2)(1993-9#1)(1994-12#6)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#6)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#6)(1996-5#7)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#3)(1997-5#2)(1997-8#5)(1997-9#1)(2007-11#2)(2008-1#2)(2008-10#123)(2008-11#31)(2008-12#12)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#20)(2008-8#13)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#4)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-10#1)(2011-2#28)(2011-3#3)(2012-12#8)(2012-2#24)(2012-3#14)(2012-4#1)(2012-5#1)(2013-1#18)(2013-8#8)
overarching##6##1##(1993-12#1)(1996-2#1)(1996-3#1)(2011-2#1)(2012-2#2)
overburdened##2##1##(2009-12#1)(2013-8#1)
overcame the resistance##2##3##(2008-10#2)
overcame the##3##2##(1993-12#1)(2008-10#2)
overcame##4##1##(1993-12#1)(2008-10#3)
overcast##3##1##(1994-3#1)(2008-10#2)
overcome any##2##2##(1995-1#1)(2008-10#1)
overcome by##16##2##(1990-6#1)(1994-8#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-9#1)(2009-6#1)(2011-1#1)(2013-1#1)
overcome in##2##2##(2008-10#1)(2012-3#1)
overcome limitations of##2##3##(2008-1#1)(2008-11#1)
overcome problems##2##2##(1992-1#1)(1996-12#1)
overcome some of the limitations##3##5##(2008-1#1)(2008-10#1)(2013-1#1)
overcome some of##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
overcome the inhibition##2##3##(1994-2#1)(2008-8#1)
overcome the limitations of##2##4##(2008-10#1)(2012-3#1)
overcome the weaknesses of##2##4##(1997-3#1)(2011-1#1)
overcome the##32##2##(1991-2#2)(1994-2#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#12)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#2)
overcome these barriers##3##3##(2010-11#1)(2013-1#2)
overcome these drawbacks##2##3##(2008-7#1)(2010-6#1)
overcome these##13##2##(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-6#1)(2011-7#1)(2013-1#2)
overcome this limitation##3##3##(1994-2#1)(2008-9#1)(2010-11#1)
overcome this problem##5##3##(1995-2#1)(2008-10#2)(2008-11#2)
overcome this##14##2##(1994-2#1)(1995-2#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)
overcome##141##1##(1990-12#1)(1990-6#1)(1991-2#2)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(2008-1#2)(2008-10#44)(2008-11#14)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#7)
overcomes the##8##2##(2008-10#5)(2008-11#1)(2008-7#1)(2009-12#1)
overcomes##12##1##(1996-5#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)
overcoming problems of##2##3##(2008-10#1)(2008-4#1)
overcoming the problem of##2##4##(2008-11#2)
overcoming the##9##2##(2008-10#5)(2008-11#3)(2009-12#1)
overcoming##29##1##(1995-3#1)(1996-9#1)(1997-3#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#3)(2009-12#2)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
overcompensation##3##1##(2008-8#2)(2008-9#1)
overcrowding and##2##2##(1997-7#1)(2013-1#1)
overcrowding##11##1##(1997-7#1)(2008-11#6)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
overdentures##5##1##(2013-1#5)
overdetermined##2##1##(2008-10#1)(2008-7#1)
overdispersed##3##1##(2008-10#1)(2008-8#2)
overdispersion of disease##2##3##(2008-10#2)
overdispersion##5##1##(2008-10#4)(2008-8#1)
overdominance or underdominance##2##3##(2008-10#2)
overdominance##3##1##(2008-10#3)
overdose have##2##2##(2010-1#2)
overdose##13##1##(1990-6#1)(1991-1#1)(1996-8#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-1#5)(2013-1#1)
overdoses##3##1##(2010-1#1)(2010-9#1)(2013-1#1)
overdue for##3##2##(2010-8#3)
overdue##5##1##(2010-8#4)(2013-1#1)
overestimate the##2##2##(1992-6#1)(2008-10#1)
overestimate##4##1##(1992-6#1)(2008-10#3)
overestimated in the##2##3##(1990-11#1)(2008-10#1)
overestimated in##3##2##(1990-11#1)(2008-10#2)
overestimated the##3##2##(2008-10#1)(2009-7#1)(2013-1#1)
overestimated##17##1##(1990-11#1)(1993-2#1)(2008-10#8)(2008-11#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#2)
overestimating the##2##2##(1994-3#1)(2008-10#1)
overestimating##3##1##(1994-3#1)(2008-10#1)(2012-3#1)
overestimation of##8##2##(1992-9#1)(1994-3#1)(2008-10#4)(2008-11#1)(2011-2#1)
overestimation##9##1##(1992-9#1)(1994-3#1)(2008-10#5)(2008-11#1)(2011-2#1)
overexpress the##2##2##(2008-11#2)
overexpress##8##1##(1993-1#1)(1995-2#1)(2008-11#3)(2009-3#1)(2009-8#1)(2011-1#1)
overexpressed in E##2##3##(1995-12#1)(2008-7#1)
overexpressed in Escherichia coli##2##4##(2008-10#1)(2011-2#1)
overexpressed in senescent human fibroblasts##2##5##(1992-9#2)
overexpressed in##14##2##(1992-9#2)(1995-12#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-7#1)(2011-2#3)
overexpressed maize AChE gene in##2##5##(2009-8#2)
overexpressed##29##1##(1992-9#2)(1994-12#1)(1994-5#2)(1995-12#1)(1995-2#2)(1997-7#1)(2008-10#4)(2008-11#6)(2008-7#1)(2009-7#1)(2009-8#3)(2010-12#1)(2011-2#3)(2013-1#1)
overexpressing EGFR##2##2##(2008-11#2)
overexpressing the human##3##3##(1992-8#2)(1995-6#1)
overexpressing the##5##2##(1992-8#2)(1994-11#1)(1995-6#2)
overexpressing transfectants##2##2##(1993-1#2)
overexpressing##23##1##(1992-8#2)(1993-1#3)(1993-3#1)(1994-11#2)(1995-2#1)(1995-6#2)(1997-7#2)(2008-10#1)(2008-11#3)(2008-8#3)(2009-10#1)(2010-12#1)(2011-2#1)
overexpression and##4##2##(1993-1#1)(1995-6#1)(2011-2#1)(2012-3#1)
overexpression has been##2##3##(2012-12#1)(2013-1#1)
overexpression in human##2##3##(1993-1#1)(1997-7#1)
overexpression in##9##2##(1993-1#1)(1995-9#1)(1997-7#1)(2008-9#1)(2011-1#2)(2013-1#2)(2013-8#1)
overexpression of copper- and zinc-containing superoxide dismutase##2##7##(1995-6#2)
overexpression of p53 protein##2##4##(2008-10#1)(2009-8#1)
overexpression of p53##5##3##(2008-10#3)(2009-8#1)(2010-10#1)
overexpression of the##5##3##(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
overexpression of##41##2##(1992-12#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-6#5)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#10)(2008-7#3)(2009-3#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#4)(2013-1#4)
overexpression on##4##2##(1997-7#2)(2009-8#1)(2013-8#1)
overexpression was##2##2##(1997-7#1)(2011-2#1)
overexpression##82##1##(1992-12#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#6)(1995-9#1)(1996-5#1)(1997-7#5)(2008-10#7)(2008-11#13)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#4)(2010-10#1)(2011-1#6)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#2)
overfilling##2##1##(1991-2#1)(1991-3#1)
overgrown##2##1##(1997-5#1)(2008-10#1)
overgrowth in##2##2##(2008-9#1)(2011-2#1)
overgrowth##12##1##(2008-11#5)(2008-8#1)(2008-9#3)(2011-2#3)
overhang##2##1##(1993-12#1)(2008-11#1)
overhaul of##2##2##(1994-8#1)(1995-2#1)
overhaul##3##1##(1994-12#1)(1994-8#1)(1995-2#1)
overhead sprinkling irrigation##2##3##(2008-10#2)
overhead##7##1##(1991-2#1)(2008-10#6)
overinfuse if##2##2##(2011-2#2)
overlaid##2##1##(2008-8#1)(2012-2#1)
overlap among##2##2##(2008-7#1)(2012-2#1)
overlap and##4##2##(1994-12#1)(2008-10#3)
overlap at##2##2##(2008-10#1)(2011-2#1)
overlap between the##2##3##(1994-12#1)(2008-10#1)
overlap between##7##2##(1994-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)
overlap each other##2##3##(1997-8#1)(2008-11#1)
overlap in the##2##3##(1997-8#1)(2008-8#1)
overlap in##7##2##(1997-3#1)(1997-8#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-1#1)
overlap is##2##2##(2008-10#1)(2008-3#1)
overlap of the##3##3##(1990-12#1)(2008-10#2)
overlap of##10##2##(1990-12#1)(2008-10#7)(2008-9#1)(2010-1#1)
overlap was##4##2##(2008-10#3)(2009-2#1)
overlap with other##2##3##(1994-2#1)(2008-8#1)
overlap with the##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
overlap with##9##2##(1994-2#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-1#1)(2009-8#1)(2010-12#1)(2011-2#1)
overlap##72##1##(1990-12#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-6#2)(1996-12#2)(1996-2#2)(1997-3#2)(1997-8#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-1#1)(2009-2#2)(2009-8#4)(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
overlapped absorption##2##2##(2008-10#2)
overlapped in##2##2##(1997-3#1)(2009-6#1)
overlapped peaks##2##2##(2008-10#2)
overlapped with QTL##2##3##(2012-3#2)
overlapped with##5##2##(1992-9#1)(2008-10#1)(2012-3#2)(2013-8#1)
overlapped##36##1##(1992-9#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-2#4)(1997-3#1)(2008-10#21)(2008-11#1)(2008-8#1)(2009-6#1)(2012-3#2)(2013-8#1)
overlapping ORFs##3##2##(1996-3#1)(2008-10#2)
overlapping and##2##2##(1995-9#1)(2008-10#1)
overlapping cDNA clones##2##3##(1996-12#2)
overlapping chromatographic##2##2##(2008-10#2)
overlapping clones covering the##2##4##(2008-8#1)(2013-8#1)
overlapping clones##4##2##(1992-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
overlapping deletions##3##2##(1993-3#3)
overlapping fluorescence##2##2##(2008-10#2)
overlapping genes in##3##3##(1996-8#1)(1997-7#2)
overlapping genes##5##2##(1996-8#1)(1997-7#4)
overlapping host##2##2##(2008-10#2)
overlapping of the##2##3##(2008-10#1)(2008-11#1)
overlapping of##7##2##(2008-10#5)(2008-11#1)(2011-2#1)
overlapping or##2##2##(2012-2#1)(2013-1#1)
overlapping pathways##2##2##(1994-6#1)(1996-12#1)
overlapping peaks##5##2##(2008-10#5)
overlapping peptides##2##2##(1993-3#1)(2008-11#1)
overlapping signals##2##2##(2008-10#2)
overlapping spectra##2##2##(2008-10#2)
overlapping spectrophotometric signals##2##3##(2008-10#2)
overlapping the##2##2##(1993-8#1)(2008-10#1)
overlapping with##4##2##(1994-6#1)(2008-10#1)(2008-8#1)(2012-3#1)
overlapping##111##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-6#2)(1995-11#1)(1995-6#1)(1995-9#1)(1996-12#4)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#4)(1997-8#1)(2008-10#49)(2008-11#6)(2008-3#2)(2008-8#7)(2008-9#1)(2009-10#1)(2009-8#2)(2010-10#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
overlaps the##5##2##(1994-11#1)(1997-3#1)(2008-10#2)(2008-8#1)
overlaps with##2##2##(1992-12#1)(2013-1#1)
overlaps##11##1##(1990-11#1)(1992-12#1)(1994-11#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-8#1)(2013-1#1)(2013-8#1)
overlay assay##2##2##(2008-10#2)
overlay of##2##2##(2008-10#1)(2008-5#1)
overlay##8##1##(1994-11#1)(2008-10#5)(2008-5#1)(2010-12#1)
overload and##4##2##(2011-1#1)(2012-2#2)(2012-3#1)
overload phenomenon##4##2##(2008-7#4)
overload##30##1##(1990-9#1)(1991-2#1)(1993-2#1)(1995-8#3)(1996-3#1)(2008-10#3)(2008-11#1)(2008-7#6)(2009-8#1)(2010-1#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
overloading##3##1##(2008-10#1)(2011-1#1)(2011-2#1)
overlook the##2##2##(2010-5#2)
overlook##3##1##(2010-5#2)(2010-9#1)
overlooked because##2##2##(1993-1#1)(1996-6#1)
overlooked by##3##2##(1991-2#1)(2008-12#1)(2011-2#1)
overlooked in##3##2##(2009-6#1)(2011-2#1)(2013-8#1)
overlooked the##2##2##(2008-11#1)(2011-3#1)
overlooked##32##1##(1991-2#1)(1991-6#1)(1991-8#1)(1993-1#1)(1994-12#1)(1996-6#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-5#1)(2013-8#2)
overly##3##1##(1995-3#1)(2008-10#1)(2013-8#1)
overlying the##3##2##(2009-1#1)(2010-11#1)(2011-2#1)
overlying##9##1##(1990-6#1)(1991-11#1)(2008-10#1)(2009-1#2)(2010-11#1)(2010-3#1)(2011-2#2)
overmodulation##2##1##(2008-3#2)
overnight darkness##2##2##(2008-10#2)
overnight##18##1##(1990-2#1)(1992-2#1)(1993-12#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-9#1)(2010-7#1)(2011-2#4)
overoxidized PPy film##2##3##(2008-10#2)
overoxidized sulfonated polypyrrole film##2##4##(2008-10#2)
overoxidized sulfonated polypyrrole##3##3##(2008-10#3)
overoxidized##5##1##(2008-10#5)
overpotential of##2##2##(2008-10#2)
overpotential##9##1##(2008-10#9)
overpriced##2##1##(1994-1#2)
overproduced in Escherichia coli##2##4##(1993-9#1)(1995-2#1)
overproduced##5##1##(1991-7#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#1)
overproducer##2##1##(1996-12#1)(2012-3#1)
overproduces##2##1##(1991-7#1)(2008-10#1)
overproducing##2##1##(1991-12#1)(2012-2#1)
overproduction of NO##2##3##(2011-1#2)
overproduction of##11##2##(1990-11#1)(1991-12#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#2)(2013-8#1)
overproduction##15##1##(1990-11#1)(1991-12#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-8#1)
overreactivity##2##1##(2012-2#2)
overrepresented among the##2##3##(1990-6#1)(1991-5#1)
overrepresented in##3##2##(2008-11#1)(2009-6#1)(2009-8#1)
overrepresented##7##1##(1990-6#1)(1991-5#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-5#2)
override the##2##2##(1996-12#1)(2008-8#1)
overriding##3##1##(2009-12#1)(2010-11#2)
overrode##2##1##(2008-10#1)(2011-2#1)
overseas military hospitals##3##3##(1995-6#3)
overseas##12##1##(1995-6#3)(1997-2#1)(2008-1#1)(2008-11#5)(2008-12#1)(2010-1#1)
overshadow the##2##2##(1996-11#1)(2008-10#1)
overshadow##3##1##(1994-3#1)(1996-11#1)(2008-10#1)
overshadowed##2##1##(2008-5#1)(2008-7#1)
overshadowing##3##1##(2008-5#3)
overshoot of##2##2##(2008-11#1)(2010-8#1)
overshoot##6##1##(1990-2#1)(2008-11#4)(2010-8#1)
oversight and##2##2##(1995-12#1)(1995-3#1)
oversight of##2##2##(2008-9#1)(2012-3#1)
oversight##6##1##(1995-12#1)(1995-3#1)(2008-11#1)(2008-9#1)(2010-11#1)(2012-3#1)
oversupplied##2##1##(2008-9#2)
overt aggression##2##2##(2008-12#1)(2010-11#1)
overt clinical##2##2##(2009-1#1)(2011-2#1)
overt##16##1##(1990-6#1)(1994-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-11#3)(2010-6#1)(2011-2#5)
overtime##3##1##(1994-3#1)(1996-6#1)(2009-3#1)
overtly##2##1##(2008-11#1)(2012-3#1)
overtone##8##1##(2008-10#2)(2008-2#1)(2008-3#4)(2010-7#1)
overtones##3##1##(2008-10#1)(2008-12#1)(2008-2#1)
overtraining##3##1##(1993-2#3)
overturn##4##1##(1992-11#1)(1995-6#1)(2008-10#1)(2008-12#1)
overuse injuries##2##2##(2011-2#1)(2013-1#1)
overuse##4##1##(1990-8#1)(1997-1#1)(2011-2#1)(2013-1#1)
overutilized##2##1##(1996-9#1)(2009-3#1)
overview describes##4##2##(1997-3#1)(2008-1#1)(2008-11#1)(2008-4#1)
overview for##3##2##(1992-3#1)(1996-2#1)(2008-4#1)
overview is presented##3##3##(1990-8#1)(1992-1#1)(2008-10#1)
overview is##4##2##(1990-8#1)(1992-1#1)(2008-10#1)(2008-11#1)
overview of a##4##3##(1995-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
overview of all##2##3##(1994-2#1)(2011-2#1)
overview of current##3##3##(2009-8#1)(2010-9#1)(2012-2#1)
overview of different##2##3##(2012-2#2)
overview of issues##2##3##(2008-4#1)(2010-4#1)
overview of recent##2##3##(2008-10#1)(2008-4#1)
overview of the application of##2##5##(2008-10#1)(2008-11#1)
overview of the current knowledge on##2##6##(2008-11#1)(2009-4#1)
overview of the current##4##4##(2008-11#1)(2009-4#1)(2011-2#2)
overview of the literature on##2##5##(1993-11#1)(2012-2#1)
overview of the literature##5##4##(1993-11#1)(2009-1#1)(2010-12#1)(2012-2#1)(2013-8#1)
overview of the most##4##4##(1991-6#1)(2010-11#1)(2010-9#1)(2011-3#1)
overview of the pathophysiology of##2##5##(2008-12#1)(2011-2#1)
overview of the recent##2##4##(2012-3#1)(2013-1#1)
overview of the types of##2##5##(1992-12#1)(1997-2#1)
overview of the##81##3##(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1993-11#2)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1995-2#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-4#4)(2008-5#3)(2008-9#6)(2009-1#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#8)(2011-3#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#2)
overview of these##2##3##(1992-1#1)(2008-10#1)
overview of##164##2##(1991-1#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-11#3)(1993-2#2)(1993-3#3)(1994-1#2)(1994-12#2)(1994-2#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#2)(2007-12#1)(2008-10#18)(2008-11#15)(2008-12#4)(2008-4#15)(2008-5#5)(2008-7#1)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#2)(2011-2#14)(2011-3#2)(2012-2#7)(2012-3#5)(2013-1#6)(2013-8#3)
overview on the generation of##2##5##(2008-4#2)
overview on the##5##3##(2008-10#1)(2008-11#1)(2008-4#2)(2010-11#1)
overview on##8##2##(2008-10#3)(2008-11#1)(2008-4#2)(2010-11#1)(2013-8#1)
overview##240##1##(1990-8#2)(1991-1#2)(1991-12#2)(1991-2#3)(1991-6#1)(1991-8#2)(1992-1#4)(1992-12#2)(1992-3#3)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#3)(1994-1#2)(1994-12#3)(1994-2#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#36)(2008-11#23)(2008-12#4)(2008-4#29)(2008-5#6)(2008-6#2)(2008-7#1)(2008-9#9)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#16)(2011-3#2)(2012-2#7)(2012-3#6)(2013-1#8)(2013-8#4)
overviewed##2##1##(2008-10#1)(2013-8#1)
overviews of##2##2##(1993-12#2)
overviews##9##1##(1993-12#7)(2008-6#1)(2010-6#1)
overweight and obese##2##3##(2008-10#1)(2011-2#1)
overweight and obesity is##2##4##(2011-2#1)(2012-2#1)
overweight and obesity##12##3##(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#4)
overweight and##18##2##(2008-10#3)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-2#4)
overweight in##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
overweight or obese##3##3##(2008-10#2)(2012-2#1)
overweight patients##5##2##(2008-10#3)(2009-8#1)(2010-10#1)
overweight##53##1##(1991-12#3)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#14)(2008-3#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-2#8)(2012-3#2)(2013-1#2)(2013-8#3)
overweight/obesity##2##1##(2009-7#1)(2011-1#1)
overwhelmed by##2##2##(2008-1#1)(2008-11#1)
overwhelming majority of##2##3##(2008-9#1)(2011-2#1)
overwhelming##11##1##(1991-1#1)(1994-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#3)(2013-1#2)
overwhelmingly preferred the##2##3##(1995-8#1)(2008-10#1)
overwhelmingly##4##1##(1995-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
overwinter in##2##2##(2008-10#1)(2008-8#1)
overwinter##3##1##(2008-10#2)(2008-8#1)
overwintered##5##1##(2008-10#5)
overwintering by##2##2##(2008-10#1)(2008-9#1)
overwintering ectotherms##2##2##(2008-8#2)
overwintering##15##1##(2008-10#10)(2008-8#2)(2008-9#2)(2010-8#1)
overwinters##2##1##(2008-10#2)
oviduct and##3##2##(1990-8#1)(2008-11#1)(2008-5#1)
oviduct transferrin receptor##2##3##(1990-8#2)
oviduct##15##1##(1990-8#4)(2007-12#1)(2008-11#3)(2008-12#5)(2008-5#1)(2008-9#1)
oviductal parts##3##2##(2008-12#3)
oviductal##4##1##(2008-12#4)
oviducts and##2##2##(1990-8#1)(1992-2#1)
oviducts##4##1##(1990-8#1)(1992-2#1)(2007-12#1)(2008-5#1)
ovine adenovirus##3##2##(1997-3#3)
ovine head impact model##2##4##(2008-7#2)
ovine##20##1##(1991-5#1)(1992-3#1)(1993-2#1)(1995-11#1)(1996-12#2)(1997-3#3)(2008-11#2)(2008-12#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
oviparae##5##1##(2008-9#5)
oviparasitica##4##1##(2008-10#4)
oviparous##2##1##(2007-12#1)(2008-8#1)
oviposit##2##1##(2008-9#1)(2013-8#1)
ovipositing##2##1##(2007-12#1)(2008-8#1)
oviposition preference##2##2##(2008-8#2)
oviposition##12##1##(1991-5#1)(2007-12#2)(2008-12#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-8#2)(2012-3#1)
ovipositor is##2##2##(2007-12#2)
ovipositor sheaths##2##2##(2007-12#2)
ovipositor##7##1##(2007-12#7)
ovis and##3##2##(1996-12#3)
ovis##6##1##(1996-12#4)(2010-10#2)
ovoid cells of the branchial heart##2##6##(2008-7#2)
ovoid cells of##3##3##(2008-7#3)
ovoid cells##4##2##(2008-7#4)
ovoid##6##1##(2007-12#1)(2008-7#4)(2011-2#1)
ovomucoid##2##1##(2008-11#2)
ovulation in##2##2##(2008-9#1)(2010-8#1)
ovulation##7##1##(2007-7#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
ovulatory##2##1##(2008-12#1)(2008-4#1)
ovule##3##1##(2008-10#1)(2008-8#2)
ovules##11##1##(2008-10#1)(2008-8#9)(2009-8#1)
owes##2##1##(2008-11#1)(2010-7#1)
owing in##2##2##(1995-12#1)(1997-5#1)
owing to a##4##3##(1990-11#1)(1995-2#1)(2008-9#1)(2013-1#1)
owing to its##6##3##(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)
owing to lack of##2##4##(1993-2#1)(1996-11#1)
owing to the lack of##2##5##(2008-9#1)(2011-2#1)
owing to the##25##3##(1991-2#1)(1994-6#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-3#3)(2008-5#1)(2008-9#2)(2010-10#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-3#1)
owing to their high##2##4##(2008-10#1)(2013-1#1)
owing to their##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
owing to##64##2##(1990-11#2)(1990-3#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-2#1)(1994-6#1)(1995-2#1)(1996-11#1)(1997-5#1)(2007-12#1)(2008-10#17)(2008-12#1)(2008-3#7)(2008-5#4)(2008-8#1)(2008-9#3)(2010-10#1)(2010-5#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
owing##69##1##(1990-11#2)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-5#2)(2007-12#1)(2008-10#17)(2008-12#1)(2008-3#7)(2008-5#4)(2008-8#1)(2008-9#3)(2010-10#1)(2010-5#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
owl monkeys##3##2##(2008-11#3)
owl##5##1##(1990-5#2)(2008-11#3)
own and##4##2##(2008-11#1)(2008-7#1)(2010-8#1)(2012-2#1)
own characteristics##2##2##(1996-2#1)(2011-2#1)
own experience##5##2##(1992-2#1)(2008-12#1)(2010-6#1)(2010-8#1)(2011-3#1)
own experiences##2##2##(2008-11#1)(2008-12#1)
own experiments##2##2##(2008-10#1)(2008-11#1)
own institution##4##2##(1994-2#1)(2009-4#3)
own or##2##2##(2008-10#1)(2009-12#1)
own patient##2##2##(1991-8#1)(2008-10#1)
own personal experience##2##3##(1994-12#1)(2008-11#1)
own personal##3##2##(1994-12#1)(2008-11#2)
own research##3##2##(1997-1#1)(2008-10#1)(2008-9#1)
own right to##2##3##(1990-12#1)(1995-12#1)
own right##7##2##(1990-12#1)(1992-2#1)(1995-12#1)(2008-11#1)(2010-10#1)(2010-7#1)(2013-1#1)
own specific##2##2##(1996-9#1)(2008-11#1)
own words##4##2##(1995-1#1)(2011-2#3)
own##239##1##(1990-12#2)(1990-5#3)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#3)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#4)(1992-6#2)(1993-1#3)(1993-12#3)(1993-2#3)(1993-3#3)(1994-1#1)(1994-12#4)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#4)(1995-2#7)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#14)(2008-11#26)(2008-12#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#6)(2009-10#5)(2009-12#1)(2009-3#1)(2009-4#5)(2009-6#1)(2009-7#1)(2010-10#6)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#11)(2011-3#2)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#2)
owned a##3##2##(2008-10#2)(2012-3#1)
owned by##2##2##(1991-12#1)(2008-10#1)
owned the##2##2##(2008-10#1)(2008-9#1)
owned##8##1##(1991-12#1)(2008-10#4)(2008-9#1)(2009-8#1)(2012-3#1)
owner and##2##2##(1992-12#1)(2008-5#1)
owner##9##1##(1991-2#1)(1992-12#1)(1996-1#1)(1996-5#2)(2008-5#1)(2008-8#1)(2011-4#1)(2013-8#1)
owner/dog walkers##4##2##(2013-1#4)
owner/non-dog walkers##2##2##(2013-1#2)
owners in the##2##3##(1996-12#1)(2008-10#1)
owners may##2##2##(2008-8#2)
owners to##2##2##(2008-8#1)(2013-1#1)
owners##15##1##(1996-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#6)(2008-9#1)(2013-1#3)(2013-8#1)
ownership of ancillary services##2##4##(1996-1#2)
ownership of##6##2##(1993-2#1)(1993-3#1)(1996-1#2)(2008-10#2)
ownership status##2##2##(2008-11#1)(2013-1#1)
ownership##14##1##(1993-2#1)(1993-3#1)(1994-3#1)(1996-1#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2013-1#1)
owns##2##1##(2008-5#1)(2008-9#1)
ox liver##3##2##(1994-8#2)(2008-4#1)
oxa cages##3##2##(1996-5#3)
oxa##4##1##(1996-5#4)
oxacillin-resistant##2##1##(2011-2#2)
oxaferrocene##2##1##(2008-10#2)
oxalate absorption##4##2##(2012-2#4)
oxalate and##4##2##(2008-10#3)(2012-2#1)
oxalate contents##2##2##(2008-10#1)(2012-2#1)
oxalate crystals rather than##2##4##(1991-11#1)(1992-9#1)
oxalate determination##2##2##(2008-10#2)
oxalate films on marble##2##4##(2008-10#2)
oxalate films##3##2##(2008-10#3)
oxalate form of##2##3##(2008-10#2)
oxalate in##6##2##(2008-10#5)(2012-2#1)
oxalate ion##2##2##(2008-10#2)
oxalate monohydrate##2##2##(1995-8#2)
oxalate oxidase##2##2##(2008-10#2)
oxalate that is##2##3##(2012-2#2)
oxalate that##3##2##(2008-10#1)(2012-2#2)
oxalate##68##1##(1991-11#1)(1991-12#2)(1992-9#5)(1995-8#2)(2008-10#48)(2012-2#10)
oxalate-degrading##2##1##(2012-2#2)
oxalates##2##1##(2008-10#2)
oxalic acid digests of##2##4##(1990-8#2)
oxalic acid in##4##3##(2008-10#2)(2013-1#2)
oxalic acid was##2##3##(2013-1#2)
oxalic acid##17##2##(1990-8#2)(2008-10#6)(2012-2#3)(2013-1#6)
oxalic##21##1##(1990-8#2)(2008-10#10)(2012-2#3)(2013-1#6)
oxalicum##8##1##(2008-10#8)
oxaloacetate##2##1##(2008-7#1)(2013-1#1)
oxalosis##5##1##(1991-11#3)(2011-2#2)
oxamniquine##5##1##(2010-12#5)
oxathiaphospholane monomers##2##2##(2008-4#2)
oxathiaphospholane##3##1##(2008-4#3)
oxazolone control group##2##3##(2011-3#2)
oxazolone-induced##3##1##(2011-3#3)
oxendolone##7##1##(1990-11#7)
oxibendazole##3##1##(2008-10#3)
oxid-LDL##2##1##(1992-5#2)
oxidant and##2##2##(2008-10#1)(2009-9#1)
oxidant compounds##3##2##(2008-10#3)
oxidant concentration##4##2##(1995-8#1)(2008-10#3)
oxidant in##2##2##(2008-10#2)
oxidant is##3##2##(2008-10#3)
oxidant solution##2##2##(2008-10#2)
oxidant than##2##2##(2008-10#1)(2012-12#1)
oxidant to##3##2##(2008-10#3)
oxidant was##2##2##(2008-10#2)
oxidant##53##1##(1990-5#1)(1992-10#1)(1995-8#3)(2008-10#43)(2008-5#1)(2009-9#2)(2012-12#1)(2013-1#1)
oxidants as##2##2##(2008-10#2)
oxidants in liquid phase##2##4##(2008-10#2)
oxidants##16##1##(1990-5#1)(2008-10#12)(2008-11#1)(2010-1#1)(2010-5#1)
oxidase (ChOx)##3##2##(2008-10#3)
oxidase (EC 1##2##3##(1995-2#1)(2008-10#1)
oxidase (GOD) and##2##3##(2008-10#2)
oxidase (GOD) was immobilized##2##4##(2008-10#2)
oxidase (GOD)##6##2##(2008-10#6)
oxidase (XO)##3##2##(2008-10#2)(2008-11#1)
oxidase I##3##2##(1997-7#1)(2008-6#2)
oxidase activity was##3##3##(2008-10#1)(2008-7#2)
oxidase activity##10##2##(1990-5#1)(1993-6#1)(1995-6#1)(2008-10#3)(2008-7#2)(2008-9#1)(2012-2#1)
oxidase and the##2##3##(2008-10#2)
oxidase and##16##2##(1990-5#1)(1993-6#1)(1994-6#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
oxidase as##3##2##(2008-10#3)
oxidase at##2##2##(1997-7#1)(2008-10#1)
oxidase electrode##3##2##(2008-10#2)(2009-10#1)
oxidase enzyme activity##3##3##(2008-10#3)
oxidase enzyme was##2##3##(2008-10#2)
oxidase enzyme##5##2##(2008-10#5)
oxidase enzymes##3##2##(2008-10#2)(2010-1#1)
oxidase from##4##2##(1997-7#3)(2008-10#1)
oxidase has been##2##3##(2008-10#1)(2009-8#1)
oxidase immobilized##8##2##(2008-10#8)
oxidase in conjunction with the##2##5##(2008-10#2)
oxidase in##11##2##(1990-5#2)(1993-2#1)(1993-8#1)(1995-8#1)(2008-10#4)(2008-7#1)(2008-9#1)
oxidase inhibitor##4##2##(1991-5#1)(1994-6#1)(2008-10#2)
oxidase is##2##2##(1995-6#1)(2008-10#1)
oxidase modified carbon##2##3##(2008-10#2)
oxidase of##2##2##(2008-10#2)
oxidase on the##4##3##(2008-10#4)
oxidase on##5##2##(2008-10#5)
oxidase subunit I##2##3##(1993-2#1)(2010-4#1)
oxidase subunit##4##2##(1990-5#1)(1993-2#1)(2008-10#1)(2010-4#1)
oxidase system##2##2##(1993-8#1)(2008-10#1)
oxidase was immobilized on##2##4##(2008-10#2)
oxidase was immobilized##4##3##(2008-10#4)
oxidase was##12##2##(1993-6#1)(1993-8#1)(2008-10#8)(2008-7#1)(2011-1#1)
oxidase with##5##2##(1993-8#1)(2008-10#4)
oxidase##234##1##(1990-12#2)(1990-5#5)(1991-5#4)(1993-2#2)(1993-6#7)(1993-8#8)(1994-11#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-2#3)(1995-3#1)(1995-6#8)(1995-8#3)(1995-9#1)(1997-7#7)(2008-10#139)(2008-11#4)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
oxidase)##2##1##(2008-10#2)
oxidase-B##2##1##(1994-8#1)(2010-12#1)
oxidase-based enzyme##2##2##(2008-10#2)
oxidase-based##3##1##(2008-10#3)
oxidases##9##1##(1994-8#1)(1995-3#1)(2008-10#2)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#2)
oxidation and dry heat##2##4##(2008-10#2)
oxidation and reduction##3##3##(2008-10#3)
oxidation and##19##2##(1993-9#1)(1996-5#1)(2008-10#13)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)
oxidation at##5##2##(1991-7#1)(2008-10#4)
oxidation by hydrogen peroxide##2##4##(2008-10#2)
oxidation by the##3##3##(2008-10#3)
oxidation by##12##2##(2008-10#12)
oxidation during##4##2##(1991-12#3)(2008-10#1)
oxidation efficiency##2##2##(2008-10#2)
oxidation for##5##2##(2008-10#5)
oxidation in the##2##3##(2008-10#2)
oxidation in##13##2##(1990-5#1)(1990-9#1)(1994-8#1)(1995-2#1)(2008-10#7)(2008-5#1)(2010-4#1)
oxidation is##5##2##(1994-5#1)(2008-10#4)
oxidation metabolites##2##2##(2011-1#1)(2011-3#1)
oxidation method##3##2##(2008-10#3)
oxidation of 1##2##3##(2008-10#2)
oxidation of 2##2##3##(2008-10#2)
oxidation of AA##2##3##(2008-10#2)
oxidation of As(III)##2##3##(2008-10#2)
oxidation of Cr(III) to Cr(VI)##2##5##(2008-10#2)
oxidation of Cr(III)##3##3##(2008-10#3)
oxidation of HSO(3)(-)##3##3##(2008-10#3)
oxidation of N##6##3##(2008-10#6)
oxidation of N-(3-sulfopropyl)-3##2##3##(2008-10#2)
oxidation of NO##4##3##(2008-10#4)
oxidation of a##3##3##(2008-10#3)
oxidation of ammonia to nitrite##2##5##(2008-10#2)
oxidation of ammonia with##2##4##(2008-10#2)
oxidation of ammonia##4##3##(2008-10#4)
oxidation of ascorbate##2##3##(2008-10#2)
oxidation of ascorbic acid##3##4##(2008-10#3)
oxidation of benzoyl hydrazine##2##4##(2008-10#2)
oxidation of cisatracurium##2##3##(2008-10#2)
oxidation of etodolac##3##3##(2008-10#3)
oxidation of glucose in the presence of##2##7##(2008-10#2)
oxidation of glucose##3##3##(2008-10#3)
oxidation of hydrazine at##2##4##(2008-10#2)
oxidation of hydrazine##5##3##(2008-10#5)
oxidation of hydrogen peroxide##3##4##(2008-10#3)
oxidation of leuco##2##3##(2008-10#2)
oxidation of luminol by##3##4##(2008-10#3)
oxidation of luminol##7##3##(2008-10#7)
oxidation of mercury in methyl ethyl ketone##2##7##(2008-10#2)
oxidation of mercury##3##3##(2008-10#3)
oxidation of nitrite ion##5##4##(2008-10#5)
oxidation of paracetamol##2##3##(2008-10#2)
oxidation of phenols##2##3##(1994-5#2)
oxidation of purpurogallin##2##3##(2008-10#2)
oxidation of pyrogallol##3##3##(2008-10#3)
oxidation of resveratrol##2##3##(2008-10#2)
oxidation of the##23##3##(1994-5#1)(2008-10#18)(2008-11#1)(2008-8#2)(2009-9#1)
oxidation of these compounds##2##4##(2008-10#2)
oxidation of these##3##3##(2008-10#3)
oxidation of this##2##3##(2008-10#2)
oxidation of##238##2##(1990-5#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-9#2)(1994-5#5)(1994-8#1)(1995-2#1)(1995-5#1)(1996-5#1)(2008-10#203)(2008-11#4)(2008-12#1)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
oxidation peak at 0##2##4##(2008-10#2)
oxidation peak current##3##3##(2008-10#3)
oxidation peak was##3##3##(2008-10#3)
oxidation peak##19##2##(2008-10#19)
oxidation peaks of##2##3##(2008-10#2)
oxidation peaks##6##2##(2008-10#6)
oxidation potential of##3##3##(2008-10#3)
oxidation potential##9##2##(1996-5#1)(2008-10#8)
oxidation process##7##2##(2008-10#7)
oxidation product of##3##3##(2008-10#3)
oxidation product##5##2##(2008-10#4)(2008-5#1)
oxidation products##6##2##(2008-10#5)(2008-11#1)
oxidation rate##3##2##(1994-5#2)(2008-10#1)
oxidation reaction of##14##3##(2008-10#14)
oxidation reaction with##2##3##(2008-10#2)
oxidation reaction##21##2##(2008-10#21)
oxidation sensitized by##2##3##(2008-10#2)
oxidation signal##2##2##(2008-10#2)
oxidation state of##6##3##(2008-10#6)
oxidation state##16##2##(1993-8#1)(2008-10#15)
oxidation states##14##2##(1993-8#1)(1994-5#1)(2008-10#11)(2012-2#1)
oxidation step##4##2##(2008-10#3)(2012-3#1)
oxidation to##5##2##(1996-5#1)(2008-10#3)(2008-11#1)
oxidation wave of the##2##4##(2008-10#2)
oxidation wave##3##2##(2008-10#3)
oxidation with N-bromosuccinimide##2##3##(2008-10#2)
oxidation with##8##2##(2008-10#8)
oxidation##528##1##(1990-5#2)(1990-9#1)(1991-12#4)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-5#9)(1994-8#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-5#5)(2008-1#2)(2008-10#420)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#14)(2008-6#4)(2008-8#4)(2008-9#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-4#2)(2010-7#4)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#4)
oxidation-reduction reactions##2##2##(2008-10#2)
oxidation-reduction##3##1##(1995-8#1)(2008-10#2)
oxidation/reduction##2##1##(1991-5#1)(2008-10#1)
oxidations##3##1##(2008-4#1)(2008-5#2)
oxidative DNA damage##2##3##(2008-10#2)
oxidative and##2##2##(2008-11#2)
oxidative burst in##4##3##(1995-6#1)(2008-10#3)
oxidative burst##15##2##(1995-6#7)(2008-10#7)(2008-9#1)
oxidative changes##2##2##(1994-5#1)(2009-9#1)
oxidative cleavage##3##2##(1994-8#2)(2013-1#1)
oxidative coupling##10##2##(2008-10#10)
oxidative damage and##2##3##(1995-6#2)
oxidative damage is##2##3##(2010-12#1)(2013-1#1)
oxidative damage of##2##3##(1992-9#1)(2008-10#1)
oxidative damage to##2##3##(1992-12#1)(2008-10#1)
oxidative damage##16##2##(1992-12#1)(1992-9#1)(1995-6#2)(1997-8#1)(2008-10#5)(2008-5#1)(2010-12#1)(2013-1#2)(2013-8#2)
oxidative damages##2##2##(1995-8#1)(2008-10#1)
oxidative decomposition##2##2##(2008-10#2)
oxidative degradation of##3##3##(2008-10#3)
oxidative degradation##4##2##(2008-10#3)(2013-1#1)
oxidative effects##2##2##(2008-5#2)
oxidative fermentation##3##2##(2011-2#3)
oxidative inactivation##2##2##(1992-12#2)
oxidative injury##2##2##(1997-3#1)(2013-7#1)
oxidative metabolism##4##2##(1994-2#2)(2008-10#1)(2008-9#1)
oxidative metabolites##2##2##(2008-10#1)(2011-3#1)
oxidative modification of LDL##3##4##(2008-10#2)(2009-8#1)
oxidative modification of##5##3##(1991-5#1)(2008-10#2)(2009-8#2)
oxidative modification##12##2##(1991-12#3)(1991-5#1)(1994-11#3)(2008-10#2)(2009-8#3)
oxidative modifications of lipids##2##4##(2009-8#2)
oxidative modifications of##4##3##(2009-8#4)
oxidative modifications##7##2##(2009-8#7)
oxidative phosphorylation##8##2##(1990-2#3)(1991-5#1)(1997-7#1)(2008-7#2)(2013-8#1)
oxidative pressure##2##2##(2010-5#1)(2012-6#1)
oxidative reaction of##4##3##(2008-10#4)
oxidative reaction##5##2##(2008-10#5)
oxidative stress and the##2##4##(2008-10#1)(2008-11#1)
oxidative stress and##13##3##(1992-9#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2012-5#2)
oxidative stress in plasma##2##4##(1993-2#1)(2013-1#1)
oxidative stress in the##2##4##(2009-10#1)(2010-12#1)
oxidative stress in##10##3##(1993-2#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#2)(2012-5#1)(2013-1#1)
oxidative stress induced##2##3##(2008-10#1)(2012-3#1)
oxidative stress involved in##2##4##(2008-10#1)(2013-1#1)
oxidative stress is##2##3##(1995-6#1)(2009-9#1)
oxidative stress markers##3##3##(2010-5#1)(2012-5#2)
oxidative stress of tumor cells##2##5##(2008-11#2)
oxidative stress##82##2##(1991-12#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-6#2)(2008-10#19)(2008-11#8)(2008-5#7)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#3)(2011-2#2)(2011-3#2)(2012-2#3)(2012-3#2)(2012-5#5)(2013-1#3)(2013-8#1)
oxidative##230##1##(1990-11#1)(1990-2#3)(1991-12#4)(1991-5#2)(1992-12#4)(1992-6#1)(1992-9#2)(1993-2#1)(1993-8#2)(1994-11#3)(1994-2#2)(1994-5#1)(1994-8#4)(1995-6#12)(1995-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#77)(2008-11#10)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#6)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#13)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#4)(2010-5#4)(2010-7#1)(2010-9#1)(2011-2#7)(2011-3#3)(2012-2#4)(2012-3#2)(2012-5#5)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#4)
oxidatively damaged##3##2##(1995-2#2)(1997-8#1)
oxide (ITO)##4##2##(2008-10#3)(2008-12#1)
oxide (NO) is##4##3##(2008-10#2)(2009-10#1)(2010-7#1)
oxide (NO) production##5##3##(1994-11#1)(1995-11#1)(2008-10#1)(2010-4#1)(2012-3#1)
oxide (NO)##39##2##(1992-12#2)(1992-5#1)(1993-8#1)(1994-11#1)(1995-11#3)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
oxide (TOPO)##3##2##(2008-10#3)
oxide and the##2##3##(2008-10#1)(2008-11#1)
oxide and##21##2##(1996-2#1)(2008-10#13)(2008-11#3)(2008-7#1)(2009-10#1)(2011-2#1)(2012-3#1)
oxide as##6##2##(2008-10#6)
oxide at##2##2##(2008-10#2)
oxide film##3##2##(2008-10#2)(2009-7#1)
oxide gas##2##2##(2009-12#2)
oxide has been##2##3##(2008-10#2)
oxide in##8##2##(1991-6#1)(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
oxide is##4##2##(2008-10#2)(2008-12#1)(2008-2#1)
oxide layer##3##2##(2008-10#3)
oxide layers##2##2##(2008-10#2)
oxide nanoparticles##5##2##(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
oxide particles##2##2##(2008-10#1)(2008-3#1)
oxide stimulates the ADP-ribosylation of##2##5##(1993-3#2)
oxide stimulates##3##2##(1993-3#2)(1994-8#1)
oxide surfaces##2##2##(1990-11#1)(2008-10#1)
oxide using##4##2##(2008-10#4)
oxide was##4##2##(1992-6#1)(2008-10#2)(2008-12#1)
oxide with##5##2##(2008-10#4)(2008-3#1)
oxide##305##1##(1990-11#1)(1990-3#1)(1991-6#5)(1992-12#4)(1992-3#3)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-3#7)(1993-5#1)(1993-8#4)(1994-11#2)(1994-8#3)(1995-11#6)(1995-12#1)(1995-2#1)(1996-12#5)(1996-2#2)(1996-5#2)(1996-6#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#138)(2008-11#11)(2008-12#9)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#8)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#4)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#2)
oxide)##6##1##(2008-10#5)(2008-11#1)
oxide-mediated##3##1##(1992-6#2)(2008-7#1)
oxides and##4##2##(2008-10#3)(2008-3#1)
oxides have been##2##3##(2008-10#1)(2012-2#1)
oxides in the##3##3##(2008-10#3)
oxides##32##1##(1991-6#2)(2008-10#22)(2008-3#1)(2008-5#3)(2010-4#1)(2012-2#3)
oxidimetric##2##1##(2008-10#1)(2008-11#1)
oxidisable##2##1##(2008-10#2)
oxidised by##4##2##(1991-12#1)(2008-10#3)
oxidised##16##1##(1990-5#1)(1991-12#1)(2008-10#13)(2008-11#1)
oxidises##3##1##(2008-10#3)
oxidising##3##1##(2008-10#3)
oxidizable amino acids##3##3##(2008-10#3)
oxidizable molecules##2##2##(2008-10#2)
oxidizable species such as##2##4##(2008-10#2)
oxidizable species##5##2##(2008-10#5)
oxidizable##14##1##(2008-10#14)
oxidization of##2##2##(2008-10#2)
oxidization##3##1##(2008-10#3)
oxidize##4##1##(2008-10#3)(2011-2#1)
oxidized LDL##10##2##(1990-8#1)(1996-2#4)(1997-8#1)(2009-8#2)(2010-3#1)(2013-7#1)
oxidized Pdx##3##2##(1994-5#3)
oxidized and reduced##4##3##(1992-9#1)(2008-10#1)(2009-7#2)
oxidized and##7##2##(1992-3#1)(1992-9#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-7#2)
oxidized at##2##2##(2008-10#2)
oxidized by H(2)O(2) system containing Cu(2+)##2##6##(2008-10#2)
oxidized by##13##2##(1992-6#1)(2008-10#11)(2009-8#1)
oxidized form of##3##3##(1992-1#1)(2008-10#2)
oxidized form##5##2##(1992-1#1)(2008-10#3)(2008-11#1)
oxidized glutathione##2##2##(2008-11#2)
oxidized in##2##2##(2008-10#2)
oxidized low density lipoprotein##2##4##(1995-2#2)
oxidized manganese##2##2##(2008-10#2)
oxidized mitochondrial pyridine nucleotides##2##4##(1994-8#2)
oxidized on##2##2##(2008-10#2)
oxidized product##2##2##(2008-10#2)
oxidized species##2##2##(2008-10#2)
oxidized to nitrate##2##3##(2008-10#2)
oxidized to##16##2##(1992-3#1)(2008-10#14)(2008-11#1)
oxidized with##5##2##(2008-10#5)
oxidized##111##1##(1990-8#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-5#7)(1994-8#2)(1995-2#4)(1996-2#6)(1997-8#1)(2008-10#61)(2008-11#9)(2008-3#1)(2008-5#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
oxidizes the##3##2##(1991-7#1)(2008-10#2)
oxidizes##5##1##(1991-7#1)(2008-10#4)
oxidizing agent is used##2##4##(2008-10#2)
oxidizing agent to##2##3##(2008-10#2)
oxidizing agent##13##2##(1996-5#1)(2008-10#11)(2012-3#1)
oxidizing agents##2##2##(2008-10#2)
oxidizing and##2##2##(2008-10#1)(2010-4#1)
oxidizing##27##1##(1996-5#1)(2008-10#23)(2008-5#1)(2010-4#1)(2012-3#1)
oxidoreductase##15##1##(1990-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-6#2)(2009-9#2)
oxidoreductases##2##1##(1994-6#1)(2009-9#1)
oxidoreduction##2##1##(1994-6#2)
oxime##3##1##(2008-10#2)(2013-1#1)
oximeter##2##1##(1993-1#1)(2013-1#1)
oximetry##6##1##(1993-1#4)(1997-1#1)(2009-5#1)
oxinate##2##1##(2008-10#2)
oxine and##2##2##(2008-10#2)
oxine##5##1##(2008-10#5)
oxine-impregnated##2##1##(2008-10#2)
oxo-arsenosugar-phosphate##2##1##(2008-10#2)
oxocarbenium ion##2##2##(1992-12#1)(2009-8#1)
oxoiron(IV)##4##1##(2012-12#4)
oxy-PAH##2##1##(2008-11#2)
oxy-sporum##2##1##(2008-10#2)
oxyR function##2##2##(2008-9#2)
oxyR##3##1##(2008-9#3)
oxybenzone and##2##2##(2008-5#2)
oxybenzone##5##1##(2008-5#5)
oxybutynin##3##1##(2008-10#3)
oxychlorination##2##1##(2009-8#2)
oxychlorine species with chloride in the potential buffer##2##8##(2008-10#2)
oxychlorine species##5##2##(2008-10#5)
oxycocci and##2##2##(2008-10#2)
oxycocci##4##1##(2008-10#4)
oxyethylene units##3##2##(2008-10#3)
oxyethylene##4##1##(2008-10#4)
oxygen (1O2)##3##2##(1992-9#1)(2008-5#2)
oxygen (O2)##2##2##(2011-1#1)(2013-8#1)
oxygen A-band absorption##2##3##(2008-2#2)
oxygen after##2##2##(1993-1#1)(1994-3#1)
oxygen and##23##2##(1993-1#2)(1994-3#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-7#2)(2009-8#2)(2011-2#2)
oxygen as the##2##3##(2008-3#2)
oxygen as##4##2##(2008-10#1)(2008-3#2)(2010-4#1)
oxygen at##3##2##(1994-8#1)(2008-11#1)(2012-12#1)
oxygen atom of##5##3##(1991-3#1)(1993-8#1)(1996-5#2)(2008-8#1)
oxygen atoms##3##2##(1990-9#1)(1996-12#1)(2011-2#1)
oxygen availability##2##2##(2008-7#1)(2013-8#1)
oxygen binding##5##2##(1990-8#1)(1993-8#2)(1994-5#1)(2010-11#1)
oxygen carriers##2##2##(2008-10#1)(2008-11#1)
oxygen concentration##5##2##(2008-10#3)(2008-7#1)(2011-2#1)
oxygen consumption by##2##3##(1997-1#1)(2008-5#1)
oxygen consumption in the##2##4##(1995-6#1)(1997-1#1)
oxygen consumption in##3##3##(1995-6#1)(1997-1#2)
oxygen consumption##16##2##(1991-3#1)(1995-6#1)(1996-3#1)(1997-1#4)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#2)(2013-8#3)
oxygen content##2##2##(2008-10#2)
oxygen deficiency##2##2##(1992-5#1)(1995-11#1)
oxygen delivery and##2##3##(1996-3#1)(2010-11#1)
oxygen delivery in##2##3##(1996-3#1)(2012-3#1)
oxygen delivery to the tissues##2##5##(1996-3#1)(2010-7#1)
oxygen delivery##6##2##(1996-3#3)(2010-11#1)(2010-7#1)(2012-3#1)
oxygen demand (BOD)##2##3##(2008-10#2)
oxygen demand##14##2##(2008-10#14)
oxygen demands##2##2##(1991-3#1)(2008-11#1)
oxygen desaturation (SpO2##2##3##(1993-1#2)
oxygen electrode##5##2##(1995-3#1)(2008-10#4)
oxygen flow##2##2##(2008-10#1)(2010-10#1)
oxygen for##3##2##(1993-1#1)(2008-11#1)(2012-3#1)
oxygen free##2##2##(1995-8#1)(2011-3#1)
oxygen in the##3##3##(2008-10#2)(2008-3#1)
oxygen in##12##2##(2008-10#9)(2008-3#1)(2012-12#2)
oxygen is##2##2##(2008-10#2)
oxygen level##4##2##(1996-3#1)(2008-10#2)(2011-2#1)
oxygen levels##2##2##(2009-11#1)(2010-7#1)
oxygen metabolism##4##2##(2008-10#1)(2008-5#1)(2008-7#2)
oxygen molecule##2##2##(1993-8#1)(2008-10#1)
oxygen molecules##2##2##(1990-8#2)
oxygen on the##2##3##(2008-10#2)
oxygen on##4##2##(2008-10#3)(2008-9#1)
oxygen or##3##2##(1994-5#1)(2008-11#1)(2008-9#1)
oxygen partial pressure##8##3##(2008-11#6)(2010-8#1)(2013-8#1)
oxygen partial##9##2##(1990-8#1)(2008-11#6)(2010-8#1)(2013-8#1)
oxygen plus##2##2##(2011-2#2)
oxygen pressure##4##2##(2008-11#1)(2010-10#1)(2013-1#2)
oxygen quenching of##2##3##(2008-10#2)
oxygen radicals and##2##3##(1993-8#1)(2010-7#1)
oxygen radicals##8##2##(1990-5#1)(1993-8#1)(1994-11#1)(1995-8#1)(2008-5#1)(2008-8#2)(2010-7#1)
oxygen removal##2##2##(2008-10#2)
oxygen saturation##12##2##(1993-1#2)(1996-3#1)(2009-11#1)(2010-10#4)(2010-7#2)(2010-8#1)(2012-2#1)
oxygen scavenger to##2##3##(2008-10#2)
oxygen sensing##8##2##(2008-10#7)(2008-11#1)
oxygen sensor was##2##3##(2008-10#2)
oxygen sensor##3##2##(2008-10#3)
oxygen species (ROS)##29##3##(1994-5#1)(1994-6#1)(2008-10#6)(2008-11#5)(2008-5#1)(2008-9#1)(2009-8#5)(2010-1#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-2#2)(2012-6#1)
oxygen species in##5##3##(1994-6#1)(1995-8#1)(2008-7#1)(2009-8#1)(2010-10#1)
oxygen species##62##2##(1992-12#1)(1992-9#1)(1994-5#1)(1994-6#2)(1995-8#1)(2008-1#1)(2008-10#15)(2008-11#10)(2008-5#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#6)(2010-1#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-2#3)(2012-6#1)(2013-8#2)
oxygen supply##5##2##(1996-3#2)(2008-11#1)(2008-9#1)(2011-1#1)
oxygen tension of##2##3##(2008-11#1)(2011-2#1)
oxygen tension##9##2##(1997-3#1)(2008-11#3)(2008-7#2)(2008-9#1)(2011-2#2)
oxygen therapy##3##2##(1991-6#1)(2010-10#1)(2011-2#1)
oxygen to##4##2##(1993-3#1)(1995-2#1)(2008-10#1)(2008-3#1)
oxygen transfer##6##2##(2008-11#4)(2008-7#2)
oxygen uptake and carbon dioxide production rates##3##7##(2008-11#3)
oxygen uptake and carbon dioxide##6##5##(2008-11#6)
oxygen uptake and##8##3##(2008-11#6)(2008-7#1)(2013-8#1)
oxygen uptake between the estimation and production##2##7##(2013-8#2)
oxygen uptake in##2##3##(2008-12#1)(2013-8#1)
oxygen uptake rate (OUR)##2##4##(2008-11#1)(2008-7#1)
oxygen uptake rate##5##3##(2008-11#4)(2008-7#1)
oxygen uptake##35##2##(2008-10#1)(2008-11#12)(2008-12#1)(2008-7#3)(2013-1#1)(2013-8#17)
oxygen utilization##5##2##(1990-5#3)(2008-7#1)(2012-2#1)
oxygen was##2##2##(2008-10#1)(2012-12#1)
oxygen with##4##2##(2008-10#3)(2008-11#1)
oxygen##494##1##(1990-12#2)(1990-5#8)(1990-8#6)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#11)(1993-3#4)(1993-6#2)(1993-8#9)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-12#4)(1996-3#9)(1996-5#5)(1997-1#5)(1997-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#162)(2008-11#54)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#8)(2008-7#24)(2008-8#4)(2008-9#8)(2009-11#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#9)(2010-1#2)(2010-10#8)(2010-11#5)(2010-4#4)(2010-5#1)(2010-7#5)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#19)(2011-3#1)(2012-12#8)(2012-2#7)(2012-3#5)(2012-6#1)(2013-1#4)(2013-8#26)
oxygen)##3##1##(1993-8#1)(2008-10#2)
oxygen-17##7##1##(1990-5#7)
oxygen-binding##2##1##(1990-8#1)(2010-4#1)
oxygen-dependent##2##1##(1991-3#1)(1993-6#1)
oxygen-derived free radicals and##2##4##(1995-8#1)(2008-10#1)
oxygen-derived free radicals are##2##4##(2010-10#2)
oxygen-derived free radicals##4##3##(1995-8#1)(2008-10#1)(2010-10#2)
oxygen-derived##5##1##(1995-8#1)(1996-2#1)(2008-10#1)(2010-10#2)
oxygen-evolving activity of##2##3##(1997-4#2)
oxygen-evolving center##2##2##(2008-8#2)
oxygen-evolving##4##1##(1997-4#2)(2008-8#2)
oxygen-rich##4##1##(2008-10#1)(2008-11#2)(2011-2#1)
oxygen-sensitive dye ion-pair##2##3##(2008-10#2)
oxygen-sensitive##6##1##(1997-1#1)(2008-10#5)
oxygen-sensitivity of optical sensor using pyrene carboxylic acid##2##8##(2008-10#2)
oxygen-sensitivity##3##1##(2008-10#3)
oxygenase##5##1##(1994-11#1)(1994-5#2)(1995-2#1)(2010-10#1)
oxygenated##9##1##(1990-8#1)(1991-3#1)(2008-10#1)(2008-11#3)(2008-12#2)(2011-2#1)
oxygenation and vascularization##2##3##(2008-11#2)
oxygenation and##6##2##(1994-6#3)(2008-11#2)(2010-7#1)
oxygenation##20##1##(1991-2#1)(1992-1#1)(1994-6#3)(1996-3#1)(2008-11#5)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-3#3)
oxygenation)##2##1##(2008-10#1)(2008-11#1)
oxygenic photosynthesis##2##2##(1995-6#1)(1996-12#1)
oxyhalides and##3##2##(2008-10#3)
oxyhalides##4##1##(2008-10#4)
oxyhemoglobin##5##1##(1990-8#2)(1993-1#1)(2008-11#2)
oxymatrine##3##1##(2008-10#2)(2013-8#1)
oxymetazoline and##3##2##(1995-11#1)(2008-10#2)
oxymetazoline##7##1##(1995-11#5)(2008-10#2)
oxysporum Fo 90105##2##3##(2008-10#2)
oxysporum and F##3##3##(2008-10#3)
oxysporum and##9##2##(2008-10#9)
oxysporum based on##2##3##(2008-10#2)
oxysporum complex was##2##3##(2008-10#2)
oxysporum complex##5##2##(2008-10#5)
oxysporum expressing##2##2##(2008-10#2)
oxysporum f##181##2##(2008-10#181)
oxysporum from##5##2##(2008-10#5)
oxysporum in##4##2##(2008-10#4)
oxysporum isolates##4##2##(2008-10#4)
oxysporum strain##2##2##(2008-10#2)
oxysporum were##3##2##(2008-10#3)
oxysporum##260##1##(2008-10#260)
oxysterols##3##1##(1993-6#3)
oxytetracycline (OTC)##3##2##(2008-10#3)
oxytetracycline and##4##2##(1996-6#2)(2008-10#2)
oxytetracycline treatment##2##2##(1996-6#2)
oxytetracycline##16##1##(1991-3#2)(1996-6#5)(2008-10#9)
oxytoca##2##1##(2010-6#2)
oxytocin and angiotensin##3##3##(1994-3#3)
oxytocin and##5##2##(1994-3#3)(1997-4#2)
oxytocin##17##1##(1994-3#3)(1996-11#1)(1996-12#3)(1997-4#7)(2008-4#2)(2008-5#1)
oyster tissue##4##2##(2008-10#4)
oyster##8##1##(2008-10#5)(2008-11#2)(2008-7#1)
ozonation and##2##2##(1992-5#2)
ozonation process##2##2##(2008-10#2)
ozonation##11##1##(1992-5#2)(2008-10#8)(2008-9#1)
ozone and##2##2##(2008-10#1)(2008-11#1)
ozone as##3##2##(2008-10#2)(2008-3#1)
ozone concentration##3##2##(2008-10#2)(2008-3#1)
ozone depletion##4##2##(1991-5#1)(1991-6#1)(1992-3#1)(1996-1#1)
ozone in##5##2##(2007-12#1)(2008-10#3)(2008-11#1)
ozone is##3##2##(2008-10#3)
ozone layer and##2##3##(1991-6#2)
ozone layer##6##2##(1991-6#3)(1996-1#3)
ozone levels##2##2##(2008-10#1)(2008-11#1)
ozone losses##2##2##(1991-5#2)
ozone measurements in clouds##2##4##(2008-3#2)
ozone measurements in##3##3##(2008-3#3)
ozone measurements##4##2##(2008-3#4)
ozone monitoring##4##2##(2008-10#3)(2008-3#1)
ozone profile##2##2##(2008-2#2)
ozone profiles##3##2##(2008-2#3)
ozone##85##1##(1991-12#1)(1991-5#6)(1991-6#4)(1992-3#1)(1995-3#1)(1996-1#8)(2007-12#1)(2007-8#6)(2008-10#35)(2008-11#8)(2008-2#6)(2008-3#8)
ozone-column density##3##2##(2008-3#3)
ozonide##2##1##(1996-5#2)
ozonides##7##1##(1996-5#7)
ozonolysis of norbornene derivatives##2##4##(1996-5#2)
p &gt##3##2##(2011-2#2)(2013-8#1)
p &lt##96##2##(1992-12#2)(1993-3#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-3#5)(1997-1#1)(2008-1#4)(2008-10#6)(2008-11#5)(2008-12#5)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#6)(2009-5#1)(2009-6#3)(2009-8#5)(2010-2#4)(2010-8#7)(2011-2#8)(2012-3#5)(2013-1#9)(2013-8#9)
p -/+ 0##2##3##(2008-11#2)
p 1##5##2##(2012-2#5)
p = 0##59##3##(1991-8#4)(1992-2#1)(1993-2#6)(1996-1#1)(2008-10#1)(2008-11#6)(2008-5#3)(2008-9#1)(2010-2#1)(2010-9#3)(2011-2#26)(2012-3#1)(2013-1#1)(2013-8#4)
p =##67##2##(1991-8#4)(1992-2#1)(1993-2#6)(1996-1#1)(2008-10#2)(2008-11#8)(2008-5#3)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-9#3)(2011-2#26)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#4)
p K (a##4##3##(2008-10#4)
p and the##2##3##(2008-10#1)(2010-8#1)
p and##5##2##(1996-12#1)(2008-10#3)(2010-8#1)
p less than 0##12##4##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1991-11#3)(1992-12#3)
p less than##16##3##(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1991-11#3)(1992-12#3)
p of##3##2##(2008-10#2)(2008-3#1)
p values &lt##3##3##(2008-3#2)(2011-2#1)
p values##5##2##(1995-1#1)(2008-10#1)(2008-3#2)(2011-2#1)
p ≤ 0##3##3##(2013-8#3)
p ≥ 0##2##3##(2013-8#2)
p##358##1##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#3)(1991-2#2)(1991-8#5)(1992-12#10)(1992-2#1)(1992-8#2)(1993-2#6)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#4)(1994-6#1)(1994-8#8)(1995-1#1)(1995-11#3)(1995-12#2)(1996-1#3)(1996-12#4)(1996-2#18)(1996-3#5)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#6)(2008-1#4)(2008-10#34)(2008-11#27)(2008-12#12)(2008-3#5)(2008-5#13)(2008-7#9)(2008-9#8)(2009-3#2)(2009-5#3)(2009-6#4)(2009-8#5)(2010-1#3)(2010-11#1)(2010-12#1)(2010-2#5)(2010-5#1)(2010-7#2)(2010-8#8)(2010-9#3)(2011-2#43)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#13)(2013-8#19)
p&gt##4##1##(2009-1#1)(2011-1#2)(2013-1#1)
p&lt##61##1##(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#5)(2009-7#2)(2009-8#1)(2010-6#13)(2010-9#4)(2011-1#6)(2011-2#2)(2012-2#1)(2013-1#11)(2013-8#3)
p'-DBP)##2##1##(2008-10#2)
p'-DDT and##3##2##(2008-11#3)
p'-DDT##5##1##(2008-10#1)(2008-11#4)
p'-DDT)##2##1##(2008-10#2)
p(low)##5##1##(2008-10#5)
p(m(H)) values##2##2##(2008-10#2)
p(t)##3##1##(2008-10#3)
p(tPA/PAZoA)##2##1##(2008-10#2)
p)##3##1##(2009-9#1)(2010-1#1)(2013-1#1)
p-(dimethylamino)benzaldehyde (DAB) and p-nitrobenzaldehyde (NB)##2##5##(2008-10#2)
p-CPA##2##1##(1993-3#2)
p-aminoacetophenone##3##1##(2008-10#3)
p-aminobenzenesulfonate)-thiourea##2##1##(2008-10#2)
p-aminobenzoate in##2##2##(2008-10#2)
p-aminobenzoate##4##1##(2008-10#3)(2012-3#1)
p-aminobenzoic acid##3##2##(2008-10#3)
p-aminophenol##8##1##(1995-11#1)(2008-10#7)
p-benzoquinone (PBQ)##2##2##(2008-10#2)
p-benzoquinone##5##1##(2008-10#5)
p-bromophenacyl##2##1##(1994-3#1)(2009-8#1)
p-chloranil##2##1##(2008-10#2)
p-coumaric acid and##2##3##(2008-10#2)
p-coumaric acid##4##2##(2008-10#3)(2008-11#1)
p-coumaric##5##1##(2008-10#4)(2008-11#1)
p-cresol##6##1##(1990-8#1)(1991-5#3)(2008-10#2)
p-cyclophane as##2##2##(2008-10#2)
p-cymene##2##1##(2008-11#1)(2012-2#1)
p-dichlorobenzene##2##1##(2008-10#2)
p-dimethylaminobenzalhyde##2##1##(2008-10#2)
p-hydroxy-m-methoxyscopolamine##2##1##(2008-10#2)
p-hydroxybenzoic##2##1##(2008-10#2)
p-iodophenol##3##1##(2008-10#3)
p-methoxyanilino-(1##2##1##(2008-10#2)
p-nitrobenzoxosulfamate##2##1##(2008-10#2)
p-nitrophenol##5##1##(2008-10#1)(2008-8#2)(2009-8#2)
p-nitrophenyl##3##1##(2008-10#2)(2011-1#1)
p-nitrophenylphosphate##3##1##(1994-6#1)(2008-10#2)
p-polarized##4##1##(1993-5#1)(2007-11#2)(2007-12#1)
p-quinone##2##1##(2008-10#2)
p-t-butyl calix[4]arene and ethyl bromoacetate##2##5##(2008-10#2)
p-tert-butyl-calix[6]arene-bonded silica gel stationary phase##2##5##(2008-10#2)
p-tert-butyl-calix[8]arene##2##1##(2008-10#2)
p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##6##5##(2008-10#6)
p-tert-butylcalix[4]arene-oxacrown-4##3##1##(2008-10#3)
p-toluenesulfonic acid##3##2##(1996-5#1)(2008-10#2)
p-toluenesulfonic##4##1##(1996-5#1)(2008-10#3)
p-type##2##1##(2008-10#1)(2012-2#1)
p-value##2##1##(2012-3#1)(2013-1#1)
p-xylene##5##1##(2008-10#5)
p1##2##1##(2008-9#2)
p101 and##2##2##(1996-2#2)
p101##4##1##(1996-2#4)
p117 and##2##2##(1996-2#2)
p120##4##1##(1996-2#4)
p130Cas SD tyrosine phosphorylation##2##4##(2011-1#2)
p130Cas##9##1##(2011-1#9)
p150Glued##9##1##(1995-2#9)
p16##4##1##(1997-7#3)(2012-3#1)
p16(INK4A)##7##1##(2013-1#7)
p16INK4A##7##1##(1997-7#7)
p16INK4a and p16beta transcripts in B-lymphoblastoid cells from##2##8##(1997-7#2)
p16INK4a and p16beta transcripts##3##4##(1997-7#3)
p16INK4a##7##1##(1997-7#7)
p16beta##4##1##(1997-7#4)
p17##2##1##(1990-2#2)
p185HER2 overexpression##2##2##(1993-1#2)
p185HER2##4##1##(1993-1#4)
p185erbB2##3##1##(1995-2#3)
p20##6##1##(1990-5#1)(2008-10#2)(2008-9#3)
p21 and Gadd45##2##3##(2008-9#2)
p21 and##3##2##(2008-11#1)(2008-9#2)
p21 expression##2##2##(1995-6#1)(2011-2#1)
p21 repression##2##2##(1995-6#2)
p21##23##1##(1995-6#7)(1997-7#3)(2008-11#1)(2008-7#3)(2008-9#4)(2011-2#5)
p21(Sdi1/CIP1/WAF1)##2##1##(2008-11#2)
p21(as)/MCF-7##2##1##(2008-9#2)
p23##3##1##(2008-10#3)
p24##4##1##(1993-8#1)(1995-5#1)(1997-3#1)(2011-3#1)
p25##2##1##(1990-2#1)(2008-10#1)
p27##6##1##(2008-11#1)(2008-7#3)(2011-2#2)
p29##4##1##(1990-11#4)
p300##3##1##(2011-2#3)
p34cdc2##2##1##(1993-9#2)
p35##11##1##(1995-6#2)(1997-3#4)(2008-8#5)
p38 MAPK##2##2##(2008-11#1)(2010-1#1)
p38 kinase##2##2##(2011-2#2)
p38##15##1##(2008-11#1)(2008-7#1)(2010-1#1)(2010-10#1)(2011-2#7)(2012-2#3)(2013-7#1)
p38) and##2##2##(1996-2#1)(2012-2#1)
p38)##3##1##(1996-2#1)(2009-6#1)(2012-2#1)
p40 and p35 mRNA##5##4##(2008-8#5)
p40##7##1##(2008-8#6)(2008-9#1)
p42/p44##2##1##(1996-2#2)
p42mapk/erk2##2##1##(1995-2#2)
p43##2##1##(1990-5#2)
p44##2##1##(1995-6#2)
p47-phox##2##1##(1993-8#2)
p48(Cre/+)-LSL-Kras(G12D/+) mice##3##2##(2013-1#3)
p48(Cre/+)-LSL-Kras(G12D/+)##4##1##(2013-1#4)
p50##2##1##(1991-7#1)(1997-3#1)
p53 Abs were##3##3##(2011-2#3)
p53 Abs##6##2##(2011-2#6)
p53 and NF-B##4##3##(2010-10#4)
p53 and T antigen##2##4##(1993-8#2)
p53 and nuclear factor-B systems##2##5##(2010-10#2)
p53 and nuclear##3##3##(2010-10#3)
p53 and##23##2##(1991-2#1)(1993-8#3)(2008-10#1)(2008-9#2)(2010-10#7)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
p53 function##3##2##(1994-12#2)(1994-5#1)
p53 gene##6##2##(1993-11#2)(2007-11#1)(2008-10#3)
p53 haploinsufficient mice administered##2##4##(2008-9#2)
p53 haploinsufficient mice were exposed to##5##6##(2008-9#5)
p53 haploinsufficient mice were exposed##6##5##(2008-9#6)
p53 haploinsufficient mice were##8##4##(2008-9#8)
p53 haploinsufficient mice##15##3##(2008-9#15)
p53 haploinsufficient##16##2##(2008-9#16)
p53 has##3##2##(1993-8#1)(2008-9#1)(2011-2#1)
p53 in the##3##3##(1991-2#2)(2008-9#1)
p53 in##10##2##(1991-2#2)(1997-7#1)(2008-9#3)(2009-4#1)(2011-2#3)
p53 is##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
p53 level##2##2##(1997-7#2)
p53 mutations##6##2##(1990-12#3)(1994-12#1)(2011-2#2)
p53 or##3##2##(1993-8#1)(1994-12#1)(2010-10#1)
p53 protein is##2##3##(1991-2#2)
p53 protein##11##2##(1990-12#2)(1991-2#4)(1991-5#1)(1994-9#1)(2008-10#1)(2008-7#1)(2009-8#1)
p53 proteins##2##2##(1991-5#1)(2011-2#1)
p53 tumor suppressor##4##3##(1994-12#1)(1994-5#1)(1997-7#1)(2011-2#1)
p53 was##2##2##(2008-10#1)(2012-12#1)
p53 were##2##2##(2008-10#1)(2011-2#1)
p53##189##1##(1990-12#6)(1991-2#7)(1991-5#9)(1993-11#4)(1993-8#5)(1994-12#12)(1994-5#2)(1994-9#5)(1995-6#3)(1995-9#2)(1997-7#8)(1997-8#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-5#8)(2008-7#5)(2008-8#1)(2008-9#32)(2009-4#6)(2009-8#1)(2010-10#13)(2010-3#2)(2011-2#33)(2012-12#4)(2012-2#2)(2013-1#2)
p53-carrying##2##1##(2009-4#2)
p53-dependent##6##1##(1997-7#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
p53-independent apoptotic mechanism that operates in a committed##2##8##(1995-6#2)
p53-independent##5##1##(1995-6#3)(2013-1#2)
p53175P##3##1##(2008-7#3)
p55##2##1##(2008-10#1)(2008-11#1)
p63##2##1##(2010-3#1)(2011-2#1)
p65##7##1##(1995-6#5)(2012-2#2)
p67-phox##3##1##(1993-6#1)(1993-8#2)
p70/p85 ribosomal protein S6 kinase##2##5##(1996-2#2)
p72syk is##3##2##(1992-6#3)
p72syk##6##1##(1992-6#6)
p73 and##2##2##(2010-3#2)
p73##5##1##(2010-3#4)(2011-2#1)
p75##8##1##(1995-8#4)(1996-12#4)
p75(NTR)##2##1##(2008-7#2)
p75LNGFR##2##1##(1996-12#2)
p76##3##1##(1992-9#3)
p85##2##1##(1995-6#1)(1996-2#1)
p=0##48##1##(2008-10#11)(2008-11#3)(2008-4#1)(2008-7#3)(2009-7#2)(2010-6#1)(2011-1#5)(2011-2#14)(2012-3#2)(2013-1#3)(2013-8#3)
pAGluT##2##1##(2008-8#2)
pAN7-1##2##1##(1991-9#1)(2008-10#1)
pAS2##2##1##(2008-8#1)(2008-9#1)
pASMM##2##1##(2008-8#2)
pAb##2##1##(2008-10#2)
pBLCAT2##3##1##(1994-6#3)
pBR322 plasmid##2##2##(2008-11#1)(2013-1#1)
pBR322##5##1##(1990-11#1)(1990-5#1)(2008-11#1)(2008-8#1)(2013-1#1)
pBS##2##1##(1993-12#1)(2008-9#1)
pBmgp64Luc##3##1##(2008-11#3)
pCO(2) measurements##3##2##(2008-10#3)
pCO(2)##10##1##(2008-10#9)(2008-11#1)
pCO2 in##2##2##(2008-11#2)
pCO2##9##1##(2008-11#9)
pCOR2##3##1##(2008-10#3)
pCP##4##1##(2008-10#4)
pDC-TNF##2##1##(2008-8#2)
pDPRIS##2##1##(1997-3#2)
pEA29##7##1##(2008-10#7)
pEJ30##4##1##(2008-10#4)
pEP36##4##1##(2008-10#4)
pETH2##3##1##(2008-10#3)
pF##2##1##(2008-10#1)(2008-11#1)
pFFK##2##1##(2008-10#2)
pG101##2##1##(2008-10#2)
pGEM-T##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
pGP315##2##1##(1991-5#2)
pGPPVPS##2##1##(2008-10#2)
pGT-trp##2##1##(2008-10#2)
pH (5##2##2##(2008-10#1)(2008-6#1)
pH (7##2##2##(1990-8#1)(2013-1#1)
pH (D)##5##2##(1991-9#5)
pH 0##2##2##(2008-10#2)
pH 1 and##2##3##(2008-10#2)
pH 1##19##2##(1990-5#1)(1992-12#1)(2008-10#16)(2008-11#1)
pH 10##21##2##(2008-10#16)(2008-5#2)(2013-1#3)
pH 10)##2##2##(2008-10#2)
pH 11##2##2##(1992-12#1)(2008-10#1)
pH 11-12##2##2##(2008-10#2)
pH 12##13##2##(2008-10#10)(2008-11#2)(2008-8#1)
pH 2 and##3##3##(2008-10#3)
pH 2##46##2##(2008-10#45)(2013-1#1)
pH 3 and##2##3##(2008-10#2)
pH 3##56##2##(1992-12#2)(1997-2#1)(2008-10#52)(2008-5#1)
pH 4 and 6##3##4##(2008-10#1)(2008-5#2)
pH 4 and##5##3##(2008-10#2)(2008-12#1)(2008-5#2)
pH 4 or##3##3##(2008-10#2)(2012-9#1)
pH 4 solution##3##3##(1990-5#1)(2008-10#2)
pH 4##77##2##(1990-5#1)(1994-11#1)(1994-5#1)(1997-2#1)(2008-10#63)(2008-12#1)(2008-5#3)(2008-7#2)(2009-7#1)(2012-9#1)(2013-1#2)
pH 4-5##2##2##(2008-10#2)
pH 5 and##2##3##(2008-10#2)
pH 5##103##2##(1990-12#1)(1991-12#1)(1992-4#1)(1993-8#1)(1994-5#2)(1994-8#1)(2006-6#1)(2008-10#85)(2008-11#6)(2008-6#1)(2009-10#1)(2009-8#1)(2011-2#1)
pH 5-6##3##2##(2008-10#3)
pH 6 and##2##3##(1990-8#1)(2008-7#1)
pH 6##65##2##(1990-5#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-8#1)(1996-2#1)(1997-2#1)(2008-10#48)(2008-11#2)(2008-5#2)(2008-7#1)(2011-2#2)(2011-3#1)
pH 6-7##2##2##(2008-10#1)(2010-4#1)
pH 6-8##3##2##(1994-8#1)(2008-10#2)
pH 7 and##5##3##(1992-4#1)(1994-5#1)(2008-10#2)(2013-1#1)
pH 7##121##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1992-10#2)(1992-3#2)(1992-4#1)(1993-8#7)(1994-5#2)(1994-8#2)(2008-10#83)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#2)(2013-1#1)
pH 8 and##2##3##(2008-10#2)
pH 8##48##2##(1990-5#1)(1993-8#1)(1996-12#1)(2008-10#40)(2008-11#2)(2008-6#2)(2012-2#1)
pH 9##35##2##(1990-8#1)(1992-12#1)(1994-11#1)(2008-10#27)(2008-7#1)(2008-9#1)(2009-3#2)(2013-8#1)
pH = 3##2##3##(2008-10#2)
pH = 7##2##3##(2008-12#1)(2008-5#1)
pH =##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2009-11#1)
pH accuracy##2##2##(2008-10#2)
pH adjusted to##2##3##(2008-10#2)
pH adjusted##4##2##(2008-10#3)(2012-2#1)
pH adjustment##4##2##(1990-5#1)(2008-10#3)
pH and available##2##3##(2008-10#2)
pH and calcium##2##3##(2008-5#1)(2008-9#1)
pH and column temperature##2##4##(2008-10#2)
pH and concentration##2##3##(2008-10#2)
pH and flow rate##5##4##(2008-10#5)
pH and flow##6##3##(2008-10#6)
pH and increasing##2##3##(2008-10#1)(2008-5#1)
pH and incubation time##2##4##(2008-10#1)(2010-5#1)
pH and ionic strength of the##3##6##(2008-10#3)
pH and ionic strength##5##4##(2008-10#4)(2008-7#1)
pH and osmolarity##2##3##(2008-11#2)
pH and phosphate concentration of##2##5##(2008-10#2)
pH and sample volume##2##4##(2008-10#2)
pH and sample##4##3##(2008-10#4)
pH and supporting electrolyte##2##4##(2008-10#2)
pH and temperature##14##3##(1993-8#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-6#1)
pH and that##2##3##(1993-6#1)(2008-10#1)
pH and the##11##3##(2008-10#11)
pH and time of##2##4##(2008-10#2)
pH and##121##2##(1991-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#3)(1996-12#1)(2008-10#88)(2008-11#8)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
pH are##5##2##(2008-10#2)(2008-5#3)
pH around##2##2##(2008-10#1)(2008-7#1)
pH at 7##2##3##(2008-10#1)(2008-11#1)
pH at##7##2##(1990-2#1)(2008-10#5)(2008-11#1)
pH below##2##2##(2008-10#2)
pH between##3##2##(2008-10#1)(2008-5#2)
pH by##2##2##(2008-10#2)
pH change from##2##3##(1993-8#1)(2008-10#1)
pH change was##2##3##(2009-12#2)
pH change##12##2##(1993-8#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-12#3)
pH changes##3##2##(2008-10#3)
pH close to##3##3##(2008-10#2)(2008-5#1)
pH conditions##9##2##(1991-5#1)(1994-8#1)(1995-2#1)(2008-10#6)
pH control##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
pH dependence of the##4##4##(1991-9#1)(1993-8#1)(2008-10#2)
pH dependence of##5##3##(1991-9#1)(1993-8#2)(2008-10#2)
pH dependent##12##2##(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-10#6)(2009-12#1)
pH determination##2##2##(2008-10#2)
pH did not##2##3##(2008-10#2)
pH effect on##3##3##(2008-10#3)
pH effect##8##2##(1995-2#1)(2008-10#7)
pH effects##2##2##(2008-10#2)
pH electrodes##2##2##(2008-10#2)
pH favored##2##2##(2008-10#2)
pH for the##6##3##(2008-10#6)
pH for##15##2##(1991-9#2)(2008-10#10)(2009-3#1)(2011-2#2)
pH from 1 to##2##4##(2008-10#2)
pH from 2##2##3##(2008-10#2)
pH from the##2##3##(2008-10#1)(2011-2#1)
pH from##10##2##(1993-12#1)(2008-10#8)(2011-2#1)
pH glass electrode##2##3##(2008-10#2)
pH glass##3##2##(2008-10#3)
pH gradient##7##2##(1995-2#1)(2008-10#6)
pH has##3##2##(2008-10#3)
pH in the##8##3##(1997-7#1)(2008-10#7)
pH in##22##2##(1990-2#1)(1993-8#1)(1997-7#1)(2008-10#14)(2008-8#2)(2010-4#1)(2010-8#2)
pH increase##2##2##(2008-10#1)(2008-11#1)
pH increased##3##2##(2008-10#3)
pH indicator##6##2##(2008-10#6)
pH is a##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
pH is##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
pH measurement##2##2##(2008-10#2)
pH measurements and##2##3##(2008-10#2)
pH measurements##12##2##(2008-10#11)(2010-8#1)
pH of 1##2##3##(2008-10#2)
pH of 2##2##3##(2008-10#2)
pH of 3##3##3##(2008-10#3)
pH of 4##2##3##(2008-10#2)
pH of 5##4##3##(2008-10#3)(2008-5#1)
pH of 6##2##3##(2008-10#2)
pH of 7##3##3##(2008-10#2)(2008-5#1)
pH of buffer##2##3##(2008-10#2)
pH of buffers##2##3##(2008-10#2)
pH of sample solution##3##4##(2008-10#3)
pH of sample##4##3##(2008-10#4)
pH of the aqueous phase##4##5##(2008-10#4)
pH of the aqueous##5##4##(2008-10#5)
pH of the buffer##2##4##(1991-5#1)(2008-10#1)
pH of the mixed solution was##3##6##(2008-10#3)
pH of the mobile phase##2##5##(2008-10#2)
pH of the sample solution##2##5##(2008-10#2)
pH of the sample##3##4##(2008-10#3)
pH of the solution##5##4##(1990-5#1)(2008-10#3)(2013-1#1)
pH of the##41##3##(1990-5#1)(1991-5#1)(2008-10#33)(2008-11#1)(2008-5#2)(2008-6#1)(2012-2#1)(2013-1#1)
pH of##100##2##(1990-5#2)(1991-5#1)(1992-12#1)(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#79)(2008-11#2)(2008-12#1)(2008-5#6)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#2)
pH on the##11##3##(2008-10#7)(2008-5#4)
pH on their##3##3##(1991-5#1)(2008-10#2)
pH on##18##2##(1991-5#2)(2008-10#12)(2008-5#4)
pH optimum##4##2##(1990-5#1)(1991-12#1)(1994-5#1)(2008-9#1)
pH or##3##2##(2008-10#2)(2013-1#1)
pH profiles##3##2##(1991-9#1)(2008-10#1)(2010-3#1)
pH range (pH##2##3##(1991-5#1)(2008-10#1)
pH range 0##2##3##(2008-10#2)
pH range 1##3##3##(2008-10#3)
pH range 2##4##3##(2008-10#4)
pH range 3-6##2##3##(1997-2#1)(2008-10#1)
pH range 5##2##3##(2008-10#2)
pH range 7##2##3##(2008-10#2)
pH range and##2##3##(2008-10#2)
pH range between##2##3##(2008-10#1)(2008-11#1)
pH range close to deprotonation of##2##6##(2008-10#2)
pH range for##3##3##(1997-2#1)(2008-10#2)
pH range from 2##2##4##(2008-10#2)
pH range from 3##3##4##(2008-10#3)
pH range from 4##2##4##(2008-10#1)(2008-11#1)
pH range from##12##3##(2008-10#11)(2008-11#1)
pH range of 2##9##4##(2008-10#9)
pH range of 3##6##4##(2008-10#6)
pH range of 4##3##4##(2008-10#3)
pH range of 5##3##4##(2008-10#3)
pH range of 6##5##4##(2008-10#4)(2008-7#1)
pH range of the##3##4##(2008-10#3)
pH range of##44##3##(1991-9#1)(2008-10#41)(2008-7#1)(2012-2#1)
pH range was between 1 and 8##2##7##(2008-10#2)
pH range was##4##3##(2008-10#4)
pH range##136##2##(1991-5#1)(1991-9#1)(1993-8#1)(1997-2#2)(2006-6#1)(2008-10#125)(2008-11#2)(2008-5#1)(2008-7#1)(2012-2#1)
pH ranges for quantitative sorption##3##5##(2008-10#3)
pH ranges##6##2##(2008-10#6)
pH rate##2##2##(1991-9#2)
pH region##3##2##(2008-10#3)
pH response##2##2##(1997-7#1)(2008-10#1)
pH sensing##2##2##(2008-10#2)
pH sensor and##2##3##(2008-10#2)
pH sensor##7##2##(2008-10#7)
pH sensors##4##2##(2008-10#4)
pH than##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
pH the##3##2##(2008-10#2)(2008-11#1)
pH titration##5##2##(2008-10#4)(2008-9#1)
pH to##3##2##(2008-10#3)
pH units##5##2##(2008-10#5)
pH using##2##2##(2008-10#2)
pH value for##2##3##(2008-10#2)
pH value of 10##2##4##(2008-10#2)
pH value of buffer##2##4##(2008-10#2)
pH value of##8##3##(1993-8#1)(2008-10#7)
pH value##30##2##(1993-8#1)(2008-10#26)(2008-5#1)(2009-11#1)(2011-3#1)
pH values &gt##2##3##(1994-11#1)(2008-10#1)
pH values (2##2##3##(2008-10#2)
pH values and##2##3##(2008-10#2)
pH values are##2##3##(2008-10#1)(2008-5#1)
pH values for##3##3##(2008-10#3)
pH values of the##2##4##(2008-10#2)
pH values of##6##3##(2008-10#4)(2008-11#1)(2010-4#1)
pH values were##3##3##(2008-10#2)(2008-5#1)
pH values##52##2##(1993-8#1)(1994-11#5)(2008-10#35)(2008-11#1)(2008-3#1)(2008-5#4)(2010-4#3)(2011-3#1)(2013-1#1)
pH variations##2##2##(2008-10#2)
pH was adjusted to##3##4##(2008-10#3)
pH was adjusted##4##3##(2008-10#4)
pH was investigated##2##3##(1994-8#1)(2008-10#1)
pH was##15##2##(1993-6#1)(1994-8#1)(1997-2#1)(2008-10#12)
pH were studied##2##3##(2008-10#2)
pH were##9##2##(2008-10#7)(2008-5#1)(2008-8#1)
pH which##2##2##(1993-3#1)(2011-2#1)
pH with a slope of##2##5##(2008-10#2)
pH with##4##2##(2008-10#4)
pH##1776##1##(1990-12#2)(1990-2#5)(1990-5#15)(1990-8#7)(1991-1#2)(1991-11#1)(1991-12#4)(1991-5#8)(1991-9#15)(1992-10#2)(1992-12#7)(1992-3#2)(1992-4#2)(1992-9#2)(1993-12#5)(1993-3#2)(1993-6#2)(1993-8#26)(1994-11#9)(1994-2#2)(1994-3#1)(1994-5#12)(1994-8#11)(1995-2#4)(1995-3#1)(1995-6#3)(1995-8#2)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#7)(1997-7#2)(2006-6#2)(2008-10#1360)(2008-11#52)(2008-12#7)(2008-3#2)(2008-4#2)(2008-5#59)(2008-6#7)(2008-7#9)(2008-8#5)(2008-9#13)(2009-10#3)(2009-11#2)(2009-12#8)(2009-3#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-3#2)(2010-4#9)(2010-5#1)(2010-8#5)(2011-1#1)(2011-2#15)(2011-3#5)(2012-2#4)(2012-3#3)(2012-6#2)(2012-9#1)(2013-1#16)(2013-8#2)
pH&gt##7##1##(2008-10#6)(2009-11#1)
pH&lt##3##1##(2008-10#3)
pH) and##2##2##(2008-10#2)
pH)##6##1##(1993-8#1)(2008-10#4)(2008-12#1)
pH-ISEs with##2##2##(2008-10#2)
pH-ISEs##3##1##(2008-10#3)
pH-Metric determination of acid##2##4##(2008-10#2)
pH-Metric##3##1##(2008-10#3)
pH-dependent##8##1##(1990-5#3)(1991-5#1)(1994-8#1)(2008-10#3)
pH-induced##3##1##(1995-6#1)(2008-5#2)
pH-metric data##2##2##(2008-10#2)
pH-metric titration##3##2##(2008-10#3)
pH-metric##14##1##(2008-10#14)
pH-metry and##3##2##(1996-3#3)
pH-metry##5##1##(1996-3#5)
pH-rate profile##2##2##(2008-10#2)
pH-rate##3##1##(1995-2#1)(2008-10#2)
pH-sensitive field-effect transistors##3##3##(2008-10#3)
pH-sensitive##7##1##(1992-7#1)(1997-1#1)(2008-10#5)
pH-sensitive-liposomes##2##1##(1997-1#2)
pH-sensors##2##1##(2008-10#1)(2013-8#1)
pH-static titration##2##2##(2008-10#2)
pH-static##3##1##(2008-10#3)
pH-values##2##1##(2008-10#1)(2013-1#1)
pH6##2##1##(2008-10#2)
pH=3##2##1##(2008-10#2)
pHSV-IL-1ra particles##2##2##(2008-8#2)
pHSV-IL-1ra##3##1##(2008-8#3)
pHSVLac##2##1##(2008-8#2)
pHg##2##1##(2008-10#1)(2011-1#1)
pHg/pSILBAγ was##2##2##(2011-1#2)
pHg/pSILBAγ##6##1##(2011-1#6)
pHs##10##1##(2008-10#8)(2009-7#1)(2013-1#1)
pI 5##2##2##(2008-11#2)
pI of 4##2##3##(2008-10#2)
pI of 5##2##3##(1990-5#1)(1995-6#1)
pI of##9##2##(1990-5#1)(1991-6#1)(1992-8#1)(1995-6#1)(2008-10#5)
pI##17##1##(1990-5#1)(1991-6#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-10#7)(2008-11#2)(2008-8#1)(2010-4#1)
pJM1##2##1##(2011-2#2)
pJalpha##3##1##(2008-7#3)
pK (a##2##2##(2008-10#2)
pK of##3##2##(1993-8#1)(1994-5#2)
pK values for the##2##4##(1991-9#1)(2008-10#1)
pK values##4##2##(1991-9#2)(2008-10#2)
pK##13##1##(1991-9#3)(1993-8#1)(1994-5#3)(2008-10#4)(2008-9#2)
pK(0)##3##1##(2008-10#3)
pK(00)##3##1##(2008-10#3)
pK(1)##2##1##(2008-10#2)
pK(2)##3##1##(2008-10#3)
pK(2)&gt##2##1##(2008-10#2)
pK(a) and##3##2##(2008-10#3)
pK(a) of##4##2##(2008-10#4)
pK(a) values for##2##3##(2008-10#2)
pK(a) values from##2##3##(2008-10#2)
pK(a) values of the##2##4##(2008-10#2)
pK(a) values of##5##3##(2008-10#5)
pK(a) values were##2##3##(2008-10#2)
pK(a) values##18##2##(2008-10#18)
pK(a) was##2##2##(2008-10#2)
pK(a)##37##1##(2008-10#36)(2009-8#1)
pK(a)(T)##2##1##(2008-10#2)
pK(a)(T)(=)8##2##1##(2008-10#2)
pK(a)s##2##1##(2008-10#2)
pK(app) values##2##2##(2008-10#2)
pK(app)##4##1##(2008-10#4)
pK(b)##2##1##(2008-10#2)
pKF2##6##1##(1993-12#6)
pKF3##5##1##(1993-12#5)
pKYM is##3##2##(1997-6#3)
pKYM##6##1##(1997-6#6)
pKZ1##4##1##(2008-7#4)
pKa of##3##2##(1993-8#2)(2008-10#1)
pKa value##2##2##(1994-11#1)(2008-10#1)
pKa values##4##2##(2008-10#2)(2009-9#2)
pKa##12##1##(1990-5#1)(1993-1#1)(1993-6#1)(1993-8#2)(1994-11#1)(2008-10#4)(2009-9#2)
pKa's of the##2##3##(2009-9#2)
pKa2##3##1##(1990-5#1)(2008-10#2)
pM##11##1##(1992-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#6)
pM)##4##1##(1995-2#3)(2009-3#1)
pMAG15##2##1##(2008-8#2)
pMCAO##2##1##(2011-2#2)
pMLZ-4##6##1##(1993-2#6)
pNF-CAT##3##1##(1994-6#3)
pNL-1##2##1##(2008-8#2)
pO(2)##5##1##(2008-11#5)
pOCs into OCLs##2##3##(2008-11#2)
pOCs into##4##2##(2008-11#4)
pOCs##8##1##(2008-11#8)
pQuattro vectors##3##2##(2008-11#3)
pSILBA##2##1##(2011-1#2)
pSILBAγ##4##1##(2011-1#4)
pSTL70##6##1##(2008-10#6)
pT1##2##1##(2011-2#2)
pT3##3##1##(1992-5#1)(2011-2#2)
pTC excitability##2##2##(2012-2#2)
pTC using##2##2##(2012-2#2)
pTC##6##1##(2012-2#6)
pTLA-GH##3##1##(2010-5#3)
pTRE-CAT expression##2##2##(1994-6#2)
pTRE-CAT##3##1##(1994-6#3)
pU6RZ107##3##1##(2008-9#3)
pUC18##3##1##(1992-3#1)(2008-10#2)
pUC19##2##1##(1990-5#1)(2008-8#1)
pUCR1##2##1##(2008-7#2)
pUCR2##2##1##(2008-7#2)
pWH14##2##1##(1997-8#2)
pYME1 and pYME2##2##3##(1993-12#2)
p[H]##2##1##(2008-10#2)
pace of information##2##3##(1995-2#1)(1996-2#1)
pace of##7##2##(1995-2#1)(1996-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
pace with##2##2##(1991-2#1)(1996-2#1)
pace##16##1##(1991-12#1)(1991-2#1)(1995-1#1)(1995-2#1)(1996-2#2)(2008-11#1)(2008-12#2)(2008-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
paced##2##1##(2009-10#1)(2013-1#1)
pacemaker activity in##2##3##(1996-2#2)
pacemaker and##2##2##(1996-3#1)(2008-12#1)
pacemaker in the eye##2##4##(1994-2#2)
pacemaker neurons##2##2##(1994-2#2)
pacemaker##16##1##(1994-11#1)(1994-2#5)(1996-2#3)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-2#1)(2010-4#1)
pacemakers##3##1##(2008-5#1)(2010-6#1)(2012-3#1)
pachydermatis##2##1##(2008-5#2)
pachyrhizi and P##3##3##(2008-10#3)
pachyrhizi and##4##2##(2008-10#4)
pachyrhizi##10##1##(2008-10#10)
pachytene bivalents with##2##3##(2008-9#2)
pachytene##4##1##(2008-9#2)(2012-2#2)
pacific division meeting##6##3##(2008-11#6)
pacific##10##1##(2008-1#1)(2008-10#2)(2008-11#6)(2012-2#1)
pacing##3##1##(1990-3#1)(2011-2#1)(2012-2#1)
pack##8##1##(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#2)
package for##2##2##(2011-1#1)(2011-3#1)
package is##3##2##(2008-11#1)(2008-4#1)(2010-11#1)
package of##4##2##(1993-3#1)(1994-2#1)(1995-6#1)(2008-3#1)
package will##2##2##(1994-8#1)(2008-6#1)
package##44##1##(1991-3#3)(1992-1#1)(1992-3#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-8#3)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#1)
packaged and##2##2##(1991-5#1)(2010-1#1)
packaged##13##1##(1991-5#5)(1995-8#1)(1996-2#1)(2008-10#2)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
packages##10##1##(1995-12#1)(2008-10#4)(2008-4#1)(2010-7#1)(2013-1#3)
packaging cell lines##2##3##(1990-5#2)
packaging for##2##2##(2010-7#1)(2011-1#1)
packaging in##2##2##(1991-5#1)(1993-6#1)
packaging is##2##2##(1994-3#1)(2010-7#1)
packaging materials##3##2##(2008-10#2)(2010-7#1)
packaging motor##3##2##(2010-5#3)
packaging of##4##2##(1993-2#1)(1997-6#1)(2008-11#1)(2009-8#1)
packaging should##2##2##(1994-3#2)
packaging system##6##2##(1996-2#2)(2008-8#4)
packaging##53##1##(1990-11#1)(1990-5#2)(1991-5#2)(1993-2#1)(1993-6#1)(1994-3#4)(1996-2#3)(1997-3#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-8#6)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#3)(2010-7#8)(2011-1#1)(2011-2#3)(2012-2#1)
packed and##4##2##(1994-5#1)(2008-7#1)(2008-9#2)
packed bed##4##2##(1997-2#1)(2008-11#3)
packed by##2##2##(2008-10#1)(2008-9#1)
packed cells##3##2##(2008-10#3)
packed column supercritical fluid chromatography##6##5##(2008-10#6)
packed column supercritical fluid##7##4##(2008-10#7)
packed column##15##2##(2008-10#14)(2010-4#1)
packed in a column and determined##5##6##(2008-10#5)
packed in a column##6##4##(2008-10#6)
packed in a flow cell##2##5##(2008-10#2)
packed in a mini-column##2##4##(2008-10#2)
packed in a minicolumn##4##4##(2008-10#4)
packed in a##18##3##(2008-10#18)
packed in##20##2##(2008-10#20)
packed into a small##2##4##(2008-10#2)
packed into a##6##3##(2008-10#6)
packed into##8##2##(2008-10#8)
packed minicolumn is proposed for##2##5##(2008-10#2)
packed minicolumn##4##2##(2008-10#4)
packed with 1##2##3##(2008-10#2)
packed with Amberlite##2##3##(2008-10#2)
packed with Chlorella vulgaris immobilised on silica gel##2##8##(2008-10#2)
packed with a##8##3##(2008-10#8)
packed with activated carbon##3##4##(2008-10#3)
packed with activated##5##3##(2008-10#5)
packed with immobilized##2##3##(2008-10#2)
packed with polytetrafluoroethylene (PTFE)##2##4##(2008-10#2)
packed with polyurethane foam##2##4##(2008-10#2)
packed with silica gel##4##4##(2008-10#4)
packed with the##3##3##(2008-10#3)
packed with##60##2##(2008-10#57)(2008-11#1)(2008-5#1)(2008-7#1)
packed##146##1##(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#117)(2008-11#7)(2008-12#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-7#1)(2010-4#1)(2012-12#2)
packed-bed bioreactor##4##2##(2008-11#2)(2008-7#2)
packed-bed##6##1##(2008-10#1)(2008-11#3)(2008-7#2)
packed-bedreactor##3##1##(2008-11#3)
packing and##4##2##(1993-8#1)(2008-10#1)(2008-8#1)(2010-4#1)
packing density of##2##3##(2008-12#1)(2008-9#1)
packing density##4##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-9#1)
packing has##2##2##(2008-10#2)
packing material##5##2##(2008-10#5)
packing materials##2##2##(2008-10#2)
packing of the##5##3##(1996-9#1)(2008-5#1)(2008-8#2)(2012-3#1)
packing of##8##2##(1994-5#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)
packing the##3##2##(2008-10#3)
packing##49##1##(1991-3#1)(1993-8#2)(1994-5#2)(1996-9#1)(2008-10#29)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2010-4#1)(2012-2#1)(2012-3#1)
packinghouses##4##1##(2008-10#4)
packings##4##1##(2008-10#4)
packs##2##1##(2008-6#1)(2010-3#1)
paclitaxel therapy##2##2##(2008-9#2)
paclitaxel##7##1##(1996-10#1)(2008-8#2)(2008-9#3)(2013-1#1)
paclitaxel-eluting stent##2##2##(2008-11#2)
paclitaxel-eluting stents##3##2##(2008-11#2)(2008-12#1)
paclitaxel-eluting##6##1##(2008-11#5)(2008-12#1)
pad##9##1##(1990-11#2)(1993-6#1)(2008-11#1)(2008-5#4)(2011-2#1)
paddle##2##1##(2008-11#1)(2012-2#1)
paddles##2##1##(2010-9#2)
paddocks##2##1##(1996-12#2)
padi and##2##2##(2008-10#2)
padi can##2##2##(2008-10#2)
padi clones##2##2##(2008-10#2)
padi during##2##2##(2008-10#2)
padi was##2##2##(2008-10#2)
padi##19##1##(2008-10#19)
padlock probes##4##2##(2008-4#3)(2008-9#1)
pads##6##1##(1996-2#2)(1997-3#1)(2008-11#3)
paediatric and##6##2##(2008-11#3)(2008-9#1)(2010-10#1)(2012-3#1)
paediatric cancer##2##2##(2008-11#2)
paediatric case##3##2##(1996-9#1)(2008-11#2)
paediatric cochlear implant##3##3##(2008-9#3)
paediatric cochlear implantation##7##3##(2008-9#7)
paediatric cochlear##11##2##(2008-9#11)
paediatric emergency department##4##3##(2008-11#3)(2013-1#1)
paediatric emergency medicine##2##3##(2008-11#2)
paediatric emergency##6##2##(2008-11#5)(2013-1#1)
paediatric hospitals##2##2##(2008-11#2)
paediatric minor head injuries##2##4##(2008-11#2)
paediatric minor##3##2##(2008-11#3)
paediatric oncology##2##2##(2008-11#1)(2010-11#1)
paediatric pain##2##2##(2008-11#2)
paediatric patients##11##2##(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#3)(2011-2#1)(2012-2#1)(2013-1#2)
paediatric population##8##2##(1996-6#1)(2008-10#3)(2008-11#2)(2013-1#2)
paediatric residents and##2##3##(2008-11#2)
paediatric surgeons##2##2##(2008-10#2)
paediatric surgery##2##2##(2008-11#1)(2012-2#1)
paediatric urology##6##2##(2008-10#6)
paediatric##129##1##(1990-2#1)(1990-3#2)(1993-12#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#56)(2008-5#1)(2008-7#1)(2008-9#18)(2009-10#2)(2010-10#1)(2010-11#1)(2010-7#4)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#10)
paediatrician##4##1##(2008-11#3)(2013-1#1)
paediatricians for##2##2##(2008-11#2)
paediatricians##10##1##(2008-11#9)(2008-7#1)
paediatrics##7##1##(1990-3#3)(2008-11#3)(2010-7#1)
paeoniflorin and 5-ASA groups (P &lt##2##6##(2011-3#2)
paeoniflorin##8##1##(2008-10#2)(2011-3#6)
paeonol##2##1##(2008-10#2)
page##6##1##(1995-3#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
pager##2##1##(2010-8#2)
pagers##5##1##(2010-8#5)
paging system##3##2##(2010-8#3)
paging systems are##2##3##(2010-8#2)
paging systems in##2##3##(2010-8#2)
paging systems##5##2##(2010-8#5)
paging##12##1##(2010-8#12)
paid a##3##2##(1990-9#1)(1995-3#1)(2008-11#1)
paid by##5##2##(1992-12#1)(1994-2#1)(1996-3#2)(2008-11#1)
paid employment##3##2##(1991-9#1)(1993-6#1)(1995-1#1)
paid for the##3##3##(1992-2#1)(1997-2#1)(2008-12#1)
paid for##7##2##(1992-2#1)(1992-3#1)(1993-3#1)(1995-11#1)(1996-3#1)(1997-2#1)(2008-12#1)
paid to the##18##3##(1990-6#1)(1991-3#1)(1992-3#1)(1994-3#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)
paid to##42##2##(1990-6#1)(1991-3#2)(1992-12#1)(1992-3#1)(1994-3#2)(1995-3#1)(1995-5#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-2#1)
paid workers##4##2##(1992-3#4)
paid##77##1##(1990-6#1)(1990-9#1)(1991-3#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#9)(1993-1#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-12#1)(1996-3#4)(1997-2#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-2#1)
pain 2##2##2##(1995-3#1)(2013-1#1)
pain after a##2##3##(1995-3#1)(2008-9#1)
pain after##8##2##(1991-11#1)(1993-2#1)(1995-3#2)(2008-10#1)(2008-9#2)(2012-2#1)
pain and a##2##3##(2010-1#1)(2012-12#1)
pain and depression##2##3##(2008-10#1)(2013-1#1)
pain and disability##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
pain and discomfort##3##3##(2008-12#3)
pain and improve##3##3##(2008-10#1)(2010-11#1)(2013-1#1)
pain and instability##2##3##(2012-3#1)(2013-1#1)
pain and loss of##2##4##(2010-11#1)(2012-2#1)
pain and related disorders##5##4##(2008-12#5)
pain and related##7##3##(2008-12#7)
pain and the##2##3##(2008-12#1)(2008-9#1)
pain and to##2##3##(2010-11#1)(2011-2#1)
pain and weight##2##3##(2007-8#1)(2008-12#1)
pain and##109##2##(1990-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-3#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#25)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-1#2)(2009-11#1)(2009-3#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#3)(2010-3#1)(2010-5#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#9)(2013-8#1)
pain and/or##2##2##(1992-6#1)(2008-7#1)
pain are##4##2##(2008-11#2)(2012-12#2)
pain areas of##3##3##(2010-9#3)
pain as a##2##3##(2008-9#1)(2010-3#1)
pain as##4##2##(2008-12#1)(2008-9#1)(2010-3#1)(2013-1#1)
pain assessment and management##2##4##(2010-7#1)(2012-2#1)
pain assessment##21##2##(2008-11#6)(2010-11#6)(2010-7#2)(2012-2#5)(2013-1#2)
pain assessments##2##2##(2010-6#1)(2012-2#1)
pain associated with##8##3##(1991-8#1)(1992-2#1)(1993-2#1)(1995-2#2)(2010-1#1)(2010-12#2)
pain associated##9##2##(1991-8#1)(1992-2#1)(1993-2#1)(1995-2#2)(2010-1#2)(2010-12#2)
pain at the##5##3##(1991-3#1)(2008-10#1)(2010-6#2)(2011-2#1)
pain at##7##2##(1991-3#1)(1994-12#1)(2008-10#1)(2008-7#1)(2010-6#2)(2011-2#1)
pain based on##3##3##(2008-9#2)(2012-2#1)
pain being##2##2##(2008-10#1)(2013-1#1)
pain but also##2##3##(2008-7#1)(2013-1#1)
pain but no##2##3##(1995-3#1)(2008-7#1)
pain but##6##2##(1995-3#1)(2008-7#3)(2009-3#1)(2013-1#1)
pain by##3##2##(1990-3#1)(2008-7#1)(2010-7#1)
pain can be##3##3##(1991-11#1)(2008-8#1)(2008-9#1)
pain can##4##2##(1991-11#2)(2008-8#1)(2008-9#1)
pain caused by##2##3##(1993-6#1)(1995-2#1)
pain characteristics##5##2##(2008-3#1)(2010-6#4)
pain control and##3##3##(2008-7#1)(2010-11#1)(2013-1#1)
pain control##5##2##(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2013-1#1)
pain crisis##2##2##(1992-2#1)(2008-10#1)
pain diagnoses##3##2##(1993-1#1)(2013-1#2)
pain disappeared##2##2##(1993-3#1)(2008-7#1)
pain disorders##3##2##(1997-8#1)(2008-12#2)
pain due to##3##3##(1997-7#1)(2010-1#1)(2012-2#1)
pain during##5##2##(2008-12#2)(2010-11#1)(2010-9#1)(2011-2#1)
pain education program##2##3##(2009-12#2)
pain education##4##2##(2008-11#1)(2009-12#3)
pain for the##2##3##(2008-10#1)(2008-11#1)
pain for##9##2##(1993-6#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-1#1)
pain from bone##2##3##(1997-3#1)(2008-10#1)
pain from##4##2##(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
pain has##3##2##(1991-9#1)(2008-12#1)(2011-2#1)
pain in a##2##3##(1995-12#1)(1997-5#1)
pain in both##2##3##(1996-11#1)(2013-8#1)
pain in childhood##3##3##(1992-5#1)(2008-11#2)
pain in children##2##3##(2008-11#2)
pain in patients with##4##4##(2008-12#2)(2009-4#2)
pain in patients##6##3##(2008-12#2)(2009-4#2)(2009-8#1)(2010-7#1)
pain in primary care##2##4##(2008-11#2)
pain in the elderly##2##4##(2008-5#2)
pain in the upper##2##4##(1991-9#1)(1993-2#1)
pain in the##16##3##(1991-9#1)(1993-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-1#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
pain in##57##2##(1991-11#2)(1991-3#1)(1991-9#1)(1992-5#2)(1993-2#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-5#1)(1997-8#2)(2008-11#8)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-4#3)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
pain intensity##14##2##(2008-12#3)(2008-9#1)(2009-12#4)(2009-3#1)(2010-12#3)(2010-7#1)(2012-2#1)
pain interference##2##2##(2008-12#2)
pain is a common##2##4##(2008-9#1)(2012-2#1)
pain is a subjective##2##4##(2010-6#1)(2012-2#1)
pain is a##4##3##(2008-9#1)(2010-6#1)(2012-2#2)
pain is##17##2##(1993-1#1)(1993-6#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#4)(2010-11#1)(2010-6#1)(2012-2#2)(2012-3#1)
pain level##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
pain levels##4##2##(1994-3#1)(2008-12#1)(2013-1#2)
pain management in patients##2##4##(2012-3#2)
pain management in##6##3##(2008-11#1)(2009-12#1)(2010-7#2)(2012-3#2)
pain management##28##2##(1991-1#1)(1992-8#1)(1994-1#1)(1997-5#1)(1997-8#1)(2008-11#4)(2008-7#2)(2009-12#3)(2010-11#5)(2010-6#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#4)
pain must##2##2##(2008-11#1)(2008-3#1)
pain occurs in##3##3##(2011-2#1)(2013-1#2)
pain of both##2##3##(1996-8#1)(2012-12#1)
pain of##5##2##(1990-9#1)(1994-3#1)(1996-8#1)(2010-1#1)(2012-12#1)
pain on day##2##3##(2008-3#2)
pain on movement##2##3##(1990-9#2)
pain on##11##2##(1990-9#3)(2008-10#1)(2008-3#2)(2008-7#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#1)
pain or##6##2##(1992-2#1)(1995-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
pain over##2##2##(2008-11#1)(2012-2#1)
pain patients##15##2##(1991-1#1)(1993-1#5)(2008-3#4)(2008-4#1)(2008-9#1)(2010-9#1)(2012-2#2)
pain patients]##2##2##(1997-8#1)(2008-12#1)
pain rating##5##2##(2008-12#3)(2008-9#2)
pain rehabilitation##5##2##(1995-2#1)(2013-1#4)
pain relief and##2##3##(2009-3#1)(2010-10#1)
pain relief for patients##2##4##(2007-8#1)(2013-1#1)
pain relief with##2##3##(1995-10#1)(2008-7#1)
pain relief##24##2##(1990-6#1)(1992-1#2)(1995-1#1)(1995-10#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-7#2)(2008-9#4)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-7#1)(2013-1#1)
pain response of infants##2##4##(2010-4#2)
pain response##4##2##(1996-12#1)(2008-5#1)(2010-4#2)
pain responses of##2##3##(2010-4#2)
pain resulting##3##2##(1992-12#1)(1992-6#2)
pain results from##2##3##(2008-9#1)(2010-7#1)
pain scales##2##2##(2008-5#1)(2011-2#1)
pain score##4##2##(1994-3#2)(2008-7#1)(2011-2#1)
pain scores##8##2##(1995-3#1)(2008-10#1)(2008-7#4)(2012-12#1)(2012-2#1)
pain sensitivity##2##2##(1994-3#2)
pain severity##4##2##(2010-11#1)(2010-6#3)
pain should be##2##3##(2008-4#1)(2012-12#1)
pain symptoms##3##2##(2008-12#2)(2009-9#1)
pain syndrome##17##2##(2007-11#2)(2008-10#1)(2008-12#6)(2008-4#3)(2008-7#1)(2009-11#1)(2010-9#1)(2012-3#2)
pain syndromes##8##2##(2008-12#2)(2008-4#5)(2008-9#1)
pain than##4##2##(1997-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
pain that##2##2##(2008-12#1)(2010-8#1)
pain therapy##4##2##(2008-11#4)
pain threshold##3##2##(1996-2#1)(2010-12#2)
pain thresholds to##3##3##(1993-1#3)
pain thresholds##4##2##(1993-1#4)
pain to##4##2##(1993-2#1)(2008-9#1)(2009-7#1)(2010-3#1)
pain transmission##2##2##(1996-12#1)(2008-9#1)
pain treatment##10##2##(1997-3#5)(2007-8#1)(2009-12#4)
pain underwent a##2##3##(2008-12#1)(2008-9#1)
pain underwent##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
pain was the##2##3##(1992-1#1)(2013-1#1)
pain was##16##2##(1992-1#1)(1995-10#1)(1996-3#1)(1997-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#3)
pain were##7##2##(1993-2#1)(1997-4#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
pain with##10##2##(1992-12#1)(1992-2#1)(1997-3#1)(1997-6#1)(2008-12#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
pain##975##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#5)(1991-1#2)(1991-11#7)(1991-2#4)(1991-3#5)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#5)(1992-12#3)(1992-2#7)(1992-3#1)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#13)(1993-2#9)(1993-3#2)(1993-6#7)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#11)(1994-9#1)(1995-1#1)(1995-10#3)(1995-12#1)(1995-2#4)(1995-3#5)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#13)(1997-4#11)(1997-5#8)(1997-6#1)(1997-7#4)(1997-8#9)(2007-11#4)(2007-12#2)(2007-8#3)(2008-1#3)(2008-10#28)(2008-11#53)(2008-12#91)(2008-2#1)(2008-3#19)(2008-4#20)(2008-5#12)(2008-7#54)(2008-8#10)(2008-9#61)(2009-1#8)(2009-10#1)(2009-11#5)(2009-12#24)(2009-3#7)(2009-4#5)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#4)(2010-1#17)(2010-10#3)(2010-11#30)(2010-12#17)(2010-3#11)(2010-4#6)(2010-5#1)(2010-6#16)(2010-7#17)(2010-8#2)(2010-9#16)(2011-1#1)(2011-2#58)(2012-12#21)(2012-2#46)(2012-3#31)(2013-1#65)(2013-8#8)
pain&quot##2##1##(2009-12#1)(2013-1#1)
pain-free##2##1##(2008-10#1)(2013-1#1)
pain?##2##1##(1992-6#1)(2008-7#1)
pain]##3##1##(1993-2#1)(1996-6#1)(1997-3#1)
painful and##2##2##(2008-10#1)(2009-11#1)
painful condition that##2##3##(1992-5#1)(2008-12#1)
painful mass in the##2##4##(2010-5#1)(2013-1#1)
painful periods##2##2##(1996-3#1)(2013-1#1)
painful regional lymphadenitis##2##3##(1991-4#2)
painful swelling of the##2##4##(1991-3#1)(2008-1#1)
painful swelling##3##2##(1991-3#1)(2008-1#1)(2010-3#1)
painful##38##1##(1991-3#1)(1991-4#2)(1992-5#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-12#1)(2013-1#5)(2013-7#1)
painless central chondrosarcoma of pubis##2##5##(2008-5#2)
painless##14##1##(1991-11#1)(1997-5#1)(2008-10#1)(2008-12#2)(2008-5#3)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
pains and##2##2##(2010-10#1)(2012-2#1)
pains##10##1##(1993-3#1)(1995-10#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
paint and##3##2##(2008-10#2)(2008-11#1)
paint##12##1##(1995-6#1)(2008-10#9)(2008-11#1)(2009-8#1)
painted in green##2##3##(2008-6#2)
painted with##2##2##(2008-10#2)
painted##9##1##(2008-10#7)(2008-6#2)
painting from the##2##3##(2008-10#2)
painting from##3##2##(2008-10#3)
painting##20##1##(1991-2#1)(2008-10#15)(2008-9#1)(2012-12#2)(2012-3#1)
paintings##17##1##(1995-12#1)(1995-6#1)(2008-10#15)
paints from##2##2##(2008-10#2)
paints##6##1##(1995-10#1)(2008-10#5)
pair and##4##2##(2008-12#2)(2008-3#1)(2008-7#1)
pair as##4##2##(2008-10#3)(2008-11#1)
pair based on##2##3##(2008-10#2)
pair fragment##2##2##(2008-10#2)
pair is##4##2##(1992-3#1)(1995-6#1)(2008-11#1)(2008-3#1)
pair of Ac elements derived from##2##6##(2012-3#2)
pair of primers##2##3##(2008-10#2)
pair of well-defined redox##3##4##(2008-10#3)
pair of well-defined##5##3##(2008-10#5)
pair of##63##2##(1990-11#1)(1991-12#1)(1993-3#1)(1995-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#3)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-3#1)(2012-3#5)
pair sequence##4##2##(1995-6#1)(1996-12#2)(1996-6#1)
pair with##3##2##(2008-10#3)
pair##185##1##(1990-11#1)(1991-11#1)(1991-12#2)(1992-11#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-5#3)(1994-8#1)(1995-12#2)(1995-6#9)(1996-12#2)(1996-6#1)(1997-2#1)(1997-7#2)(2007-11#2)(2007-12#3)(2008-10#73)(2008-11#11)(2008-12#10)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#6)(2008-9#3)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#2)(2011-3#1)(2012-3#5)
pair-fed##2##1##(1993-12#1)(2010-6#1)
pair-wise##3##1##(2008-12#1)(2008-9#1)(2011-2#1)
paired and##2##2##(1993-6#1)(2010-8#1)
paired bihemispheric##2##2##(1996-3#2)
paired ducts##2##2##(2007-12#2)
paired helical##3##2##(1991-1#1)(1992-6#2)
paired t##3##2##(1990-12#1)(2010-10#1)(2012-2#1)
paired t-test##10##2##(2008-10#9)(2008-7#1)
paired t-tests##2##2##(2009-2#1)(2010-6#1)
paired with the##2##3##(1993-8#2)
paired with##3##2##(1993-8#2)(1996-2#1)
paired##59##1##(1990-12#1)(1991-1#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-6#2)(1993-8#2)(1995-9#1)(1996-2#1)(1996-3#2)(1996-9#1)(2007-12#5)(2008-10#15)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2011-7#1)(2012-2#1)
pairing and##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
pairing between##2##2##(1990-5#1)(1995-2#1)
pairing of the##2##3##(1993-9#1)(2009-6#1)
pairing of##5##2##(1991-5#1)(1993-9#1)(1994-5#1)(2008-10#1)(2009-6#1)
pairing##31##1##(1990-5#2)(1991-5#3)(1992-6#2)(1992-8#1)(1993-9#1)(1994-5#1)(1995-2#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-7#1)(2009-6#1)(2010-11#1)(2011-2#3)(2012-2#2)(2012-3#1)
pairings between clients and##2##4##(1996-3#2)
pairings##7##1##(1996-3#2)(2008-10#2)(2008-5#3)
pairs and##11##2##(1993-11#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#1)
pairs are##2##2##(2008-10#1)(2008-3#1)
pairs between##2##2##(2008-10#1)(2008-2#1)
pairs for each##2##3##(1993-8#1)(2008-10#1)
pairs for the##2##3##(1990-8#1)(2013-8#1)
pairs for##4##2##(1990-8#1)(1993-8#1)(2008-10#1)(2013-8#1)
pairs in a##2##3##(1995-12#1)(2007-12#1)
pairs in##9##2##(1991-5#1)(1995-12#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2010-7#1)
pairs involving##2##2##(1995-6#1)(2008-4#1)
pairs is##2##2##(2008-10#1)(2008-12#1)
pairs of extended##2##3##(2008-10#2)
pairs of loci##2##3##(2008-10#2)
pairs of populations##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
pairs of primers##3##3##(2008-10#2)(2008-8#1)
pairs of the##2##3##(1997-7#1)(2008-6#1)
pairs of wavelengths##2##3##(2008-10#1)(2008-3#1)
pairs of##64##2##(1990-12#1)(1991-6#1)(1992-8#1)(1994-5#2)(1996-2#1)(1996-5#1)(1997-3#2)(1997-7#1)(1997-9#1)(2007-11#3)(2007-12#2)(2008-10#25)(2008-11#2)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
pairs or##2##2##(1994-9#1)(2008-12#1)
pairs to##2##2##(2008-10#1)(2013-1#1)
pairs were designed##2##3##(2008-10#2)
pairs were##6##2##(2008-10#5)(2011-2#1)
pairs with a##3##3##(1991-9#1)(1997-8#1)(1997-9#1)
pairs with##5##2##(1991-9#1)(1997-8#1)(1997-9#1)(2008-10#2)
pairs##188##1##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#3)(1994-5#5)(1994-9#1)(1995-1#1)(1995-12#3)(1995-6#3)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#3)(2007-11#3)(2007-12#3)(2008-10#67)(2008-11#5)(2008-12#11)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#7)(2009-11#1)(2009-6#1)(2010-7#1)(2010-8#3)(2011-2#6)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
pairs)##4##1##(1992-3#1)(2008-10#2)(2008-6#1)
pairwise contrasts##2##2##(2008-10#2)
pairwise interactions##2##2##(2008-8#1)(2012-3#1)
pairwise##21##1##(1994-5#2)(1995-6#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#6)(2010-11#1)(2012-3#4)(2013-8#1)
palF##2##1##(1997-7#2)
palF15##2##1##(1997-7#2)
palaeoenvironmental##2##1##(2012-7#1)(2012-9#1)
palate in##2##2##(2012-3#1)(2013-1#1)
palate##19##1##(1990-6#1)(1991-11#2)(1991-2#2)(1991-3#1)(1997-3#1)(2008-10#1)(2009-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#5)
palatinose##2##1##(1992-12#2)
pale eggs##3##2##(2008-8#3)
pale in comparison to the##2##5##(1994-3#1)(2008-11#1)
pale spots##2##2##(2007-12#2)
pale##12##1##(1994-3#1)(2007-12#2)(2008-11#1)(2008-5#2)(2008-8#6)
palea and##3##2##(2008-10#2)(2008-8#1)
palea##10##1##(2008-10#9)(2008-8#1)
paleontological##3##1##(2008-8#1)(2010-4#1)(2010-5#1)
palette##2##1##(2008-10#2)
palindromic##6##1##(1990-11#1)(1993-12#1)(2008-10#4)
palladin##2##1##(2009-7#2)
palladium (II)##2##2##(2008-10#2)
palladium (Pd)##3##2##(2008-10#3)
palladium and##5##2##(2008-10#4)(2008-11#1)
palladium as##2##2##(2008-10#2)
palladium by graphite furnace atomic absorption##2##6##(2008-10#2)
palladium by##4##2##(2008-10#4)
palladium catalysts##2##2##(2008-10#2)
palladium complexes##2##2##(2008-10#2)
palladium determination##3##2##(2008-10#3)
palladium film##2##2##(2008-10#2)
palladium in##8##2##(2008-10#8)
palladium with##3##2##(1991-12#1)(2008-10#2)
palladium##68##1##(1991-12#4)(2008-10#63)(2008-11#1)
palladium(II) and##4##2##(2008-10#4)
palladium(II) in##3##2##(2008-10#3)
palladium(II)##25##1##(2008-10#25)
palladium-magnesium nitrate and ammonium dihydrogenphosphate##2##5##(2008-10#2)
palladium-magnesium nitrate##4##2##(2008-10#4)
palladium-magnesium##6##1##(2008-10#6)
palladium-zirconium##3##1##(2008-10#3)
pallens##2##1##(2008-8#2)
palliate##2##1##(2008-7#2)
palliation of##3##2##(2008-12#1)(2008-7#1)(2010-6#1)
palliation##8##1##(1991-12#1)(1991-3#1)(1993-6#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-6#1)
palliative care in the##2##4##(2009-10#1)(2012-12#1)
palliative care##28##2##(1992-2#2)(2008-11#3)(2008-12#1)(2008-4#1)(2009-10#1)(2009-9#3)(2010-10#5)(2010-2#1)(2011-2#4)(2012-12#3)(2012-3#4)
palliative medicine##5##2##(2008-7#2)(2012-3#3)
palliative operation##4##2##(1990-9#3)(2008-7#1)
palliative radiation therapy##2##3##(2008-7#2)
palliative radiotherapy##3##2##(2008-10#2)(2008-11#1)
palliative treatment of##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
palliative treatment##5##2##(1993-6#1)(1997-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
palliative##57##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#5)(1992-2#2)(1993-6#1)(1994-1#1)(1997-3#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#5)(2009-10#1)(2009-9#3)(2010-10#5)(2010-2#1)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#8)(2013-1#1)(2013-8#1)
pallida populations##2##2##(2008-10#2)
pallida##6##1##(2008-10#6)
pallida)##3##1##(2008-10#3)
pallidal##3##1##(2008-7#3)
pallidotomy##2##1##(2008-7#2)
pallidum is##2##2##(2008-7#2)
pallidum##7##1##(1993-6#1)(1997-5#2)(2008-7#4)
pallor##2##1##(2008-10#1)(2013-7#1)
palm shell##3##2##(2013-1#3)
palm trees##3##2##(2008-10#3)
palm##21##1##(2008-10#13)(2009-5#1)(2011-2#3)(2013-1#4)
palmar defect##2##2##(2008-9#2)
palmar##9##1##(1997-3#1)(2008-10#2)(2008-9#4)(2011-2#2)
palmaris longus##2##2##(2008-9#1)(2009-1#1)
palmeri##2##1##(2009-8#2)
palmitate##5##1##(1993-8#1)(2008-5#2)(2008-7#1)(2010-10#1)
palmitic acid were##2##3##(1994-5#1)(2010-4#1)
palmitic acid##8##2##(1991-3#1)(1994-5#2)(2008-10#1)(2010-12#1)(2010-4#1)(2011-1#2)
palmitic##13##1##(1991-3#1)(1994-5#2)(1994-8#2)(2008-10#4)(2010-12#1)(2010-4#1)(2011-1#2)
palmitoleic##3##1##(2008-10#2)(2011-1#1)
palmitoyl-CoA##4##1##(1990-5#3)(1993-3#1)
palmivora were##2##2##(2008-10#2)
palmivora##16##1##(2008-10#16)
palms and soles##2##3##(1997-3#1)(2010-6#1)
palms and##3##2##(1997-3#1)(2008-10#1)(2010-6#1)
palms##7##1##(1997-3#1)(2008-10#3)(2008-5#1)(2010-6#1)(2012-3#1)
palpable mass##5##2##(2008-10#1)(2010-3#1)(2013-1#3)
palpable nodules##2##2##(2010-11#1)(2010-7#1)
palpable##20##1##(1990-9#1)(1995-1#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#5)
palpated##3##1##(2008-12#1)(2012-12#1)(2013-8#1)
palpation##6##1##(1991-8#1)(2008-12#2)(2010-3#1)(2010-9#1)(2011-2#1)
palpatory##2##1##(1992-1#1)(2009-9#1)
palpebral##3##1##(1997-3#1)(2008-7#1)(2013-1#1)
palsies##14##1##(1996-9#2)(1997-3#1)(2008-7#4)(2011-2#6)(2012-3#1)
palsy and##3##2##(1991-6#1)(2010-9#1)(2011-2#1)
palsy in##2##2##(1997-5#1)(2011-2#1)
palsy##39##1##(1991-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-11#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#3)(2010-7#1)(2010-9#2)(2011-2#10)(2012-12#2)(2012-3#5)(2013-1#2)(2013-8#1)
pamphlets about##2##2##(1990-2#1)(2013-1#1)
pamphlets##12##1##(1990-2#10)(2011-1#1)(2013-1#1)
pan##2##1##(1997-1#1)(2008-6#1)
panacea##2##1##(1996-3#1)(2010-1#1)
panax##3##1##(2008-10#3)
pancreas and##9##2##(1990-8#1)(1991-3#1)(1994-12#2)(1995-2#1)(2008-1#1)(2010-10#1)(2013-1#1)(2013-8#1)
pancreas in Nepalese##2##3##(2012-3#2)
pancreas in the gallbladder wall##3##5##(1997-8#3)
pancreas in##7##2##(1992-5#1)(1997-8#3)(2012-3#2)(2013-1#1)
pancreas is a##2##3##(2012-2#1)(2013-1#1)
pancreas is##5##2##(1990-3#1)(1991-3#1)(2012-2#1)(2013-1#2)
pancreas of##4##2##(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
pancreas or##2##2##(2010-12#2)
pancreas transplantation##2##2##(1995-2#2)
pancreas was##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
pancreas were##2##2##(1990-9#1)(2012-3#1)
pancreas which##2##2##(2012-3#1)(2013-7#1)
pancreas##104##1##(1990-3#3)(1990-8#1)(1990-9#8)(1991-3#2)(1991-7#1)(1991-9#1)(1992-5#2)(1992-6#1)(1992-9#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-2#6)(1996-12#1)(1997-5#1)(1997-8#3)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#3)(2012-2#10)(2012-3#11)(2013-1#13)(2013-7#6)(2013-8#1)
pancreas)##2##1##(1997-5#1)(2008-1#1)
pancreata##2##1##(2010-11#1)(2010-12#1)
pancreatectomy##5##1##(1990-6#1)(1990-9#1)(2010-1#1)(2011-2#1)(2013-1#1)
pancreatic OPN##3##2##(2010-11#3)
pancreatic acinar cells##4##3##(1991-5#1)(2008-7#1)(2009-7#2)
pancreatic acinar##5##2##(1991-5#1)(1992-8#1)(2008-7#1)(2009-7#2)
pancreatic acini and gastric chief cells from guinea pig##3##9##(1994-8#3)
pancreatic adenocarcinoma##2##2##(2008-1#1)(2013-1#1)
pancreatic and biliary##2##3##(2011-2#2)
pancreatic and##6##2##(1991-3#1)(2011-2#4)(2012-2#1)
pancreatic beta cells##2##3##(2008-10#1)(2009-8#1)
pancreatic beta##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
pancreatic beta-cell##2##2##(1994-12#1)(2008-11#1)
pancreatic beta-cells##7##2##(1994-11#2)(1996-2#2)(2008-11#1)(2012-3#1)(2013-1#1)
pancreatic cancer cells##3##3##(2013-1#3)
pancreatic cancer in##2##3##(1990-9#1)(2013-1#1)
pancreatic cancer##15##2##(1990-9#3)(1994-3#1)(2009-5#1)(2009-7#1)(2012-3#1)(2013-1#8)
pancreatic cancers##3##2##(2013-1#3)
pancreatic carcinoma##3##2##(1994-6#1)(2008-1#1)(2008-9#1)
pancreatic cells##3##2##(2008-9#2)(2010-11#1)
pancreatic duct goblet##2##3##(1994-11#2)
pancreatic duct##8##2##(1994-11#2)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
pancreatic ductal##2##2##(2012-2#1)(2013-1#1)
pancreatic ducts##2##2##(1994-11#1)(2013-1#1)
pancreatic elastase##5##2##(1990-2#1)(1991-3#2)(2008-5#2)
pancreatic endocrine neoplasms##2##3##(2011-2#2)
pancreatic endocrine##4##2##(1992-7#1)(2010-11#1)(2011-2#2)
pancreatic exocrine##2##2##(1993-3#1)(2009-7#1)
pancreatic function##2##2##(1992-11#1)(2013-7#1)
pancreatic injury##2##2##(2010-1#2)
pancreatic islet isolation##3##3##(2008-11#3)
pancreatic islet##11##2##(1991-7#1)(2008-11#3)(2008-2#2)(2010-11#4)(2010-12#1)
pancreatic islets##10##2##(1995-8#2)(2008-10#2)(2008-11#2)(2009-8#1)(2010-12#3)
pancreatic juice##3##2##(2009-7#3)
pancreatic lipase##3##2##(1992-3#2)(2012-3#1)
pancreatic necrosis##3##2##(2013-1#3)
pancreatic neoplasms##3##2##(2012-2#3)
pancreatic tissue##3##2##(1997-8#1)(2012-2#2)
pancreatic β##2##2##(2013-7#2)
pancreatic β-cell##5##2##(2010-10#2)(2010-11#3)
pancreatic β-cells##3##2##(2010-10#1)(2010-11#2)
pancreatic##196##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#8)(1991-10#1)(1991-3#7)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-11#9)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#5)(1995-3#1)(1995-8#2)(1996-2#2)(1997-8#1)(2008-1#3)(2008-10#3)(2008-11#8)(2008-2#2)(2008-5#4)(2008-7#5)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#9)(2009-8#4)(2010-1#5)(2010-10#3)(2010-11#16)(2010-12#4)(2011-1#3)(2011-2#11)(2012-2#11)(2012-3#5)(2013-1#29)(2013-7#6)(2013-8#2)
pancreatico-duodenal##2##1##(1990-9#2)
pancreaticoduodenal artery##2##2##(1991-6#2)
pancreaticoduodenal##5##1##(1991-6#3)(1995-2#1)(2013-1#1)
pancreaticoduodenectomy##2##1##(1991-3#1)(2013-1#1)
pancreaticus caused by##2##3##(2011-2#2)
pancreaticus##4##1##(2011-2#4)
pancreatin##3##1##(2008-10#3)
pancreatitis after kidney transplantation##2##4##(2012-12#2)
pancreatitis and the##3##3##(1994-3#1)(2008-3#1)(2013-1#1)
pancreatitis and##5##2##(1991-9#1)(1992-11#1)(1994-3#1)(2008-3#1)(2013-1#1)
pancreatitis following##2##2##(2008-12#1)(2013-1#1)
pancreatitis in##3##2##(2007-8#1)(2011-2#1)(2012-3#1)
pancreatitis is a##2##3##(2009-7#1)(2012-12#1)
pancreatitis is##5##2##(2009-7#1)(2012-12#1)(2013-1#3)
pancreatitis was##2##2##(1990-3#1)(2012-3#1)
pancreatitis with##2##2##(2012-12#2)
pancreatitis##63##1##(1990-3#4)(1990-9#2)(1991-9#1)(1992-11#2)(1992-9#1)(1994-3#1)(1997-8#1)(2007-8#3)(2008-12#1)(2008-3#3)(2008-5#1)(2009-12#3)(2009-7#8)(2009-8#6)(2011-2#3)(2012-12#7)(2012-3#4)(2013-1#12)
pancreatography##2##1##(1991-3#1)(2010-1#1)
pancytopenia##6##1##(1997-3#1)(2008-4#2)(2009-1#1)(2012-12#1)(2012-3#1)
panda##8##1##(2008-8#4)(2008-9#4)
pandemic (H1N1) 2009 virus##3##4##(2011-2#3)
pandemic (H1N1) 2009##4##3##(2011-2#4)
pandemic spread##6##2##(2008-10#6)
pandemic##30##1##(1990-11#1)(1992-5#1)(2008-10#9)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#12)(2012-2#1)(2013-1#2)
pandemics##4##1##(2008-10#1)(2011-2#2)(2013-8#1)
panel for##3##2##(1995-6#1)(2009-6#1)(2012-3#1)
panel in##3##2##(1994-2#1)(1995-12#1)(2010-12#1)
panel is##2##2##(1996-6#1)(2010-12#1)
panel of monoclonal antibodies##4##4##(1990-12#1)(1991-2#1)(1993-1#1)(2007-12#1)
panel of##36##2##(1990-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-6#3)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#4)(2008-9#1)(2010-12#2)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
panel selection##2##2##(2012-3#2)
panel##79##1##(1990-11#1)(1990-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#5)(1996-12#1)(1996-6#4)(1997-2#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#10)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#9)(2013-1#2)
panelists rated##2##2##(2008-5#1)(2010-12#1)
panelists##12##1##(2008-5#10)(2008-6#1)(2010-12#1)
panelists'##3##1##(2008-5#1)(2010-12#2)
panellists##2##1##(2008-5#1)(2010-4#1)
panels of##2##2##(1995-3#1)(2012-2#1)
panels##11##1##(1991-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
panhandle structure##2##2##(2008-10#1)(2008-8#1)
panhandle##3##1##(2008-10#2)(2008-8#1)
panic and##2##2##(1990-11#1)(2010-2#1)
panic disorder and agoraphobia##2##4##(1990-11#1)(2012-2#1)
panic disorder##4##2##(1990-11#1)(1991-2#1)(2012-2#2)
panic##11##1##(1990-11#2)(1991-2#1)(2008-11#2)(2008-4#1)(2010-2#3)(2012-2#2)
panicle and shoot blight of pistachio##4##6##(2008-10#4)
panicle and shoot blight##5##4##(2008-10#5)
panicle blast severity##2##3##(2008-10#2)
panicle blast##10##2##(2008-10#10)
panicle##29##1##(2008-10#18)(2008-12#1)(2008-8#1)(2008-9#2)(2009-10#7)
panicles##4##1##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
paniculata mother plants##2##3##(2008-10#2)
paniculata##4##1##(2008-10#4)
paniculate##2##1##(2008-11#2)
panmictic population##3##2##(2008-10#1)(2008-9#2)
panmictic##5##1##(2008-10#3)(2008-9#2)
panniculitis##2##1##(2008-11#1)(2012-2#1)
panning##3##1##(2008-6#1)(2008-8#1)(2008-9#1)
panoply of##3##2##(2008-8#1)(2013-1#2)
panoramic cameras##3##2##(2008-6#3)
panoramic##8##1##(2008-6#6)(2009-12#1)(2012-3#1)
pansy##4##1##(2008-10#1)(2008-7#3)
pantoprazole##2##1##(2012-3#2)
pap test##2##2##(1990-6#2)
pap##3##1##(1990-6#3)
papain cleavage##2##2##(1994-8#2)
papain##6##1##(1990-2#1)(1994-8#2)(2008-1#1)(2008-11#2)
papaveracea and##4##2##(2008-10#4)
papaveracea caused##2##2##(2008-10#2)
papaveracea conidia##2##2##(2008-10#2)
papaveracea was more##2##3##(2008-10#2)
papaveracea was##3##2##(2008-10#3)
papaveracea##25##1##(2008-10#25)
papaverine hydrochloride##2##2##(2008-10#2)
papaverine##7##1##(1993-3#1)(2008-10#6)
papaya##11##1##(2008-10#11)
paper [Appl##2##2##(2008-2#1)(2008-3#1)
paper a##8##2##(2008-10#6)(2008-11#1)(2008-2#1)
paper addresses the##5##3##(1992-3#1)(2008-12#1)(2009-12#1)(2010-1#1)(2012-2#1)
paper addresses##9##2##(1992-2#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-1#1)(2012-2#1)
paper aims to explore##2##4##(2008-11#1)(2012-2#1)
paper aims to##10##3##(1993-3#1)(1996-3#1)(2008-11#3)(2008-12#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
paper also shows##2##3##(2008-10#2)
paper also##13##2##(1990-6#1)(1995-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2009-10#1)(2010-1#1)(2010-9#1)(2013-8#1)
paper analyses the##3##3##(2008-11#1)(2008-12#2)
paper and##11##2##(1995-2#1)(1997-1#1)(2008-10#7)(2010-12#1)(2013-1#1)
paper are##7##2##(1992-9#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
paper argues for the##2##4##(2008-12#1)(2008-7#1)
paper argues that##6##3##(2008-11#1)(2008-12#2)(2009-12#1)(2010-1#1)(2013-1#1)
paper argues##8##2##(2008-11#1)(2008-12#3)(2008-7#1)(2009-12#1)(2010-1#1)(2013-1#1)
paper as##7##2##(1993-1#1)(2008-10#1)(2008-12#1)(2011-2#4)
paper attempts to##5##3##(1990-3#1)(1992-3#1)(2008-10#1)(2008-11#1)(2010-9#1)
paper begins##2##2##(2008-12#1)(2008-4#1)
paper by the European Society of Radiology##2##7##(2012-2#2)
paper by##4##2##(2008-10#2)(2012-2#2)
paper concerns the##2##3##(1991-2#1)(1996-3#1)
paper concludes by discussing##2##4##(2008-11#1)(2008-12#1)
paper concludes by##6##3##(1992-12#1)(2008-11#4)(2008-12#1)
paper concludes that##2##3##(1992-5#1)(2010-8#1)
paper concludes##10##2##(1992-12#1)(1992-5#1)(2008-11#4)(2008-12#2)(2008-5#1)(2010-8#1)
paper considers the##3##3##(1992-1#1)(2008-12#1)(2011-1#1)
paper considers##5##2##(1992-1#1)(1995-9#1)(2008-12#2)(2011-1#1)
paper deals with the##5##4##(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#1)
paper deals with##8##3##(2008-10#5)(2008-12#1)(2008-5#1)(2013-8#1)
paper deals##9##2##(2008-10#5)(2008-12#1)(2008-5#1)(2009-6#1)(2013-8#1)
paper demonstrates that##2##3##(2008-10#1)(2008-7#1)
paper demonstrates the##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
paper demonstrates##7##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)
paper describes a case of spontaneous##2##6##(1990-9#1)(2013-1#1)
paper describes a case of##3##5##(1990-9#1)(2012-3#1)(2013-1#1)
paper describes a case##4##4##(1990-9#1)(2008-11#1)(2012-3#1)(2013-1#1)
paper describes a fast and##2##5##(2008-10#2)
paper describes a method for the##2##6##(2008-10#1)(2008-11#1)
paper describes a new##3##4##(2008-10#3)
paper describes a procedure##4##4##(2008-10#4)
paper describes a##49##3##(1990-12#1)(1990-9#2)(1992-2#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-2#1)(1997-2#2)(2008-10#20)(2008-11#6)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
paper describes an##11##3##(2008-10#6)(2008-11#3)(2008-12#1)(2013-1#1)
paper describes how the##3##4##(1991-2#1)(1997-2#1)(2009-8#1)
paper describes how##7##3##(1991-2#1)(1997-2#1)(2008-11#2)(2008-12#2)(2009-8#1)
paper describes the development of##5##5##(2008-10#3)(2008-11#1)(2010-8#1)
paper describes the development##7##4##(2008-10#5)(2008-11#1)(2010-8#1)
paper describes the project##2##4##(1992-2#1)(2008-1#1)
paper describes the##57##3##(1990-12#1)(1990-2#1)(1990-9#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1995-12#2)(1996-3#3)(2008-1#2)(2008-10#25)(2008-11#9)(2008-12#2)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
paper describes##143##2##(1990-12#2)(1990-2#1)(1990-9#3)(1991-2#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-3#3)(1997-2#3)(2008-1#2)(2008-10#58)(2008-11#22)(2008-12#10)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-7#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#6)
paper develops a##2##3##(2008-10#1)(2012-3#1)
paper develops an##2##3##(2008-6#1)(2013-8#1)
paper develops##4##2##(2008-10#1)(2008-6#1)(2012-3#1)(2013-8#1)
paper discusses how##4##3##(1992-12#1)(2008-11#1)(2008-12#1)(2009-6#1)
paper discusses the##20##3##(1993-3#1)(1995-9#1)(1997-3#1)(2008-10#4)(2008-11#9)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
paper discusses##34##2##(1991-12#1)(1992-12#1)(1993-3#1)(1995-9#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#3)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
paper electrophoresis##2##2##(2008-10#2)
paper examines the##10##3##(1992-1#1)(1992-12#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-5#1)
paper examines##16##2##(1992-1#2)(1992-12#1)(1996-2#1)(1996-3#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#2)(2010-8#1)(2011-2#1)
paper explains the##2##3##(1996-3#1)(2008-10#1)
paper explores##16##2##(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-7#2)(2010-10#1)
paper focuses on an##2##4##(2008-12#1)(2012-3#1)
paper focuses on the##13##4##(1991-2#1)(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2009-10#1)(2009-9#1)(2011-2#1)
paper focuses on##18##3##(1991-2#1)(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-5#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
paper focuses##19##2##(1991-2#1)(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-5#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
paper for the determination of##2##5##(2008-10#2)
paper for the##3##3##(2008-10#3)
paper for##4##2##(1996-6#1)(2008-10#3)
paper from this laboratory##2##4##(2008-10#2)
paper from##4##2##(2008-10#4)
paper further##2##2##(1995-9#1)(1996-3#1)
paper gives an##3##3##(2008-10#1)(2010-1#1)(2013-1#1)
paper gives##6##2##(2008-10#2)(2008-6#1)(2009-10#1)(2010-1#1)(2013-1#1)
paper has##3##2##(1991-1#1)(1995-5#1)(2008-10#1)
paper highlights the##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
paper highlights##8##2##(2008-10#2)(2008-11#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
paper illustrates a method##2##4##(1992-9#1)(2009-10#1)
paper illustrates##6##2##(1990-9#1)(1991-3#1)(1992-9#1)(1993-1#1)(1996-3#1)(2009-10#1)
paper in##7##2##(1990-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-8#3)
paper indicates that##2##3##(1991-12#1)(1991-9#1)
paper indicates##3##2##(1991-12#1)(1991-9#1)(2011-2#1)
paper introduces the##3##3##(1995-9#1)(2012-3#2)
paper introduces##9##2##(1995-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-3#2)
paper investigates the##5##3##(1992-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-8#1)
paper investigates##8##2##(1992-2#1)(1995-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2010-8#1)
paper is a##5##3##(2008-11#1)(2008-12#2)(2008-7#1)(2012-3#1)
paper is an evaluation of##2##5##(1992-2#1)(2012-3#1)
paper is an##3##3##(1992-2#1)(2008-12#1)(2012-3#1)
paper is based on##3##4##(2008-12#1)(2009-11#1)(2010-10#1)
paper is based##4##3##(2008-12#1)(2009-11#1)(2010-10#1)(2012-3#1)
paper is the##4##3##(2008-10#3)(2010-10#1)
paper is to demonstrate the##2##5##(2008-11#2)
paper is to present##6##4##(2008-11#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
paper is to##39##3##(1992-1#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-10#1)(2008-11#10)(2008-12#1)(2008-5#1)(2009-10#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#4)
paper is##73##2##(1992-1#1)(1992-2#1)(1992-3#2)(1993-1#1)(1994-1#1)(1996-3#1)(1997-2#1)(2008-10#7)(2008-11#13)(2008-12#7)(2008-5#2)(2008-7#1)(2009-10#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#7)(2013-1#5)(2013-8#1)
paper looks at##2##3##(1996-3#1)(2008-5#1)
paper offers an##3##3##(1993-11#1)(2008-10#1)(2010-12#1)
paper offers##4##2##(1993-11#1)(1997-2#1)(2008-10#1)(2010-12#1)
paper on##5##2##(2008-10#2)(2009-10#1)(2009-12#1)(2012-2#1)
paper outlines the##6##3##(1997-2#1)(2008-11#2)(2008-12#2)(2008-7#1)
paper outlines##14##2##(1997-2#1)(2008-11#6)(2008-12#3)(2008-4#2)(2008-7#1)(2010-9#1)
paper points##3##2##(2010-8#1)(2013-1#2)
paper presents a case of##3##5##(2008-11#1)(2010-12#1)(2011-2#1)
paper presents a##32##3##(1995-12#1)(2008-10#11)(2008-11#4)(2008-5#1)(2008-6#3)(2009-10#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
paper presents an##7##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)
paper presents results##2##3##(1992-5#1)(2009-8#1)
paper presents the results of##6##5##(2008-10#3)(2008-11#1)(2009-10#1)(2011-2#1)
paper presents the##15##3##(1992-1#1)(1992-2#1)(2007-12#1)(2008-10#5)(2008-11#3)(2009-10#1)(2010-10#1)(2010-8#1)(2011-2#1)
paper presents##68##2##(1992-1#2)(1992-2#1)(1992-5#1)(1993-1#1)(1993-3#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#25)(2008-11#9)(2008-12#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
paper proposes a new##2##4##(2008-6#1)(2011-3#1)
paper proposes a##10##3##(1994-9#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-11#1)(2011-3#1)(2012-2#2)
paper proposes##12##2##(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-11#1)(2010-8#1)(2011-3#1)(2012-2#2)
paper provides a##9##3##(1996-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2009-6#1)
paper provides an overview of##4##5##(1992-1#1)(2008-10#2)(2008-11#1)
paper provides an##6##3##(1992-1#1)(2008-10#3)(2008-11#2)
paper provides##20##2##(1992-1#1)(1995-11#1)(1996-9#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-7#1)(2009-6#1)(2012-3#1)
paper reflects on##2##3##(2008-12#1)(2010-9#1)
paper reports on a##4##4##(2008-11#2)(2008-12#1)(2013-8#1)
paper reports on##20##3##(1994-1#1)(1996-3#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-7#1)(2008-9#1)(2010-10#2)(2013-8#1)
paper reports the results of a study carried out##2##9##(1993-3#1)(2008-5#1)
paper reports the results of a##4##6##(1991-6#1)(1993-3#1)(1994-12#1)(2008-5#1)
paper reports the results of##5##5##(1991-6#1)(1993-3#1)(1994-12#1)(2008-5#1)(2013-1#1)
paper reports the results##6##4##(1991-6#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
paper reports the study of##3##5##(1991-3#1)(2008-10#1)(2008-5#1)
paper reports the##24##3##(1991-3#1)(1991-6#1)(1993-3#1)(1994-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-5#2)(2010-10#1)(2011-2#1)(2013-1#3)
paper reports##61##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-1#2)(1994-12#1)(1995-11#1)(1996-3#1)(2008-1#1)(2008-10#18)(2008-11#12)(2008-12#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#3)(2011-2#1)(2013-1#3)(2013-8#1)
paper reviews the##19##3##(1993-3#1)(1994-3#1)(1994-6#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#4)(2013-1#2)
paper reviews##41##2##(1992-1#1)(1993-3#1)(1994-3#1)(1994-6#2)(1996-11#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-7#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#4)(2013-1#2)(2013-8#1)
paper seeks to##2##3##(2008-11#1)(2008-12#1)
paper showed that##2##3##(2008-8#1)(2008-9#1)
paper shows that the##2##4##(2008-10#1)(2008-5#1)
paper shows that##4##3##(2008-10#2)(2008-5#1)(2010-5#1)
paper shows##8##2##(1996-3#1)(2008-10#5)(2008-5#1)(2010-5#1)
paper suggests##7##2##(1991-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
paper that##2##2##(2008-11#1)(2008-7#1)
paper the authors##2##3##(1993-3#1)(2012-3#1)
paper the##12##2##(1992-9#2)(1993-3#1)(1995-1#1)(1995-5#1)(2008-10#3)(2008-12#1)(2009-8#1)(2011-3#1)(2012-3#1)
paper then##2##2##(2008-10#1)(2008-11#1)
paper was##14##2##(1992-2#1)(1994-3#2)(2008-10#5)(2008-11#1)(2009-8#2)(2011-2#2)(2013-1#1)
paper we consider##2##3##(2013-8#2)
paper we have##2##3##(2008-10#1)(2008-11#1)
paper we report##3##3##(1991-9#1)(2008-11#1)(2012-2#1)
paper we will##2##3##(2008-10#1)(2009-12#1)
paper we##49##2##(1990-12#1)(1991-9#1)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#2)(2008-10#7)(2008-11#7)(2008-12#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#2)(2011-2#2)(2012-2#4)(2013-1#6)(2013-8#6)
paper will identify##2##3##(2008-11#2)
paper will provide a##4##4##(1994-3#2)(2008-12#1)(2010-10#1)
paper will provide##5##3##(1994-3#2)(2008-12#2)(2010-10#1)
paper will##36##2##(1992-3#1)(1994-1#4)(1994-3#6)(1996-1#2)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#2)(2010-12#1)(2011-2#2)(2012-9#1)
paper##1345##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#4)(1991-1#1)(1991-12#5)(1991-2#4)(1991-3#5)(1991-6#1)(1991-9#2)(1992-1#11)(1992-12#5)(1992-2#9)(1992-3#7)(1992-5#3)(1992-9#8)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#7)(1993-6#2)(1993-8#2)(1994-1#9)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#11)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#5)(1995-12#5)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#10)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#15)(1996-6#1)(1996-9#1)(1997-1#8)(1997-2#12)(1997-3#3)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#6)(2008-1#12)(2008-10#435)(2008-11#169)(2008-12#88)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#25)(2008-6#18)(2008-7#20)(2008-8#2)(2008-9#10)(2009-10#15)(2009-11#2)(2009-12#5)(2009-3#7)(2009-4#2)(2009-5#1)(2009-6#9)(2009-7#10)(2009-8#15)(2009-9#3)(2010-1#7)(2010-10#13)(2010-11#5)(2010-12#13)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#17)(2010-9#5)(2011-1#5)(2011-2#33)(2011-3#8)(2012-12#3)(2012-2#37)(2012-3#26)(2012-9#1)(2013-1#46)(2013-7#2)(2013-8#17)
paper&gt##4##1##(2008-10#4)
paper-based##2##1##(2008-10#1)(2013-1#1)
paperless and filmless&quot##4##3##(2008-10#4)
paperless##5##1##(2008-10#4)(2010-5#1)
papers and##2##2##(2008-11#1)(2011-2#1)
papers are reviewed which concern surgery whilst taking##2##8##(2008-8#2)
papers are reviewed##3##3##(2008-8#3)
papers are##5##2##(2008-3#1)(2008-8#3)(2010-12#1)
papers examined##2##2##(2013-1#2)
papers have been##2##3##(1993-6#1)(2008-11#1)
papers on the##2##3##(2008-3#1)(2009-10#1)
papers on##5##2##(1997-8#1)(2008-3#1)(2008-5#1)(2009-10#1)(2012-3#1)
papers presented at the##6##4##(2008-10#6)
papers published in##3##3##(2008-10#1)(2013-1#2)
papers published##4##2##(2008-10#2)(2013-1#2)
papers reported##2##2##(2008-10#1)(2013-1#1)
papers that##4##2##(2008-3#2)(2013-1#1)(2013-7#1)
papers were##6##2##(1997-8#1)(2012-3#1)(2013-1#2)(2013-8#2)
papers##81##1##(1993-6#1)(1996-1#1)(1997-8#2)(2008-10#23)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#3)
paperwork##3##1##(1991-9#1)(1996-3#1)(2010-10#1)
papilla formation in##2##3##(2008-10#2)
papilla formation##7##2##(2008-10#7)
papilla##14##1##(1991-9#1)(2008-10#9)(2008-5#2)(2011-2#2)
papillae formed##2##2##(2008-10#2)
papillae in##2##2##(2008-10#2)
papillae of##3##2##(2008-10#2)(2008-5#1)
papillae was##2##2##(2008-10#2)
papillae##24##1##(1991-3#1)(1997-4#1)(2008-10#14)(2008-5#7)(2011-2#1)
papillary adenomas and##2##3##(2011-2#2)
papillary carcinoma of the male breast##2##6##(1992-2#2)
papillary carcinoma was##2##3##(1990-6#1)(2011-2#1)
papillary carcinoma##9##2##(1990-6#1)(1990-9#1)(1992-2#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
papillary dermis##3##2##(2010-6#3)
papillary distortions##2##2##(1993-2#2)
papillary mucinous##3##2##(2012-2#2)(2012-3#1)
papillary necrosis causing bilateral ureteric obstruction##2##6##(2008-10#2)
papillary thyroid carcinoma in children and##2##6##(2012-3#2)
papillary thyroid carcinoma in##3##4##(1990-6#1)(2012-3#2)
papillary thyroid carcinoma##6##3##(1990-6#2)(1993-8#1)(2012-3#3)
papillary##41##1##(1990-6#4)(1990-9#2)(1991-2#1)(1992-2#2)(1993-2#3)(1993-8#1)(1995-12#1)(1995-8#2)(2008-10#4)(2008-12#1)(2008-5#1)(2009-9#1)(2010-6#3)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#5)(2013-1#1)
papillary-cystic tumor##2##2##(1992-5#2)
papilloferous##2##1##(2008-11#2)
papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene##2##17##(1992-8#2)
papilloma virus##4##2##(2007-8#1)(2008-11#1)(2011-1#2)
papilloma##14##1##(1991-2#6)(1992-8#2)(2007-8#1)(2008-11#1)(2008-9#1)(2011-1#2)(2013-1#1)
papillomas##4##1##(1992-8#2)(2008-9#2)
papillomavirus (HPV)##3##2##(1992-3#1)(2011-2#1)(2013-1#1)
papillomavirus vaccine##2##2##(2008-11#1)(2013-1#1)
papillomavirus##18##1##(1992-3#2)(1994-1#2)(1995-2#2)(2008-11#2)(2008-12#1)(2010-7#1)(2011-2#3)(2013-1#4)(2013-8#1)
papillotomy##5##1##(1991-3#2)(1997-8#3)
papulans##7##1##(2008-10#7)
papules in##2##2##(2011-2#1)(2012-3#1)
papules##7##1##(2010-6#4)(2011-2#1)(2012-3#2)
papyraceous##2##1##(2010-8#2)
par des##4##2##(2011-2#2)(2013-1#2)
par le##3##2##(2011-2#1)(2013-1#2)
par voie##2##2##(2013-1#2)
par##24##1##(1993-1#1)(2008-11#1)(2008-5#3)(2009-10#1)(2011-2#4)(2012-2#1)(2013-1#13)
para##5##1##(2008-10#3)(2008-11#1)(2012-2#1)
para-Cl-phenylazo-R-acid##5##1##(2008-10#5)
para-acrosomal bodies##2##2##(2008-7#2)
para-aortic##2##1##(2009-11#2)
para-substituted phenols##3##2##(2008-10#3)
para-substituted##5##1##(1994-5#1)(2008-10#4)
parabens##5##1##(2008-10#5)
parabolic quantum##2##2##(2008-2#2)
parabolic##9##1##(1991-9#1)(2008-10#1)(2008-2#3)(2008-7#1)(2013-8#3)
paraboliclike quantum##2##2##(2008-2#2)
paraboliclike##3##1##(2008-2#3)
parabrachial##2##1##(2009-10#2)
paracaval##2##1##(2011-2#2)
paracellular##2##1##(2008-11#1)(2009-8#1)
paracentesis##2##1##(2008-12#1)(2009-8#1)
paracentral##2##1##(1991-12#2)
paracetamol and##4##2##(2008-10#4)
paracetamol are##2##2##(1995-11#1)(2008-10#1)
paracetamol by##3##2##(2008-10#3)
paracetamol concentration##2##2##(2008-10#2)
paracetamol has##2##2##(1990-2#1)(1995-11#1)
paracetamol in pharmaceutical formulations using##2##5##(2008-10#2)
paracetamol in pharmaceutical formulations##4##4##(2008-10#4)
paracetamol in##14##2##(1995-11#1)(2008-10#13)
paracetamol was##3##2##(1990-2#1)(2008-10#2)
paracetamol##57##1##(1990-2#5)(1995-11#9)(2007-8#1)(2008-10#42)
paraclinical##2##1##(2007-8#1)(2010-12#1)
paracoccidioidin##2##1##(2008-5#2)
paracoccidioidomycosis##5##1##(2008-5#5)
paracrine effects##2##2##(2013-1#2)
paracrine##16##1##(1992-6#1)(1993-3#1)(1995-12#1)(1995-8#2)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#6)(2013-7#1)(2013-8#1)
paracrystalline##2##1##(2008-10#1)(2008-7#1)
paradigm and##3##2##(2008-11#1)(2008-12#1)(2010-10#1)
paradigm as##2##2##(2008-10#1)(2010-4#1)
paradigm for##16##2##(1996-3#1)(2008-11#1)(2008-4#2)(2009-12#2)(2010-10#1)(2010-4#1)(2011-2#2)(2011-9#1)(2012-3#1)(2013-1#3)(2013-8#1)
paradigm in##4##2##(1996-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
paradigm may##2##2##(2013-1#1)(2013-8#1)
paradigm of##10##2##(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-7#1)
paradigm shift##9##2##(2008-11#3)(2008-5#1)(2008-7#1)(2010-1#2)(2010-4#1)(2013-1#1)
paradigm that##2##2##(1994-12#1)(2008-11#1)
paradigm to##4##2##(2008-11#1)(2008-12#1)(2009-4#1)(2013-1#1)
paradigm was used to assess##2##5##(1993-1#1)(2009-10#1)
paradigm was used to##3##4##(1993-1#1)(2009-10#1)(2013-8#1)
paradigm was##7##2##(1993-1#1)(2008-11#1)(2009-10#2)(2011-1#1)(2013-8#2)
paradigm with##2##2##(1992-12#1)(2008-11#1)
paradigm##104##1##(1990-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#2)(1993-3#1)(1994-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-11#16)(2008-12#8)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#2)(2009-8#1)(2010-1#2)(2010-10#3)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#3)(2011-7#1)(2011-9#1)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#12)
paradigmatic##2##1##(2012-3#1)(2013-1#1)
paradigms in##3##2##(2008-12#1)(2008-2#1)(2009-12#1)
paradigms of##3##2##(2008-9#1)(2009-8#2)
paradigms##23##1##(1992-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)
paradisi##2##1##(2008-10#2)
paradox of##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
paradox that##2##2##(2008-11#1)(2013-8#1)
paradox##15##1##(1994-11#1)(1994-3#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2012-3#2)(2013-8#1)
paradoxes##4##1##(2007-11#1)(2008-12#1)(2008-5#1)(2009-7#1)
paradoxical embolism may be##2##4##(2008-7#2)
paradoxical embolism##4##2##(2008-7#3)(2013-8#1)
paradoxical##17##1##(1991-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-7#5)(2008-8#2)(2009-10#1)(2011-2#1)(2013-1#3)(2013-8#1)
paradoxically##2##1##(2008-8#1)(2013-1#1)
paraduodenal hernia##2##2##(2009-8#2)
paraesthesia##2##1##(2008-12#2)
paraffin blocks##2##2##(2008-10#1)(2008-5#1)
paraffin wax##2##2##(1991-2#1)(2008-10#1)
paraffin##17##1##(1991-2#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#1)
paraffin-embedded tissue sections##2##3##(2008-10#1)(2008-4#1)
paraffin-embedded tissue##5##2##(2008-10#1)(2008-4#1)(2008-9#2)(2009-8#1)
paraffin-embedded##11##1##(1991-7#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#3)(2009-8#1)(2011-2#1)(2013-8#1)
paraffin-impregnated graphite electrodes##2##3##(2008-10#2)
paraffin-wax##2##1##(1991-2#2)
paraformaldehyde##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
paragallinarum##4##1##(2008-5#4)
paraganglioma##11##1##(1997-8#4)(2011-2#1)(2012-2#6)
paragangliomas##6##1##(1997-8#2)(2011-2#1)(2012-2#3)
paragigantocellularis##3##1##(1990-9#2)(1994-2#1)
paragraph##3##1##(2008-11#1)(2009-4#1)(2013-1#1)
paragraphs##2##1##(1996-5#1)(2009-4#1)
parahippocampus##3##1##(1990-11#3)
parallel and##2##2##(2008-7#1)(2009-9#1)
parallel arrays##2##2##(2008-10#1)(2008-3#1)
parallel data##2##2##(1992-3#1)(2008-3#1)
parallel factor analysis (PARAFAC)##4##4##(2008-10#4)
parallel factor analysis##5##3##(2008-10#5)
parallel gains or losses##2##4##(2008-10#2)
parallel increase in##5##3##(1991-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)
parallel measurements##2##2##(2008-10#2)
parallel opposed lateral and vertex fields##2##6##(1993-9#2)
parallel opposed##3##2##(1993-9#2)(2008-11#1)
parallel pathways##2##2##(2007-12#1)(2013-1#1)
parallel plate diffusion denuder coupled capillary##2##6##(2008-10#2)
parallel plate diffusion denuder##3##4##(2008-10#3)
parallel processing##2##2##(2008-10#1)(2010-7#1)
parallel reactions##3##2##(2008-10#2)(2008-11#1)
parallel the##2##2##(1993-8#1)(2008-11#1)
parallel to the##17##3##(1997-8#1)(2008-2#1)(2008-3#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-7#1)
parallel to##30##2##(1991-5#1)(1992-1#1)(1994-11#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-3#1)
parallel wire##4##2##(2009-3#4)
parallel with the##6##3##(1993-12#1)(1994-11#1)(1994-2#1)(1995-8#1)(1996-2#1)(2008-10#1)
parallel with##15##2##(1990-10#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#1)
parallel##194##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#3)(1994-11#4)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#41)(2008-11#19)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#3)(2009-10#4)(2009-12#1)(2009-3#6)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-2#1)
paralleled by a##3##3##(1990-3#1)(1995-12#1)(2008-7#1)
paralleled by the##2##3##(1991-5#1)(2013-1#1)
paralleled by##6##2##(1990-3#1)(1991-5#1)(1992-2#1)(1995-12#1)(2008-7#1)(2013-1#1)
paralleled the##4##2##(2008-10#2)(2008-11#1)(2009-9#1)
paralleled with##2##2##(2008-11#1)(2011-2#1)
paralleled##14##1##(1990-3#1)(1991-5#1)(1992-2#1)(1994-1#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
parallelism##2##1##(2008-3#1)(2013-1#1)
parallelized##3##1##(2008-3#1)(2013-1#2)
parallels between##4##2##(2008-11#2)(2008-7#1)(2012-2#1)
parallels the##2##2##(1994-8#1)(1995-6#1)
parallels with##2##2##(2008-8#1)(2013-8#1)
parallels##13##1##(1991-2#1)(1994-8#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#2)
paralogs##5##1##(2009-10#1)(2009-6#1)(2013-1#3)
paralysis and##3##2##(1997-5#1)(2007-12#1)(2011-2#1)
paralysis in##2##2##(1992-2#1)(2010-8#1)
paralysis##20##1##(1991-12#2)(1991-6#1)(1992-2#1)(1993-1#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-7#3)(2008-9#1)(2010-8#4)(2011-2#2)(2013-1#1)
paralytic acylpolyamines from the##2##4##(1990-5#2)
paralytic##7##1##(1990-5#2)(1995-5#3)(1997-8#1)(2007-12#1)
paramagnetic broadening##2##2##(1994-5#2)
paramagnetic resonance (EPR) spectroscopy##3##4##(2008-10#2)(2008-5#1)
paramagnetic resonance (EPR)##6##3##(2008-10#3)(2008-5#1)(2008-8#1)(2009-5#1)
paramagnetic resonance##9##2##(1997-1#2)(2008-10#4)(2008-5#1)(2008-8#1)(2009-5#1)
paramagnetic##18##1##(1992-12#1)(1994-5#3)(1997-1#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
parameter (the##2##2##(2007-12#1)(2008-10#1)
parameter and##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
parameter estimates derived from##2##4##(2008-10#2)
parameter estimates were used to##2##5##(2008-10#2)
parameter estimates were##3##3##(2008-10#3)
parameter estimates##19##2##(1992-9#1)(2008-10#18)
parameter estimation##3##2##(2008-10#3)
parameter evaluation and prediction##2##4##(2008-10#2)
parameter for the##4##3##(2008-10#3)(2008-7#1)
parameter for##15##2##(1993-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-7#1)
parameter in the##4##3##(1991-2#1)(2008-2#1)(2008-3#1)(2008-7#1)
parameter in##9##2##(1990-12#1)(1991-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
parameter influencing##2##2##(2008-10#1)(2008-8#1)
parameter is##5##2##(1991-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
parameter of a##2##3##(2008-10#1)(2008-3#1)
parameter of response##2##3##(2008-10#1)(2008-5#1)
parameter of the beta-binomial distribution##4##5##(2008-10#4)
parameter of the beta-binomial##5##4##(2008-10#5)
parameter of the##7##3##(2008-10#5)(2008-3#1)(2010-4#1)
parameter of##16##2##(2008-10#7)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)
parameter sets for##2##3##(2008-10#2)
parameter sets##3##2##(2008-10#3)
parameter space##6##2##(2008-11#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-10#1)
parameter that##4##2##(2008-10#3)(2008-8#1)
parameter theta##2##2##(2008-10#1)(2008-8#1)
parameter to estimate##2##3##(1992-12#1)(2008-8#1)
parameter to##9##2##(1992-12#1)(2008-10#5)(2008-8#2)(2010-7#1)
parameter v##2##2##(2013-8#2)
parameter value##2##2##(2008-10#2)
parameter values##19##2##(2008-10#9)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2010-2#1)(2013-8#1)
parameter was##7##2##(1990-12#1)(1997-4#1)(2008-10#3)(2008-5#1)(2011-2#1)
parameter which##4##2##(1994-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
parameter##237##1##(1990-12#2)(1990-5#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#2)(1993-8#1)(1994-5#1)(1994-9#1)(1995-9#2)(1996-3#3)(1997-2#2)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#104)(2008-11#11)(2008-2#9)(2008-3#14)(2008-5#11)(2008-6#5)(2008-7#9)(2008-8#16)(2008-9#7)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#7)
parameter-extended##2##1##(2009-4#2)
parameterization of the##2##3##(2008-3#1)(2008-6#1)
parameterization of##3##2##(2008-3#1)(2008-6#1)(2008-8#1)
parameterization##5##1##(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)
parameterize the##2##2##(2009-11#1)(2010-3#1)
parameterize##4##1##(2008-8#2)(2009-11#1)(2010-3#1)
parameterized with##2##2##(2008-8#1)(2008-9#1)
parameterized##9##1##(1992-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
parameters (alpha##2##2##(2008-10#2)
parameters (concentrations##2##2##(2008-10#2)
parameters (e##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
parameters (temperature##2##2##(2008-10#2)
parameters a##2##2##(2008-10#1)(2008-8#1)
parameters affecting the production and collection of the##2##8##(2008-10#2)
parameters affecting the##15##3##(2008-10#15)
parameters affecting##19##2##(2008-10#19)
parameters after##4##2##(1996-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
parameters alpha and##3##3##(2008-6#2)(2008-9#1)
parameters and a##2##3##(1995-9#1)(2008-3#1)
parameters and clinical##2##3##(2010-12#1)(2011-2#1)
parameters and the##4##3##(1995-8#1)(2008-10#3)
parameters and their##3##3##(2008-10#2)(2011-2#1)
parameters and to##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
parameters and##63##2##(1994-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-3#6)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2010-4#4)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#3)(2013-8#3)
parameters applied##2##2##(2008-10#1)(2008-11#1)
parameters are considered##2##3##(1994-8#1)(2008-5#1)
parameters are##28##2##(1991-9#1)(1994-8#1)(1995-9#1)(2008-10#12)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
parameters as##5##2##(1997-8#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-1#1)
parameters associated to##2##3##(2008-10#2)
parameters associated with the##2##4##(1993-1#1)(2008-10#1)
parameters associated with##3##3##(1993-1#1)(1997-6#1)(2008-10#1)
parameters associated##5##2##(1993-1#1)(1997-6#1)(2008-10#3)
parameters at##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
parameters based on##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
parameters being##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
parameters between the##3##3##(2007-8#1)(2008-10#1)(2010-7#1)
parameters between##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)
parameters but##3##2##(1993-8#1)(2008-3#1)(2008-7#1)
parameters by##7##2##(2008-10#1)(2008-3#1)(2008-5#2)(2010-3#1)(2012-2#2)
parameters can be##4##3##(2008-10#2)(2008-3#1)(2008-6#1)
parameters can##8##2##(1994-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
parameters characterizing##2##2##(2008-5#1)(2008-6#1)
parameters decreased##2##2##(1992-5#1)(2008-10#1)
parameters derived from##3##3##(2008-10#2)(2008-5#1)
parameters describing the##2##3##(2008-10#2)
parameters describing##5##2##(2008-10#4)(2008-7#1)
parameters during##3##2##(1990-5#1)(2008-10#2)
parameters estimated by##2##3##(1994-9#1)(2008-7#1)
parameters evaluated##4##2##(1990-9#1)(1992-3#1)(2008-1#1)(2011-7#1)
parameters for a##2##3##(2008-10#2)
parameters for both##3##3##(1995-5#1)(2008-10#2)
parameters for determination of##2##4##(2008-10#2)
parameters for the determination of##3##5##(2008-10#3)
parameters for the formation of##2##5##(1992-3#1)(2008-10#1)
parameters for the interaction of##2##5##(2008-10#2)
parameters for the interconversion##3##4##(1990-9#1)(2008-10#2)
parameters for the##32##3##(1990-9#1)(1992-3#1)(1993-8#1)(1994-5#1)(1997-2#1)(1997-4#1)(2008-10#21)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)
parameters for water quality##2##4##(2008-10#2)
parameters for##70##2##(1990-9#1)(1992-3#2)(1993-2#1)(1993-8#2)(1994-5#1)(1995-5#1)(1997-2#2)(1997-4#2)(2008-10#42)(2008-11#6)(2008-12#1)(2008-3#5)(2008-7#1)(2008-8#1)(2009-7#1)(2011-3#1)
parameters from a##2##3##(2008-8#1)(2011-2#1)
parameters from##9##2##(1995-5#1)(2008-3#4)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
parameters had##4##2##(1994-5#1)(2008-10#3)
parameters has##2##2##(2008-10#2)
parameters have been determined##2##4##(2008-10#1)(2008-3#1)
parameters have been investigated##2##4##(2008-10#2)
parameters have been optimised##2##4##(2008-10#2)
parameters have been##12##3##(2008-10#11)(2008-3#1)
parameters have##14##2##(2008-10#13)(2008-3#1)
parameters in patients with##2##4##(2010-12#1)(2013-1#1)
parameters in the model##2##4##(2008-7#2)
parameters in the##12##3##(1994-8#1)(1995-9#3)(2008-10#5)(2008-7#2)(2012-3#1)
parameters in##45##2##(1990-11#1)(1994-8#1)(1995-12#2)(1995-9#3)(2007-8#1)(2008-10#13)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-3#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
parameters include##2##2##(2008-10#1)(2008-7#1)
parameters including reagent##2##3##(2008-10#2)
parameters including the##2##3##(2008-10#1)(2008-12#1)
parameters including##11##2##(1994-5#1)(2008-10#5)(2008-12#2)(2008-3#1)(2010-12#1)(2012-2#1)
parameters influencing the##4##3##(1992-9#1)(2008-10#2)(2012-3#1)
parameters into##2##2##(2008-10#1)(2008-9#1)
parameters involved in the##2##4##(2008-10#1)(2008-11#1)
parameters involved in##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
parameters involved##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
parameters is##8##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-2#1)(2013-8#1)
parameters like the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
parameters like##10##2##(2008-10#5)(2008-11#4)(2008-7#1)
parameters measured##3##2##(1996-1#1)(2012-2#2)
parameters needed to##2##3##(2008-10#1)(2010-7#1)
parameters needed##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
parameters obtained were##2##3##(2008-10#2)
parameters obtained##5##2##(1995-12#1)(2008-10#4)
parameters of an##2##3##(2008-5#1)(2013-1#1)
parameters of both##3##3##(1990-5#1)(2008-10#1)(2008-8#1)
parameters of forensic interest##3##4##(2008-12#3)
parameters of interest##2##3##(2008-10#1)(2008-3#1)
parameters of skin##2##3##(2012-3#1)(2013-8#1)
parameters of the binary##2##4##(2008-10#2)
parameters of the calibration##2##4##(2008-10#1)(2009-8#1)
parameters of the method##2##4##(2008-10#2)
parameters of the##50##3##(1990-2#1)(1990-5#1)(1992-9#1)(1993-3#1)(1994-9#1)(2007-11#1)(2008-10#23)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-9#1)(2013-1#1)
parameters of these##2##3##(1995-2#1)(2008-10#1)
parameters of##139##2##(1990-2#1)(1990-5#2)(1991-2#1)(1992-3#1)(1992-9#2)(1993-3#1)(1994-2#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-6#1)(2007-11#3)(2008-10#53)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-8#2)(2011-2#7)(2011-3#3)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#6)(2013-8#3)
parameters on the response##2##4##(2008-10#2)
parameters on the##20##3##(1991-5#1)(1995-9#1)(1997-2#1)(2008-10#8)(2008-11#5)(2008-3#2)(2011-2#2)
parameters on##31##2##(1991-5#1)(1995-9#1)(1997-2#1)(2008-10#15)(2008-11#7)(2008-3#2)(2008-7#1)(2011-2#2)(2013-1#1)
parameters over##2##2##(2008-3#1)(2013-8#1)
parameters related to the##8##4##(1993-6#1)(2008-10#6)(2010-8#1)
parameters related to##9##3##(1993-6#1)(2008-10#7)(2010-8#1)
parameters should be##3##3##(2008-10#3)
parameters show##2##2##(1992-9#1)(2008-10#1)
parameters showed##2##2##(2008-10#1)(2008-3#1)
parameters such as pH##5##4##(2008-10#5)
parameters such as sample##2##4##(2008-10#2)
parameters such as temperature##2##4##(2008-10#1)(2008-3#1)
parameters such as the##15##4##(2008-10#10)(2008-3#2)(2008-8#1)(2009-8#1)(2011-3#1)
parameters such as##52##3##(1990-8#1)(1994-5#1)(1997-2#1)(2008-10#35)(2008-3#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
parameters that affect the##5##4##(2008-10#4)(2008-11#1)
parameters that affect##8##3##(1992-3#1)(2008-10#5)(2008-11#1)(2009-8#1)
parameters that can be##2##4##(2008-11#1)(2008-3#1)
parameters that can##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)
parameters that could##2##3##(2011-2#1)(2012-2#1)
parameters that describe the##3##4##(1990-8#1)(2008-10#1)(2008-5#1)
parameters that have prognostic##2##4##(2008-9#1)(2010-10#1)
parameters that have##3##3##(2008-9#1)(2010-10#1)(2011-3#1)
parameters that influence the##2##4##(2008-10#2)
parameters that were##2##3##(2008-10#1)(2008-6#1)
parameters that##43##2##(1990-8#1)(1992-3#1)(1995-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
parameters the##2##2##(2008-10#1)(2008-7#1)
parameters to be##4##3##(2008-10#3)(2008-3#1)
parameters to##11##2##(1991-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-4#1)(2013-8#1)
parameters used##2##2##(1990-5#1)(1992-9#1)
parameters using##4##2##(2008-2#1)(2008-6#1)(2010-12#1)(2013-3#1)
parameters was done##2##3##(2008-10#1)(2012-2#1)
parameters was observed##2##3##(1991-11#1)(2011-1#1)
parameters was##12##2##(1991-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2011-1#2)(2012-2#2)
parameters were also##2##3##(2008-10#1)(2013-1#1)
parameters were assessed##3##3##(2008-10#2)(2013-1#1)
parameters were calculated##4##3##(2008-10#3)(2008-11#1)
parameters were derived from##2##4##(2008-10#1)(2008-5#1)
parameters were determined##5##3##(1991-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
parameters were established##2##3##(2008-10#2)
parameters were evaluated in##2##4##(1994-8#1)(2008-7#1)
parameters were evaluated##5##3##(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
parameters were investigated##5##3##(2008-10#5)
parameters were measured##3##3##(2008-8#1)(2010-4#1)(2013-8#1)
parameters were normalized##2##3##(1996-3#1)(2012-3#1)
parameters were obtained##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
parameters were optimised##4##3##(2008-10#4)
parameters were optimized for the determination of##3##7##(2008-10#3)
parameters were optimized for##4##4##(2008-10#4)
parameters were optimized##11##3##(2008-10#11)
parameters were quantified##2##3##(2008-10#1)(2009-7#1)
parameters were studied##9##3##(1994-3#1)(1994-5#1)(2008-10#6)(2008-5#1)
parameters were tested##3##3##(2008-10#3)
parameters were the##2##3##(2008-10#2)
parameters were##94##2##(1991-5#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-8#1)(1996-3#1)(2008-10#59)(2008-11#2)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-7#1)(2010-4#1)(2011-10#1)(2011-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
parameters which are##2##3##(2008-10#1)(2008-7#1)
parameters which influence##2##3##(2008-10#1)(2012-2#1)
parameters which were##2##3##(2008-10#2)
parameters which##9##2##(1990-8#1)(1992-12#1)(2008-10#4)(2008-6#1)(2008-7#1)(2012-2#1)
parameters with a##2##3##(2008-10#1)(2013-1#1)
parameters with##3##2##(2008-10#1)(2011-10#1)(2013-1#1)
parameters##1197##1##(1990-11#2)(1990-2#2)(1990-4#2)(1990-5#4)(1990-8#6)(1990-9#3)(1991-1#2)(1991-11#3)(1991-2#1)(1991-3#1)(1991-5#3)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#8)(1992-5#2)(1992-9#8)(1993-1#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#4)(1994-12#1)(1994-2#3)(1994-3#6)(1994-5#6)(1994-8#6)(1994-9#3)(1995-1#2)(1995-12#5)(1995-2#1)(1995-5#3)(1995-8#2)(1995-9#8)(1996-1#1)(1996-11#1)(1996-3#6)(1997-2#8)(1997-4#2)(1997-6#4)(1997-8#2)(2007-11#4)(2007-12#1)(2007-8#4)(2008-1#4)(2008-10#521)(2008-11#51)(2008-12#23)(2008-2#13)(2008-3#81)(2008-4#6)(2008-5#35)(2008-6#10)(2008-7#41)(2008-8#26)(2008-9#23)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-7#4)(2009-8#6)(2009-9#1)(2010-10#4)(2010-11#4)(2010-12#7)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#2)(2010-7#3)(2010-8#6)(2011-1#5)(2011-10#3)(2011-2#40)(2011-3#8)(2011-7#1)(2012-12#3)(2012-2#24)(2012-3#19)(2012-5#1)(2012-7#1)(2012-9#3)(2013-1#30)(2013-3#1)(2013-8#23)
parameters&quot##2##1##(1990-9#1)(2011-2#1)
parameters'##2##1##(2008-10#1)(2008-11#1)
parameters)##2##1##(2008-11#1)(2008-4#1)
parameters]##4##1##(1990-8#1)(1991-11#1)(2011-2#1)(2012-3#1)
parametric amplification##2##2##(2007-11#1)(2008-3#1)
parametric amplifier##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
parametric and nonparametric##4##3##(2008-10#1)(2009-10#3)
parametric interaction##2##2##(2008-3#2)
parametric models in##2##3##(1995-9#1)(2013-1#1)
parametric models##3##2##(1995-9#2)(2013-1#1)
parametric oscillation##7##2##(2007-11#1)(2007-12#5)(2008-3#1)
parametric oscillator with a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
parametric oscillator##19##2##(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#8)
parametric##65##1##(1991-12#1)(1991-2#1)(1995-12#1)(1995-9#2)(2007-11#5)(2007-12#19)(2008-10#9)(2008-11#3)(2008-2#5)(2008-3#13)(2008-4#1)(2009-10#3)(2010-5#1)(2013-1#1)
parametrization##2##1##(2008-6#1)(2010-11#1)
paramount in##2##2##(2009-10#1)(2013-7#1)
paramount##10##1##(1994-12#1)(1995-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2011-3#1)(2013-7#1)
paranasal sinuses##4##2##(1990-6#1)(1991-6#1)(2008-11#1)(2011-2#1)
paranasal##7##1##(1990-6#1)(1991-6#1)(2008-11#1)(2008-5#2)(2010-6#1)(2011-2#1)
paraneoplasic neurological syndromes##3##3##(1996-11#3)
paraneoplasic##4##1##(1996-11#4)
paraneoplastic##6##1##(1994-9#1)(1996-11#1)(1997-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
paraophthalmic##2##1##(2012-3#2)
paraoxon##11##1##(2008-10#11)
paraoxonase 1 (PON1)##2##3##(2012-12#1)(2013-8#1)
paraoxonase 1##3##2##(2012-12#2)(2013-8#1)
paraparesis##4##1##(1997-6#1)(2008-12#1)(2008-7#2)
parapatellar##2##1##(2013-1#2)
parapharyngeal space##3##2##(2008-7#1)(2012-3#2)
paraphrenia##4##1##(2011-2#4)
paraphyletic##2##1##(2007-12#2)
paraplegia and##2##2##(2008-12#1)(2013-1#1)
paraplegia following##2##2##(1996-3#1)(2008-7#1)
paraplegia##11##1##(1996-3#1)(2008-12#2)(2008-7#6)(2011-2#1)(2013-1#1)
paraplegic athletes##2##2##(2013-1#2)
parapsilosis##9##1##(1997-2#3)(2008-5#5)(2013-1#1)
paraquat herbicide##2##2##(2008-10#2)
paraquat in##7##2##(2008-10#7)
paraquat using a##2##3##(2008-10#2)
paraquat##21##1##(2008-10#19)(2008-5#1)(2013-8#1)
parasagittal AVM##3##2##(2008-7#3)
parasagittal##6##1##(1994-2#1)(2008-7#4)(2013-1#1)
parasexual recombination##3##2##(2008-10#2)(2008-8#1)
parasexual##6##1##(2008-10#5)(2008-8#1)
parasite and host##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
parasite and##5##2##(2008-10#2)(2008-9#2)(2011-2#1)
parasite control of##2##3##(1997-7#1)(2008-9#1)
parasite control##6##2##(1997-7#5)(2008-9#1)
parasite cytoplasm and##2##3##(2012-2#2)
parasite infection##2##2##(1997-7#1)(2008-8#1)
parasite life-history traits##3##3##(2008-8#3)
parasite may##2##2##(2008-8#2)
parasite of the##2##3##(2011-2#2)
parasite of##11##2##(1991-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-3#1)(2011-2#2)(2013-1#1)
parasite on##2##2##(2008-8#1)(2010-8#1)
parasite population##2##2##(1997-7#1)(2008-9#1)
parasite populations##2##2##(2008-8#2)
parasite species and diagnostic method##2##5##(2012-12#2)
parasite species##6##2##(1996-12#1)(2012-12#5)
parasite success##2##2##(2008-8#2)
parasite to##2##2##(2008-9#1)(2012-2#1)
parasite virulence and##2##3##(2008-8#2)
parasite virulence##13##2##(2008-8#12)(2008-9#1)
parasite##122##1##(1991-5#2)(1993-2#3)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#2)(1997-7#9)(2007-12#1)(2008-10#12)(2008-12#1)(2008-8#32)(2008-9#12)(2009-6#3)(2009-7#2)(2009-8#2)(2010-3#1)(2010-4#2)(2010-8#4)(2011-2#5)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#3)(2013-8#2)
parasite)##2##1##(2008-8#1)(2008-9#1)
parasite-host##2##1##(2008-8#1)(2008-9#1)
parasite-induced host sterility##3##3##(2008-9#3)
parasite-induced host##4##2##(2008-9#4)
parasite-mediated selection##3##2##(2012-3#3)
parasitemia was##2##2##(1995-12#1)(2012-12#1)
parasites and diseases##2##3##(1997-7#2)
parasites and free-living animals##2##4##(2008-9#2)
parasites and their hosts##2##4##(1997-7#1)(2012-3#1)
parasites and##10##2##(1997-7#4)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#2)
parasites are##5##2##(2007-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
parasites from##3##2##(1996-12#1)(2013-8#2)
parasites in the Umbozero Lake##2##5##(2011-2#2)
parasites in the##3##3##(2008-4#1)(2011-2#2)
parasites in##10##2##(1995-12#2)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#2)
parasites of##11##2##(1996-12#1)(1997-7#1)(2008-10#4)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
parasites on##2##2##(2008-8#1)(2013-1#1)
parasites or##2##2##(1994-3#1)(1997-7#1)
parasites that##5##2##(2008-8#4)(2008-9#1)
parasites to##2##2##(2008-10#1)(2009-6#1)
parasites were##2##2##(2008-10#1)(2011-2#1)
parasites##109##1##(1990-3#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-5#1)(1996-12#6)(1997-7#13)(2006-5#1)(2007-12#4)(2008-10#10)(2008-4#1)(2008-5#1)(2008-8#18)(2008-9#10)(2009-6#5)(2010-1#1)(2011-2#7)(2012-12#2)(2012-2#8)(2012-3#10)(2013-1#2)(2013-8#3)
parasitic and##2##2##(1995-5#1)(2008-10#1)
parasitic dermatitis##2##2##(1996-6#2)
parasitic disease##4##2##(1997-7#1)(2010-1#1)(2010-11#1)(2011-2#1)
parasitic diseases##2##2##(1996-1#1)(1997-7#1)
parasitic female##2##2##(2008-8#2)
parasitic fitness##3##2##(2008-10#3)
parasitic infection##5##2##(1995-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
parasitic nematodes##3##2##(2008-10#2)(2008-8#1)
parasitic wasps##2##2##(1990-11#1)(2007-12#1)
parasitic weed##2##2##(2008-10#2)
parasitic##58##1##(1990-11#2)(1995-5#2)(1996-1#1)(1996-6#2)(1997-7#3)(2007-12#1)(2008-10#12)(2008-3#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
parasitica and##3##2##(2008-10#3)
parasitica in##5##2##(2008-10#5)
parasitica isolates##3##2##(2008-10#3)
parasitica on##3##2##(2008-10#3)
parasitica was##2##2##(2008-10#2)
parasitica were##3##2##(2008-10#3)
parasitica##46##1##(1995-6#1)(2008-10#44)(2008-9#1)
parasiticus##4##1##(2008-10#3)(2008-11#1)
parasitism and##2##2##(1997-7#1)(2008-10#1)
parasitism by##2##2##(1995-3#1)(2008-8#1)
parasitism in##6##2##(2008-8#4)(2012-12#2)
parasitism of##3##2##(2008-10#2)(2008-8#1)
parasitism##44##1##(1995-3#1)(1997-7#1)(2008-10#7)(2008-8#21)(2008-9#8)(2010-8#2)(2012-12#4)
parasitize an##2##2##(2008-8#2)
parasitize##6##1##(2008-10#3)(2008-8#2)(2013-8#1)
parasitized by the##2##3##(1992-6#1)(2008-9#1)
parasitized by##6##2##(1992-6#1)(2008-10#1)(2008-9#3)(2010-4#1)
parasitized erythrocytes##2##2##(1993-8#2)
parasitized more##2##2##(2008-10#2)
parasitized red blood cells##2##4##(1990-12#1)(2012-12#1)
parasitized##21##1##(1990-12#1)(1992-6#2)(1993-8#2)(2008-10#5)(2008-8#2)(2008-9#3)(2010-4#2)(2012-12#1)(2013-1#1)(2013-8#2)
parasitizes##3##1##(2007-12#1)(2008-10#1)(2010-4#1)
parasitizing##6##1##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
parasitoid Hymenoptera##2##2##(2007-12#1)(2008-9#1)
parasitoid species##2##2##(2008-8#2)
parasitoid virulence##2##2##(2008-8#2)
parasitoid##14##1##(1992-6#1)(2007-12#1)(2008-8#8)(2008-9#3)(2009-8#1)
parasitoids##7##1##(2008-8#1)(2008-9#4)(2009-8#2)
parasitological##5##1##(2010-1#1)(2012-12#3)(2012-2#1)
parasitology##11##1##(1994-12#1)(1997-7#5)(2010-1#5)
parasitosis among##3##2##(1996-12#1)(2012-3#2)
parasitosis##4##1##(1996-12#1)(2012-3#3)
paraspinal##2##1##(2008-12#2)
parasympathetic##7##1##(1992-6#1)(1994-9#1)(1997-1#1)(2008-10#1)(2010-5#1)(2012-2#2)
parathion##5##1##(1994-5#2)(2008-10#3)
parathormone##4##1##(1991-11#2)(2008-1#1)(2011-1#1)
parathyroid adenoma and##2##3##(1996-9#1)(2008-5#1)
parathyroid adenoma##3##2##(1996-9#1)(2008-12#1)(2008-5#1)
parathyroid adenomas and##3##3##(2008-5#3)
parathyroid adenomas##4##2##(2008-10#1)(2008-5#3)
parathyroid gland##2##2##(2008-10#1)(2011-2#1)
parathyroid hormone (PTH##3##3##(1991-6#1)(1993-12#1)(1993-6#1)
parathyroid hormone (PTH)##6##3##(1990-11#1)(1991-12#1)(1994-11#1)(2008-5#1)(2011-1#1)(2012-12#1)
parathyroid hormone##20##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-3#2)(1991-6#2)(1993-12#1)(1993-6#2)(1994-11#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
parathyroid tissue##2##2##(2008-10#2)
parathyroid##43##1##(1990-11#1)(1990-2#1)(1990-9#2)(1991-12#1)(1991-3#2)(1991-6#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1996-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#11)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)
parathyroidectomy##8##1##(1991-11#1)(1993-3#2)(2008-10#1)(2008-12#1)(2011-2#3)
paraventricular hypothalamic nucleus##2##3##(1994-2#1)(2008-8#1)
paraventricular nucleus (PVN)##2##3##(1994-8#1)(1996-12#1)
paraventricular nucleus##9##2##(1994-8#2)(1996-12#5)(2008-4#1)(2008-9#1)
paraventricular##13##1##(1994-2#1)(1994-8#2)(1996-12#7)(2008-4#1)(2008-8#1)(2008-9#1)
paravertebral##3##1##(1997-6#1)(2013-8#2)
paraxial##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
parenchyma and##3##2##(1991-12#1)(2008-10#1)(2013-7#1)
parenchyma cells##12##2##(2008-10#9)(2008-11#2)(2012-5#1)
parenchyma in##3##2##(1991-3#1)(2008-11#1)(2009-8#1)
parenchyma##44##1##(1991-12#4)(1991-3#1)(1992-1#1)(1992-12#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#2)(2013-7#1)
parenchymal cells##6##2##(1994-3#2)(2008-11#2)(2008-6#1)(2013-8#1)
parenchymal liver cells##2##3##(1996-2#1)(2011-2#1)
parenchymal##21##1##(1990-6#1)(1991-12#3)(1992-3#1)(1994-3#2)(1996-2#1)(1996-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
parenchymatous##5##1##(1992-2#1)(1996-6#1)(1997-2#1)(1997-8#2)
parent Fol007##2##2##(2008-10#2)
parent and progeny##2##3##(2008-10#2)
parent and##7##2##(1994-3#1)(2008-10#4)(2009-9#1)(2010-8#1)
parent brain##2##2##(2009-9#2)
parent cell##2##2##(2008-11#2)
parent compound##10##2##(1990-12#2)(1995-6#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-11#2)
parent compounds##3##2##(2008-10#2)(2009-12#1)
parent drug##12##2##(2008-10#5)(2008-8#1)(2010-11#3)(2011-3#1)(2013-1#2)
parent education programs##2##3##(1995-1#2)
parent education##6##2##(1991-2#1)(1995-1#4)(2011-2#1)
parent in the##2##3##(2008-10#1)(2008-11#1)
parent in##4##2##(2008-10#1)(2008-11#2)(2010-5#1)
parent isolates were##2##3##(2008-10#2)
parent isolates##6##2##(2008-10#6)
parent material##2##2##(2008-10#1)(2008-11#1)
parent molecule##4##2##(1992-12#1)(2008-3#1)(2010-7#2)
parent perceptions##2##2##(1995-1#1)(2012-2#1)
parent plants##2##2##(2008-10#2)
parent strain##3##2##(1995-2#1)(2008-10#2)
parent variables##2##2##(1995-2#1)(2008-11#1)
parent was##4##2##(2008-10#3)(2008-9#1)
parent were##2##2##(2008-10#2)
parent##178##1##(1990-12#4)(1991-2#2)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-8#1)(1995-1#5)(1995-11#1)(1995-2#6)(1995-6#1)(1995-9#1)(1996-1#1)(2008-10#82)(2008-11#21)(2008-12#2)(2008-3#1)(2008-8#3)(2008-9#6)(2009-12#1)(2009-7#1)(2009-9#3)(2010-11#5)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#4)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
parent's##6##1##(1992-3#1)(1993-2#1)(1993-3#2)(2008-11#1)(2008-8#1)
parent-adolescent communication##4##2##(1990-12#1)(2013-1#3)
parent-adolescent relationships##3##2##(2009-7#3)
parent-adolescent##9##1##(1990-12#2)(2009-7#3)(2010-1#1)(2013-1#3)
parent-child interaction tasks##2##3##(2009-11#2)
parent-child interaction##4##2##(1992-12#1)(2009-11#3)
parent-child interactions##2##2##(1995-1#1)(2009-11#1)
parent-child relationship##4##2##(1992-2#1)(1995-5#1)(1996-9#1)(2013-8#1)
parent-child##11##1##(1992-12#1)(1992-2#1)(1995-1#1)(1995-5#1)(1996-9#1)(2008-11#1)(2009-11#4)(2013-8#1)
parent-infant##2##1##(2009-9#2)
parent-offspring conflict over##2##3##(2008-8#1)(2008-9#1)
parent-offspring##4##1##(2008-10#1)(2008-8#1)(2008-9#2)
parentage##4##1##(2008-9#3)(2010-8#1)
parental MDCK cells##2##3##(2008-11#2)
parental and progeny##2##3##(2008-10#2)
parental and##8##2##(1994-8#1)(2008-10#3)(2008-11#2)(2010-8#1)(2012-2#1)
parental behavior##2##2##(1993-3#1)(2008-8#1)
parental care can##2##3##(2008-8#2)
parental care in rats and mice##2##6##(2008-4#2)
parental care in##5##3##(2008-4#2)(2008-8#3)
parental care##20##2##(1995-6#1)(2008-4#2)(2008-8#15)(2008-9#2)
parental cells##2##2##(1993-1#1)(1994-8#1)
parental chromosome##2##2##(1997-7#2)
parental clone##2##2##(1994-11#1)(2008-10#1)
parental closeness##2##2##(2010-9#2)
parental cognitions##2##2##(1995-2#2)
parental genes##2##2##(2009-10#2)
parental history of##2##3##(2010-4#1)(2010-6#1)
parental history##4##2##(2010-4#3)(2010-6#1)
parental investment is##2##3##(2008-8#1)(2008-9#1)
parental investment##15##2##(2008-8#5)(2008-9#10)
parental isolates##4##2##(2008-10#4)
parental lines##2##2##(2008-10#1)(2008-11#1)
parental myeloma##3##2##(1991-12#3)
parental notice##2##2##(1997-6#2)
parental origin##3##2##(1993-1#1)(1997-3#1)(2010-8#1)
parental quality##2##2##(2008-9#1)(2010-9#1)
parental responsibility##2##2##(2010-5#1)(2010-7#1)
parental right to make##2##4##(1995-12#2)
parental role##2##2##(1992-2#1)(1995-1#1)
parental species##6##2##(2008-10#2)(2008-8#2)(2012-3#2)
parental strain on##2##3##(2008-10#1)(2009-6#1)
parental strain##7##2##(2008-10#6)(2009-6#1)
parental strains##6##2##(2008-10#4)(2008-12#2)
parental virus##2##2##(2008-10#1)(2008-9#1)
parental warmth##6##2##(2010-1#6)
parental##173##1##(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1992-2#3)(1993-1#4)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-12#3)(1995-2#2)(1995-6#2)(1996-2#2)(1996-5#1)(1997-3#2)(1997-6#3)(1997-7#3)(2008-10#26)(2008-11#10)(2008-12#6)(2008-4#3)(2008-5#1)(2008-8#25)(2008-9#20)(2009-10#2)(2009-6#1)(2009-7#3)(2010-1#7)(2010-11#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#3)
parental-type##2##1##(2008-10#2)
parenteral administration##2##2##(2008-5#1)(2008-9#1)
parenteral drug##2##2##(1990-2#1)(2008-5#1)
parenteral nutrition (TPN)##4##3##(1992-9#2)(1994-6#1)(2008-10#1)
parenteral nutrition##10##2##(1991-6#1)(1992-9#3)(1994-6#2)(2008-10#2)(2009-5#1)(2011-2#1)
parenteral solution##2##2##(2008-10#1)(2012-12#1)
parenteral solutions##3##2##(2008-10#3)
parenteral##32##1##(1990-2#1)(1991-6#1)(1992-9#3)(1994-6#2)(2006-5#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
parenterally##2##1##(1993-3#1)(2013-7#1)
parenthood and its##2##3##(1995-1#1)(2009-10#1)
parenthood and##3##2##(1995-1#1)(1996-9#1)(2009-10#1)
parenthood##5##1##(1995-1#2)(1996-9#1)(2009-10#1)(2009-11#1)
parenting and cognitions##2##3##(2010-1#2)
parenting and##6##2##(2008-12#1)(2009-7#1)(2010-1#4)
parenting behaviors##4##2##(2009-10#1)(2009-12#2)(2009-9#1)
parenting of##2##2##(2009-12#2)
parenting practices##3##2##(2008-11#1)(2009-7#1)(2009-9#1)
parenting satisfaction and efficacy##2##4##(1995-2#2)
parenting self-esteem##2##2##(1995-2#1)(2009-11#1)
parenting skills##2##2##(1992-12#1)(1997-3#1)
parenting stress##2##2##(1995-1#1)(2012-2#1)
parenting styles##2##2##(2013-1#2)
parenting##45##1##(1992-12#1)(1995-1#2)(1995-2#4)(1997-3#1)(2008-11#3)(2008-12#2)(2009-10#1)(2009-11#2)(2009-12#6)(2009-7#5)(2009-9#6)(2010-1#7)(2012-2#2)(2013-1#3)
parents after##2##2##(1996-9#1)(2008-11#1)
parents and F(1)##2##3##(2008-10#2)
parents and children##2##3##(1995-1#1)(2013-8#1)
parents and peers##3##3##(1990-2#3)
parents and teachers##2##3##(2011-2#1)(2012-12#1)
parents and the##5##3##(1990-12#1)(1994-1#1)(1995-1#1)(2008-10#1)(2009-9#1)
parents and their##4##3##(1990-12#1)(2008-11#1)(2008-6#1)(2008-9#1)
parents and##40##2##(1990-12#3)(1990-2#3)(1994-1#1)(1995-1#2)(1995-12#1)(1997-7#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-6#2)(2008-9#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
parents are##9##2##(1991-2#1)(1992-2#1)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-9#1)
parents felt##2##2##(2008-9#1)(2010-8#1)
parents for##2##2##(1992-2#1)(2008-10#1)
parents from##2##2##(1995-1#1)(2008-10#1)
parents had##5##2##(1990-12#1)(2010-10#1)(2010-11#2)(2010-4#1)
parents have##2##2##(1990-12#1)(2013-1#1)
parents in the##2##3##(2008-10#1)(2010-5#1)
parents in##11##2##(1995-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
parents is##4##2##(1990-6#1)(1994-6#1)(2009-7#1)(2013-1#1)
parents obtain##2##2##(1993-12#1)(2008-11#1)
parents of children with cancer##2##5##(2010-7#1)(2010-9#1)
parents of children with medically complex needs##2##7##(1992-2#2)
parents of children with moderate mental retardation##2##7##(1993-3#2)
parents of children with severe##2##5##(1993-3#2)
parents of children with##12##4##(1992-2#2)(1993-3#5)(1995-2#1)(2008-11#1)(2008-9#1)(2010-7#1)(2010-9#1)
parents of children##16##3##(1992-2#3)(1993-3#5)(1995-2#1)(2008-11#1)(2008-9#2)(2010-7#2)(2010-9#1)(2012-2#1)
parents of healthy children##2##4##(1995-2#2)
parents of high-risk newborns##2##4##(1993-3#2)
parents of high-risk##4##3##(1993-3#2)(2008-11#2)
parents of young children##2##4##(1994-3#1)(1995-2#1)
parents of##37##2##(1991-11#1)(1992-2#3)(1993-3#7)(1994-3#2)(1995-12#1)(1995-2#5)(2008-10#1)(2008-11#4)(2008-7#1)(2008-9#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#2)(2012-2#2)(2013-7#1)
parents or##3##2##(1995-5#2)(2011-2#1)
parents rated##2##2##(2008-12#1)(2010-8#1)
parents reported##2##2##(2010-1#1)(2010-10#1)
parents should##2##2##(2008-12#1)(2008-9#1)
parents to##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
parents want##2##2##(2008-11#2)
parents were also##2##3##(1995-12#1)(2008-10#1)
parents were##19##2##(1991-11#2)(1991-2#1)(1992-2#2)(1994-6#3)(1995-12#2)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2013-1#2)
parents who##5##2##(1994-3#1)(1996-5#1)(2009-7#1)(2011-1#1)(2011-2#1)
parents with a##2##3##(2008-11#1)(2013-1#1)
parents with##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
parents##270##1##(1990-12#7)(1990-2#3)(1990-6#2)(1990-9#1)(1991-11#3)(1991-2#3)(1992-2#11)(1993-12#1)(1993-2#2)(1993-3#10)(1994-1#1)(1994-3#4)(1994-6#5)(1995-1#5)(1995-12#9)(1995-2#6)(1995-5#5)(1995-6#1)(1996-5#2)(1996-9#1)(1997-7#2)(1997-8#1)(2008-10#39)(2008-11#26)(2008-12#6)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#6)(2008-9#13)(2009-10#1)(2009-6#1)(2009-7#8)(2009-9#1)(2010-1#3)(2010-10#9)(2010-11#4)(2010-4#4)(2010-5#3)(2010-7#3)(2010-8#5)(2010-9#6)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#10)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#4)
parents' adherence##2##2##(1994-3#2)
parents' perceptions of##2##3##(2010-8#1)(2011-1#1)
parents' persuasion##2##2##(2010-1#2)
parents'##14##1##(1990-2#1)(1993-12#1)(1993-3#1)(1994-3#2)(2008-11#1)(2008-12#1)(2010-1#3)(2010-8#2)(2010-9#1)(2011-1#1)
parents'/guardians' health literacy##2##3##(2010-9#2)
parents?##2##1##(1995-5#1)(2009-9#1)
paresis##5##1##(1994-3#1)(2009-4#1)(2011-2#3)
paresthesia##2##1##(2008-7#1)(2011-2#1)
parietal and##4##2##(1995-6#1)(2008-11#1)(2010-7#1)(2013-8#1)
parietal cell##3##2##(1997-1#3)
parietal cells##12##2##(1992-6#1)(1995-6#2)(1997-1#6)(2007-12#3)
parietal cortex##3##2##(2010-7#1)(2013-8#2)
parietal cortical##2##2##(1990-5#1)(2010-12#1)
parietal layer##2##2##(2008-10#2)
parietal lobe##4##2##(1997-3#1)(1997-6#1)(2008-7#1)(2009-1#1)
parietal lobule##4##2##(1996-2#1)(2008-11#3)
parietal region##2##2##(2008-7#1)(2012-12#1)
parietal regions##2##2##(1991-12#1)(2008-11#1)
parietal##46##1##(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-6#1)(1995-6#3)(1996-2#3)(1997-1#9)(1997-3#1)(1997-6#1)(2007-12#3)(2008-10#2)(2008-11#5)(2008-7#2)(2009-1#1)(2009-10#1)(2010-12#1)(2010-7#3)(2011-2#1)(2012-12#1)(2013-8#4)
parieto-frontal##2##1##(1996-12#1)(2008-11#1)
parish nurse##3##2##(2008-12#3)
parish##6##1##(1991-12#1)(1993-12#2)(2008-12#3)
parish-based clergy##2##2##(2010-2#2)
parity and##2##2##(2008-11#1)(2009-4#1)
parity groups##3##2##(1990-6#3)
parity##13##1##(1990-6#3)(1991-2#1)(1993-2#1)(1995-1#2)(2008-11#2)(2008-3#1)(2009-4#1)(2010-6#1)(2011-2#1)
park##3##1##(2008-8#1)(2012-6#1)(2013-1#1)
parkin##2##1##(2008-7#2)
parking facility##2##2##(1992-12#1)(1993-12#1)
parking security##2##2##(1992-12#2)
parking##10##1##(1991-12#1)(1992-12#3)(1993-12#4)(2008-10#2)
parkinsonian motor fluctuations##2##3##(2008-7#2)
parkinsonian motor##3##2##(2008-7#2)(2012-2#1)
parkinsonian rats##2##2##(2008-12#2)
parkinsonian syndromes##2##2##(1993-11#2)
parkinsonian##11##1##(1993-11#2)(2008-12#2)(2008-7#6)(2012-2#1)
parkinsonism and##5##2##(1997-2#2)(2008-7#3)
parkinsonism##22##1##(1997-2#2)(2008-7#19)(2009-11#1)
parliament##2##1##(2008-11#1)(2013-8#1)
paroecandrum##2##1##(2008-10#2)
parotid salivary glands##2##3##(1990-11#2)
parotid##7##1##(1990-11#2)(1991-6#2)(2009-3#1)(2011-2#1)(2013-1#1)
parotidectomy##3##1##(2011-2#3)
paroxetine##2##1##(2008-11#1)(2012-3#1)
paroxysmal##7##1##(1992-12#2)(2008-11#2)(2010-12#1)(2012-12#1)(2012-3#1)
pars##12##1##(1994-8#2)(1995-2#1)(1996-12#2)(2008-6#3)(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
parsed into##2##2##(2008-10#2)
parsimonious##4##1##(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
parsimony analysis of##2##3##(2008-10#2)
parsimony and Bayesian##2##3##(2008-10#1)(2010-4#1)
parsimony and##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)
parsimony methods##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
parsimony of##2##2##(2008-10#1)(2010-11#1)
parsimony##15##1##(2008-10#7)(2008-4#3)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#1)
parsing algorithm for##2##3##(2011-3#2)
parsing algorithm##4##2##(2011-3#4)
parsing and reanalysis##2##3##(2007-12#2)
parsing##12##1##(2007-12#4)(2008-10#1)(2011-3#7)
parsley plastocyanin##5##2##(1994-5#5)
parsley seed##2##2##(2008-12#2)
parsley##11##1##(1994-5#5)(2008-10#3)(2008-11#1)(2008-12#2)
part (estimated by##2##3##(2009-8#2)
part (that##2##2##(2013-1#2)
part 2##4##2##(2008-10#1)(2009-10#1)(2009-9#1)(2011-2#1)
part I##6##2##(2008-3#2)(2008-4#2)(2008-7#2)
part II##8##2##(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)
part a##2##2##(2008-6#1)(2008-8#1)
part as##2##2##(1991-12#1)(2008-8#1)
part because of the##3##4##(1990-11#1)(2010-1#1)(2013-8#1)
part because of##5##3##(1990-11#1)(2008-1#1)(2008-8#1)(2010-1#1)(2013-8#1)
part because##10##2##(1990-11#1)(1994-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
part by##6##2##(1992-9#1)(1993-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
part discusses##3##2##(2009-6#1)(2011-2#1)(2012-3#1)
part in an##2##3##(1995-5#1)(2008-10#1)
part in development of##2##4##(2011-2#2)
part in the##8##3##(1993-9#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#2)
part in##33##2##(1991-3#1)(1993-9#2)(1995-5#1)(1996-1#1)(1996-11#2)(1996-9#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#4)(2013-1#1)(2013-8#1)
part is##7##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-8#1)
part of a broader##2##4##(2008-11#1)(2013-1#1)
part of a flow##2##4##(2008-10#2)
part of a general##2##4##(1995-1#1)(2008-10#1)
part of a large##3##4##(1991-9#1)(2008-10#1)(2008-9#1)
part of a larger study##4##5##(2008-11#2)(2009-12#1)(2010-7#1)
part of a larger##5##4##(1992-1#1)(2008-11#2)(2009-12#1)(2010-7#1)
part of a prevention programme##2##5##(1991-6#2)
part of a research##2##4##(1991-9#1)(2008-10#1)
part of a wider##3##4##(2008-10#1)(2008-12#1)(2013-8#1)
part of a##72##3##(1990-7#1)(1991-2#1)(1991-6#3)(1991-9#2)(1992-1#2)(1992-3#2)(1993-6#1)(1994-1#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-11#11)(2008-12#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
part of an integrated management##2##5##(2008-10#2)
part of an integrated##5##4##(2008-10#4)(2008-11#1)
part of an##21##3##(1990-10#1)(1990-11#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-5#1)(1995-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
part of complex##2##3##(2007-11#1)(2013-1#1)
part of her##2##3##(1995-6#1)(2013-8#1)
part of its##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
part of mainstream##2##3##(2008-11#1)(2013-1#1)
part of nursing##3##3##(1997-4#1)(2008-11#1)(2008-7#1)
part of our##5##3##(1994-8#1)(1996-2#1)(2008-5#1)(2009-7#1)(2011-2#1)
part of routine##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
part of the Genomic Encyclopedia of Bacteria and Archaea project##29##10##(2011-2#29)
part of the analysis##2##4##(1993-12#1)(2008-10#1)
part of the care##2##4##(1993-12#1)(2008-5#1)
part of the cell##3##4##(1997-8#1)(2008-10#1)(2008-7#1)
part of the disease##2##4##(2008-7#2)
part of the evaluation of##2##5##(2008-9#1)(2012-2#1)
part of the left##2##4##(1991-9#1)(1996-2#1)
part of the lung##2##4##(1994-12#2)
part of the metapopulation##3##4##(2008-9#3)
part of the molecular##2##4##(1993-12#1)(2010-4#1)
part of the natural##2##4##(1991-3#1)(2011-2#1)
part of the normal##3##4##(2008-10#1)(2008-9#1)(2013-7#1)
part of the paper##2##4##(1991-2#1)(2009-6#1)
part of the refractive index##4##5##(2008-3#4)
part of the review##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
part of the same##2##4##(2008-10#2)
part of the spectrum##2##4##(2011-2#2)
part of the standard##2##4##(2008-10#1)(2012-3#1)
part of the study##2##4##(2011-3#1)(2013-8#1)
part of the transgene mRNA##2##5##(2008-10#2)
part of the treatment of##2##5##(1992-1#1)(1996-6#1)
part of the treatment##4##4##(1992-1#1)(1996-6#1)(2011-2#1)(2013-8#1)
part of the variance##2##4##(2008-10#2)
part of the world##2##4##(2008-1#2)
part of the##299##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-9#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#2)(1992-12#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-6#2)(1994-1#3)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#4)(1997-7#1)(1997-8#3)(1997-9#1)(2007-12#2)(2008-1#2)(2008-10#43)(2008-11#13)(2008-12#4)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#13)(2009-1#1)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#3)(2011-2#50)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#7)
part of their##14##3##(1992-1#1)(1992-10#1)(1992-3#1)(1993-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#2)
part of these##2##3##(1993-2#1)(2008-10#1)
part of this##14##3##(1991-9#1)(1992-1#1)(1993-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)
part of two##3##3##(2008-10#2)(2009-4#1)
part of##558##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#6)(1991-8#2)(1991-9#7)(1992-1#8)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#4)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#4)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-1#7)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#3)(1996-6#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#8)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#79)(2008-11#39)(2008-12#12)(2008-2#2)(2008-3#10)(2008-4#5)(2008-5#12)(2008-6#4)(2008-7#16)(2008-8#9)(2008-9#18)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#2)(2010-4#1)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#4)(2011-2#67)(2011-3#2)(2012-12#3)(2012-2#12)(2012-3#8)(2013-1#14)(2013-7#2)(2013-8#12)
part per##2##2##(2008-10#1)(2008-3#1)
part reviews##2##2##(2008-8#2)
part the##4##2##(1991-3#1)(1997-8#1)(2010-4#1)(2013-1#1)
part to a##2##3##(2008-11#1)(2008-6#1)
part to##20##2##(1990-8#1)(1992-1#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-1#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-1#1)(2011-7#1)
part was##3##2##(1997-4#1)(1997-6#1)(2008-3#1)
part which##2##2##(1993-2#1)(2011-2#1)
part with##3##2##(1995-5#1)(2008-10#2)
part##835##1##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-12#4)(1991-2#5)(1991-3#3)(1991-5#4)(1991-6#8)(1991-8#2)(1991-9#7)(1992-1#9)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#7)(1993-3#2)(1993-6#5)(1993-8#4)(1993-9#4)(1994-1#8)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#5)(1994-8#7)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#2)(1995-5#5)(1995-6#5)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#8)(1996-2#5)(1996-3#6)(1996-6#4)(1996-9#4)(1997-1#6)(1997-2#4)(1997-3#8)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#6)(1997-9#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-8#2)(2008-1#4)(2008-10#122)(2008-11#64)(2008-12#12)(2008-2#4)(2008-3#17)(2008-4#13)(2008-5#17)(2008-6#6)(2008-7#23)(2008-8#23)(2008-9#26)(2009-1#3)(2009-10#4)(2009-11#1)(2009-12#3)(2009-4#3)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#9)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#3)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#7)(2011-1#1)(2011-2#86)(2011-3#2)(2011-7#1)(2012-12#4)(2012-2#16)(2012-3#15)(2013-1#22)(2013-7#2)(2013-8#17)
part-time post qualifying nursing students##3##5##(2008-11#3)
part-time post qualifying##4##3##(2008-11#4)
part-time##8##1##(2008-11#6)(2011-2#1)(2013-7#1)
parthenogenesis induction##3##2##(2008-8#3)
parthenogenesis##5##1##(2008-8#3)(2008-9#2)
parthenogenetic species##2##2##(2008-10#1)(2008-12#1)
parthenogenetic##3##1##(2007-12#1)(2008-10#1)(2008-12#1)
parthenogens##2##1##(2008-9#1)(2012-3#1)
partial DNA##2##2##(2008-8#2)
partial agonist at alpha##2##4##(1995-11#2)
partial agonist##8##2##(1992-10#1)(1992-8#1)(1993-1#1)(1995-11#4)(2008-11#1)
partial agonists##2##2##(2009-6#2)
partial amino acid sequences of##2##5##(1996-8#1)(2008-10#1)
partial amino acid sequences##3##4##(1996-8#1)(2008-10#1)(2008-8#1)
partial and full-swing##2##3##(2011-2#2)
partial and##7##2##(1992-9#1)(1993-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#2)
partial blast resistance in##2##4##(2008-10#2)
partial cDNA clones##2##3##(1990-8#2)
partial cDNA encoding##2##3##(1993-6#1)(1995-2#1)
partial cDNA##5##2##(1990-8#2)(1993-6#1)(1995-2#2)
partial cDNAs##3##2##(1991-12#1)(1993-12#2)
partial characterization of##5##3##(1992-6#1)(1993-3#1)(2008-10#3)
partial characterization##6##2##(1990-5#1)(1992-6#1)(1993-3#1)(2008-10#3)
partial complementary DNA##2##3##(1990-5#1)(1991-5#1)
partial differential equation model of##2##5##(2013-8#2)
partial differential equation model##3##4##(2008-8#1)(2013-8#2)
partial differential equation##4##3##(2008-6#1)(2008-8#1)(2013-8#2)
partial differential##6##2##(2008-6#1)(2008-8#1)(2013-8#4)
partial digestion of genomic DNA##2##5##(2008-4#2)
partial digestion of##3##3##(2008-10#1)(2008-4#2)
partial digestion##4##2##(2008-10#2)(2008-4#2)
partial embolisation##2##2##(1996-6#1)(1996-9#1)
partial gastrectomy##3##2##(1991-6#1)(1993-2#1)(2008-5#1)
partial hepatectomy and##2##3##(2013-1#1)(2013-7#1)
partial hepatectomy##3##2##(1996-2#1)(2013-1#1)(2013-7#1)
partial hospital##2##2##(1991-1#2)
partial hospitalization##13##2##(1991-1#4)(1992-1#9)
partial in##2##2##(1991-8#1)(1995-5#1)
partial least square (PLS)##2##4##(2008-10#2)
partial least square##5##3##(2008-10#5)
partial least squares (PLS) algorithm##2##5##(2008-10#2)
partial least squares (PLS) and##4##5##(2008-10#4)
partial least squares (PLS) calibration##4##5##(2008-10#4)
partial least squares (PLS) model##2##5##(2008-10#2)
partial least squares (PLS) multivariate calibration##3##6##(2008-10#3)
partial least squares (PLS) regression was##2##6##(2008-10#2)
partial least squares (PLS) regression##5##5##(2008-10#5)
partial least squares (PLS)##29##4##(2008-10#29)
partial least squares (PLS-1)##2##4##(2008-10#2)
partial least squares and##3##4##(2008-10#3)
partial least squares based on##2##5##(2008-10#2)
partial least squares calibration model##2##5##(2008-10#2)
partial least squares calibration##7##4##(2008-10#7)
partial least squares modeling##3##4##(2008-10#3)
partial least squares regression (PLS)##5##5##(2008-10#5)
partial least squares regression and##2##5##(2008-10#2)
partial least squares regression##13##4##(2008-10#13)
partial least squares##81##3##(2008-10#80)(2009-3#1)
partial least##87##2##(2008-10#86)(2009-3#1)
partial least-squares (PLS) calibration##2##4##(2008-10#2)
partial least-squares (PLS)##8##3##(2008-10#8)
partial least-squares (PLS-1) and##2##4##(2008-10#2)
partial least-squares method##2##3##(2008-10#2)
partial least-squares multivariate calibration##4##4##(2008-10#4)
partial least-squares regression##6##3##(2008-10#6)
partial least-squares##27##2##(2008-10#27)
partial library of##2##3##(2008-10#1)(2008-8#1)
partial lipodystrophy##2##2##(1996-3#2)
partial migration##2##2##(2008-8#2)
partial neuroprotective activity##2##3##(2013-8#2)
partial nucleotide##2##2##(2008-10#2)
partial or complete##4##3##(1990-6#1)(1991-2#1)(2011-7#1)(2013-1#1)
partial or total##4##3##(1992-3#1)(1997-8#1)(2009-7#1)(2012-3#1)
partial or##8##2##(1990-6#1)(1991-2#1)(1992-3#1)(1997-8#1)(2009-7#1)(2011-7#1)(2012-3#1)(2013-1#1)
partial photobleaching##2##2##(2008-3#2)
partial pressure##11##2##(2008-10#1)(2008-11#7)(2008-3#1)(2010-8#1)(2013-8#1)
partial pressures##2##2##(1990-8#1)(2008-3#1)
partial protection##2##2##(1990-6#1)(1992-7#1)
partial remission##4##2##(1990-6#1)(1991-2#1)(1991-6#1)(1991-8#1)
partial resistance to##11##3##(2008-10#11)
partial resistance##32##2##(2008-10#32)
partial resolution of##2##3##(2010-10#1)(2012-3#1)
partial response##9##2##(1990-12#1)(1990-2#2)(1991-8#1)(1992-12#2)(1997-7#1)(2008-10#1)(2010-12#1)
partial responses were##2##3##(1990-12#2)
partial responses##4##2##(1990-12#2)(1991-2#1)(1992-2#1)
partial separation of##2##3##(2008-10#2)
partial sequence of##4##3##(1993-12#1)(1996-8#1)(2008-10#1)(2008-8#1)
partial sequence##9##2##(1991-5#1)(1993-12#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#2)
partial sequences of the##2##4##(2008-10#2)
partial sequences of##3##3##(1996-8#1)(2008-10#2)
partial sequences##5##2##(1996-2#1)(1996-8#1)(2008-10#2)(2008-9#1)
partial sequencing of##2##3##(2008-10#2)
partial support##2##2##(1995-2#1)(2008-9#1)
partial tandem##2##2##(2008-10#1)(2011-3#1)
partial thromboplastin time##2##3##(2008-10#1)(2008-9#1)
partial thromboplastin##3##2##(2008-10#1)(2008-9#2)
partial tone##2##2##(2008-8#2)
partial##460##1##(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#3)(1990-6#3)(1990-8#3)(1991-1#6)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#4)(1991-8#5)(1991-9#1)(1992-1#11)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-11#6)(1995-12#1)(1995-2#7)(1995-5#2)(1995-6#2)(1996-2#4)(1996-3#2)(1996-6#2)(1996-8#3)(1996-9#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#2)(2008-1#1)(2008-10#189)(2008-11#19)(2008-12#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#17)(2008-9#9)(2009-1#1)(2009-3#1)(2009-6#4)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#10)
partial-hospital program##2##2##(1992-1#2)
partial-hospital programs##2##2##(1992-1#2)
partial-hospital##4##1##(1992-1#4)
partially and##2##2##(1995-2#1)(2008-11#1)
partially attributed to##2##3##(1996-2#1)(2008-10#1)
partially characterized##3##2##(2008-10#3)
partially coherent light##2##3##(2008-2#2)
partially coherent##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
partially cross-fertile plant species##2##4##(2008-8#2)
partially crosslinked fibers##2##3##(1995-2#2)
partially degraded##3##2##(2008-10#2)(2008-7#1)
partially dependent on##2##3##(2008-10#2)
partially developed speckle##3##3##(2008-3#3)
partially digested with##2##3##(1990-5#1)(1991-6#1)
partially digested##3##2##(1990-5#1)(1991-6#1)(1995-8#1)
partially dominant##4##2##(2008-10#4)
partially due to the##2##4##(2008-10#1)(2010-5#1)
partially due to##4##3##(1991-12#1)(1994-11#1)(2008-10#1)(2010-5#1)
partially edentulous##4##2##(2010-12#1)(2013-1#3)
partially effective##3##2##(2008-10#3)
partially explained by the##2##4##(1991-8#1)(2008-10#1)
partially explained by##6##3##(1991-8#1)(1993-11#1)(2008-10#3)(2012-3#1)
partially folded##2##2##(1993-9#1)(1995-2#1)
partially homologous to##2##3##(1993-9#1)(2008-10#1)
partially in##2##2##(2008-10#2)
partially independent##3##2##(2008-8#3)
partially inhibit the##2##3##(1994-6#1)(2009-6#1)
partially inhibited by##3##3##(1993-8#1)(1994-11#1)(1997-4#1)
partially inhibited the##2##3##(1996-5#1)(2008-9#1)
partially inhibited##8##2##(1993-8#2)(1994-11#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-9#1)(2011-2#1)
partially interdigitated##2##2##(1993-8#2)
partially liganded species##2##3##(1990-8#2)
partially mediated the##2##3##(2008-12#1)(2010-1#1)
partially mediated##3##2##(2008-12#1)(2010-1#1)(2013-1#1)
partially overcome##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
partially overlapped##2##2##(1996-3#1)(2013-8#1)
partially overlapping##3##2##(1996-3#1)(2008-8#1)(2009-10#1)
partially prevented##2##2##(1997-2#1)(2009-8#1)
partially purified and##2##3##(1994-11#1)(2008-10#1)
partially purified chlorosis toxin##3##4##(2008-10#3)
partially purified cytosolic##2##3##(1990-11#1)(1995-11#1)
partially purified from##6##3##(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-8#1)
partially purified##26##2##(1990-11#3)(1990-5#1)(1991-12#2)(1992-2#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-6#1)(2008-10#8)(2008-11#2)(2008-8#1)(2011-2#1)
partially reactivated##2##2##(1992-12#1)(1993-6#1)
partially recessive##2##2##(2008-10#2)
partially recovered##2##2##(2008-11#1)(2008-5#1)
partially resected##2##2##(2009-9#1)(2011-2#1)
partially resistant cultivar##3##3##(2008-10#3)
partially resistant cultivars##3##3##(2008-10#3)
partially resistant to##2##3##(2008-10#2)
partially resistant##18##2##(2008-10#18)
partially responsible for the##2##4##(1990-5#1)(1993-2#1)
partially selective##2##2##(2008-10#2)
partially suppressed the##2##3##(1996-5#1)(2008-9#1)
partially suppressed##4##2##(1996-5#1)(2007-12#1)(2008-8#1)(2008-9#1)
partially to##3##2##(1994-8#1)(2008-10#2)
partially##262##1##(1990-11#4)(1990-5#6)(1990-8#4)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#6)(1993-9#2)(1994-11#4)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#6)(1995-3#1)(1995-6#2)(1995-8#3)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#81)(2008-11#13)(2008-12#4)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#11)(2008-9#6)(2009-10#3)(2009-12#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#4)(2013-8#5)
partials##2##1##(2008-8#2)
participant fees##2##2##(1993-2#1)(1994-2#1)
participant in##3##2##(1995-11#1)(1996-2#1)(2013-1#1)
participant observation##2##2##(2008-11#1)(2013-1#1)
participant##39##1##(1993-2#1)(1994-2#1)(1995-11#1)(1996-2#1)(1997-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2009-1#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#1)
participant's##6##1##(1996-11#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
participants (n =##3##3##(2008-5#1)(2009-9#1)(2012-3#1)
participants about the##2##3##(1997-3#1)(2010-11#1)
participants also##2##2##(2008-11#1)(2008-12#1)
participants and##8##2##(1995-2#1)(1996-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
participants are##3##2##(1995-2#1)(2008-7#1)(2012-2#1)
participants attended to##2##3##(2008-11#2)
participants cannot##2##2##(2010-1#1)(2012-2#1)
participants compared##2##2##(1993-1#1)(2008-11#1)
participants completed a##2##3##(2008-11#1)(2010-4#1)
participants completed trauma-related questionnaires##2##4##(2009-4#2)
participants completed##5##2##(2008-11#1)(2009-4#2)(2009-9#1)(2010-4#1)
participants did not##2##3##(1995-1#1)(2009-10#1)
participants discussed##2##2##(2008-6#1)(2009-3#1)
participants found##2##2##(2008-4#1)(2013-1#1)
participants from the##2##3##(2009-1#1)(2013-1#1)
participants from##6##2##(2008-11#1)(2009-1#1)(2010-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
participants had a##4##3##(2009-10#1)(2010-10#1)(2012-12#1)(2013-8#1)
participants had the##2##3##(2008-11#1)(2012-2#1)
participants had##15##2##(1993-3#1)(1994-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-10#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
participants in Group##2##3##(2011-2#2)
participants in the##6##3##(1991-8#1)(1996-3#1)(2008-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
participants in##19##2##(1991-8#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
participants not##2##2##(2008-1#1)(2010-7#1)
participants of the##3##3##(2010-1#1)(2012-3#1)(2013-1#1)
participants performed a##2##3##(2008-11#1)(2013-8#1)
participants performed##6##2##(2008-11#2)(2009-3#1)(2010-5#1)(2013-8#2)
participants reported##4##2##(1995-1#1)(2009-3#1)(2009-5#1)(2010-7#1)
participants showed##3##2##(2008-11#1)(2008-12#1)(2009-8#1)
participants to rate##2##3##(2009-10#1)(2013-8#1)
participants to##8##2##(1992-1#1)(1996-3#1)(2008-11#1)(2009-10#2)(2010-10#1)(2010-11#1)(2013-8#1)
participants underwent functional magnetic resonance imaging##2##6##(2008-11#2)
participants underwent##4##2##(2008-11#2)(2011-2#1)(2012-3#1)
participants used##3##2##(2008-10#1)(2010-8#2)
participants using##2##2##(2013-1#1)(2013-8#1)
participants viewed##3##2##(2008-11#3)
participants was##4##2##(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#1)
participants were asked to##2##4##(2008-5#1)(2013-8#1)
participants were instructed that##2##4##(2008-11#2)
participants were interviewed##2##3##(2010-10#1)(2011-1#1)
participants were##28##2##(1995-1#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#4)
participants who had##5##3##(1992-1#1)(2010-7#1)(2013-1#1)(2013-8#2)
participants who reported##2##3##(2008-11#1)(2013-1#1)
participants who were##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
participants who##15##2##(1992-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#4)
participants with a##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
participants with##10##2##(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
participants##288##1##(1991-3#1)(1991-8#1)(1992-1#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-3#1)(1995-1#8)(1995-2#2)(1996-3#5)(1997-3#3)(2008-1#4)(2008-10#12)(2008-11#38)(2008-12#14)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#3)(2009-10#8)(2009-11#5)(2009-3#4)(2009-4#11)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#9)(2010-11#9)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#7)(2010-8#3)(2010-9#3)(2011-1#4)(2011-2#15)(2012-12#4)(2012-2#9)(2012-3#8)(2013-1#26)(2013-8#22)
participants' experiences of##2##3##(2008-11#1)(2010-10#1)
participants'##15##1##(2008-11#3)(2008-6#1)(2009-11#1)(2009-6#1)(2009-7#3)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
participants)##3##1##(2008-11#1)(2011-1#1)(2012-2#1)
participate in Michael addition reactions with##2##6##(2008-10#2)
participate in a##7##3##(1996-1#1)(2008-1#2)(2008-11#3)(2012-12#1)
participate in regulating the expression of##3##6##(1997-7#1)(2010-7#1)(2011-2#1)
participate in the regulation of##2##5##(2008-7#1)(2013-1#1)
participate in the##24##3##(1994-12#1)(1994-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-7#2)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
participate in this##4##3##(1991-2#1)(2008-11#1)(2008-7#1)(2011-1#1)
participate in##70##2##(1991-2#1)(1991-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-7#1)(2008-1#3)(2008-10#3)(2008-11#12)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
participate##80##1##(1990-12#1)(1990-2#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-7#1)(2008-1#3)(2008-10#3)(2008-11#14)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
participated actively in the##2##4##(2008-12#1)(2010-5#1)
participated as volunteers in##2##4##(2008-12#1)(2012-3#1)
participated for four months in 1992##2##6##(1994-6#2)
participated for##3##2##(1990-6#1)(1994-6#2)
participated in a##7##3##(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#1)
participated in an##8##3##(1990-6#1)(1991-2#1)(1996-2#1)(2008-1#1)(2008-11#2)(2009-1#1)(2011-1#1)
participated in the study##13##4##(1990-6#1)(1995-1#1)(1996-1#1)(2008-12#3)(2008-9#1)(2009-3#1)(2010-10#1)(2010-9#2)(2012-3#1)(2013-1#1)
participated in the survey##2##4##(1994-12#1)(2010-10#1)
participated in the##20##3##(1990-6#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2008-12#3)(2008-9#1)(2009-3#1)(2010-10#2)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
participated in this study##8##4##(2010-10#1)(2010-3#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
participated in this##13##3##(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
participated in##69##2##(1990-6#2)(1991-12#1)(1991-2#2)(1991-8#2)(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#2)(2008-1#2)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-10#5)(2010-11#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
participated##94##1##(1990-6#3)(1991-12#1)(1991-2#2)(1991-8#2)(1994-12#1)(1994-6#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#2)(1997-4#1)(2008-1#2)(2008-11#6)(2008-12#9)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#5)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#1)
participates in regulation of the##2##5##(1995-8#1)(2008-9#1)
participates in the##9##3##(1992-12#1)(1995-11#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-12#2)(2013-1#1)(2013-7#1)
participates in##23##2##(1991-6#1)(1992-12#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
participating alliances##2##2##(2013-1#2)
participating hospitals##3##2##(1991-2#2)(1994-3#1)
participating in a##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
participating in the Aligning Forces for Quality initiative##2##8##(2013-1#2)
participating in the Aligning Forces for Quality##3##7##(2013-1#3)
participating in the##11##3##(1994-3#1)(1995-12#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
participating in these##2##3##(2008-12#1)(2010-10#1)
participating in##28##2##(1991-2#1)(1992-1#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-12#3)(2008-9#1)(2009-4#1)(2010-1#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#6)
participating laboratories##4##2##(2008-10#3)(2008-12#1)
participating schools##2##2##(2008-12#1)(2013-1#1)
participating##57##1##(1990-2#1)(1991-2#3)(1992-1#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-12#4)(1996-6#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#6)(2008-3#2)(2008-9#2)(2009-4#1)(2010-1#2)(2010-10#1)(2011-2#2)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#11)
participation among##2##2##(2009-4#1)(2012-2#1)
participation and communication##2##3##(2013-1#2)
participation and##16##2##(1995-3#1)(2008-11#1)(2008-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#3)(2012-12#1)(2013-1#3)
participation by##5##2##(1994-12#1)(1997-2#1)(2008-10#2)(2008-11#1)
participation can##2##2##(1994-12#1)(2013-1#1)
participation has been##2##3##(2008-11#1)(2013-1#1)
participation in a##7##3##(1996-2#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
participation in clinical##2##3##(2008-11#1)(2008-12#1)
participation in health care##3##4##(1997-2#2)(2008-12#1)
participation in health##6##3##(1992-1#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-12#1)
participation in painting pictures or playing a musical instrument##2##9##(2012-12#2)
participation in the operation of community mental health agencies##2##9##(1997-3#2)
participation in the study##2##4##(2011-2#1)(2013-1#1)
participation in the##15##3##(1990-2#1)(1995-3#2)(1995-9#1)(1997-2#1)(1997-3#3)(2008-11#2)(2010-1#1)(2011-1#1)(2011-2#2)(2013-1#1)
participation in##62##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-2#3)(1997-2#4)(1997-3#4)(2008-1#2)(2008-10#2)(2008-11#7)(2008-12#6)(2009-4#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
participation is##4##2##(1994-12#1)(1995-12#1)(1995-3#1)(2013-1#1)
participation of community residents in##2##5##(1995-3#2)
participation of the##6##3##(1995-12#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-9#1)
participation of these##2##3##(2011-1#1)(2011-2#1)
participation of this##3##3##(1993-3#1)(1995-6#1)(2008-7#1)
participation of##35##2##(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-3#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#2)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
participation rate##4##2##(2008-11#2)(2008-6#1)(2008-7#1)
participation rates##3##2##(1994-3#1)(2013-1#2)
participation through the##2##3##(1994-2#1)(2008-11#1)
participation was associated with##2##4##(2008-12#1)(2012-12#1)
participation with##2##2##(2008-1#1)(2010-7#1)
participation##183##1##(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#1)(1993-1#2)(1993-12#1)(1993-3#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#6)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#3)(1997-1#2)(1997-2#6)(1997-3#6)(2008-1#4)(2008-10#9)(2008-11#16)(2008-12#13)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#6)(2009-6#2)(2009-7#3)(2009-9#1)(2010-1#3)(2010-10#6)(2010-4#1)(2010-7#4)(2010-9#1)(2011-1#3)(2011-2#6)(2011-9#1)(2012-12#7)(2012-2#6)(2013-1#12)(2013-8#2)
participative##3##1##(1993-12#1)(1997-2#1)(2011-2#1)
participatory research##5##2##(1997-3#4)(2012-12#1)
participatory##11##1##(1992-1#1)(1997-3#4)(2008-1#1)(2008-11#3)(2012-12#1)(2013-8#1)
particle analysis##4##2##(2008-10#4)
particle and##3##2##(1990-12#1)(1993-2#1)(2008-3#1)
particle assembly##3##2##(1993-8#1)(1995-9#1)(2008-8#1)
particle beam##2##2##(1997-2#2)
particle bombardment with##2##3##(2008-10#2)
particle bombardment##10##2##(2008-10#9)(2008-5#1)
particle capture by##2##3##(2008-9#2)
particle capture##5##2##(2008-9#5)
particle counting##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
particle deposition efficiencies##2##3##(1991-12#2)
particle deposition##6##2##(1991-12#4)(1996-1#1)(1996-12#1)
particle distribution##3##2##(1992-2#1)(1992-3#1)(2008-5#1)
particle in the##3##3##(2008-10#2)(2008-3#1)
particle in##5##2##(2008-10#2)(2008-3#3)
particle is##2##2##(2008-2#1)(2008-3#1)
particle mass##4##2##(1996-2#2)(1997-2#1)(2008-10#1)
particle matter##3##2##(2008-3#3)
particle morphology##2##2##(2008-10#1)(2011-3#1)
particle or##2##2##(2008-10#1)(2008-7#1)
particle population##3##2##(1995-6#1)(2012-2#2)
particle shape##3##2##(2008-2#1)(2008-3#2)
particle size and concentration##4##4##(1995-3#1)(2008-3#2)(2011-2#1)
particle size and the##2##4##(2008-10#1)(2008-3#1)
particle size and##13##3##(1995-3#1)(2008-10#5)(2008-2#1)(2008-3#3)(2011-1#1)(2011-2#2)
particle size distribution and##4##4##(1996-12#1)(2008-10#3)
particle size distribution is##2##4##(2008-3#1)(2008-7#1)
particle size distribution##12##3##(1992-2#1)(1992-3#1)(1993-2#1)(1996-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)
particle size distributions##3##3##(1997-2#1)(2008-3#2)
particle size in##2##3##(2008-10#1)(2011-1#1)
particle size of the##2##4##(1997-2#1)(2008-10#1)
particle size of##6##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#2)
particle size or fraction of the studied element##2##8##(2008-10#2)
particle size selective##2##3##(1992-3#1)(2008-5#1)
particle size smaller than##2##4##(2008-10#1)(2008-5#1)
particle size was##2##3##(2008-10#2)
particle size##87##2##(1992-2#1)(1992-3#4)(1993-2#2)(1995-3#2)(1995-8#2)(1996-12#2)(1997-1#2)(1997-2#5)(2008-10#32)(2008-11#3)(2008-2#2)(2008-3#10)(2008-5#10)(2008-7#1)(2009-11#1)(2011-1#5)(2011-2#2)(2013-1#1)
particle sizer##2##2##(1993-2#1)(2008-3#1)
particle sizers##2##2##(2008-3#2)
particle sizes of##2##3##(2008-10#1)(2008-7#1)
particle sizes##6##2##(1997-3#1)(2008-10#3)(2008-3#1)(2008-7#1)
particle sizing##6##2##(1992-3#1)(1995-3#1)(2008-2#1)(2008-3#3)
particle surface##3##2##(2008-10#1)(2008-3#2)
particle traversal through##2##3##(2008-8#2)
particle traversal##3##2##(2008-8#3)
particle volume##2##2##(2008-10#1)(2008-3#1)
particle was##3##2##(2008-10#2)(2011-1#1)
particle##267##1##(1990-12#3)(1991-12#5)(1992-2#2)(1992-3#6)(1993-2#4)(1993-3#1)(1993-8#2)(1994-11#2)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#3)(1996-8#1)(1997-1#3)(1997-2#9)(1997-3#2)(1997-6#1)(2008-10#82)(2008-11#8)(2008-2#8)(2008-3#47)(2008-4#1)(2008-5#14)(2008-7#4)(2008-8#5)(2008-9#8)(2009-11#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-11#1)(2011-1#6)(2011-2#5)(2011-3#3)(2012-2#5)(2012-3#1)(2013-1#2)
particle-free##2##1##(2008-2#1)(2008-9#1)
particle-image velocimetry in##2##3##(2008-3#2)
particle-induced##2##1##(2008-10#2)
particle-mediated##3##1##(1995-6#1)(2008-10#2)
particle-size distribution from angular light-scattering data##2##6##(2008-3#2)
particle-size distribution##4##2##(2008-3#4)
particle-size##6##1##(2008-3#6)
particle-sizing##2##1##(2008-3#2)
particles &lt##3##2##(1995-3#1)(1996-12#1)(2008-11#1)
particles and in##2##3##(2008-11#1)(2008-9#1)
particles and large##2##3##(2008-10#2)
particles and their##2##3##(2008-10#1)(2008-11#1)
particles and##20##2##(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2012-12#1)
particles are##13##2##(1992-12#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)
particles as##6##2##(1990-6#1)(1995-5#1)(2008-10#1)(2008-7#2)(2012-2#1)
particles at##2##2##(2008-10#1)(2009-7#1)
particles by##5##2##(1991-5#1)(2008-10#2)(2008-3#1)(2009-5#1)
particles can be##3##3##(1994-2#1)(1997-1#1)(2008-10#1)
particles can##4##2##(1994-2#1)(1997-1#1)(2008-10#2)
particles collected##2##2##(2008-10#1)(2011-2#1)
particles due to##2##3##(1990-12#1)(1992-12#1)
particles for##2##2##(2008-10#2)
particles formed##2##2##(2008-10#2)
particles from##4##2##(1992-2#1)(2008-10#3)
particles generated##2##2##(2008-10#1)(2008-11#1)
particles in the##15##3##(1991-12#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)
particles in water and##2##4##(2008-3#2)
particles in##31##2##(1991-12#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-11#3)(2008-3#6)(2008-6#1)(2008-8#2)(2013-1#1)
particles injected##2##2##(1991-12#1)(2008-11#1)
particles is##7##2##(2008-10#2)(2008-11#3)(2008-3#2)
particles may be##2##3##(1997-2#1)(2008-7#1)
particles may##5##2##(1995-2#1)(1997-2#2)(2008-3#1)(2008-7#1)
particles of the##3##3##(1996-3#1)(2008-10#2)
particles of##23##2##(1991-12#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#2)(2008-10#14)(2011-2#1)
particles on the##3##3##(2008-10#2)(2009-7#1)
particles per##2##2##(2008-10#1)(2008-9#1)
particles such##2##2##(2008-3#1)(2008-5#1)
particles than##2##2##(1995-3#1)(2008-8#1)
particles that##10##2##(1990-6#1)(1993-8#1)(1994-12#2)(1997-3#1)(2008-10#3)(2008-3#2)
particles through##2##2##(1997-1#1)(2009-5#1)
particles to the##2##3##(1995-2#1)(2008-10#1)
particles to##4##2##(1995-2#1)(2008-10#1)(2008-7#1)(2010-4#1)
particles using##2##2##(2008-10#1)(2008-8#1)
particles was##7##2##(1994-6#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-7#1)
particles were deposited##2##3##(1992-12#1)(1997-1#1)
particles were observed in##2##4##(2008-10#2)
particles were observed##4##3##(1995-3#1)(2008-10#3)
particles were##27##2##(1990-12#2)(1992-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1997-1#2)(2008-10#16)(2008-12#1)(2008-9#1)
particles which##3##2##(2008-11#1)(2008-8#1)(2012-2#1)
particles while##2##2##(1996-3#1)(2008-10#1)
particles whose##2##2##(2008-10#1)(2009-7#1)
particles with a##2##3##(2008-3#1)(2008-5#1)
particles with an##2##3##(1996-2#1)(2008-10#1)
particles with large complex refractive indices##3##6##(2008-3#3)
particles with large##4##3##(2008-2#1)(2008-3#3)
particles with the##2##3##(2008-10#2)
particles with##27##2##(1990-5#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#16)(2008-5#1)
particles within the##2##3##(2008-10#1)(2008-3#1)
particles within##4##2##(2008-10#2)(2008-3#1)(2009-7#1)
particles##412##1##(1990-12#4)(1990-2#1)(1990-5#2)(1990-6#2)(1991-12#4)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#3)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#7)(1995-6#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#9)(1996-2#4)(1996-3#3)(1997-1#6)(1997-2#6)(1997-3#7)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#141)(2008-11#29)(2008-12#4)(2008-2#7)(2008-3#50)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#7)(2008-8#9)(2008-9#10)(2009-12#1)(2009-5#3)(2009-7#10)(2009-8#1)(2010-4#2)(2010-6#3)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#2)
particles) and##2##2##(2008-11#1)(2012-12#1)
particles)##4##1##(2008-11#1)(2008-7#2)(2012-12#1)
particular and##3##2##(1990-4#1)(2008-10#1)(2008-8#1)
particular attention is##2##3##(2008-6#1)(2011-3#1)
particular attention to the##2##4##(1990-9#1)(1994-1#1)
particular attention to##7##3##(1990-9#1)(1993-12#1)(1994-1#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
particular attention##11##2##(1990-9#1)(1993-12#1)(1994-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
particular behaviour##2##2##(2008-10#1)(2011-2#1)
particular biological##2##2##(1996-2#1)(2011-3#1)
particular by##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
particular case##3##2##(1991-2#1)(2008-11#1)(2008-2#1)
particular cases##2##2##(2008-10#2)
particular cell##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
particular challenges##3##2##(1992-3#1)(2008-11#1)(2011-2#1)
particular chemical##3##2##(2008-12#1)(2008-9#2)
particular clinical##2##2##(2008-6#1)(2011-2#1)
particular concern##8##2##(1991-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
particular conditions##2##2##(2010-7#1)(2013-8#1)
particular data##2##2##(2008-10#1)(2010-3#1)
particular emphasis is placed on##2##5##(2008-10#1)(2008-4#1)
particular emphasis on##8##3##(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#3)(2011-2#1)(2012-12#1)
particular emphasis placed on##2##4##(2008-10#1)(2012-2#1)
particular emphasis##13##2##(1995-12#1)(1996-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
particular focus on##4##3##(1996-2#1)(2008-9#1)(2010-12#1)(2011-2#1)
particular food##2##2##(1994-3#1)(2010-1#1)
particular for##5##2##(2008-10#3)(2012-2#1)(2013-8#1)
particular form of##2##3##(1993-12#1)(2008-11#1)
particular forms##2##2##(2008-10#1)(2008-4#1)
particular gene##4##2##(1997-6#1)(2008-4#2)(2009-4#1)
particular genetic##2##2##(2008-4#1)(2008-9#1)
particular group of##4##3##(1990-8#1)(1996-2#1)(2008-11#1)(2008-12#1)
particular importance##5##2##(1991-12#1)(1993-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
particular in##7##2##(1995-5#1)(2008-10#3)(2010-11#1)(2010-5#1)(2012-12#1)
particular interest is##3##3##(1994-9#1)(2008-3#1)(2008-5#1)
particular interest##17##2##(1990-12#1)(1991-12#1)(1993-12#2)(1994-9#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-7#1)
particular isolate##2##2##(2008-10#2)
particular method##2##2##(2012-2#2)
particular plant##2##2##(2008-10#1)(2008-8#1)
particular problem##2##2##(2008-10#1)(2008-8#1)
particular properties of##2##3##(1995-5#1)(2008-4#1)
particular properties##4##2##(1995-5#1)(2008-4#1)(2008-5#1)(2009-8#1)
particular reference##8##2##(1992-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)
particular relevance##5##2##(1994-8#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
particular risk##3##2##(2008-10#1)(2009-10#1)(2011-2#1)
particular species##2##2##(2008-12#2)
particular the##14##2##(2008-1#1)(2008-10#4)(2008-11#3)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
particular they##2##2##(2008-5#1)(2008-7#1)
particular to the##2##3##(2008-10#1)(2010-6#1)
particular to##3##2##(1993-11#1)(2008-10#1)(2010-6#1)
particular type of##6##3##(1990-11#1)(1991-8#1)(1993-6#1)(1994-12#1)(2009-1#1)(2012-3#1)
particular##577##1##(1990-11#6)(1990-12#1)(1990-3#3)(1990-4#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#6)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-8#2)(1993-1#3)(1993-11#3)(1993-12#8)(1993-3#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#8)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-6#5)(1997-7#2)(1997-8#4)(2006-6#1)(2007-12#4)(2008-1#6)(2008-10#93)(2008-11#47)(2008-12#13)(2008-2#4)(2008-3#14)(2008-4#20)(2008-5#11)(2008-6#5)(2008-7#18)(2008-8#23)(2008-9#21)(2009-1#2)(2009-10#6)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#6)(2009-8#8)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#6)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#26)(2011-3#2)(2012-12#8)(2012-2#13)(2012-3#8)(2012-5#1)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#13)
particularities of##2##2##(2007-8#1)(2013-1#1)
particularities##4##1##(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
particularly abdominal##2##2##(1997-8#1)(2009-7#1)
particularly acute##2##2##(1991-12#1)(2008-4#1)
particularly after##3##2##(2008-10#1)(2008-7#1)(2010-12#1)
particularly amino acids##2##3##(2008-11#1)(2013-8#1)
particularly among##3##2##(1994-6#1)(2008-10#1)(2012-3#1)
particularly applicable##2##2##(2008-11#1)(2008-8#1)
particularly as a##2##3##(2008-10#1)(2012-3#1)
particularly as##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2010-6#1)(2012-3#1)
particularly at the##4##3##(1997-3#1)(2008-11#1)(2009-10#1)(2010-10#1)
particularly at##11##2##(1993-6#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-8#1)(2010-10#1)(2012-3#1)
particularly attractive for##3##3##(2008-10#2)(2010-7#1)
particularly attractive##4##2##(2008-10#2)(2008-11#1)(2010-7#1)
particularly between##3##2##(2008-5#1)(2009-7#1)(2011-2#1)
particularly by the##3##3##(1991-8#1)(2008-11#1)(2008-5#1)
particularly challenging##3##2##(2009-7#1)(2011-2#1)(2012-3#1)
particularly efficient##3##2##(2008-2#1)(2008-4#1)(2013-8#1)
particularly focused on the##2##4##(2008-10#1)(2012-2#1)
particularly for the##4##3##(2008-10#1)(2008-9#1)(2010-7#1)(2012-2#1)
particularly for##20##2##(1994-12#1)(1994-5#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-7#1)(2012-2#4)
particularly from the electronic databases Cumulative Index to Nursing and Allied Health Literature##2##13##(2013-1#2)
particularly from the##3##3##(2008-9#1)(2013-1#2)
particularly from##4##2##(2008-5#1)(2008-9#1)(2013-1#2)
particularly helpful##2##2##(2012-3#1)(2013-1#1)
particularly high##4##2##(1990-6#1)(1993-2#1)(2011-1#1)(2012-2#1)
particularly hydrogen##2##2##(2008-10#2)
particularly if the##2##3##(2008-11#1)(2012-3#1)
particularly if##8##2##(1990-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
particularly important and##2##3##(1992-4#1)(2012-2#1)
particularly important for##5##3##(1997-7#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
particularly important in the##2##4##(2008-12#1)(2008-7#1)
particularly important in##4##3##(1992-5#1)(2008-12#1)(2008-7#1)(2011-2#1)
particularly important##19##2##(1992-4#1)(1992-5#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#3)(2012-2#3)(2013-1#1)
particularly in Asian countries##2##4##(2013-1#2)
particularly in a##3##3##(1991-3#1)(1997-3#1)(2008-10#1)
particularly in areas##2##3##(2008-10#1)(2008-9#1)
particularly in patients with##3##4##(1992-3#1)(2008-8#1)(2012-3#1)
particularly in patients##4##3##(1992-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
particularly in relation to##4##4##(1993-3#1)(2009-1#1)(2009-9#1)(2011-2#1)
particularly in the cases##2##4##(2008-10#1)(2011-1#1)
particularly in the##20##3##(1990-12#1)(1993-8#1)(2008-10#6)(2008-11#2)(2008-9#3)(2009-6#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
particularly in##79##2##(1990-12#2)(1990-9#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#13)(2008-11#8)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-6#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
particularly interesting##5##2##(1990-5#1)(1991-6#1)(2009-8#1)(2010-4#1)(2013-1#1)
particularly large##2##2##(1990-11#1)(1993-12#1)
particularly of##2##2##(2007-8#1)(2008-10#1)
particularly on its##2##3##(2008-11#2)
particularly on the##3##3##(1992-12#1)(2008-5#1)(2011-2#1)
particularly on##8##2##(1992-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#2)
particularly powerful##2##2##(2008-4#2)
particularly prone to##2##3##(2012-12#1)(2012-3#1)
particularly sensitive to##2##3##(1995-12#1)(2010-4#1)
particularly significant##2##2##(1995-2#1)(1997-7#1)
particularly small##2##2##(1991-12#1)(2009-10#1)
particularly striking##2##2##(2007-12#1)(2013-8#1)
particularly suitable for##5##3##(2008-10#2)(2008-9#1)(2010-12#1)(2012-2#1)
particularly suited for##3##3##(1991-9#1)(2008-10#1)(2008-3#1)
particularly suited to##2##3##(1997-3#1)(2008-9#1)
particularly suited##5##2##(1991-9#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
particularly susceptible to##2##3##(1993-12#1)(2009-8#1)
particularly the case for##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
particularly the##27##2##(1991-10#1)(1991-3#1)(1991-6#1)(1994-1#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#3)(2013-1#1)
particularly those in##2##3##(2008-11#1)(2011-2#1)
particularly those that##3##3##(1996-12#1)(2008-11#1)(2009-3#1)
particularly those which are##2##4##(2008-10#1)(2010-12#1)
particularly those##14##2##(1990-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)
particularly through##2##2##(2008-10#1)(2013-1#1)
particularly to##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2010-9#1)
particularly true in the##2##4##(1992-1#1)(1994-12#1)
particularly true in##3##3##(1992-1#1)(1994-12#1)(2012-3#1)
particularly true##5##2##(1992-1#1)(1994-12#1)(2008-10#2)(2012-3#1)
particularly useful for detecting##2##4##(2008-12#1)(2009-7#1)
particularly useful for the##2##4##(1996-12#1)(2008-10#1)
particularly useful for##12##3##(1996-12#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-7#1)
particularly useful in##6##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)(2011-2#1)
particularly useful to##4##3##(1993-3#1)(2008-2#1)(2008-4#1)(2011-2#1)
particularly useful##27##2##(1993-12#1)(1993-3#1)(1996-12#1)(1997-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#1)
particularly valuable##2##2##(2008-10#1)(2008-11#1)
particularly vulnerable to##2##3##(1991-1#1)(1995-12#1)
particularly vulnerable##3##2##(1991-1#1)(1995-12#1)(2011-2#1)
particularly well##4##2##(1997-6#1)(2008-10#2)(2012-3#1)
particularly when the##3##3##(1996-8#1)(2008-10#2)
particularly when##16##2##(1992-12#1)(1996-8#1)(1997-1#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-10#1)(2011-2#2)(2013-1#1)
particularly where##2##2##(2008-10#1)(2009-6#1)
particularly with regard to##3##4##(2008-10#2)(2011-2#1)
particularly with respect to##6##4##(1992-9#1)(1997-2#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-12#1)
particularly with##15##2##(1992-9#1)(1994-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)
particularly##493##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#4)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#1)(1995-9#1)(1996-1#3)(1996-12#4)(1996-2#4)(1996-6#2)(1996-8#1)(1997-1#6)(1997-2#1)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#90)(2008-11#41)(2008-12#9)(2008-2#2)(2008-3#6)(2008-4#14)(2008-5#21)(2008-6#2)(2008-7#10)(2008-8#13)(2008-9#16)(2009-1#3)(2009-10#6)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#5)(2009-7#4)(2009-8#4)(2009-9#4)(2010-10#6)(2010-11#2)(2010-12#6)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#27)(2011-3#1)(2012-12#4)(2012-2#20)(2012-3#15)(2013-1#21)(2013-8#6)
particulars##2##1##(1991-2#1)(1993-3#1)
particulate by##2##2##(2008-11#1)(2012-2#1)
particulate matter and##3##3##(2008-10#2)(2013-8#1)
particulate matter collected##4##3##(2008-10#4)
particulate matter in##2##3##(2008-10#2)
particulate matter is##4##3##(2007-12#1)(2008-10#3)
particulate matter of emissions and working areas##3##7##(2008-10#3)
particulate matter of emissions and##4##5##(2008-10#4)
particulate matter of##5##3##(2008-10#5)
particulate matter was##2##3##(2008-10#2)
particulate matter##47##2##(2007-12#2)(2008-10#40)(2008-11#2)(2008-3#1)(2009-7#1)(2013-8#1)
particulate samples##3##2##(2008-10#1)(2008-9#2)
particulate##80##1##(1994-8#1)(1995-5#2)(1996-12#2)(1997-1#3)(2007-12#2)(2008-10#50)(2008-11#3)(2008-3#7)(2008-5#1)(2008-9#2)(2009-5#3)(2009-7#1)(2012-2#2)(2013-8#1)
particulate-phase mercury##3##2##(2008-10#3)
particulates##14##1##(1993-3#1)(1997-1#1)(1997-2#1)(2008-10#9)(2008-11#2)
parties in##2##2##(1994-5#1)(2011-2#1)
parties##10##1##(1991-6#1)(1992-2#1)(1994-5#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)
partition behavior##2##2##(2008-10#2)
partition coefficient##11##2##(1990-5#2)(1993-1#1)(1996-2#1)(2008-10#5)(2008-5#1)(2011-2#1)
partition coefficients for##2##3##(2008-10#2)
partition coefficients of the##2##4##(1990-5#1)(2008-10#1)
partition coefficients of##8##3##(1990-5#2)(2008-10#4)(2008-7#2)
partition coefficients##18##2##(1990-5#2)(1991-5#1)(2008-10#12)(2008-7#3)
partition the##2##2##(1991-7#1)(2008-8#1)
partition##57##1##(1990-5#4)(1991-5#1)(1991-7#1)(1993-1#1)(1993-8#1)(1995-12#4)(1996-2#1)(2008-10#30)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2010-10#1)(2011-2#3)
partitioned into##2##2##(1994-5#1)(2008-8#1)
partitioned##14##1##(1991-5#1)(1994-5#1)(2008-10#7)(2008-11#2)(2008-8#2)(2010-5#1)
partitioning analysis##4##2##(1991-12#4)
partitioning as##2##2##(2008-10#2)
partitioning between##7##2##(1991-3#2)(1993-8#2)(1994-5#1)(2008-10#2)
partitioning effects##2##2##(1990-5#1)(2008-11#1)
partitioning in##2##2##(2010-8#1)(2012-9#1)
partitioning of the##4##3##(2008-10#2)(2008-3#1)(2009-8#1)
partitioning of##17##2##(1991-3#1)(1993-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#5)(2008-9#1)(2009-8#1)
partitioning##54##1##(1990-5#4)(1991-12#5)(1991-3#3)(1993-8#3)(1993-9#1)(1994-5#1)(1995-2#2)(2008-10#19)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-8#1)(2010-8#1)(2012-9#1)
partitions##2##1##(2008-8#2)
partly abolished##2##2##(1995-8#1)(2011-1#1)
partly because of the##2##4##(1992-2#2)
partly because##5##2##(1992-2#2)(2008-11#1)(2008-9#1)(2012-2#1)
partly by the##2##3##(1990-2#1)(2008-7#1)
partly by##5##2##(1990-2#1)(1991-3#1)(2008-11#1)(2008-7#1)(2008-8#1)
partly dependent on the##2##4##(2008-10#1)(2013-8#1)
partly dependent on##4##3##(2008-10#1)(2008-11#1)(2010-5#1)(2013-8#1)
partly due to the##4##4##(1991-11#1)(1997-7#1)(2008-10#1)(2008-11#1)
partly due to##9##3##(1991-11#1)(1991-12#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-3#1)(2013-8#1)
partly explain the##2##3##(2008-11#1)(2012-2#1)
partly explain##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
partly explained by##2##3##(2008-11#1)(2010-12#1)
partly##77##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-2#2)(1993-9#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#3)(1995-9#1)(1996-2#1)(1997-5#1)(1997-7#4)(2008-10#14)(2008-11#10)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-8#3)
partner and##3##2##(1994-5#1)(2009-12#1)(2012-2#1)
partner for the##2##3##(1995-12#1)(2013-1#1)
partner of##2##2##(1990-6#1)(1994-5#1)
partner to##2##2##(1991-12#1)(2012-12#1)
partner violence and##2##3##(2008-12#1)(2008-6#1)
partner violence##8##2##(2008-12#2)(2008-6#1)(2010-11#1)(2012-12#4)
partner with##3##2##(2010-10#1)(2012-2#2)
partner##56##1##(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-11#2)(2008-12#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#2)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#1)
partner's support##2##2##(1995-1#2)
partner's##7##1##(1995-1#2)(1995-12#1)(2008-12#1)(2008-8#2)(2013-8#1)
partner(s)##4##1##(1990-6#1)(1996-2#2)(2013-1#1)
partner)##2##1##(2008-12#2)
partnered##2##1##(2012-2#2)
partnering with##2##2##(2010-11#1)(2012-2#1)
partnering##5##1##(1994-12#1)(2008-11#1)(2010-11#1)(2010-12#1)(2012-2#1)
partners and##6##2##(1997-3#2)(2010-10#1)(2012-2#3)
partners are##2##2##(2008-9#1)(2012-3#1)
partners at##2##2##(2009-5#1)(2013-1#1)
partners can##2##2##(2008-11#1)(2012-3#1)
partners from##3##2##(2008-12#2)(2010-7#1)
partners in the##6##3##(1991-3#1)(1997-3#1)(2008-12#1)(2009-4#1)(2013-1#2)
partners in##12##2##(1991-3#1)(1993-3#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-4#1)(2013-1#3)
partners of##2##2##(2008-12#1)(2012-2#1)
partners reported by##2##3##(1993-9#2)
partners reported##3##2##(1993-9#2)(2008-12#1)
partners to##4##2##(1996-1#1)(2008-9#1)(2013-1#2)
partners who##3##2##(1994-2#1)(2008-12#1)(2009-5#1)
partners##89##1##(1990-5#2)(1991-3#1)(1992-1#1)(1993-3#1)(1993-9#3)(1994-2#1)(1994-5#2)(1995-12#1)(1996-1#2)(1996-2#1)(1997-2#1)(1997-3#5)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#10)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#2)(2009-4#2)(2009-5#7)(2010-10#1)(2010-11#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#1)
partners)##2##1##(1991-6#1)(2011-2#1)
partnership between##5##2##(1994-1#1)(1995-3#1)(1996-3#2)(2012-3#1)
partnership for##2##2##(1995-3#1)(2008-12#1)
partnership has##3##2##(1992-1#1)(2008-11#1)(2009-11#1)
partnership in##3##2##(1992-1#1)(2008-11#2)
partnership model for##2##3##(2008-12#2)
partnership model##3##2##(2008-12#3)
partnership models##3##2##(1994-1#1)(2008-11#2)
partnership with the##5##3##(1997-3#1)(2008-11#2)(2008-12#2)
partnership with##10##2##(1992-1#1)(1993-12#1)(1995-12#1)(1997-3#1)(2008-11#3)(2008-12#3)
partnership##52##1##(1992-1#7)(1992-3#2)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(2008-11#15)(2008-12#8)(2008-6#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-3#1)(2012-3#1)
partnerships and##3##2##(2008-11#1)(2011-2#2)
partnerships for##2##2##(1996-3#1)(1997-1#1)
partnerships with##4##2##(1996-12#1)(1997-2#1)(1997-3#2)
partnerships##24##1##(1992-11#1)(1992-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-11#2)(2008-12#2)(2009-11#1)(2011-2#6)
parts and in##2##3##(2008-10#1)(2008-12#1)
parts and##5##2##(2008-10#4)(2008-12#1)
parts are##2##2##(2008-11#1)(2010-4#1)
parts in 10(6)##2##3##(2008-3#2)
parts in 10(9)##4##3##(2007-12#1)(2008-3#3)
parts in##9##2##(2007-12#2)(2008-3#6)(2012-2#1)
parts of Europe##2##3##(2008-10#1)(2013-8#1)
parts of a##2##3##(2008-10#1)(2008-3#1)
parts of epididymis##2##3##(2008-12#2)
parts of the brain##2##4##(2008-7#1)(2009-10#1)
parts of the environment##2##4##(2008-9#1)(2010-5#1)
parts of the plant##4##4##(2008-10#4)
parts of the world##11##4##(1990-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
parts of the##71##3##(1990-12#1)(1990-2#1)(1990-6#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-5#1)(1997-8#1)(2008-10#15)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)
parts of##103##2##(1990-12#1)(1990-2#2)(1990-6#1)(1991-2#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#2)(1997-5#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#21)(2008-11#14)(2008-12#8)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
parts per billion##4##3##(2008-2#1)(2008-3#3)
parts per million##3##3##(2008-10#1)(2008-3#2)
parts per trillion##3##3##(2008-10#3)
parts per##11##2##(2008-10#4)(2008-2#1)(2008-3#6)
parts were##2##2##(2008-12#1)(2011-2#1)
parts##181##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#2)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-5#2)(1997-8#1)(2006-6#1)(2007-12#3)(2008-10#44)(2008-11#21)(2008-12#14)(2008-2#2)(2008-3#17)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#2)
parts-per-billion level##2##2##(2008-10#2)
parts-per-billions##2##1##(2008-10#2)
parts-per-million##2##1##(2008-10#1)(2012-2#1)
parturient##2##1##(2009-10#1)(2012-3#1)
parturition##2##1##(1994-3#1)(2008-10#1)
party is##2##2##(2008-8#1)(2010-6#1)
party to##3##2##(1992-2#2)(2008-8#1)
party##16##1##(1991-1#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#2)(1995-2#1)(1996-2#2)(2008-11#3)(2008-8#3)(2010-6#1)
parva##3##1##(2008-10#1)(2008-9#1)(2010-2#1)
parviflora##4##1##(2008-10#1)(2008-11#3)
parvocellular##3##1##(1996-12#1)(1996-2#1)(1997-2#1)
parvovirus B19##3##2##(2012-3#1)(2013-1#2)
parvovirus##6##1##(2012-3#3)(2013-1#3)
parvum##6##1##(1996-12#2)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
pas##3##1##(2008-11#1)(2013-1#2)
pass a##2##2##(1994-8#1)(2008-3#1)
pass of##4##2##(2008-10#3)(2008-2#1)
pass on##2##2##(1991-11#1)(2008-7#1)
pass rates##2##2##(2012-3#2)
pass the##3##2##(1991-1#1)(1995-3#1)(2008-9#1)
pass through the disk to drain##2##6##(2008-10#2)
pass through the##5##3##(2008-10#3)(2008-9#1)(2010-10#1)
pass through##12##2##(1990-5#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#2)(2010-10#1)(2011-2#1)(2013-1#1)
pass##34##1##(1990-5#1)(1991-1#1)(1991-11#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-1#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#4)(2010-10#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
passage 2##2##2##(2008-9#2)
passage and##2##2##(1995-6#1)(2008-12#1)
passage cells##3##2##(2008-11#2)(2008-5#1)
passage in##3##2##(2008-10#2)(2008-11#1)
passage of a guidewire##2##4##(2010-12#2)
passage of a##4##3##(2008-10#2)(2010-12#2)
passage of aqueous samples through##2##5##(2008-10#2)
passage of aqueous##3##3##(2008-10#3)
passage of the Medicare##2##4##(1991-3#1)(1996-3#1)
passage of the##6##3##(1991-3#1)(1992-8#1)(1996-3#1)(1997-1#1)(2008-10#1)(2011-2#1)
passage of##25##2##(1991-3#1)(1992-8#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-9#1)(2010-12#2)(2011-2#3)(2012-2#1)
passage rate of feed through##2##5##(2008-10#2)
passage through the##3##3##(2008-10#2)(2008-3#1)
passage through##7##2##(1995-12#1)(1997-3#1)(2008-10#4)(2008-3#1)
passage##77##1##(1990-5#1)(1991-3#1)(1992-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#2)(2008-10#21)(2008-11#16)(2008-12#2)(2008-3#2)(2008-5#1)(2008-9#5)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#4)(2011-3#8)(2012-2#1)(2013-1#1)(2013-8#1)
passaged##4##1##(1991-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
passages and##4##2##(1991-3#1)(2008-11#2)(2008-9#1)
passages in##6##2##(1992-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
passages of##3##2##(1994-8#2)(2008-10#1)
passages##32##1##(1990-5#1)(1991-3#1)(1992-2#2)(1994-8#2)(2008-10#5)(2008-11#11)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-3#2)(2013-1#1)(2013-8#1)
passaging##5##1##(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
passband##3##1##(2008-2#3)
passed a##4##2##(2008-5#2)(2008-8#1)(2010-10#1)
passed and##2##2##(1991-1#1)(2008-9#1)
passed by the##2##3##(1997-2#1)(2008-10#1)
passed by##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
passed from the##2##3##(2008-10#1)(2008-7#1)
passed from##3##2##(2008-10#2)(2008-7#1)
passed in##2##2##(1997-3#1)(2008-10#1)
passed over##2##2##(1990-5#1)(2008-10#1)
passed the##2##2##(1995-12#1)(2008-10#1)
passed through a##9##3##(1992-12#1)(2008-10#8)
passed through an##2##3##(2008-10#2)
passed through the flow##2##4##(2008-10#2)
passed through the##19##3##(1997-6#1)(1997-8#1)(2008-10#16)(2013-1#1)
passed through##31##2##(1992-12#1)(1997-6#1)(1997-8#1)(2008-10#27)(2013-1#1)
passed to##3##2##(1993-1#1)(1993-8#1)(2008-10#1)
passed##67##1##(1990-5#3)(1991-1#1)(1992-12#1)(1993-1#1)(1993-8#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#41)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-10#1)(2013-1#1)
passenger instability were##2##3##(2013-1#2)
passenger##9##1##(1991-10#1)(1995-12#1)(2008-10#1)(2008-11#1)(2013-1#5)
passengers##3##1##(2010-5#1)(2011-2#1)(2013-1#1)
passerinii in##2##2##(2008-10#2)
passerinii##5##1##(2008-10#5)
passes a##2##2##(2008-11#1)(2008-3#1)
passes through a##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
passes through an##2##3##(2008-10#2)
passes through the test section##2##5##(2008-3#2)
passes through the##8##3##(2008-10#4)(2008-3#3)(2008-7#1)
passes through##15##2##(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-7#1)
passes##26##1##(1994-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#2)(2010-8#1)
passiflora isolates##2##2##(2008-10#2)
passiflora##9##1##(2008-10#9)
passing the##3##2##(2008-10#2)(2009-9#1)
passing through a##2##3##(2008-10#2)
passing through the##9##3##(2007-12#1)(2008-10#6)(2008-3#2)
passing through##13##2##(2007-12#1)(2008-10#10)(2008-3#2)
passing##32##1##(2007-12#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-9#1)(2012-12#1)(2012-2#1)
passion##3##1##(1994-2#1)(2008-12#1)(2010-8#1)
passivating layer##2##2##(2008-10#2)
passivation##5##1##(2008-10#2)(2010-4#3)
passive Q switching of a 1##2##6##(2008-3#2)
passive and active##4##3##(2009-10#1)(2010-12#1)(2012-12#1)(2012-3#1)
passive avoidance task##2##3##(1991-2#1)(2008-6#1)
passive avoidance##4##2##(1991-2#1)(1992-6#1)(2008-6#2)
passive creep-induced stretching##2##3##(2009-7#2)
passive cutaneous anaphylaxis##2##3##(1995-11#1)(2008-10#1)
passive diffusion and##2##3##(2010-12#1)(2011-2#1)
passive diffusion##3##2##(2010-12#1)(2011-2#2)
passive immunization##3##2##(1996-3#1)(2009-6#1)(2012-2#1)
passive membrane##2##2##(1991-5#1)(2011-2#1)
passive neutral##3##2##(2008-10#3)
passive permeability##2##2##(1990-2#1)(1993-3#1)
passive rewarming##2##2##(2011-2#2)
passive sampler##10##2##(2008-10#9)(2008-11#1)
passive samplers##2##2##(2008-10#1)(2008-11#1)
passive sampling##3##2##(2008-10#3)
passive to##2##2##(2008-11#1)(2010-12#1)
passive##99##1##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-3#2)(1997-3#1)(2007-11#1)(2008-10#27)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#1)(2010-12#3)(2010-5#1)(2010-8#3)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2012-9#1)
passively Q-switched operation##2##3##(2008-2#1)(2008-3#1)
passively Q-switched##6##2##(2008-2#2)(2008-3#4)
passively mode-locked##2##2##(2007-11#1)(2008-3#1)
passively quenched##2##2##(2007-12#1)(2008-3#1)
passively##14##1##(1993-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#6)
past 25 years##3##3##(1997-1#1)(1997-8#1)(2008-7#1)
past 6 years##2##3##(1991-3#1)(2013-1#1)
past achievements##2##2##(2012-3#2)
past and current##4##3##(1996-3#1)(2008-11#1)(2008-4#1)(2011-2#1)
past and##13##2##(1991-3#3)(1994-6#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-5#1)
past decade has##3##3##(1993-1#1)(1994-1#1)(2008-10#1)
past decade##44##2##(1991-2#1)(1991-3#2)(1993-1#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#1)(2007-12#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
past decades##8##2##(2008-10#2)(2009-5#1)(2010-10#1)(2011-2#3)(2013-1#1)
past editions##2##2##(2008-10#2)
past experience##3##2##(2008-11#1)(2009-12#1)(2011-2#1)
past few decades##5##3##(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
past few##23##2##(1992-9#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
past history of##5##3##(1990-3#1)(1992-2#1)(2008-12#1)(2008-8#1)(2013-1#1)
past history##6##2##(1990-3#1)(1992-2#1)(1996-12#1)(2008-12#1)(2008-8#1)(2013-1#1)
past medical history and##2##4##(2008-7#1)(2010-10#1)
past medical history##6##3##(2007-12#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-12#1)
past month use##5##3##(2010-9#5)
past month##6##2##(2010-9#6)
past research##2##2##(2008-11#1)(2012-2#1)
past several years##12##3##(1991-1#1)(1992-2#1)(1992-3#2)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)
past several##14##2##(1991-1#1)(1992-2#1)(1992-3#2)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#3)
past studies##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
past the##3##2##(2008-10#2)(2008-7#1)
past years##8##2##(1990-9#1)(1991-3#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
past##351##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#10)(1992-1#1)(1992-12#5)(1992-2#3)(1992-3#4)(1992-9#3)(1993-1#1)(1993-12#4)(1993-3#6)(1993-8#1)(1994-1#3)(1994-12#1)(1994-3#5)(1994-6#1)(1995-1#3)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#6)(1997-2#3)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-12#3)(2008-1#3)(2008-10#54)(2008-11#33)(2008-12#7)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#9)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-5#2)(2010-6#2)(2010-7#6)(2010-8#2)(2010-9#6)(2011-1#3)(2011-2#28)(2012-12#2)(2012-2#5)(2012-3#8)(2012-5#1)(2012-7#3)(2012-9#4)(2013-1#12)(2013-8#9)
pasta and##2##2##(2008-10#2)
pasta##3##1##(2008-10#3)
paste based electrodes##2##3##(2008-10#2)
paste based##3##2##(2008-10#3)
paste electrode##88##2##(2008-10#88)
paste electrodes##14##2##(2008-10#14)
paste##138##1##(2008-10#135)(2010-4#3)
pasteurised##2##1##(2008-10#1)(2010-3#1)
pasteurization##6##1##(1996-12#1)(2008-10#4)(2012-2#1)
pasteurized milk##4##2##(2008-10#1)(2008-12#3)
pasteurized soil##2##2##(2008-10#2)
pasteurized##9##1##(2008-10#5)(2008-12#4)
pastoral care##2##2##(1993-12#1)(2008-12#1)
pastoral systems##2##2##(2011-2#2)
pastoral##12##1##(1991-2#1)(1993-12#2)(2008-12#1)(2010-1#2)(2010-9#2)(2011-2#4)
pastoris##14##1##(1994-11#2)(1997-7#2)(2008-7#4)(2008-8#1)(2009-9#1)(2010-5#2)(2011-2#2)
pasture##16##1##(1994-1#1)(1996-12#4)(2008-10#5)(2010-4#4)(2013-1#2)
pastures##3##1##(2008-10#1)(2012-7#2)
patch and the##4##3##(2008-8#3)(2011-3#1)
patch and##5##2##(2008-8#3)(2011-2#1)(2011-3#1)
patch area##4##2##(2008-8#4)
patch clamp##3##2##(1994-11#1)(2008-8#1)(2011-2#1)
patch containing tamarind fruit extract##2##5##(2008-5#2)
patch density##3##2##(2008-8#3)
patch extinction rate##2##3##(2008-8#2)
patch extinction##3##2##(2008-8#3)
patch isolation##2##2##(2008-8#2)
patch network##3##2##(2008-8#3)
patch occupancy##14##2##(2008-8#10)(2008-9#4)
patch of##3##2##(2008-5#1)(2010-12#1)(2010-6#1)
patch size##6##2##(2008-8#4)(2008-9#2)
patch test##6##2##(2008-5#5)(2012-3#1)
patch##103##1##(1994-11#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#6)(2008-3#2)(2008-5#16)(2008-6#1)(2008-8#41)(2008-9#13)(2009-4#1)(2010-12#2)(2010-6#2)(2011-2#4)(2011-3#3)(2012-2#2)(2012-3#1)(2013-1#1)
patch-clamp recording##2##2##(2008-11#1)(2011-2#1)
patch-clamp technique##3##2##(1993-3#1)(1995-2#1)(2012-2#1)
patch-clamp##8##1##(1993-3#1)(1994-11#2)(1995-2#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
patched##4##1##(1997-3#1)(2008-3#1)(2008-5#2)
patches and##2##2##(2008-9#2)
patches are##2##2##(2008-8#1)(2012-2#1)
patches as well as##2##4##(2008-8#2)
patches as##4##2##(2008-8#3)(2008-9#1)
patches at##2##2##(2008-5#2)
patches have##3##2##(2008-11#2)(2008-9#1)
patches in the##2##3##(1997-1#1)(2012-3#1)
patches in##4##2##(1997-1#1)(2008-5#1)(2008-8#1)(2012-3#1)
patches of##11##2##(1992-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)
patches on##2##2##(2008-9#1)(2010-6#1)
patches that##3##2##(2008-8#3)
patches to##2##2##(2008-5#1)(2008-9#1)
patches were##3##2##(2008-5#1)(2008-6#1)(2012-2#1)
patches with##6##2##(2008-5#3)(2008-8#2)(2008-9#1)
patches##105##1##(1991-2#1)(1992-12#4)(1994-11#1)(1994-9#1)(1995-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#13)(2008-6#1)(2008-7#2)(2008-8#38)(2008-9#25)(2010-6#3)(2012-2#3)(2012-3#1)(2012-9#1)
patching##2##1##(2008-3#1)(2008-5#1)
patchwork##4##1##(1995-6#1)(1997-8#1)(2008-1#1)(2008-11#1)
patchy landscapes##2##2##(2008-8#2)
patchy##9##1##(1991-11#1)(1994-12#1)(2008-8#5)(2008-9#1)(2010-12#1)
patella fractures##2##2##(2009-3#2)
patella##7##1##(2009-3#3)(2009-4#1)(2013-1#3)
patellar tendon rupture##4##3##(2009-4#4)
patellar tendon##8##2##(2009-3#1)(2009-4#5)(2013-1#2)
patellar##15##1##(1995-8#1)(1997-8#1)(2009-3#1)(2009-4#5)(2010-9#1)(2012-2#2)(2013-1#4)
patellar-pubic percussion test##2##3##(2008-12#2)
patellofemoral pain syndrome##4##3##(2008-12#4)
patellofemoral##6##1##(2008-12#6)
patency of the##2##3##(2011-2#2)
patency of##4##2##(2011-2#2)(2011-3#2)
patency was##2##2##(1993-1#1)(2011-3#1)
patency##14##1##(1990-8#1)(1993-1#3)(1994-12#1)(1997-2#1)(2008-2#1)(2011-2#2)(2011-3#3)(2013-1#1)(2013-8#1)
patent applications##7##2##(2010-12#7)
patent blue V##2##3##(2008-10#2)
patent ductus arteriosus##5##3##(1997-8#1)(2008-11#2)(2010-10#2)
patent foramen ovale in##2##4##(2008-7#1)(2012-2#1)
patent foramen ovale##7##3##(2008-7#3)(2009-10#1)(2011-2#2)(2012-2#1)
patent offices##5##2##(2010-12#5)
patent publications##2##2##(2010-12#2)
patent##45##1##(1996-9#1)(1997-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#3)(2009-10#1)(2010-10#2)(2010-12#16)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
patented##8##1##(2008-10#1)(2010-7#6)(2012-2#1)
patents are##2##2##(2010-7#2)
patents on##3##2##(2010-7#3)
patents##14##1##(1994-12#1)(2008-5#3)(2009-12#1)(2010-7#9)
paternal care is##4##3##(2008-8#3)(2008-9#1)
paternal care##10##2##(2008-8#5)(2008-9#5)
paternal effects##3##2##(2008-9#2)(2011-2#1)
paternal investment by mating with##2##5##(2008-8#2)
paternal investment##7##2##(2008-8#6)(2008-9#1)
paternal##35##1##(1996-12#1)(1997-3#2)(2008-12#1)(2008-4#1)(2008-8#13)(2008-9#12)(2010-11#1)(2010-8#2)(2011-2#1)(2012-12#1)
paternally derived deletions##4##3##(1997-3#4)
paternally##5##1##(1997-3#4)(2010-11#1)
paternity analysis##2##2##(2008-8#1)(2008-9#1)
paternity in##5##2##(2008-8#2)(2008-9#3)
paternity testing##3##2##(2008-12#3)
paternity##27##1##(2007-12#1)(2008-12#12)(2008-6#1)(2008-8#6)(2008-9#7)
path analysis##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
path difference##9##2##(2008-3#3)(2013-8#6)
path for##2##2##(1994-2#1)(2008-6#1)
path from the##2##3##(2008-11#1)(2012-12#1)
path geometry##2##2##(2008-3#1)(2008-7#1)
path length L##2##3##(2008-3#2)
path length##17##2##(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)
path of the##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
path of##5##2##(1993-6#1)(2008-10#2)(2010-8#1)(2013-8#1)
path that##2##2##(2008-3#1)(2012-3#1)
path through##2##2##(2008-10#1)(2009-9#1)
path to##4##2##(1996-3#1)(2010-10#1)(2010-7#1)(2011-2#1)
path##84##1##(1990-5#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1996-3#1)(2008-10#18)(2008-11#3)(2008-2#2)(2008-3#27)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-8#8)
path-history##2##1##(2008-3#2)
path-length##3##1##(2008-2#2)(2008-3#1)
pathlength absorbance spectroscopy##2##3##(2008-10#2)
pathlength and##2##2##(2008-10#1)(2010-7#1)
pathlength##17##1##(2008-10#15)(2010-3#1)(2010-7#1)
patho-types##4##1##(2008-10#4)
pathobiology##2##1##(1991-12#1)(2011-1#1)
pathogen Alternaria##2##2##(1992-8#1)(2008-10#1)
pathogen Aphanomyces euteiches##2##3##(2008-10#2)
pathogen Candida albicans##2##3##(1992-8#1)(2009-8#1)
pathogen Cercospora sorghi##2##3##(2008-10#2)
pathogen Cercospora##3##2##(2008-10#3)
pathogen Colletotrichum##2##2##(2008-10#2)
pathogen DNA##13##2##(2008-10#13)
pathogen Fusarium oxysporum f##4##4##(2008-10#4)
pathogen Fusarium##5##2##(2008-10#4)(2011-10#1)
pathogen Phytophthora##4##2##(2008-10#4)
pathogen Pseudomonas syringae pv##2##4##(2008-10#2)
pathogen Puccinia##2##2##(2008-10#2)
pathogen Pythium##2##2##(2008-10#2)
pathogen Venturia inaequalis##3##3##(2008-10#3)
pathogen Xanthomonas oryzae pv##2##4##(2008-10#2)
pathogen Xanthomonas##3##2##(2008-10#3)
pathogen adaptation##2##2##(2008-10#2)
pathogen also##4##2##(2008-10#4)
pathogen and its##2##3##(1995-5#1)(2008-9#1)
pathogen and##25##2##(1995-5#1)(2008-10#21)(2008-8#1)(2008-9#2)
pathogen are##2##2##(2008-10#1)(2008-9#1)
pathogen as##4##2##(2008-10#4)
pathogen associated##3##2##(1995-2#1)(2008-7#1)(2012-2#1)
pathogen at##3##2##(2008-10#3)
pathogen attack##5##2##(2008-10#5)
pathogen by##6##2##(2008-10#5)(2009-6#1)
pathogen can be##5##3##(2008-10#5)
pathogen can have##2##3##(2008-10#2)
pathogen can spread##2##3##(2008-10#2)
pathogen can##10##2##(2008-10#10)
pathogen causing##4##2##(2008-10#4)
pathogen cell##2##2##(2008-10#2)
pathogen control by##2##3##(2008-10#2)
pathogen control##8##2##(2008-10#7)(2012-2#1)
pathogen culture collections##3##3##(2008-10#3)
pathogen defense##2##2##(2008-10#2)
pathogen densities##2##2##(2008-10#2)
pathogen detection##6##2##(2008-10#5)(2011-2#1)
pathogen development##3##2##(2008-10#3)
pathogen did not##4##3##(2008-10#4)
pathogen dissemination##2##2##(2008-10#2)
pathogen diversity##2##2##(2008-10#2)
pathogen evolution in cultivar mixtures##2##5##(2008-10#2)
pathogen evolution in##3##3##(2008-10#3)
pathogen evolution##6##2##(2008-10#5)(2011-10#1)
pathogen fitness##2##2##(2008-10#1)(2008-9#1)
pathogen free##3##2##(1991-11#2)(2008-10#1)
pathogen from##6##2##(2008-10#6)
pathogen genotype##2##2##(2008-10#2)
pathogen genotypes##6##2##(2008-10#6)
pathogen germination##2##2##(2008-10#2)
pathogen growth##8##2##(2008-10#8)
pathogen has##6##2##(2008-10#5)(2008-9#1)
pathogen hyphae##3##2##(2008-10#3)
pathogen in a##2##3##(2008-10#2)
pathogen in planta##3##3##(2008-10#3)
pathogen in the##6##3##(2008-10#4)(2008-9#1)(2012-2#1)
pathogen in vitro##2##3##(2008-10#2)
pathogen in##31##2##(2007-12#1)(2008-10#26)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
pathogen infection##3##2##(2008-10#1)(2008-9#2)
pathogen infection-induced##2##2##(2008-8#2)
pathogen ingress##4##2##(2008-10#4)
pathogen inoculation was##2##3##(2008-10#2)
pathogen inoculation##5##2##(2008-10#5)
pathogen inoculum##6##2##(2008-10#6)
pathogen into##3##2##(2008-10#3)
pathogen invasion and##2##3##(2008-10#1)(2008-9#1)
pathogen invasion##3##2##(2008-10#2)(2008-9#1)
pathogen is##10##2##(2008-10#7)(2008-8#1)(2011-2#2)
pathogen isolates##4##2##(2008-10#4)
pathogen life cycle component##2##4##(2008-10#2)
pathogen life cycle##3##3##(2008-10#3)
pathogen occurs in##2##3##(1995-5#1)(2008-10#1)
pathogen of a##2##3##(2008-10#2)
pathogen of citrus##2##3##(2008-10#2)
pathogen of wheat##2##3##(2008-10#2)
pathogen of##21##2##(2008-10#19)(2008-9#1)(2011-1#1)
pathogen on##7##2##(2008-10#7)
pathogen or##2##2##(2008-10#2)
pathogen population in##2##3##(2008-10#2)
pathogen population size##2##3##(2008-10#2)
pathogen population structure##2##3##(2008-10#2)
pathogen population was##2##3##(2008-10#2)
pathogen population##31##2##(2008-10#30)(2008-8#1)
pathogen populations##17##2##(2008-10#16)(2008-8#1)
pathogen presence##2##2##(2008-10#2)
pathogen race##3##2##(2008-10#2)(2008-8#1)
pathogen races##3##2##(2008-10#3)
pathogen resistance##5##2##(2008-10#4)(2009-8#1)
pathogen species##5##2##(2008-10#5)
pathogen spores##2##2##(2008-10#2)
pathogen sporulation##4##2##(2008-10#4)
pathogen spread##4##2##(2008-10#4)
pathogen strains##2##2##(2008-10#2)
pathogen suppression##4##2##(2008-10#4)
pathogen survival##3##2##(2008-10#3)
pathogen that is##2##3##(2008-10#2)
pathogen that##8##2##(2008-10#6)(2011-2#2)
pathogen through##2##2##(2008-10#1)(2013-8#1)
pathogen to##7##2##(2008-10#6)(2009-8#1)
pathogen variability##2##2##(2008-10#2)
pathogen virulence##4##2##(2008-10#2)(2008-9#2)
pathogen was visualized##2##3##(2008-10#2)
pathogen was##18##2##(2008-10#18)
pathogen were##10##2##(2008-10#10)
pathogen with a##2##3##(2008-10#2)
pathogen with##4##2##(2008-10#3)(2012-3#1)
pathogen##756##1##(1991-11#2)(1992-8#2)(1995-2#2)(1995-5#3)(2007-12#2)(2008-10#655)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#11)(2008-9#19)(2009-12#1)(2009-6#2)(2009-8#8)(2010-3#1)(2010-4#1)(2011-1#3)(2011-10#4)(2011-2#16)(2012-2#6)(2012-3#3)(2013-1#3)(2013-8#6)
pathogen's life cycle##2##3##(2008-10#2)
pathogen's life##3##2##(2008-10#3)
pathogen's##10##1##(2008-10#7)(2008-8#1)(2009-8#1)(2011-2#1)
pathogen)##3##1##(2008-10#3)
pathogen-derived resistance##3##2##(2008-10#3)
pathogen-derived##4##1##(1995-5#1)(2008-10#3)
pathogen-induced##3##1##(2008-10#2)(2008-9#1)
pathogen-infested##2##1##(2008-10#2)
pathogen-mimicking##2##1##(2012-2#2)
pathogenesis and management of##2##4##(2008-7#1)(2009-4#1)
pathogenesis and management##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
pathogenesis and treatment of##3##4##(1990-11#1)(2008-12#1)(2010-10#1)
pathogenesis and treatment##5##3##(1990-11#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-3#1)
pathogenesis and##21##2##(1990-11#1)(1991-11#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-10#2)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
pathogenesis are##2##2##(2010-12#1)(2011-2#1)
pathogenesis in##2##2##(2008-10#1)(2011-2#1)
pathogenesis is##3##2##(2006-6#1)(2010-12#2)
pathogenesis of Parkinson's disease##2##4##(2008-7#2)
pathogenesis of VC##2##3##(2009-1#2)
pathogenesis of atopic##2##3##(1991-2#1)(2008-10#1)
pathogenesis of disorders##2##3##(1990-11#1)(1997-2#1)
pathogenesis of immune-mediated inflammatory diseases##2##5##(2011-2#2)
pathogenesis of inflammatory##2##3##(2013-1#1)(2013-8#1)
pathogenesis of malignant##2##3##(2011-2#2)
pathogenesis of rheumatoid arthritis##2##4##(2007-11#1)(2009-1#1)
pathogenesis of this##3##3##(1997-8#1)(2008-12#1)(2013-1#1)
pathogenesis of##116##2##(1990-11#1)(1990-9#2)(1991-2#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-11#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#5)(2006-6#1)(2007-11#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#9)(2008-9#2)(2009-1#4)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-5#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#11)(2013-3#1)(2013-7#1)(2013-8#6)
pathogenesis##195##1##(1990-11#2)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-11#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#5)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#14)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#13)(2008-9#6)(2009-1#4)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-12#9)(2010-5#2)(2010-6#2)(2011-1#3)(2011-2#20)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#17)(2013-3#1)(2013-7#2)(2013-8#10)
pathogenesis- related##2##2##(2008-10#2)
pathogenesis-related (PR) proteins##2##3##(2008-10#2)
pathogenesis-related (PR)##5##2##(2008-10#5)
pathogenesis-related protein##5##2##(2008-10#3)(2009-8#1)(2011-10#1)
pathogenesis-related proteins##3##2##(2008-10#3)
pathogenesis-related##21##1##(1992-8#1)(2008-10#16)(2009-8#1)(2011-10#3)
pathogenetic mechanisms##3##2##(2008-7#1)(2010-5#1)(2012-3#1)
pathogenetic##13##1##(1991-3#1)(1995-8#1)(1997-8#1)(2008-7#3)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-3#1)
pathogenic Pythium spp##2##3##(2008-10#2)
pathogenic and nonpathogenic isolates from##2##5##(2008-10#2)
pathogenic and nonpathogenic lifestyles##2##4##(2008-10#2)
pathogenic and nonpathogenic##5##3##(2008-10#5)
pathogenic and##9##2##(2008-10#8)(2008-9#1)
pathogenic bacteria##10##2##(2008-10#2)(2008-9#1)(2009-6#2)(2010-5#1)(2010-7#1)(2012-2#2)(2013-8#1)
pathogenic bacterium##2##2##(2008-10#1)(2013-1#1)
pathogenic factors##2##2##(1991-6#1)(2008-1#1)
pathogenic fitness##5##2##(2008-10#5)
pathogenic fungi and##2##3##(2008-10#2)
pathogenic fungi##9##2##(2008-10#7)(2008-11#1)(2013-1#1)
pathogenic fungus##4##2##(1996-6#1)(2008-10#2)(2008-11#1)
pathogenic in##3##2##(2008-10#3)
pathogenic isolates from##3##3##(2008-10#3)
pathogenic isolates##7##2##(2008-10#7)
pathogenic mechanism##2##2##(1997-3#1)(2008-1#1)
pathogenic mechanisms##4##2##(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
pathogenic microorganisms##8##2##(1994-11#1)(1994-5#1)(2008-11#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-7#1)
pathogenic nematodes##2##2##(2008-10#2)
pathogenic on RL and not on MIN##2##7##(2008-10#2)
pathogenic on both##2##3##(2008-10#2)
pathogenic on lettuce##2##3##(2008-10#2)
pathogenic on potato##3##3##(2008-10#3)
pathogenic on the##2##3##(2008-10#2)
pathogenic on##38##2##(2008-10#38)
pathogenic only on##2##3##(2008-10#2)
pathogenic or are##2##3##(2008-10#1)(2011-2#1)
pathogenic organisms##2##2##(2008-4#1)(2011-2#1)
pathogenic populations##2##2##(2008-10#2)
pathogenic potential and##2##3##(2011-1#1)(2011-2#1)
pathogenic potential##6##2##(1996-12#1)(2008-10#3)(2011-1#1)(2011-2#1)
pathogenic races 0##2##3##(2008-10#2)
pathogenic races##3##2##(2008-10#3)
pathogenic role##3##2##(2008-5#2)(2010-1#1)
pathogenic species##6##2##(2008-10#5)(2008-12#1)
pathogenic spectrum of hand##2##4##(2013-8#2)
pathogenic strain of##3##3##(1992-3#1)(2008-10#2)
pathogenic strains##3##2##(2008-10#3)
pathogenic to asparagus##2##3##(2008-10#2)
pathogenic to pear##2##3##(2008-10#2)
pathogenic to pistachio##2##3##(2008-10#2)
pathogenic to strawberry##2##3##(2008-10#2)
pathogenic to##28##2##(2008-10#27)(2010-3#1)
pathogenic variability of##2##3##(2008-10#2)
pathogenic variability##3##2##(2008-10#3)
pathogenic variation##5##2##(2008-10#5)
pathogenic##237##1##(1991-6#1)(1992-3#2)(1993-3#1)(1994-11#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#165)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#7)(2009-6#3)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
pathogenicity and##5##2##(2008-10#5)
pathogenicity as##2##2##(2008-10#2)
pathogenicity assays##4##2##(2008-10#4)
pathogenicity determinant##3##2##(2008-10#3)
pathogenicity factor##2##2##(2008-10#2)
pathogenicity groups##4##2##(2008-10#4)
pathogenicity in##4##2##(2008-10#4)
pathogenicity island##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
pathogenicity of isolates##2##3##(2008-10#2)
pathogenicity of the##6##3##(2008-10#4)(2008-12#1)(2008-5#1)
pathogenicity of##25##2##(2008-10#21)(2008-12#1)(2008-5#2)(2012-3#1)
pathogenicity on tomato##2##3##(2008-10#2)
pathogenicity on##18##2##(2008-10#18)
pathogenicity test##2##2##(2008-10#2)
pathogenicity tests on##4##3##(2008-10#4)
pathogenicity tests##16##2##(2008-10#16)
pathogenicity to onion##2##3##(2008-10#2)
pathogenicity to##8##2##(2008-10#8)
pathogenicity toward##2##2##(2008-10#2)
pathogenicity was##6##2##(2008-10#5)(2011-2#1)
pathogenicity##152##1##(2008-10#139)(2008-11#1)(2008-12#1)(2008-5#3)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#2)
pathogens affecting##2##2##(2008-10#1)(2008-12#1)
pathogens and pests##2##3##(2008-10#2)
pathogens and the##3##3##(2008-10#2)(2009-3#1)
pathogens and their##3##3##(1994-3#1)(2011-2#1)(2013-1#1)
pathogens and to##2##3##(1996-1#1)(2008-10#1)
pathogens and##32##2##(1994-3#1)(1996-1#1)(2006-5#1)(2008-10#19)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
pathogens are##13##2##(1995-2#1)(2008-10#7)(2008-9#2)(2011-2#2)(2013-1#1)
pathogens as##2##2##(1995-5#1)(2008-10#1)
pathogens at the##2##3##(2008-10#1)(2011-10#1)
pathogens at##3##2##(2008-10#2)(2011-10#1)
pathogens but##3##2##(2008-10#2)(2008-6#1)
pathogens by##10##2##(1990-6#2)(2008-10#7)(2008-6#1)
pathogens can##2##2##(2008-10#2)
pathogens causing##2##2##(2008-10#2)
pathogens except##2##2##(2008-10#2)
pathogens for##7##2##(2008-10#4)(2008-7#1)(2010-4#1)(2011-2#1)
pathogens from the##3##3##(1995-5#1)(2008-10#1)(2010-3#1)
pathogens from##11##2##(1995-5#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)
pathogens had##2##2##(2008-10#2)
pathogens has been##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
pathogens have##7##2##(2008-10#4)(2008-9#2)(2011-2#1)
pathogens in a##2##3##(2008-10#2)
pathogens in nature##2##3##(2008-10#1)(2008-8#1)
pathogens in relation to host specialization##2##6##(2008-10#2)
pathogens in the##6##3##(2008-10#6)
pathogens in##29##2##(1996-11#1)(1996-8#1)(2007-12#1)(2008-10#19)(2008-12#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
pathogens is a##2##3##(2008-10#2)
pathogens is##6##2##(2008-10#5)(2009-10#1)
pathogens may have##2##3##(1996-6#1)(2008-10#1)
pathogens may##4##2##(1996-6#1)(2008-10#2)(2008-9#1)
pathogens of GSM larvae##2##4##(2009-6#2)
pathogens of Greenshell mussel##2##4##(2009-6#2)
pathogens of cereals and grasses##2##5##(2008-10#2)
pathogens of##25##2##(1995-2#1)(2008-10#16)(2009-6#4)(2010-10#1)(2010-12#1)(2013-8#2)
pathogens on##3##2##(2008-10#3)
pathogens or##2##2##(2008-10#1)(2013-7#1)
pathogens such as Clostridium##2##4##(2010-11#1)(2011-2#1)
pathogens such as##5##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)
pathogens that co-occur##2##3##(2008-10#1)(2010-3#1)
pathogens that could##2##3##(2008-10#1)(2011-2#1)
pathogens that##11##2##(1995-2#1)(2008-10#3)(2008-8#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-3#1)
pathogens to##4##2##(2007-12#1)(2008-10#3)
pathogens under##3##2##(2008-10#3)
pathogens was tested##2##3##(2008-10#2)
pathogens was##4##2##(2008-10#4)
pathogens were##9##2##(2008-10#7)(2008-12#1)(2012-2#1)
pathogens with##5##2##(2008-10#5)
pathogens##427##1##(1990-6#3)(1992-12#2)(1994-3#1)(1994-6#1)(1995-2#4)(1995-5#4)(1996-1#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-7#1)(2006-5#1)(2006-6#1)(2007-12#4)(2008-10#278)(2008-11#1)(2008-12#6)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#18)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#11)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#3)(2010-6#3)(2011-1#1)(2011-10#3)(2011-2#19)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#6)
pathogens)##2##1##(2008-10#1)(2011-2#1)
pathologic and##3##2##(1992-12#1)(2009-3#1)(2011-2#1)
pathologic conditions##5##2##(1990-12#1)(1993-12#1)(1994-8#1)(1996-6#1)(2010-6#1)
pathologic effects##2##2##(1991-12#1)(2010-6#1)
pathologic features of##4##3##(1990-6#1)(1991-8#1)(1992-2#1)(2009-1#1)
pathologic features##7##2##(1990-6#1)(1991-8#1)(1992-2#1)(2009-1#1)(2011-2#2)(2012-3#1)
pathologic findings of##2##3##(1991-8#1)(2008-9#1)
pathologic findings##5##2##(1991-8#1)(1997-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
pathologic response##2##2##(2008-10#1)(2012-3#1)
pathologic##55##1##(1990-11#2)(1990-12#3)(1990-6#2)(1990-8#1)(1991-12#2)(1991-8#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-8#1)(1996-6#2)(1997-8#1)(2008-10#3)(2008-11#2)(2008-9#7)(2009-1#1)(2009-3#3)(2010-11#1)(2010-6#3)(2011-2#7)(2012-2#1)(2012-3#4)(2013-8#2)
pathological acid gastro-oesophageal reflux and frequent sinoatrial blocks##2##8##(1996-3#2)
pathological anatomy##2##2##(1990-9#1)(1993-11#1)
pathological and##3##2##(1994-5#1)(2008-10#1)(2009-4#1)
pathological changes in the##3##4##(1991-3#1)(2013-1#2)
pathological changes in##5##3##(1991-3#1)(2008-1#1)(2008-7#1)(2013-1#2)
pathological changes of##2##3##(1991-6#1)(2011-2#1)
pathological changes##18##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-6#1)(1996-11#1)(1997-2#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-7#3)(2011-2#1)(2012-3#1)(2013-1#2)
pathological condition##4##2##(1990-5#1)(2011-2#2)(2013-1#1)
pathological conditions##10##2##(1992-2#1)(1992-5#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
pathological diagnosis was##2##3##(2008-12#1)(2011-2#1)
pathological diagnosis##4##2##(1992-5#1)(1994-8#1)(2008-12#1)(2011-2#1)
pathological effects of##3##3##(2008-6#1)(2010-12#1)(2010-4#1)
pathological examination##3##2##(2008-10#1)(2010-1#1)(2012-12#1)
pathological findings in##2##3##(1992-5#1)(1993-3#1)
pathological findings##10##2##(1992-5#1)(1993-3#1)(1995-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
pathological fractures##2##2##(2008-12#1)(2010-3#1)
pathological gambling##3##2##(2008-11#1)(2013-8#2)
pathological processes##6##2##(1996-2#1)(2008-12#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
pathological reaction##2##2##(1990-6#2)
pathological responses##2##2##(1992-3#1)(2008-10#1)
pathological role##2##2##(2008-10#1)(2008-5#1)
pathological stage##3##2##(1990-9#1)(2010-11#1)(2010-12#1)
pathological##152##1##(1990-11#1)(1990-5#1)(1990-6#5)(1990-9#6)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#4)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#2)(1996-11#1)(1996-2#2)(1996-3#3)(1997-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#8)(2008-5#4)(2008-6#2)(2008-7#7)(2008-9#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#11)(2013-8#6)
pathologically##10##1##(1991-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-1#1)(2010-1#1)(2010-12#2)(2012-12#1)
pathologies can##2##2##(2008-9#1)(2012-2#1)
pathologies of the biliary tract##2##5##(1992-9#2)
pathologies of the##3##3##(1992-9#2)(2013-1#1)
pathologies of##4##2##(1992-9#2)(2008-1#1)(2013-1#1)
pathologies that##2##2##(2012-3#1)(2013-1#1)
pathologies##35##1##(1990-3#1)(1991-2#1)(1992-9#2)(1993-3#1)(1993-5#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
pathologies)##2##1##(1992-9#1)(2012-3#1)
pathologist##6##1##(1992-12#1)(1992-2#1)(1993-1#1)(1997-5#1)(2008-1#1)(2009-1#1)
pathologists were called upon to help manage##2##7##(2008-10#2)
pathologists##21##1##(1991-12#1)(1991-2#1)(1994-12#1)(1997-2#1)(2008-10#12)(2008-11#1)(2011-2#4)
pathology and##12##2##(1991-2#1)(1994-12#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-10#1)(2011-2#1)
pathology are##3##2##(1994-12#1)(2008-10#1)(2010-1#1)
pathology as##2##2##(2008-9#1)(2013-8#1)
pathology at##2##2##(2008-9#1)(2012-3#1)
pathology examination##2##2##(1997-7#1)(2012-12#1)
pathology for the##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
pathology for##6##2##(2008-10#3)(2010-1#1)(2011-2#1)(2013-1#1)
pathology has been##2##3##(1991-3#1)(2008-1#1)
pathology has##5##2##(1991-12#1)(1991-3#1)(2008-1#1)(2008-10#1)(2008-9#1)
pathology in the##3##3##(1990-9#1)(2008-12#1)(2008-7#1)
pathology in##13##2##(1990-9#1)(1991-3#1)(1994-6#1)(2008-11#1)(2008-12#2)(2008-7#3)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
pathology is strain-specific##2##3##(2008-10#2)
pathology is##5##2##(2008-10#3)(2008-9#1)(2013-1#1)
pathology may##2##2##(2008-1#1)(2012-2#1)
pathology of the##3##3##(1997-1#1)(2008-1#1)(2008-11#1)
pathology of##13##2##(1991-3#1)(1991-6#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-8#1)(2013-1#2)
pathology or##3##2##(1991-8#1)(2011-2#1)(2012-12#1)
pathology report##2##2##(2012-12#1)(2013-1#1)
pathology that##2##2##(1991-2#1)(2008-10#1)
pathology to##2##2##(1994-6#1)(2008-9#1)
pathology was##2##2##(2008-7#1)(2013-1#1)
pathology##174##1##(1990-11#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#7)(1991-6#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-3#2)(1993-6#1)(1994-12#7)(1994-6#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-1#5)(2008-10#27)(2008-11#3)(2008-12#6)(2008-4#2)(2008-5#5)(2008-7#10)(2008-8#3)(2008-9#8)(2009-10#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#3)(2010-11#2)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#2)(2011-2#12)(2011-3#1)(2011-7#2)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#14)(2013-8#3)
pathophysiologic concept##2##2##(2008-10#2)
pathophysiologic mechanisms##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
pathophysiologic##15##1##(1993-1#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
pathophysiological and##2##2##(2008-6#1)(2012-2#1)
pathophysiological concept##2##2##(2010-12#1)(2010-4#1)
pathophysiological mechanism##2##2##(2011-2#2)
pathophysiological mechanisms of##2##3##(2008-7#1)(2011-2#1)
pathophysiological mechanisms##5##2##(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#1)
pathophysiological roles of##2##3##(2008-7#1)(2009-12#1)
pathophysiological##29##1##(1996-12#2)(1996-2#1)(1996-9#1)(2008-1#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
pathophysiologically##2##1##(2011-2#2)
pathophysiology and therapeutic##2##3##(2008-7#1)(2012-3#1)
pathophysiology and treatment of##2##4##(2008-7#1)(2013-1#1)
pathophysiology and##10##2##(1994-6#1)(2008-10#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#2)
pathophysiology is##2##2##(1996-11#1)(2012-3#1)
pathophysiology of neuropsychiatric##2##3##(2008-12#1)(2008-4#1)
pathophysiology of the##3##3##(2008-9#1)(2009-10#1)(2011-1#1)
pathophysiology of these##3##3##(1992-9#1)(2008-7#1)(2013-8#1)
pathophysiology of##47##2##(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#2)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
pathophysiology##78##1##(1990-8#1)(1992-9#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-2#1)(2008-10#3)(2008-11#3)(2008-12#7)(2008-4#2)(2008-6#1)(2008-7#8)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-2#5)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#3)
pathosystem was##2##2##(2008-10#2)
pathosystem##26##1##(2008-10#24)(2011-10#1)(2012-2#1)
pathosystems##13##1##(2008-10#13)
pathotype 1##4##2##(2008-10#4)
pathotype 2##4##2##(2008-10#4)
pathotype of A##3##3##(2008-10#3)
pathotype of##4##2##(2008-10#4)
pathotype##34##1##(2008-10#34)
pathotypes of Alternaria alternata##2##4##(2008-10#2)
pathotypes of##8##2##(2008-10#8)
pathotypes should##2##2##(2008-10#2)
pathotypes were identified##3##3##(2008-10#3)
pathotypes were##5##2##(2008-10#5)
pathotypes##52##1##(2008-10#52)
pathovar of##2##2##(2008-10#2)
pathovar##9##1##(2008-10#9)
pathovars of P##2##3##(2008-10#2)
pathovars of X##4##3##(2008-10#4)
pathovars of Xanthomonas##2##3##(2008-10#2)
pathovars of##10##2##(2008-10#10)
pathovars were##2##2##(2008-10#2)
pathovars##29##1##(2008-10#29)
paths are##3##2##(1993-3#2)(2008-6#1)
paths but also##2##3##(2008-3#1)(2011-2#1)
paths from##2##2##(2008-11#1)(2013-8#1)
paths of##5##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-6#1)
paths to##3##2##(1993-1#1)(1996-1#1)(2009-11#1)
paths##32##1##(1993-1#1)(1993-3#4)(1996-1#2)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-6#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
pathway activation##6##2##(2008-11#1)(2009-6#2)(2010-12#1)(2013-1#1)(2013-8#1)
pathway analysis##3##2##(2010-12#2)(2013-8#1)
pathway and that##2##3##(1996-3#1)(2008-11#1)
pathway and the##7##3##(2007-12#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-11#1)(2012-2#1)
pathway and##19##2##(1994-11#1)(1995-11#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2009-8#1)(2010-11#1)(2010-4#1)(2011-10#1)(2011-3#1)(2012-2#2)(2013-1#1)
pathway as a##2##3##(2008-3#1)(2011-2#1)
pathway by##6##2##(1994-8#1)(1995-12#2)(2008-10#1)(2011-2#1)(2011-3#1)
pathway can be##2##3##(2009-8#1)(2010-4#1)
pathway can##4##2##(1997-7#1)(2009-8#2)(2010-4#1)
pathway could##3##2##(1995-2#1)(2009-6#1)(2011-2#1)
pathway data##2##2##(2010-10#2)
pathway enzyme##2##2##(2008-9#2)
pathway exchange##2##2##(2010-10#2)
pathway for the##2##3##(1994-8#1)(2008-3#1)
pathway for##12##2##(1994-8#1)(2008-11#2)(2008-3#4)(2008-7#1)(2009-6#1)(2011-3#1)(2012-2#2)
pathway has been##4##3##(2008-1#1)(2008-3#1)(2008-7#1)(2010-11#1)
pathway has##5##2##(2008-1#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-11#1)
pathway in a##2##3##(2008-7#1)(2013-1#1)
pathway in regulating##2##3##(2011-2#1)(2013-1#1)
pathway in the##3##3##(1997-2#1)(2008-11#1)(2010-12#1)
pathway in##36##2##(1992-12#1)(1993-8#1)(1994-11#3)(1994-5#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
pathway intermediates##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
pathway involving##3##2##(1994-11#1)(1995-8#2)
pathway is blocked by##2##4##(2008-11#1)(2008-7#1)
pathway is important##2##3##(2012-2#1)(2013-1#1)
pathway is##18##2##(1992-12#2)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-2#2)(2013-1#1)
pathway leading to##2##3##(2008-10#1)(2008-9#1)
pathway may be##5##3##(1995-12#1)(2008-9#1)(2009-12#1)(2009-6#1)(2013-1#1)
pathway may##7##2##(1993-3#1)(1995-12#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
pathway mediated by##2##3##(2008-11#1)(2011-2#1)
pathway of the##4##3##(1996-9#1)(2007-12#1)(2008-10#1)(2012-5#1)
pathway of##26##2##(1991-2#1)(1992-6#1)(1994-11#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-3#2)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
pathway on##3##2##(1996-12#1)(2008-9#2)
pathway or##2##2##(1994-6#1)(2008-7#1)
pathway plays a##2##3##(2011-2#1)(2013-1#1)
pathway that##7##2##(2008-10#2)(2008-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)
pathway to the##2##3##(1992-12#1)(2009-8#1)
pathway to##13##2##(1992-12#1)(1997-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
pathway was##10##2##(1993-2#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#4)(2011-2#1)(2012-2#1)
pathway were##3##2##(2008-11#1)(2009-3#1)(2010-11#1)
pathway which may be##2##4##(1996-12#1)(2008-11#1)
pathway which##5##2##(1994-8#1)(1995-6#1)(1996-12#1)(2008-11#1)(2012-3#1)
pathway with##6##2##(1995-6#1)(2008-11#2)(2010-12#1)(2011-3#2)
pathway##431##1##(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#4)(1992-6#1)(1992-8#1)(1993-2#2)(1993-3#4)(1993-8#3)(1994-11#12)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#6)(1995-11#1)(1995-12#5)(1995-2#8)(1995-6#7)(1995-8#8)(1995-9#1)(1996-12#4)(1996-2#8)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#11)(1997-2#2)(1997-7#3)(1997-8#1)(2007-12#6)(2008-1#2)(2008-10#23)(2008-11#57)(2008-12#1)(2008-3#12)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#16)(2008-8#7)(2008-9#20)(2009-10#3)(2009-12#6)(2009-3#2)(2009-4#2)(2009-6#9)(2009-7#4)(2009-8#15)(2009-9#3)(2010-10#6)(2010-11#6)(2010-12#8)(2010-4#4)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#25)(2011-3#17)(2012-12#1)(2012-2#16)(2012-3#9)(2012-5#1)(2013-1#16)(2013-7#2)(2013-8#7)
pathway) or##2##2##(2011-1#1)(2012-2#1)
pathway)##6##1##(2008-6#1)(2010-10#2)(2011-1#1)(2012-2#2)
pathways activate the##2##3##(2008-1#1)(2008-11#1)
pathways and the##4##3##(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
pathways and##21##2##(1991-9#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)
pathways are involved in##2##4##(1994-11#1)(2008-10#1)
pathways are##13##2##(1993-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-10#1)(2009-3#1)(2012-3#1)
pathways as##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
pathways associated with##2##3##(2008-10#1)(2008-11#1)
pathways between the##2##3##(2008-9#1)(2010-1#1)
pathways by which##4##3##(1994-11#1)(1997-4#1)(2008-10#2)
pathways by##9##2##(1994-11#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-9#1)(2012-3#3)
pathways controlling##2##2##(2008-10#1)(2008-9#1)
pathways could##2##2##(1997-7#1)(2008-11#1)
pathways during##2##2##(2008-11#1)(2009-8#1)
pathways for the##2##3##(2008-11#1)(2009-1#1)
pathways for##15##2##(1990-11#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#4)(2008-8#1)(2009-1#1)(2010-7#2)
pathways has##2##2##(1996-2#1)(2009-4#1)
pathways have been##5##3##(2008-7#1)(2009-3#1)(2010-10#1)(2011-1#1)(2013-8#1)
pathways have##6##2##(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-1#1)(2013-8#1)
pathways in a##2##3##(1993-11#1)(2008-10#1)
pathways in the##6##3##(1993-5#1)(1994-2#1)(1996-2#1)(2009-8#1)(2011-2#1)(2012-3#1)
pathways in which##2##3##(2008-4#1)(2013-1#1)
pathways in##34##2##(1993-11#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-2#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
pathways including##4##2##(1995-2#1)(2008-10#1)(2011-2#1)(2013-7#1)
pathways involved in##4##3##(2008-10#1)(2008-11#1)(2009-1#1)(2012-3#1)
pathways involved##7##2##(2008-10#1)(2008-11#2)(2008-4#1)(2009-1#1)(2010-6#1)(2012-3#1)
pathways mediating##2##2##(1990-5#1)(2013-8#1)
pathways of apoptosis##2##3##(2008-7#1)(2013-1#1)
pathways of entry##3##3##(2008-10#3)
pathways of the##4##3##(1996-2#1)(2009-8#1)(2013-1#1)(2013-7#1)
pathways of##32##2##(1991-2#1)(1991-7#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-2#2)(2008-10#5)(2008-7#3)(2008-8#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-8#1)(2013-1#2)(2013-7#2)(2013-8#2)
pathways on##2##2##(2008-3#1)(2011-2#1)
pathways regulating##3##2##(1996-2#1)(2008-10#1)(2009-8#1)
pathways such as##2##3##(2010-7#2)
pathways that might##2##3##(2009-3#1)(2010-12#1)
pathways that regulate##2##3##(2008-7#1)(2009-12#1)
pathways that##9##2##(1997-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)
pathways through the##2##3##(1995-2#1)(2013-1#1)
pathways through##4##2##(1993-12#1)(1995-2#1)(2011-3#1)(2013-1#1)
pathways to##10##2##(1995-12#1)(1995-8#1)(2008-11#3)(2009-8#2)(2011-2#2)(2012-2#1)
pathways triggered by##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
pathways underlying##3##2##(1996-12#1)(2009-3#1)(2009-8#1)
pathways were##7##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)
pathways which##2##2##(1997-7#1)(2009-8#1)
pathways with##3##2##(2009-8#1)(2012-3#1)(2013-8#1)
pathways##382##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#2)(1993-11#2)(1993-12#2)(1993-5#1)(1993-8#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#4)(1994-8#1)(1995-12#3)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#14)(1997-1#3)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#5)(2006-6#2)(2007-12#4)(2008-1#2)(2008-10#32)(2008-11#47)(2008-12#3)(2008-3#15)(2008-4#8)(2008-5#1)(2008-6#3)(2008-7#14)(2008-8#9)(2008-9#12)(2009-1#2)(2009-10#7)(2009-12#5)(2009-3#5)(2009-4#2)(2009-6#6)(2009-8#16)(2009-9#1)(2010-1#4)(2010-10#10)(2010-11#1)(2010-12#5)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#6)(2011-1#9)(2011-2#23)(2011-3#2)(2012-2#10)(2012-3#15)(2012-8#2)(2013-1#8)(2013-7#4)(2013-8#7)
patient (0##2##2##(1994-2#1)(2007-11#1)
patient (5%)##2##2##(1996-9#1)(2010-7#1)
patient (a##2##2##(2008-11#1)(2011-2#1)
patient 6 years after##2##4##(2011-2#1)(2012-12#1)
patient a##2##2##(1995-8#1)(1996-2#1)
patient access to##2##3##(2008-6#1)(2011-3#1)
patient access##4##2##(1995-2#1)(2008-11#1)(2008-6#1)(2011-3#1)
patient affected by##4##3##(1990-3#1)(1992-12#1)(1993-6#1)(2010-7#1)
patient affected##5##2##(1990-3#1)(1992-12#1)(1993-6#2)(2010-7#1)
patient age was##3##3##(2009-12#1)(2012-3#1)(2013-1#1)
patient age##11##2##(1990-12#1)(1991-6#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-3#2)(2012-3#2)(2013-1#2)
patient and family##5##3##(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-2#1)
patient and physician##3##3##(2008-11#2)(2008-8#1)
patient and the##5##3##(1991-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
patient and##48##2##(1990-6#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1994-12#1)(1997-2#3)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)
patient are##3##2##(1996-3#1)(2008-4#1)(2009-7#1)
patient as##7##2##(1993-12#1)(1996-6#1)(2008-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
patient at the time of##2##5##(2008-7#1)(2008-9#1)
patient at the##3##3##(1993-12#1)(2008-7#1)(2008-9#1)
patient at##8##2##(1992-2#1)(1992-3#1)(1993-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)
patient autonomy##2##2##(1991-2#2)
patient became##4##2##(1996-3#2)(1997-3#1)(2013-1#1)
patient before the##2##3##(1997-4#1)(2008-12#1)
patient being##2##2##(1996-9#1)(2013-8#1)
patient but also##2##3##(1993-11#1)(2013-1#1)
patient but##3##2##(1993-11#1)(2008-10#1)(2013-1#1)
patient by##3##2##(1990-11#1)(1995-12#1)(2008-12#1)
patient care and##6##3##(1990-3#1)(1991-12#1)(1992-11#1)(2008-10#1)(2008-11#1)(2009-8#1)
patient care data##2##3##(1996-1#1)(1997-3#1)
patient care delivery##4##3##(1994-12#1)(1995-12#1)(1995-2#1)(2010-8#1)
patient care in##2##3##(1997-2#1)(2008-11#1)
patient care protocols##3##3##(1994-3#3)
patient care##68##2##(1990-3#1)(1991-12#2)(1992-11#1)(1992-12#3)(1992-2#1)(1993-1#1)(1993-3#3)(1994-1#4)(1994-12#2)(1994-3#4)(1995-12#2)(1995-2#2)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#11)(2008-12#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#5)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#5)
patient care?##2##2##(1993-2#1)(2008-11#1)
patient case##2##2##(2008-11#1)(2010-12#1)
patient cases##2##2##(1997-3#2)
patient characteristics and##2##3##(1994-12#1)(1995-12#1)
patient characteristics##4##2##(1994-12#1)(1995-12#1)(2008-7#1)(2010-7#1)
patient classification system for ambulatory care##2##6##(1994-3#2)
patient classification system##4##3##(1994-3#3)(1995-2#1)
patient classification##8##2##(1993-12#1)(1994-3#3)(1995-2#2)(2010-10#2)
patient compliance and##2##3##(1996-11#1)(2008-10#1)
patient compliance with##2##3##(1993-11#1)(2008-8#1)
patient compliance##10##2##(1993-11#1)(1996-11#2)(1996-3#2)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
patient conditions##3##2##(1992-12#1)(2009-3#1)(2011-2#1)
patient controlled##2##2##(1992-2#1)(2010-8#1)
patient data##8##2##(1993-12#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2010-8#3)
patient days in##2##3##(1992-2#1)(2008-8#1)
patient demographics##3##2##(1995-12#1)(2011-2#2)
patient developed an##3##3##(2008-4#1)(2009-3#1)(2013-1#1)
patient developed paraplegia##2##3##(1996-3#1)(2008-7#1)
patient developed##18##2##(1993-1#1)(1996-3#1)(1997-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-3#2)(2010-5#1)(2010-7#1)(2011-2#5)(2013-1#3)
patient diagnosis##3##2##(1995-2#2)(2012-2#1)
patient did not improve##2##4##(1997-4#1)(2008-5#1)
patient did not##6##3##(1991-11#1)(1997-4#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-2#1)
patient died after##2##3##(1991-8#1)(2013-1#1)
patient died following##2##3##(1997-8#1)(2010-5#1)
patient died from##2##3##(1996-6#1)(2009-8#1)
patient died of##5##3##(1990-6#1)(1991-12#1)(1994-12#1)(2008-7#1)(2010-12#1)
patient died##18##2##(1990-6#1)(1991-12#1)(1991-8#1)(1994-12#1)(1996-6#1)(1997-8#1)(2008-7#2)(2009-1#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#1)
patient discomfort##4##2##(1993-12#1)(2008-1#1)(2008-7#1)(2011-2#1)
patient education tool among African American men with prostate cancer##2##10##(2009-5#2)
patient education tool among##3##4##(2009-5#3)
patient education##7##2##(1996-12#1)(1996-3#1)(2008-5#1)(2009-5#3)(2010-2#1)
patient evaluation##4##2##(1993-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
patient evaluations##2##2##(1991-3#1)(2011-2#1)
patient event##2##2##(2008-11#2)
patient expectations##2##2##(1995-2#1)(2008-8#1)
patient experience and##3##3##(1996-1#1)(2009-8#1)(2010-3#1)
patient experience in online health communities##2##6##(2011-2#2)
patient experience##9##2##(1993-12#1)(1996-1#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#1)
patient experienced##3##2##(2012-12#1)(2012-3#2)
patient experiences##2##2##(1993-11#1)(1993-2#1)
patient exposure##2##2##(1992-3#1)(1996-1#1)
patient factors##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
patient failed to respond to##2##5##(1990-2#2)
patient failed##3##2##(1990-2#2)(2013-1#1)
patient focused care##7##3##(1993-1#1)(1993-2#3)(1993-3#2)(1996-2#1)
patient focused restructuring##4##3##(1993-1#1)(1993-12#3)
patient focused##17##2##(1993-1#3)(1993-12#3)(1993-2#4)(1993-3#3)(1994-1#1)(1994-2#1)(1996-2#2)
patient following##2##2##(2008-7#1)(2011-2#1)
patient for##4##2##(1990-2#1)(1992-3#1)(1993-11#1)(2008-9#1)
patient from##9##2##(1994-11#2)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
patient group##11##2##(1990-2#1)(1996-3#1)(1997-8#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#3)
patient grouping##2##2##(1994-3#1)(1995-3#1)
patient groups##13##2##(1991-1#1)(1993-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)
patient had a##8##3##(1990-2#1)(1996-6#2)(2008-11#1)(2010-6#1)(2011-2#2)(2013-8#1)
patient had an uneventful recovery##6##5##(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
patient had an uneventful##7##4##(2008-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient had an##9##3##(1991-1#1)(2008-12#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient had no##7##3##(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#1)(2013-1#2)
patient had##58##2##(1990-2#1)(1990-6#1)(1991-1#1)(1993-6#1)(1993-8#1)(1996-6#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#5)(2008-9#2)(2009-1#2)(2009-6#2)(2009-8#1)(2010-10#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
patient has been##2##3##(1997-5#1)(2011-2#1)
patient has had##2##3##(1996-3#1)(2012-12#1)
patient has##19##2##(1990-6#1)(1992-3#2)(1995-11#1)(1996-3#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-6#2)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
patient in a##2##3##(1997-5#1)(2011-2#1)
patient in the##4##3##(2008-5#1)(2011-2#2)(2013-8#1)
patient in##22##2##(1990-6#1)(1991-2#1)(1992-1#1)(1993-2#1)(1995-11#1)(1996-6#1)(1997-5#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-8#1)
patient included##2##2##(2008-12#1)(2012-3#1)
patient information to##2##3##(1993-2#2)
patient information##9##2##(1990-2#1)(1993-2#2)(1993-3#1)(1996-1#1)(1996-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
patient interest##2##2##(2012-2#2)
patient into a##2##3##(1994-6#1)(1995-9#1)
patient involvement##2##2##(2008-12#2)
patient is a##2##3##(2011-2#1)(2012-3#1)
patient is alive##2##3##(1990-2#1)(1991-6#1)
patient is invited to##2##4##(2010-6#2)
patient is##46##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)
patient left the##3##3##(2008-12#1)(2013-1#2)
patient left##5##2##(1997-1#1)(2008-12#1)(2008-7#1)(2013-1#2)
patient level##2##2##(1993-1#1)(2013-1#1)
patient lost##2##2##(2008-7#1)(2012-3#1)
patient made a##3##3##(1997-6#1)(2010-5#1)(2012-12#1)
patient made##6##2##(1997-3#1)(1997-6#1)(2010-5#1)(2012-12#1)(2012-3#2)
patient management and##2##3##(2007-11#1)(2012-2#1)
patient management##13##2##(1992-6#1)(1996-2#2)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
patient may##2##2##(1992-9#1)(1993-1#1)
patient morbidity and##2##3##(2010-8#1)(2011-7#1)
patient must##2##2##(1995-2#1)(2013-8#1)
patient need##2##2##(1993-12#2)
patient needs##2##2##(1994-2#1)(2010-1#1)
patient of the##2##3##(1990-6#1)(2008-5#1)
patient of##9##2##(1990-12#1)(1990-6#1)(1996-3#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#2)
patient on the##2##3##(1997-3#1)(2011-2#1)
patient on##6##2##(1997-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
patient outcome##4##2##(1995-3#1)(2008-11#1)(2011-2#1)(2013-8#1)
patient outcomes and##3##3##(2012-2#1)(2013-1#2)
patient outcomes in##3##3##(1994-3#1)(2009-11#1)(2011-2#1)
patient outcomes##23##2##(1994-3#1)(2008-11#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#14)
patient over##2##2##(1994-1#1)(2012-3#1)
patient participation and##2##3##(2008-11#1)(2010-10#1)
patient perceptions of the##2##4##(1995-2#2)
patient perceptions of##3##3##(1995-2#2)(1996-1#1)
patient population has##2##3##(2011-2#1)(2013-1#1)
patient population##17##2##(1996-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
patient populations##15##2##(1992-3#3)(1994-6#1)(1995-2#2)(1996-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-6#1)(2011-2#3)(2013-1#1)
patient preferences##2##2##(2008-4#1)(2008-7#1)
patient presented a##2##3##(1994-8#1)(2013-1#1)
patient presented with a##7##4##(1991-8#1)(1997-5#1)(2008-11#1)(2008-7#2)(2010-3#1)(2010-6#1)
patient presented with##17##3##(1991-8#1)(1997-5#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#2)
patient presented##21##2##(1991-8#1)(1994-8#1)(1997-5#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-7#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#3)
patient presenting with##4##3##(2008-12#2)(2011-2#2)
patient presenting##7##2##(2008-12#2)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
patient presents with##2##3##(1997-1#1)(2013-1#1)
patient privacy##2##2##(2010-8#1)(2011-1#1)
patient problems##3##2##(2008-12#1)(2013-1#2)
patient ratings of##2##3##(1991-3#1)(2008-4#1)
patient ratings##3##2##(1991-3#2)(2008-4#1)
patient received##5##2##(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
patient record##7##2##(1994-2#1)(1997-1#2)(1997-2#1)(2010-4#2)(2012-3#1)
patient records##7##2##(1994-12#1)(1997-1#2)(1997-4#1)(2008-11#1)(2010-8#1)(2011-2#1)
patient recovery##4##2##(1992-1#1)(2008-12#1)(2013-8#2)
patient refused##2##2##(2009-6#2)
patient remained##6##2##(1993-1#1)(1993-2#1)(1997-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
patient remains##7##2##(1993-11#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient reported with##2##3##(2011-1#1)(2013-1#1)
patient reported##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
patient reports and ratings##2##4##(1991-3#2)
patient reports##4##2##(1991-3#2)(1994-3#2)
patient request##2##2##(2007-8#1)(2010-2#1)
patient required##3##2##(2010-5#1)(2013-1#2)
patient requires##2##2##(1996-8#1)(2011-2#1)
patient returned to##3##3##(2008-1#1)(2008-7#1)(2012-12#1)
patient returned##4##2##(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
patient risk##2##2##(1995-9#1)(2012-3#1)
patient safety##10##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-11#1)(2013-1#1)(2013-8#1)
patient samples##2##2##(2008-6#1)(2013-1#1)
patient satisfaction and##5##3##(1996-1#1)(1997-1#1)(1997-2#1)(2009-10#1)(2013-1#1)
patient satisfaction data##2##3##(1996-1#1)(1997-3#1)
patient satisfaction in##2##3##(1997-1#1)(2008-9#1)
patient satisfaction is##2##3##(1994-12#1)(2008-11#1)
patient satisfaction with##3##3##(1996-3#1)(2010-10#1)(2010-8#1)
patient satisfaction##35##2##(1990-3#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#3)(1997-3#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#2)
patient scheduling can##2##3##(1996-2#2)
patient scheduling##4##2##(1996-2#4)
patient selection and##2##3##(1995-3#1)(2011-2#1)
patient selection##11##2##(1991-2#1)(1994-12#1)(1995-3#1)(1996-6#1)(2008-7#2)(2010-6#1)(2011-2#3)(2012-2#1)
patient sera##2##2##(1992-12#1)(2008-8#1)
patient setup##2##2##(2009-11#1)(2009-2#1)
patient should be##7##3##(1993-6#1)(1994-12#1)(1996-11#1)(2008-7#1)(2010-12#1)(2011-2#2)
patient should##8##2##(1993-6#2)(1994-12#1)(1996-11#1)(2008-7#1)(2010-12#1)(2011-2#2)
patient showed a##2##3##(2008-7#1)(2010-12#1)
patient showed##6##2##(1990-3#1)(2008-7#2)(2010-12#1)(2012-3#1)(2013-8#1)
patient subgroups##3##2##(1996-3#1)(2008-12#1)(2011-2#1)
patient suffered from##3##3##(1993-2#1)(1995-12#1)(2008-12#1)
patient suffered##5##2##(1993-2#1)(1995-12#1)(2008-12#2)(2013-1#1)
patient suffering from##3##3##(1994-12#1)(2008-7#1)(2012-3#1)
patient survival##6##2##(1995-2#1)(2008-2#1)(2011-2#2)(2013-1#2)
patient survived##2##2##(1990-9#1)(2008-1#1)
patient that##2##2##(1994-12#1)(1996-8#1)
patient the##3##2##(1993-11#1)(1996-6#1)(1996-9#1)
patient to return##2##3##(1993-12#1)(2012-12#1)
patient to##11##2##(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
patient treated##5##2##(1990-3#1)(1991-11#1)(1996-3#1)(2008-10#1)(2010-12#1)
patient treatment##4##2##(1992-2#1)(2008-10#1)(2009-11#1)(2011-3#1)
patient undergoing##2##2##(2010-5#1)(2012-12#1)
patient underwent a##10##3##(2008-11#1)(2008-7#1)(2009-3#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
patient underwent##20##2##(1991-11#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-3#4)(2013-1#2)
patient was admitted to our hospital with##2##7##(1993-6#1)(2011-2#1)
patient was admitted to the hospital##2##6##(1993-6#1)(2013-1#1)
patient was admitted to##4##4##(1993-6#2)(2011-2#1)(2013-1#1)
patient was admitted##7##3##(1991-8#1)(1993-6#2)(2011-2#1)(2013-1#3)
patient was asymptomatic##3##3##(1996-3#1)(2011-2#1)(2013-1#1)
patient was brought##2##3##(2010-12#1)(2012-2#1)
patient was diagnosed with##4##4##(2008-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
patient was diagnosed##5##3##(1997-8#1)(2008-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
patient was discharged##5##3##(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
patient was found to have##3##5##(2008-12#1)(2011-1#1)(2013-1#1)
patient was found to##4##4##(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
patient was free of##3##4##(2009-1#1)(2011-2#2)
patient was operated##2##3##(2013-1#2)
patient was referred to surgery##2##5##(1994-9#1)(2011-1#1)
patient was referred to##3##4##(1994-9#1)(2011-1#1)(2011-2#1)
patient was referred##7##3##(1991-11#1)(1994-9#1)(1995-5#1)(2008-8#1)(2011-1#1)(2011-2#2)
patient was started on##2##4##(2007-12#1)(2009-11#1)
patient was transferred to##2##4##(2013-1#1)(2013-8#1)
patient was treated by##2##4##(1990-8#1)(2008-10#1)
patient was treated with antibiotics##2##5##(1996-11#1)(2013-1#1)
patient was treated with##8##4##(1996-11#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
patient was treated##14##3##(1990-8#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-2#2)(2013-1#3)(2013-8#1)
patient was##122##2##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-8#1)(1993-1#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#8)(2008-5#1)(2008-7#8)(2008-8#1)(2009-1#2)(2009-11#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#5)(2010-12#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#21)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#19)(2013-8#5)
patient were##2##2##(1994-11#1)(2008-5#1)
patient who developed a##2##4##(2008-12#1)(2008-8#1)
patient who developed##7##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
patient who had an##2##4##(1991-3#1)(2008-7#1)
patient who had been##3##4##(1995-11#1)(1997-6#1)(2013-8#1)
patient who had##9##3##(1991-3#1)(1995-11#1)(1997-6#1)(2008-12#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
patient who presented with##8##4##(2009-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
patient who presented##9##3##(2009-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
patient who sustained##2##3##(2009-4#1)(2012-2#1)
patient who underwent##3##3##(2007-8#1)(2008-11#1)(2013-1#1)
patient who was##4##3##(1991-11#1)(1997-8#1)(2012-3#1)(2013-1#1)
patient who##41##2##(1990-9#1)(1991-11#1)(1991-3#1)(1992-3#1)(1995-11#1)(1995-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
patient will##3##2##(2008-8#1)(2011-2#1)(2013-8#1)
patient with HIV##3##3##(1995-12#1)(2010-12#1)(2013-1#1)
patient with a history of##4##5##(2009-4#1)(2010-12#1)(2012-3#2)
patient with a left lower lobe##2##6##(2008-1#2)
patient with a##30##3##(1991-12#1)(1991-2#1)(1992-3#1)(1994-12#1)(1996-2#2)(1996-9#1)(1997-4#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#1)
patient with acute##2##3##(2009-6#1)(2012-3#1)
patient with advanced##2##3##(1990-8#1)(2012-3#1)
patient with an isolated##2##4##(1994-5#1)(2008-9#1)
patient with an##6##3##(1994-5#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)
patient with aortic##2##3##(2011-2#1)(2012-2#1)
patient with arteria lusoria##2##4##(2008-11#2)
patient with chemical corneal burn##2##5##(2010-10#2)
patient with chronic liver disease##2##5##(1991-11#1)(2008-10#1)
patient with chronic##10##3##(1991-11#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#3)
patient with diabetes##2##3##(2008-1#1)(2010-10#1)
patient with dysphagia##2##3##(2008-1#2)
patient with epidural anesthesia##2##4##(2012-3#2)
patient with malignant##3##3##(1994-12#1)(2011-3#1)(2013-7#1)
patient with metastatic##3##3##(1991-8#1)(1992-2#1)(2008-11#1)
patient with multiple##4##3##(1992-12#1)(1997-8#1)(2008-11#1)(2011-2#1)
patient with neurological##2##3##(1997-6#1)(2008-12#1)
patient with pulmonary##2##3##(2008-7#1)(2012-3#1)
patient with symptomatic##2##3##(1997-4#1)(2012-3#1)
patient with the##2##3##(1991-12#1)(2013-1#1)
patient with type I##2##4##(2011-2#1)(2012-3#1)
patient with type##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
patient with ulcerative colitis##2##4##(2010-12#2)
patient with##234##2##(1990-12#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-8#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#7)(2008-10#8)(2008-11#13)(2008-12#17)(2008-5#1)(2008-7#17)(2008-8#2)(2008-9#4)(2009-11#3)(2009-4#1)(2009-6#2)(2009-8#4)(2010-10#5)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#27)(2011-3#2)(2012-12#6)(2012-2#5)(2012-3#24)(2013-1#22)(2013-7#2)(2013-8#3)
patient without##2##2##(1996-8#1)(2008-1#1)
patient##1829##1##(1990-11#4)(1990-12#9)(1990-2#8)(1990-3#7)(1990-5#1)(1990-6#7)(1990-8#4)(1990-9#11)(1991-1#3)(1991-11#11)(1991-12#7)(1991-2#9)(1991-3#11)(1991-5#1)(1991-6#3)(1991-8#9)(1991-9#1)(1992-1#7)(1992-11#1)(1992-12#12)(1992-2#12)(1992-3#26)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#13)(1993-11#16)(1993-12#21)(1993-2#15)(1993-3#9)(1993-6#8)(1993-8#1)(1993-9#1)(1994-1#11)(1994-11#8)(1994-12#26)(1994-2#7)(1994-3#17)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#3)(1995-11#6)(1995-12#14)(1995-2#21)(1995-3#6)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#10)(1996-11#6)(1996-12#4)(1996-2#20)(1996-3#25)(1996-5#1)(1996-6#10)(1996-8#5)(1996-9#10)(1997-1#12)(1997-2#13)(1997-3#14)(1997-4#8)(1997-5#8)(1997-6#8)(1997-8#15)(2007-11#4)(2007-12#7)(2007-8#5)(2007-9#3)(2008-1#22)(2008-10#55)(2008-11#75)(2008-12#66)(2008-2#2)(2008-3#2)(2008-4#12)(2008-5#14)(2008-6#7)(2008-7#88)(2008-8#23)(2008-9#21)(2009-1#7)(2009-10#4)(2009-11#15)(2009-12#7)(2009-2#2)(2009-3#11)(2009-4#3)(2009-5#3)(2009-6#10)(2009-7#1)(2009-8#17)(2009-9#2)(2010-1#3)(2010-10#20)(2010-11#8)(2010-12#21)(2010-2#9)(2010-3#9)(2010-4#5)(2010-5#16)(2010-6#18)(2010-7#15)(2010-8#23)(2010-9#8)(2011-1#17)(2011-10#1)(2011-2#207)(2011-3#15)(2011-7#2)(2012-12#43)(2012-2#37)(2012-3#79)(2013-1#179)(2013-2#1)(2013-7#8)(2013-8#35)
patient's age##4##2##(1997-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
patient's best interests##2##3##(1991-2#1)(1997-8#1)
patient's best##3##2##(1991-2#1)(1997-8#2)
patient's body##2##2##(1991-6#1)(2011-2#1)
patient's clinical status##2##3##(2009-5#1)(2011-2#1)
patient's clinical##6##2##(2008-6#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
patient's disease##2##2##(1994-11#1)(2013-8#1)
patient's functional##2##2##(1991-1#1)(2010-10#1)
patient's future##2##2##(1990-5#1)(1993-12#1)
patient's health##4##2##(1992-2#1)(1997-4#1)(2008-11#1)(2008-12#1)
patient's history##3##2##(1997-2#1)(2008-8#1)(2013-1#1)
patient's outcome##2##2##(1995-6#1)(2009-8#1)
patient's perspective##5##2##(2008-11#1)(2008-12#1)(2010-8#2)(2012-3#1)
patient's prognosis##2##2##(2008-7#1)(2008-9#1)
patient's right to self-determination##2##4##(1991-2#2)
patient's risk##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
patient's symptoms##5##2##(2008-12#1)(2010-1#1)(2010-3#1)(2012-3#1)(2013-1#1)
patient's##175##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-1#3)(1991-12#3)(1991-2#4)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-11#2)(1993-12#3)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#4)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#6)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#5)(2009-1#1)(2009-11#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#8)(2013-1#13)(2013-8#3)
patient)##3##1##(2008-11#1)(2012-3#1)(2013-8#1)
patient-##2##1##(2008-10#1)(2011-2#1)
patient-based measurement systems##3##3##(1994-3#3)
patient-based##8##1##(1993-12#2)(1993-2#1)(1994-3#4)(2011-2#1)
patient-centered care##3##2##(1994-3#1)(1997-3#1)(2013-8#1)
patient-centered or bottom-line?##2##3##(1994-1#2)
patient-centered##6##1##(1994-1#2)(1994-3#1)(1997-3#1)(2010-4#1)(2013-8#1)
patient-controlled##2##1##(2008-11#1)(2012-3#1)
patient-doctor##2##1##(2009-5#1)(2011-2#1)
patient-focused care##3##2##(1993-12#1)(1994-12#1)(2011-1#1)
patient-focused##7##1##(1993-12#1)(1994-12#1)(1994-2#1)(1996-3#1)(2008-11#2)(2011-1#1)
patient-friendly drug monitoring##2##3##(2010-11#2)
patient-friendly##8##1##(1996-3#1)(1997-4#1)(2010-11#5)(2012-2#1)
patient-level data##2##2##(1993-1#1)(1995-1#1)
patient-months (mean##3##2##(2011-2#3)
patient-physician communication about##2##3##(2008-10#2)
patient-physician relationship##2##2##(1993-3#1)(1997-4#1)
patient-physician##4##1##(1993-3#1)(1997-4#1)(2008-10#2)
patient-related##4##1##(1996-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
patient-reported outcomes##2##2##(2009-9#1)(2010-10#1)
patient-reported##6##1##(1995-2#2)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
patient-specific##6##1##(1992-3#1)(1994-3#1)(1995-12#2)(2008-12#1)(2010-12#1)
patient/resident##2##1##(1993-12#1)(1997-1#1)
patient]##12##1##(1990-3#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
patiente##3##1##(2013-1#3)
patientes##2##1##(2013-1#2)
patients (0##4##2##(1990-2#3)(2010-12#1)
patients (1##2##2##(1992-2#1)(2007-11#1)
patients (10##5##2##(2007-11#1)(2011-3#1)(2012-3#3)
patients (12##2##2##(1997-8#1)(2011-2#1)
patients (13 men and##2##4##(2011-2#1)(2013-1#1)
patients (13##7##2##(1990-12#1)(1991-11#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
patients (14 men and##2##4##(1990-8#1)(2011-2#1)
patients (14##3##2##(1990-8#1)(2007-8#1)(2011-2#1)
patients (14%)##2##2##(1995-12#1)(2011-2#1)
patients (16##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
patients (16%)##3##2##(1990-9#1)(2008-8#1)(2011-2#1)
patients (18##4##2##(1992-9#1)(1997-7#1)(2008-7#1)(2011-2#1)
patients (19%)##2##2##(1996-6#1)(2008-7#1)
patients (2##3##2##(1997-8#1)(2007-11#2)
patients (21##2##2##(2011-2#2)
patients (23##2##2##(1994-12#1)(1997-5#1)
patients (23%)##2##2##(2011-2#1)(2013-1#1)
patients (26##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
patients (29%)##3##2##(2008-1#1)(2008-10#2)
patients (3##3##2##(1990-3#1)(1995-10#1)(2007-11#1)
patients (30%)##3##2##(1996-9#2)(2011-2#1)
patients (31%)##3##2##(1992-3#1)(2012-3#1)(2013-1#1)
patients (32%)##2##2##(1997-6#1)(2008-7#1)
patients (33##2##2##(2008-7#1)(2011-2#1)
patients (33%)##2##2##(2008-12#1)(2008-7#1)
patients (34##3##2##(1990-2#1)(2008-10#1)(2008-12#1)
patients (34%)##2##2##(1991-8#1)(2008-8#1)
patients (35%)##2##2##(1994-9#1)(1997-5#1)
patients (4##5##2##(1990-3#1)(1991-2#2)(1996-3#1)(2012-3#1)
patients (42%)##2##2##(2008-10#1)(2011-2#1)
patients (43%)##2##2##(2008-7#2)
patients (44%)##4##2##(1993-8#1)(1996-11#1)(2008-1#1)(2011-2#1)
patients (46%)##2##2##(2008-1#1)(2008-9#1)
patients (48%)##2##2##(1990-6#1)(2008-7#1)
patients (5##2##2##(2011-2#1)(2012-3#1)
patients (5%)##2##2##(2011-2#1)(2012-3#1)
patients (50%)##2##2##(1991-3#1)(2008-11#1)
patients (55%)##3##2##(1996-9#2)(2008-11#1)
patients (58##2##2##(1992-9#1)(2009-6#1)
patients (6##5##2##(1991-8#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients (62##3##2##(1996-11#1)(2008-10#2)
patients (65%)##2##2##(1997-6#1)(2008-7#1)
patients (7##3##2##(1990-3#1)(2011-2#2)
patients (70%)##2##2##(1991-2#1)(2008-11#1)
patients (73##2##2##(1996-11#1)(2013-1#1)
patients (75%)##3##2##(2008-10#1)(2011-2#2)
patients (84%)##2##2##(1991-3#1)(2012-3#1)
patients (9##4##2##(2011-2#3)(2013-1#1)
patients (9%) had##2##3##(2008-10#1)(2011-2#1)
patients (9%)##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
patients (93##2##2##(1991-8#1)(2007-8#1)
patients (age##3##2##(2009-9#1)(2011-2#1)(2012-3#1)
patients (all##2##2##(1991-2#1)(1997-8#1)
patients (i##2##2##(2008-7#1)(2009-10#1)
patients (mean age##4##3##(2008-7#1)(2009-3#1)(2011-2#2)
patients (mean##5##2##(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#2)
patients (median##2##2##(1992-12#1)(2011-2#1)
patients (n =##5##3##(2010-4#1)(2012-3#2)(2013-1#2)
patients (p##3##2##(1991-8#1)(1993-1#1)(1993-11#1)
patients (pts) with##2##3##(1996-3#1)(2010-12#1)
patients (range##4##2##(1990-6#1)(1991-8#1)(2009-8#2)
patients a##4##2##(1994-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
patients about the##3##3##(1992-5#1)(1997-8#1)(2008-8#1)
patients about##4##2##(1992-5#1)(1997-8#1)(2008-8#2)
patients above 35 years of age##2##6##(2012-3#2)
patients above##3##2##(2008-12#1)(2012-3#2)
patients according to actuarial##2##4##(2011-2#2)
patients according to##8##3##(1994-9#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#2)
patients achieved##2##2##(2008-10#1)(2009-12#1)
patients admitted in##2##3##(1994-3#1)(2012-3#1)
patients admitted to hospital##2##4##(1990-9#1)(2012-12#1)
patients admitted to our medical service##2##6##(2008-3#2)
patients admitted to the emergency department##2##6##(2011-2#2)
patients admitted to the##4##4##(1997-4#1)(2011-2#2)(2012-3#1)
patients admitted to##10##3##(1990-9#1)(1991-11#1)(1997-4#1)(2008-3#3)(2011-2#2)(2012-12#1)(2012-3#1)
patients admitted with##2##3##(2008-3#1)(2008-7#1)
patients admitted##16##2##(1990-3#1)(1990-9#1)(1991-11#1)(1994-3#1)(1997-4#1)(2008-3#4)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
patients affected by insulin-dependent##2##4##(2013-1#2)
patients affected by##14##3##(1990-8#1)(1991-3#1)(1991-6#1)(1993-3#2)(2008-10#2)(2008-5#2)(2011-2#1)(2013-1#4)
patients affected with##4##3##(1992-2#1)(1993-6#1)(2008-5#1)(2011-3#1)
patients affected##19##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-3#2)(1993-6#1)(2008-10#2)(2008-5#3)(2011-2#2)(2011-3#1)(2013-1#4)
patients after the##2##3##(1997-8#1)(2008-12#1)
patients after total hip replacement##2##5##(2010-10#1)(2013-1#1)
patients after##30##2##(1990-11#1)(1990-12#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#3)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#2)(2010-10#1)(2010-5#1)(2011-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
patients age 30 years and older##2##5##(2012-2#2)
patients aged over##3##3##(1990-6#1)(1992-9#1)(2008-10#1)
patients aged##16##2##(1990-6#1)(1992-9#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-8#2)
patients also had##2##3##(2008-7#1)(2009-1#1)
patients also suffered from##2##4##(1990-3#1)(2010-5#1)
patients also##5##2##(1990-3#1)(1992-6#1)(2008-7#1)(2009-1#1)(2010-5#1)
patients among##2##2##(1992-4#1)(2011-2#1)
patients and 23##2##3##(2008-11#1)(2011-2#1)
patients and 7##2##3##(1995-5#2)
patients and also##2##3##(2010-10#1)(2011-2#1)
patients and control subjects##2##4##(1995-5#2)
patients and controls##4##3##(1995-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
patients and distant##2##3##(2008-10#1)(2011-2#1)
patients and families##7##3##(1990-12#1)(1991-2#1)(1994-1#1)(2008-11#1)(2008-3#1)(2010-4#1)(2010-7#1)
patients and has##2##3##(2011-2#1)(2013-1#1)
patients and healthy controls##2##4##(2008-7#1)(2011-2#1)
patients and healthy subjects##2##4##(2008-12#1)(2011-2#1)
patients and healthy##5##3##(2008-12#2)(2008-7#1)(2011-2#2)
patients and in##10##3##(1990-2#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2010-12#1)
patients and its##2##3##(1991-6#1)(1996-9#1)
patients and may be##3##4##(1990-11#1)(2008-1#1)(2008-7#1)
patients and may##5##3##(1990-11#1)(2008-1#2)(2008-7#1)(2010-10#1)
patients and normal in##2##4##(2008-7#2)
patients and normal##4##3##(1995-5#1)(2008-7#3)
patients and nurses##3##3##(2009-12#2)(2010-3#1)
patients and patients##2##3##(1990-11#1)(2011-2#1)
patients and professionals##2##3##(1996-8#1)(2009-8#1)
patients and providers##3##3##(1991-3#1)(2008-4#1)(2013-1#1)
patients and should be##2##4##(1997-3#1)(2011-3#1)
patients and the##13##3##(1990-11#1)(1991-6#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-5#1)
patients and their families##8##4##(1994-3#1)(1995-2#1)(2008-11#4)(2009-9#1)(2012-3#1)
patients and their partners##2##4##(2008-7#2)
patients and their physicians##3##4##(2008-11#2)(2012-3#1)
patients and their relatives##2##4##(1991-6#1)(2008-11#1)
patients and their##21##3##(1991-6#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#7)(2008-7#3)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
patients and those with##3##4##(1993-3#1)(2008-7#1)(2013-1#1)
patients and to##3##3##(2010-8#1)(2011-2#1)(2013-8#1)
patients and was##2##3##(2008-12#1)(2013-1#1)
patients and##234##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#4)(1991-6#3)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#6)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#3)(1997-8#5)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#18)(2008-12#4)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#22)(2008-8#3)(2009-10#1)(2009-12#2)(2009-6#1)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#6)(2011-2#26)(2011-3#1)(2011-9#1)(2012-12#4)(2012-2#2)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#12)(2013-8#5)
patients appears##2##2##(2008-1#1)(2010-1#1)
patients are alive and##2##4##(1992-5#1)(2011-2#1)
patients are at greater risk of##2##6##(2008-8#1)(2010-10#1)
patients are at##5##3##(1992-5#1)(2008-2#1)(2008-8#1)(2010-10#1)(2011-2#1)
patients are available##2##3##(2010-12#1)(2011-2#1)
patients are diagnosed##2##3##(2008-1#1)(2010-7#1)
patients are discussed in##2##4##(1993-11#1)(2012-12#1)
patients are discussed##3##3##(1993-11#1)(2009-11#1)(2012-12#1)
patients are more likely to##2##5##(2010-12#1)(2011-2#1)
patients are more##3##3##(2010-12#1)(2011-2#2)
patients are often##4##3##(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
patients are prone to##2##4##(1995-10#1)(2008-11#1)
patients are still alive##3##4##(1990-9#1)(1992-9#1)(2011-2#1)
patients are still##4##3##(1990-9#1)(1992-9#1)(2008-10#1)(2011-2#1)
patients are##67##2##(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#3)
patients as a##3##3##(1994-6#1)(1997-7#1)(2008-10#1)
patients as compared to##2##4##(1997-8#1)(2008-7#1)
patients as##15##2##(1993-1#1)(1994-5#1)(1994-6#1)(1997-4#1)(1997-7#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#4)(2009-5#1)(2012-3#1)
patients at ICUs of##2##4##(2012-2#2)
patients at a##3##3##(1995-5#1)(1997-3#1)(2008-8#1)
patients at each##2##3##(2013-8#2)
patients at high risk##3##4##(1993-1#1)(2008-4#1)(2008-7#1)
patients at risk of developing pressure##2##6##(2012-3#2)
patients at risk of developing##3##5##(1992-12#1)(2012-3#2)
patients at risk of##7##4##(1992-12#1)(1993-9#1)(2008-8#1)(2010-5#1)(2012-3#2)(2013-1#1)
patients at risk##11##3##(1992-12#1)(1993-9#1)(2008-8#1)(2010-10#1)(2010-5#1)(2012-2#3)(2012-3#2)(2013-1#1)
patients at the same##2##4##(1997-8#1)(2010-7#1)
patients at the##9##3##(1993-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
patients at##45##2##(1991-3#1)(1992-12#2)(1993-1#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#2)(2013-8#3)
patients attending the##2##3##(2008-11#1)(2011-2#1)
patients attending##8##2##(1992-12#1)(1995-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-3#1)
patients available##3##2##(1991-1#1)(2008-5#1)(2012-5#1)
patients away##2##2##(1991-3#1)(2008-6#1)
patients because the##2##3##(1996-3#1)(2010-12#1)
patients because##5##2##(1995-6#1)(1996-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
patients before treatment##2##3##(2008-10#2)
patients before##6##2##(1991-2#1)(2008-10#2)(2009-3#1)(2012-2#1)(2012-3#1)
patients being##4##2##(1993-2#1)(1995-12#1)(2008-1#1)(2008-11#1)
patients below the age of##2##5##(1997-8#2)
patients benefit##2##2##(2008-6#1)(2008-8#1)
patients between##2##2##(1996-9#1)(2011-2#1)
patients both##2##2##(1990-12#1)(2013-1#1)
patients but##6##2##(1991-1#1)(1991-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)
patients by a##3##3##(1990-12#1)(2007-8#1)(2010-2#1)
patients by##13##2##(1990-12#1)(1990-2#2)(1991-3#1)(1997-1#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)
patients came to that of##2##5##(2011-2#2)
patients came##3##2##(2011-2#2)(2013-8#1)
patients can be##7##3##(1991-3#1)(1992-3#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-11#1)
patients can##13##2##(1990-11#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-3#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-6#2)(2009-11#1)
patients chronically treated with##2##4##(1993-2#1)(1994-8#1)
patients chronically##4##2##(1993-2#1)(1994-8#1)(2008-11#2)
patients compared to##4##3##(1993-1#1)(2008-7#2)(2012-2#1)
patients compared with##2##3##(2008-10#1)(2008-11#1)
patients compared##6##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-2#1)
patients complained of##2##3##(1991-11#1)(2008-8#1)
patients complained##3##2##(1991-11#1)(2008-7#1)(2008-8#1)
patients completed the##3##3##(2008-3#1)(2010-10#1)(2010-2#1)
patients completed##6##2##(2008-3#1)(2008-9#1)(2010-10#1)(2010-2#2)(2012-12#1)
patients confirmed##2##2##(1994-9#1)(1997-8#1)
patients considering##2##2##(2008-7#1)(2010-12#1)
patients continue to##2##3##(1990-3#1)(2008-7#1)
patients continued to##2##3##(1991-3#1)(1997-3#1)
patients could##2##2##(2009-10#1)(2012-2#1)
patients delayed##2##2##(1992-5#1)(2013-1#1)
patients demonstrated##3##2##(2008-11#1)(2009-3#1)(2012-3#1)
patients develop##4##2##(1992-3#1)(1997-8#1)(2013-1#1)(2013-8#1)
patients developed local##2##3##(1991-6#1)(2008-1#1)
patients developed##9##2##(1991-2#1)(1991-6#1)(1996-1#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#2)
patients developing##2##2##(1992-9#1)(1994-3#1)
patients diagnosed as##2##3##(1997-8#1)(2008-11#1)
patients diagnosed with##10##3##(1991-7#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
patients diagnosed##14##2##(1991-7#1)(1997-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
patients did not have##2##4##(1990-12#1)(2012-12#1)
patients did not##8##3##(1990-12#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
patients did##10##2##(1990-12#1)(1992-12#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-7#2)(2011-1#1)(2012-12#1)(2013-1#1)
patients died during the##2##4##(1993-2#1)(1997-4#1)
patients died from##3##3##(1994-3#1)(1997-4#2)
patients died of##4##3##(1990-6#1)(1994-12#1)(1994-3#1)(2008-11#1)
patients died##17##2##(1990-6#1)(1990-8#1)(1990-9#1)(1993-2#1)(1994-12#1)(1994-3#2)(1996-6#1)(1997-4#3)(2008-11#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
patients discontinued##2##2##(2008-7#1)(2012-3#1)
patients divided into##2##3##(2008-7#1)(2012-4#1)
patients do not have##2##4##(2008-12#1)(2008-7#1)
patients do not##4##3##(1994-12#1)(1996-3#1)(2008-12#1)(2008-7#1)
patients do##5##2##(1994-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)
patients does not##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
patients during a##2##3##(2010-4#1)(2011-2#1)
patients during the##2##3##(1990-6#1)(2013-1#1)
patients during##10##2##(1990-6#1)(1991-6#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
patients each##2##2##(1997-8#1)(2008-7#1)
patients enrolled##2##2##(2008-11#1)(2011-2#1)
patients evaluated##2##2##(2010-11#1)(2013-1#1)
patients eventually##2##2##(2010-5#1)(2013-8#1)
patients except one##2##3##(1997-8#1)(2008-1#1)
patients except##3##2##(1997-8#1)(2008-1#1)(2008-3#1)
patients experience##3##2##(1995-1#1)(2011-2#1)(2012-12#1)
patients experienced a significant##2##4##(1994-1#1)(2008-8#1)
patients experienced a##3##3##(1994-1#1)(2007-8#1)(2008-8#1)
patients experienced##16##2##(1990-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1994-1#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-11#1)(2012-3#2)(2013-1#1)
patients experiencing##4##2##(1994-2#1)(2008-11#1)(2008-12#1)(2010-3#1)
patients fail to##2##3##(2009-10#1)(2010-12#1)
patients filled##2##2##(1994-9#1)(2010-2#1)
patients followed##5##2##(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#2)
patients following##5##2##(1991-11#1)(2008-5#1)(2011-2#1)(2013-1#2)
patients for treatment##2##3##(1995-9#1)(1997-3#1)
patients for whom##3##3##(1990-2#1)(2008-7#1)(2013-1#1)
patients for##33##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-9#2)(1993-6#1)(1994-11#1)(1994-2#1)(1995-9#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-1#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
patients from a##2##3##(2010-12#1)(2013-1#1)
patients from group##3##3##(1996-3#2)(2008-5#1)
patients from the##2##3##(2011-2#1)(2012-3#1)
patients from##30##2##(1991-2#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(1996-3#2)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
patients fulfilled the##2##3##(2008-1#1)(2008-7#1)
patients fulfilled##3##2##(2008-1#1)(2008-7#1)(2009-6#1)
patients given placebo##2##3##(1995-2#1)(2008-3#1)
patients given##3##2##(1995-2#1)(2008-3#2)
patients had a##18##3##(1990-2#1)(1990-9#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-9#1)(1993-2#1)(2008-1#1)(2008-7#2)(2008-8#1)(2009-3#2)(2010-6#1)(2011-2#2)(2013-1#1)
patients had an##6##3##(1990-11#1)(1993-11#1)(1996-6#1)(2010-1#1)(2010-3#1)(2012-3#1)
patients had been diagnosed with the##2##6##(2013-1#2)
patients had been treated##2##4##(2008-5#1)(2012-3#1)
patients had been##6##3##(1990-12#1)(1990-3#1)(2008-5#1)(2012-3#1)(2013-1#2)
patients had carcinoma of the##2##5##(1990-9#2)
patients had complete##3##3##(1995-2#1)(2008-3#1)(2012-3#1)
patients had disease##3##3##(1995-12#3)
patients had had##3##3##(1991-2#1)(1996-6#1)(2008-10#1)
patients had higher##2##3##(2008-11#1)(2013-1#1)
patients had no##5##3##(1995-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
patients had not##2##3##(1991-4#1)(2008-10#1)
patients had one or more##2##5##(2011-1#1)(2011-2#1)
patients had persistent##2##3##(1993-1#1)(1993-3#1)
patients had recurrent##2##3##(1992-6#1)(2011-2#1)
patients had type##3##3##(1997-8#1)(2012-4#2)
patients had undergone##2##3##(1991-2#1)(2011-2#1)
patients had##146##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-9#3)(1991-12#2)(1991-2#3)(1991-4#3)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-12#7)(1995-2#1)(1996-6#3)(1997-3#4)(1997-8#4)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#6)(2008-3#1)(2008-5#3)(2008-7#14)(2008-8#1)(2009-3#4)(2010-1#1)(2010-3#4)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#15)(2012-12#2)(2012-2#4)(2012-3#10)(2012-4#2)(2013-1#7)(2013-8#2)
patients has been##3##3##(2012-2#1)(2013-1#2)
patients has##7##2##(1994-3#1)(2009-1#1)(2010-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
patients have a##5##3##(1996-11#1)(2007-8#1)(2008-7#1)(2010-3#1)(2013-1#1)
patients have an##2##3##(1990-12#1)(2008-5#1)
patients have been treated##4##4##(1990-5#1)(1991-2#1)(1991-3#1)(1995-2#1)
patients have been##13##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-3#1)(2008-1#1)(2010-12#1)(2011-7#1)
patients have to be##2##4##(1996-2#1)(2010-12#1)
patients have to##3##3##(1996-2#1)(2010-12#2)
patients have##46##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
patients having##10##2##(1995-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
patients hospitalised in##2##3##(1991-11#1)(2007-8#1)
patients hospitalized for acute##2##4##(2008-10#1)(2008-7#1)
patients hospitalized for##5##3##(2008-10#1)(2008-7#2)(2012-12#1)(2012-3#1)
patients hospitalized in##3##3##(1990-3#1)(2007-8#1)(2012-12#1)
patients hospitalized with##3##3##(2010-4#1)(2012-12#2)
patients hospitalized##12##2##(1990-3#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-4#1)(2012-12#4)(2012-3#1)
patients identified##3##2##(1996-11#1)(2008-3#1)(2010-8#1)
patients if##2##2##(2008-1#1)(2010-12#1)
patients improved##4##2##(1995-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
patients in a##12##3##(1991-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-2#2)
patients in acute##2##3##(2011-1#2)
patients in an##3##3##(1991-3#1)(2008-10#1)(2012-2#1)
patients in both groups##3##4##(2008-1#1)(2009-12#1)(2012-3#1)
patients in classroom teaching##2##4##(2008-11#2)
patients in clinical##2##3##(1995-12#1)(2008-5#1)
patients in different##3##3##(2008-5#1)(2011-2#2)
patients in early##3##3##(1990-11#1)(2012-3#1)(2013-1#1)
patients in group A##2##4##(1996-6#2)
patients in group L##4##4##(1996-3#4)
patients in group##8##3##(1991-3#1)(1996-3#5)(1996-6#2)
patients in need of##2##4##(1994-6#1)(1995-2#1)
patients in order to##3##4##(1991-7#1)(2010-12#1)(2011-2#1)
patients in the ED##3##4##(2008-11#1)(2012-2#2)
patients in the study##2##4##(1994-3#1)(2008-7#1)
patients in the##57##3##(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-12#2)(1992-9#1)(1993-1#2)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-11#1)(1997-5#2)(1997-7#2)(2008-1#1)(2008-11#3)(2008-12#3)(2008-3#2)(2008-7#2)(2009-12#1)(2009-8#2)(2010-10#2)(2010-4#4)(2010-6#1)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
patients in this group##2##4##(1995-11#1)(2009-8#1)
patients in this##4##3##(1995-11#1)(2008-12#1)(2009-8#1)(2012-2#1)
patients in which##2##3##(1990-5#1)(2011-2#1)
patients in whom a##2##4##(1990-3#1)(2008-1#1)
patients in whom it##3##4##(1990-3#1)(1991-11#1)(2010-7#1)
patients in whom the##3##4##(1990-12#1)(1991-11#1)(2013-1#1)
patients in whom##20##3##(1990-12#1)(1990-3#2)(1991-11#4)(1991-2#2)(1994-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-7#2)(2011-2#2)(2013-1#1)
patients in##194##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#2)(1991-2#5)(1991-3#3)(1991-7#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#1)(1996-11#3)(1996-3#6)(1996-6#2)(1996-8#1)(1996-9#2)(1997-5#2)(1997-7#2)(2008-1#4)(2008-10#7)(2008-11#11)(2008-12#4)(2008-3#3)(2008-5#5)(2008-7#6)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#20)(2012-12#2)(2012-2#7)(2012-3#6)(2012-4#1)(2013-1#11)(2013-8#6)
patients included##3##2##(1990-9#1)(2008-3#1)(2011-2#1)
patients including##2##2##(2009-8#1)(2013-1#1)
patients increased##2##2##(2008-7#1)(2011-2#1)
patients infected by the human immunodeficiency virus (HIV)##2##8##(1996-11#1)(2008-5#1)
patients infected##3##2##(1996-11#1)(2008-11#1)(2008-5#1)
patients initially##2##2##(2010-7#1)(2011-2#1)
patients into three##2##3##(2010-11#1)(2011-2#1)
patients into##7##2##(1997-2#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
patients is a##5##3##(1991-6#1)(1996-11#1)(2008-5#1)(2008-6#1)(2010-8#1)
patients is at##2##3##(1994-5#1)(1995-2#1)
patients is critical to##2##4##(1993-3#1)(1994-12#1)
patients is critical##3##3##(1993-3#1)(1994-12#1)(2009-12#1)
patients is not associated with##2##5##(2007-11#1)(2008-7#1)
patients is not##3##3##(2007-11#1)(2008-7#1)(2010-10#1)
patients is reported##3##3##(1996-3#1)(2008-10#1)(2008-7#1)
patients is##37##2##(1990-2#1)(1990-9#2)(1991-6#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
patients left the hospital##2##4##(1993-6#1)(2012-12#1)
patients living in##2##3##(1992-1#1)(2011-2#1)
patients living##4##2##(1992-1#1)(1995-11#1)(1995-12#1)(2011-2#1)
patients made##2##2##(1994-2#1)(2009-10#1)
patients maintained##4##2##(2008-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
patients may be##9##3##(1991-2#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-4#1)(2011-2#1)
patients may benefit from##3##4##(1996-6#1)(2008-10#1)(2011-2#1)
patients may have##2##3##(1995-2#1)(2008-5#1)
patients may require##3##3##(1994-12#1)(2013-1#2)
patients may respond##2##3##(2010-1#1)(2012-3#1)
patients may##26##2##(1990-11#1)(1991-2#1)(1994-12#1)(1995-2#2)(1996-6#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#5)(2012-3#1)(2013-1#2)
patients met##2##2##(2011-2#1)(2012-12#1)
patients might##2##2##(1996-3#1)(2009-7#1)
patients more than 75 years of age##2##7##(2011-2#2)
patients more##4##2##(1990-2#1)(2011-2#3)
patients must be considered##2##4##(1990-8#1)(1997-8#1)
patients must be##4##3##(1990-8#1)(1997-5#1)(1997-8#1)(2012-3#1)
patients need##2##2##(2008-8#1)(2011-2#1)
patients needed##2##2##(1990-11#1)(1990-2#1)
patients not##8##2##(1994-3#1)(1995-12#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
patients observed##2##2##(1990-9#1)(2008-5#1)
patients of TA##2##3##(1997-8#2)
patients of a##2##3##(1997-3#1)(1997-8#1)
patients of all ages##2##4##(1992-3#1)(1993-1#1)
patients of the##3##3##(2008-10#1)(2013-1#2)
patients of this group##2##4##(1993-1#1)(1994-1#1)
patients of##39##2##(1990-5#1)(1991-3#1)(1992-3#1)(1993-1#3)(1994-1#1)(1997-3#1)(1997-8#5)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-3#3)(2013-1#6)(2013-8#3)
patients often require##2##3##(2012-2#1)(2013-8#1)
patients often##5##2##(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
patients older and younger than 65 years##2##7##(2009-8#2)
patients older than 65 years##2##5##(2009-1#1)(2011-2#1)
patients older than##8##3##(2008-7#1)(2009-1#1)(2009-8#2)(2011-2#2)(2012-2#1)(2012-3#1)
patients older##10##2##(2008-7#1)(2009-1#1)(2009-8#4)(2011-2#2)(2012-2#1)(2012-3#1)
patients on a##2##3##(2010-10#1)(2013-1#1)
patients on dialysis##4##3##(1996-2#1)(2008-1#1)(2011-2#2)
patients on the##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
patients on##21##2##(1993-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#2)
patients ont##2##2##(2011-2#1)(2013-1#1)
patients operated in##2##3##(1991-3#2)
patients operated on##3##3##(1990-6#1)(1992-12#2)
patients operated upon##3##3##(1990-11#1)(1992-5#1)(2008-10#1)
patients operated##12##2##(1990-11#1)(1990-6#1)(1990-9#2)(1991-3#2)(1991-6#1)(1992-12#2)(1992-5#1)(1993-11#1)(2008-10#1)
patients or##5##2##(1991-2#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-1#1)
patients out of##2##3##(1991-8#1)(2008-1#1)
patients over 65 years##2##4##(2008-11#1)(2011-2#1)
patients over the age of##3##5##(2011-2#3)
patients over time##2##3##(1993-12#1)(2008-12#1)
patients over##12##2##(1993-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#5)(2012-3#1)
patients participated in##2##3##(1991-2#1)(2011-1#1)
patients participated##3##2##(1991-2#1)(2008-12#1)(2011-1#1)
patients per##2##2##(2008-7#2)
patients present with##3##3##(2008-10#1)(2010-12#1)(2010-7#1)
patients present##5##2##(1994-6#1)(2008-10#1)(2010-12#1)(2010-7#1)(2013-1#1)
patients presented with subarachnoid haemorrhage##2##5##(1997-3#1)(2008-7#1)
patients presented with##8##3##(1991-8#1)(1997-3#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)
patients presented##12##2##(1991-8#1)(1994-3#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
patients presenting with acute##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
patients presenting with##17##3##(1990-12#1)(1995-10#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
patients presenting##22##2##(1990-11#1)(1990-12#1)(1995-10#1)(1995-11#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
patients pretreated with##4##3##(1991-6#1)(1992-12#2)(1994-8#1)
patients prior to##4##3##(1991-2#1)(1996-1#1)(2008-5#1)(2009-8#1)
patients prior##5##2##(1991-2#1)(1996-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
patients radiosurgery was performed after##2##5##(1996-3#2)
patients ranged from##5##3##(1997-8#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
patients readmitted within 90 days##2##5##(2011-2#2)
patients received##27##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-9#1)(1993-1#2)(1993-2#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
patients receiving##34##2##(1990-12#1)(1990-6#3)(1992-3#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
patients recently##2##2##(1993-6#1)(1997-4#1)
patients recovered##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
patients recruited##3##2##(2008-7#1)(2011-1#2)
patients referred for##6##3##(1992-3#2)(1993-3#1)(1995-11#1)(1996-3#1)(2012-2#1)
patients referred to##2##3##(2007-11#1)(2008-12#1)
patients referred##10##2##(1992-3#2)(1993-3#1)(1995-11#1)(1996-3#1)(2007-11#1)(2008-12#2)(2011-2#1)(2012-2#1)
patients regardless of##3##3##(1994-12#1)(2011-2#2)
patients registered##2##2##(1997-7#2)
patients remain##2##2##(2008-4#1)(2011-2#1)
patients reported##9##2##(1991-3#1)(1993-2#1)(1995-12#1)(1997-3#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-10#1)
patients require##3##2##(1994-12#1)(2010-11#1)(2012-3#1)
patients required##5##2##(1992-2#1)(1992-6#1)(2012-3#2)(2013-1#1)
patients requiring##3##2##(1995-2#1)(2011-2#2)
patients responded##3##2##(2008-7#1)(2010-10#1)(2010-8#1)
patients revealed##3##2##(1990-3#1)(1991-3#1)(1992-3#1)
patients reveals##2##2##(1995-2#1)(2010-5#1)
patients scheduled for elective##2##4##(2007-8#1)(2011-2#1)
patients scheduled for##7##3##(1994-2#1)(2007-8#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-2#2)
patients seen##2##2##(1996-6#1)(2012-3#1)
patients should be##9##3##(1991-3#1)(1992-3#1)(1993-2#1)(1996-11#1)(1997-1#1)(2008-11#2)(2010-8#1)(2011-2#1)
patients should include##2##3##(1994-5#1)(2009-12#1)
patients should##17##2##(1991-3#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1996-11#1)(1997-1#1)(2008-11#2)(2008-12#1)(2009-12#1)(2010-8#1)(2011-2#2)(2013-1#2)
patients showed a##6##3##(1994-12#1)(1997-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
patients showed an##2##3##(2011-2#2)
patients showed significantly##2##3##(2008-7#1)(2010-3#1)
patients showed##25##2##(1990-12#1)(1990-9#2)(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-5#1)(2008-7#4)(2010-3#1)(2011-2#4)(2013-1#4)
patients showing##5##2##(1990-2#1)(1992-2#1)(1996-1#1)(1996-2#1)(2013-1#1)
patients still had##2##3##(1991-9#1)(2008-7#1)
patients still##6##2##(1991-9#1)(1997-4#1)(2008-7#2)(2009-10#1)(2010-10#1)
patients subjected to##4##3##(2008-11#1)(2011-2#2)(2013-1#1)
patients submitted to##6##3##(1990-2#1)(1990-3#1)(1991-6#2)(1993-3#1)(2008-10#1)
patients subsequently underwent##2##3##(1995-11#1)(2008-9#1)
patients subsequently##3##2##(1995-11#1)(2008-7#1)(2008-9#1)
patients suffered from##2##3##(1991-8#1)(2011-3#1)
patients suffered##3##2##(1991-8#2)(2011-3#1)
patients suffering from chronic##4##4##(1991-2#1)(1991-3#1)(2008-10#1)(2008-12#1)
patients suffering from coronary heart disease##2##6##(1991-12#1)(2012-3#1)
patients suffering from##34##3##(1990-8#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#3)(1992-2#1)(1993-11#1)(1996-9#1)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-10#1)(2010-11#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#5)
patients suffering##38##2##(1990-8#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#3)(1992-2#1)(1993-11#1)(1996-9#1)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-5#1)(2010-10#1)(2010-11#1)(2011-2#5)(2011-3#1)(2012-3#2)(2013-1#5)
patients survived##8##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-8#1)(1992-5#1)(1994-3#1)(2011-2#2)
patients suspected of##3##3##(1990-12#1)(1997-8#2)
patients sustained##2##2##(1996-3#1)(2008-1#1)
patients taking##7##2##(1995-11#1)(2008-11#4)(2008-5#1)(2008-8#1)
patients than in controls##4##4##(1992-12#1)(1994-11#1)(2011-2#2)
patients than in the controls##3##5##(2008-7#1)(2011-1#1)(2011-2#1)
patients than in the##4##4##(1993-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
patients than in##11##3##(1992-12#1)(1993-2#1)(1994-11#1)(1995-5#1)(2008-7#1)(2011-1#1)(2011-2#4)(2012-12#1)
patients than##14##2##(1992-12#1)(1993-12#2)(1993-2#1)(1994-11#1)(1995-5#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#4)(2012-12#1)
patients that had##2##3##(2012-2#2)
patients that were##3##3##(1995-12#1)(2011-2#2)
patients that##19##2##(1995-12#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-8#1)(2010-12#1)(2011-2#6)(2012-2#2)(2013-1#3)
patients the##26##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-8#3)(2007-8#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#6)
patients themselves##2##2##(1995-2#1)(1997-2#1)
patients there was##2##3##(1990-2#1)(2013-1#1)
patients there were##2##3##(1990-6#1)(2011-2#1)
patients there##4##2##(1990-2#1)(1990-6#1)(2011-2#1)(2013-1#1)
patients they cared for##2##4##(1991-1#1)(2008-11#1)
patients they##5##2##(1991-1#1)(1991-2#1)(2007-11#1)(2008-11#1)(2009-6#1)
patients through##2##2##(2009-1#1)(2012-3#1)
patients to a##2##3##(1995-6#1)(1997-3#1)
patients to achieve##2##3##(2012-2#1)(2013-1#1)
patients to be treated##2##4##(2008-10#1)(2008-8#1)
patients to be##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
patients to decide on the##2##5##(1995-2#1)(2009-8#1)
patients to the##4##3##(1991-11#1)(1991-3#1)(2008-1#1)(2008-10#1)
patients to##58##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1993-2#1)(1994-12#2)(1994-6#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-4#1)(2010-6#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#1)
patients took part##2##3##(2008-7#1)(2011-7#1)
patients towards##2##2##(1993-11#1)(2011-2#1)
patients treated at the##2##4##(1990-6#1)(2011-2#1)
patients treated by radiosurgery##2##4##(2008-7#2)
patients treated by##8##3##(1992-9#1)(1994-6#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-5#1)
patients treated for##6##3##(1990-2#1)(1990-9#1)(1994-5#1)(1997-8#1)(2011-2#1)(2012-12#1)
patients treated in the##2##4##(2008-7#1)(2013-1#1)
patients treated in##4##3##(1997-5#1)(2007-11#1)(2008-7#1)(2013-1#1)
patients treated surgically##2##3##(2008-7#1)(2010-11#1)
patients treated using##2##3##(1991-3#1)(2008-8#1)
patients treated with band ligation##2##5##(2013-1#2)
patients treated with##42##3##(1990-11#2)(1990-6#1)(1991-8#2)(1992-12#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-3#2)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-5#1)(2010-3#2)(2011-2#1)(2012-12#2)(2013-1#7)(2013-8#1)
patients treated##71##2##(1990-11#2)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-5#1)(1997-8#3)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#12)(2008-8#3)(2009-11#1)(2009-5#2)(2010-11#1)(2010-3#2)(2011-2#3)(2012-12#3)(2013-1#8)(2013-8#1)
patients type##2##2##(1997-8#2)
patients unable to##2##3##(2010-4#1)(2011-7#1)
patients under treatment##2##3##(1994-9#1)(2008-10#1)
patients under##11##2##(1990-5#1)(1993-1#1)(1994-9#1)(2008-10#3)(2010-12#1)(2011-2#2)(2013-1#2)
patients undergo##2##2##(1990-3#1)(1997-8#1)
patients undergoing coronary artery##3##4##(1997-3#1)(2008-12#2)
patients undergoing coronary##4##3##(1997-3#1)(2008-12#2)(2008-5#1)
patients undergoing either##2##3##(2011-2#1)(2013-1#1)
patients undergoing oral surgery with##2##5##(1993-1#2)
patients undergoing oral surgery##4##4##(1993-1#4)
patients undergoing surgical##2##3##(2008-7#1)(2010-11#1)
patients undergoing total##2##3##(2009-3#1)(2012-12#1)
patients undergoing treatment##2##3##(2008-10#2)
patients undergoing##63##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-1#4)(1994-3#2)(1995-1#1)(1995-12#1)(1996-3#2)(1997-3#2)(2008-1#1)(2008-10#3)(2008-12#4)(2008-5#2)(2008-7#7)(2009-11#1)(2009-3#2)(2010-11#1)(2010-12#1)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#1)
patients underwent a##6##3##(1990-9#1)(1991-9#1)(1997-8#1)(2008-11#1)(2008-9#2)
patients underwent an##2##3##(1990-5#1)(2013-1#1)
patients underwent radical surgery##2##4##(1990-6#1)(1990-9#1)
patients underwent radical##3##3##(1990-3#1)(1990-6#1)(1990-9#1)
patients underwent surgery##2##3##(2012-3#1)(2013-1#1)
patients underwent##55##2##(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#3)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1994-3#2)(1995-10#1)(1995-11#1)(1996-3#1)(1997-8#4)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#7)(2008-9#3)(2010-3#1)(2011-2#7)(2011-3#1)(2012-3#2)(2013-1#6)
patients up to##2##3##(2008-7#1)(2010-12#1)
patients use##2##2##(1995-2#1)(2009-8#1)
patients using a##2##3##(2008-9#1)(2013-1#1)
patients using##13##2##(1993-12#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
patients via##2##2##(1991-3#1)(1996-3#1)
patients was 33##2##3##(2011-1#1)(2012-3#1)
patients was measured##2##3##(2008-7#1)(2009-6#1)
patients was the##2##3##(2008-7#2)
patients was##50##2##(1990-12#1)(1990-6#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#3)(1994-3#1)(1994-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#4)(2008-8#2)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#2)
patients we##3##2##(1996-2#1)(1996-9#2)
patients wearing##2##2##(2013-1#2)
patients were administered##2##3##(2008-10#1)(2010-7#1)
patients were administrated##3##3##(2012-3#3)
patients were admitted##2##3##(1997-8#1)(2012-3#1)
patients were alive and##3##4##(1991-8#2)(2012-12#1)
patients were alive##6##3##(1990-6#1)(1991-2#1)(1991-8#2)(2012-12#1)(2012-3#1)
patients were analyzed for##2##4##(1991-3#1)(1992-3#1)
patients were analyzed in##2##4##(1990-2#1)(2008-7#1)
patients were analyzed##8##3##(1990-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(2008-10#2)(2008-7#1)(2013-8#1)
patients were approached##2##3##(2007-12#1)(2010-12#1)
patients were assessed##3##3##(1990-5#1)(2008-9#1)(2012-3#1)
patients were clinically##2##3##(1990-9#1)(2011-1#1)
patients were cured##2##3##(1995-11#1)(2008-7#1)
patients were divided into##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
patients were divided##4##3##(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
patients were enrolled in##2##4##(2011-2#1)(2012-3#1)
patients were enrolled##5##3##(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
patients were evaluable##2##3##(1990-2#1)(1991-6#1)
patients were evaluated in##2##4##(2008-3#1)(2008-7#1)
patients were evaluated##7##3##(1992-2#1)(1993-1#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
patients were examined##4##3##(1992-9#1)(1993-2#1)(2008-9#1)(2012-2#1)
patients were excluded##2##3##(1997-8#1)(2009-8#1)
patients were female and##2##4##(1997-8#1)(2011-2#1)
patients were female##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
patients were followed for##2##4##(1996-1#1)(2009-10#1)
patients were followed up##2##4##(2008-11#1)(2011-2#1)
patients were followed##6##3##(1996-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
patients were found to have##2##5##(1995-12#1)(2008-9#1)
patients were found to##3##4##(1990-2#1)(1995-12#1)(2008-9#1)
patients were found##4##3##(1990-2#1)(1993-1#1)(1995-12#1)(2008-9#1)
patients were given##2##3##(2009-12#1)(2013-1#1)
patients were identified##5##3##(2008-9#1)(2011-1#1)(2012-3#2)(2013-8#1)
patients were in##4##3##(1991-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
patients were included in##5##4##(1993-2#1)(1997-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
patients were included##8##3##(1993-2#1)(1997-7#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
patients were induced##2##3##(2010-7#2)
patients were lost to follow up##2##6##(1993-12#1)(1996-3#1)
patients were managed##2##3##(1994-2#1)(2013-1#1)
patients were men##2##3##(1990-6#1)(2011-2#1)
patients were more likely to##3##5##(1995-12#1)(1996-3#1)(2012-3#1)
patients were more##4##3##(1995-12#1)(1996-3#1)(2008-11#1)(2012-3#1)
patients were obtained##2##3##(2012-5#1)(2013-1#1)
patients were operated on##3##4##(1991-8#1)(1992-1#1)(1993-3#1)
patients were operated##5##3##(1991-8#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-3#1)
patients were prescribed##3##3##(2008-11#1)(2010-12#1)(2013-7#1)
patients were randomly allocated##2##4##(2010-12#1)(2012-3#1)
patients were randomly assigned to receive##2##6##(1993-1#1)(2012-2#1)
patients were randomly assigned to##3##5##(1993-1#1)(2011-2#1)(2012-2#1)
patients were randomly assigned##4##4##(1993-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
patients were randomly##7##3##(1993-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients were recruited##2##3##(2009-2#1)(2011-2#1)
patients were reviewed##2##3##(1996-6#1)(2010-10#1)
patients were satisfied with the##2##5##(1997-2#1)(2013-1#1)
patients were scored for##2##4##(1997-8#1)(2008-7#1)
patients were selected##2##3##(2006-6#1)(2008-1#1)
patients were significantly higher than those##2##6##(1994-3#1)(2008-10#1)
patients were significantly##5##3##(1994-3#1)(2008-10#1)(2008-12#1)(2009-10#1)(2013-1#1)
patients were slower than##2##4##(2008-7#2)
patients were stratified##3##3##(1995-11#1)(2011-2#2)
patients were studied##7##3##(1991-11#1)(1991-3#1)(1992-2#1)(1997-8#3)(2008-1#1)
patients were subjected to##2##4##(1990-11#1)(2012-3#1)
patients were treated by laparotomy##2##5##(1991-2#1)(1991-3#1)
patients were treated by##10##4##(1991-2#1)(1991-3#1)(1991-8#2)(1994-12#1)(2008-7#3)(2011-2#1)(2012-3#1)
patients were treated conservatively##2##4##(2008-7#2)
patients were treated for##3##4##(1990-9#1)(1991-8#1)(1993-2#1)
patients were treated initially##2##4##(1992-12#1)(1996-11#1)
patients were treated with a##3##5##(1992-5#1)(2008-12#1)(2011-2#1)
patients were treated with##15##4##(1990-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1995-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
patients were treated##41##3##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#3)(1991-9#2)(1992-12#2)(1992-5#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-11#1)(1997-3#2)(1997-6#1)(1997-8#2)(2008-10#2)(2008-12#1)(2008-7#8)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)
patients were##295##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#7)(1991-11#1)(1991-2#7)(1991-3#4)(1991-6#1)(1991-8#6)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#3)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#3)(1996-3#2)(1996-6#2)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#12)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#6)(2008-10#14)(2008-11#12)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#22)(2008-8#2)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-7#4)(2010-8#1)(2011-1#4)(2011-2#29)(2012-12#2)(2012-2#2)(2012-3#29)(2012-5#2)(2013-1#19)(2013-7#2)(2013-8#3)
patients when##3##2##(1990-9#1)(2008-7#1)(2011-2#1)
patients where extensive##2##3##(1994-8#1)(2008-7#1)
patients which##2##2##(2008-10#1)(2008-12#1)
patients while##3##2##(1992-3#1)(1997-8#1)(2008-8#1)
patients who achieved##3##3##(1990-12#1)(2012-3#1)(2013-1#1)
patients who are already##2##4##(2008-6#1)(2011-2#1)
patients who are on##2##4##(2008-11#1)(2011-2#1)
patients who are##17##3##(1991-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#1)
patients who can##2##3##(2009-8#1)(2010-5#1)
patients who could##2##3##(1997-2#1)(2008-11#1)
patients who develop##3##3##(1993-11#1)(2011-2#1)(2013-8#1)
patients who developed##2##3##(2008-1#1)(2013-8#1)
patients who did not receive any treatment##2##7##(2008-7#1)(2012-3#1)
patients who did not receive##3##5##(1993-1#1)(2008-7#1)(2012-3#1)
patients who did not##10##4##(1993-1#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
patients who did##12##3##(1993-1#2)(1994-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
patients who died during##2##4##(1991-7#1)(1997-4#1)
patients who died had##2##4##(2012-12#1)(2012-3#1)
patients who died##6##3##(1991-7#1)(1991-8#1)(1997-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
patients who do not respond to##2##6##(1997-8#1)(2011-2#1)
patients who experience##2##3##(2008-7#1)(2011-2#1)
patients who had a##3##4##(1997-3#1)(2010-6#1)(2013-1#1)
patients who had been##3##4##(1991-3#1)(2008-11#1)(2008-7#1)
patients who had not##3##4##(1991-2#1)(1997-7#1)(2012-3#1)
patients who had undergone THA or TKA##2##7##(1994-3#2)
patients who had undergone THA##3##5##(1994-3#3)
patients who had undergone total##2##5##(1990-9#1)(1994-3#1)
patients who had undergone##8##4##(1990-9#1)(1994-3#4)(2008-11#1)(2008-9#1)(2009-11#1)
patients who had##42##3##(1990-2#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-3#4)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2008-1#1)(2008-11#5)(2008-7#2)(2008-9#2)(2009-11#1)(2010-6#1)(2010-7#2)(2011-2#3)(2012-3#2)(2013-1#2)
patients who have had##2##4##(1992-3#1)(2011-1#1)
patients who have undergone##5##4##(1990-9#1)(1996-3#1)(2008-7#1)(2010-6#1)(2012-12#1)
patients who have##17##3##(1990-9#1)(1992-3#1)(1993-1#1)(1994-5#1)(1996-3#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#2)(2013-8#2)
patients who met the inclusion criteria##2##6##(2010-6#1)(2012-3#1)
patients who met the##3##4##(2010-6#1)(2011-2#1)(2012-3#1)
patients who met##4##3##(2010-6#1)(2011-2#1)(2012-3#2)
patients who present with##2##4##(2008-12#1)(2011-2#1)
patients who presented##2##3##(1992-12#1)(2011-2#1)
patients who receive##3##3##(1994-5#1)(2008-6#1)(2009-11#1)
patients who received##5##3##(1992-12#1)(1993-1#1)(2008-7#2)(2011-2#1)
patients who relapsed##2##3##(1990-8#1)(2013-7#1)
patients who required##2##3##(1996-3#1)(2013-1#1)
patients who showed##3##3##(1991-11#1)(2011-2#1)(2013-1#1)
patients who suffer##2##3##(1997-2#1)(2012-2#1)
patients who survived##2##3##(1995-2#1)(2008-11#1)
patients who undergo##3##3##(1993-1#1)(2009-5#1)(2013-1#1)
patients who underwent a##2##4##(2008-9#1)(2012-2#1)
patients who underwent amniocentesis##2##4##(2012-3#2)
patients who underwent biopsy##2##4##(2010-11#1)(2012-3#1)
patients who underwent surgery##3##4##(2008-7#1)(2008-8#1)(2013-1#1)
patients who underwent surgical##2##4##(1996-3#1)(2011-2#1)
patients who underwent##33##3##(1990-8#1)(1991-1#1)(1991-6#1)(1996-3#2)(1996-9#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)
patients who were admitted##2##4##(2012-3#1)(2013-1#1)
patients who were followed##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
patients who were overweight##2##4##(2008-10#2)
patients who were selected##2##4##(1994-12#1)(2008-11#1)
patients who were treated with##3##5##(1991-12#1)(2008-7#1)(2011-2#1)
patients who were treated##4##4##(1991-12#1)(1996-11#1)(2008-7#1)(2011-2#1)
patients who were##30##3##(1990-8#1)(1991-12#2)(1991-3#1)(1993-1#1)(1994-12#1)(1996-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-8#1)(2011-2#2)(2012-3#4)(2012-5#1)(2013-1#1)
patients who will##2##3##(2009-4#1)(2012-3#1)
patients who##242##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#3)(1992-3#4)(1992-9#2)(1993-1#6)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#3)(1994-3#4)(1994-5#2)(1995-12#1)(1995-2#3)(1995-3#1)(1996-11#1)(1996-3#4)(1996-6#2)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#13)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#16)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#30)(2011-3#1)(2012-12#5)(2012-2#4)(2012-3#21)(2012-5#1)(2013-1#16)(2013-7#2)(2013-8#5)
patients whose##13##2##(1991-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(2008-11#1)(2011-2#4)(2012-3#2)(2013-8#1)
patients will be##4##3##(1993-11#1)(1994-9#1)(2012-2#1)(2013-1#1)
patients will##8##2##(1993-11#1)(1994-9#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
patients with 1-3 positive nodes##2##5##(1992-12#1)(1993-1#1)
patients with 23##2##3##(2008-9#1)(2011-2#1)
patients with ACS##2##3##(2008-3#2)
patients with AIDS and##3##4##(1996-11#1)(2008-11#1)(2011-2#1)
patients with AIDS##4##3##(1996-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
patients with ALL##2##3##(2011-2#2)
patients with AMI##2##3##(1990-12#1)(1995-12#1)
patients with AOD##3##3##(2012-12#3)
patients with ARDS##3##3##(1990-2#1)(1997-1#2)
patients with AVMs##2##3##(2008-7#1)(2012-3#1)
patients with Alzheimer's disease (AD)##2##5##(2008-7#2)
patients with Alzheimer's disease##5##4##(2008-5#1)(2008-7#3)(2009-9#1)
patients with Buerger disease##3##4##(1997-8#3)
patients with CAI##2##3##(2013-1#2)
patients with CCBIP##2##3##(2008-7#2)
patients with CES##2##3##(2012-3#2)
patients with COPD##6##3##(1997-1#1)(2009-1#1)(2011-2#1)(2013-8#3)
patients with CRC##2##3##(2012-3#2)
patients with CRF##2##3##(2008-1#1)(2011-2#1)
patients with Crohn's disease##2##4##(2010-12#2)
patients with GHF##2##3##(2011-2#2)
patients with HC##3##3##(2012-3#3)
patients with HCC##2##3##(2008-10#2)
patients with HCV##2##3##(2009-8#1)(2013-1#1)
patients with HIV and##2##4##(1993-5#1)(2008-10#1)
patients with HIV infection##3##4##(1996-11#1)(1996-3#1)(2008-7#1)
patients with HIV##8##3##(1993-5#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-7#1)(2010-12#2)
patients with HIV-1 infection##4##4##(1990-2#2)(2010-11#2)
patients with IP##2##3##(2008-7#2)
patients with LC##2##3##(2008-10#2)
patients with MS##5##3##(1995-12#1)(2008-5#1)(2010-12#3)
patients with Marfan##2##3##(2008-8#2)
patients with PD##5##3##(2008-10#1)(2008-7#1)(2013-1#2)(2013-8#1)
patients with PDTC##2##3##(2012-3#2)
patients with PHP##2##3##(2010-6#1)(2011-1#1)
patients with Parkinson disease##2##4##(2013-8#2)
patients with Parkinson##3##3##(2013-8#3)
patients with Parkinson's disease (PD)##4##5##(2008-7#4)
patients with Parkinson's disease##10##4##(1991-5#1)(1993-2#1)(2008-7#7)(2013-1#1)
patients with RA##2##3##(1993-2#1)(2012-3#1)
patients with SS##6##3##(2007-11#6)
patients with Takayasu arteritis and severe aortic regurgitation##4##8##(1997-8#4)
patients with Takayasu arteritis##6##4##(1997-8#6)
patients with VDDR##2##3##(2011-1#2)
patients with Werner's syndrome##2##4##(1994-12#2)
patients with a duration of##2##5##(1997-8#1)(2008-9#1)
patients with a high BSA##2##5##(2011-2#2)
patients with a high##4##4##(1990-3#1)(1997-8#1)(2011-2#2)
patients with a history of##4##5##(1990-3#1)(2008-1#1)(2008-11#1)(2008-9#1)
patients with a mean age of##4##6##(2008-12#1)(2011-2#1)(2013-1#2)
patients with a mean##6##4##(1991-11#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
patients with a previously implanted##2##5##(2008-10#2)
patients with a tumor##2##4##(1990-12#1)(1994-12#1)
patients with a variety of##2##5##(2008-11#2)
patients with a wrist ganglion##2##5##(2008-9#2)
patients with a##61##3##(1990-12#3)(1990-3#2)(1991-11#2)(1991-8#1)(1992-5#1)(1994-12#1)(1995-2#1)(1996-1#2)(1997-3#1)(1997-8#3)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#6)(2009-3#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#7)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
patients with abnormal thermograms##4##4##(1993-11#4)
patients with abnormal##6##3##(1990-6#1)(1992-12#1)(1993-11#4)
patients with achalasia##2##3##(1992-9#1)(2013-1#1)
patients with active##3##3##(2009-11#1)(2010-12#2)
patients with acute coronary syndrome##9##5##(2008-11#4)(2008-3#3)(2011-2#2)
patients with acute coronary syndromes##2##5##(2008-3#1)(2009-12#1)
patients with acute coronary##13##4##(2008-11#4)(2008-3#4)(2009-10#1)(2009-12#1)(2011-2#2)(2013-8#1)
patients with acute ischemic stroke##3##5##(2008-10#1)(2012-12#2)
patients with acute leukemia##2##4##(2011-2#2)
patients with acute myocardial infarction (AMI)##2##6##(1992-3#1)(1995-12#1)
patients with acute myocardial infarction##7##5##(1992-3#1)(1992-9#2)(1995-12#1)(2008-10#1)(2008-3#1)(2010-11#1)
patients with acute myocardial##8##4##(1990-12#1)(1992-3#1)(1992-9#2)(1995-12#1)(2008-10#1)(2008-3#1)(2010-11#1)
patients with acute necrotizing##2##4##(2012-3#2)
patients with acute pancreatitis##2##4##(1990-3#1)(2009-8#1)
patients with acute stroke##3##4##(2007-9#1)(2008-8#2)
patients with acute##53##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-8#1)(1992-3#1)(1992-9#2)(1994-2#1)(1995-12#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-3#5)(2008-7#1)(2008-8#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#7)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#1)
patients with additional##2##3##(2009-7#1)(2013-1#1)
patients with advanced breast cancer##4##5##(1991-6#1)(1992-2#1)(1994-8#1)(1997-7#1)
patients with advanced breast##5##4##(1991-6#1)(1992-2#1)(1994-8#1)(1997-7#1)(2011-2#1)
patients with advanced ovarian cancer##2##5##(1991-8#2)
patients with advanced renal##2##4##(1991-6#1)(2013-1#1)
patients with advanced##21##3##(1991-6#2)(1991-8#2)(1992-2#1)(1994-2#1)(1994-8#1)(1997-7#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
patients with all##2##3##(1992-3#1)(2010-12#1)
patients with an anorectal##2##4##(2011-2#2)
patients with an##13##3##(1992-12#1)(1992-5#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#3)(2012-3#1)
patients with and without AIDS##2##5##(2011-2#2)
patients with and without##7##4##(1997-7#1)(2008-5#1)(2009-8#1)(2011-2#3)(2012-3#1)
patients with aneurysms##2##3##(2011-2#1)(2013-8#1)
patients with arteriovenous##3##3##(1996-9#1)(2008-7#1)(2012-3#1)
patients with asthma##10##3##(1993-1#1)(1996-2#1)(2008-1#1)(2008-8#1)(2012-12#5)(2012-2#1)
patients with asymptomatic##3##3##(1996-3#1)(2008-7#1)(2008-8#1)
patients with autosomal dominant polycystic kidney disease (ADPKD)##3##8##(1997-1#2)(2013-1#1)
patients with bacteremia##2##3##(1990-3#1)(2008-7#1)
patients with benign prostatic hyperplasia##2##5##(1990-9#2)
patients with benign##8##3##(1990-9#4)(1991-8#1)(1992-5#1)(1995-3#1)(2011-1#1)
patients with bilateral##3##3##(1991-12#1)(2008-12#1)(2012-2#1)
patients with bladder exstrophy##2##4##(2008-10#2)
patients with blunt head trauma##3##5##(2011-2#3)
patients with blunt##4##3##(1990-2#1)(2011-2#3)
patients with bone metastases##5##4##(1990-2#1)(2008-10#2)(2011-2#2)
patients with bone##6##3##(1990-2#2)(2008-10#2)(2011-2#2)
patients with brain##2##3##(1994-3#1)(2008-12#1)
patients with breast cancer and##3##5##(1990-2#1)(1992-12#1)(1993-11#1)
patients with breast cancer##17##4##(1990-2#1)(1990-8#1)(1992-12#1)(1993-1#1)(1993-11#4)(1994-12#2)(1997-7#1)(1997-8#3)(2008-10#1)(2008-7#1)(2012-3#1)
patients with breast##20##3##(1990-2#1)(1990-8#1)(1992-12#1)(1993-1#1)(1993-11#4)(1994-12#2)(1997-7#1)(1997-8#3)(2008-10#1)(2008-7#4)(2012-3#1)
patients with cancer of the prostate##2##6##(1990-9#1)(1991-8#1)
patients with cancer of the stomach##2##6##(1991-2#2)
patients with cancer of the##6##5##(1990-9#3)(1991-2#2)(1991-8#1)
patients with cancer##29##3##(1990-6#1)(1990-9#3)(1991-2#2)(1991-8#1)(1996-11#1)(2008-2#2)(2008-7#8)(2009-12#1)(2010-11#6)(2010-4#1)(2013-1#3)
patients with carcinoid tumours##3##4##(1992-11#3)
patients with carcinoid##4##3##(1992-11#4)
patients with carcinoma##2##3##(1992-5#2)
patients with cerebral##2##3##(1990-12#1)(2008-7#1)
patients with chest pain in the##2##6##(2008-3#2)
patients with chest pain##5##4##(1992-6#1)(2008-3#2)(2012-2#2)
patients with chronic active hepatitis##2##5##(2009-8#2)
patients with chronic hepatitis B##4##5##(2009-8#2)(2011-2#2)
patients with chronic hepatitis C##4##5##(2009-10#1)(2010-4#1)(2013-1#2)
patients with chronic hepatitis##9##4##(2009-10#1)(2009-8#3)(2010-4#1)(2011-2#2)(2013-1#2)
patients with chronic kidney disease##2##5##(2008-11#1)(2011-2#1)
patients with chronic kidney##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
patients with chronic liver disease##2##5##(1991-8#1)(2008-1#1)
patients with chronic low back pain##2##6##(2012-12#2)
patients with chronic neck pain##4##5##(2010-12#4)
patients with chronic obstructive pulmonary##2##5##(1993-11#1)(2011-2#1)
patients with chronic obstructive##3##4##(1993-11#1)(2008-1#1)(2011-2#1)
patients with chronic pain##4##4##(2008-4#2)(2008-9#1)(2012-3#1)
patients with chronic pancreatitis##2##4##(1992-11#2)
patients with chronic periodontitis##2##4##(2013-1#2)
patients with chronic renal disease##2##5##(2008-1#1)(2008-10#1)
patients with chronic renal failure##6##5##(1992-6#1)(1993-1#1)(1993-2#1)(1995-5#1)(2008-1#1)(2011-2#1)
patients with chronic renal##8##4##(1992-6#1)(1993-1#1)(1993-2#1)(1995-5#1)(2008-1#2)(2008-10#1)(2011-2#1)
patients with chronic venous##2##4##(2010-7#1)(2013-1#1)
patients with chronic wrist pain##3##5##(2008-9#3)
patients with chronic##68##3##(1991-6#1)(1991-8#1)(1992-11#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-2#2)(1995-5#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#2)(2009-8#6)(2010-12#5)(2010-4#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
patients with cirrhosis##4##3##(2011-2#2)(2012-3#1)(2013-1#1)
patients with clinical##3##3##(2011-2#3)
patients with clinically##4##3##(1992-3#1)(1992-6#1)(1996-11#1)(2008-10#1)
patients with colorectal cancer##3##4##(2009-12#1)(2011-2#2)
patients with combined##2##3##(2011-2#1)(2012-3#1)
patients with communication related impairments in acute##2##7##(2011-1#2)
patients with complicated##3##3##(1991-6#1)(2010-12#1)(2012-12#1)
patients with confirmed##2##3##(2009-11#1)(2012-2#1)
patients with congenital heart disease (CHD)##2##6##(2010-10#1)(2012-2#1)
patients with congenital heart disease##7##5##(2009-10#2)(2010-10#2)(2012-2#3)
patients with congenital##10##3##(1994-11#1)(2009-10#2)(2010-10#2)(2011-1#1)(2012-2#4)
patients with coronary artery disease##4##5##(1990-3#1)(1997-8#1)(2011-2#1)(2013-7#1)
patients with coronary artery##5##4##(1990-3#1)(1997-8#1)(2008-1#1)(2011-2#1)(2013-7#1)
patients with coronary heart disease##4##5##(1992-5#1)(1993-2#1)(2008-12#1)(2012-3#1)
patients with coronary##12##3##(1990-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
patients with cystic fibrosis##4##4##(1991-12#2)(1994-12#1)(2008-10#1)
patients with degenerative##2##3##(2009-3#1)(2012-12#1)
patients with dementia##5##3##(1996-11#1)(2008-7#3)(2008-8#1)
patients with diabetes mellitus##3##4##(2008-1#1)(2008-7#1)(2013-1#1)
patients with diabetes##8##3##(2008-1#2)(2008-7#2)(2009-1#1)(2011-2#2)(2013-1#1)
patients with different##8##3##(1991-2#1)(1993-11#1)(1993-2#1)(1997-2#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
patients with dilated cardiomyopathy##4##4##(1993-2#2)(2011-2#1)(2012-2#1)
patients with drug addiction##2##4##(2009-7#2)
patients with duodenal##2##3##(2008-12#2)
patients with dural arteriovenous fistulae##2##5##(1996-9#2)
patients with early breast cancer##2##5##(1994-12#1)(2011-2#1)
patients with early##5##3##(1994-12#1)(1997-7#1)(2010-11#1)(2011-2#2)
patients with elevated##2##3##(1990-9#1)(1991-6#1)
patients with end-stage##3##3##(2011-3#1)(2013-1#2)
patients with endometriosis##3##3##(1995-2#2)(2012-3#1)
patients with epidermolysis bullosa##2##4##(2012-3#2)
patients with epilepsy##3##3##(1997-8#1)(2010-8#1)(2011-2#1)
patients with essential hypertension##2##4##(2008-5#2)
patients with essential##3##3##(1995-10#1)(2008-5#2)
patients with failed##2##3##(2012-3#2)
patients with familial##4##3##(1990-2#1)(1996-5#1)(2008-12#1)(2009-12#1)
patients with focal##2##3##(1997-8#1)(2008-11#1)
patients with gastric cancer##2##4##(2011-2#2)
patients with gastric##7##3##(1990-2#2)(2008-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
patients with gastrointestinal##3##3##(1990-6#1)(1997-3#1)(1997-8#1)
patients with hand##2##3##(2008-12#1)(2013-1#1)
patients with head##3##3##(1990-3#1)(2008-7#1)(2010-4#1)
patients with heart failure##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
patients with heart##6##3##(2008-11#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
patients with hepatic##2##3##(2008-1#1)(2009-8#1)
patients with high risk##2##4##(2013-1#2)
patients with high##7##3##(1990-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#2)
patients with histologically confirmed##2##4##(1994-12#1)(2011-2#1)
patients with histologically proven##3##4##(1990-2#1)(1991-2#1)(2008-7#1)
patients with histologically##6##3##(1990-2#1)(1991-2#1)(1994-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
patients with human immunodeficiency virus##3##5##(1996-11#1)(1996-2#1)(2010-11#1)
patients with human##4##3##(1996-11#1)(1996-2#1)(2010-11#1)(2012-3#1)
patients with hyperlipidaemia and##2##4##(2008-11#1)(2008-3#1)
patients with hyperlipidaemia##4##3##(2008-11#1)(2008-3#3)
patients with idiopathic PD##2##4##(2008-7#1)(2013-1#1)
patients with idiopathic central DI##2##5##(1997-8#2)
patients with idiopathic ulcerative colitis##2##5##(1995-10#2)
patients with idiopathic##12##3##(1991-5#2)(1995-10#2)(1997-8#2)(2008-7#2)(2009-10#1)(2013-1#2)(2013-8#1)
patients with incomplete##2##3##(2008-1#1)(2013-1#1)
patients with increased##4##3##(1993-2#1)(2008-12#2)(2011-2#1)
patients with infantile##3##3##(1991-2#1)(2009-4#2)
patients with inflammatory bowel disease##6##5##(1992-6#1)(2008-10#1)(2012-12#1)(2013-1#3)
patients with inflammatory bowel##7##4##(1992-6#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#3)
patients with inflammatory##8##3##(1992-12#1)(1992-6#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#3)
patients with initial##3##3##(1990-6#1)(2008-1#1)(2008-11#1)
patients with inoperable##3##3##(1991-2#1)(1993-6#2)
patients with intracranial##3##3##(1991-2#1)(1995-11#1)(1996-6#1)
patients with intractable##2##3##(1993-1#1)(2009-9#1)
patients with ischaemic##2##3##(2008-8#1)(2012-2#1)
patients with known##4##3##(1997-8#1)(2008-1#1)(2010-7#1)(2012-2#1)
patients with left##3##3##(2009-10#3)
patients with leukemia and lymphoma##2##5##(1992-3#2)
patients with leukemia##3##3##(1992-3#2)(2010-11#1)
patients with liver cirrhosis##4##4##(1992-2#1)(2008-10#1)(2010-12#1)(2010-8#1)
patients with liver disease##3##4##(1990-8#1)(2013-1#2)
patients with liver##8##3##(1990-8#1)(1992-2#1)(2008-10#2)(2010-12#1)(2010-8#1)(2013-1#2)
patients with localized scleroderma##2##4##(2011-2#2)
patients with localized##4##3##(1995-12#1)(2011-2#2)(2012-12#1)
patients with locally advanced##2##4##(2008-10#2)
patients with locally##3##3##(1990-8#1)(2008-10#2)
patients with low back pain##5##5##(2008-12#4)(2013-1#1)
patients with low##9##3##(2008-10#1)(2008-11#1)(2008-12#4)(2013-1#3)
patients with low-grade##3##3##(1990-12#1)(1997-1#2)
patients with lumbar##4##3##(2011-2#1)(2012-12#2)(2013-1#1)
patients with lung cancer##3##4##(1991-2#1)(1991-8#1)(2009-11#1)
patients with lung##5##3##(1991-2#1)(1991-8#1)(2009-11#1)(2009-4#1)(2012-2#1)
patients with lymph node##2##4##(1991-6#1)(2013-1#1)
patients with major depression##2##4##(2009-8#2)
patients with malignancies##2##3##(2011-2#1)(2012-3#1)
patients with malignant melanoma##2##4##(1990-6#1)(2011-2#1)
patients with malignant tumours##2##4##(1997-2#1)(2008-7#1)
patients with malignant##9##3##(1990-2#1)(1990-6#1)(1992-12#1)(1994-12#1)(1997-2#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
patients with mastectomy##2##3##(1992-12#1)(2013-1#1)
patients with metachromatic leukodystrophy##2##4##(1997-3#2)
patients with metastatic##7##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(2008-11#1)(2010-8#1)(2013-8#1)
patients with mild to moderate##2##5##(2008-5#1)(2013-8#1)
patients with mild##3##3##(2008-5#1)(2010-10#1)(2013-8#1)
patients with minor##2##3##(1992-6#1)(1996-8#1)
patients with moderate and##3##4##(2008-7#2)(2011-2#1)
patients with moderate##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
patients with multiple##5##3##(2008-11#1)(2009-3#1)(2011-2#2)(2012-12#1)
patients with muscle##2##3##(2008-10#1)(2008-7#1)
patients with myeloma##2##3##(1990-9#1)(2008-9#1)
patients with neck pain##5##4##(2008-11#1)(2008-12#3)(2010-12#1)
patients with necrotizing##2##3##(1991-11#1)(2012-3#1)
patients with neurological disorders##2##4##(1990-2#2)
patients with neurological##3##3##(1990-2#2)(1993-2#1)
patients with newly diagnosed##2##4##(1996-11#1)(2010-12#1)
patients with newly##3##3##(1990-11#1)(1996-11#1)(2010-12#1)
patients with no##4##3##(1993-12#1)(1993-2#1)(2008-3#1)(2013-1#1)
patients with non-insulin dependent diabetes mellitus##2##6##(1994-12#1)(2008-7#1)
patients with non-insulin-dependent diabetes mellitus##2##5##(1992-9#1)(1995-8#1)
patients with non-malignant ovarian##2##4##(1990-2#2)
patients with non-neuroendocrine tumours##2##4##(1992-11#2)
patients with nonthyroidal illness##2##4##(2008-7#2)
patients with normal colonoscopy##3##4##(2012-3#3)
patients with normal##12##3##(1991-11#1)(1993-11#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#3)
patients with one##2##3##(2012-12#1)(2013-1#1)
patients with open angle##2##4##(2011-2#2)
patients with operable breast##2##4##(1991-8#1)(1994-12#1)
patients with optic##2##3##(1995-12#1)(2008-7#1)
patients with or without##2##4##(1997-5#1)(2013-1#1)
patients with oral cancer##2##4##(2013-1#2)
patients with other##4##3##(1990-3#1)(1994-12#1)(1997-8#1)(2011-2#1)
patients with ovarian cancer##2##4##(1991-6#1)(1996-10#1)
patients with ovarian##5##3##(1990-2#1)(1991-6#1)(1994-2#1)(1996-1#1)(1996-10#1)
patients with overt##2##3##(2010-6#1)(2011-2#1)
patients with pTa##2##3##(2011-2#2)
patients with pain##2##3##(2008-7#1)(2009-12#1)
patients with parkinsonian##2##3##(1993-11#1)(2008-7#1)
patients with paroxysmal##2##3##(2010-12#1)(2012-3#1)
patients with patellofemoral pain syndrome##3##5##(2008-12#3)
patients with pathological##2##3##(1992-5#1)(2008-11#1)
patients with peptic ulcer##2##4##(1995-10#1)(2008-12#1)
patients with peri-implantitis##2##3##(2013-1#2)
patients with persistent##5##3##(1991-8#1)(1992-5#1)(2008-12#1)(2008-3#1)(2008-9#1)
patients with pityriasis versicolor##2##4##(2008-5#2)
patients with pneumococcal meningitis##3##4##(2011-2#3)
patients with pneumococcal##4##3##(2011-2#4)
patients with poor-grade##2##3##(2012-3#2)
patients with positive##5##3##(1993-3#1)(1994-9#1)(2011-2#2)(2012-12#1)
patients with posterior##2##3##(2008-7#1)(2012-3#1)
patients with previous##2##3##(1990-11#1)(2010-12#1)
patients with previously untreated##3##4##(1991-8#1)(2008-10#1)(2010-11#1)
patients with primary and##2##4##(2013-1#2)
patients with primary hyperparathyroidism##2##4##(1990-2#1)(1991-12#1)
patients with primary immunodeficiency##2##4##(2008-10#1)(2012-12#1)
patients with primary##13##3##(1990-2#1)(1990-8#1)(1991-12#1)(1992-9#1)(1995-10#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
patients with proctological symptoms##2##4##(2013-1#2)
patients with progressive##3##3##(1991-3#1)(2008-7#1)(2010-12#1)
patients with prostatic cancer and 14 patients with benign##2##9##(1990-9#2)
patients with prostatic##3##3##(1990-9#2)(1993-6#1)
patients with pulmonary hypertension##2##4##(2008-12#1)(2010-10#1)
patients with pulmonary##5##3##(1997-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)
patients with recurrent breast cancer##2##5##(1994-12#2)
patients with recurrent##5##3##(1991-6#1)(1994-1#1)(1994-12#2)(2008-1#1)
patients with refractory##3##3##(2008-12#1)(2011-2#2)
patients with relapsed/refractory##2##3##(2009-12#2)
patients with renal##3##3##(1996-6#1)(2012-3#1)(2013-1#1)
patients with retained##2##3##(1991-3#1)(2012-2#1)
patients with retroperitoneal##2##3##(1990-9#1)(1992-12#1)
patients with rheumatoid arthritis##4##4##(1990-2#1)(1993-1#1)(2007-11#1)(2008-9#1)
patients with rheumatoid##5##3##(1990-2#1)(1993-1#1)(2007-11#2)(2008-9#1)
patients with rtN236T##2##3##(2013-1#2)
patients with schizophrenia##8##3##(1995-12#1)(1995-5#1)(2008-11#1)(2009-12#1)(2010-1#2)(2012-3#2)
patients with secondary hyperparathyroidism##3##4##(1991-11#2)(1993-3#1)
patients with secondary##6##3##(1991-11#2)(1993-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
patients with several##2##3##(1994-3#1)(2013-1#1)
patients with severe acute asthma##2##5##(1992-3#1)(1997-1#1)
patients with severe acute##3##4##(1992-3#1)(1997-1#1)(2009-8#1)
patients with severe sepsis or septic shock##2##7##(2011-2#2)
patients with severe sepsis##7##4##(2009-6#5)(2011-2#2)
patients with severe##28##3##(1991-3#2)(1992-1#1)(1992-3#1)(1993-1#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#2)(2009-5#1)(2009-6#5)(2009-8#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
patients with shoulder##3##3##(2009-7#1)(2013-1#2)
patients with small##2##3##(2008-8#1)(2009-1#1)
patients with spinal cord injuries##2##5##(1991-6#2)
patients with spinal cord injuries]##2##5##(1991-6#1)(1993-2#1)
patients with spinal cord##6##4##(1991-6#4)(1993-2#2)
patients with spinal##8##3##(1991-6#4)(1993-2#2)(2008-7#1)(2012-3#1)
patients with spontaneous##3##3##(2011-2#3)
patients with stable angina pectoris##2##5##(2008-10#2)
patients with stable##5##3##(1992-12#1)(1997-1#1)(2008-10#2)(2008-12#1)
patients with stage III##2##4##(1990-9#1)(2008-10#1)
patients with stage##6##3##(1990-6#1)(1990-9#1)(1992-12#1)(1997-7#1)(2008-10#1)(2008-11#1)
patients with stenosis##2##3##(1993-8#2)
patients with stroke##2##3##(2008-8#1)(2013-1#1)
patients with subarachnoid haemorrhage (SAH)##2##5##(2008-7#2)
patients with subarachnoid##3##3##(1995-11#1)(2008-7#2)
patients with suspected acute##2##4##(2011-2#2)
patients with suspected or##2##4##(2010-7#1)(2012-2#1)
patients with suspected##15##3##(1990-2#1)(1990-6#1)(1997-8#1)(2008-12#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#4)
patients with symptomatic##4##3##(1993-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
patients with systemic lupus erythematosus (SLE)##2##6##(1990-12#1)(2011-2#1)
patients with systemic lupus erythematosus##3##5##(1990-12#1)(1992-5#1)(2011-2#1)
patients with systemic##6##3##(1990-12#1)(1992-5#1)(2008-5#1)(2010-10#1)(2011-2#2)
patients with the metabolic syndrome##2##5##(2008-1#1)(2010-4#1)
patients with the##17##3##(1990-9#1)(1991-12#1)(1992-12#1)(1994-3#1)(2008-1#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#2)
patients with these##3##3##(2008-3#1)(2008-7#1)(2010-6#1)
patients with this type of##2##5##(1991-11#1)(2010-3#1)
patients with this##9##3##(1991-11#1)(1993-9#1)(1997-6#1)(2008-12#1)(2008-7#2)(2010-3#1)(2011-2#2)
patients with those##2##3##(1995-3#1)(2008-8#1)
patients with thyroid dysfunction##2##4##(2013-1#2)
patients with thyroid nodules##3##4##(2011-1#1)(2012-3#2)
patients with thyroid##5##3##(2011-1#1)(2012-3#2)(2013-1#2)
patients with traumatic##2##3##(1991-6#1)(2011-2#1)
patients with tuberculosis##2##3##(1996-3#2)
patients with tumors##2##3##(2011-2#1)(2013-1#1)
patients with type 2 diabetes##12##5##(2008-3#1)(2009-1#1)(2010-10#2)(2011-2#4)(2012-12#1)(2012-3#1)(2012-5#2)
patients with type 2 diabetes?##2##5##(2010-12#1)(2012-5#1)
patients with type 2##14##4##(2008-3#1)(2009-1#1)(2010-10#2)(2010-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2012-5#3)
patients with type II diabetes##2##5##(1995-8#1)(1996-11#1)
patients with type##19##3##(1995-8#1)(1996-11#1)(2008-3#1)(2009-1#1)(2010-10#2)(2010-12#1)(2011-2#4)(2012-12#1)(2012-3#2)(2012-4#2)(2012-5#3)
patients with unilateral##3##3##(1996-2#1)(2008-12#1)(2008-9#1)
patients with unresectable##2##3##(2013-1#2)
patients with unstable angina pectoris##3##5##(1990-12#3)
patients with untreated##3##3##(2008-7#1)(2012-3#2)
patients with various##3##3##(1992-11#1)(1993-2#1)(2012-3#1)
patients with vascular disease##2##4##(1993-2#1)(2010-1#1)
patients with vascular##4##3##(1993-2#1)(2008-7#1)(2010-1#1)(2012-12#1)
patients with venous leg##2##4##(1997-3#2)
patients with visual loss due to##2##6##(2011-2#1)(2013-1#1)
patients with vivax malaria##3##4##(2012-12#2)(2012-2#1)
patients with##1689##2##(1990-10#1)(1990-11#6)(1990-12#16)(1990-2#24)(1990-3#11)(1990-5#1)(1990-6#10)(1990-8#6)(1990-9#18)(1991-1#2)(1991-11#9)(1991-12#12)(1991-2#14)(1991-3#8)(1991-5#3)(1991-6#16)(1991-7#1)(1991-8#14)(1991-9#1)(1992-1#3)(1992-11#11)(1992-12#15)(1992-2#4)(1992-3#10)(1992-5#13)(1992-6#6)(1992-8#1)(1992-9#6)(1993-1#11)(1993-11#15)(1993-12#2)(1993-2#19)(1993-3#5)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#5)(1994-12#22)(1994-2#3)(1994-3#5)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#6)(1995-11#4)(1995-12#11)(1995-2#8)(1995-3#4)(1995-5#3)(1995-8#3)(1996-1#4)(1996-10#1)(1996-11#12)(1996-12#2)(1996-2#7)(1996-3#5)(1996-5#1)(1996-6#4)(1996-8#2)(1996-9#6)(1997-1#10)(1997-2#5)(1997-3#16)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#8)(1997-8#41)(1997-9#1)(2006-6#1)(2007-11#10)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#26)(2008-10#63)(2008-11#43)(2008-12#53)(2008-2#3)(2008-3#23)(2008-4#4)(2008-5#20)(2008-6#4)(2008-7#108)(2008-8#19)(2008-9#29)(2009-1#7)(2009-10#14)(2009-11#7)(2009-12#12)(2009-3#9)(2009-4#5)(2009-5#2)(2009-6#6)(2009-7#6)(2009-8#30)(2009-9#3)(2010-1#8)(2010-10#17)(2010-11#18)(2010-12#39)(2010-3#5)(2010-4#7)(2010-5#3)(2010-6#6)(2010-7#8)(2010-8#6)(2010-9#1)(2011-1#14)(2011-2#200)(2011-3#4)(2011-7#1)(2012-12#47)(2012-2#37)(2012-3#80)(2012-4#2)(2012-5#3)(2013-1#126)(2013-7#1)(2013-8#26)
patients withdrew##2##2##(2007-11#1)(2008-3#1)
patients within##5##2##(1991-11#1)(2008-7#1)(2010-7#2)(2010-9#1)
patients without a##2##3##(1990-9#1)(1991-3#1)
patients without the##2##3##(2013-1#2)
patients without##35##2##(1990-11#1)(1990-3#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-5#1)(1992-6#1)(1994-11#1)(1995-12#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#3)(2009-10#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#6)(2013-3#1)
patients worldwide##2##2##(2011-2#1)(2012-2#1)
patients would##4##2##(1994-2#1)(1997-4#1)(2008-12#1)(2010-3#1)
patients##6266##1##(1990-10#2)(1990-11#28)(1990-12#53)(1990-2#78)(1990-3#44)(1990-4#1)(1990-5#15)(1990-6#44)(1990-8#27)(1990-9#63)(1991-1#20)(1991-11#38)(1991-12#39)(1991-2#76)(1991-3#63)(1991-4#4)(1991-5#5)(1991-6#44)(1991-7#6)(1991-8#50)(1991-9#12)(1992-1#16)(1992-11#11)(1992-12#56)(1992-2#26)(1992-3#47)(1992-4#1)(1992-5#29)(1992-6#10)(1992-8#1)(1992-9#32)(1993-1#57)(1993-11#46)(1993-12#32)(1993-2#52)(1993-3#30)(1993-5#1)(1993-6#17)(1993-8#8)(1993-9#3)(1994-1#12)(1994-11#10)(1994-12#79)(1994-2#21)(1994-3#42)(1994-5#15)(1994-6#15)(1994-8#9)(1994-9#16)(1995-1#8)(1995-10#14)(1995-11#25)(1995-12#56)(1995-2#45)(1995-3#13)(1995-5#17)(1995-6#3)(1995-8#5)(1995-9#2)(1996-1#22)(1996-10#2)(1996-11#43)(1996-12#5)(1996-2#31)(1996-3#46)(1996-5#2)(1996-6#29)(1996-8#5)(1996-9#27)(1997-1#21)(1997-2#28)(1997-3#53)(1997-4#31)(1997-5#15)(1997-6#11)(1997-7#27)(1997-8#154)(1997-9#3)(2006-6#5)(2007-11#25)(2007-12#11)(2007-7#1)(2007-8#31)(2007-9#4)(2008-1#125)(2008-10#245)(2008-11#225)(2008-12#116)(2008-2#8)(2008-3#56)(2008-4#29)(2008-5#93)(2008-6#28)(2008-7#431)(2008-8#78)(2008-9#82)(2009-1#16)(2009-10#34)(2009-11#25)(2009-12#31)(2009-2#3)(2009-3#29)(2009-4#12)(2009-5#11)(2009-6#16)(2009-7#12)(2009-8#64)(2009-9#11)(2010-1#21)(2010-10#46)(2010-11#39)(2010-12#104)(2010-2#14)(2010-3#24)(2010-4#27)(2010-5#22)(2010-6#20)(2010-7#44)(2010-8#37)(2010-9#6)(2011-1#45)(2011-2#727)(2011-3#21)(2011-7#6)(2011-9#1)(2012-12#113)(2012-2#107)(2012-3#280)(2012-4#8)(2012-5#12)(2013-1#426)(2013-3#2)(2013-7#6)(2013-8#102)
patients' ability to##2##3##(2008-12#1)(2010-4#1)
patients' age##3##2##(2010-2#1)(2012-2#1)(2013-8#1)
patients' clinical##2##2##(2008-4#1)(2012-12#1)
patients' complaints##2##2##(2008-7#1)(2009-1#1)
patients' current##3##2##(1994-3#1)(2008-11#1)(2008-5#1)
patients' experience##2##2##(2010-10#1)(2011-2#1)
patients' medical##2##2##(2008-11#1)(2008-7#1)
patients' perception of##3##3##(2008-11#1)(2013-1#2)
patients' performance status##2##3##(2010-2#2)
patients' problems##3##2##(1993-2#1)(2013-1#2)
patients' rights were##2##3##(2013-8#2)
patients' rights##9##2##(1997-8#1)(2013-8#8)
patients' satisfaction with##2##3##(1997-5#1)(2009-12#1)
patients'##116##1##(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-5#1)(1993-2#2)(1994-1#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#4)(2009-1#3)(2009-12#1)(2009-3#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-2#6)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#12)(2012-12#2)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#8)(2013-8#12)
patients(4##4##1##(1991-2#4)
patients) and the elderly##2##4##(2008-11#2)
patients) and##9##2##(1990-8#1)(1990-9#1)(1992-2#1)(2008-11#2)(2008-7#1)(2011-2#2)(2012-2#1)
patients) for tonsillitis##2##3##(2011-2#2)
patients) in the##3##3##(1990-8#1)(1990-9#1)(1997-5#1)
patients) or##3##2##(1997-4#1)(2008-7#1)(2009-12#1)
patients) were##3##2##(1990-12#1)(1992-2#1)(2008-9#1)
patients) with##2##2##(1990-12#1)(1997-3#1)
patients)##56##1##(1990-12#2)(1990-8#3)(1990-9#2)(1991-8#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#7)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#12)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
patients?##6##1##(1994-12#1)(1995-12#1)(2008-11#1)(2009-4#1)(2011-2#1)(2013-7#1)
patients?]##4##1##(1990-2#1)(1993-11#2)(1994-12#1)
patients]##37##1##(1991-11#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-11#3)(1996-3#2)(1997-2#2)(1997-8#3)(2008-10#1)(2008-12#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
patients`##2##1##(2013-1#2)
patientswith##2##1##(2009-8#2)
pations##2##1##(2012-3#2)
patrollers##3##1##(2008-8#3)
patrons##4##1##(1992-12#1)(1993-1#2)(2012-2#1)
pattern analysis of##5##3##(2008-10#5)
pattern analysis##6##2##(1994-12#1)(2008-10#5)
pattern and a##2##3##(2008-3#1)(2010-8#1)
pattern and the##2##3##(1992-3#1)(2008-4#1)
pattern and##24##2##(1991-8#1)(1992-2#1)(1992-3#3)(1993-9#1)(1994-12#2)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
pattern are##2##2##(1990-3#1)(2008-3#1)
pattern as the##3##3##(2008-10#2)(2010-1#1)
pattern as well as##2##4##(2008-10#1)(2008-7#1)
pattern as##10##2##(1994-2#1)(1997-7#1)(2008-10#5)(2008-7#1)(2008-9#1)(2010-1#1)
pattern at the##2##3##(1992-3#1)(2008-4#1)
pattern at##3##2##(1992-3#1)(2008-3#1)(2008-4#1)
pattern by age##2##3##(1992-2#1)(1997-3#1)
pattern completion##2##2##(2008-11#2)
pattern described##2##2##(1997-8#1)(2012-3#1)
pattern differences##2##2##(2012-7#1)(2013-1#1)
pattern during the##3##3##(1991-6#2)(2008-10#1)
pattern during##6##2##(1991-6#2)(2008-10#2)(2008-11#2)
pattern dynamics##2##2##(2007-12#1)(2008-11#1)
pattern evolution##2##2##(2008-9#2)
pattern for##6##2##(1991-9#1)(2007-12#1)(2008-10#3)(2008-9#1)
pattern formation in doubly resonant##2##5##(2007-12#2)
pattern formation in##4##3##(2007-12#2)(2008-6#1)(2009-8#1)
pattern formation##8##2##(1997-6#1)(2007-12#2)(2008-11#1)(2008-6#1)(2009-8#2)(2011-2#1)
pattern from##3##2##(1992-2#1)(1993-8#1)(2008-3#1)
pattern has been##3##3##(1990-9#1)(1996-12#1)(2007-12#1)
pattern in a##2##3##(2010-8#1)(2012-3#1)
pattern in all##2##3##(1993-3#1)(1994-8#1)
pattern in species richness##2##4##(2008-8#2)
pattern in the##5##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-12#1)
pattern in##25##2##(1993-3#1)(1994-8#1)(1997-3#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#7)(2009-12#1)(2010-12#1)(2010-8#2)(2012-2#2)(2012-3#2)
pattern is a##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
pattern is also##2##3##(1991-12#1)(2008-3#1)
pattern is##21##2##(1991-12#1)(1993-6#1)(1994-5#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
pattern may##2##2##(2008-10#1)(2009-8#1)
pattern obtained##2##2##(2008-10#2)
pattern occurs##2##2##(2008-3#1)(2008-8#1)
pattern of a##3##3##(1995-2#1)(1996-2#1)(2008-11#1)
pattern of accumulation##2##3##(2008-10#1)(2008-11#1)
pattern of age-related##2##3##(2008-8#1)(2010-8#1)
pattern of change##2##3##(2008-10#1)(2012-2#1)
pattern of changes##3##3##(2008-11#2)(2010-8#1)
pattern of connections##2##3##(1995-5#1)(1997-3#1)
pattern of distribution of##2##4##(1995-6#1)(2008-10#1)
pattern of distribution##7##3##(1995-6#1)(1996-3#1)(2008-10#5)
pattern of expression of##2##4##(1994-11#1)(1996-12#1)
pattern of expression##3##3##(1994-11#1)(1996-12#1)(2010-6#1)
pattern of findings##2##3##(2008-11#1)(2009-7#1)
pattern of gene expression##3##4##(1992-1#1)(2008-10#1)(2008-11#1)
pattern of growth##2##3##(2011-2#1)(2013-1#1)
pattern of inheritance##2##3##(2008-7#1)(2012-3#1)
pattern of injury##2##3##(2012-3#1)(2013-8#1)
pattern of loss##2##3##(2008-8#2)
pattern of presentation##2##3##(1991-8#1)(2010-12#1)
pattern of responding##2##3##(2008-5#2)
pattern of response to##2##4##(2008-10#1)(2008-4#1)
pattern of response##3##3##(1990-6#1)(2008-10#1)(2008-4#1)
pattern of spread##2##3##(2008-7#1)(2011-2#1)
pattern of the NR2C##2##4##(1996-12#2)
pattern of the##28##3##(1990-12#1)(1990-3#1)(1994-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-1#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2012-3#1)(2013-1#2)
pattern of their##2##3##(2008-10#1)(2008-11#1)
pattern of these##2##3##(2007-12#1)(2008-5#1)
pattern of two##3##3##(2007-12#1)(2008-11#1)(2008-12#1)
pattern of##260##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#5)(1995-8#2)(1996-12#4)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#2)(1997-8#2)(2007-12#8)(2008-10#54)(2008-11#19)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#13)(2008-8#18)(2008-9#7)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-6#3)(2010-8#5)(2011-1#2)(2011-2#8)(2012-2#7)(2012-3#8)(2012-8#1)(2013-1#8)(2013-8#2)
pattern on the##2##3##(2008-5#1)(2011-2#1)
pattern on##5##2##(1991-11#1)(1992-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
pattern over##2##2##(2008-10#1)(2013-8#1)
pattern recognition (PR)##2##3##(2008-10#2)
pattern recognition of##3##3##(2008-10#2)(2008-3#1)
pattern recognition procedures##3##3##(2008-10#3)
pattern recognition receptors##3##3##(2009-8#2)(2010-8#1)
pattern recognition techniques##4##3##(2008-10#4)
pattern recognition##28##2##(2007-12#1)(2008-10#16)(2008-11#1)(2008-3#2)(2009-8#2)(2010-7#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-8#2)
pattern separation##2##2##(2008-11#1)(2013-8#1)
pattern shows##2##2##(2008-10#2)
pattern similar to that##2##4##(2008-10#2)
pattern similar to##5##3##(1996-12#1)(2008-10#3)(2010-9#1)
pattern that was##2##3##(2008-10#2)
pattern that##8##2##(1994-5#1)(2008-1#1)(2008-10#4)(2008-9#1)(2009-8#1)
pattern to##9##2##(1990-10#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)
pattern was found##2##3##(2008-11#2)
pattern was observed in##2##4##(1994-6#1)(1996-5#1)
pattern was observed##7##3##(1994-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2010-8#1)
pattern was##20##2##(1990-11#1)(1993-6#1)(1994-6#1)(1996-5#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-1#1)
pattern with a##2##3##(2008-10#2)
pattern with the##2##3##(2008-9#1)(2013-1#1)
pattern with##12##2##(2008-10#8)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
pattern##692##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#6)(1992-5#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#5)(1995-8#3)(1996-12#7)(1996-2#6)(1996-3#4)(1996-5#3)(1997-1#1)(1997-2#3)(1997-3#6)(1997-6#2)(1997-7#4)(1997-8#6)(2007-12#17)(2008-1#4)(2008-10#168)(2008-11#52)(2008-12#8)(2008-2#3)(2008-3#24)(2008-4#4)(2008-5#15)(2008-6#8)(2008-7#27)(2008-8#40)(2008-9#23)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#12)(2009-9#1)(2010-1#4)(2010-11#6)(2010-12#7)(2010-2#1)(2010-4#1)(2010-6#5)(2010-7#2)(2010-8#10)(2010-9#2)(2011-1#4)(2011-2#27)(2011-3#1)(2012-12#1)(2012-2#15)(2012-3#13)(2012-7#1)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#11)
pattern)##5##1##(2008-10#3)(2008-11#1)(2008-8#1)
pattern-recognition techniques##2##2##(2007-12#1)(2008-10#1)
pattern-recognition##3##1##(2007-12#1)(2008-10#1)(2008-3#1)
patterned with##2##2##(1994-9#1)(2008-7#1)
patterned##8##1##(1994-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#2)(2009-8#1)
patterning of somites##2##3##(1994-12#2)
patterning of the##2##3##(1994-9#1)(2009-3#1)
patterning of##10##2##(1994-12#2)(1994-9#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)
patterning##22##1##(1993-12#1)(1994-12#2)(1994-9#2)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#2)(2009-3#1)(2009-8#3)(2011-2#1)
patterns (loss and gain) at AD and PD##2##8##(2011-2#2)
patterns across##2##2##(2008-10#1)(2008-8#1)
patterns among the##2##3##(2008-10#1)(2008-8#1)
patterns among##4##2##(2008-10#2)(2008-8#1)(2012-2#1)
patterns and that##2##3##(2008-12#1)(2012-2#1)
patterns and the##3##3##(1991-2#1)(1992-2#1)(2008-10#1)
patterns and##26##2##(1991-2#1)(1992-2#1)(1992-3#1)(1993-2#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-5#1)
patterns are the##2##3##(2008-11#1)(2008-9#1)
patterns are##12##2##(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
patterns as##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)
patterns at the##2##3##(2008-10#2)
patterns at##7##2##(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
patterns based##2##2##(1995-6#1)(2008-10#1)
patterns because##2##2##(2008-9#1)(2010-4#1)
patterns between##5##2##(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)
patterns by##2##2##(1990-2#1)(2008-11#1)
patterns can be##5##3##(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)
patterns can##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)
patterns change##2##2##(1994-12#1)(2008-8#1)
patterns could##3##2##(1990-8#1)(2008-8#2)
patterns during##5##2##(2008-10#2)(2009-10#1)(2009-8#1)(2013-1#1)
patterns for the##3##3##(2008-10#2)(2013-8#1)
patterns for##17##2##(1991-12#1)(1993-1#1)(1995-3#1)(2008-10#7)(2008-12#1)(2008-5#1)(2009-8#1)(2009-9#1)(2012-2#2)(2013-8#1)
patterns from the##2##3##(2008-10#1)(2008-11#1)
patterns from##7##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
patterns in a##2##3##(2012-3#1)(2013-1#1)
patterns in all##2##3##(1995-3#1)(2008-10#1)
patterns in response to##2##4##(2008-10#1)(2008-11#1)
patterns in the data##2##4##(2008-5#1)(2011-2#1)
patterns in the##14##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)
patterns in##54##2##(1991-3#1)(1994-2#1)(1994-6#2)(1995-3#1)(1996-2#1)(1997-7#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#3)(2009-6#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
patterns indicated##3##2##(2008-10#2)(2009-10#1)
patterns is##5##2##(1995-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
patterns may be##3##3##(1990-3#1)(1995-3#1)(2008-10#1)
patterns observed in##2##3##(2008-10#1)(2008-11#1)
patterns observed##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
patterns of DNA##3##3##(2008-10#1)(2009-4#1)(2010-4#1)
patterns of H##2##3##(2008-10#2)
patterns of a##2##3##(2008-7#1)(2010-1#1)
patterns of activity##3##3##(1990-5#1)(2008-8#1)(2009-8#1)
patterns of among-island variation in species richness##2##7##(2008-8#2)
patterns of care##3##3##(1991-2#1)(1994-3#1)(2012-3#1)
patterns of disease##6##3##(2008-10#5)(2013-1#1)
patterns of distribution that##2##4##(2009-10#1)(2012-2#1)
patterns of distribution##4##3##(1996-12#1)(2008-5#1)(2009-10#1)(2012-2#1)
patterns of diversity and##2##4##(2012-3#2)
patterns of diversity##3##3##(2008-8#1)(2012-3#2)
patterns of expression##4##3##(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)
patterns of gene expression##2##4##(2008-7#1)(2008-8#1)
patterns of genetic##2##3##(2008-10#1)(2008-9#1)
patterns of noise##2##3##(2008-3#2)
patterns of patch occupancy##4##4##(2008-8#3)(2008-9#1)
patterns of paternity##2##3##(2007-12#1)(2008-9#1)
patterns of primary##2##3##(2008-10#1)(2011-2#1)
patterns of resistance##2##3##(2008-10#1)(2013-8#1)
patterns of selection##2##3##(2008-8#1)(2012-3#1)
patterns of service##2##3##(1994-2#1)(1996-3#1)
patterns of skew##2##3##(2008-8#2)
patterns of some##2##3##(2008-10#1)(2008-11#1)
patterns of sperm##2##3##(2007-12#1)(2008-8#1)
patterns of spore deposition were##2##5##(2008-10#2)
patterns of the##14##3##(1993-12#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-7#1)(2013-1#1)
patterns of use of##2##4##(2008-11#1)(2013-1#1)
patterns of use##3##3##(2008-11#2)(2013-1#1)
patterns of variation in##2##4##(2009-8#1)(2013-1#1)
patterns of variation##4##3##(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
patterns of##238##2##(1990-5#2)(1991-1#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#3)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-5#3)(1996-1#2)(1996-12#6)(1996-3#1)(1997-2#2)(1997-5#1)(1997-7#1)(2007-12#2)(2008-1#3)(2008-10#60)(2008-11#18)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#6)(2008-8#25)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#5)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#4)(2011-3#1)(2012-2#11)(2012-3#7)(2013-1#9)(2013-8#7)
patterns on the##2##3##(1995-12#1)(2008-3#1)
patterns on##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
patterns or##2##2##(2011-2#1)(2013-1#1)
patterns produced by the##2##4##(2008-10#2)
patterns produced##3##2##(2008-10#2)(2008-9#1)
patterns recurrence plots##2##3##(2008-11#2)
patterns should be##2##3##(2008-12#1)(2008-9#1)
patterns such as##5##3##(1997-1#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#1)
patterns suggested that##5##3##(2008-10#4)(2008-7#1)
patterns surrounding the translation initiation sites##2##6##(1997-2#2)
patterns surrounding##3##2##(1997-2#3)
patterns that were##3##3##(2008-10#2)(2008-11#1)
patterns that##13##2##(1996-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#3)(2009-9#1)(2012-2#1)
patterns through##2##2##(2008-10#1)(2008-8#1)
patterns to those##2##3##(2008-8#1)(2010-4#1)
patterns to##7##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)(2012-3#1)
patterns was performed##2##3##(2008-10#1)(2008-12#1)
patterns was##5##2##(1997-3#1)(2008-10#1)(2008-12#2)(2008-8#1)
patterns were analyzed##2##3##(2008-10#1)(2008-11#1)
patterns were consistent##3##3##(1990-6#1)(2008-10#1)(2010-8#1)
patterns were found##2##3##(2008-10#1)(2008-5#1)
patterns were identified##3##3##(1991-1#1)(2008-10#2)
patterns were noted##2##3##(2008-10#1)(2010-8#1)
patterns were obtained##2##3##(2007-12#1)(2008-10#1)
patterns were produced##2##3##(2008-10#1)(2008-8#1)
patterns were studied##2##3##(2008-10#1)(2008-11#1)
patterns were##44##2##(1990-6#1)(1991-1#1)(1991-8#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-6#1)(1997-3#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
patterns when##3##2##(1993-12#1)(2008-5#1)(2008-8#1)
patterns which##2##2##(2008-10#1)(2008-11#1)
patterns with##5##2##(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
patterns within the##2##3##(2008-11#1)(2013-8#1)
patterns within##5##2##(1992-9#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
patterns##739##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#3)(1991-1#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#3)(1993-12#8)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-12#7)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#8)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#4)(1997-5#1)(1997-7#3)(1997-8#3)(2007-12#5)(2008-1#3)(2008-10#184)(2008-11#48)(2008-12#16)(2008-2#8)(2008-3#29)(2008-4#5)(2008-5#15)(2008-6#9)(2008-7#19)(2008-8#66)(2008-9#20)(2009-10#5)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#5)(2009-8#11)(2009-9#4)(2010-1#4)(2010-10#2)(2010-12#4)(2010-2#3)(2010-4#5)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#26)(2011-3#1)(2012-12#2)(2012-2#25)(2012-3#17)(2012-5#1)(2012-7#1)(2013-1#22)(2013-8#12)
patties increased##2##2##(2010-4#2)
patties were##3##2##(2010-4#3)
patties##12##1##(2010-4#12)
patuletin##2##1##(2008-11#2)
patulin accumulation in##2##3##(2008-10#2)
patulin accumulation##3##2##(2008-10#3)
patulin and##5##2##(2008-10#2)(2010-3#2)(2010-7#1)
patulin##10##1##(2008-10#7)(2010-3#2)(2010-7#1)
paucity of data##2##3##(2008-10#1)(2013-1#1)
paucity of published data##2##4##(1995-1#1)(2013-1#1)
paucity of##20##2##(1991-8#1)(1995-1#1)(1997-2#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
pause##4##1##(2008-10#1)(2009-10#1)(2011-2#2)
pauvreté##4##1##(2008-11#4)
paves the way for##2##4##(2008-9#1)(2009-8#1)
pavonina##3##1##(2008-11#3)
paw preference test##2##3##(1994-8#1)(1997-2#1)
paw preference##3##2##(1994-8#2)(1997-2#1)
paw##5##1##(1994-8#2)(1997-2#1)(2008-10#2)
paw-licking##2##1##(1992-3#2)
paws##2##1##(1997-2#1)(2008-9#1)
pay $120##2##2##(1995-6#2)
pay a##2##2##(1997-1#1)(2008-9#1)
pay attention to##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
pay dividends##2##2##(1993-2#1)(1994-2#1)
pay for##8##2##(1991-9#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#1)
pay hospitals for what they##2##5##(1992-12#2)
pay hospitals##3##2##(1992-12#2)(1995-2#1)
pay more attention to##2##4##(2010-1#1)(2010-4#1)
pay more##3##2##(1994-1#1)(2010-1#1)(2010-4#1)
pay##50##1##(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#4)(1995-1#2)(1995-12#4)(1995-2#3)(1995-6#3)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#3)(1997-2#2)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#2)(2009-4#1)(2010-1#1)(2010-4#2)(2013-1#2)
payer##5##1##(1992-11#1)(1993-1#1)(1994-12#1)(1996-1#1)(2013-8#1)
payers use##2##2##(1994-12#2)
payers##15##1##(1991-3#1)(1994-1#1)(1994-12#8)(1995-1#1)(1995-2#1)(1995-3#1)(1997-6#2)
paying attention to##3##3##(1995-5#1)(1996-8#1)(2008-10#1)
paying for##2##2##(1992-12#1)(2008-4#1)
paying particular attention to##2##4##(1990-9#1)(2008-9#1)
paying##10##1##(1990-9#1)(1992-12#2)(1992-2#1)(1995-5#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#1)
payment and cost##2##3##(1992-12#1)(1994-1#1)
payment as##2##2##(1992-12#1)(1994-1#1)
payment for##8##2##(1992-1#1)(1992-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-1#1)(2008-11#1)
payment formula##2##2##(1997-1#1)(1997-2#1)
payment methods##3##2##(1994-1#1)(1994-12#1)(1995-2#1)
payment model##3##2##(1993-12#2)(1994-3#1)
payment policies and##2##3##(1997-1#1)(1997-2#1)
payment policies##4##2##(1993-3#1)(1994-12#1)(1997-1#1)(1997-2#1)
payment policy##5##2##(1991-12#1)(1994-1#2)(1995-1#2)
payment rate##2##2##(1991-1#1)(1994-12#1)
payment rates##7##2##(1991-1#2)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-3#1)
payment reform##10##2##(1991-2#1)(1994-1#4)(1995-12#3)(1997-1#1)(2013-1#1)
payment reforms in##2##3##(1997-1#2)
payment reforms##5##2##(1995-12#1)(1997-1#4)
payment system and##2##3##(1991-3#1)(1993-3#1)
payment system for##7##3##(1991-1#2)(1991-3#2)(1992-1#1)(1992-2#2)
payment system that##2##3##(1993-3#1)(1995-2#1)
payment system##50##2##(1991-1#4)(1991-12#1)(1991-2#3)(1991-3#5)(1992-1#4)(1992-12#8)(1992-2#7)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#4)(1994-12#3)(1994-3#2)(1995-2#1)(1996-3#1)(1997-1#1)(2008-11#1)
payment systems##6##2##(1991-1#1)(1993-12#2)(1994-12#2)(1996-2#1)
payment to health maintenance organizations##2##5##(1993-1#1)(1993-3#1)
payment to##5##2##(1992-1#1)(1992-2#1)(1993-1#1)(1993-3#2)
payment under##2##2##(1991-2#1)(1995-2#1)
payment##176##1##(1991-1#14)(1991-12#4)(1991-2#8)(1991-3#9)(1992-1#10)(1992-12#17)(1992-2#15)(1993-1#7)(1993-12#7)(1993-2#1)(1993-3#10)(1994-1#12)(1994-12#15)(1994-2#1)(1994-3#4)(1995-1#3)(1995-12#4)(1995-2#6)(1995-3#2)(1996-2#2)(1996-3#3)(1997-1#10)(1997-2#4)(1997-5#1)(2008-11#5)(2011-1#1)(2013-1#1)
payments and##3##2##(1992-12#1)(1995-1#1)(1997-2#1)
payments for##7##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1994-12#1)(1997-1#1)
payments to health##3##3##(1991-1#2)(1997-1#1)
payments to the##2##3##(1992-12#1)(1994-12#1)
payments to##8##2##(1991-1#2)(1992-12#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-1#1)
payments##52##1##(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#3)(1992-1#1)(1992-12#8)(1992-2#5)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#3)(1994-1#2)(1994-12#2)(1994-2#2)(1995-1#3)(1995-2#3)(1997-1#5)(1997-2#2)(2013-8#1)
payoff##4##1##(1992-2#1)(2008-8#2)(2008-9#1)
payoffs##3##1##(2008-8#3)
payor net cost savings from a##2##6##(2008-11#2)
payor##6##1##(1992-1#2)(1994-1#1)(2008-11#3)
payors##10##1##(1991-1#1)(1994-1#6)(2008-11#2)(2012-2#1)
pays##4##1##(1992-12#1)(1993-3#1)(2009-11#1)(2013-1#1)
pcDNA3##4##1##(2008-8#4)
pcDNA3-TPO##2##1##(2008-8#2)
pcXII##2##1##(2008-10#2)
pcbC##2##1##(2011-1#2)
pePOA##7##1##(1992-3#7)
pea (Pisum sativum)##3##3##(2008-1#1)(2008-10#2)
pea DRR206##2##2##(2008-10#2)
pea and lentil##2##3##(1993-8#1)(2008-10#1)
pea and##4##2##(1993-8#1)(2008-10#3)
pea cultivars##6##2##(2008-10#6)
pea fields in##2##3##(2008-10#2)
pea is##2##2##(2008-10#1)(2009-8#1)
pea lectin and##2##3##(1993-8#2)
pea lectin##4##2##(1993-8#4)
pea lines##4##2##(2008-10#4)
pea production##2##2##(2008-10#2)
pea roots##3##2##(2008-10#3)
pea seeds##2##2##(2008-10#1)(2011-2#1)
pea##67##1##(1993-8#5)(2008-1#1)(2008-10#50)(2008-7#1)(2008-8#2)(2009-8#2)(2011-2#6)
pea-size##2##1##(2008-10#2)
peach fruit##5##2##(2008-10#5)
peach leaves##2##2##(2008-10#2)
peach orchard##2##2##(2008-10#2)
peach orchards##3##2##(2008-10#3)
peach seedlings##4##2##(2008-10#4)
peach tree susceptibility to bacterial canker infection##2##7##(2008-10#2)
peach tree##3##2##(2008-10#3)
peach trees##2##2##(2008-10#2)
peach was##2##2##(2008-10#2)
peach##50##1##(2008-10#50)
peak 2##2##2##(2008-10#2)
peak BMD and age at peak BMD##2##7##(2010-3#2)
peak BMD##7##2##(2010-3#7)
peak activation occurred between##2##4##(1997-3#2)
peak activation##3##2##(1995-2#1)(1997-3#2)
peak and the##3##3##(1995-3#1)(2008-10#2)
peak and##10##2##(1995-3#1)(1996-2#1)(2008-10#8)
peak appeared at##2##3##(1995-8#1)(1997-2#1)
peak appeared##4##2##(1995-8#1)(1997-2#1)(2008-10#2)
peak appears##2##2##(2008-10#2)
peak area and peak height##4##5##(2008-10#4)
peak area and##5##3##(2008-10#5)
peak area of the##2##4##(2008-10#2)
peak area of##6##3##(2008-10#6)
peak area was##2##3##(2008-10#2)
peak area##30##2##(2008-10#30)
peak areas of##2##3##(2008-10#2)
peak areas were##2##3##(2008-10#2)
peak areas##9##2##(2008-10#9)
peak around 1##2##3##(2008-10#2)
peak around##4##2##(2008-10#4)
peak as##2##2##(1992-12#1)(2008-10#1)
peak at -0##6##3##(1990-5#1)(2008-10#4)(2008-8#1)
peak at -1##3##3##(2008-10#3)
peak at 329##2##3##(1992-10#2)
peak at about##4##3##(2008-10#4)
peak at around##2##3##(2008-10#1)(2008-5#1)
peak at the##4##3##(1990-5#1)(2008-10#3)
peak at##41##2##(1990-5#2)(1992-10#3)(1997-3#1)(2008-10#30)(2008-11#1)(2008-5#1)(2008-8#2)(2013-8#1)
peak bone mass##2##3##(2010-3#2)
peak bone mineral density##2##4##(2010-3#2)
peak bone##4##2##(2010-3#4)
peak concentration##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
peak corresponding to##3##3##(2008-10#3)
peak current and molybdenum concentration is linear##2##7##(2008-10#2)
peak current and the concentration##2##5##(2008-10#2)
peak current and##6##3##(2008-10#6)
peak current for##3##3##(2008-10#3)
peak current had##2##3##(2008-10#2)
peak current increased##2##3##(2008-10#2)
peak current is found to be linear##2##7##(2008-10#2)
peak current is proportional to DNA concentration##2##7##(2008-10#2)
peak current is proportional to the concentration of##3##8##(2008-10#3)
peak current is proportional to##5##5##(2008-10#5)
peak current is##9##3##(2008-10#9)
peak current of ARS##2##4##(2008-10#2)
peak current of the##3##4##(2008-10#3)
peak current of##12##3##(2008-10#12)
peak current response##2##3##(2008-10#2)
peak current was linear to##2##5##(2008-10#2)
peak current was##5##3##(2008-10#5)
peak current with##2##3##(2008-10#2)
peak current##64##2##(2008-10#63)(2010-6#1)
peak currents and##3##3##(2008-10#3)
peak currents of##3##3##(2008-10#3)
peak currents were found to be##2##6##(2008-10#2)
peak currents were##4##3##(2008-10#4)
peak currents##23##2##(2008-10#23)
peak during##2##2##(1991-5#1)(2008-11#1)
peak experience##4##2##(2013-8#4)
peak experiences of psilocybin users and non-users##2##7##(2013-8#2)
peak experiences of psilocybin users##3##5##(2013-8#3)
peak experiences##8##2##(2013-8#8)
peak expiratory flow##2##3##(1996-1#1)(2008-1#1)
peak flow##3##2##(1990-9#1)(1996-2#1)(2008-10#1)
peak from##2##2##(1993-8#1)(2008-11#1)
peak glucose##2##2##(1994-12#1)(2010-8#1)
peak heart rate##2##3##(2008-7#1)(2013-1#1)
peak height absorbance##2##3##(2008-10#2)
peak height and concentration##2##4##(2008-10#2)
peak height and##9##3##(2008-10#9)
peak height by##3##3##(2008-10#3)
peak height of##3##3##(2008-10#3)
peak height values##2##3##(2008-10#2)
peak height was##3##3##(2008-10#3)
peak height##41##2##(1993-8#1)(2008-10#40)
peak heights##11##2##(2008-10#10)(2008-2#1)
peak hip##2##2##(2011-2#2)
peak identification##2##2##(2008-10#2)
peak in the##7##3##(1990-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)
peak in##17##2##(1990-5#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#2)(2012-3#1)
peak inspiratory flow##2##3##(1992-3#1)(2012-2#1)
peak inspiratory##3##2##(1992-3#1)(1994-2#1)(2012-2#1)
peak intensities##2##2##(2008-10#2)
peak intensity##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2010-10#1)
peak is##4##2##(2008-10#4)
peak level##2##2##(1996-12#2)
peak of the##7##3##(1990-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
peak of##30##2##(1990-11#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-12#2)(2008-10#15)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
peak plasma concentration of##2##4##(1990-6#1)(1993-1#1)
peak plasma##3##2##(1990-6#1)(1993-1#1)(2013-8#1)
peak position at maximum height##3##5##(2008-10#3)
peak position##6##2##(2008-10#6)
peak potential is##3##3##(2008-10#3)
peak potential of##5##3##(2008-10#5)
peak potential shifted##2##3##(2008-10#2)
peak potential##21##2##(2008-10#21)
peak potentials##5##2##(2008-10#5)
peak power and pulse width##2##5##(2008-3#2)
peak power and pulse##3##4##(2008-3#3)
peak power and##5##3##(2008-3#5)
peak power##11##2##(2007-11#1)(2008-2#1)(2008-3#8)(2008-9#1)
peak rate##2##2##(2008-11#1)(2008-9#1)
peak separation##2##2##(2008-10#2)
peak shape##3##2##(2008-10#3)
peak shaped##2##2##(2008-10#2)
peak shifts##2##2##(2008-10#2)
peak signal##2##2##(2008-10#2)
peak systolic velocity##2##3##(2011-2#1)(2013-8#1)
peak that##3##2##(1996-12#1)(1997-3#1)(2008-3#1)
peak to peak acceleration of##2##5##(2008-11#2)
peak to##5##2##(2008-10#2)(2008-11#2)(2008-8#1)
peak value##2##2##(2008-10#1)(2008-3#1)
peak values for##2##3##(1990-3#1)(2008-10#1)
peak values##4##2##(1990-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
peak was observed at##3##4##(2008-10#3)
peak was observed##6##3##(1992-10#1)(2008-10#5)
peak was obtained in##2##4##(2008-10#2)
peak was obtained##4##3##(2008-10#4)
peak was##20##2##(1992-10#1)(1997-2#1)(2008-10#17)(2011-2#1)
peak width##3##2##(2008-10#3)
peak with##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
peak##591##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#5)(1990-6#1)(1990-9#1)(1991-5#1)(1992-10#5)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#7)(1996-2#2)(1997-2#2)(1997-3#4)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#398)(2008-11#21)(2008-2#8)(2008-3#21)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#7)(2009-12#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#12)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#18)
peak)##2##1##(2008-10#2)
peak-shape##3##1##(2008-10#3)
peak-to-peak resolution##4##2##(2008-10#4)
peaked approximately##2##2##(2008-10#2)
peaked at##6##2##(1993-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-8#1)(2011-1#1)
peaked in##3##2##(1992-6#1)(1995-2#1)(1996-11#1)
peaked##23##1##(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#2)(1995-2#1)(1996-11#1)(2008-10#7)(2008-11#2)(2008-8#3)(2009-6#1)(2009-8#1)(2011-1#1)(2013-1#1)
peaking##4##1##(1992-9#1)(1993-11#1)(1996-12#1)(2008-11#1)
peaks and##6##2##(1997-2#1)(2008-10#5)
peaks appeared on the##2##4##(2008-10#2)
peaks are observed##2##3##(2008-10#1)(2009-5#1)
peaks are separated##2##3##(2008-10#2)
peaks are##5##2##(2008-10#4)(2009-5#1)
peaks at##8##2##(2008-10#7)(2011-1#1)
peaks can##2##2##(2008-10#2)
peaks corresponding to the##2##4##(2008-10#2)
peaks corresponding to##8##3##(2008-10#8)
peaks due to the##2##4##(2008-10#2)
peaks for##8##2##(2008-10#8)
peaks from##3##2##(1990-12#1)(1995-3#1)(2008-10#1)
peaks in a##2##3##(1997-2#1)(2008-10#1)
peaks in the##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
peaks in##11##2##(1997-2#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
peaks obtained##2##2##(2008-10#2)
peaks of dopamine##2##3##(2008-10#2)
peaks of the##8##3##(2007-11#1)(2008-10#6)(2013-1#1)
peaks of##27##2##(1990-5#1)(1993-6#1)(2007-11#1)(2008-10#21)(2008-8#1)(2008-9#1)(2013-1#1)
peaks on##3##2##(2008-10#2)(2008-8#1)
peaks showed##2##2##(2008-10#2)
peaks that##5##2##(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)
peaks the##2##2##(2008-10#2)
peaks were also observed##2##4##(2008-10#1)(2008-9#1)
peaks were also##4##3##(2008-10#3)(2008-9#1)
peaks were observed for##2##4##(2008-10#2)
peaks were observed##3##3##(2008-10#2)(2008-9#1)
peaks were obtained##2##3##(2008-10#2)
peaks were##23##2##(1992-12#1)(2008-10#17)(2008-11#1)(2008-9#4)
peaks with##5##2##(2008-10#4)(2008-9#1)
peaks##197##1##(1990-12#1)(1990-5#3)(1990-9#1)(1992-12#2)(1993-6#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#8)(2007-11#2)(2008-10#147)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#6)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
peaks)##4##1##(1990-5#1)(2008-10#3)
peanut agglutinin##2##2##(1994-8#2)
peanut allergen Ara h1##2##4##(2008-11#2)
peanut allergen##3##2##(2008-10#1)(2008-11#2)
peanut peroxidase##2##2##(2008-10#2)
peanut stunt virus (PSV)##2##4##(2008-10#2)
peanut##30##1##(1994-8#2)(2008-10#26)(2008-11#2)
peanuts##3##1##(1990-6#1)(1994-3#1)(2008-10#1)
pear and apple trees##3##4##(2008-10#3)
pear and apple##7##3##(2008-10#7)
pear and##9##2##(2008-10#9)
pear blossoms##5##2##(2008-10#5)
pear cultivars and##2##3##(2008-10#2)
pear cultivars##4##2##(2008-10#4)
pear in##2##2##(2008-10#2)
pear juice##3##2##(2008-10#3)
pear leaves and##2##3##(2008-10#2)
pear leaves##3##2##(2008-10#3)
pear or apple##2##3##(2008-10#2)
pear orchards##4##2##(2008-10#4)
pear psylla##7##2##(2008-10#7)
pear scab##3##2##(2008-10#3)
pear trees with##2##3##(2008-10#2)
pear trees##4##2##(2008-10#4)
pear##76##1##(2008-10#76)
pear)##2##1##(2008-10#2)
pearl millet##3##2##(2008-10#3)
pears stored##2##2##(2008-10#2)
pears was##2##2##(2008-10#2)
pears##8##1##(2008-10#8)
peas##3##1##(2008-10#3)
peat and##2##2##(2008-10#2)
peat mix##10##2##(2008-10#10)
peat moss alone##2##3##(2008-10#2)
peat moss##5##2##(2008-10#5)
peat was##3##2##(2008-10#3)
peat##37##1##(2008-10#35)(2008-8#2)
peat-bound metal species##2##3##(2008-10#2)
peat-bound##3##1##(2008-10#3)
peatlands##7##1##(2008-8#4)(2008-9#3)
pecan##3##1##(2008-10#3)
pecking behavior of##2##3##(2008-6#2)
pecking behavior##3##2##(2008-6#3)
pecking##6##1##(2008-6#6)
pecks (habituation)##2##2##(2008-6#2)
pecks##5##1##(2008-6#5)
pectate lyase##5##2##(1997-7#1)(2008-10#4)
pectate##7##1##(1997-7#1)(2008-10#6)
pectic##2##1##(2008-10#2)
pectin and##3##2##(2008-10#3)
pectin##25##1##(1990-9#2)(1991-9#2)(2008-10#16)(2011-10#1)(2011-2#4)
pectinesterase##2##1##(1997-2#2)
pectins##5##1##(2008-10#2)(2011-2#2)(2013-1#1)
pectolytic activity##2##2##(2008-10#2)
pectolytic enzymes##4##2##(1997-2#3)(2008-10#1)
pectolytic##9##1##(1997-2#4)(2008-10#5)
pectoral nerve##3##2##(2013-1#3)
pectoral##5##1##(2008-11#1)(2009-7#1)(2013-1#3)
pectoralis major##4##2##(1992-9#1)(2009-1#1)(2010-9#1)(2013-1#1)
pectoralis minor muscle##2##3##(2010-9#1)(2013-1#1)
pectoralis minor##9##2##(2010-9#4)(2013-1#5)
pectoralis##13##1##(1992-9#1)(2009-1#1)(2010-9#5)(2013-1#6)
peculiar features##2##2##(2008-7#1)(2011-2#1)
peculiar pattern##2##2##(2008-10#1)(2012-2#1)
peculiar to##2##2##(2008-2#1)(2008-9#1)
peculiar##19##1##(1990-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-2#1)
peculiarities of the##3##3##(1992-11#1)(2008-10#1)(2008-3#1)
peculiarities of##7##2##(1992-11#1)(2008-10#3)(2008-3#1)(2012-2#1)(2012-3#1)
peculiarities##10##1##(1990-9#1)(1992-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
peculiarity of##3##2##(1990-11#1)(2010-1#1)(2011-2#1)
pedagogic##2##1##(1991-6#1)(2011-2#1)
pedagogical##10##1##(2008-11#2)(2008-12#1)(2009-8#1)(2011-2#3)(2012-3#2)(2013-8#1)
pedagogy##2##1##(2012-3#1)(2013-8#1)
pedal bypass##2##2##(2011-3#2)
pedal edema##4##2##(2010-2#4)
pedal##11##1##(1997-8#3)(2010-2#4)(2011-3#4)
pedaling technique##2##2##(2011-2#2)
pedestrian##3##1##(2011-2#3)
pedestrians##4##1##(2011-2#4)
pediatric abdominal surgical##3##3##(2011-2#3)
pediatric acute lymphoblastic leukemia##2##4##(2008-11#1)(2008-9#1)
pediatric acute##3##2##(2008-11#1)(2008-9#1)(2010-2#1)
pediatric age##2##2##(1992-5#1)(2013-1#1)
pediatric airway##2##2##(2013-8#2)
pediatric and adult patients##2##4##(2011-2#1)(2012-3#1)
pediatric and##3##2##(2011-1#1)(2011-2#1)(2012-3#1)
pediatric asthma##3##2##(2010-5#1)(2010-8#1)(2011-1#1)
pediatric care##6##2##(1992-3#1)(1996-1#1)(1996-12#1)(2010-9#2)(2013-1#1)
pediatric hip fibromatosis with severe joint destruction##2##7##(2011-2#2)
pediatric hospitals and general hospitals##2##5##(1994-1#2)
pediatric hospitals##4##2##(1994-1#3)(2008-11#1)
pediatric intensive care##3##3##(2011-2#1)(2012-2#2)
pediatric medical settings##2##3##(2009-6#2)
pediatric medical##4##2##(1994-3#1)(2009-6#2)(2010-6#1)
pediatric nurse practitioners##3##3##(2009-9#2)(2010-10#1)
pediatric nurse##5##2##(2009-9#3)(2010-10#2)
pediatric nurses##4##2##(2011-1#4)
pediatric nurses'##3##2##(2011-1#3)
pediatric nursing##2##2##(1994-1#1)(2010-9#1)
pediatric oncology##2##2##(2010-7#1)(2012-2#1)
pediatric pain##2##2##(1994-1#2)
pediatric patient with##2##3##(2011-2#2)
pediatric patient##7##2##(1994-1#2)(2008-10#1)(2009-8#1)(2011-2#3)
pediatric patients with##5##3##(2010-11#2)(2011-2#2)(2013-8#1)
pediatric patients##10##2##(1993-12#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-11#2)(2011-2#3)(2013-8#1)
pediatric population##2##2##(1995-11#1)(2011-2#1)
pediatric renal##4##2##(1991-2#1)(2008-10#3)
pediatric trials##2##2##(2008-11#1)(2010-5#1)
pediatric urologic##2##2##(2008-10#2)
pediatric##149##1##(1990-5#1)(1991-11#2)(1991-2#1)(1991-3#1)(1992-2#3)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#10)(1994-3#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#2)(1997-8#1)(2008-10#13)(2008-11#4)(2008-9#1)(2009-10#1)(2009-12#3)(2009-6#2)(2009-8#1)(2009-9#6)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#12)(2011-2#27)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#9)(2013-8#3)
pediatricians##5##1##(1995-12#1)(1995-5#1)(2009-9#1)(2010-8#1)(2013-1#1)
pediatrics##10##1##(1991-3#1)(1994-12#1)(1996-9#1)(2008-5#1)(2009-10#2)(2011-2#3)(2013-1#1)
pedicel##3##1##(2008-10#3)
pedicle screw placement in##2##4##(2012-12#2)
pedicle screw placement##3##3##(2012-12#3)
pedicle screw##8##2##(2007-11#3)(2009-3#1)(2011-2#1)(2012-12#3)
pedicle screws##2##2##(2008-12#1)(2008-7#1)
pedicle##16##1##(2007-11#5)(2008-12#1)(2008-7#3)(2009-3#1)(2011-2#1)(2012-12#4)(2012-3#1)
pedicled##3##1##(2008-9#1)(2010-6#1)(2012-2#1)
pedicles##4##1##(1996-9#1)(1997-3#1)(1997-6#1)(2008-7#1)
pediculosis and scabies##2##3##(2008-12#2)
pedigree##7##1##(1994-12#1)(2008-10#5)(2010-4#1)
pedigrees##2##1##(1995-8#1)(2008-10#1)
pedunculated##3##1##(1992-5#1)(2010-3#1)(2011-2#1)
pedunculonigral##2##1##(2008-7#2)
peel tissue##2##2##(2008-10#2)
peel##10##1##(2008-10#7)(2008-5#1)(2012-3#2)
peeling of the##2##3##(2011-2#2)
peeling of##3##2##(2011-2#3)
peeling##5##1##(2008-11#1)(2011-2#4)
peer assessment##7##2##(2008-11#6)(2013-1#1)
peer connections##5##2##(2013-1#5)
peer drinking##2##2##(2010-9#2)
peer group##2##2##(2008-11#2)
peer influence##3##2##(2013-1#3)
peer review##10##2##(1991-1#2)(1992-1#1)(1992-12#1)(1994-1#1)(1994-6#1)(1996-2#1)(2008-11#1)(2008-12#1)(2010-5#1)
peer support##3##2##(1993-3#1)(2008-11#2)
peer support)##2##2##(2009-7#2)
peer victimization in adolescence##2##4##(2009-7#2)
peer victimization##4##2##(2008-12#2)(2009-7#2)
peer##56##1##(1990-12#1)(1990-9#1)(1991-1#2)(1992-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-11#12)(2008-12#3)(2008-8#1)(2009-12#1)(2009-7#7)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-2#2)(2013-1#12)
peer-group##2##1##(2008-12#1)(2009-7#1)
peer-related belongingness##2##2##(2009-7#2)
peer-reviewed##9##1##(2007-11#1)(2008-7#1)(2010-12#3)(2010-8#2)(2011-2#1)(2013-1#1)
peers and the##4##3##(2010-12#3)(2013-1#1)
peers and##8##2##(2010-1#1)(2010-10#1)(2010-12#3)(2013-1#3)
peers with##2##2##(1993-3#1)(2008-9#1)
peers##40##1##(1990-2#3)(1991-2#1)(1993-3#2)(2008-11#6)(2008-12#1)(2008-9#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#1)
peg##4##1##(1993-11#1)(2008-10#3)
pegs##4##1##(2007-12#1)(2008-10#2)(2008-7#1)
pegylated interferon and ribavirin##2##4##(2011-2#2)
pegylated interferon and##3##3##(2008-10#1)(2011-2#2)
pegylated##6##1##(2008-10#1)(2009-7#1)(2009-8#1)(2011-2#3)
pekinensis##2##1##(2008-10#1)(2013-8#1)
pelagic larval##2##2##(2008-8#1)(2008-9#1)
pelagic##5##1##(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#2)
peled##4##1##(2008-12#4)
pellet culture was##2##3##(2008-11#1)(2011-2#1)
pellet culture##3##2##(2008-11#2)(2011-2#1)
pellet size##3##2##(2008-7#3)
pellet##25##1##(1992-3#1)(1995-11#1)(2008-10#9)(2008-11#5)(2008-7#5)(2011-2#1)(2013-1#3)
pelleted##2##1##(2008-10#1)(2008-11#1)
pelleting##2##1##(2008-4#1)(2011-2#1)
pellets is##2##2##(2008-7#2)
pellets of##2##2##(2008-10#2)
pellets with a##2##3##(2008-5#1)(2009-7#1)
pellets with##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
pellets##29##1##(1993-6#1)(2008-10#16)(2008-5#1)(2008-7#10)(2009-7#1)
pellucida##6##1##(1996-9#1)(2008-4#2)(2008-9#1)(2013-1#2)
pelt##2##1##(1996-12#1)(1997-5#1)
pelts##2##1##(1996-12#2)
pelvi-ureteric junction##3##2##(2008-10#3)
pelvi-ureteric##4##1##(2008-10#4)
pelvic angiography##2##2##(1994-1#2)
pelvic endometriosis##7##2##(1991-3#3)(1992-1#2)(1995-2#1)(2013-1#1)
pelvic floor##5##2##(2008-10#1)(2012-2#1)(2012-3#3)
pelvic girdle##4##2##(2008-7#1)(2011-2#3)
pelvic mass##3##2##(1997-3#1)(1997-8#1)(2008-12#1)
pelvic obliquity##2##2##(2009-9#1)(2012-2#1)
pelvic organs##2##2##(1994-3#1)(1996-3#1)
pelvic osteotomy in##2##3##(2008-10#2)
pelvic pain##9##2##(1992-1#3)(1992-2#1)(1994-12#1)(1994-3#3)(2008-10#1)
pelvic pathology##3##2##(1991-3#2)(1992-3#1)
pelvic surgery##3##2##(2011-2#2)(2012-2#1)
pelvic tumor##2##2##(2007-8#1)(2013-1#1)
pelvic##84##1##(1990-5#2)(1991-1#2)(1991-2#1)(1991-3#6)(1992-1#5)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#1)(1993-1#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#5)(1995-2#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#2)(2009-1#1)(2009-4#1)(2009-9#3)(2011-2#10)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
pelvic-peritoneal tuberculosis##4##2##(2008-10#4)
pelvis and##8##2##(1991-11#2)(2008-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
pelvis##31##1##(1991-11#2)(1991-12#1)(1992-12#2)(1993-9#1)(2008-10#1)(2008-12#7)(2008-8#3)(2009-12#1)(2009-8#1)(2010-1#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)
pen##2##1##(1995-2#1)(2008-5#1)
pen2 NahG pmr5##2##3##(2012-2#2)
penalized log-likelihood##2##2##(2010-5#2)
penalized profile sampler##2##3##(2010-5#2)
penalized regression methods##2##3##(2009-8#2)
penalized##8##1##(1997-8#1)(2008-11#1)(2009-8#2)(2010-5#4)
penalties for##3##2##(1990-3#1)(1996-1#1)(2008-11#1)
penalties##8##1##(1990-2#1)(1990-3#1)(1991-2#1)(1996-1#1)(2008-11#2)(2009-8#1)(2012-3#1)
penalty##8##1##(1993-2#1)(1996-5#2)(2008-10#1)(2008-3#1)(2009-8#1)(2010-1#1)(2012-3#1)
pencil##5##1##(1991-9#1)(1995-5#1)(2008-10#2)(2013-1#1)
pendant le 2ème##2##3##(2013-1#2)
pendant le##3##2##(2013-1#3)
pendant##7##1##(2008-10#3)(2013-1#4)
pendants##2##1##(2008-10#2)
pendimethalin##16##1##(2008-10#4)(2008-11#5)(2011-1#7)
pending##6##1##(1997-2#1)(2008-10#1)(2008-12#1)(2009-4#1)(2011-2#2)
pendulous##3##1##(2008-10#2)(2008-5#1)
penetrance and##2##2##(2009-12#1)(2009-8#1)
penetrance of C282Y homozygous##2##4##(2008-5#2)
penetrance of##4##2##(2008-10#1)(2008-5#2)(2012-3#1)
penetrance##13##1##(1990-9#1)(2008-10#1)(2008-12#1)(2008-5#6)(2009-12#1)(2009-8#1)(2012-3#1)(2013-1#1)
penetrant inherited##2##2##(2008-12#2)
penetrant##3##1##(2008-12#2)(2010-4#1)
penetrate into the##4##3##(2008-10#1)(2008-5#2)(2008-7#1)
penetrate into##6##2##(2008-10#1)(2008-5#4)(2008-7#1)
penetrate the##11##2##(1994-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-8#2)(2012-2#1)(2013-1#1)
penetrate to##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
penetrate##29##1##(1994-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)
penetrated by the fungus##2##4##(2008-10#2)
penetrated by the##3##3##(2008-10#3)
penetrated into the##2##3##(2008-10#2)
penetrated the egg##2##3##(2008-10#2)
penetrated the host##2##3##(2008-10#2)
penetrated the##10##2##(1990-5#1)(1991-12#1)(2008-10#7)(2011-2#1)
penetrated##27##1##(1990-2#1)(1990-5#3)(1991-12#1)(2008-10#17)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
penetrates the##5##2##(1990-12#1)(2009-8#1)(2010-12#1)(2011-2#2)
penetrates##7##1##(1990-12#1)(1990-5#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#2)
penetrating keratoplasty##3##2##(2010-10#2)(2011-2#1)
penetrating neck##2##2##(2010-12#1)(2010-7#1)
penetrating rate##2##2##(2011-3#2)
penetrating the skull base##2##4##(2011-2#2)
penetrating the##7##2##(1990-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
penetrating##29##1##(1990-12#1)(2008-10#7)(2008-8#2)(2009-10#1)(2010-10#3)(2010-12#1)(2010-7#1)(2011-2#4)(2011-3#2)(2012-2#2)(2013-1#5)
penetration and colonization##2##3##(2008-10#2)
penetration and infection##2##3##(2008-10#1)(2011-10#1)
penetration and percent##2##3##(2008-10#2)
penetration and##17##2##(2008-10#10)(2008-11#1)(2008-5#2)(2011-10#1)(2012-2#2)(2013-1#1)
penetration by the##3##3##(2008-10#3)
penetration by##7##2##(2008-10#6)(2008-5#1)
penetration depth of##2##3##(1992-8#1)(2008-5#1)
penetration into##3##2##(1993-11#1)(1997-1#1)(2013-8#1)
penetration of host##2##3##(2007-12#1)(2008-10#1)
penetration of the##7##3##(1992-1#1)(1995-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#1)
penetration of##30##2##(1991-9#1)(1992-1#1)(1995-9#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#14)(2008-5#5)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)
penetration pore##5##2##(2008-10#5)
penetration process##2##2##(2008-10#2)
penetration sites##3##2##(2008-10#3)
penetration through the##2##3##(2008-10#1)(2008-5#1)
penetration through##5##2##(2007-12#1)(2008-10#2)(2008-5#2)
penetration via##2##2##(2008-10#1)(2008-5#1)
penetration was##6##2##(1990-5#1)(2007-12#1)(2008-10#4)
penetration##147##1##(1990-2#2)(1990-5#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-11#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(2007-12#3)(2008-10#80)(2008-11#3)(2008-3#1)(2008-5#24)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-10#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#4)(2013-1#5)(2013-8#2)
penetrations##2##1##(2007-12#1)(2008-10#1)
penguins##4##1##(2008-5#4)
penicillamine in##2##2##(2008-10#2)
penicillamine##11##1##(1991-8#1)(2008-10#10)
penicillatum produced##2##2##(2008-10#2)
penicillatum##11##1##(2008-10#11)
penicillin G and##2##3##(2008-12#1)(2013-8#1)
penicillin G benzathine##2##3##(1997-5#2)
penicillin G##11##2##(1992-12#1)(1997-5#2)(2008-10#4)(2008-12#1)(2013-8#3)
penicillin N##2##2##(2011-1#2)
penicillin V##2##2##(1994-9#1)(2008-10#1)
penicillin and##3##2##(2008-10#1)(2008-12#2)
penicillin by##2##2##(1992-12#1)(2011-2#1)
penicillin##38##1##(1991-10#1)(1992-12#3)(1994-9#1)(1996-12#1)(1997-5#2)(2008-10#8)(2008-11#2)(2008-12#6)(2011-1#5)(2011-2#6)(2013-8#3)
penicillins was##2##2##(2008-10#2)
penicillins##5##1##(2008-10#3)(2011-1#1)(2011-2#1)
penile length##3##2##(2011-1#3)
penile size##2##2##(2011-1#2)
penile##11##1##(1994-1#1)(2008-10#2)(2011-1#5)(2013-8#3)
peninsular Malaysia##6##2##(2008-10#1)(2008-12#4)(2008-8#1)
penis is a rare##2##4##(1990-12#1)(1991-8#1)
penis##15##1##(1990-12#2)(1991-8#2)(1994-1#1)(2008-10#7)(2013-1#2)(2013-8#1)
pennsylvanicus)##2##1##(1994-5#1)(2008-9#1)
penoscrotal transposition##3##2##(2008-10#3)
penoscrotal##6##1##(2008-10#4)(2013-1#2)
pension plans##6##2##(1993-3#6)
pension##13##1##(1991-11#3)(1992-3#1)(1993-3#7)(1993-6#1)(1995-11#1)
pensions##3##1##(1991-3#1)(1993-6#2)
penta- and##2##2##(2008-10#2)
pentaacids##2##1##(2008-10#2)
pentachlorophenol (PCP) in##2##3##(2008-10#2)
pentachlorophenol (PCP)##3##2##(2008-10#3)
pentachlorophenol and##2##2##(2008-10#2)
pentachlorophenol in##3##2##(2008-10#3)
pentachlorophenol##9##1##(2008-10#8)(2009-3#1)
pentachlorophenolate##3##1##(2008-10#3)
pentacoordinate##2##1##(2008-10#2)
pentadecapeptide##3##1##(1995-2#3)
pentaerythritol tetranitrate (PETN)##3##3##(2008-10#2)(2008-3#1)
pentaerythritol tetranitrate##5##2##(2008-10#4)(2008-3#1)
pentaethylenehexamine##2##1##(2008-10#2)
pentafluorobenzylation##4##1##(2008-10#4)
pentalenolactone (3)##2##2##(1994-5#2)
pentalenolactone##5##1##(1994-5#5)
pentamer(+) cell##3##2##(2013-1#3)
pentamer(+) cells##2##2##(2013-1#2)
pentamer(+)##5##1##(2013-1#5)
pentameric##2##1##(1993-9#1)(2013-1#1)
pentamidine aerosol##2##2##(1993-2#2)
pentamidine with##2##2##(1993-2#1)(1997-2#1)
pentamidine##12##1##(1990-9#1)(1992-3#1)(1993-2#9)(1997-2#1)
pentane##5##1##(2008-10#5)
pentanol##3##1##(2008-10#3)
pentapeptide yield was##2##3##(2008-7#2)
pentapeptide##4##1##(1992-4#1)(1995-6#1)(2008-7#2)
pentasaccharide##2##1##(1992-10#1)(2008-3#1)
pentathia-15-crown-5 and##2##2##(2008-10#2)
pentaurelia##3##1##(2008-12#3)
pentavalent##7##1##(2008-10#7)
pentose phosphate pathway##6##3##(1991-5#1)(2008-11#1)(2008-7#3)(2010-12#1)
pentose##10##1##(1991-5#1)(2008-11#1)(2008-7#5)(2010-12#1)(2011-1#1)(2012-3#1)
pentoxyverine##5##1##(2008-10#5)
pentoxyverine-tetraphenylborate##2##1##(2008-10#2)
pentyl rhamnoside##2##2##(2008-5#2)
pentyl##4##1##(1994-8#1)(2008-5#3)
penultimate leaf##3##2##(2008-10#3)
penultimate##5##1##(1992-6#2)(2008-10#3)
peony##3##1##(2011-3#3)
people about##3##2##(1991-3#1)(1997-6#2)
people age##3##2##(2008-7#1)(2009-12#1)(2013-1#1)
people aged##6##2##(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
people and##16##2##(1990-11#1)(1992-3#1)(1992-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
people are still not##2##4##(1996-5#1)(2010-12#1)
people are##13##2##(1993-3#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)
people as##4##2##(1992-9#1)(2010-10#3)
people die##2##2##(1990-6#1)(2010-11#1)
people do not##2##3##(1997-6#1)(2009-12#1)
people for##4##2##(2008-10#2)(2008-5#1)(2010-8#1)
people from##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
people go##2##2##(1993-2#1)(2008-9#1)
people have##7##2##(1993-3#1)(1995-1#1)(1997-6#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-9#1)
people in New Zealand##4##4##(1991-2#1)(1996-12#2)(2008-1#1)
people in poverty##2##3##(1995-1#1)(2008-11#1)
people in the United States##3##5##(2011-2#1)(2012-3#1)(2013-8#1)
people in the##12##3##(1990-11#1)(1995-6#2)(2008-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
people in this##2##3##(1995-12#1)(2008-11#1)
people in##36##2##(1990-11#1)(1990-6#1)(1991-2#1)(1992-1#1)(1995-1#1)(1995-12#1)(1995-6#2)(1996-12#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#4)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
people infected##3##2##(2008-10#1)(2013-1#2)
people is##2##2##(2010-10#1)(2013-1#1)
people living in the##3##4##(1996-6#1)(2008-3#1)(2012-12#1)
people living in##5##3##(1996-6#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-12#1)
people living with##2##3##(2010-10#1)(2013-1#1)
people living##7##2##(1996-6#1)(2008-10#1)(2008-3#1)(2010-10#2)(2012-12#1)(2013-1#1)
people of##4##2##(1993-12#1)(1997-8#1)(2010-8#1)(2011-2#1)
people over##3##2##(1993-9#1)(2008-10#1)(2010-10#1)
people suffering from##3##3##(1992-3#2)(1993-3#1)
people to##6##2##(1994-12#1)(2008-11#1)(2009-10#1)(2010-10#3)
people towards old age homes##2##5##(2008-7#2)
people were##8##2##(1992-9#1)(1995-8#1)(1996-6#2)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
people who are##3##3##(1993-3#1)(1995-1#1)(2008-4#1)
people who have been##2##4##(1995-1#1)(1995-12#1)
people who have##5##3##(1992-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(2012-2#1)
people who##21##2##(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#2)(1995-1#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
people whose##2##2##(1996-2#1)(2008-11#1)
people will##2##2##(1994-8#1)(1996-5#1)
people with AIDS##6##3##(1995-12#3)(1995-6#2)(1996-3#1)
people with HIV##5##3##(1992-1#1)(1995-12#2)(1995-6#2)
people with a learning disability##2##5##(2008-11#2)
people with a##4##3##(2008-11#2)(2008-9#1)(2010-12#1)
people with bipolar disorder##2##4##(2009-11#2)
people with dementia##7##3##(1991-1#1)(2008-6#1)(2013-8#5)
people with diabetes##4##3##(2008-6#1)(2010-10#2)(2012-3#1)
people with disabilities in##2##4##(1995-6#1)(1996-1#1)
people with disabilities##12##3##(1995-12#1)(1995-6#2)(1996-1#6)(1997-1#1)(2009-6#2)
people with disability##3##3##(1996-12#1)(1997-1#2)
people with mental illness##4##4##(2011-1#4)
people with mental##11##3##(1993-1#3)(1997-8#1)(2008-11#2)(2011-1#4)(2012-3#1)
people with physical disabilities##2##4##(1995-12#2)
people with schizophrenia##3##3##(2009-6#1)(2009-7#2)
people with spinal cord injury (SCI)##2##6##(2008-7#1)(2013-1#1)
people with spinal##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
people with##98##2##(1991-1#2)(1992-1#1)(1993-1#4)(1993-3#1)(1995-12#9)(1995-6#7)(1996-1#6)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#5)(1997-8#1)(2008-11#7)(2008-12#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-6#4)(2009-7#2)(2010-10#4)(2010-12#1)(2011-1#5)(2011-2#4)(2012-2#1)(2012-3#5)(2013-1#7)(2013-8#6)
people worldwide##4##2##(2008-1#1)(2008-10#2)(2009-5#1)
people##419##1##(1990-11#3)(1990-2#1)(1990-3#2)(1990-6#2)(1991-1#3)(1991-11#1)(1991-2#3)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-9#2)(1993-1#5)(1993-12#3)(1993-2#1)(1993-3#6)(1993-9#1)(1994-1#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-12#13)(1995-3#2)(1995-5#1)(1995-6#10)(1995-8#2)(1996-1#8)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#6)(1996-6#3)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#5)(1997-8#2)(2008-1#9)(2008-10#30)(2008-11#29)(2008-12#9)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#12)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#3)(2009-5#2)(2009-6#5)(2009-7#3)(2009-8#1)(2010-10#39)(2010-11#2)(2010-12#4)(2010-2#3)(2010-5#1)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#23)(2012-12#9)(2012-2#9)(2012-3#16)(2013-1#23)(2013-8#13)
people's health##2##2##(1990-11#1)(2010-4#1)
people's##29##1##(1990-11#1)(1994-3#1)(1997-5#1)(2008-11#2)(2008-12#2)(2008-5#1)(2009-10#1)(2009-3#1)(2010-10#6)(2010-12#1)(2010-2#6)(2010-4#1)(2010-6#2)(2012-12#1)(2013-8#2)
people]##2##1##(1993-9#1)(1996-6#1)
peoples in##2##2##(2008-1#1)(2008-12#1)
peoples##7##1##(2008-1#2)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#2)
peoples'##2##1##(1991-3#1)(2008-11#1)
pepo##2##1##(2008-10#2)
pepo)##4##1##(2008-10#4)
pepper (Capsicum annuum)##2##3##(2008-10#2)
pepper (Capsicum##3##2##(2008-10#3)
pepper and##4##2##(2008-10#4)
pepper genotype##2##2##(2008-10#2)
pepper genotypes carrying##2##3##(2008-10#2)
pepper genotypes##5##2##(2008-10#5)
pepper huasteco virus##2##3##(2008-10#2)
pepper huasteco##3##2##(2008-10#3)
pepper in the##2##3##(2008-10#2)
pepper leaves##2##2##(2008-10#2)
pepper plants##11##2##(2008-10#11)
pepper tissues##2##2##(2008-10#2)
pepper to##2##2##(2008-10#2)
pepper was##2##2##(2008-10#2)
pepper##76##1##(2008-10#76)
pepper)##2##1##(2008-10#2)
peppermint##4##1##(2008-10#3)(2012-2#1)
pepsin and##2##2##(2008-1#1)(2008-10#1)
pepsin##11##1##(1992-12#1)(1995-3#1)(1996-12#1)(1997-1#4)(2008-1#1)(2008-10#3)
pepsinogen secretion from guinea pig chief cells##3##7##(1995-8#3)
pepsinogen secretion from##5##3##(1995-8#5)
pepsinogen secretion##11##2##(1995-8#10)(1997-1#1)
pepstatin A##3##2##(1991-9#1)(1995-6#1)(1995-8#1)
pepstatin##4##1##(1991-9#1)(1995-6#2)(1995-8#1)
peptic activity##2##2##(1997-1#2)
peptic ulcer disease##3##3##(1992-9#1)(1997-1#2)
peptic ulcer##8##2##(1992-9#2)(1995-10#2)(1997-1#2)(2008-12#1)(2013-1#1)
peptic ulcers##4##2##(1990-3#1)(1990-5#1)(2008-12#1)(2013-1#1)
peptic##16##1##(1990-3#1)(1990-5#2)(1992-9#2)(1995-10#2)(1997-1#4)(2008-10#1)(2008-12#2)(2013-1#2)
peptidase and##2##2##(1995-6#1)(2008-11#1)
peptidase inhibitors##2##2##(1991-3#1)(1997-4#1)
peptidase##22##1##(1991-10#1)(1991-3#1)(1992-3#1)(1993-12#1)(1995-6#1)(1997-4#1)(1997-7#4)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#4)(2008-9#1)
peptidases are##2##2##(1996-2#1)(2008-5#1)
peptidases in##3##2##(1992-11#1)(1996-2#1)(2010-3#1)
peptidases that##2##2##(1991-3#1)(1996-2#1)
peptidases##12##1##(1991-3#1)(1992-11#1)(1994-8#1)(1996-2#3)(2008-4#2)(2008-5#2)(2008-6#1)(2010-3#1)
peptide (PTHrP)##2##2##(1993-3#1)(2013-7#1)
peptide 1##3##2##(1994-11#1)(1995-8#1)(2012-3#1)
peptide 14##3##2##(1993-8#3)
peptide 77-3##2##2##(2008-10#2)
peptide activity##2##2##(1992-4#1)(2008-10#1)
peptide and a##3##3##(1995-2#1)(2008-11#2)
peptide and the##2##3##(2008-10#1)(2010-6#1)
peptide and##25##2##(1990-8#1)(1992-6#2)(1993-8#2)(1994-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)
peptide antibiotics##2##2##(2008-10#1)(2008-7#1)
peptide antigen##3##2##(1995-5#1)(2008-11#1)(2008-4#1)
peptide antigens##2##2##(1990-5#1)(2008-4#1)
peptide as##2##2##(1992-6#1)(2008-10#1)
peptide at the##3##3##(1993-3#1)(1995-2#1)(1996-12#1)
peptide binding##2##2##(1995-5#1)(2008-7#1)
peptide bond at##2##3##(1995-6#1)(2008-9#1)
peptide bond##8##2##(1990-2#1)(1991-5#1)(1995-6#1)(2008-10#3)(2008-9#2)
peptide bonds##2##2##(1994-5#1)(2008-11#1)
peptide composed of##2##3##(1990-5#1)(2008-10#1)
peptide concentrations##3##2##(1992-4#1)(2008-10#1)(2009-5#1)
peptide corresponding to residues##2##4##(1994-5#1)(1995-2#1)
peptide corresponding to the##3##4##(1991-5#1)(1995-2#2)
peptide corresponding to##5##3##(1991-5#1)(1994-5#1)(1995-2#3)
peptide expression##2##2##(1995-12#1)(2011-2#1)
peptide for##2##2##(1994-5#1)(1995-6#1)
peptide found##2##2##(1996-12#1)(2008-6#1)
peptide fragment##8##2##(1992-6#2)(1993-8#1)(1994-11#1)(1995-2#1)(1997-8#1)(2008-10#1)(2011-1#1)
peptide fragments##11##2##(1992-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1997-1#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#2)
peptide from the##2##3##(1995-2#1)(2008-10#1)
peptide from##6##2##(1992-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(1997-8#1)(2008-10#1)
peptide growth factors##2##3##(1991-12#1)(1994-8#1)
peptide has been##2##3##(1990-8#1)(1994-3#1)
peptide hormone##4##2##(1992-6#2)(1995-12#2)
peptide hormones##2##2##(2010-4#1)(2011-1#1)
peptide in rat##2##3##(1991-5#1)(1993-3#1)
peptide in the brain##3##4##(1992-6#2)(2008-6#1)
peptide in the central##2##4##(1992-6#2)
peptide in the regulation of##3##5##(1992-6#3)
peptide in the##14##3##(1992-6#10)(1994-2#1)(2008-10#2)(2008-6#1)
peptide in##29##2##(1991-5#1)(1992-4#1)(1992-6#14)(1993-3#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
peptide incorporated##2##2##(1990-5#1)(2008-10#1)
peptide increased##2##2##(2008-5#2)
peptide inhibited##4##2##(1991-5#1)(1995-11#1)(1996-12#1)(2008-10#1)
peptide inhibitor##3##2##(2008-11#1)(2009-6#2)
peptide is able to##2##4##(1994-5#1)(2008-10#1)
peptide is##12##2##(1991-5#1)(1992-6#3)(1992-8#1)(1994-2#1)(1994-5#2)(1996-2#1)(2008-10#1)(2008-8#2)
peptide library##4##2##(2008-10#2)(2008-8#2)
peptide ligands##5##2##(1994-11#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)
peptide map of##2##3##(1995-2#2)
peptide map##3##2##(1990-8#1)(1995-2#2)
peptide mapping and##2##3##(1991-5#1)(1994-11#1)
peptide mapping##4##2##(1991-5#1)(1992-9#1)(1994-11#1)(2008-10#1)
peptide maps##2##2##(1990-8#1)(2008-10#1)
peptide may##2##2##(1992-12#1)(2009-5#1)
peptide modules##2##2##(1997-6#2)
peptide of interest##2##3##(2008-4#1)(2008-9#1)
peptide of##16##2##(1990-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-6#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#2)(2008-9#3)
peptide on##2##2##(1992-6#1)(2008-5#1)
peptide or##2##2##(2008-7#1)(2008-8#1)
peptide polymorphism was##2##3##(1997-8#2)
peptide polymorphism##3##2##(1997-8#3)
peptide previously isolated from##2##4##(1994-5#1)(2011-2#1)
peptide receptor##2##2##(2008-11#1)(2010-6#1)
peptide release##2##2##(1992-6#1)(2008-7#1)
peptide sequence of the##2##4##(1995-2#1)(2008-10#1)
peptide sequence of##3##3##(1995-2#1)(2008-10#2)
peptide sequence was##2##3##(1992-9#1)(2012-12#1)
peptide sequence##19##2##(1992-9#3)(1995-2#3)(1995-6#1)(2008-10#5)(2008-11#1)(2008-4#2)(2010-6#2)(2011-2#1)(2012-12#1)
peptide sequences in##2##3##(1992-6#1)(2008-11#1)
peptide sequences##12##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
peptide substrates##2##2##(1994-5#2)
peptide synthesis##3##2##(2008-10#1)(2008-4#2)
peptide system##2##2##(2008-10#1)(2009-6#1)
peptide that##8##2##(1990-2#1)(1994-5#1)(1996-12#1)(2006-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-7#1)
peptide to##6##2##(1991-11#1)(1995-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2012-3#1)
peptide transporter##3##2##(1994-8#3)
peptide vaccines##2##2##(1995-5#2)
peptide was able to##2##4##(2008-10#2)
peptide was cloned##2##3##(2008-10#2)
peptide was confirmed by##2##4##(1990-8#1)(1994-8#1)
peptide was determined by##2##4##(1997-8#1)(2008-8#1)
peptide was##16##2##(1990-8#1)(1991-5#1)(1992-6#1)(1993-8#2)(1994-8#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-8#3)(2010-6#1)
peptide were##2##2##(1994-5#1)(2008-10#1)
peptide which##4##2##(1993-3#2)(1995-2#1)(2008-5#1)
peptide with a##3##3##(1990-8#1)(1991-12#1)(2010-1#1)
peptide with##9##2##(1990-8#1)(1991-12#1)(1992-4#1)(2008-10#2)(2008-8#2)(2010-1#1)(2010-6#1)
peptide##518##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#12)(1990-8#7)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#11)(1991-9#3)(1992-12#3)(1992-3#1)(1992-4#6)(1992-6#40)(1992-7#1)(1992-8#4)(1992-9#4)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#7)(1993-6#1)(1993-8#14)(1994-11#11)(1994-2#4)(1994-3#7)(1994-5#22)(1994-6#1)(1994-8#14)(1995-11#7)(1995-12#6)(1995-2#23)(1995-3#1)(1995-5#7)(1995-6#9)(1995-8#1)(1996-12#11)(1996-2#4)(1996-6#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#4)(1997-6#2)(1997-8#8)(2006-6#1)(2008-1#3)(2008-10#63)(2008-11#20)(2008-12#2)(2008-3#1)(2008-4#29)(2008-5#12)(2008-6#5)(2008-7#9)(2008-8#23)(2008-9#11)(2009-10#2)(2009-5#7)(2009-6#5)(2009-7#1)(2009-8#1)(2010-1#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#6)(2010-7#2)(2011-1#4)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#3)(2013-8#2)
peptide)##6##1##(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-1#1)
peptide-based##2##1##(2008-10#1)(2008-5#1)
peptide-induced mast cell activation##3##4##(1995-11#3)
peptide-induced##5##1##(1994-5#1)(1995-11#4)
peptide-like##2##1##(1990-5#1)(1994-8#1)
peptide-lipid membranes##3##2##(2008-11#3)
peptide-stimulated [35S]GTP gamma S binding##4##5##(1996-2#4)
peptide-stimulated acid secretion##2##3##(1997-1#2)
peptide-stimulated##7##1##(1996-2#5)(1997-1#2)
peptides (CPPs)##2##2##(2010-10#1)(2011-3#1)
peptides also##2##2##(1992-9#1)(2008-10#1)
peptides and amino acids##3##4##(2008-10#2)(2011-2#1)
peptides and proteins##7##3##(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-7#1)
peptides and##18##2##(1990-10#1)(1994-8#1)(1995-2#2)(1995-5#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-4#3)(2010-7#1)(2011-2#1)(2013-7#1)
peptides are##8##2##(1993-8#1)(2008-1#1)(2008-4#3)(2008-5#1)(2011-2#2)
peptides as##5##2##(1994-9#1)(1995-11#1)(2008-4#1)(2008-5#1)(2011-3#1)
peptides bound##2##2##(1995-11#1)(1997-8#1)
peptides by##2##2##(1994-5#1)(1997-2#1)
peptides can be##3##3##(2008-10#2)(2008-4#1)
peptides can##5##2##(1994-5#1)(2008-10#3)(2008-4#1)
peptides containing##4##2##(1995-11#1)(1995-6#1)(2008-11#1)(2009-6#1)
peptides corresponding to the##2##4##(1994-5#1)(1995-2#1)
peptides could##3##2##(1991-3#1)(1996-12#1)(2012-3#1)
peptides covering the##2##3##(2008-11#2)
peptides derived from the##3##4##(1990-5#1)(1992-6#1)(1995-5#1)
peptides derived from##6##3##(1990-5#1)(1991-5#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-5#1)
peptides displayed on##2##3##(1995-5#1)(2008-8#1)
peptides for##4##2##(2008-1#1)(2008-4#2)(2010-6#1)
peptides from the##3##3##(1994-11#1)(1996-12#1)(1997-8#1)
peptides from##9##2##(1994-11#1)(1995-3#2)(1996-12#1)(1997-8#1)(2008-10#3)(2008-4#1)
peptides have been##3##3##(2008-5#1)(2009-5#1)(2011-2#1)
peptides have##4##2##(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
peptides in##14##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#3)(1994-9#1)(1995-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
peptides induce##2##2##(1994-5#2)
peptides inhibited the##2##3##(1995-11#1)(2012-3#1)
peptides mixture from tumor cells##2##5##(2008-9#2)
peptides mixture##3##2##(2008-9#3)
peptides of the##4##3##(1993-3#1)(1994-9#1)(1995-11#1)(2010-5#1)
peptides of##7##2##(1992-12#1)(1993-3#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2010-5#1)
peptides on##3##2##(2008-11#1)(2008-4#1)(2012-3#1)
peptides or proteins##2##3##(1995-2#2)
peptides or##4##2##(1995-2#4)
peptides phosphorylated##2##2##(1996-2#1)(2008-4#1)
peptides recognized##2##2##(1990-5#1)(2008-4#1)
peptides representing##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
peptides showed##3##2##(1993-8#1)(2008-10#1)(2008-6#1)
peptides such as##2##3##(1991-5#1)(1994-5#1)
peptides that##7##2##(1991-5#1)(1993-3#1)(1995-6#1)(1995-8#1)(2008-10#1)(2009-6#1)(2013-1#1)
peptides to##5##2##(1994-11#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-4#1)
peptides was##3##2##(1994-8#1)(1996-2#1)(1997-8#1)
peptides were found to##2##4##(1994-8#1)(1997-4#1)
peptides were##17##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-6#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
peptides which##3##2##(1992-12#1)(2008-9#1)(2011-1#1)
peptides with a##2##3##(1994-3#1)(2008-10#1)
peptides with##8##2##(1994-3#2)(1995-11#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-8#1)
peptides without##2##2##(2008-10#2)
peptides##311##1##(1990-10#1)(1990-2#2)(1990-4#2)(1990-5#6)(1991-3#2)(1991-5#6)(1992-12#5)(1992-3#1)(1992-4#2)(1992-6#9)(1992-9#3)(1993-3#5)(1993-6#1)(1993-8#5)(1994-11#12)(1994-2#1)(1994-3#5)(1994-5#12)(1994-8#12)(1994-9#4)(1995-11#7)(1995-12#4)(1995-2#13)(1995-3#6)(1995-5#4)(1995-6#3)(1995-8#2)(1996-12#10)(1996-2#4)(1997-2#2)(1997-4#3)(1997-6#2)(1997-8#3)(2008-1#4)(2008-10#35)(2008-11#11)(2008-4#27)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#12)(2009-10#1)(2009-5#4)(2009-6#3)(2009-7#1)(2010-10#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#11)(2011-3#4)(2012-2#1)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#1)
peptides)##4##1##(1994-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
peptidic##2##1##(1993-3#2)
peptidoglycan##5##1##(1990-2#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
peptidolytic reaction of##2##3##(1991-9#2)
peptidolytic reaction##4##2##(1991-9#4)
peptidomimetic##2##1##(1995-2#1)(2013-1#1)
peptidomimetics##2##1##(2013-1#2)
peptone after a preload##2##4##(1997-4#2)
peptone after##4##2##(1997-4#4)
peptone and peptone after##2##4##(1997-4#2)
peptone was found to be##2##5##(2008-10#1)(2012-2#1)
peptone was##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
peptone##18##1##(1992-6#1)(1997-4#8)(2008-10#3)(2008-7#5)(2012-2#1)
peptones##4##1##(2008-11#4)
per 0##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
per 1##10##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-5#1)(1993-1#1)(1994-8#1)(1996-11#1)(2008-10#2)(2013-1#1)
per 10 000##2##3##(2013-8#2)
per 10##4##2##(2008-10#1)(2012-2#1)(2013-8#2)
per 100 patients##2##3##(2008-7#1)(2013-1#1)
per 100##11##2##(1992-2#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#3)(2013-1#2)
per 1000 ml##3##3##(2008-10#3)
per 1000##5##2##(1990-9#1)(1997-8#1)(2008-10#3)
per 2##2##2##(1991-5#1)(2008-10#1)
per 200 g of soil)##3##5##(2008-10#3)
per 25muL) of Se(IV)##2##4##(2008-10#2)
per 25muL)##3##2##(2008-10#3)
per 50##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
per animal##4##2##(1992-8#1)(1996-12#3)
per asymmetric unit##2##3##(2008-9#2)
per batch culture##2##3##(2008-11#2)
per billion by##3##3##(2008-10#1)(2008-3#2)
per billion in##2##3##(2008-2#2)
per billion##8##2##(2008-10#2)(2008-2#2)(2008-3#4)
per canker##6##2##(2008-10#6)
per capita costs##3##3##(1991-6#1)(1993-3#1)(1996-3#1)
per capita expenditures##3##3##(1994-2#1)(1997-3#1)(2009-3#1)
per capita population growth rates##3##5##(2008-8#3)
per capita than##2##3##(1995-1#1)(1996-3#1)
per capita##29##2##(1991-3#1)(1991-6#1)(1993-2#1)(1993-3#4)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-3#2)(1997-8#1)(2008-8#7)(2009-3#1)(2009-4#1)(2012-3#1)(2013-8#1)
per caput effective dose##2##4##(1997-8#2)
per caput##3##2##(1997-8#2)(2012-2#1)
per case##9##2##(1992-12#5)(1996-2#1)(1996-3#2)(2012-12#1)
per cell after##2##3##(2008-10#1)(2008-11#1)
per cell in##2##3##(2008-11#1)(2008-9#1)
per cell##24##2##(1991-2#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#12)(2008-4#1)(2008-7#1)(2008-9#6)
per cent and##3##3##(1990-6#1)(1992-2#1)(1995-12#1)
per cent for##4##3##(1995-12#4)
per cent in the first month##2##6##(1996-8#2)
per cent of the incidence##2##5##(2008-7#2)
per cent of the##10##4##(1992-9#1)(1995-9#3)(1996-3#1)(1997-5#1)(2008-7#2)(2008-9#1)(2010-11#1)
per cent of##21##3##(1990-9#1)(1991-6#1)(1992-9#3)(1995-12#1)(1995-9#3)(1996-3#2)(1997-5#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2013-8#1)
per cent##45##2##(1990-6#5)(1990-9#1)(1991-6#1)(1992-2#3)(1992-9#3)(1995-12#7)(1995-9#3)(1996-3#2)(1996-6#2)(1996-8#2)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#5)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
per cent) and##2##3##(1991-11#1)(1996-8#1)
per cent)##10##2##(1991-11#4)(1995-9#1)(1996-8#5)
per chromosome##2##2##(2008-12#2)
per cm(2) of##2##3##(2008-10#1)(2008-5#1)
per cm(2))##3##2##(2008-10#3)
per concentration level) overestimated##2##4##(2008-10#2)
per concentration level)##4##3##(2008-10#4)
per concentration##11##2##(2008-10#11)
per cubic##2##2##(2008-5#1)(2010-7#1)
per cycle##3##2##(1992-2#1)(2008-10#1)(2008-7#1)
per day and##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
per day for##3##3##(1990-9#1)(1992-3#1)(2007-8#1)
per day of##2##3##(2010-12#1)(2011-2#1)
per day was##5##3##(1994-6#1)(1995-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
per day were##2##3##(1991-11#1)(2008-10#1)
per day##40##2##(1990-9#1)(1991-11#1)(1992-3#3)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#6)(2010-12#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
per day)##8##2##(1992-12#1)(1994-6#3)(2008-1#1)(2008-10#2)(2013-1#1)
per decade and a detection limit of##2##7##(2008-10#2)
per decade and a detection limit##3##6##(2008-10#3)
per decade and a##4##4##(2008-10#4)
per decade and##6##3##(2008-10#6)
per decade for##2##3##(2008-10#2)
per decade of activity##5##4##(2008-10#5)
per decade of##6##3##(2008-10#6)
per decade##39##2##(2008-10#39)
per decade)##5##2##(2008-10#5)
per determination were also achieved##2##5##(2008-10#2)
per determination##12##2##(2008-10#12)
per determination)##2##2##(2008-10#2)
per diem cost##2##3##(1991-12#1)(1993-12#1)
per diem##5##2##(1991-12#2)(1993-12#2)(1994-2#1)
per dish)##2##2##(1995-3#1)(2008-10#1)
per dose##3##2##(2008-10#2)(2012-12#1)
per erythrocyte##2##2##(1990-12#2)
per explant for Mentha##2##4##(2013-1#2)
per flower##4##2##(2008-10#3)(2008-12#1)
per g of soil##7##4##(2008-10#7)
per g of tissue##3##4##(1995-2#1)(2008-10#2)
per g of##16##3##(1995-2#1)(2008-10#15)
per gene##3##2##(1997-6#1)(1997-8#1)(2012-3#1)
per generation##3##2##(2008-10#2)(2008-8#1)
per genome##2##2##(2008-10#2)
per gram of root##3##4##(2008-10#3)
per gram of soil##9##4##(2008-10#9)
per gram of soil)##5##4##(2008-10#5)
per gram of##28##3##(1993-11#1)(2008-10#23)(2008-11#2)(2011-2#2)
per gram##30##2##(1993-11#1)(2008-10#24)(2008-11#2)(2011-2#2)(2013-1#1)
per group##4##2##(2008-10#2)(2008-12#1)(2010-4#1)
per group)##2##2##(2011-2#1)(2013-1#1)
per h##22##2##(2008-10#22)
per h)##3##2##(2008-10#3)
per head##2##2##(2008-10#2)
per heart in the##2##4##(2010-6#2)
per hour and is##2##4##(2008-10#2)
per hour and relative standard##3##5##(2008-10#3)
per hour and##10##3##(2008-10#10)
per hour for a##2##4##(2008-10#2)
per hour was achieved##3##4##(2008-10#3)
per hour was##5##3##(2008-10#5)
per hour were achieved##2##4##(2008-10#2)
per hour with a relative standard deviation of##3##8##(2008-10#3)
per hour with a relative standard deviation##4##7##(2008-10#4)
per hour with a relative##5##5##(2008-10#5)
per hour with a##6##4##(2008-10#6)
per hour##78##2##(1993-8#1)(2008-10#77)
per infected##2##2##(2008-10#2)
per injection##4##2##(2008-10#3)(2013-8#1)
per inter-spawning interval##2##3##(2010-8#2)
per kg##2##2##(2008-10#2)
per kilogram##3##2##(1996-12#1)(1997-8#1)(2011-3#1)
per larva##3##2##(2008-12#2)(2008-7#1)
per leaf and##2##3##(2008-10#2)
per leaf##9##2##(2008-10#9)
per leaf)##2##2##(2008-10#2)
per leaflet##4##2##(2008-10#4)
per lesion##5##2##(2008-10#5)
per liter levels##2##3##(2008-10#2)
per liter##10##2##(1992-8#1)(2008-10#9)
per litre##3##2##(2008-10#3)
per m(2)##3##2##(2008-10#3)
per mg protein##3##3##(1991-12#1)(1994-8#2)
per mg##4##2##(1991-12#1)(1994-8#2)(2008-11#1)
per milliliter level##2##3##(2008-10#2)
per milliliter levels##2##3##(2008-10#2)
per milliliter##5##2##(2008-10#5)
per million##6##2##(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#3)
per min##9##2##(1991-6#1)(1992-3#3)(1994-8#2)(2008-10#2)(2008-11#1)
per minute##7##2##(1994-11#1)(1994-12#1)(1996-3#1)(2008-10#2)(2012-2#2)
per ml of##4##3##(1993-8#1)(2008-10#3)
per ml using##2##3##(2008-10#2)
per ml##21##2##(1993-8#1)(2008-10#16)(2008-11#2)(2009-8#1)(2012-3#1)
per ml)##8##2##(2008-10#8)
per mm(2) of pellet at 713 cm(-1)##2##7##(2008-10#2)
per mm(2) of pellet at##4##5##(2008-10#4)
per mol of##3##3##(1990-10#2)(2008-10#1)
per mol##6##2##(1990-10#2)(1990-12#1)(1993-8#1)(2008-10#2)
per mole of##6##3##(1993-6#1)(1994-5#1)(2008-10#2)(2008-4#1)(2010-11#1)
per molecule of##2##3##(1991-5#1)(1993-3#1)
per monomer##2##2##(1992-4#1)(2008-10#1)
per month in##2##3##(1995-12#2)
per month##4##2##(1993-1#1)(1995-12#2)(2008-10#1)
per month)##2##2##(2008-10#2)
per mouse##2##2##(1993-8#1)(2008-12#1)
per mug##2##2##(2008-10#1)(2008-11#1)
per mutants##2##2##(1995-9#2)
per os##6##2##(1991-3#1)(1993-12#1)(2008-10#2)(2008-5#1)(2009-8#1)
per paid hour##2##3##(1992-3#2)
per patient eligible day##2##4##(1997-2#2)
per patient was##3##3##(1990-9#1)(2011-2#1)(2013-1#1)
per patient##11##2##(1990-9#1)(1992-3#1)(1997-2#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
per perithecium##2##2##(2008-10#2)
per person##4##2##(1993-1#1)(1996-3#1)(2008-10#1)(2012-2#1)
per pl-carnitine##3##2##(2008-10#3)
per plant##13##2##(2008-10#10)(2008-12#3)
per plot##3##2##(2008-10#3)
per plot)##2##2##(2008-10#2)
per population##2##2##(2008-10#1)(2009-5#1)
per porphyrin molecule##2##3##(2008-10#2)
per pseudothecium##2##2##(2008-10#2)
per pycnidium##2##2##(2008-10#2)
per quarter##2##2##(1992-9#1)(2012-2#1)
per replicate##2##2##(2008-10#1)(2008-12#1)
per sample of##2##3##(2008-10#1)(2008-5#1)
per sample were##2##3##(2008-10#2)
per sample##11##2##(2008-10#9)(2008-5#1)(2011-2#1)
per sample) and##2##3##(2008-10#2)
per se##19##2##(1990-2#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#4)(2009-8#1)(2010-8#1)(2011-2#1)(2013-8#3)
per season##2##2##(2008-10#2)
per second##5##2##(2007-9#1)(2008-10#3)(2008-6#1)
per seedling##2##2##(2008-10#2)
per site##2##2##(2008-10#2)
per slide was##2##3##(2008-10#2)
per slide##3##2##(2008-10#2)(2008-11#1)
per spot##4##2##(2008-10#4)
per square centimeter of leaf surface##2##6##(2008-10#2)
per square centimeter of##3##4##(2008-10#3)
per square centimeter##5##3##(2008-10#5)
per square meter##5##3##(1995-8#1)(2008-10#4)
per square##14##2##(1990-8#1)(1991-2#1)(1992-2#1)(1995-12#1)(1995-8#1)(2008-10#9)
per subunit##3##2##(1992-8#1)(1994-5#2)
per surface##2##2##(1993-12#1)(1995-8#1)
per testis##3##2##(1992-12#3)
per thousand##2##2##(2008-10#2)
per thousand)##4##2##(2010-3#4)
per time##3##2##(2008-10#2)(2008-11#1)
per titration)##2##2##(2008-10#2)
per total##4##2##(1993-8#1)(1994-8#2)(2008-10#1)
per tree)##2##2##(2008-10#2)
per trillion##5##2##(2008-10#5)
per unit area##3##3##(2008-10#2)(2008-8#1)
per unit infection##2##3##(2008-10#2)
per unit mass##2##3##(2008-10#2)
per unit of sporulating##2##4##(2008-10#2)
per unit of time##2##4##(1996-3#1)(2008-9#1)
per unit of##13##3##(1996-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#2)
per unit##28##2##(1996-3#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)
per visit##5##2##(1995-12#1)(1995-3#2)(1995-5#1)(2010-8#1)
per volume of##2##3##(2008-11#1)(2008-7#1)
per week for##8##3##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#2)(2013-1#1)(2013-8#1)
per week##16##2##(1991-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2013-1#4)(2013-8#1)
per well##4##2##(1991-2#1)(2008-10#1)(2008-11#2)
per woman-year##2##2##(2011-3#2)
per worker##2##2##(1994-1#2)
per year and##2##3##(1997-1#1)(2008-10#1)
per year for##2##3##(2008-10#1)(2010-8#1)
per year in##3##3##(1990-12#2)(1994-6#1)
per year or##2##3##(1990-6#1)(1997-3#1)
per year##36##2##(1990-12#2)(1990-3#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#2)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#6)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
per year)##3##2##(2008-10#1)(2008-7#2)
per##1096##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#1)(1990-6#7)(1990-8#1)(1990-9#4)(1991-11#6)(1991-12#4)(1991-2#6)(1991-3#2)(1991-5#6)(1991-6#3)(1992-1#2)(1992-12#9)(1992-2#7)(1992-3#11)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#5)(1993-1#4)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#7)(1993-6#3)(1993-8#8)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#7)(1994-8#8)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#15)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#6)(1996-1#1)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#10)(1996-6#2)(1996-8#9)(1997-1#1)(1997-2#4)(1997-3#6)(1997-5#4)(1997-6#1)(1997-8#7)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#553)(2008-11#51)(2008-12#16)(2008-2#3)(2008-3#14)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#29)(2008-8#15)(2008-9#20)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#8)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#2)(2010-3#4)(2010-4#2)(2010-6#2)(2010-7#3)(2010-8#9)(2011-1#3)(2011-2#13)(2011-3#4)(2012-12#3)(2012-2#7)(2012-3#8)(2012-6#1)(2013-1#25)(2013-8#14)
per-plant##3##1##(2008-10#3)
per-wet-pellet volume##2##2##(2008-7#2)
peracute##2##1##(2008-7#2)
perceive and##3##2##(2008-7#1)(2009-8#1)(2011-10#1)
perceive the##5##2##(1994-12#1)(2008-11#1)(2012-3#2)(2013-1#1)
perceive their own health##3##4##(1994-6#1)(1996-6#2)
perceive their##7##2##(1994-6#1)(1996-6#3)(2009-6#1)(2009-8#1)(2011-2#1)
perceive##28##1##(1991-2#1)(1994-12#1)(1994-6#1)(1996-6#3)(2008-10#1)(2008-11#4)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#4)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
perceived a##2##2##(1994-1#1)(2012-3#1)
perceived and##3##2##(2008-11#2)(2010-3#1)
perceived as a##2##3##(1990-11#1)(2010-12#1)
perceived as the most##2##4##(2008-11#1)(2013-8#1)
perceived as the##3##3##(2008-11#2)(2013-8#1)
perceived as##15##2##(1990-11#1)(1996-2#2)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
perceived barriers to a healthy##2##5##(2011-2#2)
perceived barriers to##4##3##(2010-7#1)(2011-2#3)
perceived barriers##5##2##(1995-12#1)(2010-7#1)(2011-2#3)
perceived benefits##2##2##(2008-11#1)(2009-4#1)
perceived by adolescents##2##3##(2009-7#1)(2010-9#1)
perceived by the##6##3##(1994-1#1)(2008-11#1)(2008-3#1)(2009-6#1)(2013-1#2)
perceived by##16##2##(1992-2#1)(1993-2#1)(1994-1#2)(2008-11#2)(2008-12#2)(2008-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-9#1)(2012-3#1)(2013-1#2)
perceived declines in##3##3##(2011-2#3)
perceived degree of##2##3##(2012-2#1)(2013-8#1)
perceived efficacy##3##2##(2008-11#1)(2010-6#1)(2010-9#1)
perceived emotional##2##2##(2013-1#1)(2013-8#1)
perceived exertion##6##2##(2013-1#1)(2013-8#5)
perceived family##2##2##(2009-7#1)(2010-10#1)
perceived feelings of being or thinking different##2##7##(2010-10#2)
perceived health##2##2##(2012-12#1)(2013-1#1)
perceived importance of social support##2##5##(2009-7#2)
perceived in##2##2##(2008-10#1)(2010-11#1)
perceived intensity##3##2##(2008-10#3)
perceived neighborhood##2##2##(2009-7#2)
perceived norms regarding##2##3##(2013-1#2)
perceived norms##4##2##(2011-1#1)(2013-1#3)
perceived prevalence of##3##3##(1991-12#1)(2013-1#2)
perceived problems##2##2##(1997-7#1)(2008-11#1)
perceived quality of##4##3##(2008-11#2)(2009-4#1)(2010-4#1)
perceived quality##6##2##(1995-12#1)(2008-11#3)(2009-4#1)(2010-4#1)
perceived self-efficacy##2##2##(2009-3#1)(2010-9#1)
perceived service##2##2##(1993-12#1)(1995-2#1)
perceived social support##4##3##(1992-2#1)(2009-7#1)(2010-1#2)
perceived susceptibility##2##2##(2008-4#2)
perceived that##2##2##(2009-7#1)(2011-2#1)
perceived the##4##2##(1992-2#1)(2008-11#1)(2010-11#1)(2012-3#1)
perceived their##2##2##(2008-9#1)(2011-2#1)
perceived themselves as##2##3##(1991-2#1)(1992-2#1)
perceived themselves##3##2##(1991-2#1)(1992-2#1)(2012-2#1)
perceived they##2##2##(2008-11#1)(2010-7#1)
perceived to be##3##3##(1991-2#1)(1993-3#1)(2009-4#1)
perceived to##5##2##(1991-2#1)(1993-3#1)(2008-11#1)(2009-4#1)(2013-1#1)
perceived##187##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-2#4)(1993-12#2)(1993-2#2)(1993-3#1)(1994-1#4)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#5)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#24)(2008-12#9)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#4)(2009-6#1)(2009-7#11)(2009-8#1)(2010-1#6)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#4)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#20)(2013-8#10)
perceivers have##2##2##(2008-11#1)(2013-8#1)
perceivers spontaneously##2##2##(2008-11#2)
perceivers##5##1##(2008-11#4)(2013-8#1)
perceivers' explicit##2##2##(2008-11#2)
perceivers' mental representations of##2##4##(2013-8#2)
perceivers'##4##1##(2008-11#2)(2013-8#2)
perceiving oneself as##2##3##(2012-2#2)
perceiving##5##1##(2008-11#1)(2009-10#1)(2011-2#1)(2012-2#2)
percent (95 percent CI =##3##5##(1996-1#3)
percent (95% C##2##3##(1990-6#2)
percent (95%##3##2##(1990-6#3)
percent (mol##2##2##(2008-10#2)
percent HCWA##2##2##(2008-10#2)
percent S##2##2##(2008-10#2)
percent at##3##2##(1991-5#1)(1995-6#2)
percent between##3##2##(1991-1#1)(1993-1#1)(2008-11#1)
percent body fat##3##3##(2008-11#1)(2008-4#2)
percent control##2##2##(2008-10#2)
percent extraction and##2##3##(2008-10#2)
percent extraction##4##2##(2008-10#4)
percent for##2##2##(1996-3#1)(2008-3#1)
percent from the##2##3##(1992-12#1)(2008-11#1)
percent from##4##2##(1992-12#1)(1996-1#1)(1997-3#1)(2008-11#1)
percent had##4##2##(1991-12#2)(2009-10#1)(2013-1#1)
percent have##2##2##(1995-12#1)(2008-10#1)
percent in##2##2##(1992-12#2)
percent infected spikelets (0##2##4##(2008-10#2)
percent infected##3##2##(2008-10#3)
percent inhibition##2##2##(1992-12#1)(2013-1#1)
percent leaf area##3##3##(2008-10#3)
percent leaf##4##2##(2008-10#4)
percent less##2##2##(1994-2#1)(1996-2#1)
percent nucleotide sequence##2##3##(2008-10#2)
percent of Medicaid##2##3##(1994-2#2)
percent of Medicare##2##3##(1994-1#1)(1996-3#1)
percent of adult##2##3##(1996-6#1)(2008-1#1)
percent of all##6##3##(1991-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-6#1)(2010-8#1)
percent of cases##6##3##(1995-3#1)(1996-3#1)(1997-1#2)(2008-5#1)(2010-2#1)
percent of deaths in##2##4##(1997-2#1)(2012-2#1)
percent of isolates##2##3##(2008-10#2)
percent of patients had##3##4##(1990-2#1)(1994-2#1)(2013-1#1)
percent of patients##10##3##(1990-2#1)(1992-2#1)(1992-5#1)(1994-2#1)(1995-11#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#2)
percent of prescriptions for##2##4##(2009-9#2)
percent of respondents##4##3##(1990-6#1)(1996-3#1)(2009-10#2)
percent of the applied MeBr##2##5##(1995-3#2)
percent of the patients were##2##5##(1997-6#1)(2012-3#1)
percent of the patients##4##4##(1994-3#1)(1997-6#1)(2008-11#1)(2012-3#1)
percent of the total##2##4##(1992-3#2)
percent of the##46##3##(1990-2#1)(1990-8#1)(1991-1#4)(1992-12#3)(1992-3#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-2#1)(1995-3#3)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
percent of these##4##3##(1992-1#1)(1995-2#1)(1996-6#1)(2008-8#1)
percent of total##6##3##(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1996-3#1)
percent of women##2##3##(2008-10#1)(2013-8#1)
percent of##161##2##(1990-11#1)(1990-2#3)(1990-6#2)(1990-8#1)(1991-1#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#3)(1994-12#3)(1994-2#7)(1994-3#7)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-6#4)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#9)(1996-5#1)(1996-6#3)(1997-1#3)(1997-2#4)(1997-3#3)(1997-6#2)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-9#6)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#2)
percent penetration and##2##3##(2008-10#2)
percent recovery of copper##3##4##(2008-10#3)
percent recovery of##6##3##(2008-10#6)
percent recovery values were##2##4##(2008-10#2)
percent recovery##10##2##(2008-10#10)
percent reduction in##4##3##(1992-12#1)(1993-12#1)(1997-1#1)(2008-10#1)
percent relative error##3##3##(2008-10#3)
percent relative standard deviation##2##4##(2008-10#2)
percent relative##5##2##(2008-10#5)
percent to##7##2##(1992-2#1)(1992-6#1)(1994-12#1)(1995-3#1)(1996-1#3)
percent visual##2##2##(2008-10#2)
percent were##6##2##(1994-12#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
percent##376##1##(1990-11#1)(1990-2#5)(1990-6#5)(1990-8#1)(1990-9#1)(1991-1#6)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#4)(1991-5#1)(1991-8#1)(1992-1#2)(1992-12#10)(1992-2#4)(1992-3#4)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#4)(1993-12#2)(1993-2#2)(1993-3#6)(1994-1#6)(1994-12#7)(1994-2#9)(1994-3#9)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#10)(1995-6#8)(1996-1#12)(1996-12#2)(1996-2#2)(1996-3#15)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#5)(1997-2#8)(1997-3#5)(1997-6#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#84)(2008-11#15)(2008-12#5)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#3)(2008-8#4)(2009-10#3)(2009-11#1)(2009-9#6)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#3)(2010-8#4)(2011-1#2)(2011-2#5)(2012-2#11)(2012-3#4)(2013-1#14)(2013-8#2)
percent) and##2##2##(1994-1#1)(1995-1#1)
percent) favored a##2##3##(1996-1#2)
percent) of##3##2##(1994-12#1)(1996-1#1)(1996-3#1)
percent) than##2##2##(1994-1#1)(1997-2#1)
percent) were##3##2##(1994-9#1)(2013-1#2)
percent)##32##1##(1993-1#3)(1994-1#3)(1994-12#2)(1994-9#1)(1995-1#2)(1995-12#1)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#5)(1997-3#4)(2008-10#1)(2013-1#2)
percentage and##8##2##(1995-12#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-8#1)(2010-1#1)(2013-1#1)
percentage changes of##2##3##(2012-12#2)
percentage content of##3##3##(2008-10#2)(2013-1#1)
percentage cover of##2##3##(2008-9#2)
percentage cover##4##2##(2008-9#4)
percentage ejection fraction##2##3##(2012-2#2)
percentage extraction of##2##3##(2008-10#2)
percentage extraction##3##2##(2008-10#3)
percentage fractional fiber shortening##2##4##(2012-2#2)
percentage in the##2##3##(1990-11#1)(2008-10#1)
percentage in##4##2##(1990-11#1)(2008-10#2)(2012-7#1)
percentage of M##3##3##(2008-10#3)
percentage of all##3##3##(1995-3#1)(2008-10#1)(2011-2#1)
percentage of apoptotic##2##3##(2008-12#2)
percentage of cells##7##3##(1997-3#1)(2008-10#2)(2008-11#3)(2008-4#1)
percentage of correct##2##3##(2008-10#1)(2011-1#1)
percentage of elderly clients in the practice of mental health professionals##2##11##(1994-1#2)
percentage of energy##2##3##(1997-8#1)(2012-2#1)
percentage of germinated conidia with appressoria and##2##7##(2008-10#2)
percentage of glutaraldehyde##2##3##(2008-10#2)
percentage of infected##3##3##(2008-10#3)
percentage of patients##2##3##(2011-2#2)
percentage of polychromatic erythrocytes##2##4##(2008-9#2)
percentage of samples with hemolysis##2##5##(2013-1#2)
percentage of the##23##3##(1991-3#1)(1993-3#3)(1994-2#1)(1996-2#1)(1996-3#1)(2006-6#1)(2008-10#8)(2008-11#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
percentage of##204##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#87)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#12)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#8)(2013-8#2)
percentage points##3##2##(1993-1#1)(2013-1#2)
percentage recoveries were##2##3##(2008-10#2)
percentage recoveries##9##2##(2008-10#9)
percentage recovery##3##2##(2008-10#3)
percentage was reduced##2##3##(1990-5#1)(2008-10#1)
percentage was significantly##2##3##(2008-10#1)(2009-3#1)
percentage was##11##2##(1990-5#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)
percentage##309##1##(1990-11#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1992-11#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#3)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-6#1)(1997-2#2)(1997-3#2)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#129)(2008-11#16)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#8)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#13)(2011-7#1)(2012-12#4)(2012-2#7)(2012-3#4)(2012-4#1)(2012-7#1)(2013-1#17)(2013-8#2)
percentage)##3##1##(2008-10#1)(2009-6#1)(2009-7#1)
percentages of the##4##3##(1993-8#1)(2008-10#2)(2008-11#1)
percentages of##35##2##(1991-12#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
percentages ranging between##2##3##(2008-10#1)(2011-2#1)
percentages ranging##3##2##(2008-10#2)(2011-2#1)
percentages##56##1##(1991-12#1)(1993-6#1)(1993-8#1)(1995-12#2)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-8#3)
percentile tables##2##2##(2008-1#2)
percentile##6##1##(1997-3#1)(2008-1#2)(2009-10#1)(2011-1#1)(2013-1#1)
perceptible##2##1##(2008-10#1)(2011-2#1)
perception and interpretation of##2##4##(2008-11#1)(2012-2#1)
perception and production##2##3##(2008-11#2)
perception and sense of smell##2##5##(2013-1#2)
perception and##12##2##(1994-12#2)(1997-2#1)(2008-11#3)(2008-9#1)(2009-8#1)(2012-2#2)(2013-1#2)
perception by##4##2##(1995-8#1)(2008-8#1)(2008-9#1)(2009-8#1)
perception during landing##3##3##(2011-2#3)
perception in a##2##3##(2008-11#1)(2010-5#1)
perception in children##2##3##(2008-9#1)(2012-3#1)
perception in##13##2##(1991-2#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
perception is##5##2##(1991-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2013-1#1)
perception level of nursing activities##2##5##(1991-2#2)
perception level##3##2##(1991-2#3)
perception of a##3##3##(1994-1#1)(2010-10#1)(2011-2#1)
perception of early TA##3##4##(2013-1#3)
perception of early##4##3##(2013-1#4)
perception of general health##2##4##(1992-3#2)
perception of health##4##3##(2010-10#1)(2011-2#3)
perception of professional nursing functions##2##5##(1991-2#2)
perception of the disease as cyclical##3##6##(2008-11#3)
perception of the##10##3##(1991-2#1)(1993-3#1)(2008-11#3)(2008-12#1)(2010-11#1)(2011-2#1)(2011-7#1)(2012-2#1)
perception of their##5##3##(1991-2#1)(2008-11#2)(2008-12#1)(2011-1#1)
perception of these##2##3##(2008-11#1)(2011-2#1)
perception of##66##2##(1991-2#5)(1992-3#2)(1993-2#1)(1993-3#2)(1994-1#2)(1995-2#1)(1995-5#2)(1996-3#1)(2008-11#9)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
perception performance##4##2##(2008-9#4)
perception that they##2##3##(1992-2#1)(2008-7#1)
perception that##4##2##(1992-2#1)(1994-1#1)(1994-12#1)(2008-7#1)
perception to##2##2##(2008-11#1)(2008-8#1)
perception was evaluated##2##3##(2008-7#1)(2013-1#1)
perception was##4##2##(1991-2#1)(2008-6#1)(2008-7#1)(2013-1#1)
perception##177##1##(1991-12#1)(1991-2#11)(1991-3#1)(1992-2#2)(1992-3#2)(1993-2#2)(1993-3#2)(1994-1#3)(1994-12#4)(1995-2#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#24)(2008-12#3)(2008-5#2)(2008-6#5)(2008-7#12)(2008-8#2)(2008-9#26)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#15)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#6)
perceptions about the##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
perceptions and practices##2##3##(2012-2#2)
perceptions and social##2##3##(2008-12#1)(2012-3#1)
perceptions and##20##2##(1992-2#1)(2008-1#2)(2008-11#2)(2008-12#4)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-6#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
perceptions of a##3##3##(2011-1#1)(2012-3#1)(2013-1#1)
perceptions of an individual with a laryngectomy##2##7##(2011-1#2)
perceptions of clinical decision-making##2##4##(2008-11#2)
perceptions of generic medicines##2##4##(2011-1#2)
perceptions of health##2##3##(1994-12#1)(2008-1#1)
perceptions of mental illness##2##4##(2008-12#2)
perceptions of mental##3##3##(2008-12#3)
perceptions of nurses##2##3##(1991-2#1)(2012-3#1)
perceptions of quality##2##3##(1991-2#1)(2010-10#1)
perceptions of support##2##3##(2008-12#1)(2010-1#1)
perceptions of the classroom##3##4##(2008-12#3)
perceptions of the##21##3##(1991-1#1)(1991-2#1)(1992-1#1)(1995-2#2)(2008-10#1)(2008-11#2)(2008-12#4)(2009-4#1)(2009-6#1)(2010-12#2)(2010-9#2)(2011-1#2)(2013-1#1)
perceptions of their##6##3##(1992-1#1)(1995-1#1)(2008-11#2)(2008-12#1)(2010-11#1)
perceptions of##111##2##(1991-1#1)(1991-2#3)(1992-1#3)(1994-12#1)(1995-1#1)(1995-2#5)(1995-3#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-8#3)(2008-1#1)(2008-10#1)(2008-11#14)(2008-12#13)(2008-8#1)(2008-9#1)(2009-11#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#12)(2011-2#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#2)
perceptions were##2##2##(2008-11#1)(2013-1#1)
perceptions##161##1##(1991-1#1)(1991-2#3)(1992-1#3)(1992-2#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-2#5)(1995-3#1)(1996-1#1)(1996-3#3)(1997-4#1)(1997-8#3)(2007-12#1)(2008-1#4)(2008-10#1)(2008-11#21)(2008-12#19)(2008-8#1)(2008-9#2)(2009-11#2)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#5)(2009-9#1)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#4)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#17)(2011-2#4)(2012-2#4)(2012-3#6)(2013-1#11)(2013-8#2)
perceptron##3##1##(2008-10#1)(2008-11#1)(2010-8#1)
percepts##3##1##(2008-9#1)(2009-12#2)
perceptual attributes##2##2##(2008-5#2)
perceptual error##2##2##(2008-9#2)
perceptual##17##1##(1992-12#1)(1997-2#1)(2008-11#4)(2008-5#4)(2008-8#1)(2008-9#4)(2011-2#1)(2013-1#1)
perchlorate and##3##2##(2008-10#3)
perchlorate at##2##2##(2008-10#2)
perchlorate exposure##2##2##(2008-10#2)
perchlorate in drinking water##2##4##(2008-10#2)
perchlorate in##9##2##(2008-10#9)
perchlorate ion##3##2##(2008-10#3)
perchlorate is##2##2##(2008-10#2)
perchlorate salts of##2##3##(2008-10#2)
perchlorate system is##2##3##(2008-10#2)
perchlorate system##3##2##(2008-10#3)
perchlorate than##2##2##(2008-10#2)
perchlorate##60##1##(1997-3#2)(2008-10#57)(2011-1#1)
perchlorates##2##1##(2008-10#2)
perchloric acid##9##2##(2008-10#9)
perchloric and hydrofluoric acids##2##4##(2008-10#2)
perchloric and##3##2##(2008-10#3)
perchloric##15##1##(2008-10#15)
percolate##2##1##(2007-12#1)(2008-10#1)
percolating##2##1##(2008-10#2)
percolation##3##1##(1992-11#1)(2008-10#1)(2013-8#1)
percussion pistol##2##2##(2011-2#2)
percussion##8##1##(1995-8#1)(2008-12#2)(2008-3#2)(2011-2#3)
percutaneous absorption of##4##3##(2008-5#2)(2011-3#2)
percutaneous absorption##8##2##(2008-11#1)(2008-5#5)(2011-3#2)
percutaneous closure of##2##3##(2011-2#1)(2012-12#1)
percutaneous coronary intervention for##2##4##(2011-2#1)(2013-8#1)
percutaneous coronary intervention##8##3##(2008-11#2)(2008-3#1)(2009-10#1)(2011-2#2)(2013-8#2)
percutaneous coronary interventions##5##3##(2008-11#1)(2011-2#4)
percutaneous coronary revascularization##2##3##(2008-12#2)
percutaneous coronary##18##2##(2008-11#3)(2008-12#2)(2008-3#1)(2009-10#1)(2011-2#9)(2013-8#2)
percutaneous drainage##3##2##(1991-8#1)(2010-12#1)(2011-2#1)
percutaneous injection##2##2##(1993-11#1)(2010-12#1)
percutaneous lumbar##2##2##(1996-6#1)(2011-2#1)
percutaneous nephrolithotomy in children##2##4##(2008-10#2)
percutaneous nephrolithotomy##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
percutaneous or##2##2##(1991-3#2)
percutaneous transluminal angioplasty (PTA)##2##4##(2008-7#1)(2011-2#1)
percutaneous transluminal angioplasty##3##3##(1993-8#1)(2008-7#1)(2011-2#1)
percutaneous transluminal coronary angioplasty (PTCA)##3##5##(2008-5#2)(2013-8#1)
percutaneous transluminal coronary angioplasty##4##4##(1995-2#1)(2008-5#2)(2013-8#1)
percutaneous transluminal##7##2##(1993-8#1)(1995-2#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-8#1)
percutaneous##81##1##(1990-2#1)(1990-8#1)(1991-3#2)(1991-8#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-3#2)(1996-6#2)(1997-8#1)(2008-10#4)(2008-11#7)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#1)(2009-10#1)(2010-12#4)(2010-6#1)(2011-2#21)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-8#3)
percutaneously##6##1##(1990-11#1)(1990-8#1)(2008-10#1)(2009-10#1)(2012-3#1)(2013-1#1)
perdeuterated palmitic acid##2##3##(1994-5#1)(2008-10#1)
perdeuterated##3##1##(1994-5#1)(2008-10#2)
perennial allergens##2##2##(2011-2#2)
perennial canker##3##2##(2008-10#3)
perennial crops##2##2##(2008-10#2)
perennial grasses##3##2##(2008-10#2)(2008-9#1)
perennial plants##2##2##(2008-10#1)(2010-1#1)
perennial ryegrass (Lolium perenne)##2##4##(2008-10#2)
perennial ryegrass (Lolium##3##3##(2008-10#3)
perennial ryegrass seed crops##2##4##(2008-10#2)
perennial ryegrass turf##5##3##(2008-10#5)
perennial ryegrass##18##2##(2008-10#18)
perennial##46##1##(2008-10#32)(2008-12#1)(2008-8#4)(2008-9#2)(2009-5#1)(2010-1#1)(2011-2#4)(2012-7#1)
perennials##6##1##(2008-9#6)
pereopod##2##1##(2008-6#2)
perfect double stranded##2##3##(2008-10#2)
perfect##28##1##(1993-2#1)(1994-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#4)(2010-8#1)(2010-9#1)(2013-1#2)
perfectly to##2##2##(2008-10#2)
perfectly with##2##2##(2008-1#1)(2008-10#1)
perfectly##21##1##(1995-3#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)
perfluorinated##2##1##(2008-10#1)(2010-4#1)
perfluorodecanoic acid##2##2##(1994-8#2)
perforant##3##1##(1990-5#2)(1995-12#1)
perforata##3##1##(2012-2#3)
perforated gastroduodenal ulcer##2##3##(1993-6#1)(2012-3#1)
perforated##6##1##(1993-6#2)(2007-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
perforation and##2##2##(2007-11#1)(2009-8#1)
perforation in##2##2##(1990-12#1)(1991-3#1)
perforation of a##2##3##(1993-6#1)(2008-12#1)
perforation of the##2##3##(1991-8#1)(2011-2#1)
perforation of##5##2##(1991-8#1)(1993-6#1)(2008-12#2)(2011-2#1)
perforation with##3##2##(1997-3#1)(2010-12#1)(2010-2#1)
perforation##35##1##(1990-11#1)(1990-12#1)(1991-3#1)(1991-8#1)(1993-6#4)(1995-10#2)(1996-6#1)(1997-3#1)(2007-11#1)(2008-11#3)(2008-12#5)(2009-8#1)(2010-12#2)(2010-2#1)(2011-2#6)(2013-1#4)
perforations are##2##2##(2010-12#2)
perforations##8##1##(1990-5#1)(2010-12#2)(2011-2#4)(2013-1#1)
perforator flap##2##2##(2013-1#2)
perforator##7##1##(2008-9#2)(2013-1#5)
perforators##4##1##(2011-3#1)(2013-1#3)
perforatum##2##1##(2008-10#1)(2009-3#1)
perform a##26##2##(1990-6#1)(1993-11#1)(1996-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
perform accurate##2##2##(2008-10#1)(2013-1#1)
perform an##5##2##(2008-10#3)(2010-11#1)(2012-3#1)
perform as well as##2##4##(2008-5#1)(2008-9#1)
perform better##2##2##(2008-11#1)(2008-6#1)
perform complex##2##2##(2008-7#1)(2008-9#1)
perform in##2##2##(2008-10#1)(2010-1#1)
perform more##2##2##(2010-7#1)(2012-2#1)
perform the same##2##3##(1997-6#1)(2008-5#1)
perform the sequential##2##3##(2008-10#2)
perform the##27##2##(1991-2#1)(1993-3#1)(1997-2#1)(1997-6#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
perform their##3##2##(1990-12#1)(1991-3#1)(2008-7#1)
perform well##4##2##(2008-10#1)(2010-8#1)(2011-3#1)(2013-1#1)
perform##181##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1995-11#3)(1995-6#2)(1996-11#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#60)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-9#6)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#8)(2013-8#4)
performance across##2##2##(2009-7#1)(2010-3#1)
performance after##2##2##(2008-8#1)(2012-2#1)
performance and cost-effectiveness##2##3##(1995-2#2)
performance and for##2##3##(1996-3#1)(2008-10#1)
performance and##45##2##(1993-12#2)(1994-12#1)(1995-2#2)(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-1#2)(2013-8#3)
performance are##8##2##(1996-8#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-7#1)(2013-1#1)
performance as an##2##3##(2008-10#2)
performance as measured by##2##4##(2010-9#1)(2013-1#1)
performance as##7##2##(2008-10#3)(2008-3#2)(2010-9#1)(2013-1#1)
performance assessment##2##2##(1994-1#1)(2010-12#1)
performance at a##2##3##(1996-3#1)(2008-11#1)
performance at##5##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
performance between##2##2##(2008-7#1)(2008-9#1)
performance by##6##2##(1993-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)(2013-1#1)
performance can be##3##3##(1996-3#1)(2008-11#1)(2010-8#1)
performance can##4##2##(1996-2#1)(1996-3#1)(2008-11#1)(2010-8#1)
performance capillary electrophoresis##3##3##(2008-10#3)
performance characteristics are##2##3##(2008-10#2)
performance characteristics in##2##3##(2008-10#2)
performance characteristics of the##5##4##(2008-10#4)(2008-5#1)
performance characteristics of##8##3##(2008-10#7)(2008-5#1)
performance characteristics were##2##3##(2008-10#2)
performance characteristics##27##2##(1995-2#1)(2008-10#22)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
performance compared to##2##3##(2008-10#2)
performance conditions##2##2##(2008-10#2)
performance criteria such as##2##4##(2008-10#2)
performance criteria##5##2##(2008-10#4)(2008-5#1)
performance data##3##2##(1997-3#1)(2008-2#1)(2013-1#1)
performance decreased##2##2##(2008-8#1)(2012-3#1)
performance depends##2##2##(2008-10#1)(2008-3#1)
performance during##3##2##(1993-3#1)(1996-2#1)(2008-10#1)
performance evaluation of##2##3##(2008-10#2)
performance evaluation##3##2##(1996-2#1)(2008-10#2)
performance for##12##2##(2008-10#7)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
performance has been##4##3##(1994-8#1)(2008-2#1)(2009-6#1)(2010-8#1)
performance has##6##2##(1994-8#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)
performance have been studied##2##4##(2008-10#2)
performance have been##4##3##(2008-10#3)(2011-2#1)
performance improvement##4##2##(1997-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
performance in a##5##3##(2008-11#1)(2008-5#1)(2009-10#1)(2012-7#1)(2013-8#1)
performance in both##2##3##(2008-10#1)(2008-11#1)
performance in terms of##4##4##(2008-10#3)(2008-11#1)
performance in the##16##3##(1991-2#1)(1991-3#2)(1992-12#2)(1994-12#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#3)(2009-10#1)(2010-7#1)(2012-6#1)
performance in##62##2##(1991-2#3)(1991-3#2)(1992-12#2)(1993-1#1)(1994-12#1)(1995-12#1)(1996-2#2)(2008-10#15)(2008-11#10)(2008-12#3)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-2#2)(2012-6#1)(2012-7#1)(2013-1#2)(2013-8#1)
performance indicators to##2##3##(1994-2#1)(2008-11#1)
performance indicators##5##2##(1994-2#3)(2008-11#2)
performance information##3##2##(1997-3#1)(2013-1#2)
performance is achieved##2##3##(2008-10#1)(2008-3#1)
performance is also##2##3##(2008-2#1)(2008-3#1)
performance is##17##2##(1993-2#1)(1995-2#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-8#2)(2008-9#1)(2012-2#1)
performance liquid chromatographic analysis##2##4##(1994-8#1)(2008-10#1)
performance liquid chromatographic##11##3##(1993-2#1)(1994-8#1)(2008-10#8)(2012-2#1)
performance liquid chromatography (HPLC) with##5##5##(1997-2#1)(2008-10#4)
performance liquid chromatography (HPLC)##38##4##(1997-2#1)(2008-10#33)(2008-11#1)(2008-5#2)(2008-8#1)
performance liquid chromatography and##4##4##(2008-10#4)
performance liquid chromatography method for##2##5##(2008-10#1)(2008-5#1)
performance liquid chromatography method##3##4##(2008-10#2)(2008-5#1)
performance liquid chromatography of##2##4##(2008-10#2)
performance liquid chromatography with##14##4##(1993-2#1)(1995-6#1)(2008-10#11)(2008-5#1)
performance liquid chromatography##94##3##(1990-8#2)(1993-2#1)(1993-6#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#78)(2008-11#2)(2008-5#4)(2008-8#1)(2008-9#1)(2012-2#1)
performance liquid##125##2##(1990-12#2)(1990-5#1)(1990-8#2)(1991-3#1)(1993-2#2)(1993-6#1)(1994-8#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#100)(2008-11#2)(2008-5#4)(2008-8#3)(2008-9#1)(2012-2#2)
performance makes##2##2##(2008-10#1)(2008-11#1)
performance measure##3##2##(2010-12#1)(2011-2#2)
performance measured##2##2##(1994-8#1)(2008-7#1)
performance measurement##2##2##(2008-11#1)(2009-3#1)
performance measures and##3##3##(1997-3#1)(2010-8#1)(2013-1#1)
performance measures based on##2##4##(1993-2#1)(1997-3#1)
performance measures##14##2##(1993-2#1)(1995-12#1)(1996-2#1)(1997-3#6)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#2)
performance of a new##3##4##(2008-10#3)
performance of a##39##3##(1993-12#1)(1993-3#1)(1995-5#1)(1996-6#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#13)(2008-7#2)(2008-9#1)(2009-11#1)(2013-1#1)
performance of all##2##3##(2008-10#1)(2008-6#1)
performance of an##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
performance of both##5##3##(2008-10#5)
performance of capillary##2##3##(2008-10#2)
performance of college students##3##4##(2009-3#1)(2013-8#2)
performance of health maintenance organizations##2##5##(1991-3#1)(1994-2#1)
performance of such##3##3##(1997-1#1)(2008-2#1)(2008-6#1)
performance of the SIA system##2##5##(2008-10#2)
performance of the different##2##4##(2008-10#1)(2011-1#1)
performance of the method has been evaluated##2##7##(2008-10#2)
performance of the method has been##3##6##(2008-10#3)
performance of the method##9##4##(2008-10#8)(2010-4#1)
performance of the proposed method##6##5##(2008-10#6)
performance of the proposed##11##4##(2008-10#10)(2009-10#1)
performance of the sensor##2##4##(2008-10#2)
performance of the system##9##4##(2008-10#9)
performance of the three##2##4##(1996-3#1)(2008-5#1)
performance of the two##3##4##(1991-2#1)(2008-12#1)(2008-3#1)
performance of the##115##3##(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#2)(2008-10#60)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#5)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
performance of these electrodes##2##4##(2008-10#2)
performance of these##12##3##(1997-2#1)(2008-10#8)(2008-3#1)(2008-4#1)(2010-7#1)
performance of this fungus##2##4##(2008-10#2)
performance of this sensor##2##4##(2008-10#2)
performance of this##14##3##(2008-10#10)(2008-11#2)(2008-3#1)(2012-3#1)
performance of##320##2##(1990-11#2)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#3)(1992-1#2)(1992-2#2)(1993-12#3)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-5#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#142)(2008-11#16)(2008-12#4)(2008-2#10)(2008-3#29)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#6)
performance on a##2##3##(2008-10#1)(2011-2#1)
performance on novel##2##3##(2008-8#2)
performance on the##6##3##(1996-2#1)(2008-10#1)(2008-12#2)(2008-3#1)(2011-2#1)
performance on##21##2##(1994-1#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
performance or##3##2##(2008-11#1)(2008-7#1)(2009-1#1)
performance outcomes##2##2##(1993-2#1)(2008-9#1)
performance over##5##2##(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)
performance parameters##2##2##(2008-10#1)(2013-1#1)
performance regarding##2##2##(2010-8#1)(2012-12#1)
performance standard##2##2##(1992-2#1)(2012-2#1)
performance statistics##2##2##(2008-9#2)
performance status##7##2##(1991-2#1)(1994-12#1)(1994-8#1)(2008-7#1)(2010-2#3)
performance than the##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
performance than##11##2##(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2013-8#1)
performance that##2##2##(2008-2#1)(2011-2#1)
performance to##8##2##(1990-6#1)(1994-3#2)(2008-10#2)(2008-11#1)(2009-8#1)(2013-1#1)
performance under##9##2##(1993-1#1)(1993-12#1)(1993-3#2)(2008-10#1)(2008-11#1)(2008-6#2)(2012-9#1)
performance voltage##3##2##(2008-10#3)
performance was achieved##2##3##(2008-10#2)
performance was also##3##3##(2008-10#2)(2008-7#1)
performance was evaluated by##4##4##(2008-10#4)
performance was evaluated with##3##4##(2008-10#3)
performance was evaluated##11##3##(2008-10#11)
performance was observed##3##3##(2008-10#3)
performance was studied##2##3##(1996-2#1)(2008-11#1)
performance was##46##2##(1990-11#1)(1996-2#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-8#2)(2012-3#1)
performance we found in the##2##5##(2008-11#2)
performance were investigated##2##3##(2008-10#1)(2011-1#1)
performance were##10##2##(1996-3#1)(2008-10#4)(2008-7#1)(2011-1#3)(2013-1#1)
performance when##2##2##(2008-10#1)(2012-3#1)
performance with##6##2##(1994-9#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-5#1)
performance##1144##1##(1990-11#3)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-12#2)(1991-2#8)(1991-3#8)(1991-6#1)(1992-1#4)(1992-12#3)(1992-2#4)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#10)(1993-2#8)(1993-3#11)(1993-6#1)(1994-1#7)(1994-12#10)(1994-2#7)(1994-3#5)(1994-8#8)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#10)(1995-2#10)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#4)(1996-12#2)(1996-2#14)(1996-3#7)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#8)(1997-5#2)(1997-7#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#429)(2008-11#76)(2008-12#27)(2008-2#22)(2008-3#62)(2008-4#3)(2008-5#24)(2008-6#10)(2008-7#27)(2008-8#20)(2008-9#27)(2009-1#6)(2009-10#11)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#9)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#9)(2010-8#18)(2010-9#2)(2011-1#6)(2011-2#29)(2011-3#2)(2011-7#1)(2012-12#8)(2012-2#15)(2012-3#9)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#33)(2013-8#22)
performance)##2##1##(1994-8#1)(2009-7#1)
performance-based objectives##2##2##(1996-2#2)
performance-based##5##1##(1996-2#2)(2008-10#1)(2011-2#2)
performance-measurement system##2##2##(1996-2#2)
performance?##2##1##(1992-3#2)
performances are compared##2##3##(2008-10#2)
performances are##3##2##(2008-10#3)
performances for##2##2##(1997-2#1)(2008-10#1)
performances in##3##2##(2008-3#1)(2010-8#1)(2012-5#1)
performances of a##3##3##(1993-3#1)(2008-10#2)
performances of the##10##3##(2008-10#8)(2008-3#1)(2011-2#1)
performances of##26##2##(1991-3#1)(1993-2#1)(1993-3#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2011-2#1)
performances##54##1##(1991-3#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-2#1)(2008-10#32)(2008-11#4)(2008-2#1)(2008-3#4)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-5#1)(2013-1#1)(2013-8#1)
performed a genome-wide##3##3##(2010-5#1)(2012-3#2)
performed a prospective##2##3##(1994-2#1)(2011-2#1)
performed a semiquantitative##2##3##(2008-7#1)(2013-8#1)
performed a##42##2##(1992-12#1)(1994-2#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#2)(2009-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-3#8)(2013-1#5)(2013-8#4)
performed according to##3##3##(1991-3#1)(2008-10#1)(2009-1#1)
performed after a##2##3##(1990-11#1)(2008-10#1)
performed after##15##2##(1990-11#1)(1990-8#1)(1993-11#1)(1996-3#2)(2008-10#3)(2008-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
performed against##2##2##(2008-11#1)(2012-2#1)
performed also by##2##3##(1991-2#1)(1992-9#1)
performed among##2##2##(2008-10#2)
performed an experimental##2##3##(1993-3#1)(2008-2#1)
performed an##6##2##(1993-3#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#2)
performed and a##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
performed and replicated##2##3##(2008-10#1)(2010-1#1)
performed and the##11##3##(1990-5#1)(2008-10#4)(2008-11#1)(2009-8#1)(2009-9#1)(2011-2#2)(2013-1#1)
performed and##30##2##(1990-3#1)(1990-5#1)(1991-2#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#2)
performed annually##2##2##(2008-10#1)(2010-11#1)
performed as a##2##3##(2008-10#1)(2008-11#1)
performed as##10##2##(1991-2#1)(1993-1#1)(1995-11#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2013-8#1)
performed at a constant##2##4##(2008-10#2)
performed at a##7##3##(1992-12#1)(1993-11#1)(2008-10#4)(2008-11#1)
performed at an##2##3##(1991-1#1)(2008-10#1)
performed at different##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
performed at high##2##3##(1997-8#1)(2008-7#1)
performed at the##6##3##(1997-8#1)(2008-10#1)(2008-11#2)(2010-5#1)(2011-2#1)
performed at this##2##3##(2008-7#1)(2008-8#1)
performed at##48##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-1#1)(1997-8#2)(2008-10#17)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#2)
performed because of##5##3##(1993-6#1)(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
performed before the##2##3##(1990-12#1)(1996-11#1)
performed before##4##2##(1990-12#1)(1996-11#1)(2007-8#1)(2008-10#1)
performed better than##3##3##(2009-3#1)(2009-7#1)(2009-8#1)
performed better##4##2##(2009-3#1)(2009-7#1)(2009-8#1)(2010-7#1)
performed between##6##2##(1994-11#1)(1996-12#1)(2008-10#3)(2010-11#1)
performed both##2##2##(2008-3#1)(2008-4#1)
performed by a##16##3##(1990-6#1)(1993-2#1)(2008-10#12)(2008-3#1)(2008-8#1)
performed by affinity chromatography##2##4##(1997-2#1)(2008-11#1)
performed by an##3##3##(2008-10#2)(2013-1#1)
performed by comparing##2##3##(1997-6#1)(2008-10#1)
performed by flame atomic absorption##2##5##(2008-10#2)
performed by gas chromatography-mass spectrometry##2##5##(2008-10#2)
performed by gas##3##3##(2008-10#3)
performed by means of the##2##5##(2008-10#2)
performed by means of##4##4##(2007-12#1)(2008-10#3)
performed by measuring the##3##4##(2008-10#2)(2008-11#1)
performed by one##3##3##(2008-10#1)(2008-7#2)
performed by the analysis of##2##5##(2008-10#2)
performed by the##20##3##(1990-5#1)(1993-12#3)(1995-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-3#2)(2008-5#1)(2009-12#1)(2011-2#1)
performed by two##2##3##(2008-10#1)(2013-1#1)
performed by using a##2##4##(2008-10#2)
performed by using##7##3##(1995-12#1)(2008-10#4)(2008-5#2)
performed by##151##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#77)(2008-11#5)(2008-12#2)(2008-3#3)(2008-5#5)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#2)
performed data##2##2##(2008-10#1)(2008-6#1)
performed due to##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
performed during the last##2##4##(1996-9#1)(2008-11#1)
performed during the##6##3##(1994-8#1)(1996-6#1)(1996-9#1)(2008-10#2)(2008-11#1)
performed during##12##2##(1994-3#1)(1994-8#1)(1996-6#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
performed equally well##2##3##(2008-11#1)(2011-2#1)
performed following the##2##3##(2012-12#2)
performed following##4##2##(1997-6#1)(2008-10#1)(2012-12#2)
performed for a##2##3##(2008-5#1)(2013-1#1)
performed for each##4##3##(2008-1#1)(2008-10#2)(2008-8#1)
performed for other reasons##2##4##(1991-8#1)(2011-2#1)
performed for the##11##3##(2008-10#6)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
performed for##55##2##(1990-9#2)(1991-8#1)(1996-3#1)(2008-1#3)(2008-10#17)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#2)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
performed from##5##2##(1990-5#1)(1994-8#1)(2008-1#1)(2008-10#1)(2013-8#1)
performed immediately##2##2##(1996-3#1)(2013-1#1)
performed in 0##3##3##(2008-10#3)
performed in 15##3##3##(1990-9#1)(2008-7#1)(2011-2#1)
performed in 20##2##3##(1991-3#1)(2012-12#1)
performed in 4##3##3##(1990-6#1)(2008-10#1)(2009-8#1)
performed in 42 patients##2##4##(1992-6#1)(2013-1#1)
performed in 7##2##3##(2008-10#1)(2013-1#1)
performed in a##23##3##(1996-6#1)(2008-10#10)(2008-11#3)(2008-7#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
performed in all##7##3##(1990-9#1)(1992-5#1)(1993-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
performed in an##8##3##(1991-11#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-11#1)
performed in mice##2##3##(2008-10#1)(2013-8#1)
performed in one##2##3##(2008-10#2)
performed in order to obtain##2##5##(2008-10#1)(2008-7#1)
performed in order to##12##4##(1990-2#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#2)
performed in our##4##3##(1991-8#1)(2008-11#1)(2008-9#1)(2011-1#1)
performed in parallel##2##3##(2008-5#2)
performed in patients##2##3##(1996-3#1)(2011-2#1)
performed in the hospital##3##4##(1995-2#2)(2008-3#1)
performed in the##24##3##(1990-12#1)(1995-11#1)(1995-2#2)(1996-11#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2011-2#3)(2012-12#1)(2013-1#1)
performed in this##3##3##(2008-10#2)(2008-3#1)
performed in three##2##3##(2012-2#1)(2012-3#1)
performed in two##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
performed in##196##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-2#3)(1995-11#2)(1995-2#3)(1996-11#1)(1996-12#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-8#4)(2007-8#1)(2008-10#56)(2008-11#13)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#8)(2008-7#8)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#10)(2013-8#1)
performed is##2##2##(2008-10#1)(2013-7#1)
performed less##2##2##(1997-3#1)(2011-1#1)
performed monthly##2##2##(2008-12#1)(2009-5#1)
performed normally in##2##3##(1992-12#1)(2008-11#1)
performed of the##2##3##(2008-10#1)(2012-2#1)
performed of##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
performed on a##16##3##(1990-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2011-3#2)(2013-1#1)
performed on an##4##3##(1993-6#1)(2008-10#3)
performed on both##3##3##(2008-10#2)(2008-11#1)
performed on day##3##3##(1993-12#1)(1997-3#1)(2008-11#1)
performed on different##2##3##(1990-12#1)(2010-3#1)
performed on life insurance applicants##3##5##(1995-1#3)
performed on the model##2##4##(2008-7#1)(2011-2#1)
performed on the same##4##4##(1990-2#1)(2008-10#1)(2008-5#2)
performed on the##23##3##(1990-2#1)(1991-3#1)(1993-3#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
performed on this##2##3##(2008-10#2)
performed on##118##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#41)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#2)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
performed over a##5##3##(1993-8#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#1)
performed over##6##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#1)
performed per##2##2##(1997-8#1)(2010-12#1)
performed prior to##2##3##(2008-10#1)(2010-1#1)
performed regularly##3##2##(1997-5#1)(2007-11#1)(2010-10#1)
performed significantly##2##2##(2008-12#1)(2009-9#1)
performed simulations##2##2##(2008-8#1)(2011-3#1)
performed simultaneously##2##2##(1995-2#1)(2008-10#1)
performed six##2##2##(2008-10#1)(2013-1#1)
performed the##15##2##(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
performed three##3##2##(1991-6#1)(2013-1#1)(2013-8#1)
performed through##7##2##(2008-10#2)(2008-3#1)(2009-3#1)(2011-3#1)(2012-12#1)(2013-1#1)
performed to assess the##4##4##(1995-11#1)(2012-2#1)(2013-1#2)
performed to assess##7##3##(1995-11#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
performed to compare##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
performed to confirm##3##3##(1991-11#1)(2008-10#1)(2013-8#1)
performed to determine if these##2##5##(1997-3#1)(2008-10#1)
performed to determine if##3##4##(1997-3#1)(2008-10#2)
performed to determine the##9##4##(1990-9#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-7#2)(2011-2#1)
performed to determine whether##2##4##(1997-1#1)(2008-7#1)
performed to determine##17##3##(1990-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#3)(2011-2#1)
performed to estimate the##3##4##(2008-10#1)(2010-11#1)(2013-1#1)
performed to estimate##4##3##(2008-10#2)(2010-11#1)(2013-1#1)
performed to evaluate the##6##4##(1992-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
performed to evaluate##8##3##(1992-12#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
performed to examine the##4##4##(1995-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
performed to investigate the##2##4##(2008-3#1)(2008-9#1)
performed to obtain##4##3##(1991-1#1)(1994-11#1)(2007-8#1)(2012-3#1)
performed to rule out##2##4##(2011-2#1)(2012-12#1)
performed to show the##2##4##(2007-12#1)(2008-10#1)
performed to yield##2##3##(1996-12#1)(2008-3#1)
performed to##105##2##(1990-9#1)(1991-1#1)(1991-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#6)(2008-12#3)(2008-3#6)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#7)
performed two##3##2##(2008-11#3)
performed under general##2##3##(1994-12#1)(1997-6#1)
performed under locoregional anesthesia##2##4##(2011-3#2)
performed under##13##2##(1994-12#1)(1996-1#1)(1997-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2011-3#2)(2012-2#1)
performed using a##16##3##(1990-3#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2011-2#2)(2013-1#1)
performed using data##2##3##(1993-12#1)(2008-10#1)
performed using sequential##2##3##(1992-9#1)(2008-10#1)
performed using the same##2##4##(1990-12#1)(2008-7#1)
performed using the##16##3##(1990-12#1)(1992-3#2)(1997-8#1)(2008-10#5)(2008-11#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
performed using##89##2##(1990-12#1)(1990-3#1)(1991-3#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#1)(1995-6#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-10#40)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
performed via a##3##3##(2008-10#1)(2011-2#2)
performed via the##2##3##(1996-3#1)(2012-12#1)
performed via##7##2##(1996-3#1)(2008-10#1)(2011-2#3)(2012-12#1)(2013-1#1)
performed well for##2##3##(2008-10#2)
performed well in##2##3##(2008-10#1)(2009-7#1)
performed well##6##2##(1995-3#1)(2008-10#4)(2009-7#1)
performed were##2##2##(1995-11#1)(2008-6#1)
performed when##2##2##(1990-9#1)(2008-12#1)
performed with a##20##3##(1990-12#1)(1991-2#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-10#7)(2008-2#1)(2008-3#3)(2009-2#1)(2011-2#3)
performed with an##2##3##(2007-12#1)(2008-10#1)
performed with conventional##2##3##(1994-3#1)(2008-7#1)
performed with several##3##3##(2008-10#3)
performed with the aid of##2##5##(2008-10#1)(2008-11#1)
performed with the##17##3##(1990-12#1)(1991-3#1)(2008-10#9)(2008-11#2)(2008-7#1)(2009-8#1)(2012-3#1)(2013-8#1)
performed with these##2##3##(2008-10#1)(2012-12#1)
performed with##91##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#39)(2008-11#5)(2008-2#1)(2008-3#4)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
performed within the##2##3##(1993-11#1)(1997-8#1)
performed within##6##2##(1990-12#1)(1993-11#1)(1997-8#1)(2008-10#1)(2009-11#1)(2011-2#1)
performed without any##2##3##(1991-3#1)(1992-2#1)
performed without##5##2##(1991-3#1)(1992-2#1)(1993-12#1)(2008-7#1)(2012-12#1)
performed##1458##1##(1990-11#3)(1990-12#13)(1990-2#7)(1990-3#4)(1990-5#5)(1990-6#5)(1990-8#4)(1990-9#9)(1991-1#3)(1991-11#4)(1991-2#7)(1991-3#11)(1991-5#2)(1991-6#3)(1991-8#4)(1992-1#1)(1992-12#10)(1992-2#4)(1992-3#5)(1992-5#3)(1992-6#1)(1992-9#3)(1993-1#4)(1993-11#5)(1993-12#7)(1993-2#3)(1993-3#8)(1993-6#5)(1993-8#2)(1994-11#4)(1994-12#5)(1994-2#6)(1994-3#7)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#10)(1995-11#7)(1995-12#6)(1995-2#8)(1995-3#3)(1995-6#2)(1996-1#4)(1996-11#5)(1996-12#6)(1996-2#3)(1996-3#11)(1996-5#2)(1996-6#4)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#17)(1997-9#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-8#6)(2008-1#8)(2008-10#440)(2008-11#75)(2008-12#26)(2008-2#7)(2008-3#33)(2008-4#6)(2008-5#34)(2008-6#3)(2008-7#54)(2008-8#16)(2008-9#22)(2009-1#3)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#9)(2009-4#3)(2009-5#1)(2009-7#6)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#9)(2010-12#12)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#8)(2010-7#8)(2010-8#3)(2011-1#2)(2011-2#112)(2011-3#13)(2011-7#1)(2012-12#28)(2012-2#34)(2012-3#37)(2012-5#1)(2013-1#60)(2013-7#1)(2013-8#29)
performing LM/SL##2##2##(2012-12#2)
performing a controlled##2##3##(1991-3#1)(2008-3#1)
performing a##12##2##(1991-3#1)(1991-5#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-1#1)(2012-2#1)
performing more complex##2##3##(2008-8#1)(2013-1#1)
performing more##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
performing tasks##3##2##(2008-11#2)(2013-7#1)
performing testing##2##2##(2012-2#2)
performing the##9##2##(1992-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-8#1)
performing these##2##2##(2008-11#1)(2011-3#1)
performing well##2##2##(1993-3#1)(2008-10#1)
performing wrist##2##2##(1991-6#1)(2008-9#1)
performing##110##1##(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#1)(2007-12#2)(2008-10#26)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
performs a##6##2##(1990-6#1)(1992-1#1)(1995-6#1)(2008-2#1)(2008-9#1)(2012-3#1)
performs an##2##2##(2008-10#2)
performs in##2##2##(1994-2#1)(2008-10#1)
performs the##4##2##(2008-10#3)(2008-3#1)
performs well##2##2##(2008-10#1)(2008-11#1)
performs##27##1##(1990-6#1)(1992-1#1)(1993-3#1)(1994-2#1)(1995-6#1)(1997-3#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#2)(2009-8#1)(2012-3#1)(2013-8#1)
perfringens alpha-toxin##2##2##(2010-6#2)
perfringens food poisoning##2##3##(2011-2#2)
perfringens growth in beef-in-sauce products##2##5##(2011-2#2)
perfringens growth##4##2##(2011-2#4)
perfringens strains##3##2##(2011-2#3)
perfringens type A##2##3##(2011-2#2)
perfringens##23##1##(1994-11#1)(2010-6#5)(2011-2#17)
perfume diffusion from skin##2##4##(2008-5#2)
perfume##6##1##(2008-5#6)
perfumes##3##1##(2008-5#3)
perfusate##5##1##(1992-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#1)
perfused livers##2##2##(1991-3#2)
perfused rat##4##2##(1991-3#1)(1993-3#1)(2008-10#1)(2008-11#1)
perfused with##5##2##(1991-3#1)(1992-12#1)(1997-2#2)(2008-11#1)
perfused##18##1##(1991-3#5)(1992-12#1)(1992-6#1)(1993-3#1)(1997-2#4)(2008-10#2)(2008-11#4)
perfusion CT##2##2##(2012-3#2)
perfusion and subsequent##2##3##(1992-1#1)(2008-11#1)
perfusion and##7##2##(1992-1#1)(1996-3#2)(2008-11#2)(2008-7#1)(2013-1#1)
perfusion are##2##2##(2008-11#1)(2011-3#1)
perfusion bioreactor##5##2##(2008-11#5)
perfusion bioreactors##3##2##(2008-11#3)
perfusion cultivation##4##2##(2008-11#4)
perfusion cultivations##2##2##(2008-11#2)
perfusion culture##8##2##(2008-11#8)
perfusion cultures of##3##3##(2008-11#3)
perfusion cultures##11##2##(2008-11#11)
perfusion defects##3##2##(1992-5#2)(2009-10#1)
perfusion in the##2##3##(1997-5#1)(2008-12#1)
perfusion in##4##2##(1997-5#1)(2008-12#1)(2012-12#1)(2013-8#1)
perfusion induced##2##2##(1997-2#2)
perfusion mode##3##2##(2008-11#3)
perfusion of the##2##3##(1996-3#1)(1997-1#1)
perfusion of##7##2##(1996-3#1)(1997-1#1)(2008-11#2)(2008-8#1)(2012-3#1)(2013-8#1)
perfusion parameters##2##2##(2008-11#1)(2010-12#1)
perfusion pressure and##2##3##(1993-3#1)(2012-4#1)
perfusion pressure##8##2##(1990-8#1)(1993-3#2)(2008-7#3)(2010-2#1)(2012-4#1)
perfusion rate to##2##3##(2008-11#2)
perfusion rate##12##2##(2008-10#2)(2008-11#10)
perfusion rates##6##2##(2008-11#6)
perfusion system was##2##3##(2008-11#2)
perfusion system##6##2##(2008-11#5)(2012-2#1)
perfusion through##2##2##(1997-1#1)(2008-11#1)
perfusion was##4##2##(1996-12#1)(1997-1#1)(2008-11#1)(2008-7#1)
perfusion were##2##2##(1997-2#1)(2011-3#1)
perfusion##159##1##(1990-11#2)(1990-8#1)(1992-1#2)(1992-5#3)(1993-3#5)(1996-12#1)(1996-3#3)(1997-1#7)(1997-2#8)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#71)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#10)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-12#4)(2010-2#1)(2010-9#1)(2011-2#1)(2011-3#5)(2012-12#1)(2012-2#4)(2012-3#8)(2012-4#1)(2013-1#4)(2013-8#3)
pergolide##7##1##(2008-7#7)
perhaps by##2##2##(1993-12#1)(1995-2#1)
perhaps due to##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
perhaps even##2##2##(2008-5#1)(2009-4#1)
perhaps the most##5##3##(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
perhaps the##6##2##(1992-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
perhaps##54##1##(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#2)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)
perhydroxyl-cucurbit[6]uril##2##1##(2008-10#2)
peri- and##2##2##(2008-11#1)(2008-9#1)
peri-##3##1##(1996-1#1)(2008-11#1)(2008-9#1)
peri-implant marginal bone level##2##4##(2013-1#2)
peri-implant marginal bone##3##3##(2013-1#3)
peri-implant soft##2##2##(2013-1#2)
peri-implant##7##1##(2013-1#7)
peri-implantitis##12##1##(2013-1#12)
peri-natal loss##2##2##(2008-12#2)
peri-natal##3##1##(2008-12#3)
periampullary##3##1##(1990-9#1)(1991-3#2)
perianal abscesses and fistulas##2##4##(1997-8#2)
perianal ulcer##2##2##(2010-8#2)
perianal##9##1##(1994-1#1)(1997-8#4)(2010-6#1)(2010-8#3)
periapical lesions##2##2##(2011-2#1)(2013-1#1)
periapical##6##1##(2011-2#4)(2013-1#2)
pericardial##3##1##(1997-4#1)(2009-10#1)(2013-1#1)
pericarditis##3##1##(1997-4#1)(1997-8#1)(2009-10#1)
pericardium and##2##2##(2008-9#1)(2013-1#1)
pericardium##7##1##(2008-11#1)(2008-7#1)(2008-9#2)(2009-9#1)(2013-1#2)
pericarp and aleurone tissues##2##4##(2008-10#2)
pericarp and##3##2##(2008-10#3)
pericarp##8##1##(2008-10#8)
pericentral##3##1##(2008-7#3)
pericentromeric##2##1##(2008-12#2)
pericystectomies##3##1##(1991-8#3)
pericystectomy##2##1##(1993-6#1)(2008-10#1)
pericyte##3##1##(1993-3#2)(2012-4#1)
pericytes##8##1##(1993-3#6)(1993-6#1)(2010-3#1)
periderm##3##1##(2008-10#3)
perifocal/penumbral##2##1##(1997-2#2)
perifused goldfish pituitary fragments##2##4##(1994-8#2)
perikarya and fibers##4##3##(1992-12#3)(2008-6#1)
perikarya are##2##2##(1992-12#1)(1996-2#1)
perikarya in the##4##3##(1992-12#2)(1996-12#2)
perikarya were##2##2##(1997-3#1)(2008-6#1)
perikarya##17##1##(1990-5#1)(1992-12#6)(1992-3#1)(1996-12#3)(1996-2#1)(1997-3#3)(2008-6#2)
perilesional##2##1##(2009-9#1)(2013-1#1)
perimenopausal##2##1##(1993-11#1)(1994-2#1)
perimeter##3##1##(2008-6#2)(2012-5#1)
perimicrovillar##3##1##(2007-12#3)
perimysium##2##1##(2013-1#2)
perinatal and##2##2##(2008-11#2)
perinatal care##4##2##(2008-11#1)(2013-1#3)
perinatal centres##2##2##(2008-11#2)
perinatal data##2##2##(1991-11#1)(1997-8#1)
perinatal mortality##3##2##(1990-3#1)(1994-3#1)(1996-11#1)
perinatal outcomes##3##2##(2012-3#2)(2013-8#1)
perinatal torsion##2##2##(2008-10#2)
perinatal##38##1##(1990-3#1)(1991-11#1)(1991-6#2)(1991-9#1)(1992-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-11#6)(2009-10#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#1)
perinatally##2##1##(2009-8#1)(2010-11#1)
perineal urethrostomy##2##2##(2008-10#2)
perineal##6##1##(1993-6#1)(1994-1#1)(2008-10#3)(2013-1#1)
perineum##6##1##(1993-1#2)(2008-10#3)(2010-11#1)
perineural##3##1##(2008-1#2)(2013-8#1)
perinuclear translocation##2##2##(1994-6#2)
perinuclear##12##1##(1994-6#2)(1995-3#1)(2008-7#3)(2008-9#3)(2009-10#1)(2011-2#1)(2012-3#1)
period (2##2##2##(1993-1#1)(2008-10#1)
period (January##2##2##(2008-5#1)(2011-2#1)
period (P = 0##2##4##(1996-3#1)(2008-10#1)
period after##10##2##(1991-12#1)(1995-12#1)(1995-3#1)(2008-10#4)(2010-11#1)(2010-4#1)(2012-3#1)
period and that##2##3##(1991-9#1)(2009-9#1)
period and the##7##3##(1991-12#1)(2008-10#3)(2008-7#2)(2013-8#1)
period and##44##2##(1991-12#4)(1991-2#1)(1991-9#1)(1992-3#1)(1996-2#1)(1996-3#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-7#4)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
period are##5##2##(2008-3#2)(2008-7#1)(2010-10#1)(2010-8#1)
period as##7##2##(1996-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2013-1#1)
period at##5##2##(1995-8#1)(2008-10#2)(2011-2#1)(2012-12#1)
period between##12##2##(1994-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2009-1#1)(2011-2#1)
period but##2##2##(2008-10#2)
period by##6##2##(2008-10#3)(2008-11#2)(2011-2#1)
period can be##2##3##(2008-2#1)(2010-8#1)
period compared with##2##3##(2008-11#1)(2011-2#1)
period compared##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
period due to##3##3##(2007-11#1)(2008-11#1)(2013-1#1)
period during the##2##3##(1993-3#1)(2008-10#1)
period during which##3##3##(1991-11#1)(2008-7#1)(2010-6#1)
period during##5##2##(1991-11#1)(1993-3#1)(2008-10#1)(2008-7#1)(2010-6#1)
period followed by##2##3##(2008-10#2)
period following##6##2##(1991-1#1)(1993-6#1)(1995-1#1)(2008-10#1)(2010-6#1)(2010-8#1)
period for the##2##3##(2008-6#1)(2012-2#1)
period for##10##2##(1997-4#1)(2008-10#4)(2008-11#2)(2008-6#1)(2011-2#1)(2012-2#1)
period from January##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
period from an##2##3##(2008-10#2)
period from##20##2##(1992-1#1)(1994-12#1)(1995-5#1)(1996-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
period had a##2##3##(2008-10#1)(2008-7#1)
period immediately##2##2##(2008-10#2)
period in a##6##3##(1994-12#1)(1997-2#1)(2008-10#2)(2010-5#1)(2011-1#1)
period in patients##2##3##(2012-3#1)(2013-1#1)
period in question##2##3##(1990-8#1)(2008-9#1)
period in the##4##3##(1996-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
period in which##2##3##(2008-10#1)(2008-5#1)
period in##30##2##(1990-11#1)(1990-8#1)(1991-12#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-11#2)(1997-2#1)(2008-10#6)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
period increased##2##2##(2008-10#2)
period is##9##2##(1994-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#2)
period length##4##2##(2008-10#2)(2008-5#1)(2009-9#1)
period modulation and##2##3##(2008-5#2)
period modulation##4##2##(2008-5#4)
period of 10##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
period of 12##3##3##(2008-10#1)(2008-5#1)(2010-6#1)
period of 2 h##2##4##(2008-10#2)
period of 2##6##3##(2008-10#3)(2008-7#2)(2011-2#1)
period of 24##5##3##(1997-2#1)(2008-10#2)(2008-5#1)(2010-11#1)
period of 3##4##3##(2008-10#3)(2008-7#1)
period of 30 min##2##4##(1994-8#1)(2008-10#1)
period of 30##4##3##(1994-8#1)(1997-8#1)(2008-10#2)
period of 5##6##3##(1991-2#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
period of 6 h##2##4##(2008-11#1)(2008-5#1)
period of 6 weeks##2##4##(2008-11#2)
period of 6##6##3##(2008-10#2)(2008-11#3)(2008-5#1)
period of 8 months##2##4##(2008-12#1)(2008-5#1)
period of 8##3##3##(2008-1#1)(2008-12#1)(2008-5#1)
period of 9 days##2##4##(1990-6#1)(2011-2#1)
period of 9##3##3##(1990-6#1)(1996-3#1)(2011-2#1)
period of at least##4##4##(1990-12#2)(2008-10#1)(2008-5#1)
period of berry susceptibility##2##4##(2008-10#2)
period of berry##3##3##(2008-10#3)
period of four##4##3##(1991-6#1)(1997-5#1)(2008-1#1)(2011-2#1)
period of fruit susceptibility##4##4##(2008-10#4)
period of growth##2##3##(2008-10#1)(2011-2#1)
period of maximum##3##3##(2008-10#3)
period of one year##2##4##(2008-3#1)(2012-3#1)
period of one##5##3##(1993-6#1)(2008-10#2)(2008-3#1)(2012-3#1)
period of several##2##3##(2008-10#2)
period of six##3##3##(1990-12#1)(1991-2#1)(2008-1#1)
period of storage##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
period of the##8##3##(1991-1#1)(1991-12#1)(1993-6#1)(1994-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
period of time after##2##4##(1992-3#1)(2008-10#1)
period of time in##2##4##(1997-2#1)(2008-11#1)
period of time to##3##4##(1996-3#1)(2008-12#1)(2013-1#1)
period of time##37##3##(1990-11#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-3#2)(1993-3#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-5#2)(2008-9#2)(2010-11#1)(2010-12#2)(2010-6#1)(2012-2#1)(2013-1#2)
period of##233##2##(1990-11#1)(1990-12#3)(1990-5#3)(1990-6#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-3#1)(1994-8#3)(1995-1#2)(1995-11#1)(1995-5#2)(1996-3#2)(1996-6#1)(1997-2#5)(1997-4#1)(1997-5#2)(1997-8#3)(2008-1#4)(2008-10#68)(2008-11#26)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#11)(2008-7#7)(2008-8#9)(2008-9#4)(2009-11#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#4)(2012-4#1)(2012-7#1)(2013-1#5)(2013-8#1)
period on##9##2##(1991-3#1)(2008-10#6)(2010-11#1)(2012-12#1)
period prior to##2##3##(2008-10#1)(2008-7#1)
period showed##3##2##(2008-11#1)(2008-7#1)(2010-11#1)
period studied##3##2##(1992-12#1)(1995-8#1)(2008-10#1)
period than##3##2##(1994-12#1)(1995-11#1)(2008-9#1)
period that##3##2##(2008-10#1)(2008-11#2)
period the##5##2##(1990-11#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-3#1)
period to##8##2##(1994-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2012-2#1)
period values##2##2##(2008-10#2)
period varied##2##2##(1991-12#1)(2008-11#1)
period via##2##2##(2008-10#2)
period was 4##2##3##(1996-8#1)(1997-8#1)
period was not##2##3##(2008-10#2)
period was uneventful##2##3##(1991-11#1)(2010-7#1)
period was##33##2##(1991-11#1)(1992-12#1)(1996-8#1)(1997-4#1)(1997-8#2)(2008-10#15)(2008-5#1)(2008-7#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#2)(2013-8#1)
period were##15##2##(1991-11#1)(1991-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
period when the##2##3##(1990-12#1)(1996-12#1)
period when##7##2##(1990-12#1)(1992-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
period with a##2##3##(1991-2#1)(2008-10#1)
period with the##2##3##(1997-6#1)(2011-2#1)
period with##9##2##(1991-2#1)(1996-3#1)(1997-6#1)(2008-10#3)(2011-2#2)(2013-8#1)
period##1059##1##(1990-11#5)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#5)(1990-6#6)(1990-8#7)(1990-9#5)(1991-1#2)(1991-11#4)(1991-12#14)(1991-2#10)(1991-3#3)(1991-5#1)(1991-6#8)(1991-8#7)(1991-9#7)(1992-1#4)(1992-12#6)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#5)(1993-6#4)(1993-8#1)(1994-1#3)(1994-12#10)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#6)(1995-5#4)(1995-8#4)(1995-9#2)(1996-1#3)(1996-11#6)(1996-12#6)(1996-2#4)(1996-3#15)(1996-6#1)(1996-8#2)(1997-1#3)(1997-2#10)(1997-3#4)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#12)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#6)(2008-10#290)(2008-11#76)(2008-12#21)(2008-2#7)(2008-3#14)(2008-4#1)(2008-5#34)(2008-6#6)(2008-7#38)(2008-8#22)(2008-9#17)(2009-1#1)(2009-11#3)(2009-12#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#7)(2010-11#8)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#6)(2010-7#5)(2010-8#9)(2011-1#13)(2011-2#60)(2011-3#6)(2011-9#1)(2012-12#12)(2012-2#21)(2012-3#19)(2012-4#1)(2012-5#4)(2012-7#3)(2013-1#33)(2013-7#1)(2013-8#15)
period&quot##2##1##(1995-12#1)(1997-1#1)
period)##16##1##(1997-2#2)(2008-10#10)(2008-3#1)(2008-9#1)(2010-6#1)(2012-12#1)
period]##7##1##(1993-9#1)(1997-3#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-3#2)
periodate and##6##2##(2008-10#6)
periodate ions##2##2##(2008-10#2)
periodate to##2##2##(2008-10#2)
periodate was##2##2##(2008-10#2)
periodate with##3##2##(2008-10#3)
periodate##37##1##(1996-12#1)(2008-10#36)
periodate-bromate and##4##2##(2008-10#4)
periodic limb movement##2##3##(2012-3#2)
periodic pattern##2##2##(2008-3#2)
periodic poling of##2##3##(2007-12#2)
periodic solutions for##2##3##(2013-8#2)
periodic structure##3##2##(2008-10#1)(2008-3#2)
periodic##53##1##(1990-11#1)(1991-12#3)(1992-8#1)(1993-6#1)(1995-10#1)(1996-11#1)(1997-4#1)(1997-8#1)(2007-12#4)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#2)(2012-2#1)(2012-3#2)(2013-8#4)
periodical cicadas##5##2##(2008-9#5)
periodical##7##1##(1997-2#1)(2008-9#5)(2012-3#1)
periodically interrupted amperometric##2##3##(2008-10#2)
periodically interrupted##3##2##(2008-10#3)
periodically poled KTP##4##3##(2007-11#4)
periodically poled KTiOAsO(4)##2##3##(2007-12#2)
periodically poled lithium niobate##5##4##(2007-12#1)(2008-3#4)
periodically poled structures##2##3##(2008-3#2)
periodically poled##18##2##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#7)
periodically##35##1##(1993-1#1)(1993-12#1)(1994-2#1)(1997-2#1)(2007-11#4)(2007-12#7)(2008-10#9)(2008-2#1)(2008-3#8)(2008-7#1)(2009-12#1)
periodicity and##2##2##(1990-12#1)(2013-8#1)
periodicity of##3##2##(1993-3#1)(1996-2#1)(2008-4#1)
periodicity was##2##2##(1993-3#1)(1996-2#1)
periodicity##11##1##(1990-12#1)(1993-3#2)(1996-2#3)(1996-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
periodontal disease##7##2##(1990-3#2)(1990-5#1)(1997-4#1)(2008-1#1)(2008-5#1)(2008-9#1)
periodontal diseases and##2##3##(2008-1#1)(2013-7#1)
periodontal diseases##6##2##(2008-1#1)(2008-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
periodontal ligament (PDL)##3##3##(1995-8#1)(2008-11#1)(2013-1#1)
periodontal ligament##5##2##(1995-8#2)(2008-11#1)(2013-1#2)
periodontal masseteric reflex##2##3##(1996-2#2)
periodontal pockets##3##2##(1997-4#1)(2012-12#2)
periodontal tissue##2##2##(2013-1#2)
periodontal##37##1##(1990-3#2)(1990-5#1)(1990-9#1)(1991-2#1)(1995-8#2)(1996-2#2)(1997-4#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#10)(2013-7#1)(2013-8#1)
periodontally healthy##2##2##(2008-12#1)(2013-1#1)
periodontitis in##4##2##(1991-6#1)(2008-10#3)
periodontitis patients and##3##3##(2008-12#2)(2011-2#1)
periodontitis##22##1##(1991-6#1)(2008-10#5)(2008-12#6)(2011-2#1)(2013-1#9)
periods and##9##2##(1992-8#1)(1994-6#1)(2008-10#2)(2008-12#1)(2008-8#2)(2010-11#1)(2012-2#1)
periods as##2##2##(2008-5#1)(2008-7#1)
periods at##3##2##(1996-12#1)(2008-10#2)
periods before##2##2##(2008-10#1)(2008-9#1)
periods exceeding##2##2##(2008-10#2)
periods for##3##2##(2008-10#2)(2012-2#1)
periods in a##2##3##(2008-10#1)(2012-3#1)
periods in all##2##3##(1991-2#1)(2008-10#1)
periods in the##2##3##(2008-6#1)(2009-7#1)
periods in##8##2##(1991-2#1)(2008-10#3)(2008-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
periods is##2##2##(2008-10#1)(2008-8#1)
periods of 1##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
periods of 3##2##3##(1991-11#1)(2008-10#1)
periods of more than##2##4##(2008-10#1)(2012-12#1)
periods of temperatures &gt##2##4##(2008-10#2)
periods of temperatures##3##3##(2008-10#3)
periods of the##3##3##(2008-10#2)(2008-7#1)
periods of time##13##3##(1995-1#1)(1996-2#1)(2008-10#6)(2008-11#4)(2008-7#1)
periods of treatment##2##3##(2008-10#1)(2012-3#1)
periods of up to##2##4##(2008-10#1)(2008-11#1)
periods of##77##2##(1990-6#1)(1991-11#1)(1991-2#1)(1994-1#2)(1995-1#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#37)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#4)
periods over##3##2##(2008-10#3)
periods ranging from##4##3##(1995-8#1)(2008-10#1)(2009-7#1)(2011-2#1)
periods up to##3##3##(2008-10#3)
periods using##2##2##(2008-10#2)
periods was##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
periods were##8##2##(2008-10#5)(2011-3#1)(2012-12#1)(2012-4#1)
periods with##4##2##(2008-10#2)(2008-11#1)(2010-1#1)
periods##231##1##(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#2)(1992-8#1)(1993-11#1)(1994-1#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(2008-1#2)(2008-10#120)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#14)(2008-8#5)(2008-9#2)(2009-11#3)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#9)(2011-3#2)(2012-12#3)(2012-2#4)(2012-3#3)(2012-4#1)(2012-7#1)(2012-9#1)(2013-1#10)(2013-8#1)
perioperative care##2##2##(2011-2#1)(2012-2#1)
perioperative complications##2##2##(2009-5#1)(2010-7#1)
perioperative factors##2##2##(2013-1#2)
perioperative hypothermia##3##2##(2013-8#3)
perioperative management of##2##3##(2011-2#1)(2013-1#1)
perioperative morbidity##3##2##(1995-12#1)(2008-7#2)
perioperative##39##1##(1990-11#1)(1990-2#1)(1992-3#1)(1992-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(2008-10#1)(2008-7#3)(2009-5#4)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
perioperatively##4##1##(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
perioral##2##1##(2008-5#1)(2008-7#1)
periosteal##3##1##(2008-11#1)(2010-6#1)(2011-2#1)
periovarian adhesions##2##2##(1992-3#2)
peripancreatic##3##1##(1990-3#1)(2012-2#2)
peripheral T##2##2##(1993-12#1)(2009-8#1)
peripheral T-cell lymphomas##2##3##(2009-8#2)
peripheral and central##3##3##(2007-12#2)(2010-1#1)
peripheral and##5##2##(1991-3#1)(1996-1#1)(2007-12#2)(2010-1#1)
peripheral arterial disease##2##3##(1995-2#1)(2012-2#1)
peripheral arterial##5##2##(1990-11#1)(1995-2#2)(2008-8#1)(2012-2#1)
peripheral artery disease##2##3##(2008-7#1)(2012-2#1)
peripheral benzodiazepine receptor (PBR)##2##4##(2012-2#2)
peripheral blood T##3##3##(1992-6#1)(1995-2#2)
peripheral blood cells##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
peripheral blood erythrocytes##3##3##(2008-9#3)
peripheral blood granulocytes##2##3##(2008-9#2)
peripheral blood leukocytes##3##3##(1992-6#1)(2008-10#1)(2009-6#1)
peripheral blood lymphocyte##2##3##(2008-10#1)(2008-7#1)
peripheral blood lymphocytes (PBL)##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
peripheral blood lymphocytes and monocytes##2##5##(1990-5#2)
peripheral blood lymphocytes and##3##4##(1990-5#2)(1991-12#1)
peripheral blood lymphocytes from##3##4##(1991-2#1)(1994-6#1)(1997-3#1)
peripheral blood lymphocytes##27##3##(1990-5#2)(1991-12#2)(1991-2#1)(1993-8#2)(1994-3#1)(1994-6#1)(1995-12#3)(1997-3#1)(2008-11#8)(2008-4#1)(2008-9#5)
peripheral blood mononuclear cells (PBMC)##6##5##(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2011-3#1)
peripheral blood mononuclear cells (PBMCs)##2##5##(2008-10#1)(2008-9#1)
peripheral blood mononuclear cells##17##4##(1990-2#1)(1992-6#2)(2008-10#2)(2008-11#5)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#2)(2011-3#1)
peripheral blood mononuclear##18##3##(1990-2#1)(1992-6#2)(2008-10#2)(2008-11#5)(2008-4#1)(2008-7#3)(2008-9#1)(2011-2#2)(2011-3#1)
peripheral blood samples##2##3##(2008-9#2)
peripheral blood smear##2##3##(1990-3#1)(2012-3#1)
peripheral blood stem cells##2##4##(2008-11#1)(2010-6#1)
peripheral blood stem##3##3##(2008-11#1)(2010-6#1)(2011-2#1)
peripheral blood was##2##3##(2011-2#1)(2013-1#1)
peripheral blood##109##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#3)(1991-2#1)(1992-6#4)(1993-8#2)(1994-11#2)(1994-3#1)(1994-6#1)(1995-12#3)(1995-2#3)(1997-3#1)(2008-10#10)(2008-11#19)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#20)(2009-6#1)(2010-6#1)(2010-8#3)(2011-2#7)(2011-3#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)
peripheral buttressing bone##2##3##(2013-1#2)
peripheral cells##4##2##(1994-11#1)(1997-8#1)(2008-5#2)
peripheral circulation##4##2##(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
peripheral inflammation##3##2##(1997-2#3)
peripheral injection of##2##3##(1994-2#1)(1994-8#1)
peripheral insulin##2##2##(1992-6#1)(1994-11#1)
peripheral interventions##2##2##(2011-2#2)
peripheral ligands##2##2##(2008-8#2)
peripheral lymphadenopathy##2##2##(2008-5#1)(2010-6#1)
peripheral lymphocytes##3##2##(1990-8#1)(2008-8#1)(2012-3#1)
peripheral nerve injury##3##3##(2008-9#2)(2011-2#1)
peripheral nerve sheath##2##3##(1997-8#1)(2009-1#1)
peripheral nerve##15##2##(1992-6#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-9#2)(2009-1#1)(2011-2#3)(2012-3#2)
peripheral nerves in##2##3##(2008-7#1)(2011-2#1)
peripheral nerves##13##2##(1997-3#1)(1997-4#1)(2008-7#3)(2008-9#1)(2009-11#1)(2011-2#5)(2012-3#1)
peripheral nervous system and##2##4##(2008-7#1)(2010-7#1)
peripheral nervous system##11##3##(1992-12#1)(1995-12#1)(1996-12#2)(1996-2#1)(2007-8#1)(2008-7#3)(2010-7#1)(2013-8#1)
peripheral neuropathies##3##2##(2008-12#1)(2008-2#1)(2008-4#1)
peripheral neuropathy and##2##3##(2008-12#1)(2011-2#1)
peripheral neuropathy##15##2##(1996-2#1)(1997-3#1)(2007-7#1)(2008-11#6)(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#2)
peripheral or##2##2##(2008-4#1)(2008-9#1)
peripheral organs##2##2##(1992-6#1)(2008-7#1)
peripheral parts##3##2##(1994-12#1)(1996-3#2)
peripheral signals##2##2##(2008-10#1)(2009-5#1)
peripheral stimulation##2##2##(1992-3#1)(1996-12#1)
peripheral tissues is##2##3##(1991-2#1)(1991-7#1)
peripheral tissues##7##2##(1990-11#2)(1991-2#1)(1991-7#2)(1997-8#1)(2012-2#1)
peripheral vascular disease##3##3##(2008-5#1)(2008-8#1)(2010-6#1)
peripheral vascular##7##2##(1990-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-2#1)
peripheral visual##2##2##(2010-5#1)(2011-2#1)
peripheral zone##2##2##(2008-7#1)(2011-2#1)
peripheral##325##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#3)(1991-12#3)(1991-2#3)(1991-3#3)(1991-6#2)(1991-7#2)(1992-12#1)(1992-3#1)(1992-6#10)(1993-12#1)(1993-5#1)(1993-8#2)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#6)(1995-2#6)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#3)(1996-5#1)(1996-8#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-8#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#28)(2008-12#3)(2008-2#1)(2008-4#6)(2008-5#8)(2008-7#23)(2008-8#8)(2008-9#29)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#3)(2010-9#1)(2011-2#28)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#11)(2013-1#13)(2013-7#1)(2013-8#8)
peripherally administered##2##2##(1994-2#1)(1994-8#1)
peripherally##5##1##(1990-2#1)(1991-10#1)(1994-2#1)(1994-8#1)(2008-10#1)
periphery and##2##2##(2009-2#1)(2010-1#1)
periphery of the##11##3##(1991-11#1)(1991-2#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#1)
periphery of##18##2##(1991-11#1)(1991-2#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#2)(2010-7#1)(2011-2#2)
periphery##43##1##(1991-11#1)(1991-2#1)(1994-12#1)(1994-2#1)(1996-12#2)(1996-5#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#3)(2009-8#2)(2010-1#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#1)
periplasm##6##1##(1991-10#1)(1993-9#1)(2008-7#1)(2009-6#3)
periplasmic##6##1##(1993-6#1)(1995-12#1)(1997-2#1)(2008-10#1)(2011-2#2)
periprosthetic femoral fracture##2##3##(2013-1#2)
periprosthetic femoral##3##2##(2013-1#3)
periprosthetic fractures##2##2##(2011-2#2)
periprosthetic##7##1##(2007-11#1)(2011-2#3)(2013-1#3)
perirenal fat##2##2##(2013-1#2)
perirenal urinoma##2##2##(2011-2#2)
perirenal##4##1##(2011-2#2)(2013-1#2)
peristalsis in##2##2##(2012-2#2)
peristalsis##6##1##(2008-12#1)(2008-7#2)(2012-2#3)
peristalsis-suppressing effect##2##2##(2012-2#2)
peristaltic of the small##2##4##(2011-2#2)
peristaltic pump##9##2##(2008-10#8)(2008-11#1)
peristaltic pumps##3##2##(2008-10#3)
peristaltic##19##1##(1994-8#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
peristomial lip##2##2##(2008-9#2)
perithecia were##3##2##(2008-10#3)
perithecia##10##1##(2008-10#10)
peritoneal catheter##2##2##(2011-2#2)
peritoneal cavity##8##2##(1990-2#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-9#1)(2011-2#1)
peritoneal cells##2##2##(2008-10#2)
peritoneal dialysis (PD)##4##3##(2011-2#4)
peritoneal dialysis and##2##3##(2008-10#1)(2011-2#1)
peritoneal dialysis##31##2##(1994-5#1)(1995-12#2)(1997-5#1)(2008-10#7)(2008-5#5)(2011-2#15)
peritoneal function in patients##2##4##(2011-2#2)
peritoneal function##5##2##(2011-2#5)
peritoneal inflammation##3##2##(2008-12#3)
peritoneal macrophage##3##2##(1997-4#1)(2008-11#2)
peritoneal macrophages##12##2##(1995-2#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-9#1)(2012-3#1)(2013-1#1)
peritoneal mesothelioma##4##2##(1991-12#2)(2010-12#2)
peritoneal penetration##2##2##(1990-2#2)
peritoneal sclerosis (EPS)##2##3##(2011-2#2)
peritoneal sclerosis##4##2##(2011-2#4)
peritoneal##108##1##(1990-2#5)(1990-6#1)(1991-12#3)(1991-6#1)(1991-8#1)(1992-5#1)(1993-6#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1996-11#1)(1997-4#1)(1997-5#1)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#8)(2008-5#5)(2008-8#1)(2008-9#2)(2010-12#2)(2011-2#33)(2012-3#3)(2013-1#3)
peritoneocele##2##1##(2011-2#2)
peritoneoscopy and##2##2##(2009-8#2)
peritoneoscopy##3##1##(2009-8#3)
peritoneum##6##1##(1990-2#1)(1991-12#1)(1993-6#1)(2008-5#2)(2011-2#1)
peritonitis in##4##2##(1991-2#1)(2008-12#2)(2008-5#1)
peritonitis were##2##2##(2008-12#1)(2011-2#1)
peritonitis##28##1##(1991-2#3)(1991-3#1)(1993-6#2)(2008-12#7)(2008-5#2)(2009-8#4)(2011-2#7)(2012-3#1)(2013-8#1)
periureteral fibrosis##2##2##(2008-10#2)
perivascular##12##1##(1990-12#1)(1992-12#1)(1995-12#1)(1996-11#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#3)(2013-8#1)
periventricular leucomalacia##2##2##(1996-11#2)
periventricular##6##1##(1992-3#1)(1996-11#2)(2008-8#1)(2011-2#1)(2012-3#1)
periventricularis##2##1##(2008-6#2)
perivitelline##2##1##(2008-12#1)(2008-9#1)
periwinkle and##2##2##(2008-10#2)
periwinkle##5##1##(2008-10#5)
periwinkles##5##1##(2008-10#5)
perm-selective##2##1##(2008-10#2)
permafrost peatlands##2##2##(2008-9#2)
permafrost##3##1##(2008-9#3)
permanence##3##1##(1993-1#1)(2008-5#1)(2012-2#1)
permanent and##5##2##(2008-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)
permanent calves##5##2##(1996-12#5)
permanent chemical modifier##4##3##(2008-10#4)
permanent chemical##5##2##(2008-10#5)
permanent damage##2##2##(1997-2#1)(2012-3#1)
permanent dipole moments##2##3##(1997-6#2)
permanent focal ischemia##2##3##(1997-2#1)(2008-4#1)
permanent growth##2##2##(2008-2#1)(2011-2#1)
permanent mandibular canines##2##3##(2012-3#2)
permanent modifier##12##2##(2008-10#12)
permanent modifiers for##2##3##(2008-10#2)
permanent modifiers##12##2##(2008-10#12)
permanent teeth##4##2##(2010-9#1)(2012-3#1)(2013-1#2)
permanent with optimum pyrolysis and atomization temperatures of##2##8##(2008-10#2)
permanent##137##1##(1990-9#2)(1991-11#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-9#1)(1994-3#1)(1996-1#1)(1996-12#5)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#3)(2007-11#1)(2008-1#1)(2008-10#43)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#4)(2008-9#1)(2009-3#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#3)(2010-6#2)(2010-9#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#10)(2013-8#1)
permanente##2##1##(2010-8#1)(2011-2#1)
permanently##14##1##(1991-12#1)(1996-5#1)(2008-10#6)(2008-11#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
permanganate and##5##2##(2008-10#5)
permanganate in sulfuric acid medium##2##5##(2008-10#2)
permanganate in sulphuric acid##2##4##(2008-10#2)
permanganate in##13##2##(2008-10#13)
permanganate solution##2##2##(2008-10#2)
permanganate##45##1##(2008-10#45)
permanganates##3##1##(2008-10#3)
permeabilities of##2##2##(1991-5#1)(2008-7#1)
permeabilities##3##1##(1991-5#2)(2008-7#1)
permeability (decrease in TER)##2##4##(2008-11#2)
permeability and##2##2##(1995-6#1)(2008-9#1)
permeability barrier##3##2##(1994-5#2)(2011-2#1)
permeability factor##3##2##(1994-3#2)(2008-9#1)
permeability in##4##2##(2008-1#1)(2008-11#2)(2008-7#1)
permeability increase by capsaicin##2##4##(2008-11#2)
permeability increase in##2##3##(2008-11#2)
permeability increase##6##2##(1991-5#1)(2008-11#5)
permeability of the##10##3##(1990-2#1)(1991-5#1)(1992-3#1)(2008-10#5)(2008-5#1)(2008-7#1)
permeability of##23##2##(1990-2#1)(1990-5#2)(1991-5#2)(1992-3#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)
permeability to##6##2##(1990-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
permeability transition pore##4##3##(2008-7#1)(2010-12#1)(2012-2#2)
permeability transition##7##2##(2008-11#2)(2008-7#1)(2009-9#1)(2010-12#1)(2012-2#2)
permeability was##2##2##(1990-5#1)(1991-5#1)
permeability##89##1##(1990-2#3)(1990-5#4)(1991-5#4)(1992-12#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-8#1)(2008-1#2)(2008-10#12)(2008-11#17)(2008-12#1)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#5)(2009-9#1)(2010-12#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2013-8#1)
permeabilization##6##1##(2006-6#2)(2008-6#1)(2008-9#3)
permeabilized cells in##2##3##(1992-12#2)
permeabilized##14##1##(1992-12#3)(1992-6#1)(1993-8#4)(1994-5#2)(2008-4#1)(2008-7#3)
permeabilizes##2##1##(1990-5#2)
permeable membrane##5##2##(2006-6#1)(2008-10#3)(2008-11#1)
permeable to##3##2##(1994-5#1)(2008-7#1)(2009-8#1)
permeable##9##1##(1994-3#1)(1994-5#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)
permeant penetration##2##2##(2008-5#2)
permeant##6##1##(1991-5#1)(2008-5#5)
permease and##2##2##(1991-10#2)
permease##8##1##(1991-10#7)(1996-6#1)
permeate##7##1##(2008-10#4)(2008-7#3)
permeated##5##1##(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#1)
permeation chromatography##5##2##(1990-10#1)(1996-12#1)(2008-10#3)
permeation experiments##2##2##(2008-10#1)(2008-5#1)
permeation of the UV filters##2##5##(2008-5#2)
permeation of##7##2##(2008-10#2)(2008-5#4)(2011-3#1)
permeation through##2##2##(2008-10#2)
permeation##30##1##(1990-10#1)(1991-5#2)(1995-3#1)(1996-12#1)(2008-10#11)(2008-11#1)(2008-5#10)(2008-7#1)(2008-8#1)(2011-3#1)
permed hair##2##2##(2008-5#2)
permet de##2##2##(2011-2#1)(2013-1#1)
permethrin##3##1##(1997-5#2)(2010-2#1)
permettre##2##1##(2013-1#2)
permissible##12##1##(1993-3#1)(1993-9#1)(2008-10#5)(2008-11#1)(2012-2#1)(2013-1#3)
permission from the##2##3##(1991-3#1)(1997-5#1)
permissive##8##1##(1993-8#2)(1995-6#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-4#1)
permit a##4##2##(1996-12#1)(2008-10#2)(2013-1#1)
permit an##2##2##(2008-10#2)
permit high##2##2##(2008-10#1)(2008-2#1)
permit more##2##2##(2008-3#1)(2008-9#1)
permit rapid##2##2##(2008-11#1)(2008-9#1)
permit the##15##2##(1991-12#1)(1991-3#1)(1993-12#1)(1993-3#1)(1995-9#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)
permit##62##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-11#2)(1993-12#3)(1993-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-9#1)(2011-2#1)(2013-1#2)
permits a direct##3##3##(2008-2#1)(2008-7#1)(2009-10#1)
permits a##7##2##(1995-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#1)
permits determination of##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
permits non-invasive##2##2##(1990-3#1)(1993-6#1)
permits not only##2##3##(2008-11#1)(2009-8#1)
permits rapid and##3##3##(2008-10#2)(2008-11#1)
permits sufficient timescale simulations for quantum chemical events such as ATP hydrolysis##2##12##(2013-1#2)
permits sufficient##3##2##(2012-3#1)(2013-1#2)
permits the determination of##7##4##(1990-2#1)(2008-10#6)
permits the measurement of##2##4##(2008-10#1)(2008-3#1)
permits the simultaneous##2##3##(2008-10#1)(2008-4#1)
permits the use of##2##4##(2008-10#1)(2008-3#1)
permits the##29##2##(1990-2#1)(1994-12#1)(1995-3#1)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)
permits their##2##2##(2008-10#1)(2010-11#1)
permits to##8##2##(2008-10#6)(2010-6#1)(2013-1#1)
permits##97##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#38)(2008-11#5)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
permitted a good##2##3##(2007-8#1)(2008-10#1)
permitted a high##2##3##(2008-10#2)
permitted a##5##2##(2007-8#1)(2008-10#3)(2008-11#1)
permitted identification of##2##3##(2008-10#1)(2012-2#1)
permitted limit##2##2##(2008-10#1)(2011-2#1)
permitted the detection of##2##4##(2008-10#1)(2008-11#1)
permitted the detection##3##3##(2008-10#2)(2008-11#1)
permitted the determination of##3##4##(2008-10#3)
permitted the##22##2##(1990-12#2)(1993-3#1)(2008-10#16)(2008-11#1)(2008-7#1)(2013-1#1)
permitted to##6##2##(2008-10#4)(2013-1#2)
permitted##64##1##(1990-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#35)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#3)(2013-8#1)
permitting a##4##2##(1990-12#1)(2008-10#2)(2008-11#1)
permitting analysis##2##2##(2008-10#1)(2008-9#1)
permitting the##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
permitting##25##1##(1990-12#1)(1991-11#1)(1995-12#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)
permittivity measurements##3##2##(2008-11#3)
permittivity##7##1##(1991-3#1)(2008-11#6)
permselective##3##1##(2008-10#3)
permselectivity properties##2##2##(2008-10#2)
permselectivity##4##1##(2008-10#4)
permutation##8##1##(1992-6#1)(2008-10#3)(2008-12#1)(2008-3#2)(2010-8#1)
perniciosa##5##1##(2008-10#5)
peroffskyana##3##1##(1994-11#3)
peroneal##3##1##(2009-3#1)(2012-3#1)(2013-8#1)
peroxidase (HRP) and##3##3##(2008-10#3)
peroxidase (HRP) was used##2##4##(2008-10#2)
peroxidase (HRP)##28##2##(1990-5#1)(2008-10#26)(2012-2#1)
peroxidase (MnP)##2##2##(2008-7#1)(2011-1#1)
peroxidase (POD)##2##2##(2008-10#2)
peroxidase (POD)-like##2##2##(2008-10#2)
peroxidase activities were##2##3##(1992-3#1)(2008-10#1)
peroxidase activities##5##2##(1992-3#1)(1994-5#1)(2008-10#3)
peroxidase activity in##3##3##(2008-10#3)
peroxidase activity of##3##3##(2008-10#3)
peroxidase activity was##2##3##(2008-5#2)
peroxidase activity##14##2##(1990-3#1)(2008-10#10)(2008-5#2)(2009-3#1)
peroxidase and##11##2##(1990-12#1)(2008-10#7)(2008-6#1)(2008-9#1)(2011-2#1)
peroxidase as##2##2##(2008-10#2)
peroxidase from##2##2##(2008-10#1)(2008-6#1)
peroxidase gene##3##2##(1990-12#1)(2008-10#1)(2011-1#1)
peroxidase is##3##2##(2008-10#3)
peroxidase was##3##2##(2008-10#3)
peroxidase were immobilized##2##3##(2008-10#2)
peroxidase were##6##2##(1990-3#1)(2008-10#3)(2008-5#2)
peroxidase##159##1##(1990-12#3)(1990-3#3)(1990-5#2)(1991-2#1)(1992-3#1)(1992-9#1)(1994-5#5)(1995-3#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#2)(1997-5#1)(2007-12#1)(2008-10#106)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-7#1)(2011-1#5)(2011-10#1)(2011-2#2)(2012-2#2)
peroxidase-labeled bovine lactoferrin##2##3##(1996-12#2)
peroxidase-labeled##3##1##(1996-12#2)(2008-10#1)
peroxidase-oxidase##2##1##(2008-10#2)
peroxidases in##3##2##(2008-10#2)(2009-7#1)
peroxidases##11##1##(1994-5#1)(2008-10#7)(2008-11#1)(2008-6#1)(2009-7#1)
peroxidation in##4##2##(1992-3#1)(2008-11#1)(2008-12#1)(2008-5#1)
peroxidation induced##2##2##(1996-2#1)(2008-10#1)
peroxidation of##4##2##(1991-5#2)(1994-8#1)(2008-5#1)
peroxidation with##2##2##(1994-8#1)(2008-5#1)
peroxidation##60##1##(1991-5#4)(1992-3#2)(1993-2#3)(1993-8#2)(1994-11#1)(1994-5#3)(1994-8#5)(1996-2#7)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#8)(2008-7#3)(2008-8#1)(2009-8#5)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
peroxidative reaction##3##2##(1997-8#3)
peroxide (H(2)O(2))##12##2##(2008-10#9)(2009-8#1)(2012-2#1)(2013-1#1)
peroxide (H2O2)##3##2##(1997-4#1)(2012-3#1)(2013-8#1)
peroxide and##25##2##(2008-10#20)(2008-5#1)(2009-4#1)(2009-5#1)(2011-2#2)
peroxide as##3##2##(2008-10#3)
peroxide concentrations##5##2##(1990-5#1)(2008-10#3)(2008-5#1)
peroxide in the presence of##3##5##(1996-5#1)(2008-10#2)
peroxide in the##8##3##(1994-8#1)(1995-8#1)(1996-5#1)(2008-10#5)
peroxide in##35##2##(1994-8#1)(1995-8#1)(1996-5#1)(2008-10#31)(2009-5#1)
peroxide is detected##2##3##(2008-10#2)
peroxide is##5##2##(2008-10#5)
peroxide levels##2##2##(1990-5#1)(2008-11#1)
peroxide value##4##2##(2008-10#4)
peroxide values##2##2##(1990-5#2)
peroxide was##6##2##(2008-10#5)(2011-2#1)
peroxide##251##1##(1990-5#4)(1991-5#1)(1992-12#2)(1994-5#2)(1994-8#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-10#208)(2008-11#3)(2008-5#6)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-5#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
peroxide)##3##1##(2008-10#3)
peroxide-induced haemolysis##3##2##(1991-12#3)
peroxide-induced##4##1##(1991-12#3)(2008-7#1)
peroxides in the##2##3##(2008-10#1)(2013-1#1)
peroxides in##7##2##(1990-5#4)(2008-10#2)(2013-1#1)
peroxides##11##1##(1990-5#5)(2008-10#3)(2008-7#1)(2011-2#1)(2013-1#1)
peroxisomal protein##2##2##(1990-12#1)(1991-9#1)
peroxisomal targeting##2##2##(2009-10#2)
peroxisomal##11##1##(1990-12#1)(1990-3#1)(1990-5#2)(1991-9#1)(1993-9#2)(1995-2#1)(1995-9#1)(2009-10#2)
peroxisome proliferator##3##2##(1994-8#2)(2008-10#1)
peroxisome proliferator-activated receptor##6##3##(1994-8#1)(2008-5#2)(2010-10#1)(2011-3#1)(2013-8#1)
peroxisome proliferators##3##2##(1990-12#1)(1994-8#2)
peroxisome##15##1##(1990-12#1)(1993-9#1)(1994-8#5)(1995-9#1)(2008-10#1)(2008-5#2)(2010-10#1)(2011-3#1)(2012-3#1)(2013-8#1)
peroxisome-deficient##2##1##(1995-9#2)
peroxisomes and mitochondria##4##3##(2009-10#4)
peroxisomes were##2##2##(1995-9#1)(2008-7#1)
peroxisomes##16##1##(1990-12#1)(1990-5#1)(1993-9#1)(1995-2#1)(1995-9#4)(2008-7#2)(2009-10#5)(2009-8#1)
peroxodisulfate##5##1##(2008-10#5)
peroxovanadate##2##1##(1997-1#2)
peroxydisulphate##2##1##(2008-10#2)
peroxyl radical##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
peroxyl radicals in##2##3##(1992-9#1)(2008-10#1)
peroxyl radicals##4##2##(1992-9#2)(2008-10#2)
peroxyl##7##1##(1992-9#3)(2008-10#3)(2008-7#1)
peroxynitrite (ONOO(-))##3##2##(2008-10#2)(2008-7#1)
peroxynitrite in biological samples##2##4##(2008-10#2)
peroxynitrite in##3##2##(2008-10#3)
peroxynitrite##22##1##(2008-10#19)(2008-7#1)(2011-1#1)(2011-2#1)
peroxyoxalate chemiluminescent##2##2##(2008-10#2)
peroxyoxalate##3##1##(2008-10#3)
perpendicular direction##2##2##(1997-6#1)(2010-4#1)
perpendicular to the##13##3##(1994-11#1)(2008-10#2)(2008-3#5)(2009-2#1)(2010-4#2)(2011-2#1)(2012-12#1)
perpendicular##18##1##(1994-11#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#6)(2009-2#1)(2010-4#3)(2011-2#1)(2012-12#1)
perpendicularly##2##1##(2007-12#1)(2011-2#1)
perpetration##6##1##(2010-11#2)(2013-1#4)
perpetrators##2##1##(2008-11#2)
perpetual##2##1##(1993-11#1)(2012-2#1)
perpetuate##3##1##(1996-5#1)(2008-7#1)(2008-9#1)
perpetuated by##2##2##(1994-11#1)(2008-7#1)
perpetuating##2##1##(1994-2#1)(2010-12#1)
perpetuation of##4##2##(2008-12#3)(2013-1#1)
perpetuation##5##1##(1995-3#1)(2008-12#3)(2013-1#1)
perphenazine assay##2##2##(2008-10#2)
perphenazine was##2##2##(2008-10#2)
perphenazine##18##1##(1992-12#1)(2008-10#17)
perseverance and##2##2##(2008-11#1)(2008-12#1)
persica##4##1##(2008-10#2)(2008-12#2)
persicae##7##1##(2008-10#6)(2009-8#1)
persicus and##3##2##(2008-12#3)
persicus##6##1##(2008-12#4)(2013-1#2)
persimmon fruits##2##2##(2008-10#2)
persimmon tannin gel##4##3##(2008-10#4)
persimmon##9##1##(2008-10#9)
persist at##2##2##(2008-8#1)(2011-3#1)
persist for##4##2##(1991-3#1)(1995-9#1)(1997-8#1)(2011-2#1)
persist in a##2##3##(2008-8#1)(2012-3#1)
persist in the##3##3##(1990-5#1)(2008-10#1)(2009-8#1)
persist in##10##2##(1990-11#1)(1990-5#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-8#1)(2010-12#1)(2012-3#1)
persist on##2##2##(2008-10#2)
persist##28##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1995-9#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-8#5)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
persist?##2##1##(2008-8#2)
persisted after##2##2##(1991-11#1)(2008-10#1)
persisted for several##2##3##(2008-10#1)(2012-2#1)
persisted for up to##2##4##(2008-10#1)(2008-8#1)
persisted for##9##2##(2008-10#4)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
persisted in the##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
persisted in##8##2##(1995-11#1)(2008-10#3)(2008-8#3)(2013-1#1)
persisted longer##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
persisted with##2##2##(1992-6#1)(2008-10#1)
persisted##37##1##(1990-5#1)(1991-11#1)(1992-6#1)(1992-9#1)(1994-3#1)(1995-11#2)(1995-2#1)(1997-3#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
persistence and dynamics##2##3##(1995-5#2)
persistence and##7##2##(1995-5#4)(2006-6#1)(2010-11#1)(2010-4#1)
persistence in the##2##3##(1994-6#1)(2011-2#1)
persistence in##5##2##(1994-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
persistence of the##8##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#3)(2011-2#1)(2013-8#1)
persistence of##34##2##(1993-8#2)(1994-3#1)(1994-8#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-8#7)(2009-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#2)
persistence threshold##2##2##(2008-8#2)
persistence##80##1##(1993-8#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#5)(1995-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-5#4)(2008-8#22)(2009-3#1)(2009-6#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#5)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#2)
persistent TD##3##2##(2010-12#3)
persistent alterations in##2##3##(2009-7#1)(2013-8#1)
persistent and##4##2##(1994-3#2)(2008-10#1)(2008-8#1)
persistent deficits##2##2##(2011-1#1)(2012-3#1)
persistent elevation of##2##3##(1997-3#1)(2010-1#1)
persistent epithelial defect##2##3##(2011-2#2)
persistent hepatitis##2##2##(2008-8#1)(2013-1#1)
persistent in##3##2##(1990-5#1)(2008-11#1)(2008-9#1)
persistent infections##4##2##(1997-3#1)(2010-1#1)(2013-1#2)
persistent leptokurtosis##2##2##(2008-8#2)
persistent or recurrent##2##3##(1991-2#1)(2012-2#1)
persistent or##4##2##(1991-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
persistent symptoms##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
persistent vegetative state##3##3##(1990-11#1)(1991-12#1)(1997-5#1)
persistent##130##1##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#3)(1993-1#1)(1993-3#1)(1994-3#4)(1994-6#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#15)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#10)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#3)
persistently infected##2##2##(1995-9#1)(1997-5#1)
persistently transmitted##2##2##(2008-10#2)
persistently##11##1##(1992-12#1)(1995-9#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#1)(2013-1#1)
persister##2##1##(2012-3#2)
persisting for##2##2##(1991-3#1)(2011-2#1)
persisting##11##1##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
persists after##3##2##(1993-12#2)(2008-5#1)
persists in the##2##3##(2008-11#1)(2010-10#1)
persists in##6##2##(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
persists##19##1##(1993-12#2)(1994-2#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-10#2)(2011-2#1)(2011-3#1)(2013-1#2)
person and the##2##3##(1993-6#1)(1995-8#1)
person and##5##2##(1993-6#1)(1994-1#1)(1995-8#1)(2010-10#1)(2010-6#1)
person for##2##2##(2008-10#1)(2008-9#1)
person information##2##2##(2008-11#2)
person is##4##2##(1996-5#1)(2010-10#2)(2012-3#1)
person perspective##2##2##(2008-11#2)
person through##2##2##(1994-6#1)(2008-9#1)
person to##2##2##(1991-3#1)(1994-6#1)
person with##5##2##(1996-5#1)(2010-5#1)(2010-8#1)(2011-3#1)(2013-1#1)
person##59##1##(1990-11#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-6#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#2)(2008-10#2)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#3)(2009-9#1)(2010-10#6)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2011-3#2)(2012-2#2)(2012-3#2)(2013-1#2)
person's##12##1##(1991-6#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-6#1)(2010-10#2)(2010-5#1)(2011-2#1)(2013-8#1)
personal accomplishment)##2##2##(1996-2#1)(2008-11#1)
personal account of##2##3##(1996-12#1)(2011-2#1)
personal and professional##9##3##(1993-3#1)(1994-3#1)(2008-11#5)(2008-12#1)(2011-2#1)
personal and##16##2##(1991-1#1)(1993-3#1)(1994-3#1)(1997-1#1)(2008-11#5)(2008-12#2)(2008-7#1)(2009-9#1)(2011-2#2)(2011-3#1)
personal assistance services##2##3##(1996-1#2)
personal bankruptcy filings##2##3##(2008-11#2)
personal bankruptcy##3##2##(2008-11#3)
personal care##6##2##(1996-2#1)(1997-2#2)(2008-5#3)
personal case##2##2##(1993-6#1)(2008-11#1)
personal characteristics##4##2##(1995-12#2)(2009-7#2)
personal cleansing products##4##3##(2008-5#4)
personal cleansing##5##2##(2008-5#5)
personal computer (PC)##2##3##(1994-2#1)(2008-11#1)
personal computer##9##2##(1991-1#1)(1991-12#1)(1994-2#1)(1997-2#1)(2008-10#4)(2008-11#1)
personal computers##3##2##(1993-1#1)(1994-3#1)(2010-9#1)
personal contact##2##2##(2007-12#1)(2008-11#1)
personal development##2##2##(2008-11#2)
personal digital assistant (PDA)##2##4##(2008-10#1)(2008-12#1)
personal digital assistant##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
personal digital##4##2##(2008-10#1)(2008-12#2)(2008-3#1)
personal experience is##2##3##(1991-3#1)(2013-1#1)
personal experience of the##2##4##(1990-3#1)(2008-11#1)
personal experience of##3##3##(1990-3#1)(1990-5#1)(2008-11#1)
personal experience##15##2##(1990-3#2)(1990-5#1)(1990-9#2)(1991-3#1)(1993-3#1)(1994-12#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-11#2)(2009-4#1)(2013-1#1)
personal experiences and##3##3##(2010-5#1)(2012-12#1)(2012-3#1)
personal experiences of##2##3##(2008-11#1)(2008-12#1)
personal experiences##7##2##(2008-11#1)(2008-12#2)(2010-5#2)(2012-12#1)(2012-3#1)
personal exposure to##2##3##(2008-11#2)
personal exposure##6##2##(2008-11#6)
personal health care expenditures##2##4##(1996-3#1)(1997-3#1)
personal health care##4##3##(1996-1#1)(1996-3#1)(1997-3#2)
personal health##6##2##(1996-1#1)(1996-3#1)(1997-3#2)(2008-11#1)(2010-1#1)
personal income##2##2##(1993-1#1)(1994-2#1)
personal journey##2##2##(1995-12#1)(2008-11#1)
personal moral dilemmas##3##3##(2008-11#3)
personal moral violations##2##3##(2008-11#2)
personal moral##7##2##(2008-11#7)
personal or##3##2##(1991-2#1)(2009-7#1)(2010-6#1)
personal perspective##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
personal preferences##2##2##(2012-12#1)(2013-1#1)
personal qualities##4##2##(1990-12#3)(2011-2#1)
personal reflection##4##2##(1996-12#1)(2008-11#2)(2008-12#1)
personal series of##2##3##(1993-6#1)(2008-7#1)
personal tutor role##2##3##(2008-11#2)
personal tutor##4##2##(2008-11#4)
personal view of##4##3##(1994-12#1)(1995-12#2)(1996-1#1)
personal##215##1##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#2)(1993-3#3)(1993-6#2)(1994-1#2)(1994-12#5)(1994-2#2)(1994-3#2)(1994-6#2)(1995-1#2)(1995-12#6)(1996-1#8)(1996-12#2)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#12)(2008-11#52)(2008-12#13)(2008-3#1)(2008-5#11)(2008-7#5)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#10)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
personalities##3##1##(1992-3#1)(1993-11#1)(2012-2#1)
personality assessment##2##2##(1990-2#1)(2008-7#1)
personality characteristics##4##2##(2008-11#1)(2009-5#3)
personality disorder##13##2##(1991-1#1)(2008-1#1)(2008-11#1)(2009-10#4)(2009-9#2)(2010-2#2)(2011-2#1)(2013-1#1)
personality disorders in##2##3##(1991-1#1)(2008-11#1)
personality disorders##4##2##(1991-1#1)(1992-1#1)(1992-3#1)(2008-11#1)
personality factors and##2##3##(2008-11#2)
personality trait##5##2##(2008-11#2)(2010-6#2)(2011-2#1)
personality traits and##2##3##(2008-7#2)
personality traits##5##2##(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)
personality##57##1##(1990-11#1)(1990-2#1)(1991-1#2)(1992-1#1)(1992-3#2)(1993-11#2)(1995-5#1)(1996-2#1)(2008-1#1)(2008-11#9)(2008-7#4)(2008-9#1)(2009-10#5)(2009-5#3)(2009-9#4)(2010-1#1)(2010-2#2)(2010-6#3)(2011-1#2)(2011-2#7)(2012-2#1)(2013-1#2)(2013-8#1)
personalized face##2##2##(2008-6#2)
personalized medicine##6##2##(2010-10#2)(2010-4#2)(2010-5#1)(2013-8#1)
personalized##20##1##(1991-8#1)(1992-3#1)(2008-6#2)(2010-10#4)(2010-12#1)(2010-4#3)(2010-5#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#3)
personalizing##2##1##(2008-11#1)(2013-8#1)
personally##7##1##(2008-10#1)(2008-11#3)(2010-1#1)(2012-2#1)(2013-8#1)
personatum##3##1##(2008-10#3)
personnel and the##3##3##(1992-12#1)(1993-3#1)(2013-1#1)
personnel and##11##2##(1992-12#1)(1993-3#1)(1997-1#1)(1997-8#1)(2008-10#2)(2008-8#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
personnel are##3##2##(1993-12#1)(2008-1#1)(2008-10#1)
personnel as##2##2##(1991-2#1)(1995-1#1)
personnel from##2##2##(1991-12#1)(2008-10#1)
personnel in the##2##3##(1995-2#1)(2008-11#1)
personnel in##4##2##(1990-2#1)(1995-2#1)(2008-10#1)(2008-11#1)
personnel of##2##2##(1996-3#1)(2008-10#1)
personnel portal##2##2##(2008-10#2)
personnel to##2##2##(1992-3#1)(2008-10#1)
personnel were##2##2##(1996-9#1)(2008-10#1)
personnel who##2##2##(1991-12#1)(1995-12#1)
personnel##80##1##(1990-2#3)(1991-1#1)(1991-12#4)(1991-2#4)(1991-3#1)(1992-12#2)(1992-3#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#2)(2008-1#1)(2008-10#16)(2008-11#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#2)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)
personnel]##2##1##(1992-2#1)(1996-3#1)
persons aged##3##2##(1991-6#2)(2008-7#1)
persons and##4##2##(1990-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
persons are##5##2##(1992-11#1)(1997-6#1)(2012-2#3)
persons at##2##2##(1997-3#1)(2008-7#1)
persons had##4##2##(1994-9#2)(1996-11#1)(2008-11#1)
persons has##2##2##(2009-11#1)(2011-2#1)
persons in Norway##4##3##(1994-2#1)(1994-9#1)(1996-11#1)(1996-6#1)
persons in##13##2##(1992-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-12#1)(1996-11#1)(1996-6#1)(1997-2#1)(2010-10#2)
persons is##3##2##(1990-11#1)(2012-2#2)
persons may be##2##3##(1994-9#1)(2008-10#1)
persons may##3##2##(1994-9#1)(2008-10#1)(2013-8#1)
persons of interest##2##3##(2008-10#2)
persons of##8##2##(1994-12#2)(1994-2#1)(2008-10#3)(2008-7#2)
persons recovering from##2##3##(2009-10#2)
persons residing in##2##3##(1994-9#1)(1995-12#1)
persons suffering from mental health problems##2##6##(1996-1#2)
persons suffering from##3##3##(1992-5#1)(1996-1#2)
persons were##5##2##(1991-6#1)(1992-5#1)(1994-2#1)(1995-2#1)(2008-7#1)
persons who were##2##3##(1995-2#1)(2010-10#1)
persons who##11##2##(1991-6#1)(1991-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(2008-11#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
persons with Parkinson's disease##2##4##(2008-7#2)
persons with chronic##2##3##(1993-3#1)(2008-12#1)
persons with dementia##3##3##(1991-1#1)(1992-3#1)(2010-11#1)
persons with disabilities in##2##4##(1996-1#1)(1997-2#1)
persons with disabilities##4##3##(1996-1#1)(1997-2#2)(2009-6#1)
persons with psychiatric disabilities in housing programs##2##7##(1997-1#2)
persons with psychiatric disabilities##6##4##(1997-1#3)(2009-6#3)
persons with##49##2##(1991-1#1)(1991-12#3)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-9#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#5)(1997-2#6)(1997-3#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#3)(2009-6#4)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
persons without##3##2##(1994-12#1)(1994-9#2)
persons##194##1##(1990-11#2)(1990-12#3)(1990-3#1)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-6#6)(1991-8#1)(1992-11#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-2#3)(1993-3#1)(1994-1#4)(1994-12#5)(1994-2#4)(1994-6#2)(1994-9#16)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#3)(1996-11#3)(1996-2#1)(1996-3#4)(1996-6#1)(1997-1#6)(1997-2#8)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#1)(2008-10#11)(2008-11#6)(2008-12#3)(2008-7#10)(2008-9#2)(2009-10#3)(2009-11#1)(2009-6#5)(2010-10#6)(2010-11#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#6)(2013-8#3)
persons'##2##1##(1996-3#1)(2010-10#1)
persons)##2##1##(1990-12#1)(2008-9#1)
persoonii group 1##3##3##(2008-10#3)
persoonii group##4##2##(2008-10#4)
persoonii##5##1##(2008-10#5)
perspective and##7##2##(2008-11#3)(2008-6#1)(2008-8#1)(2009-6#1)(2010-11#1)
perspective for the##2##3##(2008-10#1)(2012-3#1)
perspective for##3##2##(1992-2#1)(2008-10#1)(2012-3#1)
perspective in order to##3##4##(1994-1#2)(1994-2#1)
perspective in##7##2##(1994-1#2)(1994-2#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-10#1)
perspective is##5##2##(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
perspective of the##10##3##(1993-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-3#1)
perspective of##41##2##(1991-1#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-10#4)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-2#2)(2012-3#1)
perspective on clinical##2##3##(1995-5#1)(1997-2#1)
perspective on the##11##3##(1994-1#2)(1997-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#1)(2012-3#1)
perspective on##27##2##(1991-1#1)(1993-12#1)(1994-1#4)(1995-2#1)(1995-5#3)(1997-1#1)(1997-2#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
perspective taking##2##2##(2008-11#2)
perspective that##3##2##(1994-1#1)(2010-3#1)(2012-3#1)
perspective through##2##2##(1997-8#1)(2009-11#1)
perspective to##6##2##(1993-12#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-7#1)(2012-2#1)
perspective##257##1##(1990-11#1)(1991-1#2)(1991-12#6)(1991-2#2)(1992-12#3)(1992-2#3)(1992-3#3)(1993-1#3)(1993-12#7)(1993-3#1)(1994-1#12)(1994-12#2)(1994-2#4)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#3)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#3)(1997-1#2)(1997-2#6)(1997-3#2)(1997-8#1)(2007-12#2)(2008-1#5)(2008-10#12)(2008-11#39)(2008-12#12)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#9)(2008-7#1)(2008-8#7)(2008-9#5)(2009-10#4)(2009-11#3)(2009-3#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#4)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#6)(2013-8#4)
perspective]##2##1##(1993-11#1)(1995-11#1)
perspectives about##2##2##(2009-12#1)(2011-1#1)
perspectives and##2##2##(2008-11#1)(2008-12#1)
perspectives for the##2##3##(2008-10#1)(2009-4#1)
perspectives for##6##2##(1994-1#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-7#1)
perspectives from##2##2##(1994-1#1)(2012-2#1)
perspectives imaging##3##2##(2008-3#3)
perspectives in the##4##3##(2008-11#2)(2008-5#1)(2010-4#1)
perspectives in##6##2##(1991-12#1)(2008-11#2)(2008-5#1)(2009-9#1)(2010-4#1)
perspectives of##12##2##(1996-2#1)(1997-3#1)(2008-12#3)(2008-4#1)(2010-11#1)(2010-9#1)(2011-2#2)(2013-8#2)
perspectives on an##2##3##(1991-2#1)(2008-12#1)
perspectives on the##4##3##(1992-12#1)(2008-10#1)(2012-3#1)(2013-8#1)
perspectives on##20##2##(1991-2#1)(1992-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-3#2)(2008-10#1)(2008-11#2)(2008-12#1)(2009-4#1)(2010-10#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
perspectives##103##1##(1991-12#1)(1991-2#1)(1992-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#3)(1997-1#1)(1997-3#4)(2008-10#3)(2008-11#11)(2008-12#11)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-9#2)(2010-10#4)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
perspectives]##2##1##(2009-10#1)(2011-2#1)
perspiration##2##1##(1995-5#1)(2008-5#1)
perstraction system for##2##3##(2008-7#2)
persuasion tactics##2##2##(2010-1#2)
persuasion##5##1##(2010-1#5)
persuasive##3##1##(1995-12#1)(1997-2#1)(2008-10#1)
persuasively##2##1##(2008-11#1)(2009-10#1)
persulphate##3##1##(2008-10#3)
pertaining to a##2##3##(2008-4#1)(2012-2#1)
pertaining to the##2##3##(1997-2#1)(2010-4#1)
pertaining to these##2##3##(2008-11#1)(2013-8#1)
pertaining to##21##2##(1993-3#1)(1996-1#1)(1997-2#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
pertaining##22##1##(1993-3#1)(1996-1#1)(1997-2#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
pertains to##4##2##(1995-12#1)(2008-1#1)(2008-11#1)(2009-8#1)
pertinent information##2##2##(1994-2#1)(1994-3#1)
pertinent literature##2##2##(2012-2#2)
pertinent questions##2##2##(2010-12#1)(2012-3#1)
pertinent to##10##2##(1991-2#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2013-8#1)
pertinent##31##1##(1990-2#1)(1991-12#1)(1991-2#1)(1993-12#1)(1994-2#2)(1994-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
perturb the##3##2##(1994-5#1)(1995-9#1)(2010-4#1)
perturbation and##2##2##(1992-12#1)(2013-8#1)
perturbation caused by different amounts of##2##6##(2008-10#2)
perturbation model to predict the effect of scattering and absorbing inhomogeneities on photon migration##2##14##(2008-3#2)
perturbation of glycolysis##2##3##(1997-6#2)
perturbation of the##5##3##(1994-5#2)(1996-5#1)(2008-3#1)(2011-2#1)
perturbation of##16##2##(1994-5#2)(1994-8#1)(1995-9#1)(1996-5#1)(1997-6#2)(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
perturbation theories and the##2##4##(2008-2#2)
perturbation theory##5##2##(1992-8#1)(2008-2#2)(2009-8#1)(2010-10#1)
perturbation##51##1##(1992-12#1)(1992-8#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-6#2)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#10)(2009-8#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
perturbations and##2##2##(2008-10#2)
perturbations in##9##2##(1991-12#1)(1996-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2013-1#2)(2013-8#1)
perturbations of##2##2##(2008-11#1)(2013-1#1)
perturbations that##3##2##(2008-10#2)(2011-1#1)
perturbations##38##1##(1991-12#1)(1991-2#1)(1994-2#1)(1996-12#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#8)(2013-8#1)
perturbed##16##1##(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-8#2)(2011-2#1)(2013-1#1)(2013-8#3)
perturbing##4##1##(2008-10#2)(2008-11#1)(2012-2#1)
perturbs the##2##2##(1993-8#1)(2008-10#1)
pertussis toxin and##2##3##(1990-8#1)(1993-8#1)
pertussis toxin##13##2##(1990-8#1)(1991-1#1)(1992-9#1)(1993-8#3)(1996-2#1)(1997-1#3)(1997-2#1)(1997-7#1)(2008-4#1)
pertussis toxin-catalyzed ADP-ribosylation of##2##4##(1992-9#2)
pertussis toxin-sensitive G protein##2##4##(1997-1#2)
pertussis toxin-sensitive G##3##3##(1995-11#1)(1997-1#2)
pertussis toxin-sensitive##4##2##(1995-11#1)(1997-1#2)(1997-2#1)
pertussis vaccination##2##2##(1995-5#1)(1997-8#1)
pertussis vaccine##5##2##(1995-3#1)(1995-5#2)(2013-1#2)
pertussis vaccines with##2##3##(1995-5#1)(1997-8#1)
pertussis vaccines##6##2##(1995-5#4)(1997-8#2)
pertussis##42##1##(1990-8#1)(1991-1#1)(1992-9#3)(1993-8#3)(1995-11#1)(1995-3#1)(1995-5#11)(1996-2#1)(1997-1#5)(1997-2#2)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#2)(2013-1#4)
peruvianus##4##1##(2007-12#3)(2008-10#1)
pervaporation and##2##2##(2008-10#2)
pervaporation flow injection##2##3##(2008-10#2)
pervaporation##8##1##(2008-10#8)
pervasive##11##1##(1995-2#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
pes planovalgus deformity##3##3##(2009-10#3)
pes##4##1##(2009-10#3)(2010-3#1)
pessimistic##2##1##(2008-7#1)(2013-8#1)
pest and disease##2##3##(2008-10#1)(2008-9#1)
pest control##3##2##(1997-7#1)(2008-11#2)
pest in##2##2##(2008-10#2)
pest management is##2##3##(2008-10#2)
pest management strategies##3##3##(2008-10#2)(2008-9#1)
pest management##27##2##(1997-7#1)(2008-10#22)(2008-9#1)(2013-8#3)
pest of rice##2##3##(2013-8#2)
pest of##4##2##(2008-10#1)(2008-6#1)(2013-8#2)
pest should be##2##3##(2008-8#1)(2013-8#1)
pest##60##1##(1997-7#2)(2008-10#41)(2008-11#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-8#1)(2013-8#7)
pesticide and##2##2##(2008-10#2)
pesticide are##2##2##(2008-10#2)
pesticide dose##2##2##(2008-10#2)
pesticide formulations##7##2##(2008-10#7)
pesticide in##3##2##(2008-10#2)(2013-1#1)
pesticide is##2##2##(2008-10#2)
pesticide legislation##2##2##(1996-3#2)
pesticide residues in##5##3##(2008-10#4)(2008-11#1)
pesticide residues##8##2##(2008-10#7)(2008-11#1)
pesticide resistance##2##2##(1995-6#1)(2008-10#1)
pesticide use##2##2##(2008-10#2)
pesticide##83##1##(1995-6#1)(1996-3#3)(2008-10#69)(2008-11#3)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#1)
pesticides (OPPs) in##2##3##(2008-10#2)
pesticides (OPPs)##3##2##(2008-10#3)
pesticides and alkylphenols in##3##4##(2008-10#3)
pesticides and##12##2##(2008-10#8)(2008-11#1)(2010-5#2)(2010-7#1)
pesticides are##5##2##(2008-10#3)(2008-11#1)(2013-1#1)
pesticides at##3##2##(2008-10#3)
pesticides from the##2##3##(2008-10#2)
pesticides from##7##2##(2008-10#7)
pesticides in the##4##3##(2008-10#2)(2008-11#1)(2010-5#1)
pesticides in vegetables##2##3##(2008-10#2)
pesticides in water##6##3##(2008-10#6)
pesticides in##26##2##(2008-10#21)(2008-11#2)(2010-5#2)(2013-1#1)
pesticides is##2##2##(2008-10#2)
pesticides may##2##2##(2008-10#1)(2010-5#1)
pesticides using##2##2##(2008-10#2)
pesticides was##5##2##(2008-10#4)(2008-11#1)
pesticides were##10##2##(2008-10#9)(2008-11#1)
pesticides##133##1##(1992-2#1)(2008-10#104)(2008-11#13)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#6)(2010-7#1)(2013-1#5)
pests and can##2##3##(2008-10#2)
pests and##5##2##(1994-3#1)(2008-10#4)
pests by##2##2##(2008-10#2)
pests is##3##2##(2008-10#2)(2008-9#1)
pests on##2##2##(2008-10#2)
pests such as##2##3##(1995-6#1)(2008-10#1)
pests##41##1##(1994-3#1)(1995-6#1)(2008-10#29)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-1#1)(2010-10#1)(2013-8#1)
pet rabbits##2##2##(1995-9#2)
pet##7##1##(1992-2#1)(1995-9#2)(2012-3#1)(2013-1#1)(2013-8#2)
petal expansion##4##2##(2008-10#4)
petal fall##2##2##(2008-10#2)
petal size##2##2##(2008-8#2)
petal##8##1##(2008-10#6)(2008-8#2)
petals##9##1##(2007-11#2)(2008-10#6)(2008-12#1)
pete1 and##2##2##(2009-10#2)
pete1##4##1##(2009-10#4)
pete2 double##2##2##(2009-10#2)
pete2##4##1##(2009-10#4)
pethidine and##2##2##(2008-10#1)(2010-7#1)
pethidine##9##1##(1997-5#1)(2008-10#3)(2010-7#4)(2012-12#1)
petiole debris##2##2##(2008-10#2)
petiole##7##1##(2008-10#7)
petioles and##3##2##(2008-10#3)
petioles of inoculated leaves##3##4##(2008-10#3)
petioles of##6##2##(2008-10#6)
petioles##14##1##(2008-10#14)
petits##3##1##(2008-11#1)(2011-2#2)
petrakii##2##1##(2008-10#2)
petri dish##2##2##(2008-10#2)
petri dishes with##2##3##(2008-10#1)(2008-11#1)
petri dishes##5##2##(2008-10#4)(2008-11#1)
petri plates containing a selective medium##3##6##(2008-10#3)
petri plates##5##2##(2008-10#5)
petri##12##1##(2008-10#11)(2008-11#1)
petrochemical##6##1##(1991-12#1)(2008-10#4)(2008-7#1)
petrol##3##1##(2008-10#3)
petrolatum##9##1##(2008-5#7)(2012-3#2)
petroleum ether##3##2##(2008-12#2)(2013-8#1)
petroleum products##3##2##(2008-10#3)
petroleum##22##1##(2008-10#15)(2008-11#2)(2008-12#2)(2008-5#1)(2013-1#1)(2013-8#1)
petrous apex cholesteatoma##7##3##(2011-2#7)
petrous apex##11##2##(2008-7#1)(2010-3#1)(2011-2#9)
petrous bone cholesteatoma##4##3##(2011-2#4)
petrous bone##8##2##(2008-7#3)(2011-2#5)
petrous temporal bone##2##3##(2011-2#2)
petrous##24##1##(2008-7#5)(2010-3#2)(2011-2#17)
petunia##5##1##(1993-6#3)(2008-10#2)
peut##3##1##(2013-1#3)
pfu and##2##2##(2008-9#2)
pfu##9##1##(2008-11#2)(2008-9#7)
pfu/cm(2))##2##1##(2012-2#2)
pg (R##2##2##(2008-10#2)
pg (n=20##2##2##(2008-10#2)
pg (recommended of 20 pg)##2##5##(2008-10#2)
pg (recommended of##4##3##(2008-10#4)
pg (recommended##6##2##(2008-10#6)
pg As ml(-1)##2##3##(2008-10#2)
pg and 0##2##3##(2008-10#2)
pg and the##3##3##(2008-10#3)
pg and##8##2##(2008-10#8)
pg cell(-1 )h(-1))##2##3##(2008-11#2)
pg cell(-1) h(-1)##2##3##(2008-11#2)
pg for##7##2##(2008-10#7)
pg mL(-1)##2##2##(2011-3#2)
pg ml(-1) for##2##3##(2008-10#2)
pg ml(-1)##14##2##(2008-10#14)
pg of DNA##2##3##(2008-10#2)
pg of bismuth##2##3##(2008-10#2)
pg of##15##2##(2008-10#12)(2008-5#3)
pg x mL(-1) for##2##4##(2011-3#2)
pg##87##1##(1996-12#2)(2008-10#71)(2008-11#6)(2008-5#3)(2009-12#1)(2011-3#4)
pg) and##2##2##(1997-2#1)(2008-10#1)
pg)##12##1##(1997-2#1)(2008-10#11)
pg/mL and##3##2##(2011-1#3)
pg/mL##6##1##(2011-1#6)
pg/ml for##2##2##(1992-9#2)
pg/ml##14##1##(1990-11#1)(1992-9#4)(1995-8#5)(2011-2#4)
pg/ml)##3##1##(1995-8#1)(2011-2#2)
pg/mul##3##1##(2008-10#3)
phacoemulsification##3##1##(2010-10#1)(2011-2#1)(2013-1#1)
phacorrhiza##4##1##(2008-10#4)
phaeohyphomycosis##4##1##(2008-10#2)(2008-5#2)
phage DNA##3##2##(1990-12#1)(1992-3#1)(1995-8#1)
phage T4##2##2##(1995-12#1)(1997-3#1)
phage and##4##2##(1993-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
phage antibodies##3##2##(2008-10#2)(2008-4#1)
phage application##2##2##(2012-2#2)
phage can##2##2##(2013-1#2)
phage clone##2##2##(1991-9#1)(2008-10#1)
phage concentrations##2##2##(2012-2#2)
phage display libraries are##2##4##(2008-10#1)(2008-4#1)
phage display libraries##7##3##(2008-10#2)(2008-11#1)(2008-4#3)(2008-9#1)
phage display library##3##3##(2008-10#2)(2012-2#1)
phage display peptide##2##3##(2008-10#1)(2008-4#1)
phage display technique##2##3##(2008-10#1)(2008-8#1)
phage display##25##2##(1993-8#1)(2008-10#8)(2008-11#4)(2008-4#6)(2008-8#2)(2008-9#1)(2009-6#1)(2012-2#1)(2013-8#1)
phage displayed##6##2##(2008-10#3)(2008-8#2)(2013-8#1)
phage lambda##2##2##(1991-6#1)(1992-4#1)
phage resistance##2##2##(2013-1#2)
phage scFv##3##2##(1993-8#1)(2008-10#2)
phage therapy##6##2##(2012-2#6)
phage use as##2##3##(2012-2#2)
phage##104##1##(1990-12#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-8#4)(1993-9#1)(1994-8#1)(1995-12#2)(1995-2#4)(1995-8#1)(1996-12#1)(1996-6#1)(1997-3#2)(2008-1#1)(2008-10#22)(2008-11#5)(2008-4#11)(2008-8#6)(2008-9#3)(2009-6#1)(2012-2#22)(2013-1#7)(2013-8#2)
phage-IFN variants##2##2##(2008-8#2)
phage-IFN##4##1##(2008-8#4)
phagemid##4##1##(1994-8#3)(2008-8#1)
phages##15##1##(1993-9#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-4#3)(2012-2#7)
phagocyte##2##1##(1995-8#1)(2008-9#1)
phagocytes##10##1##(1991-11#2)(1991-3#1)(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)
phagocytic activity of##2##3##(2008-10#2)
phagocytic activity##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
phagocytic cell##2##2##(1996-12#1)(2012-2#1)
phagocytic cells##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
phagocytic system##2##2##(2008-10#2)
phagocytic##19##1##(1990-12#2)(1994-6#2)(1996-12#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#3)(2013-1#1)
phagocytophilum##7##1##(2008-12#4)(2013-1#3)
phagocytosis by##9##2##(1993-6#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-9#1)
phagocytosis in##4##2##(1993-6#1)(1994-6#3)
phagocytosis of##5##2##(1991-5#2)(1993-6#1)(1995-2#1)(2008-9#1)
phagocytosis##36##1##(1990-12#3)(1991-12#1)(1991-2#1)(1991-5#3)(1993-6#6)(1994-6#9)(1995-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#3)(2009-9#1)
phakic##4##1##(2011-2#3)(2013-1#1)
phalanges##2##1##(1997-3#1)(2011-1#1)
phalanx of##2##2##(1997-5#1)(2010-3#1)
phalanx##3##1##(1997-5#1)(2010-3#1)(2012-2#1)
phalloides##3##1##(1991-11#3)
phalloidin microinjection##2##2##(2008-11#2)
phalloidin##4##1##(1993-3#1)(2008-11#2)(2008-7#1)
phallus##5##1##(2008-10#5)
phantom and##4##2##(1993-9#1)(2009-11#1)(2009-5#1)(2010-12#1)
phantom studies##2##2##(1995-5#1)(2008-10#1)
phantom##11##1##(1993-9#1)(1995-5#1)(1997-8#2)(2008-10#1)(2009-11#1)(2009-5#1)(2010-12#2)(2011-2#1)(2012-3#1)
phantoms##4##1##(1997-8#1)(2008-3#1)(2010-12#2)
pharaonis hR##4##2##(1994-5#4)
pharaonis hRblue##2##2##(1994-5#2)
pharaonis##8##1##(1994-5#8)
pharmaceutical analysis##4##2##(2008-10#4)
pharmaceutical and biotech industries##2##4##(2008-11#1)(2011-2#1)
pharmaceutical and biotechnology##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
pharmaceutical and medical##2##3##(2008-10#1)(2008-11#1)
pharmaceutical and##9##2##(2008-10#4)(2008-11#2)(2008-5#1)(2010-7#1)(2011-2#1)
pharmaceutical applications##2##2##(2012-2#2)
pharmaceutical companies are##2##3##(2008-11#1)(2010-8#1)
pharmaceutical companies##7##2##(1996-5#1)(2008-10#2)(2008-11#2)(2010-8#2)
pharmaceutical compounds##2##2##(2008-10#2)
pharmaceutical dosage form##4##3##(2008-10#4)
pharmaceutical dosage forms and##3##4##(2008-10#3)
pharmaceutical dosage forms with##3##4##(2008-10#3)
pharmaceutical dosage forms##14##3##(2008-10#14)
pharmaceutical dosage##18##2##(2008-10#18)
pharmaceutical dosages##2##2##(2008-10#2)
pharmaceutical drug##2##2##(2008-10#2)
pharmaceutical efficacy and safety##2##4##(2012-12#2)
pharmaceutical forms##2##2##(2008-10#2)
pharmaceutical formulation##19##2##(2008-10#18)(2008-5#1)
pharmaceutical formulations and##7##3##(2008-10#7)
pharmaceutical formulations by##8##3##(2008-10#8)
pharmaceutical formulations containing##2##3##(2008-10#2)
pharmaceutical formulations using##12##3##(2008-10#12)
pharmaceutical formulations were##2##3##(2008-10#2)
pharmaceutical formulations with##3##3##(2008-10#3)
pharmaceutical formulations##98##2##(1991-12#1)(2008-10#96)(2008-5#1)
pharmaceutical industries##3##2##(2008-10#3)
pharmaceutical industry##22##2##(1991-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)(2008-10#4)(2008-11#6)(2008-5#1)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)
pharmaceutical injection samples##2##3##(2008-10#2)
pharmaceutical injections##2##2##(2008-10#2)
pharmaceutical lead plasters and painting lead mediums##2##7##(2008-10#2)
pharmaceutical powders##2##2##(2008-10#2)
pharmaceutical preparation##13##2##(2008-10#13)
pharmaceutical preparations and the results were##2##6##(2008-10#2)
pharmaceutical preparations and the results##3##5##(2008-10#3)
pharmaceutical preparations and##16##3##(2008-10#16)
pharmaceutical preparations containing##3##3##(2008-10#2)(2008-11#1)
pharmaceutical preparations in##3##3##(2008-10#3)
pharmaceutical preparations using##7##3##(2008-10#7)
pharmaceutical preparations##106##2##(2008-10#105)(2008-11#1)
pharmaceutical processes##4##2##(2008-10#1)(2012-2#3)
pharmaceutical production##2##2##(2012-2#2)
pharmaceutical products using##2##3##(2008-10#2)
pharmaceutical products##29##2##(1995-1#1)(2008-10#22)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2012-2#1)
pharmaceutical quality##2##2##(1992-5#1)(2008-11#1)
pharmaceutical residues##5##2##(2008-10#5)
pharmaceutical samples and##2##3##(2008-10#2)
pharmaceutical samples##21##2##(2008-10#19)(2012-2#2)
pharmaceutical sector##2##2##(2011-2#1)(2012-2#1)
pharmaceutical tablets##2##2##(2008-10#2)
pharmaceutical vitamin tablets##2##3##(2008-10#2)
pharmaceutical##439##1##(1991-12#1)(1991-3#2)(1991-6#1)(1992-3#1)(1992-5#1)(1995-1#3)(1995-11#1)(1995-5#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-5#1)(2008-10#355)(2008-11#17)(2008-4#2)(2008-5#7)(2008-6#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2010-11#2)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#3)(2011-3#3)(2012-12#3)(2012-2#15)(2013-1#1)
pharmaceuticals by##2##2##(2008-10#2)
pharmaceuticals in wastewater##2##3##(2008-10#2)
pharmaceuticals in##4##2##(2008-10#4)
pharmaceuticals produced excellent results##2##4##(2008-10#2)
pharmaceuticals using##5##2##(2008-10#5)
pharmaceuticals with##3##2##(2008-10#2)(2009-12#1)
pharmaceuticals##77##1##(1993-12#1)(1993-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#65)(2008-11#1)(2008-7#1)(2009-12#1)(2012-2#4)
pharmacies and##2##2##(1995-1#1)(2008-11#1)
pharmacies in##3##2##(1995-1#1)(2008-11#1)(2012-2#1)
pharmacies since 1985##2##3##(1990-2#2)
pharmacies##14##1##(1990-2#4)(1995-1#6)(2008-11#3)(2012-2#1)
pharmacist##8##1##(1991-3#1)(1994-12#1)(1995-11#1)(2008-11#4)(2013-1#1)
pharmacists and patients##2##3##(1996-1#2)
pharmacists and##3##2##(1996-1#2)(1997-8#1)
pharmacists in##4##2##(2008-11#1)(2011-1#3)
pharmacists play##2##2##(2011-1#2)
pharmacists##37##1##(1993-3#1)(1994-12#2)(1995-2#1)(1996-1#3)(1997-8#1)(2008-11#3)(2008-8#1)(2011-1#22)(2013-1#3)
pharmacists' perceptions##2##2##(2011-1#2)
pharmacists' views##4##2##(2011-1#4)
pharmacists'##8##1##(2010-9#1)(2011-1#7)
pharmacodynamic and pharmacokinetic##2##3##(1990-6#1)(2008-10#1)
pharmacodynamic response##2##2##(1996-1#1)(2008-5#1)
pharmacodynamic##13##1##(1990-6#1)(1991-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
pharmacodynamics of##4##2##(1991-1#1)(1991-2#1)(2008-9#1)(2011-3#1)
pharmacodynamics##6##1##(1991-1#1)(1991-2#1)(2008-11#1)(2008-9#1)(2011-3#2)
pharmacoepidemiological##2##1##(2008-11#1)(2012-3#1)
pharmacogenetic##2##1##(2008-10#1)(2008-11#1)
pharmacogenomic##2##1##(2013-8#2)
pharmacogenomics##3##1##(2010-8#2)(2013-8#1)
pharmacokinetic models##2##2##(2008-5#1)(2010-12#1)
pharmacokinetic parameters##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
pharmacokinetic profile##6##2##(2008-10#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2013-8#1)
pharmacokinetic studies have##2##3##(2008-5#1)(2013-1#1)
pharmacokinetic studies of##2##3##(2008-10#2)
pharmacokinetic studies##6##2##(2008-10#4)(2008-5#1)(2013-1#1)
pharmacokinetic study of##4##3##(2008-10#3)(2011-3#1)
pharmacokinetic study##6##2##(2008-10#4)(2011-3#2)
pharmacokinetic##40##1##(1990-6#1)(1991-2#1)(1993-12#1)(1997-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#2)(2011-3#2)(2013-1#5)(2013-8#2)
pharmacokinetics and##2##2##(1991-2#1)(2008-7#1)
pharmacokinetics in##2##2##(1990-11#1)(2008-10#1)
pharmacokinetics of YH439 and its metabolites##3##6##(2008-11#3)
pharmacokinetics of##8##2##(1996-1#1)(2008-10#2)(2008-11#4)(2010-11#1)
pharmacokinetics##22##1##(1990-11#1)(1991-1#1)(1991-2#1)(1994-2#1)(1996-1#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-7#3)(2009-12#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
pharmacologic ascorbate##2##2##(2012-2#2)
pharmacologic challenge##2##2##(2008-12#1)(2008-4#1)
pharmacologic inhibition of##2##3##(1994-3#1)(2012-12#1)
pharmacologic therapies##2##2##(2008-8#1)(2010-11#1)
pharmacologic##18##1##(1993-1#1)(1994-3#1)(1995-6#2)(2008-12#2)(2008-4#3)(2008-7#1)(2008-8#1)(2010-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
pharmacological activities##5##2##(2008-10#1)(2008-12#1)(2011-1#1)(2011-3#1)(2012-2#1)
pharmacological activity##2##2##(1991-3#1)(2013-1#1)
pharmacological agents##3##2##(1997-1#1)(2008-12#1)(2009-12#1)
pharmacological aids##2##2##(2009-7#2)
pharmacological and nonpharmacological##2##3##(2008-11#2)
pharmacological and##9##2##(1993-2#1)(1994-3#1)(2008-11#2)(2009-12#1)(2009-7#2)(2010-12#1)(2012-3#1)
pharmacological approaches##4##2##(1992-9#1)(1995-11#1)(2008-3#1)(2009-7#1)
pharmacological characteristics##2##2##(2009-7#2)
pharmacological effects##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
pharmacological intervention for##2##3##(2008-11#1)(2013-1#1)
pharmacological intervention##4##2##(1991-2#2)(2008-11#1)(2013-1#1)
pharmacological interventions##2##2##(2008-8#1)(2013-8#1)
pharmacological management of##3##3##(2008-3#1)(2009-9#1)(2012-3#1)
pharmacological profile##3##2##(1994-8#1)(1995-11#1)(2008-6#1)
pharmacological properties of##3##3##(1993-6#1)(1994-11#1)(1995-11#1)
pharmacological properties##4##2##(1993-6#1)(1994-11#1)(1995-11#1)(2009-12#1)
pharmacological response##2##2##(1993-8#1)(2013-8#1)
pharmacological therapy##4##2##(2010-12#1)(2013-1#1)(2013-8#2)
pharmacological treatment##7##2##(1991-2#1)(1994-6#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-7#1)(2012-3#1)
pharmacological treatments##2##2##(2011-2#1)(2011-3#1)
pharmacological##112##1##(1990-6#1)(1990-9#2)(1991-1#1)(1991-2#3)(1991-3#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#3)(1995-2#1)(1996-2#2)(1997-1#2)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#4)(2009-4#1)(2009-7#7)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#5)
pharmacologically active##3##2##(1997-8#1)(2008-10#2)
pharmacologically similar##2##2##(1995-11#1)(1996-2#1)
pharmacologically##16##1##(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-4#1)(2009-7#1)(2009-8#1)(2012-2#1)
pharmacology and##4##2##(2008-11#2)(2010-5#1)(2012-2#1)
pharmacology education for nurses##2##4##(2008-12#2)
pharmacology education##3##2##(2008-12#3)
pharmacology of the##3##3##(1995-11#2)(2008-7#1)
pharmacology of##5##2##(1995-11#3)(1996-1#1)(2008-7#1)
pharmacology##36##1##(1991-3#1)(1994-1#1)(1994-8#1)(1995-11#7)(1995-12#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-12#9)(2008-7#1)(2010-5#1)(2011-2#2)(2012-2#3)
pharmacopeia##2##1##(2008-10#1)(2013-8#1)
pharmacophore##2##1##(2011-3#1)(2012-2#1)
pharmacophoric##2##1##(1993-8#1)(2012-2#1)
pharmacopoeia##2##1##(2008-10#1)(2008-5#1)
pharmacopoeial##4##1##(2008-10#3)(2008-5#1)
pharmacopoeias##3##1##(2008-10#1)(2012-2#2)
pharmacotherapeutic##2##1##(1997-8#1)(2008-4#1)
pharmacotherapies##6##1##(2008-11#2)(2009-6#1)(2011-2#1)(2011-7#1)(2013-1#1)
pharmacotherapy for##2##2##(2008-4#1)(2013-1#1)
pharmacotherapy in##2##2##(2008-4#2)
pharmacotherapy of##5##2##(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
pharmacotherapy##30##1##(1990-6#1)(1991-2#1)(1993-11#3)(2008-11#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#7)
pharmacotherapy-assisted quit attempts##2##3##(2013-1#2)
pharmacovigilance practice##2##2##(2008-11#2)
pharmacovigilance##15##1##(2008-11#13)(2013-8#2)
pharmacy claims of##2##3##(2008-11#1)(2009-6#1)
pharmacy practice##2##2##(2010-3#1)(2013-1#1)
pharmacy##30##1##(1991-1#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#2)(1995-1#3)(1995-2#1)(1997-2#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-5#1)(2011-1#1)(2013-1#4)
pharyngeal and laryngeal##2##3##(1990-9#1)(2010-12#1)
pharyngeal swabs##2##2##(2008-5#2)
pharyngeal##7##1##(1990-9#1)(1996-9#1)(2008-5#2)(2010-12#1)(2010-8#1)(2011-2#1)
pharynx and##2##2##(1997-7#1)(2008-12#1)
pharynx##9##1##(1990-8#2)(1995-5#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-12#1)(2011-2#2)
phase (7##2##2##(1994-2#1)(2008-10#1)
phase 2##3##2##(1993-3#1)(2011-2#1)(2013-1#1)
phase 3##3##2##(2008-9#2)(2011-2#1)
phase 3)##2##2##(2008-9#2)
phase C(18) column##4##3##(2008-10#4)
phase HPLC##4##2##(1990-12#1)(2008-10#2)(2008-8#1)
phase I Coxiella burnetii##2##4##(1995-12#2)
phase I and II##2##4##(1995-12#2)
phase I and##3##3##(1995-12#3)
phase I clinical trials##2##4##(2008-11#1)(2008-5#1)
phase I clinical##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
phase I studies##2##3##(2006-6#1)(2010-12#1)
phase I study##2##3##(2008-5#1)(2008-7#1)
phase I trials##4##3##(2008-5#3)(2011-2#1)
phase I##27##2##(1994-9#1)(1995-12#7)(2006-6#1)(2008-11#1)(2008-5#6)(2008-7#1)(2010-12#1)(2010-5#2)(2011-2#5)(2011-3#2)
phase I-II study##2##3##(1990-12#1)(1991-3#1)
phase II clinical##4##3##(2008-12#1)(2008-5#2)(2013-1#1)
phase II study of##2##4##(1993-2#1)(1995-10#1)
phase II study was##2##4##(2008-10#2)
phase II study##9##3##(1992-2#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-10#1)(2008-10#4)
phase II trial##2##3##(2008-5#1)(2010-12#1)
phase II trials##3##3##(2008-5#3)
phase II##31##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-12#1)(2008-10#5)(2008-12#1)(2008-5#10)(2008-8#3)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
phase II/III##3##2##(2008-5#2)(2012-2#1)
phase III study##2##3##(1992-12#1)(1997-4#1)
phase III trial##2##3##(2008-5#1)(2010-12#1)
phase III##12##2##(1992-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#5)(2010-12#1)(2011-3#1)
phase absorbances at##2##3##(2008-10#2)
phase and a##5##3##(2008-10#5)
phase and decreased##2##3##(1997-2#1)(2008-11#1)
phase and in##2##3##(2008-10#1)(2008-7#1)
phase and the##10##3##(1990-12#1)(1991-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)
phase and##83##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1997-2#1)(2007-12#2)(2008-10#49)(2008-11#8)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#4)(2011-3#1)(2013-1#2)
phase angle##2##2##(2008-3#1)(2011-2#1)
phase appeared##2##2##(2008-10#1)(2008-8#1)
phase are##2##2##(2008-10#1)(2012-3#1)
phase as an##3##3##(2008-10#3)
phase as well as##2##4##(2008-10#1)(2008-3#1)
phase as##8##2##(2008-10#6)(2008-3#1)(2008-7#1)
phase at a##3##3##(2008-10#2)(2008-3#1)
phase at pH 7##2##4##(2008-10#2)
phase at pH##3##3##(2008-10#2)(2008-11#1)
phase at the##2##3##(1990-9#1)(2008-10#1)
phase at##13##2##(1990-9#1)(1992-10#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
phase before##2##2##(2008-10#2)
phase behavior at low CBS concentrations##2##6##(1993-8#2)
phase behavior of##2##3##(1993-8#2)
phase behavior##7##2##(1993-8#5)(1994-5#1)(2008-8#1)
phase behaviors##2##2##(2008-10#2)
phase behaviour##2##2##(2008-5#2)
phase binding##3##2##(1993-2#1)(1996-12#1)(2008-10#1)
phase boundary##2##2##(2008-10#1)(2008-5#1)
phase but##3##2##(1993-6#1)(2008-10#1)(2008-7#1)
phase by the##2##3##(2008-10#1)(2008-11#1)
phase by##14##2##(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#1)(2013-8#1)
phase callusing##2##2##(2008-12#2)
phase can be##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
phase can##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
phase cartridges##2##2##(2008-10#2)
phase causes##2##2##(1997-1#1)(2008-7#1)
phase change##2##2##(2008-10#1)(2008-3#1)
phase changes##2##2##(2008-3#1)(2008-5#1)
phase chromatographic##3##2##(2008-10#3)
phase chromatography##7##2##(2008-10#6)(2008-5#1)
phase coding of place information##2##5##(2008-11#2)
phase coding##4##2##(2008-11#4)
phase column##3##2##(1992-8#1)(2008-10#2)
phase composed of##2##3##(2008-10#1)(2008-7#1)
phase composition##12##2##(2008-10#8)(2008-11#1)(2009-7#3)
phase conjugator##3##2##(2008-2#3)
phase consisting of##5##3##(2008-10#5)
phase containing a##2##3##(2008-10#2)
phase containing##11##2##(2008-10#10)(2008-7#1)
phase contrast##5##2##(1992-12#1)(2013-1#1)(2013-3#2)(2013-8#1)
phase correction method##2##3##(2013-8#2)
phase correction##6##2##(2013-8#6)
phase could be##4##3##(2008-10#2)(2008-11#1)(2009-11#1)
phase could##5##2##(1993-8#1)(2008-10#2)(2008-11#1)(2009-11#1)
phase data##2##2##(2008-3#2)
phase delivery##2##2##(2008-10#2)
phase dependent##2##2##(2008-11#1)(2008-5#1)
phase diagram##2##2##(2008-10#2)
phase diagrams##3##2##(1991-9#1)(1993-8#1)(2008-5#1)
phase difference between##2##3##(2008-11#1)(2008-3#1)
phase difference##4##2##(2008-11#1)(2008-3#3)
phase differences pi/2 and 3pi/2##2##5##(2008-3#2)
phase dissolution##2##2##(2008-10#2)
phase distortions##2##2##(2008-2#1)(2013-8#1)
phase due to##2##3##(1991-5#1)(2008-10#1)
phase duration##3##2##(1997-2#1)(2011-2#2)
phase during##4##2##(1994-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
phase encryption##2##2##(2008-3#2)
phase enhances##2##2##(2008-10#1)(2008-5#1)
phase equilibrium##3##2##(2008-10#2)(2012-3#1)
phase exchange##2##2##(2008-10#2)
phase extraction (SPE)##29##3##(2008-10#28)(2008-11#1)
phase extraction and##8##3##(2008-10#8)
phase extraction of##9##3##(2008-10#9)
phase extraction##81##2##(2008-10#79)(2008-11#1)(2009-8#1)
phase extractive preconcentration of##4##4##(2008-10#4)
phase extractive preconcentration##5##3##(2008-10#5)
phase for the##4##3##(2008-10#4)
phase for##13##2##(2008-10#12)(2008-7#1)
phase from the##2##3##(2008-3#1)(2009-7#1)
phase from##6##2##(1996-2#2)(2008-10#1)(2008-3#1)(2009-7#1)(2012-9#1)
phase function##7##2##(2008-2#1)(2008-3#6)
phase functions##3##2##(2008-2#2)(2008-3#1)
phase gratings##3##2##(2008-3#3)
phase has##3##2##(1995-6#1)(2008-10#1)(2009-7#1)
phase have been##2##3##(2008-10#1)(2008-5#1)
phase have##3##2##(2008-10#2)(2008-5#1)
phase high performance liquid chromatography##5##5##(1990-8#1)(2008-10#4)
phase high performance liquid##6##4##(1990-8#1)(2008-10#5)
phase images##4##2##(1993-8#1)(2012-2#3)
phase in the##18##3##(1990-6#1)(1993-8#1)(1996-2#1)(1996-5#1)(2008-10#12)(2008-11#1)(2008-6#1)
phase in which##5##3##(1993-8#1)(1994-5#1)(2008-4#1)(2011-2#2)
phase in##45##2##(1990-6#1)(1991-5#1)(1993-8#2)(1994-5#1)(1995-6#2)(1996-2#1)(1996-5#1)(2008-10#23)(2008-11#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#3)
phase increases with##2##3##(2008-10#1)(2009-7#1)
phase insulin response)##2##3##(1994-12#2)
phase interaction##2##2##(2008-10#2)
phase into the##2##3##(1991-5#1)(2008-10#1)
phase into##4##2##(1991-5#1)(2008-10#3)
phase ion-pair##2##2##(2008-10#2)
phase is##26##2##(1990-5#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-4#1)
phase jump##2##2##(2008-3#2)
phase lag##2##2##(1994-8#1)(2012-2#1)
phase liquid chromatography (LC)##2##4##(2008-10#2)
phase liquid chromatography for the##2##5##(2008-10#2)
phase liquid chromatography with##2##4##(2008-10#2)
phase liquid chromatography##16##3##(2008-10#16)
phase locking##2##2##(2008-11#1)(2008-2#1)
phase maps##2##2##(2008-3#2)
phase mask##2##2##(2008-3#1)(2012-2#1)
phase masks##4##2##(2008-3#4)
phase matching##3##2##(2008-2#1)(2008-3#2)
phase micro extraction##3##3##(2008-10#3)
phase microextraction (SPME)##9##3##(2008-10#8)(2009-8#1)
phase microextraction coupled with##2##4##(2008-10#2)
phase microextraction coupled##3##3##(2008-10#3)
phase microextraction##20##2##(2008-10#19)(2009-8#1)
phase modulation##2##2##(2008-3#2)
phase modulator##2##2##(2008-3#2)
phase molecular absorption spectrometry##8##4##(2008-10#8)
phase molecular absorption##11##3##(2008-10#11)
phase object##2##2##(2008-3#2)
phase of HPLC##2##3##(2008-10#2)
phase of a##8##3##(1997-5#4)(2008-11#2)(2008-3#2)
phase of an##2##3##(2008-11#1)(2008-7#1)
phase of cell##2##3##(1993-3#1)(2008-11#1)
phase of gait##2##3##(2010-3#1)(2013-1#1)
phase of growth were##2##4##(2008-11#2)
phase of growth##3##3##(1994-8#1)(2008-11#2)
phase of the cell cycle##5##5##(1994-3#1)(2008-11#2)(2008-9#1)(2013-1#1)
phase of the cell##6##4##(1991-5#1)(1994-3#1)(2008-11#2)(2008-9#1)(2013-1#1)
phase of the disease##3##4##(1997-5#1)(2009-10#1)(2010-3#1)
phase of the study##3##4##(2008-11#1)(2010-1#1)(2010-9#1)
phase of the##41##3##(1990-12#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-5#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(1997-5#2)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#1)
phase of their##2##3##(1992-6#1)(2012-2#1)
phase of this##3##3##(1995-6#1)(2008-12#1)(2010-1#1)
phase of treatment##2##3##(2007-9#1)(2013-8#1)
phase of##137##2##(1990-12#2)(1990-6#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-5#7)(2007-11#1)(2007-9#2)(2008-1#2)(2008-10#34)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#5)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-8#1)(2010-1#2)(2010-3#2)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#2)
phase on the##4##3##(1997-1#1)(2008-10#2)(2008-11#1)
phase on##11##2##(1997-1#1)(2008-10#8)(2008-11#1)(2008-2#1)
phase out##2##2##(1996-1#2)
phase partitioning##2##2##(1990-5#1)(2008-10#1)
phase precession##7##2##(2008-11#7)
phase preconcentration##2##2##(2008-10#2)
phase profile##2##2##(2008-3#2)
phase protein##2##2##(1994-6#1)(2008-10#1)
phase separated##2##2##(2008-10#1)(2008-5#1)
phase separation of##4##3##(1997-6#1)(2008-10#3)
phase separation was##3##3##(2008-10#3)
phase separation##21##2##(1994-5#1)(1997-6#1)(2008-10#14)(2008-7#4)(2010-4#1)
phase separator for##2##3##(2008-10#2)
phase separator with a##2##4##(2008-10#2)
phase separator##10##2##(2008-10#10)
phase shift##7##2##(1994-2#1)(2008-2#2)(2008-3#3)(2008-8#1)
phase shifter##3##2##(2008-3#3)
phase shifts induced##2##3##(2007-12#1)(2008-2#1)
phase shifts##7##2##(1994-2#3)(2007-12#2)(2008-10#1)(2008-2#1)
phase should##2##2##(1994-2#1)(2008-10#1)
phase space beam model to##2##5##(2009-11#2)
phase space beam model##4##4##(2009-11#4)
phase space##5##2##(2007-12#1)(2009-11#4)
phase spectrophotometric determination of vanillin##2##5##(2008-10#2)
phase spectrophotometric determination of##3##4##(2008-10#3)
phase spectrophotometric##5##2##(2008-10#5)
phase stability of##2##3##(2010-12#1)(2010-4#1)
phase stability##4##2##(2008-10#1)(2010-12#1)(2010-4#1)(2012-2#1)
phase surface##3##2##(2008-10#2)(2008-11#1)
phase that##2##2##(2008-10#2)
phase the##2##2##(2008-10#1)(2008-11#1)
phase to the##4##3##(1991-5#1)(2008-10#3)
phase to##15##2##(1991-5#1)(2008-10#8)(2008-11#3)(2008-5#1)(2009-7#1)(2010-4#1)
phase transition temperatures of liquid crystals##2##6##(2008-10#2)
phase transition##18##2##(1991-5#1)(1991-9#1)(1992-8#1)(1994-2#1)(1995-6#1)(2008-10#10)(2008-7#1)(2008-8#1)(2009-5#1)
phase transitions in##3##3##(1991-9#2)(1993-5#1)
phase transitions##6##2##(1990-2#1)(1991-9#2)(1993-5#1)(1997-2#1)(2008-10#1)
phase unwrapping##2##2##(2008-3#2)
phase used was##7##3##(1997-2#1)(2008-10#4)(2012-2#2)
phase using##6##2##(2008-10#6)
phase volume##2##2##(2008-10#2)
phase was also##3##3##(1997-1#1)(2008-10#2)
phase was determined##2##3##(2008-10#2)
phase was evaluated##2##3##(2008-10#2)
phase was investigated in##2##4##(2008-10#2)
phase was measured at##2##4##(2008-10#2)
phase was##42##2##(1990-8#1)(1991-5#1)(1993-12#1)(1994-8#1)(1997-1#1)(1997-2#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)
phase water content##3##3##(2008-10#3)
phase water##4##2##(2008-10#3)(2008-5#1)
phase were optimised##3##3##(2008-10#3)
phase were optimized##2##3##(2008-10#2)
phase were##16##2##(1997-2#1)(2008-10#12)(2008-11#2)(2011-2#1)
phase which##4##2##(1993-8#1)(1996-3#1)(2008-10#1)(2008-11#1)
phase with 'P' values of P &lt##2##7##(2012-2#2)
phase with the##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
phase with##21##2##(2008-10#13)(2008-11#3)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#2)
phase without##2##2##(2008-10#2)
phase##1687##1##(1990-12#9)(1990-2#2)(1990-5#3)(1990-6#4)(1990-8#7)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-5#12)(1991-6#1)(1991-7#1)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#1)(1993-8#21)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#10)(1994-3#2)(1994-5#8)(1994-6#4)(1994-8#5)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#11)(1995-2#1)(1995-3#1)(1995-6#7)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#1)(1996-5#2)(1997-1#6)(1997-2#12)(1997-4#1)(1997-5#7)(1997-6#2)(1997-8#2)(2006-6#1)(2007-11#5)(2007-12#7)(2007-9#2)(2008-1#3)(2008-10#857)(2008-11#115)(2008-12#12)(2008-2#21)(2008-3#95)(2008-4#5)(2008-5#74)(2008-6#4)(2008-7#46)(2008-8#27)(2008-9#14)(2009-10#3)(2009-11#7)(2009-5#1)(2009-6#3)(2009-7#19)(2009-8#6)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-3#2)(2010-4#10)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#37)(2011-3#6)(2011-9#1)(2012-2#23)(2012-3#10)(2012-9#2)(2013-1#16)(2013-3#2)(2013-7#1)(2013-8#19)
phase)##19##1##(1994-5#1)(2008-10#15)(2008-3#1)(2008-7#2)
phase-HPLC##2##1##(2008-10#1)(2011-2#1)
phase-boundary model##2##2##(2008-10#2)
phase-boundary potential model##2##3##(2008-10#2)
phase-boundary##4##1##(2008-10#4)
phase-conjugate##4##1##(2008-2#3)(2008-3#1)
phase-contrast##5##1##(1995-11#1)(2008-4#2)(2008-8#1)(2010-1#1)
phase-correlated##2##1##(1991-9#1)(2011-2#1)
phase-locked##2##1##(2008-2#1)(2008-3#1)
phase-locking##3##1##(2008-11#2)(2013-8#1)
phase-matched##5##1##(2007-12#3)(2008-2#2)
phase-matching temperatures##2##2##(2008-3#2)
phase-matching##7##1##(2008-2#1)(2008-3#6)
phase-modulated##4##1##(2007-12#2)(2008-3#1)(2012-2#1)
phase-resolved digital data processing##2##4##(2008-3#2)
phase-resolved##3##1##(2007-11#1)(2008-3#2)
phase-separated PNIPAM##3##2##(2008-10#3)
phase-separated##5##1##(1994-5#1)(2008-10#4)
phase-shifting interferometry##3##2##(2007-12#1)(2008-3#2)
phase-shifting##8##1##(1994-2#1)(2007-11#3)(2007-12#1)(2008-3#3)
phase-unwrapping##2##1##(2008-3#2)
phased in##2##2##(1992-1#1)(2008-11#1)
phased##9##1##(1992-1#1)(1994-12#1)(1995-2#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)
phased-array##4##1##(2007-11#1)(2008-3#3)
phaseoli and X##4##3##(2008-10#4)
phaseoli and##5##2##(2008-10#5)
phaseoli in##3##2##(2008-10#3)
phaseoli strains were highly pathogenic on##2##6##(2008-10#2)
phaseoli strains##10##2##(2008-10#10)
phaseoli var##15##2##(2008-10#15)
phaseoli was##2##2##(2008-10#2)
phaseoli##43##1##(2008-10#43)
phaseolicola and glycinea##2##3##(2008-10#2)
phaseolicola and##3##2##(2008-10#3)
phaseolicola was##2##2##(2008-10#2)
phaseolicola##15##1##(2008-10#15)
phaseolina##4##1##(2008-10#4)
phaseolorum and P##2##3##(2008-10#2)
phaseolorum and##6##2##(2008-10#6)
phaseolorum var##40##2##(2008-10#40)
phaseolorum##51##1##(2008-10#51)
phaseolotoxin##2##1##(2008-10#2)
phases IV and II##2##4##(2008-10#2)
phases and the##4##3##(1991-8#1)(2008-10#3)
phases and##9##2##(1991-8#1)(2008-10#7)(2010-11#1)
phases are##6##2##(1990-5#1)(2008-10#2)(2008-11#2)(2008-3#1)
phases at##2##2##(1993-8#1)(2010-4#1)
phases by##4##2##(1992-9#1)(2008-10#1)(2008-11#2)
phases can be##2##3##(2008-10#2)
phases containing##2##2##(2008-10#2)
phases for##8##2##(2008-10#6)(2008-11#1)(2008-5#1)
phases have been##2##3##(2008-10#2)
phases in the##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#2)
phases in##7##2##(1992-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-7#2)
phases of different##3##3##(2008-10#2)(2008-3#1)
phases of infection##2##3##(2008-10#1)(2013-1#1)
phases of menstrual cycle on physical working capacity##2##8##(2012-2#2)
phases of menstrual cycle##3##4##(2012-2#3)
phases of the cell cycle##6##5##(1994-3#1)(2008-11#5)
phases of the disease##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
phases of the micellar system##3##5##(1990-5#3)
phases of the##22##3##(1990-2#1)(1990-5#3)(1994-12#1)(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#9)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
phases of##64##2##(1990-2#1)(1990-5#4)(1990-6#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#2)(1996-2#1)(2008-10#10)(2008-11#13)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#3)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#2)(2013-7#1)
phases on##2##2##(1991-5#1)(2008-10#1)
phases that##2##2##(2008-10#2)
phases was##3##2##(2008-10#3)
phases were observed##2##3##(2008-5#1)(2008-7#1)
phases were separated in a##3##5##(2008-10#3)
phases were studied##2##3##(2008-10#2)
phases were##18##2##(1993-12#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2010-11#1)
phases with the##3##3##(2008-10#2)(2008-5#1)
phases with##4##2##(2008-10#2)(2008-5#1)(2010-2#1)
phases##238##1##(1990-2#1)(1990-5#5)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#2)(1992-2#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#98)(2008-11#30)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#10)(2008-7#3)(2008-8#6)(2008-9#4)(2009-12#1)(2009-7#2)(2009-8#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#13)(2012-3#2)(2012-9#1)(2013-1#4)(2013-7#2)(2013-8#5)
phases'##2##1##(2008-11#2)
phasic inhibition##2##2##(2008-11#1)(2011-2#1)
phasic signals##2##2##(1995-12#2)
phasic##10##1##(1995-12#2)(1997-4#3)(2008-11#1)(2010-8#1)(2011-2#3)
phasing of##2##2##(2008-9#1)(2012-3#1)
phasing##3##1##(1992-4#1)(2008-9#1)(2012-3#1)
pheasants##2##1##(1990-9#1)(1996-8#1)
phenacyl##3##1##(2008-10#2)(2008-11#1)
phenanthrene and##2##2##(2008-10#2)
phenanthrene metabolism##2##2##(1994-5#2)
phenanthrene##21##1##(1994-5#5)(2008-10#12)(2008-11#4)
phenanthrene-9##2##1##(2008-11#2)
phenanthrenes##2##1##(2008-10#2)
phenanthroline##2##1##(2012-3#2)
phenazine methosulfate##2##2##(1992-3#1)(2008-11#1)
phenazine##3##1##(1992-3#1)(2008-10#1)(2008-11#1)
phenethyl alcohol and##3##3##(2008-5#3)
phenethyl alcohol in##2##3##(2008-5#2)
phenethyl alcohol##8##2##(2008-5#8)
phenethyl##9##1##(1992-8#1)(2008-5#8)
phenethylamine class##2##2##(1995-11#2)
phenethylamine##4##1##(1995-11#2)(2008-10#2)
phenetic##3##1##(2008-10#3)
phenobarbital and##3##2##(1993-11#1)(2008-10#2)
phenobarbital##10##1##(1991-5#1)(1993-11#1)(1995-2#2)(2008-10#5)(2008-8#1)
phenobarbital-induced##2##1##(1993-11#2)
phenobarbitone##2##1##(1994-8#1)(2008-10#1)
phenogram##4##1##(2008-10#2)(2008-5#2)
phenol and catechol##5##3##(2008-10#5)
phenol and##13##2##(2008-10#9)(2008-3#3)(2008-8#1)
phenol as a##2##3##(2008-10#2)
phenol as##3##2##(2008-10#3)
phenol compounds##2##2##(2008-10#2)
phenol concentration##3##2##(2008-10#1)(2008-3#2)
phenol derivatives##2##2##(2008-10#2)
phenol in the##2##3##(2008-10#2)
phenol in##9##2##(2008-10#9)
phenol ring##2##2##(2008-8#2)
phenol sulphotransferase##3##2##(1994-11#3)
phenol##88##1##(1994-11#3)(1994-5#3)(2008-10#69)(2008-11#2)(2008-3#5)(2008-5#1)(2008-8#4)(2013-1#1)
phenolate##2##1##(1990-5#1)(2008-10#1)
phenolic OH groups##4##3##(2008-10#4)
phenolic OH##5##2##(2008-10#5)
phenolic acid##3##2##(2008-10#1)(2008-5#2)
phenolic acids and##3##3##(2008-10#3)
phenolic acids##8##2##(2008-10#7)(2008-11#1)
phenolic antioxidants##4##2##(2008-10#4)
phenolic benzylamines##3##2##(2008-5#3)
phenolic compound##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
phenolic compounds and##4##3##(2008-10#4)
phenolic compounds have##2##3##(2008-10#2)
phenolic compounds in the##2##4##(1994-5#1)(2008-10#1)
phenolic compounds in##7##3##(1994-5#1)(2008-10#4)(2011-2#2)
phenolic compounds present in##2##4##(2008-10#2)
phenolic compounds with##2##3##(2008-10#2)
phenolic compounds##49##2##(1994-5#3)(2008-10#38)(2008-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)
phenolic content of##4##3##(2008-10#3)(2008-11#1)
phenolic content##6##2##(2008-10#5)(2008-11#1)
phenolic contents##3##2##(2008-11#1)(2013-8#2)
phenolic groups##2##2##(2008-10#2)
phenolic hydroxyl##2##2##(2008-10#1)(2008-9#1)
phenolic monomers##3##2##(2011-1#1)(2011-2#2)
phenolic substance from##2##3##(2008-5#2)
phenolic substance##7##2##(2008-5#7)
phenolic##116##1##(1990-5#2)(1994-5#3)(2008-10#77)(2008-11#6)(2008-5#12)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
phenolics and##2##2##(2008-10#2)
phenolics in##3##2##(2008-10#2)(2008-11#1)
phenolics is##2##2##(2008-10#2)
phenolics were##2##2##(2008-10#2)
phenolics##18##1##(2008-10#13)(2008-11#3)(2011-2#2)
phenological##6##1##(2008-10#4)(2012-6#2)
phenology in##2##2##(2008-10#1)(2012-6#1)
phenology##13##1##(2008-10#9)(2008-8#1)(2012-2#1)(2012-6#2)
phenolphthalein##6##1##(2008-10#6)
phenols and related compounds##5##4##(2008-10#5)
phenols and##11##2##(2008-10#11)
phenols by##3##2##(2008-10#3)
phenols in air##3##3##(2008-10#3)
phenols in the##2##3##(2008-10#2)
phenols in##8##2##(2008-10#8)
phenols is##2##2##(1994-5#1)(2011-1#1)
phenols on the##2##3##(2008-10#2)
phenols to##2##2##(2008-10#1)(2011-1#1)
phenols using##3##2##(2008-10#3)
phenols was##2##2##(2008-10#2)
phenols were##2##2##(2008-10#1)(2008-6#1)
phenols with##4##2##(2008-10#4)
phenols##72##1##(1994-5#2)(2008-10#63)(2008-11#1)(2008-6#2)(2011-1#4)
phenomena and##4##2##(1997-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
phenomena are##3##2##(2008-9#2)(2009-7#1)
phenomena as##2##2##(2010-10#1)(2013-8#1)
phenomena due to##2##3##(2009-12#1)(2011-2#1)
phenomena have been##2##3##(1991-5#1)(2008-2#1)
phenomena have##3##2##(1991-5#1)(2008-2#1)(2008-7#1)
phenomena in##12##2##(2008-10#3)(2008-11#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)
phenomena is##2##2##(1995-3#1)(2008-11#1)
phenomena occurred##2##2##(2008-10#2)
phenomena of##9##2##(2008-10#3)(2008-5#1)(2008-7#3)(2010-10#1)(2010-11#1)
phenomena should##3##2##(2009-7#1)(2010-11#1)(2012-3#1)
phenomena that##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2013-8#1)
phenomena was##3##2##(2008-10#1)(2008-3#2)
phenomena were observed##2##3##(2008-10#2)
phenomena##118##1##(1991-11#1)(1991-5#1)(1993-6#1)(1995-3#3)(1996-1#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#2)(2007-11#1)(2008-10#29)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#12)(2008-5#4)(2008-7#13)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
phenomena)##2##1##(2008-10#1)(2008-7#1)
phenomenal##3##1##(1991-3#1)(1997-1#1)(2008-12#1)
phenomenological approach##2##2##(2009-9#1)(2010-10#1)
phenomenological study investigated the##2##4##(2008-11#1)(2010-11#1)
phenomenological study was##2##3##(2008-11#1)(2009-5#1)
phenomenological study##9##2##(2008-11#4)(2008-12#2)(2009-5#1)(2010-11#1)(2012-3#1)
phenomenological##24##1##(1995-8#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-9#1)(2012-3#2)(2013-8#1)
phenomenology##8##1##(2008-11#3)(2008-12#1)(2008-8#1)(2010-6#1)(2010-7#1)(2013-8#1)
phenomenon and##6##2##(1995-5#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-7#1)
phenomenon are##2##2##(1997-6#1)(2008-11#1)
phenomenon called##2##2##(2008-9#1)(2009-10#1)
phenomenon commonly##2##2##(2008-12#1)(2010-4#1)
phenomenon could##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
phenomenon for##2##2##(2008-11#1)(2008-3#1)
phenomenon in humans##2##3##(2008-11#1)(2010-4#1)
phenomenon in the##2##3##(1995-5#1)(2013-8#1)
phenomenon in which##2##3##(2008-7#1)(2009-10#1)
phenomenon in##16##2##(1995-11#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#2)
phenomenon is a##3##3##(1994-11#1)(1995-5#1)(2012-2#1)
phenomenon is##15##2##(1991-2#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-7#1)(2012-2#1)
phenomenon may be##3##3##(1991-6#1)(2008-10#1)(2008-5#1)
phenomenon may##5##2##(1991-6#1)(1992-2#1)(2008-10#2)(2008-5#1)
phenomenon of late-arising##2##3##(2008-9#2)
phenomenon of the##2##3##(2008-10#1)(2008-5#1)
phenomenon of##29##2##(1993-2#1)(1994-8#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
phenomenon that may##2##3##(1992-12#1)(1997-3#1)
phenomenon that we##2##3##(2008-5#1)(2012-2#1)
phenomenon that##10##2##(1992-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
phenomenon to##2##2##(1994-5#1)(2008-7#1)
phenomenon was##9##2##(1990-5#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-9#2)(2011-2#1)
phenomenon##198##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#4)(1996-2#2)(1997-3#1)(1997-6#1)(1997-9#1)(2008-1#1)(2008-10#40)(2008-11#16)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#19)(2008-8#6)(2008-9#16)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#8)(2011-3#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
phenophases##3##1##(2012-6#3)
phenothiazine derivatives##8##2##(2008-10#8)
phenothiazine drugs##2##2##(2008-10#2)
phenothiazine##13##1##(2008-10#13)
phenothiazines##9##1##(1991-8#1)(2008-10#7)(2011-3#1)
phenotype and a##2##3##(2008-9#1)(2011-2#1)
phenotype and the##2##3##(2008-3#1)(2011-2#1)
phenotype and##23##2##(1995-2#3)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#1)
phenotype as##3##2##(1992-3#1)(2008-8#2)
phenotype between##2##2##(2008-10#1)(2009-8#1)
phenotype but##3##2##(1996-12#1)(2012-3#1)(2013-8#1)
phenotype by##2##2##(1995-9#1)(1997-3#1)
phenotype can##2##2##(2008-10#1)(2008-11#1)
phenotype characterized by##2##3##(2013-1#1)(2013-8#1)
phenotype expression##2##2##(2012-2#1)(2013-1#1)
phenotype have##2##2##(2008-10#1)(2008-11#1)
phenotype in this##2##3##(1992-3#1)(2008-10#1)
phenotype in##13##2##(1992-3#1)(1995-11#2)(1995-6#1)(1995-8#1)(2008-10#2)(2008-11#3)(2008-8#2)(2011-2#1)
phenotype is##13##2##(1991-9#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-6#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
phenotype matching##2##2##(2008-8#1)(2012-2#1)
phenotype may##3##2##(1994-11#1)(1997-3#1)(2008-10#1)
phenotype of the##6##3##(1994-3#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-9#1)(2011-1#1)
phenotype of##35##2##(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-3#3)(1997-8#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
phenotype rather than##2##3##(2008-11#1)(2008-12#1)
phenotype should##2##2##(2008-10#1)(2010-7#1)
phenotype through##2##2##(2010-4#1)(2013-1#1)
phenotype to the##2##3##(2008-10#1)(2012-2#1)
phenotype to##3##2##(1993-9#1)(2008-10#1)(2012-2#1)
phenotype was dependent on the##2##5##(1995-2#1)(1997-7#1)
phenotype was not##2##3##(1997-3#1)(2008-10#1)
phenotype was##20##2##(1995-2#3)(1996-12#1)(1997-3#2)(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-8#1)(2011-1#2)(2012-3#1)(2013-1#1)
phenotype were##3##2##(1993-9#1)(2008-10#2)
phenotype with##2##2##(2008-10#1)(2009-8#1)
phenotype##285##1##(1990-5#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#3)(1995-2#6)(1995-6#3)(1995-8#4)(1995-9#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#16)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#1)(2008-10#61)(2008-11#30)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#7)(2008-8#15)(2008-9#11)(2009-12#1)(2009-3#4)(2009-6#3)(2009-8#6)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#8)(2012-2#6)(2012-3#12)(2013-1#15)(2013-8#6)
phenotype) and##2##2##(2008-8#1)(2009-3#1)
phenotypes and##7##2##(2008-10#3)(2008-8#3)(2010-4#1)
phenotypes are also##2##3##(2008-11#1)(2009-8#1)
phenotypes by the##2##3##(2008-10#2)
phenotypes can be##2##3##(2008-8#1)(2009-5#1)
phenotypes can##3##2##(2008-8#2)(2009-5#1)
phenotypes for##3##2##(2010-1#1)(2012-3#2)
phenotypes in the##2##3##(2009-8#1)(2010-4#1)
phenotypes in their##2##3##(2008-8#1)(2008-9#1)
phenotypes in##10##2##(1991-12#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-4#1)(2010-5#1)
phenotypes of V##2##3##(2008-10#2)
phenotypes of the##2##3##(1993-9#1)(2008-9#1)
phenotypes of##19##2##(1991-9#1)(1993-9#1)(1996-2#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-8#1)(2011-2#1)
phenotypes on##3##2##(2008-10#3)
phenotypes that##5##2##(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#2)
phenotypes were##9##2##(1996-12#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-8#1)
phenotypes with##2##2##(2008-10#1)(2008-8#1)
phenotypes##146##1##(1991-12#1)(1991-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#4)(1996-2#2)(1997-3#1)(1997-6#3)(1997-8#2)(2008-10#38)(2008-11#14)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#26)(2008-9#5)(2009-3#1)(2009-5#1)(2009-8#9)(2010-1#2)(2010-12#1)(2010-4#7)(2010-5#1)(2010-7#2)(2011-2#5)(2012-2#1)(2012-3#6)(2013-1#1)(2013-8#1)
phenotypes)##3##1##(2008-10#3)
phenotypic analysis of##2##3##(2009-10#1)(2011-1#1)
phenotypic analysis##3##2##(2008-9#1)(2009-10#1)(2011-1#1)
phenotypic and genetic##2##3##(2008-10#1)(2011-2#1)
phenotypic and genotypic##4##3##(2008-10#3)(2008-8#1)
phenotypic and##9##2##(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
phenotypic changes in##2##3##(1996-12#1)(2013-1#1)
phenotypic changes##5##2##(1996-12#1)(2008-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
phenotypic characteristics##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
phenotypic characterization of##2##3##(2008-10#1)(2008-9#1)
phenotypic class##2##2##(2008-10#2)
phenotypic correlation##2##2##(2008-10#1)(2008-9#1)
phenotypic data##4##2##(2008-8#3)(2012-3#1)
phenotypic differences##2##2##(2008-10#1)(2009-5#1)
phenotypic divergence along##2##3##(2012-3#2)
phenotypic divergence##3##2##(2012-3#3)
phenotypic diversity##4##2##(2008-10#2)(2009-6#1)(2012-3#1)
phenotypic effects of the mutation in##2##6##(1993-8#1)(1993-9#1)
phenotypic effects##4##2##(1993-8#1)(1993-9#1)(2007-12#1)(2012-3#1)
phenotypic evolution##2##2##(2010-4#2)
phenotypic features##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
phenotypic groups##2##2##(2008-10#2)
phenotypic heterogeneity##2##2##(1992-2#1)(2012-3#1)
phenotypic methods##2##2##(2008-8#1)(2011-2#1)
phenotypic plasticity##8##2##(2008-10#1)(2008-8#3)(2008-9#4)
phenotypic ratios##3##2##(2008-10#3)
phenotypic response##2##2##(2008-10#1)(2008-11#1)
phenotypic selection##5##2##(2008-8#5)
phenotypic specialization##6##2##(2008-8#5)(2008-9#1)
phenotypic specializations##2##2##(2008-9#2)
phenotypic traits##6##2##(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#3)
phenotypic uniformity##2##2##(2008-10#2)
phenotypic variability##3##2##(2008-10#2)(2013-8#1)
phenotypic variance##14##2##(2008-10#12)(2008-8#2)
phenotypic variation for resistance in##3##5##(2008-10#3)
phenotypic variation for resistance##5##4##(2008-10#5)
phenotypic variation for##7##3##(2008-10#7)
phenotypic variation in##3##3##(1995-2#1)(2008-10#2)
phenotypic variation within##2##3##(2009-6#1)(2012-3#1)
phenotypic variation##22##2##(1995-2#1)(2008-10#18)(2008-8#1)(2009-6#1)(2012-3#1)
phenotypic##169##1##(1991-2#1)(1992-2#2)(1993-2#1)(1993-8#1)(1993-9#1)(1995-2#2)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#71)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#31)(2008-9#13)(2009-10#1)(2009-5#2)(2009-6#2)(2010-12#1)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#13)(2013-1#3)(2013-8#2)
phenotypical##3##1##(1995-8#1)(2008-11#1)(2010-3#1)
phenotypically and##3##2##(2008-10#2)(2013-8#1)
phenotypically from##2##2##(2008-10#1)(2008-9#1)
phenotypically similar to##2##3##(2008-10#2)
phenotypically##16##1##(1991-2#1)(1997-8#1)(2008-10#8)(2008-8#1)(2008-9#3)(2011-1#1)(2013-8#1)
phenotyping##10##1##(1995-8#1)(2008-10#3)(2008-9#4)(2012-2#1)(2012-4#1)
phenoxodiol##4##1##(2009-9#4)
phenoxy##3##1##(2008-10#3)
phenoxy-propionic acid##2##2##(2008-10#2)
phenoxyl free radicals##2##3##(2008-10#2)
phenoxyl free##3##2##(2008-10#3)
phenoxyl radicals are##2##3##(2008-10#2)
phenoxyl radicals generated in##2##4##(2008-10#2)
phenoxyl radicals##7##2##(2008-10#6)(2008-9#1)
phenoxyl##11##1##(2008-10#9)(2008-8#1)(2008-9#1)
phenoxypropionic acid##2##2##(2008-10#2)
phenyl and##2##2##(2008-10#2)
phenyl column##2##2##(2008-10#2)
phenyl group##3##2##(2008-10#3)
phenyl rings##2##2##(2008-8#2)
phenyl##21##1##(1995-11#1)(1996-5#1)(2008-10#17)(2008-8#2)
phenyl-mercury##2##1##(2008-10#2)
phenyl]##2##1##(2008-10#2)
phenylalanine ammonia lyase (PAL)##2##4##(2008-10#2)
phenylalanine ammonia lyase activity##2##4##(2008-10#2)
phenylalanine ammonia lyase and##2##4##(2008-10#2)
phenylalanine ammonia lyase##9##3##(2008-10#9)
phenylalanine in##2##2##(1992-9#1)(1995-3#1)
phenylalanine##29##1##(1992-9#2)(1994-5#2)(1995-3#1)(1997-7#1)(1997-8#1)(2008-10#16)(2008-11#1)(2008-8#1)(2010-6#1)(2013-1#3)
phenylalanyl##2##1##(1990-2#1)(2013-1#1)
phenylalkyl carboxylic acids##3##3##(2011-1#3)
phenylarsine oxide (PhAsO)##2##3##(1994-8#2)
phenylboronate##2##1##(1991-5#1)(2008-7#1)
phenylephrine in##2##2##(1991-6#1)(2013-8#1)
phenylephrine##24##1##(1991-3#4)(1991-6#2)(1994-3#5)(2008-10#8)(2008-11#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
phenylethyl##2##1##(2008-10#1)(2008-9#1)
phenylhydrazine and##2##2##(2008-10#2)
phenylhydrazine to##2##2##(2008-10#1)(2010-4#1)
phenylhydrazine##14##1##(2008-10#12)(2008-11#1)(2010-4#1)
phenylmercury##11##1##(2008-10#11)
phenylpropanoid glycoside##2##2##(2008-9#2)
phenylpropanoid##4##1##(2008-10#2)(2008-9#2)
phenylpropanolamine and##4##2##(2008-10#4)
phenylpyrroles##2##1##(2008-10#2)
phenylurea herbicides##3##2##(2008-10#3)
phenylurea##4##1##(2008-10#4)
phenytoin Na emulsion##2##3##(2008-11#2)
phenytoin Na##3##2##(2008-11#3)
phenytoin in##5##2##(1994-2#1)(2008-10#3)(2008-11#1)
phenytoin suspension##3##2##(2008-11#3)
phenytoin therapy##2##2##(2008-7#2)
phenytoin was##2##2##(1994-2#2)
phenytoin with##2##2##(1994-2#1)(2008-11#1)
phenytoin##44##1##(1994-2#8)(2008-10#9)(2008-11#17)(2008-7#7)(2008-8#2)(2011-1#1)
pheochromocytoma (PC12) cells##2##3##(1992-12#1)(2013-8#1)
pheochromocytoma cell line##6##3##(1993-8#1)(1994-11#1)(2008-11#4)
pheochromocytoma cells##5##2##(1995-2#1)(1997-2#1)(2008-11#2)(2013-8#1)
pheochromocytoma##20##1##(1992-12#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-11#1)(1997-2#1)(2008-11#6)(2009-1#4)(2012-12#1)(2012-2#1)(2013-8#2)
pheochromocytomas##2##1##(1995-11#1)(2012-2#1)
pheophytin a##3##2##(2008-11#3)
pheophytin##7##1##(2008-11#3)(2008-8#2)(2008-9#2)
pheophytins##2##1##(2008-9#2)
pheromone blend##3##2##(2008-10#3)
pheromone components of##2##3##(2008-10#2)
pheromone components##4##2##(2008-10#4)
pheromone gland##3##2##(2008-10#3)
pheromone in##2##2##(2008-10#1)(2008-8#1)
pheromone is##2##2##(1990-8#1)(2013-8#1)
pheromone##33##1##(1990-8#3)(1991-5#3)(1996-2#1)(2007-12#2)(2008-10#19)(2008-8#1)(2009-7#3)(2013-8#1)
pheromone-binding protein from the silkworm moth##2##6##(2008-10#2)
pheromone-binding protein from##3##3##(2008-10#2)(2009-7#1)
pheromone-binding protein##4##2##(2008-10#3)(2009-7#1)
pheromone-binding##5##1##(2008-10#3)(2009-7#2)
pheromones##9##1##(1990-8#2)(2008-10#7)
phi &gt##2##2##(1996-12#2)
phi &lt##4##2##(1996-12#2)(2008-3#2)
phi = 0##2##3##(1991-11#1)(2008-3#1)
phi C3208##2##2##(1993-9#2)
phi X174 DNA##2##3##(1991-5#2)
phi X174##7##2##(1991-5#7)
phi angle##2##2##(1992-4#2)
phi coefficient##2##2##(2008-10#1)(2010-1#1)
phi values##4##2##(1996-12#3)(2008-11#1)
phi##31##1##(1991-11#1)(1991-5#7)(1992-4#3)(1993-9#2)(1994-5#1)(1996-12#9)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2010-1#1)
phi-x174##2##1##(1997-6#2)
phi29 DNA packaging motor##2##4##(2010-5#2)
phiNHOH##2##1##(2008-10#2)
philanthropic##6##1##(1992-1#1)(1995-1#1)(2008-11#1)(2008-8#1)(2009-4#2)
philanthropy##5##1##(1993-1#1)(1993-12#1)(1995-1#3)
philopatric offspring##2##2##(2008-8#2)
philopatric##4##1##(2008-8#4)
philopatry and altruism##2##3##(2008-8#2)
philopatry and##3##2##(2008-8#3)
philopatry##7##1##(2008-8#7)
philosopher Michel##2##2##(1993-11#1)(2012-3#1)
philosopher##4##1##(1990-8#1)(1993-11#1)(2008-12#1)(2012-3#1)
philosophers##4##1##(2009-6#1)(2011-2#3)
philosophical ideas##2##2##(2008-12#1)(2008-4#1)
philosophical##11##1##(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2010-11#1)(2012-2#1)(2013-8#1)
philosophies##3##1##(1993-1#1)(1997-3#1)(2008-10#1)
philosophy and##3##2##(1992-2#1)(2008-11#1)(2008-12#1)
philosophy for##2##2##(1995-1#1)(1996-1#1)
philosophy of##3##2##(1991-1#1)(1993-2#1)(2010-9#1)
philosophy##27##1##(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-1#3)(1996-6#1)(2008-11#3)(2008-12#4)(2008-6#1)(2009-4#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
phlA'-'lacZ##2##1##(2008-10#2)
phlD##3##1##(2008-10#3)
phlD+ pseudomonads in no-till##2##4##(2008-10#2)
phlD+ pseudomonads in##3##3##(2008-10#3)
phlD+ pseudomonads##4##2##(2008-10#4)
phlD+##5##1##(2008-10#5)
phlD-specific PCR-based##2##2##(2008-10#2)
phlebothrombosis##2##1##(2007-8#1)(2008-11#1)
phlebotomy##2##1##(2009-8#1)(2010-8#1)
phlegmon##2##1##(2013-1#2)
phlegmonous gastritis##3##2##(2008-12#3)
phloem and xylem##3##3##(2008-11#1)(2012-8#2)
phloem and##6##2##(2008-10#3)(2008-11#1)(2012-8#2)
phloem cells##6##2##(2008-10#5)(2008-11#1)
phloem of##5##2##(2008-10#2)(2008-11#1)(2012-8#2)
phloem remained##2##2##(2012-8#2)
phloem tissue##3##2##(2008-10#2)(2008-9#1)
phloem tissues##4##2##(2008-10#4)
phloem##57##1##(2008-10#40)(2008-11#6)(2008-9#1)(2011-10#1)(2012-2#1)(2012-8#8)
phloem-feeding##2##1##(2007-12#1)(2008-10#1)
phloem-limited##6##1##(2008-10#6)
phloem-restricted##4##1##(2008-10#4)
phlorglucinol##2##1##(2008-10#2)
phloroglucinol##2##1##(2008-10#2)
phoA##3##1##(2008-8#3)
phobia and##3##2##(2008-4#2)(2013-1#1)
phobia##36##1##(2008-4#20)(2010-2#6)(2012-2#8)(2013-1#2)
phobias##2##1##(1991-2#1)(2012-2#1)
phoenicoxanthin##2##1##(2008-12#2)
phone use##2##2##(2013-1#2)
phone##13##1##(1991-3#2)(2007-9#1)(2008-12#1)(2011-1#4)(2012-3#3)(2013-1#2)
phoneme##4##1##(2008-9#4)
phonemic awareness##2##2##(2008-11#1)(2008-9#1)
phonologic##3##1##(2010-7#3)
phonological awareness and letter naming-decoding fluency##3##6##(2008-12#3)
phonological awareness and##6##3##(2008-12#4)(2011-1#2)
phonological awareness intervention##2##3##(2011-1#2)
phonological awareness##22##2##(2008-11#1)(2008-12#9)(2008-9#1)(2011-1#10)(2011-2#1)
phonological##31##1##(1991-2#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#9)(2008-7#1)(2008-9#1)(2010-1#2)(2011-1#11)(2011-2#1)
phonon##5##1##(1993-5#2)(2008-10#1)(2008-2#2)
phonons in##2##2##(1992-11#1)(1992-8#1)
phorbol 12##3##2##(1995-11#1)(1995-2#2)
phorbol 12-myristate 13-acetate (PMA)##9##4##(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#2)
phorbol 12-myristate 13-acetate##10##3##(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#3)
phorbol 12-myristate##11##2##(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#3)
phorbol ester and##3##3##(1994-11#3)
phorbol ester in##3##3##(1994-6#1)(1996-2#1)(1997-1#1)
phorbol ester treatment##2##3##(1993-8#1)(1995-6#1)
phorbol ester##25##2##(1990-12#2)(1990-5#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-11#7)(1994-6#2)(1994-8#1)(1995-6#3)(1995-8#1)(1996-2#1)(1997-1#2)(2008-11#2)
phorbol ester-induced##2##2##(1994-8#2)
phorbol ester-stimulated##3##2##(1991-5#1)(1995-6#1)(1996-12#1)
phorbol esters are##2##3##(1994-11#1)(2008-11#1)
phorbol esters##13##2##(1991-5#2)(1992-12#1)(1993-8#1)(1994-11#2)(1994-8#1)(1996-2#3)(2008-11#1)(2010-12#2)
phorbol myristate acetate (PMA)##3##4##(1993-6#1)(1994-6#1)(2006-6#1)
phorbol myristate acetate##7##3##(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#2)(2006-6#1)
phorbol myristate##11##2##(1991-5#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-6#2)(1994-8#2)(2006-6#1)(2008-10#1)
phorbol##76##1##(1990-12#2)(1990-5#1)(1991-5#5)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-11#12)(1994-3#1)(1994-6#5)(1994-8#9)(1995-11#6)(1995-2#3)(1995-6#5)(1995-8#1)(1996-12#1)(1996-2#5)(1997-1#3)(2006-6#1)(2008-10#1)(2008-11#6)(2010-12#2)
phorbol-12-myristate-13-acetate (PMA)##2##2##(2008-11#2)
phosphatase (AP)##4##2##(2008-10#3)(2008-11#1)
phosphatase 2A catalytic subunit##7##4##(1992-9#7)
phosphatase 2A enzyme##2##3##(1992-9#2)
phosphatase 2A##13##2##(1992-9#12)(1995-8#1)
phosphatase activating factor##2##3##(1993-6#2)
phosphatase activities in##2##3##(1994-11#1)(2008-10#1)
phosphatase activities of##2##3##(2008-10#1)(2008-9#1)
phosphatase activities##9##2##(1994-11#1)(2008-10#6)(2008-9#2)
phosphatase activity and##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-4#1)
phosphatase activity in the##2##4##(2008-10#1)(2008-7#1)
phosphatase activity in##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
phosphatase activity of##4##3##(2008-10#2)(2008-9#2)
phosphatase activity##25##2##(1992-9#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-2#2)(2008-10#6)(2008-11#6)(2008-7#1)(2008-8#1)(2008-9#3)(2011-1#1)(2012-4#1)
phosphatase and##8##2##(1993-3#1)(1993-6#2)(1994-11#1)(1996-2#1)(2008-10#2)(2013-1#1)
phosphatase as a##3##3##(1995-2#1)(2008-11#2)
phosphatase as##5##2##(1995-11#1)(1995-2#2)(2008-11#2)
phosphatase from##3##2##(1993-6#1)(1994-6#1)(1997-7#1)
phosphatase fusion proteins##2##3##(2008-10#2)
phosphatase in##8##2##(1991-12#1)(1993-6#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
phosphatase inhibitor okadaic acid##2##4##(1993-8#2)
phosphatase inhibitor##4##2##(1993-8#2)(1994-11#1)(1994-6#1)
phosphatase inhibitors##4##2##(1994-11#1)(1995-2#1)(2008-4#2)
phosphatase was##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
phosphatase##172##1##(1990-12#2)(1990-9#1)(1991-10#4)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#13)(1993-2#1)(1993-3#2)(1993-6#12)(1993-8#8)(1994-11#6)(1994-6#3)(1994-8#1)(1995-11#1)(1995-2#7)(1995-3#1)(1995-8#3)(1995-9#1)(1996-2#2)(1997-2#2)(1997-7#2)(2008-10#35)(2008-11#19)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#6)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#5)(2013-8#1)
phosphatase-1##2##1##(1995-8#2)
phosphatases 1 and 2A##3##4##(1991-5#1)(1992-8#1)(1994-11#1)
phosphatases 1##4##2##(1991-5#1)(1992-8#1)(1994-11#1)(1995-8#1)
phosphatases and##2##2##(1995-11#1)(2008-7#1)
phosphatases in the##2##3##(1995-8#1)(2012-2#1)
phosphatases##21##1##(1991-5#1)(1992-8#1)(1992-9#1)(1994-11#2)(1995-11#1)(1995-8#5)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-1#2)(2012-12#1)(2012-2#1)
phosphate (P)##2##2##(1995-8#1)(2008-10#1)
phosphate (TBP)##4##2##(2008-10#4)
phosphate (pH##2##2##(2008-10#2)
phosphate accumulation##2##2##(1997-1#2)
phosphate activating group on##2##4##(1994-11#2)
phosphate affinity SDS-PAGE##2##3##(2010-12#2)
phosphate and silicate##4##3##(2008-10#4)
phosphate and##19##2##(1990-2#1)(2008-10#15)(2009-10#2)(2012-12#1)
phosphate are##2##2##(2008-10#2)
phosphate as##3##2##(2008-10#3)
phosphate at##2##2##(2008-10#2)
phosphate buffer (ionic strength)##2##4##(2008-10#2)
phosphate buffer (pH 2##3##4##(2008-10#3)
phosphate buffer (pH 6##2##4##(2008-10#2)
phosphate buffer (pH 7##13##4##(2008-10#13)
phosphate buffer (pH 7)##3##4##(2008-10#3)
phosphate buffer (pH 8##2##4##(2008-10#2)
phosphate buffer (pH##25##3##(2008-10#25)
phosphate buffer and##4##3##(1992-10#1)(2008-10#3)
phosphate buffer at pH 6##3##5##(2008-10#2)(2008-5#1)
phosphate buffer at pH 7##2##5##(2008-10#2)
phosphate buffer at pH##8##4##(2008-10#7)(2008-5#1)
phosphate buffer at##9##3##(2008-10#8)(2008-5#1)
phosphate buffer concentration##2##3##(2008-10#2)
phosphate buffer pH##2##3##(2008-10#2)
phosphate buffer solution (pH 7##3##5##(2008-10#3)
phosphate buffer solution##10##3##(2008-10#9)(2009-7#1)
phosphate buffer solutions##3##3##(2008-10#3)
phosphate buffer##94##2##(1990-12#1)(1992-10#2)(2008-10#86)(2008-5#1)(2009-10#1)(2009-7#1)(2011-3#1)(2012-2#1)
phosphate buffered saline (PBS)##2##4##(2008-10#2)
phosphate buffered saline##3##3##(2008-10#3)
phosphate buffers##3##2##(2008-10#3)
phosphate concentration##3##2##(2008-10#3)
phosphate determination##3##2##(2008-10#3)
phosphate dibasic##3##2##(2008-10#2)(2009-8#1)
phosphate esters##3##2##(1993-8#1)(1994-11#1)(2008-10#1)
phosphate for preconcentration##2##3##(2008-10#2)
phosphate for##4##2##(2008-10#4)
phosphate groups of##2##3##(1992-6#1)(2008-10#1)
phosphate groups##4##2##(1991-5#1)(1992-6#2)(2008-10#1)
phosphate in the##3##3##(2008-10#3)
phosphate in##18##2##(1994-11#1)(2008-10#15)(2008-11#1)(2008-5#1)
phosphate ion in river water##2##5##(2008-10#2)
phosphate ion in##3##3##(2008-10#3)
phosphate ion##9##2##(2008-10#9)
phosphate ion-selective##2##2##(2008-10#2)
phosphate ions##2##2##(2008-10#2)
phosphate is##3##2##(1991-5#1)(2008-11#1)(2008-8#1)
phosphate isomerase##3##2##(1997-6#2)(2008-10#1)
phosphate radiolabel specifically to##2##4##(1990-2#2)
phosphate release##2##2##(2008-7#2)
phosphate rock##3##2##(2008-10#3)
phosphate synthase##2##2##(2011-2#2)
phosphate to the##3##3##(2008-10#3)
phosphate to##4##2##(2008-10#4)
phosphate transfection##2##2##(2008-11#1)(2008-2#1)
phosphate using##2##2##(2008-10#2)
phosphate was##3##2##(2008-10#3)
phosphate##368##1##(1990-10#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#4)(1991-1#1)(1991-5#4)(1992-10#2)(1992-12#2)(1992-3#1)(1992-6#3)(1993-8#3)(1994-11#7)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-6#1)(1997-1#4)(1997-2#1)(1997-6#2)(1997-7#1)(2008-1#3)(2008-10#258)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#1)(2009-10#3)(2009-7#2)(2009-8#1)(2010-10#3)(2010-12#3)(2010-8#3)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#4)
phosphate)##2##1##(2008-10#2)
phosphate-buffered saline##2##2##(2008-10#1)(2011-2#1)
phosphate-buffered##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
phosphates and##2##2##(2008-10#2)
phosphates by##2##2##(2008-10#2)
phosphates in##10##2##(1993-6#2)(1994-11#1)(1996-6#1)(2008-10#5)(2008-7#1)
phosphates was##2##2##(1993-6#1)(2008-10#1)
phosphates##43##1##(1990-5#1)(1991-5#1)(1993-6#7)(1994-11#2)(1994-3#1)(1995-2#1)(1996-6#1)(1997-1#1)(2008-10#23)(2008-7#3)(2010-5#2)
phosphatidic acid (PA)##4##3##(1991-5#1)(1995-8#1)(2008-11#1)(2008-8#1)
phosphatidic acid##13##2##(1990-8#1)(1991-5#1)(1994-3#8)(1995-8#1)(2008-11#1)(2008-8#1)
phosphatidyl##2##1##(2008-10#1)(2008-9#1)
phosphatidylcholine (PC) and##2##3##(1995-8#1)(2008-8#1)
phosphatidylcholine (PC)##6##2##(1991-5#1)(1993-8#1)(1995-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
phosphatidylcholine in##4##2##(1996-2#1)(2008-10#3)
phosphatidylcholine vesicles##2##2##(2008-10#2)
phosphatidylcholine##21##1##(1991-5#2)(1993-3#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#11)(2008-8#1)(2012-2#1)
phosphatidylcholine-selective phospholipase C##2##3##(1997-2#2)
phosphatidylcholines##5##1##(1991-5#2)(1997-2#3)
phosphatidylethanol formation##2##2##(1995-8#2)
phosphatidylethanol##4##1##(1991-5#1)(1994-3#1)(1995-8#2)
phosphatidylethanolamine (PE)##4##2##(1995-8#1)(2008-8#1)(2009-8#1)(2012-2#1)
phosphatidylethanolamine and##2##2##(1994-5#1)(2012-2#1)
phosphatidylethanolamine##9##1##(1994-5#1)(1995-8#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#4)
phosphatidylglycerol (PG)##2##2##(2008-8#1)(2012-2#1)
phosphatidylglycerol##5##1##(1994-5#1)(1995-8#1)(2008-8#2)(2012-2#1)
phosphatidylinositol (PI)##3##2##(1992-12#1)(2009-8#1)(2012-2#1)
phosphatidylinositol 3##4##2##(1993-8#2)(2009-7#1)(2012-2#1)
phosphatidylinositol 3' kinase##2##3##(1996-2#2)
phosphatidylinositol 3'-kinase##2##2##(1992-10#1)(2011-2#1)
phosphatidylinositol 3- and 4-kinases##2##4##(1997-8#2)
phosphatidylinositol 3-kinase (PI 3-kinase)##3##4##(1994-11#1)(1995-8#1)(2008-11#1)
phosphatidylinositol 3-kinase (PI##4##3##(1994-11#1)(1995-8#1)(2008-11#1)(2008-7#1)
phosphatidylinositol 3-kinase and##2##3##(2008-3#1)(2008-7#1)
phosphatidylinositol 3-kinase##11##2##(1994-11#1)(1995-6#1)(1995-8#1)(2008-11#2)(2008-3#3)(2008-7#3)
phosphatidylinositol 4##7##2##(1993-3#1)(1993-6#1)(1993-8#2)(1997-1#1)(2008-7#1)(2008-8#1)
phosphatidylinositol 4-kinase##2##2##(1997-8#2)
phosphatidylinositol 4-phosphate##4##2##(1993-8#1)(1997-8#2)(2008-8#1)
phosphatidylinositol degradation##3##2##(2008-11#3)
phosphatidylinositol kinase##3##2##(1997-8#3)
phosphatidylinositol turnover##2##2##(1994-3#1)(1997-2#1)
phosphatidylinositol##54##1##(1990-8#1)(1992-10#1)(1992-12#1)(1993-3#1)(1993-6#2)(1993-8#5)(1994-11#2)(1994-3#1)(1995-6#1)(1995-8#1)(1996-2#4)(1997-1#1)(1997-2#1)(1997-8#10)(2008-11#6)(2008-3#3)(2008-7#4)(2008-8#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
phosphatidylinositol-3##2##1##(2008-3#2)
phosphatidylinositol-4##3##1##(1993-6#1)(2009-6#1)(2013-1#1)
phosphatidylinositol-specific phospholipase C##3##3##(1993-8#2)(2008-8#1)
phosphatidylserine (PS)##4##2##(1995-8#1)(2008-11#2)(2009-8#1)
phosphatidylserine and 1##2##3##(1990-10#2)
phosphatidylserine and##3##2##(1990-10#2)(1993-8#1)
phosphatidylserine requirement of the##2##4##(1990-5#2)
phosphatidylserine requirement of##3##3##(1990-5#3)
phosphatidylserine##22##1##(1990-10#2)(1990-5#4)(1990-8#1)(1993-8#1)(1994-11#3)(1994-5#2)(1995-2#3)(1995-8#1)(2008-10#2)(2008-11#2)(2009-8#1)
phosphide##4##1##(2008-11#3)(2013-1#1)
phosphine oxide##3##2##(2008-10#3)
phosphine##13##1##(1990-8#2)(2008-10#6)(2008-11#5)
phosphite##7##1##(1996-5#1)(2008-10#6)
phosphitylation##2##1##(2008-4#2)
phospho-species##2##1##(2010-12#2)
phosphodiester##5##1##(1991-5#2)(2008-10#1)(2008-4#1)(2008-8#1)
phosphodiesterase isozyme##5##2##(1993-6#2)(1997-2#3)
phosphodiesterase was##2##2##(1994-8#1)(1997-2#1)
phosphodiesterase##16##1##(1993-6#4)(1994-6#1)(1994-8#1)(1997-2#8)(2010-10#2)
phosphoenolpyruvate carboxykinase##2##2##(1991-3#1)(1994-8#1)
phosphoenolpyruvate##4##1##(1991-3#1)(1994-8#1)(2008-7#2)
phosphofructokinase##2##1##(1994-3#1)(1994-8#1)
phosphoglucomutase##3##1##(1992-4#3)
phosphoglycerate mutase##4##2##(1993-3#1)(2010-12#2)(2012-2#1)
phosphoglycerate##5##1##(1993-3#1)(2008-5#1)(2010-12#2)(2012-2#1)
phosphohistidine##2##1##(1995-8#2)
phosphoinositide hydrolysis##6##2##(1996-12#1)(1996-2#3)(1997-1#2)
phosphoinositide kinases##2##2##(1996-2#2)
phosphoinositide turnover##2##2##(1991-12#1)(1992-10#1)
phosphoinositide##23##1##(1991-12#1)(1992-10#2)(1993-6#2)(1994-11#1)(1995-8#1)(1996-12#2)(1996-2#7)(1997-1#3)(2009-6#1)(2013-1#2)(2013-8#1)
phosphoinositides##4##1##(1993-6#1)(1993-8#1)(1995-8#1)(2011-2#1)
phospholipase A(2) and##3##3##(2008-11#3)
phospholipase A(2)##7##2##(2008-11#6)(2011-2#1)
phospholipase A2 (IC50##2##3##(1994-11#2)
phospholipase A2 (PLA2)##3##3##(1990-8#1)(1994-6#1)(2012-2#1)
phospholipase A2 activation in rabbit platelets was investigated##2##8##(1994-3#1)(1995-11#1)
phospholipase A2 activation in rabbit platelets##3##6##(1994-3#1)(1995-11#2)
phospholipase A2 activation in##4##4##(1994-3#1)(1994-6#1)(1995-11#2)
phospholipase A2 activation##5##3##(1994-3#2)(1994-6#1)(1995-11#2)
phospholipase A2##38##2##(1990-5#1)(1990-8#2)(1991-12#1)(1992-8#2)(1993-6#2)(1994-11#7)(1994-3#3)(1994-5#5)(1994-6#2)(1995-11#6)(1996-2#2)(1997-1#1)(2008-8#2)(2012-2#1)(2013-8#1)
phospholipase C (PI-PLC)##2##3##(1993-8#1)(1995-8#1)
phospholipase C activation##2##3##(1995-11#1)(1995-8#1)
phospholipase C activity##2##3##(1993-3#1)(1993-6#1)
phospholipase C alpha##4##3##(1993-6#4)
phospholipase C and##4##3##(2008-11#4)
phospholipase C in##2##3##(1994-11#1)(2008-11#1)
phospholipase C inhibitor##2##3##(1994-11#1)(2008-10#1)
phospholipase C##36##2##(1990-5#1)(1990-8#1)(1993-3#2)(1993-6#9)(1993-8#3)(1994-11#3)(1995-11#1)(1995-8#2)(1997-1#1)(1997-2#2)(2008-10#2)(2008-11#5)(2008-8#2)(2011-2#1)(2012-2#1)
phospholipase C-Ca2+ system through a receptor different from the 53-kDa ATP receptor##2##12##(1993-8#2)
phospholipase D (PLD)##2##3##(1995-8#1)(2011-2#1)
phospholipase D##12##2##(1993-3#6)(1994-3#1)(1995-8#2)(1996-6#1)(1997-2#1)(2011-2#1)
phospholipase activity and serotype distribution##2##5##(2008-5#2)
phospholipase activity and##3##3##(2008-5#3)
phospholipase activity##7##2##(1995-8#2)(2008-5#4)(2010-6#1)
phospholipase##104##1##(1990-5#2)(1990-8#3)(1991-12#1)(1992-8#2)(1993-3#8)(1993-6#11)(1993-8#5)(1994-11#10)(1994-3#4)(1994-5#5)(1994-6#2)(1995-11#7)(1995-8#6)(1996-2#2)(1996-6#1)(1997-1#2)(1997-2#3)(1997-7#1)(2008-10#2)(2008-11#11)(2008-5#5)(2008-8#4)(2010-6#1)(2011-2#3)(2012-2#2)(2013-8#1)
phospholipases C##2##2##(1990-5#1)(1991-5#1)
phospholipases##3##1##(1990-5#1)(1991-5#1)(2008-11#1)
phospholipid and energy metabolism of##2##5##(2008-8#2)
phospholipid and##7##2##(1992-11#2)(1994-5#1)(1995-3#1)(1995-6#1)(2008-8#2)
phospholipid bilayers##4##2##(1993-8#1)(1994-5#1)(2008-11#2)
phospholipid composition##4##2##(1994-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
phospholipid flip-flop in##3##3##(1994-5#3)
phospholipid flip-flop##5##2##(1994-5#5)
phospholipid membranes##2##2##(2008-9#2)
phospholipid metabolism##2##2##(1994-11#1)(1994-3#1)
phospholipid molecules##2##2##(1993-8#1)(2008-9#1)
phospholipid vesicles##3##2##(1991-5#1)(1994-11#1)(1994-5#1)
phospholipid##71##1##(1990-5#2)(1991-12#1)(1991-5#3)(1992-11#4)(1992-12#1)(1993-8#6)(1994-11#2)(1994-3#2)(1994-5#19)(1995-2#2)(1995-3#1)(1995-6#4)(2008-10#1)(2008-11#4)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#2)(2009-8#1)(2010-11#1)(2010-7#1)(2012-2#2)
phospholipid-binding protein##3##2##(2008-9#2)(2009-10#1)
phospholipid-binding##4##1##(2008-9#2)(2009-10#2)
phospholipids in the##2##3##(1991-5#1)(2008-10#1)
phospholipids in##5##2##(1991-12#1)(1991-5#2)(1994-3#1)(2008-10#1)
phospholipids of##2##2##(2008-11#1)(2009-8#1)
phospholipids on##4##2##(1994-3#1)(1995-8#3)
phospholipids to##2##2##(2008-10#1)(2011-2#1)
phospholipids##48##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#3)(1992-12#3)(1993-8#1)(1994-11#1)(1994-3#4)(1994-5#2)(1995-8#4)(1997-2#1)(2008-10#6)(2008-11#7)(2008-3#3)(2008-5#2)(2009-8#3)(2010-3#1)(2011-2#1)(2012-2#3)
phosphomolybdate##6##1##(2008-10#6)
phosphomolybdenum blue complex by##2##4##(2008-10#2)
phosphomolybdenum blue complex is##2##4##(2008-10#2)
phosphomolybdenum blue complex##5##3##(2008-10#5)
phosphomolybdenum blue##9##2##(2008-10#9)
phosphomolybdenum##10##1##(2008-10#10)
phosphomolybdic acid in##2##3##(2008-10#2)
phosphomolybdic acid##10##2##(2008-10#10)
phosphomolybdic##12##1##(2008-10#12)
phosphomonoester##2##1##(2008-7#1)(2008-8#1)
phosphonate (DBBP)##3##2##(2008-10#3)
phosphonate##13##1##(2008-10#13)
phosphonic acid##6##2##(2008-10#6)
phosphonic acids in##2##3##(1996-5#1)(2008-10#1)
phosphonic acids##4##2##(1996-5#2)(2008-10#2)
phosphonic group##2##2##(2008-10#2)
phosphonic##14##1##(1996-5#2)(2008-10#12)
phosphopeptide##5##1##(1992-10#1)(1993-8#1)(1995-2#1)(1996-2#1)(2011-2#1)
phosphopeptides##8##1##(1995-12#1)(1995-6#1)(1996-2#4)(2010-7#2)
phosphoprotein of Mr 32##2##4##(1991-10#2)
phosphoprotein that##2##2##(2010-11#1)(2013-1#1)
phosphoprotein##10##1##(1990-7#1)(1991-10#2)(1992-9#1)(1993-2#1)(1996-2#1)(2008-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
phosphoproteins that##2##2##(1992-10#1)(1995-6#1)
phosphoproteins##14##1##(1992-10#1)(1994-11#2)(1995-6#1)(2008-1#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-9#2)(2011-2#1)
phosphor molecule##2##2##(2008-10#2)
phosphor##6##1##(2008-10#5)(2008-4#1)
phosphoramidite##5##1##(2008-4#5)
phosphoramidites and##2##2##(2008-4#2)
phosphoramidites are##2##2##(2008-4#2)
phosphoramidites##9##1##(2008-4#9)
phosphorescence (RTP) emission##2##3##(2008-10#2)
phosphorescence (RTP)##7##2##(2008-10#7)
phosphorescence and##2##2##(2008-10#1)(2008-3#1)
phosphorescence development##2##2##(2008-10#2)
phosphorescence emission##8##2##(2008-10#8)
phosphorescence enhancers##2##2##(2008-10#2)
phosphorescence of the##2##3##(2008-10#1)(2008-3#1)
phosphorescence of##8##2##(2008-10#6)(2008-3#1)(2010-4#1)
phosphorescence was##2##2##(2008-10#2)
phosphorescence##49##1##(2008-10#46)(2008-3#2)(2010-4#1)
phosphorescent emission##2##2##(2008-10#2)
phosphorescent##6##1##(2008-10#3)(2008-3#3)
phosphoric acid and##2##3##(2008-10#2)
phosphoric acid as##3##3##(2008-10#3)
phosphoric acid medium##5##3##(2008-10#5)
phosphoric acid##23##2##(2008-10#22)(2008-11#1)
phosphoric##29##1##(1994-11#1)(2008-10#27)(2008-11#1)
phosphorimetric method##2##2##(2008-10#2)
phosphorimetric##6##1##(2008-10#6)
phosphorimetry##5##1##(2008-10#5)
phosphorolysis of##2##2##(1994-8#2)
phosphorolysis##3##1##(1994-8#3)
phosphorothioate antisense##2##2##(1995-11#1)(1995-12#1)
phosphorothioate linkages##2##2##(2008-4#2)
phosphorothioate oligonucleotide##2##2##(1994-5#1)(2008-10#1)
phosphorothioate##8##1##(1994-5#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-4#4)
phosphorous##8##1##(2008-10#5)(2008-11#2)(2012-3#1)
phosphorus (P)##3##2##(2011-1#2)(2013-8#1)
phosphorus amount##2##2##(2008-10#2)
phosphorus and nitrate##2##3##(2008-12#2)
phosphorus and nitrogen##2##3##(2008-12#2)
phosphorus and##6##2##(1997-5#1)(2008-11#1)(2008-12#4)
phosphorus by spectrophotometry##2##3##(2008-10#2)
phosphorus by##4##2##(2008-10#4)
phosphorus compounds##2##2##(2008-10#2)
phosphorus content##3##2##(2008-10#3)
phosphorus in soil##4##3##(2008-10#4)
phosphorus in soils##2##3##(2008-10#2)
phosphorus in the natural environment##2##5##(2008-10#2)
phosphorus in the##3##3##(2008-10#2)(2013-8#1)
phosphorus in##19##2##(2008-10#15)(2008-11#1)(2009-7#1)(2013-1#1)(2013-8#1)
phosphorus is##4##2##(2008-10#4)
phosphorus species in##4##3##(2008-10#4)
phosphorus species is##2##3##(2008-10#2)
phosphorus species##9##2##(2008-10#9)
phosphorus with##2##2##(2008-10#2)
phosphorus##107##1##(1990-5#1)(1991-11#1)(1994-2#3)(1995-11#1)(1997-5#1)(2008-10#78)(2008-11#3)(2008-12#7)(2008-7#1)(2008-8#2)(2009-7#1)(2011-1#2)(2011-10#2)(2011-2#1)(2013-1#1)(2013-8#2)
phosphorus-containing##3##1##(2008-10#2)(2008-11#1)
phosphoryl##4##1##(1996-6#3)(2008-10#1)
phosphorylase kinase with IC50 values of##2##6##(1990-8#2)
phosphorylase kinase##5##2##(1990-8#5)
phosphorylase##13##1##(1990-8#5)(1994-11#1)(1994-8#2)(1996-2#1)(1997-2#2)(2008-10#1)(2012-3#1)
phosphorylate##5##1##(1993-2#1)(1993-6#2)(1995-2#1)(1996-2#1)
phosphorylated anabolites##3##2##(2008-7#3)
phosphorylated and##2##2##(2008-9#1)(2011-2#1)
phosphorylated at##5##2##(1994-11#2)(2008-7#1)(2010-12#1)(2013-1#1)
phosphorylated by TPKI##2##3##(1995-12#2)
phosphorylated by##8##2##(1993-6#2)(1993-8#1)(1995-12#2)(1997-2#1)(2008-11#1)(2009-8#1)
phosphorylated in vivo##2##3##(1995-6#2)
phosphorylated in##8##2##(1993-8#1)(1995-2#2)(1995-6#3)(1995-8#1)(1996-2#1)
phosphorylated on serine residues##2##4##(1991-5#1)(1993-8#1)
phosphorylated on serine##3##3##(1991-5#1)(1993-8#1)(2008-4#1)
phosphorylated on tyrosine residues##2##4##(1995-8#1)(1996-2#1)
phosphorylated on##6##2##(1991-5#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-4#1)(2008-9#1)
phosphorylated peptide##2##2##(2008-8#2)
phosphorylated proteins##4##2##(1995-8#1)(2008-5#2)(2008-8#1)
phosphorylated species##2##2##(2010-12#2)
phosphorylated state##3##2##(1995-2#1)(2008-1#1)(2008-4#1)
phosphorylated the##2##2##(1995-6#1)(1996-6#1)
phosphorylated##77##1##(1991-5#1)(1993-6#2)(1993-8#5)(1994-11#6)(1994-2#1)(1995-12#2)(1995-2#5)(1995-6#8)(1995-8#3)(1996-12#2)(1996-2#4)(1996-6#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#5)(2009-8#1)(2010-10#1)(2010-12#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
phosphorylates c-Jun in vitro##2##4##(1995-2#2)
phosphorylates##5##1##(1995-2#2)(1997-1#1)(2011-1#1)(2011-2#1)
phosphorylating activity##2##2##(1995-8#1)(2011-1#1)
phosphorylating##4##1##(1993-12#1)(1995-2#1)(1995-8#1)(2011-1#1)
phosphorylation and activation of##2##4##(1995-8#1)(1996-2#1)
phosphorylation and activation##3##3##(1995-8#1)(1996-2#1)(1997-1#1)
phosphorylation and the##2##3##(1994-6#1)(2008-11#1)
phosphorylation and##19##2##(1994-6#8)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)
phosphorylation as##2##2##(1995-6#1)(1996-12#1)
phosphorylation at##5##2##(1994-11#1)(1997-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
phosphorylation but##2##2##(1996-12#1)(2008-4#1)
phosphorylation by##6##2##(1993-6#1)(1995-12#1)(1995-6#2)(1996-2#1)(1997-1#1)
phosphorylation can##2##2##(2008-8#2)
phosphorylation coupled to electron##2##4##(1991-5#2)
phosphorylation event and##2##3##(1992-8#1)(1995-8#1)
phosphorylation event##3##2##(1992-8#2)(1995-8#1)
phosphorylation events##3##2##(1994-11#1)(1995-11#1)(2008-4#1)
phosphorylation in##5##2##(1991-10#1)(1991-5#1)(1992-6#1)(1994-6#1)(1995-6#1)
phosphorylation is##3##2##(2008-4#1)(2011-1#1)(2012-3#1)
phosphorylation may be##2##3##(1995-2#1)(1997-1#1)
phosphorylation of CREB##2##3##(2008-11#2)
phosphorylation of IRS-I##4##3##(1997-1#4)
phosphorylation of PLC-gamma 1##2##4##(1992-7#2)
phosphorylation of Tir at##2##4##(2011-2#2)
phosphorylation of a##3##3##(1990-10#1)(1992-7#1)(1993-3#1)
phosphorylation of procathepsin L##2##4##(1995-6#2)
phosphorylation of tau##2##3##(1995-12#2)
phosphorylation of the postsynaptic protein kinase##2##6##(1997-2#2)
phosphorylation of the##14##3##(1990-10#1)(1990-5#1)(1992-9#1)(1994-11#1)(1995-6#2)(1996-2#1)(1997-2#3)(2008-4#1)(2009-6#1)(2010-1#1)(2012-2#1)
phosphorylation of##73##2##(1990-10#4)(1990-5#1)(1991-5#1)(1992-10#2)(1992-7#3)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#3)(1994-11#2)(1994-8#2)(1995-12#2)(1995-2#2)(1995-6#6)(1995-8#3)(1996-2#3)(1997-1#5)(1997-2#5)(1997-7#3)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#3)(2009-3#1)(2009-6#2)(2010-1#1)(2010-12#1)(2011-2#6)(2012-2#2)(2013-1#1)
phosphorylation on##4##2##(1993-9#1)(1996-2#1)(2008-11#1)(2008-9#1)
phosphorylation site##7##2##(1991-7#1)(1995-12#1)(1995-2#3)(2008-8#1)(2010-12#1)
phosphorylation sites and##2##3##(2008-8#1)(2008-9#1)
phosphorylation sites are##3##3##(1993-8#1)(1997-9#1)(2008-8#1)
phosphorylation sites of##3##3##(1994-11#1)(2008-8#2)
phosphorylation sites##16##2##(1993-8#1)(1994-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-9#1)(2008-5#1)(2008-8#4)(2008-9#2)
phosphorylation to##2##2##(2009-8#1)(2011-1#1)
phosphorylation was##6##2##(1990-10#1)(1994-6#1)(1995-6#1)(1997-1#1)(2010-12#1)(2012-3#1)
phosphorylation were##3##2##(1992-9#1)(1993-8#1)(2012-3#1)
phosphorylation which##2##2##(1995-8#1)(1996-2#1)
phosphorylation##231##1##(1990-10#5)(1990-2#3)(1990-5#2)(1991-10#1)(1991-5#5)(1991-7#1)(1992-10#3)(1992-4#1)(1992-6#2)(1992-7#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#6)(1993-9#1)(1994-11#13)(1994-6#13)(1994-8#2)(1995-11#4)(1995-12#6)(1995-2#7)(1995-6#18)(1995-8#6)(1996-12#7)(1996-2#10)(1997-1#13)(1997-2#9)(1997-7#6)(1997-9#1)(2008-11#7)(2008-4#5)(2008-5#1)(2008-7#6)(2008-8#11)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#5)(2011-1#2)(2011-2#7)(2012-2#8)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#3)
phosphorylation-induced##2##1##(1995-6#2)
phosphorylative##2##1##(1990-10#1)(1992-9#1)
phosphorylcholine##3##1##(1994-3#1)(2008-11#2)
phosphoserine##2##1##(1994-11#1)(2012-2#1)
phosphotransferase gene##2##2##(2008-10#2)
phosphotransferase##4##1##(1990-10#1)(1991-10#1)(2008-10#2)
phosphotungstic acid##2##2##(2008-10#2)
phosphotyrosine##4##1##(1994-11#1)(1994-6#2)(2008-4#1)
phosvitin at different pH values##2##5##(1994-11#2)
photic##4##1##(1994-2#2)(2008-5#1)(2008-7#1)
photo standard##5##2##(2008-5#5)
photo##9##1##(1993-12#1)(2008-10#3)(2008-5#5)
photo-##2##1##(2009-8#2)
photo-Fenton##2##1##(2008-10#2)
photo-degradation product##3##2##(2008-5#3)
photo-oxidation and##4##2##(2008-10#4)
photo-oxidation##12##1##(2008-10#10)(2008-5#2)
photo-symbiotic clams##6##2##(2008-5#6)
photo-symbiotic##7##1##(2008-5#7)
photoacoustic cell##2##2##(2008-10#1)(2008-3#1)
photoacoustic cells##2##2##(2008-2#2)
photoacoustic detection##2##2##(2008-3#2)
photoacoustic detector##2##2##(2008-10#1)(2008-2#1)
photoacoustic imaging##4##2##(2009-12#1)(2009-5#2)(2011-7#1)
photoacoustic microscopy##3##2##(2009-12#2)(2011-7#1)
photoacoustic signal##2##2##(2008-10#1)(2008-3#1)
photoacoustic##27##1##(1990-8#2)(1994-11#1)(2008-10#4)(2008-2#3)(2008-3#9)(2009-12#3)(2009-5#2)(2011-7#3)
photoactivated chromotropic acid##2##3##(2008-10#2)
photoactivated##8##1##(1993-8#1)(2008-10#4)(2009-6#1)(2012-2#1)(2012-3#1)
photoactivation##3##1##(1993-8#1)(2008-10#2)
photoactive##3##1##(2008-10#2)(2011-1#1)
photoaffinity labeling##3##2##(1991-9#1)(1993-8#1)(1995-11#1)
photoaffinity##6##1##(1991-9#1)(1993-6#1)(1993-8#3)(1995-11#1)
photoaged skin##2##2##(2011-2#2)
photoaged##3##1##(2011-2#2)(2012-2#1)
photoaging##6##1##(1991-6#1)(2008-5#1)(2011-2#4)
photobleaching is##2##2##(2008-10#1)(2008-2#1)
photobleaching of##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
photobleaching##16##1##(2008-10#2)(2008-2#5)(2008-3#2)(2008-7#2)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#1)
photocarcinogenesis##2##1##(2008-5#1)(2011-2#1)
photocatalyst##5##1##(2008-10#2)(2009-11#3)
photocatalytic degradation##2##2##(2008-10#2)
photocatalytic disinfection##2##2##(2013-1#2)
photocatalytic oxidation for##2##3##(2008-10#2)
photocatalytic oxidation##5##2##(2008-10#5)
photocatalytic##14##1##(2008-10#11)(2009-11#1)(2013-1#2)
photochemical activities##2##2##(2008-10#1)(2008-9#1)
photochemical cortical##2##2##(2008-4#2)
photochemical degradation of the##2##4##(2008-11#1)(2008-5#1)
photochemical degradation of##3##3##(2008-11#2)(2008-5#1)
photochemical derivatization##2##2##(2008-10#2)
photochemical processes in##2##3##(2008-11#2)
photochemical reaction of##2##3##(2008-10#1)(2008-8#1)
photochemical reaction##15##2##(2008-10#9)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)
photochemical reactions of##2##3##(2008-10#2)
photochemical reactions##3##2##(1994-5#1)(2008-10#2)
photochemical##46##1##(1994-3#1)(1994-5#1)(1996-5#1)(2008-10#23)(2008-11#4)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-3#1)
photochemically induced fluorescence##7##3##(2008-10#7)
photochemically##10##1##(2008-10#7)(2008-11#3)
photochemically-induced fluorescence##3##2##(2008-10#3)
photochemistry##2##1##(2011-3#1)(2012-7#1)
photochromic##4##1##(2008-3#1)(2009-8#3)
photocoagulation##5##1##(1993-1#1)(1993-6#4)
photoconductive##6##1##(2008-3#5)(2009-5#1)
photocured##2##1##(2008-10#2)
photocurrent##2##1##(2008-10#2)
photodamage##7##1##(1993-8#1)(2008-5#2)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
photodamage/photoaging##2##1##(2012-2#2)
photodecomposition##2##1##(2008-10#2)
photodegradation and##2##2##(2008-10#2)
photodegradation of the##2##3##(2008-10#1)(2008-3#1)
photodegradation processes##2##2##(2008-10#2)
photodegradation##22##1##(2008-10#20)(2008-3#1)(2008-5#1)
photodetector##10##1##(2007-12#1)(2008-10#2)(2008-3#7)
photodiode array detector##6##3##(2008-10#6)
photodiode array##11##2##(1997-2#2)(2008-10#9)
photodiode system##2##2##(2008-11#2)
photodiode##22##1##(1997-2#2)(2008-10#14)(2008-11#2)(2008-3#4)
photodiode-array##4##1##(1997-2#1)(2008-10#3)
photodiodes for##2##2##(2008-3#2)
photodiodes##9##1##(2007-12#2)(2008-10#1)(2008-3#6)
photodynamic effect of##2##3##(2009-3#1)(2012-3#1)
photodynamic effect##3##2##(1992-1#1)(2009-3#1)(2012-3#1)
photodynamic oxidation rates##3##3##(2008-5#3)
photodynamic oxidation##5##2##(2008-5#5)
photodynamic reactivity##2##2##(2008-5#2)
photodynamic therapy (PDT)##3##3##(2008-7#1)(2009-4#1)(2012-3#1)
photodynamic therapy of##2##3##(2008-7#1)(2008-8#1)
photodynamic therapy##15##2##(1992-1#1)(1994-1#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-12#1)(2012-2#1)(2012-3#6)
photodynamic##29##1##(1991-9#1)(1992-1#2)(1994-1#1)(2008-5#9)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#2)(2010-12#1)(2012-2#2)(2012-3#7)
photoelastic fringe##2##2##(2008-3#2)
photoelastic##5##1##(2008-3#5)
photoelasticity##6##1##(2008-3#6)
photoelectric modulation interferometer##3##3##(2013-8#3)
photoelectron##18##1##(1992-11#1)(1996-12#1)(2008-10#14)(2011-2#2)
photoemission from##2##2##(1991-9#1)(1993-5#1)
photoemission##3##1##(1991-9#1)(1993-5#2)
photoerythema##2##1##(2008-5#2)
photoexcitation##2##1##(2010-7#2)
photoexcited##2##1##(1993-5#1)(2008-10#1)
photofragmentation-fragment detection##2##2##(2008-3#2)
photogenerated##3##1##(2008-10#2)(2009-11#1)
photograding##3##1##(2008-5#3)
photograph##5##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(2008-10#1)
photographic##17##1##(2008-10#12)(2008-3#1)(2008-4#1)(2009-10#1)(2010-9#1)(2013-1#1)
photographs of##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
photographs##12##1##(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2009-7#1)(2012-12#1)(2013-1#1)
photography##7##1##(2008-10#2)(2008-3#4)(2011-2#1)
photoinduced electron transfer (PET)##2##4##(2008-10#2)
photoinduced##5##1##(2007-12#1)(2008-10#3)(2010-4#1)
photoinhibition and C(4) pathway##2##4##(2008-9#2)
photoinhibition and##4##2##(2008-9#4)
photoisomerization##2##1##(1995-6#1)(2008-10#1)
photolabeled##3##1##(1993-8#3)
photolinker##2##1##(2008-10#2)
photolithographic##4##1##(2008-10#3)(2008-2#1)
photolithography##8##1##(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#2)
photoluminescence spectra##2##2##(2008-10#1)(2010-4#1)
photoluminescence##6##1##(2008-10#4)(2009-11#1)(2010-4#1)
photoluminescent##3##1##(2008-10#3)
photolysed##2##1##(2008-10#2)
photolysis of##4##2##(1995-2#1)(1996-5#2)(2008-11#1)
photolysis##11##1##(1995-2#2)(1996-5#2)(2008-10#4)(2008-11#2)(2008-8#1)
photometer is##2##2##(2008-10#2)
photometer##7##1##(2008-10#6)(2008-3#1)
photometers##2##1##(2008-10#2)
photometric detection at##2##3##(2008-10#2)
photometric detection##12##2##(1997-2#1)(2008-10#11)
photometric detector##4##2##(2008-10#4)
photometric determination of iron(II)/iron(III) and nitrite/nitrate##2##6##(2008-10#2)
photometric determination of##4##3##(2008-10#4)
photometric method for##2##3##(2008-10#2)
photometric method with##2##3##(2008-10#2)
photometric method##11##2##(2008-10#11)
photometric system##3##2##(2008-10#3)
photometric titration##3##2##(2008-10#3)
photometric##51##1##(1995-6#1)(1997-2#1)(2008-10#49)
photometrically##3##1##(2008-10#3)
photometry##6##1##(2008-10#5)(2011-2#1)
photomorphogenesis##2##1##(2009-8#2)
photomultiplier tube##4##2##(2008-10#3)(2008-7#1)
photomultiplier##5##1##(2008-10#4)(2008-7#1)
photon absorptiometry##4##2##(1991-11#4)
photon correlation spectroscopy##2##3##(2008-2#1)(2013-1#1)
photon counting##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
photon detection##2##2##(1995-6#1)(2007-12#1)
photon emission computed tomography (SPECT)##2##5##(1994-1#1)(1996-12#1)
photon emission computed tomography##5##4##(1994-1#2)(1996-12#1)(2008-7#1)(2010-12#1)
photon emission##8##2##(1994-1#2)(1996-12#1)(2008-12#1)(2008-7#2)(2010-12#1)(2012-2#1)
photon flux density##4##3##(2008-10#3)(2010-10#1)
photon flux##6##2##(2008-10#4)(2010-10#2)
photon##47##1##(1991-11#4)(1992-11#1)(1993-9#2)(1994-1#2)(1995-6#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#10)(2008-7#2)(2009-11#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
photon-counting##4##1##(2007-12#1)(2008-10#1)(2008-3#2)
photonic bandgap##2##2##(2007-12#1)(2012-3#1)
photonic crystal waveguide##3##3##(2007-12#3)
photonic crystal##4##2##(2007-12#4)
photonic crystals##2##2##(2008-3#2)
photonic delay line for phased-array##2##5##(2008-3#2)
photonic delay##3##2##(2008-3#3)
photonic##19##1##(2007-12#5)(2008-3#12)(2012-2#1)(2012-3#1)
photons in##2##2##(2008-11#1)(2009-11#1)
photons##13##1##(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#2)(2011-1#1)
photooxidation##2##1##(2008-10#2)
photooxidative coupling of##2##3##(2008-10#2)
photooxidative##4##1##(2008-10#2)(2008-5#1)(2010-10#1)
photoperiod sensitivity##3##2##(1995-6#2)(2012-3#1)
photoperiod##10##1##(1995-6#2)(2008-10#1)(2008-11#5)(2012-3#2)
photoperiodic##2##1##(1995-11#1)(2009-8#1)
photophysical properties##3##2##(2008-10#2)(2009-9#1)
photopic luminance##2##2##(2011-2#2)
photopic##3##1##(2011-2#3)
photoplethysmography##3##1##(2010-7#2)(2010-8#1)
photopolymer##4##1##(2007-12#4)
photopolymerizable##2##1##(2008-3#1)(2013-1#1)
photopolymerization##3##1##(2008-2#2)(2008-3#1)
photoproducts after##2##2##(2008-10#2)
photoproducts##8##1##(2008-10#8)
photoprotection##9##1##(2008-5#3)(2011-2#3)(2012-2#3)
photoprotective agent##2##2##(2008-5#2)
photoprotective substance##2##2##(2008-11#2)
photoprotective##8##1##(2008-11#3)(2008-5#4)(2010-10#1)
photoradiation##4##1##(1990-6#4)
photoreactive##2##1##(1994-8#1)(2011-2#1)
photoreactor##2##1##(2008-10#2)
photoreceptor development##2##2##(1996-2#2)
photoreceptor regeneration##2##2##(2010-1#2)
photoreceptor##14##1##(1996-2#3)(2008-7#3)(2009-8#1)(2010-1#4)(2012-3#3)
photoreceptors and lateral eyes##2##4##(1993-3#2)
photoreceptors and##4##2##(1993-3#2)(2011-2#2)
photoreceptors in the##2##3##(1991-10#1)(2010-1#1)
photoreceptors of the##2##3##(2008-9#1)(2011-1#1)
photoreceptors to##3##2##(2008-7#2)(2011-1#1)
photoreceptors##22##1##(1991-10#1)(1993-3#3)(1996-2#3)(2008-10#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-1#4)(2011-1#2)(2011-2#2)
photoreduction##5##1##(2008-10#4)(2008-8#1)
photorefractive crystal##3##2##(2008-3#3)
photorefractive effect is##2##3##(2008-3#2)
photorefractive effect##5##2##(2008-3#5)
photorefractive##28##1##(1992-8#1)(2007-11#2)(2008-2#2)(2008-3#22)(2013-1#1)
photoresist grating##2##2##(2008-3#2)
photoresist##10##1##(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#3)
photorespiration##5##1##(2008-8#4)(2009-10#1)
photos of##2##2##(2008-5#1)(2011-2#1)
photos##3##1##(2008-5#1)(2011-2#1)(2013-1#1)
photosensitising##3##1##(2008-11#3)
photosensitive##6##1##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)
photosensitivity rashes##2##2##(2008-5#2)
photosensitivity##7##1##(1993-11#1)(2008-5#4)(2010-6#1)(2011-2#1)
photosensitization of##2##2##(2008-8#2)
photosensitization using##2##2##(2012-2#2)
photosensitization##7##1##(1991-5#1)(2008-8#3)(2012-2#3)
photosensitized##2##1##(2008-8#1)(2012-2#1)
photosensitizer##5##1##(1992-1#1)(1993-11#1)(2008-11#1)(2008-8#1)(2012-2#1)
photosensitizers in##2##2##(1993-11#2)
photosensitizers##9##1##(1991-5#1)(1993-11#6)(1993-8#1)(2008-11#1)
photosensitizing concentration of##2##3##(2012-3#2)
photosensitizing##5##1##(1993-8#2)(2008-5#1)(2012-3#2)
photospray ionization##2##2##(2008-10#2)
photostabilities of##2##2##(2008-5#2)
photostability of##3##2##(2008-10#1)(2008-5#2)
photostability was##2##2##(2008-5#2)
photostability##10##1##(2008-10#2)(2008-3#1)(2008-5#7)
photosynthesis and growth##2##3##(2008-10#1)(2009-10#1)
photosynthesis and##3##2##(2008-10#2)(2009-10#1)
photosynthesis in##3##2##(2008-10#2)(2008-9#1)
photosynthesis was##2##2##(2008-10#2)
photosynthesis##29##1##(1995-6#2)(1996-12#2)(2008-10#15)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2012-5#1)(2012-7#2)
photosynthesis-related##2##1##(1996-12#1)(2008-9#1)
photosynthetic bacteria##3##2##(1993-8#1)(2008-8#2)
photosynthetic capacity##4##2##(2008-10#3)(2008-11#1)
photosynthetic electron flow##2##3##(2009-10#2)
photosynthetic electron transport to photorespiration##3##5##(2008-8#3)
photosynthetic electron transport##5##3##(2008-8#4)(2011-2#1)
photosynthetic electron##8##2##(1994-3#1)(2008-8#4)(2009-10#2)(2011-2#1)
photosynthetic function in##2##3##(2008-9#2)
photosynthetic function##3##2##(2008-9#3)
photosynthetic pigments##2##2##(2008-12#2)
photosynthetic rate of##2##3##(2008-10#1)(2008-9#1)
photosynthetic rate##7##2##(2008-10#5)(2008-8#1)(2008-9#1)
photosynthetic rates##2##2##(2008-10#2)
photosynthetic responses of##2##3##(2012-5#1)(2012-7#1)
photosynthetic##50##1##(1993-8#2)(1994-3#1)(1994-5#1)(1996-2#1)(1996-6#1)(1997-4#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-8#7)(2008-9#5)(2009-10#3)(2009-6#1)(2009-8#1)(2011-2#2)(2012-5#2)(2012-6#1)(2012-7#2)
photosynthetically active##3##2##(2008-10#2)(2008-2#1)
photosystem II (PSII)##2##3##(2008-10#1)(2008-8#1)
photosystem II##8##2##(1997-4#1)(2008-10#2)(2008-11#2)(2008-8#3)
phototactic##2##1##(1993-3#1)(2009-10#1)
phototherapy##2##1##(2008-11#1)(2010-3#1)
photothermal deflection spectroscopy##2##3##(2008-3#2)
photothermal deflection##3##2##(2008-3#3)
photothermal signals##2##2##(2008-3#2)
photothermal##12##1##(2008-10#2)(2008-3#8)(2012-12#2)
phototoxic##2##1##(1994-8#1)(2011-2#1)
phototoxicity##2##1##(1993-11#1)(2008-11#1)
phototrophs##2##1##(2009-4#2)
phototropism of rice root##3##4##(2008-9#3)
phototropism##7##1##(2008-9#7)
phototype##9##1##(2008-5#9)
phrase##3##1##(1991-9#1)(2007-12#1)(2011-2#1)
phrases##3##1##(1991-2#1)(2011-2#1)(2012-3#1)
phthalate (DBP)##4##2##(2008-10#4)
phthalate (DEHP)##2##2##(2008-10#2)
phthalate (DOP)##6##2##(2008-10#6)
phthalate acid esters##2##3##(2008-10#2)
phthalate as##3##2##(2008-10#3)
phthalate##31##1##(2008-10#29)(2008-12#1)(2013-8#1)
phthalates##10##1##(2008-10#8)(2008-11#2)
phthaleins##3##1##(2008-10#3)
phthalic acid##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
phthalic##8##1##(1994-3#1)(1995-11#1)(2008-10#5)(2008-5#1)
phthalide##2##1##(2008-11#2)
phthalocyanine (FePc)##2##2##(2008-10#2)
phthalocyanine and##2##2##(2008-10#2)
phthalocyanine complex##4##2##(2008-10#4)
phthalocyanine##28##1##(2008-10#28)
phthirapteran##2##1##(2007-12#2)
phycobilisome##2##1##(2008-8#2)
phycocyanin 645##2##2##(1994-5#2)
phycocyanin##6##1##(1994-5#2)(2008-8#4)
phycocyanobilins##3##1##(1994-5#3)
phycoerythrin##10##1##(2008-10#1)(2008-4#2)(2008-8#6)(2008-9#1)
phyla##6##1##(2008-9#2)(2009-6#1)(2010-11#1)(2011-2#2)
phylactolaemate##2##1##(2011-2#2)
phylla##2##1##(2008-10#1)(2009-8#1)
phyllobacteria##3##1##(2008-10#3)
phyllodes tumour of the seminal vesicle##2##6##(2011-2#2)
phyllodes tumour##3##2##(2011-2#3)
phyllodes##10##1##(1994-12#1)(2011-2#4)(2011-3#5)
phyllody##3##1##(2008-10#3)
phylloplane##4##1##(2008-10#4)
phyllosilicates##4##1##(2008-6#4)
phyllosphere##2##1##(2008-10#2)
phyllotaxis##2##1##(2009-8#2)
phylogenetic analyses of the##6##4##(2008-10#4)(2008-8#1)(2010-3#1)
phylogenetic analyses of##8##3##(2008-10#6)(2008-8#1)(2010-3#1)
phylogenetic analyses##18##2##(2008-10#12)(2008-8#1)(2009-6#1)(2010-3#2)(2013-8#2)
phylogenetic analysis indicated that##2##4##(2008-10#2)
phylogenetic analysis of the##3##4##(2008-10#2)(2008-8#1)
phylogenetic analysis of##9##3##(1993-12#1)(2008-10#6)(2008-8#1)(2011-3#1)
phylogenetic analysis to##2##3##(2008-10#2)
phylogenetic analysis##26##2##(1993-12#1)(2008-10#21)(2008-8#2)(2008-9#1)(2011-3#1)
phylogenetic and##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
phylogenetic comparative##2##2##(2012-3#2)
phylogenetic coverage##2##2##(2008-10#2)
phylogenetic groups using##2##3##(2008-10#1)(2008-8#1)
phylogenetic groups##5##2##(2008-10#4)(2008-8#1)
phylogenetic implications##3##2##(2007-12#2)(2011-2#1)
phylogenetic interest because of the##2##5##(2011-2#2)
phylogenetic interest because of##4##4##(2011-2#4)
phylogenetic interest because##5##3##(2011-2#5)
phylogenetic lineages##2##2##(2008-10#2)
phylogenetic origins##2##2##(1995-12#1)(2010-7#1)
phylogenetic position of##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
phylogenetic position##5##2##(2008-10#1)(2008-8#1)(2011-2#3)
phylogenetic relationship of##3##3##(1994-11#1)(1996-12#1)(2008-8#1)
phylogenetic relationship##5##2##(1994-11#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-10#1)
phylogenetic relationships among##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
phylogenetic relationships of##2##3##(2008-10#1)(2010-3#1)
phylogenetic relationships were detected##2##4##(2008-10#2)
phylogenetic relationships were##3##3##(2008-10#2)(2008-6#1)
phylogenetic relationships within##2##3##(2008-10#2)
phylogenetic relationships##16##2##(2008-10#9)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)
phylogenetic species##2##2##(2008-10#2)
phylogenetic tree based on##2##4##(2008-10#2)
phylogenetic tree of the##2##4##(1997-2#1)(1997-7#1)
phylogenetic tree of##4##3##(1997-2#1)(1997-7#1)(2008-8#2)
phylogenetic tree was##3##3##(2010-7#1)(2013-8#2)
phylogenetic tree##21##2##(1991-5#1)(1997-2#2)(1997-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#3)(2009-10#1)(2010-7#1)(2013-8#4)
phylogenetic trees##9##2##(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#2)(2013-8#2)
phylogenetic##175##1##(1991-5#2)(1993-12#2)(1994-11#1)(1995-12#1)(1996-12#1)(1997-2#2)(1997-7#1)(2007-12#4)(2008-10#75)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#19)(2008-9#6)(2009-10#3)(2009-6#3)(2010-3#6)(2010-7#2)(2010-8#1)(2011-2#18)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#8)
phylogenetically based statistical##2##3##(2008-9#2)
phylogenetically distant##2##2##(1991-12#1)(2008-10#1)
phylogenetically distinct from the##2##4##(2008-10#1)(2010-3#1)
phylogenetically distinct from##4##3##(2008-10#3)(2010-3#1)
phylogenetically distinct##8##2##(2008-10#7)(2010-3#1)
phylogenetically independent contrasts##3##3##(2008-8#3)
phylogenetically independent##4##2##(2008-8#3)(2009-8#1)
phylogenetically##28##1##(1991-12#1)(1995-6#1)(1997-2#1)(2008-10#12)(2008-6#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
phylogenies and##2##2##(2010-5#1)(2012-3#1)
phylogenies##13##1##(2008-10#3)(2008-4#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#5)
phylogenomic##6##1##(2009-10#2)(2012-3#2)(2013-8#2)
phylogeny and##2##2##(2008-9#2)
phylogeny inferred from##2##3##(2008-10#1)(2008-9#1)
phylogeny of##5##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-6#1)
phylogeny##29##1##(2007-12#1)(2008-10#11)(2008-4#1)(2008-6#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#2)(2010-3#2)(2010-4#1)(2011-2#1)(2012-3#1)
phylotypes##3##1##(2010-6#2)(2011-2#1)
phylum Synergistetes##3##2##(2011-2#3)
phylum##13##1##(2008-10#1)(2011-2#6)(2012-2#1)(2013-8#5)
physical Health Improvement Profile##2##4##(2009-6#2)
physical Health Improvement##3##3##(2009-6#3)
physical UV filter##3##3##(2008-5#3)
physical abuse##5##2##(1995-11#1)(2009-4#1)(2010-7#1)(2012-12#1)(2012-3#1)
physical activities and##2##3##(2010-8#1)(2011-2#1)
physical activities##4##2##(1996-6#1)(2010-8#2)(2011-2#1)
physical activity (PA)##2##3##(2009-3#1)(2012-2#1)
physical activity among##3##3##(2008-4#1)(2010-11#1)(2012-12#1)
physical activity and health##2##4##(2010-1#1)(2013-1#1)
physical activity and physical##2##4##(2009-6#1)(2013-1#1)
physical activity and##13##3##(2008-11#1)(2008-4#1)(2009-6#3)(2010-1#1)(2010-11#1)(2010-7#1)(2013-1#5)
physical activity at##2##3##(2010-11#1)(2013-1#1)
physical activity counseling##4##3##(2008-4#4)
physical activity in##3##3##(2012-12#1)(2013-1#2)
physical activity is##2##3##(2008-3#1)(2012-2#1)
physical activity levels##4##3##(1996-12#1)(2008-11#1)(2008-4#1)(2012-12#1)
physical activity of healthcare workers##3##5##(2013-1#3)
physical activity on##4##3##(2010-9#1)(2012-12#2)(2013-8#1)
physical activity participation##2##3##(2009-6#1)(2012-2#1)
physical activity practice##2##3##(2010-11#1)(2013-1#1)
physical activity than subjects##2##4##(2008-4#1)(2010-11#1)
physical activity##102##2##(1991-12#2)(1993-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#10)(2008-5#1)(2009-3#1)(2009-5#1)(2009-6#8)(2010-1#3)(2010-11#13)(2010-7#1)(2010-8#4)(2010-9#2)(2011-2#1)(2012-12#8)(2012-2#6)(2013-1#27)(2013-8#3)
physical adsorption##5##2##(2008-10#5)
physical and biological##4##3##(1994-5#1)(2008-10#3)
physical and chemical characteristics##2##4##(2008-10#1)(2009-8#1)
physical and chemical properties of##2##5##(2011-2#1)(2013-8#1)
physical and chemical properties##7##4##(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#2)(2011-3#1)(2013-8#1)
physical and chemical variables##2##4##(2008-10#2)
physical and chemical##21##3##(1996-12#1)(2008-10#11)(2008-5#1)(2008-8#2)(2009-8#2)(2011-2#2)(2011-3#1)(2013-8#1)
physical and emotional##3##3##(1991-8#1)(2010-9#1)(2011-2#1)
physical and mental component##2##4##(2012-3#1)(2013-1#1)
physical and mental health##7##4##(1994-1#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-12#1)(2013-1#2)
physical and mental quality of life##2##6##(2012-3#2)
physical and mental##18##3##(1990-6#1)(1991-3#1)(1994-1#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-12#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-6#1)(2012-12#1)(2012-3#3)(2013-1#3)
physical and psychological##3##3##(2010-11#1)(2010-6#2)
physical and psychosocial##2##3##(2010-11#1)(2012-12#1)
physical and social##3##3##(2008-11#1)(2010-11#1)(2012-3#1)
physical and##69##2##(1990-6#2)(1991-2#1)(1991-3#1)(1991-8#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-3#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-6#3)(2010-9#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#4)(2013-8#1)
physical area##2##2##(2008-4#1)(2011-2#1)
physical capacity##2##2##(2010-2#1)(2012-2#1)
physical changes##5##2##(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#1)
physical characteristics of the##4##4##(1990-9#1)(1996-3#1)(2008-5#1)(2013-8#1)
physical characteristics of##9##3##(1990-9#1)(1996-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
physical characteristics##13##2##(1990-9#2)(1996-3#1)(2008-10#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
physical characterization of##2##3##(1995-5#1)(2008-3#1)
physical characterization##3##2##(1995-5#1)(2008-3#1)(2008-5#1)
physical competence##2##2##(2009-7#2)
physical condition and##2##3##(1994-12#1)(2008-5#1)
physical condition##5##2##(1994-12#2)(2008-5#1)(2010-2#1)(2011-2#1)
physical conditions##2##2##(2008-10#1)(2009-6#1)
physical contact##3##2##(1993-3#1)(1994-6#1)(2009-10#1)
physical dependence in##3##3##(1991-1#3)
physical dependence##6##2##(1991-1#4)(1996-12#1)(2009-7#1)
physical disabilities##4##2##(1993-9#1)(1995-12#2)(2008-7#1)
physical disability##3##2##(1992-12#1)(1997-1#1)(2008-11#1)
physical discomfort##2##2##(2008-9#1)(2010-6#1)
physical disorder##2##2##(1997-7#1)(2010-12#1)
physical distance##3##2##(2008-10#1)(2008-9#2)
physical education##4##2##(1993-6#1)(2008-12#2)(2012-2#1)
physical environments##2##2##(2008-11#1)(2012-2#1)
physical evidence##3##2##(2008-10#3)
physical exam##3##2##(2008-8#1)(2008-9#1)(2009-6#1)
physical examination and##4##3##(1990-6#1)(2008-10#1)(2008-8#1)(2012-3#1)
physical examination are##3##3##(2006-5#1)(2010-1#1)(2013-8#1)
physical examination screening##2##3##(1991-12#1)(2010-8#1)
physical examination##31##2##(1990-6#2)(1991-12#1)(1993-2#1)(1995-11#1)(1997-4#1)(2006-5#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#1)(2010-1#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-8#3)
physical exercise on##2##3##(2008-7#2)
physical exercise##14##2##(1993-2#1)(1993-6#1)(1996-11#1)(2008-6#1)(2008-7#3)(2009-1#1)(2010-12#1)(2010-6#2)(2013-8#3)
physical exertion##2##2##(2010-10#2)
physical explanation for##2##3##(1996-12#1)(2007-11#1)
physical features##2##2##(2010-6#1)(2011-2#1)
physical findings##3##2##(1997-8#1)(2009-9#1)(2013-1#1)
physical fitness and##3##3##(2012-2#3)
physical fitness##9##2##(1991-8#1)(2010-4#3)(2012-2#4)(2013-1#1)
physical function in##2##3##(2010-11#1)(2013-1#1)
physical function##5##2##(2010-11#2)(2011-2#1)(2013-1#2)
physical functioning##5##2##(1995-3#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)
physical health of the##2##4##(2008-11#1)(2009-6#1)
physical health of##4##3##(1996-9#1)(2008-11#1)(2009-6#1)(2012-2#1)
physical health problems##2##3##(2008-7#1)(2012-2#1)
physical health##17##2##(1996-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-2#2)(2010-3#2)(2010-9#1)(2011-2#2)(2012-2#3)(2013-8#1)
physical illness##2##2##(1997-7#1)(2010-12#1)
physical inactivity##2##2##(1997-2#1)(2008-11#1)
physical injury and##2##3##(1997-7#1)(2011-2#1)
physical injury##4##2##(1995-1#1)(1997-7#1)(2011-10#1)(2011-2#1)
physical linkage##3##2##(2008-8#2)(2008-9#1)
physical map of a##2##4##(1995-6#1)(1996-3#1)
physical map of chromosome##3##4##(1997-6#1)(1997-8#1)(2008-10#1)
physical map of the genome##2##5##(1995-6#1)(2011-2#1)
physical map of the##6##4##(1995-6#1)(1997-8#2)(2008-10#1)(2008-8#1)(2011-2#1)
physical map of##11##3##(1995-6#2)(1996-3#1)(1997-6#1)(1997-8#3)(2008-10#2)(2008-8#1)(2011-2#1)
physical map##15##2##(1995-6#2)(1996-3#1)(1997-6#2)(1997-8#3)(1997-9#1)(2008-10#2)(2008-8#2)(2011-2#1)(2012-3#1)
physical mapping of##3##3##(1996-12#1)(2008-10#2)
physical mapping##6##2##(1996-12#1)(1997-9#1)(2008-10#3)(2008-9#1)
physical maps##4##2##(1994-9#1)(1995-6#2)(2010-10#1)
physical medicine##3##2##(2008-12#3)
physical methods##2##2##(2010-7#2)
physical mixtures were##2##3##(2008-10#2)
physical mixtures##3##2##(2008-10#3)
physical ones##2##2##(1997-1#1)(2008-8#1)
physical or occupational therapists##2##4##(2008-4#2)
physical or occupational##3##3##(2008-4#3)
physical or##6##2##(2008-11#1)(2008-4#3)(2008-5#1)(2009-6#1)
physical order of##2##3##(1992-6#2)
physical parameters##8##2##(2008-10#2)(2008-7#2)(2010-12#1)(2011-2#1)(2013-8#2)
physical phenomena##2##2##(2008-10#1)(2008-3#1)
physical properties of human##2##4##(2008-5#2)
physical properties of the##6##4##(1997-3#1)(2008-5#3)(2009-12#1)(2013-1#1)
physical properties of##17##3##(1991-1#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#7)(2009-12#1)(2010-7#2)(2013-1#1)
physical properties##35##2##(1990-8#1)(1991-1#1)(1992-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#9)(2008-8#1)(2009-12#1)(2010-4#1)(2010-7#3)(2011-2#1)(2013-1#1)
physical proximity##2##2##(2008-10#2)
physical quantities##2##2##(2012-2#1)(2013-1#1)
physical rehabilitation##2##2##(1992-3#1)(1994-3#1)
physical security##3##2##(1992-12#1)(2008-9#1)(2010-8#1)
physical stability##3##2##(2008-5#3)
physical state##4##2##(2008-4#2)(2008-5#1)(2008-8#1)
physical status##4##2##(1993-1#1)(2008-7#1)(2010-7#1)(2012-3#1)
physical steady state##3##3##(2008-10#3)
physical stress##3##2##(2008-9#1)(2009-1#1)(2010-2#1)
physical stresses##2##2##(2008-10#1)(2011-2#1)
physical sunscreen films##2##3##(2008-5#2)
physical sunscreen##3##2##(2008-5#3)
physical symptoms##3##2##(1992-2#1)(2009-12#2)
physical testing##2##2##(2012-2#2)
physical therapist##2##2##(2008-12#2)
physical therapists##7##2##(1992-3#3)(2008-12#3)(2011-2#1)
physical therapy following surgery##2##4##(1994-3#2)
physical therapy in##2##3##(1993-3#1)(2008-12#1)
physical therapy management##2##3##(2008-12#2)
physical therapy treatment the weekend following##2##6##(1994-3#2)
physical therapy treatment##6##3##(1994-3#3)(2008-12#3)
physical therapy##29##2##(1993-3#1)(1994-3#6)(1995-2#1)(1996-1#2)(1997-6#1)(2008-12#14)(2010-1#1)(2010-6#1)(2012-2#2)
physical variables##2##2##(2008-10#1)(2008-9#1)
physical##707##1##(1990-2#1)(1990-5#1)(1990-6#6)(1990-8#1)(1990-9#2)(1991-1#5)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#4)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#3)(1993-1#3)(1993-2#3)(1993-3#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#8)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#4)(1995-6#6)(1996-1#2)(1996-11#1)(1996-12#7)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#4)(1997-9#2)(2006-5#2)(2007-11#2)(2008-1#1)(2008-10#80)(2008-11#29)(2008-12#36)(2008-2#4)(2008-3#12)(2008-4#19)(2008-5#38)(2008-6#1)(2008-7#16)(2008-8#16)(2008-9#12)(2009-1#2)(2009-10#3)(2009-11#5)(2009-12#6)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#15)(2009-7#6)(2009-8#2)(2009-9#1)(2010-1#10)(2010-10#7)(2010-11#22)(2010-12#6)(2010-2#7)(2010-3#2)(2010-4#5)(2010-6#8)(2010-7#12)(2010-8#10)(2010-9#5)(2011-1#2)(2011-10#1)(2011-2#33)(2011-3#1)(2012-12#12)(2012-2#29)(2012-3#13)(2012-5#1)(2013-1#45)(2013-8#23)
physical-##2##1##(2008-5#2)
physical-chemical##2##1##(1992-3#1)(2008-11#1)
physically active##4##2##(1994-3#1)(2013-1#3)
physically and mentally##2##3##(1990-2#1)(1995-11#1)
physically and##5##2##(1990-2#1)(1995-11#1)(1997-4#1)(2009-8#1)(2012-2#1)
physically assigned P1 clones##2##4##(1997-6#1)(1997-8#1)
physically interacts with##3##3##(1995-12#1)(2008-9#1)(2013-1#1)
physically interacts##4##2##(1995-12#2)(2008-9#1)(2013-1#1)
physically linked to##2##3##(1995-5#1)(2008-4#1)
physically remove##2##2##(2008-10#1)(2008-8#1)
physically##45##1##(1990-2#1)(1991-1#1)(1991-10#1)(1991-8#1)(1994-3#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-8#1)
physician and patient##4##3##(1993-11#2)(1995-2#1)(2008-11#1)
physician and the##2##3##(1990-9#1)(2010-8#1)
physician and##21##2##(1990-9#1)(1992-1#3)(1993-11#2)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-7#2)(2010-8#1)(2012-3#1)(2013-1#1)
physician as##5##2##(1992-1#1)(1994-12#1)(1995-12#1)(1997-3#1)(2008-10#1)
physician at##2##2##(1991-12#1)(1996-9#1)
physician autonomy##3##2##(1994-1#1)(1996-12#2)
physician centered##2##2##(1997-1#2)
physician charges##2##2##(1993-12#1)(1994-1#1)
physician compensation##3##2##(1993-3#1)(1996-1#2)
physician fee##3##2##(1993-12#1)(1993-3#1)(2012-3#1)
physician fees are##2##3##(1994-1#2)
physician fees##5##2##(1994-1#4)(1996-3#1)
physician for##4##2##(1990-6#1)(1991-9#1)(1997-2#1)(2008-12#1)
physician groups##3##2##(1996-3#1)(1997-1#1)(2008-11#1)
physician health##2##2##(1992-12#2)
physician if the##2##3##(1993-12#1)(2008-8#1)
physician in##7##2##(1990-6#1)(1993-11#1)(1995-11#1)(1995-2#1)(1997-4#1)(2010-12#1)(2010-8#1)
physician leaders##3##2##(1992-1#1)(1994-1#1)(2008-11#1)
physician must##2##2##(1992-3#1)(2013-8#1)
physician office##2##2##(1992-1#1)(1996-12#1)
physician or##4##2##(1992-3#1)(1995-12#1)(2008-11#1)(2008-12#1)
physician order entry##3##3##(1995-2#3)
physician ownership of##2##3##(1993-3#1)(1996-1#1)
physician payment reform##5##3##(1994-1#2)(1995-12#3)
physician payment##17##2##(1991-1#2)(1991-12#1)(1992-1#1)(1993-3#1)(1994-1#6)(1994-12#2)(1995-12#4)
physician payments##2##2##(1993-12#1)(1994-1#1)
physician performance information##2##3##(2013-1#2)
physician performance##5##2##(2013-1#5)
physician perspective##2##2##(1994-1#2)
physician practice##5##2##(1994-1#2)(1994-12#1)(1997-3#1)(2010-8#1)
physician practices##2##2##(1991-12#1)(2013-1#1)
physician resources##2##2##(1994-12#1)(2008-11#1)
physician satisfaction##2##2##(1993-1#2)
physician service##2##2##(1992-8#1)(1995-12#1)
physician services##10##2##(1992-1#1)(1992-2#2)(1993-12#2)(1994-1#2)(1994-3#2)(1995-12#1)
physician should##2##2##(1993-11#1)(2012-3#1)
physician staffing##2##2##(1992-8#2)
physician to##3##2##(1995-2#1)(2008-4#1)(2010-8#1)
physician visits##3##2##(1995-1#1)(1995-12#1)(1997-2#1)
physician##256##1##(1990-6#5)(1990-9#1)(1991-1#3)(1991-12#6)(1991-2#1)(1991-9#2)(1992-1#11)(1992-12#4)(1992-2#3)(1992-3#4)(1992-8#3)(1993-1#4)(1993-11#5)(1993-12#11)(1993-3#10)(1993-8#1)(1994-1#21)(1994-12#8)(1994-3#4)(1994-5#1)(1995-1#3)(1995-11#1)(1995-12#16)(1995-2#9)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#6)(1996-12#5)(1996-2#1)(1996-3#4)(1996-9#1)(1997-1#5)(1997-2#9)(1997-3#7)(1997-4#6)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#9)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-1#2)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#7)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#12)(2013-8#1)
physician's office##2##2##(1990-11#1)(1996-1#1)
physician's perspective##2##2##(1991-12#1)(1992-12#1)
physician's##17##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#3)(1994-1#1)(1994-12#1)(1996-1#1)(1997-2#2)(2010-8#1)
physician-based##3##1##(1995-12#2)(1996-11#1)
physician-nurse collaboration##2##2##(1992-12#2)
physician-patient discussions##2##2##(2009-5#2)
physician-patient relationship##2##2##(1995-2#1)(2011-2#1)
physician-patient##5##1##(1995-2#1)(2009-5#2)(2011-2#1)(2012-3#1)
physician]##2##1##(1991-3#1)(1996-8#1)
physicians and hospitals##4##3##(1991-3#1)(1992-11#1)(1992-3#1)(1997-5#1)
physicians and managers##4##3##(1992-2#1)(1995-1#1)(1997-1#2)
physicians and nurses##4##3##(1992-12#1)(1993-2#1)(2008-11#1)(2008-3#1)
physicians and patients##7##3##(1991-2#2)(1993-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(2008-6#1)
physicians and physician##2##3##(1992-1#1)(1996-3#1)
physicians and support##2##3##(1992-3#1)(1996-1#1)
physicians and surgeons##2##3##(1993-6#1)(2013-8#1)
physicians and their##6##3##(1991-2#1)(1992-5#1)(1995-2#1)(1996-1#1)(2008-11#1)(2011-2#1)
physicians and##57##2##(1991-2#5)(1991-3#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#3)(1995-2#2)(1996-1#3)(1996-12#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-6#2)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#2)
physicians are##9##2##(1991-3#1)(1992-1#1)(1992-5#1)(1994-12#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-4#1)(2010-8#1)
physicians as##5##2##(1991-2#1)(1993-12#1)(1995-2#1)(1997-1#1)(2008-12#1)
physicians better##2##2##(1996-3#1)(2008-11#1)
physicians by##2##2##(1993-12#1)(2008-6#1)
physicians can be##3##3##(1992-8#1)(1993-12#1)(1996-1#1)
physicians can##5##2##(1991-3#1)(1992-8#1)(1993-12#1)(1996-1#1)(2008-6#1)
physicians did not##2##3##(1990-2#1)(1993-6#1)
physicians for##6##2##(1994-1#2)(1994-3#1)(2006-5#1)(2008-11#1)(2008-3#1)
physicians from##3##2##(1991-6#1)(1996-3#1)(2009-3#1)
physicians had##2##2##(1990-2#1)(1996-1#1)
physicians has##2##2##(1990-6#1)(2008-10#1)
physicians have##2##2##(1991-1#1)(2009-3#1)
physicians in Norway##2##3##(1990-6#1)(1993-6#1)
physicians in the##7##3##(1991-8#2)(1993-6#1)(1996-2#1)(1997-3#1)(2008-1#1)(2010-7#1)
physicians in##33##2##(1990-6#1)(1991-2#1)(1991-8#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-3#6)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#1)(2009-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
physicians know about##2##3##(1990-2#1)(1994-2#1)
physicians may be##2##3##(1996-3#1)(2008-11#1)
physicians may##3##2##(1996-3#1)(1997-1#1)(2008-11#1)
physicians must##3##2##(1994-2#1)(2008-8#2)
physicians or##3##2##(1991-3#1)(1994-12#1)(2009-5#1)
physicians per##2##2##(1993-1#1)(1996-3#1)
physicians should be##2##3##(1990-6#1)(2008-10#1)
physicians should##4##2##(1990-6#1)(2008-10#1)(2010-1#1)(2011-2#1)
physicians specializing in##2##3##(1996-1#1)(2008-12#1)
physicians to##13##2##(1991-3#1)(1993-12#1)(1994-1#2)(1995-1#1)(1996-1#2)(1997-3#1)(2008-8#1)(2010-12#1)(2012-2#2)(2013-8#1)
physicians towards##2##2##(2008-1#1)(2013-1#1)
physicians under Medicare##2##3##(1991-2#1)(1992-2#1)
physicians was##3##2##(1997-3#1)(2008-11#2)
physicians were##9##2##(1993-12#1)(1996-11#1)(1997-4#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-10#1)(2011-2#2)
physicians who did not smoke##2##5##(2011-2#2)
physicians who provide##2##3##(1991-2#1)(1993-12#1)
physicians who were##2##3##(2011-2#2)
physicians who##10##2##(1991-2#1)(1993-12#1)(1994-12#1)(1996-9#1)(2008-11#1)(2011-2#5)
physicians will not##2##3##(1994-2#1)(2010-4#1)
physicians will##4##2##(1992-1#1)(1994-2#1)(1997-1#1)(2010-4#1)
physicians with##5##2##(1991-3#1)(1994-1#1)(1994-12#1)(1997-3#1)(2011-2#1)
physicians##362##1##(1990-2#7)(1990-6#3)(1990-8#1)(1991-1#3)(1991-12#2)(1991-2#15)(1991-3#9)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#6)(1992-11#1)(1992-12#5)(1992-2#6)(1992-3#2)(1992-5#2)(1992-8#2)(1993-1#5)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#11)(1993-5#2)(1993-6#7)(1994-1#12)(1994-12#9)(1994-2#5)(1994-3#9)(1994-6#2)(1995-1#8)(1995-11#1)(1995-12#5)(1995-2#7)(1995-6#3)(1995-9#1)(1996-1#14)(1996-11#4)(1996-12#1)(1996-2#3)(1996-3#9)(1996-9#1)(1997-1#10)(1997-2#3)(1997-3#11)(1997-4#2)(1997-5#1)(1997-8#4)(2006-5#1)(2008-1#7)(2008-10#5)(2008-11#23)(2008-12#6)(2008-3#4)(2008-4#2)(2008-6#6)(2008-7#3)(2008-8#5)(2008-9#3)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#16)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#6)
physicians' office records and Medicare Part B claims##2##8##(1996-2#2)
physicians' perceptions##4##2##(2011-1#4)
physicians' services##6##2##(1991-2#5)(2009-3#1)
physicians' unawareness of patients'##2##4##(2011-1#2)
physicians' work##2##2##(1995-2#2)
physicians'##33##1##(1990-6#1)(1991-12#1)(1991-2#6)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(1996-1#1)(1996-2#2)(1996-3#1)(1997-4#1)(2008-10#2)(2008-11#2)(2009-3#1)(2011-1#6)(2011-2#1)
physicians?]##2##1##(1990-6#2)
physicians]##4##1##(1990-6#1)(1995-5#1)(1996-6#1)(2008-11#1)
physicists and##2##2##(2008-10#2)
physicists##5##1##(1990-11#1)(2008-10#2)(2009-11#1)(2009-5#1)
physico-chemical and structural##2##3##(2008-10#2)
physico-chemical parameters##6##2##(2008-10#4)(2008-11#1)(2008-12#1)
physico-chemical properties of##2##3##(2008-10#1)(2008-5#1)
physico-chemical properties##10##2##(1994-8#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-5#5)
physico-chemical##27##1##(1994-8#1)(1997-1#1)(1997-7#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#5)
physicochemical characteristics##3##2##(2008-10#2)(2008-5#1)
physicochemical characterization of##2##3##(2008-10#2)
physicochemical parameters and##2##3##(2008-10#2)
physicochemical parameters##6##2##(2008-10#6)
physicochemical properties and##2##3##(2008-10#1)(2011-2#1)
physicochemical properties of##7##3##(1993-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
physicochemical properties##16##2##(1993-1#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
physicochemical##41##1##(1993-1#1)(2008-10#24)(2008-11#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
physics and##4##2##(2010-9#3)(2012-2#1)
physics##7##1##(1991-5#1)(2008-9#1)(2009-12#1)(2010-9#3)(2012-2#1)
physio-chemical parameters##3##2##(2008-10#3)
physio-chemical##4##1##(2008-10#4)
physiogenomic##2##1##(2012-3#2)
physiologic and pathologic##3##3##(1993-12#1)(2008-9#1)(2010-6#1)
physiologic and##5##2##(1992-9#1)(1993-12#1)(1995-2#1)(2008-9#1)(2010-6#1)
physiologic parameters##2##2##(1991-1#1)(1994-3#1)
physiologic role##5##2##(1993-8#1)(1994-12#1)(1995-2#1)(2008-4#1)(2013-7#1)
physiologic saline##2##2##(1993-1#1)(2012-3#1)
physiologic systems##3##2##(1997-1#1)(2010-7#2)
physiologic##43##1##(1991-1#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-6#2)(2010-7#4)(2011-2#5)(2012-3#1)(2013-7#2)(2013-8#2)
physiological activity##2##2##(2008-10#1)(2009-8#1)
physiological adaptation##2##2##(2008-11#1)(2010-12#1)
physiological adaptations##2##2##(2013-8#2)
physiological agonists##2##2##(1992-12#1)(2006-6#1)
physiological alterations##2##2##(2009-11#1)(2012-3#1)
physiological and behavioral##3##3##(2008-4#1)(2008-7#1)(2009-8#1)
physiological and biochemical##3##3##(1991-2#1)(2012-2#1)(2013-8#1)
physiological and pathological##3##3##(1990-9#1)(2012-2#1)(2013-8#1)
physiological and pathophysiological##2##3##(2009-12#1)(2011-1#1)
physiological and##21##2##(1990-9#1)(1991-2#1)(1992-2#1)(1992-6#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#2)
physiological and/or##2##2##(2008-5#1)(2009-9#1)
physiological changes in##2##3##(2008-12#1)(2008-9#1)
physiological changes##7##2##(1990-11#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-9#2)
physiological characteristics##2##2##(1991-2#1)(2008-5#1)
physiological concentrations##4##2##(2008-10#2)(2010-8#1)(2013-8#1)
physiological conditions##19##2##(1990-9#1)(1997-3#1)(2008-10#8)(2008-5#1)(2008-7#5)(2011-2#1)(2012-2#1)(2013-1#1)
physiological constraints##8##2##(2008-7#5)(2008-8#1)(2009-8#1)(2010-8#1)
physiological data##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
physiological deterioration##2##2##(2008-7#1)(2008-9#1)
physiological differences##2##2##(1996-12#1)(2008-10#1)
physiological effects##4##2##(1992-3#1)(1996-2#1)(2008-10#1)(2008-5#1)
physiological events##4##2##(2008-4#2)(2008-7#1)(2009-8#1)
physiological factors##2##2##(2008-11#1)(2008-5#1)
physiological function of##5##3##(2008-6#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)
physiological function##7##2##(1995-6#1)(2007-8#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)
physiological functions in##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
physiological functions##12##2##(1993-6#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
physiological gonadal secretions##2##3##(2008-11#2)
physiological growth##2##2##(2008-5#1)(2008-9#1)
physiological impact##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
physiological leaf spot formation in##2##5##(2008-10#2)
physiological leaf spot##3##3##(2008-10#3)
physiological leaf##4##2##(2008-10#4)
physiological levels of##2##3##(2008-10#1)(2010-1#1)
physiological levels##5##2##(2008-10#2)(2009-8#1)(2010-1#1)(2013-1#1)
physiological maturity##3##2##(2008-10#2)(2008-12#1)
physiological measures##2##2##(2008-10#1)(2008-5#1)
physiological mechanisms##6##2##(1990-11#1)(1990-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
physiological parameters of##2##3##(2008-12#2)
physiological parameters##6##2##(2008-10#1)(2008-12#2)(2008-8#1)(2009-5#1)(2012-2#1)
physiological processes such as##4##4##(2008-10#1)(2008-8#1)(2009-12#1)(2009-6#1)
physiological processes##17##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#3)
physiological properties of##5##3##(2008-5#1)(2008-7#2)(2008-8#1)(2013-8#1)
physiological properties##6##2##(2008-5#1)(2008-7#3)(2008-8#1)(2013-8#1)
physiological races of D##2##4##(2008-10#2)
physiological races##4##2##(2008-10#4)
physiological redox##2##2##(1994-5#1)(2008-11#1)
physiological regulation##2##2##(1995-11#1)(2008-9#1)
physiological response##4##2##(2011-2#2)(2013-1#2)
physiological responses of##3##3##(1997-8#1)(2008-10#1)(2008-9#1)
physiological responses##9##2##(1990-9#1)(1997-8#1)(2008-10#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-8#2)
physiological role in##4##3##(1994-8#1)(1997-4#1)(2008-6#1)(2009-8#1)
physiological role of##8##3##(1995-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-10#1)(2011-2#1)
physiological role##18##2##(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#2)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2009-8#2)(2010-10#1)(2011-2#1)
physiological roles of##2##3##(1992-12#1)(2009-8#1)
physiological roles##5##2##(1992-12#1)(1996-2#1)(1997-7#1)(2009-10#1)(2009-8#1)
physiological samples##3##2##(2008-10#3)
physiological stability and##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
physiological state of the cell##2##5##(1995-9#1)(2012-3#1)
physiological state##5##2##(1995-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
physiological status##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
physiological stress##2##2##(2008-10#1)(2008-8#1)
physiological studies##2##2##(2008-10#1)(2008-7#1)
physiological traits##4##2##(2008-10#3)(2008-8#1)
physiological##376##1##(1990-11#6)(1990-12#2)(1990-2#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#6)(1994-8#2)(1995-11#4)(1995-2#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-8#3)(2008-1#1)(2008-10#72)(2008-11#27)(2008-12#6)(2008-4#5)(2008-5#17)(2008-6#2)(2008-7#20)(2008-8#11)(2008-9#18)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#12)(2009-9#2)(2010-1#2)(2010-10#6)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#5)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#24)(2012-12#1)(2012-2#10)(2012-3#5)(2012-4#1)(2012-6#1)(2013-1#11)(2013-7#2)(2013-8#13)
physiological- and product-dependent parameters##2##4##(2008-5#2)
physiologically active compounds##2##3##(2008-10#2)
physiologically active##3##2##(2008-10#3)
physiologically and##2##2##(2009-7#1)(2012-2#1)
physiologically functional##2##2##(2008-11#1)(2009-7#1)
physiologically important##2##2##(2008-10#1)(2012-9#1)
physiologically or##2##2##(2008-4#1)(2010-1#1)
physiologically relevant##4##2##(2008-12#1)(2009-12#1)(2010-10#1)(2011-2#1)
physiologically##33##1##(1990-8#1)(1992-6#1)(1992-7#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
physiology and disease##2##3##(2008-10#1)(2011-2#1)
physiology and the##2##3##(2008-4#1)(2010-7#1)
physiology and##16##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#2)(2011-2#3)(2012-2#1)(2013-8#1)
physiology as##2##2##(2008-12#1)(2010-7#1)
physiology in##4##2##(2008-7#1)(2010-3#2)(2012-5#1)
physiology of the##9##3##(1990-5#1)(1996-2#1)(1997-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-9#1)(2011-2#2)
physiology of##21##2##(1990-5#1)(1992-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#2)
physiology through##2##2##(2011-2#2)
physiology##91##1##(1990-5#2)(1992-6#1)(1992-9#1)(1994-11#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-7#1)(2008-10#8)(2008-11#7)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#7)(2009-10#2)(2009-11#5)(2009-8#3)(2009-9#2)(2010-1#1)(2010-3#4)(2010-7#4)(2010-9#1)(2011-1#1)(2011-2#13)(2012-2#3)(2012-5#2)(2013-8#4)
physiology)##3##1##(2008-9#1)(2010-3#1)(2010-8#1)
physiopathological##5##1##(1990-9#1)(1992-5#1)(1993-6#1)(1997-5#1)(2008-10#1)
physiopathology of##2##2##(1992-3#1)(2013-1#1)
physiopathology##7##1##(1992-3#2)(1992-5#2)(2008-1#1)(2008-7#1)(2013-1#1)
physiotherapist##6##1##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(2009-3#1)(2013-1#1)
physiotherapists can##2##2##(1992-12#1)(2011-2#1)
physiotherapists in##3##2##(1993-1#1)(1994-3#2)
physiotherapists were##2##2##(1993-2#1)(1996-6#1)
physiotherapists##20##1##(1991-2#1)(1992-12#2)(1993-1#4)(1993-2#4)(1994-3#3)(1996-6#1)(2009-7#1)(2011-2#3)(2012-3#1)
physiotherapists'##3##1##(1991-6#1)(1993-3#2)
physiotherapy assessment##2##2##(1992-12#1)(2011-2#1)
physiotherapy care##2##2##(1992-2#1)(2011-2#1)
physiotherapy in prisons##2##3##(1992-2#2)
physiotherapy in##3##2##(1991-2#1)(1992-2#2)
physiotherapy utilization for##2##3##(2012-2#2)
physiotherapy utilization##3##2##(2012-2#3)
physiotherapy were##2##2##(1993-1#1)(2012-3#1)
physiotherapy##34##1##(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#3)(1993-1#2)(1993-2#2)(1993-3#1)(1994-9#1)(1995-2#2)(1995-3#1)(1997-3#3)(2008-12#2)(2011-2#3)(2012-2#7)(2012-3#3)
physodes##3##1##(2008-10#3)
physostigmine and pilocarpine##2##3##(2008-10#2)
physostigmine##3##1##(2008-10#3)
phytase##4##1##(1992-12#1)(1995-3#1)(2008-11#2)
phytoalexin accumulation##2##2##(2008-10#2)
phytoalexin response##3##2##(2008-10#3)
phytoalexin##12##1##(2008-10#12)
phytoalexins in##3##2##(2008-10#3)
phytoalexins##11##1##(2008-10#11)
phytochelatins##2##1##(2008-10#2)
phytochemical##3##1##(2008-10#1)(2010-6#1)(2011-2#1)
phytochemicals##7##1##(2008-10#2)(2008-7#2)(2008-8#1)(2010-1#2)
phytochrome##7##1##(1990-5#2)(1995-2#3)(2009-8#1)(2012-2#1)
phytoene desaturase##3##2##(1995-2#1)(2010-10#2)
phytoene synthase##5##2##(1995-2#2)(2009-10#2)(2010-10#1)
phytoene##11##1##(1995-2#6)(2009-10#2)(2010-10#3)
phytoestrogens in##2##2##(2008-10#2)
phytoestrogens to##2##2##(2008-10#2)
phytoestrogens##13##1##(2008-10#11)(2008-11#2)
phytohemagglutinin##3##1##(1992-6#1)(2008-7#1)(2011-2#1)
phytohormones##7##1##(2008-10#3)(2008-7#1)(2009-8#3)
phytomyxean species to##2##3##(2012-2#2)
phytomyxean species##4##2##(2012-2#4)
phytopathogenic bacteria##4##2##(2008-10#4)
phytopathogenic fungi##8##2##(1997-4#1)(2008-10#4)(2008-11#1)(2009-8#1)(2011-10#1)
phytopathogenic fungus##4##2##(1997-4#1)(2008-10#2)(2009-8#1)
phytopathogenic##28##1##(1997-4#2)(2008-10#21)(2008-11#1)(2009-6#1)(2009-8#2)(2011-10#1)
phytopathogens##3##1##(2008-10#2)(2009-6#1)
phytopathological literature##2##2##(2008-10#2)
phytopathological significance##2##2##(2008-10#2)
phytopathological##17##1##(2008-10#17)
phytophagous bugs##2##2##(2008-7#2)
phytophagous insects##3##2##(2008-9#3)
phytophagous##8##1##(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#4)
phytoplanktivorous bighead carp (Aristichthys nobilis)##2##5##(2010-5#2)
phytoplankton blooms##3##2##(2008-3#1)(2008-8#2)
phytoplankton class##2##2##(2008-10#2)
phytoplankton classes##2##2##(2008-10#2)
phytoplankton growth##2##2##(2013-8#2)
phytoplankton populations##2##2##(2008-8#2)
phytoplankton species##3##2##(2008-8#3)
phytoplankton were##2##2##(2008-10#1)(2009-8#1)
phytoplankton##33##1##(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#17)(2009-8#1)(2013-8#3)
phytoplasma and##2##2##(2008-10#2)
phytoplasma concentrations in##2##3##(2008-10#2)
phytoplasma concentrations##3##2##(2008-10#3)
phytoplasma could##2##2##(2008-10#2)
phytoplasma extracts##2##2##(2008-10#2)
phytoplasma from##2##2##(2008-10#2)
phytoplasma groups##2##2##(2008-10#2)
phytoplasma in the##3##3##(2008-10#3)
phytoplasma in##9##2##(2008-10#9)
phytoplasma isolates from##3##3##(2008-10#3)
phytoplasma isolates##5##2##(2008-10#5)
phytoplasma strains from##2##3##(2008-10#2)
phytoplasma strains in##2##3##(2008-10#2)
phytoplasma strains were##2##3##(2008-10#2)
phytoplasma strains##10##2##(2008-10#10)
phytoplasma taxa##2##2##(2008-10#2)
phytoplasma was##2##2##(2008-10#2)
phytoplasma were##2##2##(2008-10#2)
phytoplasma##89##1##(2008-10#89)
phytoplasma-infected##2##1##(2008-10#2)
phytoplasma-specific##3##1##(2008-10#3)
phytoplasmas and##2##2##(2008-10#2)
phytoplasmas belonging to##2##3##(2008-10#2)
phytoplasmas from##2##2##(2008-10#2)
phytoplasmas in the##3##3##(2008-10#3)
phytoplasmas in##6##2##(2008-10#6)
phytoplasmas involved in##2##3##(2008-10#2)
phytoplasmas present in##2##3##(2008-10#2)
phytoplasmas were detected in##2##4##(2008-10#2)
phytoplasmas were##4##2##(2008-10#4)
phytoplasmas with##2##2##(2008-10#2)
phytoplasmas##52##1##(2008-10#52)
phytoremediation##5##1##(2008-10#1)(2008-11#4)
phytoreovirus##2##1##(2008-10#2)
phytosanitary##3##1##(2008-10#3)
phytotherapy##2##1##(1992-5#1)(2008-10#1)
phytotoxic activity##2##2##(2008-10#1)(2008-11#1)
phytotoxic effects##2##2##(2008-10#1)(2008-11#1)
phytotoxic protein##2##2##(2008-10#2)
phytotoxic to sugarcane##2##3##(2008-10#2)
phytotoxic to##5##2##(2008-10#5)
phytotoxic##15##1##(2008-10#12)(2008-11#2)(2008-12#1)
phytotoxicity##4##1##(2008-10#1)(2008-12#1)(2011-1#2)
phytotoxin produced by##2##3##(2008-10#2)
phytotoxin##4##1##(2008-10#3)(2008-7#1)
phytotoxins in##3##2##(2008-10#3)
phytotoxins##6##1##(2008-10#5)(2008-11#1)
phéochromocytome##3##1##(2011-2#3)
pi##11##1##(1990-2#2)(1992-11#1)(1992-8#2)(1996-2#1)(2008-3#3)(2008-8#1)(2011-2#1)
pi-Electron##2##1##(1996-5#1)(2008-10#1)
pi-acceptors##2##1##(2008-10#2)
pi-bond##2##1##(1996-5#2)
pi-coordinating##4##1##(2008-10#4)
pi-pi interaction##2##2##(2008-10#2)
pi-pi##6##1##(2008-10#5)(2009-11#1)
pi-shifted Sagnac interferometer##2##3##(2007-11#2)
pi-ta allele##2##2##(2008-10#2)
piazselenol##2##1##(2008-10#2)
piceae##6##1##(2008-10#6)
picked##5##1##(1992-11#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#1)
picket fence##2##2##(2008-3#2)
picks##2##1##(1991-5#1)(1991-9#1)
pickup system##2##2##(2008-3#2)
pickup##3##1##(2008-3#3)
picomolar concentrations##2##2##(2008-10#2)
picomolar##3##1##(2008-10#3)
picornaviruses##2##1##(2008-8#1)(2013-1#1)
picosecond pulses##2##2##(2007-11#1)(2008-3#1)
picosecond##8##1##(1990-8#1)(1993-5#1)(2007-11#2)(2008-2#2)(2008-3#2)
picrate 1##2##2##(2008-10#2)
picrate anion##3##2##(2008-10#3)
picrate concentration##3##2##(2008-10#3)
picrate ion##2##2##(2008-10#2)
picrate##19##1##(2008-10#19)
picrates of##2##2##(2008-10#2)
picrates with##6##2##(2008-10#6)
picrates##18##1##(2008-10#18)
picric acid in##2##3##(2008-10#2)
picric acid##8##2##(2008-10#8)
picrotoxin (PTX)##2##2##(2008-8#1)(2008-9#1)
picrotoxin##5##1##(1990-5#2)(1995-12#1)(2008-8#1)(2008-9#1)
pictorial essay##10##2##(1997-8#2)(2012-2#8)
pictorial review is##3##3##(2012-2#3)
pictorial review##10##2##(2011-2#1)(2012-2#9)
pictorial##27##1##(1997-8#2)(2008-10#4)(2009-9#1)(2011-2#2)(2012-2#17)(2012-3#1)
picture and##3##2##(1995-6#1)(2008-3#1)(2011-2#1)
picture is##2##2##(1990-6#1)(1994-6#1)
picture naming##2##2##(1994-3#2)
picture of how these##2##4##(1995-9#1)(2008-8#1)
picture of the##10##3##(1994-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-5#1)
picture of##25##2##(1990-3#1)(1991-11#1)(1991-8#1)(1992-5#1)(1994-5#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-3#1)(2012-5#1)
picture##73##1##(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-6#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#1)
pictures and##3##2##(2009-8#1)(2011-2#1)(2012-12#1)
pictures##10##1##(2007-8#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#3)(2013-8#2)
piece in##2##2##(2008-5#1)(2008-7#1)
piece of information##2##3##(1993-6#1)(2011-2#1)
piece of the##3##3##(1992-3#1)(2008-10#1)(2009-3#1)
piece of tubing##3##3##(1997-3#3)
piece of##15##2##(1992-3#1)(1993-6#1)(1997-3#5)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
piece##25##1##(1992-3#1)(1993-6#1)(1997-3#5)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
pieces and##2##2##(2008-10#2)
pieces of the##3##3##(1997-2#1)(2008-6#1)(2013-1#1)
pieces of##17##2##(1992-8#1)(1994-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
pieces placed##2##2##(2008-10#2)
pieces were##2##2##(2008-10#1)(2008-11#1)
pieces##37##1##(1992-8#1)(1994-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
piecewise direct standardization (PDS)##3##4##(2008-10#3)
piecewise##7##1##(1995-12#1)(2008-10#3)(2008-6#2)(2013-1#1)
piercing##2##1##(2008-11#1)(2011-2#1)
piety##3##1##(2008-11#1)(2008-12#2)
piezoelectric chemical sensor array##2##4##(2008-10#2)
piezoelectric crystal##4##2##(2008-10#4)
piezoelectric crystals##2##2##(2008-10#2)
piezoelectric immunosensor##3##2##(2008-10#3)
piezoelectric quartz crystal (PQC)##5##4##(2008-10#5)
piezoelectric quartz crystal impedance (PQCI)##2##5##(2008-10#2)
piezoelectric quartz crystal impedance##3##4##(2008-10#3)
piezoelectric quartz crystal##18##3##(2008-10#18)
piezoelectric quartz##21##2##(1990-8#1)(2008-10#20)
piezoelectric response model##2##3##(2008-10#2)
piezoelectric sensor##2##2##(2008-10#2)
piezoelectric##68##1##(1990-8#5)(1992-3#1)(2007-12#1)(2008-10#51)(2008-2#1)(2008-3#3)(2009-5#5)(2012-12#1)
pig and##5##2##(1990-5#2)(1996-2#1)(2008-3#1)(2012-2#1)
pig breeds##3##2##(2008-8#3)
pig industry##2##2##(2011-2#2)
pig management in##2##3##(1996-12#2)
pig meat##3##2##(2008-10#1)(2013-1#2)
pig muscle##2##2##(1994-5#1)(2008-11#1)
pig slurry##2##2##(2008-10#2)
pig##78##1##(1990-5#2)(1990-9#3)(1991-5#1)(1992-12#1)(1992-3#3)(1992-6#4)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#3)(1995-2#1)(1995-3#1)(1995-8#5)(1996-12#2)(1996-2#2)(1997-3#3)(2006-6#2)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#6)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#6)(2012-2#2)(2013-1#5)(2013-8#2)
pigeon pea##2##2##(2008-10#2)
pigeon##7##1##(2007-12#1)(2008-10#2)(2008-5#2)(2008-8#2)
pigeonpea (Cajanus##2##2##(2008-10#1)(2010-10#1)
pigeonpea and##3##2##(2008-10#1)(2010-10#2)
pigeonpea plants##5##2##(2008-10#5)
pigeonpea##18##1##(2008-10#9)(2010-10#9)
pigeons free of##2##3##(2008-5#2)
pigeons##14##1##(1990-11#5)(2008-5#7)(2008-8#2)
piglets (n = 12)##2##4##(1994-2#2)
piglets (n =##3##3##(1990-5#1)(1994-2#2)
piglets and##2##2##(2011-2#2)
piglets from##5##2##(1990-5#2)(1996-8#1)(2013-1#2)
piglets##25##1##(1990-5#4)(1994-2#5)(1996-12#4)(1996-3#1)(1996-8#2)(2008-8#1)(2011-2#3)(2013-1#5)
pigment concentrations##2##2##(2008-10#1)(2008-3#1)
pigment dispersion##3##2##(2008-8#3)
pigment elaboration##2##2##(2008-8#2)
pigment epithelium##5##2##(2008-7#1)(2011-7#3)(2012-3#1)
pigment epithelium-derived factor##2##3##(2008-7#1)(2012-5#1)
pigment in##3##2##(2008-11#1)(2008-5#1)(2010-6#1)
pigment layers were found##2##4##(2008-10#2)
pigment metals##2##2##(2008-10#2)
pigment production##3##2##(2008-10#3)
pigment substitution##5##2##(2008-8#5)
pigment##67##1##(1993-3#7)(1997-4#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#15)(2010-10#2)(2010-6#2)(2011-2#1)(2011-7#3)(2012-3#3)(2012-5#1)(2013-1#1)
pigmentary##4##1##(1994-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
pigmentation in##2##2##(1995-2#1)(1997-3#1)
pigmentation##30##1##(1991-6#2)(1995-2#2)(1997-3#1)(2008-10#6)(2008-5#6)(2008-6#3)(2008-8#3)(2008-9#5)(2011-2#1)(2013-1#1)
pigmented Bowen's disease##2##3##(2010-6#2)
pigmented and##3##2##(2008-10#2)(2008-8#1)
pigmented cells##2##2##(1992-8#1)(2008-8#1)
pigmented epidermis##2##2##(2008-5#2)
pigmented medaka##4##2##(2008-11#4)
pigmented skin lesions##2##3##(2011-2#2)
pigmented##27##1##(1992-8#1)(2008-10#7)(2008-11#6)(2008-5#3)(2008-8#2)(2010-12#1)(2010-6#3)(2011-2#4)
pigmenti and##2##2##(2012-3#2)
pigmenti##3##1##(2012-3#3)
pigments and water##2##3##(2008-10#1)(2008-12#1)
pigments and##6##2##(2008-10#5)(2008-12#1)
pigments from##2##2##(2008-10#2)
pigments in a liquid matrix##2##5##(2008-3#2)
pigments in a##3##3##(2008-3#3)
pigments in##5##2##(2008-10#2)(2008-3#3)
pigments were##6##2##(2008-10#3)(2008-12#1)(2008-5#2)
pigments##41##1##(2008-10#25)(2008-12#2)(2008-3#5)(2008-5#3)(2008-8#2)(2009-10#2)(2010-4#1)(2011-1#1)
pigs and##3##2##(1997-4#1)(1997-8#1)(2009-6#1)
pigs by##2##2##(1992-2#1)(1995-12#1)
pigs in##5##2##(2011-2#3)(2013-1#1)(2013-8#1)
pigs to study the##2##4##(2008-11#1)(2010-4#1)
pigs were##4##2##(2008-9#1)(2011-2#1)(2013-1#2)
pigs with##2##2##(2011-2#1)(2013-8#1)
pigs##53##1##(1990-9#1)(1991-12#1)(1992-2#1)(1995-11#1)(1995-12#5)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-9#3)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#12)(2012-2#1)(2013-1#4)(2013-8#7)
pigus virgo##2##2##(2008-10#2)
pika##3##1##(2008-9#3)
pilE transcription##2##2##(1993-12#2)
pilE##8##1##(1993-12#8)
pile driving and other##3##4##(2010-8#3)
pile##6##1##(1992-11#1)(2008-10#1)(2010-8#3)(2012-12#1)
pilin##2##1##(1993-12#2)
pill##12##1##(1991-3#1)(1995-11#1)(1997-6#3)(2008-10#1)(2010-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
pillar cells##2##2##(2008-7#2)
pills##5##1##(1996-8#1)(2008-10#3)(2013-1#1)
pilocarpine##4##1##(1991-7#1)(2008-10#3)
pilocytic astrocytoma##4##2##(2013-1#4)
pilomatrix carcinoma##2##2##(1994-8#2)
pilosa##6##1##(2008-10#1)(2008-12#5)
pilot data##2##2##(2013-1#2)
pilot phase of##2##3##(2008-12#1)(2010-9#1)
pilot phase##3##2##(1990-12#1)(2008-12#1)(2010-9#1)
pilot plant##3##2##(1995-3#1)(2008-10#2)
pilot project##10##2##(1993-3#1)(1994-1#1)(1996-1#1)(2008-11#3)(2008-12#1)(2008-9#1)(2010-11#1)(2012-3#1)
pilot projects##2##2##(1996-3#2)
pilot sample##2##2##(2008-10#2)
pilot scale##10##2##(1992-5#1)(2008-11#7)(2008-7#1)(2010-4#1)
pilot sites were##2##3##(2008-11#2)
pilot sites##3##2##(2008-11#3)
pilot studies##2##2##(2008-5#1)(2009-10#1)
pilot study of##12##3##(1990-2#1)(1990-6#1)(1991-1#1)(1993-3#1)(2008-11#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-7#1)(2010-9#1)(2013-1#2)
pilot study on##2##3##(1990-8#1)(2013-8#1)
pilot study was conducted in##2##5##(1992-2#1)(2012-3#1)
pilot study was##11##3##(1991-12#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#4)(2010-10#1)(2011-2#1)(2012-3#1)
pilot study##77##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-8#1)(2008-10#5)(2008-11#4)(2008-12#11)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#2)(2010-9#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
pilot test##3##2##(1996-2#1)(2010-4#2)
pilot tested##2##2##(2010-10#1)(2013-1#1)
pilot trial##3##2##(1992-12#1)(2008-3#1)(2010-10#1)
pilot##156##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-3#8)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-2#1)(2008-10#11)(2008-11#25)(2008-12#13)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#6)(2010-7#3)(2010-9#2)(2011-2#9)(2011-3#1)(2011-9#1)(2012-2#3)(2012-3#2)(2013-1#11)(2013-8#1)
pilot&quot##2##1##(1994-3#2)
piloted##3##1##(2008-11#1)(2012-2#2)
piloting##2##1##(2008-11#1)(2013-1#1)
pim1##3##1##(1995-2#3)
pin track##2##2##(2010-12#2)
pin tracts##2##2##(2009-4#2)
pin##10##1##(2008-10#2)(2009-3#1)(2009-4#3)(2010-12#2)(2012-2#1)(2012-3#1)
pinaverium bromure and##2##3##(2013-1#2)
pindolol and##2##2##(2008-10#2)
pindolol##13##1##(1992-11#1)(1995-11#1)(2008-10#11)
pine (P##8##2##(2008-10#8)
pine (Pinus##10##2##(2008-10#10)
pine and##2##2##(2008-10#2)
pine bark##3##2##(2008-10#3)
pine blister rust in##3##4##(2008-10#3)
pine blister rust##18##3##(2008-10#18)
pine blister##19##2##(2008-10#19)
pine in##3##2##(2008-10#3)
pine needles##2##2##(2008-10#1)(2008-12#1)
pine plantations##3##2##(2008-10#3)
pine species##4##2##(2008-10#3)(2008-8#1)
pine stem rusts##2##3##(2008-10#2)
pine stem##3##2##(2008-10#3)
pine were##2##2##(2008-10#2)
pine##92##1##(2008-10#86)(2008-12#1)(2008-8#3)(2011-10#2)
pineal cysts##4##2##(2012-2#4)
pineal gland and the##2##4##(2008-10#1)(2013-7#1)
pineal gland and##3##3##(2008-10#2)(2013-7#1)
pineal gland hormone##2##3##(2008-12#2)
pineal gland##14##2##(1994-2#2)(1995-11#1)(1995-12#2)(2008-10#2)(2008-12#3)(2008-5#1)(2008-9#1)(2013-7#2)
pineal hormone melatonin (MLT)##3##4##(1992-12#1)(1995-9#1)(2013-7#1)
pineal hormone melatonin##8##3##(1990-2#2)(1990-5#1)(1991-6#1)(1992-12#2)(1995-9#1)(2013-7#1)
pineal hormone##10##2##(1990-2#3)(1990-5#1)(1991-6#1)(1992-12#2)(1995-9#1)(2008-5#1)(2013-7#1)
pineal##43##1##(1990-2#3)(1990-5#1)(1991-6#1)(1992-12#2)(1994-2#3)(1995-11#1)(1995-12#8)(1995-9#1)(2008-10#2)(2008-12#4)(2008-5#2)(2008-7#5)(2008-9#1)(2012-2#4)(2013-7#5)
pineapple mealybug##3##2##(2008-10#3)
pineapple plants##2##2##(2008-10#2)
pineapple##13##1##(2008-10#13)
pines and##3##2##(2008-10#2)(2008-12#1)
pines in##2##2##(2008-10#2)
pines##13##1##(2008-10#11)(2008-12#1)(2008-8#1)
pinhole##8##1##(2008-10#1)(2008-12#1)(2008-3#5)(2012-2#1)
pinholes and##2##2##(2008-3#1)(2012-2#1)
pinholes##11##1##(2008-2#2)(2008-3#4)(2012-2#5)
pini and##2##2##(2008-10#2)
pini##5##1##(2008-10#5)
pink coloured##2##2##(2008-10#2)
pink##20##1##(1993-8#1)(2008-10#16)(2008-5#1)(2010-10#1)(2010-12#1)
pinning##3##1##(2008-8#2)(2012-5#1)
pinocytotic##2##1##(2007-12#2)
pinodes##2##1##(2008-10#2)
pinpointed##2##1##(1997-2#1)(2008-10#1)
pinpointing##2##1##(2009-12#1)(2013-1#1)
pinpoints##2##1##(2008-5#1)(2012-3#1)
pinwheel centers##2##2##(2008-11#2)
pioneer of##3##2##(1997-6#1)(2008-10#1)(2009-1#1)
pioneer##9##1##(1991-5#1)(1991-6#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-1#1)(2010-11#1)(2013-1#1)
pioneered##3##1##(1996-3#1)(2011-7#1)(2013-1#1)
pioneering##7##1##(1992-12#1)(1994-2#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2010-8#1)
pioneers of##2##2##(2010-5#1)(2012-2#1)
pioneers##5##1##(1993-6#1)(1994-2#1)(2007-12#1)(2010-5#1)(2012-2#1)
pipe##6##1##(2008-10#6)
pipeline and##2##2##(2008-10#1)(2013-1#1)
pipeline##7##1##(2008-10#1)(2008-11#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
piperazine##2##1##(1995-11#1)(2008-10#1)
piperazine-1##2##1##(2008-10#2)
piperidine treatment##2##2##(1993-8#2)
piperidine##9##1##(1990-5#1)(1993-8#2)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#2)
piperita L##5##2##(2008-10#3)(2013-1#2)
pipes##3##1##(2008-10#3)
pipette##4##1##(2008-10#1)(2008-8#1)(2013-1#2)
pipetting##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
piracy##2##1##(2012-2#2)
piriform cortex##5##2##(1990-5#2)(2013-1#3)
piriform##6##1##(1990-5#2)(1996-12#1)(2013-1#3)
pirina on##2##2##(2008-10#2)
pirina##9##1##(2008-10#9)
piroctone olamine and salicylic acid##2##5##(2008-5#2)
piroctone olamine and##3##3##(2008-5#3)
piroctone olamine##5##2##(2008-5#5)
piroxicam##9##1##(1990-9#4)(2008-10#5)
pisi and##2##2##(2008-10#2)
pisi##22##1##(1995-3#1)(2008-10#19)(2008-7#2)
pistachio and##5##2##(2008-10#5)
pistachio in##4##2##(2008-10#4)
pistachio isolates##4##2##(2008-10#4)
pistachio orchards##6##2##(2008-10#6)
pistachio##40##1##(2008-10#40)
piston pump##2##2##(2008-10#2)
piston##3##1##(2008-10#3)
pisum##6##1##(1996-12#1)(2007-12#1)(2008-10#4)
pit cell##3##2##(1995-2#1)(1995-6#2)
pit cells##2##2##(1995-6#2)
pit on the##2##3##(2009-3#1)(2011-2#1)
pit##13##1##(1995-2#2)(1995-6#4)(2008-10#4)(2008-11#1)(2009-3#1)(2011-2#1)
pit-and-fissure sealants##2##2##(2013-1#2)
pit-and-fissure##3##1##(2013-1#3)
pit-lining##2##1##(1997-1#2)
pitch canker##3##2##(2008-10#3)
pitch##10##1##(1992-9#2)(2007-12#1)(2008-10#3)(2008-9#3)(2013-8#1)
pitfall in##2##2##(2011-2#1)(2012-12#1)
pitfall of##2##2##(1994-9#1)(2008-10#1)
pitfall##6##1##(1994-9#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
pitfalls and##4##2##(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
pitfalls in##6##2##(1993-1#1)(1995-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
pitfalls of##4##2##(1994-6#1)(2008-11#2)(2012-2#1)
pitfalls##28##1##(1992-3#1)(1993-1#2)(1993-6#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#4)(2010-8#1)(2011-2#3)(2012-2#5)(2013-8#1)
pits and##2##2##(1997-3#1)(2007-12#1)
pits##10##1##(1995-6#2)(1997-1#1)(1997-3#4)(2007-12#2)(2008-7#1)
pitted##2##1##(2008-10#1)(2008-11#1)
pitting##9##1##(1994-9#1)(2008-10#6)(2009-10#1)(2011-2#1)
pituitary PRL##2##2##(1994-3#1)(2011-2#1)
pituitary abnormalities##2##2##(1997-3#1)(2008-6#1)
pituitary adenomas##11##2##(1990-12#3)(1996-11#1)(2008-7#1)(2011-2#4)(2013-1#2)
pituitary cell line##2##3##(1996-2#2)
pituitary cells##16##2##(1990-12#3)(1990-5#2)(1991-6#1)(1992-6#3)(1992-8#1)(1993-8#1)(1996-2#5)
pituitary gland##14##2##(1992-6#2)(1993-9#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)
pituitary glands##2##2##(2008-11#1)(2011-2#1)
pituitary hormone deficiencies##2##3##(2013-1#2)
pituitary hormone##5##2##(1992-8#1)(1993-11#1)(2011-1#1)(2013-1#2)
pituitary macroadenoma##3##2##(1991-6#1)(2011-2#2)
pituitary stalk##4##2##(1997-3#1)(2013-8#3)
pituitary tumors##2##2##(2011-2#1)(2013-1#1)
pituitary##108##1##(1990-11#3)(1990-12#7)(1990-5#4)(1991-6#3)(1992-10#2)(1992-6#6)(1992-8#2)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#2)(1996-11#5)(1996-2#9)(1997-2#1)(1997-3#2)(1997-8#4)(2008-11#1)(2008-4#4)(2008-6#2)(2008-7#2)(2009-1#1)(2010-5#2)(2011-1#3)(2011-2#14)(2012-3#2)(2013-1#12)(2013-8#3)
pityocampa larvae##3##2##(2008-12#3)
pityocampa##5##1##(2008-12#5)
pityriasis versicolor and dermatitis seborrhoeica##2##5##(2008-5#2)
pityriasis versicolor##6##2##(2008-5#6)
pivot##2##1##(1992-3#1)(2008-11#1)
pivotal in##3##2##(2008-11#1)(2008-12#1)(2010-10#1)
pivotal role in##17##3##(1994-12#1)(1994-2#1)(1995-2#1)(1997-7#1)(1997-8#2)(2008-11#2)(2008-4#1)(2008-6#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#2)
pivotal role##26##2##(1992-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
pivotal roles of##2##3##(2009-10#1)(2009-6#1)
pivotal roles##4##2##(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
pivotal##49##1##(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-3#1)(1997-7#2)(1997-8#3)(2008-1#2)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#3)
pixel columns##2##2##(2008-3#2)
pixel##16##1##(1991-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#9)(2011-2#1)
pixelated lens##2##2##(2008-3#2)
pixelated##3##1##(2008-3#3)
pixels##6##1##(2008-10#1)(2008-3#4)(2013-8#1)
pixels)##2##1##(2008-10#2)
pk(a(1))=2##2##1##(2008-10#2)
pk(a(1))=7##3##1##(2008-10#3)
pk(a(2))=6##2##1##(2008-10#2)
pl##2##1##(2008-8#2)
place a##2##2##(2008-10#1)(2008-11#1)
place an##2##2##(2007-11#1)(2008-8#1)
place and head direction##2##4##(2013-8#2)
place and##6##2##(1996-11#1)(2008-11#2)(2012-12#1)(2013-8#2)
place as##4##2##(1991-9#1)(2008-10#1)(2008-9#1)(2010-11#1)
place at the##4##3##(1991-2#1)(2008-10#2)(2008-11#1)
place at##10##2##(1991-2#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-6#1)
place before##2##2##(1997-5#1)(2011-2#1)
place between##4##2##(1997-3#1)(2008-8#1)(2009-3#1)(2010-3#1)
place cell##2##2##(2008-11#2)
place during the enzymatic reaction##2##5##(2008-10#2)
place during the##3##3##(1991-12#1)(2008-10#2)
place during##5##2##(1991-12#1)(2008-10#3)(2008-12#1)
place for##12##2##(1991-12#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
place from##5##2##(1991-9#1)(2008-10#2)(2009-6#1)(2012-3#1)
place in a##6##3##(1995-3#1)(2008-10#3)(2012-2#1)(2013-8#1)
place in an##2##3##(2008-11#1)(2010-7#1)
place in the##23##3##(1991-12#1)(1991-2#1)(1992-1#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2012-3#1)(2013-1#1)
place in this area##2##4##(2008-2#2)
place in##57##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-3#2)(1994-3#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
place learning deficits##2##3##(1993-3#2)
place learning##3##2##(1993-3#3)
place of birth##2##3##(1990-6#1)(2013-1#1)
place of diagnosis##3##3##(2012-12#3)
place of the##7##3##(1995-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
place of##43##2##(1990-6#2)(1991-3#1)(1992-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(2007-8#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-9#3)(2009-12#1)(2009-6#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
place on the##4##3##(2008-10#1)(2008-8#1)(2010-8#1)(2013-1#1)
place on##5##2##(1995-2#1)(2008-10#1)(2008-8#1)(2010-8#1)(2013-1#1)
place or##2##2##(2008-12#1)(2008-9#1)
place the##6##2##(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)
place through##2##2##(1990-11#1)(2008-10#1)
place to##9##2##(1991-3#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-9#1)(2011-1#1)
place under##4##2##(2008-10#2)(2011-2#2)
place when##3##2##(2008-10#2)(2008-7#1)
place within##3##2##(1991-2#1)(2008-12#1)(2012-2#1)
place##312##1##(1990-11#2)(1990-6#3)(1990-8#1)(1991-1#2)(1991-12#8)(1991-2#3)(1991-3#4)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#55)(2008-11#38)(2008-12#11)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#12)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#4)(2009-7#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#16)(2011-3#1)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#11)(2013-8#7)
placebo effect##4##2##(2008-10#1)(2008-12#3)
placebo in short##2##3##(2011-2#1)(2013-1#1)
placebo in##5##2##(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#2)
placebo or##4##2##(2010-1#1)(2013-1#2)(2013-8#1)
placebo treatment##4##2##(2013-1#4)
placebo##64##1##(1991-3#2)(1995-2#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#9)(2008-7#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#8)(2012-2#4)(2013-1#12)(2013-8#4)
placebo)##3##1##(2008-8#1)(2013-1#2)
placebo-controlled clinical##2##2##(2008-5#1)(2011-2#1)
placebo-controlled study##3##2##(2008-5#1)(2009-8#1)(2011-2#1)
placebo-controlled trial##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
placebo-controlled trials##3##2##(2008-9#2)(2010-2#1)
placebo-controlled##21##1##(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
placed a##3##2##(2008-11#1)(2013-1#2)
placed all##2##2##(2008-10#1)(2009-10#1)
placed along##2##2##(2008-10#1)(2009-2#1)
placed at the detection point##2##5##(2008-10#2)
placed at the##4##3##(2008-10#3)(2010-8#1)
placed at##11##2##(1996-3#1)(1997-5#1)(2008-10#5)(2008-3#2)(2010-8#1)(2013-1#1)
placed between a##2##3##(2008-3#1)(2008-9#1)
placed between##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)
placed directly on##2##3##(2008-10#2)
placed either##2##2##(1994-1#1)(2008-9#1)
placed in a flow##2##4##(2008-10#2)
placed in a##21##3##(2008-10#15)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
placed in an##5##3##(2008-10#1)(2008-11#3)(2008-12#1)
placed in close##2##3##(2008-10#1)(2009-12#1)
placed in contact with##3##4##(2008-10#2)(2009-5#1)
placed in the chamber##2##4##(2008-1#1)(2008-10#1)
placed in the same##4##4##(2008-10#2)(2008-12#1)(2013-1#1)
placed in the##27##3##(2008-1#1)(2008-10#18)(2008-12#1)(2008-3#1)(2009-7#1)(2010-10#1)(2010-12#1)(2013-1#3)
placed in##89##2##(1991-3#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-11#1)(2008-1#1)(2008-10#57)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
placed inside a##3##3##(2008-10#2)(2008-3#1)
placed inside##7##2##(1997-6#1)(2008-10#4)(2008-3#1)(2009-3#1)
placed into##7##2##(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#1)
placed on a##3##3##(2008-10#2)(2008-7#1)
placed on radiology reports##2##4##(2012-2#2)
placed on the##17##3##(1993-2#1)(1993-3#1)(1996-3#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
placed on##53##2##(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-3#2)(2007-12#1)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#3)(2008-9#3)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
placed the##2##2##(1995-9#1)(1996-6#1)
placed to##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
placed under the##3##3##(1994-11#1)(1995-2#1)(2012-2#1)
placed under##5##2##(1994-11#1)(1995-2#1)(2008-10#2)(2012-2#1)
placed upstream##2##2##(1993-3#1)(2008-11#1)
placed within the##2##3##(2008-10#1)(2008-9#1)
placed##235##1##(1990-11#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#2)(1994-11#1)(1994-12#1)(1995-2#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-3#3)(1997-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#106)(2008-11#14)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#2)
placement and##7##2##(1993-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-7#2)
placement areas##2##2##(2008-11#1)(2013-8#1)
placement for##5##2##(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
placement in a##2##3##(1995-1#1)(2011-2#1)
placement in an Irish##2##4##(2008-11#1)(2008-12#1)
placement in the treatment of##2##5##(2009-1#1)(2010-7#1)
placement in the##6##3##(2008-10#1)(2008-11#1)(2009-1#1)(2010-7#2)(2012-12#1)
placement in##15##2##(1995-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#2)
placement of a##7##3##(1993-11#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
placement of an##2##3##(1990-2#1)(2008-10#1)
placement of the##5##3##(1994-5#1)(1996-5#1)(2009-10#1)(2010-7#1)(2011-2#1)
placement of##33##2##(1990-2#1)(1990-5#1)(1991-12#1)(1993-11#1)(1993-12#1)(1994-5#1)(1996-3#1)(1996-5#1)(2008-10#8)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)
placement on##2##2##(2008-10#1)(2013-1#1)
placement was##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2010-7#1)
placement while##2##2##(2008-12#1)(2008-8#1)
placement will be##2##3##(2008-5#1)(2009-10#1)
placement##134##1##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#13)(2008-11#30)(2008-12#22)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#3)(2009-5#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#9)(2011-2#5)(2012-12#6)(2012-3#4)(2013-1#7)(2013-8#1)
placements to##2##2##(2008-11#2)
placements##34##1##(1991-1#1)(2008-11#21)(2008-12#11)(2013-8#1)
placenta and fetal##2##3##(1990-5#1)(2008-9#1)
placenta and##7##2##(1990-5#1)(1992-10#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
placenta##42##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-7#1)(1992-10#1)(1993-3#1)(1993-8#1)(1994-11#2)(1995-12#6)(1995-8#1)(1997-1#2)(2008-10#6)(2008-11#1)(2008-8#4)(2008-9#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
placenta-derived multipotent cells##2##3##(2008-9#2)
placental AP##3##2##(2008-11#3)
placental P-450arom isoform##2##3##(1995-8#2)
placental P-450arom##3##2##(1995-8#3)
placental alkaline phosphatase##4##3##(2008-11#4)
placental insufficiency##2##2##(1996-11#2)
placental mammals##4##2##(1995-11#1)(2008-9#2)(2010-4#1)
placental##38##1##(1990-12#1)(1990-4#1)(1991-5#1)(1992-6#1)(1994-3#1)(1994-6#2)(1995-11#3)(1995-12#2)(1995-6#1)(1995-8#5)(1996-11#2)(2008-10#1)(2008-11#9)(2008-8#2)(2008-9#4)(2010-4#1)(2012-3#1)
places in##3##2##(2008-10#3)
places of##7##2##(1991-6#2)(1995-6#1)(2008-10#3)(2010-10#1)
places on##2##2##(2008-11#1)(2009-9#1)
places where##3##2##(2008-10#1)(2008-12#2)
places##34##1##(1991-6#3)(1992-12#1)(1992-4#1)(1994-3#1)(1995-6#1)(1996-1#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
placing the##6##2##(1992-12#1)(1995-5#1)(2008-10#2)(2008-3#1)(2011-1#1)
placing##31##1##(1992-12#4)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-5#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#2)(2011-1#1)(2013-1#2)
plagiarism##2##1##(2008-12#1)(2013-1#1)
plagued by##4##2##(1994-3#1)(1995-3#1)(2008-3#2)
plagued##5##1##(1994-3#1)(1995-3#1)(1995-5#1)(2008-3#2)
plagues##3##1##(1990-6#1)(1994-2#1)(2010-1#1)
plaguing##2##1##(1991-2#1)(2013-8#1)
plain bupivacaine plus##2##3##(2011-2#2)
plain bupivacaine##3##2##(2011-2#3)
plain radiography##3##2##(2010-6#1)(2011-2#2)
plain##22##1##(1992-6#1)(1993-1#2)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)
plains##3##1##(2008-10#3)
plaintiffs in the##2##3##(1995-6#2)
plaintiffs##4##1##(1995-6#3)(1996-5#1)
plan a##2##2##(1995-11#1)(2012-3#1)
plan and implement##6##3##(1996-3#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-7#1)
plan and provider##2##3##(1991-2#1)(1992-3#1)
plan and##17##2##(1991-2#2)(1992-3#1)(1993-3#1)(1994-1#4)(1996-3#1)(1997-1#2)(2008-1#1)(2008-11#3)(2008-12#1)(2010-7#1)
plan choices##3##2##(1997-3#3)
plan development and##2##3##(1994-2#1)(1994-3#1)
plan development##4##2##(1993-2#1)(1994-2#1)(1994-3#1)(1996-12#1)
plan for the##5##3##(1992-2#1)(1993-1#1)(1994-2#1)(2008-10#1)(2008-5#1)
plan for this##2##3##(2008-9#1)(2011-2#1)
plan for##21##2##(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-1#1)(1994-1#2)(1994-2#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#4)
plan in##2##2##(1991-1#1)(2008-11#1)
plan is##4##2##(1991-2#1)(1995-2#1)(1996-3#1)(2013-1#1)
plan of care##3##3##(2008-11#1)(2013-1#2)
plan of##5##2##(1991-1#1)(1996-12#1)(2008-11#1)(2013-1#2)
plan performance##3##2##(1994-2#1)(1995-2#1)(1997-3#1)
plan selections##2##2##(1997-3#2)
plan that##2##2##(1991-2#1)(1995-12#1)
plan to##16##2##(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#2)(1994-12#1)(1994-5#1)(1995-2#2)(1995-6#3)(2008-11#1)(2013-1#1)(2013-8#1)
plan was developed##2##3##(2008-10#1)(2010-7#1)
plan was##5##2##(1992-12#1)(2008-10#1)(2009-10#1)(2010-7#1)(2012-2#1)
plan will##4##2##(1992-2#1)(1994-3#2)(2008-7#1)
plan would##2##2##(1991-9#1)(2008-10#1)
plan##203##1##(1991-1#4)(1991-12#1)(1991-2#7)(1991-3#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#5)(1992-3#5)(1993-1#3)(1993-2#2)(1993-3#5)(1993-5#2)(1994-1#7)(1994-12#3)(1994-2#13)(1994-3#4)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#5)(1995-3#1)(1995-6#5)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#4)(1997-1#2)(1997-2#4)(1997-3#13)(2008-1#1)(2008-10#8)(2008-11#15)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#5)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#2)
plana vitrectomy##2##2##(2011-2#1)(2013-1#1)
planar imaging##3##2##(1992-3#2)(1994-1#1)
planar laser-induced fluorescence##2##3##(2008-3#2)
planar waveguide gratings##4##3##(2008-3#4)
planar waveguides##2##2##(2008-3#2)
planar##43##1##(1990-8#1)(1991-3#1)(1992-3#2)(1992-5#1)(1993-8#1)(1994-1#1)(1994-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#15)(2008-6#2)(2012-2#1)(2012-3#2)
planarian CNS##3##2##(2008-5#3)
planarian##5##1##(2008-5#5)
plane and##3##2##(2008-10#1)(2011-2#2)
plane between the##2##3##(2008-3#1)(2012-12#1)
plane is##2##2##(2008-3#2)
plane of the##3##3##(1995-2#1)(2008-3#1)(2010-8#1)
plane of##7##2##(1995-2#1)(1996-6#1)(1997-6#1)(2008-3#2)(2008-7#1)(2010-8#1)
plane wave##4##2##(2008-2#1)(2008-3#3)
plane##76##1##(1990-3#1)(1993-8#1)(1995-2#1)(1996-6#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#27)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2010-10#1)(2010-8#5)(2010-9#1)(2011-2#6)(2012-12#2)(2012-3#2)(2013-1#2)
plane-parallel resonator##3##2##(2008-3#3)
plane-parallel##5##1##(2008-2#1)(2008-3#4)
plane-wave##4##1##(2008-2#1)(2008-3#1)(2013-1#2)
planes and##3##2##(1990-11#1)(2008-2#1)(2009-10#1)
planes in##2##2##(1992-8#1)(2008-10#1)
planes##18##1##(1990-11#2)(1992-8#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-9#2)(2009-10#1)(2013-1#1)
planet##2##1##(2010-5#1)(2013-8#1)
planetary##3##1##(2008-2#1)(2008-3#2)
planets##2##1##(1995-6#1)(2012-2#1)
plankton##2##1##(2010-6#1)(2010-8#1)
planktonic##2##1##(2009-6#2)
planned action##2##2##(2008-11#1)(2013-1#1)
planned and##4##2##(1995-1#1)(2008-1#2)(2008-10#1)
planned as a##3##3##(2010-6#1)(2010-7#1)(2013-8#1)
planned as##4##2##(1990-6#1)(2010-6#1)(2010-7#1)(2013-8#1)
planned cholecystectomy##2##2##(1997-8#2)
planned for the##2##3##(1991-3#1)(2012-3#1)
planned gifts##2##2##(1991-1#1)(1992-3#1)
planned giving##3##2##(1991-3#2)(1992-3#1)
planned in##2##2##(1991-9#1)(2008-12#1)
planned suicide##3##2##(1992-1#3)
planned surgery##2##2##(1991-8#1)(1994-11#1)
planned to##9##2##(1993-1#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#3)
planned##71##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-3#2)(1992-9#2)(1993-1#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-8#7)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#2)(2009-6#1)(2010-10#1)(2010-6#2)(2010-7#3)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
planners##7##1##(1991-1#1)(1992-2#1)(1996-1#1)(1996-3#1)(2010-8#1)(2013-1#2)
planning a##2##2##(1991-2#1)(2010-12#1)
planning and development##3##3##(1996-3#1)(2008-11#1)(2008-12#1)
planning and implementation of##4##4##(1991-2#1)(1993-3#1)(1995-3#1)(2008-10#1)
planning and implementation##6##3##(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-3#1)(2008-10#1)
planning and monitoring##2##3##(1996-2#1)(2012-2#1)
planning and the##2##3##(1994-2#1)(2013-1#1)
planning and##48##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#7)(2008-12#1)(2009-11#1)(2009-12#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
planning are##2##2##(1991-12#1)(1996-2#1)
planning at the##2##3##(1991-2#1)(1994-2#1)
planning complications and surgical miscues##2##5##(2008-11#2)
planning disturbances in children who clutter##2##6##(2011-1#2)
planning efforts##3##2##(1994-1#1)(1997-1#1)(2008-11#1)
planning experiments##2##2##(2008-6#1)(2013-1#1)
planning for cancer##2##3##(1997-1#1)(2009-11#1)
planning for data collection##4##4##(1994-12#3)(1995-2#1)
planning for the##4##3##(1992-2#1)(1997-2#1)(2008-12#1)(2008-7#1)
planning for##22##2##(1991-2#1)(1991-3#1)(1992-2#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#3)(2008-12#1)(2008-7#1)(2009-11#2)(2010-11#1)(2010-7#1)(2012-2#1)
planning from##3##2##(1991-1#1)(1993-12#1)(1994-2#1)
planning in the##3##3##(2008-11#1)(2011-2#1)(2011-3#1)
planning in##14##2##(1991-1#1)(1992-1#1)(1994-12#1)(1994-2#1)(1997-2#1)(2008-11#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)
planning is##6##2##(1994-2#1)(1997-1#1)(1997-2#1)(2009-11#1)(2009-2#1)(2012-2#1)
planning methods##3##2##(1994-2#3)
planning model##4##2##(1991-1#1)(1991-3#1)(1993-12#1)(1996-2#1)
planning new##2##2##(1996-1#1)(1996-6#1)
planning of health##3##3##(1990-12#1)(1992-12#1)(1993-11#1)
planning of##11##2##(1990-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(2008-10#2)(2009-11#1)(2009-2#1)(2013-1#1)
planning process and##4##3##(1992-2#1)(1994-2#1)(1996-1#1)(2008-11#1)
planning process##16##2##(1991-2#2)(1992-2#2)(1994-2#8)(1994-3#1)(1996-1#2)(2008-11#1)
planning processes##2##2##(1994-2#1)(1996-2#1)
planning system##4##2##(1996-1#2)(2009-11#2)
planning the##2##2##(1995-2#1)(2013-1#1)
planning to return##2##3##(1993-1#2)
planning to##5##2##(1990-2#1)(1991-1#1)(1993-1#2)(1996-1#1)
planning tools##5##2##(1994-1#2)(1994-2#2)(2009-5#1)
planning treatment##2##2##(2008-11#1)(2013-8#1)
planning was##5##2##(1994-12#1)(1994-2#1)(2008-7#1)(2009-2#2)
planning with##2##2##(2008-11#1)(2008-7#1)
planning within the##2##3##(2008-11#1)(2010-10#1)
planning work##2##2##(2008-11#1)(2012-3#1)
planning##297##1##(1990-12#3)(1990-2#1)(1990-3#1)(1991-1#12)(1991-11#1)(1991-12#4)(1991-2#10)(1991-3#3)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#5)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#3)(1994-1#9)(1994-12#8)(1994-2#27)(1994-3#4)(1994-6#2)(1994-8#8)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#2)(1996-1#8)(1996-2#6)(1996-3#2)(1996-6#1)(1997-1#11)(1997-2#13)(1997-3#3)(1997-5#1)(1997-6#1)(2008-1#2)(2008-10#5)(2008-11#25)(2008-12#7)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-11#9)(2009-12#1)(2009-2#4)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#20)(2013-8#2)
plans and##6##2##(1991-2#1)(1991-3#1)(1993-1#1)(1993-3#1)(1997-2#1)(2008-6#1)
plans are##3##2##(1991-3#1)(1993-3#1)(1997-3#1)
plans for the##3##3##(1990-3#1)(1995-12#1)(1996-5#1)
plans for##14##2##(1990-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#2)(1995-12#2)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)
plans have##2##2##(1996-12#1)(2008-12#1)
plans in##6##2##(1993-3#1)(1993-5#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-11#1)
plans of##2##2##(1993-3#1)(2013-7#1)
plans that##5##2##(1994-1#1)(1995-1#1)(1997-1#1)(1997-3#2)
plans to##12##2##(1991-11#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-1#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
plans were##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
plans##124##1##(1990-3#2)(1991-1#1)(1991-11#1)(1991-2#4)(1991-3#4)(1991-9#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#8)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#6)(1994-3#1)(1995-1#3)(1995-12#6)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#7)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#8)(1997-3#7)(1997-5#5)(2008-1#1)(2008-10#6)(2008-11#9)(2008-12#2)(2008-3#1)(2008-4#4)(2008-6#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#1)
plant AChEs##3##2##(2009-8#3)
plant Arabidopsis thaliana##4##3##(2008-9#3)(2011-2#1)
plant Arabidopsis##5##2##(2008-9#3)(2009-8#1)(2011-2#1)
plant DNA##4##2##(2008-10#3)(2008-9#1)
plant RNA##4##2##(2008-10#3)(2008-9#1)
plant activators##3##2##(2008-10#3)
plant age and##2##3##(2008-10#2)
plant age at##2##3##(2008-10#2)
plant age##7##2##(2008-10#7)
plant alkaloid##2##2##(1993-8#1)(1994-8#1)
plant and a##3##3##(2008-10#2)(2012-2#1)
plant and algal systems##2##4##(2009-8#2)
plant and animal cells##2##4##(1994-12#1)(2008-4#1)
plant and animal##6##3##(1994-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-3#1)
plant and fungal##2##3##(2008-10#2)
plant and pathogen##2##3##(2011-10#2)
plant and the##3##3##(2008-10#1)(2012-2#2)
plant and##33##2##(1994-12#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#2)(2011-10#2)(2012-2#3)(2012-3#1)
plant as##2##2##(2008-10#1)(2008-11#1)
plant at##2##2##(2008-10#1)(2008-12#1)
plant biology##3##2##(2007-12#1)(2008-9#2)
plant biomass##5##2##(2008-8#5)
plant breeding##5##2##(2008-10#3)(2008-8#1)(2013-8#1)
plant by##3##2##(2008-10#3)
plant can##2##2##(2008-10#1)(2008-11#1)
plant canopy##3##2##(1993-3#1)(2008-10#2)
plant carbon/nitrogen ratio##2##3##(2008-10#2)
plant carbon/nitrogen##3##2##(2008-10#3)
plant cell death##2##3##(2009-8#2)
plant cell##5##2##(1995-2#1)(2009-10#1)(2009-8#2)(2010-3#1)
plant cells and tissues##2##4##(2008-4#1)(2010-11#1)
plant cells and##3##3##(2008-11#1)(2008-4#1)(2010-11#1)
plant cells to##2##3##(1997-8#1)(2008-8#1)
plant cells##29##2##(1994-11#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-11#5)(2008-4#1)(2008-8#6)(2008-9#2)(2009-6#1)(2009-8#7)(2010-11#1)(2011-2#1)
plant communities##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2012-6#1)
plant community##3##2##(2008-11#1)(2008-8#2)
plant compartments##2##2##(2010-11#2)
plant competition##2##2##(2008-10#1)(2008-8#1)
plant cover##4##2##(2008-8#4)
plant damage##5##2##(2008-10#2)(2008-8#3)
plant defense reactions##4##3##(2008-10#4)
plant defense response##2##3##(2008-10#2)
plant defense##16##2##(2008-10#13)(2008-8#2)(2008-9#1)
plant defenses##2##2##(2008-9#1)(2009-8#1)
plant density##4##2##(2008-10#3)(2008-8#1)
plant derived##2##2##(2008-10#1)(2011-3#1)
plant development and##5##3##(2008-10#2)(2008-9#1)(2009-8#1)(2012-3#1)
plant development##13##2##(2008-10#6)(2008-9#1)(2009-8#5)(2012-3#1)
plant digests##2##2##(2008-10#2)
plant disease epidemiology##3##3##(2008-10#3)
plant disease forecasting##2##3##(2008-10#2)
plant disease incidence##2##3##(2008-10#2)
plant disease management##2##3##(2008-10#2)
plant disease resistance##4##3##(2008-10#4)
plant disease suppression##3##3##(2008-10#3)
plant disease##31##2##(2008-10#30)(2008-8#1)
plant diseases in##2##3##(2008-10#2)
plant diseases##16##2##(2008-10#15)(2012-2#1)
plant diversification##2##2##(2010-5#1)(2012-3#1)
plant diversity##2##2##(2008-8#2)
plant expression vectors were constructed##2##5##(2008-9#2)
plant expression vectors##3##3##(2008-8#1)(2008-9#2)
plant expression##4##2##(2008-8#1)(2008-9#3)
plant extract##4##2##(2008-5#1)(2011-1#1)(2013-1#2)
plant extracts##17##2##(2008-10#10)(2008-11#1)(2008-5#3)(2011-1#3)
plant families##2##2##(2008-10#2)
plant fitness##3##2##(2008-8#3)
plant folate##2##2##(2011-2#2)
plant for##3##2##(1996-12#1)(2008-8#1)(2011-3#1)
plant from##3##2##(2008-10#2)(2008-11#1)
plant functional group richness##5##4##(2008-8#5)
plant functional group##6##3##(2008-8#6)
plant gene encoding a##2##4##(1993-2#1)(1995-6#1)
plant gene##3##2##(1993-2#1)(1995-2#1)(1995-6#1)
plant genes##2##2##(2008-10#1)(2012-2#1)
plant genome##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
plant growth and development##3##4##(2008-9#1)(2009-6#1)(2009-8#1)
plant growth and nutrient##2##4##(2008-10#1)(2013-8#1)
plant growth and##11##3##(2008-10#5)(2008-9#1)(2009-6#1)(2009-8#3)(2013-8#1)
plant growth in##2##3##(2008-10#1)(2008-8#1)
plant growth parameters##2##3##(2008-10#2)
plant growth promotion##7##3##(2008-10#4)(2013-8#3)
plant growth regulators##3##3##(2008-10#2)(2008-12#1)
plant growth stage was##2##4##(2008-10#2)
plant growth stages##2##3##(2008-10#2)
plant growth##51##2##(2008-10#31)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#5)(2011-2#1)(2012-7#1)(2013-8#5)
plant growth-promoting rhizobacteria##5##3##(2008-10#5)
plant growth-promoting##6##2##(2008-10#6)
plant height and##2##3##(2008-10#1)(2008-12#1)
plant height##14##2##(2008-10#11)(2008-12#2)(2008-9#1)
plant hormone##4##2##(2009-6#3)(2011-10#1)
plant hormones##4##2##(2008-10#1)(2008-9#1)(2009-8#2)
plant host##4##2##(2008-10#4)
plant hosts##6##2##(2008-10#6)
plant hydrolysates##3##2##(2008-11#3)
plant immune responses##2##3##(2009-8#2)
plant immunity##4##2##(2009-6#1)(2009-8#2)(2011-2#1)
plant in a##2##3##(2008-10#2)
plant in##5##2##(2008-10#5)
plant infected##3##2##(2008-10#2)(2008-9#1)
plant infection by##3##3##(2008-10#3)
plant is##4##2##(2008-10#3)(2008-8#1)
plant isolates##3##2##(2008-10#3)
plant keratin intermediate filaments##3##4##(2008-8#3)
plant keratin intermediate##4##3##(2008-8#4)
plant leaves##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
plant level##2##2##(2008-10#1)(2009-8#1)
plant lineage##2##2##(2011-2#2)
plant lineages##3##2##(2009-8#2)(2011-2#1)
plant lipids##2##2##(2008-11#2)
plant mass##2##2##(2008-10#1)(2008-9#1)
plant material and##2##3##(2008-10#1)(2008-9#1)
plant material from##2##3##(2008-10#1)(2008-9#1)
plant material is##2##3##(2008-10#1)(2008-11#1)
plant material##27##2##(2008-10#19)(2008-11#3)(2008-9#5)
plant materials from##2##3##(2008-10#2)
plant materials##9##2##(2008-10#9)
plant matrices##2##2##(2008-10#2)
plant maturity##3##2##(2008-10#3)
plant metabolism##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
plant mortality##2##2##(2011-1#2)
plant nutrition##2##2##(2009-10#1)(2011-2#1)
plant odors##2##2##(1990-11#1)(2007-12#1)
plant of##2##2##(2008-10#1)(2008-12#1)
plant on##2##2##(2008-10#2)
plant orders##3##2##(2008-10#3)
plant organs##3##2##(2008-10#2)(2008-11#1)
plant pathogen that##2##3##(2008-10#2)
plant pathogen##11##2##(2008-10#11)
plant pathogenic bacteria##3##3##(2008-10#2)(2009-6#1)
plant pathogenic##5##2##(2008-10#3)(2008-11#1)(2009-6#1)
plant pathogens and##4##3##(2008-10#3)(2009-8#1)
plant pathogens by##4##3##(2008-10#4)
plant pathogens in##4##3##(2008-10#4)
plant pathogens is##2##3##(2008-10#2)
plant pathogens##47##2##(2008-10#46)(2009-8#1)
plant pathologists##5##2##(2008-10#5)
plant pathology##12##2##(2008-10#12)
plant penetration##2##2##(2007-12#1)(2008-10#1)
plant performance##3##2##(2008-8#1)(2012-5#1)(2012-7#1)
plant pheophytin##2##2##(2008-8#1)(2008-9#1)
plant photosynthesis##2##2##(2008-10#1)(2008-8#1)
plant physiology##2##2##(2008-10#1)(2012-5#1)
plant populations##13##2##(2008-10#2)(2008-8#9)(2008-9#2)
plant production##3##2##(2008-10#2)(2008-8#1)
plant products##2##2##(1993-11#1)(2008-5#1)
plant protection##5##2##(2008-10#1)(2008-11#3)(2011-10#1)
plant protein##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
plant protoplasts##3##2##(2008-9#3)
plant quality##2##2##(2009-10#1)(2012-3#1)
plant regulatory##2##2##(2008-10#1)(2009-8#1)
plant research##2##2##(2008-9#1)(2009-10#1)
plant resistance genes##2##3##(2008-10#2)
plant resistance to##5##3##(2008-10#5)
plant resistance##18##2##(2008-10#13)(2008-8#4)(2008-9#1)
plant response to##3##3##(2008-10#2)(2009-8#1)
plant response##4##2##(2008-10#3)(2009-8#1)
plant responses to insect feeding##2##5##(2009-8#2)
plant responses to##6##3##(2008-10#1)(2008-8#1)(2009-8#4)
plant responses##7##2##(2008-10#2)(2008-8#1)(2009-8#4)
plant revealed##2##2##(1996-3#1)(2008-10#1)
plant roots##6##2##(2008-10#4)(2008-12#1)(2009-8#1)
plant samples##28##2##(2008-10#26)(2008-11#1)(2008-9#1)
plant scale##2##2##(1995-3#1)(2008-10#1)
plant scales##2##2##(2008-10#2)
plant sciences##2##2##(1994-11#1)(2011-10#1)
plant seeds##2##2##(2008-9#1)(2012-2#1)
plant size##2##2##(2008-8#2)
plant species and##5##3##(2008-10#3)(2008-11#1)(2009-8#1)
plant species are##2##3##(2008-10#1)(2008-8#1)
plant species in##2##3##(2008-10#1)(2010-3#1)
plant species richness and plant functional group richness##2##8##(2008-8#2)
plant species richness##6##3##(2008-8#5)(2008-9#1)
plant species tested##3##3##(2008-10#3)
plant species to##2##3##(2008-8#1)(2009-8#1)
plant species were##2##3##(2008-10#1)(2012-6#1)
plant species##73##2##(2008-10#41)(2008-11#2)(2008-8#17)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-3#2)(2010-5#1)(2011-2#1)(2012-6#1)
plant species/cultivars##2##2##(2008-10#2)
plant stem##3##2##(2008-10#2)(2012-5#1)
plant surfaces##3##2##(2008-10#2)(2009-8#1)
plant system##2##2##(1997-8#1)(2008-10#1)
plant systems##2##2##(2008-11#1)(2008-8#1)
plant than##3##2##(2008-10#3)
plant tissue and##3##3##(2008-10#3)
plant tissue homogenate##2##3##(2008-10#2)
plant tissue##24##2##(2008-10#22)(2008-11#1)(2008-9#1)
plant tissues and##2##3##(2008-10#1)(2009-8#1)
plant tissues##13##2##(1990-5#1)(2008-10#7)(2008-9#3)(2009-8#1)(2011-2#1)
plant to##7##2##(2008-10#4)(2008-8#1)(2009-8#2)
plant tolerance to##2##3##(2008-12#1)(2009-8#1)
plant transformation##2##2##(2008-10#1)(2008-8#1)
plant under##3##2##(2008-10#1)(2008-8#2)
plant vigor##3##2##(2008-10#3)
plant virus disease epidemics##2##4##(2008-10#2)
plant virus##8##2##(2008-10#8)
plant viruses by##3##3##(2008-10#3)
plant viruses##24##2##(2008-10#21)(2008-9#3)
plant volatiles##2##2##(2007-12#1)(2009-8#1)
plant was significantly##2##3##(2008-10#2)
plant was##8##2##(2008-10#6)(2008-9#2)
plant were##3##2##(2008-10#3)
plant with##4##2##(2008-10#3)(2008-11#1)
plant##1267##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-3#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-5#3)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-3#3)(1996-9#1)(1997-7#1)(1997-8#3)(2007-12#7)(2008-10#723)(2008-11#53)(2008-12#26)(2008-4#2)(2008-5#7)(2008-7#7)(2008-8#119)(2008-9#77)(2009-10#7)(2009-12#2)(2009-3#2)(2009-6#18)(2009-8#78)(2010-10#1)(2010-11#7)(2010-3#3)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#8)(2011-10#7)(2011-2#26)(2011-3#3)(2012-12#1)(2012-2#12)(2012-3#6)(2012-5#3)(2012-6#4)(2012-7#3)(2013-1#3)(2013-8#7)
plant's##4##1##(2008-10#1)(2008-8#1)(2009-8#2)
plant(-1)##4##1##(2008-12#4)
plant)##3##1##(2008-10#3)
plant-associated bacteria##2##2##(2008-10#2)
plant-associated microbes##3##2##(2008-10#3)
plant-associated##7##1##(2008-10#7)
plant-derived##5##1##(2008-10#2)(2008-5#1)(2011-1#1)(2012-12#1)
plant-herbivore##4##1##(2008-8#3)(2008-9#1)
plant-microbe##2##1##(2008-10#1)(2012-2#1)
plant-parasitic nematodes##3##2##(2008-10#3)
plant-parasitic##4##1##(2008-10#4)
plant-pathogen interactions##2##2##(2008-10#1)(2011-10#1)
plant-pathogen##4##1##(2008-10#3)(2011-10#1)
plant-pathogenic fungi##3##2##(2008-10#3)
plant-pathogenic##12##1##(2008-10#12)
plant-pollinator interactions##3##2##(2008-8#1)(2009-6#1)(2012-6#1)
plant-pollinator##4##1##(2008-8#2)(2009-6#1)(2012-6#1)
plant-specific##2##1##(2009-10#1)(2009-8#1)
plant-to-plant##3##1##(2008-10#1)(2009-8#2)
planta growth##2##2##(2008-10#2)
planta##46##1##(1997-3#1)(2008-10#38)(2008-9#1)(2009-12#4)(2010-11#1)(2011-2#1)
plantain##2##1##(2008-1#1)(2008-10#1)
plantains##2##1##(2008-10#2)
plantar pressure measurements##3##3##(2012-2#3)
plantar pressure##5##2##(2011-2#1)(2012-2#4)
plantar pressures and##2##3##(2011-2#2)
plantar pressures##5##2##(2011-2#5)
plantar##16##1##(1997-3#1)(1997-6#1)(2008-7#1)(2011-2#7)(2012-2#4)(2012-3#1)(2013-8#1)
plantaris muscle##5##2##(2012-2#5)
plantaris##8##1##(2011-2#1)(2012-2#7)
plantation##7##1##(2008-10#5)(2008-8#1)(2012-2#1)
plantations and##5##2##(2008-10#4)(2012-2#1)
plantations in the##2##3##(2008-10#2)
plantations in##4##2##(2008-10#4)
plantations##22##1##(2008-10#21)(2012-2#1)
planted in##14##2##(2008-10#12)(2008-12#1)(2008-9#1)
planted to a##2##3##(2008-10#2)
planted to snap##2##3##(2008-10#2)
planted to##11##2##(2008-10#11)
planted with cotton##2##3##(2008-10#2)
planted with##11##2##(2008-10#10)(2008-12#1)
planted##49##1##(2008-10#46)(2008-12#2)(2008-9#1)
planting area##2##2##(2008-10#1)(2008-9#1)
planting date##2##2##(2008-10#2)
planting densities##2##2##(2008-10#2)
planting density and the##2##4##(2008-10#2)
planting density##9##2##(2008-10#9)
planting in##2##2##(2008-10#2)
planting material##3##2##(2008-10#3)
planting of the##2##3##(2008-10#2)
planting of##4##2##(2008-10#4)
planting##50##1##(1995-6#1)(2008-10#48)(2008-9#1)
plantings and##2##2##(2008-10#2)
plantings##12##1##(2008-10#12)
plantlet##2##1##(2008-10#1)(2011-10#1)
plantlets from##4##2##(2008-10#1)(2008-12#3)
plantlets##14##1##(2008-10#5)(2008-12#4)(2008-9#3)(2009-8#1)(2013-1#1)
plants (plants##2##2##(2008-10#2)
plants also##5##2##(2008-10#3)(2010-4#1)(2012-7#1)
plants and a##2##3##(2008-10#1)(2008-8#1)
plants and animals##6##3##(2008-8#1)(2008-9#2)(2009-5#1)(2010-4#1)(2013-8#1)
plants and in##10##3##(2008-10#7)(2008-3#1)(2008-8#1)(2009-8#1)
plants and insect vectors##2##4##(2008-10#2)
plants and insects##2##3##(2008-10#1)(2009-8#1)
plants and is##3##3##(2008-10#2)(2013-8#1)
plants and resistance to##2##4##(2008-10#1)(2011-10#1)
plants and resistance##3##3##(2008-10#2)(2011-10#1)
plants and the##8##3##(1997-3#1)(2008-10#3)(2008-9#2)(2009-8#1)(2011-2#1)
plants and their##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
plants and##90##2##(1997-3#2)(2008-10#53)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#9)(2008-9#5)(2009-12#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#2)(2011-2#1)(2012-2#1)(2013-8#2)
plants and/or##2##2##(2008-10#1)(2012-3#1)
plants appear##2##2##(2008-10#2)
plants appeared to##2##3##(2008-10#2)
plants are vernalized##2##3##(2009-8#2)
plants are##16##2##(2008-10#7)(2008-11#1)(2008-9#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
plants as well##2##3##(1997-8#1)(2008-10#1)
plants as##7##2##(1997-3#1)(1997-8#1)(2008-10#4)(2008-8#1)
plants at 96 h after inoculation##2##6##(2008-10#2)
plants at various##2##3##(2008-10#2)
plants at##14##2##(2008-10#14)
plants became infected##2##3##(2008-10#2)
plants became##4##2##(2008-10#4)
plants but##3##2##(2008-10#2)(2009-8#1)
plants by GC/MS##2##3##(2008-10#2)
plants by Southern blot hybridization##2##5##(2008-10#2)
plants by Southern##3##3##(2008-10#2)(2008-9#1)
plants by##22##2##(2007-12#1)(2008-10#15)(2008-11#1)(2008-8#1)(2008-9#3)(2011-2#1)
plants can be##3##3##(2008-10#1)(2009-8#2)
plants can##9##2##(2008-10#5)(2008-9#1)(2009-8#3)
plants carrying cognate resistance proteins##2##5##(2009-8#2)
plants carrying##5##2##(2008-10#3)(2009-8#2)
plants collected from##2##3##(2008-10#2)
plants collected##3##2##(2008-10#3)
plants compared with##2##3##(2008-10#2)
plants contained##3##2##(2008-10#3)
plants containing the##3##3##(2008-10#1)(2008-9#2)
plants containing##10##2##(2008-10#5)(2008-5#1)(2008-9#3)(2009-8#1)
plants could be##3##3##(2008-10#1)(2008-8#1)(2011-10#1)
plants cultivated in##2##3##(2008-10#2)
plants developed##2##2##(2008-10#2)
plants did not##3##3##(2008-10#3)
plants display##2##2##(2008-10#1)(2008-11#1)
plants displayed##2##2##(2008-10#2)
plants displaying##5##2##(2008-10#5)
plants do not##2##3##(1995-2#1)(2008-10#1)
plants during##2##2##(2008-10#2)
plants either##2##2##(2008-10#2)
plants exhibited##3##2##(2008-10#3)
plants exhibiting##4##2##(2008-10#4)
plants exposed to##4##3##(2008-10#2)(2013-8#2)
plants expressing a##4##3##(2008-10#4)
plants expressing the##5##3##(1997-8#1)(2008-10#3)(2011-10#1)
plants expressing##16##2##(1995-2#1)(1997-8#1)(2008-10#10)(2008-8#1)(2009-8#1)(2011-10#2)
plants for the##3##3##(2008-10#2)(2008-5#1)
plants for##8##2##(2008-10#6)(2008-5#1)(2008-8#1)
plants from five##2##3##(2008-10#2)
plants from powdery mildew##2##4##(2008-10#2)
plants from the same##2##4##(2008-10#2)
plants from the##9##3##(2008-10#6)(2012-7#3)
plants from##25##2##(2008-10#21)(2012-7#4)
plants growing in field soil##2##5##(2008-10#2)
plants growing in##6##3##(2008-10#6)
plants growing##7##2##(2008-10#6)(2008-8#1)
plants grown in either mix##2##5##(2008-10#2)
plants grown in soil##3##4##(2008-10#3)
plants grown in the compost mix##2##6##(2008-10#2)
plants grown in the compost##3##5##(2008-10#3)
plants grown in the##6##4##(2008-10#6)
plants grown in##25##3##(2008-10#21)(2008-11#1)(2012-7#3)
plants grown##26##2##(2008-10#22)(2008-11#1)(2012-7#3)
plants had##11##2##(2008-10#6)(2008-8#4)(2008-9#1)
plants have been##3##3##(2008-11#1)(2009-10#1)(2009-6#1)
plants have on average##2##4##(2008-11#1)(2009-8#1)
plants have the##2##3##(2008-10#1)(2009-12#1)
plants have##11##2##(2008-10#2)(2008-11#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-10#1)(2011-2#1)(2011-3#1)
plants homozygous for the##2##4##(2012-3#2)
plants in F(2)##2##3##(2008-10#1)(2008-8#1)
plants in a##8##3##(2008-10#8)
plants in each##2##3##(2008-10#2)
plants in response to##2##4##(2008-10#2)
plants in terms of##2##4##(2008-10#2)
plants in the absence of##2##5##(1997-3#1)(2009-8#1)
plants in the family Brassicaceae##2##5##(2008-10#2)
plants in the field##4##4##(2008-10#2)(2008-11#1)(2008-8#1)
plants in the##26##3##(1997-3#1)(2008-10#19)(2008-11#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)
plants in##76##2##(1997-3#1)(2008-10#56)(2008-11#2)(2008-12#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-5#1)(2012-9#1)(2013-8#1)
plants increased##4##2##(2008-10#4)
plants incubated##2##2##(2008-10#2)
plants indicated that##5##3##(2008-10#5)
plants indicated##7##2##(2008-10#7)
plants infected with F##2##4##(2008-10#2)
plants infected with the##3##4##(2008-10#3)
plants infected with##11##3##(2008-10#11)
plants infected##13##2##(2008-10#13)
plants inoculated with the higher zoospore concentration##2##7##(2008-10#2)
plants inoculated with the##3##4##(2008-10#3)
plants inoculated with##22##3##(2008-10#21)(2008-12#1)
plants inoculated##25##2##(2008-10#24)(2008-12#1)
plants is##10##2##(2008-10#4)(2008-8#3)(2009-6#1)(2009-8#1)(2012-3#1)
plants maintained##2##2##(2008-10#2)
plants may##4##2##(2008-10#3)(2008-11#1)
plants not receiving SA##2##4##(2008-10#2)
plants not##4##2##(2008-10#4)
plants obtained from##2##3##(2008-10#2)
plants occurred##2##2##(2008-10#2)
plants of each##2##3##(2008-10#2)
plants of the resistant##2##4##(2008-10#2)
plants of the##7##3##(2008-10#5)(2008-11#2)
plants of two##2##3##(2008-10#1)(2013-1#1)
plants of##31##2##(2008-10#25)(2008-11#3)(2008-8#1)(2009-5#1)(2013-1#1)
plants on##4##2##(2008-10#3)(2008-5#1)
plants or##11##2##(2008-10#9)(2011-2#1)(2013-1#1)
plants over time##2##3##(2008-10#1)(2008-9#1)
plants per plot at##2##4##(2008-10#2)
plants per##5##2##(2008-10#5)
plants produced##2##2##(2008-10#1)(2008-8#1)
plants remain##2##2##(2008-10#1)(2012-2#1)
plants represents a##2##3##(2009-6#2)
plants revealed that the##2##4##(2008-10#2)
plants revealed##4##2##(2008-10#3)(2008-8#1)
plants sampled at##2##3##(2008-10#2)
plants sampled##4##2##(2008-10#4)
plants showed that##3##3##(2008-10#3)
plants showed##8##2##(2008-10#8)
plants showing##6##2##(2008-10#5)(2008-5#1)
plants suggests that##4##3##(2008-10#4)
plants than in##4##3##(2008-10#3)(2009-10#1)
plants than on##2##3##(2008-10#1)(2012-2#1)
plants than##9##2##(2008-10#7)(2009-10#1)(2012-2#1)
plants that are##2##3##(2008-10#2)
plants that were##5##3##(2008-10#5)
plants that##11##2##(2008-10#10)(2009-3#1)
plants to a##3##3##(2008-10#3)
plants to adapt to##2##4##(2008-8#1)(2009-6#1)
plants to the##4##3##(2008-10#2)(2009-6#1)(2011-10#1)
plants to##37##2##(2008-10#21)(2008-11#1)(2008-8#5)(2008-9#2)(2009-6#2)(2009-8#3)(2011-10#1)(2011-2#1)(2012-5#1)
plants transformed with##2##3##(2008-10#2)
plants treated with##5##3##(2008-10#5)
plants under##6##2##(2008-10#3)(2008-11#1)(2009-12#1)(2013-8#1)
plants using##5##2##(2008-10#3)(2008-9#2)
plants was demonstrated##2##3##(2008-10#2)
plants was higher##2##3##(2008-10#1)(2008-12#1)
plants was mainly##2##3##(2008-10#2)
plants was##30##2##(1995-2#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-8#2)
plants were aggregated##2##3##(2008-10#2)
plants were also##2##3##(2008-10#2)
plants were challenged with##3##4##(2008-10#3)
plants were evaluated for##3##4##(2008-10#3)
plants were evaluated##6##3##(2008-10#6)
plants were examined by##2##4##(2008-10#2)
plants were examined with##2##4##(2008-10#2)
plants were examined##4##3##(2008-10#4)
plants were grown in##2##4##(2008-10#1)(2010-11#1)
plants were grown##4##3##(2008-10#2)(2008-12#1)(2010-11#1)
plants were infected with##2##4##(2008-10#2)
plants were infected##4##3##(2008-10#4)
plants were inoculated with##2##4##(2008-10#2)
plants were inoculated##7##3##(2008-10#6)(2008-5#1)
plants were kept in##2##4##(2008-10#1)(2008-5#1)
plants were measured##2##3##(2008-10#1)(2008-12#1)
plants were more##2##3##(2008-10#1)(2008-8#1)
plants were observed##2##3##(2008-10#2)
plants were regenerated##3##3##(2008-9#2)(2013-1#1)
plants were sprayed with##2##4##(2008-10#1)(2008-8#1)
plants were subjected to##2##4##(1995-2#1)(2008-12#1)
plants were transformed with the##2##5##(2008-10#2)
plants were used##2##3##(2008-10#2)
plants were##94##2##(1995-2#2)(1997-3#1)(2008-10#73)(2008-11#1)(2008-12#3)(2008-5#2)(2008-8#7)(2008-9#2)(2010-11#1)(2013-1#2)
plants when##3##2##(2008-10#2)(2008-9#1)
plants where##2##2##(2008-10#1)(2008-8#1)
plants which were##2##3##(2008-10#2)
plants which##4##2##(2008-10#3)(2013-1#1)
plants while##2##2##(1995-2#1)(2009-8#1)
plants with a##2##3##(2008-10#2)
plants with an##2##3##(2008-10#2)
plants with the same##2##4##(2008-10#1)(2008-8#1)
plants with the##5##3##(2008-10#4)(2008-8#1)
plants with##42##2##(2008-10#36)(2008-11#1)(2008-12#1)(2008-8#3)(2009-8#1)
plants within##4##2##(2008-10#4)
plants without##2##2##(2008-10#2)
plants##1463##1##(1993-2#1)(1993-6#1)(1994-11#3)(1995-2#13)(1995-6#2)(1997-3#11)(1997-6#1)(1997-8#2)(2007-12#2)(2008-10#1038)(2008-11#39)(2008-12#20)(2008-3#1)(2008-5#10)(2008-7#5)(2008-8#81)(2008-9#54)(2009-10#13)(2009-12#8)(2009-3#1)(2009-5#2)(2009-6#19)(2009-8#50)(2010-1#2)(2010-11#3)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#3)(2011-1#2)(2011-10#8)(2011-2#14)(2011-3#1)(2012-2#8)(2012-3#5)(2012-5#2)(2012-7#9)(2012-9#2)(2013-1#7)(2013-8#11)
plants) is##2##2##(2008-10#1)(2008-8#1)
plants)##15##1##(2008-10#13)(2008-8#1)(2010-3#1)
planus is##2##2##(1991-2#2)
planus##18##1##(1990-5#1)(1991-2#4)(2009-6#5)(2011-2#3)(2013-1#5)
plaque accumulation##2##2##(2008-1#1)(2008-7#1)
plaque and##4##2##(1991-3#1)(2008-7#1)(2013-1#2)
plaque assay##4##2##(1995-12#2)(2012-2#2)
plaque development and##2##3##(2008-10#1)(2008-5#1)
plaque formation##2##2##(2008-7#1)(2008-9#1)
plaque forming##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
plaque imaging##4##2##(2010-9#4)
plaque in##2##2##(2011-2#1)(2012-3#1)
plaque of##2##2##(2008-7#1)(2012-3#1)
plaque psoriasis##2##2##(2007-11#1)(2008-6#1)
plaque size##2##2##(2010-9#2)
plaque volume##2##2##(2008-6#1)(2009-1#1)
plaque with##4##2##(2008-5#1)(2010-6#2)(2012-3#1)
plaque##68##1##(1991-10#1)(1991-3#1)(1993-11#1)(1995-12#2)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-6#2)(2010-9#16)(2011-2#4)(2012-2#10)(2012-3#3)(2013-1#3)(2013-8#2)
plaque-forming cell (PFC) assay##2##4##(2008-10#1)(2008-4#1)
plaque-forming cell (PFC)##4##3##(1993-12#1)(2008-10#1)(2008-4#2)
plaque-forming##5##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#2)
plaques and neurofibrillary tangles##3##4##(1991-1#1)(2008-5#1)(2008-7#1)
plaques and##13##2##(1991-1#1)(1991-12#3)(1991-9#1)(1992-12#1)(2008-5#1)(2008-7#4)(2012-2#2)
plaques in the##2##3##(1991-1#1)(1991-12#1)
plaques in##4##2##(1991-1#2)(1991-12#1)(2008-7#1)
plaques is##2##2##(1997-8#1)(2008-5#1)
plaques of##2##2##(1990-5#1)(2012-3#1)
plaques were##2##2##(1991-10#1)(1995-12#1)
plaques with##2##2##(1991-12#1)(2012-3#1)
plaques##56##1##(1990-5#1)(1990-6#1)(1991-1#4)(1991-10#6)(1991-12#9)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#5)(2013-8#3)
plasm##26##1##(2008-10#25)(2009-7#1)
plasma ACTH in##2##3##(1992-8#2)
plasma ACTH##3##2##(1992-8#3)
plasma ADAMTS13##2##2##(2009-7#2)
plasma CCK levels##2##3##(2008-7#2)
plasma CCK##4##2##(2008-7#4)
plasma Cardiac Troponin I##2##4##(2008-12#2)
plasma IL-6 levels in##2##4##(2011-2#2)
plasma IL-6 levels##3##3##(2011-2#3)
plasma IgM##2##2##(2008-7#2)
plasma LDL##2##2##(1991-5#1)(2010-12#1)
plasma TG levels alone##3##4##(2008-3#3)
plasma V level and V loss##3##6##(2011-2#3)
plasma V level and##4##4##(2011-2#4)
plasma V level##5##3##(2011-2#5)
plasma activity##2##2##(1993-11#2)
plasma after##2##2##(2008-10#2)
plasma albumin concentration and indices of glycaemic control##2##8##(1992-9#2)
plasma albumin concentration##5##3##(1992-9#5)
plasma and erythrocytes##2##3##(1991-12#1)(1993-2#1)
plasma and granule membranes##2##4##(1992-6#2)
plasma and saliva##4##3##(2008-10#3)(2013-8#1)
plasma and spinal cord##2##4##(1991-5#2)
plasma and the##2##3##(1992-12#1)(2008-1#1)
plasma and tissue##2##3##(2008-9#1)(2012-2#1)
plasma and urine samples##2##4##(2008-10#2)
plasma and urine##5##3##(1991-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
plasma and##49##2##(1990-12#1)(1991-12#4)(1991-5#2)(1992-11#1)(1992-12#3)(1992-6#2)(1993-2#2)(1994-8#5)(1995-8#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
plasma are##4##2##(1992-3#2)(1995-2#1)(2012-3#1)
plasma atomic emission spectrometry (ICP-AES)##13##5##(2008-10#13)
plasma atomic emission spectrometry##54##4##(1992-3#1)(2008-10#53)
plasma atomic emission##67##3##(1992-3#1)(2008-10#66)
plasma atomic##69##2##(1992-3#1)(2008-10#68)
plasma balls##2##2##(2008-2#2)
plasma by high-performance liquid chromatography and##2##6##(2008-10#2)
plasma by high-performance liquid chromatography##3##5##(2008-10#3)
plasma by##13##2##(1992-10#1)(2008-10#9)(2011-3#3)
plasma catecholamines and heart##2##4##(1994-3#2)
plasma catecholamines##3##2##(1994-3#2)(2008-7#1)
plasma cell granuloma##2##3##(1991-9#2)
plasma cell##7##2##(1991-9#2)(1993-8#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-8#1)
plasma cells and##2##3##(2012-12#1)(2013-8#1)
plasma cells##10##2##(2008-5#1)(2008-9#4)(2010-12#2)(2012-12#1)(2013-1#1)(2013-8#1)
plasma cholesterol##4##2##(1991-4#1)(1995-2#1)(1996-8#1)(1997-8#1)
plasma coagulation##3##2##(2010-12#1)(2013-1#2)
plasma concentration of the##2##4##(1993-1#1)(1994-12#1)
plasma concentration of##8##3##(1990-6#1)(1993-1#1)(1994-12#1)(2010-12#1)(2012-2#1)(2013-8#3)
plasma concentration profiles##2##3##(2008-11#2)
plasma concentration##15##2##(1990-6#1)(1992-9#1)(1993-1#1)(1994-12#1)(2008-11#3)(2008-12#1)(2008-7#2)(2010-12#1)(2012-2#1)(2013-8#3)
plasma concentrations are##2##3##(2008-7#1)(2012-2#1)
plasma concentrations of##7##3##(1992-5#1)(1994-8#1)(1995-2#1)(2008-6#1)(2008-7#2)(2012-3#1)
plasma concentrations##17##2##(1990-6#1)(1991-1#1)(1992-5#1)(1992-6#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-6#1)(2008-7#4)(2011-2#1)(2012-2#3)(2012-3#1)
plasma cortisol levels##2##3##(2008-6#2)
plasma emission spectrometer##2##3##(2008-10#2)
plasma emission##5##2##(2008-10#4)(2008-5#1)
plasma exchange##5##2##(2011-2#4)(2012-3#1)
plasma extraction rate##2##3##(2011-2#2)
plasma fibrinogen##5##2##(2008-10#5)
plasma fibronectin##3##2##(2008-7#3)
plasma for##7##2##(1995-8#1)(1997-2#1)(2008-10#4)(2008-11#1)
plasma from a##2##3##(2008-10#1)(2011-2#1)
plasma from healthy##3##3##(1992-3#1)(2008-10#1)(2008-8#1)
plasma from##8##2##(1992-3#1)(1993-2#1)(1995-12#1)(2008-10#3)(2008-8#1)(2011-2#1)
plasma fructosamine concentration##3##3##(1992-9#3)
plasma glucose concentration##6##3##(1991-7#1)(1992-9#1)(1994-12#1)(1994-2#1)(2010-10#2)
plasma glucose##9##2##(1991-7#1)(1992-9#1)(1994-12#2)(1994-2#1)(2010-10#3)(2010-7#1)
plasma half-life and##2##3##(1993-8#1)(2008-10#1)
plasma half-life##6##2##(1993-8#2)(2008-10#1)(2008-5#2)(2012-2#1)
plasma homocyst(e)ine##3##2##(1995-2#3)
plasma homocysteine##5##2##(1991-12#1)(1992-9#2)(2008-7#2)
plasma in##3##2##(1991-3#1)(1994-2#1)(2011-2#1)
plasma insulin and corticosterone##2##4##(1996-12#2)
plasma insulin and##3##3##(1996-12#2)(2010-10#1)
plasma insulin concentration##2##3##(2010-10#1)(2012-2#1)
plasma insulin levels##2##3##(1991-7#1)(1994-8#1)
plasma insulin##9##2##(1991-7#1)(1994-8#1)(1996-12#2)(2008-7#2)(2010-10#2)(2012-2#1)
plasma is reported##2##3##(2008-10#1)(2010-3#1)
plasma is##12##2##(1990-12#2)(1990-5#1)(1991-12#1)(1993-2#1)(2008-10#5)(2008-9#1)(2010-3#1)
plasma leptin##2##2##(2013-1#2)
plasma level during##2##3##(1990-9#1)(2008-12#1)
plasma level of##3##3##(1990-8#1)(1992-6#1)(2008-12#1)
plasma level##8##2##(1990-8#1)(1990-9#1)(1992-6#1)(2008-12#4)(2012-2#1)
plasma levels and##2##3##(2008-7#1)(2011-2#1)
plasma levels of##9##3##(1994-2#1)(1996-12#1)(1997-2#2)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
plasma levels were##2##3##(2008-7#1)(2011-2#1)
plasma levels##20##2##(1991-3#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-2#2)(2008-10#1)(2008-6#1)(2008-7#4)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)
plasma lipid peroxidation and##2##4##(2008-7#2)
plasma lipid##6##2##(1991-12#1)(1997-8#1)(2008-7#2)(2012-2#2)
plasma lipids and##2##3##(1993-1#1)(1996-8#1)
plasma lipids##4##2##(1993-1#1)(1996-11#1)(1996-8#2)
plasma lipoproteins##4##2##(2012-2#4)
plasma mass spectrometry and Raman##2##5##(2013-8#2)
plasma mass spectrometry##74##3##(2008-10#69)(2010-11#3)(2013-8#2)
plasma mass##79##2##(2008-10#74)(2010-11#3)(2013-8#2)
plasma materials##2##2##(2008-10#2)
plasma membrane and the##4##4##(1990-12#1)(2008-10#1)(2008-11#1)(2009-8#1)
plasma membrane and##10##3##(1990-12#1)(1994-11#1)(1995-6#1)(2008-10#3)(2008-11#1)(2009-8#1)(2009-9#1)(2011-3#1)
plasma membrane are##2##3##(1990-5#1)(2008-11#1)
plasma membrane electron transport and##2##5##(2009-9#2)
plasma membrane electron transport##3##4##(2009-9#3)
plasma membrane marker##2##3##(1990-5#1)(2008-11#1)
plasma membrane of##14##3##(1990-12#2)(1990-5#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-7#1)(2008-8#4)(2010-11#1)(2010-12#1)(2011-2#1)
plasma membrane protein##3##3##(1995-2#2)(2008-11#1)
plasma membrane proteins and##2##4##(1995-12#1)(2008-7#1)
plasma membrane proteins by##2##4##(1995-12#1)(2008-11#1)
plasma membrane proteins of##2##4##(1995-12#2)
plasma membrane proteins##7##3##(1995-12#4)(1995-2#1)(2008-11#1)(2008-7#1)
plasma membrane was##2##3##(1994-11#1)(2008-11#1)
plasma membrane were##2##3##(1993-3#1)(2012-3#1)
plasma membrane##93##2##(1990-12#3)(1990-5#6)(1991-3#1)(1992-12#2)(1993-1#1)(1993-3#2)(1993-8#2)(1994-11#3)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#4)(1995-2#8)(1995-6#3)(1996-3#1)(2008-10#7)(2008-11#13)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#8)(2010-11#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
plasma membranes in the##2##4##(1994-5#1)(1995-8#1)
plasma membranes in##3##3##(1994-5#1)(1995-8#1)(2008-7#1)
plasma membranes of##3##3##(1995-2#1)(2008-10#1)(2010-10#1)
plasma membranes##27##2##(1991-5#1)(1994-11#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#5)(1997-1#4)(2008-10#3)(2008-11#4)(2008-7#2)(2010-10#1)
plasma obtained##2##2##(2008-10#1)(2010-11#1)
plasma of the##2##3##(1992-6#1)(1994-11#1)
plasma of##12##2##(1992-6#4)(1994-11#1)(2008-10#2)(2012-2#2)(2013-1#3)
plasma or erythrocyte##2##3##(1991-12#1)(2008-7#1)
plasma or##3##2##(1991-12#1)(2008-7#1)(2010-11#1)
plasma potassium##3##2##(1993-1#3)
plasma protein##4##2##(1994-3#1)(2008-10#2)(2009-10#1)
plasma proteins##8##2##(1990-8#1)(1995-2#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-5#1)(2011-2#1)
plasma sample##2##2##(2008-10#2)
plasma samples (n =##2##4##(2012-3#2)
plasma samples and##2##3##(2008-10#2)
plasma samples of##3##3##(2008-10#2)(2013-1#1)
plasma samples using##2##3##(2008-10#2)
plasma samples were##6##3##(1990-12#1)(2008-10#4)(2011-3#1)
plasma samples##28##2##(1990-12#1)(1991-9#1)(1993-2#1)(1997-3#1)(2008-10#18)(2011-3#1)(2012-3#3)(2013-1#1)(2013-8#1)
plasma source mass spectrometry##3##4##(2008-10#3)
plasma spectrometer##2##2##(2008-10#2)
plasma spectrometric##2##2##(2008-10#2)
plasma spectrometry##6##2##(2008-10#5)(2008-7#1)
plasma torch##9##2##(2008-10#9)
plasma total##6##2##(1993-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
plasma triglyceride##2##2##(1994-11#1)(2008-3#1)
plasma using##7##2##(2008-10#7)
plasma vitamin E##2##3##(1990-8#2)
plasma vitamin##3##2##(1990-8#2)(1993-12#1)
plasma volume##3##2##(1995-2#1)(2011-2#2)
plasma was##6##2##(1991-3#1)(2008-10#4)(2013-1#1)
plasma water##4##2##(1993-2#4)
plasma were##9##2##(2008-10#9)
plasma with##6##2##(2006-6#1)(2008-10#5)
plasma##936##1##(1990-11#3)(1990-12#11)(1990-2#3)(1990-5#11)(1990-6#2)(1990-8#5)(1990-9#1)(1991-1#1)(1991-12#9)(1991-2#2)(1991-3#8)(1991-4#1)(1991-5#4)(1991-7#2)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#12)(1992-3#10)(1992-5#1)(1992-6#11)(1992-8#3)(1992-9#18)(1993-1#6)(1993-11#3)(1993-12#1)(1993-2#13)(1993-3#3)(1993-5#1)(1993-8#5)(1994-11#7)(1994-12#5)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#1)(1994-8#10)(1995-11#2)(1995-12#7)(1995-2#18)(1995-6#5)(1995-8#8)(1996-11#1)(1996-12#3)(1996-3#2)(1996-5#1)(1996-8#3)(1997-1#5)(1997-2#7)(1997-3#2)(1997-8#3)(2006-6#2)(2008-1#1)(2008-10#383)(2008-11#30)(2008-12#9)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#40)(2008-8#9)(2008-9#11)(2009-10#3)(2009-3#1)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#8)(2010-10#6)(2010-11#9)(2010-12#8)(2010-3#2)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#32)(2011-3#6)(2012-12#3)(2012-2#28)(2012-3#12)(2013-1#19)(2013-8#13)
plasma's electron temperature##2##3##(2008-3#2)
plasma)##6##1##(1992-3#1)(1995-2#1)(2008-10#2)(2008-8#1)(2010-7#1)
plasma-atomic emission spectroscopy (ICP-AES)##3##4##(2008-10#3)
plasma-atomic emission##19##2##(2008-10#19)
plasma-based##2##1##(1996-5#1)(2008-10#1)
plasma-enhanced chemical vapor deposition##3##4##(2008-3#3)
plasma-mass spectrometer (ICP-MS)##2##3##(2008-10#2)
plasma-mass spectrometer##3##2##(2008-10#3)
plasma-mass##20##1##(2008-10#20)
plasma-polymerized##2##1##(2008-10#2)
plasma]##2##1##(1992-5#1)(2011-3#1)
plasmacytoma of the##3##3##(2009-3#2)(2012-12#1)
plasmacytoma##10##1##(2008-4#1)(2009-3#3)(2011-2#2)(2012-12#4)
plasmalemma of##4##2##(1995-2#1)(2008-10#3)
plasmalemma##14##1##(1995-2#1)(1997-7#2)(2007-12#1)(2008-10#7)(2008-8#3)
plasmalemmal##2##1##(1995-2#2)
plasmapheresis##3##1##(2012-3#2)(2013-8#1)
plasmas##4##1##(1991-9#1)(1992-8#1)(1993-5#1)(2008-10#1)
plasmatic and##2##2##(2008-7#1)(2013-1#1)
plasmatic concentration##3##2##(1991-11#1)(1992-9#2)
plasmatic##5##1##(1991-11#1)(1992-9#2)(2008-7#1)(2013-1#1)
plasmepsin 2##2##2##(2008-4#2)
plasmepsin##3##1##(2008-4#3)
plasmepsins##3##1##(2008-4#3)
plasmid DNA and##2##3##(2008-10#1)(2008-11#1)
plasmid DNA from##3##3##(2008-10#1)(2008-11#2)
plasmid DNA has##2##3##(2008-10#1)(2010-8#1)
plasmid DNA into##2##3##(2008-4#2)
plasmid DNA is##2##3##(1997-8#1)(2008-2#1)
plasmid DNA##34##2##(1994-11#3)(1997-8#2)(2008-10#9)(2008-11#9)(2008-2#2)(2008-4#2)(2008-8#4)(2008-9#1)(2010-8#1)(2011-2#1)
plasmid and chromosomal##2##3##(1996-6#1)(2008-10#1)
plasmid and##9##2##(1993-9#1)(1994-8#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
plasmid by##2##2##(2008-10#1)(2008-8#1)
plasmid containing a##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
plasmid containing##7##2##(1993-8#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#2)
plasmid content##2##2##(2008-7#1)(2012-3#1)
plasmid encoding the##2##3##(2010-6#2)
plasmid encoding##4##2##(1991-3#1)(2010-11#1)(2010-6#2)
plasmid expressing##3##2##(2008-11#1)(2008-9#2)
plasmid integration##2##2##(2008-10#2)
plasmid is##5##2##(1990-11#1)(1997-2#1)(1997-3#1)(2008-8#1)(2011-1#1)
plasmid of approximately 70 kb##2##5##(2008-10#2)
plasmid of##5##2##(1995-6#1)(1996-6#1)(2008-10#2)(2008-9#1)
plasmid or##4##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
plasmid pKYM is##2##3##(1997-6#2)
plasmid pKYM##4##2##(1997-6#4)
plasmid pRL-rhTNF##2##2##(2008-8#2)
plasmid profiles##2##2##(2008-10#2)
plasmid replication##3##2##(1994-11#2)(2008-11#1)
plasmid stability and protein##2##4##(2008-7#2)
plasmid system##3##2##(1993-9#2)(2011-1#1)
plasmid that##5##2##(1993-3#2)(1997-6#2)(2008-10#1)
plasmid vector##11##2##(1990-5#2)(1992-3#1)(1993-12#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-8#1)
plasmid vectors##6##2##(1993-12#1)(1993-2#1)(1993-9#1)(1995-5#2)(2008-11#1)
plasmid was introduced into##2##4##(1990-8#1)(1994-8#1)
plasmid was##7##2##(1990-8#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
plasmid which##2##2##(1993-9#1)(2008-11#1)
plasmid with a##2##3##(1993-9#1)(2008-10#1)
plasmid with##5##2##(1993-3#1)(1993-9#1)(1995-2#2)(2008-10#1)
plasmid##226##1##(1990-11#2)(1990-5#6)(1990-8#2)(1991-3#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-12#5)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#11)(1994-11#5)(1994-12#2)(1994-8#6)(1995-2#5)(1995-5#3)(1995-6#2)(1996-12#2)(1996-3#1)(1996-6#5)(1997-2#7)(1997-3#1)(1997-6#7)(1997-8#4)(2008-10#42)(2008-11#33)(2008-2#3)(2008-4#4)(2008-7#6)(2008-8#22)(2008-9#13)(2010-11#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)
plasmid)##2##1##(2008-10#1)(2008-11#1)
plasmid-borne cpe-carrying C##2##3##(2011-2#2)
plasmid-borne cpe-carrying##3##2##(2011-2#3)
plasmid-borne##4##1##(2011-2#4)
plasmid-carrying cells##4##2##(2008-7#4)
plasmid-carrying##5##1##(2008-7#5)
plasmid-encoded##5##1##(1991-10#2)(1994-5#1)(1997-6#1)(2011-2#1)
plasmid/liposomes and##2##2##(2008-8#2)
plasmid/liposomes##3##1##(2008-8#3)
plasmids and##3##2##(1993-12#1)(1997-6#1)(2008-10#1)
plasmids carrying##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
plasmids containing the##2##3##(1994-12#1)(2008-8#1)
plasmids containing##4##2##(1994-12#1)(1997-3#1)(2008-8#1)(2013-8#1)
plasmids efficiently##2##2##(2008-8#2)
plasmids encoding the##2##3##(1993-6#1)(1995-2#1)
plasmids for the##2##3##(1993-9#1)(1997-8#1)
plasmids in##2##2##(1997-6#1)(1997-7#1)
plasmids into##2##2##(2008-11#1)(2012-3#1)
plasmids of size##2##3##(2011-2#2)
plasmids of##5##2##(2008-10#2)(2011-2#3)
plasmids were##12##2##(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-6#2)(2012-3#1)
plasmids##85##1##(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-6#3)(1997-3#1)(1997-6#3)(1997-7#2)(1997-8#3)(2008-10#13)(2008-11#4)(2008-5#3)(2008-8#11)(2008-9#5)(2010-1#1)(2010-6#2)(2011-2#6)(2012-2#1)(2012-3#10)(2013-8#2)
plasmin and MMP-2 activity##2##4##(2011-2#2)
plasmin##13##1##(1993-8#2)(1994-3#3)(1995-6#3)(2011-2#4)(2013-1#1)
plasminogen activator (t-PA)##3##3##(1995-8#1)(2008-11#2)
plasminogen activator (tPA)##2##3##(2008-11#1)(2008-8#1)
plasminogen activator activity in##4##4##(2008-11#3)(2010-3#1)
plasminogen activator activity##6##3##(2008-11#5)(2010-3#1)
plasminogen activator inhibitor-1##2##3##(1997-1#1)(2011-2#1)
plasminogen activator was##2##3##(1995-6#1)(2008-7#1)
plasminogen activator##37##2##(1990-8#1)(1992-7#1)(1994-3#2)(1994-5#1)(1995-6#2)(1995-8#1)(1997-1#2)(2007-9#1)(2008-11#13)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-8#1)
plasminogen activators##4##2##(1990-11#1)(1992-6#2)(1995-6#1)
plasminogen and##3##2##(1993-8#1)(1994-11#2)
plasminogen##64##1##(1990-11#1)(1990-8#1)(1992-6#2)(1992-7#1)(1993-2#3)(1993-8#5)(1994-11#2)(1994-3#2)(1994-5#2)(1995-6#8)(1995-8#2)(1996-8#1)(1997-1#2)(2007-9#1)(2008-11#14)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-3#2)(2011-2#1)(2013-1#2)(2013-8#2)
plasmodesmata##2##1##(1997-3#1)(2008-10#1)
plasmodia##2##1##(2008-10#2)
plasmon resonance (SPR)##17##3##(2008-10#14)(2008-11#1)(2008-4#1)(2008-9#1)
plasmon resonance##42##2##(1992-11#1)(1995-12#1)(2008-10#33)(2008-11#1)(2008-4#2)(2008-9#1)(2009-12#1)(2010-1#1)(2013-1#1)
plasmon##43##1##(1992-11#1)(1995-12#1)(2008-10#33)(2008-11#1)(2008-4#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#1)(2013-1#1)
plasmons##5##1##(2007-12#1)(2008-11#1)(2012-2#3)
plaster##2##1##(1991-12#1)(2011-2#1)
plastic and reconstructive surgery##2##4##(2008-11#2)
plastic and##7##2##(1991-3#1)(2008-10#1)(2008-11#5)
plastic beads##3##2##(2008-10#2)(2008-8#1)
plastic corrector##2##2##(2013-1#2)
plastic cover##2##2##(2008-10#2)
plastic device and ceramic knives##2##5##(2008-10#2)
plastic graded-index##2##2##(2007-12#2)
plastic optical fibers (POF's)##2##4##(2008-3#2)
plastic optical fibers##4##3##(2008-3#4)
plastic optical##7##2##(2008-3#5)(2010-4#2)
plastic pigments##3##2##(2008-3#3)
plastic products for food use##2##5##(2008-10#2)
plastic strain was##2##3##(2009-7#2)
plastic strain##7##2##(2009-7#7)
plastic surgery##11##2##(1990-3#1)(1990-9#2)(2013-1#8)
plastic type##4##2##(2008-8#4)
plastic##106##1##(1990-3#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1992-2#1)(1993-6#1)(1994-8#3)(1995-3#1)(1996-3#1)(1997-6#2)(2007-12#3)(2008-10#27)(2008-11#10)(2008-3#10)(2008-4#1)(2008-5#1)(2008-8#10)(2008-9#2)(2009-3#1)(2009-7#8)(2010-4#2)(2012-2#1)(2012-4#1)(2013-1#14)
plasticised PVC##3##2##(2008-10#3)
plasticised##4##1##(2008-10#4)
plasticiser##2##1##(2008-10#2)
plasticising##2##1##(2008-10#1)(2008-5#1)
plasticity and cellular resilience##2##4##(2008-7#2)
plasticity and##12##2##(2008-11#2)(2008-7#4)(2008-8#3)(2008-9#1)(2012-5#1)(2013-8#1)
plasticity are##2##2##(2008-8#1)(2009-9#1)
plasticity has##3##2##(2008-8#1)(2012-2#2)
plasticity in the hippocampal##2##4##(2008-4#1)(2008-7#1)
plasticity in the##10##3##(1996-12#2)(2008-11#2)(2008-4#1)(2008-7#4)(2012-2#1)
plasticity in##18##2##(1995-2#1)(1996-12#2)(2008-11#2)(2008-4#3)(2008-7#5)(2008-8#2)(2008-9#1)(2012-2#1)(2012-9#1)
plasticity is##5##2##(2008-11#1)(2008-4#1)(2008-8#3)
plasticity of nigrostriatal DAergic neurons##2##5##(2013-7#2)
plasticity of the##2##3##(2008-7#1)(2012-2#1)
plasticity of##9##2##(1996-12#1)(1997-7#1)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-7#2)
plasticity##116##1##(1993-12#3)(1995-2#2)(1996-12#3)(1997-7#3)(2008-1#2)(2008-10#1)(2008-11#13)(2008-4#5)(2008-7#17)(2008-8#27)(2008-9#6)(2009-3#4)(2009-6#1)(2009-8#2)(2009-9#2)(2010-7#1)(2011-2#2)(2012-2#11)(2012-5#1)(2012-9#2)(2013-1#4)(2013-7#2)(2013-8#2)
plasticization##2##1##(2010-4#1)(2012-2#1)
plasticized PVC membranes##5##3##(2008-10#5)
plasticized PVC##10##2##(2008-10#10)
plasticized cellulose triacetate membranes##2##4##(2008-10#2)
plasticized poly (vinyl chloride) (PVC)##2##5##(2008-10#2)
plasticized poly##3##2##(2008-10#3)
plasticized poly(vinyl chloride) (PVC) membrane##2##5##(2008-10#2)
plasticized poly(vinyl chloride) (PVC) membranes##2##5##(2008-10#2)
plasticized poly(vinyl chloride) (PVC)##5##4##(2008-10#5)
plasticized poly(vinyl chloride) membrane##4##4##(2008-10#4)
plasticized poly(vinyl chloride)##12##3##(2008-10#12)
plasticized polymer##2##2##(2008-10#2)
plasticized polymeric##2##2##(2008-10#2)
plasticized with o-NPOE##2##3##(2008-10#2)
plasticized with##8##2##(2008-10#8)
plasticized##46##1##(1995-3#1)(2008-10#45)
plasticizer admixtures##5##2##(2008-10#5)
plasticizer and molecular weight of cyanocopolymers##2##6##(2008-10#2)
plasticizer and the##2##3##(2008-10#2)
plasticizer and##10##2##(2008-10#10)
plasticizer in##2##2##(2008-10#2)
plasticizer nature##3##2##(2008-10#3)
plasticizer##41##1##(2008-10#41)
plasticizers in plastic##2##3##(2008-10#2)
plasticizers##20##1##(2008-10#16)(2008-5#4)
plastics and##2##2##(2008-10#1)(2010-9#1)
plastics##9##1##(2008-10#6)(2008-3#1)(2010-9#1)(2013-1#1)
plastid gene expression##2##3##(2011-2#2)
plastid##10##1##(2008-1#1)(2009-10#2)(2010-10#1)(2011-2#6)
plastids##6##1##(2008-10#1)(2008-9#3)(2011-2#2)
plastocyanin has been##2##3##(1994-5#1)(2009-10#1)
plastocyanin isoforms##3##2##(2009-10#3)
plastocyanin##17##1##(1990-5#1)(1994-5#6)(2009-10#10)
plastocyanins##3##1##(1994-5#3)
plastoquinone synthesis##2##2##(1994-11#2)
plastoquinone##4##1##(1994-11#3)(2010-10#1)
plate -##2##2##(2013-1#2)
plate and##10##2##(1994-12#1)(1994-5#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)
plate assay##2##2##(2008-11#1)(2008-9#1)
plate assays##3##2##(2008-10#3)
plate containing##2##2##(2008-11#1)(2008-8#1)
plate counts##4##2##(2008-10#4)
plate fixation##4##2##(2009-10#3)(2011-2#1)
plate is##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
plate lysis##2##2##(2009-6#2)
plate method##4##2##(2008-10#3)(2010-3#1)
plate numbers##2##2##(2008-10#2)
plate of##3##2##(2008-10#2)(2008-8#1)
plate reader##2##2##(2008-10#2)
plate surface##3##2##(2008-10#1)(2008-8#2)
plate test##4##2##(1992-3#1)(1996-2#2)(2011-2#1)
plate tests##3##2##(1994-3#1)(2008-10#2)
plate was used to##2##4##(2008-10#1)(2010-9#1)
plate was used##3##3##(2008-10#1)(2008-2#1)(2010-9#1)
plate was##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-9#1)
plate with##6##2##(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
plate##156##1##(1992-3#1)(1993-12#2)(1994-12#4)(1994-3#1)(1994-5#1)(1996-12#1)(1996-2#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#58)(2008-11#15)(2008-2#2)(2008-3#9)(2008-5#3)(2008-7#7)(2008-8#7)(2008-9#7)(2009-10#8)(2009-12#1)(2009-6#2)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#11)(2012-2#1)(2013-1#6)
plate)##2##1##(2008-10#1)(2008-11#1)
plateau level##3##2##(1994-6#2)(1997-1#1)
plateau stresses and elastic moduli##2##5##(2009-7#2)
plateau##40##1##(1990-12#1)(1992-3#1)(1992-9#1)(1994-6#5)(1995-6#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#6)
plateaus##2##1##(2008-10#1)(2012-2#1)
plated in situ##2##3##(2008-10#2)
plated in##7##2##(2008-10#4)(2008-12#1)(2013-1#2)
plated on a##3##3##(2008-10#2)(2012-4#1)
plated on capsules extended##2##4##(1997-3#2)
plated on##12##2##(1992-6#1)(1997-3#3)(2008-10#4)(2008-11#1)(2008-5#1)(2012-4#2)
plated##25##1##(1992-6#1)(1997-3#4)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#1)(2012-4#2)(2013-1#2)
platelet activation and aggregation##2##4##(2006-6#2)
platelet activation and##4##3##(1992-6#1)(2006-6#2)(2008-9#1)
platelet activation##15##2##(1990-5#1)(1990-8#1)(1992-4#1)(1992-6#1)(1994-3#1)(1997-6#1)(2006-6#5)(2008-10#1)(2008-9#3)
platelet aggregability##3##2##(1991-12#2)(2008-7#1)
platelet aggregation and##4##3##(1990-12#2)(1990-8#1)(1992-4#1)
platelet aggregation in response to##2##5##(1992-4#1)(2008-5#1)
platelet aggregation in vitro and##3##5##(2006-6#3)
platelet aggregation in vitro##4##4##(2006-6#4)
platelet aggregation in##7##3##(1992-4#1)(2006-6#4)(2008-5#1)(2011-2#1)
platelet aggregation##33##2##(1990-12#2)(1990-8#1)(1991-12#3)(1992-4#2)(1993-3#1)(1993-8#1)(1994-8#1)(1995-8#1)(1997-6#1)(2006-6#8)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-8#3)(2011-2#2)
platelet and leukocyte activation##2##4##(2006-6#2)
platelet and##7##2##(1992-8#1)(2006-6#2)(2008-10#2)(2008-11#1)(2008-7#1)
platelet count##8##2##(2006-6#2)(2007-12#1)(2008-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
platelet counts##9##2##(1990-10#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#3)(2011-2#1)
platelet cross-matching##4##2##(2011-2#4)
platelet deposition##4##2##(1992-9#1)(2006-6#3)
platelet derived##2##2##(2008-11#1)(2013-1#1)
platelet fatty##2##2##(1991-12#2)
platelet fibrinogen receptor##4##3##(1993-8#1)(2006-6#3)
platelet function##8##2##(1992-9#1)(1993-8#1)(2006-6#2)(2008-1#2)(2008-7#1)(2012-12#1)
platelet homogenates##2##2##(1994-8#2)
platelet lysate medium##2##3##(2008-11#2)
platelet lysate was##3##3##(2008-11#3)
platelet lysate##9##2##(2008-11#9)
platelet magnesium##3##2##(2008-7#3)
platelet membranes with##2##3##(1992-3#1)(1995-11#1)
platelet membranes##3##2##(1992-3#2)(1995-11#1)
platelet production##2##2##(2006-6#1)(2008-8#1)
platelet response##2##2##(1990-5#1)(2011-2#1)
platelet stimulation with##3##3##(1992-6#2)(2008-9#1)
platelet surface##3##2##(2006-6#1)(2008-9#2)
platelet thrombus formation##4##3##(2006-6#4)
platelet transfusion##5##2##(1991-3#1)(2006-6#1)(2011-2#3)
platelet transfusions associated with##2##4##(2011-2#2)
platelet transfusions##5##2##(2008-11#1)(2011-2#4)
platelet volume##3##2##(1991-12#1)(2008-10#1)(2008-7#1)
platelet##197##1##(1990-10#2)(1990-12#4)(1990-5#3)(1990-8#2)(1991-11#2)(1991-12#8)(1991-3#1)(1992-12#7)(1992-3#2)(1992-4#4)(1992-6#3)(1992-8#1)(1992-9#2)(1993-3#2)(1993-8#3)(1994-11#1)(1994-3#1)(1994-8#4)(1995-11#1)(1995-8#2)(1997-6#6)(2006-6#43)(2007-12#2)(2008-1#3)(2008-10#6)(2008-11#13)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#8)(2008-8#8)(2008-9#10)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#5)(2011-2#23)(2012-12#2)(2013-1#1)(2013-8#1)
platelet-activating factor (PAF)##2##3##(1991-5#1)(2009-3#1)
platelet-activating factor##4##2##(1991-5#2)(2008-10#1)(2009-3#1)
platelet-activating##5##1##(1991-5#2)(1994-5#1)(2008-10#1)(2009-3#1)
platelet-derived growth factor (PDGF)##2##4##(1995-11#1)(2008-11#1)
platelet-derived growth factor receptor##2##4##(2013-1#1)(2013-8#1)
platelet-derived growth factor##8##3##(1995-11#2)(1997-7#1)(2008-11#1)(2009-3#1)(2013-1#2)(2013-8#1)
platelet-derived growth factor-AA##2##3##(1991-12#1)(1995-11#1)
platelet-derived growth##11##2##(1991-12#1)(1995-11#4)(1997-7#1)(2008-11#1)(2009-3#1)(2013-1#2)(2013-8#1)
platelet-derived##12##1##(1991-12#1)(1995-11#4)(1997-7#1)(2008-11#2)(2009-3#1)(2013-1#2)(2013-8#1)
platelet-leukocyte conjugate formation in whole blood##3##6##(2006-6#3)
platelet-leukocyte##4##1##(2006-6#4)
platelet-monocyte##2##1##(2006-6#2)
platelet-rich plasma##2##2##(2006-6#1)(2008-1#1)
platelet-specific##2##1##(2008-9#2)
platelets aggregate with##2##3##(2008-1#1)(2008-9#1)
platelets also##2##2##(2006-6#2)
platelets and monocytes##2##3##(2006-6#1)(2008-9#1)
platelets and##16##2##(1992-12#2)(1993-8#1)(1994-5#1)(2006-6#5)(2008-11#1)(2008-7#1)(2008-9#2)(2009-3#2)(2011-2#1)
platelets are##3##2##(1992-12#1)(2006-6#1)(2011-2#1)
platelets as##2##2##(1990-5#1)(1995-8#1)
platelets at##2##2##(1992-6#1)(2008-1#1)
platelets by##6##2##(1992-12#1)(1992-4#1)(2006-6#2)(2008-7#1)(2008-9#1)
platelets can##2##2##(2006-6#1)(2008-9#1)
platelets from##3##2##(1991-12#1)(1992-12#1)(2006-6#1)
platelets had##2##2##(2006-6#2)
platelets in plasma##2##3##(1990-5#1)(2008-8#1)
platelets in##10##2##(1990-5#1)(1991-12#1)(2006-6#1)(2008-1#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#1)
platelets is##4##2##(1992-12#1)(1993-8#1)(2006-6#1)(2008-9#1)
platelets may##2##2##(1992-12#1)(2006-6#1)
platelets on##4##2##(2006-6#3)(2010-3#1)
platelets to##2##2##(2006-6#1)(2008-5#1)
platelets was##5##2##(1992-6#1)(1994-3#1)(1995-11#1)(2006-6#1)(2008-5#1)
platelets were##7##2##(1992-6#1)(1993-8#1)(1994-3#1)(2006-6#3)(2011-2#1)
platelets##139##1##(1990-10#1)(1990-11#1)(1990-5#4)(1990-8#2)(1991-12#2)(1992-12#7)(1992-4#1)(1992-6#8)(1993-3#1)(1993-8#10)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#3)(1995-8#1)(1997-6#1)(2006-6#46)(2007-12#1)(2008-1#6)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#15)(2009-12#1)(2009-3#3)(2010-3#2)(2011-2#7)(2012-3#1)
platelike##2##1##(2008-3#2)
platensis##5##1##(2008-10#1)(2008-8#4)
plates and a##2##3##(1990-12#1)(2008-10#1)
plates and##11##2##(1990-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#3)(2013-1#1)
plates are##2##2##(1990-12#1)(2008-3#1)
plates containing##4##2##(2008-10#3)(2008-5#1)
plates for##6##2##(2008-10#3)(2008-9#1)(2010-11#1)(2010-6#1)
plates have##2##2##(1996-11#1)(2008-3#1)
plates in##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
plates of##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)
plates per meter##2##3##(2008-10#2)
plates precoated with##3##3##(2008-10#1)(2008-11#2)
plates showed##2##2##(2008-11#1)(2011-2#1)
plates to##2##2##(2008-10#1)(2008-11#1)
plates was##4##2##(2008-10#4)
plates were##2##2##(1990-12#1)(2008-11#1)
plates with##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
plates##105##1##(1990-11#1)(1990-12#3)(1993-12#1)(1995-12#1)(1996-11#1)(2007-12#3)(2008-10#39)(2008-11#16)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#7)(2008-9#5)(2009-6#2)(2010-10#1)(2010-11#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#7)(2012-3#2)(2012-5#1)(2013-1#1)
platform and##3##2##(2008-9#1)(2010-7#1)(2013-8#1)
platform can be##2##3##(2008-10#1)(2013-1#1)
platform for a##2##3##(2008-10#1)(2008-11#1)
platform for the##6##3##(1994-12#1)(1996-3#1)(2008-10#3)(2011-2#1)
platform for##31##2##(1994-12#2)(1994-6#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-4#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
platform of##5##2##(2008-10#4)(2009-12#1)
platform surface##2##2##(2008-10#2)
platform that##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
platform to##9##2##(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-9#1)(2012-2#2)(2012-3#1)
platform upon which##2##3##(2010-12#1)(2012-2#1)
platform##105##1##(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#35)(2008-11#17)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#4)(2009-12#3)(2009-5#1)(2009-9#1)(2010-10#2)(2010-12#5)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#1)
platforms and##3##2##(1995-12#1)(2010-7#1)(2013-8#1)
platforms for##2##2##(2013-1#2)
platforms##20##1##(1990-11#2)(1995-12#1)(2008-10#8)(2009-4#1)(2010-7#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
plating and##3##2##(1994-3#1)(2008-10#2)
plating assays##2##2##(2008-10#2)
plating of##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
plating on##2##2##(2008-10#2)
plating onto##2##2##(2008-10#2)
plating##28##1##(1992-6#1)(1994-3#1)(2008-10#20)(2008-11#2)(2008-9#3)(2009-6#1)
platinised carbon##2##2##(2008-10#2)
platinum (Pt)##4##2##(2008-10#3)(2008-11#1)
platinum and palladium##9##3##(2008-10#9)
platinum and##17##2##(2008-10#17)
platinum black##2##2##(2008-10#2)
platinum coil##2##2##(2008-7#2)
platinum concentrations##2##2##(2008-10#2)
platinum dish##2##2##(2008-10#2)
platinum disk electrode##3##3##(2008-10#3)
platinum electrode in the##2##4##(2008-10#2)
platinum electrode in##3##3##(2008-10#3)
platinum electrode were##2##3##(2008-10#2)
platinum electrode##16##2##(2008-10#16)
platinum electrodes##7##2##(2008-10#7)
platinum group elements (PGEs)##2##4##(2008-10#2)
platinum group elements##7##3##(2008-10#5)(2008-11#2)
platinum group metals##7##3##(2008-10#7)
platinum group##15##2##(2008-10#13)(2008-11#2)
platinum in##3##2##(2008-10#2)(2008-11#1)
platinum wire##4##2##(2008-10#4)
platinum##124##1##(1993-11#1)(1993-8#1)(1997-5#1)(1997-6#1)(2008-10#111)(2008-11#5)(2008-7#3)(2008-9#1)
platinum(II)##12##1##(2008-10#10)(2012-3#2)
platinum(IV)##9##1##(2008-10#9)
platinum-based##3##1##(2008-10#2)(2008-11#1)
platyfish (Xiphophorus##2##2##(2008-12#2)
platyfish##4##1##(2008-12#4)
plausible explanation##2##2##(2008-10#1)(2008-3#1)
plausible mechanism##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
plausible##38##1##(1990-12#1)(1990-3#1)(1990-8#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-8#1)(1996-3#1)(1997-2#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#2)
play a central role in determining##2##6##(2009-10#1)(2013-1#1)
play a central role in##6##5##(1995-5#1)(2008-10#1)(2009-10#1)(2011-3#1)(2013-1#1)(2013-8#1)
play a certain role in##3##5##(2008-8#3)
play a critical role in the##4##6##(1990-11#1)(2008-11#1)(2008-8#1)(2011-2#1)
play a critical role in##15##5##(1990-11#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-7#1)
play a critical role##17##4##(1990-11#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-7#1)
play a critical##18##3##(1990-11#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-7#1)
play a crucial role in the##4##6##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
play a crucial role in##8##5##(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)
play a crucial role##10##4##(1992-10#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2012-2#1)
play a crucial##11##3##(1992-10#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)(2012-2#1)
play a key role in the development of##2##8##(2008-1#1)(2010-11#1)
play a key role in the##11##6##(1995-11#1)(2008-1#1)(2008-10#3)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#3)
play a key role in##18##5##(1994-2#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#4)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)
play a key role##20##4##(1994-2#1)(1995-11#1)(1995-2#1)(1997-5#1)(2008-1#1)(2008-10#4)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#1)
play a major role in the##2##6##(1991-6#1)(2009-7#1)
play a major role in##13##5##(1991-6#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-5#1)(2009-7#2)(2009-8#3)(2011-1#1)(2013-1#1)
play a major role##14##4##(1991-6#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#3)(2011-1#1)(2013-1#1)
play a minor role##2##4##(2008-10#2)
play a part in##2##4##(1997-1#1)(2013-8#1)
play a part##3##3##(1996-11#1)(1997-1#1)(2013-8#1)
play a pivotal role in the##3##6##(1994-2#1)(1995-2#1)(2008-11#1)
play a pivotal role in##10##5##(1994-2#1)(1995-2#1)(1997-8#1)(2008-11#2)(2008-6#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
play a pivotal role##13##4##(1992-9#1)(1994-2#1)(1995-2#1)(1997-8#1)(2008-11#2)(2008-6#1)(2009-12#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
play a primary##2##3##(2008-12#1)(2009-3#1)
play a prominent role##2##4##(1990-5#1)(2008-9#1)
play a role as##2##4##(1992-9#1)(2011-2#1)
play a role in controlling##2##5##(2008-10#2)
play a role in normal##2##5##(2008-5#1)(2009-10#1)
play a role in the early##2##6##(1994-11#1)(1997-3#1)
play a role in the modulation of##2##7##(2012-2#1)(2013-8#1)
play a role in the pathogenesis of##2##7##(1992-6#1)(2009-1#1)
play a role in the regulation of##3##7##(1990-5#1)(1992-12#1)(1992-6#1)
play a role in the survival##2##6##(2008-10#2)
play a role in the##34##5##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-6#2)(1994-1#1)(1994-11#1)(1995-8#1)(1996-12#2)(1997-3#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-4#1)(2011-10#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
play a role in##82##4##(1990-11#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-5#1)(1992-10#1)(1992-12#2)(1992-6#4)(1993-3#1)(1994-1#1)(1994-11#2)(1994-8#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-3#2)(1997-7#3)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#2)(2009-10#2)(2009-4#1)(2009-7#3)(2010-1#1)(2010-10#2)(2010-7#1)(2011-10#2)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#2)
play a role##94##3##(1990-11#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#2)(1992-6#4)(1992-9#1)(1993-3#1)(1994-1#1)(1994-11#2)(1994-8#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#2)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#2)(2009-10#3)(2009-4#1)(2009-7#3)(2010-1#1)(2010-10#2)(2010-7#1)(2011-10#2)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#2)
play a significant role in the##5##6##(1995-6#1)(2008-10#1)(2008-4#1)(2012-2#2)
play a significant role in##13##5##(1995-6#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2012-2#2)(2013-8#1)
play a significant role##14##4##(1995-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2012-2#2)(2013-8#1)
play a similar role##2##4##(1997-7#1)(2008-7#1)
play a substantial##2##3##(2008-11#1)(2008-9#1)
play a##232##2##(1990-11#2)(1990-5#3)(1990-7#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-10#2)(1992-12#2)(1992-3#1)(1992-6#4)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#3)(1994-8#3)(1995-11#1)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-7#4)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#29)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#6)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-10#2)(2011-2#17)(2011-3#1)(2012-12#3)(2012-2#10)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#6)
play an active role##2##4##(1996-3#1)(2008-11#1)
play an essential role as##2##5##(1995-6#1)(1997-7#1)
play an essential role in the##2##6##(1992-11#1)(2008-11#1)
play an essential role in##5##5##(1992-11#1)(1995-2#1)(2008-11#3)
play an essential role##7##4##(1992-11#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-11#3)
play an important part in##2##5##(1993-9#1)(1995-5#1)
play an important role during##2##5##(2008-8#1)(2008-9#1)
play an important role for##2##5##(1997-1#1)(2012-2#1)
play an important role in controlling##3##6##(1997-1#1)(2008-10#1)(2008-9#1)
play an important role in human##3##6##(2008-10#1)(2011-1#1)(2011-2#1)
play an important role in regulating the##2##7##(1994-11#1)(2008-11#1)
play an important role in the binding##2##7##(2008-10#2)
play an important role in the development of##3##8##(2006-6#1)(2010-5#1)(2011-2#1)
play an important role in the regulation of##3##8##(1995-2#1)(2008-8#1)(2012-2#1)
play an important role in the treatment of##2##8##(1995-11#1)(2011-3#1)
play an important role in the##34##6##(1991-12#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-8#2)(2008-9#4)(2010-1#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
play an important role in this##2##6##(2008-7#1)(2008-9#1)
play an important role in##92##5##(1990-9#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-11#3)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#8)(2010-1#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
play an important role##100##4##(1990-9#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#9)(2010-1#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
play an important##106##3##(1990-9#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#9)(2010-1#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
play an integral role in the##2##6##(1992-2#1)(2008-11#1)
play an##120##2##(1990-9#1)(1991-12#1)(1991-5#1)(1992-11#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#9)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#10)(2010-1#2)(2010-11#2)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
play any##2##2##(1991-11#1)(2008-10#1)
play as a##3##3##(1993-6#1)(1996-3#1)(2008-9#1)
play as##4##2##(1993-6#1)(1996-3#1)(2008-9#2)
play critical roles in##2##4##(2009-4#1)(2009-9#1)
play crucial roles in##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
play different roles in##2##4##(1995-11#1)(2008-11#1)
play different roles##3##3##(1995-11#1)(2008-11#1)(2012-2#1)
play different##4##2##(1995-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
play essential roles in##2##4##(2008-11#1)(2008-2#1)
play essential roles##3##3##(2008-11#1)(2008-2#1)(2013-8#1)
play important role##2##3##(2013-1#1)(2013-8#1)
play important roles in both##2##5##(1997-8#1)(2009-6#1)
play important roles in plant development and##2##7##(2008-9#1)(2012-3#1)
play important roles in plant##3##5##(2008-9#2)(2012-3#1)
play important roles in the regulation of##2##7##(2009-8#1)(2013-1#1)
play important roles in the##6##5##(1995-11#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
play important roles in##20##4##(1995-11#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
play important roles##22##3##(1995-11#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
play important##26##2##(1995-11#1)(1995-8#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
play in determining##2##3##(2012-2#1)(2012-3#1)
play in the##9##3##(1992-3#1)(1993-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
play in##25##2##(1992-3#1)(1993-1#1)(1995-12#1)(1997-2#2)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#2)
play key roles in##6##4##(2008-1#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
play key roles##7##3##(2008-1#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
play key##8##2##(1991-9#1)(2008-1#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
play pivotal roles##2##3##(2011-2#1)(2012-12#1)
play roles in##6##3##(1997-6#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)
play roles##7##2##(1995-6#1)(1997-6#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)
play significant roles in##2##4##(1995-2#1)(2008-9#1)
play some role in##2##4##(2008-7#1)(2008-8#1)
play some##3##2##(1993-8#1)(2008-7#1)(2008-8#1)
play the role of##3##4##(1990-12#1)(2008-10#2)
play the##5##2##(1990-12#1)(1997-9#1)(2008-10#3)
play##486##1##(1990-11#2)(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#5)(1994-12#2)(1994-2#4)(1994-5#1)(1994-8#3)(1995-11#4)(1995-12#3)(1995-2#8)(1995-5#2)(1995-6#4)(1995-8#3)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#3)(1996-6#1)(1997-1#5)(1997-2#4)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#6)(1997-9#2)(2006-6#2)(2007-12#2)(2008-1#5)(2008-10#50)(2008-11#38)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#18)(2008-8#19)(2008-9#26)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#5)(2009-8#8)(2009-9#1)(2010-1#6)(2010-10#3)(2010-11#5)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-10#2)(2011-2#31)(2011-3#2)(2011-7#1)(2012-12#8)(2012-2#21)(2012-3#8)(2012-7#1)(2013-1#13)(2013-7#2)(2013-8#12)
playback##7##1##(2008-10#1)(2008-8#4)(2009-8#2)
played a key role in##2##5##(2008-11#2)
played a major role##2##4##(1996-12#1)(2011-2#1)
played a role in##5##4##(2008-10#2)(2008-7#1)(2010-11#1)(2013-1#1)
played a##23##2##(1990-9#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
played an important role in the##2##6##(2008-8#1)(2012-2#1)
played an important role in##10##5##(1991-6#1)(2008-1#1)(2008-3#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)
played an important role##11##4##(1991-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)
played by the##7##3##(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)
played by##23##2##(1993-2#1)(1994-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#2)(2010-10#2)(2011-2#1)(2013-8#1)
played important roles##2##3##(2008-11#2)
played in##2##2##(2008-1#1)(2008-12#1)
played the##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
played##72##1##(1990-9#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-1#2)(2008-1#2)(2008-10#14)(2008-11#7)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
player in the##6##3##(1994-12#1)(2008-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
player in##9##2##(1994-12#1)(1996-2#1)(2008-11#1)(2010-11#1)(2010-12#1)(2011-2#3)(2013-8#1)
player##12##1##(1994-12#1)(1996-2#1)(2008-11#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-2#5)(2013-8#1)
players in the##5##3##(1995-6#1)(1997-2#1)(2009-10#1)(2011-1#1)(2011-2#1)
players in##11##2##(1993-3#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(2009-10#1)(2011-1#1)(2011-2#2)(2013-7#2)
players of##2##2##(2009-3#1)(2011-2#1)
players##29##1##(1993-3#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#3)(2010-3#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-1#1)(2013-7#3)
players'##4##1##(2008-8#2)(2011-2#1)(2012-3#1)
playground##2##1##(2009-10#1)(2012-2#1)
playgrounds##2##1##(2008-11#1)(2012-2#1)
playgroups##2##1##(2008-12#2)
playing a major role in##2##5##(2008-10#1)(2013-1#1)
playing a role##3##3##(2008-7#1)(2009-1#1)(2009-9#1)
playing a##14##2##(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-1#2)(2009-10#1)(2009-9#1)(2012-12#2)(2013-1#2)
playing an important role in##5##5##(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)
playing an##6##2##(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)
playing at##2##2##(1990-6#1)(1993-1#1)
playing field##2##2##(2009-8#1)(2010-7#1)
playing surfaces##4##2##(2013-1#4)
playing##38##1##(1990-6#7)(1993-1#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#7)
plays a central role in the##2##6##(1993-3#1)(1995-6#1)
plays a central role in##6##5##(1992-3#1)(1993-3#1)(1995-6#1)(2008-4#1)(2008-8#1)(2010-11#1)
plays a central role##7##4##(1992-3#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)
plays a critical role in the##7##6##(1990-5#1)(2008-11#1)(2008-5#1)(2012-2#3)(2013-1#1)
plays a critical role in##15##5##(1990-5#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#3)(2012-2#3)(2013-1#2)
plays a critical role##17##4##(1990-5#1)(1995-2#1)(2008-10#2)(2008-11#3)(2008-5#2)(2011-2#3)(2012-2#3)(2013-1#2)
plays a crucial role in the##4##6##(2008-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
plays a crucial role in##9##5##(1995-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
plays a greater role than the##2##6##(1991-11#1)(2008-10#1)
plays a key role in the##9##6##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
plays a key role in##14##5##(1991-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
plays a key role##15##4##(1991-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
plays a key##17##3##(1991-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
plays a major part in##2##5##(1993-9#1)(2011-2#1)
plays a major role in the##6##6##(1992-10#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-11#1)(2009-1#1)
plays a major role in##9##5##(1992-10#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2009-1#1)(2012-3#1)
plays a major role##10##4##(1992-10#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#3)(2008-11#1)(2009-1#1)(2012-3#1)
plays a major##12##3##(1992-10#1)(1993-9#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#3)(2008-11#1)(2009-1#1)(2011-2#1)(2012-3#1)
plays a modulatory##2##3##(1993-6#1)(2008-5#1)
plays a pivotal role in the##2##6##(1997-8#1)(2012-2#1)
plays a pivotal role in##5##5##(1994-12#1)(1997-7#1)(1997-8#1)(2010-10#1)(2012-2#1)
plays a pivotal role##7##4##(1994-12#1)(1997-7#1)(1997-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
plays a positive role##2##4##(1995-2#1)(2011-2#1)
plays a predominant role in##2##5##(2008-11#1)(2008-5#1)
plays a prominent role in##2##5##(2008-10#1)(2008-11#1)
plays a role in the development of##4##7##(1994-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
plays a role in the##14##5##(1991-8#1)(1993-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-4#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#2)
plays a role in##30##4##(1991-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-8#2)
plays a significant role in##6##5##(1995-2#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
plays a significant##8##3##(1993-8#1)(1995-2#1)(1996-1#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
plays a##131##2##(1990-5#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#4)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#2)(2008-10#14)(2008-11#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-10#1)(2011-2#11)(2012-2#10)(2012-3#2)(2013-1#7)(2013-8#4)
plays an essential role in##7##5##(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(2008-6#1)(2008-9#1)(2012-12#1)
plays an important role in a##2##6##(1990-2#1)(2008-5#1)
plays an important role in its##2##6##(2008-10#1)(2008-8#1)
plays an important role in the daily##2##7##(1991-12#1)(2008-11#1)
plays an important role in the development of##4##8##(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
plays an important role in the pathophysiology of##2##8##(2008-7#1)(2009-8#1)
plays an important role in the regulation of##2##8##(1991-5#1)(1995-11#1)
plays an important role in the##31##6##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#2)(2009-8#1)(2010-10#2)(2010-12#2)(2012-3#1)(2012-7#1)(2013-3#1)
plays an important role in tumor##2##6##(2008-8#1)(2009-3#1)
plays an important role in##56##5##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2011-2#5)(2012-3#1)(2012-7#1)(2013-1#1)(2013-3#1)
plays an important role##63##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2011-2#5)(2012-3#3)(2012-7#1)(2013-1#1)(2013-3#1)
plays an important##67##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2011-2#6)(2012-3#3)(2012-7#1)(2013-1#1)(2013-3#1)
plays an integral role in##2##5##(1993-3#1)(2010-10#1)
plays an##80##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-3#2)(1994-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-3#1)(2011-2#7)(2012-12#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-3#1)
plays important roles in the##2##5##(2008-10#1)(2008-5#1)
plays important roles in##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
plays important roles##4##3##(1996-12#1)(2008-10#2)(2008-5#1)
plays important##6##2##(1996-12#1)(2008-10#3)(2008-5#1)(2010-5#1)
plays in the##3##3##(1993-12#1)(1994-3#1)(2008-3#1)
plays in##8##2##(1992-10#1)(1993-12#2)(1994-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)
plays no role##2##3##(2008-7#1)(2010-7#1)
plays the##5##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)
plays##247##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-10#2)(1992-3#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-6#4)(1995-8#4)(1996-1#1)(1996-12#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#29)(2008-11#16)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#8)(2009-3#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#3)(2011-1#3)(2011-10#1)(2011-2#18)(2012-12#1)(2012-2#11)(2012-3#5)(2012-7#1)(2013-1#9)(2013-3#1)(2013-8#4)
pleasant##3##1##(1997-3#1)(2008-5#1)(2011-2#1)
pleasantness##2##1##(2008-11#1)(2012-2#1)
pleased with the##2##3##(1992-3#1)(2011-2#1)
pleased##3##1##(1991-1#1)(1992-3#1)(2011-2#1)
pleasure##4##1##(1990-2#1)(2008-10#1)(2008-7#1)(2009-4#1)
pleckstrin homology##3##2##(1994-11#2)(2009-7#1)
pleiotropic phenotypes##2##2##(2009-8#1)(2011-2#1)
pleiotropic##8##1##(1993-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-2#1)
pleiotropy##6##1##(2008-9#3)(2009-8#1)(2010-1#2)
plenty of##3##2##(1997-4#1)(2008-7#1)(2012-12#1)
pleomorphic xanthoastrocytoma##4##2##(2008-7#3)(2013-8#1)
pleomorphic##10##1##(1991-12#2)(1997-7#1)(2008-11#1)(2008-7#3)(2010-12#1)(2010-6#1)(2013-8#1)
pleomorphism##4##1##(1991-12#1)(2008-11#1)(2009-1#1)(2011-2#1)
plesiomorphic##2##1##(2007-12#2)
plethora of##8##2##(1991-1#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-6#2)(2009-9#1)(2013-1#1)
pleura##3##1##(1991-12#2)(2010-5#1)
pleural and peritoneal mesothelioma tissues##2##5##(1991-12#2)
pleural cavity##2##2##(1990-5#1)(1991-8#1)
pleural disease##2##2##(1991-12#2)
pleural effusion and##2##3##(2010-5#1)(2012-3#1)
pleural effusion in four##2##4##(2008-5#2)
pleural effusion in##3##3##(2008-5#2)(2010-12#1)
pleural effusion were##2##3##(1991-12#1)(1997-4#1)
pleural effusion##15##2##(1991-12#4)(1991-6#1)(1997-4#2)(1997-8#1)(2008-5#2)(2010-11#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
pleural effusions##3##2##(1991-6#2)(2008-9#1)
pleural fibrosis is##2##3##(1991-12#2)
pleural fibrosis##5##2##(1991-12#5)
pleural fluid##2##2##(1991-3#1)(2011-2#1)
pleural mesothelioma in##3##3##(1991-12#1)(1995-2#1)(1997-5#1)
pleural mesothelioma was##2##3##(1991-12#1)(1997-5#1)
pleural mesothelioma##13##2##(1991-12#2)(1992-12#3)(1995-2#2)(1997-5#4)(2008-10#1)(2010-5#1)
pleural plaques and diffuse pleural thickening##2##6##(1991-12#2)
pleural plaques and##3##3##(1991-12#3)
pleural plaques##6##2##(1991-12#6)
pleural space##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
pleural thickening##3##2##(1991-12#3)
pleural##68##1##(1990-3#1)(1990-5#2)(1991-12#25)(1991-3#2)(1991-6#3)(1991-8#1)(1992-12#3)(1995-2#2)(1996-11#1)(1997-4#3)(1997-5#4)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
pleurisy##4##1##(2011-2#4)
pleuritis##2##1##(1997-4#1)(2010-1#1)
pleuro-pulmonary##2##1##(2007-8#1)(2012-3#1)
pleuropneumoniae##4##1##(1996-12#4)
plexus and##5##2##(1995-12#1)(1996-12#1)(1997-4#1)(2011-2#2)
plexus block##5##2##(2010-7#2)(2012-2#2)(2012-3#1)
plexus in the##2##3##(1992-3#1)(1996-12#1)
plexus in##3##2##(1992-3#1)(1996-12#1)(2008-9#1)
plexus is##2##2##(1992-3#2)
plexus of##3##2##(1997-1#1)(1997-3#1)(2011-2#1)
plexus##49##1##(1990-5#2)(1992-3#5)(1994-2#1)(1995-12#1)(1996-12#4)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-8#5)(2008-9#4)(2010-7#3)(2010-9#1)(2011-2#10)(2012-2#2)(2012-3#1)(2013-1#3)
plexuses##4##1##(1990-5#1)(2011-2#3)
pliability##2##1##(2008-5#1)(2009-9#1)
plicata##2##1##(2008-6#2)
plicatilis##4##1##(2008-9#2)(2010-3#2)
ploidy and##3##2##(1993-1#1)(2008-9#2)
ploidy level##3##2##(2008-11#1)(2008-9#1)(2009-12#1)
ploidy##15##1##(1991-6#1)(1993-1#2)(1994-11#1)(2008-11#1)(2008-9#8)(2009-12#1)(2011-1#1)
plot and##4##2##(2008-10#3)(2013-8#1)
plot between the##2##3##(2008-10#2)
plot calibration##3##2##(2008-10#2)(2008-3#1)
plot for##2##2##(2008-10#2)
plot in the fall of##2##5##(2008-10#2)
plot in the##3##3##(2008-10#3)
plot in##7##2##(2008-10#5)(2008-11#1)(2008-9#1)
plot is##3##2##(2008-10#3)
plot of the##3##3##(2008-10#2)(2008-11#1)
plot of##14##2##(1991-5#1)(1993-3#1)(1994-8#1)(1997-2#1)(2008-10#9)(2008-11#1)
plot showed##2##2##(2008-10#2)
plot to##2##2##(2008-10#2)
plot was linear over the range##2##6##(2008-10#2)
plot was linear##3##3##(2008-10#3)
plot was##11##2##(1990-9#1)(2008-10#8)(2008-12#2)
plot##95##1##(1990-5#1)(1990-9#1)(1991-5#1)(1993-3#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#71)(2008-11#4)(2008-12#6)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#2)
plot) for##2##2##(2008-10#2)
plot)##6##1##(2008-10#6)
plots also##2##2##(2008-10#1)(2008-12#1)
plots amended with##4##3##(2008-10#4)
plots and##6##2##(2008-10#5)(2013-1#1)
plots are##3##2##(1995-9#1)(2008-10#2)
plots at##2##2##(2008-10#2)
plots based on##2##3##(2008-8#1)(2013-8#1)
plots by##3##2##(2008-10#3)
plots during##2##2##(2008-10#2)
plots for the##2##3##(1995-9#1)(2008-10#1)
plots for##10##2##(1995-9#2)(2008-10#8)
plots in the##5##3##(1995-9#1)(2008-10#3)(2008-11#1)
plots in##12##2##(1995-9#1)(2008-10#10)(2008-11#1)
plots increased##2##2##(2008-10#2)
plots obtained##2##2##(2008-10#2)
plots of the##9##3##(1995-9#1)(2008-10#6)(2008-3#1)(2010-12#1)
plots of##22##2##(1995-9#1)(2008-10#16)(2008-3#1)(2008-8#2)(2010-12#1)(2011-3#1)
plots planted with##3##3##(2008-10#3)
plots protected by##2##3##(2008-10#2)
plots provide##2##2##(2008-10#1)(2010-12#1)
plots ranging from##2##3##(2008-10#2)
plots received##2##2##(2008-10#1)(2008-9#1)
plots showed good##3##3##(2008-10#3)
plots than##3##2##(2008-10#2)(2013-8#1)
plots that##3##2##(2008-10#3)
plots to determine the##2##4##(2008-10#2)
plots to##4##2##(2008-10#4)
plots was##4##2##(2008-10#4)
plots were##23##2##(2008-10#22)(2011-2#1)
plots when##2##2##(2008-10#2)
plots where##5##2##(2008-10#5)
plots with##11##2##(1990-11#1)(2008-10#10)
plots##246##1##(1990-11#1)(1991-5#2)(1993-2#1)(1995-9#7)(2008-10#208)(2008-11#3)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#4)
plots)##3##1##(2008-10#3)
plotted against the##2##3##(2008-10#1)(2008-11#1)
plotted against##7##2##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)
plotted##12##1##(1997-6#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
plotting the##6##2##(2008-10#5)(2010-8#1)
plotting##9##1##(2008-10#7)(2008-5#1)(2010-8#1)
plow##3##1##(2008-12#3)
plucking##3##1##(1990-9#3)
plug and##3##2##(2008-10#2)(2013-1#1)
plug flow##3##2##(2008-7#2)(2008-9#1)
plug of##3##2##(2008-10#2)(2013-1#1)
plug test during anoscopy##2##4##(2013-1#2)
plug test##6##2##(2013-1#6)
plug was##4##2##(2008-10#1)(2013-1#3)
plug##35##1##(1994-3#1)(2008-10#16)(2008-7#2)(2008-9#1)(2011-2#2)(2013-1#13)
plug-in##2##1##(2008-10#1)(2009-10#1)
plugging##4##1##(2008-10#4)
plugs and##3##2##(2008-10#3)
plugs##12##1##(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#2)(2011-2#1)
plum and peach##2##3##(2008-10#2)
plum##15##1##(2008-10#10)(2011-2#5)
plumage##6##1##(2008-8#6)
plume protection problems##2##3##(1993-3#2)
plume with##2##2##(1996-12#1)(2008-2#1)
plume##12##1##(1993-3#2)(1996-12#1)(2008-2#5)(2008-3#4)
plumes##7##1##(2008-11#1)(2008-3#5)(2009-6#1)
plump##2##1##(2010-6#2)
pluripotency##5##1##(2008-11#2)(2008-9#1)(2010-7#1)(2013-1#1)
pluripotent stem cells##3##3##(2010-10#1)(2010-7#1)(2012-5#1)
pluripotent stem##4##2##(2008-11#1)(2010-10#1)(2010-7#1)(2012-5#1)
pluripotent##13##1##(1990-5#1)(2008-10#1)(2008-11#4)(2008-9#2)(2010-10#1)(2010-7#1)(2012-5#2)(2013-1#1)
plus 0##4##2##(2008-10#4)
plus 1##2##2##(1993-1#1)(1997-1#1)
plus 2##4##2##(2008-10#1)(2008-6#1)(2011-2#2)
plus 35##2##2##(1997-8#1)(2011-2#1)
plus 36##2##2##(1992-4#1)(2008-10#1)
plus P##2##2##(2008-10#2)
plus a##8##2##(1994-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#2)
plus alemtuzumab##3##2##(2008-12#3)
plus an##2##2##(2009-10#1)(2009-4#1)
plus canola oil##4##3##(2008-10#4)
plus clopidogrel##2##2##(2008-11#1)(2011-2#1)
plus endocervical brush##2##3##(2009-6#2)
plus etoposide##4##2##(1993-8#4)
plus glucose##3##2##(2008-10#2)(2008-7#1)
plus heparin##5##2##(1992-1#4)(1994-6#1)
plus ribavirin##2##2##(2009-5#1)(2009-7#1)
plus the##3##2##(2008-10#2)(2010-4#1)
plus##197##1##(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-3#2)(1991-7#1)(1991-8#1)(1992-1#6)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#6)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#67)(2008-11#10)(2008-12#6)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#3)(2011-2#16)(2012-2#4)(2012-3#2)(2013-1#6)
plus- and minus-strand##2##3##(2008-9#2)
plus-maze and##3##2##(1993-3#3)
plus-maze test##5##2##(1993-3#2)(1994-2#1)(2008-11#2)
plus-maze##11##1##(1993-3#5)(1994-2#1)(2008-11#5)
plus-strand##2##1##(2008-8#2)
pluton##3##1##(2013-8#3)
plutonium##4##1##(2008-10#4)
pluvialis##3##1##(2010-10#3)
plymuthica##3##1##(2008-10#3)
plywood##3##1##(2008-7#3)
pm##4##1##(2008-3#1)(2008-5#2)(2011-2#1)
pmMC##2##1##(2013-8#2)
pmol cm(-2)##2##2##(2008-10#2)
pmol cm-2 s-1##2##3##(1991-5#2)
pmol for##7##2##(2008-10#7)
pmol l(-1)##4##2##(2008-10#3)(2008-11#1)
pmol x h/10(6) PBMC##2##4##(2008-7#2)
pmol x##3##2##(2008-7#2)(2011-3#1)
pmol##29##1##(1991-5#2)(1993-8#1)(1995-11#1)(1996-2#1)(1997-2#1)(2008-10#16)(2008-11#2)(2008-7#3)(2010-4#1)(2011-3#1)
pmol)##3##1##(1992-6#1)(1994-11#1)(2008-10#1)
pmol/L##2##1##(2008-1#1)(2008-8#1)
pmol/injection##2##1##(2008-10#2)
pmol/mg protein per min##2##4##(1992-3#2)
pmol/mg protein##4##2##(1992-3#2)(1995-11#2)
pmol/mg protein)##2##2##(1993-11#2)
pmol/mg##9##1##(1992-3#3)(1993-11#2)(1995-11#2)(2008-8#2)
pmole/mg protein)##4##2##(2008-11#4)
pmoles of radioligandY mg(-1) protein##2##5##(2008-11#2)
pmol·l-1##2##1##(2013-1#2)
pneumatic dilatation##2##2##(1992-9#2)
pneumatic nebulization##3##2##(2008-10#3)
pneumatic nebulizer##3##2##(2008-10#3)
pneumatic##16##1##(1992-9#3)(2008-10#10)(2012-3#3)
pneumatosis##5##1##(2008-12#1)(2012-2#4)
pneumocephalus##7##1##(2008-7#4)(2008-9#1)(2009-6#1)(2011-2#1)
pneumococcal disease in##2##3##(2007-12#1)(2008-10#1)
pneumococcal disease##6##2##(1994-9#4)(2007-12#1)(2008-10#1)
pneumococcal meningitis##5##2##(1996-3#1)(2011-2#4)
pneumococcal polysaccharide vaccine##2##3##(1994-9#2)
pneumococcal vaccine##3##2##(1990-9#1)(1994-9#2)
pneumococcal##30##1##(1990-9#1)(1994-9#11)(1996-11#1)(1996-3#1)(2007-12#3)(2008-10#3)(2008-7#2)(2008-9#1)(2011-2#7)
pneumolysin##5##1##(2008-10#5)
pneumonectomy##2##1##(2008-1#2)
pneumonia (OP)##2##2##(2010-12#1)(2011-2#1)
pneumonia and##8##2##(1991-12#2)(1992-6#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-6#2)
pneumonia during##2##2##(1991-9#1)(2008-10#1)
pneumonia in##8##2##(1991-12#1)(1991-3#2)(1992-2#1)(1992-5#1)(2008-10#1)(2010-12#1)(2010-5#1)
pneumonia##52##1##(1990-2#1)(1990-9#1)(1991-12#4)(1991-3#2)(1991-8#1)(1991-9#1)(1992-2#2)(1992-5#2)(1992-6#1)(1993-2#1)(1994-5#1)(1994-6#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#1)(2010-12#3)(2010-5#2)(2010-6#3)(2010-8#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
pneumonia)##3##1##(2011-2#2)(2011-3#1)
pneumonia]##2##1##(1992-5#1)(1992-6#1)
pneumoniae and##8##2##(1992-5#2)(1995-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
pneumoniae fldA gene##2##3##(1997-7#2)
pneumoniae fldA##3##2##(1997-7#3)
pneumoniae gene##2##2##(1997-7#2)
pneumoniae is##3##2##(1997-7#1)(2008-7#1)(2011-2#1)
pneumoniae to cefepime##2##3##(2008-7#2)
pneumoniae to##3##2##(2008-7#2)(2013-8#1)
pneumoniae##65##1##(1992-5#5)(1994-5#1)(1994-9#2)(1995-5#4)(1997-7#13)(2007-12#1)(2008-11#1)(2008-7#8)(2008-9#3)(2010-12#2)(2010-6#2)(2011-2#15)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
pneumoniae)##3##1##(2011-2#2)(2012-3#1)
pneumonic##4##1##(1991-3#1)(1997-8#1)(2008-5#2)
pneumonie varicelleuse du nouveau-né##2##4##(2013-1#2)
pneumonie varicelleuse##3##2##(2013-1#3)
pneumonitis##6##1##(2007-12#1)(2008-10#1)(2010-12#2)(2011-2#1)(2012-12#1)
pneumopathy##2##1##(1996-3#1)(2010-12#1)
pneumoperitoneum with##2##2##(1991-12#1)(2009-8#1)
pneumoperitoneum##6##1##(1991-12#1)(1993-6#3)(2009-8#1)(2010-5#1)
pneumorrhachis##3##1##(2008-12#2)(2009-4#1)
pneumothorax##8##1##(1990-5#2)(1991-3#2)(2010-12#1)(2012-3#3)
pneumotoxicity##3##1##(1994-5#3)
pnp1-1##2##1##(2012-3#2)
poae##2##1##(2008-10#2)
pocket depth##2##2##(2008-10#1)(2013-1#1)
pocket formed by##2##3##(1991-12#1)(1992-4#1)
pocket in##2##2##(2008-8#1)(2008-9#1)
pocket##28##1##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-4#2)(1994-5#4)(1995-11#1)(2008-10#3)(2008-3#1)(2008-8#6)(2008-9#2)(2012-2#3)(2013-1#1)(2013-8#1)
pockets adjacent to##3##3##(2012-12#3)
pockets##10##1##(1997-4#1)(2008-10#4)(2008-12#1)(2012-12#4)
pod##14##1##(2008-10#8)(2008-12#3)(2010-11#2)(2013-8#1)
podophyllotoxin from##2##2##(2008-11#2)
podophyllotoxin##5##1##(2008-11#5)
podophyllum##2##1##(2008-10#2)
podoplanin expression##3##2##(2013-1#3)
podoplanin##8##1##(2013-1#8)
podospirone##2##1##(2008-11#2)
pods (12##2##2##(2008-12#2)
pods ha(-1)##2##2##(2008-12#2)
pods plant(-1)##2##2##(2008-12#2)
pods was##2##2##(2008-10#1)(2008-12#1)
pods were##2##2##(2008-10#2)
pods##24##1##(2008-10#15)(2008-12#8)(2013-8#1)
poinsettia##5##1##(2008-10#5)
point (control##2##2##(2008-7#2)
point 1##2##2##(2008-9#2)
point and interval estimates##2##4##(1994-9#1)(2008-11#1)
point and the##2##3##(2008-10#2)
point and##17##2##(1994-9#1)(1996-5#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2009-2#2)(2011-2#1)(2012-3#1)(2013-8#1)
point at##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)
point by##3##2##(1995-11#1)(2008-11#2)
point during##2##2##(2008-11#1)(2013-1#1)
point extraction of lead##2##4##(2008-10#2)
point extraction of##4##3##(2008-10#4)
point extraction was##3##3##(2008-10#3)
point extraction##19##2##(2008-10#19)
point for##18##2##(1995-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
point in the##13##3##(1992-2#1)(1992-4#1)(1994-1#1)(1995-11#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-6#1)(2012-2#1)
point in their##3##3##(2008-4#1)(2008-9#1)(2009-5#1)
point in time##5##3##(2008-10#2)(2008-11#2)(2008-9#1)
point in##29##2##(1992-2#1)(1992-4#1)(1993-5#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
point inoculation##3##2##(2008-10#3)
point is the##2##3##(1996-3#1)(2008-11#1)
point is##15##2##(1994-12#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-11#4)(2008-3#1)(2008-6#2)(2010-6#1)
point mutants##2##2##(1991-10#1)(1995-6#1)
point mutation in the##3##4##(1992-8#1)(1995-6#1)(2008-10#1)
point mutation of##3##3##(1992-8#1)(1994-12#1)(1995-8#1)
point mutation was##2##3##(1990-8#1)(1992-8#1)
point mutation##15##2##(1990-8#1)(1991-2#1)(1992-8#4)(1993-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-2#2)(2008-10#3)
point mutations and inversions##2##4##(2011-2#2)
point mutations and##3##3##(2008-7#1)(2011-2#2)
point mutations found in##2##4##(1991-5#1)(1997-6#1)
point mutations in the##5##4##(1991-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(2011-2#1)
point mutations in##8##3##(1991-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
point mutations of the##2##4##(1994-11#1)(2008-10#1)
point mutations##23##2##(1991-12#1)(1991-5#2)(1991-7#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-2#2)(1996-2#1)(1997-6#2)(1997-7#1)(2008-10#3)(2008-7#3)(2010-8#1)(2011-2#3)
point of a##4##3##(1992-12#1)(2007-12#1)(2008-6#1)(2011-2#1)
point of care##3##3##(1997-3#1)(2009-5#1)(2010-8#1)
point of no return&quot##2##4##(2008-11#2)
point of no##3##3##(2008-11#3)
point of the##15##3##(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)
point of view of##11##4##(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-10#4)(2008-11#1)(2009-12#1)(2013-8#1)
point of view##44##3##(1990-11#1)(1990-5#1)(1991-8#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#4)
point of##100##2##(1990-11#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-3#2)(1997-6#1)(2007-12#2)(2008-10#32)(2008-11#11)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#5)(2013-1#2)(2013-8#5)
point on the##4##3##(1995-12#1)(1996-3#1)(2008-3#1)(2008-7#1)
point or##2##2##(1991-12#1)(2011-2#1)
point out that##2##3##(1992-5#1)(2008-10#1)
point out the##3##3##(2008-11#1)(2008-2#1)(2012-3#1)
point out##10##2##(1992-5#1)(2008-10#3)(2008-11#2)(2008-2#1)(2009-7#1)(2010-11#1)(2012-3#1)
point patterns##2##2##(2008-10#2)
point source##9##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#3)
point the##2##2##(2008-11#1)(2012-3#1)
point to a##7##3##(1993-12#1)(1993-3#1)(2008-10#2)(2008-3#1)(2011-3#1)(2013-8#1)
point to an##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
point to the need for##3##5##(1994-2#1)(2008-10#1)(2011-2#1)
point to the##11##3##(1990-6#1)(1993-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-7#1)(2011-2#3)
point to##33##2##(1990-6#1)(1991-2#1)(1993-12#3)(1993-3#1)(1994-12#1)(1994-2#2)(1995-2#1)(1995-3#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
point was##7##2##(1991-6#1)(2008-10#3)(2008-11#1)(2009-2#1)(2012-3#1)
point were##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
point where the##2##3##(2008-8#1)(2010-9#1)
point where##5##2##(1992-3#1)(1995-8#1)(2008-5#1)(2008-8#1)(2010-9#1)
point which##2##2##(2008-12#1)(2011-2#1)
point with the##2##3##(2008-10#1)(2012-2#1)
point with##3##2##(2008-10#2)(2012-2#1)
point##494##1##(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-12#6)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#5)(1995-3#2)(1995-6#2)(1995-8#2)(1996-2#4)(1996-3#4)(1996-5#3)(1997-2#1)(1997-3#3)(1997-6#4)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#153)(2008-11#38)(2008-12#5)(2008-2#2)(2008-3#14)(2008-4#3)(2008-5#9)(2008-6#9)(2008-7#17)(2008-8#9)(2008-9#11)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-10#1)(2011-2#26)(2011-3#2)(2012-12#4)(2012-2#14)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#10)
point)##2##1##(2009-8#1)(2011-2#1)
point-of-care##6##1##(2008-12#1)(2008-6#3)(2011-2#1)(2013-1#1)
point-spread function (PSF)##3##3##(2008-3#3)
point-spread function##6##2##(2008-3#6)
point-spread functions##2##2##(2008-3#2)
point-spread##8##1##(2008-3#8)
point-to-point##2##1##(1997-3#1)(2008-3#1)
pointed out that the##2##4##(2008-10#2)
pointed out that##4##3##(2008-10#3)(2008-5#1)
pointed out##15##2##(1990-2#1)(1991-8#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
pointed to the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
pointed to##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#1)
pointed##25##1##(1990-2#1)(1990-9#1)(1991-8#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
pointing out##3##2##(2008-8#1)(2009-10#1)(2012-3#1)
pointing to the##3##3##(1994-5#1)(2008-10#1)(2009-8#1)
pointing to##8##2##(1990-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#1)(2009-8#1)(2012-12#1)
pointing##16##1##(1990-11#3)(1990-8#1)(1994-11#1)(1994-5#2)(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-3#1)
points (p##2##2##(2008-3#1)(2008-9#1)
points along the##3##3##(2008-10#1)(2009-2#1)(2011-2#1)
points along##4##2##(2008-10#1)(2009-2#1)(2011-2#2)
points and in##2##3##(1997-3#1)(2011-2#1)
points and##18##2##(1997-3#1)(2007-11#2)(2008-10#4)(2008-7#1)(2010-2#3)(2011-2#3)(2012-4#1)(2013-1#3)
points are##3##2##(1996-6#1)(2008-6#1)(2009-9#1)
points at##2##2##(2008-10#1)(2010-8#1)
points between##2##2##(2008-11#1)(2010-10#1)
points for the##2##3##(1990-11#1)(2009-2#1)
points for##9##2##(1990-11#1)(1997-8#1)(2008-10#1)(2008-4#2)(2009-2#2)(2011-2#2)
points from##3##2##(1992-2#1)(2010-11#1)(2013-1#1)
points in a##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
points in the##9##3##(1994-12#1)(1995-6#1)(1996-8#1)(2008-10#3)(2010-1#1)(2011-1#1)(2013-1#1)
points in time##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)
points in##23##2##(1991-12#1)(1994-12#1)(1995-6#1)(1996-8#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-7#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-1#1)(2013-1#3)(2013-7#1)
points is##2##2##(2008-10#2)
points more##3##2##(2008-10#1)(2013-1#2)
points of the##10##3##(1993-6#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-3#1)(2009-8#1)
points of view and##2##4##(2008-7#1)(2011-2#1)
points of view##7##3##(1991-6#1)(1993-11#1)(1993-2#1)(1996-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
points of##37##2##(1991-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-11#1)(1996-1#1)(1996-6#1)(1997-2#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
points on a##3##3##(2008-3#1)(2008-6#2)
points on##6##2##(2008-12#1)(2008-3#1)(2008-6#2)(2009-11#1)(2009-2#1)
points out that##4##3##(1994-12#1)(1996-5#1)(2010-8#1)(2011-2#1)
points out the##5##3##(1996-6#1)(1997-5#1)(2008-12#1)(2008-5#1)(2011-2#1)
points out##12##2##(1994-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#2)
points postoperatively##2##2##(2013-1#2)
points regarding the##2##3##(1995-1#1)(2010-10#1)
points that##3##2##(2007-11#1)(2008-11#1)(2009-8#1)
points to a##2##3##(2008-11#1)(2009-8#1)
points to consider##2##3##(2008-11#1)(2008-4#1)
points to the need##2##4##(1995-5#1)(1997-2#1)
points to the possibility##2##4##(1996-12#1)(2008-10#1)
points to the##8##3##(1994-9#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)
points to##18##2##(1994-9#1)(1995-5#2)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#2)(2009-9#1)(2013-7#1)
points was##3##2##(2008-10#2)(2009-2#1)
points were##8##2##(1997-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-2#3)
points with##5##2##(1993-2#1)(2008-9#2)(2011-2#1)(2013-1#1)
points##281##1##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-6#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#5)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#5)(2008-1#1)(2008-10#64)(2008-11#14)(2008-12#9)(2008-2#1)(2008-3#4)(2008-4#10)(2008-5#5)(2008-6#7)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#3)(2009-2#12)(2009-3#2)(2009-8#5)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#16)(2011-3#1)(2012-2#3)(2012-3#6)(2012-4#2)(2013-1#19)(2013-7#2)(2013-8#1)
points'##2##1##(2008-10#1)(2009-10#1)
points)##15##1##(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#7)(2009-11#1)(2009-2#1)
poised at##2##2##(2008-10#2)
poised##4##1##(1994-12#1)(2008-10#2)(2013-8#1)
poison##6##1##(1995-11#1)(1997-1#1)(2008-10#1)(2009-5#1)(2010-8#2)
poisoned by##3##2##(1991-11#1)(1997-3#1)(2008-10#1)
poisoning by##5##2##(1990-9#1)(1993-2#1)(1995-11#1)(1997-3#1)(2008-10#1)
poisoning in a##3##3##(1995-11#1)(2010-11#1)(2011-2#1)
poisoning in##4##2##(1995-11#1)(2008-11#1)(2010-11#1)(2011-2#1)
poisoning of the##2##3##(1997-3#1)(2008-10#1)
poisoning of##3##2##(1990-9#1)(1997-3#1)(2008-10#1)
poisoning##41##1##(1990-3#1)(1990-5#3)(1990-9#3)(1991-11#1)(1993-2#1)(1995-11#2)(1997-3#3)(1997-5#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2009-11#3)(2010-11#1)(2010-5#3)(2011-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
poisoning]##6##1##(1990-9#1)(1991-11#1)(1996-3#1)(1997-5#1)(2009-5#1)(2013-8#1)
poisonings##5##1##(1996-3#1)(2008-10#1)(2008-5#2)(2011-2#1)
poisonous##3##1##(2008-10#1)(2008-12#1)(2008-5#1)
poisons##2##1##(1990-9#1)(1996-2#1)
pokeweed##3##1##(2008-10#2)(2011-2#1)
pol I##3##2##(1992-6#1)(1997-8#2)
pol##7##1##(1992-6#1)(1994-12#1)(1997-8#2)(2008-11#2)(2009-8#1)
polar and non-polar##2##3##(2008-10#2)
polar and nonpolar##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
polar and##9##2##(2008-10#5)(2008-11#1)(2010-7#1)(2012-3#1)(2013-8#1)
polar compounds##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
polar growth##3##2##(2008-10#1)(2009-8#2)
polar inner-layer##2##2##(2008-10#2)
polar interactions##2##2##(2008-10#2)
polar lipids##4##2##(2008-11#3)(2011-2#1)
polar nucleus##2##2##(2009-12#2)
polar oils##2##2##(2008-5#2)
polar solvents##3##2##(2008-10#3)
polar stationary##2##2##(2008-10#1)(2008-5#1)
polar stratosphere##3##2##(1991-5#3)
polar stratospheric clouds##2##3##(1991-5#2)
polar vortex##2##2##(1991-5#2)
polar##97##1##(1990-11#1)(1990-2#1)(1991-5#11)(1994-5#2)(1995-2#1)(1996-12#2)(1997-2#1)(2008-10#39)(2008-11#9)(2008-3#3)(2008-5#6)(2008-8#1)(2008-9#2)(2009-12#4)(2009-8#3)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
polarimetric detection##2##2##(2008-10#2)
polarimetric images##2##2##(2008-6#2)
polarimetric information##2##2##(2008-3#2)
polarimetric##14##1##(2008-10#6)(2008-2#1)(2008-3#2)(2008-6#3)(2010-4#2)
polarimetry##2##1##(2008-3#2)
polarisation##4##1##(1996-12#1)(2008-10#3)
polarised##2##1##(2008-10#1)(2008-11#1)
polarities##4##1##(1992-10#2)(2008-10#2)
polarity and##5##2##(2008-10#4)(2011-2#1)
polarity are##2##2##(2008-10#1)(2008-7#1)
polarity establishment##2##2##(2009-8#2)
polarity of the##4##3##(2008-10#3)(2008-5#1)
polarity of this##2##3##(2008-10#1)(2008-7#1)
polarity of##6##2##(2008-10#4)(2008-5#1)(2008-7#1)
polarity proteins##2##2##(2012-2#2)
polarity to##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
polarity##56##1##(1990-5#1)(1991-5#1)(1993-12#3)(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#26)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#6)(2010-5#1)(2011-2#2)(2012-2#4)(2012-3#2)
polarizability of##2##2##(1997-6#1)(2008-10#1)
polarizability##5##1##(1997-6#2)(2008-10#3)
polarization and anisotropy##4##3##(2008-10#4)
polarization and##11##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-8#1)(2011-2#1)
polarization at##2##2##(1994-3#1)(1997-6#1)
polarization dependence##2##2##(2007-12#1)(2008-3#1)
polarization direction##2##2##(2008-3#2)
polarization for##2##2##(2008-3#2)
polarization holography##3##2##(2008-3#3)
polarization imaging##2##2##(2008-3#1)(2009-10#1)
polarization in##3##2##(2008-3#3)
polarization is##4##2##(2008-2#1)(2008-3#3)
polarization length##2##2##(1997-6#2)
polarization lidar##5##2##(2008-3#5)
polarization microscopy##2##2##(2008-1#1)(2012-3#1)
polarization mode dispersion (PMD)##2##4##(2007-11#1)(2007-12#1)
polarization mode dispersion##5##3##(2007-11#2)(2007-12#3)
polarization of the##5##3##(2008-2#3)(2008-3#2)
polarization of##14##2##(1990-2#1)(1991-5#1)(1993-5#1)(1995-8#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-9#2)
polarization orientation of the reference beam##2##6##(2008-3#2)
polarization orientation of the##3##4##(2008-3#3)
polarization patterns from##2##3##(2008-2#1)(2008-3#1)
polarization spectroscopy of##2##3##(2008-3#2)
polarization state of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
polarization state of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
polarization state##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
polarization states and##2##3##(2008-3#2)
polarization states in##2##3##(2007-11#2)
polarization states##10##2##(2007-11#4)(2008-3#6)
polarization techniques##3##2##(1991-5#1)(2008-10#2)
polarization##150##1##(1990-2#1)(1991-3#1)(1991-5#2)(1993-5#1)(1994-3#1)(1995-8#1)(1997-6#3)(2007-11#12)(2007-12#14)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#17)(2008-3#67)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
polarization-dependent loss##2##2##(2008-3#2)
polarization-dependent##6##1##(2008-3#6)
polarization-insensitive##3##1##(2008-2#3)
polarization-maintaining##2##1##(2008-3#2)
polarizations of##2##2##(2008-3#1)(2008-9#1)
polarizations##9##1##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-9#1)
polarize the##2##2##(2008-10#1)(2009-10#1)
polarized absorption spectra##2##3##(2008-10#1)(2008-3#1)
polarized at##4##2##(2008-10#4)
polarized beams##5##2##(2008-10#1)(2008-3#4)
polarized by##2##2##(2008-10#1)(2008-3#1)
polarized growth in##2##3##(2009-8#2)
polarized growth##4##2##(2009-8#4)
polarized light##8##2##(2007-11#2)(2007-12#2)(2008-3#3)(2008-5#1)
polarized secretion##2##2##(2008-10#1)(2008-11#1)
polarized##58##1##(1991-12#1)(1992-10#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#22)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#5)(2012-2#1)
polarizer##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
polarizers##3##1##(2008-3#3)
polarizing activity##4##2##(1993-12#4)
polarizing beam splitter##4##3##(2008-10#1)(2008-3#3)
polarizing##15##1##(1993-12#6)(1993-6#1)(2008-10#2)(2008-3#6)
polarogram of##2##2##(2008-10#2)
polarogram##3##1##(2008-10#3)
polarograms and##2##2##(1990-5#1)(2008-10#1)
polarograms##6##1##(1990-5#1)(2008-10#5)
polarographic determination of##12##3##(2008-10#12)
polarographic determination##13##2##(2008-10#13)
polarographic method for the determination of##2##6##(2008-10#2)
polarographic method##8##2##(2008-10#8)
polarographic peak##2##2##(2008-10#2)
polarographic signal##2##2##(2008-10#2)
polarographic study##2##2##(2008-10#2)
polarographic wave##4##2##(2008-10#4)
polarographic##44##1##(1990-5#1)(2008-10#43)
polarography##39##1##(2008-10#39)
pole of the##5##3##(1990-9#1)(1994-12#1)(1994-5#1)(2008-12#1)(2011-2#1)
pole##15##1##(1990-9#1)(1994-12#1)(1994-5#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#3)
polecat M##2##2##(2008-6#2)
poled KTiOPO(4)##2##2##(2007-12#1)(2008-3#1)
poled films##2##2##(2008-2#1)(2008-3#1)
poled polymer and silica films##2##5##(2008-2#2)
poled polymer##3##2##(2008-2#2)(2008-3#1)
poled##24##1##(2007-11#4)(2007-12#6)(2008-2#4)(2008-3#10)
poles##4##1##(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)
police and##2##2##(1992-12#1)(1993-2#1)
police chiefs##2##2##(1993-2#2)
police investigation##2##2##(1997-8#1)(2008-10#1)
police reports##2##2##(1991-8#1)(2012-3#1)
police##24##1##(1991-3#2)(1991-8#1)(1992-12#1)(1992-2#2)(1993-2#4)(1997-8#4)(2008-10#2)(2008-7#1)(2010-1#4)(2012-2#1)(2012-3#2)
policies affect##2##2##(1995-2#1)(2009-8#1)
policies affecting##2##2##(1995-1#1)(1995-3#1)
policies and practices##2##3##(2008-11#1)(2010-7#1)
policies and procedures##3##3##(1995-12#1)(2008-12#2)
policies and##17##2##(1992-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#3)(2008-12#2)(2008-7#1)(2010-11#1)(2010-7#2)(2011-1#1)(2012-2#1)
policies are##4##2##(1993-3#1)(1995-6#1)(1997-2#1)(2012-3#1)
policies at the##3##3##(1994-2#1)(2008-10#1)(2010-11#1)
policies directed at##2##3##(2012-2#2)
policies for volunteer programs##2##4##(1994-2#2)
policies for##12##2##(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-2#1)(1996-8#1)(2008-11#3)(2012-12#1)
policies have been##2##3##(2008-1#1)(2008-10#1)
policies have##5##2##(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
policies in the field##2##4##(1997-7#1)(2010-10#1)
policies in the##3##3##(1997-7#1)(2010-1#1)(2010-10#1)
policies in##10##2##(1994-1#1)(1995-1#1)(1995-6#1)(1996-1#1)(1997-7#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#1)
policies of##3##2##(2010-1#1)(2012-2#1)(2012-3#1)
policies on##4##2##(1995-1#1)(2009-3#2)(2012-2#1)
policies or##2##2##(1992-1#1)(2012-3#1)
policies relating to##2##3##(1991-12#1)(1993-3#1)
policies should##2##2##(1996-3#1)(2008-1#1)
policies that##5##2##(1993-11#1)(1993-3#1)(1997-2#1)(2012-3#1)(2013-1#1)
policies to##3##2##(2008-1#1)(2008-11#2)
policies will##3##2##(1993-11#1)(1994-2#1)(1995-1#1)
policies##135##1##(1991-1#2)(1991-12#1)(1991-2#3)(1991-6#1)(1992-1#3)(1992-2#1)(1993-11#2)(1993-3#6)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#9)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#5)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-7#1)(2008-1#3)(2008-10#3)(2008-11#13)(2008-12#4)(2008-7#2)(2009-12#1)(2009-3#2)(2009-8#1)(2010-1#3)(2010-10#3)(2010-11#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#7)(2012-3#6)(2013-1#1)(2013-8#2)
policing in##2##2##(2008-8#1)(2013-8#1)
policing of male production##2##4##(2008-8#2)
policing##8##1##(2008-8#7)(2013-8#1)
policy agenda##2##2##(1996-3#1)(2008-11#1)
policy allowed##2##2##(1996-5#1)(2008-7#1)
policy analysis##5##2##(1991-2#1)(1996-2#2)(1996-3#1)(1997-1#1)
policy and practice##4##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)
policy and##22##2##(1990-6#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-2#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
policy are discussed##2##3##(1995-1#1)(2013-1#1)
policy are##3##2##(1995-1#1)(1996-1#1)(2013-1#1)
policy as a##3##3##(1997-2#1)(2008-11#2)
policy as##4##2##(1994-1#1)(1997-2#1)(2008-11#2)
policy change##2##2##(1991-1#1)(1992-12#1)
policy changes##2##2##(1992-12#1)(2012-2#1)
policy context##2##2##(1994-2#1)(2008-11#1)
policy criteria##2##2##(1991-1#1)(1991-12#1)
policy decisions##3##2##(1991-3#1)(1996-1#1)(2010-4#1)
policy development and##2##3##(1992-1#1)(1996-12#1)
policy development##14##2##(1992-1#1)(1994-1#1)(1994-2#2)(1996-1#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2012-3#1)
policy directives##2##2##(2008-12#2)
policy documents##2##2##(2008-11#2)
policy for##10##2##(1990-11#1)(1990-2#1)(1991-1#2)(1991-12#1)(1995-3#1)(1996-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
policy has##2##2##(1996-3#1)(2008-7#1)
policy implications of##2##3##(1996-1#1)(2008-11#1)
policy implications##11##2##(1991-1#1)(1991-12#4)(1993-12#1)(1994-12#1)(1996-1#1)(1996-2#1)(2008-11#2)
policy in the##2##3##(1990-3#1)(1992-1#1)
policy in##7##2##(1990-3#2)(1991-6#1)(1992-1#1)(2008-10#1)(2009-3#1)(2010-10#1)
policy initiatives##2##2##(1993-2#1)(2012-3#1)
policy is##4##2##(1991-1#1)(1993-3#1)(1997-3#1)(1997-5#1)
policy issues that##2##3##(1991-1#1)(1994-2#1)
policy issues##6##2##(1991-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1996-3#1)(2010-4#1)
policy makers and##6##3##(1992-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2010-10#1)(2013-1#1)
policy makers##15##2##(1992-12#1)(1993-12#1)(1994-1#1)(1994-12#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2009-7#1)(2010-10#1)(2010-8#1)(2013-1#1)
policy of##4##2##(1993-11#1)(2012-2#2)(2013-1#1)
policy on##4##2##(1991-12#1)(1992-1#1)(1992-2#1)(2008-11#1)
policy options##3##2##(1995-11#1)(1995-3#1)(1996-12#1)
policy perspective##2##2##(1994-2#1)(2010-4#1)
policy planning##2##2##(1997-2#1)(2008-1#1)
policy process##2##2##(1995-1#1)(2008-7#1)
policy recommendations##2##2##(1996-3#1)(2009-4#1)
policy reform##4##2##(1994-1#1)(1997-2#2)(1997-3#1)
policy research##3##2##(1994-1#1)(1995-3#1)(2009-3#1)
policy review##3##2##(1991-1#1)(1994-12#1)(2009-4#1)
policy statement##2##2##(1996-3#1)(2008-11#1)
policy that##2##2##(2008-11#1)(2013-1#1)
policy to##3##2##(1997-2#1)(2009-11#1)(2010-10#1)
policy with##2##2##(1993-3#1)(2011-1#1)
policy##297##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-6#2)(1991-1#11)(1991-12#11)(1991-2#3)(1991-3#2)(1991-6#2)(1992-1#9)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#4)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#5)(1994-1#8)(1994-12#6)(1994-2#9)(1995-1#5)(1995-11#1)(1995-12#1)(1995-3#7)(1995-6#2)(1996-1#9)(1996-12#5)(1996-2#11)(1996-3#17)(1996-5#3)(1996-8#1)(1997-1#4)(1997-2#11)(1997-3#8)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#2)(2008-1#6)(2008-10#4)(2008-11#27)(2008-12#6)(2008-4#1)(2008-6#3)(2008-7#6)(2009-11#2)(2009-3#7)(2009-4#2)(2009-6#1)(2009-7#2)(2010-10#6)(2010-4#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#11)(2012-3#5)(2013-1#8)
policy-makers have##2##2##(1995-3#1)(1996-1#1)
policy-makers##5##1##(1995-3#2)(1996-1#1)(2008-11#1)(2013-1#1)
policy-making##3##1##(1996-1#1)(1997-2#1)(1997-3#1)
policymakers##11##1##(1992-3#1)(1994-1#1)(1994-2#1)(1997-2#1)(1997-3#1)(2009-4#2)(2010-4#4)
policymaking##2##1##(1991-1#1)(2010-4#1)
poling##4##1##(2007-12#3)(2008-3#1)
polio in##3##2##(1994-9#3)
polio vaccine##3##2##(1994-9#2)(2013-8#1)
polio##18##1##(1994-9#14)(1995-3#1)(2008-11#2)(2013-8#1)
poliomyelitis##6##1##(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)
poliovirus vaccines##2##2##(1995-5#2)
poliovirus##16##1##(1993-6#1)(1995-3#3)(1995-5#9)(2008-10#2)(2008-11#1)
polished##3##1##(2009-5#1)(2013-1#2)
polishing and##3##2##(2008-10#2)(2013-1#1)
polishing on an alumina paper##2##5##(2008-10#2)
polishing on##6##2##(2008-10#6)
polishing the##2##2##(2008-10#2)
polishing##25##1##(2008-10#20)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#2)
polisomnography##2##1##(2010-8#2)
polistine wasps##2##2##(2008-8#2)
political activity##2##2##(2008-4#1)(2012-2#1)
political and##2##2##(2011-2#1)(2012-2#1)
political aspects##2##2##(1996-1#1)(2009-10#1)
political at##2##2##(1996-1#1)(2008-1#1)
political climate##2##2##(2008-11#1)(2008-4#1)
political commitment to##2##3##(1992-1#1)(2008-11#1)
political consensus##2##2##(1996-2#1)(2008-10#1)
political ecology##2##2##(2008-1#2)
political forces##2##2##(1995-12#1)(1997-2#1)
political participation##2##2##(1994-2#1)(2012-2#1)
political##68##1##(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-5#1)(2008-1#6)(2008-10#1)(2008-11#10)(2008-12#2)(2008-4#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#1)
politically##6##1##(1995-3#2)(1996-1#1)(1996-2#1)(2010-9#1)(2013-1#1)
politicians##2##1##(1992-2#1)(1993-11#1)
politics and##5##2##(1991-2#1)(1994-3#2)(2012-2#1)(2012-3#1)
politics of##6##2##(1991-2#1)(1992-1#1)(1994-2#1)(1994-9#1)(1996-12#1)(2008-11#1)
politics##18##1##(1991-2#2)(1992-1#1)(1992-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1996-12#1)(1996-3#1)(2008-11#3)(2012-2#2)(2012-3#1)(2013-7#1)
poll##2##1##(1996-1#1)(2012-2#1)
pollen abortion##2##2##(2008-8#2)
pollen allergens##5##2##(2009-10#2)(2011-2#3)
pollen and ovule##2##3##(2008-8#2)
pollen and##6##2##(2008-10#2)(2008-8#2)(2009-10#1)(2013-1#1)
pollen but##2##2##(2009-10#1)(2012-12#1)
pollen fertility##3##2##(2009-10#3)
pollen from##2##2##(2008-10#2)
pollen germination##2##2##(2008-8#1)(2009-10#1)
pollen grains and##4##3##(2008-10#1)(2008-5#1)(2008-8#2)
pollen grains##10##2##(2008-10#5)(2008-5#2)(2008-8#2)(2013-1#1)
pollen in##2##2##(2012-12#1)(2012-7#1)
pollen of##4##2##(2008-11#2)(2009-12#1)(2012-7#1)
pollen production has##2##3##(2012-7#2)
pollen season##3##2##(2012-12#1)(2012-7#2)
pollen to##2##2##(2008-10#2)
pollen transfer##4##2##(2008-8#4)
pollen tube##10##2##(2008-10#1)(2008-11#3)(2008-8#1)(2009-10#1)(2009-8#4)
pollen tubes##6##2##(2008-10#3)(2008-8#3)
pollen was##3##2##(2008-10#1)(2012-12#1)(2012-7#1)
pollen were##2##2##(2008-10#1)(2012-7#1)
pollen##126##1##(2007-12#1)(2008-10#35)(2008-11#5)(2008-5#6)(2008-8#26)(2008-9#2)(2009-10#14)(2009-12#3)(2009-8#4)(2011-2#6)(2012-12#5)(2012-2#3)(2012-7#14)(2013-1#2)
pollenizer##2##1##(2008-10#2)
pollens and##2##2##(2008-8#1)(2013-1#1)
pollens##5##1##(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
pollicus longus##2##2##(2008-9#2)
pollination and seed dispersal##3##4##(2008-9#3)
pollination and##6##2##(2008-10#2)(2008-9#3)(2009-10#1)
pollination occurs##2##2##(2008-10#1)(2012-7#1)
pollination systems##3##2##(2009-8#3)
pollination##31##1##(2008-10#11)(2008-11#3)(2008-8#1)(2008-9#6)(2009-10#2)(2009-6#2)(2009-8#4)(2012-7#2)
pollinator abundance in crop fields##2##5##(2012-2#2)
pollinator abundance in##3##3##(2008-8#1)(2012-2#2)
pollinator abundance##5##2##(2008-8#1)(2012-2#4)
pollinator visitation##2##2##(2008-8#2)
pollinator##17##1##(2008-10#3)(2008-8#7)(2008-9#1)(2009-8#2)(2012-2#4)
pollinators##6##1##(2008-10#2)(2008-8#3)(2008-9#1)
pollinosis##10##1##(2012-12#10)
pollutant producers##2##2##(2011-2#2)
pollutant##21##1##(2008-10#12)(2008-11#5)(2008-3#1)(2009-3#1)(2011-2#2)
pollutants and##2##2##(1994-3#1)(2008-3#1)
pollutants at##3##2##(2008-10#2)(2008-3#1)
pollutants by##2##2##(2008-10#2)
pollutants contained in##2##3##(2008-10#2)
pollutants in a##4##3##(2008-10#4)
pollutants in the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
pollutants in##13##2##(1996-3#1)(2008-10#9)(2008-11#2)(2011-1#1)
pollutants such as##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
pollutants that##5##2##(1994-3#1)(2008-10#2)(2008-11#2)
pollutants##82##1##(1991-3#1)(1994-3#3)(1996-3#2)(2008-10#48)(2008-11#18)(2008-12#1)(2008-3#3)(2009-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#1)
polluted river##3##2##(2008-10#3)
polluted sites##2##2##(2008-11#1)(2010-5#1)
polluted waters##3##2##(2008-10#3)
polluted##23##1##(1996-3#1)(2008-10#13)(2008-11#4)(2008-3#2)(2010-5#3)
polluting##2##1##(2008-12#1)(2011-2#1)
pollution and##7##2##(1994-3#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-5#1)
pollution can##2##2##(1994-9#1)(1997-1#1)
pollution from##2##2##(2008-11#2)
pollution in Shizuoka##2##3##(2008-10#2)
pollution in the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
pollution in##11##2##(1991-12#1)(1994-11#1)(2008-10#5)(2008-11#3)(2011-2#1)
pollution is##2##2##(2008-10#2)
pollution levels##2##2##(2008-10#1)(2008-11#1)
pollution of indoor##2##3##(1994-9#2)
pollution of##5##2##(1994-3#1)(1994-9#2)(2008-10#2)
pollution sources##2##2##(2008-10#2)
pollution was##2##2##(2008-10#2)
pollution with##2##2##(2008-11#1)(2011-2#1)
pollution##76##1##(1990-8#1)(1991-12#1)(1991-3#2)(1994-11#1)(1994-3#3)(1994-9#4)(1997-1#4)(2008-10#27)(2008-11#22)(2008-12#2)(2008-2#1)(2008-5#1)(2009-12#1)(2010-7#1)(2011-2#3)(2012-3#2)
polonica in##2##2##(2008-10#2)
polonica##5##1##(2008-10#5)
poly (A)##4##2##(2008-11#1)(2010-4#3)
poly (A)(+) RNA##2##3##(2008-8#1)(2008-9#1)
poly (vinyl chloride) (PVC)##3##4##(2008-10#3)
poly (vinyl chloride) carboxylate##2##4##(2008-10#2)
poly (vinyl chloride)##7##3##(2008-10#7)
poly (vinyl##10##2##(2008-10#10)
poly vinyl##2##2##(2008-10#2)
poly##38##1##(1994-11#1)(1994-8#1)(2008-10#25)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-4#3)(2011-2#1)
poly(-caprolactone)##2##1##(2010-4#2)
poly(1##5##1##(2008-10#5)
poly(2-acrylamido-2-methylpropane sulfonate)##3##2##(2008-10#3)
poly(3##3##1##(2008-10#3)
poly(3-methylthiophene)##5##1##(2008-10#5)
poly(A) polymerase##2##2##(2013-1#2)
poly(A) tail##4##2##(1991-9#1)(2008-10#3)
poly(A) tail)##2##2##(1994-11#2)
poly(A)##10##1##(1991-9#1)(1994-11#4)(2008-10#3)(2013-1#2)
poly(A)+ RNA##4##2##(1992-6#2)(1995-12#1)(2008-2#1)
poly(A)+##5##1##(1992-6#2)(1995-12#1)(1995-6#1)(2008-2#1)
poly(A)+RNA##2##1##(1991-6#1)(1997-7#1)
poly(A+)RNA##2##1##(1990-7#1)(1990-8#1)
poly(ADP-ribose) polymerase##2##2##(1993-12#1)(2011-2#1)
poly(ADP-ribose)##3##1##(1993-12#2)(2011-2#1)
poly(L-lysine)##2##1##(1991-5#1)(2008-10#1)
poly(N-isopropylacrylamide) (PNIPAAm)##2##2##(2008-10#1)(2008-11#1)
poly(N-isopropylacrylamide)##3##1##(2008-10#2)(2008-11#1)
poly(acrylic acids)##5##2##(2008-10#5)
poly(acrylic##6##1##(2008-10#6)
poly(amphiphilic pyrrole)##2##2##(2008-10#2)
poly(beta-hydroxybutyrate)##5##1##(2008-7#5)
poly(dimethylsiloxane)##3##1##(2008-10#3)
poly(ethylene glycol)##7##2##(1993-6#1)(1993-8#1)(2008-10#2)(2009-5#1)(2010-6#1)(2013-1#1)
poly(ethylene oxide)##3##2##(2008-10#3)
poly(ethylene terephthalate) (PET)-toner##2##3##(2008-10#2)
poly(ethylene terephthalate)##4##2##(2008-10#4)
poly(ethylene##16##1##(1993-6#1)(1993-8#1)(2008-10#11)(2009-5#1)(2010-6#1)(2013-1#1)
poly(ethylenimine)##4##1##(2008-10#4)
poly(gamma-benzyl-L-glutamate) and##3##2##(2008-11#3)
poly(hydromethylsiloxane)##2##1##(2008-10#2)
poly(lactic-co-glycolic acid)##2##2##(2009-7#2)
poly(maleic##2##1##(2008-10#2)
poly(methyl methacrylate) (PMMA)##2##3##(2008-10#1)(2010-4#1)
poly(methyl methacrylate)##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
poly(pyrrolylalkylammonium) films containing an enzyme##2##5##(2008-10#2)
poly(sodium 4-styrenesulfonate) coatings##3##3##(2008-10#3)
poly(sodium 4-styrenesulfonate)##4##2##(2008-10#4)
poly(sodium 4-styrenesulfonate)-coated thin mercury film electrodes##2##6##(2008-10#2)
poly(sodium##6##1##(2008-10#6)
poly(sulfonylpiperidinylmethylene hydroxide)##2##2##(2008-10#2)
poly(tetrafluoroethylene) (PTFE)##2##2##(2008-10#1)(2008-3#1)
poly(vinyl alcohol) (PVA)##2##3##(2008-10#2)
poly(vinyl alcohol)##4##2##(2008-10#4)
poly(vinyl chloride) (PVC) matrix##2##4##(2008-10#2)
poly(vinyl chloride) (PVC) membrane electrode##2##5##(2008-10#2)
poly(vinyl chloride) (PVC) membrane##5##4##(2008-10#5)
poly(vinyl chloride) (PVC) membranes##4##4##(2008-10#4)
poly(vinyl chloride) (PVC)##13##3##(2008-10#13)
poly(vinyl chloride) matrix membrane##2##4##(2008-10#2)
poly(vinyl chloride) membrane electrode##2##4##(2008-10#2)
poly(vinyl chloride) membrane electrodes##3##4##(2008-10#3)
poly(vinyl chloride) membrane##11##3##(2008-10#11)
poly(vinyl chloride)##31##2##(2008-10#31)
poly(vinyl##37##1##(2008-10#37)
poly(vinylchloride)##2##1##(2008-10#2)
poly(vinylpyrrolidone)##2##1##(2008-10#1)(2008-5#1)
poly-1-naphthylamine##2##1##(2008-10#2)
poly-3-methylthiophene##2##1##(2008-10#2)
poly-L-lysine##5##1##(2008-10#2)(2008-11#2)(2008-8#1)
poly-drug users of##2##3##(2013-8#2)
poly-drug users who used##3##4##(2013-8#3)
poly-drug users##5##2##(2013-8#5)
poly-glutamic##2##1##(2008-11#2)
poly-l-lysine (PLL) film##2##3##(2008-10#2)
poly-l-lysine (PLL)##3##2##(2008-10#3)
poly-lysine(5)##2##1##(2008-10#2)
poly-m-aminophenol##2##1##(2008-10#2)
polyacrylamide gel electrophoresis (PAGE)##3##4##(1990-11#1)(1995-12#1)(2010-3#1)
polyacrylamide gel electrophoresis##19##3##(1990-10#1)(1990-11#1)(1992-8#1)(1993-6#1)(1995-12#2)(1997-2#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
polyacrylamide gel##24##2##(1990-10#1)(1990-11#1)(1991-12#1)(1992-8#2)(1993-6#1)(1995-12#2)(1997-2#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
polyacrylamide gels##4##2##(1997-2#1)(2008-10#2)(2008-2#1)
polyacrylamide gradient gel electrophoresis##2##4##(1991-12#1)(2008-3#1)
polyacrylamide gradient##4##2##(1991-12#1)(2008-10#2)(2008-3#1)
polyacrylamide##43##1##(1990-10#1)(1990-11#1)(1991-12#2)(1992-8#2)(1993-6#1)(1995-12#2)(1997-2#2)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2012-2#1)(2013-1#1)
polyacrylaminoimidazole chelating fiber##2##3##(2008-10#2)
polyacrylate##5##1##(2008-10#3)(2008-11#2)
polyacrylates##2##1##(2008-10#2)
polyacrylic acid##9##2##(2008-10#4)(2008-5#5)
polyacrylic##11##1##(2008-10#6)(2008-5#5)
polyacrylonitrile fiber##2##2##(2008-10#2)
polyacrylonitrile##5##1##(2008-10#5)
polyadenylated##8##1##(2008-11#2)(2008-8#2)(2008-9#1)(2010-4#3)
polyadenylation of##4##2##(1995-6#1)(1997-7#1)(2010-4#2)
polyadenylation signal##4##2##(1992-12#1)(1993-12#2)(2008-8#1)
polyadenylation site##4##2##(1990-2#2)(1991-9#1)(1994-11#1)
polyadenylation sites##4##2##(1993-2#1)(2008-8#1)(2010-4#2)
polyadenylation##23##1##(1990-2#2)(1991-9#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#4)(1995-6#1)(1997-7#2)(2008-8#2)(2010-4#6)
polyamine Metalfix-Chelamine resin##2##3##(2008-10#2)
polyamine biosynthesis##3##2##(1992-9#1)(2008-10#2)
polyamine metabolism##2##2##(1991-9#1)(2013-8#1)
polyamine##24##1##(1990-12#1)(1990-5#3)(1990-7#2)(1991-5#1)(1991-9#1)(1992-9#1)(1993-9#1)(1994-11#1)(1996-2#3)(2008-10#7)(2008-12#2)(2013-8#1)
polyamine-deficient##3##1##(2009-6#3)
polyamines and##3##2##(2008-10#3)
polyamines are##4##2##(2009-10#4)
polyamines were##3##2##(2008-10#3)
polyamines##31##1##(1991-9#1)(1993-8#2)(2008-10#14)(2008-12#5)(2009-10#9)
polyammonium cation##2##2##(2008-10#2)
polyammonium cations##5##2##(2008-10#5)
polyammonium##8##1##(2008-10#8)
polyamorphic##2##1##(1995-3#2)
polyandrous mating##2##2##(2008-8#2)
polyandrous##3##1##(2008-8#3)
polyandry##4##1##(2008-8#1)(2008-9#3)
polyaniline and##3##2##(2008-10#3)
polyaniline##18##1##(2008-10#18)
polyanion complexes##2##2##(2008-10#2)
polyanion##5##1##(2008-10#5)
polyanions by##4##2##(2008-10#4)
polyanions##11##1##(1991-11#2)(2008-10#9)
polyaromatic hydrocarbons (PAHs)##4##3##(2008-10#4)
polyaromatic hydrocarbons##8##2##(1993-8#1)(2008-10#7)
polyaromatic##9##1##(1993-8#1)(2008-10#8)
polyarteritis##3##1##(1990-9#1)(1997-8#1)(2008-11#1)
polyarthritis##3##1##(1993-6#1)(2012-3#2)
polyatomic interferences##2##2##(2008-10#2)
polyatomic ions##2##2##(2008-10#2)
polyatomic##5##1##(2008-10#5)
polybrominated diphenyl ethers (PBDEs) in##2##5##(2008-10#2)
polybrominated diphenyl ethers (PBDEs)##3##4##(2008-10#3)
polybrominated diphenyl ethers##6##3##(2008-10#6)
polybrominated##8##1##(2008-10#8)
polybutadiene##2##1##(2008-10#2)
polycarbonate and##2##2##(2008-10#1)(2008-3#1)
polycarbonate at##2##2##(2008-10#1)(2009-11#1)
polycarbonate surface##3##2##(2008-10#3)
polycarbonate##17##1##(2008-10#12)(2008-3#3)(2009-11#2)
polycationic##4##1##(1995-11#1)(2008-11#1)(2008-8#1)(2009-10#1)
polychlorinated biphenyl##3##2##(2008-10#3)
polychlorinated biphenyls (PCBs) and polychlorinated##2##5##(2008-10#2)
polychlorinated biphenyls (PCBs) and##3##4##(1994-3#1)(2008-10#2)
polychlorinated biphenyls (PCBs) in##3##4##(2008-10#3)
polychlorinated biphenyls (PCBs)##8##3##(1993-12#1)(1994-3#1)(2008-10#6)
polychlorinated biphenyls in##3##3##(2008-10#3)
polychlorinated biphenyls##17##2##(1993-12#1)(1994-3#1)(2008-10#12)(2008-11#3)
polychlorinated dibenzo-p-dioxins and dibenzo-furans##2##4##(2008-10#2)
polychlorinated dibenzo-p-dioxins and dibenzofurans##2##4##(2008-10#1)(2008-11#1)
polychlorinated dibenzo-p-dioxins and##5##3##(2008-10#4)(2008-11#1)
polychlorinated dibenzo-p-dioxins##7##2##(2008-10#6)(2008-11#1)
polychlorinated##34##1##(1993-12#1)(1994-3#2)(2008-10#26)(2008-11#4)(2008-3#1)
polychromatic erythrocytes##4##2##(1993-8#1)(2008-9#2)(2011-2#1)
polychromatic##5##1##(1993-8#1)(2008-4#1)(2008-9#2)(2011-2#1)
polycistronic##3##1##(2008-8#2)(2012-2#1)
polyclonal and##2##2##(2008-10#1)(2008-4#1)
polyclonal antibodies against##2##3##(1990-5#1)(1994-11#1)
polyclonal antibodies and##2##3##(1992-6#1)(1995-12#1)
polyclonal antibodies for##3##3##(1993-2#1)(1995-12#1)(2008-1#1)
polyclonal antibodies raised against##4##4##(1990-8#1)(1991-5#1)(1992-8#1)(1996-12#1)
polyclonal antibodies to##3##3##(1990-5#1)(1992-6#1)(1995-6#1)
polyclonal antibodies were##2##3##(1995-12#1)(2008-10#1)
polyclonal antibodies##26##2##(1990-5#3)(1990-8#1)(1991-5#1)(1992-6#3)(1992-8#1)(1993-2#1)(1994-11#1)(1995-12#4)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-9#2)
polyclonal antibody preparation##2##3##(2008-10#2)
polyclonal antibody raised against the##2##5##(2007-12#2)
polyclonal antibody raised against##3##4##(1995-2#1)(2007-12#2)
polyclonal antibody was produced against##2##5##(2008-10#2)
polyclonal antibody was##5##3##(1993-12#1)(2008-10#4)
polyclonal antibody##22##2##(1991-9#2)(1993-12#2)(1995-2#1)(2007-12#2)(2008-10#14)(2012-2#1)
polyclonal antisera in##2##3##(2008-10#2)
polyclonal antisera##5##2##(2008-10#5)
polyclonal antiserum##8##2##(1996-12#1)(1997-1#1)(2008-10#6)
polyclonal human##2##2##(1992-12#1)(2008-11#1)
polyclonal rabbit##4##2##(1992-9#1)(1996-12#1)(2008-10#2)
polyclonal##88##1##(1990-5#3)(1990-8#1)(1990-9#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1994-11#1)(1994-2#1)(1995-12#4)(1995-2#1)(1995-6#2)(1996-12#3)(1997-1#2)(2007-12#2)(2008-1#1)(2008-10#36)(2008-11#2)(2008-4#1)(2008-5#7)(2008-8#1)(2008-9#2)(2012-12#1)(2012-2#1)
polycondensation##2##1##(1992-12#2)
polycrystalline##6##1##(1991-1#1)(2008-10#4)(2008-3#1)
polycyclic aromatic compounds (PACs) in##2##5##(2008-10#2)
polycyclic aromatic compounds##6##3##(2008-10#6)
polycyclic aromatic hydrocarbon (PAH)##2##4##(2008-10#1)(2011-1#1)
polycyclic aromatic hydrocarbon##5##3##(2008-10#3)(2011-1#2)
polycyclic aromatic hydrocarbons (PAH)##2##4##(1995-11#1)(2008-10#1)
polycyclic aromatic hydrocarbons (PAHs) dissolved in aqueous micellar cetyltrimethylammonium chloride##2##10##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs) in a##2##6##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs) in##9##5##(2008-10#9)
polycyclic aromatic hydrocarbons (PAHs) is##2##5##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs)##23##4##(2008-10#22)(2010-5#1)
polycyclic aromatic hydrocarbons and##6##4##(1995-11#1)(2008-10#3)(2008-11#1)(2010-7#1)
polycyclic aromatic hydrocarbons in water samples##5##6##(2008-10#5)
polycyclic aromatic hydrocarbons in water##6##5##(2008-10#6)
polycyclic aromatic hydrocarbons in##11##4##(2008-10#11)
polycyclic aromatic hydrocarbons were##2##4##(2008-10#2)
polycyclic aromatic hydrocarbons##60##3##(1995-11#2)(2008-10#53)(2008-11#2)(2010-5#1)(2010-7#1)(2011-1#1)
polycyclic aromatic##71##2##(1995-11#2)(2008-10#62)(2008-11#2)(2010-5#1)(2010-7#1)(2011-1#3)
polycyclic epidemics##2##2##(2008-10#2)
polycyclic##75##1##(1995-11#2)(2008-10#66)(2008-11#2)(2010-5#1)(2010-7#1)(2011-1#3)
polycylic aromatic hydrocarbons##2##3##(2008-10#2)
polycylic aromatic##3##2##(2008-10#3)
polycystic ovarian syndrome##2##3##(2007-7#1)(2010-11#1)
polycystic ovarian##4##2##(2007-7#1)(2008-11#1)(2010-11#1)(2010-8#1)
polycystic ovary syndrome (PCOS) is##2##5##(2008-4#2)
polycystic ovary syndrome (PCOS)##7##4##(2008-4#7)
polycystic ovary syndrome##18##3##(2007-7#1)(2008-3#3)(2008-4#11)(2008-5#1)(2012-12#1)(2012-3#1)
polycystic##27##1##(1997-1#3)(2007-7#2)(2008-11#1)(2008-3#3)(2008-4#11)(2008-5#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
polycythemia vera##2##2##(1993-9#1)(2009-7#1)
polycythemia##4##1##(1993-9#1)(2008-10#2)(2009-7#1)
polydiacetylene##2##1##(2008-10#2)
polydimethylsiloxane (PDMS)##3##2##(2008-10#3)
polydimethylsiloxane##7##1##(2008-10#6)(2009-9#1)
polydimethylsiloxane/divinylbenzene##2##1##(2008-10#2)
polydispersity##4##1##(2008-10#1)(2008-12#2)(2008-5#1)
polydithiocarbamate resin##2##2##(2008-10#2)
polydrug use##2##2##(2013-1#2)
polyelectrolyte coatings on##2##3##(2008-10#2)
polyelectrolyte coatings##4##2##(2008-10#4)
polyelectrolyte layer##2##2##(2008-10#2)
polyelectrolyte multilayer##2##2##(2008-10#2)
polyelectrolyte##19##1##(1991-11#1)(2008-10#15)(2008-12#1)(2008-7#1)(2009-12#1)
polyelectrolytes such as##3##3##(2008-10#3)
polyelectrolytes using##2##2##(2008-10#2)
polyelectrolytes##10##1##(1997-2#1)(2008-10#9)
polyenes##2##1##(2008-11#1)(2008-5#1)
polyester##7##1##(2008-10#3)(2008-11#3)(2010-4#1)
polyether##6##1##(2008-10#6)
polyethers##5##1##(2008-10#5)
polyethoxylate##2##1##(2008-10#2)
polyethoxylated##3##1##(2008-10#3)
polyethylene glycol (PEG)##7##3##(1990-12#1)(2008-10#3)(2008-7#2)(2012-3#1)
polyethylene glycol##14##2##(1990-12#2)(1992-11#1)(2008-10#6)(2008-11#1)(2008-7#2)(2008-9#1)(2012-3#1)
polyethylene oxide##2##2##(2008-10#2)
polyethylene##32##1##(1990-12#2)(1992-11#1)(2008-10#13)(2008-11#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#3)(2011-3#1)(2012-3#1)(2013-1#1)
polyethyleneglycol (PEG) 6000##2##3##(2008-12#2)
polyethyleneglycol (PEG)##3##2##(2008-10#1)(2008-12#2)
polyethyleneglycol##5##1##(1992-12#1)(1994-11#1)(2008-10#1)(2008-12#2)
polyethyleneimide and##2##2##(1990-11#2)
polyethyleneimine##6##1##(1992-8#1)(2008-10#5)
polyethylenimine (PEI)##2##2##(2008-10#1)(2008-11#1)
polyethylenimine##6##1##(2008-10#4)(2008-11#2)
polygalacturonase activity##2##2##(2008-10#2)
polygalacturonase##6##1##(1997-2#2)(2008-10#4)
polygalacturonase-inhibiting protein##2##2##(2008-10#2)
polygalacturonase-inhibiting proteins##3##2##(2008-10#1)(2011-10#2)
polygalacturonase-inhibiting##5##1##(2008-10#3)(2011-10#2)
polygalacturonases (PGs)##2##2##(2008-10#1)(2011-10#1)
polygenic hypercholesterolemic patients##2##3##(1991-2#2)
polygenic##16##1##(1991-2#3)(1994-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#1)
polyglandular syndrome type##2##3##(2009-5#1)(2012-3#1)
polyglandular##5##1##(1997-2#2)(2009-5#1)(2012-3#2)
polyglycolic acid##2##2##(2011-2#2)
polygonal shape##2##2##(2008-11#1)(2008-7#1)
polygonal##6##1##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-6#1)
polygoni##2##1##(2012-3#1)(2013-8#1)
polygons##2##1##(2008-6#2)
polygynous##8##1##(1995-6#1)(2008-5#2)(2008-8#2)(2008-9#3)
polygyny and##2##2##(1995-6#1)(2011-2#1)
polyhedra or GFP##2##3##(2008-11#2)
polyhedra##8##1##(1993-12#1)(1995-12#1)(2008-11#6)
polyhedral prisms##2##2##(2008-3#2)
polyhedral##4##1##(2008-3#3)(2013-1#1)
polyhedrin gene##4##2##(1995-12#1)(2008-11#2)(2008-8#1)
polyhedrin promoter##4##2##(1994-11#1)(2008-11#2)(2008-7#1)
polyhedrin##8##1##(1994-11#1)(1995-12#1)(2008-11#4)(2008-7#1)(2008-8#1)
polyhydric phenols##3##2##(2008-10#3)
polyhydroxy phenols##3##2##(2008-10#3)
polyhydroxy##4##1##(1992-12#1)(2008-10#3)
polyhydroxylbenzenes##2##1##(2008-10#2)
polyimide##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
polyinosinic and polycytidylic acids##2##4##(2008-11#2)
polyketide##4##1##(2008-10#2)(2013-1#2)
polylactic acid##3##2##(2008-10#3)
polylactic##4##1##(2008-10#3)(2009-7#1)
polylysine##5##1##(1995-6#4)(2008-11#1)
polylysines##4##1##(1991-5#2)(2008-10#2)
polymer (CP) films##2##3##(2008-10#2)
polymer and silica films##3##4##(2008-2#3)
polymer and the##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
polymer and##14##2##(1995-6#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2010-4#1)
polymer as a##2##3##(2008-10#2)
polymer backbone##2##2##(2009-10#2)
polymer beads##3##2##(2008-10#3)
polymer brush##2##2##(2009-5#2)
polymer brushes##2##2##(2009-5#1)(2010-7#1)
polymer capsules##2##2##(2008-10#2)
polymer coated##4##2##(2008-10#4)
polymer coatings##2##2##(2008-10#2)
polymer composite##2##2##(2008-10#1)(2008-3#1)
polymer composition##2##2##(2008-10#1)(2013-1#1)
polymer dispersion##2##2##(2008-10#2)
polymer electrode##4##2##(2008-10#4)
polymer electrodes##2##2##(2008-10#2)
polymer electrolytes by volumetric Karl Fischer##2##6##(2008-10#2)
polymer electrolytes by##3##3##(2008-10#3)
polymer electrolytes##5##2##(2008-10#5)
polymer extrusion processes##2##3##(2008-10#2)
polymer extrusion##3##2##(2008-10#3)
polymer film were##2##3##(2008-10#2)
polymer film##11##2##(2008-10#11)
polymer films are##2##3##(2008-10#1)(2008-3#1)
polymer films for##2##3##(2008-10#2)
polymer films is##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
polymer films was##2##3##(2008-10#2)
polymer films##17##2##(1990-8#1)(2008-10#12)(2008-3#2)(2008-5#1)(2010-4#1)
polymer for##4##2##(2008-10#4)
polymer in##2##2##(2008-2#1)(2008-5#1)
polymer is##5##2##(2008-10#5)
polymer layer##5##2##(2008-10#5)
polymer materials##2##2##(1995-3#1)(2008-10#1)
polymer matrices##2##2##(2008-3#2)
polymer matrix and##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
polymer matrix##13##2##(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#4)(2010-4#1)(2012-2#1)
polymer membrane##4##2##(2008-10#3)(2008-5#1)
polymer membranes##3##2##(2008-10#3)
polymer microring resonators##3##3##(2009-5#3)
polymer modified electrode obtained##2##4##(2008-10#2)
polymer modified electrode##5##3##(2008-10#5)
polymer modified electrodes##6##3##(2008-10#6)
polymer modified##11##2##(2008-10#11)
polymer molecules##2##2##(2008-10#1)(2008-7#1)
polymer of##3##2##(1990-2#1)(2008-10#2)
polymer on##2##2##(2008-10#2)
polymer particles##4##2##(2008-10#4)
polymer resin##2##2##(2008-10#1)(2009-7#1)
polymer solar cells##2##3##(2011-2#2)
polymer solutions##2##2##(2008-10#2)
polymer surface##3##2##(2008-10#2)(2008-5#1)
polymer that##2##2##(2008-10#1)(2008-11#1)
polymer to##5##2##(2008-10#3)(2008-11#1)(2010-4#1)
polymer was prepared##2##3##(2008-10#2)
polymer was##8##2##(2008-10#7)(2008-5#1)
polymer were##4##2##(2008-10#4)
polymer with##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
polymer##340##1##(1990-2#1)(1990-8#1)(1992-11#1)(1995-3#3)(1995-6#3)(2007-11#2)(2007-12#1)(2008-10#221)(2008-11#18)(2008-12#3)(2008-2#6)(2008-3#13)(2008-5#16)(2008-7#11)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#6)(2009-7#1)(2009-8#1)(2010-4#10)(2010-6#1)(2010-7#3)(2011-2#4)(2011-3#3)(2012-12#1)(2012-2#5)(2013-1#1)
polymer-coated##4##1##(1997-3#1)(2008-10#2)(2008-12#1)
polymer-network liquid##3##2##(2008-3#3)
polymerase (PARP)##3##2##(2008-12#1)(2011-2#2)
polymerase III##5##2##(1992-3#3)(1994-12#1)(1997-7#1)
polymerase accessory protein##3##3##(1997-3#3)
polymerase activity in##2##3##(1993-8#1)(2012-3#1)
polymerase activity##4##2##(1991-5#1)(1993-8#2)(2012-3#1)
polymerase alpha##3##2##(1995-6#3)
polymerase and##5##2##(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#1)(2012-3#1)
polymerase by##2##2##(1993-8#1)(1995-2#1)
polymerase chain reaction (PCR) amplification and##2##6##(2008-10#2)
polymerase chain reaction (PCR) amplification of the##2##7##(2008-10#2)
polymerase chain reaction (PCR) amplification##5##5##(2008-10#5)
polymerase chain reaction (PCR) amplified##2##5##(1995-12#1)(2008-10#1)
polymerase chain reaction (PCR) and##11##5##(2008-10#9)(2010-6#1)(2011-2#1)
polymerase chain reaction (PCR) approach##2##5##(2008-10#2)
polymerase chain reaction (PCR) assay for##2##6##(2008-10#2)
polymerase chain reaction (PCR) assay using a##2##7##(2008-10#2)
polymerase chain reaction (PCR) assay##8##5##(2008-10#8)
polymerase chain reaction (PCR) assays##6##5##(2008-10#5)(2012-2#1)
polymerase chain reaction (PCR) detection method for##2##7##(2008-10#2)
polymerase chain reaction (PCR) has##2##5##(2008-10#1)(2008-4#1)
polymerase chain reaction (PCR) in##3##5##(1994-1#1)(2008-10#2)
polymerase chain reaction (PCR) method##2##5##(1996-12#1)(2008-10#1)
polymerase chain reaction (PCR) methods##2##5##(2008-10#1)(2011-2#1)
polymerase chain reaction (PCR) primers were##2##6##(2008-10#2)
polymerase chain reaction (PCR) primers##3##5##(2008-10#3)
polymerase chain reaction (PCR) technique##2##5##(2008-10#1)(2013-1#1)
polymerase chain reaction (PCR) using TaqMan chemistry##2##7##(2008-10#2)
polymerase chain reaction (PCR) using##5##5##(1996-12#1)(1996-8#1)(2008-10#2)(2011-2#1)
polymerase chain reaction (PCR) with##2##5##(2008-10#2)
polymerase chain reaction (PCR)##96##4##(1991-1#1)(1992-6#1)(1993-12#1)(1994-1#1)(1995-12#1)(1996-12#3)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#71)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#3)
polymerase chain reaction (PCR)-based##6##4##(2008-10#6)
polymerase chain reaction (RT-PCR) and##3##5##(2008-10#1)(2008-8#1)(2012-2#1)
polymerase chain reaction (RT-PCR) technique##2##5##(1996-12#1)(2008-10#1)
polymerase chain reaction (RT-PCR) was performed##2##6##(1994-11#1)(2008-10#1)
polymerase chain reaction (RT-PCR)##13##4##(1994-11#1)(1995-11#1)(1996-12#2)(2008-10#6)(2008-8#1)(2008-9#1)(2012-2#1)
polymerase chain reaction (qPCR)##2##4##(2009-6#2)
polymerase chain reaction (rep-PCR) and##2##5##(2008-10#2)
polymerase chain reaction (rep-PCR) with##2##5##(2008-10#2)
polymerase chain reaction (rep-PCR)##8##4##(2008-10#8)
polymerase chain reaction amplification of##3##5##(1993-8#1)(2008-10#2)
polymerase chain reaction amplification##8##4##(1993-8#1)(1995-12#1)(2008-10#6)
polymerase chain reaction analysis##2##4##(2008-10#2)
polymerase chain reaction and##14##4##(1990-8#1)(1994-12#1)(2008-10#8)(2008-5#1)(2011-2#2)(2013-1#1)
polymerase chain reaction assay##3##4##(1996-12#1)(2008-10#2)
polymerase chain reaction assays for##3##5##(2008-10#3)
polymerase chain reaction assays##6##4##(2008-10#6)
polymerase chain reaction for the##2##5##(1996-11#1)(2013-8#1)
polymerase chain reaction for##4##4##(1996-11#1)(2008-10#1)(2008-12#1)(2013-8#1)
polymerase chain reaction from##4##4##(1995-12#1)(2008-10#3)
polymerase chain reaction in real-time operation mode##3##7##(2013-1#3)
polymerase chain reaction in##5##4##(1996-3#1)(2008-10#1)(2013-1#3)
polymerase chain reaction is##2##4##(1990-8#1)(1997-7#1)
polymerase chain reaction of the##2##5##(2008-10#1)(2011-2#1)
polymerase chain reaction of##4##4##(2008-10#3)(2011-2#1)
polymerase chain reaction primers##3##4##(2008-10#3)
polymerase chain reaction product##2##4##(1995-12#1)(2008-10#1)
polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis of##2##10##(2008-10#2)
polymerase chain reaction restriction fragment length##3##6##(2008-10#3)
polymerase chain reaction showed##2##4##(2008-10#1)(2009-8#1)
polymerase chain reaction using primers based on the##2##8##(1993-2#1)(2008-10#1)
polymerase chain reaction using primers##3##5##(1992-6#1)(1993-2#1)(2008-10#1)
polymerase chain reaction using##6##4##(1992-6#1)(1993-2#1)(1997-7#1)(2008-10#2)(2012-12#1)
polymerase chain reaction was##4##4##(1991-7#1)(1992-6#1)(1995-6#1)(2008-10#1)
polymerase chain reaction with##3##4##(1993-2#1)(1994-11#1)(2008-10#1)
polymerase chain reaction##291##3##(1990-2#1)(1990-8#2)(1991-1#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#4)(1992-8#1)(1993-12#2)(1993-2#5)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#4)(1995-6#1)(1996-11#1)(1996-12#6)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#1)(2008-10#185)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#5)(2008-8#1)(2008-9#2)(2009-6#2)(2009-8#2)(2010-4#1)(2010-6#4)(2011-2#13)(2012-12#2)(2012-2#3)(2013-1#9)(2013-8#2)
polymerase chain reaction-allele specific oligonucleotide##2##5##(1997-8#2)
polymerase chain reaction-amplified##5##3##(2008-10#5)
polymerase chain reaction-based markers##3##4##(2008-10#3)
polymerase chain reaction-based##10##3##(1993-8#1)(2008-10#9)
polymerase chain reaction-restriction fragment length polymorphism##6##6##(1997-8#1)(2008-10#4)(2011-2#1)
polymerase chain reaction-restriction fragment length##7##5##(1997-8#1)(2008-10#5)(2011-2#1)
polymerase chain reaction-sequence-specific##2##3##(1997-8#1)(2012-2#1)
polymerase chain reactions (PCR)##2##4##(1993-8#1)(2008-10#1)
polymerase chain reactions##4##3##(1993-8#1)(1997-4#1)(2008-10#2)
polymerase chain##327##2##(1990-2#1)(1990-8#3)(1991-1#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#5)(1992-8#1)(1993-12#2)(1993-2#5)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-6#1)(1996-11#1)(1996-12#6)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#6)(2008-10#206)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#6)(2008-8#1)(2008-9#2)(2009-6#2)(2009-8#2)(2010-4#1)(2010-6#4)(2011-2#14)(2012-12#2)(2012-2#4)(2013-1#9)(2013-8#2)
polymerase gene##3##2##(1993-8#2)(2008-10#1)
polymerase has been##3##3##(1990-5#1)(1993-9#1)(1995-8#1)
polymerase has##4##2##(1990-5#1)(1993-9#1)(1995-8#1)(1997-8#1)
polymerase in a##2##3##(1995-2#1)(2008-4#1)
polymerase in##4##2##(1990-12#1)(1994-11#1)(1995-2#1)(2008-4#1)
polymerase mutations##2##2##(2013-1#2)
polymerase reaction##2##2##(1990-8#1)(1997-8#1)
polymerase to##2##2##(1993-8#1)(1995-2#1)
polymerase was##3##2##(1993-12#1)(1993-8#1)(1994-5#1)
polymerase##450##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#3)(1990-8#4)(1991-1#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#3)(1992-6#5)(1992-8#1)(1993-12#7)(1993-2#5)(1993-8#14)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#8)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#10)(1995-6#7)(1995-8#3)(1996-11#1)(1996-12#6)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-7#6)(1997-8#12)(1997-9#1)(2008-10#220)(2008-11#7)(2008-12#2)(2008-4#4)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#4)(2009-6#2)(2009-8#2)(2010-4#1)(2010-5#1)(2010-6#4)(2011-2#19)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#14)(2013-8#4)
polymerase)##2##1##(2008-10#1)(2013-1#1)
polymerases by##2##2##(1992-6#1)(2010-7#1)
polymerases##13##1##(1992-6#2)(1995-6#1)(1997-8#1)(2008-10#3)(2008-9#1)(2010-7#3)(2012-3#1)(2013-8#1)
polymeric CTA membrane##2##3##(2008-10#2)
polymeric MB##2##2##(2008-10#2)
polymeric and##2##2##(2008-5#1)(2012-12#1)
polymeric composites##2##2##(2010-4#2)
polymeric dye##2##2##(2008-3#1)(2011-1#1)
polymeric emulsifier##2##2##(2008-5#2)
polymeric film##6##2##(2008-10#6)
polymeric films##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
polymeric materials##6##2##(1996-12#1)(2008-10#4)(2008-11#1)
polymeric matrices##3##2##(2008-10#2)(2008-5#1)
polymeric matrix##11##2##(2008-10#8)(2008-11#1)(2008-5#1)(2010-4#1)
polymeric membrane electrode based on##2##5##(2008-10#2)
polymeric membrane electrode##5##3##(2008-10#5)
polymeric membrane electrodes based on##2##5##(2008-10#2)
polymeric membrane electrodes##8##3##(2008-10#8)
polymeric membrane sensor##3##3##(2008-10#3)
polymeric membrane##20##2##(2008-10#20)
polymeric membranes for the effective batch pre-concentration and determination of zinc traces with flame atomic absorption spectrometry##2##17##(2008-10#2)
polymeric membranes##10##2##(2008-10#10)
polymeric resin beads##2##3##(2008-10#2)
polymeric resin##7##2##(2008-10#7)
polymeric supports##2##2##(2008-10#2)
polymeric##123##1##(1995-3#1)(1996-12#1)(2008-10#92)(2008-11#5)(2008-2#1)(2008-3#5)(2008-5#8)(2009-4#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
polymerisation of##2##2##(2008-10#2)
polymerisation##4##1##(1992-12#1)(2008-10#3)
polymerised##2##1##(2008-10#2)
polymerizable carbon double bonds##2##4##(2009-7#2)
polymerizable##4##1##(2007-12#1)(2009-7#2)(2011-2#1)
polymerization and##4##2##(1993-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
polymerization from##2##2##(2008-10#1)(2008-2#1)
polymerization of phenothiazine derivatives##2##4##(2008-10#2)
polymerization of tert-butyl acrylate##2##4##(2008-12#2)
polymerization of the##3##3##(2008-10#2)(2008-2#1)
polymerization of##20##2##(1992-4#1)(1995-3#1)(2008-10#8)(2008-12#5)(2008-2#1)(2009-10#1)(2011-1#3)
polymerization process##3##2##(2008-12#1)(2008-3#1)(2010-10#1)
polymerization##63##1##(1990-6#1)(1992-4#1)(1993-8#3)(1994-6#1)(1995-3#2)(1995-6#1)(1996-12#1)(2008-10#24)(2008-12#6)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#3)(2013-1#2)
polymers and##13##2##(1991-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#3)(2009-12#1)(2010-7#1)(2010-8#1)
polymers are##5##2##(2008-10#2)(2008-11#1)(2008-5#2)
polymers as##3##2##(2008-10#2)(2008-11#1)
polymers by##2##2##(2008-10#2)
polymers can##2##2##(2008-10#1)(2008-5#1)
polymers demonstrated##2##2##(2008-10#1)(2010-8#1)
polymers for##6##2##(2008-10#5)(2008-5#1)
polymers from##2##2##(1995-3#1)(2008-12#1)
polymers have##2##2##(1995-6#1)(2008-11#1)
polymers in soil##2##3##(2008-11#2)
polymers in##9##2##(1997-6#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
polymers offer##2##2##(2008-10#2)
polymers that##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
polymers under##2##2##(2008-10#1)(2008-5#1)
polymers were##7##2##(2008-10#5)(2008-11#1)(2008-5#1)
polymers with a##2##3##(2008-10#1)(2008-5#1)
polymers with##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
polymers##150##1##(1990-8#1)(1991-7#1)(1994-11#1)(1995-3#6)(1995-6#2)(1997-6#1)(2008-10#70)(2008-11#13)(2008-12#6)(2008-2#3)(2008-3#1)(2008-5#24)(2008-6#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-10#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#2)
polymetallic##3##1##(2008-10#1)(2013-8#2)
polymethacrylates##2##1##(2008-10#2)
polymethacrylic-acid-co-vinyl-acetate (PMAVA)##2##2##(2008-10#2)
polymicrobial##2##1##(2008-10#1)(2012-3#1)
polymorph##2##1##(2011-3#2)
polymorpha##2##1##(1995-9#2)
polymorphic AFLP markers were##2##4##(2008-10#2)
polymorphic AFLP markers##3##3##(2008-10#3)
polymorphic AFLP##4##2##(2008-10#4)
polymorphic DNA##66##2##(1995-6#1)(1997-8#1)(2008-10#64)
polymorphic and##3##2##(2008-10#2)(2008-4#1)
polymorphic bands##6##2##(2008-10#3)(2008-12#1)(2008-8#2)
polymorphic for##2##2##(2008-10#1)(2008-9#1)
polymorphic fragments##2##2##(1995-6#2)
polymorphic loci in##3##3##(2008-10#1)(2008-9#2)
polymorphic loci##8##2##(2008-10#5)(2008-9#3)
polymorphic markers##7##2##(1997-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2013-8#1)
polymorphic microsatellite##2##2##(2008-9#1)(2013-8#1)
polymorphic probes were##3##3##(2008-10#3)
polymorphic sites##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
polymorphic##144##1##(1990-6#1)(1992-6#4)(1993-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-8#2)(1997-8#2)(2007-12#1)(2008-10#98)(2008-12#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#7)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#3)
polymorphism (SNP)##6##2##(2008-10#1)(2009-7#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
polymorphism analysis of the##4##4##(2008-10#3)(2011-2#1)
polymorphism analysis of##10##3##(2008-10#9)(2011-2#1)
polymorphism analysis##22##2##(1991-12#1)(2008-10#16)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#2)
polymorphism and the##2##3##(2008-12#1)(2008-8#1)
polymorphism and##23##2##(2008-10#14)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#4)(2013-8#1)
polymorphism as##2##2##(1994-5#1)(2008-11#1)
polymorphism at##2##2##(2006-6#1)(2008-9#1)
polymorphism between the##2##3##(2008-10#1)(2008-8#1)
polymorphism for##6##2##(1995-12#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-9#1)
polymorphism has##2##2##(1997-9#1)(2006-6#1)
polymorphism in a##2##3##(1995-3#1)(2008-9#1)
polymorphism in the promoter##2##4##(2008-7#1)(2011-2#1)
polymorphism in the##7##3##(1993-6#1)(1995-12#1)(1997-9#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
polymorphism in##23##2##(1993-6#1)(1995-12#2)(1995-3#1)(1995-9#1)(1997-9#1)(2006-6#2)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#1)
polymorphism is##2##2##(2008-10#1)(2008-6#1)
polymorphism markers##11##2##(2008-10#11)
polymorphism of the##5##3##(1997-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
polymorphism of##18##2##(1993-2#1)(1997-8#1)(2006-6#1)(2008-10#8)(2008-12#1)(2008-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
polymorphism on the##2##3##(2006-6#1)(2012-3#1)
polymorphism on##4##2##(2006-6#1)(2008-10#1)(2011-2#1)(2012-3#1)
polymorphism that##2##2##(2008-10#2)
polymorphism was observed between##2##4##(1995-12#1)(2008-10#1)
polymorphism was observed##3##3##(1995-12#1)(2008-10#1)(2008-12#1)
polymorphism was##9##2##(1995-12#1)(1997-8#3)(2008-10#4)(2008-12#1)
polymorphism with##5##2##(2008-10#2)(2008-9#3)
polymorphism##312##1##(1991-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-12#5)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-8#2)(1997-3#1)(1997-5#2)(1997-8#5)(1997-9#2)(2006-6#7)(2008-10#204)(2008-11#2)(2008-12#9)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#13)(2009-10#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#13)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#4)
polymorphism)##2##1##(1992-8#1)(2010-10#1)
polymorphisms (SNPs)##12##2##(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
polymorphisms among##2##2##(2008-10#1)(2008-12#1)
polymorphisms and##9##2##(2008-10#3)(2008-11#1)(2008-12#1)(2010-6#1)(2013-1#2)(2013-8#1)
polymorphisms are##5##2##(2008-10#2)(2008-8#1)(2012-12#1)(2012-3#1)
polymorphisms at the##2##3##(1996-12#1)(2008-10#1)
polymorphisms between the##2##3##(2008-10#2)
polymorphisms between##4##2##(2008-10#4)
polymorphisms in a##2##3##(2008-10#2)
polymorphisms in the##4##3##(1997-9#1)(2008-10#1)(2009-8#1)(2010-11#1)
polymorphisms in##12##2##(1997-9#1)(2008-10#6)(2008-12#1)(2008-4#1)(2009-8#1)(2010-11#1)(2013-1#1)
polymorphisms is##2##2##(2012-12#1)(2012-3#1)
polymorphisms of Y chromosome at YAP locus##2##7##(2008-9#2)
polymorphisms of##8##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#2)
polymorphisms that##2##2##(2008-10#1)(2008-6#1)
polymorphisms using##3##2##(2008-10#2)(2008-8#1)
polymorphisms were observed##2##3##(2008-10#2)
polymorphisms were##6##2##(1996-12#1)(2008-10#5)
polymorphisms with##5##2##(1996-12#1)(2008-10#1)(2009-12#1)(2009-7#1)(2010-4#1)
polymorphisms##130##1##(1994-12#1)(1994-9#1)(1996-12#3)(1996-6#1)(1997-8#2)(1997-9#3)(2008-1#1)(2008-10#62)(2008-11#2)(2008-12#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#5)(2008-9#4)(2009-12#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#3)(2010-6#2)(2010-7#1)(2011-2#7)(2012-12#3)(2012-3#7)(2013-1#5)(2013-8#1)
polymorphonuclear leucocytes##3##2##(1991-11#3)
polymorphonuclear leukocyte##2##2##(1992-12#1)(1993-8#1)
polymorphonuclear leukocytes (PMNs)##2##3##(1995-6#1)(2008-12#1)
polymorphonuclear leukocytes were##2##3##(1990-3#1)(1992-12#1)
polymorphonuclear leukocytes##9##2##(1990-3#1)(1992-12#1)(1995-6#1)(1996-11#1)(1996-12#2)(1997-1#1)(2008-12#1)(2010-1#1)
polymorphonuclear neutrophils##3##2##(1990-12#1)(1992-10#1)(2009-10#1)
polymorphonuclear##21##1##(1990-12#2)(1990-3#1)(1991-11#3)(1992-10#1)(1992-12#2)(1993-8#1)(1995-6#1)(1996-11#1)(1996-12#2)(1997-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-10#1)(2010-1#1)
polymorphous##4##1##(2008-11#1)(2008-5#1)(2010-12#1)(2010-6#1)
polymorphs##5##1##(2008-10#2)(2009-11#1)(2011-3#2)
polymyalgia rheumatica and temporal arteritis##7##5##(1994-9#2)(1997-8#5)
polymyalgia rheumatica##13##2##(1994-11#2)(1994-9#4)(1997-8#5)(2008-7#2)
polymyalgia##14##1##(1994-11#2)(1994-9#4)(1997-8#5)(2008-7#3)
polymyositis##6##1##(1995-5#1)(1997-8#1)(2008-7#4)
polymyxin B##2##2##(1996-12#1)(2008-10#1)
polymyxins##3##1##(2008-10#3)
polyneuropathy in##2##2##(1994-6#1)(2008-7#1)
polyneuropathy##12##1##(1992-12#1)(1994-6#1)(2008-2#1)(2008-7#4)(2012-3#5)
polynitroaromatic##3##1##(2008-10#3)
polynomial model##3##2##(2008-10#2)(2010-3#1)
polynomial##15##1##(2008-10#8)(2008-3#1)(2008-6#2)(2009-3#3)(2010-3#1)
polynomials##4##1##(2008-10#1)(2008-3#2)(2008-6#1)
polynuclear aromatic hydrocarbons (PAH)##2##4##(2008-10#1)(2008-11#1)
polynuclear aromatic hydrocarbons in##2##4##(2008-10#2)
polynuclear aromatic hydrocarbons##6##3##(2008-10#5)(2008-11#1)
polynuclear##10##1##(2008-10#9)(2008-11#1)
polynucleated##3##1##(1993-8#2)(1994-11#1)
polynucleotide phosphorylase##3##2##(1997-2#2)(2012-3#1)
polynucleotide##4##1##(1997-2#2)(2008-4#1)(2012-3#1)
polyol##2##1##(2008-1#1)(2008-11#1)
polyoxometalate##2##1##(2008-10#2)
polyoxometalates##5##1##(2008-10#5)
polyoxyalkylene systems##2##2##(2008-10#2)
polyoxyalkylene##3##1##(2008-10#3)
polyoxyethylene##5##1##(2008-10#5)
polyp has##2##2##(2009-12#2)
polyp##18##1##(1993-3#1)(1994-2#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-12#5)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
polypectomy##6##1##(1994-2#1)(2009-12#5)
polypeptide and##3##2##(1990-5#1)(1994-11#1)(1994-5#1)
polypeptide chain##6##2##(1992-4#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-8#2)
polypeptide chains##2##2##(1993-9#1)(1994-11#1)
polypeptide containing##2##2##(1990-11#1)(1995-2#1)
polypeptide has##2##2##(1994-5#2)
polypeptide in##3##2##(1991-9#1)(1993-8#1)(1995-6#1)
polypeptide of approximately##5##3##(1992-10#1)(1996-2#1)(1997-7#1)(2008-10#2)
polypeptide of##15##2##(1990-11#2)(1990-5#1)(1992-10#1)(1993-1#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#1)
polypeptide signal in plants##2##4##(2008-8#2)
polypeptide signal in##3##3##(2008-8#3)
polypeptide was##5##2##(1993-1#1)(1993-3#1)(2008-8#2)(2008-9#1)
polypeptide with a##3##3##(1991-12#1)(1993-2#1)(2008-10#1)
polypeptide with##4##2##(1991-12#1)(1993-2#1)(1995-9#1)(2008-10#1)
polypeptide##108##1##(1990-11#3)(1990-5#7)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#3)(1992-10#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#7)(1993-9#1)(1994-11#2)(1994-5#5)(1995-11#2)(1995-12#2)(1995-2#7)(1995-6#5)(1995-9#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#11)(2008-9#3)(2009-7#1)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
polypeptides and##2##2##(1991-5#1)(1995-2#1)
polypeptides are##4##2##(1993-12#1)(1994-5#2)(2007-12#1)
polypeptides from##2##2##(2008-5#1)(2008-7#1)
polypeptides of##4##2##(1993-9#1)(1995-2#1)(1995-6#1)(2008-9#1)
polypeptides was##2##2##(1991-12#1)(1994-11#1)
polypeptides were##2##2##(1994-5#1)(2008-7#1)
polypeptides##32##1##(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-5#5)(1995-12#1)(1995-2#3)(1995-6#2)(1997-4#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
polypharmacy##3##1##(1991-8#1)(2011-1#1)(2012-3#1)
polyphenol index##3##2##(2008-10#3)
polyphenol oxidase (PPO)##5##3##(2008-10#5)
polyphenol oxidase into##2##3##(2008-10#2)
polyphenol oxidase##13##2##(2008-10#13)
polyphenol##21##1##(1995-9#2)(2008-10#17)(2009-12#1)(2012-12#1)
polyphenolic compounds in wastewater##2##4##(2008-10#2)
polyphenolic compounds##3##2##(2008-10#3)
polyphenolic##7##1##(2008-10#5)(2008-11#1)(2011-2#1)
polyphenoloxidase##2##1##(2008-10#2)
polyphenols can##2##2##(2009-3#2)
polyphenols have been##2##3##(2008-10#1)(2012-12#1)
polyphenols in##6##2##(2008-10#2)(2009-12#1)(2009-3#1)(2009-8#2)
polyphenols may##4##2##(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)
polyphenols##38##1##(2008-10#11)(2008-5#1)(2008-7#2)(2009-12#6)(2009-3#6)(2009-8#6)(2011-2#1)(2011-3#1)(2012-12#3)(2013-8#1)
polyphenols-rich foods##2##2##(2012-12#2)
polyphenylalanine synthesis##2##2##(1996-2#2)
polyphosphate##2##1##(2008-10#2)
polyphosphates##3##1##(2008-10#3)
polyphosphoinositide##2##1##(2008-8#1)(2012-2#1)
polyphosphoinositides##3##1##(1993-6#1)(2012-2#2)
polyphyletic##4##1##(2008-10#4)
polyploid##5##1##(1993-3#1)(2008-10#1)(2009-12#1)(2012-3#2)
polyploidization by##2##2##(1994-11#1)(2009-12#1)
polyploidization was##2##2##(1994-11#2)
polyploidization##7##1##(1994-11#5)(2007-12#1)(2009-12#1)
polyploids##2##1##(2007-12#2)
polypoid tumor with##2##3##(1997-8#1)(2008-11#1)
polypoid tumor##4##2##(1991-12#1)(1997-8#1)(2008-11#1)(2013-8#1)
polypoid##8##1##(1991-12#1)(1997-8#1)(2008-11#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
polyposis##18##1##(2009-12#13)(2011-2#4)(2012-3#1)
polypropylene and human hair##3##4##(2012-3#3)
polypropylene and##4##2##(2008-10#1)(2012-3#3)
polypropylene fiber##3##2##(2012-3#3)
polypropylene glycol##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
polypropylene mesh##2##2##(2008-12#1)(2008-7#1)
polypropylene##22##1##(2008-10#9)(2008-12#1)(2008-7#3)(2012-3#9)
polyprotein##12##1##(1991-9#1)(1992-6#1)(1994-11#2)(2008-10#2)(2008-8#2)(2008-9#2)(2009-7#1)(2013-8#1)
polyps and##5##2##(2009-1#1)(2009-12#1)(2009-8#2)(2012-3#1)
polyps are##5##2##(2009-12#4)(2011-2#1)
polyps or##2##2##(2009-12#1)(2013-1#1)
polyps##40##1##(1994-2#2)(2008-1#2)(2008-11#2)(2008-7#1)(2009-1#1)(2009-12#19)(2009-8#3)(2011-2#4)(2012-3#4)(2013-1#1)(2013-8#1)
polypurine##2##1##(1994-2#1)(2012-3#1)
polypyrrole (PPY)##2##2##(2008-10#2)
polypyrrole (PPy)##3##2##(2008-10#3)
polypyrrole and##3##2##(2008-10#3)
polypyrrole electrode modified with a##2##5##(2008-10#2)
polypyrrole electrode modified##3##3##(2008-10#3)
polypyrrole electrode##4##2##(2008-10#4)
polypyrrole film##7##2##(2008-10#7)
polypyrrole##36##1##(2008-10#36)
polypyrrole/beta-cyclodextrin (Ppy/beta-CD) film##2##3##(2008-10#2)
polyradiculoneuropathy##4##1##(2007-8#2)(2008-2#2)
polysaccharide of##2##2##(1990-12#1)(1995-6#1)
polysaccharide##20##1##(1990-12#1)(1991-3#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-6#2)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
polysaccharides at##2##2##(2008-10#2)
polysaccharides in##3##2##(2008-10#2)(2011-2#1)
polysaccharides were##2##2##(2013-1#2)
polysaccharides##23##1##(1995-12#1)(1996-12#1)(2008-10#12)(2008-5#2)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#3)
polysomes##6##1##(1997-7#1)(2008-11#3)(2008-12#1)(2008-7#1)
polysorbate 80##2##2##(2008-10#2)
polysorbate##3##1##(2008-10#2)(2008-5#1)
polyspermy under sperm-limited conditions##2##4##(2008-8#2)
polyspermy##9##1##(2008-8#9)
polystyrene and##3##2##(2008-11#2)(2008-3#1)
polystyrene beads and##2##3##(2009-5#1)(2011-2#1)
polystyrene beads loaded with##2##4##(2008-10#2)
polystyrene beads##8##2##(1990-12#1)(2008-10#4)(2008-11#1)(2009-5#1)(2011-2#1)
polystyrene divinyl benzene##2##3##(2008-10#2)
polystyrene latex spheres##3##3##(2008-3#3)
polystyrene latex##5##2##(2008-3#3)(2010-6#2)
polystyrene particles##3##2##(2008-10#3)
polystyrene plate##4##2##(2008-11#4)
polystyrene spheres##2##2##(2008-2#1)(2008-3#1)
polystyrene##57##1##(1990-12#1)(1995-11#1)(1996-12#1)(2008-10#26)(2008-11#16)(2008-2#1)(2008-3#6)(2009-5#1)(2010-6#2)(2011-2#1)(2012-5#1)
polystyrene-divinylbenzene reversed-phase HPLC##2##3##(1997-2#2)
polystyrene-divinylbenzene##5##1##(1997-2#3)(2008-10#2)
polystyrenesulfonate##3##1##(2008-10#3)
polytene region##2##2##(1995-8#1)(2008-9#1)
polytene##4##1##(1995-8#2)(1996-6#1)(2008-9#1)
polytetrafluoroethylene (PTFE) turnings##2##3##(2008-10#2)
polytetrafluoroethylene (PTFE)##7##2##(2008-10#7)
polytetrafluoroethylene##11##1##(2008-10#10)(2011-3#1)
polythiophene##2##1##(2008-10#2)
polytopic##2##1##(1990-5#1)(2011-2#1)
polyunsaturated Fatty##2##2##(2010-1#1)(2013-1#1)
polyunsaturated fatty acid##5##3##(1995-11#1)(2008-5#2)(2008-7#1)(2010-1#1)
polyunsaturated fatty acids (PUFAs) in##3##5##(2008-10#1)(2010-4#1)(2010-6#1)
polyunsaturated fatty acids (PUFAs)##5##4##(2008-10#2)(2010-4#1)(2010-6#1)(2013-1#1)
polyunsaturated fatty acids##11##3##(1991-12#2)(1994-12#1)(2008-10#3)(2010-1#1)(2010-4#1)(2010-6#1)(2013-1#2)
polyunsaturated fatty##17##2##(1991-12#2)(1994-12#1)(1995-11#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-1#2)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#2)
polyunsaturated##19##1##(1991-12#2)(1994-12#1)(1995-11#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-1#3)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#3)
polyurethane foam (PUF) were##2##4##(2008-10#1)(2008-11#1)
polyurethane foam (PUF)##6##3##(2008-10#4)(2008-11#2)
polyurethane foam column##2##3##(2008-10#2)
polyurethane foam loaded with##4##4##(2008-10#4)
polyurethane foam mini-column##2##3##(2008-10#2)
polyurethane foam##34##2##(2008-10#29)(2008-11#3)(2008-7#2)
polyurethane foams##2##2##(2008-10#2)
polyurethane membrane has been##2##4##(2008-10#2)
polyurethane membrane##10##2##(2008-10#10)
polyurethane##58##1##(2008-10#51)(2008-11#3)(2008-7#2)(2009-7#2)
polyvalent##5##1##(1995-5#1)(2008-5#1)(2009-10#3)
polyvinyl alcohol##9##2##(2008-10#6)(2008-2#1)(2012-3#2)
polyvinyl chloride (PVC) membrane##3##4##(2008-10#3)
polyvinyl chloride (PVC)##7##3##(2008-10#7)
polyvinyl chloride##12##2##(2008-10#12)
polyvinyl pyrrolidine##2##2##(2012-2#2)
polyvinyl pyrrolidone##2##2##(2008-10#1)(2008-5#1)
polyvinyl##30##1##(2008-10#21)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#2)(2012-3#2)(2013-1#2)
polyvinylalcohol##2##1##(1991-2#1)(2008-10#1)
polyvinylchloride##2##1##(1992-1#1)(2008-10#1)
polyvinylidene difluoride##2##2##(2008-11#1)(2012-2#1)
polyvinylidene##3##1##(2008-11#1)(2009-5#1)(2012-2#1)
pomaceous flowers##2##2##(2008-10#2)
pombe##18##1##(1995-2#3)(1995-9#1)(1997-2#1)(1997-3#4)(1997-4#1)(2008-4#1)(2008-9#1)(2010-11#1)(2012-3#5)
pome fruit##3##2##(2008-10#3)
pome##4##1##(2008-10#4)
pomegranate antioxidants##2##2##(2013-8#2)
pomegranate##9##1##(2012-12#3)(2013-8#6)
ponceau 4R##2##2##(2008-10#2)
pond water##3##2##(2008-10#2)(2012-2#1)
pond##10##1##(1991-2#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
ponds##3##1##(2008-10#1)(2008-8#1)(2012-2#1)
ponies##2##1##(1990-6#2)
pons and medulla##4##3##(1997-2#4)
pons##5##1##(1995-2#1)(1997-2#4)
ponticum##5##1##(2008-10#5)
pontine##12##1##(1990-12#1)(1997-8#1)(2008-11#6)(2008-7#2)(2011-2#2)
pool and##6##2##(1991-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-10#1)
pool for##3##2##(1992-12#1)(1993-12#1)(1993-3#1)
pool in##4##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
pool is##2##2##(1993-12#1)(2008-11#1)
pool of docked granules##2##4##(1997-7#2)
pool of##27##2##(1990-12#1)(1991-6#1)(1993-2#1)(1994-2#2)(1994-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-7#3)(2008-10#5)(2008-11#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#1)
pool to be##2##3##(2008-4#1)(2008-8#1)
pool##85##1##(1990-12#3)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1997-2#1)(1997-6#1)(1997-7#4)(1997-8#1)(2008-10#18)(2008-11#13)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#3)(2013-1#1)(2013-7#1)
pooled analysis of##2##3##(2012-3#2)
pooled data##4##2##(2008-10#2)(2008-12#1)(2009-11#1)
pooled samples##2##2##(2012-2#1)(2013-8#1)
pooled##26##1##(1990-6#1)(1991-9#1)(1995-8#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2012-2#2)(2012-3#4)(2013-8#2)
pooling##4##1##(1994-9#1)(1995-9#1)(2008-10#1)(2008-11#1)
pools and##2##2##(2008-11#2)
pools as##2##2##(1995-6#1)(2008-7#1)
pools in##2##2##(1991-6#1)(2008-11#1)
pools of##8##2##(1990-5#1)(1995-11#2)(1995-6#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
pools##39##1##(1990-5#1)(1991-6#3)(1994-11#2)(1995-11#2)(1995-6#3)(1996-8#1)(2008-10#9)(2008-11#10)(2008-7#3)(2008-9#2)(2009-8#1)(2011-2#2)
poor adaptation##2##2##(2008-11#2)
poor and the##2##3##(1993-3#1)(2008-10#1)
poor and##9##2##(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
poor are not##2##3##(2008-11#2)
poor bioavailability##2##2##(2011-3#1)(2012-2#1)
poor bone quality##2##3##(1995-9#1)(2011-7#1)
poor children##2##2##(1992-2#1)(2008-11#1)
poor clinical##2##2##(1990-5#1)(1991-3#1)
poor condition##3##2##(2008-10#1)(2008-5#1)(2010-10#1)
poor crop##2##2##(2008-12#1)(2010-10#1)
poor differentiation (P &lt##2##4##(2012-3#2)
poor differentiation##5##2##(2009-12#1)(2011-2#1)(2012-3#3)
poor for##2##2##(1990-2#1)(2008-10#1)
poor functional##2##2##(2008-5#1)(2008-7#1)
poor general##2##2##(2008-7#2)
poor health status##2##3##(2009-5#2)
poor health##7##2##(1990-2#1)(1993-12#1)(1997-2#1)(2008-11#2)(2009-5#2)
poor households##2##2##(2012-12#2)
poor in##5##2##(1991-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
poor mental health##2##3##(2009-5#2)
poor mental##3##2##(2009-5#3)
poor or##2##2##(1992-2#1)(2013-1#1)
poor oral##2##2##(2008-1#1)(2008-5#1)
poor outcome in##3##3##(2008-12#1)(2011-2#2)
poor outcome##13##2##(1994-12#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-3#3)
poor outcomes##5##2##(2009-1#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
poor patient##2##2##(1996-11#1)(2009-11#1)
poor performance##4##2##(1997-5#1)(2008-10#1)(2010-2#1)(2011-2#1)
poor physical##2##2##(2008-11#1)(2011-2#1)
poor precision and##2##3##(2008-10#2)
poor precision##3##2##(2008-10#3)
poor predictors##2##2##(1994-3#2)
poor prognosis##28##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1993-1#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-5#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
poor quality of the##2##4##(1995-9#1)(2008-5#1)
poor quality of##4##3##(1991-9#1)(1995-9#1)(2008-5#1)(2013-1#1)
poor quality##6##2##(1991-9#1)(1995-9#2)(2008-11#1)(2008-5#1)(2013-1#1)
poor recovery##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
poor relief in##2##3##(2008-11#2)
poor responders##3##2##(2012-2#1)(2012-3#2)
poor response to##3##3##(2010-12#1)(2010-6#1)(2013-8#1)
poor response##9##2##(2008-10#3)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
poor school##2##2##(2008-11#1)(2008-12#1)
poor sensitivity of##2##3##(2008-10#2)
poor substrate for##4##3##(1991-5#1)(1992-3#1)(1994-11#1)(1997-3#1)
poor survival##3##2##(1991-2#1)(2008-7#1)(2009-10#1)
poor vision##2##2##(1993-11#1)(2010-8#1)
poor wound healing##2##3##(2012-3#2)
poor##300##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-2#3)(1992-3#2)(1993-1#1)(1993-11#6)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#4)(1995-9#3)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#3)(1997-8#1)(2008-1#3)(2008-10#43)(2008-11#25)(2008-12#7)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#8)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#4)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#15)(2011-3#2)(2011-7#1)(2012-12#5)(2012-2#6)(2012-3#17)(2013-1#16)(2013-8#9)
poor&quot##2##1##(2011-2#2)
poor-risk##2##1##(1994-12#1)(2010-11#1)
poorer child social development##2##4##(2009-9#2)
poorer health status##2##3##(1996-2#1)(1997-2#1)
poorer health##7##2##(1993-1#1)(1995-12#2)(1996-2#1)(1997-2#1)(2008-1#1)(2008-11#1)
poorer performance in##2##3##(2008-11#1)(2008-12#1)
poorer performance##4##2##(2008-11#2)(2008-12#1)(2011-2#1)
poorer physical##2##2##(1994-1#1)(2013-8#1)
poorer prognosis##3##2##(1991-2#1)(1993-11#1)(1994-12#1)
poorer spatial##2##2##(1994-3#1)(2008-3#1)
poorer##44##1##(1991-12#1)(1991-2#1)(1991-8#2)(1992-2#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
poorest##7##1##(1990-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-12#1)
poorly controlled##5##2##(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
poorly defined##9##2##(1995-6#1)(1996-2#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)
poorly developed##2##2##(1990-2#1)(2008-10#1)
poorly differentiated##5##2##(1990-2#1)(1990-3#1)(2008-9#1)(2012-3#2)
poorly expressed##2##2##(1992-9#1)(2011-2#1)
poorly immunogenic##2##2##(1994-5#1)(2007-11#1)
poorly in##2##2##(1996-12#1)(2009-10#1)
poorly resolved##2##2##(2008-10#2)
poorly soluble##2##2##(2008-10#1)(2008-7#1)
poorly studied##4##2##(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
poorly to##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
poorly understood and##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
poorly understood##42##2##(1991-11#1)(1992-12#1)(1994-1#1)(1996-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-8#2)
poorly water-soluble drugs##2##3##(2012-2#2)
poorly with##3##2##(1997-1#1)(2008-5#1)(2012-3#1)
poorly##126##1##(1990-2#3)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-12#2)(1996-2#2)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#2)(2009-3#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#8)(2012-12#2)(2012-2#9)(2012-3#9)(2013-1#4)(2013-8#3)
pop##5##1##(2008-12#4)(2008-9#1)
poplar##14##1##(2008-10#13)(2013-1#1)
popliteal artery##4##2##(1991-3#4)
popliteal lymph node assay##3##4##(2008-10#3)
popliteal lymph node##4##3##(2008-10#3)(2008-5#1)
popliteal lymph##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
popliteal##11##1##(1991-3#6)(2008-10#3)(2008-11#1)(2008-5#1)
poppy (Papaver somniferum)##2##3##(2008-10#2)
poppy leaves##2##2##(2008-10#2)
poppy##16##1##(2008-10#16)
pops##9##1##(2008-12#8)(2008-9#1)
popular belief##3##2##(1993-1#1)(2008-7#1)(2009-9#1)
popular for##2##2##(1994-9#1)(2012-2#1)
popular in the##2##3##(1993-1#1)(2008-10#1)
popular in##7##2##(1993-1#1)(1995-2#1)(2008-10#4)(2009-12#1)
popular method##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
popular##59##1##(1993-1#3)(1994-3#1)(1994-9#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-3#2)(2008-10#13)(2008-11#9)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-2#3)(2012-3#1)
popularity as##2##2##(2010-12#1)(2013-1#1)
popularity in##4##2##(1992-12#1)(2008-11#1)(2010-1#1)(2010-7#1)
popularity of##3##2##(2008-10#1)(2009-12#1)(2011-2#1)
popularity was##2##2##(2010-1#2)
popularity##21##1##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-1#1)(2009-12#1)(2010-1#7)(2010-12#1)(2010-7#1)(2011-2#4)(2013-1#2)
populated by##3##2##(1997-5#1)(2008-5#2)
populated##8##1##(1991-1#1)(1994-8#1)(1997-5#1)(2008-5#2)(2008-9#1)(2011-2#2)
population adapted to##2##3##(2008-8#2)
population after##2##2##(1992-2#1)(2008-10#1)
population also##2##2##(2008-10#2)
population and for##2##3##(1991-1#1)(1995-12#1)
population and its##3##3##(1991-12#1)(1993-5#1)(2008-9#1)
population and more##2##3##(1997-1#1)(1997-2#1)
population and the##2##3##(2008-10#1)(2008-9#1)
population and##47##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-2#1)(1993-5#1)(1995-12#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)
population appears to##2##3##(2008-10#1)(2011-2#1)
population appears##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
population approach##2##2##(1991-6#1)(2008-10#1)
population are##9##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-7#1)(2011-2#1)
population as a whole##4##4##(2008-11#2)(2008-8#1)(2010-8#1)
population as well as##3##4##(1992-2#1)(1994-2#1)(1995-9#1)
population as##9##2##(1992-2#1)(1994-2#1)(1995-9#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-8#1)
population at large##4##3##(1992-2#2)(2008-4#1)(2012-2#1)
population at##11##2##(1991-1#1)(1992-2#2)(1997-4#1)(2008-10#3)(2008-4#1)(2009-6#1)(2012-12#1)(2012-2#1)
population based##4##2##(1996-2#1)(2008-11#1)(2009-10#1)(2011-3#1)
population between##3##2##(1990-8#1)(1994-6#1)(2008-10#1)
population biology##7##2##(2008-10#2)(2008-8#4)(2008-9#1)
population bottleneck##3##2##(2008-10#1)(2008-9#2)
population but##2##2##(2008-10#1)(2009-11#1)
population by##9##2##(1991-3#1)(1994-11#1)(1997-7#1)(2008-11#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#1)
population can##2##2##(2008-10#1)(2008-8#1)
population carrying Rcm##2##3##(2008-10#2)
population change##2##2##(2008-8#1)(2008-9#1)
population composition##2##2##(2008-10#2)
population consisted of##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
population control##4##2##(1993-9#1)(1994-8#1)(1994-9#1)(2011-2#1)
population cultured##3##2##(2008-11#2)(2008-9#1)
population data##11##2##(2008-10#3)(2008-12#7)(2008-7#1)
population database##2##2##(2008-12#1)(2010-5#1)
population decline##6##2##(1995-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#2)
population densities at##2##3##(2008-10#2)
population densities in the##2##4##(2008-10#2)
population densities in##3##3##(2008-10#3)
population densities of H##4##4##(2008-10#4)
population densities of the##2##4##(2008-10#2)
population densities of##14##3##(2008-10#14)
population densities than the##2##4##(2008-10#2)
population densities were##2##3##(2008-10#2)
population densities##47##2##(2008-10#38)(2008-8#4)(2008-9#4)(2010-8#1)
population density and##9##3##(1993-1#1)(2008-10#4)(2008-8#2)(2008-9#2)
population density of strain##2##4##(2008-10#2)
population density of the##4##4##(2008-10#4)
population density of##11##3##(2008-10#11)
population density or##2##3##(2008-8#1)(2012-2#1)
population density when##2##3##(2008-8#1)(2008-9#1)
population density##49##2##(1993-1#1)(1994-5#1)(1996-3#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-8#7)(2008-9#9)(2009-7#1)(2011-2#3)(2012-2#2)(2013-8#1)
population derived from a cross between##3##6##(2008-10#3)
population derived from a cross##4##5##(2008-10#4)
population derived from a##5##4##(2008-10#5)
population derived from the cross##2##5##(2008-10#2)
population derived from##11##3##(2008-10#9)(2008-8#1)(2009-10#1)
population development##2##2##(2008-10#2)
population did not##3##3##(2008-10#2)(2008-11#1)
population differences##2##2##(2008-10#1)(2008-8#1)
population differentiation at##3##3##(2012-3#3)
population differentiation was##2##3##(2008-10#2)
population differentiation##14##2##(2008-10#9)(2008-8#1)(2012-3#4)
population distributions##2##2##(2008-8#1)(2008-9#1)
population diversity##2##2##(2008-10#2)
population does##2##2##(1997-3#1)(2008-10#1)
population doubling##5##2##(2008-11#3)(2011-1#2)
population doublings##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
population during a##2##3##(2008-10#1)(2008-7#1)
population during##6##2##(2008-10#2)(2008-7#1)(2011-2#2)(2013-1#1)
population dynamics and##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
population dynamics in##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
population dynamics of each##2##4##(2008-10#2)
population dynamics of the##5##4##(2008-10#5)
population dynamics of##19##3##(2008-10#14)(2008-8#2)(2008-9#1)(2012-3#1)(2013-8#1)
population dynamics##49##2##(1994-8#1)(1997-6#1)(2008-10#21)(2008-11#1)(2008-8#13)(2008-9#5)(2010-5#1)(2010-8#1)(2012-3#1)(2013-8#4)
population exhibited##3##2##(2008-10#2)(2013-8#1)
population for##9##2##(1996-12#1)(2008-10#2)(2008-11#4)(2009-8#1)(2013-1#1)
population from a##3##3##(2008-10#2)(2012-3#1)
population from the cross##2##4##(2008-10#2)
population from##20##2##(2008-1#1)(2008-10#15)(2008-12#3)(2012-3#1)
population genetic models##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
population genetic structure of##6##4##(2008-10#4)(2008-8#1)(2013-8#1)
population genetic structure##10##3##(2008-10#6)(2008-8#3)(2013-8#1)
population genetic studies of##2##4##(2008-10#1)(2012-3#1)
population genetic studies##3##3##(2008-10#2)(2012-3#1)
population genetic##22##2##(2008-10#12)(2008-12#3)(2008-8#4)(2008-9#1)(2012-3#1)(2013-8#1)
population genetics of##2##3##(2008-10#2)
population genetics##8##2##(2008-10#5)(2008-12#1)(2008-8#1)(2012-3#1)
population groups##4##2##(1990-12#1)(1997-8#1)(2011-2#2)
population growth is##2##3##(2008-9#2)
population growth of##2##3##(2008-10#2)
population growth rate##7##3##(2008-8#4)(2008-9#2)(2010-8#1)
population growth rates and##3##4##(2008-8#3)
population growth rates##8##3##(2008-8#6)(2008-9#1)(2010-8#1)
population growth##33##2##(1991-3#1)(1994-2#1)(1994-9#1)(2008-10#4)(2008-11#5)(2008-8#12)(2008-9#6)(2010-4#1)(2010-8#2)
population had a##3##3##(2008-10#2)(2008-8#1)
population had##5##2##(2008-10#2)(2008-8#2)(2012-7#1)
population has a##2##3##(2008-10#2)
population has been##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
population has##13##2##(1991-2#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
population have##6##2##(1991-8#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
population health##7##2##(1997-2#1)(2009-7#1)(2010-8#3)(2011-2#1)(2013-8#1)
population identified##2##2##(2008-10#2)
population in Nepal##2##3##(2008-10#1)(2012-3#1)
population in a##3##3##(1997-2#1)(2008-8#1)(2012-12#1)
population in the North Fiji Basin##2##6##(2008-6#2)
population in the##20##3##(1992-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#3)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
population in this##2##3##(2008-10#2)
population in which##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
population in##57##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-2#2)(1992-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#1)
population included##2##2##(1996-9#1)(2012-12#1)
population increase##2##2##(2008-10#1)(2010-8#1)
population increases##3##2##(2008-10#2)(2008-8#1)
population indicated that the##2##4##(2008-10#1)(2012-3#1)
population interactions##2##2##(2008-10#1)(2008-8#1)
population into a##2##3##(1997-6#1)(2008-8#1)
population into##3##2##(1997-6#1)(2008-10#1)(2008-8#1)
population is affected##2##3##(2008-9#1)(2010-7#1)
population is also##2##3##(2011-2#1)(2013-1#1)
population is capable of##2##4##(2008-10#1)(2010-1#1)
population is increasing##2##3##(1992-11#1)(1997-8#1)
population is##43##2##(1990-12#1)(1990-6#1)(1991-3#3)(1991-9#1)(1992-11#1)(1994-2#1)(1994-9#1)(1997-8#2)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-8#5)(2008-9#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#1)
population isolated from##2##3##(2008-10#2)
population level##9##2##(2008-10#4)(2008-11#1)(2008-8#3)(2011-2#1)
population levels of##2##3##(2008-10#2)
population levels##10##2##(2008-10#9)(2010-5#1)
population makes##2##2##(2011-2#1)(2013-8#1)
population may be##2##3##(2008-10#1)(2010-8#1)
population may##6##2##(2008-10#2)(2008-7#1)(2010-8#1)(2011-2#2)
population might##3##2##(1994-3#1)(2008-10#2)
population model##2##2##(2008-10#1)(2008-8#1)
population models##2##2##(2008-9#1)(2010-10#1)
population movements##2##2##(2008-8#1)(2013-1#1)
population norms##2##2##(2010-10#1)(2013-1#1)
population of 1##4##3##(1997-3#1)(1997-6#1)(2008-10#1)(2012-2#1)
population of 330##2##3##(1991-11#2)
population of C##2##3##(2008-10#1)(2008-8#1)
population of P##2##3##(2008-10#2)
population of Phytophthora##3##3##(2008-10#3)
population of R##2##3##(2008-10#2)
population of a##4##3##(1993-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
population of bacteria##2##3##(1996-6#1)(2011-2#1)
population of cells##3##3##(2008-11#1)(2008-9#1)(2010-10#1)
population of children##2##3##(1991-12#1)(2008-11#1)
population of each##2##3##(2008-10#1)(2013-1#1)
population of elderly##2##3##(2007-12#1)(2008-7#1)
population of healthy##2##3##(1990-12#1)(2008-11#1)
population of interest##2##3##(1994-1#1)(2008-9#1)
population of isolates##2##3##(2008-10#2)
population of neurons##4##3##(1991-2#2)(1996-12#1)(2009-10#1)
population of patients##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
population of recombinant inbred lines (RILs) was##2##7##(2008-10#2)
population of recombinant inbred lines##3##5##(2008-10#3)
population of sequence variants##2##4##(2008-10#2)
population of the##13##3##(1991-2#1)(1994-2#1)(1995-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#2)
population of this##3##3##(2008-10#2)(2011-2#1)
population of young adults##2##4##(1991-1#1)(2010-5#1)
population of young##3##3##(1991-1#1)(2010-5#1)(2012-2#1)
population of##203##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#1)(1992-6#2)(1993-11#1)(1993-5#1)(1994-1#1)(1994-2#3)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-3#3)(1997-6#2)(2007-12#2)(2008-1#2)(2008-10#72)(2008-11#15)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#10)(2009-10#1)(2009-3#1)(2009-6#1)(2010-10#4)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#7)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#7)
population on##2##2##(2008-10#1)(2012-3#1)
population only##2##2##(2008-10#1)(2008-8#1)
population or##2##2##(2008-11#1)(2012-12#1)
population over##5##2##(2008-10#2)(2011-2#3)
population parameters##4##2##(2008-8#3)(2008-9#1)
population per year##2##3##(2008-10#1)(2011-2#1)
population persistence##5##2##(2008-8#5)
population projections##2##2##(2012-12#2)
population redistribution##3##2##(2011-2#3)
population regulation##5##2##(2008-8#5)
population sample from##3##3##(2008-12#3)
population sample of##4##3##(1992-2#1)(2008-10#1)(2008-11#2)
population sample##8##2##(1992-2#1)(2008-10#1)(2008-11#3)(2008-12#3)
population samples##2##2##(2008-11#1)(2008-12#1)
population sampling##2##2##(2008-1#1)(2008-10#1)
population segregated##2##2##(2008-10#2)
population sex ratio##2##3##(2008-8#1)(2010-8#1)
population showed that##3##3##(2008-10#2)(2008-9#1)
population showed##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
population size and##5##3##(1991-3#1)(2008-10#3)(2008-8#1)
population size below##3##3##(2008-10#1)(2008-8#2)
population size in##2##3##(2008-1#1)(2008-8#1)
population size is##3##3##(2008-8#2)(2010-7#1)
population size of the##3##4##(2008-10#3)
population size of##13##3##(2008-10#10)(2008-9#1)(2010-8#1)(2012-5#1)
population size was##3##3##(2008-10#1)(2008-8#2)
population size##59##2##(1991-3#1)(1992-12#1)(1996-3#1)(2008-1#3)(2008-10#22)(2008-12#1)(2008-8#21)(2008-9#6)(2010-7#1)(2010-8#1)(2012-5#1)
population sizes and##2##3##(2008-10#2)
population sizes in##3##3##(2008-10#2)(2008-9#1)
population sizes of the##2##4##(2008-10#2)
population sizes of##5##3##(2008-10#5)
population sizes##21##2##(2008-10#13)(2008-8#6)(2008-9#2)
population spike##2##2##(1995-12#1)(2008-7#1)
population spikes##3##2##(2008-11#3)
population strategy##2##2##(1991-6#2)
population structure and##7##3##(2008-10#3)(2008-9#2)(2010-5#1)(2011-1#1)
population structure can##2##3##(2008-8#1)(2008-9#1)
population structure in##2##3##(2008-10#1)(2008-8#1)
population structure of##13##3##(2008-10#12)(2013-8#1)
population structure##44##2##(2008-10#31)(2008-8#4)(2008-9#4)(2010-5#2)(2011-1#1)(2012-3#1)(2013-8#1)
population studies##6##2##(1991-12#2)(2008-10#3)(2008-12#1)
population study##2##2##(1993-11#1)(2008-11#1)
population subdivision##2##2##(2008-10#1)(2008-8#1)
population surveillance##2##2##(1991-12#2)
population than##2##2##(2008-10#2)
population that is##4##3##(1996-2#1)(2007-12#1)(2008-10#2)
population that was##2##3##(2008-10#2)
population that##18##2##(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#7)(2008-7#1)(2008-8#2)(2010-12#1)(2012-12#1)(2012-3#1)
population the##3##2##(1994-12#1)(2008-8#1)(2011-2#1)
population to be##3##3##(1997-2#1)(2008-10#2)
population to##12##2##(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-8#2)(2008-9#2)(2011-2#1)
population trends##4##2##(1997-2#1)(2008-8#1)(2008-9#2)
population turnover##2##2##(2008-8#1)(2008-9#1)
population using##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
population viability##2##2##(2008-9#2)
population was compared##2##3##(2008-10#1)(2012-3#1)
population was composed of##3##4##(2008-10#2)(2010-1#1)
population was created from##2##4##(2008-10#2)
population was reduced##2##3##(1995-2#1)(2008-11#1)
population was##51##2##(1991-6#1)(1995-2#1)(2008-1#1)(2008-10#32)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#2)(2009-7#1)(2010-1#2)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
population were studied##3##3##(2008-7#1)(2012-12#1)(2013-8#1)
population were##13##2##(2008-10#6)(2008-11#1)(2008-7#1)(2012-12#3)(2012-4#1)(2013-8#1)
population while##2##2##(2008-11#1)(2010-9#1)
population who##2##2##(2010-9#1)(2013-1#1)
population will be##2##3##(1994-9#1)(2008-8#1)
population with a##3##3##(1994-12#1)(2008-10#2)
population with##11##2##(1990-3#1)(1993-3#1)(1994-12#1)(2008-10#4)(2008-9#1)(2011-2#2)(2012-12#1)
population within##3##2##(1992-1#1)(2008-10#1)(2008-11#1)
population without##3##2##(2008-10#2)(2008-8#1)
population##1822##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#5)(1990-8#3)(1991-1#8)(1991-11#2)(1991-12#20)(1991-2#9)(1991-3#13)(1991-5#1)(1991-6#5)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#10)(1992-3#1)(1992-6#3)(1992-9#3)(1993-1#5)(1993-11#3)(1993-12#4)(1993-2#4)(1993-3#5)(1993-5#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#11)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#7)(1995-1#4)(1995-11#5)(1995-12#14)(1995-2#9)(1995-3#1)(1995-5#5)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#12)(1996-6#6)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#12)(1997-3#8)(1997-4#3)(1997-5#1)(1997-6#10)(1997-7#2)(1997-8#10)(2006-6#1)(2007-12#10)(2008-1#13)(2008-10#596)(2008-11#109)(2008-12#45)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#37)(2008-8#192)(2008-9#119)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#6)(2010-10#15)(2010-11#3)(2010-12#5)(2010-2#2)(2010-4#3)(2010-5#11)(2010-6#13)(2010-7#6)(2010-8#20)(2010-9#2)(2011-1#6)(2011-2#76)(2011-3#5)(2011-7#1)(2012-12#22)(2012-2#18)(2012-3#39)(2012-4#2)(2012-5#1)(2012-7#2)(2013-1#56)(2013-3#1)(2013-7#1)(2013-8#37)
population's##7##1##(1994-6#1)(1996-1#1)(1997-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
population)##7##1##(1990-12#1)(2008-10#3)(2008-8#2)(2013-8#1)
population-based services##2##2##(1995-12#1)(1996-2#1)
population-based studies##2##2##(2008-1#1)(2013-1#1)
population-based study##4##2##(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
population-based survey##2##2##(1994-8#1)(2013-8#1)
population-based##39##1##(1991-6#2)(1992-12#1)(1992-2#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-8#2)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#1)(2008-7#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
population-genetic structure##2##2##(2008-9#1)(2011-2#1)
population-genetic##3##1##(2008-9#2)(2011-2#1)
population-groups##2##1##(2008-12#2)
population-level and individual-level##2##3##(1994-9#1)(2008-8#1)
population-level##11##1##(1994-9#1)(2008-10#1)(2008-8#2)(2008-9#4)(2010-8#1)(2012-2#1)(2012-3#1)
population-specific##2##1##(2008-10#1)(2008-8#1)
population-wide##4##1##(2008-8#3)(2011-2#1)
population]##5##1##(1993-11#1)(1993-3#1)(1995-5#1)(1996-6#1)(2013-8#1)
populations (from##2##2##(2008-10#2)
populations 881-WT and 882-WT on##2##5##(2008-10#2)
populations 881-WT and 882-WT##3##4##(2008-10#3)
populations adapted to##3##3##(2008-10#1)(2012-3#2)
populations after##2##2##(2008-10#1)(2008-9#1)
populations along##2##2##(2012-3#1)(2013-8#1)
populations also##2##2##(2008-10#1)(2010-5#1)
populations and in##2##3##(1994-1#1)(2008-10#1)
populations and that##2##3##(2008-10#1)(2008-8#1)
populations and the##2##3##(2008-10#1)(2008-8#1)
populations and##44##2##(1991-12#1)(1993-12#1)(1994-1#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-8#6)(2009-8#1)(2010-5#1)(2011-2#2)(2012-3#1)(2012-4#1)(2012-7#1)(2013-1#1)
populations are##23##2##(1994-3#1)(1995-3#1)(2008-10#9)(2008-12#1)(2008-6#1)(2008-8#5)(2008-9#4)(2010-5#1)
populations as well as##2##4##(2008-10#1)(2008-8#1)
populations as##4##2##(1995-12#1)(2008-10#2)(2008-8#1)
populations associated with##2##3##(2008-10#2)
populations at risk##2##3##(2008-6#2)
populations at the##4##3##(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#1)
populations at##11##2##(1997-1#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
populations based on##2##3##(2012-3#1)(2013-8#1)
populations by##9##2##(2008-10#4)(2008-9#2)(2009-8#1)(2011-2#2)
populations can be##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
populations can##8##2##(2008-10#3)(2008-11#1)(2008-8#4)
populations changed##4##2##(2008-10#4)
populations collected from##8##3##(2008-10#8)
populations collected##10##2##(2008-10#10)
populations compared with the##2##4##(2008-10#2)
populations containing##2##2##(2012-12#1)(2013-1#1)
populations could be##2##3##(2008-10#2)
populations could##3##2##(2008-10#3)
populations decreased##2##2##(2008-10#2)
populations derived from crosses##2##4##(2008-10#2)
populations derived from##7##3##(2008-10#6)(2008-8#1)
populations displayed##2##2##(2008-10#1)(2013-1#1)
populations during the##2##3##(2008-10#2)
populations during##3##2##(2008-10#3)
populations even##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
populations for##5##2##(1992-3#1)(1995-11#1)(1997-6#1)(2008-10#1)(2011-2#1)
populations from component pure stands##2##5##(2008-10#2)
populations from different locations##2##4##(2008-10#2)
populations from different##3##3##(2008-10#2)(2012-7#1)
populations from the##7##3##(2008-10#7)
populations from##44##2##(2008-10#34)(2008-8#6)(2008-9#1)(2010-5#1)(2012-7#1)(2013-1#1)
populations generally##2##2##(2008-10#1)(2008-9#1)
populations has##2##2##(1996-3#1)(2009-4#1)
populations have not##2##3##(2008-10#1)(2008-8#1)
populations have##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
populations in a##2##3##(2008-8#1)(2012-3#1)
populations in sympatry##2##3##(2008-10#2)
populations in the field##2##4##(2008-10#1)(2008-9#1)
populations in the greenhouse##2##4##(2008-10#2)
populations in the##15##3##(2008-10#12)(2008-11#1)(2008-9#2)
populations in their##2##3##(2008-10#1)(2008-12#1)
populations in which##2##3##(2008-10#1)(2008-8#1)
populations in##58##2##(1995-12#2)(1995-3#1)(1995-6#1)(1996-3#1)(2008-10#35)(2008-11#2)(2008-12#2)(2008-8#5)(2008-9#3)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
populations include##2##2##(2008-11#2)
populations increased##2##2##(2008-10#1)(2008-8#1)
populations indicated##2##2##(2008-10#2)
populations into##2##2##(2008-10#1)(2008-8#1)
populations involved in##2##3##(2008-10#1)(2008-11#1)
populations is a##2##3##(2008-9#2)
populations is##8##2##(1991-2#1)(2008-10#2)(2008-9#4)(2013-8#1)
populations located##2##2##(2008-10#1)(2012-7#1)
populations may##2##2##(2008-8#1)(2010-5#1)
populations of A##2##3##(2008-10#2)
populations of B##5##3##(2008-10#5)
populations of C##6##3##(2008-10#6)
populations of CMV and its satRNA##2##6##(2008-10#2)
populations of CMV##3##3##(2008-10#3)
populations of D##2##3##(2013-8#2)
populations of Drosophila##2##3##(2008-9#1)(2012-3#1)
populations of Erwinia amylovora##2##4##(2008-10#2)
populations of F##3##3##(2008-10#3)
populations of G##4##3##(2008-10#4)
populations of H##2##3##(2008-10#2)
populations of L##3##3##(2008-10#2)(2010-8#1)
populations of M##4##3##(2008-10#3)(2008-11#1)
populations of Mycosphaerella graminicola##2##4##(2008-10#2)
populations of P##14##3##(2008-10#13)(2009-5#1)
populations of Phytophthora capsici##2##4##(2008-10#2)
populations of Phytophthora infestans in the United States##2##8##(2008-10#2)
populations of Phytophthora parasitica were significantly reduced in##2##8##(2008-10#2)
populations of Phytophthora parasitica##4##4##(2008-10#4)
populations of Phytophthora##9##3##(2008-10#9)
populations of Pseudomonas putida 06909-rif/nal##2##5##(2008-10#2)
populations of Pseudomonas##4##3##(2008-10#4)
populations of R##2##3##(2008-10#2)
populations of S##2##3##(2008-10#2)
populations of T##2##3##(2008-10#2)
populations of V##3##3##(2008-10#3)
populations of Venturia inaequalis was##2##5##(2008-10#2)
populations of Venturia inaequalis##3##4##(2008-10#3)
populations of Western##2##3##(2008-10#1)(2011-2#1)
populations of a##6##3##(2008-10#1)(2008-6#1)(2008-8#2)(2012-3#1)(2012-7#1)
populations of bacteria##2##3##(2008-10#1)(2012-3#1)
populations of birds##2##3##(2008-8#1)(2008-9#1)
populations of cells from##2##4##(2008-11#1)(2008-4#1)
populations of cells##3##3##(1995-2#1)(2008-11#1)(2008-4#1)
populations of culturable bacteria##2##4##(2008-10#2)
populations of different##2##3##(2008-10#1)(2008-9#1)
populations of each##2##3##(2008-10#2)
populations of hybrids between##2##4##(2008-9#2)
populations of hybrids##4##3##(2008-10#2)(2008-9#2)
populations of neurons##5##3##(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)
populations of strain##2##3##(2008-10#2)
populations of the pathogen##4##4##(2008-10#4)
populations of the##29##3##(1991-4#1)(1997-7#1)(2008-10#18)(2008-8#5)(2008-9#2)(2011-2#1)(2012-3#1)
populations of these two##2##4##(2008-10#2)
populations of three##2##3##(2008-10#2)
populations of##240##2##(1990-5#3)(1991-4#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2008-1#1)(2008-10#155)(2008-11#7)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#14)(2008-9#11)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#5)(2012-7#2)(2013-1#1)(2013-8#3)
populations on a##2##3##(2008-10#1)(2008-9#1)
populations on the##2##3##(2010-8#1)(2012-9#1)
populations on##14##2##(2008-10#11)(2008-9#1)(2010-8#1)(2012-9#1)
populations or##5##2##(1996-2#1)(2008-10#2)(2008-8#1)(2013-1#1)
populations over the##2##3##(2008-10#2)
populations over##3##2##(2008-10#3)
populations prior to##2##3##(2008-10#1)(2008-11#1)
populations probably##2##2##(2008-10#2)
populations ranged from##3##3##(2008-10#3)
populations remained##2##2##(2008-10#1)(2008-8#1)
populations resistant to##2##3##(2008-10#2)
populations respond to##2##3##(2008-8#2)
populations revealed that##2##3##(2008-10#1)(2008-8#1)
populations revealed##5##2##(2008-10#3)(2008-12#1)(2008-8#1)
populations sampled from the##2##4##(2008-10#2)
populations sampled from##3##3##(2008-10#3)
populations sampled in##2##3##(2008-10#2)
populations sampled##8##2##(2008-10#7)(2008-9#1)
populations should be##2##3##(2008-8#1)(2008-9#1)
populations show##2##2##(2008-8#1)(2013-1#1)
populations showed a##2##3##(2008-9#1)(2011-1#1)
populations showed##4##2##(2008-9#2)(2011-1#1)(2011-2#1)
populations studied##7##2##(2008-1#1)(2008-10#3)(2008-9#2)(2013-8#1)
populations than##3##2##(2008-10#2)(2008-11#1)
populations that are##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
populations that had been##2##4##(2008-10#1)(2008-8#1)
populations that##19##2##(2008-10#8)(2008-4#1)(2008-8#3)(2008-9#4)(2009-12#1)(2010-10#1)(2010-6#1)
populations through##4##2##(2008-10#2)(2008-8#2)
populations to be##2##3##(2008-11#1)(2009-6#1)
populations to the##3##3##(2008-10#2)(2008-8#1)
populations to##17##2##(1997-8#1)(2008-10#8)(2008-11#1)(2008-8#3)(2008-9#2)(2009-6#1)(2012-7#1)
populations under##3##2##(2008-10#1)(2008-8#1)(2010-10#1)
populations using##4##2##(2008-10#2)(2008-11#1)(2009-7#1)
populations was 0##2##3##(2008-10#2)
populations was observed##2##3##(2008-10#1)(2012-3#1)
populations was significantly##2##3##(2008-10#2)
populations was studied##2##3##(2008-10#2)
populations was##24##2##(2008-10#20)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
populations were compared##2##3##(1990-6#1)(1995-12#1)
populations were developed by crossing##2##5##(2008-10#2)
populations were evaluated##2##3##(2008-10#2)
populations were genotyped##2##3##(2008-10#1)(2013-8#1)
populations were highly diverse##2##4##(2008-10#2)
populations were highly##5##3##(2008-10#5)
populations were monitored##2##3##(2008-10#2)
populations were more aggressive on##2##5##(2008-10#2)
populations were more##3##3##(2008-10#2)(2008-9#1)
populations were not##2##3##(2008-10#2)
populations were reduced##2##3##(2008-10#2)
populations were sampled from##2##4##(2008-10#2)
populations were##54##2##(1990-6#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#41)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
populations who##3##2##(1995-12#1)(2008-1#1)(2010-1#1)
populations with a##3##3##(2008-11#1)(2008-8#1)(2012-3#1)
populations with##15##2##(1990-8#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#4)
populations within the##2##3##(1991-12#1)(2008-10#1)
populations within##10##2##(1991-12#1)(2008-10#8)(2008-12#1)
populations##1213##1##(1990-5#3)(1990-6#2)(1990-8#5)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-3#3)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#10)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#2)(1996-2#5)(1996-3#6)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#2)(2007-12#1)(2008-1#9)(2008-10#651)(2008-11#38)(2008-12#24)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#7)(2008-7#6)(2008-8#120)(2008-9#79)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#9)(2009-9#1)(2010-1#3)(2010-10#10)(2010-11#1)(2010-2#1)(2010-3#3)(2010-5#8)(2010-6#2)(2010-8#4)(2011-1#2)(2011-2#24)(2012-12#3)(2012-2#15)(2012-3#26)(2012-4#1)(2012-7#8)(2012-9#1)(2013-1#21)(2013-7#1)(2013-8#15)
populations)##5##1##(2008-10#1)(2008-8#2)(2008-9#2)
porA from##2##2##(1993-12#2)
porA##5##1##(1993-12#5)
porcelain##2##1##(1994-6#1)(2010-12#1)
porcine AF cells##2##3##(2012-2#2)
porcine DOs##2##2##(2013-1#2)
porcine Tex11 is##2##3##(2012-2#2)
porcine Tex11##4##2##(2012-2#4)
porcine aortic tissue##2##3##(2009-7#2)
porcine aortic##4##2##(1992-8#1)(2008-8#1)(2009-7#2)
porcine brain##2##2##(1994-8#1)(1996-12#1)
porcine ciliary##2##2##(1992-8#2)
porcine coronary arteries with##2##4##(1994-11#2)
porcine coronary arteries##4##3##(1994-11#3)(1997-8#1)
porcine coronary##8##2##(1990-8#1)(1994-11#4)(1997-8#1)(2008-11#2)
porcine endogenous##2##2##(2010-10#1)(2011-2#1)
porcine granulosa cells##2##3##(1995-12#2)
porcine hepatocyte spheroids##2##3##(2008-11#2)
porcine hepatocyte##3##2##(2008-11#3)
porcine hepatocytes was##2##3##(2008-11#2)
porcine hepatocytes##6##2##(2008-11#5)(2011-2#1)
porcine leukocyte 12-lipoxygenase##2##3##(1994-11#2)
porcine model##2##2##(2011-2#2)
porcine oocytes##2##2##(2013-1#2)
porcine pancreatic elastase (PPE)##3##4##(1991-3#1)(2008-5#2)
porcine pancreatic elastase##4##3##(1991-3#2)(2008-5#2)
porcine pancreatic##8##2##(1990-9#2)(1991-3#2)(1992-12#2)(2008-5#2)
porcine placental##2##2##(1995-8#2)
porcine platelet lysate##2##3##(2008-11#2)
porcine skin model##2##3##(2008-5#2)
porcine skin##5##2##(2008-5#5)
porcine tumor necrosis factor-encoding genes##2##5##(1991-6#2)
porcine##102##1##(1990-11#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-3#2)(1991-6#3)(1991-9#1)(1992-12#3)(1992-6#3)(1992-8#3)(1993-6#1)(1994-11#7)(1994-8#1)(1995-12#3)(1995-8#4)(1996-12#2)(1996-8#3)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#15)(2008-12#1)(2008-4#1)(2008-5#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#4)(2010-10#1)(2010-6#1)(2011-2#4)(2012-2#7)(2013-1#8)
pore and the##2##3##(2008-10#1)(2011-2#1)
pore and##3##2##(2008-10#1)(2011-2#2)
pore complex##8##2##(1994-11#3)(1995-2#2)(2011-2#3)
pore complexes##2##2##(2011-2#2)
pore formation##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
pore glass##8##2##(2008-10#8)
pore network##2##2##(2008-6#1)(2009-7#1)
pore size and##3##3##(2008-10#2)(2010-9#1)
pore size distribution##4##3##(2008-10#1)(2008-7#1)(2009-11#2)
pore size##12##2##(2008-10#6)(2008-7#3)(2009-11#2)(2010-9#1)
pore sizes##6##2##(1994-5#1)(2008-10#1)(2008-6#2)(2012-2#1)(2013-1#1)
pore water##4##2##(2008-10#3)(2013-8#1)
pore waters##4##2##(2008-10#4)
pore##94##1##(1994-11#3)(1994-5#3)(1995-2#2)(2007-12#7)(2008-10#38)(2008-11#8)(2008-6#3)(2008-7#5)(2008-8#3)(2009-11#2)(2009-7#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#8)(2012-2#4)(2013-1#1)(2013-8#1)
porencephaly##3##1##(1997-3#3)
pores and##2##2##(2008-10#1)(2010-12#1)
pores in##3##2##(2007-12#1)(2008-10#2)
pores with##2##2##(2008-10#2)
pores##32##1##(2007-12#1)(2008-10#19)(2008-11#7)(2010-10#1)(2010-12#2)(2011-2#1)(2013-8#1)
porins##5##1##(1997-8#2)(2008-10#3)
pork and##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
pork freshness using potentiometric##2##4##(2008-10#2)
pork freshness##3##2##(2008-10#3)
pork meat##4##2##(1990-8#1)(2010-4#3)
pork##25##1##(1990-8#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-7#1)(2010-4#10)(2010-6#1)(2013-8#1)
poroelastic##2##1##(2011-2#2)
porogens##3##1##(2008-10#3)
porosities##3##1##(2009-12#1)(2009-7#2)
porosity and##3##2##(2009-12#1)(2009-7#2)
porosity of the##2##3##(2008-10#2)
porosity of##3##2##(2008-10#2)(2008-7#1)
porosity##18##1##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#8)(2010-12#1)(2010-7#1)(2010-9#1)
porous beads (CPB##2##3##(2008-11#2)
porous carriers was investigated in order##2##6##(2008-11#2)
porous carriers##4##2##(2008-11#4)
porous cellulose##2##2##(2008-10#1)(2008-11#1)
porous collagen##2##2##(2008-11#1)(2009-7#1)
porous core##4##2##(2008-10#4)
porous glass##5##2##(2008-10#4)(2008-11#1)
porous microcarrier Cytopore##2##3##(2008-11#2)
porous microcarrier##3##2##(2008-11#3)
porous microcarriers##2##2##(2008-11#2)
porous silica##3##2##(2008-10#3)
porous silicon samples##2##3##(2008-10#2)
porous silicon##10##2##(1992-11#1)(2008-10#7)(2008-3#2)
porous structure##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)
porous##79##1##(1992-11#1)(2008-1#1)(2008-10#32)(2008-11#19)(2008-12#2)(2008-3#5)(2008-5#1)(2008-7#2)(2009-11#3)(2009-12#2)(2009-7#3)(2010-7#1)(2012-2#5)(2012-4#1)(2013-1#1)
porphyria##2##1##(1991-2#1)(2011-2#1)
porphyrin (TAPP)##2##2##(2008-10#2)
porphyrin and its##3##3##(2008-10#3)
porphyrin and##8##2##(2008-10#8)
porphyrin compounds##3##2##(1994-5#1)(2008-10#2)
porphyrin film##3##2##(2008-10#3)
porphyrin fluorescence##3##2##(1991-5#2)(1993-11#1)
porphyrin is##2##2##(2008-10#2)
porphyrin molecules##2##2##(2008-10#2)
porphyrin pi-cation##2##2##(1994-5#2)
porphyrin with##3##2##(2008-10#3)
porphyrin##59##1##(1991-5#3)(1993-11#2)(1994-5#3)(1996-5#1)(2008-10#47)(2008-3#2)(2008-9#1)
porphyrinogen##2##1##(1996-5#2)
porphyrins can##2##2##(2008-10#2)
porphyrins in##3##2##(1991-5#1)(1996-5#2)
porphyrins with##2##2##(2008-10#2)
porphyrins##15##1##(1991-5#1)(1993-8#1)(1996-5#3)(2008-10#10)
port access surgery##2##3##(2008-11#1)(2012-12#1)
port access##4##2##(2008-11#2)(2012-12#2)
port and##2##2##(2008-10#1)(2008-11#1)
port of a##3##3##(2008-10#2)(2008-3#1)
port of the##2##3##(2008-10#2)
port of##6##2##(1997-1#1)(2008-10#4)(2008-3#1)
port wine stain##2##3##(2007-11#1)(2009-4#1)
port wine##3##2##(1996-11#1)(2007-11#1)(2009-4#1)
port##35##1##(1995-5#1)(1996-11#1)(1997-1#1)(1997-6#2)(2007-11#1)(2008-10#18)(2008-11#3)(2008-3#1)(2009-4#1)(2011-2#2)(2012-12#4)
porta-caval anastomosis##5##2##(1993-3#5)
portability and##4##2##(2008-10#4)
portability##9##1##(1996-12#1)(2008-10#6)(2009-12#1)(2011-1#1)
portable analytical##2##2##(2008-10#2)
portable analyzer for##2##3##(2008-10#2)
portable analyzer##3##2##(2008-10#3)
portable and##4##2##(1997-8#1)(2008-10#2)(2010-7#1)
portable micro-XRF##2##2##(2008-10#2)
portable optical##2##2##(2008-10#2)
portable ventilators##3##2##(2011-1#2)(2011-2#1)
portable##59##1##(1992-3#1)(1993-11#1)(1993-9#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-10#37)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-1#2)(2009-10#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)
portacaval##2##1##(1991-11#1)(1993-3#1)
portal and##2##2##(2010-12#1)(2012-3#1)
portal hypertension##11##2##(1991-11#1)(2009-8#5)(2009-9#3)(2010-10#1)(2013-1#1)
portal hypertensive##2##2##(2009-8#2)
portal pressure##3##2##(1993-3#1)(2009-8#1)(2009-9#1)
portal technology##2##2##(2008-10#2)
portal vein##5##2##(1995-2#1)(1997-8#1)(2009-9#1)(2012-2#1)(2012-3#1)
portal venous##4##2##(1997-8#2)(2010-12#2)
portal##42##1##(1991-11#2)(1993-3#2)(1993-9#1)(1995-2#1)(1997-8#3)(2008-10#6)(2008-5#1)(2009-2#3)(2009-8#8)(2009-9#5)(2010-10#1)(2010-12#3)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
portals##11##1##(1991-8#1)(2008-10#7)(2009-2#2)(2011-2#1)
portfolio development##3##2##(2008-11#2)(2008-12#1)
portfolio is##2##2##(2008-12#2)
portfolio selection##2##2##(2013-1#2)
portfolio##21##1##(2008-11#3)(2008-12#15)(2013-1#3)
portfolios in##2##2##(2008-11#2)
portfolios##10##1##(1997-1#1)(2008-11#6)(2008-12#1)(2013-1#2)
portion consists of##2##3##(2008-10#2)
portion is##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
portion of a##4##3##(1995-12#1)(1997-7#1)(2008-10#2)
portion of the Golgi complex##2##5##(2008-7#2)
portion of the genome##3##4##(2008-10#2)(2010-8#1)
portion of the lateral##2##4##(1991-8#1)(2007-12#1)
portion of the##66##3##(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#2)(1996-3#1)(1997-1#1)(1997-6#2)(1997-9#1)(2007-12#3)(2008-1#1)(2008-10#18)(2008-11#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-1#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#2)
portion of these##2##3##(1993-9#1)(1995-9#1)
portion of##108##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-9#2)(2007-12#3)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#10)(2008-8#2)(2008-9#4)(2009-1#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#6)(2013-1#3)
portion##135##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-9#2)(2007-12#5)(2008-1#2)(2008-10#35)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#12)(2008-8#2)(2008-9#6)(2009-1#2)(2009-10#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#8)(2012-2#1)(2012-3#6)(2013-1#4)(2013-8#1)
portion)##2##1##(2008-10#1)(2008-7#1)
portions and##2##2##(2007-12#1)(2008-12#1)
portions of the facial skin##2##5##(2008-5#2)
portions of the##11##3##(1990-5#1)(1990-9#1)(1992-6#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#2)
portions of their##2##3##(1994-1#1)(1995-6#1)
portions of these##2##3##(1993-2#1)(2008-6#1)
portions of##33##2##(1990-5#2)(1990-9#1)(1991-12#1)(1992-6#1)(1993-2#2)(1993-8#1)(1994-1#1)(1995-2#1)(1995-6#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2010-5#1)(2011-2#2)(2012-3#1)
portions##51##1##(1990-5#2)(1990-9#1)(1991-12#1)(1992-6#1)(1993-2#2)(1993-8#1)(1994-1#1)(1995-2#1)(1995-6#1)(2007-12#6)(2008-10#12)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-8#1)
portoenterostomy##3##1##(1994-6#3)
portosystemic##3##1##(2009-8#1)(2009-9#2)
portrait of##3##2##(1992-1#1)(2008-12#1)(2009-1#1)
portrait##5##1##(1992-1#1)(2008-10#1)(2008-12#2)(2009-1#1)
portray##3##1##(1993-2#1)(1995-1#1)(2008-11#1)
portrayal of the##2##3##(2009-9#1)(2012-3#1)
portrayal of##3##2##(2009-9#1)(2012-2#1)(2012-3#1)
portrayed##3##1##(1996-6#1)(2008-11#1)(2010-5#1)
ports##2##1##(2010-11#1)(2010-7#1)
portuguese##2##1##(2013-1#2)
pose a challenge to##2##4##(2013-1#2)
pose a##12##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-2#1)(2013-1#4)
pose an##2##2##(2008-10#2)
pose any##2##2##(2008-10#1)(2012-12#1)
pose un problème##2##3##(2011-2#1)(2013-1#1)
pose##32##1##(1991-12#1)(1992-3#1)(1993-1#1)(1995-6#1)(1996-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#3)(2009-12#2)(2010-1#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#7)(2013-8#1)
posed a##2##2##(2009-4#1)(2013-8#1)
posed by##7##2##(1991-3#1)(1995-1#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)
posed to##2##2##(2008-11#2)
posed##18##1##(1991-3#1)(1992-2#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-9#2)(2009-4#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
poses a challenge to##2##4##(1994-12#1)(1995-2#1)
poses a challenge##3##3##(1994-12#1)(1995-2#1)(2010-5#1)
poses a##15##2##(1992-1#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-5#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
poses challenges##2##2##(1996-2#1)(2013-1#1)
poses##32##1##(1992-1#1)(1994-12#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
posing a risk of shocks##2##5##(2011-1#1)(2011-2#1)
posing##5##1##(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
posited##2##1##(2008-12#1)(2012-3#1)
position 33##2##2##(1991-11#1)(1993-8#1)
position 4##2##2##(1996-5#1)(2013-8#1)
position among##3##2##(1995-6#1)(2008-11#1)(2009-8#1)
position and shape##2##3##(2008-10#1)(2008-9#1)
position and##19##2##(1990-12#1)(1993-12#1)(1993-6#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
position as##6##2##(1990-2#1)(1993-1#1)(1993-2#1)(1996-3#1)(2009-11#1)(2010-3#1)
position at##5##2##(1993-8#1)(2008-10#3)(2011-2#1)
position by##3##2##(1997-2#1)(2009-11#2)
position during##4##2##(1993-1#1)(2008-10#1)(2009-2#2)
position for##6##2##(1994-5#1)(2008-10#1)(2009-11#1)(2011-2#3)
position from the##2##3##(1990-2#1)(1994-11#1)
position from##3##2##(1990-2#1)(1994-11#1)(2012-3#1)
position has##2##2##(1994-11#1)(1997-4#1)
position in relation to the##2##5##(2008-10#1)(2008-9#1)
position in the##11##3##(1996-1#1)(2008-12#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-3#1)(2012-2#1)(2012-3#1)
position in##26##2##(1991-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#3)(2008-12#2)(2008-6#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
position is##6##2##(1990-11#1)(1993-1#1)(1996-9#1)(2008-7#1)(2008-8#1)(2010-3#1)
position of a##2##3##(1997-7#1)(2008-3#1)
position of the sun and associated celestial##2##7##(1994-3#2)
position of the##34##3##(1991-3#1)(1992-3#1)(1993-1#1)(1994-3#2)(1995-11#2)(1995-2#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-3#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-2#1)
position of##65##2##(1990-2#1)(1990-5#2)(1991-3#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-3#2)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#5)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#1)
position on the##6##3##(1995-12#1)(1995-9#1)(2008-10#1)(2008-9#1)(2010-9#1)(2013-1#1)
position on##9##2##(1995-12#1)(1995-9#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-9#1)(2013-1#1)
position or##2##2##(2008-10#1)(2008-12#1)
position sense##2##2##(2012-3#2)
position sensitive detector##3##3##(2008-10#3)
position sensitive##4##2##(2008-10#4)
position specific##2##2##(1997-7#1)(2008-11#1)
position that the##2##3##(1993-3#1)(2008-12#1)
position their##2##2##(1996-3#1)(1997-1#1)
position to##10##2##(1990-12#1)(1993-1#1)(1994-1#1)(1995-6#1)(1996-1#1)(2008-11#3)(2008-3#1)(2010-4#1)
position was##7##2##(1993-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-11#1)(2009-8#1)
position were##2##2##(2008-10#1)(2008-3#1)
position which##2##2##(2011-2#1)(2012-12#1)
position with the##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
position with##5##2##(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
position within the##6##3##(1993-12#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
position within##7##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#2)
position##375##1##(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#1)(1990-5#4)(1991-11#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-1#10)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#5)(1994-12#1)(1994-3#7)(1994-5#7)(1994-8#3)(1995-11#4)(1995-12#3)(1995-2#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#4)(1996-12#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#7)(1997-8#4)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#58)(2008-11#18)(2008-12#19)(2008-2#2)(2008-3#15)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#14)(2008-9#11)(2009-10#5)(2009-11#7)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-3#7)(2010-4#2)(2010-6#1)(2010-7#2)(2010-9#2)(2011-2#26)(2012-12#3)(2012-2#11)(2012-3#11)(2013-1#5)(2013-8#3)
positional and##2##2##(2008-10#1)(2008-2#1)
positional cloning approach##2##3##(1995-6#1)(2008-2#1)
positional cloning of the##3##4##(2008-10#2)(2008-7#1)
positional cloning of##4##3##(2008-10#3)(2008-7#1)
positional cloning##8##2##(1995-6#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)
positional effects##2##2##(1995-5#1)(2008-4#1)
positional isomers##4##2##(2008-10#4)
positional##31##1##(1995-5#1)(1995-6#1)(1996-6#1)(1997-6#1)(2008-10#14)(2008-12#2)(2008-2#2)(2008-4#3)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
positioned as##2##2##(2008-3#1)(2013-1#1)
positioned at the##4##3##(1995-8#1)(2008-10#3)
positioned at##7##2##(1992-8#1)(1995-8#1)(2008-10#4)(2008-3#1)
positioned between##2##2##(1994-11#1)(1997-7#1)
positioned in the##5##3##(2008-10#4)(2013-1#1)
positioned in##9##2##(2008-10#5)(2011-1#1)(2011-2#2)(2013-1#1)
positioned on the##2##3##(1997-9#1)(2008-10#1)
positioned on##5##2##(1996-12#1)(1997-9#1)(2008-10#3)
positioned to##3##2##(1992-1#1)(1993-8#1)(2010-4#1)
positioned##48##1##(1991-12#1)(1992-1#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-7#1)(1997-9#1)(2008-10#18)(2008-3#3)(2008-6#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#3)
positioning a##3##2##(1993-11#1)(2008-6#1)(2013-1#1)
positioning and##2##2##(2008-7#1)(2013-1#1)
positioning of the stimulating electrode##2##5##(2008-9#2)
positioning of the##9##3##(1991-9#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-9#3)(2010-7#1)(2011-2#1)
positioning of##16##2##(1991-9#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#2)
positioning##43##1##(1991-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#3)(2010-1#1)(2010-3#1)(2010-7#3)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)
positions 2##2##2##(1994-3#1)(2012-3#1)
positions and##9##2##(1994-1#2)(1994-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
positions as##4##2##(1993-6#1)(1994-1#1)(2008-8#1)(2009-6#1)
positions by##2##2##(1991-7#1)(2008-7#1)
positions in the##6##3##(1992-9#1)(1993-6#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-12#1)
positions in##12##2##(1990-6#1)(1991-6#1)(1992-9#1)(1993-6#2)(1993-8#1)(1997-3#1)(2008-10#2)(2008-12#1)(2009-11#1)(2011-2#1)
positions of the##10##3##(1990-5#2)(1996-5#1)(2008-10#4)(2008-4#1)(2008-8#1)(2013-1#1)
positions of##33##2##(1990-5#3)(1994-12#1)(1994-5#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-6#2)(1997-8#3)(1997-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-8#2)(2013-1#2)(2013-7#1)
positions was##2##2##(1993-8#1)(2013-1#1)
positions were##6##2##(1990-6#2)(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#1)
positions within##3##2##(1994-5#1)(1995-5#1)(1997-9#1)
positions##151##1##(1990-2#3)(1990-5#3)(1990-6#4)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#6)(1993-8#2)(1994-1#3)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#8)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-3#3)(1996-5#1)(1997-2#3)(1997-3#1)(1997-6#3)(1997-8#4)(1997-9#4)(2007-12#1)(2008-10#19)(2008-11#5)(2008-12#4)(2008-3#6)(2008-4#5)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-5#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
positive (CD4+##2##2##(1997-7#2)
positive Kleihauer tests##2##3##(2009-3#2)
positive Kleihauer##3##2##(2009-3#3)
positive P##2##2##(2008-10#2)
positive adjustment##2##2##(2009-7#2)
positive affect##3##2##(2008-11#2)(2009-7#1)
positive airway pressure (CPAP)##2##4##(2010-7#1)(2011-1#1)
positive and negative aspects of the##2##6##(2008-11#2)
positive and negative aspects of##4##5##(1993-1#1)(2008-11#2)(2009-12#1)
positive and negative aspects##5##4##(1993-1#1)(1995-11#1)(2008-11#2)(2009-12#1)
positive and negative cases##2##4##(2008-10#2)
positive and negative information##2##4##(1993-12#2)
positive and negative predictive##3##4##(1992-3#1)(2008-11#1)(2011-2#1)
positive and negative values##2##4##(2008-3#1)(2012-2#1)
positive and negative##32##3##(1992-3#1)(1993-1#1)(1993-12#2)(1995-11#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
positive and the##3##3##(1996-12#1)(2008-11#1)(2013-1#1)
positive and##52##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#10)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
positive association between##9##3##(1990-8#1)(1993-12#1)(1994-2#1)(2008-11#1)(2009-7#1)(2010-1#1)(2010-6#1)(2012-2#1)(2013-1#1)
positive association##12##2##(1990-8#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-11#1)(2009-7#1)(2010-1#1)(2010-6#1)(2012-2#2)(2013-1#2)
positive associations of##2##3##(1997-8#2)
positive assortment##4##2##(2008-8#4)
positive at##2##2##(1997-2#1)(2008-5#1)
positive attitude toward##2##3##(1996-11#1)(2009-5#1)
positive attitude##4##2##(1996-11#1)(2009-5#1)(2013-1#2)
positive attitudes to##2##3##(2008-12#1)(2013-1#1)
positive attitudes towards##2##3##(2008-9#1)(2013-1#1)
positive attitudes##5##2##(1994-3#1)(2008-12#1)(2008-9#1)(2013-1#2)
positive axillary##2##2##(1993-2#1)(1997-7#1)
positive bacteria##4##2##(1997-8#1)(2008-12#1)(2012-2#1)(2013-8#1)
positive biopsy##2##2##(1994-12#1)(1994-9#1)
positive blood##2##2##(2010-6#2)
positive breast##3##2##(2011-2#2)(2012-3#1)
positive cases##5##2##(1990-6#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
positive cells of##2##3##(1995-8#2)
positive cells##7##2##(1990-12#1)(1995-8#3)(2008-11#2)(2008-8#1)
positive changes##4##2##(1992-3#1)(2008-11#1)(2012-3#1)(2013-7#1)
positive charge of##2##3##(2008-10#1)(2011-2#1)
positive charge##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
positive charges##2##2##(2008-10#1)(2011-2#1)
positive chemical ionization##4##3##(2008-10#3)(2013-8#1)
positive clinical##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
positive clone was##2##3##(2008-8#1)(2008-9#1)
positive clones were obtained##2##4##(2008-9#2)
positive clones were##4##3##(2008-8#2)(2008-9#2)
positive clones##7##2##(1990-8#1)(1993-6#1)(2008-8#3)(2008-9#2)
positive control group##2##3##(2010-1#1)(2013-1#1)
positive control in##3##3##(2008-10#2)(2008-5#1)
positive control##18##2##(1992-12#1)(1992-8#1)(1995-6#1)(2008-10#8)(2008-11#2)(2008-5#2)(2010-1#1)(2010-7#1)(2013-1#1)
positive controls##6##2##(2008-10#3)(2008-9#2)(2013-1#1)
positive cooperativity##3##2##(1994-5#2)(1997-2#1)
positive correlation between the##4##4##(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
positive correlation between##11##3##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
positive correlation of##3##3##(1995-9#1)(2008-10#1)(2008-11#1)
positive correlation was##4##3##(1995-12#1)(2008-10#1)(2009-8#1)(2011-1#1)
positive correlation with the##3##4##(1991-11#1)(1991-12#1)(2008-12#1)
positive correlation with##5##3##(1991-11#1)(1991-12#1)(2008-12#1)(2010-8#1)(2013-1#1)
positive correlation##24##2##(1991-11#1)(1991-12#1)(1995-12#1)(1995-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)
positive correlations among##2##3##(2008-9#1)(2012-3#1)
positive correlations between size at maturity and asymptotic size##3##9##(2008-9#3)
positive correlations between##6##3##(2008-8#1)(2008-9#4)(2010-8#1)
positive correlations were##3##3##(2008-10#1)(2008-7#1)(2011-3#1)
positive correlations##15##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-10#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)
positive direction##2##2##(2008-10#2)
positive discography##9##2##(2012-12#9)
positive effect in##2##3##(2011-2#1)(2012-3#1)
positive effect of##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
positive effect on##12##3##(1990-9#1)(2008-11#1)(2008-12#2)(2008-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
positive effect##19##2##(1990-9#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-8#3)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
positive effects of##3##3##(2008-8#1)(2012-12#1)(2012-2#1)
positive effects on##7##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
positive effects##16##2##(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#4)(2009-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
positive emotions##2##2##(2013-1#1)(2013-8#1)
positive errors##2##2##(2008-10#2)
positive experiences of##2##3##(2008-10#1)(2013-1#1)
positive experiences##3##2##(2008-10#2)(2013-1#1)
positive expiratory pressure##2##3##(1991-2#1)(1997-3#1)
positive factor##2##2##(1993-8#1)(1995-2#1)
positive factors##2##2##(2009-12#1)(2009-8#1)
positive family history##3##3##(1997-6#1)(2011-2#1)(2012-3#1)
positive feedback loop##2##3##(1991-5#2)
positive feedback##7##2##(1991-5#2)(2008-11#2)(2008-8#1)(2009-8#1)(2010-10#1)
positive feelings##2##2##(2009-6#1)(2012-3#1)
positive findings##2##2##(1994-12#1)(1995-1#1)
positive for HIV##2##3##(1995-6#1)(1996-5#1)
positive for PE##3##3##(2011-2#1)(2012-2#2)
positive for both##2##3##(2011-2#2)
positive for the##4##3##(1991-6#1)(1997-8#1)(2008-10#1)(2011-2#1)
positive for##51##2##(1990-12#1)(1990-6#2)(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1995-6#1)(1996-5#1)(1997-8#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2009-6#1)(2010-6#1)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
positive health##2##2##(2008-10#1)(2008-11#1)
positive impact on the##5##4##(1995-5#1)(2008-11#1)(2008-12#1)(2013-8#2)
positive impact on##6##3##(1995-5#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#2)
positive impact##7##2##(1995-5#1)(2008-11#2)(2008-12#1)(2011-2#1)(2013-8#2)
positive in all##4##3##(1991-3#1)(1995-11#1)(1996-8#1)(2012-12#1)
positive in media alone##2##4##(1995-12#2)
positive in the##4##3##(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
positive in##20##2##(1990-2#1)(1991-3#1)(1994-1#1)(1995-11#1)(1995-12#2)(1996-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
positive influence of##4##3##(2007-8#1)(2008-10#1)(2008-8#1)(2009-8#1)
positive influence on##4##3##(1994-3#1)(2008-11#1)(2008-7#1)(2013-8#1)
positive influence##8##2##(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
positive ion mode##4##3##(2008-10#2)(2011-3#2)
positive ion##5##2##(2008-10#3)(2011-3#2)
positive likelihood##2##2##(2008-11#1)(2008-12#1)
positive long-term##2##2##(2011-1#1)(2013-1#1)
positive lymph nodes##2##3##(1990-8#1)(2011-2#1)
positive messages##2##2##(2008-11#1)(2010-11#1)
positive net##2##2##(2008-10#2)
positive nodes##4##2##(1992-12#1)(1993-1#1)(2011-2#1)(2012-3#1)
positive on##3##2##(2008-10#1)(2009-7#2)
positive one##2##2##(2008-12#1)(2010-1#1)
positive or negative##10##3##(1995-11#1)(1995-12#1)(2008-10#3)(2008-8#2)(2008-9#1)(2012-2#1)(2013-8#1)
positive or neutral##2##3##(1994-1#1)(2009-4#1)
positive or##13##2##(1993-11#1)(1994-1#1)(1995-11#1)(1995-12#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-4#1)(2012-2#1)(2013-8#1)
positive outcome##2##2##(2008-12#1)(2008-6#1)
positive outcomes for##3##3##(2008-11#2)(2013-8#1)
positive outcomes##9##2##(1995-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#2)(2013-8#1)
positive patient##3##2##(1997-8#1)(2010-12#2)
positive patients##9##2##(1990-8#1)(1993-11#1)(2008-10#1)(2008-5#5)(2010-12#1)
positive polymerase chain reaction##3##4##(2008-12#1)(2011-2#2)
positive population##3##2##(1995-2#1)(2008-8#1)(2008-9#1)
positive potential to##2##3##(2008-10#2)
positive potential##7##2##(2008-10#7)
positive potentials##4##2##(1990-5#2)(2008-10#2)
positive predictive value and##2##4##(2012-12#1)(2012-3#1)
positive predictive value##13##3##(1992-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)
positive predictive##15##2##(1992-11#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)
positive pressure##2##2##(1991-6#1)(2008-10#1)
positive proliferative responses to##2##4##(2011-2#2)
positive psychological##2##2##(2008-12#1)(2011-2#1)
positive rate was 9##2##4##(2011-3#1)(2013-8#1)
positive rate was##3##3##(2011-3#1)(2013-8#2)
positive rate##8##2##(1992-3#1)(1993-1#1)(1994-12#1)(1997-4#1)(2011-3#1)(2013-8#3)
positive ratings of##2##3##(2012-2#2)
positive reactions##2##2##(2008-5#1)(2011-2#1)
positive regulation##2##2##(2008-4#1)(2008-8#1)
positive regulator##2##2##(2008-11#1)(2013-1#1)
positive regulatory##3##2##(1997-1#1)(1997-8#1)(2011-1#1)
positive reinforcement##2##2##(1993-6#1)(1994-2#1)
positive relation between##3##3##(1990-8#1)(2008-12#1)(2009-10#1)
positive relationship between##6##3##(1995-3#1)(1996-12#1)(2008-10#2)(2010-10#1)(2010-11#1)
positive religious coping##2##3##(2008-12#2)
positive residue##2##2##(2008-8#2)
positive residues in##3##3##(2008-8#3)
positive response##3##2##(1997-3#1)(2008-10#2)
positive responses to##4##3##(1992-12#1)(2011-2#2)(2012-3#1)
positive responses##5##2##(1992-12#1)(2008-10#1)(2011-2#2)(2012-3#1)
positive result##2##2##(2010-3#1)(2012-3#1)
positive results in##3##3##(2008-5#2)(2011-3#1)
positive results##17##2##(1991-1#1)(1992-12#1)(1993-3#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#3)(2011-3#1)
positive role##5##2##(1993-6#1)(1995-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
positive samples of##2##3##(1996-12#1)(2008-10#1)
positive samples##11##2##(1996-12#2)(2008-1#1)(2008-10#3)(2010-6#3)(2011-2#1)(2012-12#1)
positive selection##4##2##(2008-9#2)(2010-7#1)(2012-3#1)
positive sera (dot-blot##2##3##(1990-8#2)
positive sera##5##2##(1990-8#4)(1997-5#1)
positive social##2##2##(2010-10#1)(2011-2#1)
positive staining for CD-117##2##4##(2012-12#2)
positive staining##4##2##(1997-7#1)(2008-8#1)(2012-12#2)
positive steady state##2##3##(2013-8#2)
positive subjects##2##2##(1990-6#1)(2008-10#1)
positive surgical margins##2##3##(2011-2#2)
positive surgical##3##2##(2011-2#3)
positive test##3##2##(1990-2#1)(1994-1#1)(2008-10#1)
positive than##4##2##(1993-3#1)(1997-2#1)(2008-10#1)(2009-8#1)
positive tits were##2##3##(2008-5#2)
positive to##6##2##(1990-2#1)(1990-3#1)(1996-6#1)(2008-10#1)(2013-8#2)
positive transcription##2##2##(2011-1#1)(2012-12#1)
positive using##2##2##(1996-12#1)(2012-12#1)
positive values in the##2##4##(2008-10#2)
positive values##6##2##(1990-11#1)(2008-10#5)
positive well-being##3##2##(2010-6#3)
positive with C##2##3##(2008-10#2)
positive with##4##2##(1995-12#1)(2008-10#2)(2012-2#1)
positive##879##1##(1990-11#3)(1990-12#3)(1990-2#8)(1990-3#2)(1990-5#2)(1990-6#10)(1990-8#11)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#4)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#9)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#4)(1993-11#5)(1993-12#7)(1993-2#2)(1993-3#5)(1993-6#3)(1993-8#1)(1994-1#4)(1994-11#1)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#4)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#6)(1995-9#2)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#8)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#136)(2008-11#59)(2008-12#28)(2008-3#2)(2008-4#3)(2008-5#38)(2008-6#2)(2008-7#9)(2008-8#46)(2008-9#23)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#5)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#9)(2009-8#10)(2010-1#6)(2010-10#8)(2010-11#9)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#10)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#12)(2011-2#63)(2011-3#6)(2012-12#24)(2012-2#19)(2012-3#22)(2013-1#35)(2013-7#1)(2013-8#22)
positive&quot##2##1##(1991-8#1)(1992-5#1)
positive- and##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
positive-ion mode##2##2##(2008-10#2)
positive-ion##6##1##(2008-10#5)(2009-6#1)
positive-sense##3##1##(2008-10#1)(2008-9#2)
positively affected##2##2##(1990-11#1)(2008-10#1)
positively and negatively##2##3##(2008-11#1)(2011-2#1)
positively and##6##2##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
positively associated with the##3##4##(2008-11#1)(2008-8#1)(2009-11#1)
positively associated with##10##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
positively associated##12##2##(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-2#2)(2012-3#1)(2013-1#2)
positively by the##2##3##(1996-12#1)(2011-2#1)
positively by##3##2##(1996-12#1)(1996-3#1)(2011-2#1)
positively charged complexes##2##3##(2008-10#2)
positively charged residues##5##3##(1997-8#2)(2008-8#2)(2011-1#1)
positively charged##30##2##(1990-5#2)(1995-11#1)(1995-2#1)(1997-8#3)(2008-10#14)(2008-11#3)(2008-7#1)(2008-8#3)(2009-3#1)(2011-1#1)
positively correlated to host##2##4##(2008-10#2)
positively correlated to##4##3##(2008-10#3)(2008-7#1)
positively correlated with children's##3##4##(2010-11#3)
positively correlated with the##8##4##(1991-12#1)(1991-7#1)(2008-10#4)(2009-7#1)(2010-1#1)
positively correlated with##50##3##(1991-12#2)(1991-7#1)(1994-1#1)(1994-12#1)(1994-6#2)(2008-10#25)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-10#2)(2011-2#3)(2012-3#1)(2013-1#2)
positively correlated##56##2##(1991-12#2)(1991-7#1)(1994-1#1)(1994-12#1)(1994-6#2)(2008-10#29)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-10#2)(2011-2#3)(2012-3#1)(2013-1#2)
positively correlates with##2##3##(2008-4#1)(2013-1#1)
positively identified as##2##3##(2008-10#2)
positively identified##6##2##(1995-11#1)(2008-10#5)
positively impact##2##2##(2008-11#1)(2009-8#1)
positively predicted##2##2##(2011-2#2)
positively related to the##2##4##(1992-2#1)(1996-12#1)
positively related to##18##3##(1991-12#1)(1992-2#2)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-3#1)(2013-1#1)
positively related with##2##3##(2010-12#2)
positively related##21##2##(1991-12#1)(1992-2#2)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-2#3)(2012-3#1)(2013-1#1)
positively selected##2##2##(2008-10#1)(2010-8#1)
positively stained##2##2##(1992-3#1)(1997-2#1)
positively to##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
positively with the##5##3##(1995-8#1)(2008-10#2)(2013-8#2)
positively with##20##2##(1990-2#1)(1995-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-8#2)(2011-10#1)(2011-2#3)(2013-1#2)(2013-8#2)
positively##189##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1991-12#3)(1991-5#1)(1991-7#1)(1992-2#2)(1992-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#2)(1996-3#1)(1997-2#1)(1997-8#3)(2008-1#1)(2008-10#60)(2008-11#10)(2008-12#3)(2008-4#3)(2008-7#6)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-8#4)(2011-1#4)(2011-10#3)(2011-2#15)(2012-3#4)(2013-1#10)(2013-8#3)
positives and##5##2##(1995-3#1)(2008-10#3)(2012-3#1)
positives##14##1##(1995-3#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#2)(2012-3#1)
positivist##2##1##(2008-11#1)(2009-10#1)
positivity by##2##2##(1994-1#1)(2011-2#1)
positivity constraint##3##2##(2013-1#3)
positivity for##3##2##(1991-12#1)(1995-12#1)(2010-6#1)
positivity in##2##2##(2012-3#2)
positivity of the##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
positivity of##6##2##(1991-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
positivity was##3##2##(1996-12#1)(1996-3#1)(2008-10#1)
positivity##30##1##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-8#2)(1994-1#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#3)(2012-3#3)(2013-1#5)
positron emission tomographic##2##3##(1995-8#1)(2009-10#1)
positron emission tomography (PET) in##2##5##(1996-2#1)(2008-7#1)
positron emission tomography (PET)##5##4##(1990-8#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-7#1)
positron emission tomography and##2##4##(1994-3#1)(2010-12#1)
positron emission tomography in##2##4##(1996-2#1)(2008-12#1)
positron emission tomography##18##3##(1990-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
positron emission##23##2##(1990-8#1)(1992-11#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
positron##25##1##(1990-8#1)(1992-11#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
positron-emission##2##1##(2011-2#2)
posits that the##2##3##(2008-11#2)
posits that##3##2##(2008-11#2)(2010-1#1)
posits##5##1##(2008-11#2)(2008-12#1)(2009-7#1)(2010-1#1)
posses a##3##2##(2008-10#2)(2008-11#1)
posses##6##1##(2008-10#2)(2008-11#3)(2009-8#1)
possess a##14##2##(1991-6#1)(1995-8#1)(2007-12#1)(2008-10#5)(2008-8#2)(2009-6#1)(2009-8#1)(2010-5#1)(2013-1#1)
possess an##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
possess both##3##2##(1990-5#1)(1995-8#1)(2008-10#1)
possess immunomodulatory##2##2##(1993-12#1)(2012-2#1)
possess inhibitory##2##2##(2008-11#1)(2008-7#1)
possess significant##2##2##(2008-3#1)(2008-9#1)
possess the ability to differentiate into##2##6##(2008-9#2)
possess the ability to##3##4##(2008-10#1)(2008-9#2)
possess the same##3##3##(1993-9#1)(2008-10#1)(2008-9#1)
possess the##18##2##(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-9#3)(2009-8#1)(2011-2#1)(2012-2#1)
possess unique##2##2##(2008-11#1)(2008-3#1)
possess##104##1##(1990-11#1)(1990-5#1)(1991-6#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-1#2)(1995-8#4)(1996-1#1)(2006-6#1)(2007-12#2)(2008-10#28)(2008-11#9)(2008-3#2)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)
possessed a##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
possessed high##3##2##(2008-10#1)(2010-6#1)(2013-8#1)
possessed the##7##2##(1993-9#1)(2008-10#3)(2008-11#1)(2008-6#1)(2013-8#1)
possessed##38##1##(1990-12#1)(1991-5#1)(1993-1#1)(1993-8#2)(1993-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#2)(2013-8#2)
possesses a##12##2##(1990-7#1)(1993-12#2)(1994-11#1)(2007-12#2)(2008-10#3)(2008-3#1)(2009-5#1)(2009-8#1)
possesses an##2##2##(1993-1#1)(2008-9#1)
possesses the##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)
possesses##46##1##(1990-10#1)(1990-7#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-9#1)(1997-3#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-3#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#2)(2011-1#1)(2011-3#2)(2012-3#1)
possessing a##3##2##(2008-10#2)(2008-7#1)
possessing inhibition##2##2##(2008-10#1)(2008-7#1)
possessing the##7##2##(1992-10#1)(1994-11#1)(2008-10#2)(2008-11#2)(2012-2#1)
possessing various##2##2##(2008-10#2)
possessing##41##1##(1990-12#1)(1992-10#1)(1993-8#1)(1994-11#2)(1996-5#2)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#2)
possession of##3##2##(1991-12#1)(1996-5#1)(2008-1#1)
possession##4##1##(1991-12#1)(1996-5#1)(2008-1#1)(2009-10#1)
possibilistic##2##1##(2009-10#2)
possibilities and limits##2##3##(1997-4#1)(2012-2#1)
possibilities and##7##2##(1992-3#1)(1997-2#1)(1997-4#1)(2008-10#2)(2010-8#1)(2012-2#1)
possibilities for##11##2##(1992-5#1)(1993-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2011-2#1)
possibilities in##3##2##(2008-10#2)(2008-12#1)
possibilities of inductively coupled plasma##2##5##(2008-10#2)
possibilities of treatment##2##3##(1993-11#1)(2012-12#1)
possibilities of##22##2##(1991-3#1)(1991-8#1)(1993-11#1)(1994-6#1)(2007-11#1)(2008-10#8)(2008-6#1)(2010-4#1)(2011-3#2)(2012-12#3)(2012-3#1)(2013-1#1)
possibilities offered by##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
possibilities to##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)
possibilities##65##1##(1990-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#21)(2008-11#5)(2008-12#2)(2008-6#1)(2008-8#3)(2009-1#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
possibilities]##3##1##(1991-3#2)(2008-10#1)
possibility and##2##2##(2011-2#1)(2012-3#1)
possibility for##9##2##(1991-2#1)(1996-3#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
possibility in the##2##3##(1991-3#1)(2010-10#1)
possibility of a##16##3##(1992-2#1)(1993-12#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
possibility of developing##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
possibility of on-line##2##3##(2008-10#2)
possibility of the##8##3##(1990-9#2)(2008-10#3)(2008-11#1)(2009-5#1)(2011-2#1)
possibility of using##20##3##(1991-1#1)(1991-8#1)(1993-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
possibility of##175##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-5#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#51)(2008-11#13)(2008-12#4)(2008-3#6)(2008-5#3)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#8)(2013-8#3)
possibility that the##9##3##(1991-5#1)(1994-8#1)(1995-9#1)(2008-10#2)(2009-10#1)(2010-4#1)(2011-2#2)
possibility that these##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
possibility that##59##2##(1990-9#1)(1991-5#2)(1991-8#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(2008-10#9)(2008-11#6)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#4)(2010-4#2)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
possibility to apply##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
possibility to develop##2##3##(2008-11#1)(2011-2#1)
possibility to##27##2##(1996-11#1)(1996-6#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
possibility##295##1##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#79)(2008-11#22)(2008-12#5)(2008-3#7)(2008-5#5)(2008-7#11)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#2)(2009-12#2)(2009-5#3)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#4)(2010-8#2)(2011-2#21)(2011-3#1)(2012-12#4)(2012-2#6)(2012-3#10)(2013-1#12)(2013-7#1)(2013-8#5)
possible &quot##3##2##(1994-11#1)(2008-6#1)(2009-3#1)
possible a##4##2##(2008-10#3)(2008-11#1)
possible adulteration##2##2##(2008-10#1)(2010-4#1)
possible advantages##2##2##(1993-2#1)(2011-2#1)
possible adverse effects of##3##4##(2008-8#2)(2012-2#1)
possible adverse effects##4##3##(2008-8#2)(2012-2#1)(2012-3#1)
possible adverse##6##2##(1991-2#1)(1992-11#1)(2008-8#2)(2012-2#1)(2012-3#1)
possible alterations##2##2##(2008-5#1)(2010-6#1)
possible alternative##3##2##(1997-5#1)(2008-10#1)(2008-7#1)
possible alternatives##2##2##(1992-3#1)(1993-1#1)
possible and easy##2##3##(1997-3#1)(2008-10#1)
possible and##16##2##(1993-3#1)(1994-1#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
possible application to##2##3##(2008-10#1)(2008-11#1)
possible application##3##2##(2008-10#2)(2008-11#1)
possible applications##4##2##(1993-1#1)(2008-10#1)(2008-11#2)
possible as##2##2##(1991-12#1)(2008-5#1)
possible association between##3##3##(2008-11#1)(2013-1#1)(2013-8#1)
possible association of##4##3##(1997-3#1)(2011-2#3)
possible association with##2##3##(2008-10#1)(2008-11#1)
possible association##10##2##(1997-3#1)(2008-10#1)(2008-11#2)(2011-2#3)(2012-5#1)(2013-1#1)(2013-8#1)
possible associations##2##2##(2008-10#1)(2008-7#1)
possible at##4##2##(2008-10#3)(2008-11#1)
possible because of##3##3##(1991-11#1)(2008-10#1)(2008-5#1)
possible benefits##2##2##(2012-3#1)(2013-1#1)
possible but##2##2##(1996-1#1)(2013-1#1)
possible by means of##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
possible by the##3##3##(2008-10#2)(2011-2#1)
possible by use of##3##4##(2008-3#3)
possible by using##2##3##(1996-12#1)(2008-10#1)
possible by##27##2##(1994-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
possible candidates##2##2##(2008-7#1)(2013-1#1)
possible causal##2##2##(1992-5#1)(2009-4#1)
possible cause of##5##3##(1995-2#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
possible cause##9##2##(1992-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#2)
possible causes of##4##3##(2008-7#2)(2008-8#1)(2008-9#1)
possible causes##7##2##(1993-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)
possible cellular##4##2##(2008-10#1)(2009-8#2)(2011-2#1)
possible changes in the##2##4##(2009-12#1)(2010-8#1)
possible changes in##4##3##(1996-12#1)(2008-10#1)(2009-12#1)(2010-8#1)
possible changes##5##2##(1996-12#1)(2008-10#1)(2009-12#1)(2010-1#1)(2010-8#1)
possible clinical##3##2##(2009-8#1)(2012-3#1)(2013-1#1)
possible combinations of##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
possible combinations##6##2##(2008-10#4)(2008-12#1)(2008-3#1)
possible common##2##2##(1991-5#1)(2008-10#1)
possible complication##4##2##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
possible complications of##2##3##(1990-11#1)(1993-8#1)
possible complications##6##2##(1990-11#1)(1991-6#1)(1993-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
possible confounding##2##2##(1991-3#1)(2008-2#1)
possible consequences of##2##3##(2008-10#1)(2011-2#1)
possible contributing##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
possible contribution##2##2##(2009-6#1)(2012-2#1)
possible correlation between##2##3##(2011-2#1)(2013-1#1)
possible differences##3##2##(1990-5#1)(2008-3#1)(2012-3#1)
possible differential##2##2##(2012-3#1)(2012-8#1)
possible disadvantages##2##2##(2008-11#1)(2012-2#1)
possible effect of##4##3##(1996-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
possible effects on##2##3##(2008-10#1)(2013-7#1)
possible effects##4##2##(1996-8#1)(2008-10#2)(2013-7#1)
possible endemic area##2##3##(1996-11#2)
possible environmental##2##2##(2008-10#1)(2008-5#1)
possible errors##2##2##(2008-10#1)(2011-2#1)
possible etiologies##2##2##(2008-8#1)(2011-1#1)
possible even##2##2##(1990-11#1)(2008-10#1)
possible existence of##5##3##(1992-3#1)(1992-9#1)(1997-1#1)(2010-11#1)(2012-2#1)
possible explanation is##3##3##(2008-3#1)(2009-7#1)(2011-2#1)
possible explanation of##2##3##(1993-1#1)(1996-12#1)
possible explanation##9##2##(1992-3#1)(1993-1#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-1#1)(2011-2#1)
possible explanations for this##2##4##(1993-11#1)(2008-8#1)
possible explanations for##3##3##(1992-3#1)(1993-11#1)(2008-8#1)
possible explanations##4##2##(1991-11#1)(1992-3#1)(1993-11#1)(2008-8#1)
possible extension of##2##3##(2008-10#1)(2008-3#1)
possible for a##2##3##(2008-3#1)(2010-12#1)
possible for these##2##3##(2008-9#2)
possible for us to##2##4##(2008-3#1)(2010-6#1)
possible for##15##2##(1992-3#1)(1992-9#1)(1994-3#1)(1995-5#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-9#2)(2010-12#1)(2010-6#1)
possible from the##3##3##(1991-12#1)(1994-6#2)
possible from##5##2##(1991-12#1)(1994-6#2)(2008-11#2)
possible functional role##3##3##(1990-8#1)(2009-10#1)(2013-1#1)
possible functions##3##2##(2008-11#1)(2008-6#1)(2009-10#1)
possible further##2##2##(1995-5#1)(1997-3#1)
possible future directions##3##3##(1996-12#1)(2008-11#1)(2011-2#1)
possible future##6##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2011-7#1)
possible genetic##2##2##(2008-10#1)(2008-7#1)
possible harmful##2##2##(2011-2#2)
possible health##3##2##(1994-9#1)(1996-3#1)(2008-11#1)
possible if the##2##3##(2008-10#1)(2008-8#1)
possible if##6##2##(2008-10#2)(2008-11#1)(2008-8#3)
possible impact of##3##3##(1991-2#1)(1995-12#1)(2008-11#1)
possible impact on the##2##4##(2011-1#1)(2011-2#1)
possible impact##5##2##(1991-2#1)(1995-12#1)(2008-11#1)(2011-1#1)(2011-2#1)
possible implications of##3##3##(1991-5#1)(1991-6#1)(2009-8#1)
possible implications##6##2##(1990-8#1)(1991-5#1)(1991-6#1)(2009-8#2)(2009-9#1)
possible importance##2##2##(2008-10#1)(2008-9#1)
possible in a##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
possible in all##2##3##(2008-10#1)(2010-7#1)
possible in the##8##3##(1994-6#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
possible in##34##2##(1990-12#1)(1991-11#1)(1991-6#2)(1992-12#1)(1993-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
possible indications##2##2##(1993-8#1)(1994-12#1)
possible influence of##6##3##(2006-6#2)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
possible influence##7##2##(2006-6#2)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
possible inhibition##2##2##(2008-10#1)(2008-11#1)
possible interactions between##2##3##(1993-9#1)(1996-2#1)
possible interactions##5##2##(1991-3#1)(1993-9#1)(1996-2#1)(2008-10#1)(2010-8#1)
possible interference##2##2##(1994-6#1)(2008-10#1)
possible interferences of##3##3##(2008-10#2)(2008-2#1)
possible interferences were##2##3##(2008-10#2)
possible interferences##9##2##(2008-10#8)(2008-2#1)
possible interferents##3##2##(2008-10#3)
possible interfering##5##2##(2008-10#5)
possible involvement of cAMP##2##4##(1997-2#2)
possible involvement of##14##3##(1991-9#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-12#2)(1997-2#3)(2008-10#2)(2008-11#2)(2008-6#1)
possible involvement##16##2##(1991-9#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-12#2)(1997-2#3)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)
possible is##2##2##(1990-3#1)(1997-3#1)
possible link##2##2##(2008-10#1)(2013-1#1)
possible loss or##2##3##(1994-3#1)(2008-10#1)
possible matrix##2##2##(2008-10#2)
possible means for##2##3##(2008-10#1)(2012-3#1)
possible means##4##2##(2008-10#2)(2012-3#1)(2013-1#1)
possible mechanism for the##6##4##(2008-10#5)(2010-6#1)
possible mechanism for##9##3##(1994-8#1)(2008-10#6)(2010-6#1)(2011-2#1)
possible mechanism is##2##3##(2008-10#1)(2008-7#1)
possible mechanism of the##6##4##(2008-10#5)(2011-3#1)
possible mechanism of##18##3##(1993-6#1)(2008-10#13)(2008-8#1)(2009-12#1)(2011-2#1)(2011-3#1)
possible mechanism##34##2##(1993-6#2)(1994-8#1)(2008-10#22)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-6#1)(2011-2#2)(2011-3#1)
possible mechanisms by which##2##4##(2007-12#1)(2008-10#1)
possible mechanisms for the##3##4##(1991-5#1)(1992-8#1)(2008-10#1)
possible mechanisms for##4##3##(1991-5#1)(1992-8#1)(2008-10#1)(2009-8#1)
possible mechanisms involved in##2##4##(2008-10#1)(2008-9#1)
possible mechanisms of##8##3##(1992-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-4#1)(2013-1#1)
possible mechanisms##21##2##(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2013-1#1)
possible method of##2##3##(2009-7#1)(2011-2#1)
possible models##2##2##(1993-8#1)(2008-11#1)
possible molecular##3##2##(1994-3#1)(2008-11#1)(2010-7#1)
possible new##4##2##(1990-8#1)(2008-10#1)(2008-11#2)
possible novel##2##2##(2008-10#1)(2008-7#1)
possible occurrence##2##2##(1991-3#1)(2010-5#1)
possible only##4##2##(1993-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
possible pathogenic##2##2##(1991-6#1)(2008-7#1)
possible pathological##2##2##(2009-10#1)(2010-12#1)
possible pathways for##2##3##(1990-11#1)(2010-7#1)
possible physiological roles##2##3##(2009-10#1)(2009-8#1)
possible points of##2##3##(2008-7#1)(2013-1#1)
possible reaction mechanism##4##3##(2008-10#3)(2009-11#1)
possible reason##2##2##(2008-9#1)(2012-12#1)
possible reasons for##2##3##(2008-10#1)(2011-2#1)
possible relationship between##3##3##(1992-2#1)(1993-2#1)(2013-1#1)
possible relationship##6##2##(1992-2#1)(1993-2#1)(2008-10#2)(2013-1#2)
possible relevance##5##2##(1992-12#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
possible risk##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
possible role in the##3##4##(1996-3#1)(2008-12#1)(2008-7#1)
possible role in##7##3##(1990-5#1)(1993-12#1)(1996-3#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
possible role of##17##3##(1992-5#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-9#2)(1996-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-3#1)
possible role##31##2##(1990-5#1)(1991-1#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-9#2)(1996-2#1)(1996-3#1)(2008-10#6)(2008-12#2)(2008-7#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-1#1)
possible role(s)##2##2##(1991-5#1)(2008-11#1)
possible roles in##2##3##(1993-12#1)(2009-6#1)
possible roles##4##2##(1993-12#1)(2008-10#1)(2009-6#1)(2010-8#1)
possible sequence##2##2##(1997-6#1)(2008-12#1)
possible significance##2##2##(2008-10#1)(2011-2#1)
possible situations##2##2##(2008-8#2)
possible solution##2##2##(2008-10#1)(2009-10#1)
possible solutions to##2##3##(2009-6#1)(2013-1#1)
possible solutions##4##2##(2009-6#1)(2010-6#1)(2011-1#1)(2013-1#1)
possible sources of##3##3##(1995-3#1)(2008-10#2)
possible target##2##2##(1992-12#1)(1994-8#1)
possible techniques##2##2##(2008-10#1)(2010-11#1)
possible that this##3##3##(1995-5#1)(1997-1#1)(1997-5#1)
possible that##34##2##(1992-2#1)(1993-2#1)(1994-5#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
possible the##6##2##(2008-10#5)(2008-11#1)
possible time##2##2##(2008-10#1)(2013-1#1)
possible to adopt a##2##4##(2008-10#2)
possible to analyse##2##3##(2008-10#2)
possible to analyze##2##3##(2008-10#1)(2012-2#1)
possible to assess the##2##4##(2008-10#2)
possible to avoid##2##3##(1992-5#1)(1996-3#1)
possible to carry out##3##4##(1993-11#1)(1996-3#1)(1997-6#1)
possible to combine##2##3##(1995-5#1)(2013-1#1)
possible to confirm##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
possible to control##2##3##(2008-10#1)(2008-7#1)
possible to define##2##3##(1996-11#1)(2011-2#1)
possible to design##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
possible to detect and##2##4##(1991-6#1)(2008-10#1)
possible to detect##10##3##(1991-6#1)(1994-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-3#1)
possible to determine the##5##4##(1993-8#1)(2008-10#2)(2008-4#1)(2008-9#1)
possible to determine##11##3##(1990-8#1)(1993-8#1)(2008-10#6)(2008-4#1)(2008-9#1)(2013-1#1)
possible to develop##2##3##(2008-11#1)(2011-2#1)
possible to differentiate##2##3##(1994-9#1)(2008-10#1)
possible to distinguish##3##3##(2008-10#2)(2010-4#1)
possible to employ##2##3##(2008-10#1)(2013-1#1)
possible to estimate the##3##4##(2008-10#2)(2008-3#1)
possible to estimate##6##3##(1991-3#1)(2008-10#3)(2008-3#1)(2012-12#1)
possible to extract##6##3##(2008-10#2)(2008-11#1)(2008-3#3)
possible to follow the##2##4##(1995-9#1)(2008-10#1)
possible to follow##3##3##(1995-9#1)(1997-6#1)(2008-10#1)
possible to identify some##2##4##(2008-10#2)
possible to identify the##4##4##(2008-10#1)(2008-11#2)(2012-3#1)
possible to identify##8##3##(2008-10#3)(2008-11#3)(2008-4#1)(2012-3#1)
possible to increase##2##3##(2008-10#1)(2009-4#1)
possible to introduce##2##3##(1993-8#1)(2008-10#1)
possible to investigate the##2##4##(1997-8#1)(2008-8#1)
possible to measure the##2##4##(1997-4#1)(2009-12#1)
possible to measure##3##3##(1990-12#1)(1997-4#1)(2009-12#1)
possible to monitor the##3##4##(2008-10#3)
possible to obtain a model##3##5##(2008-10#3)
possible to obtain a##6##4##(2008-10#4)(2010-7#1)(2013-1#1)
possible to obtain##14##3##(2008-10#10)(2008-3#1)(2010-7#1)(2011-3#1)(2013-1#1)
possible to perform the##2##4##(2008-10#2)
possible to perform##6##3##(2008-10#4)(2008-7#1)(2012-2#1)
possible to place##3##3##(2008-6#1)(2008-7#1)(2010-6#1)
possible to predict##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
possible to prepare##2##3##(1990-12#1)(1995-8#1)
possible to produce##4##3##(2008-10#1)(2008-11#2)(2008-4#1)
possible to quantify the##3##4##(2008-7#2)(2010-3#1)
possible to resolve##2##3##(2008-10#1)(2008-9#1)
possible to select##3##3##(1997-2#1)(2008-10#2)
possible to use##4##3##(2008-3#2)(2008-5#1)(2008-7#1)
possible to##247##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#3)(1991-6#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2007-11#1)(2008-10#99)(2008-11#23)(2008-12#1)(2008-2#1)(2008-3#15)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#11)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)
possible treatment##4##2##(1995-12#1)(2008-6#1)(2008-7#2)
possible treatments##2##2##(2012-3#1)(2013-8#1)
possible underlying mechanisms for##2##4##(2008-11#1)(2013-1#1)
possible underlying##8##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-2#2)(2013-1#1)
possible use in##2##3##(2008-5#1)(2013-1#1)
possible use of the##2##4##(2008-10#2)
possible use of##8##3##(1992-9#1)(2008-10#4)(2008-5#2)(2009-8#1)
possible use##12##2##(1992-9#1)(2008-10#5)(2008-11#1)(2008-5#3)(2009-8#1)(2013-1#1)
possible using a##3##3##(2008-10#3)
possible using##7##2##(2008-10#7)
possible values##2##2##(1992-4#1)(2008-10#1)
possible ways of##2##3##(1992-9#1)(2008-11#1)
possible ways##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
possible when##2##2##(2008-10#2)
possible with a limit of detection of##2##7##(2008-10#2)
possible with a##4##3##(2008-10#4)
possible with the##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
possible with##19##2##(1993-3#1)(1994-3#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#2)
possible without##2##2##(1997-3#1)(2008-11#1)
possible##1305##1##(1990-11#6)(1990-12#4)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#6)(1990-9#5)(1991-1#2)(1991-11#5)(1991-12#6)(1991-2#5)(1991-3#6)(1991-5#4)(1991-6#7)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#6)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#4)(1992-6#3)(1992-8#1)(1992-9#6)(1993-1#4)(1993-11#4)(1993-12#7)(1993-2#4)(1993-3#5)(1993-6#5)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#11)(1994-5#9)(1994-6#7)(1994-8#6)(1994-9#3)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#8)(1995-6#2)(1995-8#4)(1995-9#3)(1996-1#2)(1996-11#6)(1996-12#9)(1996-2#5)(1996-3#8)(1996-5#1)(1996-6#1)(1996-8#3)(1997-1#4)(1997-2#5)(1997-3#7)(1997-4#3)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#5)(2006-6#2)(2007-11#1)(2007-12#7)(2008-1#5)(2008-10#383)(2008-11#90)(2008-12#17)(2008-2#3)(2008-3#33)(2008-4#12)(2008-5#25)(2008-6#9)(2008-7#45)(2008-8#36)(2008-9#31)(2009-1#2)(2009-10#8)(2009-11#4)(2009-12#7)(2009-3#2)(2009-4#3)(2009-6#4)(2009-7#8)(2009-8#11)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#6)(2010-12#11)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#8)(2010-7#8)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#67)(2011-3#5)(2011-7#1)(2012-12#9)(2012-2#33)(2012-3#21)(2012-4#1)(2012-5#2)(2012-8#2)(2013-1#49)(2013-7#1)(2013-8#15)
possibly a##6##2##(1994-12#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-12#1)(2011-1#1)
possibly as a##3##3##(1991-1#1)(1993-12#1)(2008-10#1)
possibly as##4##2##(1991-1#1)(1993-12#1)(1995-8#1)(2008-10#1)
possibly associated with##2##3##(1997-7#1)(2010-10#1)
possibly be##6##2##(1990-5#1)(1991-1#1)(1993-11#1)(2008-11#2)(2008-3#1)
possibly because of the##2##4##(1994-2#1)(2008-11#1)
possibly because##5##2##(1994-2#1)(2008-11#2)(2009-4#1)(2012-3#1)
possibly by##3##2##(2008-11#2)(2008-7#1)
possibly caused by##2##3##(2008-10#1)(2011-2#1)
possibly due to##10##3##(1992-9#1)(1993-12#1)(1996-8#1)(2008-10#2)(2008-11#2)(2010-4#1)(2011-2#1)(2013-1#1)
possibly in combination with##2##4##(1993-6#1)(2012-2#1)
possibly in##4##2##(1990-5#1)(1993-6#1)(2009-8#1)(2012-2#1)
possibly indicating a##2##3##(2008-10#1)(2012-5#1)
possibly indicating##4##2##(1997-5#1)(2008-10#2)(2012-5#1)
possibly involved in the##2##4##(2008-10#1)(2010-11#1)
possibly involving the##2##3##(1997-3#1)(2008-10#1)
possibly less##2##2##(2008-11#1)(2008-5#1)
possibly reflecting##3##2##(1996-2#1)(1997-1#1)(2012-5#1)
possibly related to the##2##4##(2009-11#1)(2010-12#1)
possibly related to##4##3##(2008-10#1)(2009-11#1)(2009-9#1)(2010-12#1)
possibly representing##2##2##(1991-2#1)(2011-2#1)
possibly result from##2##3##(2009-9#1)(2012-3#1)
possibly the##4##2##(1992-12#1)(2006-6#1)(2008-10#1)(2010-7#1)
possibly through##3##2##(1993-6#2)(2009-11#1)
possibly to##2##2##(2010-8#1)(2011-2#1)
possibly via a##2##3##(1997-1#1)(2007-12#1)
possibly via##5##2##(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
possibly##164##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-12#2)(2008-10#29)(2008-11#14)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#6)(2009-11#2)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-2#1)(2012-3#3)(2012-5#2)(2013-1#5)(2013-8#1)
post exercise##3##2##(2013-1#3)
post exposure##3##2##(1996-12#2)(2013-1#1)
post germinative growth and productivity of##2##6##(2008-12#2)
post hoc analysis##3##3##(2008-9#1)(2010-9#1)(2011-2#1)
post hoc##4##2##(2008-9#1)(2010-10#1)(2010-9#1)(2011-2#1)
post infection##5##2##(1995-12#1)(2008-11#4)
post inoculation##3##2##(1994-5#1)(2008-10#2)
post intervention##2##2##(2013-1#2)
post mortem##8##2##(1991-11#1)(1995-9#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-4#1)(2012-3#1)
post operative period##2##3##(2010-7#1)(2012-3#1)
post operative##5##2##(2010-7#2)(2012-2#1)(2012-3#2)
post parathyroidectomy##2##2##(2011-2#2)
post registration##4##2##(2008-11#3)(2008-12#1)
post traumatic stress disorder##2##4##(1991-2#1)(2013-8#1)
post treatment##4##2##(1996-12#1)(2010-12#2)(2010-9#1)
post##105##1##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#2)(1994-5#3)(1995-12#1)(1995-9#1)(1996-12#4)(1996-6#1)(1996-8#3)(1997-2#1)(2008-10#8)(2008-11#19)(2008-12#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-4#1)(2010-7#3)(2010-8#2)(2010-9#4)(2011-2#6)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#12)(2013-8#2)
post-##5##1##(2008-10#1)(2008-11#2)(2013-1#2)
post-PCR##2##1##(2008-10#2)
post-PTCA##2##1##(1992-9#2)
post-acute care##3##2##(1991-1#2)(1994-2#1)
post-acute rehabilitation##4##2##(1991-12#1)(1992-3#1)(1993-3#1)(1995-3#1)
post-acute##10##1##(1991-1#2)(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-3#1)
post-annealing##2##1##(2013-8#2)
post-binding##2##1##(1994-11#1)(1995-11#1)
post-burn##2##1##(2008-12#2)
post-cataract surgery optical images##2##4##(2010-8#2)
post-cataract surgery##3##2##(2010-8#3)
post-cessation weight gain##3##3##(2013-1#3)
post-cessation weight##4##2##(2013-1#4)
post-challenge##3##1##(2009-6#2)(2011-2#1)
post-chromatographic##2##1##(2008-10#2)
post-column derivatization with##2##3##(2008-10#2)
post-column derivatization##3##2##(2008-10#3)
post-column reaction##3##2##(2008-10#3)
post-column##15##1##(2008-10#15)
post-diffusion samples##2##2##(2008-11#2)
post-dose##2##1##(1995-11#1)(2008-6#1)
post-experience hour##2##2##(2008-11#2)
post-genomic era##4##2##(2010-4#1)(2011-2#1)(2012-3#2)
post-genomic##7##1##(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#3)
post-graduate##3##1##(1994-12#2)(2008-1#1)
post-hemodialysis##3##1##(2008-10#3)
post-herpetic##2##1##(2008-5#1)(2008-7#1)
post-hoc analysis##2##2##(2009-3#1)(2012-2#1)
post-hoc##5##1##(2008-10#1)(2008-8#1)(2009-3#1)(2012-2#1)(2012-3#1)
post-implant##6##1##(2008-9#6)
post-implantation##2##1##(2008-10#1)(2013-1#1)
post-infection##15##1##(1996-12#4)(2008-10#1)(2008-11#6)(2008-12#1)(2008-7#2)(2009-6#1)
post-injection##2##1##(1993-8#1)(1994-5#1)
post-injury##4##1##(2009-10#1)(2011-2#3)
post-inoculation##8##1##(2008-5#5)(2010-10#2)(2012-2#1)
post-intervention##10##1##(2008-12#8)(2011-2#1)(2013-1#1)
post-irradiation##2##1##(2011-2#1)(2013-1#1)
post-lingually deaf adults using##2##4##(2008-9#2)
post-lingually deaf adults##4##3##(2008-9#4)
post-lingually deaf##5##2##(2008-9#5)
post-lingually deafened##2##2##(2008-9#2)
post-lingually##7##1##(2008-9#7)
post-market##4##1##(2011-2#3)(2012-3#1)
post-marketing##2##1##(2008-10#1)(2008-8#1)
post-meningitic deafness##3##2##(2008-9#3)
post-menopausal women##9##2##(2008-11#3)(2008-5#2)(2011-2#1)(2013-1#2)(2013-8#1)
post-menopausal##15##1##(1993-1#2)(2008-10#1)(2008-11#5)(2008-5#2)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
post-mortem cerebral cortex##2##3##(1996-12#2)
post-mortem human brain tissue##2##4##(1996-12#2)
post-mortem##14##1##(1991-11#1)(1992-3#3)(1996-12#4)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
post-natal##2##1##(2008-11#1)(2008-12#1)
post-obturation##2##1##(2012-3#2)
post-operation##2##1##(2008-7#1)(2008-9#1)
post-operative cardiac surgical patients##2##4##(2008-12#2)
post-operative complications##2##2##(1990-9#1)(2012-2#1)
post-operative pain##2##2##(2008-11#2)
post-operative period##2##2##(2008-11#1)(2013-1#1)
post-operative##27##1##(1990-9#2)(1997-7#1)(2008-11#3)(2008-12#2)(2008-2#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#3)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#1)
post-operatively and##2##2##(2011-2#1)(2012-2#1)
post-operatively##3##1##(2008-9#1)(2011-2#1)(2012-2#1)
post-oxidation##2##1##(2012-12#2)
post-partum period##2##2##(1994-3#1)(2010-11#1)
post-partum##3##1##(1994-3#2)(2010-11#1)
post-prandial##6##1##(1994-12#1)(2008-6#5)
post-processing##2##1##(2009-10#1)(2012-2#1)
post-radioiodine hypothyroidism##2##2##(2008-11#2)
post-receptor##4##1##(1994-12#2)(1996-2#1)(2009-7#1)
post-registration students##2##2##(2008-11#1)(2008-12#1)
post-registration##9##1##(2008-11#8)(2008-12#1)
post-session##2##1##(2013-1#2)
post-spike##2##1##(1990-12#1)(1996-2#1)
post-stimulus##4##1##(1990-5#1)(1996-2#3)
post-stroke##3##1##(2008-7#1)(2009-10#2)
post-surgery##3##1##(2008-12#1)(2011-2#1)(2013-1#1)
post-surgical##5##1##(1991-1#1)(2007-8#1)(2010-3#1)(2011-1#1)(2012-2#1)
post-synaptic##3##1##(1996-2#1)(1997-5#1)(2008-11#1)
post-target mechanisms##2##2##(2008-11#2)
post-test and##2##2##(2008-12#2)
post-test##12##1##(1993-1#1)(1994-1#3)(1996-1#1)(1996-5#1)(2008-11#1)(2008-12#2)(2010-12#1)(2013-1#2)
post-training##4##1##(1991-2#2)(2008-12#1)(2008-6#1)
post-transcriptional gene##3##2##(1993-12#1)(2008-10#1)(2013-8#1)
post-transcriptional level##2##2##(2010-11#1)(2011-2#1)
post-transcriptional##16##1##(1991-6#1)(1992-1#2)(1993-12#1)(1995-6#1)(1996-12#2)(2008-10#2)(2008-11#1)(2008-9#2)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
post-transcriptionally by##2##2##(1994-11#1)(2011-2#1)
post-transcriptionally##4##1##(1994-11#1)(2010-7#1)(2011-2#2)
post-translational modification of##2##3##(1997-1#1)(2013-1#1)
post-translational modification##8##2##(1990-8#1)(1997-1#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2013-1#2)
post-translational modifications of the##2##4##(1994-8#1)(2008-11#1)
post-translational modifications of##3##3##(1994-8#1)(2008-11#1)(2011-2#1)
post-translational modifications on##2##3##(2008-11#1)(2008-4#1)
post-translational modifications##13##2##(1992-6#1)(1994-8#1)(2008-11#5)(2008-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
post-translational processing##3##2##(1995-8#3)
post-translational##42##1##(1990-8#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-8#1)(1995-6#1)(1995-8#3)(1997-1#1)(2008-1#1)(2008-11#5)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#1)
post-translationally modified##4##2##(2008-4#1)(2009-5#1)(2009-7#1)(2011-1#1)
post-translationally##6##1##(1996-12#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)
post-transplant##7##1##(2007-11#3)(2008-10#2)(2010-11#1)(2011-3#1)
post-traumatic stress disorder (PTSD)##4##4##(2008-6#1)(2012-12#2)(2013-8#1)
post-traumatic stress disorder##7##3##(2008-6#2)(2012-12#2)(2012-2#1)(2013-8#2)
post-traumatic stress##8##2##(1991-2#1)(2008-6#2)(2012-12#2)(2012-2#1)(2013-8#2)
post-traumatic##16##1##(1990-9#1)(1991-2#1)(1997-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
post-treatment##19##1##(1992-9#2)(1994-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#2)(2010-12#1)(2011-2#1)(2013-1#6)
post-vaccination##2##1##(2008-5#1)(2009-12#1)
postadmission##3##1##(2008-3#2)(2010-11#1)
postal questionnaire##3##2##(2008-1#1)(2008-9#1)(2011-1#1)
postal questionnaires and##2##3##(2008-11#1)(2009-6#1)
postal survey##4##2##(1997-4#1)(1997-8#1)(2011-2#1)(2012-2#1)
postal##10##1##(1997-4#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
postamplifier##2##1##(2008-3#2)
postanthesis##2##1##(2008-10#2)
postbloom##9##1##(2008-10#9)
postburn##2##1##(2008-8#2)
postcastration syndrome##2##2##(2008-11#2)
postconcussive symptoms##2##2##(2013-1#2)
postcontrast##2##1##(2008-7#1)(2013-8#1)
postdischarge##2##1##(2008-11#2)
postdoctoral##2##1##(1994-12#1)(1997-2#1)
postdonation platelet##2##2##(2011-2#2)
posted for##3##2##(1994-1#1)(2010-5#1)(2010-7#1)
posted##4##1##(1994-1#1)(2008-11#1)(2010-5#1)(2010-7#1)
postemergence##2##1##(2008-10#2)
poster##2##1##(2008-12#1)(2011-2#1)
posterior and##3##2##(1994-9#1)(2008-12#1)(2011-7#1)
posterior approach##4##2##(2008-9#1)(2011-2#3)
posterior canal wall during##2##4##(2008-9#2)
posterior canal wall##4##3##(2008-9#4)
posterior canal##5##2##(2008-9#4)(2012-12#1)
posterior capsule##2##2##(2011-2#2)
posterior cerebral artery (PCA)##2##4##(1997-6#1)(2008-7#1)
posterior cerebral##3##2##(1997-6#2)(2008-7#1)
posterior cervical space##2##3##(1997-6#2)
posterior cervical##5##2##(1997-6#2)(2011-2#1)(2012-3#2)
posterior chamber##2##2##(1991-2#1)(2011-2#1)
posterior circulation##7##2##(1993-3#1)(2008-7#4)(2012-3#2)
posterior cruciate ligament (PCL)##2##4##(2009-7#1)(2013-1#1)
posterior elements of the upper##2##5##(2013-1#2)
posterior elements of the##3##4##(2012-3#1)(2013-1#2)
posterior epidural##2##2##(2011-2#2)
posterior facets##2##2##(2011-2#2)
posterior fossa and##2##3##(1996-6#1)(2008-7#1)
posterior fossa##14##2##(1993-1#1)(1996-6#2)(1996-9#1)(2008-7#6)(2009-9#1)(2011-2#3)
posterior instrumentation to the##2##4##(2008-8#2)
posterior instrumentation##3##2##(2008-8#3)
posterior lobe##5##2##(1992-9#2)(1997-8#1)(2012-3#2)
posterior mediastinal##2##2##(2012-3#2)
posterior only##2##2##(2008-8#2)
posterior parietal##3##2##(1996-2#1)(2008-11#1)(2009-10#1)
posterior part of##2##3##(2011-2#2)
posterior pituitary##5##2##(1997-8#4)(2008-4#1)
posterior region##2##2##(2007-12#2)
posterior tibial artery##2##3##(2013-1#2)
posterior tibial##4##2##(1990-11#1)(2008-8#1)(2013-1#2)
posterior to##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
posterior tympanotomy##2##2##(2008-9#2)
posterior urethra##4##2##(2008-10#4)
posterior urethral valve##5##3##(2008-10#2)(2011-2#3)
posterior urethral valves##5##3##(2008-10#5)
posterior urethral##10##2##(2008-10#7)(2011-2#3)
posterior uterine##2##2##(1993-1#1)(2011-2#1)
posterior wall##5##2##(1997-8#1)(2008-7#1)(2011-2#2)(2013-1#1)
posterior##227##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#2)(1991-6#5)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-9#2)(1995-2#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-9#2)(1997-3#5)(1997-6#4)(1997-8#8)(2007-12#11)(2008-10#17)(2008-11#7)(2008-12#8)(2008-4#1)(2008-5#1)(2008-7#22)(2008-8#18)(2008-9#9)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#32)(2011-7#2)(2012-12#5)(2012-2#5)(2012-3#13)(2013-1#11)(2013-8#1)
posterior-only##4##1##(2008-8#2)(2009-3#1)(2012-3#1)
posterioris##3##1##(2008-6#3)
posterolateral knee pain##2##3##(2011-2#2)
posterolateral##11##1##(2008-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#3)
posteromedial fragment##2##2##(2013-1#2)
posteromedial##7##1##(2009-3#1)(2011-2#2)(2013-1#4)
posters##5##1##(1996-2#1)(2008-3#1)(2008-5#1)(2013-1#2)
postexercise##4##1##(2013-1#1)(2013-8#3)
postexposure prophylaxis##2##2##(2012-3#2)
postexposure##3##1##(2008-3#1)(2012-3#2)
postflame region of##2##3##(2008-2#1)(2008-3#1)
postflame region##4##2##(2008-2#2)(2008-3#2)
postflame##6##1##(2008-2#2)(2008-3#4)
postgraduate education##3##2##(1993-6#1)(1994-12#1)(2011-2#1)
postgraduate students in India##2##4##(2013-1#2)
postgraduate students##3##2##(2008-11#1)(2013-1#2)
postgraduate training##4##2##(1992-5#1)(1993-11#1)(1994-12#1)(1997-5#1)
postgraduate##26##1##(1991-2#1)(1992-1#2)(1992-5#1)(1993-11#1)(1993-6#1)(1994-12#8)(1994-3#1)(1997-5#1)(2008-10#1)(2008-11#3)(2009-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
postharvest biocontrol##2##2##(2008-10#2)
postharvest blue mold##2##3##(2008-10#2)
postharvest decay##3##2##(2008-10#3)
postharvest fungal##2##2##(2008-10#2)
postharvest pathogen##4##2##(2008-10#4)
postharvest pathogens##4##2##(2008-10#4)
postharvest##34##1##(2008-10#34)
postherpetic##2##1##(1994-3#1)(2008-9#1)
postictal behavioral depression##2##3##(1992-12#2)
postimplantation##2##1##(1993-12#1)(1995-2#1)
postinfection##10##1##(2008-10#7)(2008-5#1)(2009-8#2)
postinfectious##5##1##(1993-3#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
postinjection##2##1##(1991-9#1)(1993-1#1)
postinjury##2##1##(2008-7#2)
postinoculation and##2##2##(2008-10#2)
postinoculation##23##1##(2008-10#23)
postinstitutionalized Romanian##2##2##(2008-11#2)
postinstitutionalized##3##1##(2008-11#3)
postintervention##5##1##(2010-7#1)(2013-1#4)
postlabeling assay of AAF modified##2##5##(1991-5#2)
postlabeling assay##3##2##(1991-5#3)
postlabeling##6##1##(1991-5#6)
postlesion##13##1##(1993-6#1)(1997-3#12)
postlingually and prelingually deafened##2##4##(2008-9#2)
postlingually deafened adult##2##3##(2008-9#2)
postlingually deafened adults##2##3##(2008-9#2)
postlingually deafened##6##2##(2008-9#6)
postlingually##8##1##(2008-9#8)
postmarketing##4##1##(2008-11#3)(2013-1#1)
postmastectomy##2##1##(2013-1#2)
postmating barriers##3##2##(2008-6#1)(2012-3#2)
postmenopausal or climacteric bleeding##2##4##(1992-12#2)
postmenopausal patients##4##2##(1994-12#2)(1994-2#1)(2010-7#1)
postmenopausal women were##3##3##(1992-1#1)(1992-3#1)(1994-12#1)
postmenopausal women##12##2##(1992-1#3)(1992-3#3)(1993-2#1)(1994-12#1)(2008-11#2)(2010-12#1)(2012-3#1)
postmenopausal##23##1##(1992-1#4)(1992-12#2)(1992-3#3)(1993-11#1)(1993-2#1)(1994-12#3)(1994-2#1)(2008-11#3)(2010-12#1)(2010-7#1)(2012-3#3)
postmortem examination##2##2##(2013-1#1)(2013-8#1)
postmortem studies have##2##3##(2008-7#1)(2013-1#1)
postmortem##13##1##(1990-11#1)(1991-3#1)(1993-9#1)(1996-12#2)(1997-3#1)(2008-12#1)(2008-7#3)(2013-1#2)(2013-8#1)
postnatal day##10##2##(1991-2#1)(1993-3#2)(1995-6#1)(1996-12#3)(2008-10#1)(2008-7#1)(2012-12#1)
postnatal development##6##2##(1992-6#2)(1996-1#1)(2009-8#1)(2011-2#2)
postnatal period##6##2##(1990-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-1#1)
postnatal##59##1##(1990-5#4)(1991-2#2)(1991-6#1)(1992-12#1)(1992-6#3)(1993-12#1)(1993-3#4)(1994-11#3)(1994-2#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#5)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-1#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)
postnatally to##2##2##(1996-2#1)(1997-3#1)
postnatally##4##1##(1995-11#1)(1996-2#1)(1997-3#1)(2012-3#1)
postoperative CSF leak and wound dehiscence##2##6##(2008-7#2)
postoperative LOS##2##2##(1994-3#2)
postoperative adhesion formation or reproductive##2##5##(1992-3#2)
postoperative adhesion formation##4##3##(1992-3#4)
postoperative adhesions##4##2##(1992-3#2)(1995-2#2)
postoperative bleeding##3##2##(1990-3#1)(2008-7#1)(2011-3#1)
postoperative care##4##2##(1990-9#1)(1991-3#1)(2010-7#2)
postoperative complication##4##2##(1991-3#1)(2008-9#1)(2011-2#2)
postoperative complications were##2##3##(1994-2#1)(2008-9#1)
postoperative complications##16##2##(1992-2#1)(1994-2#2)(1997-3#1)(2008-12#1)(2008-9#1)(2011-2#3)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
postoperative course was uneventful and##2##5##(2008-10#1)(2008-12#1)
postoperative course was uneventful##4##4##(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)
postoperative course was##7##3##(1992-9#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#2)
postoperative course##10##2##(1992-9#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#4)(2013-1#2)
postoperative day##15##2##(1993-1#1)(1994-6#1)(2008-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2011-2#1)(2012-12#2)(2013-1#3)
postoperative hospital mortality and morbidity after##2##6##(2011-2#2)
postoperative ileus##3##2##(2010-4#2)(2013-1#1)
postoperative immobilization##3##2##(2009-3#3)
postoperative infections##2##2##(1990-11#1)(2008-9#1)
postoperative irradiation##2##2##(1990-9#1)(1994-8#1)
postoperative management##2##2##(2011-3#1)(2013-1#1)
postoperative morbidity##8##2##(1991-8#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-7#3)(2012-3#1)
postoperative mortality was##2##3##(2008-7#1)(2011-3#1)
postoperative mortality##3##2##(2008-7#1)(2011-2#1)(2011-3#1)
postoperative neurological deficit##2##3##(2008-7#1)(2011-2#1)
postoperative neurological##3##2##(1992-5#1)(2008-7#1)(2011-2#1)
postoperative pain characteristics##2##3##(2010-6#2)
postoperative pain management##3##3##(1992-8#1)(2010-6#1)(2012-3#1)
postoperative pain relief##2##3##(2010-11#2)
postoperative pain##25##2##(1992-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-11#8)(2010-6#4)(2010-7#4)(2012-3#1)(2013-1#2)
postoperative patients with ARM##2##4##(2011-2#2)
postoperative patients with##3##3##(2010-4#1)(2011-2#2)
postoperative patients##5##2##(2010-11#1)(2010-4#1)(2011-2#3)
postoperative period##15##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1994-3#1)(2007-11#1)(2008-8#1)(2010-10#2)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#3)
postoperative pulmonary##2##2##(2011-2#1)(2012-2#1)
postoperative radiotherapy##3##2##(1990-12#1)(1994-8#1)(2008-7#1)
postoperative recovery##3##2##(1996-3#1)(2010-5#1)(2012-3#1)
postoperative rehabilitation##2##2##(2010-10#1)(2013-1#1)
postoperative scar##2##2##(2011-2#2)
postoperative shivering##6##2##(2010-7#6)
postoperative speech##2##2##(2008-9#2)
postoperative time##2##2##(2011-2#2)
postoperative treatment##3##2##(1990-12#1)(1990-9#1)(1992-9#1)
postoperative##258##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#5)(1991-11#1)(1991-2#6)(1991-3#4)(1991-6#1)(1991-8#3)(1992-2#2)(1992-3#7)(1992-5#2)(1992-8#1)(1992-9#3)(1993-1#3)(1993-12#3)(1993-2#2)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#8)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#2)(1996-3#3)(1997-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-7#20)(2008-8#3)(2008-9#9)(2009-2#1)(2009-3#5)(2009-5#2)(2010-10#3)(2010-11#9)(2010-12#3)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#7)(2010-7#13)(2010-8#3)(2011-2#28)(2011-3#7)(2011-7#1)(2012-12#7)(2012-2#4)(2012-3#12)(2013-1#22)
postoperatively and##4##2##(1990-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
postoperatively in##4##2##(1993-12#2)(2007-8#1)(2011-2#1)
postoperatively##55##1##(1990-2#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-1#4)(1993-12#3)(1994-1#1)(1994-3#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#2)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
postpandemic season##2##2##(2013-1#2)
postpandemic##3##1##(2013-1#3)
postpartum checkup##4##2##(2013-1#4)
postpartum contraceptive use##2##3##(2013-1#2)
postpartum depressive##2##2##(2010-6#1)(2013-1#1)
postpartum hysterectomy##3##2##(1995-12#3)
postpartum women##2##2##(1996-8#1)(2013-1#1)
postpartum##31##1##(1995-12#3)(1996-11#1)(1996-3#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#4)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#10)(2013-8#1)
postpone##4##1##(1990-11#1)(1996-11#1)(2009-12#1)(2012-12#1)
postponed##7##1##(1991-11#1)(1994-2#1)(1995-6#1)(2009-7#1)(2010-5#1)(2013-1#2)
postponement##3##1##(1991-6#1)(1992-2#1)(2008-11#1)
postprandial blood##2##2##(1994-12#1)(2012-3#1)
postprandial##18##1##(1994-12#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-12#1)(2010-10#1)(2010-8#2)(2011-1#3)(2012-3#3)(2012-4#1)
postprocessing##4##1##(2008-3#4)
postproduction##2##1##(1993-2#1)(2010-4#1)
posts##6##1##(1996-8#1)(2008-11#4)(2012-2#1)
postsecondary education##4##2##(1992-3#1)(1995-3#1)(2007-12#1)(2008-11#1)
postsecondary##6##1##(1992-3#2)(1995-3#1)(2007-12#1)(2008-11#1)(2011-2#1)
postspawning mass##3##2##(2010-8#3)
postspawning##4##1##(2010-8#4)
poststroke patients##2##2##(2013-1#2)
poststroke##4##1##(2009-11#1)(2013-1#3)
postsupplementation##4##1##(2013-8#4)
postsurgery##3##1##(1991-3#1)(1992-12#1)(2008-12#1)
postsurgical##6##1##(1995-12#3)(2009-9#1)(2010-11#1)(2011-3#1)
postsynaptic densities##4##2##(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)
postsynaptic density##5##2##(1996-12#3)(2008-11#1)(2012-2#1)
postsynaptic differentiation at the##2##4##(2009-8#2)
postsynaptic differentiation##3##2##(2009-8#3)
postsynaptic neurons##3##2##(2008-11#2)(2009-8#1)
postsynaptic##47##1##(1990-12#1)(1990-9#1)(1992-3#2)(1993-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#9)(1997-2#5)(1997-3#2)(1997-7#3)(2008-11#6)(2008-7#1)(2009-8#5)(2009-9#3)(2010-1#1)(2011-2#1)(2012-2#1)
postsynaptically##2##1##(1992-3#1)(2012-3#1)
posttest##8##1##(2008-12#2)(2010-10#1)(2010-4#2)(2011-1#1)(2012-2#2)
posttranscriptional gene silencing (PTGS)##2##4##(2008-10#2)
posttranscriptional gene silencing##4##3##(2008-10#3)(2012-3#1)
posttranscriptional gene##5##2##(2008-10#3)(2012-3#1)(2013-1#1)
posttranscriptional##13##1##(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
posttranslational modifications##3##2##(1991-6#1)(2009-3#1)(2012-2#1)
posttranslational processing of the##2##4##(1991-7#1)(1993-8#1)
posttranslational processing of##3##3##(1991-7#1)(1992-10#1)(1993-8#1)
posttranslational processing##4##2##(1991-7#1)(1992-10#1)(1993-12#1)(1993-8#1)
posttranslational##13##1##(1991-6#1)(1991-7#1)(1992-10#2)(1992-12#1)(1993-12#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-4#1)(2012-2#1)
posttransplant (median##2##2##(2011-2#2)
posttransplant##3##1##(2011-2#2)(2012-12#1)
posttraumatic cerebrospinal fluid##2##3##(2008-12#2)
posttraumatic stress disorder (PTSD)##2##4##(2009-11#1)(2010-10#1)
posttraumatic stress disorder##5##3##(2009-11#2)(2010-10#1)(2013-1#1)(2013-8#1)
posttraumatic stress symptoms##2##3##(2009-11#2)
posttraumatic stress##9##2##(2009-11#4)(2010-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
posttraumatic##17##1##(2007-8#1)(2008-12#3)(2008-9#1)(2009-11#4)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
posttreatment##4##1##(1991-1#1)(2008-10#2)(2012-2#1)
postulate that the##4##3##(1996-12#1)(2008-11#1)(2008-5#1)(2008-9#1)
postulate that##11##2##(1994-12#2)(1996-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
postulate the##2##2##(1995-3#1)(2009-10#1)
postulate##17##1##(1990-8#1)(1992-6#1)(1994-12#2)(1995-3#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2012-3#1)(2013-8#1)
postulated and##2##2##(2008-8#1)(2010-10#1)
postulated that the##2##3##(2008-10#2)
postulated that##12##2##(1990-5#1)(1991-2#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2013-1#1)
postulated the##2##2##(2008-7#1)(2008-8#1)
postulated to be a##3##4##(2008-7#2)(2012-2#1)
postulated to be in##2##4##(1994-5#1)(2008-10#1)
postulated to be##9##3##(1994-5#1)(2008-10#4)(2008-7#3)(2012-2#1)
postulated to##14##2##(1994-3#1)(1994-5#1)(1995-2#1)(2008-10#6)(2008-2#1)(2008-7#3)(2012-2#1)
postulated##45##1##(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-8#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-5#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
postulates##9##1##(2008-10#8)(2009-6#1)
postural and movement##3##3##(2008-12#3)
postural and##5##2##(1991-2#1)(2008-12#3)(2008-7#1)
postural changes##4##2##(2008-12#2)(2010-12#1)(2011-2#1)
postural perturbations##2##2##(2013-1#2)
postural stability##2##2##(2010-12#1)(2010-9#1)
postural##26##1##(1991-2#2)(2008-1#1)(2008-12#7)(2008-7#3)(2009-11#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#6)(2013-8#1)
posture and##2##2##(1991-2#1)(2008-12#1)
posture in##2##2##(2007-12#1)(2010-9#1)
posture on##2##2##(2010-9#1)(2012-3#1)
posture##20##1##(1991-2#1)(1993-3#1)(2007-12#1)(2008-12#1)(2009-8#4)(2010-9#7)(2012-3#4)(2013-8#1)
postures##2##1##(2008-12#1)(2010-12#1)
postzygotic##5##1##(2008-10#2)(2012-3#3)
pot experiments##3##2##(2008-10#3)
pot##12##1##(1996-12#1)(1996-5#1)(2008-10#9)(2009-10#1)
pot(-1) and##2##2##(2008-10#1)(2008-12#1)
pot(-1)##4##1##(2008-10#3)(2008-12#1)
potable water##4##2##(2008-10#4)
potable##5##1##(2008-10#5)
potassium and calcium##2##3##(2008-10#2)
potassium and magnesium##2##3##(1997-8#1)(2008-10#1)
potassium and sodium##2##3##(2008-10#2)
potassium and##12##2##(1993-1#2)(1997-8#1)(2008-10#7)(2008-12#1)(2012-2#1)
potassium bromate##8##2##(2008-10#7)(2008-9#1)
potassium bromide##6##2##(2008-10#6)
potassium channel##7##2##(1994-11#3)(1994-12#1)(1997-2#3)
potassium channels##7##2##(1990-8#1)(1992-6#2)(1994-12#1)(1996-2#2)(2009-8#1)
potassium chlorate##3##2##(2008-10#3)
potassium chloride and##5##3##(1996-6#1)(2008-10#4)
potassium chloride solution##2##3##(1992-3#1)(2008-10#1)
potassium chloride##11##2##(1992-3#1)(1996-6#1)(2008-10#9)
potassium concentration##2##2##(1993-1#1)(2009-8#1)
potassium concentrations##3##2##(1995-8#2)(2008-10#1)
potassium currents in##2##3##(1993-3#1)(2010-12#1)
potassium currents##4##2##(1993-3#1)(1996-2#1)(1997-2#1)(2010-12#1)
potassium cyanide##2##2##(2008-10#1)(2008-7#1)
potassium dichromate##3##2##(2008-10#3)
potassium dihydrogen phosphate##2##3##(2008-10#1)(2008-5#1)
potassium ferricyanide##9##2##(2008-10#8)(2009-9#1)
potassium ferrocyanide##2##2##(2008-10#2)
potassium hexacyanoferrate(III)##6##2##(2008-10#6)
potassium hydrogen phthalate##4##3##(2008-10#4)
potassium hydrogen##5##2##(2008-10#5)
potassium hydroxide and##2##3##(2008-10#2)
potassium hydroxide solution##3##3##(2008-10#3)
potassium hydroxide##8##2##(2008-10#8)
potassium iodate and##2##3##(2008-10#2)
potassium iodide (KI)##2##3##(2008-10#2)
potassium iodide and##3##3##(2008-10#3)
potassium iodide##11##2##(2008-10#11)
potassium ion in##2##3##(2008-10#2)
potassium ion##10##2##(2008-10#9)(2011-2#1)
potassium ions in##2##3##(2008-10#2)
potassium ions##4##2##(2008-10#4)
potassium nitrate##4##2##(2008-10#3)(2008-5#1)
potassium periodate##6##2##(2008-10#6)
potassium permanganate and##3##3##(2008-10#3)
potassium permanganate in##8##3##(2008-10#8)
potassium permanganate##20##2##(2008-10#20)
potassium permanganate-sodium sulfite##2##3##(2008-10#2)
potassium phosphate buffer (pH##3##4##(2008-10#3)
potassium phosphate##9##2##(2008-10#6)(2008-5#1)(2008-7#2)
potassium poly (vinyl sulfate) (PVSK)##2##5##(2008-10#2)
potassium tetrakis##2##2##(2008-10#2)
potassium tetrakis(4-chlorophenyl)borate as##2##3##(2008-10#2)
potassium tetrakis(4-chlorophenyl)borate##3##2##(2008-10#3)
potassium tetrakis(p-chlorophenyl)borate (KTpClPB)##2##3##(2008-10#2)
potassium tetrakis(p-chlorophenyl)borate##3##2##(2008-10#3)
potassium titanyl phosphate (KTP)##2##4##(2008-10#1)(2008-3#1)
potassium titanyl phosphate##3##3##(2008-10#2)(2008-3#1)
potassium was##3##2##(1993-1#1)(2008-10#2)
potassium##269##1##(1990-8#1)(1991-5#3)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#5)(1993-3#1)(1994-11#3)(1994-12#2)(1995-11#2)(1995-8#4)(1996-2#3)(1996-5#2)(1996-6#1)(1997-2#5)(1997-8#2)(2008-10#199)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#2)
potassium-selective electrode##3##2##(2008-10#3)
potassium-selective##5##1##(2008-10#5)
potato and tomato production##2##4##(2008-10#2)
potato and tomato##16##3##(2008-10#16)
potato and##26##2##(2008-10#26)
potato based ready-to-eat food products##3##5##(2011-2#3)
potato collected##2##2##(2008-10#2)
potato crops in##2##3##(2008-10#2)
potato crops##6##2##(2008-10#6)
potato cultivar##3##2##(2008-10#3)
potato cultivars##10##2##(2008-10#10)
potato cv##5##2##(2008-10#5)
potato cvs##3##2##(2008-10#3)
potato cyst nematode##2##3##(2008-10#2)
potato cyst##3##2##(2008-10#3)
potato dextrose agar##12##3##(2008-10#12)
potato dextrose##15##2##(2008-10#15)
potato differentials##4##2##(2008-10#4)
potato feathery mottle##5##3##(2008-10#5)
potato fields in##4##3##(2008-10#4)
potato fields##5##2##(2008-10#5)
potato growers##2##2##(2008-10#2)
potato had a##2##3##(2008-10#2)
potato in##2##2##(2008-10#2)
potato isolate##2##2##(2008-10#2)
potato isolates collected in##2##4##(2008-10#2)
potato isolates##7##2##(2008-10#7)
potato late blight##13##3##(2008-10#13)
potato leafroll virus##3##3##(2008-10#3)
potato leaves##4##2##(2008-10#4)
potato mixtures##2##2##(2008-10#2)
potato or tomato##2##3##(2008-10#2)
potato or##4##2##(2008-10#3)(2008-5#1)
potato plants were##2##3##(2008-10#1)(2008-8#1)
potato plants##10##2##(2008-10#8)(2008-8#1)(2009-6#1)
potato production##6##2##(2008-10#5)(2008-12#1)
potato samples##3##2##(2008-10#3)
potato seed tubers##3##3##(2008-10#3)
potato seed##4##2##(2008-10#4)
potato stems##2##2##(2008-10#2)
potato stocks##2##2##(2008-10#2)
potato tissue##2##2##(2008-10#2)
potato tuber discs##2##3##(2008-10#2)
potato tuber##7##2##(2008-10#7)
potato tubers##6##2##(2008-10#6)
potato virus X (PVX)##2##4##(1997-3#1)(2008-10#1)
potato virus Y##5##3##(2008-10#5)
potato virus##10##2##(1997-3#1)(2008-10#9)
potato##285##1##(1993-12#2)(1997-3#1)(2008-10#262)(2008-12#4)(2008-5#1)(2008-8#4)(2008-9#1)(2009-6#4)(2010-4#2)(2011-2#4)
potatoes and##6##2##(2008-10#6)
potatoes in the##3##3##(2008-10#3)
potatoes in##6##2##(2008-10#6)
potatoes##18##1##(1990-8#1)(2008-10#16)(2008-9#1)
potencies and##2##2##(1994-8#1)(2008-12#1)
potencies of##5##2##(1991-3#2)(1992-9#1)(1995-11#2)
potencies##15##1##(1990-12#1)(1991-3#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-11#3)(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)
potency and##5##2##(1991-1#1)(1992-3#1)(1993-8#2)(1997-1#1)
potency as##2##2##(1997-4#1)(2008-12#1)
potency for##4##2##(1995-11#1)(1995-12#2)(2008-10#1)
potency in the aerosol##2##4##(1991-1#2)
potency in the##3##3##(1991-1#3)
potency in##8##2##(1991-1#3)(1991-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)
potency of the##4##3##(1991-1#1)(1994-8#1)(1996-12#1)(2008-5#1)
potency of these##2##3##(1995-3#1)(2008-11#1)
potency of##24##2##(1991-1#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-8#5)(1995-11#2)(1995-3#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-5#4)
potency to##6##2##(1993-12#1)(1994-8#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#1)
potency##90##1##(1990-12#2)(1991-1#6)(1991-12#1)(1991-3#3)(1992-3#3)(1993-12#3)(1993-6#2)(1993-8#4)(1994-11#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#7)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-12#4)(1997-1#1)(1997-4#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#10)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
potent CYP26 inhibitors##2##3##(2008-8#2)
potent activator##2##2##(1990-2#1)(1993-8#1)
potent activity against##2##3##(2011-2#1)(2011-3#1)
potent activity with##2##3##(2008-11#1)(2011-2#1)
potent activity##6##2##(2008-11#1)(2008-5#1)(2011-2#3)(2011-3#1)
potent agonist##2##2##(1995-11#1)(1997-7#1)
potent and selective##4##3##(1990-8#1)(1992-8#1)(1994-2#1)(2008-5#1)
potent and##10##2##(1990-8#1)(1992-8#1)(1994-11#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
potent anti-HIV activities##3##3##(2011-3#3)
potent anti-HIV##5##2##(1991-3#1)(2011-3#4)
potent anti-inflammatory effects##2##3##(2009-8#1)(2013-1#1)
potent anti-inflammatory##3##2##(2008-5#1)(2009-8#1)(2013-1#1)
potent anticancer##2##2##(2009-7#1)(2011-2#1)
potent antifungal##2##2##(2008-11#2)
potent antitumor activity##3##3##(1994-5#1)(2008-5#2)
potent cytotoxic##2##2##(1996-3#1)(2008-8#1)
potent drugs##2##2##(1995-3#1)(2011-2#1)
potent immunosuppressive##3##2##(1993-8#1)(1994-5#1)(2008-10#1)
potent in inhibiting the tail-flick response evoked by##2##8##(1992-3#2)
potent in inhibiting the##3##4##(1992-3#3)
potent in##8##2##(1990-12#1)(1992-3#4)(1993-1#1)(2008-12#1)(2013-1#1)
potent inhibition##2##2##(2008-5#1)(2011-1#1)
potent inhibitor of##18##3##(1990-5#1)(1992-12#1)(1993-8#1)(1994-11#4)(1994-3#1)(1995-2#1)(1996-12#2)(1997-1#1)(1997-4#2)(2008-10#1)(2008-11#2)(2011-2#1)
potent inhibitors of the##2##4##(1994-11#1)(2008-5#1)
potent inhibitors of##13##3##(1990-8#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-11#2)(2008-10#1)(2008-5#1)(2009-9#1)
potent inhibitors##15##2##(1990-8#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-11#2)(2008-10#2)(2008-5#1)(2009-9#1)(2012-2#1)
potent inhibitory activity##2##3##(2008-8#1)(2011-1#1)
potent inhibitory##3##2##(1993-1#1)(2008-8#1)(2011-1#1)
potent oxidant##2##2##(1992-10#1)(2008-10#1)
potent than the##4##3##(1990-12#1)(1992-4#1)(1994-5#1)(1994-6#1)
potent than##13##2##(1990-12#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-12#1)(2008-7#1)
potent therapeutic##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
potent tumor##2##2##(1993-8#1)(2013-1#1)
potent##237##1##(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#2)(1991-3#3)(1991-5#5)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#3)(1992-3#6)(1992-4#1)(1992-6#4)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#3)(1993-8#8)(1994-11#12)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#6)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#6)(1996-3#1)(1997-1#3)(1997-4#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#13)(2008-12#5)(2008-5#13)(2008-6#2)(2008-7#5)(2008-8#10)(2008-9#1)(2009-10#3)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#6)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
potential (0##2##2##(2008-10#2)
potential (versus##2##2##(2008-10#2)
potential 0##3##2##(2008-10#2)(2009-10#1)
potential B-cell epitopes##2##3##(2008-10#2)
potential E##2##2##(2008-10#2)
potential EF-hand##2##2##(1995-6#2)
potential N-glycosylation site##2##3##(1993-8#1)(2008-10#1)
potential ORFs##2##2##(1995-8#2)
potential ability of##2##3##(2008-10#2)
potential advantages of##5##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
potential advantages##8##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2011-7#1)(2012-2#1)
potential adverse effects##2##3##(2008-10#1)(2008-8#1)
potential adverse##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)
potential against##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
potential agent##2##2##(2008-10#1)(2008-5#1)
potential alternative##6##2##(1996-1#1)(2008-10#3)(2011-2#1)(2013-1#1)
potential analytical##2##2##(2008-10#2)
potential and cytosolic free##2##4##(1997-1#2)
potential and persistence##2##3##(2008-11#2)
potential and the##4##3##(2008-10#4)
potential and##44##2##(1991-1#1)(1993-11#1)(1994-11#2)(1994-5#1)(1997-1#3)(1997-3#1)(2008-10#20)(2008-11#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
potential antagonist##3##2##(2008-10#3)
potential anticancer##2##2##(2008-5#1)(2010-7#1)
potential application as##3##3##(2008-10#1)(2013-1#2)
potential application in##5##3##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
potential application of the##3##4##(1990-12#1)(2008-10#2)
potential application of##10##3##(1990-12#1)(2008-10#6)(2008-8#1)(2012-3#1)(2013-7#1)
potential application to the##2##4##(2008-7#1)(2012-4#1)
potential application to##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-4#1)
potential application##24##2##(1990-12#1)(2008-10#10)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#3)(2013-7#1)
potential applications in##6##3##(1995-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)
potential applications of##3##3##(2008-10#1)(2009-4#1)(2013-1#1)
potential applications to##2##3##(2007-11#1)(2013-1#1)
potential applications##13##2##(1995-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-5#1)(2013-1#2)
potential approaches##2##2##(2008-10#1)(2009-12#1)
potential are##3##2##(2008-11#1)(2008-9#2)
potential as a##10##3##(2008-10#6)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#1)
potential as an##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
potential as##19##2##(1992-3#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#2)
potential ascospore dose (PAD)##2##4##(2008-10#2)
potential at pH##2##3##(1990-5#1)(2008-10#1)
potential at the##2##3##(1991-6#1)(1997-6#1)
potential at##11##2##(1990-5#1)(1991-3#1)(1991-6#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-8#1)
potential beneficial effects of##2##4##(2008-10#1)(2008-7#1)
potential beneficial##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
potential benefit of##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
potential benefit##5##2##(1993-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
potential benefits and risks##2##4##(2008-10#1)(2010-4#1)
potential benefits and##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
potential benefits of##7##3##(1994-3#1)(1995-12#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-1#1)(2013-7#1)
potential benefits##12##2##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-7#1)
potential between##4##2##(1995-11#1)(2008-10#2)(2008-12#1)
potential bias##2##2##(2008-12#1)(2011-2#1)
potential binding sites for##2##4##(1994-11#1)(1995-8#1)
potential bioavailability##2##2##(2008-10#1)(2008-11#1)
potential biomarker##2##2##(2008-10#1)(2011-2#1)
potential biomarkers for##2##3##(2010-12#1)(2011-2#1)
potential biomarkers##5##2##(2010-12#1)(2010-5#2)(2011-2#2)
potential bleeding##2##2##(2011-2#1)(2013-1#1)
potential buffer from 10(-3) to 10(-5) M##2##7##(2008-10#2)
potential buffer solution containing##2##4##(2008-10#2)
potential buffer solution##5##3##(2008-10#5)
potential buffer##12##2##(2008-10#12)
potential by##5##2##(1997-7#1)(2008-10#2)(2008-9#1)(2012-2#1)
potential candidates for##4##3##(2008-10#1)(2009-10#1)(2009-4#1)(2010-12#1)
potential candidates##6##2##(1994-1#2)(2008-10#1)(2009-10#1)(2009-4#1)(2010-12#1)
potential cause of##3##3##(1997-6#1)(2008-4#1)(2008-7#1)
potential causes of##5##3##(2008-10#1)(2008-7#2)(2011-1#1)(2013-1#1)
potential causes##6##2##(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#1)
potential cellular##2##2##(2008-10#1)(2008-7#1)
potential change of the##2##4##(2008-10#2)
potential change##11##2##(2008-10#11)
potential changes in##2##3##(1993-3#1)(2010-6#1)
potential changes##4##2##(1993-3#1)(2008-10#2)(2010-6#1)
potential chemical##2##2##(1994-5#1)(2012-2#1)
potential clinical##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-7#1)(2012-2#1)(2013-1#1)
potential complications##3##2##(1994-5#1)(2012-12#2)
potential conditions##3##2##(2008-10#3)
potential confounders##3##2##(2013-1#3)
potential confounding factors##6##3##(2008-6#1)(2010-1#3)(2010-11#1)(2013-1#1)
potential confounding##7##2##(2008-4#1)(2008-6#1)(2010-1#3)(2010-11#1)(2013-1#1)
potential contamination##2##2##(2008-11#1)(2012-2#1)
potential cosmetic odourants##2##3##(2008-5#2)
potential cosmetic##3##2##(2008-5#3)
potential curves##2##2##(2008-10#2)
potential cycling in##2##3##(2008-10#2)
potential detrimental##2##2##(1995-5#1)(2010-1#1)
potential diagnostic##3##2##(1992-11#1)(2011-2#1)(2013-8#1)
potential difference between the two electrodes##2##6##(2008-10#2)
potential difference##7##2##(2008-10#4)(2008-12#2)(2008-8#1)
potential disease##4##2##(2008-10#2)(2008-12#1)(2009-12#1)
potential drug##4##2##(1994-5#1)(2008-11#1)(2011-1#1)(2012-2#1)
potential due to##3##3##(2008-10#2)(2008-5#1)
potential effect of##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
potential effect##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
potential effectiveness of##2##3##(2008-11#1)(2010-12#1)
potential effects of the##2##4##(2008-10#1)(2008-11#1)
potential effects of##6##3##(1991-5#1)(2008-10#1)(2008-11#2)(2010-8#1)(2013-1#1)
potential effects on##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
potential effects##9##2##(1991-12#1)(1991-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-8#1)(2013-1#1)
potential efficacy##4##2##(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
potential energy##3##2##(1995-3#1)(2008-10#2)
potential estrogenic##2##2##(2008-10#2)
potential exposure##2##2##(1990-8#1)(2012-3#1)
potential for application##2##3##(1994-11#1)(2008-10#1)
potential for decreasing in##4##4##(2008-10#4)
potential for distant##2##3##(1997-7#1)(2008-5#1)
potential for enhancing##2##3##(2007-12#1)(2009-1#1)
potential for further development##2##4##(2008-10#1)(2011-2#1)
potential for further##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
potential for improved##3##3##(2008-3#1)(2008-9#2)
potential for improving##2##3##(2008-10#1)(2012-2#1)
potential for outcrossing in##2##4##(2008-10#2)
potential for outcrossing##4##3##(2008-10#4)
potential for preventing##2##3##(2008-11#1)(2008-5#1)
potential for recovery##2##3##(2008-7#2)
potential for regeneration##2##3##(2008-11#1)(2013-1#1)
potential for studying##2##3##(2008-8#1)(2010-11#1)
potential for the development of##2##5##(2008-10#1)(2008-11#1)
potential for the##10##3##(1992-1#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
potential for use as##2##4##(2008-11#1)(2008-7#1)
potential for use in##2##4##(2008-10#2)
potential for use##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
potential for##142##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1994-11#1)(1995-1#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#35)(2008-11#17)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#5)(2009-1#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#3)
potential from##6##2##(2008-10#5)(2008-12#1)
potential function##2##2##(2008-11#1)(2011-2#1)
potential gains and##2##3##(2011-7#1)(2013-1#1)
potential genetic biomarkers##2##3##(2011-2#2)
potential genetic##4##2##(2008-7#1)(2011-2#3)
potential has##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
potential have##3##2##(1994-2#1)(2008-11#1)(2008-9#1)
potential hazard##2##2##(1994-11#1)(2008-5#1)
potential hazards of##2##3##(2008-10#1)(2008-9#1)
potential hazards##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
potential health##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)
potential high##2##2##(2010-10#1)(2012-12#1)
potential immunotoxicity of chemicals##2##4##(2008-10#2)
potential immunotoxicity##3##2##(2008-10#3)
potential impact of these##2##4##(2008-10#1)(2008-7#1)
potential impact of##8##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#2)
potential impact on##4##3##(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#1)
potential impact##14##2##(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-8#2)
potential implications for##2##3##(1996-2#1)(2008-10#1)
potential implications##3##2##(1996-2#1)(2007-12#1)(2008-10#1)
potential importance##5##2##(1997-8#1)(2008-10#1)(2008-7#1)(2010-1#1)(2010-7#1)
potential improvement##2##2##(1997-1#1)(2012-2#1)
potential in a##2##3##(2008-10#1)(2008-11#1)
potential in comparison to##2##4##(2008-10#2)
potential in developing##2##3##(2008-1#1)(2008-10#1)
potential in the##7##3##(2008-10#5)(2008-11#1)(2008-12#1)
potential in##35##2##(1995-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-3#1)(2012-2#1)(2013-1#1)
potential indicator##2##2##(1993-3#1)(2008-10#1)
potential indicators of##2##3##(2008-10#1)(2012-3#1)
potential industrial##2##2##(2008-11#1)(2013-1#1)
potential inhibitors of##2##3##(2008-11#1)(2011-2#1)
potential inhibitory##2##2##(2009-12#1)(2011-3#1)
potential interaction##2##2##(1990-6#1)(1995-6#1)
potential interference##5##2##(2008-10#5)
potential interferences##5##2##(2008-10#5)
potential interferents##4##2##(2008-10#4)
potential interfering species##2##3##(2008-10#2)
potential interfering##7##2##(2008-10#7)
potential is##16##2##(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2010-8#1)
potential latency##4##2##(2008-7#3)(2011-2#1)
potential liability of##2##3##(1991-12#2)
potential liability##3##2##(1991-12#2)(1993-2#1)
potential ligands##2##2##(1991-12#1)(1991-7#1)
potential link##2##2##(2009-10#1)(2009-12#1)
potential links between##2##3##(2009-7#1)(2012-3#1)
potential major##2##2##(1994-8#1)(2010-12#1)
potential male##2##2##(2008-9#1)(2012-2#1)
potential management##2##2##(2008-10#2)
potential markers##3##2##(2008-10#1)(2010-12#1)(2012-3#1)
potential mates##8##2##(2008-8#8)
potential may be##2##3##(2008-10#1)(2012-3#1)
potential mechanism for##2##3##(1991-3#1)(2008-10#1)
potential mechanism of##5##3##(2008-10#3)(2011-2#2)
potential mechanism##10##2##(1990-8#1)(1991-3#1)(2008-10#4)(2011-2#2)(2012-2#1)(2012-3#1)
potential mechanisms of action of the##2##6##(2008-7#1)(2011-1#1)
potential mechanisms of##5##3##(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
potential mechanisms##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
potential medical##3##2##(1993-3#1)(2008-11#1)(2013-1#1)
potential method (MPM)##3##3##(2008-10#3)
potential method##7##2##(2008-10#7)
potential methods##2##2##(2008-11#1)(2012-2#1)
potential model##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
potential moderators##2##2##(2008-12#1)(2012-2#1)
potential modifiers##3##2##(1991-3#2)(2010-12#1)
potential molecular##3##2##(2008-11#1)(2009-12#1)(2012-3#1)
potential negative##3##2##(1995-12#1)(2008-10#1)(2012-2#1)
potential neural##2##2##(2008-11#1)(2013-1#1)
potential new##4##2##(2008-11#2)(2008-5#1)(2011-2#1)
potential novel##2##2##(2008-7#1)(2011-2#1)
potential of +0##4##3##(2008-10#4)
potential of +1##2##3##(2008-10#2)
potential of -0##18##3##(2008-10#18)
potential of -1##2##3##(2008-10#2)
potential of -300 mV##2##4##(2008-10#2)
potential of 0##8##3##(2008-10#8)
potential of 10V##2##3##(2013-1#2)
potential of AA##2##3##(2008-10#2)
potential of a##7##3##(1992-2#1)(2008-10#5)(2008-5#1)
potential of biotechnology##2##3##(2008-11#2)
potential of combining solid-phase optosensing and multicommutation principles##2##8##(2008-10#2)
potential of drugs##2##3##(2008-10#2)
potential of mean##2##3##(2008-10#2)
potential of personal cleansing products##2##5##(2008-5#2)
potential of solid-phase extraction and##2##5##(2008-10#2)
potential of stem cells##2##4##(2008-11#2)
potential of stem##3##3##(2008-11#3)
potential of sunflower stem##2##4##(2008-10#2)
potential of terahertz imaging##2##4##(2012-12#2)
potential of the working electrode##2##5##(2008-10#2)
potential of the##31##3##(1993-11#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-3#1)(2011-2#1)
potential of these chiral amines to catalyze two organic reactions##2##10##(2009-10#2)
potential of these##7##3##(1990-5#1)(2008-10#2)(2008-8#1)(2009-10#2)(2011-2#1)
potential of this##11##3##(1995-8#1)(2008-10#6)(2008-3#1)(2008-5#2)(2013-1#1)
potential of using##3##3##(2008-10#3)
potential of working electrode##3##4##(2008-10#3)
potential of##266##2##(1990-5#1)(1991-10#1)(1991-5#2)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-6#2)(1997-7#1)(2008-10#138)(2008-11#27)(2008-12#3)(2008-3#3)(2008-5#13)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#7)(2013-8#3)
potential on##8##2##(1990-8#1)(1990-9#1)(1997-8#1)(2008-10#5)
potential open reading frames##3##4##(1996-12#2)(1996-6#1)
potential or##2##2##(2008-10#2)
potential participants##2##2##(2009-4#1)(2012-2#1)
potential pathogens##3##2##(1994-6#1)(2007-12#1)(2009-6#1)
potential phosphorylation sites##2##3##(1997-7#1)(2008-5#1)
potential pitfalls in##2##3##(2008-4#1)(2011-2#1)
potential pitfalls##4##2##(1992-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
potential positive##2##2##(1991-5#1)(2008-5#1)
potential prevention##2##2##(2008-10#1)(2010-7#1)
potential problem##2##2##(2007-12#1)(2008-10#1)
potential problems##3##2##(1995-9#1)(2008-4#1)(2008-9#1)
potential promising##2##2##(2008-10#1)(2009-7#1)
potential protective##6##2##(1990-12#1)(1993-2#1)(1994-5#1)(2008-10#1)(2008-12#1)(2009-11#1)
potential protein genes##3##3##(1996-6#3)
potential protein-coding genes and/or gene segments with known or predicted functions were identified##2##13##(1997-6#1)(1997-8#1)
potential protein-coding regions##3##3##(1996-6#3)
potential protein-coding##5##2##(1996-6#3)(1997-6#1)(1997-8#1)
potential public health##2##3##(1991-3#1)(2012-3#1)
potential pulse##4##2##(2008-10#4)
potential pulses##2##2##(1995-6#2)
potential quantitative trait loci (QTL)##2##5##(2008-10#2)
potential range##6##2##(2008-10#6)
potential reasons for##2##3##(2008-10#1)(2010-9#1)
potential reasons##3##2##(2008-10#2)(2010-9#1)
potential regulatory##3##2##(1991-7#1)(2008-10#1)(2012-3#1)
potential release##2##2##(2008-10#2)
potential reproductive##2##2##(2008-8#1)(2012-3#1)
potential research##4##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
potential response of##5##3##(2008-10#5)
potential response##10##2##(1996-3#1)(2008-10#9)
potential risk factors##4##3##(1994-12#1)(2011-2#2)(2013-1#1)
potential risk for##2##3##(2008-10#2)
potential risk of##6##3##(2008-10#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
potential risk##15##2##(1994-12#1)(1995-5#1)(2008-10#4)(2008-7#1)(2009-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
potential risks and##2##3##(2008-10#1)(2013-1#1)
potential risks##7##2##(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#2)
potential role in the##2##4##(2008-7#1)(2011-2#1)
potential role in##8##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#2)
potential role of these##2##4##(1992-12#1)(2011-2#1)
potential role of##11##3##(1992-1#1)(1992-12#1)(1993-3#1)(1994-11#1)(2008-5#1)(2009-1#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
potential role##26##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-6#2)(2009-8#1)(2011-2#3)(2013-1#3)(2013-8#1)
potential roles##3##2##(2009-8#1)(2012-2#1)(2013-1#1)
potential scan rate##2##3##(2008-10#2)
potential scan##4##2##(2008-10#4)
potential scans##2##2##(2008-10#2)
potential selection pressures##2##3##(2012-3#2)
potential shifts##3##2##(2008-10#3)
potential sites for##2##3##(1992-1#1)(1993-2#1)
potential solid phase##2##3##(2008-10#2)
potential source of##5##3##(1991-12#1)(2008-10#4)
potential source##7##2##(1991-12#1)(2008-10#4)(2011-2#1)(2012-2#1)
potential sources of contamination##2##4##(2008-10#1)(2012-2#1)
potential sources of inoculum##2##4##(2008-10#2)
potential sources of##9##3##(2008-10#5)(2008-11#2)(2011-2#1)(2012-2#1)
potential stability and reproducibility##2##4##(2008-10#2)
potential stability and##3##3##(2008-10#3)
potential stability##6##2##(2008-10#6)
potential strength of##2##3##(2008-10#1)(2008-9#1)
potential subgroups##2##2##(2008-12#2)
potential substrates##2##2##(1994-5#1)(2008-11#1)
potential synergistic##2##2##(2008-10#1)(2008-5#1)
potential target##7##2##(1995-2#1)(1995-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#2)
potential targeting##2##2##(2008-10#1)(2011-2#1)
potential targets for##3##3##(1997-7#1)(2008-4#1)(2011-2#1)
potential targets##4##2##(1997-7#1)(2008-4#1)(2011-2#2)
potential than##3##2##(2008-5#2)(2012-7#1)
potential that##3##2##(1995-6#1)(2008-10#1)(2009-6#1)
potential therapeutic benefit##2##3##(2008-11#1)(2009-4#1)
potential therapeutic targets##4##3##(2010-12#2)(2013-7#1)(2013-8#1)
potential therapeutic use##3##3##(1992-9#1)(1993-8#1)(2012-2#1)
potential therapeutic##17##2##(1992-9#1)(1993-8#1)(1997-1#1)(2008-11#1)(2009-12#1)(2009-4#1)(2010-12#2)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
potential therapies for##2##3##(2008-5#1)(2012-3#1)
potential therapies##3##2##(2008-4#1)(2008-5#1)(2012-3#1)
potential therapy##2##2##(1994-5#1)(2008-5#1)
potential threat##3##2##(2008-10#2)(2011-2#1)
potential titration##2##2##(2008-10#2)
potential to alter the##2##4##(2008-10#1)(2012-2#1)
potential to be used in##2##5##(2008-10#1)(2012-2#1)
potential to be used##4##4##(2008-10#2)(2009-3#1)(2012-2#1)
potential to be##16##3##(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2012-2#4)
potential to become a##2##4##(2008-10#1)(2008-9#1)
potential to become##3##3##(2008-10#1)(2008-9#1)(2011-7#1)
potential to cause##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
potential to control##2##3##(1994-6#1)(2008-10#1)
potential to differentiate into##3##4##(2008-11#3)
potential to enhance the##2##4##(2008-1#1)(2008-9#1)
potential to enhance##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
potential to improve##3##3##(1994-12#1)(2008-11#1)(2009-8#1)
potential to induce##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
potential to infect##2##3##(2008-10#2)
potential to mature##2##3##(2008-5#2)
potential to provide a##4##4##(2008-10#1)(2008-11#1)(2011-7#1)(2012-2#1)
potential to provide##7##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-7#1)(2012-2#1)(2013-1#1)
potential to##118##2##(1991-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#2)(2008-10#33)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#4)(2011-7#4)(2012-12#1)(2012-2#10)(2012-3#3)(2012-6#1)(2013-1#5)(2013-8#2)
potential toxicity##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
potential transmembrane##2##2##(1996-12#1)(1996-6#1)
potential treatment of##4##3##(2008-5#4)
potential treatment##12##2##(1997-1#1)(2008-5#9)(2011-2#1)(2012-2#1)
potential use as an##3##4##(1993-12#1)(1995-2#1)(1996-5#1)
potential use for##4##3##(1995-5#1)(2008-10#1)(2008-11#1)(2009-8#1)
potential use in##7##3##(1993-2#1)(2008-10#1)(2008-3#1)(2008-5#3)(2010-4#1)
potential use of##11##3##(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-9#3)(2010-12#1)
potential use##26##2##(1993-12#1)(1993-2#1)(1995-2#1)(1995-5#1)(1996-5#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#5)(2008-9#3)(2009-8#1)(2010-12#1)(2010-4#1)
potential usefulness##6##2##(1990-2#1)(2008-10#3)(2008-7#1)(2009-7#1)
potential users##2##2##(1991-3#1)(2013-8#1)
potential uses of the##2##4##(1991-12#1)(2008-3#1)
potential uses of##6##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-5#1)
potential uses##7##2##(1991-12#1)(1996-3#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-5#1)
potential utility for##2##3##(2008-5#1)(2008-9#1)
potential utility of the##2##4##(1996-2#1)(2008-10#1)
potential utility of##8##3##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#1)
potential utility##11##2##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)
potential value for##2##3##(2008-10#1)(2012-3#1)
potential value of##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
potential value##7##2##(2008-10#3)(2008-5#1)(2008-7#1)(2009-1#1)(2012-3#1)
potential values##2##2##(2008-10#2)
potential versus##3##2##(2008-10#3)
potential was +0##2##3##(2008-10#2)
potential was##16##2##(1990-8#1)(1993-2#1)(2008-10#13)(2012-4#1)
potential waveform##2##2##(2008-10#2)
potential were##2##2##(1990-8#1)(2008-10#1)
potential window was##2##3##(2008-10#2)
potential window##5##2##(2008-10#5)
potential with##4##2##(2008-10#3)(2008-11#1)
potential within##2##2##(2008-10#1)(2012-2#1)
potential##2024##1##(1990-12#4)(1990-2#2)(1990-5#4)(1990-6#1)(1990-8#7)(1990-9#2)(1991-1#4)(1991-10#1)(1991-12#9)(1991-3#10)(1991-5#6)(1991-6#3)(1991-7#5)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#3)(1992-3#6)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#8)(1993-3#6)(1993-6#2)(1993-8#5)(1993-9#2)(1994-1#6)(1994-11#8)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#9)(1994-6#2)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#8)(1995-2#8)(1995-3#2)(1995-5#6)(1995-6#10)(1995-8#4)(1995-9#3)(1996-1#8)(1996-12#11)(1996-2#10)(1996-3#5)(1996-5#3)(1996-6#8)(1997-1#11)(1997-2#8)(1997-3#5)(1997-4#2)(1997-6#9)(1997-7#12)(1997-8#13)(2006-6#1)(2007-11#3)(2007-12#6)(2008-1#8)(2008-10#757)(2008-11#155)(2008-12#27)(2008-2#2)(2008-3#18)(2008-4#19)(2008-5#75)(2008-6#6)(2008-7#42)(2008-8#57)(2008-9#53)(2009-1#7)(2009-10#11)(2009-11#3)(2009-12#13)(2009-3#5)(2009-4#9)(2009-5#5)(2009-6#7)(2009-7#7)(2009-8#12)(2009-9#1)(2010-1#7)(2010-10#4)(2010-11#6)(2010-12#25)(2010-3#2)(2010-4#10)(2010-5#6)(2010-6#9)(2010-7#6)(2010-8#4)(2010-9#3)(2011-1#12)(2011-2#83)(2011-3#5)(2011-7#7)(2012-12#14)(2012-2#61)(2012-3#38)(2012-4#2)(2012-6#2)(2012-7#2)(2013-1#68)(2013-7#6)(2013-8#31)
potential)##5##1##(1996-12#1)(2008-10#1)(2008-5#1)(2013-1#2)
potentialities of the##2##3##(2008-10#2)
potentialities of##5##2##(2008-10#4)(2008-7#1)
potentialities##10##1##(2008-10#5)(2008-7#1)(2009-10#1)(2009-6#2)(2013-1#1)
potentiality of##7##2##(2008-10#3)(2008-8#1)(2010-3#1)(2013-1#2)
potentiality##8##1##(2008-10#4)(2008-8#1)(2010-3#1)(2013-1#2)
potentially applicable##3##2##(2008-2#1)(2008-8#1)(2013-1#1)
potentially be used##2##3##(2008-11#1)(2008-8#1)
potentially be##11##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2010-10#2)(2011-2#1)(2013-1#2)
potentially beneficial##3##2##(2008-10#1)(2010-1#2)
potentially causal##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
potentially causing##2##2##(2008-12#1)(2008-8#1)
potentially could##3##2##(2008-10#2)(2008-3#1)
potentially curative##3##2##(1992-12#1)(1996-11#1)(1997-8#1)
potentially dangerous##5##2##(1996-9#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-3#1)
potentially deleterious##2##2##(1992-9#1)(2008-11#1)
potentially encodes a polypeptide##2##4##(1996-6#1)(2008-10#1)
potentially encodes##3##2##(1996-6#1)(2008-10#2)
potentially fatal##6##2##(1996-12#1)(2009-11#1)(2011-2#2)(2012-3#2)
potentially forming a##2##3##(1991-5#1)(2008-10#1)
potentially harmful to##2##3##(1994-3#1)(2008-11#1)
potentially harmful##4##2##(1994-3#1)(2008-11#1)(2010-1#1)(2012-12#1)
potentially hazardous##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
potentially hepatotoxic drugs##2##3##(2008-11#2)
potentially important##7##2##(1995-11#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2013-8#1)
potentially increasing the##2##3##(2008-5#1)(2010-2#1)
potentially influence##2##2##(1991-6#1)(2007-12#1)
potentially lead to##3##3##(2008-7#1)(2009-9#2)
potentially leading to##2##3##(2009-9#1)(2012-3#1)
potentially lethal##4##2##(2012-2#1)(2012-3#1)(2013-1#2)
potentially life threatening##2##3##(2012-2#1)(2013-1#1)
potentially life-threatening##7##2##(1997-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2013-1#2)(2013-8#1)
potentially more##2##2##(2008-11#1)(2012-2#1)
potentially new##2##2##(1996-12#1)(2013-1#1)
potentially other##2##2##(1995-6#1)(2011-2#1)
potentially play##2##2##(2008-10#1)(2012-2#1)
potentially provide a##2##3##(2008-10#1)(2012-3#1)
potentially related to##2##3##(1992-6#1)(1996-1#1)
potentially related##3##2##(1992-6#1)(1996-1#1)(2011-2#1)
potentially relevant##2##2##(2012-12#1)(2013-8#1)
potentially resulting in##3##3##(2008-9#1)(2010-9#1)(2011-2#1)
potentially serious##9##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-3#2)
potentially severe##2##2##(2008-11#1)(2011-3#1)
potentially therapeutic##2##2##(1994-5#1)(1995-12#1)
potentially toxic##4##2##(1990-5#1)(2008-10#1)(2008-7#2)
potentially useful for studying##2##4##(1993-9#1)(1995-11#1)
potentially useful for##6##3##(1993-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)
potentially useful##17##2##(1992-12#1)(1992-3#1)(1993-9#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-5#1)(2012-2#1)
potentially valuable##2##2##(2008-9#1)(2012-2#1)
potentially violent##2##2##(2008-7#2)
potentially##277##1##(1990-11#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-3#2)(1994-5#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-6#2)(1996-9#1)(1997-2#2)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#50)(2008-11#24)(2008-12#11)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#11)(2008-9#8)(2009-10#2)(2009-11#3)(2009-12#3)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#4)(2010-1#6)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#19)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#12)(2013-1#15)(2013-8#3)
potentials (0##2##2##(2008-10#2)
potentials (ERPs)##3##2##(1995-2#1)(2008-11#1)(2008-8#1)
potentials and##9##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2010-12#1)(2013-8#1)
potentials are##4##2##(1992-2#1)(2008-10#1)(2008-8#1)(2009-10#1)
potentials evoked by##2##3##(2008-11#1)(2008-7#1)
potentials for further##2##3##(2008-10#2)
potentials for##5##2##(2008-10#4)(2008-2#1)
potentials in the##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2009-12#1)
potentials in##10##2##(1991-1#1)(1992-12#1)(1996-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2009-12#1)(2011-2#1)
potentials more negative than##2##4##(1993-3#1)(1997-2#1)
potentials more positive than##2##4##(1993-3#1)(1997-2#1)
potentials more##4##2##(1993-3#2)(1997-2#2)
potentials of -1##2##3##(2008-10#1)(2012-7#1)
potentials of hMSCs##3##3##(2008-11#3)
potentials of the##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
potentials of##28##2##(1997-8#1)(2008-10#14)(2008-11#7)(2008-12#2)(2008-5#1)(2008-8#1)(2012-7#1)(2013-8#1)
potentials on##3##2##(2008-10#3)
potentials or##3##2##(1997-6#1)(2008-10#1)(2009-12#1)
potentials recorded##3##2##(1996-6#1)(2008-4#1)(2008-9#1)
potentials to##2##2##(1996-6#1)(2008-10#1)
potentials were recorded##3##3##(1996-6#1)(2008-11#1)(2008-7#1)
potentials were##12##2##(1990-9#1)(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#1)
potentials which##2##2##(2008-7#1)(2012-2#1)
potentials with##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
potentials##179##1##(1990-5#5)(1990-9#1)(1991-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#2)(1996-6#5)(1997-2#3)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#79)(2008-11#29)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-7#1)(2013-8#2)
potentiate diacylglycerol-activated protein kinase C##2##5##(1990-5#2)
potentiate the effects of##3##4##(1996-2#1)(2008-5#1)(2010-4#1)
potentiate the##9##2##(1990-12#1)(1993-3#1)(1993-6#1)(1996-2#3)(2008-11#1)(2008-5#1)(2010-4#1)
potentiate##19##1##(1990-12#1)(1990-5#2)(1990-7#1)(1992-12#1)(1993-3#1)(1993-6#3)(1995-11#1)(1996-2#3)(2008-11#2)(2008-5#2)(2008-7#1)(2010-4#1)
potentiated by adenosine##2##3##(1994-11#1)(2008-5#1)
potentiated by##11##2##(1990-5#1)(1990-7#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(2008-11#2)(2008-5#1)(2013-1#1)
potentiated fear##2##2##(2008-11#2)
potentiated in##2##2##(1996-2#2)
potentiated the responses##2##3##(1990-7#1)(2008-8#1)
potentiated the##10##2##(1990-7#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-2#1)(1997-4#1)(2008-11#1)(2008-8#2)
potentiated##41##1##(1990-12#1)(1990-5#2)(1990-7#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-11#4)(1995-8#2)(1996-2#5)(1997-1#2)(1997-4#2)(2008-10#1)(2008-11#6)(2008-5#2)(2008-8#2)(2013-1#2)(2013-8#1)
potentiates the##2##2##(1997-4#1)(2010-12#1)
potentiates##17##1##(1990-12#1)(1990-2#1)(1994-2#1)(1994-3#1)(1995-11#2)(1996-2#1)(1997-4#3)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
potentiating effect of CGRP##3##4##(1997-4#3)
potentiating effect of##5##3##(1990-5#1)(1997-4#4)
potentiating effect##7##2##(1990-5#1)(1995-11#1)(1996-12#1)(1997-4#4)
potentiating effects##2##2##(1995-11#2)
potentiating##11##1##(1990-5#1)(1995-11#4)(1996-12#1)(1997-4#4)(2013-7#1)
potentiation (LTP) was##2##3##(1995-12#1)(2008-7#1)
potentiation (LTP)##11##2##(1990-5#1)(1993-12#2)(1995-12#2)(1995-2#1)(1997-2#1)(2008-11#1)(2008-7#3)
potentiation by##2##2##(1993-6#1)(2008-7#1)
potentiation of ileal contractions##2##4##(1992-8#2)
potentiation of phagocytosis##4##3##(1993-6#4)
potentiation of the##11##3##(1990-5#1)(1993-6#2)(1994-2#1)(1995-11#1)(1995-12#2)(1997-4#2)(2008-10#1)(2008-5#1)
potentiation of##30##2##(1990-5#1)(1992-6#1)(1992-8#2)(1993-6#7)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-4#3)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)(2009-3#1)(2012-2#1)
potentiation was##2##2##(1993-6#1)(1995-12#1)
potentiation##65##1##(1990-5#3)(1990-8#1)(1992-6#1)(1992-8#2)(1993-12#3)(1993-6#9)(1994-2#1)(1995-11#1)(1995-12#10)(1995-2#2)(1996-2#3)(1997-2#2)(1997-4#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#8)(2009-1#2)(2009-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
potentiometer##3##1##(2008-10#3)
potentiometric and spectrophotometric##2##3##(2008-10#2)
potentiometric and##8##2##(2008-10#8)
potentiometric anion##2##2##(2008-10#2)
potentiometric back-titration##2##2##(2008-10#2)
potentiometric biosensor for##2##3##(2008-10#2)
potentiometric biosensor##3##2##(2008-10#3)
potentiometric clinical analyser##2##3##(2008-10#2)
potentiometric detection of##3##3##(2008-10#3)
potentiometric detection##7##2##(2008-10#7)
potentiometric detector##2##2##(2008-10#2)
potentiometric detectors##2##2##(2008-10#2)
potentiometric determination of nitrite ion##2##5##(2008-10#2)
potentiometric determination of##21##3##(2008-10#21)
potentiometric electronic tongue##2##3##(2008-10#2)
potentiometric end-point detection##2##3##(2008-10#2)
potentiometric flow injection determination##3##4##(2008-10#3)
potentiometric flow injection##6##3##(2008-10#6)
potentiometric flow titration##2##3##(2008-10#2)
potentiometric flow##9##2##(2008-10#9)
potentiometric indicator##3##2##(2008-10#3)
potentiometric ion##2##2##(2008-10#2)
potentiometric measurements and##2##3##(2008-10#2)
potentiometric measurements##5##2##(2008-10#5)
potentiometric membrane electrode##2##3##(2008-10#2)
potentiometric membrane electrodes (EPMEs) based on##2##6##(2008-10#2)
potentiometric membrane electrodes based on##3##5##(2008-10#3)
potentiometric membrane electrodes for the##2##5##(2008-10#2)
potentiometric membrane electrodes##8##3##(2008-10#8)
potentiometric membrane##11##2##(2008-10#11)
potentiometric method based on##2##4##(2008-10#2)
potentiometric method for the##2##4##(2008-10#2)
potentiometric method for##3##3##(2008-10#3)
potentiometric method##11##2##(2008-10#11)
potentiometric pH-sensitive field-effect transistors##2##4##(2008-10#2)
potentiometric response characteristics of##4##4##(2008-10#4)
potentiometric response characteristics##6##3##(2008-10#6)
potentiometric response was##2##3##(2008-10#2)
potentiometric response##18##2##(2008-10#18)
potentiometric responses##3##2##(2008-10#3)
potentiometric selectivity coefficient##3##3##(2008-10#3)
potentiometric selectivity coefficients of ion-selective##2##5##(2008-10#2)
potentiometric selectivity coefficients of##4##4##(2008-10#4)
potentiometric selectivity coefficients##6##3##(2008-10#6)
potentiometric selectivity##19##2##(2008-10#19)
potentiometric sensor based on##2##4##(2008-10#2)
potentiometric sensor for##4##3##(2008-10#4)
potentiometric sensor##20##2##(2008-10#20)
potentiometric sensors based on##2##4##(2008-10#2)
potentiometric sensors for##3##3##(2008-10#3)
potentiometric sensors##13##2##(2008-10#13)
potentiometric stripping analysis##2##3##(2008-10#2)
potentiometric study##3##2##(2008-10#3)
potentiometric technique##2##2##(2008-10#2)
potentiometric titration is##2##3##(2008-10#2)
potentiometric titration method##4##3##(2008-10#4)
potentiometric titration of Mg(2+)##2##4##(2008-10#2)
potentiometric titration of##31##3##(2008-10#31)
potentiometric titration was##2##3##(2008-10#2)
potentiometric titration with##2##3##(2008-10#2)
potentiometric titration##54##2##(2008-10#54)
potentiometric titrations of##5##3##(2008-10#5)
potentiometric titrations##19##2##(2008-10#19)
potentiometric##287##1##(2008-10#287)
potentiometrically in##4##2##(2008-10#4)
potentiometrically using a##2##3##(2008-10#1)(2008-11#1)
potentiometrically with##2##2##(2008-10#2)
potentiometrically##19##1##(2008-10#18)(2008-11#1)
potentiometry and##6##2##(2008-10#6)
potentiometry by##3##2##(2008-10#3)
potentiometry for##2##2##(2008-10#2)
potentiometry in##2##2##(2008-10#2)
potentiometry with##2##2##(2008-10#1)(2008-5#1)
potentiometry##35##1##(2008-10#34)(2008-5#1)
potentiostat and##2##2##(2008-10#2)
potentiostat##4##1##(2008-10#4)
potentiostatic##2##1##(2008-10#2)
potently##5##1##(1994-8#2)(1996-2#1)(2009-7#1)(2010-7#1)
potocytosis and##2##2##(1995-2#1)(1995-6#1)
potocytosis##5##1##(1994-6#1)(1995-2#2)(1995-6#2)
potomac division meeting##7##3##(2008-11#7)
potomac##9##1##(2008-11#9)
pots and##2##2##(2008-10#2)
pots containing##2##2##(2008-10#2)
pots##10##1##(2008-10#9)(2008-12#1)
potted plants##3##2##(2008-10#2)(2008-12#1)
potted##9##1##(2008-10#8)(2008-12#1)
pottery##2##1##(2008-10#2)
potting media##3##2##(2008-10#3)
potting medium##2##2##(2008-10#2)
potting mix was##2##3##(2008-10#2)
potting mix were##2##3##(2008-10#2)
potting mix##23##2##(2008-10#22)(2013-1#1)
potting mixes##3##2##(2008-10#3)
potting##33##1##(2008-10#32)(2013-1#1)
potyvirus##23##1##(2008-10#22)(2008-9#1)
potyviruses##15##1##(2008-10#14)(2008-9#1)
pouch II##2##2##(1996-3#2)
pouch polyps##2##2##(2009-12#2)
pouch##13##1##(1996-3#2)(2008-10#2)(2009-12#7)(2011-2#1)(2012-3#1)
pouches##3##1##(1994-3#1)(2008-10#2)
poultry farms in##2##3##(2011-2#1)(2011-3#1)
poultry farms##3##2##(1997-5#1)(2011-2#1)(2011-3#1)
poultry in##2##2##(2008-5#1)(2011-2#1)
poultry intake##2##2##(2011-2#2)
poultry production##2##2##(1990-3#1)(2011-3#1)
poultry##18##1##(1990-3#1)(1990-8#1)(1995-9#1)(1997-5#3)(2008-10#2)(2008-5#2)(2010-7#1)(2011-2#5)(2011-3#2)
poults##11##1##(1990-6#1)(1992-2#1)(2008-5#9)
poumons##2##1##(2011-2#1)(2013-1#1)
pound 13 billion##2##3##(2012-12#2)
pounds##3##1##(1992-8#1)(1996-8#1)(2008-1#1)
pour##10##1##(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#5)
pour-on##3##1##(1996-12#3)
poured##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
pouring##2##1##(1992-8#1)(2009-7#1)
poverty and##3##2##(2008-11#3)
poverty in##2##2##(2008-11#2)
poverty is##2##2##(2008-11#2)
poverty rates##2##2##(2008-11#1)(2013-8#1)
poverty##49##1##(1990-6#2)(1995-1#1)(1997-6#1)(2007-12#1)(2008-11#39)(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
poverty-reduction strategy##2##2##(2008-11#2)
povidone##2##1##(1990-3#1)(2008-10#1)
powder X-ray diffraction##2##3##(2008-10#1)(2010-4#1)
powder and infant##2##3##(2008-10#2)
powder and then##2##3##(2008-10#1)(2013-1#1)
powder and##8##2##(2008-10#7)(2013-1#1)
powder by##2##2##(2008-10#1)(2008-11#1)
powder catalysts##3##2##(2008-10#3)
powder diffraction (XRD)##2##3##(2008-10#2)
powder diffraction##3##2##(2008-10#2)(2011-3#1)
powder form##2##2##(2008-10#1)(2012-2#1)
powder has##2##2##(2008-10#1)(2011-2#1)
powder in##4##2##(2008-10#3)(2009-7#1)
powder inhaler (DPI)##3##3##(1997-1#1)(1997-2#2)
powder inhaler##11##2##(1994-2#3)(1996-2#5)(1997-1#1)(1997-2#2)
powder inhalers (DPI's)##2##3##(1992-3#2)
powder inhalers##6##2##(1992-3#4)(1996-1#2)
powder metallurgy##3##2##(2009-7#3)
powder of##2##2##(2008-10#1)(2008-12#1)
powder samples##2##2##(2008-10#2)
powder spray containing##2##3##(2008-5#2)
powder spray##3##2##(2008-5#3)
powder was##6##2##(2008-10#5)(2008-5#1)
powder##128##1##(1991-5#1)(1992-3#6)(1994-11#1)(1994-2#3)(1994-5#1)(1995-11#2)(1995-3#2)(1996-1#2)(1996-2#7)(1996-9#1)(1997-1#2)(1997-2#2)(2007-11#4)(2008-1#1)(2008-10#68)(2008-11#2)(2008-12#1)(2008-5#4)(2009-7#5)(2010-4#1)(2011-2#4)(2011-3#3)(2012-2#1)(2013-1#1)(2013-8#3)
powder)##5##1##(2008-10#5)
powdered milk##2##2##(2009-8#2)
powdered##15##1##(1990-3#1)(2008-10#8)(2008-11#1)(2008-5#2)(2009-8#2)(2013-1#1)
powders may##2##2##(1995-3#1)(2008-10#1)
powders of##2##2##(2008-10#1)(2010-4#1)
powders with##2##2##(2008-10#2)
powders##22##1##(1995-3#3)(2008-10#17)(2009-7#1)(2010-4#1)
powdery mildew (Podosphaera##2##3##(2008-10#2)
powdery mildew and##4##3##(2008-10#4)
powdery mildew development on##2##4##(2008-10#2)
powdery mildew fungus##3##3##(2008-10#3)
powdery mildew in##4##3##(2008-10#4)
powdery mildew resistance gene in Suwon 92##2##7##(2008-10#2)
powdery mildew resistance gene in##3##5##(2008-10#3)
powdery mildew resistance in NC96BGTA5##2##5##(2008-10#2)
powdery mildew resistance in Suwon 92##2##6##(2008-10#2)
powdery mildew resistance in the##2##5##(2008-10#2)
powdery mildew resistance in##8##4##(2008-10#8)
powdery mildew resistance##15##3##(2008-10#15)
powdery mildew was evaluated##2##4##(2008-10#2)
powdery mildew was##4##3##(2008-10#4)
powdery mildew were##2##3##(2008-10#2)
powdery mildew##77##2##(2008-10#77)
powdery mildews##2##2##(2008-10#2)
powdery##81##1##(2008-10#80)(2008-5#1)
power (relative##2##2##(2008-7#1)(2009-7#1)
power absorption in##2##3##(1992-3#2)
power absorption##3##2##(1992-3#2)(1992-8#1)
power analysis##3##2##(2008-11#1)(2008-2#1)(2013-1#1)
power and a##2##3##(2007-11#1)(2008-10#1)
power and potential of##2##4##(2008-11#1)(2010-7#1)
power and resolution##3##3##(2008-10#2)(2012-3#1)
power and the##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)
power and##41##2##(1991-1#1)(1994-1#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#9)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-8#2)
power as##4##2##(1996-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
power at##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2013-8#1)
power between##2##2##(1997-3#1)(2011-2#1)
power can be##2##3##(1995-12#1)(2012-12#1)
power can##4##2##(1995-12#1)(2008-3#1)(2010-9#1)(2012-12#1)
power consumption##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
power conversion efficiencies##2##3##(2008-3#1)(2011-2#1)
power cords from service##2##4##(2011-1#1)(2011-2#1)
power cords from##3##3##(2011-1#1)(2011-2#2)
power cords##6##2##(2011-1#2)(2011-2#4)
power density at the##2##4##(1992-12#2)
power density at##3##3##(1992-12#2)(1995-2#1)
power density##5##2##(1992-1#1)(1992-12#2)(1995-2#1)(2008-3#1)
power efficiency of##2##3##(1995-3#1)(2007-12#1)
power for a##2##3##(2008-10#1)(2008-3#1)
power for the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
power for##12##2##(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2010-3#1)
power frequency##3##2##(2010-12#1)(2012-2#2)
power from##4##2##(2007-12#1)(2008-3#1)(2013-1#2)
power function##4##2##(1994-8#1)(1995-8#1)(2008-6#1)(2008-7#1)
power has been##3##3##(2008-2#1)(2008-3#2)
power has##5##2##(1992-3#1)(2008-2#1)(2008-3#2)(2010-5#1)
power imbalances##2##2##(1997-3#2)
power in the##4##3##(1991-3#1)(1995-2#1)(2007-11#1)(2008-7#1)
power in##16##2##(1991-3#1)(1992-3#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-3#2)(2008-7#4)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
power into the##2##3##(2008-3#2)
power is##13##2##(1992-12#1)(1997-3#1)(2007-12#2)(2008-2#2)(2008-3#4)(2008-7#1)(2011-2#1)(2012-3#1)
power law was used to##2##5##(2008-10#2)
power law with##3##3##(2008-10#2)(2008-8#1)
power law##18##2##(2008-10#14)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
power levels##2##2##(2008-3#2)
power loss##2##2##(1992-12#1)(2008-3#1)
power microwave##2##2##(2008-10#1)(2011-2#1)
power near##2##2##(2008-2#1)(2008-3#1)
power of 1##3##3##(2008-3#3)
power of 10 mW and a##2##6##(2008-2#1)(2008-3#1)
power of 10 mW##3##4##(2008-2#2)(2008-3#1)
power of a##6##3##(1993-5#1)(1995-9#1)(2008-10#1)(2008-3#3)
power of an##2##3##(2008-10#1)(2012-2#1)
power of the models##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
power of the system##2##4##(1995-11#1)(2008-11#1)
power of the test##2##4##(1992-9#1)(1996-3#1)
power of the##27##3##(1992-9#3)(1993-12#1)(1995-11#1)(1996-3#3)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)
power of these##2##3##(2008-10#1)(2013-1#1)
power of##101##2##(1991-3#2)(1992-1#1)(1992-12#1)(1992-9#3)(1993-12#1)(1993-3#1)(1993-5#1)(1995-11#1)(1995-9#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-2#11)(2008-3#16)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#1)
power on##2##2##(1993-3#1)(2008-3#1)
power plant##5##2##(2008-10#2)(2009-10#1)(2010-8#1)(2011-2#1)
power required##2##2##(2008-3#1)(2013-1#1)
power requirements##3##2##(2008-10#3)
power spectra##2##2##(2008-8#1)(2008-9#1)
power spectrum##3##2##(2008-11#1)(2008-3#2)
power stations##6##2##(2008-10#6)
power supply##2##2##(2008-10#1)(2008-11#1)
power than##4##2##(1997-1#1)(2008-10#2)(2008-2#1)
power to a prosthetic knee##2##5##(2013-1#2)
power to the##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
power to##16##2##(1992-1#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#3)
power transmission and thermal##2##4##(2008-3#2)
power transmission and##3##3##(2008-3#3)
power transmission##5##2##(2008-10#1)(2008-3#4)
power was##10##2##(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#2)
power were generated##2##3##(2008-10#1)(2008-3#1)
power with##5##2##(1996-3#1)(2008-2#2)(2008-3#1)(2013-8#1)
power##507##1##(1991-1#1)(1991-3#3)(1992-1#3)(1992-12#7)(1992-3#5)(1992-8#1)(1992-9#5)(1993-12#1)(1993-3#3)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#7)(1997-1#3)(1997-2#4)(1997-3#7)(1997-5#1)(1997-6#1)(2007-11#5)(2007-12#14)(2008-10#118)(2008-11#17)(2008-12#4)(2008-2#38)(2008-3#97)(2008-5#5)(2008-6#2)(2008-7#19)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#23)(2012-12#2)(2012-2#12)(2012-3#10)(2013-1#13)(2013-8#4)
power)##2##1##(2008-10#1)(2008-3#1)
power-law model##2##2##(2008-10#2)
power-law##10##1##(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#3)
power-series method##2##2##(2008-3#2)
powered##4##1##(2008-8#1)(2010-10#3)
powerful alternative##3##2##(2008-10#2)(2008-3#1)
powerful analytical tool##5##3##(2008-10#3)(2008-7#1)(2011-1#1)
powerful analytical##7##2##(2008-10#5)(2008-7#1)(2011-1#1)
powerful anti-oxidants##2##2##(2008-5#2)
powerful but##2##2##(2008-12#1)(2008-3#1)
powerful for##2##2##(2008-10#1)(2008-4#1)
powerful in##2##2##(2008-10#2)
powerful means##2##2##(2008-11#2)
powerful method##3##2##(1993-8#1)(1995-2#1)(2013-1#1)
powerful predictor of##2##3##(2008-12#1)(2009-5#1)
powerful predictor##4##2##(2008-12#1)(2009-5#1)(2011-2#1)(2012-2#1)
powerful techniques##2##2##(2008-10#2)
powerful technologies##2##2##(2009-4#1)(2010-7#1)
powerful tool for##20##3##(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#2)(2008-8#2)(2009-12#1)
powerful tool in##6##3##(2008-10#2)(2008-11#1)(2008-9#1)(2010-8#1)(2013-8#1)
powerful tool to##5##3##(2008-11#2)(2008-4#1)(2008-7#1)(2012-3#1)
powerful tool##33##2##(1993-2#1)(1997-3#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
powerful tools in##2##3##(1993-3#1)(2012-3#1)
powerful tools##4##2##(1993-3#1)(2008-4#2)(2012-3#1)
powerful##142##1##(1990-5#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#33)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#13)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#1)
powerfully##3##1##(1990-11#1)(1995-8#1)(2008-10#1)
powers of the##3##3##(2008-10#1)(2008-8#1)(2010-7#1)
powers of##6##2##(1994-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-7#1)
powers to##2##2##(2007-11#1)(2008-3#1)
powers##18##1##(1994-1#1)(1996-2#1)(1996-3#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-8#1)(2010-7#1)(2011-2#2)
pox potyvirus##2##2##(2008-10#2)
pox virus Strain##2##3##(2008-10#2)
pox virus##7##2##(2008-10#7)
pox##11##1##(1992-2#1)(2008-10#10)
poxviruses##3##1##(1995-5#1)(2008-11#2)
pp##24##1##(1990-11#6)(1990-8#4)(1993-8#4)(2008-11#2)(2008-12#3)(2008-5#2)(2010-10#1)(2011-2#2)
pp15##3##1##(1991-5#3)
pp185##5##1##(1992-10#5)
pp33 and pp15##2##3##(1991-5#2)
pp60c-src##4##1##(1990-12#4)
ppb (signal to noise ratio##2##5##(2008-10#2)
ppb and##3##2##(2008-10#3)
ppb at##2##2##(2008-10#2)
ppb for the##2##3##(2008-10#2)
ppb for##11##2##(2008-10#10)(2008-3#1)
ppb in dimethylformamide solution##2##4##(2008-10#2)
ppb in the##2##3##(2008-10#2)
ppb in##5##2##(2008-10#5)
ppb is##2##2##(2008-10#2)
ppb level##4##2##(2008-10#4)
ppb levels##6##2##(2008-10#6)
ppb of##2##2##(2008-10#2)
ppb##74##1##(2008-10#70)(2008-3#4)
ppb) were##2##2##(2008-10#2)
ppb)##8##1##(2008-10#8)
ppbV for##2##2##(2008-10#2)
ppbV##3##1##(2008-10#3)
ppbv##2##1##(2007-12#1)(2008-3#1)
ppm and##4##2##(1990-5#1)(2008-10#2)(2008-11#1)
ppm at##3##2##(2008-10#3)
ppm detection##2##2##(2008-10#2)
ppm enrofloxacin##2##2##(2008-5#2)
ppm for##11##2##(2008-10#11)
ppm in the##2##3##(1995-11#1)(2008-10#1)
ppm in##5##2##(1995-11#1)(2008-10#2)(2010-1#2)
ppm level was##2##3##(2008-10#2)
ppm level##3##2##(2008-10#3)
ppm levels of##2##3##(2008-10#2)
ppm levels##3##2##(2008-10#3)
ppm m##2##2##(2008-3#2)
ppm of##16##2##(1997-2#1)(2008-10#15)
ppm or 0##2##3##(2008-10#2)
ppm or##3##2##(2008-10#3)
ppm per unit IND and##2##5##(2008-10#2)
ppm per unit IND##3##4##(2008-10#3)
ppm to##3##2##(1995-11#1)(2008-10#2)
ppm was##5##2##(2008-10#4)(2008-5#1)
ppm with a correlation coefficient##2##5##(2008-10#2)
ppm with a##5##3##(2008-10#5)
ppm with##10##2##(2008-10#10)
ppm##150##1##(1990-3#1)(1990-5#3)(1990-8#2)(1993-1#2)(1995-11#2)(1997-2#2)(2008-10#117)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#4)(2010-1#3)(2011-2#5)
ppm) and the##2##3##(2008-10#2)
ppm) and##4##2##(2008-10#4)
ppm) were##4##2##(2008-10#4)
ppm)##20##1##(2008-10#20)
ppm-hr##2##1##(1993-1#2)
pps##3##1##(2008-9#3)
ppt##3##1##(2008-10#3)
pr actice##2##2##(2008-11#2)
prC4##4##1##(1997-8#4)
pra1##3##1##(2008-10#3)
practicability##2##1##(2008-10#2)
practicable##4##1##(1990-5#1)(2008-10#1)(2008-3#1)(2009-10#1)
practical advantages##2##2##(2008-10#2)
practical advice and##2##3##(2008-12#1)(2012-2#1)
practical analytical##3##2##(1997-2#1)(2008-10#2)
practical and economic##2##3##(2008-8#1)(2013-1#1)
practical and ethical##2##3##(1991-11#1)(2008-11#1)
practical and##21##2##(1991-11#1)(1992-3#1)(1996-3#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#2)
practical applicability of the developed resin##2##6##(2008-10#2)
practical applicability of the##5##4##(2008-10#5)
practical applicability of##6##3##(2008-10#6)
practical application of##5##3##(1992-3#1)(1996-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
practical application##12##2##(1992-3#1)(1994-12#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
practical applications of##4##3##(1997-2#1)(2008-10#3)
practical applications##15##2##(1995-3#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
practical approach for##3##3##(1990-5#1)(2008-11#1)(2012-2#1)
practical approach to##5##3##(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
practical approach##10##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#2)
practical aspects of##5##3##(1991-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
practical aspects##8##2##(1991-12#1)(1994-12#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
practical assessment##2##2##(2008-11#2)
practical benefits##2##2##(1997-7#1)(2008-11#1)
practical clinical##3##2##(1991-6#1)(2008-4#1)(2008-6#1)
practical considerations##5##2##(1993-1#1)(1995-5#1)(2008-1#1)(2008-11#1)(2009-12#1)
practical detection##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
practical determination of##2##3##(2008-10#1)(2008-2#1)
practical difficulties of##2##3##(2008-11#2)
practical difficulties##3##2##(1992-3#1)(2008-11#2)
practical examples##2##2##(2008-10#1)(2013-1#1)
practical for##6##2##(2008-10#3)(2008-4#1)(2008-9#1)(2013-1#1)
practical guidance##2##2##(2008-10#1)(2011-2#1)
practical guide for##3##3##(1991-2#1)(2008-10#2)
practical guide to##2##3##(1994-3#1)(2008-3#1)
practical guide##5##2##(1991-2#1)(1994-3#1)(2008-10#2)(2008-3#1)
practical implications of##3##3##(2008-11#2)(2008-4#1)
practical implications##6##2##(2008-11#2)(2008-4#1)(2008-8#1)(2010-10#1)(2010-5#1)
practical importance##5##2##(1995-11#1)(2008-8#1)(2009-3#1)(2010-7#1)(2013-1#1)
practical interest for##2##3##(2008-10#1)(2008-3#1)
practical interest##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
practical issues##5##2##(1992-9#1)(1996-6#1)(2008-10#1)(2010-7#1)(2011-2#1)
practical method for the##2##4##(2008-10#2)
practical method##4##2##(2008-10#3)(2008-11#1)
practical piety##2##2##(2008-12#2)
practical problem##3##2##(1993-3#1)(1997-2#1)(2008-12#1)
practical recommendations##2##2##(1992-9#1)(2010-12#1)
practical requirements##2##2##(2008-3#1)(2011-1#1)
practical samples##4##2##(2008-10#4)
practical skills and performance indicators##2##5##(2008-11#2)
practical skills of##2##3##(1997-4#1)(2008-11#1)
practical skills##7##2##(1996-1#1)(1997-4#1)(2008-11#4)(2008-12#1)
practical strategies##2##2##(1994-12#1)(2013-1#1)
practical use of##2##3##(2008-10#2)
practical use##7##2##(1992-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)
practical utility of the##3##4##(2008-10#2)(2008-7#1)
practical utility##4##2##(2008-10#3)(2008-7#1)
practical value##2##2##(2008-10#1)(2008-2#1)
practical way##4##2##(2008-10#2)(2012-3#1)(2013-1#1)
practical##288##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#2)(1992-3#3)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#8)(1994-2#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-4#2)(1997-5#2)(1997-7#2)(2008-1#1)(2008-10#79)(2008-11#37)(2008-12#15)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-5#6)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#10)
practicality##3##1##(1990-2#1)(2008-11#1)(2008-7#1)
practically constant##2##2##(2008-10#2)
practically no##2##2##(2008-10#2)
practically relevant##4##2##(2008-10#3)(2008-5#1)
practically##32##1##(1990-6#1)(1993-11#1)(1993-3#1)(1995-9#1)(1997-6#1)(1997-8#1)(2008-10#19)(2008-11#3)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)
practice BSE##2##2##(1990-6#2)
practice activity##3##2##(1990-3#3)
practice among##5##2##(1991-6#1)(1992-3#1)(1996-11#1)(2008-11#1)(2010-11#1)
practice and a##2##3##(2008-11#1)(2012-3#1)
practice and attitude##3##3##(2013-1#3)
practice and education##3##3##(2008-11#3)
practice and higher education##3##4##(1991-1#1)(2008-12#2)
practice and presents##2##3##(2008-10#1)(2008-11#1)
practice and research##6##3##(2008-6#3)(2010-10#1)(2010-11#1)(2012-2#1)
practice and that##2##3##(2008-12#1)(2011-2#1)
practice and the##6##3##(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)
practice and theory##4##3##(1996-2#1)(2008-11#3)
practice and to##2##3##(1996-3#1)(2010-10#1)
practice and##73##2##(1991-1#1)(1991-11#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#16)(2008-12#10)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#3)(2010-11#2)(2010-12#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#5)
practice are discussed##3##3##(1994-3#1)(2008-11#1)(2008-12#1)
practice are##10##2##(1994-3#1)(2008-11#4)(2008-12#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)
practice areas##2##2##(2008-11#2)
practice as a##2##3##(2008-11#1)(2008-7#1)
practice as##8##2##(1996-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2013-1#1)
practice association##3##2##(1993-12#1)(1993-2#1)(1996-3#1)
practice at##2##2##(2008-11#2)
practice by##4##2##(2008-10#1)(2008-11#3)
practice can be##2##3##(1995-12#1)(2008-12#1)
practice can##4##2##(1995-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
practice change##3##2##(2008-11#3)
practice context##3##2##(1993-1#1)(2008-11#2)
practice cost##2##2##(1994-1#2)
practice development##4##2##(2008-11#4)
practice especially##2##2##(2008-6#1)(2009-11#1)
practice expense##4##2##(1994-1#4)
practice expenses##2##2##(1994-1#2)
practice experience##2##2##(2008-11#1)(2008-12#1)
practice for##11##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#2)(2011-1#1)(2012-2#2)(2013-1#1)
practice group##2##2##(2008-12#1)(2008-9#1)
practice guideline##6##2##(1992-8#1)(2009-7#1)(2010-10#2)(2010-8#1)(2012-3#1)
practice guidelines for##2##3##(1993-12#1)(2013-8#1)
practice guidelines in##3##3##(1996-2#1)(2008-8#1)(2009-7#1)
practice guidelines##15##2##(1992-8#1)(1993-12#5)(1994-12#1)(1996-2#2)(1997-1#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-8#1)(2013-8#1)
practice has##7##2##(1997-4#1)(2008-11#3)(2013-1#2)(2013-8#1)
practice in a##4##3##(1993-3#1)(1997-4#1)(2008-11#1)(2008-12#1)
practice in clinical##2##3##(2006-6#1)(2008-11#1)
practice in order to##2##4##(2008-11#1)(2011-2#1)
practice in the field of##2##5##(2008-11#1)(2012-12#1)
practice in the##15##3##(1991-3#1)(1992-1#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2009-9#1)(2010-11#1)(2012-12#1)
practice in this##2##3##(2008-10#1)(2008-12#1)
practice in##62##2##(1991-1#1)(1991-3#1)(1992-1#2)(1993-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-6#1)(2008-1#3)(2008-10#4)(2008-11#17)(2008-12#5)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
practice into##3##2##(2008-11#2)(2010-10#1)
practice is inadequate and##2##4##(2012-2#1)(2013-8#1)
practice is not##2##3##(1996-3#1)(1997-8#1)
practice is presented##2##3##(2008-11#1)(2008-12#1)
practice is the##2##3##(1992-3#1)(2008-11#1)
practice is##28##2##(1992-3#1)(1994-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-11#9)(2008-12#8)(2010-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
practice issues##2##2##(2008-11#1)(2008-9#1)
practice it##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
practice knowledge##2##2##(2008-12#1)(2010-10#1)
practice learning in##2##3##(2008-11#2)
practice learning##8##2##(2008-11#8)
practice management skills##2##3##(1993-1#1)(1994-3#1)
practice management##7##2##(1991-12#1)(1993-1#1)(1994-12#1)(1994-3#2)(1997-3#1)(2008-1#1)
practice may be##2##3##(1997-4#1)(2008-11#1)
practice may##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
practice medical##2##2##(2008-10#1)(2008-8#1)
practice module##2##2##(2008-11#2)
practice moves##2##2##(1997-4#1)(2008-11#1)
practice nurses##4##2##(2008-12#2)(2011-2#1)(2012-3#1)
practice of a##2##3##(1991-6#1)(2008-11#1)
practice of medicine##3##3##(1992-2#1)(1993-3#1)(1995-1#1)
practice of physical activity##5##4##(2010-11#5)
practice of public health##3##4##(1996-2#1)(1997-3#1)(2013-1#1)
practice of the##3##3##(1993-11#1)(1994-6#1)(2008-11#1)
practice of##78##2##(1990-2#1)(1990-6#1)(1991-6#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#4)(2008-10#7)(2008-11#9)(2008-12#3)(2008-5#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#6)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)
practice on##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
practice or##3##2##(1995-1#1)(2009-10#1)(2012-12#1)
practice outcomes##2##2##(2008-11#1)(2008-8#1)
practice parameters##2##2##(1993-3#1)(1995-1#1)
practice pattern##2##2##(1994-12#1)(1995-12#1)
practice patterns are##2##3##(1994-12#1)(2008-11#1)
practice patterns##10##2##(1990-6#2)(1993-2#1)(1994-12#3)(1994-2#1)(1995-12#1)(2008-11#1)(2012-2#1)
practice performance##3##2##(1996-2#3)
practice placement##10##2##(2008-11#10)
practice placements##5##2##(2008-11#5)
practice places##2##2##(2008-12#1)(2009-5#1)
practice relating to care of the older person##2##8##(2010-10#2)
practice remains##2##2##(2010-10#1)(2010-5#1)
practice setting##8##2##(1993-2#1)(1994-3#2)(1996-1#1)(2008-11#2)(2008-12#1)(2008-3#1)
practice settings##7##2##(2008-11#5)(2010-7#1)(2010-8#1)
practice skills##2##2##(2008-11#1)(2008-12#1)
practice than##2##2##(1994-12#1)(2013-1#1)
practice that##4##2##(2008-10#1)(2008-11#1)(2010-10#1)(2013-8#1)
practice the##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
practice through##7##2##(1991-3#1)(2008-11#3)(2008-12#3)
practice to##13##2##(1993-3#1)(1994-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2009-8#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-8#1)
practice using##2##2##(2008-11#1)(2013-1#1)
practice was##8##2##(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-1#1)
practice were##5##2##(1991-11#1)(1994-6#1)(2008-11#1)(2008-9#1)(2009-2#1)
practice with##6##2##(2008-11#2)(2008-9#1)(2010-7#1)(2013-1#2)
practice within##2##2##(1996-8#1)(2008-10#1)
practice would be##2##3##(2008-10#1)(2008-11#1)
practice##1052##1##(1990-2#1)(1990-3#11)(1990-6#6)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#7)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#5)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#6)(1993-11#5)(1993-12#16)(1993-2#11)(1993-3#5)(1993-6#1)(1993-8#1)(1994-1#20)(1994-12#12)(1994-2#1)(1994-3#7)(1994-5#2)(1994-6#6)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#7)(1995-2#3)(1995-6#1)(1995-9#1)(1996-1#14)(1996-11#3)(1996-12#5)(1996-2#14)(1996-3#8)(1996-6#3)(1996-8#6)(1997-1#1)(1997-2#5)(1997-3#14)(1997-4#12)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#3)(2006-6#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#9)(2008-10#44)(2008-11#290)(2008-12#88)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#10)(2008-7#15)(2008-8#12)(2008-9#15)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#44)(2010-11#15)(2010-12#10)(2010-3#3)(2010-4#3)(2010-5#4)(2010-7#6)(2010-8#7)(2010-9#4)(2011-1#6)(2011-2#31)(2011-3#2)(2011-7#1)(2012-12#9)(2012-2#24)(2012-3#21)(2013-1#50)(2013-8#16)
practice'##6##1##(2008-11#4)(2008-12#2)
practice's##2##1##(1995-1#1)(1996-12#1)
practice--a##2##1##(1992-3#1)(1993-2#1)
practice-based teaching##4##2##(2008-11#4)
practice-based##10##1##(2007-12#1)(2008-11#7)(2008-12#2)
practice?]##2##1##(1991-6#1)(1994-5#1)
practice]##19##1##(1990-11#1)(1991-3#1)(1993-11#1)(1993-2#2)(1993-5#1)(1994-6#2)(1994-8#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#2)(2008-10#1)(2008-11#1)(2009-5#1)(2012-3#1)(2013-1#1)
practiced by##3##2##(1994-12#1)(1995-1#1)(2008-10#1)
practiced##15##1##(1990-2#1)(1991-2#1)(1991-8#1)(1994-12#1)(1995-1#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
practices among##4##2##(1993-12#1)(2008-11#1)(2009-4#1)(2012-2#1)
practices and a##2##3##(1992-2#1)(2008-10#1)
practices and policies##2##3##(1996-12#1)(2010-1#1)
practices and training##2##3##(2008-11#1)(2011-2#1)
practices and##37##2##(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#5)(2008-12#6)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-6#4)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#3)(2013-8#1)
practices are described##2##3##(2008-4#1)(2010-11#1)
practices are##8##2##(1993-12#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-3#1)
practices associated with##4##3##(1996-3#1)(1996-9#1)(2008-9#1)(2010-9#1)
practices for the##2##3##(2010-11#1)(2011-2#1)
practices for##6##2##(2008-10#1)(2008-11#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#1)
practices have##5##2##(1992-3#1)(1993-3#1)(2008-10#2)(2008-11#1)
practices in the United States##2##5##(1993-3#1)(2012-2#1)
practices in the United##3##4##(1993-3#1)(2008-11#1)(2012-2#1)
practices in the##10##3##(1993-3#1)(1994-1#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
practices in##27##2##(1991-12#1)(1993-3#1)(1994-1#1)(1994-8#1)(1996-5#1)(1997-7#2)(2008-10#3)(2008-11#3)(2008-7#2)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
practices is##3##2##(1997-3#1)(2008-4#1)(2010-11#1)
practices of##12##2##(1990-6#1)(1990-8#1)(1993-12#1)(1995-9#1)(2008-10#2)(2008-11#2)(2010-4#2)(2011-2#1)(2012-2#1)
practices on the##2##3##(2008-10#2)
practices on##4##2##(2008-10#4)
practices such as##4##3##(1994-2#1)(2008-10#2)(2012-12#1)
practices that may##2##3##(1995-3#1)(2008-5#1)
practices that reduce##3##3##(2008-10#3)
practices that##13##2##(1993-1#1)(1995-3#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)
practices to children's perceptions and##2##5##(2008-12#2)
practices to the##2##3##(2008-12#1)(2012-3#1)
practices to##11##2##(1993-3#2)(2008-10#1)(2008-12#3)(2008-6#2)(2012-3#1)(2013-1#1)(2013-8#1)
practices used##2##2##(1991-12#1)(2010-11#1)
practices were##3##2##(2008-4#2)(2010-4#1)
practices with##2##2##(1991-12#1)(2008-6#1)
practices##292##1##(1990-6#1)(1990-8#1)(1991-12#6)(1991-2#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1993-1#2)(1993-12#8)(1993-3#8)(1993-5#1)(1994-1#1)(1994-12#5)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-6#2)(1997-7#7)(1997-8#1)(2007-12#3)(2008-1#4)(2008-10#37)(2008-11#29)(2008-12#15)(2008-4#10)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#8)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#13)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#1)(2010-9#5)(2011-2#9)(2012-12#2)(2012-2#10)(2012-3#6)(2013-1#9)(2013-8#5)
practicing physicians##3##2##(1992-12#1)(1996-1#1)(2008-6#1)
practicing##15##1##(1990-6#1)(1992-12#1)(1993-12#1)(1996-1#2)(1996-2#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
practicum##5##1##(1996-1#5)
practicums##2##1##(1997-3#1)(2008-12#1)
practise##2##1##(1994-12#1)(2013-8#1)
practised by##2##2##(1994-12#2)
practised##7##1##(1991-8#2)(1993-11#1)(1994-12#2)(2009-6#1)(2010-6#1)
practising##10##1##(1993-1#5)(1996-6#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-5#1)
practitioner and##8##2##(1996-8#1)(1997-4#1)(2008-1#1)(2008-11#4)(2008-12#1)
practitioner has##2##2##(1995-11#1)(2008-7#1)
practitioner in##7##2##(1992-12#1)(1993-11#1)(1993-2#1)(2008-1#1)(2008-12#1)(2009-9#1)(2010-10#1)
practitioner is##3##2##(1994-1#1)(1995-11#1)(2008-11#1)
practitioner##62##1##(1990-3#3)(1990-6#1)(1991-12#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-6#1)(1995-11#2)(1995-6#1)(1996-11#1)(1996-8#1)(1997-4#5)(2008-1#3)(2008-10#1)(2008-11#16)(2008-12#9)(2008-4#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-10#2)(2011-2#1)(2012-12#1)
practitioner's perspective##2##2##(1991-1#1)(1996-3#1)
practitioner's##8##1##(1990-9#1)(1991-1#2)(1996-3#1)(1997-4#1)(2008-1#2)(2008-11#1)
practitioners and educationalists##3##3##(2008-11#3)
practitioners and the##2##3##(1997-4#1)(2010-10#1)
practitioners and##23##2##(1991-1#1)(1993-11#1)(1993-2#1)(1996-3#1)(1996-6#1)(1997-4#4)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-8#1)(2010-10#2)(2010-7#1)(2011-2#2)
practitioners are##4##2##(1995-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
practitioners consider##2##2##(1993-2#1)(2008-10#1)
practitioners do##2##2##(1994-6#1)(2008-12#1)
practitioners during##2##2##(1991-12#1)(2008-11#1)
practitioners from##3##2##(1993-3#1)(1994-6#1)(2008-1#1)
practitioners have##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
practitioners in the##6##3##(1997-4#1)(2008-10#1)(2008-11#3)(2013-1#1)
practitioners in##15##2##(1991-9#1)(1994-6#1)(1997-2#1)(1997-4#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-8#2)(2013-1#2)
practitioners may be##2##3##(2008-5#1)(2011-1#1)
practitioners must##2##2##(2008-11#1)(2008-12#1)
practitioners of##2##2##(1996-3#1)(2008-11#1)
practitioners regarding##2##2##(2010-5#1)(2011-2#1)
practitioners to develop##2##3##(2008-12#1)(2010-9#1)
practitioners to##17##2##(1996-1#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-8#1)
practitioners were willing to##2##4##(2008-1#1)(2008-8#1)
practitioners were##3##2##(2008-1#1)(2008-11#1)(2008-8#1)
practitioners who##2##2##(1997-8#1)(2008-11#1)
practitioners with the##2##3##(2008-1#1)(2011-2#1)
practitioners with##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
practitioners##173##1##(1990-2#1)(1991-1#3)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#2)(1993-11#3)(1993-2#4)(1993-3#1)(1994-2#1)(1994-6#4)(1995-11#1)(1995-12#3)(1995-2#1)(1996-1#2)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#5)(1997-4#10)(1997-5#2)(1997-8#2)(2008-1#11)(2008-10#12)(2008-11#33)(2008-12#19)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#2)(2010-10#3)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#1)(2013-1#5)(2013-8#2)
practitioners' knowledge##2##2##(2008-8#1)(2009-6#1)
practitioners'##8##1##(1990-11#1)(1997-8#3)(2008-12#1)(2008-8#1)(2009-6#1)(2010-6#1)
pragmatic and##2##2##(2009-3#1)(2010-1#1)
pragmatic##15##1##(1993-3#1)(2008-11#2)(2008-12#4)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
pragmatics##2##1##(2008-11#1)(2008-9#1)
prairie and aspen forest##2##4##(2008-9#2)
prairie and forest##3##3##(2008-8#1)(2008-9#2)
prairie and##6##2##(2008-8#2)(2008-9#4)
prairie voles did##2##3##(2008-9#2)
prairie voles##4##2##(2008-9#4)
prairie##17##1##(2008-8#3)(2008-9#14)
praised##2##1##(2008-11#1)(2013-1#1)
prajmaline##3##1##(1996-3#3)
praseodymium (Pr)##2##2##(2007-12#1)(2012-2#1)
praseodymium in the##2##3##(2008-10#2)
praseodymium in##4##2##(2008-10#4)
praseodymium##10##1##(2007-12#1)(2008-10#8)(2012-2#1)
prawn##3##1##(2008-5#1)(2008-6#1)(2012-3#1)
praxis of##2##2##(2008-11#2)
praxis##6##1##(2008-11#2)(2011-3#1)(2012-3#2)(2013-1#1)
prayer##4##1##(2008-12#3)(2010-10#1)
praying##4##1##(2008-12#4)
prazepam##5##1##(2008-10#5)
praziquantel or oxamniquine##4##3##(2010-12#4)
praziquantel##6##1##(1995-12#1)(2010-12#5)
prazosin##4##1##(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)
pre and post##4##3##(2008-11#1)(2008-7#1)(2010-9#1)(2011-3#1)
pre and##5##2##(1994-12#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-3#1)
pre##9##1##(1990-8#1)(1994-12#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-9#1)(2011-3#1)(2012-3#1)(2013-8#1)
pre- and post-emergence##2##3##(2008-10#1)(2013-8#1)
pre- and post-intervention##5##3##(2008-12#3)(2011-2#1)(2013-1#1)
pre- and post-test##3##3##(1993-1#1)(1994-1#1)(1996-5#1)
pre- and post-treatment##2##3##(2008-10#1)(2008-3#1)
pre- and postintervention##3##3##(2010-7#1)(2013-1#2)
pre- and postnatal##3##3##(1993-3#1)(2012-2#2)
pre- and postsynaptic##4##3##(1990-12#1)(2009-8#1)(2009-9#2)
pre- and##47##2##(1990-12#1)(1990-9#1)(1991-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1996-5#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#5)(2008-3#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
pre- to post-intervention##3##3##(2008-12#3)
pre- to##8##2##(1992-12#1)(2008-12#6)(2012-2#1)
pre-##59##1##(1990-12#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-1#1)(1996-5#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#11)(2008-3#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
pre-LT##3##1##(2011-3#3)
pre-PPS##2##1##(1991-2#1)(1992-2#1)
pre-activated##2##1##(2008-10#2)
pre-analytical##2##1##(2010-9#1)(2013-1#1)
pre-arthritic deformities##2##2##(1997-6#2)
pre-case biosurveillance##2##2##(2010-8#2)
pre-clinical and##2##2##(2008-11#1)(2013-8#1)
pre-clinical validation##2##2##(2009-7#2)
pre-clinical##12##1##(2008-10#3)(2008-11#1)(2009-7#2)(2011-2#2)(2013-1#3)(2013-8#1)
pre-column and##2##2##(2008-10#2)
pre-column chelating reagent for##2##4##(2008-10#2)
pre-column chelating##3##2##(2008-10#3)
pre-column derivatization##6##2##(2008-10#6)
pre-column fluorescence derivatization##2##3##(2008-10#2)
pre-column##19##1##(2008-10#19)
pre-concentrated##2##1##(2008-10#2)
pre-concentrating##3##1##(2008-10#3)
pre-concentration and##12##2##(2008-10#12)
pre-concentration factor of##2##3##(2008-10#2)
pre-concentration factor##6##2##(2008-10#6)
pre-concentration in##3##2##(2008-10#3)
pre-concentration of mercury##2##3##(2008-10#2)
pre-concentration of selenite##2##3##(2008-10#2)
pre-concentration of the##3##3##(2008-10#3)
pre-concentration of##19##2##(2008-10#19)
pre-concentration procedure##3##2##(2008-10#3)
pre-concentration step##3##2##(2008-10#3)
pre-concentration time##2##2##(2008-10#2)
pre-concentration with##2##2##(2008-10#2)
pre-concentration##71##1##(2008-10#71)
pre-contrast##2##1##(1997-8#1)(2012-2#1)
pre-determined##3##1##(1995-6#1)(1995-9#1)(2008-5#1)
pre-ecdysis##4##1##(2008-7#4)
pre-eclampsia is##2##2##(2008-6#1)(2011-2#1)
pre-eclampsia##20##1##(1995-2#1)(2008-6#1)(2011-2#16)(2013-1#1)(2013-8#1)
pre-emergence##2##1##(2008-10#1)(2013-8#1)
pre-employment testing##2##2##(1997-1#2)
pre-emptive culling##2##2##(2011-3#2)
pre-emptive services that##2##3##(2009-6#2)
pre-emptive##5##1##(2009-6#2)(2009-7#1)(2011-3#2)
pre-end stage renal disease##3##4##(2008-1#3)
pre-end stage renal##4##3##(2008-1#4)
pre-established##2##1##(2008-11#1)(2013-1#1)
pre-existing##18##1##(1995-12#1)(1995-6#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-11#3)(2010-12#1)(2010-6#1)(2012-2#1)(2012-5#1)(2013-8#3)
pre-experimental values##2##2##(2011-2#2)
pre-experimental##3##1##(2011-2#3)
pre-exposure prophylaxis##3##2##(2012-2#1)(2013-1#2)
pre-exposure##4##1##(1996-2#1)(2012-2#1)(2013-1#2)
pre-harvest application of##2##3##(2011-2#2)
pre-implant##2##1##(2008-9#2)
pre-implantation##2##1##(2008-8#1)(2008-9#1)
pre-incubation##2##1##(1995-11#1)(2008-12#1)
pre-infection##2##1##(2008-10#1)(2008-11#1)
pre-injection##2##1##(2010-12#2)
pre-intervention AROM##2##2##(2008-12#2)
pre-karyote##7##1##(2009-6#7)
pre-karyotes##2##1##(2009-6#2)
pre-lingual##2##1##(2008-9#2)
pre-lingually deaf children##2##3##(2008-9#2)
pre-lingually##3##1##(2008-9#3)
pre-mRNA##4##1##(1993-8#3)(2009-7#1)
pre-mRNAs containing##2##2##(1993-6#2)
pre-maxilla##2##1##(2013-1#2)
pre-mix##3##1##(2008-10#3)
pre-mixed##2##1##(2012-2#1)(2013-8#1)
pre-normative research##2##2##(2008-10#2)
pre-operative radiotherapy and##2##3##(2008-12#2)
pre-operative##13##1##(1995-12#1)(1997-6#1)(2008-11#1)(2008-12#2)(2008-9#2)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
pre-operatively##3##1##(2008-11#1)(2008-7#1)(2013-1#1)
pre-parietal##5##1##(1995-6#5)
pre-peritoneal##4##1##(1992-5#2)(2012-12#2)
pre-plant##5##1##(2008-10#5)
pre-procedure##2##1##(1993-3#1)(2011-2#1)
pre-processing##3##1##(2008-10#2)(2008-7#1)
pre-prosthetic##2##1##(2013-1#2)
pre-pyloric site gastric cancer after PPG##2##6##(2008-12#2)
pre-qualification##2##1##(2008-11#2)
pre-reduced##4##1##(2008-10#4)
pre-reducing##4##1##(2008-10#4)
pre-reduction of##4##2##(2008-10#4)
pre-reduction step##2##2##(2008-10#2)
pre-reduction##10##1##(2008-10#10)
pre-reflective self##5##2##(2008-11#5)
pre-registration diploma##2##2##(2008-11#1)(2008-12#1)
pre-registration education##2##2##(2008-11#2)
pre-registration nursing programmes##2##3##(2008-11#2)
pre-registration nursing student##2##3##(2008-11#1)(2008-12#1)
pre-registration nursing students##3##3##(2008-11#3)
pre-registration nursing students'##4##3##(2008-11#3)(2008-12#1)
pre-registration nursing##15##2##(2008-11#13)(2008-12#2)
pre-registration programmes##2##2##(2008-11#2)
pre-registration student##2##2##(2008-11#2)
pre-registration##37##1##(2008-11#31)(2008-12#5)(2012-3#1)
pre-ruminant##2##1##(2012-2#2)
pre-school children##3##2##(2008-9#1)(2011-2#2)
pre-selected##3##1##(1992-1#1)(2008-10#1)(2008-5#1)
pre-separation##5##1##(2008-10#5)
pre-stage salivary##2##2##(2013-8#2)
pre-test and##2##2##(1996-1#1)(2008-11#1)
pre-test##7##1##(1996-1#2)(1996-5#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
pre-transplant##3##1##(2008-10#1)(2012-2#2)
pre-treated with 2##2##3##(2008-10#2)
pre-treated with##7##2##(2008-10#6)(2008-11#1)
pre-treated##11##1##(1990-6#1)(1995-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2013-1#1)
pre-treatment and##4##2##(2008-10#4)
pre-treatment baseline##2##2##(2010-9#1)(2012-3#1)
pre-treatment by##2##2##(2008-10#2)
pre-treatment methods##2##2##(2008-10#1)(2013-1#1)
pre-treatment of the sample##3##4##(2008-10#3)
pre-treatment of the samples##2##4##(2008-10#2)
pre-treatment of the##6##3##(2008-10#6)
pre-treatment or##2##2##(2008-10#2)
pre-treatment was##2##2##(2008-10#1)(2013-1#1)
pre-treatment with ozone##2##3##(2008-10#2)
pre-treatment with##8##2##(1996-12#1)(2008-10#7)
pre-treatment##57##1##(1991-2#1)(1992-9#2)(1996-12#1)(2008-1#1)(2008-10#41)(2008-2#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#6)
pre-treatments of##2##2##(2008-10#1)(2013-1#1)
pre-treatments##7##1##(2008-10#4)(2013-1#3)
pre-warmed##2##1##(2008-8#2)
pre-zymogenic##2##1##(1995-6#2)
preAD##3##1##(2009-10#3)
preS##2##1##(1993-8#2)
preS1 peptide##3##2##(1994-8#3)
preS1##8##1##(1993-8#3)(1994-8#4)(2008-8#1)
preS2##5##1##(1993-8#3)(2008-8#2)
preZad##4##1##(1991-10#4)
preabsorbed with##2##2##(1995-12#1)(1996-12#1)
preabsorbed##3##1##(1995-12#1)(1996-12#1)(2008-4#1)
preactivated conidia##2##2##(2008-10#2)
preactivated##5##1##(1990-5#1)(2008-10#4)
preadapted##3##1##(2008-11#3)
preadipocytes and##3##2##(1993-6#2)(2008-5#1)
preadipocytes##7##1##(1993-6#2)(2008-11#1)(2008-5#4)
preadult##2##1##(2008-8#1)(2008-9#1)
prealbumin##3##1##(2008-5#2)(2011-2#1)
preantral and antral follicles##2##4##(2008-8#2)
preantral and##3##2##(2008-8#3)
preantral##4##1##(2008-8#3)(2008-9#1)
prebiotics##2##1##(2008-8#1)(2011-2#1)
prebleaching##2##1##(2008-6#2)
prebloom##5##1##(2008-10#5)
prebottleneck##2##1##(2008-9#2)
precancer and cancer of the##2##5##(2008-11#2)
precancerous and cancerous##2##3##(1990-6#1)(2008-5#1)
precancerous lesions and##3##3##(2011-2#2)(2012-3#1)
precancerous lesions##11##2##(2011-2#3)(2011-3#7)(2012-3#1)
precancerous##15##1##(1990-6#1)(2008-4#1)(2008-5#1)(2011-2#4)(2011-3#7)(2012-3#1)
precautionary measures##3##2##(1991-1#1)(2012-3#1)(2013-1#1)
precautionary##4##1##(1991-1#1)(2008-11#1)(2012-3#1)(2013-1#1)
precautions are##2##2##(1995-2#1)(2008-10#1)
precautions##15##1##(1991-12#3)(1992-3#1)(1993-2#1)(1995-2#1)(1996-3#1)(1996-5#2)(2008-10#2)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
precede the development of##3##4##(2008-1#1)(2008-10#2)
precede the##5##2##(1994-3#1)(2008-1#1)(2008-10#2)(2013-8#1)
precede##13##1##(1991-5#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-12#1)(2012-3#1)(2013-8#1)
preceded by a##7##3##(1993-12#1)(1994-2#1)(2008-10#3)(2008-12#1)(2011-2#1)
preceded by the##3##3##(1994-5#1)(1995-8#1)(2008-10#1)
preceded by##23##2##(1991-3#1)(1992-4#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-8#1)
preceded the admission of##2##4##(1991-2#2)
preceded the##9##2##(1990-7#1)(1991-2#2)(1996-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-8#1)
preceded##43##1##(1990-7#1)(1991-2#2)(1991-3#1)(1992-4#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#3)(2012-3#3)(2013-8#2)
precedence##4##1##(1994-1#1)(2008-8#2)(2008-9#1)
precedes and##2##2##(2008-10#1)(2008-7#1)
precedes the##3##2##(1990-12#1)(1993-2#1)(2011-2#1)
precedes##10##1##(1990-12#1)(1992-8#1)(1993-2#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-7#1)(2011-2#3)
preceding a##2##2##(1993-12#1)(2008-10#1)
preceding the##6##2##(1990-3#1)(1992-5#1)(1996-8#1)(2008-11#1)(2010-6#1)(2013-8#1)
preceding##38##1##(1990-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-9#1)(1996-6#2)(1996-8#1)(1997-5#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
preceeds##2##1##(1996-2#1)(1996-5#1)
preceptors##3##1##(1994-12#1)(2008-11#1)(2008-12#1)
preceptorship within the workplace##2##4##(2008-11#2)
preceptorship##4##1##(2008-11#4)
precession##8##1##(2008-11#7)(2008-3#1)
prechecklist##2##1##(2013-1#2)
precious metal ions##2##3##(2008-10#2)
precious metal##5##2##(2008-10#5)
precious metals in##2##3##(2008-10#2)
precious metals##5##2##(2008-10#5)
precious##14##1##(1994-8#1)(2008-10#13)
precipitate formation##2##2##(2008-10#2)
precipitate is##4##2##(2008-10#4)
precipitate of##4##2##(2008-10#3)(2008-11#1)
precipitate that##2##2##(2008-2#2)
precipitate was##7##2##(2008-10#7)
precipitate with##3##2##(2008-10#3)
precipitate##46##1##(1993-2#1)(1993-8#1)(1996-2#1)(1996-3#1)(2008-10#35)(2008-11#2)(2008-2#3)(2008-4#1)(2013-1#1)
precipitated by a##2##3##(1993-6#1)(2008-5#1)
precipitated by##8##2##(1991-3#1)(1993-6#1)(1994-1#2)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
precipitated in##3##2##(2008-10#2)(2013-1#1)
precipitated polysaccharides##2##2##(2013-1#2)
precipitated with##3##2##(2008-10#2)(2008-11#1)
precipitated##33##1##(1990-11#1)(1991-3#1)(1993-6#1)(1994-1#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2012-2#1)(2013-1#6)
precipitates and##2##2##(2008-10#2)
precipitates were##5##2##(2008-10#5)
precipitates##27##1##(1994-11#1)(2008-10#26)
precipitating factor##2##2##(2009-11#1)(2012-3#1)
precipitating factors##5##2##(1990-11#1)(2010-10#3)(2011-2#1)
precipitating##15##1##(1990-11#1)(1991-2#2)(2008-10#5)(2008-9#1)(2009-11#1)(2010-10#3)(2011-2#1)(2012-3#1)
precipitation F(ab')2 anti-C3 ELISA##2##4##(1990-12#2)
precipitation and##20##2##(1991-9#1)(1993-3#1)(2008-10#10)(2008-3#1)(2008-4#1)(2008-8#4)(2010-4#1)(2011-3#1)
precipitation events##4##2##(2008-10#4)
precipitation from##2##2##(2008-10#2)
precipitation is##3##2##(2008-10#2)(2008-7#1)
precipitation of alpha-lactalbumin##2##3##(2008-7#2)
precipitation of the##3##3##(2008-10#2)(2008-5#1)
precipitation of##24##2##(1990-2#1)(2008-10#17)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2012-5#1)
precipitation patterns##2##2##(2008-10#1)(2012-5#1)
precipitation reaction of##3##3##(2008-10#3)
precipitation reaction##4##2##(2008-10#4)
precipitation step##2##2##(1994-6#1)(2008-7#1)
precipitation using##3##2##(2008-10#2)(2008-8#1)
precipitation was##2##2##(2008-10#1)(2008-11#1)
precipitation were##4##2##(2008-10#3)(2009-7#1)
precipitation with##5##2##(1990-11#1)(1995-6#1)(2008-10#2)(2008-8#1)
precipitation##137##1##(1990-11#1)(1990-12#2)(1990-2#3)(1991-9#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-6#1)(2008-10#84)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#9)(2008-8#8)(2008-9#1)(2009-7#2)(2010-11#1)(2010-4#2)(2011-3#1)(2012-2#1)(2012-5#2)(2013-1#2)
precipitation-dissolution##4##1##(2008-10#4)
precipitation/dissolution##4##1##(2008-10#4)
precipitations##2##1##(1992-12#1)(2008-10#1)
precipitator##5##1##(2008-10#5)
precise and accurate##12##3##(2008-10#11)(2012-2#1)
precise and##28##2##(1992-12#1)(1997-5#1)(1997-7#1)(2008-10#23)(2008-11#1)(2012-2#1)
precise control of##2##3##(1995-1#1)(2008-9#1)
precise delivery##2##2##(2008-10#1)(2010-5#1)
precise description of##2##3##(2008-10#1)(2013-8#1)
precise determination of the##2##4##(2008-10#1)(2008-2#1)
precise determination of##6##3##(2008-10#5)(2008-2#1)
precise determination##7##2##(2008-10#5)(2008-2#1)(2012-3#1)
precise diagnosis and##2##3##(1992-5#1)(2013-1#1)
precise diagnosis##5##2##(1992-5#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-1#1)
precise etiology##2##2##(2009-12#1)(2012-3#1)
precise evaluation of##3##3##(1994-12#1)(2008-2#1)(2011-7#1)
precise for##2##2##(2008-10#1)(2012-2#1)
precise individual##3##2##(1996-2#1)(2008-10#2)
precise localisation##2##2##(1991-3#1)(2011-2#1)
precise localization of##2##3##(2008-11#1)(2008-3#1)
precise localization##3##2##(1993-6#1)(2008-11#1)(2008-3#1)
precise measurement##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
precise measurements##3##2##(1990-11#1)(2008-11#1)(2008-6#1)
precise mechanism##2##2##(2008-9#2)
precise molecular mechanisms##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
precise molecular##4##2##(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)
precise quantification of##2##3##(1993-2#1)(2008-10#1)
precise quantification##3##2##(1993-2#1)(2008-10#2)
precise results##7##2##(2008-10#7)
precise##208##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-2#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#102)(2008-11#10)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#8)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#4)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#5)(2013-1#1)(2013-8#3)
precisely analyzed by##2##3##(1997-2#1)(2008-10#1)
precisely at##2##2##(2008-10#2)
precisely controlled##2##2##(2008-10#1)(2008-7#1)
precisely defined##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
precisely determined##3##2##(2008-10#2)(2008-9#1)
precisely in##2##2##(2008-3#1)(2009-9#1)
precisely known##3##2##(1993-6#1)(1994-5#1)(1997-8#1)
precisely mapped##2##2##(1997-3#1)(2012-3#1)
precisely the##4##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
precisely##55##1##(1991-10#1)(1993-12#1)(1993-6#1)(1994-5#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2008-10#15)(2008-11#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
precision (CV##3##2##(2008-10#3)
precision (R##17##2##(1992-11#1)(2008-10#16)
precision (RSD##5##2##(2008-10#5)
precision (assessed as the relative standard deviation)##2##7##(2008-10#2)
precision (n=8)##2##2##(2008-10#2)
precision (relative standard deviation)##2##4##(2008-10#2)
precision and accuracy of the method##2##6##(2008-10#2)
precision and accuracy of the##10##5##(2008-10#9)(2008-3#1)
precision and accuracy of##16##4##(2008-10#12)(2008-3#2)(2009-8#1)(2010-11#1)
precision and accuracy##34##3##(1997-2#1)(2008-10#29)(2008-3#2)(2009-8#1)(2010-11#1)
precision and efficiency##2##3##(2008-10#1)(2008-3#1)
precision and linearity##3##3##(2008-10#3)
precision and reproducibility##2##3##(2008-10#2)
precision and selectivity##2##3##(2008-10#2)
precision and sensitivity##4##3##(2008-10#4)
precision and specificity##2##3##(2008-10#1)(2012-2#1)
precision and##67##2##(1997-2#1)(2008-10#55)(2008-11#1)(2008-3#7)(2009-8#1)(2010-11#1)(2012-2#1)
precision at the##3##3##(2008-10#3)
precision at##4##2##(2008-10#4)
precision better than##2##3##(2008-10#2)
precision between##2##2##(2008-10#2)
precision by##2##2##(2008-10#2)
precision characteristics##3##2##(2008-10#3)
precision expressed as relative standard deviation (RSD)##2##7##(2008-10#1)(2009-8#1)
precision expressed as relative standard deviation was##2##7##(2008-10#2)
precision expressed as relative standard deviation##8##6##(2008-10#7)(2009-8#1)
precision expressed as##9##3##(2008-10#8)(2009-8#1)
precision filter radiometer##2##3##(2008-3#2)
precision for all##2##3##(2008-10#2)
precision for the##3##3##(2008-10#3)
precision for##17##2##(2008-10#15)(2008-3#2)
precision grip##2##2##(1996-2#2)
precision in the##6##3##(1993-9#1)(2008-10#4)(2008-3#1)
precision in##15##2##(1993-9#1)(2008-10#9)(2008-3#3)(2008-7#1)(2008-8#1)
precision is##7##2##(1990-2#1)(1997-2#1)(2008-10#2)(2008-3#1)(2010-4#1)(2012-2#1)
precision of 1##7##3##(2008-10#7)
precision of direct analyses##2##4##(2008-10#2)
precision of less than##2##4##(2008-10#2)
precision of measurement##3##3##(2008-10#2)(2008-3#1)
precision of the calibrator##2##4##(2008-10#2)
precision of the determination##3##4##(2008-10#3)
precision of the measurement##2##4##(2008-10#2)
precision of the method was estimated by##2##7##(2008-10#2)
precision of the method was estimated##3##6##(2008-10#3)
precision of the method was##8##5##(2008-10#8)
precision of the method##21##4##(2008-10#21)
precision of the proposed method was##3##6##(2008-10#3)
precision of the proposed method##5##5##(2008-10#5)
precision of the proposed##6##4##(2008-10#6)
precision of the results##2##4##(2008-10#2)
precision of the technique##2##4##(2008-10#2)
precision of the##50##3##(2008-10#49)(2013-1#1)
precision of this##3##3##(2008-10#2)(2008-2#1)
precision of##102##2##(2008-10#92)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2013-1#1)
precision on the##2##3##(2008-10#2)
precision on##3##2##(1990-2#1)(2008-10#2)
precision or##3##2##(2008-10#3)
precision than##2##2##(2008-10#2)
precision values##2##2##(2008-10#2)
precision was between##2##3##(1990-2#1)(2008-10#1)
precision was found to be##2##5##(2008-10#2)
precision was less than##2##4##(2008-10#1)(2011-3#1)
precision was obtained##2##3##(2008-10#2)
precision was##26##2##(1990-2#1)(1993-2#1)(2008-10#23)(2011-3#1)
precision were studied##2##3##(2008-10#2)
precision were##7##2##(1990-2#1)(2008-10#4)(2009-8#1)(2011-3#1)
precision##450##1##(1990-2#4)(1990-5#1)(1992-11#1)(1993-2#1)(1993-9#1)(1996-2#2)(1997-2#3)(2008-10#392)(2008-11#3)(2008-2#2)(2008-3#22)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-4#1)(2011-3#2)(2012-2#3)(2013-1#1)
precisions (RSD##2##2##(2008-10#2)
precisions and##2##2##(2008-10#2)
precisions of##4##2##(2008-10#4)
precisions##17##1##(2008-10#17)
preclinical AD##2##2##(2011-2#2)
preclinical CS##2##2##(2011-2#2)
preclinical and clinical research##3##4##(1995-5#1)(2008-5#1)(2008-7#1)
preclinical and clinical##8##3##(1995-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
preclinical and##11##2##(1995-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
preclinical development##2##2##(2008-11#1)(2008-4#1)
preclinical phase##2##2##(2008-10#2)
preclinical studies##3##2##(2008-5#1)(2010-10#1)(2010-11#1)
preclinical testing of##2##3##(2008-9#1)(2010-6#1)
preclinical##38##1##(1991-9#1)(1994-3#1)(1995-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#3)(2010-11#3)(2010-5#1)(2010-6#3)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
preclinically##2##1##(2008-11#1)(2010-10#1)
preclude##7##1##(1992-11#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-8#2)(2011-2#1)
precluded the##2##2##(1997-3#1)(2010-12#1)
precluded##10##1##(1990-12#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#3)(2009-6#1)(2010-10#1)(2010-12#1)
precludes their##2##2##(2008-7#1)(2008-8#1)
precludes##6##1##(1990-3#1)(1995-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)
precluding##4##1##(1991-5#1)(1994-11#1)(2011-2#1)(2013-1#1)
precoated with##5##2##(2008-10#2)(2008-11#3)
precoated##6##1##(2008-10#3)(2008-11#3)
precocious puberty##3##2##(2011-1#2)(2012-2#1)
precolumn derivatization with##2##3##(1991-12#1)(2008-5#1)
precolumn derivatization##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
precolumn enzymatic##2##2##(2008-10#2)
precolumn system##2##2##(2008-10#2)
precolumn##24##1##(1990-12#1)(1991-12#1)(2008-10#21)(2008-5#1)
precompetitive distribution##2##2##(2008-8#2)
precompetitive distributions##3##2##(2008-8#3)
precompetitive##5##1##(2008-8#5)
preconcentrate the##2##2##(2008-10#2)
preconcentrate##10##1##(2008-10#10)
preconcentrated and##2##2##(2008-10#2)
preconcentrated by##3##2##(2008-10#3)
preconcentrated from##2##2##(2008-10#2)
preconcentrated in a membrane cell and##2##6##(2008-10#2)
preconcentrated in a membrane cell using##2##6##(2008-10#2)
preconcentrated in a membrane cell##4##5##(2008-10#4)
preconcentrated in a##6##3##(2008-10#6)
preconcentrated in the##2##3##(2008-10#2)
preconcentrated in##10##2##(2008-10#10)
preconcentrated on a##3##3##(2008-10#3)
preconcentrated on the##5##3##(2008-10#5)
preconcentrated on##11##2##(2008-10#11)
preconcentrated onto the##3##3##(2008-10#3)
preconcentrated onto##5##2##(2008-10#5)
preconcentrated with##3##2##(2008-10#3)
preconcentrated##49##1##(2008-10#48)(2009-8#1)
preconcentrates the##3##2##(2008-10#3)
preconcentrating##7##1##(2008-10#7)
preconcentration and determination by##2##4##(2008-10#2)
preconcentration and determination in##3##4##(2008-10#3)
preconcentration and determination of Cr(III)##2##5##(2008-10#2)
preconcentration and determination of cobalt##2##5##(2008-10#2)
preconcentration and determination of copper by flame##2##7##(2008-10#2)
preconcentration and determination of copper##7##5##(2008-10#7)
preconcentration and determination of lead in##2##6##(2008-10#2)
preconcentration and determination of lead##4##5##(2008-10#4)
preconcentration and determination of trace amounts of##2##7##(2008-10#2)
preconcentration and determination of trace##3##5##(2008-10#3)
preconcentration and determination of##25##4##(2008-10#25)
preconcentration and determination system implemented with##2##6##(2008-10#2)
preconcentration and determination##35##3##(2008-10#35)
preconcentration and elution##2##3##(2008-10#2)
preconcentration and separation of trace##4##5##(2008-10#4)
preconcentration and separation of##8##4##(2008-10#8)
preconcentration and separation##13##3##(2008-10#13)
preconcentration and speciation of chromium##2##5##(2008-10#2)
preconcentration and speciation of##5##4##(2008-10#5)
preconcentration and speciation##6##3##(2008-10#6)
preconcentration and spectrophotometric##2##3##(2008-10#2)
preconcentration and##87##2##(2008-10#87)
preconcentration at##2##2##(2008-10#2)
preconcentration by##9##2##(2008-10#9)
preconcentration column##4##2##(2008-10#4)
preconcentration coupled with##2##3##(2008-10#2)
preconcentration efficiency##2##2##(2008-10#2)
preconcentration factor of##10##3##(2008-10#10)
preconcentration factor was##4##3##(2008-10#4)
preconcentration factor##25##2##(2008-10#25)
preconcentration factors of##3##3##(2008-10#3)
preconcentration factors##8##2##(2008-10#8)
preconcentration for##4##2##(2008-10#4)
preconcentration from##2##2##(2008-10#2)
preconcentration in a##3##3##(2008-10#3)
preconcentration in##6##2##(2008-10#6)
preconcentration is##2##2##(2008-10#2)
preconcentration method and##2##3##(2008-10#2)
preconcentration method for the determination of trace##2##7##(2008-10#2)
preconcentration method for the determination of##3##6##(2008-10#3)
preconcentration method for##6##3##(2008-10#6)
preconcentration method is described for the determination of##2##8##(2008-10#2)
preconcentration method is##4##3##(2008-10#4)
preconcentration method was##3##3##(2008-10#3)
preconcentration method##23##2##(2008-10#23)
preconcentration of 100 ml of##2##5##(2008-10#2)
preconcentration of Cd##2##3##(2008-10#2)
preconcentration of Cd(II)##2##3##(2008-10#2)
preconcentration of U(VI)##3##3##(2008-10#3)
preconcentration of both##2##3##(2008-10#2)
preconcentration of cobalt##3##3##(2008-10#3)
preconcentration of copper##4##3##(2008-10#4)
preconcentration of fulvic and humic acids##2##6##(2008-10#2)
preconcentration of inorganic and##2##4##(2008-10#2)
preconcentration of inorganic##4##3##(2008-10#4)
preconcentration of iron##3##3##(2008-10#3)
preconcentration of its##4##3##(2008-10#4)
preconcentration of lead and##2##4##(2008-10#2)
preconcentration of lead##5##3##(2008-10#5)
preconcentration of mercury##2##3##(2008-10#2)
preconcentration of metal ions##4##4##(2008-10#4)
preconcentration of metal##5##3##(2008-10#5)
preconcentration of platinum##2##3##(2008-10#2)
preconcentration of the##5##3##(2008-10#5)
preconcentration of thorium##3##3##(2008-10#3)
preconcentration of trace amounts of##2##5##(2008-10#2)
preconcentration of trace and ultratrace amounts of lanthanides##2##8##(2008-10#2)
preconcentration of trace and ultratrace amounts of##3##7##(2008-10#3)
preconcentration of trace elements##2##4##(2008-10#2)
preconcentration of trace mercury##2##4##(2008-10#2)
preconcentration of trace##17##3##(2008-10#17)
preconcentration of ultra trace##2##4##(2008-10#2)
preconcentration of uranium(VI)##3##3##(2008-10#3)
preconcentration of##134##2##(2008-10#134)
preconcentration on a##4##3##(2008-10#4)
preconcentration on##8##2##(2008-10#8)
preconcentration onto the##2##3##(2008-10#2)
preconcentration onto##5##2##(2008-10#5)
preconcentration procedure based on##2##4##(2008-10#2)
preconcentration procedure for lead determination##2##5##(2008-10#2)
preconcentration procedure for##4##3##(2008-10#4)
preconcentration procedure##10##2##(2008-10#10)
preconcentration procedures##2##2##(2008-10#2)
preconcentration step by##2##3##(2008-10#2)
preconcentration step##15##2##(2008-10#15)
preconcentration system for bismuth##2##4##(2008-10#2)
preconcentration system for palladium##2##4##(2008-10#2)
preconcentration system for the##2##4##(2008-10#2)
preconcentration system for##15##3##(2008-10#15)
preconcentration system using##2##3##(2008-10#2)
preconcentration system##32##2##(2008-10#32)
preconcentration systems##3##2##(2008-10#3)
preconcentration technique##3##2##(2008-10#3)
preconcentration techniques##4##2##(2008-10#3)(2010-7#1)
preconcentration time and##2##3##(2008-10#2)
preconcentration time of 120 s and a sample flow rate of##2##11##(2008-10#2)
preconcentration time of 120 s##5##5##(2008-10#5)
preconcentration time of 5 min##2##5##(2008-10#2)
preconcentration time of##19##3##(2008-10#19)
preconcentration time##45##2##(2008-10#45)
preconcentration time)##3##2##(2008-10#3)
preconcentration using the##2##3##(2008-10#2)
preconcentration using##8##2##(2008-10#8)
preconcentration was##8##2##(2008-10#8)
preconcentration were##3##2##(2008-10#3)
preconcentration with the##3##3##(2008-10#3)
preconcentration with##10##2##(2008-10#10)
preconcentration##545##1##(2008-10#542)(2008-11#1)(2010-7#2)
preconcentration)##3##1##(2008-10#3)
preconcentration/separation of##2##2##(2008-10#2)
preconcentration/separation##9##1##(2008-10#9)
preconditioned with##3##2##(2008-10#2)(2013-1#1)
preconditioning##4##1##(2008-10#2)(2008-5#1)(2010-12#1)
preconditions##2##1##(1992-5#1)(2008-8#1)
precontemplation##2##1##(2008-4#1)(2010-2#1)
precooled##3##1##(2008-9#3)
precooling##4##1##(1992-3#4)
precordial pain##4##2##(2008-10#1)(2008-7#3)
precorneous layers##2##2##(2011-2#2)
precue##3##1##(2008-7#3)
precuneus##3##1##(2008-11#3)
precursor (APP)##2##2##(1992-12#1)(1994-11#1)
precursor and the##4##3##(1993-12#2)(1994-11#2)
precursor and##7##2##(1993-12#3)(1994-11#2)(1995-2#1)(1995-6#1)
precursor as##2##2##(1992-12#1)(1995-6#1)
precursor cDNA##2##2##(2010-5#2)
precursor cell lines##4##3##(1995-2#1)(2008-11#3)
precursor cell##5##2##(1994-12#1)(1995-2#1)(2008-11#3)
precursor cells to##2##3##(1995-8#1)(2010-8#1)
precursor cells##32##2##(1990-11#3)(1993-6#1)(1994-11#1)(1995-8#5)(1996-2#1)(2008-11#14)(2008-7#3)(2008-9#2)(2010-8#1)(2013-1#1)
precursor cleavage##3##2##(2008-11#3)
precursor for##3##2##(1993-12#1)(1997-2#1)(2010-11#1)
precursor form##2##2##(1991-9#1)(2008-4#1)
precursor is##3##2##(1992-6#1)(1993-3#1)(1996-5#1)
precursor lesion##2##2##(2010-12#1)(2011-2#1)
precursor molecule##2##2##(1994-8#1)(1995-2#1)
precursor molecules##2##2##(2008-10#1)(2008-11#1)
precursor of dehydroalanine in the active site of##2##8##(1994-5#2)
precursor of the##6##3##(1991-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2012-3#1)
precursor of##24##2##(1990-8#1)(1991-11#2)(1991-6#1)(1991-7#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-5#3)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
precursor processing##4##2##(1994-8#3)(2008-11#1)
precursor protein (APP)##4##3##(1993-8#1)(1995-12#1)(1996-12#2)
precursor protein##15##2##(1991-10#2)(1992-12#3)(1992-6#1)(1993-8#4)(1995-12#1)(1996-12#2)(2008-11#1)(2008-4#1)
precursor proteins##3##2##(1991-2#1)(1994-11#1)(2008-1#1)
precursor that##2##2##(1993-12#1)(2008-4#1)
precursor to##5##2##(1992-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-3#1)
precursor was##3##2##(1991-9#1)(1995-2#1)(2008-5#1)
precursor##177##1##(1990-11#3)(1990-5#1)(1990-8#2)(1991-10#2)(1991-11#2)(1991-2#1)(1991-6#2)(1991-7#2)(1991-9#2)(1992-10#2)(1992-12#5)(1992-6#6)(1992-8#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#5)(1994-11#8)(1994-12#1)(1994-5#3)(1994-8#5)(1995-12#1)(1995-2#5)(1995-6#2)(1995-8#7)(1996-12#3)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-4#1)(2008-1#1)(2008-10#14)(2008-11#27)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#2)(2010-8#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
precursor-derived peptides##2##2##(1994-8#2)
precursors and##5##2##(2008-10#2)(2010-4#1)(2012-2#1)(2013-8#1)
precursors for the##2##3##(2008-10#1)(2010-5#1)
precursors for##4##2##(1995-3#1)(2008-10#1)(2010-5#1)(2013-1#1)
precursors in the##2##3##(1994-11#1)(2013-1#1)
precursors in##8##2##(1990-5#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-1#1)(2013-1#1)
precursors of##13##2##(1990-12#1)(1990-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1996-5#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
precursors present in##2##3##(2008-5#2)
precursors to##5##2##(1992-6#1)(1993-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
precursors were##2##2##(2008-5#1)(2008-7#1)
precursors##68##1##(1990-12#1)(1990-5#2)(1991-6#1)(1992-6#1)(1993-12#3)(1993-6#1)(1994-1#1)(1994-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-10#11)(2008-11#6)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#2)(2011-2#1)(2011-3#3)(2012-2#3)(2013-1#5)(2013-8#1)
pred##2##1##(1993-2#2)
predates##2##1##(1997-1#1)(2009-6#1)
predation and##5##2##(1995-3#1)(2008-8#2)(2008-9#2)
predation on##5##2##(2008-8#3)(2008-9#2)
predation risk##7##2##(2008-8#1)(2008-9#3)(2010-8#1)(2012-3#2)
predation##51##1##(1995-3#1)(2008-8#20)(2008-9#22)(2010-8#2)(2012-2#1)(2012-3#5)
predation)##2##1##(2008-9#1)(2012-3#1)
predator and##4##2##(2008-8#2)(2009-8#1)(2012-3#1)
predator cues##2##2##(2012-3#2)
predator density##2##2##(2012-3#2)
predator in##4##2##(2008-8#1)(2008-9#1)(2010-8#2)
predator species##3##2##(2008-8#1)(2008-9#2)
predator##43##1##(1994-8#1)(2008-6#1)(2008-8#19)(2008-9#9)(2009-10#1)(2009-8#1)(2010-8#3)(2012-3#8)
predator-induced##4##1##(2008-4#1)(2008-8#3)
predator-prey system##3##2##(2008-8#2)(2008-9#1)
predator-prey##9##1##(1997-6#1)(2008-10#1)(2008-8#4)(2008-9#3)
predators and prey##3##3##(2008-8#3)
predators and##6##2##(1997-7#1)(2008-8#5)
predators but##2##2##(2008-8#1)(2008-9#1)
predators in##3##2##(2008-6#1)(2008-8#2)
predators with##2##2##(2008-8#1)(2012-2#1)
predators##42##1##(1997-7#1)(2008-6#1)(2008-8#25)(2008-9#6)(2012-2#2)(2012-3#6)(2013-1#1)
predatory behaviour##2##2##(2012-2#2)
predatory##4##1##(2008-8#1)(2012-2#3)
predefined##9##1##(1993-1#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-12#1)
predeposit##2##1##(1996-9#2)
predetermined##12##1##(1993-12#1)(1996-3#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2009-1#1)(2012-3#1)
predialysis##6##1##(1994-5#1)(2008-1#3)(2008-12#2)
predicament##2##1##(2009-11#1)(2013-1#1)
predicated on##2##2##(2008-11#1)(2013-8#1)
predicated##3##1##(2008-11#1)(2008-9#1)(2013-8#1)
predict binding##2##2##(1992-9#1)(2010-7#1)
predict disease severity##2##3##(2008-10#1)(2013-1#1)
predict disease##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
predict future##2##2##(2008-11#1)(2012-2#1)
predict its##2##2##(1996-2#1)(1997-2#1)
predict mortality##2##2##(2009-4#1)(2013-1#1)
predict readmission##2##2##(2011-2#2)
predict response##2##2##(1992-3#1)(2008-7#1)
predict stem cell##2##3##(2008-11#2)
predict that it##2##3##(2008-10#1)(2008-5#1)
predict that the##2##3##(2010-10#1)(2010-4#1)
predict that##20##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#7)(2008-9#3)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
predict the enantiomeric composition##2##4##(2008-10#2)
predict the existence of##2##4##(1997-9#1)(2008-3#1)
predict the level of##2##4##(2011-2#1)(2013-1#1)
predict the likelihood of##3##4##(2009-6#2)(2012-12#1)
predict the number##2##3##(2008-11#1)(2008-6#1)
predict the potential##3##3##(1996-6#1)(2011-3#1)(2013-8#1)
predict the prognosis of##2##4##(2010-8#1)(2011-2#1)
predict the##83##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-6#1)(1996-12#1)(1996-6#1)(1997-9#1)(2007-8#1)(2008-10#23)(2008-11#4)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
predict##255##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#4)(1991-2#2)(1992-3#4)(1992-4#1)(1992-9#2)(1993-2#1)(1993-6#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-8#1)(2008-10#56)(2008-11#13)(2008-12#6)(2008-2#1)(2008-3#8)(2008-5#5)(2008-6#2)(2008-7#14)(2008-8#19)(2008-9#9)(2009-10#2)(2009-12#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#3)(2010-10#2)(2010-12#1)(2010-4#4)(2010-5#1)(2010-7#4)(2010-8#3)(2011-2#18)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#10)(2013-8#6)
predictability of##6##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2011-7#1)
predictability##9##1##(1994-3#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-7#1)
predictable and##2##2##(2008-11#1)(2013-1#1)
predictable##29##1##(1993-3#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
predictably##3##1##(1994-3#1)(1996-9#1)(1997-1#1)
predicted a##4##2##(2008-11#1)(2008-7#2)(2008-9#1)
predicted amino acid (aa) sequences##2##5##(1993-6#1)(1993-9#1)
predicted amino acid sequence##9##4##(1993-12#1)(1993-8#1)(1994-6#1)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#1)(2008-9#1)
predicted amino acid sequences##2##4##(1997-2#1)(2008-10#1)
predicted amino acid##14##3##(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-6#2)(1995-8#1)(1997-2#2)(2008-10#3)(2008-9#1)
predicted and experimental##3##3##(2008-10#3)
predicted and observed##2##3##(2008-10#1)(2008-3#1)
predicted and the##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
predicted and##11##2##(1990-5#1)(2008-10#6)(2008-3#2)(2008-8#1)(2010-6#1)
predicted as##3##2##(1990-12#1)(2008-10#2)
predicted by a##2##3##(2008-10#1)(2013-8#1)
predicted by model##2##3##(2008-10#2)
predicted by models of##3##4##(2008-8#2)(2008-9#1)
predicted by the model##2##4##(2008-8#1)(2009-10#1)
predicted by the##18##3##(1991-10#1)(1993-3#1)(1995-12#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-8#5)(2009-10#1)(2009-8#1)(2010-8#1)
predicted by##57##2##(1990-5#1)(1991-1#1)(1991-10#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#14)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#11)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-8#1)
predicted concentration##2##2##(2008-10#2)
predicted for the##3##3##(2008-10#2)(2012-5#1)
predicted for##7##2##(1992-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-5#1)
predicted from a##2##3##(1996-2#1)(2008-3#1)
predicted from the##6##3##(1991-5#1)(1991-9#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-3#1)
predicted from##17##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-2#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-9#1)
predicted growth##2##2##(2011-1#1)(2011-2#1)
predicted in##5##2##(1992-3#1)(1997-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
predicted initial levels##2##3##(2009-7#1)(2011-2#1)
predicted molecular##3##2##(2008-10#2)(2008-8#1)
predicted only##3##2##(2008-10#2)(2012-3#1)
predicted open reading frames##2##4##(1994-11#1)(2008-10#1)
predicted open reading##3##3##(1994-11#2)(2008-10#1)
predicted optimal##2##2##(2008-7#1)(2013-1#1)
predicted or##2##2##(1991-12#1)(1994-9#1)
predicted polypeptide##3##2##(1990-5#1)(1995-6#1)(2008-10#1)
predicted product##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
predicted protein##6##2##(1993-12#2)(1996-12#1)(1996-6#1)(1997-7#1)(2008-10#1)
predicted response##3##2##(2008-10#1)(2012-2#2)
predicted results##2##2##(2008-10#1)(2008-8#1)
predicted slopes of##3##3##(2008-8#3)
predicted solely from##2##3##(1994-8#1)(2011-2#1)
predicted that a##3##3##(1995-12#1)(2008-7#1)(2008-9#1)
predicted that##9##2##(1995-12#1)(1995-3#1)(1996-8#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)
predicted the##11##2##(1995-8#1)(1996-2#1)(2008-10#4)(2008-7#1)(2008-8#2)(2010-7#1)(2011-2#1)
predicted to be##8##3##(1990-11#1)(1993-12#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)
predicted to encode a##4##4##(1996-3#1)(1996-6#1)(2008-10#1)(2008-8#1)
predicted to encode##6##3##(1994-9#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-8#1)
predicted to form##2##3##(1994-12#1)(2008-8#1)
predicted to produce##2##3##(2008-9#1)(2011-2#1)
predicted to##30##2##(1990-11#1)(1990-5#2)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-6#1)(2008-10#5)(2008-5#1)(2008-8#4)(2008-9#5)(2011-2#2)(2013-8#2)
predicted translation product##2##3##(1991-5#1)(1997-8#1)
predicted transmembrane##2##2##(1995-2#1)(1996-3#1)
predicted using an##2##3##(2008-10#2)
predicted using##6##2##(2008-10#5)(2008-7#1)
predicted values##5##2##(1992-3#1)(2008-10#4)
predicted with a##2##3##(2008-10#1)(2008-3#1)
predicted with##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
predicted##368##1##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#7)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1993-1#3)(1993-12#7)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-12#4)(1995-2#1)(1995-3#3)(1995-6#4)(1995-8#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#6)(1997-4#1)(1997-6#5)(1997-7#4)(1997-8#4)(2007-12#2)(2007-8#1)(2008-10#93)(2008-11#9)(2008-12#6)(2008-3#14)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#39)(2008-9#18)(2009-10#2)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#19)(2011-3#2)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#8)
predicted)##2##1##(2008-3#1)(2008-8#1)
predicting RNA##3##2##(1992-3#1)(2008-4#1)(2011-3#1)
predicting an##2##2##(2008-10#1)(2012-3#1)
predicting future##2##2##(1996-6#1)(2008-8#1)
predicting the risk of##2##4##(1994-3#1)(2011-2#1)
predicting the##34##2##(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-3#1)
predicting these##2##2##(2008-11#1)(2008-2#1)
predicting treatment##2##2##(2008-6#1)(2013-1#1)
predicting##109##1##(1991-11#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#2)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#34)(2008-11#8)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
prediction ability and##2##3##(2008-10#2)
prediction ability##10##2##(2008-10#10)
prediction accuracy##5##2##(2008-10#4)(2010-7#1)
prediction and real samples data##2##5##(2008-10#2)
prediction and the##2##3##(2009-7#1)(2013-8#1)
prediction and##8##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2013-8#2)
prediction are##3##2##(2008-10#1)(2008-11#2)
prediction by##3##2##(2008-8#2)(2010-12#1)
prediction error of##2##3##(2008-10#2)
prediction error##12##2##(2008-10#7)(2008-11#3)(2008-7#1)(2013-8#1)
prediction errors##2##2##(2008-10#2)
prediction for##5##2##(2008-10#3)(2008-8#1)(2012-2#1)
prediction from##2##2##(1991-6#1)(2008-10#1)
prediction in##5##2##(1991-12#1)(2008-11#1)(2010-12#3)
prediction is##3##2##(2007-12#1)(2008-12#1)(2008-9#1)
prediction model for##2##3##(2008-10#2)
prediction model##5##2##(2008-10#4)(2008-11#1)
prediction models were##2##3##(2008-10#2)
prediction models##3##2##(2008-10#2)(2010-5#1)
prediction of all-cause mortality##2##4##(2008-7#2)
prediction of gray leaf spot of##2##6##(2008-10#2)
prediction of light##2##3##(2008-3#2)
prediction of long term##2##4##(2013-1#2)
prediction of long-term##2##3##(1992-12#1)(2008-9#1)
prediction of moisture##2##3##(2008-10#2)
prediction of pregnancy-induced hypertension##2##4##(1994-3#1)(2012-2#1)
prediction of the##15##3##(1990-5#1)(1993-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-8#1)
prediction of##92##2##(1990-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-8#1)(2008-10#28)(2008-11#4)(2008-3#6)(2008-4#3)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#3)(2013-1#5)
prediction performance of the##2##4##(2008-10#1)(2013-1#1)
prediction performance##3##2##(2008-10#2)(2013-1#1)
prediction programs##2##2##(2008-8#1)(2008-9#1)
prediction rate of##2##3##(1997-6#1)(2010-8#1)
prediction rate##3##2##(1997-6#1)(2010-8#2)
prediction results##4##2##(2008-10#4)
prediction rules##2##2##(1993-12#1)(2008-12#1)
prediction samples##2##2##(2008-10#2)
prediction that##5##2##(2008-8#3)(2008-9#1)(2012-3#1)
prediction was##2##2##(2008-10#1)(2008-8#1)
prediction##251##1##(1990-4#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#3)(1994-3#1)(1995-11#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#3)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#113)(2008-11#13)(2008-12#3)(2008-3#8)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#14)(2008-9#10)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#6)
predictions about the##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
predictions about##6##2##(1992-1#1)(2008-11#1)(2008-8#2)(2008-9#2)
predictions and##5##2##(2008-10#2)(2008-11#3)
predictions are given##2##3##(1991-12#1)(2008-8#1)
predictions are##5##2##(1991-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2013-8#1)
predictions for the##2##3##(1990-12#1)(2008-11#1)
predictions for##10##2##(1990-12#1)(1992-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#1)
predictions from the##2##3##(2008-11#1)(2008-9#1)
predictions from##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
predictions have been##2##3##(2008-10#1)(2008-11#1)
predictions in the##2##3##(2008-10#1)(2008-8#1)
predictions in##4##2##(2008-10#2)(2008-8#2)
predictions of the model##3##4##(1990-8#1)(1992-3#1)(2008-8#1)
predictions of the##20##3##(1990-8#1)(1992-3#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#6)(2008-9#3)(2009-5#1)(2009-7#1)
predictions of##40##2##(1990-8#1)(1992-3#2)(1994-3#2)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#8)(2008-9#6)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-8#1)
predictions that##5##2##(1995-2#1)(2008-10#1)(2008-8#2)(2013-8#1)
predictions using##5##2##(2008-10#1)(2008-11#1)(2008-8#3)
predictions was##2##2##(2008-10#1)(2008-11#1)
predictions were compared with##2##4##(1994-3#1)(2008-8#1)
predictions were##12##2##(1993-12#1)(1994-3#1)(2008-10#5)(2008-7#1)(2008-8#3)(2009-7#1)
predictions##160##1##(1990-12#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-3#3)(1992-9#2)(1993-12#1)(1994-3#3)(1995-2#1)(2007-12#1)(2008-10#33)(2008-11#15)(2008-2#2)(2008-3#12)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#34)(2008-9#15)(2009-11#1)(2009-4#1)(2009-5#2)(2009-7#4)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#6)
predictive ability of the##6##4##(2008-10#4)(2009-3#1)(2012-3#1)
predictive ability of##9##3##(2008-10#6)(2009-3#1)(2012-12#1)(2012-3#1)
predictive ability##12##2##(2008-10#9)(2009-3#1)(2012-12#1)(2012-3#1)
predictive accuracy for##2##3##(2012-3#2)
predictive accuracy##4##2##(1993-3#1)(2012-3#2)(2013-1#1)
predictive and prognostic##2##3##(2008-7#1)(2011-3#1)
predictive and##5##2##(2008-10#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-3#1)
predictive factors for##2##3##(2009-5#1)(2012-3#1)
predictive factors##9##2##(2008-10#1)(2009-4#2)(2009-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
predictive for a substitution of##2##5##(1994-11#2)
predictive for##4##2##(1994-11#2)(2008-7#1)(2013-1#1)
predictive information##2##2##(2008-10#1)(2012-2#1)
predictive markers##2##2##(2013-1#2)
predictive microbiology##2##2##(2011-2#2)
predictive model for##4##3##(2008-10#3)(2008-5#1)
predictive model with##2##3##(2010-8#1)(2012-12#1)
predictive model##11##2##(2008-10#4)(2008-11#2)(2008-5#1)(2009-3#1)(2010-7#1)(2010-8#1)(2012-12#1)
predictive models##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
predictive of a##2##3##(1993-12#1)(2008-10#1)
predictive of increased##3##3##(2008-10#1)(2012-3#2)
predictive of the##4##3##(1996-6#1)(2008-11#1)(2008-5#1)(2008-6#1)
predictive of##26##2##(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#1)(2010-11#2)(2012-3#3)(2013-1#1)
predictive performance##4##2##(2008-7#2)(2009-7#1)(2012-3#1)
predictive power and##2##3##(2008-8#1)(2013-8#1)
predictive power of the models##2##5##(2008-5#1)(2009-8#1)
predictive power of the##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
predictive power of##7##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2012-2#1)
predictive power##10##2##(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
predictive test##2##2##(1992-3#1)(2013-8#1)
predictive validity and effects of using the##2##7##(2013-1#2)
predictive validity##7##2##(1994-2#3)(1994-3#1)(2010-7#1)(2013-1#2)
predictive value and##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
predictive value for##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
predictive value of the##2##4##(1990-2#1)(2008-10#1)
predictive value of##11##3##(1990-2#1)(1991-12#1)(1993-2#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-2#3)
predictive value##40##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#2)(1993-2#1)(1995-3#1)(1996-1#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-2#14)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
predictive values of##2##3##(2008-11#1)(2012-12#1)
predictive values##4##2##(1994-3#1)(2008-11#1)(2012-12#2)
predictive##180##1##(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#4)(1994-3#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-10#38)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#3)(2009-11#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-7#4)(2010-8#1)(2011-2#20)(2011-3#1)(2012-12#8)(2012-2#4)(2012-3#10)(2013-1#8)(2013-8#7)
predictor for the##2##3##(2009-8#1)(2013-1#1)
predictor for##12##2##(2008-10#1)(2008-11#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#3)
predictor of acute coronary##2##4##(2008-3#2)
predictor of depression##2##3##(2007-12#1)(2013-1#1)
predictor of later##2##3##(2008-12#1)(2012-2#1)
predictor of the##5##3##(1995-2#1)(2008-10#2)(2008-9#1)(2012-3#1)
predictor of##44##2##(1991-3#1)(1993-1#1)(1995-2#1)(1996-3#2)(1996-8#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#5)(2013-1#4)
predictor variables##7##2##(2008-10#6)(2012-2#1)
predictor##70##1##(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#2)(1994-12#1)(1995-2#1)(1996-3#2)(1996-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#2)(2010-10#3)(2010-8#1)(2011-2#7)(2012-2#5)(2012-3#5)(2013-1#7)
predictors for##2##2##(1994-3#1)(2010-5#1)
predictors of hypertension##3##3##(2008-11#3)
predictors of memory performance in##2##5##(2008-12#1)(2008-7#1)
predictors of mortality in##4##4##(2011-2#4)
predictors of mortality##8##3##(2008-7#3)(2011-2#5)
predictors of peripheral neuropathy occurrence in HIV-1 infected##2##8##(2008-11#2)
predictors of the##3##3##(2008-11#1)(2008-7#1)(2011-3#1)
predictors of##59##2##(1992-3#1)(1994-3#1)(1995-12#2)(1996-1#1)(1996-3#1)(2008-10#3)(2008-11#7)(2008-12#3)(2008-4#1)(2008-7#8)(2009-11#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#1)(2013-3#1)
predictors that##2##2##(1994-3#1)(2008-11#1)
predictors were##2##2##(2008-10#1)(2009-9#1)
predictors##87##1##(1992-12#1)(1992-3#2)(1994-3#3)(1995-12#4)(1996-1#1)(1996-3#1)(1996-8#1)(2008-10#5)(2008-11#12)(2008-12#5)(2008-4#1)(2008-7#8)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#2)(2013-3#1)
predicts a##7##2##(1993-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)
predicts some##2##2##(2008-11#1)(2008-3#1)
predicts that cooperation can##2##4##(2008-8#2)
predicts that the##8##3##(1993-9#1)(1997-8#1)(2008-7#1)(2008-8#3)(2010-10#1)(2012-3#1)
predicts that this##2##3##(1995-8#1)(2008-10#1)
predicts that##34##2##(1993-6#2)(1993-9#1)(1994-9#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#13)(2008-9#5)(2010-10#1)(2011-2#1)(2012-3#1)
predicts the##7##2##(1997-6#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-7#1)(2013-1#1)
predicts##76##1##(1993-11#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#18)(2008-9#7)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
predilection for the##3##3##(2013-1#3)
predilection for##6##2##(1991-8#1)(1997-1#1)(2009-5#1)(2013-1#3)
predispose for##2##2##(1993-2#1)(1997-4#1)
predispose some##2##2##(2008-10#1)(2009-12#1)
predispose to the development of##2##5##(2008-11#1)(2011-2#1)
predispose to##7##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
predispose##14##1##(1993-2#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
predisposed to memorize##2##3##(2008-6#2)
predisposed to##5##2##(1992-6#1)(2008-6#2)(2010-6#1)(2011-2#1)
predisposed##11##1##(1992-6#1)(1994-3#2)(2008-10#3)(2008-6#2)(2010-6#1)(2011-2#1)(2013-1#1)
predisposes to##2##2##(1997-7#1)(2008-7#1)
predisposes##5##1##(1992-12#1)(1996-12#1)(1997-7#1)(2008-7#1)(2009-12#1)
predisposing factor##2##2##(2010-12#2)
predisposing factors##9##2##(1992-1#1)(1997-9#1)(2008-5#2)(2008-7#1)(2010-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
predisposing gene##2##2##(1993-1#1)(2008-8#1)
predisposing lung conditions##2##3##(2007-12#2)
predisposing to##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
predisposing##27##1##(1991-8#1)(1992-1#1)(1993-1#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-7#1)(2013-8#1)
predisposition and environmental influences##2##4##(1995-2#1)(2008-10#1)
predisposition is##2##2##(2008-11#1)(2011-2#1)
predisposition to LDL oxidation during copper-catalyzed oxidative modification##2##8##(1991-12#2)
predisposition to##10##2##(1991-12#2)(1993-6#1)(1997-7#1)(2008-11#2)(2008-7#2)(2010-12#1)(2011-2#1)
predisposition##19##1##(1991-12#3)(1993-6#1)(1995-2#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-7#3)(2010-12#1)(2011-2#2)(2012-2#1)
predispositions##2##1##(2008-10#1)(2008-12#1)
prednisolone##10##1##(1992-2#2)(1994-3#1)(1995-5#1)(1997-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
prednisone##12##1##(1990-12#1)(1992-2#1)(1997-3#1)(1997-8#1)(2008-12#1)(2008-7#3)(2010-12#3)(2012-3#1)
predominance in the##2##3##(1994-12#2)
predominance in##4##2##(1994-12#2)(2008-10#1)(2012-3#1)
predominance of the##3##3##(2008-10#2)(2012-3#1)
predominance of##16##2##(1990-8#1)(1992-6#1)(1993-1#1)(1994-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
predominance##25##1##(1990-8#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-12#2)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#3)(2013-8#1)
predominant among##2##2##(2008-10#1)(2008-11#1)
predominant component##2##2##(2008-10#1)(2008-12#1)
predominant in the##3##3##(1990-5#2)(2009-12#1)
predominant in##11##2##(1990-5#2)(1994-2#1)(2008-10#4)(2008-5#2)(2009-12#1)(2011-2#1)
predominant mode of##2##3##(2008-10#2)
predominant mode##4##2##(2008-10#4)
predominant pattern##2##2##(2011-2#1)(2012-3#1)
predominant serotype##2##2##(2008-5#1)(2013-8#1)
predominant species##8##2##(1994-11#1)(1996-12#1)(2008-10#4)(2013-8#2)
predominant##110##1##(1990-11#1)(1990-5#2)(1990-6#1)(1991-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-6#1)(1996-12#3)(1997-1#1)(1997-2#1)(1997-4#1)(2008-1#3)(2008-10#35)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#2)(2009-12#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#6)
predominantly detected in##2##3##(2008-10#2)
predominantly during##2##2##(1994-8#1)(1995-8#1)
predominantly expressed##6##2##(1991-9#1)(1995-8#2)(1997-2#1)(2009-8#1)(2011-1#1)
predominantly in the posterior fossa##2##5##(2008-7#2)
predominantly in the##10##3##(1993-8#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)
predominantly in##13##2##(1992-3#1)(1993-8#1)(1995-12#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
predominantly male##2##2##(2012-12#1)(2012-2#1)
predominantly of##2##2##(2008-5#1)(2012-2#1)
predominantly on##3##2##(2008-10#2)(2008-11#1)
predominantly seen in##2##3##(1995-8#1)(2012-3#1)
predominantly to##2##2##(2008-10#1)(2012-2#1)
predominantly##108##1##(1990-11#1)(1990-9#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-8#3)(1995-12#2)(1995-5#1)(1995-8#4)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#1)
predominate in##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
predominate##9##1##(1995-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)
predominated in the##2##3##(2008-10#1)(2011-2#1)
predominated in##9##2##(1991-11#2)(2008-10#5)(2011-2#1)(2013-1#1)
predominated over the other##2##4##(2008-10#2)
predominated over##3##2##(2008-10#2)(2012-12#1)
predominated##23##1##(1990-11#1)(1991-11#2)(1994-11#2)(1994-9#1)(2008-10#8)(2009-8#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
predominately##9##1##(1993-2#1)(1996-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-9#1)(2012-2#1)
predominates##4##1##(1994-11#1)(1997-1#1)(2008-12#1)(2008-5#1)
predominating in##2##2##(2008-5#1)(2013-1#1)
predominating##9##1##(1990-11#1)(1991-2#1)(2008-10#5)(2008-5#1)(2013-1#1)
predonation hemoglobin##2##2##(1996-9#2)
predonation##4##1##(1996-9#3)(2011-2#1)
preeclampsia and##4##2##(1996-11#1)(2008-10#1)(2008-11#2)
preeclampsia##15##1##(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#7)(2009-1#1)(2009-8#3)(2012-2#1)
preeclampsia]##2##1##(1995-11#1)(2008-11#1)
preeclamptic##3##1##(2008-10#2)(2009-8#1)
preemptive##2##1##(2008-10#1)(2008-8#1)
preexisting##8##1##(1994-2#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-3#1)
preexposure to##2##2##(1994-6#1)(2008-10#1)
preexposure##5##1##(1994-6#1)(2008-10#3)(2008-4#1)
preface##3##1##(2009-11#1)(2009-4#1)(2010-5#1)
prefatigue values##2##2##(2013-8#2)
prefecture##3##1##(2008-10#2)(2013-1#1)
prefectures##2##1##(2008-10#1)(2011-2#1)
prefer males with##2##3##(2008-8#1)(2008-9#1)
prefer to##2##2##(1997-3#1)(2008-10#1)
prefer##12##1##(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#2)(2012-3#1)
preferable to use##2##3##(2008-10#1)(2011-2#1)
preferable to##12##2##(1990-6#1)(1993-3#2)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
preferable##30##1##(1990-6#1)(1991-9#1)(1993-3#3)(1994-12#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
preferably by##2##2##(1990-9#2)
preferably##24##1##(1990-3#1)(1990-9#2)(1991-2#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-6#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-8#2)(2012-3#1)
preference and the##2##3##(2008-2#1)(2008-8#1)
preference and##7##2##(2008-1#1)(2008-2#1)(2008-8#4)(2008-9#1)
preference for the##4##3##(1990-11#1)(1992-3#1)(1995-6#1)(2008-9#1)
preference for##18##2##(1990-11#1)(1992-3#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-3#1)(2012-3#2)
preference in##2##2##(1994-8#1)(1997-5#1)
preference is##3##2##(1993-6#1)(2008-3#1)(2008-8#1)
preference of##6##2##(1996-5#1)(2008-10#3)(2008-9#1)(2010-8#1)
preference tests##3##2##(2008-10#1)(2008-5#2)
preference to##4##2##(2007-11#1)(2008-10#1)(2008-9#2)
preference##80##1##(1990-11#1)(1990-9#1)(1992-3#1)(1992-8#1)(1993-6#3)(1994-2#1)(1994-8#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#17)(2008-9#9)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-8#2)(2012-3#3)
preferences among##2##2##(2008-2#1)(2011-2#1)
preferences and##5##2##(1992-2#1)(1995-5#1)(1995-6#1)(2009-8#1)(2013-1#1)
preferences are##2##2##(2008-8#1)(2008-9#1)
preferences by##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
preferences for the##4##3##(1992-3#1)(2008-8#2)(2013-1#1)
preferences for##19##2##(1990-3#1)(1992-3#1)(2008-4#1)(2008-8#5)(2008-9#3)(2009-11#1)(2010-1#2)(2010-8#1)(2012-12#1)(2013-1#3)
preferences have##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
preferences in the##2##3##(2009-6#1)(2010-8#1)
preferences in##7##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-8#1)
preferences of##10##2##(1995-5#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-2#2)(2010-8#1)(2013-1#1)
preferences to##2##2##(2008-8#1)(2010-1#1)
preferences were##2##2##(2010-3#1)(2012-12#1)
preferences##77##1##(1990-3#1)(1992-2#1)(1992-3#1)(1994-6#1)(1995-5#2)(1995-6#1)(2008-10#5)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#13)(2008-9#11)(2009-11#3)(2009-6#3)(2009-8#1)(2010-1#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#4)(2011-1#1)(2011-10#1)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#5)
preferential accumulation of##2##3##(2008-11#1)(2012-2#1)
preferential solvation##2##2##(2008-10#1)(2010-7#1)
preferential uptake of##2##3##(1997-1#1)(2008-10#1)
preferential##31##1##(1990-11#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
preferentially binds##3##2##(1995-11#1)(2007-11#1)(2008-11#1)
preferentially expressed in##4##3##(1997-2#1)(2008-8#1)(2009-10#1)(2010-1#1)
preferentially in##2##2##(2008-10#1)(2008-8#1)
preferentially to the##4##3##(1994-5#1)(1996-2#1)(1997-2#1)(2009-8#1)
preferentially to##5##2##(1994-5#1)(1996-2#1)(1997-2#1)(2007-11#1)(2009-8#1)
preferentially##49##1##(1990-2#1)(1990-5#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#2)(1997-1#2)(1997-2#2)(1997-6#1)(2007-11#2)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-8#3)(2010-1#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
preferred and##2##2##(2008-3#1)(2008-9#1)
preferred by##2##2##(1992-12#1)(2008-10#1)
preferred drug##2##2##(2011-10#1)(2013-1#1)
preferred in##2##2##(2008-3#2)
preferred method##2##2##(2008-9#1)(2010-7#1)
preferred orientation##4##2##(2008-11#2)(2008-3#1)(2008-8#1)
preferred over##2##2##(2010-8#1)(2012-12#1)
preferred provider organizations (PPOs)##2##4##(1991-3#1)(1994-1#1)
preferred provider organizations##3##3##(1991-3#1)(1992-2#1)(1994-1#1)
preferred provider##4##2##(1991-3#2)(1992-2#1)(1994-1#1)
preferred resources##2##2##(2008-9#2)
preferred target##2##2##(2010-12#1)(2011-2#1)
preferred the##3##2##(1995-8#1)(2008-10#1)(2013-1#1)
preferred to visit##2##3##(2008-8#2)
preferred to##8##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#2)(2013-8#1)
preferred treatment##2##2##(1996-3#1)(2008-10#1)
preferred##93##1##(1990-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#3)(1994-1#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(2008-1#3)(2008-10#12)(2008-11#5)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#10)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#7)(2013-8#3)
preferring##4##1##(1994-5#2)(1995-6#1)(2008-9#1)
preformed DAPs in##2##3##(2010-5#2)
preformed DAPs##4##2##(2010-5#4)
preformed antifungal diene##2##3##(2008-10#2)
preformed antifungal##3##2##(2008-10#3)
preformed in##3##2##(2008-10#2)(2008-11#1)
preformed metal##2##2##(2013-1#2)
preformed##20##1##(1993-8#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-5#1)(2010-5#4)(2011-2#2)(2013-1#2)
prefrontal activity##2##2##(2008-11#2)
prefrontal and##2##2##(1997-2#1)(2008-11#1)
prefrontal cortex (PFC)##5##3##(1996-5#1)(1997-2#1)(2008-11#1)(2013-8#2)
prefrontal cortex and##4##3##(2008-11#3)(2013-8#1)
prefrontal cortex in##2##3##(1997-2#1)(2010-7#1)
prefrontal cortex##32##2##(1991-4#1)(1993-6#1)(1994-2#1)(1994-8#2)(1996-2#4)(1996-5#2)(1997-2#3)(2008-10#1)(2008-11#12)(2010-7#2)(2013-8#3)
prefrontal cortical##2##2##(1991-2#2)
prefrontal lesions##3##2##(1993-3#3)
prefrontal##57##1##(1991-2#3)(1991-4#1)(1993-3#4)(1993-6#1)(1994-2#1)(1994-8#4)(1996-2#5)(1996-5#2)(1997-2#6)(2008-10#1)(2008-11#21)(2010-7#2)(2011-2#2)(2013-8#4)
preglobular##2##1##(2011-2#2)
pregnancies and##6##2##(1991-3#1)(1993-3#1)(2008-1#1)(2010-11#1)(2011-1#1)(2011-2#1)
pregnancies are##2##2##(1991-6#1)(2008-11#1)
pregnancies have##2##2##(1991-1#1)(1993-1#1)
pregnancies in##4##2##(1990-9#1)(1991-3#1)(1994-3#1)(2011-1#1)
pregnancies is##2##2##(2010-8#1)(2013-1#1)
pregnancies were##2##2##(2008-11#1)(2008-9#1)
pregnancies##56##1##(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#3)(1991-6#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#3)(1994-3#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#2)(1997-3#1)(2008-1#3)(2008-11#9)(2008-12#1)(2008-9#1)(2010-11#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#7)
pregnancy after##2##2##(2011-2#1)(2013-1#1)
pregnancy and in##2##3##(1990-9#1)(1995-12#1)
pregnancy and its effect on perinatal##2##6##(2012-3#2)
pregnancy and its##4##3##(1995-12#1)(2012-3#3)
pregnancy and lactation##4##3##(2008-11#1)(2008-4#3)
pregnancy and postpartum##3##3##(2008-9#3)
pregnancy and##41##2##(1990-11#2)(1990-6#1)(1990-9#1)(1991-3#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-8#1)(1996-9#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-8#1)(2008-9#3)(2009-1#2)(2009-5#1)(2010-11#1)(2010-12#2)(2012-2#2)(2012-3#7)(2013-8#1)
pregnancy are##3##2##(1991-3#1)(2008-11#1)(2010-6#1)
pregnancy at##2##2##(1995-8#1)(2013-1#1)
pregnancy complicated by fetal##2##4##(1990-9#1)(2012-3#1)
pregnancy complicated by##3##3##(1990-9#1)(2012-3#1)(2013-1#1)
pregnancy complications##4##2##(1994-12#1)(2008-11#2)(2012-3#1)
pregnancy had a##2##3##(1994-12#1)(2010-11#1)
pregnancy has been reported in##2##5##(1990-6#1)(1994-3#1)
pregnancy has been##3##3##(1990-6#1)(1994-3#1)(1995-6#1)
pregnancy has##7##2##(1990-6#1)(1990-9#1)(1992-5#1)(1994-3#1)(1995-6#1)(2008-11#1)(2008-7#1)
pregnancy in a##5##3##(1992-12#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
pregnancy in group##2##3##(1991-3#1)(2012-2#1)
pregnancy in##11##2##(1991-3#1)(1992-12#1)(1995-3#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
pregnancy is a##4##3##(2009-6#1)(2011-1#1)(2013-1#2)
pregnancy is##11##2##(1990-9#1)(1994-3#1)(2008-12#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-1#5)
pregnancy loss##2##2##(2011-1#1)(2012-3#1)
pregnancy may be##2##3##(1994-8#1)(2012-3#1)
pregnancy occurred in##2##3##(1991-12#1)(1991-3#1)
pregnancy of##2##2##(1995-8#1)(2010-11#1)
pregnancy or##5##2##(1991-3#1)(2008-12#1)(2010-12#2)(2012-3#1)
pregnancy outcome in##2##3##(1991-12#1)(2011-1#1)
pregnancy outcome##7##2##(1991-12#1)(1992-9#1)(2008-11#2)(2010-8#1)(2011-1#1)(2013-1#1)
pregnancy outcomes##2##2##(2007-12#1)(2008-11#1)
pregnancy rate##3##2##(1992-1#1)(1994-12#1)(2008-10#1)
pregnancy rates to those##2##4##(1991-3#1)(1992-2#1)
pregnancy rates##11##2##(1991-12#2)(1991-3#3)(1992-2#3)(1994-12#2)(1996-9#1)
pregnancy serum##2##2##(1991-6#1)(2008-10#1)
pregnancy tests##2##2##(2011-2#1)(2013-1#1)
pregnancy the##2##2##(1991-12#1)(1994-8#1)
pregnancy to##2##2##(1995-8#1)(2013-1#1)
pregnancy was##4##2##(1993-3#2)(2012-3#1)(2013-1#1)
pregnancy were##4##2##(1995-12#3)(2013-1#1)
pregnancy when##2##2##(1993-12#1)(1994-3#1)
pregnancy with##3##2##(2009-1#1)(2010-8#2)
pregnancy##314##1##(1990-11#3)(1990-5#1)(1990-6#4)(1990-9#5)(1991-11#3)(1991-12#9)(1991-2#1)(1991-3#13)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#3)(1992-5#5)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#4)(1994-12#7)(1994-3#12)(1994-5#1)(1994-6#2)(1994-8#5)(1995-1#1)(1995-12#12)(1995-3#1)(1995-6#2)(1995-8#9)(1996-11#6)(1996-3#2)(1996-8#2)(1996-9#4)(1997-2#1)(1997-4#3)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#21)(2008-12#7)(2008-4#3)(2008-7#6)(2008-8#2)(2008-9#7)(2009-1#7)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-6#6)(2010-8#4)(2011-1#5)(2011-2#10)(2012-12#3)(2012-2#5)(2012-3#34)(2013-1#30)(2013-8#3)
pregnancy-associated diseases with abnormal fetal growth##2##6##(2008-10#2)
pregnancy-associated##7##1##(1994-8#1)(2008-10#2)(2013-1#4)
pregnancy-induced hypertension##4##2##(1994-3#1)(2010-10#1)(2012-2#2)
pregnancy-induced##5##1##(1994-3#2)(2010-10#1)(2012-2#2)
pregnancy]##13##1##(1991-11#1)(1991-3#1)(1992-5#1)(1993-9#1)(1994-6#1)(1996-11#4)(1997-8#1)(2012-3#1)(2013-1#2)
pregnant and non-pregnant##2##3##(1994-8#1)(2010-6#1)
pregnant and##7##2##(1990-11#2)(1994-8#1)(1996-8#1)(2010-6#2)(2011-2#1)
pregnant female##3##2##(1990-11#1)(2008-7#1)(2009-4#1)
pregnant mother##2##2##(1990-9#1)(2012-3#1)
pregnant patients##3##2##(2008-11#1)(2009-1#1)(2013-1#1)
pregnant rats##4##2##(1990-11#2)(1993-12#1)(2008-11#1)
pregnant woman##7##2##(1990-6#1)(1991-9#1)(1997-7#1)(1997-8#1)(2008-7#1)(2009-1#1)(2009-10#1)
pregnant women and their##2##4##(2007-12#1)(2012-2#1)
pregnant women and##4##3##(1992-12#1)(1994-3#1)(2007-12#1)(2012-2#1)
pregnant women are##4##3##(1993-3#1)(2008-12#1)(2009-4#1)(2012-3#1)
pregnant women in the##2##4##(2007-12#1)(2013-8#1)
pregnant women in##14##3##(1990-6#3)(1994-6#1)(1995-2#1)(1997-6#1)(2007-12#1)(2010-6#3)(2012-3#1)(2013-1#2)(2013-8#1)
pregnant women were##2##3##(2008-10#1)(2012-3#1)
pregnant women who##2##3##(1990-6#1)(1995-6#1)
pregnant women with risk factors##2##5##(2012-2#2)
pregnant women with symptoms of##2##5##(2008-11#2)
pregnant women with##7##3##(1996-11#1)(2008-11#3)(2012-2#2)(2013-8#1)
pregnant women##72##2##(1990-6#4)(1990-9#1)(1991-11#1)(1991-12#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-6#3)(1996-11#3)(1996-3#1)(1997-4#3)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#6)(2008-12#4)(2009-4#4)(2010-6#4)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#6)(2013-1#8)(2013-8#2)
pregnant##121##1##(1990-11#6)(1990-2#3)(1990-6#5)(1990-9#2)(1991-11#1)(1991-12#1)(1991-9#2)(1992-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-6#3)(1996-11#3)(1996-3#1)(1996-8#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-11#10)(2008-12#4)(2008-7#3)(2008-8#5)(2008-9#1)(2009-1#2)(2009-10#1)(2009-4#5)(2009-6#1)(2010-6#6)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#7)(2013-1#10)(2013-8#2)
pregnenolone production##4##2##(2012-2#4)
pregnenolone production&quot##5##2##(2012-2#5)
pregnenolone sulfate##7##2##(1996-2#7)
pregnenolone##19##1##(1990-11#1)(1996-2#9)(2012-2#9)
pregomisin##2##1##(2008-11#2)
preharvest##5##1##(2008-10#5)
preheated glassy carbon electrode modified with##2##6##(2008-10#2)
preheated glassy carbon electrode##3##4##(2008-10#3)
prehension##6##1##(1996-2#4)(2008-7#2)
prehistoric##2##1##(2008-9#1)(2013-1#1)
prehospital cardiac arrest##2##3##(1990-12#2)
prehospital phase of##2##3##(2007-9#2)
prehospital##8##1##(1990-12#2)(1991-2#2)(2007-9#3)(2008-7#1)
prehospitalization##2##1##(2008-7#2)
preimmune serum and##2##3##(1991-9#1)(1996-12#1)
preimmune serum##3##2##(1991-9#2)(1996-12#1)
preimplantation##5##1##(2008-5#4)(2012-3#1)
preincubated with##6##2##(1993-6#1)(1994-8#2)(1995-12#1)(1995-6#2)
preincubated##8##1##(1993-6#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-6#2)(2008-8#1)
preincubation of the##3##3##(1992-8#1)(1997-1#1)(2008-5#1)
preincubation of##6##2##(1992-8#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
preincubation with##3##2##(1990-5#1)(1994-8#1)(1995-11#1)
preincubation##15##1##(1990-5#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-6#1)(1994-8#3)(1995-11#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-9#1)
preinoculated##4##1##(2008-10#4)
preinoculation with##2##2##(2008-10#2)
preinoculation##4##1##(2008-10#4)
preintensification time##2##2##(2008-10#2)
preirrigated with##2##2##(2008-10#2)
prejudice and hate crimes##2##4##(2008-12#2)
prejudice##11##1##(1994-3#1)(2008-11#2)(2008-12#7)(2012-3#1)
prejudices##3##1##(1994-1#1)(2013-1#2)
prelabeled with##3##2##(1990-12#1)(1991-12#1)(1997-2#1)
prelamin A##2##2##(2011-2#2)
preleptotene##3##1##(2009-10#2)(2012-2#1)
prelicensure##2##1##(2008-10#2)
prelimbic cortex##2##2##(1993-6#2)
preliminarily##3##1##(2008-9#1)(2011-3#1)(2012-2#1)
preliminary analysis##2##2##(2008-5#1)(2010-7#1)
preliminary assessment of##2##3##(1992-2#1)(1993-9#1)
preliminary assessment##3##2##(1992-2#1)(1993-9#1)(2013-1#1)
preliminary data from##2##3##(1994-1#1)(2008-11#1)
preliminary data##8##2##(1992-12#2)(1994-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#1)
preliminary diagnosis##2##2##(1995-11#1)(2012-3#1)
preliminary evaluation of##5##3##(1991-12#1)(2008-10#2)(2008-12#1)(2012-12#1)
preliminary evaluation##7##2##(1991-12#1)(1993-1#1)(2008-10#3)(2008-12#1)(2012-12#1)
preliminary evidence for the##3##4##(2008-12#2)(2012-2#1)
preliminary evidence##6##2##(1993-3#1)(1995-5#1)(2008-12#3)(2012-2#1)
preliminary experiments were##2##3##(2008-10#1)(2008-3#1)
preliminary experiments##6##2##(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)
preliminary findings from##3##3##(2012-2#1)(2013-1#2)
preliminary findings##7##2##(1991-1#3)(1992-1#1)(2012-2#1)(2013-1#2)
preliminary genetic##2##2##(2008-10#1)(2011-2#1)
preliminary investigation##8##2##(1990-6#1)(1995-2#1)(2008-10#1)(2008-9#3)(2010-3#1)(2011-2#1)
preliminary nutrient##2##2##(2008-10#1)(2008-8#1)
preliminary report##4##2##(1990-12#1)(1993-2#1)(1994-3#1)(2008-10#1)
preliminary results demonstrated the##2##4##(2008-8#1)(2010-12#1)
preliminary results of##2##3##(2008-10#1)(2008-3#1)
preliminary results on##2##3##(2008-3#1)(2013-1#1)
preliminary results show that##2##4##(1990-2#1)(2008-10#1)
preliminary results suggest that##3##4##(1990-12#1)(1992-12#1)(2011-2#1)
preliminary results##26##2##(1990-12#2)(1990-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-8#1)(1997-3#1)(2008-10#5)(2008-3#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
preliminary screening of##2##3##(2008-10#1)(2009-10#1)
preliminary studies##2##2##(2008-10#1)(2011-2#1)
preliminary study of##3##3##(2010-7#1)(2013-8#2)
preliminary study on the##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
preliminary study on##4##3##(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
preliminary study##25##2##(1993-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
preliminary targets##2##2##(1991-2#2)
preliminary tests##4##2##(2008-10#4)
preliminary##190##1##(1990-12#3)(1990-2#2)(1990-6#1)(1991-1#4)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#49)(2008-11#8)(2008-12#8)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#8)(2008-9#6)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#12)(2013-8#4)
prelingually deafened##4##2##(2008-9#4)
prelingually##7##1##(2008-9#7)
preload##8##1##(1996-3#1)(1997-4#4)(2011-2#3)
prelude##2##1##(2008-10#1)(2008-8#1)
premalignant##4##1##(2009-12#1)(2011-2#1)(2013-1#2)
premammillary nucleus##2##2##(1994-2#2)
premammillary##4##1##(1994-2#4)
premating barriers##4##2##(2008-8#2)(2012-3#2)
premating isolation##5##2##(2008-8#3)(2008-9#2)
premating##13##1##(2008-8#6)(2008-9#3)(2012-3#4)
premature activation of HIV-1##2##4##(2011-3#2)
premature adrenarche##6##2##(2008-4#6)
premature aging and##2##3##(1994-12#1)(2008-11#1)
premature aging##4##2##(1992-9#1)(1994-12#1)(2008-11#1)(2011-2#1)
premature and low birth weight##2##5##(1991-12#1)(2008-10#1)
premature babies##2##2##(1994-3#1)(1994-6#1)
premature birth##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
premature children##2##2##(2011-2#2)
premature delivery##3##2##(2008-11#1)(2012-3#2)
premature infant##3##2##(1994-3#1)(2007-12#1)(2011-2#1)
premature infants are##2##3##(1996-11#1)(2007-11#1)
premature infants##22##2##(1990-11#4)(1994-3#1)(1995-8#2)(1996-11#1)(2007-11#9)(2008-11#1)(2008-9#1)(2011-2#2)(2012-12#1)
premature infants]##2##2##(1990-11#1)(1996-11#1)
premature myocardial infarction##2##3##(1991-6#2)
premature newborn##3##2##(1996-11#1)(2009-9#1)(2011-2#1)
premature newborns##2##2##(2008-11#1)(2009-9#1)
premature ovarian failure##4##3##(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
premature rupture of##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
premature senescence##3##2##(2008-11#3)
premature to##2##2##(2008-11#1)(2013-1#1)
premature##96##1##(1990-11#6)(1991-1#1)(1991-12#1)(1991-6#2)(1992-6#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-8#2)(1996-11#3)(1996-3#1)(1997-6#1)(2007-11#9)(2007-12#1)(2008-10#3)(2008-11#12)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#3)(2010-3#1)(2011-1#3)(2011-2#9)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
prematurely##8##1##(1994-1#1)(1994-3#1)(1996-11#1)(2008-10#3)(2008-9#1)(2010-9#1)
prematurity##7##1##(1991-9#1)(1994-3#1)(2007-12#1)(2008-11#2)(2012-12#1)(2012-3#1)
premeiotic and meiotic periods##2##4##(2008-7#2)
premenopausal and##2##2##(1994-12#1)(1994-2#1)
premenopausal women##4##2##(1990-12#1)(2009-8#1)(2010-6#1)(2010-8#1)
premenopausal##12##1##(1990-12#1)(1991-9#1)(1992-12#1)(1994-12#2)(1994-2#2)(1997-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)
premenstrual dysphoric##2##2##(2009-10#2)
premenstrual##3##1##(2008-8#1)(2009-10#2)
premicellar aggregates##3##2##(2008-10#3)
premier##2##1##(2013-1#1)(2013-8#1)
premise that##11##2##(1992-3#1)(1992-6#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
premise##16##1##(1991-3#1)(1992-3#2)(1992-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
premises##6##1##(1991-1#1)(1991-12#1)(1995-12#1)(1996-3#1)(2008-10#1)(2009-6#1)
premium##5##1##(1993-3#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#1)
premiums##15##1##(1991-12#1)(1991-3#1)(1993-3#2)(1994-3#2)(1996-3#3)(1996-5#1)(1997-3#1)(2008-7#4)
premixed flames##2##2##(2008-3#2)
premixed twin flames stabilized in##2##5##(2008-2#1)(2008-3#1)
premixed##9##1##(2008-10#1)(2008-2#2)(2008-3#6)
premolars##3##1##(2013-1#3)
premolt##2##1##(2008-6#2)
premotor cortex##4##2##(1995-8#1)(2010-7#2)(2013-8#1)
premotor##6##1##(1995-8#1)(1996-2#1)(2008-11#1)(2010-7#2)(2013-8#1)
prenalterol##4##1##(2008-10#4)
prenatal DEX##2##2##(1995-12#2)
prenatal GC##2##2##(1995-12#2)
prenatal alcohol consumption##2##3##(2008-11#2)
prenatal alcohol use##3##3##(2008-11#3)
prenatal alcohol##6##2##(2008-11#6)
prenatal and postnatal##2##3##(1993-3#1)(1995-1#1)
prenatal and##3##2##(1993-3#1)(1995-1#1)(2008-10#1)
prenatal care and##6##3##(1992-2#2)(1993-3#1)(1995-2#2)(2008-11#1)
prenatal care in##2##3##(2008-10#2)
prenatal care##19##2##(1992-2#3)(1993-3#2)(1994-3#1)(1995-12#1)(1995-2#5)(2008-10#4)(2008-11#2)(2013-1#1)
prenatal cytogenetic diagnosis##3##3##(2008-11#1)(2012-3#2)
prenatal detection of##2##3##(1993-12#1)(2012-3#1)
prenatal diagnosis is##2##3##(1990-9#1)(2013-1#1)
prenatal diagnosis of##2##3##(2008-4#1)(2012-3#1)
prenatal diagnosis##6##2##(1990-9#1)(2007-7#1)(2008-4#1)(2012-3#2)(2013-1#1)
prenatal exposure to DEX##2##4##(1995-12#2)
prenatal malnutrition##2##2##(2008-11#2)
prenatal period##3##2##(1995-5#1)(2012-2#1)(2013-7#1)
prenatal vascular disruptions##3##3##(1997-3#3)
prenatal##82##1##(1990-9#1)(1991-12#1)(1992-2#3)(1993-12#2)(1993-3#4)(1994-3#1)(1995-1#2)(1995-12#7)(1995-2#5)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#3)(2007-7#1)(2008-10#8)(2008-11#13)(2008-12#1)(2008-4#2)(2010-6#1)(2011-1#1)(2011-5#1)(2012-12#2)(2012-2#3)(2012-3#10)(2013-1#6)(2013-7#1)
prenatally androgenized female rhesus monkeys##2##5##(2008-4#2)
prenatally##8##1##(1997-3#1)(2008-10#2)(2008-11#2)(2008-4#2)(2013-1#1)
preneoplastic transformation##2##2##(1991-12#1)(1995-9#1)
preneoplastic##3##1##(1991-12#1)(1995-9#1)(2013-7#1)
prenylated##4##1##(2008-5#1)(2011-2#3)
prenyltransferase##3##1##(2011-2#3)
preoccupation of##2##2##(1994-3#1)(2008-12#1)
preoccupation##3##1##(1993-2#1)(1994-3#1)(2008-12#1)
preoperative and postoperative##2##3##(1994-3#1)(2011-7#1)
preoperative and##4##2##(1994-3#1)(2011-2#1)(2011-7#1)(2012-3#1)
preoperative angiography##3##2##(1996-9#1)(2008-12#1)(2012-3#1)
preoperative assessment##2##2##(2009-3#1)(2012-3#1)
preoperative clinical##4##2##(1997-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
preoperative diagnosis##7##2##(1991-3#1)(1992-9#2)(1997-8#1)(2008-7#2)(2011-2#1)
preoperative embolization of##2##3##(2008-7#2)
preoperative embolization##9##2##(2008-7#8)(2012-3#1)
preoperative evaluation##2##2##(2008-12#1)(2012-12#1)
preoperative feeding##3##2##(2011-2#3)
preoperative hemoglobin##2##2##(1994-3#1)(2009-3#1)
preoperative investigation##2##2##(1990-11#2)
preoperative levels by 6##2##4##(2013-1#2)
preoperative levels##3##2##(1990-9#1)(2013-1#2)
preoperative planning##4##2##(1997-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
preoperative teaching program##2##3##(1995-1#2)
preoperative teaching##3##2##(1995-1#3)
preoperative treatment##2##2##(1993-8#1)(2010-7#1)
preoperative values##2##2##(1991-2#2)
preoperative weight##3##2##(2010-8#3)
preoperative##117##1##(1990-11#4)(1990-9#4)(1991-2#3)(1991-3#1)(1991-6#1)(1992-3#1)(1992-9#4)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-1#3)(1996-1#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-7#14)(2008-9#2)(2009-12#1)(2009-3#3)(2009-4#2)(2009-8#1)(2010-7#2)(2010-8#3)(2011-2#21)(2011-7#1)(2012-12#1)(2012-3#14)(2013-1#12)(2013-8#1)
preoperatively and postoperatively##2##3##(2009-10#2)
preoperatively and##4##2##(2008-9#1)(2009-10#2)(2013-1#1)
preoperatively to##2##2##(2009-3#1)(2013-1#1)
preoperatively##29##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-9#1)(1993-1#2)(1996-1#1)(1996-9#1)(1997-8#1)(2008-12#1)(2008-9#1)(2009-10#3)(2009-3#1)(2009-9#1)(2010-8#3)(2011-2#2)(2013-1#5)(2013-8#1)
preoptic area of the##2##4##(1992-3#1)(1994-2#1)
preoptic area##9##2##(1992-1#1)(1992-12#1)(1992-3#2)(1994-2#1)(1997-3#2)(2008-8#1)(2008-9#1)
preoptic##11##1##(1992-1#1)(1992-12#1)(1992-3#2)(1994-2#1)(1997-3#2)(2008-8#2)(2008-9#2)
preovulatory follicles##7##2##(2008-12#4)(2008-8#3)
prepaid health plans##2##3##(1994-2#2)
prepaid plans##3##2##(1991-2#2)(1994-2#1)
prepaid##8##1##(1991-2#2)(1991-3#1)(1994-2#3)(1994-3#1)(1997-1#1)
preparation and application times##2##4##(2012-3#2)
preparation and application##3##3##(2008-5#1)(2012-3#2)
preparation and handling##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
preparation and##41##2##(1990-8#1)(1996-2#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#6)(2010-7#1)(2012-3#3)
preparation are##3##2##(1994-2#1)(2008-10#1)(2009-10#1)
preparation as##2##2##(2008-10#1)(2008-5#1)
preparation by##7##2##(1990-12#1)(2007-12#1)(2008-10#2)(2010-11#1)(2012-12#1)(2013-1#1)
preparation conditions##3##2##(1994-11#1)(2008-10#2)
preparation for a##2##3##(1994-12#1)(2008-11#1)
preparation for the##4##3##(1994-1#1)(1997-2#1)(2008-12#1)(2008-5#1)
preparation for##26##2##(1993-2#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#2)
preparation from##7##2##(1994-2#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)
preparation has been##2##3##(1996-1#1)(2008-8#1)
preparation in the##2##3##(2008-10#1)(2008-7#1)
preparation in##9##2##(1990-12#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)
preparation is rapid and simple##2##5##(2008-10#2)
preparation is##11##2##(2008-10#8)(2008-2#1)(2008-4#1)(2008-7#1)
preparation method is##2##3##(2008-10#1)(2008-9#1)
preparation method##11##2##(1994-11#1)(2008-10#8)(2008-9#1)(2012-2#1)
preparation methods##5##2##(2008-10#4)(2008-11#1)
preparation must##2##2##(1992-5#1)(1997-2#1)
preparation of a new##2##4##(2008-10#2)
preparation of a##11##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)
preparation of an##2##3##(1994-5#1)(2008-10#1)
preparation of intact##2##3##(2008-4#1)(2008-9#1)
preparation of phage##2##3##(1995-12#1)(2008-9#1)
preparation of phosphoramidites##2##3##(2008-4#2)
preparation of solid##2##3##(2008-10#2)
preparation of staff##2##3##(2008-11#1)(2008-12#1)
preparation of the##14##3##(1990-5#1)(1990-6#1)(1991-6#1)(1992-3#1)(1994-11#1)(1997-2#1)(2008-10#6)(2008-11#1)(2011-2#1)
preparation of##139##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-5#4)(1997-2#2)(2008-1#2)(2008-10#40)(2008-11#13)(2008-12#4)(2008-2#1)(2008-4#23)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#17)(2009-3#1)(2009-7#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-1#1)
preparation on the##2##3##(2008-10#2)
preparation or##3##2##(1990-12#1)(1993-2#1)(2008-10#1)
preparation procedure for##4##3##(2008-10#4)
preparation procedure##11##2##(2008-10#11)
preparation procedures were##2##3##(2008-10#2)
preparation procedures##4##2##(2008-10#4)
preparation process was##2##3##(2008-10#1)(2008-11#1)
preparation process##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
preparation processes##2##2##(2008-10#1)(2008-7#1)
preparation recipes##2##2##(2008-10#2)
preparation steps##3##2##(2008-10#3)
preparation technique for the##2##4##(2008-10#2)
preparation technique##4##2##(2008-10#3)(2008-9#1)
preparation that##3##2##(1993-1#1)(2009-9#2)
preparation time##2##2##(2008-10#1)(2012-3#1)
preparation to##4##2##(1996-2#1)(2008-10#2)(2008-7#1)
preparation using##2##2##(1991-2#1)(2008-9#1)
preparation was developed##2##3##(2008-10#2)
preparation was performed by##2##4##(1991-5#1)(2008-10#1)
preparation was##13##2##(1991-2#1)(1991-5#2)(1993-6#1)(2008-10#7)(2008-11#1)(2008-7#1)
preparation were##2##2##(2008-10#2)
preparation will##2##2##(1997-2#1)(2008-9#1)
preparation##465##1##(1990-12#4)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#5)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#2)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-5#2)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#3)(1996-2#2)(1996-5#4)(1997-2#8)(2007-12#2)(2008-1#4)(2008-10#193)(2008-11#30)(2008-12#13)(2008-2#2)(2008-3#1)(2008-4#34)(2008-5#7)(2008-7#18)(2008-8#4)(2008-9#35)(2009-10#1)(2009-3#1)(2009-7#2)(2009-9#3)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#9)(2013-1#8)(2013-8#1)
preparations agreed with those##2##4##(2008-10#2)
preparations and the##4##3##(1991-5#1)(2008-10#3)
preparations and##26##2##(1991-5#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#19)(2013-1#1)
preparations are##5##2##(2008-1#1)(2008-4#2)(2008-9#2)
preparations by capillary electrophoresis##2##4##(2008-10#2)
preparations by using##2##3##(2008-10#2)
preparations by##15##2##(2008-10#15)
preparations can be##2##3##(2008-10#1)(2008-4#1)
preparations contained##2##2##(2008-10#1)(2008-5#1)
preparations containing##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)
preparations from both##2##3##(1994-8#1)(2008-10#1)
preparations from##11##2##(1993-1#1)(1994-11#1)(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-5#1)
preparations in the##2##3##(2008-10#2)
preparations in vitro##2##3##(1990-12#1)(2008-7#1)
preparations in##8##2##(1990-12#1)(1994-6#1)(2008-10#4)(2008-12#1)(2008-7#1)
preparations of##16##2##(1991-5#1)(1992-9#1)(1995-6#2)(2008-10#5)(2008-11#2)(2008-4#2)(2009-8#1)(2012-3#1)(2013-1#1)
preparations on##2##2##(2008-10#1)(2008-5#1)
preparations to##2##2##(2008-4#1)(2008-5#1)
preparations using 1##2##3##(2008-10#2)
preparations using##10##2##(2008-10#8)(2008-4#1)(2011-2#1)
preparations were used to produce##2##5##(2008-10#2)
preparations were##6##2##(1996-2#1)(2008-10#5)
preparations with##4##2##(2008-10#3)(2009-8#1)
preparations##257##1##(1990-11#1)(1990-12#2)(1990-3#1)(1991-5#2)(1992-12#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#5)(1997-7#1)(2007-8#1)(2008-1#3)(2008-10#156)(2008-11#9)(2008-12#2)(2008-4#13)(2008-5#18)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#2)(2009-9#1)(2010-11#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
preparative SEC##2##2##(1997-2#2)
preparative column##2##2##(2008-10#2)
preparative gel electrophoresis##2##3##(1991-9#1)(1995-6#1)
preparative gel##3##2##(1991-9#1)(1994-6#1)(1995-6#1)
preparative procedures##2##2##(2008-9#2)
preparative scale##2##2##(2008-10#1)(2011-1#1)
preparative techniques##2##2##(2008-9#2)
preparative thin layer chromatography and##2##5##(2008-10#1)(2012-2#1)
preparative thin layer chromatography##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
preparative##23##1##(1990-2#1)(1991-9#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#2)(2008-10#7)(2008-5#2)(2008-9#4)(2011-1#1)(2012-2#1)
preparatory grief##4##2##(2010-2#4)
preparatory work##4##2##(2010-12#3)(2010-7#1)
preparatory##20##1##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#4)(2010-6#2)(2010-7#1)(2013-1#1)(2013-8#2)
prepare for the future should##2##5##(2007-12#1)(2008-11#1)
prepare for the##5##3##(2007-12#1)(2008-11#2)(2010-4#1)(2012-3#1)
prepare for##7##2##(1997-1#1)(2007-12#1)(2008-11#3)(2010-4#1)(2012-3#1)
prepare nurses to##2##3##(2008-11#1)(2008-12#1)
prepare nurses##3##2##(2008-11#2)(2008-12#1)
prepare the##10##2##(1995-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2010-12#1)
prepare them for##2##3##(2008-12#1)(2009-9#1)
prepare##72##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#2)(1993-12#1)(1993-9#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#9)(2008-12#5)(2008-2#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#4)(2011-3#2)(2012-2#2)(2012-3#1)(2013-8#1)
prepared a##3##2##(1993-6#1)(2008-11#1)(2008-9#1)
prepared against##3##2##(1990-11#1)(1994-11#1)(2008-5#1)
prepared and characterized##2##3##(2008-10#2)
prepared and demonstrated##2##3##(2008-10#2)
prepared and evaluated##5##3##(1992-12#1)(1993-9#1)(2008-10#2)(2008-5#1)
prepared and investigated as##5##4##(2008-10#5)
prepared and its##4##3##(2008-10#3)(2008-5#1)
prepared and studied##2##3##(2008-10#1)(2009-9#1)
prepared and used as an##2##5##(1992-3#1)(2008-10#1)
prepared and used as##3##4##(1992-3#1)(2008-10#2)
prepared and used##7##3##(1992-3#1)(2008-10#5)(2008-11#1)
prepared and##49##2##(1992-12#1)(1992-3#1)(1993-9#1)(1994-11#1)(1995-8#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-9#1)(2011-3#1)
prepared as described##2##3##(2008-4#2)
prepared as##10##2##(1991-12#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-9#1)(2013-1#1)
prepared at##5##2##(2008-10#2)(2009-11#1)(2011-2#1)(2012-2#1)
prepared by a##8##3##(2008-10#6)(2008-11#1)(2013-1#1)
prepared by an##2##3##(2008-10#2)
prepared by coupling Amberlite XAD-2 with##2##6##(2008-10#2)
prepared by coupling##3##3##(2008-10#3)
prepared by dissolving in##2##4##(2008-10#1)(2008-5#1)
prepared by dissolving##6##3##(2008-10#4)(2008-5#1)(2010-4#1)
prepared by electropolymerization of##2##4##(2008-10#2)
prepared by entrapping##2##3##(2008-10#2)
prepared by immobilizing##2##3##(2008-10#2)
prepared by incorporating##3##3##(2008-10#3)
prepared by mixing##6##3##(2008-10#6)
prepared by packing##2##3##(2008-10#2)
prepared by reacting##2##3##(2008-10#2)
prepared by sol-gel method and##2##5##(2008-10#2)
prepared by sol-gel##4##3##(2008-10#4)
prepared by the##16##3##(1996-5#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-4#1)(2008-9#1)
prepared by this##2##3##(1997-1#1)(2008-6#1)
prepared by using##7##3##(2008-10#6)(2008-9#1)
prepared by weighing##3##3##(2008-10#3)
prepared by##125##2##(1992-11#1)(1992-6#1)(1993-8#2)(1996-5#2)(1997-1#1)(1997-9#1)(2008-10#89)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#5)(2009-7#2)(2010-4#1)(2012-2#3)(2013-1#1)(2013-8#1)
prepared can##2##2##(2008-10#2)
prepared for analysis##2##3##(2008-10#1)(2008-12#1)
prepared for or##2##3##(1992-2#2)
prepared for the##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
prepared for##18##2##(1992-2#3)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-7#1)(2012-3#1)
prepared from a##3##3##(2008-10#3)
prepared from control##2##3##(2008-11#1)(2008-5#1)
prepared from embryonic day##2##4##(1994-2#1)(2008-7#1)
prepared from rat##2##3##(1991-5#1)(2008-7#1)
prepared from the##5##3##(1991-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
prepared from##55##2##(1990-12#1)(1991-12#2)(1991-5#3)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#14)(2008-11#8)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)
prepared in a##4##3##(1992-11#1)(2008-10#2)(2008-4#1)
prepared in aqueous phase##3##4##(2008-10#3)
prepared in aqueous solutions##2##4##(2008-10#2)
prepared in aqueous##6##3##(2008-10#6)
prepared in the##4##3##(1990-11#1)(2008-10#3)
prepared in this study##2##4##(2008-10#2)
prepared in two different##2##4##(1992-11#1)(2008-10#1)
prepared in water##3##3##(2008-10#3)
prepared in##47##2##(1990-11#1)(1992-11#3)(1992-2#1)(1992-3#1)(1996-5#1)(2008-10#31)(2008-11#5)(2008-4#2)(2011-2#1)(2013-1#1)
prepared of##2##2##(1991-3#1)(2008-5#1)
prepared on the##2##3##(2008-10#1)(2008-5#1)
prepared on##3##2##(1993-1#1)(2008-10#1)(2008-5#1)
prepared resin##2##2##(2008-10#2)
prepared samples##2##2##(1997-2#1)(2008-10#1)
prepared through##3##2##(2008-11#2)(2008-5#1)
prepared to meet the##2##4##(1994-1#1)(2011-1#1)
prepared to##17##2##(1991-1#1)(1994-1#1)(1994-8#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)
prepared under##2##2##(2008-10#2)
prepared using a##2##3##(2008-11#1)(2008-9#1)
prepared using the##3##3##(2008-5#2)(2011-2#1)
prepared using##21##2##(1990-2#1)(1993-9#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-5#5)(2008-7#1)(2008-9#1)(2011-2#1)
prepared via a##2##3##(1996-5#1)(2008-10#1)
prepared via##3##2##(1996-5#1)(2008-10#2)
prepared were##2##2##(2008-10#2)
prepared with a##5##3##(2008-10#4)(2008-5#1)
prepared with different##2##3##(2008-10#2)
prepared with the##3##3##(2008-10#2)(2011-3#1)
prepared with##40##2##(1993-6#1)(1994-2#2)(1995-3#1)(2008-10#28)(2008-11#1)(2008-5#3)(2008-9#1)(2011-3#1)(2012-2#1)(2013-8#1)
prepared within##2##2##(2008-10#2)
prepared##533##1##(1990-11#2)(1990-12#3)(1990-2#1)(1991-1#1)(1991-12#5)(1991-3#1)(1991-5#3)(1991-6#1)(1992-11#4)(1992-12#2)(1992-2#4)(1992-3#2)(1992-6#1)(1993-1#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#5)(1994-2#3)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#6)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#295)(2008-11#44)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#26)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#16)(2009-11#4)(2009-7#3)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#5)(2011-3#2)(2011-7#1)(2012-2#8)(2012-3#3)(2013-1#5)(2013-8#2)
preparedness##6##1##(2008-10#1)(2008-11#2)(2008-9#2)(2009-12#1)
prepares##5##1##(1992-8#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-6#1)
preparing DNA##2##2##(1994-11#1)(2008-9#1)
preparing a##8##2##(2008-10#3)(2008-12#1)(2008-4#2)(2008-9#2)
preparing an abstract##2##3##(2010-4#2)
preparing and##4##2##(1993-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
preparing for the##2##3##(1992-2#1)(1996-5#1)
preparing for##3##2##(1992-2#1)(1996-5#1)(2012-3#1)
preparing the##10##2##(2008-10#3)(2008-12#1)(2008-4#2)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
preparing##59##1##(1991-12#1)(1992-2#1)(1993-12#2)(1994-11#1)(1994-3#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#6)(2008-4#8)(2008-5#1)(2008-9#10)(2009-12#1)(2009-4#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
prepayment and##2##2##(1994-2#2)
prepayment##3##1##(1994-2#2)(1997-1#1)
prepenetration development##2##2##(2008-10#2)
prepenetration morphogenesis in C##2##4##(2008-10#2)
prepenetration morphogenesis##3##2##(2008-10#3)
prepenetration##5##1##(2008-10#5)
preplant##3##1##(2008-10#3)
preplanting##2##1##(2008-10#2)
preplated##3##1##(2008-10#3)
preponderance of##4##2##(1990-2#1)(1996-5#1)(2011-2#1)(2012-2#1)
preponderance##5##1##(1990-2#1)(1996-5#1)(1996-9#1)(2011-2#1)(2012-2#1)
preprocecropinA##2##1##(1994-11#2)
preprocessed##2##1##(2008-3#1)(2010-8#1)
preprocessing method for partial least squares##2##6##(2008-10#2)
preprocessing##5##1##(2008-10#4)(2008-6#1)
preprodynorphin (PPD)##2##2##(1996-12#2)
preprodynorphin##3##1##(1996-12#3)
preproenkephalin (PPE)##2##2##(1996-12#2)
preproenkephalin##4##1##(1996-12#3)(2013-8#1)
preproinsulin##3##1##(2008-11#2)(2010-11#1)
prepromelittin##2##1##(1994-11#2)
preproteins##2##1##(2008-1#2)
prepubertal male calves##3##3##(2013-1#3)
prepubertal##12##1##(2008-10#1)(2008-4#2)(2011-1#4)(2012-2#1)(2012-3#1)(2013-1#3)
preputial##4##1##(2008-10#4)
prereduction##2##1##(2008-10#2)
prerequisite for the##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
prerequisite for##19##2##(1990-2#1)(1991-11#1)(1991-8#1)(1994-3#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
prerequisite to##4##2##(1990-5#1)(1994-12#1)(1995-6#1)(2008-11#1)
prerequisite##26##1##(1990-2#1)(1990-5#1)(1991-11#1)(1991-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
prerequisites for the##2##3##(1991-3#1)(1995-5#1)
prerequisites for##4##2##(1991-3#1)(1994-1#1)(1995-5#1)(2008-11#1)
prerequisites##8##1##(1991-2#1)(1991-3#1)(1994-1#1)(1995-5#3)(1997-5#1)(2008-11#1)
presacral neurectomy##4##2##(1994-3#4)
presacral##6##1##(1994-3#6)
presbyopia treatment##3##2##(2011-2#3)
presbyopia##4##1##(2011-2#4)
preschool children##6##2##(1993-3#1)(1996-12#1)(2008-11#2)(2008-4#1)(2009-9#1)
preschool##11##1##(1993-3#1)(1996-12#1)(2007-12#1)(2008-11#3)(2008-4#2)(2009-9#2)(2011-2#1)
preschoolers##2##1##(1992-9#1)(2013-8#1)
prescribe##10##1##(1990-2#1)(1991-6#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-4#2)(2008-11#1)(2008-8#1)(2013-8#1)
prescribed a##3##2##(2008-7#1)(2010-12#1)(2011-2#1)
prescribed and##2##2##(2008-7#1)(2010-4#1)
prescribed drugs##4##2##(2008-11#4)
prescribed for the##2##3##(2008-10#1)(2012-12#1)
prescribed for##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2012-12#1)
prescribed in the##2##3##(2008-10#1)(2009-9#1)
prescribed in##5##2##(1991-11#1)(2008-10#1)(2009-9#1)(2012-12#1)(2012-3#1)
prescribed medication##5##2##(1993-11#1)(1995-2#1)(2008-11#1)(2010-1#2)
prescribed to##6##2##(1991-2#1)(2008-11#3)(2011-2#2)
prescribed##79##1##(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1993-11#2)(1993-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#23)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#2)(2009-9#1)(2010-1#3)(2010-12#2)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
prescriber##2##1##(2008-11#1)(2013-1#1)
prescribers##6##1##(2008-11#1)(2008-12#3)(2008-8#1)(2009-3#1)
prescribing and##4##2##(1992-2#1)(2008-11#2)(2009-3#1)
prescribing for##3##2##(2008-11#1)(2010-4#1)(2013-1#1)
prescribing in##2##2##(2008-11#2)
prescribing of cotrimoxazole##2##3##(2008-11#2)
prescribing of##5##2##(2008-11#3)(2009-3#1)(2010-3#1)
prescribing patterns##6##2##(2008-11#5)(2013-1#1)
prescribing practices##2##2##(2008-11#1)(2012-3#1)
prescribing preventive medication##2##3##(2008-11#2)
prescribing##56##1##(1992-2#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-5#1)(2008-11#36)(2008-5#1)(2009-10#1)(2009-3#3)(2010-3#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#4)
prescription and##5##2##(1991-1#1)(1993-1#1)(2008-5#1)(2011-1#1)(2013-1#1)
prescription drug benefit##2##3##(1995-1#2)
prescription drug benefits##3##3##(1995-1#3)
prescription drug coverage##2##3##(1992-1#1)(1995-1#1)
prescription drug expenditures##2##3##(1995-1#2)
prescription drug spending##2##3##(1995-1#2)
prescription drug use##4##3##(1992-1#1)(1995-1#1)(2013-1#2)
prescription drug##23##2##(1992-1#2)(1993-1#1)(1995-1#13)(1995-6#1)(2013-1#3)(2013-8#3)
prescription drugs and##3##3##(1993-1#2)(2013-1#1)
prescription drugs##15##2##(1993-1#3)(1993-3#1)(1994-3#1)(1995-1#3)(1997-2#1)(2008-11#3)(2013-1#2)(2013-8#1)
prescription for##5##2##(1991-3#2)(1993-12#1)(2009-6#1)(2010-1#1)
prescription in##2##2##(1996-11#1)(1997-5#1)
prescription of##6##2##(1991-11#1)(2008-11#2)(2008-8#1)(2012-3#2)
prescription or##2##2##(1994-6#2)
prescription##92##1##(1990-2#2)(1991-1#1)(1991-11#1)(1991-3#2)(1991-9#1)(1992-1#2)(1993-1#5)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#2)(1995-1#19)(1995-11#3)(1995-6#1)(1996-11#4)(1996-2#1)(1997-2#2)(1997-4#2)(1997-5#1)(2008-10#1)(2008-11#16)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#7)(2013-8#5)
prescription]##2##1##(1993-11#1)(1995-5#1)
prescriptions and##2##2##(1995-6#1)(2013-1#1)
prescriptions for##5##2##(1993-11#1)(1996-3#1)(2008-8#1)(2009-9#2)
prescriptions in##2##2##(1995-11#1)(2008-11#1)
prescriptions were##3##2##(2008-11#3)
prescriptions##27##1##(1991-12#1)(1992-1#1)(1993-11#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#2)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#8)(2008-8#1)(2009-9#5)(2013-1#1)
presecretory proteins##3##2##(1994-11#3)
presecretory##4##1##(1994-11#4)
preseizure##4##1##(2013-8#4)
preselected##3##1##(2008-10#2)(2008-11#1)
preselection##2##1##(2008-10#1)(2008-5#1)
presence and absence of##31##4##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1997-1#1)(2008-10#11)(2008-11#4)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
presence and the##3##3##(2008-10#3)
presence and##53##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1997-1#3)(1997-8#1)(2008-10#19)(2008-11#5)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
presence in some##2##3##(2008-10#1)(2008-11#1)
presence in the##6##3##(1993-8#1)(1995-11#1)(2008-10#2)(2009-4#1)(2013-8#1)
presence in##28##2##(1990-5#1)(1991-8#1)(1993-8#1)(1995-11#1)(1996-1#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
presence of &quot##3##3##(1990-3#1)(2008-10#1)(2009-7#1)
presence of 0##12##3##(1991-3#1)(1993-8#1)(1995-8#2)(2008-10#5)(2008-11#2)(2011-2#1)
presence of 1##11##3##(1991-12#1)(1994-11#1)(1994-5#1)(1997-2#1)(2008-10#7)
presence of 1%##3##3##(2008-10#3)
presence of 10 mM##2##4##(1995-11#1)(2008-11#1)
presence of 10##3##3##(1995-11#1)(1997-3#1)(2008-11#1)
presence of 10(-3) M##2##4##(2008-10#2)
presence of 18-crown-6##2##3##(2008-10#2)
presence of 2##9##3##(1990-8#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#4)(2013-1#1)
presence of 5 microM##2##4##(1994-11#1)(1995-11#1)
presence of 5##4##3##(1994-11#1)(1995-11#1)(2008-10#1)(2008-7#1)
presence of Co(III)##2##3##(2008-10#2)
presence of EDTA##4##3##(2008-10#4)
presence of EGTA##3##3##(1990-10#2)(1995-8#1)
presence of Fusarium##3##3##(2008-10#3)
presence of GAP-43##2##3##(2008-9#2)
presence of HNO(3)##2##3##(2008-10#2)
presence of L-histidine##2##3##(1995-8#2)
presence of NO##4##3##(1995-11#1)(2008-10#3)
presence of P##4##3##(2008-10#4)
presence of PAP in##2##4##(2008-12#2)
presence of T##2##3##(1997-8#1)(2008-10#1)
presence of T22##3##3##(2008-10#3)
presence of a cationic surfactant##3##5##(2008-10#3)
presence of a metabolic syndrome##2##5##(2008-10#2)
presence of a neutral surfactant##2##5##(2008-10#2)
presence of a non-ionic##2##4##(1997-7#1)(2008-10#1)
presence of a##128##3##(1990-10#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-5#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-8#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-6#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#2)(2008-10#50)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
presence of abnormal##3##3##(1990-12#1)(2009-12#1)(2011-2#1)
presence of active##4##3##(1993-12#1)(2008-11#2)(2008-7#1)
presence of alkyl##2##3##(2008-10#1)(2012-2#1)
presence of an##41##3##(1990-11#2)(1991-11#1)(1991-12#1)(1991-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
presence of antibodies##2##3##(2008-10#2)
presence of any##6##3##(2008-10#3)(2008-11#1)(2010-6#1)(2013-1#1)
presence of ascorbic acid (AA)##2##5##(2008-10#2)
presence of ascorbic acid##9##4##(2008-10#9)
presence of beta-CD##5##3##(2008-10#5)
presence of bilateral##2##3##(2013-1#2)
presence of bone metastases##2##4##(1991-8#2)
presence of both##10##3##(1991-8#1)(2008-10#6)(2008-11#2)(2008-7#1)
presence of cagA##2##3##(1997-8#2)
presence of cancer##2##3##(2012-12#1)(2013-1#1)
presence of carbonate##2##3##(2008-10#2)
presence of central##2##3##(1997-8#1)(2008-1#1)
presence of chloride ions##2##4##(2008-10#2)
presence of chloride##3##3##(2008-10#3)
presence of circulating##4##3##(1991-2#1)(1992-3#1)(2006-6#1)(2008-10#1)
presence of concomitant##3##3##(2008-10#1)(2009-9#1)(2012-12#1)
presence of copper(II)##2##3##(2008-10#2)
presence of different percentages of##2##5##(2008-10#2)
presence of different##8##3##(1991-5#1)(2008-10#5)(2008-5#1)(2010-4#1)
presence of disease##3##3##(1996-2#1)(2008-10#2)
presence of distant metastases##2##4##(1991-8#1)(2011-2#1)
presence of either##6##3##(1991-8#1)(1995-9#1)(1997-3#1)(2008-10#1)(2008-11#2)
presence of ethanol##3##3##(1991-5#1)(2008-10#2)
presence of gas##2##3##(2012-12#1)(2012-2#1)
presence of glucose oxidase##2##4##(2008-10#2)
presence of glucose##4##3##(1995-8#1)(2008-10#3)
presence of great##2##3##(2008-10#2)
presence of high concentrations of##3##5##(1990-12#1)(2008-10#1)(2008-11#1)
presence of high##14##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2010-6#1)(2012-5#1)
presence of higher##3##3##(1993-11#1)(2008-10#1)(2011-1#1)
presence of hydrogen peroxide catalyses the oxidation of hydroquinone to##2##10##(2008-10#2)
presence of hydrogen peroxide catalyses the oxidation of##3##8##(2008-10#3)
presence of hydrogen peroxide##10##4##(2008-10#10)
presence of hydrogen##11##3##(2008-10#11)
presence of imidazole##3##3##(1994-5#2)(2008-10#1)
presence of insulin##2##3##(2008-11#1)(2008-8#1)
presence of interfering ions##2##4##(2008-10#2)
presence of interfering##4##3##(2008-10#3)(2013-1#1)
presence of internal##2##3##(2010-4#1)(2013-1#1)
presence of iron##4##3##(1991-5#1)(2008-10#2)(2013-1#1)
presence of its##6##3##(1993-8#1)(2008-10#3)(2011-2#1)(2013-7#1)
presence of large number of cations and anions##2##8##(2008-10#2)
presence of large##8##3##(2008-10#7)(2011-2#1)
presence of low##8##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
presence of metastases##2##3##(1990-12#1)(1990-6#1)
presence of microorganisms##2##3##(2008-11#2)
presence of more than##2##4##(1990-12#1)(2008-10#1)
presence of more##3##3##(1990-12#1)(1991-3#1)(2008-10#1)
presence of necrosis##3##3##(2011-2#2)(2012-3#1)
presence of nitrate##4##3##(2008-10#2)(2008-11#2)
presence of normal##2##3##(2006-6#1)(2011-2#1)
presence of one##6##3##(1994-6#1)(2008-10#4)(2008-8#1)
presence of other##18##3##(1993-8#1)(2008-10#13)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)
presence of phytoplasma in##2##4##(2008-10#2)
presence of predators##3##3##(2008-8#3)
presence of relatively##2##3##(2008-10#2)
presence of residual##3##3##(1992-10#1)(2008-10#1)(2009-7#1)
presence of selenium##2##3##(2008-10#2)
presence of serum##7##3##(1991-5#1)(2008-10#1)(2008-11#4)(2011-2#1)
presence of several cations##2##4##(2008-10#2)
presence of several##15##3##(1991-6#1)(1997-8#1)(2008-10#11)(2008-12#1)(2008-8#1)
presence of sodium##20##3##(1990-11#1)(1996-12#1)(2008-10#16)(2008-11#1)(2008-9#1)
presence of soluble##2##3##(2008-11#2)
presence of squamous##2##3##(1991-2#1)(2011-2#1)
presence of surfactant##3##3##(2008-10#3)
presence of testosterone##3##3##(1995-2#2)(2012-2#1)
presence of the pathogen##3##4##(2008-10#3)
presence of the two##3##4##(1994-11#2)(2008-11#1)
presence of the##107##3##(1990-5#3)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-6#2)(1995-12#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#55)(2008-11#4)(2008-12#4)(2008-3#2)(2008-4#1)(2008-8#4)(2009-9#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-12#2)(2013-1#1)
presence of these##7##3##(1994-8#1)(1995-12#1)(2008-10#1)(2010-4#1)(2011-2#2)(2013-1#1)
presence of this##10##3##(1990-5#1)(1991-5#1)(1993-8#1)(1994-5#1)(1996-8#1)(2008-10#3)(2009-9#1)(2013-7#1)
presence of two##28##3##(1990-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-8#2)(1996-2#1)(2007-12#1)(2008-10#10)(2008-7#1)(2008-9#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
presence of underlying##2##3##(2011-2#1)(2012-12#1)
presence of urea##2##3##(2008-10#2)
presence of various##4##3##(1996-5#2)(2008-10#2)
presence of##1786##2##(1990-10#5)(1990-11#8)(1990-12#8)(1990-2#7)(1990-3#1)(1990-5#16)(1990-6#1)(1990-7#1)(1990-8#9)(1991-11#3)(1991-12#5)(1991-2#8)(1991-3#6)(1991-5#16)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#6)(1993-6#9)(1993-8#26)(1993-9#1)(1994-1#1)(1994-11#18)(1994-2#1)(1994-3#3)(1994-5#16)(1994-6#6)(1994-8#15)(1994-9#1)(1995-11#11)(1995-12#13)(1995-2#10)(1995-3#4)(1995-5#1)(1995-6#7)(1995-8#17)(1995-9#2)(1996-12#8)(1996-2#7)(1996-3#6)(1996-5#14)(1996-6#2)(1996-8#2)(1997-1#7)(1997-2#5)(1997-3#8)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#10)(2006-6#2)(2007-11#1)(2007-12#10)(2007-8#1)(2008-1#4)(2008-10#856)(2008-11#102)(2008-12#24)(2008-2#4)(2008-3#15)(2008-4#10)(2008-5#25)(2008-6#3)(2008-7#36)(2008-8#23)(2008-9#26)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#16)(2009-9#5)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#10)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#60)(2011-3#1)(2011-7#1)(2012-12#16)(2012-2#16)(2012-3#19)(2012-5#1)(2013-1#38)(2013-7#4)(2013-8#8)
presence on the##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
presence or absence of the##9##5##(1991-5#1)(1995-11#1)(1995-8#1)(2008-10#5)(2008-5#1)
presence or absence of##55##4##(1990-5#1)(1991-11#1)(1991-5#2)(1992-1#1)(1993-3#3)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#25)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#4)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
presence or absence##56##3##(1990-5#1)(1991-11#1)(1991-5#2)(1992-1#1)(1993-3#3)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#25)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#4)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
presence or##58##2##(1990-5#1)(1991-11#1)(1991-5#2)(1992-1#1)(1993-3#3)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#25)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
presence was##2##2##(2009-9#1)(2011-2#1)
presence##1965##1##(1990-10#5)(1990-11#9)(1990-12#8)(1990-2#7)(1990-3#1)(1990-5#19)(1990-6#2)(1990-7#1)(1990-8#9)(1991-11#4)(1991-12#6)(1991-2#8)(1991-3#7)(1991-5#18)(1991-6#2)(1991-7#1)(1991-8#7)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#10)(1993-6#9)(1993-8#28)(1993-9#1)(1994-1#1)(1994-11#19)(1994-2#2)(1994-3#3)(1994-5#17)(1994-6#6)(1994-8#17)(1994-9#1)(1995-11#14)(1995-12#13)(1995-2#10)(1995-3#5)(1995-5#1)(1995-6#8)(1995-8#18)(1995-9#2)(1996-1#2)(1996-12#8)(1996-2#7)(1996-3#6)(1996-5#14)(1996-6#2)(1996-8#2)(1997-1#10)(1997-2#5)(1997-3#8)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#12)(2006-6#2)(2007-11#1)(2007-12#11)(2007-8#1)(2008-1#4)(2008-10#924)(2008-11#116)(2008-12#30)(2008-2#5)(2008-3#15)(2008-4#12)(2008-5#27)(2008-6#3)(2008-7#40)(2008-8#32)(2008-9#27)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#5)(2009-7#3)(2009-8#17)(2009-9#8)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#10)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#66)(2011-3#1)(2011-7#1)(2012-12#18)(2012-2#19)(2012-3#22)(2012-5#1)(2013-1#43)(2013-7#4)(2013-8#9)
presence/absence##2##1##(1993-2#1)(2008-10#1)
presences##2##1##(2008-10#1)(2008-8#1)
presenilin 1 gene##2##3##(1996-2#2)
presenilin##3##1##(1996-2#3)
presensitized##2##1##(1991-3#1)(2007-12#1)
present 2 cases of##2##4##(2009-1#1)(2012-3#1)
present 3##2##2##(2008-7#1)(2012-12#1)
present SPE/LC method##2##3##(2008-10#2)
present a case in which##4##5##(2008-11#1)(2008-7#1)(2010-7#1)(2012-12#1)
present a case of a giant##2##6##(2008-12#1)(2012-12#1)
present a case of a##11##5##(2008-10#2)(2008-12#2)(2008-7#1)(2009-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
present a case of an##2##5##(2012-2#1)(2013-1#1)
present a case of secondary##2##5##(2008-12#1)(2010-3#1)
present a case of##53##4##(1991-3#1)(1991-6#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#7)(2008-7#3)(2008-9#1)(2009-1#2)(2009-8#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#9)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
present a case with##2##4##(2008-12#1)(2011-1#1)
present a case##65##3##(1990-3#1)(1991-3#1)(1991-6#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#8)(2008-7#4)(2008-9#1)(2009-1#2)(2009-8#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#9)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
present a challenge##2##3##(2009-6#1)(2012-2#1)
present a discussion of##2##4##(1994-3#1)(2007-12#1)
present a mathematical##2##3##(1991-11#1)(2008-3#1)
present a method of##2##4##(2008-3#2)
present a method##4##3##(2008-3#3)(2008-8#1)
present a new##11##3##(1997-3#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
present a novel##7##3##(1992-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
present a patient who##3##4##(1990-9#1)(2011-1#1)(2013-1#1)
present a patient with##7##4##(2008-12#2)(2008-9#2)(2009-11#1)(2009-8#1)(2013-1#1)
present a patient##10##3##(1990-9#1)(2008-12#2)(2008-9#2)(2009-11#1)(2009-8#1)(2011-1#1)(2013-1#2)
present a problem for##2##4##(2008-10#1)(2011-2#1)
present a review of##2##4##(2008-10#2)
present a series of##3##4##(1990-9#1)(2008-11#1)(2008-9#1)
present a strategy##2##3##(2008-11#1)(2008-2#1)
present a study##3##3##(1990-3#1)(2012-3#2)
present a technique for##5##4##(2007-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
present a##212##2##(1990-3#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#4)(2008-10#21)(2008-11#11)(2008-12#13)(2008-2#3)(2008-3#20)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#11)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#2)(2010-11#3)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#15)(2012-12#8)(2012-2#7)(2012-3#6)(2013-1#15)(2013-8#4)
present after##2##2##(1992-3#1)(2013-1#1)
present alone##2##2##(2008-10#2)
present among##4##2##(2008-10#3)(2008-9#1)
present an investigation of the##2##5##(2008-2#1)(2009-5#1)
present an overview of the##4##5##(2008-4#1)(2008-5#1)(2010-1#1)(2012-3#1)
present an overview of##5##4##(2008-10#1)(2008-4#1)(2008-5#1)(2010-1#1)(2012-3#1)
present an overview##6##3##(2008-10#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-10#1)(2012-3#1)
present an##33##2##(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-9#1)(2012-3#1)(2013-1#2)
present analysis##3##2##(1991-5#1)(2008-5#1)(2008-9#1)
present analytical##2##2##(2008-10#1)(2008-2#1)
present and future##8##3##(1992-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2013-8#1)
present and##25##2##(1991-11#1)(1991-7#1)(1992-12#1)(1994-12#1)(1997-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
present application##2##2##(2008-10#2)
present approach##4##2##(1995-8#1)(2008-10#3)
present article highlights##3##3##(2008-10#1)(2008-11#2)
present article is##3##3##(1994-6#1)(2008-11#1)(2012-2#1)
present article provides a##2##4##(2008-11#1)(2013-8#1)
present article##37##2##(1992-1#1)(1994-6#1)(2008-10#3)(2008-11#19)(2008-5#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
present as a single copy##3##5##(1993-2#1)(1997-4#1)(2008-8#1)
present as a##8##3##(1993-2#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-8#1)(2012-2#1)(2012-3#1)
present as an##2##3##(1992-2#1)(2013-1#1)
present as multiple##2##3##(2011-2#1)(2012-12#1)
present as##28##2##(1991-5#1)(1992-2#1)(1993-2#1)(1995-2#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
present at a level##2##4##(1991-12#1)(2008-10#1)
present at a##6##3##(1991-12#1)(2008-10#4)(2008-12#1)
present at birth##2##3##(2008-11#1)(2012-3#1)
present at concentrations##2##3##(2008-10#1)(2012-12#1)
present at low##4##3##(1993-9#1)(1995-11#1)(2008-10#1)(2008-9#1)
present at the##7##3##(1992-6#1)(1992-8#1)(1995-9#1)(1996-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
present at##49##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
present between##2##2##(2008-10#1)(2008-7#1)
present both in##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
present both##5##2##(1992-2#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
present but##3##2##(1991-12#1)(2008-11#1)(2011-1#1)
present case reports of three patients who successfully underwent##2##9##(2008-11#2)
present case##18##2##(1990-5#1)(1990-8#1)(1996-2#1)(1997-7#1)(2008-11#2)(2008-12#1)(2008-7#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)
present challenges##2##2##(2008-10#1)(2010-5#1)
present data indicate that##2##4##(1993-8#1)(1995-12#1)
present data indicate##3##3##(1993-8#1)(1995-12#1)(2008-8#1)
present data##17##2##(1991-6#1)(1992-3#1)(1993-1#1)(1993-8#2)(1994-3#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
present detailed##2##2##(1994-3#1)(2008-6#1)
present different##2##2##(2008-5#1)(2010-12#1)
present during##8##2##(1991-5#1)(2008-10#4)(2008-11#1)(2010-3#1)(2013-8#1)
present estimates##2##2##(1992-12#1)(2010-11#1)
present evidence that##4##3##(1991-5#1)(1993-8#1)(1994-11#1)(2008-7#1)
present evidence##9##2##(1991-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)
present experimental data##2##3##(1995-3#1)(2009-3#1)
present experimental evidence##3##3##(2008-3#2)(2008-9#1)
present experimental results of##2##4##(2007-11#1)(2007-12#1)
present experimental results##9##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2008-6#1)
present experimental##18##2##(1993-1#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-4#1)
present experiments were designed to##2##5##(1993-3#1)(1993-6#1)
present experiments were##3##3##(1993-3#1)(1993-6#1)(1994-2#1)
present experiments##8##2##(1990-5#1)(1993-3#2)(1993-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
present findings demonstrate##2##3##(1993-3#1)(2008-5#1)
present findings suggest that##3##4##(1994-5#1)(1996-12#1)(1997-2#1)
present findings##10##2##(1991-5#1)(1993-3#2)(1994-5#1)(1996-12#1)(1997-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-3#1)
present for the##2##3##(2008-10#2)
present for##9##2##(1990-3#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-6#1)
present four##2##2##(1996-1#1)(1997-3#1)
present here the##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2013-1#1)
present here##17##2##(1993-12#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
present higher##3##2##(2008-10#2)(2008-5#1)
present in 1##3##3##(2008-10#2)(2008-12#1)
present in 46%##2##3##(1990-9#1)(2010-4#1)
present in C##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
present in a number of##2##5##(1996-12#1)(2008-5#1)
present in a variety of##2##5##(1992-6#1)(2012-3#1)
present in a##19##3##(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-2#1)(1996-12#1)(2008-10#7)(2008-4#1)(2008-5#2)(2012-2#1)(2012-3#1)
present in all the##2##4##(2008-1#1)(2008-10#1)
present in all##20##3##(1992-12#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
present in aqueous##3##3##(1992-9#1)(2008-10#2)
present in biological##2##3##(1997-7#1)(2008-10#1)
present in both the##2##4##(2010-4#1)(2012-3#1)
present in both##4##3##(2006-6#1)(2008-10#1)(2010-4#1)(2012-3#1)
present in carrot##2##3##(2008-10#1)(2008-9#1)
present in cells##2##3##(1991-5#1)(1995-12#1)
present in different##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
present in each##6##3##(1990-2#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-12#1)(2012-3#1)
present in early##2##3##(2008-7#1)(2010-6#1)
present in equal##2##3##(2008-10#1)(2008-11#1)
present in excess##2##3##(1994-11#1)(2008-10#1)
present in five##2##3##(2008-10#1)(2008-5#1)
present in food##2##3##(2010-5#1)(2011-2#1)
present in high##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
present in human##4##3##(1992-3#1)(2008-10#1)(2009-4#1)(2013-8#1)
present in irrigation water##2##4##(2008-10#2)
present in isolates##2##3##(2008-10#2)
present in layers II##2##4##(1994-2#2)
present in low##2##3##(1994-2#1)(2008-10#1)
present in many##2##3##(1997-2#1)(2008-12#1)
present in most##5##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
present in multiple##2##3##(2008-10#1)(2009-10#1)
present in natural waters##4##4##(2008-10#4)
present in natural##6##3##(1991-5#1)(2008-10#5)
present in nearly##2##3##(2008-10#1)(2008-9#1)
present in necrotic##2##3##(2008-10#1)(2008-7#1)
present in other##4##3##(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)
present in patients##2##3##(1995-2#1)(2008-8#1)
present in petrochemical##2##3##(2008-10#2)
present in pharmaceutical##2##3##(2008-10#1)(2012-2#1)
present in plants##3##3##(2008-10#2)(2011-2#1)
present in real samples##4##4##(2008-10#4)
present in samples##2##3##(2008-10#2)
present in several##4##3##(2008-10#2)(2008-12#1)(2008-7#1)
present in solution##3##3##(2008-10#3)
present in some##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
present in surrounding##2##3##(1992-12#1)(2012-12#1)
present in the cell##2##4##(1992-9#1)(2013-8#1)
present in the central##2##4##(1997-8#1)(2008-10#1)
present in the coding##2##4##(1993-2#1)(1997-7#1)
present in the environmental##2##4##(2008-10#2)
present in the form of##3##5##(1994-9#1)(2008-10#2)
present in the host##2##4##(1993-6#1)(2008-10#1)
present in the majority of##2##5##(1994-12#1)(1995-12#1)
present in the material##2##4##(2008-10#1)(2009-7#1)
present in the medium##3##4##(2008-10#1)(2008-11#1)(2012-7#1)
present in the parents##2##4##(2008-10#2)
present in the pePOA of the male##2##7##(1992-3#2)
present in the plasma##2##4##(1994-6#1)(2008-10#1)
present in the reaction##2##4##(2008-10#2)
present in the same##2##4##(2008-10#2)
present in the sample solution##2##5##(2008-10#2)
present in the sample##11##4##(2008-10#9)(2008-4#2)
present in the samples##6##4##(2008-10#5)(2012-2#1)
present in the solution##2##4##(2008-10#2)
present in the wine##2##4##(2008-10#2)
present in the##194##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-10#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#3)(2008-10#86)(2008-11#9)(2008-12#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2012-7#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
present in these##10##3##(1990-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2009-1#1)
present in this##9##3##(1995-2#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
present in trace amounts##2##4##(2008-11#1)(2008-5#1)
present in various##2##3##(1993-8#1)(2008-10#1)
present in##538##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#4)(1991-5#4)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#6)(1992-5#1)(1992-6#4)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#5)(1993-6#7)(1993-8#6)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#6)(1995-6#1)(1995-8#3)(1995-9#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-1#4)(2008-10#236)(2008-11#22)(2008-12#15)(2008-3#6)(2008-4#9)(2008-5#12)(2008-6#2)(2008-7#16)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#5)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#5)(2012-3#13)(2012-7#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#4)
present investigation##12##2##(1990-12#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
present is##2##2##(2008-10#1)(2009-10#1)
present knowledge about##2##3##(1993-11#1)(1995-2#1)
present knowledge of the##2##4##(2008-10#2)
present knowledge of##3##3##(2008-10#2)(2008-11#1)
present knowledge##8##2##(1991-6#1)(1993-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)
present mainly as##2##3##(2008-10#1)(2009-3#1)
present mainly in the##2##4##(1991-5#1)(2008-10#1)
present mainly in##3##3##(1991-5#1)(2008-10#2)
present mainly##5##2##(1991-5#1)(2008-10#3)(2009-3#1)
present matrix##2##2##(2008-10#2)
present method has##2##3##(2008-10#2)
present method is##3##3##(2008-10#3)
present method showed a##2##4##(2008-10#2)
present method was##8##3##(2008-10#8)
present method##51##2##(1991-3#1)(1994-8#1)(1995-3#1)(2008-10#48)
present methods for##3##3##(1997-7#1)(2008-4#1)(2008-9#1)
present methods##6##2##(1997-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
present more##2##2##(1992-1#1)(2008-10#1)
present new data##2##3##(2008-11#1)(2009-8#1)
present new##6##2##(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)
present novel##2##2##(1996-12#1)(2012-2#1)
present observations##2##2##(1995-3#1)(2013-8#1)
present on all##2##3##(1997-8#1)(2008-4#1)
present on the surface##2##4##(1994-11#1)(2013-8#1)
present on the##8##3##(1991-6#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
present on##25##2##(1991-5#1)(1991-6#1)(1992-10#1)(1994-11#2)(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
present one##2##2##(2008-10#1)(2008-8#1)
present only in##6##3##(1991-12#1)(1993-3#1)(1997-6#1)(2008-10#3)
present only##8##2##(1991-12#1)(1993-3#1)(1997-6#1)(2007-12#1)(2008-10#4)
present or##6##2##(1990-6#1)(1991-11#1)(1992-2#1)(1994-8#1)(2008-10#1)(2008-11#1)
present our experience##2##3##(2008-10#1)(2012-3#1)
present our preliminary results##2##4##(2008-3#1)(2010-4#1)
present our##13##2##(2008-10#3)(2008-3#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
present paper##70##2##(1990-8#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-6#1)(2007-12#1)(2008-10#33)(2008-11#10)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
present predominantly##2##2##(2008-10#2)
present report##15##2##(1990-12#1)(1994-12#1)(1994-3#1)(2008-10#3)(2008-11#4)(2011-2#4)(2013-1#1)
present research was##2##3##(2008-12#1)(2013-8#1)
present research##7##2##(2008-10#1)(2008-12#3)(2013-8#3)
present results from a##2##4##(2008-3#1)(2008-8#1)
present results from##3##3##(1995-5#1)(2008-3#1)(2008-8#1)
present results indicate that##2##4##(1991-5#1)(2010-1#1)
present results of measurements##2##4##(2008-2#1)(2011-2#1)
present results of##5##3##(1995-5#1)(1996-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
present results suggest that the##5##5##(1990-2#1)(1997-2#1)(2008-10#2)(2008-6#1)
present results suggest that##11##4##(1990-2#1)(1991-9#1)(1993-3#1)(1993-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)
present results that demonstrate##2##4##(2008-2#1)(2008-3#1)
present results##42##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1993-3#1)(1993-6#2)(1995-12#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
present review is##4##3##(1992-6#1)(2008-10#2)(2010-1#1)
present review##24##2##(1992-6#1)(1994-8#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
present several##4##2##(1997-2#1)(2008-10#1)(2008-8#1)(2011-3#1)
present situation##3##2##(1991-3#1)(2008-10#2)
present some##2##2##(1990-2#1)(2008-8#1)
present state of knowledge##2##4##(1990-8#1)(1991-3#1)
present state of##4##3##(1990-8#1)(1991-3#1)(2008-11#1)(2011-3#1)
present status of##2##3##(1990-11#1)(2008-7#1)
present status##3##2##(1990-11#1)(2008-11#1)(2008-7#1)
present studies were##3##3##(1991-3#1)(1994-6#1)(1995-11#1)
present studies##6##2##(1991-3#1)(1992-4#1)(1994-6#1)(1995-11#1)(1997-2#1)(2008-8#1)
present study examined the influence of##2##6##(1994-3#1)(1994-8#1)
present study examined the##11##4##(1991-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-9#1)(2010-1#2)(2010-10#1)(2011-2#1)
present study examined##18##3##(1991-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2011-2#2)(2012-2#2)
present study has##4##3##(1997-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
present study indicated that the##2##5##(2008-10#1)(2008-9#1)
present study indicated that##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
present study indicates##2##3##(2009-8#1)(2011-2#1)
present study investigated##7##3##(1991-7#1)(1991-9#1)(1995-12#1)(1996-12#1)(2008-5#1)(2010-10#1)(2013-1#1)
present study is the##2##4##(2012-5#1)(2013-3#1)
present study is to discuss##2##5##(2008-12#1)(2011-2#1)
present study is to##10##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2011-2#2)(2012-3#1)(2013-1#1)
present study is##19##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-3#1)(2013-8#1)
present study revealed that##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
present study sought to##2##4##(2008-11#1)(2008-9#1)
present study the##4##3##(1991-8#1)(1996-2#1)(2008-10#2)
present study was aimed to##3##5##(2008-12#1)(2012-12#1)(2012-3#1)
present study was aimed##4##4##(1994-2#1)(2008-12#1)(2012-12#1)(2012-3#1)
present study was to investigate the relationship between##2##8##(2008-8#1)(2013-8#1)
present study was to investigate the##7##6##(2008-12#1)(2008-8#1)(2009-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
present study was to investigate##10##5##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-1#1)(2010-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
present study was to##50##4##(1990-8#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-5#4)(2008-7#1)(2008-8#1)(2009-1#1)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
present study was##95##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-5#1)(1995-10#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-5#1)(2008-10#10)(2008-11#4)(2008-12#6)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#1)(2009-1#1)(2009-8#1)(2010-10#2)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#3)
present study we have##9##4##(1994-2#1)(1995-12#2)(1996-12#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
present study we##25##3##(1992-12#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#2)(2008-5#1)(2008-7#2)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
present study##430##2##(1990-11#3)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#6)(1993-6#4)(1993-8#2)(1994-11#4)(1994-12#2)(1994-2#11)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#7)(1995-10#1)(1995-11#2)(1995-12#9)(1995-2#5)(1995-8#5)(1996-12#4)(1996-2#8)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#62)(2008-11#31)(2008-12#17)(2008-3#1)(2008-5#18)(2008-6#4)(2008-7#15)(2008-8#3)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#4)(2010-2#1)(2010-3#4)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#32)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#21)(2012-3#10)(2012-5#4)(2012-6#1)(2013-1#20)(2013-3#1)(2013-8#7)
present system##9##2##(2008-10#7)(2008-8#2)
present the case of a##13##5##(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#4)(2012-3#1)
present the case of##17##4##(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#4)(2012-3#3)
present the case##18##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#4)(2012-3#3)(2013-1#1)
present the first##5##3##(1993-2#1)(1993-3#1)(2008-10#1)(2010-12#1)(2013-8#1)
present the most##4##3##(1993-2#1)(2008-10#1)(2008-9#1)(2010-9#1)
present the results of a##2##5##(1990-5#1)(2008-9#1)
present the results of an##2##5##(1993-2#1)(2008-3#1)
present the results of the##2##5##(2008-3#1)(2010-9#1)
present the results of##12##4##(1990-5#1)(1990-6#1)(1993-2#1)(1994-3#1)(1996-1#1)(2007-12#1)(2008-3#3)(2008-9#1)(2010-9#1)(2011-2#1)
present the results##17##3##(1990-5#1)(1990-6#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)
present the##98##2##(1990-3#1)(1990-5#2)(1990-6#1)(1993-2#3)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-11#1)(1996-1#3)(1997-3#1)(1997-7#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-9#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#4)(2013-1#5)(2013-8#2)
present their##5##2##(1990-5#1)(1993-3#1)(1995-5#1)(2008-9#1)(2012-2#1)
present there##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
present this##3##2##(2008-8#1)(2009-6#1)(2012-3#1)
present throughout the##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
present throughout##7##2##(1994-2#1)(1997-2#2)(2008-10#2)(2008-7#1)(2011-2#1)
present time##12##2##(1992-3#2)(1993-3#1)(1994-5#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-8#1)(2008-12#1)(2008-7#1)(2012-3#1)
present to a##2##3##(1991-8#1)(2008-10#1)
present to the##2##3##(2008-4#1)(2013-1#1)
present to##14##2##(1991-8#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
present two cases of##8##4##(2008-10#2)(2008-12#1)(2010-5#1)(2012-3#3)(2013-1#1)
present two##17##2##(1992-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-3#3)(2013-1#2)
present under##2##2##(2008-10#1)(2008-8#1)
present unique##2##2##(1997-2#1)(2009-10#1)
present were##4##2##(1994-2#1)(2008-10#2)(2013-8#1)
present when##4##2##(2008-10#3)(2011-2#1)
present which##3##2##(1996-3#1)(2008-10#1)(2010-12#1)
present with a##4##3##(2008-10#1)(2008-7#2)(2010-9#1)
present with abdominal##2##3##(2010-12#1)(2013-1#1)
present with severe##2##3##(2010-1#1)(2011-2#1)
present with##36##2##(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2013-1#2)
present within the##5##3##(1992-12#1)(1992-3#1)(2008-10#2)(2008-5#1)
present within##8##2##(1992-12#1)(1992-3#1)(1994-12#1)(2008-10#3)(2008-5#1)(2011-2#1)
present work is##5##3##(1996-12#1)(1997-2#1)(2008-10#2)(2009-12#1)
present work was##11##3##(1992-12#1)(1993-11#1)(2008-10#3)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#3)
present work##86##2##(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#51)(2008-11#5)(2008-5#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
present##2558##1##(1990-11#8)(1990-12#12)(1990-2#5)(1990-3#8)(1990-5#12)(1990-6#6)(1990-8#8)(1990-9#6)(1991-1#1)(1991-11#6)(1991-12#12)(1991-2#3)(1991-3#10)(1991-5#15)(1991-6#10)(1991-7#2)(1991-8#7)(1991-9#5)(1992-1#3)(1992-10#3)(1992-12#11)(1992-2#4)(1992-3#19)(1992-4#2)(1992-5#4)(1992-6#8)(1992-8#2)(1992-9#5)(1993-1#4)(1993-11#5)(1993-12#8)(1993-2#8)(1993-3#24)(1993-6#15)(1993-8#13)(1993-9#3)(1994-1#2)(1994-11#12)(1994-12#11)(1994-2#22)(1994-3#15)(1994-5#9)(1994-6#9)(1994-8#15)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#7)(1995-12#15)(1995-2#18)(1995-3#5)(1995-5#7)(1995-6#3)(1995-8#10)(1995-9#4)(1996-1#4)(1996-12#19)(1996-2#13)(1996-3#8)(1996-5#5)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#17)(1997-3#9)(1997-4#7)(1997-6#4)(1997-7#11)(1997-8#12)(1997-9#1)(2006-6#1)(2007-11#4)(2007-12#21)(2008-1#11)(2008-10#708)(2008-11#164)(2008-12#68)(2008-2#19)(2008-3#65)(2008-4#19)(2008-5#64)(2008-6#17)(2008-7#82)(2008-8#54)(2008-9#69)(2009-1#7)(2009-10#16)(2009-11#6)(2009-12#12)(2009-3#6)(2009-4#4)(2009-5#3)(2009-6#7)(2009-7#12)(2009-8#27)(2009-9#2)(2010-1#14)(2010-10#13)(2010-11#8)(2010-12#14)(2010-2#1)(2010-3#9)(2010-4#8)(2010-5#10)(2010-6#11)(2010-7#7)(2010-8#6)(2010-9#4)(2011-1#13)(2011-10#2)(2011-2#117)(2011-3#4)(2011-7#1)(2012-12#24)(2012-2#60)(2012-3#57)(2012-5#4)(2012-6#1)(2012-7#2)(2012-9#3)(2013-1#84)(2013-3#1)(2013-7#2)(2013-8#41)
present)##4##1##(1990-12#2)(2008-10#2)
present-day##2##1##(2008-8#2)
presentation after##2##2##(2008-1#1)(2013-1#1)
presentation and advanced HIV disease were##2##6##(2013-1#2)
presentation and diagnostic##2##3##(1991-8#1)(2008-7#1)
presentation and##23##2##(1991-2#1)(1991-6#1)(1991-8#1)(1995-10#1)(1995-11#1)(1996-2#1)(1997-2#1)(2008-12#1)(2008-7#3)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
presentation at a conference##2##4##(2008-10#1)(2008-12#1)
presentation because of##2##3##(2008-11#1)(2012-3#1)
presentation focuses on##2##3##(2008-1#1)(2012-12#1)
presentation for##5##2##(1995-5#1)(2008-10#1)(2010-10#1)(2013-1#2)
presentation in##10##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
presentation is very##2##3##(1997-8#1)(2008-9#1)
presentation is##9##2##(1995-1#1)(1996-1#1)(1997-4#1)(1997-8#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)
presentation of a##8##3##(1996-12#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-10#1)(2010-3#1)(2012-3#1)
presentation of metastatic##2##3##(1990-12#1)(2009-3#1)
presentation of the##10##3##(1993-6#1)(2008-10#2)(2008-11#3)(2008-12#2)(2009-6#1)(2010-12#1)
presentation of this##2##3##(2008-11#1)(2011-2#1)
presentation of tuberculosis##2##3##(2011-2#2)
presentation of words##2##3##(1990-8#2)
presentation of##70##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-11#9)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
presentation on##2##2##(1992-12#1)(2008-10#1)
presentation order##2##2##(2008-12#2)
presentation skills##2##2##(1997-4#1)(2008-11#1)
presentation status##2##2##(2013-1#2)
presentation to the##2##3##(2008-10#1)(2012-2#1)
presentation to##5##2##(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)(2012-3#1)
presentation was##4##2##(1996-3#1)(2008-11#1)(2013-1#2)
presentation will##2##2##(2008-7#2)
presentation with a##2##3##(1997-3#1)(2008-7#1)
presentation with##3##2##(1997-3#1)(2008-7#1)(2009-1#1)
presentation##243##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-8#6)(2007-12#2)(2008-1#2)(2008-10#15)(2008-11#19)(2008-12#13)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#15)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-8#11)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-3#2)(2010-5#5)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#18)(2012-12#5)(2012-2#3)(2012-3#12)(2013-1#20)(2013-7#3)(2013-8#4)
presentations and##4##2##(2008-7#1)(2010-6#2)(2012-12#1)
presentations are##2##2##(2008-12#1)(2008-5#1)
presentations at the##46##3##(2008-11#45)(2008-5#1)
presentations at##48##2##(2008-11#45)(2008-5#2)(2010-4#1)
presentations of tropical diseases in travelers##2##6##(2011-2#2)
presentations of##4##2##(2008-12#1)(2008-6#1)(2011-2#2)
presentations that##3##2##(2008-12#1)(2008-7#1)(2010-6#1)
presentations##74##1##(1996-2#1)(2008-11#47)(2008-12#3)(2008-5#3)(2008-6#2)(2008-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#3)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)
presented a good##3##3##(2008-10#3)
presented a high##2##3##(2008-5#1)(2011-2#1)
presented a##28##2##(1991-2#1)(1993-11#1)(1994-8#1)(1997-8#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
presented alteration##2##2##(2008-10#1)(2013-1#1)
presented an analytical##4##3##(2008-10#3)(2008-3#1)
presented an##11##2##(1991-3#1)(1994-5#1)(2008-10#5)(2008-3#1)(2008-6#1)(2009-10#1)(2011-2#1)
presented and a##2##3##(1991-12#1)(1995-12#1)
presented and compared to##2##4##(1993-6#1)(2008-11#1)
presented and compared with##2##4##(2008-10#1)(2008-3#1)
presented and compared##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
presented and discussed##10##3##(1996-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2009-3#1)
presented and explained##2##3##(2008-10#2)
presented and the##5##3##(1990-12#1)(2008-10#2)(2009-9#1)(2011-7#1)
presented and used to##2##4##(1994-5#1)(2008-12#1)
presented and##41##2##(1990-12#1)(1990-3#1)(1991-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-7#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-7#1)(2012-2#1)(2013-8#1)
presented are##3##2##(2008-10#1)(2008-4#2)
presented as a new##3##4##(2008-10#2)(2012-2#1)
presented as a working hypothesis in Part 1##2##8##(2008-12#2)
presented as a##20##3##(1991-12#2)(1993-1#1)(1996-5#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#2)
presented as an example##3##4##(1997-8#1)(2009-8#1)(2013-8#1)
presented as an##10##3##(1997-8#1)(2008-10#4)(2008-12#1)(2009-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
presented as powerful analytical tools for##2##6##(2008-10#2)
presented as the##2##3##(2008-10#1)(2011-2#1)
presented as##49##2##(1991-12#2)(1993-1#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#17)(2008-12#4)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
presented at a##2##3##(2008-10#1)(2008-11#1)
presented at the##12##3##(1992-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-8#1)
presented at##17##2##(1992-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
presented based on the##2##4##(2008-10#1)(2008-4#1)
presented better performance##2##3##(2008-10#2)
presented by the##3##3##(1997-4#1)(2008-10#2)
presented by##11##2##(1992-12#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-9#1)
presented case##2##2##(1990-9#1)(2012-12#1)
presented data##2##2##(1991-12#1)(2008-5#1)
presented different##4##2##(1996-12#1)(2008-10#1)(2013-1#2)
presented during##2##2##(2008-4#1)(2013-8#1)
presented elsewhere##2##2##(2008-4#1)(2008-8#1)
presented evidence that##2##3##(2008-10#1)(2011-2#1)
presented evidence##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
presented for a##3##3##(2008-11#1)(2009-10#1)(2010-1#1)
presented for determination of##3##4##(2008-10#3)
presented for the detection##2##4##(2008-10#1)(2008-3#1)
presented for the determination of the##2##6##(2008-10#2)
presented for the determination of##8##5##(2008-10#8)
presented for the##28##3##(1991-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(2008-1#1)(2008-10#17)(2008-3#2)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)
presented for##69##2##(1991-2#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#1)(2007-12#2)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#2)(2008-3#8)(2008-4#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
presented from a##2##3##(2008-1#1)(2008-12#1)
presented from##4##2##(1993-6#1)(2008-1#1)(2008-10#1)(2008-12#1)
presented good##4##2##(2008-10#3)(2012-3#1)
presented here are##2##3##(2008-3#1)(2013-8#1)
presented here for##3##3##(1990-8#1)(1992-2#1)(2011-3#1)
presented here is capable of##2##5##(2008-10#1)(2008-11#1)
presented here is##8##3##(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)(2013-1#1)
presented here provide##2##3##(2008-11#1)(2009-10#1)
presented here provides a##2##4##(2008-12#1)(2013-8#1)
presented here show that##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
presented here suggest that##4##4##(1996-6#1)(2008-10#1)(2008-7#1)(2010-8#1)
presented here##59##2##(1990-8#1)(1992-2#2)(1993-3#1)(1994-9#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#11)(2008-11#9)(2008-12#2)(2008-3#5)(2008-4#1)(2008-7#5)(2008-8#4)(2009-10#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
presented herein##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
presented higher##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-9#1)
presented in a##4##3##(1994-2#1)(2008-10#2)(2009-8#1)
presented in an##2##3##(2008-10#1)(2008-11#1)
presented in detail##3##3##(2008-10#2)(2008-9#1)
presented in part##2##3##(2008-3#2)
presented in terms of##2##4##(2008-10#1)(2009-7#1)
presented in the article##2##4##(2010-11#1)(2012-3#1)
presented in the literature##2##4##(2008-9#1)(2010-9#1)
presented in the main theme##3##5##(2010-10#3)
presented in the##21##3##(1990-3#1)(1991-3#1)(1993-12#1)(1996-3#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#3)(2010-11#1)(2010-9#1)(2012-12#1)(2012-3#1)
presented in this article##10##4##(1991-2#1)(1992-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#2)
presented in this paper##15##4##(1991-12#1)(1993-6#1)(2008-10#11)(2008-11#1)(2009-7#1)
presented in this report##2##4##(1993-3#1)(2008-10#1)
presented in this study##4##4##(2008-10#1)(2008-12#1)(2009-3#1)(2010-1#1)
presented in this unit##6##4##(2008-4#3)(2008-9#3)
presented in this##45##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-4#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2013-1#2)
presented in##106##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#2)(1995-3#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-2#2)(2007-12#1)(2008-10#34)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
presented is a##2##3##(1990-8#1)(2010-11#1)
presented is the##2##3##(2008-10#1)(2008-7#1)
presented is##6##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
presented itself##2##2##(1990-9#1)(2008-8#1)
presented method of##2##3##(2008-11#2)
presented method##4##2##(2008-10#2)(2008-11#2)
presented new##2##2##(2008-10#1)(2008-2#1)
presented on##9##2##(1991-3#1)(1992-1#1)(1993-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)
presented paper##2##2##(2008-10#2)
presented recoveries##2##2##(2008-10#2)
presented results##2##2##(1997-6#1)(2008-10#1)
presented similar##3##2##(2008-10#1)(2013-1#2)
presented some##3##2##(1997-3#1)(2008-10#2)
presented such##2##2##(2008-10#1)(2012-3#1)
presented that##22##2##(1990-2#1)(1992-12#1)(1993-1#1)(1993-6#1)(1995-1#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-9#1)(2010-11#2)(2012-2#1)(2012-3#1)
presented the highest##5##3##(2009-7#1)(2011-2#1)(2013-1#3)
presented the same##2##3##(2008-10#2)
presented the##14##2##(2007-11#1)(2008-10#2)(2009-7#2)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#5)
presented three##2##2##(2008-12#1)(2012-12#1)
presented to demonstrate##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
presented to describe##2##3##(2008-10#1)(2010-11#1)
presented to illustrate the##3##4##(1996-12#1)(1996-9#1)(2008-1#1)
presented to illustrate##4##3##(1996-12#1)(1996-9#1)(1997-2#1)(2008-1#1)
presented to our hospital##2##4##(2011-2#1)(2012-12#1)
presented to our institution with##2##5##(2008-8#1)(2013-1#1)
presented to our##5##3##(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
presented to the Radiation Oncology and##2##6##(2008-10#2)
presented to the emergency room##2##5##(2007-12#2)
presented to the emergency##3##4##(2007-12#2)(2013-1#1)
presented to the##10##3##(1993-12#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#2)
presented to us with##2##4##(2013-1#2)
presented to us##3##3##(2010-5#1)(2013-1#2)
presented to##57##2##(1990-9#1)(1993-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#8)(2013-8#1)
presented together with##5##3##(1990-2#1)(2008-10#2)(2008-3#1)(2011-2#1)
presented two##2##2##(2008-10#1)(2010-10#1)
presented which##7##2##(1993-1#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#1)
presented will##2##2##(1997-2#1)(1997-4#1)
presented with a 4-year history of a##2##7##(2010-6#1)(2012-3#1)
presented with a history of intermittent##2##6##(2011-2#1)(2012-2#1)
presented with a history of##7##5##(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
presented with a one year history of##2##7##(2008-12#1)(2008-7#1)
presented with a one##3##4##(1996-9#1)(2008-12#1)(2008-7#1)
presented with a solitary##2##4##(2010-6#2)
presented with a subarachnoid haemorrhage##2##5##(1996-9#1)(2008-7#1)
presented with a subarachnoid##3##4##(1996-9#1)(2008-7#1)(2013-8#1)
presented with a##48##3##(1990-2#1)(1991-8#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#9)(2009-3#1)(2009-5#1)(2010-3#1)(2010-6#7)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
presented with acute##5##3##(1997-3#1)(2008-10#1)(2008-12#1)(2010-8#1)(2013-1#1)
presented with an impalpable right testis##2##6##(2008-10#2)
presented with an##8##3##(1991-8#1)(2008-10#2)(2009-6#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
presented with bilateral##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
presented with complaints of##2##4##(2013-7#1)(2013-8#1)
presented with different##2##3##(1997-3#1)(2008-11#1)
presented with fever##2##3##(2009-11#2)
presented with hearing loss##2##4##(2008-1#1)(2011-2#1)
presented with hemorrhage##2##3##(2008-12#1)(2008-7#1)
presented with increased##2##3##(2008-12#1)(2011-2#1)
presented with lower##2##3##(2008-8#1)(2011-2#1)
presented with multiple##2##3##(2010-6#1)(2013-1#1)
presented with neck##2##3##(1991-8#1)(2009-3#1)
presented with orbital swelling##2##4##(2013-1#2)
presented with progressive##2##3##(2008-7#1)(2011-2#1)
presented with recurrent urinary tract infections##2##6##(2008-10#1)(2013-1#1)
presented with recurrent##7##3##(2008-10#2)(2008-11#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
presented with severe##4##3##(1996-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
presented with subarachnoid haemorrhage (SAH)##2##5##(2008-7#2)
presented with subarachnoid haemorrhage##5##4##(1997-3#1)(2008-7#4)
presented with subarachnoid##6##3##(1997-3#1)(2008-7#4)(2011-2#1)
presented with sudden onset of coma##2##6##(2008-7#2)
presented with sudden onset of##4##5##(2008-10#1)(2008-7#3)
presented with sudden onset##5##4##(2008-10#1)(2008-7#3)(2013-1#1)
presented with sudden##7##3##(2008-10#1)(2008-7#3)(2010-10#1)(2011-2#1)(2013-1#1)
presented with symptoms##2##3##(2008-12#1)(2008-7#1)
presented with the##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
presented with two##2##3##(2010-11#1)(2011-2#1)
presented with##204##2##(1990-2#1)(1990-6#1)(1991-8#3)(1992-12#1)(1994-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-3#5)(1997-5#2)(1997-6#1)(1997-8#1)(2008-1#6)(2008-10#21)(2008-11#7)(2008-12#13)(2008-5#2)(2008-7#22)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#4)(2010-6#10)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#22)(2012-12#3)(2012-2#4)(2012-3#10)(2013-1#18)(2013-7#3)(2013-8#8)
presented within the##2##3##(1991-10#1)(2008-7#1)
presented within##4##2##(1991-10#1)(2008-7#1)(2008-9#1)(2010-11#1)
presented##1349##1##(1990-12#2)(1990-2#4)(1990-3#4)(1990-5#2)(1990-6#4)(1990-8#4)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#11)(1991-3#8)(1991-6#1)(1991-7#1)(1991-8#4)(1992-1#5)(1992-12#7)(1992-2#10)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#6)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#6)(1993-6#8)(1993-8#2)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#9)(1996-3#5)(1996-5#3)(1996-6#7)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#7)(1997-3#7)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#8)(2006-6#1)(2007-11#5)(2007-12#12)(2007-8#1)(2008-1#11)(2008-10#389)(2008-11#65)(2008-12#36)(2008-2#20)(2008-3#99)(2008-4#30)(2008-5#31)(2008-6#5)(2008-7#52)(2008-8#21)(2008-9#22)(2009-1#1)(2009-10#6)(2009-11#4)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#8)(2009-8#5)(2009-9#5)(2010-1#5)(2010-10#8)(2010-11#12)(2010-12#4)(2010-3#3)(2010-5#6)(2010-6#13)(2010-7#4)(2010-8#6)(2010-9#8)(2011-1#3)(2011-10#1)(2011-2#57)(2011-3#2)(2011-7#1)(2012-12#10)(2012-2#20)(2012-3#26)(2013-1#62)(2013-7#6)(2013-8#27)
presenting a##9##2##(1991-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
presenting as a##8##3##(1990-2#1)(2008-4#1)(2009-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
presenting as acute##2##3##(2008-11#1)(2011-2#1)
presenting as an isolated##2##4##(2008-7#2)
presenting as an##3##3##(2008-11#1)(2008-7#2)
presenting as massive##2##3##(2008-12#2)
presenting as multiple##2##3##(1990-2#1)(2010-6#1)
presenting as##31##2##(1990-2#2)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#5)(2008-4#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
presenting data on##2##3##(1996-3#1)(2011-2#1)
presenting feature of##4##3##(2008-11#1)(2008-9#2)(2010-6#1)
presenting for##3##2##(2008-1#1)(2008-6#1)(2009-10#1)
presenting in a##2##3##(2008-7#1)(2009-1#1)
presenting in the##2##3##(2010-12#1)(2013-8#1)
presenting in##7##2##(2008-10#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
presenting information##2##2##(1992-3#1)(2008-10#1)
presenting metabolism in the context of##2##6##(2008-3#2)
presenting much higher peak currents than those##2##7##(2008-10#2)
presenting relative##2##2##(2008-10#2)
presenting sign of##3##3##(2008-1#1)(2009-7#1)(2010-10#1)
presenting symptom##3##2##(1995-10#1)(2008-7#1)(2013-7#1)
presenting symptoms##6##2##(1990-6#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
presenting syndrome of HIV disease##2##5##(2011-2#2)
presenting the risk##2##3##(2011-2#2)
presenting the##7##2##(1997-3#1)(2008-5#2)(2008-6#1)(2011-2#3)
presenting to the emergency department##3##5##(2008-11#1)(2009-9#1)(2012-3#1)
presenting to the##4##3##(2008-11#1)(2009-8#1)(2009-9#1)(2012-3#1)
presenting to##7##2##(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-3#1)
presenting unique##2##2##(2008-5#1)(2013-8#1)
presenting with a##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
presenting with abdominal pain##2##4##(2011-2#1)(2013-1#1)
presenting with acute##6##3##(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#2)
presenting with an##3##3##(2008-11#1)(2010-10#1)(2013-1#1)
presenting with atypical##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
presenting with gross hematuria##3##4##(2008-11#3)
presenting with symptoms of##2##4##(1995-5#1)(2008-4#1)
presenting with this condition##2##4##(2008-10#1)(2008-12#1)
presenting with##71##2##(1990-12#1)(1990-6#1)(1992-1#1)(1995-10#1)(1995-5#1)(1996-9#1)(1997-8#4)(2007-12#1)(2008-10#6)(2008-11#5)(2008-12#5)(2008-4#1)(2008-5#1)(2008-7#10)(2010-1#1)(2010-10#2)(2010-7#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
presenting##214##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-8#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#5)(2006-5#1)(2007-12#1)(2008-1#5)(2008-10#20)(2008-11#16)(2008-12#13)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#21)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#21)(2012-12#4)(2012-2#5)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#7)
presently available##2##2##(2008-10#1)(2008-11#1)
presently being##3##2##(1993-2#1)(1997-1#1)(2008-11#1)
presently##21##1##(1991-2#1)(1992-1#1)(1993-2#1)(1995-12#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-7#1)(2010-12#1)(2010-6#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
presents a brief##3##3##(1990-12#1)(1991-9#1)(2008-9#1)
presents a case of a##2##5##(2010-12#1)(2013-1#1)
presents a case of##4##4##(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
presents a case study of##2##5##(1997-2#2)
presents a case##7##3##(1997-2#2)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#2)
presents a challenge##2##3##(1993-3#1)(2010-5#1)
presents a comprehensive overview of the##2##6##(1992-12#1)(2013-1#1)
presents a detailed##2##3##(1994-1#1)(1996-1#1)
presents a general##3##3##(1995-5#1)(2008-11#1)(2008-4#1)
presents a method for##3##4##(2008-10#2)(2008-6#1)
presents a method##6##3##(2008-10#4)(2008-6#1)(2008-9#1)
presents a methodology##2##3##(1993-2#1)(2008-10#1)
presents a new##2##3##(2008-10#1)(2013-1#1)
presents a novel##2##3##(2008-10#1)(2008-6#1)
presents a number of##2##4##(1995-12#1)(2008-7#1)
presents a procedure##2##3##(2009-8#1)(2013-1#1)
presents a retrospective##2##3##(2008-11#1)(2013-1#1)
presents a review of##2##4##(2010-1#1)(2011-7#1)
presents a short##3##3##(2008-7#1)(2012-2#2)
presents a simple##5##3##(2008-10#3)(2008-4#1)(2009-8#1)
presents a solution to these##2##5##(2008-6#1)(2008-9#1)
presents a study of##2##4##(2008-10#2)
presents a summary of the##3##5##(2009-10#1)(2011-3#1)(2013-1#1)
presents a unique challenge to##2##5##(1997-2#1)(2008-10#1)
presents a unique##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
presents a variety of##4##4##(1991-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
presents a##128##2##(1990-12#1)(1990-3#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#3)(1997-2#3)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#29)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#9)(2009-10#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#8)
presents an alternative##4##3##(2008-2#3)(2008-7#1)
presents an analysis of##2##4##(1993-6#1)(2008-11#1)
presents an investigation on##2##4##(2008-10#2)
presents an overview of the##3##5##(2008-5#1)(2008-9#1)(2011-2#1)
presents an overview of##7##4##(2008-4#2)(2008-5#2)(2008-9#1)(2011-2#1)(2013-8#1)
presents an update of##2##4##(2008-11#1)(2008-9#1)
presents an##33##2##(1993-6#1)(1995-9#2)(1996-11#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#4)(2010-11#1)(2011-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
presents as a##4##3##(1990-9#1)(2008-7#1)(2009-12#1)(2012-3#1)
presents as##7##2##(1990-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-3#1)
presents certain##2##2##(2008-10#1)(2008-5#1)
presents clinical##2##2##(1993-1#1)(2008-4#1)
presents concise##2##2##(2008-9#1)(2010-5#1)
presents data on##4##3##(1994-2#1)(1995-3#1)(1997-3#1)(2008-10#1)
presents data##8##2##(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2010-8#1)
presents diagnostic##2##2##(2010-11#1)(2013-1#1)
presents findings from##2##3##(1994-1#1)(2008-11#1)
presents in##4##2##(2006-5#1)(2009-1#2)(2013-1#1)
presents information on##2##3##(1991-12#1)(2008-9#1)
presents itself##2##2##(2008-11#1)(2012-3#1)
presents many challenges##3##3##(2008-11#1)(2008-12#1)(2009-10#1)
presents many##4##2##(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#1)
presents new##2##2##(2008-12#1)(2009-8#1)
presents numerous##2##2##(1992-3#1)(2008-10#1)
presents practical##2##2##(2008-9#1)(2012-2#1)
presents procedures for##2##3##(2008-4#1)(2008-9#1)
presents recent research##2##3##(1991-2#1)(2008-10#1)
presents results##3##2##(1992-5#1)(1997-2#1)(2009-8#1)
presents some of the##2##4##(2008-12#1)(2008-5#1)
presents some##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
presents the case of##2##4##(1992-1#1)(2013-8#1)
presents the case##3##3##(1992-1#1)(2010-5#1)(2013-8#1)
presents the findings##2##3##(1994-2#1)(2008-11#1)
presents the historical##2##3##(1996-2#1)(2008-9#1)
presents the main##2##3##(1991-2#1)(2008-10#1)
presents the results of a survey##2##6##(1994-3#1)(2008-11#1)
presents the results of a##9##5##(1993-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
presents the results of the first##2##6##(1995-3#1)(2013-8#1)
presents the results of the##3##5##(1995-3#1)(2008-10#1)(2013-8#1)
presents the results of##15##4##(1993-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2009-10#1)(2011-2#2)(2013-8#1)
presents the validation##2##3##(2008-10#1)(2008-5#1)
presents the##62##2##(1990-6#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#2)(2008-9#5)(2009-10#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-2#5)(2011-7#2)(2013-1#1)(2013-8#3)
presents three##2##2##(1991-1#1)(1994-1#1)
presents two##5##2##(2008-10#1)(2008-2#1)(2008-9#2)(2009-1#1)
presents with##14##2##(1997-1#1)(1997-3#1)(2006-5#4)(2008-10#1)(2008-11#2)(2008-9#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
presents##379##1##(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#5)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#5)(1994-12#1)(1994-2#5)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-9#2)(1996-1#5)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#8)(1997-3#6)(1997-6#1)(1997-7#1)(2006-5#6)(2007-12#2)(2008-1#1)(2008-10#64)(2008-11#22)(2008-12#10)(2008-2#5)(2008-3#1)(2008-4#16)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#47)(2009-1#3)(2009-10#5)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#1)(2011-10#1)(2011-2#16)(2011-3#1)(2011-7#3)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#16)(2013-8#4)
preservation and##8##2##(1991-3#1)(1995-3#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-9#1)
preservation at##2##2##(2008-10#1)(2008-11#1)
preservation in the##2##3##(1997-2#1)(2008-10#1)
preservation in##4##2##(1996-3#1)(1997-2#1)(2008-10#1)(2008-5#1)
preservation is##2##2##(1996-3#1)(2011-2#1)
preservation medium was##2##3##(2008-10#2)
preservation medium##3##2##(2008-10#3)
preservation method##3##2##(2008-10#2)(2008-5#1)
preservation of arsenic species in##2##5##(2008-10#2)
preservation of soft tissue##2##4##(2008-12#2)
preservation of the##10##3##(1990-9#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
preservation of these##2##3##(2008-10#1)(2011-2#1)
preservation of##33##2##(1990-9#1)(1993-12#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-3#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-9#2)(2011-2#4)(2012-3#1)(2013-1#3)
preservation##77##1##(1990-9#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#23)(2008-11#8)(2008-12#6)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-4#1)(2010-7#2)(2010-9#3)(2011-2#8)(2011-3#1)(2012-3#1)(2013-1#3)
preservative efficacy##2##2##(2008-5#2)
preservative in##2##2##(1995-5#1)(2008-5#1)
preservative system##7##2##(2008-5#7)
preservative##19##1##(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#14)(2011-2#2)
preservatives in cosmetic##2##3##(2008-10#2)
preservatives##6##1##(2008-10#2)(2008-5#4)
preserve or##2##2##(2008-5#1)(2010-7#1)
preserve the##16##2##(1994-1#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
preserve##36##1##(1994-1#1)(1994-3#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-3#5)(2008-5#4)(2008-6#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
preserved and##2##2##(1991-10#1)(2008-10#1)
preserved at##2##2##(1993-2#2)
preserved cells##3##2##(2008-11#3)
preserved for##2##2##(2008-10#2)
preserved in the##3##3##(2008-11#2)(2008-7#1)
preserved in##10##2##(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-1#1)(2011-2#1)(2012-3#1)(2012-9#1)
preserved the##3##2##(1995-6#1)(2008-11#1)(2012-6#1)
preserved through the##2##3##(1997-6#1)(2009-12#1)
preserved with the##2##3##(2008-10#2)
preserved with thymol##2##3##(1997-2#1)(2008-10#1)
preserved with##8##2##(1996-12#1)(1997-2#1)(2008-10#4)(2008-5#2)
preserved##64##1##(1990-11#1)(1990-5#1)(1991-10#1)(1991-2#2)(1993-2#3)(1995-6#3)(1995-8#1)(1996-12#3)(1997-2#1)(1997-6#1)(2008-10#14)(2008-11#7)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#4)(2009-1#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#4)(2012-6#1)(2012-9#1)(2013-1#1)(2013-8#1)
preserves the##4##2##(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
preserves##14##1##(1993-3#1)(1994-5#1)(1996-3#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
preserving the##10##2##(1994-9#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
preserving treatment##2##2##(2011-1#1)(2012-3#1)
preserving##23##1##(1991-3#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
preset##7##1##(1995-3#1)(2008-10#4)(2008-6#1)(2013-8#1)
president of##4##2##(1993-12#1)(1994-1#1)(1994-9#1)(2008-5#1)
president##6##1##(1993-12#1)(1994-1#1)(1994-8#1)(1994-9#1)(2008-5#1)(2009-5#1)
president's##2##1##(1992-3#1)(1995-6#1)
presidential##4##1##(1991-3#1)(1997-2#1)(2008-4#1)(2012-2#1)
presidents##4##1##(1994-12#2)(1995-3#2)
press##17##1##(1993-6#1)(1994-1#1)(1994-2#1)(1996-11#1)(1997-6#1)(2008-10#4)(2008-12#2)(2008-8#2)(2009-1#1)(2009-4#1)(2010-1#1)(2013-8#1)
pressed##5##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)
pressing##7##1##(1995-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-8#1)
pressor effects##2##2##(1991-1#1)(1995-11#1)
pressor response to##3##3##(1994-3#1)(1997-2#2)
pressor##7##1##(1991-1#1)(1994-3#1)(1995-11#1)(1997-2#3)(2012-2#1)
pressure (25##2##2##(2010-7#1)(2012-3#1)
pressure (ICP)##7##2##(1993-1#1)(2008-12#1)(2008-7#3)(2010-5#1)(2011-2#1)
pressure (MAP)##3##2##(2009-8#1)(2011-2#1)(2013-8#1)
pressure (PPA##2##2##(1991-6#2)
pressure (odds ratio##2##3##(1994-3#2)
pressure after##2##2##(1995-11#1)(2010-10#1)
pressure and heart##2##3##(1990-9#1)(1997-8#1)
pressure and temperature##5##3##(1995-6#1)(2008-3#3)(2009-11#1)
pressure and the##6##3##(1990-5#1)(1997-8#1)(2008-10#1)(2008-11#2)(2012-3#1)
pressure and##43##2##(1990-5#1)(1990-9#2)(1991-3#1)(1991-6#2)(1993-1#1)(1993-3#1)(1994-6#1)(1995-6#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-8#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-11#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2012-4#1)(2012-6#1)(2013-1#2)(2013-8#2)
pressure as##3##2##(2008-1#1)(2008-10#2)
pressure at##6##2##(2008-10#3)(2008-7#2)(2012-3#1)
pressure by##3##2##(2008-11#1)(2009-5#1)(2009-9#1)
pressure chemical##2##2##(2008-10#2)
pressure chromatographic##2##2##(2008-10#2)
pressure decreased##3##2##(1990-11#1)(1991-6#1)(2010-4#1)
pressure dependence of##2##3##(2008-2#2)
pressure difference##4##2##(2008-8#3)(2010-10#1)
pressure drop##5##2##(1990-11#1)(1994-2#1)(2008-10#1)(2008-7#2)
pressure during the##2##3##(2008-10#1)(2013-1#1)
pressure during##7##2##(1993-1#1)(1994-3#1)(2008-10#2)(2008-11#2)(2013-1#1)
pressure flow##2##2##(2008-10#2)
pressure for the##2##3##(2008-10#1)(2010-7#1)
pressure for##9##2##(1996-3#1)(1997-2#1)(2008-10#3)(2008-5#1)(2009-3#1)(2010-7#2)
pressure from##5##2##(1990-11#1)(1993-2#1)(2008-11#3)
pressure has##4##2##(1994-3#1)(2008-10#1)(2010-4#1)(2012-3#1)
pressure in men##2##3##(1991-6#1)(2013-1#1)
pressure in the##7##3##(1997-5#3)(2008-10#2)(2010-5#1)(2011-2#1)
pressure in##24##2##(1991-6#1)(1993-1#1)(1994-3#1)(1996-1#1)(1997-5#3)(1997-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-5#2)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
pressure inside the##2##3##(2008-10#2)
pressure inside##3##2##(2008-10#2)(2008-3#1)
pressure is##12##2##(1993-11#1)(1993-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-10#3)(2008-3#1)(2008-5#3)
pressure level##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
pressure liquid chromatography (HPLC)##4##4##(2008-10#3)(2011-1#1)
pressure liquid chromatography##5##3##(2008-10#3)(2011-1#2)
pressure liquid##8##2##(2008-10#6)(2011-1#2)
pressure may##2##2##(1997-5#1)(2008-7#1)
pressure measurement##7##2##(1990-8#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2010-8#1)
pressure measurements##5##2##(1990-11#1)(2008-3#1)(2012-2#3)
pressure monitoring##12##2##(1990-11#2)(1994-9#1)(1997-8#1)(2008-1#4)(2010-1#3)(2012-3#1)
pressure of &lt##2##3##(1997-5#2)
pressure of 0##2##3##(2009-5#1)(2011-2#1)
pressure of the##3##3##(2008-5#2)(2010-7#1)
pressure of##31##2##(1991-12#1)(1993-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(2008-1#3)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#5)(2009-5#1)(2010-7#2)(2011-2#2)(2013-8#1)
pressure on the##6##3##(1992-6#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-1#1)
pressure on##19##2##(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#1)(2009-1#1)(2012-2#1)
pressure or##4##2##(1993-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
pressure pain threshold##2##3##(2010-12#2)
pressure profile is##2##3##(2008-3#2)
pressure range from##3##3##(2008-10#1)(2008-3#2)
pressure range##7##2##(2008-10#3)(2008-3#3)(2008-7#1)
pressure reservoir##2##2##(1990-9#1)(1996-3#1)
pressure response during##2##3##(1990-5#2)
pressure secondary to##2##3##(2008-7#1)(2010-10#1)
pressure sensitivity of##2##3##(2008-3#1)(2010-9#1)
pressure sensitivity##4##2##(2008-3#3)(2010-9#1)
pressure sensor##3##2##(2008-10#1)(2008-2#2)
pressure should##4##2##(1993-2#1)(1994-6#1)(1996-6#2)
pressure signal##5##2##(2008-10#4)(2012-3#1)
pressure signals##2##2##(2008-10#2)
pressure tactics##4##2##(2010-1#4)
pressure to a##3##3##(2008-11#1)(2008-5#1)(2009-7#1)
pressure to reduce##2##3##(2008-9#1)(2011-2#1)
pressure to##13##2##(1991-3#1)(1995-2#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-2#1)
pressure ulcer##3##2##(2012-3#3)
pressure using##2##2##(2008-10#2)
pressure was##18##2##(1990-5#1)(1993-3#1)(1997-8#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-4#2)(2010-7#1)(2012-3#1)
pressure wave by a rigid body##2##6##(2009-10#2)
pressure wave##3##2##(1996-3#1)(2009-10#2)
pressure were##7##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)(2013-8#1)
pressure with##4##2##(1990-9#1)(1994-3#1)(2008-3#1)(2008-7#1)
pressure without alerting##2##3##(2011-2#2)
pressure##687##1##(1990-11#9)(1990-5#4)(1990-8#2)(1990-9#5)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#12)(1991-8#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#10)(1993-11#1)(1993-12#4)(1993-2#7)(1993-3#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#8)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#7)(1996-5#2)(1996-6#4)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#4)(1997-4#1)(1997-5#8)(1997-6#2)(1997-8#10)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#17)(2008-10#156)(2008-11#48)(2008-12#9)(2008-2#6)(2008-3#39)(2008-4#1)(2008-5#22)(2008-6#1)(2008-7#43)(2008-8#8)(2008-9#5)(2009-1#8)(2009-10#3)(2009-11#2)(2009-3#2)(2009-5#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#8)(2010-10#4)(2010-12#3)(2010-2#1)(2010-4#13)(2010-5#3)(2010-6#2)(2010-7#13)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#23)(2012-12#3)(2012-2#12)(2012-3#20)(2012-4#1)(2012-6#1)(2013-1#13)(2013-8#15)
pressure)##3##1##(1993-3#1)(2012-3#2)
pressure-dependent##2##1##(2008-3#1)(2008-7#1)
pressure/displacement curves##2##2##(2008-5#2)
pressure]##2##1##(1991-11#1)(2010-12#1)
pressures and##8##2##(1996-3#1)(2008-10#2)(2009-1#1)(2011-2#3)(2012-2#1)
pressures are##2##2##(2008-10#1)(2011-2#1)
pressures as##2##2##(2008-3#1)(2011-2#1)
pressures at the##2##3##(1990-8#1)(2011-2#1)
pressures at##3##2##(1990-8#1)(2010-4#1)(2011-2#1)
pressures for##4##2##(1990-8#1)(1993-3#2)(1997-3#1)
pressures from##2##2##(2008-11#1)(2008-8#1)
pressures in##2##2##(1997-9#1)(2008-10#1)
pressures of phenethyl alcohol and limonene in##2##7##(2008-5#2)
pressures of##7##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)
pressures on##2##2##(2011-7#1)(2012-3#1)
pressures that##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
pressures to##3##2##(2008-11#1)(2008-3#1)(2010-4#1)
pressures were##3##2##(2008-10#2)(2008-3#1)
pressures##89##1##(1990-8#3)(1991-2#1)(1991-5#1)(1992-3#1)(1993-1#3)(1993-12#2)(1993-3#2)(1994-6#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(1997-9#1)(2008-10#15)(2008-11#5)(2008-2#3)(2008-3#10)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-1#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-2#10)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
pressurised##2##1##(1997-1#1)(2008-10#1)
pressurized hot water extraction##2##4##(2008-10#2)
pressurized liquid extraction (PLE)##3##4##(2008-10#3)
pressurized liquid extraction##4##3##(2008-10#4)
pressurized metered dose##3##3##(1992-3#2)(1996-2#1)
pressurized microwave digestion##2##3##(2008-10#2)
pressurized##19##1##(1992-3#4)(1996-12#1)(1996-2#1)(2008-10#12)(2008-4#1)
pressurizing##2##1##(1992-3#1)(2008-10#1)
presternal catheters##3##2##(2011-2#3)
presternal##4##1##(2011-2#4)
prestige of diseases and##3##4##(1991-11#1)(1991-6#2)
prestige##9##1##(1991-11#1)(1991-2#1)(1991-6#6)(1993-6#1)
presumably as a result of##2##5##(1990-3#1)(2008-10#1)
presumably as##3##2##(1990-3#1)(1997-3#1)(2008-10#1)
presumably because of the##2##4##(2008-3#1)(2013-1#1)
presumably because##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
presumably by##2##2##(1996-12#1)(2008-10#1)
presumably caused by##2##3##(1991-3#1)(2009-7#1)
presumably due to differences in the##2##6##(1997-2#1)(2009-12#1)
presumably due to##5##3##(1997-2#1)(1997-3#1)(2008-10#2)(2009-12#1)
presumably reflecting##3##2##(1993-2#1)(1994-2#1)(2010-3#1)
presumably through##2##2##(1995-2#1)(2008-10#1)
presumably to##2##2##(2008-11#1)(2009-8#1)
presumably via the##2##3##(1991-10#1)(1991-12#1)
presumably via##3##2##(1991-10#1)(1991-12#1)(2008-10#1)
presumably##53##1##(1990-3#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#2)(1995-2#1)(1995-6#2)(1996-12#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-7#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
presume##3##1##(2008-5#1)(2011-2#1)(2013-1#1)
presumed that the##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
presumed that##5##2##(1995-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
presumed to be##6##3##(1994-5#1)(1995-6#1)(2008-10#3)(2008-4#1)
presumed to have##2##3##(1993-6#1)(2009-10#1)
presumed to##12##2##(1993-6#1)(1994-5#1)(1995-6#1)(2008-10#4)(2008-4#2)(2008-8#1)(2009-10#1)(2009-9#1)
presumed##42##1##(1991-12#1)(1992-3#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#2)(2006-5#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-3#2)
presumptive##11##1##(1993-2#1)(1993-8#1)(1994-12#3)(1997-3#1)(2008-10#4)(2008-7#1)
presupplementation resting##2##2##(2013-8#2)
presupposes##3##1##(2008-11#1)(2009-10#1)(2010-10#1)
presurgical##4##1##(1991-1#1)(2008-7#1)(2009-9#1)(2013-1#1)
presymptomatic##3##1##(1997-3#1)(2008-10#1)(2013-7#1)
presynaptic membrane##2##2##(1997-7#1)(2008-7#1)
presynaptic nerve terminal protein##2##4##(1995-6#1)(1996-12#1)
presynaptic plasma membrane##2##3##(1995-2#1)(2008-7#1)
presynaptic terminals##2##2##(2008-4#1)(2012-2#1)
presynaptic##30##1##(1990-12#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#5)(1996-2#2)(1997-2#3)(1997-7#9)(2008-11#1)(2008-4#1)(2008-7#2)(2009-9#1)(2012-2#1)
preteen and##4##2##(2013-1#4)
pretends##2##1##(2008-10#1)(2013-1#1)
preterm and##2##2##(1991-12#1)(1993-12#1)
preterm babies##2##2##(1990-11#1)(1997-5#1)
preterm birth and cerebral palsy##2##5##(2011-2#2)
preterm birth##8##2##(2008-11#1)(2008-9#1)(2011-2#4)(2012-2#1)(2013-8#1)
preterm infant##11##2##(1993-12#3)(1993-3#1)(1994-3#2)(2008-11#3)(2010-11#2)
preterm infants with##2##3##(2010-5#2)
preterm infants##13##2##(1990-3#1)(1991-1#1)(1992-2#1)(1993-12#4)(1994-1#1)(2007-11#1)(2010-5#2)(2011-2#1)(2012-12#1)
preterm labor##3##2##(2010-11#1)(2012-12#1)(2012-3#1)
preterm labour##2##2##(1994-3#2)
preterm newborn##3##2##(2008-11#2)(2011-2#1)
preterm##58##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1992-2#1)(1993-12#8)(1993-3#2)(1994-1#1)(1994-3#6)(1996-11#2)(1997-5#1)(2007-11#1)(2008-11#7)(2008-9#1)(2010-11#3)(2010-5#2)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#2)
pretest##3##1##(2010-10#2)(2011-1#1)
pretest-posttest design study##2##3##(2010-7#2)
pretest-posttest##3##1##(2010-7#2)(2013-1#1)
pretransplant##3##1##(1994-5#1)(2010-11#1)(2012-12#1)
pretreated advanced breast cancer##3##4##(1992-2#1)(1993-2#1)(1994-8#1)
pretreated by##2##2##(2008-10#2)
pretreated patients with advanced breast cancer##2##6##(1992-2#1)(1994-8#1)
pretreated patients##3##2##(1992-2#1)(1994-8#1)(2007-12#1)
pretreated plants##2##2##(2008-10#2)
pretreated platinum electrode##2##3##(2008-10#2)
pretreated samples##3##2##(1993-2#1)(2008-10#2)
pretreated teflon membrane served as##2##5##(2008-10#2)
pretreated teflon membrane##3##3##(2008-10#3)
pretreated with ASM##3##3##(2008-10#3)
pretreated with aDON the##2##4##(1995-12#2)
pretreated with##31##2##(1990-11#3)(1991-12#1)(1991-6#2)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#4)(1995-12#3)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-11#1)(2010-4#1)
pretreated##57##1##(1990-11#3)(1991-12#1)(1991-6#3)(1992-12#2)(1992-2#3)(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-8#6)(1995-12#4)(1995-8#2)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#19)(2008-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
pretreating the##2##2##(1992-6#1)(2008-5#1)
pretreatment and##8##2##(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
pretreatment followed by##2##3##(2008-11#1)(2013-1#1)
pretreatment for##3##2##(2008-10#3)
pretreatment glassy carbon electrode##2##4##(2008-10#2)
pretreatment in##6##2##(1992-6#1)(1996-2#1)(2008-10#3)(2012-3#1)
pretreatment of a lignocellulosic biomass##2##5##(2013-1#2)
pretreatment of a##3##3##(2008-8#1)(2013-1#2)
pretreatment of cells with##3##4##(2008-11#1)(2011-2#2)
pretreatment of cells##4##3##(1990-11#1)(2008-11#1)(2011-2#2)
pretreatment of the samples##2##4##(2008-10#1)(2008-11#1)
pretreatment of the##11##3##(1995-11#1)(1995-2#1)(1997-1#2)(2008-10#6)(2008-11#1)
pretreatment of##29##2##(1990-11#1)(1991-12#1)(1995-11#1)(1995-2#1)(1997-1#2)(2008-10#13)(2008-11#4)(2008-8#1)(2011-2#3)(2013-1#2)
pretreatment on##4##2##(1993-12#2)(2008-10#1)(2013-8#1)
pretreatment procedure##4##2##(2008-10#4)
pretreatment was##2##2##(2008-10#1)(2008-6#1)
pretreatment with##25##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1996-5#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-7#1)(2012-2#1)(2013-1#2)
pretreatment##151##1##(1990-11#4)(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-6#2)(1993-12#6)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-4#1)(2008-10#73)(2008-11#10)(2008-12#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2011-2#5)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#7)(2013-8#2)
pretreatments##4##1##(2008-10#4)
pretty##2##1##(1991-1#1)(2010-12#1)
prevail in##2##2##(2008-9#1)(2009-8#1)
prevail##7##1##(1995-3#1)(1997-8#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2013-1#1)
prevailed in##4##2##(1991-8#1)(2008-12#1)(2011-2#1)(2012-12#1)
prevailed##6##1##(1991-8#1)(2008-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
prevailing in##2##2##(2008-10#1)(2008-11#1)
prevailing##20##1##(1991-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1996-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-2#1)(2013-8#1)
prevails over##2##2##(1994-2#1)(2008-10#1)
prevails##6##1##(1994-2#1)(2008-10#3)(2008-3#1)(2012-3#1)
prevalence among##2##2##(1990-2#1)(1990-6#1)
prevalence and incidence##2##3##(2009-5#1)(2011-2#1)
prevalence and risk factors in##2##5##(2012-12#1)(2013-8#1)
prevalence and the##2##3##(2008-6#1)(2011-7#1)
prevalence and##34##2##(1991-1#1)(1992-1#1)(1992-9#2)(1994-6#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#4)(2013-8#3)
prevalence between##2##2##(1994-6#1)(2008-10#1)
prevalence data##2##2##(2008-10#1)(2011-2#1)
prevalence has##2##2##(1992-2#1)(2008-11#1)
prevalence in the north-central region of the United States##2##9##(2008-10#2)
prevalence in the##7##3##(2008-10#3)(2008-8#2)(2011-2#1)(2013-8#1)
prevalence in##24##2##(1990-6#2)(1992-2#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
prevalence is##5##2##(1991-12#1)(2008-5#1)(2011-2#2)(2012-12#1)
prevalence of CVD risks##2##4##(2011-1#2)
prevalence of CVD##3##3##(2010-12#1)(2011-1#2)
prevalence of HBV##2##3##(2008-10#2)
prevalence of HBsAg##2##3##(2008-10#1)(2013-1#1)
prevalence of HIV infection in##2##5##(1993-11#1)(1996-11#1)
prevalence of HIV infection##4##4##(1993-11#1)(1996-11#1)(2011-2#2)
prevalence of Helicobacter##2##3##(1990-2#1)(2011-2#1)
prevalence of a##2##3##(2008-7#1)(2012-2#1)
prevalence of abnormal##3##3##(1991-12#1)(2012-12#2)
prevalence of about##2##3##(2008-11#1)(2008-6#1)
prevalence of active##2##3##(2008-12#1)(2009-12#1)
prevalence of and##3##3##(2009-8#1)(2010-4#1)(2011-2#1)
prevalence of autoimmune diseases##2##4##(2008-10#1)(2011-2#1)
prevalence of brown stem rot##4##5##(2008-10#4)
prevalence of cigarette##3##3##(2013-1#1)(2013-8#2)
prevalence of circumportal pancreas##3##4##(2012-2#3)
prevalence of delirium in##2##4##(2010-10#1)(2012-12#1)
prevalence of dementia##3##3##(2008-7#3)
prevalence of drug##2##3##(2012-3#1)(2013-8#1)
prevalence of ergot##2##3##(2008-10#2)
prevalence of hepatitis B##2##4##(1996-3#2)
prevalence of hepatitis##3##3##(1996-3#2)(2008-1#1)
prevalence of hypertension was##2##4##(2008-11#1)(2008-7#1)
prevalence of hypertension##7##3##(2008-11#5)(2008-7#2)
prevalence of infection##2##3##(2008-10#1)(2008-11#1)
prevalence of intestinal parasitism in##2##5##(2012-12#2)
prevalence of intestinal##3##3##(2012-12#2)(2012-3#1)
prevalence of low##3##3##(1997-5#1)(2010-1#1)(2011-2#1)
prevalence of mental##3##3##(1993-5#1)(2008-11#1)(2008-12#1)
prevalence of metabolic syndrome##3##4##(2008-3#2)(2010-10#1)
prevalence of musculoskeletal pain and discomfort##2##6##(2008-12#2)
prevalence of obesity##5##3##(1993-11#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
prevalence of occult##2##3##(1990-6#2)
prevalence of oocysts##2##3##(1996-12#2)
prevalence of osteoporosis##5##3##(1996-11#1)(2010-3#4)
prevalence of overweight and##2##4##(2008-3#1)(2011-1#1)
prevalence of pain##2##3##(2008-12#1)(2008-5#1)
prevalence of radiographic##2##3##(1991-12#1)(2012-3#1)
prevalence of smoking among##2##4##(1991-11#1)(2009-7#1)
prevalence of smoking##4##3##(1991-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
prevalence of soybean##2##3##(2008-10#2)
prevalence of the disease was##2##5##(2008-10#2)
prevalence of the disease##3##4##(2008-10#3)
prevalence of the##13##3##(1993-2#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#1)(2010-12#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
prevalence of these##2##3##(2008-5#1)(2010-5#1)
prevalence of this##4##3##(1991-9#1)(1996-12#1)(2008-12#1)(2010-5#1)
prevalence of transmitted##2##3##(2013-1#2)
prevalence of treatment##2##3##(1992-9#1)(2008-11#1)
prevalence of tuberculosis##2##3##(1995-10#1)(2012-3#1)
prevalence of use##2##3##(1991-12#1)(2008-1#1)
prevalence of##283##2##(1990-2#2)(1990-3#1)(1990-6#4)(1991-11#1)(1991-12#5)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#3)(1993-11#2)(1993-2#3)(1993-5#2)(1994-12#1)(1994-2#1)(1994-6#4)(1994-9#2)(1995-10#2)(1996-1#2)(1996-11#3)(1996-12#5)(1996-3#2)(1997-3#1)(1997-4#1)(1997-5#2)(2007-12#2)(2007-8#1)(2008-1#7)(2008-10#31)(2008-11#15)(2008-12#16)(2008-3#4)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#9)(2008-9#2)(2009-12#4)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#5)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#22)(2011-7#1)(2012-12#8)(2012-2#15)(2012-3#13)(2012-5#1)(2013-1#15)(2013-8#8)
prevalence rate of##6##3##(2008-1#1)(2008-12#1)(2013-8#4)
prevalence rate##8##2##(1990-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2013-8#4)
prevalence rates##5##2##(2008-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
prevalence studies##2##2##(2008-1#1)(2011-2#1)
prevalence was 0##2##3##(2008-10#1)(2013-1#1)
prevalence was significantly##2##3##(1996-12#1)(2012-3#1)
prevalence was##13##2##(1996-12#1)(2008-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)
prevalence with##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
prevalence##439##1##(1990-2#3)(1990-3#1)(1990-6#8)(1991-1#1)(1991-11#1)(1991-12#7)(1991-6#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-5#1)(1992-9#6)(1993-11#2)(1993-2#3)(1993-5#2)(1994-12#1)(1994-2#1)(1994-6#8)(1994-9#2)(1995-10#2)(1995-12#1)(1996-1#2)(1996-11#3)(1996-12#7)(1996-3#6)(1997-3#1)(1997-4#3)(1997-5#2)(2007-12#2)(2007-8#1)(2008-1#12)(2008-10#51)(2008-11#19)(2008-12#22)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#17)(2008-8#11)(2008-9#4)(2009-10#1)(2009-12#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#3)(2010-6#5)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#42)(2011-7#2)(2012-12#20)(2012-2#23)(2012-3#17)(2012-5#1)(2013-1#26)(2013-8#19)
prevalences of##2##2##(2008-10#1)(2011-2#1)
prevalences##3##1##(2008-10#1)(2010-8#1)(2011-2#1)
prevalent among T##2##3##(2012-3#2)
prevalent among##3##2##(2012-3#3)
prevalent and##4##2##(2008-10#3)(2012-3#1)
prevalent disease##2##2##(2012-3#1)(2013-8#1)
prevalent forms of##2##3##(1992-1#1)(1994-12#1)
prevalent in the##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
prevalent in##33##2##(1991-1#1)(1991-2#1)(1996-12#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
prevalent of##2##2##(2008-12#1)(2008-5#1)
prevalent throughout##2##2##(2008-10#1)(2011-2#1)
prevalent when##2##2##(2008-10#2)
prevalent wind##3##2##(2008-5#3)
prevalent##109##1##(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#2)(1997-7#1)(2008-1#3)(2008-10#30)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#9)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#11)(2013-1#8)(2013-8#2)
prevalently##3##1##(2008-10#2)(2010-8#1)
prevalidation##2##1##(2008-10#1)(2008-5#1)
prevent a##6##2##(1993-1#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-5#1)
prevent against##3##2##(2009-8#2)(2010-2#1)
prevent and control##4##3##(2007-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
prevent and##13##2##(1993-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
prevent any##2##2##(2008-11#1)(2008-4#1)
prevent bone##2##2##(2008-7#1)(2012-3#1)
prevent cardiovascular##3##2##(1993-2#1)(2008-11#1)(2013-1#1)
prevent chronic disease and##2##4##(2010-1#1)(2011-2#1)
prevent chronic##3##2##(2009-5#1)(2010-1#1)(2011-2#1)
prevent complications##2##2##(1991-2#1)(2011-2#1)
prevent disease##4##2##(2008-10#1)(2009-8#1)(2013-7#2)
prevent further##2##2##(1995-12#1)(2008-10#1)
prevent growth##2##2##(1990-12#1)(2011-2#1)
prevent interference from##3##3##(2008-10#2)(2008-3#1)
prevent interference##4##2##(2008-10#3)(2008-3#1)
prevent it##3##2##(1995-5#1)(2008-10#1)(2008-7#1)
prevent myocardial##2##2##(1993-2#1)(2008-12#1)
prevent obesity##2##2##(2011-2#1)(2012-2#1)
prevent or##14##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
prevent overfitting##2##2##(1995-9#1)(2008-10#1)
prevent pathogen ingress##2##3##(2008-10#2)
prevent the development of##3##4##(2006-6#1)(2008-10#1)(2008-7#1)
prevent the increase in##2##4##(1994-2#1)(2008-10#1)
prevent the progression of##2##4##(2008-7#1)(2010-12#1)
prevent the##45##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-6#1)(1997-6#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2009-8#1)(2010-12#1)(2010-6#1)(2013-1#1)
prevent their##4##2##(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
prevent these##3##2##(2008-5#2)(2013-8#1)
prevent##306##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#3)(1991-7#1)(1992-10#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#1)(2006-6#2)(2007-12#3)(2008-1#3)(2008-10#52)(2008-11#18)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#5)(2009-1#2)(2009-10#3)(2009-12#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#19)(2011-3#2)(2012-12#2)(2012-2#8)(2012-3#6)(2013-1#21)(2013-7#3)(2013-8#6)
preventable causes##3##2##(1990-2#1)(1997-2#1)(2011-1#1)
preventable in##3##2##(1992-2#1)(1993-2#1)(2013-8#1)
preventable##12##1##(1990-2#1)(1992-2#1)(1993-2#1)(1994-9#1)(1997-2#1)(2008-11#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#2)
preventative measures are##2##3##(1995-9#1)(2008-7#1)
preventative measures##3##2##(1995-9#1)(2008-7#1)(2011-2#1)
preventative##8##1##(1995-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)
prevented (range##2##2##(2009-8#2)
prevented by a##3##3##(1991-3#1)(1994-3#1)(2007-8#1)
prevented by the##3##3##(1994-8#1)(1997-1#1)(2008-11#1)
prevented by##30##2##(1991-3#2)(1992-5#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
prevented cytotoxicity##2##2##(1994-8#2)
prevented disease##2##2##(2008-10#2)
prevented from##2##2##(1995-2#1)(2008-9#1)
prevented in cirrhotics##2##3##(2009-8#2)
prevented in the##2##3##(1997-1#1)(2008-5#1)
prevented in##7##2##(1995-2#1)(1997-1#2)(2008-5#1)(2009-8#2)(2013-8#1)
prevented infection##3##2##(1996-12#1)(2008-10#2)
prevented or##3##2##(1996-12#1)(2008-12#1)(2008-5#1)
prevented the generation of##2##4##(2008-11#2)
prevented the increase in##2##4##(1997-2#1)(2013-1#1)
prevented the inhibitory##2##3##(1994-2#1)(1994-8#1)
prevented the use of##2##4##(2008-10#1)(2011-10#1)
prevented the##30##2##(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-2#3)(1997-2#1)(2006-6#1)(2008-10#3)(2008-11#3)(2008-5#1)(2010-10#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
prevented these##2##2##(2008-10#1)(2009-8#1)
prevented with##2##2##(1994-2#1)(2008-7#1)
prevented##140##1##(1990-11#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1992-5#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-5#5)(1994-8#5)(1995-1#1)(1995-12#1)(1995-2#4)(1996-12#5)(1996-2#5)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-7#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#10)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-8#6)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#2)
preventing HIV##2##2##(1992-12#1)(2012-2#1)
preventing a##2##2##(1992-3#1)(2008-10#1)
preventing acute##2##2##(1990-6#1)(2008-12#1)
preventing and treating##2##3##(2013-1#1)(2013-7#1)
preventing and##5##2##(2008-5#2)(2011-2#1)(2013-1#1)(2013-7#1)
preventing its##3##2##(1990-7#1)(2008-12#1)(2008-9#1)
preventing or##3##2##(1993-1#1)(2008-10#1)(2013-1#1)
preventing the##21##2##(1992-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#2)(2009-8#1)(2010-5#1)(2011-2#1)(2011-3#1)
preventing their##2##2##(2008-10#1)(2013-1#1)
preventing##133##1##(1990-11#1)(1990-5#1)(1990-6#3)(1990-7#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-9#4)(1993-1#1)(1993-2#3)(1994-5#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#9)(2008-12#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#3)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#14)(2013-7#1)
prevention among##4##2##(1990-2#1)(2008-12#1)(2009-5#1)(2013-8#1)
prevention and control measures##2##4##(1996-1#1)(2008-10#1)
prevention and control of##5##4##(2008-9#1)(2010-5#1)(2011-2#3)
prevention and control##15##3##(1996-1#1)(1996-2#1)(1997-1#4)(2008-10#1)(2008-9#1)(2010-5#2)(2011-2#3)(2012-12#2)
prevention and early##2##3##(1993-2#1)(2010-11#1)
prevention and intervention##4##3##(2008-11#1)(2009-7#1)(2010-12#2)
prevention and management##3##3##(1995-12#1)(2011-1#2)
prevention and therapy##2##3##(1991-12#1)(2010-12#1)
prevention and treatment of##13##4##(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)
prevention and treatment##21##3##(1990-12#1)(1992-5#1)(1996-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)
prevention and##69##2##(1990-12#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-2#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#5)(1997-2#1)(1997-3#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-12#3)(2013-1#3)(2013-7#1)
prevention are##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
prevention behavior##2##2##(2008-1#2)
prevention concentrations##2##2##(2011-2#2)
prevention education##3##2##(2008-10#2)(2010-7#1)
prevention efforts##5##2##(1996-9#1)(2008-11#1)(2009-5#1)(2012-2#2)
prevention in##8##2##(1990-6#1)(1993-12#1)(1994-9#1)(1996-11#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
prevention initiative##3##2##(1995-12#1)(1995-3#1)(2008-7#1)
prevention initiatives##3##2##(1995-12#1)(1995-3#1)(2009-5#1)
prevention is##6##2##(1993-6#1)(1994-8#1)(2010-12#1)(2011-2#3)
prevention measures##4##2##(2011-2#4)
prevention of AMD##2##3##(2011-2#2)
prevention of cancer##3##3##(2009-4#2)(2011-2#1)
prevention of cardiovascular disease##2##4##(2013-1#2)
prevention of cardiovascular##3##3##(2010-1#1)(2013-1#2)
prevention of cervical cancer##2##4##(2008-11#1)(2010-8#1)
prevention of coronary##2##3##(1996-8#1)(2010-2#1)
prevention of dental caries##3##4##(2008-7#2)(2013-7#1)
prevention of dental##4##3##(2008-5#1)(2008-7#2)(2013-7#1)
prevention of infection##2##3##(2008-10#1)(2011-2#1)
prevention of postoperative##3##3##(2010-7#1)(2012-3#2)
prevention of recurrence##2##3##(2009-7#1)(2010-12#1)
prevention of recurrences##2##3##(1996-12#1)(2008-7#1)
prevention of sexually##2##3##(1996-8#1)(2013-8#1)
prevention of the##2##3##(1996-3#1)(2008-7#1)
prevention of this##2##3##(1995-5#1)(1996-6#1)
prevention of##114##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#2)(1991-6#1)(1992-9#1)(1993-2#2)(1993-3#1)(1994-8#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#3)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#6)(2009-10#3)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-2#11)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#3)
prevention or##2##2##(1991-2#1)(1997-1#1)
prevention policy##2##2##(1995-3#1)(2008-11#1)
prevention program on##3##3##(1990-3#1)(2010-7#2)
prevention program##12##2##(1990-3#2)(1991-1#2)(1992-2#1)(1993-2#1)(1994-2#1)(1995-3#2)(2008-12#1)(2010-7#2)
prevention programs are##2##3##(1997-2#1)(2013-1#1)
prevention programs for##3##3##(1995-12#1)(2008-11#1)(2013-1#1)
prevention programs##20##2##(1993-3#1)(1995-12#1)(1995-3#4)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-11#2)(2008-12#1)(2012-12#1)(2012-2#2)(2013-1#3)
prevention project##3##2##(1995-3#3)
prevention services##2##2##(2008-6#1)(2012-12#1)
prevention strategies for##2##3##(2008-10#1)(2008-3#1)
prevention strategies##7##2##(2008-10#2)(2008-3#1)(2009-5#2)(2011-2#2)
prevention trials##3##2##(1994-9#2)(2013-1#1)
prevention##405##1##(1990-12#3)(1990-2#1)(1990-3#4)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#4)(1991-3#2)(1991-6#5)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-6#1)(1993-9#1)(1994-2#4)(1994-3#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-12#12)(1995-3#16)(1995-5#4)(1995-6#1)(1996-1#1)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#5)(1996-5#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#9)(1997-2#10)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#21)(2008-11#27)(2008-12#11)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#2)(2010-1#6)(2010-10#3)(2010-11#6)(2010-12#12)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#1)(2011-1#5)(2011-2#35)(2011-3#4)(2012-12#11)(2012-2#11)(2012-3#8)(2013-1#12)(2013-7#4)(2013-8#6)
prevention]##3##1##(1994-5#1)(1996-6#1)(1997-8#1)
preventive and control measures##2##4##(2011-2#1)(2012-12#1)
preventive and educational interventions##3##4##(2012-2#3)
preventive and primary care for children with chronic##2##8##(1997-2#2)
preventive and therapeutic##5##3##(1990-6#1)(2008-11#3)(2009-3#1)
preventive and##14##2##(1990-6#1)(1990-9#1)(1996-2#1)(1997-2#2)(2008-11#3)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#3)
preventive care for##2##3##(2010-9#1)(2011-2#1)
preventive care##9##2##(1994-8#1)(1996-1#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#2)
preventive effect of black tea##2##5##(2009-8#2)
preventive effect of##4##3##(2008-5#1)(2009-8#2)(2010-1#1)
preventive effect##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#3)(2010-1#1)
preventive health care##7##3##(1995-2#1)(2008-11#1)(2009-5#1)(2010-8#4)
preventive health##10##2##(1994-2#1)(1995-12#1)(1995-2#1)(2008-11#1)(2009-5#2)(2010-8#4)
preventive ingredients##2##2##(2008-5#2)
preventive intervention##2##2##(2008-12#2)
preventive interventions##2##2##(1992-3#1)(2011-1#1)
preventive management##2##2##(2008-10#1)(2008-9#1)
preventive measures and##2##3##(1993-9#1)(2010-1#1)
preventive measures##13##2##(1991-12#1)(1992-9#1)(1993-9#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-5#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
preventive medication was##2##3##(2008-11#2)
preventive medication##3##2##(2008-11#3)
preventive medications##4##2##(2008-10#1)(2008-11#2)(2010-9#1)
preventive services to##2##3##(1995-12#2)
preventive services##10##2##(1995-12#4)(1995-2#2)(1996-12#1)(1996-2#1)(2009-5#1)(2010-8#1)
preventive strategies##7##2##(1993-11#1)(1996-12#1)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
preventive therapy##6##2##(1995-11#1)(1996-3#1)(1997-2#4)
preventive treatment##3##2##(1990-6#1)(2011-2#1)(2012-3#1)
preventive##131##1##(1990-6#4)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#7)(1995-2#4)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#7)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#9)(2008-11#12)(2008-12#2)(2008-3#1)(2008-5#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-8#3)(2010-1#3)(2010-12#1)(2010-8#6)(2010-9#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
prevents pregnancy##2##2##(1996-9#2)
prevents the degeneration of##2##4##(1990-5#2)
prevents the##18##2##(1990-5#3)(1991-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1997-7#1)(2008-10#3)(2008-8#2)(2009-8#1)(2011-10#1)(2013-1#1)
prevents transformation##2##2##(2008-10#1)(2008-11#1)
prevents tumor##2##2##(2013-1#2)
prevents##73##1##(1990-12#2)(1990-5#3)(1991-2#1)(1991-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2009-8#3)(2010-11#1)(2011-10#1)(2011-2#5)(2012-2#1)(2013-1#5)(2013-8#1)
preverbal child##2##2##(2008-9#2)
preverbal children##3##2##(2008-9#3)
preverbal##5##1##(2008-9#5)
previous analyses##3##2##(2008-7#1)(2008-9#2)
previous analysis##2##2##(2008-9#1)(2011-2#1)
previous approaches##3##2##(2009-7#1)(2011-3#1)(2013-1#1)
previous case##2##2##(2009-1#1)(2013-8#1)
previous cases##2##2##(1996-12#1)(2008-10#1)
previous clinical##2##2##(2008-6#1)(2009-10#1)
previous data##3##2##(2008-10#2)(2008-5#1)
previous decade##4##2##(2008-11#1)(2008-5#1)(2013-1#2)
previous derivatization##2##2##(2008-10#2)
previous educational##2##2##(2008-11#2)
previous estimates##6##2##(1993-3#1)(1996-12#1)(2008-10#3)(2008-9#1)
previous evaluation##2##2##(1995-1#2)
previous experience with##2##3##(2008-12#1)(2008-7#1)
previous experiments##2##2##(2008-10#2)
previous exposure to##3##3##(1995-2#1)(1997-3#1)(2009-8#1)
previous exposure##4##2##(1995-2#1)(1996-12#1)(1997-3#1)(2009-8#1)
previous extraction##3##2##(2008-10#3)
previous field##2##2##(2008-9#1)(2011-10#1)
previous finding##3##2##(1993-8#1)(1996-12#1)(2008-9#1)
previous findings in##2##3##(1995-12#1)(2008-7#1)
previous findings that##4##3##(1994-2#1)(1994-5#1)(1996-12#1)(2008-7#1)
previous findings##19##2##(1993-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#3)(2010-2#1)(2011-2#1)
previous history of##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
previous hospitalization##3##2##(1992-2#1)(1995-1#1)(2010-10#1)
previous hospitalizations##3##2##(1991-2#2)(1992-2#1)
previous investigations##4##2##(1990-8#1)(1994-3#1)(1997-1#1)(2008-10#1)
previous knowledge##2##2##(2008-11#1)(2012-12#1)
previous learning##2##2##(2008-11#1)(2008-5#1)
previous literature##4##2##(2008-11#1)(2008-6#1)(2011-2#1)(2013-2#1)
previous methods##2##2##(2008-10#2)
previous models##3##2##(1997-7#1)(2008-8#2)
previous observation##2##2##(1991-9#1)(2008-10#1)
previous observations##7##2##(1991-9#1)(1993-8#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
previous paper##7##2##(1994-5#1)(2008-10#4)(2008-2#2)
previous papers##2##2##(2008-10#1)(2008-3#1)
previous pelvic surgery##2##3##(2011-2#2)
previous preconcentration##3##2##(2008-10#3)
previous published##2##2##(2008-10#2)
previous report of##2##3##(1996-9#1)(2008-7#1)
previous report##8##2##(1990-4#1)(1990-5#1)(1994-8#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
previous reports have##2##3##(1991-3#1)(2011-2#1)
previous reports of##5##3##(1991-8#1)(1994-3#1)(2008-10#2)(2008-8#1)
previous reports on##2##3##(1993-6#1)(2008-10#1)
previous reports##22##2##(1991-3#1)(1991-8#1)(1992-3#1)(1993-6#1)(1994-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#3)(2012-3#1)(2013-8#1)
previous research that##2##3##(1992-3#1)(2008-10#1)
previous research##14##2##(1991-3#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
previous results##8##2##(1990-8#1)(1995-11#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-8#1)
previous sample##3##2##(2008-10#3)
previous separation##7##2##(2008-10#7)
previous separations##3##2##(2008-10#3)
previous studies and##2##3##(2008-10#1)(2012-3#1)
previous studies by##2##3##(1994-12#1)(2008-3#1)
previous studies have shown that##2##5##(1995-8#1)(2013-1#1)
previous studies have##11##3##(1994-5#1)(1995-12#1)(1995-8#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-5#1)(2010-8#2)(2013-1#1)
previous studies in##2##3##(1997-7#1)(2008-10#1)
previous studies of##6##3##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
previous studies on the##2##4##(1996-5#1)(2008-11#1)
previous studies on##5##3##(1996-5#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-6#1)
previous studies that##2##3##(2008-10#1)(2010-11#1)
previous studies with##3##3##(1993-12#1)(2008-10#1)(2009-8#1)
previous studies##76##2##(1990-12#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(2007-12#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
previous study with##3##3##(1991-2#1)(1993-12#1)(1994-5#1)
previous study##29##2##(1990-2#1)(1991-2#1)(1993-12#2)(1994-5#1)(1994-8#2)(1995-12#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#3)(2011-2#3)(2013-1#1)
previous study)##3##2##(2008-10#1)(2008-9#2)
previous surgery##2##2##(2010-6#1)(2013-1#1)
previous surgical##2##2##(1994-5#1)(2012-2#1)
previous system##2##2##(2008-10#1)(2008-11#1)
previous theoretical##3##2##(2008-11#1)(2008-3#2)
previous theory##2##2##(2008-3#1)(2008-8#1)
previous to##2##2##(2008-10#1)(2009-4#1)
previous trauma##2##2##(1992-2#1)(2011-2#1)
previous treatment declined from##2##4##(2013-8#2)
previous treatment of the##2##4##(2008-10#2)
previous treatment of##4##3##(2008-10#2)(2010-10#2)
previous treatment##15##2##(1992-2#1)(1992-3#1)(2008-10#5)(2008-7#1)(2010-10#2)(2012-3#1)(2013-1#1)(2013-8#3)
previous treatments##2##2##(2008-7#1)(2011-2#1)
previous trials##4##2##(1996-6#1)(2009-10#2)(2013-8#1)
previous work on##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
previous work that##2##3##(2008-10#2)
previous work to##2##3##(1992-10#1)(2008-10#1)
previous work##23##2##(1992-10#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
previous works##2##2##(2008-10#1)(2010-8#1)
previous year's##2##2##(2008-10#2)
previous years##4##2##(1990-12#1)(1995-6#1)(2008-10#1)(2008-8#1)
previous##579##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#7)(1991-3#4)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#3)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#6)(1994-6#1)(1994-8#6)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#9)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#4)(1997-7#5)(1997-8#2)(2007-12#3)(2008-1#5)(2008-10#146)(2008-11#39)(2008-12#13)(2008-2#5)(2008-3#8)(2008-5#9)(2008-6#6)(2008-7#19)(2008-8#22)(2008-9#22)(2009-1#2)(2009-10#4)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#3)(2010-10#7)(2010-11#4)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#31)(2011-3#4)(2012-12#6)(2012-2#9)(2012-3#10)(2013-1#17)(2013-2#1)(2013-8#14)
previously acidified##2##2##(2008-10#2)
previously acquired##2##2##(2008-11#1)(2009-6#1)
previously amplified##2##2##(2008-10#1)(2011-2#1)
previously and##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-6#1)(2013-1#1)
previously as##2##2##(2008-7#1)(2008-8#1)
previously ascribed to##2##3##(2008-10#1)(2011-1#1)
previously assigned ORFs##2##3##(1995-12#2)
previously assigned##5##2##(1995-12#4)(1995-6#1)
previously been described##4##3##(1990-6#1)(1992-10#1)(2008-10#1)(2008-12#1)
previously been implicated in##2##4##(1993-12#1)(1994-5#1)
previously been reported##5##3##(1993-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
previously been shown to be##3##5##(1993-12#1)(2008-10#1)(2008-6#1)
previously been shown to##9##4##(1990-12#1)(1993-12#2)(1995-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)
previously been shown##10##3##(1990-12#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)
previously been used##2##3##(2008-10#2)
previously been##41##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-6#1)(1992-10#1)(1993-1#1)(1993-12#3)(1993-8#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
previously by##3##2##(1997-8#1)(2008-10#2)
previously characterized in##2##3##(1997-3#1)(2008-10#1)
previously characterized##17##2##(1991-9#1)(1994-12#1)(1997-3#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-7#1)(2013-1#1)
previously checked for the absence of##3##6##(2008-10#3)
previously cloned##2##2##(1991-9#1)(1995-11#1)
previously collected##2##2##(2008-10#2)
previously considered##5##2##(1997-3#1)(2008-10#3)(2008-8#1)
previously constructed##4##2##(1995-6#1)(1996-12#1)(2008-10#1)(2008-7#1)
previously defined##3##2##(1993-6#1)(2008-10#2)
previously demonstrated that##11##3##(1990-12#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-2#1)(2008-11#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
previously demonstrated the##2##3##(1993-11#1)(2009-3#1)
previously demonstrated to##2##3##(1993-9#1)(2008-8#1)
previously demonstrated##20##2##(1990-12#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-2#1)(2008-11#2)(2008-7#1)(2008-8#2)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
previously derived##3##2##(2008-10#2)(2008-3#1)
previously described EC-2##3##3##(2008-10#3)
previously described and##2##3##(1994-2#1)(2008-10#1)
previously described as a##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
previously described as##5##3##(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#1)
previously described for##3##3##(2007-12#1)(2008-10#2)
previously described genes##2##3##(1995-9#1)(1996-3#1)
previously described in##3##3##(1991-6#1)(2008-10#1)(2008-7#1)
previously described methods##2##3##(2008-10#1)(2008-11#1)
previously described##64##2##(1990-5#1)(1991-5#2)(1991-6#2)(1992-3#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(2007-12#1)(2008-10#29)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2010-1#1)(2010-11#1)(2012-3#2)
previously designed##2##2##(2008-5#1)(2008-7#1)
previously detected##4##2##(1997-2#1)(2008-10#3)
previously determined##7##2##(1993-8#1)(1997-2#1)(2008-10#4)(2008-8#1)
previously developed for##4##3##(2008-10#3)(2008-3#1)
previously developed##16##2##(1996-2#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2012-12#1)
previously discussed##2##2##(2008-10#1)(2011-2#1)
previously diseased plants##2##3##(2008-10#2)
previously established##8##2##(1996-2#1)(2008-10#3)(2008-11#2)(2008-12#2)
previously examined##2##2##(2008-10#1)(2012-2#1)
previously existing##2##2##(2008-10#1)(2013-8#1)
previously for the##2##3##(1992-3#1)(2008-10#1)
previously for##7##2##(1992-3#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-10#3)
previously found in the##2##4##(1993-3#1)(1994-11#1)
previously found in##3##3##(1993-3#1)(1994-11#2)
previously found to be associated with##2##6##(2008-10#1)(2013-1#1)
previously found to be##4##4##(1994-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
previously found##9##2##(1993-3#1)(1994-11#3)(1995-11#1)(1996-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
previously frozen##2##2##(2010-4#2)
previously generated##2##2##(1995-6#1)(2011-1#1)
previously have##2##2##(2008-10#1)(2008-12#1)
previously having##2##2##(1996-12#1)(2007-12#1)
previously healthy##6##2##(2008-10#1)(2009-8#3)(2011-2#2)
previously heated##2##2##(2008-10#2)
previously identified as##2##3##(2008-10#1)(2010-3#1)
previously identified genes##3##3##(1996-3#1)(1997-8#1)(2008-10#1)
previously identified in##4##3##(1994-8#1)(1995-6#1)(1997-7#1)(2008-10#1)
previously identified resistance##2##3##(2008-10#1)(2008-9#1)
previously identified##32##2##(1992-9#1)(1993-6#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-3#2)
previously immunized with##2##3##(1995-5#2)
previously implicated in the##2##4##(1991-9#1)(2008-11#1)
previously implicated in##6##3##(1991-9#1)(1995-2#1)(1995-6#1)(2008-11#1)(2009-8#1)(2010-12#1)
previously in a##2##3##(2007-12#1)(2008-9#1)
previously in the##3##3##(1993-9#1)(2008-10#1)(2008-3#1)
previously in##12##2##(1993-9#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-9#1)(2011-1#1)
previously infected with##2##3##(2008-10#1)(2011-2#1)
previously inoculated with highly virulent infectious bursal disease virus##2##9##(2008-5#2)
previously isolated from the##2##4##(2008-5#1)(2011-2#1)
previously isolated from##5##3##(1994-5#2)(2008-10#1)(2008-5#1)(2011-2#1)
previously isolated##12##2##(1991-12#1)(1994-5#2)(1995-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
previously known to##2##3##(1994-11#1)(2008-10#1)
previously known##11##2##(1992-3#1)(1994-11#1)(1996-6#1)(2008-10#3)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
previously mapped##6##2##(1993-12#1)(2008-10#3)(2012-3#2)
previously not been##2##3##(1993-2#1)(2009-6#1)
previously not##3##2##(1993-2#1)(2009-6#1)(2010-10#1)
previously observed in##2##3##(1995-11#1)(2010-8#1)
previously observed##5##2##(1993-8#1)(1995-11#1)(2008-10#1)(2010-8#1)(2011-1#1)
previously obtained by##2##3##(2008-10#2)
previously obtained##6##2##(1990-2#1)(2008-10#4)(2013-1#1)
previously on##3##2##(2008-10#2)(2011-2#1)
previously operated##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
previously partially characterized##2##3##(2008-10#2)
previously partially##3##2##(1990-8#1)(2008-10#2)
previously presented##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
previously proposed##8##2##(1996-8#1)(1997-7#1)(2008-10#3)(2010-4#1)(2011-2#1)(2013-1#1)
previously published cases##2##3##(2008-10#1)(2013-8#1)
previously published results##3##3##(1993-8#1)(2007-11#1)(2008-10#1)
previously published study##2##3##(2008-5#1)(2008-8#1)
previously published##28##2##(1992-6#1)(1993-11#1)(1993-8#1)(1995-12#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2013-8#1)
previously recognized that##2##3##(1996-2#1)(2011-2#1)
previously recognized##6##2##(1990-8#1)(1996-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
previously reported as##3##3##(1995-8#1)(2008-10#1)(2008-9#1)
previously reported case##2##3##(2012-3#2)
previously reported cases##4##3##(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#1)
previously reported for##4##3##(1996-12#1)(2008-10#1)(2008-8#2)
previously reported in the literature##5##5##(1995-9#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#1)
previously reported in the##7##4##(1995-9#1)(2008-10#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-2#1)
previously reported in##16##3##(1991-3#1)(1995-12#1)(1995-9#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
previously reported ones##2##3##(2008-10#1)(2008-9#1)
previously reported that##9##3##(1994-11#1)(1994-2#2)(1996-12#1)(2008-12#1)(2009-12#2)(2013-1#2)
previously reported to be##2##4##(1992-6#1)(2008-10#1)
previously reported to##4##3##(1992-6#1)(2008-10#1)(2011-2#1)(2012-3#1)
previously reported values##2##3##(2008-10#2)
previously reported with##2##3##(1993-1#1)(2008-10#1)
previously reported##125##2##(1990-5#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-6#1)(1994-11#3)(1994-2#2)(1994-5#2)(1994-8#3)(1995-11#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#46)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#2)
previously seen##4##2##(1991-2#1)(1995-12#1)(2008-8#1)(2009-10#1)
previously selected##2##2##(2008-10#2)
previously sequenced##4##2##(1991-6#1)(1996-6#1)(1997-8#1)(2008-10#1)
previously shocked animals##2##3##(2008-6#2)
previously shown that##16##3##(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
previously shown to be essential for##2##6##(1993-12#1)(2008-11#1)
previously shown to be##8##4##(1991-5#1)(1993-12#1)(1993-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
previously shown to##20##3##(1990-12#1)(1991-5#1)(1993-12#1)(1993-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-9#1)(2012-12#1)
previously shown##38##2##(1990-11#1)(1990-12#1)(1991-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
previously spiked with different amounts of##2##6##(2008-10#2)
previously standardized##2##2##(1992-1#1)(2008-10#1)
previously studied##6##2##(2008-10#3)(2008-5#1)(2008-9#1)(2010-8#1)
previously suggested##4##2##(2008-10#4)
previously tested##3##2##(2008-10#2)(2008-7#1)
previously that the##3##3##(1994-8#1)(2008-5#1)(2008-7#1)
previously that##8##2##(1990-11#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
previously thought##7##2##(1990-5#1)(1995-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
previously to##4##2##(1994-8#1)(1995-2#1)(2008-10#1)(2009-10#1)
previously transferred to##2##3##(2008-10#2)
previously treated with##5##3##(1991-6#1)(1992-12#1)(2008-10#3)
previously treated##7##2##(1991-6#2)(1992-12#1)(2008-10#4)
previously uncharacterized##5##2##(2008-10#3)(2009-8#1)(2012-3#1)
previously underappreciated##2##2##(2011-2#1)(2012-3#1)
previously undescribed species of##2##4##(2008-10#2)
previously undescribed##8##2##(2008-10#7)(2012-3#1)
previously undetected##2##2##(1997-7#1)(2008-10#1)
previously unidentified##3##2##(1992-4#1)(2008-10#1)(2011-2#1)
previously unknown##14##2##(1993-2#1)(1995-2#1)(1997-7#1)(2008-10#5)(2008-3#2)(2008-7#1)(2010-4#1)(2012-12#1)(2012-3#1)
previously unrecognized##6##2##(1995-2#1)(1996-2#1)(2008-10#4)
previously unreported##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
previously unsuspected##3##2##(1994-3#1)(2012-2#1)(2012-3#1)
previously untreated patients##3##3##(1990-12#1)(1990-6#2)
previously untreated##7##2##(1990-12#1)(1990-6#2)(1991-8#1)(2008-10#1)(2010-11#1)(2011-2#1)
previously used to##2##3##(2008-10#2)
previously used##5##2##(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
previously validated##4##2##(2008-10#3)(2008-3#1)
previously was thought##2##3##(2008-10#2)
previously was##6##2##(2008-10#6)
previously were##4##2##(2008-10#4)
previously with##2##2##(1992-9#1)(1997-3#1)
previously##898##1##(1990-11#3)(1990-12#6)(1990-2#2)(1990-5#4)(1990-6#3)(1990-8#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#7)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-12#2)(1992-3#4)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#4)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#3)(1993-6#5)(1993-8#6)(1993-9#3)(1994-1#1)(1994-11#13)(1994-12#2)(1994-2#8)(1994-3#3)(1994-5#6)(1994-8#12)(1994-9#1)(1995-11#5)(1995-12#10)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#10)(1995-8#1)(1995-9#4)(1996-1#2)(1996-12#14)(1996-2#11)(1996-3#4)(1996-6#6)(1996-8#2)(1997-2#4)(1997-3#7)(1997-4#1)(1997-6#1)(1997-7#6)(1997-8#5)(2006-6#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#348)(2008-11#34)(2008-12#13)(2008-2#2)(2008-3#14)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#26)(2008-8#17)(2008-9#14)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#8)(2010-1#3)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#1)(2010-6#7)(2010-7#2)(2010-8#3)(2011-1#8)(2011-2#29)(2011-3#1)(2012-12#4)(2012-2#10)(2012-3#25)(2013-1#15)(2013-8#7)
previtellogenesis##3##1##(2007-12#2)(2008-7#1)
previtellogenic oocytes (phase I oocytes)##2##5##(2008-8#2)
previtellogenic oocytes##5##2##(2007-12#2)(2008-8#3)
previtellogenic##8##1##(2007-12#3)(2008-8#4)(2010-5#1)
prey by##2##2##(2008-8#1)(2008-9#1)
prey can##2##2##(2008-8#1)(2008-9#1)
prey consumption##2##2##(2008-8#2)
prey density##2##2##(2008-8#1)(2008-9#1)
prey productivity##2##2##(2008-9#2)
prey selection##4##2##(2010-8#4)
prey species##9##2##(2008-8#7)(2008-9#1)(2012-3#1)
prey to##2##2##(2008-8#1)(2012-3#1)
prey##72##1##(1994-6#1)(1995-12#2)(2008-10#2)(2008-8#32)(2008-9#20)(2010-8#11)(2012-3#4)
prezygotic##3##1##(2008-10#1)(2008-8#1)(2012-3#1)
prg##9##1##(2008-10#9)
priB##2##1##(1991-7#2)
priapism##5##1##(2008-10#4)(2013-8#1)
price changes##2##2##(1994-1#1)(1994-12#1)
price index##5##2##(1992-2#1)(1993-1#3)(1993-3#1)
price indexes##2##2##(1992-1#1)(1993-3#1)
price of these##2##3##(1994-2#1)(2008-10#1)
price of##8##2##(1990-9#1)(1994-1#1)(1994-2#1)(1997-7#1)(2008-10#3)(2010-5#1)
price setting##4##2##(1993-2#4)
price to##2##2##(2008-11#1)(2008-12#1)
price trends##2##2##(1993-3#2)
price without##2##2##(1992-1#1)(1993-2#1)
price##52##1##(1990-9#1)(1991-1#1)(1991-12#1)(1992-1#4)(1992-12#1)(1992-2#1)(1993-1#3)(1993-12#1)(1993-2#5)(1993-3#4)(1994-1#4)(1994-12#5)(1994-2#2)(1995-1#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2010-5#1)(2012-2#2)(2013-1#1)
prices are##2##2##(1992-2#1)(1993-1#1)
prices for##5##2##(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-6#1)
prices of##2##2##(2008-11#1)(2013-8#1)
prices##35##1##(1991-1#1)(1991-12#3)(1991-2#2)(1992-1#2)(1992-11#1)(1992-2#3)(1992-5#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#4)(1994-12#3)(1995-1#2)(1995-6#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
pricing and fair##2##3##(2008-11#2)
pricing and##4##2##(2008-11#3)(2008-12#1)
pricing##19##1##(1991-3#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#2)(1997-1#1)(1997-5#1)(1997-6#2)(2008-11#7)(2008-12#1)
prick##6##1##(1990-11#1)(2008-10#3)(2012-12#1)(2012-3#1)
pride##4##1##(1996-1#1)(2009-10#1)(2013-8#2)
prilocaine##2##1##(1993-1#1)(2008-10#1)
primarily a##5##2##(1992-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2012-12#1)
primarily about##2##2##(1995-2#1)(2008-11#1)
primarily affecting##2##2##(2010-12#1)(2013-1#1)
primarily affects the##2##3##(2008-1#1)(2012-2#1)
primarily associated with##2##3##(1997-7#1)(2008-9#1)
primarily at the##2##3##(2008-8#1)(2012-2#1)
primarily because of slow##2##4##(1991-3#1)(1997-3#1)
primarily because of##4##3##(1991-3#1)(1997-3#1)(2010-7#1)(2013-1#1)
primarily by the##5##3##(1994-5#1)(2008-10#2)(2008-11#1)(2009-9#1)
primarily by##34##2##(1991-5#1)(1991-6#1)(1991-8#1)(1994-5#1)(1996-12#1)(1996-2#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
primarily characterized by##3##3##(1994-8#1)(2008-10#2)
primarily cultured scar##2##3##(2008-9#2)
primarily cultured##3##2##(2008-2#1)(2008-9#2)
primarily determined##3##2##(2009-7#1)(2013-1#2)
primarily diagnosed##2##2##(2012-12#1)(2013-1#1)
primarily driven by##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
primarily due to the##2##4##(1997-7#1)(2012-12#1)
primarily due to##3##3##(1997-7#1)(2012-12#1)(2013-1#1)
primarily during##2##2##(1994-8#1)(2008-10#1)
primarily focused on the##2##4##(2011-2#1)(2012-3#1)
primarily for##2##2##(2008-1#1)(2008-10#1)
primarily from the##2##3##(2008-11#1)(2011-2#1)
primarily from##8##2##(1995-2#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#2)
primarily in the form of##2##5##(1995-3#1)(2008-7#1)
primarily in the##14##3##(1992-10#1)(1995-3#1)(1997-1#2)(1997-8#2)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)
primarily in##18##2##(1992-10#1)(1995-3#1)(1997-1#2)(1997-8#3)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#4)(2011-2#1)(2012-2#1)
primarily influenced by##2##3##(2008-10#1)(2008-9#1)
primarily involved in##2##3##(1997-8#1)(2013-1#1)
primarily of##4##2##(2009-1#1)(2009-11#1)(2009-7#1)(2012-3#1)
primarily on the##3##3##(1995-12#1)(1996-1#1)(1997-5#1)
primarily on##15##2##(1991-3#1)(1992-4#1)(1993-12#1)(1994-1#2)(1995-12#2)(1996-1#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-8#1)(2012-2#1)
primarily provider expertise##2##3##(1994-1#2)
primarily responsible for the##3##4##(2008-11#1)(2008-5#2)
primarily responsible for##4##3##(2008-11#1)(2008-5#2)(2008-9#1)
primarily the##3##2##(1991-8#1)(2010-8#1)(2012-2#1)
primarily through##3##2##(2008-9#1)(2010-5#1)(2011-2#1)
primarily to the##3##3##(1994-5#1)(2008-10#1)(2008-4#1)
primarily to##20##2##(1990-12#1)(1991-6#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-3#1)(2008-10#7)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)(2013-1#1)(2013-8#1)
primarily used##2##2##(2008-11#1)(2013-8#1)
primarily via##2##2##(2008-7#1)(2008-9#1)
primarily##242##1##(1990-12#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#3)(1992-10#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#2)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#5)(2008-1#3)(2008-10#48)(2008-11#18)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#11)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#3)
primary ACC##2##2##(2013-8#2)
primary afferent neurons##2##3##(1995-12#2)
primary afferent terminals##2##3##(1997-3#1)(2008-8#1)
primary afferent##9##2##(1995-12#4)(1997-3#3)(1997-4#1)(2008-8#1)
primary afferents##5##2##(1992-6#1)(1997-3#4)
primary aim##4##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)
primary aliphatic##3##2##(2008-10#3)
primary amine##6##2##(2008-10#6)
primary amines##2##2##(1996-5#1)(2012-3#1)
primary amino##5##2##(1996-12#1)(2008-10#3)(2008-5#1)
primary and interfering ions##2##4##(2008-10#2)
primary and interfering##3##3##(2008-10#3)
primary and recurrent bladder##2##4##(1991-6#2)
primary and recurrent##5##3##(1990-9#1)(1991-6#4)
primary and secondary amines##2##4##(1996-5#1)(2008-10#1)
primary and secondary education##2##4##(2009-10#1)(2011-2#1)
primary and secondary patency of pedal bypasses##2##7##(2011-3#2)
primary and secondary prevention have##2##5##(1994-2#1)(2011-2#1)
primary and secondary prevention of##2##5##(2008-11#1)(2010-2#1)
primary and secondary prevention##5##4##(1994-2#1)(2008-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
primary and secondary sexual characters##2##5##(1995-2#2)
primary and secondary##28##3##(1994-2#1)(1995-2#2)(1996-5#1)(2008-10#10)(2008-11#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#4)(2011-3#2)(2013-1#3)
primary and##56##2##(1990-9#1)(1991-3#1)(1991-6#4)(1991-8#1)(1992-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-2#1)(1995-2#2)(1996-5#1)(1997-8#2)(2008-10#13)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#7)
primary antibodies##2##2##(1990-12#1)(2008-8#1)
primary antibody##7##2##(2008-10#5)(2008-11#1)(2008-9#1)
primary auditory cortex##6##3##(1996-2#2)(2008-11#3)(2013-8#1)
primary biliary cirrhosis##5##3##(1992-12#3)(1992-9#2)
primary biliary##6##2##(1992-12#4)(1992-9#2)
primary binding site##2##3##(1997-3#1)(2008-10#1)
primary bone tumors##3##3##(2008-2#3)
primary bone##4##2##(1990-11#1)(2008-2#3)
primary brain##2##2##(2008-11#1)(2013-8#1)
primary breast cancer (n =##2##5##(1993-1#2)
primary breast cancer##9##3##(1990-8#3)(1991-8#1)(1992-12#1)(1993-1#2)(1994-12#1)(1997-7#1)
primary breast##11##2##(1990-8#3)(1991-8#1)(1992-12#1)(1993-1#2)(1994-12#1)(1997-7#1)(2011-2#1)(2011-3#1)
primary cancer##4##2##(1990-12#1)(1993-1#1)(2008-1#1)(2008-10#1)
primary cancers##2##2##(1991-6#1)(2009-9#1)
primary carbon##3##2##(1994-5#1)(2008-3#1)(2008-7#1)
primary care and##3##3##(1993-5#1)(1993-9#1)(1996-12#1)
primary care case##2##3##(1991-2#1)(1994-3#1)
primary care medical practices##2##4##(2008-4#2)
primary care physician##4##3##(1997-2#1)(2008-10#1)(2008-12#1)(2010-8#1)
primary care physicians##6##3##(1994-12#1)(1996-11#2)(2008-9#1)(2011-1#1)(2012-2#1)
primary care practices##2##3##(2008-11#1)(2013-1#1)
primary care providers##2##3##(2010-4#1)(2013-8#1)
primary care services##2##3##(1995-12#1)(1997-8#1)
primary care setting##8##3##(2008-11#2)(2008-4#1)(2010-1#2)(2010-2#1)(2013-1#2)
primary care settings##5##3##(1996-12#1)(2008-11#2)(2009-12#1)(2009-9#1)
primary care to##2##3##(1995-12#1)(1996-9#1)
primary care##116##2##(1991-2#1)(1991-9#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#2)(1993-9#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#5)(1994-9#3)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#1)(1996-1#4)(1996-11#5)(1996-12#3)(1996-2#3)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-5#4)(1997-8#4)(2008-10#1)(2008-11#11)(2008-12#3)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-2#1)(2010-4#3)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#3)(2013-8#2)
primary care]##23##2##(1993-11#2)(1993-2#4)(1993-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1996-11#1)(1996-3#3)(1996-6#2)(1997-3#1)(1997-5#1)
primary caregivers##2##2##(2010-7#1)(2010-8#1)
primary cause for##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
primary cause of##5##3##(1996-12#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-8#1)
primary cause##9##2##(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
primary cell cultures##5##3##(1990-5#1)(1996-12#1)(2008-11#2)(2008-7#1)
primary cell##7##2##(1990-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
primary cells##6##2##(2008-11#4)(2008-9#1)(2011-2#1)
primary central nervous system lymphoma##3##5##(1991-6#1)(1996-11#1)(2008-7#1)
primary central nervous system##4##4##(1991-6#1)(1996-11#1)(2008-7#1)(2010-5#1)
primary chicken##2##2##(1991-3#1)(2008-11#1)
primary cilium##3##2##(2013-1#3)
primary component##2##2##(2008-10#1)(2009-4#1)
primary concern was##2##3##(1997-2#1)(2011-2#1)
primary concern##5##2##(1992-8#1)(1997-2#1)(2008-11#1)(2010-8#1)(2011-2#1)
primary culture of##4##3##(1993-8#2)(2008-11#1)(2013-1#1)
primary culture##11##2##(1993-3#1)(1993-8#2)(1994-8#3)(1995-11#1)(2008-11#2)(2008-6#1)(2013-1#1)
primary cultured##3##2##(1996-2#1)(2008-5#2)
primary cultures of human##3##4##(1993-3#2)(2008-11#1)
primary cultures of rat##2##4##(1995-11#1)(2008-11#1)
primary cultures of the##2##4##(1996-2#1)(2011-2#1)
primary cultures of##18##3##(1990-5#1)(1991-5#2)(1993-3#2)(1994-2#2)(1994-3#1)(1995-11#2)(1995-12#2)(1995-8#1)(1996-2#1)(2008-11#2)(2009-9#1)(2011-2#1)
primary cultures##19##2##(1990-5#1)(1991-5#2)(1993-3#2)(1994-2#2)(1994-3#1)(1995-11#2)(1995-12#2)(1995-8#1)(1996-2#1)(2008-11#3)(2009-9#1)(2011-2#1)
primary data##2##2##(2008-1#1)(2008-10#1)
primary degradation##2##2##(2008-10#2)
primary diagnosis##4##2##(1992-1#2)(1994-2#1)(2008-1#1)
primary diagnostic##3##2##(1990-6#1)(2008-2#1)(2012-12#1)
primary disease##3##2##(1991-3#1)(2008-10#1)(2013-1#1)
primary diseases##2##2##(1997-6#1)(2012-12#1)
primary electron donor is##3##4##(2008-8#3)
primary electron donor##4##3##(2008-8#4)
primary emulsifier##3##2##(2008-5#3)
primary endosperm##5##2##(2008-9#5)
primary endpoint##2##2##(2008-10#1)(2010-4#1)
primary esophageal carcinomas##2##3##(1992-8#2)
primary esophageal##3##2##(1992-8#2)(2012-2#1)
primary factor##4##2##(2008-10#3)(2008-9#1)
primary focus of this##2##4##(2008-11#1)(2008-7#1)
primary focus##4##2##(1990-3#1)(2008-11#1)(2008-7#1)(2013-1#1)
primary function of##2##3##(1997-1#1)(2008-11#1)
primary gastric carcinoma##2##3##(2008-9#1)(2012-2#1)
primary gastric##3##2##(2008-9#1)(2009-8#1)(2012-2#1)
primary generated##2##2##(1995-3#2)
primary germinoma originating in the basal ganglia##2##7##(2008-7#2)
primary goal##2##2##(2010-2#1)(2013-1#1)
primary health care and##3##4##(1991-6#1)(1992-1#1)(2008-6#1)
primary health care centers in##2##5##(2007-8#1)(2011-2#1)
primary health care centers##3##4##(2007-8#1)(2011-2#2)
primary health care for##4##4##(1996-12#1)(2010-10#3)
primary health care services##2##4##(1991-6#1)(1991-8#1)
primary health care staff##2##4##(2011-2#2)
primary health care##30##3##(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#2)(2007-8#2)(2008-6#1)(2010-10#3)(2011-2#7)(2012-3#1)
primary health care]##5##3##(1991-9#1)(1993-3#1)(1994-6#1)(1997-5#1)(1997-8#1)
primary health##37##2##(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#2)(1997-5#1)(1997-8#1)(2007-8#2)(2008-6#1)(2010-10#3)(2011-2#7)(2012-3#1)
primary health-care centres##2##3##(2008-10#2)
primary healthcare##5##2##(2009-3#3)(2009-6#2)
primary hepatocellular carcinoma##3##3##(2008-8#1)(2010-12#1)(2010-7#1)
primary hepatocyte##3##2##(1990-5#1)(2008-11#2)
primary hepatocytes##5##2##(2008-11#4)(2008-9#1)
primary host##2##2##(2008-10#2)
primary human cells##4##3##(2008-11#4)
primary human##16##2##(1992-8#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-11#8)(2008-9#1)(2009-12#1)(2012-12#1)(2012-5#1)
primary hydroxyl groups##4##3##(1990-9#2)(1996-5#1)(2008-7#1)
primary hyperparathyroidism and##2##3##(1990-2#2)
primary hyperparathyroidism##13##2##(1990-2#5)(1991-12#1)(1996-9#1)(2008-10#2)(2008-12#2)(2011-2#1)(2012-12#1)
primary hyphae##4##2##(2008-10#4)
primary immune##4##2##(2008-10#3)(2008-11#1)
primary immunodeficiency diseases##2##3##(2012-12#2)
primary immunodeficiency##4##2##(2008-10#1)(2012-12#3)
primary in##2##2##(2010-2#1)(2013-1#1)
primary infection##10##2##(1997-5#1)(2008-10#9)
primary infections##2##2##(2008-10#2)
primary inoculum in##2##3##(2008-10#2)
primary inoculum##19##2##(2008-10#19)
primary leiomyoma of the ureter##2##5##(2013-7#2)
primary lesion in##2##3##(1997-7#1)(2013-8#1)
primary lesion##4##2##(1992-2#1)(1997-7#1)(2008-10#1)(2013-8#1)
primary lesions##2##2##(2008-10#2)
primary ligand and##2##3##(2008-10#2)
primary liver##2##2##(2011-1#1)(2013-1#1)
primary lung cancer##3##3##(1993-8#1)(2008-11#1)(2008-2#1)
primary lung##6##2##(1993-2#1)(1993-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
primary lymphocytes##2##2##(2008-2#1)(2011-3#1)
primary malignancies##3##2##(1990-12#3)
primary malignant##3##2##(1990-12#1)(2011-2#1)(2013-1#1)
primary mechanism of##2##3##(2008-10#2)
primary mechanism##4##2##(1997-3#1)(2008-10#2)(2012-12#1)
primary medical care##2##3##(1993-11#1)(1997-4#1)
primary medical##3##2##(1993-11#1)(1997-2#1)(1997-4#1)
primary melanoma##6##2##(2008-9#1)(2011-2#5)
primary melanomas##3##2##(2008-9#1)(2011-2#2)
primary mesangial cells##2##3##(2011-2#2)
primary methods##2##2##(1997-3#1)(2008-10#1)
primary motor area##2##3##(2008-11#2)
primary motor cortex##3##3##(2010-7#1)(2011-2#1)(2012-2#1)
primary motor##5##2##(2008-11#2)(2010-7#1)(2011-2#1)(2012-2#1)
primary musical cues##2##3##(2013-8#2)
primary nephropathies##2##2##(2008-1#2)
primary nevoid melanoma##2##3##(2011-2#2)
primary nocturnal enuresis?##2##3##(1994-8#1)(2008-10#1)
primary objective of this study##3##5##(1991-2#1)(2008-10#2)
primary objective of this##5##4##(1991-2#1)(2008-10#2)(2010-4#1)(2011-1#1)
primary objective of##6##3##(1991-2#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#1)
primary ocular##3##2##(2012-3#3)
primary open angle glaucoma##3##4##(2011-2#2)(2012-2#1)
primary open angle##4##3##(2011-2#3)(2012-2#1)
primary or secondary##4##3##(1991-2#1)(1995-10#1)(2008-10#1)(2012-3#1)
primary or##7##2##(1990-12#1)(1991-2#1)(1993-6#1)(1995-10#1)(1997-4#1)(2008-10#1)(2012-3#1)
primary orbital##2##2##(2010-11#2)
primary osteogenic sarcoma of the breast##2##6##(1992-2#2)
primary outcomes##3##2##(2008-7#1)(2010-1#1)(2010-4#1)
primary outpatient care##2##3##(2011-1#2)
primary oxalosis##2##2##(1991-11#2)
primary ozonides##3##2##(1996-5#3)
primary parenchymatous##2##2##(1997-8#2)
primary particles##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
primary patients##2##2##(2012-3#1)(2013-1#1)
primary porcine hepatocytes##4##3##(2008-11#3)(2011-2#1)
primary predecessors##3##2##(2013-1#3)
primary prevention and##2##3##(2007-8#1)(2008-12#1)
primary prevention groups that##2##4##(2010-12#2)
primary prevention groups##3##3##(2010-12#3)
primary prevention strategies##2##3##(2008-3#1)(2011-2#1)
primary prevention##22##2##(1995-3#7)(1995-5#1)(1996-12#2)(1996-3#1)(1997-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-1#1)(2010-12#3)(2011-2#1)(2013-1#1)
primary preventive##2##2##(1996-12#2)
primary producers##3##2##(2008-8#1)(2009-4#1)(2012-2#1)
primary production##4##2##(2008-8#2)(2009-8#1)(2012-2#1)
primary productivity##2##2##(2008-8#2)
primary radiotherapy##3##2##(1992-3#1)(1993-11#2)
primary rat hepatocytes##7##3##(1993-8#2)(2008-11#2)(2008-9#3)
primary rat##11##2##(1992-3#1)(1993-2#1)(1993-8#2)(1996-12#1)(1996-2#1)(2008-11#2)(2008-9#3)
primary reaction##3##2##(2008-8#3)
primary repair##3##2##(2010-12#2)(2010-8#1)
primary resection##2##2##(1990-9#1)(2008-11#1)
primary resistance to HER2-targeted therapies##2##5##(2013-1#2)
primary role##3##2##(2008-10#1)(2008-9#1)(2009-3#1)
primary school children##3##3##(2008-10#2)(2008-12#1)
primary school##6##2##(2008-10#2)(2008-12#2)(2009-12#1)(2013-8#1)
primary schools##5##2##(2008-10#3)(2008-7#1)(2013-8#1)
primary sclerosing cholangitis##2##3##(2009-8#1)(2010-12#1)
primary sequence##6##2##(1992-3#2)(1993-2#2)(1993-9#1)(1997-9#1)
primary site of##7##3##(1997-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-3#1)
primary site##12##2##(1990-8#1)(1992-2#2)(1997-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
primary sites##3##2##(1990-8#1)(1993-3#1)(2008-10#1)
primary source of##5##3##(1995-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
primary specialization courses##2##3##(1994-12#2)
primary structure of goat Mb##3##5##(2010-4#3)
primary structure of the##5##4##(1990-7#1)(1991-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
primary structure of##18##3##(1990-4#1)(1990-7#1)(1991-6#2)(1992-3#1)(1992-8#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#3)(2011-2#2)
primary structure##26##2##(1990-2#1)(1990-4#2)(1990-7#2)(1991-6#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-3#2)(1995-6#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#3)(2011-2#2)
primary structures##3##2##(1991-6#1)(1993-12#1)(1997-2#1)
primary success rate of##2##4##(1991-3#1)(2008-11#1)
primary success rate##4##3##(1991-3#1)(2008-11#1)(2008-12#2)
primary surgery##3##2##(1990-6#1)(2008-9#2)
primary synovial##2##2##(2010-5#1)(2013-1#1)
primary systemic##2##2##(1995-5#1)(2011-2#1)
primary target of##2##3##(1995-2#1)(2008-10#1)
primary targets##2##2##(1992-12#1)(2011-2#1)
primary teaching##2##2##(2008-11#2)
primary teeth with##2##3##(2011-2#2)
primary teeth##7##2##(2011-2#6)(2013-1#1)
primary teratoma of the penis##2##5##(2008-10#2)
primary therapy##4##2##(1990-11#1)(2010-12#1)(2011-2#2)
primary tumor##14##2##(1990-6#2)(1991-3#1)(1993-1#1)(1994-12#1)(1996-3#1)(2008-1#1)(2009-10#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
primary tumors and##3##3##(1992-12#1)(1994-12#1)(2011-2#1)
primary tumors##10##2##(1992-12#1)(1994-12#2)(1997-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
primary tumours##2##2##(1997-3#1)(2012-2#1)
primary varicella zoster infection##2##4##(2008-7#2)
primary visual cortex (V1)##3##4##(2008-11#2)(2008-8#1)
primary visual cortex of##2##4##(2008-11#1)(2008-8#1)
primary visual cortex##5##3##(2008-11#3)(2008-8#2)
primary visual##6##2##(2008-11#3)(2008-8#3)
primary##1224##1##(1990-11#2)(1990-12#12)(1990-2#8)(1990-3#1)(1990-4#2)(1990-5#8)(1990-6#4)(1990-7#2)(1990-8#7)(1990-9#5)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#5)(1991-5#3)(1991-6#18)(1991-8#5)(1991-9#3)(1992-1#3)(1992-11#2)(1992-12#9)(1992-2#7)(1992-3#6)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#7)(1992-9#3)(1993-1#6)(1993-11#7)(1993-12#7)(1993-2#11)(1993-3#9)(1993-5#3)(1993-6#6)(1993-8#5)(1993-9#5)(1994-11#1)(1994-12#9)(1994-2#6)(1994-3#4)(1994-5#5)(1994-6#10)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#9)(1995-12#13)(1995-2#7)(1995-3#14)(1995-5#7)(1995-6#5)(1995-8#3)(1996-1#5)(1996-11#11)(1996-12#15)(1996-2#10)(1996-3#10)(1996-5#9)(1996-6#5)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#9)(1997-3#19)(1997-4#5)(1997-5#8)(1997-6#1)(1997-7#6)(1997-8#13)(1997-9#2)(2007-12#4)(2007-8#4)(2008-1#13)(2008-10#180)(2008-11#94)(2008-12#14)(2008-2#10)(2008-3#9)(2008-4#10)(2008-5#21)(2008-6#5)(2008-7#21)(2008-8#28)(2008-9#33)(2009-1#1)(2009-10#10)(2009-11#3)(2009-12#3)(2009-3#6)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#4)(2010-11#5)(2010-12#13)(2010-2#4)(2010-3#1)(2010-4#9)(2010-5#5)(2010-6#5)(2010-7#4)(2010-8#7)(2011-1#8)(2011-2#77)(2011-3#6)(2012-12#14)(2012-2#25)(2012-3#25)(2012-5#1)(2013-1#58)(2013-7#2)(2013-8#23)
primary-care providers##2##2##(1992-8#1)(1996-3#1)
primary-care##10##1##(1992-8#2)(1996-2#2)(1996-3#2)(1997-2#4)
primary-cultured##3##1##(2008-11#3)
primary-tertiary##3##1##(2008-10#3)
primate ES cells##2##3##(2008-9#2)
primate brain##4##2##(1992-12#1)(1997-2#2)(2012-3#1)
primate embryonic stem##2##3##(2008-9#1)(2009-12#1)
primate species##3##2##(1997-8#1)(2008-11#1)(2008-8#1)
primate##21##1##(1992-12#1)(1993-6#1)(1995-11#2)(1995-5#4)(1997-2#3)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#4)(2009-12#1)(2012-3#2)
primates##18##1##(1993-12#1)(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#3)(2012-3#6)(2013-8#1)
primaurelia##4##1##(2008-12#4)
prime importance##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
prime naïve CD4(+) T cells##2##5##(2008-11#2)
prime##25##1##(1991-3#1)(1994-11#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#1)(2008-9#4)(2010-4#1)(2011-2#3)(2012-2#1)(2013-8#1)
primed for apoptosis##2##3##(1995-2#2)
primed polymerase chain reaction##6##4##(2008-10#5)(2008-11#1)
primed with##3##2##(1992-1#1)(1995-2#1)(2008-10#1)
primed##20##1##(1991-6#1)(1992-1#1)(1994-6#1)(1995-2#4)(2008-10#6)(2008-11#3)(2008-5#1)(2008-9#1)(2013-1#2)
primer analysis##3##2##(2008-10#3)
primer and##7##2##(1992-6#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
primer binding site##2##3##(2008-12#1)(2012-3#1)
primer binding##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
primer extension##5##2##(1991-9#1)(1993-12#1)(1993-2#1)(2008-4#1)(2008-9#1)
primer have##2##2##(2008-10#1)(2008-8#1)
primer of##2##2##(2008-11#1)(2008-8#1)
primer on##4##2##(1993-12#2)(1994-3#1)(2013-1#1)
primer pair##20##2##(1995-12#1)(2008-10#18)(2008-5#1)
primer pairs and##2##3##(1995-6#1)(2008-11#1)
primer pairs derived from##2##4##(1995-12#1)(2008-10#1)
primer pairs for##2##3##(2008-10#1)(2013-8#1)
primer pairs used##2##3##(2008-10#2)
primer pairs were##2##3##(2008-10#2)
primer pairs##23##2##(1995-12#1)(1995-6#1)(2008-10#18)(2008-11#1)(2008-5#1)(2013-8#1)
primer set is##2##3##(2008-10#2)
primer set was##3##3##(2008-10#3)
primer set##13##2##(2008-10#12)(2008-4#1)
primer sets##11##2##(1997-2#1)(2008-10#8)(2008-12#1)(2008-9#1)
primer##139##1##(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-3#2)(1994-3#1)(1995-11#1)(1995-12#2)(1995-6#1)(1997-2#1)(1997-6#1)(1997-7#4)(2008-10#87)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#6)(2010-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
primer-probe systems##2##2##(2008-10#1)(2010-4#1)
primer-probe##5##1##(2008-10#3)(2010-4#2)
primer/probe sets were##3##3##(2008-10#3)
primer/probe sets##4##2##(2008-10#4)
primer/probe##6##1##(2008-10#6)
primers also were##2##3##(2008-10#2)
primers also##3##2##(2008-10#3)
primers amplified the##2##3##(2008-10#2)
primers amplified##7##2##(2008-10#7)
primers and TaqMan probes##2##4##(2008-10#1)(2010-4#1)
primers and##14##2##(2008-10#11)(2008-8#1)(2008-9#1)(2010-4#1)
primers based on the##3##4##(1993-2#1)(2008-10#2)
primers based on##4##3##(1993-2#1)(2008-10#3)
primers corresponding to##2##3##(1992-6#1)(1997-2#1)
primers could##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
primers derived from##2##3##(2008-10#2)
primers designed according to##2##4##(2008-8#1)(2008-9#1)
primers designed from the##2##4##(2008-10#2)
primers designed in this##2##4##(2008-10#1)(2010-4#1)
primers designed to##2##3##(2008-10#2)
primers designed##9##2##(2008-10#6)(2008-8#1)(2008-9#1)(2010-4#1)
primers detected##2##2##(2008-10#2)
primers flanking the##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
primers for polymerase chain reaction##2##5##(2008-10#2)
primers for the##2##3##(2008-10#2)
primers for##17##2##(1994-11#1)(1995-6#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#1)
primers from##6##2##(1994-11#1)(2008-10#4)(2008-9#1)
primers in##4##2##(2008-10#3)(2008-12#1)
primers is##3##2##(2008-10#3)
primers resulted in##2##3##(2008-10#2)
primers revealed##2##2##(2008-10#1)(2011-2#1)
primers specific for the##3##4##(2008-10#2)(2008-5#1)
primers specific for##6##3##(2008-10#5)(2008-5#1)
primers specific##7##2##(2008-10#6)(2008-5#1)
primers targeting the conserved##2##4##(2008-10#2)
primers that amplified##2##3##(1993-12#1)(2008-10#1)
primers that amplify##3##3##(2008-10#3)
primers that specifically amplified##2##4##(1993-12#1)(2008-10#1)
primers that were##2##3##(2008-10#2)
primers that##10##2##(1993-12#2)(2008-10#8)
primers to##8##2##(1991-5#1)(1996-2#1)(2008-10#6)
primers used##2##2##(1997-7#1)(2008-10#1)
primers was found to be##2##5##(2008-10#1)(2008-12#1)
primers was##5##2##(1993-2#1)(2008-10#3)(2008-12#1)
primers were designed and used to##2##6##(2008-10#2)
primers were designed and##3##4##(2008-10#2)(2008-8#1)
primers were designed for##2##4##(2008-10#2)
primers were designed##9##3##(2008-10#7)(2008-8#1)(2013-8#1)
primers were developed##2##3##(2008-10#2)
primers were screened##3##3##(2008-10#3)
primers were used in##2##4##(2008-10#2)
primers were used to##4##4##(2008-10#3)(2008-8#1)
primers were used##7##3##(2008-10#6)(2008-8#1)
primers were##31##2##(2008-10#28)(2008-8#2)(2013-8#1)
primers with##2##2##(2008-10#1)(2010-4#1)
primers##243##1##(1990-5#2)(1991-5#1)(1992-6#1)(1993-12#4)(1993-2#2)(1994-11#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-8#2)(1997-2#3)(1997-4#1)(1997-7#4)(1997-8#1)(2008-10#176)(2008-11#5)(2008-12#7)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#7)(2010-4#4)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
primes##3##1##(1995-2#1)(1995-5#1)(2012-3#1)
primexine##2##1##(2011-2#2)
priming for##2##2##(2008-10#1)(2013-1#1)
priming may##4##2##(2013-8#4)
priming of##3##2##(2008-10#3)
priming##36##1##(1992-6#1)(1995-2#3)(1995-5#2)(2008-10#8)(2008-11#1)(2008-7#2)(2010-7#4)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#9)
priming&quot##2##1##(1992-3#2)
primipara##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
primitive neuroectodermal##4##2##(2008-7#1)(2009-1#3)
primitive##24##1##(1990-3#1)(1990-5#1)(1992-3#1)(1993-8#1)(1994-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#3)(2009-10#1)(2009-12#1)(2013-1#2)(2013-8#1)
primitives##4##1##(2008-11#2)(2008-6#2)
primordia##6##1##(2008-8#2)(2009-8#4)
primordial and primary follicles##2##4##(1995-12#2)
primordial endoblast##2##2##(2007-12#2)
primordial germ cells (PGCs)##2##4##(2008-11#2)
primordial germ cells between chicken##2##5##(2008-11#2)
primordial germ cells##9##3##(2008-11#4)(2010-5#5)
primordial germ##11##2##(2007-12#1)(2008-11#4)(2008-12#1)(2010-5#5)
primordial mesoteloblast##2##2##(2007-12#2)
primordial##24##1##(1995-12#2)(2007-12#5)(2008-11#5)(2008-12#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#5)(2013-1#2)
primosome##2##1##(1991-7#1)(1992-3#1)
principal axis##2##2##(2008-3#1)(2009-5#1)
principal component analysis (PCA) and partial least##2##7##(2008-10#2)
principal component analysis (PCA) and##11##5##(2008-10#11)
principal component analysis (PCA)##26##4##(2008-10#26)
principal component analysis and cluster analysis##2##6##(2008-10#2)
principal component analysis and improved BP##2##6##(2013-8#2)
principal component analysis and##7##4##(2008-10#4)(2011-2#1)(2013-8#2)
principal component analysis is##2##4##(2013-1#2)
principal component analysis to##2##4##(2008-10#1)(2010-8#1)
principal component analysis##57##3##(2008-10#44)(2008-11#1)(2010-10#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#2)
principal component and##2##3##(2008-10#2)
principal component artificial neural network##2##5##(2008-10#2)
principal component of##4##3##(1993-11#1)(1995-2#1)(1995-6#1)(2008-10#1)
principal component regression (PCR) and partial##2##6##(2008-10#2)
principal component regression (PCR)##10##4##(2008-10#10)
principal component regression##15##3##(2008-10#15)
principal component##87##2##(1993-11#1)(1995-2#1)(1995-6#1)(2008-10#68)(2008-11#2)(2010-10#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#4)(2013-8#2)
principal components (PCs)##4##3##(2008-10#4)
principal components analysis (PCA)##5##4##(2008-10#5)
principal components analysis##12##3##(2008-10#11)(2012-2#1)
principal components and cluster##2##4##(2008-10#2)
principal components of##2##3##(2008-6#1)(2008-9#1)
principal components scores##2##3##(2008-10#1)(2010-7#1)
principal components##27##2##(2008-10#23)(2008-6#1)(2008-9#1)(2010-7#1)(2012-2#1)
principal cortical##2##2##(1991-3#1)(2008-11#1)
principal direction##2##2##(2008-6#2)
principal findings##2##2##(2008-7#1)(2011-1#1)
principal map##2##2##(2008-11#2)
principal peak##2##2##(1992-12#2)
principal plane##4##2##(2008-3#4)
principal strain##2##2##(2013-1#2)
principal##195##1##(1990-11#1)(1990-9#3)(1991-1#1)(1991-12#1)(1991-3#3)(1992-12#2)(1992-3#1)(1993-11#1)(1994-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-3#2)(2007-11#1)(2008-10#106)(2008-11#8)(2008-2#1)(2008-3#9)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-7#5)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#8)(2013-8#3)
principal-component analysis##3##2##(2008-10#3)
principally due to##3##3##(1991-12#1)(2008-7#1)(2013-1#1)
principally in the##3##3##(1994-2#1)(1996-12#1)(2008-12#1)
principally responsible for##2##3##(1996-12#1)(1996-2#1)
principally through##3##2##(2008-10#2)(2008-4#1)
principally##22##1##(1990-2#1)(1991-12#1)(1991-2#1)(1994-2#1)(1995-11#1)(1996-12#2)(1996-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2013-1#1)(2013-7#1)
principle and##5##2##(1992-3#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
principle behind##3##2##(2008-2#1)(2008-9#1)(2011-7#1)
principle component analysis##2##3##(2008-10#2)
principle component##3##2##(2008-10#3)
principle for##3##2##(1993-11#1)(2008-6#1)(2010-4#1)
principle in massage##2##3##(2009-3#2)
principle in##6##2##(1992-1#1)(1997-6#1)(2008-10#1)(2009-3#2)(2012-2#1)
principle is based on the##2##5##(2008-10#1)(2010-7#1)
principle is##11##2##(1992-3#1)(1995-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#2)
principle of early##2##3##(2008-11#2)
principle of the##8##3##(1997-6#1)(2008-10#5)(2008-12#1)(2008-5#1)
principle of this##2##3##(2008-10#2)
principle of##40##2##(1992-1#1)(1993-9#1)(1995-9#3)(1996-3#1)(1997-6#1)(2007-11#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2012-3#2)(2013-8#2)
principle that##4##2##(1992-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
principle using a##2##3##(2008-10#2)
principle using##4##2##(2008-10#4)
principle was##4##2##(2008-10#3)(2008-12#1)
principle with##2##2##(1996-3#1)(2008-10#1)
principle##145##1##(1992-1#2)(1992-2#1)(1992-3#3)(1993-11#1)(1993-9#1)(1994-6#2)(1995-3#2)(1995-9#3)(1996-3#2)(1997-1#1)(1997-5#1)(1997-6#2)(2007-11#1)(2008-10#57)(2008-11#9)(2008-12#5)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-3#4)(2009-5#2)(2009-6#1)(2009-8#3)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#3)(2011-7#2)(2012-2#4)(2012-3#3)(2013-8#3)
principle)##2##1##(2008-10#1)(2008-5#1)
principled##3##1##(1993-12#1)(2008-5#1)(2013-8#1)
principles and applications##3##3##(2008-10#2)(2013-8#1)
principles and practice of##3##4##(1993-12#1)(1994-5#1)(1997-3#1)
principles and practice##5##3##(1993-12#1)(1994-5#1)(1997-3#1)(2008-4#1)(2008-5#1)
principles and practices##2##3##(2008-6#1)(2008-9#1)
principles and strategies##2##3##(2010-1#1)(2013-1#1)
principles and##24##2##(1993-11#1)(1993-12#2)(1994-5#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#1)(2013-1#2)(2013-8#4)
principles are discussed##2##3##(2008-2#1)(2008-3#1)
principles are##10##2##(1993-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-7#1)(2010-8#1)(2012-2#1)
principles based on##2##3##(2008-5#1)(2008-8#1)
principles for the##3##3##(1991-9#1)(1997-2#1)(1997-6#1)
principles for##13##2##(1991-9#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#2)(2013-1#1)
principles from the##2##3##(2008-10#1)(2008-12#1)
principles have been##2##3##(2008-10#1)(2008-3#1)
principles have##4##2##(1992-2#1)(2008-10#1)(2008-3#1)(2009-4#1)
principles in the##2##3##(2008-11#1)(2013-8#1)
principles in##4##2##(1992-1#1)(1992-2#1)(2008-11#1)(2013-8#1)
principles of action##2##3##(2010-6#1)(2010-7#1)
principles of adult##2##3##(1992-1#1)(2008-12#1)
principles of general##2##3##(2008-10#1)(2008-11#1)
principles of pharmacology and therapeutics##2##5##(2008-11#2)
principles of the##10##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-6#1)(2011-7#1)
principles of##80##2##(1990-11#1)(1990-5#1)(1991-2#2)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#9)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-8#2)(2008-9#7)(2009-1#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-11#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#2)
principles that##4##2##(2008-1#1)(2008-8#1)(2009-12#1)(2012-2#1)
principles to##5##2##(1992-1#1)(1994-3#1)(2008-3#1)(2008-8#1)(2011-2#1)
principles underlying the##3##3##(1992-12#1)(2008-9#1)(2010-8#1)
principles underlying##5##2##(1992-12#1)(1995-1#1)(2008-11#1)(2008-9#1)(2010-8#1)
principles##217##1##(1990-11#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#4)(1992-12#1)(1992-2#5)(1992-3#2)(1993-11#1)(1993-12#3)(1993-3#3)(1994-1#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(2007-12#1)(2008-1#2)(2008-10#27)(2008-11#19)(2008-12#9)(2008-2#2)(2008-3#8)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#14)(2009-1#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-2#7)(2012-3#2)(2013-1#8)(2013-8#8)
print awareness##2##2##(2009-9#2)
print##11##1##(1991-12#1)(1993-1#1)(2008-10#2)(2008-9#1)(2009-9#3)(2011-2#1)(2012-2#1)(2013-1#1)
printed on##2##2##(2008-10#1)(2008-3#1)
printed standards of care##2##4##(2008-3#2)
printed##10##1##(1991-1#1)(1992-3#1)(2008-10#3)(2008-3#4)(2011-3#1)
printing##7##1##(2008-10#4)(2008-2#1)(2008-9#2)
prion disease##3##2##(2010-12#3)
prion protein##4##2##(2008-11#2)(2008-5#2)
prion transmission##2##2##(2008-10#1)(2010-11#1)
prion##13##1##(2008-10#1)(2008-11#6)(2008-5#2)(2010-11#1)(2010-12#3)
prions##3##1##(2010-4#3)
prior conditions##2##2##(2010-11#2)
prior diagnosis of##2##3##(1997-3#1)(2008-12#1)
prior distributions##2##2##(1995-12#1)(2009-4#1)
prior experience##4##2##(2010-8#2)(2011-2#1)(2013-1#1)
prior exposure to##2##3##(1997-1#1)(2008-10#1)
prior for##2##2##(2008-6#1)(2010-5#1)
prior history of##2##3##(2008-5#1)(2013-1#1)
prior history##3##2##(2008-4#1)(2008-5#1)(2013-1#1)
prior i##3##2##(1990-11#1)(1996-2#1)(1997-4#1)
prior information##4##2##(1995-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
prior knowledge of the##2##4##(2008-10#1)(2010-3#1)
prior knowledge of##3##3##(2008-10#1)(2008-8#1)(2010-3#1)
prior knowledge##6##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)
prior separation##8##2##(2008-10#8)
prior studies##2##2##(1993-1#1)(2012-3#1)
prior the##2##2##(2008-10#1)(2011-2#1)
prior to 1990/91##2##3##(2008-5#2)
prior to 37##2##3##(2011-2#2)
prior to HSG##2##3##(2011-2#2)
prior to PCR##2##3##(1996-12#1)(2008-10#1)
prior to a##4##3##(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)
prior to an##2##3##(2008-12#1)(2008-3#1)
prior to analysis by##2##4##(2008-10#2)
prior to analysis##10##3##(2008-10#10)
prior to and after##2##4##(1997-2#2)
prior to and##4##3##(1990-11#1)(1997-2#2)(2008-7#1)
prior to any##2##3##(1993-12#1)(2008-11#1)
prior to application of##2##4##(2008-10#2)
prior to application##3##3##(2008-10#3)
prior to commitment##2##3##(1994-12#2)
prior to contact with##3##4##(2008-10#2)(2008-8#1)
prior to death##2##3##(1991-12#1)(1995-1#1)
prior to detection##2##3##(2008-10#2)
prior to determination##2##3##(2008-10#2)
prior to differentiation##2##3##(2011-2#2)
prior to each##5##3##(1990-12#1)(1994-2#1)(1997-2#1)(2008-10#2)
prior to entering##2##3##(1994-12#1)(2008-11#1)
prior to exposure##2##3##(2008-10#1)(2008-11#1)
prior to flame atomic absorption##2##5##(2008-10#2)
prior to gastric##2##3##(1996-12#1)(2012-5#1)
prior to harvest##3##3##(2008-10#3)
prior to high##3##3##(2008-10#2)(2008-11#1)
prior to implementation##2##3##(1994-3#1)(2008-6#1)
prior to incubation##2##3##(1990-12#1)(2008-5#1)
prior to infestation with##2##4##(2008-10#2)
prior to initiating##2##3##(2012-12#1)(2013-1#1)
prior to initiation of##2##4##(2008-10#1)(2008-11#1)
prior to inoculation with the pathogen##2##6##(2008-10#2)
prior to inoculation with the##3##5##(2008-10#3)
prior to inoculation with##6##4##(2008-10#6)
prior to inoculation##11##3##(2008-10#11)
prior to irradiation##2##3##(1994-12#1)(2008-7#1)
prior to its determination by inductively coupled plasma##2##8##(2008-10#2)
prior to its##5##3##(2008-10#3)(2008-11#1)(2013-8#1)
prior to obliteration##2##3##(2008-7#2)
prior to pathogen##2##3##(2008-10#2)
prior to petal expansion##2##4##(2008-10#2)
prior to planting of##2##4##(2008-10#2)
prior to planting##5##3##(2008-10#5)
prior to sacrifice##2##3##(1996-2#1)(2008-10#1)
prior to sampling##3##3##(1996-12#2)(2008-10#1)
prior to surgery or radiosurgery##2##5##(2008-7#2)
prior to surgery or##3##4##(2008-10#1)(2008-7#2)
prior to surgery##9##3##(1991-2#1)(1991-3#1)(1997-8#1)(2008-10#1)(2008-2#2)(2008-7#2)(2008-8#1)
prior to surgical##3##3##(1997-6#1)(2011-2#1)(2012-12#1)
prior to testing##3##3##(2008-10#1)(2008-5#2)
prior to the addition of##2##5##(1996-1#1)(2008-10#1)
prior to the analysis##4##4##(1994-6#1)(2008-10#3)
prior to the appearance of##2##5##(1992-12#1)(2012-3#1)
prior to the determination by##2##5##(2008-10#2)
prior to the determination of##4##5##(2008-10#4)
prior to the determination##6##4##(2008-10#6)
prior to the development of##3##5##(2008-10#1)(2009-3#1)(2010-1#1)
prior to the formation of##2##5##(2008-10#2)
prior to the onset of##3##5##(2008-10#1)(2009-10#1)(2012-2#1)
prior to the pathogen##2##4##(2008-10#2)
prior to the radiation##2##4##(2007-12#1)(2008-3#1)
prior to the third injection##2##5##(2013-8#2)
prior to the##64##3##(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#29)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
prior to their determination by flame atomic absorption spectrometry##5##9##(2008-10#5)
prior to their determination by graphite furnace atomic absorption spectrometry##2##10##(2008-10#2)
prior to their determination by inductively coupled plasma atomic emission spectrometry##2##11##(2008-10#2)
prior to their determination by inductively coupled##3##7##(2008-10#3)
prior to their determination by##13##5##(2008-10#13)
prior to their##26##3##(1991-2#1)(1995-1#1)(2008-10#22)(2008-4#1)(2011-1#1)
prior to this##2##3##(2008-10#2)
prior to transfection##2##3##(2008-11#2)
prior to treatment##3##3##(1991-3#1)(2008-5#1)(2011-2#1)
prior to wound closure##3##4##(2008-7#3)
prior to##371##2##(1990-11#2)(1990-12#3)(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#3)(1994-8#4)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-12#6)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#4)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#1)(2007-12#4)(2008-10#168)(2008-11#18)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#15)(2008-8#4)(2008-9#5)(2009-10#2)(2009-3#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-8#5)(2011-1#2)(2011-2#12)(2012-12#6)(2012-2#2)(2012-3#5)(2012-5#2)(2013-1#6)(2013-8#3)
prior training##2##2##(2008-10#2)
prior treatment with##2##3##(1991-4#1)(2009-8#1)
prior treatment##7##2##(1991-4#1)(2008-10#3)(2009-8#1)(2012-3#2)
prior use##2##2##(1994-3#1)(2008-12#1)
prior work##2##2##(2008-10#1)(2013-8#1)
prior##518##1##(1990-11#4)(1990-12#3)(1990-6#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#4)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#5)(1994-6#3)(1994-8#5)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#3)(1996-12#7)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#1)(1997-8#1)(2007-12#4)(2008-1#2)(2008-10#214)(2008-11#22)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#12)(2008-6#4)(2008-7#17)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#4)(2009-8#2)(2010-1#3)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-8#7)(2011-1#3)(2011-2#17)(2012-12#6)(2012-2#3)(2012-3#10)(2012-5#2)(2013-1#11)(2013-8#5)
priori##22##1##(1991-12#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
priorities and##4##2##(1991-12#1)(1994-3#1)(1997-3#1)(2013-1#1)
priorities for the##3##3##(1992-2#1)(2008-10#1)(2008-5#1)
priorities for##10##2##(1992-2#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-8#1)(2010-12#1)
priorities in##5##2##(1991-1#1)(1991-6#1)(1992-2#1)(2008-10#1)(2010-10#1)
priorities##42##1##(1991-1#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-2#2)(1992-8#1)(1994-2#4)(1994-3#1)(1996-1#1)(1997-1#1)(1997-3#5)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
prioritised##2##1##(2009-4#1)(2011-2#1)
prioritization##10##1##(1994-9#1)(1996-1#1)(1996-2#1)(1997-2#1)(2010-8#3)(2011-2#3)
prioritize##6##1##(2008-10#2)(2008-8#2)(2010-12#1)(2011-2#1)
prioritized##4##1##(1996-1#1)(2008-10#1)(2009-8#1)(2010-7#1)
prioritizing##4##1##(1994-12#1)(1994-9#1)(2008-11#2)
priority for##5##2##(1996-2#1)(2008-11#1)(2012-2#1)(2013-1#2)
priority in##8##2##(1992-12#1)(1993-11#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-4#1)
priority of##2##2##(1991-11#1)(1993-3#1)
priority on##3##2##(1996-1#1)(2008-8#1)(2010-10#1)
priority##55##1##(1990-3#1)(1991-11#1)(1991-2#1)(1992-12#3)(1992-2#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#2)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)
priority-setting##2##1##(1992-2#1)(2008-10#1)
prise en charge##4##3##(2013-1#4)
prism##9##1##(2007-11#1)(2008-10#1)(2008-3#3)(2008-9#1)(2013-8#3)
prisms after the##2##3##(2008-3#2)
prisms##8##1##(2008-3#7)(2013-8#1)
prison and##2##2##(2008-7#1)(2009-11#1)
prison##15##1##(1990-2#1)(1992-2#4)(1996-5#4)(2008-7#1)(2009-11#4)(2009-5#1)
prisoner's dilemma##5##2##(2008-8#5)
prisoner's##6##1##(1996-12#1)(2008-8#5)
prisoners##4##1##(2008-12#4)
prisons##3##1##(1992-2#2)(2010-5#1)
pristinamycin resistance##2##2##(2010-2#2)
pristinamycin##4##1##(2010-2#4)
privacy in##2##2##(1996-9#1)(1997-5#1)
privacy of##3##2##(1996-5#1)(1997-5#1)(2010-8#1)
privacy rule requirements##3##3##(2007-12#3)
privacy rule##6##2##(2007-12#6)
privacy##32##1##(1994-3#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-1#1)(1996-5#3)(1996-9#1)(1997-5#3)(2007-12#8)(2008-10#1)(2008-11#1)(2008-12#2)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-9#1)
private accreditation##2##2##(1995-3#2)
private and public health##2##4##(1997-3#1)(1997-4#1)
private and public##6##3##(1994-1#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-4#1)(2010-11#1)
private and##7##2##(1994-1#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-4#1)(2010-11#1)(2011-2#1)
private fees##5##2##(1994-1#5)
private health care providers##2##4##(1996-2#1)(1996-3#1)
private health care##3##3##(1990-6#1)(1996-2#1)(1996-3#1)
private health insurance##7##3##(1992-2#1)(1993-1#1)(1993-3#1)(1994-3#1)(1997-2#1)(1997-3#1)(2008-1#1)
private health##12##2##(1990-6#1)(1991-2#1)(1992-2#2)(1993-1#1)(1993-3#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-1#1)
private insurance coverage##3##3##(1991-12#1)(1992-2#1)(1994-3#1)
private insurance##10##2##(1991-12#1)(1992-2#2)(1994-1#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-2#1)
private insurers##3##2##(1993-1#1)(1994-1#1)(1994-2#1)
private laboratories##4##2##(1991-6#1)(1997-4#2)(1997-5#1)
private medical##4##2##(1992-3#1)(1996-1#1)(2012-2#1)(2013-7#1)
private or##2##2##(1992-3#1)(2008-11#1)
private physician##2##2##(1990-6#1)(1995-12#1)
private practice##8##2##(1993-2#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-1#1)
private psychiatric hospitals##3##3##(1992-1#1)(1992-2#1)(1993-2#1)
private psychiatric##5##2##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-2#1)
private sector employment##2##3##(1994-12#1)(1996-2#1)
private sector##18##2##(1991-1#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-5#5)(2008-1#1)(2012-2#1)(2012-3#1)
private supplementary##3##2##(1991-2#1)(1996-3#2)
private##136##1##(1990-6#3)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#7)(1992-3#4)(1993-1#3)(1993-2#4)(1993-3#2)(1994-1#10)(1994-12#4)(1994-2#2)(1994-3#3)(1995-12#3)(1995-3#5)(1996-1#2)(1996-12#4)(1996-2#5)(1996-3#9)(1997-2#3)(1997-3#7)(1997-4#5)(1997-5#9)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-8#2)(2009-10#1)(2009-11#2)(2009-4#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#2)
private-sector##3##1##(1996-2#2)(1997-3#1)
privately funded abortions at military facilities##2##6##(1996-5#2)
privately funded abortions at##3##4##(1995-6#1)(1996-5#2)
privately funded##4##2##(1995-6#1)(1996-5#2)(2013-1#1)
privately insured##4##2##(1997-3#3)(2012-2#1)
privately##8##1##(1995-6#1)(1996-5#2)(1997-3#3)(2012-2#1)(2013-1#1)
privatization of##2##2##(1993-2#1)(1997-1#1)
privatization##5##1##(1993-2#1)(1996-2#1)(1997-1#1)(2008-12#2)
privilege##7##1##(2008-11#1)(2008-12#1)(2010-1#5)
privileged##5##1##(2008-1#1)(2008-4#1)(2009-10#2)(2010-8#1)
privileges##7##1##(1991-12#1)(1993-1#1)(1993-3#2)(1994-1#1)(1996-9#1)(2013-8#1)
privileging##2##1##(1994-3#2)
prized##2##1##(2008-11#1)(2010-4#1)
prmt5##5##1##(2009-7#5)
pro##5##1##(1995-6#2)(1996-3#1)(2010-11#1)(2010-7#1)
pro- and anti-apoptotic##4##3##(2009-12#2)(2010-10#1)(2012-2#1)
pro- and##6##2##(2008-10#1)(2009-12#2)(2010-10#1)(2012-2#1)(2013-7#1)
pro-C3 and proalbumin##2##3##(1990-8#2)
pro-C3##4##1##(1990-8#4)
pro-EGF##3##1##(1990-12#3)
pro-Urokinase##2##1##(2008-7#2)
pro-active approach##2##2##(1991-1#1)(1994-1#1)
pro-active##5##1##(1991-1#1)(1994-1#1)(2008-11#3)
pro-angiogenic##2##1##(2013-1#2)
pro-apoptotic proteins##2##2##(2009-12#2)
pro-apoptotic##11##1##(1995-6#1)(2008-11#1)(2009-12#3)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-7#1)
pro-atherogenic##2##1##(2008-10#1)(2008-3#1)
pro-inflammatory cytokines##6##2##(2008-10#4)(2009-12#1)(2010-1#1)
pro-inflammatory mediators##2##2##(2008-11#1)(2012-2#1)
pro-inflammatory##20##1##(2008-10#9)(2008-11#1)(2008-3#2)(2009-12#2)(2009-7#1)(2010-1#2)(2012-2#3)
pro-opiomelanocortin (POMC)##2##2##(1995-12#1)(2009-8#1)
pro-opiomelanocortin##3##1##(1992-10#1)(1995-12#1)(2009-8#1)
pro-region##2##1##(1992-8#1)(1993-12#1)
pro-urokinase##3##1##(1990-8#3)
pro-vitamins##2##1##(2008-5#2)
proactive LVs##2##2##(2008-11#2)
proactive approach##2##2##(2008-10#1)(2008-11#1)
proactive in##2##2##(1995-12#1)(2013-8#1)
proactive##17##1##(1991-12#1)(1992-2#1)(1994-2#1)(1995-12#2)(1996-3#1)(2008-10#1)(2008-11#6)(2009-3#1)(2010-11#1)(2010-8#1)(2013-8#1)
proactively##4##1##(1991-12#1)(1992-1#1)(1993-1#1)(2010-10#1)
proalbumin associated with a second##2##5##(1993-2#2)
proalbumin##8##1##(1990-8#3)(1993-2#5)
proangiogenic##3##1##(2011-2#2)(2013-1#1)
proanthocyanidins (100 mg/kg/day##2##3##(2011-2#2)
proanthocyanidins can##2##2##(2011-2#2)
proanthocyanidins##8##1##(2011-2#8)
proapoptotic##4##1##(2008-11#1)(2009-4#1)(2010-1#1)(2012-2#1)
probabilistic description##2##2##(2008-7#2)
probabilistic neural##2##2##(2008-10#2)
probabilistic##15##1##(2008-10#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#3)(2009-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
probabilities and##5##2##(2008-8#3)(2008-9#1)(2012-3#1)
probabilities are##6##2##(1992-9#1)(1994-12#2)(2008-8#3)
probabilities for##4##2##(1992-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
probabilities of##9##2##(1995-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)
probabilities##46##1##(1992-9#3)(1994-12#2)(1995-2#1)(1997-2#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#15)(2008-9#3)(2009-10#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
probability and the##2##3##(2008-10#1)(2008-6#1)
probability and##4##2##(1992-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
probability density functions##3##3##(2008-10#2)(2008-3#1)
probability density##5##2##(2008-10#2)(2008-3#2)(2008-7#1)
probability distribution##4##2##(2008-10#4)
probability distributions for##2##3##(2008-10#2)
probability distributions##7##2##(2008-10#5)(2008-11#1)(2008-4#1)
probability equal to##2##3##(1995-9#1)(2013-8#1)
probability for##3##2##(2008-11#2)(2011-2#1)
probability is##2##2##(2008-10#1)(2011-2#1)
probability model##2##2##(2008-10#2)
probability models##3##2##(2010-10#3)
probability of ASD##2##3##(2012-3#2)
probability of a##10##3##(1990-6#1)(1993-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
probability of achieving##2##3##(2008-10#1)(2012-3#1)
probability of being##4##3##(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)
probability of death##2##3##(1995-2#1)(2008-11#1)
probability of detection##2##3##(2008-10#2)
probability of developing##4##3##(1992-9#2)(2012-3#1)(2013-8#1)
probability of divorce##2##3##(2011-2#2)
probability of each##2##3##(2009-10#1)(2010-11#1)
probability of entry##2##3##(2008-10#2)
probability of limb salvage##2##4##(2011-3#2)
probability of success##2##3##(2008-11#1)(2010-8#1)
probability of the##2##3##(2008-10#1)(2008-8#1)
probability of##107##2##(1990-11#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#1)(1992-2#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-2#1)(1997-8#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#7)(2008-8#9)(2008-9#4)(2009-10#4)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-2#5)(2011-3#4)(2012-3#10)(2013-1#1)(2013-8#1)
probability p of type I error##2##6##(2008-10#2)
probability sample of##4##3##(1996-2#1)(2008-12#1)(2011-2#1)(2012-12#1)
probability that the##2##3##(1990-5#1)(2008-9#1)
probability that##16##2##(1990-5#1)(1991-12#2)(1994-3#1)(1997-9#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2013-1#2)(2013-8#2)
probability to##2##2##(1990-11#1)(1990-12#1)
probability##208##1##(1990-11#2)(1990-12#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-8#1)(1991-12#4)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-9#2)(1996-2#2)(1997-3#1)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#61)(2008-11#8)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#16)(2008-9#5)(2009-10#5)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#11)(2011-3#5)(2012-12#1)(2012-3#10)(2013-1#3)(2013-8#5)
probable cause of##2##3##(2008-10#1)(2009-11#1)
probable cause##3##2##(1995-12#1)(2008-10#1)(2009-11#1)
probable or possible##2##3##(1996-11#1)(2008-7#1)
probable that##4##2##(1995-8#1)(2007-12#1)(2008-12#1)(2008-9#1)
probable##62##1##(1990-5#1)(1991-10#1)(1991-12#2)(1992-4#1)(1992-6#1)(1992-9#1)(1994-5#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-11#2)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#5)
probably a major##3##3##(2008-10#2)(2012-12#1)
probably a##8##2##(1995-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
probably accounts for the##2##4##(1991-8#1)(1993-6#1)
probably acts##2##2##(1990-5#1)(2008-7#1)
probably after##2##2##(2008-5#1)(2008-6#1)
probably also##8##2##(1991-11#1)(1992-6#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#1)
probably an##5##2##(1994-2#1)(1994-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
probably as a result of##5##5##(1997-5#1)(1997-7#1)(2008-10#2)(2012-5#1)
probably as a##6##3##(1990-2#1)(1997-5#1)(1997-7#1)(2008-10#2)(2012-5#1)
probably as##7##2##(1990-2#1)(1995-6#1)(1997-5#1)(1997-7#1)(2008-10#2)(2012-5#1)
probably associated with##2##3##(2008-3#1)(2008-8#1)
probably be##8##2##(1994-6#1)(1996-1#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2010-1#1)
probably because of##5##3##(2008-10#2)(2008-3#1)(2008-5#2)
probably because##8##2##(1994-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-10#1)
probably been##2##2##(1995-12#1)(2010-1#1)
probably by##3##2##(2008-10#2)(2008-7#1)
probably caused by##2##3##(1991-7#1)(2008-10#1)
probably contribute to the##2##4##(2008-10#1)(2008-11#1)
probably did not##2##3##(1990-7#1)(2008-10#1)
probably due to a##4##4##(1991-11#1)(1991-3#1)(1992-6#1)(2012-12#1)
probably due to enhanced##2##4##(1992-8#1)(2012-5#1)
probably due to the formation of##2##6##(2008-10#2)
probably due to the##8##4##(2008-10#5)(2008-11#1)(2010-5#2)
probably due to##31##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-6#1)(1992-8#1)(1996-2#1)(1996-6#2)(1997-2#1)(2006-6#1)(2008-10#11)(2008-11#2)(2008-7#1)(2009-5#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-5#1)
probably even##2##2##(2008-10#1)(2013-1#1)
probably had##3##2##(2008-10#3)
probably has##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
probably have##3##2##(1994-6#1)(2008-10#2)
probably in##4##2##(1992-9#1)(2008-10#1)(2008-12#1)(2010-1#1)
probably involved in the##2##4##(2008-11#1)(2009-8#1)
probably involved in##5##3##(2008-11#2)(2008-6#1)(2008-8#1)(2009-8#1)
probably involved##6##2##(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)
probably is##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
probably largely##2##2##(1991-12#1)(2008-7#1)
probably lead##2##2##(1996-3#1)(2008-11#1)
probably mediated by##3##3##(1994-11#1)(1996-2#1)(1997-2#1)
probably mediated##4##2##(1994-11#1)(1996-2#1)(1997-2#1)(2008-10#1)
probably not##8##2##(1992-12#2)(1994-5#1)(1994-8#1)(1997-6#1)(2008-10#3)
probably play a##2##3##(2008-12#1)(2008-7#1)
probably produce##2##2##(2007-12#1)(2010-5#1)
probably reflected##2##2##(2008-10#1)(2008-8#1)
probably related to the##5##4##(1991-11#1)(1997-2#1)(2008-12#1)(2009-8#1)(2011-2#1)
probably related to##8##3##(1991-11#1)(1996-2#1)(1997-2#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
probably responsible for the displacement of##2##6##(1997-1#1)(2008-10#1)
probably responsible for##3##3##(1997-1#1)(2008-10#2)
probably resulted##2##2##(2008-10#1)(2012-3#1)
probably resulting in##2##3##(2008-10#1)(2008-11#1)
probably the most widely used##2##5##(2008-4#1)(2008-9#1)
probably the most##8##3##(1993-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#1)(2013-1#1)
probably the##23##2##(1991-12#2)(1993-11#1)(1994-5#1)(1994-6#1)(1996-12#1)(2006-6#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#2)(2013-1#1)
probably through##5##2##(1991-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
probably was##2##2##(2008-10#2)
probably##295##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#5)(1991-12#6)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-6#3)(1992-8#1)(1992-9#3)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-6#3)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#3)(2007-12#2)(2008-10#83)(2008-11#14)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#11)(2008-6#5)(2008-7#9)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#5)(2009-5#1)(2009-8#3)(2010-1#3)(2010-12#1)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#4)(2012-5#2)(2013-1#5)
probands##2##1##(1997-8#1)(2008-9#1)
probe DNA##5##2##(1992-4#1)(2008-10#4)
probe RG57##6##2##(2008-10#6)
probe and by##2##3##(2008-10#2)
probe and target##2##3##(2008-10#2)
probe and the##3##3##(2008-10#2)(2008-3#1)
probe and##14##2##(1993-2#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-8#1)
probe angle##3##2##(1994-5#3)
probe are##2##2##(2008-10#2)
probe based on##2##3##(2008-10#1)(2008-11#1)
probe beam)##2##2##(2008-3#2)
probe containing##4##2##(1991-2#1)(1995-6#1)(1996-3#1)(2008-10#1)
probe demonstrated##2##2##(1991-5#1)(1995-11#1)
probe derived from##2##3##(2008-10#1)(2008-8#1)
probe for the##7##3##(1990-2#1)(1990-8#1)(1995-11#1)(2008-10#4)
probe for##30##2##(1990-2#2)(1990-8#1)(1993-2#1)(1994-8#2)(1995-11#2)(1996-5#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
probe in the##2##3##(1994-8#1)(2012-2#1)
probe in##6##2##(1990-5#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
probe indicated that##2##3##(1995-6#1)(2008-9#1)
probe into the##2##3##(2008-10#1)(2008-8#1)
probe is##8##2##(2008-10#5)(2008-11#1)(2008-9#1)(2013-1#1)
probe labeling##3##2##(2008-9#3)
probe laser beam##2##3##(2008-2#1)(2008-3#1)
probe laser##3##2##(2008-2#1)(2008-3#2)
probe may be##2##3##(2008-4#1)(2011-2#1)
probe modified CPE##2##3##(2008-10#2)
probe modified##3##2##(2008-10#2)(2009-3#1)
probe of the##2##3##(1991-6#1)(2008-3#1)
probe of##11##2##(1991-6#1)(1992-4#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-5#1)
probe on the##4##3##(1997-6#1)(2008-10#3)
probe on##5##2##(1997-6#1)(2008-10#3)(2008-9#1)
probe revealed##2##2##(1996-12#1)(2008-10#1)
probe sequences##3##2##(2008-10#2)(2012-3#1)
probe sets##5##2##(2012-3#5)
probe showed##2##2##(1993-8#1)(1997-2#1)
probe sonication##4##2##(2008-10#4)
probe specific for##2##3##(2008-10#2)
probe synthesis##2##2##(2008-9#2)
probe that##2##2##(1997-7#1)(2008-3#1)
probe the##15##2##(1990-8#1)(1991-3#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)
probe tip##3##2##(2007-12#1)(2008-3#2)
probe to determine##2##3##(2008-10#2)
probe to##12##2##(1992-12#1)(1993-2#1)(1996-6#1)(1997-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
probe volume##4##2##(2008-3#4)
probe was immobilized##2##3##(2008-10#1)(2008-12#1)
probe was performed##2##3##(2008-8#1)(2008-9#1)
probe was used to##3##4##(1996-12#1)(2008-10#1)(2009-3#1)
probe was##18##2##(1993-8#1)(1994-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-12#1)(2008-8#2)(2008-9#1)(2009-3#1)
probe were##4##2##(1996-2#1)(1997-6#2)(2008-10#1)
probe with##2##2##(2008-10#2)
probe##399##1##(1990-2#3)(1990-5#2)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#4)(1992-10#1)(1992-12#3)(1992-3#2)(1992-4#2)(1992-6#1)(1993-1#2)(1993-12#3)(1993-2#6)(1993-3#3)(1993-6#4)(1993-8#3)(1993-9#3)(1994-11#2)(1994-3#1)(1994-5#5)(1994-8#3)(1994-9#2)(1995-11#4)(1995-12#2)(1995-6#6)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#2)(2007-12#5)(2008-1#1)(2008-10#172)(2008-11#7)(2008-12#4)(2008-2#7)(2008-3#16)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#21)(2008-9#23)(2009-10#1)(2009-12#1)(2009-3#3)(2009-5#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#2)
probe)##3##1##(2008-10#3)
probe-enzyme combinations##2##2##(2008-10#2)
probed at##2##2##(2008-10#1)(2008-3#1)
probed by##3##2##(1990-12#1)(1992-4#1)(2008-10#1)
probed with a##2##3##(2008-10#1)(2008-4#1)
probed with the##3##3##(1991-6#1)(1993-6#1)(2008-10#1)
probed with##8##2##(1991-6#1)(1993-6#1)(2008-10#4)(2008-3#1)(2008-4#1)
probed##19##1##(1990-12#1)(1990-8#1)(1991-6#1)(1992-4#1)(1993-6#1)(2008-10#8)(2008-3#4)(2008-4#1)(2008-9#1)
probenecid-sensitive folate transporter##2##3##(1994-6#2)
probes and##13##2##(1991-6#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#3)(2012-3#1)
probes are##7##2##(1992-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#2)
probes at##3##2##(1997-8#1)(2008-10#2)
probes derived from##4##3##(1997-2#1)(2008-10#2)(2012-3#1)
probes designed to##2##3##(2008-10#1)(2008-4#1)
probes encapsulated by biologically localized embedding (PEBBLEs)##2##7##(2008-10#2)
probes for molecular##2##3##(1994-8#1)(2008-9#1)
probes for##16##2##(1990-12#1)(1992-6#1)(1994-8#2)(2008-10#6)(2008-4#1)(2008-9#4)(2012-3#1)
probes from##6##2##(1991-5#1)(1992-3#1)(2008-10#3)(2008-4#1)
probes generated from##2##3##(1992-6#1)(2008-10#1)
probes have##2##2##(2008-10#2)
probes hybridized##2##2##(1997-6#1)(2008-10#1)
probes in##9##2##(1990-2#1)(1993-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#2)(2012-3#1)(2013-8#1)
probes is also included##2##4##(2008-4#2)
probes is##3##2##(2008-10#1)(2008-4#2)
probes might##2##2##(1996-3#1)(2008-10#1)
probes of the##2##3##(1991-5#2)
probes of##8##2##(1991-3#1)(1991-5#2)(1996-3#1)(1996-6#2)(2008-9#1)(2009-6#1)
probes on a##2##3##(2008-12#1)(2010-9#1)
probes on##3##2##(1990-5#1)(2008-12#1)(2010-9#1)
probes such as##2##3##(2008-10#1)(2012-2#1)
probes that are##2##3##(2008-10#1)(2012-2#1)
probes that recognize##2##3##(1996-12#2)
probes that##7##2##(1996-12#2)(2008-10#4)(2012-2#1)
probes to detect##2##3##(1990-5#1)(1994-11#1)
probes to investigate the##2##4##(1993-2#1)(2008-10#1)
probes to##12##2##(1990-5#1)(1993-2#1)(1994-11#1)(2008-10#9)
probes used in##2##3##(2008-4#1)(2008-9#1)
probes were applied##2##3##(2008-10#2)
probes were tested##2##3##(2008-10#2)
probes were then used to analyze##2##6##(2008-10#2)
probes were used in##2##4##(2008-10#2)
probes were used to##2##4##(2008-10#2)
probes were used##5##3##(2008-10#5)
probes were##20##2##(1992-6#1)(2008-10#18)(2010-4#1)
probes which##2##2##(2008-10#1)(2008-9#1)
probes with##3##2##(2008-10#1)(2008-12#1)(2009-7#1)
probes##238##1##(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#4)(1993-1#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-12#4)(1996-3#2)(1996-6#3)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2008-10#107)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#1)(2008-4#19)(2008-7#1)(2008-8#7)(2008-9#28)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-9#1)(2012-2#3)(2012-3#4)(2013-8#3)
probing depth##3##2##(2008-12#1)(2013-1#2)
probing of##6##2##(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
probing the##5##2##(1990-3#1)(1990-8#1)(1994-5#1)(1994-8#1)(2008-6#1)
probing##31##1##(1990-3#1)(1990-8#1)(1991-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-8#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-8#1)(2009-6#1)(2013-1#4)(2013-8#1)
probiotic E##2##2##(2011-2#2)
probiotic bacteria##3##2##(2010-10#1)(2013-1#2)
probiotic effects##2##2##(2010-10#1)(2011-2#1)
probiotic microorganisms##3##2##(2009-11#3)
probiotic strains##2##2##(2009-12#1)(2011-2#1)
probiotic##32##1##(2008-12#1)(2009-11#8)(2009-12#2)(2010-10#5)(2011-2#9)(2012-2#1)(2013-1#6)
probiotics and##2##2##(2008-10#1)(2010-12#1)
probiotics are##2##2##(2009-12#1)(2010-10#1)
probiotics for##2##2##(2011-2#1)(2013-1#1)
probiotics have##2##2##(2011-2#1)(2013-7#1)
probiotics is##3##2##(2011-2#2)(2013-7#1)
probiotics##38##1##(2008-10#6)(2009-11#1)(2009-12#2)(2010-10#3)(2010-12#2)(2011-2#12)(2012-2#2)(2013-1#3)(2013-7#7)
probit model##3##2##(2008-10#1)(2009-4#1)(2011-2#1)
probit##7##1##(2008-10#1)(2008-12#1)(2009-4#4)(2011-2#1)
problem among##2##2##(2010-11#1)(2013-1#1)
problem and a##2##3##(1995-9#1)(2008-11#1)
problem and##14##2##(1992-12#1)(1994-12#1)(1995-1#1)(1995-9#1)(2008-10#3)(2008-11#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
problem are##4##2##(2007-11#1)(2008-11#1)(2010-11#1)(2011-2#1)
problem as##2##2##(1995-5#1)(2008-10#1)
problem associated with##3##3##(2008-10#2)(2008-11#1)
problem at the##2##3##(2006-6#1)(2008-12#1)
problem at##3##2##(2006-6#1)(2008-12#1)(2009-4#1)
problem based learning##5##3##(2008-11#3)(2008-12#2)
problem based##8##2##(2008-11#5)(2008-12#3)
problem behavior##3##2##(2008-12#3)
problem behaviors were##3##3##(2008-12#2)(2008-9#1)
problem behaviors##5##2##(2008-12#4)(2008-9#1)
problem by solving##2##3##(2010-10#1)(2010-7#1)
problem by##6##2##(1992-9#1)(2008-10#2)(2010-10#1)(2010-7#1)(2011-2#1)
problem can be solved##2##4##(2008-3#1)(2009-12#1)
problem can be##3##3##(2008-3#1)(2009-12#1)(2011-2#1)
problem drinkers##2##2##(1995-5#1)(2013-8#1)
problem for many##2##3##(1997-4#1)(2008-11#1)
problem for the##5##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
problem for##23##2##(1991-12#1)(1991-2#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
problem from##2##2##(2008-10#2)
problem gambling##2##2##(2008-11#2)
problem has been##2##3##(1997-4#1)(2008-9#1)
problem has##4##2##(1995-5#1)(1997-4#1)(2008-9#1)(2013-1#1)
problem have##2##2##(1994-6#1)(2010-1#1)
problem identification##2##2##(1993-1#1)(2008-12#1)
problem in analytical chemistry##3##4##(2008-10#3)
problem in children##2##3##(1996-8#1)(2008-10#1)
problem in many##2##3##(1991-6#1)(2008-11#1)
problem in the United States##2##5##(2008-11#1)(2013-8#1)
problem in the treatment of##2##5##(1991-9#1)(2013-8#1)
problem in the##17##3##(1991-3#1)(1991-9#1)(1995-5#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
problem in##54##2##(1990-6#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-2#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#3)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
problem is presented##2##3##(2008-10#1)(2008-3#1)
problem is that##2##3##(1996-2#1)(2008-8#1)
problem is the##4##3##(1997-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
problem is##25##2##(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#1)
problem may##2##2##(2011-1#1)(2011-2#1)
problem of computing the##2##4##(2008-3#1)(2011-3#1)
problem of how to##2##4##(1994-2#1)(2008-12#1)
problem of multivariate classification##2##4##(2008-10#2)
problem of the##11##3##(1990-12#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2012-12#1)
problem of##90##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-9#1)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-6#1)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
problem on##2##2##(2008-10#2)
problem pre-definition##2##2##(2008-12#2)
problem should##3##2##(1997-8#1)(2007-12#1)(2011-2#1)
problem solve##2##2##(2008-11#1)(2010-11#1)
problem solving and##2##3##(2008-11#1)(2010-10#1)
problem solving##14##2##(1991-2#1)(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
problem that can##2##3##(2008-10#1)(2009-5#1)
problem that is##3##3##(1997-3#1)(2009-12#1)(2011-2#1)
problem that##12##2##(1990-11#1)(1993-12#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-2#1)
problem to be##3##3##(1990-2#1)(1991-2#1)(1997-5#1)
problem to##8##2##(1990-12#1)(1990-2#1)(1991-2#1)(1997-5#1)(2008-10#1)(2008-7#2)(2009-12#1)
problem using##2##2##(2008-11#1)(2008-8#1)
problem was to##2##3##(2008-10#2)
problem was##8##2##(1992-3#1)(2008-10#7)
problem which##2##2##(1991-9#1)(2008-7#1)
problem with the##2##3##(2008-10#1)(2013-1#1)
problem with##13##2##(1995-12#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#3)
problem##481##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-6#3)(1991-9#3)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#2)(1995-9#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#5)(1997-2#1)(1997-3#5)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#80)(2008-11#43)(2008-12#23)(2008-2#3)(2008-3#15)(2008-4#3)(2008-5#5)(2008-6#8)(2008-7#8)(2008-8#7)(2008-9#11)(2009-10#5)(2009-12#4)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#6)(2010-10#4)(2010-11#9)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#5)(2011-2#31)(2011-3#2)(2012-12#14)(2012-2#11)(2012-3#8)(2013-1#15)(2013-8#13)
problem&quot##3##1##(1993-1#1)(1994-12#1)(2008-9#1)
problem-based learning (PBL) in##2##4##(2008-12#2)
problem-based learning (PBL)##6##3##(2008-10#1)(2008-11#1)(2008-12#3)(2013-8#1)
problem-based learning curriculum##2##3##(2008-10#1)(2011-1#1)
problem-based learning in a##2##4##(2008-11#1)(2008-12#1)
problem-based learning is##2##3##(1995-2#2)
problem-based learning##20##2##(1995-2#3)(2008-10#2)(2008-11#7)(2008-12#5)(2011-1#1)(2013-8#2)
problem-based##22##1##(1995-2#3)(2008-10#2)(2008-11#8)(2008-12#6)(2011-1#1)(2013-8#2)
problem-focused coping strategies##3##3##(1991-1#1)(2008-1#1)(2008-11#1)
problem-focused##4##1##(1991-1#2)(2008-1#1)(2008-11#1)
problem-solving approach to##2##3##(1993-2#1)(2010-10#1)
problem-solving approach##4##2##(1993-2#2)(2010-10#2)
problem-solving skills and##2##3##(2008-12#1)(2009-10#1)
problem-solving skills##5##2##(2008-12#1)(2009-10#4)
problem-solving##26##1##(1992-5#1)(1993-2#4)(1994-1#1)(1994-3#2)(1995-2#1)(1996-2#2)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2009-10#4)(2009-7#1)(2010-10#2)(2013-1#1)
problem?##5##1##(1991-3#1)(1992-12#1)(1994-2#1)(2008-10#1)(2012-12#1)
problem]##4##1##(1991-5#1)(1992-2#1)(1994-6#1)(2013-1#1)
problematic alcohol use##2##3##(2008-11#1)(2010-7#1)
problematic area##2##2##(2008-10#1)(2011-2#1)
problematic in##4##2##(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#1)
problematic##33##1##(1992-12#1)(1993-6#1)(1994-6#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-12#2)(2009-3#1)(2010-10#1)(2010-7#1)(2011-2#4)(2011-3#1)(2013-1#2)
problematic)##2##1##(2012-2#2)
problematical##2##1##(2008-10#1)(2008-5#1)
problems among##4##2##(1994-12#1)(1996-1#1)(2008-11#2)
problems and new##2##3##(1995-1#1)(2008-10#1)
problems and prospects##2##3##(1992-3#1)(2009-10#1)
problems and solutions##3##3##(1991-12#1)(1992-2#2)
problems and the##2##3##(1993-2#1)(1997-1#1)
problems and##47##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#3)(1995-1#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(2008-10#4)(2008-11#4)(2008-9#4)(2009-10#2)(2009-12#1)(2010-9#1)(2011-2#4)(2012-12#2)(2013-8#2)
problems are discussed##2##3##(1997-4#1)(2008-9#1)
problems are##21##2##(1990-2#2)(1991-12#1)(1994-5#1)(1994-6#1)(1995-9#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2012-2#1)
problems arise##3##2##(2008-7#1)(2010-10#1)(2010-11#1)
problems arising##2##2##(2008-10#2)
problems associated with the##5##4##(1996-9#1)(2008-10#1)(2008-11#1)(2009-9#1)(2013-1#1)
problems associated with their##2##4##(2011-2#1)(2011-3#1)
problems associated with##21##3##(1991-3#2)(1993-1#1)(1993-11#1)(1996-12#1)(1996-9#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
problems at the##3##3##(1997-2#1)(2008-12#1)(2011-1#1)
problems by##3##2##(1991-3#1)(2008-10#1)(2009-12#1)
problems can be avoided##2##4##(1993-2#1)(2008-7#1)
problems can be##6##3##(1993-2#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
problems can##7##2##(1993-2#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#1)
problems caused by##2##3##(1991-1#1)(2009-3#1)
problems concerning##2##2##(1997-7#1)(2008-10#1)
problems connected to##2##3##(1994-6#1)(2008-11#1)
problems connected##3##2##(1994-6#1)(2008-10#1)(2008-11#1)
problems currently##2##2##(1995-12#1)(2008-7#1)
problems due to the##3##4##(2008-10#2)(2012-3#1)
problems due to##5##3##(1995-12#1)(2008-10#2)(2008-11#1)(2012-3#1)
problems during##2##2##(1990-3#1)(2011-2#1)
problems encountered in the##2##4##(2008-10#1)(2008-2#1)
problems encountered##7##2##(1990-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#1)
problems experienced by patients in the postoperative period##2##8##(2010-10#2)
problems experienced##3##2##(2008-11#1)(2010-10#2)
problems faced by##4##3##(1993-12#1)(2008-11#1)(2010-1#1)(2013-8#1)
problems facing##5##2##(1991-2#2)(1992-2#1)(2008-3#1)(2010-7#1)
problems for##8##2##(1993-6#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)
problems have been##2##3##(2008-10#1)(2008-11#1)
problems in analytical chemistry##3##4##(2008-10#3)
problems in children with##2##4##(1992-2#1)(2011-1#1)
problems in children##5##3##(1992-2#1)(1995-3#1)(1996-1#1)(2008-11#1)(2011-1#1)
problems in clinical##2##3##(2008-12#1)(2010-11#1)
problems in defining##2##3##(1996-1#1)(2008-10#1)
problems in modern##2##3##(2010-7#1)(2013-8#1)
problems in patients##3##3##(2008-7#2)(2009-11#1)
problems in primary##2##3##(1997-5#1)(2008-10#1)
problems in the##12##3##(1993-1#1)(1993-3#1)(1993-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2009-12#1)(2010-12#1)(2013-1#1)
problems in##71##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-1#2)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-6#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#4)(2013-8#1)
problems inherent##2##2##(1993-3#1)(2008-10#1)
problems involved in##3##3##(1994-8#1)(1997-2#1)(2008-12#1)
problems involving the##2##3##(1990-3#1)(2008-1#1)
problems is##3##2##(1992-1#1)(1993-12#1)(1997-3#1)
problems may##3##2##(1992-2#1)(1993-12#1)(1993-6#1)
problems now##2##2##(1992-2#1)(1993-3#1)
problems of the##4##3##(1990-5#1)(1991-3#1)(1994-2#1)(1995-3#1)
problems of##47##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-3#1)(2007-8#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-5#1)(2010-9#1)(2012-3#2)
problems or##5##2##(2008-11#1)(2008-4#1)(2009-7#1)(2013-1#2)
problems presented##2##2##(1992-12#1)(2010-11#1)
problems provides##2##2##(1994-2#1)(2008-7#1)
problems regarding##2##2##(1997-8#2)
problems related to##5##3##(1991-3#1)(1996-12#1)(2008-10#2)(2010-5#1)
problems related with##2##3##(2008-10#2)
problems related##7##2##(1991-3#1)(1996-12#1)(2008-10#4)(2010-5#1)
problems relating to the##2##4##(1992-5#1)(1993-6#1)
problems remain##2##2##(2008-11#2)
problems such as##2##3##(1996-11#1)(2011-7#1)
problems than##4##2##(1992-1#1)(1994-3#1)(1996-6#1)(2008-7#1)
problems that are##2##3##(2008-4#1)(2012-3#1)
problems that##14##2##(1990-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
problems they##2##2##(2008-4#1)(2010-10#1)
problems to##5##2##(1991-2#1)(1991-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
problems unique to##2##3##(1992-2#1)(2013-1#1)
problems was##3##2##(1996-6#1)(2010-7#1)(2013-1#1)
problems were##15##2##(1990-2#1)(1991-2#1)(1994-3#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#2)
problems when##2##2##(1996-6#1)(2008-10#1)
problems with the##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)
problems with##28##2##(1990-11#2)(1991-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-9#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-3#1)(2010-7#2)(2012-12#1)
problems##645##1##(1990-11#6)(1990-12#3)(1990-2#7)(1990-3#3)(1990-5#1)(1990-6#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#8)(1991-3#8)(1991-6#2)(1992-1#8)(1992-11#1)(1992-12#1)(1992-2#9)(1992-3#8)(1992-5#3)(1993-1#6)(1993-11#1)(1993-12#7)(1993-2#6)(1993-3#6)(1993-5#1)(1993-6#4)(1993-9#1)(1994-1#4)(1994-12#3)(1994-2#6)(1994-3#5)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#1)(1995-9#4)(1996-1#7)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#5)(1996-6#3)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#4)(1997-5#5)(1997-6#1)(1997-7#3)(1997-8#8)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#80)(2008-11#64)(2008-12#21)(2008-2#1)(2008-3#12)(2008-4#9)(2008-5#10)(2008-6#4)(2008-7#21)(2008-8#7)(2008-9#15)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#10)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#7)(2009-9#3)(2010-1#3)(2010-10#6)(2010-11#13)(2010-12#2)(2010-5#4)(2010-6#1)(2010-7#9)(2010-8#1)(2010-9#6)(2011-1#6)(2011-2#21)(2011-3#3)(2011-7#1)(2012-12#3)(2012-2#8)(2012-3#9)(2013-1#26)(2013-8#7)
problems)##4##1##(1993-11#1)(2008-11#1)(2008-7#1)(2009-11#1)
problems]##8##1##(1990-12#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-9#1)(1997-5#1)(1997-8#1)(2012-3#1)
probucol##2##1##(1991-5#1)(2008-11#1)
procaine hydrochloride##10##2##(2008-10#10)
procaine##15##1##(1990-2#1)(2008-10#14)
procalcitonin##4##1##(2008-5#3)(2011-2#1)
procathepsin L##9##2##(1995-6#9)
procedural and sensory information##2##4##(1995-1#2)
procedural and##3##2##(1995-1#2)(2008-10#1)
procedural pain##3##2##(1993-2#1)(2009-12#2)
procedural parameters##2##2##(2008-10#1)(2009-5#1)
procedural success rates##2##3##(2008-11#1)(2008-12#1)
procedural##21##1##(1992-9#1)(1993-2#1)(1995-1#2)(1996-1#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#3)(2009-12#2)(2009-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
procedure DROPCORA##2##2##(2008-10#2)
procedure Part##3##2##(2008-10#3)
procedure a##2##2##(2008-10#2)
procedure agree##2##2##(2008-10#2)
procedure aimed at##2##3##(2008-4#1)(2009-8#1)
procedure allowed##3##2##(2008-10#3)
procedure allows determination of##2##4##(2008-10#2)
procedure allows the##6##3##(2008-10#6)
procedure allows##11##2##(2008-10#11)
procedure and an##2##3##(2008-10#1)(2008-6#1)
procedure and the##12##3##(2008-10#8)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
procedure and##45##2##(1990-11#1)(1991-8#1)(1992-12#1)(1993-1#1)(1995-9#1)(1996-9#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#2)
procedure applied##2##2##(2008-10#2)
procedure are##9##2##(1991-3#1)(1994-9#1)(1997-5#1)(2008-10#4)(2008-5#1)(2008-6#1)
procedure as an alternative to##2##5##(1990-9#1)(2008-11#1)
procedure as##4##2##(1990-9#1)(2008-10#1)(2008-11#1)(2010-11#1)
procedure at the##3##3##(2008-10#2)(2008-11#1)
procedure at##5##2##(2008-10#4)(2008-11#1)
procedure based on the##5##4##(1990-12#1)(2008-10#3)(2008-3#1)
procedure based on##18##3##(1990-12#1)(2008-10#14)(2008-3#2)(2012-2#1)
procedure before##2##2##(1993-3#1)(2008-10#1)
procedure by the##2##3##(2008-10#1)(2008-12#1)
procedure by##6##2##(1994-8#1)(2008-10#4)(2008-12#1)
procedure can be##10##3##(1994-8#2)(1995-1#1)(2006-6#1)(2008-10#4)(2008-3#1)(2010-5#1)
procedure can##13##2##(1994-8#2)(1995-1#1)(2006-6#1)(2008-10#7)(2008-3#1)(2010-5#1)
procedure combined##2##2##(2008-10#2)
procedure consists in the##2##4##(1991-11#1)(2008-10#1)
procedure consists of##4##3##(2008-10#3)(2008-3#1)
procedure consists##6##2##(1991-11#1)(2008-10#4)(2008-3#1)
procedure could also be used##2##5##(2008-10#1)(2008-11#1)
procedure could also be##3##4##(2008-10#2)(2008-11#1)
procedure could be##2##3##(1996-9#1)(2008-10#1)
procedure could##5##2##(1996-9#1)(2008-10#3)(2008-11#1)
procedure described##2##2##(2008-10#2)
procedure developed##10##2##(2008-10#9)(2008-9#1)
procedure due to##2##3##(2008-10#1)(2008-7#1)
procedure followed by##2##3##(2008-10#1)(2011-1#1)
procedure for a##5##3##(2008-10#3)(2008-11#2)
procedure for analysis of##2##4##(2008-10#2)
procedure for arsenic##3##3##(2008-10#3)
procedure for casting a solid##2##5##(2008-5#2)
procedure for determination of##6##4##(2008-10#5)(2008-2#1)
procedure for determining##3##3##(2008-10#3)
procedure for handling and##2##4##(2008-10#1)(2008-4#1)
procedure for iron##2##3##(2008-10#2)
procedure for lead determination##3##4##(2008-10#3)
procedure for lead##4##3##(2008-10#4)
procedure for measuring the##2##4##(2008-10#2)
procedure for organotin##2##3##(2008-10#2)
procedure for separation##2##3##(2008-10#2)
procedure for simultaneous##2##3##(2008-10#2)
procedure for solid phase microextraction-gas chromatographic##2##6##(2008-10#2)
procedure for spectrophotometric determination of##3##5##(2008-10#3)
procedure for the analysis of polycyclic aromatic hydrocarbons (PAHs)##2##9##(2008-10#2)
procedure for the analysis of##3##5##(2008-10#3)
procedure for the determination of the##2##6##(2008-10#2)
procedure for the determination of trace levels of##2##8##(2008-10#2)
procedure for the determination of trace##4##6##(2008-10#4)
procedure for the determination of##33##5##(1990-12#2)(2008-10#31)
procedure for the isolation##2##4##(2008-11#2)
procedure for the simultaneous determination of##4##6##(2008-10#4)
procedure for the simultaneous##5##4##(2008-10#5)
procedure for the speciation of antimony##2##6##(2008-10#2)
procedure for the spectrophotometric determination of##2##6##(2008-10#2)
procedure for the synthesis of##2##5##(2008-12#1)(2008-5#1)
procedure for the##78##3##(1990-12#2)(1995-9#1)(2008-10#60)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
procedure for##211##2##(1990-12#3)(1992-12#1)(1992-5#2)(1992-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-2#1)(2008-10#146)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#7)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#3)(2013-1#4)
procedure had##3##2##(2008-10#2)(2008-6#1)
procedure has a##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
procedure has been developed for the##3##6##(2008-10#3)
procedure has been developed for##9##5##(2008-10#9)
procedure has been performed##2##4##(2008-4#1)(2009-9#1)
procedure has been successfully##4##4##(2008-10#4)
procedure has been##33##3##(1993-12#1)(2008-10#28)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)
procedure has to be##2##4##(2008-10#1)(2008-11#1)
procedure has##42##2##(1991-12#1)(1993-12#2)(1994-12#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-9#1)
procedure have been##2##3##(2008-10#2)
procedure in a##2##3##(1995-1#1)(2008-10#1)
procedure in preteen and teen patients with brachial plexus birth palsy##2##11##(2013-1#2)
procedure in terms of##2##4##(2008-10#1)(2008-4#1)
procedure in the##6##3##(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
procedure in##31##2##(1995-1#1)(1997-3#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-3#1)(2011-2#3)(2012-3#4)(2013-1#4)
procedure includes##3##2##(2008-10#2)(2008-7#1)
procedure involved the##2##3##(2008-10#2)
procedure involved##5##2##(2008-10#4)(2008-8#1)
procedure involves the##3##3##(1990-12#1)(2008-10#1)(2013-1#1)
procedure involves##6##2##(1990-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
procedure involving the##3##3##(2008-10#3)
procedure involving##10##2##(1994-8#1)(1996-5#1)(2008-10#8)
procedure is a##2##3##(1990-11#1)(2008-11#1)
procedure is based on the##12##5##(2008-10#12)
procedure is based on##14##4##(2008-10#14)
procedure is demonstrated##2##3##(2008-10#2)
procedure is described for the determination of##3##7##(2008-10#3)
procedure is described for the##4##5##(2008-10#4)
procedure is described for##7##4##(2008-10#4)(2008-4#3)
procedure is described##12##3##(1994-5#1)(2008-10#7)(2008-4#3)(2011-2#1)
procedure is developed for##2##4##(2008-10#2)
procedure is developed##3##3##(2008-10#2)(2008-3#1)
procedure is not affected by##2##5##(2008-10#2)
procedure is not##5##3##(2008-10#4)(2011-1#1)
procedure is performed##2##3##(1996-3#1)(2008-10#1)
procedure is presented for the##2##5##(2008-10#2)
procedure is presented for##3##4##(2008-10#2)(2008-4#1)
procedure is presented##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)
procedure is proposed for the##5##5##(2008-10#5)
procedure is proposed for##8##4##(2008-10#7)(2010-11#1)
procedure is proposed##10##3##(2008-10#9)(2010-11#1)
procedure is rapid##2##3##(2008-10#1)(2008-9#1)
procedure is shown##2##3##(2008-2#1)(2010-7#1)
procedure is the##3##3##(2008-10#1)(2008-11#2)
procedure is used##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
procedure is##114##2##(1990-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-10#67)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#9)(2008-5#1)(2008-9#4)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)
procedure may be##2##3##(1997-8#1)(2011-2#1)
procedure may##4##2##(1997-8#1)(2008-5#1)(2009-8#1)(2011-2#1)
procedure of the##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2010-8#1)
procedure of##25##2##(1996-5#1)(1996-8#1)(2008-10#15)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
procedure offers high selectivity##2##4##(2008-10#2)
procedure offers##4##2##(2008-10#4)
procedure on##4##2##(2008-10#3)(2012-2#1)
procedure or##3##2##(1993-9#1)(2008-1#1)(2008-11#1)
procedure permits##2##2##(2008-10#2)
procedure presents##2##2##(2008-10#1)(2008-4#1)
procedure previously reported##2##3##(2008-10#2)
procedure prior to##2##3##(2012-12#1)(2012-3#1)
procedure proposed##6##2##(2008-10#6)
procedure provided##4##2##(2008-10#4)
procedure provides a##4##3##(2008-10#2)(2008-5#2)
procedure provides##5##2##(2008-10#3)(2008-5#2)
procedure reduces##2##2##(2008-10#1)(2011-2#1)
procedure requires##2##2##(2008-10#1)(2008-9#1)
procedure resulted in##3##3##(1991-2#1)(1995-11#1)(2008-10#1)
procedure should be##3##3##(1990-5#1)(1994-3#1)(2008-9#1)
procedure should##4##2##(1990-5#1)(1994-3#1)(2008-11#1)(2008-9#1)
procedure shows##3##2##(1991-2#1)(2008-10#2)
procedure similar to##3##3##(2008-10#2)(2008-5#1)
procedure such as##2##3##(1990-11#1)(2008-10#1)
procedure than##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
procedure that allows##2##3##(2008-10#1)(2011-2#1)
procedure that can be##2##4##(2008-9#1)(2011-2#1)
procedure that##14##2##(1993-11#1)(1996-2#1)(2008-10#6)(2008-9#2)(2010-7#1)(2011-2#3)
procedure the##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
procedure through##2##2##(1992-9#1)(2008-10#1)
procedure to be##2##3##(1993-6#1)(2008-10#1)
procedure to the##4##3##(2008-10#3)(2012-12#1)
procedure to##34##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-6#2)(1994-8#1)(1997-2#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
procedure until##2##2##(2008-10#1)(2012-2#1)
procedure used in this##2##4##(1996-8#1)(2008-10#1)
procedure used##8##2##(1992-6#1)(1996-5#1)(1996-8#1)(2008-10#4)(2008-11#1)
procedure using the##3##3##(2008-10#2)(2008-9#1)
procedure using##10##2##(2008-10#8)(2008-11#1)(2008-9#1)
procedure volume##3##2##(1991-2#1)(1991-3#1)(1994-1#1)
procedure was achieved##2##3##(2008-10#2)
procedure was also##3##3##(2008-10#3)
procedure was applied for copper determination##2##6##(2008-10#2)
procedure was applied for the determination of##2##7##(2008-10#2)
procedure was applied for##5##4##(2008-10#5)
procedure was applied successfully##3##4##(2008-10#3)
procedure was applied to determination of##2##6##(2008-10#2)
procedure was applied to the analysis of##4##7##(2008-10#4)
procedure was applied to the determination of##5##7##(2008-10#5)
procedure was applied to the speciation of##2##7##(2008-10#2)
procedure was applied to the##12##5##(2008-10#12)
procedure was applied to##26##4##(1996-12#1)(2008-10#25)
procedure was applied##35##3##(1996-12#1)(2008-10#34)
procedure was based on the##5##5##(2008-10#5)
procedure was based on##7##4##(1995-12#1)(2008-10#6)
procedure was carried out##4##4##(1991-8#1)(2008-10#2)(2008-11#1)
procedure was checked by the##2##5##(2008-10#2)
procedure was checked by##3##4##(2008-10#3)
procedure was checked##5##3##(2008-10#5)
procedure was confirmed by##3##4##(2008-10#3)
procedure was developed for simultaneous determination of##2##7##(2008-10#2)
procedure was developed for the determination of##3##7##(2008-10#3)
procedure was developed for the##6##5##(2008-10#6)
procedure was developed for##11##4##(1995-12#1)(2008-10#10)
procedure was developed in##2##4##(2008-10#2)
procedure was developed to##2##4##(2008-10#1)(2008-6#1)
procedure was developed##20##3##(1995-12#1)(2008-10#18)(2008-6#1)
procedure was evaluated by##3##4##(2008-10#3)
procedure was evaluated##4##3##(2008-10#4)
procedure was not##2##3##(2008-10#1)(2008-7#1)
procedure was optimized by##2##4##(2008-10#2)
procedure was optimized##4##3##(2008-10#4)
procedure was performed##6##3##(1991-2#1)(1995-12#1)(2007-12#1)(2008-10#3)
procedure was repeated##3##3##(1990-8#1)(1997-6#1)(2011-3#1)
procedure was successfully applied for the determination of##2##8##(2008-10#2)
procedure was successfully applied for the##3##6##(2008-10#3)
procedure was successfully applied to the determination of##5##8##(2008-10#5)
procedure was successfully applied to the extraction and determination of##2##10##(2008-10#2)
procedure was successfully applied to the##8##6##(2008-10#8)
procedure was successfully applied to##9##5##(2008-10#9)
procedure was successfully applied##12##4##(2008-10#12)
procedure was tested##5##3##(2008-10#5)
procedure was then##2##3##(2008-10#1)(2008-7#1)
procedure was used for##3##4##(2008-10#3)
procedure was used to##4##4##(2008-10#3)(2008-9#1)
procedure was used##9##3##(2008-10#8)(2008-9#1)
procedure was##167##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-12#1)(1994-2#1)(1995-12#4)(1996-12#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#139)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#2)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#1)
procedure were evaluated##2##3##(2008-10#2)
procedure were in good agreement with those obtained by##2##9##(2008-10#2)
procedure were in##4##3##(2008-10#4)
procedure were studied##2##3##(2008-10#2)
procedure were##23##2##(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#17)(2010-7#1)(2011-2#2)
procedure which is##2##3##(2008-12#1)(2012-3#1)
procedure which##7##2##(2008-10#3)(2008-12#1)(2011-2#1)(2012-3#2)
procedure with a##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
procedure with ethyl##2##3##(2008-10#2)
procedure with##18##2##(1991-3#1)(1993-3#1)(2008-10#12)(2008-7#1)(2008-9#1)(2012-3#2)
procedure without##3##2##(2008-10#3)
procedure yielded##2##2##(1993-8#1)(2008-10#1)
procedure##1415##1##(1990-11#6)(1990-12#5)(1990-2#2)(1990-5#2)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#7)(1991-5#2)(1991-8#2)(1992-1#2)(1992-12#9)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#9)(1995-2#3)(1995-3#1)(1995-8#3)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#6)(1996-5#5)(1996-6#2)(1996-8#2)(1996-9#5)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#7)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#877)(2008-11#45)(2008-12#11)(2008-2#9)(2008-3#21)(2008-4#26)(2008-5#17)(2008-6#6)(2008-7#19)(2008-8#8)(2008-9#28)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#10)(2010-8#1)(2011-1#3)(2011-2#49)(2011-3#5)(2012-12#12)(2012-2#22)(2012-3#15)(2013-1#27)(2013-8#2)
procedure)##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
procedure-related pain in##2##3##(2008-11#2)
procedure-related stress##2##2##(1994-12#2)
procedure-related##5##1##(1994-12#2)(2008-11#2)(2013-1#1)
procedure?##4##1##(2008-11#3)(2009-4#1)
procedures (e##2##2##(2008-10#1)(2011-2#1)
procedures also##2##2##(2008-10#2)
procedures and an##2##3##(1997-5#1)(2008-7#1)
procedures and in##2##3##(2008-10#1)(2011-2#1)
procedures and remarkable stability in##2##5##(2008-10#2)
procedures and their##3##3##(1994-3#1)(2012-2#2)
procedures and##45##2##(1992-2#2)(1993-3#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-5#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#4)(2013-1#1)
procedures are also##2##3##(2008-2#1)(2008-4#1)
procedures are currently##2##3##(2008-10#1)(2009-9#1)
procedures are described##6##3##(2008-10#1)(2008-4#3)(2008-9#1)(2010-6#1)
procedures are discussed##2##3##(2008-10#1)(2008-4#1)
procedures are provided##2##3##(2008-4#1)(2008-9#1)
procedures are time consuming##2##4##(2008-10#2)
procedures are##43##2##(1990-3#1)(1990-9#1)(1993-6#1)(1997-6#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#8)(2008-9#4)(2009-12#1)(2009-9#1)(2010-6#1)(2011-2#3)(2013-1#2)
procedures as##3##2##(1991-3#1)(2008-11#1)(2013-1#1)
procedures based on##4##3##(1994-9#1)(2008-10#3)
procedures can also be##2##4##(2008-4#1)(2012-3#1)
procedures can be##3##3##(1993-3#1)(1996-2#1)(2008-10#1)
procedures can##6##2##(1993-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
procedures developed for##3##3##(2008-10#2)(2008-11#1)
procedures developed##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
procedures do##2##2##(2008-10#1)(2008-11#1)
procedures for a##2##3##(1992-9#1)(2008-10#1)
procedures for simultaneous##2##3##(2008-10#2)
procedures for the determination of##6##5##(2008-10#6)
procedures for the preparation of##2##5##(2008-4#1)(2008-9#1)
procedures for the preparation##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
procedures for the##20##3##(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#4)(2008-9#2)(2010-8#1)(2012-3#1)
procedures for which##2##3##(1995-2#1)(1996-9#1)
procedures for##88##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-9#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(2008-10#40)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#12)(2008-9#10)(2009-4#1)(2010-11#1)(2010-3#1)(2010-7#2)(2010-8#1)(2012-3#3)
procedures has##2##2##(2008-10#1)(2011-2#1)
procedures have been applied to the##2##6##(2008-10#2)
procedures have been applied##3##4##(2008-10#3)
procedures have been developed##2##4##(1994-12#1)(2010-1#1)
procedures have been used##2##4##(2008-10#1)(2008-4#1)
procedures have been##14##3##(1994-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2010-1#2)(2010-7#1)(2011-7#1)
procedures have##22##2##(1993-2#1)(1994-12#1)(1994-9#1)(1996-3#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2010-1#2)(2010-7#1)(2011-2#1)(2011-7#1)(2012-2#1)
procedures in the##4##3##(2008-10#1)(2008-11#1)(2011-3#1)(2012-12#1)
procedures in##23##2##(1990-9#1)(1997-6#2)(2008-10#5)(2008-11#1)(2008-7#2)(2009-12#1)(2010-11#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
procedures included##2##2##(1992-2#1)(1993-2#1)
procedures including##3##2##(2008-10#2)(2012-3#1)
procedures involved##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
procedures involving the##2##3##(1990-9#1)(2008-10#1)
procedures involving##4##2##(1990-9#1)(2008-10#3)
procedures is an##2##3##(2010-7#1)(2011-2#1)
procedures is##14##2##(1990-9#1)(1991-2#1)(1992-3#1)(1993-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#2)
procedures like##2##2##(2008-10#1)(2008-11#1)
procedures may##3##2##(1997-5#1)(2008-9#1)(2012-3#1)
procedures occurred in##2##3##(1996-9#1)(2008-7#1)
procedures of##17##2##(1992-3#1)(1992-9#2)(1996-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
procedures on the##3##3##(1996-9#2)(2008-9#1)
procedures or##3##2##(1993-3#1)(1995-9#1)(1997-8#1)
procedures performed in the hospital##2##5##(1995-2#2)
procedures performed in##3##3##(1995-2#3)
procedures performed##9##2##(1992-12#1)(1993-1#1)(1995-1#1)(1995-2#3)(1997-3#1)(2011-2#1)(2013-1#1)
procedures present##2##2##(2008-10#1)(2012-2#1)
procedures required to##2##3##(1993-12#1)(2008-4#1)
procedures should be##2##3##(2008-8#1)(2009-11#1)
procedures such as##7##3##(1996-5#1)(2008-10#3)(2008-9#2)(2012-3#1)
procedures that are##3##3##(2008-4#3)
procedures that have##2##3##(2008-12#1)(2008-7#1)
procedures that##14##2##(1992-5#1)(1993-3#1)(1995-3#1)(2008-10#3)(2008-12#2)(2008-4#4)(2008-7#1)(2012-3#1)
procedures the##2##2##(1990-3#1)(2008-4#1)
procedures to a minimum##2##4##(1992-12#1)(2008-7#1)
procedures to achieve##2##3##(2008-11#1)(2008-3#1)
procedures to be##2##3##(1996-6#1)(2008-10#1)
procedures to identify##2##3##(2008-12#1)(2009-12#1)
procedures to the##2##3##(2008-10#1)(2008-3#1)
procedures to##25##2##(1992-12#1)(1993-12#1)(1996-1#1)(1996-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
procedures used for##2##3##(2008-10#2)
procedures used to##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
procedures used##7##2##(1992-3#1)(2008-10#4)(2008-11#1)(2012-2#1)
procedures using##8##2##(1990-12#1)(1993-1#1)(2008-10#4)(2008-9#2)
procedures was##6##2##(2008-10#6)
procedures were also carried out##2##5##(2008-10#1)(2008-5#1)
procedures were applied to the##2##5##(1991-8#1)(2008-10#1)
procedures were applied to##4##4##(1991-8#1)(2008-10#3)
procedures were applied##5##3##(1991-8#1)(2008-10#4)
procedures were evaluated##2##3##(2008-10#2)
procedures were investigated##2##3##(2008-10#2)
procedures were performed##5##3##(1991-8#1)(2009-4#1)(2011-3#3)
procedures were used to##2##4##(2011-2#1)(2012-2#1)
procedures were##36##2##(1991-8#2)(1993-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#18)(2008-5#1)(2009-4#1)(2010-1#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#1)(2012-3#1)
procedures which##2##2##(2008-11#1)(2013-1#1)
procedures with##10##2##(1990-5#1)(2008-10#6)(2008-12#1)(2008-8#1)(2012-3#1)
procedures without##2##2##(2012-12#1)(2012-3#1)
procedures##749##1##(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#3)(1990-9#6)(1991-1#3)(1991-11#1)(1991-2#4)(1991-3#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#4)(1993-1#3)(1993-12#8)(1993-2#4)(1993-3#7)(1993-6#2)(1994-1#3)(1994-12#3)(1994-3#4)(1994-6#1)(1994-9#2)(1995-1#3)(1995-12#7)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#8)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#3)(1997-8#3)(2007-12#3)(2007-8#3)(2008-10#270)(2008-11#31)(2008-12#13)(2008-2#5)(2008-3#4)(2008-4#39)(2008-5#7)(2008-7#13)(2008-8#4)(2008-9#39)(2009-10#1)(2009-11#1)(2009-12#7)(2009-3#1)(2009-4#3)(2009-5#2)(2009-8#3)(2009-9#5)(2010-1#3)(2010-11#4)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#4)(2011-2#39)(2011-3#6)(2011-7#1)(2012-12#11)(2012-2#16)(2012-3#14)(2013-1#23)(2013-8#1)
procedures)##2##1##(2008-10#1)(2008-4#1)
procedures]##2##1##(1991-11#1)(2011-2#1)
proceed by##2##2##(1993-8#1)(2008-2#1)
proceed to##3##2##(1991-5#1)(2008-11#1)(2011-2#1)
proceed with##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
proceed##18##1##(1991-3#1)(1991-5#1)(1993-8#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#2)
proceeded at##2##2##(2008-10#1)(2008-5#1)
proceeded in##5##2##(1992-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2013-1#1)
proceeded to##3##2##(1995-6#1)(2008-10#1)(2008-7#1)
proceeded##17##1##(1992-12#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#9)(2008-5#1)(2008-7#1)(2013-1#1)
proceeding##5##1##(1990-5#1)(1992-2#1)(2008-10#3)
proceedings##12##1##(1995-12#2)(1995-5#1)(1995-6#1)(1996-5#1)(1997-6#1)(2008-12#1)(2010-1#1)(2011-2#4)
proceeds along##2##2##(2009-8#1)(2012-2#1)
proceeds by##2##2##(1995-8#1)(2008-10#1)
proceeds in##2##2##(1995-8#1)(2008-10#1)
proceeds through a process that##2##5##(2008-10#2)
proceeds through a##3##3##(2008-10#2)(2008-11#1)
proceeds with##5##2##(1996-5#3)(2008-10#1)(2008-7#1)
proceeds##21##1##(1993-1#1)(1995-8#2)(1996-5#3)(2007-12#1)(2008-10#7)(2008-11#2)(2008-7#1)(2009-8#1)(2010-7#1)(2012-2#2)
process a special##2##3##(2008-10#1)(2008-5#1)
process a##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)
process achieved##2##2##(1997-5#1)(2008-11#1)
process aimed at##2##3##(1993-9#1)(2008-11#1)
process allows##2##2##(2008-10#1)(2008-11#1)
process also##2##2##(2008-10#2)
process among##2##2##(2008-10#1)(2013-1#1)
process and are##2##3##(1995-2#1)(2013-1#1)
process and how##2##3##(1993-3#1)(1996-1#1)
process and its##2##3##(1992-2#1)(2008-1#1)
process and may##2##3##(1991-12#1)(2008-10#1)
process and outcome##2##3##(2008-12#1)(2013-1#1)
process and presentation##3##3##(2008-8#3)
process and that##2##3##(2008-10#2)
process and the##18##3##(1990-9#1)(1993-3#1)(1994-3#2)(2008-10#5)(2008-11#1)(2008-7#1)(2009-7#1)(2010-10#2)(2010-12#1)(2011-2#2)(2011-3#1)
process and to##2##3##(2008-10#2)
process and##80##2##(1990-9#1)(1991-12#2)(1992-2#2)(1993-3#2)(1994-2#2)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-1#1)(2009-7#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
process are##12##2##(1993-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-2#1)
process as well as##4##4##(2008-10#3)(2012-2#1)
process as##8##2##(1992-3#1)(1994-5#1)(2008-10#3)(2008-6#1)(2012-2#2)
process associated with##3##3##(2007-12#1)(2008-11#1)(2009-8#1)
process at a##3##3##(2008-10#2)(2008-8#1)
process at the##2##3##(2008-10#1)(2008-3#1)
process at##12##2##(1993-12#1)(1993-3#1)(1994-2#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-8#1)(2009-11#1)
process before##2##2##(1991-12#1)(2008-10#1)
process between##2##2##(1993-1#1)(2008-10#1)
process blank##2##2##(2008-10#2)
process but also##2##3##(1993-3#1)(1995-5#1)
process but##4##2##(1993-3#1)(1995-5#1)(2008-12#1)(2011-2#1)
process by the##4##3##(1993-8#1)(2008-10#2)(2008-5#1)
process by which##11##3##(1995-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
process by##27##2##(1993-8#1)(1995-2#1)(1996-1#1)(2008-10#12)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
process can be##9##3##(1991-2#1)(1994-12#1)(1994-2#1)(2008-10#3)(2008-6#1)(2010-4#1)(2011-2#1)
process can##12##2##(1991-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-4#1)(2011-2#1)
process change##3##2##(1993-2#1)(1995-2#1)(2013-8#1)
process continues##2##2##(2010-10#1)(2010-7#1)
process control (SPC)##3##3##(1995-2#1)(1996-1#1)(2008-10#1)
process control in##2##3##(1995-2#1)(2008-10#1)
process control##8##2##(1995-2#2)(1996-1#1)(2008-10#5)
process could be##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
process could##9##2##(1994-2#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#1)
process described here##2##3##(2008-11#2)
process described##4##2##(2008-11#3)(2008-12#1)
process design##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
process despite##2##2##(2008-11#1)(2009-10#1)
process developed##2##2##(2008-10#1)(2013-1#1)
process development##10##2##(2008-11#5)(2010-11#1)(2011-2#4)
process does not##4##3##(1995-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
process does##5##2##(1995-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
process dominates##2##2##(2008-11#1)(2008-3#1)
process during the##3##3##(2008-10#3)
process during##5##2##(1997-6#1)(2008-10#4)
process for in vitro##2##4##(2008-11#1)(2008-7#1)
process for the synthesis of##3##5##(1992-11#1)(2008-11#1)(2011-2#1)
process for the##13##3##(1992-11#1)(1996-6#1)(2008-10#1)(2008-11#5)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
process for##39##2##(1992-11#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#2)
process from##7##2##(2008-10#3)(2008-11#1)(2008-8#1)(2009-10#1)(2012-2#1)
process has been##9##3##(1991-12#1)(1992-11#1)(1995-1#1)(1996-2#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-2#2)
process has not been##3##4##(1995-8#1)(2008-11#1)(2008-7#1)
process has##20##2##(1991-12#1)(1992-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
process have##2##2##(2008-9#1)(2010-12#1)
process improvement##7##2##(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-3#1)(2010-2#1)(2011-2#1)
process improvements##2##2##(1996-1#1)(2008-3#1)
process in a##4##3##(1993-3#1)(1995-12#1)(1996-1#1)(2008-11#1)
process in an##2##3##(2008-10#1)(2008-3#1)
process in order to##2##4##(2008-10#2)
process in social##2##3##(2010-4#1)(2013-8#1)
process in the##11##3##(1991-12#1)(1992-6#1)(1993-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#1)
process in which an##2##4##(2008-10#1)(2011-8#1)
process in which the##4##4##(1996-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
process in which##16##3##(1990-6#1)(1991-6#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2011-8#1)(2012-2#1)(2013-1#1)
process in##64##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-3#2)(1994-1#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-8#1)(2012-2#1)(2013-1#2)(2013-8#2)
process included##4##2##(2008-10#3)(2013-1#1)
process includes##2##2##(2008-10#1)(2008-11#1)
process information##2##2##(2008-4#1)(2008-7#1)
process involves a##2##3##(1993-8#1)(1996-5#1)
process involves the##2##3##(2008-11#1)(2009-10#1)
process involves##8##2##(1993-8#1)(1994-3#2)(1996-5#1)(2008-11#1)(2009-10#1)(2009-7#1)(2011-8#1)
process involving##8##2##(1991-2#1)(1992-9#1)(2007-12#1)(2008-10#3)(2009-10#1)(2012-2#1)
process is a##3##3##(1991-2#1)(1996-1#1)(2008-10#1)
process is also##3##3##(2008-3#1)(2008-5#1)(2009-10#1)
process is described##3##3##(1991-2#1)(2008-12#1)(2008-4#1)
process is made##2##3##(1996-1#1)(2008-10#1)
process is presented##2##3##(1993-6#1)(2008-7#1)
process is that##2##3##(2008-3#1)(2010-1#1)
process is##68##2##(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#2)(1993-2#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-1#2)(1997-2#1)(2008-10#12)(2008-11#5)(2008-12#3)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#7)(2012-2#1)(2013-1#1)
process itself##2##2##(1997-1#1)(2012-2#1)
process knowledge##2##2##(2008-11#1)(2013-1#1)
process leading to##2##3##(1990-11#1)(2008-5#1)
process may##4##2##(2008-10#1)(2008-5#1)(2009-11#1)(2010-12#1)
process measures##2##2##(2013-1#2)
process model##2##2##(2010-10#1)(2013-1#1)
process monitoring##6##2##(2008-10#3)(2008-11#3)
process of DNA##3##3##(2008-10#3)
process of a##5##3##(1994-2#1)(1996-6#1)(2008-10#1)(2008-12#1)(2009-7#1)
process of beer##2##3##(1991-5#1)(2008-10#1)
process of bone##2##3##(1996-3#1)(2011-2#1)
process of carcinogenesis##2##3##(2008-12#1)(2009-3#1)
process of care##5##3##(1994-12#2)(1997-1#1)(2008-3#2)
process of chronic##2##3##(2012-2#2)
process of degradation of##2##4##(2008-8#1)(2013-1#1)
process of disease##2##3##(2008-8#1)(2009-6#1)
process of getting##2##3##(2009-9#1)(2010-4#1)
process of grating regeneration##2##4##(2013-8#2)
process of in##2##3##(2008-11#1)(2009-12#1)
process of post-testicular maturation##2##4##(2008-8#2)
process of programmed cell death##2##5##(2008-8#1)(2011-2#1)
process of the##22##3##(1992-1#1)(1993-1#1)(1996-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#2)
process of this##3##3##(1990-5#1)(2008-11#1)(2013-1#1)
process of##261##2##(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#3)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-7#1)(1997-8#2)(2008-10#46)(2008-11#32)(2008-12#16)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#15)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-10#1)(2011-2#10)(2012-2#6)(2012-3#15)(2013-1#5)(2013-8#5)
process often##2##2##(1997-1#1)(2008-10#1)
process on##4##2##(2008-10#4)
process or##7##2##(1990-12#1)(1996-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
process parameters and##2##3##(2008-11#1)(2010-4#1)
process parameters##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
process performance##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
process producing##2##2##(1995-2#1)(2010-12#1)
process redesign##3##2##(1993-12#1)(1993-3#2)
process requiring##2##2##(1992-7#1)(2009-6#1)
process samples##2##2##(2008-10#2)
process should##4##2##(1990-8#1)(1995-5#1)(2011-1#1)(2011-2#1)
process startup##4##2##(2008-11#4)
process termed##2##2##(2010-5#1)(2011-2#1)
process that can be##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
process that can##5##3##(1993-2#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-1#1)
process that involves##3##3##(2008-10#1)(2011-2#2)
process that is##3##3##(1991-6#1)(2008-10#1)(2009-8#1)
process that may be##2##4##(1996-12#1)(2010-10#1)
process that may##3##3##(1996-12#1)(2008-9#1)(2010-10#1)
process that was##3##3##(2008-10#1)(2008-12#1)(2009-3#1)
process that##36##2##(1991-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#1)(2011-2#3)(2011-3#1)(2013-1#1)(2013-7#1)
process the##6##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
process there is##2##3##(1994-2#1)(2008-5#1)
process they##2##2##(1994-3#1)(1997-2#1)
process through##5##2##(1993-12#2)(1996-12#1)(2008-10#1)(2013-8#1)
process to improve##2##3##(1993-12#1)(2008-11#1)
process to remove##2##3##(2008-3#1)(2013-1#1)
process to##20##2##(1992-12#1)(1993-12#1)(1995-12#1)(1997-1#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#2)
process used in##2##3##(1996-2#1)(2008-7#1)
process used to identify##2##4##(1995-1#1)(2008-11#1)
process used to##5##3##(1994-2#1)(1995-1#1)(1996-2#1)(2008-11#1)(2011-2#1)
process used##9##2##(1991-2#1)(1994-2#1)(1995-1#1)(1996-2#2)(2008-11#2)(2008-7#1)(2011-2#1)
process using the##3##3##(1995-2#1)(2008-9#1)(2009-4#1)
process using##10##2##(1995-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
process variables##2##2##(1993-12#1)(2013-1#1)
process was also##3##3##(1991-5#1)(2008-10#1)(2009-11#1)
process was based on##2##4##(2008-10#1)(2008-11#1)
process was carried out using##2##5##(2008-10#2)
process was carried out##3##4##(2008-10#3)
process was developed for##2##4##(2008-10#1)(2008-11#1)
process was developed##3##3##(2008-10#1)(2008-11#2)
process was investigated##2##3##(2008-10#2)
process was observed##2##3##(2008-10#1)(2008-3#1)
process was then##2##3##(1993-2#1)(2008-10#1)
process was used##2##3##(2008-10#1)(2013-1#1)
process was##47##2##(1991-2#1)(1991-5#1)(1993-2#2)(2008-10#27)(2008-11#8)(2008-12#1)(2008-3#1)(2008-9#2)(2009-11#1)(2010-4#1)(2013-1#2)
process were##16##2##(1991-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2013-1#1)
process whereby##3##2##(1996-1#1)(2008-5#1)(2013-8#1)
process which allows##2##3##(2008-12#1)(2008-7#1)
process which##8##2##(1990-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#2)
process while##2##2##(1992-5#1)(2008-10#1)
process will##4##2##(1996-1#1)(1997-1#1)(2008-5#1)(2008-9#1)
process with a##2##3##(2008-10#1)(2008-7#1)
process with##14##2##(1992-1#1)(1997-3#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
process within the##2##3##(2008-10#2)
process within##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
process without##2##2##(2008-7#1)(2011-2#1)
process##1653##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#7)(1991-2#16)(1991-3#5)(1991-5#3)(1991-6#5)(1992-1#4)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#4)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#7)(1993-11#3)(1993-12#18)(1993-2#8)(1993-3#17)(1993-6#6)(1993-8#5)(1993-9#1)(1994-1#10)(1994-11#1)(1994-12#12)(1994-2#17)(1994-3#15)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#6)(1995-11#1)(1995-12#11)(1995-2#17)(1995-3#5)(1995-5#3)(1995-6#6)(1995-8#4)(1995-9#3)(1996-1#20)(1996-11#1)(1996-12#4)(1996-2#14)(1996-3#5)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#19)(1997-2#20)(1997-3#10)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#2)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#6)(2008-10#406)(2008-11#182)(2008-12#50)(2008-2#5)(2008-3#43)(2008-4#13)(2008-5#47)(2008-6#7)(2008-7#70)(2008-8#36)(2008-9#37)(2009-1#3)(2009-10#14)(2009-11#7)(2009-12#7)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#6)(2009-7#10)(2009-8#15)(2009-9#1)(2010-1#4)(2010-10#15)(2010-11#6)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#12)(2010-5#7)(2010-6#5)(2010-7#4)(2010-8#6)(2010-9#4)(2011-1#5)(2011-10#2)(2011-2#72)(2011-3#4)(2011-8#2)(2012-12#1)(2012-2#40)(2012-3#32)(2013-1#41)(2013-7#2)(2013-8#20)
process)##3##1##(2008-10#1)(2008-7#1)(2012-2#1)
processed and##3##2##(1992-3#1)(1995-5#1)(1997-2#1)
processed by the##2##3##(2008-10#1)(2010-8#1)
processed by##17##2##(1996-12#1)(1996-2#1)(2008-10#13)(2010-11#1)(2010-8#1)
processed food##2##2##(2008-10#1)(2011-2#1)
processed foods##3##2##(1991-6#1)(2008-10#1)(2011-2#1)
processed for##4##2##(2008-7#2)(2011-2#1)(2013-8#1)
processed in a##2##3##(2008-10#1)(2008-11#1)
processed in such a way that##2##6##(1997-5#1)(2008-3#1)
processed in##10##2##(1991-9#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2013-8#1)
processed into the##2##3##(1990-8#2)
processed into##3##2##(1990-5#1)(1990-8#2)
processed protein##3##2##(1995-6#3)
processed pseudogene##4##2##(1990-8#2)(1993-2#1)(1994-11#1)
processed to a##2##3##(1990-5#1)(1995-8#1)
processed to generate##2##3##(1997-7#1)(2009-8#1)
processed to the mature##2##4##(1995-2#1)(1997-1#1)
processed to##12##2##(1990-5#2)(1992-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
processed using partial least squares##2##5##(2008-10#2)
processed using##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
processed with a##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
processed with##7##2##(1990-12#1)(2008-10#4)(2008-3#1)(2008-7#1)
processed##104##1##(1990-12#1)(1990-5#3)(1990-8#4)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#3)(1993-6#2)(1993-8#2)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#7)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#31)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#5)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
processes also##2##2##(2008-10#2)
processes and in##2##3##(2008-10#1)(2009-12#1)
processes and mechanisms##2##3##(2009-8#1)(2010-3#1)
processes and outcomes##3##3##(1993-3#1)(2008-12#1)(2008-8#1)
processes and systems##3##3##(1995-1#1)(2012-2#2)
processes and the##9##3##(1994-1#1)(1996-2#1)(2008-11#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
processes and##53##2##(1993-3#1)(1994-1#1)(1995-1#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
processes are described##2##3##(2008-10#1)(2008-11#1)
processes are discussed##2##3##(1996-2#1)(2008-10#1)
processes are involved in##2##4##(2008-7#1)(2011-2#1)
processes are of##2##3##(2008-5#1)(2013-8#1)
processes are the##2##3##(1995-2#1)(2011-2#1)
processes are##39##2##(1990-8#2)(1992-3#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
processes arise##2##2##(2008-11#1)(2008-6#1)
processes as well as the##2##5##(2008-11#2)
processes as well as##6##4##(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)
processes as##11##2##(1996-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2010-12#1)
processes associated with##4##3##(1992-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
processes at##4##2##(1997-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
processes being##2##2##(2008-11#1)(2011-2#1)
processes between the##2##3##(2008-11#1)(2008-12#1)
processes but also##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
processes but##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
processes by which##2##3##(1996-5#1)(2008-10#1)
processes by##5##2##(1995-6#1)(1996-5#1)(2008-10#3)
processes can be##3##3##(1990-8#1)(2008-10#1)(2008-8#1)
processes can##6##2##(1990-8#1)(1991-6#2)(2008-10#1)(2008-8#1)(2009-8#1)
processes could##2##2##(2008-10#1)(2012-3#1)
processes described##2##2##(1996-5#1)(2008-11#1)
processes during##2##2##(2008-11#2)
processes for the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
processes for##11##2##(1992-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
processes has been##2##3##(2008-10#1)(2008-7#1)
processes has##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
processes have been##4##3##(1994-2#1)(2008-10#2)(2008-5#1)
processes have##5##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
processes in response to low doses##2##6##(2008-7#2)
processes in response to##3##4##(2008-7#2)(2009-6#1)
processes in the##12##3##(1991-6#1)(1993-3#1)(1994-3#1)(2008-11#4)(2008-3#1)(2008-7#1)(2009-8#1)(2012-2#2)
processes in##46##2##(1991-6#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-7#1)(2011-2#1)(2012-2#5)(2012-3#4)(2013-7#1)(2013-8#1)
processes including##5##2##(1995-12#1)(2008-1#1)(2010-10#1)(2011-9#1)(2013-8#1)
processes induced##2##2##(2008-11#1)(2012-12#1)
processes into##2##2##(2007-12#1)(2008-11#1)
processes involved in the##6##4##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)
processes involved in this##2##4##(2010-12#1)(2011-2#1)
processes involved in##15##3##(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#2)
processes involved##16##2##(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#2)
processes involving##3##2##(2008-10#2)(2009-6#1)
processes is unknown##2##3##(1990-3#1)(1995-2#1)
processes is##10##2##(1990-3#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
processes leading to##3##3##(2008-10#1)(2009-4#1)(2012-12#1)
processes linked to##2##3##(2008-10#2)
processes must##2##2##(1994-3#1)(2008-11#1)
processes not##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
processes occurring##4##2##(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
processes of bone##2##3##(2007-8#2)
processes of the two##2##4##(2008-10#2)
processes of the##8##3##(2008-10#5)(2008-5#1)(2010-5#1)(2011-2#1)
processes of##67##2##(1991-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1995-2#1)(1997-3#2)(2007-8#3)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
processes on##3##2##(2008-8#1)(2008-9#1)(2012-5#1)
processes or to##2##3##(2007-12#1)(2012-2#1)
processes present##2##2##(1997-2#1)(2013-1#1)
processes related to##2##3##(2008-10#1)(2013-8#1)
processes required to##2##3##(2008-11#1)(2012-2#1)
processes responsible for##2##3##(2007-12#1)(2008-11#1)
processes should##2##2##(2008-8#1)(2009-10#1)
processes such as##16##3##(1995-3#1)(1997-1#1)(2008-10#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
processes taking place in##2##4##(2008-12#1)(2010-12#1)
processes taking place##4##3##(2008-10#1)(2008-12#1)(2010-12#1)(2013-1#1)
processes that are linked to##2##5##(2008-10#1)(2008-3#1)
processes that are##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2013-8#1)
processes that have##3##3##(1991-3#1)(2010-12#1)(2012-3#1)
processes that involve##2##3##(2008-10#1)(2009-8#1)
processes that##32##2##(1991-3#1)(1993-3#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
processes to be##2##3##(2011-2#1)(2013-8#1)
processes to the##2##3##(1991-10#1)(2008-10#1)
processes to##10##2##(1991-10#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-8#1)
processes used in##2##3##(1994-3#1)(2008-11#1)
processes used##4##2##(1993-12#1)(1994-3#1)(2008-11#2)
processes was##4##2##(2008-10#3)(2008-8#1)
processes we##2##2##(2009-12#1)(2012-2#1)
processes were inhibited by##2##4##(2008-11#2)
processes were##13##2##(1992-3#1)(2008-10#6)(2008-11#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
processes where##3##2##(2008-11#2)(2013-1#1)
processes which may##2##3##(2008-7#1)(2009-10#1)
processes which##7##2##(1993-2#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)
processes will##3##2##(1995-1#1)(2008-11#1)(2008-3#1)
processes with##5##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)
processes##775##1##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#4)(1991-10#2)(1991-3#1)(1991-5#1)(1991-6#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#8)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#8)(1994-6#1)(1994-8#4)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#9)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#7)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#8)(1997-6#3)(1997-7#3)(2007-11#3)(2007-12#4)(2007-8#4)(2008-1#3)(2008-10#150)(2008-11#94)(2008-12#18)(2008-2#6)(2008-3#10)(2008-4#8)(2008-5#16)(2008-6#3)(2008-7#31)(2008-8#30)(2008-9#23)(2009-10#8)(2009-11#1)(2009-12#5)(2009-3#3)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#5)(2009-8#25)(2009-9#1)(2010-10#6)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#5)(2010-7#6)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#42)(2011-3#1)(2011-9#1)(2012-12#3)(2012-2#34)(2012-3#17)(2012-5#1)(2012-7#1)(2013-1#21)(2013-7#1)(2013-8#20)
processes)##3##1##(1994-2#1)(1997-3#1)(2008-12#1)
processing ability##2##2##(1994-6#1)(2010-10#1)
processing and joining##3##3##(1997-3#2)(1997-7#1)
processing and the##3##3##(1992-12#1)(1992-6#1)(1994-8#1)
processing and##26##2##(1992-12#1)(1992-6#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1997-3#3)(1997-7#1)(2008-10#3)(2008-11#4)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-8#2)
processing approach##2##2##(2008-10#1)(2008-3#1)
processing as##2##2##(2008-7#1)(2010-8#1)
processing at the##2##3##(1995-8#1)(2008-4#1)
processing at##4##2##(1995-8#1)(1996-2#1)(2008-11#1)(2008-4#1)
processing by##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
processing can be##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
processing can##5##2##(2008-10#1)(2008-3#2)(2013-8#2)
processing chain##5##2##(2008-12#3)(2009-12#1)(2011-2#1)
processing chains##2##2##(2008-12#2)
processing characteristics of##2##3##(2010-4#2)
processing conditions##3##2##(2008-2#1)(2008-5#2)
processing efficiency##2##2##(2008-10#1)(2010-7#1)
processing events##2##2##(1992-6#1)(1997-7#1)
processing for##6##2##(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)
processing has##2##2##(1990-8#1)(1991-2#1)
processing in the##5##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-9#1)
processing in##18##2##(1990-8#1)(1993-6#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2010-4#2)(2010-9#1)(2012-2#1)(2013-8#2)
processing industries##2##2##(2008-10#2)
processing into##2##2##(1995-12#1)(2008-10#1)
processing is##4##2##(1997-1#1)(2008-10#1)(2008-11#1)(2010-7#1)
processing may##3##2##(2008-11#2)(2009-10#1)
processing method##2##2##(2008-3#1)(2012-3#1)
processing mode##2##2##(2010-10#2)
processing of angry##2##3##(2008-11#2)
processing of emotional##2##3##(2008-11#1)(2008-4#1)
processing of the precursor##2##4##(1991-7#1)(1997-1#1)
processing of the##14##3##(1991-7#1)(1992-12#2)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-10#1)(2011-3#1)(2013-8#1)
processing of this##3##3##(1991-10#1)(1992-10#1)(2009-12#1)
processing of wh-questions is##2##4##(2011-1#2)
processing of##78##2##(1990-5#2)(1990-8#5)(1991-10#2)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#2)(1992-6#1)(1993-6#3)(1993-8#1)(1994-6#1)(1994-8#1)(1995-2#4)(1995-8#1)(1997-1#1)(2007-11#1)(2008-10#9)(2008-11#12)(2008-3#3)(2008-4#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
processing on##2##2##(2008-11#1)(2013-8#1)
processing or##2##2##(1993-12#1)(2008-5#1)
processing procedure##2##2##(2008-11#1)(2008-9#1)
processing rate##2##2##(2008-12#2)
processing site##3##2##(1991-10#2)(1995-6#1)
processing software##2##2##(2008-11#1)(2011-7#1)
processing speed##3##2##(2008-2#1)(2012-2#2)
processing steps##2##2##(2008-10#1)(2008-7#1)
processing strategies in children##2##4##(2008-9#2)
processing strategies##3##2##(2008-9#3)
processing system##2##2##(1994-12#1)(2008-11#1)
processing techniques##3##2##(1992-9#1)(2008-10#1)(2012-2#1)
processing to##3##2##(2008-11#1)(2008-6#1)(2008-8#1)
processing tomato production##2##3##(2008-10#2)
processing tomato##5##2##(2008-10#5)
processing was##5##2##(1991-10#1)(2008-10#2)(2008-11#1)(2008-12#1)
processing were##3##2##(1990-8#1)(2010-10#1)(2011-2#1)
processing##405##1##(1990-3#1)(1990-5#2)(1990-8#9)(1991-10#5)(1991-2#3)(1991-5#1)(1991-7#1)(1992-10#2)(1992-12#3)(1992-6#5)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#6)(1993-8#6)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#4)(1995-12#1)(1995-2#7)(1995-5#3)(1995-6#5)(1995-8#4)(1996-12#1)(1996-2#7)(1997-1#3)(1997-3#5)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#67)(2008-11#74)(2008-12#11)(2008-2#4)(2008-3#22)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#4)(2008-8#5)(2008-9#14)(2009-10#5)(2009-12#3)(2009-4#2)(2009-7#5)(2009-8#1)(2010-10#5)(2010-11#1)(2010-4#4)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#12)(2011-3#1)(2011-7#1)(2012-2#9)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#15)
processivity factor##4##2##(1994-12#2)(1995-2#1)(1995-6#1)
processivity##5##1##(1994-12#2)(1995-2#2)(1995-6#1)
processor is##2##2##(2008-3#2)
processor##20##1##(2008-10#1)(2008-3#2)(2008-6#1)(2008-9#16)
processors##5##1##(2008-3#1)(2008-9#4)
procidentia in##2##2##(2008-10#2)
procoagulant##2##1##(2008-9#1)(2009-3#1)
procrustes discriminant analysis##2##3##(2008-10#2)
proctocolectomy##2##1##(1990-6#1)(2009-12#1)
procurement##10##1##(1992-3#1)(2010-9#2)(2011-3#1)(2012-2#6)
procymidone and##2##2##(2008-10#2)
procymidone##3##1##(2008-10#3)
prodigal son##2##2##(2008-12#2)
prodigious##2##1##(2008-10#1)(2008-11#1)
prodromal##3##1##(1992-12#1)(2011-8#2)
prodrug of##3##2##(1995-6#2)(2008-5#1)
prodrug##5##1##(1994-5#1)(1995-6#2)(2008-5#1)(2011-3#1)
produce IAA##3##2##(2008-10#3)
produce a more##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
produce a new##2##3##(1994-1#1)(2010-12#1)
produce a##69##2##(1991-1#1)(1991-3#1)(1992-9#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#2)(2012-3#2)(2013-1#1)
produce aflatoxin##2##2##(2008-10#2)
produce an##15##2##(1990-8#1)(1991-7#1)(1995-9#1)(1996-5#2)(1996-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-7#1)(2012-2#1)
produce and secrete##4##3##(1995-2#1)(2008-10#1)(2013-1#2)
produce and##6##2##(1995-2#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#2)
produce both##4##2##(2008-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
produce compounds that##2##3##(2008-10#2)
produce different##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
produce either##2##2##(1993-9#1)(2008-8#1)
produce fumonisin##2##2##(2008-10#1)(2013-1#1)
produce good##2##2##(1996-3#1)(2008-3#1)
produce greater quantities of aflatoxins than##2##6##(2008-10#2)
produce greater##4##2##(2008-10#2)(2009-8#1)(2012-3#1)
produce high##2##2##(2008-10#1)(2009-5#1)
produce higher##2##2##(1993-2#1)(2008-10#1)
produce holes##2##2##(2008-10#1)(2008-3#1)
produce information##2##2##(1995-12#1)(2012-12#1)
produce large offspring##2##3##(2008-8#2)
produce large quantities of##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
produce large##11##2##(1995-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#2)
produce many##2##2##(1993-1#1)(2008-8#1)
produce material for##2##3##(2008-11#2)
produce more##6##2##(1993-11#1)(1994-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
produce mycotoxins##2##2##(2008-10#1)(2010-3#1)
produce new##2##2##(2008-11#1)(2008-12#1)
produce novel##3##2##(2008-7#1)(2009-11#1)(2013-8#1)
produce oospores in##4##3##(2008-10#4)
produce oospores##8##2##(2008-10#8)
produce or##2##2##(2008-10#1)(2009-5#1)
produce positive##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
produce side effects##2##3##(1993-11#1)(2008-7#1)
produce significant##5##2##(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
produce similar##2##2##(1991-12#1)(2008-12#1)
produce sound##2##2##(2008-10#1)(2008-8#1)
produce specific##3##2##(2008-10#2)(2008-11#1)
produce sufficient amounts of##2##4##(2008-11#1)(2011-2#1)
produce sufficient##3##2##(1997-7#1)(2008-11#1)(2011-2#1)
produce the##28##2##(1992-3#1)(1993-8#1)(1996-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)
produce them##2##2##(2008-5#2)
produce this##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
produce two##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
produce very##2##2##(2008-5#1)(2012-2#1)
produce##497##1##(1990-12#2)(1990-2#4)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#4)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#6)(1995-5#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#3)(1997-7#2)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#160)(2008-11#41)(2008-12#13)(2008-2#6)(2008-3#11)(2008-4#8)(2008-5#18)(2008-6#2)(2008-7#9)(2008-8#30)(2008-9#11)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#13)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#8)(2013-1#12)(2013-8#4)
produced BHV-1##2##2##(2008-11#2)
produced DNA products##2##3##(2008-10#2)
produced DNA##3##2##(2008-10#3)
produced IgG##2##2##(2008-11#2)
produced a concentration-dependent##4##3##(1992-1#1)(1995-11#1)(1997-4#2)
produced a gradual##2##3##(1993-6#1)(1994-11#1)
produced a marked##2##3##(1995-11#1)(1996-12#1)
produced a protein##2##3##(1993-8#1)(2008-9#1)
produced a significant enhancement##2##4##(2008-10#1)(2008-12#1)
produced a significant increase in##2##5##(2008-10#1)(2013-1#1)
produced a significant##6##3##(2008-10#2)(2008-12#1)(2008-3#1)(2010-8#1)(2013-1#1)
produced a##63##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-11#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#2)(2008-10#21)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#2)
produced aflatoxin in##3##3##(2008-10#3)
produced aflatoxin##4##2##(2008-10#4)
produced against the##2##3##(2008-10#2)
produced against##8##2##(1996-12#2)(2008-10#5)(2008-11#1)
produced ammonia##2##2##(2008-10#2)
produced an increase in##2##4##(1996-12#1)(2012-3#1)
produced an increase##3##3##(1996-12#1)(2008-11#1)(2012-3#1)
produced an##12##2##(1991-5#1)(1994-11#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
produced and purified##2##3##(1993-8#1)(1994-5#1)
produced and secreted by##2##4##(1993-3#1)(2008-5#1)
produced and##18##2##(1993-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#2)(2008-9#1)(2011-2#1)(2011-3#1)
produced antibody##2##2##(2008-11#2)
produced as a##4##3##(1993-12#1)(2008-10#1)(2010-5#1)(2010-8#1)
produced as one of the##2##5##(2008-10#1)(2009-5#1)
produced as##10##2##(1993-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-5#2)(2010-8#1)
produced at 10°C and 30°C##3##5##(2011-2#3)
produced at 10°C##4##3##(2011-2#4)
produced at 30°C##2##3##(2011-2#2)
produced at least##2##3##(2008-10#2)
produced at##13##2##(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#6)(2012-5#1)
produced better##2##2##(2008-10#1)(2011-2#1)
produced by A##2##3##(1991-9#1)(2013-8#1)
produced by CHO cells##3##4##(1992-10#1)(2008-11#2)
produced by Chinese hamster ovary##5##5##(2008-11#4)(2008-7#1)
produced by Fusarium##2##3##(2008-10#2)
produced by P##3##3##(2008-10#3)
produced by Pseudomonas##3##3##(1995-2#1)(2008-10#2)
produced by U##2##3##(2008-10#2)
produced by a##16##3##(1991-2#1)(1995-6#1)(1996-3#1)(2008-10#5)(2008-3#3)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#1)
produced by all##5##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
produced by an##5##3##(1997-2#1)(2008-3#2)(2008-8#1)(2013-8#1)
produced by bile-pancreatic juice diversion##2##5##(2008-7#2)
produced by both##2##3##(1993-1#1)(2008-10#1)
produced by conidial##2##3##(2008-10#2)
produced by different##3##3##(1995-3#1)(2008-10#1)(2011-2#1)
produced by digestion with##2##4##(2008-1#2)
produced by each strain##2##4##(2008-10#2)
produced by each##3##3##(2008-10#3)
produced by enzyme##2##3##(2008-10#2)
produced by fusing splenocytes##2##4##(2008-11#2)
produced by fusing##4##3##(2008-11#4)
produced by human##2##3##(2008-11#1)(2008-8#1)
produced by jet nebulizers##2##4##(1995-3#2)
produced by jet##3##3##(1991-1#1)(1995-3#2)
produced by less##2##3##(2008-10#1)(2011-2#1)
produced by several##2##3##(2008-10#2)
produced by simple##2##3##(2008-10#1)(2010-7#1)
produced by strain##2##3##(2008-10#2)
produced by the different##2##4##(2008-10#2)
produced by the reaction between##3##5##(2008-10#3)
produced by the##51##3##(1991-3#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#3)(1996-2#2)(1997-2#1)(2007-12#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-8#1)
produced by these cells##3##4##(2008-11#2)(2008-9#1)
produced by these##6##3##(2008-10#1)(2008-11#4)(2008-9#1)
produced by two##2##3##(2008-10#1)(2008-11#1)
produced by##292##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-1#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-9#1)(1992-10#3)(1992-12#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-9#2)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#4)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#109)(2008-11#35)(2008-12#1)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#10)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#2)(2010-1#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#5)(2013-8#2)
produced conidia##2##2##(2008-10#2)
produced consistent##2##2##(2008-10#1)(2008-12#1)
produced distinct##2##2##(2008-10#2)
produced during##5##2##(1993-2#1)(2008-10#2)(2009-3#1)(2013-1#1)
produced ethylene at##2##3##(2008-10#2)
produced fewer##2##2##(2008-10#1)(2008-4#1)
produced for##3##2##(2008-10#2)(2008-11#1)
produced from the enzymatic reaction##2##5##(2008-10#2)
produced from the reaction##2##4##(2008-10#2)
produced from the##11##3##(1994-11#2)(1997-6#1)(2008-10#7)(2008-11#1)
produced from##35##2##(1991-3#1)(1994-11#2)(1994-3#1)(1996-6#1)(1997-6#1)(2008-10#21)(2008-11#5)(2009-3#1)(2011-2#2)
produced good##2##2##(1990-9#1)(2008-10#1)
produced greater##3##2##(2008-10#3)
produced high amounts##3##3##(2008-10#2)(2010-11#1)
produced high levels of##2##4##(2008-10#2)
produced high##5##2##(2008-10#4)(2010-11#1)
produced higher##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
produced hydrogen peroxide##4##3##(2008-10#3)(2009-8#1)
produced in E##2##3##(1990-5#1)(1990-8#1)
produced in Escherichia coli##5##4##(1991-5#1)(1991-9#1)(1993-6#1)(2008-4#1)(2010-6#1)
produced in a##7##3##(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-7#1)
produced in an##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
produced in bacteria and##2##4##(1993-12#1)(2013-8#1)
produced in bacteria##4##3##(1993-12#1)(2008-4#1)(2009-6#1)(2013-8#1)
produced in large##2##3##(2008-11#1)(2011-1#1)
produced in less than##2##4##(2008-11#2)
produced in less##3##3##(2008-11#2)(2008-9#1)
produced in the reaction##2##4##(2008-10#2)
produced in the##17##3##(1993-1#1)(1994-11#1)(1995-12#1)(2008-10#8)(2008-11#5)(2008-7#1)
produced in this##2##3##(2008-10#1)(2008-5#1)
produced in vitro by##3##4##(1990-11#1)(2008-10#1)(2008-7#1)
produced in vitro##6##3##(1990-11#1)(1991-3#1)(2008-10#3)(2008-7#1)
produced in##100##2##(1990-11#2)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-7#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#38)(2008-11#18)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#2)
produced increased##3##2##(2008-10#2)(2008-11#1)
produced is##2##2##(2008-10#1)(2008-7#1)
produced large amounts of ethanol##2##5##(2013-1#2)
produced large amounts of##4##4##(2008-10#1)(2008-11#1)(2013-1#2)
produced large##5##2##(1994-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
produced less##6##2##(1993-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)
produced little or no##2##4##(2008-10#1)(2008-11#1)
produced long##2##2##(2008-10#1)(2008-8#1)
produced mainly by##3##3##(1992-5#1)(2008-10#2)
produced males and oviparae##2##4##(2008-9#2)
produced many##2##2##(1996-5#1)(2008-11#1)
produced more##13##2##(1991-9#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-8#2)(2011-2#1)
produced mostly##2##2##(2008-10#1)(2012-3#1)
produced multiple##3##2##(2008-10#2)(2008-8#1)
produced no significant##2##3##(1993-1#1)(2008-7#1)
produced no##8##2##(1993-1#1)(1995-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-2#1)
produced on infected plants##2##4##(2008-10#2)
produced on leaves##2##3##(2008-10#2)
produced on the##4##3##(2008-10#3)(2012-3#1)
produced on##23##2##(2008-10#21)(2008-8#1)(2012-3#1)
produced one##2##2##(2008-10#1)(2009-5#1)
produced only a##2##3##(2008-10#1)(2008-11#1)
produced only modest##2##3##(2008-10#1)(2009-7#1)
produced only##7##2##(1990-11#1)(2008-10#4)(2008-11#1)(2009-7#1)
produced oospores when grown on##2##5##(2008-10#2)
produced per cotyledon##2##3##(2008-10#2)
produced per##6##2##(2008-10#5)(2008-11#1)
produced pycnidia on##2##3##(2008-10#2)
produced results##3##2##(2008-10#2)(2013-1#1)
produced significant changes##2##3##(1993-6#1)(2008-10#1)
produced significant##12##2##(1992-12#1)(1992-6#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-7#3)(2010-8#1)(2011-2#1)(2012-2#1)
produced significantly more##7##3##(1990-12#1)(1990-5#1)(1990-8#1)(2008-10#2)(2009-10#1)(2013-1#1)
produced significantly##12##2##(1990-12#1)(1990-5#1)(1990-8#1)(1993-1#1)(2008-10#6)(2009-10#1)(2013-1#1)
produced similar symptoms##2##3##(1997-3#1)(2008-10#1)
produced similar##8##2##(1992-2#1)(1997-3#1)(2008-10#5)(2008-8#1)
produced that##3##2##(1995-6#1)(2008-10#2)
produced the best results##2##4##(1990-11#1)(2008-10#1)
produced the highest##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
produced the largest##2##3##(1995-11#1)(2008-10#1)
produced the##17##2##(1990-11#1)(1990-5#1)(1995-11#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#1)
produced through##7##2##(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)
produced two##5##2##(1995-12#1)(2008-10#3)(2011-1#1)
produced typical##2##2##(2008-10#2)
produced using a##2##3##(2008-10#2)
produced using##4##2##(2008-10#2)(2008-11#2)
produced various##2##2##(2008-10#2)
produced via the##2##3##(2008-10#1)(2008-7#1)
produced was##3##2##(2008-10#2)(2008-12#1)
produced water samples##2##3##(2008-10#2)
produced water##4##2##(2008-10#2)(2008-7#2)
produced waters##3##2##(2008-10#3)
produced with a##2##3##(2008-11#1)(2008-3#1)
produced with##11##2##(2008-10#7)(2008-11#1)(2008-3#2)(2010-4#1)
produced##1051##1##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#2)(1990-5#6)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#2)(1991-12#8)(1991-2#2)(1991-3#5)(1991-5#6)(1991-9#4)(1992-1#1)(1992-10#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#4)(1992-7#1)(1993-1#5)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#3)(1993-6#8)(1993-8#7)(1993-9#1)(1994-11#8)(1994-12#1)(1994-2#8)(1994-3#3)(1994-5#2)(1994-8#3)(1994-9#2)(1995-11#9)(1995-12#9)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#13)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#454)(2008-11#113)(2008-12#15)(2008-2#2)(2008-3#31)(2008-4#12)(2008-5#16)(2008-6#3)(2008-7#30)(2008-8#31)(2008-9#18)(2009-10#4)(2009-12#2)(2009-3#5)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#4)(2010-1#2)(2010-11#4)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#4)(2011-1#5)(2011-2#24)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#17)(2013-8#6)
producer cell line##3##3##(1990-5#1)(2008-11#2)
producer cell##5##2##(1990-5#1)(2008-11#4)
producer cells##3##2##(2008-11#3)
producer##17##1##(1990-5#1)(1993-2#1)(1993-3#1)(2008-10#3)(2008-11#10)(2008-9#1)
producers and##4##2##(2008-10#3)(2008-9#1)
producers have##2##2##(1997-6#1)(2008-10#1)
producers in the##4##3##(2008-10#2)(2010-6#1)(2012-2#1)
producers in##5##2##(2008-10#3)(2010-6#1)(2012-2#1)
producers of##2##2##(2008-11#1)(2012-12#1)
producers to##2##2##(2008-10#1)(2013-8#1)
producers##34##1##(1996-2#2)(1997-6#1)(2008-10#18)(2008-11#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
produces a decrease in##2##4##(1994-2#1)(2008-5#1)
produces a decrease##3##3##(1994-2#1)(2008-10#1)(2008-5#1)
produces a single##2##3##(2008-10#1)(2008-8#1)
produces a toxin##2##3##(2008-10#2)
produces a##41##2##(1990-5#1)(1990-8#1)(1990-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-7#2)(1997-8#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-1#1)
produces an##12##2##(1992-3#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
produces and##2##2##(1997-4#1)(2009-6#1)
produces multiple##3##2##(2008-10#2)(2008-3#1)
produces pseudothecia and ascospores##2##4##(2008-10#2)
produces pseudothecia##3##2##(2008-10#3)
produces the##9##2##(1993-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)
produces##140##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#49)(2008-11#4)(2008-12#1)(2008-3#6)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#3)(2009-12#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#4)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
producing Escherichia coli##3##3##(2012-2#2)(2013-1#1)
producing a##23##2##(1994-5#1)(1997-8#2)(2008-10#7)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#1)
producing an##4##2##(1994-8#1)(2008-10#2)(2008-5#1)
producing cell lines##3##3##(2008-11#3)
producing cell##4##2##(2008-11#4)
producing cells##5##2##(1994-12#1)(2008-11#4)
producing large##3##2##(2008-10#1)(2009-12#1)(2009-5#1)
producing light##2##2##(1991-2#1)(2008-3#1)
producing new##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
producing recombinant human##3##3##(2008-11#3)
producing recombinant##8##2##(2008-11#6)(2008-8#2)
producing relatively##2##2##(2008-11#2)
producing reliable##2##2##(2008-9#1)(2010-10#1)
producing strains were##2##3##(2008-10#1)(2008-11#1)
producing strains##4##2##(2008-10#1)(2008-11#1)(2012-2#2)
producing the antibiotic 2##2##4##(2008-10#2)
producing the##15##2##(1992-1#1)(1993-2#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-7#3)(2008-9#1)(2013-7#1)
producing this##3##2##(2008-11#1)(2011-2#2)
producing##196##1##(1990-11#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#2)(2008-10#50)(2008-11#47)(2008-12#6)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#7)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#8)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)
product 2##2##2##(2008-10#2)
product CL##2##2##(2008-3#2)
product analysis##2##2##(2008-10#1)(2008-4#1)
product and##13##2##(1991-2#1)(1991-5#1)(1992-9#1)(1995-5#1)(2008-10#6)(2008-5#2)(2008-7#1)
product and/or##2##2##(2012-2#2)
product are##2##2##(2008-10#2)
product at##3##2##(2008-10#3)
product by##2##2##(2008-10#2)
product can be##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
product characteristics##3##2##(2008-5#2)(2012-3#1)
product contained##2##2##(1995-2#1)(2008-10#1)
product containing##2##2##(2008-10#1)(2008-5#1)
product could be##2##3##(1993-3#1)(2009-12#1)
product could##4##2##(1993-3#1)(2008-10#1)(2008-12#1)(2009-12#1)
product design##3##2##(2009-7#3)
product development##5##2##(1994-12#1)(2008-10#1)(2008-5#3)
product during##2##2##(2008-10#1)(2008-7#1)
product efficacy##2##2##(2008-10#1)(2008-5#1)
product flux##2##2##(2008-7#1)(2010-10#1)
product for##5##2##(1993-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
product formation##4##2##(2008-10#1)(2008-7#1)(2009-8#2)
product from all##2##3##(2008-10#2)
product from##5##2##(1993-3#1)(2008-10#4)
product has been##3##3##(2008-10#2)(2008-11#1)
product has##4##2##(1993-2#1)(2008-10#2)(2008-11#1)
product in the##3##3##(2008-10#2)(2013-1#1)
product in##13##2##(1991-5#1)(1993-12#1)(2008-10#8)(2008-7#1)(2008-9#1)(2013-1#1)
product inhibition##3##2##(1991-9#1)(1993-8#1)(2008-7#1)
product into##2##2##(1991-9#1)(2008-9#1)
product ion##4##2##(2008-10#4)
product is required for##2##4##(1995-6#1)(1996-3#1)
product is##28##2##(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#3)(1995-6#1)(1996-12#2)(1996-3#2)(1997-2#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-9#1)
product may##3##2##(1990-12#1)(2008-5#2)
product obtained##2##2##(1993-12#1)(2008-10#1)
product of Cr(VI)##2##3##(2008-10#2)
product of reaction between##2##4##(2008-10#2)
product of reaction##5##3##(2008-10#5)
product of the enzymatic reaction##4##5##(2008-10#4)
product of the enzymatic##5##4##(2008-10#5)
product of the enzyme reaction##2##5##(2008-10#2)
product of the enzyme##3##4##(1995-2#1)(2008-10#2)
product of the##35##3##(1990-2#1)(1990-5#1)(1993-8#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-3#2)(1997-8#1)(2007-12#2)(2008-10#16)(2008-3#1)(2008-9#2)(2009-10#1)(2011-2#2)(2012-12#1)
product of this gene##2##4##(1993-8#1)(1995-6#1)
product of##95##2##(1990-11#1)(1990-2#1)(1990-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-12#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-8#1)(1997-3#2)(1997-8#1)(1997-9#1)(2007-12#2)(2008-10#52)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
product on##2##2##(2008-5#2)
product or##4##2##(1994-12#1)(1997-3#1)(2008-10#2)
product per##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
product performance##3##2##(2008-5#3)
product profile##2##2##(2008-10#1)(2011-2#1)
product quality and##2##3##(2011-2#2)
product quality##12##2##(2008-10#3)(2008-11#2)(2008-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
product release##4##2##(1991-9#1)(2008-5#1)(2008-7#2)
product should be##2##3##(2008-5#1)(2010-11#1)
product showed##3##2##(2008-10#2)(2008-5#1)
product spoilage##2##2##(2011-2#2)
product synthesis##3##2##(1996-5#1)(2008-11#2)
product that##3##2##(1990-5#1)(1991-10#1)(2008-12#1)
product titre##3##2##(2008-11#3)
product to##5##2##(1992-6#1)(1995-12#1)(2008-3#1)(2011-2#2)
product use##5##2##(2008-10#3)(2008-5#2)
product using##2##2##(2008-4#1)(2008-5#1)
product was used##2##3##(2008-10#2)
product was##23##2##(1992-3#1)(1992-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-2#1)
product were##8##2##(1992-6#1)(1996-1#1)(2008-10#6)
product which##6##2##(1994-11#1)(2008-10#1)(2008-11#3)(2012-3#1)
product with##5##2##(1994-11#1)(2008-10#3)(2008-5#1)
product world##2##2##(2008-5#2)
product worlds##3##2##(2008-5#3)
product yield##5##2##(2008-11#2)(2008-7#3)
product yields##3##2##(1996-5#1)(2008-11#1)(2008-7#1)
product##640##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#4)(1991-8#1)(1991-9#7)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#4)(1993-8#4)(1993-9#3)(1994-11#9)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#12)(1995-5#2)(1995-6#9)(1995-8#4)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#6)(1996-8#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#5)(1997-8#3)(1997-9#1)(2007-12#7)(2008-10#236)(2008-11#48)(2008-12#3)(2008-3#7)(2008-4#6)(2008-5#71)(2008-7#22)(2008-8#2)(2008-9#9)(2009-10#1)(2009-12#2)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-4#3)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#23)(2012-12#2)(2012-2#20)(2012-3#2)(2013-1#6)(2013-8#2)
product(s)##3##1##(1990-5#1)(2008-10#1)(2008-7#1)
product) in##2##2##(2008-10#1)(2008-3#1)
product)##6##1##(2008-10#4)(2008-3#1)(2008-5#1)
production and a##2##3##(1995-2#1)(2008-11#1)
production and characterization of##2##4##(1992-2#1)(2011-2#1)
production and dissemination##2##3##(1992-12#1)(2008-10#1)
production and glycosylation##3##3##(2008-11#2)(2011-2#1)
production and recovery##2##3##(2008-11#2)
production and the##3##3##(2008-10#2)(2010-4#1)
production and their##2##3##(2008-10#2)
production and use##2##3##(1991-12#1)(2008-11#1)
production and##94##2##(1991-12#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#1)(2006-6#1)(2008-1#1)(2008-10#33)(2008-11#17)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#3)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
production and/or##3##2##(1994-8#1)(1997-3#1)(2010-10#1)
production are##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
production area##2##2##(2008-10#2)
production areas in Canada##2##4##(2008-10#2)
production areas of the world##2##5##(2008-10#2)
production areas of the##3##4##(2008-10#3)
production areas of##4##3##(2008-10#3)(2008-12#1)
production areas##13##2##(2008-10#12)(2008-12#1)
production as a result of##2##5##(1991-12#1)(2011-2#1)
production as a##3##3##(1991-12#1)(2011-2#2)
production as##7##2##(1991-12#1)(1997-7#1)(2008-10#2)(2009-3#1)(2011-2#2)
production assay##4##2##(2008-11#4)
production assays##2##2##(2008-11#2)
production at##7##2##(2008-11#5)(2008-3#1)(2008-7#1)
production between##2##2##(2008-10#1)(2008-12#1)
production by A##2##3##(2008-10#2)
production by a##2##3##(1993-9#1)(2012-2#1)
production by human##4##3##(2008-11#3)(2008-5#1)
production by in##4##3##(2008-11#4)
production by the##5##3##(2008-10#4)(2008-11#1)
production by##64##2##(1990-5#1)(1991-3#3)(1991-5#1)(1993-9#1)(1994-11#1)(1994-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#13)(2008-11#20)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
production capacity##3##2##(2008-11#3)
production cell lines##2##3##(2008-11#2)
production chain##2##2##(2008-10#2)
production decreased##3##2##(2008-10#1)(2008-11#2)
production depend##2##2##(1991-2#1)(1995-5#1)
production fields in##2##3##(2008-10#2)
production fields##10##2##(2008-10#10)
production food safety##2##3##(2011-2#2)
production for##7##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-8#1)
production from a##3##3##(2008-11#3)
production from the##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
production from##25##2##(1993-3#1)(1994-8#1)(1997-6#1)(2008-10#3)(2008-11#11)(2008-4#1)(2008-7#1)(2011-3#1)(2013-1#5)
production has not been##3##4##(2008-10#1)(2008-11#1)(2012-7#1)
production has##7##2##(1991-3#1)(2008-10#2)(2008-11#2)(2012-7#2)
production in Bacillus megaterium##2##4##(2011-1#2)
production in Bacillus##3##3##(2011-1#2)(2011-2#1)
production in CHO cells##2##4##(2008-11#2)
production in Canada##2##3##(2008-10#2)
production in Escherichia coli##2##4##(1993-9#1)(2008-7#1)
production in a dose-dependent manner##2##5##(1993-6#1)(2008-11#1)
production in a##5##3##(1993-3#1)(1993-6#1)(2008-11#3)
production in all##3##3##(2008-10#2)(2008-11#1)
production in batch##2##3##(1994-8#1)(2008-11#1)
production in cultured##2##3##(2008-10#1)(2013-1#1)
production in human##2##3##(2008-10#2)
production in insulin-secreting##2##3##(1997-1#2)
production in rat##2##3##(1991-12#1)(2012-2#1)
production in recombinant Chinese hamster ovary##2##6##(2008-11#2)
production in recombinant##4##3##(2008-11#2)(2008-7#2)
production in response to##2##4##(1990-11#1)(2012-2#1)
production in serum-free##2##3##(2008-11#2)
production in suspension##2##3##(2008-11#2)
production in the brain##3##4##(1994-2#1)(1995-12#1)(2012-2#1)
production in the presence of cell walls from##2##8##(2008-10#2)
production in the##24##3##(1994-2#1)(1995-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
production in three##2##3##(2008-12#1)(2011-2#1)
production in various##2##3##(2006-6#1)(2011-2#1)
production in vitro##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
production in##146##2##(1990-11#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#45)(2008-11#28)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#4)(2009-6#1)(2009-8#2)(2010-12#1)(2011-1#8)(2011-2#5)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)
production increased##5##2##(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
production induced by##4##3##(1991-5#1)(1996-2#1)(2008-10#2)
production is not##2##3##(1994-8#1)(2008-11#1)
production is##19##2##(1991-3#2)(1991-7#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)
production level of##3##3##(1993-6#1)(2008-11#1)(2008-7#1)
production level##5##2##(1993-6#1)(2008-11#3)(2008-7#1)
production line and##2##3##(2012-2#2)
production line##3##2##(2008-10#1)(2012-2#2)
production methods##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
production obtained##2##2##(2008-10#1)(2008-11#1)
production occurred##2##2##(2008-11#1)(2013-1#1)
production occurs##3##2##(1997-1#1)(2008-11#1)(2008-7#1)
production of 6-APA##3##3##(2008-12#3)
production of A##2##3##(2008-10#2)
production of Anticarsia gemmatalis##3##4##(2008-11#3)
production of CEA per cell##2##5##(2008-11#2)
production of CEA##3##3##(2008-11#3)
production of IFN-beta##3##3##(2008-11#3)
production of IL-6##2##3##(1990-5#1)(2008-10#1)
production of MAb##2##3##(2008-11#2)
production of P##2##3##(2008-10#2)
production of ROS##5##3##(1994-5#3)(2008-10#1)(2008-11#1)
production of a mature##2##4##(2011-3#2)
production of a recombinant##2##4##(2008-11#2)
production of a##26##3##(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-2#2)(2011-3#2)(2012-2#1)
production of abnormal##2##3##(1992-12#1)(2008-10#1)
production of an##5##3##(2008-10#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
production of antibodies against##2##4##(2008-4#1)(2011-2#1)
production of antibodies##7##3##(1990-12#1)(1995-5#1)(2008-11#2)(2008-4#2)(2011-2#1)
production of antibody##2##3##(2008-11#1)(2011-2#1)
production of apothecia##3##3##(2008-10#3)
production of beta-galactosidase##2##3##(2008-11#1)(2008-7#1)
production of biologically active##3##4##(1993-6#2)(2008-11#1)
production of biopharmaceuticals##3##3##(2008-11#2)(2011-2#1)
production of extracellular##3##3##(2008-10#2)(2011-2#1)
production of functional##2##3##(1993-9#1)(1994-11#1)
production of high levels of##2##5##(2008-10#1)(2008-11#1)
production of high##4##3##(1994-11#1)(2008-10#1)(2008-11#1)(2012-7#1)
production of human monoclonal antibodies##2##5##(2008-11#2)
production of human##3##3##(2008-11#3)
production of inflammatory mediators##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
production of inositol trisphosphate##3##4##(1990-8#2)(1991-12#1)
production of inositol##5##3##(1990-8#3)(1991-12#1)(1997-1#1)
production of interferon-beta per unit cell##2##6##(2008-11#2)
production of interferon-beta##5##3##(2008-11#5)
production of lignin##2##3##(2008-11#1)(2008-6#1)
production of local##2##3##(2008-10#1)(2008-8#1)
production of mRNA##2##3##(1997-8#1)(2009-10#1)
production of monoclonal antibodies##4##4##(2008-11#2)(2008-9#1)(2011-2#1)
production of monoclonal antibody##3##4##(2008-11#3)
production of monoclonal##7##3##(2008-11#5)(2008-9#1)(2011-2#1)
production of nitric oxide##2##4##(2008-11#1)(2008-7#1)
production of podophyllotoxin##2##3##(2008-11#2)
production of poly-beta-hydroxybutyrate##2##3##(2008-7#2)
production of progeny##2##3##(1994-11#1)(1997-3#1)
production of proteins##2##3##(2008-11#1)(2011-1#1)
production of pseudothecia##2##3##(2008-10#2)
production of reactive oxygen species (ROS)##3##6##(1994-5#1)(2008-11#1)(2009-8#1)
production of reactive oxygen species##6##5##(1994-5#1)(2008-10#2)(2008-11#1)(2009-8#1)(2013-8#1)
production of reactive oxygen##7##4##(1994-5#2)(2008-10#2)(2008-11#1)(2009-8#1)(2013-8#1)
production of recombinant protein##2##4##(2008-11#2)
production of recombinant proteins by##2##5##(2008-11#2)
production of recombinant proteins##11##4##(2008-11#11)
production of recombinant##25##3##(1997-7#1)(2008-11#22)(2008-7#1)(2010-5#1)
production of secondary##4##3##(2008-10#4)
production of sporangia and zoospores##2##5##(2008-10#2)
production of superoxide##3##3##(1994-8#1)(1995-6#1)(2009-9#1)
production of the##31##3##(1990-11#1)(1991-12#1)(1991-5#1)(1994-11#1)(1995-2#1)(2008-10#13)(2008-11#3)(2008-5#1)(2008-7#2)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
production of this##2##3##(2008-10#1)(2008-11#1)
production of three##2##3##(2008-12#1)(2011-1#1)
production of various viruses##2##4##(2008-11#2)
production of various##5##3##(2008-11#4)(2008-4#1)
production of viral##3##3##(1994-11#1)(2008-11#1)(2011-3#1)
production of##476##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#4)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#7)(1994-2#2)(1994-3#1)(1994-5#5)(1994-8#5)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-2#3)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#3)(2008-10#113)(2008-11#135)(2008-12#10)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#22)(2008-8#10)(2008-9#6)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#17)(2011-3#4)(2012-2#9)(2012-3#6)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#4)
production ofinterferon-beta##2##2##(2008-11#2)
production on the##2##3##(2008-10#2)
production on##7##2##(2008-10#3)(2008-11#1)(2008-8#1)(2010-3#1)(2012-3#1)
production or##6##2##(1992-2#1)(2008-10#2)(2008-11#2)(2008-4#1)
production per lesion##3##3##(2008-10#3)
production per##9##2##(1992-12#1)(2008-10#6)(2008-11#1)(2008-9#1)
production period##2##2##(2008-10#1)(2008-5#1)
production phase##9##2##(2008-11#7)(2008-7#2)
production plant and the##2##4##(2012-2#2)
production plant##7##2##(2008-10#4)(2012-2#3)
production plants##2##2##(2008-10#1)(2012-2#1)
production platform for##2##3##(2008-11#2)
production process was##2##3##(2008-11#2)
production process##18##2##(1993-3#1)(2008-10#2)(2008-11#7)(2008-7#1)(2011-2#1)(2012-2#6)
production processes and##2##3##(2008-11#1)(2012-2#1)
production processes are##2##3##(2008-11#2)
production processes##9##2##(2008-10#2)(2008-11#5)(2012-2#2)
production rate and egg number##2##5##(2008-12#2)
production rate and##4##3##(2008-11#1)(2008-12#2)(2008-8#1)
production rate in the##2##4##(2008-11#2)
production rate of##3##3##(2008-11#2)(2011-2#1)
production rate per cell##2##4##(2008-11#2)
production rate per##3##3##(2008-10#1)(2008-11#2)
production rate was##3##3##(2008-11#3)
production rate##27##2##(1994-8#1)(2008-10#1)(2008-11#19)(2008-12#2)(2008-7#1)(2008-8#2)(2011-2#1)
production rates of##2##3##(2008-11#2)
production rates were##3##3##(2008-11#2)(2008-7#1)
production rates##12##2##(2008-11#8)(2008-12#1)(2008-7#2)(2008-8#1)
production region##2##2##(2008-10#2)
production requires##2##2##(2008-11#2)
production samples##3##2##(2008-10#3)
production significantly##2##2##(2007-11#1)(2010-12#1)
production situations and##2##3##(2008-10#2)
production situations##4##2##(2008-10#4)
production system for##3##3##(2008-11#1)(2008-9#2)
production system##11##2##(2008-10#3)(2008-11#4)(2008-7#1)(2008-9#2)(2011-2#1)
production systems##16##2##(2008-10#9)(2008-11#1)(2011-2#1)(2013-1#2)(2013-8#3)
production techniques##3##2##(2008-10#2)(2011-2#1)
production through##2##2##(1995-11#1)(2008-11#1)
production to control##2##3##(2008-10#2)
production to the##2##3##(1994-5#1)(2008-10#1)
production to##7##2##(1994-5#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#1)
production trial##5##2##(2013-8#5)
production under##3##2##(1992-9#1)(1994-11#1)(2011-1#1)
production using##9##2##(1994-8#1)(1995-11#1)(2008-11#5)(2008-4#1)(2011-2#1)
production via##6##2##(1991-3#2)(1993-11#1)(1995-11#1)(2008-11#1)(2008-6#1)
production was achieved##2##3##(2008-10#1)(2008-6#1)
production was also##2##3##(2008-10#2)
production was enhanced##2##3##(1996-12#1)(2008-11#1)
production was measured##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
production was not affected##2##4##(1996-2#1)(2008-11#1)
production was not##6##3##(1996-2#1)(2008-10#1)(2008-11#4)
production was observed##3##3##(2008-10#1)(2008-11#2)
production was reduced by##2##4##(1997-1#1)(2008-10#1)
production was seen##2##3##(1994-5#1)(2008-5#1)
production was similar##2##3##(2008-10#1)(2008-11#1)
production was##67##2##(1990-11#1)(1991-5#1)(1993-3#1)(1993-9#1)(1994-5#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#1)(2008-10#24)(2008-11#21)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#1)(2011-3#1)(2013-1#1)
production were evaluated##2##3##(2008-10#2)
production were investigated##2##3##(1997-1#1)(2008-11#1)
production were obtained by##2##4##(2008-10#2)
production were obtained##3##3##(2008-10#2)(2008-11#1)
production were##23##2##(1991-3#1)(1997-1#1)(1997-2#1)(2008-10#13)(2008-11#4)(2008-5#1)(2010-12#1)(2011-2#1)
production when##3##2##(1996-12#1)(1997-2#1)(2011-2#1)
production with##5##2##(1995-3#1)(2008-11#1)(2009-7#1)(2010-1#1)(2011-2#1)
production without##2##2##(1996-2#1)(2011-2#1)
production yield##2##2##(2008-11#2)
production yields##2##2##(1993-12#1)(2013-1#1)
production##1659##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#5)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#11)(1991-5#7)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#11)(1992-2#3)(1992-5#2)(1992-6#3)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-6#9)(1993-8#4)(1993-9#6)(1994-11#16)(1994-2#3)(1994-3#9)(1994-5#9)(1994-8#15)(1995-11#7)(1995-12#6)(1995-2#7)(1995-3#3)(1995-5#4)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#13)(1996-2#15)(1996-6#1)(1997-1#9)(1997-2#5)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#2)(2006-6#3)(2007-11#6)(2007-12#1)(2008-1#4)(2008-10#455)(2008-11#435)(2008-12#31)(2008-2#2)(2008-3#4)(2008-4#24)(2008-5#30)(2008-6#7)(2008-7#61)(2008-8#37)(2008-9#21)(2009-10#5)(2009-3#7)(2009-4#2)(2009-5#3)(2009-6#11)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#2)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#23)(2011-10#2)(2011-2#67)(2011-3#7)(2012-2#49)(2012-3#15)(2012-4#1)(2012-7#4)(2013-1#36)(2013-7#2)(2013-8#19)
production)##6##1##(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-3#1)
productions##6##1##(2008-11#3)(2011-2#1)(2012-3#2)
productive and##2##2##(1996-1#1)(2010-7#1)
productive areas##2##2##(2008-10#1)(2008-9#1)
productive binding##2##2##(1993-8#1)(1994-5#1)
productive cell##2##2##(1992-8#1)(2008-11#1)
productive patches##3##2##(2008-9#3)
productive tree holes##2##3##(2008-9#2)
productive##36##1##(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1997-1#2)(2008-10#1)(2008-11#8)(2008-7#2)(2008-9#8)(2010-12#2)(2010-7#1)(2013-1#1)
productively##2##1##(1996-6#1)(1997-9#1)
productivities in##2##2##(2008-11#1)(2008-7#1)
productivities##11##1##(2008-11#4)(2008-7#2)(2008-8#4)(2008-9#1)
productivity and the##3##3##(2008-11#2)(2008-8#1)
productivity and##19##2##(1991-2#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-11#8)(2008-8#3)(2008-9#1)(2010-8#1)(2012-3#1)(2012-5#1)
productivity because##2##2##(2008-11#1)(2008-9#1)
productivity but##2##2##(2008-8#2)
productivity by##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
productivity during##2##2##(2008-11#1)(2008-7#1)
productivity for##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
productivity gradient##4##2##(2008-8#1)(2008-9#3)
productivity in CHO##2##3##(2008-11#2)
productivity in terms of##2##4##(2008-11#1)(2009-4#1)
productivity in the##3##3##(1997-1#1)(2008-11#1)(2008-7#1)
productivity in##18##2##(1992-6#1)(1997-1#2)(2008-11#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)
productivity increased##2##2##(2008-11#2)
productivity is##6##2##(2008-11#4)(2008-7#1)(2008-9#1)
productivity of 0##2##3##(2008-11#1)(2013-1#1)
productivity of 293##2##3##(2008-11#2)
productivity of hybridoma##2##3##(2008-11#2)
productivity of recombinant##5##3##(2008-11#5)
productivity of the##6##3##(2008-10#1)(2008-11#3)(2008-7#1)(2010-8#1)
productivity of##42##2##(1991-3#1)(2008-10#2)(2008-11#27)(2008-12#2)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#2)(2010-8#1)(2012-9#1)(2013-1#1)
productivity or##2##2##(1992-3#1)(2008-11#1)
productivity rate of##3##3##(2008-11#3)
productivity rate##6##2##(2008-11#6)
productivity was##7##2##(2008-11#6)(2011-2#1)
productivity##221##1##(1991-2#4)(1991-3#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-3#2)(1994-12#2)(1995-6#1)(1997-1#2)(1997-6#1)(2008-10#12)(2008-11#109)(2008-12#2)(2008-7#15)(2008-8#21)(2008-9#22)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-8#2)(2011-2#7)(2012-12#1)(2012-3#1)(2012-5#1)(2012-9#1)(2013-1#2)
productivity)##2##1##(2008-8#1)(2008-9#1)
products against##2##2##(2012-2#1)(2013-1#1)
products and in the##2##4##(2008-10#1)(2009-10#1)
products and the##4##3##(1993-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
products and their##5##3##(1995-3#1)(1997-3#1)(2008-10#1)(2008-5#2)
products and##44##2##(1991-12#1)(1992-7#1)(1993-11#1)(1994-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#18)(2008-4#1)(2008-5#5)(2008-7#2)(2009-10#1)(2009-2#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
products are applied in##2##4##(2008-10#1)(2008-5#1)
products are being##2##3##(2007-12#1)(2011-2#1)
products are in good agreement with those obtained by##2##9##(2008-10#2)
products are in##4##3##(1991-12#1)(2008-10#3)
products are to##2##3##(2008-10#1)(2012-2#1)
products are##33##2##(1990-2#1)(1991-12#1)(1992-12#1)(1994-11#1)(1994-12#1)(1996-12#2)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-2#2)
products as##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
products at##5##2##(1996-12#1)(2008-10#3)(2008-7#1)
products by high-performance liquid chromatography##2##5##(1992-11#1)(2008-5#1)
products by##18##2##(1990-11#1)(1992-11#1)(1992-6#1)(1994-5#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)
products can be##2##3##(1992-5#1)(2008-5#1)
products can##4##2##(1992-5#1)(1995-2#1)(2008-11#1)(2008-5#1)
products consumption (p = 0##2##5##(2011-2#2)
products containing##5##2##(1991-12#1)(2008-10#3)(2011-2#1)
products could be##2##3##(2008-11#1)(2009-12#1)
products derived from##2##3##(2008-11#1)(2012-2#1)
products faster##2##2##(2008-11#1)(2008-5#1)
products for the##2##3##(1992-3#1)(2008-11#1)
products for##12##2##(1990-12#1)(1992-3#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-8#1)
products formed##3##2##(2008-10#2)(2008-7#1)
products from a##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
products from the##5##3##(1994-9#1)(2008-10#3)(2008-11#1)
products from##22##2##(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-9#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-5#1)(2010-7#2)(2011-2#1)(2013-8#1)
products generated by##2##3##(2008-10#2)
products generated##3##2##(2008-10#3)
products had a##3##3##(1997-2#1)(2008-5#1)(2011-2#1)
products has been##2##3##(1996-5#1)(2008-10#1)
products have been##7##3##(2008-10#3)(2008-11#1)(2008-5#1)(2012-2#2)
products have##15##2##(1991-6#1)(1994-5#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#2)(2012-2#2)
products in a##2##3##(2008-10#1)(2008-5#1)
products in an##2##3##(1996-12#1)(2008-3#1)
products in the##10##3##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-9#1)(2009-10#1)(2012-12#1)
products in##40##2##(1991-3#1)(1993-8#1)(1994-5#1)(1996-12#1)(2008-10#12)(2008-11#4)(2008-3#2)(2008-5#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
products including##4##2##(2008-10#3)(2008-5#1)
products involved in##3##3##(1995-9#1)(1996-3#1)(2008-10#1)
products is##13##2##(1994-11#1)(1995-9#1)(2008-10#9)(2008-12#1)(2009-11#1)
products like##2##2##(2008-10#2)
products may##3##2##(1996-12#1)(2007-12#1)(2008-6#1)
products more##2##2##(1996-5#1)(2008-10#1)
products observed during##2##3##(1993-8#2)
products observed##3##2##(1993-8#2)(2008-10#1)
products of incomplete combustion are##2##5##(1996-12#2)
products of incomplete combustion##3##4##(1996-12#3)
products of organophosphorous##2##3##(2010-5#2)
products of the reaction##2##4##(2008-10#2)
products of the##19##3##(1990-7#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-8#2)(2008-10#10)(2008-11#2)(2008-7#1)
products of two##2##3##(1995-8#1)(2008-10#1)
products of##75##2##(1990-7#1)(1991-12#2)(1991-3#2)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1994-8#3)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#30)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-5#2)(2010-7#1)(2013-8#2)
products on a##2##3##(2008-10#1)(2008-8#1)
products on the##2##3##(2008-11#1)(2008-5#1)
products on##6##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)
products or##6##2##(1996-12#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-2#1)
products resulting from##2##3##(2007-12#1)(2008-10#1)
products revealed##2##2##(1995-12#1)(1996-5#1)
products such as##5##3##(2008-10#3)(2008-11#1)(2009-8#1)
products suggests##2##2##(1993-12#1)(1995-2#1)
products that are##2##3##(1996-2#1)(2008-11#1)
products that were##3##3##(1995-12#1)(2008-10#2)
products that##10##2##(1992-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-6#1)
products to the##2##3##(2008-11#1)(2008-9#1)
products to##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)
products typically##2##2##(2008-5#1)(2008-7#1)
products using##7##2##(1996-2#1)(2008-10#4)(2008-5#2)
products was##7##2##(2008-10#3)(2008-5#2)(2011-2#1)(2013-1#1)
products were detected##2##3##(2008-10#1)(2008-12#1)
products were identified by##2##4##(2008-10#1)(2008-7#1)
products were identified##4##3##(1995-6#1)(2008-10#2)(2008-7#1)
products were observed##3##3##(1992-10#1)(2008-10#2)
products were separated##2##3##(2008-10#2)
products were##45##2##(1992-10#1)(1994-11#1)(1994-8#1)(1995-6#3)(1997-3#2)(2008-10#27)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
products which##4##2##(1994-8#1)(1996-6#1)(1997-4#1)(2008-5#1)
products whose##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
products with a new##2##4##(2008-10#2)
products with a##4##3##(1996-12#1)(2008-10#3)
products with the##3##3##(1996-1#1)(2008-10#2)
products with##18##2##(1990-2#1)(1993-6#1)(1996-1#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-5#3)(2009-10#1)(2009-11#1)(2010-7#1)(2011-2#1)
products##837##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#6)(1991-3#5)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#4)(1994-1#1)(1994-11#5)(1994-12#2)(1994-3#1)(1994-5#3)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#9)(1995-8#2)(1995-9#3)(1996-1#1)(1996-12#15)(1996-2#2)(1996-3#1)(1996-5#21)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#9)(1997-3#7)(1997-4#1)(1997-7#2)(1997-8#1)(2007-12#9)(2008-1#1)(2008-10#305)(2008-11#57)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#10)(2008-5#103)(2008-6#1)(2008-7#19)(2008-8#8)(2008-9#9)(2009-10#3)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#9)(2009-9#2)(2010-10#1)(2010-11#2)(2010-3#2)(2010-4#8)(2010-5#4)(2010-6#1)(2010-7#9)(2010-9#1)(2011-1#4)(2011-2#37)(2011-3#3)(2012-12#3)(2012-2#17)(2012-3#4)(2013-1#8)(2013-8#3)
products'##2##1##(2008-5#2)
products)##3##1##(2008-10#3)
products]##3##1##(1991-2#1)(1993-11#1)(2010-3#1)
producís##2##1##(2013-8#2)
proenzymes##2##1##(1995-6#1)(2013-1#1)
profession and##5##2##(1993-1#1)(1994-12#1)(2007-12#1)(2008-12#1)(2012-3#1)
profession is##2##2##(1994-12#2)
profession of##4##2##(1994-12#1)(1996-1#1)(2008-10#1)(2008-12#1)
profession##57##1##(1990-2#1)(1991-2#3)(1991-3#1)(1992-1#1)(1993-1#3)(1993-12#1)(1993-3#2)(1993-6#2)(1994-12#9)(1994-3#1)(1995-11#1)(1996-1#2)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#9)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#4)(2012-3#5)(2013-1#1)
profession's##4##1##(1992-12#2)(2008-12#1)(2008-4#1)
professional and legal issues in nursing##2##6##(2008-11#2)
professional and##11##2##(1991-12#1)(1992-12#1)(1994-1#1)(1994-3#1)(1996-3#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#2)
professional associations and private training and development corporations##2##8##(1993-3#1)(1997-3#1)
professional associations##4##2##(1993-3#1)(1996-12#1)(1997-3#1)(2008-12#1)
professional attitude##5##2##(1990-2#5)
professional boundaries##3##2##(2008-11#2)(2008-12#1)
professional characteristics##2##2##(1992-3#1)(1994-3#1)
professional competence##2##2##(1993-3#1)(2008-12#1)
professional confidence as perceived by##2##5##(2008-11#1)(2008-12#1)
professional confidence as##3##3##(2008-11#1)(2008-12#2)
professional confidence in nursing##2##4##(2008-11#1)(2008-12#1)
professional confidence is##2##3##(2008-11#2)
professional confidence##11##2##(2008-11#7)(2008-12#4)
professional development and##2##3##(2008-11#1)(2013-8#1)
professional development in##2##3##(2008-11#1)(2010-9#1)
professional development of the##2##4##(2008-12#2)
professional development##20##2##(1993-1#1)(2008-11#12)(2008-12#2)(2009-10#1)(2010-10#1)(2010-9#1)(2013-8#2)
professional education in##2##3##(1997-3#1)(2008-12#1)
professional education##10##2##(1993-1#1)(1994-12#2)(1997-3#2)(2008-11#1)(2008-12#3)(2010-5#1)
professional experience##3##2##(1994-3#1)(2008-9#1)(2010-5#1)
professional history##2##2##(2008-11#1)(2008-12#1)
professional image##2##2##(1993-3#2)
professional knowledge and##2##3##(1993-3#1)(2010-10#1)
professional knowledge##4##2##(1993-3#1)(2008-11#2)(2010-10#1)
professional learning##4##2##(2008-11#1)(2008-12#3)
professional lives##2##2##(2008-11#2)
professional misconduct##2##2##(2008-12#2)
professional norms##2##2##(1993-3#1)(2008-12#1)
professional nurses##2##2##(2008-11#1)(2008-12#1)
professional nursing journals##2##3##(2010-11#2)
professional nursing##8##2##(1991-2#2)(2008-11#1)(2010-10#1)(2010-11#2)(2013-1#2)
professional organizations##5##2##(1994-12#1)(1996-1#1)(2008-1#1)(2008-12#1)(2008-9#1)
professional paper##23##2##(1992-3#1)(1993-1#1)(1994-1#4)(1994-3#9)(1996-1#2)(1996-3#2)(1997-1#4)
professional practice##13##2##(1991-3#1)(2008-1#1)(2008-11#7)(2008-12#3)(2013-1#1)
professional practices and##2##3##(2008-11#2)
professional practices##4##2##(2008-11#3)(2009-6#1)
professional profile##5##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(2012-2#1)
professional public##2##2##(1991-3#1)(2010-8#1)
professional qualifications##2##2##(1990-12#2)
professional relationships##4##2##(2008-7#2)(2008-8#1)(2010-1#1)
professional role##4##2##(1996-2#1)(2008-11#2)(2010-10#1)
professional self-esteem##2##2##(2008-11#2)
professional service firms##2##3##(1993-1#2)
professional service##3##2##(1993-1#2)(1994-12#1)
professional skill##2##2##(2008-12#1)(2010-4#1)
professional skills##4##2##(1993-6#2)(2008-11#1)(2013-1#1)
professional staff##2##2##(1993-2#1)(2008-8#1)
professional support##3##2##(1992-3#2)(1993-2#1)
professional uncertainty##2##2##(1993-3#2)
professional who##2##2##(1992-1#1)(2012-3#1)
professional work##2##2##(1990-6#1)(2012-2#1)
professional##289##1##(1990-12#3)(1990-2#6)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#5)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#6)(1992-5#2)(1993-1#7)(1993-12#1)(1993-2#3)(1993-3#13)(1993-6#4)(1994-1#7)(1994-12#7)(1994-2#1)(1994-3#13)(1995-1#2)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#8)(1996-8#1)(1997-1#7)(1997-2#2)(1997-3#3)(2008-1#3)(2008-10#1)(2008-11#64)(2008-12#37)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-2#6)(2012-2#7)(2012-3#4)(2013-1#9)(2013-8#4)
professionalism##7##1##(1993-12#1)(1993-3#1)(2008-12#1)(2013-1#4)
professionalization##3##1##(1994-3#2)(2012-2#1)
professionally led##2##2##(1996-3#1)(2008-11#1)
professionally##4##1##(1991-3#1)(1996-3#1)(2008-11#1)(2013-8#1)
professionals &quot##2##2##(1993-2#2)
professionals and##10##2##(1992-3#2)(1993-2#1)(1997-1#1)(2008-11#3)(2010-12#1)(2012-3#2)
professionals are##2##2##(1990-6#1)(1996-1#1)
professionals as##2##2##(1993-1#1)(2007-12#1)
professionals by##2##2##(2007-12#1)(2011-2#1)
professionals can##2##2##(2007-12#1)(2013-8#1)
professionals caring for##2##3##(1992-3#1)(2008-11#1)
professionals from##3##2##(1992-3#1)(1995-3#1)(2013-1#1)
professionals in health##2##3##(1996-1#1)(2010-2#1)
professionals in##11##2##(1991-1#1)(1991-2#2)(1993-12#1)(1994-12#1)(1996-1#1)(1996-2#1)(2008-1#2)(2008-12#1)(2010-2#1)
professionals is##3##2##(1992-3#1)(1994-1#1)(2008-12#1)
professionals may##2##2##(1996-3#1)(2013-1#1)
professionals need##3##2##(1993-1#1)(1994-3#1)(2008-9#1)
professionals of##4##2##(1994-1#2)(2008-12#1)(2009-10#1)
professionals should be aware##2##4##(2010-1#1)(2013-1#1)
professionals should##3##2##(1993-12#1)(2010-1#1)(2013-1#1)
professionals that##2##2##(2008-12#1)(2012-3#1)
professionals through##2##2##(2008-12#1)(2012-2#1)
professionals to##11##2##(1994-1#1)(1995-6#1)(2008-11#4)(2008-12#1)(2009-9#2)(2010-8#1)(2011-2#1)
professionals towards##2##2##(2008-11#1)(2008-12#1)
professionals view their##2##3##(1993-2#1)(1994-3#1)
professionals was##2##2##(1994-1#1)(2009-5#1)
professionals who##8##2##(1991-12#1)(2007-12#1)(2008-11#2)(2008-12#1)(2010-1#2)(2011-2#1)
professionals with a##3##3##(1991-1#1)(1994-12#1)(2013-8#1)
professionals working with##2##3##(2008-10#1)(2008-11#1)
professionals working##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
professionals##167##1##(1990-6#1)(1991-1#2)(1991-12#3)(1991-2#6)(1992-1#1)(1992-12#1)(1992-3#7)(1993-1#3)(1993-12#2)(1993-2#7)(1993-3#1)(1993-6#1)(1994-1#7)(1994-12#6)(1994-3#3)(1994-6#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-1#3)(1996-2#1)(1996-3#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#5)(2008-1#4)(2008-10#2)(2008-11#29)(2008-12#13)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-1#6)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#2)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#4)
professionals' attitudes##2##2##(1994-3#1)(2010-10#1)
professionals'##5##1##(1994-1#1)(1994-3#1)(2010-10#1)(2012-12#1)(2013-1#1)
professions##17##1##(1991-6#2)(1992-1#1)(1992-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-12#3)(2012-2#2)(2013-1#1)
professor of##2##2##(1997-5#1)(2010-7#1)
professor##6##1##(1997-5#1)(2008-10#2)(2010-7#1)(2011-2#1)(2013-8#1)
professors of##2##2##(1993-6#1)(2010-1#1)
professors##4##1##(1993-6#1)(2010-1#1)(2012-2#2)
proficiency and##2##2##(2008-12#1)(2010-9#1)
proficiency of##2##2##(1992-12#1)(1996-6#1)
proficiency testing##2##2##(2008-10#1)(2008-4#1)
proficiency##16##1##(1992-12#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
proficient mentor##4##2##(2008-7#4)
proficient##6##1##(2008-7#6)
profile and for##2##3##(2008-10#1)(2011-2#1)
profile and the##5##3##(1990-8#1)(1995-11#1)(1995-8#1)(2008-3#2)
profile and##21##2##(1990-8#1)(1995-11#1)(1995-8#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-7#1)(2009-10#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-3#1)
profile are##2##2##(2008-2#1)(2008-3#1)
profile as##2##2##(1995-5#1)(2008-10#1)
profile by##2##2##(1993-11#1)(2008-3#1)
profile can##4##2##(1991-2#1)(1993-8#1)(1996-1#1)(2008-3#1)
profile characteristics##2##2##(1996-2#1)(2008-3#1)
profile comparisons##2##2##(2008-10#1)(2008-4#1)
profile for##7##2##(1990-2#1)(1992-4#1)(1994-8#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)
profile from##4##2##(1990-11#1)(2008-10#2)(2008-3#1)
profile in the##4##3##(1996-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
profile in##15##2##(1996-12#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-1#1)(2009-10#1)(2010-11#1)(2010-12#1)(2012-2#3)(2013-8#1)
profile is##12##2##(1993-2#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-12#1)(2008-11#1)(2008-3#4)(2012-3#1)
profile measurements##3##2##(2008-2#2)(2008-3#1)
profile of a##6##3##(1993-2#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-3#2)
profile of acute##2##3##(1992-3#1)(2009-12#1)
profile of an elderly population in Tabasco##2##7##(2012-12#2)
profile of an##4##3##(2008-3#1)(2011-2#1)(2012-12#2)
profile of different##2##3##(2008-10#1)(2008-2#1)
profile of patients with##2##4##(2009-5#1)(2012-3#1)
profile of patients##3##3##(2009-5#1)(2010-5#1)(2012-3#1)
profile of the##18##3##(1995-11#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)
profile of these##2##3##(2007-11#1)(2008-11#1)
profile of##119##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-2#2)(2008-3#8)(2008-5#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#7)(2012-4#1)(2013-1#2)(2013-8#3)
profile or##2##2##(2007-12#1)(2010-11#1)
profile sampler##3##2##(2010-5#3)
profile showed##2##2##(2010-5#1)(2011-2#1)
profile shows##2##2##(1992-9#1)(2008-11#1)
profile the##2##2##(1994-12#1)(2009-6#1)
profile to##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2012-3#1)
profile was studied##2##3##(2008-10#2)
profile was##10##2##(1992-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-3#1)
profile with##5##2##(1996-2#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)
profile within##2##2##(2008-10#1)(2013-1#1)
profile##347##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#4)(1991-6#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#5)(1994-12#1)(1994-5#2)(1994-8#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#2)(1995-5#1)(1995-8#3)(1996-1#4)(1996-12#6)(1996-2#5)(1996-3#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#3)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#61)(2008-11#19)(2008-12#2)(2008-2#11)(2008-3#32)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#3)(2009-1#2)(2009-10#7)(2009-11#1)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#2)(2010-10#4)(2010-11#6)(2010-12#3)(2010-4#2)(2010-5#7)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#14)(2011-3#1)(2012-12#5)(2012-2#8)(2012-3#12)(2012-4#2)(2013-1#10)(2013-8#5)
profiled##3##1##(2008-10#1)(2008-5#1)(2010-5#1)
profiles and the##4##3##(1994-8#1)(2008-10#2)(2008-2#1)
profiles and##18##2##(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#2)(2009-11#2)(2012-12#1)(2012-3#1)(2013-1#1)
profiles are##8##2##(1992-4#1)(1996-2#1)(2008-10#3)(2008-3#2)(2012-3#1)
profiles between##4##2##(2008-10#2)(2008-3#2)
profiles could##2##2##(2008-12#1)(2011-3#1)
profiles did not##2##3##(2008-10#2)
profiles due to##2##3##(1992-8#1)(2012-3#1)
profiles for the##3##3##(1991-9#1)(2008-3#1)(2008-8#1)
profiles for##17##2##(1991-9#1)(1994-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
profiles from##7##2##(1996-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
profiles have been##4##3##(1990-5#1)(1991-5#1)(2008-8#1)(2009-12#1)
profiles in the##3##3##(2008-11#1)(2008-3#2)
profiles in##15##2##(1991-12#1)(1996-2#1)(2008-10#3)(2008-11#3)(2008-3#3)(2010-11#1)(2010-4#1)(2011-2#1)(2013-7#1)
profiles indicated that##2##3##(1990-12#1)(2008-10#1)
profiles is##2##2##(2008-10#1)(2008-3#1)
profiles obtained by##5##3##(2008-10#2)(2008-2#2)(2008-5#1)
profiles obtained##10##2##(2008-10#5)(2008-12#1)(2008-2#2)(2008-5#2)
profiles of a##2##3##(1995-8#1)(2009-6#1)
profiles of all##2##3##(2008-10#1)(2012-2#1)
profiles of cell##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
profiles of fragrance##2##3##(2008-5#2)
profiles of the two##2##4##(2008-11#1)(2009-6#1)
profiles of the##17##3##(1995-6#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-6#1)
profiles of three different##2##4##(2008-10#1)(2008-11#1)
profiles of various##3##3##(2008-10#3)
profiles of##87##2##(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#32)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2011-10#2)(2011-2#2)(2011-3#1)(2012-2#3)(2012-6#1)(2013-1#2)
profiles on the##2##3##(1993-1#1)(2008-10#1)
profiles retrieved##2##2##(2008-3#2)
profiles revealed##3##2##(2008-10#2)(2012-2#1)
profiles showed that##3##3##(2008-10#2)(2010-12#1)
profiles showed##4##2##(2008-10#3)(2010-12#1)
profiles that were##3##3##(2008-10#1)(2008-12#2)
profiles that##5##2##(2008-10#2)(2008-12#2)(2011-2#1)
profiles to##2##2##(1997-2#1)(2008-10#1)
profiles using##4##2##(1991-9#1)(1992-1#1)(2008-10#1)(2012-3#1)
profiles was##2##2##(2008-10#2)
profiles were also##2##3##(2008-10#1)(2008-2#1)
profiles were found to##2##4##(2008-10#2)
profiles were generated from##2##4##(2008-10#1)(2008-12#1)
profiles were generated##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
profiles were obtained for##3##4##(2008-10#2)(2008-12#1)
profiles were obtained##6##3##(2008-10#5)(2008-12#1)
profiles were similar##2##3##(1996-12#1)(2011-10#1)
profiles were##31##2##(1994-11#1)(1996-12#2)(1997-2#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-10#1)(2013-1#1)
profiles##372##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#5)(1991-5#1)(1991-9#2)(1992-1#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#6)(1996-2#4)(1996-8#1)(1997-1#1)(1997-2#4)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#137)(2008-11#20)(2008-12#11)(2008-2#10)(2008-3#37)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#4)(2010-3#3)(2010-4#4)(2010-7#1)(2011-10#6)(2011-2#18)(2011-3#5)(2012-12#3)(2012-2#10)(2012-3#9)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#1)
profilin##2##1##(2009-10#1)(2010-12#1)
profiling and##4##2##(1995-11#1)(2008-10#1)(2008-12#1)(2010-5#1)
profiling has##4##2##(1995-11#1)(2008-11#1)(2010-12#1)(2012-3#1)
profiling in##3##2##(2008-10#1)(2009-10#1)(2013-1#1)
profiling of##19##2##(2008-10#5)(2008-11#2)(2008-4#1)(2008-6#2)(2008-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
profiling systems for##2##3##(2008-12#2)
profiling systems##4##2##(2008-12#4)
profiling using##3##2##(2008-10#1)(2008-4#1)(2009-6#1)
profiling##66##1##(1993-3#1)(1995-11#2)(1995-2#1)(2008-10#16)(2008-11#6)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#1)(2009-10#4)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
profilometer##2##1##(2008-2#1)(2009-7#1)
profit from##3##2##(1993-2#1)(1994-3#1)(2008-8#1)
profit rates##2##2##(1993-12#1)(1993-3#1)
profit##10##1##(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-2#1)(2008-11#2)(2008-8#1)
profitability##11##1##(1991-1#2)(1995-1#2)(2008-11#7)
profitable features such as a##2##5##(2008-10#2)
profitable features such as##5##4##(2008-10#5)
profitable##10##1##(2008-10#10)
profits in the##2##3##(1992-2#1)(1993-3#1)
profits##18##1##(1991-1#1)(1991-3#2)(1992-2#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-2#1)(1994-3#1)(1996-9#1)(1997-2#1)(2008-11#2)(2010-5#2)
proflavine##2##1##(2008-10#2)
proform##2##1##(1995-6#1)(2008-4#1)
profound and##2##2##(1992-8#1)(2013-1#1)
profound changes in the##2##4##(1994-12#2)
profound deafness##3##2##(2008-9#3)
profound effect on##4##3##(2008-10#1)(2008-5#1)(2010-4#1)(2010-6#1)
profound effects on##3##3##(1995-2#1)(2008-8#1)(2010-1#1)
profound effects##4##2##(1995-11#1)(1995-2#1)(2008-8#1)(2010-1#1)
profound hearing loss##6##3##(2008-9#6)
profound impact on the##2##4##(2008-11#1)(2010-11#1)
profound implications for##2##3##(2008-8#1)(2009-9#1)
profound implications##3##2##(2008-11#1)(2008-8#1)(2009-9#1)
profound##43##1##(1991-6#1)(1992-8#1)(1994-12#2)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#11)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-7#1)
profoundly affect the##2##3##(1995-5#1)(1997-6#1)
profoundly affects##2##2##(2008-11#1)(2011-2#1)
profoundly decreased##2##2##(2008-5#1)(2008-7#1)
profoundly##18##1##(1992-3#1)(1993-12#1)(1995-2#1)(1995-5#1)(1997-6#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2011-2#4)
profundus##3##1##(2010-6#1)(2011-2#2)
profuse diarrhoea##2##2##(2008-5#2)
profuse##6##1##(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)
profusion of##2##2##(2008-7#1)(2008-9#1)
progenies from##2##2##(2008-10#2)
progenies of crosses##2##3##(2008-10#2)
progenies of##5##2##(2008-10#4)(2008-9#1)
progenies were##4##2##(2008-10#4)
progenies##22##1##(2008-10#17)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
progenitor cell populations##2##3##(1995-6#1)(2008-9#1)
progenitor cell##7##2##(1995-6#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)
progenitor cells and##3##3##(2008-11#2)(2010-6#1)
progenitor cells are##3##3##(2008-11#1)(2008-9#1)(2009-12#1)
progenitor cells derived from##2##4##(2008-11#1)(2008-7#1)
progenitor cells in the##2##4##(2010-11#1)(2012-3#1)
progenitor cells in##4##3##(2010-1#1)(2010-11#1)(2012-3#1)(2013-1#1)
progenitor cells of the##3##4##(2008-11#2)(2013-1#1)
progenitor cells of##5##3##(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
progenitor cells that##2##3##(2008-9#1)(2013-1#1)
progenitor cells##51##2##(1990-12#1)(1994-5#4)(1997-7#2)(2008-11#18)(2008-7#4)(2008-8#1)(2008-9#6)(2009-12#2)(2010-1#2)(2010-11#2)(2010-6#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
progenitor of##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
progenitor##79##1##(1990-12#1)(1991-5#1)(1992-3#2)(1994-5#4)(1995-6#4)(1997-7#2)(2008-10#1)(2008-11#21)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#5)(2010-1#2)(2010-10#1)(2010-11#2)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)
progenitors and##2##2##(2009-12#1)(2013-1#1)
progenitors from##2##2##(2008-4#2)
progenitors in##6##2##(2008-10#2)(2008-4#4)
progenitors into##2##2##(2011-2#2)
progenitors##35##1##(1991-6#1)(1995-6#1)(1996-12#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#12)(2008-5#1)(2009-12#2)(2010-1#1)(2010-8#2)(2011-2#4)(2013-1#1)
progeny and##2##2##(2008-10#1)(2008-9#1)
progeny derived from the cross between##3##6##(2008-10#3)
progeny derived from##7##3##(2008-10#6)(2013-8#1)
progeny from a##2##3##(2008-10#2)
progeny from crosses between##2##4##(2008-10#1)(2012-3#1)
progeny from crosses##3##3##(2008-10#2)(2012-3#1)
progeny from the##2##3##(2008-10#1)(2008-9#1)
progeny from##12##2##(2008-10#9)(2008-11#1)(2008-9#1)(2012-3#1)
progeny in##2##2##(2008-10#1)(2012-3#1)
progeny isolates were##2##3##(2008-10#2)
progeny isolates##4##2##(2008-10#4)
progeny lines##2##2##(2008-10#1)(2012-3#1)
progeny of a cross between##2##5##(2008-10#1)(2008-9#1)
progeny of line##3##3##(2008-10#3)
progeny of matings between##2##4##(2008-10#2)
progeny of the##6##3##(2008-10#6)
progeny of two##2##3##(2008-10#1)(2009-10#1)
progeny of##24##2##(2007-12#1)(2008-10#20)(2008-9#1)(2009-10#1)(2010-8#1)
progeny segregated##2##2##(2008-10#2)
progeny testing##2##2##(2008-10#2)
progeny virus derived from cloned DNA##2##6##(2008-10#2)
progeny virus derived from##3##4##(2008-10#3)
progeny virus##7##2##(1995-12#1)(1997-3#1)(2008-10#5)
progeny was##3##2##(2008-10#3)
progeny were examined for virulence##2##5##(2008-10#2)
progeny were##11##2##(2008-10#10)(2008-11#1)
progeny##123##1##(1994-11#1)(1995-11#1)(1995-12#1)(1997-3#3)(2007-12#1)(2008-10#95)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#2)(2012-3#4)(2013-8#1)
progesteron##4##1##(2008-11#4)
progesterone (P)##2##2##(1995-11#1)(2008-10#1)
progesterone and##4##2##(1991-12#1)(2008-12#1)(2008-7#1)(2013-1#1)
progesterone in##3##2##(1990-5#2)(1995-11#1)
progesterone receptor level as well as plasminogen activator activity in MCF-7 cells##2##12##(2008-11#2)
progesterone receptor##5##2##(1993-11#1)(2008-11#3)(2011-2#1)
progesterone to##2##2##(1990-11#1)(1995-12#1)
progesterone##39##1##(1990-11#6)(1990-5#2)(1991-12#1)(1991-3#2)(1993-11#1)(1994-2#1)(1994-3#2)(1995-11#4)(1995-12#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-7#2)(2008-8#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
progestin##2##1##(1990-11#1)(2011-2#1)
progestins##2##1##(1990-11#1)(2008-11#1)
progestogen##3##1##(2008-5#1)(2011-2#2)
progestrone receptor##2##2##(2008-11#2)
prognoses##3##1##(1996-11#1)(2011-2#1)(2012-3#1)
prognosis after treatment##2##3##(2008-7#2)
prognosis after##3##2##(1991-2#1)(2008-7#2)
prognosis and##15##2##(1990-3#1)(1991-8#1)(1994-9#1)(2008-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
prognosis associated with##2##3##(1993-1#1)(1997-7#1)
prognosis because##2##2##(1996-11#1)(2011-2#1)
prognosis for##10##2##(1992-5#1)(1993-11#1)(2008-6#1)(2008-7#4)(2011-2#3)
prognosis in patients with##2##4##(2009-10#1)(2013-1#1)
prognosis in##9##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#1)(1996-11#1)(2009-10#1)(2011-2#2)(2013-1#1)
prognosis is generally##2##3##(2010-7#1)(2013-1#1)
prognosis is##7##2##(1990-9#1)(1996-8#1)(1996-9#3)(2010-7#1)(2013-1#1)
prognosis of RCC##2##3##(2012-3#2)
prognosis of course##2##3##(2013-1#2)
prognosis of patients##2##3##(2008-7#1)(2011-2#1)
prognosis of the##4##3##(1993-2#1)(2010-8#1)(2011-3#1)(2012-3#1)
prognosis of these##3##3##(1994-6#1)(2008-10#1)(2010-8#1)
prognosis of this##4##3##(1992-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
prognosis of##44##2##(1991-2#1)(1991-6#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#4)(2011-2#3)(2011-3#1)(2011-7#1)(2012-3#4)(2013-1#2)
prognosis than##2##2##(2009-5#1)(2013-1#1)
prognosis was##4##2##(1990-8#1)(1991-8#1)(1994-12#1)(2008-1#1)
prognosis with##3##2##(1990-12#1)(2013-1#1)(2013-8#1)
prognosis##211##1##(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#7)(1990-9#3)(1991-11#2)(1991-2#4)(1991-3#1)(1991-6#4)(1991-8#6)(1992-11#1)(1992-5#2)(1992-9#1)(1993-1#4)(1993-11#4)(1993-2#1)(1994-12#4)(1994-6#4)(1994-9#1)(1995-9#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#3)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#2)(2009-1#2)(2009-10#2)(2009-11#2)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#2)(2010-11#4)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2011-2#19)(2011-3#5)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#12)(2013-1#17)(2013-8#2)
prognostic and predictive##2##3##(2008-7#1)(2013-8#1)
prognostic and##4##2##(2008-7#2)(2010-9#1)(2013-8#1)
prognostic assessment##3##2##(1991-6#1)(2008-10#1)(2011-2#1)
prognostic factor for##2##3##(1993-11#1)(2012-3#1)
prognostic factor in##2##3##(2011-2#1)(2012-3#1)
prognostic factor##9##2##(1993-11#1)(2007-8#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#2)
prognostic factors and##3##3##(1994-12#1)(2008-10#1)(2010-11#1)
prognostic factors are##2##3##(1990-9#1)(2011-2#1)
prognostic factors for##2##3##(1991-9#1)(2011-2#1)
prognostic factors##18##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-9#1)(1994-12#2)(1997-8#2)(2008-10#1)(2008-7#1)(2010-11#2)(2011-2#3)(2012-3#2)
prognostic features##4##2##(1992-2#1)(2008-9#1)(2011-1#2)
prognostic indicator##5##2##(1993-11#2)(1994-12#1)(2008-7#1)(2010-11#1)
prognostic indicators for##2##3##(1991-8#1)(2012-2#1)
prognostic indicators##6##2##(1991-8#1)(1993-11#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
prognostic information##4##2##(1991-2#1)(2009-4#1)(2010-11#1)(2011-2#1)
prognostic marker##3##2##(2011-2#2)(2012-2#1)
prognostic markers##3##2##(2008-3#1)(2010-5#1)(2011-2#1)
prognostic model##3##2##(1995-9#3)
prognostic parameters##2##2##(1997-8#1)(2011-2#1)
prognostic significance of##7##3##(1991-12#1)(1993-1#1)(2008-11#2)(2008-7#2)(2012-3#1)
prognostic significance##10##2##(1990-12#1)(1991-12#1)(1993-1#1)(1994-8#1)(2008-11#2)(2008-7#3)(2012-3#1)
prognostic signs##2##2##(1990-3#2)
prognostic value for##2##3##(2012-12#2)
prognostic value of##6##3##(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
prognostic value##13##2##(1990-8#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
prognostic variables and##2##3##(1994-6#1)(2012-3#1)
prognostic variables##5##2##(1991-3#1)(1994-6#1)(2009-8#1)(2012-3#2)
prognostic##127##1##(1990-12#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#5)(1994-12#4)(1994-6#1)(1994-8#1)(1995-9#3)(1997-5#1)(1997-8#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-7#8)(2008-9#2)(2009-11#1)(2009-4#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#8)(2010-12#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#17)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#12)(2013-1#2)(2013-8#1)
prognostication##6##1##(1994-12#1)(2008-11#1)(2010-11#1)(2011-2#3)
program aimed at##2##3##(1990-6#1)(2013-1#1)
program and an##2##3##(1994-12#1)(1995-3#1)
program and its##2##3##(1991-2#2)
program and the##2##3##(1994-12#1)(2008-11#1)
program and to##2##3##(1995-1#1)(1997-1#1)
program and##21##2##(1991-1#1)(1991-2#2)(1994-12#3)(1994-2#1)(1995-1#2)(1995-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-9#1)(2010-7#1)(2013-1#1)
program appears to##2##3##(1994-2#1)(1997-2#1)
program are##5##2##(1993-5#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-4#1)
program at a##2##3##(1992-2#1)(1997-4#1)
program at his hospital##2##4##(1991-1#1)(1994-2#1)
program at his##3##3##(1991-1#2)(1994-2#1)
program at the##3##3##(1994-12#1)(2009-3#1)(2013-1#1)
program at##11##2##(1991-1#2)(1992-2#1)(1994-12#2)(1994-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
program based on##3##3##(1996-12#1)(2008-10#2)
program based##4##2##(1996-12#1)(2008-10#2)(2013-8#1)
program because##2##2##(1991-1#1)(2012-2#1)
program by##2##2##(1991-1#1)(1991-12#1)
program called##3##2##(2008-6#1)(2008-9#1)(2012-12#1)
program can##4##2##(1994-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
program changes##2##2##(1995-2#1)(2008-11#1)
program components##2##2##(1992-1#1)(1993-3#1)
program cost##2##2##(1992-3#1)(1995-3#1)
program could##2##2##(1992-12#1)(2008-10#1)
program demonstrated##2##2##(1991-2#1)(1995-1#1)
program design and##2##3##(1991-2#1)(1997-3#1)
program design##3##2##(1991-2#1)(1997-3#1)(2008-1#1)
program designed to improve##2##4##(1997-2#1)(2008-12#1)
program designed to##5##3##(1994-3#1)(1996-1#1)(1997-2#1)(2008-12#1)(2013-1#1)
program developed##2##2##(1991-2#1)(1995-2#1)
program development##5##2##(1991-2#1)(1992-2#1)(1997-1#1)(2008-11#1)(2010-7#1)
program directors##3##2##(1994-3#1)(2009-8#2)
program during the##2##3##(1992-3#1)(1993-3#1)
program during##3##2##(1992-3#1)(1993-3#1)(1997-2#1)
program enrollment##2##2##(1991-3#1)(1997-2#1)
program evaluation##3##2##(1993-2#1)(1997-1#1)(1997-2#1)
program expenditures##2##2##(1993-1#1)(1993-3#1)
program for a##5##3##(1991-1#1)(1992-2#1)(1994-12#1)(1996-3#1)(2008-11#1)
program for persons with##2##4##(1993-1#1)(1993-3#1)
program for prevention##2##3##(1995-3#2)
program for rural##3##3##(1992-12#1)(1996-2#1)(2013-1#1)
program for##53##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#4)(1995-9#2)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#4)(2008-12#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
program from##4##2##(1993-1#1)(1994-1#1)(1995-12#1)(2008-10#1)
program has also been##2##4##(1993-3#1)(2008-3#1)
program has been##5##3##(1991-2#1)(1996-3#1)(2008-11#1)(2011-3#1)(2013-1#1)
program has##16##2##(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-12#2)(1996-3#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2011-3#1)(2013-1#1)
program in an##3##3##(1996-3#1)(1997-1#1)(2008-7#1)
program in the##11##3##(1990-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-1#2)(1996-1#1)(1996-11#1)(2009-8#1)
program in##36##2##(1990-11#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-1#2)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#2)(1997-2#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2009-8#1)(2012-12#3)(2012-3#1)
program into##2##2##(2008-11#2)
program is a##3##3##(1991-1#2)(1996-6#1)
program is to##2##3##(2008-11#2)
program is##19##2##(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-3#1)(1995-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#1)
program location and program reputation##2##5##(1996-1#2)
program location and##3##3##(1996-1#3)
program management##7##2##(1994-12#2)(1994-3#3)(1996-2#1)(1996-3#1)
program managers##2##2##(1994-12#1)(1996-12#1)
program may##3##2##(1993-3#1)(2008-12#1)(2013-8#1)
program of instruction in operative laparoscopy##2##6##(1993-12#2)
program of##27##2##(1991-12#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1994-12#2)(1994-2#2)(1995-2#2)(1996-12#1)(1996-6#1)(1997-2#2)(2008-10#3)(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
program on the##4##3##(1990-3#1)(1992-1#1)(1995-1#1)(2008-10#1)
program on##12##2##(1990-3#1)(1991-2#1)(1992-1#1)(1995-1#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-7#2)(2011-3#1)(2012-12#1)
program over the##2##3##(1992-1#1)(2008-4#1)
program participation##4##2##(1995-12#1)(2008-12#3)
program payments##3##2##(1991-2#1)(1991-3#2)
program performance##2##2##(1995-1#2)
program providers##2##2##(1994-2#1)(2008-11#1)
program provides##4##2##(1993-12#1)(2008-10#2)(2008-11#1)
program providing##2##2##(1996-3#1)(2008-10#1)
program reputation##3##2##(1996-1#3)
program staff##3##2##(1995-12#1)(1996-2#1)(1996-3#1)
program that creates##2##3##(2008-11#1)(2008-9#1)
program that is##2##3##(1997-3#1)(2012-3#1)
program that was##2##3##(1990-3#1)(1996-1#1)
program that##20##2##(1990-3#1)(1991-12#1)(1992-12#3)(1993-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)(2010-8#1)(2012-3#1)
program to ensure##2##3##(1996-2#1)(2008-9#1)
program to improve##2##3##(2013-1#2)
program to##24##2##(1991-1#2)(1991-2#1)(1995-12#1)(1995-2#1)(1996-2#2)(1997-1#2)(1997-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
program was carried out by employing a heating cycle in four steps##2##12##(2008-10#2)
program was carried out##3##4##(2008-10#2)(2008-11#1)
program was developed##2##3##(1997-2#1)(2008-11#1)
program was established in##2##4##(1993-3#1)(1996-1#1)
program was used to##2##4##(1992-1#1)(2008-11#1)
program was used##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
program was##27##2##(1991-1#1)(1991-2#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#2)(1997-2#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#1)(2010-10#2)(2010-11#1)(2010-7#1)
program were##5##2##(1991-12#1)(1991-2#1)(2008-10#3)
program which##4##2##(1992-1#1)(1994-9#1)(2008-10#2)
program will##4##2##(1993-12#1)(1994-2#2)(2008-5#1)
program with a##2##3##(1997-1#1)(2011-3#1)
program with##10##2##(1992-12#1)(1995-1#1)(1997-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-3#1)(2013-1#1)(2013-8#1)
program within##2##2##(1991-1#1)(1991-2#1)
program would be##2##3##(1997-6#1)(2012-12#1)
program would##6##2##(1992-12#1)(1995-1#1)(1997-6#1)(2008-11#1)(2012-12#1)(2013-1#1)
program##783##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-6#2)(1991-1#22)(1991-12#14)(1991-2#24)(1991-3#12)(1991-6#2)(1991-9#1)(1992-1#15)(1992-12#15)(1992-2#15)(1992-3#9)(1992-6#1)(1993-1#9)(1993-11#3)(1993-12#9)(1993-2#14)(1993-3#20)(1993-5#1)(1994-1#1)(1994-12#25)(1994-2#15)(1994-3#17)(1994-5#2)(1994-6#2)(1994-9#3)(1995-1#17)(1995-12#17)(1995-2#10)(1995-3#13)(1995-6#1)(1995-9#3)(1996-1#20)(1996-11#1)(1996-12#10)(1996-2#12)(1996-3#15)(1996-6#3)(1996-9#1)(1997-1#13)(1997-2#27)(1997-3#6)(1997-4#1)(1997-6#4)(1997-7#1)(2008-1#1)(2008-10#84)(2008-11#43)(2008-12#25)(2008-2#1)(2008-3#8)(2008-4#19)(2008-5#4)(2008-6#8)(2008-7#9)(2008-8#11)(2008-9#13)(2009-12#4)(2009-3#3)(2009-8#5)(2010-10#6)(2010-11#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#8)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#3)(2011-7#1)(2012-12#15)(2012-2#8)(2012-3#7)(2013-1#37)(2013-8#9)
program's##5##1##(2008-10#1)(2008-6#2)(2012-12#2)
program]##2##1##(1997-4#1)(1997-5#1)
programmable temperature vaporizer (PTV-LV) injection##2##5##(2008-10#2)
programmable##5##1##(2008-10#5)
programmatic areas##3##2##(2013-1#3)
programmatic##9##1##(1996-12#1)(1997-3#2)(2008-10#1)(2012-2#1)(2013-1#3)(2013-8#1)
programme and##8##2##(2008-10#2)(2008-11#2)(2008-12#3)(2013-8#1)
programme directors##2##2##(2011-2#2)
programme for nurses##2##3##(2008-11#1)(2008-12#1)
programme for the##2##3##(2008-11#1)(2010-10#1)
programme for##13##2##(1990-12#1)(1991-2#1)(1993-6#1)(1995-2#1)(2008-11#4)(2008-12#2)(2010-10#1)(2010-11#1)(2011-2#1)
programme has##2##2##(1993-6#1)(2012-3#1)
programme in##7##2##(1990-11#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-9#2)(2010-7#1)
programme is##5##2##(1994-12#1)(2008-11#2)(2008-12#2)
programme on##3##2##(2008-11#1)(2008-12#2)
programme provides##2##2##(2008-12#2)
programme should##2##2##(2008-11#1)(2010-10#1)
programme that##3##2##(2008-11#1)(2008-12#1)(2012-3#1)
programme to##2##2##(2008-11#1)(2012-2#1)
programme was applied to##2##4##(2008-10#1)(2008-8#1)
programme was applied##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
programme was optimized##2##3##(2008-10#1)(2010-1#1)
programme was##11##2##(1990-2#1)(1995-11#1)(2008-10#2)(2008-8#2)(2008-9#2)(2010-1#2)(2013-8#1)
programme##149##1##(1990-11#3)(1990-12#1)(1990-2#2)(1991-2#1)(1991-6#4)(1991-8#1)(1993-6#5)(1994-12#1)(1995-11#1)(1995-2#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#16)(2008-11#33)(2008-12#19)(2008-5#1)(2008-8#3)(2008-9#15)(2009-1#2)(2009-4#2)(2010-1#3)(2010-10#5)(2010-11#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#6)
programme's##2##1##(2008-11#1)(2011-2#1)
programmed cell death (PCD)##2##4##(2009-8#2)
programmed cell death or##2##4##(1996-12#1)(2008-11#1)
programmed cell death##21##3##(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(2008-11#2)(2008-4#3)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2011-2#2)
programmed cell##22##2##(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2011-2#2)
programmed death##2##2##(2010-5#1)(2012-3#1)
programmed decomposition (TPDE) of [Mo(CO)(6)]##2##5##(2008-10#2)
programmed diode array photometric detection##2##5##(2008-10#2)
programmed electrical stimulation##2##3##(2008-12#1)(2011-2#1)
programmed electrical##3##2##(1992-3#1)(2008-12#1)(2011-2#1)
programmed flow systems##2##3##(2008-10#2)
programmed flow##3##2##(2008-10#3)
programmed sequence##3##2##(2008-10#3)
programmed to##3##2##(1992-3#1)(2008-11#1)(2011-2#1)
programmed##56##1##(1992-3#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-3#2)
programmes and##5##2##(1996-11#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-12#1)
programmes are##2##2##(1997-8#1)(2008-11#1)
programmes as well as##2##4##(1991-6#1)(2012-2#1)
programmes as##3##2##(1991-6#1)(1993-6#1)(2012-2#1)
programmes for##13##2##(1994-12#1)(1995-12#1)(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2011-2#1)
programmes in##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2013-7#1)
programmes is##4##2##(1991-6#2)(1997-7#1)(2013-1#1)
programmes of##2##2##(1991-6#1)(2008-11#1)
programmes that can be##2##4##(2008-11#1)(2008-12#1)
programmes that##3##2##(1994-6#1)(2008-11#1)(2008-12#1)
programmes were##3##2##(2008-10#2)(2011-2#1)
programmes##83##1##(1991-6#5)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-9#1)(1996-11#2)(1996-8#1)(1997-7#2)(1997-8#1)(2008-1#3)(2008-10#9)(2008-11#24)(2008-12#10)(2008-6#1)(2008-9#6)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
programming (LP)##2##2##(2008-11#1)(2008-7#1)
programming and##5##2##(1994-3#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)
programming can be used##2##4##(2008-11#1)(2008-7#1)
programming language##2##2##(2008-10#2)
programming of##2##2##(2008-10#1)(2008-11#1)
programming the speech processor of##2##5##(2008-9#2)
programming##43##1##(1990-3#1)(1991-6#1)(1994-3#2)(2008-10#10)(2008-11#5)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#10)(2009-10#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-3#2)(2013-8#2)
programs aimed at##2##3##(2008-10#1)(2012-2#1)
programs and for##2##3##(1994-2#1)(2008-10#1)
programs and services##2##3##(1991-2#1)(1995-3#1)
programs and the##2##3##(1996-1#1)(2008-10#1)
programs and##25##2##(1991-1#1)(1991-2#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
programs are presented##2##3##(1997-2#1)(2008-4#1)
programs are##24##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-1#2)(1996-3#1)(1997-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#3)
programs as well as##2##4##(1994-12#1)(2008-8#1)
programs as##5##2##(1994-12#1)(1995-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
programs can be##4##3##(1993-1#1)(1995-3#1)(2008-10#1)(2012-2#1)
programs can##11##2##(1991-1#1)(1992-3#1)(1993-1#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2012-2#1)(2013-8#1)
programs dealing with##2##3##(1995-12#1)(2008-10#1)
programs designed to##4##3##(1993-1#1)(2008-11#2)(2008-4#1)
programs do##2##2##(1993-1#1)(2008-9#1)
programs for clinical##3##3##(1994-12#2)(2008-12#1)
programs for the##7##3##(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
programs for##38##2##(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#6)
programs has##2##2##(1992-1#1)(2013-1#1)
programs have been##3##3##(1991-12#1)(1994-12#1)(1997-2#1)
programs have##15##2##(1991-1#1)(1991-12#2)(1994-12#2)(1995-3#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-12#1)
programs in Canada##2##3##(1991-3#1)(2008-11#1)
programs in TRM##3##3##(2008-1#3)
programs in health administration##8##4##(1991-1#1)(1994-1#1)(1996-1#3)(1996-2#1)(1996-3#2)
programs in health services administration##2##5##(1996-2#1)(1996-3#1)
programs in health services##3##4##(1992-1#1)(1996-2#1)(1996-3#1)
programs in health##12##3##(1991-1#1)(1992-1#1)(1994-1#1)(1996-1#3)(1996-2#3)(1996-3#3)
programs in the United States##3##5##(1993-1#1)(1997-2#1)(2012-12#1)
programs in the##10##3##(1991-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-11#2)(2012-12#1)
programs in their##3##3##(1995-3#1)(1996-3#1)(2008-11#1)
programs in##47##2##(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#2)(1993-1#1)(1993-11#1)(1993-2#1)(1994-1#2)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#5)(1996-2#3)(1996-3#5)(1997-1#2)(1997-2#1)(1997-3#1)(2008-1#3)(2008-10#3)(2008-11#5)(2009-8#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
programs is##8##2##(1992-12#1)(1994-2#2)(2008-11#2)(2008-12#1)(2011-2#1)(2011-3#1)
programs like the##2##3##(1994-2#1)(2010-5#1)
programs may##4##2##(1992-12#1)(1997-2#1)(2008-12#1)(2008-9#1)
programs must##5##2##(1991-1#1)(1993-12#1)(1997-2#3)
programs of##6##2##(1991-3#1)(1992-3#1)(1995-2#2)(1995-6#1)(2008-12#1)
programs on##4##2##(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
programs provide##3##2##(1995-1#1)(2008-11#2)
programs requires##2##2##(1994-12#1)(1995-2#1)
programs should##4##2##(1992-1#1)(1997-2#1)(2008-12#1)(2009-12#1)
programs such as##2##3##(2008-10#2)
programs targeting##3##2##(1996-2#1)(2008-11#1)(2008-12#1)
programs that have proven##2##4##(1996-12#1)(1996-2#1)
programs that provide##2##3##(1995-1#1)(2008-11#1)
programs that##18##2##(1991-1#1)(1993-1#1)(1994-1#1)(1995-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-6#2)(2008-9#1)(2009-7#1)(2013-1#2)
programs to be##2##3##(2008-10#1)(2010-9#1)
programs to improve##3##3##(1994-3#1)(2008-11#1)(2008-3#1)
programs to reduce##3##3##(1993-2#1)(2008-11#1)(2013-1#1)
programs to##21##2##(1991-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-6#2)(2008-10#2)(2008-11#2)(2008-3#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
programs under##2##2##(1994-1#1)(1995-3#1)
programs was##2##2##(1992-2#1)(2008-10#1)
programs were examined##2##3##(2008-10#2)
programs were identified as##2##4##(1996-1#2)
programs were##10##2##(1995-1#1)(1996-1#2)(1996-5#1)(1997-3#1)(2008-10#3)(2008-9#1)(2012-12#1)
programs will be##2##3##(1994-1#1)(1994-12#1)
programs will##3##2##(1994-1#1)(1994-12#1)(1996-12#1)
programs with the##2##3##(2008-10#1)(2010-9#1)
programs with##4##2##(1992-1#1)(2008-10#1)(2009-12#1)(2010-9#1)
programs within##2##2##(1995-1#1)(1997-2#1)
programs would help##2##3##(1990-2#1)(2010-8#1)
programs would##4##2##(1990-2#1)(1992-12#1)(1994-3#1)(2010-8#1)
programs##572##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#12)(1991-12#5)(1991-2#6)(1991-3#3)(1991-8#1)(1992-1#18)(1992-12#8)(1992-2#6)(1992-3#7)(1992-8#1)(1992-9#1)(1993-1#10)(1993-11#1)(1993-12#2)(1993-2#10)(1993-3#5)(1994-1#10)(1994-12#11)(1994-2#15)(1994-3#10)(1995-1#13)(1995-12#11)(1995-2#10)(1995-3#14)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#21)(1996-12#8)(1996-2#9)(1996-3#19)(1996-5#5)(1997-1#9)(1997-2#27)(1997-3#12)(1997-6#3)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#57)(2008-11#38)(2008-12#10)(2008-3#2)(2008-4#10)(2008-6#12)(2008-7#1)(2008-8#5)(2008-9#13)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#8)(2011-3#7)(2012-12#14)(2012-2#15)(2012-3#2)(2013-1#29)(2013-8#4)
programs)##2##1##(1994-1#1)(2009-1#1)
progress and people##2##3##(2008-10#2)
progress and##10##2##(1994-12#1)(1996-3#1)(2008-10#4)(2008-7#2)(2008-8#1)(2010-12#1)
progress are##2##2##(2012-2#1)(2012-3#1)
progress as##2##2##(2010-12#1)(2012-2#1)
progress at##2##2##(1991-2#1)(2012-2#1)
progress based on the##2##4##(2008-10#2)
progress can be##2##3##(2008-8#1)(2013-8#1)
progress could##2##2##(2008-11#1)(2012-2#1)
progress curve##30##2##(2008-10#30)
progress curves##8##2##(2008-10#8)
progress feedback##3##2##(2012-2#3)
progress for##2##2##(2008-10#2)
progress has been achieved in the##3##6##(1997-7#1)(2008-12#1)(2008-7#1)
progress has been achieved in##4##5##(1997-6#1)(1997-7#1)(2008-12#1)(2008-7#1)
progress has been made in the understanding of##2##8##(2008-11#2)
progress has been made in the##4##6##(2008-11#3)(2009-12#1)
progress has been made in##10##5##(1997-1#1)(2008-10#1)(2008-11#5)(2009-12#1)(2009-8#1)(2011-2#1)
progress has been made##13##4##(1997-1#1)(2008-10#1)(2008-11#5)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
progress has been##18##3##(1990-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
progress has##19##2##(1990-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
progress in development##2##3##(2010-10#1)(2011-2#1)
progress in learning##2##3##(2008-11#2)
progress in researches of##2##4##(2013-8#2)
progress in the development of HIV-1 fusion##2##7##(2011-3#2)
progress in the development of##7##5##(2008-10#3)(2011-2#1)(2011-3#2)(2013-1#1)
progress in the field##2##4##(2009-4#1)(2012-2#1)
progress in the##21##3##(1991-2#1)(1994-8#1)(1994-9#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
progress in this field##2##4##(2008-10#1)(2013-8#1)
progress in this##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
progress in understanding the##3##4##(2007-12#1)(2008-11#1)(2012-2#1)
progress in understanding##4##3##(2007-12#1)(2008-11#1)(2012-2#2)
progress in##62##2##(1990-11#1)(1991-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#6)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#5)
progress is being made##2##4##(1993-2#1)(2012-12#1)
progress is##4##2##(1993-2#1)(1994-2#1)(2008-10#1)(2012-12#1)
progress made in the##2##4##(2008-10#1)(2011-2#1)
progress made in##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
progress made##6##2##(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-2#1)
progress monitoring##8##2##(2008-12#1)(2011-2#7)
progress of the##5##3##(2008-10#3)(2011-1#1)(2012-2#1)
progress of##28##2##(1993-3#1)(1994-5#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-9#2)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#1)
progress on the##2##3##(2011-2#1)(2012-3#1)
progress on##7##2##(1995-1#1)(2008-10#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
progress over##2##2##(1996-11#1)(2008-10#1)
progress signal##2##2##(2008-11#2)
progress through##4##2##(1993-12#1)(2008-11#1)(2009-10#1)(2010-9#1)
progress to develop##2##3##(2008-10#1)(2009-8#1)
progress to##12##2##(1992-5#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#2)(2009-8#1)(2013-1#1)
progress towards##4##2##(1993-9#1)(1996-1#1)(2008-11#1)(2008-5#1)
progress was##5##2##(2008-10#3)(2010-1#1)(2012-2#1)
progress##288##1##(1990-11#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-11#3)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#91)(2008-11#30)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#7)(2009-10#6)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#21)(2011-3#3)(2012-12#1)(2012-2#18)(2012-3#5)(2013-1#5)(2013-8#8)
progress)##2##1##(2008-10#1)(2012-3#1)
progressed from##2##2##(1993-2#1)(2010-6#1)
progressed in the##2##3##(1992-3#1)(2008-10#1)
progressed through##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
progressed to##7##2##(1994-12#1)(1995-2#1)(1997-3#1)(2008-1#3)(2010-6#1)
progressed with##2##2##(2008-12#1)(2011-2#1)
progressed##35##1##(1990-2#1)(1990-6#1)(1991-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-3#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#2)(2008-7#1)(2009-8#1)(2010-6#2)(2011-2#2)(2012-3#1)
progresses in##2##2##(2009-12#1)(2011-2#1)
progresses through##2##2##(1997-1#1)(2013-1#1)
progresses##14##1##(1997-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#2)
progressing to##7##2##(1993-1#1)(1996-3#1)(2008-10#1)(2008-2#1)(2009-12#1)(2011-2#1)(2012-2#1)
progressing##16##1##(1991-1#1)(1993-1#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
progression and axial eye growth##2##5##(2010-1#2)
progression and##24##2##(2008-10#3)(2008-11#3)(2008-7#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
progression by##2##2##(1997-7#1)(2009-3#1)
progression for##2##2##(2012-3#2)
progression free survival##3##3##(2008-10#3)
progression from##4##2##(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
progression in the##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
progression in##20##2##(1994-8#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-5#1)(2012-2#1)(2012-3#1)(2012-8#3)(2013-1#3)
progression is##3##2##(2008-11#1)(2011-7#1)(2013-8#1)
progression of ARM in##2##4##(2011-2#2)
progression of ARM##3##3##(2011-2#3)
progression of a##2##3##(2011-2#1)(2013-1#1)
progression of atherosclerosis##4##3##(2008-1#3)(2013-7#1)
progression of cancer##2##3##(1993-9#1)(2013-1#1)
progression of chronic renal##2##4##(1994-3#1)(2008-1#1)
progression of chronic##3##3##(1994-3#1)(2008-1#1)(2009-8#1)
progression of disease##8##3##(1991-8#1)(1992-12#2)(1992-2#1)(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
progression of his##2##3##(2010-6#1)(2011-2#1)
progression of prostate cancer##2##4##(2011-2#2)
progression of spine curve##2##4##(2007-8#2)
progression of the disease##7##4##(1993-12#1)(1994-5#1)(1996-6#1)(2010-10#1)(2011-2#2)(2012-3#1)
progression of the neurological##2##4##(1991-11#1)(1997-5#1)
progression of the##17##3##(1991-11#1)(1993-12#2)(1994-5#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-7#3)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
progression of vascular##2##3##(2012-12#2)
progression of##95##2##(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-2#1)(1993-12#2)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(2007-8#2)(2008-1#5)(2008-10#6)(2008-7#10)(2008-8#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#19)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
progression through the cell cycle##2##5##(1993-8#1)(2008-9#1)
progression through##5##2##(1993-8#1)(1995-6#1)(1997-8#1)(2008-9#1)(2009-8#1)
progression to##10##2##(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#3)(2011-3#1)(2013-1#1)
progression was##5##2##(1991-8#1)(1993-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
progression were##3##2##(1993-8#1)(1994-11#1)(2008-10#1)
progression##258##1##(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#2)(1992-10#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-3#2)(1994-5#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#3)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-8#2)(2008-1#6)(2008-10#26)(2008-11#7)(2008-2#2)(2008-5#2)(2008-7#13)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#5)(2009-4#1)(2009-6#5)(2009-7#3)(2009-8#3)(2010-1#13)(2010-10#3)(2010-11#4)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#30)(2011-3#6)(2011-7#3)(2012-12#5)(2012-2#7)(2012-3#13)(2012-8#3)(2013-1#25)(2013-7#2)(2013-8#7)
progression-free survival##2##2##(2013-1#2)
progressions##3##1##(1991-2#1)(1991-8#1)(2010-1#1)
progressive MS##2##2##(2010-12#2)
progressive accumulation##2##2##(2008-7#1)(2008-9#1)
progressive changes in##2##3##(2008-7#1)(2013-8#1)
progressive decline in##2##3##(2011-2#1)(2013-7#1)
progressive decline##4##2##(1993-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
progressive decrease##3##2##(1991-2#1)(1995-8#1)(2011-2#1)
progressive deterioration of##2##3##(1991-2#1)(2013-7#1)
progressive deterioration##3##2##(1991-2#1)(2012-12#1)(2013-7#1)
progressive development of##2##3##(2010-11#1)(2010-12#1)
progressive disease##9##2##(1990-12#1)(1990-2#1)(1991-6#1)(1991-8#1)(1992-12#3)(1994-8#1)(2010-12#1)
progressive increase in##6##3##(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#1)
progressive increase##7##2##(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)(2011-1#1)
progressive liver##2##2##(2009-8#1)(2012-2#1)
progressive loss of##6##3##(1990-3#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
progressive multiple##2##2##(2010-12#1)(2011-2#1)
progressive neurological##6##2##(2008-4#1)(2008-7#2)(2011-2#2)(2013-8#1)
progressive systemic##2##2##(1991-3#2)
progressive##148##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#4)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-8#1)(1997-3#2)(1997-5#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#13)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#7)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#11)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#14)(2013-1#10)(2013-7#3)(2013-8#3)
progressively decreases##2##2##(2008-10#1)(2008-5#1)
progressively from##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
progressively increasing the##2##3##(1997-2#1)(2010-7#1)
progressively increasing##3##2##(1997-2#1)(2008-9#1)(2010-7#1)
progressively more##3##2##(1993-12#2)(2010-7#1)
progressively with##3##2##(1994-12#1)(2008-10#2)
progressively##57##1##(1990-2#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(2007-12#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#3)(2008-9#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#5)(2013-1#2)(2013-8#2)
prohemostatic##2##1##(2013-1#2)
prohibit or##2##2##(2008-10#1)(2009-7#1)
prohibit the##3##2##(1990-2#2)(2007-12#1)
prohibit##9##1##(1990-2#3)(1996-1#1)(2007-12#1)(2008-10#2)(2009-7#1)(2013-8#1)
prohibited in##2##2##(1995-2#1)(2008-10#1)
prohibited##8##1##(1990-9#1)(1991-6#1)(1992-12#1)(1995-2#1)(1996-5#1)(2008-10#1)(2010-11#1)(2010-7#1)
prohibiting##2##1##(1996-5#1)(2009-6#1)
prohibition on##2##2##(1995-6#1)(1996-5#1)
prohibitive##2##1##(1996-1#1)(2008-11#1)
prohibits discrimination##2##2##(1994-1#1)(1995-6#1)
prohibits##3##1##(1994-1#1)(1995-6#2)
proinflammatory cytokine##3##2##(1995-12#1)(2009-10#1)(2009-8#1)
proinflammatory cytokines##10##2##(1995-12#1)(2007-11#2)(2008-1#1)(2008-11#4)(2009-8#1)(2012-2#1)
proinflammatory mediator##2##2##(2008-10#1)(2008-7#1)
proinflammatory mediators##2##2##(1992-6#1)(2010-1#1)
proinflammatory##27##1##(1992-6#1)(1995-12#2)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
proinsulin secretion##2##2##(2008-11#2)
proinsulin##6##1##(1995-5#1)(1995-8#1)(2008-11#4)
project aimed at##3##3##(1997-7#1)(2008-10#2)
project aimed to##2##3##(2008-11#2)
project aimed##5##2##(1997-7#1)(2008-10#2)(2008-11#2)
project and##3##2##(1992-2#1)(2008-12#1)(2009-8#1)
project are##3##2##(1996-1#1)(2008-11#1)(2008-12#1)
project as##2##2##(2008-11#1)(2008-12#1)
project could have##2##3##(1997-3#2)
project explored the##2##3##(2008-9#1)(2012-12#1)
project for the##2##3##(1995-12#1)(2008-12#1)
project for##3##2##(1993-1#1)(1995-12#1)(2008-12#1)
project in the##3##3##(1991-1#1)(1993-3#1)(2008-9#1)
project in##7##2##(1991-1#1)(1993-3#1)(1994-1#1)(2008-12#3)(2008-9#1)
project is to##2##3##(1996-2#1)(2010-7#1)
project is##7##2##(1991-1#1)(1994-3#1)(1996-2#1)(2008-11#2)(2008-9#1)(2010-7#1)
project itself##2##2##(1993-12#1)(2010-10#1)
project of##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
project offers##2##2##(1995-12#1)(2010-5#1)
project that##11##2##(1991-9#1)(1996-2#1)(2008-11#3)(2008-12#3)(2008-8#1)(2010-10#1)(2010-11#1)
project to the##3##3##(1996-5#1)(1997-3#1)(2013-8#1)
project to##12##2##(1991-6#1)(1991-9#1)(1993-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-12#1)(2010-10#2)(2013-8#1)
project was to##5##3##(1991-9#1)(1994-3#1)(1997-4#1)(2010-8#1)(2011-2#1)
project was undertaken##2##3##(1992-2#1)(2008-11#1)
project was##24##2##(1991-9#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-6#1)(1997-4#2)(2008-11#4)(2008-12#2)(2008-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-9#4)(2012-2#1)
project whose purpose is to##2##5##(1994-12#1)(2010-8#1)
project whose##3##2##(1992-1#1)(1994-12#1)(2010-8#1)
project will##3##2##(1996-1#1)(2008-11#1)(2009-10#1)
project##233##1##(1991-1#2)(1991-6#1)(1991-9#4)(1992-1#3)(1992-2#6)(1993-1#2)(1993-12#4)(1993-3#4)(1994-1#5)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1995-12#2)(1995-2#3)(1995-3#8)(1995-8#1)(1996-1#3)(1996-11#1)(1996-2#4)(1996-3#1)(1996-5#1)(1997-3#7)(1997-4#2)(1997-7#1)(2007-12#3)(2008-1#2)(2008-10#14)(2008-11#32)(2008-12#18)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#8)(2009-10#2)(2009-8#2)(2010-10#4)(2010-11#1)(2010-5#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#31)(2011-9#5)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#4)
project]##2##1##(1991-2#1)(1997-2#1)
projected for##3##2##(1995-12#1)(2007-12#2)
projected increase in##2##3##(2008-6#1)(2013-1#1)
projected to##5##2##(1994-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-3#1)
projected##27##1##(1991-1#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#5)(2008-10#3)(2008-12#1)(2008-3#4)(2008-6#1)(2009-7#1)(2010-11#1)(2011-7#1)(2013-1#1)
projecting##6##1##(1992-9#1)(1993-2#1)(1994-2#2)(1996-5#1)(1997-3#1)
projection areas##2##2##(1993-6#1)(1997-2#1)
projection in##2##2##(1990-5#1)(2008-7#1)
projection neurons in the##2##4##(1994-2#1)(2008-7#1)
projection neurons##9##2##(1994-2#1)(1996-12#3)(2008-7#3)(2009-12#1)(2013-8#1)
projection of##3##2##(1994-2#1)(2008-7#1)(2011-2#1)
projection to the##4##3##(1990-5#2)(1996-5#1)(2011-2#1)
projection was##2##2##(2008-6#1)(2008-7#1)
projection##47##1##(1990-5#3)(1991-5#1)(1993-6#1)(1994-2#3)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-6#3)(2008-7#9)(2009-12#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-8#2)
projectional##2##1##(2010-12#2)
projections and##2##2##(1994-2#1)(2013-8#1)
projections for##2##2##(1991-9#1)(2008-11#1)
projections from the medial##2##4##(1997-3#1)(2013-8#1)
projections from the##5##3##(1997-3#1)(2008-11#1)(2008-7#1)(2009-10#1)(2013-8#1)
projections from##8##2##(1994-2#1)(1997-3#1)(2008-11#2)(2008-7#1)(2009-10#1)(2012-12#1)(2013-8#1)
projections in##2##2##(2010-12#1)(2011-2#1)
projections of the##2##3##(1994-9#1)(2008-7#1)
projections of##5##2##(1992-9#1)(1994-9#1)(2008-7#1)(2009-10#1)(2010-12#1)
projections to the##5##3##(1993-6#1)(1995-8#1)(1997-2#1)(2009-10#1)(2011-2#1)
projections##51##1##(1991-1#2)(1991-12#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-3#3)(1993-6#2)(1994-2#3)(1994-9#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#2)(2007-12#2)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#3)(2009-10#3)(2009-8#2)(2010-12#2)(2011-2#2)(2012-12#2)(2013-8#2)
projective-introjective identification##2##2##(2009-11#2)
projector##2##1##(2008-10#2)
projects and##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
projects for##2##2##(1994-3#1)(2011-2#1)
projects from the##2##3##(1991-5#1)(2008-10#1)
projects in##3##2##(1991-12#1)(2010-8#1)(2012-2#1)
projects of##3##2##(1990-6#1)(2008-11#1)(2010-8#1)
projects that##3##2##(1993-12#1)(1997-1#1)(2008-6#1)
projects to##3##2##(1993-3#1)(1994-2#1)(2011-2#1)
projects undertaken in##2##3##(2008-10#1)(2008-11#1)
projects which##2##2##(1996-3#2)
projects##66##1##(1990-6#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#3)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-6#1)(2010-10#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#3)
prokaryote##7##1##(1996-12#1)(2008-10#4)(2008-8#1)(2008-9#1)
prokaryotes and eukaryotes##3##3##(1996-12#1)(2011-2#1)(2012-3#1)
prokaryotes and##4##2##(1996-12#1)(1997-7#1)(2011-2#1)(2012-3#1)
prokaryotes##9##1##(1996-12#1)(1997-6#1)(1997-7#1)(2008-4#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-3#1)
prokaryotic DNA##2##2##(1994-12#1)(2008-10#1)
prokaryotic and eukaryotic##4##3##(1997-7#2)(2008-10#1)(2009-9#1)
prokaryotic and##6##2##(1993-9#1)(1997-7#2)(2008-10#1)(2008-5#1)(2009-9#1)
prokaryotic as well as##2##4##(1996-2#1)(2011-2#1)
prokaryotic organisms##2##2##(1995-2#1)(2011-2#1)
prokaryotic vector##2##2##(2008-11#2)
prokaryotic##30##1##(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-7#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2009-9#1)(2010-4#1)(2011-1#3)(2011-2#5)(2012-2#1)(2012-3#2)
prolactin in##2##2##(1993-2#1)(2008-12#1)
prolactin receptor##3##2##(1995-11#2)(2011-2#1)
prolactin release##2##2##(1991-3#1)(1994-6#1)
prolactin secretion##5##2##(1994-3#1)(1996-2#4)
prolactin##31##1##(1990-2#1)(1991-3#3)(1993-2#3)(1994-11#5)(1994-3#1)(1994-6#2)(1995-11#3)(1996-2#4)(2008-11#2)(2008-12#6)(2011-2#1)
prolapse and##5##2##(2013-1#5)
prolapse in##2##2##(1992-5#1)(2011-2#1)
prolapse was##4##2##(2013-1#4)
prolapse##34##1##(1992-5#1)(1997-3#1)(2008-10#2)(2011-2#6)(2012-3#1)(2013-1#23)
prolate##2##1##(2008-3#2)
prolene mesh##2##2##(2008-12#1)(2008-7#1)
proliferate and differentiate##3##3##(1995-12#1)(2008-4#1)(2010-3#1)
proliferate and mature into##2##4##(2008-11#1)(2008-4#1)
proliferate and##7##2##(1995-12#1)(2008-11#3)(2008-4#2)(2010-3#1)
proliferate in##6##2##(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2013-8#1)
proliferate##22##1##(1990-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#9)(2008-4#2)(2008-9#1)(2010-3#1)(2013-8#1)
proliferated in##4##2##(1993-8#1)(2008-10#1)(2008-11#2)
proliferated more##2##2##(2008-11#2)
proliferated##16##1##(1993-8#1)(2007-12#2)(2008-10#4)(2008-11#7)(2009-10#1)(2012-4#1)
proliferating HeLa interphase cells##2##4##(1992-6#2)
proliferating and##5##2##(1992-3#2)(1993-11#1)(2008-8#1)(2008-9#1)
proliferating cell nuclear antigen (PCNA)##3##5##(1994-12#1)(1995-6#1)(2011-2#1)
proliferating cell nuclear antigen##6##4##(1992-10#1)(1994-12#1)(1995-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
proliferating cells##6##2##(1992-6#1)(1995-12#1)(2008-5#2)(2008-9#2)
proliferating##29##1##(1992-10#1)(1992-3#2)(1992-6#3)(1993-11#2)(1993-8#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-3#1)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
proliferation ability##2##2##(2008-11#1)(2013-1#1)
proliferation after##3##2##(1997-8#1)(2008-11#1)(2013-1#1)
proliferation and a##3##3##(1993-11#1)(2008-11#1)(2012-3#1)
proliferation and apoptosis in##2##4##(2008-11#1)(2011-2#1)
proliferation and apoptosis##4##3##(2008-11#2)(2011-2#2)
proliferation and cell death##3##4##(2008-11#3)
proliferation and cell##5##3##(2008-11#3)(2008-9#1)(2011-2#1)
proliferation and differentiation of##3##4##(1993-3#1)(2008-11#2)
proliferation and differentiation##12##3##(1993-3#1)(1995-12#1)(1995-2#1)(2008-11#4)(2008-9#2)(2010-9#1)(2012-2#2)
proliferation and increased##2##3##(2009-12#1)(2012-4#1)
proliferation and induction of##2##4##(1995-11#1)(2008-10#1)
proliferation and invasion of##7##4##(2008-11#6)(2013-1#1)
proliferation and invasion##8##3##(2008-11#7)(2013-1#1)
proliferation and neuronal differentiation of human fetal##2##7##(2009-10#2)
proliferation and recombinant##2##3##(2008-11#2)
proliferation and survival##4##3##(2013-1#3)(2013-8#1)
proliferation and the##4##3##(1990-11#1)(1992-3#1)(1993-3#1)(2008-11#1)
proliferation and to##3##3##(1993-12#1)(1995-2#1)(2012-2#1)
proliferation and##88##2##(1990-11#1)(1990-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#4)(1997-1#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#24)(2008-12#1)(2008-5#2)(2008-9#5)(2009-10#2)(2009-12#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#7)(2012-2#5)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#6)(2013-8#3)
proliferation assay##7##2##(1993-8#1)(1995-12#1)(2008-11#2)(2008-12#1)(2011-2#2)
proliferation assays##5##2##(1993-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
proliferation by##7##2##(1993-9#1)(1995-2#3)(2008-5#1)(2008-9#2)
proliferation control##2##2##(2008-11#2)
proliferation for##2##2##(2006-6#1)(2008-11#1)
proliferation in a##2##3##(1995-11#1)(2008-11#1)
proliferation in both##2##3##(1993-8#1)(2008-11#1)
proliferation in different##2##3##(2012-3#1)(2013-7#1)
proliferation in the##5##3##(1994-3#1)(1995-12#1)(2008-11#1)(2010-6#1)(2013-1#1)
proliferation in vitro##4##3##(2008-1#1)(2008-11#2)(2010-3#1)
proliferation in##29##2##(1990-11#1)(1990-6#1)(1993-8#2)(1993-9#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-9#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#7)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
proliferation is##5##2##(1995-6#1)(2008-1#1)(2008-7#1)(2010-11#1)(2011-2#1)
proliferation kinetics of adapted strain##2##5##(2013-8#2)
proliferation kinetics of adapted##3##4##(2013-8#3)
proliferation kinetics##5##2##(2009-12#1)(2013-8#4)
proliferation of CHO cells##2##4##(1995-2#1)(1997-1#1)
proliferation of MCF-7 human breast cancer cells that contained high levels of estrogen receptor (1##2##15##(2008-11#2)
proliferation of MCF-7##4##3##(2008-11#4)
proliferation of RPMI 1788 cells##2##5##(1990-12#2)
proliferation of RPMI 1788##3##4##(1990-12#3)
proliferation of a##2##3##(1994-5#1)(2010-6#1)
proliferation of gastric cancer##2##4##(2008-11#2)
proliferation of gastric##3##3##(2008-11#2)(2008-9#1)
proliferation of human cells##2##4##(1997-3#2)
proliferation of human##8##3##(1994-3#1)(1995-3#1)(1997-3#2)(2008-11#2)(2008-5#1)(2008-8#1)
proliferation of mammalian cells##2##4##(1997-1#1)(2008-11#1)
proliferation of mature##2##3##(2010-6#1)(2013-7#1)
proliferation of mouse##4##3##(2008-11#1)(2008-6#1)(2008-9#2)
proliferation of neural stem cells##2##5##(1994-11#2)
proliferation of pre-existing β-cells##2##4##(2010-11#2)
proliferation of quiescent##2##3##(1997-3#2)
proliferation of rat PASMCs##3##4##(2011-3#3)
proliferation of rat##5##3##(2011-3#5)
proliferation of smooth muscle cells##2##5##(1992-9#1)(2008-11#1)
proliferation of the##13##3##(1993-11#1)(1995-6#1)(1996-3#2)(2006-6#1)(2008-11#5)(2008-4#2)(2008-7#1)
proliferation of these##2##3##(1995-3#1)(2008-10#1)
proliferation of vascular smooth muscle##2##5##(1990-12#1)(2010-12#1)
proliferation of vascular##4##3##(1990-12#1)(1993-3#1)(1997-1#1)(2010-12#1)
proliferation of##140##2##(1990-12#4)(1990-5#1)(1991-3#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-8#1)(1994-11#2)(1994-3#4)(1994-5#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-3#3)(1997-1#4)(1997-3#4)(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#6)(2008-11#33)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#4)(2009-1#1)(2009-6#1)(2010-1#2)(2010-11#3)(2010-12#3)(2010-3#1)(2010-6#3)(2011-2#5)(2011-3#6)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#1)(2013-7#2)(2013-8#3)
proliferation or##6##2##(1992-8#1)(1992-9#1)(2008-11#1)(2012-3#1)(2013-8#2)
proliferation over that of control##2##5##(2008-11#2)
proliferation potential##2##2##(2008-11#2)
proliferation rate##5##2##(1991-8#1)(2008-11#3)(2012-3#1)
proliferation was investigated##2##3##(1996-12#1)(2008-11#1)
proliferation was##12##2##(1995-2#1)(1996-12#1)(2008-11#6)(2008-8#1)(2008-9#1)(2010-3#1)(2012-3#1)
proliferation were##7##2##(2008-11#5)(2008-5#2)
proliferation with##2##2##(2008-11#1)(2012-5#1)
proliferation##467##1##(1990-11#4)(1990-12#7)(1990-5#3)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#4)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#6)(1993-8#5)(1993-9#3)(1994-11#4)(1994-3#9)(1994-5#2)(1994-8#1)(1994-9#2)(1995-11#6)(1995-12#8)(1995-2#16)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#4)(1997-1#5)(1997-3#4)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#6)(2008-1#3)(2008-10#28)(2008-11#117)(2008-12#2)(2008-4#5)(2008-5#13)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#19)(2009-1#1)(2009-10#3)(2009-12#3)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#6)(2010-12#5)(2010-3#9)(2010-6#5)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#24)(2011-3#6)(2012-2#11)(2012-3#10)(2012-4#3)(2012-5#2)(2013-1#14)(2013-7#6)(2013-8#14)
proliferation-associated##2##1##(1993-11#1)(2008-9#1)
proliferation-controlled cell lines##2##3##(2008-11#2)
proliferation-controlled##3##1##(2008-11#3)
proliferations are##2##2##(2010-1#1)(2011-2#1)
proliferations in##2##2##(2010-12#1)(2011-2#1)
proliferations##9##1##(1993-11#1)(2008-11#1)(2010-1#1)(2010-12#1)(2011-2#4)(2013-1#1)
proliferative activity in##2##3##(1995-12#2)
proliferative activity of##2##3##(1993-11#1)(2008-11#1)
proliferative activity##7##2##(1990-8#1)(1993-11#2)(1995-12#2)(2008-11#1)(2010-11#1)
proliferative capacity##2##2##(2008-11#1)(2008-7#1)
proliferative changes##2##2##(1994-5#1)(2009-1#1)
proliferative endometrium##2##2##(2011-2#2)
proliferative index##4##2##(1993-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
proliferative response of##4##3##(1994-8#2)(1995-12#1)(1995-8#1)
proliferative response##6##2##(1990-12#1)(1994-8#2)(1995-12#1)(1995-8#1)(2012-3#1)
proliferative responses in##2##3##(1995-5#1)(2008-11#1)
proliferative responses##4##2##(1995-5#1)(2008-11#1)(2011-2#2)
proliferative stimulation##2##2##(1994-5#2)
proliferative vitreoretinopathy##3##2##(1991-2#3)
proliferative##68##1##(1990-12#1)(1990-8#1)(1991-2#3)(1991-3#1)(1992-3#1)(1993-11#4)(1993-12#1)(1994-12#2)(1994-5#4)(1994-8#3)(1995-11#2)(1995-12#3)(1995-5#1)(1995-8#1)(1997-5#1)(1997-8#1)(2008-11#13)(2008-5#1)(2008-7#2)(2008-9#5)(2009-1#1)(2009-3#1)(2009-9#2)(2010-11#1)(2010-3#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
proliferator-activated receptor##8##2##(1994-12#1)(1994-8#1)(2008-1#1)(2008-5#2)(2010-10#1)(2011-3#1)(2013-8#1)
proliferators##4##1##(1990-12#2)(1994-8#2)
proliferatum##13##1##(2008-10#13)
prolific##3##1##(1994-3#1)(2008-11#1)(2009-9#1)
proline at##3##2##(1994-11#1)(1994-3#1)(2008-10#1)
proline in##4##2##(1991-12#1)(2008-10#3)
proline or##2##2##(1994-5#1)(2013-1#1)
proline residue##2##2##(1991-5#1)(1994-5#1)
proline##32##1##(1990-9#1)(1991-12#1)(1991-5#2)(1992-4#1)(1994-11#5)(1994-3#1)(1994-5#2)(1995-2#1)(1995-6#1)(2006-6#2)(2008-10#6)(2008-12#5)(2008-5#1)(2011-1#1)(2012-7#1)(2013-1#1)
proline-rich domain##2##2##(2008-8#1)(2013-8#1)
proline-rich##4##1##(1991-10#1)(1997-7#1)(2008-8#1)(2013-8#1)
prolong survival##2##2##(1990-12#1)(2013-1#1)
prolong the##4##2##(1991-3#1)(2008-10#1)(2010-7#1)(2013-8#1)
prolong##16##1##(1990-12#1)(1991-2#1)(1991-3#1)(1995-1#1)(2008-10#1)(2008-5#2)(2008-8#2)(2010-7#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
prolongation of cell##2##3##(2008-11#2)
prolongation of the##9##3##(1991-3#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#1)(2011-2#2)
prolongation of##15##2##(1990-11#1)(1991-3#1)(2008-11#4)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#1)(2011-2#2)(2013-1#2)
prolongation##17##1##(1990-11#1)(1991-3#1)(1995-8#1)(2008-11#4)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#1)(2011-2#3)(2013-1#2)
prolonged (p &lt##2##3##(2008-12#1)(2008-9#1)
prolonged elevation##2##2##(2008-5#1)(2008-8#1)
prolonged exposure of##2##3##(1995-12#1)(2013-1#1)
prolonged exposure to##5##3##(1995-12#1)(1997-1#1)(2008-10#3)
prolonged exposure##7##2##(1995-12#2)(1997-1#1)(2008-10#3)(2013-1#1)
prolonged food deprivation##2##3##(1997-2#2)
prolonged group##2##2##(2011-2#2)
prolonged period of##4##3##(2008-8#1)(2008-9#2)(2011-2#1)
prolonged period##6##2##(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)
prolonged periods of##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
prolonged periods##8##2##(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-5#1)(2011-2#1)
prolonged response to sunitinib##2##4##(2013-1#2)
prolonged response##4##2##(2008-11#1)(2013-1#3)
prolonged significantly##2##2##(2008-7#1)(2011-3#1)
prolonged stays##2##2##(1996-3#2)
prolonged survival in##2##3##(1995-2#1)(2011-2#1)
prolonged survival##4##2##(1995-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
prolonged the culture period by##2##5##(2008-11#2)
prolonged the##6##2##(1993-8#1)(1996-2#1)(2008-11#2)(2008-8#1)(2011-3#1)
prolonged treatment with##2##3##(1990-12#1)(2008-5#1)
prolonged treatment##3##2##(1990-12#1)(2008-5#2)
prolonged use of##3##3##(2008-1#1)(2010-1#1)(2012-3#1)
prolonged##145##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#3)(1996-2#2)(1996-3#5)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-5#1)(2008-1#1)(2008-10#14)(2008-11#16)(2008-12#3)(2008-5#8)(2008-7#10)(2008-8#6)(2008-9#8)(2009-1#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#10)(2011-3#2)(2012-3#4)(2013-1#10)(2013-8#2)
prolonging the##5##2##(1994-2#1)(1995-6#1)(2008-11#1)(2008-5#1)(2013-1#1)
prolonging##9##1##(1994-2#1)(1995-6#1)(2008-11#3)(2008-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
prolongs survival##2##2##(2008-10#1)(2008-7#1)
prolongs##3##1##(2008-10#1)(2008-7#1)(2010-5#1)
prolyl##6##1##(1990-2#1)(1992-3#1)(2006-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
prolymphocytes##2##1##(2008-4#2)
promastigote##3##1##(2012-2#2)(2013-1#1)
promazines in bovine##2##3##(2008-10#2)
promethazine hydrochloride##5##2##(2008-10#5)
promethazine##7##1##(1990-6#1)(2008-10#6)
promethazine-HCl##4##1##(2008-10#4)
prometryne##2##1##(2008-10#2)
prominence##6##1##(1994-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#2)
prominent at##2##2##(2008-10#1)(2013-8#1)
prominent feature##5##2##(1990-5#1)(1994-11#2)(1996-11#1)(1997-3#1)
prominent in##6##2##(1992-6#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
prominent part of the##2##4##(1991-8#1)(2008-9#1)
prominent role in the##2##4##(1990-5#1)(2011-2#1)
prominent role in##5##3##(1990-5#1)(1992-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
prominent role##7##2##(1990-5#1)(1992-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
prominent##78##1##(1990-5#2)(1991-12#2)(1991-8#1)(1992-6#2)(1993-8#1)(1994-11#2)(1994-2#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#17)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#7)(2009-1#1)(2009-10#2)(2009-8#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
prominently##6##1##(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#2)(2013-8#1)
promiscuity##3##1##(2008-9#1)(2009-3#2)
promiscuous##3##1##(1990-3#1)(1997-4#1)(2011-3#1)
promise as a##5##3##(2008-11#2)(2008-5#1)(2010-5#1)(2013-1#1)
promise for##21##2##(1991-2#1)(1991-3#1)(1996-12#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#2)(2012-3#1)
promise in##6##2##(1994-5#1)(1997-2#1)(2008-10#1)(2010-4#1)(2010-6#1)(2012-3#1)
promise into##2##2##(2008-11#1)(2010-5#1)
promise of##9##2##(1993-2#1)(1996-3#1)(2008-11#2)(2008-5#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
promise to##6##2##(1993-12#1)(2008-10#3)(2008-4#1)(2008-7#1)
promise##60##1##(1991-2#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-5#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-2#1)(2008-10#12)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
promised##2##1##(1995-12#1)(2008-11#1)
promises a##2##2##(2010-8#1)(2011-2#1)
promises to be a##3##4##(1994-1#1)(2008-11#1)(2009-6#1)
promises to be##4##3##(1994-1#1)(1996-2#1)(2008-11#1)(2009-6#1)
promises to##7##2##(1994-1#1)(1996-2#1)(2008-11#2)(2009-12#1)(2009-6#1)(2010-7#1)
promises##15##1##(1994-1#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-5#2)(2009-12#1)(2009-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)
promising alternative to##3##3##(2008-10#2)(2010-8#1)
promising and##7##2##(1996-3#1)(2008-10#2)(2008-9#1)(2009-3#1)(2012-2#2)
promising application##2##2##(2008-10#1)(2010-7#1)
promising applications##2##2##(1994-5#1)(2008-10#1)
promising approach for##4##3##(2008-10#1)(2008-5#1)(2012-2#2)
promising approach to##3##3##(2008-8#1)(2009-10#1)(2010-5#1)
promising approach##10##2##(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-5#1)(2012-2#2)
promising but##2##2##(2008-7#1)(2012-2#1)
promising candidates for##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
promising evidence##2##2##(2008-6#1)(2008-8#1)
promising for the##4##3##(2008-10#1)(2008-7#1)(2009-1#1)(2009-7#1)
promising for##9##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-7#1)
promising in##7##2##(1991-1#1)(2008-10#2)(2008-11#2)(2009-10#1)(2013-8#1)
promising materials##2##2##(1995-6#1)(2010-7#1)
promising method for##4##3##(2008-10#4)
promising method##6##2##(1991-9#1)(2008-10#4)(2010-7#1)
promising new##5##2##(2008-4#1)(2009-8#1)(2010-8#1)(2013-8#2)
promising novel##3##2##(2008-11#1)(2010-11#1)(2011-7#1)
promising option for##2##3##(2009-7#1)(2012-3#1)
promising result##2##2##(2008-9#1)(2011-3#1)
promising results in##4##3##(1992-3#1)(2010-12#1)(2010-6#1)(2013-8#1)
promising results obtained##2##3##(2008-10#2)
promising results##14##2##(1992-3#1)(2008-10#3)(2008-5#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
promising strategy to##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
promising therapeutic approach##2##3##(1997-5#1)(2013-1#1)
promising therapeutic##6##2##(1994-6#1)(1997-5#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
promising to##3##2##(1992-12#1)(2013-1#1)(2013-8#1)
promising tool##5##2##(2008-10#5)
promising tools for##2##3##(2008-10#2)
promising treatment of##2##3##(2008-11#1)(2011-2#1)
promising##188##1##(1990-11#1)(1991-1#2)(1991-9#2)(1992-12#2)(1992-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#49)(2008-11#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#3)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-11#2)(2010-12#2)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#5)(2011-1#1)(2011-2#8)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#11)(2012-3#5)(2012-5#1)(2013-1#5)(2013-8#6)
promontory##4##1##(2008-9#4)
promote a##7##2##(1992-12#1)(1993-1#1)(1996-3#1)(2008-10#3)(2008-7#1)
promote and##6##2##(1996-2#1)(2008-12#2)(2008-5#1)(2010-6#1)(2012-3#1)
promote autoimmunity was##2##3##(2008-10#2)
promote cellular##2##2##(2008-5#1)(2008-9#1)
promote coexistence between##2##3##(2008-9#2)
promote functional recovery##2##3##(1994-8#1)(2008-7#1)
promote genetic##2##2##(2009-8#1)(2012-3#1)
promote growth##3##2##(1995-11#1)(2008-9#1)(2013-8#1)
promote health##2##2##(2008-1#1)(2009-6#1)
promote learning##2##2##(2008-11#1)(2012-12#1)
promote lifestyle##2##2##(2008-8#2)
promote more##2##2##(2008-4#1)(2012-2#1)
promote or##3##2##(2008-12#1)(2013-1#2)
promote plant##2##2##(2008-9#1)(2013-8#1)
promote professional##2##2##(2008-11#1)(2008-12#1)
promote the development of##3##4##(2008-11#2)(2011-2#1)
promote the differentiation of##2##4##(1994-12#1)(2008-11#1)
promote the formation of##4##4##(1995-2#2)(1995-6#1)(2008-9#1)
promote the growth and##3##4##(2008-8#1)(2013-1#2)
promote the growth of##2##4##(2013-1#2)
promote the growth##5##3##(2008-8#1)(2013-1#4)
promote the health of##2##4##(2010-8#1)(2012-2#1)
promote the##48##2##(1990-6#1)(1991-3#1)(1992-12#1)(1994-12#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-1#1)(1997-2#1)(2008-10#6)(2008-11#5)(2008-4#1)(2008-8#4)(2008-9#2)(2009-10#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
promote tumor cell migration##2##4##(2011-2#2)
promote tumor##4##2##(1991-5#1)(2009-3#1)(2011-2#2)
promote wound##2##2##(2010-3#1)(2012-3#1)
promote##203##1##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-12#2)(1992-6#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2008-1#2)(2008-10#24)(2008-11#19)(2008-12#8)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#9)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#10)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#17)(2013-7#2)(2013-8#5)
promoted by the##5##3##(1993-12#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-8#1)
promoted by##14##2##(1990-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2013-1#1)
promoted cell##2##2##(1990-11#1)(2008-10#1)
promoted cell-attachment of##2##3##(1997-1#2)
promoted platelet thrombus formation##2##4##(2006-6#2)
promoted the##6##2##(1994-11#1)(1995-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
promoted##61##1##(1990-11#1)(1990-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-11#3)(1995-6#1)(1997-1#2)(1997-2#2)(1997-7#1)(2006-6#2)(2008-10#7)(2008-11#8)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#4)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
promoter DNA##5##2##(1994-3#2)(2008-10#1)(2008-8#1)(2008-9#1)
promoter activation##3##2##(2008-11#3)
promoter activity in##3##3##(1995-6#2)(2008-9#1)
promoter activity of the##2##4##(1997-7#1)(1997-8#1)
promoter activity of##3##3##(1993-8#1)(1997-7#1)(1997-8#1)
promoter activity when##2##3##(1993-3#1)(2008-9#1)
promoter activity##23##2##(1991-5#2)(1991-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-6#4)(1995-8#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-11#1)(2008-9#2)(2009-8#1)(2010-11#3)
promoter and enhancer##2##3##(2011-2#2)
promoter and terminator##4##3##(2008-10#1)(2008-8#3)
promoter and the##2##3##(2008-10#1)(2008-8#1)
promoter and##32##2##(1990-11#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#3)(2013-8#1)
promoter and/or##2##2##(1992-6#1)(2011-2#1)
promoter as##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
promoter at##2##2##(1991-5#1)(1993-12#1)
promoter but not##2##3##(1990-5#1)(1995-2#1)
promoter by##5##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#1)
promoter contains##2##2##(1994-11#1)(1995-6#1)
promoter element##6##2##(1993-6#1)(1995-6#4)(2008-9#1)
promoter elements##4##2##(1995-6#1)(2008-11#1)(2008-9#2)
promoter for the##4##3##(1991-6#1)(1992-8#1)(1993-12#1)(1995-2#1)
promoter for##8##2##(1991-6#2)(1992-8#1)(1993-12#2)(1995-2#1)(1995-6#1)(2008-10#1)
promoter from##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
promoter has been##3##3##(1991-5#1)(1996-3#1)(2008-5#1)
promoter in a##2##3##(1994-11#1)(1997-8#1)
promoter in the##2##3##(1997-6#1)(2007-12#1)
promoter in##16##2##(1992-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#2)(1995-9#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)
promoter is##7##2##(1990-12#1)(1990-5#1)(1991-9#1)(1993-12#1)(1996-12#1)(2008-11#1)(2008-9#1)
promoter methylation##2##2##(2009-8#1)(2013-1#1)
promoter of the gene##2##4##(1993-3#1)(1996-12#1)
promoter of the##6##3##(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#2)(2011-2#1)
promoter of##17##2##(1993-3#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#4)(2011-2#1)
promoter or##6##2##(1996-3#1)(2008-10#1)(2011-2#2)(2012-3#2)
promoter region contains##2##3##(1993-3#1)(1993-6#1)
promoter region is##2##3##(1991-6#1)(1993-12#1)
promoter region of the##4##4##(1991-6#1)(1993-3#1)(1995-11#1)(1997-2#1)
promoter region of##9##3##(1991-6#1)(1993-2#1)(1993-3#1)(1995-11#1)(1997-2#1)(2009-8#2)(2011-2#1)(2012-2#1)
promoter region##28##2##(1991-6#5)(1991-7#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-9#1)(2008-9#1)(2009-8#3)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
promoter regions of the##2##4##(1993-3#1)(2009-10#1)
promoter regions of##4##3##(1993-3#1)(1997-2#2)(2009-10#1)
promoter regions##11##2##(1991-9#1)(1993-3#1)(1994-11#1)(1997-2#2)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-3#2)
promoter sequence##7##2##(1991-9#1)(1993-12#1)(1993-3#1)(1997-7#1)(2008-10#1)(2011-1#2)
promoter sequences of the##2##4##(2010-7#2)
promoter sequences of##3##3##(2010-7#3)
promoter sequences##4##2##(1993-12#1)(2010-7#3)
promoter showed##2##2##(2008-8#1)(2011-2#1)
promoter that is##3##3##(1990-12#1)(1993-12#1)(1994-2#1)
promoter to##2##2##(1994-5#1)(1997-8#1)
promoter was inserted into##2##4##(2008-11#1)(2010-5#1)
promoter was then##2##3##(1996-6#1)(2010-5#1)
promoter was used to##2##4##(2008-8#1)(2010-5#1)
promoter was##14##2##(1995-2#1)(1996-6#1)(1997-8#1)(2008-11#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#3)(2012-2#1)
promoter were##2##2##(2008-10#1)(2008-9#1)
promoter when##2##2##(1991-6#1)(2008-9#1)
promoter which was##2##3##(1997-3#1)(2008-11#1)
promoter##403##1##(1990-11#4)(1990-12#3)(1990-5#5)(1991-5#12)(1991-6#9)(1991-7#1)(1991-9#4)(1992-10#1)(1992-6#3)(1992-8#2)(1993-12#14)(1993-2#1)(1993-3#7)(1993-6#5)(1993-8#4)(1993-9#4)(1994-11#9)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#15)(1995-6#23)(1995-8#2)(1995-9#2)(1996-12#9)(1996-3#3)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#7)(1997-6#1)(1997-7#6)(1997-8#8)(1997-9#1)(2007-12#2)(2008-10#28)(2008-11#48)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#23)(2008-9#35)(2009-10#3)(2009-12#1)(2009-3#1)(2009-8#11)(2010-1#1)(2010-11#4)(2010-3#1)(2010-5#5)(2010-7#3)(2011-1#9)(2011-10#1)(2011-2#13)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#3)(2013-8#1)
promoter)##3##1##(2008-10#1)(2008-9#2)
promoter-activated production##2##2##(2008-11#2)
promoter-containing segment##2##2##(2008-10#1)(2011-1#1)
promoter-reporter##2##1##(1994-2#1)(2011-1#1)
promoterless##2##1##(1993-12#1)(1997-8#1)
promoters and##6##2##(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-4#1)
promoters in##4##2##(1992-6#1)(1994-3#1)(2008-11#1)(2008-5#1)
promoters is##3##2##(1995-2#1)(2008-4#2)
promoters of##8##2##(1991-5#1)(1997-2#1)(1997-8#2)(2008-9#1)(2009-8#3)
promoters was##3##2##(1996-3#1)(1997-8#1)(2008-8#1)
promoters##65##1##(1990-12#1)(1991-5#3)(1992-3#1)(1992-6#4)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#8)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#5)(2008-10#3)(2008-11#4)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)
promotes a##3##2##(2008-10#2)(2009-8#1)
promotes adherence##2##2##(1991-3#1)(2013-8#1)
promotes an##2##2##(2008-10#1)(2008-12#1)
promotes high##2##2##(2008-4#1)(2008-9#1)
promotes neurite outgrowth and##2##4##(1996-12#1)(2008-11#1)
promotes the binding##2##3##(1994-11#1)(1995-2#1)
promotes the proliferation##2##3##(2008-9#1)(2013-1#1)
promotes the##16##2##(1994-11#2)(1994-12#1)(1995-2#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-6#1)(2013-1#3)
promotes##59##1##(1990-5#1)(1991-3#1)(1992-11#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#4)(2009-3#1)(2009-7#1)(2009-8#2)(2010-6#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#2)
promoting a##4##2##(1994-8#1)(2008-11#2)(2010-10#1)
promoting activity of##2##3##(1994-11#1)(2008-11#1)
promoting activity##4##2##(1994-11#1)(2008-11#3)
promoting blood##2##2##(2008-10#1)(2013-8#1)
promoting growth##2##2##(2008-11#1)(2013-1#1)
promoting phorbol##3##2##(1994-11#3)
promoting the##11##2##(1994-11#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)
promoting##80##1##(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#5)(1994-12#1)(1994-3#3)(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#9)(2008-11#23)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#5)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
promotion and disease##4##3##(1995-12#2)(2008-10#1)(2008-7#1)
promotion and##10##2##(1993-12#1)(1995-12#2)(1995-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)
promotion campaigns##2##2##(2008-11#1)(2009-7#1)
promotion for##2##2##(2008-10#1)(2013-1#1)
promotion in a##2##3##(2008-11#1)(2008-12#1)
promotion in the##4##3##(1994-9#1)(2008-11#2)(2013-8#1)
promotion in##13##2##(1992-8#2)(1993-8#1)(1994-9#1)(2007-8#1)(2008-11#5)(2008-12#1)(2013-8#2)
promotion of the##3##3##(2008-3#1)(2010-5#1)(2013-1#1)
promotion of##27##2##(1991-12#1)(1991-2#1)(1992-12#2)(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
promotion##116##1##(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#3)(1994-1#1)(1994-9#1)(1995-12#4)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#23)(2008-12#13)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#7)
promotion'##3##1##(2008-11#3)
promotion-focused##2##1##(2009-6#2)
promotional##3##1##(1991-1#1)(1994-12#1)(2008-11#1)
promotor##3##1##(1994-8#1)(1997-8#1)(2008-8#1)
promotors##2##1##(1994-11#1)(1997-4#1)
prompt and proper treatment##2##4##(2011-1#1)(2011-2#1)
prompt and##5##2##(1991-12#1)(2008-1#1)(2011-1#1)(2011-2#2)
prompt diagnosis and##2##3##(2008-7#1)(2012-3#1)
prompt diagnosis may##2##3##(2008-7#1)(2011-2#1)
prompt diagnosis##7##2##(1991-8#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
prompt recognition and##4##3##(2008-1#1)(2012-3#2)(2013-1#1)
prompt surgical##3##2##(2008-12#1)(2011-2#2)
prompt the##3##2##(1993-8#1)(2009-5#1)(2013-1#1)
prompt treatment and##2##3##(2008-9#1)(2013-1#1)
prompt treatment##4##2##(2008-12#1)(2008-9#1)(2013-1#2)
prompt##43##1##(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-3#1)(1993-8#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#7)(2013-8#1)
prompt&quot##2##1##(1994-11#2)
prompted a##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
prompted the##3##2##(1994-12#1)(2008-10#1)(2008-7#1)
prompted us to initiate##2##4##(1995-12#1)(2008-10#1)
prompted us to##7##3##(1995-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
prompted##28##1##(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
prompting a need to educate underwriters about this technology##2##9##(1993-12#2)
prompting##6##1##(1992-12#1)(1993-12#2)(1996-1#1)(1997-6#1)(2012-2#1)
promptly report the results of##2##5##(2010-6#2)
promptly##8##1##(1993-12#1)(2008-11#2)(2010-1#1)(2010-6#2)(2012-12#1)(2012-3#1)
promulgated##2##1##(1994-12#1)(2010-1#1)
promyelocytic leukemia##7##2##(1991-9#2)(2008-11#2)(2008-8#2)(2011-2#1)
promyelocytic##10##1##(1991-9#2)(1993-3#1)(1993-6#1)(2008-11#2)(2008-8#2)(2011-2#1)(2013-1#1)
pronase##2##1##(2008-10#2)
pronase-treated##2##1##(1992-6#2)
prone position##4##2##(1993-1#1)(1996-9#1)(2008-7#1)(2013-1#1)
prone to the##3##3##(2008-4#1)(2008-8#1)(2012-3#1)
prone to##22##2##(1995-10#1)(1995-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
prone##32##1##(1993-1#1)(1995-10#2)(1995-9#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
proneness##2##1##(2007-12#2)
pronephros##3##1##(1997-9#3)
pronounced and##2##2##(2008-11#1)(2012-2#1)
pronounced at##6##2##(1991-2#1)(1994-8#1)(2008-10#4)
pronounced effect on the##2##4##(2008-10#1)(2008-5#1)
pronounced effect##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
pronounced in the##7##3##(1993-3#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
pronounced in##18##2##(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-6#1)
pronounced on##2##2##(1994-5#1)(2008-3#1)
pronounced than##4##2##(2006-6#1)(2008-10#2)(2008-7#1)
pronounced when##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
pronounced##89##1##(1990-11#1)(1990-5#2)(1991-2#2)(1992-9#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#2)(2006-6#1)(2007-12#1)(2008-10#27)(2008-11#4)(2008-3#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#2)
pronouncedly##3##1##(2008-10#1)(2008-8#1)(2012-2#1)
pronuclear formation##2##2##(2008-9#1)(2013-1#1)
pronuclear##3##1##(2008-9#2)(2013-1#1)
proof for##5##2##(1994-2#1)(1997-4#1)(2008-5#1)(2008-9#1)(2009-12#1)
proof of concept##4##3##(1996-6#1)(2010-10#1)(2011-9#1)(2013-1#1)
proof of efficacy##2##3##(1996-12#1)(2011-2#1)
proof of principle##2##3##(2008-10#1)(2010-4#1)
proof of##16##2##(1992-3#1)(1996-12#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-9#1)(2013-1#1)
proof that##2##2##(1993-3#1)(2009-12#1)
proof##25##1##(1992-3#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-12#2)(1996-6#1)(1997-4#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#2)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-9#1)(2013-1#1)
proof-of-concept##2##1##(2008-10#2)
proopiomelanocortin (POMC)##2##2##(1996-12#1)(2008-4#1)
proopiomelanocortin##3##1##(1993-5#1)(1996-12#1)(2008-4#1)
propagate along##2##2##(2007-12#1)(2008-11#1)
propagate through##2##2##(2007-11#1)(2009-7#1)
propagate##9##1##(1997-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2013-8#1)
propagated as##2##2##(2008-10#1)(2008-8#1)
propagated from the##2##3##(1992-8#1)(1993-3#1)
propagated in the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
propagated in##6##2##(1991-5#1)(2008-10#1)(2008-11#2)(2011-1#1)(2012-2#1)
propagated on##2##2##(2008-10#1)(2008-11#1)
propagated##21##1##(1991-5#1)(1992-8#1)(1993-3#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-6#1)(2008-8#2)(2011-1#1)(2012-2#1)
propagates##5##1##(1997-7#2)(2008-11#1)(2008-3#1)(2009-7#1)
propagating along the longitudinal##2##4##(2008-9#2)
propagating##14##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#3)(2009-8#1)(2012-2#1)
propagation and##4##2##(2008-11#1)(2008-3#1)(2008-9#2)
propagation constants##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
propagation in a##3##3##(1993-5#1)(2007-11#1)(2008-10#1)
propagation in##8##2##(1993-5#1)(2007-11#1)(2008-10#1)(2008-3#3)(2009-7#1)(2009-8#1)
propagation modes##2##2##(2008-10#1)(2008-3#1)
propagation of action potentials##2##4##(2009-12#1)(2009-8#1)
propagation of depression to##2##4##(1997-7#2)
propagation of error##2##3##(2008-10#2)
propagation of light##2##3##(2008-10#1)(2008-2#1)
propagation of the##2##3##(2008-10#1)(2011-1#1)
propagation of##25##2##(1990-5#1)(1995-2#1)(1997-7#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-9#2)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#2)
propagation phase##2##2##(2008-11#2)
propagation through##4##2##(2007-12#1)(2008-3#3)
propagation time delay##2##3##(2008-2#2)
propagation##95##1##(1990-5#2)(1991-12#3)(1993-12#1)(1993-5#1)(1994-2#1)(1995-2#1)(1997-7#3)(2007-11#3)(2007-12#3)(2008-10#15)(2008-11#7)(2008-12#2)(2008-2#8)(2008-3#19)(2008-5#4)(2008-8#1)(2008-9#8)(2009-12#1)(2009-7#3)(2009-8#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)
propagule germination##2##2##(2008-10#2)
propagule production##2##2##(2008-10#1)(2008-8#1)
propagule size##9##2##(2008-8#9)
propagule##20##1##(2008-10#7)(2008-8#11)(2008-9#2)
propagules and##2##2##(2008-10#1)(2008-8#1)
propagules in the##3##3##(2008-10#3)
propagules in##6##2##(2008-10#6)
propagules of F##3##3##(2008-10#3)
propagules of the pathogen##2##4##(2008-10#2)
propagules of##8##2##(2008-10#6)(2008-8#2)
propagules##39##1##(2008-10#29)(2008-8#10)
propamocarb##3##1##(2008-10#3)
propan-2-ol##3##1##(1990-2#1)(2008-10#2)
propane##6##1##(2008-10#3)(2008-7#2)(2011-2#1)
propanil##3##1##(2008-10#3)
propanol and##2##2##(2008-10#1)(2008-3#1)
propanol vapor##3##2##(2008-3#3)
propanol##9##1##(2008-10#3)(2008-3#6)
propel the##2##2##(2008-10#2)
propellant HFA134a##2##2##(1996-1#2)
propellant and##2##2##(1992-3#1)(1996-1#1)
propellant compositions##2##2##(2008-10#1)(2012-2#1)
propellant##19##1##(1991-12#1)(1992-3#2)(1996-1#9)(1996-2#1)(2008-10#5)(2012-2#1)
propellants in metered dose inhalers (MDIs)##2##6##(1992-3#1)(1996-1#1)
propellants in##4##2##(1992-3#3)(1996-1#1)
propellants##28##1##(1991-12#1)(1992-3#9)(1996-1#13)(1996-2#1)(2008-10#4)
propelled##3##1##(2008-10#2)(2013-1#1)
propelling##3##1##(2008-10#3)
propensities##4##1##(2008-11#3)(2008-9#1)
propensity for##11##2##(1992-12#1)(1993-6#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#2)(2013-8#1)
propensity of##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
propensity scores##3##2##(2008-11#2)(2008-12#1)
propensity to##7##2##(1993-6#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-1#1)
propensity##26##1##(1992-12#1)(1993-6#2)(1994-2#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-7#1)(2012-2#2)(2013-8#1)
propeptide##11##1##(1990-5#2)(1993-12#1)(1995-2#1)(1995-6#4)(1997-1#2)(2008-11#1)
proper and##2##2##(1992-2#1)(2013-1#1)
proper approach for##2##3##(2008-12#1)(2009-12#1)
proper balance##2##2##(1997-2#1)(2008-5#1)
proper choice##2##2##(1990-2#1)(2008-9#1)
proper diagnosis##2##2##(2012-12#2)
proper interpretation of##2##3##(1996-12#1)(2011-3#1)
proper management of##3##3##(2010-6#1)(2010-8#1)(2013-1#1)
proper management##5##2##(2008-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2013-1#1)
proper membrane##2##2##(2008-7#2)
proper names##2##2##(1991-2#1)(2008-11#1)
proper patient selection##2##3##(2011-2#2)
proper selection of##4##3##(2008-11#1)(2008-2#1)(2010-5#1)(2012-2#1)
proper training##2##2##(1993-3#1)(2008-12#1)
proper treatment##8##2##(1993-2#1)(1996-11#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
proper##157##1##(1990-2#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-1#2)(1994-6#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#3)(2009-5#1)(2009-8#2)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#20)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#10)(2013-8#5)
properly evaluated##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
properly in##3##2##(1990-12#1)(1993-3#1)(2008-9#1)
properly structured##2##2##(1993-12#1)(1996-3#1)
properly the##2##2##(2008-10#2)
properly##63##1##(1990-12#1)(1991-12#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-6#2)(1996-3#2)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
properties after##2##2##(1992-2#1)(2009-7#1)
properties and analytical##2##3##(2008-10#1)(2011-3#1)
properties and applications of##3##4##(1996-3#1)(2008-10#1)(2008-11#1)
properties and can##2##3##(2008-11#1)(2010-10#1)
properties and surface##2##3##(1997-2#1)(2008-10#1)
properties and the##5##3##(1992-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
properties and their##2##3##(1991-6#1)(2008-5#1)
properties and##69##2##(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#3)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)
properties are##14##2##(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#1)
properties as well as##2##4##(2008-10#1)(2008-5#1)
properties as well##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
properties as##11##2##(1992-10#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)
properties associated with##2##3##(1997-3#1)(2012-3#1)
properties at##4##2##(1993-8#1)(2008-10#1)(2009-11#1)(2012-2#1)
properties between##4##2##(1997-7#1)(2008-10#1)(2008-11#2)
properties but##5##2##(1996-1#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
properties by##2##2##(2008-10#2)
properties can be##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2010-11#1)
properties can##5##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-11#1)
properties depend##2##2##(2008-10#1)(2008-3#1)
properties different from##2##3##(2008-10#1)(2009-7#1)
properties during##2##2##(2008-3#1)(2011-2#1)
properties for##10##2##(1993-8#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-3#1)(2013-1#1)
properties from downwelling##2##3##(2008-3#2)
properties from##5##2##(1993-6#1)(2008-10#1)(2008-3#3)
properties have##2##2##(1992-1#1)(2010-7#1)
properties in several##2##3##(2008-10#1)(2008-7#1)
properties in the##9##3##(1990-5#1)(1992-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2011-2#1)
properties in vitro##2##3##(1992-9#1)(2009-3#1)
properties in##29##2##(1990-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
properties is##4##2##(1993-11#1)(2008-10#3)
properties like##4##2##(1994-8#1)(1996-2#1)(2008-10#1)(2008-3#1)
properties of 1-phenyl-1##2##3##(2008-10#2)
properties of 2##2##3##(2008-10#1)(2009-3#1)
properties of 5##2##3##(2008-10#2)
properties of NO##2##3##(2008-10#1)(2010-6#1)
properties of a mutant##2##4##(1995-8#1)(2008-11#1)
properties of a new##2##4##(1991-3#1)(2008-5#1)
properties of a##25##3##(1991-3#1)(1991-5#1)(1992-3#1)(1993-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-3#3)(2008-5#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
properties of an##9##3##(1994-11#1)(1994-5#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-7#1)
properties of biological##2##3##(1997-6#1)(2008-4#1)
properties of both##3##3##(2008-4#1)(2008-5#1)(2009-8#1)
properties of cat AMLS##2##4##(2008-9#2)
properties of cathepsin D##2##4##(1994-5#2)
properties of collagen##2##3##(2008-5#2)
properties of different##2##3##(2008-10#1)(2008-8#1)
properties of distributed##3##3##(2008-3#2)(2008-8#1)
properties of each##2##3##(2008-11#1)(2008-5#1)
properties of fac-Re(CO)(3)(dpknph)Cl##3##3##(2008-10#3)
properties of human skin in vivo##2##6##(2008-5#2)
properties of human##4##3##(2008-5#4)
properties of hydrazine##2##3##(2010-5#2)
properties of large##3##3##(1994-11#1)(2008-3#1)(2010-4#1)
properties of molecules##2##3##(1991-5#1)(2010-7#1)
properties of new##3##3##(2008-10#3)
properties of our##2##3##(2008-6#1)(2010-1#1)
properties of polymer##2##3##(2008-10#1)(2008-5#1)
properties of rat##2##3##(2010-12#1)(2013-8#1)
properties of scattering##2##3##(2008-3#2)
properties of selected##2##3##(1991-5#1)(2009-7#1)
properties of skin##3##3##(2008-5#3)
properties of solid##2##3##(2008-10#2)
properties of some##2##3##(2008-10#1)(2009-9#1)
properties of such##3##3##(2008-10#2)(2008-3#1)
properties of supercritical fluids##2##4##(2008-10#1)(2012-2#1)
properties of the TiNi##2##4##(2009-7#2)
properties of the aerosol##2##4##(1992-3#1)(2008-3#1)
properties of the biosensors##2##4##(2008-10#2)
properties of the dye##3##4##(2008-10#1)(2008-9#1)(2010-4#1)
properties of the electrode##3##4##(2008-10#3)
properties of the films##2##4##(2008-10#2)
properties of the membrane##5##4##(1993-8#1)(2008-10#2)(2009-5#1)(2012-2#1)
properties of the native##3##4##(1993-8#1)(1994-11#1)(2008-10#1)
properties of the newly##2##4##(2008-10#1)(2010-11#1)
properties of the proposed##2##4##(2008-3#1)(2010-11#1)
properties of the resin##2##4##(2008-10#2)
properties of the scaffolds##3##4##(2009-7#3)
properties of the silica##2##4##(2008-10#2)
properties of the stratum corneum##3##5##(2008-5#3)
properties of the two##3##4##(1996-1#1)(1997-2#1)(2008-10#1)
properties of the yeast##2##4##(1993-8#1)(1996-3#1)
properties of the##171##3##(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-8#7)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#48)(2008-11#10)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#8)(2009-8#2)(2010-1#2)(2010-11#2)(2010-4#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
properties of these systems##2##4##(2008-3#1)(2008-8#1)
properties of these##10##3##(1993-6#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)
properties of thin##2##3##(2008-10#1)(2008-3#1)
properties of this##10##3##(1995-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-2#1)
properties of three##2##3##(2008-10#2)
properties of titanium##2##3##(2009-7#2)
properties of trypsin immobilized on##2##5##(1997-2#2)
properties of two##4##3##(2008-10#4)
properties of water##2##3##(1992-9#1)(2008-2#1)
properties of##548##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#9)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#5)(1994-8#6)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#6)(1996-5#3)(1997-1#3)(1997-2#4)(1997-3#2)(1997-6#2)(2007-11#2)(2007-12#4)(2007-8#4)(2008-1#2)(2008-10#155)(2008-11#25)(2008-12#2)(2008-2#4)(2008-3#37)(2008-4#7)(2008-5#35)(2008-6#5)(2008-7#9)(2008-8#15)(2008-9#8)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#2)(2009-5#3)(2009-7#22)(2009-8#8)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#12)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-2#13)(2012-12#1)(2012-2#13)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#5)
properties on the##4##3##(2008-10#3)(2011-2#1)
properties on##8##2##(1996-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
properties or##2##2##(2008-11#1)(2008-4#1)
properties provide##3##2##(1994-11#1)(1997-7#1)(2012-2#1)
properties related to the##2##4##(2008-10#1)(2010-4#1)
properties related to##3##3##(2008-10#2)(2010-4#1)
properties relevant##2##2##(2008-11#1)(2011-2#1)
properties similar to those of the##2##6##(1991-5#1)(2007-12#1)
properties similar to those of##3##5##(1991-5#1)(2007-12#1)(2008-3#1)
properties similar to##7##3##(1991-5#1)(1991-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-9#1)
properties such as##4##3##(2008-10#2)(2008-9#1)(2009-7#1)
properties suggest that##2##3##(1993-8#1)(2011-2#1)
properties suitable for##2##3##(2008-10#2)
properties than##2##2##(2008-10#1)(2008-11#1)
properties that are##4##3##(1995-3#1)(1997-6#1)(2008-7#1)(2009-10#1)
properties that##13##2##(1991-6#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-11#1)(2012-2#2)
properties this##2##2##(2008-11#1)(2008-2#1)
properties to the##2##3##(2010-4#1)(2011-2#1)
properties to##6##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)
properties towards##2##2##(2008-10#2)
properties was##4##2##(2008-11#1)(2008-3#1)(2009-7#1)(2011-2#1)
properties were compared##2##3##(2008-8#1)(2010-4#1)
properties were determined##2##3##(2008-5#1)(2010-4#1)
properties were established##2##3##(2008-10#2)
properties were found##2##3##(2008-3#1)(2011-2#1)
properties were measured##3##3##(1995-3#1)(2008-3#1)(2009-7#1)
properties were##23##2##(1995-3#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-7#2)(2010-4#2)(2011-2#3)(2012-12#1)
properties which may##2##3##(2008-5#1)(2010-4#1)
properties which##5##2##(1994-8#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-4#1)
properties with a##2##3##(2008-10#2)
properties with the##4##3##(1993-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
properties with##10##2##(1993-11#1)(1995-9#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#1)
properties##1145##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#4)(1991-1#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#9)(1991-6#4)(1991-8#1)(1992-1#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#7)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#23)(1994-11#7)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#9)(1994-8#13)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#4)(1995-3#8)(1995-5#1)(1995-6#7)(1995-8#4)(1995-9#2)(1996-1#3)(1996-12#6)(1996-2#6)(1996-3#8)(1996-5#3)(1997-1#4)(1997-2#7)(1997-3#5)(1997-6#4)(1997-7#4)(2007-11#3)(2007-12#7)(2007-8#5)(2008-1#2)(2008-10#302)(2008-11#67)(2008-12#3)(2008-2#9)(2008-3#68)(2008-4#13)(2008-5#73)(2008-6#10)(2008-7#22)(2008-8#26)(2008-9#17)(2009-10#8)(2009-11#7)(2009-12#7)(2009-3#6)(2009-4#1)(2009-5#7)(2009-7#46)(2009-8#19)(2009-9#4)(2010-1#7)(2010-10#4)(2010-11#7)(2010-12#2)(2010-4#26)(2010-5#3)(2010-6#3)(2010-7#14)(2010-8#4)(2010-9#7)(2011-1#2)(2011-2#40)(2011-3#3)(2012-12#3)(2012-2#30)(2012-3#7)(2012-9#1)(2013-1#24)(2013-7#3)(2013-8#8)
properties)##2##1##(2008-3#1)(2008-5#1)
property and##5##2##(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)
property for##2##2##(2008-10#2)
property in##2##2##(2010-1#1)(2012-3#1)
property is##2##2##(2008-7#1)(2008-9#1)
property may##2##2##(2008-12#1)(2008-5#1)
property of dopamine##2##3##(2008-10#2)
property of the##11##3##(1990-2#1)(1993-9#1)(1994-11#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2009-1#1)(2011-2#1)
property of these##3##3##(2008-10#2)(2009-10#1)
property of##32##2##(1990-2#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-3#1)(2008-10#8)(2008-11#5)(2008-7#1)(2009-1#1)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)
property to##2##2##(2008-10#1)(2008-11#1)
property was##2##2##(2008-10#1)(2008-11#1)
property##92##1##(1990-2#1)(1991-5#1)(1992-2#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(2008-10#22)(2008-11#13)(2008-12#3)(2008-2#3)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-8#1)
prophage##2##1##(1993-9#1)(1996-12#1)
prophages##2##1##(1993-9#1)(1997-3#1)
prophase spindle##3##2##(2009-10#3)
prophase##15##1##(1997-3#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#6)(2011-2#3)
prophylactic analgesic##2##2##(2011-2#2)
prophylactic and##2##2##(1995-5#1)(2008-10#1)
prophylactic cholecystectomy##3##2##(1993-3#3)
prophylactic efficacy##2##2##(2009-12#1)(2013-1#1)
prophylactic use of##2##3##(1990-5#1)(2010-7#1)
prophylactic##37##1##(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1993-3#3)(1995-5#1)(1996-11#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#3)(2013-8#1)
prophylactically##3##1##(2008-10#1)(2008-5#1)(2012-2#1)
prophylaxis against##5##2##(1990-9#2)(2008-7#2)(2009-8#1)
prophylaxis and treatment of##2##4##(1990-6#1)(1993-2#1)
prophylaxis and treatment##3##3##(1990-6#1)(1992-12#1)(1993-2#1)
prophylaxis and##6##2##(1990-6#1)(1992-12#1)(1993-2#1)(2010-8#1)(2013-1#2)
prophylaxis in##3##2##(1990-3#1)(1990-5#1)(1991-3#1)
prophylaxis of diarrhea##2##3##(1991-3#1)(1991-8#1)
prophylaxis of##6##2##(1991-3#1)(1991-8#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-6#1)
prophylaxis with##5##2##(1990-11#1)(1990-6#1)(1991-3#1)(1997-6#1)(2008-7#1)
prophylaxis##60##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#5)(1991-3#3)(1991-8#1)(1992-12#1)(1992-9#2)(1993-2#1)(1994-6#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#5)(2009-12#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)
propiconazole resistance##2##2##(2008-10#2)
propiconazole sensitivity##3##2##(2008-10#3)
propiconazole##14##1##(2008-10#14)
propidium iodide (PI)##4##3##(2008-4#1)(2008-9#3)
propidium iodide##8##2##(1994-2#1)(2008-11#2)(2008-4#1)(2008-9#3)(2009-6#1)
propidium##10##1##(1994-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-6#1)
propionate##10##1##(1990-11#1)(1995-2#1)(1996-1#1)(1996-2#2)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)
propionic acid##6##2##(1995-11#1)(1995-3#1)(2008-10#1)(2008-7#3)
propionic##11##1##(1991-5#1)(1995-11#1)(1995-3#1)(2008-10#5)(2008-7#3)
propionyl-CoA##5##1##(1991-12#4)(1992-9#1)
propiverine and##5##2##(2008-10#5)
propiverine##8##1##(2008-10#8)
propofol and##2##2##(2011-2#2)
propofol##14##1##(1993-1#2)(1995-12#1)(2009-8#3)(2010-7#3)(2011-2#4)(2012-3#1)
propolis and##2##2##(2008-10#2)
propolis in##2##2##(2008-10#2)
propolis is##2##2##(2008-10#2)
propolis##17##1##(2008-10#11)(2008-11#5)(2013-1#1)
proponents##4##1##(1992-2#1)(1994-1#1)(1996-5#1)(2008-6#1)
proportion in##3##2##(2008-10#2)(2012-3#1)
proportion of 0##2##3##(2008-10#2)
proportion of P##4##3##(2008-10#3)(2010-8#1)
proportion of blossoms##2##3##(2008-10#2)
proportion of cases##5##3##(2010-12#1)(2011-2#2)(2013-8#2)
proportion of cells in the S and##2##7##(1994-3#1)(2008-11#1)
proportion of cells in##3##4##(1993-11#1)(1994-3#1)(2008-11#1)
proportion of cells##6##3##(1993-11#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
proportion of chicks##2##3##(1990-3#1)(2008-6#1)
proportion of children##3##3##(1996-11#1)(2008-2#2)
proportion of correct know responses##2##5##(2008-9#2)
proportion of correct remember responses and##2##6##(2008-9#2)
proportion of correct##4##3##(2008-9#4)
proportion of deaths##2##3##(1991-3#1)(2008-9#1)
proportion of disease##3##3##(2008-10#3)
proportion of diseased##4##3##(2008-10#4)
proportion of individuals##2##3##(2008-8#1)(2011-2#1)
proportion of isolates##3##3##(2008-10#3)
proportion of older##2##3##(2008-1#1)(2012-12#1)
proportion of other clinically relevant findings##2##6##(2011-2#2)
proportion of patients with##5##4##(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
proportion of patients##11##3##(2008-7#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
proportion of pseudosclerotia##2##3##(2008-10#2)
proportion of recombinant offspring##2##4##(2012-3#2)
proportion of seed##2##3##(2008-10#1)(2013-8#1)
proportion of sink habitat##2##4##(2008-8#2)
proportion of subjects##4##3##(1997-1#1)(2010-12#1)(2012-2#2)
proportion of susceptible host##2##4##(2008-10#2)
proportion of the total##6##4##(1994-1#1)(1994-8#1)(2008-10#3)(2008-11#1)
proportion of the##48##3##(1990-6#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-3#2)(1994-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1997-5#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
proportion of their##2##3##(1992-12#2)
proportion of them##2##3##(2008-11#1)(2011-2#1)
proportion of those##2##3##(1990-6#1)(1997-6#1)
proportion of total##6##3##(1990-5#1)(2008-10#3)(2008-8#1)(2012-2#1)
proportion of##285##2##(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#2)(1991-12#3)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#6)(1992-9#3)(1993-11#1)(1993-3#5)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#84)(2008-11#19)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#17)(2008-9#13)(2009-3#1)(2009-5#2)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-8#2)(2011-2#18)(2012-12#3)(2012-2#4)(2012-3#11)(2013-1#10)(2013-8#5)
proportion to the##13##3##(1990-8#1)(1994-8#1)(2008-10#8)(2008-7#2)(2010-3#1)
proportion to##16##2##(1990-8#1)(1994-5#1)(1994-8#1)(2008-10#8)(2008-11#2)(2008-7#2)(2010-3#1)
proportion##329##1##(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#7)(1992-9#3)(1993-11#1)(1993-3#5)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#100)(2008-11#23)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#18)(2008-9#14)(2009-3#1)(2009-5#2)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#20)(2012-12#4)(2012-2#5)(2012-3#12)(2013-1#10)(2013-8#8)
proportional equations##3##2##(2008-10#3)
proportional hazards##4##2##(2008-10#1)(2009-6#1)(2011-2#1)(2013-1#1)
proportional increase in##2##3##(2008-11#1)(2008-9#1)
proportional systematic error##2##3##(2008-10#2)
proportional to logarithm of##2##4##(2008-10#2)
proportional to that of##2##4##(1992-12#1)(2008-10#1)
proportional to the absorption##2##4##(2008-10#1)(2008-3#1)
proportional to the amount of##2##5##(2008-10#2)
proportional to the concentration of nucleic acids##2##7##(2008-10#2)
proportional to the concentration of the##3##6##(2008-10#3)
proportional to the concentration of##29##5##(1990-8#1)(2008-10#27)(2008-12#1)
proportional to the concentration##31##4##(1990-8#1)(2008-10#29)(2008-12#1)
proportional to the degree of##2##5##(2008-11#1)(2010-11#1)
proportional to the level of##2##5##(2008-11#1)(2012-2#1)
proportional to the specific energy dissipation rate##2##7##(2008-7#2)
proportional to the square##3##4##(2007-12#1)(2008-3#2)
proportional to the total##2##4##(2012-2#2)
proportional to the##90##3##(1990-3#1)(1990-8#1)(1990-9#1)(1993-6#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#61)(2008-11#4)(2008-12#1)(2008-3#7)(2008-5#1)(2008-7#3)(2010-11#1)(2012-2#3)(2012-3#1)
proportional to their##2##3##(2008-10#1)(2008-7#1)
proportional to viable##3##3##(2008-11#3)
proportional to##119##2##(1990-3#1)(1990-8#1)(1990-9#1)(1992-12#1)(1993-6#1)(1993-8#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#76)(2008-11#8)(2008-12#1)(2008-3#7)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#2)(2010-11#1)(2012-2#3)(2012-3#1)
proportional##147##1##(1990-3#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#89)(2008-11#9)(2008-12#1)(2008-3#7)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#3)(2009-6#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
proportionally to the##4##3##(1995-12#1)(2008-10#3)
proportionally to##5##2##(1995-12#1)(2008-10#3)(2012-2#1)
proportionally##9##1##(1991-12#1)(1991-6#1)(1995-12#1)(2008-10#5)(2012-2#1)
proportionate to the##2##3##(1993-1#1)(2008-7#1)
proportionate##3##1##(1993-1#1)(2008-11#1)(2008-7#1)
proportionately with##2##2##(1994-3#1)(2008-10#1)
proportionately##5##1##(1992-3#1)(1994-3#1)(2008-10#2)(2008-6#1)
proportions and##4##2##(2008-10#2)(2013-1#2)
proportions by##2##2##(2008-10#2)
proportions in##4##2##(2008-10#1)(2009-9#1)(2010-10#1)(2010-4#1)
proportions of 0##2##3##(2008-10#2)
proportions of affected relatives##2##4##(1992-9#2)
proportions of affected##3##3##(1992-9#3)
proportions of the##5##3##(2008-10#4)(2013-8#1)
proportions of##32##2##(1990-3#1)(1991-10#1)(1992-3#1)(1992-9#3)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#10)(2008-7#1)(2009-7#1)(2010-4#2)(2012-2#3)(2012-3#3)(2013-8#2)
proportions to##2##2##(1990-12#1)(2013-8#1)
proportions were##3##2##(2008-10#2)(2011-2#1)
proportions##73##1##(1990-12#1)(1990-3#1)(1991-10#2)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#3)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#28)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#3)
proposal and##2##2##(1992-2#1)(2012-2#1)
proposal for a##6##3##(1993-11#1)(1994-6#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
proposal for##10##2##(1993-11#1)(1993-2#1)(1994-1#1)(1994-6#1)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-8#1)
proposal in##2##2##(1995-6#1)(2008-10#1)
proposal includes##2##2##(1992-2#1)(2008-10#1)
proposal is##2##2##(1992-2#1)(1993-12#1)
proposal of##3##2##(1990-5#1)(2008-5#1)(2010-4#1)
proposal that the##2##3##(1990-10#1)(1991-5#1)
proposal that##5##2##(1990-10#1)(1990-5#1)(1991-5#1)(2009-4#1)(2013-8#1)
proposal to##3##2##(1995-5#1)(2008-10#1)(2008-5#1)
proposal##52##1##(1990-10#1)(1990-5#2)(1991-2#1)(1991-5#1)(1992-2#8)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#5)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-8#3)
proposals for##9##2##(1991-2#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#4)(2013-1#1)
proposals in the##2##3##(1992-1#1)(1993-3#1)
proposals##21##1##(1991-2#1)(1992-1#1)(1993-3#2)(1996-3#1)(1997-3#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
propose a method for the##2##5##(2008-10#1)(2010-8#1)
propose a method for##6##4##(2008-10#2)(2008-3#2)(2010-6#1)(2010-8#1)
propose a method##9##3##(1994-9#1)(2007-11#1)(2008-10#2)(2008-3#3)(2010-6#1)(2010-8#1)
propose a model of##2##4##(2008-10#1)(2008-11#1)
propose a model##6##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#2)
propose a new approach to the##2##6##(2008-3#1)(2012-3#1)
propose a new approach to##4##5##(2008-3#1)(2008-6#1)(2012-3#1)(2013-8#1)
propose a new approach##5##4##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-8#1)
propose a new##13##3##(1993-9#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-6#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
propose a novel approach for##2##5##(2010-10#1)(2013-1#1)
propose a novel##6##3##(2008-2#1)(2008-3#1)(2010-10#2)(2010-8#1)(2013-1#1)
propose a simple##4##3##(2008-11#1)(2008-8#1)(2009-2#1)(2013-1#1)
propose a##74##2##(1991-5#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#6)(2008-2#1)(2008-3#11)(2008-6#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2009-8#3)(2010-10#3)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
propose an##18##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2012-2#4)(2012-3#2)(2013-1#2)
propose and##3##2##(1991-3#1)(2008-3#1)(2013-8#1)
propose better##2##2##(1991-2#1)(2009-8#1)
propose here##2##2##(2008-11#1)(2010-8#1)
propose separate##2##2##(1996-3#1)(2008-10#1)
propose that an##2##3##(1995-2#1)(1996-2#1)
propose that the##25##3##(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1994-3#1)(1995-12#1)(1995-2#2)(1997-1#1)(1997-3#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
propose that these##5##3##(1995-2#1)(2008-10#1)(2008-11#2)(2008-6#1)
propose that this##8##3##(1992-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)
propose that##85##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-6#1)(1995-8#1)(1996-2#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#2)(2009-3#1)(2009-8#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
propose the following##2##3##(2008-10#1)(2008-7#1)
propose the##13##2##(1990-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-1#1)(2011-2#1)(2013-8#1)
propose to##10##2##(1990-11#1)(1991-2#1)(2008-10#2)(2008-3#3)(2008-5#1)(2011-3#1)(2013-1#1)
propose two##4##2##(1992-9#1)(2008-10#1)(2008-2#1)(2008-6#1)
propose##244##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#7)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#40)(2008-11#14)(2008-12#2)(2008-2#5)(2008-3#19)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#14)(2008-8#7)(2008-9#4)(2009-10#3)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#6)(2012-7#1)(2013-1#13)(2013-8#7)
proposed FI system##2##3##(2008-10#2)
proposed FI##5##2##(2008-10#5)
proposed FIA##2##2##(2008-10#2)
proposed SIA##3##2##(2008-10#3)
proposed a method##2##3##(2009-8#1)(2013-1#1)
proposed a new##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
proposed a##20##2##(1995-6#1)(1996-5#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#2)(2009-10#2)(2009-8#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
proposed algorithm is##3##3##(2008-10#1)(2008-6#1)(2011-3#1)
proposed an##2##2##(1996-1#1)(2008-10#1)
proposed and applied to##3##4##(2008-10#3)
proposed and applied##4##3##(2008-10#4)
proposed and compared##2##3##(2008-10#1)(2010-6#1)
proposed and discussed##3##3##(2008-10#2)(2008-3#1)
proposed and experimentally##2##3##(1997-2#1)(2008-3#1)
proposed and tested##3##3##(2008-10#1)(2008-3#2)
proposed and the results##2##4##(2008-10#2)
proposed and the##4##3##(2008-10#4)
proposed and##40##2##(1996-5#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#24)(2008-3#8)(2009-4#1)(2010-11#1)(2010-6#1)(2012-3#1)
proposed approach is##2##3##(2008-10#1)(2009-7#1)
proposed approach##12##2##(2008-10#7)(2008-3#1)(2009-10#1)(2009-7#1)(2013-1#1)(2013-8#1)
proposed are##2##2##(1996-8#1)(2008-10#1)
proposed as a simple##2##4##(2008-10#1)(2008-11#1)
proposed as a##21##3##(1990-5#2)(1993-12#1)(1995-1#1)(1997-2#1)(2008-10#8)(2008-11#3)(2008-9#1)(2009-10#1)(2011-7#1)(2012-2#1)(2013-1#1)
proposed as an alternative##3##4##(1994-2#1)(2008-10#1)(2013-7#1)
proposed as an important##2##4##(2008-10#1)(2012-2#1)
proposed as an##11##3##(1991-5#1)(1992-6#1)(1994-2#1)(2008-10#3)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
proposed as the##2##3##(2008-5#1)(2013-1#1)
proposed as##41##2##(1990-5#2)(1991-5#1)(1992-6#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-2#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-3#1)(2011-7#1)(2012-2#3)(2013-1#3)(2013-7#1)
proposed based on a##2##4##(1990-8#1)(2008-10#1)
proposed based on the##6##4##(2008-10#5)(2013-1#1)
proposed based on##10##3##(1990-8#1)(2008-10#7)(2008-11#1)(2013-1#1)
proposed before##2##2##(1994-8#1)(2008-11#1)
proposed by the authors##2##4##(2008-10#2)
proposed by the##7##3##(1997-6#1)(2008-10#4)(2008-5#1)(2013-1#1)
proposed by using##2##3##(2008-10#2)
proposed by##35##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1997-6#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#3)(2013-1#1)
proposed can be##2##3##(1993-6#1)(2008-10#1)
proposed changes##2##2##(2008-10#1)(2008-11#1)
proposed design##2##2##(2008-3#1)(2011-2#1)
proposed device##2##2##(2008-3#2)
proposed diagnostic##2##2##(2008-10#1)(2011-1#1)
proposed electrochemical method##2##3##(2008-10#2)
proposed electrode has##2##3##(2008-10#2)
proposed electrode was##3##3##(2008-10#3)
proposed electrode##16##2##(2008-10#16)
proposed electrodes##7##2##(2008-10#7)
proposed extraction##2##2##(2008-10#2)
proposed flow system##2##3##(2008-10#2)
proposed flow##5##2##(2008-10#5)
proposed flow-injection##3##2##(2008-10#3)
proposed for assessment of##2##4##(2008-10#1)(2009-5#1)
proposed for determination of##2##4##(2008-10#2)
proposed for genomic sequencing##2##4##(2008-10#2)
proposed for simultaneous##4##3##(2008-10#4)
proposed for the determination of ascorbic acid##2##7##(2008-10#2)
proposed for the determination of trace##5##6##(2008-10#5)
proposed for the determination of##41##5##(2008-10#41)
proposed for the speciation##2##4##(2008-10#2)
proposed for the##95##3##(1990-5#1)(1995-6#1)(1996-2#1)(2008-10#87)(2008-11#1)(2008-9#1)(2010-5#1)(2010-6#1)(2012-12#1)
proposed for this##2##3##(1996-5#1)(2008-10#1)
proposed for##157##2##(1990-5#2)(1991-11#1)(1993-1#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(2008-10#121)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
proposed framework##4##2##(2008-7#2)(2012-2#2)
proposed government##2##2##(1993-3#2)
proposed here is##3##3##(1991-5#1)(2008-10#2)
proposed here##7##2##(1991-5#1)(1994-1#1)(2008-10#4)(2008-3#1)
proposed immunosensor##3##2##(2008-10#3)
proposed in order to##2##4##(2008-10#1)(2008-9#1)
proposed in the literature##4##4##(1996-11#1)(2008-10#1)(2008-7#2)
proposed in the##10##3##(1996-11#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-5#1)(2011-1#1)(2013-8#1)
proposed in this article##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
proposed in this paper##11##4##(2008-10#9)(2008-6#1)(2013-8#1)
proposed in this work for the determination of##2##8##(2008-10#2)
proposed in this##16##3##(2008-10#12)(2008-6#1)(2008-7#1)(2013-8#2)
proposed in which##4##3##(1991-5#1)(1991-9#1)(2008-3#1)(2008-9#1)
proposed in##39##2##(1990-11#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-6#1)(1996-11#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-5#1)(2011-1#1)(2013-8#3)
proposed is##4##2##(2008-10#3)(2008-3#1)
proposed mechanism of##2##3##(2008-5#1)(2009-10#1)
proposed mechanism##9##2##(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-3#1)
proposed method allows the determination of##3##6##(2008-10#3)
proposed method allows the##4##4##(2008-10#4)
proposed method allows##7##3##(2008-10#7)
proposed method can be used##4##5##(2008-10#4)
proposed method can be##8##4##(2008-10#4)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
proposed method could be##2##4##(2008-10#2)
proposed method could##4##3##(2008-10#4)
proposed method for the##2##4##(2008-10#1)(2010-8#1)
proposed method for##13##3##(2008-10#10)(2008-7#2)(2010-8#1)
proposed method had been successfully applied to##2##7##(2008-10#2)
proposed method had been##3##4##(2008-10#3)
proposed method had##5##3##(1992-11#1)(2008-10#4)
proposed method has been applied to determine##2##7##(2008-10#2)
proposed method has been applied to the determination of##15##9##(2008-10#15)
proposed method has been applied to the##18##7##(2008-10#18)
proposed method has been applied to##23##6##(2008-10#23)
proposed method has been applied##26##5##(2008-10#26)
proposed method has been successfully applied to the determination of##3##10##(2008-10#3)
proposed method has been successfully applied to the##5##8##(2008-10#5)
proposed method has been successfully applied to##8##7##(2008-10#8)
proposed method has been successfully applied##9##6##(2008-10#9)
proposed method has been##42##4##(2008-10#42)
proposed method has##48##3##(2008-10#48)
proposed method is applied to##4##5##(2008-10#4)
proposed method is promising for##2##5##(2008-10#2)
proposed method is simple##12##4##(2008-10#12)
proposed method is##63##3##(2008-10#62)(2012-3#1)
proposed method was applied to the analysis of##3##8##(2008-10#3)
proposed method was applied to the##23##6##(2008-10#23)
proposed method was applied to##35##5##(2008-10#35)
proposed method was applied##43##4##(2008-10#43)
proposed method was compared with##4##5##(2008-10#4)
proposed method was evaluated by analyzing certified reference##2##8##(2008-10#2)
proposed method was evaluated by analyzing##4##6##(2008-10#4)
proposed method was evaluated by##6##5##(2008-10#6)
proposed method was evaluated##7##4##(2008-10#7)
proposed method was successfully applied to the simultaneous determination of##8##10##(2008-10#8)
proposed method was successfully applied to the##22##7##(2008-10#22)
proposed method was successfully applied to##25##6##(2008-10#25)
proposed method was successfully applied##33##5##(2008-10#33)
proposed method was successfully##37##4##(2008-10#37)
proposed method was##122##3##(2008-10#122)
proposed method##397##2##(1992-11#1)(2007-12#1)(2008-10#383)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
proposed methodology has been##3##4##(2008-10#3)
proposed methodology was applied##2##4##(2008-10#2)
proposed methodology was##6##3##(2008-10#6)
proposed methodology##18##2##(2008-10#18)
proposed methods have been applied##2##5##(2008-10#2)
proposed methods have been##3##4##(2008-10#3)
proposed methods have##4##3##(2008-10#4)
proposed methods to##2##3##(2008-10#2)
proposed methods were selective and##2##5##(2008-10#2)
proposed methods were successfully applied to the determination of##2##9##(2008-10#2)
proposed methods were successfully applied to the##3##7##(2008-10#3)
proposed methods were validated by using##2##6##(2008-10#2)
proposed methods were##9##3##(2008-10#9)
proposed methods##25##2##(2008-10#22)(2008-11#1)(2008-3#1)(2010-11#1)
proposed model and##3##3##(2008-10#1)(2009-8#1)(2010-11#1)
proposed model for##3##3##(2010-8#2)(2013-1#1)
proposed model of##2##3##(1991-5#1)(2009-9#1)
proposed model##22##2##(1991-5#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#3)(2011-1#1)(2011-2#1)(2013-1#2)
proposed models##5##2##(1996-3#1)(2008-10#3)(2009-8#1)
proposed new##4##2##(1991-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
proposed over##2##2##(2008-10#1)(2013-8#1)
proposed previously##4##2##(1994-11#1)(2008-10#2)(2009-10#1)
proposed procedure for##3##3##(2008-10#2)(2010-5#1)
proposed procedure has been##7##4##(2008-10#7)
proposed procedure has##8##3##(2008-10#8)
proposed procedure is##4##3##(2008-10#4)
proposed procedure was##11##3##(2008-10#11)
proposed procedure##51##2##(2008-10#48)(2008-6#1)(2010-1#1)(2010-5#1)
proposed procedures##8##2##(2008-10#6)(2009-10#1)(2013-1#1)
proposed reagent-injection FI method##2##4##(2008-10#2)
proposed refractive-index##2##2##(2008-2#2)
proposed sensor##20##2##(2008-10#20)
proposed sensors##3##2##(2008-10#3)
proposed separation##2##2##(2008-10#2)
proposed sequential##2##2##(2008-10#2)
proposed strategy of##2##3##(2008-10#1)(2011-2#1)
proposed system handles about##2##4##(2008-10#2)
proposed system is##3##3##(2008-10#3)
proposed system was##6##3##(2008-10#6)
proposed system##22##2##(2008-10#20)(2008-3#2)
proposed technique is##5##3##(2008-10#4)(2008-6#1)
proposed technique##14##2##(2008-10#12)(2008-3#1)(2008-6#1)
proposed techniques##3##2##(2008-10#1)(2008-6#1)(2010-7#1)
proposed that the##20##3##(1990-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2013-8#3)
proposed that this##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
proposed that##56##2##(1990-5#1)(1991-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(2006-6#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-6#2)(2009-8#4)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
proposed the##6##2##(1995-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
proposed to be a##2##4##(1991-10#1)(2013-1#1)
proposed to be involved in##2##5##(1997-7#1)(2011-2#1)
proposed to be##11##3##(1991-10#1)(1992-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
proposed to describe the##2##4##(2008-10#2)
proposed to describe##3##3##(1991-12#1)(2008-10#2)
proposed to evaluate##2##3##(2008-10#1)(2008-2#1)
proposed to explain the##8##4##(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
proposed to explain##10##3##(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2012-3#1)
proposed to improve##2##3##(2008-3#1)(2011-2#1)
proposed to model the##2##4##(2008-3#1)(2011-2#1)
proposed to play a##4##4##(1990-11#1)(2011-2#1)(2013-8#2)
proposed to regulate##2##3##(1993-6#1)(2012-2#1)
proposed to study the##2##4##(2008-10#2)
proposed to##73##2##(1990-11#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-8#2)(1995-12#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#26)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#5)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
proposed using a##2##3##(2008-10#2)
proposed using##6##2##(1993-11#1)(2008-10#4)(2010-8#1)
proposed was##8##2##(2008-10#8)
proposed were##4##2##(2008-10#4)
proposed when##3##2##(1991-2#2)(2008-10#1)
proposed which##2##2##(2008-11#1)(2009-12#1)
proposed with##4##2##(2008-10#4)
proposed##1699##1##(1990-11#2)(1990-5#6)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#6)(1991-5#6)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#4)(1995-5#4)(1995-6#3)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#6)(1996-8#3)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#4)(2006-6#1)(2007-12#5)(2008-1#2)(2008-10#1183)(2008-11#38)(2008-12#7)(2008-2#9)(2008-3#55)(2008-4#4)(2008-5#9)(2008-6#16)(2008-7#22)(2008-8#18)(2008-9#18)(2009-1#1)(2009-10#10)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#11)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#9)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#14)(2010-9#1)(2011-1#4)(2011-2#22)(2011-3#2)(2011-7#2)(2012-12#7)(2012-2#16)(2012-3#16)(2013-1#18)(2013-7#1)(2013-8#16)
proposes a new##4##3##(1997-3#1)(2008-10#1)(2008-6#1)(2011-3#1)
proposes a##21##2##(1991-6#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-3#1)(2012-2#2)
proposes possible##2##2##(1991-12#1)(2008-11#1)
proposes that##4##2##(1996-2#1)(2008-11#1)(2008-9#1)(2012-3#1)
proposes##38##1##(1991-12#1)(1991-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
proposing that##2##2##(1996-3#1)(2012-12#1)
proposing##6##1##(1996-3#1)(2008-10#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#1)
proposition that##7##2##(1991-5#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-8#1)(2012-2#1)
proposition##9##1##(1991-5#1)(1993-3#1)(1995-6#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-2#1)
propositions##2##1##(1993-11#1)(2013-1#1)
propranolol and pindolol##4##3##(2008-10#4)
propranolol and##7##2##(1994-5#2)(2008-10#5)
propranolol in##4##2##(1993-5#1)(2008-10#1)(2009-8#2)
propranolol##29##1##(1990-5#1)(1993-5#1)(1994-3#1)(1994-5#4)(1996-2#1)(2008-10#11)(2008-7#2)(2009-8#7)(2013-1#1)
propria of##4##2##(2008-11#1)(2009-1#1)(2011-2#2)
propria##13##1##(1997-1#1)(1997-8#1)(2008-11#4)(2008-4#1)(2009-1#1)(2009-10#3)(2011-2#2)
proprietary security##2##2##(1992-12#2)
proprietary##8##1##(1992-12#2)(1993-3#1)(2008-10#4)(2008-5#1)
proprioception##4##1##(2009-8#1)(2010-12#3)
proprioceptive##4##1##(1994-8#1)(2009-1#2)(2013-1#1)
proprotein convertase subtilisin/kexin##2##3##(2008-6#1)(2013-1#1)
proprotein convertase##3##2##(1993-2#1)(2008-6#1)(2013-1#1)
proptosis##5##1##(2008-7#2)(2010-11#1)(2011-2#1)(2013-7#1)
propulsion##4##1##(2008-10#4)
propyl##9##1##(1996-2#1)(2008-10#7)(2008-7#1)
propylene glycol and isopropanol##2##4##(1991-5#2)
propylene glycol and triethyl phosphate##2##5##(2008-11#2)
propylene glycol and##5##3##(1991-5#2)(2008-11#3)
propylene glycol##13##2##(1991-5#6)(2008-10#1)(2008-11#4)(2008-5#2)
propylene oxide##2##2##(1993-8#2)
propylene##17##1##(1991-5#6)(1993-8#2)(2008-10#3)(2008-11#4)(2008-5#2)
propylparaben and##3##2##(2008-10#3)
propylparaben##4##1##(2008-10#4)
pros and cons of##8##4##(1992-1#1)(1996-6#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
pros and cons##12##3##(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
pros of changing##2##3##(2008-11#2)
pros##14##1##(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#5)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
prosaikogenin##3##1##(2008-11#3)
prosecution##3##1##(1990-6#1)(1994-3#1)(2008-10#1)
prosecutor##2##1##(1995-12#2)
prosocial behavior##3##2##(2008-12#1)(2013-1#2)
prosocial norms##4##2##(2013-1#4)
prosocial##10##1##(2008-12#2)(2013-1#7)(2013-8#1)
prosodic##5##1##(2009-10#2)(2010-9#3)
prosody in##2##2##(2009-10#1)(2010-9#1)
prosody##9##1##(2009-10#4)(2010-9#5)
prosopagnosia##3##1##(1991-11#3)
prosopagnosics##4##1##(2008-11#4)
prospect for##2##2##(2008-9#1)(2012-2#1)
prospect in##2##2##(2011-3#1)(2013-8#1)
prospect of##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)
prospect##9##1##(1994-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
prospective and retrospective##3##3##(2008-11#1)(2008-7#1)(2012-3#1)
prospective case series we investigated the##2##6##(2011-2#2)
prospective case-based system##2##3##(1992-12#2)
prospective cohort of##3##3##(2012-12#1)(2013-1#2)
prospective cohort studies##2##3##(2008-11#1)(2008-8#1)
prospective cohort study##4##3##(2008-12#1)(2010-5#1)(2013-1#2)
prospective cohort##10##2##(2008-11#1)(2008-12#1)(2008-8#1)(2010-5#1)(2012-12#1)(2013-1#5)
prospective controlled##4##2##(1991-2#1)(2008-10#1)(2008-3#1)(2009-7#1)
prospective evaluation##3##2##(1992-12#1)(2008-7#1)(2010-12#1)
prospective longitudinal##2##2##(2009-10#1)(2010-4#1)
prospective multicenter##2##2##(2009-10#1)(2011-2#1)
prospective observational study##5##3##(2008-3#1)(2011-2#2)(2012-5#1)(2013-8#1)
prospective observational##6##2##(2008-11#1)(2008-3#1)(2011-2#2)(2012-5#1)(2013-8#1)
prospective payment by##2##3##(1991-3#1)(1992-1#1)
prospective payment rates##2##3##(1991-1#2)
prospective payment system (PPS) for##3##5##(1993-3#1)(1994-12#1)(1994-3#1)
prospective payment system (PPS)##16##4##(1991-2#1)(1992-1#1)(1992-12#6)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1996-3#1)
prospective payment system for hospitals##2##5##(1992-2#2)
prospective payment system for##4##4##(1991-1#2)(1992-2#2)
prospective payment system##38##3##(1991-1#4)(1991-2#3)(1991-3#3)(1992-1#2)(1992-12#8)(1992-2#6)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#2)(1995-2#1)(1996-3#1)(2008-11#1)
prospective payment##56##2##(1991-1#8)(1991-12#1)(1991-2#4)(1991-3#6)(1992-1#4)(1992-12#10)(1992-2#7)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#3)(1995-2#1)(1996-2#1)(1996-3#1)(2008-11#1)
prospective phase II study##3##4##(2008-10#3)
prospective phase##4##2##(2008-10#4)
prospective randomized double blind##2##4##(2009-8#1)(2010-7#1)
prospective randomized study##3##3##(2011-2#1)(2012-3#2)
prospective randomized trial of##2##4##(1993-9#1)(2008-10#1)
prospective randomized##10##2##(1991-2#1)(1993-9#1)(1997-4#1)(2008-10#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#3)
prospective studies have##3##3##(1997-6#1)(2008-7#1)(2012-3#1)
prospective studies to##2##3##(1997-5#1)(2013-1#1)
prospective studies##12##2##(1995-5#1)(1996-11#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#3)
prospective study in##2##3##(2008-9#1)(2009-8#1)
prospective study of##7##3##(1990-2#1)(1990-3#1)(1992-6#1)(1995-2#1)(2008-7#1)(2009-8#1)(2012-12#1)
prospective study was##5##3##(1992-12#1)(1997-8#1)(2010-8#1)(2012-3#2)
prospective study##34##2##(1990-11#1)(1990-2#1)(1990-3#3)(1992-12#2)(1992-6#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#1)
prospective study]##3##2##(1990-3#1)(1991-3#1)(2009-5#1)
prospective surveys##3##2##(2008-10#3)
prospective systems##2##2##(1994-2#2)
prospective trial##2##2##(1991-2#1)(2011-2#1)
prospective trials##2##2##(2010-12#1)(2011-2#1)
prospective triple-blind randomized##2##3##(1997-3#2)
prospective##232##1##(1990-11#1)(1990-2#1)(1990-3#4)(1990-6#1)(1991-1#9)(1991-12#1)(1991-2#7)(1991-3#8)(1991-9#1)(1992-1#4)(1992-12#16)(1992-2#7)(1992-6#1)(1993-1#4)(1993-12#3)(1993-2#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#5)(1995-1#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#3)(2008-3#2)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#18)(2012-12#4)(2012-2#1)(2012-3#14)(2012-5#2)(2013-1#17)(2013-8#2)
prospectively assessed##2##2##(1994-12#1)(2013-1#1)
prospectively evaluated##2##2##(2008-3#1)(2011-2#1)
prospectively included##2##2##(2010-4#1)(2011-2#1)
prospectively studied##6##2##(1994-12#1)(1997-8#1)(2008-7#3)(2013-8#1)
prospectively##36##1##(1990-3#1)(1992-2#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#4)(2008-9#1)(2010-11#1)(2010-4#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
prospects and##2##2##(1995-2#1)(2009-10#1)
prospects for the##4##3##(1991-2#1)(1997-7#1)(2008-5#1)(2010-11#1)
prospects for##24##2##(1990-11#1)(1991-2#2)(1992-12#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)
prospects of##5##2##(1993-3#1)(1997-7#1)(2008-10#1)(2011-2#1)(2011-7#1)
prospects##45##1##(1990-11#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#3)(2011-7#2)(2012-3#1)(2013-1#1)
prostacyclin release from##2##3##(1991-5#2)
prostacyclin release##3##2##(1991-5#3)
prostacyclin synthase##2##2##(1995-11#2)
prostacyclin##17##1##(1991-5#5)(1992-6#1)(1994-5#4)(1995-11#2)(1996-2#2)(1996-8#1)(2008-11#1)(2010-10#1)
prostaglandin E##2##2##(1994-6#1)(2012-2#1)
prostaglandin E1 (PGE1)##3##3##(1993-12#1)(1993-8#1)(1994-2#1)
prostaglandin E2 (PGE2) and##2##4##(1993-12#1)(2007-11#1)
prostaglandin E2 (PGE2)##4##3##(1993-12#1)(1997-1#1)(1997-2#1)(2007-11#1)
prostaglandin E2 synthesis by##3##4##(1997-1#3)
prostaglandin E2##17##2##(1993-12#1)(1995-6#2)(1996-2#2)(1997-1#7)(1997-2#2)(2007-11#1)(2011-2#2)
prostaglandin H synthase##5##3##(1994-5#5)
prostaglandin H synthase-2 in##2##4##(1993-3#2)
prostaglandin H synthase-2##5##3##(1993-3#5)
prostaglandin H##11##2##(1993-3#5)(1994-5#6)
prostaglandin endoperoxide##2##2##(1992-3#2)
prostaglandin production##2##2##(1996-2#2)
prostaglandin synthesis was##2##3##(1997-1#2)
prostaglandin synthesis##5##2##(1991-3#1)(1996-6#1)(1997-1#3)
prostaglandin##53##1##(1991-3#1)(1992-3#2)(1993-12#2)(1993-3#5)(1993-8#2)(1994-2#1)(1994-5#6)(1994-6#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#5)(1996-6#1)(1997-1#12)(1997-2#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2011-2#2)(2012-2#2)
prostaglandins (PGs)##2##2##(2008-11#2)
prostaglandins##14##1##(1993-6#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-1#2)(2008-10#2)(2008-11#4)(2010-1#2)
prostanoid synthesis##4##2##(1994-3#4)
prostanoid##6##1##(1993-3#1)(1994-3#4)(2010-10#1)
prostanoids##3##1##(1993-3#1)(2010-10#2)
prostate and##2##2##(1990-8#1)(2008-2#1)
prostate cancer and##2##3##(2008-7#1)(2011-2#1)
prostate cancer are##2##3##(2008-4#1)(2009-5#1)
prostate cancer cell##2##3##(2008-8#1)(2010-1#1)
prostate cancer cells and##2##4##(2011-2#2)
prostate cancer cells is##2##4##(2011-2#2)
prostate cancer cells##8##3##(2008-6#1)(2011-2#7)
prostate cancer in the United States##2##6##(1995-9#1)(2009-5#1)
prostate cancer in##7##3##(1994-12#1)(1995-9#1)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#2)
prostate cancer is##6##3##(1992-2#1)(2008-7#2)(2010-10#1)(2011-2#1)(2013-8#1)
prostate cancer pathogenesis##2##3##(2011-2#2)
prostate cancer patients##3##3##(1994-8#1)(2009-5#1)(2011-2#1)
prostate cancer screening##4##3##(2009-5#4)
prostate cancer support groups##2##4##(2009-5#2)
prostate cancer survivors##2##3##(2012-3#2)
prostate cancer survivorship care##2##4##(2012-3#2)
prostate cancer survivorship##3##3##(2012-3#3)
prostate cancer using##2##3##(2008-6#1)(2009-12#1)
prostate cancer##125##2##(1991-8#1)(1992-2#1)(1994-12#1)(1994-8#1)(1995-9#2)(2008-10#2)(2008-11#1)(2008-4#5)(2008-5#2)(2008-6#5)(2008-7#11)(2008-8#6)(2009-12#1)(2009-5#17)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#4)(2010-6#1)(2011-2#39)(2012-3#8)(2013-1#3)(2013-8#5)
prostate cancers##5##2##(2011-2#5)
prostate carcinoma##6##2##(1990-12#1)(1994-12#2)(2008-9#2)(2011-2#1)
prostate cell##2##2##(2008-11#1)(2008-9#1)
prostate disease and##2##3##(2008-1#2)
prostate epithelial cells##2##3##(2008-11#1)(2011-2#1)
prostate gland of##2##3##(2008-7#2)
prostate gland##6##2##(2008-11#1)(2008-12#1)(2008-7#2)(2012-3#2)
prostate health##4##2##(2008-1#4)
prostate in##2##2##(1993-8#1)(2012-3#1)
prostate specific antigen (PSA)##2##4##(1994-12#1)(2011-2#1)
prostate specific antigen##4##3##(1994-12#2)(2011-2#1)(2013-8#1)
prostate specific##5##2##(1994-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
prostate specimens##2##2##(2008-6#1)(2011-2#1)
prostate tumors##2##2##(2008-4#2)
prostate##215##1##(1990-11#2)(1990-12#1)(1990-8#1)(1990-9#3)(1991-5#2)(1991-8#4)(1992-12#1)(1992-2#1)(1993-8#3)(1994-12#6)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#3)(1995-9#2)(2008-1#7)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#11)(2008-5#3)(2008-6#8)(2008-7#13)(2008-8#6)(2008-9#3)(2009-12#2)(2009-5#17)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#5)(2010-6#1)(2010-8#1)(2011-2#53)(2012-2#5)(2012-3#11)(2013-1#6)(2013-8#6)
prostate-specific antigen (PSA)##3##3##(2008-9#1)(2009-5#1)(2010-12#1)
prostate-specific antigen##7##2##(1994-3#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
prostatectomies##3##1##(1996-9#1)(2008-10#1)(2010-11#1)
prostatectomy##9##1##(1990-9#1)(1994-12#1)(2010-10#2)(2010-11#2)(2011-2#2)(2013-1#1)
prostatic Zn##2##2##(2008-10#2)
prostatic cancer##12##2##(1990-9#3)(1991-7#6)(1991-9#1)(1993-8#1)(2013-8#1)
prostatic carcinoma##7##2##(1990-12#1)(1991-2#5)(1993-8#1)
prostatic epithelial##2##2##(1993-8#1)(2008-11#1)
prostatic hypertrophy##2##2##(1990-11#1)(2008-5#1)
prostatic urethra##2##2##(1997-8#1)(2012-3#1)
prostatic##46##1##(1990-11#2)(1990-12#1)(1990-9#6)(1991-2#10)(1991-7#6)(1991-9#1)(1992-2#1)(1993-6#1)(1993-8#3)(1994-12#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-5#2)(2009-5#1)(2010-11#1)(2012-3#1)(2013-8#1)
prostatitis syndrome##3##2##(2008-10#3)
prostatitis##16##1##(2008-10#12)(2008-12#1)(2008-8#1)(2010-11#1)(2011-2#1)
prostheses and##3##2##(1991-3#1)(2009-1#1)(2013-1#1)
prostheses were##2##2##(2009-1#1)(2011-2#1)
prostheses##32##1##(1990-8#1)(1991-3#2)(1992-3#1)(2009-1#9)(2009-3#1)(2009-4#2)(2009-7#4)(2011-2#2)(2011-3#2)(2011-7#1)(2013-1#7)
prosthesis after##2##2##(2009-4#1)(2013-1#1)
prosthesis and##2##2##(1993-6#1)(2013-1#1)
prosthesis during##2##2##(2011-7#1)(2013-1#1)
prosthesis in##2##2##(1992-9#1)(2009-3#1)
prosthesis insertion##5##2##(1993-6#1)(2008-10#1)(2013-8#3)
prosthesis is##3##2##(2010-5#1)(2013-1#2)
prosthesis that##2##2##(2013-1#2)
prosthesis was##2##2##(2009-4#1)(2011-2#1)
prosthesis with##2##2##(2010-5#1)(2010-8#1)
prosthesis##56##1##(1991-2#3)(1992-9#1)(1993-11#3)(1993-6#3)(1994-3#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-1#1)(2009-3#3)(2009-4#4)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#5)(2011-7#1)(2012-2#1)(2013-1#13)(2013-8#4)
prosthesis)##2##1##(1992-5#2)
prosthetic complications were##2##3##(2013-1#2)
prosthetic components##2##2##(2013-1#2)
prosthetic group##3##2##(1992-10#1)(1993-8#1)(2008-12#1)
prosthetic groups##4##2##(2008-11#1)(2008-7#3)
prosthetic knee##3##2##(2013-1#3)
prosthetic##38##1##(1990-5#1)(1991-3#2)(1992-10#1)(1992-5#3)(1993-2#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#4)(2010-6#1)(2011-2#2)(2011-3#3)(2012-12#1)(2013-1#11)
prosthodontic##3##1##(2007-12#1)(2008-11#1)(2013-1#1)
prosthodontics##2##1##(2013-1#2)
prostitute##4##1##(1992-9#2)(1996-5#1)(2008-5#1)
prostitutes##4##1##(1990-2#1)(1990-6#1)(1993-3#1)(1995-12#1)
prostitution##2##1##(1990-2#1)(1997-6#1)
protamine##3##1##(1996-6#1)(2008-8#1)(2011-1#1)
protean##3##1##(2008-7#1)(2010-12#1)(2012-2#1)
protease activity in##2##3##(2008-11#1)(2008-4#1)
protease activity##6##2##(1995-8#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
protease and##4##2##(1991-9#1)(1994-12#1)(2011-3#2)
protease cleavage##2##2##(2008-10#1)(2008-11#1)
protease digestion##2##2##(1995-3#1)(2008-5#1)
protease has been##2##3##(1991-9#2)
protease in the##2##3##(1992-6#1)(2011-3#1)
protease in##6##2##(1991-9#1)(1992-6#1)(1997-1#1)(2008-10#1)(2011-3#2)
protease inhibitor (KPI)##3##3##(1992-12#1)(1996-12#2)
protease inhibitor domain##2##3##(1994-11#2)
protease inhibitor##9##2##(1992-12#2)(1994-11#2)(1996-12#2)(2008-10#2)(2013-1#1)
protease inhibitors##11##2##(1990-11#1)(1992-6#3)(1996-5#1)(1997-7#1)(2006-6#1)(2011-2#1)(2011-3#2)(2012-3#1)
protease is##5##2##(1991-9#1)(1994-5#1)(1995-8#1)(2008-10#1)(2009-7#1)
protease of##2##2##(1993-12#1)(2008-4#1)
protease production##3##2##(1992-6#2)(2008-10#1)
protease was not##2##3##(2008-10#2)
protease was##4##2##(2008-10#4)
protease##119##1##(1990-11#1)(1990-5#1)(1991-10#1)(1991-6#1)(1991-9#11)(1992-12#4)(1992-3#1)(1992-6#16)(1993-12#7)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#3)(1995-3#3)(1995-6#3)(1995-8#4)(1996-12#2)(1996-5#1)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#20)(2008-11#6)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#2)(2011-3#7)(2012-3#1)(2013-1#1)
protease)##2##1##(1992-6#1)(2009-8#1)
protease-resistant##2##1##(1992-12#1)(1995-6#1)
protease-treated##2##1##(2008-10#2)
proteases and their##4##3##(2008-4#3)(2010-3#1)
proteases and##5##2##(2008-10#1)(2008-4#3)(2010-3#1)
proteases in the##2##3##(1990-11#1)(2008-11#1)
proteases in##3##2##(1990-11#1)(2008-11#1)(2008-4#1)
proteases##51##1##(1990-11#1)(1990-2#2)(1991-9#1)(1992-12#1)(1992-6#3)(1993-3#1)(1995-2#1)(1995-3#2)(1995-6#4)(1997-1#2)(2008-10#5)(2008-11#5)(2008-4#13)(2008-5#3)(2008-7#2)(2008-9#1)(2010-3#1)(2012-3#3)
proteasomal##2##1##(2008-4#1)(2012-2#1)
proteasome is##3##2##(2008-4#3)
proteasome##19##1##(1993-9#1)(2008-4#11)(2008-5#2)(2010-12#2)(2010-7#1)(2013-1#1)(2013-8#1)
proteasomes from Saccharomyces cerevisiae##2##4##(2008-4#2)
protect a##2##2##(2008-11#1)(2011-2#1)
protect against the##2##3##(1991-6#1)(2008-7#1)
protect against##20##2##(1991-6#4)(1994-3#1)(1995-11#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-2#1)(2011-2#5)(2011-9#1)(2012-2#1)(2013-1#1)
protect human subjects##2##3##(2009-4#2)
protect in##2##2##(1995-11#2)
protect mice##2##2##(1995-5#1)(2009-6#1)
protect other##2##2##(2008-11#1)(2011-2#1)
protect the health of the##2##5##(2008-10#1)(2010-6#1)
protect the health of##3##4##(2008-10#1)(2008-11#1)(2010-6#1)
protect the##25##2##(1994-3#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(2008-10#2)(2008-11#6)(2008-5#3)(2008-7#1)(2009-5#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
protect them against##3##3##(1994-3#1)(2008-5#1)(2013-1#1)
protect themselves##2##2##(2008-12#1)(2012-2#1)
protect wheat##2##2##(2008-10#2)
protect##108##1##(1990-12#1)(1990-2#2)(1990-3#1)(1991-12#1)(1991-6#5)(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-3#5)(1994-9#1)(1995-11#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(2008-10#8)(2008-11#13)(2008-12#2)(2008-4#1)(2008-5#10)(2008-7#4)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-10#1)(2011-2#8)(2011-3#1)(2011-9#1)(2012-2#4)(2013-1#5)(2013-7#2)(2013-8#1)
protectant fungicide##2##2##(2008-10#2)
protectant fungicides##2##2##(2008-10#2)
protectant##6##1##(2008-10#5)(2013-8#1)
protected against the##4##3##(1994-5#1)(1994-8#1)(2008-10#1)(2008-9#1)
protected against##9##2##(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
protected by the##2##3##(1991-9#1)(2010-1#1)
protected by##7##2##(1991-9#1)(1995-5#1)(2008-10#3)(2008-7#1)(2010-1#1)
protected fragments of##2##3##(1996-2#2)
protected from the##2##3##(2008-10#1)(2013-1#1)
protected from##13##2##(1993-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
protected mice##2##2##(2009-6#1)(2012-12#1)
protected the##5##2##(1996-3#1)(1997-8#1)(2008-11#2)(2008-7#1)
protected with##2##2##(2008-10#1)(2010-12#1)
protected##85##1##(1990-11#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-4#1)(1993-6#2)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-5#7)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-8#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
protecting against##6##2##(1994-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
protecting cells##3##2##(1992-7#1)(2008-11#1)(2011-2#1)
protecting groups##3##2##(1996-5#1)(2008-4#1)(2008-7#1)
protecting it##2##2##(1994-2#1)(2008-7#1)
protecting patients##2##2##(1997-5#1)(2011-2#1)
protecting the##8##2##(1996-2#1)(2008-11#1)(2008-5#2)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
protecting##44##1##(1992-7#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-10#9)(2008-11#3)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-8#2)
protection afforded by##3##3##(1996-12#1)(2008-5#2)
protection against a##4##3##(1995-5#1)(2008-10#2)(2012-2#1)
protection against both##3##3##(2008-10#2)(2008-5#1)
protection against infection by##2##4##(2008-10#1)(2008-9#1)
protection against infection with##2##4##(2009-6#1)(2011-2#1)
protection against infection##4##3##(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
protection against the development of##2##5##(1991-2#1)(2009-6#1)
protection against the##14##3##(1991-2#1)(1991-6#2)(2008-10#4)(2008-11#2)(2008-12#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
protection against typical##2##3##(1995-5#2)
protection against##77##2##(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-5#1)(1993-11#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#10)(1996-1#1)(1996-2#1)(1996-5#1)(2008-10#23)(2008-11#5)(2008-12#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#2)(2010-1#2)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-8#2)
protection and in##2##3##(1995-2#1)(2008-1#1)
protection and##12##2##(1990-2#1)(1992-6#1)(1995-2#1)(1997-1#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2010-11#1)(2013-1#1)
protection assay enables##2##3##(1996-12#1)(2008-4#1)
protection assay for##2##3##(1996-12#1)(2008-4#1)
protection assay##13##2##(1993-6#1)(1996-12#4)(1997-7#1)(2008-10#2)(2008-4#5)
protection assays##6##2##(1995-2#1)(1996-12#1)(2008-10#2)(2008-4#2)
protection at##2##2##(1995-5#1)(2011-2#1)
protection by##8##2##(1992-9#1)(2008-10#1)(2008-5#3)(2008-8#1)(2010-1#1)(2012-2#1)
protection devices##2##2##(2008-11#1)(2011-2#1)
protection during##2##2##(1991-3#1)(1996-6#1)
protection elicited by##2##3##(2008-10#2)
protection even when##2##3##(2008-10#2)
protection factor (SPF)##3##3##(2008-5#3)
protection factor##7##2##(1991-6#1)(2008-5#5)(2011-2#1)
protection for nurses##2##3##(2013-8#2)
protection for the##3##3##(2008-10#1)(2012-2#1)(2013-7#1)
protection for##9##2##(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
protection from##13##2##(1990-6#1)(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-11#1)(2011-2#2)
protection in the##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
protection in##18##2##(1990-12#1)(1993-3#1)(1995-11#3)(1995-5#3)(2008-10#2)(2008-4#1)(2008-5#4)(2010-1#1)(2011-2#1)(2013-1#1)
protection is##6##2##(1995-5#3)(2008-5#2)(2008-7#1)
protection of children##2##3##(1996-12#1)(2011-2#1)
protection of target mRNA##2##4##(2008-4#2)
protection of the##9##3##(1990-5#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-4#1)(2011-3#1)(2012-7#1)
protection of##32##2##(1990-2#2)(1990-5#1)(1992-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#2)(2012-7#1)
protection provided by##2##3##(2008-10#1)(2013-1#1)
protection services##2##2##(1996-12#1)(1997-2#1)
protection studies##2##2##(1995-5#2)
protection systems##2##2##(1990-5#1)(2012-2#1)
protection to the##3##3##(1995-11#1)(2008-10#1)(2010-7#1)
protection to##6##2##(1992-7#1)(1995-11#1)(2008-10#2)(2010-7#1)(2011-2#1)
protection was##10##2##(1990-6#1)(1991-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#4)(2013-1#1)
protection when##3##2##(1996-6#1)(2008-10#2)
protection with##3##2##(2008-10#3)
protection##368##1##(1990-12#1)(1990-2#4)(1990-5#3)(1990-6#4)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#6)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#6)(1995-12#3)(1995-2#5)(1995-5#23)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#10)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-1#3)(2008-10#85)(2008-11#21)(2008-12#8)(2008-4#16)(2008-5#48)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#2)(2010-1#4)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-10#1)(2011-2#18)(2011-3#2)(2012-12#1)(2012-2#8)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#7)
protection)##5##1##(1995-5#2)(2008-10#1)(2008-4#1)(2010-1#1)
protective action of adenosine##2##4##(1996-2#2)
protective action of##3##3##(1996-2#2)(2008-11#1)
protective activity##2##2##(2008-10#1)(2008-11#1)
protective against##6##2##(1990-12#1)(1995-5#2)(1997-3#1)(2008-5#1)(2008-8#1)
protective agent##2##2##(1993-2#1)(2008-10#1)
protective agents##3##2##(1995-11#1)(2008-5#2)
protective and##4##2##(1992-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
protective behaviors##3##2##(2010-2#2)(2013-1#1)
protective effect against##2##3##(2008-11#1)(2009-8#1)
protective effect in##2##3##(1990-3#1)(1995-11#1)
protective effect of the##3##4##(2008-10#2)(2013-1#1)
protective effect of##16##3##(1993-2#1)(1996-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
protective effect on##6##3##(1992-12#1)(1994-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
protective effect##38##2##(1990-3#1)(1992-12#1)(1993-11#1)(1993-2#3)(1993-6#1)(1994-2#3)(1995-11#1)(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
protective effects of##10##3##(1992-6#1)(1994-5#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#1)
protective effects on the##2##4##(2008-7#1)(2008-9#1)
protective effects on##7##3##(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-3#1)
protective effects##21##2##(1992-6#1)(1994-5#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-7#2)(2010-12#1)(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#1)
protective efficacy of##2##3##(1995-12#1)(1995-5#1)
protective efficacy##6##2##(1995-12#1)(1995-5#3)(2008-5#2)
protective enzyme activities##2##3##(2008-12#2)
protective enzymes##2##2##(2008-12#2)
protective factor against doping##2##4##(2009-11#2)
protective factor against##3##3##(1995-12#1)(2009-11#2)
protective factor##8##2##(1994-12#1)(1994-2#1)(1995-12#1)(2009-11#2)(2009-12#1)(2011-2#1)(2013-8#1)
protective factors##3##2##(2009-7#1)(2010-5#1)(2013-1#1)
protective film##2##2##(2008-10#2)
protective function of##2##3##(2008-11#1)(2013-1#1)
protective function##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
protective immunity##6##2##(1995-2#1)(2008-4#1)(2011-2#4)
protective layer##2##2##(2008-10#1)(2008-3#1)
protective mechanism##2##2##(2010-5#1)(2013-8#1)
protective potential##3##2##(1992-12#1)(1994-2#1)(2008-5#1)
protective protein##6##2##(1994-11#6)
protective role in##3##3##(2008-12#1)(2011-2#2)
protective role of##6##3##(1996-12#1)(2010-11#1)(2012-4#1)(2013-1#3)
protective role##12##2##(1996-12#2)(1997-2#1)(2008-12#1)(2010-11#1)(2011-2#3)(2012-4#1)(2013-1#3)
protective services##2##2##(1991-1#2)
protective##193##1##(1990-12#1)(1990-3#1)(1991-1#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-6#3)(1993-11#1)(1993-2#4)(1993-6#1)(1994-11#7)(1994-12#1)(1994-2#5)(1994-5#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-5#8)(1996-12#4)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#21)(2008-11#7)(2008-12#10)(2008-3#1)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#14)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-7#4)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#11)(2013-8#4)
protector##4##1##(1991-5#1)(1992-11#1)(1992-12#1)(2011-2#1)
protects against##7##2##(1993-3#1)(1995-12#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-6#1)(2012-2#1)
protects cells from##3##3##(1992-7#1)(2008-9#1)(2009-12#1)
protects cells##4##2##(1991-5#1)(1992-7#1)(2008-9#1)(2009-12#1)
protects the##7##2##(2007-12#1)(2008-10#2)(2008-11#2)(2009-8#1)(2010-4#1)
protects##28##1##(1991-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-5#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
protein (A##2##2##(1995-12#1)(1995-6#1)
protein (CP) gene##13##3##(2008-10#12)(2008-8#1)
protein (CP)##28##2##(2008-10#27)(2008-8#1)
protein (CREB)##4##2##(1996-12#2)(2008-7#1)(2009-3#1)
protein (FABP)##2##2##(1994-8#1)(2013-1#1)
protein (GFP)##19##2##(1996-6#1)(2008-10#5)(2008-11#4)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#1)(2011-3#1)(2013-8#1)
protein (MAP) kinase##2##3##(1996-2#1)(2008-7#1)
protein (MAP) kinases##2##3##(1993-8#1)(1995-8#1)
protein (MAP)##4##2##(1993-8#1)(1995-8#1)(1996-2#1)(2008-7#1)
protein (MBP) fusion##2##3##(1995-12#2)
protein (MBP)##7##2##(1992-9#1)(1993-3#1)(1994-8#1)(1995-12#3)(2008-8#1)
protein (MRP)##2##2##(2008-11#2)
protein (Mr =##2##3##(1992-3#2)
protein (P50)##2##2##(2008-10#2)
protein (TSPO) is a##3##4##(2012-2#3)
protein (TSPO)##6##2##(2012-2#6)
protein (r = 0##2##4##(2010-4#1)(2011-2#1)
protein (r =##3##3##(1993-2#1)(2010-4#1)(2011-2#1)
protein 1 (CaBP1)##2##3##(2009-7#2)
protein 1##12##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
protein 2##4##2##(1996-12#2)(2008-10#1)(2012-3#1)
protein 3##5##2##(2008-10#1)(2008-11#1)(2012-2#2)(2013-8#1)
protein 4##5##2##(2009-7#1)(2010-5#1)(2012-2#2)(2013-1#1)
protein 5##2##2##(2008-10#1)(2008-8#1)
protein 7##2##2##(2011-2#1)(2013-1#1)
protein 70##9##2##(1993-9#1)(1995-11#1)(2008-10#3)(2010-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
protein A in human plasma##2##5##(1990-12#2)
protein A in##4##3##(1990-12#4)
protein A##20##2##(1990-11#1)(1990-12#8)(1991-5#1)(1994-3#2)(1995-5#1)(1996-12#3)(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
protein C and##2##3##(2008-1#1)(2011-2#1)
protein C deficiency##4##3##(2008-12#3)(2013-1#1)
protein C##14##2##(1997-3#2)(2008-1#1)(2008-12#7)(2008-3#1)(2011-2#2)(2013-1#1)
protein G and##2##3##(1990-12#2)
protein G##12##2##(1990-12#5)(2008-10#7)
protein G-binding antibodies##2##3##(1990-12#2)
protein G-liposomal nanovesicles##8##3##(2008-10#8)
protein G-tagged##2##2##(2008-10#2)
protein L##2##2##(1990-12#2)
protein L3##3##2##(1992-8#3)
protein LRP##2##2##(2008-11#2)
protein SNAP-25 (synaptosome-associated protein##2##4##(1995-2#1)(1997-7#1)
protein SNAP-25##4##2##(1995-2#1)(1996-12#1)(1997-7#2)
protein accumulated##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
protein accumulation##2##2##(2008-10#1)(2009-12#1)
protein activities##2##2##(2008-10#1)(2008-11#1)
protein activity##2##2##(2009-7#1)(2011-2#1)
protein adsorption##6##2##(2008-10#4)(2010-7#1)(2013-1#1)
protein aerosols##2##2##(1996-1#2)
protein after##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
protein aggregation##3##2##(2008-4#1)(2008-7#2)
protein also##4##2##(1991-10#1)(1994-11#2)(1995-6#1)
protein amino acid##2##3##(2008-10#1)(2012-2#1)
protein analysis##4##2##(1990-5#1)(2008-10#2)(2010-7#1)
protein and DNA##5##3##(1993-12#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-4#1)
protein and RNA##2##3##(2010-12#1)(2011-2#1)
protein and a##8##3##(1990-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-8#1)(2008-10#1)(2010-11#1)(2011-2#1)
protein and are##2##3##(1994-5#1)(1995-2#1)
protein and asialo-orosomucoid were##2##4##(1995-6#2)
protein and asialo-orosomucoid##4##3##(1995-6#4)
protein and its##2##3##(2008-10#1)(2011-1#1)
protein and lipid##2##3##(2008-7#1)(2008-9#1)
protein and mRNA levels##2##4##(1993-3#1)(2010-1#1)
protein and mRNA##3##3##(1993-3#1)(2010-1#1)(2013-1#1)
protein and membrane##2##3##(2008-11#2)
protein and peptide##2##3##(1995-5#2)
protein and the##8##3##(1991-7#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#2)
protein and to##4##3##(1994-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
protein and##112##2##(1990-6#1)(1990-8#3)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#6)(1995-8#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#3)(2007-11#1)(2008-10#14)(2008-11#6)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
protein antigens##2##2##(1995-5#1)(2008-11#1)
protein are discussed##2##3##(1992-12#1)(2008-10#1)
protein are##7##2##(1992-12#1)(1993-2#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-4#1)
protein array##2##2##(2008-4#2)
protein as a##5##3##(1993-1#1)(1994-11#1)(1996-6#1)(2008-11#1)(2013-8#1)
protein as well as##3##4##(1990-8#1)(2008-11#1)(2011-2#1)
protein as##20##2##(1990-5#3)(1990-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
protein assay##5##2##(2008-10#4)(2008-12#1)
protein associated with##2##3##(1995-6#1)(2009-7#1)
protein at##8##2##(1991-12#1)(1993-8#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-7#1)
protein band of##2##3##(1993-8#1)(1994-5#1)
protein band with##2##3##(2009-9#1)(2010-3#1)
protein band##9##2##(1993-8#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-3#2)(2011-3#1)
protein bands of##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
protein bands that##2##3##(2008-10#2)
protein bands##14##2##(1990-5#1)(1993-3#1)(2008-10#6)(2008-11#3)(2008-7#1)(2010-11#1)(2010-3#1)
protein based on##3##3##(2008-10#3)
protein based##5##2##(2008-10#3)(2008-5#1)(2012-12#1)
protein before##2##2##(1995-12#1)(2008-10#1)
protein being analyzed##2##3##(2008-10#2)
protein being##3##2##(2008-10#2)(2008-11#1)
protein binding assay for activin A/EDF##2##6##(1992-6#2)
protein binding sites##3##3##(1991-5#2)(2013-1#1)
protein binding##11##2##(1991-5#2)(1992-6#3)(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
protein binds##2##2##(2011-2#1)(2012-2#1)
protein bioavailability##2##2##(2011-2#1)(2012-2#1)
protein biomarkers##5##2##(2008-10#2)(2010-9#3)
protein biopharmaceuticals##2##2##(2011-2#2)
protein biosynthesis##2##2##(1992-8#1)(1995-3#1)
protein blot##3##2##(2008-10#3)
protein bound to##3##3##(1993-6#1)(1997-6#1)(2008-1#1)
protein bound##5##2##(1993-6#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-8#1)
protein by##16##2##(1990-10#1)(1990-5#1)(1990-9#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#2)
protein can be##2##3##(1995-2#1)(2008-8#1)
protein can##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
protein coding regions##5##3##(1993-6#1)(1996-12#2)(1997-2#1)(2010-7#1)
protein coding sequence##2##3##(1991-7#1)(2011-2#1)
protein coding##11##2##(1991-7#1)(1993-6#1)(1996-12#2)(1997-2#1)(1997-4#1)(2008-4#2)(2010-7#2)(2011-2#1)
protein complex involved in##2##4##(1997-1#1)(1997-7#1)
protein complex that is required##2##5##(1995-2#1)(2008-5#1)
protein complex##15##2##(1990-11#1)(1995-2#2)(1997-1#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-8#3)(2011-2#1)(2012-2#1)
protein complexes formed##2##3##(1995-6#1)(1997-3#1)
protein complexes in##2##3##(1994-5#1)(1995-8#1)
protein complexes that##2##3##(2008-4#1)(2010-10#1)
protein complexes##11##2##(1993-8#2)(1994-5#1)(1995-6#1)(1995-8#1)(1997-3#1)(2008-4#2)(2010-10#1)(2011-2#1)(2013-8#1)
protein component##5##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
protein components of nucleolar skeleton##2##5##(2008-8#2)
protein components of##5##3##(1995-2#1)(2008-2#1)(2008-8#2)(2010-11#1)
protein components##8##2##(1991-12#1)(1993-8#1)(1995-2#1)(2008-2#1)(2008-8#2)(2010-11#1)(2013-8#1)
protein composition of the nucleolar skeleton of HeLa cells##2##9##(2008-8#2)
protein composition of the##3##4##(1991-2#1)(2008-8#2)
protein composition of##5##3##(1991-2#1)(2008-8#3)(2009-6#1)
protein composition##7##2##(1991-2#1)(1995-9#1)(2008-8#3)(2009-6#1)(2010-11#1)
protein comprised##2##2##(2008-10#1)(2008-11#1)
protein concentrates##2##2##(2010-4#2)
protein concentration in##2##3##(1991-11#1)(2008-10#1)
protein concentration##12##2##(1991-11#1)(1991-12#1)(1991-2#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-7#1)(2010-11#1)(2011-1#1)
protein concentrations##3##2##(1991-12#1)(2008-10#1)(2013-1#1)
protein conformation##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
protein conformational change##2##3##(1995-6#2)
protein conformational##3##2##(1995-6#2)(2008-10#1)
protein consisting of##3##3##(1994-11#1)(1995-8#1)(2008-9#1)
protein consists of##2##3##(1993-12#1)(1993-2#1)
protein contained##2##2##(1992-8#1)(1993-12#1)
protein containing a##4##3##(1994-5#1)(1995-12#1)(1997-7#1)(2009-9#1)
protein containing the##5##3##(1990-8#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-4#1)
protein containing##11##2##(1990-8#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#2)(2008-4#1)(2009-9#1)
protein contains a##2##3##(1993-12#1)(2008-8#1)
protein contains two##2##3##(1993-2#1)(2008-10#1)
protein contains##9##2##(1992-10#1)(1993-12#1)(1993-2#2)(1995-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
protein content and##2##3##(1995-12#1)(2011-3#1)
protein content of##2##3##(1995-9#1)(2009-11#1)
protein content##14##2##(1992-8#1)(1995-11#1)(1995-12#1)(1995-9#2)(2008-10#2)(2008-11#1)(2009-11#1)(2010-11#2)(2010-4#1)(2011-3#1)(2012-7#1)
protein contents of##2##3##(1994-5#1)(2008-10#1)
protein contents##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
protein core##3##2##(1993-2#2)(2009-8#1)
protein could be##4##3##(1994-5#1)(2008-8#2)(2013-8#1)
protein could##8##2##(1994-5#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-6#1)(2012-2#1)(2013-8#1)
protein coupled##2##2##(1997-2#1)(2008-7#1)
protein coupling##2##2##(1990-2#1)(1993-8#1)
protein database##2##2##(1997-2#1)(2010-4#1)
protein databases##2##2##(2008-9#1)(2010-4#1)
protein deficiency##2##2##(1993-12#1)(1994-11#1)
protein degradation were##2##3##(2011-2#1)(2011-3#1)
protein degradation##8##2##(1992-8#1)(1995-2#1)(1995-5#1)(2008-11#1)(2009-7#1)(2011-2#2)(2011-3#1)
protein delivery##4##2##(2008-11#4)
protein demonstrated##2##2##(2008-10#1)(2008-8#1)
protein derivative##3##2##(1992-6#1)(1997-2#1)(2008-10#1)
protein detected##2##2##(2008-10#1)(2008-5#1)
protein determination##4##2##(2008-10#3)(2008-9#1)
protein digestion within the phagocytic vacuole of##2##7##(1990-12#2)
protein digestion##8##2##(1990-12#2)(2008-10#2)(2012-3#4)
protein displayed##2##2##(1993-8#1)(2008-11#1)
protein disulfide isomerase##8##3##(1993-6#6)(2013-1#2)
protein disulfide##11##2##(1993-6#6)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
protein disulfide-thiol interchange##2##3##(2009-9#2)
protein domain##3##2##(2009-10#1)(2011-2#2)
protein domains##6##2##(1995-2#1)(2008-4#1)(2008-7#1)(2011-2#3)
protein driven by##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
protein during##2##2##(1993-8#1)(2008-11#1)
protein encoded by the small RNA##2##6##(2008-10#2)
protein encoded by the##5##4##(1993-12#1)(1994-3#1)(1995-5#1)(2008-10#2)
protein encoded by##7##3##(1993-12#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(2008-10#2)
protein encoded##9##2##(1993-12#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-11#1)
protein engineering##10##2##(1991-6#2)(1992-11#2)(1994-8#4)(2008-9#1)(2011-2#1)
protein evolution##4##2##(1991-12#1)(1997-6#1)(2008-6#1)(2011-1#1)
protein excretion##3##2##(1993-12#1)(1997-8#1)(2011-3#1)
protein expressed in the##2##4##(1996-12#1)(1997-7#1)
protein expressed in##4##3##(1996-12#1)(1997-7#1)(2008-9#1)(2009-9#1)
protein expressed##6##2##(1996-12#1)(1997-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)
protein expression analysis##2##3##(2008-11#1)(2010-12#1)
protein expression and##5##3##(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-3#1)
protein expression in the##3##4##(1994-2#1)(2008-11#1)(2013-1#1)
protein expression in##15##3##(1991-10#1)(1994-2#1)(2008-11#8)(2008-4#1)(2009-8#1)(2009-9#1)(2010-5#1)(2013-1#1)
protein expression levels##3##3##(2008-11#2)(2013-1#1)
protein expression of##5##3##(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-8#1)
protein expression were##2##3##(2008-7#1)(2013-1#1)
protein expression##62##2##(1991-10#1)(1994-2#1)(1995-11#1)(2008-10#1)(2008-11#23)(2008-12#1)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#7)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
protein expressions##3##2##(2008-12#1)(2012-3#2)
protein extract##2##2##(2008-10#1)(2008-9#1)
protein extraction and##2##3##(2008-11#2)
protein extraction##4##2##(2008-10#1)(2008-11#2)(2010-4#1)
protein extracts from##3##3##(1991-12#1)(2008-10#1)(2010-12#1)
protein extracts##8##2##(1991-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2010-12#1)
protein factors##4##2##(1994-5#1)(2008-11#1)(2008-9#1)(2012-2#1)
protein families##6##2##(2008-9#3)(2009-10#1)(2009-8#1)(2011-1#1)
protein family are##2##3##(1995-2#1)(2009-8#1)
protein family##15##2##(1992-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2013-1#1)
protein farnesyltransferase##2##2##(1993-9#1)(1995-2#1)
protein films##3##2##(2008-10#1)(2008-12#2)
protein fingerprints##2##2##(2008-10#1)(2013-1#1)
protein fluorescence##2##2##(1992-12#1)(1995-8#1)
protein folding machinery##2##3##(1994-12#2)
protein folding##10##2##(1991-6#2)(1994-12#2)(2008-8#1)(2009-8#1)(2010-4#3)(2011-2#1)
protein for the##2##3##(1995-11#1)(2008-10#1)
protein for##9##2##(1994-11#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2012-2#1)
protein found in##2##3##(1990-5#1)(2007-12#1)
protein found##4##2##(1990-5#1)(2007-12#1)(2013-7#1)(2013-8#1)
protein fraction##9##2##(1991-5#1)(1994-11#3)(1996-2#1)(2008-10#3)(2011-2#1)
protein fractions##8##2##(1991-12#3)(1991-6#1)(2008-10#2)(2008-5#1)(2011-2#1)
protein from a##2##3##(1997-3#1)(2008-11#1)
protein from flax seeds##2##4##(1992-8#2)
protein from the##5##3##(1995-8#1)(2008-10#2)(2009-7#1)(2009-8#1)
protein from##36##2##(1990-5#2)(1992-12#1)(1992-8#2)(1993-8#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-3#1)(2008-10#7)(2008-11#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-7#6)(2009-8#1)(2010-12#1)(2013-1#1)
protein function and##3##3##(2008-9#1)(2011-2#2)
protein function specificity##2##3##(2011-2#2)
protein function##6##2##(1997-3#1)(2008-9#1)(2011-2#4)
protein gene and##2##3##(2008-10#1)(2008-8#1)
protein gene expression##2##3##(2008-8#1)(2011-10#1)
protein gene in##4##3##(1993-8#1)(2008-8#2)(2013-1#1)
protein gene##29##2##(1993-8#1)(1996-12#1)(1997-3#2)(2008-10#15)(2008-11#1)(2008-8#7)(2011-10#1)(2013-1#1)
protein genes and##2##3##(2008-10#1)(2008-8#1)
protein genes##16##2##(1994-8#1)(1996-3#1)(1996-6#3)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)
protein glycosylation##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
protein had a##2##3##(2008-10#2)
protein had an##2##3##(1993-8#1)(2008-10#1)
protein had##6##2##(1991-3#1)(1993-8#1)(2008-10#3)(2008-8#1)
protein half-life##2##2##(1995-12#1)(2008-11#1)
protein has a##2##3##(1990-11#1)(1992-8#1)
protein has been found in##2##5##(2008-7#1)(2008-8#1)
protein has been##7##3##(1993-3#1)(1993-9#1)(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
protein has##17##2##(1990-11#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-2#1)(2012-2#1)
protein have been##2##3##(2008-11#1)(2011-1#1)
protein have##3##2##(1995-6#1)(2008-11#1)(2011-1#1)
protein hydrolysate##3##2##(2008-10#1)(2008-11#2)
protein hydrolysates##9##2##(2008-10#1)(2008-11#6)(2008-5#2)
protein hydrolyzates##3##2##(1997-2#3)
protein hyper-producing cell lines##2##4##(2008-11#2)
protein hyper-producing##4##2##(2008-11#4)
protein identification##2##2##(2008-10#1)(2008-9#1)
protein immobilization and##2##3##(2008-10#1)(2010-7#1)
protein implicated in##3##3##(1994-11#1)(1995-2#1)(2009-7#1)
protein import##3##2##(1995-2#1)(2008-1#1)(2012-2#1)
protein in a##4##3##(1993-3#1)(2008-11#3)
protein in human serum##5##4##(1995-8#1)(2008-10#4)
protein in human##11##3##(1990-12#1)(1994-11#1)(1995-8#2)(2008-10#5)(2008-11#1)(2013-8#1)
protein in insect larvae##2##4##(2008-7#2)
protein in mammalian cells##2##4##(1997-7#1)(2008-11#1)
protein in mammalian##3##3##(1993-11#1)(1997-7#1)(2008-11#1)
protein in the cytoplasm##2##4##(1995-8#1)(2008-10#1)
protein in the cytosol##2##4##(1990-5#1)(1997-4#1)
protein in the##23##3##(1990-12#1)(1990-5#2)(1993-1#2)(1993-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-11#2)(1995-8#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#1)
protein in vivo##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
protein in##108##2##(1990-12#3)(1990-5#3)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-7#2)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-6#1)(1995-8#3)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-12#2)(2007-8#1)(2008-10#17)(2008-11#18)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-7#3)(2009-8#1)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
protein including##2##2##(2008-10#1)(2008-8#1)
protein increased##2##2##(1993-8#1)(2013-8#1)
protein indicated##2##2##(1990-11#1)(1992-8#1)
protein induction##3##2##(2008-10#2)(2008-11#1)
protein intake and##3##3##(2013-8#3)
protein intake in healthy adults##2##5##(2013-8#2)
protein intake##11##2##(2013-8#11)
protein interaction##4##2##(2008-4#1)(2009-8#1)(2011-2#2)
protein interactions##11##2##(1997-7#1)(2008-4#6)(2010-10#1)(2011-2#2)(2013-8#1)
protein interacts with##2##3##(1997-3#1)(2008-9#1)
protein into the cytoplasm##2##4##(1994-11#1)(2008-11#1)
protein into the##3##3##(1991-5#1)(1994-11#1)(2008-11#1)
protein into##7##2##(1991-5#1)(1994-11#1)(1997-1#1)(1997-8#2)(2008-11#1)(2008-8#1)
protein involved in##6##3##(1992-9#1)(2008-5#1)(2009-7#1)(2011-2#2)(2012-2#1)
protein involved##7##2##(1992-9#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#2)(2012-2#1)
protein is a##5##3##(1991-9#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-7#1)
protein is able to##2##4##(1993-9#1)(2009-8#1)
protein is an essential##2##4##(1994-3#1)(2013-1#1)
protein is an##4##3##(1994-3#1)(2008-7#1)(2009-6#1)(2013-1#1)
protein is capable of##2##4##(1995-6#1)(2008-9#1)
protein is induced by##2##4##(1992-7#1)(1995-12#1)
protein is less##2##3##(2008-9#2)
protein is present in##3##4##(1992-6#1)(2008-10#1)(2009-8#1)
protein is present##4##3##(1992-6#1)(2008-10#2)(2009-8#1)
protein is the##5##3##(1996-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
protein is##81##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-2#2)(1991-9#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-6#5)(1996-12#1)(1996-2#1)(1997-2#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#2)(2011-2#3)(2013-1#2)(2013-8#1)
protein isoforms##2##2##(1995-2#1)(2008-7#1)
protein isolate##4##2##(2011-2#2)(2013-1#2)
protein isolated from the##3##4##(1991-9#1)(1994-11#1)(2008-9#1)
protein isolated from##6##3##(1990-12#1)(1991-9#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-9#1)
protein isolated##7##2##(1990-12#1)(1991-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-9#1)
protein isolates##4##2##(2010-4#2)(2011-2#2)
protein it##2##2##(1995-2#1)(2011-2#1)
protein kinase (MAPK) cascade##3##4##(1995-2#2)(2009-8#1)
protein kinase (MAPK)##8##3##(1995-2#2)(1996-2#1)(2008-10#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
protein kinase (PK)##3##3##(1993-2#2)(1993-9#1)
protein kinase (PKA)##4##3##(1993-3#1)(1994-11#1)(1995-2#1)(1997-2#1)
protein kinase (PKC)##2##3##(1993-12#1)(1997-2#1)
protein kinase (protein kinase##2##4##(1993-8#2)
protein kinase A (PKA)##3##4##(1994-8#1)(2008-10#1)(2009-7#1)
protein kinase A activity)##2##4##(1993-8#2)
protein kinase A##18##3##(1993-8#4)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
protein kinase C (PKC) activator##2##5##(1994-11#1)(1997-1#1)
protein kinase C (PKC) and##3##5##(1993-3#1)(1993-8#1)(2008-11#1)
protein kinase C (PKC)##24##4##(1990-5#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2013-8#1)
protein kinase C activation##7##4##(1992-8#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-3#1)
protein kinase C activity in##2##5##(1990-8#1)(1993-8#1)
protein kinase C activity##6##4##(1990-5#1)(1990-8#2)(1993-8#1)(2008-11#1)(2008-3#1)
protein kinase C and protein kinase A##2##7##(1995-6#1)(2008-11#1)
protein kinase C and protein kinase##3##6##(1995-6#1)(2008-11#1)(2008-3#1)
protein kinase C and##9##4##(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(2008-11#3)(2008-3#1)
protein kinase C by##6##4##(1990-12#1)(1990-5#1)(1993-8#1)(2008-3#2)(2008-8#1)
protein kinase C in the##3##5##(1994-11#1)(1997-1#2)
protein kinase C in##7##4##(1992-8#1)(1994-11#1)(1997-1#2)(2008-11#3)
protein kinase C inhibitor##4##4##(1994-11#1)(1995-6#1)(1995-8#1)(2008-11#1)
protein kinase C phosphorylation##2##4##(1991-7#1)(2008-8#1)
protein kinase C was##2##4##(1990-5#1)(2008-11#1)
protein kinase C##130##3##(1990-12#2)(1990-5#11)(1990-8#6)(1991-5#2)(1991-7#1)(1992-12#2)(1992-8#5)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#7)(1994-11#9)(1994-3#1)(1994-5#9)(1994-6#2)(1994-8#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-6#3)(1995-8#4)(1996-12#1)(1996-6#2)(1997-1#4)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#20)(2008-3#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-12#2)(2013-8#1)
protein kinase C's##2##3##(1994-5#2)
protein kinase II (CaMKII)##2##4##(2008-8#1)(2012-2#1)
protein kinase II##17##3##(1990-5#1)(1993-6#3)(1995-2#4)(1995-8#2)(1996-2#3)(2008-10#1)(2008-8#2)(2012-2#1)
protein kinase activation##2##3##(1994-11#1)(1995-6#1)
protein kinase activity##2##3##(1993-8#1)(1997-2#1)
protein kinase and##3##3##(1990-8#1)(1993-6#1)(2012-3#1)
protein kinase in##3##3##(1993-8#1)(2010-10#1)(2013-1#1)
protein kinase inhibitor##7##3##(1990-12#3)(1995-2#2)(1997-2#1)(2008-10#1)
protein kinase inhibitors##3##3##(1990-8#2)(1994-11#1)
protein kinase##251##2##(1990-10#1)(1990-12#6)(1990-2#1)(1990-5#12)(1990-8#11)(1991-5#2)(1991-7#1)(1992-12#2)(1992-8#5)(1992-9#2)(1993-12#3)(1993-2#4)(1993-3#3)(1993-6#8)(1993-8#15)(1993-9#1)(1994-11#15)(1994-3#2)(1994-5#11)(1994-6#4)(1994-8#5)(1995-11#6)(1995-12#3)(1995-2#15)(1995-6#5)(1995-8#6)(1996-12#2)(1996-2#6)(1996-6#2)(1997-1#4)(1997-2#8)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#24)(2008-3#7)(2008-7#3)(2008-8#8)(2008-9#5)(2009-6#1)(2009-7#3)(2009-8#3)(2010-10#2)(2010-12#3)(2010-4#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
protein kinases##27##2##(1990-8#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#4)(1994-6#1)(1995-2#1)(1995-6#3)(1996-2#4)(1997-1#1)(1997-2#1)(2008-11#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
protein known to##2##3##(1995-8#1)(2008-10#1)
protein lacking##3##2##(1992-6#1)(1993-6#1)(2012-2#1)
protein level was##2##3##(1993-1#1)(2012-3#1)
protein level##13##2##(1993-1#2)(1994-11#1)(1994-8#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
protein levels and##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
protein levels as##2##3##(1997-7#1)(2011-2#1)
protein levels in##8##3##(1995-12#1)(2008-11#2)(2011-2#1)(2013-8#4)
protein levels of##6##3##(2008-11#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-8#1)
protein levels were##2##3##(1991-12#1)(2009-6#1)
protein levels##33##2##(1991-12#1)(1993-6#3)(1995-12#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#1)(2013-8#5)
protein liquid##3##2##(2008-10#3)
protein loss##2##2##(2008-11#1)(2008-5#1)
protein losses##2##2##(2011-2#2)
protein mRNA##2##2##(1995-8#1)(1996-12#1)
protein maize##2##2##(2012-2#2)
protein malnutrition##2##2##(2008-11#1)(2012-2#1)
protein marker##3##2##(2008-10#2)(2008-4#1)
protein mass##2##2##(2008-10#1)(2008-11#1)
protein matrix##2##2##(1994-5#1)(2008-10#1)
protein may be##6##3##(1993-8#1)(1997-3#1)(2008-10#2)(2008-5#1)(2009-9#1)
protein may play a role in##2##6##(2009-4#1)(2009-7#1)
protein may play an important role in##2##7##(2008-8#1)(2008-9#1)
protein may play##4##3##(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)
protein may##14##2##(1990-5#1)(1991-9#1)(1993-8#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2009-9#1)
protein metabolism##3##2##(2008-10#2)(2009-10#1)
protein methyltransferase##2##2##(1993-8#2)
protein microarray##2##2##(2008-10#2)
protein microarrays##2##2##(2009-12#1)(2010-7#1)
protein might##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
protein mixture##2##2##(2008-10#2)
protein mixtures##2##2##(2008-11#1)(2008-4#1)
protein modification##3##2##(1993-3#1)(2008-10#1)(2009-8#1)
protein molecules##5##2##(1990-12#1)(2008-10#1)(2008-9#2)(2010-10#1)
protein monomers##2##2##(1997-6#1)(2008-10#1)
protein myristoylation##2##2##(2009-8#2)
protein not only##2##3##(2008-10#1)(2012-2#1)
protein occurred in##2##3##(1994-11#1)(2009-8#1)
protein of 1##2##3##(2008-10#1)(2010-5#1)
protein of 294 amino acids##2##5##(1990-11#1)(1996-6#1)
protein of Escherichia coli##2##4##(1991-12#1)(1991-7#1)
protein of M(r)##2##3##(1993-9#1)(2010-4#1)
protein of interest##3##3##(2008-4#2)(2008-9#1)
protein of the##10##3##(1990-5#1)(1991-2#1)(1995-2#1)(1996-12#2)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
protein of unknown function##2##4##(2008-10#2)
protein of##119##2##(1990-11#1)(1990-5#5)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#3)(1993-12#3)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#4)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#7)(1996-6#5)(1997-3#1)(1997-7#4)(2008-10#25)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-6#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
protein on immunoblots of##2##4##(1991-9#1)(1995-6#1)
protein on the##3##3##(1994-3#1)(2008-11#1)(2008-9#1)
protein on##10##2##(1991-9#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-9#1)
protein only##3##2##(1994-3#1)(1997-7#1)(2008-4#1)
protein or peptide##2##3##(1995-5#1)(2008-11#1)
protein or##12##2##(1993-12#1)(1993-3#1)(1994-8#2)(1995-5#2)(2008-11#1)(2008-4#3)(2008-9#1)(2009-9#1)
protein p20##3##2##(2008-9#3)
protein part of##2##3##(2009-8#2)
protein part##3##2##(2009-8#3)
protein particles##2##2##(1996-1#1)(2008-11#1)
protein peaks##2##2##(2008-10#2)
protein per min##6##3##(1992-3#3)(2008-10#2)(2008-11#1)
protein per##8##2##(1992-3#3)(2008-10#2)(2008-11#2)(2010-7#1)
protein phosphatase 1##3##3##(1995-8#2)(2008-10#1)
protein phosphatase 1/2A##3##3##(1993-8#2)(1994-11#1)
protein phosphatase activator##2##3##(1993-6#2)
protein phosphatase and##4##3##(1993-6#2)(1994-11#1)(1996-2#1)
protein phosphatase##21##2##(1993-6#7)(1993-8#5)(1994-11#2)(1995-8#3)(1996-2#2)(2008-10#1)(2008-4#1)
protein phosphatases 1##2##3##(1991-5#1)(1995-8#1)
protein phosphatases##6##2##(1991-5#1)(1994-11#1)(1995-11#1)(1995-8#2)(2012-12#1)
protein phosphorylation##11##2##(1994-11#1)(1994-6#1)(1995-11#2)(1995-12#1)(1996-2#1)(2008-4#3)(2008-8#2)
protein plugs##3##2##(2008-10#1)(2009-7#2)
protein plus##2##2##(1994-11#1)(2008-10#1)
protein precipitation##2##2##(2008-7#1)(2011-3#1)
protein precursor##8##2##(1992-6#2)(1993-12#2)(1994-11#2)(2008-11#1)(2010-12#1)
protein predicted##2##2##(1997-2#1)(2008-10#1)
protein present in##2##3##(1995-8#1)(2008-10#1)
protein produced##5##2##(1993-12#1)(2008-11#3)(2011-2#1)
protein product of##2##3##(1993-11#1)(1997-9#1)
protein product##7##2##(1993-11#1)(1993-12#1)(1993-2#1)(1997-7#1)(1997-9#1)(2008-10#1)(2008-5#1)
protein production and##3##3##(2008-11#3)
protein production in##7##3##(2008-11#3)(2008-7#2)(2011-2#2)
protein production is##2##3##(2008-7#1)(2011-2#1)
protein production of##3##3##(2008-11#3)
protein production was##2##3##(2008-11#2)
protein production##44##2##(1992-12#1)(2008-10#1)(2008-11#27)(2008-7#7)(2011-1#2)(2011-2#6)
protein productivity of##2##3##(2008-11#2)
protein productivity##7##2##(2008-11#5)(2008-7#2)
protein products are##2##3##(1992-12#1)(2011-2#1)
protein products##6##2##(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
protein profile##6##2##(1997-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
protein profiles##6##2##(2007-12#1)(2008-10#2)(2008-5#1)(2010-12#2)
protein promoter##2##2##(1996-12#1)(2008-12#1)
protein purification##4##2##(2008-4#3)(2013-1#1)
protein purified##3##2##(1995-6#2)(2008-10#1)
protein quality##2##2##(2008-11#1)(2008-7#1)
protein rather than##2##3##(2008-10#2)
protein recently##2##2##(1993-3#1)(2010-5#1)
protein required for##4##3##(1993-9#1)(2008-9#2)(2009-8#1)
protein required##5##2##(1991-3#1)(1993-9#1)(2008-9#2)(2009-8#1)
protein requires##2##2##(1994-11#1)(2008-4#1)
protein responses##2##2##(2008-7#1)(2013-8#1)
protein revealed that the##2##4##(1993-2#1)(2008-10#1)
protein revealed##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
protein samples##3##2##(1997-2#1)(2008-4#1)(2008-8#1)
protein secreted by##2##3##(1993-2#1)(1994-5#1)
protein secretion##8##2##(1993-8#1)(1996-12#1)(2008-11#2)(2008-7#2)(2012-2#2)
protein separation##2##2##(2008-10#2)
protein sequence comparisons##2##3##(2008-9#2)
protein sequence from##2##3##(1994-8#1)(2008-4#1)
protein sequence##17##2##(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#6)(2010-11#1)(2011-2#1)(2013-1#1)
protein sequences that##2##3##(1995-2#1)(2008-4#1)
protein sequences##9##2##(1994-6#1)(1995-2#2)(2008-10#1)(2008-4#2)(2008-9#2)(2013-8#1)
protein sequencing##4##2##(1991-6#1)(1995-6#1)(1996-8#1)(1997-2#1)
protein serine/threonine phosphatases##2##3##(1994-11#1)(1995-8#1)
protein serine/threonine##3##2##(1994-11#1)(1995-8#2)
protein serum-free medium##2##3##(2008-11#2)
protein showed high homology##2##4##(1990-5#1)(1993-8#1)
protein showed##7##2##(1990-5#1)(1991-5#1)(1993-8#1)(1995-12#1)(1997-2#1)(2008-10#1)(2010-12#1)
protein shows##5##2##(1991-2#1)(1992-7#1)(1993-6#1)(2007-12#1)(2008-8#1)
protein significantly##2##2##(1994-8#1)(2008-9#1)
protein similar to##2##3##(1992-9#1)(2008-8#1)
protein solution##2##2##(2008-7#1)(2011-2#1)
protein solutions##2##2##(2008-10#1)(2011-2#1)
protein species of approximately##2##4##(2008-10#2)
protein species##4##2##(1993-8#1)(2008-10#3)
protein splicing##4##2##(1993-12#3)(2011-3#1)
protein spots were##3##3##(1996-8#1)(2008-10#1)(2010-12#1)
protein spots##7##2##(1996-8#1)(2008-10#3)(2010-12#2)(2011-3#1)
protein strongly##2##2##(1992-8#1)(2012-2#1)
protein structural##2##2##(1990-8#1)(2008-10#1)
protein structure##12##2##(1991-3#1)(1994-5#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-5#1)(2009-8#1)(2012-2#1)(2012-3#1)
protein structures##6##2##(1992-4#1)(1994-8#2)(2008-10#1)(2009-5#1)(2012-2#1)
protein substrate##3##2##(1995-2#3)
protein substrates##2##2##(1990-5#1)(1992-6#1)
protein subunit##3##2##(1993-8#2)(1994-11#1)
protein such as##2##3##(2008-10#1)(2008-7#1)
protein superfamily##2##2##(1997-6#1)(2008-9#1)
protein surface##3##2##(1990-5#1)(2008-8#1)(2011-1#1)
protein symbol##2##2##(2008-7#2)
protein synthesis at##2##3##(1991-2#1)(2008-10#1)
protein synthesis in L6 myotubes##3##5##(2008-11#3)
protein synthesis in RLC-16##2##4##(2008-11#2)
protein synthesis in a##2##4##(1995-11#1)(1995-12#1)
protein synthesis in##11##3##(1993-12#1)(1995-11#1)(1995-12#1)(2008-11#6)(2008-12#1)(2011-3#1)
protein synthesis inhibitors##4##3##(1991-2#1)(1991-5#3)
protein synthesis may##2##3##(1990-12#1)(1997-1#1)
protein synthesis or##2##3##(1994-2#1)(2008-7#1)
protein synthesis was##2##3##(1994-11#1)(2008-7#1)
protein synthesis##57##2##(1990-11#1)(1990-12#2)(1991-2#3)(1991-5#3)(1993-12#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-5#1)(1996-12#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#21)(2008-12#1)(2008-7#3)(2008-9#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-8#1)
protein termed##2##2##(2008-10#1)(2009-8#1)
protein that are##2##3##(1993-12#1)(2008-10#1)
protein that binds##2##3##(1991-10#1)(1995-2#1)
protein that has##2##3##(1992-4#1)(2011-2#1)
protein that is expressed##2##4##(2008-1#1)(2008-11#1)
protein that is required for##3##5##(1995-12#1)(2009-10#2)
protein that is##12##3##(1991-7#1)(1995-12#1)(1995-6#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#2)(2009-3#1)(2010-3#1)(2011-2#1)
protein that may##2##3##(1990-5#1)(1991-12#1)
protein that mediates##2##3##(1993-12#1)(2012-2#1)
protein that##37##2##(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-4#1)(1993-12#3)(1993-6#2)(1993-8#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-2#1)
protein therapeutics##3##2##(2008-10#3)
protein through##2##2##(1992-8#1)(2013-1#1)
protein to be##2##3##(2008-10#1)(2008-11#1)
protein to the##4##3##(1995-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
protein to##25##2##(1990-5#1)(1991-7#1)(1992-12#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
protein toxin##3##2##(2008-10#3)
protein trafficking##3##2##(2008-9#1)(2009-7#1)(2012-2#1)
protein translation##2##2##(2012-2#2)
protein translocation into##2##3##(1991-2#1)(1997-8#1)
protein translocation##4##2##(1991-2#1)(1991-5#1)(1997-8#2)
protein turnover##5##2##(1990-2#1)(1992-12#1)(2008-3#2)(2013-1#1)
protein types##2##2##(2009-12#1)(2013-1#1)
protein tyrosine kinase##8##3##(1993-8#2)(1994-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-8#1)(2009-8#1)
protein tyrosine kinases##3##3##(1996-2#2)(2012-2#1)
protein tyrosine phosphatase##6##3##(1994-6#1)(1995-9#1)(1997-7#1)(2008-8#1)(2009-6#1)(2009-7#1)
protein tyrosine phosphorylation and phospholipase A2##2##6##(1994-6#2)
protein tyrosine phosphorylation##3##3##(1994-6#3)
protein tyrosine##21##2##(1993-8#2)(1994-6#5)(1994-8#1)(1995-8#1)(1995-9#1)(1996-2#2)(1997-7#2)(2008-4#1)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#1)(2012-2#1)
protein under##2##2##(1996-12#1)(2008-11#1)
protein using##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2010-6#1)
protein variants##2##2##(2008-8#1)(2011-1#1)
protein was detected in##4##4##(1994-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
protein was detected##6##3##(1994-11#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)
protein was expressed in##2##4##(2008-9#2)
protein was expressed##3##3##(2008-8#1)(2008-9#2)
protein was extracted##2##3##(2008-10#1)(2008-8#1)
protein was found to##3##4##(1991-7#1)(1994-5#1)(2009-9#1)
protein was highly##3##3##(1994-8#1)(1997-4#1)(2008-8#1)
protein was identified##5##3##(1990-8#1)(2008-10#2)(2008-8#1)(2011-2#1)
protein was measured by##2##4##(2008-11#1)(2011-2#1)
protein was measured##6##3##(1993-1#1)(1994-8#1)(2008-11#3)(2011-2#1)
protein was not##4##3##(1993-11#1)(2008-11#2)(2008-8#1)
protein was observed in##3##4##(1991-5#1)(1995-6#1)(2008-10#1)
protein was observed##6##3##(1991-5#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-11#1)
protein was produced in##2##4##(1993-12#1)(2008-11#1)
protein was produced##4##3##(1993-12#1)(2008-11#3)
protein was purified to homogeneity##2##5##(1995-12#1)(2009-3#1)
protein was purified to##4##4##(1994-5#1)(1994-8#1)(1995-12#1)(2009-3#1)
protein was purified##7##3##(1994-5#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-2#1)
protein was significantly##2##3##(2008-8#1)(2011-2#1)
protein was upregulated in##2##4##(2010-12#2)
protein was##108##2##(1990-5#4)(1990-8#1)(1991-10#1)(1991-5#2)(1991-7#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#3)(1994-5#3)(1994-8#5)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-4#2)(2008-10#18)(2008-11#16)(2008-5#1)(2008-8#9)(2008-9#5)(2009-10#1)(2009-3#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#8)(2012-2#1)(2012-3#1)
protein were not##2##3##(1990-5#1)(1993-3#1)
protein were produced##2##3##(1990-5#1)(1996-1#1)
protein were similar##2##3##(2008-10#2)
protein were studied##2##3##(2008-10#2)
protein were##27##2##(1990-5#2)(1991-10#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-9#4)(2009-12#1)(2009-3#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
protein which is temperature-sensitive for nuclear transport##2##7##(1991-2#2)
protein which is##6##3##(1991-2#2)(1994-11#1)(1995-6#1)(1997-3#1)(2008-11#1)
protein which was##3##3##(1993-6#1)(1994-11#1)(1995-6#1)
protein which##18##2##(1990-7#2)(1991-2#2)(1991-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-6#2)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
protein whose##2##2##(1990-5#1)(1994-2#1)
protein with GARS##2##3##(1993-12#2)
protein with a molecular mass of##4##6##(1993-6#1)(1994-8#1)(1997-7#1)(2008-10#1)
protein with a##13##3##(1990-12#1)(1993-6#3)(1994-11#1)(1994-8#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-2#1)
protein with an##4##3##(1995-5#1)(2008-11#2)(2010-4#1)
protein with some##2##3##(1993-8#1)(2008-9#1)
protein with strong##2##3##(2008-8#2)
protein with the same##2##4##(1996-3#1)(2009-10#1)
protein with the##6##3##(1993-8#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-9#1)(2009-10#1)
protein with##52##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1993-12#2)(1993-6#3)(1993-8#3)(1994-11#1)(1994-6#1)(1994-8#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#3)(1997-8#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#7)(2008-9#3)(2009-10#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-2#1)
protein yield##4##2##(2008-11#2)(2011-2#2)
protein##3676##1##(1990-10#3)(1990-11#15)(1990-12#42)(1990-2#9)(1990-5#64)(1990-6#1)(1990-7#7)(1990-8#27)(1990-9#2)(1991-10#12)(1991-11#3)(1991-12#19)(1991-2#15)(1991-3#4)(1991-5#33)(1991-6#14)(1991-7#12)(1991-8#2)(1991-9#12)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#16)(1992-2#2)(1992-3#9)(1992-4#6)(1992-6#20)(1992-7#10)(1992-8#26)(1992-9#13)(1993-1#9)(1993-11#4)(1993-12#58)(1993-2#38)(1993-3#25)(1993-6#47)(1993-8#81)(1993-9#25)(1994-11#92)(1994-12#13)(1994-2#4)(1994-3#17)(1994-5#56)(1994-6#17)(1994-8#43)(1994-9#2)(1995-11#30)(1995-12#48)(1995-2#69)(1995-3#3)(1995-5#12)(1995-6#82)(1995-8#44)(1995-9#7)(1996-1#6)(1996-12#47)(1996-2#31)(1996-3#8)(1996-6#23)(1996-8#5)(1997-1#16)(1997-2#39)(1997-3#29)(1997-4#6)(1997-6#14)(1997-7#41)(1997-8#17)(1997-9#2)(2007-11#1)(2007-12#9)(2007-8#1)(2008-1#8)(2008-10#521)(2008-11#372)(2008-12#20)(2008-2#5)(2008-3#17)(2008-4#86)(2008-5#34)(2008-6#7)(2008-7#84)(2008-8#134)(2008-9#161)(2009-1#1)(2009-10#15)(2009-11#1)(2009-12#7)(2009-3#12)(2009-4#3)(2009-5#6)(2009-6#14)(2009-7#43)(2009-8#52)(2009-9#20)(2010-1#3)(2010-10#11)(2010-11#14)(2010-12#35)(2010-3#5)(2010-4#27)(2010-5#8)(2010-6#8)(2010-7#12)(2010-8#1)(2010-9#6)(2011-1#19)(2011-10#3)(2011-2#140)(2011-3#20)(2011-9#1)(2012-12#7)(2012-2#73)(2012-3#25)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#60)(2013-7#2)(2013-8#43)
protein's##7##1##(1994-11#2)(1997-2#1)(2008-8#1)(2008-9#2)(2010-10#1)
protein(s)##7##1##(1993-6#1)(1994-6#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
protein) and##8##2##(1993-11#1)(1995-11#1)(1996-2#1)(1997-8#1)(2008-11#1)(2011-2#2)(2012-2#1)
protein) was##2##2##(1996-2#1)(2008-7#1)
protein) were##2##2##(1994-8#1)(2010-6#1)
protein)##40##1##(1990-11#1)(1990-8#1)(1991-12#1)(1993-11#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#4)(1997-8#1)(2008-10#1)(2008-11#8)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
protein-##2##1##(1996-6#1)(2008-11#1)
protein-1 and##3##2##(1994-6#2)(2011-2#1)
protein-1##8##1##(1994-6#4)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
protein-1)##2##1##(1991-3#1)(2008-9#1)
protein-2##6##1##(1991-1#1)(2008-7#1)(2008-8#2)(2011-2#2)
protein-3##3##1##(2008-11#1)(2010-6#1)(2011-1#1)
protein-DNA complex##2##2##(1995-2#2)
protein-DNA interactions##3##2##(1991-11#1)(2008-4#1)(2008-8#1)
protein-DNA##8##1##(1991-11#1)(1995-2#2)(2008-10#1)(2008-4#1)(2008-8#2)(2009-8#1)
protein-based##2##1##(2008-4#1)(2010-4#1)
protein-binding##2##1##(1993-6#1)(2008-10#1)
protein-bound urinary##2##2##(1991-12#2)
protein-bound##12##1##(1991-12#4)(1991-9#1)(2008-10#5)(2008-7#1)(2008-9#1)
protein-coding and 47 RNA genes is##2##6##(2011-2#2)
protein-coding and 52 RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##2##17##(2011-2#2)
protein-coding and 52 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and 52 RNA genes is##4##6##(2011-2#4)
protein-coding and 53 RNA genes is##2##6##(2011-2#2)
protein-coding and 55 RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##3##17##(2011-2#3)
protein-coding and 56 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and 60 RNA genes##2##5##(2011-2#2)
protein-coding and 63 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and##30##2##(2011-2#29)(2012-3#1)
protein-coding genes and##2##3##(2011-2#2)
protein-coding genes##5##2##(1997-6#1)(1997-8#1)(2011-2#3)
protein-coding##42##1##(1996-6#4)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2011-2#33)(2012-3#1)
protein-coupled##7##1##(1991-5#1)(1993-6#1)(1994-12#2)(1995-6#1)(1997-2#1)(2009-7#1)
protein-dependent##2##1##(1993-8#1)(1995-6#1)
protein-encoding genes##2##2##(1993-12#1)(1993-9#1)
protein-encoding##5##1##(1993-12#2)(1993-2#1)(1993-9#1)(2008-10#1)
protein-free and##2##2##(2008-11#2)
protein-free cell culture media##2##4##(2008-11#1)(2011-2#1)
protein-free culture##4##2##(2008-11#4)
protein-free diet##3##2##(1993-12#3)
protein-free media##6##2##(2008-11#6)
protein-free medium and to be##2##5##(2008-11#2)
protein-free medium in##3##3##(2008-11#2)(2011-2#1)
protein-free medium##16##2##(2008-11#15)(2011-2#1)
protein-free##39##1##(1991-5#1)(1993-12#3)(2008-11#32)(2011-2#3)
protein-freeculture##3##1##(2008-11#3)
protein-ligand##3##1##(1997-2#2)(2011-3#1)
protein-lipid interactions##2##2##(2008-9#1)(2011-3#1)
protein-mediated activation of##2##3##(1992-6#1)(1995-11#1)
protein-mediated##4##1##(1992-6#1)(1995-11#1)(2008-10#1)(2011-2#1)
protein-protein and peptide-protein interactions##2##4##(1992-9#2)
protein-protein interaction networks##2##3##(2008-4#2)
protein-protein interaction##9##2##(2008-11#1)(2008-4#4)(2008-9#1)(2009-6#1)(2009-7#2)
protein-protein interactions of##2##3##(2008-10#1)(2008-4#1)
protein-protein interactions##22##2##(1992-3#1)(1993-9#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#8)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2011-2#1)(2013-8#1)
protein-protein##40##1##(1992-3#1)(1992-9#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#13)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
protein-specific##2##1##(1995-5#1)(2013-8#1)
protein-sugar binding##2##2##(2008-10#2)
protein-tyrosine kinase##3##2##(1992-6#2)(1995-6#1)
proteinaceous binding media##4##3##(2008-10#4)
proteinaceous compounds##2##2##(2008-10#2)
proteinaceous metabolites##2##2##(2008-10#2)
proteinaceous##20##1##(1996-12#1)(2008-10#13)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)
proteinase K treatment##2##3##(1996-12#1)(2008-10#1)
proteinase K##6##2##(1990-5#1)(1996-12#1)(2008-10#4)
proteinase from##2##2##(1995-6#1)(2008-10#1)
proteinase inhibitor##2##2##(1995-6#1)(2008-11#1)
proteinase##31##1##(1990-2#1)(1990-5#6)(1991-5#1)(1993-3#3)(1994-3#1)(1994-5#2)(1995-6#2)(1996-12#1)(2008-10#9)(2008-11#4)(2012-3#1)
proteinase-inhibitory##2##1##(1995-6#2)
proteinases##11##1##(1991-5#1)(1993-3#2)(1994-5#1)(1995-6#1)(2008-10#2)(2008-11#2)(2012-3#2)
proteins (30##2##2##(2008-10#1)(2011-2#1)
proteins (43##2##2##(2008-11#2)
proteins (G##2##2##(1995-8#1)(1997-7#1)
proteins (MAPs)##2##2##(2009-8#1)(2011-2#1)
proteins (PGIPs)##2##2##(2008-10#1)(2011-10#1)
proteins (RIPs)##2##2##(1990-12#1)(2008-10#1)
proteins (e##3##2##(2008-11#2)(2012-2#1)
proteins (including##2##2##(1994-8#2)
proteins (such as##2##3##(2008-10#1)(2009-10#1)
proteins across##2##2##(1991-5#1)(1992-12#1)
proteins also##2##2##(1992-5#1)(2009-6#1)
proteins and endogenous##2##3##(2008-10#2)
proteins and formation and##2##4##(2008-10#1)(2011-2#1)
proteins and found##2##3##(2008-5#1)(2009-8#1)
proteins and in##3##3##(2008-7#1)(2009-6#1)(2009-8#1)
proteins and its function##2##4##(2008-9#1)(2011-3#1)
proteins and its modulation by##2##5##(1990-3#2)
proteins and its##6##3##(1990-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2011-3#1)
proteins and lipids##6##3##(1990-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)
proteins and peptides##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2011-3#1)
proteins and play##2##3##(1992-11#1)(1997-8#1)
proteins and small##2##3##(2008-10#1)(2012-2#1)
proteins and the##8##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2013-7#1)(2013-8#1)
proteins and their##2##3##(1993-9#1)(1995-2#1)
proteins and transcription factors##2##4##(2008-10#1)(2008-8#1)
proteins and##113##2##(1990-2#1)(1990-3#2)(1990-7#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-8#1)(1993-9#2)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#20)(2008-11#11)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#6)(2010-12#1)(2010-4#2)(2011-2#5)(2011-3#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
proteins are a##2##3##(1993-3#1)(2010-3#1)
proteins are also##2##3##(1994-6#1)(2008-4#1)
proteins are associated with##2##4##(1997-3#1)(2011-2#1)
proteins are expressed##2##3##(2008-1#1)(2008-7#1)
proteins are involved in##2##4##(1996-12#1)(2008-9#1)
proteins are not##3##3##(1994-11#1)(1997-7#1)(2009-8#1)
proteins are required for the##2##5##(1993-12#1)(2012-3#1)
proteins are separated##2##3##(2008-10#1)(2008-4#1)
proteins are shed##2##3##(2009-9#2)
proteins are well##2##3##(2008-1#1)(2008-4#1)
proteins are##61##2##(1990-8#1)(1991-2#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
proteins as##9##2##(2008-10#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#2)(2013-8#1)
proteins associated with##5##3##(1997-3#1)(2008-10#2)(2008-11#1)(2009-7#1)
proteins at the apical##2##4##(2012-2#2)
proteins at the##8##3##(1993-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#3)(2012-3#1)
proteins at##12##2##(1990-5#1)(1993-8#1)(1993-9#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-2#3)(2012-3#1)
proteins belonging to the##2##4##(1997-6#1)(2009-12#1)
proteins belonging to##3##3##(1995-12#1)(1997-6#1)(2009-12#1)
proteins bind##2##2##(1996-12#1)(2008-9#1)
proteins by a##2##3##(1995-11#1)(2008-11#1)
proteins by high##2##3##(1995-8#1)(2008-8#1)
proteins by the##2##3##(2008-10#1)(2008-11#1)
proteins by##30##2##(1990-5#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#2)(2008-10#4)(2008-11#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#2)(2012-2#1)(2013-8#1)
proteins can be##9##3##(1991-5#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-4#4)(2009-5#1)
proteins can##12##2##(1991-5#1)(1994-3#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-4#4)(2009-5#1)(2010-4#1)
proteins contain a##2##3##(1993-6#1)(1995-6#1)
proteins contain##3##2##(1993-6#1)(1995-6#1)(1997-7#1)
proteins containing##9##2##(1992-12#1)(1995-2#2)(2008-10#1)(2008-4#2)(2009-6#1)(2010-11#1)(2011-2#1)
proteins content##2##2##(2008-10#2)
proteins contribute to the##2##4##(2008-6#1)(2013-1#1)
proteins could##2##2##(1993-8#1)(1995-8#1)
proteins during##3##2##(2006-6#1)(2008-10#1)(2010-5#1)
proteins encoded by##5##3##(1993-6#1)(2008-10#3)(2009-8#1)
proteins expressed##2##2##(2008-4#1)(2009-3#1)
proteins extracted from##3##3##(1996-8#1)(2008-10#1)(2008-9#1)
proteins extracted##4##2##(1996-8#1)(1997-2#1)(2008-10#1)(2008-9#1)
proteins for the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
proteins for##21##2##(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
proteins form##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
proteins found in##2##3##(1995-2#1)(1997-3#1)
proteins from different##2##3##(1993-6#1)(2008-9#1)
proteins from each of##2##4##(1995-5#1)(2008-10#1)
proteins from maize##2##3##(1995-2#1)(2008-10#1)
proteins from other##4##3##(1991-12#1)(1992-8#1)(1995-9#1)(1997-2#1)
proteins from the##10##3##(1991-12#1)(1993-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#2)
proteins from##50##2##(1990-12#1)(1991-12#2)(1991-8#1)(1992-6#1)(1992-8#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-10#2)(2009-7#1)(2010-4#2)(2011-3#1)(2013-1#1)
proteins had##2##2##(1991-12#1)(2008-10#1)
proteins has been developed##2##4##(2008-10#2)
proteins has been##6##3##(1996-11#1)(1997-6#3)(2008-10#2)
proteins has##9##2##(1996-11#1)(1997-6#3)(2008-10#2)(2008-2#1)(2010-4#1)(2012-12#1)
proteins have been found to##2##5##(1996-2#1)(2011-2#1)
proteins have been identified##2##4##(2008-7#1)(2011-2#1)
proteins have been##9##3##(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-7#2)(2009-8#1)(2011-2#2)
proteins have##15##2##(1991-6#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#2)(2013-8#1)
proteins identified##2##2##(2008-10#1)(2011-3#1)
proteins immunoreactivity##2##2##(1995-8#2)
proteins in BCG##2##3##(1995-5#2)
proteins in a single##2##4##(2008-4#1)(2010-12#1)
proteins in a##5##3##(1992-12#1)(2008-12#1)(2008-4#2)(2010-12#1)
proteins in animal##2##3##(1993-2#1)(2009-8#1)
proteins in human##6##3##(1997-6#1)(2008-10#3)(2008-9#1)(2011-2#1)
proteins in infected##2##3##(2008-10#1)(2009-8#1)
proteins in other##2##3##(1992-9#1)(2008-8#1)
proteins in rat skeletal muscle##2##5##(2008-8#2)
proteins in rat##3##3##(1996-2#1)(2008-8#2)
proteins in the development of##2##5##(1995-6#1)(2008-11#1)
proteins in the presence of##2##5##(2008-10#2)
proteins in the##29##3##(1990-11#1)(1990-12#1)(1993-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-3#1)
proteins in these##3##3##(1997-2#1)(2009-7#1)(2010-11#1)
proteins in##130##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(2008-1#3)(2008-10#27)(2008-11#8)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#14)(2008-9#4)(2009-7#1)(2009-8#6)(2010-10#1)(2010-11#2)(2010-12#4)(2010-4#2)(2011-10#1)(2011-2#6)(2011-3#1)(2011-9#1)(2012-2#1)(2012-3#2)
proteins including##6##2##(1997-2#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)
proteins induce##2##2##(2008-10#1)(2008-9#1)
proteins into the##2##3##(1991-2#1)(1992-12#1)
proteins into##7##2##(1991-2#2)(1992-12#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
proteins involved in cell##2##4##(2011-3#1)(2013-7#1)
proteins involved in the regulation of##2##6##(1996-2#1)(2008-4#1)
proteins involved in##17##3##(1991-2#1)(1993-9#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)
proteins is presented##2##3##(2008-10#1)(2008-7#1)
proteins is##24##2##(1993-9#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-3#1)
proteins isolated from##2##3##(1992-6#1)(1997-2#1)
proteins isolated##3##2##(1992-6#1)(1997-2#1)(2008-10#1)
proteins known as##4##3##(1993-9#1)(1995-2#1)(2008-5#1)(2008-9#1)
proteins known##5##2##(1993-9#1)(1995-2#1)(2008-5#1)(2008-9#1)(2012-7#1)
proteins localize##2##2##(1995-2#1)(2011-2#1)
proteins localized##2##2##(1997-7#1)(2008-9#1)
proteins may be##6##3##(2008-10#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#1)
proteins may play##2##3##(1996-12#1)(2008-8#1)
proteins may##12##2##(1990-3#1)(1993-2#1)(1994-11#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#3)(2009-10#1)(2011-2#1)
proteins mediate##2##2##(2008-10#1)(2009-10#1)
proteins might be##2##3##(1994-5#1)(2008-9#1)
proteins might##5##2##(1994-5#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)
proteins must##2##2##(2008-10#1)(2008-9#1)
proteins named##2##2##(2008-8#1)(2011-2#1)
proteins obtained##2##2##(1990-5#1)(1994-8#1)
proteins of interest##2##3##(2008-4#1)(2008-9#1)
proteins of other##3##3##(1992-2#1)(2008-10#1)(2008-8#1)
proteins of rat##2##3##(1991-8#1)(1995-12#1)
proteins of the Mre11 complex in irradiated##2##7##(2011-2#2)
proteins of the Mre11 complex##3##5##(2011-2#3)
proteins of the cell surface##2##5##(2009-9#2)
proteins of the##13##3##(1991-5#1)(1995-12#1)(2008-10#4)(2008-5#1)(2009-12#1)(2009-9#2)(2011-2#3)
proteins of##64##2##(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-9#1)(1995-12#2)(1995-2#5)(1995-6#2)(1995-8#1)(1995-9#1)(1997-4#1)(2007-12#1)(2008-10#21)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#4)(2009-12#1)(2009-9#2)(2011-2#5)(2012-3#2)
proteins on the surface of##2##5##(1995-2#2)
proteins on the##7##3##(1995-12#1)(1995-2#2)(2008-10#2)(2008-11#1)(2012-5#1)
proteins on##14##2##(1991-12#1)(1995-12#2)(1995-2#2)(2008-10#5)(2008-11#2)(2008-4#1)(2012-5#1)
proteins or DNA##3##3##(1996-2#1)(2008-12#1)(2008-4#1)
proteins or peptides##3##3##(1995-5#1)(2008-11#1)(2008-5#1)
proteins or##11##2##(1995-5#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#1)
proteins play##2##2##(2008-2#1)(2011-2#1)
proteins plays##2##2##(1994-12#1)(2008-1#1)
proteins present in the##6##4##(1991-5#1)(1993-8#1)(2008-10#2)(2008-11#2)
proteins present in##11##3##(1991-5#1)(1993-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2011-2#1)
proteins produced by##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
proteins produced##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
proteins regulate the##2##3##(2008-11#1)(2008-4#1)
proteins related to##2##3##(2008-10#1)(2009-6#1)
proteins released##3##2##(1991-2#1)(1992-3#1)(2010-3#1)
proteins remains##2##2##(1997-7#1)(2009-7#1)
proteins revealed the##2##3##(2008-10#1)(2008-11#1)
proteins revealed##4##2##(1995-12#1)(2008-10#2)(2008-11#1)
proteins secreted by##2##3##(1997-1#1)(2008-10#1)
proteins shared by##2##3##(2008-9#2)
proteins should be##2##3##(1993-8#1)(2008-10#1)
proteins show##3##2##(1994-11#1)(2009-10#1)(2012-3#1)
proteins showed##4##2##(1994-8#1)(1995-6#1)(2010-12#1)(2010-3#1)
proteins specifically##3##2##(1997-7#1)(2008-10#1)(2012-2#1)
proteins such as##6##3##(1994-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
proteins synthesized##4##2##(1995-9#1)(2008-10#1)(2008-6#1)(2010-12#1)
proteins that are similar to##2##5##(1993-12#1)(1994-9#1)
proteins that are##13##3##(1993-12#1)(1994-9#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-3#1)(2013-1#1)
proteins that could##2##3##(2010-12#1)(2010-3#1)
proteins that have##3##3##(1995-2#1)(2009-7#1)(2011-2#1)
proteins that##47##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#4)(2010-3#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
proteins through##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
proteins to the##9##3##(1994-12#1)(1996-1#1)(1996-12#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)
proteins to##25##2##(1994-12#1)(1996-1#1)(1996-12#2)(1997-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-2#1)(2012-7#1)(2013-1#3)
proteins under##4##2##(2008-7#2)(2008-9#1)(2011-2#1)
proteins unique to a given##2##5##(2008-9#2)
proteins using the##2##3##(2008-10#2)
proteins using##8##2##(2008-10#2)(2008-11#4)(2011-1#1)(2013-8#1)
proteins via##2##2##(2008-9#1)(2010-7#1)
proteins was investigated by##2##4##(1994-6#1)(1995-11#1)
proteins was observed##3##3##(1994-6#1)(1995-8#1)(2008-10#1)
proteins was##18##2##(1990-5#1)(1993-6#1)(1994-11#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-8#1)
proteins were completely##2##3##(2008-10#1)(2008-12#1)
proteins were detected in the##2##5##(1997-3#1)(2008-10#1)
proteins were detected in##3##4##(1995-2#1)(1997-3#1)(2008-10#1)
proteins were detected##4##3##(1995-2#1)(1997-3#1)(2008-10#1)(2009-8#1)
proteins were downregulated##2##3##(2010-12#2)
proteins were examined##2##3##(1997-3#1)(2008-10#1)
proteins were excluded from##2##4##(1995-2#1)(2009-8#1)
proteins were found to bind##2##5##(1990-11#1)(1995-6#1)
proteins were found to##3##4##(1990-11#1)(1995-6#1)(2009-10#1)
proteins were identified as##2##4##(2008-10#1)(2010-12#1)
proteins were identified##3##3##(2008-10#2)(2010-12#1)
proteins were isolated##2##3##(1996-12#1)(2008-9#1)
proteins were observed##2##3##(1997-2#1)(2008-11#1)
proteins were obtained##2##3##(2008-10#2)
proteins were separated by##3##4##(1990-10#1)(2008-10#1)(2008-11#1)
proteins were studied##2##3##(2008-10#1)(2008-8#1)
proteins were tested##2##3##(2008-10#1)(2010-3#1)
proteins were##67##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#3)(2009-8#2)(2010-12#6)(2010-3#2)(2011-2#1)(2011-3#1)
proteins which are##2##3##(1996-2#1)(2008-8#1)
proteins which##13##2##(1992-10#1)(1993-6#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)(2013-7#1)
proteins whose##4##2##(1992-4#1)(1996-6#1)(2008-10#1)(2012-3#1)
proteins with a##3##3##(1993-8#1)(2008-11#1)(2009-3#1)
proteins with an##3##3##(1994-11#2)(2009-9#1)
proteins with molecular masses of##2##5##(2008-10#1)(2008-8#1)
proteins with molecular masses##3##4##(2008-10#2)(2008-8#1)
proteins with the##2##3##(1996-3#1)(2008-11#1)
proteins with##41##2##(1990-5#1)(1991-10#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-8#1)(2009-9#2)(2011-1#2)(2011-2#2)
proteins within the##2##3##(2008-1#1)(2011-2#1)
proteins within##4##2##(2008-1#1)(2008-4#1)(2010-11#1)(2011-2#1)
proteins work##2##2##(2008-4#1)(2009-8#1)
proteins##1702##1##(1990-10#2)(1990-11#6)(1990-12#7)(1990-2#2)(1990-3#3)(1990-5#15)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#2)(1991-12#8)(1991-2#10)(1991-5#12)(1991-6#6)(1991-7#1)(1991-8#2)(1991-9#4)(1992-10#2)(1992-11#2)(1992-12#9)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#6)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#13)(1993-2#7)(1993-3#7)(1993-5#1)(1993-6#15)(1993-8#18)(1993-9#10)(1994-11#17)(1994-12#5)(1994-3#3)(1994-5#17)(1994-6#6)(1994-8#9)(1994-9#3)(1995-11#8)(1995-12#19)(1995-2#44)(1995-3#3)(1995-5#7)(1995-6#30)(1995-8#22)(1995-9#7)(1996-1#3)(1996-11#1)(1996-12#26)(1996-2#13)(1996-3#3)(1996-6#3)(1996-8#6)(1997-1#6)(1997-2#26)(1997-3#10)(1997-4#3)(1997-5#1)(1997-6#15)(1997-7#21)(1997-8#3)(1997-9#1)(2006-6#1)(2007-12#3)(2008-1#10)(2008-10#308)(2008-11#121)(2008-12#9)(2008-2#7)(2008-4#78)(2008-5#36)(2008-6#5)(2008-7#33)(2008-8#60)(2008-9#72)(2009-1#1)(2009-10#23)(2009-12#11)(2009-3#7)(2009-4#1)(2009-5#3)(2009-6#14)(2009-7#13)(2009-8#42)(2009-9#16)(2010-10#4)(2010-11#9)(2010-12#32)(2010-3#9)(2010-4#13)(2010-5#6)(2010-7#5)(2010-9#2)(2011-1#11)(2011-10#2)(2011-2#88)(2011-3#13)(2011-9#1)(2012-12#2)(2012-2#31)(2012-3#19)(2012-5#1)(2012-7#2)(2013-1#16)(2013-7#5)(2013-8#15)
proteins) and##2##2##(2008-10#1)(2008-5#1)
proteins)##7##1##(1990-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
proteins?##2##1##(2008-11#1)(2009-8#1)
proteinuria##8##1##(1990-12#1)(1993-12#1)(1993-3#1)(1994-5#1)(1996-6#1)(2011-2#1)(2013-8#2)
proteoglycan core protein##2##3##(1991-5#1)(2008-11#1)
proteoglycan##9##1##(1991-5#2)(1992-1#2)(1992-11#1)(1993-2#1)(2008-11#2)(2008-7#1)
proteoglycans and##2##2##(1995-6#1)(2007-11#1)
proteoglycans##11##1##(1990-2#2)(1991-5#1)(1992-12#2)(1993-2#1)(1994-8#1)(1995-6#2)(2007-11#1)(2008-5#1)
proteolipid##3##1##(1996-12#1)(2009-6#2)
proteoliposomes with##2##2##(1995-8#2)
proteoliposomes##7##1##(1995-8#7)
proteolysis and##6##2##(1995-6#1)(1995-8#1)(2008-4#1)(2008-9#1)(2011-1#1)(2013-1#1)
proteolysis can##2##2##(1995-6#1)(2008-5#1)
proteolysis in##3##2##(2011-2#1)(2013-1#2)
proteolysis of##3##2##(1995-6#1)(2009-7#1)(2010-3#1)
proteolysis plays an important role##2##5##(1990-11#1)(2012-3#1)
proteolysis##34##1##(1990-11#1)(1990-12#1)(1991-10#1)(1993-8#2)(1995-6#5)(1995-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#7)(2013-1#4)
proteolytic activities##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
proteolytic activity of##2##3##(1992-11#1)(2008-10#1)
proteolytic activity##9##2##(1992-11#1)(1993-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-4#1)(2013-8#1)
proteolytic cleavage of##2##3##(1990-5#1)(1994-11#1)
proteolytic degradation of##2##3##(2008-11#1)(2011-2#1)
proteolytic degradation##4##2##(2008-11#3)(2011-2#1)
proteolytic digestion##2##2##(1993-8#1)(1994-8#1)
proteolytic enzyme##4##2##(1990-11#1)(1990-5#1)(2008-10#1)(2008-9#1)
proteolytic enzymes##7##2##(1990-11#1)(2006-6#1)(2008-10#2)(2008-7#1)(2010-3#1)(2013-1#1)
proteolytic fragments##3##2##(1992-6#1)(2008-1#1)(2008-8#1)
proteolytic genes##2##2##(2013-1#2)
proteolytic processing of##2##3##(1990-8#1)(2008-11#1)
proteolytic processing##8##2##(1990-8#1)(1992-10#1)(1993-6#1)(1995-8#1)(2007-12#2)(2008-11#2)
proteolytic##65##1##(1990-11#2)(1990-5#2)(1990-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#8)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#2)(2011-2#5)(2012-12#1)(2013-1#4)(2013-8#1)
proteolytically processed to##2##3##(1995-6#1)(1997-7#1)
proteolytically##5##1##(1992-12#1)(1995-6#1)(1997-7#1)(2007-12#1)(2009-7#1)
proteome analysis##8##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-9#1)(2010-12#1)
proteome catalog##3##2##(2008-9#3)
proteome research##2##2##(2012-3#2)
proteome##40##1##(2008-10#2)(2008-11#4)(2008-12#3)(2008-4#5)(2008-9#13)(2009-6#2)(2009-7#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)
proteomes##11##1##(2008-4#3)(2008-9#5)(2010-12#1)(2010-7#1)(2011-2#1)
proteomic analysis of##5##3##(2008-10#1)(2009-7#1)(2010-12#2)(2013-8#1)
proteomic analysis##13##2##(2008-10#2)(2008-9#2)(2009-7#1)(2010-12#6)(2013-8#2)
proteomic approaches##2##2##(2008-4#1)(2008-7#1)
proteomic data##3##2##(2008-11#1)(2010-12#2)
proteomic technology##2##2##(2009-7#1)(2010-12#1)
proteomic##32##1##(2008-1#1)(2008-10#4)(2008-11#6)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#2)(2010-12#12)(2012-12#1)(2013-8#2)
proteomics and##5##2##(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#2)
proteomics approach##3##2##(2008-10#1)(2009-9#1)(2010-12#1)
proteomics##29##1##(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-1#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
protested##2##1##(1994-9#1)(2009-10#1)
prothoracic gland##2##2##(1995-11#2)
prothoracic glands##4##2##(1995-11#3)(2008-6#1)
prothoracic##9##1##(1995-11#6)(2007-12#2)(2008-6#1)
prothoracicotropic hormone##2##2##(1995-11#2)
prothoracicotropic##3##1##(1995-11#3)
prothrombin time##2##2##(2008-10#1)(2010-3#1)
prothrombin##3##1##(2008-10#1)(2010-3#1)(2013-1#1)
prothrombotic##2##1##(2011-2#1)(2013-1#1)
protic solvents##3##2##(2008-10#3)
protic##4##1##(2008-10#4)
protists on bacterial density##2##4##(2008-8#2)
protists##4##1##(2008-8#4)
proto-oncogene induction##3##2##(1991-5#2)(1996-12#1)
proto-oncogene mRNA##2##2##(1990-12#2)
proto-oncogene##19##1##(1990-12#2)(1991-5#2)(1993-11#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-8#1)(2008-9#4)(2011-2#1)(2011-3#2)
proto-oncogenes##2##1##(2009-4#1)(2011-2#1)
protocatechuic acid##2##2##(2008-10#1)(2008-11#1)
protocerebral commissure##2##2##(2007-12#2)
protocerebral##4##1##(2007-12#4)
protocerebrum##6##1##(2007-12#6)
protocol and a##2##3##(2008-11#1)(2008-5#1)
protocol and##7##2##(2008-11#1)(2008-4#1)(2008-5#1)(2009-1#1)(2013-1#3)
protocol based on##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
protocol based##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)
protocol can be##2##3##(2008-4#1)(2008-9#1)
protocol combining##2##2##(2008-10#1)(2008-5#1)
protocol consisted of##2##3##(1990-3#1)(2008-10#1)
protocol described##2##2##(2008-2#1)(2008-4#1)
protocol describes a method for##2##5##(2008-4#1)(2008-9#1)
protocol describes a##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
protocol describes an##2##3##(2008-4#2)
protocol describes the##3##3##(2008-4#1)(2008-9#2)
protocol describes##13##2##(2008-11#1)(2008-4#7)(2008-9#5)
protocol details##4##2##(2008-4#4)
protocol detected##3##2##(2008-10#3)
protocol developed##2##2##(2008-10#1)(2008-11#1)
protocol for flow cytometric##2##4##(2008-4#1)(2008-9#1)
protocol for the analysis of##2##5##(2008-10#1)(2008-4#1)
protocol for the##12##3##(1993-6#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2010-7#1)
protocol for##56##2##(1992-5#1)(1993-6#1)(1995-12#1)(1997-1#1)(1997-2#3)(2008-1#4)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#12)(2008-9#5)(2009-2#2)(2009-3#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
protocol in this unit is##2##5##(2008-4#2)
protocol in this unit##3##4##(2008-4#3)
protocol in which the##2##4##(2008-10#1)(2008-4#1)
protocol in which##4##3##(1993-11#1)(2008-10#1)(2008-4#2)
protocol in##12##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-7#1)(2009-2#1)(2012-3#1)(2013-8#1)
protocol is a##2##3##(2008-10#1)(2008-4#1)
protocol is also##2##3##(2008-11#1)(2008-4#1)
protocol is based on the##3##5##(2008-10#1)(2008-4#1)(2008-9#1)
protocol is based on##4##4##(2008-10#1)(2008-4#1)(2008-9#2)
protocol is included for##2##4##(2008-4#1)(2008-9#1)
protocol is provided for##2##4##(2008-4#2)
protocol is##24##2##(1994-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#10)(2008-5#1)(2008-9#4)(2009-12#1)(2010-11#1)
protocol of##5##2##(1996-2#1)(2008-10#2)(2008-11#2)
protocol offers##3##2##(2008-10#1)(2008-4#2)
protocol on##4##2##(1994-11#1)(2008-4#1)(2008-9#1)(2009-2#1)
protocol produced##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
protocol provides##3##2##(2008-9#3)
protocol should##2##2##(1997-5#1)(2008-10#1)
protocol that##5##2##(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)
protocol therapy##2##2##(2011-2#2)
protocol to##9##2##(2008-10#3)(2008-4#2)(2008-5#1)(2008-9#1)(2010-3#1)(2012-3#1)
protocol used##2##2##(2008-11#1)(2012-3#1)
protocol uses a##2##3##(2008-4#2)
protocol uses##4##2##(2008-4#3)(2008-9#1)
protocol using the##2##3##(2008-11#1)(2008-9#1)
protocol using##4##2##(1995-12#1)(2008-11#1)(2008-9#1)(2009-1#1)
protocol was designed##2##3##(2008-10#1)(2010-10#1)
protocol was developed##2##3##(2008-10#2)
protocol was used to##2##4##(2008-10#1)(2008-7#1)
protocol was##16##2##(2008-10#6)(2008-5#2)(2008-7#1)(2009-1#1)(2010-10#3)(2010-7#1)(2013-1#1)(2013-8#1)
protocol will##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
protocol with##8##2##(1994-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)
protocol##321##1##(1990-3#1)(1990-6#2)(1991-6#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-5#3)(1995-12#4)(1995-6#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-5#2)(1997-8#1)(2007-11#1)(2008-1#4)(2008-10#73)(2008-11#25)(2008-12#5)(2008-2#4)(2008-3#1)(2008-4#64)(2008-5#9)(2008-7#5)(2008-8#3)(2008-9#33)(2009-1#3)(2009-12#1)(2009-2#7)(2009-3#1)(2009-8#1)(2010-10#4)(2010-11#2)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#10)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#10)(2013-8#9)
protocols and##5##2##(1991-12#1)(1994-3#1)(2006-6#1)(2008-11#1)(2013-8#1)
protocols are also##2##3##(2008-4#2)
protocols are available##2##3##(2008-8#2)
protocols are provided for##4##4##(2008-4#3)(2008-9#1)
protocols are provided##8##3##(2008-4#6)(2008-9#2)
protocols are##24##2##(2008-2#1)(2008-4#12)(2008-8#2)(2008-9#7)(2009-4#1)(2013-1#1)
protocols can be used##2##4##(2008-1#1)(2008-9#1)
protocols can be##3##3##(1994-3#1)(2008-1#1)(2008-9#1)
protocols cover##3##2##(2008-4#1)(2008-9#2)
protocols describe how to##2##4##(2008-4#1)(2008-9#1)
protocols describe the preparation of##2##5##(2008-4#2)
protocols describe the##6##3##(2008-4#6)
protocols describe##15##2##(2008-4#12)(2008-9#3)
protocols described in this unit##2##5##(2008-4#2)
protocols described##5##2##(2008-4#5)
protocols detail##2##2##(2008-4#1)(2008-9#1)
protocols discuss##2##2##(2008-4#2)
protocols for isolating##2##3##(2008-1#1)(2008-4#1)
protocols for preparing##3##3##(2008-4#2)(2008-9#1)
protocols for probe labeling##2##4##(2008-9#2)
protocols for the##18##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#6)(2008-6#1)(2008-9#7)
protocols for##78##2##(1993-12#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#22)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#34)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
protocols from the##2##3##(1991-9#1)(2008-9#1)
protocols have##2##2##(2008-10#1)(2008-9#1)
protocols in this unit are##2##5##(2008-4#1)(2008-9#1)
protocols in this unit##6##4##(2008-4#3)(2008-9#3)
protocols in##12##2##(1991-2#1)(2008-10#2)(2008-4#4)(2008-9#3)(2010-10#1)(2013-8#1)
protocols is##6##2##(1994-3#1)(2008-11#3)(2008-9#1)(2013-1#1)
protocols may be##2##3##(2008-10#1)(2008-4#1)
protocols present methods for##2##4##(2008-4#1)(2008-9#1)
protocols provide##3##2##(2008-4#2)(2008-9#1)
protocols that##6##2##(1995-8#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
protocols to##9##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#4)
protocols used##2##2##(2008-10#1)(2008-9#1)
protocols was##3##2##(2008-10#2)(2009-4#1)
protocols were##3##2##(2008-10#2)(2013-1#1)
protocols which##2##2##(1997-1#1)(2008-4#1)
protocols will##2##2##(1994-3#1)(2008-9#1)
protocols with##2##2##(2008-11#1)(2008-4#1)
protocols##292##1##(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#6)(1995-8#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-8#2)(2006-6#1)(2008-1#4)(2008-10#33)(2008-11#17)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#82)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#79)(2009-4#3)(2009-7#2)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#8)
protogynous##2##1##(2010-5#2)
protolytic constants from##2##3##(2008-10#2)
protolytic equilibrium##2##2##(2008-10#2)
protolytic##5##1##(2008-10#5)
proton NMR##5##2##(1992-7#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-9#1)
proton abstraction##2##2##(1993-8#1)(2008-10#1)
proton and##3##2##(2008-10#3)
proton gradient is##2##3##(1990-2#1)(1994-8#1)
proton gradient##5##2##(1990-2#2)(1994-8#1)(1995-2#1)(2008-11#1)
proton in##2##2##(2008-10#1)(2008-9#1)
proton ionophore##2##2##(1990-2#1)(2008-9#1)
proton magnetic resonance spectroscopy##4##4##(1991-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
proton pump inhibitor##6##3##(1996-3#2)(2008-11#1)(2009-11#1)(2010-12#1)(2012-2#1)
proton pump inhibitors##4##3##(2011-2#1)(2012-2#3)
proton pump##11##2##(1994-6#1)(1996-3#2)(2008-11#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#4)
proton pumping##3##2##(1995-2#2)(2008-7#1)
proton reactions##2##2##(2008-10#2)
proton release##2##2##(1994-3#2)
proton transfer in the##2##4##(2008-10#2)
proton transfer##4##2##(2008-10#3)(2009-8#1)
proton translocation activity of##3##4##(2008-8#3)
proton translocation activity##4##3##(2008-8#4)
proton translocation##5##2##(2008-8#5)
proton##71##1##(1990-2#3)(1991-1#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-4#2)(1992-7#1)(1993-8#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#6)(1996-3#2)(1997-7#1)(2008-10#19)(2008-11#2)(2008-7#2)(2008-8#6)(2008-9#5)(2009-11#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-2#4)
proton-coupled##4##1##(1994-8#1)(1997-7#2)(2008-10#1)
protonated form of##2##3##(2008-10#2)
protonated form##5##2##(1991-5#1)(2008-10#4)
protonated molecular ion##4##3##(2008-10#4)
protonated species##3##2##(2008-10#3)
protonated##35##1##(1991-5#1)(1991-9#3)(1995-6#1)(2008-10#30)
protonation and##2##2##(2008-10#2)
protonation constant of##2##3##(2008-10#2)
protonation constant##3##2##(2008-10#3)
protonation constants and##3##3##(2008-10#3)
protonation constants for##2##3##(2008-10#2)
protonation constants of##5##3##(2008-10#5)
protonation constants##15##2##(2008-10#15)
protonation of the amine##2##4##(2008-10#2)
protonation of the##4##3##(2008-10#4)
protonation of##10##2##(1991-9#1)(2008-10#9)
protonation sites of the##2##4##(2009-9#2)
protonation##38##1##(1991-9#1)(1993-8#1)(1996-5#1)(1997-7#1)(2008-10#32)(2009-9#2)
protonic##2##1##(1992-12#1)(2008-5#1)
protonizable nitrogen##2##2##(1993-12#2)
protons in##2##2##(1991-9#1)(2010-12#1)
protons##10##1##(1990-5#1)(1991-9#1)(1993-8#1)(2008-10#5)(2008-9#1)(2010-12#1)
protoplasm##3##1##(2008-10#3)
protoplasmic##3##1##(2008-12#2)(2008-7#1)
protoplast culture##3##2##(2008-8#3)
protoplast fusion between##2##3##(2008-11#1)(2008-8#1)
protoplast fusion##3##2##(2008-11#1)(2008-8#2)
protoplast preparation##2##2##(2008-9#2)
protoplast##14##1##(2008-10#3)(2008-11#1)(2008-8#7)(2008-9#2)(2009-10#1)
protoplasts derived from##2##3##(2008-11#1)(2008-9#1)
protoplasts from##3##2##(2008-9#3)
protoplasts inoculated with##2##3##(2008-10#2)
protoplasts of##4##2##(1997-3#1)(2008-8#2)(2008-9#1)
protoplasts or##3##2##(1997-3#1)(2008-10#2)
protoplasts were##3##2##(1997-3#2)(2008-8#1)
protoplasts##49##1##(1994-11#1)(1997-3#7)(2008-10#7)(2008-11#4)(2008-8#16)(2008-9#13)(2009-8#1)
protoporphyrin IX##5##2##(1993-8#4)(2012-2#1)
protoporphyrin##9##1##(1991-5#1)(1993-8#4)(1994-5#1)(1995-2#2)(2012-2#1)
protoporphyrine IX##4##2##(2008-11#4)
prototrophic##4##1##(2008-10#4)
prototype for##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-6#1)
prototype of a##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
prototype of##7##2##(1991-12#1)(2008-10#4)(2008-11#1)(2011-2#1)
prototype was##2##2##(2008-10#1)(2008-2#1)
prototype were##2##2##(2008-10#1)(2008-5#1)
prototype##47##1##(1991-12#1)(1991-9#1)(1992-3#1)(1997-3#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2009-12#1)(2011-2#1)(2013-1#1)
prototypes of##2##2##(2008-10#1)(2010-12#1)
prototypes were##2##2##(2008-10#1)(2008-5#1)
prototypes##5##1##(2008-10#2)(2008-5#2)(2010-12#1)
prototypic##2##1##(2008-10#1)(2008-4#1)
prototypical##6##1##(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-2#1)
prototyping##5##1##(2008-3#1)(2009-12#1)(2010-9#2)(2012-2#1)
protozoa isolates##3##2##(2008-12#3)
protozoa##12##1##(1994-11#1)(2007-12#1)(2008-12#5)(2008-5#1)(2008-9#2)(2012-12#2)
protozoal##2##1##(1995-5#1)(1997-7#1)
protozoan parasite##4##2##(2009-6#1)(2009-7#1)(2009-8#1)(2012-2#1)
protozoan##9##1##(1992-2#1)(1993-9#2)(1996-3#1)(2008-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-2#1)
protozoans##2##1##(2007-12#1)(2008-11#1)
protracted and##3##2##(1995-12#1)(2008-10#1)(2009-7#1)
protracted##11##1##(1995-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-7#2)(2011-2#1)(2013-1#1)
protrude##2##1##(2008-5#1)(2009-8#1)
protruded into the##2##3##(1991-12#1)(2012-12#1)
protruded##3##1##(1991-12#1)(2012-12#1)(2013-1#1)
protruding##5##1##(1994-2#1)(2008-10#1)(2008-12#2)(2009-10#1)
protrusion at the##3##3##(2008-12#2)(2012-2#1)
protrusion of the##5##3##(2008-9#1)(2010-11#1)(2013-1#2)(2013-7#1)
protrusion of##6##2##(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#2)(2013-7#1)
protrusion##18##1##(1990-2#1)(2008-10#1)(2008-12#2)(2008-3#3)(2008-7#3)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
protrusions##9##1##(1991-5#1)(2007-12#3)(2008-7#1)(2009-9#2)(2011-2#2)
protuberans##2##1##(1992-2#2)
proud##3##1##(1990-2#1)(1992-3#1)(2011-2#1)
prourokinase and##2##2##(2008-11#2)
prourokinase##4##1##(2008-11#4)
prove that the##3##3##(2008-10#2)(2008-3#1)
prove that this##2##3##(2008-10#1)(2008-3#1)
prove that##13##2##(1990-11#1)(1994-5#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2013-8#1)
prove the##6##2##(1991-3#1)(2008-10#3)(2008-5#1)(2009-8#1)
prove to be instrumental##2##4##(1993-11#1)(2008-10#1)
prove to be very##2##4##(1994-2#1)(2008-10#1)
prove to be##14##3##(1991-5#1)(1993-11#1)(1994-2#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-3#1)
prove to##15##2##(1991-5#1)(1993-11#1)(1994-2#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-3#1)
prove useful for##3##3##(2008-10#2)(2012-2#1)
prove useful in the##2##4##(2008-5#1)(2012-2#1)
prove useful in##5##3##(1996-2#1)(1997-2#1)(2008-5#1)(2012-2#1)(2013-1#1)
prove useful##12##2##(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-2#2)(2013-1#1)
prove##79##1##(1990-11#1)(1990-2#1)(1991-3#2)(1991-5#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
proved a##2##2##(1991-5#1)(2008-6#1)
proved also that##4##3##(2007-11#2)(2008-10#2)
proved as##2##2##(2010-5#1)(2012-3#1)
proved by the##3##3##(2008-10#3)
proved by##10##2##(1997-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
proved difficult to##3##3##(1997-7#1)(2008-8#1)(2011-2#1)
proved difficult##4##2##(1997-7#1)(2008-12#1)(2008-8#1)(2011-2#1)
proved effective in##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
proved effective##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
proved experimentally##2##2##(2008-10#1)(2008-3#1)
proved for##2##2##(2008-10#1)(2008-9#1)
proved lethal##2##2##(1993-12#1)(2008-10#1)
proved relatively##2##2##(1991-3#1)(2008-11#1)
proved successful##2##2##(2008-10#1)(2008-3#1)
proved superior##2##2##(2008-10#2)
proved that both##2##3##(2008-10#2)
proved that the##13##3##(1992-2#1)(1992-5#1)(2008-10#3)(2008-5#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
proved that there##2##3##(2008-10#1)(2008-8#1)
proved that##36##2##(1990-8#1)(1992-2#1)(1992-5#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#5)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
proved the##12##2##(2008-10#4)(2008-11#1)(2008-8#2)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#2)
proved to be a characteristic##2##5##(2008-10#2)
proved to be a rapid##3##5##(2008-10#2)(2008-11#1)
proved to be a reliable##2##5##(1996-6#1)(2008-10#1)
proved to be a##21##4##(1990-2#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-2#1)(1994-8#1)(1996-6#1)(2008-10#8)(2008-11#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-7#1)(2012-2#1)
proved to be an##3##4##(1992-2#1)(1994-12#1)(2008-10#1)
proved to be applicable##2##4##(2008-10#2)
proved to be effective in##4##5##(1992-12#1)(1992-9#1)(2011-2#1)(2013-1#1)
proved to be good##2##4##(2008-10#2)
proved to be highly##3##4##(1995-11#1)(2008-10#2)
proved to be less important##2##5##(2008-10#1)(2008-7#1)
proved to be less##3##4##(2008-10#1)(2008-7#2)
proved to be more##2##4##(2008-10#2)
proved to be much##2##4##(2008-10#1)(2011-2#1)
proved to be of##2##4##(1991-2#1)(1991-6#1)
proved to be stable##2##4##(2008-11#1)(2008-3#1)
proved to be suitable##2##4##(2008-10#2)
proved to be the main##2##5##(2008-10#1)(2008-11#1)
proved to be the most effective##2##6##(2008-10#2)
proved to be the most##6##5##(2008-10#5)(2008-9#1)
proved to be the##13##4##(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
proved to be useful for##3##5##(2008-10#3)
proved to be useful##4##4##(2008-10#4)
proved to be very##5##4##(2008-10#4)(2013-1#1)
proved to be##116##3##(1990-2#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#2)(1993-8#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#3)(1997-7#1)(2008-1#1)(2008-10#52)(2008-11#5)(2008-12#1)(2008-3#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#4)(2011-7#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
proved to have##4##3##(1994-6#1)(2008-10#3)
proved to##129##2##(1990-2#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#2)(1993-8#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#3)(1997-7#1)(2008-1#1)(2008-10#59)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#4)(2011-7#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
proved useful for##2##3##(2008-11#1)(2011-2#1)
proved useful##6##2##(1991-12#1)(1992-9#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
proved valuable in##2##3##(1992-1#1)(2008-7#1)
proved very##3##2##(1995-5#1)(1997-3#1)(1997-7#1)
proved##273##1##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-7#3)(2007-11#3)(2008-1#1)(2008-10#111)(2008-11#14)(2008-12#4)(2008-2#3)(2008-3#6)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#10)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#15)(2011-7#2)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#4)(2013-8#1)
proven by##3##2##(2008-11#1)(2010-7#1)(2011-2#1)
proven efficacy in##2##3##(2008-9#1)(2011-2#1)
proven efficacy##3##2##(2008-9#1)(2011-2#2)
proven for##4##2##(1993-3#1)(1996-5#1)(2011-2#1)(2013-8#1)
proven strategies to##2##3##(1994-2#1)(2010-12#1)
proven strategies##3##2##(1994-2#2)(2010-12#1)
proven that##3##2##(2008-10#1)(2008-11#2)
proven the##3##2##(1996-12#1)(2008-10#1)(2011-1#1)
proven to be a very##2##5##(2008-10#2)
proven to be a viable##2##5##(2008-10#1)(2008-11#1)
proven to be a##8##4##(2008-10#3)(2008-11#2)(2008-9#1)(2010-7#1)(2012-2#1)
proven to be an##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
proven to be effective##2##4##(1996-2#1)(2011-2#1)
proven to be more clinically##2##5##(2008-11#1)(2008-6#1)
proven to be more##3##4##(2008-11#1)(2008-6#1)(2012-2#1)
proven to be safe##2##4##(1996-2#1)(2009-1#1)
proven to be very powerful##2##5##(1995-12#1)(2008-10#1)
proven to be very##5##4##(1995-12#1)(2008-10#2)(2008-7#1)(2010-9#1)
proven to be##33##3##(1994-11#1)(1995-12#1)(1996-2#2)(1997-2#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-3#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-8#2)
proven to##38##2##(1994-11#1)(1995-12#1)(1996-2#2)(1997-2#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-2#3)(2013-1#1)(2013-8#2)
proven useful in a##2##4##(2008-12#1)(2008-5#1)
proven useful in##5##3##(2008-11#2)(2008-12#1)(2008-5#1)(2011-7#1)
proven useful##6##2##(2008-11#2)(2008-12#1)(2008-5#1)(2010-7#1)(2011-7#1)
proven with##2##2##(2008-10#1)(2008-7#1)
proven##117##1##(1990-2#1)(1991-2#1)(1992-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#2)(2008-10#13)(2008-11#9)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#4)(2010-9#1)(2011-1#1)(2011-2#15)(2011-7#2)(2012-12#2)(2012-2#5)(2013-1#2)(2013-8#3)
provenance##12##1##(2008-10#6)(2008-11#3)(2008-2#1)(2012-5#1)(2012-9#1)
provenance)##3##1##(2008-10#1)(2011-10#2)
provenances of##2##2##(2012-5#1)(2012-9#1)
provenances or species##2##3##(2012-9#2)
provenances##16##1##(2008-10#1)(2011-10#2)(2012-5#7)(2012-9#6)
proves inadequate##2##2##(1994-6#1)(2013-1#1)
proves that the##2##3##(2008-10#2)
proves that##7##2##(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
proves the##5##2##(1991-12#1)(1995-1#1)(2008-10#2)(2011-2#1)
proves to be##4##3##(1995-3#1)(2008-10#2)(2008-11#1)
proves##26##1##(1991-12#1)(1991-6#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#2)
provide a basis for understanding##2##5##(2008-10#1)(2010-12#1)
provide a basis for##6##4##(1991-11#1)(2008-10#1)(2010-12#3)(2010-7#1)
provide a better understanding of the##2##6##(1997-2#1)(2008-10#1)
provide a better##4##3##(1994-6#1)(1995-3#1)(1997-2#1)(2008-10#1)
provide a brief overview of##2##5##(2008-11#1)(2011-2#1)
provide a brief##6##3##(1996-2#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
provide a clinically##2##3##(1996-2#1)(2011-2#1)
provide a comprehensive overview of the##2##6##(2008-11#1)(2013-8#1)
provide a comprehensive overview of##3##5##(2008-11#1)(2011-2#1)(2013-8#1)
provide a comprehensive##8##3##(1993-12#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#3)(2013-8#1)
provide a concise##2##3##(2008-11#1)(2008-7#1)
provide a critical review##2##4##(2009-10#1)(2012-2#1)
provide a critical##3##3##(2008-8#1)(2009-10#1)(2012-2#1)
provide a description of the##2##5##(2008-12#1)(2009-7#1)
provide a description of##3##4##(1991-12#1)(2008-12#1)(2009-7#1)
provide a flexible##2##3##(2008-4#1)(2010-10#1)
provide a foundation for##3##4##(1996-2#1)(2008-10#1)(2009-5#1)
provide a foundation##4##3##(1996-2#1)(2008-10#1)(2008-12#1)(2009-5#1)
provide a framework for the##2##5##(1993-3#1)(2012-12#1)
provide a framework for##3##4##(1993-3#1)(2010-10#1)(2012-12#1)
provide a functional##2##3##(2008-10#1)(2008-11#1)
provide a general##7##3##(1997-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)
provide a good##4##3##(1994-8#1)(2008-10#2)(2008-3#1)
provide a high degree of protection for##2##7##(2012-2#2)
provide a high##3##3##(2008-11#1)(2012-2#2)
provide a link between##2##4##(1994-11#1)(2008-9#1)
provide a means for##3##4##(1996-2#1)(1997-8#1)(2008-10#1)
provide a means##5##3##(1990-5#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)
provide a measure##2##3##(1990-8#1)(2012-2#1)
provide a mechanism for##2##4##(1995-8#1)(2008-3#1)
provide a mechanistic##2##3##(2008-10#1)(2011-2#1)
provide a method##2##3##(2008-3#1)(2008-6#1)
provide a model##4##3##(1992-6#1)(1993-3#1)(2008-9#1)(2011-10#1)
provide a more accurate identification of microorganisms##2##7##(2012-2#2)
provide a more accurate##3##4##(2012-2#2)(2012-3#1)
provide a more##7##3##(1994-12#1)(2008-11#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
provide a new##5##3##(1993-2#1)(1996-2#1)(2008-11#1)(2008-8#1)(2012-2#1)
provide a novel##6##3##(1991-5#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
provide a potential##2##3##(2008-7#1)(2009-10#1)
provide a practical##3##3##(2008-11#1)(2008-6#1)(2012-5#1)
provide a principled##2##3##(2008-5#1)(2013-8#1)
provide a promising##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
provide a rapid##2##3##(2008-10#2)
provide a reliable##5##3##(2008-3#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
provide a review of##3##4##(2010-10#1)(2011-1#1)(2012-2#1)
provide a robust method for##2##5##(2008-1#1)(2008-10#1)
provide a robust##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
provide a safe##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
provide a simple##5##3##(2008-10#3)(2010-7#1)(2012-3#1)
provide a supportive##2##3##(2010-9#1)(2013-1#1)
provide a theoretical framework##2##4##(2008-8#2)
provide a theoretical##3##3##(2008-8#2)(2013-8#1)
provide a unique##2##3##(2009-6#1)(2013-8#1)
provide a useful##8##3##(1990-5#1)(1992-2#1)(1994-3#1)(2008-10#1)(2008-11#3)(2012-3#1)
provide a valuable tool for##2##5##(2008-11#1)(2009-12#1)
provide a valuable tool##3##4##(2008-10#1)(2008-11#1)(2009-12#1)
provide a valuable##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)
provide a way to##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
provide a##273##2##(1990-5#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#3)(1994-11#2)(1994-12#3)(1994-3#6)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#6)(1996-3#5)(1996-5#1)(1997-2#2)(1997-3#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#39)(2008-11#27)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#9)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#12)(2011-7#2)(2012-12#2)(2012-2#17)(2012-3#8)(2012-5#1)(2012-9#1)(2013-1#8)(2013-8#7)
provide acceptable##2##2##(2008-10#1)(2010-10#1)
provide access to##2##3##(1991-12#1)(1993-1#1)
provide access##3##2##(1991-12#1)(1993-1#1)(2008-7#1)
provide accurate##3##2##(2010-8#1)(2013-1#1)(2013-8#1)
provide additional evidence for##2##4##(1992-3#2)
provide additional information##3##3##(2008-10#1)(2008-4#1)(2010-12#1)
provide additional insight into##2##4##(1991-10#1)(2012-3#1)
provide additional support to##2##4##(2008-12#1)(2013-1#1)
provide additional support##3##3##(2008-12#1)(2013-1#2)
provide additional tools for##2##4##(1995-1#1)(2008-11#1)
provide additional##16##2##(1991-10#1)(1992-3#2)(1995-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-1#2)
provide adequate##11##2##(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
provide an additional##2##3##(2008-10#1)(2008-7#1)
provide an alternative to##3##4##(2008-4#1)(2008-9#2)
provide an alternative##7##3##(2008-10#2)(2008-4#1)(2008-9#4)
provide an attractive##3##3##(1995-2#1)(2008-11#1)(2008-9#1)
provide an effective tool##2##4##(2008-11#1)(2013-8#1)
provide an effective##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
provide an efficient##2##3##(1994-2#1)(2011-2#1)
provide an evidence-based##2##3##(2011-2#1)(2011-7#1)
provide an example##2##3##(1996-3#1)(2010-11#1)
provide an excellent##5##3##(1997-6#1)(2006-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
provide an important##6##3##(1996-1#1)(2008-1#1)(2008-11#2)(2008-4#1)(2013-8#1)
provide an improved##2##3##(2008-10#1)(2012-2#1)
provide an optimal##3##3##(2008-10#2)(2010-10#1)
provide an overview of the##6##5##(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
provide an overview of##10##4##(1995-3#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
provide an overview##12##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
provide an##87##2##(1992-12#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#3)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#20)(2008-11#9)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#6)(2009-4#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2011-7#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
provide and##4##2##(1996-2#1)(2012-2#2)(2013-1#1)
provide any protection##3##3##(1995-11#2)(2008-10#1)
provide any##5##2##(1991-2#1)(1995-11#2)(2008-10#1)(2013-1#1)
provide appropriate##2##2##(1993-3#1)(2012-12#1)
provide avenues for##2##3##(2008-10#1)(2008-2#1)
provide benefits##2##2##(2009-11#1)(2012-2#1)
provide better habitats##2##3##(2008-8#2)
provide better##9##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2012-2#1)(2013-8#1)
provide both a##2##3##(2009-11#1)(2010-4#1)
provide both##3##2##(2009-11#1)(2010-4#1)(2011-2#1)
provide care to##2##3##(2008-11#1)(2008-9#1)
provide care##9##2##(1991-2#1)(1993-12#1)(1994-3#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)
provide clinical##3##2##(2008-11#1)(2008-4#1)(2010-10#1)
provide clues##5##2##(1997-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-12#1)
provide compelling evidence that##2##4##(2009-8#1)(2011-2#1)
provide compelling##3##2##(2009-8#1)(2011-2#1)(2012-3#1)
provide comprehensive##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
provide consistent##2##2##(2008-5#1)(2009-7#1)
provide continuous##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
provide data on##2##3##(2011-2#1)(2013-1#1)
provide data##7##2##(1990-2#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
provide detailed##3##2##(1991-1#1)(2008-9#2)
provide details on the##2##4##(2008-10#1)(2008-11#1)
provide details##5##2##(1990-11#1)(1992-3#1)(1994-11#1)(2008-10#1)(2008-11#1)
provide direct evidence that##2##4##(2008-10#1)(2009-8#1)
provide direct evidence##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
provide direct##11##2##(1991-5#1)(1994-3#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-3#1)
provide documentation##2##2##(1991-12#1)(1992-12#1)
provide durable##2##2##(2008-10#2)
provide education##2##2##(1991-12#1)(2008-11#1)
provide effective##2##2##(1991-8#1)(2008-10#1)
provide equivalent##3##2##(1996-1#1)(1996-2#1)(2008-3#1)
provide essential information##3##3##(1993-2#1)(2008-11#1)(2012-2#1)
provide evidence for a##3##4##(1993-12#1)(1997-2#1)(2013-1#1)
provide evidence for the##2##4##(1997-6#1)(2011-2#1)
provide evidence for##10##3##(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
provide evidence of an##2##4##(1991-12#1)(2010-12#1)
provide evidence of the existence of##2##6##(1995-8#1)(2008-3#1)
provide evidence of the##3##4##(1995-8#1)(2008-3#1)(2009-7#1)
provide evidence of##7##3##(1991-12#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-12#1)
provide evidence on##2##3##(2008-11#1)(2012-2#1)
provide evidence that a##2##4##(1993-6#1)(2008-7#1)
provide evidence that##22##3##(1990-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-3#2)(2008-10#5)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
provide evidence##47##2##(1990-11#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
provide excellent##2##2##(2008-10#1)(2012-3#1)
provide extensive##4##2##(2008-7#1)(2008-9#2)(2011-2#1)
provide for##9##2##(1990-2#1)(1991-3#1)(1992-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2013-1#2)
provide further evidence##2##3##(1996-2#1)(1997-8#1)
provide further##6##2##(1991-9#1)(1993-12#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-7#1)
provide general##2##2##(1994-2#1)(2010-12#1)
provide genetic##2##2##(2008-10#1)(2008-4#1)
provide good##6##2##(1990-12#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
provide greater##3##2##(2008-10#2)(2009-10#1)
provide guidance for##4##3##(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
provide guidance to##2##3##(1993-12#1)(2008-11#1)
provide guidance##9##2##(1993-12#1)(1996-3#1)(2008-11#3)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
provide guidelines for##2##3##(2008-10#1)(2011-2#1)
provide guidelines##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
provide high quality##2##3##(1997-2#1)(2008-11#1)
provide high##5##2##(1997-2#1)(2008-10#2)(2008-11#2)
provide high-resolution##2##2##(2008-3#1)(2011-2#1)
provide higher##3##2##(1993-1#1)(2008-10#1)(2009-9#1)
provide important information for##2##4##(2008-10#1)(2013-1#1)
provide important information on##2##4##(1991-2#1)(2013-1#1)
provide important information##6##3##(1990-8#1)(1991-2#1)(2008-10#1)(2009-6#1)(2013-1#2)
provide important##15##2##(1990-8#1)(1991-2#2)(1993-3#2)(1995-12#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-6#1)(2011-2#1)(2013-1#3)
provide increased##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
provide independent##2##2##(2008-10#1)(2008-9#1)
provide information about the##5##4##(1993-12#1)(2008-10#1)(2008-4#1)(2009-10#1)(2013-8#1)
provide information about##11##3##(1991-1#1)(1992-2#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-10#1)(2011-3#1)(2013-1#1)(2013-8#1)
provide information for##3##3##(2008-10#1)(2008-11#2)
provide information on the##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
provide information on##6##3##(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
provide information to##3##3##(1991-2#1)(1993-2#1)(1996-2#1)
provide information##27##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-2#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-3#1)(2013-1#1)(2013-8#1)
provide insight as##2##3##(1991-2#1)(2013-1#1)
provide insight into how##2##4##(1997-7#1)(2008-11#1)
provide insight into the##6##4##(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
provide insight into##14##3##(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
provide insight##17##2##(1991-2#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
provide insights into the##8##4##(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
provide insights into##13##3##(1993-12#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
provide insights##15##2##(1993-12#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2012-2#2)(2012-3#2)(2013-1#1)
provide invaluable##3##2##(2008-11#1)(2008-6#1)(2012-3#1)
provide little##2##2##(1996-11#1)(2008-10#1)
provide mechanistic##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
provide moderate##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
provide more##9##2##(1990-3#1)(1991-1#1)(1992-3#1)(2008-10#2)(2009-7#1)(2011-2#2)(2013-1#1)
provide most##2##2##(2009-11#1)(2011-2#1)
provide multiple##2##2##(2008-11#1)(2013-1#1)
provide new information##2##3##(1997-7#1)(2008-3#1)
provide new insight into##2##4##(1991-5#1)(2008-10#1)
provide new insights into the##3##5##(2008-10#1)(2008-7#1)(2008-8#1)
provide new insights into##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)
provide new insights##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)
provide new##19##2##(1991-5#1)(1996-1#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-11#1)
provide no##2##2##(1993-6#1)(1997-3#1)
provide not only##3##3##(1991-2#1)(2008-10#1)(2010-12#1)
provide novel insights into the##2##5##(2010-12#1)(2013-8#1)
provide novel##4##2##(2009-6#1)(2010-12#1)(2013-8#2)
provide one of the##3##4##(1992-1#1)(2008-10#1)(2012-3#1)
provide opportunities for##5##3##(1993-6#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)
provide opportunities##6##2##(1993-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)
provide optimal##3##2##(1993-11#1)(2010-11#1)(2011-3#1)
provide other##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
provide parental care##2##3##(2008-8#2)
provide powerful##2##2##(2008-11#1)(2008-7#1)
provide practical##3##2##(1997-7#1)(2008-10#1)(2008-12#1)
provide preliminary##2##2##(2008-12#1)(2011-1#1)
provide promising##2##2##(2008-6#1)(2010-6#1)
provide protection against##2##3##(2008-10#1)(2008-9#1)
provide protection##6##2##(1993-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
provide quantitative##3##2##(2008-10#2)(2008-11#1)
provide quick##2##2##(2008-3#1)(2012-2#1)
provide real##2##2##(1995-6#1)(2008-10#1)
provide recommendations##3##2##(1992-3#1)(2008-11#1)(2012-3#1)
provide reliable##4##2##(1993-9#1)(1997-3#1)(2008-10#1)(2012-2#1)
provide robust##2##2##(2008-8#1)(2013-1#1)
provide satisfactory results##2##3##(2008-10#2)
provide satisfactory##3##2##(1993-2#1)(2008-10#2)
provide services##5##2##(1993-12#1)(1994-1#2)(2008-11#2)
provide significant##6##2##(1991-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
provide similar##2##2##(1996-6#1)(2008-3#1)
provide some##9##2##(1991-3#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)
provide stable##2##2##(2008-4#1)(2009-1#1)
provide strong support for##2##4##(1992-2#1)(2008-11#1)
provide strong##4##2##(1992-2#1)(1996-8#1)(2008-11#1)(2008-8#1)
provide students with##2##3##(2008-11#1)(2008-12#1)
provide substantial##3##2##(1990-11#1)(2010-12#1)(2011-2#1)
provide such##3##2##(1996-3#1)(2008-11#1)(2011-2#1)
provide superior##3##2##(1994-1#2)(2008-10#1)
provide support for the hypothesis##2##5##(1994-8#1)(2008-10#1)
provide support for##5##3##(1994-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
provide support to##3##3##(1994-12#1)(2008-8#1)(2013-8#1)
provide support##9##2##(1994-12#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-6#1)(2011-2#1)(2013-8#1)
provide that##2##2##(1990-2#1)(1996-1#1)
provide the basis for##4##4##(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)
provide the best##7##3##(2008-10#5)(2010-11#1)(2013-1#1)
provide the evidence##2##3##(2008-12#1)(2012-3#1)
provide the first##9##3##(1994-5#1)(2008-10#5)(2008-9#1)(2009-6#1)(2010-11#1)
provide the highest##2##3##(2008-10#1)(2013-1#1)
provide the means for##2##4##(1992-6#1)(1994-2#1)
provide the means to##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
provide the means##5##3##(1992-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2010-10#1)
provide the most##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
provide the necessary##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
provide the only##2##3##(1991-5#1)(2008-4#1)
provide the opportunity##2##3##(1995-9#1)(2011-2#1)
provide the reader with an##2##5##(2008-10#1)(2009-12#1)
provide the reader with##3##4##(2008-10#1)(2009-12#1)(2010-9#1)
provide the substrate for##2##4##(2008-4#1)(2011-2#1)
provide the##95##2##(1990-11#2)(1990-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#1)(1997-8#1)(2008-10#20)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-9#2)(2011-10#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)
provide their##3##2##(1997-2#1)(2008-9#1)(2013-1#1)
provide timely##2##2##(1997-3#1)(2012-12#1)
provide training##2##2##(2011-2#2)
provide useful information for the##2##5##(2008-10#1)(2010-5#1)
provide useful information for##4##4##(2008-10#2)(2008-2#1)(2010-5#1)
provide useful information##5##3##(1991-2#1)(2008-10#2)(2008-2#1)(2010-5#1)
provide useful##12##2##(1991-2#1)(1994-5#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-5#1)(2012-3#1)
provide valid##2##2##(1994-2#1)(1995-2#1)
provide valuable information about##2##4##(2008-11#1)(2008-4#1)
provide valuable information##5##3##(1996-12#1)(1996-8#1)(2008-11#1)(2008-4#1)(2012-12#1)
provide valuable##10##2##(1995-1#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#1)
provide visual##2##2##(2008-10#1)(2009-12#1)
provide##1197##1##(1990-11#7)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#3)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#14)(1991-3#3)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#9)(1992-3#9)(1992-6#3)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#11)(1993-2#5)(1993-3#9)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#5)(1994-11#6)(1994-12#5)(1994-2#7)(1994-3#12)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#5)(1995-11#3)(1995-12#8)(1995-2#9)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#3)(1996-1#9)(1996-11#1)(1996-12#3)(1996-2#14)(1996-3#12)(1996-5#3)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#10)(1997-3#9)(1997-6#3)(1997-7#4)(1997-8#6)(2006-6#2)(2007-11#2)(2007-12#3)(2007-9#2)(2008-1#4)(2008-10#188)(2008-11#115)(2008-12#22)(2008-2#4)(2008-3#30)(2008-4#28)(2008-5#17)(2008-6#9)(2008-7#26)(2008-8#27)(2008-9#43)(2009-1#1)(2009-10#10)(2009-11#7)(2009-12#6)(2009-4#2)(2009-5#4)(2009-6#6)(2009-7#8)(2009-8#8)(2009-9#4)(2010-1#4)(2010-10#20)(2010-11#13)(2010-12#20)(2010-4#6)(2010-5#5)(2010-6#5)(2010-7#5)(2010-8#4)(2010-9#3)(2011-1#5)(2011-10#2)(2011-2#57)(2011-3#4)(2011-7#3)(2012-12#9)(2012-2#51)(2012-3#28)(2012-5#1)(2012-9#1)(2013-1#54)(2013-3#1)(2013-7#1)(2013-8#28)
provided a better##2##3##(2008-10#1)(2012-2#1)
provided a good##2##3##(2008-10#1)(2008-7#1)
provided a linear##3##3##(2008-10#3)
provided a more##2##3##(2008-1#1)(2008-10#1)
provided a significant##2##3##(2008-10#2)
provided a variety of##2##4##(2011-1#1)(2013-8#1)
provided a##61##2##(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#28)(2008-11#7)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
provided accurate predictions of##2##4##(2008-10#2)
provided additional information##2##3##(2011-2#1)(2013-1#1)
provided additional##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
provided an opportunity to##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
provided an opportunity##4##3##(2008-10#2)(2008-11#1)(2010-8#1)
provided an##16##2##(1994-6#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
provided and##6##2##(2008-11#4)(2008-9#1)(2011-2#1)
provided as##2##2##(1991-12#1)(2008-4#1)
provided at##4##2##(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
provided better##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
provided by Trichoderma spp##2##4##(2008-10#2)
provided by a##8##3##(1993-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2009-10#1)
provided by an##2##3##(2008-10#1)(2010-8#1)
provided by both##4##3##(2008-1#1)(2008-11#1)(2011-2#2)
provided by the##34##3##(1992-12#1)(1992-2#1)(1996-12#1)(1997-2#2)(1997-9#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
provided by this##3##3##(2008-10#2)(2011-3#1)
provided by##106##2##(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-1#2)(1996-12#2)(1997-2#3)(1997-6#1)(1997-9#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#9)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-8#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
provided data##2##2##(2009-10#1)(2012-3#1)
provided during##3##2##(1992-12#1)(1993-2#1)(2008-10#1)
provided encouraging results##2##3##(1992-9#1)(2010-2#1)
provided evidence for##2##3##(1991-2#1)(2009-11#1)
provided evidence of##4##3##(1994-1#1)(2008-10#2)(2011-2#1)
provided evidence supporting the##2##4##(2008-12#1)(2008-8#1)
provided evidence that the##2##4##(2008-10#1)(2010-11#1)
provided evidence that##5##3##(2008-10#2)(2008-12#1)(2010-1#1)(2010-11#1)
provided evidence##13##2##(1991-2#1)(1994-1#1)(2008-10#4)(2008-12#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-11#1)(2011-2#1)
provided examples##2##2##(2009-10#1)(2010-10#1)
provided excellent##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
provided facilities to##2##3##(2008-10#2)
provided for a##5##3##(1992-2#1)(1993-1#1)(1995-3#1)(2008-10#1)(2008-7#1)
provided for both##2##3##(2007-9#1)(2008-4#1)
provided for preparation of##2##4##(2008-4#1)(2008-9#1)
provided for the##3##3##(1997-3#1)(2008-4#2)
provided for##43##2##(1990-3#1)(1991-2#1)(1992-2#1)(1993-1#1)(1995-3#1)(1996-3#1)(1997-3#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#15)(2008-7#1)(2008-9#6)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-8#2)
provided from##2##2##(2008-11#1)(2008-12#1)
provided further evidence##3##3##(2008-10#2)(2011-2#1)
provided further##5##2##(2008-10#2)(2008-12#1)(2011-2#2)
provided herein##2##2##(1992-1#1)(2008-7#1)
provided high sensitivity##2##3##(2008-10#2)
provided highly##2##2##(2008-10#1)(2012-3#1)
provided important clues##2##3##(1991-2#1)(2008-9#1)
provided in the##7##3##(1994-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
provided in this##5##3##(2008-10#3)(2008-11#1)(2008-4#1)
provided in##20##2##(1994-12#1)(1994-3#2)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-4#1)(2008-9#1)(2011-2#2)(2012-3#1)
provided including##2##2##(2008-11#2)
provided information about##2##3##(2008-11#1)(2013-8#1)
provided information##6##2##(2008-10#3)(2008-11#1)(2013-1#1)(2013-8#1)
provided insight into##2##3##(1995-5#1)(2008-10#1)
provided insight##3##2##(1995-5#1)(2008-10#1)(2008-9#1)
provided insights##3##2##(2008-9#1)(2010-1#1)(2012-2#1)
provided is##3##2##(2008-4#2)(2008-9#1)
provided more##6##2##(1994-1#1)(1997-2#1)(2008-10#3)(2008-5#1)
provided new insights into the##3##5##(1997-8#1)(2008-10#2)
provided new insights##4##3##(1997-8#1)(2008-10#2)(2011-2#1)
provided new##10##2##(1993-2#2)(1997-8#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)
provided no##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
provided on the##2##3##(2008-4#1)(2008-7#1)
provided one of##2##3##(1995-6#1)(2008-5#1)
provided only##5##2##(2008-10#4)(2008-11#1)
provided over##2##2##(2008-12#1)(2013-1#1)
provided regarding##3##2##(2008-4#3)
provided reliable##2##2##(2008-10#1)(2008-12#1)
provided results between##2##3##(2008-10#2)
provided results##6##2##(2008-10#4)(2011-2#1)(2012-2#1)
provided satisfactory results##3##3##(2008-10#3)
provided services##2##2##(1992-12#1)(2008-6#1)
provided significant##3##2##(2008-10#2)(2013-1#1)
provided similar##2##2##(2008-7#1)(2009-3#1)
provided some##3##2##(1994-1#1)(2008-2#1)(2008-9#1)
provided that a##3##3##(1991-6#1)(1994-5#1)(2008-3#1)
provided that species##2##3##(2008-8#2)
provided that the##10##3##(1990-11#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-8#2)
provided that##29##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-6#1)(1994-5#1)(2008-10#5)(2008-11#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)
provided the best##5##3##(1996-8#1)(2008-10#3)(2013-1#1)
provided the flexibility##2##3##(2008-10#1)(2009-9#1)
provided the means##2##3##(2008-11#1)(2008-4#1)
provided the most##2##3##(2008-10#2)
provided the opportunity for##2##4##(1994-12#1)(2008-11#1)
provided the scientific##2##3##(2008-10#2)
provided the##46##2##(1994-12#1)(1994-3#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#2)(2008-8#5)(2009-9#1)(2010-1#1)(2010-12#1)(2013-1#5)
provided they##2##2##(1994-12#1)(2010-8#1)
provided through##2##2##(1994-12#1)(1995-2#1)
provided to Medicare##2##3##(1991-3#1)(1996-2#1)
provided to a##2##3##(1995-3#1)(2012-3#1)
provided to illustrate the##2##4##(2008-11#2)
provided to people with disabilities##2##5##(1996-1#1)(2009-6#1)
provided to the##3##3##(1991-3#1)(1992-2#1)(2008-7#1)
provided to##32##2##(1991-3#2)(1992-1#1)(1992-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2012-2#1)(2012-3#3)
provided unsatisfactory##2##2##(2008-12#1)(2008-7#1)
provided us with##3##3##(1997-3#1)(2008-11#1)(2008-9#1)
provided useful##2##2##(2008-10#1)(2008-7#1)
provided using##2##2##(2008-10#1)(2010-4#1)
provided valuable information##2##3##(2008-10#1)(2012-12#1)
provided valuable##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
provided very##3##2##(2008-10#2)(2008-7#1)
provided with an##2##3##(2008-10#1)(2008-11#1)
provided with continuous##2##3##(1992-1#1)(2007-8#1)
provided with the##2##3##(1992-3#1)(2009-2#1)
provided with##20##2##(1992-1#1)(1992-3#1)(1994-6#1)(1995-12#1)(1996-1#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2009-11#1)(2009-2#1)(2011-1#1)(2013-8#1)
provided within the##2##3##(2008-12#1)(2008-2#1)
provided##735##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-12#2)(1991-2#6)(1991-3#2)(1991-5#2)(1991-6#2)(1992-1#5)(1992-12#5)(1992-2#5)(1992-3#4)(1992-5#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#4)(1993-3#3)(1993-8#1)(1994-1#3)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#6)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-6#2)(1997-7#3)(1997-8#2)(1997-9#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#199)(2008-11#60)(2008-12#24)(2008-2#5)(2008-3#16)(2008-4#43)(2008-5#11)(2008-6#6)(2008-7#21)(2008-8#24)(2008-9#35)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#4)(2010-11#7)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#14)(2010-9#1)(2011-1#5)(2011-2#20)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#11)(2012-3#10)(2013-1#23)(2013-7#1)(2013-8#10)
provider analysis and##5##3##(1991-12#1)(1993-12#2)(1994-12#1)(1995-2#1)
provider analysis##6##2##(1991-12#1)(1992-12#1)(1993-12#2)(1994-12#1)(1995-2#1)
provider and##5##2##(1993-2#1)(1994-1#1)(1996-12#1)(2008-10#1)(2009-3#1)
provider choice##2##2##(1991-3#1)(1997-2#1)
provider expertise##4##2##(1994-1#4)
provider obligations##2##2##(1991-2#1)(1994-1#1)
provider organizations##5##2##(1991-3#2)(1992-2#1)(1994-1#2)
provider payment##3##2##(1995-2#2)(1997-1#1)
provider performance##2##2##(2010-12#1)(2013-1#1)
provider practices##2##2##(1996-1#1)(2013-1#1)
provider##84##1##(1991-12#2)(1991-2#3)(1991-3#4)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#10)(1994-12#4)(1994-2#2)(1994-3#1)(1995-12#2)(1995-2#6)(1995-3#3)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#3)(1997-2#4)(1997-3#1)(2008-10#1)(2008-11#4)(2009-3#2)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#9)(2013-8#2)
provider-patient relationship##5##2##(2013-8#5)
provider-patient##6##1##(2013-8#6)
providers and the##2##3##(1996-2#1)(2008-12#1)
providers and##19##2##(1992-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#1)(2008-11#4)(2008-12#1)(2010-5#1)(2011-1#1)(2013-1#1)
providers are##11##2##(1991-3#1)(1992-8#1)(1994-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-8#1)(2008-11#1)(2010-10#1)(2010-2#1)
providers coded##2##2##(2011-2#2)
providers for##3##2##(1993-12#1)(1996-1#1)(1996-2#1)
providers has##2##2##(1992-1#1)(1996-3#1)
providers have##4##2##(1992-11#1)(1993-12#1)(1997-5#1)(2008-12#1)
providers in##9##2##(1992-2#1)(1994-1#1)(1994-12#1)(1995-3#2)(1996-3#1)(2008-11#2)(2010-7#1)
providers into##2##2##(1993-3#2)
providers is to##3##3##(1992-12#1)(2008-11#1)(2008-6#1)
providers is##5##2##(1992-12#1)(1994-12#1)(2008-11#1)(2008-6#1)(2011-1#1)
providers must##2##2##(1991-12#1)(2008-6#1)
providers need to##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2012-3#1)
providers of##7##2##(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#1)(2010-10#1)(2012-2#1)
providers that##2##2##(1995-1#1)(2013-1#1)
providers to##13##2##(1991-2#1)(1994-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(2008-11#2)(2008-6#1)(2009-5#1)(2011-2#1)(2013-1#2)
providers would##2##2##(1996-5#1)(1997-2#1)
providers##193##1##(1991-12#1)(1991-2#4)(1991-3#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-8#1)(1993-1#2)(1993-12#7)(1993-2#1)(1993-3#4)(1993-5#2)(1994-1#8)(1994-12#10)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#8)(1996-3#11)(1996-5#2)(1996-9#1)(1997-1#3)(1997-2#14)(1997-3#5)(1997-5#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#20)(2008-12#4)(2008-4#1)(2008-6#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#6)(2013-1#14)(2013-8#10)
providers'##7##1##(1994-1#1)(1994-2#1)(1994-3#1)(2010-10#2)(2010-4#1)(2013-8#1)
providers) in##2##2##(1995-2#1)(1995-3#1)
providers)##3##1##(1995-2#1)(1995-3#1)(2009-10#1)
provides a basis for##5##4##(2008-10#1)(2008-11#2)(2010-12#1)(2010-8#1)
provides a better##2##3##(1995-12#1)(2008-9#1)
provides a brief description of the##2##6##(2008-11#1)(2010-5#1)
provides a brief overview of the##4##6##(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)
provides a brief overview##5##4##(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)
provides a brief##11##3##(1996-9#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)
provides a case##2##3##(1994-12#1)(2009-3#1)
provides a comprehensive##3##3##(2008-11#1)(2008-4#1)(2011-3#1)
provides a conceptual##3##3##(2008-11#1)(2008-8#1)(2013-8#1)
provides a cost-effective##3##3##(1994-3#2)(2008-10#1)
provides a critical##2##3##(1995-3#1)(2008-10#1)
provides a description of##3##4##(1997-1#1)(2008-12#2)
provides a detailed method for##2##5##(2008-4#1)(2008-9#1)
provides a detailed##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
provides a fast##2##3##(2008-10#2)
provides a framework##4##3##(1997-8#1)(2009-6#1)(2012-2#1)(2013-8#1)
provides a general##6##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#2)
provides a good##4##3##(1991-2#1)(2008-5#1)(2010-10#1)(2012-2#1)
provides a guide##2##3##(2008-7#1)(2011-2#1)
provides a limit of detection##2##5##(2008-10#2)
provides a means of##2##4##(2008-10#1)(2010-11#1)
provides a means to##2##4##(1997-2#1)(2009-10#1)
provides a means##5##3##(1997-2#1)(2008-10#1)(2009-10#1)(2009-3#1)(2010-11#1)
provides a measure of the##2##5##(1997-2#1)(2008-2#1)
provides a measure of##3##4##(1996-2#1)(1997-2#1)(2008-2#1)
provides a mechanism for##3##4##(2008-11#1)(2009-5#1)(2013-1#1)
provides a mechanism##4##3##(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
provides a more##3##3##(2008-10#2)(2008-7#1)
provides a new and##2##4##(1996-5#1)(2013-8#1)
provides a new tool##2##4##(1996-12#2)
provides a new##14##3##(1996-12#2)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-2#1)(2013-8#3)
provides a plausible##2##3##(2008-10#2)
provides a possible explanation for the##2##6##(1992-3#1)(1997-1#1)
provides a possible##4##3##(1992-3#1)(1997-1#1)(2008-10#1)(2012-2#1)
provides a potent##2##3##(1992-8#1)(2008-10#1)
provides a powerful tool for##3##5##(2008-10#1)(2008-12#1)(2008-5#1)
provides a powerful tool##4##4##(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
provides a powerful##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-3#1)
provides a practical approach##2##4##(2010-12#1)(2012-2#1)
provides a practical##3##3##(2010-12#1)(2012-2#1)(2012-3#1)
provides a promising##2##3##(2009-5#1)(2013-1#1)
provides a rapid and sensitive##3##5##(1993-8#1)(2008-10#2)
provides a rapid and##5##4##(1993-8#1)(2008-10#4)
provides a reliable and##2##4##(1990-12#1)(2013-1#1)
provides a reliable##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
provides a review of the current##2##6##(2010-12#1)(2011-7#1)
provides a review of the##3##5##(2010-12#2)(2011-7#1)
provides a review of##5##4##(2008-4#1)(2010-12#2)(2011-7#1)(2013-1#1)
provides a review##6##3##(2008-10#1)(2008-4#1)(2010-12#2)(2011-7#1)(2013-1#1)
provides a simple and##2##4##(2008-10#1)(2008-9#1)
provides a simple way to##4##5##(2008-10#1)(2008-3#2)(2008-9#1)
provides a simple##9##3##(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)
provides a suitable##3##3##(1995-12#1)(2008-11#1)(2012-2#1)
provides a summary of the##2##5##(1992-3#1)(2008-7#1)
provides a summary of##6##4##(1992-3#1)(2008-4#3)(2008-7#1)(2011-2#1)
provides a testable##2##3##(2008-8#1)(2008-9#1)
provides a unique##7##3##(1992-6#1)(1993-1#1)(1996-6#1)(2008-12#1)(2008-9#1)(2011-2#1)(2011-7#1)
provides a useful tool to##2##5##(2008-4#1)(2008-5#1)
provides a useful##7##3##(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
provides a valuable##2##3##(2008-11#1)(2008-12#1)
provides a very##4##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
provides a##256##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#4)(1995-3#1)(1995-6#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#52)(2008-11#18)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#17)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#18)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#3)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#9)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#7)
provides access to##2##3##(1994-12#1)(2008-8#1)
provides additional evidence##2##3##(2009-8#1)(2013-1#1)
provides additional##5##2##(1995-2#1)(1997-8#1)(2008-7#1)(2009-8#1)(2013-1#1)
provides adequate##2##2##(1992-1#1)(1992-12#1)
provides an acceptable##2##3##(2008-10#1)(2013-8#1)
provides an alternative and##2##4##(2008-10#2)
provides an alternative##3##3##(2008-10#3)
provides an analysis of the##2##5##(2008-8#1)(2010-8#1)
provides an analysis of##3##4##(2008-8#1)(2010-10#1)(2010-8#1)
provides an analysis##4##3##(2008-1#1)(2008-8#1)(2010-10#1)(2010-8#1)
provides an efficient means to##2##5##(1997-2#1)(2008-10#1)
provides an efficient method of##2##5##(2008-11#1)(2008-4#1)
provides an efficient##7##3##(1995-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)
provides an estimate of the##2##5##(2008-10#2)
provides an excellent platform##2##4##(2008-10#1)(2009-12#1)
provides an excellent##9##3##(2008-10#2)(2008-3#1)(2008-9#4)(2009-12#1)(2009-9#1)
provides an explanation for##2##4##(1997-2#1)(2010-3#1)
provides an important##3##3##(1995-6#1)(2008-9#1)(2009-12#1)
provides an introduction to##4##4##(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
provides an opportunity for##2##4##(1996-12#1)(2008-10#1)
provides an opportunity to##7##4##(1994-2#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-1#2)
provides an opportunity##10##3##(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2013-1#2)
provides an overview of the##19##5##(1993-3#3)(1994-1#1)(1994-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-4#2)(2009-1#1)(2010-6#1)(2011-3#1)(2012-3#2)(2013-1#2)
provides an overview of##32##4##(1992-1#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#1)(1997-1#1)(1997-2#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#6)(2009-1#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)
provides an##102##2##(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#4)(2007-11#1)(2008-1#2)(2008-10#19)(2008-11#7)(2008-12#3)(2008-3#2)(2008-4#9)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#1)(2009-12#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
provides background##4##2##(1991-12#1)(2008-9#1)(2012-12#1)(2012-2#1)
provides basic information##2##3##(2008-10#1)(2008-4#1)
provides basic##3##2##(2008-10#1)(2008-4#2)
provides better##3##2##(2007-8#1)(2012-3#1)(2013-8#1)
provides both##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
provides brief##2##2##(1993-12#1)(1996-12#1)
provides clear##2##2##(2008-9#1)(2013-8#1)
provides compelling##2##2##(1995-2#1)(2008-2#1)
provides considerable##2##2##(1995-1#1)(2008-10#1)
provides current##2##2##(2010-11#1)(2011-1#1)
provides data##2##2##(2008-9#1)(2011-2#1)
provides direct evidence##2##3##(2011-2#1)(2012-2#1)
provides evidence for the##2##4##(1994-8#1)(1996-5#1)
provides evidence for##8##3##(1990-11#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-5#1)(2009-5#1)(2013-1#1)(2013-8#1)
provides evidence of the##2##4##(2008-10#1)(2010-5#1)
provides evidence of##6##3##(1992-3#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)
provides evidence that##4##3##(2008-10#2)(2008-9#1)(2009-8#1)
provides evidence##18##2##(1990-11#1)(1992-3#1)(1994-8#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
provides examples of##2##3##(1997-3#1)(2008-11#1)
provides examples##3##2##(1993-12#1)(1997-3#1)(2008-11#1)
provides excellent##4##2##(2008-10#3)(2011-7#1)
provides for a##3##3##(1996-3#1)(2008-9#1)(2012-2#1)
provides for the##5##3##(1994-3#1)(1995-5#1)(2011-2#2)(2012-2#1)
provides for##11##2##(1994-3#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-9#3)(2011-2#2)(2012-2#2)
provides further evidence for the##2##5##(2008-10#2)
provides further evidence for##3##4##(2008-10#2)(2008-7#1)
provides further evidence that##3##4##(1994-2#1)(1994-8#1)(1995-12#1)
provides further evidence##6##3##(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-7#1)
provides further support for##2##4##(1990-11#1)(2008-10#1)
provides further##9##2##(1990-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#3)(2008-7#2)
provides good results##2##3##(2008-10#1)(2008-3#1)
provides good##7##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
provides guidance##2##2##(1993-1#1)(2008-9#1)
provides high##6##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)
provides higher##2##2##(2008-10#1)(2008-4#1)
provides information about the##5##4##(2008-10#3)(2008-5#1)(2011-2#1)
provides information about##6##3##(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
provides information concerning##2##3##(1994-5#1)(1997-6#1)
provides information on the##3##4##(1991-6#1)(1995-11#1)(2008-5#1)
provides information on##4##3##(1991-6#1)(1992-3#1)(1995-11#1)(2008-5#1)
provides information##18##2##(1990-8#1)(1991-6#1)(1992-3#1)(1994-5#1)(1995-11#2)(1997-6#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)
provides insight into the potential of##2##6##(2012-2#1)(2013-1#1)
provides insight into the##5##4##(1994-1#1)(2008-9#1)(2012-2#1)(2013-1#2)
provides insight into##7##3##(1994-1#1)(2008-10#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#2)
provides insight##8##2##(1994-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#2)
provides insights into the##2##4##(2008-4#1)(2010-11#1)
provides instructions for##2##3##(2008-4#2)
provides managers with##2##3##(1993-12#1)(2009-3#1)
provides methods for the##2##4##(2008-4#2)
provides molecular##2##2##(2008-10#1)(2011-2#1)
provides more##3##2##(1990-8#1)(2011-7#2)
provides new insights into the##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
provides new insights into##5##4##(2008-10#2)(2008-11#1)(2008-8#1)(2013-8#1)
provides new insights##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2013-8#1)
provides new##10##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
provides no##2##2##(1990-12#1)(2011-2#1)
provides novel##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
provides only##3##2##(2008-10#3)
provides protocols for##2##3##(2008-4#1)(2008-9#1)
provides quantitative information##2##3##(2008-10#2)
provides quantitative##4##2##(2008-10#3)(2008-7#1)
provides rapid##2##2##(2008-10#1)(2013-8#1)
provides resistance to##2##3##(2008-10#2)
provides results##2##2##(2008-10#1)(2008-11#1)
provides simultaneous##2##2##(2008-2#1)(2008-3#1)
provides some##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2012-2#1)
provides spatial##2##2##(2007-12#1)(2008-10#1)
provides statistically##2##2##(2008-10#1)(2011-2#1)
provides step-by-step##2##2##(1993-3#1)(2008-12#1)
provides strong evidence##2##3##(1995-12#1)(2012-3#1)
provides strong support##2##3##(2012-3#2)
provides strong##4##2##(1995-12#1)(2012-3#3)
provides the basis for##3##4##(2008-10#1)(2008-4#1)(2012-3#1)
provides the opportunity to##3##4##(1994-3#1)(2008-10#1)(2008-12#1)
provides the potential to##2##4##(1994-8#1)(2008-10#1)
provides the required##2##3##(2008-5#1)(2008-7#1)
provides the same##3##3##(2008-10#2)(2009-8#1)
provides the##46##2##(1992-3#1)(1994-12#1)(1994-3#2)(1994-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2011-8#1)(2012-3#3)(2013-8#1)
provides treatment##2##2##(2011-2#1)(2013-1#1)
provides us with a##2##4##(1992-1#1)(2008-6#1)
provides us with##3##3##(1992-1#1)(2008-6#1)(2012-12#1)
provides useful information and##2##4##(2008-4#1)(2009-12#1)
provides useful information##3##3##(2008-10#1)(2008-4#1)(2009-12#1)
provides useful##4##2##(2008-10#2)(2008-4#1)(2009-12#1)
provides valuable##4##2##(2007-12#1)(2008-4#1)(2010-11#1)(2013-1#1)
provides##752##1##(1990-11#3)(1990-12#2)(1990-5#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#7)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#1)(1994-1#4)(1994-12#6)(1994-2#5)(1994-3#7)(1994-5#1)(1994-6#2)(1994-8#3)(1995-1#3)(1995-11#3)(1995-12#9)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#4)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#4)(1996-3#3)(1996-5#5)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#5)(2008-10#161)(2008-11#38)(2008-12#23)(2008-2#8)(2008-3#21)(2008-4#43)(2008-5#10)(2008-6#2)(2008-7#19)(2008-8#12)(2008-9#51)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#5)(2009-3#3)(2009-5#4)(2009-6#3)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#9)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#33)(2011-3#2)(2011-7#5)(2011-8#1)(2012-12#8)(2012-2#24)(2012-3#14)(2013-1#24)(2013-7#1)(2013-8#16)
providing a major##2##3##(2008-10#2)
providing a mean level of disease reduction of##2##8##(2008-10#2)
providing a method##2##3##(1997-2#1)(2008-10#1)
providing a new##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
providing a possible##2##3##(1993-1#1)(2011-2#1)
providing a potential##3##3##(2008-10#3)
providing a ready source of##2##5##(2008-10#1)(2010-12#1)
providing a solid##2##3##(2008-9#1)(2012-2#1)
providing a suitable##2##3##(2008-10#2)
providing a##69##2##(1992-2#1)(1993-1#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#20)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#4)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
providing access to##2##3##(1994-2#1)(2008-8#1)
providing access##3##2##(1992-12#1)(1994-2#1)(2008-8#1)
providing additional##4##2##(2008-10#3)(2013-1#1)
providing adequate##2##2##(1991-2#1)(2012-12#1)
providing an estimate##2##3##(1996-3#1)(2008-11#1)
providing an overview of##2##4##(2008-4#1)(2011-2#1)
providing an##12##2##(1993-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
providing and##2##2##(1997-2#1)(2008-10#1)
providing appropriate##2##2##(1996-2#1)(2008-11#1)
providing better##4##2##(1991-2#1)(2008-11#2)(2008-7#1)
providing both##2##2##(2008-10#1)(2011-2#1)
providing care to a##2##4##(2009-5#1)(2010-9#1)
providing care to people with mental illness##2##7##(2011-1#2)
providing care to##7##3##(2008-6#1)(2009-5#2)(2010-4#1)(2010-9#1)(2011-1#2)
providing care##12##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#2)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#1)
providing evidence of##2##3##(1994-11#1)(2009-12#1)
providing evidence that the##3##4##(2008-10#2)(2013-8#1)
providing evidence that##5##3##(2008-10#3)(2008-11#1)(2013-8#1)
providing evidence##7##2##(1994-11#1)(2008-10#3)(2008-11#1)(2009-12#1)(2013-8#1)
providing examples of##2##3##(1996-3#1)(2013-8#1)
providing examples##3##2##(1996-3#1)(2010-7#1)(2013-8#1)
providing excellent##2##2##(1993-12#1)(2012-3#1)
providing further##3##2##(1993-6#1)(2008-11#2)
providing health##3##2##(1996-12#1)(2011-2#2)
providing high##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)
providing home##2##2##(1991-1#1)(1995-3#1)
providing information on the##3##4##(1997-3#1)(2008-10#1)(2013-1#1)
providing information on##5##3##(1994-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2013-1#1)
providing information##8##2##(1994-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-5#1)(2013-1#1)
providing more##3##2##(2010-10#1)(2011-1#1)(2012-3#1)
providing new##5##2##(2008-5#1)(2009-12#1)(2010-7#1)(2011-3#1)(2013-8#1)
providing no##2##2##(2008-10#1)(2008-8#1)
providing optimal##3##2##(1995-5#1)(2008-11#1)(2008-9#1)
providing responses##2##2##(2008-1#1)(2010-11#1)
providing some##3##2##(2008-6#1)(2010-1#1)(2011-3#1)
providing spiritual care##4##3##(2009-11#1)(2011-1#3)
providing such##2##2##(1994-12#1)(1997-3#1)
providing support for##2##3##(2012-12#1)(2012-3#1)
providing support##3##2##(2008-11#1)(2012-12#1)(2012-3#1)
providing the appropriate##2##3##(2010-7#1)(2013-8#1)
providing the best##2##3##(2008-10#2)
providing the necessary##2##3##(2010-12#1)(2012-12#1)
providing the##23##2##(1994-3#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
providing timely##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
providing##320##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#3)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-9#2)(1995-1#5)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#5)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#3)(2008-1#3)(2008-10#60)(2008-11#36)(2008-12#9)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#6)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#13)(2011-3#2)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#9)
province in##2##2##(2009-6#1)(2013-1#1)
province of##15##2##(1993-2#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2012-12#1)
province##35##1##(1992-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
province-wide##2##1##(1991-2#1)(1994-1#1)
province]##2##1##(2013-8#2)
provinces in##4##2##(2008-10#2)(2008-9#1)(2013-8#1)
provinces of##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
provinces##27##1##(1992-12#1)(1993-3#2)(1994-2#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-8#1)(2008-9#2)(2013-8#1)
provincial and##2##2##(1997-5#1)(2009-5#1)
provincial##18##1##(1991-1#1)(1991-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#5)(2008-7#1)(2009-3#2)(2009-5#1)
provincially##2##1##(2008-10#1)(2008-12#1)
proving the##4##2##(1991-3#1)(2008-10#2)(2008-12#1)
proving to be##2##3##(2008-10#1)(2008-8#1)
proving##9##1##(1991-3#1)(1994-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)
proviral DNA##3##2##(1997-3#1)(2008-5#1)(2008-9#1)
proviral cell line##2##3##(2008-9#2)
proviral##6##1##(1994-12#1)(1997-3#1)(2008-5#1)(2008-9#3)
provirus##3##1##(2008-11#1)(2008-5#1)(2008-9#1)
provision and##2##2##(1996-2#1)(2012-3#1)
provision during##2##2##(1996-5#1)(2013-8#1)
provision for##7##2##(1994-1#2)(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)
provision in##2##2##(1995-11#1)(2008-11#1)
provision of adequate##2##3##(2008-11#1)(2008-5#1)
provision of care##2##3##(1997-8#1)(2011-1#1)
provision of health##2##3##(1996-3#1)(1997-5#1)
provision of safe and##2##4##(2008-12#1)(2010-10#1)
provision of services##2##3##(1992-12#1)(1996-3#1)
provision of the##2##3##(1995-12#1)(2012-3#1)
provision of this##2##3##(2008-12#1)(2013-1#1)
provision of##53##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#4)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
provision##90##1##(1991-1#1)(1991-12#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-3#1)(1994-1#4)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#3)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#12)(2008-12#7)(2008-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#6)
provisional##4##1##(1995-3#1)(2008-10#1)(2013-1#2)
provisionally##3##1##(1994-6#1)(2008-10#2)
provisioning##2##1##(2008-9#2)
provisions for##2##2##(1994-1#1)(1995-1#1)
provisions of the##3##3##(1991-1#1)(1992-1#1)(2010-5#1)
provisions of##4##2##(1991-1#1)(1992-1#1)(1996-1#1)(2010-5#1)
provisions##20##1##(1991-1#1)(1991-12#1)(1991-3#3)(1992-1#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-1#3)(1995-2#1)(1996-1#1)(1997-1#1)(1997-8#1)(2008-11#2)(2010-5#1)(2012-3#1)
provocation test##2##2##(2010-6#2)
provocation##8##1##(1996-1#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-12#1)(2009-11#1)(2010-6#2)
provocative##5##1##(1996-3#1)(1997-1#1)(1997-6#1)(2012-3#1)(2013-1#1)
provoke##4##1##(1991-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
provoked a##3##2##(1994-8#1)(2008-6#1)(2011-2#1)
provoked by##3##2##(2008-10#2)(2012-2#1)
provoked##14##1##(1991-2#1)(1992-1#1)(1994-8#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
provokes##3##1##(2009-10#1)(2009-7#1)(2009-8#1)
provoking and##2##2##(2008-11#1)(2008-7#1)
provoking##5##1##(1997-5#1)(2008-11#2)(2008-7#1)(2013-1#1)
proxies##2##1##(1992-1#1)(1992-12#1)
proximal VS cells and##2##4##(2008-11#2)
proximal VS cells##3##3##(2008-11#3)
proximal and distal##8##3##(1993-1#2)(1997-8#1)(2007-12#2)(2008-7#1)(2012-3#1)(2013-1#1)
proximal and##10##2##(1993-1#2)(1997-8#1)(2007-12#2)(2008-11#2)(2008-7#1)(2012-3#1)(2013-1#1)
proximal bond##2##2##(1994-5#2)
proximal colon##2##2##(1997-4#1)(2008-12#1)
proximal contact##2##2##(1990-9#1)(2010-12#1)
proximal cortical##2##2##(2013-8#2)
proximal end##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
proximal femoral##2##2##(2013-1#1)(2013-7#1)
proximal heme##2##2##(1990-8#1)(1991-9#1)
proximal humeral plate can provide##2##5##(2013-1#2)
proximal humeral plate##3##3##(2013-1#3)
proximal humeral##4##2##(2009-3#1)(2013-1#3)
proximal humerus of a dog##2##5##(2012-3#2)
proximal humerus of##3##3##(1996-11#1)(2012-3#2)
proximal humerus##4##2##(1996-11#1)(2009-4#1)(2012-3#2)
proximal interphalangeal##4##2##(2008-9#2)(2011-2#1)(2012-3#1)
proximal ligand of sperm whale##2##5##(1994-5#2)
proximal ligand##4##2##(1994-5#4)
proximal obstruction##2##2##(1993-1#1)(1997-8#1)
proximal occlusion##2##2##(1997-3#2)
proximal patency##2##2##(1993-1#2)
proximal phalanx##2##2##(2010-3#1)(2012-2#1)
proximal region of the##2##4##(1994-11#1)(2008-10#1)
proximal to the##8##3##(1990-8#1)(1993-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
proximal to##11##2##(1990-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
proximal tubular epithelium##2##3##(1994-5#2)
proximal tubular##9##2##(1993-3#1)(1994-5#4)(1995-11#2)(2007-12#1)(2011-2#1)
proximal tubule##6##2##(1991-5#1)(1997-1#1)(2008-11#2)(2008-12#1)(2013-8#1)
proximal tubules##4##2##(1997-1#4)
proximal##152##1##(1990-8#2)(1990-9#2)(1991-5#2)(1991-7#1)(1991-9#1)(1993-1#8)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#3)(1994-11#2)(1994-3#1)(1994-5#12)(1995-11#2)(1995-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#3)(1997-9#1)(2007-12#7)(2008-1#1)(2008-10#7)(2008-11#9)(2008-12#5)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-3#4)(2009-4#2)(2010-12#4)(2010-3#1)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#9)(2013-3#1)(2013-7#1)(2013-8#7)
proximal-to-distal##3##1##(2011-2#3)
proximally##4##1##(1997-3#1)(1997-8#1)(2008-10#1)(2009-4#1)
proximate##9##1##(1991-5#2)(2008-8#2)(2008-9#1)(2010-11#2)(2011-2#1)(2013-1#1)
proximities of##2##2##(1995-6#1)(2012-3#1)
proximities##3##1##(1995-6#1)(2008-5#1)(2012-3#1)
proximity assay##4##2##(2008-11#1)(2008-4#2)(2013-1#1)
proximity in##2##2##(2008-9#2)
proximity of the##3##3##(1994-5#1)(2008-11#1)(2011-2#1)
proximity of##7##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
proximity patterns##5##2##(2008-10#5)
proximity to the##4##3##(1993-6#1)(1994-5#1)(1997-5#1)(2008-10#1)
proximity to##11##2##(1993-6#1)(1994-5#1)(1997-5#1)(2008-10#5)(2009-12#1)(2010-6#1)(2012-3#1)
proximity was##2##2##(2008-7#1)(2008-9#1)
proximity##49##1##(1993-6#1)(1994-5#2)(1995-2#1)(1997-5#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-4#4)(2008-7#3)(2008-9#7)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#2)
proxy for##4##2##(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
proxy##11##1##(1993-3#1)(1994-12#1)(1995-5#2)(1996-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
prudent exploitation##2##2##(2008-8#2)
prudent to##3##2##(1991-12#1)(1997-3#1)(2013-1#1)
prudent##10##1##(1991-12#2)(1997-3#2)(2008-11#1)(2008-8#3)(2012-2#1)(2013-1#1)
prune (Prunus##2##2##(2008-10#2)
prune orchards##3##2##(2008-10#3)
prune##8##1##(2008-10#8)
pruni##4##1##(2008-10#4)
pruning##3##1##(2008-10#3)
pruritic##6##1##(2010-6#5)(2012-3#1)
pruritis##2##1##(2010-1#1)(2013-1#1)
pruritus##5##1##(1991-2#1)(1993-3#1)(2008-5#1)(2008-8#1)(2010-6#1)
ps and##2##2##(2008-2#1)(2008-8#1)
ps##14##1##(1996-2#1)(2007-12#2)(2008-2#2)(2008-3#5)(2008-8#4)
psbA-trnH intergenic##2##2##(2011-2#2)
psbA-trnH sequences##2##2##(2011-2#2)
psbA-trnH##6##1##(2011-2#6)
pseudarthrosis##2##1##(2009-3#1)(2012-2#1)
pseudo first-order kinetics##2##3##(2008-10#1)(2008-11#1)
pseudo first-order##3##2##(2008-10#2)(2008-11#1)
pseudo##7##1##(2008-10#5)(2008-11#1)(2008-9#1)
pseudo-digestion of##3##2##(2008-10#3)
pseudo-digestion were as follows##2##4##(2008-10#2)
pseudo-digestion##9##1##(2008-10#9)
pseudo-first order##4##2##(2008-10#4)
pseudo-first-order##3##1##(1993-8#1)(1994-8#1)(2008-10#1)
pseudo-pneumatosis##2##1##(2012-2#2)
pseudo-steady state##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
pseudo-syringae##2##1##(2008-10#2)
pseudoaneurysm of the MMA##2##4##(2008-12#2)
pseudoaneurysm of the##3##3##(2008-12#3)
pseudoaneurysm##13##1##(1991-3#1)(2008-12#6)(2008-7#2)(2012-2#4)
pseudoaneurysms##3##1##(2008-12#2)(2012-2#1)
pseudoarthroses##2##1##(2009-3#2)
pseudoarthrosis##3##1##(1997-6#1)(2009-3#2)
pseudobactin production##3##2##(2008-10#3)
pseudobactin##5##1##(2008-10#5)
pseudocyst of the##3##3##(1991-6#2)(2011-2#1)
pseudocyst##8##1##(1990-12#1)(1991-6#2)(2009-2#1)(2011-2#4)
pseudodipeptides##3##1##(2008-5#3)
pseudoephedrine##6##1##(2008-10#6)
pseudoexfoliation glaucoma##3##2##(2011-2#3)
pseudoexfoliation##4##1##(2011-2#4)
pseudoexfoliative glaucoma in Primorsko-Goranska County##2##5##(2011-2#2)
pseudoexfoliative glaucoma##6##2##(2011-2#6)
pseudogene from Bos taurus##2##4##(1993-2#2)
pseudogene is##3##2##(1993-12#1)(1993-2#1)(1994-11#1)
pseudogene was##2##2##(1990-8#1)(1994-11#1)
pseudogene##25##1##(1990-8#5)(1991-6#2)(1993-12#5)(1993-2#5)(1993-6#4)(1994-11#2)(2008-10#1)(2008-11#1)
pseudogenes##6##1##(1990-8#3)(1993-2#1)(1993-8#1)(2009-10#1)
pseudoknot##2##1##(2008-10#2)
pseudomonad##9##1##(2008-10#9)
pseudomonad-based##2##1##(2008-10#2)
pseudomonads and xanthomonads##2##3##(2008-10#2)
pseudomonads and##3##2##(2008-10#3)
pseudomonads in##4##2##(2008-10#4)
pseudomonads##22##1##(2008-10#22)
pseudonygamai##3##1##(2008-10#3)
pseudophakic##6##1##(1991-2#1)(2011-2#4)(2013-1#1)
pseudophases##2##1##(1990-5#1)(2008-10#1)
pseudopregnancy##2##1##(1992-9#2)
pseudopregnant rat##2##2##(2008-8#1)(2008-9#1)
pseudopregnant##3##1##(2008-8#2)(2008-9#1)
pseudopseudohypoparathyroidism##2##1##(2010-6#2)
pseudorecombinant##2##1##(2008-10#2)
pseudorecombinants##2##1##(2008-10#2)
pseudosarcomatous polyp##2##2##(2008-11#2)
pseudosarcomatous##3##1##(2008-11#3)
pseudosclerotia and##2##2##(2008-10#2)
pseudosclerotia or##2##2##(2008-10#2)
pseudosclerotia##12##1##(2008-10#12)
pseudostationary phase##2##2##(2008-10#2)
pseudostationary##3##1##(2008-10#3)
pseudosyringae##4##1##(2008-10#4)
pseudothecia and ascospores##5##3##(2008-10#5)
pseudothecia and pycnidia##2##3##(2008-10#2)
pseudothecia and##9##2##(2008-10#9)
pseudothecia formed##3##2##(2008-10#3)
pseudothecia matured##2##2##(2008-10#2)
pseudothecia maturity##6##2##(2008-10#6)
pseudothecia were##3##2##(2008-10#3)
pseudothecia##38##1##(2008-10#38)
pseudothecial density and##2##3##(2008-10#2)
pseudothecial initials##2##2##(2008-10#2)
pseudothecial##6##1##(2008-10#6)
pseudothecium##6##1##(2008-10#6)
pseudotumor of the##3##3##(2008-12#2)(2010-12#1)
pseudotumor##9##1##(1991-9#1)(2007-8#2)(2008-12#2)(2009-3#1)(2010-12#3)
pseudotumour of the lung##4##4##(2008-7#1)(2013-1#3)
pseudotumour of the##5##3##(2008-7#1)(2012-12#1)(2013-1#3)
pseudotumour syndrome##2##2##(2008-7#2)
pseudotumour##8##1##(2008-7#4)(2012-12#1)(2013-1#3)
pseudotumoural lesions##2##2##(2012-2#2)
pseudotumoural##4##1##(2010-10#1)(2012-2#3)
pseudotype##2##1##(1990-5#2)
pseudouridine and 1-methyladenosine##5##3##(1992-3#5)
pseudouridine##8##1##(1992-3#5)(1993-8#1)(1997-2#2)
pseudowords##4##1##(1990-8#2)(2010-7#1)(2013-8#1)
psi##10##1##(1992-8#1)(1993-2#3)(1993-8#2)(1994-2#1)(2008-10#2)(2008-3#1)
psilocin and psilocybin##4##3##(2008-10#4)
psilocin##5##1##(2008-10#5)
psilocybin##17##1##(2008-10#4)(2013-8#13)
psittaci##5##1##(1990-5#1)(1992-5#1)(1993-9#2)(2013-1#1)
psittacine circovirus (PsCV)##2##3##(2008-5#2)
psittacine##5##1##(2008-5#5)
psittacines##2##1##(1992-2#2)
psoas hitch procedure##2##3##(2008-10#2)
psoas hitch##3##2##(2008-10#3)
psoas major muscle##3##3##(2011-2#3)
psoas muscle##4##2##(1995-2#1)(2008-10#1)(2009-2#1)(2009-4#1)
psoas##18##1##(1991-3#1)(1995-2#1)(1996-11#1)(1996-6#1)(2008-10#5)(2009-2#1)(2009-4#5)(2011-2#3)
psoralen was##2##2##(2008-11#2)
psoralen##7##1##(2008-11#7)
psoriasis and##4##2##(2008-6#1)(2013-1#3)
psoriasis in##3##2##(1997-8#1)(2008-6#1)(2011-2#1)
psoriasis that##2##2##(1997-8#1)(2008-6#1)
psoriasis##28##1##(1993-11#4)(1997-8#3)(2007-11#6)(2008-6#8)(2011-2#2)(2013-1#5)
psychiatric adverse##2##2##(2009-7#2)
psychiatric and neurological##2##3##(1993-1#1)(2011-2#1)
psychiatric and##8##2##(1991-2#1)(1993-1#3)(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#1)
psychiatric assessment##2##2##(2010-12#2)
psychiatric care##3##2##(1990-6#1)(1992-3#1)(1993-12#1)
psychiatric comorbidities##2##2##(2009-4#1)(2013-1#1)
psychiatric comorbidity##4##2##(1991-1#1)(2008-4#1)(2008-6#1)(2013-1#1)
psychiatric condition##2##2##(2008-4#2)
psychiatric conditions##2##2##(2008-7#1)(2012-3#1)
psychiatric diagnoses##2##2##(2012-2#1)(2013-1#1)
psychiatric diseases##3##2##(1996-12#1)(2013-1#1)(2013-8#1)
psychiatric disorder##2##2##(2008-12#1)(2008-4#1)
psychiatric disorders##18##2##(1991-1#1)(1996-11#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2009-11#1)(2009-8#1)(2010-7#1)(2012-2#4)(2013-1#2)
psychiatric facilities##4##2##(1991-2#1)(1993-2#1)(1996-1#1)(1997-5#1)
psychiatric facility##2##2##(1991-2#1)(1993-2#1)
psychiatric hospital##16##2##(1991-12#1)(1991-2#3)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#5)(2008-11#1)(2010-6#1)(2011-2#1)
psychiatric hospitalization on##2##3##(1991-2#1)(1993-1#1)
psychiatric hospitalization##5##2##(1991-2#2)(1993-1#1)(1995-1#1)(2012-3#1)
psychiatric hospitals is##2##3##(1991-12#1)(1993-2#1)
psychiatric hospitals##10##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#3)(1993-2#1)
psychiatric illness##2##2##(1993-12#1)(2008-4#1)
psychiatric illnesses##2##2##(2008-11#1)(2008-4#1)
psychiatric inpatient##3##2##(1991-2#1)(1992-3#1)(1993-2#1)
psychiatric inpatients##3##2##(1993-2#1)(2008-11#1)(2013-1#1)
psychiatric intervention##2##2##(1992-1#1)(1996-1#1)
psychiatric mental health##2##3##(2008-12#2)
psychiatric morbidity##5##2##(1993-2#1)(1993-5#1)(2008-11#1)(2012-3#2)
psychiatric nurse##2##2##(2008-11#2)
psychiatric nurses'##3##2##(2008-11#2)(2008-12#1)
psychiatric nursing students##4##3##(2008-11#3)(2008-12#1)
psychiatric nursing##7##2##(2008-11#6)(2008-12#1)
psychiatric or medical##2##3##(2009-4#1)(2009-9#1)
psychiatric patients##9##2##(1992-1#1)(1992-3#1)(1993-12#2)(2008-10#1)(2008-4#2)(2009-9#1)(2013-1#1)
psychiatric practice##2##2##(1991-3#1)(1992-1#1)
psychiatric presentation of##2##3##(2008-11#1)(2010-3#1)
psychiatric services##3##2##(1991-1#1)(1991-3#1)(1991-6#1)
psychiatric setting##3##2##(1992-2#2)(2009-6#1)
psychiatric subjects##2##2##(2009-4#2)
psychiatric symptoms##7##2##(2009-5#2)(2009-9#2)(2013-8#3)
psychiatric treatment are##2##3##(1992-2#1)(1993-2#1)
psychiatric treatment##10##2##(1991-2#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-2#1)(2008-11#1)(2009-7#1)(2010-11#1)(2013-1#1)
psychiatric unit##2##2##(1993-1#1)(1995-1#1)
psychiatric ward##3##2##(1993-2#1)(2011-2#1)(2012-3#1)
psychiatric##231##1##(1990-6#1)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#17)(1991-3#3)(1991-6#1)(1992-1#4)(1992-2#9)(1992-3#9)(1993-1#9)(1993-12#7)(1993-2#14)(1993-3#2)(1993-5#1)(1993-6#1)(1994-6#1)(1995-1#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-3#1)(1997-5#2)(1997-8#3)(2008-10#2)(2008-11#20)(2008-12#7)(2008-2#1)(2008-4#13)(2008-6#4)(2008-7#1)(2009-10#2)(2009-11#1)(2009-4#4)(2009-5#2)(2009-6#5)(2009-7#7)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2011-4#2)(2012-2#6)(2012-3#5)(2013-1#14)(2013-8#5)
psychiatrically##3##1##(1993-3#1)(1995-1#1)(1995-8#1)
psychiatrist##3##1##(1996-11#1)(2009-9#1)(2013-1#1)
psychiatrists and psychologists##3##3##(2008-12#2)(2010-12#1)
psychiatrists and##6##2##(1995-11#1)(2008-12#2)(2008-4#1)(2010-12#1)(2012-3#1)
psychiatrists##14##1##(1993-6#1)(1995-11#1)(1996-1#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#2)
psychiatry and##6##2##(1991-3#1)(1996-1#1)(2008-4#1)(2009-9#1)(2011-2#1)(2011-3#1)
psychiatry##32##1##(1991-12#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-2#2)(1996-1#1)(1996-6#1)(1997-8#1)(2008-11#5)(2008-4#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#7)(2011-3#2)(2013-8#2)
psychiatry]##3##1##(2009-10#1)(2011-3#1)(2013-8#1)
psychic##3##1##(1993-11#1)(1995-5#1)(2008-7#1)
psycho-educational##2##1##(2010-7#2)
psycho-physical##2##1##(1992-11#1)(2010-6#1)
psychoactive drugs##3##2##(1994-2#1)(2008-1#2)
psychoanalytic##3##1##(2008-4#2)(2009-10#1)
psychoanalytical##4##1##(1991-2#2)(2008-12#1)(2010-6#1)
psychodynamic##3##1##(1993-1#1)(2008-11#1)(2008-4#1)
psychoeducational interventions##2##2##(2009-11#2)
psychoeducational##3##1##(2008-8#1)(2009-11#2)
psychogenic and neurogenic stressors##2##4##(2008-11#2)
psychogenic##6##1##(1994-9#1)(2008-11#4)(2010-11#1)
psychologic##3##1##(2008-10#1)(2008-11#1)(2009-11#1)
psychological adjustment and##2##3##(2009-11#1)(2010-2#1)
psychological adjustment of##2##3##(2010-2#1)(2012-3#1)
psychological adjustment##8##2##(1996-3#1)(2009-11#2)(2009-7#1)(2010-2#3)(2012-3#1)
psychological and social##2##3##(1995-1#1)(2008-7#1)
psychological and##12##2##(1995-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-11#1)(2010-1#2)(2010-4#1)(2013-1#1)
psychological aspects of##3##3##(2008-12#1)(2008-4#1)(2010-11#1)
psychological aspects##4##2##(2008-12#2)(2008-4#1)(2010-11#1)
psychological condition##2##2##(1994-12#2)
psychological descriptors##2##2##(2008-5#2)
psychological development##2##2##(2011-2#2)
psychological distress and##2##3##(2009-12#1)(2012-3#1)
psychological distress##11##2##(2008-7#1)(2008-9#1)(2009-12#2)(2010-6#3)(2011-2#1)(2012-3#3)
psychological effects##2##2##(1996-3#1)(2008-11#1)
psychological functioning##2##2##(2008-12#2)
psychological impact of##2##3##(2008-4#1)(2008-5#1)
psychological impact##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
psychological methods##2##2##(1992-12#1)(2008-11#1)
psychological processes##2##2##(2008-11#2)
psychological states##2##2##(2008-11#1)(2010-6#1)
psychological stress##4##2##(2008-11#1)(2008-6#2)(2011-2#1)
psychological stressors (adjusted OR 1##2##5##(2008-10#2)
psychological stressors##3##2##(2008-10#3)
psychological symptoms##3##2##(2008-4#2)(2010-6#1)
psychological well-being of##2##3##(2008-11#2)
psychological well-being##18##2##(1992-2#1)(1996-11#1)(2008-11#3)(2009-7#1)(2010-2#1)(2012-2#6)(2013-1#5)
psychological##162##1##(1990-6#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-6#2)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#1)(2008-1#1)(2008-10#11)(2008-11#15)(2008-12#12)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-7#3)(2009-9#1)(2010-1#2)(2010-11#5)(2010-12#1)(2010-2#5)(2010-4#2)(2010-6#7)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#10)(2012-3#4)(2012-5#1)(2013-1#6)(2013-8#3)
psychologically##5##1##(1993-11#1)(1995-1#1)(1995-9#1)(2008-11#1)(2008-12#1)
psychologist training program##2##3##(2012-2#2)
psychologist##6##1##(1994-12#1)(2008-11#1)(2012-2#2)(2013-1#2)
psychologists of##2##2##(2008-12#1)(2008-5#1)
psychologists##9##1##(1990-6#1)(1995-11#1)(2008-12#2)(2008-5#1)(2009-10#1)(2009-12#1)(2010-12#1)(2013-8#1)
psychology and religion##2##3##(2008-12#2)
psychology and##9##2##(1990-8#1)(1993-3#1)(1994-2#1)(2008-11#1)(2008-12#2)(2009-12#1)(2010-12#1)(2011-2#1)
psychology as a##2##3##(2008-11#1)(2008-5#1)
psychology##29##1##(1990-2#1)(1990-8#1)(1993-2#1)(1993-3#1)(1994-12#4)(1994-2#1)(1996-6#1)(2008-11#2)(2008-12#7)(2008-5#1)(2009-12#2)(2010-12#2)(2010-6#3)(2011-2#1)(2012-3#1)
psychometric analysis##2##2##(2008-7#1)(2011-2#1)
psychometric properties and##2##3##(2010-10#1)(2013-1#1)
psychometric properties of the instrument##2##5##(2008-1#1)(2008-11#1)
psychometric properties of the##7##4##(2008-1#1)(2008-11#2)(2010-11#1)(2011-2#2)(2013-1#1)
psychometric properties of##11##3##(2008-1#1)(2008-11#3)(2010-11#2)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
psychometric properties##17##2##(2008-1#1)(2008-11#3)(2009-11#1)(2010-10#1)(2010-11#3)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
psychometric##32##1##(1995-3#1)(1997-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-7#3)(2009-11#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-7#2)(2010-9#1)(2011-2#4)(2012-2#1)(2013-1#4)(2013-8#1)
psychometrically sound##3##2##(2010-11#1)(2011-8#1)(2012-2#1)
psychometrically##4##1##(2010-11#1)(2011-8#1)(2012-2#1)(2012-3#1)
psychomotor development##2##2##(1994-6#2)
psychomotor##6##1##(1993-6#1)(1994-6#2)(2008-11#1)(2011-2#1)(2013-8#1)
psychoorganic##2##1##(2011-2#2)
psychopathological features##2##2##(2010-11#1)(2012-5#1)
psychopathological##6##1##(2009-10#2)(2010-11#1)(2010-6#1)(2011-2#1)(2012-5#1)
psychopathology##14##1##(1991-1#1)(1995-5#1)(2008-11#3)(2009-11#3)(2012-5#3)(2013-8#3)
psychopharmacologic##5##1##(2008-4#5)
psychopharmacology##4##1##(2008-11#1)(2008-4#3)
psychophysical##15##1##(1990-5#1)(1991-2#1)(2008-10#2)(2008-11#3)(2008-9#4)(2009-8#2)(2011-2#1)(2013-8#1)
psychophysiological##6##1##(1992-12#3)(2008-11#1)(2008-5#2)
psychosis in##3##2##(1993-1#1)(2008-11#1)(2008-7#1)
psychosis##17##1##(1992-12#1)(1993-1#1)(1997-2#1)(2008-11#2)(2008-7#1)(2009-9#1)(2011-1#5)(2011-2#4)(2012-3#1)
psychosis&quot##4##1##(2011-2#1)(2013-8#3)
psychosocial and economic##2##3##(2012-2#1)(2013-1#1)
psychosocial and spiritual distress##2##4##(2013-8#2)
psychosocial and spiritual suffering##2##4##(2013-8#2)
psychosocial and spiritual##4##3##(2013-8#4)
psychosocial and##9##2##(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#5)
psychosocial aspects of##2##3##(1992-3#1)(2008-1#1)
psychosocial factors##5##2##(1994-6#1)(2008-2#3)(2010-2#1)
psychosocial impact##2##2##(2008-11#2)
psychosocial interventions##5##2##(1995-1#1)(2008-4#2)(2009-6#1)(2013-1#1)
psychosocial model##2##2##(1991-1#1)(1994-3#1)
psychosocial needs of##3##3##(1991-2#1)(2008-4#1)(2008-9#1)
psychosocial responses of school-age children to hospitalization##2##7##(1991-2#2)
psychosocial services##2##2##(1994-1#2)
psychosocial support##2##2##(1992-3#2)
psychosocial treatments##5##2##(1993-2#1)(2008-4#2)(2008-6#1)(2009-7#1)
psychosocial##72##1##(1990-6#1)(1991-1#1)(1991-2#3)(1992-3#5)(1993-2#1)(1994-1#2)(1994-3#1)(1994-6#1)(1995-1#1)(1997-2#1)(2008-1#3)(2008-10#3)(2008-11#9)(2008-2#3)(2008-4#6)(2008-6#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#6)
psychosocially##3##1##(2010-11#2)(2010-4#1)
psychosomatic##4##1##(1990-2#1)(2008-4#1)(2010-6#1)(2012-2#1)
psychostimulant##3##1##(1994-2#1)(1996-12#1)(2009-7#1)
psychotherapeutic##7##1##(2008-12#1)(2009-10#1)(2010-9#1)(2012-3#1)(2013-1#3)
psychotherapists##2##1##(2010-9#1)(2012-2#1)
psychotherapy for##2##2##(1991-1#1)(2008-4#1)
psychotherapy research##2##2##(2013-1#2)
psychotherapy##17##1##(1991-1#1)(1991-2#1)(1993-1#1)(2008-10#1)(2008-4#3)(2010-1#1)(2010-4#1)(2013-1#8)
psychotic disorder##4##2##(2008-4#2)(2011-2#2)
psychotic disorders##4##2##(1995-1#1)(2008-11#1)(2008-4#1)(2009-12#1)
psychotic patients##4##2##(1995-5#1)(2011-2#3)
psychotic symptoms##5##2##(2008-4#3)(2008-7#1)(2009-12#1)
psychotic##20##1##(1995-1#1)(1995-5#1)(2008-11#1)(2008-4#6)(2008-7#1)(2009-12#2)(2009-7#1)(2011-10#1)(2011-2#6)
psychotropes##2##1##(2013-1#2)
psychotropic drugs##4##2##(1995-2#1)(1996-9#1)(2008-11#1)(2009-3#1)
psychotropic effects of##2##3##(2008-10#1)(2008-4#1)
psychotropic medication##2##2##(2008-8#1)(2012-3#1)
psychotropic##12##1##(1995-2#1)(1996-11#1)(1996-9#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
psychrophilic##2##1##(2008-10#1)(2011-2#1)
psychrophilum and F##2##3##(2008-9#2)
psychrophilum and##3##2##(2008-9#3)
psychrotrophic##4##1##(2011-2#4)
psylla were##3##2##(2008-10#3)
psylla##11##1##(2008-10#11)
psyllium##3##1##(1993-11#3)
pterional##2##1##(2011-2#2)
pterostilbene##3##1##(2008-10#3)
pthN##3##1##(2008-10#3)
ptosis##3##1##(1992-9#1)(2008-7#1)(2008-9#1)
ptpf##2##1##(1997-7#2)
pts##4##1##(1996-3#1)(2010-12#3)
pts) and##2##2##(2008-7#1)(2010-12#1)
pts)##4##1##(2008-7#1)(2010-12#3)
pu##2##1##(2013-1#2)
pu-erh and black teas##2##4##(2008-10#2)
pu-erh##4##1##(2008-10#4)
pubertal##7##1##(2011-1#7)
puberty and##4##2##(1991-2#1)(1995-12#1)(2008-4#1)(2008-5#1)
puberty##26##1##(1990-5#2)(1991-2#2)(1995-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2009-6#4)(2010-4#2)(2011-1#5)(2012-2#1)(2012-3#1)(2013-8#1)
pubescens##4##1##(2008-10#1)(2008-11#1)(2012-6#2)
pubic symphysis##2##2##(2011-1#1)(2012-12#1)
pubic##3##1##(2008-4#1)(2011-1#1)(2012-12#1)
pubis##5##1##(1994-3#1)(2008-5#2)(2012-12#2)
public acceptance##2##2##(1996-12#1)(1996-3#1)
public and private health##2##4##(1993-3#1)(1996-3#1)
public and private##12##3##(1993-3#1)(1994-12#1)(1996-2#2)(1996-3#1)(1997-3#3)(1997-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
public and##24##2##(1993-1#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-3#3)(1997-6#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
public attitudes toward##2##3##(2008-11#1)(2010-12#1)
public awareness##3##2##(1992-1#1)(1994-1#1)(2008-10#1)
public concern##2##2##(2008-10#2)
public databases indicated that the sequences of##2##7##(1995-8#1)(1996-2#1)
public debate on##2##3##(1993-6#1)(2010-11#1)
public debate##3##2##(1993-6#1)(2008-11#1)(2010-11#1)
public disclosure##2##2##(2009-4#2)
public domain##5##2##(1996-1#1)(2008-4#2)(2009-12#1)(2013-1#1)
public expenditures##4##2##(1993-6#1)(1994-2#3)
public funding##2##2##(1991-12#1)(1996-1#1)
public health activities##3##3##(1992-1#2)(2008-11#1)
public health agencies to##2##4##(1995-12#2)
public health agencies##14##3##(1995-12#5)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)
public health agenda##2##3##(1997-1#2)
public health and##15##3##(1994-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
public health authorities##2##3##(1997-3#1)(2010-5#1)
public health burden##2##3##(2010-12#1)(2010-3#1)
public health care##5##3##(1991-3#1)(1994-9#2)(1997-4#1)(2011-1#1)
public health concern##4##3##(2008-11#2)(2012-3#1)(2013-1#1)
public health concerns with##2##4##(1995-12#1)(2012-2#1)
public health concerns##3##3##(1995-12#1)(2012-2#1)(2013-8#1)
public health core functions##2##4##(1995-12#1)(1996-3#1)
public health decision making##3##4##(1996-2#2)(1997-3#1)
public health decision##4##3##(1996-2#3)(1997-3#1)
public health departments##3##3##(1996-12#1)(1996-2#1)(1997-1#1)
public health education##2##3##(1996-1#1)(1997-3#1)
public health efforts##2##3##(1996-2#1)(2012-2#1)
public health functions##6##3##(1995-12#2)(1996-2#3)(1996-3#1)
public health goals##2##3##(1996-2#2)
public health has##2##3##(1996-3#2)
public health impact of##3##4##(1991-3#2)(1997-3#1)
public health impact##5##3##(1991-3#3)(1993-12#1)(1997-3#1)
public health implications of##2##4##(2011-2#1)(2013-1#1)
public health implications##6##3##(1996-1#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
public health importance##5##3##(1997-3#1)(2008-7#1)(2009-5#1)(2010-1#1)(2011-2#1)
public health in##3##3##(1996-2#1)(1996-3#1)(1997-3#1)
public health information and##3##4##(1995-12#1)(1997-2#1)(1997-3#1)
public health information systems##5##4##(1996-3#1)(1997-3#4)
public health information##14##3##(1995-12#3)(1996-3#1)(1997-2#2)(1997-3#7)(2013-1#1)
public health infrastructure##2##3##(1995-12#1)(1997-1#1)
public health initiatives##4##3##(1995-12#1)(1996-3#3)
public health insurance##5##3##(1995-3#1)(2008-7#2)(2013-1#2)
public health is to##2##4##(1996-3#1)(1997-1#1)
public health is##5##3##(1996-3#1)(1997-1#1)(2010-8#1)(2012-12#1)(2013-1#1)
public health issue##3##3##(1991-6#1)(1996-1#1)(2010-7#1)
public health issues##5##3##(1993-2#1)(1995-5#1)(1996-2#1)(2009-12#1)(2012-2#1)
public health measures##4##3##(1997-3#1)(2008-9#1)(2010-1#1)(2011-2#1)
public health needs##2##3##(1996-3#1)(1997-3#1)
public health nurses and##4##4##(2010-9#4)
public health nurses##8##3##(1995-3#1)(1996-2#2)(2010-9#5)
public health nursing##5##3##(1996-2#5)
public health nutritionists##2##3##(1991-2#2)
public health officials##5##3##(1995-12#3)(1996-1#1)(1996-5#1)
public health overlap with##2##4##(1996-2#1)(2010-12#1)
public health performance##7##3##(1995-12#4)(1996-3#3)
public health perspective##2##3##(1995-12#1)(2008-6#1)
public health policy##4##3##(1993-2#1)(1997-2#1)(1997-3#2)
public health practice content##2##4##(1997-2#2)
public health practice in##2##4##(1996-2#1)(1997-3#1)
public health practice##16##3##(1995-12#1)(1996-1#4)(1996-2#3)(1996-3#2)(1997-2#3)(1997-3#2)(2012-2#1)
public health practitioners##4##3##(1995-12#1)(1997-2#3)
public health problem in the##4##5##(1997-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
public health problem in##5##4##(1997-1#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
public health problem of##2##4##(2008-11#1)(2011-2#1)
public health problem##19##3##(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
public health problems##3##3##(1993-1#1)(2010-7#1)(2011-2#1)
public health professionals##2##3##(1996-1#1)(1996-2#1)
public health program##4##3##(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
public health programs##3##3##(1995-12#1)(1996-3#1)(1997-3#1)
public health providers##2##3##(1997-2#1)(1997-3#1)
public health response to##3##4##(1991-3#1)(1997-1#2)
public health services##3##3##(1996-3#1)(1997-1#1)(1997-2#1)
public health students##2##3##(1996-1#1)(2008-1#1)
public health surveillance and assessment##2##5##(1997-3#2)
public health surveillance and##4##4##(1997-3#3)(2012-2#1)
public health surveillance in the##2##5##(1997-3#2)
public health surveillance system##3##4##(1997-3#2)(2012-12#1)
public health surveillance systems##5##4##(1997-3#1)(2008-7#4)
public health surveillance##24##3##(1997-3#16)(2008-1#1)(2008-7#5)(2012-12#1)(2012-2#1)
public health system in Arizona##2##5##(1995-12#2)
public health system in##4##4##(1995-12#2)(1996-2#1)(1997-2#1)
public health system##8##3##(1995-12#3)(1996-2#2)(1997-2#2)(2008-6#1)
public health threat##5##3##(1996-3#1)(2007-12#1)(2008-10#2)(2011-2#1)
public health to##4##3##(1991-12#1)(1996-11#1)(1997-2#1)(2008-7#1)
public health training by##2##4##(1996-3#2)
public health training##3##3##(1996-3#2)(1997-2#1)
public health was##2##3##(1996-3#1)(1997-2#1)
public health will##2##3##(1996-12#1)(1997-2#1)
public health workforce##2##3##(1997-3#1)(2013-1#1)
public health##416##2##(1990-11#1)(1991-12#1)(1991-2#4)(1991-3#6)(1991-6#1)(1992-1#8)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#2)(1994-9#2)(1995-12#43)(1995-2#3)(1995-3#3)(1995-5#1)(1996-1#23)(1996-11#1)(1996-12#6)(1996-2#34)(1996-3#36)(1996-5#1)(1996-6#1)(1997-1#16)(1997-2#26)(1997-3#58)(1997-4#1)(2007-12#3)(2008-1#5)(2008-10#13)(2008-11#13)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-1#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#6)(2011-1#1)(2011-2#17)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#9)(2013-8#3)
public health's core functions##2##4##(1996-2#1)(1997-2#1)
public health's##5##2##(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#2)
public hospital##5##2##(1992-1#1)(1992-11#1)(2012-2#1)(2013-1#2)
public hospitals##6##2##(1990-6#1)(1996-3#1)(2010-8#1)(2013-1#2)(2013-8#1)
public image##2##2##(1996-1#1)(1997-1#1)
public information campaign##3##3##(1992-2#3)
public information##6##2##(1992-2#5)(1996-6#1)
public interest in##2##3##(1991-3#1)(2008-10#1)
public interest##3##2##(1991-3#2)(2008-10#1)
public involvement##4##2##(2008-7#4)
public is##5##2##(1991-3#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-12#1)
public library##2##2##(1993-1#2)
public opinion##3##2##(1991-3#1)(2013-1#2)
public places##3##2##(1996-1#2)(2009-7#1)
public policy##11##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#2)(2012-2#1)
public relations##2##2##(1991-1#1)(1991-2#1)
public reporting##3##2##(2013-1#3)
public safety##4##2##(1991-3#1)(2008-1#1)(2008-6#2)
public sector##5##2##(1995-3#2)(1996-1#1)(1996-12#2)
public service##2##2##(1994-2#1)(2012-12#1)
public sources##2##2##(1995-2#1)(2009-11#1)
public##679##1##(1990-11#1)(1990-6#2)(1991-1#2)(1991-12#6)(1991-2#7)(1991-3#15)(1991-6#1)(1992-1#12)(1992-11#1)(1992-12#1)(1992-2#6)(1992-3#1)(1992-9#2)(1993-1#5)(1993-12#2)(1993-2#6)(1993-3#5)(1993-5#2)(1993-6#2)(1994-1#5)(1994-12#2)(1994-2#9)(1994-3#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#48)(1995-2#5)(1995-3#6)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#30)(1996-11#4)(1996-12#13)(1996-2#42)(1996-3#46)(1996-5#4)(1996-6#3)(1996-9#1)(1997-1#17)(1997-2#30)(1997-3#63)(1997-4#1)(1997-6#3)(1997-8#2)(2007-12#3)(2008-1#6)(2008-10#23)(2008-11#23)(2008-12#6)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#6)(2008-7#21)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#4)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#9)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#11)(2010-9#6)(2011-1#2)(2011-2#22)(2011-3#2)(2012-12#10)(2012-2#11)(2012-3#10)(2013-1#29)(2013-7#1)(2013-8#6)
public-private partnerships##2##2##(1995-3#1)(1996-12#1)
public-private##3##1##(1995-3#2)(1996-12#1)
publication bias##2##2##(1993-12#2)
publication in##6##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-1#1)
publication of clinical##2##3##(1992-2#1)(2008-3#1)
publication of the##5##3##(1994-3#1)(1996-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
publication of##15##2##(1992-12#1)(1992-2#1)(1994-3#2)(1996-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
publication or##2##2##(1992-9#1)(2008-9#1)
publication##66##1##(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#5)(1994-3#2)(1994-6#1)(1996-2#2)(1996-6#1)(2007-12#1)(2008-10#9)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#1)(2013-1#5)(2013-8#1)
publications about##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
publications are##2##2##(2008-8#1)(2010-7#1)
publications in##4##2##(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
publications on the##3##3##(2008-10#2)(2008-9#1)
publications on##7##2##(1996-3#1)(2008-10#3)(2008-9#2)(2011-2#1)
publications that##2##2##(2011-2#1)(2013-7#1)
publications using##2##2##(2008-10#1)(2008-11#1)
publications##58##1##(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#3)(2010-7#1)(2011-2#10)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
publications]##2##1##(1992-2#1)(1993-3#1)
publicity plan##3##2##(1992-12#3)
publicity##12##1##(1992-12#4)(1993-12#1)(1993-9#2)(2008-11#2)(2008-8#1)(2009-6#1)(2010-5#1)
publicly available##6##2##(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
publicly financed competition##2##3##(1992-2#2)
publicly financed##3##2##(1992-2#2)(1994-2#1)
publicly insured##3##2##(1994-2#2)(1997-3#1)
publicly##14##1##(1992-2#2)(1994-2#3)(1995-2#1)(1996-12#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
publish##8##1##(1991-12#1)(1991-2#1)(1993-12#1)(2010-12#3)(2011-2#1)(2012-2#1)
published DNA##2##2##(2008-10#2)
published ET cases##3##3##(2013-1#3)
published a##5##2##(1993-2#1)(1996-2#1)(2008-5#1)(2010-11#1)(2011-2#1)
published and##2##2##(2008-10#1)(2008-9#1)
published articles on##2##3##(2008-10#1)(2011-7#1)
published articles##4##2##(1994-3#1)(2008-10#1)(2010-2#1)(2011-7#1)
published between##9##2##(2008-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
published by##2##2##(2008-10#1)(2008-5#1)
published case of##2##3##(1991-11#1)(2008-5#1)
published case##3##2##(1991-11#1)(2008-5#1)(2013-1#1)
published cases##4##2##(2008-10#1)(2010-1#1)(2011-2#1)(2013-8#1)
published clinical##2##2##(1990-9#1)(2006-6#1)
published criteria for##2##3##(2008-8#1)(2008-9#1)
published data and##2##3##(2008-10#1)(2011-2#1)
published data from##3##3##(2008-11#2)(2011-2#1)
published data on##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
published data##20##2##(1991-2#1)(1992-7#1)(1995-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#5)(2012-3#1)(2013-1#1)
published during the##2##3##(1994-3#1)(1997-6#1)
published during##3##2##(1994-3#1)(1997-6#1)(2010-12#1)
published examples##2##2##(2008-10#1)(2008-11#1)
published experimental##2##2##(2008-11#1)(2010-10#1)
published for the##2##3##(1993-6#1)(2011-2#1)
published for##5##2##(1993-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
published from January##2##3##(2009-8#1)(2013-1#1)
published from##8##2##(1993-12#1)(1993-6#1)(2008-12#1)(2009-8#1)(2011-2#3)(2013-1#1)
published in Mexico##2##3##(1997-8#2)
published in the##12##3##(1993-12#1)(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-3#1)(2010-5#1)
published in##45##2##(1993-12#2)(1993-2#1)(1994-12#2)(1995-1#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#4)(2008-10#6)(2008-11#7)(2008-3#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#5)
published literature and##3##3##(2008-10#1)(2010-12#2)
published literature##9##2##(1991-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#2)(2012-12#1)
published meta-analyses##2##2##(2010-2#1)(2013-1#1)
published method##2##2##(2008-10#2)
published methods##3##2##(1997-2#1)(2008-10#1)(2008-6#1)
published model##3##2##(2008-3#1)(2010-10#1)(2012-3#1)
published more than##2##3##(1993-12#1)(2012-2#1)
published on##10##2##(1991-2#1)(2008-10#1)(2008-11#1)(2010-12#4)(2012-3#1)(2013-1#2)
published papers##4##2##(2008-10#2)(2013-1#1)(2013-7#1)
published previously##3##2##(2008-10#2)(2008-7#1)
published report##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
published reports##6##2##(1990-9#1)(1993-12#1)(2008-10#2)(2012-12#1)(2013-1#1)
published research##3##2##(1992-12#1)(1993-12#1)(2008-10#1)
published results##8##2##(1993-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
published series of##2##3##(2008-9#1)(2012-3#1)
published series##3##2##(1995-11#1)(2008-9#1)(2012-3#1)
published since##2##2##(1997-5#1)(2008-10#1)
published studies of##2##3##(2008-12#1)(2008-8#1)
published studies##14##2##(1990-2#1)(1991-5#1)(1993-11#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#2)(2011-2#2)(2012-3#1)
published the##3##2##(2008-10#1)(2010-12#1)(2010-8#1)
published to date##2##3##(2008-9#1)(2011-2#1)
published to##3##2##(2008-9#1)(2010-8#1)(2011-2#1)
published trials##2##2##(1996-6#1)(2008-12#1)
published values##2##2##(2008-10#1)(2008-9#1)
published##312##1##(1990-2#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#1)(1997-8#4)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#59)(2008-11#24)(2008-12#7)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#15)(2009-3#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-2#19)(2011-7#2)(2012-12#12)(2012-2#6)(2012-3#9)(2013-1#22)(2013-7#1)(2013-8#3)
publisher##12##1##(2008-11#2)(2013-8#10)
publishes a##2##2##(1993-1#1)(1994-12#1)
publishing##12##1##(1993-12#2)(1994-12#1)(1996-2#1)(2008-10#2)(2010-12#3)(2010-6#1)(2011-4#1)(2013-1#1)
puerarin##2##1##(2008-10#1)(2011-3#1)
puerperal madness&quot##3##2##(2009-10#3)
puerperal##6##1##(2009-10#5)(2013-1#1)
puerperium##3##1##(1991-3#1)(1992-5#1)(2008-11#1)
puff##2##1##(1995-8#2)
puffs##3##1##(1992-2#1)(1995-8#2)
pugp##2##1##(1990-5#2)
puis##3##1##(2013-1#3)
pulcherrima isolated##2##2##(2008-10#2)
pulcherrima##5##1##(2008-10#5)
pulcherrimum disomic##2##2##(2008-8#2)
pulcherrimum##4##1##(2008-8#4)
pulegium L##3##2##(2008-10#3)
pulegone##2##1##(2008-10#2)
pulicaria##2##1##(2008-10#1)(2012-3#1)
pull the##3##2##(1994-3#1)(1995-2#1)(2008-11#1)
pull##7##1##(1994-3#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
pull-out strength##3##2##(2007-11#3)
pull-out##4##1##(2007-11#3)(2012-3#1)
pull-through##3##1##(2008-10#1)(2013-1#2)
pulled straw##2##2##(2013-8#2)
pulled##7##1##(1992-5#1)(2008-7#1)(2009-7#1)(2013-1#2)(2013-8#2)
pulling rates##4##2##(2009-7#4)
pulling##8##1##(1990-5#1)(2008-11#1)(2009-7#5)(2011-2#1)
pullulans and##2##2##(2008-10#2)
pullulans##7##1##(2008-10#7)
pulmonary adenomas##3##2##(2008-9#3)
pulmonary air leaks##2##3##(1994-6#2)
pulmonary alveolar macrophages (PAM)##2##4##(1993-8#1)(1996-3#1)
pulmonary alveolar##4##2##(1993-2#1)(1993-8#1)(1996-3#1)(2012-12#1)
pulmonary and systemic##3##3##(1996-3#1)(1997-1#1)(2008-11#1)
pulmonary and##12##2##(1991-3#1)(1995-10#1)(1996-3#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2013-1#1)
pulmonary angiography##2##2##(2010-10#1)(2011-2#1)
pulmonary arterial circulation of RHR##2##5##(2008-11#2)
pulmonary arterial hypertension (PAH)##5##4##(2009-10#1)(2010-10#4)
pulmonary arterial hypertension##14##3##(1996-3#1)(2008-11#1)(2009-10#1)(2010-10#10)(2011-3#1)
pulmonary arterial pressure##2##3##(1991-6#1)(2008-11#1)
pulmonary arterial##23##2##(1991-6#1)(1996-3#1)(2008-10#2)(2008-11#5)(2009-10#1)(2010-10#10)(2011-2#1)(2011-3#1)(2012-2#1)
pulmonary arteries and##2##3##(2010-5#1)(2012-3#1)
pulmonary arteries##6##2##(2008-1#2)(2008-10#1)(2010-10#1)(2010-5#1)(2012-3#1)
pulmonary arteriovenous fistulae##2##3##(2008-11#1)(2008-7#1)
pulmonary arteriovenous##5##2##(2008-11#3)(2008-7#1)(2010-10#1)
pulmonary artery and##2##3##(1997-8#1)(2008-11#1)
pulmonary artery dissection##2##3##(2010-10#2)
pulmonary artery occlusion##2##3##(1997-8#2)
pulmonary artery pressure##3##3##(1997-5#1)(2010-10#1)(2010-4#1)
pulmonary artery smooth muscle cells##2##5##(1995-2#1)(2011-3#1)
pulmonary artery smooth muscle##3##4##(1995-2#1)(2010-12#1)(2011-3#1)
pulmonary artery thrombosis##2##3##(2013-1#2)
pulmonary artery##38##2##(1991-5#1)(1993-12#1)(1993-6#2)(1995-2#1)(1997-5#2)(1997-8#6)(2008-11#6)(2008-12#1)(2010-10#7)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2011-3#2)(2012-12#2)(2013-1#2)
pulmonary aspergillosis##4##2##(2008-5#2)(2011-2#1)(2013-1#1)
pulmonary carcinoma##2##2##(1997-5#1)(2008-9#1)
pulmonary complications after##2##3##(1997-3#1)(2011-2#1)
pulmonary complications##6##2##(1991-8#1)(1997-3#2)(2011-2#3)
pulmonary cryptococcosis##2##2##(2008-10#1)(2012-3#1)
pulmonary deposition##2##2##(1996-12#2)
pulmonary disease in##4##3##(1992-1#1)(1995-12#1)(1997-3#1)(2007-12#1)
pulmonary disease##39##2##(1991-8#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-3#2)(1995-12#2)(1996-1#2)(1997-3#1)(2007-12#2)(2008-1#1)(2008-5#1)(2009-1#1)(2010-10#4)(2010-12#2)(2010-2#1)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#2)
pulmonary diseases##6##2##(1991-12#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-3#1)(2012-2#1)
pulmonary drug##2##2##(1992-3#1)(1997-1#1)
pulmonary edema formation in##2##4##(1994-8#1)(2010-10#1)
pulmonary edema in##3##3##(1994-8#1)(2008-11#1)(2011-2#1)
pulmonary edema##13##2##(1994-8#3)(2008-11#2)(2009-1#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-2#1)
pulmonary embolism (PE)##3##3##(2011-2#2)(2012-2#1)
pulmonary embolism and##2##3##(2010-10#1)(2013-1#1)
pulmonary embolism##22##2##(1991-11#6)(1992-5#1)(2008-12#1)(2008-7#2)(2010-1#1)(2010-10#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
pulmonary emphysema##3##2##(2008-7#3)
pulmonary endarterectomy##3##2##(2010-10#1)(2013-1#2)
pulmonary fibrosis and pulmonary##2##4##(2011-3#2)
pulmonary fibrosis##8##2##(1994-3#1)(2009-10#1)(2010-5#3)(2011-3#2)(2013-8#1)
pulmonary function and##2##3##(2011-2#1)(2012-12#1)
pulmonary function deterioration##2##3##(2011-2#2)
pulmonary function tests and##2##4##(1996-1#1)(1996-3#1)
pulmonary function tests##3##3##(1991-12#1)(1996-1#1)(1996-3#1)
pulmonary function##19##2##(1991-12#2)(1992-6#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2009-12#1)(2010-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
pulmonary functions in##2##3##(2012-2#2)
pulmonary functions##3##2##(2012-2#3)
pulmonary heart disease##3##3##(2011-2#3)
pulmonary hemorrhage as##2##3##(2011-2#2)
pulmonary hypertension (PH)##2##3##(2010-10#2)
pulmonary hypertension and other##2##4##(2009-10#1)(2012-2#1)
pulmonary hypertension and##3##3##(2009-10#1)(2012-12#1)(2012-2#1)
pulmonary hypertension##29##2##(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(1997-5#2)(2008-1#1)(2008-11#1)(2008-12#1)(2009-10#3)(2010-10#7)(2010-12#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
pulmonary hypoplasia##2##2##(1994-6#1)(2012-3#1)
pulmonary infarction##2##2##(2007-8#2)
pulmonary infection##2##2##(1990-12#1)(1996-11#1)
pulmonary infections##2##2##(1997-1#1)(2008-10#1)
pulmonary infiltrates##2##2##(2008-5#1)(2010-11#1)
pulmonary maintenance program##3##3##(2010-10#3)
pulmonary metastases##2##2##(2008-10#1)(2008-8#1)
pulmonary metastasis in##2##3##(2008-5#1)(2011-2#1)
pulmonary nodules##3##2##(2008-10#1)(2012-3#2)
pulmonary oedema##5##2##(1995-11#1)(2010-7#3)(2011-2#1)
pulmonary rehabilitation##3##2##(1997-8#1)(2010-1#2)
pulmonary system##2##2##(2012-3#1)(2013-8#1)
pulmonary thromboembolism in a patient with hereditary spherocytosis##2##8##(2008-12#2)
pulmonary tuberculosis and##2##3##(1996-11#1)(2010-5#1)
pulmonary tuberculosis##6##2##(1995-2#1)(1996-11#1)(1997-3#1)(2008-7#1)(2010-5#1)(2013-8#1)
pulmonary valvotomy##2##2##(2008-11#2)
pulmonary vascular remodeling##2##3##(2008-1#2)
pulmonary vascular resistance##8##3##(1990-11#1)(1997-5#1)(2008-11#1)(2008-12#2)(2010-10#2)(2012-2#1)
pulmonary vascular##14##2##(1990-11#1)(1997-5#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2010-10#3)(2012-2#1)
pulmonary vein##4##2##(2010-4#1)(2011-2#3)
pulmonary veins##2##2##(1997-1#1)(2008-11#1)
pulmonary##423##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#7)(1991-12#8)(1991-3#4)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#2)(1994-2#1)(1994-3#5)(1994-5#5)(1994-6#3)(1994-8#4)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1996-1#3)(1996-11#3)(1996-12#3)(1996-3#6)(1996-6#1)(1997-1#7)(1997-3#5)(1997-4#1)(1997-5#6)(1997-8#8)(2007-12#2)(2007-8#4)(2008-1#9)(2008-10#18)(2008-11#28)(2008-12#9)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#5)(2009-1#2)(2009-10#7)(2009-12#1)(2009-5#3)(2009-9#1)(2010-1#5)(2010-10#44)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#10)(2010-6#1)(2010-7#4)(2011-1#1)(2011-2#48)(2011-3#11)(2012-12#8)(2012-2#12)(2012-3#17)(2013-1#14)(2013-8#9)
pulmonology##2##1##(2013-1#2)
pulp and paper##2##3##(2008-10#2)
pulp and##3##2##(2008-10#3)
pulp is##2##2##(2008-10#1)(2011-2#1)
pulp therapy##2##2##(2011-2#2)
pulp##43##1##(1990-9#1)(1991-2#3)(1996-2#1)(2008-10#14)(2008-11#1)(2008-5#4)(2008-6#7)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#8)(2013-1#1)
pulpal##2##1##(2011-2#1)(2013-1#1)
pulpotomy##6##1##(1990-3#1)(2011-2#5)
pulsatile##8##1##(1994-11#1)(1995-3#1)(1997-2#2)(2008-11#1)(2010-6#2)(2012-3#1)
pulsatility##2##1##(1996-6#1)(2013-1#1)
pulsating##2##1##(1997-3#1)(2008-12#1)
pulsation##5##1##(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#1)
pulsations##4##1##(1993-1#1)(2007-11#2)(2008-3#1)
pulse ECT##3##2##(2012-12#3)
pulse amperometry##2##2##(2008-10#2)
pulse amplitude and##2##3##(1997-2#1)(2008-10#1)
pulse amplitude of##3##3##(2008-10#3)
pulse amplitude##10##2##(1997-2#2)(2008-10#8)
pulse and##11##2##(1992-12#1)(2008-10#9)(2008-3#1)
pulse anodic stripping voltammetric##4##4##(2008-10#4)
pulse anodic stripping voltammetry##17##4##(2008-10#17)
pulse anodic stripping##21##3##(2008-10#21)
pulse cathodic stripping voltammetry##5##4##(2008-10#5)
pulse cathodic stripping##8##3##(2008-10#8)
pulse cathodic##9##2##(2008-10#9)
pulse compression##4##2##(2007-12#4)
pulse contrast##2##2##(2007-11#1)(2010-1#1)
pulse current##2##2##(2008-10#2)
pulse differential voltammetry##2##3##(2008-10#2)
pulse differential##3##2##(2008-10#3)
pulse duration is##2##3##(1991-2#1)(2008-3#1)
pulse duration of##2##3##(2008-2#1)(2008-3#1)
pulse duration##11##2##(1991-2#4)(2008-10#1)(2008-2#2)(2008-3#2)(2009-8#2)
pulse durations of less than##2##5##(2008-3#2)
pulse energy and##2##3##(1992-12#1)(2008-3#1)
pulse energy##5##2##(1992-12#1)(2008-3#4)
pulse frequency##5##2##(1992-12#1)(2008-10#1)(2013-1#3)
pulse from##2##2##(2008-3#2)
pulse generation##2##2##(2007-11#2)
pulse height##3##2##(2008-10#3)
pulse in##3##2##(2007-12#2)(2008-10#1)
pulse irradiation of##2##3##(2008-8#1)(2008-9#1)
pulse irradiation##3##2##(2008-8#2)(2008-9#1)
pulse is##9##2##(1991-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)
pulse length##3##2##(1991-5#1)(2008-3#2)
pulse of the##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
pulse of##6##2##(1991-6#1)(2008-10#1)(2008-2#1)(2008-7#2)(2013-1#1)
pulse oximetry##4##2##(1993-1#3)(2009-5#1)
pulse per##2##2##(2008-10#1)(2008-5#1)
pulse polarographic determination##7##3##(2008-10#7)
pulse polarographic##14##2##(2008-10#14)
pulse polarography (DPP)##7##3##(2008-10#7)
pulse polarography##22##2##(2008-10#22)
pulse propagation##2##2##(2007-11#1)(2008-3#1)
pulse radiolysis technique##2##3##(2008-9#2)
pulse radiolysis##3##2##(2008-9#3)
pulse rate##2##2##(2008-11#1)(2009-5#1)
pulse repetition##2##2##(2008-3#2)
pulse sequence##5##2##(1997-8#3)(2008-10#1)(2012-2#1)
pulse sequences##3##2##(1997-8#1)(2010-9#1)(2012-2#1)
pulse that##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
pulse to##2##2##(2008-10#2)
pulse train##4##2##(1991-2#1)(2007-11#3)
pulse trains##3##2##(2008-3#3)
pulse voltammetric determination of##2##4##(2008-10#2)
pulse voltammetric determination##3##3##(2008-10#3)
pulse voltammetric##10##2##(2008-10#10)
pulse voltammetry (DPV)##11##3##(2008-10#11)
pulse voltammetry##23##2##(2008-10#23)
pulse wave##2##2##(2013-3#1)(2013-8#1)
pulse width ECT##3##3##(2012-12#3)
pulse width of##4##3##(2007-12#2)(2008-3#1)(2012-12#1)
pulse width##21##2##(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#6)(2012-12#5)
pulse widths##2##2##(2008-3#2)
pulse with##4##2##(2007-11#1)(2008-3#2)(2010-8#1)
pulse##365##1##(1991-2#6)(1991-5#3)(1991-6#1)(1992-12#3)(1992-3#1)(1993-1#5)(1994-2#2)(1994-9#1)(1995-2#1)(1995-6#1)(1997-2#2)(1997-4#2)(1997-8#5)(2007-11#16)(2007-12#17)(2008-10#185)(2008-11#4)(2008-2#10)(2008-3#47)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-5#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#10)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#7)(2013-3#1)(2013-8#4)
pulse-voltammetric##2##1##(2008-10#2)
pulsed Nd##4##2##(2008-10#2)(2008-2#2)
pulsed UV laser##2##3##(2012-2#2)
pulsed UV##4##2##(2012-2#4)
pulsed amperometric detection (PAD)##3##4##(1991-7#1)(2008-10#2)
pulsed amperometric detection##13##3##(1991-7#2)(1992-1#1)(2008-10#10)
pulsed amperometric##15##2##(1991-7#2)(1992-1#1)(2008-10#12)
pulsed coherent##2##2##(2008-2#1)(2008-3#1)
pulsed dye laser##3##3##(1996-11#1)(2008-3#1)(2009-4#1)
pulsed dye##4##2##(1996-11#2)(2008-3#1)(2009-4#1)
pulsed electric##3##2##(2008-9#3)
pulsed excitation##2##2##(2008-2#1)(2008-3#1)
pulsed field gel electrophoresis##3##4##(1995-8#1)(2008-10#1)(2012-3#1)
pulsed flow of solution##2##4##(2008-10#2)
pulsed flow##4##2##(2008-10#4)
pulsed galvanostatic##2##2##(2008-10#2)
pulsed gradient magnetic field##3##4##(2008-9#3)
pulsed laser beam##2##3##(2008-3#1)(2012-2#1)
pulsed laser##11##2##(1992-1#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2012-2#1)
pulsed light##2##2##(2010-6#1)(2011-2#1)
pulsed optical parametric oscillator##3##4##(2008-3#3)
pulsed quantum-cascade distributed feedback laser##2##5##(2008-3#2)
pulsed quench-flow apparatus##3##3##(1990-2#3)
pulsed treatment##2##2##(1995-5#2)
pulsed with##2##2##(2008-11#1)(2008-8#1)
pulsed##108##1##(1990-2#3)(1991-3#1)(1991-7#2)(1992-1#4)(1992-12#1)(1992-3#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-11#2)(2007-12#2)(2008-10#34)(2008-11#1)(2008-2#9)(2008-3#20)(2008-7#1)(2008-8#2)(2008-9#6)(2009-4#1)(2009-5#1)(2010-6#2)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#1)
pulsed-field gel electrophoresis (PFGE)##3##4##(1993-12#2)(2008-10#1)
pulsed-field gel electrophoresis##11##3##(1993-12#2)(1996-12#1)(1997-2#2)(1997-3#1)(2008-10#5)
pulsed-field##12##1##(1993-12#2)(1996-12#1)(1997-2#2)(1997-3#1)(2008-10#6)
pulses (10##2##2##(2007-11#1)(2008-3#1)
pulses and##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2009-8#1)
pulses are analyzed##2##3##(2008-2#2)
pulses are detected##2##3##(2008-2#1)(2008-3#1)
pulses are##5##2##(2008-2#3)(2008-3#2)
pulses at##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
pulses by use of a##2##5##(2007-11#1)(2008-2#1)
pulses by##3##2##(2007-11#1)(2008-2#2)
pulses for##2##2##(2008-3#2)
pulses from##2##2##(2007-11#2)
pulses in a##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
pulses in the##3##3##(1992-11#1)(1997-2#1)(2007-12#1)
pulses in##7##2##(1992-11#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
pulses of##4##2##(1991-5#1)(2007-11#1)(2008-3#2)
pulses that are##2##3##(2007-11#1)(2007-12#1)
pulses that##3##2##(2007-11#1)(2007-12#2)
pulses to a##2##3##(2008-3#2)
pulses were##5##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)
pulses with a##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
pulses with an##2##3##(2008-3#2)
pulses with##13##2##(2007-12#2)(2008-2#1)(2008-3#10)
pulses##113##1##(1991-2#4)(1991-5#6)(1991-9#1)(1992-11#1)(1992-8#1)(1995-6#2)(1997-2#1)(2007-11#12)(2007-12#10)(2008-10#5)(2008-11#1)(2008-2#16)(2008-3#39)(2008-5#7)(2008-6#3)(2008-8#1)(2009-8#1)(2010-7#1)(2013-1#1)
pulsing##2##1##(2008-11#1)(2008-5#1)
pulverized##3##1##(2008-10#3)
pumice##6##1##(2008-10#4)(2008-7#2)
pumilus##5##1##(2008-10#3)(2011-1#1)(2011-2#1)
pumilus)##4##1##(2008-10#4)
pummelo##2##1##(2008-10#2)
pump absorption##3##2##(2007-12#2)(2008-3#1)
pump and##6##2##(1992-1#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
pump at##2##2##(2008-10#1)(2008-3#1)
pump beam in##2##3##(2008-2#1)(2008-3#1)
pump beam##11##2##(2007-11#1)(2008-2#4)(2008-3#6)
pump can##2##2##(2008-10#2)
pump carrier solution##2##3##(2008-10#2)
pump cavity##2##2##(2008-2#2)
pump efficiency##2##2##(2008-10#1)(2008-3#1)
pump energies##4##2##(2008-3#4)
pump energy##2##2##(2008-3#2)
pump flow##3##2##(2008-10#3)
pump for##3##2##(2008-10#3)
pump inhibitor##10##2##(1996-2#2)(1996-3#4)(2008-11#1)(2009-11#1)(2010-12#1)(2012-2#1)
pump inhibitors##6##2##(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#3)
pump intensities##2##2##(2008-3#2)
pump intensity##3##2##(2008-3#3)
pump is##3##2##(2008-11#2)(2008-8#1)
pump light##2##2##(2008-2#2)
pump polarization is##2##3##(2008-2#1)(2008-3#1)
pump polarization##3##2##(2008-2#2)(2008-3#1)
pump power and##2##3##(2008-3#2)
pump power of##5##3##(2008-2#3)(2008-3#2)
pump power##18##2##(2007-12#1)(2008-2#5)(2008-3#12)
pump powers##2##2##(2007-11#1)(2008-3#1)
pump source##4##2##(2008-3#4)
pump speed##2##2##(1991-3#1)(2008-10#1)
pump that##2##2##(1997-8#1)(2010-6#1)
pump to##3##2##(1991-3#1)(2008-10#2)
pump was used##3##3##(2008-10#2)(2013-1#1)
pump was##5##2##(2008-10#4)(2013-1#1)
pump were##2##2##(2008-10#2)
pump with an##2##3##(2008-10#2)
pump##177##1##(1991-3#2)(1992-1#4)(1994-5#1)(1994-6#3)(1995-11#1)(1996-2#2)(1996-3#4)(1997-8#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#46)(2008-11#12)(2008-2#18)(2008-3#45)(2008-5#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-6#2)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
pump-beam##3##1##(2008-3#3)
pump-power##2##1##(2008-3#2)
pump-probe##2##1##(1996-2#1)(2010-7#1)
pumped at 0##2##3##(2008-10#2)
pumped at 1##2##3##(2007-12#1)(2008-3#1)
pumped at##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
pumped by a pulsed##2##4##(2008-10#1)(2008-3#1)
pumped by a##12##3##(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#4)
pumped by the##2##3##(2008-2#1)(2008-3#1)
pumped by##17##2##(2007-12#5)(2008-10#1)(2008-2#6)(2008-3#5)
pumped optical parametric##3##3##(2007-11#1)(2008-3#2)
pumped through a##2##3##(2008-10#2)
pumped through the##5##3##(2008-10#4)(2008-11#1)
pumped through##7##2##(2008-10#6)(2008-11#1)
pumped to##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
pumped with##2##2##(2007-11#1)(2008-3#1)
pumped##58##1##(1990-2#1)(1993-5#1)(1994-2#1)(2007-11#3)(2007-12#8)(2008-10#14)(2008-11#2)(2008-2#8)(2008-3#20)
pumping at##2##2##(2008-3#1)(2008-7#1)
pumping by##3##2##(1995-2#2)(2007-11#1)
pumping efficiency##3##2##(2008-2#2)(2008-3#1)
pumping of##4##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
pumping system##2##2##(2008-10#1)(2008-3#1)
pumping the##2##2##(1990-6#1)(2008-3#1)
pumping##47##1##(1990-6#1)(1990-8#1)(1995-2#4)(1997-8#1)(2007-11#8)(2007-12#1)(2008-10#5)(2008-2#6)(2008-3#16)(2008-7#2)(2008-9#1)(2010-6#1)
pumpkin##6##1##(2008-10#6)
pumps a##2##2##(2008-10#2)
pumps and##2##2##(2010-6#1)(2011-2#1)
pumps can##2##2##(2011-2#2)
pumps##45##1##(1991-12#1)(1997-1#1)(2007-11#3)(2008-10#9)(2008-11#4)(2008-4#1)(2008-8#2)(2010-6#3)(2010-9#3)(2011-1#1)(2011-2#17)
punch##4##1##(1994-1#1)(2008-5#1)(2011-2#1)(2012-3#1)
punctata##9##1##(1995-11#3)(2008-10#5)(2009-10#1)
punctate##4##1##(1995-6#1)(1996-12#1)(2008-8#1)(2009-8#1)
punctuate##5##1##(1994-5#1)(2008-11#2)(2010-6#2)
puncture of the##3##3##(1994-9#1)(1997-6#1)(1997-8#1)
puncture or##3##2##(2008-7#1)(2012-2#2)
puncture site##2##2##(1991-12#1)(2011-2#1)
puncture##25##1##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-12#1)(1994-9#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#1)
punctures and##2##2##(2008-7#1)(2012-2#1)
punctures##3##1##(2008-7#1)(2012-2#1)(2012-3#1)
pungency##4##1##(2008-10#4)
punic##2##1##(2008-5#2)
punishment that##2##2##(2008-8#2)
punishment##19##1##(1992-1#1)(1993-9#1)(1994-3#6)(1995-5#1)(1996-5#1)(2008-11#1)(2008-8#6)(2010-11#1)(2013-8#1)
pup##5##1##(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#2)
pup-directed##2##1##(2008-11#2)
pupae of##2##2##(2008-11#1)(2008-6#1)
pupae##6##1##(1997-8#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#2)
pupal##7##1##(2007-12#4)(2008-11#1)(2008-5#2)
pupation##3##1##(2008-10#1)(2008-9#2)
pupil diameter##2##2##(2013-1#2)
pupil##10##1##(2008-3#4)(2008-7#1)(2010-1#1)(2010-8#1)(2013-1#3)
pupils##7##1##(1994-6#1)(1995-12#1)(1996-6#3)(2008-10#1)(2008-7#1)
puppy##3##1##(2012-2#3)
pups born##2##2##(1995-6#1)(2008-11#1)
pups were##2##2##(2008-11#1)(2012-3#1)
pups##13##1##(1994-3#1)(1995-11#1)(1995-6#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-8#1)(2012-3#1)
purchase and##3##2##(1991-1#1)(1996-2#1)(2010-9#1)
purchase of##3##2##(1996-2#1)(2008-4#1)(2010-9#1)
purchase##17##1##(1991-1#1)(1993-12#3)(1993-3#1)(1994-3#1)(1995-2#3)(1996-2#2)(1997-3#1)(2008-11#1)(2008-4#2)(2010-9#2)
purchased##7##1##(1992-3#1)(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2010-3#1)
purchaser##3##1##(1994-1#1)(1996-1#1)(1996-2#1)
purchasers and providers##4##3##(1994-1#2)(1994-12#1)(1997-1#1)
purchasers and##5##2##(1994-1#2)(1994-12#1)(1995-2#1)(1997-1#1)
purchasers of care##2##3##(1993-3#1)(1996-2#1)
purchasers of##3##2##(1993-3#1)(1996-2#1)(1997-3#1)
purchasers to##4##2##(1994-12#1)(1996-2#2)(1997-1#1)
purchasers##16##1##(1991-3#1)(1993-3#1)(1994-1#3)(1994-12#2)(1995-2#1)(1996-2#3)(1997-1#2)(1997-3#2)(2008-11#1)
purchases##7##1##(1991-1#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-3#1)(2011-2#2)
purchasing decisions##4##2##(1991-2#1)(1996-8#1)(1997-3#1)(2008-10#1)
purchasing##10##1##(1991-2#1)(1994-1#1)(1994-2#1)(1996-8#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2010-9#1)
pure L-amino acids##3##3##(1995-3#3)
pure and mixed cultures##2##4##(2008-10#1)(2011-1#1)
pure and mixed##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
pure and pharmaceutical##3##3##(2008-10#3)
pure and##10##2##(2008-10#4)(2008-2#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
pure cells##2##2##(2008-4#1)(2008-9#1)
pure components emission##2##3##(2008-10#2)
pure components##5##2##(2008-10#5)
pure compound##2##2##(2008-10#2)
pure conjugate##2##2##(1990-8#2)
pure copper##4##2##(2008-8#4)
pure culture##6##2##(2008-10#3)(2008-7#1)(2010-4#1)(2012-2#1)
pure cultures##4##2##(2008-10#4)
pure drug##4##2##(2008-10#3)(2012-2#1)
pure fetal##2##2##(2013-1#2)
pure form and in pharmaceutical##2##5##(2008-10#2)
pure form and in##3##4##(2008-10#3)
pure form##12##2##(2008-10#10)(2008-5#1)(2010-5#1)
pure gold##3##2##(2008-10#3)
pure nitrogen##2##2##(2008-10#1)(2008-3#1)
pure pesticide vapor and##2##4##(2008-10#2)
pure populations of##2##3##(2008-11#1)(2008-4#1)
pure protein##2##2##(2009-3#1)(2010-7#1)
pure recombinant##2##2##(2008-4#2)
pure red cell aplasia (PRCA)##2##5##(2008-10#1)(2008-12#1)
pure red cell##3##3##(2008-10#1)(2008-12#2)
pure rotational coherent##2##3##(2008-3#2)
pure solutions##2##2##(2008-10#2)
pure stand##2##2##(2008-10#2)
pure stands and mixtures##2##4##(2008-10#2)
pure stands and##3##3##(2008-10#3)
pure stands##11##2##(2008-10#11)
pure variables##2##2##(2008-10#2)
pure water and seawater##2##4##(2008-2#2)
pure water##13##2##(2008-10#7)(2008-11#1)(2008-2#4)(2010-4#1)
pure##215##1##(1990-2#2)(1990-5#1)(1990-8#2)(1992-11#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-3#5)(1996-5#2)(1997-2#1)(1997-5#2)(2008-1#1)(2008-10#111)(2008-11#8)(2008-12#4)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#4)(2009-3#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#5)(2013-8#3)
pure)##3##1##(2008-9#3)
purely##14##1##(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)
purge and trap##3##3##(2008-10#2)(2010-11#1)
purge and##4##2##(2008-10#3)(2010-11#1)
purge gas##2##2##(2008-10#2)
purge##10##1##(1990-11#1)(1995-6#1)(2008-10#7)(2010-11#1)
purge-and-trap and##2##2##(2008-10#2)
purge-and-trap##5##1##(2008-10#5)
purged into the##2##3##(2008-10#2)
purged##3##1##(1997-7#1)(2008-10#2)
purging##9##1##(1994-5#1)(2008-10#7)(2008-3#1)
purification and characterization of the##2##5##(1991-5#1)(2008-4#1)
purification and characterization of##4##4##(1990-8#1)(1991-5#1)(1996-12#1)(2008-4#1)
purification and characterization##5##3##(1990-8#1)(1991-5#1)(1996-12#1)(2008-4#2)
purification and##18##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-8#1)(1995-2#1)(1996-12#1)(2008-10#4)(2008-4#3)(2008-8#1)(2008-9#2)(2009-11#1)
purification by##3##2##(1993-8#1)(2008-11#1)(2012-2#1)
purification can be##2##3##(2008-10#1)(2008-4#1)
purification from##5##2##(1993-6#1)(1993-8#1)(1995-12#1)(2008-10#2)
purification methods##2##2##(2008-11#1)(2008-4#1)
purification of a##3##3##(2008-10#2)(2008-4#1)
purification of recombinant##3##3##(1995-6#1)(2008-1#1)(2008-4#1)
purification of streptokinase##2##3##(2012-2#2)
purification of the enzyme##3##4##(1993-9#1)(1995-8#1)(2011-1#1)
purification of the##24##3##(1991-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-9#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(2008-10#3)(2008-11#5)(2008-4#2)(2008-5#1)(2009-9#1)(2011-1#1)
purification of##83##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-9#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1997-2#3)(2008-1#5)(2008-10#14)(2008-11#10)(2008-4#18)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
purification procedure for##2##3##(1992-12#1)(2008-10#1)
purification procedure##9##2##(1992-12#1)(1993-6#1)(1994-8#2)(2008-10#4)(2008-11#1)
purification procedures##5##2##(2008-10#3)(2008-4#1)(2008-8#1)
purification process of##2##3##(2008-11#1)(2012-3#1)
purification process##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
purification step##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
purification steps##6##2##(1996-12#1)(2008-10#3)(2008-12#1)(2008-7#1)
purification using##2##2##(2008-11#1)(2008-4#1)
purification was##3##2##(2008-10#2)(2008-11#1)
purification##197##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#2)(1997-2#3)(2008-1#5)(2008-10#51)(2008-11#20)(2008-12#1)(2008-4#36)(2008-5#1)(2008-7#6)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
purifications##3##1##(1996-5#1)(2008-10#2)
purified GDH##2##2##(1993-9#2)
purified HC##2##2##(2008-10#2)
purified PLRV##2##2##(2008-10#2)
purified RNA##3##2##(1994-3#1)(1995-5#1)(2008-10#1)
purified a##2##2##(1992-8#1)(2008-11#1)
purified alpha##3##2##(1991-12#1)(1992-2#1)(1992-9#1)
purified and characterized##2##3##(1995-6#1)(2008-8#1)
purified and cloned##2##3##(1992-10#1)(2009-8#1)
purified and##20##2##(1990-5#1)(1992-10#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-6#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-8#2)(2009-8#2)
purified as a stable##2##4##(1994-5#1)(2008-4#1)
purified as a##3##3##(1993-8#1)(1994-5#1)(2008-4#1)
purified by affinity chromatography##6##4##(1991-9#1)(1995-6#1)(1997-2#1)(2008-5#1)(2008-9#2)
purified by immunoaffinity##2##3##(1994-11#1)(2008-10#1)
purified by##40##2##(1990-5#1)(1990-8#1)(1991-9#2)(1992-12#1)(1994-11#3)(1994-8#2)(1995-12#1)(1995-6#2)(1995-8#1)(1996-6#1)(1997-2#3)(2008-10#7)(2008-11#3)(2008-5#2)(2008-8#4)(2008-9#3)(2010-12#1)(2011-2#1)(2013-8#1)
purified caveolae##2##2##(1995-2#2)
purified compound##2##2##(2008-10#1)(2008-11#1)
purified cultures of##2##3##(2008-11#1)(2008-7#1)
purified cultures##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
purified cytosolic##3##2##(1990-11#2)(1995-11#1)
purified enzyme##10##2##(1990-11#2)(1991-5#1)(1992-9#2)(1993-8#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#1)
purified fibrinogen##3##2##(2008-10#3)
purified from Escherichia coli##2##4##(1993-8#1)(2008-9#1)
purified from a##2##3##(1994-5#1)(2008-10#1)
purified from bovine##4##3##(1992-8#1)(1994-6#1)(2008-8#1)(2008-9#1)
purified from culture##2##3##(2008-10#2)
purified from rat liver and##2##5##(1990-5#1)(1995-6#1)
purified from rat liver##5##4##(1990-5#1)(1993-8#2)(1995-6#1)(2008-10#1)
purified from rat##6##3##(1990-5#1)(1993-8#2)(1994-8#1)(1995-6#1)(2008-10#1)
purified from the##9##3##(1991-5#1)(1993-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)
purified from##63##2##(1990-5#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#5)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#3)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-5#5)(2008-8#5)(2008-9#3)(2009-6#1)(2012-2#1)
purified human fibrinogen##2##3##(2008-10#2)
purified human##5##2##(1991-12#1)(1991-5#1)(1992-12#1)(2008-10#2)
purified in a single step##2##5##(2008-10#1)(2008-11#1)
purified in##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
purified insulin receptors##2##3##(1993-8#2)
purified materials##2##2##(2008-10#2)
purified mutant##2##2##(1990-10#1)(1993-8#1)
purified on##3##2##(1995-11#1)(1995-6#1)(2008-10#1)
purified p29##2##2##(1990-11#2)
purified placental AP##2##3##(2008-11#2)
purified protein derivative (PPD)##2##4##(1997-2#1)(2008-10#1)
purified protein was##4##3##(1995-11#1)(1996-12#1)(2008-10#1)(2008-9#1)
purified protein##14##2##(1990-11#1)(1992-3#1)(1992-7#2)(1992-8#2)(1994-5#1)(1995-11#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-9#1)
purified proteins##4##2##(1997-3#1)(2008-4#2)(2009-9#1)
purified rabbit##2##2##(1993-8#1)(2008-11#1)
purified rat##3##2##(1990-5#1)(1994-8#1)(1995-11#1)
purified recombinant##5##2##(1995-2#2)(2008-11#2)(2008-8#1)
purified single compound showed##2##4##(2008-11#2)
purified the##6##2##(1992-12#1)(1992-7#1)(1993-8#1)(1994-3#1)(1995-6#1)(2012-2#1)
purified to electrophoretic homogeneity##2##4##(1993-8#1)(1994-8#1)
purified to homogeneity by##5##4##(1991-12#1)(1993-8#1)(2008-8#1)(2009-3#1)(2010-4#1)
purified to homogeneity from##7##4##(1990-11#1)(1990-5#1)(1992-8#1)(1997-2#1)(2008-10#1)(2008-8#2)
purified to homogeneity##20##3##(1990-10#1)(1990-11#2)(1990-5#1)(1991-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#4)(2009-3#1)(2010-4#1)
purified to near homogeneity from##2##5##(1990-5#1)(1990-8#1)
purified to near homogeneity##5##4##(1990-5#1)(1990-8#1)(1991-5#1)(1993-6#1)(1994-8#1)
purified to##33##2##(1990-10#1)(1990-11#3)(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#6)(2009-3#1)(2010-4#1)(2011-2#1)
purified using##4##2##(1994-6#1)(2008-10#2)(2008-9#1)
purified virions##3##2##(2008-10#3)
purified virus##6##2##(2008-10#5)(2013-8#1)
purified water##2##2##(2008-10#1)(2012-2#1)
purified with##4##2##(1995-12#1)(2008-10#3)
purified##425##1##(1990-10#2)(1990-11#15)(1990-12#1)(1990-5#10)(1990-8#3)(1991-12#6)(1991-3#1)(1991-5#8)(1991-7#1)(1991-9#4)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#5)(1992-7#3)(1992-8#7)(1992-9#4)(1993-12#4)(1993-3#3)(1993-6#3)(1993-8#20)(1993-9#3)(1994-11#11)(1994-3#2)(1994-5#8)(1994-6#3)(1994-8#14)(1995-11#6)(1995-12#4)(1995-2#13)(1995-5#3)(1995-6#11)(1995-8#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#95)(2008-11#26)(2008-12#3)(2008-2#4)(2008-4#6)(2008-5#8)(2008-7#3)(2008-8#27)(2008-9#12)(2009-3#2)(2009-6#3)(2009-8#3)(2009-9#2)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#8)(2013-8#3)
purify##12##1##(1990-11#1)(1991-7#1)(1993-8#1)(1994-11#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
purifying##3##1##(2008-10#1)(2008-4#2)
purine and pyrimidine##4##3##(1992-8#2)(2008-10#2)
purine deoxynucleotide radical cations##2##4##(2008-9#2)
purine nucleoside##2##2##(1994-8#2)
purine nucleotides##3##2##(1993-8#1)(1996-8#1)(2008-10#1)
purine residues##2##2##(1992-4#1)(2008-10#1)
purine units within the ODN-chains##2##5##(2008-10#2)
purine units within the##3##4##(2008-10#3)
purine units##5##2##(2008-10#5)
purine##43##1##(1990-5#1)(1992-4#4)(1992-8#2)(1993-12#2)(1993-8#3)(1994-11#4)(1994-8#3)(1995-8#1)(1996-8#1)(2008-10#14)(2008-11#1)(2008-4#2)(2008-9#3)(2013-1#2)
purinergic##8##1##(1990-5#1)(1994-11#1)(1995-8#4)(2013-8#2)
purines are##2##2##(2013-8#2)
purines##10##1##(1992-4#1)(1997-2#1)(2008-10#2)(2008-4#1)(2013-8#5)
purinoceptor##5##1##(1995-11#5)
purity and enantiopurity##2##3##(2008-10#2)
purity and##11##2##(2008-10#6)(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-2#1)
purity fluorapatite##2##2##(2008-10#2)
purity in##2##2##(2008-10#1)(2008-7#1)
purity of the##6##3##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
purity of##19##2##(1992-11#2)(1994-5#1)(1994-6#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2013-1#1)
purity##63##1##(1992-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1996-5#1)(2008-10#32)(2008-11#7)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#4)(2009-10#1)(2009-3#1)(2011-1#1)(2012-2#2)(2013-1#1)
purity)##2##1##(2008-11#1)(2009-3#1)
puromycin##3##1##(1997-1#1)(2009-6#2)
purple color##3##2##(1994-5#1)(2008-10#2)
purple coloured##2##2##(2008-10#2)
purple coneflower (Echinacea purpurea)##2##4##(2008-10#2)
purple coneflower##3##2##(2008-10#3)
purple gene##2##2##(1997-8#2)
purple##26##1##(1990-12#1)(1993-8#2)(1994-5#1)(1997-8#4)(2008-10#12)(2008-8#1)(2009-9#2)(2011-2#2)(2011-3#1)
purported benefits of the##2##4##(1992-2#2)
purported benefits of##3##3##(1992-2#2)(2012-3#1)
purported##5##1##(1992-2#2)(2008-11#1)(2010-1#1)(2012-3#1)
purportedly##4##1##(2008-10#2)(2009-7#1)(2012-2#1)
purpose and##8##2##(1993-2#1)(1995-5#1)(2008-11#2)(2008-12#2)(2008-4#1)(2012-2#1)
purpose in##3##2##(1994-1#1)(2008-12#1)(2010-2#1)
purpose is to assess the##2##5##(1994-12#1)(1995-3#1)
purpose is to##16##3##(1994-12#1)(1995-3#1)(1996-2#2)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#4)
purpose is##18##2##(1994-12#1)(1995-3#1)(1996-2#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#4)
purpose of a##2##3##(2008-11#1)(2008-9#1)
purpose of launching##6##3##(2010-12#6)
purpose of the present##16##4##(1990-8#1)(1992-12#1)(1993-6#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
purpose of the##37##3##(1990-8#2)(1991-6#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-5#1)(1995-12#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-5#2)(2010-1#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
purpose of this article is to##23##6##(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
purpose of this article##26##4##(1992-1#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
purpose of this paper is to##13##6##(1992-1#1)(2008-11#5)(2008-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-3#2)
purpose of this paper##14##4##(1992-1#1)(1992-2#1)(2008-11#5)(2008-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-3#2)
purpose of this pilot study was to examine the##2##9##(2008-11#1)(2008-12#1)
purpose of this pilot study was to investigate##2##8##(2008-12#2)
purpose of this pilot study was to##5##7##(2008-11#1)(2008-12#4)
purpose of this study is to##15##6##(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
purpose of this study is##16##5##(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
purpose of this study was to describe##3##7##(2008-12#1)(2013-1#2)
purpose of this study was to determine if a##2##9##(2008-12#1)(2008-9#1)
purpose of this study was to determine if##3##8##(2008-12#1)(2008-9#1)(2010-6#1)
purpose of this study was to determine##18##7##(1991-11#1)(1994-5#1)(1997-8#1)(2008-12#3)(2008-7#1)(2008-9#2)(2010-2#1)(2010-4#1)(2010-6#3)(2012-2#2)(2013-1#2)
purpose of this study was to obtain##2##7##(1997-3#1)(2008-10#1)
purpose of this study was to##73##6##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#2)(2008-10#6)(2008-11#3)(2008-12#7)(2008-7#2)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
purpose of this study was##75##5##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#2)(2008-10#6)(2008-11#3)(2008-12#7)(2008-7#2)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#1)
purpose of this study##96##4##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#2)(2008-10#9)(2008-11#5)(2008-12#7)(2008-5#1)(2008-7#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#2)
purpose of this work##5##4##(1997-8#1)(2007-11#1)(2008-10#3)
purpose of this##194##3##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#2)(1992-1#2)(1992-2#2)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#2)(1996-6#2)(1997-3#2)(1997-8#3)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#13)(2008-12#17)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#2)(2010-11#4)(2010-12#5)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#12)(2012-3#5)(2013-1#10)(2013-8#5)
purpose of##291##2##(1990-11#1)(1990-2#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-1#3)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#2)(1996-2#2)(1996-5#2)(1996-6#2)(1997-3#3)(1997-8#3)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#31)(2008-11#22)(2008-12#19)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#13)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#3)(2012-2#17)(2012-3#8)(2013-1#13)(2013-8#10)
purpose the##3##2##(1997-1#1)(2008-3#1)(2008-5#1)
purpose to##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
purpose was to determine##3##4##(1991-6#1)(1993-2#1)(2013-1#1)
purpose was to##8##3##(1991-6#1)(1992-3#1)(1993-2#1)(1995-12#1)(2009-7#1)(2013-1#3)
purpose we##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
purpose##442##1##(1990-11#1)(1990-2#2)(1990-8#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#4)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#4)(1993-6#3)(1993-8#1)(1994-1#4)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-5#2)(1996-6#2)(1997-1#1)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#3)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#80)(2008-11#36)(2008-12#22)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#13)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#2)(2011-2#19)(2011-3#1)(2012-12#4)(2012-2#22)(2012-3#10)(2012-9#1)(2013-1#23)(2013-8#11)
purpose&quot##2##1##(2008-10#1)(2009-4#1)
purposeful##5##1##(1995-5#1)(2008-11#1)(2010-8#2)(2013-1#1)
purposes and##6##2##(1991-2#1)(2008-10#2)(2008-11#1)(2008-12#2)
purposes are##2##2##(2008-10#1)(2013-8#1)
purposes for##2##2##(1993-1#1)(1996-9#1)
purposes in##4##2##(1990-6#1)(2008-10#2)(2008-7#1)
purposes is presented##2##3##(2008-3#2)
purposes is##4##2##(1990-3#1)(2008-10#1)(2008-3#2)
purposes of the##2##3##(1994-12#1)(1994-3#1)
purposes of this review##2##4##(2009-1#1)(2013-1#1)
purposes of this study were##2##5##(1993-12#1)(2010-11#1)
purposes of this study##3##4##(1993-12#1)(2008-6#1)(2010-11#1)
purposes of this##8##3##(1993-12#1)(2008-3#1)(2008-6#1)(2009-1#1)(2010-11#1)(2010-9#1)(2012-3#1)(2013-1#1)
purposes of##25##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
purposes would##2##2##(1992-12#1)(2008-11#1)
purposes##142##1##(1990-2#1)(1990-3#2)(1990-6#2)(1991-12#4)(1991-2#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-8#1)(2008-1#1)(2008-10#40)(2008-11#13)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-7#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
purposes)##2##1##(2008-10#2)
purposive sample of##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
purposive##5##1##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)
purposively##2##1##(2008-11#1)(2010-11#1)
purpura in##2##2##(1997-8#1)(2008-10#1)
purpura##8##1##(1991-11#1)(1997-4#1)(1997-8#3)(2006-6#1)(2008-10#1)(2009-7#1)
purpuratus##4##1##(2011-2#1)(2013-8#3)
purpurea##9##1##(2008-10#9)
purpurea)##4##1##(2008-10#4)
purpuric rash##2##2##(1997-8#1)(2008-8#1)
purpuric##4##1##(1997-8#2)(2008-8#1)(2010-6#1)
purpurin##3##1##(1992-1#1)(2008-10#2)
pursue##17##1##(1991-2#1)(1992-1#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
pursued##8##1##(1991-2#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-2#1)(2010-1#1)(2010-4#1)(2013-1#1)
pursuing a##2##2##(1995-12#1)(2009-12#1)
pursuing##11##1##(1993-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-10#1)(2009-12#1)(2010-2#1)
pursuit of a moving##2##4##(2009-8#2)
pursuit of##10##2##(1993-2#1)(1996-1#1)(2008-12#1)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
pursuit##13##1##(1993-2#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#3)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
pursuits##2##1##(1996-1#1)(2010-4#1)
purulent drainage##2##2##(2011-2#2)
purulent secretion##2##2##(1993-2#2)
purulent##10##1##(1993-2#3)(2008-10#1)(2011-2#4)(2013-1#1)(2013-8#1)
push component##2##2##(2009-8#2)
push to##2##2##(1994-2#1)(2013-1#1)
push##10##1##(1991-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-10#2)(2009-8#2)(2010-10#1)(2013-1#1)
pushed##3##1##(1996-5#1)(2008-10#1)(2009-7#1)
pushes the##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
pushing the##2##2##(1993-3#1)(2013-1#1)
pushing##5##1##(1992-1#1)(1993-3#1)(1996-11#1)(2009-7#1)(2013-1#1)
pustular##3##1##(1997-5#2)(2012-3#1)
pustule production was##2##3##(2008-10#2)
pustule production##3##2##(2008-10#3)
pustule##11##1##(2008-10#11)
pustules on##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
pustules per##3##2##(2008-10#3)
pustules##11##1##(2008-10#7)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
put a##3##2##(2010-5#1)(2012-3#1)(2013-8#1)
put forth##3##2##(1997-3#1)(2008-11#1)(2012-2#1)
put forward##3##2##(1993-11#1)(2007-11#1)(2008-10#1)
put in place##7##3##(1991-1#1)(1991-3#1)(1995-2#2)(2010-1#1)(2011-3#1)(2012-12#1)
put in##10##2##(1991-1#1)(1991-3#1)(1992-12#1)(1992-8#1)(1995-2#2)(2010-1#2)(2011-3#1)(2012-12#1)
put into##6##2##(1990-11#1)(1994-1#2)(2008-8#1)(2010-10#1)(2010-8#1)
put it##2##2##(2008-11#1)(2009-10#1)
put on##2##2##(1995-2#1)(2011-2#1)
put the##4##2##(1991-3#1)(1994-1#1)(2008-11#1)(2010-5#1)
put them##2##2##(1996-3#1)(2008-10#1)
put together##2##2##(2010-7#1)(2011-2#1)
put##49##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#3)(1992-12#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-1#3)(1994-8#1)(1995-2#3)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#2)(2010-10#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
putamen and##5##2##(1995-8#1)(1996-12#2)(2008-7#2)
putamen##14##1##(1995-6#1)(1995-8#2)(1996-12#5)(2008-7#6)
putative &quot##2##2##(1996-6#1)(2008-10#1)
putative RNA##2##2##(2008-10#2)
putative avirulence gene##2##3##(2008-10#2)
putative avirulence##3##2##(2008-10#3)
putative binding sites##2##3##(1993-3#1)(2009-8#1)
putative binding##4##2##(1993-12#1)(1993-3#2)(2009-8#1)
putative closteroviruses##2##2##(2008-10#2)
putative converted isolates##2##3##(2008-10#2)
putative endogenous##2##2##(2012-2#2)
putative functional##2##2##(2008-10#2)
putative genes were identified##2##4##(1995-12#2)
putative genes##6##2##(1995-12#4)(2008-8#2)
putative genetic loci##3##3##(2008-10#3)
putative genetic##5##2##(2008-10#4)(2008-7#1)
putative identification##2##2##(2008-10#1)(2012-3#1)
putative membrane-spanning domains##2##3##(1995-2#1)(1997-7#1)
putative molecular##2##2##(1990-5#1)(2011-2#1)
putative movement protein##3##3##(2008-10#3)
putative new##6##2##(1992-6#1)(1994-8#1)(1995-9#1)(1997-8#1)(2008-10#1)(2011-2#1)
putative product of##2##3##(1993-2#1)(1995-6#1)
putative product##3##2##(1993-2#1)(1995-6#1)(1997-7#1)
putative promoter##6##2##(1992-6#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-9#1)(2009-10#1)
putative protein kinase##3##3##(1991-7#1)(2008-10#1)(2008-9#1)
putative protein##7##2##(1991-7#1)(1996-3#2)(2008-10#2)(2008-9#1)(2010-5#1)
putative proteins##3##2##(1995-9#1)(2008-10#1)(2008-8#1)
putative random amplified polymorphic DNA (RAPD) loci and##2##8##(2008-10#2)
putative random amplified polymorphic DNA##3##5##(2008-10#3)
putative ras gene of##2##4##(1997-4#2)
putative recombinant isolates##2##3##(2008-10#2)
putative resistance##2##2##(2008-10#2)
putative rice P450s##2##3##(2008-9#2)
putative role in##3##3##(1990-5#1)(1992-5#1)(2009-8#1)
putative role##10##2##(1990-11#1)(1990-5#1)(1992-5#1)(1993-3#1)(2008-10#3)(2008-12#1)(2009-8#2)
putative signal peptide of##2##4##(1992-8#1)(1993-2#1)
putative signal##3##2##(1992-8#1)(1993-2#1)(1993-3#1)
putative sister##2##2##(2008-10#2)
putative species##2##2##(2008-10#2)
putative transcription##2##2##(1991-9#1)(1993-6#1)
putative transmembrane##2##2##(1990-5#1)(1995-9#1)
putative transposable##3##2##(1995-12#1)(2008-10#2)
putative tumor suppressor##2##3##(1991-10#1)(1997-2#1)
putative virus-resistant transgenic##2##3##(2008-10#2)
putative virus-resistant##3##2##(2008-10#3)
putative##263##1##(1990-10#1)(1990-11#2)(1990-5#5)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#5)(1992-8#1)(1993-12#7)(1993-2#6)(1993-3#7)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-5#3)(1994-8#1)(1995-12#5)(1995-2#5)(1995-6#4)(1995-8#5)(1995-9#4)(1996-12#4)(1996-2#1)(1996-3#2)(1996-6#3)(1997-2#2)(1997-4#2)(1997-7#6)(1997-8#4)(1997-9#2)(2008-1#1)(2008-10#82)(2008-11#9)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#6)(2009-10#8)(2009-3#1)(2009-8#5)(2009-9#2)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#5)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#1)
putatively responsible for##2##3##(2007-12#1)(2011-1#1)
putatively##13##1##(1995-2#1)(1997-2#1)(2007-12#2)(2008-10#5)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
putida WCS358##5##2##(2008-10#5)
putida and##2##2##(2008-10#2)
putida strain##2##2##(2008-10#1)(2012-2#1)
putida was##3##2##(2008-10#2)(2008-7#1)
putida##49##1##(1994-5#1)(2008-10#35)(2008-7#4)(2011-2#6)(2012-2#3)
putidaredoxin##3##1##(1994-5#3)
putorius##2##1##(2008-6#2)
putrefaction##2##1##(2008-10#1)(2012-2#1)
putrescine and cadaverine##3##3##(2008-10#3)
putrescine and##6##2##(2008-10#6)
putrescine oxidase (PUO)##2##3##(2008-10#2)
putrescine oxidase enzyme activity##2##4##(2008-10#2)
putrescine oxidase##6##2##(2008-10#6)
putrescine was##2##2##(2008-10#1)(2009-6#1)
putrescine##26##1##(1994-8#1)(2008-10#18)(2009-6#1)(2011-2#2)(2012-2#1)(2013-8#3)
puts into##2##2##(2008-10#1)(2008-3#1)
puts this##2##2##(1997-8#1)(2010-11#1)
puts##13##1##(1992-3#2)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-3#1)(2009-10#1)(2010-11#1)(2012-2#1)(2012-3#2)
putting on##2##2##(1990-3#1)(2013-1#1)
putting##11##1##(1990-3#1)(1992-2#1)(1995-3#1)(1997-3#2)(1997-4#1)(2008-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2013-1#1)
puzzle##6##1##(1990-8#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2011-2#1)
puzzles##3##1##(2008-12#1)(2008-8#1)(2012-3#1)
puzzling##4##1##(1997-7#1)(2008-11#2)(2008-8#1)
pv##271##1##(2008-10#267)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)
pvs##11##1##(2008-10#11)
pycnia##2##1##(2008-10#2)
pycnial##2##1##(2008-10#2)
pycnidia and conidia##2##3##(2008-10#2)
pycnidia and##3##2##(2008-10#3)
pycnidia on##3##2##(2008-10#3)
pycnidia or ascocarps##2##3##(2008-10#2)
pycnidia per canker##2##3##(2008-10#2)
pycnidia##24##1##(2008-10#24)
pycnidial coverage##2##2##(2008-10#2)
pycnidiospore-derived isolates##3##2##(2008-10#3)
pycnometric density##2##2##(2008-10#2)
pyelogram##2##1##(1991-1#1)(2009-1#1)
pyelonephritic group##2##2##(2011-2#2)
pyelonephritic##4##1##(2011-2#4)
pyelonephritis and##2##2##(2011-2#2)
pyelonephritis in##2##2##(2011-2#1)(2012-3#1)
pyelonephritis were##2##2##(2008-10#1)(2011-2#1)
pyelonephritis##16##1##(2008-10#3)(2011-2#7)(2012-3#2)(2013-1#4)
pyeloplasty##3##1##(2008-10#3)
pygmy hogs##3##2##(2011-2#3)
pygmy phenotype##2##2##(1995-8#2)
pygmy##7##1##(1995-8#2)(1995-9#1)(2011-2#4)
pylori and##8##2##(1996-6#1)(1997-1#3)(1997-4#1)(2008-12#2)(2013-1#1)
pylori bound to##2##3##(1995-2#1)(1996-12#1)
pylori can##2##2##(1996-11#1)(1997-1#1)
pylori cells##2##2##(1996-12#2)
pylori eradication##4##2##(1997-1#2)(2010-12#2)
pylori from gastric biopsy specimens##2##5##(2008-12#2)
pylori from##3##2##(1997-1#1)(2008-12#2)
pylori has been shown##2##4##(1997-1#1)(2011-2#1)
pylori has been##3##3##(1997-1#2)(2011-2#1)
pylori infected##2##2##(2008-12#1)(2012-12#1)
pylori infection and IR##3##4##(2013-1#3)
pylori infection and##5##3##(1997-1#1)(2013-1#4)
pylori infection##25##2##(1990-2#1)(1992-5#2)(1995-2#2)(1996-11#1)(1997-1#8)(2008-10#1)(2008-12#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#5)
pylori proteins##2##2##(2009-6#2)
pylori strains##3##2##(2008-12#3)
pylori was##2##2##(1990-3#1)(2008-12#1)
pylori were##2##2##(1997-8#1)(2008-12#1)
pylori##101##1##(1990-11#1)(1990-2#1)(1990-3#1)(1992-5#3)(1995-2#4)(1996-11#3)(1996-12#9)(1996-6#1)(1997-1#27)(1997-4#1)(1997-8#5)(2008-10#2)(2008-12#15)(2009-6#5)(2009-8#1)(2010-12#5)(2011-2#8)(2012-12#3)(2013-1#6)
pylori-infection##2##1##(1990-2#2)
pylori-mediated activation of NFκB and##2##5##(2011-2#2)
pyloric foregut##2##2##(2007-12#2)
pyloric stenosis##2##2##(1990-9#1)(2010-12#1)
pyloric##9##1##(1990-9#2)(1991-3#1)(1997-1#1)(2007-12#3)(2010-12#2)
pyoderma##6##1##(1996-6#1)(2013-1#5)
pyogenes infection##2##2##(2008-9#2)
pyogenes is##2##2##(2008-9#2)
pyogenes##15##1##(1991-8#1)(1996-12#2)(2008-9#6)(2011-2#6)
pyogenic##2##1##(2010-6#1)(2013-7#1)
pyoverdin##2##1##(2008-10#2)
pyramid##13##1##(1992-1#1)(2008-10#2)(2008-6#9)(2008-7#1)
pyramid-based##2##1##(2008-6#2)
pyramidal cells and##2##3##(1990-5#2)
pyramidal cells in##4##3##(1995-3#1)(1997-3#1)(2008-11#2)
pyramidal cells##14##2##(1990-5#3)(1991-7#1)(1995-3#1)(1996-12#1)(1997-3#1)(2008-11#6)(2009-8#1)
pyramidal neurons of the##2##4##(1995-3#1)(2013-8#1)
pyramidal neurons##10##2##(1991-2#1)(1992-12#1)(1995-3#2)(1995-8#2)(2008-11#2)(2009-8#1)(2013-8#1)
pyramidal##36##1##(1990-5#3)(1991-2#1)(1991-7#1)(1992-1#1)(1992-12#1)(1995-3#3)(1995-8#3)(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#14)(2008-7#2)(2009-8#2)(2013-8#1)
pyramiding of##2##2##(2008-10#2)
pyramiding##8##1##(2008-10#7)(2008-8#1)
pyramids##4##1##(2008-10#2)(2008-6#1)(2011-2#1)
pyrantel pamoate and mebendazole##2##4##(2008-10#2)
pyrantel pamoate in##2##3##(2008-10#2)
pyrantel pamoate##7##2##(2008-10#7)
pyrantel##8##1##(2008-10#8)
pyrazinamide##3##1##(2008-1#1)(2008-10#2)
pyrazine##3##1##(1991-6#2)(1992-10#1)
pyrazole##3##1##(1994-11#1)(2008-10#1)(2008-5#1)
pyrazolone##2##1##(2008-10#2)
pyrenaica##2##1##(2008-10#2)
pyrene carboxylic acid to##2##4##(2008-10#2)
pyrene carboxylic acid##8##3##(2008-10#8)
pyrene##19##1##(2008-10#18)(2009-11#1)
pyrenoid##2##1##(2009-10#2)
pyrethroid##8##1##(1996-12#1)(1997-5#2)(2008-10#4)(2008-9#1)
pyrethroids in##2##2##(1997-5#1)(2008-10#1)
pyrethroids##8##1##(1997-5#1)(2008-10#6)(2012-12#1)
pyrexia##2##1##(1991-3#1)(2011-2#1)
pyri##3##1##(2008-10#3)
pyridine 2##2##2##(2008-10#2)
pyridine and##2##2##(2008-10#2)
pyridine derivatives##3##2##(2008-10#3)
pyridine nucleotide##7##2##(1992-1#3)(1994-3#1)(1994-8#1)(1996-2#1)(2009-9#1)
pyridine nucleotides##3##2##(1994-8#2)(1996-2#1)
pyridine or##2##2##(2008-10#1)(2012-12#1)
pyridine ring as ionophores##2##4##(2008-10#2)
pyridine ring##3##2##(2008-10#3)
pyridine##40##1##(1990-6#1)(1992-1#3)(1992-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#4)(1996-2#2)(2008-10#20)(2008-3#2)(2009-9#2)(2012-12#2)
pyridines##6##1##(1993-8#3)(2008-10#2)(2009-10#1)
pyridinium##11##1##(1992-12#2)(1995-8#1)(1996-12#1)(2008-10#4)(2010-6#1)(2011-2#2)
pyridoxine HCl##2##2##(2008-10#1)(2008-11#1)
pyridoxine hydrochloride##6##2##(2008-10#6)
pyridoxine##14##1##(2008-10#10)(2008-11#1)(2010-9#1)(2013-1#2)
pyridyl##2##1##(2008-10#2)
pyridylazo##3##1##(2008-10#3)
pyrifoliae and##3##2##(2008-10#3)
pyrifoliae##6##1##(2008-10#6)
pyrimethamine##5##1##(1990-9#1)(2008-10#4)
pyrimidine bases##2##2##(2008-10#1)(2008-11#1)
pyrimidine biosynthesis##2##2##(1990-7#1)(1992-8#1)
pyrimidine##13##1##(1990-7#1)(1992-8#2)(1993-8#2)(1994-8#1)(1996-8#1)(2008-10#3)(2008-11#2)(2008-9#1)
pyrimidines and purines on##2##4##(2008-10#2)
pyrimidines##4##1##(2008-10#2)(2008-9#2)
pyrina##2##1##(2008-10#2)
pyrite as a sensor##2##4##(2008-10#2)
pyrite##3##1##(2008-10#3)
pyrithione (ZPT)##2##2##(2008-10#1)(2008-5#1)
pyrithione##9##1##(2008-10#2)(2008-11#1)(2008-5#6)
pyrocatechol violet complexes on##2##4##(2008-10#2)
pyrocatechol violet##5##2##(2008-10#5)
pyrocatechol##15##1##(2008-10#15)
pyrochlore##3##1##(1992-11#1)(2008-10#2)
pyrogallic acid##2##2##(2008-10#2)
pyrogallol and##2##2##(2008-10#2)
pyrogallol red##2##2##(2008-10#2)
pyrogallol##23##1##(2008-10#23)
pyrolysis and atomization steps were##2##5##(2008-10#2)
pyrolysis and atomization temperatures were##2##5##(2008-10#2)
pyrolysis and atomization temperatures##13##4##(2008-10#13)
pyrolysis and atomization were respectively of##2##6##(2008-10#2)
pyrolysis and atomization were##3##4##(2008-10#3)
pyrolysis and atomization##21##3##(2008-10#21)
pyrolysis and vaporization##2##3##(2008-10#2)
pyrolysis and##26##2##(2008-10#25)(2008-11#1)
pyrolysis at 1350 degrees C##2##5##(2008-10#2)
pyrolysis behavior of##2##3##(2008-10#2)
pyrolysis of the##3##3##(2008-10#2)(2008-3#1)
pyrolysis of##5##2##(2008-10#4)(2008-3#1)
pyrolysis products##2##2##(2008-3#1)(2010-3#1)
pyrolysis temperature of##2##3##(2008-10#2)
pyrolysis temperature##8##2##(2008-10#8)
pyrolysis temperatures of##2##3##(2008-10#2)
pyrolysis temperatures##7##2##(2008-10#7)
pyrolysis##67##1##(2008-10#61)(2008-11#2)(2008-3#2)(2010-3#2)
pyrolysis-gas chromatography/mass spectrometry##3##3##(2008-10#3)
pyrolysis-mass spectrometry##2##2##(2008-10#2)
pyrolytic graphite electrode##2##3##(2008-10#2)
pyrolytic graphite##11##2##(2008-10#10)(2008-8#1)
pyrolytic##12##1##(2008-10#11)(2008-8#1)
pyronin Y##2##2##(2008-9#2)
pyrophosphatase##2##1##(2008-11#1)(2008-7#1)
pyrophosphate synthase##2##2##(2008-8#2)
pyrophosphate##12##1##(1990-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(2008-10#4)(2008-8#3)
pyrosequencing##5##1##(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
pyrrole and##2##2##(2008-10#2)
pyrrole in the##2##3##(1996-5#1)(2008-10#1)
pyrrole moiety##2##2##(2008-10#2)
pyrrole monomer##2##2##(2008-10#2)
pyrrole##16##1##(1992-3#1)(1994-5#2)(1996-5#2)(2008-10#11)
pyrrolidine dithiocarbamate (APDC)##9##3##(2008-10#9)
pyrrolidine dithiocarbamate##10##2##(2008-10#10)
pyrrolidine##16##1##(1991-5#1)(1995-11#1)(2008-10#11)(2012-2#3)
pyrrolidinecarbodithioate chelates##2##2##(2008-10#2)
pyrrolidinecarbodithioate##3##1##(2008-10#3)
pyrrolidinedithiocarbamate##3##1##(2008-10#2)(2008-11#1)
pyrrolidone##5##1##(2008-10#2)(2008-5#3)
pyrrolo[1##2##1##(2008-11#2)
pyrrolobenzoxazepines##2##1##(2012-2#2)
pyrroloquinoline##2##1##(2008-10#2)
pyruvate carboxylase##3##2##(1991-3#1)(2008-11#2)
pyruvate decarboxylase and##2##3##(2008-10#1)(2011-2#1)
pyruvate decarboxylase##4##2##(1993-8#1)(2008-10#2)(2011-2#1)
pyruvate dehydrogenase##2##2##(1991-3#2)
pyruvate in##5##2##(2008-10#5)
pyruvate kinase (PK)##2##3##(1997-6#1)(2008-7#1)
pyruvate kinase activity##4##3##(1995-12#4)
pyruvate kinase only##2##3##(1990-5#2)
pyruvate kinase##19##2##(1990-5#7)(1991-3#1)(1994-3#1)(1994-8#1)(1995-12#5)(1997-6#1)(2008-7#3)
pyruvate oxidase G##2##3##(2008-10#2)
pyruvate oxidase##3##2##(2008-10#3)
pyruvate##55##1##(1990-5#7)(1991-3#4)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#3)(1995-12#5)(1995-8#2)(1997-1#1)(1997-6#2)(2008-10#18)(2008-11#2)(2008-7#6)(2011-2#1)(2013-1#1)
pyruvate-kinase##2##1##(1991-3#2)
pyruvic##2##1##(1993-8#1)(2008-11#1)
pythiaceous species##3##2##(2008-10#3)
pythium species##2##2##(2008-10#2)
pythium##5##1##(2008-10#5)
p &lt##10##1##(2012-5#7)(2013-1#1)(2013-8#2)
p =##3##1##(2013-1#3)
p = 0##8##1##(2012-5#3)(2013-1#2)(2013-8#3)
p &lt##9##1##(2010-11#7)(2011-2#1)(2012-2#1)
p = 0##12##1##(2010-11#4)(2011-2#3)(2012-2#2)(2013-1#3)
q (Ab)##3##2##(2008-11#3)
q##7##1##(1996-12#1)(2008-10#2)(2008-11#3)(2011-2#1)
q-PCR##3##1##(2008-10#3)
q-switched laser##2##2##(2008-2#1)(2008-3#1)
q-switched##3##1##(2008-2#1)(2008-3#2)
q/ha)##2##1##(2011-1#2)
q21) translocation##2##2##(1990-5#1)(2010-11#1)
q21)##4##1##(1990-5#1)(2009-8#2)(2010-11#1)
qEEG##6##1##(2008-7#6)
qPCR assay##2##2##(2009-6#1)(2013-1#1)
qPCR##7##1##(2009-6#3)(2013-1#3)(2013-8#1)
q] and##2##2##(2009-3#2)
q] nanotubes##2##2##(2009-3#2)
q]##4##1##(2009-3#4)
qcr1 and qcr4##2##3##(2012-3#2)
qcr1##4##1##(2012-3#4)
qcr4##4##1##(2012-3#4)
qdot##2##1##(2008-10#2)
qdots##3##1##(2008-10#3)
qi and strengthening##2##3##(2013-8#2)
qi##6##1##(2008-10#3)(2013-8#3)
qigong##3##1##(2008-10#3)
quad##2##1##(2008-10#1)(2013-1#1)
quadecaurelia##2##1##(2008-12#2)
quadrant of the##3##3##(1991-12#1)(2009-7#1)(2011-2#1)
quadrant##10##1##(1991-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
quadrantectomy and##3##2##(1992-12#1)(1994-12#2)
quadrantectomy##4##1##(1992-12#2)(1994-12#2)
quadrants##3##1##(2009-7#2)(2011-2#1)
quadrapole detector in Shimadzu QP-5000 gas chromatograph-mass spectrometer##2##8##(2008-10#2)
quadrat shape##3##2##(2008-10#3)
quadrat size and shape##3##4##(2008-10#3)
quadrat size and##5##3##(2008-10#5)
quadrat size##15##2##(2008-10#14)(2008-8#1)
quadrat sizes tested##3##3##(2008-10#3)
quadrat sizes##6##2##(2008-10#6)
quadrat to the##2##3##(2008-10#2)
quadrat variance##3##2##(2008-10#3)
quadrat was##2##2##(2008-10#2)
quadrat##47##1##(2008-10#45)(2008-8#2)
quadrat-based##2##1##(2008-10#2)
quadratic discriminant analysis (QDA)##2##4##(2008-10#2)
quadratic discriminant##4##2##(1991-12#2)(2008-10#2)
quadratic equation##3##2##(2008-10#3)
quadratic selection##4##2##(2008-8#4)
quadratic##27##1##(1991-12#3)(1993-9#1)(2007-11#2)(2008-10#11)(2008-3#2)(2008-6#2)(2008-8#4)(2013-1#1)(2013-8#1)
quadrats of##4##2##(2008-10#3)(2008-8#1)
quadrats with##2##2##(2008-10#2)
quadrats##22##1##(2008-10#21)(2008-8#1)
quadrature scheme for##2##3##(2008-3#2)
quadrature scheme##5##2##(2008-3#5)
quadrature##6##1##(2008-3#5)(2009-3#1)
quadriceps muscle strength##5##3##(2011-2#3)(2013-1#2)
quadriceps muscle##8##2##(2008-4#1)(2011-2#3)(2012-3#1)(2013-1#3)
quadriceps##15##1##(2008-12#2)(2008-4#1)(2009-3#1)(2009-4#1)(2011-2#3)(2012-3#1)(2013-1#6)
quadrigeminal plate##2##2##(2008-7#2)
quadriparesis##2##1##(2008-12#1)(2008-7#1)
quadrivalent HPV-6/11/16/18##2##2##(2013-1#2)
quadrivalent meningococcal vaccine##2##3##(2013-1#2)
quadrivalent meningococcal##3##2##(2013-1#3)
quadrivalent##7##1##(1995-5#1)(2013-1#6)
quadrupedal##2##1##(1994-8#2)
quadruple##2##1##(2010-12#2)
quadrupled##2##1##(2008-11#1)(2008-3#1)
quadruplex##3##1##(1995-11#2)(2008-4#1)
quadrupole and##2##2##(2008-10#2)
quadrupole ion##2##2##(2008-10#1)(2010-7#1)
quadrupole mass spectrometer##2##3##(2008-10#1)(2010-9#1)
quadrupole mass spectrometry##3##3##(2008-10#3)
quadrupole mass##6##2##(2008-10#5)(2010-9#1)
quadrupole time-of-flight mass##2##3##(2008-10#2)
quadrupole time-of-flight##3##2##(2008-10#3)
quadrupole##20##1##(2008-10#17)(2010-7#1)(2010-9#1)(2013-8#1)
quail (Coturnix##2##2##(2008-12#2)
quail OPN##2##2##(2009-7#2)
quail and##2##2##(1993-6#1)(2008-12#1)
quail chicks##4##2##(2008-6#4)
quail embryo fibroblasts##3##3##(1993-6#2)(1995-2#1)
quail##26##1##(1993-6#5)(1995-2#2)(1995-6#3)(2008-12#9)(2008-6#4)(2008-8#1)(2009-7#2)
quails##7##1##(2008-12#7)
qualia##5##1##(2012-2#5)
qualification##7##1##(1994-12#2)(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
qualifications of##2##2##(1990-12#1)(1992-1#1)
qualifications##12##1##(1990-12#3)(1992-1#2)(1993-3#1)(1994-12#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
qualified and##2##2##(1992-3#1)(2008-11#1)
qualified as##3##2##(1991-6#1)(2012-3#2)
qualified by##2##2##(2008-11#1)(2010-1#1)
qualified for the##2##3##(1995-1#1)(2012-3#1)
qualified for##4##2##(1991-12#1)(1995-1#1)(2012-3#2)
qualified in the##2##3##(2008-10#1)(2013-8#1)
qualified in##3##2##(2008-10#1)(2009-12#1)(2013-8#1)
qualified managers##2##2##(1995-2#1)(2012-3#1)
qualified nurses##3##2##(2008-11#2)(2008-12#1)
qualified##30##1##(1991-12#1)(1991-6#1)(1992-3#2)(1994-1#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-10#3)(2008-11#7)(2008-12#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2012-3#5)(2013-8#1)
qualify for##2##2##(1994-2#1)(2008-1#1)
qualify##4##1##(1992-12#1)(1994-2#1)(2008-1#1)(2012-3#1)
qualifying##9##1##(2008-11#5)(2012-12#1)(2013-8#3)
qualitative agreement##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
qualitative analysis of the##2##4##(1993-3#1)(1994-2#1)
qualitative analysis of##11##3##(1993-3#1)(1994-2#1)(2008-10#7)(2013-1#2)
qualitative analysis##16##2##(1993-3#1)(1994-2#1)(2008-10#7)(2008-9#1)(2010-10#2)(2013-1#4)
qualitative and quantitative analysis of##4##5##(2008-10#2)(2008-5#1)(2012-3#1)
qualitative and quantitative analysis##5##4##(2008-10#3)(2008-5#1)(2012-3#1)
qualitative and quantitative differences in the##2##6##(2008-10#1)(2013-1#1)
qualitative and quantitative differences in##3##5##(2008-10#1)(2013-1#2)
qualitative and quantitative information##2##4##(2008-10#1)(2013-1#1)
qualitative and quantitative##24##3##(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
qualitative and##28##2##(1991-5#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-10#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#4)
qualitative approach was##2##3##(2012-3#1)(2013-1#1)
qualitative approach##6##2##(2008-10#1)(2009-5#1)(2010-10#1)(2012-3#2)(2013-1#1)
qualitative aspects of##3##3##(1992-9#1)(2009-10#1)(2011-2#1)
qualitative conclusions##2##2##(1995-5#1)(2008-8#1)
qualitative content analysis##5##3##(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#2)
qualitative content##7##2##(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#2)(2013-1#2)
qualitative data on##3##3##(1991-8#1)(2009-5#1)(2012-2#1)
qualitative data##12##2##(1990-9#1)(1991-8#1)(2008-10#1)(2008-11#3)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
qualitative descriptive study##4##3##(2008-11#1)(2010-10#1)(2010-9#1)(2013-8#1)
qualitative descriptive##5##2##(2008-11#1)(2010-10#1)(2010-9#1)(2012-3#1)(2013-8#1)
qualitative detection##2##2##(2008-9#2)
qualitative differences in##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
qualitative differences##5##2##(1995-5#1)(2008-10#2)(2008-8#1)(2013-8#1)
qualitative evaluation of##2##3##(2008-1#1)(2008-10#1)
qualitative evaluation##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
qualitative features of##2##3##(1992-9#1)(2008-8#1)
qualitative features##3##2##(1992-9#1)(2008-8#2)
qualitative information##4##2##(1994-9#1)(2008-10#2)(2008-11#1)
qualitative interviews were##2##3##(2010-4#1)(2013-1#1)
qualitative interviews##5##2##(2008-1#1)(2008-11#1)(2008-12#1)(2010-4#1)(2013-1#1)
qualitative methodology##2##2##(2008-12#2)
qualitative methods to##2##3##(2008-12#1)(2013-1#1)
qualitative methods##3##2##(2008-12#1)(2013-1#2)
qualitative or quantitative##2##3##(2008-10#1)(2012-2#1)
qualitative phase##2##2##(2008-11#1)(2011-2#1)
qualitative research and##3##3##(1997-3#1)(2008-10#1)(2012-3#1)
qualitative research is##2##3##(1997-3#2)
qualitative research methodology##4##3##(1995-3#2)(2008-11#1)(2008-9#1)
qualitative research##22##2##(1995-3#2)(1997-1#2)(1997-3#5)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-9#1)(2010-10#1)(2010-9#1)(2012-3#2)
qualitative resistance##2##2##(2008-10#2)
qualitative result##2##2##(2008-10#1)(2011-2#1)
qualitative studies##2##2##(1997-3#1)(2008-10#1)
qualitative study of the experiences of##2##6##(2008-11#1)(2008-9#1)
qualitative study of the##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
qualitative study was##4##3##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#1)
qualitative study##25##2##(2008-11#5)(2008-12#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
qualitative##238##1##(1990-9#1)(1991-5#1)(1991-8#1)(1992-9#2)(1993-1#2)(1993-3#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#3)(1995-5#2)(1996-11#1)(1997-1#2)(1997-3#7)(2006-6#1)(2008-1#4)(2008-10#49)(2008-11#30)(2008-12#13)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#7)(2009-10#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#14)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#4)(2011-2#9)(2011-7#1)(2012-2#7)(2012-3#10)(2013-1#23)(2013-8#6)
qualitatively and quantitatively##7##3##(1991-5#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
qualitatively different from the##2##4##(2008-7#1)(2008-9#1)
qualitatively different to##2##3##(2008-10#1)(2008-12#1)
qualitatively different##7##2##(1996-5#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)
qualitatively for##3##2##(1997-8#1)(2008-10#2)
qualitatively preserved##2##2##(2008-7#2)
qualitatively similar##3##2##(1997-2#1)(2008-11#1)(2008-8#1)
qualitatively##44##1##(1991-5#1)(1991-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#2)(2008-10#11)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
qualities and##3##2##(1990-12#1)(2011-2#1)(2012-5#1)
qualities of the##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
qualities of##8##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-11#1)
qualities were##2##2##(2011-2#2)
qualities##32##1##(1990-12#4)(1993-12#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-11#1)(2011-2#4)(2012-3#1)(2012-5#1)
quality after##2##2##(2008-10#1)(2008-3#1)
quality and accessibility##2##3##(2008-11#2)
quality and cost##2##3##(2008-10#1)(2008-11#1)
quality and efficiency##2##3##(1992-2#1)(2013-1#1)
quality and outcomes##2##3##(1994-2#1)(2009-12#1)
quality and quantity of##4##4##(1997-6#1)(2008-11#1)(2011-10#1)(2012-2#1)
quality and safety of##2##4##(2011-2#1)(2013-1#1)
quality and safety##6##3##(2010-7#1)(2010-8#1)(2011-2#3)(2013-1#1)
quality and service##2##3##(1995-12#1)(1996-2#1)
quality and the##6##3##(1993-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-2#1)
quality and value##2##3##(1993-3#1)(1995-2#1)
quality and##74##2##(1991-3#1)(1991-6#1)(1992-2#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)
quality are##4##2##(1993-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
quality as##4##2##(1994-1#1)(2008-8#1)(2008-9#1)(2011-2#1)
quality assessment and improvement system for long-term care##2##8##(1997-1#2)
quality assessment and improvement##4##4##(1996-1#1)(1997-1#2)(1997-2#1)
quality assessment and##6##3##(1993-3#1)(1996-1#1)(1997-1#2)(1997-2#1)(2008-10#1)
quality assessment##17##2##(1991-3#1)(1993-3#1)(1996-1#1)(1997-1#3)(1997-2#1)(2008-10#3)(2008-12#2)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
quality assurance (QA)##3##3##(1994-2#1)(1995-3#2)
quality assurance and audits##2##4##(2008-11#2)
quality assurance and quality control##2##5##(2008-10#2)
quality assurance and##9##3##(1994-1#1)(1994-6#1)(1995-3#1)(2008-10#3)(2008-11#2)(2012-2#1)
quality assurance in##3##3##(1992-1#1)(2010-12#1)(2012-2#1)
quality assurance program##5##3##(2008-4#1)(2008-6#4)
quality assurance programs##3##3##(1995-1#1)(2010-12#1)(2012-2#1)
quality assurance system##3##3##(2012-12#2)(2012-2#1)
quality assurance##62##2##(1990-9#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-5#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#4)(1996-1#1)(1996-12#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#7)(2008-9#1)(2010-12#2)(2012-12#3)(2012-2#5)
quality at the community level##2##5##(2013-1#2)
quality at##6##2##(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#2)
quality attributes##2##2##(1995-12#1)(2012-2#1)
quality can be##3##3##(2008-4#1)(2008-6#1)(2008-8#1)
quality can##4##2##(2008-4#1)(2008-6#1)(2008-8#2)
quality care##11##2##(1992-3#1)(1993-1#2)(1994-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#2)(2010-7#1)(2013-8#1)
quality changes##3##2##(1993-1#2)(2011-2#1)
quality clinical##2##2##(1992-3#1)(2008-11#1)
quality control analysis##3##3##(2008-10#2)(2012-2#1)
quality control and##6##3##(1994-6#1)(2008-10#2)(2010-9#1)(2011-3#1)(2013-1#1)
quality control during##2##3##(2010-8#1)(2012-2#1)
quality control in the##2##4##(2008-10#1)(2008-9#1)
quality control in##8##3##(1994-3#1)(2008-10#4)(2008-4#1)(2008-9#2)
quality control material##2##3##(2008-10#2)
quality control measures##2##3##(1994-6#1)(2013-1#1)
quality control of##19##3##(1991-9#1)(1994-1#1)(1995-5#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-3#1)
quality control program##2##3##(1994-12#1)(2008-9#1)
quality control##78##2##(1991-9#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#2)(1995-5#1)(2008-10#33)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-9#11)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#2)(2012-2#3)(2013-1#2)
quality could##2##2##(2008-11#1)(2011-2#1)
quality course management##2##3##(2008-12#2)
quality criteria##5##2##(1995-2#1)(2008-11#4)
quality differences between##2##3##(1992-3#1)(2008-8#1)
quality differences##3##2##(1992-3#1)(2008-8#2)
quality evaluation of##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
quality evaluation##5##2##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
quality factor##4##2##(2007-11#2)(2008-3#1)(2009-5#1)
quality for##6##2##(1996-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)
quality health care##4##3##(1992-1#1)(1997-3#1)(2008-11#1)(2010-11#1)
quality improvement (CQI)##4##3##(1993-3#2)(1994-1#1)(1994-2#1)
quality improvement and##6##3##(1993-12#1)(1993-3#2)(1994-3#1)(1996-2#1)(2009-3#1)
quality improvement at##2##3##(1993-3#1)(2010-6#1)
quality improvement efforts##2##3##(1997-1#1)(2013-1#1)
quality improvement in the##3##4##(1993-3#2)(1994-2#1)
quality improvement in##8##3##(1993-3#2)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-11#1)(1997-1#1)
quality improvement initiative##3##3##(2013-1#3)
quality improvement initiatives##2##3##(1997-1#1)(2010-8#1)
quality improvement of##2##3##(1993-12#1)(1997-8#1)
quality improvement paradigm##2##3##(1996-2#2)
quality improvement project models##2##4##(1993-12#2)
quality improvement project##3##3##(1993-12#2)(1993-3#1)
quality improvement strategies##2##3##(1994-3#1)(2013-1#1)
quality improvement team##3##3##(1993-12#2)(1994-12#1)
quality improvement teams##4##3##(1993-12#3)(1994-1#1)
quality improvement to manage##2##4##(1994-3#1)(1995-12#1)
quality improvement##79##2##(1993-12#10)(1993-3#12)(1994-1#8)(1994-12#4)(1994-2#4)(1994-3#4)(1995-1#1)(1995-12#1)(1995-2#6)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#3)(1997-1#6)(1997-3#1)(1997-8#1)(2009-3#4)(2010-6#1)(2010-8#1)(2012-2#2)(2013-1#6)
quality in a##2##3##(1993-12#1)(2011-2#1)
quality in qualitative research##2##4##(2008-11#2)
quality in the##6##3##(1992-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-9#1)(2008-10#1)
quality in##26##2##(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#3)(2010-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
quality indicators (QIs)##2##3##(1996-2#2)
quality indicators and##2##3##(1997-3#1)(2008-11#1)
quality indicators in##2##3##(2010-12#2)
quality indicators##15##2##(1996-2#4)(1997-3#4)(2008-11#3)(2009-8#1)(2010-12#2)(2012-2#1)
quality indices##2##2##(2008-11#1)(2012-2#1)
quality information##6##2##(1993-2#1)(1994-2#1)(1997-3#2)(2008-11#1)(2008-8#1)
quality initiative##5##2##(1995-3#1)(2013-1#4)
quality is##11##2##(1991-3#1)(1991-6#1)(1993-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#3)(2013-8#1)
quality management (TQM)##8##3##(1993-12#1)(1993-3#3)(1994-1#1)(1994-2#2)(1995-3#1)
quality management and##2##3##(1993-12#1)(1997-3#1)
quality management in##3##3##(1994-12#1)(1994-2#2)
quality management to improve##2##4##(1993-3#1)(1994-1#1)
quality management##45##2##(1992-12#1)(1993-12#3)(1993-2#1)(1993-3#6)(1994-1#12)(1994-12#2)(1994-2#6)(1994-3#1)(1995-1#2)(1995-3#3)(1996-1#2)(1997-3#1)(2008-11#4)(2008-6#1)
quality measure##2##2##(1991-3#1)(2012-2#1)
quality measurement##3##2##(1994-3#1)(2008-11#1)(2008-4#1)
quality monitoring##4##2##(2008-10#4)
quality movement##2##2##(1992-11#1)(1996-2#1)
quality nursing##2##2##(1991-2#1)(2008-11#1)
quality of a##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
quality of all##2##3##(2008-10#1)(2013-1#1)
quality of care and##2##4##(1996-2#1)(2008-12#1)
quality of care delivered##2##4##(1995-2#1)(2008-7#1)
quality of care for##2##4##(1997-2#1)(2008-3#1)
quality of care in these##2##5##(1992-3#1)(1997-1#1)
quality of care in##9##4##(1992-3#1)(1994-12#1)(1995-12#1)(1996-2#3)(1997-1#1)(2008-11#1)(2008-3#1)
quality of care under##3##4##(1992-2#1)(1996-2#2)
quality of care##62##3##(1990-6#1)(1991-3#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1995-12#2)(1995-2#3)(1995-3#3)(1996-1#2)(1996-2#10)(1997-1#2)(1997-2#5)(1997-3#1)(1997-8#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-3#3)(2008-7#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
quality of communication##3##3##(2010-4#1)(2011-2#1)(2013-1#1)
quality of data##2##3##(1994-2#1)(2009-10#1)
quality of food##2##3##(2008-10#1)(2008-11#1)
quality of health care in##2##5##(1997-4#1)(2008-1#1)
quality of health care##5##4##(1993-12#1)(1993-2#1)(1996-2#1)(1997-4#1)(2008-1#1)
quality of health services##2##4##(1997-1#1)(2008-11#1)
quality of health##8##3##(1993-12#2)(1993-2#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-11#1)
quality of healthcare##2##3##(2008-1#1)(2013-1#1)
quality of life (QOL) in##2##5##(1994-12#1)(2011-2#1)
quality of life (QOL)##5##4##(1994-12#1)(2008-7#1)(2010-4#1)(2011-2#2)
quality of life (QoL)##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
quality of life and reduce the##2##6##(2010-11#1)(2011-2#1)
quality of life and##15##4##(1992-1#1)(1995-2#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
quality of life for##6##4##(1994-5#1)(2008-5#1)(2010-12#1)(2012-12#2)(2012-3#1)
quality of life in Bulgaria##3##5##(2013-1#3)
quality of life in patients with##7##6##(2008-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#1)(2013-8#2)
quality of life in patients##8##5##(2008-12#1)(2008-7#2)(2009-7#1)(2009-9#1)(2011-2#1)(2013-8#2)
quality of life in the##3##5##(1993-6#1)(2008-10#1)(2011-2#1)
quality of life in##26##4##(1990-2#1)(1992-11#1)(1993-6#1)(2008-10#1)(2008-12#2)(2008-7#3)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#5)(2012-3#1)(2013-1#4)(2013-8#2)
quality of life is##2##4##(1996-11#1)(2013-1#1)
quality of life of patients with##3##6##(2008-7#1)(2009-1#1)(2011-2#1)
quality of life of patients##4##5##(1996-2#1)(2008-7#1)(2009-1#1)(2011-2#1)
quality of life of the patient##2##6##(1993-11#1)(2011-3#1)
quality of life of the##3##5##(1993-11#1)(2010-11#1)(2011-3#1)
quality of life of##10##4##(1993-11#1)(1996-2#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-11#1)(2011-2#2)(2011-3#1)
quality of life than##2##4##(1991-2#1)(2013-1#1)
quality of life through##2##4##(2012-3#1)(2013-8#1)
quality of life with##2##4##(1995-3#1)(2009-6#1)
quality of life##143##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#4)(1996-3#1)(1997-1#2)(1997-5#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#14)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#3)(2010-10#3)(2010-11#4)(2010-12#6)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#18)(2011-3#2)(2011-7#1)(2012-12#6)(2012-2#2)(2012-3#9)(2013-1#13)(2013-7#1)(2013-8#7)
quality of life)##2##3##(2010-11#1)(2010-5#1)
quality of middle age and older women from Primorsko-Goranska County##2##10##(2011-2#2)
quality of nursing##4##3##(1990-2#1)(2008-12#1)(2009-3#1)(2012-3#1)
quality of our##3##3##(1994-12#1)(2009-4#1)(2011-2#1)
quality of patient care##6##4##(1991-12#1)(1993-3#1)(1997-1#1)(2008-11#2)(2009-8#1)
quality of prenatal##3##3##(1993-3#1)(1996-6#1)(2013-1#1)
quality of the##57##3##(1991-6#1)(1992-2#1)(1992-5#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
quality of working life##3##4##(1992-3#1)(2008-11#2)
quality of working##4##3##(1992-3#1)(2008-11#2)(2012-3#1)
quality of##417##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#5)(1992-3#5)(1992-5#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#6)(1993-6#2)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#5)(1995-5#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#17)(1996-3#2)(1996-6#1)(1997-1#6)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#3)(1997-8#3)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#37)(2008-11#30)(2008-12#10)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#18)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#6)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#7)(2010-12#7)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#33)(2011-3#2)(2011-7#1)(2012-12#7)(2012-2#3)(2012-3#18)(2013-1#28)(2013-7#1)(2013-8#11)
quality on a##2##3##(1995-12#1)(2008-9#1)
quality on##5##2##(1995-12#1)(2008-11#1)(2008-9#2)(2009-11#1)
quality parameters and##2##3##(2008-10#2)
quality parameters of beers##2##4##(2008-10#2)
quality parameters of##3##3##(2008-10#3)
quality parameters##7##2##(2008-10#6)(2013-1#1)
quality patient care##2##3##(1994-3#1)(1997-2#1)
quality planning##7##2##(1993-12#4)(1994-2#3)
quality process##2##2##(1993-3#1)(1994-1#1)
quality requirements##2##2##(2008-11#1)(2012-2#1)
quality revealed##2##2##(2008-12#1)(2011-2#1)
quality review##2##2##(1993-2#1)(1996-2#1)
quality services##3##2##(1993-12#1)(1995-12#1)(1997-2#1)
quality should be##2##3##(1994-2#1)(2013-1#1)
quality standard##2##2##(1991-3#1)(2012-3#1)
quality standards##2##2##(2008-10#1)(2008-3#1)
quality studies were##2##3##(2008-11#1)(2013-1#1)
quality that##2##2##(1993-12#1)(2007-11#1)
quality to##4##2##(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#1)
quality treatment##2##2##(1993-6#1)(1994-12#1)
quality was##8##2##(1995-9#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
quality were##3##2##(2008-10#2)(2012-3#1)
quality with##3##2##(1995-2#1)(2008-12#1)(2010-4#1)
quality##1259##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#3)(1991-2#5)(1991-3#13)(1991-6#3)(1991-9#2)(1992-1#4)(1992-11#3)(1992-12#4)(1992-2#9)(1992-3#11)(1992-5#2)(1993-1#11)(1993-11#3)(1993-12#27)(1993-2#9)(1993-3#39)(1993-6#5)(1993-8#1)(1993-9#1)(1994-1#30)(1994-12#24)(1994-2#24)(1994-3#14)(1994-5#1)(1994-6#4)(1994-8#2)(1995-1#7)(1995-11#1)(1995-12#13)(1995-2#24)(1995-3#18)(1995-5#2)(1995-9#3)(1996-1#8)(1996-11#2)(1996-12#2)(1996-2#38)(1996-3#6)(1996-6#1)(1996-9#1)(1997-1#21)(1997-2#15)(1997-3#14)(1997-4#2)(1997-5#5)(1997-6#2)(1997-8#9)(2007-11#5)(2007-12#3)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#151)(2008-11#95)(2008-12#28)(2008-2#4)(2008-3#28)(2008-4#7)(2008-5#9)(2008-6#18)(2008-7#20)(2008-8#27)(2008-9#35)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#7)(2009-3#11)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#4)(2010-10#6)(2010-11#8)(2010-12#11)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#4)(2010-6#4)(2010-7#6)(2010-8#10)(2010-9#6)(2011-1#10)(2011-10#1)(2011-2#66)(2011-3#5)(2011-7#3)(2012-12#14)(2012-2#35)(2012-3#28)(2013-1#63)(2013-7#2)(2013-8#19)
quality-adjusted life##2##2##(2008-4#1)(2012-12#1)
quality-adjusted##4##1##(1993-1#1)(2008-4#1)(2012-12#1)(2012-3#1)
quality-assurance (QA)##2##2##(1996-2#2)
quality-assurance##4##1##(1991-12#2)(1996-2#2)
quality-improvement##2##1##(1996-2#1)(2010-8#1)
quality-measurement##2##1##(1996-2#2)
quality-monitoring system##2##2##(1996-2#1)(1997-1#1)
quality-of-care issues##2##2##(1992-3#2)
quality-of-care##4##1##(1992-3#2)(1993-12#1)(1996-2#1)
quality-of-life##8##1##(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#2)
quality?##2##1##(1992-5#1)(1993-3#1)
quandary##2##1##(2013-8#2)
quantal presynaptic##2##2##(1997-7#2)
quantal##6##1##(1996-2#1)(1997-7#4)(2009-9#1)
quantifiable##6##1##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
quantification (LOQ) were 0##2##4##(2008-10#2)
quantification (LOQ)##9##2##(2008-10#9)
quantification analysis##3##2##(2008-11#1)(2011-1#1)(2011-7#1)
quantification and##8##2##(1991-5#1)(2008-10#4)(2008-11#2)(2013-8#1)
quantification are##2##2##(2008-10#2)
quantification at##2##2##(2008-10#2)
quantification by##2##2##(2008-10#1)(2008-9#1)
quantification for##3##2##(2008-10#2)(2012-2#1)
quantification have been##2##3##(2008-10#2)
quantification have##3##2##(2008-10#2)(2010-7#1)
quantification in##8##2##(2008-10#6)(2008-9#1)(2010-4#1)
quantification is##3##2##(2008-10#2)(2008-5#1)
quantification limit (0##2##3##(2008-10#2)
quantification limit for##3##3##(2008-10#3)
quantification limit of##3##3##(2008-10#3)
quantification limit was 0##2##4##(2008-10#2)
quantification limit was##4##3##(2008-10#4)
quantification limit##17##2##(2008-10#17)
quantification limits were##4##3##(2008-10#4)
quantification limits##17##2##(2008-10#17)
quantification of 0##2##3##(2008-10#2)
quantification of M##2##3##(2008-10#2)
quantification of ammonium##2##3##(2008-10#2)
quantification of ascorbic acid##2##4##(2008-10#2)
quantification of changes in##2##4##(2008-12#1)(2013-1#1)
quantification of eight##2##3##(2008-10#2)
quantification of protein##2##3##(1990-12#1)(2008-10#1)
quantification of pyruvate##2##3##(2008-10#2)
quantification of sodium##2##3##(2008-10#2)
quantification of the##19##3##(1990-12#1)(2008-10#15)(2010-9#1)(2011-1#1)(2011-2#1)
quantification of these##3##3##(2008-10#2)(2010-1#1)
quantification of##136##2##(1990-12#3)(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1996-12#1)(2008-10#94)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#3)(2008-9#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
quantification techniques##2##2##(2008-10#1)(2012-2#1)
quantification was carried out##2##4##(2008-10#2)
quantification was##6##2##(2008-10#5)(2008-5#1)
quantification were 0##3##3##(2008-10#3)
quantification were carried out##2##4##(2008-10#1)(2010-5#1)
quantification were##11##2##(2008-10#9)(2010-5#1)(2011-3#1)
quantification##270##1##(1990-12#3)(1991-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1996-12#1)(2008-10#204)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#6)(2008-9#6)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#2)(2011-7#1)(2012-2#3)(2013-1#2)(2013-8#3)
quantifications##2##1##(2008-10#2)
quantified and##3##2##(2008-10#2)(2013-1#1)
quantified as##4##2##(2008-10#2)(2008-7#2)
quantified at##2##2##(2008-10#1)(2011-2#1)
quantified by an##2##3##(2008-10#2)
quantified by measuring the##2##4##(2008-11#1)(2008-7#1)
quantified by the##5##3##(2006-6#1)(2008-10#2)(2008-11#1)(2008-9#1)
quantified by##30##2##(1991-12#1)(2006-6#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-4#1)
quantified directly##2##2##(2008-10#1)(2008-11#1)
quantified for##2##2##(2008-10#2)
quantified in the##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
quantified in##16##2##(1991-11#1)(1996-6#1)(2008-10#10)(2008-2#1)(2010-8#1)(2013-1#1)(2013-8#1)
quantified on a##2##3##(2008-10#1)(2008-9#1)
quantified on##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
quantified over a##2##3##(2008-10#1)(2008-5#1)
quantified smoking##3##2##(2008-10#3)
quantified the##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)
quantified using an##2##3##(1991-12#1)(2008-10#1)
quantified using##13##2##(1991-12#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-7#1)(2011-2#2)
quantified with##7##2##(2008-10#6)(2008-5#1)
quantified##131##1##(1990-2#1)(1991-11#1)(1991-12#3)(1992-9#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-6#2)(2008-10#68)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#7)(2008-8#4)(2008-9#4)(2009-7#1)(2009-8#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#3)(2013-8#3)
quantifier##2##1##(2012-2#1)(2013-1#1)
quantifies the##4##2##(1992-9#1)(2008-10#2)(2008-8#1)
quantifies##6##1##(1992-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)
quantify and##4##2##(2008-10#3)(2008-11#1)
quantify differences##2##2##(1996-3#1)(2008-10#1)
quantify five##2##2##(2008-10#2)
quantify its##2##2##(2008-10#1)(2008-5#1)
quantify the degree of##3##4##(2008-10#1)(2008-8#1)(2010-3#1)
quantify the effects of##4##4##(2008-10#2)(2008-11#1)(2012-3#1)
quantify the##55##2##(1990-7#1)(1993-6#1)(1994-2#2)(1994-6#1)(1994-8#1)(2008-10#20)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#2)
quantify##141##1##(1990-7#1)(1991-12#1)(1993-6#1)(1994-2#3)(1994-6#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#70)(2008-11#6)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#3)
quantifying and##3##2##(2008-11#2)(2008-8#1)
quantifying the##17##2##(1992-9#1)(1995-12#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#3)
quantifying##44##1##(1992-9#1)(1995-12#1)(1997-7#1)(2008-10#22)(2008-11#4)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#3)(2012-2#2)(2013-1#2)
quantitate##19##1##(1990-12#1)(1991-9#1)(1992-12#2)(1994-8#1)(2008-10#7)(2008-11#1)(2008-4#4)(2008-9#1)(2012-2#1)
quantitated by##2##2##(2008-4#1)(2008-9#1)
quantitated in##2##2##(1992-11#1)(1994-5#1)
quantitated using##3##2##(2008-10#2)(2008-7#1)
quantitated##12##1##(1992-11#1)(1994-5#1)(2008-10#5)(2008-4#2)(2008-7#2)(2008-9#1)
quantitating the##5##2##(1990-12#1)(1994-5#1)(1995-2#1)(2006-6#1)(2008-4#1)
quantitating##12##1##(1990-12#1)(1994-5#1)(1995-2#1)(2006-6#1)(2008-10#3)(2008-4#3)(2008-9#1)(2012-2#1)
quantitation (LOQ)##7##2##(2008-10#7)
quantitation by##3##2##(1995-11#1)(2008-10#2)
quantitation limit of##2##3##(2008-10#2)
quantitation limit##5##2##(2008-10#5)
quantitation method##2##2##(2008-10#2)
quantitation of the##10##3##(1993-3#1)(1997-2#1)(2008-10#7)(2008-9#1)
quantitation of##53##2##(1990-12#1)(1992-12#1)(1993-3#1)(1997-2#2)(1997-3#1)(2008-10#37)(2008-11#1)(2008-4#5)(2008-9#2)(2012-12#1)(2013-8#1)
quantitation was##5##2##(2008-10#4)(2008-5#1)
quantitation were##5##2##(2008-10#5)
quantitation##95##1##(1990-12#1)(1991-9#1)(1992-12#1)(1993-3#1)(1995-11#1)(1997-2#2)(1997-3#1)(2008-10#74)(2008-11#1)(2008-4#5)(2008-5#1)(2008-9#4)(2012-12#1)(2013-8#1)
quantitative PCR assays were##2##4##(2008-10#2)
quantitative PCR in##3##3##(1993-6#1)(2008-11#1)(2011-2#1)
quantitative PCR##15##2##(1993-6#2)(1995-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
quantitative RT-PCR##3##2##(2008-11#2)(2008-5#1)
quantitative agreement##2##2##(2008-3#1)(2009-5#1)
quantitative analyses of##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
quantitative analyses##7##2##(2008-10#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
quantitative analysis and##2##3##(2008-10#2)
quantitative analysis of calcium carbonate##2##5##(2008-10#2)
quantitative analysis of the##8##4##(1996-12#1)(1997-6#1)(2008-10#3)(2008-5#1)(2008-9#1)(2012-3#1)
quantitative analysis of##47##3##(1996-12#1)(1997-6#1)(2008-10#36)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#2)(2010-1#1)(2012-3#2)
quantitative analysis##69##2##(1996-12#1)(1996-2#1)(1997-6#1)(2008-10#54)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#2)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)
quantitative analytical##3##2##(2008-10#2)(2012-2#1)
quantitative and qualitative data##3##4##(1991-8#1)(2008-11#1)(2013-8#1)
quantitative and qualitative##13##3##(1991-8#1)(1993-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-8#1)(2009-10#1)(2013-8#1)
quantitative and reproducible##2##3##(2008-10#2)
quantitative and##23##2##(1991-8#1)(1993-1#1)(1995-2#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-8#1)(2009-10#1)(2013-8#1)
quantitative approach to##2##3##(2008-10#1)(2008-9#1)
quantitative approach##9##2##(2008-10#6)(2008-8#1)(2008-9#1)(2012-3#1)
quantitative assay of##2##3##(2008-10#2)
quantitative assay##6##2##(2008-10#4)(2008-12#1)(2010-4#1)
quantitative assessment of the##3##4##(2008-11#1)(2008-5#1)(2009-10#1)
quantitative assessment of##10##3##(1995-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-10#1)
quantitative at##2##2##(2008-10#2)
quantitative changes##2##2##(1996-11#1)(2008-11#1)
quantitative characterisation of##2##3##(2008-10#2)
quantitative comparison##3##2##(2008-10#2)(2008-5#1)
quantitative contribution of##2##3##(2008-10#1)(2009-10#1)
quantitative data##5##2##(1990-9#1)(2008-10#1)(2009-5#1)(2010-10#1)(2013-1#1)
quantitative description of the##3##4##(1997-6#1)(2008-10#1)(2008-11#1)
quantitative description of##5##3##(1996-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
quantitative detection of##4##3##(2008-10#3)(2008-12#1)
quantitative detection##6##2##(2008-10#5)(2008-12#1)
quantitative determination by##2##3##(2008-10#1)(2008-5#1)
quantitative determination method for##2##4##(2008-10#2)
quantitative determination method##3##3##(2008-10#3)
quantitative determination of both##2##4##(1991-2#1)(2008-10#1)
quantitative determination of lead##2##4##(2008-10#2)
quantitative determination of small##3##4##(2008-10#3)
quantitative determination of the##4##4##(1991-5#1)(2008-10#3)
quantitative determination of various##2##4##(2008-10#2)
quantitative determination of##52##3##(1991-2#1)(1991-5#1)(1997-2#1)(2008-10#44)(2008-12#1)(2008-5#4)
quantitative determination##67##2##(1991-2#1)(1991-5#1)(1997-2#1)(2008-10#56)(2008-12#1)(2008-5#7)
quantitative estimates of##2##3##(2008-10#1)(2008-8#1)
quantitative estimates##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
quantitative estimation of##2##3##(2008-10#1)(2008-4#1)
quantitative evaluation of the##3##4##(1990-12#1)(2008-10#2)
quantitative evaluation of##6##3##(1990-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
quantitative evaluation##9##2##(1990-12#1)(1991-12#1)(1993-1#1)(2008-10#3)(2010-5#1)(2011-2#1)(2013-1#1)
quantitative extraction of##9##3##(2008-10#9)
quantitative extraction##12##2##(2008-10#12)
quantitative genetic##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
quantitative host resistance##4##3##(2008-10#4)
quantitative in##3##2##(1993-1#1)(1996-12#1)(2008-10#1)
quantitative information about the##2##4##(2008-10#2)
quantitative information on##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
quantitative information##12##2##(2008-10#7)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
quantitative investigation of##2##3##(2008-10#1)(2008-3#1)
quantitative measurement of the##2##4##(2007-12#1)(2012-2#1)
quantitative measurement of##8##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-2#1)
quantitative measurement##10##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-2#1)
quantitative measurements of##3##3##(2008-2#1)(2008-9#2)
quantitative measurements##8##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#3)(2013-1#1)
quantitative measures##3##2##(1992-9#1)(2008-10#2)
quantitative metal ion##2##3##(2008-10#2)
quantitative metal##3##2##(2008-10#3)
quantitative method has been##2##4##(2008-10#2)
quantitative method##5##2##(2008-10#4)(2012-2#1)
quantitative methods##2##2##(2008-10#1)(2008-11#1)
quantitative model##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
quantitative monitoring of##2##3##(2008-10#1)(2008-11#1)
quantitative monitoring##3##2##(2008-10#2)(2008-11#1)
quantitative parameters##2##2##(2008-10#1)(2008-6#1)
quantitative polymerase chain reaction (PCR)##4##5##(2008-10#3)(2013-1#1)
quantitative polymerase chain reaction (Q-PCR)##2##5##(2008-10#2)
quantitative polymerase chain reaction##11##4##(2008-10#8)(2009-6#1)(2013-1#1)(2013-8#1)
quantitative prediction##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
quantitative real-time PCR##3##3##(2010-11#1)(2010-7#1)(2012-3#1)
quantitative real-time polymerase chain reaction##3##5##(2008-10#1)(2009-6#1)(2012-2#1)
quantitative real-time##9##2##(2008-10#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
quantitative recoveries of##2##3##(2008-10#2)
quantitative recoveries were##2##3##(2008-10#2)
quantitative recoveries##7##2##(2008-10#7)
quantitative recovery and##3##3##(2008-10#3)
quantitative recovery of##5##3##(2008-10#5)
quantitative recovery##12##2##(2008-10#12)
quantitative relationship between##2##3##(2008-12#1)(2010-11#1)
quantitative relationship##3##2##(2008-10#1)(2008-12#1)(2010-11#1)
quantitative research##4##2##(2008-1#1)(2008-11#3)
quantitative resistance to##7##3##(2008-10#7)
quantitative resistance##16##2##(2008-10#12)(2008-9#1)(2009-10#2)(2011-10#1)
quantitative results for##2##3##(2008-10#2)
quantitative results were obtained##2##4##(2008-10#2)
quantitative results##7##2##(2008-10#6)(2011-2#1)
quantitative reverse transcription-polymerase chain reaction##2##5##(2008-10#1)(2011-2#1)
quantitative risk assessments##2##3##(2008-10#1)(2011-2#1)
quantitative risk##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
quantitative screening##2##2##(2008-10#1)(2012-2#1)
quantitative separation of##2##3##(2008-10#2)
quantitative solution hybridisation-RNase protection assay##2##5##(1996-12#2)
quantitative sorption of metal##2##4##(2008-10#2)
quantitative sorption of##3##3##(2008-10#3)
quantitative sorption##9##2##(2008-10#9)
quantitative structure-activity relationship##3##3##(2008-10#1)(2009-3#1)(2010-12#1)
quantitative structure-property relationship##2##3##(2008-10#2)
quantitative studies##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
quantitative study of the##2##4##(2008-10#1)(2012-2#1)
quantitative study##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
quantitative trait Loci for##4##4##(2008-10#4)
quantitative trait Loci##5##3##(2008-10#5)
quantitative trait loci (QTL) analysis##2##5##(2008-10#1)(2012-3#1)
quantitative trait loci (QTL) associated with##3##6##(2008-10#3)
quantitative trait loci (QTL) for##6##5##(2008-10#6)
quantitative trait loci (QTL) studies##2##5##(2008-10#1)(2008-8#1)
quantitative trait loci (QTL) that##3##5##(2008-10#3)
quantitative trait loci (QTL) were identified##2##6##(2008-10#2)
quantitative trait loci (QTL)##25##4##(2008-10#22)(2008-8#1)(2012-3#2)
quantitative trait loci (QTLs) for##2##5##(2008-10#1)(2008-8#1)
quantitative trait loci (QTLs)##5##4##(2008-10#2)(2008-8#2)(2008-9#1)
quantitative trait loci##37##3##(2008-10#26)(2008-8#3)(2008-9#2)(2009-10#1)(2012-3#5)
quantitative trait locus (QTL) on chromosome##3##6##(2008-10#3)
quantitative trait locus (QTL)##9##4##(2008-10#7)(2012-3#1)(2013-8#1)
quantitative trait locus##15##3##(2008-10#12)(2010-4#1)(2012-3#1)(2013-8#1)
quantitative trait##64##2##(2008-10#43)(2008-8#6)(2008-9#3)(2009-10#1)(2010-4#1)(2012-3#9)(2013-8#1)
quantitative traits##10##2##(2008-10#5)(2008-12#1)(2008-8#2)(2008-9#2)
quantitative two-dimensional##2##2##(2008-3#1)(2008-4#1)
quantitative##686##1##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-9#2)(1993-1#4)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#3)(1997-6#2)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#403)(2008-11#23)(2008-12#8)(2008-2#5)(2008-3#10)(2008-4#7)(2008-5#18)(2008-6#1)(2008-7#7)(2008-8#14)(2008-9#33)(2009-10#6)(2009-12#1)(2009-3#2)(2009-5#5)(2009-6#2)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#4)(2010-8#1)(2011-10#1)(2011-2#13)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#14)(2012-3#16)(2013-1#11)(2013-7#1)(2013-8#9)
quantitatively adsorbed on##7##3##(2008-10#7)
quantitatively adsorbed##8##2##(2008-10#8)
quantitatively analyzed##5##2##(2008-10#2)(2008-8#2)(2012-2#1)
quantitatively and qualitatively##2##3##(1997-8#1)(2008-10#1)
quantitatively and##6##2##(1997-8#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-12#1)
quantitatively assess##3##2##(2008-10#2)(2008-8#1)
quantitatively at##2##2##(2008-10#2)
quantitatively by##7##2##(1997-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-8#1)
quantitatively compared to##2##3##(2008-10#1)(2008-11#1)
quantitatively compared##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
quantitatively determined in##2##3##(2008-10#1)(2011-2#1)
quantitatively determined##8##2##(2008-10#7)(2011-2#1)
quantitatively during passage of aqueous##2##5##(2008-10#2)
quantitatively eluted with 0##2##4##(2008-10#2)
quantitatively eluted with##3##3##(2008-10#3)
quantitatively eluted##4##2##(2008-10#4)
quantitatively enriched##2##2##(2008-10#2)
quantitatively extracted into##2##3##(2008-10#2)
quantitatively extracted to the##2##4##(2008-10#2)
quantitatively extracted##8##2##(2008-10#8)
quantitatively for##2##2##(2008-10#2)
quantitatively from##2##2##(2008-10#2)
quantitatively in the##2##3##(2008-10#1)(2008-11#1)
quantitatively in##4##2##(1994-8#1)(2008-10#1)(2008-11#2)
quantitatively measure##2##2##(2008-10#1)(2008-11#1)
quantitatively monitor##2##2##(2008-7#1)(2011-7#1)
quantitatively on a##2##3##(2008-10#2)
quantitatively on##3##2##(2008-10#3)
quantitatively retained on##7##3##(2008-10#7)
quantitatively retained##11##2##(2008-10#11)
quantitatively the##11##2##(1991-9#1)(1994-8#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#1)
quantitatively to##3##2##(1993-8#1)(2008-10#2)
quantitatively using##2##2##(2008-10#1)(2008-5#1)
quantitatively with the##2##3##(2008-10#1)(2008-3#1)
quantitatively with##8##2##(1990-12#1)(2008-10#6)(2008-3#1)
quantitatively##189##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-10#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-8#2)(2008-1#1)(2008-10#125)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#3)(2009-11#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
quantities and##3##2##(2008-10#2)(2008-5#1)
quantities are##2##2##(2008-10#1)(2012-2#1)
quantities can be separated##2##4##(2008-10#1)(2008-4#1)
quantities can be##3##3##(2008-10#2)(2008-4#1)
quantities from##3##2##(1990-8#1)(2008-10#2)
quantities in##5##2##(2008-10#4)(2008-11#1)
quantities of DNA of##2##4##(2008-10#2)
quantities of DNA##4##3##(2008-10#4)
quantities of a##2##3##(2008-10#1)(2008-11#1)
quantities of the##3##3##(2008-10#2)(2008-9#1)
quantities of these##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
quantities of##63##2##(1990-5#1)(1992-10#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-1#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#29)(2008-11#9)(2008-5#2)(2008-7#1)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#1)(2013-1#2)
quantities such as##2##3##(2008-10#1)(2013-1#1)
quantities were##3##2##(2008-10#2)(2008-5#1)
quantities##113##1##(1990-5#1)(1990-8#2)(1992-10#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-10#54)(2008-11#15)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#3)
quantity and quality of##3##4##(1994-2#1)(2008-5#1)(2012-3#1)
quantity and quality##6##3##(1994-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
quantity and##10##2##(1994-1#1)(1994-2#1)(2008-10#4)(2008-5#1)(2008-9#2)(2012-3#1)
quantity but##2##2##(2008-11#1)(2008-9#1)
quantity is##2##2##(2008-2#1)(2011-2#1)
quantity of HCl##2##3##(2008-10#2)
quantity of drug##3##3##(1992-3#3)
quantity of food##2##3##(2008-9#2)
quantity of the##5##3##(2008-10#4)(2008-9#1)
quantity of##47##2##(1992-1#1)(1992-12#1)(1992-3#3)(1993-2#2)(1995-5#1)(1996-1#1)(1996-12#2)(1997-6#1)(2008-10#18)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#4)(2009-6#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
quantity on##2##2##(2008-10#1)(2008-9#1)
quantity to##2##2##(1995-6#1)(2008-5#1)
quantity##87##1##(1991-11#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-2#2)(1994-1#1)(1994-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#2)(1997-3#1)(1997-6#1)(2008-10#34)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#9)(2009-6#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
quantum chemical##10##2##(2008-10#3)(2008-5#1)(2010-7#1)(2011-3#1)(2013-1#4)
quantum chemistry##3##2##(2011-2#2)(2011-3#1)
quantum coherence##2##2##(1991-9#1)(1993-3#1)
quantum dot##4##2##(1992-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
quantum dots (QDs)##5##3##(2008-10#4)(2009-11#1)
quantum dots##23##2##(1995-3#2)(2008-10#14)(2008-3#1)(2008-7#1)(2009-10#1)(2009-11#4)
quantum efficiency##4##2##(2008-10#1)(2008-3#3)
quantum interference##3##2##(1992-11#1)(2008-7#2)
quantum mechanics##4##2##(1996-5#1)(2008-5#2)(2010-10#1)
quantum phase##2##2##(2007-12#1)(2008-7#1)
quantum size##2##2##(1993-5#1)(2010-7#1)
quantum well structure can be used to produce##2##8##(2008-2#2)
quantum well##5##2##(2008-2#5)
quantum wells##8##2##(1994-2#1)(2008-2#6)(2008-3#1)
quantum yield of##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
quantum yield##12##2##(2008-10#7)(2008-11#1)(2008-2#1)(2008-9#3)
quantum yields##3##2##(2008-10#3)
quantum##107##1##(1990-12#1)(1991-9#1)(1992-11#2)(1992-8#2)(1993-3#1)(1993-5#3)(1994-2#1)(1995-3#3)(1996-5#1)(2007-12#1)(2008-10#33)(2008-11#1)(2008-2#12)(2008-3#9)(2008-5#3)(2008-7#6)(2008-9#3)(2009-10#1)(2009-11#4)(2009-9#1)(2010-10#1)(2010-12#2)(2010-7#4)(2011-2#2)(2011-3#2)(2013-1#6)(2013-8#1)
quantum-cascade lasers##3##2##(2007-12#1)(2008-3#2)
quantum-cascade##8##1##(2007-12#1)(2008-3#7)
quantum-well##3##1##(2008-3#3)
quarantine measures##3##2##(2008-10#3)
quarantine##20##1##(1996-11#1)(1996-8#1)(2008-10#16)(2008-12#1)(2010-3#1)
quarries##2##1##(2008-10#2)
quarter 1995##2##2##(1995-12#1)(1997-2#1)
quarter and center layer##2##4##(2013-8#2)
quarter cases##2##2##(1996-8#2)
quarter of the##5##3##(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
quarter of##9##2##(1992-3#1)(1992-6#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
quarter##22##1##(1992-3#1)(1992-6#2)(1992-9#1)(1995-12#1)(1996-8#2)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
quartered##2##1##(2008-10#1)(2012-2#1)
quarterly##3##1##(1995-2#1)(1997-2#1)(2012-3#1)
quarters of the cows in##2##5##(1990-6#2)
quarters of##3##2##(1990-6#2)(2012-2#1)
quarters##8##1##(1990-6#3)(1996-8#2)(1997-8#1)(2010-5#1)(2012-2#1)
quartets##3##1##(1997-6#1)(2013-1#2)
quartile of##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
quartz and##3##2##(2008-10#2)(2008-5#1)
quartz cell##4##2##(2008-10#4)
quartz crystal impedance analysis##2##4##(2008-10#2)
quartz crystal impedance##6##3##(2008-10#6)
quartz crystal in##3##3##(2008-10#2)(2013-8#1)
quartz crystal microbalance (QCM) was##2##5##(2008-10#2)
quartz crystal microbalance (QCM)##11##4##(2008-10#11)
quartz crystal microbalance##25##3##(2008-10#25)
quartz crystal##60##2##(2008-10#56)(2009-5#2)(2013-8#2)
quartz crystals##2##2##(2008-10#2)
quartz fiber##3##2##(2008-10#3)
quartz filter##2##2##(2008-10#2)
quartz filters##2##2##(2008-5#2)
quartz flow cell##3##3##(2008-10#3)
quartz in##6##2##(2008-10#1)(2013-8#5)
quartz or##2##2##(2008-10#1)(2008-5#1)
quartz surface##2##2##(2008-10#2)
quartz surfaces##4##2##(2008-10#4)
quartz##121##1##(1990-8#1)(2007-12#1)(2008-10#96)(2008-5#6)(2008-7#1)(2009-5#2)(2013-8#14)
quasi extinction##2##2##(2008-8#2)
quasi##9##1##(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2012-2#1)
quasi-continuous##3##1##(2008-11#2)(2008-3#1)
quasi-cw mode##2##2##(2007-12#1)(2008-3#1)
quasi-cw##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
quasi-elastic##3##1##(1995-3#1)(2008-10#2)
quasi-experimental design##2##2##(2008-11#1)(2013-1#1)
quasi-experimental study##4##2##(2008-12#2)(2008-4#1)(2013-1#1)
quasi-experimental##8##1##(1995-1#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-4#1)(2013-1#2)
quasi-phase-matched##3##1##(2007-12#1)(2008-3#2)
quasi-reversible##3##1##(2008-10#3)
quasi-species##2##1##(1997-6#1)(2012-2#1)
quasi-static elastography##3##2##(2010-8#3)
quasi-static##7##1##(2008-2#3)(2010-8#3)(2012-2#1)
quasi-three-level longitudinally pumped##2##3##(2008-3#2)
quasispecies##9##1##(1997-3#1)(2013-1#1)(2013-8#7)
quaternary alkylammonium cations##2##3##(2008-10#2)
quaternary ammonium ions##2##3##(2008-10#2)
quaternary ammonium salt is##2##4##(2008-10#2)
quaternary ammonium salts in##2##4##(2008-10#2)
quaternary ammonium salts##3##3##(2008-10#3)
quaternary ammonium##18##2##(2008-10#17)(2011-2#1)
quaternary mixtures of##2##3##(2008-10#2)
quaternary mixtures##4##2##(2008-10#4)
quaternary##30##1##(1990-8#1)(1995-11#1)(1996-5#1)(2008-10#25)(2009-8#1)(2011-2#1)
quaternized##4##1##(2008-10#3)(2008-5#1)
quatrième ventricule##2##2##(2013-1#2)
quattrocistronic artificial##2##2##(2008-11#2)
que##4##1##(2008-11#2)(2013-1#2)
queen number##2##2##(2008-5#1)(2008-8#1)
queen##6##1##(2008-5#1)(2008-8#4)(2008-9#1)
queen)##2##1##(2008-5#2)
queen-worker conflict over reproductive allocation##3##5##(2008-8#3)
queen-worker conflict over##4##3##(2008-8#4)
queens and workers##4##3##(2008-8#4)
queens and##5##2##(2008-5#1)(2008-8#4)
queens in##3##2##(2008-5#2)(2008-8#1)
queens##12##1##(2008-11#1)(2008-5#4)(2008-8#7)
queleas##3##1##(2008-8#3)
quench the fluorescence of##3##4##(2008-10#2)(2008-9#1)
quench the##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
quench##8##1##(1990-5#1)(1992-9#1)(2008-10#3)(2008-8#2)(2008-9#1)
quenched by##2##2##(2008-10#2)
quenched fluorescence##3##2##(2008-10#3)
quenched in##2##2##(1996-6#1)(2008-10#1)
quenched the##2##2##(1995-6#2)
quenched##14##1##(1990-12#1)(1995-6#2)(1996-6#1)(2007-12#1)(2008-10#8)(2008-3#1)
quencher in##2##2##(2008-10#2)
quencher##7##1##(1994-5#1)(2008-10#5)(2008-9#1)
quenches the fluorescence##2##3##(2008-10#2)
quenches the##3##2##(2008-10#3)
quenches##5##1##(2008-10#4)(2012-2#1)
quenching and##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
quenching by##4##2##(1994-5#1)(2008-10#2)(2008-8#1)
quenching constant##4##2##(2008-10#3)(2008-9#1)
quenching constants##2##2##(2008-10#2)
quenching data##3##2##(1995-6#1)(2008-10#2)
quenching effect of##3##3##(2008-10#3)
quenching effect##8##2##(2008-10#8)
quenching mechanism is##2##3##(2008-10#2)
quenching method##5##2##(2008-10#5)
quenching of dansyl fluorescence##2##4##(2008-10#2)
quenching of the fluorescence of##2##5##(2008-10#2)
quenching of the fluorescence##3##4##(2008-10#3)
quenching of the##10##3##(1992-12#1)(1994-5#1)(1994-6#1)(2008-10#6)(2008-8#1)
quenching of##39##2##(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1994-5#1)(1994-6#1)(1995-8#1)(2008-10#29)(2008-8#1)(2008-9#1)(2009-7#1)
quenching reaction of##2##3##(2008-10#2)
quenching reaction##4##2##(2008-10#4)
quenching the##2##2##(2008-11#1)(2010-4#1)
quenching was##2##2##(2008-10#2)
quenching will##2##2##(2008-9#2)
quenching##120##1##(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#3)(1994-6#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#91)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#3)(2008-9#5)(2009-7#1)(2010-4#1)(2012-2#1)
quercetagetin##2##1##(2008-11#2)
quercetin and##5##2##(2008-10#4)(2008-5#1)
quercetin##24##1##(1994-8#1)(2008-10#16)(2008-11#3)(2008-5#1)(2008-9#3)
quercina from##2##2##(2008-10#2)
quercina##6##1##(2008-10#6)
quercitrin##2##1##(2008-10#2)
queried##2##1##(2011-2#1)(2012-2#1)
queries##2##1##(1995-12#1)(2008-4#1)
query##7##1##(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#2)
querying##2##1##(1997-2#1)(2011-9#1)
quest for mercy##2##3##(2008-8#2)
quest for##5##2##(1993-3#1)(2008-12#1)(2008-8#2)(2012-2#1)
quest##7##1##(1993-3#1)(2008-11#1)(2008-12#2)(2008-8#2)(2012-2#1)
question and##6##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-8#2)(2013-1#1)
question arises##3##2##(2011-1#1)(2011-2#2)
question as##5##2##(1991-12#1)(1995-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
question in##8##2##(1995-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-2#1)
question is how##3##3##(2007-12#1)(2008-8#1)(2011-2#1)
question is##4##2##(2007-12#1)(2008-8#1)(2010-8#1)(2011-2#1)
question of interest##2##3##(2008-11#1)(2008-7#1)
question of the##8##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-12#1)(2011-2#1)
question of whether##10##3##(1991-3#1)(1992-12#1)(1996-2#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)
question of##38##2##(1990-2#1)(1991-12#1)(1991-3#2)(1992-12#2)(1993-12#1)(1993-2#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
question that##5##2##(1996-2#1)(2008-11#2)(2008-6#1)(2013-1#1)
question the##10##2##(1992-3#1)(1993-2#1)(1995-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-6#1)(2013-1#1)
question to##3##2##(2008-11#1)(2009-10#1)(2011-2#1)
question was##3##2##(1996-11#1)(1997-5#1)(2010-11#1)
question whether##2##2##(1993-3#1)(1994-8#1)
question##155##1##(1990-2#2)(1990-8#1)(1991-1#1)(1991-12#4)(1991-3#2)(1992-12#2)(1992-3#1)(1993-12#4)(1993-2#3)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#5)(2008-11#16)(2008-12#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#8)(2009-10#2)(2009-12#1)(2009-6#5)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#1)
questionable and##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
questionable##24##1##(1991-2#1)(1991-3#1)(1991-6#1)(1993-6#1)(1995-11#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
questionable]##2##1##(1992-6#1)(1996-9#1)
questioned##22##1##(1991-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-5#1)(1994-9#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2012-12#1)
questioning##8##1##(1992-12#1)(1995-11#1)(1996-5#2)(2008-11#2)(2008-5#1)(2009-6#1)
questionnaire and a##2##3##(2008-7#1)(2013-1#1)
questionnaire and##9##2##(1993-2#1)(1994-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
questionnaire as##2##2##(2012-3#1)(2013-1#1)
questionnaire consisted of##2##3##(1991-2#1)(2011-2#1)
questionnaire contained##2##2##(2012-2#1)(2013-1#1)
questionnaire data##2##2##(1996-2#1)(2008-12#1)
questionnaire designed##2##2##(1992-2#1)(2008-11#1)
questionnaire during##2##2##(2008-1#1)(2010-10#1)
questionnaire for the diagnosis of##2##5##(1994-6#1)(1997-2#1)
questionnaire for##5##2##(1994-6#1)(1997-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
questionnaire in the##3##3##(1992-12#1)(1996-3#1)(2008-11#1)
questionnaire in##6##2##(1992-12#1)(1996-3#1)(2008-11#2)(2012-2#1)(2013-1#1)
questionnaire on##2##2##(1997-4#1)(2008-11#1)
questionnaire regarding##3##2##(2008-10#1)(2008-11#1)(2013-7#1)
questionnaire study##5##2##(1993-6#1)(1995-2#1)(1996-8#1)(2008-11#1)(2010-10#1)
questionnaire survey of##3##3##(1994-6#1)(1997-5#1)(2008-1#1)
questionnaire survey was##4##3##(1997-3#1)(2008-11#1)(2010-1#1)(2010-5#1)
questionnaire survey##9##2##(1994-6#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-2#1)(2010-5#1)
questionnaire to examine##3##3##(2008-11#2)(2009-5#1)
questionnaire to##10##2##(1992-1#1)(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#3)(2009-5#1)(2012-12#1)
questionnaire was conducted##2##3##(2010-2#1)(2011-1#1)
questionnaire was developed##2##3##(1992-1#1)(2010-9#1)
questionnaire was given##3##3##(1993-12#1)(2008-7#1)(2011-2#1)
questionnaire was sent to##7##4##(1990-2#1)(1993-2#1)(1994-1#1)(1997-3#1)(2008-1#1)(2012-2#1)(2013-1#1)
questionnaire was used to##4##4##(1990-9#1)(1994-12#1)(2008-1#1)(2008-10#1)
questionnaire was used##6##3##(1990-9#1)(1994-12#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
questionnaire was##26##2##(1990-2#1)(1990-9#1)(1991-1#1)(1992-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1996-3#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
questionnaire were##3##2##(1992-3#1)(2010-1#1)(2013-8#1)
questionnaire##180##1##(1990-2#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#5)(1992-12#2)(1992-2#2)(1992-3#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#3)(1994-3#1)(1994-6#3)(1994-9#1)(1995-10#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(2008-1#6)(2008-10#9)(2008-11#27)(2008-12#6)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#5)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-2#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#9)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#2)
questionnaire-based##2##1##(2012-12#1)(2013-1#1)
questionnaires about##2##2##(1995-1#1)(2008-9#1)
questionnaires and##10##2##(1993-2#1)(1994-12#1)(1997-3#1)(2008-11#2)(2008-12#1)(2009-6#1)(2010-2#1)(2013-1#1)(2013-8#1)
questionnaires are##2##2##(2010-1#1)(2012-2#1)
questionnaires assessing##2##2##(2012-2#1)(2013-1#1)
questionnaires based on##2##3##(2010-11#1)(2012-2#1)
questionnaires for##2##2##(2010-11#1)(2012-12#1)
questionnaires on##2##2##(2012-2#1)(2013-1#1)
questionnaires or##2##2##(2008-11#2)
questionnaires plus##2##2##(2009-4#2)
questionnaires to##4##2##(1992-5#1)(1997-4#1)(2008-11#1)(2012-12#1)
questionnaires were mailed##2##3##(1993-12#1)(2008-1#1)
questionnaires were sent to##2##4##(1997-8#1)(2011-1#1)
questionnaires were used to##2##4##(2008-8#1)(2008-9#1)
questionnaires were used##3##3##(2008-1#1)(2008-8#1)(2008-9#1)
questionnaires were##15##2##(1993-12#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
questionnaires##80##1##(1990-2#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-1#2)(1997-3#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#9)(2008-12#2)(2008-8#1)(2008-9#3)(2009-12#2)(2009-4#3)(2009-6#1)(2010-1#2)(2010-11#3)(2010-2#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#6)(2013-1#9)(2013-8#1)
questions about how##3##3##(2008-11#2)(2009-12#1)
questions about the##13##3##(1991-2#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-1#1)(2008-11#3)(2009-8#2)(2010-1#1)(2012-2#1)(2012-3#1)
questions about whether##2##3##(1995-2#1)(2008-9#1)
questions about##29##2##(1990-5#1)(1991-2#2)(1991-8#1)(1992-12#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-2#1)(2008-11#7)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
questions addressed##2##2##(1996-2#1)(2008-11#1)
questions and##12##2##(1990-2#1)(1990-9#1)(1991-1#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(2009-2#1)(2009-5#1)(2013-1#1)(2013-8#2)
questions are addressed##2##3##(1996-3#1)(2009-5#1)
questions are##11##2##(1991-12#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-10#1)(2012-2#2)
questions as to##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
questions but##2##2##(2008-11#1)(2011-1#1)
questions can##2##2##(2008-11#1)(2008-8#1)
questions concerning##6##2##(1992-1#1)(1994-12#1)(1995-3#1)(2008-10#2)(2009-5#1)
questions emerge##2##2##(2008-11#1)(2008-12#1)
questions from##3##2##(1990-2#1)(2012-3#1)(2013-1#1)
questions in##3##2##(1991-6#1)(2008-11#1)(2008-12#1)
questions of##6##2##(1991-1#1)(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
questions on the##4##3##(2008-10#1)(2008-7#1)(2010-12#1)(2013-8#1)
questions on##8##2##(1992-3#1)(2008-10#3)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
questions pertaining to##2##3##(1997-2#1)(2012-2#1)
questions raised by##3##3##(1997-8#1)(2008-11#1)(2008-3#1)
questions regarding the##6##3##(1992-10#1)(1993-2#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
questions regarding##14##2##(1990-11#1)(1992-10#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
questions remain##3##2##(2009-4#1)(2011-2#1)(2013-8#1)
questions resulting from##2##3##(2008-10#1)(2010-12#1)
questions should##2##2##(2007-11#1)(2011-8#1)
questions that remain##2##3##(2009-6#1)(2013-8#1)
questions that will##2##3##(1995-1#1)(1996-1#1)
questions that##15##2##(1993-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(2008-11#2)(2008-7#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2013-8#1)
questions to be##2##3##(2008-10#1)(2011-2#1)
questions to##8##2##(1992-5#1)(1995-6#1)(2008-10#2)(2011-1#1)(2011-2#2)(2012-2#1)
questions used in##2##3##(2008-12#2)
questions was##2##2##(1996-1#1)(2012-3#1)
questions were used##2##3##(2008-8#1)(2013-8#1)
questions were##9##2##(1991-8#1)(1992-1#1)(2008-12#3)(2008-8#1)(2009-10#1)(2010-11#1)(2013-8#1)
questions which have to be##2##5##(1994-1#1)(2012-3#1)
questions will be##2##3##(2008-4#1)(2009-10#1)
questions##240##1##(1990-11#1)(1990-2#4)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-6#1)(1991-8#2)(1992-1#3)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#4)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#12)(2008-11#36)(2008-12#15)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#10)(2011-8#2)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#11)(2013-8#7)
questions?##2##1##(2008-8#2)
quetiapine##2##1##(2013-1#2)
queuing##6##1##(2008-8#3)(2008-9#2)(2009-3#1)
qui a été##2##3##(2013-1#2)
qui##5##1##(2011-2#1)(2013-1#4)
quick and effective##3##3##(2008-10#2)(2009-8#1)
quick and simple method##2##4##(2008-10#2)
quick and simple##3##3##(2008-10#3)
quick and##14##2##(1990-8#1)(2008-10#9)(2008-11#2)(2008-9#1)(2009-8#1)
quick leaching test##3##3##(2008-10#3)
quick method##2##2##(2008-10#2)
quick##56##1##(1990-8#1)(1990-9#1)(1991-3#1)(1992-5#1)(1992-9#1)(1994-12#2)(1995-8#1)(1997-5#1)(2008-10#30)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
quicker and##3##2##(2008-10#3)
quicker##9##1##(1996-1#1)(1997-2#1)(2007-8#1)(2008-10#4)(2010-1#1)(2013-1#1)
quickly and easily##2##3##(2008-12#1)(2013-7#1)
quickly and reproducibly##2##3##(2012-2#2)
quickly and##9##2##(2008-10#2)(2008-12#1)(2011-3#1)(2012-2#3)(2013-1#1)(2013-7#1)
quickly if##2##2##(1994-8#1)(2012-2#1)
quickly in the##2##3##(2008-11#1)(2011-2#1)
quickly in##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
quickly to##3##2##(1995-1#1)(1997-3#1)(2008-6#1)
quickly with##2##2##(2008-10#1)(2008-9#1)
quickly##84##1##(1990-9#1)(1992-12#1)(1993-2#1)(1994-8#1)(1995-1#2)(1995-6#1)(1996-1#1)(1997-3#1)(2008-10#22)(2008-11#12)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#8)(2009-1#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#6)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
quiescence##10##1##(2008-10#4)(2008-11#2)(2008-8#1)(2009-12#1)(2012-2#1)(2013-8#1)
quiescent conditions##2##2##(2008-10#1)(2008-7#1)
quiescent infections##5##2##(2008-10#5)
quiescent##30##1##(1991-5#1)(1992-3#2)(1993-12#4)(1994-9#2)(1995-3#1)(1997-3#3)(2008-10#14)(2008-11#1)(2008-7#1)(2008-8#1)
quiet##2##1##(2010-9#1)(2011-2#1)
quin 2##2##2##(1990-8#2)
quinalizarine##2##1##(2008-10#2)
quinalphos in##3##2##(2008-10#3)
quinine and##3##2##(1993-8#1)(2008-10#2)
quinine modified resin##3##3##(2008-10#3)
quinine##20##1##(1993-8#2)(1994-8#1)(2008-10#16)(2012-12#1)
quinoa##9##1##(2008-10#9)
quinoidal base##2##2##(2008-10#2)
quinoidal##3##1##(2008-10#3)
quinol##3##1##(2008-10#3)
quinoline degradation##2##2##(2008-7#2)
quinoline##9##1##(1993-8#1)(2008-10#3)(2008-7#5)
quinoline-8-ol##2##1##(2008-10#2)
quinolinic acid##4##2##(1994-8#1)(1995-12#2)(2008-5#1)
quinolinone acid-containing compounds##2##3##(2011-3#2)
quinolone antibacterials##2##2##(2008-10#2)
quinolone##9##1##(2008-10#6)(2009-6#1)(2011-2#1)(2012-3#1)
quinolones##9##1##(2008-10#8)(2011-2#1)
quinone carbonyl##2##2##(1996-5#2)
quinone oxidoreductase##3##2##(1993-3#1)(1997-8#1)(2008-11#1)
quinone##16##1##(1991-5#2)(1993-3#1)(1993-8#1)(1996-5#2)(1997-8#1)(2008-10#8)(2008-11#1)
quinones and##2##2##(2008-10#1)(2011-2#1)
quinones are more##2##3##(2009-9#2)
quinones on##2##2##(2009-9#2)
quinones##20##1##(1991-5#1)(1993-8#6)(2008-10#3)(2008-11#1)(2009-9#8)(2011-2#1)
quis##3##1##(1991-9#3)
quisqualic##2##1##(1991-9#2)
quisqualis##6##1##(2008-10#6)
quit attempts and##2##3##(2013-1#2)
quit attempts##7##2##(2008-4#1)(2010-11#1)(2013-1#5)
quit smoking##8##2##(1993-2#1)(2008-11#1)(2013-1#2)(2013-8#4)
quit##31##1##(1991-12#2)(1993-2#1)(1996-3#1)(2008-11#2)(2008-4#3)(2010-11#1)(2010-2#2)(2011-2#2)(2013-1#11)(2013-8#6)
quite a##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
quite common in the##2##4##(1991-6#1)(2008-10#1)
quite common in##4##3##(1991-6#1)(1995-3#1)(2008-10#1)(2008-8#1)
quite common##5##2##(1991-6#1)(1995-3#1)(2008-10#2)(2008-8#1)
quite complex##5##2##(1993-8#1)(1994-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
quite different from that of##2##5##(1996-2#1)(2010-12#1)
quite different from##5##3##(1996-2#1)(1997-8#1)(2008-9#1)(2010-11#1)(2010-12#1)
quite different##17##2##(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
quite difficult to##2##3##(2008-10#1)(2008-9#1)
quite difficult##6##2##(2008-10#3)(2008-9#2)(2009-1#1)
quite effective in##2##3##(1992-12#1)(2009-12#1)
quite frequent##2##2##(2012-2#1)(2013-1#1)
quite good##3##2##(2008-10#3)
quite heterogeneous##2##2##(2008-10#1)(2008-11#1)
quite high##2##2##(2008-10#2)
quite low##7##2##(1996-2#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-3#1)
quite often##3##2##(1990-9#1)(1996-2#1)(2011-2#1)
quite satisfactory##3##2##(2008-10#3)
quite sensitive to##2##3##(2008-10#2)
quite similar##5##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
quite stable##3##2##(2008-10#3)
quite variable##5##2##(1994-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
quite well##3##2##(2008-10#2)(2008-3#1)
quite##126##1##(1990-6#3)(1990-9#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-3#1)(1995-6#1)(1996-2#3)(1997-1#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#44)(2008-11#3)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#5)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
quitting smoking##2##2##(2010-2#1)(2011-2#1)
quitting##7##1##(1991-12#1)(1993-12#1)(2008-4#1)(2010-2#1)(2011-2#2)(2013-1#1)
quiz##2##1##(2008-11#1)(2011-1#1)
quorum sensing (QS)##2##3##(2008-10#1)(2009-6#1)
quorum sensing##7##2##(1995-2#1)(2008-10#3)(2009-6#1)(2009-8#2)
quorum##11##1##(1995-2#1)(2008-10#3)(2008-7#1)(2009-6#2)(2009-8#3)(2012-2#1)
quorum-quenching enzymes##4##2##(2008-9#4)
quorum-quenching##5##1##(2008-9#5)
quorum-sensing signal##2##2##(2008-9#1)(2009-6#1)
quorum-sensing signals##3##2##(2008-9#3)
quorum-sensing##6##1##(2008-9#5)(2009-6#1)
quot##6##1##(2012-2#6)
quota##3##1##(1993-6#1)(2008-10#1)(2008-11#1)
quote the##2##2##(2008-10#1)(2009-4#1)
quoted##4##1##(1991-3#1)(2008-10#1)(2008-12#1)(2010-7#1)
quotidian##2##1##(2012-3#2)
quotient between##3##2##(1994-5#1)(2008-10#2)
quotient##7##1##(1994-5#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-6#1)
quotients##2##1##(2008-11#2)
r = -0##3##3##(1991-2#1)(2011-3#2)
r = 0##16##3##(1991-2#2)(1991-8#2)(1992-2#2)(1995-11#2)(2008-10#3)(2011-2#1)(2011-3#4)
r =##21##2##(1991-2#3)(1991-8#2)(1992-2#2)(1995-11#2)(2008-10#3)(2008-9#2)(2011-2#1)(2011-3#6)
r and##3##2##(2008-10#3)
r##57##1##(1990-9#5)(1991-2#3)(1991-6#1)(1991-8#2)(1992-2#2)(1995-11#2)(2008-10#21)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#4)(2011-2#1)(2011-3#6)(2012-2#1)(2013-1#1)
r(2) = 0##6##3##(2008-10#6)
r(2)##13##1##(2008-10#11)(2009-3#2)
r(2)&gt##2##1##(1995-3#2)
r(2)=0##18##1##(2008-10#18)
r(G) = 0##2##3##(2008-10#2)
r(g)##4##1##(2008-10#4)
r-HuEPO##4##1##(2008-1#4)
r-[K4HPgK5HPg]##3##1##(1993-8#3)
r-[K4HPg]##3##1##(1993-8#3)
r-[K5HPg]##3##1##(1993-8#3)
r-bp key strings##2##3##(2008-7#2)
r-l##3##1##(1993-2#3)
r-proteins##3##1##(1991-6#1)(2008-11#1)(2008-8#1)
r-selected##2##1##(2008-10#2)
r1-sc##2##1##(2012-3#2)
r=##2##1##(2008-4#2)
r=0##19##1##(2008-10#18)(2010-11#1)
r=1##5##1##(2008-10#5)
rAAV production##3##2##(2008-11#1)(2008-8#2)
rAAV was##2##2##(2008-8#1)(2008-9#1)
rAAV##15##1##(2008-11#2)(2008-8#5)(2008-9#8)
rAAV-mediated gene##2##2##(2008-8#1)(2008-9#1)
rBCG expressing##2##2##(1995-5#2)
rBCG##6##1##(1995-5#6)
rCBF in the##2##3##(1996-2#1)(2008-7#1)
rCBF in##3##2##(1995-5#1)(1996-2#1)(2008-7#1)
rCBF##6##1##(1995-5#3)(1996-2#2)(2008-7#1)
rCHO cells##2##2##(2008-11#2)
rCHO##3##1##(2008-11#3)
rCHO-A##2##1##(2008-11#2)
rCHO-B##2##1##(2008-11#2)
rDNA and##7##2##(2008-10#7)
rDNA fragment##2##2##(2008-10#1)(2008-9#1)
rDNA from isolates of AG-13##2##5##(2008-10#2)
rDNA from##4##2##(2008-10#4)
rDNA gene##5##2##(2008-10#3)(2008-12#2)
rDNA genotypes##2##2##(2008-10#2)
rDNA in the##2##3##(2008-10#1)(2012-2#1)
rDNA revealed##2##2##(2008-10#2)
rDNA sequence and RAPD##2##4##(2008-10#2)
rDNA sequence##7##2##(2008-10#6)(2008-11#1)
rDNA showed that##2##3##(2008-10#2)
rDNA spacer##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
rDNA was##3##2##(2008-10#3)
rDNA were used to##2##4##(2008-10#2)
rDNA were##4##2##(2008-10#4)
rDNA##94##1##(2007-12#4)(2008-10#78)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#2)(2012-2#2)
rDNA)##2##1##(2008-10#2)
rDNA-ITS region##3##2##(2008-10#3)
rDNA-ITS sequences##3##2##(2008-10#2)(2012-3#1)
rDNA-ITS##6##1##(2008-10#5)(2012-3#1)
rFurin##8##1##(2008-11#8)
rGO sheets##2##2##(2013-1#2)
rGO##4##1##(2013-1#4)
rGO/SWCNT-modified##2##1##(2013-1#2)
rHuEPO##5##1##(1995-1#5)
rIFN-gamma##2##1##(1994-8#2)
rIL-2##6##1##(1990-12#5)(1991-8#1)
rMtL##4##1##(2008-10#4)
rNG-hCGalpha##7##1##(1995-8#7)
rNT-3##3##1##(2008-8#3)
rP27(kip 1)##2##2##(2008-9#2)
rP27(kip##3##1##(2008-9#3)
rPEA##4##1##(2008-10#4)
rPlg##6##1##(1995-6#6)
rRNA and##4##2##(1996-6#1)(2008-10#3)
rRNA gene of##2##3##(2008-12#1)(2008-8#1)
rRNA gene##30##2##(2008-10#9)(2008-12#2)(2008-6#1)(2008-8#4)(2009-6#3)(2010-4#1)(2010-6#2)(2011-2#5)(2012-2#1)(2013-8#2)
rRNA genes and##2##3##(2008-10#1)(2008-8#1)
rRNA genes are##2##3##(2011-2#2)
rRNA genes##11##2##(1992-3#1)(2008-10#4)(2008-8#2)(2011-2#3)(2012-2#1)
rRNA in this##2##3##(2010-4#2)
rRNA in##3##2##(2010-4#3)
rRNA internal##2##2##(2008-10#1)(2008-9#1)
rRNA is##2##2##(2008-8#2)
rRNA sequences##2##2##(2008-10#1)(2011-1#1)
rRNA##82##1##(1992-3#1)(1993-12#1)(1995-3#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#23)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#14)(2008-9#2)(2009-6#3)(2010-4#7)(2010-6#2)(2011-1#1)(2011-2#11)(2012-2#4)(2013-1#1)(2013-8#2)
rRNAs##2##1##(2008-5#1)(2010-4#1)
rTFPI##2##1##(1992-10#2)
rTMS to##2##2##(2011-2#2)
rTMS##7##1##(2010-7#1)(2011-2#6)
rTNF-alpha was##2##2##(1994-8#2)
rTNF-alpha##4##1##(1994-8#4)
rZIC gene##2##2##(2008-9#2)
rabbit CK-II##2##2##(1993-2#2)
rabbit DSIP##2##2##(1990-5#2)
rabbit IgG##4##2##(2008-10#3)(2009-6#1)
rabbit and rat##2##3##(1992-6#1)(2008-10#1)
rabbit and##4##2##(1990-5#1)(1992-6#1)(2008-10#2)
rabbit antibodies##2##2##(1991-5#1)(2008-10#1)
rabbit antibody##2##2##(1995-6#1)(2008-10#1)
rabbit antisera##2##2##(1992-9#1)(1996-12#1)
rabbit antiserum raised against##2##4##(2008-10#2)
rabbit antiserum##5##2##(2008-10#5)
rabbit beta-globin##2##2##(2008-11#2)
rabbit bladder smooth muscle##2##4##(1994-8#2)
rabbit bladder##3##2##(1994-8#3)
rabbit blood##2##2##(2008-10#2)
rabbit by##2##2##(2008-9#1)(2012-3#1)
rabbit cardiac muscle microvessel endothelial##2##5##(1991-5#2)
rabbit genomic##2##2##(1992-6#1)(1993-6#1)
rabbit immunoglobulin##2##2##(2008-10#2)
rabbit kidney##2##2##(1993-6#1)(1994-8#1)
rabbit liver##3##2##(2008-10#3)
rabbit lung##2##2##(1993-8#1)(1994-12#1)
rabbit model##3##2##(2008-4#1)(2009-3#1)(2012-3#1)
rabbit muscle##6##2##(1992-4#1)(1994-5#1)(2008-11#4)
rabbit myocardium##2##2##(1994-8#2)
rabbit ooplasm##3##2##(2008-9#3)
rabbit or##2##2##(1993-8#1)(1995-6#1)
rabbit polyclonal antibodies raised against##2##5##(1990-8#1)(1996-12#1)
rabbit polyclonal antibodies##3##3##(1990-8#1)(1992-6#1)(1996-12#1)
rabbit polyclonal antibody##3##3##(2008-10#3)
rabbit polyclonal##6##2##(1990-8#1)(1992-6#1)(1996-12#1)(2008-10#3)
rabbit reticulocyte lysate##2##3##(1991-10#1)(1993-12#1)
rabbit reticulocyte##3##2##(1990-11#1)(1991-10#1)(1993-12#1)
rabbit reticulocytes##2##2##(1996-2#2)
rabbit skeletal muscle ryanodine##2##4##(2008-9#2)
rabbit skin##6##2##(1992-6#3)(2008-5#2)(2008-8#1)
rabbit using##2##2##(2008-10#1)(2008-11#1)
rabbit##155##1##(1990-11#1)(1990-12#1)(1990-5#5)(1990-8#1)(1991-10#1)(1991-5#6)(1991-6#1)(1992-1#1)(1992-4#1)(1992-6#11)(1992-9#3)(1993-12#1)(1993-2#3)(1993-6#4)(1993-8#2)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#10)(1995-11#3)(1995-2#1)(1995-6#5)(1996-12#3)(1996-2#2)(1997-1#2)(2008-10#32)(2008-11#13)(2008-12#1)(2008-4#2)(2008-5#5)(2008-8#2)(2008-9#16)(2009-3#2)(2009-6#1)(2010-4#1)(2011-3#1)(2012-3#2)(2013-1#2)
rabbit's##2##1##(2008-10#1)(2008-5#1)
rabbits after##2##2##(2008-10#1)(2012-3#1)
rabbits and##5##2##(2008-10#1)(2008-9#2)(2009-7#1)(2010-7#1)
rabbits are##2##2##(1995-9#1)(2008-11#1)
rabbits expressing##2##2##(2008-11#2)
rabbits in the##4##3##(1996-3#1)(2008-11#2)(2013-1#1)
rabbits in##5##2##(1996-3#1)(2008-11#3)(2013-1#1)
rabbits is##2##2##(1994-8#1)(1995-9#1)
rabbits showed##2##2##(2008-10#1)(2008-5#1)
rabbits was##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
rabbits were##9##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-3#4)(1996-3#1)(2012-3#1)
rabbits with the##2##3##(1996-2#1)(2008-10#1)
rabbits with##8##2##(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-8#2)
rabbits##92##1##(1990-11#3)(1990-12#3)(1990-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-3#4)(1992-6#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-5#1)(1995-6#3)(1995-9#5)(1996-12#1)(1996-2#1)(1996-3#3)(1997-8#2)(2008-10#9)(2008-11#10)(2008-12#5)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#5)(2013-1#1)
rabeprazole and lansoprazole##4##3##(2012-2#4)
rabeprazole##7##1##(2008-10#2)(2012-2#5)
rabiei in##3##2##(2008-10#3)
rabiei##13##1##(2008-10#13)
rabies in##3##2##(1992-5#1)(2011-2#2)
rabies incidence##2##2##(2011-2#2)
rabies##12##1##(1992-5#1)(2008-10#1)(2008-11#1)(2011-2#8)(2013-1#1)
rac p21s##7##2##(1993-8#7)
rac##10##1##(1993-8#7)(1996-2#3)
raccoon dogs##2##2##(2008-12#2)
raccoon##3##1##(2008-12#3)
race (race##2##2##(2008-10#2)
race 0##4##2##(2008-10#4)
race 1 and race##3##4##(2008-10#3)
race 1 and##6##3##(2008-10#6)
race 1 in##2##3##(2008-10#2)
race 1 isolate##2##3##(2008-10#2)
race 1 isolates##9##3##(2008-10#9)
race 1 of##3##3##(2008-10#3)
race 1##42##2##(2008-10#42)
race 2 and race##2##4##(2008-10#2)
race 2 isolates##3##3##(2008-10#3)
race 2 of##2##3##(2008-10#2)
race 2##35##2##(2008-10#35)
race 3 (T3)##2##3##(2008-10#2)
race 3 in the##2##4##(2008-10#2)
race 3 in##3##3##(2008-10#3)
race 3 isolates from##2##4##(2008-10#2)
race 3 isolates##4##3##(2008-10#4)
race 3 was##3##3##(2008-10#3)
race 3##18##2##(2008-10#18)
race 4##6##2##(2008-10#6)
race 5##10##2##(2008-10#10)
race 6##6##2##(2008-10#6)
race 6-specific##2##2##(2008-10#2)
race 7##4##2##(2008-10#4)
race 8##3##2##(2008-10#3)
race Ct1##2##2##(2008-10#2)
race and##5##2##(2008-10#2)(2008-11#1)(2010-9#1)(2012-2#1)
race clusters using the 195 isolates##2##6##(2008-10#2)
race clusters##4##2##(2008-10#4)
race designation##2##2##(2008-10#2)
race in##4##2##(1995-2#2)(2008-10#1)(2011-2#1)
race is##2##2##(1991-11#1)(2008-11#1)
race of G##4##3##(2008-10#4)
race of##9##2##(2008-10#8)(2008-8#1)
race specificity##2##2##(2008-8#2)
race structure##8##2##(2008-10#8)
race with##2##2##(1990-2#1)(2008-10#1)
race##253##1##(1990-2#1)(1991-11#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-2#3)(2008-10#215)(2008-11#8)(2008-12#1)(2008-5#2)(2008-8#5)(2009-12#1)(2009-5#2)(2009-6#2)(2010-9#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
race-change mutants##6##2##(2008-10#6)
race-nonspecific resistance##3##2##(2008-10#3)
race-related amygdala activity##2##3##(2008-11#2)
race-specific genes##3##2##(2008-10#3)
race-specific resistance to##3##3##(2008-10#3)
race-specific resistance##7##2##(2008-10#7)
race-specific##15##1##(2008-10#15)
race/ethnicity and language##2##3##(2013-1#2)
race/ethnicity and##3##2##(2013-1#2)(2013-8#1)
race/ethnicity##8##1##(2008-12#1)(2009-5#1)(2013-1#5)(2013-8#1)
racemates##5##1##(1990-6#1)(2008-10#4)
racemic##7##1##(1992-11#1)(1992-12#1)(1996-5#2)(1997-4#1)(2008-10#1)(2011-1#1)
racemosus##4##1##(2008-10#1)(2013-1#3)
races 0##3##2##(2008-10#3)
races 1 and 2 of##2##5##(2008-10#2)
races 1 and 2##3##4##(2008-10#3)
races 1 and 3##2##4##(2008-10#2)
races 1 and 8##3##4##(2008-10#3)
races 1 and##14##3##(2008-10#14)
races 1##26##2##(2008-10#26)
races 2 and 5##2##4##(2008-10#2)
races 2##5##2##(2008-10#5)
races 6##2##2##(2008-10#2)
races and##6##2##(1992-2#1)(2008-10#4)(2008-9#1)
races are##2##2##(2008-10#2)
races in##5##2##(2008-10#3)(2008-9#1)(2010-1#1)
races of F##4##3##(2008-10#4)
races of P##7##3##(2008-10#7)
races of Podosphaera xanthii and one race of G##2##9##(2008-10#2)
races of the fungus##2##4##(2008-10#2)
races of the pathogen##5##4##(2008-10#5)
races of the##7##3##(2008-10#7)
races of##31##2##(2008-10#29)(2008-9#1)(2010-1#1)
races that##2##2##(2008-10#2)
races was##3##2##(2008-10#3)
races were##6##2##(2008-10#6)
races with race 1##2##4##(2008-10#2)
races with##4##2##(2008-10#4)
races##143##1##(1992-2#1)(1995-12#1)(1995-2#1)(2008-10#130)(2008-12#1)(2008-8#1)(2008-9#4)(2010-1#2)(2010-11#1)(2011-2#1)
rachis susceptibility##3##2##(2008-10#3)
rachis##13##1##(2008-10#12)(2008-9#1)
rachises##2##1##(2008-10#2)
racial and ethnic groups##2##4##(1997-1#1)(2011-2#1)
racial and ethnic##5##3##(1997-1#1)(2008-10#1)(2008-5#1)(2011-2#2)
racial differences##2##2##(1991-7#1)(2011-2#1)
racial gap##2##2##(2011-2#2)
racial##17##1##(1991-7#1)(1994-12#1)(1994-3#2)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2011-2#6)
racial/ethnic groups##2##2##(2011-2#1)(2012-12#1)
racial/ethnic##5##1##(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
racially diverse##2##2##(1994-2#1)(2010-11#1)
racially##4##1##(1994-2#1)(2008-11#1)(2010-1#1)(2010-11#1)
rack##2##1##(2008-11#1)(2012-2#1)
racket and ball kinematics##2##4##(2011-2#2)
racket and ball##3##3##(2011-2#3)
racket##5##1##(2011-2#5)
racquet##3##1##(2011-2#3)
rad9 delta cells##2##3##(1996-3#2)
rad9 delta##3##2##(1996-3#3)
radA null mutants##2##3##(1997-4#2)
radA##6##1##(1997-4#6)
radar and the##2##3##(2008-3#2)
radar cross sections##2##3##(2008-3#2)
radar cross##3##2##(2008-3#3)
radar parameters##2##2##(2008-3#2)
radar safety##2##2##(2008-3#2)
radar##29##1##(2008-2#1)(2008-3#27)(2008-6#1)
radial access##4##2##(2011-2#4)
radial approach##3##2##(2011-2#3)
radial arm maze##2##3##(1992-12#1)(2012-2#1)
radial artery is##3##3##(2008-11#1)(2011-2#2)
radial artery occlusion and radial artery spasm##3##7##(2011-2#3)
radial artery occlusion##4##3##(2011-2#4)
radial artery spasm##5##3##(2011-2#5)
radial artery##26##2##(2008-11#2)(2008-7#1)(2008-9#2)(2011-2#20)(2013-1#1)
radial basis function networks##2##4##(2008-10#2)
radial basis function neural##3##4##(2008-10#3)
radial basis function##6##3##(2008-10#6)
radial basis##7##2##(2008-10#7)
radial data##2##2##(2008-10#2)
radial distribution functions##2##3##(1992-9#1)(2008-10#1)
radial distribution of##2##3##(2008-10#2)
radial distribution##4##2##(1992-9#1)(2008-10#3)
radial flow cell for##2##4##(2008-10#2)
radial flow cell##4##3##(2008-10#4)
radial flow monolithic column##2##4##(2008-10#2)
radial flow##8##2##(2008-10#8)
radial forearm flap##3##3##(2008-9#3)
radial forearm##4##2##(2008-9#3)(2011-2#1)
radial growth of strain##2##4##(2008-10#1)(2008-5#1)
radial growth of##3##3##(2008-10#2)(2008-5#1)
radial growth##7##2##(2008-10#5)(2008-5#1)(2012-5#1)
radial immunodiffusion##2##2##(1990-2#1)(1993-2#1)
radial maze##2##2##(1993-6#1)(1994-2#1)
radial nerve##4##2##(2008-9#2)(2012-2#2)
radial occlusion##2##2##(2011-2#2)
radial or##2##2##(1990-11#1)(2008-10#1)
radial rate##2##2##(2008-10#2)
radial recurrent fasciocutaneous flap##2##4##(2011-2#2)
radial shrinkage of fresh##2##4##(2012-2#2)
radial shrinkage##3##2##(2012-2#3)
radial##135##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-5#1)(1997-3#2)(2008-10#36)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#9)(2009-6#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#49)(2012-2#6)(2012-5#1)(2013-1#2)(2013-8#4)
radial-growing##2##1##(2008-10#2)
radially symmetric##3##2##(1994-2#1)(2008-3#1)(2013-8#1)
radially##7##1##(1994-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#1)(2013-8#1)
radiance and##3##2##(2008-3#3)
radiance for##3##2##(2008-3#3)
radiance model##2##2##(2008-2#2)
radiance spectra##2##2##(2008-3#2)
radiance##30##1##(2008-2#3)(2008-3#27)
radiances##8##1##(2008-2#3)(2008-3#5)
radiata and##2##2##(2010-8#2)
radiata##15##1##(1995-2#2)(2008-10#4)(2008-12#6)(2010-8#3)
radiated##3##1##(2008-2#1)(2008-8#2)
radiating##2##1##(2008-2#1)(2013-8#1)
radiation X-ray fluorescence##2##3##(2008-10#2)
radiation after##3##2##(1991-2#1)(1995-6#1)(2009-11#1)
radiation and chemotherapy##2##3##(1993-2#1)(2013-1#1)
radiation and##15##2##(1993-2#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-1#2)(2013-1#2)
radiation are##4##2##(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
radiation as##2##2##(2008-11#1)(2011-2#1)
radiation at wavelengths##2##3##(2008-3#2)
radiation at##12##2##(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#5)
radiation by##2##2##(2008-3#1)(2008-7#1)
radiation can be##2##3##(2008-10#1)(2008-7#1)
radiation can cause##2##3##(2008-7#2)
radiation can##5##2##(2008-10#1)(2008-7#4)
radiation compared##2##2##(2008-7#1)(2011-2#1)
radiation damage##4##2##(1990-12#1)(1995-6#1)(2008-10#2)
radiation dose of##2##3##(2008-7#1)(2011-2#1)
radiation dose##7##2##(1997-8#1)(2008-2#1)(2008-7#2)(2011-2#2)(2013-1#1)
radiation doses##4##2##(1995-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
radiation during##2##2##(1995-12#1)(2008-10#1)
radiation effects##2##2##(2008-11#1)(2008-7#1)
radiation exposure and##2##3##(1994-3#1)(2008-7#1)
radiation exposure##10##2##(1994-3#1)(2008-1#1)(2008-12#2)(2008-7#4)(2012-2#1)(2013-8#1)
radiation for##4##2##(2008-10#1)(2008-3#1)(2009-11#1)(2011-2#1)
radiation from a##2##3##(2008-10#1)(2008-2#1)
radiation from the##3##3##(1990-12#2)(2008-10#1)
radiation from##7##2##(1990-12#2)(1994-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
radiation has been##2##3##(2008-10#2)
radiation has##8##2##(2008-10#4)(2008-7#1)(2011-2#2)(2012-12#1)
radiation hormesis in##2##3##(2013-1#2)
radiation hormesis##4##2##(2008-7#1)(2013-1#3)
radiation hybrid##3##2##(1997-8#2)(2008-8#1)
radiation hybrids##2##2##(1996-6#2)
radiation in the range##2##4##(2008-3#1)(2010-4#1)
radiation in the##6##3##(1993-9#1)(2008-2#3)(2008-3#1)(2010-4#1)
radiation in##18##2##(1990-9#1)(1993-9#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#3)(2010-4#1)(2013-1#1)
radiation induced##5##2##(2008-10#1)(2008-5#2)(2013-8#2)
radiation intensity##2##2##(2008-10#1)(2009-10#1)
radiation is##10##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)
radiation level##2##2##(2013-1#2)
radiation loss##2##2##(2008-3#2)
radiation of##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
radiation on the##2##3##(2011-2#1)(2013-1#1)
radiation on##9##2##(1993-9#1)(2008-10#1)(2008-7#1)(2010-1#2)(2011-2#3)(2013-1#1)
radiation oncologists##3##2##(2008-10#2)(2009-2#1)
radiation or##4##2##(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
radiation protection##13##2##(2008-12#2)(2008-7#4)(2012-2#3)(2013-1#2)(2013-8#2)
radiation safety##2##2##(2013-1#2)
radiation sensitivity of##5##3##(1994-8#1)(2008-5#1)(2008-9#3)
radiation sensitivity##8##2##(1994-8#1)(2008-5#1)(2008-9#5)(2013-1#1)
radiation source##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
radiation than##2##2##(1991-5#1)(2008-11#1)
radiation therapy and##4##3##(1993-8#1)(2008-11#1)(2008-7#1)(2013-8#1)
radiation therapy for##5##3##(1993-8#1)(1994-12#1)(2008-7#2)(2013-8#1)
radiation therapy in##3##3##(1994-12#1)(1994-6#1)(2008-7#1)
radiation therapy is##2##3##(1990-12#1)(2008-10#1)
radiation therapy of##3##3##(1990-12#1)(1992-12#1)(2011-2#1)
radiation therapy##43##2##(1990-12#2)(1990-2#1)(1991-2#1)(1992-12#2)(1993-2#1)(1993-8#5)(1993-9#1)(1994-12#5)(1994-3#1)(1994-6#1)(1995-10#1)(1997-3#1)(1997-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#10)(2008-9#1)(2009-11#1)(2011-2#2)(2013-8#2)
radiation to the##4##3##(1993-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
radiation to##8##2##(1993-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2011-2#2)
radiation treatment##6##2##(1992-7#1)(2008-7#2)(2009-11#1)(2011-2#1)(2013-1#1)
radiation using##2##2##(2008-10#1)(2010-1#1)
radiation was significantly##2##3##(2008-9#1)(2010-1#1)
radiation was##7##2##(1993-2#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)
radiation were performed##2##3##(1997-8#1)(2008-3#1)
radiation with a##2##3##(2008-3#1)(2008-7#1)
radiation with respect to the##2##5##(2008-3#1)(2013-1#1)
radiation with##4##2##(2008-3#2)(2008-7#1)(2013-1#1)
radiation##445##1##(1990-12#5)(1990-2#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#2)(1992-7#1)(1993-11#1)(1993-2#4)(1993-3#2)(1993-6#2)(1993-8#6)(1993-9#6)(1994-12#5)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#3)(1995-6#3)(1995-8#2)(1996-11#1)(1996-6#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#7)(2007-12#5)(2007-8#1)(2008-1#4)(2008-10#68)(2008-11#19)(2008-12#5)(2008-2#18)(2008-3#42)(2008-5#17)(2008-7#66)(2008-8#8)(2008-9#17)(2009-10#2)(2009-11#6)(2009-2#1)(2009-7#1)(2010-1#7)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#31)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#30)(2013-8#8)
radiation)##2##1##(2008-10#1)(2013-1#1)
radiation-induced CAS##2##2##(2011-2#2)
radiation-induced DSBs##2##2##(2011-2#1)(2013-1#1)
radiation-induced cancer##2##2##(2008-7#2)
radiation-induced cell death##2##3##(1995-12#2)
radiation-induced heritable##2##2##(2008-7#2)
radiation-induced##25##1##(1991-3#1)(1992-12#1)(1993-5#1)(1995-11#1)(1995-12#3)(1996-10#1)(2008-12#2)(2008-7#11)(2011-2#3)(2013-1#1)
radiations##6##1##(2008-10#1)(2008-5#2)(2008-8#2)(2011-2#1)
radiative properties of##2##3##(2008-2#1)(2008-3#1)
radiative transfer code for##2##4##(2008-3#2)
radiative transfer equation for##2##4##(2008-3#2)
radiative transfer equation##5##3##(2008-2#2)(2008-3#3)
radiative transfer in a##2##4##(2008-10#1)(2008-3#1)
radiative transfer in##4##3##(2008-10#1)(2008-3#3)
radiative transfer problem##2##3##(2008-3#2)
radiative transfer##20##2##(2008-10#1)(2008-2#4)(2008-3#15)
radiative transport##2##2##(2008-3#2)
radiative##28##1##(1992-3#1)(2008-10#1)(2008-2#6)(2008-3#20)
radiative-transfer##2##1##(2008-3#2)
radiatively##2##1##(2008-11#1)(2008-2#1)
radiatum##3##1##(1994-2#1)(1996-12#1)(2008-7#1)
radical and its##2##3##(1996-5#1)(2008-10#1)
radical and##6##2##(1996-5#1)(1997-1#1)(2008-10#2)(2008-7#2)
radical cations##5##2##(2008-9#5)
radical chain reaction##2##3##(2008-10#2)
radical concentration in##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
radical cyclization##2##2##(1996-5#2)
radical formation##3##2##(2008-10#2)(2008-11#1)
radical from##2##2##(1996-5#1)(2008-10#1)
radical hysterectomy##4##2##(1994-2#4)
radical in##3##2##(1996-5#1)(2008-10#2)
radical is##4##2##(2008-10#3)(2008-4#1)
radical mastectomy and##2##3##(1990-12#1)(1992-12#1)
radical mastectomy##6##2##(1990-12#1)(1992-12#2)(1994-12#2)(2008-10#1)
radical nephrectomy and thrombectomy of the IVC##2##7##(2011-2#2)
radical operation##6##2##(1990-3#2)(1990-9#2)(1993-11#1)(2008-12#1)
radical operations for##2##3##(1990-9#2)
radical operations##3##2##(1990-9#2)(2012-3#1)
radical polymerization of##2##3##(2008-12#1)(2009-10#1)
radical polymerization##4##2##(2008-10#2)(2008-12#1)(2009-10#1)
radical prostatectomies##2##2##(2008-10#1)(2010-11#1)
radical prostatectomy in##2##3##(2010-10#1)(2011-2#1)
radical prostatectomy##5##2##(1990-9#1)(2010-10#1)(2010-11#1)(2011-2#2)
radical reaction##5##2##(1996-2#4)(2010-4#1)
radical scavenger##14##2##(1992-9#1)(1993-6#1)(1995-11#1)(1995-8#3)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
radical scavengers and antioxidants##2##4##(2008-11#1)(2008-5#1)
radical scavengers and##3##3##(2008-11#2)(2008-5#1)
radical scavengers##6##2##(1996-2#1)(2008-11#2)(2008-5#1)(2011-2#2)
radical scavenging activities of the##2##5##(2008-12#1)(2008-5#1)
radical scavenging activities##4##3##(2008-12#1)(2008-5#1)(2009-3#1)(2013-1#1)
radical scavenging activity##5##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)
radical scavenging effect##2##3##(2008-11#2)
radical scavenging##15##2##(1996-2#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-5#3)(2009-3#1)(2013-1#2)
radical surgery as##2##3##(1990-9#1)(2011-2#1)
radical surgery##11##2##(1990-6#1)(1990-9#4)(1994-6#1)(1997-7#1)(2007-8#1)(2010-11#2)(2011-2#1)
radical surgical resection##2##3##(1994-6#1)(2008-7#1)
radical surgical##6##2##(1991-11#1)(1994-6#1)(2007-11#1)(2008-7#1)(2011-2#2)
radical to##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
radical##215##1##(1990-12#3)(1990-3#3)(1990-6#2)(1990-9#9)(1991-11#1)(1991-3#2)(1992-12#3)(1992-3#2)(1992-9#4)(1993-11#1)(1993-6#1)(1994-12#2)(1994-2#4)(1994-5#2)(1994-6#4)(1995-11#1)(1995-6#1)(1995-8#4)(1996-2#7)(1996-5#12)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-10#45)(2008-11#19)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#9)(2008-7#6)(2008-8#3)(2008-9#9)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#11)(2011-3#1)(2012-3#3)(2013-1#2)(2013-8#3)
radical-induced##2##1##(1990-5#1)(1992-9#1)
radical-scavenging##2##1##(2008-10#1)(2008-12#1)
radicalHz##3##1##(2007-12#1)(2008-3#2)
radicale##2##1##(2011-2#2)
radically##3##1##(1994-1#1)(2008-10#1)(2008-9#1)
radicals and##11##2##(1992-9#1)(1993-8#1)(1995-8#2)(2008-10#3)(2008-5#1)(2009-6#1)(2010-12#1)(2010-7#1)
radicals are##6##2##(2008-10#3)(2008-8#1)(2010-10#2)
radicals generated from##2##3##(1995-8#1)(2008-10#1)
radicals generated##5##2##(1995-8#1)(1997-8#1)(2008-10#3)
radicals in a##2##3##(2008-10#2)
radicals in##7##2##(1992-9#1)(2008-10#4)(2008-11#1)(2008-5#1)
radicals play##2##2##(1992-9#1)(1995-8#1)
radicals produced##2##2##(1993-2#1)(1993-6#1)
radicals that##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2009-8#1)
radicals##92##1##(1990-5#1)(1992-9#8)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#5)(1993-8#1)(1994-11#1)(1995-6#1)(1995-8#5)(1996-2#1)(1997-8#3)(2007-8#1)(2008-10#32)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-7#3)(2013-1#1)(2013-8#3)
radicicola##2##1##(2008-10#2)
radicina and##3##2##(2008-10#3)
radicina##6##1##(2008-10#6)
radicis-cucumerinum##5##1##(2008-10#5)
radicis-lycopersici and##3##2##(2008-10#3)
radicis-lycopersici##18##1##(2008-10#18)
radicle##2##1##(2008-9#2)
radicles##2##1##(2008-10#2)
radicular pain##3##2##(2011-2#1)(2012-2#2)
radicular symptoms##2##2##(2008-7#2)
radicular##10##1##(1991-11#1)(1997-3#1)(2008-7#3)(2011-2#1)(2012-2#3)(2013-1#1)
radiculopathy and##3##2##(2008-7#2)(2012-3#1)
radiculopathy##15##1##(2008-12#1)(2008-7#5)(2008-8#1)(2011-2#1)(2012-12#2)(2012-3#4)(2013-8#1)
radii and##2##2##(2008-10#1)(2008-3#1)
radii##7##1##(2008-10#6)(2008-3#1)
radio and##4##2##(1996-5#1)(2009-3#1)(2009-4#1)(2013-1#1)
radio frequency##2##2##(2008-9#1)(2010-7#1)
radio to##2##2##(1995-2#1)(2009-3#1)
radio##21##1##(1990-11#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-9#2)(2009-3#2)(2009-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2013-1#2)
radio-HPLC##2##1##(1991-5#1)(2013-1#1)
radio-frequency##3##1##(1992-3#1)(2008-11#1)(2011-2#1)
radioactive dynamic##2##2##(2008-10#2)
radioactive materials##2##2##(1991-9#1)(2008-10#1)
radioactive or##2##2##(2008-10#1)(2008-4#1)
radioactive spot on##2##3##(1995-2#1)(2008-9#1)
radioactive tracer##2##2##(1993-8#1)(2008-7#1)
radioactive waste##3##2##(1990-3#1)(2008-10#2)
radioactive##35##1##(1990-3#1)(1990-6#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-2#1)(2008-1#2)(2008-10#13)(2008-4#5)(2008-7#1)(2008-9#3)(2012-12#1)(2013-1#1)
radioactively##2##1##(1993-11#1)(2008-4#1)
radioactivity and##3##2##(1990-12#1)(1991-3#1)(1992-2#1)
radioactivity from##3##2##(1994-8#1)(1995-8#1)(2008-11#1)
radioactivity in##2##2##(2008-4#1)(2008-8#1)
radioactivity of##4##2##(1991-3#1)(1993-11#1)(2008-11#2)
radioactivity was##3##2##(1993-11#1)(1994-11#1)(2008-10#1)
radioactivity##34##1##(1990-12#4)(1991-12#1)(1991-3#2)(1992-2#1)(1993-11#2)(1993-8#2)(1994-11#1)(1994-8#3)(1995-8#1)(1996-2#2)(1997-1#1)(2008-10#2)(2008-11#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)
radiobacter strain K84##3##3##(2008-10#3)
radiobacter##7##1##(2008-10#7)
radiobiology##6##1##(2008-10#3)(2008-7#2)(2013-1#1)
radiocarpal##2##1##(2008-9#2)
radiochemical separation##2##2##(2008-10#2)
radiochemical##3##1##(2008-10#3)
radioembolization##4##1##(2013-1#4)
radiofrequency (RF) ablation##2##3##(2010-12#1)(2010-6#1)
radiofrequency (RF)##3##2##(2010-12#1)(2010-6#1)(2011-2#1)
radiofrequency ablation##5##2##(2008-11#1)(2010-12#1)(2010-6#1)(2011-2#2)
radiofrequency device##2##2##(2013-1#2)
radiofrequency##20##1##(2008-10#3)(2008-11#1)(2009-3#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#2)
radiograms##6##1##(2007-8#6)
radiograph and##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
radiograph revealed##2##2##(2010-2#1)(2012-3#1)
radiograph##11##1##(1991-11#1)(1997-8#2)(2007-12#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#2)(2013-7#1)
radiographed##2##1##(1997-8#1)(2011-2#1)
radiographers##4##1##(1991-2#1)(1996-1#2)(2008-10#1)
radiographers' organizational commitment##2##3##(1996-1#2)
radiographic ASD##2##2##(2012-12#2)
radiographic and clinical##2##3##(2011-2#1)(2012-12#1)
radiographic and##5##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
radiographic evaluation##2##2##(2008-2#1)(2008-9#1)
radiographic examination##2##2##(1997-4#1)(2011-2#1)
radiographic findings were##2##3##(2009-1#1)(2013-8#1)
radiographic findings##4##2##(2009-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
radiographic follow-up##2##2##(2012-3#1)(2013-1#1)
radiographic interpretation##2##2##(2012-12#1)(2013-1#1)
radiographic outcomes##4##2##(2011-2#1)(2013-1#3)
radiographic results##2##2##(2009-3#1)(2013-1#1)
radiographic##47##1##(1991-12#3)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-2#6)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#10)(2013-8#1)
radiographically##5##1##(1990-12#1)(1997-4#2)(1997-8#1)(2009-10#1)
radiographs (DRRs)##2##2##(2009-11#1)(2009-2#1)
radiographs and CT scan##2##4##(2008-12#1)(2013-1#1)
radiographs and##7##2##(2008-12#2)(2008-8#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
radiographs in##2##2##(2013-1#2)
radiographs revealed##2##2##(2008-12#1)(2008-9#1)
radiographs were##5##2##(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#2)
radiographs##33##1##(1991-12#2)(1992-5#1)(1997-3#1)(2008-12#3)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#8)
radiography in the##3##3##(1997-8#1)(2008-9#1)(2011-2#1)
radiography in##4##2##(1997-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
radiography is##5##2##(1997-8#2)(2008-9#2)(2011-2#1)
radiography of##4##2##(1997-8#1)(2009-1#2)(2013-1#1)
radiography##30##1##(1990-3#1)(1991-12#1)(1995-5#1)(1997-8#6)(2008-2#1)(2008-9#3)(2009-1#2)(2009-9#2)(2010-6#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
radioimmunoassay (RIA)##2##2##(1990-11#1)(2008-8#1)
radioimmunoassay##12##1##(1990-11#1)(1990-9#2)(1991-12#1)(1991-3#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-8#1)
radioimmunoassays##2##1##(1990-2#1)(2008-4#1)
radioiodine##3##1##(1992-5#1)(2008-11#1)(2013-1#1)
radioisotope##3##1##(1992-2#3)
radioisotopes##2##1##(2008-10#1)(2008-7#1)
radiolabel##14##1##(1990-2#4)(1991-12#1)(1991-3#1)(1992-2#2)(1992-3#1)(1993-6#1)(1996-2#1)(2008-11#2)(2008-7#1)
radiolabeled DNA##2##2##(1996-3#1)(2008-4#1)
radiolabeled proteins##2##2##(2008-4#2)
radiolabeled##28##1##(1990-2#1)(1991-12#1)(1992-2#1)(1993-11#1)(1993-8#2)(1994-11#2)(1994-5#1)(1994-8#1)(1995-11#1)(1996-3#3)(1997-1#1)(2008-10#3)(2008-11#1)(2008-4#4)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
radiolabeling method##2##2##(1992-2#1)(2008-4#1)
radiolabeling##3##1##(1992-2#2)(2008-4#1)
radiolabelled##11##1##(1990-11#1)(1990-12#1)(1990-2#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-11#1)(2008-7#1)
radiolar appendages##2##2##(2011-2#2)
radiolar##5##1##(2011-2#5)
radioligand binding##7##2##(1991-6#2)(1993-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)
radioligand was##2##2##(1994-8#2)
radioligand##15##1##(1990-11#1)(1991-6#2)(1993-6#1)(1994-2#1)(1994-8#5)(1995-11#3)(1995-12#2)
radiologic evaluation##2##2##(1994-6#1)(2012-3#1)
radiologic technologists##3##2##(1994-1#2)(1995-1#1)
radiologic##22##1##(1992-1#1)(1994-1#3)(1994-6#1)(1995-1#1)(1996-1#1)(1997-4#1)(1997-8#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
radiological and##11##2##(1991-11#2)(1991-6#1)(2007-8#3)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)
radiological appearance##2##2##(2010-11#1)(2012-3#1)
radiological clearance##2##2##(2010-5#2)
radiological diagnosis##3##2##(2010-5#1)(2011-2#1)(2012-2#1)
radiological evaluation##2##2##(2011-2#1)(2012-3#1)
radiological examination was##2##3##(1993-3#1)(2011-1#1)
radiological examination##9##2##(1991-3#1)(1993-3#1)(1995-9#1)(1997-4#1)(2008-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
radiological features of##3##3##(1992-12#1)(2012-2#2)
radiological features##5##2##(1992-12#1)(2008-7#1)(2012-2#2)(2013-1#1)
radiological findings and##2##3##(2012-3#1)(2013-1#1)
radiological findings##9##2##(1991-3#1)(2009-5#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
radiological imaging##2##2##(2007-8#1)(2012-2#1)
radiological methods##2##2##(1990-5#1)(2012-2#1)
radiological parameters##3##2##(2010-3#1)(2011-2#2)
radiological physics and technology##3##4##(2010-9#3)
radiological report##2##2##(2012-2#1)(2013-8#1)
radiological signs of##2##3##(1991-9#1)(2011-2#1)
radiological signs##3##2##(1991-9#1)(1997-3#1)(2011-2#1)
radiological##97##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#7)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#2)(1993-3#2)(1995-9#1)(1997-3#2)(1997-4#1)(1997-8#2)(2007-8#7)(2008-10#1)(2008-5#2)(2008-7#8)(2008-9#1)(2009-12#1)(2009-5#2)(2009-8#2)(2010-11#3)(2010-3#2)(2010-5#3)(2010-9#3)(2011-1#1)(2011-2#9)(2012-12#6)(2012-2#11)(2012-3#5)(2013-1#4)(2013-8#1)
radiologically##8##1##(2008-11#1)(2008-12#1)(2008-7#2)(2010-11#1)(2010-3#1)(2012-3#1)(2013-1#1)
radiologist and##3##2##(1991-3#1)(2010-8#1)(2013-1#1)
radiologist to##4##2##(2011-2#1)(2012-2#3)
radiologist##17##1##(1991-3#1)(1993-3#2)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#7)(2013-1#3)
radiologists and##4##2##(1992-1#1)(1993-1#1)(2012-12#1)(2012-2#1)
radiologists##19##1##(1991-2#1)(1992-1#1)(1993-1#1)(1993-3#2)(1997-8#2)(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#1)
radiology administrators##3##2##(1993-1#1)(1994-1#1)(1996-2#1)
radiology administrators' salaries and##2##4##(1991-2#1)(1991-3#1)
radiology and##3##2##(1990-5#1)(2009-9#1)(2013-1#1)
radiology department##9##2##(1991-2#1)(1993-3#2)(1994-3#1)(1996-1#3)(2009-6#1)(2012-2#1)
radiology departments##5##2##(1993-1#1)(1993-3#1)(1996-1#1)(2012-2#2)
radiology in##4##2##(2009-9#4)
radiology information##2##2##(1991-1#1)(1993-1#1)
radiology managers##4##2##(1991-1#1)(1993-3#1)(1994-1#1)(1995-1#1)
radiology practice##3##2##(1996-1#1)(2009-9#2)
radiology practices to##2##3##(1993-3#2)
radiology practices##6##2##(1993-3#6)
radiology reports##3##2##(2012-2#3)
radiology service##2##2##(1993-1#1)(2012-2#1)
radiology services##2##2##(1993-1#1)(2012-2#1)
radiology##85##1##(1990-5#1)(1991-1#6)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#2)(1992-2#1)(1993-1#7)(1993-3#14)(1994-1#3)(1994-3#1)(1995-1#3)(1995-2#1)(1996-1#6)(1996-2#3)(1997-8#1)(2008-10#1)(2009-6#2)(2009-9#8)(2011-2#2)(2012-2#16)(2013-1#1)(2013-8#1)
radiometer##13##1##(1995-6#1)(2008-10#1)(2008-2#3)(2008-3#8)
radiometers##4##1##(2008-2#2)(2008-3#2)
radiometric calibration##2##2##(2008-3#2)
radiometric method##3##2##(2008-10#3)
radiometric##9##1##(2008-10#3)(2008-3#6)
radiometry##3##1##(2008-10#3)
radionecrosis of rectum##2##3##(2008-12#2)
radionuclide imaging##2##2##(2007-11#2)
radionuclide##7##1##(1991-2#1)(1994-1#1)(2007-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
radionuclides##4##1##(1995-12#2)(2008-10#1)(2010-6#1)
radiopacifier##2##1##(2013-1#2)
radiopaque##3##1##(2012-2#1)(2013-1#2)
radiopharmaceuticals for##2##2##(2010-6#1)(2012-12#1)
radiopharmaceuticals##7##1##(2010-6#1)(2012-12#3)(2013-1#3)
radioresistant##2##1##(1993-9#1)(2013-1#1)
radiosensitive##5##1##(1990-12#1)(1993-9#1)(1997-3#2)(2013-1#1)
radiosensitivity of##3##2##(2008-5#3)
radiosensitivity##6##1##(1993-9#1)(2008-5#3)(2008-9#1)(2013-1#1)
radiosensitizer in##2##2##(1991-2#1)(2013-1#1)
radiosensitizer##4##1##(1990-6#1)(1991-2#1)(2008-9#1)(2013-1#1)
radiosurgery after##2##2##(1996-3#2)
radiosurgery for##3##2##(1997-4#1)(2011-2#2)
radiosurgery or##2##2##(2008-7#2)
radiosurgery##37##1##(1993-9#3)(1995-12#1)(1996-3#5)(1997-4#3)(2008-7#16)(2010-9#1)(2011-2#8)
radiosurgical treatment##2##2##(1996-3#2)
radiosurgical##3##1##(1996-3#3)
radiotherapeutic##3##1##(1993-9#3)
radiotherapy (IMRT)##2##2##(2008-2#1)(2011-2#1)
radiotherapy alone##4##2##(1990-6#2)(2011-3#1)(2012-3#1)
radiotherapy and chemotherapy##5##3##(1990-8#1)(1993-9#1)(2008-11#1)(2008-7#1)(2010-12#1)
radiotherapy and the##2##3##(2008-7#2)
radiotherapy and##17##2##(1990-6#1)(1990-8#1)(1991-8#1)(1992-12#1)(1993-9#2)(1996-11#1)(2008-11#1)(2008-12#2)(2008-7#4)(2009-11#1)(2010-12#1)(2013-1#1)
radiotherapy and/or chemotherapy##3##3##(1990-5#1)(1992-12#1)(2012-3#1)
radiotherapy are##2##2##(2010-8#1)(2013-1#1)
radiotherapy for##8##2##(1992-12#1)(1992-3#1)(1994-8#1)(1997-3#2)(2008-10#1)(2011-2#1)(2011-3#1)
radiotherapy had##2##2##(1990-6#1)(2008-11#1)
radiotherapy in the treatment of##3##5##(1990-6#1)(1994-8#1)(2011-2#1)
radiotherapy in the##4##3##(1990-6#1)(1993-9#1)(1994-8#1)(2011-2#1)
radiotherapy in##11##2##(1990-6#2)(1993-2#1)(1993-9#2)(1994-8#1)(2007-8#1)(2008-10#1)(2009-11#1)(2011-2#2)
radiotherapy is##4##2##(1990-12#1)(2009-1#1)(2013-1#1)(2013-8#1)
radiotherapy of the pelvis##2##4##(1992-12#2)
radiotherapy of##7##2##(1992-12#2)(2008-5#1)(2008-7#2)(2009-11#1)(2012-12#1)
radiotherapy or##2##2##(1993-11#1)(2013-1#1)
radiotherapy to##2##2##(2008-10#1)(2008-12#1)
radiotherapy was##3##2##(1990-6#1)(1991-8#1)(2008-10#1)
radiotherapy were##2##2##(1990-12#2)
radiotherapy with##4##2##(1990-12#1)(2009-11#2)(2011-2#1)
radiotherapy##132##1##(1990-12#4)(1990-5#1)(1990-6#8)(1990-8#3)(1991-2#1)(1991-8#2)(1991-9#4)(1992-12#10)(1992-3#4)(1993-11#2)(1993-2#2)(1993-9#6)(1994-8#2)(1995-5#1)(1996-11#1)(1997-3#3)(1997-4#1)(1997-5#3)(2007-8#2)(2008-10#12)(2008-11#5)(2008-12#3)(2008-2#1)(2008-5#2)(2008-7#12)(2009-1#1)(2009-11#7)(2009-2#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#6)(2011-3#3)(2012-12#1)(2012-3#6)(2013-1#5)(2013-8#1)
radiotracers##6##1##(2010-6#5)(2013-1#1)
radioulnar ligaments##3##2##(2008-9#3)
radioulnar##5##1##(2008-9#4)(2011-2#1)
radish and##2##2##(2008-10#2)
radish##25##1##(2008-10#24)(2008-5#1)
radius and the##3##3##(2008-2#1)(2008-3#2)
radius and##6##2##(1993-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
radius deformity##2##2##(2008-9#2)
radius in##2##2##(1991-11#1)(2010-11#1)
radius is##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
radius of curvature of##2##4##(2008-2#1)(2008-3#1)
radius of curvature##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
radius of the##4##3##(1994-5#1)(1995-3#1)(2008-10#2)
radius of##13##2##(1990-11#1)(1994-5#1)(1995-3#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-9#1)
radius on##2##2##(2008-10#1)(2008-3#1)
radius##50##1##(1990-11#1)(1991-11#2)(1993-8#1)(1994-5#1)(1995-3#1)(2008-10#13)(2008-2#4)(2008-3#10)(2008-4#1)(2008-7#2)(2008-9#7)(2010-11#2)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
radius)##2##1##(2008-10#1)(2009-7#1)
radix##7##1##(2008-10#2)(2011-2#1)(2012-3#3)(2013-8#1)
radon##4##1##(1991-3#1)(1995-2#1)(2008-11#1)(2008-7#1)
radula##2##1##(1990-2#1)(2011-2#1)
raf##2##1##(1994-6#2)
raffinose##4##1##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
raft##2##1##(2008-4#1)(2009-7#1)
rafts##7##1##(2008-4#3)(2008-7#3)(2011-2#1)
ragged##2##1##(1994-11#1)(2008-10#1)
rai (Brassica juncea)##2##3##(2011-1#2)
rail##4##1##(2009-10#4)
railroad workers##3##2##(1991-12#3)
railroads##5##1##(1991-12#5)
rain and##3##2##(2008-10#3)
rain but##2##2##(2008-10#2)
rain episodes##2##2##(2008-10#2)
rain event##2##2##(2008-10#2)
rain events##6##2##(2008-10#6)
rain intensity##3##2##(2008-10#3)
rain or##3##2##(2008-10#3)
rain shields##2##2##(2008-10#2)
rain simulation##2##2##(2008-10#2)
rain simulator##2##2##(2008-10#2)
rain splash##2##2##(2008-10#2)
rain was##3##2##(2008-10#3)
rain water##2##2##(2008-10#2)
rain##71##1##(2008-10#64)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2012-7#1)
rainbow lorikeet (Trichoglossus haematodus)##2##4##(2008-5#2)
rainbow trout Oncorhynchus##2##3##(2010-8#2)
rainbow trout cell##2##3##(2008-11#2)
rainbow trout##16##2##(1994-11#1)(1994-5#3)(1997-9#2)(2008-11#2)(2008-5#2)(2008-6#2)(2009-6#1)(2010-8#3)
rainbow##27##1##(1994-11#1)(1994-5#3)(1997-9#2)(2008-11#3)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#2)(2009-6#1)(2010-8#3)
rainbows##4##1##(2008-3#4)
raindrop##4##1##(2008-10#2)(2008-3#2)
raindrops##8##1##(2008-10#2)(2008-3#6)
rainfall amounts##2##2##(2008-10#2)
rainfall and##2##2##(2008-10#1)(2008-8#1)
rainfall during##2##2##(2008-10#2)
rainfall environment##2##2##(2008-10#2)
rainfall events##3##2##(2008-10#3)
rainfall for infection##2##3##(2008-10#2)
rainfall in##2##2##(2008-10#2)
rainfall or##3##2##(2008-10#3)
rainfall##39##1##(2008-10#34)(2008-8#2)(2008-9#1)(2012-9#1)(2013-8#1)
rainfall)##4##1##(2008-10#4)
rains##7##1##(2008-10#7)
rainstorms with wind##2##3##(2008-10#2)
rainstorms##3##1##(2008-10#3)
rainwater and##2##2##(2008-10#2)
rainwater collected##2##2##(2008-10#2)
rainwater samples##3##2##(2008-10#3)
rainwater##25##1##(2008-10#25)
rainy days in##4##3##(2008-10#4)
rainy days##5##2##(2008-10#5)
rainy season##5##2##(1994-9#1)(2008-10#4)
rainy##11##1##(1994-9#1)(2008-10#9)(2008-8#1)
raise a##4##2##(1994-12#1)(1996-1#1)(2010-11#1)(2011-2#1)
raise questions about the##2##4##(2009-8#1)(2012-2#1)
raise questions about##5##3##(1993-1#1)(1995-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
raise the possibility that##4##4##(1994-8#1)(1995-5#1)(2008-9#1)(2010-4#1)
raise the possibility##6##3##(1994-8#1)(1995-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)
raise the question##2##3##(2008-8#1)(2011-2#1)
raise the##21##2##(1991-5#1)(1993-2#1)(1994-8#1)(1995-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
raise##50##1##(1991-5#1)(1991-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-11#1)(2009-8#2)(2010-11#2)(2010-3#1)(2010-4#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)
raised ICP##8##2##(1996-9#1)(2008-7#2)(2010-5#5)
raised a##3##2##(2009-6#1)(2011-2#1)(2012-3#1)
raised against purified##2##3##(1992-8#1)(1993-9#1)
raised against the##13##3##(1991-5#2)(1992-2#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-10#3)(2008-11#1)
raised against##32##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-5#3)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#4)(2008-10#8)(2008-11#2)(2008-6#1)
raised as to the##3##4##(2008-10#2)(2010-10#1)
raised blood##2##2##(1997-2#1)(2010-12#1)
raised by these##2##3##(1991-3#1)(2013-1#1)
raised by this##2##3##(1991-12#1)(1997-8#1)
raised by##13##2##(1991-12#1)(1991-3#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
raised concentrations##2##2##(1991-12#1)(1992-11#1)
raised from##2##2##(2008-11#1)(2011-2#1)
raised in rabbit##4##3##(1991-5#2)(2008-10#2)
raised in##13##2##(1990-9#1)(1991-12#1)(1991-5#2)(1992-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
raised serum##4##2##(1991-12#1)(1994-3#1)(2011-2#1)(2013-1#1)
raised the question##2##3##(1992-12#1)(2008-10#1)
raised the##6##2##(1992-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
raised to##6##2##(1990-2#1)(1990-9#1)(1993-3#1)(2008-10#2)(2008-9#1)
raised##146##1##(1990-11#1)(1990-2#3)(1990-8#3)(1990-9#3)(1991-12#7)(1991-2#1)(1991-3#1)(1991-5#5)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-12#4)(2008-1#1)(2008-10#27)(2008-11#11)(2008-12#4)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-6#1)(2010-10#1)(2010-12#2)(2010-5#7)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-1#6)(2013-8#1)
raises a##2##2##(1996-5#1)(2008-11#1)
raises an##2##2##(2008-10#1)(2012-3#1)
raises concerns about the##2##4##(1995-1#1)(2008-11#1)
raises questions about how##2##4##(2008-11#1)(2009-12#1)
raises questions about##3##3##(1990-5#1)(2008-11#1)(2009-12#1)
raises questions##6##2##(1990-5#1)(2008-10#2)(2008-11#1)(2009-12#1)(2013-8#1)
raises the possibility of##2##4##(1995-6#1)(1997-1#1)
raises the possibility that##2##4##(1995-8#1)(2011-2#1)
raises the possibility##4##3##(1995-6#1)(1995-8#1)(1997-1#1)(2011-2#1)
raises the question as to##2##5##(1995-12#1)(2012-3#1)
raises the question of whether##2##5##(1996-2#1)(2012-2#1)
raises the question of##3##4##(1993-2#1)(1996-2#1)(2012-2#1)
raises the question##5##3##(1993-2#1)(1995-12#1)(1996-2#1)(2012-2#1)(2012-3#1)
raises the##15##2##(1993-12#1)(1993-2#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
raises##41##1##(1990-5#1)(1993-12#1)(1993-2#2)(1993-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-10#4)(2008-11#5)(2008-8#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-8#2)
raising a##2##2##(1993-1#1)(2008-8#1)
raising an##2##2##(2008-10#1)(2009-12#1)
raising in##3##2##(1991-3#1)(1992-3#1)(1997-1#1)
raising the possibility of##2##4##(2008-7#1)(2012-3#1)
raising the possibility that##5##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
raising the possibility##7##3##(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
raising the##15##2##(1996-6#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
raising##49##1##(1991-1#1)(1991-12#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-3#2)(1992-8#1)(1993-1#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#2)
raisins##6##1##(2008-10#6)
raked##2##1##(2008-10#2)
ramifications that##2##2##(1995-12#1)(2008-11#1)
ramifications##7##1##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-9#1)
ramified##4##1##(2007-12#2)(2008-10#1)(2008-12#1)
ramnogalacturonan##3##1##(2008-10#3)
ramorum DNA##2##2##(2008-10#2)
ramorum and##3##2##(2008-10#3)
ramorum elicitins##2##2##(2008-10#2)
ramorum from##3##2##(2008-10#3)
ramorum in plant material##3##4##(2008-10#3)
ramorum in##6##2##(2008-10#6)
ramorum was detected##2##3##(2008-10#2)
ramorum was recovered from##2##4##(2008-10#2)
ramorum was##8##2##(2008-10#8)
ramorum##58##1##(2008-10#58)
ramosa##5##1##(2008-10#5)
ramp and##2##2##(2012-2#1)(2013-1#1)
ramp direction##3##2##(2008-10#3)
ramp##12##1##(1993-5#1)(2008-10#8)(2012-2#1)(2013-1#2)
ramped##3##1##(2008-10#3)
ran parallel##2##2##(1993-12#1)(2013-2#1)
ran##5##1##(1993-12#1)(1995-12#1)(2011-2#1)(2013-1#1)(2013-2#1)
random DNA##2##2##(1996-3#1)(2008-8#1)
random amplified polymorphic DNA (RAPD) analysis##5##6##(2008-10#5)
random amplified polymorphic DNA (RAPD) markers##9##6##(2008-10#9)
random amplified polymorphic DNA (RAPD)##30##5##(2008-10#30)
random amplified polymorphic DNA and##3##5##(2008-10#3)
random amplified polymorphic DNA loci##2##5##(2008-10#2)
random amplified polymorphic DNA marker##3##5##(2008-10#3)
random amplified polymorphic DNA markers##6##5##(2008-10#6)
random amplified polymorphic DNA##50##4##(2008-10#50)
random amplified polymorphism DNA##2##4##(2008-10#2)
random amplified##55##2##(2008-10#55)
random and conditional##2##3##(2012-2#2)
random and##8##2##(1996-2#1)(1996-3#1)(2008-10#2)(2008-8#1)(2012-2#3)
random assignment##3##2##(2012-2#1)(2013-1#2)
random coil##4##2##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
random distribution of##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
random distribution##5##2##(1995-9#1)(2008-10#2)(2008-12#1)(2008-3#1)
random drift##2##2##(1995-5#1)(2008-10#1)
random effects method##2##3##(1996-3#2)
random effects##7##2##(1993-11#1)(1996-3#4)(2008-10#1)(2008-8#1)
random error##3##2##(2008-10#2)(2008-3#1)
random errors of##2##3##(2008-10#1)(2011-2#1)
random errors##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
random from##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
random gain##2##2##(2008-3#2)
random genetic drift##3##3##(2008-10#3)
random genomic##2##2##(2008-10#1)(2008-8#1)
random in##2##2##(2008-10#1)(2010-8#1)
random mating model##2##3##(2008-9#2)
random mating##9##2##(2008-10#7)(2008-9#2)
random mutation##2##2##(2008-10#1)(2010-5#1)
random number##3##2##(2008-11#1)(2008-3#1)(2010-8#1)
random or##2##2##(1991-9#1)(2011-1#1)
random order##3##2##(1994-12#1)(1995-6#1)(2013-8#1)
random peptides##2##2##(2008-4#1)(2008-8#1)
random phase masks##3##3##(2008-3#3)
random phase##4##2##(2008-3#4)
random primers were##2##3##(2008-10#2)
random sample of 500##2##4##(1991-3#1)(1993-12#1)
random sample of the##2##4##(2010-11#1)(2013-1#1)
random sample of##27##3##(1991-3#1)(1991-8#2)(1992-12#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
random sample##32##2##(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
random sampling##6##2##(1993-11#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
random sequence##2##2##(1996-3#1)(2008-10#1)
random sequences##2##2##(1995-8#1)(2008-11#1)
random sound##2##2##(2013-8#2)
random targets##3##2##(2008-10#3)
random variates##2##2##(1992-9#1)(2008-10#1)
random walk##3##2##(2008-9#1)(2012-3#1)(2013-8#1)
random##286##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#3)(1996-1#1)(1996-2#3)(1996-3#8)(1996-6#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#123)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#19)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#14)(2008-9#8)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#7)(2013-8#6)
random-effects meta-analysis##2##2##(1995-12#1)(2008-10#1)
random-effects##4##1##(1995-12#3)(2008-10#1)
random-mated populations##2##2##(2008-10#2)
random-mated##4##1##(2008-10#4)
random-time (45##2##2##(2008-5#2)
randomised clinical trial##2##3##(1991-3#1)(2010-5#1)
randomised clinical##3##2##(1991-3#1)(2010-5#2)
randomised controlled clinical trial##2##4##(2010-5#2)
randomised controlled trial##7##3##(2010-10#1)(2010-4#1)(2013-1#5)
randomised controlled trials##3##3##(1993-12#1)(2010-10#1)(2011-2#1)
randomised controlled##13##2##(1993-12#1)(2010-10#2)(2010-4#1)(2010-5#2)(2011-2#2)(2013-1#5)
randomised to##2##2##(2008-3#1)(2008-8#1)
randomised trial##2##2##(1990-2#1)(2013-1#1)
randomised##27##1##(1990-2#1)(1990-3#1)(1991-3#1)(1993-12#1)(2007-11#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-10#2)(2010-4#1)(2010-5#4)(2011-2#2)(2011-3#1)(2013-1#7)
randomization##8##1##(1993-8#1)(1995-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
randomized block design##2##3##(2008-10#2)
randomized clinical trial##12##3##(1991-2#1)(1993-9#1)(1996-6#2)(2008-7#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
randomized clinical trials in##2##4##(2008-12#1)(2008-9#1)
randomized clinical trials##7##3##(1992-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
randomized clinical##21##2##(1991-2#1)(1992-9#1)(1993-9#1)(1996-6#2)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#2)
randomized control trial##2##3##(2008-10#1)(2010-7#1)
randomized control##5##2##(1995-12#1)(2008-10#1)(2008-8#1)(2010-7#1)(2013-8#1)
randomized controlled clinical trials##2##4##(2010-11#1)(2010-4#1)
randomized controlled clinical##3##3##(2010-11#1)(2010-4#1)(2013-1#1)
randomized controlled pilot##2##3##(2009-11#1)(2010-10#1)
randomized controlled study##4##3##(2008-12#2)(2008-8#1)(2009-12#1)
randomized controlled trial (RCT)##2##4##(2013-1#2)
randomized controlled trial of##5##4##(2008-8#1)(2012-2#2)(2013-1#2)
randomized controlled trial to##2##4##(2008-8#1)(2010-3#1)
randomized controlled trial##16##3##(1997-2#1)(2008-8#3)(2009-12#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#7)
randomized controlled trials (RCTs)##3##4##(1993-12#1)(2008-10#1)(2011-2#1)
randomized controlled trials and##2##4##(1995-2#1)(2012-12#1)
randomized controlled trials that##3##4##(1993-12#1)(2010-2#1)(2012-3#1)
randomized controlled trials##15##3##(1993-12#2)(1994-6#1)(1995-2#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-2#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
randomized controlled##47##2##(1993-12#2)(1994-6#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#4)(2009-11#1)(2009-12#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#12)
randomized placebo-controlled##2##2##(2010-2#1)(2013-1#1)
randomized studies##4##2##(1990-6#1)(1991-8#1)(1996-11#1)(2008-10#1)
randomized study##10##2##(1991-8#1)(1994-12#1)(1997-3#1)(2008-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#3)
randomized to either##2##3##(2009-12#1)(2010-4#1)
randomized to##13##2##(2008-4#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-4#2)(2011-2#2)(2012-3#1)(2013-1#3)
randomized trial comparing##4##3##(1993-1#2)(1993-11#1)(1995-12#1)
randomized trial of##7##3##(1993-9#1)(1994-3#1)(1995-3#1)(1997-7#1)(2008-10#1)(2010-4#1)(2012-2#1)
randomized trial##23##2##(1992-12#1)(1993-1#2)(1993-11#2)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-4#1)(2012-2#2)(2012-3#3)
randomized trials are##3##3##(1997-4#1)(2012-3#1)(2013-1#1)
randomized trials##14##2##(1993-12#4)(1996-3#1)(1997-4#1)(2008-12#1)(2008-8#1)(2009-5#1)(2012-3#4)(2013-1#1)
randomized##210##1##(1990-6#1)(1991-2#2)(1991-3#1)(1991-8#3)(1992-12#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#8)(1993-2#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#3)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#8)(2008-4#5)(2008-5#4)(2008-7#7)(2008-8#9)(2008-9#2)(2009-11#1)(2009-12#5)(2009-5#1)(2009-8#1)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#5)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#15)(2012-12#5)(2012-2#6)(2012-3#18)(2013-1#25)(2013-8#2)
randomly amplified polymorphic DNA (RAPD)##5##5##(1995-6#1)(2008-10#4)
randomly amplified polymorphic DNA##6##4##(1995-6#1)(1997-8#1)(2008-10#4)
randomly and##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
randomly assigned to 10##2##4##(2008-10#1)(2013-1#1)
randomly assigned to a##5##4##(2008-12#2)(2009-11#1)(2012-2#1)(2013-1#1)
randomly assigned to##34##3##(1992-12#1)(1993-1#2)(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#7)(2008-4#3)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#5)(2012-2#2)(2013-1#4)(2013-8#1)
randomly assigned##39##2##(1992-12#1)(1993-1#2)(1994-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#7)(2008-4#3)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#5)(2013-8#2)
randomly chosen##6##2##(2008-10#5)(2008-6#1)
randomly distributed in##2##3##(2008-9#1)(2013-8#1)
randomly distributed##7##2##(2008-10#3)(2008-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
randomly divided into two groups of##2##6##(1991-3#1)(2010-7#1)
randomly divided into two groups##4##5##(1991-3#1)(1993-2#1)(2010-7#1)(2013-1#1)
randomly divided into##12##3##(1991-3#1)(1993-2#1)(2008-11#1)(2010-1#1)(2010-7#3)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
randomly from##6##2##(1993-1#1)(1994-3#1)(2008-10#2)(2008-12#1)(2011-2#1)
randomly in##2##2##(2008-10#1)(2008-11#1)
randomly oriented in the horizontal plane##2##6##(2008-3#2)
randomly oriented##4##2##(2008-3#4)
randomly primed##2##2##(1991-6#1)(2008-10#1)
randomly rough##2##2##(2008-2#2)
randomly sampled##5##2##(1997-2#1)(2008-10#2)(2012-2#2)
randomly selected for##5##3##(1996-12#1)(1997-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
randomly selected from##3##3##(2008-7#1)(2010-3#1)(2013-1#1)
randomly selected samples##2##3##(2008-10#1)(2012-2#1)
randomly selected##32##2##(1993-1#1)(1993-12#2)(1994-12#1)(1994-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
randomly to##5##2##(1991-1#1)(1992-1#1)(2008-5#1)(2008-8#1)(2009-6#1)
randomly##171##1##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-1#4)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-9#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#39)(2008-11#3)(2008-12#12)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#1)(2009-6#1)(2010-1#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#5)(2011-1#3)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#14)(2013-8#4)
randomness of##2##2##(2008-10#2)
randomness##3##1##(2008-10#2)(2010-10#1)
range (0##3##2##(2008-10#3)
range (1##11##2##(2008-10#11)
range (2##2##2##(2008-10#2)
range (3##2##2##(1993-8#1)(2008-10#1)
range (alb/Cr ratio &gt##2##4##(1992-9#2)
range (pH##3##2##(1991-5#1)(2008-10#2)
range 0##124##2##(1990-2#1)(1993-8#1)(2008-10#118)(2008-3#3)(2008-5#1)
range 0-2##2##2##(1990-2#1)(2008-10#1)
range 1##32##2##(2008-10#30)(2013-1#2)
range 2##20##2##(2008-10#20)
range 2-8##2##2##(2008-10#1)(2008-5#1)
range 20-100 ng ml(-1)##2##4##(2008-10#2)
range 20-100##3##2##(2008-10#3)
range 3##13##2##(2008-10#13)
range 4##10##2##(1990-5#1)(2008-10#9)
range 5##13##2##(2008-10#13)
range 6##8##2##(2008-10#8)
range 7##4##2##(2008-10#4)
range 8##2##2##(2008-10#2)
range 9##2##2##(2008-10#2)
range and a##2##3##(1994-12#1)(2008-3#1)
range and detection##3##3##(2008-10#3)
range and in the##2##4##(2008-10#1)(2008-3#1)
range and slope##4##3##(2008-10#4)
range and symptomatology##2##3##(2008-10#2)
range and that##2##3##(1990-12#1)(1997-2#1)
range and the##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
range and##56##2##(1990-12#1)(1993-2#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#40)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#2)
range as##4##2##(1990-11#1)(1994-11#1)(2008-2#1)(2012-2#1)
range between 0 and##2##4##(2008-10#2)
range between 0##13##3##(2008-10#13)
range between 1 and##2##4##(2008-10#2)
range between 1##8##3##(2008-10#8)
range between 10 and##2##4##(2008-10#2)
range between 10 pg and##2##5##(2008-10#2)
range between 10##4##3##(2008-10#4)
range between 2##2##3##(2008-10#2)
range between 4 and##2##4##(2008-10#2)
range between 4##4##3##(2008-10#3)(2008-3#1)
range between 7##2##3##(2008-10#1)(2008-11#1)
range between 96##2##3##(2008-10#2)
range between##46##2##(2008-10#42)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)
range by##8##2##(2008-10#3)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
range can be extended up to##2##6##(2008-10#2)
range can be##3##3##(2008-10#3)
range during the##2##3##(2010-8#1)(2012-2#1)
range examined##4##2##(2008-10#4)
range extends##2##2##(2008-10#2)
range for a set of##2##5##(2008-10#2)
range for a##3##3##(2008-10#2)(2008-3#1)
range for determination of##2##4##(2008-10#1)(2008-3#1)
range for determination##3##3##(2008-10#2)(2008-3#1)
range for the determination of##5##5##(2008-10#5)
range for the##14##3##(2008-10#12)(2008-3#1)(2008-7#1)
range for this##2##3##(2008-10#1)(2008-11#1)
range for##49##2##(1991-12#1)(1992-9#1)(1993-2#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#36)(2008-11#2)(2008-3#3)(2008-7#1)(2011-2#1)
range from 0 to 0##2##5##(2008-10#1)(2010-4#1)
range from 0 to##13##4##(1993-8#1)(2008-10#8)(2008-3#2)(2010-4#1)(2013-1#1)
range from 0##36##3##(1993-8#1)(1995-5#1)(2008-10#29)(2008-3#3)(2010-4#1)(2013-1#1)
range from 1 to##4##4##(2008-10#4)
range from 1##20##3##(1990-2#1)(2008-10#16)(2008-11#1)(2008-3#1)(2013-1#1)
range from 10 to##3##4##(2008-10#3)
range from 10(-1) to##2##4##(2008-10#2)
range from 10(-4) to##2##4##(2008-10#2)
range from 2 to##6##4##(2008-10#5)(2012-2#1)
range from 2##11##3##(2008-10#10)(2012-2#1)
range from 20 to##2##4##(2008-10#1)(2008-12#1)
range from 25 to##2##4##(2008-10#2)
range from 3##5##3##(2008-10#5)
range from 4 to##2##4##(2008-10#1)(2008-11#1)
range from 4##7##3##(2007-12#1)(2008-10#5)(2008-11#1)
range from 5 to##6##4##(2008-10#5)(2008-3#1)
range from 5##13##3##(2008-10#11)(2008-3#2)
range from 70##2##3##(1992-2#1)(2008-10#1)
range from 8##3##3##(2008-10#3)
range from 80 to##2##4##(2008-10#2)
range from 91 to##4##4##(2008-10#4)
range from assessing##2##3##(1997-2#1)(2008-10#1)
range from the##2##3##(2008-10#1)(2008-9#1)
range from##174##2##(1990-2#1)(1992-12#1)(1992-2#2)(1993-8#1)(1995-3#1)(1995-5#1)(1997-2#3)(2007-12#2)(2008-10#135)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#10)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
range has been##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
range in the##2##3##(2008-10#2)
range in##20##2##(1994-2#1)(1995-11#1)(1997-8#1)(2008-10#11)(2008-2#1)(2008-7#3)(2010-7#1)(2013-8#1)
range investigated##2##2##(2008-10#2)
range is 0##3##3##(2008-10#3)
range is 1##3##3##(2008-10#3)
range is 2##3##3##(2008-10#3)
range is between##2##3##(2008-10#1)(2013-8#1)
range is##32##2##(1990-12#1)(2008-10#25)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
range limits##3##2##(2008-8#2)(2008-9#1)
range of 0##132##3##(1993-12#1)(2008-10#122)(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#1)
range of 0-10##2##3##(2008-10#2)
range of 0-7##2##3##(2008-10#2)
range of 1##35##3##(1995-11#1)(1995-3#1)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#1)
range of 1-10##2##3##(1994-12#1)(2008-10#1)
range of 10##6##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-3#1)
range of 10-100##3##3##(1994-8#1)(2008-10#2)
range of 100##3##3##(1994-5#1)(2008-11#1)(2010-11#1)
range of 100-10##2##3##(2008-10#2)
range of 15##2##3##(2008-10#1)(2008-3#1)
range of 2##31##3##(2008-10#30)(2013-1#1)
range of 3##15##3##(2008-10#15)
range of 3-7 for##2##4##(1991-9#2)
range of 4##13##3##(1995-12#1)(2008-10#10)(2008-11#1)(2013-1#1)
range of 5##20##3##(2008-10#19)(2008-3#1)
range of 50-1000##2##3##(2008-10#2)
range of 6##8##3##(2008-10#6)(2008-7#1)(2013-1#1)
range of 7##8##3##(2008-10#7)(2012-2#1)
range of 8##3##3##(2008-10#3)
range of 9##3##3##(2008-10#3)
range of 94-100%##2##3##(2008-10#2)
range of H(2)O(2) and##2##4##(2008-10#1)(2013-1#1)
range of a##2##3##(2008-1#1)(2008-10#1)
range of about##3##3##(1997-3#1)(2008-10#2)
range of amino acids##2##4##(1992-9#1)(2011-2#1)
range of annual##3##3##(2011-2#3)
range of application##2##3##(2008-10#2)
range of applications##5##3##(2008-10#2)(2008-11#1)(2010-12#1)(2012-2#1)
range of available##2##3##(2008-10#1)(2008-11#1)
range of biological##4##3##(2008-11#1)(2008-4#1)(2011-3#1)(2012-3#1)
range of cellular processes##2##4##(2008-4#1)(2012-3#1)
range of cellular##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
range of clinical##3##3##(1990-2#1)(2008-11#2)
range of compounds##2##3##(2008-10#1)(2011-1#1)
range of concentration##4##3##(2008-10#2)(2008-5#1)(2010-3#1)
range of concentrations##10##3##(1994-11#1)(2008-10#8)(2008-5#1)
range of conditions##7##3##(2008-10#4)(2008-8#2)(2009-7#1)
range of copper##2##3##(2008-10#2)
range of detection##2##3##(2008-10#2)
range of different##4##3##(1997-6#1)(2008-11#1)(2009-10#1)(2009-6#1)
range of disease##2##3##(2008-10#2)
range of dissolved##2##3##(2008-10#1)(2008-11#1)
range of effects##2##3##(2012-3#1)(2013-1#1)
range of elements##2##3##(2008-10#1)(2013-8#1)
range of environmental chemicals##2##4##(1994-3#1)(2009-9#1)
range of environmental conditions##3##4##(2008-10#3)
range of environmental##5##3##(1994-3#1)(2008-10#3)(2009-9#1)
range of environments##3##3##(2008-8#1)(2011-2#2)
range of experimental##3##3##(1997-2#1)(2008-11#1)(2008-7#1)
range of genetic##2##3##(2008-10#1)(2008-9#1)
range of health##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
range of host plants##3##4##(2008-10#3)
range of host##5##3##(2008-10#5)
range of human##4##3##(2008-10#1)(2009-8#1)(2012-3#1)(2013-1#1)
range of influence##2##3##(2008-10#1)(2013-1#1)
range of issues##2##3##(1994-12#1)(2008-11#1)
range of linear response##2##4##(2008-10#2)
range of linear##3##3##(2008-10#3)
range of linearity##7##3##(2008-10#6)(2009-8#1)
range of low##2##3##(2008-10#1)(2008-7#1)
range of medical##2##3##(2008-11#1)(2010-6#1)
range of molecular##2##3##(2009-10#1)(2009-12#1)
range of motion (AROM)##2##4##(2008-12#2)
range of motion (ROM)##4##4##(2008-12#2)(2009-1#1)(2013-1#1)
range of motion and##2##4##(2009-1#1)(2010-12#1)
range of motion in##2##4##(2008-12#1)(2013-1#1)
range of motion of the##2##5##(2011-2#1)(2013-1#1)
range of motion##31##3##(2008-12#9)(2008-9#4)(2009-1#2)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#6)
range of organisms##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
range of other##3##3##(2008-10#3)
range of pH 2##2##4##(2008-10#2)
range of pH from##2##4##(2008-10#2)
range of pH##15##3##(2008-10#12)(2008-5#2)(2013-1#1)
range of parameter##4##3##(2008-8#3)(2008-9#1)
range of parameters##4##3##(2008-3#1)(2008-8#2)(2008-9#1)
range of parasites##2##3##(1997-7#1)(2008-8#1)
range of pathogens##4##3##(2008-10#4)
range of physiological and##2##4##(1991-2#1)(1992-6#1)
range of physiological##6##3##(1990-11#1)(1991-2#1)(1992-6#1)(1996-2#1)(2008-11#1)(2011-2#1)
range of productivities##2##3##(2008-8#1)(2008-9#1)
range of sensitivities##2##3##(2008-10#2)
range of spatial##5##3##(2008-10#4)(2008-9#1)
range of species##4##3##(2008-11#2)(2008-8#1)(2013-8#1)
range of stability##2##3##(2008-11#1)(2008-6#1)
range of studies##2##3##(2008-12#1)(2013-8#1)
range of targets##2##3##(2008-11#1)(2013-1#1)
range of temperatures##10##3##(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2012-8#1)
range of the assay##3##4##(2008-10#1)(2008-11#2)
range of the calibration graph is##2##6##(2008-10#2)
range of the calibration graph##3##5##(2008-10#3)
range of the calibration##6##4##(2008-10#6)
range of the instrument##2##4##(2008-10#1)(2008-3#1)
range of the method was##2##5##(2008-10#2)
range of the method##7##4##(2008-10#7)
range of the optical path##2##5##(2013-8#2)
range of the optical##3##4##(2011-2#1)(2013-8#2)
range of the proposed##2##4##(2008-10#1)(2008-3#1)
range of the sensor##4##4##(2008-10#4)
range of the##70##3##(1990-11#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#50)(2008-11#3)(2008-3#5)(2008-8#2)(2011-2#1)(2013-8#4)
range of these##4##3##(2008-10#3)(2012-2#1)
range of this method was##3##5##(2008-10#3)
range of this method##4##4##(2008-10#4)
range of this##6##3##(2008-10#6)
range of topics##2##3##(1994-12#1)(2012-2#1)
range of tree##2##3##(2008-8#1)(2008-9#1)
range of typical##2##3##(2008-5#1)(2012-2#1)
range of values##5##3##(1990-2#1)(2008-10#2)(2008-3#2)
range of variation in the##2##5##(2008-10#1)(2011-2#1)
range of variation in##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
range of wavelengths##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
range of##1172##2##(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#7)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#4)(2008-1#3)(2008-10#712)(2008-11#58)(2008-12#19)(2008-2#4)(2008-3#35)(2008-4#5)(2008-5#17)(2008-6#3)(2008-7#13)(2008-8#36)(2008-9#23)(2009-1#2)(2009-10#3)(2009-12#4)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#3)(2011-1#2)(2011-2#30)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#9)(2012-8#2)(2013-1#27)(2013-8#11)
range on##2##2##(2008-10#1)(2010-10#1)
range over##4##2##(2008-10#4)
range pH##4##2##(2008-10#4)
range resolution of##2##3##(2008-2#1)(2008-3#1)
range resolution##5##2##(2008-2#3)(2008-3#2)
range shifts##2##2##(2010-4#1)(2013-8#1)
range size and##2##3##(2008-8#2)
range size##4##2##(2008-8#4)
range spanning##3##2##(1994-5#1)(2008-10#1)(2012-2#1)
range studied##6##2##(1991-5#1)(2008-10#4)(2008-11#1)
range studies##3##2##(2008-10#3)
range than##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
range that##5##2##(1995-8#1)(1997-7#1)(2008-3#1)(2008-7#1)(2013-8#1)
range the##2##2##(2008-10#2)
range to 1##2##3##(2008-10#2)
range to be##2##3##(2008-10#2)
range to the##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
range to##9##2##(1993-8#1)(2008-10#6)(2008-3#1)(2010-8#1)
range up to##9##3##(2008-10#8)(2008-3#1)
range was 0##5##3##(2008-10#5)
range was 1##2##3##(2008-10#2)
range was also##2##3##(2008-10#1)(2008-2#1)
range was between 1##3##4##(2008-10#3)
range was between##4##3##(2008-10#4)
range was found to be 3##2##6##(2008-10#2)
range was from 1##2##4##(2008-10#2)
range was from##7##3##(2008-10#7)
range was obtained##2##3##(2008-10#2)
range was##61##2##(1992-12#1)(1992-9#1)(2008-10#55)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
range were obtained##3##3##(2008-10#3)
range were##14##2##(1994-12#1)(2008-10#10)(2008-3#1)(2012-2#2)
range where##2##2##(1993-9#2)
range which##2##2##(2008-10#2)
range with a detection limit##3##5##(2008-10#3)
range with a##7##3##(2007-12#1)(2008-10#5)(2008-3#1)
range with##9##2##(2006-6#1)(2007-12#1)(2008-10#5)(2008-3#2)
range within the##2##3##(2008-10#1)(2008-5#1)
range within##3##2##(2008-10#2)(2008-5#1)
range##2555##1##(1990-11#4)(1990-12#4)(1990-2#5)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#4)(1991-5#5)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#3)(1992-9#7)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-6#2)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#6)(1994-12#7)(1994-2#3)(1994-3#2)(1994-5#7)(1994-8#8)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#2)(1995-8#4)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#2)(2006-6#3)(2007-11#6)(2007-12#8)(2008-1#4)(2008-10#1764)(2008-11#86)(2008-12#24)(2008-2#22)(2008-3#94)(2008-4#8)(2008-5#28)(2008-6#5)(2008-7#36)(2008-8#54)(2008-9#28)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#5)(2009-4#2)(2009-5#3)(2009-6#6)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#7)(2010-8#9)(2011-1#2)(2011-2#41)(2011-3#6)(2011-7#1)(2012-12#1)(2012-2#18)(2012-3#13)(2012-5#1)(2012-8#2)(2013-1#43)(2013-8#16)
range)##13##1##(1992-3#1)(1995-12#1)(2008-10#8)(2008-7#1)(2012-3#1)(2013-1#1)
range-resolved##3##1##(2008-3#3)
ranged as high as##3##4##(1993-8#1)(1995-12#1)(2008-10#1)
ranged between 0##9##3##(2008-10#7)(2008-12#2)
ranged between 1##2##3##(2008-10#2)
ranged between 86##2##3##(2008-10#2)
ranged between 95##3##3##(2008-10#3)
ranged between 97##2##3##(2008-10#2)
ranged between 98##2##3##(2008-10#2)
ranged between##34##2##(1991-8#1)(2008-10#26)(2008-12#2)(2009-10#1)(2011-10#1)(2011-2#3)
ranged from &lt##2##3##(2008-10#1)(2008-7#1)
ranged from 0 to##6##4##(2008-10#2)(2008-9#2)(2012-8#1)(2013-8#1)
ranged from 0##74##3##(1990-11#1)(2008-10#57)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#2)(2010-11#2)(2011-2#2)(2012-8#1)(2013-1#1)(2013-8#3)
ranged from 0%##2##3##(2008-10#1)(2011-2#1)
ranged from 1 to##6##4##(1997-3#2)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
ranged from 1##17##3##(1997-3#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
ranged from 10 to##3##4##(2008-10#3)
ranged from 100 to##2##4##(2008-7#1)(2011-1#1)
ranged from 12 to##3##4##(1997-8#1)(2008-10#1)(2009-7#1)
ranged from 17##3##3##(2008-10#3)
ranged from 2##11##3##(1991-2#1)(1993-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-5#1)
ranged from 20 to##2##4##(1996-12#1)(2008-10#1)
ranged from 25##2##3##(2008-7#1)(2008-9#1)
ranged from 27##2##3##(2008-10#2)
ranged from 28%##2##3##(1995-3#1)(2008-10#1)
ranged from 3 to##2##4##(2008-10#1)(2013-8#1)
ranged from 3##6##3##(1997-2#1)(2008-10#4)(2013-8#1)
ranged from 30 to##3##4##(1997-8#1)(2008-5#1)(2011-2#1)
ranged from 31 to##2##4##(2007-12#1)(2008-10#1)
ranged from 35##2##3##(2008-10#2)
ranged from 4##8##3##(1990-11#1)(2008-10#3)(2008-12#2)(2008-9#1)(2010-10#1)
ranged from 5 to##4##4##(1990-6#1)(2008-10#2)(2012-2#1)
ranged from 5##9##3##(1990-6#1)(2008-10#4)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
ranged from 5%##3##3##(2008-10#2)(2008-9#1)
ranged from 54 to##2##4##(2008-10#2)
ranged from 6##4##3##(1993-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
ranged from 60##2##3##(1996-12#1)(2012-12#1)
ranged from 68 to##2##4##(2008-10#2)
ranged from 68##3##3##(2008-10#3)
ranged from 7 to##2##4##(2008-10#2)
ranged from 7##3##3##(2008-10#3)
ranged from 80 to##2##4##(2008-10#2)
ranged from 81##2##3##(2008-10#2)
ranged from 86 to##2##4##(2008-10#2)
ranged from 88 to##2##4##(2008-10#2)
ranged from 88##3##3##(2008-10#3)
ranged from 89##2##3##(2008-10#2)
ranged from 9 to##2##4##(2008-7#1)(2012-2#1)
ranged from 9##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
ranged from 90 to##2##4##(2008-10#2)
ranged from 95##4##3##(2008-10#4)
ranged from 96 to 103%##2##5##(2008-10#2)
ranged from 96 to##3##4##(2008-10#3)
ranged from 96##4##3##(2008-10#4)
ranged from 97##4##3##(1992-11#1)(2008-10#3)
ranged from 98##2##3##(2008-10#2)
ranged from 99 to 101%##3##5##(2008-10#3)
ranged from 99 to##4##4##(2008-10#4)
ranged from 99##9##3##(1992-11#1)(2008-10#8)
ranged from approximately 0##2##4##(2008-10#1)(2008-2#1)
ranged from approximately##4##3##(2008-10#2)(2008-2#1)(2012-2#1)
ranged from##291##2##(1990-11#2)(1990-2#1)(1990-6#2)(1991-2#1)(1991-8#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-12#2)(1993-8#1)(1995-3#2)(1995-8#1)(1996-12#3)(1996-9#2)(1997-2#2)(1997-3#2)(1997-8#2)(2007-12#1)(2008-10#185)(2008-11#3)(2008-12#9)(2008-2#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-9#7)(2009-12#2)(2009-7#2)(2010-10#1)(2010-11#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#7)(2012-8#1)(2013-1#6)(2013-8#5)
ranged over##3##2##(1991-5#1)(1994-11#1)(2008-5#1)
ranged##338##1##(1990-11#2)(1990-2#1)(1990-6#2)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#2)(1992-6#1)(1992-9#1)(1993-12#2)(1993-8#2)(1994-11#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-12#3)(1996-9#2)(1997-2#2)(1997-3#3)(1997-8#2)(2007-12#1)(2008-10#216)(2008-11#4)(2008-12#11)(2008-2#1)(2008-5#7)(2008-6#1)(2008-7#8)(2008-9#8)(2009-10#1)(2009-12#2)(2009-7#2)(2010-10#1)(2010-11#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#8)(2012-12#2)(2012-2#7)(2012-8#1)(2013-1#6)(2013-8#5)
rangeof##2##1##(2008-11#2)
ranges (1##2##2##(2008-10#1)(2008-2#1)
ranges 1##2##2##(2008-10#2)
ranges 4##2##2##(2008-10#2)
ranges and##6##2##(1991-11#1)(1997-2#1)(2008-10#3)(2008-3#1)
ranges are 0##5##3##(2008-10#5)
ranges are##10##2##(2008-10#9)(2008-8#1)
ranges at the##2##3##(2008-10#1)(2008-9#1)
ranges at##3##2##(2008-10#2)(2008-9#1)
ranges between 0##2##3##(2008-10#1)(2012-2#1)
ranges between##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
ranges for the analysis of##2##5##(2008-10#2)
ranges for the##5##3##(2008-10#5)
ranges for##15##2##(1992-9#1)(1995-3#1)(2008-10#12)(2008-8#1)
ranges from 0##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
ranges from 1##2##3##(1995-11#1)(2008-10#1)
ranges from 5 to##2##4##(2008-10#2)
ranges from one##2##3##(2008-10#2)
ranges from##33##2##(1991-3#1)(1991-5#1)(1995-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
ranges in##3##2##(2008-10#2)(2008-3#1)
ranges of 0##3##3##(2008-10#3)
ranges of 1##5##3##(2008-10#5)
ranges of 2##3##3##(2008-10#3)
ranges of CEC and CEP##2##5##(2010-1#2)
ranges of motion##3##3##(2011-2#3)
ranges of the calibration##4##4##(2008-10#4)
ranges of the order of##2##5##(2008-3#2)
ranges of the##8##3##(2008-10#4)(2008-3#2)(2008-7#1)(2012-2#1)
ranges of##68##2##(2008-10#48)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2009-11#1)(2010-1#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
ranges over##2##2##(2008-10#1)(2010-4#1)
ranges studied##2##2##(2008-10#1)(2008-11#1)
ranges than##3##2##(2008-10#1)(2008-8#2)
ranges to be##2##3##(2008-10#2)
ranges to##4##2##(2008-10#3)(2008-3#1)
ranges were 0##4##3##(2008-10#3)(2008-7#1)
ranges were 5##2##3##(2008-10#2)
ranges were obtained##2##3##(2008-10#2)
ranges were##22##2##(1994-12#1)(1997-2#1)(2008-10#19)(2008-7#1)
ranges##266##1##(1991-11#1)(1991-3#1)(1991-5#1)(1992-9#1)(1994-12#2)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#174)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#2)(2009-11#1)(2009-12#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#6)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)
ranging and##2##2##(2008-2#1)(2008-3#1)
ranging between 0##7##3##(2008-10#6)(2011-2#1)
ranging between 1##2##3##(2008-10#1)(2011-3#1)
ranging between 97##2##3##(2008-10#2)
ranging between##16##2##(2008-10#13)(2008-7#1)(2011-2#1)(2011-3#1)
ranging from 0 to##5##4##(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#1)
ranging from 0##50##3##(1991-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#30)(2008-11#3)(2008-3#1)(2008-5#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-10#1)(2011-2#3)(2012-2#1)
ranging from 1 to 4##2##5##(2008-10#1)(2011-2#1)
ranging from 1 to##9##4##(2008-10#8)(2011-2#1)
ranging from 1##20##3##(2008-10#15)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
ranging from 12 to##2##4##(2008-10#2)
ranging from 12##3##3##(2008-10#2)(2010-8#1)
ranging from 2##6##3##(2008-10#5)(2013-1#1)
ranging from 20##2##3##(1994-8#1)(2008-10#1)
ranging from 22 to##2##4##(1997-2#1)(2008-10#1)
ranging from 25 to##2##4##(1995-8#1)(2008-10#1)
ranging from 250 to##2##4##(2008-10#1)(2008-2#1)
ranging from 3 to##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
ranging from 3##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
ranging from 30 to##2##4##(1996-12#1)(2008-10#1)
ranging from 30##3##3##(1994-11#1)(1996-12#1)(2008-10#1)
ranging from 4 to##2##4##(2008-10#1)(2008-5#1)
ranging from 4##4##3##(2008-10#3)(2008-5#1)
ranging from 40 to##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
ranging from 400 to##3##4##(2008-10#2)(2008-2#1)
ranging from 400##4##3##(2008-10#3)(2008-2#1)
ranging from 5 to 15##2##5##(2008-10#2)
ranging from 5 to##5##4##(1996-12#1)(2008-10#4)
ranging from 5##7##3##(1996-12#1)(2008-10#6)
ranging from 5% to##2##4##(2008-3#1)(2013-1#1)
ranging from 50 to##3##4##(2008-10#3)
ranging from 50##4##3##(2008-10#3)(2011-2#1)
ranging from 6 to##3##4##(2008-10#2)(2010-4#1)
ranging from 6##4##3##(2008-10#2)(2010-4#1)(2013-8#1)
ranging from 7 to##2##4##(2008-10#2)
ranging from 90 to##2##4##(2008-10#2)
ranging from 97##2##3##(2008-10#2)
ranging from approximately##4##3##(1997-8#1)(2008-10#3)
ranging from fully susceptible to highly resistant##2##7##(2008-10#2)
ranging from less than##2##4##(1990-12#1)(2008-10#1)
ranging from the dipeptide sugar-substitute aspartame to clinically used hormones##2##10##(2008-4#2)
ranging from the##4##3##(2008-10#1)(2008-4#2)(2008-8#1)
ranging from very low##2##4##(1997-1#1)(2008-10#1)
ranging from very##3##3##(1994-12#1)(1997-1#1)(2008-10#1)
ranging from##237##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#127)(2008-11#10)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#5)(2009-8#2)(2010-10#1)(2010-4#1)(2010-8#2)(2011-2#10)(2012-2#8)(2012-3#3)(2013-1#5)(2013-8#7)
ranging in age from##2##4##(1997-3#1)(2008-11#1)
ranging in size from##4##4##(1990-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
ranging in##7##2##(1990-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2012-3#1)
ranging##274##1##(1990-12#2)(1991-12#1)(1991-7#1)(1992-12#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-8#3)(2007-12#1)(2008-1#3)(2008-10#144)(2008-11#11)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#5)(2009-8#3)(2010-10#1)(2010-4#2)(2010-8#2)(2011-2#11)(2011-3#1)(2012-2#8)(2012-3#4)(2013-1#5)(2013-8#7)
ranitidine##20##1##(1992-11#4)(1992-8#2)(1995-12#1)(1996-11#2)(2008-10#4)(2008-11#7)
rank correlation coefficients##2##3##(2008-10#2)
rank correlation##4##2##(2008-10#4)
rank order of potency##2##4##(1993-6#1)(2009-12#1)
rank order of##8##3##(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-8#1)(2008-10#1)(2009-12#1)
rank order##11##2##(1990-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-8#2)(2008-10#1)(2009-12#1)(2009-4#1)
rank test##3##2##(1997-8#1)(2010-6#1)(2013-1#1)
rank test)##2##2##(1990-6#1)(1997-7#1)
rank the##4##2##(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#1)
rank##49##1##(1990-11#1)(1990-6#1)(1990-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-8#2)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#6)(2008-3#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
rank-order of the##2##3##(1995-11#2)
ranked highest##2##2##(1991-6#1)(2008-10#1)
ranked on##2##2##(1993-12#1)(2008-10#1)
ranked the##2##2##(2008-7#1)(2008-9#1)
ranked##24##1##(1991-6#2)(1993-12#3)(1995-1#1)(1996-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#4)(2013-1#1)(2013-8#2)
ranking of the##4##3##(1993-12#1)(1993-2#1)(2008-5#1)(2009-4#1)
ranking of##8##2##(1990-6#1)(1991-2#1)(1993-12#1)(1993-2#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-4#1)
ranking##27##1##(1990-6#1)(1991-2#1)(1993-12#2)(1993-2#1)(1995-6#1)(2008-10#2)(2008-11#6)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
rankings##6##1##(1993-2#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)
ranks##10##1##(1990-8#1)(1993-6#1)(1997-2#1)(2008-10#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
rapa cv##4##2##(2008-10#4)
rapa##12##1##(2008-10#12)
rapae crucivora##2##2##(2008-6#2)
rapae##10##1##(1997-8#2)(2008-6#2)(2008-8#1)(2009-8#5)
rapamycin##8##1##(1996-2#1)(2008-11#2)(2008-7#1)(2009-7#1)(2013-1#3)
rape##13##1##(1996-5#1)(2008-10#10)(2008-11#2)
rapeseed meal##2##2##(2008-10#2)
rapeseed##10##1##(2008-10#5)(2008-11#4)(2011-2#1)
raphani and##2##2##(2008-10#2)
raphani##5##1##(2008-10#5)
raphe nuclei of the##2##4##(1996-12#1)(2008-7#1)
raphe nuclei##8##2##(1996-12#1)(2008-7#7)
raphe nucleus##2##2##(1993-3#1)(2012-3#1)
raphe##22##1##(1991-12#2)(1993-3#2)(1994-2#3)(1996-12#3)(1997-3#1)(2008-7#10)(2012-3#1)
rapid (&lt##2##2##(2008-10#2)
rapid (within##2##2##(2008-10#1)(2008-12#1)
rapid Ca2+##2##2##(1993-8#1)(1996-2#1)
rapid DNA extraction##2##3##(2008-10#1)(2008-12#1)
rapid advances in##2##3##(1992-1#1)(1994-9#1)
rapid advances##3##2##(1992-1#1)(1994-9#1)(2011-2#1)
rapid amplification of cDNA ends (RACE)##2##6##(2010-5#2)
rapid analysis of##6##3##(2008-10#4)(2008-11#1)(2010-9#1)
rapid analysis##7##2##(2008-10#5)(2008-11#1)(2010-9#1)
rapid analytical test methods##2##4##(2008-10#2)
rapid analytical##5##2##(2008-10#5)
rapid and accurate method for the##2##6##(2008-10#2)
rapid and accurate##10##3##(2008-10#9)(2010-5#1)
rapid and cost-effective##3##3##(2008-9#1)(2010-6#1)(2011-2#1)
rapid and direct##3##3##(2008-10#2)(2008-11#1)
rapid and easy##2##3##(2008-10#1)(2008-11#1)
rapid and economical##3##3##(2008-10#3)
rapid and efficient##8##3##(1991-12#1)(1994-11#1)(2008-10#5)(2008-7#1)
rapid and highly sensitive##2##4##(2008-10#2)
rapid and highly##4##3##(1994-5#1)(2008-10#3)
rapid and inexpensive##2##3##(2008-10#2)
rapid and precise##7##3##(2008-10#6)(2011-2#1)
rapid and reliable method##2##4##(2008-10#2)
rapid and reliable##5##3##(2008-10#3)(2011-2#1)(2013-8#1)
rapid and reproducible##4##3##(1994-3#1)(2008-10#2)(2008-5#1)
rapid and selective determination##2##4##(2008-10#2)
rapid and selective##6##3##(2008-10#6)
rapid and sensitive and##3##4##(2008-10#3)
rapid and sensitive flow injection##3##5##(2008-10#3)
rapid and sensitive method for the determination of##3##8##(2008-10#3)
rapid and sensitive method for the##9##6##(2008-10#7)(2008-5#1)(2010-4#1)
rapid and sensitive method for##10##5##(2008-10#8)(2008-5#1)(2010-4#1)
rapid and sensitive method is##3##5##(2008-10#3)
rapid and sensitive method was##2##5##(2008-10#2)
rapid and sensitive method##16##4##(2008-10#13)(2008-5#1)(2010-4#1)(2011-2#1)
rapid and sensitive spectrophotometric##3##4##(2008-10#3)
rapid and sensitive##51##3##(1993-12#1)(1993-8#1)(1994-3#1)(2008-10#42)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
rapid and simple method##3##4##(2008-10#2)(2008-12#1)
rapid and simple##19##3##(2008-10#15)(2008-11#2)(2008-12#1)(2008-4#1)
rapid and simultaneous##3##3##(2008-10#2)(2008-9#1)
rapid and specific##5##3##(2008-10#4)(2008-7#1)
rapid and suitable for automatic and continuous analysis##2##8##(2008-10#2)
rapid and suitable for##3##4##(2008-10#3)
rapid and##185##2##(1990-12#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-3#2)(1994-5#1)(1995-1#1)(1996-2#1)(1997-1#1)(2008-10#136)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#5)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#5)(2011-3#1)(2013-1#1)(2013-8#2)
rapid assay##3##2##(2008-10#2)(2008-11#1)
rapid assays of##2##3##(2008-10#1)(2008-9#1)
rapid assessment of##3##3##(2008-10#2)(2008-9#1)
rapid cell death##2##3##(2008-10#2)
rapid cell##6##2##(2008-10#3)(2008-11#2)(2008-7#1)
rapid change in##3##3##(1996-2#1)(2008-10#1)(2013-1#1)
rapid change##5##2##(1993-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2013-1#1)
rapid changes in##2##3##(2008-11#1)(2008-9#1)
rapid changes##4##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
rapid clearance##2##2##(1992-10#1)(2008-10#1)
rapid clinical##3##2##(2008-7#1)(2011-2#1)(2013-7#1)
rapid decline##5##2##(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
rapid decrease of##2##3##(1996-11#1)(2008-7#1)
rapid decrease##4##2##(1990-12#1)(1996-11#1)(2008-11#1)(2008-7#1)
rapid depletion of##2##3##(2008-10#1)(2008-5#1)
rapid desensitization protocols##2##3##(2008-8#2)
rapid desensitization##4##2##(2008-8#4)
rapid desensitizations##3##2##(2008-8#3)
rapid detection of the##2##4##(2008-10#2)
rapid detection of##8##3##(2008-10#3)(2008-11#1)(2009-6#1)(2010-5#1)(2010-6#1)(2012-2#1)
rapid detection##12##2##(1993-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2012-2#1)
rapid determination of the##2##4##(2008-10#2)
rapid determination of##18##3##(2008-10#18)
rapid determination##19##2##(2008-10#19)
rapid development of##7##3##(1994-12#1)(1996-11#1)(2008-10#4)(2010-6#1)
rapid development##9##2##(1994-12#1)(1996-11#1)(2008-10#4)(2008-5#1)(2010-6#1)(2013-8#1)
rapid diagnosis of##3##3##(2008-10#2)(2012-2#1)
rapid diagnosis##4##2##(2008-10#2)(2010-10#1)(2012-2#1)
rapid diagnostic tests##3##3##(2013-1#3)
rapid diagnostic##6##2##(2008-10#2)(2011-2#1)(2013-1#3)
rapid differential##3##2##(2008-10#2)(2013-8#1)
rapid diversification of##2##3##(2008-8#1)(2010-5#1)
rapid enzymatic assay of##2##4##(2008-10#2)
rapid evolution of##4##3##(2008-10#1)(2008-8#3)
rapid evolution##5##2##(2008-10#1)(2008-8#3)(2010-8#1)
rapid evolutionary##2##2##(2007-12#1)(2011-2#1)
rapid expansion of##5##3##(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
rapid expression of##2##3##(1995-2#1)(2008-11#1)
rapid extraction##3##2##(2008-10#3)
rapid growth in##2##3##(1992-1#1)(1994-2#1)
rapid growth of##3##3##(2010-7#1)(2012-3#2)
rapid growth##14##2##(1991-3#1)(1992-1#1)(1992-11#1)(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-7#2)(2012-3#2)
rapid identification of##6##3##(2008-10#3)(2010-4#2)(2013-1#1)
rapid identification##8##2##(2008-10#4)(2008-12#1)(2010-4#2)(2013-1#1)
rapid in##2##2##(2008-10#2)
rapid increase in electrolyte leakage##2##5##(2008-10#2)
rapid increase in the demand for medical manpower##2##8##(1990-6#2)
rapid increase in the##4##4##(1990-6#2)(1995-6#1)(2008-10#1)
rapid increase in##10##3##(1990-6#2)(1995-6#1)(1997-1#1)(2008-10#5)(2012-2#1)
rapid increase of##2##3##(2008-11#1)(2013-1#1)
rapid increase##12##2##(1990-6#2)(1995-6#1)(1997-1#1)(2008-10#5)(2008-11#1)(2012-2#1)(2013-1#1)
rapid increases in##2##3##(1996-12#1)(2008-10#1)
rapid increases##3##2##(1996-12#1)(2008-10#1)(2010-12#1)
rapid induction of##2##3##(2008-10#2)
rapid influenza##3##2##(2011-2#3)
rapid initial##2##2##(2008-3#1)(2013-1#1)
rapid intravenous administration of phenytoin##2##5##(2008-7#2)
rapid isolation##2##2##(2008-10#1)(2008-11#1)
rapid local##2##2##(2008-11#1)(2008-7#1)
rapid manner##2##2##(2010-7#1)(2012-2#1)
rapid means of##2##3##(1994-12#1)(2008-10#1)
rapid method for determining##2##4##(2008-10#2)
rapid method for simultaneous determination of##2##6##(2008-10#2)
rapid method for the determination of##5##6##(2008-10#5)
rapid method for the##10##4##(2008-10#10)
rapid method for##20##3##(1991-11#1)(2008-10#18)(2008-11#1)
rapid method has been developed for the determination##2##8##(2008-10#2)
rapid method##29##2##(1991-11#1)(1994-11#1)(2008-10#24)(2008-11#2)(2008-5#1)
rapid methods##2##2##(2008-10#1)(2008-5#1)
rapid migration of##2##3##(1992-6#1)(2011-2#1)
rapid on-line##2##2##(2008-10#2)
rapid phase##2##2##(1996-1#1)(2008-5#1)
rapid potentiometric##2##2##(2008-10#2)
rapid procedure##5##2##(1994-8#1)(1996-12#1)(2008-10#3)
rapid production of large quantities of##2##6##(2008-11#2)
rapid production##3##2##(2008-10#1)(2008-11#2)
rapid progress##4##2##(1993-3#1)(2008-10#1)(2008-11#2)
rapid progression##3##2##(2008-1#1)(2009-10#1)(2011-2#1)
rapid prototyping##2##2##(2010-9#2)
rapid response##5##2##(1992-1#1)(2008-10#3)(2011-2#1)
rapid responses##2##2##(1994-3#1)(2012-2#1)
rapid screening of##3##3##(2008-11#2)(2008-4#1)
rapid screening##5##2##(2008-10#2)(2008-11#2)(2008-4#1)
rapid separation and purification of acid-soluble nuclear proteins##2##8##(1997-2#2)
rapid separation and purification of##3##5##(1997-2#2)(2008-10#1)
rapid separation and##6##3##(1997-2#2)(2008-10#4)
rapid separation##9##2##(1997-2#2)(2008-10#7)
rapid spectrophotometric method for the determination of##2##7##(2008-10#2)
rapid spectrophotometric method##4##3##(2008-10#4)
rapid spectrophotometric##6##2##(2008-10#6)
rapid spread of the##2##4##(2008-10#1)(2011-2#1)
rapid spread of##4##3##(2008-10#3)(2011-2#1)
rapid spread##5##2##(2008-1#1)(2008-10#3)(2011-2#1)
rapid technique##4##2##(1997-7#1)(2008-10#2)(2008-12#1)
rapid test##2##2##(1990-12#1)(2008-10#1)
rapid trace##2##2##(2008-10#2)
rapid turnover of##2##3##(1992-1#1)(1993-9#1)
rapid wastewater toxicity assessment##2##4##(2008-10#2)
rapid##814##1##(1990-12#7)(1990-2#3)(1990-6#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#2)(1992-1#4)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#7)(1996-3#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#2)(2006-6#1)(2007-12#3)(2008-1#2)(2008-10#431)(2008-11#44)(2008-12#10)(2008-3#2)(2008-4#12)(2008-5#14)(2008-7#19)(2008-8#18)(2008-9#23)(2009-10#3)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#4)(2010-5#8)(2010-6#6)(2010-7#5)(2010-8#3)(2010-9#4)(2011-2#29)(2011-3#2)(2012-12#1)(2012-2#9)(2012-3#6)(2013-1#17)(2013-7#2)(2013-8#8)
rapide##2##1##(2011-2#1)(2013-1#1)
rapidity and##4##2##(1990-12#1)(2008-10#2)(2009-6#1)
rapidity of##4##2##(1992-9#1)(2008-10#2)(2011-2#1)
rapidity##22##1##(1990-12#1)(1991-2#1)(1992-9#1)(2008-10#16)(2008-8#1)(2009-6#1)(2011-2#1)
rapidly (within##3##2##(1996-2#1)(1997-6#1)(2008-10#1)
rapidly after##5##2##(1994-3#1)(1996-1#1)(2008-10#2)(2008-11#1)
rapidly among##3##2##(1996-11#2)(2008-10#1)
rapidly and accurately##2##3##(2008-10#1)(2008-11#1)
rapidly and easily##3##3##(2008-10#2)(2010-6#1)
rapidly and effectively##2##3##(1995-1#1)(1995-5#1)
rapidly and quantitatively##2##3##(2008-10#2)
rapidly and##30##2##(1990-6#1)(1995-1#1)(1995-5#1)(1996-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-6#1)(2013-1#1)
rapidly as the##2##3##(2008-10#1)(2008-9#1)
rapidly as##5##2##(2008-10#3)(2008-11#1)(2008-9#1)
rapidly at higher temperatures##2##4##(2008-10#1)(2008-6#1)
rapidly at##5##2##(2008-10#4)(2008-6#1)
rapidly by##3##2##(1992-5#1)(2008-11#1)(2008-3#1)
rapidly changing##11##2##(1991-12#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)
rapidly decreased in##2##3##(2008-10#1)(2008-11#1)
rapidly decreased##4##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-6#1)
rapidly decreases##3##2##(1997-1#1)(2008-5#1)(2010-12#1)
rapidly degraded##2##2##(2006-6#1)(2008-7#1)
rapidly detect##4##2##(2008-10#2)(2012-2#2)
rapidly developing##2##2##(2008-11#1)(2008-12#1)
rapidly during the##2##3##(1993-12#1)(2008-10#1)
rapidly emerging##3##2##(1993-12#1)(2008-10#1)(2010-8#1)
rapidly established##2##2##(2008-10#1)(2008-11#1)
rapidly evolving##6##2##(1994-1#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
rapidly expanding##7##2##(1994-9#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-7#1)(2013-1#1)
rapidly fatal##3##2##(1995-1#1)(1996-3#1)(2013-1#1)
rapidly following##2##2##(2008-10#1)(2008-11#1)
rapidly from##6##2##(1991-2#1)(2008-10#3)(2008-3#1)(2010-6#1)
rapidly growing##13##2##(1990-5#1)(1991-6#1)(1992-8#1)(1993-2#1)(1994-8#1)(2008-12#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
rapidly identified##2##2##(2008-10#2)
rapidly improving##2##2##(1990-8#1)(2008-7#1)
rapidly in the##2##3##(1997-3#1)(2008-11#1)
rapidly in##12##2##(1992-11#1)(1994-1#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2011-7#1)
rapidly increased##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
rapidly increasing##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
rapidly induced by##2##3##(1994-11#1)(1996-12#1)
rapidly induced##5##2##(1991-5#1)(1991-7#1)(1994-11#1)(1996-12#1)(2008-1#1)
rapidly lost##2##2##(2008-11#1)(2011-3#1)
rapidly on##2##2##(2008-10#1)(2008-8#1)
rapidly over##2##2##(1991-2#1)(2008-8#1)
rapidly progressing##2##2##(2008-1#1)(2011-2#1)
rapidly progressive##4##2##(1993-2#1)(2011-2#1)(2013-1#2)
rapidly spread##2##2##(2008-10#1)(2008-6#1)
rapidly stimulates##2##2##(1992-10#1)(1997-1#1)
rapidly than other##2##3##(2008-10#1)(2012-3#1)
rapidly than##11##2##(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)
rapidly the##2##2##(1994-9#1)(2008-10#1)
rapidly through##4##2##(1992-6#1)(1996-3#1)(2008-10#1)(2012-3#1)
rapidly to##6##2##(1990-8#1)(1993-12#1)(2008-10#2)(2008-9#1)(2013-1#1)
rapidly when##3##2##(2008-10#2)(2008-7#1)
rapidly with##4##2##(2008-10#3)(2008-7#1)
rapidly##337##1##(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#2)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-8#2)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#4)(1997-1#4)(1997-3#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#2)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#95)(2008-11#29)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#6)(2009-12#2)(2009-3#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-10#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#2)
rapidly-growing##2##1##(1990-5#2)
rapifera##2##1##(2008-10#2)
rapport and##2##2##(2008-11#1)(2008-8#1)
rapport##3##1##(2008-11#1)(2008-8#1)(2013-1#1)
rapportons un cas##2##3##(2011-2#1)(2013-1#1)
rapportons##8##1##(2011-2#2)(2013-1#6)
rare and are##2##3##(2008-7#2)
rare and is##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
rare and the##2##3##(2012-3#1)(2013-1#1)
rare and was##2##3##(2008-12#1)(2012-3#1)
rare and##41##2##(1990-9#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-6#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#2)(2009-8#2)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
rare anomaly##2##2##(2008-10#1)(2008-11#1)
rare association##5##2##(2008-10#1)(2010-8#2)(2012-2#2)
rare benign tumors of the##2##5##(2010-3#1)(2013-8#1)
rare benign##8##2##(1992-2#1)(2008-10#1)(2009-1#1)(2009-5#1)(2010-3#1)(2010-6#1)(2012-12#1)(2013-8#1)
rare but life-threatening##2##3##(2008-12#1)(2012-12#1)
rare but##14##2##(1992-12#1)(1996-12#1)(2008-11#1)(2008-12#2)(2008-8#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
rare case and review##2##4##(2013-1#2)
rare case of a##4##4##(2008-11#1)(2008-7#1)(2012-3#1)(2013-2#1)
rare case of##41##3##(1990-5#2)(1991-12#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-7#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-2#1)(2013-7#1)
rare case report##5##3##(2010-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
rare case##50##2##(1990-5#2)(1991-11#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-7#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#8)(2013-2#1)(2013-7#1)(2013-8#1)
rare cases##6##2##(1993-3#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#2)
rare cause of intestinal obstruction##2##5##(2008-12#2)
rare cause of##13##3##(2008-12#3)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
rare cause##16##2##(1996-6#1)(2008-12#3)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
rare cells##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
rare chez##2##2##(2013-1#2)
rare clinical##5##2##(1991-12#1)(2008-10#1)(2009-2#1)(2012-2#1)(2013-1#1)
rare combination of##2##3##(2009-11#1)(2012-3#1)
rare complication of##18##3##(1990-5#1)(1996-3#1)(2008-7#1)(2009-1#1)(2010-8#1)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
rare complication##23##2##(1990-5#1)(1996-3#1)(2008-12#2)(2008-7#1)(2009-1#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)
rare condition with##2##3##(2008-10#1)(2012-3#1)
rare condition##13##2##(1990-12#1)(1997-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-1#1)(2010-5#1)(2012-3#1)(2013-1#3)
rare congenital cardiac##2##3##(2010-6#1)(2012-2#1)
rare congenital malformation##3##3##(2008-10#1)(2008-11#2)
rare congenital##10##2##(1991-8#1)(2008-10#2)(2008-11#3)(2010-11#1)(2010-5#1)(2010-6#1)(2012-2#1)
rare cutting enzymes##2##3##(1992-6#1)(1996-6#1)
rare cutting##3##2##(1992-6#1)(1996-6#1)(2008-10#1)
rare diagnosis##2##2##(2008-10#1)(2008-7#1)
rare disease with a##2##4##(1997-5#1)(2008-12#1)
rare disease##17##2##(1992-12#1)(1993-6#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-12#2)(2009-1#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
rare diseases##5##2##(2008-9#1)(2010-12#1)(2011-7#3)
rare disorder##5##2##(1991-11#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
rare earth element##4##3##(2008-10#4)
rare earth elements (REE) in##2##5##(2008-10#2)
rare earth elements (REE)##6##4##(2008-10#5)(2012-2#1)
rare earth elements (REEs)##3##4##(2008-10#2)(2008-9#1)
rare earth elements and##2##4##(2008-10#2)
rare earth elements in soils and sediments##2##7##(2008-10#2)
rare earth elements in##6##4##(2008-10#6)
rare earth elements##22##3##(2008-10#20)(2008-9#1)(2012-2#1)
rare earth mixtures##2##3##(2008-10#2)
rare earth##39##2##(2008-10#37)(2008-9#1)(2012-2#1)
rare earths and##3##3##(2008-10#3)
rare earths has been##2##4##(2008-10#2)
rare earths with##2##3##(2008-10#2)
rare earths##16##2##(2008-10#16)
rare entity having##2##3##(2010-11#1)(2012-3#1)
rare entity in##2##3##(2011-2#1)(2013-8#1)
rare entity##18##2##(2008-10#3)(2008-11#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
rare event##6##2##(2008-1#1)(2008-10#2)(2008-7#1)(2009-9#1)(2011-2#1)
rare events##2##2##(2008-9#1)(2010-1#1)
rare exceptions##2##2##(2008-12#2)
rare finding##2##2##(2011-2#1)(2013-8#1)
rare form of##5##3##(1991-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
rare form##6##2##(1991-6#1)(1994-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
rare in adults##3##3##(2008-5#1)(2012-12#1)(2013-8#1)
rare in the##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2010-5#1)
rare in##22##2##(2007-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
rare inflammatory##2##2##(2013-1#2)
rare injury##2##2##(2010-7#1)(2012-2#1)
rare location##3##2##(1996-9#1)(2012-12#1)(2013-1#1)
rare mutation##2##2##(2011-1#1)(2011-3#1)
rare mutations##2##2##(1993-6#1)(2011-1#1)
rare neoplasms##2##2##(2008-1#1)(2011-2#1)
rare occurrence of##3##3##(2008-10#2)(2013-1#1)
rare occurrence##10##2##(1992-9#1)(2008-10#3)(2008-12#2)(2010-12#1)(2011-2#1)(2013-1#2)
rare presentation##5##2##(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
rare primary##4##2##(1993-3#1)(2010-11#1)(2010-6#1)(2012-12#1)
rare soft tissue##2##3##(2011-2#1)(2013-7#1)
rare to##2##2##(2008-10#1)(2008-11#1)
rare tumor and##2##3##(2011-2#1)(2013-1#1)
rare tumor of the##2##4##(2008-10#1)(2012-3#1)
rare tumor##5##2##(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
rare tumors##5##2##(1997-8#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
rare tumour##2##2##(2012-2#1)(2013-7#1)
rare tumours##5##2##(2008-7#1)(2010-11#1)(2012-2#2)(2013-1#1)
rare type of##2##3##(1997-7#1)(2011-2#1)
rare variant of##5##3##(1990-6#1)(2008-12#1)(2009-10#1)(2012-3#1)(2013-1#1)
rare variant##7##2##(1990-6#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-6#1)(2012-3#1)(2013-1#1)
rare variety##2##2##(1994-2#1)(2008-10#1)
rare with##4##2##(1997-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
rare##673##1##(1990-11#1)(1990-12#2)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#4)(1991-6#5)(1991-8#1)(1992-12#4)(1992-2#2)(1992-5#3)(1992-6#1)(1992-9#3)(1993-2#1)(1993-3#2)(1993-6#4)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#4)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#4)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#5)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#120)(2008-11#21)(2008-12#32)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#25)(2008-8#8)(2008-9#17)(2009-1#6)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#5)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#10)(2010-12#15)(2010-3#5)(2010-5#11)(2010-6#10)(2010-7#5)(2010-8#4)(2011-1#8)(2011-2#62)(2011-3#3)(2011-7#4)(2012-12#18)(2012-2#21)(2012-3#41)(2012-9#1)(2013-1#72)(2013-2#1)(2013-7#6)(2013-8#19)
rare-cutting##3##1##(1996-6#1)(1997-2#1)(2008-10#1)
rare-earth elements##4##2##(2008-10#4)
rare-earth##6##1##(2008-10#5)(2008-3#1)
rare-event analysis##2##2##(2008-9#2)
rarefaction##5##1##(1991-11#2)(2008-10#1)(2008-8#1)(2012-3#1)
rarely affected##2##2##(2008-10#2)
rarely been described##2##3##(2011-2#1)(2012-2#1)
rarely been reported##5##3##(1990-6#1)(1991-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
rarely been##10##2##(1990-6#1)(1991-8#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
rarely described in##2##3##(2008-7#1)(2010-12#1)
rarely described##3##2##(2008-7#2)(2010-12#1)
rarely discussed##3##2##(1996-2#1)(1996-6#1)(2008-11#1)
rarely found in##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
rarely found##5##2##(1991-12#1)(1991-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
rarely in the##3##3##(2008-10#2)(2008-5#1)
rarely in##6##2##(1991-2#1)(2008-10#2)(2008-5#2)(2013-1#1)
rarely observed in##3##3##(1990-3#2)(2008-5#1)
rarely observed##5##2##(1990-3#2)(1997-3#1)(2008-10#1)(2008-5#1)
rarely reported##2##2##(2011-2#1)(2013-1#1)
rarely studied in##2##3##(2007-12#1)(2009-11#1)
rarely studied##3##2##(2007-12#1)(2009-11#1)(2010-1#1)
rarely to##2##2##(2010-3#1)(2011-1#1)
rarely used##2##2##(1996-5#1)(2008-10#1)
rarely##117##1##(1990-3#3)(1990-6#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#2)(1992-2#1)(1992-5#2)(1993-12#2)(1994-1#1)(1994-9#1)(1995-1#1)(1996-11#3)(1996-2#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-3#2)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#7)(2008-7#6)(2008-8#5)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#2)
rarer##13##1##(2008-10#1)(2008-12#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
rarest##3##1##(1997-7#1)(2010-3#1)(2011-2#1)
rarity and##3##2##(1990-12#1)(2008-12#1)(2011-2#1)
rarity of this##5##3##(1990-9#1)(1992-5#1)(2010-12#1)(2011-2#2)
rarity of##10##2##(1990-5#1)(1990-9#1)(1991-11#1)(1992-5#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
rarity##22##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-5#1)(1992-9#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#3)
ras clone I##6##3##(2008-11#6)
ras gene##5##2##(1995-2#1)(1997-4#4)
ras oncogene##6##2##(1991-2#1)(1992-8#1)(2008-11#4)
ras##24##1##(1991-2#1)(1992-8#1)(1994-6#1)(1995-2#2)(1997-4#4)(2008-11#15)
ras-amplified recombinant BHK-21##2##3##(2008-11#2)
ras-amplified##3##1##(2008-11#3)
ras-rBHK-IgG##3##1##(2008-11#3)
rash and##2##2##(1997-8#1)(2008-11#1)
rash is##2##2##(2013-1#2)
rash on##2##2##(2009-12#1)(2012-3#1)
rash##19##1##(1997-8#3)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-12#1)(2011-2#2)(2012-3#1)(2013-1#6)
rashes##4##1##(2008-12#1)(2008-5#2)(2008-8#1)
rat C6##2##2##(1994-11#1)(2012-2#1)
rat CBF-C##2##2##(1995-2#2)
rat CL##5##2##(2008-8#2)(2008-9#3)
rat DRG##2##2##(1996-12#1)(2010-12#1)
rat EFIA cDNA##3##3##(1993-2#3)
rat EFIA##4##2##(1993-2#4)
rat Epo##4##2##(2008-11#4)
rat IA2 and IA1##2##4##(1990-5#2)
rat IA2##3##2##(1990-5#3)
rat L1##2##2##(1996-12#2)
rat MPP alpha##2##3##(1993-8#2)
rat MTHFR##2##2##(2008-8#2)
rat NR2C##2##2##(1996-12#2)
rat P-450(11 beta)##2##3##(1990-5#2)
rat PROT##2##2##(1995-6#2)
rat Schwann cell incorporation of [3H]thymidine##2##6##(1995-2#2)
rat adipocytes##6##2##(1994-8#1)(1997-1#2)(2008-8#2)(2011-2#1)
rat adipose tissue##3##3##(2008-11#2)(2010-6#1)
rat adipose##4##2##(2008-11#3)(2010-6#1)
rat adrenal gland##3##3##(1990-5#1)(1996-12#2)
rat adrenal medulla pheochromocytoma cell line##2##6##(2008-11#2)
rat adrenal##8##2##(1990-5#1)(1991-5#1)(1996-12#2)(2008-11#4)
rat alpha 1-protease inhibitor##2##4##(1990-8#2)
rat alpha-CGRP##2##2##(1992-6#2)
rat and bovine##2##3##(1992-3#1)(1993-6#1)
rat and chick##5##3##(1990-7#1)(1996-2#1)(1997-1#3)
rat and human liver##2##4##(1991-5#1)(1995-2#1)
rat and human##9##3##(1991-5#1)(1992-6#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#1)(2012-2#2)
rat and mouse liver##2##4##(1991-8#2)
rat and mouse##14##3##(1991-12#1)(1991-6#2)(1991-8#4)(1992-6#2)(1993-8#1)(1994-11#1)(2008-4#2)(2010-11#1)
rat and the##2##3##(2008-11#2)
rat and##39##2##(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#4)(1992-3#2)(1992-6#3)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#3)(2008-10#3)(2008-11#3)(2008-4#2)(2010-11#1)(2012-2#2)
rat anterior pituitary cells##2##4##(1990-12#1)(1996-2#1)
rat aorta##2##2##(1990-2#1)(1993-3#1)
rat aortic##3##2##(1991-5#1)(1994-5#1)(1995-2#1)
rat as##3##2##(1992-12#1)(1995-2#1)(2013-8#1)
rat ascites hepatoma##6##3##(2008-11#6)
rat ascites##8##2##(1993-8#1)(2008-11#7)
rat bone##2##2##(1990-11#1)(1995-11#1)
rat brain and##3##3##(1991-7#1)(1994-11#1)(1996-12#1)
rat brain by##6##3##(1992-12#1)(1996-12#2)(1997-1#2)(2008-10#1)
rat brain cDNA library##2##4##(1992-6#1)(1996-12#1)
rat brain in vivo##2##4##(1993-3#1)(1995-11#1)
rat brain in##3##3##(1993-3#1)(1994-8#1)(1995-11#1)
rat brain is##3##3##(1993-8#1)(2008-10#2)
rat brain regions##2##3##(1995-11#1)(1996-12#1)
rat brain using##2##3##(1993-8#1)(2008-7#1)
rat brain##66##2##(1990-5#3)(1990-7#1)(1991-10#1)(1991-5#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-3#4)(1993-6#3)(1993-8#2)(1994-11#2)(1994-8#4)(1995-11#3)(1995-6#1)(1996-12#9)(1996-2#5)(1997-1#3)(2008-10#14)(2008-4#1)(2008-7#2)
rat brains##4##2##(1991-7#1)(1996-12#2)(2008-8#1)
rat by##3##2##(1992-6#1)(1994-2#1)(1996-12#1)
rat cDNA##3##2##(1992-10#1)(1995-2#1)(1995-6#1)
rat cardiac myocytes in##2##4##(1993-3#1)(2008-7#1)
rat cardiac myocytes##4##3##(1993-3#2)(2008-7#1)(2008-9#1)
rat cardiomyocytes##4##2##(1994-3#1)(1995-11#1)(2010-12#2)
rat cdk4 is##2##3##(1993-3#2)
rat cells##6##2##(1995-6#1)(1996-2#5)
rat central nervous system##2##4##(1991-12#1)(1996-12#1)
rat cerebellar cortex##2##3##(1995-2#1)(1995-8#1)
rat cerebellar##3##2##(1995-2#1)(1995-8#1)(1996-2#1)
rat cerebral##3##2##(1996-12#1)(2008-11#1)(2010-12#1)
rat cortical membranes##2##3##(1990-5#1)(1996-2#1)
rat cortical##3##2##(1990-5#1)(1996-12#1)(1996-2#1)
rat cultures##3##2##(1996-2#3)
rat dorsal##2##2##(1997-3#1)(2008-9#1)
rat embryo fibroblasts##2##3##(1993-8#2)
rat embryo##3##2##(1990-11#1)(1993-8#2)
rat embryos##2##2##(1993-12#1)(2011-2#1)
rat epiphyseal cartilage cells##2##4##(1990-11#2)
rat epiphyseal cartilage##3##3##(1990-11#3)
rat erythrocyte##2##2##(1990-2#1)(1991-5#1)
rat fat##2##2##(1990-11#1)(1997-1#1)
rat fetuses##2##2##(1993-12#1)(1995-11#1)
rat fibronectin##2##2##(1993-8#2)
rat forebrain##2##2##(1992-3#1)(1995-11#1)
rat galanin##2##2##(1994-8#2)
rat genomic##3##2##(1993-12#2)(1993-8#1)
rat glucagon receptor##2##3##(1994-11#2)
rat heart##3##2##(1994-11#1)(1994-5#1)(1995-11#1)
rat hepatic microsomes##4##3##(1994-6#1)(2011-1#3)
rat hepatic stellate##2##3##(2008-11#1)(2013-8#1)
rat hepatic##11##2##(1990-11#1)(1993-12#1)(1994-11#1)(1994-6#2)(1995-2#1)(2008-11#1)(2011-1#3)(2013-8#1)
rat hepatocyte cell lines##2##4##(2008-11#2)
rat hepatocyte##3##2##(2008-11#3)
rat hepatocytes and##2##3##(1993-8#1)(2008-11#1)
rat hepatocytes were##2##3##(1993-3#1)(1995-12#1)
rat hepatocytes##30##2##(1990-2#2)(1990-5#1)(1991-12#2)(1992-3#3)(1993-3#2)(1993-8#4)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-2#2)(2008-11#6)(2008-9#3)
rat hepatoma 3924A##2##3##(1990-5#2)
rat hepatoma cells##3##3##(1992-10#1)(1994-11#1)(2008-11#1)
rat hepatoma##7##2##(1990-5#2)(1992-10#1)(1994-11#2)(2008-11#2)
rat hippocampal CA1##2##3##(1990-12#1)(1996-5#1)
rat hippocampal slices##4##3##(1990-12#2)(1995-12#1)(1996-2#1)
rat hippocampal##9##2##(1990-12#3)(1995-12#1)(1995-6#1)(1996-2#2)(1996-5#1)(2008-7#1)
rat hippocampus##8##2##(1990-5#2)(1995-12#3)(1996-12#1)(1997-2#1)(2008-7#1)
rat homolog of##2##3##(1993-3#1)(1996-12#1)
rat ileal brush border membrane##2##5##(1991-9#2)
rat intestinal mucin##2##3##(1991-12#2)
rat intestinal##7##2##(1991-12#2)(1992-9#1)(1994-8#2)(2008-11#1)(2011-3#1)
rat is##4##2##(1992-3#1)(1994-8#2)(2008-9#1)
rat islet isolation##2##3##(2008-11#2)
rat islet##3##2##(1993-8#1)(2008-11#2)
rat jejunum##4##2##(1991-12#1)(1991-5#3)
rat kidney##12##2##(1991-5#1)(1992-6#1)(1993-2#1)(1994-5#2)(1995-11#2)(1995-12#2)(2008-11#3)
rat liver and##7##3##(1990-5#1)(1992-6#2)(1995-6#1)(2008-10#3)
rat liver by##5##3##(1993-8#1)(1994-6#1)(1994-8#2)(1995-2#1)
rat liver cells##5##3##(1993-6#1)(1995-6#1)(2008-8#3)
rat liver membranes##2##3##(1994-3#2)
rat liver microsomes but##2##4##(1994-8#2)
rat liver microsomes containing##2##4##(1994-8#2)
rat liver microsomes##12##3##(1991-5#3)(1993-8#1)(1994-8#6)(2011-3#2)
rat liver mitochondria in the presence of##2##7##(1991-5#1)(1994-8#1)
rat liver mitochondria##5##3##(1990-2#1)(1991-5#1)(1994-11#1)(1994-8#2)
rat liver plasma membranes##3##4##(1995-8#3)
rat liver was##3##3##(1992-6#1)(1994-11#1)(2009-8#1)
rat liver##83##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-8#1)(1991-5#4)(1992-10#2)(1992-6#5)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#3)(1994-3#4)(1994-6#1)(1994-8#13)(1995-12#1)(1995-2#4)(1995-6#3)(1995-8#5)(1995-9#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-8#4)(2009-8#2)(2011-3#2)
rat livers##3##2##(1991-3#2)(2008-8#1)
rat lung##6##2##(1994-11#1)(1995-2#3)(1995-8#2)
rat lungs##3##2##(1994-5#1)(2008-12#2)
rat macrophages##3##2##(2008-10#3)
rat mammary cells##3##3##(1995-11#3)
rat mammary tumors##2##3##(1993-1#1)(1995-9#1)
rat mammary##10##2##(1993-1#1)(1993-11#2)(1995-11#5)(1995-9#1)(2008-10#1)
rat mandible##3##2##(2008-7#3)
rat mesentery-derived mesothelial-cell (M-cell)##2##4##(2008-11#2)
rat mesentery-derived##3##2##(2008-11#3)
rat model of##11##3##(2008-10#1)(2008-11#2)(2008-12#1)(2009-12#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
rat model was##2##3##(1995-2#1)(2011-3#1)
rat model##19##2##(1990-12#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-12#1)(2009-6#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
rat models of parkinsonism and##2##5##(1997-2#2)
rat models of##3##3##(1997-2#3)
rat motor##2##2##(1990-5#1)(2013-8#1)
rat muscle##2##2##(2008-8#1)(2008-9#1)
rat myocardial cell culture system##2##5##(1992-3#2)
rat myocardium##2##2##(2010-6#2)
rat neocortex##2##2##(2008-11#2)
rat neuronal cell##6##3##(1993-6#2)(1995-12#1)(2008-11#3)
rat neuronal##9##2##(1993-6#3)(1995-12#1)(2008-11#3)(2008-9#1)(2010-12#1)
rat or rabbit##2##3##(1992-6#1)(1995-11#1)
rat or##3##2##(1992-6#1)(1995-11#1)(2008-9#1)
rat ovarian##2##2##(1995-8#1)(2008-9#1)
rat ovary##3##2##(1997-1#1)(2008-9#2)
rat pancreatic islets##2##3##(1995-8#1)(2008-11#1)
rat pancreatic##5##2##(1991-5#1)(1994-11#1)(1995-8#1)(2008-11#2)
rat peritoneal macrophages##2##3##(2008-10#1)(2008-11#1)
rat peritoneal##4##2##(1995-11#1)(2008-10#1)(2008-11#2)
rat pheochromocytoma cell line##4##4##(1993-8#1)(1994-11#1)(2008-11#2)
rat pheochromocytoma##6##2##(1993-8#1)(1994-11#1)(2008-11#2)(2013-8#2)
rat pineal gland and##2##4##(2008-10#2)
rat pituitary cells##5##3##(1991-6#1)(1992-6#3)(1996-2#1)
rat pituitary##9##2##(1990-11#1)(1991-6#1)(1992-6#5)(1993-5#1)(1996-2#1)
rat placenta##3##2##(1995-12#2)(2008-10#1)
rat plasma##10##2##(1991-3#3)(1991-5#1)(1997-2#2)(2008-10#4)
rat platelets##2##2##(1993-8#2)
rat primary##6##2##(1990-5#1)(2008-11#4)(2011-2#1)
rat prostate##2##2##(1991-5#1)(1993-8#1)
rat pulmonary artery##2##3##(1993-6#1)(2011-3#1)
rat pups##3##2##(1994-3#1)(2008-10#2)
rat renal anemia##2##3##(2008-8#2)
rat renal##6##2##(1994-5#1)(1995-11#1)(1997-1#2)(2008-8#2)
rat retina##2##2##(1996-2#1)(2008-7#1)
rat sera##4##2##(2008-10#1)(2008-11#3)
rat serum##2##2##(2008-11#2)
rat single-pass intestinal perfusion##2##4##(2011-3#2)
rat skeletal muscle extensor digitorum longus##2##6##(2008-9#2)
rat skeletal muscle##10##3##(1991-2#1)(1991-5#1)(1993-3#1)(1995-12#1)(1995-8#2)(2008-8#2)(2008-9#2)
rat skin##2##2##(1992-6#2)
rat small intestine##2##3##(1991-12#1)(1995-11#1)
rat soleus##2##2##(1991-2#1)(1995-12#1)
rat spinal cord##2##3##(1994-2#1)(2008-11#1)
rat spinal##3##2##(1992-6#1)(1994-2#1)(2008-11#1)
rat splenic##2##2##(1995-12#2)
rat stomach##3##2##(1992-6#1)(1997-4#2)
rat strains##3##2##(1993-12#1)(2008-11#1)(2012-3#1)
rat striatal##3##2##(1995-11#1)(1995-12#1)(1996-2#1)
rat striatum##7##2##(1995-11#1)(1995-6#1)(1996-12#3)(1996-2#2)
rat stroke model##2##3##(2008-7#2)
rat testis##5##2##(1994-11#1)(2008-9#2)(2009-10#1)(2012-2#1)
rat tissues##7##2##(1990-12#1)(1992-3#1)(1992-9#1)(1993-3#2)(1994-11#1)(2009-8#1)
rat trachea##6##2##(2008-9#6)
rat trigeminal##3##2##(1996-12#2)(1997-2#1)
rat type##2##2##(1991-5#1)(1992-3#1)
rat urine##5##2##(1994-8#1)(2008-10#4)
rat uterine model of##2##4##(1992-12#2)
rat uterine##3##2##(1992-12#2)(1994-8#1)
rat uterus##3##2##(1991-5#1)(1992-10#1)(2013-7#1)
rat vibrissal##3##2##(2011-2#3)
rat was##5##2##(1993-6#2)(1996-12#1)(1997-2#1)(2011-3#1)
rat were##2##2##(1994-2#1)(2011-3#1)
rat whole embryo culture##2##4##(1993-12#2)
rat##1005##1##(1990-10#2)(1990-11#11)(1990-12#7)(1990-2#7)(1990-3#2)(1990-5#33)(1990-7#2)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#10)(1991-2#4)(1991-3#6)(1991-4#2)(1991-5#26)(1991-6#6)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#9)(1992-12#9)(1992-3#15)(1992-6#36)(1992-8#5)(1992-9#3)(1993-1#3)(1993-11#4)(1993-12#17)(1993-2#8)(1993-3#26)(1993-5#1)(1993-6#16)(1993-8#35)(1994-11#25)(1994-2#16)(1994-3#11)(1994-5#7)(1994-6#4)(1994-8#46)(1995-11#32)(1995-12#32)(1995-2#26)(1995-3#1)(1995-6#14)(1995-8#17)(1995-9#5)(1996-12#44)(1996-2#35)(1996-5#4)(1996-6#1)(1997-1#15)(1997-2#10)(1997-3#3)(1997-4#2)(1997-7#2)(1997-9#1)(2006-6#1)(2008-10#66)(2008-11#87)(2008-12#6)(2008-4#6)(2008-7#18)(2008-8#29)(2008-9#35)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-4#1)(2010-6#4)(2011-1#3)(2011-2#14)(2011-3#14)(2012-2#6)(2012-3#5)(2012-4#1)(2013-1#4)(2013-7#1)(2013-8#8)
rat's blood and brain##4##4##(2008-10#4)
rat's ileum##2##2##(2008-12#2)
rat's##8##1##(1991-2#1)(2008-10#4)(2008-12#3)
rat]##2##1##(2010-12#1)(2011-3#1)
rate (0##2##2##(2008-10#1)(2008-5#1)
rate (5##2##2##(1996-11#1)(2012-3#1)
rate (GFR)##2##2##(2010-4#1)(2013-1#1)
rate (HR) and##4##3##(1992-12#1)(2013-8#3)
rate (HR)##11##2##(1992-12#1)(2008-11#2)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#5)
rate (P &lt##2##3##(2008-10#1)(2011-2#1)
rate (P##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
rate (RR)##4##2##(1992-12#1)(2008-10#2)(2012-2#1)
rate (per 100##2##3##(1994-12#1)(2013-8#1)
rate 5##2##2##(1990-3#1)(2008-10#1)
rate V(max)) of the##2##4##(2008-10#2)
rate after treatment was##2##4##(1990-12#1)(1991-9#1)
rate after##5##2##(1990-12#1)(1991-9#1)(1993-8#1)(1994-6#1)(2012-2#1)
rate among##5##2##(1991-11#1)(1995-1#1)(1997-2#1)(2008-4#1)(2011-2#1)
rate and a##3##3##(1990-8#1)(1992-8#1)(1995-12#1)
rate and extent of deuterium oxide-mediated fluorescence enhancement of##2##9##(1992-6#2)
rate and extent of##4##4##(1992-6#2)(2008-10#2)
rate and final##2##3##(2008-10#1)(2008-11#1)
rate and in##2##3##(1990-9#1)(2008-3#1)
rate and maximum cell##2##4##(2008-11#2)
rate and maximum##3##3##(2008-11#2)(2011-2#1)
rate and relative##3##3##(2008-10#2)(2008-8#1)
rate and temperature on##2##4##(2009-7#1)(2010-4#1)
rate and temperature##3##3##(2008-10#1)(2009-7#1)(2010-4#1)
rate and that the##2##4##(2008-10#1)(2008-7#1)
rate and the##12##3##(1994-12#1)(1996-3#1)(2008-10#3)(2008-3#1)(2008-7#4)(2008-8#1)(2009-7#1)
rate and##144##2##(1990-8#1)(1990-9#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#51)(2008-11#17)(2008-12#5)(2008-3#2)(2008-5#4)(2008-7#9)(2008-8#8)(2008-9#1)(2009-1#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#2)
rate are##6##2##(1993-2#1)(1997-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2010-4#1)
rate as well as##2##4##(2008-10#1)(2011-2#1)
rate as well##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
rate as##10##2##(1995-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
rate associated with##3##3##(1995-12#1)(2008-10#1)(2013-8#1)
rate at the##2##3##(1990-9#1)(2008-3#1)
rate at which the##7##4##(1991-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#1)
rate at which##17##3##(1991-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#6)(2010-12#1)(2010-8#1)(2013-8#1)
rate at##28##2##(1990-9#1)(1991-2#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#8)(2010-12#1)(2010-8#1)(2013-8#1)
rate between##11##2##(1990-6#2)(1990-8#1)(1993-11#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
rate both##2##2##(1996-12#1)(2008-7#1)
rate by the##2##3##(2008-11#2)
rate by##10##2##(1996-2#1)(2008-10#4)(2008-11#3)(2008-9#2)
rate calibration##2##2##(2008-9#2)
rate can be decreased##2##4##(2008-11#1)(2008-5#1)
rate can be##7##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2011-3#1)
rate comparable##3##2##(1997-4#2)(2009-8#1)
rate compared to##3##3##(1992-8#1)(1995-1#1)(2008-7#1)
rate compared##4##2##(1992-8#1)(1995-1#1)(2008-7#1)(2010-8#1)
rate condition##2##2##(1996-2#1)(2007-12#1)
rate conditions##2##2##(2008-10#1)(2008-11#1)
rate constant (k(s)) for##2##4##(2008-10#2)
rate constant (k(s))##5##3##(2008-10#5)
rate constant for the reaction##2##5##(1994-5#1)(2008-10#1)
rate constant for the##6##4##(1991-5#1)(1994-5#1)(1996-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
rate constant for##8##3##(1991-5#1)(1994-5#1)(1996-5#1)(2008-10#2)(2008-7#2)(2008-8#1)
rate constant k##2##3##(2008-10#1)(2008-7#1)
rate constant of the##4##4##(2008-10#4)
rate constant of##10##3##(1995-6#2)(2008-10#6)(2008-11#1)(2008-4#1)
rate constant##53##2##(1990-5#1)(1990-9#1)(1991-5#1)(1993-3#1)(1993-8#2)(1994-5#3)(1995-6#2)(1996-5#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#6)(2008-8#2)(2009-8#2)
rate constants and##2##3##(2008-10#2)
rate constants are##2##3##(2008-11#1)(2008-5#1)
rate constants by##2##3##(1995-8#1)(2008-10#1)
rate constants for##2##3##(2008-10#1)(2008-4#1)
rate constants obtained##2##3##(2008-10#2)
rate constants of the##4##4##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
rate constants of##6##3##(1990-9#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)
rate constants were##3##3##(1993-1#1)(2008-10#1)(2008-9#1)
rate constants##32##2##(1990-9#2)(1991-5#3)(1993-1#2)(1994-8#1)(1995-8#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-8#1)
rate control##2##2##(2008-7#1)(2012-2#1)
rate coupled with##2##3##(1995-11#1)(2008-7#1)
rate data##4##2##(2008-10#3)(2008-7#1)
rate decrease##2##2##(2008-11#1)(2008-8#1)
rate decreased with increasing##2##4##(2008-11#1)(2008-7#1)
rate decreased##7##2##(1991-8#1)(1996-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2012-12#1)
rate decreases with increasing##2##4##(1993-8#1)(2008-10#1)
rate decreases##4##2##(1991-11#1)(1993-8#1)(2008-10#1)(2011-2#1)
rate dependence##3##2##(2008-10#2)(2009-10#1)
rate determined##2##2##(2008-10#1)(2009-11#1)
rate determining##3##2##(1991-6#1)(2008-10#1)(2009-8#1)
rate due to the##2##4##(2008-11#1)(2012-2#1)
rate due to##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
rate during the##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2009-11#1)
rate during##5##2##(1993-6#1)(2008-10#2)(2008-11#1)(2009-11#1)
rate enhancement##2##2##(1993-9#1)(2011-2#1)
rate equation##11##2##(1990-8#1)(1993-3#1)(2008-10#4)(2008-3#5)
rate equations##5##2##(1990-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
rate exceeds##2##2##(2008-7#1)(2008-8#1)
rate expressed as##2##3##(2008-7#1)(2008-9#1)
rate following##5##2##(1992-1#1)(1993-3#1)(1994-9#1)(1995-8#1)(2008-7#1)
rate for a##4##3##(1994-12#1)(2008-3#2)(2008-9#1)
rate for each##2##3##(1995-3#1)(2008-7#1)
rate for the##9##3##(1992-5#1)(1995-6#2)(2008-10#6)
rate for##33##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#2)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
rate from##11##2##(1991-6#2)(1995-11#1)(1995-8#1)(1996-11#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)
rate has##2##2##(1997-7#1)(2010-12#1)
rate imaging##2##2##(2008-6#1)(2009-10#1)
rate in both##2##3##(2008-9#1)(2012-3#1)
rate in the range##2##4##(2008-10#2)
rate in the##16##3##(1990-2#1)(1991-2#1)(1991-6#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
rate in this##2##3##(1991-12#1)(2012-3#1)
rate in##65##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-11#1)(1993-11#1)(1994-12#2)(1995-2#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#14)(2008-11#6)(2008-12#5)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2010-3#1)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#2)
rate increased with##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
rate increased##12##2##(1994-12#1)(2008-10#4)(2008-11#3)(2008-9#2)(2012-3#1)(2013-8#1)
rate increases with age##2##4##(2008-7#1)(2011-2#1)
rate increases with##3##3##(1990-6#1)(2008-7#1)(2011-2#1)
rate increases##7##2##(1990-6#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
rate information##2##2##(2008-11#1)(2008-4#1)
rate is every##2##3##(2008-10#2)
rate is high##3##3##(2008-11#1)(2008-8#2)
rate is low##2##3##(2008-8#2)
rate is##49##2##(1990-5#2)(1992-5#1)(1992-9#2)(1993-1#1)(1994-2#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-8#11)(2008-9#2)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
rate isomorphy in##2##3##(2008-8#2)
rate isomorphy##8##2##(2008-8#8)
rate limiting step in##2##4##(2008-11#1)(2008-5#1)
rate limiting##8##2##(1993-8#1)(1993-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2013-1#1)
rate may be##2##3##(1991-3#1)(2012-12#1)
rate may vary##2##3##(1997-2#1)(2007-11#1)
rate may##5##2##(1991-3#1)(1997-2#1)(2007-11#1)(2008-11#1)(2012-12#1)
rate measurements##3##2##(1994-5#1)(2008-10#2)
rate method##3##2##(2008-10#3)
rate methods##2##2##(2008-10#2)
rate models##2##2##(2012-3#2)
rate obtained##2##2##(2008-10#1)(2012-12#1)
rate of 0##17##3##(1992-12#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
rate of 1##24##3##(1990-9#1)(2008-10#21)(2008-3#1)(2011-1#1)
rate of 10##4##3##(2008-10#2)(2008-3#1)(2008-6#1)
rate of 100##4##3##(2008-10#4)
rate of 12##2##3##(2008-11#1)(2008-3#1)
rate of 15 samples h(-1)##2##5##(2008-10#2)
rate of 15##6##3##(2008-1#1)(2008-10#5)
rate of 2##10##3##(2007-12#1)(2008-10#8)(2008-7#1)
rate of 20##3##3##(2008-10#2)(2013-1#1)
rate of 24##2##3##(2008-10#2)
rate of 25##2##3##(2008-10#1)(2008-7#1)
rate of 3##5##3##(2008-10#3)(2008-4#1)(2008-7#1)
rate of 30##4##3##(2008-10#4)
rate of 40##5##3##(1991-6#1)(2008-10#4)
rate of 5##6##3##(2008-10#4)(2008-7#1)(2012-12#1)
rate of 500##2##3##(2008-10#2)
rate of 6##7##3##(1993-3#1)(2008-10#4)(2012-2#1)(2013-8#1)
rate of 60##6##3##(2008-10#5)(2011-2#1)
rate of 7##2##3##(1990-6#1)(2012-3#1)
rate of 90##4##3##(2008-10#4)
rate of 93##2##3##(2010-8#1)(2013-1#1)
rate of DNA##2##3##(1993-3#1)(1993-8#1)
rate of a##4##3##(2008-10#1)(2008-11#1)(2008-8#2)
rate of about##7##3##(1996-11#1)(2008-10#6)
rate of aging in##2##4##(2008-9#2)
rate of aging is##2##4##(2008-9#2)
rate of aging##6##3##(2008-9#6)
rate of approximately##3##3##(2008-10#1)(2008-11#2)
rate of ascospore##2##3##(2008-10#2)
rate of aspartate##2##3##(1991-3#2)
rate of cells##2##3##(2008-11#2)
rate of change##4##3##(2008-10#4)
rate of complete##2##3##(1994-2#1)(2010-12#1)
rate of complications and##2##4##(2013-1#2)
rate of complications in##2##4##(1990-9#1)(1991-9#1)
rate of complications##10##3##(1990-9#1)(1991-3#1)(1991-9#2)(1997-8#1)(2010-7#1)(2013-1#4)
rate of disease increase##3##4##(2008-10#3)
rate of disease progress and##2##5##(2008-10#2)
rate of disease progress##3##4##(2008-10#3)
rate of disease progression##2##4##(2008-10#2)
rate of disease##10##3##(2008-10#10)
rate of eggs##2##3##(1996-12#1)(2010-8#1)
rate of first##2##3##(2010-7#1)(2013-1#1)
rate of glucose##2##3##(1991-7#1)(2008-11#1)
rate of growth of##4##4##(1996-3#1)(1997-1#1)(2011-2#1)(2012-2#1)
rate of growth##11##3##(1991-1#1)(1992-2#1)(1996-3#1)(1997-1#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
rate of hepatic##3##3##(1991-7#2)(2012-2#1)
rate of incorporation##2##3##(1997-1#1)(2008-11#1)
rate of increase in##3##4##(1993-12#1)(1993-3#1)(2008-9#1)
rate of increase of##2##4##(2008-10#2)
rate of increase##8##3##(1993-12#1)(1993-3#3)(2008-10#3)(2008-9#1)
rate of infected and##2##4##(1994-9#1)(2008-10#1)
rate of infection of##2##4##(2008-10#2)
rate of infection##3##3##(2008-10#3)
rate of isolation##2##3##(2008-12#1)(2008-5#1)
rate of late##2##3##(2008-8#1)(2010-11#1)
rate of local##2##3##(2008-11#1)(2009-12#1)
rate of major##2##3##(1994-1#1)(2008-11#1)
rate of metal ion##2##4##(2008-10#2)
rate of metal##3##3##(2008-10#3)
rate of movement of##2##4##(1991-5#2)
rate of oxidation##3##3##(2008-10#2)(2008-12#1)
rate of oxygen consumption##4##4##(1997-1#1)(2008-10#1)(2010-11#2)
rate of oxygen##5##3##(1997-1#1)(2008-10#1)(2008-7#1)(2010-11#2)
rate of population##2##3##(2008-10#1)(2008-8#1)
rate of positivity##2##3##(1997-2#2)
rate of pustule appearance##3##4##(2008-10#3)
rate of pustule##4##3##(2008-10#4)
rate of reaction##2##3##(2008-10#2)
rate of recovery of##2##4##(2008-11#1)(2008-7#1)
rate of recovery##4##3##(2008-11#1)(2008-12#2)(2008-7#1)
rate of recurrence##2##3##(2012-3#1)(2013-1#1)
rate of renal##2##3##(1994-5#1)(1995-12#1)
rate of resistance##2##3##(2008-10#1)(2012-2#1)
rate of resource##3##3##(2008-8#3)
rate of responding##2##3##(1993-6#1)(2008-5#1)
rate of response to##2##4##(1993-11#1)(2009-8#1)
rate of response##3##3##(1993-11#1)(2009-12#1)(2009-8#1)
rate of spread of the##2##5##(2008-10#2)
rate of streptokinase production##2##4##(2012-2#2)
rate of substrate##2##3##(2008-10#1)(2008-7#1)
rate of surfactant##2##3##(1994-5#2)
rate of the disease##2##4##(2008-8#1)(2011-2#1)
rate of the overall##3##4##(1995-9#1)(2008-7#1)(2008-8#1)
rate of the propagation period##3##5##(1991-12#3)
rate of the reaction##3##4##(2008-10#3)
rate of the titrant##3##4##(2008-10#3)
rate of the##69##3##(1991-12#3)(1991-6#1)(1992-1#1)(1993-8#1)(1994-8#1)(1995-2#2)(1995-9#1)(1996-3#1)(1997-6#1)(2008-10#30)(2008-11#3)(2008-12#3)(2008-3#3)(2008-7#4)(2008-8#4)(2008-9#4)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
rate of these##2##3##(1997-4#1)(2008-10#1)
rate of this##2##3##(1994-2#1)(2008-10#1)
rate of tobacco##2##3##(2013-1#2)
rate of transport##3##3##(2008-10#3)
rate of tumor##2##3##(1997-7#1)(2013-8#1)
rate of up to 30##2##5##(1997-1#1)(2008-10#1)
rate of up to##3##4##(1997-1#1)(2008-10#1)(2010-8#1)
rate of uptake##2##3##(1991-5#1)(2008-10#1)
rate of##726##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#5)(1991-5#6)(1991-6#4)(1991-7#3)(1991-9#5)(1992-1#2)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#6)(1993-6#3)(1993-8#2)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#6)(1994-6#1)(1994-8#6)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#3)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#276)(2008-11#51)(2008-12#17)(2008-3#10)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#29)(2008-8#26)(2008-9#25)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#6)(2010-12#4)(2010-4#2)(2010-6#1)(2010-7#4)(2010-8#9)(2011-1#4)(2011-2#18)(2011-3#3)(2011-7#1)(2012-12#11)(2012-2#15)(2012-3#16)(2013-1#20)(2013-7#1)(2013-8#9)
rate on the##10##3##(1993-8#1)(1997-2#2)(2008-10#4)(2009-7#1)(2009-8#1)(2011-2#1)
rate on##22##2##(1993-8#1)(1996-12#2)(1997-2#2)(2008-10#8)(2008-11#3)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)
rate or##5##2##(1990-2#1)(2008-10#3)(2008-8#1)
rate over##5##2##(1994-9#1)(2008-11#2)(2008-6#1)(2011-2#1)
rate parameters##4##2##(1994-9#1)(2008-10#1)(2008-11#1)(2010-11#1)
rate per##5##2##(2008-10#1)(2008-11#2)(2008-8#2)
rate profiles##2##2##(1991-9#1)(2008-5#1)
rate ratio##2##2##(2008-10#1)(2008-11#1)
rate ratios and##2##3##(2008-10#1)(2011-2#1)
rate ratios##4##2##(1996-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
rate reached##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
rate remains constant##2##3##(2008-10#1)(2008-11#1)
rate showed a##2##3##(2008-11#1)(2012-12#1)
rate significantly##2##2##(2008-10#1)(2008-11#1)
rate similar to that of the##2##6##(1994-8#1)(1995-2#1)
rate similar to that##3##4##(1993-8#1)(1994-8#1)(1995-2#1)
rate stability##2##2##(1991-1#1)(2008-10#1)
rate studies##2##2##(1991-9#1)(1993-8#1)
rate than the##5##3##(1992-12#1)(1995-3#1)(1996-8#1)(2008-11#1)(2008-5#1)
rate than##21##2##(1990-8#1)(1991-3#2)(1992-12#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
rate that##5##2##(1994-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
rate the##4##2##(1995-3#1)(2008-10#1)(2008-3#1)(2013-8#1)
rate their##4##2##(1996-2#1)(2008-12#1)(2008-7#1)(2010-4#1)
rate times##3##2##(1993-1#1)(1994-12#1)(1996-12#1)
rate to be##2##3##(2008-11#1)(2010-12#1)
rate to##15##2##(1990-9#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#3)(2010-12#1)(2012-8#1)
rate using##2##2##(2008-10#1)(2008-12#1)
rate variability (HRV)##6##3##(2008-12#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
rate variability##13##2##(2008-12#3)(2008-7#1)(2009-11#2)(2010-12#2)(2010-5#2)(2011-2#1)(2012-2#1)(2013-8#1)
rate was 0##2##3##(1990-6#1)(2011-2#1)
rate was 1##2##3##(2008-10#1)(2008-7#1)
rate was 12##2##3##(1996-8#1)(1997-7#1)
rate was 20##3##3##(2008-10#1)(2013-1#2)
rate was 30##2##3##(2008-10#1)(2013-8#1)
rate was 4##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
rate was 40%##2##3##(1995-5#1)(2012-2#1)
rate was 58%##2##3##(1993-1#1)(2008-12#1)
rate was 61##2##3##(1990-9#1)(2011-1#1)
rate was 64##2##3##(1996-12#1)(1997-7#1)
rate was 90##2##3##(2008-10#1)(2008-11#1)
rate was about##3##3##(2008-10#2)(2008-11#1)
rate was calculated##3##3##(1990-9#1)(2008-10#1)(2008-5#1)
rate was found to be##3##5##(1994-3#1)(1995-12#2)
rate was high##3##3##(1991-6#1)(2008-10#1)(2008-8#1)
rate was low##2##3##(1990-3#1)(2008-11#1)
rate was lower than##2##4##(2008-10#1)(2008-7#1)
rate was lower##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
rate was measured##2##3##(1995-3#1)(2009-11#1)
rate was not significantly affected##2##5##(2008-11#1)(2010-11#1)
rate was significantly higher in##3##5##(1991-6#1)(2008-10#1)(2008-7#1)
rate was significantly##4##3##(1991-6#1)(1996-2#1)(2008-10#1)(2008-7#1)
rate was##146##2##(1990-3#1)(1990-6#2)(1990-9#2)(1991-2#2)(1991-6#3)(1991-9#1)(1992-2#1)(1992-6#1)(1993-1#5)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-7#5)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#37)(2008-11#15)(2008-12#3)(2008-5#2)(2008-7#12)(2008-8#1)(2008-9#2)(2009-11#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
rate were also##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
rate were optimized##3##3##(2008-10#3)
rate were##18##2##(1993-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
rate when##3##2##(2007-11#1)(2008-8#1)(2009-10#1)
rate which##2##2##(1991-9#1)(2008-11#1)
rate with the##3##3##(1993-8#1)(2008-12#1)(2008-7#1)
rate with##8##2##(1993-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)
rate would##2##2##(2012-12#1)(2013-8#1)
rate##2271##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#4)(1990-5#6)(1990-6#8)(1990-8#7)(1990-9#14)(1991-1#4)(1991-11#5)(1991-12#10)(1991-2#8)(1991-3#9)(1991-5#11)(1991-6#13)(1991-7#3)(1991-8#3)(1991-9#10)(1992-1#3)(1992-11#1)(1992-12#5)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#3)(1992-9#3)(1993-1#18)(1993-11#5)(1993-12#4)(1993-2#4)(1993-3#10)(1993-6#9)(1993-8#13)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#11)(1994-2#8)(1994-3#9)(1994-5#13)(1994-6#3)(1994-8#10)(1994-9#4)(1995-1#2)(1995-11#5)(1995-12#11)(1995-2#7)(1995-3#14)(1995-5#2)(1995-6#9)(1995-8#4)(1995-9#3)(1996-1#2)(1996-11#9)(1996-12#16)(1996-2#11)(1996-3#11)(1996-5#1)(1996-6#4)(1996-8#4)(1996-9#1)(1997-1#9)(1997-2#11)(1997-3#3)(1997-4#9)(1997-6#2)(1997-7#20)(1997-8#10)(2006-6#2)(2007-11#12)(2007-12#6)(2007-8#3)(2008-1#4)(2008-10#715)(2008-11#206)(2008-12#47)(2008-2#5)(2008-3#29)(2008-4#10)(2008-5#31)(2008-6#5)(2008-7#121)(2008-8#104)(2008-9#78)(2009-1#1)(2009-10#9)(2009-11#8)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#9)(2009-8#12)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#11)(2010-12#14)(2010-3#2)(2010-4#8)(2010-5#6)(2010-6#2)(2010-7#6)(2010-8#19)(2010-9#1)(2011-1#9)(2011-10#2)(2011-2#75)(2011-3#8)(2011-7#1)(2012-12#26)(2012-2#44)(2012-3#42)(2012-5#2)(2012-8#1)(2013-1#53)(2013-7#1)(2013-8#45)
rate) and##3##2##(1994-3#1)(2008-7#1)(2009-7#1)
rate) were##6##2##(2008-10#5)(2013-1#1)
rate)##25##1##(1991-8#1)(1994-3#1)(1996-3#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2011-1#1)(2013-1#1)
rate-equation##3##1##(2008-3#2)(2009-11#1)
rate-limiting chemical step in##2##4##(1991-9#2)
rate-limiting during##2##2##(1991-5#2)
rate-limiting enzyme in##3##3##(1991-9#1)(1994-11#1)(2008-5#1)
rate-limiting enzyme##5##2##(1991-9#1)(1994-11#1)(2008-11#1)(2008-5#1)(2010-12#1)
rate-limiting step##6##2##(1991-5#1)(1991-9#1)(1996-2#1)(2008-1#1)(2012-2#2)
rate-limiting##20##1##(1991-5#3)(1991-9#5)(1994-11#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#2)
rated as more##2##3##(2009-7#1)(2012-2#1)
rated as##9##2##(1993-2#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
rated by##5##2##(1991-2#1)(2008-10#1)(2008-12#1)(2012-2#2)
rated highest##2##2##(1993-2#1)(2011-2#1)
rated on a##2##3##(2010-12#1)(2012-3#1)
rated significantly higher than##2##4##(1993-2#2)
rated the overall##2##3##(2008-11#1)(2012-12#1)
rated the##7##2##(1993-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
rated##52##1##(1991-2#1)(1992-2#1)(1993-2#6)(1993-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-5#3)(2008-9#4)(2009-11#1)(2009-4#2)(2009-7#1)(2010-12#6)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
ratemeter##5##1##(1996-2#5)
rater##3##1##(2008-10#1)(2012-2#2)
raters##17##1##(1995-5#1)(2008-10#3)(2008-12#2)(2008-9#2)(2012-2#4)(2013-1#5)
rates (1##2##2##(2008-10#1)(2010-5#1)
rates 4##2##2##(1991-8#1)(2008-7#1)
rates across##2##2##(2008-8#1)(2012-3#1)
rates affect##2##2##(1994-3#1)(1995-3#1)
rates after##5##2##(1992-11#1)(2009-6#1)(2010-12#2)(2010-8#1)
rates allowed##2##2##(2008-10#1)(2008-7#1)
rates among##4##2##(1990-6#1)(1991-1#1)(1996-12#1)(2012-3#1)
rates and population##2##3##(2008-11#1)(2008-8#1)
rates and the##4##3##(1990-8#1)(1995-12#1)(2008-10#2)
rates and##63##2##(1990-8#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-8#1)(1995-12#3)(1996-3#3)(2008-10#12)(2008-11#13)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#8)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#3)
rates approaching##2##2##(2008-10#1)(2013-8#1)
rates are high##2##3##(2008-3#1)(2013-8#1)
rates are linear##2##3##(2008-10#1)(2012-3#1)
rates are##26##2##(1992-1#1)(1992-12#1)(1992-2#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
rates as high as##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
rates as##9##2##(1992-1#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-8#2)(2012-3#1)
rates at which##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
rates at##6##2##(1992-12#1)(1994-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
rates below##2##2##(2008-7#1)(2009-7#1)
rates between##7##2##(1991-12#1)(1996-2#1)(2008-1#2)(2008-10#2)(2013-1#1)
rates but##2##2##(1993-6#1)(2008-9#1)
rates by##4##2##(1993-12#1)(1996-12#1)(2008-10#2)
rates can be##2##3##(1992-6#1)(2010-12#1)
rates can##5##2##(1992-6#1)(2008-10#1)(2008-8#2)(2010-12#1)
rates comparable##2##2##(2008-6#1)(2013-8#1)
rates could be##2##3##(2008-7#1)(2012-12#1)
rates decreased##3##2##(2008-11#1)(2011-3#1)(2012-3#1)
rates depend on the##3##4##(2008-11#2)(2013-1#1)
rates due to##2##3##(2008-11#2)
rates during##3##2##(1992-2#1)(2008-12#1)(2010-7#1)
rates following##4##2##(1991-3#1)(2008-11#1)(2011-2#1)(2012-12#1)
rates for Medicare##2##3##(1992-1#1)(2012-3#1)
rates for a##2##3##(1991-2#1)(2008-8#1)
rates for patients with##2##4##(2010-11#1)(2012-3#1)
rates for the##5##3##(1993-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
rates for##33##2##(1991-2#2)(1992-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
rates from##10##2##(1996-12#1)(1997-7#1)(2008-10#3)(2008-12#2)(2009-7#1)(2010-6#1)(2011-2#1)
rates had##2##2##(2008-10#1)(2010-4#1)
rates have been##7##3##(1991-1#1)(1992-12#1)(1993-12#1)(2008-10#3)(2009-5#1)
rates have##12##2##(1991-1#1)(1991-2#1)(1992-12#1)(1993-12#1)(1997-8#1)(2008-10#3)(2008-9#1)(2009-5#2)(2012-3#1)
rates in New##2##3##(1996-3#1)(2008-8#1)
rates in a##3##3##(2008-11#1)(2008-8#1)(2010-11#1)
rates in the population##2##4##(1994-6#1)(2008-8#1)
rates in the##9##3##(1993-12#1)(1994-12#1)(1994-6#1)(2008-11#3)(2008-7#1)(2008-8#1)(2013-8#1)
rates in##41##2##(1990-2#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#8)(2008-7#1)(2008-8#6)(2010-11#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
rates increase##2##2##(1990-6#1)(2008-8#1)
rates increased##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
rates investigated##2##2##(2008-10#1)(2008-11#1)
rates is##3##2##(1991-1#1)(1992-12#1)(2008-9#1)
rates may be##2##3##(1994-3#1)(1996-12#1)
rates may##5##2##(1993-12#1)(1994-3#1)(1996-12#1)(2008-8#1)(2010-4#1)
rates occurred##2##2##(2008-11#1)(2013-1#1)
rates of 2##2##3##(2008-11#2)
rates of 8##2##3##(1991-12#1)(2008-10#1)
rates of 9##2##3##(2008-10#2)
rates of a##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)
rates of acquisition##2##3##(2008-10#1)(2008-5#1)
rates of all##2##3##(1997-4#1)(2008-7#1)
rates of change##3##3##(1992-12#2)(2009-7#1)
rates of dephosphorylation##2##3##(1996-2#2)
rates of different##2##3##(2008-11#1)(2008-7#1)
rates of dispersal##2##3##(2008-8#2)
rates of formation##2##3##(1993-6#1)(2008-10#1)
rates of heterotopic ossification##2##4##(2012-12#2)
rates of infection##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
rates of low##3##3##(1992-2#1)(1994-8#1)(2008-7#1)
rates of mortality##4##3##(2008-9#1)(2009-10#1)(2013-1#1)(2013-8#1)
rates of oxygen uptake and carbon dioxide evolution of animal cell##2##11##(2008-11#2)
rates of oxygen uptake and carbon dioxide evolution##3##8##(2008-11#3)
rates of population##2##3##(2008-9#1)(2010-8#1)
rates of re-bleeding and mortality in##2##6##(2013-1#2)
rates of recombination and##4##4##(2008-10#3)(2009-10#1)
rates of recombination##5##3##(2008-10#4)(2009-10#1)
rates of recurrence##2##3##(2012-2#1)(2013-1#1)
rates of response##2##3##(1993-6#2)
rates of schizotypal traits in##2##5##(2008-1#2)
rates of serious##2##3##(2008-11#1)(2011-2#1)
rates of the cell##2##4##(2008-11#2)
rates of the##17##3##(1990-8#1)(1995-3#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)
rates of their##2##3##(2008-10#2)
rates of these##2##3##(1995-6#1)(2008-2#1)
rates of total##2##3##(2009-3#1)(2013-1#1)
rates of up to##2##4##(2008-11#1)(2008-3#1)
rates of##281##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#2)(1992-2#2)(1992-4#1)(1993-1#2)(1993-3#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-1#4)(2008-10#70)(2008-11#36)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#10)(2008-8#19)(2008-9#13)(2009-10#4)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#5)(2011-7#1)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#14)(2013-8#6)
rates on##9##2##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)
rates or##3##2##(2008-7#1)(2009-7#1)(2011-2#1)
rates ranging from 0##2##4##(2008-10#1)(2009-7#1)
rates ranging from##3##3##(2008-10#1)(2009-7#2)
rates remained##2##2##(1996-3#1)(2008-11#1)
rates reported##4##2##(1991-3#1)(1993-12#1)(2013-8#2)
rates seen##2##2##(2008-11#1)(2013-1#1)
rates should be##3##3##(2008-10#1)(2008-9#2)
rates should##4##2##(2008-10#2)(2008-9#2)
rates showed##2##2##(1991-6#1)(2008-11#1)
rates than other##2##3##(2008-10#1)(2008-11#1)
rates than##10##2##(1991-8#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-6#2)(2009-7#1)(2012-12#1)(2012-7#1)
rates that are##3##3##(2013-8#3)
rates that were##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
rates that##11##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-8#4)
rates to those##3##3##(1991-3#1)(1992-2#1)(2008-8#1)
rates to##12##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-2#1)(2008-10#1)(2008-8#2)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
rates up to##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
rates was##2##2##(2012-12#1)(2013-8#1)
rates were analyzed##2##3##(2008-12#1)(2011-2#1)
rates were calculated and##2##4##(2008-11#1)(2013-8#1)
rates were calculated##4##3##(2008-11#3)(2013-8#1)
rates were determined##2##3##(2008-10#1)(2012-3#1)
rates were found##2##3##(1993-12#1)(1995-3#1)
rates were higher##2##3##(2008-11#1)(2013-8#1)
rates were not##2##3##(2008-11#1)(2011-2#1)
rates were observed in##2##4##(1990-8#1)(2013-8#1)
rates were observed##5##3##(1990-8#2)(2008-10#1)(2008-12#1)(2013-8#1)
rates were obtained##2##3##(2008-10#1)(2008-11#1)
rates were significantly lower##2##4##(2008-10#1)(2012-3#1)
rates were significantly##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
rates were##65##2##(1990-8#2)(1991-8#2)(1992-6#1)(1993-12#1)(1993-6#1)(1995-3#2)(1996-12#1)(2008-10#15)(2008-11#14)(2008-12#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#4)(2012-12#1)(2012-3#5)(2013-1#1)(2013-8#4)
rates with##9##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-3#1)
rates within##2##2##(2008-11#1)(2008-8#1)
rates without##2##2##(1997-6#1)(2008-8#1)
rates##1019##1##(1990-11#3)(1990-2#3)(1990-6#2)(1990-8#6)(1990-9#2)(1991-1#6)(1991-11#2)(1991-12#6)(1991-2#5)(1991-3#8)(1991-5#3)(1991-6#2)(1991-8#4)(1992-1#5)(1992-11#1)(1992-12#12)(1992-2#10)(1992-4#1)(1992-6#2)(1993-1#6)(1993-12#13)(1993-2#1)(1993-3#4)(1993-6#7)(1993-9#1)(1994-1#2)(1994-12#10)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#6)(1995-2#3)(1995-3#7)(1995-6#5)(1995-8#2)(1996-1#2)(1996-12#16)(1996-2#8)(1996-3#8)(1996-6#1)(1996-9#1)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-12#3)(2008-1#8)(2008-10#201)(2008-11#132)(2008-12#20)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#15)(2008-6#6)(2008-7#41)(2008-8#76)(2008-9#30)(2009-10#5)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#17)(2009-8#5)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#7)(2010-3#2)(2010-4#9)(2010-5#1)(2010-6#3)(2010-7#6)(2010-8#7)(2011-1#3)(2011-10#3)(2011-2#29)(2011-3#2)(2011-7#1)(2012-12#23)(2012-2#12)(2012-3#28)(2012-6#1)(2012-7#1)(2013-1#37)(2013-8#38)
ratesetting##5##1##(1991-2#2)(1993-12#2)(1994-2#1)
rather high##9##2##(1991-11#2)(2008-10#5)(2008-3#1)(2008-8#1)
rather it##2##2##(1994-11#1)(1996-3#1)
rather low##6##2##(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)
rather rare##2##2##(2008-5#1)(2008-9#1)
rather scarce##2##2##(1990-5#1)(2008-10#1)
rather similar##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
rather specific##2##2##(1994-11#1)(2008-7#1)
rather than a single##2##4##(2008-5#1)(2008-9#1)
rather than a specific##2##4##(2009-8#1)(2012-2#1)
rather than a##24##3##(1990-5#1)(1990-8#1)(1992-2#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
rather than an##6##3##(1993-8#1)(1997-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
rather than as a##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
rather than as an##4##4##(1996-3#1)(2008-7#1)(2013-1#2)
rather than as##7##3##(1990-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
rather than being##5##3##(1990-5#1)(1995-3#1)(2008-12#1)(2008-2#1)(2008-4#1)
rather than between##3##3##(2008-10#2)(2010-10#1)
rather than by##6##3##(1994-3#1)(1996-5#1)(2008-10#1)(2008-8#2)(2009-6#1)
rather than conventional##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
rather than for##2##3##(2008-9#1)(2013-8#1)
rather than from##3##3##(2008-10#2)(2008-9#1)
rather than improving##2##3##(1995-3#1)(2012-2#1)
rather than in the##2##4##(1995-3#1)(2013-1#1)
rather than in##8##3##(1993-8#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
rather than increase##2##3##(2008-10#1)(2013-1#1)
rather than just##4##3##(1990-9#1)(1994-2#1)(2008-11#1)(2009-8#1)
rather than making##2##3##(1995-12#1)(2008-9#1)
rather than on more##2##4##(1990-11#1)(2012-2#1)
rather than on the##2##4##(1993-2#1)(2011-2#1)
rather than on##5##3##(1990-11#1)(1991-11#1)(1993-2#1)(2011-2#1)(2012-2#1)
rather than only##2##3##(2009-8#1)(2010-11#1)
rather than pure##2##3##(2009-8#1)(2010-5#1)
rather than sexual##2##3##(2008-10#1)(2012-3#1)
rather than simply##2##3##(2008-10#1)(2008-11#1)
rather than solely##2##3##(1995-2#1)(2008-11#1)
rather than species-specific##2##3##(2007-12#1)(2008-10#1)
rather than specific##2##3##(1995-6#1)(2008-11#1)
rather than the number of##2##5##(1993-12#1)(2011-2#1)
rather than the traditional##2##4##(2008-10#2)
rather than the##40##3##(1990-11#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-7#3)(2011-2#1)(2012-12#1)
rather than their##2##3##(2008-10#1)(2008-11#1)
rather than those##2##3##(1993-3#1)(1994-1#1)
rather than to a##2##4##(1993-8#1)(2008-10#1)
rather than to##10##3##(1992-12#1)(1992-6#1)(1993-8#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#2)
rather than with##2##3##(2008-10#1)(2008-8#1)
rather than##293##2##(1990-11#3)(1990-12#1)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#3)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#4)(1994-1#5)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-3#3)(1997-7#3)(1997-8#2)(2007-12#1)(2008-10#56)(2008-11#18)(2008-12#5)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#13)(2008-9#9)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#6)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#12)(2012-3#2)(2013-1#8)(2013-8#3)
rather##411##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#6)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#2)(1992-9#2)(1993-12#4)(1993-2#3)(1993-3#5)(1993-6#3)(1993-8#5)(1994-1#6)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#3)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#2)(2007-12#2)(2008-10#82)(2008-11#23)(2008-12#8)(2008-2#3)(2008-3#13)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#17)(2008-9#15)(2009-10#3)(2009-11#2)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#14)(2012-12#3)(2012-2#16)(2012-3#4)(2013-1#13)(2013-8#6)
rating and##5##2##(1994-2#1)(2008-10#3)(2012-12#1)
rating categories##2##2##(2011-2#2)
rating for##2##2##(1991-12#1)(2008-10#1)
rating of##9##2##(1993-3#1)(2008-10#1)(2008-8#2)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
rating or##2##2##(2008-10#1)(2008-9#1)
rating scale##14##2##(1993-2#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2011-2#2)(2011-8#1)(2012-2#3)
rating scales##5##2##(2008-6#1)(2008-7#2)(2010-8#1)(2012-2#1)
rating system##2##2##(2011-2#2)
rating the##3##2##(2008-11#1)(2008-9#2)
rating were##2##2##(2008-10#2)
rating##70##1##(1991-12#1)(1992-1#3)(1993-2#1)(1993-3#2)(1994-2#1)(1997-3#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2010-1#1)(2010-8#1)(2011-2#6)(2011-8#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#1)
ratings and##4##2##(1991-3#1)(1994-2#1)(1997-3#1)(2013-8#1)
ratings in##5##2##(1990-5#1)(2008-10#4)
ratings of perceived exertion (RPE)##2##5##(2013-8#2)
ratings of perceived exertion##3##4##(2013-8#3)
ratings of the##6##3##(1991-6#1)(2008-10#2)(2008-4#1)(2009-7#1)(2012-2#1)
ratings of##22##2##(1991-3#2)(1991-6#1)(1993-5#1)(1994-3#2)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-7#2)(2011-2#1)(2012-2#2)(2013-8#3)
ratings were significantly##2##3##(2008-10#1)(2009-11#1)
ratings were##12##2##(2008-10#6)(2008-4#1)(2008-9#1)(2009-11#2)(2010-12#1)(2011-1#1)
ratings##74##1##(1990-5#1)(1991-3#5)(1991-6#1)(1992-2#2)(1993-5#1)(1994-2#1)(1994-3#2)(1997-3#2)(2008-10#26)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#2)(2009-7#2)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#4)(2013-8#5)
ratio &gt##5##2##(1992-9#2)(1994-3#1)(2008-10#2)
ratio (0##2##2##(1996-2#1)(2011-2#1)
ratio (OR)##4##2##(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
ratio (SNR) of##2##3##(2008-10#1)(2013-8#1)
ratio (SNR)##5##2##(2008-10#1)(2008-3#2)(2008-9#1)(2013-8#1)
ratio (r =##2##3##(2008-11#1)(2011-2#1)
ratio 0##4##2##(1994-6#2)(2010-6#1)(2012-3#1)
ratio 1##11##2##(2008-10#8)(2008-3#2)(2012-3#1)
ratio = 4##2##3##(2008-12#1)(2013-8#1)
ratio =##5##2##(2008-10#2)(2008-12#2)(2013-8#1)
ratio LOA##2##2##(2009-1#2)
ratio and a##2##3##(1991-12#1)(2008-10#1)
ratio and heavy metals##2##4##(2008-12#2)
ratio and heavy##3##3##(2008-12#3)
ratio and the##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
ratio and varied pH##3##4##(2008-10#3)
ratio and##33##2##(1991-12#1)(1994-6#1)(1995-8#1)(2007-12#1)(2008-10#11)(2008-12#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#2)
ratio are##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
ratio as a##2##3##(1991-12#1)(2008-3#1)
ratio as##4##2##(1991-12#1)(2007-12#1)(2008-3#1)(2013-7#1)
ratio at##3##2##(1993-8#1)(2008-10#2)
ratio between the##10##3##(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2012-12#1)
ratio between##18##2##(1995-11#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-6#1)(2012-12#1)(2012-3#2)
ratio can##2##2##(2008-2#1)(2008-8#1)
ratio could##2##2##(2008-8#1)(2012-12#1)
ratio data##2##2##(2008-10#2)
ratio decreased with##3##3##(2008-10#2)(2008-2#1)
ratio decreased##4##2##(2008-10#2)(2008-2#1)(2010-4#1)
ratio decreases##2##2##(2008-10#1)(2008-3#1)
ratio derivative polarography##2##3##(2008-10#2)
ratio derivative##3##2##(2008-10#3)
ratio for the##5##3##(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)
ratio for two##2##3##(2008-3#1)(2008-7#1)
ratio for##22##2##(1991-11#1)(1991-3#1)(1991-5#1)(1995-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2012-3#2)
ratio had##2##2##(2008-10#1)(2012-2#1)
ratio in the##5##3##(1990-5#1)(1991-11#1)(2008-10#2)(2008-8#1)
ratio in##19##2##(1990-5#1)(1991-11#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-8#2)(2009-12#1)(2010-1#2)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
ratio increased##2##2##(2010-4#1)(2011-2#1)
ratio index##2##2##(2008-12#2)
ratio influenced the##2##3##(1997-1#1)(2008-8#1)
ratio is not##2##3##(2008-10#1)(2008-11#1)
ratio is##16##2##(1992-5#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)
ratio measurements##2##2##(2008-10#2)
ratio method##4##2##(2008-10#4)
ratio obtained in##2##3##(1993-6#1)(2008-10#1)
ratio of 0##4##3##(2008-10#3)(2008-11#1)
ratio of 1##12##3##(1992-3#1)(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2013-1#1)
ratio of 10##2##3##(2008-10#2)
ratio of 100##2##3##(2008-10#2)
ratio of 2##2##3##(2008-10#2)
ratio of 3##11##3##(2008-10#10)(2008-3#1)
ratio of 5##3##3##(2008-10#2)(2008-3#1)
ratio of a##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
ratio of approximately 3##2##4##(1992-6#1)(2008-11#1)
ratio of approximately##4##3##(1992-6#1)(2008-11#1)(2008-2#1)(2008-3#1)
ratio of hapten##3##3##(2008-11#3)
ratio of male to female##2##5##(1993-9#1)(2011-2#1)
ratio of the CH(2)##2##4##(2008-10#2)
ratio of the ion##2##4##(2008-10#2)
ratio of the metal##2##4##(2008-10#2)
ratio of the number of##3##5##(1997-7#1)(2008-11#1)(2010-8#1)
ratio of the##46##3##(1991-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1996-2#1)(1997-7#1)(2008-10#24)(2008-11#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-8#2)
ratio of three##2##3##(2008-10#2)
ratio of unsaturated to##2##4##(1994-3#1)(2010-4#1)
ratio of##263##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#119)(2008-11#21)(2008-12#2)(2008-2#3)(2008-3#22)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
ratio on##3##2##(2008-10#3)
ratio or##3##2##(1994-9#1)(2008-5#1)(2010-1#1)
ratio profiles##3##2##(2008-3#3)
ratio represents a unique context for selection on attractive traits##2##10##(2008-8#2)
ratio showed##2##2##(1994-8#1)(2008-11#1)
ratio spectra derivative spectrophotometry##2##4##(2008-10#2)
ratio spectra##6##2##(2008-10#6)
ratio statistic##2##2##(2008-10#1)(2008-12#1)
ratio test is##2##3##(2008-10#1)(2008-11#1)
ratio test##5##2##(2008-10#4)(2008-11#1)
ratio than that of the##2##5##(2008-10#1)(2009-7#1)
ratio to##5##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
ratio values##5##2##(1990-8#1)(2008-10#4)
ratio was 0##2##3##(2008-10#1)(2008-8#1)
ratio was 6##2##3##(1991-11#1)(2008-7#1)
ratio was found to be##2##5##(1994-3#1)(2010-4#1)
ratio was found to##3##4##(1994-3#1)(2010-4#2)
ratio was found##4##3##(1994-3#1)(2008-10#1)(2010-4#2)
ratio was higher##2##3##(2008-10#1)(2011-2#1)
ratio was significantly##3##3##(1993-8#1)(2008-7#1)(2010-8#1)
ratio was##37##2##(1991-11#1)(1992-12#1)(1992-6#1)(1993-8#2)(1994-12#1)(1994-3#2)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
ratio were##8##2##(1990-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
ratio which##4##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
ratio with the##2##3##(2008-12#1)(2008-3#1)
ratio with##7##2##(2008-10#1)(2008-12#1)(2008-3#3)(2012-2#1)(2012-3#1)
ratio##821##1##(1990-12#2)(1990-5#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#6)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#3)(1991-8#2)(1992-12#8)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-9#5)(1993-12#1)(1993-2#1)(1993-6#4)(1993-8#6)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#1)(1996-5#1)(1997-1#3)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#5)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#314)(2008-11#43)(2008-12#22)(2008-2#13)(2008-3#72)(2008-4#3)(2008-5#21)(2008-6#3)(2008-7#15)(2008-8#32)(2008-9#15)(2009-1#4)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#26)(2011-3#3)(2012-12#11)(2012-2#8)(2012-3#17)(2013-1#8)(2013-7#1)(2013-8#10)
ratio'##2##1##(2008-10#2)
ratio) was##2##2##(1993-12#1)(2008-7#1)
ratio)##14##1##(1993-12#1)(1994-12#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
ratio=2) and the##3##3##(2008-10#3)
ratio=3)##3##1##(2008-10#3)
ratiometric##5##1##(2008-10#4)(2008-3#1)
ratiometry is##2##2##(2008-10#2)
ratiometry##9##1##(2008-10#9)
ration and##3##2##(2010-8#3)
ration##15##1##(2010-8#14)(2011-2#1)
rational and##4##2##(2008-10#1)(2008-9#1)(2010-10#2)
rational approach to the treatment of##2##6##(1996-3#1)(2008-7#1)
rational approach to the##3##4##(1996-3#1)(2008-7#1)(2011-2#1)
rational approach to##4##3##(1996-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
rational approach##5##2##(1996-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)
rational design of##2##3##(2008-10#1)(2011-2#1)
rational design##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
rational drug design##3##3##(1992-9#1)(2011-3#2)
rational for##2##2##(1997-6#1)(2011-2#1)
rational treatment##3##2##(1990-11#1)(1993-9#1)(1997-8#1)
rational##57##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-5#3)(1992-9#2)(1993-12#1)(1993-9#1)(1994-8#1)(1995-5#2)(1996-11#1)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#8)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-5#1)(2011-2#5)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
rationale and design##2##3##(2008-8#1)(2008-9#1)
rationale and##7##2##(1990-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-3#1)
rationale behind##5##2##(2008-12#2)(2008-3#1)(2008-9#1)(2011-2#1)
rationale for a##2##3##(2008-6#1)(2010-5#1)
rationale for the use of##2##5##(2008-10#1)(2008-11#1)
rationale for the##6##3##(1993-8#1)(1995-6#1)(2008-10#1)(2008-11#2)(2013-8#1)
rationale for using this##2##4##(2008-11#1)(2008-5#1)
rationale for using##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
rationale for##37##2##(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-8#2)(1994-2#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-7#1)(2013-1#1)(2013-8#1)
rationale is##3##2##(2008-8#1)(2008-9#1)(2009-7#1)
rationale##66##1##(1990-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-8#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#2)(2008-9#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
rationalisation of##2##2##(2008-1#1)(2013-1#1)
rationality##3##1##(2008-11#1)(2008-5#1)(2011-3#1)
rationalization##3##1##(1992-3#1)(1996-5#1)(2008-11#1)
rationalize the##3##2##(1996-5#1)(2008-11#1)(2008-7#1)
rationalize##4##1##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
rationalized by##2##2##(1994-5#1)(2008-12#1)
rationalized in terms of##2##4##(2008-10#2)
rationalized##5##1##(1994-5#1)(1994-8#1)(2008-10#2)(2008-12#1)
rationally designed##2##2##(1995-2#1)(1995-6#1)
rationally##5##1##(1993-12#1)(1995-2#1)(1995-6#1)(2008-4#1)(2008-5#1)
rationing in##2##2##(1992-2#1)(1996-8#1)
rationing##5##1##(1992-2#1)(1995-2#1)(1996-8#2)(2012-3#1)
rations##10##1##(2008-10#1)(2008-12#1)(2010-11#1)(2010-7#1)(2010-8#6)
ratios (1##2##2##(1996-2#1)(2008-10#1)
ratios among##3##2##(2008-10#2)(2009-4#1)
ratios and##15##2##(1991-12#1)(1993-11#1)(1995-9#1)(2008-10#5)(2008-5#2)(2008-8#1)(2011-2#4)
ratios are##6##2##(2008-10#4)(2008-3#2)
ratios as high as##2##4##(2008-10#2)
ratios as##4##2##(2008-10#3)(2008-11#1)
ratios at the##2##3##(1993-11#1)(2008-10#1)
ratios at##3##2##(1993-11#1)(2008-10#2)
ratios between##5##2##(1994-8#1)(2008-10#3)(2010-11#1)
ratios by##3##2##(2008-10#2)(2011-2#1)
ratios could##2##2##(1993-1#1)(2008-10#1)
ratios for##8##2##(1992-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
ratios from##2##2##(2008-10#1)(2008-3#1)
ratios has##2##2##(1997-2#1)(2008-10#1)
ratios in##15##2##(1993-5#1)(2008-10#7)(2008-8#1)(2010-7#1)(2010-8#2)(2011-2#2)(2013-1#1)
ratios of approximately##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
ratios of the##6##3##(1996-12#1)(2008-10#5)
ratios of##53##2##(1991-12#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-12#2)(1996-3#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-10#26)(2008-11#5)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#3)(2011-2#1)(2013-1#1)
ratios or##2##2##(2008-3#2)
ratios ranging from##2##3##(1994-5#1)(2008-3#1)
ratios that##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
ratios up to 1##2##4##(2008-10#2)
ratios up to##4##3##(2008-10#3)(2008-3#1)
ratios was##3##2##(2008-10#2)(2008-12#1)
ratios were significantly##4##3##(1994-8#1)(2008-10#2)(2008-7#1)
ratios were##23##2##(1992-1#2)(1993-11#1)(1994-8#1)(1996-12#3)(1996-2#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-2#1)
ratios##259##1##(1990-12#1)(1991-12#5)(1991-3#1)(1991-5#1)(1992-1#2)(1992-12#2)(1993-1#2)(1993-11#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-5#2)(1994-8#2)(1995-12#2)(1995-9#1)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#112)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#19)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#10)(2008-9#4)(2009-4#3)(2009-8#4)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#5)(2011-2#15)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#4)
rats (0##2##2##(1991-9#1)(1997-2#1)
rats (i##2##2##(1997-2#2)
rats (n =##4##3##(1993-6#1)(1993-8#1)(1997-8#1)(2008-11#1)
rats (p &lt##2##3##(1994-11#1)(2008-9#1)
rats after##10##2##(1991-12#1)(1992-3#1)(1993-8#1)(1994-8#2)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
rats aged##2##2##(1995-8#1)(2008-7#1)
rats and dogs##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
rats and mice##13##3##(1991-1#1)(1996-1#1)(2008-10#3)(2008-4#6)(2008-7#1)(2008-9#1)
rats and other##2##3##(1990-12#1)(2008-4#1)
rats and rabbits##3##3##(1990-11#3)
rats and that##2##3##(1991-2#1)(2010-1#1)
rats and##50##2##(1990-11#3)(1990-12#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-5#3)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-11#4)(1995-2#1)(1996-1#1)(1996-12#5)(1997-2#2)(2008-10#5)(2008-11#2)(2008-4#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
rats anesthetized with##2##3##(1997-2#1)(2008-10#1)
rats are##4##2##(1990-2#1)(1994-11#1)(1994-8#1)(2008-4#1)
rats as compared to##3##4##(1994-2#2)(2008-11#1)
rats as compared with##2##4##(1993-12#1)(2008-7#1)
rats as compared##5##3##(1993-12#1)(1994-2#2)(2008-11#1)(2008-7#1)
rats as##10##2##(1993-12#1)(1994-11#1)(1994-2#2)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
rats at any time##2##4##(1994-5#2)
rats at##11##2##(1990-2#1)(1993-12#1)(1994-5#3)(1996-2#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-6#2)
rats bearing##5##2##(1993-6#1)(1993-8#3)(1994-8#1)
rats but##5##2##(1994-2#2)(1995-12#1)(1997-1#1)(2008-7#1)
rats by##11##2##(1990-11#1)(1990-5#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-7#1)(2011-3#1)(2013-1#1)(2013-7#1)
rats can be##2##3##(2008-10#1)(2011-2#1)
rats chronically intoxicated with ethanol##2##5##(2009-8#2)
rats chronically##3##2##(1993-12#1)(2009-8#2)
rats compared with##3##3##(1994-8#1)(1995-11#1)(2008-7#1)
rats compared##4##2##(1994-8#1)(1995-11#1)(2008-7#1)(2011-2#1)
rats could##2##2##(2008-10#1)(2012-2#1)
rats decreased##3##2##(1995-12#1)(1995-8#1)(2008-8#1)
rats develop##2##2##(1993-6#1)(1995-12#1)
rats did not##4##3##(1991-9#1)(1992-12#1)(2008-10#1)(2008-7#1)
rats during##2##2##(1992-12#1)(2011-2#1)
rats every##2##2##(1994-2#1)(1995-12#1)
rats exposed to##5##3##(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#1)
rats fasted##2##2##(1994-8#1)(1995-11#1)
rats fed a diet##2##4##(1991-12#1)(1995-11#1)
rats fed vitamin E##3##4##(1994-5#3)
rats fed vitamin##4##3##(1993-12#1)(1994-5#3)
rats fed##13##2##(1991-12#1)(1993-12#3)(1994-5#3)(1995-11#1)(2008-11#2)(2011-2#1)(2013-1#2)
rats following##2##2##(1993-11#1)(1995-11#1)
rats for##4##2##(1990-5#1)(1995-8#1)(2008-10#1)(2008-11#1)
rats from##4##2##(1991-5#1)(1993-3#1)(2008-10#1)(2011-2#1)
rats given Ni3S2 +##2##4##(1994-5#2)
rats given##3##2##(1994-5#2)(2008-11#1)
rats had##3##2##(1993-8#2)(2008-7#1)
rats have##5##2##(1993-12#1)(1994-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
rats implanted with##2##3##(1997-2#1)(2008-8#1)
rats in the##5##3##(1990-5#1)(1991-5#1)(2011-2#3)
rats in##13##2##(1990-5#1)(1991-5#1)(1992-1#1)(1992-12#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#3)
rats injected with##2##3##(1993-11#1)(2008-11#1)
rats is##8##2##(1990-11#1)(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#2)(2010-1#1)(2013-8#1)
rats it##2##2##(2008-7#1)(2008-8#1)
rats may##3##2##(1992-1#1)(1992-12#1)(1996-2#1)
rats of both sexes##6##4##(1995-8#1)(2008-10#1)(2008-7#4)
rats of##9##2##(1993-3#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-7#4)
rats on day##2##3##(1993-12#1)(1994-2#1)
rats on the##2##3##(1997-3#1)(2008-11#1)
rats on##7##2##(1993-12#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-11#2)
rats only##3##2##(2008-10#2)(2012-2#1)
rats or##2##2##(1991-12#1)(1996-1#1)
rats orally##3##2##(2008-11#2)(2012-2#1)
rats pretreated with##3##3##(1993-12#1)(1995-12#2)
rats produce##2##2##(1993-6#1)(2008-10#1)
rats produced##3##2##(1994-2#1)(1996-12#1)(2012-2#1)
rats received##10##2##(1990-5#1)(1992-12#1)(1993-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
rats resulted in##2##3##(1993-12#1)(1995-2#1)
rats show##3##2##(1990-11#2)(1994-3#1)
rats showed a##3##3##(1993-3#2)(1997-2#1)
rats showed##6##2##(1993-3#2)(1994-2#2)(1994-8#1)(1997-2#1)
rats still##2##2##(1993-3#2)
rats subjected to porta-caval anastomosis##3##5##(1993-3#3)
rats subsequently##2##2##(1993-6#2)
rats suggests##2##2##(1994-11#1)(1997-2#1)
rats than in##2##3##(1993-12#2)
rats that had##2##3##(1992-1#1)(2008-11#1)
rats that inhaled oxygen-17 gas##2##5##(1990-5#2)
rats that received##2##3##(2008-10#1)(2012-2#1)
rats that##8##2##(1990-5#2)(1992-1#1)(1993-6#1)(2008-10#2)(2008-11#1)(2012-2#1)
rats the##5##2##(1990-11#1)(1994-2#2)(1994-8#1)(2008-7#1)
rats to##9##2##(1993-6#1)(1993-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2012-2#2)
rats treated with##9##3##(1990-12#1)(1994-5#2)(1995-12#1)(1997-1#1)(2008-10#2)(2011-2#1)(2012-2#1)
rats treated##10##2##(1990-12#1)(1994-5#2)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2011-2#1)(2012-2#1)
rats under##2##2##(1991-5#1)(1993-6#1)
rats using##5##2##(1994-2#1)(1995-8#1)(2008-10#1)(2008-4#1)(2009-11#1)
rats was studied##3##3##(1995-12#1)(1996-2#1)(2008-8#1)
rats was##12##2##(1990-11#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)
rats were administered##2##3##(2008-10#2)
rats were also##2##3##(1994-5#1)(2008-10#1)
rats were divided into##3##4##(2008-12#1)(2008-7#1)(2011-2#1)
rats were fed##3##3##(1993-11#1)(1996-12#1)(2013-1#1)
rats were given drinking water containing 0##2##7##(2008-10#2)
rats were given##6##3##(1993-3#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-9#1)
rats were injected##2##3##(2008-11#1)(2011-2#1)
rats were intratracheally##2##3##(2008-10#2)
rats were investigated##4##3##(1990-11#1)(1993-8#1)(1994-5#1)(1996-2#1)
rats were randomly divided into five groups##2##7##(2010-1#1)(2011-3#1)
rats were randomly divided into##3##5##(2010-1#1)(2011-2#1)(2011-3#1)
rats were studied##2##3##(1990-5#1)(2012-2#1)
rats were subjected to##3##4##(1993-3#1)(1997-2#1)(2008-11#1)
rats were tested##3##3##(1993-3#1)(2008-11#1)(2011-2#1)
rats were trained##2##3##(1992-12#1)(1997-2#1)
rats were treated##5##3##(1993-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
rats were used##2##3##(1993-3#1)(2008-7#1)
rats were##67##2##(1990-11#1)(1990-5#2)(1991-2#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#6)(1993-8#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#3)(1996-2#1)(1997-2#3)(1997-4#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-7#4)(2008-9#1)(2009-8#2)(2010-1#1)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#2)
rats which##3##2##(1993-12#1)(1994-8#1)(2011-2#1)
rats with a##3##3##(1993-2#1)(1993-3#2)
rats with an##2##3##(1997-2#1)(2008-8#1)
rats with myocardial infarction##2##4##(1996-2#2)
rats with nephrotic syndrome##2##4##(2009-6#2)
rats with##39##2##(1990-12#1)(1990-5#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#3)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#2)(2008-11#3)(2008-8#2)(2009-6#3)(2009-8#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-1#5)(2013-8#3)
rats without##2##2##(1993-2#1)(2011-2#1)
rats##921##1##(1990-11#15)(1990-12#3)(1990-2#3)(1990-3#6)(1990-5#13)(1990-6#4)(1991-1#1)(1991-10#1)(1991-12#8)(1991-2#8)(1991-5#12)(1991-6#3)(1991-9#2)(1992-1#4)(1992-12#23)(1992-3#8)(1992-6#4)(1992-8#4)(1992-9#4)(1993-11#5)(1993-12#29)(1993-2#3)(1993-3#29)(1993-6#18)(1993-8#16)(1994-11#11)(1994-12#4)(1994-2#39)(1994-3#4)(1994-5#31)(1994-8#36)(1995-11#18)(1995-12#20)(1995-2#8)(1995-6#2)(1995-8#9)(1996-1#2)(1996-12#27)(1996-2#17)(1996-3#2)(1996-5#2)(1997-1#5)(1997-2#33)(1997-3#1)(1997-4#5)(1997-6#1)(1997-8#1)(2008-10#81)(2008-11#59)(2008-12#21)(2008-4#15)(2008-5#7)(2008-6#1)(2008-7#55)(2008-8#15)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#6)(2009-8#10)(2010-1#6)(2010-12#1)(2010-2#2)(2010-6#2)(2010-7#3)(2011-2#35)(2011-3#9)(2012-12#1)(2012-2#25)(2012-3#5)(2013-1#28)(2013-7#11)(2013-8#9)
rats' skin##6##2##(2011-3#6)
rats'##9##1##(1994-8#1)(2010-12#1)(2011-3#7)
rats)##3##1##(1994-8#1)(2008-11#2)
rats]##17##1##(2010-12#9)(2011-3#1)(2012-3#1)(2013-8#6)
raw IR##2##2##(2008-10#2)
raw and cooked##3##3##(2010-4#3)
raw and pasteurized##2##3##(2008-12#2)
raw and##10##2##(2008-10#2)(2008-12#4)(2010-4#4)
raw beef patties##3##3##(2010-4#3)
raw data##6##2##(2008-10#3)(2008-8#1)(2011-7#1)(2012-12#1)
raw material and from##2##4##(2008-10#2)
raw material and##5##3##(2008-10#5)
raw material for the##2##4##(2008-10#1)(2008-5#1)
raw material for##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
raw material##20##2##(1997-2#1)(2008-10#10)(2008-4#1)(2008-5#3)(2011-2#2)(2013-1#3)
raw materials and##5##3##(2008-10#2)(2008-11#1)(2008-5#2)
raw materials used for the##2##5##(2008-10#2)
raw materials used##3##3##(2008-10#3)
raw materials with##2##3##(2008-10#1)(2008-11#1)
raw materials##24##2##(1994-3#3)(2008-10#12)(2008-11#4)(2008-5#3)(2009-11#1)(2011-2#1)
raw milk##5##2##(2008-10#5)
raw pork meat##2##3##(2010-4#2)
raw seeds##2##2##(2011-2#2)
raw water##2##2##(1992-5#1)(2008-10#1)
raw##104##1##(1992-5#1)(1994-3#3)(1997-2#1)(2007-12#1)(2008-10#48)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2009-10#1)(2009-11#1)(2010-4#12)(2010-8#1)(2011-2#11)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#4)
ray and##2##2##(2008-10#1)(2008-3#1)
ray optics##3##2##(2008-3#3)
ray tracing##2##2##(2008-3#2)
ray##20##1##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#11)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
ray-optics##4##1##(2008-3#4)
ray-tracing simulations##2##2##(2008-3#2)
ray-tracing technique##2##2##(2008-3#2)
ray-tracing##10##1##(2008-3#10)
rays##18##1##(1993-9#1)(1994-12#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
razor##2##1##(2008-5#2)
rbcS genes##3##2##(1993-12#3)
rbcS##4##1##(1993-12#4)
rbsA##2##1##(2011-1#2)
rdo##5##1##(2008-9#5)
re##7##1##(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(2008-1#1)(2010-7#1)(2013-8#1)
re-addition of serum##2##3##(1996-2#2)
re-assessed##2##1##(2008-10#1)(2011-1#1)
re-bleeding##4##1##(2013-1#4)
re-calibration##2##1##(2008-10#2)
re-emergence of##2##2##(2011-2#1)(2013-1#1)
re-engagement##6##1##(2010-2#6)
re-engineered##2##1##(1996-1#1)(1996-2#1)
re-engineering##2##1##(1995-2#1)(2008-11#1)
re-entry##3##1##(2008-11#3)
re-established##6##1##(1994-3#2)(1997-5#1)(2012-2#1)(2012-4#1)(2013-1#1)
re-establishment of##2##2##(2008-11#1)(2013-1#1)
re-establishment##4##1##(2008-1#1)(2008-11#1)(2012-12#1)(2013-1#1)
re-evaluated##6##1##(2008-10#2)(2008-11#1)(2008-12#1)(2010-2#1)(2012-2#1)
re-evaluation of the##3##3##(1993-11#1)(1993-2#1)(2013-8#1)
re-evaluation of##4##2##(1993-11#1)(1993-2#1)(2013-1#1)(2013-8#1)
re-evaluation##6##1##(1993-11#1)(1993-2#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
re-exacerbation##3##1##(2011-2#3)
re-examination of##2##2##(1991-2#1)(2008-11#1)
re-examination##5##1##(1991-2#2)(1991-8#1)(2008-11#1)(2008-12#1)
re-examined##5##1##(1991-8#1)(1991-9#1)(1995-12#1)(2008-10#1)(2008-11#1)
re-exploration##2##1##(1991-3#1)(2008-7#1)
re-growth##2##1##(2012-2#1)(2013-7#1)
re-implantation##3##1##(2008-10#2)(2013-1#1)
re-infarction or death##2##3##(2009-6#2)
re-infarction##5##1##(2009-6#5)
re-initiates DNA replication##2##3##(1997-6#2)
re-initiation of##2##2##(1997-6#1)(2012-12#1)
re-initiation##3##1##(1997-6#2)(2012-12#1)
re-integration##2##1##(2008-10#2)
re-introduction of##2##2##(2008-8#1)(2011-2#1)
re-occurrence of##2##2##(2008-10#1)(2008-8#1)
re-operation##2##1##(1991-3#1)(2011-2#1)
re-oxidation of the##2##3##(2008-10#2)
re-oxidation of##3##2##(2008-10#3)
re-oxidation##4##1##(2008-10#3)(2008-5#1)
re-treatment##3##1##(1991-3#1)(2011-2#1)(2013-1#1)
re-uptake##3##1##(1996-12#2)(2012-3#1)
re-used rockwool##2##2##(2008-10#2)
re-used##3##1##(2008-10#3)
re-virus##4##1##(1993-6#4)
reabsorption##5##1##(1997-8#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
reach a plateau##2##3##(2008-10#2)
reach a##12##2##(1993-1#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2012-3#1)
reach considerable##2##2##(2011-2#1)(2013-1#1)
reach out to##2##3##(2010-8#1)(2011-2#1)
reach out##3##2##(1997-2#1)(2010-8#1)(2011-2#1)
reach the##25##2##(1990-12#1)(1990-5#1)(1991-2#1)(1995-11#1)(1996-1#1)(1997-1#1)(1997-3#2)(1997-6#1)(2008-10#10)(2008-11#1)(2008-2#1)(2009-10#1)(2011-2#2)(2012-2#1)
reach their peak##2##3##(2008-10#1)(2008-5#1)
reach their##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
reach##125##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#3)(1992-3#1)(1993-1#1)(1993-3#2)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#2)(2008-1#1)(2008-10#40)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-8#5)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
reached 0##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
reached 100%##2##2##(2008-10#1)(2013-1#1)
reached 5##2##2##(2008-8#1)(2010-12#1)
reached a maximal level##2##4##(1997-7#1)(2008-10#1)
reached a maximal##4##3##(1995-3#1)(1997-7#1)(2008-10#1)(2008-8#1)
reached a maximum 1##2##4##(2008-10#2)
reached a maximum at##2##4##(1993-8#1)(2013-1#1)
reached a maximum cell##2##4##(2008-11#2)
reached a maximum in##2##4##(1997-8#1)(2008-10#1)
reached a maximum##13##3##(1993-8#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#3)(2012-2#1)(2013-1#1)(2013-8#1)
reached a mean##2##3##(1990-6#1)(2008-7#1)
reached a peak##2##3##(2008-10#1)(2008-11#1)
reached a plateau##4##3##(1990-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
reached a##34##2##(1990-12#1)(1990-6#1)(1991-3#1)(1993-8#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#8)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
reached about##2##2##(2008-10#1)(2008-7#1)
reached after##4##2##(1995-12#1)(2008-10#2)(2008-5#1)
reached an##3##2##(2008-10#2)(2012-2#1)
reached and##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
reached as##3##2##(1994-6#1)(1995-2#1)(2013-8#1)
reached at##3##2##(2008-10#2)(2008-11#1)
reached by##8##2##(1990-6#1)(2008-10#4)(2008-3#1)(2011-2#1)(2013-8#1)
reached confluence##2##2##(2008-11#2)
reached for the##2##3##(2008-10#2)
reached for##5##2##(2008-10#4)(2008-3#1)
reached in##10##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-1#2)(2011-2#1)(2012-12#1)
reached its maximum after##2##4##(2008-10#2)
reached its##4##2##(1991-5#1)(2008-10#2)(2009-8#1)
reached the highest##2##3##(2008-10#1)(2008-11#1)
reached the maximum##2##3##(2008-9#2)
reached the recommended levels##2##4##(2011-2#2)
reached the##22##2##(1991-2#1)(1991-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#3)(2010-1#1)(2010-12#1)(2011-2#2)(2012-3#1)
reached their##2##2##(2008-10#1)(2012-3#1)
reached three##2##2##(1990-12#1)(2008-11#1)
reached to##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
reached using##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
reached when##2##2##(2008-5#1)(2008-8#1)
reached with##3##2##(1990-12#1)(2008-10#2)
reached##212##1##(1990-12#3)(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-8#2)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#1)(2007-8#3)(2008-10#71)(2008-11#28)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#5)(2009-12#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#3)
reaches a maximum##3##3##(1991-5#1)(2008-10#1)(2008-8#1)
reaches a##8##2##(1991-5#1)(1996-11#1)(2007-11#1)(2008-10#3)(2008-8#1)(2012-2#1)
reaches the peak##2##3##(2008-9#2)
reaches the##7##2##(1997-1#1)(2008-10#1)(2008-5#2)(2008-9#2)(2009-5#1)
reaches##30##1##(1991-5#1)(1993-11#1)(1993-8#1)(1996-11#1)(1997-1#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
reaching a maximum##3##3##(1995-2#1)(1997-1#1)(2008-10#1)
reaching a##9##2##(1990-9#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
reaching an##2##2##(2008-11#1)(2011-2#1)
reaching and##4##2##(1996-2#1)(2012-2#2)(2013-1#1)
reaching equilibrium##2##2##(2008-10#1)(2012-2#1)
reaching target##2##2##(1991-6#2)
reaching the liver##2##3##(1994-5#2)
reaching the lowest level##2##4##(2008-10#1)(2013-1#1)
reaching the same##2##3##(2008-10#1)(2008-5#1)
reaching the##16##2##(1994-5#2)(1997-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#3)(2013-1#1)
reaching their##2##2##(2010-12#1)(2012-2#1)
reaching work area##2##3##(2010-7#2)
reaching##68##1##(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-2#1)(1996-2#2)(1997-1#1)(1997-2#3)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#7)(2013-1#4)
reacquisition##4##1##(1994-8#1)(2007-12#1)(2008-5#2)
react against##2##2##(1990-8#1)(2013-7#1)
react at##2##2##(2008-10#2)
react more##4##2##(1996-11#1)(1997-8#2)(2008-10#1)
react to##4##2##(1993-3#1)(1995-6#1)(2011-1#1)(2011-2#1)
react with common##2##3##(2008-10#2)
react with the##10##3##(1990-5#1)(1990-8#1)(1995-2#1)(2006-6#1)(2008-10#4)(2008-7#1)(2008-8#1)
react with##65##2##(1990-5#1)(1990-8#1)(1992-6#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-7#1)(2006-6#1)(2008-10#42)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
react##90##1##(1990-5#1)(1990-8#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-12#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-10#50)(2008-11#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-7#1)
reactant and##2##2##(1996-5#1)(2008-10#1)
reactant ion chemistry##3##3##(2008-10#3)
reactant ion##6##2##(2008-10#6)
reactant ions and##2##3##(2008-10#2)
reactant ions##6##2##(2008-10#6)
reactant##20##1##(1996-5#1)(2008-10#14)(2013-8#5)
reactants and##2##2##(2008-10#1)(2013-8#1)
reactants are##3##2##(1990-5#1)(2008-10#2)
reactants were##2##2##(1995-6#1)(2008-10#1)
reactants##14##1##(1990-5#1)(1995-6#1)(1996-5#1)(2008-10#8)(2008-11#1)(2013-8#2)
reactants)##2##1##(2008-10#2)
reacted in##2##2##(1995-12#1)(2010-8#1)
reacted on##3##2##(1992-2#1)(1995-6#1)(2008-10#1)
reacted positively##3##2##(1990-3#1)(2008-10#2)
reacted specifically with##2##3##(2008-10#2)
reacted subsequently with##2##3##(2008-10#2)
reacted to##4##2##(1990-3#1)(1992-1#1)(2008-10#1)(2008-11#1)
reacted with a##7##3##(1996-5#1)(2008-10#5)(2008-5#1)
reacted with anti-A beta##3##4##(1995-12#3)
reacted with antibodies##2##3##(1993-6#1)(2008-5#1)
reacted with hydrazine##2##3##(2008-10#1)(2008-11#1)
reacted with iodide##2##3##(2008-10#2)
reacted with the##11##3##(2008-10#8)(2008-11#2)(2008-5#1)
reacted with##66##2##(1990-5#1)(1991-1#1)(1991-5#1)(1992-6#2)(1993-6#2)(1994-11#1)(1995-12#3)(1995-6#1)(1996-12#1)(1996-5#3)(2006-6#1)(2008-10#37)(2008-11#7)(2008-12#1)(2008-5#3)(2012-12#1)
reacted##104##1##(1990-3#2)(1990-5#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-6#2)(1993-6#2)(1994-11#1)(1994-3#1)(1995-12#5)(1995-6#2)(1996-12#1)(1996-5#3)(2006-6#1)(2008-10#58)(2008-11#10)(2008-12#1)(2008-5#3)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)
reacting material##2##2##(1997-8#1)(2008-10#1)
reacting to##4##2##(1991-1#1)(1993-12#1)(2008-11#1)(2008-8#1)
reacting with##14##2##(1990-12#2)(1990-8#1)(1991-2#1)(1997-2#1)(2008-10#5)(2008-5#2)(2008-8#1)(2011-2#1)
reacting##30##1##(1990-12#2)(1990-8#1)(1991-1#1)(1991-2#1)(1993-12#1)(1997-2#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-5#2)(2008-8#3)(2010-4#1)(2011-2#1)(2013-8#1)
reaction (2)##2##2##(2008-10#2)
reaction a##2##2##(1991-6#1)(2008-10#1)
reaction after##3##2##(1997-8#1)(2008-10#2)
reaction alone##2##2##(2008-10#2)
reaction and a##3##3##(2008-10#2)(2008-5#1)
reaction and chemiluminescence detection##2##4##(2008-10#2)
reaction and chemiluminescence##3##3##(2008-10#3)
reaction and the##7##3##(1990-12#1)(1992-3#1)(1995-11#1)(2008-10#3)(2011-2#1)
reaction and##68##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-2#2)(1996-5#1)(2008-10#40)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#4)(2011-2#3)(2013-1#2)
reaction are##6##2##(2008-10#3)(2008-7#1)(2009-10#1)(2010-6#1)
reaction as##3##2##(2008-10#3)
reaction at low pH##2##4##(1993-8#1)(2010-4#1)
reaction at the##4##3##(1990-6#1)(1996-5#1)(2008-10#2)
reaction at##12##2##(1990-6#1)(1993-8#2)(1996-5#1)(2008-10#6)(2010-4#1)(2012-3#1)
reaction before##2##2##(2008-8#1)(2013-1#1)
reaction between 1##2##3##(2008-10#1)(2010-7#1)
reaction between a##2##3##(2008-10#2)
reaction between ascorbic acid and##2##5##(2008-10#2)
reaction between hydrogen peroxide and##2##5##(2008-10#2)
reaction between hydrogen peroxide##3##4##(2008-10#3)
reaction between iron(III)##2##3##(2008-10#2)
reaction between luminol and periodate##2##5##(2008-10#2)
reaction between luminol and##5##4##(2008-10#5)
reaction between luminol##6##3##(2008-10#6)
reaction between nitrite##2##3##(2008-10#2)
reaction between tetrabutylammonium periodate and phenothiazine in##2##7##(2008-10#2)
reaction between the##11##3##(2008-10#11)
reaction between##93##2##(1990-5#1)(1991-12#1)(1996-5#1)(2008-10#85)(2008-12#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
reaction by##6##2##(1992-1#1)(1997-8#1)(2008-10#3)(2008-9#1)
reaction can be##4##3##(1996-5#1)(2008-10#3)
reaction can complete##2##3##(2008-10#2)
reaction can##7##2##(1996-5#1)(1997-7#1)(2008-10#5)
reaction catalyzed by##4##3##(1992-3#1)(1995-6#1)(2008-10#2)
reaction cell and##3##3##(2008-10#3)
reaction cell##7##2##(2008-10#7)
reaction center associated##2##3##(1993-8#2)
reaction center##6##2##(1993-8#3)(2008-8#3)
reaction centers from Rhodobacter sphaeroides RS601##2##6##(2008-9#2)
reaction centers was##2##3##(2008-8#1)(2008-9#1)
reaction centers##9##2##(2008-10#1)(2008-8#2)(2008-9#6)
reaction coil and##2##3##(2008-10#2)
reaction coil length##3##3##(2008-10#3)
reaction coil to##3##3##(2008-10#3)
reaction coil was##3##3##(2008-10#3)
reaction coil##20##2##(2008-10#20)
reaction coils##2##2##(2008-10#2)
reaction components##2##2##(2008-10#2)
reaction conditions and##5##3##(2008-10#5)
reaction conditions are##2##3##(2008-10#2)
reaction conditions for##2##3##(2008-10#1)(2011-1#1)
reaction conditions were##8##3##(2008-10#6)(2009-12#1)(2013-8#1)
reaction conditions with##2##3##(1996-5#1)(2008-10#1)
reaction conditions##39##2##(1992-12#1)(1996-2#1)(1996-5#2)(2008-10#27)(2008-4#2)(2008-5#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
reaction developed##2##2##(2008-10#1)(2008-7#1)
reaction equilibrium##2##2##(2008-10#1)(2008-9#1)
reaction events##3##2##(1995-6#3)
reaction field##3##2##(2008-10#2)(2013-1#1)
reaction followed##2##2##(1993-3#1)(2008-10#1)
reaction for the determination of##2##5##(2008-10#2)
reaction for the##8##3##(1996-11#1)(2008-10#4)(2008-4#1)(2010-4#1)(2013-8#1)
reaction for##15##2##(1996-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2010-4#1)(2013-8#1)
reaction forces##2##2##(2010-9#1)(2013-1#1)
reaction from the##2##3##(1995-12#1)(2008-4#1)
reaction from##8##2##(1994-11#1)(1995-12#1)(2008-10#5)(2008-4#1)
reaction has been proposed##2##4##(2008-10#1)(2008-8#1)
reaction has been##6##3##(1995-6#1)(2008-10#4)(2008-8#1)
reaction has##8##2##(1995-6#1)(2008-10#6)(2008-8#1)
reaction in a##2##3##(1997-7#1)(2008-10#1)
reaction in all##2##3##(1990-8#1)(2008-8#1)
reaction in the##7##3##(2008-10#5)(2008-5#1)(2009-6#1)
reaction in##39##2##(1990-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1996-3#1)(1997-7#1)(2008-10#18)(2008-5#1)(2008-8#4)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#7)
reaction induced by##3##3##(2008-3#1)(2008-8#2)
reaction induces##2##2##(2008-4#1)(2008-5#1)
reaction interface##5##2##(2008-10#5)
reaction involving##2##2##(2008-10#2)
reaction is a##5##3##(1996-5#1)(2008-10#3)(2008-8#1)
reaction is also##2##3##(2008-10#2)
reaction is monitored spectrophotometrically by measuring the decrease in##2##9##(2008-10#2)
reaction is monitored spectrophotometrically##3##4##(2008-10#3)
reaction is monitored##4##3##(2008-10#4)
reaction is not##2##3##(1990-6#1)(2008-10#1)
reaction is proposed##3##3##(2008-10#3)
reaction is##57##2##(1990-6#2)(1990-8#1)(1991-9#1)(1992-1#1)(1994-5#1)(1995-6#1)(1996-5#3)(1997-7#1)(2008-10#39)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
reaction kinetics##8##2##(1990-5#1)(1995-3#1)(2008-10#4)(2010-4#1)(2013-1#1)
reaction mechanism in##2##3##(2008-10#1)(2009-11#1)
reaction mechanism is##3##3##(2008-10#2)(2008-12#1)
reaction mechanism of the##2##4##(1995-3#1)(2008-10#1)
reaction mechanism of##3##3##(1995-3#1)(1995-6#1)(2008-10#1)
reaction mechanism was##3##3##(2008-10#3)
reaction mechanism##19##2##(1995-3#1)(1995-6#1)(2008-10#13)(2008-11#1)(2008-12#2)(2009-11#1)
reaction mechanisms##4##2##(2008-10#4)
reaction medium##18##2##(1996-5#1)(2008-10#14)(2008-7#3)
reaction method##3##2##(1997-8#1)(2008-10#2)
reaction mixture##9##2##(1994-5#1)(2008-10#5)(2008-5#1)(2008-8#1)(2010-4#1)
reaction mixtures##5##2##(1992-3#1)(2008-10#3)(2008-7#1)
reaction monitoring##8##2##(2008-10#6)(2011-3#2)
reaction norm##3##2##(2008-10#1)(2008-8#2)
reaction norms for##2##3##(2008-8#2)
reaction norms##7##2##(2008-8#7)
reaction occurs##3##2##(2008-10#2)(2008-7#1)
reaction of 4 with##2##4##(1996-5#2)
reaction of 5 with##2##4##(1996-5#2)
reaction of 5##4##3##(1996-5#3)(2008-10#1)
reaction of Cr(VI) with##2##4##(2008-10#2)
reaction of Cu(II) with##5##4##(2008-10#5)
reaction of HRP with hydrogen peroxide and p-iodophenol##2##8##(2008-10#2)
reaction of HRP##3##3##(2008-10#3)
reaction of a##3##3##(2008-10#2)(2009-8#1)
reaction of aromatic##2##3##(2008-10#1)(2012-3#1)
reaction of ascorbic acid##2##4##(2008-10#2)
reaction of bilirubin##2##3##(2008-10#2)
reaction of cobalt(II)##2##3##(2008-10#2)
reaction of l-cysteine with##2##4##(2008-10#2)
reaction of luminol with hydrogen peroxide##3##6##(2008-10#3)
reaction of luminol with##7##4##(2008-10#7)
reaction of methyl##2##3##(1996-5#1)(2008-10#1)
reaction of metoclopramide##2##3##(2008-10#2)
reaction of silver##2##3##(2008-10#2)
reaction of sulfide with##2##4##(2008-10#2)
reaction of sulfide##3##3##(2008-10#3)
reaction of the analyte with##2##5##(2008-10#2)
reaction of the produced##2##4##(2008-10#2)
reaction of the##30##3##(1991-5#1)(1994-5#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-10#20)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)
reaction of this##3##3##(2008-10#3)
reaction of##243##2##(1991-5#1)(1991-9#2)(1993-3#1)(1993-6#2)(1994-5#5)(1995-6#1)(1995-9#1)(1996-5#19)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2008-10#187)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#2)(2011-2#2)(2012-3#3)
reaction on tobacco##2##3##(2008-10#2)
reaction on##5##2##(1994-11#1)(2008-10#4)
reaction or##3##2##(1991-9#1)(1993-3#1)(2008-10#1)
reaction pathway##3##2##(1991-9#1)(2008-10#2)
reaction pattern##2##2##(1996-5#1)(2008-10#1)
reaction proceeds##2##2##(1996-5#1)(2008-10#1)
reaction process##3##2##(2008-10#2)(2008-2#1)
reaction product is##3##3##(2008-10#3)
reaction product##14##2##(1992-3#1)(1995-12#1)(2008-10#12)
reaction products by##2##3##(1992-6#1)(2008-4#1)
reaction products of##2##3##(2008-10#2)
reaction products were##3##3##(1994-8#1)(2008-11#2)
reaction products##17##2##(1992-6#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-5#1)(2008-10#6)(2008-11#3)(2008-4#2)(2008-7#1)
reaction profiles##3##2##(2008-10#3)
reaction progress##2##2##(1994-5#1)(2008-10#1)
reaction rate and##2##3##(2008-10#2)
reaction rate constant##3##3##(2008-10#2)(2008-8#1)
reaction rate of##2##3##(2008-10#2)
reaction rate was##3##3##(2008-10#3)
reaction rate##18##2##(2008-10#13)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
reaction rates##8##2##(2008-10#3)(2008-7#4)(2008-9#1)
reaction scheme##2##2##(1993-6#1)(1997-2#1)
reaction sequence##4##2##(1996-5#3)(2008-10#1)
reaction solution##3##2##(2008-10#2)(2013-8#1)
reaction step##2##2##(2008-10#2)
reaction system was##2##3##(2008-10#2)
reaction system##17##2##(2008-10#14)(2008-7#1)(2009-8#1)(2011-1#1)
reaction systems##2##2##(1992-3#1)(2008-10#1)
reaction taking place##2##3##(2008-11#1)(2008-8#1)
reaction temperature and##4##3##(2008-10#3)(2011-2#1)
reaction temperature##7##2##(2008-10#5)(2011-2#2)
reaction that##7##2##(1993-2#1)(2008-10#2)(2008-4#1)(2009-3#1)(2009-6#1)(2012-2#1)
reaction the K(m) for the##2##5##(2008-7#2)
reaction the##3##2##(2008-10#1)(2008-7#2)
reaction time (RT)##3##3##(2008-11#1)(2008-7#1)(2010-1#1)
reaction time and##6##3##(2008-10#6)
reaction time of##4##3##(1996-2#1)(2008-10#2)(2008-6#1)
reaction time##33##2##(1991-6#1)(1996-2#1)(1996-5#2)(2008-10#20)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#2)(2011-2#1)
reaction time)##2##2##(2008-10#2)
reaction times##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)
reaction to P##2##3##(2008-10#2)
reaction to isolates##2##3##(2008-10#2)
reaction to the##6##3##(1991-1#1)(1993-6#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
reaction to tuberculin##2##3##(1990-6#2)
reaction to##42##2##(1990-6#2)(1990-7#1)(1991-1#1)(1991-12#1)(1992-4#1)(1993-6#1)(1994-1#1)(1994-12#1)(1996-12#2)(1996-6#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-7#1)
reaction types##2##2##(2010-10#2)
reaction using the analyte pulse perturbation technique##2##7##(2008-10#2)
reaction using##19##2##(1992-6#1)(1993-2#1)(1994-11#1)(1997-7#1)(2008-10#10)(2008-7#2)(2010-6#1)(2012-12#1)(2012-2#1)
reaction vessel##3##2##(2008-10#2)(2008-7#1)
reaction was also discussed##3##4##(2008-10#3)
reaction was also##5##3##(2008-10#5)
reaction was applied to the##2##5##(2008-10#2)
reaction was applied to##3##4##(2008-10#3)
reaction was carried out using##2##5##(1991-5#1)(2008-10#1)
reaction was carried out##4##4##(1991-5#1)(2008-10#2)(2008-7#1)
reaction was developed##2##3##(2008-10#2)
reaction was examined##2##3##(1992-6#1)(1996-12#1)
reaction was first##2##3##(1995-6#1)(2008-10#1)
reaction was found to##2##4##(2008-10#2)
reaction was found##3##3##(1993-6#1)(2008-10#2)
reaction was investigated##3##3##(1993-8#1)(2008-10#2)
reaction was monitored##6##3##(2008-10#6)
reaction was not##2##3##(1996-2#1)(2008-10#1)
reaction was observed between##2##4##(2008-10#1)(2010-4#1)
reaction was observed##3##3##(1990-6#1)(2008-10#1)(2010-4#1)
reaction was studied##4##3##(2008-10#4)
reaction was used to##5##4##(1991-7#1)(1992-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
reaction was##79##2##(1990-5#1)(1990-6#2)(1991-5#1)(1991-7#1)(1992-12#2)(1992-6#2)(1993-6#2)(1993-8#1)(1995-6#2)(1996-12#2)(1996-2#2)(1996-5#1)(2008-10#47)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
reaction were investigated##2##3##(2008-10#2)
reaction were##13##2##(1997-2#1)(2008-10#10)(2008-11#1)(2008-8#1)
reaction when##2##2##(2008-10#2)
reaction where##2##2##(2008-10#1)(2009-8#1)
reaction wherein##2##2##(2008-10#2)
reaction which##4##2##(1990-8#1)(2008-10#3)
reaction with a##3##3##(1997-1#1)(2008-10#2)
reaction with potassium##3##3##(2008-10#3)
reaction with the studied##2##4##(2008-10#2)
reaction with the##8##3##(1993-8#1)(2008-10#7)
reaction with##96##2##(1992-3#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-5#2)(1996-5#1)(1997-1#1)(2008-10#80)(2008-11#3)(2008-5#2)(2009-10#1)
reaction yield##2##2##(2008-10#1)(2008-5#1)
reaction zones##3##2##(2008-3#3)
reaction##1870##1##(1990-12#2)(1990-2#1)(1990-5#4)(1990-6#9)(1990-7#1)(1990-8#6)(1991-1#2)(1991-11#1)(1991-12#2)(1991-5#5)(1991-6#4)(1991-7#1)(1991-9#9)(1992-1#2)(1992-10#1)(1992-12#4)(1992-3#7)(1992-4#1)(1992-6#6)(1992-8#2)(1992-9#3)(1993-12#3)(1993-2#6)(1993-3#5)(1993-6#9)(1993-8#17)(1993-9#1)(1994-1#2)(1994-11#7)(1994-12#2)(1994-2#1)(1994-5#14)(1994-8#3)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#2)(1995-6#16)(1995-9#1)(1996-11#2)(1996-12#13)(1996-2#7)(1996-3#1)(1996-5#45)(1996-6#1)(1996-8#1)(1997-1#4)(1997-2#6)(1997-4#1)(1997-6#4)(1997-7#9)(1997-8#8)(1997-9#1)(2008-1#1)(2008-10#1237)(2008-11#38)(2008-12#10)(2008-2#2)(2008-3#6)(2008-4#15)(2008-5#29)(2008-6#1)(2008-7#37)(2008-8#50)(2008-9#20)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#4)(2009-8#12)(2010-1#3)(2010-10#3)(2010-11#2)(2010-4#11)(2010-6#7)(2010-7#4)(2010-9#1)(2011-1#4)(2011-2#31)(2011-3#3)(2012-12#4)(2012-2#6)(2012-3#7)(2013-1#29)(2013-7#1)(2013-8#7)
reaction)##7##1##(1990-6#1)(1993-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
reaction-diffusion model##2##2##(2008-8#2)
reaction-diffusion models##2##2##(2008-8#1)(2008-9#1)
reaction-diffusion##8##1##(2008-10#1)(2008-8#4)(2008-9#1)(2013-8#2)
reactional##10##1##(1991-11#1)(2008-10#1)(2011-2#8)
reactions after##2##2##(1996-8#1)(2008-10#1)
reactions among##2##2##(2008-10#2)
reactions and##23##2##(1991-1#1)(1992-11#1)(1993-9#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#4)
reactions are common and##2##4##(2008-10#1)(2008-8#1)
reactions are common##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
reactions are##20##2##(1990-9#1)(1992-9#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#9)(2008-4#1)(2008-8#3)(2010-7#1)
reactions at the##2##3##(1990-6#1)(2008-10#1)
reactions at##3##2##(1990-6#1)(2008-10#2)
reactions between the##3##3##(1996-11#1)(1997-7#1)(2008-10#1)
reactions between##13##2##(1992-6#1)(1996-11#1)(1996-5#1)(1997-7#1)(2008-10#8)(2008-7#1)
reactions by##3##2##(2008-10#2)(2008-11#1)
reactions can##4##2##(1996-5#1)(2008-10#2)(2008-2#1)
reactions catalyzed by##3##3##(1990-8#1)(1994-8#1)(2008-7#1)
reactions commonly##2##2##(2008-10#1)(2009-12#1)
reactions during the##2##3##(2008-10#1)(2008-8#1)
reactions during##4##2##(1991-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
reactions for##4##2##(1997-3#1)(2008-10#3)
reactions from##2##2##(1996-8#1)(2008-10#1)
reactions has been##2##3##(1994-5#1)(2008-10#1)
reactions have been##3##3##(2008-10#2)(2012-3#1)
reactions in an##2##3##(2008-8#1)(2011-2#1)
reactions in solution##2##3##(1995-6#1)(1997-2#1)
reactions in the presence of##2##5##(2008-10#1)(2009-8#1)
reactions in the##10##3##(2008-10#5)(2008-11#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
reactions in which##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
reactions in##41##2##(1990-5#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#4)(2013-1#3)(2013-8#1)
reactions including##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
reactions involved##2##2##(2008-10#2)
reactions involving##2##2##(2011-1#1)(2012-3#1)
reactions is##5##2##(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#2)
reactions may be##2##3##(2008-4#1)(2008-5#1)
reactions may##3##2##(2008-4#1)(2008-5#1)(2010-10#1)
reactions occur##3##2##(2008-10#1)(2008-8#1)(2010-7#1)
reactions of iodine##2##3##(2008-10#2)
reactions of the##13##3##(1991-3#1)(1992-6#1)(1996-5#1)(2008-10#8)(2008-7#1)(2012-2#1)
reactions of##59##2##(1990-5#1)(1990-8#2)(1991-3#2)(1992-6#1)(1993-11#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#32)(2008-11#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-8#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
reactions on##7##2##(1991-5#1)(1995-6#1)(2008-10#5)
reactions that##6##2##(1994-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#1)
reactions through##2##2##(2010-11#1)(2013-8#1)
reactions to drugs##2##3##(1994-9#1)(2008-10#1)
reactions to the##5##3##(1990-2#1)(2008-10#2)(2008-11#1)(2009-4#1)
reactions to##26##2##(1990-2#1)(1994-12#1)(1994-9#1)(1995-11#1)(1997-3#2)(2008-10#8)(2008-11#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
reactions using##5##2##(2008-10#3)(2008-4#1)(2009-6#1)
reactions was##9##2##(1994-8#1)(2008-10#6)(2008-11#1)(2011-2#1)
reactions were observed##2##3##(1990-2#1)(2008-10#1)
reactions were reported in##2##4##(1991-11#1)(2011-2#1)
reactions were##21##2##(1990-2#1)(1991-11#1)(1993-8#1)(1995-6#2)(2008-10#9)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#3)(2012-2#1)
reactions which##3##2##(1991-3#1)(1997-2#1)(2008-11#1)
reactions will##2##2##(2010-7#1)(2012-6#1)
reactions with the##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
reactions with##26##2##(1994-5#2)(1996-5#2)(1997-6#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-3#1)
reactions within the##3##3##(2008-7#1)(2009-12#1)(2009-9#1)
reactions within##4##2##(2008-10#1)(2008-7#1)(2009-12#1)(2009-9#1)
reactions##512##1##(1990-2#2)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#6)(1992-9#4)(1993-11#1)(1993-12#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#6)(1995-8#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#9)(1996-6#3)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#3)(2008-10#208)(2008-11#27)(2008-12#5)(2008-2#2)(2008-4#7)(2008-5#13)(2008-7#17)(2008-8#24)(2008-9#4)(2009-1#1)(2009-10#6)(2009-12#4)(2009-4#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-10#4)(2010-11#2)(2010-4#2)(2010-6#3)(2010-7#8)(2010-8#3)(2011-1#6)(2011-2#26)(2012-12#2)(2012-2#5)(2012-3#5)(2012-6#1)(2013-1#3)(2013-8#7)
reactivate HIV from latency##2##4##(2012-12#2)
reactivate##5##1##(1990-5#1)(2008-9#1)(2009-4#1)(2012-12#2)
reactivated by##2##2##(1992-12#1)(1995-8#1)
reactivated##7##1##(1992-12#2)(1993-6#1)(1995-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
reactivation and##2##2##(2008-5#1)(2009-4#1)
reactivation of##6##2##(1993-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
reactivation##18##1##(1992-9#1)(1993-8#1)(1994-3#1)(1995-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
reactive and##6##2##(2008-10#4)(2010-4#1)(2011-2#1)
reactive cells##2##2##(1990-2#1)(2008-9#1)
reactive centers##2##2##(1994-5#2)
reactive changes##2##2##(1997-3#1)(2010-9#1)
reactive control##4##2##(2011-2#4)
reactive dye##2##2##(2008-10#2)
reactive dyes##2##2##(2008-10#2)
reactive for cytokeratin AE1/3##2##4##(1994-8#2)
reactive group##2##2##(2008-10#1)(2008-11#1)
reactive iron##3##2##(2008-10#3)
reactive mechanism##2##2##(2008-10#2)
reactive metabolites to##2##3##(1991-1#1)(1994-5#1)
reactive nitrogen##3##2##(1991-6#1)(2009-8#1)(2011-2#1)
reactive nurses who##2##3##(1996-2#2)
reactive oxidant##2##2##(2008-10#1)(2012-12#1)
reactive oxygen and nitrogen##2##4##(2008-7#1)(2011-2#1)
reactive oxygen and##4##3##(2008-7#1)(2009-8#2)(2011-2#1)
reactive oxygen metabolites and paraoxonase 1##2##6##(2012-12#2)
reactive oxygen metabolites and##3##4##(2012-12#2)(2012-3#1)
reactive oxygen metabolites produced by##2##5##(1993-6#2)
reactive oxygen metabolites##6##3##(1993-6#2)(2012-12#3)(2012-3#1)
reactive oxygen species (ROS) and##2##5##(2010-5#1)(2012-2#1)
reactive oxygen species (ROS) are##2##5##(2008-10#2)
reactive oxygen species (ROS) superoxide##2##5##(2008-10#1)(2011-2#1)
reactive oxygen species (ROS) which##2##5##(2008-10#1)(2008-11#1)
reactive oxygen species (ROS)##27##4##(1994-5#1)(1994-6#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-9#1)(2009-8#4)(2010-1#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-2#2)(2012-6#1)
reactive oxygen species by##4##4##(2008-10#1)(2008-11#1)(2009-3#1)(2010-1#1)
reactive oxygen species in the##2##5##(2009-8#1)(2010-10#1)
reactive oxygen species in##3##4##(1994-6#1)(2009-8#1)(2010-10#1)
reactive oxygen species##52##3##(1992-12#1)(1994-5#1)(1994-6#2)(2008-1#1)(2008-10#11)(2008-11#9)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#5)(2010-1#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-2#3)(2012-6#1)(2013-8#1)
reactive oxygen species-potentiated invasive capacity by simultaneously treating AH109A cells with##2##11##(2008-11#2)
reactive oxygen##69##2##(1992-12#1)(1993-6#2)(1994-5#2)(1994-6#2)(1994-8#1)(1995-8#1)(2008-1#1)(2008-10#11)(2008-11#11)(2008-5#1)(2008-7#5)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#7)(2010-1#2)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#1)(2012-6#1)(2013-8#1)
reactive phosphate##2##2##(2008-10#2)
reactive phosphorus (DRP)##2##3##(2008-10#2)
reactive protein##2##2##(1996-1#1)(2008-3#1)
reactive site loop of maspin##2##5##(1995-6#2)
reactive species##7##2##(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)
reactive surface##2##2##(2008-10#2)
reactive to##6##2##(1991-5#1)(1995-12#1)(2008-10#1)(2008-11#3)
reactive with##9##2##(1992-3#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-5#1)
reactive##214##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-6#2)(1992-12#2)(1992-3#5)(1993-2#1)(1993-6#2)(1993-8#3)(1994-5#5)(1994-6#2)(1994-8#3)(1995-12#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(2008-1#2)(2008-10#56)(2008-11#23)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#7)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#12)(2010-1#2)(2010-10#1)(2010-11#2)(2010-4#2)(2010-5#2)(2010-9#3)(2011-1#1)(2011-10#1)(2011-2#12)(2012-12#5)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#3)(2013-7#2)(2013-8#1)
reactive-ion etching##2##2##(2008-3#2)
reactivities##4##1##(1995-6#1)(2008-11#1)(2010-12#1)(2012-3#1)
reactivity and##4##2##(2008-10#2)(2010-12#1)(2013-1#1)
reactivity in Gujarati Indian##2##4##(2012-2#2)
reactivity in the##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
reactivity in##8##2##(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#3)(2012-3#1)
reactivity is##2##2##(1995-8#1)(2013-1#1)
reactivity of the##6##3##(1996-5#1)(1997-2#1)(2008-10#4)
reactivity of these##2##3##(1992-2#1)(2008-10#1)
reactivity of two##2##3##(1990-12#1)(1994-11#1)
reactivity of##23##2##(1990-12#1)(1990-5#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-5#1)(1996-5#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-9#1)
reactivity on##2##2##(1990-12#1)(2013-1#1)
reactivity through Mcl-1/Bim##2##3##(2013-1#2)
reactivity to##13##2##(1991-12#1)(1992-5#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-5#3)(2011-2#3)(2012-2#1)
reactivity towards##2##2##(1992-9#1)(2008-10#1)
reactivity was##3##2##(1990-12#1)(1991-9#1)(2008-10#1)
reactivity with##8##2##(1990-12#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2010-11#1)
reactivity##105##1##(1990-12#4)(1990-5#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(2007-11#1)(2008-10#29)(2008-11#6)(2008-5#9)(2008-7#2)(2008-8#3)(2008-9#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#6)
reactor (KR)##2##2##(2008-10#2)
reactor 1##2##2##(2008-10#2)
reactor 2##2##2##(2008-10#2)
reactor and a##2##3##(2008-10#2)
reactor and##6##2##(2008-10#3)(2008-11#2)(2008-7#1)
reactor at##3##2##(1995-3#1)(2008-11#1)(2008-7#1)
reactor coil##2##2##(2008-10#2)
reactor column##4##2##(2008-10#4)
reactor containing##2##2##(2008-10#2)
reactor for##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
reactor in the##2##3##(2008-10#2)
reactor in##3##2##(2008-10#3)
reactor is##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
reactor length##3##2##(2008-10#3)
reactor performance##2##2##(2008-11#1)(2008-7#1)
reactor productivity##2##2##(2008-11#1)(2008-7#1)
reactor used##2##2##(2008-3#1)(2008-7#1)
reactor using##3##2##(2008-10#2)(2008-7#1)
reactor volume##2##2##(2008-10#1)(2008-11#1)
reactor was##5##2##(2008-10#5)
reactor with##3##2##(2008-10#2)(2008-11#1)
reactor##124##1##(1995-3#3)(1997-2#1)(2008-10#75)(2008-11#23)(2008-2#1)(2008-3#1)(2008-7#15)(2008-9#1)(2011-2#2)(2013-1#2)
reactors and##4##2##(2008-10#2)(2008-12#2)
reactors for the determination of##3##5##(2008-10#3)
reactors for##4##2##(2008-10#3)(2008-7#1)
reactors have##2##2##(1997-6#1)(2008-12#1)
reactors in##2##2##(2008-10#2)
reactors using##2##2##(2008-10#1)(2008-7#1)
reactors was##4##2##(2008-10#2)(2008-7#2)
reactors with##2##2##(2008-10#1)(2008-12#1)
reactors##51##1##(1997-6#1)(2008-10#27)(2008-11#3)(2008-12#6)(2008-7#12)(2011-2#2)
reacts in slightly acidic (0##2##5##(2008-10#2)
reacts in##5##2##(2008-10#5)
reacts with Fe(III)##2##3##(2008-10#2)
reacts with a##2##3##(2008-10#1)(2008-8#1)
reacts with excess##2##3##(2008-10#2)
reacts with silylated##2##3##(1996-5#2)
reacts with the##5##3##(1997-1#1)(2008-10#4)
reacts with##67##2##(1990-2#1)(1994-5#2)(1995-12#2)(1996-5#3)(1997-1#2)(2008-10#56)(2008-8#1)
reacts##79##1##(1990-2#1)(1990-5#1)(1994-3#1)(1994-5#2)(1995-12#3)(1996-5#4)(1997-1#2)(2008-10#63)(2008-5#1)(2008-8#1)
read and##3##2##(2008-4#1)(2008-9#1)(2009-4#1)
read at##2##2##(2008-10#2)
read data##2##2##(2012-3#2)
read the##5##2##(1993-2#1)(2008-3#1)(2009-4#1)(2010-7#1)(2013-8#1)
read##37##1##(1990-12#3)(1993-2#1)(1994-2#1)(1996-2#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#4)(2010-11#1)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
read-out##3##1##(2008-9#1)(2013-8#2)
readability and comprehensiveness of consumer##2##5##(2011-1#2)
readability and comprehensiveness of##3##4##(2011-1#3)
readability##6##1##(2008-12#2)(2011-1#4)
readable##5##1##(2008-10#1)(2008-4#1)(2010-8#3)
reader##18##1##(1990-12#1)(1992-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-3#1)
readers in##2##2##(1996-2#1)(2008-9#1)
readers through##2##2##(1995-2#1)(2008-12#1)
readers to##2##2##(2008-11#1)(2009-4#1)
readers##22##1##(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#2)(2010-12#3)(2011-2#1)(2012-2#2)
readership##2##1##(1995-1#1)(2008-11#1)
readily accept##2##2##(2008-7#1)(2010-8#1)
readily accepted##2##2##(1995-3#1)(2008-9#1)
readily accessible##2##2##(2008-7#2)
readily adaptable##2##2##(2008-10#2)
readily adapted to##2##3##(2008-6#1)(2010-7#1)
readily amenable to##2##3##(2008-10#1)(2008-8#1)
readily applicable to##2##3##(2008-10#1)(2008-2#1)
readily applicable##3##2##(2008-10#2)(2008-2#1)
readily as##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
readily available and##2##3##(2008-6#1)(2011-2#1)
readily available components##2##3##(2008-10#1)(2008-4#1)
readily available in##3##3##(2008-11#2)(2008-9#1)
readily available##24##2##(1992-9#1)(1994-3#1)(1995-12#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#2)
readily be##8##2##(1990-3#1)(1992-12#1)(1994-8#1)(2008-10#2)(2008-4#2)(2008-9#1)
readily detectable##2##2##(1996-12#1)(2011-2#1)
readily detected in##2##3##(1995-2#1)(2008-10#1)
readily detected with##2##3##(2008-10#2)
readily detected##6##2##(1993-2#1)(1995-2#1)(2008-10#4)
readily determined##3##2##(1995-2#1)(2008-10#1)(2009-11#1)
readily distinguishable##2##2##(2008-5#2)
readily distinguished##2##2##(2008-10#2)
readily extended##2##2##(2008-10#1)(2008-9#1)
readily formed##2##2##(2007-12#1)(2008-10#1)
readily identified##3##2##(2008-10#1)(2009-8#1)(2010-6#1)
readily in the##2##3##(2008-10#2)
readily observed##2##2##(2008-10#2)
readily obtained##2##2##(1991-5#2)
readily performed##2##2##(1990-8#1)(2008-10#1)
readily prepared##2##2##(1996-5#1)(2008-10#1)
readily regenerated with##2##3##(2008-10#2)
readily reversible##2##2##(1992-8#1)(2008-10#1)
readily to##2##2##(1992-6#1)(2008-11#1)
readily with##3##2##(2008-11#2)(2012-12#1)
readily##171##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-5#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#3)(1997-3#1)(2007-12#2)(2008-1#2)(2008-10#60)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#7)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
readiness assessment##2##2##(1996-1#1)(2013-1#1)
readiness for##6##2##(2008-11#2)(2008-4#3)(2010-2#1)
readiness to change##4##3##(2008-11#3)(2013-8#1)
readiness to##6##2##(1995-12#1)(2008-11#3)(2008-4#1)(2013-8#1)
readiness##19##1##(1995-12#1)(1996-1#2)(2008-11#6)(2008-12#3)(2008-4#4)(2010-2#1)(2013-1#1)(2013-8#1)
reading ability##3##2##(2012-2#3)
reading accuracy##2##2##(2010-7#2)
reading acquisition##2##2##(2008-11#2)
reading aloud##2##2##(1995-2#1)(2008-9#1)
reading and writing##2##3##(2008-12#2)
reading and##9##2##(2008-12#3)(2009-4#1)(2011-1#1)(2011-2#3)(2013-1#1)
reading comprehension##6##2##(2008-12#3)(2011-2#2)(2013-1#1)
reading efficiency in##3##3##(2012-2#3)
reading efficiency##5##2##(2012-2#5)
reading experience##2##2##(2011-2#2)
reading frame in##2##3##(1994-11#1)(1995-9#1)
reading frame of the##4##4##(1990-2#1)(1992-6#1)(1993-12#1)(2008-10#1)
reading frame of##25##3##(1990-2#1)(1990-5#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#2)(1994-6#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)
reading frame##94##2##(1990-11#2)(1990-2#1)(1990-5#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-6#2)(1995-2#3)(1995-6#3)(1995-8#1)(1995-9#3)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#3)(1997-9#1)(2008-10#19)(2008-5#1)(2008-6#1)(2008-8#9)(2008-9#6)(2012-3#1)(2013-1#1)(2013-8#1)
reading frames (ORFs) in##2##4##(2008-10#2)
reading frames (ORFs)##24##3##(1995-12#1)(1995-9#3)(1996-3#5)(1996-6#4)(1997-6#1)(2008-10#10)
reading frames##65##2##(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#2)(1995-12#2)(1995-9#6)(1996-12#2)(1996-3#8)(1996-6#8)(1997-3#3)(1997-6#1)(1997-7#1)(1997-9#1)(2008-10#23)(2008-8#1)(2008-9#3)
reading in##3##2##(2008-12#2)(2011-2#1)
reading instruction##2##2##(2008-12#1)(2013-1#1)
reading of##5##2##(2010-3#1)(2010-7#2)(2012-2#1)(2012-3#1)
reading performance##2##2##(2008-11#1)(2008-12#1)
reading sentences##2##2##(2008-9#1)(2013-8#1)
reading skills##7##2##(2008-12#5)(2011-2#2)
reading tests##2##2##(2008-11#1)(2012-2#1)
reading the##4##2##(2008-11#1)(2008-5#1)(2010-1#1)(2010-12#1)
reading times##2##2##(2007-12#1)(2013-1#1)
reading##280##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#3)(1991-12#1)(1991-5#1)(1991-9#3)(1992-10#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#8)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#7)(1994-12#1)(1994-6#2)(1995-12#2)(1995-2#4)(1995-6#3)(1995-8#1)(1995-9#9)(1996-12#3)(1996-2#3)(1996-3#9)(1996-6#8)(1996-8#1)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#4)(1997-8#1)(1997-9#2)(2007-12#3)(2008-10#43)(2008-11#7)(2008-12#28)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#14)(2009-4#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#9)(2011-1#5)(2011-2#11)(2012-12#1)(2012-2#11)(2012-3#2)(2013-1#11)(2013-8#6)
readings and##2##2##(1994-3#1)(2008-11#1)
readings at##3##2##(2008-10#3)
readings in##2##2##(2008-10#1)(2008-5#1)
readings of the##3##3##(2008-10#3)
readings of##5##2##(2007-8#1)(2008-10#3)(2010-3#1)
readings##23##1##(1991-12#1)(1993-1#1)(1994-3#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-5#4)(2010-3#1)(2010-7#1)
readmission##9##1##(2008-11#1)(2011-2#6)(2013-1#2)
readmissions during##2##2##(1990-12#1)(2011-2#1)
readmissions##8##1##(1990-12#1)(1997-5#2)(2011-2#4)(2013-8#1)
readmitted##4##1##(2011-2#3)(2012-12#1)
readout mechanism for match##2##4##(2013-8#2)
readout##6##1##(2008-10#1)(2008-3#2)(2013-1#1)(2013-8#2)
reads##9##1##(1995-8#1)(2008-11#1)(2008-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
reads)##2##1##(2011-2#1)(2012-2#1)
readthrough##3##1##(2008-10#3)
ready for a##2##3##(1992-2#1)(2013-8#1)
ready for##13##2##(1991-9#1)(1992-2#1)(1997-2#1)(2008-10#4)(2008-4#2)(2012-2#1)(2012-3#1)(2013-8#2)
ready to be used in a new assay##2##8##(2008-10#2)
ready to eat##2##3##(2010-4#1)(2010-7#1)
ready to##9##2##(1995-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-7#2)
ready##31##1##(1991-9#1)(1992-2#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-7#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
ready-to-eat##4##1##(2011-2#4)
ready?##2##1##(1995-12#1)(2010-12#1)
reaffirms##2##1##(1994-3#1)(2011-2#1)
reagent 1##5##2##(2008-10#5)
reagent addition##4##2##(2008-10#4)
reagent amounts and##2##3##(2008-10#2)
reagent amounts##5##2##(2008-10#5)
reagent and ammonium tetraphenylborate##2##4##(2008-10#2)
reagent and organic solvent##2##4##(2008-10#2)
reagent and sample##3##3##(2008-10#3)
reagent and the##3##3##(2008-10#3)
reagent and their##2##3##(2008-10#2)
reagent and##34##2##(2008-10#33)(2008-4#1)
reagent because##2##2##(2008-10#2)
reagent blank##7##2##(2008-10#7)
reagent blanks of microwave digestion system##2##6##(2008-10#2)
reagent carrier##2##2##(2008-10#2)
reagent channel##2##2##(2008-10#2)
reagent chemical##2##2##(2008-10#2)
reagent chemistry##2##2##(2008-10#2)
reagent composition##2##2##(2008-10#2)
reagent concentration and of various foreign ions##2##7##(2008-10#2)
reagent concentration gradient##2##3##(2008-10#2)
reagent concentration##13##2##(2008-10#13)
reagent concentrations##4##2##(2008-10#4)
reagent consumption and the##2##4##(2008-10#2)
reagent consumption and##3##3##(2008-10#3)
reagent consumption of##3##3##(2008-10#3)
reagent consumption##14##2##(2008-10#14)
reagent containing##2##2##(1995-8#1)(2008-10#1)
reagent flow##2##2##(2008-10#2)
reagent for determination of##3##4##(2008-10#3)
reagent for selective##2##3##(2008-10#2)
reagent for spectrophotometric determination of boron##2##6##(2008-10#2)
reagent for spectrophotometric determination of##3##5##(2008-10#3)
reagent for the spectrophotometric determination of cobalt##2##7##(2008-10#2)
reagent for the spectrophotometric determination of##3##6##(2008-10#3)
reagent for the##10##3##(2008-10#9)(2009-12#1)
reagent for##38##2##(2008-10#35)(2008-8#1)(2008-9#1)(2009-12#1)
reagent gas##2##2##(2008-10#2)
reagent gives##3##2##(2008-10#2)(2008-8#1)
reagent has##2##2##(2008-10#2)
reagent in a##3##3##(2008-10#3)
reagent in alkaline medium##3##4##(2008-10#3)
reagent in the##7##3##(2008-10#6)(2008-5#1)
reagent in xylene from 0##2##5##(2008-10#2)
reagent in xylene from##3##4##(2008-10#3)
reagent in##25##2##(2008-10#24)(2008-5#1)
reagent is##4##2##(1990-2#1)(2008-10#2)(2012-2#1)
reagent mixture##2##2##(2008-10#2)
reagent of##3##2##(2008-10#2)(2008-8#1)
reagent on the##5##3##(2008-10#4)(2008-11#1)
reagent reacts with##3##3##(2008-10#3)
reagent reacts##4##2##(2008-10#4)
reagent regeneration##2##2##(2008-10#2)
reagent solution##10##2##(2008-10#10)
reagent solutions##4##2##(2008-10#4)
reagent stream containing##2##3##(2008-10#2)
reagent stream##7##2##(2008-10#7)
reagent to form##2##3##(2008-10#2)
reagent to##7##2##(2008-10#7)
reagent used##4##2##(2008-10#4)
reagent volumes##4##2##(2008-10#4)
reagent was replaced by 1##2##5##(2008-10#2)
reagent was##11##2##(2008-10#9)(2012-2#2)
reagent zones##3##2##(2008-10#3)
reagent##433##1##(1990-12#3)(1990-2#3)(1991-5#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-5#2)(2008-10#392)(2008-11#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#4)(2009-12#3)(2012-2#6)
reagent)##3##1##(2008-10#2)(2012-3#1)
reagent-injection FI method##3##3##(2008-10#3)
reagent-injection flow injection photometric method##2##5##(2008-10#2)
reagent-injection flow injection technique##2##4##(2008-10#2)
reagent-injection flow injection##5##3##(2008-10#5)
reagent-injection##8##1##(2008-10#8)
reagentless pH sensors##2##3##(2008-10#2)
reagentless##10##1##(2008-10#10)
reagents and sample##3##3##(2008-10#3)
reagents and##23##2##(2008-10#16)(2008-11#1)(2008-5#1)(2008-9#2)(2012-12#1)(2012-3#1)(2013-8#1)
reagents are used##2##3##(1990-2#1)(2008-10#1)
reagents are##8##2##(1990-2#1)(2008-10#7)
reagents for the##5##3##(1992-2#1)(2008-10#4)
reagents for use in immunoassays##2##5##(2008-10#2)
reagents for##16##2##(1992-2#1)(2008-10#11)(2008-11#1)(2008-4#2)(2012-2#1)
reagents has been##2##3##(2008-10#2)
reagents in the##2##3##(2008-10#1)(2008-11#1)
reagents in##7##2##(2008-10#5)(2008-11#1)(2010-7#1)
reagents is##4##2##(2008-10#3)(2008-11#1)
reagents of##6##2##(2008-10#4)(2008-4#1)(2008-9#1)
reagents or##2##2##(1996-5#1)(2008-10#1)
reagents such as##3##3##(1990-2#1)(2008-11#1)(2009-12#1)
reagents that##3##2##(2008-10#2)(2008-9#1)
reagents to##5##2##(2008-10#4)(2008-4#1)
reagents used for##2##3##(1996-6#1)(2008-9#1)
reagents used in the##2##4##(1992-3#1)(2008-10#1)
reagents used##5##2##(1992-3#1)(1996-6#1)(2008-10#2)(2008-9#1)
reagents was also##2##3##(2008-10#2)
reagents was##7##2##(2008-10#7)
reagents were##8##2##(1993-6#1)(2008-10#7)
reagents with##2##2##(2008-10#1)(2008-8#1)
reagents##221##1##(1990-12#1)(1990-2#2)(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-5#2)(1996-6#1)(2008-10#151)(2008-11#12)(2008-4#11)(2008-5#4)(2008-8#2)(2008-9#12)(2009-12#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
real and artificial##2##3##(1996-2#1)(2008-10#1)
real and##10##2##(1991-3#1)(1992-2#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
real benefit##2##2##(1996-1#1)(1997-1#1)
real biological##2##2##(2008-8#1)(2012-3#1)
real communities##2##2##(2008-9#2)
real conditions##2##2##(2008-10#2)
real contaminated##2##2##(2008-10#2)
real danger of##3##3##(1994-2#1)(1995-12#1)(1996-11#1)
real data##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2010-1#1)(2013-8#1)
real life##6##2##(2008-10#1)(2008-11#3)(2010-4#1)(2012-3#1)
real need##3##2##(1991-2#1)(1993-12#1)(2008-11#1)
real part of the refractive index##3##6##(2008-3#3)
real sample analysis##7##3##(2008-10#7)
real sample##19##2##(2008-10#19)
real samples (pharmaceutical preparations)##2##4##(2008-10#2)
real samples analysis##2##3##(2008-10#2)
real samples and##5##3##(2008-10#5)
real samples are##2##3##(2008-10#2)
real samples by##4##3##(2008-10#4)
real samples from##5##3##(2008-10#5)
real samples of water##2##4##(2008-10#2)
real samples of##4##3##(2008-10#4)
real samples such as##6##4##(2008-10#6)
real samples to##2##3##(2008-10#1)(2008-5#1)
real samples was##2##3##(2008-10#2)
real samples were also##2##4##(2008-10#2)
real samples were##5##3##(2008-10#5)
real samples with##4##3##(2008-10#4)
real samples##108##2##(1997-2#1)(2008-10#105)(2008-5#2)
real sediment##2##2##(2008-10#2)
real soil samples##2##3##(2008-10#2)
real soil##3##2##(2008-10#3)
real spectra##2##2##(2008-10#2)
real time and##4##3##(2008-10#2)(2008-3#1)(2011-1#1)
real time determination##2##3##(2008-10#2)
real time##41##2##(1995-12#1)(1995-2#1)(1997-6#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
real urine samples were##2##4##(2008-10#2)
real urine samples##3##3##(2008-10#3)
real urine##4##2##(2008-10#4)
real water samples##10##3##(2008-10#10)
real water##12##2##(2008-10#11)(2010-4#1)
real words##2##2##(1996-2#1)(2010-7#1)
real world samples##3##3##(2008-10#3)
real world##14##2##(1993-2#1)(1994-1#1)(1995-6#1)(1996-2#1)(2008-10#7)(2008-11#1)(2009-12#1)(2013-8#1)
real world&quot##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
real##355##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#6)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#5)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-8#1)(2008-10#224)(2008-11#15)(2008-12#2)(2008-2#3)(2008-3#15)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#5)(2009-12#1)(2009-3#2)(2009-7#2)(2010-1#1)(2010-12#3)(2010-4#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#4)
real-life##8##1##(1991-12#1)(2008-10#3)(2009-1#1)(2011-1#1)(2013-1#2)
real-time PCR assay##7##3##(2008-10#4)(2010-4#2)(2011-2#1)
real-time PCR assays##6##3##(2008-10#5)(2008-9#1)
real-time PCR method##2##3##(2010-6#1)(2013-8#1)
real-time PCR technique##2##3##(2008-10#2)
real-time PCR##44##2##(2008-10#24)(2008-9#1)(2009-6#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
real-time and##2##2##(2008-10#2)
real-time data##2##2##(2008-10#1)(2008-8#1)
real-time detection of##2##3##(2008-3#1)(2009-12#1)
real-time detection##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
real-time fluorescent##2##2##(2008-10#2)
real-time gray-scale##2##2##(2007-11#2)
real-time imaging##2##2##(2009-7#1)(2011-7#1)
real-time monitoring of##4##3##(2008-10#3)(2008-3#1)
real-time monitoring##6##2##(2008-10#5)(2008-3#1)
real-time operation##4##2##(2008-3#1)(2013-1#3)
real-time polymerase chain reaction (PCR) assay was developed to##2##9##(2008-10#2)
real-time polymerase chain reaction (PCR) assay was developed##3##8##(2008-10#3)
real-time polymerase chain reaction (PCR) assay##5##6##(2008-10#5)
real-time polymerase chain reaction (PCR)##10##5##(2008-10#10)
real-time polymerase chain reaction assays##2##5##(2008-10#2)
real-time polymerase chain reaction##24##4##(2008-10#20)(2009-6#1)(2010-6#1)(2012-2#1)(2013-1#1)
real-time polymerase chain##26##3##(2008-10#21)(2008-5#1)(2009-6#1)(2010-6#1)(2012-2#1)(2013-1#1)
real-time quantitative PCR##2##3##(2008-10#2)
real-time quantitative polymerase chain reaction (PCR)##2##6##(2008-10#2)
real-time quantitative polymerase chain reaction##5##5##(2008-10#5)
real-time quantitative##10##2##(2008-10#8)(2008-11#1)(2010-4#1)
real-time reverse transcription PCR##2##4##(2010-5#1)(2011-2#1)
real-time reverse transcription-polymerase chain reaction##4##5##(2008-10#3)(2013-1#1)
real-time reverse##7##2##(2008-10#3)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
real-time ultrasound##2##2##(1991-6#1)(2012-2#1)
real-time##175##1##(1991-2#1)(1991-6#1)(1992-3#1)(1995-5#1)(1996-1#1)(1997-8#1)(2007-11#2)(2007-9#1)(2008-10#88)(2008-11#8)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#2)(2010-11#2)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#10)(2011-7#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#3)
real-time&quot##2##1##(2008-10#1)(2008-4#1)
real-world applications##2##2##(2008-3#1)(2010-7#1)
real-world samples##2##2##(2008-10#2)
real-world##12##1##(1994-3#1)(1995-11#1)(2008-10#4)(2008-11#2)(2008-3#2)(2010-7#1)(2011-2#1)
realign##2##1##(1995-3#1)(2009-8#1)
realigned##3##1##(1993-3#1)(2008-3#1)(2009-3#1)
realignment of pelvic fracture urethral injuries##2##6##(2013-8#2)
realignment of##4##2##(1991-3#1)(1995-3#1)(2013-8#2)
realignment##8##1##(1991-3#2)(1993-3#1)(1995-3#1)(1995-5#1)(2013-8#3)
realised in##2##2##(2008-11#1)(2008-5#1)
realised##9##1##(1991-3#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-1#1)(2011-2#1)
realism of sexually threatening role plays##2##6##(2009-11#2)
realism of##4##2##(2009-11#4)
realism##6##1##(2008-8#1)(2009-11#5)
realistic and##4##2##(1995-1#1)(1996-2#1)(2008-10#1)(2008-12#1)
realistic application##2##2##(2008-5#2)
realistic in##2##2##(1991-12#1)(2009-7#1)
realistic model##2##2##(2009-8#1)(2013-1#1)
realistic simulation of##2##3##(2008-11#1)(2008-3#1)
realistic simulation##3##2##(2008-11#1)(2008-3#1)(2010-12#1)
realistic##59##1##(1990-8#1)(1991-12#2)(1991-2#1)(1992-9#1)(1993-12#1)(1993-2#2)(1995-1#1)(1995-11#1)(1995-12#1)(1996-2#2)(1997-3#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-3#9)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-7#1)(2009-8#3)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
realistically##5##1##(1996-2#1)(1997-6#1)(2008-3#1)(2008-9#1)(2010-10#1)
realities and##2##2##(1995-2#1)(2008-11#1)
realities of##4##2##(2008-10#1)(2008-11#2)(2010-4#1)
realities##11##1##(1990-6#1)(1991-3#1)(1992-12#1)(1995-1#1)(1995-2#1)(2008-10#1)(2008-11#4)(2010-4#1)
reality for the##2##3##(1995-2#1)(2011-2#1)
reality for##3##2##(1994-12#1)(1995-2#1)(2011-2#1)
reality in the##2##3##(2009-10#1)(2013-8#1)
reality in##4##2##(2008-10#1)(2009-10#1)(2012-3#1)(2013-8#1)
reality is##2##2##(1994-2#1)(2008-11#1)
reality of the##3##3##(1997-2#1)(2008-11#2)
reality of##8##2##(1994-12#1)(1997-2#1)(2008-11#3)(2009-5#1)(2011-2#1)(2013-1#1)
reality to##2##2##(2010-1#1)(2010-8#1)
reality##61##1##(1990-6#1)(1992-12#1)(1993-3#2)(1994-1#2)(1994-12#3)(1994-2#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#2)(2008-10#6)(2008-11#11)(2008-12#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-8#1)(2011-2#5)(2011-7#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
reality?##3##1##(1991-8#1)(2008-11#2)
realization of a##3##3##(2008-3#3)
realization of the##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
realization of##16##2##(1995-1#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
realization##20##1##(1995-1#1)(1995-3#1)(1996-5#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
realize that##3##2##(1991-2#1)(1994-2#1)(2008-10#1)
realize the##7##2##(1994-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
realize##22##1##(1991-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
realized as##2##2##(2008-10#1)(2008-3#1)
realized by##6##2##(2008-10#3)(2008-2#1)(2012-3#1)(2013-1#1)
realized in##3##2##(1997-6#1)(2008-3#1)(2012-3#1)
realized##45##1##(1992-1#1)(1993-1#1)(1993-2#1)(1995-1#1)(1995-12#2)(1996-3#1)(1997-6#1)(2008-10#16)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#6)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
realizes the##2##2##(2008-3#1)(2008-4#1)
realizes##4##1##(1997-1#1)(2008-3#1)(2008-4#1)(2008-7#1)
realizing the##3##2##(1991-3#1)(2008-10#2)
realizing##5##1##(1991-3#1)(1994-1#2)(2008-10#2)
reallocation of resources##2##3##(1994-2#1)(2010-7#1)
reallocation of##3##2##(1994-2#1)(2010-7#1)(2011-2#1)
reallocation##7##1##(1994-2#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-3#2)
really a##2##2##(2008-10#1)(2013-8#1)
really high##2##2##(2008-10#1)(2011-2#1)
really know##2##2##(1991-12#1)(1992-3#1)
really##41##1##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
realm##7##1##(1990-6#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-6#1)(2013-7#1)
realms##2##1##(2008-11#1)(2010-9#1)
reanalysed in##2##2##(2008-10#1)(2008-5#1)
reanalysed##3##1##(2008-10#2)(2008-5#1)
reanalysis of##2##2##(1991-2#1)(2008-10#1)
reanalysis##5##1##(1991-2#1)(2007-12#3)(2008-10#1)
reap the##2##2##(1991-2#1)(2008-10#1)
reap##4##1##(1991-2#1)(1997-1#1)(2008-10#1)(2008-11#1)
reappeared##2##1##(2008-11#1)(2012-12#1)
reappointment##2##1##(1994-12#1)(1994-3#1)
reappraisal of the##2##3##(1991-12#1)(2013-8#1)
reappraisal of##3##2##(1991-12#1)(2008-3#1)(2013-8#1)
rear mirror##2##2##(2008-10#1)(2008-3#1)
rear##8##1##(1991-2#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-3#1)(2013-1#1)
reared by##2##2##(2008-8#1)(2008-9#1)
reared in##3##2##(2008-12#2)(2008-8#1)
reared on##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
reared##16##1##(1997-7#1)(2008-10#4)(2008-12#2)(2008-8#2)(2008-9#3)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
rearing conditions##3##2##(1991-2#3)
rearing##12##1##(1990-3#2)(1991-2#3)(1997-2#1)(2008-11#2)(2008-5#1)(2008-9#2)(2012-2#1)
rearranged into##3##2##(1996-6#2)(2008-5#1)
rearranged##12##1##(1990-6#1)(1996-5#1)(1996-6#2)(1997-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
rearrangement of the##4##3##(1996-5#1)(1996-6#1)(2008-10#1)(2008-11#1)
rearrangement of##12##2##(1995-6#1)(1996-5#5)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-12#1)
rearrangement##33##1##(1990-6#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-5#12)(1996-6#1)(1997-3#1)(1997-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2009-8#4)(2011-1#1)
rearrangements were##2##2##(1993-6#1)(1997-9#1)
rearrangements##28##1##(1993-6#1)(1994-3#1)(1995-11#1)(1997-3#1)(1997-7#1)(1997-9#3)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#2)(2011-3#1)(2012-3#6)
rearranges##2##1##(1996-5#2)
reason for admission##2##3##(1995-5#1)(2013-1#1)
reason for encounter in general practice##2##6##(2012-3#2)
reason for revision##2##3##(2008-8#1)(2013-1#1)
reason for the low##2##4##(1991-9#1)(1997-7#1)
reason for the##13##3##(1991-9#1)(1994-6#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2009-8#1)(2012-12#1)(2013-1#1)
reason for this##6##3##(2008-10#2)(2008-7#1)(2009-8#1)(2012-3#1)(2013-1#1)
reason for##45##2##(1991-12#1)(1991-9#2)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)
reason is that the##2##4##(2008-9#1)(2013-1#1)
reason is the##2##3##(2010-7#1)(2012-2#1)
reason is##4##2##(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
reason that##4##2##(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
reason to believe that##3##4##(1993-12#1)(1994-6#1)(2012-2#1)
reason to consider##2##3##(2008-12#1)(2012-3#1)
reason to##10##2##(1990-8#1)(1993-12#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-5#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
reason was##2##2##(1990-6#1)(2008-10#1)
reason why the##2##3##(2008-10#1)(2012-2#1)
reason why##5##2##(2008-10#2)(2008-9#1)(2010-6#1)(2012-2#1)
reason##105##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#3)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#1)(2007-11#1)(2008-10#14)(2008-11#9)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-1#2)(2009-11#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#7)(2013-8#2)
reasonable accommodation##2##2##(1995-6#2)
reasonable agreement##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
reasonable and##4##2##(2008-10#4)
reasonable cost##4##2##(1991-1#1)(1992-1#1)(2008-10#2)
reasonable selectivity##2##2##(2008-10#2)
reasonable separation##2##2##(2008-10#2)
reasonable to##7##2##(1990-9#1)(1991-6#2)(2008-10#1)(2008-12#1)(2010-4#1)(2012-3#1)
reasonable##60##1##(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-12#2)(1995-6#2)(1997-3#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-4#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
reasonableness##2##1##(1992-2#1)(1993-12#1)
reasonably good##4##2##(2008-10#3)(2008-2#1)
reasonably well with the##2##4##(2008-10#2)
reasonably well##6##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)
reasonably##35##1##(1990-8#1)(1992-2#1)(1993-12#1)(1994-2#1)(1997-1#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
reasoned##2##1##(1995-12#1)(2009-6#1)
reasoning and##3##2##(2008-11#1)(2008-12#1)(2009-8#1)
reasoning in the##2##3##(2008-12#1)(2010-11#1)
reasoning in##4##2##(2008-10#1)(2008-12#1)(2010-11#1)(2010-9#1)
reasoning of##2##2##(2008-11#1)(2010-9#1)
reasoning with##2##2##(2008-11#1)(2008-9#1)
reasoning##30##1##(1997-2#1)(2008-10#1)(2008-11#14)(2008-12#4)(2008-7#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-9#2)
reasons and##3##2##(1997-1#1)(2007-11#1)(2008-12#1)
reasons are##5##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)
reasons behind##2##2##(1993-2#1)(2010-12#1)
reasons for contacting##2##3##(1991-9#1)(1996-6#1)
reasons for failure of##2##4##(2008-7#1)(2012-12#1)
reasons for failure##4##3##(2008-7#1)(2012-12#1)(2013-1#2)
reasons for the##10##3##(1992-12#1)(1995-11#1)(1996-2#1)(1997-7#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
reasons for these##2##3##(1991-9#1)(1993-11#1)
reasons for this##9##3##(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
reasons for##61##2##(1991-6#2)(1991-9#2)(1992-1#1)(1992-12#1)(1993-1#2)(1993-11#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#10)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)
reasons of##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
reasons that##2##2##(2008-10#1)(2013-1#1)
reasons to##3##2##(1997-3#1)(2008-7#1)(2008-9#1)
reasons why the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
reasons why##11##2##(1991-2#1)(1991-9#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#2)
reasons##156##1##(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-6#3)(1991-8#2)(1991-9#5)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#3)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#23)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#11)(2013-8#4)
reassembled##2##1##(2008-8#1)(2012-2#1)
reassembly of##3##2##(1993-8#1)(2008-9#1)(2011-2#1)
reassembly##7##1##(1993-8#1)(2008-8#4)(2008-9#1)(2011-2#1)
reassessed##5##1##(1995-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
reassessment of##5##2##(1991-2#1)(2008-11#2)(2008-8#1)(2008-9#1)
reassessment##12##1##(1991-2#1)(1994-9#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
reassortant strain##3##2##(2008-10#3)
reassortant##10##1##(2008-10#8)(2011-2#1)(2013-8#1)
reassortants##3##1##(2008-10#3)
reassortment##4##1##(2008-10#2)(2011-2#1)(2013-8#1)
reassuring##3##1##(1990-6#1)(1995-2#1)(2007-11#1)
rebagliati##2##1##(2013-1#2)
rebalanced hemostasis##2##2##(2013-1#2)
rebased##2##1##(1992-1#2)
rebasing##2##1##(1993-12#2)
rebinding##2##1##(1994-5#1)(2008-10#1)
rebled##2##1##(1997-6#1)(2008-7#1)
rebleeding and##2##2##(2008-7#1)(2013-1#1)
rebleeding rate##2##2##(2008-7#2)
rebleeding##11##1##(1995-11#1)(1997-3#1)(2008-7#6)(2013-1#3)
rebound##4##1##(1990-5#2)(1992-3#1)(2012-2#1)
reboxetine##2##1##(2008-4#1)(2011-2#1)
rebuilding##2##1##(1992-11#1)(1992-12#1)
rebuilt##2##1##(2008-11#1)(2010-8#1)
recA##3##1##(2008-10#3)
recA-like genes##4##2##(1995-6#2)(1995-8#2)
recA-like proteins##2##2##(1995-6#1)(1995-8#1)
recA-like##7##1##(1995-6#4)(1995-8#3)
recalcitrant coronary artery spasm##2##4##(2008-7#2)
recalcitrant rural smokers##2##3##(2013-1#2)
recalcitrant##10##1##(1991-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#3)
recalculated##3##1##(1994-1#1)(2008-10#2)
recalibrated##2##1##(1993-1#1)(2008-12#1)
recalibration##5##1##(1992-12#1)(1992-2#1)(2008-10#2)(2011-2#1)
recall and##3##2##(1991-2#1)(2008-7#1)(2010-11#1)
recall of##3##2##(1991-2#1)(2011-2#2)
recall processes##2##2##(1994-8#2)
recall##29##1##(1991-10#1)(1991-2#2)(1994-12#1)(1994-8#2)(2007-12#1)(2008-11#2)(2008-12#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-1#2)(2010-11#1)(2010-6#1)(2011-2#7)(2013-1#2)
recalled##5##1##(1990-3#1)(1992-1#1)(1993-12#2)(2011-2#1)
recalling##3##1##(1996-11#1)(2008-10#1)(2008-11#1)
recalls##3##1##(1991-12#2)(2011-2#1)
recanalisation##2##1##(2011-2#2)
recanalization during##2##2##(2013-1#2)
recanalization of the##2##3##(2009-9#2)
recanalization of##5##2##(1997-6#1)(2008-12#1)(2009-9#3)
recanalization##13##1##(1991-2#1)(1997-6#1)(2008-12#1)(2009-9#3)(2013-1#6)(2013-8#1)
recanalized##2##1##(1997-8#1)(2008-7#1)
recapitulate##4##1##(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
recapitulated in##2##2##(2011-2#1)(2012-3#1)
recapitulated##3##1##(1993-12#1)(2011-2#1)(2012-3#1)
recapitulates the##2##2##(2008-11#2)
recapitulates##4##1##(2008-11#2)(2008-7#1)(2012-2#1)
recapture##3##1##(2008-11#1)(2008-2#1)(2008-9#1)
receding##2##1##(2008-10#1)(2008-9#1)
receipt of##6##2##(1995-12#1)(2008-11#1)(2008-4#1)(2013-1#3)
receipt##10##1##(1995-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2013-1#3)
receive a##7##2##(1994-3#1)(1994-5#1)(1995-12#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-3#1)
receive an##2##2##(1995-6#1)(2013-1#1)
receive care##3##2##(1994-3#1)(1996-12#2)
receive either##5##2##(2008-5#2)(2009-6#1)(2010-7#1)(2013-1#1)
receive excitatory##2##2##(1996-2#1)(2013-8#1)
receive feedback##2##2##(2009-10#2)
receive greater##4##2##(1997-8#1)(2011-2#1)(2013-1#2)
receive help##2##2##(1992-2#1)(1996-3#1)
receive less##2##2##(2009-11#1)(2012-2#1)
receive postanesthesia##2##2##(1993-1#2)
receive services##2##2##(1994-2#1)(2009-6#1)
receive the##8##2##(1990-2#1)(1992-2#1)(1994-6#1)(1994-9#2)(1997-3#1)(2008-1#1)(2011-2#1)
receive this##3##2##(1995-1#2)(2008-11#1)
receive##120##1##(1990-2#2)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#3)(1993-12#3)(1994-1#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-9#2)(1995-1#4)(1995-12#2)(1995-2#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#3)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-4#2)(2010-7#2)(2010-9#1)(2011-2#6)(2012-2#3)(2012-3#6)(2013-1#8)(2013-8#3)
received 0##3##2##(1996-12#1)(2008-12#1)(2011-2#1)
received 15##2##2##(1996-8#1)(2008-8#1)
received a##19##2##(1990-12#1)(1991-8#1)(1992-12#1)(1995-8#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#2)
received an##8##2##(1990-6#1)(1991-3#1)(1992-3#1)(1995-8#1)(2008-10#1)(2008-7#2)(2012-2#1)
received and##3##2##(1996-2#1)(1996-3#1)(2010-1#1)
received as##3##2##(2008-10#3)
received at##2##2##(2008-3#1)(2012-3#1)
received attention as##2##3##(2008-10#1)(2012-2#1)
received attention##3##2##(2008-10#1)(2012-2#2)
received between##2##2##(1993-6#1)(2008-12#1)
received bilateral##2##2##(1993-3#1)(1994-3#1)
received by the plants##2##4##(2008-10#2)
received by the##7##3##(1991-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)
received by##17##2##(1991-2#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-12#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
received chemotherapy##3##2##(1990-2#1)(2008-7#1)(2011-2#1)
received cochlear implants##4##3##(2008-9#4)
received considerable attention##2##3##(2008-11#1)(2013-1#1)
received either##5##2##(1990-5#1)(1994-8#2)(2008-10#1)(2010-1#1)
received equal##2##2##(2008-12#1)(2012-2#1)
received from the##4##3##(1991-1#1)(2008-12#1)(2008-7#1)(2008-9#1)
received from##13##2##(1991-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-8#1)
received in##2##2##(2008-11#1)(2008-3#1)
received increased attention##2##3##(1992-1#1)(2008-10#1)
received increasing##3##2##(1994-2#1)(2008-4#1)(2008-8#1)
received less##3##2##(1994-1#1)(1996-2#1)(2008-9#1)
received little attention##6##3##(2008-10#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-1#1)
received little##9##2##(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-1#2)
received mandibular##3##2##(2013-1#3)
received more than##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
received much##3##2##(1990-6#1)(2008-5#1)(2008-9#1)
received one##3##2##(2008-10#2)(2008-9#1)
received only##7##2##(1991-3#1)(1993-1#2)(1995-2#1)(1996-11#1)(2008-11#1)(2008-9#1)
received prior##2##2##(1990-6#1)(1991-4#1)
received proper##2##2##(1996-6#1)(2008-12#1)
received radiotherapy##2##2##(1992-12#1)(2009-11#1)
received routine##2##2##(1991-12#1)(2009-12#1)
received significantly##2##2##(1991-2#1)(2010-7#1)
received standard care##3##3##(2008-4#1)(2010-4#2)
received supplemental oxygen##2##3##(1993-1#2)
received the##10##2##(1990-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#2)(2010-4#1)(2010-5#1)(2013-1#2)
received this diagnosis##2##3##(1991-9#2)
received this##3##2##(1991-9#2)(2008-1#1)
received three##2##2##(1994-3#1)(2008-8#1)
received treatment with##2##3##(1991-11#1)(1991-3#1)
received two##4##2##(1994-3#1)(2012-2#1)(2013-1#2)
received various##2##2##(2008-11#1)(2008-5#1)
received was##3##2##(1992-2#1)(2008-9#1)(2009-5#1)
received##350##1##(1990-12#3)(1990-2#5)(1990-5#2)(1990-6#6)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-8#1)(1993-1#12)(1993-2#1)(1993-3#3)(1993-6#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#34)(2008-11#25)(2008-12#14)(2008-3#9)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#13)(2008-8#8)(2008-9#19)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-1#5)(2010-10#2)(2010-11#3)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#20)(2012-12#1)(2012-2#8)(2012-3#7)(2013-1#20)(2013-8#3)
receiver aperture##2##2##(2008-10#1)(2008-3#1)
receiver is##2##2##(2008-2#1)(2008-3#1)
receiver operating characteristic (ROC)##2##4##(2008-10#1)(2011-1#1)
receiver operating characteristic##3##3##(2008-10#2)(2011-1#1)
receiver operating##4##2##(2008-10#2)(2008-3#1)(2011-1#1)
receiver##32##1##(1995-5#2)(1996-12#1)(2008-10#6)(2008-2#5)(2008-3#13)(2008-8#2)(2008-9#1)(2011-1#1)(2013-1#1)
receiver-stimulator##3##1##(2008-9#3)
receivers##12##1##(1995-5#4)(2008-10#1)(2008-3#2)(2008-8#1)(2009-8#1)(2013-1#3)
receives a##2##2##(1996-5#1)(2008-10#1)
receives##14##1##(1994-12#1)(1994-2#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
receiving 6##2##2##(1996-12#1)(2012-3#1)
receiving a total##2##3##(1990-6#1)(2013-1#1)
receiving a##7##2##(1990-6#1)(1991-11#1)(1994-3#1)(2008-10#1)(2008-9#1)(2010-6#1)(2013-1#1)
receiving an##3##2##(1992-2#1)(2008-7#1)(2008-9#1)
receiving chemotherapy##6##2##(2008-7#4)(2010-2#1)(2013-1#1)
receiving erythropoietin##2##2##(1993-2#1)(2008-1#1)
receiving esomeprazole##2##2##(2011-2#2)
receiving home##2##2##(1995-3#1)(2012-12#1)
receiving inpatient##2##2##(1991-2#1)(1993-1#1)
receiving other##2##2##(1991-12#1)(2008-11#1)
receiving single fraction##2##3##(2008-10#2)
receiving single##3##2##(2008-10#3)
receiving synthetic##2##2##(2008-10#2)
receiving the##6##2##(2008-1#1)(2008-3#1)(2012-12#2)(2013-1#2)
receiving treatment at##2##3##(2012-2#1)(2013-8#1)
receiving treatment##3##2##(2008-6#1)(2012-2#1)(2013-8#1)
receiving##145##1##(1990-12#1)(1990-6#3)(1990-7#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#3)(1996-3#2)(1997-3#1)(2007-11#3)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#4)(2008-12#4)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#3)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-12#9)(2012-2#2)(2012-3#3)(2013-1#11)(2013-8#5)
recency##2##1##(1990-12#1)(1993-3#1)
recent Canadian##2##2##(1997-3#1)(2008-11#1)
recent achievements in##2##3##(2008-10#1)(2008-11#1)
recent achievements##3##2##(2008-10#2)(2008-11#1)
recent advances in the##10##4##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#1)(2011-3#1)(2012-3#1)
recent advances in understanding the##2##5##(2010-12#1)(2012-2#1)
recent advances in##27##3##(1994-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-7#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
recent advances##33##2##(1994-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-7#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)
recent analytical##2##2##(2008-11#1)(2010-7#1)
recent and##6##2##(1994-2#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
recent applications of##2##3##(2008-10#1)(2010-9#1)
recent applications to##2##3##(1994-9#1)(2008-9#1)
recent applications##4##2##(1994-9#1)(2008-10#1)(2008-9#1)(2010-9#1)
recent case of##2##3##(1990-9#1)(1991-12#1)
recent case##5##2##(1990-9#2)(1991-12#1)(2008-7#1)(2008-9#1)
recent cases##3##2##(1990-9#1)(1992-12#1)(2008-7#1)
recent changes in##2##3##(1990-8#1)(2012-3#1)
recent claims##2##2##(2010-4#1)(2010-7#1)
recent clinical trials of##2##4##(2012-12#1)(2012-3#1)
recent clinical trials##5##3##(2008-11#1)(2008-9#2)(2012-12#1)(2012-3#1)
recent clinical##6##2##(1996-11#1)(2008-11#1)(2008-9#2)(2012-12#1)(2012-3#1)
recent common ancestor##3##3##(2008-10#3)
recent comprehensive##2##2##(1996-2#1)(2008-7#1)
recent conceptual syntheses##2##3##(2008-9#2)
recent conceptual##3##2##(2008-9#2)(2009-4#1)
recent data from##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
recent data##11##2##(1993-3#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2011-2#2)(2011-3#1)
recent decades##5##2##(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
recent demonstration##2##2##(1996-2#1)(2009-5#1)
recent development of##8##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#1)
recent development##9##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)
recent developments in the##7##4##(1994-9#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-6#1)
recent developments in##18##3##(1990-8#1)(1994-9#1)(1996-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)
recent developments on cost-effective flow-based analysis##2##6##(2008-10#2)
recent developments regarding##2##3##(2009-10#1)(2011-2#1)
recent developments##30##2##(1990-8#1)(1991-2#1)(1992-11#1)(1994-9#1)(1996-3#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-7#2)(2011-2#3)(2013-8#1)
recent evidence##3##2##(1995-6#1)(2008-7#1)(2013-1#1)
recent examples##2##2##(1996-6#1)(2008-7#1)
recent experience of##2##3##(2008-11#2)
recent experimental##3##2##(2008-11#1)(2008-5#1)(2010-7#1)
recent experiments##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
recent finding that##2##3##(2009-8#2)
recent finding##4##2##(2008-10#1)(2009-8#2)(2010-11#1)
recent findings in##4##3##(2008-1#1)(2009-10#1)(2011-2#1)(2012-2#1)
recent findings on##2##3##(2011-2#1)(2013-8#1)
recent findings showing that##2##4##(2008-7#1)(2013-7#1)
recent findings that##2##3##(1994-8#1)(2008-8#1)
recent findings##27##2##(1991-2#1)(1991-3#1)(1994-8#1)(1995-8#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2010-9#1)(2011-2#4)(2011-7#1)(2012-2#2)(2013-7#1)(2013-8#3)
recent genetic##2##2##(1995-6#1)(2011-2#1)
recent government##2##2##(2008-11#2)
recent improvement##2##2##(1996-3#1)(2008-7#1)
recent improvements##2##2##(2008-10#1)(2009-3#1)
recent innovations in##2##3##(2008-8#1)(2010-1#1)
recent insights into##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
recent interest##2##2##(1995-5#1)(2010-7#1)
recent introduction of##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
recent introduction##5##2##(1991-2#1)(2008-10#2)(2008-3#1)(2011-2#1)
recent investigations##2##2##(1992-3#1)(2008-11#1)
recent large##4##2##(1992-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
recent legal##5##2##(2008-11#4)(2009-11#1)
recent literature on##2##3##(1994-6#1)(1996-1#1)
recent literature##12##2##(1991-2#1)(1994-6#1)(1996-1#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
recent neuroimaging##2##2##(2008-11#2)
recent observations##3##2##(1992-5#1)(2008-10#1)(2008-3#1)
recent ongoing##2##2##(2008-11#1)(2010-5#1)
recent onset of##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
recent onset##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
recent outbreak of##2##3##(2007-12#1)(2008-10#1)
recent paper in##3##3##(2009-8#3)
recent paper##7##2##(2008-10#1)(2008-2#1)(2009-6#1)(2009-8#4)
recent progress in the development of##3##6##(2011-2#1)(2011-3#1)(2013-1#1)
recent progress in the##7##4##(1991-2#1)(2008-11#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#1)
recent progress in##12##3##(1991-2#1)(2008-1#1)(2008-11#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2013-1#1)
recent progress on##2##3##(2009-7#1)(2011-2#1)
recent progress##17##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#1)(2011-2#4)(2011-3#1)(2013-1#1)
recent publication##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
recent publications##6##2##(1993-3#1)(1996-8#1)(2008-10#1)(2009-10#1)(2011-2#2)
recent published##3##2##(1995-11#1)(1995-12#1)(2006-6#1)
recent recommendations##2##2##(2008-10#1)(2008-11#1)
recent report##4##2##(1992-3#1)(1992-8#1)(2008-6#1)(2009-8#1)
recent reports##7##2##(1990-5#1)(1991-2#1)(1992-12#1)(2007-11#1)(2008-11#1)(2009-8#1)(2012-2#1)
recent research findings##3##3##(1991-2#2)(2008-11#1)
recent research has##4##3##(2008-11#2)(2008-8#1)(2013-8#1)
recent research on the##2##4##(2008-10#1)(2008-9#1)
recent research suggests##2##3##(2008-8#1)(2013-1#1)
recent research##17##2##(1991-2#2)(1991-6#1)(2008-10#4)(2008-11#4)(2008-8#2)(2008-9#1)(2009-8#1)(2013-1#1)(2013-8#1)
recent results obtained##2##3##(2008-5#1)(2011-2#1)
recent results of##2##3##(2008-10#1)(2008-4#1)
recent results##8##2##(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#2)
recent resurgence##2##2##(2008-7#1)(2008-8#1)
recent state##2##2##(1993-2#1)(2008-11#1)
recent studies conducted in##2##4##(1996-1#1)(2009-1#1)
recent studies have demonstrated that##2##5##(2008-1#1)(2011-2#1)
recent studies have suggested that##2##5##(2010-12#1)(2013-1#1)
recent studies have suggested##3##4##(2010-12#1)(2013-1#2)
recent studies have##10##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
recent studies of##2##3##(2008-4#1)(2012-2#1)
recent studies on the##3##4##(2008-5#1)(2009-6#1)(2011-2#1)
recent studies on##6##3##(1997-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#1)
recent studies show##2##3##(2007-11#1)(2008-3#1)
recent studies suggest that##2##4##(1993-6#1)(2011-2#1)
recent studies##37##2##(1993-11#1)(1993-6#1)(1995-6#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#7)(2012-2#1)(2013-1#3)
recent study of##2##3##(1997-7#1)(2008-1#1)
recent study showed##2##3##(2008-5#1)(2013-1#1)
recent study##21##2##(1990-11#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2009-8#3)(2010-12#1)(2010-4#1)(2011-2#5)(2013-1#1)
recent surge in##2##3##(2008-10#1)(2008-11#1)
recent synaptic##2##2##(2008-11#2)
recent technological##2##2##(2008-11#1)(2010-7#1)
recent trends in##5##3##(1992-12#1)(1994-6#1)(2008-1#1)(2011-2#2)
recent trends##7##2##(1992-12#1)(1994-6#1)(2008-1#1)(2008-11#2)(2011-2#2)
recent trials and##2##3##(2008-8#1)(2009-10#1)
recent work has identified##2##4##(1991-3#1)(2008-11#1)
recent work has##3##3##(1991-3#1)(1996-2#1)(2008-11#1)
recent work##9##2##(1991-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#1)
recent years as##3##3##(1996-1#1)(2008-10#2)
recent years has##2##3##(1997-4#1)(2008-4#1)
recent years there have been##2##5##(1990-11#1)(2008-11#1)
recent years there##4##3##(1990-11#1)(2008-11#1)(2008-3#1)(2008-7#1)
recent years##105##2##(1990-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-1#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-11#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#11)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2010-12#2)(2010-6#2)(2010-7#2)(2010-9#1)(2011-2#9)(2011-3#5)(2011-7#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#1)
recent##738##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#4)(1991-2#10)(1991-3#5)(1991-6#5)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#2)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#3)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#5)(1996-11#4)(1996-2#7)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#5)(2006-6#1)(2007-11#2)(2007-12#5)(2008-1#12)(2008-10#105)(2008-11#72)(2008-12#6)(2008-2#4)(2008-3#11)(2008-4#8)(2008-5#12)(2008-6#6)(2008-7#32)(2008-8#20)(2008-9#22)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#6)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#5)(2009-7#7)(2009-8#23)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#5)(2010-12#11)(2010-3#1)(2010-4#5)(2010-5#6)(2010-6#5)(2010-7#14)(2010-8#3)(2010-9#4)(2011-1#1)(2011-2#63)(2011-3#9)(2011-7#4)(2012-12#6)(2012-2#13)(2012-3#14)(2012-5#1)(2013-1#27)(2013-7#1)(2013-8#12)
recently acquired##3##2##(1990-5#1)(2008-2#1)(2009-8#1)
recently and##6##2##(1993-3#1)(1994-9#1)(2008-10#1)(2008-9#2)(2009-12#1)
recently available data##2##3##(1993-2#1)(2009-10#1)
recently became##2##2##(2006-6#1)(2009-7#1)
recently become##4##2##(1993-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
recently been described##3##3##(1990-5#1)(2010-12#1)(2013-1#1)
recently been developed##5##3##(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
recently been found##2##3##(2008-10#1)(2009-4#1)
recently been identified as a##3##5##(1994-11#1)(1994-12#1)(2008-5#1)
recently been identified as##4##4##(1994-11#1)(1994-12#1)(1996-2#1)(2008-5#1)
recently been identified##5##3##(1993-2#1)(1994-11#1)(1994-12#1)(1996-2#1)(2008-5#1)
recently been investigated##2##3##(2011-1#1)(2012-4#1)
recently been made##2##3##(1993-1#1)(2011-1#1)
recently been observed##2##3##(2008-10#1)(2012-2#1)
recently been proposed##4##3##(1994-6#1)(1995-12#1)(2013-1#2)
recently been reported##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
recently been shown to be##2##5##(1995-2#1)(2012-2#1)
recently been shown to##7##4##(1993-8#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-2#1)
recently been suggested##3##3##(1994-12#1)(2010-12#1)(2013-1#1)
recently been##67##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-6#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#8)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#2)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#5)(2013-7#1)
recently characterized##4##2##(1993-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
recently cloned from##2##3##(1997-2#1)(2008-10#1)
recently cloned##5##2##(1992-6#1)(1997-2#1)(2008-10#2)(2008-8#1)
recently completed##3##2##(1997-2#1)(2008-11#1)(2010-11#1)
recently demonstrated in##2##3##(2008-11#2)
recently demonstrated that##6##3##(1994-2#1)(1994-8#1)(2009-8#3)(2011-1#1)
recently demonstrated##10##2##(1994-2#1)(1994-8#1)(2008-11#2)(2009-8#3)(2011-1#1)(2011-2#1)(2012-2#1)
recently described S##2##3##(2008-10#1)(2009-6#1)
recently described an##3##3##(1990-8#1)(1994-5#1)(2011-2#1)
recently described in##2##3##(2008-11#1)(2010-10#1)
recently described##19##2##(1990-8#1)(1991-7#1)(1994-5#1)(1995-6#1)(2008-10#5)(2008-11#3)(2008-6#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#2)
recently detected##3##2##(1990-5#1)(2008-10#1)(2012-2#1)
recently determined##2##2##(1996-12#1)(2012-2#1)
recently developed a##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
recently developed by##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
recently developed for##3##3##(2008-11#2)(2008-3#1)
recently developed##37##2##(1994-2#1)(1995-11#2)(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#5)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
recently diagnosed##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
recently discovered that the##3##4##(2009-6#1)(2011-2#2)
recently discovered that##4##3##(2009-6#1)(2010-7#1)(2011-2#2)
recently discovered##11##2##(1990-3#1)(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-7#1)(2011-2#2)(2013-1#2)
recently emerged as##2##3##(2008-11#2)
recently emerged##5##2##(2008-11#2)(2008-4#1)(2012-12#1)(2013-1#1)
recently enacted##2##2##(1991-2#2)
recently established##4##2##(1994-12#1)(2008-10#2)(2008-11#1)
recently evolved##4##2##(2008-10#3)(2011-2#1)
recently for##3##2##(2008-11#1)(2010-6#1)(2013-1#1)
recently found that##3##3##(1991-12#1)(1994-3#1)(2011-2#1)
recently found##7##2##(1991-12#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
recently had##2##2##(2010-12#1)(2010-6#1)
recently has been##2##3##(2011-7#1)(2013-8#1)
recently has##3##2##(2008-9#1)(2011-7#1)(2013-8#1)
recently have been##2##3##(2008-10#1)(2008-8#1)
recently have##5##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-7#1)
recently identified as##4##3##(1994-11#2)(1996-12#1)(2008-10#1)
recently identified in the##2##4##(1991-5#1)(1994-11#1)
recently identified##16##2##(1991-5#1)(1994-11#3)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#3)(2013-7#1)
recently in##2##2##(2008-10#1)(2008-11#1)
recently introduced##8##2##(2008-10#6)(2008-11#1)(2008-3#1)
recently is##2##2##(1993-3#1)(1997-6#1)
recently isolated viruses##2##3##(2013-8#2)
recently isolated##5##2##(1992-6#1)(1995-12#1)(2008-5#1)(2013-8#2)
recently joined##2##2##(1991-1#1)(2011-2#1)
recently led to##2##3##(1995-5#1)(2011-2#1)
recently made##2##2##(2007-8#1)(2008-11#1)
recently observed in##2##3##(2008-10#1)(2008-3#1)
recently observed that##3##3##(1990-5#1)(1997-7#1)(2008-10#1)
recently observed##7##2##(1990-5#1)(1992-9#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-3#1)
recently obtained##2##2##(2009-3#1)(2011-2#1)
recently proposed for##3##3##(2008-10#2)(2012-2#1)
recently proposed that the##2##4##(2008-10#1)(2008-11#1)
recently proposed that##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
recently proposed##20##2##(1991-5#1)(1994-9#1)(1995-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-8#1)(2012-2#1)
recently published model##2##3##(2008-3#1)(2012-3#1)
recently published studies##2##3##(2008-12#1)(2012-3#1)
recently published##15##2##(1993-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
recently received##4##2##(1992-1#1)(1992-12#1)(2008-11#1)(2010-10#1)
recently reported on##2##3##(2008-11#1)(2011-2#1)
recently reported that##7##3##(1995-2#1)(1995-6#1)(1997-3#1)(2008-8#1)(2009-8#2)(2012-2#1)
recently reported##22##2##(1992-4#1)(1992-8#1)(1993-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-3#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2009-8#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
recently revised##4##2##(1994-5#1)(2008-5#1)(2009-4#1)(2012-2#1)
recently shown that##13##3##(1990-5#1)(1994-5#1)(2008-1#1)(2008-11#1)(2009-8#7)(2011-2#2)
recently shown to##2##3##(1994-5#1)(2009-10#1)
recently shown##15##2##(1990-5#1)(1994-5#2)(2008-1#1)(2008-11#1)(2009-10#1)(2009-8#7)(2011-2#2)
recently suggested##2##2##(2008-5#1)(2010-12#1)
recently synthesized 1##2##3##(2008-10#2)
recently synthesized##15##2##(1990-11#1)(2008-10#14)
recently that##2##2##(2008-10#1)(2008-11#1)
recently the##2##2##(1996-6#1)(2011-2#1)
recently to the##2##3##(2008-10#2)
recently to##5##2##(2008-10#2)(2008-7#2)(2008-8#1)
recently under##2##2##(2008-10#2)
recently used##2##2##(2008-10#1)(2009-8#1)
recently utilized##2##2##(2008-10#1)(2008-12#1)
recently with##2##2##(1993-3#1)(2008-2#1)
recently##563##1##(1990-11#2)(1990-3#1)(1990-5#5)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#3)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#6)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#5)(1994-12#8)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#7)(1995-2#3)(1995-5#3)(1995-6#6)(1996-12#3)(1996-2#3)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#4)(1997-9#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#5)(2008-10#108)(2008-11#46)(2008-12#10)(2008-2#3)(2008-3#11)(2008-4#7)(2008-5#15)(2008-6#2)(2008-7#9)(2008-8#13)(2008-9#10)(2009-10#6)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#20)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#6)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#44)(2011-3#1)(2011-7#2)(2012-12#4)(2012-2#18)(2012-3#10)(2012-4#1)(2013-1#17)(2013-7#2)(2013-8#9)
receptacle area##8##2##(2008-10#8)
receptacle##14##1##(1996-9#1)(2007-12#2)(2008-10#11)
reception of##3##2##(2008-11#2)(2008-2#1)
reception##8##1##(1996-1#1)(2008-11#2)(2008-2#1)(2009-8#2)(2012-12#1)(2012-2#1)
receptive and expressive##2##3##(2011-1#1)(2012-2#1)
receptive field##6##2##(1996-2#1)(2008-11#1)(2008-8#4)
receptive fields of simple cells in the##2##7##(1996-2#1)(2008-11#1)
receptive fields##8##2##(1996-2#1)(2007-12#1)(2008-11#3)(2008-8#3)
receptive language##2##2##(2008-9#2)
receptive neurons in the##2##4##(1992-3#2)
receptive neurons##3##2##(1992-3#3)
receptive to##3##2##(1991-6#1)(2008-10#1)(2010-11#1)
receptive##30##1##(1991-6#1)(1992-3#3)(1996-2#2)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-8#7)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
receptivity##4##1##(2008-10#1)(2008-9#2)(2012-3#1)
receptor (AR)##3##2##(1990-11#2)(1995-12#1)
receptor (EGFR)##3##2##(1995-11#1)(2008-11#1)(2013-1#1)
receptor (ER)##13##2##(1990-11#1)(1990-12#1)(1992-6#1)(1993-1#2)(1994-12#1)(1995-11#1)(2008-10#1)(2008-11#3)(2008-6#1)(2011-2#1)
receptor (GHR)##3##2##(1995-8#1)(2008-9#1)(2010-5#1)
receptor (LDLR)##2##2##(1995-2#1)(2013-1#1)
receptor (LHR)##2##2##(2008-8#2)
receptor (TCR) transgenic mice##2##4##(2008-11#2)
receptor (TCR)##4##2##(1994-3#1)(2008-11#3)
receptor (hIL-6R)##2##2##(2008-8#2)
receptor (nAChR)##2##2##(1994-5#1)(2008-8#1)
receptor 1##4##2##(1995-2#1)(1997-1#1)(2008-11#1)(2012-2#1)
receptor 2##3##2##(2012-3#3)
receptor Flt-1##2##2##(2008-8#2)
receptor activation by##3##3##(1990-5#1)(1994-6#1)(2008-10#1)
receptor activation##11##2##(1990-5#2)(1992-4#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-10#1)(2009-8#1)
receptor activator of##2##3##(2008-11#2)
receptor activity##5##2##(1991-2#3)(1995-6#1)(2011-2#1)
receptor affinity and##2##3##(1994-5#1)(2008-11#1)
receptor affinity##4##2##(1993-8#1)(1994-5#1)(1997-1#1)(2008-11#1)
receptor agonist##18##2##(1994-2#2)(1995-11#1)(1995-2#1)(1996-2#6)(1997-1#1)(1997-2#2)(2008-10#2)(2008-8#1)(2010-6#1)(2010-8#1)
receptor agonists and##2##3##(1993-12#1)(2009-7#1)
receptor agonists##11##2##(1993-12#2)(1993-3#1)(1994-2#3)(1995-12#1)(1995-8#1)(1996-2#2)(2009-7#1)
receptor alpha subunit##2##3##(1993-12#1)(1995-6#1)
receptor alpha##15##2##(1991-9#1)(1993-12#2)(1995-11#1)(1995-6#1)(1996-12#1)(1997-9#2)(2008-11#2)(2008-12#2)(2011-2#1)(2012-12#1)(2013-8#1)
receptor alpha-chain##2##2##(1995-6#1)(1997-7#1)
receptor also mediates##2##3##(2008-4#1)(2008-5#1)
receptor also##3##2##(2008-4#2)(2008-5#1)
receptor and a##3##3##(1992-3#1)(1993-3#1)(2008-11#1)
receptor and is##2##3##(1996-12#1)(2008-10#1)
receptor and its##2##3##(1995-11#1)(2008-8#1)
receptor and plasminogen activator activity by estrogen are related to the##2##11##(2008-11#2)
receptor and subsequent##3##3##(1995-6#1)(2008-11#1)(2013-7#1)
receptor and that##2##3##(1991-12#1)(1992-4#1)
receptor and with the##2##4##(1996-2#2)
receptor and##44##2##(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-2#3)(1995-11#2)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#4)(2008-10#2)(2008-11#10)(2008-4#2)(2008-8#4)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2013-7#1)
receptor antagonist (IL-1ra)##2##3##(1995-2#1)(2008-5#1)
receptor antagonist and##2##3##(1995-8#1)(2012-12#1)
receptor antagonist##54##2##(1990-12#2)(1990-5#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#4)(1994-8#1)(1995-12#2)(1995-2#3)(1995-8#1)(1996-12#1)(1996-2#8)(1997-2#3)(1997-4#4)(2006-6#3)(2008-10#1)(2008-11#4)(2008-5#1)(2008-8#5)(2008-9#1)(2010-12#1)(2012-12#1)
receptor antagonist)##2##2##(1995-12#1)(2008-5#1)
receptor antagonists in##2##3##(1992-11#1)(2008-1#1)
receptor antagonists##25##2##(1991-5#2)(1992-11#1)(1994-11#3)(1994-2#1)(1995-10#2)(1995-11#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-12#1)
receptor antibodies##2##2##(1995-6#1)(2009-11#1)
receptor antibody##3##2##(1991-5#1)(1994-3#1)(2008-11#1)
receptor as##4##2##(1995-11#1)(2008-4#1)(2008-8#1)(2009-6#1)
receptor at##6##2##(1992-12#1)(1993-1#1)(1993-6#1)(1995-6#2)(2008-8#1)
receptor autophosphorylation##2##2##(1990-12#1)(1992-10#1)
receptor beta##3##2##(1995-8#1)(1996-2#1)(2008-4#1)
receptor beta-chain##3##2##(1994-11#2)(1995-6#1)
receptor binding affinity##2##3##(1993-1#1)(1997-4#1)
receptor binding and##4##3##(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)
receptor binding assays##3##3##(1992-12#1)(1994-5#1)(1995-8#1)
receptor binding capacity##2##3##(2008-9#2)
receptor binding in##2##3##(1990-11#1)(1992-3#1)
receptor binding sites##2##3##(1990-12#1)(1995-11#1)
receptor binding was##2##3##(1996-12#1)(1996-2#1)
receptor binding##33##2##(1990-11#2)(1990-12#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-8#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#1)(1997-4#2)(2007-11#1)(2008-8#1)(2008-9#4)
receptor binds and##2##3##(1995-2#1)(1995-6#1)
receptor blockade##3##2##(1994-11#1)(2010-4#1)(2011-2#1)
receptor blocker##6##2##(1994-2#4)(1996-2#1)(2008-9#1)
receptor blockers and##2##3##(1996-3#1)(2008-11#1)
receptor blockers##8##2##(1996-3#1)(1996-6#3)(2008-11#3)(2011-2#1)
receptor but##2##2##(1990-11#2)
receptor by##8##2##(1991-5#1)(1993-6#1)(1994-11#1)(1995-6#2)(1995-8#1)(1996-12#1)(2008-8#1)
receptor c-Mpl##2##2##(2008-8#2)
receptor cDNA as a probe##2##5##(1994-11#1)(1995-6#1)
receptor cDNA##12##2##(1990-5#1)(1991-5#1)(1992-3#1)(1994-11#2)(1995-12#2)(1995-6#4)(1997-9#1)
receptor cDNAs##2##2##(1995-12#1)(1997-2#1)
receptor can##4##2##(1995-11#1)(1996-12#1)(2008-8#1)(2011-2#1)
receptor cell##2##2##(2008-10#1)(2008-7#1)
receptor cells##2##2##(1994-2#1)(2008-7#1)
receptor chains##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
receptor complex##11##2##(1991-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#2)(2009-8#1)
receptor complexes##2##2##(1995-11#1)(1996-2#1)
receptor consists of##2##3##(1991-5#1)(1995-6#1)
receptor contact##2##2##(1994-5#2)
receptor deficient mice##2##3##(2008-6#2)
receptor degradation##2##2##(1993-8#1)(1997-5#1)
receptor densities and##2##3##(1994-2#2)
receptor densities##7##2##(1994-2#4)(2008-11#3)
receptor density and mRNA##3##4##(1995-2#3)
receptor density##6##2##(1995-2#4)(2008-11#2)
receptor domains##4##2##(1993-6#3)(1996-2#1)
receptor exhibited##2##2##(1994-12#1)(1995-6#1)
receptor expressed in##3##3##(1992-3#2)(1995-11#1)
receptor expression and##2##3##(2008-11#1)(2010-8#1)
receptor expression in##5##3##(1991-5#1)(1994-11#2)(1995-12#1)(2013-7#1)
receptor expression##21##2##(1991-3#2)(1991-5#2)(1994-11#4)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-7#1)
receptor family##7##2##(1993-2#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-12#1)(2008-4#1)
receptor for sperm##2##3##(1994-5#1)(1995-6#1)
receptor for the##2##3##(1995-2#1)(2011-2#1)
receptor for##13##2##(1990-11#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-6#2)(1996-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
receptor from##2##2##(1990-8#1)(2008-11#1)
receptor function##4##2##(1991-5#1)(1995-11#3)
receptor gamma 2 subunit subtype##3##5##(1995-11#3)
receptor gamma 2 subunit##4##4##(1995-11#3)(1995-12#1)
receptor gamma 2##5##3##(1994-12#1)(1995-11#3)(1995-12#1)
receptor gamma##6##2##(1994-12#1)(1995-11#3)(1995-12#1)(2009-8#1)
receptor gene in the##2##4##(1991-5#1)(1995-6#1)
receptor gene in##6##3##(1991-5#1)(1994-11#1)(1994-12#2)(1995-6#1)(2008-11#1)
receptor gene##35##2##(1991-5#4)(1991-7#1)(1991-9#1)(1992-3#2)(1993-3#3)(1993-9#1)(1994-11#2)(1994-12#7)(1995-2#2)(1995-6#2)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2013-8#1)
receptor genes##4##2##(1993-6#1)(1997-2#2)(1997-7#1)
receptor has been##3##3##(1995-11#1)(1995-2#1)(2008-4#1)
receptor has##5##2##(1993-2#1)(1995-11#1)(1995-2#1)(2008-4#1)(2009-6#1)
receptor in a##2##3##(1993-8#1)(1995-11#1)
receptor in human##2##3##(2008-10#1)(2008-5#1)
receptor in the maintenance of thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat##2##19##(1995-12#2)
receptor in the##14##3##(1990-11#1)(1991-7#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(2008-8#2)(2011-2#1)(2012-3#1)
receptor in##39##2##(1990-11#2)(1991-7#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#5)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#3)(2011-2#2)(2012-3#1)(2013-7#1)
receptor inhibitors in##2##3##(2008-1#1)(2009-4#1)
receptor inhibitors##3##2##(2006-6#1)(2008-1#1)(2009-4#1)
receptor interaction##2##2##(1995-2#1)(1995-6#1)
receptor interactions##5##2##(1990-4#1)(1994-5#1)(1996-2#1)(2008-4#1)(2008-9#1)
receptor internalization##2##2##(1995-2#1)(1996-2#1)
receptor is a##2##3##(1993-6#1)(1995-11#1)
receptor is involved in##2##4##(2008-5#1)(2008-8#1)
receptor is##21##2##(1990-11#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-6#2)(1997-2#1)(2008-11#2)(2008-5#2)(2008-8#1)(2011-2#1)
receptor isoforms##2##2##(1997-1#1)(2008-10#1)
receptor kinases##2##2##(1995-2#1)(2009-8#1)
receptor level as well as plasminogen activator activity in MCF-7 cells##3##11##(2008-11#3)
receptor levels and the##2##4##(1991-2#1)(1993-11#1)
receptor levels##7##2##(1991-2#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-12#3)
receptor ligand##4##2##(1993-3#1)(1996-2#1)(1997-1#1)(2009-8#1)
receptor ligands including##2##3##(1995-6#1)(2009-8#1)
receptor ligands##9##2##(1994-2#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-9#3)(2009-8#1)
receptor mRNA and##3##3##(1991-5#1)(1996-2#2)
receptor mRNA expression##2##3##(1996-2#1)(2010-12#1)
receptor mRNA in##4##3##(1993-5#1)(1994-6#1)(1996-12#1)(1996-2#1)
receptor mRNA level##2##3##(1991-5#1)(1995-2#1)
receptor mRNA were##2##3##(1993-3#1)(1994-11#1)
receptor mRNA##21##2##(1991-5#2)(1993-3#1)(1993-5#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1996-12#3)(1996-2#6)(2010-12#1)
receptor mRNAs##3##2##(1995-12#1)(1996-2#1)(2008-6#1)
receptor may be##3##3##(1995-2#1)(2008-10#2)
receptor may##8##2##(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-5#1)(2008-8#1)
receptor mediated##4##2##(1991-5#1)(1994-8#1)(2008-10#1)(2008-8#1)
receptor molecules and##2##3##(1996-12#2)
receptor molecules in##2##3##(1993-8#1)(1996-12#1)
receptor molecules##9##2##(1993-8#3)(1996-12#5)(2009-8#1)
receptor neurons##5##2##(2007-12#3)(2008-7#1)(2009-12#1)
receptor nor##2##2##(1994-6#1)(2008-11#1)
receptor of the##2##3##(1995-8#1)(2011-2#1)
receptor of##12##2##(1993-3#1)(1993-8#2)(1994-5#2)(1995-2#1)(1995-8#1)(1997-7#1)(2008-11#1)(2008-8#2)(2011-2#1)
receptor on the##2##3##(1990-5#1)(2008-11#1)
receptor on##7##2##(1990-5#1)(1992-10#1)(1992-12#1)(1995-2#1)(2008-11#3)
receptor phosphorylation##4##2##(1995-6#2)(1996-12#1)(2013-7#1)
receptor plays a##4##3##(1993-3#1)(1995-2#1)(1995-6#1)(2008-11#1)
receptor populations##2##2##(1991-4#1)(1994-11#1)
receptor present##2##2##(1993-6#1)(1994-11#1)
receptor production##2##2##(2008-11#2)
receptor protein tyrosine kinase##3##4##(1993-8#2)(1997-7#1)
receptor protein##8##2##(1992-6#1)(1993-8#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-9#1)
receptor proteins##3##2##(1995-8#2)(2009-12#1)
receptor pseudogene##2##2##(1993-12#1)(1993-2#1)
receptor recognition##2##2##(1995-12#1)(2008-8#1)
receptor regulated##2##2##(1993-6#1)(2008-8#1)
receptor remains##2##2##(1994-8#1)(1995-6#1)
receptor represents a##2##3##(1995-11#1)(1996-12#1)
receptor selectivity##2##2##(1992-3#1)(2011-2#1)
receptor sequence##2##2##(1995-6#1)(2011-2#1)
receptor showed##2##2##(1995-11#1)(1997-2#1)
receptor signaling##3##2##(1991-9#1)(2008-11#1)(2009-12#1)
receptor since##2##2##(1993-1#1)(1995-6#1)
receptor sites##2##2##(1995-11#1)(2008-5#1)
receptor status##4##2##(1993-11#2)(1995-9#1)(2013-1#1)
receptor stimulation##4##2##(1995-11#2)(1995-2#1)(2010-12#1)
receptor subtype##11##2##(1992-3#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(2008-10#1)
receptor subtypes##11##2##(1994-11#1)(1995-11#2)(1995-2#2)(1996-2#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
receptor subunit in the##2##4##(1995-12#2)
receptor subunit##16##2##(1993-12#2)(1994-5#1)(1995-11#1)(1995-12#3)(1996-12#5)(1996-2#1)(1997-2#2)(2008-7#1)
receptor subunits##2##2##(1997-2#1)(2010-8#1)
receptor superfamily##5##2##(1995-12#1)(1995-2#2)(1996-2#2)
receptor that##4##2##(1994-12#1)(1995-2#1)(1996-12#1)(2008-4#1)
receptor to##5##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
receptor type##3##2##(1994-6#1)(1996-12#1)(2011-2#1)
receptor tyrosine kinase activity##3##4##(1990-12#2)(1997-1#1)
receptor tyrosine kinase##8##3##(1990-12#2)(1992-7#1)(1993-8#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-7#1)
receptor tyrosine kinases (RTKs)##2##4##(1993-8#1)(2009-9#1)
receptor tyrosine kinases##7##3##(1993-8#1)(1994-11#1)(1995-2#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)
receptor tyrosine##15##2##(1990-12#2)(1992-7#1)(1993-8#2)(1994-11#1)(1995-2#2)(1995-8#1)(1997-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)
receptor varies##2##2##(1995-12#1)(1996-2#1)
receptor was##14##2##(1990-11#1)(1993-12#1)(1993-3#1)(1995-8#1)(1997-2#1)(2008-11#3)(2008-8#3)(2008-9#1)(2011-2#1)(2013-7#1)
receptor were##4##2##(1991-5#1)(1993-6#1)(2008-11#1)(2008-8#1)
receptor with a##2##3##(1994-12#1)(1995-11#1)
receptor with##5##2##(1990-8#1)(1991-12#1)(1994-12#1)(1995-11#1)(2013-7#1)
receptor##1302##1##(1990-11#23)(1990-12#8)(1990-2#4)(1990-4#4)(1990-5#8)(1990-7#1)(1990-8#8)(1991-1#3)(1991-12#5)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#23)(1991-6#5)(1991-7#3)(1991-9#4)(1992-10#4)(1992-11#1)(1992-12#6)(1992-3#17)(1992-4#4)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#4)(1993-1#7)(1993-11#7)(1993-12#10)(1993-2#5)(1993-3#18)(1993-5#1)(1993-6#17)(1993-8#39)(1993-9#3)(1994-11#37)(1994-12#20)(1994-2#26)(1994-3#3)(1994-5#24)(1994-6#9)(1994-8#20)(1994-9#1)(1995-10#2)(1995-11#58)(1995-12#34)(1995-2#63)(1995-6#55)(1995-8#28)(1995-9#1)(1996-12#49)(1996-2#57)(1996-3#2)(1996-5#1)(1996-6#3)(1997-1#13)(1997-2#20)(1997-3#1)(1997-4#9)(1997-5#2)(1997-7#15)(1997-8#2)(1997-9#5)(2006-6#10)(2007-11#3)(2007-12#5)(2008-1#4)(2008-10#36)(2008-11#110)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#23)(2008-5#17)(2008-6#9)(2008-7#15)(2008-8#60)(2008-9#30)(2009-11#1)(2009-12#5)(2009-3#2)(2009-4#1)(2009-6#4)(2009-7#5)(2009-8#18)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#7)(2011-1#6)(2011-2#31)(2011-3#2)(2012-12#4)(2012-2#12)(2012-3#8)(2013-1#13)(2013-7#8)(2013-8#5)
receptor(s) in##2##2##(2008-10#1)(2013-1#1)
receptor(s)##6##1##(1990-5#2)(1993-3#1)(1997-2#1)(2008-10#1)(2013-1#1)
receptor)##6##1##(1993-12#1)(1995-6#1)(2008-11#2)(2008-8#1)(2011-2#1)
receptor-1##4##1##(1993-6#2)(1995-8#1)(2009-3#1)
receptor-alpha##3##1##(2011-2#2)(2013-1#1)
receptor-associated##2##1##(1995-8#1)(2008-8#1)
receptor-bearing neurons##3##2##(1991-12#3)
receptor-binding affinity##4##2##(2012-2#4)
receptor-binding region##2##2##(1990-4#2)
receptor-binding##10##1##(1990-4#2)(1995-12#1)(2008-10#1)(2012-2#6)
receptor-bound##5##1##(1993-8#3)(1994-5#1)(1995-11#1)
receptor-dependent##5##1##(1993-12#1)(1995-8#1)(1997-1#1)(2009-8#1)(2013-1#1)
receptor-derived##2##1##(1992-4#1)(2008-11#1)
receptor-encoding gene##2##2##(1993-6#1)(2013-8#1)
receptor-independent##2##1##(1993-12#1)(1995-2#1)
receptor-induced##2##1##(1992-6#1)(2011-2#1)
receptor-ligand interactions##2##2##(1995-11#1)(2008-4#1)
receptor-ligand##3##1##(1995-11#1)(2008-4#1)(2009-3#1)
receptor-like##7##1##(1996-2#2)(2008-10#1)(2008-11#2)(2009-10#2)
receptor-mediated endocytosis##6##2##(1993-9#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-11#2)
receptor-mediated inhibition##3##2##(1997-1#1)(2011-2#2)
receptor-mediated inositol##2##2##(1995-11#1)(1997-1#1)
receptor-mediated inward current##2##3##(1995-11#2)
receptor-mediated inward currents evoked##2##4##(1995-11#2)
receptor-mediated inward currents##4##3##(1995-11#4)
receptor-mediated inward##6##2##(1995-11#6)
receptor-mediated##38##1##(1990-12#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-11#8)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#3)(2013-8#2)
receptor-negative##3##1##(1990-8#1)(1997-7#1)(2011-1#1)
receptor-positive##6##1##(1991-12#1)(1992-4#1)(1997-7#1)(1997-8#1)(2008-11#1)(2011-1#1)
receptor-specific regulation of the##2##4##(1993-6#2)
receptor-specific##5##1##(1993-1#1)(1993-6#2)(1994-2#1)(2010-5#1)
receptor-stimulated##2##1##(1992-10#1)(1996-2#1)
receptor-type##2##1##(1997-7#2)
receptors activate##2##2##(1996-2#1)(2008-7#1)
receptors and the##8##3##(1993-2#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-11#2)(2008-4#1)(2008-7#1)
receptors and their##3##3##(1994-2#1)(2008-4#1)(2009-7#1)
receptors and##53##2##(1990-11#1)(1990-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#3)(1995-11#2)(1995-2#2)(1996-12#2)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-11#4)(2008-12#1)(2008-4#3)(2008-7#4)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#4)(2013-7#1)(2013-8#2)
receptors are also##2##3##(1995-2#1)(2009-8#1)
receptors are expressed in##2##4##(2008-4#1)(2008-6#1)
receptors are involved in##2##4##(1994-8#1)(2008-8#1)
receptors are known to##2##4##(1991-12#1)(2011-1#1)
receptors are localized##2##3##(1996-12#1)(2008-4#1)
receptors are##23##2##(1990-8#1)(1991-12#1)(1991-7#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#3)(1997-2#1)(1997-7#1)(2008-4#3)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)
receptors as well as##2##4##(1995-11#1)(2013-8#1)
receptors as##6##2##(1995-11#1)(1996-12#1)(2008-11#2)(2008-7#1)(2013-8#1)
receptors associated with##2##3##(1991-5#1)(2010-5#1)
receptors but##2##2##(1992-12#1)(1995-11#1)
receptors by both##2##3##(1995-11#1)(1995-6#1)
receptors by##13##2##(1990-11#1)(1991-12#1)(1992-4#1)(1993-6#1)(1994-2#1)(1995-11#3)(1995-2#1)(1995-6#1)(1996-2#2)(2008-8#1)
receptors can##3##2##(1995-11#1)(1996-12#1)(2007-12#1)
receptors expressed in Xenopus oocytes##2##5##(1995-11#2)
receptors expressed##3##2##(1995-11#3)
receptors for the##2##3##(1995-8#1)(2011-2#1)
receptors for##17##2##(1990-11#1)(1991-12#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
receptors from##3##2##(1995-11#1)(1995-2#1)(2008-7#1)
receptors have been identified##2##4##(1995-12#1)(1995-2#1)
receptors have been##6##3##(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-4#1)
receptors have##9##2##(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-4#1)(2008-9#1)
receptors in different##2##3##(2008-9#1)(2009-7#1)
receptors in human##2##3##(1994-3#1)(2009-7#1)
receptors in rat##2##3##(1995-11#1)(1997-1#1)
receptors in the hippocampus##2##4##(1996-12#1)(2008-11#1)
receptors in the striatum##2##4##(1991-4#1)(1994-2#1)
receptors in the substantia nigra##3##5##(1995-2#3)
receptors in the##22##3##(1991-4#2)(1992-10#2)(1992-3#1)(1993-8#1)(1994-2#1)(1995-2#3)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
receptors in these##2##3##(1991-10#1)(2009-7#1)
receptors in##60##2##(1990-11#1)(1991-10#1)(1991-4#2)(1992-10#2)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-7#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#5)(2009-8#1)(2012-3#1)(2013-1#1)
receptors induced##2##2##(1995-6#1)(2008-8#1)
receptors inhibit##2##2##(2008-7#2)
receptors is##10##2##(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-4#1)(2011-2#2)
receptors may be##2##3##(1995-11#1)(2008-9#1)
receptors may##9##2##(1990-11#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-3#1)
receptors of the##3##3##(1996-2#1)(2009-8#1)(2013-1#1)
receptors of##12##2##(1991-3#1)(1993-2#2)(1994-2#1)(1996-2#1)(1997-2#1)(1997-9#1)(2008-11#1)(2009-12#1)(2009-8#1)(2013-1#2)
receptors on the##2##3##(1997-2#1)(2008-7#1)
receptors on##12##2##(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-2#1)(1997-2#1)(2008-11#1)(2008-7#1)(2013-7#1)
receptors per cell##2##3##(2008-11#2)
receptors stimulated##2##2##(1995-11#1)(1996-2#1)
receptors that##6##2##(1995-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)
receptors then##2##2##(1993-8#1)(2008-8#1)
receptors to a##2##3##(1995-11#1)(1997-7#1)
receptors to##7##2##(1993-8#1)(1995-11#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
receptors was##6##2##(1991-12#1)(1995-12#1)(1996-2#1)(1997-1#1)(2008-10#1)(2012-2#1)
receptors were undetectable in##2##4##(1990-11#2)
receptors were##17##2##(1990-11#3)(1994-2#1)(1994-3#1)(1995-11#5)(1995-6#1)(1996-12#1)(1996-2#4)(2008-8#1)
receptors which##5##2##(1992-7#1)(1993-9#1)(1994-8#1)(1996-12#1)(1996-2#1)
receptors with##4##2##(1995-11#1)(1996-2#1)(2008-5#1)(2013-1#1)
receptors##602##1##(1990-11#9)(1990-12#1)(1990-2#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-12#8)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#5)(1991-7#2)(1991-9#1)(1992-10#2)(1992-12#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#9)(1993-3#3)(1993-5#1)(1993-6#5)(1993-8#13)(1993-9#9)(1994-11#8)(1994-12#4)(1994-2#23)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#10)(1995-11#46)(1995-12#16)(1995-2#27)(1995-5#1)(1995-6#10)(1995-8#11)(1996-12#24)(1996-2#42)(1997-1#6)(1997-2#13)(1997-4#7)(1997-7#11)(1997-9#1)(2006-6#3)(2007-11#1)(2007-12#2)(2008-10#18)(2008-11#27)(2008-12#1)(2008-2#2)(2008-4#22)(2008-5#11)(2008-6#2)(2008-7#25)(2008-8#14)(2008-9#12)(2009-1#1)(2009-12#5)(2009-3#3)(2009-6#2)(2009-7#11)(2009-8#10)(2009-9#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#23)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#5)(2013-8#7)
receptors) are##2##2##(1996-2#1)(2009-12#1)
receptors)##8##1##(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#2)(1997-2#1)(2009-12#1)(2009-8#1)
recess##11##1##(1990-5#1)(2008-9#1)(2011-2#5)(2012-2#2)(2013-1#2)
recessive dystrophic epidermolysis bullosa##3##4##(2012-3#3)
recessive form##2##2##(2008-11#2)
recessive gene for##3##3##(2008-10#3)
recessive gene##20##2##(1990-9#1)(2008-10#15)(2008-8#1)(2008-9#3)
recessive genes were detected in##4##5##(2008-10#4)
recessive genes were##5##3##(2008-10#5)
recessive genes##9##2##(2008-10#9)
recessive genetic##2##2##(2008-10#1)(2011-3#1)
recessive inheritance of##3##3##(1994-11#1)(2008-10#2)
recessive inheritance##4##2##(1994-11#1)(2008-10#2)(2008-7#1)
recessive juvenile parkinsonism (AR-JP)##2##4##(2008-7#2)
recessive mutation##2##2##(1994-12#1)(2008-10#1)
recessive phenotype##2##2##(1994-12#2)
recessive##83##1##(1990-8#1)(1990-9#1)(1994-11#1)(1994-12#4)(1995-6#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#38)(2008-11#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2010-2#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#6)
recidive##2##1##(2011-2#2)
recidivism##2##1##(2008-6#1)(2011-2#1)
recidivisms##2##1##(2011-2#2)
recipe##4##1##(2008-9#1)(2012-2#1)(2013-8#2)
recipes##4##1##(2008-10#3)(2012-2#1)
recipient and the donor##2##4##(2008-9#1)(2011-2#1)
recipient and##4##2##(1997-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
recipient cells##2##2##(1995-2#1)(2013-1#1)
recipient embryos##2##2##(2008-11#2)
recipient strain##3##2##(1991-9#1)(2008-10#2)
recipient##47##1##(1991-9#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-5#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#7)(2009-5#1)(2010-11#4)(2010-6#1)(2011-2#1)(2011-3#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
recipients and##8##2##(2008-5#1)(2008-9#3)(2010-12#2)(2012-2#2)
recipients have##2##2##(1991-12#1)(1995-12#1)
recipients with##5##2##(1991-12#1)(1994-2#1)(1995-2#2)(1997-2#1)
recipients##58##1##(1991-1#1)(1991-12#4)(1991-2#1)(1992-2#4)(1994-2#3)(1994-3#3)(1995-1#3)(1995-12#2)(1995-2#2)(1995-5#1)(1996-2#1)(1996-8#3)(1997-2#4)(2007-11#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#8)(2009-5#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-2#3)
reciprocal altruism##4##2##(2008-8#2)(2012-3#2)
reciprocal and##2##2##(2009-7#2)
reciprocal cross##2##2##(2008-10#1)(2008-9#1)
reciprocal crosses##4##2##(2008-10#1)(2008-12#2)(2012-3#1)
reciprocal friends##3##2##(2009-7#3)
reciprocal inhibition##2##2##(1993-3#2)
reciprocal interactions##2##2##(1990-11#1)(2008-7#1)
reciprocal populations##2##2##(2008-10#2)
reciprocal relationship##2##2##(2009-7#2)
reciprocal##54##1##(1990-11#2)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-10#10)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#8)(2009-8#1)(2010-1#2)(2011-2#4)(2012-2#1)(2012-3#5)(2012-7#1)(2013-1#1)
reciprocally##3##1##(1996-5#1)(2008-11#1)(2012-2#1)
reciprocating##2##1##(2008-10#1)(2008-8#1)
reciprocity##12##1##(1992-3#1)(2007-12#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-3#5)
recirculating##4##1##(2008-10#3)(2008-2#1)
recirculation##3##1##(1990-5#1)(2008-7#1)(2011-2#1)
reclaiming##2##1##(1997-3#1)(2012-2#1)
reclassification of##3##2##(1993-1#1)(2008-10#1)(2009-12#1)
recognise the##5##2##(1991-6#1)(2008-12#1)(2008-7#1)(2011-2#2)
recognise##14##1##(1991-6#1)(1996-8#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
recognised and##2##2##(2008-11#2)
recognised as a##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
recognised as##4##2##(2008-11#2)(2008-12#1)(2012-2#1)
recognised by##4##2##(1990-11#1)(2007-12#1)(2009-7#1)(2012-12#1)
recognised in##3##2##(1991-3#1)(1992-6#1)(2008-10#1)
recognised that##2##2##(2008-11#2)
recognised##27##1##(1990-11#1)(1991-3#1)(1992-6#1)(1993-12#1)(2007-12#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-7#2)(2009-7#1)(2010-12#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
recognises##2##1##(1995-12#1)(2008-12#1)
recognising the##3##2##(1991-6#1)(2008-11#2)
recognising##4##1##(1991-6#1)(2008-1#1)(2008-11#2)
recognition ability##3##2##(2008-10#2)(2012-2#1)
recognition and treatment of##2##4##(2008-1#1)(2013-1#1)
recognition and treatment##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
recognition and##35##2##(1990-5#1)(1992-4#2)(1995-5#1)(1997-1#1)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
recognition as##3##2##(1994-12#1)(2008-1#1)(2012-2#1)
recognition between##3##2##(1992-6#1)(2008-10#2)
recognition by the##3##3##(1992-4#1)(1993-12#1)(1994-3#1)
recognition by use of##2##4##(2007-12#2)
recognition by##10##2##(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-6#1)(2007-12#2)(2008-10#1)(2011-2#1)
recognition capability##2##2##(2008-10#2)
recognition element##2##2##(2008-10#2)
recognition elements##3##2##(2008-10#3)
recognition for##5##2##(1991-3#1)(1994-2#1)(2008-10#2)(2008-9#1)
recognition in the##2##3##(1990-12#1)(1992-4#1)
recognition in##15##2##(1990-12#1)(1991-6#1)(1992-4#1)(1994-9#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#4)
recognition is##4##2##(1994-5#1)(1995-2#1)(2008-10#2)
recognition material##2##2##(2008-10#2)
recognition memory##6##2##(1991-2#1)(1993-3#2)(2008-11#1)(2008-6#1)(2008-9#1)
recognition methods##3##2##(2008-10#2)(2010-7#1)
recognition of MHC##2##3##(2008-8#2)
recognition of a##4##3##(1991-10#1)(2007-12#1)(2008-11#1)(2008-3#1)
recognition of damaged and apoptotic cells##2##6##(1995-2#2)
recognition of damaged##3##3##(1993-3#1)(1995-2#2)
recognition of danger signs##2##4##(2012-12#2)
recognition of new##2##3##(1997-3#1)(2008-10#1)
recognition of pathogens and##2##4##(2009-3#1)(2009-8#1)
recognition of the##21##3##(1990-12#1)(1991-9#1)(1995-1#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2010-6#1)(2012-2#1)
recognition of their##2##3##(2008-11#1)(2011-1#1)
recognition of this##5##3##(1997-3#1)(2008-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
recognition of##85##2##(1990-12#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#6)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#16)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
recognition on##2##2##(2008-10#2)
recognition pattern##2##2##(1995-2#1)(1996-12#1)
recognition procedures##5##2##(2008-10#5)
recognition properties##3##2##(2008-10#1)(2008-8#1)(2010-7#1)
recognition sequence##6##2##(1992-10#1)(1993-12#1)(1995-6#1)(1995-8#3)
recognition site##11##2##(1991-3#1)(1992-6#1)(1993-2#1)(1994-5#2)(1995-12#1)(1995-6#4)(2013-1#1)
recognition sites##3##2##(1991-6#1)(1995-5#1)(2008-10#1)
recognition system##5##2##(2008-6#1)(2008-8#1)(2008-9#3)
recognition task##3##2##(1993-3#1)(2008-6#1)(2008-7#1)
recognition techniques##7##2##(2008-10#7)
recognition that##7##2##(1992-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-3#1)(2013-8#1)
recognition was##2##2##(2008-10#1)(2008-9#1)
recognition with##2##2##(2008-3#2)
recognition within##2##2##(1994-12#1)(2008-9#1)
recognition##338##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-6#3)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#5)(1992-6#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#7)(1993-8#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#4)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#10)(1995-5#2)(1995-6#11)(1995-8#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#4)(2008-1#7)(2008-10#78)(2008-11#21)(2008-12#3)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#12)(2008-7#8)(2008-8#16)(2008-9#24)(2009-1#1)(2009-12#1)(2009-3#5)(2009-7#2)(2009-8#5)(2010-10#1)(2010-12#1)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#3)
recognizable##4##1##(1991-5#1)(1994-11#1)(2007-12#2)
recognize a##6##2##(1991-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
recognize all##3##2##(1997-2#1)(2008-4#1)(2008-5#1)
recognize and bind##2##3##(2008-9#1)(2011-1#1)
recognize and##17##2##(1993-1#1)(1993-12#1)(1994-1#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
recognize cell surface##2##3##(1995-6#1)(2008-10#1)
recognize specific##3##2##(2008-1#1)(2008-4#2)
recognize such##2##2##(1995-6#1)(2008-1#1)
recognize taste stimuli##2##3##(2008-7#2)
recognize that##3##2##(1995-11#1)(1996-3#1)(2009-8#1)
recognize the illness##2##3##(2011-2#2)
recognize the same##2##3##(1992-2#1)(2008-10#1)
recognize the##28##2##(1990-2#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#2)
recognize two##2##2##(1995-2#1)(1996-12#1)
recognize various##2##2##(1996-12#1)(2013-1#1)
recognize##120##1##(1990-2#1)(1991-2#2)(1991-3#2)(1991-8#1)(1992-2#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-2#5)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-6#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-3#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#10)(2009-8#1)(2009-9#3)(2010-1#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-3#2)(2013-1#4)(2013-7#2)
recognized a single##3##3##(1991-9#1)(1995-6#1)(1997-7#1)
recognized a##9##2##(1991-12#1)(1991-9#1)(1993-9#1)(1995-6#1)(1996-12#2)(1997-7#1)(2008-11#1)(2008-8#1)
recognized all##2##2##(2008-10#1)(2008-5#1)
recognized and##6##2##(1994-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2009-8#1)
recognized antigens##2##2##(1990-12#1)(2008-5#1)
recognized as a critical##2##4##(2009-3#1)(2013-1#1)
recognized as a major##2##4##(1997-1#1)(2008-4#1)
recognized as a##14##3##(1992-1#1)(1995-6#1)(1997-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-8#1)(2012-2#2)(2013-1#1)
recognized as an##2##3##(1997-2#1)(2008-5#1)
recognized as one of the##2##5##(2008-10#2)
recognized as safe##2##3##(2008-10#1)(2012-12#1)
recognized as the##8##3##(2008-10#2)(2008-12#2)(2008-3#1)(2008-9#1)(2009-10#1)(2010-12#1)
recognized as##38##2##(1992-1#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
recognized by a##2##3##(1995-2#1)(1995-6#1)
recognized by an##2##3##(1993-8#1)(1997-8#1)
recognized by antibodies##2##3##(1994-11#1)(2011-2#1)
recognized by mAbs##2##3##(2008-4#2)
recognized by sera from##2##4##(1990-5#1)(2009-6#1)
recognized by the##13##3##(1990-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2009-6#1)
recognized by##40##2##(1990-2#1)(1990-5#1)(1991-5#2)(1993-8#2)(1994-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-4#2)(2008-5#2)(2008-8#4)(2008-9#1)(2009-6#2)(2011-2#1)
recognized complication##2##2##(2008-7#1)(2009-7#1)
recognized early##3##2##(1995-11#1)(2008-12#1)(2008-8#1)
recognized for its role in##2##5##(1995-2#1)(2012-2#1)
recognized for its##3##3##(1995-12#1)(1995-2#1)(2012-2#1)
recognized human##2##2##(1990-5#1)(2008-5#1)
recognized in the##4##3##(2008-10#1)(2008-5#1)(2009-7#1)(2009-8#1)
recognized in##11##2##(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#2)(2009-7#1)(2009-8#1)(2011-2#1)
recognized on##4##2##(1993-12#1)(1995-12#1)(2008-10#1)(2008-9#1)
recognized that##13##2##(1990-9#1)(1993-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2010-1#1)(2011-2#1)(2012-3#1)
recognized the##16##2##(1991-3#1)(1991-5#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
recognized to be##2##3##(2008-7#2)
recognized to##5##2##(2008-7#3)(2011-2#1)(2013-7#1)
recognized with##2##2##(1995-11#1)(1997-2#1)
recognized##238##1##(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#3)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#5)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#4)(2008-10#38)(2008-11#19)(2008-12#5)(2008-3#3)(2008-4#4)(2008-5#11)(2008-7#15)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#12)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#1)
recognizes a##5##2##(1995-8#1)(1997-7#1)(1997-8#1)(2008-11#1)(2009-8#1)
recognizes both##2##2##(1995-6#1)(2008-11#1)
recognizes specifically##2##2##(1995-12#1)(2008-11#1)
recognizes that##2##2##(1995-2#1)(1997-3#1)
recognizes the##5##2##(1992-10#1)(1992-9#1)(1993-9#1)(1994-5#1)(2009-8#1)
recognizes##26##1##(1990-5#1)(1992-10#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-8#1)(2009-8#2)(2013-1#1)
recognizing a##5##2##(1991-3#1)(1995-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
recognizing and##2##2##(2008-10#1)(2008-11#1)
recognizing the##10##2##(1990-2#1)(1991-12#1)(1992-12#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2013-1#1)
recognizing##41##1##(1990-2#1)(1991-12#2)(1991-3#1)(1992-12#1)(1993-12#2)(1993-8#1)(1994-1#1)(1994-8#1)(1995-2#2)(2007-12#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
recollective experience##2##2##(2008-9#2)
recolonization##5##1##(2008-10#3)(2008-8#1)(2008-9#1)
recombinant (r)##2##2##(1993-8#1)(2013-1#1)
recombinant C-terminal##2##2##(2008-11#1)(2011-2#1)
recombinant CHO and BHK##2##4##(2008-11#2)
recombinant CHO cell line##6##4##(2008-11#6)
recombinant CHO cell lines##3##4##(2008-11#3)
recombinant CHO cell##10##3##(2008-11#10)
recombinant CHO cells##2##3##(2008-11#2)
recombinant CHO##15##2##(2008-11#15)
recombinant Chinese hamster ovary (rCHO) cells##2##6##(2008-11#2)
recombinant Chinese hamster ovary cell##2##5##(2008-11#2)
recombinant Chinese hamster ovary cells##2##5##(2008-11#2)
recombinant Chinese hamster ovary##9##4##(2008-11#9)
recombinant Chinese##10##2##(2008-11#10)
recombinant DNA##9##2##(1991-5#1)(1991-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
recombinant E##6##2##(1995-2#1)(2008-7#3)(2011-1#1)(2011-2#1)
recombinant Escherichia coli##6##3##(1995-2#1)(2008-10#1)(2008-7#3)(2011-1#1)
recombinant IFN-gamma##2##2##(2008-11#2)
recombinant IFN-γ##2##2##(2011-2#2)
recombinant M##2##2##(2008-10#1)(2011-2#1)
recombinant NS0##2##2##(2008-11#1)(2008-7#1)
recombinant PVX##4##2##(2008-10#4)
recombinant Potato virus X (PVX)##2##5##(2008-10#2)
recombinant SIV-PR##2##2##(1991-9#2)
recombinant XFGFR-1##2##2##(1993-6#2)
recombinant adeno-associated viral vector##2##4##(2008-9#2)
recombinant adeno-associated viral##3##3##(2008-9#3)
recombinant adeno-associated virus vector##2##4##(2008-8#1)(2008-9#1)
recombinant adeno-associated virus##5##3##(1993-2#1)(2008-8#3)(2008-9#1)
recombinant adeno-associated##8##2##(1993-2#1)(2008-8#3)(2008-9#4)
recombinant adenoviral vector##4##3##(2008-11#1)(2008-8#1)(2010-1#2)
recombinant adenoviral vectors##2##3##(2008-11#2)
recombinant adenoviral##6##2##(2008-11#3)(2008-8#1)(2010-1#2)
recombinant adenovirus could##2##3##(2008-8#2)
recombinant adenovirus##10##2##(1995-2#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#5)
recombinant adenoviruses##2##2##(1992-9#1)(2008-11#1)
recombinant alpha-toxin##3##2##(2010-6#3)
recombinant and##2##2##(2008-10#2)
recombinant antibodies against the##2##4##(2008-11#2)
recombinant antibodies##4##2##(2008-10#1)(2008-11#2)(2013-8#1)
recombinant antibody##6##2##(1997-2#1)(2008-11#5)
recombinant antigens##2##2##(1995-5#1)(1997-7#1)
recombinant baculovirus with an##2##4##(2008-11#1)(2008-7#1)
recombinant baculovirus##11##2##(1992-3#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#4)(2008-7#2)
recombinant baculoviruses##3##2##(1997-8#2)(2008-7#1)
recombinant cDNA##2##2##(1992-8#1)(1997-2#1)
recombinant cell line##2##3##(2008-10#1)(2008-11#1)
recombinant cell lines##5##3##(2008-11#5)
recombinant cell##7##2##(2008-10#1)(2008-11#6)
recombinant cells##2##2##(2008-11#2)
recombinant chicken PTH-(1-88)##2##3##(1991-3#2)
recombinant chicken##3##2##(1991-3#2)(2008-11#1)
recombinant cutinase##3##2##(1995-3#1)(2008-7#2)
recombinant enzyme##4##2##(1992-8#2)(1994-6#1)(2011-1#1)
recombinant erythropoietin##2##2##(2008-11#1)(2010-7#1)
recombinant factor##2##2##(2008-11#1)(2011-2#1)
recombinant forms of##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
recombinant fusion##2##2##(1995-12#1)(1997-2#1)
recombinant genes into##2##3##(1994-5#1)(2008-4#1)
recombinant genes##4##2##(1994-5#2)(2008-4#1)(2008-7#1)
recombinant genotypes##2##2##(2008-10#2)
recombinant glycoprotein##7##2##(2008-11#2)(2008-7#4)(2011-2#1)
recombinant glycoproteins##2##2##(2008-11#2)
recombinant hFGF-10 adenovirus##3##3##(2011-3#3)
recombinant hepatitis B##2##3##(1994-11#1)(2008-11#1)
recombinant human NGF was##3##4##(1990-8#3)
recombinant human and##2##3##(1993-8#2)
recombinant human erythropoietin##4##3##(2008-1#1)(2008-10#1)(2008-11#2)
recombinant human glucagon##4##3##(2008-8#4)
recombinant human monoclonal antibody##2##4##(2008-11#2)
recombinant human plasminogen##2##3##(1995-6#2)
recombinant human thyrotropin##3##3##(1995-12#1)(2013-1#2)
recombinant human tissue##2##3##(2008-11#1)(2008-7#1)
recombinant human transferrin produced##2##4##(2008-11#2)
recombinant human transferrin##3##3##(2008-11#3)
recombinant human uPA##4##3##(2008-11#4)
recombinant human##67##2##(1990-5#3)(1990-8#5)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#2)(1995-11#1)(1995-12#3)(1995-6#6)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#21)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#5)(2010-11#1)(2011-2#2)(2013-1#2)
recombinant inbred (RI) strains##2##4##(1994-8#1)(2008-12#1)
recombinant inbred (RI)##4##3##(1994-8#1)(2008-10#2)(2008-12#1)
recombinant inbred line population##4##4##(2008-10#4)
recombinant inbred line##5##3##(2008-10#5)
recombinant inbred lines (RILs) derived##2##5##(2008-10#2)
recombinant inbred lines (RILs) from##2##5##(2008-10#1)(2008-8#1)
recombinant inbred lines (RILs)##8##4##(2008-10#6)(2008-8#1)(2012-3#1)
recombinant inbred lines derived from##2##5##(2008-10#2)
recombinant inbred lines from the cross##2##6##(2008-10#2)
recombinant inbred lines of the##2##5##(2008-10#1)(2012-3#1)
recombinant inbred lines##16##3##(2008-10#13)(2008-8#1)(2012-3#2)
recombinant inbred population##4##3##(2008-10#4)
recombinant inbred##29##2##(1994-8#1)(2008-10#24)(2008-12#1)(2008-8#1)(2012-3#2)
recombinant insulin##2##2##(2008-11#2)
recombinant interferon-gamma##2##2##(2008-11#2)
recombinant isolates##3##2##(2008-10#3)
recombinant line##3##2##(2008-10#3)
recombinant mammalian cell cultures##2##4##(2008-11#2)
recombinant mammalian cell lines##3##4##(2008-11#3)
recombinant mammalian cell##5##3##(2008-11#5)
recombinant mammalian##7##2##(2008-11#7)
recombinant mouse##2##2##(2008-10#2)
recombinant phage##2##2##(1991-9#1)(1992-3#1)
recombinant phosphatase 2A##2##3##(1992-9#2)
recombinant plasmid##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
recombinant plasmids##3##2##(2008-10#1)(2008-8#2)
recombinant precursor##2##2##(2008-9#1)(2011-2#1)
recombinant product##4##2##(1994-11#1)(2008-11#1)(2008-7#1)(2010-11#1)
recombinant production##2##2##(2011-1#1)(2013-8#1)
recombinant protein by##2##3##(2008-11#2)
recombinant protein expression in##3##4##(2008-11#3)
recombinant protein expression##7##3##(2008-11#6)(2008-7#1)
recombinant protein hyper-producing##2##3##(2008-11#2)
recombinant protein is##4##3##(1993-2#1)(2008-11#1)(2008-8#2)
recombinant protein production in##6##4##(2008-11#3)(2008-7#1)(2011-2#2)
recombinant protein production of##2##4##(2008-11#2)
recombinant protein production##24##3##(1992-12#1)(2008-11#15)(2008-7#3)(2011-1#2)(2011-2#3)
recombinant protein purification##2##3##(2008-4#2)
recombinant protein was##5##3##(2008-11#4)(2008-8#1)
recombinant protein##73##2##(1990-11#2)(1992-12#1)(1993-2#1)(1994-11#1)(2008-10#1)(2008-11#45)(2008-4#2)(2008-7#7)(2008-8#3)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#6)
recombinant proteins for research##2##4##(2008-11#1)(2012-2#1)
recombinant proteins for##7##3##(1995-5#1)(2008-11#5)(2012-2#1)
recombinant proteins produced by##2##4##(2008-11#1)(2011-2#1)
recombinant proteins produced in##2##4##(2008-4#1)(2008-7#1)
recombinant proteins produced##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
recombinant proteins##44##2##(1990-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-5#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-11#28)(2008-4#2)(2008-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
recombinant rat##7##2##(1993-8#1)(2008-11#4)(2008-8#2)
recombinant receptor##3##2##(1995-11#3)
recombinant retrovirus##5##2##(1990-5#1)(1997-8#1)(2009-10#3)
recombinant retroviruses##2##2##(1990-5#2)
recombinant tPA##2##2##(2008-11#2)
recombinant therapeutic##3##2##(2008-11#2)(2011-2#1)
recombinant tissue plasminogen activator##4##4##(2008-7#2)(2009-11#1)(2009-6#1)
recombinant tissular plasminogen activator (t-PA)##2##5##(2008-11#2)
recombinant tumor necrosis##2##3##(1994-8#2)
recombinant uPA##5##2##(2008-11#5)
recombinant vaccine##2##2##(1995-5#1)(2008-8#1)
recombinant vaccines##2##2##(1996-3#1)(2008-4#1)
recombinant vaccinia virus##4##3##(1995-6#1)(2008-8#3)
recombinant vaccinia##5##2##(1995-6#1)(2008-8#4)
recombinant vector##4##2##(1994-5#1)(2008-9#1)(2010-4#1)(2011-2#1)
recombinant virus##5##2##(1994-11#1)(1997-8#1)(2008-10#2)(2008-11#1)
recombinant viruses##6##2##(1993-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
recombinant yeast##8##2##(1993-9#1)(1995-2#1)(1997-2#1)(2008-7#3)(2008-8#1)(2011-1#1)
recombinant zebrafish FSH##2##3##(2010-5#2)
recombinant zebrafish##3##2##(2010-5#3)
recombinant##677##1##(1990-11#5)(1990-12#1)(1990-5#6)(1990-8#6)(1991-3#3)(1991-5#3)(1991-8#2)(1991-9#7)(1992-10#2)(1992-12#1)(1992-3#2)(1992-8#5)(1992-9#5)(1993-2#3)(1993-6#6)(1993-8#7)(1993-9#2)(1994-11#8)(1994-5#5)(1994-6#2)(1994-8#6)(1995-11#11)(1995-12#6)(1995-2#11)(1995-3#1)(1995-5#6)(1995-6#10)(1995-8#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#4)(1997-3#3)(1997-7#4)(1997-8#5)(2008-1#4)(2008-10#78)(2008-11#229)(2008-12#3)(2008-4#12)(2008-5#2)(2008-6#1)(2008-7#42)(2008-8#37)(2008-9#14)(2009-10#3)(2009-11#1)(2009-3#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#3)(2010-11#3)(2010-12#2)(2010-4#2)(2010-5#5)(2010-6#5)(2010-7#1)(2011-1#7)(2011-2#38)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#3)(2013-8#5)
recombinant-inbred lines (RILs)##2##3##(2008-10#2)
recombinantantibody##2##1##(2008-11#2)
recombinants and##2##2##(2008-10#1)(2008-11#1)
recombinants were##3##2##(1995-2#1)(2008-10#2)
recombinants##21##1##(1992-6#2)(1995-2#2)(1995-9#1)(1997-3#2)(2008-10#11)(2008-11#1)(2008-6#1)(2013-1#1)
recombinase target##2##2##(2008-11#2)
recombinase##8##1##(1991-9#1)(1994-11#2)(2008-11#2)(2008-4#1)(2008-9#1)(2012-2#1)
recombinases##5##1##(2008-11#4)(2012-3#1)
recombination among##4##2##(2008-10#3)(2012-2#1)
recombination and##16##2##(1994-9#2)(1997-7#2)(2008-10#5)(2008-11#1)(2009-10#3)(2010-4#1)(2011-2#1)(2013-8#1)
recombination between EV71##2##3##(2013-8#2)
recombination between the##3##3##(1997-3#1)(2008-10#2)
recombination between##8##2##(1996-6#1)(1997-3#1)(2008-10#4)(2013-8#2)
recombination event##2##2##(1997-3#1)(2008-10#1)
recombination events between##2##3##(2008-10#1)(2013-8#1)
recombination events was##2##3##(2008-10#1)(2008-12#1)
recombination events##11##2##(1994-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2013-8#1)
recombination experiments##3##2##(1992-6#1)(2008-10#1)(2008-6#1)
recombination in the##5##3##(1993-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
recombination in##17##2##(1991-3#1)(1993-12#3)(1995-2#2)(1996-6#1)(2008-10#4)(2008-4#3)(2008-8#1)(2008-9#1)(2010-1#1)
recombination is##5##2##(1997-7#1)(2008-10#3)(2009-3#1)
recombination may##5##2##(2008-10#4)(2013-1#1)
recombination occurred between##2##3##(2008-10#1)(2013-8#1)
recombination occurred##3##2##(1993-9#1)(2008-10#1)(2013-8#1)
recombination of the##2##3##(1995-2#1)(2008-9#1)
recombination of##9##2##(1990-8#1)(1991-3#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-8#2)(2008-9#2)
recombination process##2##2##(2009-3#1)(2013-1#1)
recombination rate##7##2##(2008-12#1)(2008-8#5)(2012-3#1)
recombination rates##3##2##(2012-3#3)
recombination reaction in##2##3##(1997-7#1)(2008-10#1)
recombination reaction##3##2##(1997-7#2)(2008-10#1)
recombination vectors##2##2##(1993-12#2)
recombination was found##2##3##(2008-10#2)
recombination was##4##2##(1990-8#1)(1991-3#1)(2008-10#2)
recombination were##2##2##(1990-8#1)(2008-10#1)
recombination within##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
recombination##198##1##(1990-5#2)(1990-8#4)(1991-3#4)(1991-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#7)(1993-2#1)(1993-9#3)(1994-9#4)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#1)(1995-9#2)(1996-2#2)(1996-6#2)(1997-3#3)(1997-7#11)(2008-10#63)(2008-11#7)(2008-12#5)(2008-4#7)(2008-6#1)(2008-7#3)(2008-8#17)(2008-9#7)(2009-10#3)(2009-3#3)(2010-1#1)(2010-4#2)(2011-2#2)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#5)(2013-8#8)
recombination)##2##1##(2008-10#2)
recombine##5##1##(1991-3#1)(1992-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
recombined single chain insulin##5##4##(2008-9#5)
recombined##6##1##(2008-9#6)
recombining##4##1##(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
recommend a##3##2##(1997-8#1)(2008-10#1)(2009-10#1)
recommend directions for##2##3##(1991-2#1)(2010-9#1)
recommend that the##2##3##(2008-10#2)
recommend that##11##2##(1990-3#1)(1993-3#1)(1994-2#1)(1994-9#1)(2008-10#3)(2010-8#2)(2010-9#1)(2013-1#1)
recommend the use of##2##4##(2008-10#2)
recommend the##8##2##(1991-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#2)
recommend##58##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#1)
recommendable##2##1##(1990-6#1)(1993-11#1)
recommendation for##5##2##(2008-10#1)(2008-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
recommendation##24##1##(1991-8#1)(1996-11#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
recommendations about the##2##3##(2008-10#1)(2011-2#1)
recommendations about##4##2##(1992-3#1)(1995-1#1)(2008-10#1)(2011-2#1)
recommendations and##4##2##(1996-1#1)(2008-11#1)(2010-7#1)(2012-12#1)
recommendations are made##4##3##(1992-12#1)(1992-9#1)(2008-11#1)(2008-12#1)
recommendations are provided##2##3##(2009-5#1)(2011-2#1)
recommendations are##17##2##(1992-12#1)(1992-9#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-5#1)(2010-12#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
recommendations based on the##2##4##(1995-5#1)(2008-12#1)
recommendations based on##5##3##(1993-12#2)(1995-5#1)(2008-12#1)(2013-1#1)
recommendations developed##2##2##(1995-12#1)(2011-2#1)
recommendations for further##3##3##(2008-11#1)(2008-12#1)(2008-4#1)
recommendations for future##3##3##(2008-11#1)(2009-4#1)(2012-2#1)
recommendations for the use of##3##5##(1996-6#1)(2008-11#1)(2008-9#1)
recommendations for the##11##3##(1993-12#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-9#2)(2010-12#1)(2012-2#2)
recommendations for##52##2##(1990-8#1)(1993-12#2)(1994-6#1)(1995-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-1#2)(2008-11#12)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#5)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
recommendations from the##3##3##(1996-6#1)(2008-7#1)(2013-1#1)
recommendations from##5##2##(1996-6#1)(2008-7#1)(2008-9#1)(2011-3#1)(2013-1#1)
recommendations in the##3##3##(1990-6#1)(2008-10#2)
recommendations in##7##2##(1990-6#1)(1993-12#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
recommendations of the##6##3##(2008-10#1)(2008-12#1)(2009-10#1)(2011-3#1)(2012-3#1)(2013-1#1)
recommendations of##8##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-3#1)(2012-3#1)(2013-1#1)
recommendations on how##2##3##(2012-2#1)(2013-8#1)
recommendations on##8##2##(1991-1#1)(2008-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
recommendations regarding the##2##3##(2008-3#1)(2013-1#1)
recommendations regarding##4##2##(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#1)
recommendations that##6##2##(1991-1#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)
recommendations to help##2##3##(1996-3#1)(2011-2#1)
recommendations to the##2##3##(1996-1#1)(2008-12#1)
recommendations to##6##2##(1996-1#1)(1996-3#1)(2008-12#1)(2009-4#1)(2011-2#1)(2013-1#1)
recommendations were##5##2##(1992-3#1)(1996-1#1)(2008-10#1)(2010-10#1)(2013-1#1)
recommendations##202##1##(1990-6#2)(1990-8#2)(1991-1#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#7)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#3)(1996-3#3)(1996-6#3)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#1)(2008-1#6)(2008-10#13)(2008-11#22)(2008-12#13)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2011-2#16)(2011-3#2)(2012-12#6)(2012-2#6)(2012-3#10)(2013-1#11)(2013-8#6)
recommended as a first-line##2##4##(2008-10#1)(2013-1#1)
recommended as a##4##3##(1991-3#1)(2008-10#2)(2013-1#1)
recommended as first choice##2##4##(1991-6#1)(2008-3#1)
recommended as##13##2##(1991-3#2)(1991-6#1)(2008-10#5)(2008-3#1)(2008-9#1)(2011-2#2)(2013-1#1)
recommended because##2##2##(1991-12#1)(2008-2#1)
recommended by the American##2##4##(2008-10#1)(2010-8#1)
recommended by the Association##2##4##(1990-6#1)(2008-10#1)
recommended by the World Health Organization##2##6##(2008-1#1)(2011-2#1)
recommended by the##13##3##(1990-6#1)(1996-11#1)(2008-1#1)(2008-10#6)(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
recommended by##18##2##(1990-6#1)(1996-11#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
recommended daily##3##2##(2010-6#1)(2011-2#1)(2013-1#1)
recommended for patients with##5##4##(1990-12#1)(1994-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
recommended for patients##7##3##(1990-12#1)(1994-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
recommended for the##5##3##(1990-8#1)(2008-10#2)(2008-11#1)(2012-3#1)
recommended for##36##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-9#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
recommended in the##2##3##(2008-10#1)(2011-1#1)
recommended in##10##2##(1990-2#1)(1990-3#1)(1993-8#1)(1997-4#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-1#1)
recommended levels of##4##3##(2011-2#4)
recommended levels##6##2##(2010-11#1)(2011-2#5)
recommended method was##2##3##(2008-10#2)
recommended method##6##2##(2008-10#6)
recommended procedure##6##2##(2008-10#6)
recommended procedures##2##2##(2008-10#1)(2008-11#1)
recommended that the##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
recommended that##20##2##(1991-3#2)(1993-12#1)(1995-6#2)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2010-8#1)(2012-12#1)(2012-2#2)
recommended the##2##2##(2008-7#1)(2011-2#1)
recommended to be##2##3##(2009-4#1)(2011-2#1)
recommended to reduce##2##3##(2008-12#1)(2009-2#1)
recommended to##17##2##(1992-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
recommended values##4##2##(2008-10#4)
recommended##265##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#5)(1992-11#2)(1992-5#1)(1992-6#2)(1993-1#2)(1993-12#3)(1993-2#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-9#2)(1995-12#1)(1995-6#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#6)(2008-1#4)(2008-10#69)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#3)(2008-7#6)(2008-8#5)(2008-9#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#33)(2011-3#1)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#13)(2013-8#3)
recommending##7##1##(1992-12#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-1#1)(2013-8#1)
recommends against##2##2##(2010-9#1)(2011-1#1)
recommends that the##2##3##(2008-10#1)(2008-11#1)
recommends that##6##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
recommends the##3##2##(1995-12#1)(2008-10#1)(2011-3#1)
recommends##15##1##(1990-9#1)(1991-3#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)
recompression##2##1##(1991-6#2)
reconcile the##5##2##(1994-11#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-3#1)
reconcile##9##1##(1994-11#1)(1995-5#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-3#1)(2013-8#1)
reconciliation##3##1##(2008-11#2)(2013-1#1)
recondita##5##1##(2008-10#5)
reconditioning##2##1##(2008-10#1)(2011-3#1)
reconfiguration of the##2##3##(1992-2#1)(2008-10#1)
reconfiguration##6##1##(1991-1#2)(1992-2#1)(1993-2#1)(2008-10#2)
reconsider##3##1##(2008-12#1)(2008-6#1)(2008-8#1)
reconsideration of##2##2##(2009-3#1)(2009-7#1)
reconsidered##4##1##(1991-2#1)(2008-11#1)(2009-7#1)(2011-2#1)
reconstitute the##2##2##(1992-3#1)(1997-7#1)
reconstitute##7##1##(1992-3#1)(1992-6#1)(1993-6#1)(1997-7#1)(2008-10#1)(2008-4#2)
reconstituted InsP(3) receptor##4##3##(2008-8#4)
reconstituted basement membrane##4##3##(2008-11#4)
reconstituted complexes##2##2##(1993-8#2)
reconstituted in vitro##4##3##(1992-12#1)(1993-8#1)(1994-11#1)(1994-8#1)
reconstituted in##7##2##(1992-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-8#1)
reconstituted into liposomes##2##3##(1995-2#1)(2008-8#1)
reconstituted into##4##2##(1995-2#1)(1995-8#1)(2008-8#2)
reconstituted serum##3##2##(2008-10#3)
reconstituted with##6##2##(1994-5#1)(1995-2#2)(1995-6#1)(2008-8#1)(2011-2#1)
reconstituted##57##1##(1990-2#1)(1991-5#1)(1992-12#2)(1992-8#4)(1993-8#4)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#6)(2008-5#3)(2008-8#11)(2008-9#2)(2010-12#1)(2011-2#2)(2013-1#1)
reconstitution and##3##2##(1995-8#1)(2008-8#1)(2009-9#1)
reconstitution into##2##2##(1995-2#1)(1995-8#1)
reconstitution of the##3##3##(1990-5#1)(1991-5#1)(2008-7#1)
reconstitution of##11##2##(1990-5#1)(1991-5#1)(1992-8#2)(1994-5#1)(1995-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2013-7#1)
reconstitution##32##1##(1990-5#1)(1991-5#4)(1992-8#2)(1994-5#1)(1995-2#1)(1995-8#5)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-7#2)(2009-9#1)(2010-5#2)(2013-7#1)
reconstruct the##10##2##(2008-12#1)(2008-3#2)(2010-11#1)(2010-6#1)(2012-3#3)(2013-1#1)(2013-8#1)
reconstruct##21##1##(1994-6#1)(1995-5#1)(2008-12#1)(2008-3#5)(2008-6#1)(2008-8#2)(2010-11#1)(2010-4#1)(2010-6#2)(2012-3#4)(2013-1#1)(2013-8#1)
reconstructed blastocyst##2##2##(2008-9#2)
reconstructed breast##2##2##(2013-1#2)
reconstructed by##2##2##(1992-3#1)(2008-9#1)
reconstructed embryos were##2##3##(2008-9#2)
reconstructed epidermis##9##2##(2008-5#9)
reconstructed from##2##2##(1997-3#1)(2008-9#1)
reconstructed human epidermis##3##3##(2008-5#3)
reconstructed image##4##2##(2007-11#2)(2008-3#1)(2012-12#1)
reconstructed on##2##2##(1994-12#1)(2008-5#1)
reconstructed skin model##2##3##(2008-5#2)
reconstructed skin##4##2##(2008-5#4)
reconstructed to##2##2##(2010-10#1)(2013-8#1)
reconstructed using##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
reconstructed with##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
reconstructed##70##1##(1990-5#1)(1991-5#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-5#19)(2008-7#3)(2008-8#2)(2008-9#11)(2009-1#1)(2009-2#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
reconstructing a##2##2##(2011-3#1)(2012-12#1)
reconstructing the##3##2##(2007-12#1)(2008-12#1)(2008-3#1)
reconstructing##11##1##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-3#1)(2011-7#1)(2012-12#1)
reconstruction after##2##2##(1996-3#1)(2010-6#1)
reconstruction algorithms for##2##3##(2008-3#2)
reconstruction algorithms##3##2##(2008-3#3)
reconstruction and##5##2##(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2011-7#1)
reconstruction can##2##2##(2012-3#1)(2013-8#1)
reconstruction following##2##2##(1990-9#1)(1992-9#1)
reconstruction in##4##2##(1992-5#1)(2008-10#1)(2008-12#1)(2012-2#1)
reconstruction is##3##2##(1992-5#1)(2008-3#1)(2013-1#1)
reconstruction of a##3##3##(2008-10#1)(2008-3#2)
reconstruction of the##25##3##(1990-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#4)(2009-1#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
reconstruction of##48##2##(1990-3#1)(1990-5#1)(1993-6#2)(1994-3#1)(1996-3#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-3#7)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#2)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#5)(2013-1#5)(2013-8#2)
reconstruction techniques##2##2##(2008-8#2)
reconstruction using a##2##3##(2008-3#1)(2009-1#1)
reconstruction using##6##2##(1990-9#1)(2008-3#1)(2009-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
reconstruction was##2##2##(2008-11#1)(2008-7#1)
reconstruction were identified##2##3##(2013-1#2)
reconstruction with a##3##3##(2008-7#2)(2008-9#1)
reconstruction with hamstrings##4##3##(2013-1#4)
reconstruction with##19##2##(1993-11#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-7#3)(2008-9#3)(2009-1#2)(2011-2#1)(2013-1#6)
reconstruction##180##1##(1990-3#1)(1990-5#1)(1990-9#4)(1991-12#1)(1992-5#3)(1992-9#1)(1993-11#2)(1993-6#2)(1994-12#1)(1994-3#1)(1996-3#4)(1996-8#1)(2007-12#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#21)(2008-6#5)(2008-7#13)(2008-8#4)(2008-9#8)(2009-1#4)(2009-10#1)(2009-11#2)(2009-3#4)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-2#7)(2012-3#11)(2013-1#33)(2013-8#4)
reconstructions for##2##2##(2008-10#1)(2013-1#1)
reconstructions have##2##2##(2008-7#1)(2012-2#1)
reconstructions in##2##2##(1992-5#1)(2012-2#1)
reconstructions of##3##2##(2008-11#1)(2008-3#1)(2010-5#1)
reconstructions##22##1##(1992-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#5)(2012-7#1)(2013-1#6)
reconstructive options##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
reconstructive surgery##13##2##(1990-9#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-11#1)(2008-11#3)(2009-5#1)(2011-2#1)(2013-1#3)
reconstructive surgical##2##2##(1992-5#1)(2011-2#1)
reconstructive techniques##2##2##(1994-12#1)(2013-8#1)
reconstructive treatment##2##2##(1992-1#1)(1992-3#1)
reconstructive##35##1##(1990-3#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-11#1)(1994-12#1)(2008-10#1)(2008-11#3)(2008-9#3)(2009-5#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#2)
reconstructs the##2##2##(2008-3#1)(2008-9#1)
reconstructs##4##1##(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)
record a##2##2##(2008-11#1)(2008-3#1)
record and##2##2##(2008-11#1)(2008-5#1)
record for the##2##3##(1992-3#1)(2008-6#1)
record in##3##2##(1994-6#1)(2008-10#2)
record is##3##2##(1992-2#1)(2013-1#2)
record of the##2##3##(2008-5#1)(2010-8#1)
record of##10##2##(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
record system##2##2##(2009-10#1)(2012-3#1)
record that##2##2##(1993-12#1)(1995-12#1)
record the##9##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-6#1)(2011-3#1)(2013-8#1)
record was##2##2##(2008-11#1)(2013-1#1)
record##93##1##(1990-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-12#2)(1996-2#3)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#9)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-6#1)(2010-8#5)(2011-1#1)(2011-2#3)(2011-3#1)(2011-9#1)(2012-3#4)(2013-1#10)(2013-8#2)
record-keeping##2##1##(1992-12#2)
recordable compact##2##2##(2008-10#2)
recordable##5##1##(2008-10#3)(2008-3#1)(2008-9#1)
recorded after##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
recorded among##2##2##(2008-10#2)
recorded and analysed using##2##4##(2008-11#1)(2008-12#1)
recorded and analysed##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
recorded and##12##2##(1996-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)
recorded as##7##2##(1994-2#1)(2008-10#3)(2008-6#1)(2008-9#1)(2010-11#1)
recorded at a##2##3##(2007-12#1)(2008-8#1)
recorded at the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
recorded at##21##2##(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#5)
recorded between##6##2##(1995-12#1)(2008-10#4)(2010-8#1)
recorded by a##3##3##(1990-9#1)(2008-10#1)(2008-7#1)
recorded by the##3##3##(1995-2#1)(2008-10#1)(2008-12#1)
recorded by use of##2##4##(2007-12#1)(2008-10#1)
recorded by##17##2##(1990-9#1)(1995-2#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#2)(2013-1#1)
recorded during the##2##3##(2008-5#1)(2013-8#1)
recorded during##13##2##(1993-6#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-8#1)(2013-1#1)(2013-8#2)
recorded for a##2##3##(1994-8#1)(2008-10#1)
recorded for the wild-type##2##4##(2008-10#2)
recorded for the##4##3##(2008-10#2)(2010-12#1)(2013-8#1)
recorded for##15##2##(1991-9#1)(1994-8#1)(2008-10#8)(2008-11#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
recorded from the##2##3##(1996-6#1)(2010-9#1)
recorded from##16##2##(1995-11#1)(1995-8#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#1)(2010-9#1)(2013-1#1)(2013-8#2)
recorded holograms##2##2##(2007-12#1)(2008-3#1)
recorded in a##5##3##(1993-6#1)(2008-10#2)(2008-9#1)(2011-2#1)
recorded in all##3##3##(2008-5#1)(2009-12#1)(2013-1#1)
recorded in an##2##3##(2008-10#1)(2013-8#1)
recorded in the##11##3##(1990-3#1)(1991-7#1)(1991-8#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-9#1)(2011-2#1)
recorded in##63##2##(1990-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-6#1)(1994-12#2)(1994-8#1)(1996-12#1)(1997-6#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-12#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-3#2)(2013-1#3)(2013-8#3)
recorded on a##3##3##(2008-3#2)(2008-7#1)
recorded on##10##2##(1994-3#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)
recorded only##2##2##(2012-3#1)(2013-8#1)
recorded simultaneously##2##2##(2008-3#1)(2008-4#1)
recorded the##5##2##(1997-3#1)(2008-12#2)(2008-3#1)(2008-9#1)
recorded under##2##2##(1996-6#1)(2011-2#1)
recorded using##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
recorded weekly##2##2##(2008-10#2)
recorded when##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
recorded with##9##2##(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-8#1)
recorded##327##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#5)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#98)(2008-11#18)(2008-12#14)(2008-3#29)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#16)(2008-8#10)(2008-9#9)(2009-10#3)(2009-12#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#4)(2011-2#13)(2011-3#1)(2012-2#8)(2012-3#5)(2013-1#11)(2013-8#11)
recorder##4##1##(2008-10#2)(2011-1#1)(2012-3#1)
recording a##2##2##(2008-2#1)(2008-7#1)
recording and##2##2##(2008-3#2)
recording chamber##2##2##(2009-9#1)(2013-1#1)
recording characteristics##3##2##(2008-3#3)
recording in a##3##3##(2007-12#2)(2008-7#1)
recording in the##2##3##(1994-2#1)(2011-2#1)
recording in##9##2##(1991-6#1)(1994-11#1)(1994-2#1)(2007-12#2)(2008-7#1)(2011-2#3)
recording material##3##2##(2007-12#2)(2008-3#1)
recording medium##2##2##(2008-3#1)(2008-4#1)
recording of the##5##3##(1994-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
recording of##22##2##(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
recording speed##2##2##(2008-3#2)
recording system##2##2##(1993-3#1)(2008-10#1)
recording techniques##2##2##(1996-2#1)(2009-10#1)
recording the##10##2##(1993-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-4#1)
recording were##2##2##(1991-12#1)(2008-3#1)
recording with##3##2##(2008-3#2)(2008-4#1)
recording##121##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-12#6)(2008-10#18)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#26)(2008-4#6)(2008-5#4)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
recordings and##2##2##(2008-11#1)(2012-2#1)
recordings during##2##2##(1993-1#1)(2010-8#1)
recordings from##5##2##(1994-2#1)(1997-7#1)(2008-11#1)(2009-8#1)(2013-1#1)
recordings have##2##2##(1997-7#1)(2010-8#1)
recordings of##5##2##(1991-6#1)(1995-6#1)(2008-4#1)(2008-5#1)(2009-9#1)
recordings were made from##3##4##(1995-12#1)(2008-8#1)(2008-9#1)
recordings were made##4##3##(1995-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
recordings were##6##2##(1995-12#1)(1995-8#1)(2008-7#2)(2008-8#1)(2008-9#1)
recordings##40##1##(1990-11#1)(1991-6#1)(1993-1#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
records analysis##2##2##(1995-12#1)(2012-3#1)
records and##15##2##(1990-9#1)(1994-12#1)(1994-3#2)(1996-2#2)(2008-10#1)(2009-10#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
records data##2##2##(2012-3#1)(2013-1#1)
records for##5##2##(1990-6#1)(1993-12#1)(1995-2#1)(1996-12#1)(2012-9#1)
records from##4##2##(1992-9#1)(1994-3#2)(2013-8#1)
records in##5##2##(1993-11#2)(1994-6#2)(2011-2#1)
records information##2##2##(2010-8#1)(2012-3#1)
records of patients who had##2##5##(1992-3#1)(1993-11#1)
records of patients with##4##4##(1996-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
records of patients##7##3##(1992-3#1)(1993-11#1)(1996-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
records of the##7##3##(1992-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-11#1)
records of##36##2##(1990-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
records to identify##2##3##(2008-11#1)(2012-12#1)
records to##5##2##(1994-3#2)(2008-11#1)(2009-10#1)(2012-12#1)
records were reviewed##2##3##(1996-1#1)(2008-9#1)
records were##7##2##(1993-12#1)(1996-1#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#1)
records##153##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#5)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#5)(1994-3#9)(1994-6#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#9)(2008-11#11)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#5)(2009-11#1)(2009-8#1)(2009-9#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#7)(2011-1#1)(2011-2#8)(2012-12#5)(2012-2#1)(2012-3#9)(2012-7#1)(2012-9#1)(2013-1#7)(2013-8#2)
recount##2##1##(2008-6#1)(2011-2#1)
recourse to##6##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
recover after##3##2##(1991-9#1)(1995-8#1)(2008-10#1)
recover and##3##2##(2008-7#1)(2013-1#2)
recover from##2##2##(2008-10#2)
recover the original##2##3##(2008-10#1)(2008-3#1)
recover the##7##2##(1995-12#1)(2008-10#2)(2008-3#2)(2008-8#2)
recover##35##1##(1990-5#1)(1991-12#1)(1991-9#2)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#11)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2013-1#3)(2013-8#2)
recoverable##3##1##(2008-10#1)(2009-3#1)(2009-7#1)
recovered after##5##2##(1995-12#2)(2007-8#1)(2008-10#1)(2013-1#1)
recovered and##8##2##(1996-8#1)(2008-10#4)(2008-7#1)(2011-2#1)(2013-1#1)
recovered apple trees##2##3##(2008-10#2)
recovered at##3##2##(2008-10#3)
recovered between years##2##3##(2008-10#2)
recovered between##3##2##(2008-10#3)
recovered by##10##2##(1993-12#1)(1995-8#1)(2008-10#5)(2008-2#1)(2008-7#1)(2013-8#1)
recovered completely##2##2##(1996-6#1)(2013-1#1)
recovered fluorescence##2##2##(2008-10#1)(2008-12#1)
recovered following##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
recovered four##2##2##(2008-10#1)(2010-4#1)
recovered from PD after the following winter##2##7##(2008-10#2)
recovered from PD##3##3##(2008-10#3)
recovered from a POI##2##4##(2008-10#2)
recovered from a##8##3##(2008-10#8)
recovered from all of the##2##5##(2011-2#1)(2012-3#1)
recovered from all##5##3##(1990-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
recovered from diseased lettuce and tomato plants##2##7##(2008-10#2)
recovered from diseased##5##3##(2008-10#5)
recovered from individual##2##3##(2008-10#2)
recovered from soil samples##2##4##(2008-10#2)
recovered from the##25##3##(1996-12#2)(1997-7#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-7#2)(2010-6#1)(2012-12#1)
recovered from these##2##3##(2008-10#2)
recovered from##116##2##(1990-12#1)(1990-5#1)(1993-12#1)(1994-5#1)(1996-12#3)(1996-8#1)(1997-7#1)(2008-10#84)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
recovered in##6##2##(1994-5#1)(2008-10#3)(2010-3#1)(2011-2#1)
recovered more##2##2##(2011-1#2)
recovered most##2##2##(1991-2#1)(2008-10#1)
recovered on##7##2##(2008-10#6)(2008-12#1)
recovered only##2##2##(2008-10#1)(2012-3#1)
recovered quantitatively##5##2##(2008-10#5)
recovered spectral images##2##3##(2013-8#2)
recovered the##2##2##(2010-4#1)(2011-2#1)
recovered to immediate preoperative##2##4##(2013-1#2)
recovered to##5##2##(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
recovered trees##3##2##(2008-10#3)
recovered well##2##2##(2011-2#1)(2013-1#1)
recovered when##2##2##(2008-11#1)(2008-5#1)
recovered with the##3##3##(2008-10#2)(2008-3#1)
recovered with##8##2##(1997-3#1)(2008-10#6)(2008-3#1)
recovered##275##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-12#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#166)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#3)(2008-9#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#8)(2013-8#5)
recovered)##4##1##(2008-10#4)
recoveries (&gt##5##2##(2008-10#5)
recoveries and##3##2##(2008-10#3)
recoveries are##8##2##(2008-10#8)
recoveries between 95##2##3##(2008-10#2)
recoveries between 98##2##3##(2008-10#2)
recoveries between##10##2##(2008-10#10)
recoveries for all##2##3##(2008-10#2)
recoveries for both##3##3##(2008-10#3)
recoveries for the##6##3##(1997-2#1)(2008-10#5)
recoveries for##24##2##(1997-2#1)(2008-10#23)
recoveries from spiked##2##3##(2008-10#2)
recoveries from the##3##3##(2008-10#3)
recoveries from##10##2##(2008-10#9)(2012-3#1)
recoveries in##4##2##(2008-10#4)
recoveries obtained for##2##3##(2008-10#2)
recoveries obtained##12##2##(2008-10#12)
recoveries of 101##4##3##(2008-10#4)
recoveries of PAHs from##2##4##(2008-10#2)
recoveries of analytes##2##3##(2008-10#2)
recoveries of certified values##2##4##(2008-10#2)
recoveries of spiked##2##3##(2008-10#2)
recoveries of the analytes##2##4##(2008-10#2)
recoveries of the two##2##4##(2008-10#2)
recoveries of the##13##3##(2008-10#12)(2008-7#1)
recoveries of these##3##3##(2008-10#3)
recoveries of##87##2##(1990-2#1)(1992-11#2)(2008-10#81)(2008-11#1)(2008-5#1)(2008-7#1)
recoveries range from##2##3##(2008-10#2)
recoveries range##3##2##(2008-10#3)
recoveries ranged between##4##3##(2008-10#4)
recoveries ranged from##6##3##(2008-10#6)
recoveries ranged##10##2##(2008-10#10)
recoveries were found to be##3##5##(2008-10#3)
recoveries were in the range of 99##2##7##(2008-10#2)
recoveries were in the range of##3##6##(2008-10#3)
recoveries were in the##4##4##(2008-10#4)
recoveries were in##5##3##(2008-10#5)
recoveries were observed##2##3##(2008-10#2)
recoveries were obtained in##3##4##(2008-10#3)
recoveries were obtained##5##3##(2008-10#5)
recoveries were reached##2##3##(2008-10#2)
recoveries were##33##2##(1992-11#1)(2008-10#32)
recoveries##258##1##(1990-2#1)(1992-11#3)(1993-2#1)(1997-2#2)(2008-10#246)(2008-11#1)(2008-5#1)(2008-7#2)(2012-3#1)
recovering from##4##2##(1997-6#1)(2009-10#2)(2010-4#1)
recovering##11##1##(1992-9#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-10#2)(2010-4#1)(2013-1#1)
recovers##3##1##(2008-10#1)(2008-8#1)(2010-7#1)
recovery (&gt##2##2##(2008-10#2)
recovery achieved for##2##3##(2008-10#2)
recovery after hip fracture##3##4##(2008-8#3)
recovery after##9##2##(1994-8#1)(2008-12#1)(2008-7#2)(2008-8#3)(2009-8#1)(2013-1#1)
recovery and high##2##3##(2008-10#2)
recovery and its##2##3##(2008-10#2)
recovery and the##2##3##(2008-10#1)(2008-9#1)
recovery and##37##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-2#1)(1994-3#1)(2008-10#21)(2008-11#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#3)
recovery assay##2##2##(2008-10#2)
recovery at##5##2##(2008-10#4)(2013-1#1)
recovery can##2##2##(1994-5#1)(2013-1#1)
recovery compared##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
recovery during##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
recovery efficiency##2##2##(2008-10#1)(2013-1#1)
recovery experiment and##2##3##(2008-10#1)(2008-5#1)
recovery factor##3##2##(2008-10#3)
recovery following##2##2##(1996-12#1)(2013-1#1)
recovery for all##2##3##(1991-12#1)(2008-10#1)
recovery for##17##2##(1991-12#1)(2008-10#12)(2008-5#2)(2008-6#1)(2013-1#1)
recovery from neuromuscular blockade##2##4##(2010-7#2)
recovery from refractoriness in##2##4##(1991-2#2)
recovery from refractoriness##3##3##(1991-2#3)
recovery from the##6##3##(2008-10#4)(2008-11#1)(2010-7#1)
recovery from##36##2##(1990-5#1)(1990-7#1)(1991-2#3)(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-5#1)(2010-1#1)(2010-7#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
recovery in the##2##3##(2008-10#1)(2013-1#1)
recovery in##8##2##(1992-3#1)(1996-3#1)(1997-3#1)(2008-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
recovery is from##2##3##(2008-10#2)
recovery is in the range##2##5##(2008-10#2)
recovery is in##3##3##(2008-10#2)(2008-6#1)
recovery is##12##2##(2008-10#9)(2008-6#1)(2008-7#2)
recovery level##2##2##(1992-1#1)(2008-10#1)
recovery method##3##2##(2008-10#2)(2012-12#1)
recovery of &gt##2##3##(2008-10#2)
recovery of 0##2##3##(2008-10#2)
recovery of 100##3##3##(2008-10#3)
recovery of 101%##2##3##(2008-10#2)
recovery of 95##2##3##(2008-10#2)
recovery of 99##4##3##(2008-10#4)
recovery of U(VI)##2##3##(2008-10#2)
recovery of a##3##3##(1994-12#1)(2008-10#1)(2008-7#1)
recovery of added##2##3##(1990-11#1)(2008-10#1)
recovery of all##3##3##(2008-10#3)
recovery of both##2##3##(2008-10#2)
recovery of copper was##2##4##(2008-10#2)
recovery of copper##7##3##(2008-10#7)
recovery of each##3##3##(2008-10#2)(2008-5#1)
recovery of function following##3##4##(1991-2#3)
recovery of human##2##3##(2008-12#1)(2008-7#1)
recovery of perchlorate##2##3##(2008-10#2)
recovery of responding to the extinguished stimulus during##2##8##(2008-5#2)
recovery of spiked##5##3##(1997-2#1)(2008-10#4)
recovery of spikes##2##3##(2008-10#2)
recovery of the analyte##4##4##(2008-10#3)(2012-12#1)
recovery of the method##2##4##(2008-10#2)
recovery of the spiked##2##4##(2008-10#2)
recovery of the##35##3##(1990-3#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-8#1)(2008-10#22)(2008-11#2)(2008-7#2)(2008-9#1)(2009-8#1)(2012-12#1)(2013-1#1)
recovery of these##2##3##(2008-10#2)
recovery of total##2##3##(2008-10#2)
recovery of##216##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#4)(1992-11#1)(1992-12#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#154)(2008-11#12)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-9#3)(2009-8#2)(2010-5#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#2)
recovery on##2##2##(2008-10#1)(2012-3#1)
recovery or##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
recovery percentages##3##2##(2008-10#3)
recovery period##6##2##(1992-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#2)
recovery phase##3##2##(1996-2#2)(2010-7#1)
recovery process##2##2##(1991-2#1)(2008-10#1)
recovery range##4##2##(2008-10#4)
recovery rate (RR)##2##3##(2008-10#2)
recovery rate of##3##3##(1996-12#1)(2008-10#2)
recovery rate was##6##3##(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)
recovery rate##13##2##(1996-12#2)(2008-10#8)(2008-11#2)(2008-12#1)
recovery rates##11##2##(1996-12#1)(2008-10#9)(2008-12#1)
recovery requirements##2##2##(2008-10#2)
recovery results##2##2##(2008-10#2)
recovery room##4##2##(2008-7#1)(2010-7#2)(2011-2#1)
recovery studies were##2##3##(2008-10#1)(2011-2#1)
recovery studies##8##2##(2008-10#7)(2011-2#1)
recovery study##3##2##(2008-10#3)
recovery term##2##2##(2008-10#2)
recovery test was performed##2##4##(2008-10#2)
recovery test##6##2##(2008-10#6)
recovery tests##5##2##(2008-10#5)
recovery the##2##2##(1991-2#1)(2008-10#1)
recovery time in semiconductor optical amplifiers##2##6##(2007-11#2)
recovery time in##3##3##(2007-11#2)(2008-9#1)
recovery time##10##2##(1996-3#1)(2007-11#3)(2008-10#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
recovery times##3##2##(2008-10#2)(2013-1#1)
recovery to##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
recovery under##3##2##(2013-8#3)
recovery value##2##2##(2008-10#2)
recovery values are##4##3##(2008-10#4)
recovery values from##2##3##(2008-10#2)
recovery values obtained##4##3##(2008-10#4)
recovery values were obtained##2##4##(2008-10#1)(2011-2#1)
recovery values were##5##3##(2008-10#4)(2011-2#1)
recovery values##22##2##(2008-10#21)(2011-2#1)
recovery was calculated##2##3##(2008-10#2)
recovery was found##2##3##(2008-10#2)
recovery was obtained##2##3##(2008-10#2)
recovery was##30##2##(1991-2#1)(2008-10#21)(2008-11#1)(2008-12#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)
recovery were obtained for##2##4##(2008-10#2)
recovery were##10##2##(1994-8#1)(1996-12#1)(2008-10#6)(2010-2#1)(2012-3#1)
recovery with##2##2##(1995-5#1)(2010-5#1)
recovery##695##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#4)(1990-7#1)(1991-11#1)(1991-12#3)(1991-2#12)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-6#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#6)(1996-2#3)(1996-3#2)(1996-6#1)(1997-2#3)(1997-3#2)(1997-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#410)(2008-11#28)(2008-12#11)(2008-3#2)(2008-5#9)(2008-6#4)(2008-7#19)(2008-8#6)(2008-9#10)(2009-1#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#8)(2011-2#11)(2011-3#3)(2012-12#8)(2012-2#8)(2012-3#15)(2013-1#24)(2013-8#14)
recreated##2##1##(2008-11#1)(2009-11#1)
recreating the##2##2##(2013-1#2)
recreation and leisure activities##2##4##(2012-12#2)
recreation therapy##2##2##(1993-2#2)
recreation##5##1##(1993-2#2)(1994-3#1)(2012-12#2)
recreational drugs##2##2##(1991-1#1)(2011-2#1)
recreational screen-based##2##2##(2013-1#2)
recreational soccer player##2##3##(2011-2#2)
recreational##13##1##(1990-2#1)(1991-1#1)(2008-10#2)(2009-7#1)(2011-2#5)(2013-1#3)
recruit##20##1##(1993-1#1)(1993-6#1)(1995-2#1)(1996-2#1)(2008-11#4)(2008-5#2)(2009-5#3)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)(2013-8#1)
recruited and##3##2##(2008-4#1)(2013-1#1)(2013-8#1)
recruited by##4##2##(2008-11#3)(2009-5#1)
recruited for the study##3##4##(2008-3#1)(2011-2#1)(2012-12#1)
recruited for the##5##3##(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
recruited for##9##2##(1995-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
recruited from a##2##3##(2008-7#1)(2013-1#1)
recruited from the##2##3##(2010-11#1)(2010-2#1)
recruited from##17##2##(1995-1#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-2#1)(2013-1#5)
recruited in##4##2##(2009-2#1)(2009-8#1)(2013-1#1)(2013-8#1)
recruited into##5##2##(1994-3#1)(2008-1#1)(2008-4#1)(2011-1#1)(2013-1#1)
recruited to##5##2##(1994-3#1)(1995-2#1)(1996-2#1)(2011-2#1)(2012-2#1)
recruited##69##1##(1994-3#2)(1995-1#2)(1995-2#1)(1995-3#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#11)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#12)(2013-8#5)
recruiting patients##2##2##(2008-11#1)(2012-3#1)
recruiting##11##1##(1991-2#1)(1993-6#1)(1996-3#2)(2008-11#2)(2009-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
recruitment and retention of##3##4##(1994-3#1)(2008-12#1)(2009-5#1)
recruitment and retention##12##3##(1991-2#1)(1994-3#2)(1995-2#1)(2008-11#3)(2008-12#2)(2008-8#1)(2009-5#1)(2010-11#1)
recruitment and##23##2##(1991-11#1)(1991-2#1)(1991-6#1)(1994-3#2)(1995-2#1)(2008-1#1)(2008-11#4)(2008-12#2)(2008-8#4)(2009-5#1)(2010-10#1)(2010-11#2)(2010-12#1)(2012-2#1)
recruitment challenges##2##2##(2010-10#1)(2010-11#1)
recruitment efforts##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
recruitment of blood##2##3##(1997-8#1)(2008-7#1)
recruitment of small-diameter fibers by the long-duration pulses##2##8##(1991-2#2)
recruitment of##20##2##(1991-2#2)(1993-6#1)(1996-2#1)(1997-8#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-6#3)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
recruitment to the##3##3##(1997-2#1)(2008-10#1)(2013-1#1)
recruitment to##6##2##(1997-2#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-3#1)(2013-1#1)
recruitment##92##1##(1990-2#2)(1991-11#1)(1991-2#4)(1991-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#10)(2008-12#3)(2008-7#1)(2008-8#8)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#3)(2010-10#4)(2010-11#7)(2010-12#2)(2010-4#1)(2010-8#6)(2011-2#2)(2012-2#7)(2012-3#2)(2013-1#5)(2013-8#1)
recruits and blood donors##2##4##(1996-11#2)
recruits and##3##2##(1990-2#1)(1996-11#2)
recruits in##3##2##(2008-12#1)(2013-1#2)
recruits##16##1##(1990-2#1)(1990-3#1)(1994-11#1)(1996-11#2)(2008-11#1)(2008-12#3)(2009-7#1)(2011-2#1)(2013-1#4)(2013-8#1)
rectal and sacral tumor##2##4##(2013-8#2)
rectal and##4##2##(2009-11#2)(2013-8#2)
rectal bleeding##3##2##(2011-2#2)(2013-1#1)
rectal cancer with##2##3##(2009-8#1)(2013-8#1)
rectal cancer##18##2##(1990-9#1)(1993-6#1)(1997-7#3)(1997-8#1)(2009-12#4)(2009-8#1)(2010-6#2)(2011-3#1)(2013-8#4)
rectal cancers##2##2##(1991-6#1)(2007-8#1)
rectal carcinoma]##2##2##(1990-3#1)(1996-8#1)
rectal examination in##2##3##(2008-7#2)
rectal examination##5##2##(1991-7#1)(2008-7#4)
rectal examinations##5##2##(1991-7#4)(1994-12#1)
rectal lumen##3##2##(2013-1#3)
rectal mucosa following its topical##2##5##(2010-12#2)
rectal mucosal prolapse and##3##4##(2013-1#3)
rectal mucosal prolapse##6##3##(2013-1#6)
rectal temperature##3##2##(1990-5#1)(1990-9#1)(1991-3#1)
rectal tumor##2##2##(2013-8#2)
rectal##74##1##(1990-3#1)(1990-5#1)(1990-9#2)(1991-3#1)(1991-6#1)(1991-7#6)(1992-9#1)(1993-6#1)(1994-12#1)(1996-3#1)(1996-8#1)(1997-7#3)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#4)(2009-11#4)(2009-12#8)(2009-8#2)(2010-12#3)(2010-6#3)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#10)(2013-8#9)
rectangular##19##1##(1992-12#1)(1996-2#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#4)(2008-7#1)(2009-11#1)(2009-7#1)(2013-1#1)
rectification (type##2##2##(1996-2#2)
rectification##6##1##(1996-2#2)(2007-11#2)(2007-12#1)(2011-2#1)
rectified##4##1##(1997-7#1)(2007-11#1)(2008-8#2)
rectifier K(+)-channel##2##2##(1993-3#2)
rectifying##2##1##(1996-2#1)(2011-2#1)
rectilinear in the##2##3##(2008-10#2)
rectilinear over the##4##3##(2008-10#4)
rectilinear##10##1##(2008-10#10)
rectocolitis##5##1##(1990-3#1)(1992-3#3)(1996-6#1)
rectosigmoid##3##1##(1993-12#2)(2013-1#1)
rectum and##5##2##(2007-8#1)(2009-12#2)(2012-12#2)
rectum presenting##2##2##(2008-12#1)(2013-8#1)
rectum wall##2##2##(2007-12#1)(2012-12#1)
rectum##32##1##(1990-3#1)(1991-2#1)(1991-6#3)(1992-5#2)(1994-2#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-12#3)(2008-5#1)(2009-11#1)(2009-12#2)(2009-8#1)(2011-2#1)(2012-12#6)(2012-3#1)(2013-8#4)
rectus abdominis myocutaneous flap##2##4##(1990-9#1)(2013-1#1)
rectus femoris muscle length##3##4##(2008-12#3)
rectus femoris muscle##6##3##(2008-12#4)(2011-2#2)
rectus femoris##8##2##(2008-12#5)(2011-2#3)
rectus muscle##2##2##(1991-12#1)(2012-3#1)
rectus##13##1##(1990-9#1)(1991-12#1)(2008-12#5)(2011-2#3)(2012-3#1)(2013-1#2)
recuperation##2##1##(1996-1#1)(2008-10#1)
recur##10##1##(1993-11#1)(1993-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#3)
recurred in##2##2##(1997-6#1)(1997-7#1)
recurred locally##2##2##(1990-9#1)(1991-6#1)
recurred##10##1##(1990-9#1)(1991-6#1)(1992-5#1)(1994-1#1)(1997-6#1)(1997-7#1)(2008-8#1)(2009-1#1)(2011-2#1)(2012-3#1)
recurrence after surgical##2##3##(2009-1#1)(2013-1#1)
recurrence after##7##2##(1990-3#1)(1990-6#1)(1993-3#1)(2009-1#1)(2012-3#1)(2013-1#2)
recurrence along##2##2##(2010-11#1)(2011-2#1)
recurrence and metastasis##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
recurrence and##15##2##(1990-12#1)(1996-11#1)(2008-11#1)(2008-2#1)(2008-7#3)(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
recurrence for##2##2##(2008-7#1)(2013-1#1)
recurrence from##2##2##(1990-12#1)(2008-10#1)
recurrence has been##2##3##(2011-2#2)
recurrence has##3##2##(2008-8#1)(2011-2#2)
recurrence in##4##2##(1997-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
recurrence of the##5##3##(2008-11#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
recurrence of##17##2##(1990-11#1)(1990-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
recurrence or##3##2##(1993-11#1)(2011-2#1)(2013-8#1)
recurrence plots##3##2##(2008-11#3)
recurrence rate was##2##3##(1995-5#1)(2013-1#1)
recurrence rate##9##2##(1992-11#1)(1995-5#1)(1997-7#1)(2010-3#1)(2011-2#3)(2013-1#2)
recurrence rates to##2##3##(2009-12#1)(2010-8#1)
recurrence rates##6##2##(1993-1#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
recurrence was seen##2##3##(2008-10#1)(2011-2#1)
recurrence was##9##2##(1994-12#1)(1997-3#2)(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#2)(2012-3#1)
recurrence##147##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#3)(1993-11#2)(1993-3#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-11#2)(1997-3#2)(1997-7#4)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#21)(2012-12#2)(2012-2#4)(2012-3#11)(2013-1#19)(2013-8#4)
recurrences and##2##2##(2008-11#1)(2008-7#1)
recurrences by##3##2##(1990-6#1)(1992-5#2)
recurrences following##2##2##(1990-6#1)(2013-1#1)
recurrences in##2##2##(1992-12#1)(2011-2#1)
recurrences is##2##2##(1991-9#1)(2007-8#1)
recurrences of##4##2##(1991-2#1)(1991-6#1)(1996-12#1)(2013-1#1)
recurrences##34##1##(1990-3#1)(1990-6#6)(1991-2#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-5#2)(1993-3#1)(1994-1#1)(1995-5#1)(1996-12#1)(1997-8#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#2)(2013-1#3)
recurrent abdominal pain in##2##4##(1992-5#2)
recurrent bladder tumours##3##3##(1991-6#3)
recurrent bladder##4##2##(1991-6#4)
recurrent breast cancer##4##3##(1993-1#2)(1994-12#2)
recurrent carcinoma##2##2##(1994-1#1)(2013-1#1)
recurrent collaterals of##2##3##(1996-5#2)
recurrent disease after##2##3##(1994-5#1)(1997-4#1)
recurrent disease##4##2##(1994-5#1)(1997-4#1)(2010-7#1)(2012-3#1)
recurrent episodes##2##2##(2008-11#1)(2013-1#1)
recurrent epistaxis##2##2##(2008-7#1)(2010-6#1)
recurrent hernias)##2##2##(1992-5#2)
recurrent infection##4##2##(2008-8#2)(2011-2#1)(2011-3#1)
recurrent infections##2##2##(2010-5#1)(2011-1#1)
recurrent malignancies of the##2##4##(1993-6#1)(1994-1#1)
recurrent network##2##2##(2013-8#2)
recurrent neural networks##5##3##(2010-8#5)
recurrent neural##9##2##(2008-11#4)(2010-8#5)
recurrent pain##4##2##(2008-11#4)
recurrent parent##6##2##(2008-10#5)(2008-9#1)
recurrent post-bronchiolitis##2##2##(2008-1#2)
recurrent seizures##2##2##(2009-8#1)(2011-2#1)
recurrent stasis ulcers##2##3##(2013-1#2)
recurrent superficial bladder tumours##2##4##(1991-6#2)
recurrent ventricular##2##2##(2008-12#2)
recurrent wheals##2##2##(2010-6#2)
recurrent##186##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-6#10)(1992-11#1)(1992-2#1)(1992-5#6)(1992-6#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-6#1)(1994-1#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1996-11#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#2)(2007-7#1)(2008-1#3)(2008-10#11)(2008-11#16)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#5)(2008-9#6)(2009-12#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#7)(2010-7#1)(2010-8#6)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#14)(2013-1#10)(2013-7#2)(2013-8#2)
recurring##8##1##(1991-3#2)(1993-1#1)(2008-10#2)(2008-12#2)(2008-3#1)
recurs##2##1##(1995-12#1)(1997-7#1)
recursive partitioning##3##2##(1991-12#2)(1995-2#1)
recursive##5##1##(1991-12#2)(1995-12#1)(1995-2#1)(2008-6#1)
recycle batch##5##2##(2008-11#1)(2008-7#4)
recycle##8##1##(1995-6#1)(2008-11#2)(2008-7#4)(2008-8#1)
recycled HDPE##5##2##(2009-3#5)
recycled##10##1##(2008-10#4)(2009-3#6)
recycling of##10##2##(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#1)
recycling site##2##2##(2008-10#2)
recycling##29##1##(1993-3#1)(1994-11#1)(1994-8#1)(1997-1#4)(1997-7#2)(2008-10#9)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#2)(2012-2#3)
red (NR)##2##2##(2008-10#2)
red S##4##2##(2008-10#4)
red alga##5##2##(2008-10#2)(2008-11#3)
red algae##3##2##(2008-10#1)(2008-8#1)(2011-10#1)
red and blue##2##3##(2008-3#1)(2008-8#1)
red and white##3##3##(2008-10#3)
red and##9##2##(2008-10#7)(2008-3#1)(2008-8#1)
red beds##6##2##(2013-8#6)
red blood cell##12##3##(1990-8#1)(1993-12#1)(1995-8#1)(1997-6#2)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#3)
red blood cells (RBC)##2##4##(2008-10#1)(2010-8#1)
red blood cells in##2##4##(2008-10#1)(2008-9#1)
red blood cells##39##3##(1990-12#2)(1990-2#1)(1990-8#2)(1992-11#2)(1993-12#2)(1994-11#2)(1995-2#1)(1997-6#1)(2008-10#14)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
red blood##51##2##(1990-12#2)(1990-2#1)(1990-8#3)(1992-11#2)(1993-12#3)(1994-11#2)(1995-2#1)(1995-8#1)(1997-6#3)(2008-10#16)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
red cell##13##2##(1990-12#1)(1990-8#1)(1992-12#1)(1995-6#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2011-3#1)(2012-2#1)
red cells lack##2##3##(1995-6#2)
red cells were##2##3##(2008-10#1)(2008-3#1)
red cells##7##2##(1990-8#1)(1995-6#2)(2008-10#1)(2008-3#2)(2010-11#1)
red clover mottle##2##3##(1995-12#2)
red clover##3##2##(1995-12#2)(2008-10#1)
red coloured##3##2##(2008-10#3)
red complex with##2##3##(2008-10#2)
red complex##8##2##(2008-10#8)
red disarrayed&quot##2##2##(1990-3#2)
red discoloration of##2##3##(1995-11#1)(2013-1#1)
red dyes##2##2##(2008-10#2)
red flag documentation##2##3##(2008-12#2)
red flag items##3##3##(2008-12#3)
red flag##5##2##(2008-12#5)
red flags##3##2##(2008-12#3)
red in##3##2##(2008-10#3)
red leading edges stimulated an ETR under##2##7##(2011-2#2)
red light##9##2##(1990-5#4)(1992-1#1)(2008-8#1)(2008-9#1)(2012-2#2)
red ochre##3##2##(2008-10#3)
red orange extract##2##3##(2008-5#2)
red pine##3##2##(2008-10#3)
red resinous exudates##2##3##(2008-10#2)
red shift of##2##3##(2008-10#2)
red shift##4##2##(2008-10#4)
red wine might##2##3##(2008-10#2)
red wine samples##3##3##(2008-10#3)
red wine##17##2##(2008-10#13)(2008-7#3)(2012-12#1)
red wines using##2##3##(2008-10#2)
red wines##10##2##(2008-10#10)
red winter wheat##2##3##(2008-10#2)
red with##2##2##(2008-10#2)
red##283##1##(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#4)(1990-8#5)(1992-1#2)(1992-11#2)(1992-12#1)(1993-12#3)(1994-11#3)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-8#2)(1997-5#2)(1997-6#4)(2006-6#1)(2008-10#131)(2008-11#11)(2008-12#11)(2008-3#7)(2008-4#3)(2008-5#9)(2008-7#7)(2008-8#9)(2008-9#3)(2009-12#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#5)(2011-1#1)(2011-10#1)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#8)(2013-1#7)(2013-8#6)
red-coloured##2##1##(1990-12#1)(2008-10#1)
red-emitting CdTe quantum dots##2##4##(2008-10#2)
red-green-blue##2##1##(2008-3#1)(2009-11#1)
red-region fluorescent reagent##2##3##(2008-10#2)
red-region fluorescent##3##2##(2008-10#3)
red-shifted to##2##2##(2008-10#2)
red-shifted##4##1##(2008-10#3)(2008-11#1)
red-smear##3##1##(2012-2#3)
red/infrared irradiation had##2##3##(2008-10#2)
reddish-brown##2##1##(2008-10#2)
redefine the##2##2##(1994-3#1)(1995-2#1)
redefine##3##1##(1994-3#1)(1995-2#1)(2008-7#1)
redefining the##3##2##(1995-12#1)(2008-3#1)(2011-3#1)
redefining##5##1##(1993-3#1)(1995-12#1)(2008-10#1)(2008-3#1)(2011-3#1)
redeployment##7##1##(1993-1#3)(1995-1#3)(1995-2#1)
redesign of##4##2##(1997-2#2)(1997-3#1)(2008-7#1)
redesign##15##1##(1993-12#2)(1993-3#2)(1995-2#1)(1996-1#2)(1996-2#2)(1997-1#2)(1997-2#2)(1997-3#1)(2008-7#1)
redesigned to##2##2##(1995-1#1)(2008-6#1)
redesigned##7##1##(1995-1#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
redesigning of##2##2##(1992-3#1)(2008-11#1)
redesigning##8##1##(1992-3#2)(1993-2#1)(1995-3#1)(1997-2#1)(1997-7#1)(2008-11#1)(2010-7#1)
redirected to##2##2##(2008-10#1)(2008-11#1)
redirection of##2##2##(2008-11#2)
redirection##3##1##(2008-11#3)
redisplacement##6##1##(1991-9#1)(2011-2#5)
redissolution##3##1##(2008-10#3)
redistribution in##2##2##(1992-5#1)(1995-8#1)
redistribution of the##2##3##(1995-6#1)(2008-10#1)
redistribution of##7##2##(1993-8#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-8#3)
redistribution was##2##2##(1992-5#2)
redistribution##18##1##(1992-5#3)(1993-8#1)(1994-6#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-8#4)(2011-2#3)(2012-2#1)(2013-7#1)
redistributive##2##1##(1997-2#2)
redness of##2##2##(2008-5#1)(2008-8#1)
redness##4##1##(2008-5#2)(2008-8#1)(2011-2#1)
redolens f##2##2##(2008-10#2)
redolens##5##1##(2008-10#5)
redolens-F##3##1##(2008-10#3)
redox and##2##2##(2009-9#1)(2010-4#1)
redox behavior of##2##3##(2008-10#2)
redox behavior##6##2##(2008-10#6)
redox catalyst##2##2##(2008-10#2)
redox couple due to##2##4##(2008-10#2)
redox couple##8##2##(2008-10#8)
redox cycle##3##2##(1992-8#3)
redox cycling##4##2##(1992-8#2)(2008-10#1)(2008-11#1)
redox electrode detector##3##3##(2008-10#3)
redox electrode##6##2##(2008-10#6)
redox enzymes##2##2##(1997-7#1)(2008-10#1)
redox equilibrium##2##2##(2008-10#1)(2008-7#1)
redox homeostasis##5##2##(1994-8#2)(2009-6#1)(2009-9#1)(2012-2#1)
redox indicator##2##2##(2008-10#2)
redox indicators##3##2##(2008-10#3)
redox labels##2##2##(2008-12#2)
redox mechanism##2##2##(2008-10#2)
redox mediator##9##2##(2008-10#9)
redox peak##3##2##(2008-10#2)(2008-8#1)
redox peaks##4##2##(2008-10#4)
redox polymer##4##2##(2008-10#4)
redox potential##9##2##(2008-10#6)(2008-11#3)
redox potentials##5##2##(2008-10#5)
redox process##4##2##(2008-10#4)
redox processes##3##2##(2008-10#2)(2009-9#1)
redox properties of##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
redox properties##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
redox protein##2##2##(1993-9#1)(2009-9#1)
redox reaction between bromate and##3##5##(2008-10#3)
redox reaction between##8##3##(2008-10#8)
redox reaction of cysteine with iron(III)##2##6##(2008-10#2)
redox reaction of##6##3##(2008-10#6)
redox reaction with##2##3##(2008-10#2)
redox reaction##24##2##(2008-10#24)
redox reactions##4##2##(1997-7#1)(2008-10#2)(2009-10#1)
redox speciation##2##2##(2008-10#2)
redox species##2##2##(2008-10#2)
redox state of##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
redox state##5##2##(1994-3#1)(2008-10#2)(2008-11#1)(2009-10#1)
redox system##4##2##(2008-10#4)
redox waves##4##2##(1996-5#1)(2008-10#3)
redox##183##1##(1990-5#2)(1992-6#1)(1992-8#5)(1993-8#2)(1993-9#1)(1994-3#3)(1994-5#2)(1994-8#2)(1996-5#1)(1997-7#2)(2008-10#133)(2008-11#11)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#5)(2010-4#1)(2010-6#1)(2012-2#1)
redox-active mediator##2##2##(2008-10#2)
redox-active##7##1##(1993-9#1)(2008-10#5)(2008-12#1)
redox-cycling quinones##3##2##(2009-9#3)
redox-cycling##5##1##(2009-9#5)
redox-potentiometric##2##1##(2008-10#2)
reduce FBS##2##2##(2008-11#2)
reduce Fusarium##2##2##(2008-10#2)
reduce a##4##2##(1993-1#1)(1995-6#1)(2008-10#1)(2013-1#1)
reduce aflatoxin##2##2##(2008-10#2)
reduce cell##2##2##(2010-11#1)(2011-2#1)
reduce costs##4##2##(1991-12#1)(1995-2#1)(1996-1#1)(1997-1#1)
reduce damage##2##2##(2008-10#1)(2008-7#1)
reduce disease##5##2##(2008-10#4)(2011-2#1)
reduce exposure to##2##3##(2008-11#1)(2008-5#1)
reduce growth##2##2##(1995-6#1)(2008-12#1)
reduce host##2##2##(2008-8#1)(2008-9#1)
reduce inflammation and##2##3##(1993-9#1)(2011-2#1)
reduce life##2##2##(1997-4#1)(2008-8#1)
reduce long-term##2##2##(2008-2#1)(2013-1#1)
reduce maternal mortality##2##3##(2008-11#2)
reduce morbidity##2##2##(2008-7#1)(2011-2#1)
reduce mortality##4##2##(1997-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
reduce or##9##2##(1992-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)(2010-5#1)(2013-1#1)
reduce redundancy##2##2##(1996-2#1)(2010-8#1)
reduce risk in##2##3##(1997-1#1)(2008-7#1)
reduce risk of##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
reduce risk##7##2##(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#3)
reduce risks from##2##3##(1991-3#1)(2008-9#1)
reduce risks##3##2##(1991-3#2)(2008-9#1)
reduce root disease severity##2##4##(2008-10#2)
reduce significantly the##2##3##(2008-3#1)(2013-8#1)
reduce symptoms##2##2##(2008-10#1)(2008-12#1)
reduce the amount of##4##4##(2008-10#2)(2008-11#2)
reduce the burden of##5##4##(2007-12#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-3#1)
reduce the cost##2##3##(2008-3#1)(2013-8#1)
reduce the degree of##3##4##(1997-3#2)(2009-11#1)
reduce the growth##2##3##(1990-11#1)(1995-6#1)
reduce the incidence of##11##4##(1991-12#1)(1992-12#2)(1997-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
reduce the level of##2##4##(1997-6#1)(2008-10#1)
reduce the likelihood of##3##4##(2010-12#1)(2011-2#2)
reduce the matrix##2##3##(2009-8#1)(2010-11#1)
reduce the morbidity##3##3##(2008-7#1)(2010-12#1)(2012-12#1)
reduce the need for##2##4##(2008-9#1)(2009-6#1)
reduce the need##3##3##(2008-11#1)(2008-9#1)(2009-6#1)
reduce the number of##10##4##(1997-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
reduce the overall##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
reduce the potential for##2##4##(2008-10#1)(2013-1#1)
reduce the probability of##2##4##(2008-10#1)(2012-3#1)
reduce the probability##3##3##(1991-12#1)(2008-10#1)(2012-3#1)
reduce the range of##2##4##(2008-8#2)
reduce the range##3##3##(2008-10#1)(2008-8#2)
reduce the risk of##14##4##(1990-2#1)(1993-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-1#2)(2013-8#3)
reduce the risk##16##3##(1990-2#1)(1993-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-1#2)(2013-1#1)(2013-8#3)
reduce the risks of##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
reduce the risks##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
reduce the severity of the disease##2##6##(2008-10#1)(2012-3#1)
reduce the severity of##6##4##(2008-10#4)(2010-1#1)(2012-3#1)
reduce the time required to develop##2##6##(2008-11#2)
reduce the time required to##3##5##(2008-10#1)(2008-11#2)
reduce the time##6##3##(2008-10#3)(2008-11#2)(2010-12#1)
reduce the use of##2##4##(1991-1#1)(2012-3#1)
reduce the variability of##2##4##(2008-10#2)
reduce the##209##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-12#3)(1992-4#1)(1992-9#2)(1993-2#2)(1993-9#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#48)(2008-11#13)(2008-12#3)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#9)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#10)
reduce their##10##2##(1991-6#1)(1996-9#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2013-1#1)
reduce to##2##2##(1994-5#1)(2008-3#1)
reduce viral##2##2##(1994-6#1)(2013-8#1)
reduce##522##1##(1990-11#2)(1990-2#2)(1990-8#1)(1991-1#3)(1991-12#4)(1991-2#3)(1991-3#4)(1991-6#3)(1991-7#1)(1991-9#1)(1992-12#3)(1992-2#2)(1992-4#1)(1992-9#4)(1993-1#2)(1993-11#2)(1993-2#5)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#8)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#6)(1997-2#7)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#116)(2008-11#39)(2008-12#6)(2008-2#6)(2008-3#15)(2008-4#3)(2008-5#13)(2008-6#3)(2008-7#21)(2008-8#22)(2008-9#18)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#18)(2011-3#2)(2011-7#1)(2012-12#7)(2012-2#8)(2012-3#12)(2013-1#29)(2013-7#1)(2013-8#14)
reduced (P &lt##3##3##(1992-12#2)(2011-3#1)
reduced 13##2##2##(2008-10#2)
reduced Fusarium##2##2##(2008-10#2)
reduced GSH##2##2##(2008-7#2)
reduced MR image artifact##2##4##(2009-7#2)
reduced ability of##2##3##(1991-7#1)(2008-10#1)
reduced ability##3##2##(1991-7#1)(1992-10#1)(2008-10#1)
reduced activity##4##2##(1995-2#1)(1995-8#1)(2011-2#1)(2012-3#1)
reduced after##8##2##(1990-12#1)(1990-9#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-5#1)(2013-1#1)
reduced among##2##2##(2010-1#1)(2012-2#1)
reduced amounts##2##2##(1993-9#1)(2008-5#1)
reduced and a##2##3##(2008-10#1)(2008-11#1)
reduced and the##2##3##(1991-5#1)(2008-5#1)
reduced and##17##2##(1991-5#1)(1992-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#1)
reduced as##6##2##(1997-2#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-5#1)
reduced at -0##2##3##(2008-10#2)
reduced at a##6##3##(1990-8#1)(2008-10#5)
reduced at the##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
reduced at##17##2##(1990-8#1)(1995-8#1)(2008-10#14)(2008-7#1)
reduced bacterial##3##2##(2008-10#3)
reduced barrier function##3##3##(2008-5#3)
reduced below##2##2##(2008-3#1)(2008-8#1)
reduced biological##2##2##(1993-8#1)(2008-8#1)
reduced both the##2##3##(1990-5#1)(2008-10#1)
reduced both##7##2##(1990-5#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
reduced but##4##2##(1990-5#1)(2008-10#1)(2009-12#1)(2012-2#1)
reduced by 10%##2##3##(2008-10#1)(2008-2#1)
reduced by 50%##2##3##(1995-8#1)(2008-10#1)
reduced by a factor of##3##5##(2007-12#1)(2008-10#2)
reduced by a##5##3##(1995-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
reduced by about##5##3##(2008-10#2)(2008-6#1)(2012-12#1)(2013-8#1)
reduced by applying##2##3##(2008-10#2)
reduced by increasing##2##3##(1997-8#1)(2008-8#1)
reduced by more than##2##4##(2008-10#1)(2010-3#1)
reduced by the##7##3##(1992-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2009-4#1)(2011-2#1)
reduced by##108##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-2#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#3)(1997-1#5)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#45)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-4#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
reduced capacity##2##2##(1996-11#1)(2008-7#1)
reduced cell growth##2##3##(2008-11#2)
reduced cell##6##2##(1996-3#1)(2008-10#2)(2008-11#3)
reduced cellular##2##2##(1990-2#1)(2008-11#1)
reduced colonization##2##2##(2008-10#2)
reduced compared with the##3##4##(1996-11#1)(2008-10#1)(2008-3#1)
reduced compared with##8##3##(1995-8#1)(1996-11#1)(2008-10#3)(2008-3#2)(2012-12#1)
reduced compared##9##2##(1995-8#1)(1996-11#1)(2008-10#3)(2008-3#2)(2008-5#1)(2012-12#1)
reduced concentration of##2##3##(1992-8#1)(1993-1#1)
reduced concentration##3##2##(1992-8#1)(1993-1#1)(2008-11#1)
reduced concentrations of##2##3##(1992-12#1)(2011-2#1)
reduced considerably##2##2##(1996-2#1)(2008-2#1)
reduced cost##4##2##(1996-2#1)(2008-10#1)(2008-11#2)
reduced costs##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
reduced decay caused by all three##2##6##(2008-10#2)
reduced decay##3##2##(2008-10#3)
reduced disease in##3##3##(2008-10#3)
reduced disease incidence and##2##4##(2008-10#2)
reduced disease incidence in the##2##5##(2008-10#2)
reduced disease incidence##7##3##(2008-10#7)
reduced disease severity by##2##4##(2008-10#2)
reduced disease severity##5##3##(2008-10#5)
reduced disease##24##2##(2008-10#24)
reduced doses of##2##3##(2008-10#1)(2011-1#1)
reduced doses##3##2##(2008-10#2)(2011-1#1)
reduced drug accumulation##2##3##(2008-11#2)
reduced effect##2##2##(2008-12#1)(2008-8#1)
reduced expression of##3##3##(1992-1#1)(2008-5#1)(2010-7#1)
reduced expression##4##2##(1992-1#1)(1993-12#1)(2008-5#1)(2010-7#1)
reduced fertility##2##2##(1994-2#1)(2012-3#1)
reduced food intake##2##3##(1993-12#1)(1996-2#1)
reduced food##3##2##(1993-12#1)(1996-2#1)(2008-9#1)
reduced for##5##2##(1993-8#1)(2008-10#3)(2011-2#1)
reduced form of the##2##4##(2008-10#1)(2009-7#1)
reduced form of##7##3##(1991-3#1)(1994-5#1)(2008-10#4)(2009-7#1)
reduced form##11##2##(1991-3#1)(1994-5#1)(2008-10#6)(2009-7#1)(2011-2#1)(2013-8#1)
reduced formation of##2##3##(1995-12#1)(2008-10#1)
reduced from##14##2##(1991-3#1)(1993-8#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-5#1)
reduced germination##3##2##(2008-10#2)(2011-2#1)
reduced glutathione (GSH)##6##3##(1990-2#1)(1995-2#1)(2008-10#4)
reduced glutathione as##2##3##(1990-12#1)(1993-2#1)
reduced glutathione in##3##3##(2008-10#3)
reduced glutathione##17##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-2#1)(1995-2#3)(2008-10#7)(2012-2#2)(2013-1#1)
reduced growth and development##2##4##(2008-8#2)
reduced growth and##4##3##(2008-11#1)(2008-12#1)(2008-8#2)
reduced growth of##2##3##(2008-10#2)
reduced growth rate##2##3##(2008-11#1)(2010-8#1)
reduced growth rates##2##3##(2008-11#2)
reduced growth##13##2##(1997-2#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-8#2)(2009-8#1)(2010-8#1)(2011-1#1)
reduced human##2##2##(1995-2#2)
reduced hyphal##3##2##(2008-10#3)
reduced if the##2##3##(2008-10#1)(2008-7#1)
reduced if##6##2##(2008-10#5)(2008-7#1)
reduced in Gadd45(as)/MCF-7##2##3##(2008-9#2)
reduced in a##5##3##(1990-5#1)(1992-12#1)(2008-10#3)
reduced in comparison with##2##4##(2008-12#1)(2008-8#1)
reduced in comparison##3##3##(2008-12#1)(2008-5#1)(2008-8#1)
reduced in its ability to##2##5##(2008-10#2)
reduced in one##3##3##(2008-10#1)(2008-7#2)
reduced in the presence of##2##5##(1995-11#1)(1997-8#1)
reduced in the##18##3##(1992-5#1)(1993-6#1)(1995-11#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#3)
reduced in##93##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-2#1)(1992-12#2)(1992-5#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#2)(1995-11#2)(1995-8#1)(1996-12#6)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#11)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#3)
reduced incidence of##7##3##(1997-3#1)(2008-10#4)(2009-4#1)(2010-1#1)
reduced incidence##8##2##(1997-3#1)(2008-10#5)(2009-4#1)(2010-1#1)
reduced infection by##2##3##(2008-10#2)
reduced infection##4##2##(2008-10#4)
reduced insulin##3##2##(1991-7#1)(2008-4#1)(2009-9#1)
reduced interest in##2##3##(1996-2#2)
reduced into##2##2##(1991-5#1)(2008-10#1)
reduced leaf##3##2##(2008-10#3)
reduced lesion##4##2##(1995-12#1)(2008-10#3)
reduced levels of##5##3##(2008-10#2)(2008-7#1)(2012-3#1)(2013-7#1)
reduced levels##6##2##(2008-10#3)(2008-7#1)(2012-3#1)(2013-7#1)
reduced mobility constants##2##3##(2008-10#2)
reduced morbidity and##2##3##(2008-7#1)(2010-12#1)
reduced morbidity##5##2##(2008-10#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)
reduced more##2##2##(2008-10#2)
reduced number of##4##3##(1991-11#1)(1996-2#1)(2008-10#2)
reduced numbers of##4##3##(1991-5#1)(2008-10#2)(2013-1#1)
reduced ocelli##2##2##(2008-9#2)
reduced on the##5##3##(1990-5#1)(2008-10#4)
reduced on##7##2##(1990-5#1)(2008-10#6)
reduced only##3##2##(1993-12#1)(1996-12#1)(2008-10#1)
reduced opportunities for##2##3##(2008-10#1)(2013-1#1)
reduced or eliminated##2##3##(2008-9#1)(2013-8#1)
reduced or##8##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-8#1)
reduced oxygen##2##2##(2008-10#1)(2011-2#1)
reduced pain scores##2##3##(2008-7#2)
reduced pain##4##2##(2008-12#1)(2008-7#2)(2013-1#1)
reduced pathogen populations##2##3##(2008-10#2)
reduced pathogen##3##2##(2008-10#3)
reduced perfusion##2##2##(1990-8#1)(2008-11#1)
reduced phosphorus##3##2##(2008-10#3)
reduced population##4##2##(2008-10#2)(2008-9#2)
reduced pregnenolone production&quot##2##3##(2012-2#2)
reduced pressure to##2##3##(2008-11#1)(2008-5#1)
reduced pressure##5##2##(2008-11#2)(2008-3#1)(2008-5#1)(2010-4#1)
reduced production of##2##3##(2008-10#1)(2009-6#1)
reduced production##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
reduced proliferation of##2##3##(2011-2#1)(2012-4#1)
reduced protein##3##2##(1990-12#1)(1993-8#1)(1995-12#1)
reduced pyridine##2##2##(1996-2#2)
reduced quality##2##2##(1996-2#1)(2008-10#1)
reduced rates##2##2##(1993-6#1)(2008-9#1)
reduced replication##3##2##(2011-2#2)(2013-1#1)
reduced respiration##2##2##(2008-9#1)(2011-2#1)
reduced risk of##6##3##(1991-8#1)(2008-10#2)(2008-9#1)(2010-1#1)(2010-7#1)
reduced risk##7##2##(1991-8#1)(1992-9#1)(2008-10#2)(2008-9#1)(2010-1#1)(2010-7#1)
reduced root galling##2##3##(2008-10#2)
reduced root rot severity##3##4##(2008-10#3)
reduced root##5##2##(2008-10#5)
reduced sample##2##2##(2008-10#1)(2008-7#1)
reduced sclerotia##2##2##(2008-10#2)
reduced sensitivity and##2##3##(2008-10#2)
reduced sensitivity##3##2##(2008-10#2)(2012-2#1)
reduced serum##2##2##(2008-11#1)(2009-9#1)
reduced significantly the##2##3##(2008-10#1)(2011-2#1)
reduced significantly##14##2##(1997-2#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
reduced speck severity##2##3##(2008-10#2)
reduced sporulation##2##2##(2008-10#2)
reduced stress-induced##3##2##(2008-4#1)(2011-2#2)
reduced substantially##3##2##(2008-2#1)(2008-3#1)(2009-10#1)
reduced sulfur compounds (RSC)##3##4##(2008-10#3)
reduced sulfur compounds##5##3##(2008-10#5)
reduced sulfur##8##2##(2008-10#8)
reduced survival##4##2##(1993-1#1)(2008-7#2)(2012-3#1)
reduced symptoms of##3##3##(2008-10#3)
reduced temperature##2##2##(1996-2#1)(2008-11#1)
reduced the disease##2##3##(2008-10#2)
reduced the effect of##2##4##(1991-5#1)(1995-6#1)
reduced the effectiveness of##2##4##(2008-10#2)
reduced the growth of soybeans##2##5##(2008-10#2)
reduced the growth of##6##4##(2008-10#6)
reduced the growth##7##3##(1996-3#1)(2008-10#6)
reduced the incidence of fire blight##2##6##(2008-10#2)
reduced the incidence of##8##4##(2008-10#6)(2008-5#1)(2008-6#1)
reduced the incidence##9##3##(2008-10#7)(2008-5#1)(2008-6#1)
reduced the increase##2##3##(1995-8#1)(1996-2#1)
reduced the infarct##3##3##(2011-2#3)
reduced the infection##2##3##(2008-10#2)
reduced the intracellular##2##3##(2008-11#2)
reduced the levels of##3##4##(2008-10#1)(2008-11#2)
reduced the number of infected##2##5##(2008-10#2)
reduced the number of##14##4##(1990-6#1)(1993-11#1)(1996-2#1)(2008-10#9)(2008-9#1)(2011-2#1)
reduced the occurrence of##2##4##(1992-12#1)(2011-2#1)
reduced the occurrence##3##3##(1992-12#1)(1996-11#1)(2011-2#1)
reduced the predictive ability of the##2##6##(2008-10#2)
reduced the rate of##4##4##(1991-12#1)(2008-10#3)
reduced the rate##5##3##(1991-12#1)(1992-6#1)(2008-10#3)
reduced the response##3##3##(1992-8#1)(1996-2#1)(1997-3#1)
reduced the risk of##2##4##(2008-7#1)(2010-6#1)
reduced the severity of##4##4##(2008-10#3)(2008-5#1)
reduced the time required to inactivate chlamydospores##2##7##(2008-10#2)
reduced the time required to##3##5##(1993-12#1)(2008-10#2)
reduced the time required##4##4##(1993-12#1)(2008-10#3)
reduced the time to##2##4##(2008-9#1)(2010-7#1)
reduced the time##6##3##(1993-12#1)(2008-10#3)(2008-9#1)(2010-7#1)
reduced the total amount of##2##5##(2008-10#1)(2008-11#1)
reduced the variability##2##3##(2008-10#2)
reduced the yield of cv##2##5##(2008-10#2)
reduced the##164##2##(1990-3#2)(1990-5#1)(1990-6#1)(1991-12#2)(1991-5#2)(1992-12#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#73)(2008-11#12)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#11)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#1)
reduced their##3##2##(1990-6#1)(1991-11#1)(2008-10#1)
reduced this##2##2##(2008-10#2)
reduced tillage##3##2##(2008-10#3)
reduced time of analysis##2##4##(2008-10#2)
reduced time to exhaustion##2##4##(2013-8#2)
reduced time##5##2##(1994-8#1)(2008-10#2)(2013-8#2)
reduced to Cr(III)##3##3##(2008-10#2)(2011-2#1)
reduced to Fe(II)##3##3##(2008-10#3)
reduced to a##2##3##(1997-5#1)(2008-10#1)
reduced to about##3##3##(1995-12#1)(1996-6#1)(2010-8#1)
reduced to the##8##3##(2008-10#6)(2008-7#1)(2009-10#1)
reduced to##59##2##(1990-5#1)(1991-5#1)(1992-4#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-6#1)(1997-5#1)(2008-10#30)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
reduced toxicity in##2##3##(2008-9#1)(2010-11#1)
reduced tumor##2##2##(2008-11#1)(2013-1#1)
reduced under##3##2##(2008-10#1)(2012-6#1)(2013-1#1)
reduced use of##2##3##(2008-10#1)(2008-9#1)
reduced viability##2##2##(1997-3#1)(2008-10#1)
reduced viral replication##2##3##(2013-1#2)
reduced visual##2##2##(2011-2#1)(2013-1#1)
reduced water##4##2##(2008-11#4)
reduced when the##2##3##(2008-10#2)
reduced when##9##2##(1993-3#1)(2008-10#5)(2008-7#1)(2011-2#1)(2012-2#1)
reduced with##7##2##(1996-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
reduced within##2##2##(2008-10#2)
reduced without##2##2##(1991-12#1)(2011-2#1)
reduced yield##3##2##(2008-10#2)(2011-1#1)
reduced##1348##1##(1990-11#5)(1990-12#9)(1990-2#3)(1990-3#3)(1990-5#11)(1990-6#4)(1990-8#3)(1990-9#3)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#2)(1991-5#10)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#11)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#3)(1993-1#5)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#5)(1993-6#6)(1993-8#16)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#4)(1994-5#8)(1994-6#2)(1994-8#7)(1995-11#5)(1995-12#8)(1995-2#15)(1995-5#2)(1995-6#5)(1995-8#8)(1996-1#1)(1996-11#4)(1996-12#14)(1996-2#17)(1996-3#2)(1996-6#5)(1997-1#11)(1997-2#4)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#540)(2008-11#75)(2008-12#14)(2008-2#8)(2008-3#16)(2008-4#5)(2008-5#37)(2008-6#6)(2008-7#49)(2008-8#26)(2008-9#31)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-6#2)(2009-7#7)(2009-8#3)(2009-9#2)(2010-1#6)(2010-10#5)(2010-11#4)(2010-12#2)(2010-3#2)(2010-4#5)(2010-5#5)(2010-6#4)(2010-7#5)(2010-8#6)(2010-9#5)(2011-1#5)(2011-10#1)(2011-2#51)(2011-3#3)(2012-12#9)(2012-2#21)(2012-3#12)(2012-4#2)(2012-5#3)(2012-6#2)(2012-7#3)(2012-8#1)(2013-1#41)(2013-7#3)(2013-8#11)
reduced)##2##1##(2008-8#1)(2009-4#1)
reduced-pathogenicity##2##1##(2008-10#2)
reduces blood##2##2##(2008-11#1)(2008-4#1)
reduces both the##3##3##(2008-10#2)(2011-2#1)
reduces both##7##2##(2008-10#2)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
reduces pain##2##2##(1995-3#1)(2008-12#1)
reduces postoperative##2##2##(2010-7#1)(2013-1#1)
reduces reagent##2##2##(2008-10#1)(2009-12#1)
reduces sample##3##2##(2008-10#2)(2010-11#1)
reduces the affinity of##2##4##(1992-6#1)(1996-2#1)
reduces the incidence of##2##4##(1990-9#1)(1992-9#1)
reduces the number of##4##4##(1995-5#1)(1995-9#1)(2008-10#1)(2008-11#1)
reduces the prevalence of##2##4##(2008-10#1)(2013-8#1)
reduces the risk of##2##4##(2008-8#1)(2011-2#1)
reduces the time required for##2##5##(2008-10#2)
reduces the##58##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#11)(2008-11#5)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
reduces to##3##2##(2008-10#1)(2008-3#1)(2009-8#1)
reduces waste##2##2##(2008-10#2)
reduces##144##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-3#3)(1995-5#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#35)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#3)(2009-12#1)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#8)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
reducible##5##1##(1996-5#1)(2008-10#2)(2008-12#1)(2009-9#1)
reducing LOS##3##2##(1993-12#1)(1995-12#2)
reducing a##3##2##(1995-1#1)(1996-9#1)(2008-10#1)
reducing agent and##2##3##(1990-9#1)(2008-10#1)
reducing agent for##2##3##(1996-5#1)(2008-10#1)
reducing agent##18##2##(1990-9#1)(1995-11#3)(1996-5#1)(2008-10#12)(2011-2#1)
reducing agents and##2##3##(2008-10#1)(2012-2#1)
reducing agents##6##2##(1990-5#2)(1992-9#1)(2008-10#2)(2012-2#1)
reducing airway##2##2##(1994-6#2)
reducing and##2##2##(1995-12#1)(2008-5#1)
reducing capacity of##2##3##(2008-11#2)
reducing capacity##3##2##(2008-11#3)
reducing child poverty##2##3##(2008-11#2)
reducing conditions##5##2##(1995-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#1)
reducing coronary##2##2##(1995-12#1)(2013-1#1)
reducing costs##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
reducing disease incidence##2##3##(2008-10#2)
reducing disease##5##2##(2008-10#5)
reducing disparities in##2##3##(2013-1#2)
reducing drug##2##2##(1996-2#1)(2008-6#1)
reducing equivalents##2##2##(2009-9#2)
reducing germination of##2##3##(2008-10#2)
reducing health##3##2##(2008-11#1)(2009-7#1)(2012-2#1)
reducing hospital##3##2##(1991-11#1)(1992-12#1)(1992-2#1)
reducing its##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
reducing or##2##2##(1992-5#1)(2008-11#1)
reducing overall##2##2##(1997-1#1)(2013-1#1)
reducing power##2##2##(2008-7#2)
reducing sugar##3##2##(2008-10#2)(2008-7#1)
reducing sugars content##2##3##(2008-10#2)
reducing sugars in##3##3##(2008-10#3)
reducing sugars##11##2##(1992-12#1)(2008-10#10)
reducing the ability of##2##4##(1997-7#1)(2008-10#1)
reducing the incidence of##2##4##(2008-8#1)(2012-2#1)
reducing the number of##5##4##(1995-5#1)(1997-2#1)(2008-10#2)(2009-8#1)
reducing the risk of##3##4##(2008-10#2)(2011-2#1)
reducing the risk##6##3##(1991-12#1)(2008-10#3)(2008-11#1)(2011-2#1)
reducing the severity of##3##4##(2008-10#3)
reducing the severity##4##3##(2008-10#3)(2008-5#1)
reducing the time of##2##4##(2008-10#2)
reducing the time##3##3##(2008-10#3)
reducing the use of##2##4##(1992-3#1)(2008-11#1)
reducing the##86##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2008-10#35)(2008-11#7)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
reducing their##3##2##(2008-10#2)(2008-8#1)
reducing total##2##2##(1991-6#1)(2008-10#1)
reducing wound##2##2##(2010-12#1)(2012-2#1)
reducing##339##1##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-10#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#4)(1995-12#6)(1995-2#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-7#1)(1997-8#1)(2008-10#121)(2008-11#24)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#10)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#14)(2011-3#1)(2012-12#4)(2012-2#12)(2012-3#3)(2013-1#18)(2013-7#2)(2013-8#3)
reductance##2##1##(2008-11#2)
reductant and##2##2##(1994-5#1)(2008-10#1)
reductant##11##1##(1994-5#1)(2008-10#9)(2008-8#1)
reductants##4##1##(1990-5#1)(1994-8#1)(2008-10#2)
reductase (EC 1##2##3##(1995-8#2)
reductase (MTHFR)##2##2##(2008-11#1)(2008-8#1)
reductase activity in##2##3##(1993-6#1)(1996-3#1)
reductase activity##10##2##(1992-8#1)(1993-6#2)(1996-3#1)(2008-10#3)(2008-11#1)(2009-9#2)
reductase and sorbitol dehydrogenase##3##4##(1996-2#3)
reductase and##8##2##(1992-1#1)(1992-8#1)(1993-3#1)(1996-2#3)(1996-8#1)(2008-11#1)
reductase cDNA##2##2##(1990-8#1)(1993-3#1)
reductase component of##4##3##(2008-11#4)
reductase from##8##2##(1992-3#1)(1993-6#1)(1994-11#2)(1996-3#1)(1996-8#1)(2009-7#1)(2011-1#1)
reductase gene##2##2##(2008-11#1)(2011-1#1)
reductase in##2##2##(2008-11#1)(2009-7#1)
reductase inhibitor##6##2##(1991-12#2)(1993-6#1)(1994-8#1)(2008-5#1)(2009-11#1)
reductase inhibitors##4##2##(1994-8#1)(2007-7#1)(2008-11#1)(2013-1#1)
reductase is##3##2##(1993-6#1)(2009-7#1)(2009-8#1)
reductase was##7##2##(1990-8#1)(1993-6#1)(1994-11#1)(1996-3#3)(2008-11#1)
reductase##116##1##(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#3)(1992-1#3)(1992-10#2)(1992-3#2)(1992-4#1)(1992-8#3)(1993-3#2)(1993-6#11)(1993-8#2)(1994-11#4)(1994-3#1)(1994-8#2)(1995-6#1)(1995-8#4)(1996-2#4)(1996-3#7)(1996-8#3)(2007-7#1)(2008-10#9)(2008-11#18)(2008-5#1)(2008-8#2)(2009-11#1)(2009-3#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
reductase)##2##1##(1996-12#1)(2008-10#1)
reductases##5##1##(1992-4#1)(1996-3#1)(2009-9#2)(2012-2#1)
reduction (p&lt##2##2##(2011-2#1)(2013-1#1)
reduction after##2##2##(1995-2#1)(2008-7#1)
reduction and oxidation of##2##4##(2008-10#2)
reduction and oxidation##5##3##(2008-10#5)
reduction and the##2##3##(2008-8#1)(2010-7#1)
reduction and uptake##2##3##(2009-9#2)
reduction and##35##2##(1990-5#1)(1991-9#1)(1993-11#1)(1993-8#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2009-9#2)(2010-11#1)(2010-7#1)(2011-2#4)(2013-7#2)
reduction at -1##4##3##(2008-10#4)
reduction at##8##2##(2008-10#6)(2009-9#1)(2012-2#1)
reduction based on##3##3##(2008-10#1)(2012-2#2)
reduction by the##2##3##(1992-1#1)(1994-3#1)
reduction by##13##2##(1992-1#1)(1994-3#1)(2008-10#6)(2008-11#2)(2009-9#2)(2010-6#1)
reduction can be##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
reduction can##4##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)
reduction coil##4##2##(2008-10#4)
reduction column##3##2##(2008-10#3)
reduction constant##2##2##(1993-8#2)
reduction current of the adsorbed##2##5##(2008-10#2)
reduction current of##4##3##(2008-10#4)
reduction current##6##2##(2008-10#6)
reduction due to##3##3##(2008-10#3)
reduction for the##2##3##(1997-2#1)(2008-10#1)
reduction for##3##2##(1997-2#1)(2008-10#2)
reduction from##2##2##(1994-3#1)(2012-3#1)
reduction in LDL##2##3##(2008-3#2)
reduction in RH##3##3##(2008-10#3)
reduction in apple##2##3##(2008-10#2)
reduction in body##2##3##(1993-8#1)(2012-3#1)
reduction in cell##2##3##(1990-6#1)(1993-8#1)
reduction in circulating white blood cells##2##6##(1994-8#2)
reduction in disease severity##2##4##(2008-10#2)
reduction in disease##5##3##(2008-10#5)
reduction in energy##2##3##(2008-10#1)(2012-2#1)
reduction in host density as a result of parasite-induced host##2##10##(2008-9#2)
reduction in incidence of##2##4##(2011-1#1)(2013-1#1)
reduction in intensity of##2##4##(2008-10#2)
reduction in luc expression##2##4##(1993-6#2)
reduction in morbidity##2##3##(1990-11#1)(1992-11#1)
reduction in mortality##2##3##(1995-12#1)(2009-7#1)
reduction in numbers of##3##4##(1997-3#1)(2008-5#1)(2010-1#1)
reduction in pain##2##3##(1994-3#1)(2010-7#1)
reduction in pathogen##2##3##(2008-10#2)
reduction in plasma##3##3##(1995-2#2)(2008-10#1)
reduction in root lesions)##2##4##(2008-10#2)
reduction in serum##4##3##(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
reduction in size of the##2##5##(2008-10#1)(2008-8#1)
reduction in size of##3##4##(2008-10#2)(2008-8#1)
reduction in size##4##3##(1995-3#1)(2008-10#2)(2008-8#1)
reduction in the amount of##3##5##(2008-10#2)(2008-12#1)
reduction in the incidence of##2##5##(1992-9#1)(2008-10#1)
reduction in the number of##7##5##(1995-12#1)(1995-9#1)(2008-10#4)(2010-8#1)
reduction in the presence of##2##5##(2009-9#2)
reduction in the rate of##4##5##(2008-10#1)(2008-5#2)(2011-2#1)
reduction in the risk of##3##5##(1991-8#1)(2010-6#1)(2013-8#1)
reduction in the##73##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-9#3)(1993-12#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-9#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#3)
reduction in their##3##3##(1990-5#1)(1996-12#1)(2009-10#1)
reduction in total##3##3##(2008-3#1)(2008-8#2)
reduction in viability##2##3##(2008-10#1)(2009-4#1)
reduction in yield##2##3##(2008-10#2)
reduction in##301##2##(1990-11#3)(1990-12#2)(1990-5#4)(1990-6#2)(1990-8#1)(1990-9#1)(1991-3#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#1)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#77)(2008-11#13)(2008-12#4)(2008-3#14)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#6)(2011-3#1)(2012-2#11)(2012-3#1)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#14)
reduction is a##2##3##(1995-12#1)(2013-1#1)
reduction is##11##2##(1991-1#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
reduction mechanism##2##2##(2008-10#2)
reduction method##6##2##(2012-2#5)(2013-1#1)
reduction occurs##2##2##(1994-3#1)(2008-10#1)
reduction of 2-heptanone##2##3##(2008-10#2)
reduction of Cu(2+)##2##3##(2008-10#2)
reduction of Fe(3+)##2##3##(2008-10#2)
reduction of Fe(III)##2##3##(2008-10#2)
reduction of H(2)O(2)##3##3##(2008-10#3)
reduction of Hg(II) ions##2##4##(2008-10#2)
reduction of Hg(II)##3##3##(2008-10#3)
reduction of NO by##2##4##(1992-3#1)(2010-6#1)
reduction of a##2##3##(2008-10#1)(2011-2#1)
reduction of about##2##3##(1996-6#1)(2008-11#1)
reduction of adhesion formation##2##4##(1991-1#1)(1992-1#1)
reduction of adhesion##3##3##(1991-1#1)(1992-1#2)
reduction of benzodiazepine##2##3##(1995-11#1)(1995-12#1)
reduction of bone##2##3##(2009-7#1)(2013-1#1)
reduction of both##2##3##(1992-1#1)(2008-10#1)
reduction of breast cancer##3##4##(2011-2#1)(2012-3#2)
reduction of growth##2##3##(2008-10#1)(2008-11#1)
reduction of hearing##3##3##(1990-12#3)
reduction of hydrogen peroxide##5##4##(2008-10#5)
reduction of hydrogen##6##3##(2008-10#6)
reduction of iNOS expression and nitrite production##2##7##(1996-12#2)
reduction of iNOS expression##3##4##(1996-12#3)
reduction of inoculum##2##3##(2008-10#2)
reduction of lead##2##3##(2008-10#2)
reduction of nitrate to nitrite##2##5##(2008-10#2)
reduction of nitrate to##3##4##(2008-10#3)
reduction of oxygen##3##3##(1995-2#1)(2008-10#2)
reduction of risk##2##3##(1991-8#2)
reduction of symptoms##2##3##(2011-10#1)(2011-2#1)
reduction of the hip##2##4##(2008-8#1)(2013-7#1)
reduction of the nidus##3##4##(1991-2#1)(2008-7#2)
reduction of the##79##3##(1990-2#1)(1991-2#1)(1992-1#2)(1992-12#2)(1992-6#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-6#2)(2008-10#32)(2008-11#10)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
reduction of this##2##3##(2008-4#1)(2011-2#1)
reduction of virus##2##3##(2008-10#2)
reduction of##337##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-1#6)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-5#2)(1996-6#5)(1997-2#2)(1997-3#2)(2007-8#1)(2008-10#150)(2008-11#24)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#14)(2012-2#4)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#5)
reduction on the##3##3##(2008-10#2)(2009-8#1)
reduction on##7##2##(2008-10#4)(2008-11#2)(2009-8#1)
reduction or complete##2##3##(1990-9#1)(2008-11#1)
reduction or##5##2##(1990-9#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
reduction peak at -0##2##4##(1990-5#1)(2008-10#1)
reduction peak current of##3##4##(2008-10#3)
reduction peak current##5##3##(2008-10#5)
reduction peak of##2##3##(2008-10#2)
reduction peak##14##2##(1990-5#1)(2008-10#13)
reduction peaks##4##2##(1990-5#1)(2008-10#3)
reduction potential of##2##3##(2008-10#2)
reduction potential##5##2##(1990-5#1)(2008-10#4)
reduction potentials##2##2##(1990-5#1)(1995-8#1)
reduction process was##3##3##(2008-10#3)
reduction process##10##2##(2008-10#9)(2011-2#1)
reduction product of##2##3##(2008-10#2)
reduction product##5##2##(2008-10#5)
reduction products##3##2##(2008-10#3)
reduction programs##2##2##(1994-3#1)(1995-2#1)
reduction rate of##2##3##(1995-8#1)(2008-7#1)
reduction rate##4##2##(1995-8#2)(1997-7#1)(2008-7#1)
reduction rates##2##2##(1990-8#2)
reduction reaction##4##2##(2008-10#3)(2008-8#1)
reduction should be##2##3##(1996-11#1)(2008-8#1)
reduction step##3##2##(2008-10#3)
reduction through##3##2##(2008-10#1)(2009-7#1)(2013-8#1)
reduction to nitrite##2##3##(2008-10#2)
reduction to##9##2##(2008-10#9)
reduction was also##2##3##(1993-12#1)(2008-10#1)
reduction was observed in##2##4##(1991-8#1)(1993-12#1)
reduction was performed##2##3##(2008-10#1)(2011-2#1)
reduction was the##2##3##(1990-6#1)(1994-3#1)
reduction was##25##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#2)(1994-3#1)(1994-6#1)(2008-10#10)(2008-11#1)(2008-7#1)(2011-2#1)(2012-5#1)(2013-8#1)
reduction wave##2##2##(2008-10#2)
reduction with##15##2##(1993-6#1)(1996-5#6)(2008-10#6)(2008-7#1)(2013-1#1)
reduction##996##1##(1990-11#5)(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#9)(1990-6#4)(1990-8#4)(1990-9#5)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#2)(1992-1#8)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#4)(1993-1#3)(1993-11#3)(1993-12#8)(1993-3#5)(1993-6#3)(1993-8#8)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#11)(1994-5#4)(1994-6#5)(1994-8#6)(1994-9#1)(1995-11#2)(1995-12#7)(1995-2#13)(1995-3#2)(1995-5#3)(1995-8#6)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#1)(1996-5#10)(1996-6#5)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#4)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#396)(2008-11#52)(2008-12#11)(2008-2#4)(2008-3#28)(2008-4#1)(2008-5#14)(2008-6#6)(2008-7#23)(2008-8#13)(2008-9#13)(2009-1#3)(2009-10#4)(2009-11#4)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#6)(2009-8#4)(2009-9#12)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#4)(2010-7#9)(2010-8#2)(2011-1#5)(2011-10#2)(2011-2#37)(2011-3#1)(2012-12#1)(2012-2#26)(2012-3#7)(2012-5#3)(2013-1#26)(2013-7#7)(2013-8#27)
reduction) and##4##2##(1990-12#1)(1996-2#1)(2008-10#1)(2009-9#1)
reduction) in the CMM group and from 7##2##8##(2008-7#2)
reduction) in the##4##3##(2008-7#4)
reduction) in##6##2##(2008-10#2)(2008-7#4)
reduction)##19##1##(1990-12#1)(1996-2#3)(2008-10#9)(2008-7#4)(2009-9#1)(2010-4#1)
reductions and##2##2##(2008-10#2)
reductions for##2##2##(2012-3#1)(2013-1#1)
reductions in a##2##3##(1994-12#1)(2008-10#1)
reductions in host##2##3##(2008-10#1)(2008-9#1)
reductions in lesion##2##3##(2008-10#1)(2012-3#1)
reductions in the levels##2##4##(2008-5#2)
reductions in the##13##3##(1995-1#1)(1997-2#1)(1997-5#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2011-2#1)
reductions in##62##2##(1991-2#1)(1992-2#1)(1994-12#1)(1995-1#1)(1995-2#2)(1995-8#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#24)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
reductions of##17##2##(1992-12#4)(1993-3#1)(1993-8#1)(1995-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
reductions were##6##2##(1995-12#1)(2008-10#3)(2008-12#1)(2008-9#1)
reductions##106##1##(1991-2#1)(1992-12#4)(1992-2#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-12#3)(1995-1#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#39)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#1)
reductive amination##3##2##(1996-5#3)
reductive dechlorination##2##2##(2011-1#2)
reductive elution##2##2##(2008-10#2)
reductive sulphur##6##2##(2008-10#6)
reductive##25##1##(1994-8#1)(1996-5#3)(2008-10#14)(2008-11#3)(2009-3#1)(2011-1#3)
redundancy and##2##2##(2011-3#2)
redundancy in##3##2##(2009-6#1)(2010-8#1)(2012-3#1)
redundancy##13##1##(1993-12#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-3#3)
redundant information##2##2##(2008-3#2)
redundant role in##2##3##(2009-10#1)(2013-1#1)
redundant role##3##2##(2009-10#2)(2013-1#1)
redundant##16##1##(1991-5#1)(1993-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#3)(2013-1#1)(2013-8#1)
redundantly##3##1##(1991-2#2)(2009-10#1)
redwater##2##1##(2010-1#2)
reeducation##3##1##(1990-2#1)(2013-1#2)
reef fish##3##2##(2008-8#2)(2013-1#1)
reef sharks Carcharhinus melanopterus##2##4##(2010-8#2)
reef##10##1##(2008-6#2)(2008-8#2)(2008-9#2)(2010-8#3)(2013-1#1)
reemerged in##2##2##(1995-3#1)(2008-10#1)
reemergence of##2##2##(2008-10#1)(2012-2#1)
reengineering##8##1##(1994-12#3)(1995-3#2)(1996-1#1)(1997-3#2)
reentrant tachycardia##3##2##(1993-2#2)(2008-11#1)
reentrant##4##1##(1993-2#3)(2008-11#1)
reesei##7##1##(1993-8#2)(2008-10#2)(2008-9#2)(2011-2#1)
reestablished##2##1##(1991-2#1)(2009-8#1)
reevaluation of##3##2##(1993-12#1)(2009-6#1)(2011-2#1)
reevaluation##5##1##(1992-1#1)(1993-12#1)(1996-11#1)(2009-6#1)(2011-2#1)
reevii Hr##3##2##(1991-10#3)
reevii##5##1##(1991-10#5)
reexamination of##3##2##(1993-8#1)(1994-12#1)(2008-9#1)
reexamine##4##1##(1995-2#1)(1996-12#1)(2008-8#2)
reexamined in##2##2##(1996-11#1)(1997-1#1)
reexamined##5##1##(1996-11#1)(1997-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
reexcision##2##1##(2008-11#1)(2013-1#1)
reextraction##2##1##(2008-10#2)
ref##2##1##(1993-9#1)(2008-10#1)
refeeding##5##1##(2008-3#1)(2008-7#4)
refer a##2##2##(1996-1#1)(2008-9#1)
refer the##2##2##(1992-5#1)(2008-11#1)
refer to a##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
refer to the##3##3##(1993-2#1)(2008-10#1)(2008-7#1)
refer to##21##2##(1992-12#1)(1992-6#1)(1993-2#1)(1994-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
refer##30##1##(1991-1#1)(1991-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-9#1)(1996-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
reference and##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
reference compounds##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
reference drug##2##2##(2008-11#1)(2012-3#1)
reference electrode and a##2##4##(2008-10#2)
reference electrode was##2##3##(2008-10#2)
reference electrode##25##2##(2008-10#24)(2008-9#1)
reference electrode)##7##2##(2008-10#7)
reference electrodes##2##2##(2008-10#2)
reference food##2##2##(2008-1#2)
reference for the##3##3##(1990-12#1)(2008-9#1)(2011-2#1)
reference for those##2##3##(2008-11#1)(2008-12#1)
reference for##6##2##(1990-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#2)
reference frame##3##2##(2008-3#3)
reference groups were##2##3##(2011-2#2)
reference groups##4##2##(2008-5#1)(2011-2#3)
reference haplotypes##2##2##(2012-3#2)
reference is##3##2##(1990-2#1)(2008-10#2)
reference isolates of##2##3##(2008-10#1)(2008-5#1)
reference isolates##4##2##(2008-10#3)(2008-5#1)
reference levels##3##2##(2011-2#1)(2012-2#2)
reference lists of##4##3##(2012-12#3)(2013-8#1)
reference material (CRM) of##2##4##(2008-10#2)
reference material (CRM)##3##3##(2008-10#3)
reference material (GBW##3##3##(2008-10#3)
reference material NIST##3##3##(2008-10#3)
reference material and applied to##2##5##(2008-10#2)
reference material and##11##3##(2008-10#11)
reference material for the##2##4##(2008-10#2)
reference material##80##2##(2008-10#80)
reference materials (CRM##2##3##(2008-10#2)
reference materials (CRMs)##7##3##(2008-10#7)
reference materials SRM##2##3##(2008-10#2)
reference materials and comparing the##2##5##(2008-10#2)
reference materials and##16##3##(2008-10#16)
reference materials are##3##3##(2008-10#3)
reference materials by##3##3##(2008-10#3)
reference materials of biological origin##2##5##(2008-10#2)
reference materials of##12##3##(2008-10#12)
reference materials were in##2##4##(2008-10#2)
reference materials were##6##3##(2008-10#6)
reference materials##142##2##(2008-10#142)
reference materials)##2##2##(2008-10#2)
reference memory group##2##3##(2008-12#2)
reference memory##7##2##(1994-8#1)(2008-11#1)(2008-12#4)(2008-7#1)
reference method at the 95% confidence level##2##7##(2008-10#2)
reference method for##4##3##(2008-10#4)
reference method##38##2##(2008-10#38)
reference methods##14##2##(2008-10#14)
reference or##2##2##(2008-10#2)
reference orientations##2##2##(1990-11#2)
reference panel to##2##3##(2012-3#2)
reference panel##3##2##(2012-3#3)
reference point##2##2##(2008-12#1)(2010-10#1)
reference points##2##2##(1992-2#1)(2008-4#1)
reference population##2##2##(2008-11#2)
reference procedure##8##2##(2008-10#8)
reference pulse##2##2##(2008-3#2)
reference range and##2##3##(1993-2#1)(2013-1#1)
reference range##7##2##(1990-2#1)(1991-2#1)(1993-2#3)(2013-1#2)
reference sample##3##2##(2008-10#3)
reference samples##4##2##(2008-10#3)(2008-12#1)
reference scales##2##2##(2011-2#2)
reference solid and water materials with##2##6##(2008-10#2)
reference solution##5##2##(2008-10#5)
reference solutions##5##2##(2008-10#5)
reference spectrophotometric##2##2##(2008-10#2)
reference standard##7##2##(1991-5#1)(2008-10#6)
reference standards##2##2##(2008-10#2)
reference strain##11##2##(2008-10#7)(2008-5#1)(2011-10#1)(2011-2#2)
reference strains for##2##3##(2008-10#2)
reference strains of##5##3##(1996-12#1)(2008-10#4)
reference strains were##3##3##(2008-10#2)(2008-5#1)
reference strains##19##2##(1996-12#1)(2008-10#15)(2008-5#3)
reference technique##2##2##(2008-10#2)
reference to the##15##3##(1990-5#1)(1991-6#1)(1991-8#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
reference to their##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
reference to understand the##2##4##(1996-1#1)(2008-10#1)
reference to##47##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-5#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2011-1#1)(2012-2#1)(2013-1#2)
reference value##4##2##(1996-1#1)(2008-10#2)(2008-3#1)
reference values##16##2##(1991-8#1)(1993-2#2)(2008-10#11)(2008-11#1)(2012-2#1)
reference##668##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#5)(1993-8#1)(1994-12#3)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#473)(2008-11#20)(2008-12#14)(2008-2#3)(2008-3#26)(2008-4#1)(2008-5#10)(2008-7#4)(2008-8#1)(2008-9#5)(2009-10#4)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#16)(2011-3#1)(2012-12#3)(2012-2#7)(2012-3#10)(2012-5#1)(2013-1#6)(2013-8#2)
reference)##2##1##(2008-10#2)
referenced##6##1##(1997-2#1)(2008-10#5)
references and##2##2##(2008-10#1)(2008-4#1)
references for the##2##3##(2008-10#1)(2011-2#1)
references for##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
references of##2##2##(2008-11#1)(2013-1#1)
references to the##2##3##(2008-10#1)(2008-8#1)
references##22##1##(2008-10#12)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
references)##2##1##(2008-10#1)(2009-12#1)
referent group##5##2##(1996-6#4)(2008-11#1)
referent##6##1##(1995-2#1)(1996-6#4)(2008-11#1)
referential##2##1##(2008-10#1)(2010-12#1)
referents##2##1##(1995-2#1)(2010-6#1)
referral center##2##2##(2011-2#1)(2012-2#1)
referral centre##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
referral centres for##2##3##(2008-11#1)(2008-9#1)
referral centres##3##2##(1995-10#1)(2008-11#1)(2008-9#1)
referral decisions##4##2##(1994-1#4)
referral for##2##2##(2008-11#1)(2008-12#1)
referral hospital##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
referral hospitals##2##2##(1990-11#1)(2010-8#1)
referral of patients##2##3##(2008-1#1)(2010-1#1)
referral of##4##2##(1990-12#1)(1992-12#1)(2008-1#1)(2010-1#1)
referral patterns##3##2##(1992-1#1)(1993-12#1)(2008-6#1)
referral sources##2##2##(1992-1#1)(1996-1#1)
referral to the##2##3##(1993-12#1)(2008-8#1)
referral to##7##2##(1993-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-9#1)
referral##65##1##(1990-11#1)(1990-12#1)(1992-1#2)(1992-12#1)(1993-12#2)(1994-1#7)(1994-3#2)(1994-6#2)(1995-10#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(2008-1#6)(2008-11#7)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#5)(2013-8#1)
referrals for##2##2##(1994-1#1)(2008-12#1)
referrals from##3##2##(1993-12#1)(2008-12#1)(2011-2#1)
referrals##21##1##(1990-12#1)(1991-11#3)(1991-8#3)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-3#1)(1997-8#1)(2008-12#4)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
referred as##2##2##(2008-10#1)(2008-12#1)
referred back to##2##3##(1994-9#1)(2008-12#1)
referred by##5##2##(1990-12#2)(2008-12#2)(2011-2#1)
referred cardiac pain and##2##4##(2008-9#2)
referred for evaluation##3##3##(1997-3#1)(2008-10#1)(2013-8#1)
referred for##19##2##(1990-2#1)(1992-3#2)(1993-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
referred pain areas of##2##4##(2010-9#2)
referred pain##12##2##(2008-12#2)(2008-9#3)(2010-9#7)
referred the##2##2##(1993-12#1)(1995-6#1)
referred to a##4##3##(2008-12#1)(2009-7#1)(2011-2#1)(2013-8#1)
referred to an##2##3##(1990-12#1)(2010-10#1)
referred to as &quot##4##4##(1997-6#1)(2008-10#1)(2008-12#1)(2009-12#1)
referred to as a##3##4##(2008-7#1)(2009-5#1)(2010-4#1)
referred to as the &quot##5##5##(1991-2#1)(1996-1#1)(1996-12#1)(2008-11#1)(2011-2#1)
referred to as the##7##4##(1991-2#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
referred to as##51##3##(1991-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#13)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
referred to our##10##3##(1994-1#1)(2008-10#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
referred to the##8##3##(1990-12#1)(1990-3#1)(1990-5#1)(1993-3#1)(1994-2#1)(1997-8#1)(2007-11#1)(2008-10#1)
referred to##94##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#18)(2008-11#3)(2008-12#6)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
referred with##2##2##(2009-8#1)(2011-2#1)
referred without ADHD##2##3##(2010-8#2)
referred##157##1##(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#21)(2008-11#4)(2008-12#14)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#2)(2010-9#7)(2011-1#2)(2011-2#13)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
referring clinicians##2##2##(2012-2#2)
referring physicians and##2##3##(1993-1#1)(1996-1#1)
referring physicians##5##2##(1991-1#1)(1993-1#1)(1993-12#1)(1995-1#1)(1996-1#1)
referring to##3##2##(1991-3#1)(2008-10#1)(2010-12#1)
referring##20##1##(1990-8#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-6#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2012-2#2)
refers to a##3##3##(2008-10#2)(2008-12#1)
refers to the##11##3##(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#2)(2011-2#1)
refers to##23##2##(1990-11#1)(1992-6#1)(1995-3#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2009-10#3)(2011-1#1)(2011-2#1)(2013-1#1)
refill##2##1##(2010-11#1)(2010-7#1)
refine the##10##2##(2008-10#3)(2008-11#1)(2008-6#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#2)
refine##15##1##(2008-10#4)(2008-11#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
refined and##5##2##(1991-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
refined at 2##4##3##(1992-4#2)(1993-8#2)
refined in##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
refined structures##2##2##(1994-5#2)
refined through the##2##3##(2008-10#2)
refined to##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
refined##45##1##(1990-8#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#4)(1993-12#1)(1993-8#3)(1994-5#2)(1995-5#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#5)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-7#1)(2010-1#1)(2011-1#2)(2011-2#1)
refinement and##6##2##(1992-2#1)(1993-3#1)(1993-8#1)(1996-2#1)(2008-10#2)
refinement of the##4##3##(1994-2#1)(2008-10#1)(2009-7#1)(2011-2#1)
refinement of##10##2##(1994-2#1)(1997-7#1)(2008-10#3)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
refinement to the absolute optimum##2##5##(2008-10#2)
refinement to##4##2##(1992-9#1)(2008-10#3)
refinement##34##1##(1992-2#3)(1992-4#1)(1992-9#1)(1993-3#1)(1993-8#3)(1994-2#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-8#2)(2009-7#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#2)
refinements and##2##2##(2008-5#1)(2013-1#1)
refinements in the##2##3##(1992-2#2)
refinements to##2##2##(1994-5#1)(2012-2#1)
refinements##8##1##(1992-2#3)(1994-5#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
refineries##2##1##(2008-10#1)(2009-10#1)
refinery##5##1##(1991-12#2)(2008-10#2)(2011-2#1)
refining##12##1##(1992-2#1)(1992-3#1)(1993-12#2)(1994-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2012-2#1)
reflect a##9##2##(1993-1#1)(1993-6#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-5#1)(2013-8#1)
reflect changes in##2##3##(2008-11#1)(2013-1#1)
reflect different##4##2##(2008-11#2)(2008-8#1)(2011-1#1)
reflect on the##3##3##(1994-9#1)(2008-12#1)(2012-3#1)
reflect on their##2##3##(2008-11#2)
reflect on##9##2##(1994-9#2)(2008-11#2)(2008-12#2)(2011-2#1)(2012-3#2)
reflect only##2##2##(2008-10#1)(2011-2#1)
reflect physiological constraints##2##3##(2009-8#1)(2010-8#1)
reflect physiological##3##2##(2008-11#1)(2009-8#1)(2010-8#1)
reflect similar##2##2##(1995-11#1)(1995-2#1)
reflect the ability of##2##4##(2008-10#1)(2012-2#1)
reflect the effects of##2##4##(1991-3#1)(2008-2#1)
reflect the state of##2##4##(2008-11#1)(2009-12#1)
reflect the true##2##3##(2008-11#1)(2011-2#1)
reflect the##56##2##(1991-12#2)(1991-3#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2010-1#1)(2010-2#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-8#1)
reflect their##4##2##(2008-10#1)(2009-10#1)(2011-1#1)(2013-1#1)
reflect##141##1##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#4)(1992-11#1)(1992-12#3)(1992-2#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#3)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-8#2)(2008-1#1)(2008-10#19)(2008-11#17)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#3)
reflectance NIR##2##2##(2008-10#2)
reflectance and##4##2##(2008-10#1)(2008-3#3)
reflectance at##4##2##(1991-2#1)(2008-10#2)(2008-3#1)
reflectance components##2##2##(2008-3#2)
reflectance distribution##4##2##(2008-3#4)
reflectance in the##2##3##(2008-10#1)(2008-3#1)
reflectance infrared##8##2##(2008-10#8)
reflectance is##4##2##(2008-10#2)(2008-3#2)
reflectance measurements##5##2##(2008-10#5)
reflectance of sunlight from##2##4##(2008-10#2)
reflectance of##3##2##(2008-10#3)
reflectance sensor##2##2##(2008-10#2)
reflectance spectra and##4##3##(2008-10#4)
reflectance spectra##7##2##(2008-10#5)(2008-3#2)
reflectance spectrometry and##2##3##(2008-10#1)(2008-8#1)
reflectance spectrometry##4##2##(2008-10#3)(2008-8#1)
reflectance spectroscopic##4##2##(2008-10#4)
reflectance spectroscopy (NIRS)##3##3##(2008-10#3)
reflectance spectroscopy##11##2##(2008-10#10)(2008-5#1)
reflectance values##2##2##(2008-10#2)
reflectance were##3##2##(2008-10#3)
reflectance##122##1##(1991-2#1)(2008-10#85)(2008-3#29)(2008-5#4)(2008-8#1)(2009-8#1)(2012-2#1)
reflectances##4##1##(2008-3#4)
reflected a##4##2##(1991-8#2)(2008-10#1)(2012-12#1)
reflected both##2##2##(2008-10#1)(2012-3#1)
reflected by the##3##3##(1994-12#1)(1995-9#1)(1996-3#1)
reflected by##12##2##(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2013-1#1)
reflected in a##5##3##(1993-6#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-11#1)
reflected in an##2##3##(1996-12#1)(2008-10#1)
reflected in the##20##3##(1990-5#1)(1991-12#1)(1992-3#2)(1992-6#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2011-2#1)
reflected in##39##2##(1990-5#1)(1991-12#1)(1992-3#2)(1992-6#2)(1993-6#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-11#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#3)(2011-2#1)
reflected light##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
reflected the##11##2##(1992-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)
reflected their##2##2##(1995-11#1)(2008-11#1)
reflected through##2##2##(2008-1#1)(2008-12#1)
reflected##108##1##(1990-5#1)(1991-12#2)(1991-2#2)(1991-8#2)(1992-12#1)(1992-3#4)(1992-6#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
reflecting an##5##2##(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-7#1)
reflecting on the##4##3##(2008-10#2)(2008-12#2)
reflecting on##5##2##(2008-10#2)(2008-11#1)(2008-12#2)
reflecting the presence of##2##4##(2008-10#1)(2013-8#1)
reflecting the reproducibility and reliability of the developed method##3##9##(2008-10#3)
reflecting the##23##2##(1991-5#1)(1994-2#2)(1997-3#1)(1997-6#1)(2008-10#10)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
reflecting their##2##2##(2008-11#1)(2013-7#1)
reflecting##66##1##(1991-5#1)(1993-2#1)(1994-2#3)(1994-9#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#17)(2008-11#6)(2008-12#5)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#2)(2013-8#3)
reflection FTIR##2##2##(2008-10#2)
reflection X-ray fluorescence##2##3##(2008-10#2)
reflection and##11##2##(2007-12#1)(2008-11#7)(2008-12#1)(2008-3#2)
reflection as a##4##3##(2008-11#1)(2008-12#3)
reflection as an##2##3##(2008-11#1)(2008-12#1)
reflection as##6##2##(2008-11#2)(2008-12#4)
reflection characteristics##2##2##(2008-3#2)
reflection coefficient of a stratified sea##2##6##(2008-2#2)
reflection coefficient of##3##3##(2008-2#3)
reflection for##3##2##(2008-11#2)(2008-12#1)
reflection gratings##2##2##(2008-2#1)(2008-3#1)
reflection in##6##2##(2008-11#4)(2008-12#2)
reflection is##2##2##(2008-11#1)(2008-12#1)
reflection may be instrumental in##2##5##(2008-11#2)
reflection of the##4##3##(1991-5#1)(2008-10#2)(2008-2#1)
reflection of##10##2##(1991-5#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2012-3#1)
reflection on practice##2##3##(2008-11#2)
reflection on the##2##3##(2008-11#1)(2012-3#1)
reflection on##8##2##(1996-12#1)(2008-11#5)(2008-3#1)(2012-3#1)
reflection spectroscopy##3##2##(2008-10#3)
reflection to##2##2##(2008-11#1)(2008-3#1)
reflection upon##2##2##(2008-11#2)
reflection##117##1##(1991-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-12#1)(2007-12#4)(2008-10#22)(2008-11#43)(2008-12#14)(2008-2#6)(2008-3#17)(2008-5#1)(2008-8#1)(2010-7#1)(2012-3#2)(2013-8#1)
reflection-type confocal microscope with a phase-conjugate mirror##2##7##(2008-2#2)
reflections and##2##2##(1996-9#1)(2008-3#1)
reflections of##6##2##(1996-5#1)(1996-8#1)(2008-11#2)(2008-3#1)(2012-2#1)
reflections on the##7##3##(1994-2#1)(1995-2#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-9#1)
reflections on##12##2##(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-11#4)(2009-8#1)(2010-9#1)(2012-2#1)
reflections##28##1##(1992-12#1)(1992-4#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(2008-1#1)(2008-11#7)(2008-12#2)(2008-3#4)(2009-8#1)(2010-9#1)(2012-2#2)(2013-8#1)
reflective learning##2##2##(2008-11#1)(2008-12#1)
reflective of the##4##3##(1992-3#1)(2009-4#1)(2010-11#2)
reflective of##5##2##(1992-3#1)(2008-10#1)(2009-4#1)(2010-11#2)
reflective phases##3##2##(2008-11#3)
reflective practice in##3##3##(1997-4#1)(2008-11#2)
reflective practice##12##2##(1997-4#3)(2008-11#8)(2008-12#1)
reflective practitioners##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
reflective sessions##2##2##(2008-12#2)
reflective##58##1##(1992-3#1)(1997-4#3)(2007-12#1)(2008-10#5)(2008-11#24)(2008-12#8)(2008-3#11)(2008-9#1)(2009-4#1)(2010-11#2)(2010-3#1)
reflectivities##2##1##(2008-3#2)
reflectivity measurements##3##2##(2008-3#3)
reflectivity of a##2##3##(2008-2#1)(2008-3#1)
reflectivity of##6##2##(2008-2#3)(2008-3#3)
reflectivity##20##1##(2008-2#6)(2008-3#14)
reflectometer##2##1##(2008-10#1)(2008-3#1)
reflectometric interference spectroscopy##2##3##(2008-10#2)
reflectometric##3##1##(2008-10#3)
reflectometry##3##1##(2008-10#1)(2008-3#2)
reflector##6##1##(2008-2#2)(2008-3#4)
reflectors##2##1##(2008-3#2)
reflects a##5##2##(1991-9#1)(2008-10#2)(2008-5#1)(2009-10#1)
reflects alterations##2##2##(2008-5#1)(2009-6#1)
reflects that##2##2##(1992-8#1)(2008-10#1)
reflects the##21##2##(1990-12#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-9#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-3#1)(2011-2#4)(2013-1#1)
reflects##52##1##(1990-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-12#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#5)(2013-1#3)(2013-8#1)
reflex in##2##2##(1994-2#2)
reflex irradiation was##2##3##(1995-8#2)
reflex is##2##2##(1990-11#1)(1994-2#1)
reflex##33##1##(1990-11#1)(1992-3#2)(1994-2#8)(1994-3#4)(1994-8#1)(1995-8#4)(1996-2#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#3)(2009-11#1)(2011-2#1)(2013-8#1)
reflexes are##2##2##(1996-2#1)(2008-12#1)
reflexes in the##2##3##(1992-12#1)(2008-7#1)
reflexes in##3##2##(1992-12#1)(1996-2#1)(2008-7#1)
reflexes were##2##2##(1995-8#1)(1996-2#1)
reflexes##20##1##(1992-12#6)(1994-2#1)(1995-8#2)(1996-2#5)(2008-12#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-1#1)
reflexive shift of##2##3##(2008-11#2)
reflexive##7##1##(2008-11#4)(2008-12#1)(2010-6#1)(2013-8#1)
reflux and##5##2##(1996-3#3)(2008-10#2)
reflux disease and##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
reflux disease in an impoverished##2##5##(2011-2#2)
reflux disease in##3##3##(2009-1#1)(2011-2#2)
reflux disease##12##2##(1990-2#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-12#2)(2011-2#4)(2013-1#2)
reflux esophagitis##2##2##(2008-12#2)
reflux in the##2##3##(1991-6#1)(1992-3#1)
reflux in##5##2##(1991-6#1)(1992-11#1)(1992-3#1)(2008-10#1)(2010-11#1)
reflux is##2##2##(1990-12#1)(2008-10#1)
reflux##61##1##(1990-12#2)(1990-2#1)(1991-6#2)(1992-11#3)(1992-3#2)(1995-10#1)(1996-3#6)(1997-1#1)(2008-1#1)(2008-10#25)(2008-12#2)(2009-1#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#2)
refluxing##4##1##(2008-10#4)
refocus##2##1##(1993-12#1)(2008-11#1)
refolded##4##1##(1995-11#2)(2009-3#1)(2011-2#1)
refolding of the##4##3##(1997-4#1)(2008-4#1)(2008-8#2)
refolding of##7##2##(1995-8#2)(1997-4#1)(2008-4#1)(2008-8#2)(2009-3#1)
refolding##15##1##(1992-5#1)(1995-3#1)(1995-8#3)(1997-4#1)(2008-10#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-3#1)(2011-2#1)
reform and##8##2##(1991-12#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(1997-1#1)(2008-4#1)(2010-8#1)
reform debate##4##2##(1993-3#1)(1994-12#1)(1994-2#1)(1997-1#1)
reform efforts##2##2##(1994-1#1)(1996-2#1)
reform has##2##2##(1994-1#1)(1997-2#1)
reform have##3##2##(1994-8#1)(1996-3#1)(1997-3#1)
reform in the##5##3##(1993-12#1)(1994-1#1)(1995-12#1)(1996-6#1)(1997-3#1)
reform in##8##2##(1993-12#1)(1994-1#1)(1995-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#1)
reform initiative##2##2##(1995-1#1)(1995-12#1)
reform initiatives##5##2##(1994-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2013-1#1)
reform is##7##2##(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1997-2#1)(2013-1#1)
reform legislation##5##2##(1994-8#1)(1995-12#1)(1997-3#2)(2012-3#1)
reform of the##3##3##(1992-1#1)(1992-12#1)(1997-2#1)
reform of##4##2##(1992-1#1)(1992-12#1)(1997-2#2)
reform on##3##2##(1994-1#1)(1995-12#2)
reform that##2##2##(1996-3#1)(1997-5#1)
reform was##2##2##(1994-1#1)(2008-10#1)
reform##165##1##(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#13)(1993-2#2)(1993-3#3)(1993-5#4)(1994-1#10)(1994-12#8)(1994-2#8)(1994-3#1)(1994-8#5)(1995-1#7)(1995-12#22)(1995-2#10)(1995-3#1)(1995-6#1)(1996-1#5)(1996-12#3)(1996-2#4)(1996-3#9)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#9)(1997-5#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#3)
reform?##4##1##(1993-3#1)(1995-2#1)(1996-2#1)(1997-2#1)
reform]##2##1##(1990-2#1)(1997-8#1)
reformation##8##1##(1991-1#1)(1992-1#5)(1994-12#1)(2009-8#1)
reformed##3##1##(1994-12#1)(1995-1#1)(1995-12#1)
reforming the##2##2##(2008-10#1)(2008-11#1)
reforming##4##1##(1994-1#1)(1994-3#1)(2008-10#1)(2008-11#1)
reforms and health##2##3##(1997-1#1)(2013-8#1)
reforms and##4##2##(1997-1#1)(2008-11#1)(2009-6#1)(2013-8#1)
reforms in the##2##3##(1993-2#1)(1997-1#1)
reforms in##5##2##(1993-2#1)(1994-12#1)(1996-1#1)(1997-1#2)
reforms##27##1##(1991-8#1)(1993-2#4)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#2)(1996-1#1)(1996-2#1)(1997-1#6)(1997-5#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-6#1)(2013-8#1)
reformulated##4##1##(1996-1#1)(1996-2#1)(2008-2#1)(2010-1#1)
reformulation##4##1##(1993-1#1)(1996-1#1)(1996-2#1)(2010-4#1)
refractile##2##1##(1995-11#1)(2012-2#1)
refraction in##2##2##(2008-10#1)(2008-3#1)
refraction with##2##2##(2008-3#1)(2010-1#1)
refraction##19##1##(1991-9#1)(2008-10#1)(2008-2#1)(2008-3#15)(2010-1#1)
refractive index (RI)##3##3##(1991-7#1)(2008-10#2)
refractive index and thickness##3##4##(2007-11#3)
refractive index and##5##3##(2007-11#4)(2008-2#1)
refractive index gradient##2##3##(2008-10#2)
refractive index is##3##3##(2008-3#3)
refractive index of air##2##4##(2008-2#1)(2008-3#1)
refractive index of##13##3##(2008-10#4)(2008-2#1)(2008-3#8)
refractive index##53##2##(1991-7#1)(2007-11#4)(2008-10#19)(2008-2#5)(2008-3#22)(2008-4#1)(2013-8#1)
refractive indices and##2##3##(2008-2#2)
refractive indices##7##2##(2008-2#3)(2008-3#4)
refractive surgery##2##2##(1991-9#1)(2013-1#1)
refractive##72##1##(1991-7#1)(1991-9#1)(2007-11#4)(2008-10#19)(2008-2#8)(2008-3#33)(2008-4#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
refractive-index change in##2##3##(2008-3#2)
refractive-index change##4##2##(2008-3#4)
refractive-index changes##2##2##(2008-3#2)
refractive-index detection scheme##2##3##(2008-2#2)
refractive-index detection##4##2##(2008-2#4)
refractive-index distribution##3##2##(2008-2#1)(2008-3#2)
refractive-index gradients##2##2##(2008-2#2)
refractive-index modulation##2##2##(2008-3#2)
refractive-index profile##2##2##(2008-2#1)(2008-3#1)
refractive-index variation##2##2##(2008-3#2)
refractive-index##35##1##(2008-2#13)(2008-3#22)
refractometer##3##1##(2008-3#3)
refractoriness##5##1##(1991-2#4)(2013-1#1)
refractory DME##2##2##(2011-2#2)
refractory angina##3##2##(2008-12#1)(2008-3#1)(2010-6#1)
refractory diabetic macular oedema##2##4##(2011-2#2)
refractory period##5##2##(1991-2#1)(1992-6#1)(2008-11#3)
refractory to infliximab##2##3##(2012-3#2)
refractory to##16##2##(1993-8#1)(1994-6#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#5)(2013-1#2)
refractory yttrium##2##2##(2008-10#2)
refractory##54##1##(1991-2#2)(1992-6#1)(1993-8#1)(1994-6#1)(1997-7#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-3#7)(2013-1#5)
refraining from##2##2##(1993-6#1)(2008-10#1)
refresher course##2##2##(2008-1#1)(2009-3#1)
refrigerated##4##1##(1994-9#1)(2008-10#3)
refrigeration##3##1##(1996-1#1)(2010-7#1)(2011-2#1)
refrigerator##3##1##(2008-10#1)(2010-4#1)(2012-12#1)
refuge##6##1##(1993-6#3)(1995-6#1)(2009-5#2)
refugee campuses##2##2##(2011-2#2)
refugee##6##1##(1994-9#1)(2008-11#1)(2008-8#1)(2011-2#3)
refugees in##2##2##(1990-6#1)(2010-1#1)
refugees##8##1##(1990-6#1)(1995-11#2)(2010-1#1)(2011-2#1)(2013-1#3)
refuges##2##1##(2008-10#1)(2013-1#1)
refusal to##3##2##(1995-12#1)(1995-6#1)(2008-11#1)
refusal##6##1##(1991-6#1)(1992-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-11#1)
refuse##7##1##(1990-11#1)(1994-12#1)(1995-12#2)(1995-2#1)(2008-11#2)
refused to dismiss##2##3##(1995-12#1)(1996-5#1)
refused to##7##2##(1995-12#1)(1995-6#4)(1996-5#1)(2011-1#1)
refused##20##1##(1990-2#1)(1991-6#1)(1992-9#1)(1995-12#4)(1995-6#6)(1996-5#2)(1997-6#1)(2008-11#1)(2009-6#2)(2011-1#1)
refusers##7##1##(1990-6#1)(1991-6#6)
refuses to##2##2##(1995-6#2)
refusing to##3##2##(1995-6#3)
refusing##5##1##(1993-6#1)(1995-6#3)(1997-5#1)
refute##2##1##(1991-12#1)(2008-3#1)
refuting##2##1##(1995-5#1)(2008-10#1)
regain##7##1##(1995-8#1)(2008-10#4)(2010-10#1)(2011-3#1)
regained a##2##2##(2008-10#1)(2013-1#1)
regained##8##1##(1994-5#2)(1995-6#1)(2008-10#3)(2010-9#1)(2013-1#1)
regalis##2##1##(2010-8#2)
regard to confounding##2##3##(1992-3#1)(2008-9#1)
regard to the clinical##2##4##(2008-10#1)(2008-11#1)
regard to the influence##2##4##(2008-10#2)
regard to the##34##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1993-3#1)(1994-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
regard to their##9##3##(1992-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)
regard to these##2##3##(2008-10#1)(2011-1#1)
regard to##123##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#2)(2007-11#1)(2008-10#26)(2008-11#18)(2008-12#10)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#3)
regard##153##1##(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#2)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#2)(2007-11#1)(2008-10#30)(2008-11#25)(2008-12#12)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#8)(2011-3#1)(2012-2#4)(2012-3#3)(2012-9#1)(2013-1#1)(2013-8#4)
regarded as a##18##3##(1990-3#1)(1991-3#1)(1991-9#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-3#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
regarded as an##6##3##(1995-11#1)(1996-2#1)(1997-4#1)(2008-11#2)(2009-12#1)
regarded as important##2##3##(1991-6#1)(2008-11#1)
regarded as one of the##2##5##(2008-10#1)(2012-2#1)
regarded as the##6##3##(1993-2#1)(1994-3#1)(2008-10#2)(2008-5#1)(2010-5#1)
regarded as##63##2##(1990-3#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-6#2)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
regarded to be##2##3##(1994-9#1)(1996-3#1)
regarded##74##1##(1990-2#1)(1990-3#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-6#2)(2010-11#1)(2010-5#2)(2010-7#2)(2011-2#2)(2012-2#2)(2013-1#1)
regarding a##3##2##(1990-3#1)(2007-12#1)(2009-4#1)
regarding appropriate##4##2##(2008-3#1)(2010-1#1)(2012-12#1)(2013-8#1)
regarding breast##2##2##(1990-8#1)(2010-8#1)
regarding cigarette use##2##3##(2013-1#2)
regarding decision##2##2##(1996-1#1)(2010-2#1)
regarding early##2##2##(2008-11#1)(2012-3#1)
regarding further##2##2##(2008-10#1)(2012-2#1)
regarding how##5##2##(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)
regarding its##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
regarding management of##3##3##(2008-10#1)(2008-7#1)(2010-2#1)
regarding physician##2##2##(1996-1#2)
regarding potential##3##2##(2010-12#1)(2011-1#1)(2012-2#1)
regarding sexual##3##2##(2009-5#1)(2010-4#1)(2012-12#1)
regarding student##3##2##(2008-11#2)(2011-2#1)
regarding the &quot##2##3##(1995-11#1)(2010-7#1)
regarding the best##2##3##(2008-7#1)(2011-2#1)
regarding the degree of##2##4##(1997-3#2)
regarding the development of##2##4##(2008-12#1)(2012-12#1)
regarding the effect of##2##4##(2008-6#1)(2013-8#1)
regarding the effectiveness of##2##4##(2008-12#1)(2012-2#1)
regarding the effects of##3##4##(1991-10#1)(1993-3#1)(2013-8#1)
regarding the efficacy##2##3##(2008-11#2)
regarding the etiology##2##3##(2008-10#1)(2008-7#1)
regarding the functional##2##3##(2009-10#2)
regarding the genetic##2##3##(2009-10#1)(2011-2#1)
regarding the identity##2##3##(2008-11#2)
regarding the impact of##5##4##(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
regarding the impact##6##3##(1995-5#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
regarding the management of##3##4##(2008-11#1)(2008-3#1)(2010-2#1)
regarding the possibility##2##3##(2008-7#1)(2011-2#1)
regarding the pros and cons of##2##6##(1996-6#1)(2008-4#1)
regarding the relationship between##3##4##(2008-4#1)(2009-10#1)(2011-2#1)
regarding the relationship##4##3##(1991-2#1)(2008-4#1)(2009-10#1)(2011-2#1)
regarding the results##2##3##(1991-3#1)(2010-6#1)
regarding the role of##7##4##(1995-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#1)
regarding the safety of##2##4##(2008-11#1)(2010-12#1)
regarding the surrounding##2##3##(2008-12#1)(2008-7#1)
regarding the topic##2##3##(2012-12#1)(2013-8#1)
regarding the use of##5##4##(1992-9#1)(2008-12#1)(2009-11#1)(2013-1#2)
regarding the##194##2##(1990-6#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1994-1#2)(1994-11#1)(1994-12#4)(1994-5#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-8#3)(2007-11#1)(2008-1#2)(2008-10#13)(2008-11#25)(2008-12#10)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#8)(2009-11#1)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#9)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#14)(2013-8#6)
regarding their##17##2##(1994-12#1)(1994-3#1)(1995-1#2)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2012-12#1)(2012-5#1)(2013-1#2)(2013-7#1)
regarding these##5##2##(1996-2#1)(1997-1#1)(2008-8#1)(2011-2#1)(2012-2#1)
regarding this##3##2##(1990-11#1)(2010-10#1)(2013-1#1)
regarding use of##3##3##(1996-2#1)(2013-1#2)
regarding use##4##2##(1996-2#1)(2013-1#3)
regarding which##3##2##(2011-8#1)(2012-3#1)(2013-8#1)
regarding##434##1##(1990-11#2)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#5)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#5)(1995-11#2)(1995-12#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#5)(1996-12#2)(1996-2#4)(1996-6#1)(1997-1#4)(1997-2#2)(1997-3#4)(1997-5#2)(1997-8#6)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#4)(2008-10#29)(2008-11#46)(2008-12#19)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#16)(2008-8#5)(2008-9#7)(2009-10#9)(2009-11#3)(2009-12#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#5)(2010-10#5)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#7)(2011-2#24)(2011-3#3)(2011-7#1)(2011-8#1)(2012-12#19)(2012-2#23)(2012-3#10)(2012-5#1)(2013-1#32)(2013-7#2)(2013-8#10)
regardless of RH##2##3##(2008-10#2)
regardless of affective valence##2##4##(2008-11#2)
regardless of age##3##3##(1993-12#1)(2008-5#1)(2008-7#1)
regardless of size##2##3##(1996-12#1)(2008-10#1)
regardless of stage##2##3##(2008-8#1)(2012-3#1)
regardless of the cause##2##4##(1991-7#1)(2011-1#1)
regardless of the host##2##4##(2008-10#2)
regardless of the irrigation##2##4##(2008-10#2)
regardless of the presence of##3##5##(1993-8#1)(2008-10#2)
regardless of the presence or absence of##2##7##(1993-3#1)(2008-10#1)
regardless of the presence##5##4##(1993-3#1)(1993-8#1)(2008-10#3)
regardless of the##45##3##(1991-7#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-8#1)(1995-6#1)(1996-5#1)(1996-6#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
regardless of their##7##3##(1994-9#1)(1995-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-2#1)
regardless of whether the##8##4##(1995-11#1)(2008-10#4)(2008-12#1)(2009-3#1)(2010-5#1)
regardless of whether they are##2##5##(1994-9#1)(2009-4#1)
regardless of whether they##3##4##(1994-9#1)(2008-10#1)(2009-4#1)
regardless of whether##15##3##(1994-9#1)(1995-11#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-5#1)
regardless of which definition is selected##2##6##(2013-1#2)
regardless of which##3##3##(2008-7#1)(2013-1#2)
regardless of year##2##3##(2008-10#2)
regardless of##122##2##(1991-7#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-11#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#41)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#6)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#12)(2013-8#1)
regardless##123##1##(1991-7#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-11#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#41)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#6)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#12)(2013-8#1)
regards the##6##2##(1995-5#1)(1996-5#1)(2008-10#3)(2011-2#1)
regards to the##4##3##(2008-8#1)(2009-10#1)(2011-2#2)
regards to##11##2##(2008-10#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
regards##29##1##(1990-2#1)(1990-6#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-5#1)(2008-10#6)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#1)
regenerable chemiluminescent##2##2##(2008-10#2)
regenerable##3##1##(2008-10#3)
regenerants##3##1##(2008-10#1)(2008-9#2)
regenerate##13##1##(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2012-2#1)(2013-8#1)
regenerated by passing##2##3##(2008-10#1)(2008-12#1)
regenerated by simple polishing##2##4##(2008-10#2)
regenerated by using##2##3##(2008-10#2)
regenerated by##15##2##(2008-10#14)(2008-12#1)
regenerated from##3##2##(2008-10#1)(2008-8#2)
regenerated host##3##2##(2011-2#3)
regenerated in##2##2##(1992-9#1)(2013-1#1)
regenerated using##2##2##(2008-10#2)
regenerated##59##1##(1992-1#1)(1992-9#1)(1995-12#1)(1995-5#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#4)(2011-7#1)(2013-1#3)(2013-8#5)
regenerating liver##2##2##(1990-5#2)
regenerating the##2##2##(2008-10#1)(2012-2#1)
regenerating##17##1##(1990-5#2)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
regeneration after DEX exposure##2##4##(1995-12#2)
regeneration after##6##2##(1993-2#1)(1995-12#2)(2010-11#1)(2012-2#2)
regeneration and##8##2##(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#4)
regeneration at##2##2##(2013-1#1)(2013-8#1)
regeneration by##4##2##(1995-12#2)(2011-2#1)(2012-3#1)
regeneration capacity##3##2##(2008-9#2)(2009-12#1)
regeneration cycles##2##2##(2008-10#2)
regeneration following##3##2##(1993-3#1)(2008-10#1)(2010-5#1)
regeneration from##2##2##(2008-12#1)(2010-10#1)
regeneration in the##2##3##(1996-12#1)(2010-1#1)
regeneration in##6##2##(1995-12#1)(1996-12#1)(2008-10#1)(2010-1#1)(2010-6#1)(2012-2#1)
regeneration is##3##2##(1995-12#1)(2010-1#1)(2013-1#1)
regeneration of the##10##3##(1995-12#1)(2008-10#7)(2010-7#1)(2012-2#1)
regeneration of##21##2##(1993-8#1)(1995-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-7#2)(2012-12#1)(2012-2#2)(2013-8#1)
regeneration process##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
regeneration whole plantlets from root##2##5##(2008-12#2)
regeneration whole plantlets##3##3##(2008-12#3)
regeneration with##3##2##(1993-8#1)(2007-12#1)(2009-5#1)
regeneration##125##1##(1990-9#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1995-12#7)(1996-12#1)(2007-12#2)(2008-10#25)(2008-11#5)(2008-12#6)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#2)(2009-5#1)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#4)(2011-2#4)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#8)
regenerative amplifier##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
regenerative medicine##14##2##(2008-11#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-7#1)(2010-3#2)(2012-5#2)(2013-1#1)
regenerative potential##2##2##(2010-8#1)(2012-12#1)
regenerative process##2##2##(2010-12#1)(2013-8#1)
regenerative sprouting##2##2##(1996-12#1)(1997-3#1)
regenerative##35##1##(1994-5#2)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#4)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#3)(2009-12#2)(2009-7#1)(2010-1#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-8#1)(2012-12#1)(2012-5#2)(2013-1#2)(2013-8#2)
regia and##3##2##(2008-10#2)(2013-1#1)
regia##17##1##(2008-10#16)(2013-1#1)
regime and##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
regime in##2##2##(2008-8#1)(2011-1#1)
regime of a##2##3##(1992-11#1)(2007-11#1)
regime of##6##2##(1992-11#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
regime##50##1##(1992-11#1)(1995-6#1)(1996-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#14)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
regimen A##4##2##(1997-7#4)
regimen and##3##2##(1990-6#1)(1994-3#1)(2008-11#1)
regimen for the##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
regimen for##7##2##(1992-12#1)(1996-3#1)(1997-1#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-3#1)
regimen in the treatment of advanced##2##6##(1990-12#2)
regimen in the treatment of##3##5##(1990-12#2)(1990-2#1)
regimen in##9##2##(1990-12#3)(1990-2#1)(1992-12#1)(1994-3#1)(2008-11#1)(2011-2#1)(2013-8#1)
regimen is##5##2##(1990-2#1)(1992-12#1)(2007-11#1)(2008-8#1)(2011-2#1)
regimen may##3##2##(2007-11#1)(2008-11#1)(2010-12#1)
regimen of##5##2##(1992-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
regimen to treat##2##3##(2010-12#1)(2012-3#1)
regimen to##3##2##(1992-9#1)(2010-12#1)(2012-3#1)
regimen was effective in##2##4##(1990-12#1)(2009-12#1)
regimen was##5##2##(1990-12#1)(1994-12#1)(2008-10#1)(2009-12#1)(2010-12#1)
regimen with##3##2##(1991-9#1)(1993-2#1)(2008-7#1)
regimen##88##1##(1990-12#6)(1990-2#2)(1990-6#2)(1990-9#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-12#4)(1992-2#1)(1992-9#2)(1993-2#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-7#6)(2007-11#2)(2008-10#8)(2008-11#11)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#4)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#2)
regimens and##2##2##(2008-10#1)(2008-7#1)
regimens are##2##2##(2010-12#1)(2010-6#1)
regimens for##3##2##(1991-2#1)(2012-3#1)(2013-1#1)
regimens have##2##2##(2008-11#1)(2013-1#1)
regimens in##2##2##(2007-12#1)(2012-3#1)
regimens of##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
regimens or##3##2##(2008-7#1)(2009-8#1)(2010-6#1)
regimens that##3##2##(2008-11#2)(2011-2#1)
regimens were##2##2##(2008-11#1)(2011-2#1)
regimens##60##1##(1990-12#1)(1991-2#1)(1991-6#1)(1993-1#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-11#1)(1997-7#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-5#1)(2010-6#3)(2011-2#6)(2011-3#1)(2012-3#6)(2013-1#5)
regimes in the##2##3##(2008-10#2)
regimes in##6##2##(2008-10#4)(2008-11#2)
regimes of##5##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)
regimes ranging from##2##3##(2008-10#2)
regimes that##2##2##(2008-10#1)(2008-8#1)
regimes were##2##2##(1996-12#1)(2008-10#1)
regimes with##2##2##(2008-10#2)
regimes##52##1##(1990-11#1)(1990-8#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#29)(2008-11#6)(2008-3#3)(2008-8#3)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
regimes)##2##1##(2008-10#2)
regio- and stereoselective##2##3##(1996-5#2)
regio- and##3##2##(1996-5#3)
regioisomers##2##1##(1996-5#1)(2010-7#1)
region (4##2##2##(1992-10#1)(1997-2#1)
region (France)##2##2##(2008-10#2)
region (MAR)##2##2##(1992-10#1)(2008-8#1)
region (NTR)##2##2##(2008-10#1)(2013-8#1)
region (UTR)##4##2##(1997-7#1)(2008-10#3)
region (residues##2##2##(1993-8#1)(1997-3#1)
region 1##3##2##(2008-10#3)
region 2##2##2##(2008-10#2)
region alone##3##2##(2008-10#3)
region also##3##2##(1992-9#1)(1993-6#1)(2008-8#1)
region and a##6##3##(1991-7#1)(1995-8#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#1)
region and an##2##3##(1990-6#1)(2008-8#1)
region and the##11##3##(1994-11#2)(1994-3#1)(1994-5#1)(2008-10#3)(2008-9#1)(2009-1#1)(2010-5#1)(2011-2#1)
region and to##2##3##(1994-2#1)(1996-2#1)
region and##63##2##(1990-6#1)(1991-6#1)(1991-7#1)(1992-2#2)(1993-12#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-8#2)(2008-10#15)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-1#1)(2009-7#1)(2010-5#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
region are##7##2##(1990-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
region as the##2##3##(2008-10#2)
region as##7##2##(1993-3#1)(1994-11#1)(1995-6#1)(2008-10#3)(2008-6#1)
region at the##5##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
region at##14##2##(1990-5#1)(1993-12#1)(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
region before##2##2##(1997-6#1)(2012-2#1)
region between the##6##3##(1995-12#1)(2008-10#3)(2008-7#1)(2012-2#1)
region between##20##2##(1991-6#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
region but##3##2##(2008-10#2)(2008-7#1)
region by use of##2##4##(2008-3#2)
region by##10##2##(1994-12#1)(1995-5#1)(1996-8#1)(1997-8#1)(2008-10#3)(2008-3#3)
region can be used##2##4##(1993-9#1)(2008-3#1)
region close to the GRPR locus on the X chromosome##2##10##(1996-12#2)
region close to the##3##4##(1996-12#2)(1996-3#1)
region compared to##2##3##(1992-6#1)(2008-10#1)
region compared##3##2##(1992-6#1)(2008-10#2)
region contained##3##2##(1996-12#1)(1996-3#1)(2009-10#1)
region containing the##2##3##(1996-12#1)(1997-7#1)
region containing##3##2##(1996-12#1)(1997-7#1)(2008-10#1)
region contains at least##2##4##(1995-8#1)(1996-6#1)
region contains##10##2##(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-6#2)(1996-8#1)(2008-8#1)
region could##2##2##(2008-10#2)
region during the##3##3##(2008-10#2)(2012-3#1)
region during##5##2##(1992-10#1)(2008-10#3)(2012-3#1)
region encompassing##2##2##(1991-5#1)(2008-10#1)
region extending##3##2##(2010-11#1)(2011-2#1)(2013-1#1)
region for##23##2##(1990-7#2)(1992-3#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#7)(2008-3#1)(2008-9#1)(2009-3#1)(2010-7#1)(2012-3#2)
region from both##2##3##(2008-10#2)
region from the##2##3##(1996-3#1)(2008-11#1)
region from##14##2##(1993-9#1)(1994-5#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)
region gene##3##2##(1994-8#1)(1997-8#1)(2008-11#1)
region had##2##2##(1990-9#1)(2008-10#1)
region has been##7##3##(1993-6#1)(1994-8#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#1)
region has##10##2##(1990-10#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-12#1)
region have##2##2##(1997-3#1)(2008-12#1)
region homologous to##2##3##(1993-6#1)(2008-10#1)
region in the##15##3##(1995-6#1)(1996-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
region in##36##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-9#1)(1993-8#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-9#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#2)
region including the##2##3##(1996-12#1)(2008-10#1)
region into##2##2##(2008-10#1)(2013-8#1)
region involved in##2##3##(1997-2#1)(2008-10#1)
region is a##2##3##(1992-9#1)(1996-12#1)
region is an##2##3##(1995-6#1)(2008-9#1)
region is##29##2##(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-12#1)(2013-8#1)
region lies between##2##3##(2008-2#1)(2012-12#1)
region located##2##2##(1993-2#1)(1996-6#1)
region might be##2##3##(2008-10#2)
region might##3##2##(2008-10#2)(2008-8#1)
region near##2##2##(1993-6#1)(2007-11#1)
region of 1##2##3##(2007-12#1)(2008-10#1)
region of 55 bp##2##4##(1990-11#2)
region of P##2##3##(2008-10#2)
region of Poland##3##3##(2008-12#3)
region of Venezuela##2##3##(2008-10#2)
region of WSMoV NSs protein##2##5##(2008-10#2)
region of a##10##3##(1990-12#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)
region of all##2##3##(1993-12#1)(2012-3#1)
region of chromosome 6##2##4##(1994-11#1)(2008-8#1)
region of chromosome##14##3##(1994-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-8#3)(2009-10#1)
region of each##3##3##(1995-12#1)(1997-3#1)(2008-10#1)
region of human##7##3##(1990-8#1)(1994-6#2)(1995-12#1)(1996-6#1)(2009-7#2)
region of interest##4##3##(1995-6#1)(2008-5#1)(2009-7#1)(2010-6#1)
region of lambdaN##4##3##(2008-8#4)
region of mitochondrial DNA##2##4##(2008-10#2)
region of mouse chromosome##2##4##(1995-2#1)(1997-2#1)
region of nodD3##2##3##(2008-8#1)(2008-9#1)
region of origin##4##3##(2008-10#4)
region of rDNA##2##3##(2008-10#2)
region of ribosomal DNA##2##4##(2008-10#2)
region of sorghumpsbA gene##2##4##(2008-9#2)
region of target##2##3##(2008-4#1)(2011-2#1)
region of the Bacillus subtilis genome##4##6##(1995-12#1)(1996-8#2)(1997-7#1)
region of the United States##11##5##(2008-10#9)(2008-11#1)(2008-12#1)
region of the brachial fascia##2##5##(2009-1#2)
region of the brain##4##4##(1996-12#1)(1996-5#1)(2008-11#1)(2010-1#1)
region of the genome##2##4##(2008-10#1)(2012-3#1)
region of the hippocampus##2##4##(1996-12#1)(2008-7#1)
region of the human##13##4##(1991-6#1)(1991-7#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-2#1)(1997-2#1)(1997-8#1)(2008-4#1)
region of the long arm##2##5##(2008-10#1)(2008-9#1)
region of the major##2##4##(1994-11#1)(1995-6#1)
region of the mouse##2##4##(1991-6#2)
region of the nuclear ribosomal RNA gene##3##7##(2008-10#3)
region of the nuclear ribosomal##4##5##(2008-10#4)
region of the protein##4##4##(1990-5#1)(1994-5#1)(1995-6#1)(1996-3#1)
region of the rDNA##4##4##(2008-10#4)
region of the rat##2##4##(1993-8#1)(2008-9#1)
region of the spectrum##3##4##(2008-10#3)
region of the state##2##4##(2008-10#1)(2011-2#1)
region of the##161##3##(1990-11#2)(1990-2#2)(1990-5#2)(1991-12#1)(1991-6#4)(1991-7#3)(1992-12#2)(1992-3#2)(1992-6#1)(1993-12#3)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#2)(1994-2#3)(1994-5#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-6#4)(1996-12#6)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#5)(1997-8#3)(2007-12#1)(2008-10#39)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#3)(2010-1#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#3)
region of these##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
region of this##3##3##(1997-3#1)(2008-11#1)(2009-8#1)
region of##377##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#4)(1991-7#3)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1993-12#9)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#6)(1993-9#1)(1994-11#6)(1994-12#1)(1994-2#3)(1994-5#5)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#9)(1995-6#11)(1995-8#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#6)(1996-5#2)(1996-6#3)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#3)(1997-7#8)(1997-8#5)(2007-12#3)(2008-1#1)(2008-10#92)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#14)(2008-6#1)(2008-7#7)(2008-8#17)(2008-9#10)(2009-1#3)(2009-10#2)(2009-7#3)(2009-8#4)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#3)(2012-3#7)(2012-7#1)(2013-1#5)(2013-8#1)
region on chromosome##4##3##(1996-2#1)(1997-2#1)(2009-10#1)(2012-3#1)
region on the##10##3##(1996-12#6)(1996-6#2)(2008-10#1)(2008-11#1)
region on##18##2##(1992-4#1)(1996-12#6)(1996-2#1)(1996-6#2)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-5#1)(2012-3#1)
region or##9##2##(1990-8#1)(1993-9#1)(2007-12#1)(2008-10#5)(2008-11#1)
region previously##2##2##(1993-9#1)(2008-11#1)
region revealed##2##2##(1993-2#1)(2008-10#1)
region sequences##3##2##(1997-3#1)(2008-12#2)
region showed that##3##3##(2008-10#3)
region showed##6##2##(1991-5#1)(1993-12#1)(2008-10#4)
region shows##2##2##(1992-3#1)(2008-10#1)
region specific to##2##3##(1990-7#1)(2008-10#1)
region specific##3##2##(1990-7#1)(1996-8#1)(2008-10#1)
region surrounding the##3##3##(1991-7#1)(1997-5#1)(2012-3#1)
region surrounding##4##2##(1991-7#1)(1994-11#1)(1997-5#1)(2012-3#1)
region that has##2##3##(1994-11#1)(2008-10#1)
region that is most important##2##5##(1994-3#1)(2008-10#1)
region that is##3##3##(1991-12#1)(1994-3#1)(2008-10#1)
region that was##3##3##(1993-12#1)(2008-10#2)
region that##16##2##(1991-12#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1996-12#1)(2008-10#8)(2008-8#1)
region to another##2##3##(2008-1#1)(2013-1#1)
region to the##2##3##(2008-10#1)(2008-3#1)
region to##13##2##(1992-2#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2013-1#2)
region upstream of the##2##4##(1993-8#1)(1997-7#1)
region upstream##3##2##(1993-8#1)(1994-11#1)(1997-7#1)
region using##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
region was used##2##3##(2008-10#2)
region was##28##2##(1991-12#1)(1991-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1997-7#1)(2008-10#8)(2008-12#2)(2008-5#2)(2008-8#3)(2008-9#4)(2010-5#1)(2012-2#1)(2012-3#1)
region we##2##2##(2008-3#1)(2012-2#1)
region were##19##2##(1990-5#1)(1993-6#1)(1995-11#1)(1996-8#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-12#3)(2008-5#1)(2010-5#1)
region where##2##2##(2008-10#2)
region which##5##2##(1992-6#1)(1993-12#1)(1993-6#1)(1996-12#1)(1997-3#1)
region with##17##2##(1992-2#1)(1994-11#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
region within the##2##3##(1995-6#1)(2008-11#1)
region within##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
region##1423##1##(1990-10#2)(1990-11#8)(1990-12#3)(1990-2#3)(1990-4#2)(1990-5#9)(1990-6#3)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-3#2)(1991-5#7)(1991-6#11)(1991-7#9)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#4)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#8)(1992-9#7)(1993-1#1)(1993-11#3)(1993-12#26)(1993-2#12)(1993-3#8)(1993-6#17)(1993-8#16)(1993-9#6)(1994-11#22)(1994-12#4)(1994-2#9)(1994-3#3)(1994-5#12)(1994-6#3)(1994-8#6)(1994-9#1)(1995-11#5)(1995-12#13)(1995-2#16)(1995-3#1)(1995-5#3)(1995-6#23)(1995-8#8)(1996-1#3)(1996-11#5)(1996-12#32)(1996-2#9)(1996-3#14)(1996-5#2)(1996-6#19)(1996-8#12)(1996-9#1)(1997-1#1)(1997-2#17)(1997-3#17)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#18)(1997-8#24)(1997-9#7)(2007-11#2)(2007-12#15)(2008-1#5)(2008-10#358)(2008-11#56)(2008-12#36)(2008-2#6)(2008-3#36)(2008-4#11)(2008-5#28)(2008-6#4)(2008-7#29)(2008-8#68)(2008-9#48)(2009-1#4)(2009-10#9)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#6)(2009-8#8)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#11)(2010-6#2)(2010-7#6)(2010-8#6)(2011-1#4)(2011-2#31)(2011-3#1)(2011-9#1)(2012-12#9)(2012-2#14)(2012-3#24)(2012-6#1)(2012-7#1)(2013-1#32)(2013-8#13)
region) and##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
region) of##3##2##(2008-5#1)(2008-6#1)(2010-7#1)
region)##14##1##(1991-12#1)(1996-2#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-7#1)(2012-2#1)(2012-3#1)
region-specific##4##1##(1993-9#1)(1996-8#1)(2008-10#1)(2008-8#1)
regional PWV##2##2##(2013-3#2)
regional anaesthesia##2##2##(1990-6#1)(2010-7#1)
regional anaesthetic techniques##2##3##(1994-3#2)
regional and general##2##3##(2008-12#1)(2010-7#1)
regional and local##2##3##(2008-9#1)(2012-3#1)
regional and##9##2##(1992-5#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-3#1)
regional anesthesia##6##2##(2008-8#1)(2012-2#4)(2012-3#1)
regional attrition##5##2##(1994-3#5)
regional brain syndromes##4##3##(2008-7#4)
regional brain##9##2##(1990-9#1)(1991-10#1)(2008-4#1)(2008-7#5)(2013-8#1)
regional cerebral blood flow (rCBF)##2##5##(1995-5#1)(1996-2#1)
regional cerebral blood flow##5##4##(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(2008-7#1)
regional coexistence##2##2##(2008-8#2)
regional continuity##2##2##(1994-3#2)
regional differences in the##2##4##(1994-2#1)(2013-8#1)
regional differences in##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
regional differences##8##2##(1994-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#1)
regional distribution of##2##3##(1994-5#1)(2010-12#1)
regional distribution##3##2##(1994-5#1)(1996-12#1)(2010-12#1)
regional dosages delivered##2##3##(1994-12#2)
regional dosages##4##2##(1994-12#4)
regional health authorities##2##3##(1997-2#1)(2008-11#1)
regional health##4##2##(1995-3#1)(1997-2#2)(2008-11#1)
regional hospitals##3##2##(1995-5#1)(2008-1#1)(2011-2#1)
regional invasion##2##2##(2008-10#2)
regional level##5##2##(1990-11#1)(1994-2#1)(2008-10#3)
regional lymph nodes##2##3##(2008-1#1)(2009-1#1)
regional lymph##3##2##(2008-1#1)(2009-1#1)(2012-12#1)
regional planning##2##2##(1992-12#1)(1994-12#1)
regional scale##5##2##(2008-10#5)
regional spread of##3##3##(1997-3#1)(2008-10#2)
regional spread##4##2##(1997-3#1)(2008-10#3)
regional variation in##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
regional wall motion abnormalities##2##4##(2013-1#2)
regional##195##1##(1990-11#4)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#6)(1994-2#3)(1994-3#9)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#4)(1996-3#4)(1997-2#4)(1997-3#2)(1997-6#1)(2008-1#6)(2008-10#28)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#7)(2013-3#4)(2013-8#5)
regionally based study was adopted in 2008##2##7##(2013-1#2)
regionally##8##1##(1996-2#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-3#1)(2013-1#2)
regions and in##4##3##(1996-12#1)(2008-11#1)(2008-12#1)(2012-3#1)
regions and the##8##3##(1993-12#1)(1993-8#1)(1995-5#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-2#1)
regions and their##2##3##(1994-11#1)(1997-2#1)
regions and##32##2##(1993-12#1)(1993-8#1)(1994-11#1)(1995-5#2)(1996-12#1)(1997-2#5)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-4#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
regions are associated with##2##4##(2008-10#1)(2008-7#1)
regions are characterized##2##3##(2008-10#1)(2008-9#1)
regions are##21##2##(1993-3#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#2)(2010-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
regions around the##2##3##(1992-9#1)(2009-5#1)
regions as the##2##3##(1993-8#1)(1994-3#1)
regions associated with resistance##2##4##(2008-10#2)
regions associated with##4##3##(1995-12#1)(2008-10#2)(2008-11#1)
regions at the dough stage##2##5##(2008-10#2)
regions at##3##2##(2008-10#2)(2008-3#1)
regions between##4##2##(2008-10#2)(2008-9#2)
regions common##2##2##(1993-6#1)(2008-10#1)
regions corresponding to##3##3##(1993-2#1)(2008-8#1)(2013-1#1)
regions derived from the##2##4##(1991-10#2)
regions derived from##3##3##(1991-10#2)(2008-10#1)
regions did##2##2##(2008-10#1)(2008-11#1)
regions during##4##2##(1995-12#1)(2008-10#2)(2008-11#1)
regions for##12##2##(1990-8#1)(1992-6#1)(1993-3#1)(1993-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
regions from the##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
regions from##9##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
regions had elevated##2##3##(2009-10#2)
regions had##3##2##(2008-10#1)(2009-10#2)
regions have##3##2##(1993-8#1)(1994-2#1)(2010-8#1)
regions implicated in##2##3##(1995-2#1)(2013-8#1)
regions in normal##2##3##(1997-3#1)(2012-2#1)
regions in the##10##3##(1991-12#1)(1992-12#1)(1993-12#1)(1993-2#1)(2008-10#4)(2008-11#1)(2012-3#1)
regions in which##2##3##(2008-10#1)(2008-9#1)
regions in##33##2##(1991-10#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-2#1)(1995-6#1)(1996-12#1)(1997-3#2)(2008-10#11)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
regions indicated that##3##3##(2008-10#2)(2013-8#1)
regions involved in the##2##4##(1996-8#1)(2009-5#1)
regions involved in##4##3##(1996-8#1)(2008-4#1)(2009-5#1)(2013-8#1)
regions is##6##2##(1991-10#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-7#1)
regions may##2##2##(1995-11#1)(2008-11#1)
regions of Brazil##2##3##(2008-10#2)
regions of France##2##3##(2008-10#2)
regions of Malawi##2##3##(2008-10#2)
regions of North America##2##4##(2008-10#1)(2008-8#1)
regions of apple pectin with##2##5##(1990-9#2)
regions of high##2##3##(1997-8#1)(2011-2#1)
regions of homology##2##3##(1990-7#1)(2008-4#1)
regions of human plasminogen##2##4##(1993-8#2)
regions of interest##4##3##(2008-11#1)(2008-6#2)(2009-8#1)
regions of rDNA##2##3##(2008-10#2)
regions of rice##2##3##(2008-8#1)(2008-9#1)
regions of the L genes##2##5##(2008-10#2)
regions of the United States##3##5##(2008-10#2)(2013-8#1)
regions of the amygdala##2##4##(1991-10#2)
regions of the brain##3##4##(2008-4#1)(2009-12#1)(2012-2#1)
regions of the different##2##4##(1990-5#1)(2013-8#1)
regions of the genome##7##4##(2008-10#4)(2008-4#1)(2008-9#1)(2011-2#1)
regions of the human##4##4##(1993-2#2)(1993-6#1)(2008-11#1)
regions of the mouse and human genes are##2##8##(1993-3#1)(1993-6#1)
regions of the nuclear ribosomal DNA##2##6##(2008-10#2)
regions of the protein##2##4##(1993-12#1)(1995-6#1)
regions of the rat brain##2##5##(1993-8#1)(1994-8#1)
regions of the rat##3##4##(1993-8#2)(1994-8#1)
regions of the respiratory tract##2##5##(1994-12#1)(2008-10#1)
regions of the world##11##4##(2008-10#5)(2008-11#2)(2008-5#1)(2009-8#1)(2010-10#1)(2010-3#1)
regions of the##121##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-6#1)(1992-12#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#3)(1994-12#3)(1994-2#2)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#2)(1997-2#1)(1997-6#1)(1997-9#1)(2008-10#44)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
regions of these##3##3##(2008-10#1)(2008-11#2)
regions of##246##2##(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-10#3)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#6)(1993-8#8)(1994-12#3)(1994-2#2)(1994-5#2)(1994-8#2)(1995-12#2)(1995-2#4)(1995-6#3)(1995-8#2)(1996-1#1)(1996-12#7)(1996-2#4)(1997-2#4)(1997-3#1)(1997-6#2)(1997-8#2)(1997-9#1)(2008-10#79)(2008-11#13)(2008-12#4)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#6)(2009-10#4)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#6)
regions on the##5##3##(1993-3#1)(1995-2#1)(1997-8#1)(2008-10#1)(2010-7#1)
regions on##8##2##(1993-3#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2010-7#1)(2013-1#1)
regions or##6##2##(1996-6#1)(2008-10#4)(2009-10#1)
regions previously##4##2##(1993-9#1)(1994-2#1)(1995-2#1)(2008-10#1)
regions revealed##3##2##(2008-10#1)(2009-8#1)(2013-8#1)
regions share##2##2##(1991-12#1)(1991-9#1)
regions should##2##2##(2008-4#1)(2008-8#1)
regions show##2##2##(2008-10#1)(2008-11#1)
regions showed##3##2##(1993-12#1)(1997-8#1)(2008-10#1)
regions studied##3##2##(1996-12#1)(2008-10#2)
regions tested##2##2##(2008-10#1)(2008-5#1)
regions than##2##2##(1996-12#1)(2013-8#1)
regions that are##2##3##(2008-11#1)(2012-3#1)
regions that have##2##3##(1994-2#1)(1995-2#1)
regions that##13##2##(1993-6#1)(1994-2#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-10#1)(2012-2#1)(2012-3#3)
regions to##4##2##(1995-2#1)(2008-11#1)(2008-4#1)(2013-1#1)
regions using##3##2##(1994-11#1)(2008-10#1)(2011-2#1)
regions was##5##2##(1990-11#1)(1994-5#1)(1997-8#1)(2008-10#1)(2013-8#1)
regions were also##2##3##(1994-12#1)(2008-8#1)
regions were identical##2##3##(1991-9#1)(2008-10#1)
regions were identified##2##3##(2008-10#2)
regions were##22##2##(1990-5#1)(1991-12#1)(1991-7#1)(1991-9#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-6#1)(1997-8#1)(2008-10#9)(2008-8#2)(2009-10#1)
regions where the##3##3##(2008-3#1)(2008-4#1)(2013-1#1)
regions where##11##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#3)(2013-1#1)
regions which##4##2##(1992-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
regions with different##2##3##(2008-10#1)(2008-6#1)
regions with high##2##3##(2008-10#1)(2008-3#1)
regions with##14##2##(1993-1#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-6#1)(2010-3#1)(2013-8#1)
regions within the##4##3##(1992-6#1)(1993-8#1)(1995-12#1)(1996-12#1)
regions within##6##2##(1991-6#1)(1992-6#2)(1993-8#1)(1995-12#1)(1996-12#1)
regions worldwide##4##2##(2008-10#4)
regions##804##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#3)(1990-5#6)(1990-7#1)(1990-8#4)(1990-9#3)(1991-10#12)(1991-11#1)(1991-12#5)(1991-2#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#3)(1992-9#2)(1993-1#1)(1993-12#11)(1993-2#6)(1993-3#5)(1993-6#9)(1993-8#20)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#11)(1994-3#2)(1994-5#4)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#9)(1995-2#13)(1995-5#6)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#23)(1996-2#6)(1996-3#1)(1996-6#5)(1996-8#2)(1997-2#11)(1997-3#3)(1997-6#6)(1997-7#3)(1997-8#9)(1997-9#2)(2007-12#6)(2008-1#1)(2008-10#233)(2008-11#51)(2008-12#17)(2008-2#1)(2008-3#18)(2008-4#17)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#23)(2008-9#14)(2009-10#15)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#2)(2010-12#1)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#25)(2011-3#3)(2011-7#1)(2012-12#2)(2012-2#8)(2012-3#12)(2012-7#1)(2013-1#16)(2013-8#23)
regions]##2##1##(1991-2#1)(1997-8#1)
regioselective formation of##2##3##(1994-11#1)(2009-8#1)
regioselective ring opening of the oxabicycloheptadienes##2##6##(2008-8#2)
regioselective##11##1##(1992-3#1)(1994-11#1)(1996-5#3)(2008-10#2)(2008-4#1)(2008-8#2)(2009-8#1)
regioselectivity at##2##2##(1996-5#1)(2009-8#1)
regioselectivity##7##1##(1994-11#1)(1994-5#1)(1996-5#2)(2008-8#2)(2009-8#1)
register of all##2##3##(2008-10#2)
register##17##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-9#1)(2013-8#1)
registered and##3##2##(1994-12#1)(2008-10#1)(2010-5#1)
registered at##2##2##(1996-12#1)(2013-8#1)
registered by the Ragusa Cancer Registry##2##6##(1991-2#1)(1992-12#1)
registered for the##2##3##(1997-7#1)(2012-2#1)
registered for##5##2##(1995-8#1)(1997-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
registered in a##3##3##(1996-6#1)(2008-7#1)(2012-3#1)
registered in the##5##3##(1991-11#1)(1997-2#1)(1997-7#1)(2008-12#1)(2013-8#1)
registered in##18##2##(1991-11#1)(1991-6#1)(1992-5#1)(1993-11#1)(1996-12#2)(1996-6#2)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
registered mental##2##2##(2008-11#1)(2010-5#1)
registered nurse##4##2##(2008-11#3)(2010-2#1)
registered nurses (RNs)##5##3##(1991-2#1)(2008-12#1)(2010-10#1)(2013-1#2)
registered nurses who##2##3##(2008-1#1)(2008-11#1)
registered nurses##22##2##(1991-2#1)(1994-3#1)(2008-1#1)(2008-11#8)(2008-12#3)(2008-7#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#4)
registered when##2##2##(1991-11#1)(2008-11#1)
registered with the##2##3##(1996-8#1)(2008-10#1)
registered with##3##2##(1996-8#1)(2008-10#1)(2010-1#1)
registered##97##1##(1991-11#2)(1991-2#3)(1991-6#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#2)(1996-12#3)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#3)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#7)(2008-11#16)(2008-12#5)(2008-5#2)(2008-7#2)(2008-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#3)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
registering##3##1##(2008-11#1)(2009-10#1)(2010-8#1)
registers of##2##2##(1995-2#1)(2008-10#1)
registers##9##1##(1991-11#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#2)
registrars##2##1##(1992-2#1)(2008-11#1)
registration and##2##2##(1991-11#1)(2008-11#1)
registration in##2##2##(1990-12#1)(2008-10#1)
registration of births##2##3##(2008-10#1)(2008-11#1)
registration of pain##2##3##(1991-11#2)
registration of the##3##3##(2008-10#1)(2009-12#1)(2013-8#1)
registration of##10##2##(1990-6#2)(1991-11#3)(2008-10#2)(2008-11#1)(2009-12#1)(2013-8#1)
registration##43##1##(1990-12#2)(1990-6#2)(1991-11#5)(1991-3#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1996-12#1)(2008-10#4)(2008-11#14)(2008-12#1)(2009-12#4)(2009-2#1)(2011-2#1)(2013-8#1)
registrations##3##1##(1990-2#1)(1991-6#1)(2012-12#1)
registries were##2##2##(1996-12#1)(2012-12#1)
registries##12##1##(1991-2#1)(1993-12#1)(1996-12#2)(2008-11#1)(2009-10#1)(2011-2#2)(2011-3#1)(2012-12#3)
registry##14##1##(1993-5#1)(1996-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-6#3)(2011-2#3)(2012-12#2)
región of##2##2##(2013-8#2)
regress##3##1##(1991-11#1)(1997-1#1)(2008-10#1)
regressed with##3##2##(2008-10#1)(2008-5#2)
regressed##11##1##(1991-3#1)(1993-1#1)(1993-11#1)(2008-10#3)(2008-3#2)(2008-5#2)(2010-2#1)
regressing##2##1##(2008-3#1)(2009-8#1)
regression (MLR)##6##2##(2008-10#6)
regression (PCR) and partial least squares (PLS)##2##7##(2008-10#2)
regression (PCR) and partial##3##4##(2008-10#3)
regression (PCR)##11##2##(2008-10#11)
regression (PLS) and artificial neural##2##5##(2008-10#2)
regression (PLS)##8##2##(2008-10#8)
regression analyses found##2##3##(1996-2#1)(2013-1#1)
regression analyses of the##2##4##(2008-10#2)
regression analyses were performed to##3##5##(2008-10#1)(2008-3#1)(2010-11#1)
regression analyses were performed##4##4##(2008-10#1)(2008-3#1)(2010-11#1)(2012-2#1)
regression analyses were used to##2##5##(2008-10#1)(2010-4#1)
regression analyses were##7##3##(2008-10#2)(2008-3#1)(2008-4#1)(2010-11#1)(2010-4#1)(2012-2#1)
regression analyses##26##2##(1992-2#1)(1994-12#1)(1996-2#1)(1996-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
regression analysis and##3##3##(2008-10#2)(2008-11#1)
regression analysis between##4##3##(2008-10#2)(2009-11#1)(2011-2#1)
regression analysis indicated that##2##4##(2008-10#1)(2010-7#1)
regression analysis of potentiometric##2##4##(2008-10#2)
regression analysis of the##3##4##(1993-3#1)(2008-10#1)(2012-3#1)
regression analysis of##13##3##(1993-3#1)(2008-10#8)(2008-11#2)(2012-3#2)
regression analysis revealed that##3##4##(2008-11#1)(2010-2#1)(2012-2#1)
regression analysis revealed##5##3##(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)(2012-2#1)
regression analysis showed that##5##4##(2008-10#1)(2008-11#2)(2008-7#1)(2011-1#1)
regression analysis showed##9##3##(1993-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2011-1#1)
regression analysis was utilized to##2##5##(2008-11#1)(2008-12#1)
regression analysis was##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
regression analysis were##2##3##(2008-11#2)
regression analysis##83##2##(1991-1#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1995-1#1)(2008-10#39)(2008-11#11)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#2)
regression and##14##2##(1991-8#1)(2008-10#9)(2009-8#3)(2013-8#1)
regression approach##3##2##(2008-10#3)
regression approaches##2##2##(2008-10#2)
regression are##3##2##(1991-8#1)(2008-10#2)
regression coefficient of 0##2##4##(2008-10#2)
regression coefficient of##3##3##(2008-10#3)
regression coefficient##7##2##(2008-10#7)
regression coefficients of##3##3##(1995-9#1)(2008-10#2)
regression coefficients##11##2##(1995-9#1)(2008-10#9)(2010-11#1)
regression diagnostics##2##2##(2008-10#2)
regression equation has##2##3##(2008-10#1)(2011-3#1)
regression equation of the calibration graph##4##6##(2008-10#4)
regression equation of##5##3##(2008-10#5)
regression equation##18##2##(2008-10#16)(2008-7#1)(2011-3#1)
regression for##2##2##(1991-1#1)(2008-11#1)
regression in the##2##3##(2008-10#2)
regression in##7##2##(1992-12#1)(2008-10#3)(2009-4#1)(2009-8#1)(2011-2#1)
regression line##6##2##(2008-10#6)
regression method to##2##3##(2008-10#1)(2013-8#1)
regression method##16##2##(2008-10#14)(2013-8#2)
regression methods to##3##3##(2008-10#2)(2009-8#1)
regression methods##12##2##(2008-10#10)(2009-8#2)
regression model for##2##3##(1995-9#1)(2011-2#1)
regression model was used to##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
regression model was##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
regression model##31##2##(1992-1#1)(1995-9#2)(2008-10#12)(2008-11#4)(2008-4#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#5)(2013-1#1)(2013-8#1)
regression modeling of##2##3##(2008-10#2)
regression modeling##3##2##(2008-10#3)
regression models for##2##3##(1991-1#1)(2008-10#1)
regression models were used to##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
regression models were##8##3##(2008-10#4)(2011-3#1)(2012-2#1)(2013-1#2)
regression models##33##2##(1990-2#1)(1991-1#1)(1992-9#2)(2008-10#14)(2008-11#3)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
regression neural##2##2##(2008-10#2)
regression of laryngeal##2##3##(1990-6#2)
regression of the##7##3##(1992-12#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-1#1)
regression of##31##2##(1990-3#1)(1990-6#3)(1992-12#1)(1992-3#1)(1994-5#2)(1995-9#1)(1997-1#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
regression on##3##2##(2008-10#2)(2013-8#1)
regression results##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
regression showed##2##2##(2008-11#1)(2011-2#1)
regression slope##3##2##(2008-10#3)
regression technique##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
regression techniques##3##2##(2008-10#3)
regression to##8##2##(1991-1#1)(2008-10#5)(2008-9#1)(2013-1#1)
regression tree##4##2##(2008-10#4)
regression triplet##3##2##(2008-10#3)
regression was used for##2##4##(2008-10#2)
regression was used to estimate##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
regression was used to find the straight line that fitted the experimental data##2##13##(2008-10#2)
regression was used to test##2##5##(2013-1#2)
regression was used to##13##4##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#2)
regression was used##16##3##(1994-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#2)
regression was##26##2##(1992-12#1)(1994-12#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#3)
regression were##3##2##(2009-8#1)(2013-1#1)(2013-8#1)
regression with##7##2##(2008-10#4)(2010-1#1)(2011-2#1)(2013-8#1)
regression##506##1##(1990-2#1)(1990-3#1)(1990-6#3)(1991-1#4)(1991-3#1)(1991-8#3)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-9#7)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-5#2)(1995-1#1)(1995-9#6)(1996-2#1)(1996-8#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#286)(2008-11#25)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#10)(2009-9#1)(2010-1#1)(2010-11#5)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#16)(2011-3#3)(2012-12#4)(2012-2#6)(2012-3#9)(2013-1#16)(2013-8#18)
regressions were##2##2##(2008-10#1)(2013-1#1)
regressions##7##1##(1991-2#1)(2008-10#2)(2009-12#1)(2013-1#3)
regressive##5##1##(1991-3#1)(1993-2#1)(1996-6#1)(2008-11#1)(2009-10#1)
regrets that this article is an accidental duplication of an article that has already been published in##5##17##(2008-11#5)
regrets that this article is an accidental duplication of an article that has already been published##6##16##(2008-11#5)(2012-3#1)
regrets that this article##7##4##(2008-11#6)(2012-3#1)
regrow a noticeable amount of hair##2##6##(2008-5#2)
regrowth than##2##2##(1997-7#1)(2008-7#1)
regrowth##6##1##(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#3)
regular and##3##2##(1993-3#1)(2008-3#1)(2011-2#1)
regular contact with##2##3##(2008-11#2)
regular exercise##3##2##(2008-8#1)(2010-2#1)(2013-1#1)
regular follow up##3##3##(2011-2#3)
regular follow-up##2##2##(2011-2#1)(2013-1#1)
regular grid##3##2##(2008-10#2)(2008-6#1)
regular labeling of##2##3##(2008-10#2)
regular medical##2##2##(1994-12#1)(2010-8#1)
regular night nursing##2##3##(2010-7#2)
regular pattern##2##2##(1994-9#1)(2009-8#1)
regular primary##2##2##(1996-1#1)(2009-3#1)
regular solution theory##6##3##(2008-10#6)
regular suture##2##2##(1991-12#2)
regular use of these##2##4##(1991-9#1)(2008-5#1)
regular use of##5##3##(1990-9#1)(1991-9#2)(2008-11#1)(2008-5#1)
regular use##6##2##(1990-9#1)(1991-9#2)(2008-11#1)(2008-5#1)(2011-2#1)
regular##128##1##(1990-12#2)(1990-3#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-8#2)(1991-9#2)(1992-2#2)(1993-3#3)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#25)(2008-11#10)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#15)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
regularities in the##2##3##(2012-2#2)
regularities##5##1##(2008-11#1)(2010-9#1)(2012-2#3)
regularity of##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
regularity##8##1##(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#4)
regularization##7##1##(2008-10#2)(2008-3#4)(2008-6#1)
regularized##5##1##(2008-6#4)(2010-1#1)
regularly and##4##2##(1990-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
regularly documented included##2##3##(2008-12#2)
regularly from##2##2##(1990-12#1)(1996-2#1)
regularly in##3##2##(1997-8#1)(2007-11#1)(2013-8#1)
regularly observed in##2##3##(1992-3#1)(1993-11#1)
regularly scheduled##3##2##(2008-4#2)(2012-12#1)
regularly updated##2##2##(2011-2#1)(2013-1#1)
regularly##60##1##(1990-12#2)(1990-3#1)(1990-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-8#3)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-7#3)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
regulatable##2##1##(2008-11#2)
regulate a number of##2##4##(1996-12#1)(2008-11#1)
regulate a##7##2##(1996-12#1)(1997-7#1)(2008-11#3)(2008-9#1)(2009-8#1)
regulate actin##3##2##(2012-2#3)
regulate cell growth##2##3##(1995-8#1)(2008-11#1)
regulate cell##3##2##(1995-8#1)(2008-11#2)
regulate cellular##2##2##(2009-12#1)(2013-1#1)
regulate gene expression##5##3##(1993-6#1)(2008-11#1)(2010-7#1)(2011-2#2)
regulate glucose##2##2##(2008-1#1)(2011-2#1)
regulate its##2##2##(2007-12#1)(2008-11#1)
regulate many##2##2##(2008-4#1)(2008-8#1)
regulate plant##2##2##(2008-8#1)(2009-6#1)
regulate the activity of##3##4##(1995-5#1)(2008-9#1)(2009-8#1)
regulate the cell##3##3##(1994-11#1)(2008-11#1)(2012-3#1)
regulate the expression of##10##4##(1993-12#1)(1995-12#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-1#1)(2011-2#2)
regulate the gene expression##2##4##(2008-9#1)(2011-2#1)
regulate the##43##2##(1991-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-2#3)(2012-3#1)
regulate their##3##2##(1995-8#1)(2008-10#1)(2012-2#1)
regulate these##2##2##(1992-3#1)(2012-2#1)
regulate this##3##2##(2008-7#1)(2009-6#1)(2009-8#1)
regulate vascular tone##2##3##(1995-2#1)(2012-4#1)
regulate##149##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-3#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#6)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#3)(1996-2#5)(1997-1#1)(1997-2#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#14)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#7)(2008-9#6)(2009-10#2)(2009-12#2)(2009-6#2)(2009-8#7)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#9)(2012-12#1)(2012-2#17)(2012-3#4)(2012-4#1)(2013-1#6)(2013-8#2)
regulated and constitutive secretory##3##4##(1992-12#3)
regulated and constitutive##4##3##(1992-12#4)
regulated and##7##2##(1992-12#4)(1995-3#1)(2009-8#1)(2012-2#1)
regulated are##2##2##(2008-9#1)(2012-2#1)
regulated at the##2##3##(2009-6#1)(2013-1#1)
regulated at translation level##2##4##(2008-9#2)
regulated at##9##2##(2008-11#1)(2008-5#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-11#1)(2013-1#2)
regulated by Ca(2+)##2##3##(2008-8#2)
regulated by a complex##3##4##(2009-8#1)(2010-8#1)(2012-2#1)
regulated by a##10##3##(1990-9#1)(1994-12#1)(1997-1#1)(2008-11#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
regulated by carbon sources##2##4##(1991-9#2)
regulated by cell##2##3##(1995-8#1)(2010-7#1)
regulated by the##10##3##(1993-6#1)(1994-12#2)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
regulated by these##2##3##(1997-2#1)(1997-7#1)
regulated by two##3##3##(1995-8#1)(2008-9#1)(2011-2#1)
regulated by##88##2##(1990-9#1)(1991-5#1)(1991-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-8#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-3#1)(2009-6#2)(2009-8#8)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
regulated expression of##5##3##(1992-6#1)(1993-3#1)(1993-9#2)(2008-11#1)
regulated expression##6##2##(1992-6#1)(1993-3#1)(1993-9#2)(2008-11#2)
regulated has##2##2##(2008-11#1)(2008-9#1)
regulated in a##2##3##(1993-8#1)(1997-2#1)
regulated in response to##3##4##(1996-2#1)(2009-8#1)(2011-1#1)
regulated in the##5##3##(2008-10#3)(2010-12#1)(2011-2#1)
regulated in##19##2##(1993-8#1)(1994-11#2)(1996-2#2)(1997-2#1)(2008-10#4)(2008-4#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
regulated mainly##2##2##(1993-6#1)(2008-5#1)
regulated manner##3##2##(2009-8#1)(2012-2#1)(2012-3#1)
regulated or##2##2##(1991-12#1)(2008-8#1)
regulated processes##2##2##(2009-8#1)(2011-2#1)
regulated secretory granules##2##3##(1992-12#2)
regulated secretory##4##2##(1992-12#2)(1993-5#1)(2010-11#1)
regulated the expression of##2##4##(1997-7#1)(2008-11#1)
regulated the##7##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2013-1#1)
regulated through the##2##3##(1995-11#1)(2012-2#1)
regulated through##3##2##(1993-6#1)(1995-11#1)(2012-2#1)
regulated under##2##2##(1996-3#1)(2009-9#1)
regulated via##2##2##(1997-1#1)(2008-9#1)
regulated##231##1##(1990-9#1)(1991-12#2)(1991-5#4)(1991-9#2)(1992-12#6)(1992-3#1)(1992-6#3)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#5)(1994-2#1)(1994-8#3)(1995-11#5)(1995-12#1)(1995-2#6)(1995-3#1)(1995-6#3)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#16)(2008-11#15)(2008-12#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#12)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#3)(2009-8#17)(2009-9#3)(2010-11#6)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#9)(2012-2#12)(2012-3#2)(2013-1#9)(2013-8#2)
regulates ERK##2##2##(2009-8#1)(2010-10#1)
regulates a##2##2##(1995-12#1)(2008-11#1)
regulates gene##2##2##(1995-2#1)(2011-2#1)
regulates migration of##2##3##(1995-8#1)(2010-8#1)
regulates the##11##2##(1991-5#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
regulates##61##1##(1991-5#1)(1994-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#6)(2012-3#4)(2013-1#5)
regulating activity of##2##3##(1993-3#1)(1993-8#1)
regulating angiogenesis##3##2##(2008-9#2)(2013-1#1)
regulating cell##7##2##(1996-2#1)(2008-11#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-2#1)
regulating lipid##2##2##(2008-1#1)(2008-9#1)
regulating proteins##3##2##(2008-9#2)(2012-2#1)
regulating the expression of the##3##5##(1997-7#2)(1997-8#1)
regulating the expression of##7##4##(1997-7#2)(1997-8#1)(2008-8#1)(2010-7#1)(2011-2#1)(2011-3#1)
regulating the synthesis##2##3##(1997-8#1)(2013-1#1)
regulating the##36##2##(1994-11#2)(1994-5#1)(1996-12#1)(1997-3#1)(1997-7#2)(1997-8#2)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#4)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
regulating their##2##2##(1996-12#1)(2013-1#1)
regulating β-cell mass##2##3##(2010-11#2)
regulating##129##1##(1990-2#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#6)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#6)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#4)(1996-3#1)(1997-3#1)(1997-7#2)(1997-8#2)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#14)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#7)(2009-10#2)(2009-3#1)(2009-5#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-11#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-10#2)(2011-2#11)(2011-3#1)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#1)
regulation and apoptosis##4##3##(1995-2#3)(2011-2#1)
regulation and to##2##3##(1995-2#1)(2008-8#1)
regulation and##29##2##(1990-6#1)(1991-9#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-2#5)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#2)
regulation as well as##2##4##(2008-11#1)(2009-8#1)
regulation as##3##2##(1997-1#1)(2008-11#1)(2009-8#1)
regulation at##2##2##(2011-2#2)
regulation by 1alpha##2##3##(2008-11#2)
regulation by the##3##3##(1993-2#1)(1994-3#1)(2012-2#1)
regulation by##20##2##(1990-5#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
regulation can##2##2##(2008-11#1)(2013-1#1)
regulation effects##3##2##(2008-10#2)(2008-9#1)
regulation for##3##2##(1991-3#1)(2008-10#1)(2008-8#1)
regulation have##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
regulation in the##7##3##(1993-11#1)(1994-11#1)(1997-1#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-11#1)
regulation in##21##2##(1991-3#1)(1993-11#1)(1994-11#2)(1995-11#1)(1995-3#1)(1997-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-3#2)(2013-7#1)
regulation is##13##2##(1991-12#1)(1993-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#1)
regulation may##2##2##(1994-2#1)(2010-12#1)
regulation mechanisms of##2##3##(2008-11#1)(2008-7#1)
regulation mechanisms##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
regulation of APS reductase by##2##5##(2009-8#2)
regulation of PEPCK gene transcription##3##5##(1996-2#3)
regulation of PEPCK gene##5##4##(1996-2#5)
regulation of a##3##3##(1990-11#1)(1997-7#1)(2010-12#1)
regulation of angiogenesis##2##3##(2008-1#2)
regulation of blood##2##3##(1992-12#1)(2010-11#1)
regulation of cell cycle##2##4##(2009-3#1)(2012-3#1)
regulation of cell##4##3##(2008-11#1)(2009-3#1)(2009-8#1)(2012-3#1)
regulation of cellular##4##3##(1991-5#1)(2008-9#1)(2009-6#1)(2013-7#1)
regulation of energy##6##3##(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)
regulation of gastric function##2##4##(1992-6#2)
regulation of gastric##3##3##(1992-6#2)(1997-1#1)
regulation of gene expression##7##4##(1991-6#1)(1992-6#1)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
regulation of genes##2##3##(1996-12#1)(2012-12#1)
regulation of growth##3##3##(1994-8#2)(1995-11#1)
regulation of human##5##3##(1990-2#2)(1993-8#1)(1995-2#1)(2008-4#1)
regulation of immune##2##3##(2011-2#1)(2013-1#1)
regulation of intracellular##2##3##(1990-12#1)(2013-1#1)
regulation of many##2##3##(2008-5#1)(2009-4#1)
regulation of nuclear##2##3##(1994-5#1)(2009-6#1)
regulation of proliferation##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
regulation of protein kinase C activity##2##6##(1990-5#1)(1990-8#1)
regulation of protein##4##3##(1990-5#1)(1990-8#1)(1996-2#1)(2008-11#1)
regulation of synaptic##2##3##(1996-12#1)(2012-2#1)
regulation of the expression of##2##5##(1993-9#1)(2008-9#1)
regulation of the gene##2##4##(1991-5#1)(1993-12#1)
regulation of the human##3##4##(1994-8#1)(2008-11#1)(2008-8#1)
regulation of the metabolism of##2##5##(1992-11#1)(1993-6#1)
regulation of the##52##3##(1990-2#1)(1991-5#1)(1992-11#1)(1993-12#2)(1993-2#1)(1993-6#5)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#3)(1996-12#4)(1997-1#1)(2008-1#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
regulation of their##2##3##(1994-11#1)(2011-2#1)
regulation of these two##2##4##(1991-5#1)(2009-8#1)
regulation of these##4##3##(1991-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
regulation of this##2##3##(1994-11#1)(2011-2#1)
regulation of various biological##2##4##(2008-11#1)(2008-9#1)
regulation of##333##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#7)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#9)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#7)(1993-8#6)(1993-9#1)(1994-11#8)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#6)(1995-11#8)(1995-12#4)(1995-2#6)(1995-6#2)(1995-8#7)(1996-12#10)(1996-2#15)(1996-3#1)(1997-1#5)(1997-2#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#3)(2008-10#5)(2008-11#29)(2008-12#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#18)(2008-8#14)(2008-9#12)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#12)(2009-9#2)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#21)(2011-3#2)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#13)(2013-7#4)(2013-8#4)
regulation on##3##2##(1995-2#1)(2010-7#1)(2011-2#1)
regulation properties##2##2##(2008-10#1)(2009-10#1)
regulation remains to be##2##4##(1995-2#1)(2008-9#1)
regulation requires##2##2##(2008-4#1)(2012-3#1)
regulation systems##4##2##(1991-5#1)(2008-10#1)(2008-11#2)
regulation to##2##2##(1996-3#1)(1997-7#1)
regulation using##2##2##(1995-11#1)(2013-8#1)
regulation was##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
regulation which##2##2##(1994-6#1)(2008-11#1)
regulation##575##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#7)(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#5)(1991-5#12)(1991-6#2)(1991-7#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#10)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#9)(1993-8#9)(1993-9#1)(1994-1#1)(1994-11#12)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#1)(1995-11#13)(1995-12#6)(1995-2#15)(1995-3#2)(1995-6#5)(1995-8#8)(1996-12#10)(1996-2#18)(1996-3#3)(1997-1#7)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#3)(1997-9#2)(2006-6#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#52)(2008-12#1)(2008-4#9)(2008-5#3)(2008-6#5)(2008-7#25)(2008-8#31)(2008-9#33)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#7)(2009-7#3)(2009-8#20)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#6)(2010-3#1)(2010-5#1)(2010-7#4)(2010-8#3)(2011-1#5)(2011-2#38)(2011-3#3)(2012-12#2)(2012-2#13)(2012-3#12)(2013-1#19)(2013-7#6)(2013-8#8)
regulation)##4##1##(1991-1#1)(1993-12#1)(2008-11#1)(2009-10#1)
regulations and##8##2##(1991-1#1)(1991-12#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2013-1#1)
regulations are##5##2##(1993-12#1)(1993-3#1)(1995-9#1)(2008-11#1)(2012-3#1)
regulations concerning##2##2##(1991-11#1)(1995-2#1)
regulations of the##2##3##(2008-11#1)(2012-3#1)
regulations of##3##2##(2008-11#2)(2012-3#1)
regulations on##4##2##(1990-2#1)(1991-2#1)(1995-2#2)
regulations such as those imposed by the USP##2##8##(2012-2#2)
regulations##57##1##(1990-2#3)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1993-11#1)(1993-12#1)(1993-3#4)(1994-2#1)(1995-11#1)(1995-2#7)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#8)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
regulations'##2##1##(1994-2#1)(2008-11#1)
regulative##4##1##(2008-11#1)(2008-9#2)(2009-6#1)
regulator (Fur) protein##2##3##(1997-7#1)(2009-6#1)
regulator for##2##2##(2008-11#1)(2011-2#1)
regulator in##2##2##(1993-12#1)(2008-11#1)
regulator of angiogenesis##2##3##(2013-1#1)(2013-8#1)
regulator of cell##4##3##(1995-12#1)(2008-11#1)(2009-10#1)(2013-1#1)
regulator of the##4##3##(1991-9#1)(2008-11#1)(2008-9#1)(2009-8#1)
regulator of##27##2##(1991-9#1)(1994-12#1)(1995-12#2)(1995-2#2)(1997-4#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
regulator that##2##2##(2009-8#1)(2012-2#1)
regulator which##2##2##(1991-12#1)(2008-8#1)
regulator##53##1##(1991-12#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-12#2)(1995-2#2)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#4)(2009-8#4)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
regulators and##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
regulators in##2##2##(2009-8#1)(2013-1#1)
regulators of##18##2##(1995-12#1)(1995-2#3)(1995-8#1)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#3)(2010-4#1)(2011-2#3)(2012-2#2)(2013-1#1)
regulators or##3##2##(2008-9#1)(2012-2#2)
regulators##56##1##(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#5)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-2#6)(2012-3#1)(2013-1#4)
regulatory T cells##8##3##(2010-5#1)(2011-2#5)(2012-3#1)(2013-8#1)
regulatory T##10##2##(2010-5#1)(2011-2#7)(2012-3#1)(2013-8#1)
regulatory agencies##8##2##(1992-2#1)(1992-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2012-2#1)
regulatory and##6##2##(1991-3#1)(1993-3#1)(2008-11#1)(2010-11#1)(2010-5#1)(2013-7#1)
regulatory aspects##2##2##(2008-11#1)(2009-9#1)
regulatory authorities##2##2##(2008-10#1)(2008-11#1)
regulatory binding sites##2##3##(1993-8#1)(2008-11#1)
regulatory binding##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
regulatory bodies##3##2##(2008-10#1)(2008-11#2)
regulatory cascade##2##2##(1994-8#1)(2009-9#1)
regulatory changes##2##2##(1991-3#1)(2008-11#1)
regulatory control##3##2##(1994-1#1)(1994-11#1)(1996-12#1)
regulatory domain##4##2##(1995-6#1)(1997-6#1)(2011-3#1)(2012-2#1)
regulatory elements in##5##3##(1993-12#3)(1993-6#1)(2008-7#1)
regulatory elements with##2##3##(1995-2#1)(2008-11#1)
regulatory elements##23##2##(1991-7#1)(1993-12#7)(1993-6#4)(1995-2#3)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)
regulatory environment##4##2##(2008-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
regulatory factor##2##2##(2008-10#1)(2012-3#1)
regulatory factors##4##2##(1991-5#1)(1993-12#1)(1995-6#2)
regulatory focus theory##2##3##(2009-6#2)
regulatory focus##3##2##(2009-6#3)
regulatory function of##2##3##(2008-8#1)(2008-9#1)
regulatory function##4##2##(1991-5#1)(2008-8#1)(2008-9#2)
regulatory functions##2##2##(1993-2#1)(2010-11#1)
regulatory gene##7##2##(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2011-1#1)
regulatory genes##5##2##(1993-9#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
regulatory impacts##2##2##(1996-1#2)
regulatory issues##2##2##(1995-5#2)
regulatory level##2##2##(2008-10#2)
regulatory limit##2##2##(2008-10#2)
regulatory loop##5##2##(1995-6#1)(2011-1#2)(2011-2#2)
regulatory mechanism of##2##3##(1992-8#1)(2013-1#1)
regulatory mechanism##6##2##(1992-8#1)(1996-12#1)(2008-2#1)(2008-8#1)(2011-10#1)(2013-1#1)
regulatory mechanisms are##2##3##(2008-11#1)(2013-8#1)
regulatory mechanisms of gene##2##4##(2007-12#1)(2011-2#1)
regulatory mechanisms of##4##3##(2007-12#1)(2008-11#1)(2011-2#2)
regulatory mechanisms##13##2##(1992-12#1)(1994-8#1)(2007-12#1)(2008-11#4)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
regulatory molecules##5##2##(1990-9#1)(1991-2#1)(2008-1#1)(2008-11#1)(2013-1#1)
regulatory motifs##3##2##(1992-3#2)(2008-11#1)
regulatory network##7##2##(2008-5#1)(2008-7#2)(2010-10#1)(2010-4#1)(2011-2#2)
regulatory networks in##2##3##(2008-7#1)(2011-2#1)
regulatory networks##10##2##(2008-11#4)(2008-7#2)(2010-10#2)(2010-4#1)(2011-2#1)
regulatory pathway in##2##3##(2007-12#1)(2008-11#1)
regulatory pathway##4##2##(1994-6#1)(1995-2#1)(2007-12#1)(2008-11#1)
regulatory pathways##3##2##(1994-5#1)(2012-2#1)(2012-3#1)
regulatory properties of##2##3##(1990-5#1)(1997-6#1)
regulatory properties##3##2##(1990-5#1)(1997-6#1)(1997-7#1)
regulatory protein##6##2##(1995-12#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-1#1)
regulatory proteins and transcriptional factors##2##5##(2008-9#2)
regulatory proteins and##3##3##(1997-8#1)(2008-9#2)
regulatory proteins##18##2##(1993-8#1)(1993-9#1)(1994-3#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2011-1#1)(2012-2#3)(2013-7#1)
regulatory region of##3##3##(1990-7#1)(2008-11#1)(2008-4#1)
regulatory region##7##2##(1990-7#1)(2008-11#4)(2008-4#1)(2008-8#1)
regulatory regions of##2##3##(2008-11#2)
regulatory regions##5##2##(1992-6#1)(2008-11#4)
regulatory requirements and##3##3##(2008-11#1)(2010-11#1)(2011-2#1)
regulatory requirements##4##2##(1991-12#1)(2008-11#1)(2010-11#1)(2011-2#1)
regulatory role for##3##3##(1991-5#1)(1993-8#1)(1995-6#1)
regulatory role in the##3##4##(1993-3#1)(2008-2#1)(2008-7#1)
regulatory role of##4##3##(1995-2#1)(2009-12#1)(2012-12#1)(2012-2#1)
regulatory role##11##2##(1991-5#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(2008-2#1)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
regulatory roles##3##2##(1995-8#1)(2009-6#1)(2010-1#1)
regulatory sequence##4##2##(1994-12#1)(1994-3#1)(2008-11#1)(2008-9#1)
regulatory sequences##5##2##(1995-2#2)(1995-8#1)(1997-7#1)(2008-7#1)
regulatory sites##2##2##(1993-8#1)(1997-9#1)
regulatory subunit of##3##3##(1990-2#1)(1995-2#1)(1997-1#1)
regulatory subunit##6##2##(1990-2#3)(1995-2#1)(1997-1#1)(2011-2#1)
regulatory system##3##2##(1996-12#1)(2008-11#1)(2008-4#1)
regulatory systems##5##2##(1996-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2008-9#1)
regulatory##346##1##(1990-2#4)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#10)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#5)(1993-9#3)(1994-1#2)(1994-11#5)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#5)(1995-2#12)(1995-3#1)(1995-5#2)(1995-6#7)(1995-8#4)(1996-1#4)(1996-12#5)(1996-2#1)(1997-1#5)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#2)(2007-12#4)(2008-1#1)(2008-10#30)(2008-11#49)(2008-12#2)(2008-2#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#14)(2008-8#8)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#20)(2011-3#1)(2012-12#1)(2012-2#10)(2012-3#9)(2013-1#5)(2013-7#2)(2013-8#6)
regulon##3##1##(1995-6#1)(2011-2#2)
regurgitation##17##1##(1997-5#2)(1997-8#5)(2008-11#3)(2009-10#2)(2010-5#2)(2010-7#2)(2013-1#1)
regúlate the##2##2##(2013-8#2)
rehabilitated##3##1##(1996-6#1)(2010-10#1)(2010-5#1)
rehabilitation (PR)##2##2##(2010-1#1)(2013-8#1)
rehabilitation after##5##2##(1991-12#1)(1997-2#1)(2010-10#1)(2010-4#1)(2013-1#1)
rehabilitation and reintegration##2##3##(1990-9#1)(1992-3#1)
rehabilitation and##13##2##(1990-9#1)(1991-12#2)(1992-3#1)(1993-12#1)(1995-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2013-1#3)
rehabilitation as##2##2##(1994-5#1)(2013-1#1)
rehabilitation center##3##2##(1992-1#1)(1993-1#2)
rehabilitation for##3##2##(2008-7#1)(2013-1#2)
rehabilitation in patients##2##3##(2013-1#2)
rehabilitation in##5##2##(1992-3#1)(2010-10#1)(2013-1#3)
rehabilitation of a##2##3##(2011-2#1)(2013-1#1)
rehabilitation of patients with##2##4##(2013-1#2)
rehabilitation of the##4##3##(1992-12#1)(1995-2#1)(2008-10#1)(2009-3#1)
rehabilitation of##17##2##(1992-12#1)(1992-3#1)(1995-2#1)(2008-10#2)(2009-3#1)(2010-10#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-3#2)(2013-1#5)
rehabilitation patients##2##2##(1993-12#1)(2013-1#1)
rehabilitation professionals##2##2##(1992-3#1)(2008-9#1)
rehabilitation program##5##2##(1995-3#1)(2008-7#1)(2013-1#3)
rehabilitation programme##6##2##(2008-10#1)(2008-9#1)(2010-10#1)(2013-1#3)
rehabilitation programmes##2##2##(1996-11#1)(1997-8#1)
rehabilitation programs##3##2##(1992-3#1)(1993-3#1)(2013-1#1)
rehabilitation services##2##2##(1991-6#1)(1994-3#1)
rehabilitation sessions##2##2##(2008-9#2)
rehabilitation should be##2##3##(2010-10#1)(2013-1#1)
rehabilitation specialists##2##2##(1993-3#1)(2013-1#1)
rehabilitation strategies after rotator cuff repair##2##6##(2013-1#2)
rehabilitation strategies##3##2##(2008-8#1)(2013-1#2)
rehabilitation to##2##2##(1995-12#1)(2008-10#1)
rehabilitation treatment##2##2##(2013-1#2)
rehabilitation was##2##2##(2008-9#1)(2013-1#1)
rehabilitation with##2##2##(2010-10#1)(2011-2#1)
rehabilitation##160##1##(1990-9#1)(1991-11#1)(1991-12#7)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#8)(1993-1#3)(1993-12#5)(1993-3#3)(1993-6#3)(1994-12#2)(1994-3#2)(1994-5#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#1)(1996-11#2)(1996-3#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-7#4)(2008-8#3)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-10#9)(2010-4#1)(2010-7#2)(2010-9#3)(2011-2#5)(2011-3#1)(2011-7#1)(2012-2#3)(2012-3#3)(2013-1#44)(2013-8#1)
rehabilitation]##2##1##(1993-6#1)(2008-11#1)
rehabilitative programme##3##2##(2008-10#3)
rehabilitative##12##1##(2008-10#4)(2008-9#3)(2013-1#5)
rehydration##5##1##(1990-3#1)(1992-5#1)(2008-10#1)(2011-1#1)(2013-1#1)
rei##2##1##(2008-10#2)
reimbursed##5##1##(1990-9#1)(1991-1#1)(1995-3#1)(1997-1#1)(2012-12#1)
reimbursement and##2##2##(1991-3#1)(1994-1#1)
reimbursement for partial##2##3##(1991-1#1)(1992-1#1)
reimbursement for##10##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1994-2#1)(1996-3#1)(1997-1#2)(2008-11#1)(2011-2#1)
reimbursement in##2##2##(1992-12#1)(2011-2#1)
reimbursement is##2##2##(1994-2#1)(1996-12#1)
reimbursement of##2##2##(1993-12#1)(1995-1#1)
reimbursement patterns##3##2##(1992-2#1)(1995-3#2)
reimbursement policy##2##2##(2008-11#1)(2012-3#1)
reimbursement rates##4##2##(1993-12#3)(1997-2#1)
reimbursement system##2##2##(1991-2#1)(1993-12#1)
reimbursement to the prospective payment system##2##6##(1991-2#1)(1991-3#1)
reimbursement to##5##2##(1991-1#2)(1991-2#1)(1991-3#1)(1996-3#1)
reimbursement##56##1##(1991-1#4)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#2)(1993-12#5)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#4)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#4)(1997-2#1)(2007-12#1)(2008-11#4)(2011-2#2)(2012-3#1)
reimbursements##4##1##(1991-1#1)(1997-2#1)(2011-7#1)(2012-3#1)
reimplantation and##2##2##(2008-9#2)
reimplantation##10##1##(2008-10#1)(2008-9#7)(2012-2#1)(2013-1#1)
reimplanted##3##1##(2008-10#1)(2008-5#1)(2008-9#1)
reinforce the##5##2##(1995-1#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-9#1)
reinforce##13##1##(1994-2#1)(1995-1#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
reinforced by the##3##3##(1996-2#1)(2009-7#1)(2009-8#1)
reinforced by##6##2##(1990-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)
reinforced polycarbonate##2##2##(2009-11#2)
reinforced##18##1##(1990-3#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-2#2)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2009-7#1)(2009-8#1)(2010-8#2)
reinforcement and##5##2##(1993-6#3)(1994-2#1)(2009-7#1)
reinforcement mechanisms##3##2##(2009-7#2)(2012-3#1)
reinforcement of##6##2##(1991-1#1)(1992-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
reinforcement##36##1##(1991-1#1)(1992-12#1)(1993-6#11)(1994-2#2)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
reinforcer##7##1##(1993-6#3)(1996-5#1)(1997-7#2)(2008-5#1)
reinforcers##4##1##(1991-1#1)(1993-6#1)(1996-5#1)(2009-10#1)
reinforces the##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
reinforces##8##1##(1993-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
reinforcing and##3##2##(1993-6#1)(1994-2#1)(2013-1#1)
reinforcing effects##2##2##(1994-2#1)(1994-8#1)
reinforcing##14##1##(1991-1#1)(1993-6#3)(1994-2#2)(1994-8#1)(2008-12#1)(2009-10#1)(2009-6#1)(2009-7#2)(2010-10#1)(2013-1#1)
reinhardti##3##1##(2008-7#2)(2008-9#1)
reinhardtii##5##1##(2009-10#3)(2012-3#2)
reinjection##4##1##(1992-5#3)(2013-1#1)
reinnervation of CGRP(+) IENFs##2##4##(2013-8#2)
reinnervation of##3##2##(2013-8#3)
reinnervation##4##1##(2013-8#4)
reinsurance##2##1##(1991-12#1)(1995-2#1)
reintegration##3##1##(1990-9#1)(1992-1#1)(1992-3#1)
reintroduced##3##1##(1990-3#1)(1991-12#1)(2010-1#1)
reintroduction of##2##2##(1994-5#1)(1997-7#1)
reinvestigated##5##1##(1991-5#1)(1992-12#1)(1994-11#1)(2008-10#1)(2011-2#1)
reirradiation##2##1##(2008-10#2)
reisolated from##2##2##(2008-10#2)
reisolated##3##1##(1997-3#1)(2008-10#2)
reisolation##2##1##(2008-10#2)
reiterative##2##1##(2008-11#1)(2009-6#1)
reject the##8##2##(1995-5#1)(2008-10#5)(2008-7#1)(2008-9#1)
reject##15##1##(1990-2#1)(1995-5#2)(1996-5#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)
rejected an##3##2##(1995-12#1)(1995-6#2)
rejected by##2##2##(2008-10#1)(2008-8#1)
rejected for##3##2##(1991-1#1)(2008-10#1)(2012-3#1)
rejected the##5##2##(1995-6#3)(1996-5#1)(2008-10#1)
rejected##28##1##(1991-1#1)(1995-12#4)(1995-6#5)(1996-5#2)(2008-10#7)(2008-8#2)(2008-9#2)(2010-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
rejecting the##3##2##(1991-12#1)(1993-1#1)(1996-5#1)
rejecting##4##1##(1991-12#1)(1993-1#1)(1996-5#1)(2012-12#1)
rejection after##3##2##(1993-2#1)(1994-3#1)(2008-10#1)
rejection and##3##2##(2008-10#1)(2008-5#1)(2011-3#1)
rejection of the hypothesis##2##4##(1995-5#1)(2008-9#1)
rejection of the##5##3##(1995-5#1)(2008-10#2)(2008-8#1)(2008-9#1)
rejection of##13##2##(1995-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-3#1)
rejection##38##1##(1991-11#1)(1993-2#3)(1994-3#1)(1994-5#1)(1995-5#1)(1997-5#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-3#2)(2012-2#1)(2012-3#2)
rejections##4##1##(1997-5#1)(2010-8#3)
rejects##3##1##(1995-6#1)(1996-5#1)(2008-10#1)
rejuvenation##5##1##(2008-5#1)(2008-7#4)
relapse and##3##2##(1992-3#1)(1993-1#1)(1997-5#1)
relapse in##2##2##(1994-5#1)(2009-7#1)
relapse of the##2##3##(1990-6#1)(2009-11#1)
relapse of##5##2##(1990-6#1)(2009-11#1)(2013-1#2)(2013-8#1)
relapse or##2##2##(1991-1#1)(2010-12#1)
relapse rate##2##2##(1996-11#1)(2008-1#1)
relapse triggers##4##2##(2009-9#4)
relapse##49##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-5#2)(1994-6#1)(1996-11#2)(1997-5#1)(1997-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#3)(2009-7#1)(2009-9#7)(2010-12#2)(2011-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
relapse-free survival##3##2##(1990-8#1)(1994-12#1)(2012-3#1)
relapse-free##4##1##(1990-8#1)(1994-12#1)(1995-12#1)(2012-3#1)
relapsed after##3##2##(1990-8#1)(2008-1#1)(2011-2#1)
relapsed##13##1##(1990-12#1)(1990-8#1)(1991-4#1)(1991-6#1)(1994-5#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#2)(2011-2#1)(2013-7#1)
relapsed/refractory CLL##2##2##(2009-12#2)
relapsed/refractory patients##2##2##(2011-2#2)
relapsed/refractory##6##1##(1994-12#1)(2009-12#3)(2011-2#2)
relapses and##3##2##(1991-6#1)(1996-11#1)(2013-8#1)
relapses##14##1##(1990-3#2)(1990-9#1)(1991-6#1)(1994-6#1)(1996-11#2)(2008-1#2)(2010-11#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
relapsing and demyelinating##2##3##(1995-12#2)
relapsing patients##3##2##(1991-2#3)
relapsing##16##1##(1991-2#6)(1993-3#1)(1993-8#1)(1995-12#3)(2009-7#1)(2010-12#1)(2012-3#2)(2013-7#1)
relate directly to##2##3##(2008-10#1)(2008-9#1)
relate it##2##2##(2008-10#1)(2011-2#1)
relate these##3##2##(2008-8#1)(2010-4#1)(2013-1#1)
relate to the##10##3##(1991-2#1)(1996-12#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)
relate to##31##2##(1990-5#1)(1990-6#1)(1991-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-9#2)(2011-2#2)(2012-5#1)
relate##70##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-3#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#14)(2008-11#9)(2008-12#3)(2008-2#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-7#1)(2009-8#1)(2010-4#1)(2010-9#2)(2011-2#4)(2012-2#3)(2012-5#1)(2013-1#1)(2013-8#1)
related DNA##2##2##(1996-2#1)(2008-9#1)
related P##2##2##(2008-10#1)(2008-5#1)
related Quercus##2##2##(2012-5#2)
related TCAA##2##2##(2008-10#2)
related and##6##2##(1993-1#1)(1994-2#1)(2008-10#2)(2008-6#1)(2010-7#1)
related but##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
related by##2##2##(1991-12#1)(1993-8#1)
related changes in the##4##4##(1990-11#3)(2010-8#1)
related changes in##5##3##(1990-11#3)(2010-8#1)(2011-2#1)
related changes of##2##3##(1994-3#1)(2011-2#1)
related changes##9##2##(1990-11#3)(1994-3#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#2)
related complexes##2##2##(1992-4#1)(2008-10#1)
related compound##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
related compounds and##2##3##(2008-10#1)(2008-5#1)
related compounds on##4##3##(2008-11#4)
related compounds were##2##3##(2008-10#1)(2008-11#1)
related compounds##25##2##(2007-12#1)(2008-10#16)(2008-11#7)(2008-5#1)
related directly##2##2##(1993-6#1)(2012-3#1)
related diseases##2##2##(2008-9#1)(2013-8#1)
related disorders##12##2##(1992-6#2)(1996-8#1)(2008-11#2)(2008-12#5)(2008-3#1)(2012-2#1)
related effects##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
related either to##2##3##(1991-8#1)(1994-3#1)
related events##4##2##(1991-2#2)(2008-11#1)(2008-7#1)
related factors##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
related forms of##2##3##(1990-12#1)(1995-11#1)
related fungi##5##2##(2008-10#4)(2008-5#1)
related gene (protein)##3##3##(2011-3#3)
related gene##5##2##(2008-8#2)(2011-3#3)
related genes##3##2##(1994-11#1)(2008-4#1)(2008-9#1)
related genus##2##2##(2008-6#2)
related growth factors##3##3##(1991-3#2)(2010-8#1)
related impairments##8##2##(2011-1#8)
related in part to##2##4##(1990-8#1)(2009-10#1)
related in##3##2##(1990-8#1)(2008-10#1)(2009-10#1)
related isolates##3##2##(2008-10#1)(2011-2#2)
related issues##4##2##(2008-11#1)(2008-5#1)(2009-9#1)(2012-3#1)
related mainly to##2##3##(2008-10#2)
related minor##2##2##(2008-10#1)(2013-1#1)
related more to##2##3##(1995-2#1)(2009-5#1)
related only to the##2##4##(1991-2#1)(2008-10#1)
related parameters##3##2##(2008-10#1)(2010-5#1)(2011-3#1)
related peptide##5##2##(1994-2#3)(2013-7#2)
related peptides##2##2##(1992-6#1)(1994-3#1)
related potentials##2##2##(2008-11#2)
related primarily to##2##3##(1994-2#1)(2009-3#1)
related problems##5##2##(2008-10#2)(2008-11#1)(2010-7#1)(2013-8#1)
related protein##4##2##(1990-11#1)(1995-6#1)(1997-7#1)(2008-9#1)
related proteins##7##2##(1990-5#1)(1991-5#1)(1995-6#1)(1997-7#1)(2008-10#3)
related sequences##2##2##(1993-2#1)(1994-11#1)
related species were##2##3##(2008-10#2)
related species##24##2##(1991-5#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-8#4)(2012-3#1)(2013-8#1)
related strains##2##2##(2008-4#1)(2011-2#1)
related structures##3##2##(1993-6#1)(2010-6#1)(2012-3#1)
related substances##3##2##(2008-10#3)
related taxonomic traits were##3##4##(2008-8#3)
related taxonomic traits##4##3##(2008-8#4)
related to E##2##3##(2008-10#2)
related to EPS##2##3##(2011-2#2)
related to SA##2##3##(2008-10#2)
related to a decrease in the##2##6##(1990-5#1)(2008-10#1)
related to a deficiency in##3##5##(2013-1#3)
related to a particular##2##4##(2008-12#1)(2012-12#1)
related to a##21##3##(1990-5#1)(1991-8#1)(1992-6#1)(1994-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-9#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
related to abnormal induction of sister chromatid exchanges##2##8##(1997-7#2)
related to age at##2##4##(1994-6#1)(2008-9#1)
related to age##3##3##(1992-2#1)(1994-6#1)(2008-9#1)
related to an##7##3##(1990-5#1)(1990-8#1)(1996-6#1)(2008-10#2)(2008-5#1)(2012-2#1)
related to average##2##3##(2008-10#1)(2008-9#1)
related to being a successful##2##5##(2012-3#2)
related to better health##2##4##(2010-2#2)
related to better##3##3##(2010-2#2)(2011-2#1)
related to both##2##3##(1992-9#1)(2008-5#1)
related to breast cancer##2##4##(1990-8#1)(1997-1#1)
related to cardiovascular##2##3##(2010-6#1)(2011-2#1)
related to cell##3##3##(1990-5#1)(2008-9#1)(2011-1#1)
related to cerebral##2##3##(2011-2#1)(2013-1#1)
related to change##2##3##(1994-6#1)(2012-12#1)
related to changes in##4##4##(1991-8#1)(2008-10#2)(2012-7#1)
related to concentration of##2##4##(2008-10#2)
related to delayed##2##3##(2008-7#1)(2008-8#1)
related to differences in##4##4##(1994-5#1)(2008-10#1)(2008-5#1)(2009-7#1)
related to different##3##3##(2008-3#1)(2009-10#1)(2010-12#1)
related to disease##2##3##(2007-12#1)(2008-10#1)
related to drought##2##3##(2008-10#1)(2012-7#1)
related to drug##2##3##(1991-3#1)(2012-2#1)
related to each other and##2##5##(2008-10#1)(2008-5#1)
related to each other##6##4##(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
related to each##10##3##(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
related to either##2##3##(1995-1#1)(2008-11#1)
related to exposure##2##3##(1990-5#1)(1995-2#1)
related to family##2##3##(2008-7#1)(2009-10#1)
related to feeding##2##3##(2010-6#1)(2011-2#1)
related to gender or##2##4##(1994-6#1)(2013-1#1)
related to gender##5##3##(1994-6#1)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#1)
related to genetic##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
related to groups based##2##4##(1991-3#1)(2008-10#1)
related to health##2##3##(1997-3#1)(2010-11#1)
related to higher##2##3##(1992-3#1)(2009-7#1)
related to home##2##3##(1991-12#1)(1995-3#1)
related to human##4##3##(1996-12#1)(2008-11#1)(2008-8#1)(2013-8#1)
related to hydraulic conductance##2##4##(2008-10#1)(2009-8#1)
related to increased##2##3##(2009-9#1)(2011-1#1)
related to individual##2##3##(2008-11#1)(2010-10#1)
related to initial##2##3##(2008-10#1)(2008-9#1)
related to it##2##3##(1996-6#1)(2012-3#1)
related to its##7##3##(1995-8#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)
related to loss of##2##4##(1992-2#1)(2008-10#1)
related to low##3##3##(2008-10#1)(2009-10#1)(2013-1#1)
related to lower levels of##2##5##(2009-7#2)
related to managed care##2##4##(1995-12#1)(1997-2#1)
related to multiple##3##3##(2008-11#2)(2012-2#1)
related to other##2##3##(2008-10#2)
related to people's satisfaction##3##4##(2010-2#3)
related to physical##5##3##(2008-12#1)(2009-11#1)(2009-7#1)(2010-3#1)(2010-6#1)
related to plant##3##3##(2008-8#2)(2008-9#1)
related to population##2##3##(1996-3#1)(2008-9#1)
related to postoperative##2##3##(2008-7#2)
related to prolonged##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
related to public##2##3##(1996-2#1)(2008-7#1)
related to rainfall##2##3##(2008-10#2)
related to respiratory##2##3##(2008-10#1)(2010-5#1)
related to several##3##3##(2008-10#2)(2012-3#1)
related to sexual##2##3##(2008-9#1)(2013-1#1)
related to social##2##3##(2008-4#1)(2010-1#1)
related to socioeconomic##2##3##(1994-6#2)
related to stocking rate##2##4##(1996-12#2)
related to students'##2##3##(2008-12#2)
related to such##2##3##(2008-10#1)(2010-1#1)
related to suicide##2##3##(1996-1#2)
related to that of##2##4##(2008-10#1)(2008-12#1)
related to the ability of the##2##6##(2008-10#2)
related to the ability of##3##5##(2008-10#2)(2013-8#1)
related to the amount of##3##5##(1994-11#1)(2008-10#1)(2008-8#1)
related to the application of##2##5##(2008-10#1)(2011-1#1)
related to the availability of##2##5##(1994-3#1)(2012-2#1)
related to the concentration of##8##5##(2008-10#8)
related to the content of##2##5##(2008-10#2)
related to the decrease of##2##5##(2008-10#2)
related to the degree of##3##5##(1991-7#1)(2008-10#2)
related to the different##2##4##(1997-7#1)(2008-7#1)
related to the dose##2##4##(1992-12#1)(2009-8#1)
related to the duration of##2##5##(2008-10#2)
related to the energy transfer##2##5##(2008-10#2)
related to the energy##3##4##(1995-11#1)(2008-10#2)
related to the establishment of##2##5##(1994-5#1)(2008-11#1)
related to the exposure to##2##5##(1991-12#1)(2011-2#1)
related to the formation of##2##5##(2008-10#1)(2008-7#1)
related to the formation##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
related to the function of the##2##6##(2008-4#1)(2008-7#1)
related to the glucose concentration##3##5##(2008-10#3)
related to the increased##2##4##(1994-5#1)(2008-10#1)
related to the magnitude of the##2##6##(1990-5#1)(2013-8#1)
related to the magnitude of##5##5##(1990-11#1)(1990-5#1)(1990-8#1)(2010-5#1)(2013-8#1)
related to the organization##2##4##(1994-2#1)(2011-1#1)
related to the potential##2##4##(2008-10#2)
related to the presence of##6##5##(1996-12#1)(2008-10#3)(2008-11#1)(2013-7#1)
related to the properties of##2##5##(1992-3#1)(2008-11#1)
related to the size of the##2##6##(1991-11#1)(1996-12#1)
related to the structure of##2##5##(2008-10#2)
related to the structure##3##4##(2008-10#2)(2008-9#1)
related to the total##2##4##(1991-12#1)(2008-5#1)
related to the unique##2##4##(2008-10#1)(2009-11#1)
related to the vaccine##2##4##(1990-3#1)(2013-8#1)
related to the##302##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#4)(1990-8#2)(1991-11#2)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-8#3)(1996-1#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#100)(2008-11#16)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#11)(2008-7#10)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#3)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#4)
related to their degree of##2##5##(1995-3#1)(1997-3#1)
related to their##16##3##(1991-2#1)(1995-1#2)(1995-3#1)(1997-3#1)(2008-10#6)(2008-8#1)(2008-9#2)(2011-2#1)(2013-7#1)
related to thermographic results##2##4##(1993-11#2)
related to these two##2##4##(2008-10#1)(2008-11#1)
related to these##7##3##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#1)
related to those##3##3##(2008-10#3)
related to treatment##2##3##(2008-4#1)(2010-11#1)
related to type##2##3##(1990-8#1)(2008-10#1)
related to##920##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#10)(1990-8#6)(1991-11#2)(1991-12#9)(1991-2#3)(1991-3#6)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#2)(1992-12#6)(1992-2#7)(1992-3#5)(1992-6#6)(1992-9#1)(1993-11#3)(1993-12#3)(1993-3#3)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#4)(1994-5#5)(1994-6#6)(1994-8#4)(1995-1#4)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#7)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#12)(1996-2#2)(1996-3#2)(1996-6#4)(1996-8#1)(1997-1#4)(1997-2#8)(1997-3#4)(1997-7#4)(1997-8#3)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#239)(2008-11#48)(2008-12#16)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#24)(2008-6#1)(2008-7#32)(2008-8#25)(2008-9#42)(2009-1#1)(2009-10#10)(2009-11#3)(2009-12#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#9)(2009-8#8)(2009-9#3)(2010-1#8)(2010-10#10)(2010-11#8)(2010-12#8)(2010-2#7)(2010-3#3)(2010-4#3)(2010-5#7)(2010-6#5)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#13)(2011-10#1)(2011-2#46)(2011-3#3)(2012-12#8)(2012-2#11)(2012-3#21)(2012-5#1)(2012-7#2)(2013-1#28)(2013-7#4)(2013-8#14)
related with a better working memory##2##6##(2012-3#2)
related with a##4##3##(2011-2#1)(2012-2#1)(2012-3#2)
related with the##7##3##(1991-11#1)(2008-10#4)(2008-11#1)(2012-3#1)
related with##27##2##(1991-11#1)(1993-12#1)(1996-2#1)(2008-10#11)(2008-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-8#1)
related##1454##1##(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#11)(1990-8#8)(1991-1#1)(1991-11#3)(1991-12#11)(1991-2#8)(1991-3#12)(1991-5#3)(1991-6#6)(1991-7#2)(1991-8#3)(1992-1#1)(1992-12#9)(1992-2#9)(1992-3#5)(1992-4#1)(1992-6#10)(1992-7#1)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#9)(1993-2#2)(1993-3#3)(1993-6#10)(1993-8#6)(1993-9#1)(1994-1#1)(1994-11#7)(1994-12#6)(1994-2#10)(1994-3#8)(1994-5#6)(1994-6#7)(1994-8#4)(1995-1#4)(1995-11#5)(1995-12#8)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#8)(1995-8#9)(1995-9#1)(1996-1#7)(1996-11#1)(1996-12#15)(1996-2#8)(1996-3#2)(1996-5#3)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#6)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#3)(1997-9#1)(2006-6#1)(2007-12#4)(2008-1#4)(2008-10#387)(2008-11#82)(2008-12#35)(2008-2#3)(2008-3#14)(2008-4#13)(2008-5#39)(2008-6#4)(2008-7#42)(2008-8#44)(2008-9#54)(2009-1#2)(2009-10#15)(2009-11#3)(2009-12#5)(2009-3#5)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#10)(2009-8#12)(2009-9#4)(2010-1#8)(2010-10#12)(2010-11#10)(2010-12#11)(2010-2#7)(2010-3#6)(2010-4#4)(2010-5#8)(2010-6#7)(2010-7#8)(2010-8#15)(2010-9#2)(2011-1#22)(2011-10#1)(2011-2#68)(2011-3#10)(2012-12#14)(2012-2#20)(2012-3#38)(2012-5#4)(2012-7#2)(2013-1#30)(2013-7#7)(2013-8#25)
related)##2##1##(2008-10#2)
relatedness and##3##2##(2009-10#2)(2010-4#1)
relatedness in##2##2##(2008-8#1)(2010-4#1)
relatedness of##3##2##(2008-10#3)
relatedness to SbDV##2##3##(2008-10#2)
relatedness to##3##2##(2008-10#2)(2012-2#1)
relatedness##30##1##(1996-12#1)(2008-10#7)(2008-12#1)(2008-8#9)(2008-9#6)(2009-10#2)(2010-4#2)(2010-8#1)(2012-2#1)
relates the##5##2##(1995-1#1)(2008-10#1)(2008-3#2)(2008-8#1)
relates to the##4##3##(1996-2#1)(1997-3#1)(2008-10#1)(2008-5#1)
relates to##26##2##(1992-9#1)(1994-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
relates##38##1##(1990-8#1)(1992-2#1)(1992-9#1)(1994-2#2)(1995-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
relating the##9##2##(1992-12#1)(1993-5#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-7#1)
relating to a##2##3##(1993-11#1)(2011-2#1)
relating to the##11##3##(1992-1#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-12#1)(1996-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
relating to##56##2##(1990-9#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
relating##89##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-8#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1994-12#2)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#16)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
relation between RC teacher practices and child##2##7##(2008-12#2)
relation between RC teacher practices and##3##6##(2008-12#3)
relation between RC##4##3##(2008-12#4)
relation between physician and patient##2##5##(1993-11#2)
relation between the##11##3##(1991-11#1)(1991-6#1)(1992-6#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-10#1)(2011-2#1)
relation between##62##2##(1990-8#3)(1991-1#1)(1991-11#2)(1991-6#2)(1992-6#1)(1992-9#1)(1993-11#2)(1994-1#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-3#2)(2008-10#6)(2008-11#2)(2008-12#7)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#5)(2009-10#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
relation for##2##2##(1995-3#1)(2013-1#1)
relation of the##2##3##(2008-7#1)(2011-2#1)
relation of##7##2##(1994-3#1)(1996-2#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
relation to different##3##3##(1995-3#1)(1996-6#1)(2008-10#1)
relation to the genetic##2##4##(1997-2#1)(2008-9#1)
relation to the##71##3##(1990-11#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-1#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
relation to their##5##3##(1993-9#1)(2008-10#2)(2008-11#1)(2012-2#1)
relation to##241##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-9#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#4)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#57)(2008-11#24)(2008-12#10)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#5)(2008-9#8)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#15)(2013-8#5)
relation was found between##4##4##(1991-5#1)(1991-6#1)(1993-2#1)(2008-10#1)
relation was found##6##3##(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(2008-10#2)
relation with the##4##3##(1990-5#1)(2008-10#1)(2008-12#1)(2013-1#1)
relation with##10##2##(1990-5#1)(1990-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
relation##343##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#4)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#8)(1991-8#1)(1992-12#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#75)(2008-11#26)(2008-12#18)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#8)(2008-7#14)(2008-8#10)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#4)(2010-12#3)(2010-2#4)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#18)(2013-8#7)
relational climate##2##2##(2008-11#2)
relational contexts##2##2##(2009-7#2)
relational database##4##2##(1992-3#1)(2008-4#3)
relational databases##2##2##(2008-4#1)(2008-9#1)
relational##22##1##(1992-3#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-4#5)(2008-9#1)(2009-11#2)(2009-7#3)(2010-1#1)(2010-10#1)(2010-8#1)
relations among##4##2##(1990-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
relations and##5##2##(2008-11#1)(2008-12#2)(2009-8#2)
relations are##3##2##(1991-1#1)(1991-12#1)(2008-3#1)
relations as##2##2##(1995-3#1)(2008-10#1)
relations between the##5##3##(1996-1#1)(1996-2#1)(2010-1#1)(2010-6#1)(2010-8#1)
relations between##18##2##(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
relations in the##2##3##(1990-8#1)(2008-3#1)
relations in##4##2##(1990-8#1)(2008-3#1)(2008-7#2)
relations of##3##2##(1997-3#1)(2008-8#1)(2009-10#1)
relations to the##3##3##(1993-6#1)(1994-12#1)(2008-10#1)
relations to##5##2##(1993-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
relations were##4##2##(2008-10#2)(2008-11#1)(2010-2#1)
relations with##4##2##(1991-8#1)(1994-2#1)(2010-1#1)(2010-6#1)
relations##84##1##(1990-12#2)(1990-8#4)(1991-1#2)(1991-12#1)(1991-2#2)(1991-8#1)(1993-6#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-3#2)(2008-10#7)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-2#4)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
relationship among isolates##2##3##(2008-10#2)
relationship among the##4##3##(2008-10#2)(2010-9#1)(2011-2#1)
relationship among##13##2##(1995-11#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
relationship and a##2##3##(2008-10#1)(2011-2#1)
relationship and the##4##3##(1995-5#1)(2008-10#1)(2008-8#1)(2013-8#1)
relationship and##18##2##(1995-5#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#2)(2011-2#4)(2012-3#1)(2013-8#1)
relationship are discussed##2##3##(1995-3#1)(2008-10#1)
relationship are##5##2##(1995-1#2)(1995-3#1)(2008-10#2)
relationship as##2##2##(2008-10#1)(2013-1#1)
relationship between HMO##2##3##(1991-3#1)(2008-11#1)
relationship between I##2##3##(2008-10#1)(2008-11#1)
relationship between a##8##3##(1991-3#1)(1994-1#1)(2008-10#1)(2008-12#2)(2009-3#1)(2011-2#1)(2013-8#1)
relationship between absorbance##2##3##(2008-10#2)
relationship between anger##2##3##(2010-11#2)
relationship between barriers##2##3##(2010-11#2)
relationship between body mass index##2##5##(2011-1#1)(2011-2#1)
relationship between body##6##3##(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#3)
relationship between both##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
relationship between brain development and feeding##2##6##(2012-2#2)
relationship between brain##3##3##(2008-7#1)(2012-2#2)
relationship between breastfeeding##2##3##(2008-10#1)(2010-6#1)
relationship between cardiovascular##2##3##(2013-8#2)
relationship between early##2##3##(1990-3#1)(2008-12#1)
relationship between estimated and actual severity##2##6##(2008-10#2)
relationship between expression of##2##4##(2008-11#2)
relationship between growth##2##3##(2008-10#1)(2008-8#1)
relationship between home range area and##2##6##(2008-8#2)
relationship between home range##3##4##(2008-8#3)
relationship between home##5##3##(1992-2#1)(2008-8#3)(2010-7#1)
relationship between hospital##3##3##(1996-3#2)(2013-1#1)
relationship between incidence##4##3##(2008-10#4)
relationship between increased##3##3##(2008-8#1)(2013-8#2)
relationship between invasiveness and##2##4##(1997-3#2)
relationship between lipid##2##3##(1994-5#1)(1996-2#1)
relationship between mean##2##3##(2008-10#1)(2008-8#1)
relationship between medical care costs and##2##6##(2008-11#2)
relationship between peak height and##3##5##(2008-10#3)
relationship between peak##6##3##(2008-10#6)
relationship between prenatal##2##3##(1995-2#1)(2008-11#1)
relationship between protein##2##3##(2008-11#1)(2013-8#1)
relationship between psoas tension and low back pain##2##8##(2009-4#2)
relationship between relative##2##3##(2008-3#1)(2013-1#1)
relationship between religion and##2##4##(2009-11#2)
relationship between rumination and##2##4##(2009-11#1)(2010-10#1)
relationship between sexting and##2##4##(2013-1#2)
relationship between social support and##2##5##(2009-7#1)(2013-8#1)
relationship between social##3##3##(2009-7#1)(2013-8#2)
relationship between species##3##3##(2008-10#1)(2008-8#2)
relationship between structure and##4##4##(1992-6#1)(2009-5#2)(2012-2#1)
relationship between the age at which##2##6##(2008-8#1)(2009-5#1)
relationship between the catalytic current and##2##6##(2008-10#2)
relationship between the concentration of the##2##6##(2008-10#2)
relationship between the concentration of##6##5##(2008-10#5)(2008-8#1)
relationship between the degree of##2##5##(1990-2#1)(2008-8#1)
relationship between the distribution of##2##5##(2008-10#2)
relationship between the frequency shift and the##2##7##(2007-12#1)(2008-10#1)
relationship between the number of audible pops##2##7##(2008-12#2)
relationship between the number of##6##5##(2008-11#1)(2008-12#3)(2008-8#1)(2013-8#1)
relationship between the outcome##2##4##(2008-9#1)(2011-2#1)
relationship between the peak current and##2##6##(2008-10#2)
relationship between the primary##2##4##(2008-10#1)(2011-2#1)
relationship between the rate of##2##5##(2008-7#1)(2008-8#1)
relationship between the two##4##4##(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)
relationship between the##133##3##(1990-2#1)(1991-11#2)(1991-2#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#47)(2008-11#8)(2008-12#5)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#11)(2008-9#7)(2009-5#1)(2009-7#2)(2009-8#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#4)
relationship between these##2##3##(1994-3#1)(2012-3#1)
relationship between##511##2##(1990-2#2)(1990-3#1)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#4)(1991-5#2)(1991-9#1)(1992-1#2)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#3)(1994-1#3)(1994-11#2)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#2)(1994-8#3)(1995-12#4)(1995-2#7)(1995-3#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#4)(1996-2#3)(1996-3#4)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#4)(1997-8#3)(2006-6#2)(2007-12#2)(2008-1#1)(2008-10#132)(2008-11#33)(2008-12#16)(2008-3#3)(2008-4#2)(2008-5#11)(2008-6#6)(2008-7#5)(2008-8#32)(2008-9#16)(2009-10#6)(2009-11#5)(2009-3#2)(2009-4#2)(2009-5#4)(2009-7#10)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#6)(2010-4#2)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#1)(2011-10#1)(2011-2#24)(2011-3#1)(2012-12#1)(2012-2#16)(2012-3#2)(2012-5#1)(2013-1#15)(2013-8#20)
relationship can##2##2##(2008-10#2)
relationship could be##2##3##(2008-10#2)
relationship development##2##2##(2008-11#1)(2012-2#1)
relationship distress##5##2##(2008-12#3)(2012-2#2)
relationship education##7##2##(2012-2#7)
relationship existed between##2##3##(1992-2#1)(2008-12#1)
relationship existed##3##2##(1992-2#1)(1993-12#1)(2008-12#1)
relationship exists between##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2013-7#1)
relationship for the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
relationship for##10##2##(1991-12#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
relationship functioning##2##2##(2008-12#1)(2012-2#1)
relationship has been##2##3##(1990-8#1)(1991-12#1)
relationship has##3##2##(1990-8#1)(1991-12#1)(2008-9#1)
relationship in the range of##3##5##(2008-10#3)
relationship in the##9##3##(2008-10#6)(2008-11#1)(2012-3#1)(2013-1#1)
relationship in##15##2##(2008-10#6)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
relationship is##12##2##(1991-3#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#1)(2013-1#1)(2013-8#1)
relationship may##2##2##(2008-10#1)(2012-12#1)
relationship of cardiovascular risk factors measured at different ages to##2##10##(2008-7#2)
relationship of the##17##3##(1991-2#1)(1991-3#1)(1995-9#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2011-3#1)(2012-2#1)
relationship of these##5##3##(1990-2#1)(1994-2#1)(1996-12#1)(1996-2#1)(2011-3#1)
relationship of##70##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-8#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-2#3)(2013-1#3)(2013-8#1)
relationship over the entire##2##4##(2008-10#1)(2013-1#1)
relationship study of##2##3##(2008-10#1)(2010-12#1)
relationship study##3##2##(2008-10#2)(2010-12#1)
relationship that##4##2##(1991-6#1)(1993-3#1)(1995-3#1)(2008-7#1)
relationship to health##2##3##(2008-7#1)(2012-12#1)
relationship to the##10##3##(1993-11#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2013-8#1)
relationship to##46##2##(1990-11#1)(1990-9#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-3#2)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2010-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
relationship was found between the##3##5##(1991-2#2)(2008-10#1)
relationship was found between##11##4##(1990-12#1)(1991-2#2)(1995-8#1)(2008-10#6)(2011-2#1)
relationship was found to be##2##5##(2008-10#2)
relationship was found to##3##4##(2008-10#3)
relationship was found with##2##4##(1991-2#1)(2008-10#1)
relationship was found##17##3##(1990-12#1)(1991-2#3)(1995-8#1)(2008-10#11)(2011-2#1)
relationship was not observed##2##4##(2008-10#1)(2012-12#1)
relationship was not##3##3##(2008-10#2)(2012-12#1)
relationship was observed between##3##4##(2008-10#3)
relationship was##39##2##(1990-12#1)(1991-2#3)(1995-8#1)(2008-10#30)(2008-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
relationship with an##2##3##(2007-12#1)(2012-2#1)
relationship with clinical##2##3##(1994-12#1)(2013-1#1)
relationship with its##2##3##(2008-10#2)
relationship with the##19##3##(1990-5#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-5#1)(2008-10#9)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
relationship with their##4##3##(2008-10#3)(2012-3#1)
relationship with##74##2##(1990-5#1)(1990-6#1)(1991-12#1)(1993-12#1)(1993-2#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#27)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#9)
relationship within##3##2##(1997-1#1)(2007-12#1)(2008-12#1)
relationship##987##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#10)(1991-2#7)(1991-3#6)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#6)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#10)(1993-2#2)(1993-3#4)(1993-8#3)(1993-9#1)(1994-1#3)(1994-11#3)(1994-12#6)(1994-2#8)(1994-3#7)(1994-5#5)(1994-6#2)(1994-8#5)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#8)(1995-3#6)(1995-5#2)(1995-8#2)(1995-9#3)(1996-1#1)(1996-10#1)(1996-12#7)(1996-2#5)(1996-3#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#9)(1997-2#1)(1997-3#5)(1997-4#3)(1997-7#1)(1997-8#4)(2006-6#2)(2007-12#5)(2008-1#2)(2008-10#275)(2008-11#49)(2008-12#29)(2008-2#4)(2008-3#8)(2008-4#7)(2008-5#21)(2008-6#10)(2008-7#19)(2008-8#47)(2008-9#30)(2009-1#1)(2009-10#9)(2009-11#7)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#5)(2009-7#12)(2009-8#3)(2009-9#2)(2010-1#6)(2010-10#4)(2010-11#6)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#7)(2010-9#8)(2011-1#2)(2011-10#1)(2011-2#39)(2011-3#8)(2012-12#9)(2012-2#45)(2012-3#7)(2012-5#1)(2012-9#1)(2013-1#40)(2013-7#1)(2013-8#33)
relationship)##3##1##(1994-12#2)(2008-12#1)
relationship?##3##1##(1995-3#1)(2009-8#1)(2011-2#1)
relationships among all##2##3##(2008-8#1)(2008-9#1)
relationships among different##2##3##(2008-10#1)(2008-3#1)
relationships among several##2##3##(1997-3#1)(2010-7#1)
relationships among temperature##2##3##(2008-10#2)
relationships among the##7##3##(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-5#1)
relationships among these##5##3##(1992-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
relationships among##53##2##(1992-2#1)(1992-3#1)(1994-11#1)(1995-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#8)(2010-5#1)(2010-7#3)(2011-2#2)(2013-8#2)
relationships and provided information on the##2##6##(2008-10#2)
relationships and the##2##3##(2008-12#1)(2011-2#1)
relationships and##11##2##(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-8#1)
relationships are##8##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
relationships at##2##2##(2008-12#1)(2008-7#1)
relationships become##2##2##(2008-10#1)(2009-7#1)
relationships between disease incidence##2##4##(2008-10#2)
relationships between disease##4##3##(2008-10#4)
relationships between family members##2##4##(1996-9#1)(2008-11#1)
relationships between individual##2##3##(2008-7#1)(2010-8#1)
relationships between physical health and spiritual##2##6##(2010-2#2)
relationships between physical##3##3##(2008-9#1)(2010-2#2)
relationships between species##2##3##(2008-8#2)
relationships between stress##2##3##(1992-3#1)(2008-7#1)
relationships between the##16##3##(1997-8#1)(2008-10#8)(2008-11#3)(2008-6#2)(2008-9#1)(2009-7#1)
relationships between these two##2##4##(2008-10#1)(2009-12#1)
relationships between these##6##3##(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)
relationships between##111##2##(1991-2#1)(1992-1#1)(1992-3#3)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#35)(2008-11#7)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#11)(2008-9#11)(2009-11#1)(2009-12#2)(2009-7#2)(2010-1#1)(2010-2#2)(2010-6#1)(2010-8#3)(2011-2#3)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
relationships by##3##2##(2009-7#1)(2011-2#2)
relationships can be##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
relationships for##9##2##(1991-1#1)(1991-12#1)(1991-3#1)(1995-8#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-7#1)
relationships have##2##2##(1990-5#1)(2008-9#1)
relationships in a##3##3##(2008-10#1)(2013-1#2)
relationships in human experimental exposure to##2##6##(2008-7#2)
relationships in the##5##3##(1991-3#1)(1992-4#1)(2008-10#1)(2008-6#1)(2008-7#1)
relationships in##20##2##(1991-3#1)(1992-4#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#3)
relationships is##2##2##(2008-8#1)(2010-2#1)
relationships may be##2##3##(1993-12#1)(2008-10#1)
relationships of resistance##2##3##(2008-10#2)
relationships of the##4##3##(2008-10#2)(2012-3#2)
relationships of##27##2##(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-11#1)(1996-2#1)(1997-3#1)(2008-10#9)(2008-11#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-9#3)(2012-3#2)
relationships should be disclosed to research participants##2##7##(2009-4#2)
relationships should be##4##3##(2008-11#1)(2009-4#3)
relationships suggest that##2##3##(1991-5#1)(2008-10#1)
relationships suggested that##2##3##(2008-10#2)
relationships that##4##2##(1994-1#1)(2008-10#1)(2008-11#1)(2011-7#1)
relationships to##8##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
relationships we##2##2##(2013-1#2)
relationships were established##2##3##(1991-2#1)(2008-10#1)
relationships were found between##2##4##(2008-10#1)(2008-7#1)
relationships were similar to the##2##5##(2008-11#1)(2008-8#1)
relationships were##16##2##(1991-2#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-1#1)
relationships with the##2##3##(2008-10#1)(2008-7#1)
relationships with their teachers##2##4##(2008-12#2)
relationships with their##5##3##(1994-12#1)(2008-12#2)(2009-7#1)(2011-1#1)
relationships with##30##2##(1994-1#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-2#1)(2008-10#5)(2008-12#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
relationships within the genus##2##4##(2008-10#1)(2010-4#1)
relationships within the##4##3##(2008-10#1)(2008-6#1)(2008-9#1)(2010-4#1)
relationships within##7##2##(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)
relationships##458##1##(1990-5#2)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1993-11#2)(1993-12#3)(1993-3#2)(1994-1#4)(1994-11#2)(1994-12#5)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#125)(2008-11#21)(2008-12#17)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#10)(2008-7#20)(2008-8#33)(2008-9#28)(2009-10#2)(2009-11#2)(2009-12#4)(2009-4#7)(2009-5#4)(2009-7#8)(2009-8#1)(2010-1#6)(2010-10#1)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#5)(2011-1#4)(2011-2#16)(2011-7#1)(2012-12#1)(2012-2#8)(2012-3#8)(2012-5#1)(2013-1#13)(2013-8#8)
relative EC50/IC50##5##2##(2012-2#5)
relative PKA activity levels##2##4##(2008-10#2)
relative S##7##2##(2008-10#7)
relative abundance and##4##3##(2008-10#1)(2012-6#3)
relative abundance of C##2##4##(2012-6#2)
relative abundance of##9##3##(1994-11#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-6#2)
relative abundance patterns##2##3##(2008-8#2)
relative abundance##18##2##(1994-11#1)(1997-6#1)(2008-10#5)(2008-8#5)(2008-9#1)(2012-6#5)
relative abundances of##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
relative abundances##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
relative accuracy##5##2##(1990-5#1)(2008-10#4)
relative activities##4##2##(1992-12#1)(2008-10#1)(2008-11#2)
relative activity of##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
relative affinity for##2##3##(1991-12#1)(2008-10#1)
relative amounts of the metabolites##2##5##(2011-3#2)
relative amounts of the##3##4##(2008-7#1)(2011-3#2)
relative amounts of##7##3##(1991-5#1)(1992-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-3#2)
relative amounts##8##2##(1991-5#1)(1992-12#1)(1993-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-3#2)
relative and absolute##3##3##(2008-8#2)(2012-2#1)
relative and##5##2##(1992-2#1)(2008-10#1)(2008-8#2)(2012-2#1)
relative area under the disease progress##2##6##(2008-10#2)
relative area under the##5##4##(2008-10#5)
relative attractiveness##3##2##(2008-10#3)
relative binding affinities of##2##4##(1990-11#1)(1993-6#1)
relative binding##5##2##(1990-11#1)(1993-6#1)(2008-10#1)(2008-9#1)(2010-1#1)
relative cell counts##2##3##(2011-1#2)
relative changes##2##2##(1990-5#1)(2008-7#1)
relative collision##2##2##(2008-10#2)
relative concentration##2##2##(2008-10#2)
relative contribution of##6##3##(2008-10#4)(2009-1#1)(2011-2#1)
relative contribution##7##2##(2008-10#4)(2009-1#1)(2010-6#1)(2011-2#1)
relative contributions##8##2##(2008-10#4)(2008-12#1)(2008-9#1)(2012-3#1)(2013-8#1)
relative costs##2##2##(1993-2#1)(2008-8#1)
relative deviations##2##2##(2008-10#2)
relative difference##2##2##(1995-9#1)(2008-10#1)
relative differences##2##2##(2008-10#2)
relative disease##2##2##(2008-10#1)(2012-2#1)
relative efficacy##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
relative electrophoretic mobility##2##3##(2008-10#1)(2008-4#1)
relative error &lt##3##3##(2008-10#3)
relative error in the##3##4##(2008-10#3)
relative error in##4##3##(2008-10#4)
relative error lower than 10%##2##5##(2008-10#2)
relative error of 5##2##4##(2008-10#2)
relative error of##12##3##(2008-10#12)
relative error##28##2##(2008-10#27)(2013-8#1)
relative errors of##2##3##(2008-10#2)
relative errors##8##2##(2008-10#8)
relative expression##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
relative fitness cost##2##3##(2008-8#2)
relative fitness##5##2##(2008-10#3)(2008-8#2)
relative fluorescence intensity of##3##4##(2008-10#3)
relative fluorescence intensity was##2##4##(2008-10#2)
relative fluorescence intensity##6##3##(2008-10#6)
relative fluorescence##9##2##(2008-10#9)
relative frequencies##2##2##(2008-10#2)
relative frequency of##2##3##(2008-10#1)(2012-3#1)
relative frequency##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
relative growth rates##2##3##(2008-7#2)
relative growth##6##2##(1992-12#1)(2008-10#2)(2008-7#2)(2008-8#1)
relative humidities##10##2##(1996-12#1)(2008-10#9)
relative humidity &gt##2##3##(2008-10#2)
relative humidity (RH) on##2##4##(1996-12#1)(2008-10#1)
relative humidity (RH)##18##3##(1996-12#1)(2008-10#17)
relative humidity and##5##3##(2008-10#4)(2013-1#1)
relative humidity at##5##3##(2008-10#2)(2008-2#2)(2008-5#1)
relative humidity during##2##3##(2008-10#2)
relative humidity was##3##3##(2008-10#3)
relative humidity##69##2##(1995-3#3)(1996-12#1)(2008-10#57)(2008-2#2)(2008-5#2)(2013-1#2)(2013-8#2)
relative humidity)##3##2##(1996-2#1)(2008-10#2)
relative importance in##2##3##(2008-10#1)(2008-8#1)
relative importance##24##2##(1992-2#1)(1994-2#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
relative inclusion rate##2##3##(1994-9#2)
relative increase in cell counts##2##5##(2011-1#2)
relative increase##4##2##(1991-12#1)(1995-5#1)(2011-1#2)
relative influence##3##2##(1996-3#1)(2008-10#1)(2010-1#1)
relative intensity of##6##3##(2008-10#3)(2008-3#1)(2008-8#2)
relative interfacial pressure##2##3##(2008-10#2)
relative levels of##4##3##(1990-3#1)(2008-7#3)
relative localization##2##2##(1990-3#2)
relative merits of##2##3##(2008-4#1)(2011-2#1)
relative merits##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
relative molecular mass of##6##4##(1991-12#2)(1993-8#1)(2008-10#1)(2008-11#2)
relative molecular##8##2##(1991-12#2)(1992-12#1)(1993-8#1)(2008-10#2)(2008-11#2)
relative nuclear DNA content##2##4##(2008-9#2)
relative of##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
relative order of##2##3##(2008-10#1)(2008-4#1)
relative orientation of##2##3##(2008-10#1)(2009-7#1)
relative parameters##3##2##(2008-10#1)(2008-5#2)
relative peak##2##2##(1995-6#1)(2008-10#1)
relative percentage##2##2##(1991-3#1)(2008-10#1)
relative performance of##3##3##(1994-1#1)(1994-9#1)(2008-5#1)
relative performance##4##2##(1994-1#1)(1994-9#1)(2008-5#1)(2010-12#1)
relative photodynamic oxidation rates of##2##5##(2008-5#2)
relative photosynthetic rate##3##3##(2008-10#3)
relative population doubling##2##3##(2011-1#2)
relative populations##2##2##(2008-10#1)(2008-8#1)
relative potency##4##2##(1993-8#1)(1995-12#1)(2008-10#1)(2008-5#1)
relative power in spectral band##2##5##(2008-7#2)
relative power##5##2##(2008-3#1)(2008-7#4)
relative prediction error##2##3##(2008-10#2)
relative predictive error##2##3##(2008-10#2)
relative predictive##3##2##(2008-10#3)
relative prices##2##2##(1991-12#2)
relative proportions of##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
relative rate of##3##3##(2008-10#2)(2008-11#1)
relative resource##2##2##(2008-8#1)(2009-10#1)
relative rigidity##2##2##(1995-8#1)(2008-10#1)
relative risk estimates##2##3##(1996-3#2)
relative risk of##6##3##(1991-7#1)(1994-9#2)(2008-5#1)(2013-1#2)
relative risk##18##2##(1991-2#1)(1991-3#1)(1991-7#1)(1994-9#2)(1995-2#1)(1995-9#1)(1996-3#2)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#1)(2013-1#3)
relative risks were##2##3##(1991-3#1)(1996-11#1)
relative risks##4##2##(1990-6#1)(1991-3#1)(1996-11#1)(2008-11#1)
relative roles of##5##3##(2008-10#1)(2008-8#4)
relative roles##6##2##(2008-10#1)(2008-8#5)
relative seed##2##2##(2008-10#2)
relative selectivity##2##2##(2008-10#2)
relative sensitivity of the composite##2##5##(2008-10#2)
relative sensitivity##5##2##(2008-10#4)(2008-12#1)
relative signal##2##2##(2008-10#1)(2008-3#1)
relative standard derivation##2##3##(2008-10#2)
relative standard deviation &lt##2##4##(2008-10#2)
relative standard deviation (%R##2##4##(2008-10#2)
relative standard deviation (R##74##4##(2008-10#74)
relative standard deviation (RSD) of 0##2##6##(2008-10#2)
relative standard deviation (RSD) of##5##5##(2008-10#5)
relative standard deviation (RSD)##17##4##(2008-10#16)(2009-8#1)
relative standard deviation (n=10) was##3##5##(2008-10#3)
relative standard deviation (n=10)##4##4##(2008-10#4)
relative standard deviation (n=11)##3##4##(2008-10#3)
relative standard deviation (n=5)##2##4##(2008-10#2)
relative standard deviation 0##2##4##(2008-10#2)
relative standard deviation 1##2##4##(2008-10#2)
relative standard deviation at##3##4##(2008-10#3)
relative standard deviation between##3##4##(2008-10#3)
relative standard deviation for eight replicate##3##6##(2008-10#3)
relative standard deviation for eight##4##5##(2008-10#4)
relative standard deviation for six##2##5##(2008-10#2)
relative standard deviation for ten##2##5##(2008-10#2)
relative standard deviation for the determination of##2##7##(2008-10#2)
relative standard deviation for the##5##5##(2008-10#5)
relative standard deviation for##34##4##(2008-10#34)
relative standard deviation in##3##4##(2008-10#3)
relative standard deviation is 2##3##5##(2008-10#3)
relative standard deviation is 3##3##5##(2008-10#3)
relative standard deviation is##17##4##(2008-10#17)
relative standard deviation obtained##3##4##(2008-10#3)
relative standard deviation of +/-0##3##5##(2008-10#3)
relative standard deviation of 0##6##5##(2008-10#6)
relative standard deviation of 1##16##5##(2008-10#16)
relative standard deviation of 1%##2##5##(2008-10#2)
relative standard deviation of 2##13##5##(2008-10#13)
relative standard deviation of 3##6##5##(2008-10#6)
relative standard deviation of less than##8##6##(2008-10#8)
relative standard deviation of the##10##5##(2008-10#10)
relative standard deviation of three##2##5##(2008-10#2)
relative standard deviation of##102##4##(2008-10#102)
relative standard deviation ranging from##2##5##(2008-10#2)
relative standard deviation values for##3##5##(2008-10#3)
relative standard deviation values of##2##5##(2008-10#2)
relative standard deviation values##8##4##(2008-10#8)
relative standard deviation was 1##6##5##(2008-10#6)
relative standard deviation was 2##5##5##(2008-10#5)
relative standard deviation was 3##4##5##(2008-10#4)
relative standard deviation was 4##2##5##(2008-10#2)
relative standard deviation was 5##2##5##(2008-10#2)
relative standard deviation was below##2##5##(2008-10#2)
relative standard deviation was##34##4##(2008-10#34)
relative standard deviation were##3##4##(2008-10#3)
relative standard deviation##359##3##(1995-12#1)(2008-10#357)(2009-8#1)
relative standard deviation) of##2##4##(2008-10#2)
relative standard deviation)##3##3##(2008-10#3)
relative standard deviations (R##17##4##(2008-10#17)
relative standard deviations (RSD) for##2##5##(2008-10#1)(2008-5#1)
relative standard deviations (RSD)##3##4##(2008-10#2)(2008-5#1)
relative standard deviations (RSDs)##2##4##(2008-10#2)
relative standard deviations (n = 5)##3##6##(2008-10#3)
relative standard deviations are##2##4##(2008-10#2)
relative standard deviations for samples were##2##6##(2008-10#1)(2008-5#1)
relative standard deviations for the##2##5##(2008-10#2)
relative standard deviations for##16##4##(2008-10#15)(2008-5#1)
relative standard deviations obtained for##2##5##(2008-10#2)
relative standard deviations of 2##4##5##(2008-10#4)
relative standard deviations of less than##4##6##(2008-10#4)
relative standard deviations of migration times and##2##7##(2008-10#2)
relative standard deviations of##28##4##(2008-10#28)
relative standard deviations ranging from##2##5##(1997-2#1)(2008-10#1)
relative standard deviations ranging##3##4##(1997-2#1)(2008-10#2)
relative standard deviations were 2##2##5##(2008-10#2)
relative standard deviations were lower than##2##6##(2008-10#2)
relative standard deviations were##14##4##(2008-10#14)
relative standard deviations##103##3##(1997-2#1)(2008-10#100)(2008-5#2)
relative standard error (R##2##4##(2008-10#2)
relative standard error for##2##4##(2008-10#2)
relative standard error##6##3##(2008-10#6)
relative standard##477##2##(1995-12#1)(1997-2#1)(2008-10#471)(2008-2#1)(2008-5#2)(2009-8#1)
relative strengths##2##2##(2008-4#1)(2012-3#1)
relative surface##2##2##(2008-10#2)
relative to EO baseline than to EC##2##7##(2013-8#2)
relative to a visual##2##4##(2008-10#2)
relative to a##11##3##(1995-2#1)(2008-10#7)(2008-11#1)(2009-7#1)(2011-1#1)
relative to controls##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
relative to conventional##2##3##(2008-10#1)(2008-12#1)
relative to either##2##3##(2008-10#1)(2008-9#1)
relative to other##3##3##(2008-10#2)(2008-9#1)
relative to pure##2##3##(2008-10#2)
relative to that of##4##4##(1991-3#1)(1994-5#1)(2008-10#1)(2008-8#1)
relative to that##7##3##(1991-3#1)(1994-5#1)(2008-10#3)(2008-3#1)(2008-8#1)
relative to the control was##2##5##(1994-11#1)(2008-10#1)
relative to the control##3##4##(1994-11#1)(2008-10#1)(2008-11#1)
relative to the noninoculated control##2##5##(2008-10#2)
relative to the number of##2##5##(1994-11#1)(2011-2#1)
relative to the other##2##4##(2008-10#1)(2010-2#1)
relative to the strength of stabilizing selection##2##7##(2008-8#2)
relative to the strength of##3##5##(2008-8#3)
relative to the two##2##4##(2008-10#1)(2011-2#1)
relative to the value of current reproduction##2##7##(2008-8#2)
relative to the##74##3##(1992-12#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#2)(1996-12#1)(1996-3#3)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#23)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#3)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#2)
relative to their##8##3##(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#1)
relative to those##3##3##(1995-3#1)(2011-2#1)(2013-1#1)
relative to total##2##3##(1993-6#1)(2008-10#1)
relative to wild type##2##4##(1995-2#1)(2011-1#1)
relative to##189##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#4)(1991-3#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-5#3)(1994-8#1)(1995-2#4)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#3)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#63)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#15)(2008-9#10)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2012-6#1)(2013-1#6)(2013-8#4)
relative uncertainty of##2##3##(2008-10#1)(2008-3#1)
relative value scales##2##3##(1991-2#2)
relative value units##2##3##(1994-1#1)(2013-1#1)
relative value##8##2##(1991-2#2)(1992-1#1)(1994-1#1)(1994-12#2)(2008-4#1)(2013-1#1)
relative variability##2##2##(1996-3#1)(2008-10#1)
relative##1312##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#4)(1990-5#4)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#10)(1991-2#4)(1991-3#5)(1991-5#1)(1991-7#1)(1992-1#3)(1992-12#6)(1992-2#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#4)(1993-8#4)(1994-1#2)(1994-11#5)(1994-12#4)(1994-2#1)(1994-5#3)(1994-8#3)(1994-9#5)(1995-12#3)(1995-2#6)(1995-3#6)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#2)(1996-12#6)(1996-2#3)(1996-3#7)(1996-5#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#833)(2008-11#26)(2008-12#7)(2008-2#11)(2008-3#19)(2008-4#9)(2008-5#19)(2008-7#16)(2008-8#63)(2008-9#26)(2009-1#1)(2009-10#6)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#10)(2011-2#16)(2011-3#3)(2012-12#2)(2012-2#13)(2012-3#9)(2012-6#6)(2012-7#1)(2012-9#2)(2013-1#13)(2013-8#13)
relatively abundant##3##2##(1996-8#1)(2008-10#1)(2009-7#1)
relatively better##2##2##(2008-11#1)(2008-3#1)
relatively brief##2##2##(1994-8#1)(1996-12#1)
relatively cheap##2##2##(2008-1#1)(2009-5#1)
relatively common##8##2##(1991-12#1)(1997-8#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-3#1)
relatively complex##2##2##(2008-8#2)
relatively consistent##3##2##(2008-10#1)(2008-11#2)
relatively constant for##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
relatively constant in##2##3##(2008-10#1)(2012-2#1)
relatively constant##9##2##(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2012-2#1)
relatively early##4##2##(1991-6#1)(1993-6#1)(2011-1#2)
relatively easy to##6##3##(1991-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
relatively easy##11##2##(1991-3#2)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)
relatively effective##3##2##(2008-10#2)(2013-1#1)
relatively fast response time and can be used##3##8##(2008-10#3)
relatively fast response time##4##4##(2008-10#4)
relatively fast##7##2##(2008-10#6)(2011-2#1)
relatively few##11##2##(1991-12#2)(1995-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-3#2)
relatively free##2##2##(2008-10#1)(2012-2#1)
relatively frequent##4##2##(1991-12#1)(2008-11#1)(2010-5#1)(2013-1#1)
relatively good##3##2##(2008-10#2)(2009-11#1)
relatively high concentration##4##3##(1997-2#1)(2008-10#2)(2008-8#1)
relatively high concentrations of##3##4##(1996-1#1)(2008-10#1)(2012-12#1)
relatively high concentrations##4##3##(1996-1#1)(2008-10#2)(2012-12#1)
relatively high in the##2##4##(1993-3#1)(2008-9#1)
relatively high in##4##3##(1991-6#1)(1993-3#1)(2008-7#1)(2008-9#1)
relatively high levels of##3##4##(1994-3#1)(1997-1#1)(2008-10#1)
relatively high levels##4##3##(1994-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
relatively high proportion##3##3##(1990-12#1)(1997-2#1)(2008-9#1)
relatively high##59##2##(1990-12#1)(1991-6#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-8#1)(2008-10#22)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
relatively higher##8##2##(1990-3#1)(1994-6#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2012-7#1)
relatively homogeneous##3##2##(1995-12#1)(2008-10#2)
relatively inexpensive##6##2##(2008-10#5)(2008-8#1)
relatively insensitive to the##2##4##(2008-10#1)(2008-9#1)
relatively insensitive to##4##3##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
relatively insensitive##6##2##(1991-12#1)(1993-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
relatively intact##2##2##(2008-10#1)(2008-4#1)
relatively large amounts of##3##4##(2008-10#3)
relatively large proteins##2##3##(1997-2#2)
relatively large##23##2##(1990-8#1)(1991-5#1)(1994-12#1)(1997-2#2)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
relatively late in##2##3##(2009-8#1)(2010-2#1)
relatively late##3##2##(2006-6#1)(2009-8#1)(2010-2#1)
relatively less##4##2##(1990-12#1)(2008-1#1)(2008-8#2)
relatively little is known about the##2##6##(2009-5#1)(2013-1#1)
relatively little##12##2##(1995-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2013-1#1)
relatively long and##3##3##(1992-12#1)(1996-2#1)(2010-8#1)
relatively long##8##2##(1991-2#1)(1992-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
relatively low concentrations##3##3##(2008-10#3)
relatively low cost##3##3##(2008-10#2)(2009-1#1)
relatively low##44##2##(1992-3#1)(1993-2#1)(1994-2#1)(1995-9#1)(1996-2#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#2)(2010-10#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#2)
relatively lower##2##2##(2008-10#1)(2010-7#1)
relatively mild##2##2##(1995-8#1)(2011-2#1)
relatively minor##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
relatively modest##2##2##(1991-11#1)(1992-3#1)
relatively more##6##2##(1991-12#1)(1993-12#2)(1995-2#1)(2008-11#2)
relatively narrow##3##2##(2008-10#2)(2008-5#1)
relatively new technique##3##3##(2008-10#1)(2010-1#1)(2010-3#1)
relatively new##17##2##(1995-11#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-3#1)(2012-2#1)(2013-8#1)
relatively poor##5##2##(1994-1#1)(1994-3#1)(2008-10#1)(2008-6#1)(2010-12#1)
relatively pure##2##2##(2008-4#1)(2008-5#1)
relatively quickly##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
relatively rapid##2##2##(2008-10#1)(2011-3#1)
relatively rare##14##2##(1991-12#1)(1992-5#1)(2008-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
relatively recent##3##2##(1991-12#1)(2008-11#1)(2008-6#1)
relatively recently##2##2##(1993-3#1)(1994-9#1)
relatively resistant to##4##3##(1994-11#1)(1995-8#1)(2007-12#1)(2008-7#1)
relatively safe and##2##3##(1996-1#1)(2008-9#1)
relatively selective and##3##3##(1995-11#1)(2008-10#2)
relatively selective##4##2##(1995-11#1)(2008-10#3)
relatively short distances##2##3##(2008-10#1)(2013-8#1)
relatively short##9##2##(1994-2#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
relatively simple and##3##3##(1990-11#1)(2006-6#1)(2008-3#1)
relatively simple##13##2##(1990-11#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-6#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)
relatively slow##6##2##(2006-6#1)(2008-10#3)(2009-6#1)(2010-8#1)
relatively small compared##2##3##(2008-10#2)
relatively small proportion of##2##4##(1991-12#1)(2008-10#1)
relatively small##30##2##(1991-12#2)(1992-8#1)(1995-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)
relatively stable##6##2##(1991-12#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
relatively strong for##2##3##(2008-10#1)(2011-2#1)
relatively to##2##2##(2008-10#1)(2013-1#1)
relatively uncommon in##2##3##(2008-8#1)(2013-1#1)
relatively uncommon##7##2##(2008-1#1)(2008-8#1)(2009-1#1)(2013-1#4)
relatively unexplored##2##2##(2008-10#1)(2010-12#1)
relatively uniform##2##2##(2008-10#2)
relatively unimportant for##2##3##(2008-9#1)(2012-3#1)
relatively volatile##2##2##(2008-10#2)
relatively weak##5##2##(1997-1#1)(2008-3#2)(2010-4#1)(2012-2#1)
relatively well##3##2##(1994-12#1)(1996-3#1)(2012-2#1)
relatively young##3##2##(1991-8#1)(1995-5#1)(2008-5#1)
relatively##521##1##(1990-11#3)(1990-12#4)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#12)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#3)(1992-3#5)(1992-5#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-6#4)(1994-8#3)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#6)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#3)(2006-6#3)(2007-11#1)(2007-12#3)(2008-1#5)(2008-10#156)(2008-11#35)(2008-12#1)(2008-2#3)(2008-3#15)(2008-4#6)(2008-5#13)(2008-6#4)(2008-7#10)(2008-8#21)(2008-9#19)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#18)(2011-3#1)(2012-12#2)(2012-2#13)(2012-3#7)(2012-7#1)(2013-1#16)(2013-8#5)
relatives and##2##2##(2010-6#1)(2011-2#1)
relatives are##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
relatives in the##2##3##(1992-9#1)(1997-8#1)
relatives in##3##2##(1992-9#1)(1997-8#1)(2009-10#1)
relatives is##2##2##(1991-6#1)(2009-10#1)
relatives may be##2##3##(1997-7#1)(2008-7#1)
relatives of patients##2##3##(2008-7#1)(2012-12#1)
relatives of wheat##2##3##(2008-10#2)
relatives of##10##2##(1992-9#3)(1997-4#1)(2008-10#2)(2008-7#2)(2012-12#1)(2013-8#1)
relatives with##2##2##(1990-11#1)(2011-1#1)
relatives##55##1##(1990-11#1)(1991-6#1)(1992-9#4)(1993-11#1)(1994-12#1)(1995-1#1)(1995-9#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#7)(2008-8#1)(2008-9#5)(2009-10#3)(2009-11#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#5)(2013-8#1)
relativity##5##1##(1992-8#1)(2008-3#4)
relaxant##6##1##(1992-3#2)(1996-2#2)(1997-4#1)(2008-12#1)
relaxation and##3##2##(2008-10#1)(2012-3#2)
relaxation effect##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
relaxation of the##5##3##(1995-3#1)(2009-10#2)(2013-1#2)
relaxation of##9##2##(1993-6#2)(1995-3#1)(2008-5#1)(2009-10#2)(2012-3#1)(2013-1#2)
relaxation on##2##2##(1991-12#1)(2012-3#1)
relaxation process##2##2##(2008-3#1)(2008-5#1)
relaxation processes##2##2##(1990-8#1)(1995-3#1)
relaxation techniques##2##2##(1996-6#1)(2010-7#1)
relaxation time##8##2##(1994-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-2#1)
relaxation times##2##2##(1991-5#1)(1995-3#1)
relaxation to##3##2##(1993-8#1)(2013-1#2)
relaxation##77##1##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#3)(1992-6#3)(1992-8#1)(1993-6#4)(1993-8#3)(1994-11#2)(1994-5#1)(1994-8#2)(1995-2#1)(1995-3#3)(1996-2#1)(1996-6#1)(1997-4#2)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-7#6)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#6)(2013-1#8)
relaxations##2##1##(1994-11#1)(2010-10#1)
relaxed DNA##2##2##(1995-6#1)(2008-9#1)
relaxed and##2##2##(1990-2#1)(2010-4#1)
relaxed##15##1##(1990-2#1)(1993-8#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)
relaxes the##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
relaxes##5##1##(1992-12#1)(1994-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
relaxin##3##1##(1995-8#3)
relaxing##6##1##(1993-8#1)(1995-3#1)(2008-8#2)(2008-9#1)(2010-10#1)
relay##10##1##(1995-2#1)(1996-2#2)(1996-5#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-11#3)
relayed##2##1##(1995-12#1)(2010-1#1)
release MT##4##2##(2008-11#4)
release a##2##2##(1997-1#1)(2008-11#1)
release and antibacterial##2##3##(2008-5#2)
release and heavy metal##2##4##(2008-7#2)
release and permeation##3##3##(2008-5#3)
release and the##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
release and##25##2##(1990-5#1)(1991-12#1)(1993-8#1)(1997-1#1)(1997-2#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#7)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#2)
release are##2##2##(2008-10#1)(2008-4#1)
release as##6##2##(1990-5#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#2)
release assay##3##2##(1990-12#1)(1994-11#1)(2013-1#1)
release associated with##2##3##(1992-12#1)(2008-10#1)
release associated##3##2##(1992-12#1)(2008-10#1)(2010-5#1)
release both in##2##3##(1994-8#1)(1995-11#1)
release by Kupffer cells##3##4##(1997-4#3)
release by the##2##3##(1991-7#1)(1997-1#1)
release by##24##2##(1990-12#1)(1991-5#1)(1991-7#1)(1992-6#4)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-4#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-5#1)
release can##2##2##(1997-6#1)(2008-10#1)
release channel##2##2##(2008-8#1)(2008-9#1)
release data##2##2##(1992-1#1)(2012-2#1)
release during##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
release for##2##2##(2012-2#2)
release from a##2##3##(1990-2#1)(2008-10#1)
release from intracellular stores##2##4##(1994-11#1)(1996-12#1)
release from rat peritoneal##2##4##(2008-11#2)
release from rat##4##3##(1992-3#1)(1994-8#1)(2008-11#2)
release from the mesenteric##2##4##(1992-3#2)
release from the##10##3##(1992-3#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-8#1)
release from##39##2##(1990-2#1)(1991-5#2)(1992-3#3)(1992-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-11#2)(1995-6#4)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-11#6)(2008-5#1)(2008-8#1)(2009-11#2)(2009-8#1)(2013-1#1)
release has##2##2##(2008-10#1)(2013-7#1)
release in a##2##3##(1992-6#1)(2008-10#1)
release in the##9##3##(1990-2#1)(1995-11#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-8#1)(2013-8#1)
release in##33##2##(1990-2#1)(1992-12#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(2008-10#6)(2008-11#3)(2008-7#4)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-8#3)(2013-8#1)
release increased##5##2##(1991-12#1)(2008-10#4)
release into the##5##3##(1996-2#1)(2006-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
release is##6##2##(1991-2#1)(1994-8#1)(1996-2#1)(2008-9#1)(2010-3#1)(2013-7#1)
release mechanism##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
release melatonin##2##2##(2008-11#2)
release of CGRP from##2##4##(1992-6#2)
release of Ca2+##2##3##(1993-8#2)
release of LDH##2##3##(1994-2#1)(2008-11#1)
release of NO##2##3##(1996-2#1)(2008-10#1)
release of Smac/DIABLO##2##3##(2008-11#2)
release of a##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
release of acetylcholine##2##3##(1992-3#1)(2008-8#1)
release of adenosine from##2##4##(1996-2#2)
release of adenosine##3##3##(1996-2#3)
release of an##2##3##(1992-8#1)(1994-11#1)
release of ascospores occurred##2##4##(2008-10#2)
release of ascospores##5##3##(2008-10#5)
release of beta-APP##2##3##(1993-8#2)
release of creatine kinase##2##4##(1995-8#2)
release of cytosolic##2##3##(1991-2#1)(2008-7#1)
release of dopamine##3##3##(1992-3#1)(1997-2#2)
release of glucose##2##3##(2008-10#2)
release of hormones##2##3##(2013-7#2)
release of insulin##3##3##(1992-6#1)(1995-8#1)(2008-11#1)
release of intracellular##3##3##(1990-8#1)(2008-11#2)
release of low numbers of##2##5##(2008-10#2)
release of pollutants##2##3##(2008-10#2)
release of pro-inflammatory##2##3##(2008-11#1)(2009-12#1)
release of the##23##3##(1990-2#2)(1990-5#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-2#1)(2008-10#11)(2008-11#1)(2008-5#1)(2009-10#1)(2009-8#1)(2013-1#1)
release of toxic##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
release of##181##2##(1990-12#3)(1990-2#2)(1990-5#3)(1990-8#2)(1991-2#1)(1991-5#3)(1991-6#1)(1992-12#1)(1992-3#4)(1992-6#4)(1992-8#2)(1993-6#1)(1993-8#4)(1994-11#3)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#9)(1995-2#2)(1995-5#1)(1995-8#4)(1996-12#1)(1996-2#7)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#4)(2006-6#1)(2008-10#46)(2008-11#15)(2008-12#6)(2008-5#7)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-8#4)(2010-4#1)(2011-2#6)(2013-1#4)(2013-7#2)(2013-8#2)
release phenomena##2##2##(2008-7#1)(2011-2#1)
release profiles of##2##3##(2008-11#1)(2008-5#1)
release profiles##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
release rate##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
release rates##4##2##(1996-12#1)(2008-10#3)
release reaction##2##2##(1990-5#1)(2008-8#1)
release sites##2##2##(2012-2#2)
release tests##2##2##(2008-10#2)
release the cells from##2##4##(1992-6#1)(2008-11#1)
release the##10##2##(1990-2#1)(1992-6#1)(1994-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
release to the##2##3##(1996-2#1)(2008-5#1)
release to##4##2##(1995-8#1)(1996-2#1)(2008-10#1)(2008-5#1)
release under##2##2##(2008-10#1)(2008-7#1)
release was also##2##3##(1991-3#1)(1993-8#1)
release was significantly##2##3##(1992-12#1)(1994-8#1)
release was##17##2##(1991-3#1)(1992-12#1)(1992-6#2)(1993-8#2)(1994-8#1)(2008-10#5)(2008-5#3)(2008-7#1)(2011-2#1)
release were##4##2##(1994-3#1)(1995-11#2)(2008-10#1)
release which was##2##3##(1990-12#1)(1995-11#1)
release which##3##2##(1990-12#1)(1995-11#1)(1997-2#1)
release with##2##2##(1990-5#1)(2008-5#1)
release##587##1##(1990-11#3)(1990-12#8)(1990-2#8)(1990-5#8)(1990-8#5)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#8)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#5)(1992-3#7)(1992-6#16)(1992-8#2)(1993-3#1)(1993-6#3)(1993-8#12)(1994-11#11)(1994-2#3)(1994-3#5)(1994-6#1)(1994-8#18)(1995-11#19)(1995-2#4)(1995-5#1)(1995-6#10)(1995-8#7)(1996-1#1)(1996-12#5)(1996-2#17)(1997-1#9)(1997-2#14)(1997-3#1)(1997-4#8)(1997-6#1)(1997-8#1)(2006-6#2)(2008-1#2)(2008-10#120)(2008-11#50)(2008-12#8)(2008-2#1)(2008-4#2)(2008-5#37)(2008-6#1)(2008-7#27)(2008-8#12)(2008-9#9)(2009-10#2)(2009-11#4)(2009-12#3)(2009-7#1)(2009-8#7)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-2#15)(2012-3#1)(2012-5#1)(2012-8#4)(2013-1#9)(2013-7#6)(2013-8#6)
release)##2##1##(1991-9#1)(2008-10#1)
released CGRP##2##2##(1992-6#2)
released a##2##2##(1992-3#1)(2008-10#1)
released amount##3##2##(2008-5#3)
released as a##2##3##(2008-11#1)(2008-7#1)
released as##3##2##(1995-3#1)(2008-11#1)(2008-7#1)
released at##3##2##(2008-10#2)(2008-5#1)
released between##2##2##(2008-10#2)
released by proteolysis##2##3##(2008-4#1)(2008-5#1)
released by the##5##3##(1990-8#1)(1992-3#1)(2008-10#2)(2008-7#1)
released by##24##2##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1994-11#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-4#1)(2012-4#1)(2013-1#1)
released during the##3##3##(1990-5#1)(1992-6#1)(2008-10#1)
released during##7##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-2#1)(1996-2#1)(1997-4#1)(2008-10#1)
released for transplantation##2##3##(2011-2#2)
released for##3##2##(2008-10#1)(2011-2#2)
released from a point source##2##5##(2008-10#2)
released from a##3##3##(2008-10#3)
released from activated platelets##2##4##(2010-3#2)
released from activated##3##3##(1997-1#1)(2010-3#2)
released from an##2##3##(2008-10#1)(2008-2#1)
released from the##14##3##(1991-5#1)(1994-5#1)(2008-10#4)(2008-11#3)(2008-5#2)(2011-2#3)
released from##50##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#2)(1993-1#1)(1994-5#1)(1995-2#1)(1997-1#1)(1997-8#2)(2008-10#16)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#3)(2011-2#3)(2013-1#1)
released in a##3##3##(1991-2#1)(2008-1#1)(2008-10#1)
released in the##4##3##(2008-10#2)(2008-11#1)(2009-12#1)
released in##14##2##(1991-2#1)(1992-6#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#2)(2009-12#1)(2010-6#1)
released into the culture##2##4##(1992-8#1)(1993-6#1)
released into the medium##2##4##(1990-2#1)(2013-7#1)
released into the##11##3##(1990-2#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-6#1)(2008-11#3)(2011-2#1)(2013-1#1)(2013-7#1)
released substances##2##2##(1994-8#1)(1997-1#1)
released their##2##2##(2008-10#2)
released to##3##2##(1991-1#1)(2008-10#1)(2008-7#1)
released was##2##2##(2008-10#2)
released when##2##2##(1990-12#1)(2008-10#1)
released with##3##2##(1994-11#1)(2008-10#2)
released##194##1##(1990-12#2)(1990-2#3)(1990-5#2)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#3)(1992-3#3)(1992-6#7)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#4)(1997-4#4)(1997-6#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#64)(2008-11#15)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#14)(2008-7#6)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#4)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-10#1)(2011-2#6)(2011-3#1)(2012-4#1)(2013-1#3)(2013-7#1)
releaser##2##1##(2008-10#1)(2008-7#1)
releasers##3##1##(1995-2#1)(2008-10#1)(2010-7#1)
releases of##4##2##(1990-11#1)(2008-10#2)(2008-7#1)
releases the##2##2##(2008-10#1)(2008-9#1)
releases##22##1##(1990-11#2)(1991-6#1)(1992-6#1)(1996-2#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)
releasing hormone##8##2##(1991-3#3)(1992-6#4)(1992-9#1)
releasing of##2##2##(2008-10#1)(2009-8#1)
releasing##29##1##(1990-12#1)(1991-3#3)(1992-6#4)(1992-9#2)(1994-2#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)
relegated to##3##2##(1992-2#1)(1994-2#1)(2008-5#1)
relevance and##3##2##(1991-2#1)(2010-6#1)(2010-8#1)
relevance for the##2##3##(1994-8#1)(1997-1#1)
relevance for##10##2##(1994-8#1)(1997-1#1)(2008-12#1)(2008-3#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
relevance in the##3##3##(1990-5#1)(1991-1#1)(2008-10#1)
relevance in##5##2##(1990-5#1)(1991-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
relevance is##3##2##(1991-3#1)(2008-12#1)(2013-1#1)
relevance of the##8##3##(1991-2#1)(1994-3#1)(1995-11#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
relevance of these results##2##4##(1995-2#1)(2009-8#1)
relevance of these##11##3##(1995-2#1)(1997-1#1)(2008-10#4)(2008-3#1)(2009-8#1)(2011-2#1)(2012-4#1)(2013-1#1)
relevance of this##5##3##(1992-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)
relevance of##55##2##(1990-3#1)(1991-12#1)(1991-2#1)(1992-12#3)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
relevance to the##13##3##(1992-12#1)(1994-8#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
relevance to##26##2##(1992-12#1)(1993-2#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
relevance##120##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-12#4)(1993-11#1)(1993-2#3)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-7#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#6)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#6)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-2#6)(2012-3#3)(2012-4#1)(2013-1#3)(2013-8#3)
relevant analytical parameters##2##3##(2008-10#2)
relevant anatomy##2##2##(2011-2#1)(2013-8#1)
relevant and##8##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-2#2)(2012-3#1)
relevant applications in##2##3##(2008-10#2)
relevant applications##4##2##(2008-10#4)
relevant articles##4##2##(1994-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
relevant clinical##2##2##(2009-11#1)(2012-2#1)
relevant data##2##2##(1990-3#1)(2008-11#1)
relevant disease##4##2##(2010-11#4)
relevant doses##2##2##(2008-10#2)
relevant environmental##2##2##(2008-10#1)(2011-2#1)
relevant evidence##2##2##(2011-2#2)
relevant factors##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
relevant findings##4##2##(2008-7#1)(2011-1#1)(2011-2#2)
relevant for the##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
relevant for##18##2##(1995-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-10#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
relevant fungi##2##2##(2008-11#2)
relevant in the##2##3##(1993-2#1)(2008-10#1)
relevant in##7##2##(1993-2#1)(1994-8#1)(1996-5#1)(2008-10#2)(2010-11#1)(2013-1#1)
relevant information from the##2##4##(2008-4#1)(2008-6#1)
relevant information##17##2##(1993-12#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
relevant issues##2##2##(1994-6#1)(1997-2#1)
relevant levels##2##2##(1997-1#1)(2008-11#1)
relevant literature##7##2##(1994-12#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#3)
relevant markers##2##2##(2008-7#1)(2008-9#1)
relevant model for##2##3##(1996-2#1)(2012-3#1)
relevant parameters##3##2##(2008-10#2)(2008-11#1)
relevant publications##2##2##(2008-8#1)(2008-9#1)
relevant research##2##2##(1995-2#1)(2008-7#1)
relevant studies##5##2##(2011-2#2)(2013-1#3)
relevant to both##2##3##(2008-10#1)(2008-12#1)
relevant to public##2##3##(2008-10#1)(2008-7#1)
relevant to the##12##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-3#1)
relevant to their##3##3##(1992-1#1)(1992-3#1)(2008-12#1)
relevant to##58##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1995-8#1)(1996-2#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-10#1)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
relevant variables##3##2##(2008-10#2)(2008-8#1)
relevant##338##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#4)(1995-2#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-1#2)(2008-10#63)(2008-11#29)(2008-12#10)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#12)(2008-8#13)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#7)(2010-12#3)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#23)(2011-8#1)(2012-12#1)(2012-2#11)(2012-3#10)(2012-5#1)(2013-1#18)(2013-8#5)
reliabilities##2##1##(2010-4#1)(2012-2#1)
reliability and validity##7##3##(1992-3#1)(1993-11#1)(1993-3#1)(2008-12#2)(2010-10#1)(2012-2#1)
reliability and##21##2##(1992-3#1)(1993-11#1)(1993-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#2)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
reliability for##2##2##(2008-10#1)(2008-7#1)
reliability in##4##2##(2008-10#1)(2010-12#2)(2013-8#1)
reliability is##2##2##(2008-1#1)(2008-10#1)
reliability of a##6##3##(1992-12#1)(1995-11#1)(2008-10#3)(2010-9#1)
reliability of the audit##2##4##(1993-1#2)
reliability of the determination was proved##3##6##(2008-10#3)
reliability of the developed method##4##5##(2008-10#4)
reliability of the marking process##2##5##(2008-11#2)
reliability of the method##6##4##(2008-10#4)(2008-3#1)(2008-7#1)
reliability of the##37##3##(1991-6#1)(1993-1#2)(1994-6#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
reliability of these methods##2##4##(2008-10#2)
reliability of these##4##3##(2008-10#3)(2008-4#1)
reliability of this##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2013-8#1)
reliability of##77##2##(1990-2#1)(1991-6#1)(1992-12#1)(1993-1#2)(1994-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#37)(2008-11#6)(2008-12#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#2)
reliability testing of the##2##4##(2010-10#2)
reliability testing##3##2##(2010-10#3)
reliability was tested by##2##4##(2008-10#2)
reliability was tested##3##3##(2008-10#2)(2010-10#1)
reliability was##6##2##(2008-10#4)(2010-10#1)(2013-1#1)
reliability##171##1##(1990-11#1)(1990-2#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-1#2)(2008-10#62)(2008-11#12)(2008-12#11)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#3)(2010-1#1)(2010-10#8)(2010-11#1)(2010-12#6)(2010-2#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#4)
reliability)##2##1##(2008-10#2)
reliable analytical procedures##2##3##(2008-10#1)(2010-11#1)
reliable analytical techniques##2##3##(2008-10#1)(2010-11#1)
reliable analytical##8##2##(2008-10#6)(2010-11#2)
reliable and can##2##3##(2008-10#1)(2008-4#1)
reliable and consistent with##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
reliable and effective##2##3##(2008-11#1)(2008-9#1)
reliable and quick##2##3##(2008-10#1)(2010-6#1)
reliable and rapid##2##3##(2008-10#2)
reliable and reproducible##4##3##(1990-11#1)(2008-10#2)(2008-12#1)
reliable and robust##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
reliable and sensitive##4##3##(1991-3#1)(2008-10#2)(2008-12#1)
reliable and specific##2##3##(2008-10#1)(2013-8#1)
reliable and valid##6##3##(2010-10#2)(2010-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
reliable and##51##2##(1990-11#1)(1990-12#1)(1991-3#1)(1992-12#1)(1995-1#1)(1995-11#1)(2008-10#23)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
reliable as##2##2##(1997-7#1)(2008-10#1)
reliable assessment of##2##3##(2008-10#2)
reliable clinical##2##2##(1996-3#1)(2010-11#1)
reliable data##4##2##(1993-9#1)(2008-10#2)(2012-2#1)
reliable detection methods##2##3##(2008-11#2)
reliable detection of##6##3##(2008-10#3)(2011-2#2)(2013-8#1)
reliable detection##9##2##(2008-10#4)(2008-11#2)(2011-2#2)(2013-8#1)
reliable determination of##3##3##(2008-10#2)(2008-9#1)
reliable diagnosis##3##2##(2008-7#2)(2011-3#1)
reliable diagnostic##2##2##(2011-1#1)(2012-3#1)
reliable estimate of##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
reliable estimates of the##2##4##(2008-10#1)(2008-9#1)
reliable estimates of##3##3##(1992-9#1)(2008-10#1)(2008-9#1)
reliable estimates##4##2##(1992-9#1)(2008-10#2)(2008-9#1)
reliable features##2##2##(1996-3#1)(2008-12#1)
reliable for the determination of##2##5##(1996-3#1)(2008-10#1)
reliable for the##4##3##(1996-3#1)(2008-10#3)
reliable for##12##2##(1996-3#1)(2008-10#8)(2008-3#1)(2008-5#2)
reliable identification of##2##3##(2008-10#1)(2011-2#1)
reliable identification##3##2##(2008-10#2)(2011-2#1)
reliable in##2##2##(2006-5#1)(2013-8#1)
reliable indicator of##4##3##(1991-12#1)(1993-12#1)(2013-7#2)
reliable information##3##2##(1997-3#1)(2008-9#2)
reliable instrument##2##2##(2008-10#1)(2010-10#1)
reliable means of##3##3##(1990-8#1)(2008-10#1)(2011-7#1)
reliable means##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2011-7#1)
reliable method for##11##3##(1997-7#1)(2008-10#9)(2008-11#1)
reliable method to##2##3##(2008-10#1)(2011-2#1)
reliable method##21##2##(1997-7#1)(2008-10#16)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#1)
reliable methods for##2##3##(2008-10#1)(2008-9#1)
reliable or##2##2##(2008-10#1)(2010-10#1)
reliable procedures##2##2##(2008-10#2)
reliable real-time##2##2##(2008-10#2)
reliable results for##2##3##(2008-10#1)(2008-9#1)
reliable results##8##2##(2008-10#6)(2008-11#1)(2008-9#1)
reliable technique##4##2##(1996-6#1)(2012-2#3)
reliable than##4##2##(2008-10#1)(2008-12#1)(2010-6#1)(2012-2#1)
reliable to##2##2##(1990-9#1)(2008-3#1)
reliable tool##3##2##(2008-5#1)(2010-12#1)(2011-2#1)
reliable use of##2##3##(2008-10#1)(2008-6#1)
reliable way##3##2##(1993-12#1)(2008-10#2)
reliable with##2##2##(2008-10#1)(2008-5#1)
reliable##298##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-12#6)(1993-2#3)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-5#1)(2008-10#134)(2008-11#9)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#13)(2009-12#1)(2010-10#5)(2010-11#4)(2010-12#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#5)
reliably employed for##2##3##(2008-10#1)(2008-11#1)
reliably employed##3##2##(2008-10#2)(2008-11#1)
reliably for the##2##3##(2008-10#2)
reliably higher than##2##3##(1992-1#2)
reliably measured##2##2##(2008-12#1)(2008-4#1)
reliably the##2##2##(1995-12#1)(1995-2#1)
reliably used for##2##3##(1990-12#1)(2008-10#1)
reliably used##5##2##(1990-12#1)(1992-3#1)(1997-3#1)(2008-10#2)
reliably##58##1##(1990-12#1)(1990-8#1)(1991-3#1)(1992-1#2)(1992-3#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-8#2)(2009-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-2#5)(2013-1#4)
reliance on the##2##3##(1991-2#1)(1994-3#1)
reliance on##10##2##(1991-2#3)(1994-3#1)(2008-11#2)(2008-12#1)(2008-6#2)(2009-7#1)
reliance##13##1##(1991-2#3)(1992-1#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#2)(2009-7#1)
reliant on##2##2##(2008-12#1)(2011-2#1)
relics of##2##2##(2008-10#1)(2008-7#1)
relied heavily on##2##3##(1995-1#1)(2008-10#1)
relied on a##2##3##(1996-5#1)(1997-1#1)
relied on##10##2##(1991-3#1)(1994-11#1)(1996-5#1)(1997-1#2)(2008-10#2)(2008-11#1)(2011-2#2)
relied upon##6##2##(1995-11#1)(2008-1#2)(2008-10#1)(2008-11#2)
relied##19##1##(1991-3#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-5#1)(1997-1#2)(2008-1#2)(2008-10#4)(2008-11#4)(2011-2#2)
relief after##2##2##(1990-6#1)(2012-12#1)
relief and##3##2##(2008-12#1)(2009-3#1)(2010-10#1)
relief for##4##2##(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
relief from##2##2##(2008-9#1)(2011-3#1)
relief of dentin hypersensitivity##3##4##(2011-2#3)
relief of pain##3##3##(2008-9#2)(2011-2#1)
relief of symptomatology##2##3##(1994-6#1)(1996-9#1)
relief of symptoms##3##3##(1996-9#1)(1997-1#1)(2008-9#1)
relief of the##3##3##(1996-3#1)(2008-11#1)(2009-1#1)
relief of##23##2##(1993-1#1)(1994-6#1)(1996-3#1)(1996-9#2)(1997-1#1)(2008-11#2)(2008-12#2)(2008-9#3)(2009-1#1)(2011-1#1)(2011-2#6)(2013-1#2)
relief that##2##2##(2008-10#1)(2008-3#1)
relief with##3##2##(1995-10#2)(2008-7#1)
relief##78##1##(1990-6#1)(1991-3#2)(1992-1#2)(1993-1#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-12#3)(1995-2#2)(1996-3#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-12#3)(2008-3#5)(2008-7#4)(2008-9#7)(2009-1#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
relief)##2##1##(2008-11#1)(2010-2#1)
relies heavily on##2##3##(2008-9#1)(2009-10#1)
relies heavily upon##2##3##(1996-1#1)(2007-11#1)
relies heavily##4##2##(1996-1#1)(2007-11#1)(2008-9#1)(2009-10#1)
relies on a##4##3##(2008-3#1)(2008-6#1)(2010-10#1)(2013-8#1)
relies on the immobilization of##2##5##(2008-10#2)
relies on the##19##3##(1992-5#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-3#3)(2008-9#1)(2013-1#1)(2013-8#1)
relies on##34##2##(1992-5#1)(1997-8#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
relies upon the##2##3##(2008-10#2)
relies upon##3##2##(2008-10#2)(2008-12#1)
relies##46##1##(1992-5#1)(1996-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-10#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#3)
relieve the##4##2##(1995-8#1)(2008-9#1)(2010-9#1)(2011-2#1)
relieve##17##1##(1991-9#1)(1993-3#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
relieved by##4##2##(1991-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
relieved##14##1##(1990-9#2)(1991-12#1)(1991-5#1)(1997-8#1)(2008-10#2)(2008-7#2)(2009-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
reliever and##2##2##(2008-10#1)(2010-9#1)
relieves the symptoms##2##3##(2008-1#1)(2010-7#1)
relieves the##3##2##(1993-8#1)(2008-1#1)(2010-7#1)
relieves##5##1##(1993-8#1)(2008-1#1)(2010-7#1)(2011-2#1)(2013-8#1)
relieving##5##1##(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#2)
religion and##7##2##(2009-11#5)(2009-6#2)
religion are##4##2##(2008-12#2)(2010-10#1)(2013-1#1)
religion is##2##2##(2008-12#1)(2009-6#1)
religion##26##1##(1991-2#1)(2008-11#1)(2008-12#4)(2009-11#8)(2009-5#1)(2009-6#6)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#2)
religiosity is##2##2##(2010-12#2)
religiosity##8##1##(2009-11#2)(2010-12#3)(2010-8#1)(2011-1#2)
religious affiliation of##2##3##(1993-12#1)(2009-6#1)
religious affiliation##7##2##(1993-12#5)(2009-11#1)(2009-6#1)
religious and spiritual##2##3##(2010-2#1)(2011-1#1)
religious and##4##2##(1996-9#1)(2008-12#1)(2010-2#1)(2011-1#1)
religious beliefs##2##2##(2008-12#2)
religious coping styles##3##3##(2008-12#1)(2009-11#2)
religious coping##14##2##(2008-12#7)(2009-11#7)
religious groups##2##2##(2009-11#1)(2010-8#1)
religious paradigms##2##2##(2008-12#2)
religious participation##3##2##(2010-10#3)
religious perspectives##2##2##(2008-12#2)
religious practices##2##2##(2010-2#2)
religious values and beliefs##2##4##(2008-12#2)
religious##64##1##(1991-3#1)(1991-6#1)(1993-12#5)(1996-9#1)(2008-11#1)(2008-12#24)(2009-10#4)(2009-11#11)(2009-6#2)(2010-10#5)(2010-2#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
religiousness##2##1##(2009-11#2)
relining##2##1##(2013-1#2)
relocation of a posterior dislocation of##2##6##(2012-12#2)
relocation of the##2##3##(1991-1#1)(2009-9#1)
relocation of##5##2##(1991-1#1)(2008-7#1)(2009-9#1)(2012-12#2)
relocation##6##1##(1991-1#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-12#2)
reluctance to##4##2##(1990-6#1)(1996-5#1)(1997-4#1)(2010-9#1)
reluctance##5##1##(1990-6#1)(1996-5#1)(1997-4#1)(2008-10#1)(2010-9#1)
reluctant to##4##2##(1991-2#1)(2008-12#1)(2010-8#2)
reluctant##5##1##(1991-2#1)(2008-12#1)(2010-8#2)(2011-2#1)
rely on a##2##3##(2012-3#1)(2013-8#1)
rely on the use of##2##5##(1997-7#1)(2008-10#1)
rely on the##12##3##(1990-12#1)(1990-8#1)(1997-7#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-7#1)(2013-8#1)
rely on##32##2##(1990-12#1)(1990-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-7#1)(2006-6#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
rely##41##1##(1990-12#1)(1990-8#1)(1994-1#2)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
relying on the##3##3##(1997-6#1)(1997-7#1)(2008-3#1)
relying on##13##2##(1992-12#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-3#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-1#2)
relying##15##1##(1992-12#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-3#1)(2009-10#1)(2010-10#1)(2012-2#2)(2013-1#2)
remain a##7##2##(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#2)(2012-3#1)
remain about the##2##3##(2008-11#1)(2012-2#1)
remain about##3##2##(2008-11#1)(2012-12#1)(2012-2#1)
remain alive##2##2##(1994-12#1)(2008-10#1)
remain as the##2##3##(2011-3#2)
remain asymptomatic##5##2##(2008-10#1)(2009-8#2)(2011-2#1)(2012-12#1)
remain at a local##2##4##(1993-6#2)
remain at##8##2##(1993-6#2)(1995-1#1)(1996-12#1)(2008-8#3)(2012-12#1)
remain available for##3##3##(1992-3#1)(1996-1#1)(2008-10#1)
remain challenging##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
remain constant##2##2##(1995-9#1)(2008-10#1)
remain controversial##4##2##(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
remain elevated##2##2##(1997-7#1)(2011-2#1)
remain elusive##7##2##(2008-11#2)(2009-10#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
remain free of##2##3##(1994-1#1)(2008-10#1)
remain high##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
remain highly##2##2##(1996-3#1)(2011-2#1)
remain in the##3##3##(1994-12#1)(2008-12#2)
remain in##9##2##(1991-3#1)(1994-12#1)(1997-1#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)
remain intact##3##2##(1992-10#1)(1996-5#1)(1996-6#1)
remain invariant##2##2##(2007-12#1)(2013-8#1)
remain largely unknown##2##3##(1995-12#1)(2011-2#1)
remain largely##3##2##(1995-12#1)(2010-12#1)(2011-2#1)
remain limited##2##2##(2008-9#1)(2011-7#1)
remain low##2##2##(2008-8#1)(2012-12#1)
remain major##2##2##(2008-11#1)(2008-12#1)
remain poorly defined##3##3##(2009-8#1)(2010-11#1)(2011-2#1)
remain poorly understood##2##3##(2012-2#2)
remain poorly##5##2##(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#2)
remain relatively##2##2##(1993-12#1)(2008-10#1)
remain stable for##6##3##(1993-2#2)(2008-10#4)
remain stable##11##2##(1993-2#2)(1993-3#1)(2008-10#6)(2008-7#1)(2013-1#1)
remain the mainstay of##2##4##(1995-5#1)(2011-2#1)
remain the most##2##3##(2006-6#1)(2009-1#1)
remain the same or##2##4##(1993-1#1)(2008-4#1)
remain the##13##2##(1993-1#1)(1995-5#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-1#1)(2010-12#2)(2010-7#1)(2011-2#1)
remain to be elucidated##3##4##(1994-5#1)(1994-8#1)(2013-1#1)
remain to be fully##2##4##(2008-12#1)(2011-2#1)
remain to be identified##2##4##(2008-2#1)(2008-7#1)
remain to be investigated##2##4##(2008-4#1)(2013-8#1)
remain to be##16##3##(1994-5#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
remain unanswered##4##2##(1992-2#1)(2008-11#1)(2009-4#1)(2013-8#1)
remain unchanged##3##2##(2008-10#1)(2008-2#1)(2010-9#1)
remain unclear##6##2##(1995-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-11#1)
remain undescribed##2##2##(2008-10#2)
remain unknown##4##2##(1993-8#1)(2009-8#1)(2013-8#2)
remain unloaded##2##2##(2013-1#2)
remain unresolved##4##2##(2008-10#1)(2008-7#1)(2010-10#1)(2010-7#1)
remain viable##5##2##(1994-12#1)(1996-1#1)(1997-3#1)(2008-7#2)
remain##236##1##(1990-9#1)(1991-1#2)(1991-3#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-3#3)(1996-5#3)(1996-6#1)(1997-1#4)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#39)(2008-11#15)(2008-12#6)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-2#19)(2011-3#3)(2011-7#1)(2012-12#7)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#9)(2013-8#10)
remainder of the##5##3##(1991-12#1)(1992-4#1)(1993-12#1)(2008-10#1)(2010-10#1)
remainder were##2##2##(1997-3#1)(2008-9#1)
remainder##20##1##(1991-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-12#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-8#2)
remained a##5##2##(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
remained after##2##2##(2008-10#1)(2012-12#1)
remained an##2##2##(1995-11#1)(2008-5#1)
remained as##2##2##(1990-5#1)(2008-10#1)
remained at##6##2##(1996-11#2)(1997-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
remained constant##7##2##(1992-12#1)(1994-6#1)(1995-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-8#1)
remained effective##2##2##(2008-10#2)
remained elevated during##2##3##(1993-1#1)(1994-2#1)
remained elevated in##2##3##(1994-3#1)(1994-5#1)
remained elevated##7##2##(1993-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1997-3#1)(2013-1#1)
remained elusive##2##2##(2008-10#1)(2010-1#1)
remained enigmatic##2##2##(2009-8#1)(2010-1#1)
remained essentially identical##2##3##(2008-10#1)(2008-11#1)
remained essentially unchanged##2##3##(1992-6#1)(2008-10#1)
remained essentially##6##2##(1992-6#1)(1994-1#1)(1994-11#1)(2008-10#2)(2008-11#1)
remained high throughout the##2##4##(2008-10#2)
remained high##8##2##(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#3)
remained higher than in##2##4##(1996-3#1)(2008-10#1)
remained highly##2##2##(2008-10#2)
remained in the##7##3##(1993-3#1)(1996-3#1)(2008-10#2)(2008-9#1)(2011-2#2)
remained in##10##2##(1993-3#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#2)
remained intact##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
remained largely##4##2##(1991-8#1)(2007-12#1)(2008-11#1)(2008-9#1)
remained limited##2##2##(2008-2#1)(2010-1#1)
remained low##7##2##(1994-2#1)(2008-10#2)(2010-1#1)(2010-8#2)(2011-1#1)
remained minimal##2##2##(2008-10#1)(2011-2#1)
remained moist##3##2##(2008-10#3)
remained negative##2##2##(1997-5#1)(2011-2#1)
remained normal##4##2##(2006-6#1)(2008-7#2)(2010-4#1)
remained on the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
remained on##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
remained positive##2##2##(1996-12#1)(2008-5#1)
remained relatively constant##4##3##(2008-10#3)(2012-2#1)
remained relatively##7##2##(2008-10#4)(2008-11#1)(2008-8#1)(2012-2#1)
remained significant##3##2##(2008-10#1)(2010-10#1)(2012-5#1)
remained significantly##4##2##(2008-10#1)(2008-7#1)(2009-2#1)(2010-9#1)
remained stable at##2##3##(1993-3#1)(2011-1#1)
remained stable##13##2##(1993-3#1)(1996-9#1)(2008-10#3)(2008-11#2)(2008-5#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
remained susceptible to##2##3##(2008-10#1)(2013-1#1)
remained susceptible##3##2##(2008-10#2)(2013-1#1)
remained the same##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
remained the##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2010-1#1)
remained unaffected##3##2##(1990-5#1)(2008-10#1)(2012-8#1)
remained unaltered##5##2##(1994-11#1)(1994-2#1)(2008-11#3)
remained unchanged for##2##3##(1991-11#1)(1995-8#1)
remained unchanged in the##3##4##(1991-6#1)(1996-12#1)(2011-2#1)
remained unchanged in##5##3##(1991-6#1)(1996-1#1)(1996-12#1)(2011-2#1)(2013-1#1)
remained unchanged##26##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
remained unclear##2##2##(2009-6#1)(2011-2#1)
remained under the##2##3##(1993-12#1)(2011-2#1)
remained under##3##2##(1993-12#1)(2010-8#1)(2011-2#1)
remained uninfected##2##2##(2008-10#2)
remained untreated##2##2##(2008-7#1)(2013-8#1)
remained viable##4##2##(2008-10#1)(2008-11#2)(2010-11#1)
remained well##2##2##(1997-5#1)(2008-7#1)
remained within normal##2##3##(2008-5#1)(2010-7#1)
remained within##3##2##(2008-5#1)(2010-7#1)(2013-1#1)
remained##266##1##(1990-11#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#7)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#70)(2008-11#22)(2008-12#2)(2008-2#1)(2008-5#11)(2008-6#2)(2008-7#14)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#2)(2010-1#8)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#1)(2011-9#1)(2012-12#2)(2012-2#3)(2012-3#3)(2012-5#2)(2012-8#2)(2013-1#10)(2013-8#5)
remaining 2##3##2##(1994-12#1)(2011-2#1)(2013-8#1)
remaining 20##2##2##(1996-2#1)(2008-10#1)
remaining 3##3##2##(1993-12#1)(1993-2#1)(2008-8#1)
remaining 4##2##2##(2008-11#1)(2008-7#1)
remaining at##2##2##(2008-10#1)(2008-11#1)
remaining dopaminergic##2##2##(1996-12#2)
remaining five##2##2##(2008-10#1)(2008-9#1)
remaining green leaf area##2##4##(2008-10#2)
remaining in##5##2##(1995-6#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
remaining isolates were of the US-8 strain##2##7##(2008-10#2)
remaining isolates were##3##3##(2008-10#3)
remaining isolates##6##2##(2008-10#6)
remaining nidus and##2##3##(2008-7#2)
remaining nidus##5##2##(2008-7#5)
remaining nine##2##2##(2008-11#1)(2009-1#1)
remaining patients##5##2##(1990-11#1)(1990-12#1)(1992-5#1)(1992-9#1)(2011-1#1)
remaining solution##2##2##(2008-10#1)(2008-11#1)
remaining vegetation##2##2##(2008-8#2)
remaining##193##1##(1990-11#1)(1990-12#2)(1990-6#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#2)(2008-10#62)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#10)(2008-8#9)(2008-9#1)(2009-1#1)(2009-8#2)(2010-3#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#9)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#8)(2013-8#3)
remains a challenge for the##3##5##(2008-11#2)(2013-8#1)
remains a challenge##5##3##(2008-11#2)(2008-3#1)(2012-12#1)(2013-8#1)
remains a challenging problem##2##4##(2010-6#1)(2012-2#1)
remains a challenging##4##3##(2010-6#2)(2011-2#1)(2012-2#1)
remains a concern##2##3##(2011-2#1)(2013-8#1)
remains a key##2##3##(2008-11#1)(2011-3#1)
remains a major health problem##2##5##(2008-9#1)(2013-8#1)
remains a major problem in##2##5##(1997-1#1)(2008-11#1)
remains a major##8##3##(1997-1#1)(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
remains a matter of debate##2##5##(1997-5#1)(2010-11#1)
remains a matter of##4##4##(1997-5#1)(2008-10#1)(2010-11#1)(2013-8#1)
remains a mystery##3##3##(1996-12#1)(2008-7#2)
remains a problem##2##3##(1993-12#1)(2010-12#1)
remains a significant##2##3##(1997-1#1)(2008-11#1)
remains a##51##2##(1993-12#1)(1996-12#2)(1997-1#2)(1997-3#1)(1997-5#2)(1997-8#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#4)
remains an enigma##2##3##(2011-2#1)(2012-2#1)
remains an important cause of##2##5##(2011-2#2)
remains an important##3##3##(2011-2#2)(2013-8#1)
remains an##10##2##(1992-3#1)(1996-11#1)(1997-4#1)(2008-10#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
remains as##3##2##(2008-11#1)(2010-10#1)(2010-11#1)
remains at##2##2##(1993-6#1)(1996-2#1)
remains below##2##2##(1996-2#1)(2008-3#1)
remains considerable##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
remains constant##7##2##(1992-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
remains controversial and##3##3##(2008-7#1)(2011-2#2)
remains controversial in##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
remains controversial whether##2##3##(1994-12#1)(2008-7#1)
remains controversial##14##2##(1992-3#1)(1994-12#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-3#1)
remains difficult to##4##3##(1997-3#1)(2008-10#2)(2011-2#1)
remains difficult##7##2##(1997-3#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
remains disease-free##2##2##(2011-2#2)
remains elusive##8##2##(1992-9#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
remains enigmatic##2##2##(2008-7#1)(2009-10#1)
remains high##3##2##(1997-2#1)(2008-8#1)(2009-9#1)
remains in the membrane of the##2##6##(1990-12#2)
remains in the##6##3##(1990-12#2)(1992-8#1)(1993-8#1)(2008-10#1)(2008-5#1)
remains in##8##2##(1990-12#2)(1992-8#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
remains largely unexplored##2##3##(1992-12#1)(2008-8#1)
remains largely unknown##5##3##(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
remains largely##10##2##(1992-12#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
remains limited##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
remains necessary##2##2##(2008-12#1)(2010-10#1)
remains of##3##2##(1990-8#1)(2008-10#2)
remains one of the most##2##5##(2013-1#2)
remains one of the##3##4##(2007-11#1)(2013-1#2)
remains poorly studied##2##3##(2008-9#1)(2012-2#1)
remains poorly understood##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
remains poorly##8##2##(2008-10#1)(2008-11#1)(2008-9#2)(2010-5#1)(2012-12#1)(2012-2#2)
remains relatively##2##2##(1996-2#1)(1997-1#1)
remains sparse##2##2##(2011-2#1)(2012-2#1)
remains the gold standard for##2##5##(2011-2#1)(2012-3#1)
remains the gold standard##5##4##(2008-7#1)(2011-2#2)(2012-3#2)
remains the most##2##3##(1997-5#1)(2008-7#1)
remains the only##2##3##(1991-11#1)(1996-3#1)
remains the##25##2##(1991-11#1)(1994-5#1)(1995-11#1)(1996-3#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#2)(2010-10#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-3#3)(2013-7#1)
remains tightly##2##2##(1990-5#1)(1991-12#1)
remains to be ascertained##2##4##(1991-2#1)(1995-12#1)
remains to be determined##8##4##(1995-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)
remains to be done##3##4##(1992-3#1)(2008-10#1)(2009-7#1)
remains to be elucidated##6##4##(1994-12#1)(1997-7#1)(2008-9#1)(2009-7#2)(2009-8#1)
remains to be established##4##4##(1991-9#1)(1995-6#1)(1997-6#1)(2010-5#1)
remains to be fully##2##4##(2008-12#1)(2011-2#1)
remains to be investigated##2##4##(2009-8#1)(2011-2#1)
remains to be shown##3##4##(2008-10#2)(2013-8#1)
remains to be##46##3##(1991-2#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-8#2)
remains to##49##2##(1991-2#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
remains uncertain##3##2##(1997-6#1)(2008-10#1)(2008-7#1)
remains unchanged##4##2##(1995-2#1)(2008-10#1)(2012-3#2)
remains unclear if##2##3##(2010-5#1)(2013-8#1)
remains unclear##29##2##(1991-2#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#2)(2011-2#1)(2013-1#1)(2013-8#2)
remains undetermined##2##2##(1993-1#1)(2008-11#1)
remains unknown##19##2##(1990-3#1)(1994-12#1)(1994-8#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)
remains unresolved##4##2##(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
remains valid##2##2##(2008-9#1)(2012-12#1)
remains very##2##2##(2008-11#1)(2012-3#1)
remains##375##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#30)(2008-12#11)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#25)(2008-8#12)(2008-9#8)(2009-10#3)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#4)(2010-5#5)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#35)(2011-3#4)(2012-12#6)(2012-2#22)(2012-3#20)(2013-1#13)(2013-7#2)(2013-8#12)
remapping##2##1##(2009-8#2)
remark##3##1##(2008-11#3)
remarkable ability to##2##3##(2008-11#1)(2013-1#1)
remarkable and##2##2##(2008-12#1)(2008-5#1)
remarkable change##2##2##(1991-3#1)(1993-8#1)
remarkable decrease in the##2##4##(1994-3#1)(2008-1#1)
remarkable decrease in##3##3##(1994-3#1)(2008-1#1)(2008-11#1)
remarkable decrease##4##2##(1994-3#1)(2008-1#1)(2008-11#1)(2011-2#1)
remarkable difference##2##2##(1993-8#1)(2011-2#1)
remarkable feature##2##2##(1992-3#1)(2008-10#1)
remarkable improvement in##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
remarkable increase in the##3##4##(1991-2#1)(2008-5#1)(2012-3#1)
remarkable increase in##4##3##(1991-2#1)(2008-11#1)(2008-5#1)(2012-3#1)
remarkable increase##7##2##(1991-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
remarkable increases##2##2##(1996-2#1)(2008-10#1)
remarkable long-term stability##2##3##(2008-10#2)
remarkable progress##2##2##(2008-10#1)(2008-11#1)
remarkable properties##2##2##(2008-3#1)(2009-12#1)
remarkable resemblance in##2##3##(2010-12#2)
remarkable sensitivity##2##2##(2008-10#2)
remarkable stability##5##2##(1990-5#1)(2008-10#3)(2008-5#1)
remarkable##104##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#6)(1994-3#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#23)(2008-11#9)(2008-12#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-2#5)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
remarkably higher than that##2##4##(2008-9#2)
remarkably increased##2##2##(2008-9#1)(2012-2#1)
remarkably low compared##2##3##(2008-1#1)(2008-10#1)
remarkably low##4##2##(2008-1#1)(2008-10#3)
remarkably reduced##2##2##(1995-8#1)(2008-10#1)
remarkably similar to##3##3##(1993-3#1)(1995-6#1)(2008-9#1)
remarkably similar##7##2##(1991-1#1)(1993-3#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-9#1)
remarkably##47##1##(1991-1#1)(1993-3#2)(1994-11#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#6)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
remarks on the##4##3##(1994-12#1)(1995-5#1)(1996-5#1)(2007-12#1)
remarks##7##1##(1991-6#1)(1994-12#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-8#1)
remedial approach##2##2##(1994-2#1)(1995-11#1)
remedial computer##2##2##(2013-1#2)
remedial##6##1##(1994-2#1)(1995-11#1)(1996-6#1)(2007-11#1)(2013-1#2)
remediation##2##1##(2008-10#1)(2008-4#1)
remedies##6##1##(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)
remedy for##2##2##(1994-12#1)(2008-10#1)
remedy##7##1##(1994-12#1)(1995-6#1)(2008-10#1)(2008-11#2)(2010-11#1)(2013-8#1)
remedy)##2##1##(2008-10#2)
remember that##3##2##(1991-11#1)(1992-1#1)(2013-1#1)
remember##11##1##(1991-11#1)(1992-1#1)(1994-3#1)(2008-11#2)(2008-9#3)(2010-8#1)(2011-2#1)(2013-1#1)
remembered##7##1##(1994-9#1)(1996-11#1)(2007-12#1)(2008-10#1)(2010-1#1)(2010-11#1)(2013-8#1)
remembering##3##1##(1997-3#1)(2008-12#1)(2008-5#1)
remifentanil##10##1##(2011-2#10)
remind##2##1##(2008-12#1)(2008-3#1)
reminder letter##2##2##(1997-2#1)(2008-1#1)
reminder##6##1##(1994-3#1)(1996-2#1)(1997-2#1)(2008-1#1)(2010-8#1)(2011-2#1)
reminds us##2##2##(2012-3#2)
reminds##4##1##(2012-3#3)(2013-1#1)
reminiscence##2##1##(2008-10#1)(2008-11#1)
reminiscent of the##6##3##(1993-3#1)(1997-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)
reminiscent of##9##2##(1993-3#1)(1993-8#1)(1995-2#1)(1997-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)
remission and##2##2##(1996-11#1)(2010-12#1)
remission as##2##2##(2008-8#1)(2013-8#1)
remission from##3##2##(2009-3#3)
remission in depression##2##3##(2012-3#2)
remission in patients with##2##4##(2008-10#1)(2008-8#1)
remission in##6##2##(2008-10#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-3#2)
remission of##9##2##(1991-8#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-11#1)(2008-10#1)(2010-11#1)(2011-2#2)
remission or##2##2##(1990-8#1)(1992-3#1)
remission rate##2##2##(1990-12#1)(1992-2#1)
remission rates##2##2##(2008-10#1)(2013-8#1)
remission was##3##2##(1992-2#1)(2011-2#1)(2012-3#1)
remission##70##1##(1990-12#2)(1990-6#2)(1990-8#2)(1991-2#5)(1991-6#2)(1991-8#4)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-11#1)(1996-11#3)(2008-1#3)(2008-10#7)(2008-3#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#4)(2012-3#7)(2013-1#1)(2013-8#3)
remit of##2##2##(2008-11#2)
remit##5##1##(2008-11#5)
remnant of the##2##3##(1995-5#1)(2008-10#1)
remnant of##5##2##(1995-5#1)(2008-10#1)(2009-6#1)(2009-8#1)(2011-2#1)
remnant##19##1##(1991-1#2)(1995-5#1)(2008-10#4)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#2)(2013-1#5)
remnants of triglyceride-rich lipoproteins##2##4##(1995-6#2)
remnants of##3##2##(1995-6#2)(2011-2#1)
remnants##5##1##(1995-6#2)(2008-11#1)(2011-2#1)(2012-3#1)
remodeling and##8##2##(2008-1#1)(2009-1#2)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
remodeling associated##2##2##(1997-8#1)(2008-1#1)
remodeling by##2##2##(2008-11#1)(2012-3#1)
remodeling in##5##2##(2008-9#1)(2009-10#1)(2012-12#1)(2013-8#2)
remodeling is##3##2##(2009-1#1)(2011-2#2)
remodeling of the extracellular matrix##2##5##(2008-1#1)(2009-8#1)
remodeling of the##4##3##(2008-1#1)(2008-11#1)(2009-7#1)(2009-8#1)
remodeling of##7##2##(2008-1#1)(2008-11#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-3#1)
remodeling##47##1##(1991-11#2)(1996-12#1)(1997-8#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-9#1)(2009-1#5)(2009-10#2)(2009-7#2)(2009-8#3)(2009-9#1)(2011-2#6)(2011-9#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#6)
remodelling and##2##2##(2008-11#1)(2010-10#1)
remodelling##13##1##(1993-3#1)(1995-11#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
remote and##2##2##(2008-11#1)(2010-8#1)
remote areas##3##2##(1990-6#1)(2008-10#1)(2008-9#1)
remote carbonyl groups##2##3##(1996-5#2)
remote communities##2##2##(1997-4#1)(2010-9#1)
remote consultation##3##2##(2008-1#3)
remote control##2##2##(2008-10#1)(2011-2#1)
remote detection##2##2##(2008-3#2)
remote locations##2##2##(2008-10#2)
remote sensing of atmospheric ammonia by use of a coherent##2##10##(2008-3#2)
remote sensing of atmospheric##3##4##(2008-3#3)
remote sensing of the##2##4##(2008-3#2)
remote sensing of##11##3##(2008-10#1)(2008-2#1)(2008-3#9)
remote sensing##21##2##(2008-10#5)(2008-2#3)(2008-3#13)
remote##82##1##(1990-5#2)(1990-6#1)(1992-1#1)(1993-6#1)(1995-12#1)(1996-5#2)(1997-4#5)(1997-8#2)(2007-11#2)(2007-12#1)(2008-1#4)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#19)(2008-7#1)(2008-9#3)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
remote-sensing##6##1##(2008-2#1)(2008-3#5)
remotely from the##2##3##(2008-10#1)(2008-6#1)
remotely from##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
remotely sensed images##2##3##(2008-3#2)
remotely sensed##3##2##(2008-3#3)
remotely##12##1##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#4)(2008-6#1)(2008-9#2)(2012-12#1)
removable##7##1##(2008-10#1)(2008-11#1)(2013-1#5)
removal ability##2##2##(2008-12#2)
removal and##6##2##(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)
removal are##2##2##(2008-11#1)(2008-4#1)
removal by##5##2##(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
removal from the##3##3##(1991-3#1)(1995-8#1)(1996-2#1)
removal from water##2##3##(2008-10#2)
removal from##9##2##(1991-3#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2013-1#1)
removal in##4##2##(1990-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
removal is##3##2##(1994-12#1)(2008-10#2)
removal of a##2##3##(2008-7#2)
removal of debris##2##3##(2008-9#1)(2012-3#1)
removal of large##2##3##(2008-10#1)(2008-7#1)
removal of necrotic##2##3##(2011-2#2)
removal of submucous leiomyomas##2##4##(1991-2#2)
removal of surface##2##3##(2008-10#1)(2008-11#1)
removal of susceptible##2##3##(2008-10#2)
removal of the medial##2##4##(1994-8#1)(2008-7#1)
removal of the salivary glands##2##5##(2008-4#2)
removal of the tumor##2##4##(2008-12#1)(2011-2#1)
removal of the tumour##3##4##(2008-7#3)
removal of the##61##3##(1990-10#1)(1990-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-8#1)(1995-12#2)(1997-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#10)(2008-9#1)(2009-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#1)(2013-1#5)(2013-7#1)
removal of##197##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#2)(1991-2#4)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-11#2)(1995-12#2)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#50)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#23)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2010-10#2)(2010-12#3)(2010-7#1)(2011-1#5)(2011-2#19)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#13)(2013-7#1)
removal or##3##2##(2008-6#1)(2009-6#1)(2013-1#1)
removal process##3##2##(1997-5#1)(2011-1#1)(2011-2#1)
removal rate##2##2##(2008-8#1)(2012-3#1)
removal torque##4##2##(2009-7#4)
removal was##6##2##(1991-6#1)(2008-10#2)(2008-7#2)(2010-12#1)
removal with##2##2##(2008-10#1)(2012-3#1)
removal##306##1##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#3)(1991-12#2)(1991-2#7)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#5)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2008-1#3)(2008-10#72)(2008-11#11)(2008-12#9)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#3)(2008-7#36)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#5)(2010-10#2)(2010-12#4)(2010-7#1)(2011-1#6)(2011-2#25)(2012-12#3)(2012-2#2)(2012-3#8)(2013-1#18)(2013-7#1)
removals##4##1##(2008-8#2)(2008-9#1)(2009-10#1)
remove the##32##2##(1990-11#1)(1993-3#1)(2007-12#1)(2008-10#20)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#2)(2013-8#2)
remove##98##1##(1990-11#1)(1990-12#1)(1991-6#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#48)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#2)(2010-12#1)(2011-1#1)(2011-2#5)(2011-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
removed after##2##2##(2008-7#1)(2013-8#1)
removed all##3##2##(1996-12#1)(1997-2#1)(1997-3#1)
removed and the##3##3##(1993-8#1)(2008-7#2)
removed and##13##2##(1993-8#1)(2008-10#1)(2008-12#3)(2008-7#5)(2011-2#2)(2013-1#1)
removed at surgery##2##3##(2010-3#1)(2012-3#1)
removed at the##2##3##(1990-11#1)(2011-2#1)
removed at##7##2##(1990-11#1)(1990-8#1)(2008-5#1)(2009-1#1)(2010-3#1)(2011-2#1)(2012-3#1)
removed by a##2##3##(1993-12#1)(2008-11#1)
removed by an endoscopic transsphenoidal approach##2##6##(2011-2#2)
removed by treatment with##2##4##(2008-10#1)(2008-4#1)
removed by##28##2##(1991-6#1)(1992-9#1)(1993-12#1)(1993-6#2)(1993-8#1)(1995-5#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#4)
removed from the##22##3##(1991-11#2)(1996-12#1)(2008-10#12)(2008-11#3)(2008-5#2)(2008-7#1)(2011-2#1)
removed from##36##2##(1991-11#2)(1991-3#1)(1994-8#1)(1996-12#1)(1996-6#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-5#4)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
removed in##2##2##(1997-3#1)(2008-10#1)
removed or##2##2##(1997-3#2)
removed the##3##2##(1990-9#1)(1994-8#1)(2012-12#1)
removed using##2##2##(2008-10#2)
removed via a##2##3##(2008-7#1)(2011-2#1)
removed with##5##2##(2008-10#2)(2008-9#1)(2010-11#1)(2012-3#1)
removed##179##1##(1990-11#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-9#1)(1993-12#3)(1993-6#2)(1993-8#2)(1994-8#3)(1995-12#1)(1995-5#1)(1996-12#3)(1996-6#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-7#1)(2006-6#1)(2008-10#51)(2008-11#10)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#9)(2008-7#14)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#20)(2012-12#2)(2012-3#3)(2013-1#6)(2013-8#1)
removes some##2##2##(2008-10#1)(2008-8#1)
removes the##4##2##(1990-3#1)(1995-10#1)(2008-10#2)
removes##16##1##(1990-3#1)(1993-12#1)(1995-10#1)(2008-10#5)(2008-11#2)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
removing Cu(II) ions##2##3##(2008-10#2)
removing a##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
removing formulations##2##2##(2008-10#2)
removing the##15##2##(1995-5#1)(1996-5#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2012-3#1)(2013-1#1)
removing##67##1##(1990-5#1)(1990-9#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#29)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
remunerated##3##1##(1994-12#3)
remuneration##5##1##(1990-6#1)(2008-1#2)(2008-7#1)(2010-10#1)
remyelination##2##1##(2008-7#1)(2012-2#1)
renaissance in##2##2##(2008-10#1)(2008-8#1)
renal ECM accumulation##2##3##(2011-2#2)
renal MT##2##2##(1993-12#2)
renal and subclavian##2##3##(2011-2#2)
renal and##6##2##(1994-5#3)(1997-8#1)(2011-2#2)
renal anemia##5##2##(2008-10#1)(2008-8#4)
renal arteries were##2##3##(1993-8#1)(1997-8#1)
renal arteries##6##2##(1993-8#2)(1997-8#3)(2008-12#1)
renal artery stenosis##7##3##(1997-8#3)(2008-12#4)
renal artery##13##2##(1994-9#2)(1997-8#4)(2008-11#1)(2008-12#5)(2010-12#1)
renal aspergillosis##2##2##(2008-10#2)
renal biopsy##5##2##(1995-5#1)(2008-1#1)(2011-2#1)(2013-8#2)
renal blood flow##3##3##(1996-6#1)(2010-12#1)(2013-8#1)
renal calculi##2##2##(1995-8#1)(2008-1#1)
renal cancer##4##2##(1991-6#1)(2008-5#1)(2011-2#2)
renal carcinomas##2##2##(1995-10#2)
renal cell carcinoma (RCC)##4##4##(1990-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
renal cell carcinoma cell##2##4##(2008-11#1)(2010-8#1)
renal cell carcinoma##25##3##(1990-2#2)(1990-8#2)(1991-8#4)(1992-3#4)(1994-12#1)(2008-10#1)(2008-11#3)(2010-8#2)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
renal cell carcinoma]##2##3##(2011-3#1)(2012-3#1)
renal cell carcinomas##3##3##(2009-4#1)(2010-8#1)(2011-2#1)
renal cell##32##2##(1990-2#2)(1990-8#2)(1991-8#4)(1992-3#4)(1994-12#1)(1994-3#1)(2008-10#1)(2008-11#3)(2009-4#1)(2010-8#3)(2010-9#1)(2011-2#5)(2011-3#1)(2012-3#2)(2013-1#1)
renal cortical slices##2##3##(1994-5#2)
renal disease (ESRD)##8##3##(1991-3#1)(1995-1#1)(1995-12#2)(1996-2#2)(2008-1#1)(2012-2#1)
renal disease##37##2##(1991-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1996-2#2)(2008-1#9)(2008-10#4)(2009-6#3)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#3)
renal disease]##2##2##(1991-2#2)
renal diseases##8##2##(1991-12#1)(1994-5#1)(1997-5#1)(2008-1#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
renal dysfunction in##2##3##(2011-2#1)(2013-1#1)
renal dysfunction##8##2##(2011-2#3)(2012-3#3)(2013-1#2)
renal effects##2##2##(1990-9#1)(2008-5#1)
renal failure and##6##3##(1993-3#1)(1997-8#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
renal failure due to##2##4##(1997-5#1)(1997-8#1)
renal failure in##4##3##(1995-5#1)(2008-1#3)
renal failure is##3##3##(1994-5#1)(2008-1#2)
renal failure to##3##3##(1995-12#2)(2008-1#1)
renal failure##48##2##(1991-11#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#3)(1995-5#1)(1997-5#1)(1997-8#3)(2007-12#1)(2008-1#11)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#4)(2012-3#2)(2013-1#7)(2013-8#1)
renal function in##2##3##(2011-2#1)(2013-1#1)
renal function is##2##3##(2008-1#1)(2011-2#1)
renal function##22##2##(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2011-2#8)(2011-3#2)(2013-1#2)(2013-8#1)
renal hydatid##2##2##(2008-10#2)
renal impairment##7##2##(2011-2#1)(2013-1#6)
renal injuries##4##2##(1990-9#2)(2008-10#1)(2012-2#1)
renal injury##4##2##(2008-1#1)(2009-6#1)(2013-8#2)
renal insufficiency##10##2##(1990-2#2)(1993-3#1)(2008-12#1)(2008-7#1)(2011-2#2)(2011-3#1)(2013-1#2)
renal involvement##2##2##(1997-8#1)(2011-2#1)
renal length##3##2##(2008-10#3)
renal lesions were##2##3##(2008-5#2)
renal lesions##5##2##(2008-5#3)(2013-1#2)
renal manifestations of##2##3##(2013-1#2)
renal manifestations##3##2##(2013-1#3)
renal measures##2##2##(2013-1#2)
renal or hepatic##2##3##(1995-11#1)(2012-3#1)
renal or##4##2##(1995-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
renal ossifying tumor of infancy##2##5##(2008-10#2)
renal ossifying tumor##3##3##(2008-10#3)
renal osteodystrophy##2##2##(2011-2#2)
renal pelvis and##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
renal protection##3##2##(1996-6#2)(2013-1#1)
renal proximal tubule cells##2##4##(1991-5#1)(2008-11#1)
renal proximal tubule##3##3##(1991-5#1)(1997-1#1)(2008-11#1)
renal proximal tubules##3##3##(1997-1#3)
renal proximal##6##2##(1991-5#1)(1997-1#4)(2008-11#1)
renal regulation##2##2##(2008-6#2)
renal replacement therapy in##2##4##(2008-11#2)
renal replacement therapy##5##3##(2008-10#1)(2008-11#2)(2010-3#1)(2012-3#1)
renal replacement##6##2##(2008-10#1)(2008-11#2)(2010-11#1)(2010-3#1)(2012-3#1)
renal scarring##2##2##(1990-3#1)(2008-10#1)
renal tissue##5##2##(1990-12#1)(1992-3#1)(2011-2#3)
renal toxicity of gold##4##4##(1994-5#4)
renal toxicity##6##2##(1994-5#6)
renal transplant patients##2##3##(2008-1#1)(2010-7#1)
renal transplant##7##2##(1995-2#2)(2008-1#1)(2008-10#1)(2010-7#2)(2013-1#1)
renal transplantation##13##2##(1992-12#1)(1994-5#2)(2008-1#3)(2010-7#2)(2011-2#2)(2012-12#2)(2013-1#1)
renal tubular cells##2##3##(1992-3#1)(1996-12#1)
renal tubular dysfunction##2##3##(1996-6#2)
renal tubular##7##2##(1992-3#2)(1996-12#1)(1996-6#2)(2008-1#2)
renal tubule##2##2##(2008-11#1)(2008-9#1)
renal tumor of infancy##2##4##(2008-10#2)
renal tumor##5##2##(1992-2#1)(2008-10#3)(2013-1#1)
renal tumors##4##2##(1994-5#3)(2009-5#1)
renal vein##5##2##(2010-11#4)(2011-2#1)
renal##438##1##(1990-12#2)(1990-2#6)(1990-3#1)(1990-8#2)(1990-9#4)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#5)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#7)(1992-5#2)(1992-6#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#2)(1994-12#2)(1994-3#3)(1994-5#23)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#7)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#8)(1997-1#4)(1997-2#1)(1997-3#2)(1997-5#3)(1997-8#12)(2007-12#1)(2008-1#32)(2008-10#50)(2008-11#11)(2008-12#9)(2008-3#1)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2009-5#2)(2009-6#6)(2010-10#2)(2010-11#7)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#52)(2011-3#7)(2012-12#3)(2012-2#4)(2012-3#12)(2013-1#44)(2013-8#16)
renal&quot##2##1##(2008-1#2)
renaturation##3##1##(2008-10#2)(2009-3#1)
renatured##2##1##(1990-11#1)(1995-6#1)
rendement scolaire##2##2##(2008-11#2)
rendement##3##1##(2008-11#3)
render the##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
render them##2##2##(2010-7#2)
render##17##1##(1994-1#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
rendered it##2##2##(1995-6#1)(2008-10#1)
rendered more##2##2##(1997-4#1)(1997-7#1)
rendered##25##1##(1991-2#1)(1992-1#1)(1992-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-5#2)(2008-6#2)(2008-7#2)(2010-1#1)(2011-7#1)(2012-2#1)(2013-1#1)
rendering the method suitable for determination of##2##7##(2008-10#2)
rendering the method suitable for##3##5##(2008-10#3)
rendering the##8##2##(1994-11#1)(1996-9#1)(2008-10#4)(2008-7#1)(2013-1#1)
rendering##26##1##(1992-1#1)(1994-11#1)(1996-9#2)(2008-10#5)(2008-11#4)(2008-4#1)(2008-6#7)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#2)
renderings##3##1##(2011-7#3)
renders it##2##2##(1997-2#1)(2008-10#1)
renders the##2##2##(1996-11#1)(1997-7#1)
renders##8##1##(1996-11#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-1#1)
rendition of##2##2##(2008-8#1)(2013-1#1)
renewable microcolumn##2##2##(2008-10#2)
renewable surface##3##2##(2008-10#3)
renewable##16##1##(1993-3#1)(2008-10#13)(2008-8#1)(2013-1#1)
renewal and##2##2##(2008-11#1)(2008-5#1)
renewal of##3##2##(1994-12#1)(2008-10#2)
renewal##18##1##(1990-11#1)(1993-2#3)(1994-12#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-2#1)
renewed attention##2##2##(1992-12#1)(2013-1#1)
renewed by##2##2##(2008-10#2)
renewed focus on##2##3##(2008-11#1)(2008-12#1)
renewed##24##1##(1991-2#1)(1992-12#1)(1993-1#1)(1995-1#1)(1996-12#1)(1996-3#2)(1997-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
renewing##3##1##(1995-6#1)(2008-11#1)(2008-8#1)
renews##2##1##(1994-2#1)(2012-2#1)
reniformis##4##1##(2008-10#4)
renin angiotensin system in##2##4##(2008-11#2)
renin angiotensin system##4##3##(2008-11#3)(2013-1#1)
renin mRNA levels and renin production##2##6##(1993-6#2)
renin mRNA levels##3##3##(1993-6#3)
renin mRNA##5##2##(1993-6#5)
renin production##3##2##(1993-6#3)
renin##15##1##(1993-6#11)(2008-11#3)(2013-1#1)
renin-angiotensin system##2##2##(2008-11#1)(2013-7#1)
renocolic fistula##4##2##(2013-1#4)
renogram##2##1##(2008-10#1)(2013-1#1)
renovascular##2##1##(1994-9#1)(1997-2#1)
renovation of##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2012-3#2)
renovation##8##1##(1991-12#1)(1992-2#1)(1994-12#1)(2008-10#2)(2008-11#1)(2012-3#2)
reocclusion and##2##2##(1992-9#1)(2006-6#1)
reocclusion##3##1##(1992-9#1)(1993-1#1)(2006-6#1)
reopened##3##1##(1996-9#1)(1997-3#1)(2008-11#1)
reoperation##9##1##(1995-3#1)(1996-11#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#3)(2013-1#1)
reorganisation##2##1##(1991-3#1)(2011-2#1)
reorganization and recruitment##3##3##(2012-2#3)
reorganization and##6##2##(1994-9#1)(2008-11#1)(2012-2#4)
reorganization of the##4##3##(2008-9#1)(2011-2#1)(2013-1#2)
reorganization of##6##2##(1997-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)
reorganization##22##1##(1991-2#1)(1992-5#1)(1994-9#1)(1996-6#1)(1997-3#1)(2008-11#1)(2008-9#3)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#4)(2013-1#3)(2013-8#1)
reorganized##3##1##(2008-3#1)(2011-2#2)
reorient##2##1##(1993-2#1)(2008-1#1)
reorientation of the##5##3##(1993-1#1)(2008-1#1)(2008-10#2)(2011-2#1)
reorients##3##1##(1991-5#2)(1994-5#1)
reovirus##3##1##(2008-10#3)
reoxidation of the##2##3##(1990-5#1)(2008-10#1)
reoxidation##4##1##(1990-5#1)(2008-10#3)
reoxygenation##2##1##(2008-11#2)
rep gene mutants##2##3##(2008-10#2)
rep gene##6##2##(2008-10#6)
rep##10##1##(2008-10#8)(2008-8#2)
rep-PCR and##2##2##(2008-10#2)
rep-PCR data##2##2##(2008-10#2)
rep-PCR fingerprints of##2##3##(2008-10#2)
rep-PCR fingerprints##4##2##(2008-10#4)
rep-PCR##23##1##(2008-10#23)
repK mRNA##2##2##(1997-6#2)
repK##4##1##(1997-6#4)
repair activity##2##2##(1993-11#1)(2008-8#1)
repair and V(D)J recombination##4##4##(1996-2#2)(2013-1#2)
repair and##17##2##(1993-8#1)(1994-9#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#3)(2013-1#7)
repair at##2##2##(2008-12#1)(2012-3#1)
repair by##3##2##(1994-8#1)(2008-11#1)(2011-2#1)
repair capacity##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
repair foci##2##2##(2011-2#2)
repair has##2##2##(2008-10#1)(2010-7#1)
repair in##8##2##(1992-5#2)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)
repair is##4##2##(1992-5#1)(1993-3#1)(2008-11#2)
repair mechanism##4##2##(2007-12#2)(2008-8#1)(2013-1#1)
repair of bladder exstrophy##2##4##(2008-10#2)
repair of distal##2##3##(1993-1#1)(2012-3#1)
repair of proximal##2##3##(2008-10#1)(2008-9#1)
repair of type##2##3##(2008-8#1)(2013-1#1)
repair of##29##2##(1992-5#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-9#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-2#5)(2012-3#1)(2013-1#1)
repair or##6##2##(2008-11#1)(2008-9#2)(2009-9#1)(2011-2#2)
repair processes of##2##3##(2007-8#2)
repair processes##3##2##(2007-8#2)(2008-11#1)
repair rates##3##2##(2008-11#3)
repair the damage##2##3##(2008-5#1)(2008-7#1)
repair the##4##2##(2008-5#2)(2008-7#1)(2013-8#1)
repair with##2##2##(2008-11#1)(2011-2#1)
repair##223##1##(1990-5#1)(1990-9#1)(1991-2#1)(1992-5#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-8#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#2)(1997-4#1)(1997-7#1)(1997-9#1)(2007-12#5)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#32)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#7)(2008-9#7)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#7)(2010-6#2)(2010-7#3)(2010-8#6)(2011-1#1)(2011-2#28)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#26)(2013-8#3)
repaired by##5##2##(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#1)
repaired with a##2##3##(2008-12#1)(2011-2#1)
repaired with##4##2##(1991-2#1)(1993-3#1)(2008-12#1)(2011-2#1)
repaired##19##1##(1991-2#1)(1993-3#1)(2008-11#3)(2008-12#3)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#3)(2012-3#2)(2013-1#1)
repairing##5##1##(2008-5#1)(2011-2#1)(2011-3#1)(2012-5#1)(2013-1#1)
repairs##4##1##(1993-1#1)(2008-10#2)(2010-6#1)
repanda##4##1##(2008-10#4)
repealed##2##1##(1996-5#2)
repeat and a##2##3##(2008-11#1)(2008-6#1)
repeat and##6##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-1#1)
repeat domain##2##2##(1993-12#1)(1996-2#1)
repeat in##3##2##(2008-6#2)(2008-7#1)
repeat of the##2##3##(1992-3#1)(2013-8#1)
repeat of##6##2##(1992-3#1)(2008-10#3)(2008-7#1)(2013-8#1)
repeat prescribing and##2##3##(2008-11#2)
repeat prescribing has not been##2##5##(2008-11#2)
repeat prescribing##5##2##(2008-11#5)
repeat prescription##2##2##(2008-11#2)
repeat prescriptions##4##2##(1995-11#1)(2008-11#3)
repeat protein##2##2##(2008-9#1)(2009-8#1)
repeat purchase##2##2##(1993-12#2)
repeat region of##2##3##(1991-7#1)(1997-7#1)
repeat region##6##2##(1991-7#1)(1997-7#1)(2008-10#3)(2010-8#1)
repeat sequence##4##2##(1993-2#1)(1995-5#1)(2008-11#1)(2008-8#1)
repeat sequences##6##2##(1991-2#1)(2008-10#1)(2008-8#3)(2009-10#1)
repeat to consultation ratios##2##4##(2008-11#2)
repeat to consultation##3##3##(2008-11#3)
repeat unit##3##2##(1995-6#1)(2008-10#2)
repeat units##3##2##(1997-6#2)(2008-7#1)
repeat##147##1##(1990-3#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#6)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#1)(2008-10#30)(2008-11#18)(2008-12#8)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#9)(2008-9#5)(2009-10#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
repeatabilities##2##1##(2008-10#2)
repeatability and recovery##2##3##(2008-10#2)
repeatability and reproducibility of##2##4##(2008-10#1)(2008-5#1)
repeatability and reproducibility##3##3##(2008-10#2)(2008-5#1)
repeatability and##19##2##(2008-10#17)(2008-5#1)(2012-12#1)
repeatability at the##3##3##(2008-10#3)
repeatability for##4##2##(2008-10#4)
repeatability is##3##2##(2008-10#3)
repeatability of determination (R##2##4##(2008-10#2)
repeatability of the##17##3##(2008-10#17)
repeatability of##33##2##(1996-3#1)(2008-10#29)(2008-5#2)(2013-8#1)
repeatability was 0##2##3##(2008-10#2)
repeatability was##5##2##(2008-10#5)
repeatability were##2##2##(2008-10#2)
repeatability##111##1##(1996-3#1)(2008-10#105)(2008-5#3)(2012-12#1)(2013-8#1)
repeatable (R##2##2##(2008-10#2)
repeatable and reproducible##2##3##(2008-10#1)(2008-5#1)
repeatable##15##1##(1995-12#1)(2008-10#8)(2008-12#2)(2008-5#1)(2010-10#1)(2010-7#1)(2013-1#1)
repeated AMPH##2##2##(2013-8#2)
repeated DNA##2##2##(2008-10#1)(2008-8#1)
repeated administration##2##2##(1996-12#1)(2008-11#1)
repeated after##2##2##(2011-2#1)(2013-1#1)
repeated analysis##2##2##(2008-10#2)
repeated application of##2##3##(2008-5#2)
repeated applications##2##2##(1990-7#1)(2008-8#1)
repeated aspirating/dispensing cycles##2##3##(2008-10#2)
repeated at##2##2##(1992-3#1)(2008-10#1)
repeated attacks of##3##3##(1995-5#1)(2009-7#2)
repeated attacks##4##2##(1995-5#1)(2009-7#3)
repeated batch##5##2##(2008-11#3)(2008-7#2)
repeated cycles##2##2##(2008-10#1)(2008-7#1)
repeated every##3##2##(1992-2#1)(2008-10#2)
repeated exposure##4##2##(2008-10#1)(2012-2#3)
repeated exposures##2##2##(2008-10#2)
repeated haemorrhage##2##2##(1997-6#1)(2008-7#1)
repeated in reverse order##2##4##(1993-2#1)(2008-10#1)
repeated in##7##2##(1993-2#1)(1997-3#1)(2008-10#2)(2008-9#1)(2010-6#1)(2011-1#1)
repeated injections##2##2##(2008-10#1)(2013-8#1)
repeated measurements of##3##3##(1992-9#1)(2008-10#2)
repeated measurements on##2##3##(1996-3#2)
repeated measurements##9##2##(1992-9#2)(1996-3#2)(2008-10#4)(2013-1#1)
repeated measures analysis of variance##2##5##(2010-9#1)(2013-1#1)
repeated measures analysis##3##3##(2008-10#1)(2010-9#1)(2013-1#1)
repeated measures and##2##3##(2008-12#1)(2008-9#1)
repeated measures with##2##3##(2010-10#1)(2013-1#1)
repeated measures##17##2##(1992-9#3)(1993-3#1)(1994-9#2)(2008-10#2)(2008-12#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-9#1)(2013-1#3)(2013-8#1)
repeated observations##2##2##(1996-3#1)(2009-12#1)
repeated on##3##2##(1996-3#1)(2008-10#2)
repeated or chronic##2##3##(2010-12#2)
repeated sequences##2##2##(1996-6#1)(2008-10#1)
repeated testing##2##2##(1993-6#2)
repeated the##2##2##(2008-10#1)(2013-8#1)
repeated treatments##2##2##(2008-10#1)(2012-2#1)
repeated use##3##2##(2008-10#2)(2011-2#1)
repeated##203##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-9#5)(1993-2#2)(1993-3#1)(1993-6#3)(1994-2#4)(1994-6#1)(1994-9#4)(1995-2#1)(1995-5#2)(1995-8#4)(1996-12#1)(1996-2#1)(1996-3#5)(1996-6#3)(1996-8#1)(1997-3#1)(1997-6#2)(1997-8#1)(2008-1#2)(2008-10#44)(2008-11#14)(2008-12#3)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#13)(2013-8#8)
repeatedly applied##2##2##(2008-10#1)(2013-1#1)
repeatedly exposed to##2##3##(1992-3#1)(1995-5#1)
repeatedly in##2##2##(2008-10#1)(2008-9#1)
repeatedly over time##2##3##(2008-9#1)(2010-1#1)
repeatedly over##3##2##(1991-12#1)(2008-9#1)(2010-1#1)
repeatedly##41##1##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-5#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#2)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
repeating the##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
repeating units there was one##2##5##(2008-10#2)
repeating units##4##2##(1992-12#1)(1994-11#1)(2008-10#2)
repeating##14##1##(1992-12#2)(1992-9#1)(1994-11#1)(2008-10#4)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-3#1)
repeats and several##2##3##(1993-12#1)(1995-12#1)
repeats and##6##2##(1993-12#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-7#1)
repeats in the##2##3##(1996-8#1)(2011-2#1)
repeats in##5##2##(1993-8#1)(1996-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
repeats located##2##2##(2008-10#1)(2008-11#1)
repeats of a##2##3##(1992-10#1)(1997-7#1)
repeats of the##4##3##(1991-7#1)(1991-9#1)(1996-6#1)(2008-10#1)
repeats of##9##2##(1991-7#1)(1991-9#1)(1992-10#1)(1996-6#1)(1997-7#1)(2008-10#4)
repeats was##2##2##(1995-8#1)(2008-10#1)
repeats within the##2##3##(1995-6#1)(2008-7#1)
repeats##72##1##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#2)(1993-12#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-5#2)(1995-12#2)(1995-6#3)(1995-8#3)(1996-2#1)(1996-6#2)(1996-8#3)(1997-6#4)(1997-7#2)(2008-10#20)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#2)(2010-7#2)(2011-2#2)(2012-3#1)
repelled from the##2##3##(2008-10#1)(2008-5#1)
repellent formulations##2##2##(2008-5#2)
repellent##6##1##(2008-10#3)(2008-5#3)
repercussion in##2##2##(1991-11#1)(2011-2#1)
repercussion##4##1##(1991-11#1)(2008-11#2)(2011-2#1)
reperfusion and##3##2##(1996-12#1)(2012-3#1)(2013-1#1)
reperfusion for 240 min##2##4##(2010-1#2)
reperfusion injury##4##2##(1992-9#3)(1996-2#1)
reperfusion##21##1##(1992-9#4)(1994-3#1)(1996-12#3)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-1#4)(2011-2#3)(2012-3#1)(2013-1#1)
repertoire of B cells##3##4##(2008-11#3)
repertoire of behaviors##2##3##(2008-10#1)(2012-2#1)
repertoire of the##3##3##(1996-12#1)(1997-9#1)(2008-11#1)
repertoire of##15##2##(1991-2#1)(1996-12#1)(1997-9#1)(2008-10#2)(2008-11#6)(2009-8#1)(2011-1#1)(2012-2#2)
repertoire##22##1##(1991-2#1)(1996-12#1)(1997-9#1)(2008-10#2)(2008-11#8)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#3)
repertoires of##2##2##(2008-11#2)
repertoires##9##1##(2007-12#1)(2008-11#3)(2008-8#2)(2008-9#1)(2010-2#2)
repetition detection##2##2##(2013-8#2)
repetition priming to##2##3##(2010-7#2)
repetition priming##3##2##(2010-7#3)
repetition rate and##2##3##(2007-11#2)
repetition rate are##2##3##(2007-11#1)(2008-2#1)
repetition rate for a##2##4##(2008-3#2)
repetition rate of the##2##4##(2008-3#2)
repetition rate of##7##3##(2007-12#1)(2008-3#6)
repetition rate##17##2##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#10)(2010-1#1)
repetition rates##4##2##(2008-3#4)
repetition##36##1##(2007-11#4)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#16)(2009-11#2)(2010-1#1)(2010-7#3)(2011-1#1)(2011-2#2)(2013-8#3)
repetitions of##3##2##(1992-4#1)(2008-11#1)(2010-1#1)
repetitions were completed##2##3##(2010-1#2)
repetitions were##3##2##(2008-10#1)(2010-1#2)
repetitions##12##1##(1992-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-1#3)(2010-7#1)(2011-2#1)(2013-1#1)
repetitive DNA sequences##3##3##(1990-5#1)(2008-10#2)
repetitive DNA##11##2##(1990-5#1)(1995-12#1)(1995-2#1)(2008-10#7)(2008-11#1)
repetitive SIB##2##2##(2008-11#2)
repetitive and##3##2##(2008-10#3)
repetitive applications of Pseudomonas putida 06909-rif/nal##2##6##(2008-10#2)
repetitive determinations of##2##3##(2008-10#2)
repetitive element-based polymerase chain reaction (rep-PCR)##2##6##(2008-10#2)
repetitive elements##2##2##(1993-12#1)(2008-10#1)
repetitive extragenic palindromic polymerase chain reaction##2##6##(2008-10#2)
repetitive extragenic palindromic##5##3##(1990-11#1)(2008-10#4)
repetitive injections of##2##3##(2008-10#2)
repetitive intrathecal##2##2##(2010-12#2)
repetitive measurements##2##2##(2008-10#1)(2008-2#1)
repetitive peptide with a consensus sequence of##2##7##(1990-8#1)(1991-12#1)
repetitive sequence-based polymerase chain reaction (rep-PCR)##2##6##(2008-10#2)
repetitive sequence-based polymerase chain reaction##7##5##(2008-10#7)
repetitive sequences##10##2##(1991-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-10#3)(2009-10#1)(2010-8#1)(2012-2#1)
repetitive stimulation##2##2##(1990-5#1)(2012-3#1)
repetitive transcranial magnetic stimulation (rTMS) to##2##6##(2010-5#1)(2011-2#1)
repetitive transcranial magnetic stimulation (rTMS)##3##5##(2010-5#1)(2010-7#1)(2011-2#1)
repetitive transcranial magnetic stimulation##4##4##(2010-5#1)(2010-7#2)(2011-2#1)
repetitive##107##1##(1990-11#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#1)(1993-12#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-6#1)(2008-10#55)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2009-10#1)(2010-12#2)(2010-5#1)(2010-7#3)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)
repetitively##7##1##(1995-12#1)(2008-10#4)(2008-3#1)(2008-7#1)
replace Ca2+##3##2##(1990-5#1)(1995-11#2)
replace or##2##2##(1990-11#1)(2010-7#1)
replace the##9##2##(1990-2#1)(1992-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-4#1)(2012-3#1)
replace##49##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#2)(1996-2#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-7#1)(2012-2#1)(2012-3#3)(2013-8#1)
replaceable##2##1##(2008-10#1)(2008-11#1)
replaced at##2##2##(1997-7#1)(2008-10#1)
replaced by Ala##2##3##(1994-5#2)
replaced by a##11##3##(1992-6#1)(2008-10#6)(2008-11#2)(2009-8#1)(2010-5#1)
replaced by an##2##3##(1996-11#1)(2009-1#1)
replaced by the##7##3##(1990-2#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)
replaced by##48##2##(1990-10#1)(1990-2#1)(1991-2#1)(1992-10#1)(1992-6#1)(1992-9#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#3)(1996-2#1)(1997-3#2)(2008-10#12)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-8#2)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
replaced the##6##2##(1991-10#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
replaced with a##3##3##(1991-3#1)(2008-10#1)(2009-5#1)
replaced with one##2##3##(1993-2#1)(1993-8#1)
replaced with valine##2##3##(1996-2#2)
replaced with##22##2##(1990-5#1)(1991-3#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-2#3)(2008-10#3)(2008-11#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
replaced##96##1##(1990-10#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#3)(1996-2#5)(1997-3#2)(1997-7#1)(2008-10#19)(2008-11#10)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#8)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
replacement and##4##2##(1996-1#1)(2010-10#1)(2012-12#1)(2013-1#1)
replacement at##2##2##(2008-11#1)(2008-9#1)
replacement cassette##2##2##(1996-6#2)
replacement for the##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
replacement for##8##2##(1992-3#1)(2008-10#1)(2008-11#4)(2008-5#1)(2011-2#1)
replacement in##5##2##(2011-2#3)(2012-12#1)(2012-2#1)
replacement is##3##2##(2009-4#1)(2010-10#1)(2013-1#1)
replacement materials##3##2##(2009-9#2)(2011-2#1)
replacement of the##6##3##(1992-12#1)(1993-1#1)(1994-8#1)(2008-10#1)(2008-4#1)(2012-2#1)
replacement of##34##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-8#2)(1994-8#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
replacement series##2##2##(2008-10#1)(2008-8#1)
replacement surgery##2##2##(2008-10#1)(2011-2#1)
replacement therapy for##2##3##(1997-1#1)(2010-3#1)
replacement therapy in##6##3##(1993-2#1)(1996-11#1)(2008-11#2)(2012-3#2)
replacement therapy to##2##3##(1996-6#1)(2008-11#1)
replacement therapy with imiglucerase##2##4##(2008-10#2)
replacement therapy with##3##3##(2008-10#3)
replacement therapy##32##2##(1991-3#1)(1993-2#1)(1994-5#1)(1996-11#2)(1996-6#1)(1997-1#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-7#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2012-12#2)(2012-3#3)(2013-8#1)
replacement using the##3##3##(1992-4#1)(1993-8#1)(2011-2#1)
replacement using##5##2##(1992-4#1)(1993-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
replacement vector##3##2##(2008-8#3)
replacement were##2##2##(1994-3#1)(2011-2#1)
replacement with a##2##3##(1991-10#1)(2012-2#1)
replacement with##7##2##(1991-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-2#1)
replacement##208##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-2#2)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-1#2)(1997-5#2)(1997-8#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#18)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#11)(2008-9#5)(2009-12#1)(2009-3#3)(2009-4#1)(2009-7#2)(2009-9#3)(2010-10#10)(2010-11#1)(2010-12#3)(2010-3#1)(2011-1#3)(2011-2#11)(2011-3#1)(2012-12#18)(2012-2#11)(2012-3#7)(2013-1#11)(2013-8#3)
replacements and##4##2##(1991-5#1)(1992-3#1)(1997-9#1)(2008-11#1)
replacements are##2##2##(1991-6#1)(2009-7#1)
replacements for##2##2##(1992-3#1)(2008-10#1)
replacements in##3##2##(1997-9#1)(2008-10#1)(2008-11#1)
replacements##22##1##(1991-5#1)(1991-6#1)(1991-9#3)(1992-3#6)(1996-1#1)(1997-9#2)(2008-10#2)(2008-11#2)(2009-7#2)(2012-3#2)
replaces the##4##2##(1992-5#1)(1994-12#1)(2008-10#1)(2008-8#1)
replaces##8##1##(1992-5#1)(1994-12#1)(1995-11#2)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
replacing a##2##2##(2008-11#2)
replacing the##10##2##(1996-9#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-10#1)(2013-1#1)
replacing##34##1##(1991-1#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-4#1)(2008-10#8)(2008-11#8)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
replant disease and##2##3##(2008-10#2)
replant disease##11##2##(2008-10#11)
replant orchard soils##3##3##(2008-10#3)
replant orchard##4##2##(2008-10#4)
replant soils with##2##3##(2008-10#2)
replant soils##7##2##(2008-10#7)
replant##23##1##(2008-10#23)
replantation of##2##2##(2008-9#2)
replantation##8##1##(2008-9#8)
replanted##6##1##(2008-10#3)(2008-9#3)
replenished##4##1##(2008-10#1)(2008-11#2)(2008-5#1)
replenishment##3##1##(1993-3#1)(2007-12#1)(2010-7#1)
repletion##3##1##(1992-9#1)(2012-2#1)(2013-1#1)
replica exchange##3##2##(2008-12#3)
replica##5##1##(2008-11#1)(2008-12#3)(2010-5#1)
replicability of##2##2##(2008-11#2)
replicas##3##1##(1992-12#1)(2008-5#1)(2011-2#1)
replicase and movement protein##2##4##(2008-9#2)
replicase gene##3##2##(2008-10#2)(2008-9#1)
replicase##11##1##(2008-10#6)(2008-9#5)
replicase-mediated resistance##2##2##(2008-10#2)
replicase-mediated##3##1##(2008-10#3)
replicate analyses of##6##3##(2008-10#6)
replicate analyses##8##2##(2008-10#7)(2008-5#1)
replicate analysis (n=5) of##2##4##(2008-10#2)
replicate analysis of##3##3##(2008-10#3)
replicate analysis##9##2##(2008-10#9)
replicate and##2##2##(1995-2#1)(2008-9#1)
replicate determination of##3##3##(2008-10#3)
replicate determinations at the 0##2##5##(2008-10#2)
replicate determinations at the##4##4##(2008-10#4)
replicate determinations at##7##3##(2008-10#7)
replicate determinations of 0##2##4##(2008-10#2)
replicate determinations of 1##3##4##(2008-10#3)
replicate determinations of 5##2##4##(2008-10#2)
replicate determinations of##18##3##(2008-10#18)
replicate determinations##27##2##(2008-10#27)
replicate in the##2##3##(1997-3#1)(2008-5#1)
replicate in##4##2##(1997-3#2)(2008-5#1)(2013-8#1)
replicate injections of##2##3##(2008-10#2)
replicate injections##5##2##(2008-10#5)
replicate lines of##2##3##(2008-8#1)(2008-9#1)
replicate lines##3##2##(2008-8#2)(2008-9#1)
replicate measurements is##2##3##(2008-10#2)
replicate measurements of##5##3##(2008-10#5)
replicate measurements##9##2##(2008-10#9)
replicate sample##2##2##(2008-10#2)
replicate samples##2##2##(2008-10#2)
replicate##95##1##(1995-2#1)(1995-5#1)(1997-3#2)(2008-10#74)(2008-11#4)(2008-12#1)(2008-5#3)(2008-8#3)(2008-9#3)(2009-6#1)(2010-12#1)(2013-8#1)
replicated field##4##2##(2008-10#3)(2008-8#1)
replicated in##8##2##(1997-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-10#1)
replicated##31##1##(1995-6#1)(1997-3#2)(2008-10#18)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-4#1)(2012-3#1)
replicates of##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
replicates the phase##2##3##(2008-11#2)
replicates##33##1##(1993-6#1)(1994-5#1)(1996-12#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)
replicates)##2##1##(2008-10#2)
replicating##10##1##(1997-8#1)(2008-11#1)(2008-12#2)(2008-8#2)(2009-8#1)(2011-3#2)(2013-8#1)
replication after##2##2##(1995-12#1)(2010-11#1)
replication and##23##2##(1990-5#1)(1995-2#1)(1997-3#2)(2008-10#7)(2008-11#3)(2008-9#4)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
replication at##2##2##(1997-8#1)(2008-10#1)
replication by##7##2##(1990-5#2)(1991-12#1)(1995-2#2)(2013-1#2)
replication compared with##2##3##(2008-5#1)(2013-1#1)
replication complex##2##2##(1994-11#2)
replication cycle##7##2##(2008-10#2)(2008-4#1)(2011-3#4)
replication efficiency##2##2##(2011-2#1)(2013-1#1)
replication fork progression##3##3##(2012-3#3)
replication fork##12##2##(1991-12#3)(1992-3#4)(2011-2#1)(2012-3#4)
replication forks##7##2##(1992-3#1)(2011-2#1)(2012-3#5)
replication from##2##2##(1997-6#2)
replication in Escherichia coli##2##4##(1991-12#1)(1994-11#1)
replication in##9##2##(1990-8#1)(1991-12#2)(1994-11#1)(1994-5#1)(1995-5#1)(1997-3#2)(2013-1#1)
replication is##6##2##(1990-5#1)(1997-3#1)(2008-10#3)(2008-7#1)
replication occurred##2##2##(2008-10#2)
replication of HIV-1##3##3##(2011-2#1)(2011-3#2)
replication of a##2##3##(1991-12#1)(1995-2#1)
replication of the virus##2##4##(2008-5#2)
replication of the##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
replication of##25##2##(1991-12#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-11#5)(2008-5#2)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#1)(2011-3#3)(2012-3#1)
replication origin##2##2##(1994-11#1)(2008-10#1)
replication specificity element##2##3##(2008-10#2)
replication specificity##5##2##(2008-10#5)
replication stress##6##2##(2011-2#5)(2012-3#1)
replication to##2##2##(2008-5#1)(2013-1#1)
replication was##8##2##(1997-3#2)(2008-10#4)(2008-11#1)(2008-5#1)
replication##238##1##(1990-5#4)(1990-8#1)(1991-12#8)(1991-7#1)(1992-12#1)(1992-3#5)(1993-12#1)(1993-2#1)(1993-9#3)(1994-11#12)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#7)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1997-1#1)(1997-3#16)(1997-6#5)(1997-8#1)(2008-10#55)(2008-11#14)(2008-12#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#9)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#3)(2011-2#14)(2011-3#11)(2012-2#1)(2012-3#14)(2013-1#19)(2013-8#2)
replication-associated protein##2##2##(2008-10#2)
replication-associated##4##1##(2008-10#2)(2011-2#2)
replication-competent##2##1##(1995-2#1)(2008-11#1)
replication-defective##2##1##(2008-5#1)(2008-9#1)
replication-related##2##1##(1995-6#2)
replications in##2##2##(2008-10#1)(2008-12#1)
replications##18##1##(1993-2#1)(2008-10#12)(2008-12#4)(2010-4#1)
replicative senescence##4##2##(1992-9#2)(1997-7#1)(2011-2#1)
replicative##13##1##(1991-5#1)(1992-9#2)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2011-2#2)(2011-3#3)
replicon##5##1##(2008-8#1)(2011-2#4)
replicons##3##1##(1997-3#1)(2011-2#2)
replies##3##1##(1990-9#1)(1993-5#2)
reply##19##1##(1990-11#2)(1990-12#1)(1991-9#3)(1992-11#1)(1992-8#2)(1993-3#1)(1994-2#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-8#2)
repolarization##6##1##(2010-1#1)(2012-3#5)
report a case of a##24##5##(1991-11#1)(1992-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
report a case of an##6##5##(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
report a case of congenital##2##5##(2008-12#1)(2010-11#1)
report a case of familial##2##5##(1992-9#1)(2009-12#1)
report a case of primary##5##5##(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
report a case of spontaneous##2##5##(1992-2#1)(2008-7#1)
report a case of##106##4##(1990-12#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-2#3)(1992-5#1)(1992-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1997-6#1)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#12)(2008-5#2)(2008-7#6)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-6#4)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#6)(2012-2#2)(2012-3#7)(2013-1#7)(2013-8#6)
report a case##113##3##(1990-12#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-2#4)(1992-5#1)(1992-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1997-6#1)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#13)(2008-5#2)(2008-7#6)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-6#4)(2010-8#2)(2011-1#3)(2011-2#7)(2012-12#6)(2012-2#2)(2012-3#7)(2013-1#8)(2013-8#6)
report a new case##3##4##(1991-11#1)(2007-8#1)(2009-1#1)
report a new##6##3##(1991-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-1#1)(2012-2#1)
report a novel method##3##4##(2008-11#1)(2009-7#1)(2013-1#1)
report a novel##6##3##(2008-11#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
report a patient who developed##2##5##(2008-12#1)(2008-7#1)
report a patient who##3##4##(2008-12#1)(2008-7#1)(2011-1#1)
report a patient with##7##4##(2008-1#1)(2008-7#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
report a patient##11##3##(2008-1#1)(2008-12#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
report a rare case of##13##5##(1991-12#1)(1992-12#1)(2008-12#4)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-2#1)
report a rare complication##2##4##(2008-7#1)(2012-3#1)
report a rare##16##3##(1991-12#1)(1992-12#1)(2008-12#4)(2008-7#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-2#1)
report a series of##2##4##(2008-12#1)(2009-7#1)
report a single##2##3##(2009-10#1)(2013-1#1)
report a##205##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#4)(1992-5#1)(1992-8#1)(1992-9#2)(1994-12#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#10)(2008-12#20)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#14)(2008-8#1)(2008-9#1)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#5)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#12)(2012-12#11)(2012-2#10)(2012-3#11)(2013-1#18)(2013-2#1)(2013-8#12)
report about a##2##3##(1990-3#1)(1994-5#1)
report about##4##2##(1990-3#1)(1994-5#1)(2009-3#1)(2013-8#1)
report adverse##2##2##(2011-2#1)(2013-8#1)
report an unusual case of##7##5##(2008-10#2)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#2)
report an##28##2##(1990-11#1)(1991-3#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-7#2)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)
report and discuss##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
report and literature##15##3##(1993-8#1)(2008-12#6)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#2)
report and management##2##3##(2008-12#1)(2013-1#1)
report and review of the##15##5##(1992-9#1)(1993-6#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
report and review of##23##4##(1992-9#1)(1993-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#4)
report and review##24##3##(1992-9#1)(1993-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#4)
report and##52##2##(1992-9#1)(1993-6#1)(1993-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#10)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#6)(2012-3#3)(2013-1#9)(2013-8#2)
report are##5##2##(1991-12#1)(1993-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
report being##3##2##(1997-6#1)(2008-9#2)
report by##2##2##(1992-3#1)(1993-3#1)
report card##6##2##(1992-3#1)(1994-2#1)(1997-3#4)
report cards for##2##3##(1997-2#2)
report cards on##2##3##(1997-3#2)
report cards##7##2##(1997-2#2)(1997-3#4)(2008-11#1)
report confirming##3##2##(2011-2#2)(2013-1#1)
report contains##2##2##(1991-2#1)(1993-12#1)
report data on##2##3##(2012-2#1)(2013-1#1)
report data##4##2##(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
report demonstrates that##3##3##(1994-3#1)(2008-10#1)(2009-4#1)
report demonstrates##4##2##(1994-3#1)(2008-10#1)(2009-4#1)(2012-2#1)
report demonstrating##3##2##(2008-10#2)(2008-11#1)
report describes a case of##2##5##(1994-12#1)(2008-11#1)
report describes a##12##3##(1993-12#1)(1994-12#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-6#1)(2012-12#1)(2013-1#3)
report describes an##2##3##(2008-5#1)(2013-1#1)
report describes the##22##3##(1992-1#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-7#2)(2008-10#3)(2008-12#5)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#3)(2013-8#1)
report describes##43##2##(1990-12#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-9#1)(1997-7#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#5)(2008-5#2)(2008-7#3)(2009-6#1)(2010-11#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
report detailed##2##2##(2008-11#1)(2013-8#1)
report discusses##3##2##(1991-6#1)(2008-11#1)(2008-12#1)
report evaluates##2##2##(2008-11#1)(2008-7#1)
report examined at least##2##4##(2008-7#2)
report experience##2##2##(1990-11#1)(1996-3#1)
report for the first time the successful##2##7##(1995-6#1)(2010-12#1)
report for the first time##6##5##(1992-6#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-2#1)(2010-12#1)
report for##7##2##(1992-6#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)
report from the##3##3##(1996-1#1)(2008-11#1)(2011-2#1)
report from##10##2##(1992-8#1)(1994-3#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-2#1)(2013-1#1)
report further##2##2##(2008-7#1)(2013-1#1)
report gene##3##2##(2008-8#1)(2008-9#2)
report gives an##2##3##(2008-10#1)(2008-11#1)
report gives##4##2##(2008-10#3)(2008-11#1)
report here a##5##3##(1997-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-1#1)
report here on##7##3##(1993-12#1)(2008-1#1)(2008-10#2)(2010-6#2)(2012-3#1)
report here the##13##3##(1993-12#1)(1993-2#1)(1993-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)(2009-7#1)(2011-2#1)(2011-8#1)
report here##47##2##(1990-5#1)(1991-5#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-2#2)(1997-2#1)(1997-7#3)(1997-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-6#2)(2011-2#3)(2011-8#1)(2012-2#1)(2012-3#1)
report herein##4##2##(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
report highlights the##3##3##(2008-10#3)
report illustrates the##5##3##(1996-1#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-8#1)
report illustrates##6##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-8#1)
report in this##2##3##(2012-3#1)(2013-1#1)
report in##6##2##(1997-2#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
report is a##3##3##(2011-2#1)(2013-1#2)
report is of a##2##4##(2008-11#1)(2008-12#1)
report is to describe##2##4##(2008-10#1)(2010-9#1)
report is to##7##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
report is##20##2##(1990-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#3)
report low##2##2##(2010-10#1)(2013-8#1)
report more##2##2##(1995-3#1)(2011-2#1)
report of 2##2##3##(1992-5#1)(2013-1#1)
report of a case and review of literature##2##8##(2008-12#1)(2008-7#1)
report of a case and review of##3##7##(2008-12#2)(2008-7#1)
report of a case and##4##5##(2008-12#2)(2008-7#1)(2012-3#1)
report of a case of##2##5##(2008-10#1)(2012-3#1)
report of a case with review of literature##2##8##(2008-11#1)(2008-12#1)
report of a case with##4##5##(1991-6#1)(1992-5#1)(2008-11#1)(2008-12#1)
report of a case##17##4##(1991-12#1)(1991-6#1)(1992-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-7#1)(2011-2#3)(2012-3#2)
report of a patient##2##4##(2007-8#1)(2012-3#1)
report of a rare##2##4##(1995-11#1)(2013-1#1)
report of a##45##3##(1991-12#1)(1991-6#1)(1992-5#1)(1995-10#1)(1995-11#1)(1996-9#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-12#7)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2010-9#1)(2011-2#4)(2012-3#3)(2013-1#4)
report of an##9##3##(1992-10#1)(1992-5#1)(1993-9#1)(1994-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
report of five cases##2##4##(2008-7#1)(2009-12#1)
report of four cases##3##4##(1990-12#1)(1991-12#1)(2011-2#1)
report of four##4##3##(1990-12#1)(1991-12#1)(2011-2#2)
report of the##16##3##(1996-9#1)(1997-2#1)(2008-10#9)(2008-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
report of this##4##3##(1990-6#1)(1991-11#1)(1992-3#1)(1996-9#1)
report of three cases##5##4##(1991-6#1)(2008-7#1)(2010-10#1)(2013-1#2)
report of two cases##6##4##(2008-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
report of two##7##3##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
report of##143##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#3)(1993-2#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-11#1)(1996-9#3)(1997-2#1)(1997-7#1)(2007-8#2)(2008-10#31)(2008-11#10)(2008-12#10)(2008-6#1)(2008-7#7)(2008-9#2)(2009-1#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-2#10)(2011-3#3)(2012-12#2)(2012-2#2)(2012-3#11)(2013-1#14)(2013-8#2)
report on a comparative##2##4##(2008-3#1)(2008-9#1)
report on a pilot##2##4##(1996-2#1)(2008-11#1)
report on a##30##3##(1990-12#1)(1990-8#1)(1991-3#1)(1991-8#1)(1993-12#1)(1996-2#1)(1996-3#1)(1997-3#4)(1997-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#3)
report on an##5##3##(1993-12#1)(1993-2#1)(2007-12#1)(2008-3#2)
report on our##2##3##(1991-12#1)(1996-8#1)
report on the development##2##4##(1996-2#1)(2008-12#1)
report on the##44##3##(1990-2#1)(1990-8#1)(1990-9#1)(1992-2#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#3)(2008-9#4)(2009-12#1)(2010-12#1)(2011-2#2)
report on three##2##3##(2009-7#1)(2011-2#1)
report on##119##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-8#1)(1997-3#5)(1997-5#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#10)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-6#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#4)
report or not##2##3##(1991-2#1)(1995-12#1)
report or##3##2##(1991-2#1)(1995-12#1)(2012-12#1)
report our experience of##2##4##(1991-9#1)(1995-10#1)
report our experience with##3##4##(1995-3#1)(2008-11#1)(2011-2#1)
report our experience##6##3##(1991-9#1)(1995-10#1)(1995-3#1)(2008-11#1)(2011-2#2)
report our##7##2##(1991-9#1)(1995-10#1)(1995-3#1)(2008-11#1)(2009-8#1)(2011-2#2)
report outcome##2##2##(2012-3#1)(2013-1#1)
report poor##2##2##(2009-5#1)(2013-8#1)
report presents a##2##3##(2008-11#1)(2012-12#1)
report presents the##4##3##(1993-8#1)(1995-3#1)(2008-11#1)(2013-1#1)
report presents##10##2##(1991-11#1)(1993-12#1)(1993-8#1)(1995-3#1)(2008-11#2)(2011-2#1)(2012-12#1)(2013-1#2)
report reviews##3##2##(1991-2#1)(2008-11#1)(2011-10#1)
report shows##3##2##(1994-12#1)(1995-2#1)(2008-10#1)
report some##2##2##(1994-8#1)(2008-11#1)
report such a case##2##4##(2009-10#1)(2012-3#1)
report summarizes##7##2##(1994-9#3)(2008-11#1)(2010-4#1)(2011-2#2)
report that a##3##3##(1990-5#1)(1994-12#1)(2008-10#1)
report that the##12##3##(1991-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-7#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
report that##57##2##(1990-2#1)(1990-5#2)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#3)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#1)(1995-8#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#7)(2008-7#2)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2011-2#4)(2012-2#6)(2013-1#1)
report the NMR##4##3##(2009-7#4)
report the assignment of##2##4##(2009-7#2)
report the case of a##36##5##(1991-11#2)(1993-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#1)(2009-1#1)(2010-5#2)(2010-6#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
report the case of##43##4##(1990-6#1)(1991-11#2)(1991-6#1)(1993-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#5)(2008-9#1)(2009-1#1)(2010-12#1)(2010-5#2)(2010-6#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
report the case##46##3##(1990-6#1)(1991-11#2)(1991-6#1)(1993-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#5)(2008-9#1)(2009-1#1)(2010-12#1)(2010-5#2)(2010-6#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#1)
report the clinical##3##3##(2008-5#1)(2013-1#2)
report the cloning of##3##4##(1993-2#1)(1995-11#1)(1995-8#1)
report the construction##4##3##(1993-9#1)(1997-8#1)(2008-10#1)(2008-11#1)
report the development of##3##4##(1990-12#1)(2008-10#1)(2013-8#1)
report the development##4##3##(1990-12#1)(2008-10#2)(2013-8#1)
report the effects of##2##4##(2009-5#1)(2010-4#1)
report the first##15##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-7#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
report the identification of##8##4##(1993-6#2)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#2)
report the identification##9##3##(1993-6#2)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#2)(2013-8#1)
report the isolation and##2##4##(1993-12#1)(1997-7#1)
report the isolation of a##2##5##(1995-2#1)(2008-8#1)
report the isolation of##3##4##(1995-2#1)(2008-10#1)(2008-8#1)
report the isolation##6##3##(1993-12#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-8#1)
report the management##2##3##(2008-7#1)(2011-2#1)
report the observation of##2##4##(2008-5#1)(2013-1#1)
report the occurrence##2##3##(1993-11#1)(2010-10#1)
report the results of a##6##5##(1990-5#1)(1993-12#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
report the results of##16##4##(1990-5#1)(1990-9#1)(1993-12#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-6#2)(2012-3#1)(2013-1#1)(2013-8#1)
report the results##18##3##(1990-5#2)(1990-9#1)(1993-12#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-6#3)(2012-3#1)(2013-1#1)(2013-8#1)
report the structure and##2##4##(1991-6#1)(2008-10#1)
report the successful##3##3##(1994-6#1)(2008-7#1)(2010-6#1)
report the technique##2##3##(1994-2#2)
report the use of##6##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)
report the##208##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-6#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#3)(1994-6#1)(1995-11#1)(1995-2#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#22)(2008-11#6)(2008-12#3)(2008-3#3)(2008-5#6)(2008-7#11)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#15)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#6)(2010-7#1)(2011-2#14)(2012-12#2)(2012-2#6)(2012-3#8)(2012-4#1)(2013-1#21)(2013-7#1)(2013-8#6)
report their experience of##2##4##(1990-3#1)(1990-9#1)
report their experience##6##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#1)(1992-5#2)
report their##7##2##(1990-3#1)(1990-5#1)(1990-9#2)(1991-3#1)(1992-5#2)
report this##3##2##(1996-3#1)(2008-12#1)(2013-1#1)
report three cases of##2##4##(1991-11#1)(2012-12#1)
report three cases##3##3##(1991-11#1)(2008-7#1)(2012-12#1)
report three##5##2##(1991-11#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
report to##4##2##(1990-5#1)(1991-6#1)(1993-3#1)(2009-12#1)
report two cases of##10##4##(1992-5#1)(2007-8#1)(2008-10#2)(2009-4#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#2)
report two cases##12##3##(1992-5#1)(2007-8#1)(2008-10#2)(2009-1#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#3)
report two##18##2##(1992-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-1#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#4)
report was to##2##3##(2011-2#1)(2013-8#1)
report was##7##2##(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
report we have##3##3##(1990-5#1)(1996-3#1)(2011-2#1)
report we##16##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-7#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-9#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#4)
report will provide##2##3##(2008-11#1)(2008-9#1)
report will##5##2##(2008-11#2)(2008-7#1)(2008-9#1)(2012-3#1)
report##1526##1##(1990-10#1)(1990-11#5)(1990-12#10)(1990-2#3)(1990-3#6)(1990-4#1)(1990-5#10)(1990-6#6)(1990-8#5)(1990-9#6)(1991-1#2)(1991-11#8)(1991-12#7)(1991-2#8)(1991-3#6)(1991-4#1)(1991-5#3)(1991-6#9)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#1)(1992-12#6)(1992-2#13)(1992-3#7)(1992-5#7)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#6)(1993-11#2)(1993-12#13)(1993-2#6)(1993-3#8)(1993-6#8)(1993-8#7)(1993-9#5)(1994-1#2)(1994-11#8)(1994-12#8)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#3)(1995-10#3)(1995-11#5)(1995-12#7)(1995-2#12)(1995-3#6)(1995-6#5)(1995-8#7)(1995-9#1)(1996-1#5)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#7)(1996-5#3)(1996-6#1)(1996-8#3)(1996-9#6)(1997-1#2)(1997-2#10)(1997-3#15)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#8)(1997-8#7)(1997-9#2)(2007-11#1)(2007-12#9)(2007-8#6)(2007-9#1)(2008-1#11)(2008-10#155)(2008-11#100)(2008-12#74)(2008-2#6)(2008-3#17)(2008-4#4)(2008-5#16)(2008-6#2)(2008-7#64)(2008-8#13)(2008-9#35)(2009-1#10)(2009-10#8)(2009-11#2)(2009-12#4)(2009-3#7)(2009-4#5)(2009-5#7)(2009-6#6)(2009-7#27)(2009-8#7)(2009-9#12)(2010-1#5)(2010-10#6)(2010-11#13)(2010-12#14)(2010-2#2)(2010-3#11)(2010-4#4)(2010-5#8)(2010-6#18)(2010-7#7)(2010-8#2)(2010-9#7)(2011-1#19)(2011-10#1)(2011-2#128)(2011-3#4)(2011-8#1)(2012-12#34)(2012-2#39)(2012-3#60)(2012-4#1)(2013-1#118)(2013-2#1)(2013-7#1)(2013-8#40)
report)##5##1##(2011-2#3)(2012-2#1)(2012-3#1)
report]##22##1##(1990-9#1)(1992-9#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-11#3)(2009-1#1)(2009-5#5)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)
reportable##7##1##(1997-3#3)(2007-12#1)(2010-11#1)(2010-2#1)(2012-2#1)
reported 826 cases of AIDS to the World Health Organization##2##10##(1997-6#2)
reported VCGs##2##2##(2008-10#2)
reported a case of##3##4##(1997-3#1)(2010-12#1)(2011-1#1)
reported a lower##2##3##(2009-5#1)(2011-2#1)
reported a##26##2##(1992-6#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-12#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-8#1)
reported acquiring##2##2##(1993-1#1)(2008-12#1)
reported adverse events##2##3##(2008-11#2)
reported after##2##2##(1990-5#1)(2010-12#1)
reported along with##2##3##(2008-10#1)(2011-2#1)
reported among##2##2##(2008-10#1)(2008-4#1)
reported an IIEF5##2##3##(2011-2#2)
reported an##7##2##(1990-12#1)(1990-6#1)(1995-2#1)(2008-10#1)(2008-7#1)(2011-2#2)
reported and##15##2##(1993-3#1)(1994-9#1)(1996-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2010-6#1)(2010-7#1)
reported as &quot##2##3##(2008-10#1)(2010-6#1)
reported as a##5##3##(1995-8#1)(2008-10#2)(2008-7#1)(2013-1#1)
reported as being##3##3##(1991-8#1)(1996-11#1)(2008-9#1)
reported as benign##2##3##(2011-1#2)
reported as the##4##3##(1994-11#1)(2008-10#1)(2008-9#1)(2013-8#1)
reported as##30##2##(1991-12#1)(1991-2#1)(1991-8#1)(1994-11#1)(1995-8#1)(1996-11#3)(1997-2#1)(2008-10#8)(2008-3#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
reported at least##2##3##(2012-12#1)(2013-1#1)
reported at##3##2##(1996-12#1)(2012-12#1)(2013-1#1)
reported before##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
reported being &quot##3##3##(2008-12#3)
reported being##9##2##(1993-1#1)(1995-1#1)(2008-10#1)(2008-12#3)(2009-5#1)(2010-4#1)(2011-2#1)
reported beneficial effects of##2##4##(2008-5#1)(2012-2#1)
reported bite rate##2##3##(2013-8#2)
reported both##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
reported but##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
reported by others##3##3##(1993-12#1)(1993-8#1)(2011-2#1)
reported by the##9##3##(1996-1#1)(2008-10#7)(2011-2#1)
reported by us##2##3##(1995-6#1)(2008-10#1)
reported by##46##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#2)(1995-6#1)(1996-1#1)(1996-6#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-3#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
reported case in##2##3##(2008-10#1)(2010-6#1)
reported case is##2##3##(2008-7#1)(2011-2#1)
reported case of a##2##4##(2008-10#1)(2008-7#1)
reported case of##18##3##(2008-10#2)(2008-11#1)(2008-7#3)(2009-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
reported case##25##2##(2008-10#3)(2008-11#1)(2008-7#4)(2009-1#1)(2010-11#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
reported cases of##5##3##(1992-2#1)(1994-9#1)(2011-2#3)
reported cases##18##2##(1991-2#1)(1992-2#1)(1994-9#1)(2008-1#2)(2008-7#2)(2009-1#1)(2009-3#1)(2010-6#1)(2011-2#6)(2013-1#2)
reported complication##2##2##(2008-1#1)(2012-12#1)
reported data##6##2##(1992-5#1)(2008-10#4)(2013-8#1)
reported earlier##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
reported elsewhere##2##2##(2008-10#2)
reported ever##2##2##(2008-12#1)(2012-12#1)
reported findings##2##2##(1993-1#1)(2009-8#1)
reported for each##2##3##(2010-11#1)(2013-1#1)
reported for natural##2##3##(2008-10#1)(2008-8#1)
reported for the analysis##2##4##(2008-10#2)
reported for the first time##8##5##(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#1)(2010-9#1)
reported for the##30##3##(1995-2#1)(2008-10#17)(2008-11#3)(2008-3#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
reported for this##2##3##(1993-8#1)(1996-12#1)
reported for##66##2##(1990-3#1)(1990-5#1)(1990-9#1)(1993-1#1)(1993-8#2)(1994-11#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#27)(2008-11#5)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
reported from a##2##3##(1994-3#1)(2008-10#1)
reported from other##3##3##(1993-2#1)(2008-10#1)(2010-6#1)
reported from##17##2##(1990-11#1)(1990-6#1)(1992-6#1)(1993-2#1)(1994-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2010-6#1)(2011-3#1)(2012-2#1)
reported gene##2##2##(2008-10#1)(2008-8#1)
reported genes##5##2##(1995-8#3)(1996-2#1)(1996-6#1)
reported greater##3##2##(1996-3#1)(2008-6#1)(2010-9#1)
reported having been vaccinated for##2##5##(2009-5#2)
reported having##5##2##(2008-11#1)(2009-5#3)(2013-1#1)
reported here and##2##3##(1995-11#1)(1996-12#1)
reported here for the first time##2##6##(2008-10#1)(2010-8#1)
reported here is##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)
reported here was a##2##4##(1997-8#1)(2008-12#1)
reported here was##3##3##(1997-8#1)(2008-11#1)(2008-12#1)
reported here##37##2##(1990-5#1)(1991-1#1)(1991-2#1)(1992-1#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-5#2)(2010-8#1)(2011-2#2)(2013-8#1)
reported herein##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
reported high levels of##3##4##(2008-10#2)(2008-12#1)
reported high##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)
reported higher levels of##2##4##(2008-6#1)(2010-1#1)
reported higher##3##2##(2008-6#1)(2008-9#1)(2010-1#1)
reported in a##6##3##(1990-6#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
reported in clinical##2##3##(2011-2#1)(2013-1#1)
reported in drinking water##2##4##(2008-10#2)
reported in literature##11##3##(2007-8#1)(2008-10#7)(2008-12#1)(2010-12#1)(2011-7#1)
reported in other species##2##4##(1991-3#1)(1997-9#1)
reported in other##8##3##(1991-3#1)(1992-2#1)(1997-1#1)(1997-7#1)(1997-9#1)(2008-10#2)(2013-1#1)
reported in patients with##6##4##(1994-12#1)(1997-8#1)(2008-8#1)(2009-3#1)(2010-1#1)(2012-3#1)
reported in several##2##3##(1991-12#1)(1995-12#1)
reported in the United States##3##5##(2007-12#1)(2008-10#1)(2011-2#1)
reported in the included##2##4##(2008-10#1)(2013-1#1)
reported in the international literature##2##5##(1997-8#1)(2011-3#1)
reported in the literature and##2##5##(2008-2#1)(2011-2#1)
reported in the literature for##4##5##(1991-3#2)(2008-10#2)
reported in the literature in##2##5##(1991-3#1)(2013-1#1)
reported in the literature##49##4##(1990-12#1)(1991-2#1)(1991-3#3)(1992-12#1)(1994-6#1)(1995-9#1)(1996-11#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#3)(2009-5#1)(2009-7#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#8)(2013-8#1)
reported in the past##2##4##(1991-12#1)(1992-2#1)
reported in the##84##3##(1990-12#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#3)(1992-12#1)(1992-2#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#3)(2009-5#1)(2009-7#2)(2010-5#1)(2010-6#7)(2010-7#2)(2011-1#1)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#11)(2013-8#3)
reported in these##3##3##(1991-2#1)(2008-2#1)(2011-2#1)
reported in this article##2##4##(1991-1#1)(2010-3#1)
reported in this paper##6##4##(1995-3#1)(2008-10#5)
reported in this study##5##4##(2008-10#1)(2009-11#1)(2011-2#3)
reported in this work##2##4##(2008-10#2)
reported in this##19##3##(1991-1#1)(1995-3#1)(2008-10#10)(2008-12#1)(2009-11#1)(2010-3#1)(2011-2#3)(2013-8#1)
reported in three##2##3##(2008-10#2)
reported in vitro##2##3##(2008-9#1)(2013-8#1)
reported in which##3##3##(1995-3#1)(1997-8#1)(2008-10#1)
reported in##226##2##(1990-12#1)(1990-5#1)(1990-6#4)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#6)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-9#2)(1993-2#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-7#1)(1997-8#6)(1997-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#54)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#6)(2008-7#5)(2008-8#4)(2008-9#3)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#9)(2010-7#2)(2011-1#2)(2011-2#14)(2011-3#3)(2011-7#1)(2012-2#3)(2012-3#5)(2013-1#16)(2013-8#7)
reported incidence of##2##3##(2008-7#1)(2013-8#1)
reported increased##2##2##(2008-12#1)(2013-1#1)
reported instances of##2##3##(1991-12#1)(2008-7#1)
reported is##2##2##(2008-10#1)(2009-8#1)
reported less##5##2##(2008-12#1)(2011-1#1)(2013-1#3)
reported levels of##2##3##(2008-4#1)(2009-7#1)
reported levels##3##2##(2008-11#1)(2008-4#1)(2009-7#1)
reported lower##2##2##(2012-12#1)(2013-1#1)
reported method##2##2##(1997-2#1)(2008-10#1)
reported methods##8##2##(2008-10#7)(2009-10#1)
reported more##9##2##(1996-6#1)(2008-4#1)(2008-9#3)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
reported nausea or vomiting##2##4##(2008-7#2)
reported no use##2##3##(2009-5#2)
reported no##4##2##(1993-1#1)(2009-5#2)(2009-8#1)
reported not using condoms during##2##5##(2010-7#2)
reported occurrence##2##2##(2008-10#1)(2010-8#1)
reported on children's##2##3##(2009-10#1)(2009-4#1)
reported on the##3##3##(1990-11#1)(2008-11#1)(2013-1#1)
reported on##15##2##(1990-11#1)(2008-10#5)(2008-11#2)(2009-10#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
reported one##2##2##(2008-10#1)(2008-11#1)
reported only##6##2##(1996-3#1)(2008-10#2)(2008-12#1)(2012-3#1)(2013-1#1)
reported over##2##2##(2008-11#1)(2008-8#1)
reported previously in##3##3##(2008-10#2)(2011-1#1)
reported previously using##2##3##(2008-10#2)
reported previously##30##2##(1990-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
reported recently##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
reported relief##2##2##(2008-7#1)(2008-9#1)
reported results##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)
reported series##2##2##(1992-8#1)(2009-10#1)
reported showing##2##2##(1996-3#1)(1997-3#1)
reported side effects##3##3##(1991-3#1)(1993-2#2)
reported side##4##2##(1991-3#1)(1993-2#2)(2007-8#1)
reported significantly lower##2##3##(1995-2#1)(2010-10#1)
reported significantly##5##2##(1995-2#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
reported since##4##2##(1995-12#1)(2008-12#1)(2010-1#1)(2013-7#1)
reported smoking##2##2##(1991-9#1)(2011-2#1)
reported so far##11##3##(1990-5#1)(1990-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
reported some##2##2##(2010-11#1)(2013-1#1)
reported studies##5##2##(1992-1#1)(2008-11#1)(2009-8#1)(2009-9#1)(2013-1#1)
reported that a##3##3##(1996-5#1)(2010-6#1)(2011-2#1)
reported that in##2##3##(1996-12#1)(2008-12#1)
reported that the group##2##4##(1993-3#2)
reported that the use of##2##5##(2011-2#1)(2013-1#1)
reported that the##21##3##(1992-12#1)(1993-3#2)(1995-11#2)(1995-6#1)(1996-5#1)(2008-11#3)(2008-12#2)(2008-5#1)(2008-9#2)(2009-11#1)(2010-7#1)(2011-2#3)(2013-1#1)
reported that their##3##3##(1990-8#1)(2008-11#1)(2010-10#1)
reported that they had##2##4##(1996-2#1)(2009-3#1)
reported that they were &quot##2##5##(2008-7#2)
reported that they##19##3##(1991-12#1)(1993-1#2)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2010-4#4)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
reported that##94##2##(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1993-1#2)(1993-3#2)(1994-11#1)(1994-2#2)(1994-5#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-11#10)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#1)
reported the presence of##2##4##(1994-6#1)(2008-11#1)
reported the use of##2##4##(2008-10#1)(2013-1#1)
reported the##24##2##(1991-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-1#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#3)(2013-8#1)
reported their peak##2##3##(2013-8#2)
reported their##7##2##(1994-6#1)(1994-9#1)(2008-12#1)(2008-4#1)(2010-1#1)(2013-8#2)
reported they##2##2##(1994-1#1)(2012-2#1)
reported to CDC were##2##4##(1992-6#2)
reported to be a##2##4##(1992-6#1)(2008-10#1)
reported to be associated with##2##5##(1994-5#1)(2011-2#1)
reported to be between##2##4##(2007-12#1)(2011-2#1)
reported to be important##2##4##(1992-8#1)(2009-5#1)
reported to be more##2##4##(2008-10#1)(2008-7#1)
reported to be present in##2##5##(1994-12#1)(2008-9#1)
reported to be##34##3##(1992-6#1)(1992-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#1)(2011-2#4)
reported to cause##4##3##(2008-10#3)(2012-3#1)
reported to contain##2##3##(2008-10#2)
reported to date##9##3##(1991-12#1)(2008-2#1)(2008-7#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
reported to decrease##2##3##(2011-2#1)(2013-1#1)
reported to exhibit##4##3##(1995-2#1)(2008-11#1)(2008-5#1)(2013-8#1)
reported to have a##3##4##(2010-11#1)(2012-3#1)(2013-8#1)
reported to have##10##3##(1991-5#1)(1992-5#1)(1994-12#1)(2008-10#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#3)
reported to occur##6##3##(1995-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
reported to produce##2##3##(2008-8#1)(2011-2#1)
reported to the##7##3##(1993-12#1)(1994-9#1)(1996-11#1)(1997-8#2)(2008-1#1)(2008-11#1)
reported to##117##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#1)(1993-12#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#1)(2008-2#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-8#2)(2011-2#11)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#7)
reported use##3##2##(1991-9#1)(2008-10#2)
reported using##6##2##(1993-12#2)(1995-9#1)(2009-5#1)(2010-10#1)(2013-1#1)
reported values##8##2##(2008-10#7)(2009-11#1)
reported which##2##2##(1990-5#1)(2008-7#1)
reported with a##2##3##(2008-10#2)
reported with the##4##3##(2008-10#3)(2013-1#1)
reported with##20##2##(1993-1#1)(1996-11#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
reported##1646##1##(1990-11#4)(1990-12#8)(1990-2#3)(1990-3#5)(1990-5#11)(1990-6#10)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#12)(1991-2#9)(1991-3#11)(1991-5#5)(1991-6#6)(1991-8#6)(1991-9#5)(1992-1#2)(1992-10#1)(1992-12#5)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#13)(1992-8#4)(1992-9#4)(1993-1#11)(1993-11#1)(1993-12#9)(1993-2#7)(1993-3#6)(1993-6#8)(1993-8#5)(1993-9#3)(1994-1#2)(1994-11#7)(1994-12#6)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#6)(1994-8#9)(1994-9#8)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#9)(1995-2#7)(1995-3#4)(1995-6#8)(1995-8#7)(1995-9#2)(1996-1#3)(1996-11#8)(1996-12#14)(1996-2#4)(1996-3#7)(1996-5#4)(1996-6#7)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#14)(1997-9#1)(2006-6#1)(2007-12#6)(2007-8#2)(2008-1#8)(2008-10#445)(2008-11#77)(2008-12#46)(2008-2#13)(2008-3#21)(2008-4#4)(2008-5#25)(2008-6#4)(2008-7#62)(2008-8#20)(2008-9#38)(2009-1#3)(2009-10#7)(2009-11#6)(2009-12#7)(2009-3#3)(2009-4#6)(2009-5#11)(2009-7#7)(2009-8#14)(2009-9#3)(2010-1#8)(2010-10#7)(2010-11#8)(2010-12#8)(2010-2#1)(2010-3#5)(2010-4#6)(2010-5#4)(2010-6#22)(2010-7#12)(2010-8#8)(2010-9#3)(2011-1#13)(2011-2#97)(2011-3#6)(2011-7#1)(2011-9#1)(2012-12#31)(2012-2#25)(2012-3#23)(2013-1#84)(2013-7#1)(2013-8#46)
reportedly##2##1##(1991-12#1)(2008-11#1)
reporter and##2##2##(2008-10#1)(2008-9#1)
reporter assay##2##2##(2010-5#1)(2011-2#1)
reporter construct##2##2##(1995-2#1)(1996-3#1)
reporter gene construct##2##3##(2008-10#2)
reporter gene expression was##2##4##(1995-2#1)(2008-10#1)
reporter gene expression##10##3##(1995-2#1)(2008-10#2)(2008-11#2)(2008-8#4)(2009-10#1)
reporter gene in##2##3##(1991-6#2)
reporter gene to##3##3##(1991-5#1)(2008-10#1)(2010-5#1)
reporter gene under the control of CaMV35S##2##7##(2008-9#2)
reporter gene under the control of##4##6##(1994-5#2)(2008-9#2)
reporter gene##66##2##(1990-5#1)(1991-5#1)(1991-6#2)(1992-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-2#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#15)(2008-11#10)(2008-4#3)(2008-5#1)(2008-8#7)(2008-9#7)(2009-10#1)(2009-12#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-3#1)
reporter genes##7##2##(1990-5#1)(1993-6#1)(2008-10#2)(2008-11#2)(2008-8#1)
reporter molecule##4##2##(1996-6#1)(2008-7#1)(2008-9#2)
reporter plasmid##2##2##(1995-2#1)(1996-3#1)
reporter protein##6##2##(1996-3#1)(2008-11#5)
reporter##126##1##(1990-5#2)(1991-5#1)(1991-6#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-5#2)(1995-2#8)(1995-6#2)(1995-8#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#27)(2008-11#23)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#9)(2008-9#13)(2009-10#1)(2009-12#1)(2010-10#1)(2010-5#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
reporter-gene##2##1##(2009-12#2)
reporters of##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
reporters##9##1##(1997-8#1)(2007-12#1)(2008-11#1)(2009-10#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
reporting a##4##2##(2008-12#2)(2008-6#1)(2010-5#1)
reporting an##3##2##(1995-2#1)(2008-11#1)(2009-3#1)
reporting and##6##2##(1997-3#1)(2008-10#3)(2010-8#1)(2013-8#1)
reporting bias##2##2##(2008-11#1)(2008-9#1)
reporting diagnostic##2##2##(2010-5#2)
reporting fewer##2##2##(1993-9#1)(1995-12#1)
reporting form##2##2##(2012-12#2)
reporting format##2##2##(2011-2#2)
reporting forms##4##2##(2008-10#1)(2012-12#3)
reporting guidelines##2##2##(2013-7#2)
reporting in the##2##3##(1991-2#1)(2006-5#1)
reporting in##3##2##(1991-2#1)(2006-5#1)(2009-9#1)
reporting is##2##2##(2008-11#1)(2010-7#1)
reporting of adverse##3##3##(2008-11#1)(2011-2#2)
reporting of health##2##3##(1997-3#1)(2013-7#1)
reporting of the##2##3##(2008-10#1)(2012-2#1)
reporting of##21##2##(1991-11#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#2)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
reporting on the##3##3##(2008-4#1)(2008-7#1)(2010-7#1)
reporting on##4##2##(1997-1#1)(2008-4#1)(2008-7#1)(2010-7#1)
reporting outcomes following C-ADR (Bryan disc##2##6##(2012-12#2)
reporting outcomes following C-ADR##3##4##(2012-12#3)
reporting outcomes##4##2##(2012-12#4)
reporting requirements##3##2##(1993-3#1)(1997-3#1)(2012-2#1)
reporting the##3##2##(1990-2#1)(2008-12#1)(2008-5#1)
reporting##152##1##(1990-12#2)(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#4)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-3#6)(2006-5#1)(2008-1#1)(2008-10#12)(2008-11#11)(2008-12#8)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#16)(2011-3#1)(2012-12#12)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#6)
reports a case of##4##4##(1992-5#1)(2007-12#1)(2010-1#1)(2011-2#1)
reports a##14##2##(1992-5#1)(1995-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2009-9#1)(2010-1#1)(2011-2#1)
reports about the##2##3##(2008-10#1)(2008-9#1)
reports about##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
reports an##6##2##(1992-9#1)(1994-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
reports and##17##2##(1991-2#2)(1991-3#2)(1993-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-4#1)(2010-10#2)(2010-7#1)(2011-2#2)(2012-12#1)
reports are published##2##3##(1993-12#1)(2008-11#1)
reports are##6##2##(1990-9#1)(1993-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
reports based##2##2##(2008-5#1)(2013-1#1)
reports by##4##2##(1996-3#1)(1996-8#1)(2008-5#1)(2008-9#1)
reports can be##2##3##(1991-3#1)(1994-3#1)
reports concerning##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
reports demonstrate##2##2##(2009-8#1)(2011-2#1)
reports describe##2##2##(2008-10#1)(2013-1#1)
reports describing##2##2##(2008-3#1)(2010-6#1)
reports documenting##2##2##(2011-2#1)(2012-2#1)
reports findings##3##2##(2008-11#2)(2010-2#1)
reports for##2##2##(1996-12#1)(2011-2#1)
reports from a##2##3##(2009-5#1)(2011-2#1)
reports from##11##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
reports have been published##2##4##(2008-10#1)(2008-11#1)
reports have described the##2##4##(2011-2#1)(2012-3#1)
reports have described##5##3##(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
reports have shown that##2##4##(2008-7#2)
reports have shown##3##3##(1992-12#1)(2008-7#2)
reports have##20##2##(1991-3#1)(1992-12#1)(1994-1#1)(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#2)(2008-9#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
reports in the literature##6##4##(1991-2#1)(1994-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)
reports in##10##2##(1991-2#1)(1994-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
reports of a##4##3##(1991-8#1)(2008-10#1)(2008-9#1)(2010-4#1)
reports of physician quality##2##4##(2013-1#2)
reports of the##5##3##(2008-10#3)(2008-12#1)(2008-7#1)
reports of##62##2##(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#1)(1993-6#1)(1994-3#1)(1994-6#1)(1997-3#3)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-3#2)(2013-1#5)(2013-8#1)
reports on a##7##3##(1993-3#1)(1996-11#1)(2008-11#2)(2008-12#1)(2008-7#1)(2013-8#1)
reports on an##4##3##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
reports on the design##2##4##(1996-2#1)(2008-12#1)
reports on the use of##3##5##(2008-10#3)
reports on the##21##3##(1990-3#1)(1994-2#1)(1996-2#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
reports on two##2##3##(1994-2#1)(2010-12#1)
reports on##55##2##(1990-3#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-3#1)(1996-11#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#10)(2008-12#4)(2008-7#3)(2008-9#2)(2010-1#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
reports or##2##2##(2008-11#1)(2013-1#1)
reports results from a##2##4##(1994-3#1)(1996-3#1)
reports show that##2##3##(2008-3#1)(2011-2#1)
reports showed that##2##3##(2008-12#1)(2008-9#1)
reports showing##4##2##(1990-5#1)(1997-5#1)(2011-2#1)(2012-12#1)
reports suggest that##3##3##(1993-6#1)(2007-11#1)(2011-2#1)
reports suggested##2##2##(2008-11#1)(2009-7#1)
reports that the##2##3##(1990-5#1)(1995-2#1)
reports that##17##2##(1990-12#1)(1990-5#1)(1991-1#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#3)(2012-3#2)(2013-1#2)
reports the development of a##4##5##(2008-10#3)(2008-5#1)
reports the findings of a##3##5##(1995-1#1)(2008-11#2)
reports the results obtained##2##4##(2008-10#1)(2008-11#1)
reports the results of a study##4##6##(1992-1#1)(1993-3#1)(1996-1#1)(2008-5#1)
reports the results of a survey##2##6##(1994-12#1)(1996-12#1)
reports the results of a##8##5##(1991-6#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-5#1)
reports the results of##10##4##(1991-6#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
reports the results##12##3##(1991-6#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
reports the synthesis of##2##4##(2008-4#1)(2010-4#1)
reports the use of##5##4##(2008-10#4)(2013-1#1)
reports the##48##2##(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-4#1)(2008-5#3)(2008-9#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-3#1)(2012-7#1)(2013-1#4)
reports to the##2##3##(1993-6#1)(2008-11#1)
reports to##8##2##(1991-1#1)(1993-12#1)(1993-6#1)(1994-3#1)(2008-11#1)(2013-1#2)(2013-8#1)
reports were##5##2##(1990-3#1)(1990-6#1)(1991-1#1)(2011-2#1)(2013-1#1)
reports which##3##2##(1991-6#1)(2008-12#1)(2008-7#1)
reports##439##1##(1990-12#2)(1990-3#7)(1990-5#2)(1990-6#1)(1990-9#2)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#6)(1991-5#1)(1991-6#3)(1991-8#2)(1992-1#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#5)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#7)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#4)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-5#1)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#68)(2008-11#47)(2008-12#10)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#6)(2008-7#19)(2008-8#1)(2008-9#13)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#6)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#31)(2011-3#1)(2011-7#1)(2012-12#10)(2012-2#6)(2012-3#12)(2012-7#1)(2013-1#27)(2013-7#1)(2013-8#9)
reports)##3##1##(1991-8#1)(2008-12#1)(2011-2#1)
reports]##2##1##(1992-5#1)(2008-10#1)
repositioning in##2##2##(2008-11#1)(2010-7#1)
repositioning##8##1##(2008-11#1)(2009-8#1)(2010-7#1)(2011-2#4)(2013-1#1)
repositories##4##1##(2008-7#1)(2010-12#3)
repository##3##1##(1996-3#1)(2008-7#1)(2010-10#1)
represent a class of##2##4##(1995-2#1)(2008-3#1)
represent a common##2##3##(1995-12#1)(2008-10#1)
represent a distinct##3##3##(2008-10#3)
represent a major##3##3##(1995-2#1)(2008-7#1)(2009-3#1)
represent a new##6##3##(1991-2#1)(2008-10#3)(2008-5#1)(2009-7#1)
represent a novel##5##3##(1990-5#1)(1991-9#1)(2008-8#1)(2012-12#1)(2013-8#1)
represent a potential##3##3##(2008-10#3)
represent a promising##2##3##(1992-12#1)(2008-11#1)
represent a rare##3##3##(1990-6#1)(2008-10#1)(2010-12#1)
represent a relatively##2##3##(2008-5#2)
represent a significant##3##3##(2008-10#1)(2008-11#1)(2010-6#1)
represent a single##2##3##(2008-10#1)(2008-5#1)
represent a unique##2##3##(2008-7#1)(2009-8#1)
represent a useful##2##3##(1990-8#1)(2008-11#1)
represent a wide##2##3##(2008-10#1)(2008-3#1)
represent a##101##2##(1990-5#2)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#3)(1996-11#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#23)(2008-11#7)(2008-3#3)(2008-5#7)(2008-7#7)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#2)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
represent an altered##2##3##(1993-1#1)(2011-2#1)
represent an important##6##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
represent an##21##2##(1993-1#1)(1995-9#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
represent different##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
represent distinct##2##2##(2008-10#2)
represent early##3##2##(1991-12#1)(2008-9#2)
represent important##2##2##(2008-7#1)(2013-8#1)
represent its##2##2##(1992-2#1)(2013-1#1)
represent more##2##2##(2008-5#1)(2008-8#1)
represent one of the most##2##5##(1992-5#1)(2010-11#1)
represent one of the##4##4##(1992-5#1)(2008-5#1)(2010-11#2)
represent only a##2##3##(2008-10#1)(2011-2#1)
represent output function##2##3##(1991-6#2)
represent the effects of##2##4##(2008-10#1)(2013-1#1)
represent the first##6##3##(1990-2#1)(1990-5#1)(1994-5#1)(2008-10#2)(2009-10#1)
represent the major source##2##4##(2008-11#1)(2010-11#1)
represent the major##3##3##(1993-6#1)(2008-11#1)(2010-11#1)
represent the most##6##3##(1993-1#1)(1996-2#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-3#1)
represent the##63##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-9#2)(1996-2#2)(1996-8#1)(2007-12#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
represent three##3##2##(2008-10#3)
represent two different##2##3##(1996-1#1)(2008-10#1)
represent two##6##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-3#1)
represent##289##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-8#2)(1991-12#4)(1991-2#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#2)(1993-1#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-5#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#2)(2007-12#3)(2008-1#1)(2008-10#67)(2008-11#23)(2008-12#3)(2008-3#5)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#6)(2010-1#2)(2010-11#6)(2010-12#5)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#20)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#8)
representation for a##2##3##(2008-6#2)
representation of the##14##3##(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
representation of##34##2##(1992-3#1)(1994-3#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#4)(2009-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
representation##62##1##(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#8)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#7)(2009-6#1)(2009-8#1)(2010-2#2)(2010-7#2)(2011-2#5)(2012-3#3)(2013-1#1)(2013-8#2)
representational##3##1##(2009-10#2)(2012-3#1)
representations of the##4##3##(2008-6#1)(2009-12#1)(2011-2#1)(2013-8#1)
representations of##12##2##(2008-11#1)(2008-6#1)(2009-12#1)(2009-7#1)(2011-2#1)(2013-8#7)
representations##31##1##(1994-3#1)(1995-12#1)(2008-1#1)(2008-11#3)(2008-6#2)(2009-10#2)(2009-12#3)(2009-7#1)(2009-8#2)(2010-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#9)
representative chemicals##2##2##(2008-11#2)
representative examples##4##2##(2008-10#1)(2010-10#1)(2010-7#1)(2012-3#1)
representative isolates of##4##3##(2008-10#4)
representative isolates##9##2##(2008-10#8)(2011-2#1)
representative material##2##2##(1991-11#1)(2012-2#1)
representative of the##17##3##(1992-2#1)(1993-6#1)(1994-6#1)(2008-10#7)(2008-4#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#3)
representative of##34##2##(1990-6#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-6#1)(1994-6#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#5)(2012-7#1)(2013-8#1)
representative sample of##8##3##(1991-12#1)(1993-1#1)(1996-6#1)(2008-1#1)(2009-7#2)(2012-2#1)(2013-8#1)
representative sample##9##2##(1991-12#1)(1993-1#1)(1996-6#1)(2008-1#1)(2009-7#2)(2010-6#1)(2012-2#1)(2013-8#1)
representative samples of##2##3##(1991-9#1)(2008-10#1)
representative strains##4##2##(2008-10#4)
representative##138##1##(1990-11#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#53)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#10)(2012-2#3)(2012-3#2)(2012-7#2)(2013-1#3)(2013-8#5)
representatives from all##2##3##(2008-11#1)(2008-12#1)
representatives from##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
representatives of these genera##2##4##(2008-10#1)(2008-12#1)
representatives of these##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
representatives of##19##2##(1991-6#1)(1992-7#1)(1994-1#2)(1995-6#1)(1997-2#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
representatives##36##1##(1991-1#1)(1991-12#1)(1991-6#1)(1992-7#1)(1994-1#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#11)(2008-11#4)(2008-12#3)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
represented HEV71##2##2##(2013-8#2)
represented a significant##2##3##(1994-2#1)(2008-11#1)
represented a##14##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-8#1)(1992-3#1)(1994-2#2)(1996-3#1)(2008-10#3)(2008-11#2)(2008-7#1)
represented all##3##2##(2008-10#2)(2008-11#1)
represented as##3##2##(1992-3#1)(2008-11#1)(2009-5#1)
represented by a single##2##4##(2008-10#2)
represented by a##10##3##(1990-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)
represented by the##15##3##(1992-9#1)(1995-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-1#2)(2011-2#3)
represented by##51##2##(1990-12#1)(1990-8#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-12#1)(1997-8#1)(2008-10#14)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#4)(2008-8#1)(2008-9#1)(2009-1#2)(2009-11#1)(2010-12#1)(2011-2#5)(2011-3#3)(2013-1#2)
represented each##2##2##(2008-10#1)(2008-12#1)
represented in the##7##3##(1991-2#2)(1994-9#1)(1995-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
represented in this##2##3##(1997-3#1)(2008-12#1)
represented in##18##2##(1991-2#2)(1992-12#1)(1994-9#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#2)(2013-1#2)
represented only##2##2##(1993-8#1)(1994-8#1)
represented the main##2##3##(1994-2#1)(2008-11#1)
represented the major##3##3##(1992-6#1)(1994-2#2)
represented the most##3##3##(2008-10#2)(2009-5#1)
represented the##16##2##(1992-6#1)(1994-2#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#2)(2011-2#1)(2012-3#1)
represented two##3##2##(1993-12#1)(2008-10#2)
represented##152##1##(1990-12#2)(1990-4#1)(1990-8#2)(1991-12#1)(1991-2#4)(1991-8#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#7)(1994-8#2)(1994-9#1)(1995-12#3)(1995-6#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#42)(2008-11#12)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#2)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#10)(2011-3#3)(2012-3#1)(2013-1#4)(2013-8#3)
representing 2##2##2##(2008-10#2)
representing 56##2##2##(2008-10#1)(2009-9#1)
representing 92##2##2##(2008-11#1)(2008-12#1)
representing a range of##3##4##(1995-11#1)(2008-10#2)
representing a##18##2##(1994-3#1)(1995-11#1)(1996-5#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
representing all##2##2##(1992-2#1)(1995-1#1)
representing an##4##2##(1993-6#1)(2008-7#1)(2010-12#1)(2010-8#1)
representing approximately##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
representing four##2##2##(1996-1#1)(2008-10#1)
representing the known genetic and pathogenic diversity##2##7##(2008-10#2)
representing the known##3##3##(2008-10#3)
representing the two##2##3##(2008-10#2)
representing the##34##2##(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#2)(2009-6#1)(2009-7#1)(2010-12#1)(2012-3#3)(2013-8#1)
representing three##2##2##(2008-10#2)
representing unique##2##2##(2008-10#1)(2010-4#1)
representing various##2##2##(1993-8#1)(2008-10#1)
representing##134##1##(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(2008-10#53)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#5)
represents a fundamental##2##3##(2008-11#1)(2009-6#1)
represents a key##2##3##(1990-8#1)(2008-9#1)
represents a limiting##2##3##(1994-11#1)(2008-11#1)
represents a major##7##3##(1991-1#1)(2008-10#2)(2008-11#2)(2011-2#2)
represents a mechanism##3##3##(1993-3#1)(1995-2#1)(1996-12#1)
represents a new##6##3##(1991-5#1)(2008-10#3)(2008-4#1)(2009-6#1)
represents a novel and##3##4##(2008-11#1)(2008-8#1)(2011-1#1)
represents a novel##5##3##(1991-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
represents a potentially##2##3##(2008-10#1)(2008-5#1)
represents a promising##2##3##(2008-10#1)(2013-1#1)
represents a safe and##2##4##(1995-11#1)(1995-8#1)
represents a serious##3##3##(2008-10#1)(2012-12#2)
represents a significant improvement in##2##5##(1990-2#1)(2008-11#1)
represents a significant improvement##3##4##(1990-2#1)(2008-11#1)(2010-5#1)
represents a significant##7##3##(1990-2#1)(1991-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)
represents a small##2##3##(1990-2#1)(1997-7#1)
represents a unique##5##3##(2008-11#1)(2008-8#2)(2009-8#1)(2013-8#1)
represents a useful model for##2##5##(1995-12#1)(2008-10#1)
represents a useful##3##3##(1995-12#1)(2008-10#1)(2009-10#1)
represents a valid alternative for the determination of##2##8##(2008-10#2)
represents a valid##3##3##(1990-3#1)(2008-10#2)
represents a valuable##2##3##(1990-2#1)(2009-1#1)
represents a viable##3##3##(1992-2#1)(2008-11#1)(2013-1#1)
represents a##129##2##(1990-2#3)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-2#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#12)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#3)(2012-4#1)(2013-1#5)(2013-8#1)
represents an approach##2##3##(1995-2#1)(2008-10#1)
represents an attractive target for##2##5##(2008-11#1)(2011-2#1)
represents an exciting##2##3##(2008-4#1)(2009-5#1)
represents an important##2##3##(2008-10#1)(2008-9#1)
represents an##30##2##(1991-2#1)(1991-6#2)(1992-11#1)(1995-2#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
represents one of the most##4##5##(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
represents one of the##8##4##(2008-10#3)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
represents one of##9##3##(2008-10#3)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
represents that##2##2##(1990-8#1)(1992-3#1)
represents the first evidence##2##4##(2008-9#1)(2013-8#1)
represents the first example of##2##5##(1995-2#1)(2008-10#1)
represents the first report##2##4##(2008-10#2)
represents the first##15##3##(1991-3#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#5)(2008-8#1)(2008-9#2)(2010-5#1)(2013-8#1)
represents the major##2##3##(2008-10#1)(2008-7#1)
represents the most common##2##4##(2011-2#1)(2012-12#1)
represents the most##5##3##(1993-3#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
represents the##59##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-8#1)
represents##264##1##(1990-2#3)(1990-3#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#9)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#2)(2007-12#5)(2008-1#3)(2008-10#50)(2008-11#18)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#12)(2008-9#9)(2009-1#3)(2009-10#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#4)(2010-5#3)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#16)(2011-3#1)(2012-12#5)(2012-2#7)(2012-3#3)(2012-4#1)(2013-1#9)(2013-8#3)
repress the##5##2##(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-7#1)
repress##10##1##(1991-5#1)(1993-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
repressed by##4##2##(1993-9#1)(1996-12#1)(1996-3#1)(2008-9#1)
repressed expression after pathogen infection##2##5##(2008-9#2)
repressed expression##3##2##(2008-9#2)(2009-10#1)
repressed in##3##2##(1990-5#1)(1997-7#1)(2008-11#1)
repressed##17##1##(1990-5#1)(1993-9#1)(1996-12#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#4)(2008-8#1)(2008-9#3)(2009-10#1)
represses the##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
represses transcription##2##2##(2008-11#1)(2011-1#1)
represses##13##1##(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-8#2)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
repressible##2##1##(1993-12#1)(1997-7#1)
repressing the##2##2##(2008-11#1)(2011-2#1)
repressing##5##1##(1997-3#1)(2008-11#2)(2011-2#1)(2013-1#1)
repression by##4##2##(1993-12#1)(1995-6#1)(2008-10#2)
repression of fabA transcription##2##4##(1992-8#2)
repression of the expression of##2##5##(1995-12#2)
repression of the##6##3##(1991-10#1)(1993-5#1)(1995-12#2)(2008-10#1)(2008-11#1)
repression of##18##2##(1991-10#1)(1992-8#2)(1993-5#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)
repression##37##1##(1991-10#3)(1992-8#3)(1993-12#1)(1993-5#1)(1995-12#3)(1995-2#1)(1995-6#3)(1996-3#2)(1996-6#1)(2008-10#10)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#3)
repressive##3##1##(1990-6#1)(1992-6#1)(2012-2#1)
repressor and activator##2##3##(2012-3#2)
repressor and##5##2##(1990-11#1)(1991-5#1)(2010-4#1)(2012-3#2)
repressor protein##3##2##(1994-3#1)(2008-9#2)
repressor to its##2##3##(2008-11#1)(2008-8#1)
repressor##30##1##(1990-11#2)(1991-10#2)(1991-5#1)(1992-4#5)(1994-3#1)(1996-2#1)(1996-6#1)(2008-11#2)(2008-8#7)(2008-9#2)(2009-6#1)(2010-4#2)(2011-2#1)(2012-3#2)
repressor/operator##2##1##(1994-3#2)
repressors##6##1##(1991-5#1)(1992-4#1)(1996-2#1)(1997-3#1)(2008-10#1)(2009-8#1)
reprint##2##1##(1991-3#2)
reprocessing##4##1##(1995-2#1)(2008-10#1)(2011-2#2)
reproduce in##2##2##(2008-10#1)(2013-8#1)
reproduce our##2##2##(2008-10#1)(2008-3#1)
reproduce the behavior##2##3##(2008-11#1)(2008-8#1)
reproduce the##10##2##(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#1)(2013-1#1)
reproduce##36##1##(1992-9#1)(1995-8#1)(1997-7#1)(2008-10#8)(2008-11#7)(2008-2#1)(2008-3#2)(2008-8#8)(2008-9#2)(2009-5#1)(2013-1#1)(2013-8#3)
reproduced by##2##2##(1991-1#1)(2009-8#1)
reproduced in##7##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-3#1)
reproduced the##2##2##(1994-6#1)(2011-2#1)
reproduced when##2##2##(2008-10#1)(2011-2#1)
reproduced with##4##2##(1992-3#1)(2008-10#2)(2008-11#1)
reproduced##26##1##(1991-1#1)(1992-3#1)(1994-6#1)(1997-7#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#2)(2009-8#1)(2010-9#1)(2011-2#4)(2012-3#1)
reproduces at##2##2##(2008-10#1)(2008-8#1)
reproduces the##3##2##(2008-10#2)(2008-5#1)
reproduces##7##1##(2008-10#5)(2008-5#1)(2008-8#1)
reproducibilities##4##1##(2008-10#4)
reproducibility ( approximately##2##3##(2008-10#2)
reproducibility (0##2##2##(2008-10#2)
reproducibility (S##3##2##(2008-10#3)
reproducibility (n=5) of##2##3##(2008-10#2)
reproducibility and accuracy of##3##4##(1991-3#1)(2008-10#2)
reproducibility and accuracy##4##3##(1991-3#1)(2008-10#3)
reproducibility and detection##2##3##(2008-10#2)
reproducibility and high##2##3##(2008-10#2)
reproducibility and lifetime##3##3##(2008-10#3)
reproducibility and reliability of##4##4##(2008-10#3)(2008-11#1)
reproducibility and the##2##3##(2008-10#2)
reproducibility and##29##2##(1991-3#1)(2008-10#24)(2008-11#2)(2008-5#1)(2009-11#1)
reproducibility are##2##2##(2008-10#2)
reproducibility between##4##2##(2008-10#4)
reproducibility for the##2##3##(2008-10#2)
reproducibility for##5##2##(2008-10#4)(2010-9#1)
reproducibility in##2##2##(2008-10#1)(2009-1#1)
reproducibility is around##2##3##(2008-10#2)
reproducibility is##8##2##(1997-2#1)(2008-10#6)(2008-5#1)
reproducibility obtained##2##2##(2008-10#2)
reproducibility of 1##4##3##(2008-10#4)
reproducibility of different##2##3##(2008-10#2)
reproducibility of the method##7##4##(2008-10#4)(2008-11#1)(2010-7#2)
reproducibility of the tumor position##2##5##(2009-11#2)
reproducibility of the##31##3##(1997-8#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#2)(2009-2#1)(2010-7#2)(2012-2#1)(2013-8#1)
reproducibility of##53##2##(1997-8#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#2)(2009-11#2)(2009-2#1)(2010-5#1)(2010-7#2)(2012-2#1)(2013-8#1)
reproducibility to##3##2##(2008-10#2)(2008-2#1)
reproducibility was##14##2##(2008-10#13)(2009-11#1)
reproducibility were##4##2##(2008-10#4)
reproducibility with##5##2##(2008-10#5)
reproducibility##238##1##(1991-3#1)(1992-11#1)(1995-3#1)(1996-6#1)(1997-2#2)(1997-8#5)(2008-10#194)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#4)(2009-2#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-8#2)
reproducible (relative standard##2##3##(2008-10#2)
reproducible and highly##2##3##(2008-10#1)(2008-11#1)
reproducible and selective##2##3##(2008-10#2)
reproducible and sensitive##2##3##(1990-12#1)(2008-10#1)
reproducible and specific##2##3##(2008-10#2)
reproducible and##26##2##(1990-12#1)(1996-2#1)(1997-2#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#2)
reproducible experimental##3##2##(2008-11#3)
reproducible method##7##2##(1994-6#1)(2008-10#3)(2008-11#3)
reproducible response of##2##3##(2008-10#2)
reproducible response##4##2##(2008-10#4)
reproducible results##6##2##(1990-12#1)(2008-10#3)(2008-12#1)(2008-7#1)
reproducible within a relative standard deviation of 1##2##8##(2008-10#2)
reproducible within a##3##3##(2008-10#3)
reproducible within##6##2##(2008-10#6)
reproducible##162##1##(1990-11#1)(1990-12#2)(1991-3#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-8#1)(2006-6#1)(2008-10#100)(2008-11#12)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-7#7)(2008-9#3)(2009-1#1)(2009-12#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#3)(2013-1#2)(2013-8#1)
reproducibly##12##1##(1997-2#1)(2008-10#3)(2008-11#4)(2009-8#1)(2011-2#1)(2012-2#2)
reproducing in##2##2##(2008-5#1)(2008-8#1)
reproducing##13##1##(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2013-8#2)
reproduction among##2##2##(2008-8#2)
reproduction and##10##2##(2008-10#1)(2008-8#5)(2008-9#3)(2010-5#1)
reproduction are##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
reproduction by##2##2##(2008-10#1)(2008-3#1)
reproduction for##3##2##(2008-8#1)(2008-9#2)
reproduction in the##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
reproduction in##11##2##(1997-7#1)(2008-10#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2012-3#2)
reproduction occurs##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
reproduction of the##2##3##(2007-11#1)(2008-10#1)
reproduction of##12##2##(2007-11#1)(2008-10#5)(2008-11#2)(2008-8#3)(2008-9#1)
reproduction probably##2##2##(2008-10#1)(2008-8#1)
reproduction rate##2##2##(2008-10#2)
reproduction was##2##2##(2008-10#1)(2008-9#1)
reproduction with##2##2##(2008-9#1)(2010-1#1)
reproduction##153##1##(1991-3#1)(1992-12#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#42)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#48)(2008-9#24)(2009-5#2)(2009-6#2)(2010-1#1)(2010-4#1)(2010-5#4)(2011-3#1)(2012-3#7)(2013-1#1)(2013-8#1)
reproductive age groups##3##3##(2011-2#3)
reproductive age##7##2##(2011-1#2)(2011-2#4)(2013-1#1)
reproductive and developmental##2##3##(2008-11#1)(2010-1#1)
reproductive and sexual health##2##4##(2008-11#2)
reproductive and##4##2##(2008-11#3)(2010-1#1)
reproductive assurance##2##2##(2008-9#2)
reproductive biology##2##2##(2008-12#1)(2009-6#1)
reproductive competition##3##2##(2008-9#3)
reproductive cost##2##2##(2008-9#2)
reproductive costs##2##2##(2008-8#1)(2008-9#1)
reproductive development##2##2##(2008-10#1)(2009-10#1)
reproductive diapause##2##2##(2008-8#2)
reproductive dormancy##3##2##(2008-8#3)
reproductive effort in##2##3##(2008-8#2)
reproductive effort##14##2##(2008-8#11)(2008-9#1)(2010-8#2)
reproductive events##2##2##(2008-8#1)(2012-2#1)
reproductive factors##2##2##(1990-6#1)(2008-10#1)
reproductive function##7##2##(1992-3#1)(2008-4#2)(2008-6#1)(2009-6#1)(2012-3#1)(2013-8#1)
reproductive health in##3##3##(2008-1#1)(2012-12#2)
reproductive health services##5##3##(1995-6#1)(2008-1#1)(2008-11#3)
reproductive health##26##2##(1994-9#1)(1995-6#1)(2008-1#7)(2008-11#10)(2010-12#1)(2012-12#4)(2012-2#1)(2013-8#1)
reproductive history##2##2##(1990-6#1)(2012-12#1)
reproductive investment##2##2##(2010-8#2)
reproductive isolation between##3##3##(2008-8#2)(2012-3#1)
reproductive isolation##8##2##(2008-8#7)(2012-3#1)
reproductive number##9##2##(2008-10#6)(2008-8#1)(2011-3#1)(2013-8#1)
reproductive organs##5##2##(2008-12#3)(2008-8#1)(2010-1#1)
reproductive outcome##4##2##(1992-3#3)(2011-1#1)
reproductive output and##2##3##(2008-8#2)
reproductive output##9##2##(2008-10#1)(2008-8#7)(2008-9#1)
reproductive parasitism##2##2##(2008-9#2)
reproductive performance of##4##3##(2009-5#2)(2010-8#2)
reproductive performance##5##2##(1996-1#1)(2009-5#2)(2010-8#2)
reproductive potential##8##2##(2008-10#1)(2008-8#3)(2008-9#2)(2013-8#2)
reproductive rate##2##2##(2008-8#1)(2008-9#1)
reproductive roles##2##2##(2008-9#2)
reproductive strategy##2##2##(2008-10#1)(2013-8#1)
reproductive structure of##2##3##(2011-2#2)
reproductive structure##3##2##(2011-2#3)
reproductive success and##2##3##(2008-9#2)
reproductive success in##3##3##(2008-9#1)(2010-8#1)(2012-3#1)
reproductive success of##5##3##(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
reproductive success than##2##3##(2008-9#2)
reproductive success was##3##3##(2008-10#1)(2008-8#2)
reproductive success##33##2##(2008-10#2)(2008-8#13)(2008-9#10)(2010-8#2)(2012-2#1)(2012-3#5)
reproductive surgery##3##2##(1992-2#2)(1992-3#1)
reproductive system##7##2##(1993-3#1)(2007-12#2)(2008-10#1)(2009-10#1)(2010-8#1)(2012-2#1)
reproductive tactics##3##2##(2008-8#1)(2010-8#2)
reproductive technologies##3##2##(1992-2#2)(2008-11#1)
reproductive tract##5##2##(1990-11#1)(1993-2#1)(2008-11#1)(2010-3#1)(2011-2#1)
reproductive tracts##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
reproductive traits that##2##3##(1995-2#1)(2012-3#1)
reproductive traits##5##2##(1995-2#1)(2008-8#1)(2008-9#1)(2012-3#2)
reproductive vacancies##3##2##(2008-9#3)
reproductive##280##1##(1990-11#1)(1990-6#2)(1991-1#1)(1991-12#1)(1992-2#5)(1992-3#5)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-2#1)(1996-8#1)(1996-9#2)(2007-12#4)(2008-1#7)(2008-10#21)(2008-11#17)(2008-12#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#70)(2008-9#38)(2009-10#2)(2009-5#3)(2009-6#2)(2009-8#1)(2010-1#3)(2010-12#1)(2010-3#1)(2010-8#17)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#7)(2012-2#6)(2012-3#13)(2012-8#2)(2013-1#2)(2013-8#7)
reproductively active##2##2##(1995-12#1)(2012-3#1)
reproductively isolated##2##2##(2008-10#1)(2008-6#1)
reproductively##6##1##(1995-12#1)(2008-10#1)(2008-6#1)(2008-8#2)(2012-3#1)
reproductives##4##1##(2007-12#4)
reproductivity##2##1##(2008-10#2)
reprogramming##4##1##(1990-11#1)(2008-8#1)(2009-3#1)(2010-7#1)
reprotonation##3##1##(2008-10#3)
reps during##2##2##(2013-1#2)
reptile##2##1##(2008-10#1)(2008-8#1)
reptilian##3##1##(2008-10#1)(2009-10#1)(2011-2#1)
repulsion between##3##2##(2008-10#2)(2008-9#1)
repulsion phase##3##2##(2008-10#3)
repulsion##14##1##(1996-5#1)(1997-2#1)(2008-10#9)(2008-8#1)(2008-9#1)(2012-2#1)
repurified##2##1##(1990-8#1)(2008-8#1)
reputation##12##1##(1992-12#1)(1996-1#7)(2008-7#1)(2012-2#1)(2013-8#2)
request for##7##2##(1990-3#1)(1995-12#2)(1995-2#1)(1995-6#1)(2008-11#1)(2010-11#1)
request in##2##2##(1995-12#1)(2007-8#1)
request##28##1##(1990-11#1)(1990-3#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-3#1)(1994-12#2)(1995-12#3)(1995-2#1)(1995-6#3)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2013-8#1)
requested to##5##2##(1991-11#1)(2008-11#2)(2010-1#1)(2012-2#1)
requested##16##1##(1991-11#1)(1991-3#1)(1993-12#1)(1995-1#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#4)(2008-5#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
requesting support##2##2##(2012-12#2)
requesting##8##1##(1992-1#1)(1992-8#1)(1996-1#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-12#2)
requests for##3##2##(1994-1#1)(1994-2#1)(2008-11#1)
requests##15##1##(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-6#1)(2008-10#2)(2008-11#1)(2010-2#1)(2012-2#1)(2013-1#2)
require a##33##2##(1992-3#2)(1993-8#1)(1994-1#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#2)
require activation##2##2##(1995-6#1)(1996-2#1)
require active participation##2##3##(1996-12#1)(2010-1#1)
require active##3##2##(1996-12#1)(2010-1#1)(2012-3#1)
require additional##3##2##(2009-8#1)(2012-12#1)(2013-1#1)
require an understanding of##2##4##(2008-8#1)(2008-9#1)
require an##7##2##(1990-12#1)(1991-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
require and##2##2##(1994-3#1)(2009-6#1)
require approximately##2##2##(2008-10#1)(2008-11#1)
require being##2##2##(2008-10#1)(2013-8#1)
require both##2##2##(2009-12#1)(2011-2#1)
require careful attention##2##3##(1992-3#1)(2008-7#1)
require careful##3##2##(1992-3#1)(2008-11#1)(2008-7#1)
require complete##2##2##(2007-11#1)(2012-3#1)
require complex##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
require considerable##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
require continued##2##2##(2008-11#1)(2011-2#1)
require extra##2##2##(1997-8#1)(2008-11#1)
require further research##2##3##(2008-11#1)(2013-1#1)
require further study##2##3##(2008-10#1)(2011-2#1)
require further##7##2##(1995-5#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
require higher##2##2##(2008-10#2)
require less##2##2##(1994-11#1)(2012-3#1)
require more##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#1)
require new and##2##3##(1990-12#1)(1996-3#1)
require new##4##2##(1990-12#1)(1996-3#1)(2010-12#1)(2010-9#1)
require only one##2##3##(2008-10#1)(2008-8#1)
require only##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
require prior##2##2##(2008-10#1)(2009-7#1)
require several years##2##3##(1992-12#1)(2008-10#1)
require skills##2##2##(2008-11#1)(2008-9#1)
require specialized##2##2##(2008-9#2)
require specific##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-1#1)
require surgery##2##2##(2008-10#1)(2012-2#1)
require surgical repair##2##3##(2008-7#1)(2011-2#1)
require surgical##5##2##(1991-2#1)(2008-7#1)(2011-2#1)(2013-1#2)
require that##2##2##(2008-10#1)(2008-9#1)
require the input of##2##4##(2009-11#1)(2011-3#1)
require the use of##5##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
require the##31##2##(1992-6#1)(1993-3#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#4)(2013-1#1)(2013-8#1)
require treatment##2##2##(2011-2#1)(2013-1#1)
require##310##1##(1990-12#2)(1990-5#1)(1991-12#2)(1991-2#6)(1991-3#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#5)(1992-6#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#4)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#5)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#64)(2008-11#24)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#5)(2009-3#2)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#14)(2011-3#2)(2012-12#2)(2012-2#9)(2012-3#8)(2013-1#22)(2013-7#1)(2013-8#5)
required NADPH##2##2##(1990-11#1)(2008-11#1)
required a second##3##3##(1995-2#1)(1996-1#1)(2012-12#1)
required a##12##2##(1994-6#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
required additional##2##2##(1997-8#1)(2013-1#1)
required admission to the##2##4##(2012-3#1)(2013-1#1)
required admission to##3##3##(2012-3#1)(2013-1#2)
required an##2##2##(2008-11#1)(2013-8#1)
required and##5##2##(1990-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
required approximately##2##2##(2008-10#2)
required are##2##2##(1995-12#1)(2008-11#1)
required as##5##2##(2008-10#3)(2008-11#1)(2012-3#1)
required at##4##2##(1995-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
required before##4##2##(1992-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
required by the##6##3##(1990-8#1)(2008-10#3)(2008-11#1)(2010-7#1)
required by##25##2##(1990-12#1)(1990-8#1)(1991-1#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
required cardiopulmonary bypass##2##3##(2008-7#1)(2013-1#1)
required costly equipment##2##3##(2012-2#2)
required due to the##3##4##(2008-10#2)(2012-3#1)
required fewer##2##2##(1996-11#1)(2008-10#1)
required for 90% control of the disease##2##7##(2008-10#2)
required for a##6##3##(1992-9#1)(2008-10#2)(2008-2#1)(2009-9#1)(2013-1#1)
required for accurate##3##3##(2008-10#2)(2008-6#1)
required for both##6##3##(1993-12#1)(1994-5#1)(1994-9#2)(2008-3#1)(2009-7#1)
required for complete##2##3##(1996-2#1)(2010-7#1)
required for development##2##3##(2008-10#2)
required for effective##3##3##(2008-12#1)(2009-10#1)(2011-2#1)
required for growth##3##3##(1996-8#1)(2008-11#1)(2008-7#1)
required for infection and##2##4##(2008-10#2)
required for infection##4##3##(2008-10#4)
required for its##4##3##(2008-10#2)(2011-2#1)(2013-8#1)
required for maintenance of##3##4##(1995-2#1)(2008-11#1)(2010-1#1)
required for maximal##3##3##(1991-5#1)(1997-3#2)
required for mitogenic##2##3##(1994-11#1)(1996-2#1)
required for normal##4##3##(1992-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
required for nuclear migration in differentiating##2##6##(2008-9#2)
required for nuclear##3##3##(1995-2#1)(2008-9#2)
required for obtaining##2##3##(2008-10#2)
required for pathogen##2##3##(2008-10#1)(2011-2#1)
required for persistence##2##3##(2008-8#1)(2013-1#1)
required for pollen##3##3##(2008-10#1)(2009-10#2)
required for proper##2##3##(2008-10#1)(2011-2#1)
required for sample##2##3##(2008-10#2)
required for sporulation##2##3##(1995-9#2)
required for successful##2##3##(1991-1#1)(2008-11#1)
required for the determination of##3##5##(1993-12#1)(2008-10#2)
required for the determination##5##4##(1993-12#1)(2008-10#3)(2010-11#1)
required for the diagnosis##2##4##(2010-8#1)(2013-1#1)
required for the first##2##4##(2008-9#1)(2010-4#1)
required for the formation of##4##5##(1993-12#1)(1993-2#1)(2008-10#1)(2013-1#1)
required for the##55##3##(1991-5#1)(1991-6#1)(1992-10#2)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-8#2)(1997-3#1)(2008-10#11)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#3)(2013-1#4)(2013-7#1)
required for their##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
required for these##2##3##(1991-12#1)(2008-3#1)
required for this##3##3##(1990-5#1)(1994-11#1)(2012-2#1)
required for transcription##2##3##(1992-6#1)(1993-12#1)
required for##306##2##(1990-11#1)(1990-5#3)(1991-1#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#10)(1995-6#8)(1995-9#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#4)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#69)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#13)(2009-10#6)(2009-6#3)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#13)(2012-2#8)(2012-3#9)(2013-1#7)(2013-7#2)(2013-8#4)
required from##3##2##(1992-12#1)(2010-6#1)(2013-1#1)
required hospitalization##2##2##(1992-2#1)(2013-1#1)
required in order to##4##4##(1994-12#1)(1994-5#1)(2010-11#1)(2010-6#1)
required in the##8##3##(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-11#1)(2010-12#1)(2012-12#1)
required in this##4##3##(1992-11#1)(2008-10#2)(2010-6#1)
required in##30##2##(1990-2#1)(1991-12#1)(1992-11#1)(1994-12#1)(1994-5#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
required less##3##2##(1993-2#1)(1996-3#1)(2010-9#1)
required long##2##2##(1992-12#1)(2008-9#1)
required longer##2##2##(2008-10#1)(2013-1#1)
required minimal##2##2##(2008-10#2)
required more than##2##3##(1993-12#1)(2008-10#1)
required number of##3##3##(1996-3#2)(2008-11#1)
required of##2##2##(1994-3#1)(2011-2#1)
required on the##3##3##(1997-5#1)(2008-12#1)(2010-11#1)
required on##4##2##(1997-5#1)(2008-12#1)(2010-11#2)
required only##6##2##(1990-2#1)(1991-3#1)(2008-10#3)(2013-8#1)
required removal##2##2##(2008-9#1)(2010-12#1)
required revision##2##2##(2008-9#1)(2012-12#1)
required significantly##2##2##(2008-10#1)(2012-3#1)
required subsequent##2##2##(1994-12#1)(2013-1#1)
required suction curettage##2##3##(1995-8#2)
required surgical##3##2##(1990-9#1)(1991-8#1)(2010-7#1)
required that##2##2##(2008-5#1)(2011-2#1)
required the presence of##2##4##(1991-3#1)(1997-3#1)
required the use of##2##4##(2008-10#1)(2013-1#1)
required the##11##2##(1991-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
required time##2##2##(2008-10#2)
required to achieve##4##3##(1994-12#1)(1996-2#1)(2008-10#1)(2010-12#1)
required to assess##2##3##(1996-1#1)(2008-10#1)
required to be##5##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-6#2)
required to better##2##3##(1990-6#1)(2008-11#1)
required to clarify the##2##4##(2011-2#1)(2012-2#1)
required to clarify##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
required to complement##2##3##(1995-5#1)(2012-3#1)
required to complete##4##3##(1993-12#1)(2008-10#1)(2008-12#1)(2013-7#1)
required to confirm the##3##4##(2008-10#2)(2008-11#1)
required to confirm##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
required to decide whether##2##4##(1993-2#1)(2006-6#1)
required to detect##4##3##(1992-9#1)(1995-10#1)(2008-10#1)(2008-11#1)
required to determine##2##3##(1992-12#1)(1997-7#1)
required to develop##4##3##(1993-12#1)(2008-11#2)(2010-3#1)
required to ensure that##4##4##(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
required to ensure##5##3##(2008-11#2)(2008-3#1)(2008-5#1)(2012-3#1)
required to establish##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
required to evaluate##2##3##(2008-10#1)(2011-2#1)
required to exceed a cumulative catch of##2##7##(2008-10#2)
required to gather##3##3##(2011-2#3)
required to generate the##2##4##(1995-2#1)(2008-10#1)
required to generate##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
required to have##2##3##(2010-8#1)(2013-1#1)
required to initiate##2##3##(1995-8#1)(2011-2#1)
required to maintain##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
required to manage##2##3##(1993-12#1)(1996-3#1)
required to obtain a##3##4##(1995-9#1)(2008-10#1)(2008-11#1)
required to obtain##11##3##(1992-12#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2011-2#1)
required to optimize##2##3##(2008-10#1)(2008-11#1)
required to produce##3##3##(1992-9#1)(2008-11#2)
required to protect##2##3##(2008-10#1)(2008-11#1)
required to provide##2##3##(1993-3#1)(2011-2#1)
required to reach##4##3##(1991-11#1)(2008-10#3)
required to remove##2##3##(1994-3#1)(2013-1#1)
required to respond##2##3##(2008-9#2)
required to show##2##3##(1992-2#1)(1995-5#1)
required to suppress##2##3##(2008-10#2)
required to undertake##2##3##(2008-11#2)
required to##190##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1992-12#3)(1992-2#2)(1992-4#1)(1992-9#3)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#37)(2008-11#25)(2008-12#4)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#6)(2008-9#8)(2009-1#1)(2009-10#3)(2009-3#1)(2009-6#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#11)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
required was##4##2##(2008-11#1)(2010-6#3)
required##918##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#5)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#2)(1992-4#1)(1992-6#6)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#12)(1993-2#4)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-1#2)(1994-11#5)(1994-12#11)(1994-2#4)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#20)(1995-5#3)(1995-6#10)(1995-8#4)(1995-9#3)(1996-1#7)(1996-11#1)(1996-12#6)(1996-2#7)(1996-3#9)(1996-5#1)(1996-6#1)(1996-8#4)(1997-1#3)(1997-2#1)(1997-3#11)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#3)(2006-6#2)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#5)(2008-10#218)(2008-11#74)(2008-12#12)(2008-2#3)(2008-3#20)(2008-4#10)(2008-5#13)(2008-6#7)(2008-7#22)(2008-8#6)(2008-9#34)(2009-1#1)(2009-10#15)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#10)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#5)(2010-6#6)(2010-7#8)(2010-8#4)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#44)(2012-12#6)(2012-2#22)(2012-3#23)(2012-4#1)(2013-1#33)(2013-7#3)(2013-8#11)
requirement for a##4##3##(1993-12#1)(2007-12#1)(2008-7#1)(2010-1#1)
requirement for more than##2##4##(1996-1#1)(2011-2#1)
requirement for the##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
requirement for##42##2##(1991-10#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#2)(1995-6#2)(1996-1#1)(1997-5#1)(1997-8#1)(2007-12#2)(2008-10#6)(2008-11#7)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2010-1#3)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
requirement in##3##2##(1994-11#1)(2008-10#1)(2009-8#1)
requirement is##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
requirement of protein##2##3##(1990-5#1)(2013-8#1)
requirement of##19##2##(1990-5#3)(1992-10#1)(1993-3#1)(1994-11#1)(1995-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
requirement to##5##2##(1993-11#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-12#1)
requirement was##4##2##(1993-6#1)(2007-9#1)(2008-10#1)(2011-1#1)
requirement##103##1##(1990-2#1)(1990-5#3)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#2)(1995-6#2)(1995-8#1)(1996-1#2)(1997-5#1)(1997-8#2)(2007-12#3)(2007-9#1)(2008-10#16)(2008-11#16)(2008-12#2)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#3)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#3)(2012-8#1)(2013-1#1)(2013-8#5)
requirements and the##2##3##(2008-10#1)(2010-11#1)
requirements and##19##2##(1991-12#1)(1992-2#1)(1994-2#1)(1996-3#1)(2008-10#5)(2008-11#3)(2008-3#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
requirements are##7##2##(1994-2#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-12#1)(2010-8#1)(2010-9#1)
requirements as##3##2##(1997-3#1)(2008-11#1)(2012-3#1)
requirements by##2##2##(2012-2#1)(2013-1#1)
requirements can##2##2##(1997-1#1)(2010-7#1)
requirements for a##2##3##(2008-4#1)(2010-8#1)
requirements for oxygen##2##3##(1991-6#1)(2008-9#1)
requirements for the##8##3##(1990-8#1)(1991-12#1)(1991-6#1)(2008-10#2)(2008-7#1)(2013-1#1)(2013-8#1)
requirements for##63##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#2)(1992-10#1)(1992-9#2)(1993-3#2)(1993-8#2)(1994-1#1)(1994-12#2)(1994-8#1)(1996-1#1)(1997-6#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#2)(2010-12#1)(2010-8#3)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#1)
requirements have##2##2##(1991-12#1)(2009-3#1)
requirements in##5##2##(1996-9#1)(2008-11#2)(2010-8#2)
requirements must be##2##3##(1993-12#1)(1994-1#1)
requirements of the##13##3##(1992-1#1)(1993-8#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-11#2)(2008-3#3)(2008-7#1)(2008-8#1)(2013-1#1)
requirements of##41##2##(1992-1#1)(1993-8#2)(1994-12#1)(1994-2#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
requirements on##2##2##(2008-10#1)(2010-5#1)
requirements that##4##2##(1993-3#1)(1994-5#1)(2008-8#1)(2013-1#1)
requirements to##4##2##(1997-3#1)(2009-12#1)(2013-1#1)(2013-8#1)
requirements were##2##2##(1994-2#1)(2008-7#1)
requirements##253##1##(1990-5#1)(1990-8#1)(1991-1#4)(1991-12#6)(1991-6#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-8#5)(1994-1#3)(1994-12#7)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#4)(1996-12#1)(1996-3#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#4)(1997-6#1)(2007-12#4)(2008-1#2)(2008-10#34)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#3)(2009-12#2)(2009-3#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#14)(2010-9#3)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#13)(2012-3#8)(2012-4#1)(2013-1#15)(2013-8#4)
requires a good##2##3##(2008-3#1)(2008-7#1)
requires a high index of suspicion##2##6##(2011-2#2)
requires a high##3##3##(2008-10#1)(2011-2#2)
requires a large##2##3##(2011-2#1)(2013-1#1)
requires a long-term##2##3##(1994-1#1)(2008-7#1)
requires a multidisciplinary approach##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
requires a suitable##2##3##(2008-11#2)
requires a##47##2##(1992-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(2008-10#8)(2008-11#4)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#2)
requires accurate##2##2##(2008-10#1)(2010-4#1)
requires additional##3##2##(1990-3#1)(2008-10#1)(2008-11#1)
requires an understanding of the##2##5##(2008-10#1)(2008-7#1)
requires an understanding of##4##4##(1995-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
requires an##12##2##(1993-8#1)(1995-2#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#2)
requires at least##2##3##(2011-2#1)(2012-2#1)
requires at##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
requires attention to##2##3##(2007-11#1)(2008-9#1)
requires attention##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
requires both an##2##3##(1991-5#1)(2007-12#1)
requires both##4##2##(1991-5#1)(2007-12#1)(2008-10#1)(2008-6#1)
requires careful##6##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
requires close##2##2##(1997-4#1)(2008-9#1)
requires considerable##2##2##(2008-11#1)(2008-3#1)
requires direct##2##2##(2008-4#1)(2011-2#1)
requires extraction##2##2##(2008-10#2)
requires further development##3##3##(2008-10#2)(2008-11#1)
requires further##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2012-2#1)
requires high##2##2##(2008-11#1)(2008-8#1)
requires identification of##2##3##(1996-3#1)(2008-11#1)
requires in##2##2##(2008-11#1)(2008-8#1)
requires investigation##2##2##(1996-1#1)(2011-2#1)
requires knowledge of##4##3##(2008-10#2)(2010-12#1)(2012-2#1)
requires less##2##2##(2008-11#1)(2010-7#1)
requires little##3##2##(2008-10#2)(2008-2#1)
requires minimal##2##2##(2008-11#1)(2013-1#1)
requires more than##2##3##(2008-11#1)(2008-8#1)
requires more##5##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)
requires new##2##2##(1996-2#1)(2008-7#1)
requires no##10##2##(1994-1#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)
requires only a##4##3##(1997-4#1)(2008-11#1)(2008-12#1)(2008-4#1)
requires only##9##2##(1997-4#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)
requires patients to##2##3##(2008-10#1)(2010-4#1)
requires precise##2##2##(2008-11#1)(2010-6#1)
requires simple##2##2##(2008-10#2)
requires some##3##2##(1992-1#1)(2008-9#2)
requires sophisticated##2##2##(1992-3#1)(2008-10#1)
requires specific##2##2##(2011-2#1)(2013-1#1)
requires strong##2##2##(1994-3#1)(2008-10#1)
requires that a##2##3##(1994-3#1)(2008-3#1)
requires that the##4##3##(1990-6#1)(1995-12#1)(2008-8#2)
requires that##10##2##(1990-6#1)(1994-1#1)(1994-3#1)(1995-12#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-8#2)(2011-2#1)
requires the availability of##2##4##(2008-10#2)
requires the use of##2##4##(2008-10#1)(2008-4#1)
requires the##30##2##(1991-1#1)(1991-12#1)(1993-1#1)(1994-2#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
requires to##2##2##(2010-1#1)(2011-2#1)
requires##342##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#6)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-9#1)(1995-12#2)(1995-2#7)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#67)(2008-11#39)(2008-12#7)(2008-2#3)(2008-3#12)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#16)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#4)(2011-2#21)(2012-2#9)(2012-3#6)(2013-1#11)(2013-8#4)
requiring a##6##2##(2007-8#1)(2008-10#1)(2008-9#1)(2011-3#1)(2012-3#1)(2013-1#1)
requiring additional##3##2##(1995-5#1)(2008-10#1)(2009-1#1)
requiring an##4##2##(1995-2#1)(2008-10#2)(2012-12#1)
requiring at least##2##3##(2008-10#1)(2011-2#1)
requiring both##2##2##(1995-2#1)(2008-10#1)
requiring endoscopic##2##2##(2008-10#1)(2013-8#1)
requiring hospitalization##2##2##(2013-1#2)
requiring immediate##4##2##(1994-3#1)(1997-5#1)(2010-12#1)(2011-2#1)
requiring more##2##2##(1993-11#1)(2008-7#1)
requiring no sample##2##3##(2008-10#2)
requiring no##3##2##(2008-10#3)
requiring only##5##2##(1993-8#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-11#1)
requiring specific##2##2##(2011-2#2)
requiring the##3##2##(1992-7#1)(2011-2#2)
requiring##93##1##(1990-2#1)(1991-1#2)(1991-11#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-5#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#3)(2008-3#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
requisite for##2##2##(1994-8#1)(1995-11#1)
requisite##9##1##(1991-3#2)(1994-2#1)(1994-8#1)(1995-11#1)(2008-12#2)(2008-4#1)(2013-1#1)
rer##5##1##(1996-9#2)(1997-2#1)(1997-8#2)
rerio##2##1##(1993-12#1)(2012-3#1)
rerio) as##2##2##(2008-11#1)(2013-1#1)
rerio)##4##1##(2008-11#1)(2008-9#2)(2013-1#1)
rerupture##2##1##(1993-11#1)(1997-3#1)
resampling the##2##2##(2008-3#1)(2008-6#1)
resampling##4##1##(2008-10#2)(2008-3#1)(2008-6#1)
resazurin##2##1##(2008-10#1)(2008-11#1)
rescreening##2##1##(1991-6#2)
rescue and##2##2##(2008-10#1)(2008-4#1)
rescue of##2##2##(1993-12#1)(2008-10#1)
rescue therapy##3##2##(2008-11#2)(2010-12#1)
rescue##27##1##(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1995-2#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
rescued by##5##2##(1995-2#1)(1995-9#1)(1996-3#1)(2008-7#1)(2011-2#1)
rescued##12##1##(1990-2#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)
rescues##2##1##(2008-8#2)
research about##2##2##(2009-11#1)(2012-2#1)
research activities##3##2##(2008-11#1)(2009-4#1)(2010-5#1)
research activity and##2##3##(1997-6#1)(2008-7#1)
research agenda for##2##3##(2008-12#1)(2011-2#1)
research agenda##6##2##(1991-1#1)(1994-12#1)(2008-12#2)(2009-3#1)(2011-2#1)
research aimed at##6##3##(1991-6#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)
research also suggests that##2##4##(2007-12#1)(2010-2#1)
research and clinical##10##3##(1997-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-7#1)(2013-8#1)
research and development (R&amp##2##4##(2008-5#1)(2010-12#1)
research and development of##5##4##(1991-1#1)(2008-10#3)(2011-3#1)
research and development##14##3##(1991-1#1)(1992-12#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-5#2)(2010-12#1)(2011-3#1)
research and in##2##3##(2008-11#1)(2010-7#1)
research and practice##13##3##(2010-10#11)(2013-1#2)
research and technology##2##3##(1992-3#1)(1997-7#1)
research and the##4##3##(1995-1#1)(2008-5#1)(2009-8#1)(2011-7#1)
research and training##2##3##(1997-7#1)(2008-10#1)
research and##108##2##(1990-11#2)(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#3)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-2#2)(1997-1#3)(1997-3#2)(1997-5#1)(1997-7#3)(2008-10#13)(2008-11#16)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#12)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#1)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
research applications##4##2##(1993-3#1)(2008-4#2)(2012-2#1)
research approach to##2##3##(2008-11#1)(2012-12#1)
research approach was adopted##2##4##(2008-11#1)(2008-12#1)
research approach##6##2##(1995-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2012-12#1)
research are being##2##3##(1997-8#1)(2008-11#1)
research are discussed##5##3##(2008-11#1)(2008-2#1)(2009-10#1)(2011-7#1)(2012-2#1)
research are presented##2##3##(1990-2#1)(1991-2#1)
research are provided##2##3##(2009-5#1)(2012-12#1)
research are##22##2##(1990-2#1)(1991-2#1)(1991-3#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-8#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
research area##7##2##(1997-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)
research areas##5##2##(1993-2#2)(2009-10#1)(2010-5#1)(2012-3#1)
research as the##2##3##(2008-12#1)(2011-2#1)
research as##4##2##(2008-12#1)(2008-7#1)(2011-2#2)
research assistants##2##2##(2009-4#2)
research at##3##2##(2008-11#1)(2008-12#1)(2010-2#1)
research attention##2##2##(2008-6#1)(2008-9#1)
research available##3##2##(1992-1#1)(2008-11#2)
research awareness##2##2##(2008-12#2)
research based on##2##3##(1994-2#1)(2009-10#1)
research based##3##2##(1994-2#1)(2008-12#1)(2009-10#1)
research by##9##2##(1995-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)(2013-1#1)
research can be##2##3##(1994-3#1)(2008-10#1)
research can##4##2##(1994-12#1)(1994-3#1)(1997-7#1)(2008-10#1)
research carried out in##2##4##(1991-9#1)(2012-3#1)
research carried out##3##3##(1991-9#1)(2010-1#1)(2012-3#1)
research centres##3##2##(1997-5#1)(2008-11#2)
research challenges##2##2##(1994-12#1)(2010-12#1)
research community##2##2##(2008-6#1)(2009-4#1)
research concerning##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
research conducted in the##2##4##(2008-1#1)(2008-11#1)
research conducted in##3##3##(1993-1#1)(2008-1#1)(2008-11#1)
research contributions##2##2##(2008-10#1)(2008-11#1)
research data##7##2##(1997-2#1)(1997-5#1)(2008-10#3)(2008-11#1)(2010-8#1)
research design for the##2##4##(2013-1#2)
research design for##3##3##(2013-1#3)
research design was##2##3##(2008-1#1)(2008-12#1)
research design##10##2##(1991-3#1)(1994-3#1)(2008-1#1)(2008-12#1)(2010-11#1)(2013-1#5)
research directions##5##2##(1994-3#1)(2008-1#1)(2008-9#1)(2009-9#1)(2011-2#1)
research education##2##2##(2008-11#2)
research efforts are##3##3##(1997-1#1)(2008-5#1)(2010-12#1)
research efforts##6##2##(1993-2#1)(1997-1#1)(2008-5#1)(2010-12#2)(2012-2#1)
research ethics##2##2##(2008-9#1)(2011-3#1)
research evidence##5##2##(2008-11#4)(2008-12#1)
research examining##3##2##(2008-12#1)(2010-10#1)(2013-1#1)
research exists##2##2##(2008-12#1)(2008-9#1)
research experience##4##2##(1994-12#1)(2009-4#2)(2012-2#1)
research field of##2##3##(2008-5#1)(2008-7#1)
research field##3##2##(2008-5#1)(2008-7#1)(2010-11#1)
research fields##2##2##(2011-3#1)(2012-12#1)
research findings and##5##3##(2008-12#1)(2013-1#4)
research findings are##3##3##(1993-2#2)(2009-12#1)
research findings in##2##3##(2008-12#1)(2013-1#1)
research findings on##3##3##(1991-2#1)(1991-3#1)(1994-1#1)
research findings##21##2##(1991-2#2)(1991-3#1)(1993-2#2)(1994-1#1)(2008-11#1)(2008-12#2)(2009-12#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#5)
research foci##2##2##(2008-9#2)
research focus##2##2##(2011-2#2)
research focused on##2##3##(2008-10#1)(2010-9#1)
research for the##2##3##(2008-10#2)
research for##7##2##(1992-1#1)(2008-10#2)(2008-12#1)(2011-3#1)(2012-2#1)(2013-8#1)
research found##2##2##(1996-3#1)(2009-7#1)
research funding##4##2##(2008-10#1)(2008-11#1)(2009-3#2)
research group##2##2##(2008-10#1)(2011-2#1)
research groups and##2##3##(1991-6#1)(1992-8#1)
research groups##11##2##(1991-6#1)(1992-8#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-7#3)(2010-10#1)(2011-1#1)
research has accumulated##2##3##(2008-9#1)(2012-2#1)
research has been conducted on##2##5##(2011-2#1)(2012-2#1)
research has been conducted to##3##5##(2008-11#2)(2008-12#1)
research has been conducted##6##4##(2008-11#2)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
research has been devoted to##2##5##(1993-3#1)(2008-10#1)
research has been done##3##4##(1991-3#1)(1994-3#1)(2013-1#1)
research has been##14##3##(1991-3#1)(1993-3#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
research has demonstrated a##2##4##(2008-8#1)(2012-2#1)
research has demonstrated that##2##4##(2008-11#1)(2008-7#1)
research has demonstrated##6##3##(1990-11#1)(1992-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
research has examined##3##3##(1995-1#1)(2008-11#2)
research has focused on##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
research has identified##3##3##(2008-6#1)(2010-3#1)(2012-3#1)
research has shown that##6##4##(1990-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
research has shown##7##3##(1990-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-9#1)
research has suggested that##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
research has suggested##4##3##(2008-11#1)(2010-2#1)(2011-2#1)(2013-8#1)
research has##63##2##(1990-11#2)(1991-3#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#8)(2008-11#9)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-9#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
research have been##4##3##(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)
research have##8##2##(1997-1#1)(1997-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)
research help##2##2##(2008-12#1)(2010-9#1)
research highlights##3##2##(1996-1#1)(2008-11#1)(2008-12#1)
research in a##2##3##(1995-3#1)(2008-9#1)
research in child and adolescent partial hospitalization##2##7##(1992-1#2)
research in stroke##2##3##(2008-8#2)
research in the area of##3##5##(2008-10#1)(2008-11#1)(2008-12#1)
research in the field of##2##5##(1993-1#1)(2012-2#1)
research in the field##4##4##(1992-1#1)(1993-1#1)(1994-3#1)(2012-2#1)
research in the past decades##2##5##(2009-5#1)(2010-10#1)
research in the past##5##4##(2008-11#1)(2009-1#1)(2009-5#1)(2010-10#1)(2011-2#1)
research in the##21##3##(1992-1#1)(1993-1#1)(1993-2#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#2)(2011-2#1)(2012-2#2)
research in this area##5##4##(1992-9#1)(2008-10#1)(2010-9#1)(2013-8#2)
research in this field##2##4##(2008-4#1)(2010-12#1)
research in this##9##3##(1992-9#1)(1994-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-9#1)(2013-1#1)(2013-8#2)
research in##79##2##(1991-6#1)(1992-1#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
research include##2##2##(2008-10#1)(2013-1#1)
research including##2##2##(2010-12#1)(2013-1#1)
research indicates that##4##3##(2008-10#1)(2008-11#1)(2010-2#1)(2011-3#1)
research institution##2##2##(2009-4#1)(2010-1#1)
research instruments##2##2##(1994-12#1)(2008-9#1)
research into practice##2##3##(2009-11#1)(2010-10#1)
research into the##8##3##(2008-10#2)(2008-11#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#1)
research into##23##2##(1991-2#1)(1994-1#1)(1994-12#1)(1997-7#2)(2008-10#2)(2008-11#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#2)(2011-2#2)(2013-1#2)
research investigating##3##2##(1992-1#1)(2008-1#1)(2010-2#1)
research investigations##2##2##(2008-10#1)(2008-6#1)
research is being conducted##2##4##(2008-10#1)(2009-7#1)
research is being##3##3##(1997-5#1)(2008-10#1)(2009-7#1)
research is necessary to##3##4##(2008-3#1)(2012-3#1)(2013-8#1)
research is needed on##2##4##(2008-11#1)(2012-2#1)
research is needed to determine##3##5##(1994-12#1)(2008-11#1)(2008-12#1)
research is needed to evaluate this##2##6##(2008-11#1)(2009-12#1)
research is needed to evaluate##3##5##(2008-11#1)(2009-12#1)(2010-7#1)
research is needed to##15##4##(1994-12#1)(2008-11#6)(2008-12#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-7#1)(2013-1#1)
research is needed##20##3##(1994-12#1)(2008-11#7)(2008-12#1)(2008-3#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-7#1)(2012-2#1)(2013-1#1)
research is required to##2##4##(2008-11#1)(2011-2#1)
research is required##3##3##(2008-11#2)(2011-2#1)
research is still##2##3##(1994-1#1)(2012-2#1)
research is the##2##3##(2008-10#1)(2012-2#1)
research is to##4##3##(1994-8#1)(2008-3#1)(2012-2#1)(2013-1#1)
research is warranted##3##3##(2009-4#1)(2012-2#1)(2013-1#1)
research is##63##2##(1990-12#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-8#1)(1996-1#1)(1997-1#1)(1997-3#3)(1997-5#1)(2008-10#3)(2008-11#13)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-10#2)(2010-3#1)(2010-7#2)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
research issues##4##2##(2008-11#1)(2008-6#2)(2012-2#1)
research laboratories##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
research linking##2##2##(2009-5#1)(2010-7#1)
research literature##7##2##(1992-12#1)(1995-3#1)(1997-3#1)(2008-11#1)(2008-4#1)(2011-10#1)(2013-1#1)
research may##4##2##(1992-12#1)(2008-10#1)(2008-9#1)(2010-4#1)
research methodology##6##2##(1995-3#2)(2008-11#2)(2008-9#1)(2009-6#1)
research methods##8##2##(1992-5#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#1)
research must be##3##3##(1995-2#1)(2013-1#2)
research needs in##2##3##(2009-4#1)(2010-7#1)
research needs##5##2##(2008-11#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-7#1)
research nurse##3##2##(2008-11#3)
research of##17##2##(1994-12#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-3#1)(2011-2#1)(2012-3#3)(2013-1#1)
research on biological control of##2##5##(2008-10#2)
research on biological##4##3##(1992-12#2)(2008-10#2)
research on epidemiology##2##3##(2008-10#1)(2012-3#1)
research on social##2##3##(2010-3#1)(2012-2#1)
research on the effects of##3##5##(1991-2#1)(1995-2#1)(2008-11#1)
research on the##30##3##(1991-2#1)(1995-2#2)(1995-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#3)
research on this##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
research on##84##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-12#5)(1992-9#1)(1993-12#1)(1995-2#4)(1995-6#1)(1996-3#1)(1997-8#1)(2008-1#2)(2008-10#15)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#4)
research opportunities##2##2##(2008-10#2)
research organization##4##2##(1991-9#1)(1994-1#1)(2008-10#1)(2010-5#1)
research over the last few decades##2##6##(1995-1#1)(2008-5#1)
research over##3##2##(1995-1#1)(2008-11#1)(2008-5#1)
research participants##5##2##(1995-1#2)(2009-4#3)
research participation##3##2##(2009-4#3)
research plan##3##2##(1997-1#1)(2008-7#1)(2011-2#1)
research plots##2##2##(2008-10#2)
research presented##2##2##(2007-12#1)(2008-3#1)
research priorities for##2##3##(2008-10#1)(2010-12#1)
research priorities##3##2##(2008-10#1)(2010-10#1)(2010-12#1)
research process##6##2##(1997-3#1)(2008-11#1)(2008-12#1)(2009-4#2)(2010-8#1)
research productivity in##3##3##(1997-1#2)(2009-4#1)
research profile##3##2##(2008-11#3)
research program on##2##3##(2008-8#1)(2011-3#1)
research program##8##2##(1992-12#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-3#1)(2012-3#1)
research programmes##2##2##(1993-6#1)(2013-1#1)
research programs##4##2##(1996-2#1)(1996-5#1)(2008-11#1)(2008-4#1)
research project to##2##3##(1991-6#1)(2010-10#1)
research project##11##2##(1991-6#1)(1991-9#1)(1992-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#3)(2013-8#1)
research projects that##2##3##(1997-1#1)(2008-6#1)
research projects##8##2##(1992-5#1)(1994-9#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-10#1)(2010-8#1)
research proposals##3##2##(2008-1#1)(2010-4#1)(2012-2#1)
research protocols##6##2##(1997-1#1)(2008-1#1)(2009-4#2)(2011-1#2)
research provides##2##2##(2009-5#1)(2011-2#1)
research publications##2##2##(2013-7#2)
research purposes##4##2##(1993-1#1)(2008-11#1)(2008-7#1)(2011-1#1)
research quality##2##2##(2010-5#2)
research question that##2##3##(1996-2#1)(2008-11#1)
research question##5##2##(1996-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)
research questions##5##2##(2008-11#1)(2008-12#2)(2009-5#1)(2012-2#1)
research related to##5##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
research relationship##2##2##(1997-1#2)
research reputation##2##2##(1996-1#2)
research results##7##2##(1992-1#1)(1992-12#1)(1993-1#1)(1995-2#1)(1997-8#1)(2008-10#2)
research setting##2##2##(2011-2#1)(2012-12#1)
research should be##2##3##(2010-11#1)(2013-8#1)
research should focus##2##3##(2010-11#1)(2013-1#1)
research should##7##2##(2008-12#1)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
research show that##3##3##(1991-2#1)(2008-12#1)(2010-10#1)
research show##4##2##(1991-2#1)(2008-10#1)(2008-12#1)(2010-10#1)
research showed that##3##3##(1997-3#1)(2008-12#2)
research shows that the##2##4##(2009-8#1)(2013-8#1)
research shows that##7##3##(2008-10#1)(2009-8#2)(2010-12#1)(2012-2#1)(2013-8#2)
research shows##8##2##(2008-10#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
research skills##2##2##(2008-11#2)
research station##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
research stations##2##2##(2008-10#2)
research studies are##2##3##(2008-10#1)(2013-1#1)
research studies on the##2##4##(2008-11#1)(2013-1#1)
research studies##12##2##(2008-10#1)(2008-11#2)(2008-4#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2013-1#4)
research study##5##2##(2008-11#3)(2008-4#1)(2013-1#1)
research subjects##2##2##(2009-4#2)
research suggests that##6##3##(2008-11#1)(2008-12#1)(2008-8#2)(2012-2#1)(2013-1#1)
research suggests##7##2##(2008-11#1)(2008-12#1)(2008-8#2)(2012-2#1)(2013-1#2)
research supports the##2##3##(2008-8#1)(2012-2#1)
research targeting##2##2##(2009-4#1)(2011-2#1)
research team##2##2##(1992-12#1)(2010-11#1)
research teams##2##2##(1993-12#1)(1993-2#1)
research that is##2##3##(2009-11#1)(2012-3#1)
research that would##2##3##(1992-12#1)(2011-3#1)
research that##32##2##(1992-12#1)(1992-3#1)(1993-12#1)(1996-3#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
research the##2##2##(2008-10#1)(2010-1#1)
research to develop and evaluate##2##5##(2008-11#2)
research to develop##4##3##(1991-12#1)(2008-11#2)(2011-2#1)
research to policymakers##3##3##(2010-4#3)
research to##26##2##(1991-12#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-11#5)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-4#4)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
research tool##5##2##(2008-11#2)(2008-9#2)(2009-10#1)
research topics##2##2##(2010-12#2)
research trends##2##2##(2008-10#1)(2010-7#1)
research uptake as##2##3##(2010-10#2)
research uptake##5##2##(2010-10#5)
research use##2##2##(1992-11#1)(2008-11#1)
research using##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#2)
research utilisation##4##2##(2008-11#4)
research was based on the##2##5##(2008-11#1)(2010-8#1)
research was conducted##3##3##(1992-1#1)(1997-6#1)(2011-2#1)
research was to determine##2##4##(1994-3#1)(2008-10#1)
research was to evaluate the##2##5##(2008-10#1)(2012-2#1)
research was to evaluate##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
research was to provide##2##4##(2011-1#1)(2012-2#1)
research was to##21##3##(1994-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#2)
research was##42##2##(1992-1#1)(1992-12#1)(1994-3#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-5#2)(2008-7#2)(2009-4#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#3)(2013-8#1)
research were to determine##3##4##(2008-1#1)(2008-10#2)
research were to##5##3##(2008-1#1)(2008-10#4)
research were##9##2##(2008-1#1)(2008-10#7)(2009-4#1)
research which##2##2##(1990-11#1)(1996-6#1)
research while##3##2##(2008-11#1)(2008-12#2)
research will be##3##3##(2008-11#2)(2008-9#1)
research will##7##2##(2008-10#2)(2008-11#3)(2008-9#1)(2009-4#1)
research with##11##2##(1994-9#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#3)(2012-2#1)
research within##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
research work##3##2##(1997-8#1)(2008-10#2)
research works##2##2##(2008-10#2)
research would##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
research##1580##1##(1990-11#6)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#2)(1991-1#5)(1991-12#7)(1991-2#8)(1991-3#7)(1991-5#1)(1991-6#5)(1991-9#3)(1992-1#11)(1992-11#2)(1992-12#24)(1992-3#6)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#5)(1993-11#2)(1993-12#14)(1993-2#11)(1993-3#6)(1993-6#5)(1993-9#1)(1994-1#4)(1994-12#15)(1994-2#2)(1994-3#8)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#6)(1995-11#1)(1995-12#4)(1995-2#14)(1995-3#11)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#9)(1996-12#1)(1996-2#8)(1996-3#5)(1996-5#1)(1996-6#3)(1996-9#3)(1997-1#24)(1997-2#4)(1997-3#17)(1997-4#1)(1997-5#5)(1997-6#2)(1997-7#7)(1997-8#9)(2006-6#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#23)(2008-10#154)(2008-11#202)(2008-12#81)(2008-2#6)(2008-3#8)(2008-4#25)(2008-5#25)(2008-6#21)(2008-7#27)(2008-8#20)(2008-9#43)(2009-1#8)(2009-10#9)(2009-11#7)(2009-12#8)(2009-3#11)(2009-4#61)(2009-5#10)(2009-6#4)(2009-7#16)(2009-8#6)(2009-9#2)(2010-1#13)(2010-10#43)(2010-11#17)(2010-12#21)(2010-2#7)(2010-3#5)(2010-4#16)(2010-5#20)(2010-6#3)(2010-7#17)(2010-8#16)(2010-9#11)(2011-1#11)(2011-10#1)(2011-2#57)(2011-3#9)(2011-7#4)(2011-9#1)(2012-12#10)(2012-2#60)(2012-3#24)(2013-1#75)(2013-7#4)(2013-8#30)
research)##3##1##(1997-8#1)(2010-8#1)(2013-1#1)
research-based##6##1##(1996-2#1)(2008-11#2)(2008-12#2)(2010-5#1)
research-practice gap##2##2##(2008-11#2)
research/practice##2##1##(2010-10#2)
research?##2##1##(2011-1#1)(2013-8#1)
research]##13##1##(1991-6#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-6#1)(1996-11#1)(1997-4#1)(2008-11#1)(2013-8#5)
researchable questions that##2##3##(2009-3#2)
researched##15##1##(1992-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
researcher to##3##2##(2008-9#1)(2010-7#1)(2013-1#1)
researcher##14##1##(1990-12#2)(1992-12#1)(1994-3#2)(1997-1#1)(1997-3#1)(2008-6#1)(2008-9#2)(2010-11#1)(2010-5#1)(2010-7#1)(2013-1#1)
researcher's##4##1##(1997-1#1)(1997-6#1)(2008-4#1)(2008-7#1)
researchers and clinicians##4##3##(1992-2#1)(2008-2#1)(2008-8#1)(2013-1#1)
researchers and practitioners to##2##4##(2010-11#1)(2010-9#1)
researchers and practitioners##3##3##(2010-10#1)(2010-11#1)(2010-9#1)
researchers and the##2##3##(1994-3#1)(1995-1#1)
researchers and##16##2##(1992-2#1)(1994-3#1)(1995-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
researchers are##2##2##(2008-10#1)(2008-3#1)
researchers for##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
researchers have focused##2##3##(2008-10#1)(2010-10#1)
researchers have##9##2##(1992-3#1)(1996-5#1)(2008-10#2)(2008-6#1)(2010-10#1)(2011-3#1)(2013-1#1)(2013-8#1)
researchers in the##4##3##(1995-1#1)(2008-10#2)(2010-7#1)
researchers in##9##2##(1995-1#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-7#1)
researchers interested in##2##3##(2011-2#1)(2013-8#1)
researchers is##2##2##(2008-9#1)(2009-12#1)
researchers should##2##2##(1992-3#1)(1997-5#1)
researchers since##2##2##(2009-8#1)(2010-5#1)
researchers to consider##2##3##(2008-7#1)(2013-8#1)
researchers to develop##2##3##(2008-6#1)(2011-2#1)
researchers to speculate that##2##4##(1994-2#1)(2008-11#1)
researchers to##15##2##(1992-3#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
researchers who##2##2##(2008-10#1)(2009-3#1)
researchers with##3##2##(2008-12#1)(2008-9#1)(2010-5#1)
researchers##133##1##(1992-2#1)(1992-3#4)(1993-2#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#13)(2008-11#10)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#8)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#7)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#4)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#3)(2010-9#2)(2011-2#7)(2011-3#1)(2012-2#3)(2013-1#8)(2013-8#3)
researchers'##3##1##(1994-9#1)(1995-6#1)(2012-2#1)
researches are##2##2##(2011-3#1)(2012-3#1)
researches of##3##2##(2013-8#3)
researches##14##1##(1990-5#1)(2008-12#1)(2010-1#2)(2010-10#1)(2010-9#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
researching##3##1##(1994-3#1)(2008-8#1)(2010-1#1)
resectability##7##1##(2008-1#2)(2008-2#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
resectable##3##1##(1992-12#1)(1992-3#1)(2012-3#1)
resected by##2##2##(2011-2#1)(2012-2#1)
resected endoscopically##2##2##(2008-10#1)(2011-2#1)
resected tumors##2##2##(2010-12#1)(2011-2#1)
resected##31##1##(1990-8#1)(1991-9#1)(1992-9#1)(1993-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#4)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)
resection and reconstruction##2##3##(2008-7#1)(2010-7#1)
resection and##19##2##(1990-6#1)(1990-9#2)(1991-6#1)(1994-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#2)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#2)
resection are##2##2##(1997-8#1)(2008-7#1)
resection can##2##2##(1992-3#1)(2008-9#1)
resection combined with##2##3##(2007-8#1)(2012-3#1)
resection followed by##2##3##(2007-8#1)(2013-1#1)
resection for##12##2##(1993-12#1)(1994-12#1)(1996-3#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-12#1)(2011-2#3)(2013-1#2)
resection has been##2##3##(1991-6#1)(1992-3#1)
resection has##3##2##(1991-6#1)(1992-3#1)(2010-12#1)
resection in##5##2##(2008-7#2)(2011-2#2)(2012-3#1)
resection is##6##2##(1990-9#1)(1997-3#1)(2008-1#1)(2008-7#2)(2009-12#1)
resection margin##3##2##(1990-9#1)(1992-3#1)(2009-12#1)
resection may##2##2##(2011-2#1)(2013-1#1)
resection of AVMs##2##3##(2008-7#2)
resection of a giant##2##4##(2011-2#1)(2013-1#1)
resection of a##5##3##(2008-7#1)(2011-2#3)(2013-1#1)
resection of the tumor##2##4##(2008-12#1)(2011-2#1)
resection of the tumour was performed##2##6##(2008-7#1)(2012-12#1)
resection of the tumour##4##4##(2008-10#1)(2008-7#2)(2012-12#1)
resection of the##23##3##(1992-9#2)(1997-8#1)(2008-10#2)(2008-12#1)(2008-7#3)(2008-9#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-12#3)(2012-3#2)
resection of this##2##3##(2008-10#1)(2011-2#1)
resection of##54##2##(1992-9#3)(1993-2#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-7#9)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#17)(2011-3#1)(2012-12#4)(2012-3#5)(2013-1#3)(2013-8#1)
resection or##5##2##(1990-3#1)(1990-9#1)(1996-3#1)(2008-7#1)(2013-1#1)
resection using##2##2##(1991-6#1)(2012-12#1)
resection was achieved in##2##4##(2008-10#1)(2011-2#1)
resection was performed##2##3##(2011-2#2)
resection was##8##2##(1990-11#1)(2008-10#1)(2011-2#5)(2012-12#1)
resection were##2##2##(2010-12#1)(2011-2#1)
resection with##5##2##(1992-9#1)(1994-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
resection##213##1##(1990-11#3)(1990-3#3)(1990-6#1)(1990-8#1)(1990-9#7)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#4)(1991-9#1)(1992-12#2)(1992-3#4)(1992-5#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#3)(1994-6#1)(1995-12#1)(1996-3#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#24)(2008-8#5)(2008-9#7)(2009-1#2)(2009-12#5)(2010-12#7)(2010-3#1)(2010-7#3)(2011-2#43)(2011-3#2)(2012-12#9)(2012-3#16)(2013-1#15)(2013-8#2)
resection)##2##1##(1990-12#1)(2009-12#1)
resections##10##1##(1990-9#1)(1991-3#2)(1991-8#1)(1993-3#1)(1996-9#1)(2011-2#4)
resemblance to those##2##3##(1997-3#1)(2008-3#1)
resemblance to##5##2##(1991-12#1)(1997-3#1)(2008-3#1)(2009-1#1)(2011-2#1)
resemblance##9##1##(1991-12#1)(1997-3#1)(2008-3#1)(2009-1#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
resemble native##2##2##(1994-3#1)(2013-1#1)
resemble the##6##2##(1994-6#1)(2008-11#2)(2008-7#1)(2009-8#1)(2012-2#1)
resemble those of##2##3##(1995-11#1)(2007-12#1)
resemble those seen in##2##4##(2008-4#1)(2008-7#1)
resemble those##5##2##(1991-5#1)(1995-11#1)(2007-12#1)(2008-4#1)(2008-7#1)
resemble##25##1##(1991-5#1)(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
resembled a##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
resembled that of the##2##4##(2008-10#1)(2008-7#1)
resembled that of##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
resembled the##4##2##(1992-5#1)(1994-5#1)(2008-10#1)(2008-11#1)
resembled those##2##2##(1991-3#1)(2008-10#1)
resembled##20##1##(1991-3#1)(1992-12#1)(1992-5#1)(1994-5#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#2)(2013-1#1)
resembles an##2##2##(2008-9#1)(2009-8#1)
resembles that of##5##3##(1994-12#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#1)
resembles that##6##2##(1994-12#1)(2007-12#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#1)
resembles the##5##2##(1997-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
resembles##27##1##(1990-8#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-6#1)(2011-2#2)(2013-1#1)
resembling a##3##2##(1994-12#1)(2011-2#1)(2012-2#1)
resembling native##2##2##(1995-12#1)(1996-12#1)
resembling the##3##2##(1996-12#1)(1997-7#1)(2008-7#1)
resembling those of##4##3##(1994-12#1)(1997-2#1)(2007-12#1)(2010-11#1)
resembling those##6##2##(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2010-11#1)(2011-2#1)
resembling##40##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-8#1)(1994-12#2)(1994-6#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-2#1)(2013-1#1)
resequenced##2##1##(2012-2#1)(2012-3#1)
resequencing##4##1##(2012-2#2)(2012-3#2)
reserpine##14##1##(1996-2#1)(2008-10#8)(2008-12#5)
reserve capacity of##2##3##(1990-11#1)(1992-12#1)
reserve in##2##2##(1990-3#1)(2012-2#1)
reserve of##3##2##(2008-10#2)(2008-12#1)
reserve##17##1##(1990-11#1)(1990-3#1)(1992-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#5)
reserved as a##2##3##(1997-2#1)(2010-12#1)
reserved for patients with##3##4##(2011-2#2)(2012-3#1)
reserved for##8##2##(1992-5#1)(1992-9#1)(1996-2#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-3#1)
reserved##10##1##(1992-5#1)(1992-9#1)(1996-2#1)(1997-2#1)(2008-8#1)(2010-12#2)(2011-2#2)(2012-3#1)
reserves##18##1##(1990-3#2)(1995-3#1)(2008-10#5)(2008-8#6)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#1)
reservoir (H)##3##2##(2008-10#3)
reservoir and##4##2##(2007-12#2)(2008-10#1)(2008-12#1)
reservoir hosts##2##2##(2008-10#1)(2008-12#1)
reservoir of cpe-positive C##2##4##(2011-2#2)
reservoir of##4##2##(1995-2#1)(2008-10#1)(2011-2#2)
reservoir powder inhaler##4##3##(1996-2#4)
reservoir water##4##2##(2008-10#4)
reservoir##48##1##(1990-9#3)(1992-9#1)(1995-2#1)(1996-2#5)(1996-3#1)(1997-5#1)(2007-12#2)(2008-10#28)(2008-12#2)(2011-2#3)(2013-1#1)
reservoirs and##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
reservoirs for the##2##3##(2008-10#2)
reservoirs of##3##2##(2008-10#2)(2013-1#1)
reservoirs##13##1##(2008-10#6)(2009-8#1)(2010-1#1)(2011-2#2)(2013-1#3)
reset##2##1##(2013-1#1)(2013-8#1)
reshape##2##1##(1991-1#1)(1994-1#1)
reshaping of##2##2##(2008-10#1)(2008-11#1)
reshaping##5##1##(1992-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)
reside in the##2##3##(2008-7#1)(2008-9#1)
reside in##6##2##(1990-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-4#1)
reside on##2##2##(1992-1#1)(2008-10#1)
reside within##2##2##(1992-4#1)(2008-9#1)
reside##14##1##(1990-5#1)(1992-1#1)(1992-4#1)(2008-10#4)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
resided in the##3##3##(1995-6#1)(1995-9#1)(2012-3#1)
resided in##5##2##(1995-6#1)(1995-9#1)(2008-11#1)(2012-3#1)(2013-8#1)
resided##7##1##(1995-6#1)(1995-9#1)(2008-11#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
residence and##4##2##(1994-6#1)(1996-11#1)(2011-2#1)(2012-3#1)
residence time##8##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)
residence times##2##2##(1991-12#1)(1995-2#1)
residence##27##1##(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-11#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#2)
residencies##3##1##(1993-2#1)(1994-12#1)(1994-3#1)
residency and##2##2##(1994-12#1)(1994-3#1)
residency in##5##2##(1993-12#1)(1994-2#1)(2008-8#2)(2010-8#1)
residency of##2##2##(2010-8#1)(2012-2#1)
residency program##5##2##(1994-12#2)(1995-1#2)(1996-9#1)
residency programs##5##2##(1994-1#1)(1994-3#1)(2008-11#1)(2008-7#1)(2010-1#1)
residency##30##1##(1991-8#1)(1992-1#1)(1993-12#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#3)(1995-1#3)(1996-1#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-2#1)
resident and##2##2##(1997-1#1)(2008-8#1)
resident assessment##3##2##(1993-2#1)(1997-1#1)(2012-2#1)
resident bacteria##3##2##(2008-5#3)
resident characteristics##2##2##(1991-2#1)(1991-3#1)
resident epidermal Langerhans cells##2##4##(2008-5#2)
resident flora##2##2##(2008-5#2)
resident in##4##2##(1991-9#1)(1994-2#1)(2008-10#2)
resident microflora##3##2##(2008-10#3)
resident on##2##2##(2008-1#2)
resident peritoneal macrophages##2##3##(2008-11#1)(2008-12#1)
resident##56##1##(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-12#3)(1993-2#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1997-1#2)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#8)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-8#2)(2012-2#1)(2013-1#2)(2013-8#3)
resident-level##2##1##(1996-2#1)(1996-3#1)
residential care##6##2##(1997-1#2)(2008-12#1)(2012-12#2)(2013-1#1)
residential patterns##2##2##(2011-2#2)
residential segregation##2##2##(2011-2#2)
residential treatment##5##2##(2008-6#1)(2013-8#4)
residential##36##1##(1991-1#1)(1991-12#2)(1991-2#1)(1993-1#1)(1993-12#2)(1994-2#1)(1995-2#1)(1996-3#2)(1997-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#3)(2010-10#2)(2011-2#5)(2012-12#3)(2013-1#2)(2013-8#4)
residents aged##3##2##(1991-6#2)(2008-12#1)
residents and##11##2##(1991-6#1)(1994-3#1)(1995-3#1)(1997-1#2)(2008-1#2)(2008-11#2)(2010-5#1)(2013-8#1)
residents from the##3##3##(1992-1#1)(1995-3#1)(2008-1#1)
residents from##6##2##(1992-1#1)(1995-3#1)(2008-1#1)(2008-12#1)(2010-10#1)(2013-1#1)
residents had##2##2##(2008-1#2)
residents in a##2##3##(1995-3#1)(2011-2#1)
residents in the##2##3##(1995-3#1)(1996-9#1)
residents in##14##2##(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-3#4)(1996-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
residents increased by##2##3##(1991-8#2)
residents of a##2##3##(2008-7#1)(2013-1#1)
residents of##11##2##(1990-12#1)(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
residents who are##2##3##(1997-1#1)(2011-2#1)
residents who##3##2##(1997-1#1)(2008-11#1)(2011-2#1)
residents with dementia##3##3##(2010-10#3)
residents with##5##2##(2010-10#3)(2011-2#2)
residents##113##1##(1990-12#1)(1991-1#1)(1991-2#2)(1991-3#2)(1991-6#3)(1991-8#4)(1992-1#4)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-12#3)(1994-2#1)(1994-3#1)(1995-12#5)(1995-2#5)(1995-3#12)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#5)(1997-2#2)(2008-1#7)(2008-10#1)(2008-11#4)(2008-12#6)(2008-4#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#7)(2010-5#1)(2010-8#3)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#4)
residents'##5##1##(1991-2#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-3#1)
resides in the##6##3##(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
resides in##12##2##(1994-11#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-8#1)(2013-1#1)
resides##15##1##(1994-11#1)(1994-6#1)(1995-6#2)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-9#1)(2009-8#1)(2013-1#1)
residing in the##8##3##(1993-6#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#2)(2013-1#1)
residing in##16##2##(1992-12#1)(1993-6#1)(1994-9#1)(1995-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#4)(2013-1#1)
residing##17##1##(1991-12#1)(1992-12#1)(1993-6#1)(1994-9#1)(1995-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#4)(2013-1#1)
residual anabolic##3##2##(2008-10#3)
residual and##3##2##(1991-3#1)(2008-10#1)(2008-12#1)
residual chlorine in##2##3##(2008-10#2)
residual chlorine##8##2##(2008-10#8)
residual confounding##6##2##(1992-9#5)(1997-1#1)
residual disease##10##2##(1995-12#2)(1996-11#1)(2008-10#1)(2009-12#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#2)
residual effect##2##2##(2008-10#2)
residual effects##2##2##(2008-10#1)(2008-8#1)
residual glass##2##2##(2009-7#2)
residual leak##2##2##(1997-8#1)(2011-2#1)
residual nutrients##2##2##(2008-10#2)
residual or##2##2##(1993-1#1)(2011-2#1)
residual plots##2##2##(1995-9#1)(2008-10#1)
residual potency##2##2##(1991-1#2)
residual renal function##3##3##(2011-2#3)
residual shunt##3##2##(1994-9#1)(2008-11#2)
residual solution##2##2##(2008-10#2)
residual strains in the##3##4##(2008-9#3)
residual strains in##5##3##(2008-9#5)
residual strains##7##2##(2008-9#7)
residual stresses##2##2##(2009-7#2)
residual urine volume##2##3##(1993-2#2)
residual urine volumes after##2##4##(1993-2#2)
residual urine##5##2##(1993-2#4)(2011-2#1)
residual variance##2##2##(2008-10#1)(2010-11#1)
residual vinyl groups in##2##4##(2008-10#2)
residual vinyl groups##3##3##(2008-10#3)
residual volume##2##2##(1993-2#1)(1996-2#1)
residual white blood cells##2##4##(2008-9#2)
residual##170##1##(1990-2#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-9#5)(1993-1#1)(1993-2#6)(1993-3#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#52)(2008-11#8)(2008-12#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#11)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#6)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2011-2#12)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#3)
residuals##12##1##(1995-12#1)(1995-9#1)(2008-10#7)(2008-7#1)(2011-2#1)(2012-2#1)
residue (I184Y)##2##2##(1992-1#2)
residue C##2##2##(2008-11#2)
residue analysis##3##2##(2008-10#2)(2008-11#1)
residue and the##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
residue and##6##2##(1994-5#1)(2008-10#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
residue at the##5##3##(1990-2#1)(1994-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
residue at##6##2##(1990-2#1)(1991-3#1)(1994-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
residue by##2##2##(2008-10#2)
residue decomposition##2##2##(2008-11#2)
residue from the##2##3##(2008-10#2)
residue from##4##2##(2008-10#4)
residue in the##8##3##(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#2)(1995-6#1)(2008-10#1)(2011-2#1)
residue in##23##2##(1990-12#1)(1992-1#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-5#4)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#4)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
residue is##5##2##(1990-8#1)(1992-6#1)(1993-8#1)(1995-6#1)(1995-8#1)
residue may##2##2##(1990-2#1)(2008-10#1)
residue of##10##2##(1991-5#1)(1991-9#1)(1992-3#1)(1993-8#1)(2008-10#4)(2008-11#1)(2008-8#1)
residue on##3##2##(2008-10#3)
residue size##2##2##(2008-10#2)
residue that is conserved in##2##5##(1993-9#1)(1995-6#1)
residue that is##3##3##(1993-9#1)(1995-6#1)(2009-5#1)
residue that##5##2##(1993-9#1)(1994-5#1)(1995-6#1)(1996-8#1)(2009-5#1)
residue to##4##2##(1993-8#1)(1995-6#1)(2008-10#1)(2012-3#1)
residue was dissolved in##3##4##(2008-10#2)(2008-11#1)
residue was##9##2##(1991-5#1)(1992-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2012-2#1)
residue were##2##2##(1991-5#1)(2008-10#1)
residue which##2##2##(1993-8#1)(2008-5#1)
residue with a##2##3##(1991-12#1)(2008-10#1)
residue with##5##2##(1991-12#1)(2008-10#4)
residue##176##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-10#3)(1991-12#1)(1991-3#2)(1991-5#4)(1991-9#2)(1992-1#4)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-12#2)(1993-8#6)(1993-9#1)(1994-12#4)(1994-3#1)(1994-5#10)(1995-11#1)(1995-2#3)(1995-6#8)(1995-8#3)(1996-2#1)(1996-8#1)(1997-3#2)(1997-7#2)(1997-9#1)(2008-10#59)(2008-11#8)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#3)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#3)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
residue(s)##2##1##(1994-11#1)(2008-8#1)
residues 20##2##2##(1993-8#2)
residues 39##2##2##(1992-4#1)(1993-3#1)
residues A##2##2##(2008-11#2)
residues N-terminal to##2##3##(1992-10#2)
residues and is##2##3##(1992-9#1)(1994-5#1)
residues and the##2##3##(1992-6#1)(1997-9#1)
residues and##18##2##(1990-9#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-6#3)(1992-9#1)(1994-5#1)(1997-8#1)(1997-9#1)(2008-10#4)(2008-11#3)
residues are##9##2##(1992-3#1)(1992-4#1)(1994-11#1)(1994-5#1)(1995-6#2)(2008-10#1)(2008-8#1)(2012-2#1)
residues at positions##6##3##(1991-12#1)(1994-3#1)(1994-5#4)
residues at the##4##3##(1990-2#1)(2008-10#2)(2008-8#1)
residues at##11##2##(1990-2#1)(1991-12#1)(1994-3#1)(1994-5#4)(2008-10#3)(2008-8#1)
residues by the##2##3##(1993-8#1)(1996-2#1)
residues by##3##2##(1992-3#1)(1993-8#1)(1996-2#1)
residues close to the##2##4##(1993-8#1)(2009-7#1)
residues conserved##2##2##(1991-5#1)(1994-5#1)
residues do not##2##3##(2008-10#1)(2012-2#1)
residues exposed on the##2##4##(1995-6#1)(2008-10#1)
residues exposed##3##2##(1990-5#1)(1995-6#1)(2008-10#1)
residues for##2##2##(1993-8#1)(2008-8#1)
residues from the##2##3##(2008-10#2)
residues from##9##2##(1995-6#1)(2008-10#6)(2008-5#1)(2008-8#1)
residues in the N-terminal##2##4##(1994-5#1)(2008-9#1)
residues in the##30##3##(1992-3#1)(1992-4#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-6#4)(1997-7#2)(1997-8#1)(1997-9#1)(2008-10#3)(2008-11#2)(2008-8#3)(2008-9#3)
residues in this region##2##4##(1994-5#1)(2008-10#1)
residues in three##2##3##(2008-10#1)(2008-8#1)
residues in##66##2##(1992-3#1)(1992-4#2)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-5#4)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#5)(1995-8#2)(1997-7#2)(1997-8#1)(1997-9#1)(2008-10#19)(2008-11#4)(2008-4#1)(2008-8#7)(2008-9#4)(2009-8#1)(2012-3#1)
residues involved in##3##3##(1992-12#1)(2008-4#1)(2008-8#1)
residues involved##4##2##(1992-12#1)(1995-6#1)(2008-4#1)(2008-8#1)
residues is##7##2##(1991-9#1)(1992-4#2)(1993-2#1)(1993-9#1)(1994-11#1)(2008-10#1)
residues known to##2##3##(1993-2#1)(1995-2#1)
residues located##2##2##(1995-6#1)(2011-2#1)
residues may##2##2##(1994-11#1)(2008-11#1)
residues of the##9##3##(1990-5#1)(1991-10#2)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
residues of##38##2##(1990-5#1)(1991-10#2)(1991-7#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-6#5)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)
residues on##5##2##(1994-5#1)(1997-9#1)(2008-5#1)(2008-8#1)(2012-2#1)
residues or##2##2##(1994-3#1)(2008-4#1)
residues substituted##2##2##(1995-6#1)(2008-8#1)
residues than in##2##3##(2008-10#2)
residues that are##3##3##(1994-11#1)(2008-10#2)
residues that were##3##3##(1997-4#1)(2008-10#2)
residues that##9##2##(1994-11#1)(1994-5#1)(1997-4#1)(2008-10#5)(2011-1#1)
residues to##2##2##(2008-7#1)(2011-1#1)
residues were replanted into the##2##5##(2008-10#2)
residues were##11##2##(1991-9#1)(1992-6#1)(1995-6#3)(2008-10#6)
residues which##2##2##(2008-11#1)(2012-2#1)
residues with a##3##3##(1993-8#1)(1994-3#1)(1995-6#1)
residues with##9##2##(1993-8#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-6#1)(2008-2#1)(2008-4#1)(2008-8#2)
residues within the##3##3##(1990-11#1)(2008-8#1)(2011-1#1)
residues within##4##2##(1990-11#1)(1991-5#1)(2008-8#1)(2011-1#1)
residues##411##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-5#4)(1990-8#1)(1990-9#2)(1991-10#3)(1991-12#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-9#3)(1992-10#4)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#13)(1992-6#6)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#14)(1993-9#2)(1994-11#13)(1994-3#5)(1994-5#29)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-6#32)(1995-8#6)(1996-2#1)(1996-6#2)(1997-4#2)(1997-7#5)(1997-8#6)(1997-9#7)(2008-1#1)(2008-10#94)(2008-11#20)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#29)(2008-9#9)(2009-12#1)(2009-7#1)(2009-8#2)(2010-4#2)(2010-5#3)(2011-1#5)(2011-2#11)(2012-2#8)(2012-3#2)
residues) and##3##2##(1991-5#2)(1994-8#1)
residues)##10##1##(1991-5#2)(1992-3#1)(1994-8#2)(1995-8#1)(1997-9#1)(2008-10#2)(2011-2#1)
resignation of##2##2##(2008-11#2)
resignation##4##1##(1993-1#1)(1995-8#1)(2008-11#2)
resilience##11##1##(2008-12#3)(2008-6#1)(2008-7#2)(2009-7#2)(2009-9#1)(2010-5#1)(2012-4#1)
resiliency##2##1##(2008-12#1)(2010-1#1)
resilient##8##1##(2008-11#2)(2008-5#1)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#2)
resin (Amberlite##2##2##(2008-10#2)
resin Amberlite##6##2##(2008-10#6)
resin acids##3##2##(1997-2#1)(2008-10#2)
resin and a##2##3##(2008-10#2)
resin and the##6##3##(2008-10#5)(2010-4#1)
resin and##20##2##(2008-10#18)(2008-7#1)(2010-4#1)
resin are##4##2##(2008-10#3)(2009-7#1)
resin as a##2##3##(2008-10#2)
resin as##4##2##(2008-10#4)
resin at pH##2##3##(2008-10#2)
resin at##4##2##(2008-10#4)
resin beads##6##2##(2008-10#6)
resin by##3##2##(2008-10#2)(2010-4#1)
resin coated with##3##3##(2008-10#3)
resin column##5##2##(2008-10#5)
resin composites##3##2##(2010-10#1)(2013-1#2)
resin containing the##2##3##(2008-10#2)
resin containing##10##2##(2008-10#10)
resin for the separation of##2##5##(2008-10#2)
resin for the##6##3##(2008-10#6)
resin for##18##2##(2008-10#17)(2008-9#1)
resin from##2##2##(2008-10#2)
resin functionalized with##5##3##(2008-10#5)
resin has been##6##3##(2008-10#6)
resin has##9##2##(2008-10#9)
resin have been##2##3##(2008-10#2)
resin in##3##2##(2008-10#3)
resin is highly##2##3##(2008-10#2)
resin is##10##2##(2008-10#10)
resin loaded with calmagite##2##4##(2008-10#2)
resin loaded with##10##3##(2008-10#10)
resin loading##2##2##(2008-10#2)
resin luting cement##3##3##(2013-1#3)
resin matrix was##2##3##(2008-10#2)
resin matrix##4##2##(2008-10#4)
resin mini-column is##2##3##(2008-10#2)
resin mini-column##5##2##(2008-10#5)
resin modified with##3##3##(2008-10#3)
resin modified##4##2##(2008-10#3)(2013-1#1)
resin packed##2##2##(2008-10#2)
resin phase##11##2##(2008-10#11)
resin shows##2##2##(2008-10#2)
resin that##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
resin to##3##2##(2008-10#2)(2012-2#1)
resin used##3##2##(1990-11#1)(2008-10#2)
resin was characterised by##2##4##(2008-10#2)
resin was characterized by##3##4##(2008-10#3)
resin was found to##2##4##(2008-10#2)
resin was found##3##3##(2008-10#3)
resin was prepared by##2##4##(2008-10#2)
resin was prepared##3##3##(2008-10#3)
resin was synthesized by##2##4##(2008-10#2)
resin was used as##2##4##(2008-10#2)
resin was used##5##3##(2008-10#5)
resin was##42##2##(2008-10#42)
resin were##5##2##(2008-10#4)(2013-1#1)
resin which is##3##3##(2008-10#3)
resin with a spacer##2##4##(2008-10#2)
resin with the##2##3##(2008-10#2)
resin with##11##2##(2008-10#10)(2008-7#1)
resin##399##1##(1990-11#1)(1990-5#1)(1995-8#1)(1996-12#1)(1997-2#2)(2008-10#363)(2008-3#3)(2008-7#2)(2008-9#2)(2009-7#2)(2010-10#1)(2010-4#2)(2010-9#1)(2012-2#1)(2013-1#15)(2013-8#1)
resin)##4##1##(2008-10#4)
resin-composite applications##2##2##(2010-10#2)
resinifera##3##1##(2008-10#3)
resiniferatoxin##3##1##(1992-6#2)(2013-8#1)
resinous##6##1##(2008-10#6)
resins and##3##2##(2008-10#3)
resins as a##2##3##(2008-10#2)
resins as##3##2##(2008-10#3)
resins for##3##2##(2008-10#3)
resins had##2##2##(2008-10#2)
resins of##2##2##(2008-10#2)
resins was##2##2##(1991-7#1)(2008-10#1)
resins were##2##2##(2008-10#2)
resins##64##1##(1990-9#1)(1991-7#1)(2008-10#55)(2008-5#1)(2008-7#1)(2009-7#3)(2013-1#2)
resist##11##1##(2008-10#1)(2008-11#1)(2008-8#4)(2009-11#2)(2010-4#1)(2010-7#1)(2013-1#1)
resistance (APR)##2##2##(2008-10#2)
resistance (MDR)##2##2##(2008-11#1)(2013-8#1)
resistance (R) genes##5##3##(2008-10#4)(2008-8#1)
resistance (R)##9##2##(2008-10#6)(2008-12#1)(2008-8#1)(2009-6#1)
resistance QTL were##2##3##(2008-10#2)
resistance QTL##7##2##(2008-10#7)
resistance QTLs##6##2##(2008-9#2)(2009-10#4)
resistance affects##2##2##(2008-10#2)
resistance after##4##2##(1996-6#1)(2008-10#1)(2010-5#1)(2012-3#1)
resistance against all##2##3##(2008-10#1)(2008-8#1)
resistance against fusarium##2##3##(2008-10#2)
resistance against##28##2##(1992-7#1)(1996-12#2)(2008-10#22)(2008-11#1)(2008-8#1)(2009-6#1)
resistance allele##4##2##(2008-10#4)
resistance alleles##2##2##(2008-10#2)
resistance and a##4##3##(2008-10#4)
resistance and an##2##3##(2008-10#2)
resistance and capacitance##2##3##(2008-10#1)(2008-11#1)
resistance and days to##2##4##(2008-10#2)
resistance and molecular##2##3##(2008-10#2)
resistance and obesity##2##3##(2008-11#1)(2011-1#1)
resistance and susceptibility##3##3##(2008-10#3)
resistance and that##2##3##(2008-10#2)
resistance and the##6##3##(1996-3#1)(2008-10#3)(2008-4#1)(2012-2#1)
resistance and tolerance profiles##2##4##(2011-10#2)
resistance and tolerance to##3##4##(2008-12#2)(2011-10#1)
resistance and tolerance##6##3##(2008-12#2)(2011-10#4)
resistance and virulence##3##3##(2008-10#2)(2011-2#1)
resistance and##96##2##(1991-5#1)(1992-2#1)(1994-11#2)(1994-2#1)(1995-6#1)(1996-3#1)(2008-10#43)(2008-11#5)(2008-12#2)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-8#2)(2010-10#2)(2010-12#2)(2010-5#1)(2011-1#3)(2011-10#4)(2011-2#4)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#2)
resistance are##5##2##(2008-10#2)(2009-10#1)(2009-9#1)(2011-1#1)
resistance arteries##2##2##(1997-4#2)
resistance as##5##2##(2008-10#3)(2008-8#1)(2012-2#1)
resistance associated with##3##3##(2008-10#2)(2011-2#1)
resistance associated##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
resistance at the##2##3##(2008-10#2)
resistance at##4##2##(2008-10#4)
resistance based on##3##3##(2008-10#3)
resistance breaking##2##2##(2008-10#2)
resistance breeding##4##2##(2008-10#4)
resistance by##10##2##(1990-2#1)(2008-10#9)
resistance can be##5##3##(2008-10#3)(2008-12#1)(2009-9#1)
resistance can##11##2##(2008-10#6)(2008-12#1)(2008-8#3)(2009-9#1)
resistance combined with##2##3##(2008-10#2)
resistance components##2##2##(2008-10#2)
resistance conferred by##5##3##(2008-10#4)(2008-9#1)
resistance could be##3##3##(1990-2#1)(2008-10#1)(2009-8#1)
resistance could##5##2##(1990-2#1)(2008-10#3)(2009-8#1)
resistance derived from##2##3##(2008-10#2)
resistance described here##2##3##(2008-10#2)
resistance described##3##2##(2008-10#2)(2008-11#1)
resistance development##3##2##(2008-10#3)
resistance did not##2##3##(2008-10#2)
resistance during##3##2##(2008-10#2)(2008-5#1)
resistance elicitors providing##2##3##(2008-10#2)
resistance elicitors##5##2##(2008-10#5)
resistance even##2##2##(2008-1#1)(2008-10#1)
resistance expressed at the##2##4##(2008-10#2)
resistance expressed in##2##3##(2008-10#2)
resistance expressed##6##2##(2008-10#6)
resistance factors##5##2##(2008-10#5)
resistance for##6##2##(2008-10#4)(2008-11#1)(2008-8#1)
resistance found##2##2##(2008-12#1)(2013-8#1)
resistance from##6##2##(2008-10#5)(2008-12#1)
resistance gene Bs2##2##3##(2008-10#2)
resistance gene analog polymorphism (RGAP) markers##2##6##(2008-10#2)
resistance gene analogs (RGAs)##2##4##(2008-10#2)
resistance gene analogs##3##3##(2008-10#3)
resistance gene and##2##3##(2008-10#2)
resistance gene at##2##3##(2008-10#2)
resistance gene in wheat##2##4##(2008-10#2)
resistance gene in##8##3##(2008-10#8)
resistance gene into barley##2##4##(2008-10#2)
resistance gene is##2##3##(2008-10#2)
resistance gene number in##2##4##(2008-10#2)
resistance gene to##2##3##(2008-10#2)
resistance gene was##2##3##(2008-10#2)
resistance gene were##2##3##(2008-10#2)
resistance gene##94##2##(2008-10#86)(2008-11#1)(2008-8#5)(2012-3#2)
resistance genes Lr1##2##3##(2008-10#2)
resistance genes and##3##3##(2008-10#3)
resistance genes are##2##3##(2008-10#2)
resistance genes as##2##3##(2008-10#2)
resistance genes for##3##3##(2008-10#3)
resistance genes identified##2##3##(2008-10#2)
resistance genes in the##3##4##(2008-10#3)
resistance genes in##14##3##(2008-10#13)(2008-11#1)
resistance genes on##2##3##(2008-10#2)
resistance genes or##2##3##(2008-10#2)
resistance genes present in cultivar AB 136##2##7##(2008-10#2)
resistance genes present in##3##4##(2008-10#3)
resistance genes to powdery mildew##2##5##(2008-10#2)
resistance genes to##5##3##(2008-10#5)
resistance genes using##2##3##(2008-10#2)
resistance genes were##2##3##(2008-10#2)
resistance genes##104##2##(2008-10#100)(2008-11#2)(2008-8#1)(2011-2#1)
resistance had##2##2##(2008-10#1)(2008-8#1)
resistance has##8##2##(2008-10#2)(2008-11#2)(2008-9#1)(2010-6#1)(2012-3#1)(2013-8#1)
resistance have been identified##2##4##(2008-10#1)(2009-10#1)
resistance have been##3##3##(2008-10#2)(2009-10#1)
resistance have##4##2##(2008-10#3)(2009-10#1)
resistance in Candida##2##3##(2008-5#1)(2011-2#1)
resistance in a##6##3##(2008-10#5)(2008-11#1)
resistance in barley##5##3##(2008-10#5)
resistance in both##3##3##(2008-10#3)
resistance in cucumber##2##3##(2008-10#2)
resistance in cv##2##3##(2008-10#2)
resistance in greenhouse##3##3##(2008-10#3)
resistance in host##2##3##(2008-10#2)
resistance in maize##2##3##(2008-10#2)
resistance in oat##3##3##(2008-10#3)
resistance in plants by##2##4##(2008-10#2)
resistance in plants##8##3##(2008-10#7)(2009-8#1)
resistance in radish##2##3##(2008-10#2)
resistance in replicated##2##3##(2008-10#2)
resistance in rice##4##3##(2008-10#2)(2008-9#1)(2009-10#1)
resistance in six##2##3##(2008-10#2)
resistance in sugar##2##3##(2008-10#2)
resistance in the field##4##4##(2008-10#4)
resistance in the host##3##4##(2008-10#3)
resistance in the slash pine-fusiform rust pathosystem##2##7##(2008-10#2)
resistance in the##31##3##(1993-8#1)(2008-10#26)(2008-9#2)(2011-1#2)
resistance in these##2##3##(2008-10#2)
resistance in this##3##3##(2008-10#3)
resistance in tobacco##3##3##(2008-10#3)
resistance in tomato##2##3##(2008-10#2)
resistance in transgenic##2##3##(2008-10#2)
resistance in tumor cells##2##4##(2008-11#2)
resistance in wheat##5##3##(2008-10#5)
resistance in##190##2##(1992-11#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-1#3)(2008-10#149)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-8#2)(2010-2#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
resistance increased##2##2##(2008-10#2)
resistance index##6##2##(1992-6#2)(1996-6#1)(2012-3#2)(2013-1#1)
resistance induced by##2##3##(2008-10#2)
resistance induced##3##2##(2008-10#3)
resistance into##4##2##(2008-10#4)
resistance is an##4##3##(2008-10#3)(2010-12#1)
resistance is associated with##2##4##(2008-10#1)(2012-5#1)
resistance is conferred by##2##4##(2008-10#2)
resistance is discussed##2##3##(2008-10#2)
resistance is not##4##3##(1994-12#1)(2008-10#2)(2008-8#1)
resistance is the##5##3##(1990-2#1)(2008-10#3)(2008-7#1)
resistance is unstable##2##3##(2008-10#2)
resistance is##52##2##(1990-2#1)(1994-12#1)(2008-10#40)(2008-11#1)(2008-7#1)(2008-8#4)(2010-12#1)(2010-6#1)(2012-5#1)(2013-1#1)
resistance level##2##2##(2008-10#2)
resistance levels##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
resistance loci in##3##3##(2008-10#2)(2008-9#1)
resistance loci were##2##3##(2008-10#2)
resistance loci##9##2##(2008-10#7)(2008-8#1)(2008-9#1)
resistance locus##5##2##(2008-10#3)(2012-3#2)
resistance management##2##2##(2008-10#2)
resistance markers##2##2##(2008-10#2)
resistance may be##5##3##(1997-7#1)(2008-10#2)(2008-8#1)(2009-6#1)
resistance may##8##2##(1994-12#1)(1997-7#1)(2008-10#4)(2008-8#1)(2009-6#1)
resistance measured by##4##3##(1996-3#1)(2008-1#2)(2008-10#1)
resistance measurement##2##2##(2011-2#2)
resistance mechanism##4##2##(2008-10#4)
resistance mechanisms in##2##3##(2008-10#1)(2012-2#1)
resistance mechanisms##13##2##(2008-10#5)(2008-11#4)(2008-4#1)(2011-2#2)(2012-2#1)
resistance mediated by##2##3##(2008-10#1)(2008-11#1)
resistance might##2##2##(2008-10#2)
resistance modes##2##2##(2008-10#2)
resistance mutations##5##2##(2013-1#5)
resistance occurs##2##2##(2008-10#1)(2008-3#1)
resistance of a##3##3##(2008-10#3)
resistance of bermudagrass genotypes to##2##5##(2008-10#2)
resistance of bermudagrass genotypes##3##4##(2008-10#3)
resistance of cucumber##2##3##(2008-10#2)
resistance of human##2##3##(1993-3#1)(2008-9#1)
resistance of maize##2##3##(2008-10#2)
resistance of the host##2##4##(2008-10#2)
resistance of the##8##3##(1991-5#1)(2008-10#5)(2008-5#2)
resistance of these##2##3##(2008-10#2)
resistance of##61##2##(1991-3#1)(1991-5#1)(1993-3#1)(1997-5#2)(2008-10#39)(2008-11#2)(2008-5#4)(2008-9#4)(2009-5#1)(2011-1#1)(2011-2#4)(2013-1#1)
resistance on chromosome##2##3##(2008-10#2)
resistance on the##3##3##(2008-10#3)
resistance on##9##2##(2008-10#6)(2008-8#1)(2009-1#1)(2011-1#1)
resistance only##2##2##(2008-10#2)
resistance or tolerance##2##3##(2008-10#1)(2011-10#1)
resistance or##13##2##(1994-5#1)(2008-10#9)(2008-8#1)(2011-10#1)(2013-1#1)
resistance patterns of##2##3##(2013-8#2)
resistance patterns##4##2##(2008-7#1)(2012-2#1)(2013-8#2)
resistance phenotype##4##2##(2008-10#2)(2008-11#2)
resistance phenotypes##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
resistance probably##2##2##(2008-10#2)
resistance profiles##3##2##(2008-10#2)(2011-3#1)
resistance protein##4##2##(1996-8#2)(2008-11#2)
resistance rating##3##2##(2008-10#3)
resistance response##4##2##(2008-10#3)(2008-9#1)
resistance responses##3##2##(2008-10#2)(2009-6#1)
resistance resulted in a##2##4##(2008-10#2)
resistance resulted in lower population growth rates and stronger density dependence than##2##12##(2008-8#2)
resistance resulted in##4##3##(2008-10#2)(2008-8#2)
resistance should##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
resistance status##5##2##(2008-10#5)
resistance test##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
resistance than##4##2##(2008-10#1)(2012-2#1)(2012-5#1)(2013-1#1)
resistance that is##2##3##(2008-10#1)(2008-11#1)
resistance that##7##2##(2008-10#4)(2008-11#1)(2008-6#1)(2011-1#1)
resistance through##4##2##(2008-10#3)(2009-6#1)
resistance to A##4##3##(1996-12#1)(2008-10#3)
resistance to Aphanomyces root rot##3##5##(2008-10#3)
resistance to Aspergillus ear rot and aflatoxin production##3##8##(2008-10#3)
resistance to Aspergillus ear rot and aflatoxin##4##7##(2008-10#4)
resistance to B##2##3##(2008-10#2)
resistance to Colletotrichum##2##3##(2008-10#2)
resistance to F##4##3##(2008-10#4)
resistance to FHB##7##3##(2008-10#5)(2011-10#2)
resistance to Fusarium wilt##5##4##(2008-10#5)
resistance to Fusarium##8##3##(2008-10#8)
resistance to HER2-targeted therapies##3##4##(2013-1#3)
resistance to IB-49##2##3##(2008-10#2)
resistance to IC-17 was##2##4##(2008-10#2)
resistance to Leptosphaeria maculans##2##4##(2008-10#2)
resistance to M##12##3##(2008-10#9)(2011-10#1)(2012-2#2)
resistance to Magnaporthe##2##3##(2008-10#1)(2013-8#1)
resistance to Melampsora larici-populina leaf rust##2##6##(2008-10#2)
resistance to P##8##3##(2008-10#7)(2009-6#1)
resistance to R##3##3##(2008-10#3)
resistance to SLB##2##3##(2008-10#2)
resistance to STB in##2##4##(2008-10#2)
resistance to STB##5##3##(2008-10#5)
resistance to Sclerotinia trifoliorum and Sclerotium rolfsii##2##7##(2008-10#2)
resistance to Sclerotinia trifoliorum##6##4##(2008-10#6)
resistance to Sclerotinia##7##3##(2008-10#7)
resistance to Sclerotium rolfsii as expressed in excised leaf tissues and whole plants##2##13##(2008-10#2)
resistance to Sclerotium rolfsii##4##4##(2008-10#4)
resistance to Septoria##2##3##(2008-10#2)
resistance to Stewart's wilt##2##4##(2008-10#2)
resistance to Tobacco mosaic virus (TMV)##2##6##(2008-10#2)
resistance to TuMV##3##3##(2008-10#3)
resistance to X##2##3##(2008-10#2)
resistance to a broad range of##2##6##(2008-10#1)(2008-11#1)
resistance to a broad##3##4##(2008-10#2)(2008-11#1)
resistance to a##9##3##(1997-5#1)(2008-10#4)(2008-11#3)(2008-8#1)
resistance to aflatoxin production and##2##5##(2008-10#2)
resistance to aflatoxin production in##2##5##(2008-10#2)
resistance to aflatoxin production##5##4##(2008-10#5)
resistance to aflatoxin##6##3##(2008-10#6)
resistance to all##3##3##(2008-10#3)
resistance to anthracnose in the cultivar TO##2##7##(2008-10#2)
resistance to anthracnose##5##3##(2008-10#5)
resistance to anticancer##2##3##(2008-11#2)
resistance to apoptosis##2##3##(2011-2#1)(2013-1#1)
resistance to bacterial blight##3##4##(2008-10#3)
resistance to bacterial##10##3##(2008-10#8)(2013-8#2)
resistance to be##2##3##(2012-12#1)(2012-3#1)
resistance to blast##4##3##(2008-10#3)(2012-2#1)
resistance to both##5##3##(2008-10#5)
resistance to change##2##3##(2010-10#1)(2011-2#1)
resistance to chemotherapy##2##3##(2008-11#1)(2011-2#1)
resistance to colonization of the##2##5##(2008-10#2)
resistance to colonization##3##3##(2008-10#3)
resistance to cytotoxic##2##3##(2008-11#2)
resistance to deer##2##3##(2008-8#2)
resistance to disease##3##3##(2008-10#2)(2008-8#1)
resistance to downy mildew##2##4##(2008-10#2)
resistance to each##2##3##(1993-8#1)(2008-10#1)
resistance to eyespot##3##3##(2008-10#3)
resistance to fluconazole##2##3##(2008-5#2)
resistance to fungal##2##3##(2008-10#2)
resistance to fusarium head blight##2##5##(2008-10#2)
resistance to fusarium##3##3##(2008-10#3)
resistance to gray leaf spot##3##5##(2008-10#3)
resistance to gray##4##3##(2008-10#4)
resistance to hygromycin B##2##4##(2008-10#2)
resistance to hygromycin##3##3##(2008-10#3)
resistance to infection by##2##4##(2008-10#2)
resistance to infection##4##3##(2008-10#4)
resistance to infectious diseases##3##4##(2008-10#3)
resistance to iprodione and##2##4##(2008-10#2)
resistance to iprodione##4##3##(2008-10#4)
resistance to isolate##3##3##(2008-10#3)
resistance to isolates##2##3##(2008-10#2)
resistance to late blight##2##4##(2008-10#2)
resistance to leaf rust and##3##5##(2008-10#3)
resistance to leaf rust##9##4##(2008-10#9)
resistance to leaf##10##3##(2008-10#10)
resistance to malaria##2##3##(1995-12#1)(2013-8#1)
resistance to many##2##3##(2008-10#1)(2011-10#1)
resistance to necrosis induced by##2##5##(2008-10#2)
resistance to one or more##2##5##(2008-10#1)(2013-8#1)
resistance to other##2##3##(2008-10#1)(2011-1#1)
resistance to pathogen##2##3##(2008-10#2)
resistance to pathogens##2##3##(1997-7#1)(2008-10#1)
resistance to pathotype##2##3##(2008-10#2)
resistance to powdery mildew in##2##5##(2008-10#2)
resistance to powdery mildew##6##4##(2008-10#6)
resistance to race 2##4##4##(2008-10#4)
resistance to race##9##3##(2008-10#9)
resistance to races 1 and 4##3##6##(2008-10#3)
resistance to races 1##5##4##(2008-10#5)
resistance to rice blast##6##4##(2008-10#6)
resistance to septoria speckled leaf blotch in barley##2##8##(2008-10#2)
resistance to septoria##3##3##(2008-10#3)
resistance to spread of scab within a spike##2##8##(2008-10#2)
resistance to stem rust and##2##5##(2008-10#2)
resistance to stripe rust##8##4##(2008-10#8)
resistance to the heterologous##2##4##(2008-10#2)
resistance to the root-lesion nematode##2##5##(2008-10#2)
resistance to the three##2##4##(2008-10#2)
resistance to the##29##3##(1991-3#1)(1993-2#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-10#2)(2012-12#1)(2012-3#1)(2013-1#1)
resistance to these pathogens##3##4##(2008-10#2)(2009-10#1)
resistance to these##6##3##(2008-10#5)(2009-10#1)
resistance to this class of##2##5##(2008-11#1)(2011-2#1)
resistance to this##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
resistance to three##3##3##(2008-10#2)(2008-8#1)
resistance to thyroid hormone##3##4##(1995-8#3)
resistance to two##4##3##(2008-10#3)(2011-3#1)
resistance to various##2##3##(1994-8#1)(2008-12#1)
resistance to vincristine##2##3##(1993-8#2)
resistance to virus infection##2##4##(2008-10#2)
resistance to water##2##3##(2008-5#1)(2013-1#1)
resistance to white pine blister rust##6##6##(2008-10#6)
resistance to white pine blister##7##5##(2008-10#7)
resistance to##529##2##(1990-2#1)(1990-8#1)(1991-3#3)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#4)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-5#2)(1997-7#1)(2008-10#382)(2008-11#18)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#9)(2008-9#7)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#4)(2011-10#6)(2011-2#10)(2011-3#4)(2012-12#3)(2012-2#7)(2012-3#6)(2013-1#13)(2013-8#7)
resistance toward##2##2##(2008-10#2)
resistance training group##2##3##(2013-1#2)
resistance training##6##2##(2010-1#1)(2013-1#5)
resistance trait##2##2##(2008-10#2)
resistance traits in##2##3##(2008-10#2)
resistance traits##6##2##(2008-10#4)(2008-8#2)
resistance transferred##2##2##(2008-10#2)
resistance types##2##2##(2008-8#2)
resistance used in##2##3##(2008-10#2)
resistance using##7##2##(2008-10#5)(2008-11#1)(2012-2#1)
resistance via##2##2##(2008-10#2)
resistance was also##2##3##(2008-10#2)
resistance was estimated##2##3##(2008-10#2)
resistance was evaluated##2##3##(2008-10#2)
resistance was found to be##3##5##(2008-10#2)(2011-1#1)
resistance was found##4##3##(2008-10#3)(2011-1#1)
resistance was induced##2##3##(2008-10#2)
resistance was manifested##2##3##(2008-10#2)
resistance was measured##2##3##(2008-1#1)(2008-10#1)
resistance was not##2##3##(2008-10#2)
resistance was observed in##2##4##(2008-10#2)
resistance was observed##4##3##(2008-10#4)
resistance was obtained##2##3##(2008-10#2)
resistance was##51##2##(2008-1#1)(2008-10#48)(2011-1#1)(2013-8#1)
resistance were identified##4##3##(2008-10#3)(2013-8#1)
resistance were not##2##3##(2008-10#2)
resistance were##20##2##(2008-10#16)(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
resistance will##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2011-10#1)
resistance with##4##2##(1994-12#1)(2008-10#1)(2010-7#1)(2013-1#1)
resistance##2099##1##(1990-11#1)(1990-2#5)(1990-8#1)(1991-2#1)(1991-3#5)(1991-5#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-7#2)(1992-9#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#6)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#4)(1996-1#1)(1996-11#5)(1996-12#6)(1996-3#3)(1996-6#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#4)(1997-7#8)(2008-1#10)(2008-10#1449)(2008-11#88)(2008-12#11)(2008-2#2)(2008-3#4)(2008-4#13)(2008-5#21)(2008-6#2)(2008-7#12)(2008-8#69)(2008-9#26)(2009-1#1)(2009-10#11)(2009-3#1)(2009-5#1)(2009-6#8)(2009-7#1)(2009-8#13)(2009-9#3)(2010-1#3)(2010-10#7)(2010-11#4)(2010-12#6)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#26)(2011-10#15)(2011-2#39)(2011-3#7)(2012-12#3)(2012-2#24)(2012-3#23)(2012-5#5)(2013-1#57)(2013-7#1)(2013-8#23)
resistance)##4##1##(1991-8#1)(2008-10#2)(2008-11#1)
resistance-associated proteins##2##2##(2008-10#2)
resistance-associated##7##1##(2008-10#2)(2008-11#4)(2013-8#1)
resistance-breaking (RB)##2##2##(2008-10#2)
resistance-breaking strains##2##2##(2008-10#2)
resistance-breaking##7##1##(2008-10#7)
resistance-inducing##3##1##(2008-10#2)(2008-11#1)
resistances and virulence##2##3##(2012-3#2)
resistances in##2##2##(1997-5#1)(2008-8#1)
resistances to##6##2##(2008-10#6)
resistances##12##1##(1997-5#1)(2008-10#7)(2008-8#2)(2012-3#2)
resistant 'Burley 21' transgenic lines##2##5##(2008-10#2)
resistant A(549)/DDP cells##3##3##(2008-9#3)
resistant B##2##2##(2008-10#2)
resistant QTL##2##2##(2012-3#2)
resistant Staphylococcus##2##2##(1991-3#1)(2010-2#1)
resistant TB (XDR-TB)##2##3##(2008-10#1)(2010-5#1)
resistant TB##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
resistant accession##3##2##(2008-10#3)
resistant accessions##4##2##(2008-10#4)
resistant and susceptible barley##2##4##(2008-10#2)
resistant and susceptible cultivar##2##4##(2008-10#2)
resistant and susceptible cultivars##3##4##(2008-10#3)
resistant and susceptible families##2##4##(2008-10#1)(2011-10#1)
resistant and susceptible genotypes##2##4##(2008-10#2)
resistant and susceptible plants##2##4##(2008-10#2)
resistant and susceptible to##2##4##(2008-10#2)
resistant and susceptible##26##3##(1996-12#1)(2008-10#24)(2011-10#1)
resistant and##35##2##(1996-12#1)(2008-10#31)(2008-5#1)(2010-3#1)(2011-10#1)
resistant apple fruits##2##3##(2008-10#2)
resistant apple##4##2##(2008-10#4)
resistant at the adult##2##4##(2008-10#2)
resistant at##6##2##(2008-10#6)
resistant bacteria##2##2##(2012-2#1)(2013-1#1)
resistant berries##4##2##(2008-10#4)
resistant by resistant##2##3##(2008-10#2)
resistant by##3##2##(2008-10#3)
resistant cactus##4##2##(2008-10#4)
resistant cell lines##2##3##(1994-8#1)(2008-11#1)
resistant cell##3##2##(1994-8#1)(2008-11#2)
resistant cells##12##2##(1990-2#2)(1992-2#1)(1994-8#1)(2008-11#8)
resistant clinical isolates of Pseudomonas aeruginosa##2##6##(2012-2#2)
resistant clinical isolates##3##3##(2012-2#3)
resistant corn genotypes##3##3##(2008-10#3)
resistant corn##4##2##(2008-10#4)
resistant crosses##2##2##(2008-10#2)
resistant cultivar##16##2##(2008-10#15)(2011-10#1)
resistant cultivars is the##2##4##(2008-10#2)
resistant cultivars of##3##3##(2008-10#3)
resistant cultivars would be##2##4##(2008-10#2)
resistant cultivars##39##2##(2008-10#38)(2008-12#1)
resistant cv##7##2##(2008-10#7)
resistant cvs##3##2##(2008-10#3)
resistant ecotype S96##2##3##(2008-10#2)
resistant families##3##2##(2008-10#3)
resistant fruit##2##2##(2008-10#2)
resistant gene##4##2##(1993-8#1)(1997-8#1)(2008-11#1)(2008-8#1)
resistant genotype##8##2##(2008-10#7)(2008-8#1)
resistant genotypes and##2##3##(2008-10#2)
resistant genotypes##16##2##(2008-10#15)(2008-12#1)
resistant host##4##2##(2008-10#3)(2008-8#1)
resistant in##2##2##(2008-10#2)
resistant inbred##3##2##(2008-10#3)
resistant individuals##2##2##(2008-10#2)
resistant isolates of##3##3##(2008-10#3)
resistant isolates##18##2##(2008-10#17)(2008-5#1)
resistant line##3##2##(2008-10#3)
resistant lines##13##2##(2008-10#13)
resistant maize lines##2##3##(2008-10#2)
resistant maize##3##2##(2008-10#3)
resistant mutations##2##2##(1997-4#1)(2010-11#1)
resistant only to vinclozolin (S(T)R(V))##2##5##(2008-10#2)
resistant or susceptible to##3##4##(2008-10#3)
resistant or susceptible##5##3##(2008-10#5)
resistant or##7##2##(2008-10#7)
resistant organisms##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
resistant parent##7##2##(2008-10#7)
resistant plants and##2##3##(2008-10#1)(2008-8#1)
resistant plants showed##2##3##(2008-10#2)
resistant plants##19##2##(2008-10#18)(2008-8#1)
resistant potato##2##2##(2008-10#2)
resistant reactions##2##2##(2008-10#2)
resistant roots##4##2##(2008-10#4)
resistant seedlings##5##2##(2008-10#5)
resistant sorghum##2##2##(2008-10#2)
resistant stems##3##2##(2008-10#3)
resistant strain##3##2##(2008-10#1)(2011-2#2)
resistant strains##7##2##(1990-5#1)(1996-12#1)(2008-10#3)(2008-7#1)(2012-2#1)
resistant subline##2##2##(1990-2#2)
resistant than##9##2##(2008-10#5)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
resistant to A##2##3##(2008-10#2)
resistant to Fusarium##2##3##(2008-10#2)
resistant to P##4##3##(2008-10#3)(2008-8#1)
resistant to TRAIL##2##3##(2009-9#1)(2012-2#1)
resistant to Verticillium##2##3##(2008-10#2)
resistant to activation-induced apoptosis##2##4##(2008-10#2)
resistant to all##6##3##(2008-10#5)(2008-5#1)
resistant to apoptosis##2##3##(2008-8#1)(2009-9#1)
resistant to at least##2##4##(1993-8#1)(2011-2#1)
resistant to attack##2##3##(2008-10#1)(2011-10#1)
resistant to azoxystrobin and##2##4##(2008-10#2)
resistant to both fungicides (R(T)R(V))##3##5##(2008-10#3)
resistant to both##11##3##(1991-2#1)(2008-10#10)
resistant to conservative##2##3##(2010-3#1)(2013-1#1)
resistant to crown rust##2##4##(2008-10#2)
resistant to enzymatic##2##3##(1993-2#1)(2009-8#1)
resistant to fluconazole##2##3##(2008-10#1)(2008-5#1)
resistant to fluorouracil##3##3##(1990-2#3)
resistant to hydrolysis##2##3##(1994-11#2)
resistant to infection by##2##4##(2008-10#1)(2010-7#1)
resistant to most##2##3##(2008-10#1)(2008-11#1)
resistant to one or##2##4##(2008-10#1)(2013-8#1)
resistant to one##3##3##(2008-10#2)(2013-8#1)
resistant to penicillin##4##3##(2008-12#2)(2011-2#1)(2013-8#1)
resistant to powdery mildew##3##4##(2008-10#3)
resistant to race 1##2##4##(2008-10#2)
resistant to race##3##3##(2008-10#3)
resistant to strain GMI1000##2##4##(2008-10#2)
resistant to stress##2##3##(1996-2#2)
resistant to the action of IGF-1##2##6##(1994-11#2)
resistant to the##12##3##(1993-12#1)(1994-11#2)(1995-2#1)(2008-10#6)(2008-11#1)(2011-10#1)
resistant to thiophanate-methy1##2##3##(2008-10#2)
resistant to thiophanate-methyl##3##3##(2008-10#3)
resistant to two##2##3##(2008-10#2)
resistant to vinclozolin (S(T)R(V))##2##4##(2008-10#2)
resistant to vinclozolin##3##3##(2008-10#3)
resistant to##208##2##(1990-12#1)(1990-2#3)(1990-5#1)(1991-2#1)(1992-12#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#5)(1994-11#6)(1994-2#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#108)(2008-11#9)(2008-12#4)(2008-5#5)(2008-7#3)(2008-8#6)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#2)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
resistant tomato##2##2##(2008-10#2)
resistant transgenic##2##2##(2008-8#2)
resistant varieties##2##2##(2008-10#2)
resistant wheat cultivars##2##3##(2008-10#2)
resistant wheat##5##2##(2008-10#5)
resistant x##2##2##(2008-10#2)
resistant##716##1##(1990-12#1)(1990-2#8)(1990-5#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#6)(1994-11#6)(1994-2#1)(1994-8#5)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#9)(1996-2#2)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#495)(2008-11#25)(2008-12#6)(2008-3#1)(2008-5#8)(2008-7#8)(2008-8#15)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-10#4)(2011-2#22)(2011-3#1)(2012-2#10)(2012-3#8)(2012-5#1)(2012-6#1)(2013-1#8)(2013-8#6)
resistant)##7##1##(2008-10#6)(2011-2#1)
resisted removal##2##2##(2008-10#1)(2011-2#1)
resisted##6##1##(1996-3#1)(2008-10#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
resisting##3##1##(1991-12#1)(1996-3#1)(2011-3#1)
resistivity##7##1##(2008-2#1)(2008-3#1)(2011-2#2)(2013-1#2)(2013-8#1)
resistor electrodes##2##2##(2008-10#2)
resistors##3##1##(2008-10#3)
resolution 0##2##2##(2013-8#2)
resolution and a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
resolution and sensitivity##3##3##(1991-7#1)(1995-6#1)(2008-10#1)
resolution and signal-to-noise ratio##2##4##(1997-8#1)(2010-9#1)
resolution and##34##2##(1991-7#1)(1993-9#1)(1995-2#1)(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#3)
resolution are##2##2##(2007-12#1)(2008-3#1)
resolution as##2##2##(2008-2#1)(2008-3#1)
resolution at##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
resolution between##5##2##(2008-10#4)(2009-9#1)
resolution by using##2##3##(1992-4#1)(2008-8#1)
resolution by##6##2##(1992-4#1)(1993-8#1)(2007-11#1)(2008-10#2)(2008-8#1)
resolution can be obtained##2##4##(2008-4#1)(2008-9#1)
resolution can be##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
resolution compared##2##2##(2008-10#1)(2008-3#1)
resolution computed pulmonary##2##3##(2007-8#2)
resolution enhancement##3##2##(2008-10#1)(2008-3#2)
resolution for the##2##3##(2008-10#2)
resolution for##8##2##(2008-10#6)(2011-7#1)(2012-3#1)
resolution imaging of##2##3##(1990-11#1)(2011-7#1)
resolution in HPLC##2##3##(2008-10#2)
resolution in order to##2##4##(2010-3#1)(2011-2#1)
resolution in the##2##3##(1996-12#1)(2008-5#1)
resolution in##17##2##(1991-9#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)
resolution inductively##2##2##(2008-10#2)
resolution is not##2##3##(2008-10#1)(2008-2#1)
resolution is##7##2##(1993-8#1)(2008-10#1)(2008-2#2)(2008-3#3)
resolution limits##2##2##(2008-10#1)(2009-7#1)
resolution makes##2##2##(2008-9#1)(2010-7#1)
resolution mass spectrometry##6##3##(2008-10#5)(2008-11#1)
resolution mass##7##2##(2008-10#6)(2008-11#1)
resolution method##3##2##(2008-10#2)(2008-3#1)
resolution methods##3##2##(2008-10#3)
resolution of 0##2##3##(2008-3#2)
resolution of 1##2##3##(2008-10#2)
resolution of 10##2##3##(2007-12#1)(2008-3#1)
resolution of 4##2##3##(2007-12#1)(2008-10#1)
resolution of 7##2##3##(2008-11#1)(2013-8#1)
resolution of better than##2##4##(2007-12#1)(2008-2#1)
resolution of binary##3##3##(2008-10#3)
resolution of her symptoms##2##4##(2008-7#1)(2013-1#1)
resolution of his##2##3##(2008-7#1)(2010-1#1)
resolution of the analytes##2##4##(2008-10#2)
resolution of the##36##3##(1993-8#2)(1995-3#1)(1995-6#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-3#7)(2008-7#2)(2009-12#1)(2009-6#1)(2010-10#1)(2013-8#2)
resolution of##123##2##(1991-2#1)(1991-3#1)(1991-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-12#9)(2008-10#49)(2008-11#4)(2008-2#2)(2008-3#19)(2008-5#1)(2008-7#6)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#5)
resolution on##3##2##(2008-10#1)(2008-8#1)(2009-12#1)
resolution or##2##2##(1996-11#1)(2008-6#1)
resolution range##2##2##(2008-3#1)(2008-8#1)
resolution results##2##2##(2008-10#2)
resolution than##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)
resolution that##3##2##(2008-10#2)(2008-4#1)
resolution to##5##2##(1992-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-6#1)
resolution values were shown in the extraction##2##7##(2008-10#2)
resolution was##3##2##(2008-10#2)(2008-3#1)
resolution were##6##2##(2008-10#4)(2008-3#1)(2011-3#1)
resolution with a##3##3##(1991-3#1)(1993-8#1)(2008-3#1)
resolution with##5##2##(1991-3#1)(1993-8#1)(2008-10#2)(2008-3#1)
resolution##431##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#4)(1992-9#2)(1993-12#1)(1993-8#6)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#2)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#17)(2007-8#2)(2008-10#159)(2008-11#13)(2008-12#2)(2008-2#12)(2008-3#56)(2008-4#9)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#8)(2008-9#13)(2009-1#2)(2009-12#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#8)(2011-3#1)(2011-7#6)(2012-12#1)(2012-2#10)(2012-3#6)(2013-1#2)(2013-8#9)
resolutions are##3##2##(2008-10#3)
resolutions of##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
resolutions##18##1##(1994-1#2)(1994-9#1)(1995-3#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-6#2)(2008-8#2)
resolvable from##2##2##(2008-9#2)
resolvable##5##1##(2008-10#2)(2008-12#1)(2008-9#2)
resolve problems##2##2##(1995-5#1)(2008-10#1)
resolve the apparent##2##3##(1993-9#1)(2008-8#1)
resolve the##15##2##(1992-9#1)(1993-9#1)(1995-5#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-5#1)(2013-8#1)
resolve##49##1##(1990-12#1)(1992-9#1)(1993-9#1)(1995-3#1)(1995-5#3)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
resolved after##3##2##(2008-7#1)(2010-2#1)(2013-8#1)
resolved and##5##2##(2008-10#3)(2008-7#1)(2009-6#1)
resolved at##2##2##(2008-10#2)
resolved by the##2##3##(2008-10#1)(2011-1#1)
resolved by##27##2##(1990-5#1)(1991-12#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#9)(2008-6#1)(2008-9#2)(2009-9#1)(2010-2#1)(2011-1#2)(2012-12#3)
resolved from the##3##3##(2008-10#3)
resolved in two##2##3##(1997-8#1)(2008-3#1)
resolved in##7##2##(1997-6#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-8#1)
resolved into##2##2##(2008-10#1)(2008-11#1)
resolved on the basis of##2##5##(1993-9#1)(2008-10#1)
resolved on the##4##3##(1993-9#1)(2008-10#3)
resolved on##5##2##(1993-9#1)(2008-10#3)(2008-7#1)
resolved or improved in##2##4##(2008-10#1)(2012-3#1)
resolved the##3##2##(2008-3#1)(2009-8#1)(2011-2#1)
resolved when##2##2##(1994-5#1)(2008-9#1)
resolved with no##2##3##(2011-2#1)(2013-8#1)
resolved with##9##2##(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-3#1)(2011-2#2)(2013-8#1)
resolved##131##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#4)(1992-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-8#1)(1996-9#1)(1997-6#2)(1997-8#1)(2007-12#3)(2008-10#47)(2008-11#5)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#2)
resolves##2##1##(2008-10#1)(2008-3#1)
resolving chemical mixed signals##2##4##(2008-10#2)
resolving chemical##3##2##(2008-10#3)
resolving power and resolution##2##4##(2008-10#2)
resolving power##13##2##(2008-10#10)(2008-2#1)(2008-3#1)(2011-2#1)
resolving##38##1##(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
resonance &quot##2##2##(1994-8#1)(1995-5#1)
resonance (MR) imaging##4##3##(1996-2#1)(2010-12#1)(2011-2#2)
resonance (MR)##9##2##(1995-11#1)(1995-5#1)(1996-2#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)
resonance Raman##8##2##(1990-8#2)(1995-2#1)(2008-10#4)(2008-2#1)
resonance Rayleigh scattering (RRS)##3##4##(2008-10#3)
resonance Rayleigh scattering##4##3##(2008-10#4)
resonance and##7##2##(1996-11#1)(1997-8#1)(2008-10#3)(2009-10#1)(2012-2#1)
resonance angiography##5##2##(1997-4#1)(2008-12#2)(2008-7#1)(2009-8#1)
resonance angle##2##2##(2008-10#2)
resonance assignment of Urm1 from Trypanosoma brucei##2##7##(2009-7#2)
resonance assignment of the##6##4##(2009-7#6)
resonance assignment of##11##3##(2009-7#11)
resonance assignments for the##2##4##(1994-5#1)(2009-7#1)
resonance assignments of the##6##4##(2009-7#6)
resonance assignments of##11##3##(2009-7#11)
resonance assignments##14##2##(1994-5#1)(2009-7#13)
resonance at##3##2##(1990-8#2)(2008-10#1)
resonance energy transfer (FRET)##6##4##(2008-10#3)(2008-4#2)(2010-12#1)
resonance energy transfer##14##3##(1994-5#1)(2008-10#5)(2008-4#3)(2008-9#1)(2010-12#2)(2011-3#1)(2013-8#1)
resonance energy##15##2##(1994-5#1)(2008-10#5)(2008-4#3)(2008-9#2)(2010-12#2)(2011-3#1)(2013-8#1)
resonance experiments##2##2##(2008-8#1)(2009-7#1)
resonance for the##2##3##(2008-10#1)(2009-10#1)
resonance for##5##2##(2008-10#2)(2008-12#1)(2009-10#2)
resonance frequency shift##5##3##(2009-5#4)(2012-2#1)
resonance frequency##8##2##(2008-10#1)(2009-5#4)(2012-2#1)(2013-8#2)
resonance image##3##2##(2008-12#1)(2008-7#2)
resonance images (MRI)##2##3##(2010-7#1)(2012-3#1)
resonance images##6##2##(2008-7#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
resonance imaging (MRI) findings##5##4##(1996-11#1)(2008-6#1)(2012-12#2)(2012-3#1)
resonance imaging (MRI) is##5##4##(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#2)
resonance imaging (MRI) showed##4##4##(2008-7#1)(2013-1#1)(2013-8#2)
resonance imaging (MRI) with##2##4##(2008-7#1)(2010-9#1)
resonance imaging (MRI)##41##3##(1995-5#1)(1996-11#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-11#1)(2010-12#2)(2010-3#1)(2010-9#3)(2011-2#1)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
resonance imaging and multidetector computed tomography##2##6##(2012-2#2)
resonance imaging and##12##3##(1992-3#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#4)
resonance imaging demonstrated a##2##4##(2008-7#1)(2011-2#1)
resonance imaging findings##2##3##(1997-8#1)(2008-7#1)
resonance imaging for##2##3##(2010-12#1)(2010-7#1)
resonance imaging in##5##3##(1990-12#1)(2010-12#2)(2012-12#1)(2013-3#1)
resonance imaging is the##3##4##(2010-6#1)(2011-2#1)(2012-12#1)
resonance imaging is##6##3##(1990-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
resonance imaging of the##5##4##(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#2)
resonance imaging of##16##3##(1991-11#1)(1997-8#1)(2008-7#1)(2009-3#1)(2010-12#5)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#1)
resonance imaging revealed a##2##4##(2008-11#1)(2008-12#1)
resonance imaging revealed##4##3##(2008-11#1)(2008-12#2)(2013-8#1)
resonance imaging should be##2##4##(2008-8#1)(2010-3#1)
resonance imaging showed a##2##4##(2008-7#1)(2011-2#1)
resonance imaging showed##5##3##(2008-7#2)(2010-10#1)(2011-2#1)(2013-7#1)
resonance imaging was performed##3##4##(2011-2#1)(2012-12#2)
resonance imaging was##6##3##(1996-2#1)(2008-11#1)(2011-2#2)(2012-12#2)
resonance imaging##169##2##(1990-11#1)(1990-12#3)(1991-11#1)(1992-12#1)(1992-3#5)(1994-3#1)(1995-5#3)(1996-11#1)(1996-2#2)(1996-9#1)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#1)(2008-11#12)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#18)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#3)(2009-3#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#15)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-9#5)(2011-1#1)(2011-2#20)(2012-12#9)(2012-2#16)(2012-3#5)(2013-1#4)(2013-3#2)(2013-7#2)(2013-8#4)
resonance ionization imaging detector##2##4##(2008-3#2)
resonance ionization imaging##3##3##(2007-12#1)(2008-3#2)
resonance ionization##4##2##(2007-12#1)(2008-3#3)
resonance light scattering (RLS)##4##4##(2008-10#4)
resonance light scattering of##3##4##(2008-10#3)
resonance light scattering ratiometry##2##4##(2008-10#2)
resonance light scattering technique##2##4##(2008-10#2)
resonance light scattering##13##3##(2008-10#13)
resonance light##14##2##(2008-10#14)
resonance light-scattering (RLS)##2##3##(2008-10#2)
resonance light-scattering##3##2##(2008-10#3)
resonance linewidth##2##2##(2008-2#1)(2008-3#1)
resonance of the##2##3##(2008-10#1)(2008-3#1)
resonance of##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
resonance phenomenon##2##2##(1995-12#1)(2010-7#1)
resonance scattering spectral method for##2##5##(2008-10#2)
resonance scattering spectral method##3##4##(2008-10#3)
resonance scattering spectral##4##3##(2008-10#4)
resonance scattering##10##2##(2008-10#10)
resonance spectroscopy##18##2##(1991-1#1)(1994-2#1)(1994-5#1)(1997-1#1)(2008-10#7)(2008-11#3)(2008-7#2)(2010-12#2)
resonance study##2##2##(1991-5#1)(2008-10#1)
resonance systems##2##2##(2011-2#2)
resonance##456##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#9)(1992-4#1)(1992-8#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-11#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#5)(1996-11#3)(1996-2#4)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#5)(2007-12#1)(2008-1#1)(2008-10#113)(2008-11#19)(2008-12#6)(2008-2#7)(2008-3#13)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#25)(2008-8#5)(2008-9#8)(2009-1#3)(2009-10#5)(2009-11#3)(2009-12#2)(2009-3#2)(2009-5#8)(2009-6#1)(2009-7#25)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#1)(2010-12#20)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#6)(2010-8#4)(2010-9#5)(2011-1#1)(2011-2#29)(2011-3#1)(2012-12#9)(2012-2#20)(2012-3#6)(2013-1#6)(2013-3#2)(2013-7#2)(2013-8#7)
resonances in cylindrical microparticles##2##4##(2008-3#2)
resonances in##3##2##(1992-4#1)(2008-3#2)
resonances of the##3##3##(2009-7#3)
resonances of##5##2##(2008-3#2)(2009-7#3)
resonances##18##1##(1992-4#1)(1994-5#2)(1995-2#1)(2008-10#1)(2008-3#7)(2008-9#1)(2009-7#4)(2010-7#1)
resonant frequency of the quartz crystal##2##6##(2008-10#2)
resonant frequency of the##3##4##(2008-10#3)
resonant frequency of##4##3##(1990-8#1)(2008-10#3)
resonant frequency##5##2##(1990-8#1)(2008-10#3)(2009-5#1)
resonant laser ablation##2##3##(2008-3#2)
resonant tunneling##2##2##(1992-11#1)(2007-12#1)
resonant##32##1##(1990-8#1)(1992-11#1)(2007-12#5)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#13)(2009-5#1)
resonantly##3##1##(2007-12#1)(2008-3#2)
resonator and##2##2##(2008-2#1)(2008-3#1)
resonator with##3##2##(2008-2#1)(2008-3#2)
resonator##40##1##(2008-10#1)(2008-2#13)(2008-3#23)(2009-5#3)
resonators are##2##2##(2008-3#2)
resonators with a##3##3##(2008-3#2)(2009-5#1)
resonators with##5##2##(2008-3#4)(2009-5#1)
resonators##24##1##(2008-2#2)(2008-3#18)(2009-5#4)
resorbed by##2##2##(1995-2#1)(2008-12#1)
resorbed##7##1##(1995-2#1)(2008-12#2)(2009-7#1)(2013-1#3)
resorcinol (PAR) and##2##3##(2008-10#2)
resorcinol (PAR)##5##2##(2008-10#5)
resorcinol and hydroquinone##2##3##(2008-10#2)
resorcinol and##6##2##(2008-10#6)
resorcinol##22##1##(2008-10#20)(2008-11#1)(2008-6#1)
resorption and##2##2##(2008-11#1)(2013-1#1)
resorption by##3##2##(2008-11#2)(2013-1#1)
resorption markers##2##2##(2008-10#2)
resorption of the##2##3##(2013-1#2)
resorption of##5##2##(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#2)
resorption was##3##2##(1991-11#1)(2008-7#2)
resorption##48##1##(1991-11#4)(1993-6#10)(2007-11#1)(2008-10#4)(2008-11#7)(2008-12#2)(2008-7#4)(2011-2#3)(2011-7#1)(2012-12#1)(2013-1#11)
resort to##3##2##(2008-10#1)(2009-12#1)(2013-1#1)
resort##7##1##(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-10#1)(2013-1#1)
resorting to##6##2##(1995-6#1)(2008-10#4)(2013-1#1)
resorufin##3##1##(1994-8#1)(2008-10#2)
resource acquisition##2##2##(2008-8#2)
resource allocation##8##2##(1992-1#1)(1995-2#1)(1997-1#1)(2008-11#1)(2008-8#3)(2013-8#1)
resource and##3##2##(1991-3#1)(2008-12#1)(2008-8#1)
resource availability can##2##3##(2008-8#1)(2008-9#1)
resource availability##7##2##(2008-8#4)(2008-9#1)(2012-2#2)
resource competition##4##2##(2008-8#3)(2008-9#1)
resource consumption##4##2##(1991-12#2)(1995-2#1)(2008-8#1)
resource defense##2##2##(2008-8#1)(2012-2#1)
resource densities##3##2##(2008-8#1)(2008-9#2)
resource density##2##2##(2008-8#2)
resource dynamics##3##2##(2008-8#3)
resource extraction rate is##2##4##(2008-8#2)
resource extraction##3##2##(2008-8#3)
resource for##18##2##(1992-3#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-2#1)(2008-10#2)(2008-12#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2012-3#2)
resource intensive##2##2##(2008-12#1)(2013-1#1)
resource is##2##2##(1997-2#1)(2008-12#1)
resource limited##2##2##(1995-12#1)(2010-8#1)
resource management##2##2##(1996-2#1)(2011-2#1)
resource of##2##2##(1995-2#1)(1996-3#1)
resource patches##2##2##(2008-9#2)
resource requirements##3##2##(2008-8#2)(2008-9#1)
resource supply##3##2##(2008-8#3)
resource that##6##2##(2008-12#1)(2008-4#3)(2008-9#1)(2012-2#1)
resource use##10##2##(1991-12#2)(1991-2#1)(1993-12#2)(1993-2#1)(1997-2#1)(2008-11#1)(2008-9#2)
resource utilization and##2##3##(1993-3#1)(2009-11#1)
resource utilization##6##2##(1992-4#1)(1993-3#1)(1995-12#1)(1997-1#1)(2008-8#1)(2009-11#1)
resource##185##1##(1990-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#5)(1995-2#5)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#3)(1997-2#3)(1997-3#1)(2008-10#6)(2008-11#10)(2008-12#7)(2008-4#4)(2008-8#56)(2008-9#27)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#5)(2011-2#4)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#1)
resource-based model##3##2##(2008-8#3)
resource-based relative value##4##3##(1991-2#1)(1992-1#1)(1994-12#2)
resource-based##10##1##(1991-2#1)(1992-1#1)(1994-1#2)(1994-12#2)(2008-8#3)(2012-2#1)
resource-poor##4##1##(2008-11#1)(2008-9#1)(2009-8#1)(2013-1#1)
resources allocated##2##2##(2008-10#1)(2008-9#1)
resources and had##2##3##(1991-12#1)(1995-1#1)
resources and personnel##2##3##(1993-12#1)(2008-10#1)
resources and services##2##3##(1993-1#2)
resources and the##2##3##(1996-8#1)(1997-3#1)
resources and to##2##3##(2008-1#1)(2008-10#1)
resources and##33##2##(1991-12#1)(1991-3#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#2)(1996-1#1)(1996-8#1)(1997-2#1)(1997-3#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#3)
resources are scarce##2##3##(2008-12#1)(2008-9#1)
resources are##14##2##(1994-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-8#3)(2008-9#4)(2009-10#1)(2010-8#1)(2013-1#1)
resources at##2##2##(2009-10#2)
resources available and the##2##4##(2007-11#1)(2012-2#1)
resources available to##3##3##(1994-1#1)(1996-2#1)(2010-9#1)
resources available##5##2##(1994-1#1)(1996-2#1)(2007-11#1)(2010-9#1)(2012-2#1)
resources but##3##2##(2008-8#1)(2008-9#2)
resources by##2##2##(2008-11#1)(2008-5#1)
resources for health##2##3##(1991-6#1)(1997-2#1)
resources for nursing##2##3##(2008-11#2)
resources for public health##2##4##(1995-12#1)(1997-3#1)
resources for##13##2##(1991-6#1)(1992-3#2)(1995-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#3)(2008-8#1)
resources from##3##2##(1994-2#1)(2008-11#1)(2008-8#1)
resources in the##5##3##(1990-9#1)(1991-3#1)(1991-6#1)(2008-11#1)(2009-6#1)
resources in this##2##3##(1990-12#1)(2010-10#1)
resources in##16##2##(1990-12#1)(1990-9#1)(1991-3#1)(1991-6#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
resources it##2##2##(2008-10#1)(2008-8#1)
resources might be##2##3##(2008-11#1)(2009-5#1)
resources might##3##2##(2008-11#1)(2008-8#1)(2009-5#1)
resources needed##2##2##(1991-8#1)(2008-2#1)
resources of the##3##3##(1996-2#1)(2008-10#1)(2012-2#1)
resources of##10##2##(1990-2#1)(1991-3#1)(1995-1#1)(1996-2#2)(2008-10#3)(2012-2#2)
resources on##5##2##(1996-3#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-7#1)
resources or##2##2##(2008-8#1)(2008-9#1)
resources required##3##2##(2008-9#1)(2012-2#2)
resources that##4##2##(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
resources to a##2##3##(1990-12#1)(2009-3#1)
resources to the##2##3##(2008-10#1)(2012-3#1)
resources to##28##2##(1990-12#1)(1992-12#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#2)(2011-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
resources used##3##2##(1996-11#1)(1997-4#1)(2008-8#1)
resources was##2##2##(1994-1#1)(2012-2#1)
resources will##2##2##(1990-12#1)(1996-3#1)
resources with##2##2##(1996-3#1)(2008-10#1)
resources without##2##2##(2008-8#1)(2008-9#1)
resources##306##1##(1990-12#3)(1990-2#2)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#2)(1993-1#3)(1993-11#1)(1993-12#3)(1994-1#2)(1994-12#5)(1994-2#1)(1994-3#4)(1994-6#1)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#3)(1996-1#3)(1996-11#1)(1996-2#5)(1996-3#6)(1996-8#1)(1997-1#4)(1997-2#7)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#28)(2008-11#40)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#31)(2008-9#28)(2009-10#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#3)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#16)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
resourcing##2##1##(2008-11#1)(2013-8#1)
resp##2##1##(1995-5#1)(2008-11#1)
respect and##4##2##(1991-3#1)(2008-12#1)(2011-2#2)
respect for the##3##3##(1992-2#1)(1992-3#1)(1997-3#1)
respect for##9##2##(1992-2#1)(1992-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#2)(2008-10#1)(2011-2#1)
respect of##6##2##(1995-6#1)(2008-10#4)(2008-7#1)
respect to different##4##3##(2008-6#2)(2008-7#1)(2010-12#1)
respect to human##3##3##(2008-10#2)(2012-2#1)
respect to its##10##3##(1991-2#1)(1993-8#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
respect to morphology##2##3##(1995-9#1)(2008-5#1)
respect to practical applications##2##4##(2008-10#1)(2008-2#1)
respect to the conventional##2##4##(2008-10#1)(2013-1#1)
respect to the##92##3##(1990-11#2)(1990-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-6#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#30)(2008-11#4)(2008-2#4)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
respect to##305##2##(1990-11#2)(1990-12#3)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#5)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-12#5)(2008-1#1)(2008-10#105)(2008-11#19)(2008-12#4)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#7)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#5)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#7)(2013-8#4)
respect##343##1##(1990-11#2)(1990-12#3)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1992-10#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#5)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2006-6#1)(2007-12#5)(2008-1#1)(2008-10#112)(2008-11#22)(2008-12#5)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#7)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#5)(2011-2#10)(2011-7#1)(2012-12#6)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#8)(2013-8#4)
respected##5##1##(1996-6#1)(2008-10#1)(2008-9#1)(2011-3#1)(2012-3#1)
respectful manner##2##2##(1990-6#1)(1996-3#1)
respectful of##2##2##(2008-5#1)(2008-9#1)
respectful##4##1##(1990-6#1)(1996-3#1)(2008-5#1)(2008-9#1)
respective calibration##2##2##(2008-10#2)
respective control##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
respective enzymes##3##2##(1991-3#1)(2010-7#1)(2011-2#1)
respective hosts##2##2##(2008-10#2)
respective pathogens##3##2##(2008-10#3)
respective roles of##2##3##(1992-12#1)(2009-8#1)
respective state##2##2##(1995-12#1)(2012-3#1)
respective##109##1##(1990-12#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-11#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-1#2)(2008-10#43)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#1)(2010-12#4)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-4#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
respectively (P##2##2##(2012-3#2)
respectively (p &lt##3##3##(1995-3#1)(2013-1#2)
respectively (p = NS)##2##4##(1994-12#2)
respectively (p##6##2##(1994-1#1)(1994-12#2)(1995-3#1)(2013-1#2)
respectively about##2##2##(1991-5#1)(2008-10#1)
respectively and##11##2##(1993-12#1)(1996-2#1)(2008-10#2)(2008-12#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#2)
respectively as##5##2##(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#1)
respectively at the##2##3##(1996-6#1)(2008-10#1)
respectively at##5##2##(1996-6#1)(2008-10#3)(2008-12#1)
respectively by the##2##3##(2008-8#1)(2011-2#1)
respectively by##4##2##(1991-5#1)(2008-8#2)(2011-2#1)
respectively for##8##2##(1994-12#1)(1994-2#1)(1996-1#1)(1996-11#1)(2008-10#3)(2010-11#1)
respectively in the##7##3##(1991-3#1)(2008-10#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-3#1)
respectively in##15##2##(1991-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#3)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#2)
respectively of##3##2##(2008-1#1)(2008-10#2)
respectively on the##2##3##(1993-12#1)(2008-10#1)
respectively were studied##2##3##(2008-5#1)(2013-8#1)
respectively were##9##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
respectively when##3##2##(1994-12#1)(1996-12#1)(2011-3#1)
respectively while the##2##3##(2008-10#1)(2008-11#1)
respectively with##4##2##(1996-2#1)(2008-10#3)
respectively##2200##1##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#5)(1990-3#5)(1990-5#5)(1990-6#5)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#8)(1991-6#5)(1991-7#1)(1991-8#7)(1991-9#5)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#9)(1992-4#3)(1992-6#4)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#8)(1993-2#4)(1993-3#5)(1993-6#4)(1993-8#17)(1993-9#2)(1994-1#2)(1994-11#10)(1994-12#11)(1994-2#5)(1994-3#3)(1994-5#6)(1994-6#1)(1994-8#16)(1995-11#12)(1995-12#8)(1995-2#10)(1995-3#5)(1995-5#2)(1995-6#7)(1995-8#6)(1996-1#3)(1996-11#1)(1996-12#22)(1996-2#14)(1996-3#2)(1996-5#13)(1996-6#3)(1996-8#3)(1997-1#1)(1997-2#15)(1997-3#7)(1997-4#3)(1997-7#1)(1997-8#12)(2006-6#3)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#1263)(2008-11#98)(2008-12#45)(2008-2#3)(2008-3#19)(2008-4#4)(2008-5#20)(2008-6#3)(2008-7#22)(2008-8#50)(2008-9#46)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#2)(2010-11#3)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#12)(2010-5#5)(2010-6#5)(2010-7#5)(2010-8#4)(2011-1#11)(2011-10#1)(2011-2#45)(2011-3#9)(2012-12#2)(2012-2#22)(2012-3#27)(2012-8#1)(2013-1#41)(2013-7#1)(2013-8#29)
respectively) after##2##2##(2008-10#1)(2008-12#1)
respectively) and by##2##3##(1991-2#1)(2008-10#1)
respectively) and##18##2##(1991-2#2)(1995-11#1)(1995-2#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2012-3#1)(2012-5#1)
respectively) for##2##2##(2008-10#1)(2013-8#1)
respectively) in##4##2##(1990-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
respectively) of##2##2##(2008-11#1)(2008-2#1)
respectively) than##2##2##(2008-10#1)(2013-8#1)
respectively) was##4##2##(2008-10#2)(2008-3#1)(2013-3#1)
respectively) were obtained##2##3##(2008-10#1)(2008-9#1)
respectively) were##13##2##(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-2#1)
respectively)##211##1##(1990-12#2)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#4)(1996-12#1)(1996-2#3)(1996-6#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#2)(2008-10#69)(2008-11#10)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-10#2)(2011-2#22)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#8)(2013-3#1)(2013-8#7)
respectively]##3##1##(1996-6#1)(2008-5#1)(2008-7#1)
respects to##2##2##(1991-5#1)(1995-2#1)
respects##5##1##(1991-5#1)(1995-2#1)(1997-5#1)(2008-12#1)(2010-8#1)
respirable dust##2##2##(1991-12#2)
respirable##9##1##(1991-12#5)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)
respirable-sized protein##2##2##(1996-1#2)
respirable-sized##3##1##(1996-1#3)
respiration and##3##2##(2008-1#1)(2008-9#1)(2012-5#1)
respiration of##5##2##(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)
respiration rate##6##2##(2008-10#2)(2008-7#2)(2011-2#2)
respiration was##2##2##(2008-7#2)
respiration##44##1##(1990-2#2)(1990-5#3)(1993-12#1)(1997-1#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#9)(2008-9#4)(2009-5#1)(2009-8#1)(2011-2#3)(2012-5#1)
respiration)##2##1##(2008-10#1)(2009-8#1)
respirator##2##1##(1991-6#1)(1994-6#1)
respiratory activity##4##2##(1997-2#1)(2008-10#1)(2008-5#2)
respiratory allergies##2##2##(2012-3#1)(2013-1#1)
respiratory and contact##2##3##(2008-10#2)
respiratory and##10##2##(1994-3#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
respiratory burst##8##2##(1991-2#1)(1992-9#1)(1993-6#2)(1994-6#4)
respiratory chain enzyme activities##3##4##(1994-11#3)
respiratory chain##8##2##(1994-11#4)(1995-11#2)(1995-2#1)(1995-6#1)
respiratory complex##2##2##(1993-12#1)(2008-10#1)
respiratory complications##3##2##(2008-12#1)(2009-5#1)(2011-2#1)
respiratory depression##3##2##(1993-1#1)(1996-2#2)
respiratory difficulty with wheeze##2##4##(2012-3#2)
respiratory disease and associated##2##4##(2009-10#1)(2013-8#1)
respiratory disease##9##2##(1997-1#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
respiratory diseases##10##2##(1996-3#4)(2008-11#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
respiratory disorders##4##2##(1990-9#1)(2008-7#3)
respiratory distress and##2##3##(1990-3#1)(2010-1#1)
respiratory distress syndrome (ARDS)##3##4##(1993-2#1)(1997-1#1)(2012-3#1)
respiratory distress syndrome##10##3##(1990-11#1)(1993-2#1)(1994-6#1)(1997-1#2)(2010-12#1)(2012-12#1)(2012-3#3)
respiratory distress syndrome' (ARDS)##2##4##(2010-5#2)
respiratory distress syndrome]##2##3##(1990-11#1)(2012-3#1)
respiratory distress##21##2##(1990-11#2)(1990-3#1)(1992-2#1)(1993-2#1)(1994-6#1)(1997-1#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-7#1)(2012-12#2)(2012-3#4)
respiratory exchange ratio (RER)##2##4##(1992-12#1)(2013-8#1)
respiratory failure and##2##3##(2008-1#1)(2008-7#1)
respiratory failure with##2##3##(2013-1#2)
respiratory failure##20##2##(1991-6#1)(1992-3#1)(2008-1#3)(2008-7#1)(2009-5#2)(2009-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#7)
respiratory frequency##2##2##(1996-2#1)(1996-5#1)
respiratory function##4##2##(1991-12#2)(2011-2#1)(2012-2#1)
respiratory illness##4##2##(2008-10#1)(2012-12#2)(2013-8#1)
respiratory illnesses##2##2##(2008-11#1)(2012-12#1)
respiratory infection##3##2##(1991-9#1)(1993-5#1)(2012-2#1)
respiratory infections in##4##3##(2010-4#1)(2010-6#1)(2013-8#2)
respiratory infections##10##2##(1994-9#1)(1996-1#1)(1997-3#1)(1997-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-8#3)
respiratory insufficiency##3##2##(2010-12#1)(2010-7#2)
respiratory manifestations##3##2##(2007-8#1)(2008-5#2)
respiratory muscle##3##2##(1991-6#2)(2012-2#1)
respiratory muscles##3##2##(1991-6#1)(2012-2#1)(2012-3#1)
respiratory outcomes##7##2##(2010-6#7)
respiratory parameters##4##2##(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#1)
respiratory rate (RR)##2##3##(1992-12#1)(2012-2#1)
respiratory rate##8##2##(1990-2#1)(1992-12#1)(1995-11#1)(1996-3#1)(2007-8#2)(2012-2#1)(2012-3#1)
respiratory responses##2##2##(1996-5#2)
respiratory symptoms and##2##3##(2009-9#1)(2010-12#1)
respiratory symptoms##11##2##(1997-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-9#1)(2010-12#2)(2013-1#1)(2013-8#3)
respiratory syncytial virus (RSV)##3##4##(1996-3#1)(2008-11#1)(2011-2#1)
respiratory syncytial virus##7##3##(1994-6#3)(1995-5#1)(1996-3#1)(2008-11#1)(2011-2#1)
respiratory syndrome##3##2##(1992-2#1)(2008-10#1)(2010-2#1)
respiratory system##8##2##(1996-3#2)(2008-5#2)(2009-12#1)(2010-7#1)(2011-2#2)
respiratory tract and##2##3##(2008-11#1)(2008-5#1)
respiratory tract diseases##2##3##(1992-6#1)(2012-12#1)
respiratory tract infections in children##2##5##(2009-5#1)(2012-12#1)
respiratory tract infections in##3##4##(2008-11#1)(2009-5#1)(2012-12#1)
respiratory tract infections##4##3##(2008-11#1)(2009-5#1)(2011-2#1)(2012-12#1)
respiratory tract##38##2##(1992-3#1)(1992-6#1)(1992-9#1)(1994-12#3)(1995-12#1)(1995-3#1)(1996-1#3)(1996-3#3)(1997-1#2)(2008-10#4)(2008-11#4)(2008-5#2)(2009-5#2)(2011-2#5)(2012-12#2)(2013-1#1)(2013-8#2)
respiratory virus##2##2##(1995-5#1)(2013-8#1)
respiratory##302##1##(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-6#5)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#5)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#8)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#3)(1996-3#13)(1996-5#4)(1997-1#9)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-8#3)(2008-1#4)(2008-10#16)(2008-11#12)(2008-12#2)(2008-5#16)(2008-7#7)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#6)(2009-7#1)(2009-9#2)(2010-1#2)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#6)(2010-6#9)(2010-7#7)(2011-1#1)(2011-2#19)(2011-3#1)(2012-12#11)(2012-2#10)(2012-3#16)(2013-1#11)(2013-8#20)
respiring cells##2##2##(2008-7#2)
respiring##4##1##(2008-7#3)(2011-2#1)
respite care##2##2##(1990-3#1)(1992-3#1)
respite##6##1##(1990-3#1)(1992-3#4)(2009-6#1)
respond adequately##2##2##(1990-12#1)(1993-11#1)
respond appropriately##2##2##(2008-12#1)(2009-9#1)
respond better to##2##3##(2008-7#1)(2013-1#1)
respond in##2##2##(2008-10#1)(2013-8#1)
respond similarly to##2##3##(1994-5#1)(2008-10#1)
respond to a##3##3##(2008-7#2)(2008-9#1)
respond to environmental##3##3##(2008-8#1)(2012-3#1)(2013-8#1)
respond to medical##3##3##(1991-11#1)(1996-11#1)(1997-8#1)
respond to new therapies##2##4##(2008-6#2)
respond to the##12##3##(1991-1#1)(1991-12#1)(1991-2#1)(1994-3#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
respond to them##2##3##(1990-12#1)(1992-12#1)
respond to these##5##3##(1991-12#1)(1994-12#1)(2008-10#3)
respond to treatment##3##3##(1990-12#1)(1990-2#1)(2008-11#1)
respond to##102##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-9#1)(1994-12#4)(1994-3#2)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#3)(2008-10#9)(2008-11#9)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#3)(2009-3#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2012-5#1)(2013-8#3)
respond well to##2##3##(2010-5#1)(2012-3#1)
respond##136##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-9#1)(1993-11#2)(1994-12#4)(1994-3#2)(1994-5#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#3)(2008-10#15)(2008-11#17)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#10)(2008-9#4)(2009-3#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#1)(2013-8#4)
respondants' answers##2##2##(2012-2#2)
responded by##2##2##(2008-10#1)(2010-8#1)
responded more##2##2##(2008-5#1)(2008-8#1)
responded positively##2##2##(1990-2#1)(2013-1#1)
responded similarly to##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
responded that it was &quot##2##5##(1990-2#2)
responded that they##2##3##(1992-2#1)(2012-12#1)
responded that##4##2##(1990-2#2)(1992-2#1)(2012-12#1)
responded to a##2##3##(1990-2#1)(2008-9#1)
responded to activin A##2##4##(1992-6#2)
responded to conventional##2##3##(2008-12#1)(2013-7#1)
responded to predation##2##3##(2010-8#2)
responded to the survey##3##4##(1995-1#1)(2008-12#1)(2012-2#1)
responded to the treatment##2##4##(1991-2#1)(2011-2#1)
responded to the##16##3##(1990-2#1)(1991-2#1)(1992-12#1)(1993-6#1)(1995-1#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-9#1)
responded to##66##2##(1990-2#2)(1990-5#1)(1991-2#2)(1992-12#2)(1992-6#6)(1992-9#1)(1993-6#3)(1994-2#3)(1994-8#1)(1995-1#1)(1997-3#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2012-9#1)(2013-7#2)
responded well to##2##3##(1995-10#1)(2008-10#1)
responded with a##2##3##(1994-3#1)(2008-10#1)
responded with##3##2##(1994-3#1)(2008-10#2)
responded##107##1##(1990-2#5)(1990-5#1)(1991-2#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#6)(1992-9#1)(1993-6#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#9)(2008-9#3)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#1)(2013-7#2)
respondent##4##1##(2012-2#1)(2013-1#3)
respondents and##3##2##(1990-9#1)(2008-12#1)(2009-5#1)
respondents are##2##2##(2009-12#1)(2012-2#1)
respondents had##3##2##(2013-1#2)(2013-8#1)
respondents in the##2##3##(1990-6#1)(1991-12#1)
respondents in##3##2##(1990-6#1)(1991-12#1)(1997-2#1)
respondents reported##4##2##(1990-6#1)(2008-1#1)(2010-8#2)
respondents stated that##2##3##(1996-1#1)(2008-11#1)
respondents were aware of##2##4##(1996-1#1)(2009-10#1)
respondents were more likely to be##2##6##(2013-1#2)
respondents were##11##2##(1995-3#1)(1996-1#1)(1997-2#1)(2008-9#2)(2009-10#1)(2010-8#1)(2013-1#4)
respondents who would##2##3##(2008-1#2)
respondents who##4##2##(1995-1#1)(1997-3#1)(2008-1#2)
respondents##82##1##(1990-6#2)(1990-9#1)(1991-12#3)(1992-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1995-1#3)(1995-3#1)(1996-1#2)(1996-3#3)(1996-9#1)(1997-2#3)(1997-3#1)(2007-12#3)(2008-1#5)(2008-10#1)(2008-11#6)(2008-12#2)(2008-9#2)(2009-10#4)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-8#3)(2011-1#2)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#10)(2013-8#1)
respondents' knowledge##2##2##(2009-10#1)(2013-1#1)
respondents'##7##1##(1991-2#1)(2007-12#1)(2009-10#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-1#1)
responder analysis of##2##3##(2011-2#2)
responder##7##1##(1990-2#1)(2008-9#2)(2011-2#3)(2012-2#1)
responders and##5##2##(1994-2#1)(1994-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
responders to##2##2##(2009-6#1)(2012-2#1)
responders##19##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1994-2#1)(1994-8#1)(1997-8#2)(2008-1#2)(2008-10#1)(2008-7#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#2)
responders)##3##1##(1990-6#1)(1991-8#2)
responding and##4##2##(1992-12#1)(2007-11#1)(2008-10#2)
responding on##2##2##(1993-6#2)
responding to a##2##3##(1996-3#1)(2008-10#1)
responding to the##8##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)(2012-12#1)
responding to##21##2##(1992-6#2)(1994-2#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
responding with##4##2##(1993-6#2)(2012-2#2)
responding##55##1##(1992-12#1)(1992-2#1)(1992-6#2)(1993-6#13)(1994-2#2)(1996-2#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-5#9)(2008-6#2)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#3)(2012-3#2)
responds linearly##3##2##(2008-10#3)
responds to the##6##3##(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
responds to##21##2##(1990-8#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2009-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
responds##34##1##(1990-8#1)(1996-2#1)(1997-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#3)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
response (30##2##2##(2008-10#2)
response (CR)##2##2##(1997-7#1)(2008-10#1)
response (P =##2##3##(2011-2#1)(2012-3#1)
response (TDAR)##5##2##(2008-10#5)
response (i##2##2##(2008-10#2)
response above##2##2##(2008-10#1)(2008-8#1)
response against the##2##3##(2008-11#1)(2012-2#1)
response against##9##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#3)(2012-2#1)(2013-1#2)
response and a##4##3##(1992-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
response and recovery times##2##4##(2008-10#2)
response and recovery##4##3##(2008-10#4)
response and that##2##3##(2008-10#1)(2009-8#1)
response and the##7##3##(2008-10#3)(2008-11#1)(2011-2#1)(2012-3#1)(2012-4#1)
response and##68##2##(1990-5#1)(1991-6#1)(1992-10#1)(1992-9#2)(1993-1#1)(1993-9#2)(1994-3#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#5)(2012-4#1)(2013-1#6)
response appears to be##3##4##(1992-1#1)(1992-2#1)(1995-5#1)
response appears to##4##3##(1992-1#1)(1992-2#1)(1995-5#1)(2008-7#1)
response are discussed##2##3##(1997-7#1)(2008-10#1)
response are##8##2##(1991-2#1)(1992-2#1)(1997-7#1)(2008-10#3)(2008-4#1)(2012-3#1)
response as a##3##3##(1991-12#1)(2009-8#1)(2010-3#1)
response as compared to##2##4##(2008-10#1)(2009-10#1)
response as##6##2##(1991-12#1)(2008-10#2)(2009-10#1)(2009-8#1)(2010-3#1)
response assessment##2##2##(2008-1#1)(2012-2#1)
response associated with the##2##4##(2008-11#1)(2011-2#1)
response at different##2##3##(1992-12#1)(1992-3#1)
response at pH 5##3##4##(2008-10#2)(2009-10#1)
response at pH##4##3##(2008-10#3)(2009-10#1)
response at the##4##3##(1991-8#1)(2008-10#3)
response at##20##2##(1991-8#1)(1992-12#1)(1992-3#1)(1994-1#1)(1995-11#1)(1996-12#1)(2008-10#12)(2009-10#1)(2013-1#1)
response based on the##2##4##(2008-10#2)
response because##2##2##(2008-10#2)
response being##2##2##(2008-10#2)
response between the##2##3##(1990-6#1)(2008-5#1)
response between##4##2##(1990-6#1)(2008-10#1)(2008-5#1)(2010-10#1)
response bias##2##2##(2008-11#2)
response by##18##2##(1991-3#1)(1997-8#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#2)
response can be##4##3##(1994-5#1)(1997-7#1)(2008-10#1)(2008-11#1)
response can##6##2##(1994-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2011-2#1)
response categories##5##2##(2010-1#2)(2012-2#3)
response caused by##2##3##(1990-5#1)(1996-2#1)
response characteristics and##2##3##(2008-10#2)
response characteristics of the##3##4##(2008-10#3)
response characteristics of##11##3##(2008-10#11)
response characteristics##21##2##(2008-10#21)
response compared to the##2##4##(2008-10#2)
response compared to##4##3##(2008-10#3)(2008-7#1)
response correctness##5##2##(2008-11#5)
response correlates with##2##3##(2008-10#1)(2012-3#1)
response current##3##2##(2008-10#3)
response curve is##2##3##(1995-9#1)(2008-10#1)
response curve##9##2##(1994-11#1)(1995-9#2)(1997-2#1)(2008-10#5)
response curves for##2##3##(2008-7#1)(2012-2#1)
response curves##6##2##(2008-10#2)(2008-11#1)(2008-7#2)(2012-2#1)
response data##6##2##(1990-8#1)(2008-10#4)(2008-5#1)
response depended on##2##3##(1995-12#1)(2008-7#1)
response depends linearly on##5##4##(2008-10#5)
response depends##7##2##(1997-2#1)(2008-10#6)
response differed##3##2##(1990-12#1)(1992-12#1)(2008-8#1)
response during##9##2##(1990-5#4)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
response element##13##2##(1991-7#1)(1992-6#3)(1993-3#1)(1993-8#1)(1997-2#2)(2008-9#1)(2011-3#1)(2012-12#2)(2012-3#1)
response element-binding protein (CREB)##2##4##(2008-7#1)(2009-3#1)
response element-binding##3##2##(2008-7#1)(2009-3#1)(2012-3#1)
response elements##8##2##(1994-11#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-3#1)(2008-9#1)(2012-3#1)
response evaluation and prediction in##2##5##(2010-12#2)
response failure##2##2##(2008-7#1)(2011-2#1)
response following##3##2##(2008-10#1)(2008-12#1)(2010-6#1)
response for Cu(2+)##2##3##(2008-10#2)
response for H(2)O(2) in the##2##5##(2008-10#2)
response for UO(2)(2+)##2##3##(2008-10#2)
response for both##4##3##(2008-10#4)
response for each##2##3##(2008-10#2)
response for the##5##3##(1990-2#1)(1990-8#1)(2008-10#2)(2008-11#1)
response for##55##2##(1990-2#1)(1990-8#1)(1991-12#1)(1996-3#1)(2008-10#49)(2008-11#1)(2009-5#1)
response from the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
response from##7##2##(2008-10#5)(2008-11#1)(2008-3#1)
response function##7##2##(2008-10#7)
response functions##3##2##(2007-12#2)(2008-3#1)
response gene##2##2##(1992-7#1)(1997-7#1)
response genes##6##2##(1992-7#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)
response group##2##2##(2013-1#2)
response had##2##2##(1995-12#1)(2008-12#1)
response has been##3##3##(1994-5#1)(1997-3#1)(2008-2#1)
response has##4##2##(1994-5#1)(1997-3#1)(2008-10#1)(2008-2#1)
response have been##2##3##(2008-10#2)
response in a##2##3##(1993-6#1)(1994-6#1)
response in old rats##2##4##(2008-7#2)
response in patients with##2##4##(2008-10#1)(2010-1#1)
response in patients##3##3##(2008-10#1)(2008-5#1)(2010-1#1)
response in terms of##2##4##(2008-10#2)
response in the concentration range of##3##6##(2008-10#3)
response in the concentration range##5##5##(2008-10#5)
response in the range##2##4##(2008-10#2)
response in the##27##3##(1992-3#1)(1993-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(2008-10#13)(2008-11#1)(2008-7#3)(2010-12#1)(2012-3#1)(2013-8#1)
response in##91##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-6#2)(1994-2#3)(1994-6#2)(1994-8#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#29)(2008-11#9)(2008-12#1)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#2)(2010-1#1)(2010-12#1)(2010-5#2)(2011-2#7)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
response increase##2##2##(2008-10#1)(2008-7#1)
response induced by immunising##2##4##(1995-12#2)
response induced by##5##3##(1995-12#2)(1996-2#1)(1997-4#1)(2012-2#1)
response induced##6##2##(1995-12#3)(1996-2#1)(1997-4#1)(2012-2#1)
response inhibition##2##2##(1992-12#2)
response initiated##2##2##(2008-10#1)(2008-8#1)
response involving##2##2##(2008-7#1)(2012-3#1)
response is evaluated##2##3##(2008-10#2)
response is explained##2##3##(2008-10#2)
response is independent of pH##2##5##(2008-10#2)
response is independent of##3##4##(2008-10#3)
response is linear up to##2##5##(2008-10#2)
response is linear##6##3##(2008-10#5)(2008-3#1)
response is not sensitive to##2##5##(1992-8#1)(2008-10#1)
response is not sensitive##3##4##(1992-8#1)(2008-10#2)
response is not##7##3##(1991-5#1)(1992-8#1)(2008-10#4)(2010-11#1)
response is stable##2##3##(2008-10#2)
response is the##2##3##(2008-7#2)
response is##65##2##(1990-9#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-8#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#40)(2008-3#2)(2008-7#2)(2008-8#2)(2009-12#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#3)
response linearity##3##2##(2008-10#3)
response may be##5##3##(1990-12#1)(1993-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
response mechanism of##2##3##(2008-10#2)
response mechanism##6##2##(2008-10#6)
response mechanisms##3##2##(2008-10#1)(2008-7#2)
response might##2##2##(2008-7#1)(2008-8#1)
response model for##2##3##(2008-10#2)
response model##7##2##(2008-10#6)(2008-7#1)
response observed after##2##3##(1994-2#2)
response obtained##2##2##(2008-10#2)
response of 30##2##3##(2008-10#1)(2008-3#1)
response of B##2##3##(2011-2#2)
response of M##3##3##(2008-10#2)(2008-7#1)
response of a##7##3##(1996-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-5#1)
response of all##3##3##(2008-10#2)(2008-9#1)
response of allopurinol was##2##4##(2008-10#2)
response of an##2##3##(2008-10#1)(2008-3#1)
response of ascorbic acid##2##4##(2008-10#2)
response of each##2##3##(2008-10#2)
response of human##5##3##(1992-10#1)(1992-2#1)(1994-8#1)(1995-12#2)
response of lead(II)##3##3##(2008-10#3)
response of lymphocytes##2##3##(1995-8#1)(2008-10#1)
response of norepinephrine##2##3##(2008-10#2)
response of plants to herbivore removal##2##6##(2008-8#2)
response of plants to##4##4##(2008-10#1)(2008-8#2)(2009-8#1)
response of populations##2##3##(2008-9#2)
response of splenic CD4 T cells##2##6##(2008-11#2)
response of the electrode##4##4##(2008-10#4)
response of the laser##3##4##(2008-3#3)
response of the method##2##4##(2008-10#2)
response of the sensor to##4##5##(2008-10#4)
response of the sensor##8##4##(2008-10#8)
response of the##69##3##(1992-12#1)(1992-8#1)(1993-8#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#44)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#2)(2013-1#3)(2013-8#1)
response of these##4##3##(2008-10#2)(2008-11#1)(2012-7#1)
response of vascular##2##3##(1990-8#1)(1994-8#1)
response of##236##2##(1990-2#1)(1990-8#1)(1991-12#2)(1991-3#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#2)(1994-8#4)(1995-12#2)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#3)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#121)(2008-11#11)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#6)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#3)(2012-7#1)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#2)
response on##5##2##(1993-6#1)(1995-9#1)(2008-10#2)(2008-7#1)
response or##3##2##(1991-5#1)(1993-11#1)(2012-3#1)
response over a wide concentration range##3##6##(2008-10#3)
response over a wide##4##4##(2008-10#4)
response over a##6##3##(2008-10#5)(2010-3#1)
response over the concentration range##3##5##(2008-10#3)
response over the concentration##4##4##(2008-10#4)
response over the range##2##4##(2008-10#2)
response over the##8##3##(2008-10#8)
response over##16##2##(2008-10#15)(2010-3#1)
response pathway##4##2##(1996-2#1)(2009-8#2)(2012-2#1)
response pattern##4##2##(1990-10#1)(2008-11#1)(2009-8#2)
response patterns for##3##3##(2008-10#3)
response patterns##6##2##(2008-10#3)(2008-11#2)(2013-8#1)
response properties of the##3##4##(2008-10#2)(2008-8#1)
response properties of##7##3##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#1)
response properties##11##2##(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2013-8#1)
response protein##4##2##(1997-7#2)(2008-10#1)(2011-2#1)
response range and##2##3##(2008-10#2)
response range of the sensor##2##5##(2008-10#2)
response range of##7##3##(2008-10#7)
response range##20##2##(2008-10#20)
response ranges##2##2##(2008-10#1)(2010-7#1)
response rate of##7##3##(1992-2#2)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
response rate was##7##3##(1990-9#1)(1991-6#1)(1993-1#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
response rate##32##2##(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#2)(1993-1#2)(1993-6#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-7#1)(2009-8#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
response rate)##3##2##(1996-3#1)(2011-1#1)(2013-1#1)
response rates were##2##3##(1991-8#1)(1993-6#1)
response rates##8##2##(1990-2#1)(1991-8#1)(1993-6#3)(1997-5#1)(2011-2#1)(2012-2#1)
response region##2##2##(2008-10#2)
response regulator##2##2##(2008-10#1)(2009-6#1)
response relationships##2##2##(2008-10#1)(2008-7#1)
response rules##2##2##(2012-2#2)
response similar to##2##3##(1992-10#1)(2008-10#1)
response slope of##2##3##(2008-10#2)
response slope##5##2##(2008-10#5)
response stability##2##2##(2008-10#2)
response style##3##2##(2010-1#3)
response surface##12##2##(2008-10#11)(2012-3#1)
response surfaces##3##2##(2008-10#3)
response telemetry##3##2##(2008-9#3)
response test##2##2##(2008-10#1)(2008-8#1)
response than##6##2##(1990-12#1)(1990-5#1)(2008-10#2)(2009-8#1)(2012-3#1)
response that is##3##3##(1995-5#1)(2007-11#1)(2009-5#1)
response that##13##2##(1993-8#1)(1994-5#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-3#1)
response time &lt##2##3##(2008-10#2)
response time (&lt##4##3##(2008-10#4)
response time (within##3##3##(2008-10#3)
response time and##8##3##(2008-10#8)
response time are##2##3##(2007-11#1)(2008-10#1)
response time for##3##3##(2008-10#2)(2013-8#1)
response time is##2##3##(2008-10#2)
response time of &lt##7##4##(2008-10#7)
response time of about##6##4##(2008-10#6)
response time of less than##2##5##(2008-10#2)
response time of sensor is##2##5##(2008-10#2)
response time of the electrode is##4##6##(2008-10#4)
response time of the electrode was##3##6##(2008-10#3)
response time of the electrode##7##5##(2008-10#7)
response time of the sensor is##3##6##(2008-10#3)
response time of the sensor##4##5##(2008-10#4)
response time of the##12##4##(2008-10#12)
response time of##47##3##(2008-10#47)
response time to##2##3##(2008-10#1)(2010-2#1)
response time was##2##3##(2008-10#2)
response time##111##2##(1996-12#1)(2007-11#1)(2008-10#105)(2008-6#1)(2010-2#1)(2012-3#1)(2013-8#1)
response times and##2##3##(1994-3#1)(2011-1#1)
response times##11##2##(1994-3#2)(2008-10#4)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)
response to AIDS##2##3##(1990-3#1)(1993-3#1)
response to ATP binding##2##4##(1995-2#2)
response to Cu(II) over##2##4##(2008-10#2)
response to Cu(II)##3##3##(2008-10#3)
response to E2##3##3##(1990-11#3)
response to L-Glu##2##3##(1997-2#2)
response to M##2##3##(2008-10#2)
response to PTH##2##3##(1990-11#2)
response to UV##2##3##(2008-3#1)(2008-5#1)
response to a fire##2##4##(1993-12#1)(1994-12#1)
response to a particular##2##4##(2008-12#1)(2009-7#1)
response to a plasma cholesterol-lowering diet##2##6##(2012-2#2)
response to a variety of##3##5##(2008-11#2)(2008-4#1)
response to a##45##3##(1990-2#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-10#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
response to acute##4##3##(1993-2#1)(1995-6#1)(1996-2#1)(2010-10#1)
response to all##4##3##(1995-5#1)(2008-10#2)(2008-5#1)
response to an##7##3##(2008-10#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)
response to antibiotics##2##3##(2012-3#2)
response to cAMP##2##3##(1996-12#1)(1996-2#1)
response to cage transfer##3##4##(2008-11#3)
response to cancer##2##3##(1997-1#1)(2011-2#1)
response to cellular##2##3##(1996-2#1)(2010-7#1)
response to changes in##3##4##(2008-10#2)(2009-8#1)
response to changing##3##3##(1992-2#1)(2008-7#1)(2009-6#1)
response to chemotherapy##3##3##(1997-7#1)(2012-3#1)(2013-1#1)
response to chronic##2##3##(2008-10#1)(2010-4#1)
response to clenbuterol##2##3##(2010-6#2)
response to contact sensitizers##2##4##(2008-10#2)
response to dietary##2##3##(1991-2#1)(2012-2#1)
response to different##7##3##(1994-12#1)(1996-12#1)(2008-10#3)(2010-10#1)(2012-2#1)
response to disturbance##2##3##(2008-8#2)
response to drought##3##3##(2012-5#1)(2012-8#2)
response to drugs##2##3##(1993-11#1)(2013-8#1)
response to electrical stimulation##2##4##(1990-5#1)(2008-7#1)
response to exogenous##4##3##(1994-3#1)(1997-1#1)(2008-10#1)(2008-7#1)
response to glucocorticoids##2##3##(1990-11#1)(2008-11#1)
response to glucose##5##3##(1995-8#2)(1996-3#1)(2008-10#1)(2010-11#1)
response to growth factors##4##4##(1990-12#1)(1991-5#1)(1992-10#1)(1994-5#1)
response to hypertension##2##3##(2009-7#2)
response to hypoxia##2##3##(1994-5#1)(2010-11#1)
response to infection was##2##4##(2008-10#2)
response to infection##9##3##(1993-12#1)(2008-10#8)
response to initial##2##3##(1996-1#1)(2010-11#1)
response to injury##6##3##(1990-7#2)(2008-1#3)(2008-4#1)
response to innocuous##2##3##(1996-12#2)
response to integrated treatment##2##4##(2012-3#2)
response to interventions##2##3##(2008-1#1)(2008-6#1)
response to low##5##3##(2008-7#4)(2009-8#1)
response to management##2##3##(2008-10#1)(2008-7#1)
response to mechanical##2##3##(1997-3#1)(2008-9#1)
response to mirtazapine in##2##4##(2008-6#2)
response to neoadjuvant chemotherapy##2##4##(1993-11#1)(2010-12#1)
response to neoadjuvant##3##3##(1993-11#1)(2010-12#1)(2010-7#1)
response to other##2##3##(1994-11#1)(1995-5#1)
response to oxygen##2##3##(1990-8#1)(2008-10#1)
response to pH##5##3##(1993-12#1)(2008-10#3)(2008-5#1)
response to parasitism##2##3##(2008-8#2)
response to reduced##2##3##(1990-2#1)(2008-7#1)
response to salicylate##2##3##(2008-10#2)
response to selection for##2##4##(2008-8#1)(2008-9#1)
response to selection in##2##4##(2008-8#2)
response to selection##10##3##(2008-8#9)(2008-9#1)
response to shear stress##2##4##(2008-11#1)(2010-1#1)
response to sheep red blood cells##4##6##(1993-12#1)(2008-10#3)
response to sheep##5##3##(1993-12#1)(2008-10#4)
response to standing and to hyperventilation##2##6##(2008-7#2)
response to standing##3##3##(2008-7#3)
response to stimuli##2##3##(1995-8#1)(2010-1#1)
response to stress##4##3##(1997-4#1)(2008-11#1)(2008-7#1)(2012-2#1)
response to such##2##3##(2008-11#1)(2010-8#1)
response to surgical stimulation##2##4##(2011-2#2)
response to surgical##4##3##(2008-12#1)(2011-2#3)
response to the current##2##4##(1996-1#1)(2008-12#1)
response to the fungicides##2##4##(2008-10#2)
response to the pathogen##2##4##(2008-10#2)
response to the presence of##2##5##(1994-1#1)(2008-8#1)
response to the##59##3##(1990-12#1)(1991-2#1)(1991-8#2)(1993-12#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2012-9#1)(2013-7#1)(2013-8#2)
response to therapies##2##3##(2012-3#1)(2013-1#1)
response to therapy##6##3##(1991-2#1)(1997-2#1)(2008-11#1)(2008-7#1)(2009-12#1)(2013-8#1)
response to these##3##3##(1992-4#1)(2008-10#2)
response to this challenge##2##4##(1993-12#1)(1994-12#1)
response to this##5##3##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
response to treatment and##2##4##(2012-2#1)(2013-8#1)
response to treatment are##2##4##(1996-8#1)(2013-8#1)
response to treatment of##3##4##(2008-10#1)(2011-7#1)(2013-8#1)
response to treatment was##2##4##(1996-6#1)(2008-6#1)
response to treatment##12##3##(1996-6#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-7#1)(2012-2#1)(2013-8#4)
response to uric acid##2##4##(2008-10#2)
response to water##3##3##(2008-10#1)(2009-8#2)
response to wounding and##2##4##(2008-10#1)(2009-8#1)
response to##691##2##(1990-10#2)(1990-11#8)(1990-12#7)(1990-2#3)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-2#5)(1991-3#1)(1991-5#3)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#4)(1992-8#7)(1992-9#3)(1993-11#3)(1993-12#12)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#11)(1993-8#2)(1994-1#2)(1994-11#6)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#4)(1994-8#6)(1994-9#1)(1995-11#4)(1995-12#3)(1995-2#6)(1995-5#5)(1995-6#4)(1995-8#11)(1996-1#2)(1996-12#12)(1996-2#11)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#11)(1997-2#9)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#9)(2008-10#150)(2008-11#38)(2008-12#12)(2008-3#1)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#29)(2008-8#30)(2008-9#19)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#2)(2009-5#1)(2009-6#6)(2009-7#4)(2009-8#12)(2009-9#2)(2010-1#6)(2010-10#4)(2010-11#4)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#19)(2011-7#1)(2012-2#12)(2012-3#14)(2012-4#1)(2012-5#1)(2012-7#1)(2012-8#2)(2012-9#2)(2013-1#13)(2013-7#2)(2013-8#17)
response toward fluoride##2##3##(2008-10#2)
response toward##8##2##(2008-10#7)(2010-11#1)
response towards##6##2##(2008-10#6)
response under##4##2##(2008-10#3)(2011-2#1)
response upon##2##2##(1995-5#1)(2012-3#1)
response variable##3##2##(2008-10#2)(2008-7#1)
response variables##5##2##(1995-12#2)(2008-10#2)(2008-7#1)
response was achieved in##2##4##(1991-6#1)(2008-10#1)
response was achieved##4##3##(1991-6#1)(2008-10#2)(2012-12#1)
response was also##2##3##(1995-12#1)(2008-10#1)
response was due##2##3##(2008-10#1)(2010-8#1)
response was evaluated##3##3##(2008-10#2)(2008-5#1)
response was linear##7##3##(1997-2#1)(2008-10#6)
response was not affected##2##4##(1990-5#1)(1994-12#1)
response was not significantly##2##4##(1997-8#1)(2008-10#1)
response was not##6##3##(1990-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1997-8#1)(2008-10#1)
response was observed in##6##4##(1990-2#1)(1990-6#1)(1991-2#1)(1995-12#1)(2008-10#1)(2008-9#1)
response was observed##9##3##(1990-2#1)(1990-6#1)(1991-2#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-9#1)
response was obtained in##4##4##(1992-12#1)(2008-10#2)(2008-5#1)
response was obtained##11##3##(1992-12#2)(2008-10#8)(2008-5#1)
response was seen##2##3##(1991-12#1)(2008-10#1)
response was significantly##2##3##(1997-3#1)(2008-11#1)
response was studied##3##3##(1997-2#1)(2008-10#2)
response was##93##2##(1990-2#2)(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#2)(1992-2#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-12#2)(1995-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#2)(2008-10#48)(2008-11#4)(2008-12#2)(2008-5#2)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
response were also##2##3##(2008-10#1)(2010-11#1)
response were##8##2##(1991-6#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-6#1)(2010-11#1)
response when a##2##3##(1990-5#1)(2008-9#1)
response when##5##2##(1990-5#1)(2008-10#2)(2008-12#1)(2008-9#1)
response which##3##2##(2008-11#1)(2008-9#2)
response while##4##2##(1990-5#1)(2008-10#2)(2010-12#1)
response with a slope of##2##5##(2008-10#2)
response with a##6##3##(1990-12#1)(2008-10#4)(2009-4#1)
response with##17##2##(1990-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-5#1)(2008-10#9)(2008-7#1)(2009-4#1)(2010-1#1)
response##2446##1##(1990-10#3)(1990-11#8)(1990-12#15)(1990-2#13)(1990-3#1)(1990-5#18)(1990-6#6)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#3)(1991-12#9)(1991-2#10)(1991-3#8)(1991-5#7)(1991-6#8)(1991-7#1)(1991-8#8)(1991-9#1)(1992-1#3)(1992-10#7)(1992-12#16)(1992-2#11)(1992-3#8)(1992-4#2)(1992-5#1)(1992-6#9)(1992-7#2)(1992-8#10)(1992-9#8)(1993-1#3)(1993-11#4)(1993-12#21)(1993-2#2)(1993-3#6)(1993-5#1)(1993-6#22)(1993-8#9)(1993-9#2)(1994-1#3)(1994-11#8)(1994-12#5)(1994-2#15)(1994-3#9)(1994-5#11)(1994-6#4)(1994-8#16)(1994-9#1)(1995-11#5)(1995-12#18)(1995-2#7)(1995-5#15)(1995-6#6)(1995-8#20)(1995-9#3)(1996-1#2)(1996-12#21)(1996-2#25)(1996-3#8)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#15)(1997-2#19)(1997-3#12)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#8)(1997-8#9)(2006-6#3)(2007-11#5)(2007-12#6)(2008-1#14)(2008-10#969)(2008-11#111)(2008-12#27)(2008-2#7)(2008-3#17)(2008-4#14)(2008-5#31)(2008-6#11)(2008-7#89)(2008-8#69)(2008-9#57)(2009-1#1)(2009-10#8)(2009-11#5)(2009-12#8)(2009-3#4)(2009-4#2)(2009-5#6)(2009-6#8)(2009-7#4)(2009-8#37)(2009-9#2)(2010-1#20)(2010-10#7)(2010-11#10)(2010-12#14)(2010-2#1)(2010-3#5)(2010-4#8)(2010-5#9)(2010-6#4)(2010-7#6)(2010-8#8)(2011-1#8)(2011-10#1)(2011-2#70)(2011-3#1)(2011-7#1)(2012-12#6)(2012-2#46)(2012-3#58)(2012-4#2)(2012-5#1)(2012-6#2)(2012-7#2)(2012-8#2)(2012-9#3)(2013-1#52)(2013-7#4)(2013-8#29)
response) was##2##2##(2008-10#2)
response)##12##1##(1990-12#1)(1994-12#2)(1995-11#1)(1997-2#1)(2008-10#4)(2008-3#1)(2009-11#1)(2010-8#1)
response)/(untreated control response)##2##3##(2008-10#2)
responses after##7##2##(1995-5#1)(1997-2#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-2#1)
responses against a##2##3##(2008-11#1)(2009-6#1)
responses against bacterial##3##3##(1992-5#1)(2008-10#1)(2012-12#1)
responses against##11##2##(1992-5#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)
responses and the##2##3##(2008-9#2)
responses and##33##2##(1992-3#1)(1995-2#2)(1995-5#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#4)(2009-12#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
responses are##20##2##(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#3)(2010-12#1)(2011-2#1)(2013-8#2)
responses as a function of##3##5##(2008-11#1)(2008-5#1)(2008-6#1)
responses as a##4##3##(1994-5#1)(2008-11#1)(2008-5#1)(2008-6#1)
responses as compared to##2##4##(1995-5#1)(2013-1#1)
responses as##7##2##(1994-11#1)(1994-5#1)(1995-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
responses associated with##3##3##(2008-10#1)(2009-10#1)(2011-1#1)
responses at the##2##3##(2009-8#1)(2013-8#1)
responses at##4##2##(2008-10#1)(2008-12#1)(2009-8#1)(2013-8#1)
responses before and after##2##4##(1993-6#1)(1996-5#1)
responses but##4##2##(1994-8#1)(1996-5#1)(2008-11#1)(2008-9#1)
responses by##7##2##(1990-5#1)(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
responses compared to##2##3##(1994-3#1)(2008-11#1)
responses could be##3##3##(2008-10#2)(2008-5#1)
responses during##7##2##(1993-3#1)(1995-2#1)(2012-12#1)(2013-8#4)
responses evoked##2##2##(1992-3#1)(1996-5#1)
responses following##2##2##(1995-5#2)
responses for each##3##3##(2010-11#2)(2013-1#1)
responses for##12##2##(2008-10#8)(2010-11#2)(2012-2#1)(2013-1#1)
responses from##5##2##(1993-11#1)(1994-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
responses have##3##2##(2008-11#1)(2008-7#1)(2009-8#1)
responses in Arabidopsis##4##3##(1997-8#2)(2009-8#2)
responses in a##2##3##(1993-12#1)(1996-2#1)
responses in mice##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
responses in muscles##2##3##(1995-8#2)
responses in primary##2##3##(2008-11#1)(2008-9#1)
responses in the rat##2##4##(1996-5#1)(2008-10#1)
responses in the##19##3##(1993-6#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-8#2)(2008-9#1)(2013-8#2)
responses in##82##2##(1990-11#1)(1990-12#1)(1991-12#2)(1992-3#1)(1993-12#1)(1993-6#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#3)(1996-5#1)(1997-8#2)(2007-11#1)(2008-10#27)(2008-11#7)(2008-12#2)(2008-5#1)(2008-8#3)(2008-9#7)(2009-8#3)(2010-8#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#4)
responses included##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
responses induced by##2##3##(1991-6#1)(2009-5#1)
responses leading to##2##3##(2008-10#1)(2008-9#1)
responses may be##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
responses may##5##2##(1994-6#1)(2008-10#1)(2008-12#1)(2012-5#1)(2013-8#1)
responses mediated by##2##3##(1995-11#1)(2012-12#1)
responses observed in##2##3##(2008-10#1)(2009-7#1)
responses of 1x10(-5) to##2##4##(2008-10#2)
responses of European##2##3##(2008-9#1)(2012-7#1)
responses of Xenopus oocytes##2##4##(1990-7#2)
responses of cells##2##3##(1996-12#1)(2008-11#1)
responses of male##2##3##(2012-3#1)(2013-1#1)
responses of patients##2##3##(1992-3#2)
responses of plant##4##3##(1997-8#1)(2008-8#1)(2012-2#1)(2012-6#1)
responses of plants to##3##4##(2008-10#1)(2008-8#1)(2012-5#1)
responses of the##20##3##(1990-5#2)(1990-9#1)(1997-2#3)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)
responses of these##2##3##(2008-10#1)(2008-11#1)
responses of##116##2##(1990-11#2)(1990-5#2)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#3)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#4)(1997-8#1)(2008-10#24)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#11)(2008-9#5)(2009-10#3)(2009-7#1)(2009-8#6)(2010-4#2)(2010-5#2)(2010-8#1)(2012-2#1)(2012-3#2)(2012-5#4)(2012-6#3)(2012-7#2)(2012-9#1)(2013-1#5)
responses on##5##2##(1993-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
responses or##3##2##(1994-8#1)(2008-11#1)(2008-7#1)
responses over the##2##3##(2008-10#1)(2010-10#1)
responses over##3##2##(2008-10#2)(2010-10#1)
responses than##6##2##(2007-12#1)(2008-10#2)(2008-9#3)
responses that are##2##3##(2008-10#1)(2009-10#1)
responses that were##2##3##(2008-10#1)(2008-6#1)
responses that##13##2##(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-3#1)
responses to &quot##2##3##(1994-1#1)(2010-4#1)
responses to VIP##2##3##(1995-11#2)
responses to a thermogenic nutritional supplement at rest##2##8##(2013-8#2)
responses to a##7##3##(1994-12#1)(1995-5#1)(2008-10#1)(2008-8#1)(2010-8#1)(2013-8#2)
responses to an##3##3##(1991-6#1)(2008-10#1)(2012-3#1)
responses to certain##2##3##(1990-5#1)(2008-10#1)
responses to exercise##2##3##(2009-1#1)(2013-8#1)
responses to infection##2##3##(2008-10#2)
responses to low##2##3##(2008-7#2)
responses to nicotine and##2##4##(1990-7#1)(2011-2#1)
responses to noise##2##3##(2008-11#1)(2008-9#1)
responses to oral##2##3##(1993-1#1)(1994-12#1)
responses to selection##2##3##(2008-8#1)(2012-3#1)
responses to sheep red blood cells##2##6##(2008-10#2)
responses to tetanus toxoid##2##4##(2011-2#2)
responses to the##15##3##(1990-12#1)(1993-6#1)(1995-5#2)(1996-2#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
responses to treatment##3##3##(2008-6#1)(2011-2#1)(2013-8#1)
responses to vaccines##2##3##(2007-11#1)(2013-1#1)
responses to##197##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#6)(1992-3#2)(1993-1#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#2)(1994-2#4)(1994-6#1)(1994-8#1)(1995-11#3)(1995-2#2)(1995-5#7)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-10#31)(2008-11#10)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#16)(2008-9#8)(2009-1#1)(2009-4#1)(2009-8#10)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#4)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#5)(2012-3#7)(2012-5#1)(2013-1#4)(2013-8#7)
responses towards##2##2##(1995-5#1)(2008-10#1)
responses was##5##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
responses were compared##2##3##(2008-11#1)(2013-1#1)
responses were internally coherent##2##4##(2013-8#2)
responses were linear##2##3##(2008-10#2)
responses were located##2##3##(2008-12#2)
responses were not##2##3##(1990-5#1)(2008-10#1)
responses were observed in##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
responses were observed##8##3##(1990-12#1)(2008-10#5)(2011-1#1)(2013-8#1)
responses were obtained##2##3##(1991-6#1)(2008-10#1)
responses were recorded##2##3##(1992-12#1)(1994-8#1)
responses were##50##2##(1990-12#3)(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#1)(1994-8#1)(1995-8#1)(1996-2#3)(1997-2#2)(2008-10#17)(2008-11#4)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
responses when##2##2##(2009-8#1)(2013-8#1)
responses with##4##2##(2008-10#3)(2010-12#1)
responses##879##1##(1990-11#4)(1990-12#5)(1990-5#6)(1990-7#5)(1990-9#2)(1991-1#1)(1991-12#6)(1991-2#6)(1991-3#1)(1991-6#5)(1991-7#1)(1992-1#1)(1992-12#11)(1992-2#1)(1992-3#8)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#8)(1994-1#3)(1994-11#2)(1994-12#4)(1994-2#9)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#4)(1995-11#8)(1995-12#4)(1995-2#6)(1995-5#26)(1995-6#1)(1995-8#6)(1995-9#1)(1996-12#4)(1996-2#14)(1996-3#2)(1996-5#8)(1997-1#2)(1997-2#10)(1997-3#2)(1997-4#3)(1997-7#2)(1997-8#5)(2006-6#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#212)(2008-11#62)(2008-12#19)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#14)(2008-6#5)(2008-7#14)(2008-8#49)(2008-9#54)(2009-1#1)(2009-10#10)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#30)(2009-9#1)(2010-1#4)(2010-10#5)(2010-11#4)(2010-12#4)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#21)(2012-12#6)(2012-2#12)(2012-3#13)(2012-5#9)(2012-6#5)(2012-7#2)(2012-9#1)(2013-1#17)(2013-7#2)(2013-8#28)
responses)##2##1##(2008-9#2)
responsibilities for##3##2##(1991-2#1)(1995-12#2)
responsibilities to##2##2##(1992-1#1)(1996-1#1)
responsibilities##29##1##(1990-12#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(1997-2#2)(1997-4#1)(2007-12#1)(2008-11#3)(2009-4#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
responsibility and##2##2##(1994-2#1)(2008-11#1)
responsibility for the management of##2##5##(1992-12#1)(1992-3#1)
responsibility for the##8##3##(1990-3#1)(1991-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1996-3#1)(2008-11#1)
responsibility for##25##2##(1990-3#1)(1991-1#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-11#3)(2008-12#2)(2010-7#1)
responsibility in##5##2##(1993-12#1)(1997-2#1)(2008-10#1)(2009-4#1)(2010-5#1)
responsibility of the##6##3##(1991-3#2)(1995-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
responsibility of##12##2##(1991-3#2)(1993-1#1)(1994-3#1)(1995-9#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#1)(2012-12#1)
responsibility to##4##2##(1993-3#1)(1996-1#1)(2011-2#1)(2012-3#1)
responsibility##62##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-3#2)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#10)(2008-12#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
responsible for a variety of##2##5##(2011-2#1)(2012-2#1)
responsible for a##14##3##(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-9#1)(2009-12#1)(2011-2#3)(2012-2#1)
responsible for both the##2##4##(2008-7#1)(2010-5#1)
responsible for cell##2##3##(2008-11#2)
responsible for different##2##3##(2008-10#1)(2012-2#1)
responsible for disease suppression##2##4##(2008-10#2)
responsible for disease##3##3##(2008-10#2)(2011-2#1)
responsible for expression of##2##4##(1990-5#1)(2008-11#1)
responsible for generating the##2##4##(1996-2#1)(2008-8#1)
responsible for generating##3##3##(1996-2#1)(2008-11#1)(2008-8#1)
responsible for increased##2##3##(1995-11#1)(2008-10#1)
responsible for inducing##2##3##(1995-2#1)(2008-10#1)
responsible for light##2##3##(2008-10#2)
responsible for membranoproliferative glomerulonephritis##2##4##(2012-2#2)
responsible for more than##2##4##(1990-12#1)(2013-1#1)
responsible for not##2##3##(2011-2#1)(2013-7#1)
responsible for resistance##2##3##(2008-10#2)
responsible for severe##2##3##(1994-5#1)(2011-2#1)
responsible for significant##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
responsible for some##2##3##(1996-12#1)(2012-3#1)
responsible for such##2##3##(2008-7#1)(2012-2#1)
responsible for systemic##2##3##(2008-10#1)(2009-11#1)
responsible for the DS##2##4##(1996-2#2)
responsible for the activation of##2##5##(1995-2#1)(2008-5#1)
responsible for the binding of##2##5##(1997-9#1)(2008-10#1)
responsible for the changes##2##4##(2008-7#1)(2011-2#1)
responsible for the degradation of##3##5##(1995-6#1)(1995-8#1)(2008-4#1)
responsible for the development of##2##5##(2008-7#1)(2011-2#1)
responsible for the differences##2##4##(1994-5#1)(1997-9#1)
responsible for the high##3##4##(1996-12#1)(1996-6#1)(2008-8#1)
responsible for the increase in##2##5##(2008-12#2)
responsible for the majority of##3##5##(2008-1#1)(2009-5#1)(2009-8#1)
responsible for the observed##3##4##(1997-1#1)(2008-10#2)
responsible for the production of##2##5##(1990-8#1)(1996-12#1)
responsible for the recent##2##4##(1996-3#1)(2008-10#1)
responsible for the reduced##2##4##(2008-10#1)(2008-5#1)
responsible for the##120##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-9#2)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
responsible for their##6##3##(1992-10#1)(1995-3#1)(1996-1#2)(2008-10#1)(2010-4#1)
responsible for these effects##2##4##(2008-11#1)(2011-2#1)
responsible for these##8##3##(1993-3#1)(1995-12#1)(1997-7#1)(2008-11#2)(2008-12#1)(2011-2#2)
responsible for this##7##3##(1990-5#1)(1991-5#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2013-1#1)
responsible for tumor##2##3##(1994-8#1)(2011-2#1)
responsible for##342##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#5)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#4)(1995-8#3)(1996-1#2)(1996-12#3)(1996-2#5)(1996-3#1)(1996-6#2)(1997-1#2)(1997-2#6)(1997-3#3)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(1997-9#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#78)(2008-11#17)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#13)(2008-7#8)(2008-8#8)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#3)(2010-5#4)(2011-1#2)(2011-10#1)(2011-2#24)(2012-12#1)(2012-2#11)(2012-3#10)(2013-1#8)(2013-7#1)(2013-8#4)
responsible of##2##2##(2008-10#2)
responsible to##2##2##(2008-10#1)(2008-11#1)
responsible##370##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#5)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#5)(1995-8#3)(1996-1#2)(1996-12#4)(1996-2#6)(1996-3#1)(1996-6#2)(1997-1#3)(1997-2#7)(1997-3#4)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#3)(1997-9#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#84)(2008-11#20)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#13)(2008-7#9)(2008-8#9)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#4)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#24)(2012-12#1)(2012-2#11)(2012-3#10)(2013-1#8)(2013-7#1)(2013-8#4)
responsive breast##2##2##(1990-5#1)(2011-2#1)
responsive cells##3##2##(1990-11#1)(2008-10#1)(2008-9#1)
responsive element##7##2##(1992-8#1)(1993-3#1)(1993-8#2)(2008-10#1)(2009-8#1)(2011-2#1)
responsive genes in##3##3##(2008-9#3)
responsive genes##4##2##(1994-8#1)(2008-9#3)
responsive to insulin##2##3##(1994-11#1)(2008-1#1)
responsive to the##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
responsive to##32##2##(1990-12#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-8#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-1#1)
responsive##66##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-7#4)(2008-8#1)(2008-9#10)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#3)(2011-9#1)(2012-2#2)(2013-1#1)
responsiveness as##2##2##(1995-2#1)(2009-6#1)
responsiveness of the##2##3##(1995-12#1)(1997-3#1)
responsiveness of##9##2##(1990-5#2)(1992-12#1)(1994-11#1)(1994-2#1)(1995-12#2)(1997-3#1)(2008-7#1)
responsiveness to a##3##3##(1990-11#1)(1994-5#1)(2008-4#1)
responsiveness to##17##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-7#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#3)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
responsiveness was##2##2##(1993-12#1)(1994-3#1)
responsiveness##45##1##(1990-11#1)(1990-12#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#5)(1995-2#2)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
responsivity and##2##2##(2008-4#1)(2009-10#1)
responsivity to##2##2##(1995-8#1)(2008-3#1)
responsivity##9##1##(1995-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#4)(2012-2#1)
rest and##6##2##(1996-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2013-1#1)(2013-8#1)
rest as##2##2##(2008-10#1)(2010-6#1)
rest in##3##2##(1992-12#1)(1997-4#1)(2012-12#1)
rest of the##25##3##(1991-5#1)(1991-8#2)(1992-3#1)(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-9#1)(2013-1#1)
rest of##33##2##(1991-5#1)(1991-8#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#5)(2012-9#1)(2013-1#1)
rest on##2##2##(1991-1#1)(1996-2#1)
rest went##2##2##(1991-1#1)(1992-2#1)
rest with##2##2##(2007-12#1)(2008-7#1)
rest##88##1##(1991-1#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#2)(2009-3#2)(2010-11#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-3#2)(2012-9#1)(2013-1#7)(2013-8#5)
restate##2##1##(2010-5#1)(2013-1#1)
restenosis after##3##2##(1991-5#1)(1992-9#1)(2008-7#1)
restenosis and##3##2##(2006-6#1)(2008-12#2)
restenosis in the##2##3##(1992-9#1)(1994-9#1)
restenosis in##3##2##(1992-9#1)(1994-9#1)(2008-11#1)
restenosis is##2##2##(1994-9#2)
restenosis was##2##2##(2008-11#2)
restenosis##37##1##(1991-5#1)(1992-9#9)(1994-9#3)(2006-6#2)(2008-11#10)(2008-12#6)(2008-5#3)(2008-7#3)
resting HR##2##2##(2012-2#2)
resting and##3##2##(2008-7#1)(2008-9#1)(2010-1#1)
resting blood pressure##3##3##(1994-3#3)
resting blood##4##2##(1990-3#1)(1994-3#3)
resting cells of##2##3##(1990-2#1)(1995-3#1)
resting cells##3##2##(1990-2#1)(1994-3#1)(1995-3#1)
resting limb during##2##3##(2013-8#2)
resting limb##3##2##(2013-8#3)
resting motor threshold##3##3##(2011-2#3)
resting on##2##2##(2008-10#1)(2012-2#1)
resting platelets##6##2##(1992-6#2)(1993-8#1)(2006-6#3)
resting spores##4##2##(2008-10#4)
resting state##3##2##(2008-11#1)(2013-8#2)
resting upper arm##2##3##(2013-8#2)
resting##71##1##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-6#6)(1993-8#1)(1994-3#8)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#2)(2006-6#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#5)(2011-2#3)(2012-2#4)(2013-1#1)(2013-8#12)
restitution##2##1##(1995-12#1)(1997-1#1)
restless legs##2##2##(2012-3#1)(2013-8#1)
restlessness##3##1##(2008-12#1)(2008-7#1)(2011-2#1)
restoration and##4##2##(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
restoration of the##9##3##(1995-9#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
restoration of##36##2##(1990-12#1)(1991-5#1)(1993-3#1)(1995-3#1)(1995-9#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-7#1)(2008-9#2)(2010-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#7)(2013-7#1)
restoration##64##1##(1990-12#1)(1990-5#1)(1991-5#1)(1993-3#1)(1995-3#1)(1995-9#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-3#5)(2008-4#1)(2008-7#2)(2008-9#2)(2010-10#2)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-2#5)(2012-3#1)(2013-1#12)(2013-7#2)
restorations in##2##2##(2012-12#1)(2013-1#1)
restorations were provided##2##3##(2013-1#2)
restorations##8##1##(1990-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#4)
restorative and prosthetic##2##3##(2013-1#2)
restorative and##3##2##(2008-11#1)(2013-1#2)
restorative dentistry##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
restorative##28##1##(1992-3#1)(2008-10#1)(2008-11#6)(2008-12#3)(2008-7#2)(2009-7#5)(2011-2#4)(2012-12#1)(2013-1#5)
restore the##9##2##(1993-3#1)(1995-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
restore##27##1##(1990-2#1)(1991-7#1)(1993-3#1)(1995-6#1)(1996-3#2)(2008-10#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
restored a portion of the life that would have been lost due to##2##13##(2008-7#2)
restored a##3##2##(2008-10#1)(2008-7#2)
restored by increasing the##2##4##(2008-7#2)
restored by##13##2##(1990-5#1)(1991-5#2)(1996-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)(2011-3#1)
restored if##2##2##(1994-8#1)(2008-11#1)
restored in the##2##3##(1997-3#1)(1997-7#1)
restored in##6##2##(1997-3#1)(1997-7#1)(2008-11#1)(2009-8#1)(2012-3#2)
restored the##5##2##(1991-5#1)(1997-1#1)(2008-10#2)(2008-11#1)
restored to the level##2##4##(1993-8#1)(2008-9#1)
restored to##3##2##(1993-8#1)(2008-9#1)(2011-2#1)
restored with a##4##3##(2013-1#4)
restored with composite resin##2##4##(2013-1#2)
restored with##9##2##(1990-2#1)(2011-2#1)(2012-3#1)(2013-1#6)
restored##64##1##(1990-12#1)(1990-2#2)(1990-5#1)(1991-5#3)(1993-1#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#9)
restorer line##2##2##(2008-10#2)
restorer##3##1##(2008-10#2)(2008-9#1)
restores the##3##2##(1990-5#1)(1993-9#1)(2008-10#1)
restores##7##1##(1990-5#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-8#1)(2008-10#1)(2009-7#1)
restoring the##4##2##(1993-2#1)(1993-8#1)(2010-1#1)(2012-2#1)
restoring##13##1##(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
restrain the##2##2##(2008-11#1)(2013-1#1)
restrain##4##1##(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
restrained by##2##2##(1992-2#1)(2008-11#1)
restrained least-squares##2##2##(1992-4#1)(1993-8#1)
restrained##12##1##(1990-11#1)(1990-4#1)(1992-2#1)(1992-4#1)(1993-8#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)
restraint rates##2##2##(2008-7#2)
restraint stress##5##2##(1994-2#5)
restraint##25##1##(1994-2#6)(1995-1#1)(1995-3#2)(1995-5#1)(1997-2#4)(2008-7#5)(2008-8#2)(2009-6#2)(2011-2#1)(2013-1#1)
restraints##6##1##(1994-5#1)(2008-7#1)(2009-3#1)(2010-10#2)(2010-7#1)
restrict the##6##2##(1990-12#1)(1992-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
restrict##19##1##(1990-12#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1996-5#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-2#1)
restricta##2##1##(2008-5#2)
restricted and##2##2##(1995-5#1)(2008-10#1)
restricted by the##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-3#1)
restricted by##6##2##(1992-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-3#1)
restricted diet##2##2##(2008-3#2)
restricted gene flow between##2##4##(2008-10#1)(2012-3#1)
restricted gene flow##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
restricted in##3##2##(2008-10#2)(2012-12#1)
restricted number of##2##3##(1990-8#1)(1993-12#1)
restricted primarily to##2##3##(2008-4#1)(2008-7#1)
restricted the##3##2##(1992-6#1)(2008-10#1)(2009-12#1)
restricted to a##8##3##(1994-2#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
restricted to any##2##3##(1995-2#1)(2008-11#1)
restricted to certain##2##3##(1990-5#1)(2011-2#1)
restricted to the epidermis and outer cortex tissues##2##8##(2008-10#2)
restricted to the epidermis and##3##5##(2008-10#3)
restricted to the##29##3##(1990-5#1)(1991-5#1)(1994-12#2)(1995-2#2)(1995-6#1)(1997-1#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#2)(2012-3#1)
restricted to##81##2##(1990-5#2)(1991-1#1)(1991-12#1)(1991-5#1)(1992-1#1)(1993-12#2)(1994-12#2)(1994-2#1)(1994-3#2)(1995-2#3)(1995-6#2)(1995-9#1)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#21)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
restricted use##2##2##(1992-3#1)(2008-10#1)
restricted##170##1##(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#1)(1995-2#3)(1995-5#1)(1995-6#2)(1995-9#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#48)(2008-11#11)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#5)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#2)
restricting the##4##2##(1996-11#1)(2008-11#1)(2008-5#1)(2011-10#1)
restricting##11##1##(1996-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-10#1)(2011-2#2)(2013-1#1)
restriction (CR)##2##2##(2008-11#1)(2008-7#1)
restriction analysis and##2##3##(1992-3#1)(2008-10#1)
restriction analysis of##5##3##(1993-6#1)(1996-3#1)(1996-6#1)(2008-10#2)
restriction analysis##8##2##(1992-3#1)(1993-6#1)(1996-3#1)(1996-6#1)(2008-10#4)
restriction and##6##2##(1994-3#1)(1995-6#1)(1996-11#1)(2008-10#1)(2008-7#2)
restriction by##2##2##(1995-5#1)(2008-10#1)
restriction did not##2##3##(1990-3#1)(2008-4#1)
restriction digestion of##2##3##(2008-10#1)(2008-4#1)
restriction digestion##5##2##(1994-8#1)(2008-10#2)(2008-4#2)
restriction endonuclease (ENase)##2##3##(1993-12#1)(1993-9#1)
restriction endonuclease##8##2##(1991-7#1)(1991-9#1)(1993-12#2)(1993-9#1)(1996-12#1)(2008-10#1)(2008-8#1)
restriction enzyme digestion and##2##4##(1993-12#1)(2008-10#1)
restriction enzyme digestion##3##3##(1993-12#1)(2008-10#2)
restriction enzyme##18##2##(1991-5#1)(1991-9#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#9)(2008-7#1)
restriction enzyme-mediated integration (REMI)##3##4##(2008-10#3)
restriction enzyme-mediated integration##4##3##(2008-10#4)
restriction enzymes##20##2##(1996-2#1)(1997-2#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-8#1)(2009-10#1)
restriction fragment length polymorphism (RFLP) analyses##2##6##(2008-10#2)
restriction fragment length polymorphism (RFLP) analysis of##2##7##(2008-10#2)
restriction fragment length polymorphism (RFLP) analysis##6##6##(2008-10#5)(2012-3#1)
restriction fragment length polymorphism (RFLP) loci##2##6##(2008-10#2)
restriction fragment length polymorphism (RFLP) markers were##2##7##(2008-10#1)(2008-9#1)
restriction fragment length polymorphism (RFLP) markers##7##6##(1995-6#1)(1996-12#1)(2008-10#4)(2008-9#1)
restriction fragment length polymorphism (RFLP)##27##5##(1995-6#1)(1996-12#1)(2008-10#23)(2008-9#1)(2012-3#1)
restriction fragment length polymorphism analysis of a##2##7##(2008-10#2)
restriction fragment length polymorphism analysis of the##3##7##(2008-10#3)
restriction fragment length polymorphism analysis of##7##6##(2008-10#7)
restriction fragment length polymorphism analysis##10##5##(2008-10#10)
restriction fragment length polymorphism and##2##5##(2008-10#2)
restriction fragment length polymorphism banding##2##5##(2008-10#2)
restriction fragment length polymorphism loci##2##5##(2008-10#2)
restriction fragment length polymorphism map##2##5##(2008-10#2)
restriction fragment length polymorphism marker##2##5##(2008-10#2)
restriction fragment length polymorphism of##3##5##(2008-10#3)
restriction fragment length polymorphism probes##3##5##(2008-10#3)
restriction fragment length polymorphism with##2##5##(2008-10#1)(2008-9#1)
restriction fragment length polymorphism##75##4##(1995-6#1)(1996-12#1)(2008-10#69)(2008-9#2)(2012-3#1)(2013-1#1)
restriction fragment length polymorphisms (RFLPs)##4##5##(2008-10#4)
restriction fragment length polymorphisms##10##4##(1996-12#2)(2008-10#8)
restriction fragment length##86##3##(1995-6#1)(1996-12#3)(2008-10#78)(2008-9#2)(2012-3#1)(2013-1#1)
restriction fragment##88##2##(1993-12#1)(1995-6#1)(1996-12#3)(2008-10#79)(2008-9#2)(2012-3#1)(2013-1#1)
restriction fragments from##2##3##(1992-6#1)(1993-2#1)
restriction fragments##6##2##(1992-6#2)(1993-2#1)(1995-6#1)(2008-10#2)
restriction map of##2##3##(1992-3#1)(1993-6#1)
restriction of fungal##2##3##(2008-10#2)
restriction of the##3##3##(2008-10#2)(2008-7#1)
restriction of##14##2##(1993-1#1)(1993-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)
restriction on the##4##3##(1990-3#1)(1993-12#2)(2008-10#1)
restriction on##9##2##(1990-3#1)(1990-9#1)(1993-12#2)(1996-5#1)(2008-10#2)(2008-7#2)
restriction pattern##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
restriction patterns##3##2##(1997-2#1)(2008-10#2)
restriction profile##2##2##(1997-2#1)(2008-10#1)
restriction profiles##2##2##(1997-2#1)(2008-10#1)
restriction site polymorphism##2##3##(2008-10#2)
restriction site##4##2##(2008-10#4)
restriction sites for##2##3##(1991-5#1)(1996-2#1)
restriction sites##7##2##(1991-5#1)(1991-7#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-9#1)
restriction to##2##2##(1990-3#1)(2008-10#1)
restriction##261##1##(1990-3#7)(1990-9#2)(1991-11#1)(1991-5#2)(1991-7#2)(1991-9#2)(1992-2#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-3#2)(1994-8#2)(1995-12#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#142)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#13)(2008-7#9)(2008-8#4)(2008-9#5)(2009-10#1)(2009-8#2)(2010-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
restriction-modification (R-M) system##2##3##(1991-9#1)(1993-9#1)
restriction-modification##3##1##(1991-9#1)(1993-9#2)
restrictions during##2##2##(1992-3#1)(2010-6#1)
restrictions in##2##2##(2008-10#1)(2013-1#1)
restrictions on the##5##3##(1991-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
restrictions on##9##2##(1991-10#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-4#1)
restrictions##27##1##(1990-2#1)(1991-10#1)(1992-3#2)(1993-3#1)(1996-3#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#2)(2009-4#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
restrictive anorexia nervosa##3##3##(2012-3#3)
restrictive lung function##3##3##(1991-12#3)
restrictive pattern##2##2##(1997-3#1)(2010-2#1)
restrictive##26##1##(1990-9#1)(1991-12#3)(1992-2#1)(1995-3#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-5#2)(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
restricts the##3##2##(2008-10#2)(2008-3#1)
restricts##5##1##(1994-8#1)(2008-10#2)(2008-3#1)(2010-5#1)
restrictus##2##1##(1993-2#1)(2008-11#1)
restructured environment##3##2##(1994-3#1)(1995-2#1)(1996-3#1)
restructured hospital is##2##3##(1994-12#1)(1994-3#1)
restructured##17##1##(1994-1#1)(1994-12#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#3)(2010-8#1)(2012-2#1)
restructuring at##2##2##(1994-3#1)(2009-10#1)
restructuring education##2##2##(1995-2#2)
restructuring initiative##5##2##(1994-12#1)(1994-3#1)(1996-1#3)
restructuring initiatives##2##2##(1995-2#1)(1996-1#1)
restructuring of the##2##3##(1992-1#1)(1996-1#1)
restructuring of##5##2##(1991-3#1)(1992-1#1)(1994-12#1)(1996-1#1)(1997-2#1)
restructuring program##4##2##(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)
restructuring that##2##2##(1996-3#1)(2009-10#1)
restructuring the##3##2##(1991-3#1)(1995-2#1)(2008-6#1)
restructuring##69##1##(1991-1#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#6)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#6)(1995-1#4)(1995-12#1)(1995-2#6)(1995-3#3)(1996-1#11)(1996-3#3)(1997-2#1)(1997-3#1)(2008-6#1)(2009-10#5)(2012-2#1)(2012-3#4)
restructuring?##3##1##(1994-2#1)(1994-3#2)
rests on the##3##3##(1994-12#1)(2008-12#1)(2008-8#1)
rests on##4##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
rests with##2##2##(1997-7#1)(2007-12#1)
rests##7##1##(1994-12#1)(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
result after##2##2##(2008-7#1)(2012-3#1)
result and the##3##3##(1995-9#1)(2008-9#1)(2011-2#1)
result and##6##2##(1991-3#1)(1995-9#1)(1996-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
result at##2##2##(2008-10#1)(2012-3#1)
result by##2##2##(1990-11#1)(2008-8#1)
result confirms##3##2##(2008-8#3)
result demonstrates that##2##3##(2007-11#1)(2008-9#1)
result for the##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
result for##10##2##(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
result from a##12##3##(1994-3#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-5#2)(2008-10#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-6#1)(2013-8#1)
result from applying##2##3##(2008-10#1)(2008-5#1)
result from differential##2##3##(2008-6#2)
result from interactions between##2##4##(1997-7#1)(2012-2#1)
result from progressive##2##3##(2012-2#1)(2013-7#1)
result from selective##2##3##(2008-7#1)(2011-2#1)
result from strong##2##3##(2008-8#1)(2008-9#1)
result from the##13##3##(1990-11#1)(1994-8#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
result from their##2##3##(1990-11#1)(1995-6#1)
result from##86##2##(1990-11#2)(1990-8#2)(1991-12#1)(1991-3#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
result implies that##5##3##(1996-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
result in a better##3##4##(1991-6#1)(2008-11#1)(2008-5#1)
result in a decline##2##4##(1991-7#1)(1995-5#1)
result in a higher##2##4##(1994-12#1)(2008-10#1)
result in a significant increase in##2##6##(2008-10#1)(2008-11#1)
result in a significant##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
result in a##39##3##(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#2)(2012-2#1)(2013-1#2)(2013-8#1)
result in an increase in the number##3##7##(1995-3#1)(1997-6#1)(2008-10#1)
result in an increase##5##4##(1994-9#1)(1995-3#1)(1997-6#1)(2008-10#2)
result in an##10##3##(1994-9#1)(1995-3#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#3)(2009-7#1)(2012-3#1)
result in behavioral##2##3##(2008-4#1)(2010-9#1)
result in better##2##3##(2007-11#1)(2011-2#1)
result in different##2##3##(2008-9#1)(2011-2#1)
result in high##5##3##(2008-10#2)(2008-4#1)(2010-12#1)(2012-3#1)
result in immunotoxicity##2##3##(2008-10#2)
result in improved##3##3##(1997-1#1)(2009-6#1)(2010-12#1)
result in increased##6##3##(1997-2#1)(2008-1#1)(2008-10#1)(2009-6#1)(2009-9#1)(2012-3#1)
result in misleading##2##3##(1994-12#1)(2008-11#1)
result in more##2##3##(1994-3#1)(2009-3#1)
result in reduced##3##3##(2008-10#1)(2008-5#1)(2010-1#1)
result in reduction of##2##4##(2012-3#2)
result in severe##2##3##(2008-3#1)(2011-2#1)
result in significant##5##3##(1997-2#1)(1997-3#1)(2010-1#1)(2011-2#2)
result in systemic##2##3##(1991-4#1)(2008-10#1)
result in the accumulation of##2##5##(1995-6#1)(2008-7#1)
result in the loss of##2##5##(2008-8#1)(2008-9#1)
result in the##27##3##(1991-3#1)(1992-3#1)(1995-2#1)(1995-6#1)(2006-6#1)(2008-10#5)(2008-11#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
result in##234##2##(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#2)(1996-2#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#4)(1997-3#2)(1997-6#2)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#41)(2008-11#22)(2008-12#1)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#8)(2009-10#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#6)(2010-1#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#20)(2012-2#7)(2012-3#8)(2013-1#6)(2013-8#4)
result indicated that the##3##4##(2008-8#3)
result indicated that##7##3##(2008-8#6)(2008-9#1)
result indicates that##9##3##(1991-3#1)(1991-6#1)(1994-11#1)(2008-10#4)(2009-9#1)(2012-2#1)
result is a##2##3##(2008-3#1)(2009-3#1)
result is an##2##3##(1992-3#1)(2008-10#1)
result is not##2##3##(2008-10#1)(2008-5#1)
result is that the##2##4##(2008-8#1)(2010-1#1)
result is that##8##3##(1991-12#1)(1997-1#1)(2008-8#3)(2008-9#2)(2010-1#1)
result is##31##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#1)(2010-1#1)(2013-8#1)
result may##4##2##(1994-5#1)(2008-10#2)(2008-3#1)
result means that the##2##4##(1993-8#1)(2008-11#1)
result of DNA##2##3##(2008-10#1)(2008-11#1)
result of a complex##2##4##(2009-10#1)(2010-12#1)
result of a##29##3##(1991-11#1)(1991-2#1)(1994-1#2)(1995-1#1)(1995-12#1)(1995-6#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2012-2#1)
result of an##7##3##(1994-2#1)(1996-6#1)(1997-1#2)(2008-5#1)(2013-1#2)
result of both##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
result of the interaction##2##4##(2008-10#1)(2008-3#1)
result of the present study##3##5##(1995-8#1)(2009-12#1)(2012-3#1)
result of the previous##2##4##(1990-2#1)(2010-11#1)
result of the##68##3##(1990-2#2)(1991-12#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-2#1)(2008-10#23)(2008-11#6)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)
result of this study##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
result of this##12##3##(1991-12#1)(1995-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-3#1)(2010-5#2)(2012-2#1)(2013-1#1)
result of treatment##2##3##(1992-5#1)(2012-12#1)
result of##303##2##(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#5)(1991-2#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#67)(2008-11#27)(2008-12#6)(2008-3#9)(2008-5#11)(2008-7#12)(2008-8#16)(2008-9#13)(2009-10#1)(2009-11#2)(2009-12#4)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#6)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#6)
result on##2##2##(2008-6#1)(2008-8#1)
result reveals##2##2##(2008-10#1)(2010-11#1)
result shows that the##2##4##(2008-10#1)(2008-11#1)
result shows that##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2010-7#1)
result shows##8##2##(2008-10#5)(2008-11#1)(2008-5#1)(2010-7#1)
result suggested that##8##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-3#1)(2013-8#1)
result suggests that the##2##4##(1997-3#1)(2008-10#1)
result suggests that##7##3##(1997-3#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-7#1)(2013-1#1)
result supports the##3##3##(1997-1#1)(2008-8#1)(2011-2#1)
result supports##4##2##(1997-1#1)(2008-8#2)(2011-2#1)
result that##6##2##(1992-2#1)(1992-3#1)(2008-10#3)(2011-2#1)
result was a##2##3##(2008-12#1)(2013-8#1)
result was achieved##2##3##(2008-9#1)(2009-4#1)
result was in##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
result was not##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
result was obtained with##2##4##(2008-10#2)
result was obtained##5##3##(1991-8#1)(2008-10#3)(2008-11#1)
result was##25##2##(1991-8#1)(1994-11#1)(1994-2#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#3)(2009-4#1)(2013-1#1)(2013-8#1)
result will##2##2##(1997-3#1)(2008-9#1)
result##988##1##(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#4)(1990-9#1)(1991-11#2)(1991-12#8)(1991-2#5)(1991-3#10)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#6)(1993-9#3)(1994-1#4)(1994-11#6)(1994-12#4)(1994-2#2)(1994-3#6)(1994-5#4)(1994-8#4)(1994-9#3)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#8)(1995-8#5)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#5)(1996-5#7)(1996-6#5)(1996-8#2)(1996-9#4)(1997-1#11)(1997-2#8)(1997-3#8)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#5)(2006-6#1)(2007-11#3)(2007-12#6)(2007-8#3)(2008-1#3)(2008-10#199)(2008-11#80)(2008-12#12)(2008-2#4)(2008-3#27)(2008-4#5)(2008-5#26)(2008-6#5)(2008-7#25)(2008-8#55)(2008-9#52)(2009-10#7)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#9)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#8)(2010-1#3)(2010-10#6)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#4)(2010-5#6)(2010-6#4)(2010-7#7)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#46)(2011-3#4)(2012-12#4)(2012-2#21)(2012-3#23)(2012-5#1)(2013-1#31)(2013-7#4)(2013-8#21)
resultant acidic##2##2##(2008-5#2)
resultant##55##1##(1990-5#1)(1991-10#1)(1991-12#1)(1991-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#2)(2007-11#1)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#2)(2011-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
resulted from increased##2##3##(2008-10#1)(2008-9#1)
resulted from the##10##3##(1995-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)
resulted from##31##2##(1994-12#1)(1995-6#1)(1996-11#1)(1997-8#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
resulted in a change##2##4##(2008-10#1)(2008-11#1)
resulted in a complete##2##4##(1997-3#1)(2008-10#1)
resulted in a considerable##2##4##(2008-10#2)
resulted in a decrease in the##2##6##(2008-10#1)(2008-7#1)
resulted in a decrease in##3##5##(1993-8#1)(2008-10#1)(2008-7#1)
resulted in a drastic##3##4##(1997-5#1)(2008-10#2)
resulted in a high##3##4##(2008-10#2)(2010-4#1)
resulted in a linear##2##4##(2008-10#2)
resulted in a loss of##2##5##(1997-3#1)(2008-10#1)
resulted in a marked##2##4##(1996-12#1)(2008-10#1)
resulted in a rapid decrease in##2##6##(1990-12#1)(2008-11#1)
resulted in a rapid##8##4##(1990-12#1)(1991-3#1)(1992-3#1)(2008-10#2)(2008-11#3)
resulted in a reduced##2##4##(2008-10#1)(2008-7#1)
resulted in a significant decrease in##3##6##(1991-6#1)(1995-3#1)(2008-5#1)
resulted in a significant decrease##4##5##(1991-6#1)(1995-3#1)(2008-5#1)(2012-2#1)
resulted in a significant increase in##5##6##(1992-12#1)(2008-10#2)(2008-11#1)(2009-6#1)
resulted in a significant increase of##2##6##(2008-10#1)(2008-5#1)
resulted in a significant increase##7##5##(1992-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#1)
resulted in a significant reduction of##3##6##(1992-1#1)(2008-10#1)(2008-3#1)
resulted in a significant reduction##4##5##(1992-1#1)(2008-10#2)(2008-3#1)
resulted in a significant##23##4##(1991-6#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2009-6#1)(2012-2#2)(2013-1#1)
resulted in a significantly lower##2##5##(1997-3#1)(2008-10#1)
resulted in a significantly##3##4##(1997-3#1)(2008-10#2)
resulted in a slight decrease##2##5##(2008-10#1)(2011-2#1)
resulted in a substantial##2##4##(1993-8#1)(2008-10#1)
resulted in a##140##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#5)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-12#3)(1996-2#1)(1997-3#4)(1997-5#1)(2008-10#55)(2008-11#14)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-4#2)(2011-2#2)(2012-2#4)(2013-1#3)(2013-8#2)
resulted in about##2##3##(2008-11#1)(2008-12#1)
resulted in activation of##2##4##(1994-5#1)(2010-12#1)
resulted in almost complete##3##4##(1990-2#1)(2008-12#1)(2008-7#1)
resulted in an increase in##6##5##(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)
resulted in an increase of##2##5##(1993-8#1)(1995-8#1)
resulted in an increase##8##4##(1993-8#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)
resulted in an increased##4##4##(1991-12#1)(1995-12#1)(1995-6#1)(2008-11#1)
resulted in an##31##3##(1990-5#1)(1991-10#1)(1991-12#1)(1993-8#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
resulted in both##2##3##(1991-3#1)(2008-10#1)
resulted in changes in##3##4##(1992-6#1)(2008-10#2)
resulted in changes##4##3##(1992-6#1)(2008-10#2)(2008-5#1)
resulted in complete##6##3##(1991-8#1)(1992-12#1)(1993-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
resulted in decreased##5##3##(1990-12#1)(1994-6#1)(1995-12#1)(2011-1#1)(2013-1#1)
resulted in detection limits of##2##5##(2008-10#2)
resulted in detection##3##3##(2008-10#3)
resulted in distinct##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
resulted in extensive##2##3##(1991-5#1)(2008-10#1)
resulted in further##2##3##(2008-11#1)(2011-1#1)
resulted in greater##2##3##(2008-10#1)(2010-1#1)
resulted in higher##5##3##(1996-12#1)(1997-5#1)(2008-10#2)(2012-3#1)
resulted in immediate##2##3##(2008-11#1)(2012-2#1)
resulted in improved##4##3##(1993-3#1)(2008-12#1)(2008-2#1)(2008-7#1)
resulted in increased##15##3##(1990-11#1)(1993-6#1)(1994-8#1)(1995-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-1#1)
resulted in infection##2##3##(2008-10#2)
resulted in inhibition##2##3##(1990-7#1)(1995-12#1)
resulted in inoculum##2##3##(2008-10#2)
resulted in large##2##3##(2008-10#1)(2008-6#1)
resulted in larger##2##3##(2008-10#2)
resulted in less##3##3##(2008-10#2)(2013-1#1)
resulted in loss of##2##4##(1993-8#1)(2008-10#1)
resulted in lower##9##3##(1997-3#1)(2008-10#3)(2008-8#3)(2010-4#1)(2011-2#1)
resulted in marked##3##3##(1993-12#1)(1996-12#1)(2008-5#1)
resulted in more##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
resulted in new##2##3##(2008-10#2)
resulted in plants##2##3##(2008-10#1)(2009-10#1)
resulted in production of##2##4##(2008-10#2)
resulted in progressive##2##3##(2012-2#1)(2012-3#1)
resulted in pronounced##2##3##(2008-10#2)
resulted in reduced##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2009-6#1)
resulted in reduction##2##3##(1990-9#1)(2013-8#1)
resulted in relatively##3##3##(2008-10#2)(2012-2#1)
resulted in significant changes in##2##5##(2008-10#1)(2012-2#1)
resulted in significant reductions in##2##5##(2008-10#2)
resulted in significant##12##3##(1992-6#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2009-10#1)(2012-2#1)
resulted in significantly greater##2##4##(2008-10#2)
resulted in significantly##6##3##(2008-10#5)(2008-9#1)
resulted in similar##3##3##(2008-10#2)(2010-4#1)
resulted in slightly##2##3##(1992-2#1)(2009-7#1)
resulted in stronger##2##3##(2008-9#1)(2011-2#1)
resulted in systemic##2##3##(2008-10#2)
resulted in the complete##2##4##(2008-10#1)(2011-1#1)
resulted in the conversion of##2##5##(1993-3#1)(2008-5#1)
resulted in the development of##3##5##(2008-10#1)(2008-11#1)(2008-9#1)
resulted in the emergence of##2##5##(2008-11#2)
resulted in the expression of##3##5##(1992-3#2)(2008-10#1)
resulted in the formation of##4##5##(1990-11#1)(1996-5#1)(2008-10#2)
resulted in the greatest##3##4##(2008-10#1)(2008-8#1)(2012-5#1)
resulted in the identification of##3##5##(2008-10#3)
resulted in the induction of##3##5##(1992-8#1)(1995-5#1)(2008-10#1)
resulted in the inhibition of##2##5##(1990-8#1)(2012-2#1)
resulted in the isolation of##3##5##(1994-11#1)(1997-3#1)(2008-11#1)
resulted in the largest##2##4##(1992-12#1)(1992-8#1)
resulted in the production of##3##5##(1993-6#1)(1994-11#1)(1995-11#1)
resulted in the reduction of##2##5##(1996-12#1)(2011-1#1)
resulted in the successful##2##4##(2008-10#1)(2008-7#1)
resulted in the suppression of##2##5##(1990-12#1)(2010-1#1)
resulted in the##90##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-8#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(2008-10#19)(2008-11#11)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#7)(2009-11#1)(2009-2#1)(2009-6#1)(2010-1#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#4)
resulted in two##2##3##(1996-5#1)(2008-11#1)
resulted in up to##2##4##(2008-10#1)(2011-1#1)
resulted in very##2##3##(2008-10#2)
resulted in yields##2##3##(2008-10#1)(2008-11#1)
resulted in##582##2##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#7)(1992-2#1)(1992-3#4)(1992-6#4)(1992-8#4)(1992-9#1)(1993-12#5)(1993-3#3)(1993-6#4)(1993-8#12)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#10)(1997-5#3)(1997-6#1)(1997-7#1)(2008-10#212)(2008-11#53)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#11)(2008-6#4)(2008-7#15)(2008-8#9)(2008-9#14)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#5)(2010-12#1)(2010-4#4)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#17)(2012-12#2)(2012-2#11)(2012-3#8)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#5)
resulted only##2##2##(2008-10#2)
resulted##636##1##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#7)(1992-2#1)(1992-3#4)(1992-6#4)(1992-8#4)(1992-9#1)(1993-12#5)(1993-3#3)(1993-6#4)(1993-8#12)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#7)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#10)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#241)(2008-11#55)(2008-12#10)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#18)(2008-8#10)(2008-9#16)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#5)(2010-12#2)(2010-3#1)(2010-4#5)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#21)(2012-12#2)(2012-2#11)(2012-3#8)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#5)
resulting complex##2##2##(2008-10#2)
resulting data##4##2##(1995-2#1)(2008-10#3)
resulting derivative##2##2##(2008-10#1)(2008-9#1)
resulting fluorescent##2##2##(1994-11#1)(2008-10#1)
resulting from a##6##3##(1994-2#1)(2006-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2012-3#1)
resulting from activation of##2##4##(1996-5#2)
resulting from an##2##3##(2008-10#2)
resulting from changes in##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
resulting from chronic##2##3##(1993-3#1)(2008-6#1)
resulting from differences in##2##4##(2008-5#1)(2012-3#1)
resulting from presence of##2##4##(2008-10#1)(2013-8#1)
resulting from recycled tires##2##4##(2008-10#2)
resulting from small##2##3##(2008-10#1)(2013-8#1)
resulting from the use of##2##5##(2008-10#1)(2011-3#1)
resulting from the##30##3##(1990-12#1)(1991-3#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#1)
resulting from these##2##3##(2008-11#1)(2008-2#1)
resulting from##128##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-3#5)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-8#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#35)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#3)(2013-8#2)
resulting fusion protein was##3##4##(1994-8#1)(2008-10#2)
resulting fusion protein##4##3##(1994-8#1)(2008-10#2)(2008-4#1)
resulting high##3##2##(1995-12#1)(2008-11#1)(2008-3#1)
resulting in a decrease in##2##5##(2006-6#1)(2008-1#1)
resulting in a decreased##2##4##(2008-10#1)(2008-11#1)
resulting in a more##2##4##(2008-12#1)(2008-7#1)
resulting in a reduced##2##4##(2008-10#1)(2008-7#1)
resulting in a sensitive assay##2##5##(1995-11#1)(2008-11#1)
resulting in a significant##4##4##(1994-5#1)(2008-10#2)(2008-11#1)
resulting in a##60##3##(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#10)(2008-12#1)(2008-3#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#2)
resulting in an amino acid substitution##2##6##(1994-11#1)(2008-10#1)
resulting in an intense##2##4##(2008-10#2)
resulting in an##14##3##(1990-5#1)(1994-11#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2013-1#1)
resulting in better##2##3##(2007-12#1)(2008-10#1)
resulting in chronic##2##3##(2008-7#1)(2013-7#1)
resulting in considerable##2##3##(2008-10#1)(2011-2#1)
resulting in efficient##2##3##(2007-12#1)(2012-2#1)
resulting in endothelial##2##3##(2008-1#1)(2008-12#1)
resulting in erratic dosing##2##4##(1996-3#2)
resulting in high sensitivity##2##4##(2009-5#1)(2012-2#1)
resulting in high##4##3##(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)
resulting in higher##3##3##(1993-12#1)(2008-7#1)(2008-8#1)
resulting in increased##2##3##(2008-11#1)(2012-3#1)
resulting in lower##2##3##(1992-12#1)(2009-10#1)
resulting in the ability##2##4##(2008-10#1)(2011-1#1)
resulting in the formation of##3##5##(2008-10#2)(2009-8#1)
resulting in the generation of##4##5##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
resulting in the generation##5##4##(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#1)
resulting in the loss of##2##5##(1993-6#1)(2011-2#1)
resulting in the production of##2##5##(1993-12#1)(2011-3#1)
resulting in the##36##3##(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-12#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
resulting in two##5##3##(1991-5#1)(2008-10#4)
resulting in up to##2##4##(2008-3#1)(2008-8#1)
resulting in yield##2##3##(2008-10#1)(2011-10#1)
resulting in##266##2##(1990-5#1)(1991-5#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#2)(2006-6#1)(2007-12#4)(2008-1#3)(2008-10#88)(2008-11#28)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-10#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#8)(2012-3#4)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
resulting material##2##2##(2008-10#1)(2008-11#1)
resulting modified##3##2##(2008-10#3)
resulting mutant##2##2##(1991-9#1)(1994-5#1)
resulting plasmid##2##2##(2008-8#2)
resulting resin##2##2##(2008-10#2)
resulting uncertainty##2##2##(1992-6#1)(2013-1#1)
resulting##618##1##(1990-11#1)(1990-12#2)(1990-5#3)(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#5)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-12#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#8)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#6)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#5)(1996-5#3)(1996-8#1)(1997-1#2)(1997-3#3)(1997-6#1)(1997-7#4)(1997-8#4)(2006-6#2)(2007-12#6)(2008-1#4)(2008-10#221)(2008-11#54)(2008-12#7)(2008-2#3)(2008-3#15)(2008-4#9)(2008-5#10)(2008-6#3)(2008-7#18)(2008-8#21)(2008-9#12)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-3#5)(2010-4#3)(2010-5#2)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#6)(2011-10#1)(2011-2#15)(2011-3#2)(2011-7#1)(2012-12#5)(2012-2#14)(2012-3#11)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#5)
results (R##4##2##(2008-10#4)
results a##2##2##(2008-10#1)(2008-3#1)
results achieved##5##2##(1991-3#1)(1995-2#1)(1997-6#1)(2008-10#2)
results across##2##2##(1991-9#1)(2008-11#1)
results after##8##2##(1990-11#1)(1994-6#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-3#1)(2013-1#2)
results agree well with##3##4##(2008-10#2)(2008-2#1)
results agree with the##2##4##(2008-10#2)
results agree with##4##3##(2008-10#4)
results agree##9##2##(2008-10#8)(2008-2#1)
results agreed well with the##2##5##(2008-10#2)
results agreed with##6##3##(2008-10#5)(2011-2#1)
results agreed##8##2##(2008-10#7)(2011-2#1)
results allowed##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
results also demonstrate##2##3##(1995-2#1)(2013-1#1)
results also indicate that##3##4##(1995-8#1)(2008-10#1)(2008-8#1)
results also indicate##5##3##(1995-8#1)(2008-10#2)(2008-8#1)(2013-1#1)
results also provide##4##3##(1992-3#1)(2008-8#2)(2009-8#1)
results also show that##3##4##(2008-10#2)(2008-9#1)
results also show##5##3##(2008-10#4)(2008-9#1)
results also showed that the##2##5##(2008-10#1)(2008-7#1)
results also showed that##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
results also showed##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
results also suggest that the##3##5##(2008-10#1)(2008-6#1)(2008-8#1)
results also suggest that##11##4##(1993-3#2)(1996-12#1)(2008-10#5)(2008-6#1)(2008-8#1)(2009-10#1)
results also##44##2##(1990-5#1)(1992-3#2)(1993-3#2)(1995-2#2)(1995-8#1)(1996-12#1)(2008-10#16)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-8#1)(2010-4#1)(2013-1#3)
results and a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
results and also##2##3##(2008-10#1)(2012-2#1)
results and is##4##3##(1996-5#1)(2008-10#2)(2008-3#1)
results and publication##2##3##(1993-12#2)
results and the##11##3##(1990-2#1)(1992-6#1)(2008-10#5)(2008-8#2)(2009-9#1)(2012-3#1)
results and those of##2##4##(2008-10#1)(2008-5#1)
results and those##3##3##(2008-10#2)(2008-5#1)
results and##73##2##(1990-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-3#2)(1996-5#1)(2007-12#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#3)
results appear to##2##3##(1991-12#1)(2008-11#1)
results are also##2##3##(2008-10#1)(2008-11#1)
results are applicable to##2##4##(2008-3#1)(2008-8#1)
results are comparable##2##3##(1991-3#1)(2008-10#1)
results are compared to those##2##5##(2008-10#2)
results are compared to##6##4##(2008-10#4)(2008-8#1)(2010-8#1)
results are compared with the##5##5##(2008-10#4)(2008-3#1)
results are compared with those##6##5##(2008-10#5)(2008-3#1)
results are compared with##15##4##(2008-10#9)(2008-3#5)(2008-5#1)
results are compared##23##3##(2008-10#15)(2008-3#5)(2008-5#1)(2008-8#1)(2010-8#1)
results are consistent with a##7##5##(1994-5#1)(1995-2#1)(1997-6#1)(2008-10#3)(2009-12#1)
results are consistent with previous##2##5##(2008-10#1)(2011-2#1)
results are consistent with the hypothesis that the##3##8##(1994-2#1)(1997-3#1)(2007-12#1)
results are consistent with the hypothesis that##7##7##(1993-12#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)
results are consistent with the##15##5##(1990-8#1)(1992-3#1)(1993-12#1)(1993-8#2)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)
results are consistent with##33##4##(1990-8#1)(1992-3#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-2#2)(1996-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-9#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-8#2)(2008-9#2)(2009-12#1)(2011-2#1)
results are demonstrated##2##3##(2008-2#1)(2008-3#1)
results are discussed in light of##3##6##(1997-8#1)(2008-10#1)(2008-8#1)
results are discussed in relation to the##2##7##(1992-12#1)(2008-10#1)
results are discussed in relation to##4##6##(1992-12#1)(1993-6#1)(2008-10#1)(2008-11#1)
results are discussed in terms of the##4##7##(1990-7#1)(1993-6#1)(1995-11#1)(2008-10#1)
results are discussed in terms of##8##6##(1990-7#1)(1991-3#1)(1993-6#2)(1995-11#1)(2008-10#2)(2008-5#1)
results are discussed in##17##4##(1990-7#1)(1991-3#1)(1992-12#1)(1993-6#3)(1995-11#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)
results are discussed with##3##4##(1993-3#1)(1995-12#1)(2011-1#1)
results are discussed##30##3##(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#3)(1995-11#1)(1995-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)
results are due##2##3##(1990-12#1)(2008-10#1)
results are encouraging##2##3##(1994-2#1)(2008-5#1)
results are important for##3##4##(2007-12#1)(2008-10#1)(2008-12#1)
results are important##4##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
results are in agreement with##3##5##(1994-5#1)(2008-10#1)(2008-7#1)
results are in excellent agreement##2##5##(2008-3#2)
results are in good agreement with those obtained by##2##9##(2008-10#2)
results are in good agreement with those obtained##3##8##(2008-10#2)(2008-3#1)
results are in good agreement with##6##6##(2008-10#3)(2008-3#3)
results are in##17##3##(1994-5#1)(1994-8#1)(2008-10#7)(2008-3#5)(2008-7#1)(2008-9#1)(2010-4#1)
results are interpreted with##2##4##(2007-12#1)(2011-2#1)
results are interpreted##4##3##(1991-5#1)(2007-12#1)(2008-3#1)(2011-2#1)
results are not##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
results are obtained in##2##4##(1990-12#1)(2008-3#1)
results are obtained##9##3##(1990-12#1)(2008-10#6)(2008-3#1)(2012-2#1)
results are presented and##2##4##(2008-3#2)
results are presented for##6##4##(1992-12#1)(2008-10#2)(2008-3#3)
results are presented in##3##4##(2008-10#1)(2008-3#1)(2009-5#1)
results are presented to##2##4##(2008-3#1)(2008-7#1)
results are presented##20##3##(1992-12#1)(2007-12#1)(2008-10#4)(2008-3#10)(2008-7#1)(2009-5#1)(2010-7#1)(2011-2#1)
results are promising##2##3##(1995-11#1)(2008-9#1)
results are##217##2##(1990-12#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#3)(1992-3#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#3)(1994-2#2)(1994-5#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2007-12#4)(2008-10#68)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#30)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#7)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-2#4)(2013-1#2)(2013-8#2)
results argue##2##2##(1993-6#1)(2008-8#1)
results as well##2##3##(2008-10#1)(2008-3#1)
results as##13##2##(1990-3#1)(1991-3#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#1)(2011-2#1)
results at different stages##2##4##(2008-8#2)
results at the##2##3##(1997-3#1)(2008-10#1)
results at##8##2##(1993-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2013-1#1)
results based on##6##3##(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
results being##2##2##(2008-10#1)(2008-11#1)
results better than##3##3##(2008-10#3)
results between##8##2##(2008-10#5)(2008-7#1)(2010-6#1)(2013-1#1)
results both##3##2##(1990-12#1)(2008-3#1)(2008-8#1)
results brought##2##2##(1994-6#1)(2008-10#1)
results by##9##2##(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#3)
results can be explained##2##4##(1993-8#1)(1994-5#1)
results can be obtained##5##4##(1993-3#1)(2008-10#3)(2008-11#1)
results can be used to##4##5##(2008-10#3)(2010-7#1)
results can be##15##3##(1990-12#1)(1990-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-9#1)(2010-7#1)
results can##17##2##(1990-12#1)(1990-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-9#1)(2010-7#1)(2013-1#1)
results cannot be##4##3##(1991-6#1)(1996-2#1)(2008-11#1)(2008-8#1)
results cannot##5##2##(1991-6#1)(1996-2#1)(2008-11#2)(2008-8#1)
results caused by the##2##4##(2008-11#2)
results clearly demonstrate that##3##4##(2008-5#1)(2009-6#1)(2009-8#1)
results clearly demonstrate##5##3##(2008-10#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-8#1)
results clearly indicate that##2##4##(1997-1#1)(2013-1#1)
results clearly show that##4##4##(1990-5#1)(1991-9#1)(1994-5#1)(2008-7#1)
results clearly showed##3##3##(1993-11#1)(2008-10#1)(2008-5#1)
results clearly##16##2##(1990-5#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-5#1)(1997-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
results comparable to those obtained using##2##6##(2008-10#2)
results comparable to those##4##4##(1991-2#1)(2008-10#3)
results comparable to##6##3##(1991-2#1)(2008-10#4)(2013-8#1)
results comparable##7##2##(1991-2#1)(2008-10#5)(2013-8#1)
results compare favourably##2##3##(2008-10#2)
results compare##3##2##(2008-10#3)
results compared with##5##3##(2008-10#4)(2009-11#1)
results compared##7##2##(2008-10#6)(2009-11#1)
results concerning the##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
results concerning##9##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
results confirm that the##2##4##(1990-8#1)(2008-10#1)
results confirm that##7##3##(1990-2#1)(1990-8#1)(1991-5#1)(2008-10#2)(2008-5#1)(2008-9#1)
results confirm the##10##3##(1992-4#1)(1992-5#1)(1996-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-9#1)
results confirm##22##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-5#1)(1996-8#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-3#1)
results confirmed our##2##3##(1994-8#1)(2013-8#1)
results confirmed that the use of##2##6##(2008-10#1)(2010-6#1)
results confirmed that the##3##4##(2008-10#2)(2010-6#1)
results confirmed that##7##3##(2008-10#3)(2008-12#1)(2008-9#1)(2009-7#1)(2010-6#1)
results confirmed the##3##3##(2008-8#1)(2010-6#1)(2010-8#1)
results confirmed##13##2##(1994-3#1)(1994-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#2)(2010-8#1)(2013-8#1)
results considering the##2##3##(2008-10#2)
results consistent with the##2##4##(2008-3#1)(2011-2#1)
results consistent with##3##3##(1997-3#1)(2008-3#1)(2011-2#1)
results consistent##4##2##(1997-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
results correlated##3##2##(2008-10#3)
results could be##2##3##(2008-10#1)(2008-5#1)
results could##6##2##(2008-10#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)
results demonstrate a##6##3##(1994-3#1)(1996-12#1)(1997-4#1)(2008-11#1)(2010-10#1)(2012-2#1)
results demonstrate that both##4##4##(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
results demonstrate that exposure to##2##5##(2008-10#1)(2013-1#1)
results demonstrate that the##21##4##(1991-12#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-12#2)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2013-1#2)
results demonstrate that##100##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-3#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-6#1)(1996-12#3)(1996-2#2)(1997-2#1)(2008-10#29)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#2)(2009-10#2)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
results demonstrate the importance of##2##5##(1995-9#1)(2008-10#1)
results demonstrate the potential of##2##5##(2008-10#1)(2009-5#1)
results demonstrate the utility of##2##5##(1990-5#1)(2012-2#1)
results demonstrate the##20##3##(1990-5#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2009-5#1)(2012-2#3)
results demonstrate##134##2##(1990-12#1)(1990-5#2)(1990-8#2)(1991-12#2)(1991-3#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#36)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
results demonstrated that the##8##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2009-3#1)
results demonstrated that##27##3##(1990-6#1)(1995-8#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#1)(2009-5#1)(2010-1#1)(2011-2#2)(2013-1#1)
results demonstrated the##7##3##(2008-10#3)(2008-8#2)(2008-9#1)(2010-12#1)
results demonstrated##42##2##(1990-6#1)(1992-5#1)(1995-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#3)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
results derived##2##2##(1990-12#1)(2008-2#1)
results determined by##4##3##(2008-10#4)
results determined##5##2##(2008-10#4)(2013-1#1)
results did not differ##2##4##(2012-2#1)(2013-1#1)
results did not##4##3##(2008-10#1)(2012-2#1)(2013-1#2)
results differ##2##2##(2008-2#1)(2008-8#1)
results do not support the##3##5##(1990-2#1)(1991-12#1)(2008-8#1)
results do not support##4##4##(1990-2#1)(1991-12#1)(2008-11#1)(2008-8#1)
results do not##8##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
results due to##3##3##(2008-10#2)(2011-2#1)
results emphasize the importance of##2##5##(1991-12#1)(2008-10#1)
results emphasize the##4##3##(1990-5#1)(1991-12#1)(2008-10#1)(2008-5#1)
results equivalent to##2##3##(2008-8#1)(2011-2#1)
results establish##3##2##(1994-11#1)(2008-10#1)(2009-6#1)
results extend previous##2##3##(1994-12#1)(1994-8#1)
results extend##5##2##(1994-12#1)(1994-8#1)(2007-12#1)(2008-9#2)
results focused on##2##3##(1996-6#1)(2009-10#1)
results for a##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
results for an##2##3##(2008-3#1)(2008-8#1)
results for both##2##3##(1997-1#1)(2008-10#1)
results for homogeneous##2##3##(2008-2#1)(2008-3#1)
results for the determination of##3##5##(2008-10#3)
results for the##20##3##(1991-9#2)(1994-1#1)(2008-10#12)(2008-2#1)(2008-3#2)(2010-11#1)(2011-2#1)
results for this##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
results for##91##2##(1991-9#2)(1994-1#1)(1994-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#46)(2008-12#2)(2008-2#5)(2008-3#10)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#3)
results found by##3##3##(2008-10#3)
results found##6##2##(2008-10#5)(2009-7#1)
results from a series of##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
results from a##26##3##(1990-9#1)(1992-12#1)(1994-3#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
results from an##2##3##(2008-10#1)(2010-12#1)
results from different studies##3##4##(2008-10#3)
results from different##6##3##(1996-3#1)(2008-10#3)(2008-2#1)(2011-2#1)
results from impaired##2##3##(1991-7#1)(2008-10#1)
results from its##2##3##(1994-11#1)(1997-2#1)
results from laboratory##2##3##(2008-10#2)
results from our##2##3##(2008-10#1)(2013-1#1)
results from random##2##3##(2008-10#1)(2008-3#1)
results from reduced##2##3##(2008-5#1)(2008-9#1)
results from several##3##3##(2008-10#2)(2008-7#1)
results from the measurement##2##4##(2008-10#2)
results from the scattering of light by deformed liquid droplets and droplets with inclusions##2##14##(2008-3#2)
results from the##35##3##(1991-6#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2009-11#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
results from these##4##3##(1992-10#1)(2008-10#3)
results from this study##7##4##(2008-10#3)(2008-11#1)(2008-9#1)(2010-7#1)(2010-8#1)
results from this##10##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2010-8#1)
results from two##2##3##(2008-5#1)(2012-12#1)
results from##163##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#2)(1991-7#1)(1992-10#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#4)(1996-6#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#48)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
results further support the##2##4##(1993-12#1)(2008-7#1)
results further##6##2##(1991-1#1)(1993-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
results generally support the view that##2##6##(1993-3#1)(2008-8#1)
results give##3##2##(2008-11#2)(2008-8#1)
results given##2##2##(2008-10#1)(2008-3#1)
results had##3##2##(1990-12#1)(2008-2#1)(2013-8#1)
results has been##4##3##(1990-3#1)(1995-2#1)(1996-5#1)(2008-10#1)
results have been compared##2##4##(2008-10#2)
results have been obtained##3##4##(2008-10#2)(2013-1#1)
results have been reported##2##4##(2012-3#1)(2013-1#1)
results have been##12##3##(2008-10#6)(2010-1#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
results have demonstrated that##2##4##(2008-10#1)(2008-12#1)
results have implications for##4##4##(1994-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
results have important implications for##2##5##(2008-7#1)(2009-5#1)
results have shown that##2##4##(2008-10#2)
results have##30##2##(1994-6#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#2)
results highlight the importance of##3##5##(2008-5#1)(2009-8#1)(2011-2#1)
results highlight the need to##2##5##(2008-10#1)(2012-12#1)
results highlight the need##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
results highlight the##13##3##(1992-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
results highlighted that##2##3##(2008-10#1)(2008-8#1)
results i##2##2##(2007-11#2)
results identify##5##2##(1990-11#1)(1993-12#1)(1995-6#1)(2011-2#1)(2012-12#1)
results illustrate how##2##3##(2008-10#1)(2008-8#1)
results illustrate that the##2##4##(2008-10#1)(2010-8#1)
results illustrate that##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
results illustrate the importance of##3##5##(2008-8#1)(2010-1#1)(2011-2#1)
results illustrate the potential##2##4##(2008-3#2)
results illustrate the##8##3##(1994-9#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-1#1)(2011-2#1)
results illustrate##13##2##(1994-9#1)(1997-7#1)(2008-10#3)(2008-3#2)(2008-8#3)(2010-1#1)(2010-8#1)(2011-2#1)
results implicate##4##2##(1992-3#1)(1995-6#1)(2008-10#1)(2008-11#1)
results implied that##2##3##(1997-3#1)(2008-9#1)
results implied##3##2##(1997-3#1)(2008-8#1)(2008-9#1)
results imply that a##3##4##(1995-2#1)(2008-8#1)(2009-8#1)
results imply that the##6##4##(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
results imply that##20##3##(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
results in a decrease##2##4##(2008-10#1)(2013-1#1)
results in a marked reduction in##2##6##(1993-8#1)(1996-12#1)
results in a very##2##4##(1990-12#1)(2008-10#1)
results in a##64##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-6#2)(2006-6#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)
results in about##2##3##(1990-12#1)(1992-9#1)
results in an increase in##5##5##(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
results in an increase##6##4##(1991-5#1)(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
results in an increased##2##4##(1990-2#1)(2013-7#1)
results in an##18##3##(1990-12#1)(1990-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-9#1)(2009-6#1)(2013-7#1)
results in both##2##3##(2008-10#2)
results in cellular##2##3##(2008-10#1)(2008-9#1)
results in comparison with##3##4##(1997-8#1)(2008-10#1)(2008-7#1)
results in embryonic##2##3##(1995-2#1)(2008-8#1)
results in enhanced##2##3##(2008-10#2)
results in higher##2##3##(2008-11#2)
results in improved##2##3##(2008-11#1)(2012-2#1)
results in increased##8##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
results in patients with##2##4##(2010-10#1)(2013-8#1)
results in prolonged##2##3##(2008-10#1)(2008-11#1)
results in reduced##2##3##(2008-10#1)(2008-5#1)
results in reduction of the##2##5##(2008-10#1)(2008-9#1)
results in repeated##2##3##(2008-11#1)(2008-5#1)
results in several##3##3##(1992-3#1)(1993-3#1)(2008-10#1)
results in severe##2##3##(2008-9#1)(2011-2#1)
results in significant##6##3##(1992-7#1)(1993-2#1)(2008-10#3)(2010-12#1)
results in substantial##2##3##(2008-8#1)(2011-3#1)
results in terms of##5##4##(1996-2#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
results in the case of##2##5##(2008-10#2)
results in the context of##2##5##(2008-10#1)(2008-8#1)
results in the determination of##2##5##(2008-10#2)
results in the formation of a##2##6##(2007-12#1)(2008-10#1)
results in the formation of##7##5##(1996-5#2)(2007-12#1)(2008-10#3)(2009-10#1)
results in the inhibition of##2##5##(1990-8#1)(1995-2#1)
results in the local##2##4##(1991-5#1)(1992-12#1)
results in the##57##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-12#2)(1995-11#1)(1995-12#2)(1995-2#1)(1996-5#2)(2007-12#2)(2008-10#18)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#4)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#3)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
results in this##3##3##(1995-11#1)(2008-9#1)(2012-12#1)
results in tyrosine phosphorylation of Shc##2##6##(1997-7#2)
results in##331##2##(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#3)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#2)(1995-11#4)(1995-12#2)(1995-2#4)(1995-6#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#72)(2008-11#23)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#10)(2008-7#12)(2008-8#15)(2008-9#13)(2009-10#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-12#5)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#11)(2011-3#3)(2012-12#2)(2012-2#9)(2012-3#7)(2013-1#15)(2013-7#1)(2013-8#3)
results include the following##2##4##(1993-8#1)(2008-11#1)
results include##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
results indicate a##3##3##(1991-6#1)(1995-11#1)(2008-10#1)
results indicate that GABA##2##4##(2008-8#2)
results indicate that a##5##4##(1991-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
results indicate that adenosine##2##4##(1994-11#1)(1994-6#1)
results indicate that an##2##4##(1992-8#1)(1995-2#1)
results indicate that both##4##4##(1991-12#1)(1996-12#1)(2008-8#1)(2012-3#1)
results indicate that for##2##4##(1992-1#1)(2008-10#1)
results indicate that in the##2##5##(1997-1#1)(2008-5#1)
results indicate that in##4##4##(1997-1#2)(2008-10#1)(2008-5#1)
results indicate that it##2##4##(1992-12#1)(2008-3#1)
results indicate that the electrode##2##5##(2008-10#2)
results indicate that the procedure##2##5##(2008-10#1)(2011-2#1)
results indicate that the proposed##2##5##(2007-12#1)(2012-3#1)
results indicate that the shape of the##2##7##(1994-8#1)(2007-12#1)
results indicate that the transmission##2##5##(2008-3#1)(2013-8#1)
results indicate that the##78##4##(1990-12#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-5#1)(1994-8#2)(1995-6#1)(1996-2#3)(1997-1#1)(1997-2#2)(1997-3#1)(2007-12#2)(2008-10#22)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
results indicate that there is a##2##6##(1990-2#1)(2008-5#1)
results indicate that there is no##2##6##(1992-12#1)(1997-1#1)
results indicate that there is##4##5##(1990-2#1)(1992-12#1)(1997-1#1)(2008-5#1)
results indicate that there was##2##5##(2008-5#1)(2013-1#1)
results indicate that there##6##4##(1990-2#1)(1992-12#1)(1997-1#1)(2008-5#2)(2013-1#1)
results indicate that these##3##4##(1994-5#1)(1995-12#1)(2008-10#1)
results indicate that this##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
results indicate that##286##3##(1990-12#3)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#4)(1994-11#7)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#4)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#5)(1996-2#6)(1997-1#7)(1997-2#3)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#71)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#15)(2008-9#8)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#11)(2013-8#5)
results indicate the importance of##2##5##(1990-10#1)(2010-6#1)
results indicate the##9##3##(1990-10#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-6#1)
results indicate##310##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#4)(1994-11#7)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#5)(1995-2#4)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#5)(1996-2#6)(1997-1#7)(1997-2#3)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#77)(2008-11#19)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#15)(2008-9#9)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#5)(2012-6#1)(2013-1#12)(2013-8#5)
results indicated a##7##3##(1992-2#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)
results indicated that the##30##4##(1996-5#1)(1996-6#1)(2008-10#15)(2008-11#4)(2008-5#1)(2008-8#3)(2009-1#1)(2011-3#4)
results indicated that##82##3##(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-5#1)(1996-6#2)(1997-8#1)(2008-10#36)(2008-11#6)(2008-12#3)(2008-5#2)(2008-8#6)(2008-9#8)(2009-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#5)(2012-12#1)(2012-2#1)(2013-8#1)
results indicated##96##2##(1990-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1996-5#1)(1996-6#2)(1997-7#1)(1997-8#1)(2008-10#39)(2008-11#7)(2008-12#4)(2008-5#2)(2008-8#6)(2008-9#10)(2009-1#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#5)(2012-12#1)(2012-2#1)(2013-8#1)
results indicating that the##2##4##(2008-10#1)(2008-11#1)
results indicating that##3##3##(2008-10#1)(2008-11#2)
results indicating##4##2##(2008-10#2)(2008-11#2)
results influenced##2##2##(1992-1#1)(2009-9#1)
results into the##2##3##(1996-6#1)(1997-2#1)
results introduce##2##2##(2008-11#1)(2011-2#1)
results is##12##2##(1991-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2011-7#1)
results it is##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
results lend##2##2##(2008-9#1)(2009-7#1)
results may be##4##3##(1997-6#1)(2008-10#1)(2008-9#1)(2012-2#1)
results may explain##2##3##(1994-8#1)(2008-10#1)
results may indicate that##2##4##(1991-5#1)(2008-10#1)
results may##20##2##(1991-5#1)(1994-1#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-6#1)(2008-10#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#2)
results observed in##2##3##(1997-3#1)(2011-2#1)
results obtained after##3##3##(2008-10#3)
results obtained are in good agreement with##2##7##(2008-10#2)
results obtained are in##3##4##(2008-10#3)
results obtained are##11##3##(2008-10#9)(2008-11#1)(2008-3#1)
results obtained by ICP-AES##2##4##(2008-10#2)
results obtained by both##3##4##(2008-10#3)
results obtained by the present##2##5##(2008-10#2)
results obtained by the proposed method and those##2##8##(2008-10#2)
results obtained by the proposed method and##4##7##(2008-10#4)
results obtained by the proposed method were##3##7##(2008-10#3)
results obtained by the proposed method##8##6##(2008-10#8)
results obtained by the proposed##10##5##(2008-10#10)
results obtained by the two methods##2##6##(2008-10#2)
results obtained by the two##3##5##(2008-10#3)
results obtained by the##25##4##(2008-10#25)
results obtained by this method were compared with the##2##9##(2008-10#2)
results obtained by this method##4##5##(2008-10#4)
results obtained by this##7##4##(2008-10#7)
results obtained by using this electrode##2##6##(2008-10#2)
results obtained by using##4##4##(2008-10#4)
results obtained by##65##3##(1990-5#1)(1991-9#1)(1993-11#1)(1994-3#1)(2008-10#59)(2008-11#1)(2008-3#1)
results obtained compared##2##3##(2008-10#2)
results obtained for the assay of##2##6##(2008-10#2)
results obtained for the##10##4##(2008-10#10)
results obtained for##34##3##(2008-10#34)
results obtained from in##3##4##(2008-10#2)(2008-11#1)
results obtained from##20##3##(1995-11#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#1)(2010-3#1)
results obtained have##2##3##(1993-8#1)(2008-10#1)
results obtained here##2##3##(2008-10#2)
results obtained in the analysis of##3##6##(2008-10#3)
results obtained in the present study##2##6##(2008-10#1)(2008-5#1)
results obtained in the##12##4##(1992-9#1)(1996-5#1)(2008-10#7)(2008-5#2)(2009-12#1)
results obtained in this##5##4##(2008-10#3)(2008-5#1)(2011-2#1)
results obtained in##27##3##(1992-5#1)(1992-9#1)(1996-5#1)(2008-10#15)(2008-11#1)(2008-5#4)(2009-12#2)(2011-2#1)(2013-8#1)
results obtained indicated##3##3##(2008-10#3)
results obtained it##2##3##(1991-3#1)(2011-2#1)
results obtained on##2##3##(2008-5#1)(2011-3#1)
results obtained show that##5##4##(2008-10#5)
results obtained show##7##3##(2008-10#6)(2008-5#1)
results obtained showed##6##3##(1993-3#1)(2008-10#5)
results obtained using the##7##4##(2008-10#7)
results obtained using##18##3##(2008-10#17)(2009-8#1)
results obtained were in##2##4##(2008-10#2)
results obtained were##15##3##(2008-10#14)(2008-5#1)
results obtained with a##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
results obtained with an##2##4##(2007-12#1)(2008-11#1)
results obtained with both##2##4##(2008-10#1)(2008-3#1)
results obtained with the proposed method##2##6##(2008-10#2)
results obtained with the proposed##3##5##(2008-10#3)
results obtained with the##18##4##(2006-6#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
results obtained with##41##3##(1992-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#23)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
results obtained##312##2##(1990-5#1)(1991-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-5#2)(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#242)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#13)(2008-7#2)(2009-12#2)(2009-8#1)(2010-3#1)(2011-2#7)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
results of MTT##2##3##(2008-8#1)(2011-3#1)
results of Western##4##3##(1995-6#1)(2008-8#1)(2008-9#2)
results of a follow-up##2##4##(1990-3#1)(1991-6#1)
results of a multidisciplinary##2##4##(1994-1#1)(2013-8#1)
results of a pilot##2##4##(1993-1#1)(2010-9#1)
results of a randomized##2##4##(1994-8#1)(2009-12#1)
results of a similar##2##4##(1990-6#1)(1996-11#1)
results of a study of##4##5##(1992-1#1)(1993-9#1)(2009-8#1)(2010-10#1)
results of a study##8##4##(1992-1#1)(1993-3#1)(1993-9#1)(1996-1#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-9#1)
results of a survey##7##4##(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-11#1)
results of a systematic##2##4##(2008-12#1)(2013-1#1)
results of a##74##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
results of all##2##3##(1993-2#1)(2008-10#1)
results of an##12##3##(1990-12#1)(1991-11#1)(1991-8#1)(1993-2#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
results of analyses of##2##4##(2008-10#2)
results of ankle arthrodesis with screws##2##6##(2011-2#2)
results of both##5##3##(1996-6#1)(2008-2#1)(2008-3#1)(2008-7#2)
results of clinical trials##4##4##(1993-12#1)(1995-1#1)(2008-8#1)(2013-1#1)
results of clinical##6##3##(1993-12#1)(1995-1#1)(2008-10#1)(2008-8#1)(2013-1#2)
results of determination of##3##4##(2008-10#2)(2009-8#1)
results of determination##6##3##(2008-10#5)(2009-8#1)
results of experiments##2##3##(2008-11#1)(2008-5#1)
results of human##2##3##(1994-2#1)(2008-10#1)
results of in##2##3##(1995-12#1)(2008-11#1)
results of many##2##3##(2010-10#1)(2013-7#1)
results of our study##5##4##(1992-12#1)(2008-10#2)(2008-8#1)(2012-3#1)
results of our##17##3##(1990-9#1)(1992-12#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2012-3#1)(2013-1#1)(2013-8#3)
results of prospective##2##3##(1997-6#1)(2012-3#1)
results of real sample analysis##2##5##(2008-10#2)
results of real sample##3##4##(2008-10#3)
results of recent##3##3##(1996-11#1)(2008-10#1)(2013-1#1)
results of several##2##3##(2008-10#1)(2012-3#1)
results of six##2##3##(1991-3#1)(2008-10#1)
results of studies on the##2##5##(2008-10#1)(2008-12#1)
results of studies on##3##4##(2008-10#2)(2008-12#1)
results of studies##6##3##(2008-10#4)(2008-12#1)(2008-3#1)
results of such##4##3##(1991-2#1)(1996-12#1)(2013-1#1)(2013-7#1)
results of surgical treatment##2##4##(2008-8#2)
results of the analyses##2##4##(1995-5#1)(2008-11#1)
results of the analysis of synthetic##2##6##(2008-10#2)
results of the analysis##4##4##(1995-12#1)(2008-10#2)(2008-3#1)
results of the first##7##4##(1990-2#1)(1995-3#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-8#1)
results of the investigation##2##4##(2008-10#2)
results of the present study##7##5##(1997-3#1)(2008-10#1)(2008-12#2)(2008-5#1)(2011-7#1)(2012-5#1)
results of the present##8##4##(1997-3#1)(2008-10#1)(2008-12#2)(2008-5#1)(2011-7#1)(2012-5#1)(2013-8#1)
results of the proposed##4##4##(2008-10#3)(2009-8#1)
results of the reflectivity measurements based on##2##7##(2008-3#2)
results of the study##7##4##(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#1)
results of the two##3##4##(2008-10#2)(2008-11#1)
results of the##115##3##(1990-2#2)(1990-9#2)(1991-12#1)(1991-3#2)(1992-1#1)(1992-5#1)(1993-1#1)(1994-1#1)(1995-12#3)(1995-3#2)(1995-5#2)(1996-1#1)(1996-12#1)(1996-6#2)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#38)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-7#2)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#2)
results of their##4##3##(1990-9#1)(1991-1#1)(1996-1#1)(2010-8#1)
results of these analyses##4##4##(1994-1#1)(1995-5#1)(1996-1#1)(2008-10#1)
results of these experiments##4##4##(2008-10#4)
results of these##18##3##(1991-9#1)(1994-1#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(2008-10#8)(2008-11#1)(2008-5#2)
results of this analysis##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
results of this study also show##2##6##(1991-12#1)(1997-2#1)
results of this study are##4##5##(1996-12#1)(1996-2#1)(2008-3#1)(2008-7#1)
results of this study indicate that##9##6##(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2008-10#3)(2009-7#1)(2011-2#1)
results of this study may##2##5##(2008-10#1)(2008-12#1)
results of this study suggest that##7##6##(1994-12#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-7#1)(2013-1#1)
results of this study suggested that##2##6##(1992-2#1)(2011-3#1)
results of this study with##2##5##(2008-11#1)(2009-5#1)
results of this study##52##4##(1991-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-1#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#14)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#2)(2011-2#1)(2011-3#1)(2013-1#2)
results of this##73##3##(1991-12#1)(1991-2#2)(1992-2#1)(1993-12#1)(1994-12#1)(1995-1#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#18)(2008-11#5)(2008-12#9)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#3)
results of total##2##3##(2007-8#1)(2008-10#1)
results of treating the##2##4##(1992-5#1)(2013-1#1)
results of treating##3##3##(1992-5#1)(1996-11#1)(2013-1#1)
results of treatment with##2##4##(1992-2#1)(2013-1#1)
results of treatment##3##3##(1992-2#1)(2008-7#1)(2013-1#1)
results of two##5##3##(1991-2#1)(1996-9#1)(2008-5#1)(2008-6#1)(2011-2#1)
results of##603##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#3)(1990-9#6)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#5)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#3)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#1)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#5)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#4)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#6)(1995-6#2)(1995-8#1)(1996-1#5)(1996-11#3)(1996-12#6)(1996-2#2)(1996-3#2)(1996-6#6)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#152)(2008-11#29)(2008-12#20)(2008-2#6)(2008-3#23)(2008-4#5)(2008-5#20)(2008-6#4)(2008-7#13)(2008-8#17)(2008-9#18)(2009-10#4)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#2)(2009-8#6)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#4)(2010-8#5)(2010-9#3)(2011-1#2)(2011-2#16)(2011-3#4)(2011-7#2)(2012-12#3)(2012-2#8)(2012-3#15)(2012-5#1)(2013-1#22)(2013-7#3)(2013-8#11)
results offer##2##2##(2008-10#1)(2012-2#1)
results on the##9##3##(1991-10#1)(1993-12#1)(2008-10#4)(2008-11#1)(2008-3#2)
results on##22##2##(1990-8#1)(1991-1#1)(1991-10#1)(1991-6#1)(1993-12#1)(1993-3#1)(1995-12#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-6#1)(2013-1#1)(2013-8#1)
results only##3##2##(1994-3#1)(1996-5#1)(2010-2#1)
results open##3##2##(1992-1#1)(2008-10#1)(2008-2#1)
results or##2##2##(1991-12#1)(1994-12#1)
results point to the##4##4##(1990-6#1)(1993-12#1)(1995-2#1)(1995-3#1)
results point to##7##3##(1990-6#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)
results point##8##2##(1990-6#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#1)
results presented here show that##2##5##(2008-10#1)(2008-3#1)
results presented here##11##3##(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-10#1)
results presented in this paper##2##5##(1993-6#1)(2008-10#1)
results presented in this##4##4##(1992-6#1)(1993-6#1)(2008-10#2)
results presented##21##2##(1992-6#1)(1993-6#1)(1995-3#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
results primarily##2##2##(1995-2#1)(2008-8#1)
results prove that##2##3##(1994-5#1)(2008-3#1)
results prove##3##2##(1994-5#1)(2007-8#1)(2008-3#1)
results proved##5##2##(1990-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
results provide a theoretical##2##4##(2008-8#1)(2013-8#1)
results provide a##8##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-12#1)(2013-8#1)
results provide additional##2##3##(1991-10#1)(1992-3#1)
results provide evidence for a##2##5##(1997-2#1)(2013-1#1)
results provide evidence that##5##4##(1993-6#1)(2008-10#3)(2013-1#1)
results provide evidence##8##3##(1993-6#1)(1997-2#1)(2008-10#3)(2009-7#1)(2013-1#2)
results provide information##2##3##(2008-11#1)(2013-8#1)
results provide strong##2##3##(1992-2#1)(1996-8#1)
results provide support for##2##4##(1994-8#1)(2011-2#1)
results provide the##3##3##(1995-2#1)(2008-10#1)(2012-2#1)
results provide useful information for##2##5##(2008-2#1)(2010-5#1)
results provide##48##2##(1991-10#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-6#2)(1994-8#1)(1995-2#2)(1996-8#1)(1997-2#4)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
results provided a##2##3##(2008-10#1)(2008-8#1)
results provided by the proposed method##2##6##(2008-10#2)
results provided##11##2##(2008-10#4)(2008-12#1)(2008-8#2)(2008-9#3)(2012-12#1)
results regarding##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
results relative to the##2##4##(2008-10#2)
results remain##2##2##(1996-5#1)(2008-8#1)
results reported by the labs using the##2##7##(2008-10#2)
results reported from##2##3##(1990-11#1)(1994-3#1)
results reported here##2##3##(2008-10#1)(2008-5#1)
results reported in the literature##3##5##(1994-6#1)(2008-10#1)(2013-1#1)
results reported in##5##3##(1991-2#1)(1994-6#1)(2008-10#2)(2013-1#1)
results reported##12##2##(1990-11#1)(1991-2#1)(1994-3#1)(1994-6#1)(2008-10#6)(2008-5#1)(2013-1#1)
results reveal that the##3##4##(1994-1#1)(2008-10#1)(2012-2#1)
results reveal that##6##3##(1993-12#1)(1994-1#1)(2008-10#1)(2010-10#1)(2012-2#1)(2012-3#1)
results reveal##9##2##(1992-9#1)(1993-12#1)(1994-1#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
results revealed that the##5##4##(2008-10#3)(2008-5#1)(2008-9#1)
results revealed that##20##3##(1994-12#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)
results revealed the##3##3##(1997-3#1)(2008-10#2)
results revealed##27##2##(1991-1#1)(1994-12#1)(1997-3#1)(2008-10#12)(2008-11#2)(2008-12#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)
results should be##6##3##(1991-12#1)(1996-12#1)(1997-5#1)(2010-4#1)(2010-6#1)(2011-1#1)
results should##11##2##(1991-12#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)
results show a##9##3##(1990-5#2)(1993-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)
results show an##3##3##(2008-10#1)(2010-12#1)(2010-5#1)
results show good agreement##2##4##(2008-10#1)(2008-2#1)
results show good##3##3##(2008-10#2)(2008-2#1)
results show that T##2##4##(1996-2#1)(2008-10#1)
results show that a##5##4##(1990-11#1)(1994-2#1)(2006-6#1)(2008-7#1)(2008-8#1)
results show that both##4##4##(1997-3#1)(2008-10#3)
results show that by##2##4##(2008-10#1)(2008-11#1)
results show that in##4##4##(1994-8#1)(2008-10#2)(2008-9#1)
results show that more##2##4##(2008-10#1)(2010-12#1)
results show that only##2##4##(2007-12#1)(2008-3#1)
results show that the interference##2##5##(2008-3#1)(2013-8#1)
results show that the##84##4##(1991-12#1)(1992-4#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#36)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#11)(2008-9#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#6)
results show that there are two##2##6##(2008-3#1)(2008-8#1)
results show that there##4##4##(1991-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
results show that this##5##4##(2008-10#2)(2008-5#2)(2009-8#1)
results show that##207##3##(1990-11#2)(1990-2#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#3)(1994-1#1)(1994-2#2)(1994-3#1)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#69)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#9)(2008-5#6)(2008-7#5)(2008-8#17)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#5)(2012-6#1)(2013-8#7)
results show the potential##2##4##(2008-10#2)
results show the##13##3##(1995-11#1)(1996-12#1)(2008-10#7)(2010-10#1)(2010-4#1)(2012-2#1)(2013-8#1)
results show##250##2##(1990-11#2)(1990-2#1)(1990-5#3)(1991-12#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#5)(1994-1#1)(1994-2#3)(1994-3#1)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#85)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#11)(2008-5#7)(2008-7#5)(2008-8#17)(2008-9#9)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-10#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#5)(2012-6#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#9)
results showed a significant decrease of##2##6##(2008-1#1)(2009-6#1)
results showed a significant decrease##3##5##(2008-1#1)(2008-12#1)(2009-6#1)
results showed a significant##5##4##(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)
results showed a##12##3##(2008-1#1)(2008-10#4)(2008-12#3)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
results showed for##2##3##(2008-10#1)(2008-5#1)
results showed good agreement##2##4##(2008-10#2)
results showed significant##3##3##(2008-12#1)(2010-3#1)(2010-8#1)
results showed that all##2##4##(2008-10#1)(2008-7#1)
results showed that both##4##4##(2008-10#2)(2008-9#1)(2010-10#1)
results showed that in##5##4##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
results showed that the majority of##2##6##(1997-3#1)(2008-8#1)
results showed that the same##2##5##(2008-10#1)(2008-8#1)
results showed that the##50##4##(1996-2#1)(1997-3#1)(2008-10#20)(2008-11#3)(2008-5#4)(2008-8#9)(2008-9#6)(2009-11#1)(2011-2#2)(2011-3#3)
results showed that there##3##4##(1997-3#1)(2008-12#1)(2008-8#1)
results showed that with##2##4##(2011-2#1)(2013-1#1)
results showed that##159##3##(1990-12#1)(1993-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#56)(2008-11#14)(2008-12#4)(2008-5#6)(2008-7#1)(2008-8#18)(2008-9#21)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#4)(2011-3#4)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#5)
results showed the##11##3##(1993-1#1)(2008-10#6)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
results showed##214##2##(1990-12#1)(1991-2#1)(1993-1#1)(1993-6#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#2)(2008-1#2)(2008-10#78)(2008-11#17)(2008-12#9)(2008-5#7)(2008-7#1)(2008-8#20)(2008-9#22)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#8)(2011-3#4)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#6)
results showing##3##2##(1991-11#1)(2008-3#1)(2010-4#1)
results shown##2##2##(2008-10#1)(2008-11#1)
results shows that##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
results similar to those##2##4##(2008-10#2)
results similar to##3##3##(2008-10#2)(2008-3#1)
results strongly suggest that the##2##5##(1994-6#1)(2008-8#1)
results strongly suggest that##9##4##(1991-12#1)(1994-6#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)
results strongly suggest the##2##4##(1994-5#1)(2010-11#1)
results strongly suggest##11##3##(1991-12#1)(1994-5#1)(1994-6#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2010-11#1)
results strongly support##2##3##(1992-3#1)(2008-10#1)
results strongly##15##2##(1991-12#1)(1992-3#1)(1993-8#1)(1994-5#1)(1994-6#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2010-11#1)
results suggest a possible##4##4##(1990-8#1)(1991-1#1)(1991-5#1)(1993-6#1)
results suggest a##14##3##(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-5#1)(1996-2#1)(2010-4#1)(2010-6#1)(2012-3#1)
results suggest that DNA##2##4##(1990-6#1)(2010-5#1)
results suggest that IL-6##2##4##(1990-5#1)(1996-2#1)
results suggest that PKC##2##4##(1993-3#1)(1995-2#1)
results suggest that a##10##4##(1992-6#1)(1993-6#2)(1996-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-10#1)
results suggest that an##4##4##(1990-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
results suggest that both##3##4##(1994-5#1)(2008-10#1)(2008-9#1)
results suggest that in##5##4##(1990-2#1)(1993-3#1)(1993-8#2)(2008-10#1)
results suggest that it##2##4##(2008-10#2)
results suggest that local##2##4##(2008-9#1)(2009-10#1)
results suggest that multiple##2##4##(1991-6#1)(1997-3#1)
results suggest that phage##2##4##(2008-8#1)(2013-1#1)
results suggest that some##3##4##(1996-6#1)(2008-10#1)(2008-9#1)
results suggest that such##2##4##(1993-3#1)(2008-11#1)
results suggest that the amygdala##2##5##(1993-6#2)
results suggest that the inhibition of##3##6##(1993-12#1)(1997-4#1)(2008-11#1)
results suggest that the inhibitory##2##5##(1990-5#1)(1995-11#1)
results suggest that the presence of##2##6##(1990-5#1)(2008-10#1)
results suggest that the role of##2##6##(1996-12#1)(2010-1#1)
results suggest that the##104##4##(1990-2#2)(1990-5#2)(1991-6#1)(1992-1#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#26)(2008-11#9)(2008-12#1)(2008-5#3)(2008-6#2)(2008-8#6)(2008-9#4)(2009-7#1)(2010-1#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
results suggest that there is a##2##6##(2008-3#1)(2010-12#1)
results suggest that there is##5##5##(2008-10#3)(2008-3#1)(2010-12#1)
results suggest that there##9##4##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)
results suggest that these##2##4##(1993-11#1)(2008-10#1)
results suggest that this##2##4##(2008-10#1)(2008-11#1)
results suggest that when##3##4##(1992-10#1)(2008-8#1)(2012-2#1)
results suggest that##414##3##(1990-12#2)(1990-2#7)(1990-5#6)(1990-6#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#5)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#8)(1993-6#6)(1993-8#10)(1994-11#6)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#8)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#3)(1995-9#2)(1996-12#4)(1996-2#10)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#3)(2007-12#2)(2008-10#93)(2008-11#46)(2008-12#4)(2008-3#1)(2008-5#6)(2008-6#6)(2008-7#4)(2008-8#19)(2008-9#17)(2009-10#3)(2009-4#1)(2009-7#2)(2009-8#4)(2010-1#3)(2010-12#3)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#16)(2012-12#1)(2012-2#7)(2012-3#8)(2013-1#7)(2013-8#3)
results suggest the potential##4##4##(1993-11#1)(2008-10#2)(2008-11#1)
results suggest the##24##3##(1990-5#1)(1991-2#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#2)(2013-8#1)
results suggest##473##2##(1990-12#2)(1990-2#7)(1990-5#7)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#6)(1992-4#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#9)(1993-6#8)(1993-8#11)(1994-11#7)(1994-12#6)(1994-2#3)(1994-3#7)(1994-5#3)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#8)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#4)(1995-9#2)(1996-12#5)(1996-2#11)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#3)(2007-12#2)(2008-1#1)(2008-10#103)(2008-11#52)(2008-12#5)(2008-3#1)(2008-5#7)(2008-6#6)(2008-7#6)(2008-8#20)(2008-9#20)(2009-10#3)(2009-4#1)(2009-7#2)(2009-8#4)(2010-1#3)(2010-12#3)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#17)(2012-12#1)(2012-2#7)(2012-3#10)(2013-1#7)(2013-8#4)
results suggested that the##15##4##(1997-7#1)(1997-8#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#2)(2010-4#1)(2011-3#1)(2013-1#1)
results suggested that##33##3##(1991-5#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#6)(2008-11#5)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
results suggested the##2##3##(2008-5#1)(2008-9#1)
results suggested##38##2##(1991-5#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2008-10#6)(2008-11#5)(2008-5#2)(2008-6#1)(2008-8#7)(2008-9#2)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
results suggesting that##2##3##(1993-2#1)(2008-3#1)
results support an##2##3##(1995-2#1)(2013-8#1)
results support that##2##3##(2008-5#1)(2010-1#1)
results support the hypotheses that##3##5##(2008-10#1)(2008-7#1)(2010-6#1)
results support the hypothesis that the##2##6##(2008-10#2)
results support the hypothesis that##9##5##(1992-6#1)(1992-7#1)(1993-8#1)(2008-10#6)
results support the hypothesis##11##4##(1992-6#1)(1992-7#1)(1993-8#1)(2008-10#7)(2010-12#1)
results support the##29##3##(1990-10#1)(1992-12#1)(1992-6#2)(1992-7#1)(1993-8#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2010-5#1)(2010-6#1)(2013-8#1)
results support##40##2##(1990-10#1)(1992-12#1)(1992-6#2)(1992-7#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-5#3)(2008-7#2)(2008-8#4)(2009-12#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2013-8#2)
results supported##2##2##(2008-10#2)
results taken together##3##3##(1990-12#1)(1996-12#1)(2008-11#1)
results than##10##2##(1991-6#1)(1993-11#1)(1997-7#3)(2008-10#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
results that are in##2##4##(1994-5#1)(2008-10#1)
results that are##6##3##(1992-11#1)(1994-5#1)(1997-2#1)(2008-10#2)(2012-12#1)
results that demonstrate the##2##4##(2008-2#1)(2008-3#1)
results that demonstrate##4##3##(2008-2#2)(2008-3#1)(2010-8#1)
results that were##2##3##(2008-10#1)(2012-2#1)
results that##24##2##(1992-11#1)(1994-5#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
results the##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
results thus indicate a##2##4##(1995-2#1)(1996-5#1)
results thus##6##2##(1990-3#1)(1995-2#1)(1996-5#1)(2008-10#2)(2013-1#1)
results to date##3##3##(1990-11#1)(1997-3#1)(2008-4#1)
results to the analysis of##2##5##(2008-10#2)
results to the##7##3##(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
results to those obtained##2##4##(1994-2#1)(2008-10#1)
results to those##4##3##(1991-3#1)(1994-2#1)(1995-12#1)(2008-10#1)
results to##28##2##(1990-11#1)(1991-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2012-12#1)(2013-7#1)
results underscore the##2##3##(1990-6#1)(1997-1#1)
results underscore##3##2##(1990-6#1)(1997-1#1)(2013-1#1)
results using a##2##3##(1994-12#1)(2008-6#1)
results using the##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
results using##12##2##(1994-12#1)(1994-8#1)(1996-3#1)(2008-10#5)(2008-6#2)(2008-8#1)(2011-2#1)
results verify the##3##3##(2008-3#2)(2008-8#1)
results warrant further##2##3##(2008-10#1)(2010-12#1)
results was checked by##2##4##(2008-10#2)
results was checked##3##3##(2008-10#3)
results was##16##2##(1992-12#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
results well##3##2##(2008-10#3)
results were achieved##3##3##(1990-5#1)(1994-1#1)(2008-10#1)
results were also##5##3##(2008-10#3)(2008-5#1)(2010-8#1)
results were analyzed by##2##4##(2008-10#1)(2012-2#1)
results were analyzed##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
results were as follows##4##4##(1990-12#1)(1990-2#1)(1993-8#1)(1995-2#1)
results were comparable##2##3##(2008-10#2)
results were compared to those obtained by##2##7##(2008-10#2)
results were compared to those##5##5##(2008-10#4)(2008-8#1)
results were compared to##7##4##(2008-10#6)(2008-8#1)
results were compared with other##2##5##(2008-10#2)
results were compared with the results obtained##2##7##(2008-10#2)
results were compared with the##6##5##(1996-3#1)(2008-10#5)
results were compared with those obtained by##6##7##(2008-10#6)
results were compared with those obtained using##4##7##(2008-10#4)
results were compared with those obtained with##2##7##(2008-10#2)
results were compared with those obtained##12##6##(2008-10#12)
results were compared with those of the##2##7##(2008-10#2)
results were compared with those of##3##6##(2008-10#3)
results were compared with those##16##5##(2008-10#16)
results were compared with##37##4##(1991-8#1)(1996-3#1)(2007-11#1)(2008-10#32)(2008-12#1)(2012-3#1)
results were compared##53##3##(1991-8#1)(1994-3#1)(1996-3#1)(2007-11#1)(2008-10#46)(2008-12#1)(2008-8#1)(2012-3#1)
results were confirmed by##3##4##(1994-11#1)(2008-10#1)(2011-2#1)
results were confirmed##7##3##(1994-11#1)(2008-10#4)(2008-5#1)(2011-2#1)
results were consistent with the##2##5##(2008-8#1)(2013-1#1)
results were consistent with those##2##5##(2008-10#2)
results were consistent with##4##4##(2008-10#2)(2008-8#1)(2013-1#1)
results were consistent##6##3##(2008-10#3)(2008-8#1)(2013-1#2)
results were discussed in##2##4##(2008-10#1)(2008-12#1)
results were excellent##3##3##(1992-6#1)(1992-9#1)(1996-9#1)
results were found for##4##4##(1997-1#1)(2008-10#1)(2008-9#1)(2010-9#1)
results were found to be in good agreement with##3##9##(2008-10#3)
results were found to be in##4##6##(2008-10#4)
results were found to be##9##5##(1997-2#1)(2008-10#8)
results were found##14##3##(1997-1#1)(1997-2#1)(2008-10#9)(2008-9#1)(2010-9#1)(2011-2#1)
results were further##6##3##(1993-3#1)(1994-11#1)(1997-1#1)(2009-6#1)(2010-6#1)(2011-2#1)
results were in agreement with the certified##2##7##(2008-10#2)
results were in agreement with those obtained by##3##8##(2008-10#3)
results were in agreement with those##4##6##(2008-10#4)
results were in agreement with##6##5##(2008-10#6)
results were in good agreement with those obtained by##2##9##(2008-10#2)
results were in good agreement with those obtained##3##8##(2008-10#3)
results were in good agreement with those##7##7##(2008-10#7)
results were in good agreement with##13##6##(2008-10#13)
results were in##21##3##(2008-10#21)
results were interpreted##7##3##(1990-11#1)(1993-8#1)(1994-5#1)(2008-10#2)(2008-5#2)
results were not##3##3##(1991-2#1)(1992-2#1)(2008-11#1)
results were observed##3##3##(2008-5#1)(2008-8#1)(2013-1#1)
results were obtained at##2##4##(2008-10#2)
results were obtained by##7##4##(2008-10#6)(2008-5#1)
results were obtained for all##2##5##(2008-10#2)
results were obtained for the##4##5##(1994-11#1)(2008-10#3)
results were obtained for##11##4##(1994-11#1)(2008-10#10)
results were obtained in the determination of##3##7##(2008-10#3)
results were obtained in the##6##5##(2008-10#5)(2008-11#1)
results were obtained in##9##4##(2008-10#7)(2008-11#1)(2008-7#1)
results were obtained using the##2##5##(2008-10#1)(2008-3#1)
results were obtained using##9##4##(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#2)
results were obtained when##4##4##(2008-10#4)
results were obtained with a##3##5##(2008-10#2)(2008-5#1)
results were obtained with the##7##5##(1995-8#1)(1997-3#1)(2008-10#4)(2008-11#1)
results were obtained with##17##4##(1995-12#1)(1995-8#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-5#1)
results were obtained##76##3##(1990-2#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-3#1)(2008-10#58)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-6#1)
results were satisfactory##5##3##(2008-10#5)
results were similar to those##2##5##(2008-10#1)(2008-8#1)
results were similar to##3##4##(2008-10#2)(2008-8#1)
results were similar##6##3##(1994-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
results were statistically compared with##2##5##(2008-10#2)
results were statistically compared##3##4##(2008-10#3)
results were statistically##5##3##(2008-10#4)(2010-5#1)
results were still##2##3##(2008-10#1)(2011-2#1)
results were then##2##3##(2008-10#1)(2012-2#1)
results were used for##2##4##(2008-10#2)
results were used##5##3##(2008-10#5)
results were##294##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-2#2)(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#191)(2008-11#7)(2008-12#4)(2008-3#4)(2008-5#10)(2008-7#4)(2008-8#5)(2008-9#3)(2009-6#2)(2010-1#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)
results when the##2##3##(2008-10#2)
results when##10##2##(1994-3#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-9#1)
results will be##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)
results will facilitate##3##3##(2008-8#1)(2008-9#2)
results will help##2##3##(2008-9#1)(2010-6#1)
results will##13##2##(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#4)(2008-9#3)(2010-6#1)
results with a##4##3##(1992-9#1)(1993-8#1)(2008-10#2)
results with the##11##3##(2008-10#6)(2008-2#1)(2008-7#2)(2008-8#1)(2009-3#1)
results with those obtained by##5##5##(2008-10#5)
results with those obtained from##2##5##(2008-10#1)(2008-7#1)
results with those obtained##8##4##(2008-10#6)(2008-2#1)(2008-7#1)
results with those of the##2##5##(2008-7#1)(2010-11#1)
results with those of##4##4##(2008-10#2)(2008-7#1)(2010-11#1)
results with those##14##3##(2008-10#9)(2008-2#1)(2008-5#1)(2008-7#2)(2010-11#1)
results with##62##2##(1991-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1996-8#1)(2008-10#29)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#3)(2013-1#2)
results within##8##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-3#1)(2012-2#1)
results would##2##2##(2008-10#1)(2008-9#1)
results##5280##1##(1990-10#2)(1990-11#10)(1990-12#26)(1990-2#20)(1990-3#7)(1990-5#24)(1990-6#11)(1990-7#1)(1990-8#11)(1990-9#13)(1991-1#9)(1991-10#2)(1991-11#6)(1991-12#25)(1991-2#20)(1991-3#19)(1991-5#14)(1991-6#15)(1991-7#2)(1991-8#5)(1991-9#13)(1992-1#9)(1992-10#4)(1992-11#1)(1992-12#19)(1992-2#8)(1992-3#25)(1992-4#4)(1992-5#5)(1992-6#12)(1992-7#2)(1992-8#5)(1992-9#13)(1993-1#9)(1993-11#21)(1993-12#29)(1993-2#15)(1993-3#26)(1993-6#25)(1993-8#39)(1993-9#4)(1994-1#9)(1994-11#24)(1994-12#23)(1994-2#17)(1994-3#30)(1994-5#22)(1994-6#8)(1994-8#29)(1994-9#5)(1995-1#6)(1995-11#31)(1995-12#28)(1995-2#37)(1995-3#9)(1995-5#8)(1995-6#14)(1995-8#13)(1995-9#4)(1996-1#8)(1996-11#8)(1996-12#37)(1996-2#32)(1996-3#16)(1996-5#16)(1996-6#16)(1996-8#4)(1996-9#8)(1997-1#25)(1997-2#33)(1997-3#28)(1997-4#6)(1997-5#4)(1997-6#13)(1997-7#20)(1997-8#21)(1997-9#1)(2006-6#4)(2007-11#9)(2007-12#26)(2007-8#5)(2008-1#17)(2008-10#1862)(2008-11#301)(2008-12#84)(2008-2#39)(2008-3#163)(2008-4#19)(2008-5#146)(2008-6#26)(2008-7#106)(2008-8#224)(2008-9#175)(2009-1#1)(2009-10#25)(2009-11#5)(2009-12#15)(2009-3#14)(2009-4#4)(2009-5#11)(2009-6#7)(2009-7#18)(2009-8#33)(2009-9#7)(2010-1#13)(2010-10#18)(2010-11#9)(2010-12#31)(2010-2#5)(2010-3#5)(2010-4#20)(2010-5#12)(2010-6#26)(2010-7#14)(2010-8#29)(2010-9#6)(2011-1#17)(2011-10#3)(2011-2#155)(2011-3#27)(2011-7#3)(2012-12#25)(2012-2#72)(2012-3#75)(2012-5#2)(2012-6#2)(2012-9#2)(2013-1#145)(2013-7#6)(2013-8#69)
results]##4##1##(1990-9#1)(1992-2#1)(1996-11#1)(2007-8#1)
resume the##2##2##(2008-9#1)(2013-1#1)
resume##6##1##(2008-11#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
resumed##4##1##(1993-6#1)(1994-3#1)(2011-2#1)(2012-12#1)
resumption##3##1##(1996-3#1)(2008-1#1)(2008-10#1)
resurfacing##3##1##(2009-4#1)(2012-2#2)
resurgence in the##3##3##(2008-11#1)(2008-8#1)(2009-12#1)
resurgence of interest in##3##4##(1997-7#1)(2008-7#1)(2013-1#1)
resurgence of##5##2##(1994-9#1)(1997-7#1)(2008-12#1)(2008-7#1)(2013-1#1)
resurgence##8##1##(1994-9#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#1)
resurrect##2##1##(1995-12#1)(2008-8#1)
resuscitated and##2##2##(2010-7#1)(2012-3#1)
resuscitated##3##1##(1996-6#1)(2010-7#1)(2012-3#1)
resuscitation guidelines##2##2##(2008-11#2)
resuscitation package##2##2##(2011-2#2)
resuscitation##32##1##(1990-12#1)(1990-9#4)(1994-3#1)(1994-6#2)(1994-9#2)(1995-11#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-3#1)
resuspended in##2##2##(2008-11#1)(2008-8#1)
resuspended##6##1##(2008-10#1)(2008-11#2)(2008-8#3)
resveratrol in##2##2##(2008-7#2)
resveratrol##20##1##(2008-10#10)(2008-11#2)(2008-5#3)(2008-7#2)(2012-4#3)
resynchronisation therapy##2##2##(2008-10#1)(2012-2#1)
resynchronisation##3##1##(2008-10#2)(2012-2#1)
resynchronization##4##1##(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)
ret##3##1##(1993-8#3)
retail##8##1##(1991-12#1)(1993-3#2)(1994-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
retailing##3##1##(1994-12#3)
retain a##5##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#2)
retain the##9##2##(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-1#1)
retain their##2##2##(1991-5#1)(2008-4#1)
retain##39##1##(1991-12#1)(1991-5#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
retained Cr(VI)##3##2##(2008-10#3)
retained a good activity##2##4##(2008-10#2)
retained a##3##2##(2008-10#2)(2010-11#1)
retained analytes##2##2##(2008-10#2)
retained and promoted children##2##4##(2008-12#2)
retained and##10##2##(1990-5#1)(1995-2#3)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#2)
retained as##3##2##(2008-10#2)(2008-11#1)
retained at pH##2##3##(2008-10#2)
retained at##6##2##(2008-10#5)(2008-9#1)
retained by the##2##3##(2008-10#2)
retained by##12##2##(1992-2#1)(1992-6#1)(1993-1#1)(1995-2#1)(2008-10#6)(2013-1#2)
retained in the##14##3##(1992-12#1)(1995-2#1)(2008-10#7)(2008-9#2)(2011-2#2)(2012-12#1)
retained in##19##2##(1992-12#1)(1995-12#1)(1995-2#1)(2008-10#10)(2008-7#1)(2008-9#2)(2011-2#2)(2012-12#1)
retained its##8##2##(1991-12#1)(1995-11#1)(1997-1#1)(2008-10#4)(2008-5#1)
retained on C(18)##3##3##(2008-10#3)
retained on a##6##3##(2008-10#6)
retained on the column##3##4##(2008-10#3)
retained on the filter##2##4##(2008-10#2)
retained on the sorbent##2##4##(2008-10#2)
retained on the surface##2##4##(2008-10#1)(2012-2#1)
retained on the##18##3##(2008-10#17)(2012-2#1)
retained on##35##2##(2008-10#34)(2012-2#1)
retained the ability to##2##4##(2008-10#2)
retained the bacteria##2##3##(2008-10#2)
retained the##9##2##(1997-2#1)(2008-10#4)(2008-11#2)(2011-2#1)(2013-1#1)
retained their##5##2##(1996-12#1)(2008-10#3)(2011-2#1)
retained within the##2##3##(2008-8#2)
retained##182##1##(1990-5#3)(1991-12#1)(1991-3#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#104)(2008-11#6)(2008-12#6)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#4)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#6)
retaining the##4##2##(1991-5#1)(2008-10#2)(2008-3#1)
retaining their##2##2##(1993-2#1)(2008-11#1)
retaining##28##1##(1991-5#1)(1991-9#1)(1992-3#2)(1993-2#1)(1993-8#1)(1994-1#1)(1995-2#2)(1996-3#2)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
retains its##2##2##(2008-10#1)(2009-3#1)
retains the##7##2##(1990-5#2)(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)
retains##15##1##(1990-5#2)(1993-8#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-3#1)
retard##6##1##(1992-9#1)(1997-4#1)(2008-10#1)(2008-11#2)(2013-1#1)
retardance##3##1##(2008-3#3)
retardation and##7##2##(1993-3#1)(1995-2#2)(2008-10#2)(2013-1#2)
retardation in the##2##3##(1995-6#1)(2008-11#1)
retardation of the##4##3##(2008-10#3)(2008-11#1)
retardation of##8##2##(1991-5#1)(2008-10#6)(2008-11#1)
retardation or##3##2##(1993-3#1)(1997-3#1)(2008-10#1)
retardation##44##1##(1991-5#1)(1992-6#1)(1993-3#5)(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-2#2)(1995-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#3)(2008-8#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#2)
retarded and##2##2##(1993-1#1)(2008-11#1)
retarded growth##3##2##(1991-6#1)(1995-9#1)(2013-8#1)
retarded in##2##2##(1997-8#1)(2008-10#1)
retarded##24##1##(1991-1#2)(1991-6#3)(1993-1#2)(1995-9#1)(1997-8#5)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2013-8#1)
retarder##5##1##(2008-2#1)(2008-3#2)(2010-4#2)
retarding##2##1##(2008-8#1)(2010-1#1)
retards##4##1##(1995-6#1)(2008-7#2)(2009-8#1)
retentate and filtrate##2##3##(2008-10#1)(2008-7#1)
retentate and##3##2##(2008-10#2)(2008-7#1)
retentate##6##1##(2008-10#3)(2008-12#1)(2008-7#2)
retentates##3##1##(2008-10#1)(2008-12#2)
retention among##2##2##(2010-6#1)(2013-8#1)
retention and complexation mechanisms##3##4##(2008-10#3)
retention and elution conditions##3##4##(2008-10#3)
retention and elution##6##3##(2008-10#6)
retention and enantioselectivity of##2##4##(2008-10#2)
retention and enantioselectivity were##2##4##(2008-10#2)
retention and enantioselectivity##4##3##(2008-10#4)
retention and selectivity##4##3##(2008-10#4)
retention and##36##2##(1993-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
retention at##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
retention behavior of##4##3##(2008-10#4)
retention behavior##10##2##(2008-10#10)
retention behaviors of polyaromatic hydrocarbons##2##5##(2008-10#2)
retention behaviour##3##2##(2008-10#3)
retention characteristics##2##2##(2008-10#2)
retention efficiencies##2##2##(2008-10#2)
retention efficiency##4##2##(2008-10#4)
retention factor##4##2##(2008-10#4)
retention factors of##2##3##(2008-10#2)
retention for##3##2##(1994-3#1)(1995-12#1)(2008-10#1)
retention in the##5##3##(1995-12#1)(1996-3#1)(2008-11#1)(2009-12#1)(2013-8#1)
retention in##11##2##(1995-12#1)(1996-3#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-12#1)(2009-9#1)(2013-8#2)
retention increased##2##2##(2008-10#1)(2008-11#1)
retention index##3##2##(2008-10#2)(2011-2#1)
retention indicated that##2##3##(1990-2#1)(2008-10#1)
retention indices for##2##3##(2008-10#2)
retention indices of##3##3##(2008-10#3)
retention indices##8##2##(2008-10#8)
retention is##5##2##(1993-12#1)(2008-10#3)(2008-8#1)
retention mechanism of##2##3##(2008-10#2)
retention mechanism##6##2##(2008-10#6)
retention mechanisms of the##2##4##(2008-10#2)
retention mechanisms##5##2##(2008-10#5)
retention of arsenic##2##3##(1995-11#2)
retention of the##6##3##(1994-8#1)(1995-12#1)(2008-10#3)(2013-8#1)
retention of viable cells in##2##5##(2008-11#2)
retention of##59##2##(1991-2#1)(1992-7#1)(1993-3#1)(1994-1#1)(1994-3#3)(1994-8#1)(1995-11#2)(1995-12#3)(1996-12#1)(1996-3#2)(1996-5#1)(1997-4#1)(2008-10#22)(2008-11#5)(2008-12#1)(2008-9#1)(2009-5#2)(2009-6#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#1)
retention on the##2##3##(2008-10#1)(2008-12#1)
retention on##3##2##(2008-10#1)(2008-12#2)
retention performance##4##2##(1994-8#1)(2008-10#1)(2008-11#2)
retention process##3##2##(2008-10#3)
retention time and##2##3##(2008-10#1)(2008-5#1)
retention time of##5##3##(2008-10#2)(2008-11#2)(2011-3#1)
retention time##21##2##(1991-1#1)(2008-10#10)(2008-11#4)(2008-5#1)(2008-9#2)(2010-6#1)(2011-3#2)
retention times and##3##3##(1997-2#1)(2008-10#1)(2010-11#1)
retention times are##2##3##(2008-10#2)
retention times of the##3##4##(2008-10#1)(2008-11#2)
retention times of##8##3##(1992-6#1)(2008-10#4)(2008-11#2)(2009-8#1)
retention times##27##2##(1992-6#4)(1997-2#1)(2008-10#18)(2008-11#2)(2009-8#1)(2010-11#1)
retention was##6##2##(1997-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2012-2#1)
retention##323##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#5)(1992-12#1)(1992-6#4)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#5)(1994-5#1)(1994-8#3)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#2)(2008-10#159)(2008-11#29)(2008-12#9)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#3)(2009-12#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#2)(2010-4#1)(2010-6#3)(2011-2#11)(2011-3#5)(2012-2#6)(2013-1#5)(2013-8#6)
retention)##2##1##(1996-1#1)(2008-8#1)
retested##4##1##(1994-3#1)(2012-2#1)(2013-1#2)
retesting##2##1##(1996-12#2)
rethink the##3##2##(2011-3#1)(2012-3#1)(2013-8#1)
rethink##5##1##(1995-2#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
rethinking##5##1##(1995-12#1)(1996-1#1)(1996-2#1)(2008-11#1)(2011-2#1)
reticular and erosive##2##3##(2013-1#2)
reticular and##4##2##(1997-2#1)(2013-1#3)
reticular formation##6##2##(1990-9#4)(1997-3#2)
reticular##18##1##(1990-9#4)(1991-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#2)(2008-7#1)(2011-2#1)(2013-1#6)
reticularis##3##1##(1990-5#1)(2008-6#1)(2012-3#1)
reticulata##2##1##(1995-2#1)(2008-10#1)
reticulata) and##2##2##(2008-10#2)
reticulata)##6##1##(2008-10#3)(2008-8#3)
reticulated platelets##7##2##(2006-6#5)(2008-9#2)
reticulated vitreous carbon##4##3##(2008-10#4)
reticulated##12##1##(1997-8#1)(2006-6#5)(2008-10#4)(2008-9#2)
reticulation##2##1##(2008-10#1)(2009-6#1)
reticulocyte##10##1##(1990-11#1)(1991-10#1)(1993-12#1)(1993-2#2)(1995-8#1)(2006-6#2)(2008-1#1)(2008-9#1)
reticulocytes by##2##2##(1993-2#1)(1996-2#1)
reticulocytes in##3##2##(1996-2#1)(2008-9#2)
reticulocytes is##2##2##(1993-2#2)
reticulocytes##17##1##(1993-2#3)(1996-2#5)(2008-9#8)(2010-8#1)
reticuloendothelial cells##3##2##(1992-10#2)(1997-7#1)
reticuloendotheliosis##2##1##(2008-5#2)
reticulum aminopeptidase##2##2##(2012-2#2)
reticulum and##12##2##(1994-11#1)(1995-5#1)(2007-12#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)
reticulum was##2##2##(2008-11#1)(2009-7#1)
reticulum##81##1##(1990-2#2)(1991-10#1)(1991-2#2)(1991-9#1)(1992-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-3#3)(1997-1#1)(1997-7#1)(2007-12#4)(2008-10#2)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#8)(2008-8#7)(2009-10#1)(2009-7#3)(2009-8#5)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
retina and the##2##3##(2008-8#1)(2011-2#1)
retina and##9##2##(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#2)
retina explants##3##2##(2010-1#3)
retina in vivo##2##3##(2010-1#2)
retina in##3##2##(2010-1#2)(2011-2#1)
retina##55##1##(1991-10#3)(1993-3#1)(1993-9#1)(1996-12#2)(1996-2#2)(2008-1#3)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2010-1#11)(2010-8#1)(2011-2#7)(2011-7#2)(2012-3#1)(2013-1#2)
retinal and choroidal##2##3##(2010-1#1)(2011-7#1)
retinal artery##2##2##(2010-3#1)(2013-7#1)
retinal degeneration##4##2##(2008-7#1)(2011-1#1)(2012-3#2)
retinal detachment##2##2##(2013-1#1)(2013-8#1)
retinal diseases##2##2##(2010-10#2)
retinal imaging##2##2##(2011-7#2)
retinal on-bipolar cell##3##3##(1993-8#3)
retinal pericyte##2##2##(1993-3#1)(2012-4#1)
retinal pigment epithelial cells##5##4##(1993-3#3)(2008-12#1)(2012-3#1)
retinal pigment epithelial##6##3##(1993-3#3)(2008-12#1)(2010-10#1)(2012-3#1)
retinal pigment epithelium##4##3##(2008-7#1)(2011-7#2)(2012-3#1)
retinal pigment##11##2##(1993-3#3)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-7#2)(2012-3#2)
retinal thickness##2##2##(2011-2#1)(2011-7#1)
retinal tissue in##2##3##(1996-12#2)
retinal toxicity secondary to hydroxychloroquine##2##5##(2013-1#2)
retinal toxicity##6##2##(2013-1#6)
retinal vascular##2##2##(2009-10#2)
retinal vein occlusion##3##3##(2011-2#2)(2013-1#1)
retinal##98##1##(1990-3#1)(1991-2#1)(1993-3#4)(1993-8#4)(1993-9#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-12#2)(1997-1#2)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#4)(2009-12#1)(2009-6#2)(2010-1#2)(2010-10#4)(2010-3#1)(2011-1#1)(2011-2#11)(2011-7#13)(2011-9#2)(2012-3#4)(2012-4#3)(2013-1#14)(2013-7#1)(2013-8#2)
retinitis pigmentosa and##2##3##(2008-7#1)(2008-9#1)
retinitis##3##1##(2008-7#1)(2008-9#1)(2011-2#1)
retinoblastoma gene##2##2##(1997-7#2)
retinoblastoma##5##1##(1995-11#1)(1997-7#2)(2008-11#1)(2011-2#1)
retinoic acid (RA)##5##3##(1990-6#1)(1995-9#1)(2008-11#1)(2008-5#2)
retinoic acid in##4##3##(1990-6#1)(1994-11#1)(2007-11#1)(2011-2#1)
retinoic acid##30##2##(1990-6#2)(1991-9#2)(1993-3#6)(1994-11#3)(1995-9#1)(2007-11#2)(2008-11#3)(2008-5#4)(2008-8#1)(2009-6#2)(2011-2#2)(2013-1#2)
retinoic##34##1##(1990-6#2)(1991-9#2)(1993-3#7)(1994-11#3)(1995-9#1)(1997-7#2)(2007-11#2)(2008-11#3)(2008-5#4)(2008-8#1)(2009-10#1)(2009-6#2)(2011-2#2)(2013-1#2)
retinoid X receptor##2##3##(1995-8#1)(2012-12#1)
retinoid X receptors##2##3##(1995-8#1)(2008-10#1)
retinoid X##5##2##(1995-8#3)(2008-10#1)(2012-12#1)
retinoid##10##1##(1995-8#3)(2007-11#2)(2008-10#1)(2008-5#1)(2009-6#1)(2010-4#1)(2012-12#1)
retinoids may##2##2##(1994-6#2)
retinoids##6##1##(1994-6#3)(2007-11#2)(2008-5#1)
retinol and##3##2##(2009-6#3)
retinol deficient groups##2##3##(1994-8#2)
retinol deficient##7##2##(1994-8#7)
retinol in##2##2##(2008-5#2)
retinol per se##3##3##(2008-5#3)
retinol##36##1##(1993-2#1)(1994-8#9)(2008-5#18)(2009-6#6)(2010-6#1)(2013-1#1)
retinol'##2##1##(2008-5#2)
retinol-binding protein and asialo-orosomucoid##2##4##(1995-6#2)
retinol-binding protein is##2##3##(1995-6#2)
retinol-binding protein##7##2##(1990-12#1)(1995-6#5)(2009-6#1)
retinol-deficient##2##1##(1994-8#2)
retinopathy##30##1##(1991-12#1)(1991-8#1)(1991-9#1)(1993-9#1)(1995-9#5)(1996-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-10#7)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
retinula cells##2##2##(2007-12#2)
retinula##3##1##(2007-12#3)
retinyl acetate and tocopherols##2##4##(2008-10#2)
retinyl acetate##3##2##(2008-10#3)
retired workers who##2##3##(1993-1#2)
retired workers##3##2##(1993-1#3)
retired##5##1##(1991-12#1)(1993-1#3)(2008-11#1)
retiree##2##1##(1992-2#1)(1995-1#1)
retirees##3##1##(1991-12#2)(1992-2#1)
retirement plan##2##2##(1992-3#2)
retirement##13##1##(1991-2#2)(1992-3#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
retract##3##1##(2008-5#1)(2010-9#1)(2013-1#1)
retracted##6##1##(1992-1#1)(2008-10#5)
retracting this article##2##3##(2008-10#2)
retracting##3##1##(1992-1#1)(2008-10#2)
retraction of the##2##3##(2008-10#1)(2008-11#1)
retraction of##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
retraction##8##1##(1997-4#1)(2008-10#2)(2008-11#2)(2011-2#2)(2013-1#1)
retractor##5##1##(1990-2#1)(1992-1#4)
retransfusion##3##1##(1990-2#2)(2009-3#1)
retreatment##2##1##(2011-2#1)(2012-12#1)
retrenchment##2##1##(1995-3#2)
retrenchment)##2##1##(1995-3#2)
retrievable##2##1##(2008-10#2)
retrieval and##2##2##(2008-11#1)(2011-3#1)
retrieval error##2##2##(2008-3#2)
retrieval in##2##2##(1994-8#1)(2008-3#1)
retrieval is##2##2##(2008-3#1)(2013-8#1)
retrieval of dilysine-tagged proteins##2##4##(1994-12#2)
retrieval of information##2##3##(2008-11#1)(2008-3#1)
retrieval of the##7##3##(1993-12#1)(2008-2#1)(2008-3#5)
retrieval of urban##2##3##(2008-3#2)
retrieval of##24##2##(1993-12#2)(1994-12#2)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#13)(2008-6#1)(2008-8#1)
retrieval performance##2##2##(2008-3#1)(2009-10#1)
retrieval software##2##2##(2008-3#2)
retrieval techniques##2##2##(2008-11#1)(2008-9#1)
retrieval was##2##2##(1994-12#2)
retrieval with##2##2##(2008-8#2)
retrieval##87##1##(1992-1#3)(1993-12#2)(1993-6#1)(1994-12#7)(1994-3#1)(1994-8#3)(1997-2#1)(2007-12#4)(2008-11#8)(2008-2#5)(2008-3#35)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#2)(2010-12#1)(2011-3#1)(2012-12#1)(2013-8#1)
retrievals from##2##2##(2008-2#1)(2008-3#1)
retrievals of##4##2##(2008-2#1)(2008-3#3)
retrievals##13##1##(1992-12#1)(2008-2#4)(2008-3#8)
retrieve the##9##2##(1997-3#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
retrieve##20##1##(1994-3#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
retrieved at##2##2##(1993-11#1)(2008-10#1)
retrieved cloud optical thicknesses from##2##5##(2008-2#2)
retrieved from the##2##3##(2008-3#2)
retrieved from##4##2##(1995-3#1)(2008-10#1)(2008-3#2)
retrieved in##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
retrieved through##2##2##(2008-3#1)(2012-2#1)
retrieved with##4##2##(2008-3#4)
retrieved##42##1##(1993-11#1)(1994-3#3)(1995-3#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#21)(2008-8#1)(2008-9#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
retriever##5##1##(2013-8#5)
retrieving the##2##2##(2008-3#2)
retrieving##7##1##(1994-3#2)(1997-2#1)(2008-3#2)(2008-6#1)(2009-12#1)
retro-portal##2##1##(2012-2#2)
retroauricular##5##1##(2008-7#3)(2008-9#2)
retroelement##2##1##(1995-12#1)(2008-10#1)
retroelements##2##1##(1995-12#1)(2008-10#1)
retroesophageal##2##1##(2008-11#1)(2011-3#1)
retrograde axonal##2##2##(1996-2#1)(2007-12#1)
retrograde balloon dilatation##2##3##(2013-1#2)
retrograde labeling##2##2##(1990-5#1)(1991-12#1)
retrograde transport of##2##3##(1997-2#1)(2008-7#1)
retrograde transport##4##2##(1991-12#2)(1997-2#1)(2008-7#1)
retrograde##22##1##(1990-11#1)(1990-5#1)(1991-12#4)(1991-3#1)(1992-12#1)(1994-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-9#1)(2013-1#5)
retrogradely##5##1##(1991-12#4)(1997-2#1)
retropatellar crepitus##2##2##(2011-2#2)
retroperitoneal approach##3##2##(2008-10#1)(2012-12#2)
retroperitoneal benign##2##2##(2012-3#1)(2013-1#1)
retroperitoneal dissection##2##2##(1994-3#2)
retroperitoneal fibrosis##3##2##(2009-8#2)(2013-1#1)
retroperitoneal hemangiopericytoma##2##2##(1993-6#2)
retroperitoneal liposarcoma##3##2##(1990-9#2)(2009-9#1)
retroperitoneal malignant schwannoma##2##3##(1994-6#2)
retroperitoneal malignant##3##2##(1994-6#3)
retroperitoneal soft tissue sarcomas##3##4##(1992-12#3)
retroperitoneal tumors of the pelvic##2##5##(1990-5#2)
retroperitoneal tumors##3##2##(1990-5#2)(2013-1#1)
retroperitoneal##43##1##(1990-5#2)(1990-9#3)(1992-12#3)(1993-6#2)(1994-3#3)(1994-6#4)(1996-6#1)(2008-10#1)(2009-8#2)(2009-9#2)(2010-11#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#4)
retroperitoneoscopic##8##1##(2008-10#3)(2012-12#5)
retroperitoneum##5##1##(1992-12#1)(1993-6#1)(2009-1#1)(2009-9#1)(2012-3#1)
retroreflected##3##1##(2008-2#2)(2008-3#1)
retroreflection##2##1##(2008-3#2)
retroreflective##3##1##(2008-3#1)(2011-2#1)(2013-1#1)
retroreflector##7##1##(2008-3#7)
retroreflectors##4##1##(2008-3#4)
retrosigmoid##2##1##(2011-2#2)
retrospective analysis of##16##3##(1990-6#1)(1990-9#1)(1993-11#2)(1993-9#1)(1994-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
retrospective analysis was##2##3##(1995-11#1)(2011-2#1)
retrospective analysis##23##2##(1990-6#1)(1990-9#1)(1993-11#2)(1993-9#1)(1994-12#1)(1995-11#1)(1996-11#2)(1997-3#1)(1997-8#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)
retrospective approach##2##2##(2008-11#2)
retrospective case series##3##3##(2011-2#1)(2012-3#1)(2013-7#1)
retrospective case##5##2##(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
retrospective chart review of##4##4##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
retrospective chart review##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
retrospective chart##7##2##(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
retrospective clinical study of##2##4##(2010-5#1)(2012-3#1)
retrospective clinical##3##2##(2010-5#1)(2011-2#1)(2012-3#1)
retrospective cohort analysis##3##3##(1996-11#1)(2012-2#1)(2013-8#1)
retrospective cohort study##3##3##(2010-10#1)(2012-3#1)(2013-1#1)
retrospective cohort##7##2##(1996-11#1)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
retrospective comparison of##2##3##(1992-9#1)(2013-8#1)
retrospective data analysis##2##3##(2008-6#1)(2011-2#1)
retrospective data##5##2##(1994-6#1)(2008-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
retrospective descriptive study of##2##4##(2012-12#1)(2012-2#1)
retrospective evaluation of##2##3##(1993-6#1)(2007-11#1)
retrospective medical##2##2##(2008-11#1)(2012-3#1)
retrospective review of the##2##4##(2008-9#1)(2010-12#1)
retrospective review of##12##3##(1995-12#1)(1997-8#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
retrospective review was##2##3##(1996-1#1)(2009-10#1)
retrospective review##18##2##(1994-3#1)(1995-12#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
retrospective series##3##2##(1990-12#1)(1994-6#1)(2013-1#1)
retrospective studies##3##2##(1996-6#1)(2008-7#1)(2012-3#1)
retrospective study is##2##3##(1997-5#1)(2008-11#1)
retrospective study of##10##3##(1993-11#1)(1995-1#1)(1995-5#1)(2007-8#1)(2009-1#1)(2010-11#1)(2011-2#2)(2012-3#2)
retrospective study was carried out##2##5##(1991-8#2)
retrospective study was undertaken##2##4##(1990-12#1)(1996-1#1)
retrospective study was##9##3##(1990-12#1)(1990-6#1)(1991-8#2)(1996-1#1)(1997-8#1)(2011-2#2)(2012-12#1)
retrospective study were to##2##4##(2012-3#1)(2013-1#1)
retrospective study##47##2##(1990-12#1)(1990-6#1)(1991-8#2)(1993-11#1)(1993-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-6#1)(1997-5#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-11#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#7)(2013-1#3)
retrospective##169##1##(1990-12#3)(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-9#1)(1993-11#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-1#2)(1996-11#6)(1996-6#3)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#3)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#20)(2012-12#6)(2012-2#6)(2012-3#16)(2013-1#12)(2013-7#1)(2013-8#3)
retrospectively analysed##3##2##(1991-3#1)(2011-2#1)(2013-1#1)
retrospectively analyzed##7##2##(1993-2#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#3)
retrospectively and the##2##3##(1997-8#1)(2013-1#1)
retrospectively and##3##2##(1997-8#2)(2013-1#1)
retrospectively enrolled##2##2##(2012-3#1)(2013-1#1)
retrospectively evaluate the##2##3##(2011-1#1)(2011-2#1)
retrospectively examined##2##2##(1997-8#1)(2011-2#1)
retrospectively identified##2##2##(2009-8#1)(2012-2#1)
retrospectively in##2##2##(1994-12#1)(1997-3#1)
retrospectively investigated##2##2##(2008-7#1)(2013-8#1)
retrospectively reviewed to##2##3##(2012-2#1)(2012-3#1)
retrospectively reviewed##10##2##(1997-8#1)(2008-12#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
retrospectively studied##4##2##(1995-10#1)(2008-1#1)(2010-8#1)(2011-2#1)
retrospectively to##2##2##(1990-6#1)(2008-11#1)
retrospectively##62##1##(1990-6#1)(1991-2#2)(1991-3#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-8#6)(2008-1#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#4)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#9)(2013-1#7)(2013-8#1)
retrotransposon##6##1##(1995-5#2)(2008-10#1)(2009-10#1)(2012-3#2)
retrotransposons##2##1##(2008-10#1)(2008-11#1)
retroviral replication##4##2##(1995-2#3)(2011-3#1)
retroviral vector in##3##3##(2008-11#3)
retroviral vector that##2##3##(1997-8#1)(2008-11#1)
retroviral vector##14##2##(1994-5#1)(1997-8#2)(2008-11#8)(2008-8#1)(2008-9#2)
retroviral vectors are##2##3##(1995-2#1)(2008-11#1)
retroviral vectors for##2##3##(1994-5#1)(2008-11#1)
retroviral vectors##9##2##(1994-5#1)(1995-2#1)(1997-8#2)(2008-11#5)
retroviral##48##1##(1992-6#1)(1994-12#1)(1994-5#3)(1995-2#6)(1997-3#2)(1997-8#4)(2008-10#1)(2008-11#19)(2008-4#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2011-3#1)(2012-3#1)
retroviral-mediated##2##1##(1995-2#1)(1997-7#1)
retrovirus carrying the##2##3##(2008-11#2)
retrovirus particles##6##2##(2008-11#6)
retrovirus vector##5##2##(1994-5#1)(1997-8#2)(2008-11#1)(2008-8#1)
retrovirus##29##1##(1990-5#1)(1994-5#1)(1995-2#1)(1997-8#2)(2008-11#15)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#3)(2010-10#1)
retrovirus-like element Ty3##2##3##(1997-7#2)
retrovirus-like##4##1##(1996-12#2)(1997-7#2)
retrovirus-mediated gene##2##2##(1994-5#1)(2010-12#1)
retroviruses in cell cultures##2##4##(2008-11#2)
retroviruses in##3##2##(1990-5#1)(2008-11#2)
retroviruses##17##1##(1990-5#5)(1994-6#1)(1995-2#1)(1997-3#1)(2008-11#7)(2009-7#1)(2011-2#1)
return and##2##2##(1996-3#1)(2010-12#1)
return for##5##2##(1992-2#1)(1993-6#1)(1995-12#1)(2008-10#1)(2013-1#1)
return of##6##2##(1997-3#1)(2008-8#1)(2008-9#2)(2010-6#2)
return on##2##2##(1995-12#1)(2008-11#1)
return signals from##2##3##(2008-3#2)
return signals##5##2##(2008-3#5)
return to a##3##3##(1991-3#1)(1994-3#1)(1997-3#1)
return to normal##4##3##(1991-6#2)(1992-5#1)(1994-3#1)
return to the##9##3##(1991-12#1)(1991-3#1)(2008-10#3)(2008-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
return to work##5##3##(1993-12#1)(2012-12#3)(2012-3#1)
return to##38##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-5#1)(1993-12#1)(1994-12#1)(1994-3#2)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-6#1)(2010-1#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#2)
return were##2##2##(1993-1#1)(2008-12#1)
return##89##1##(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-2#1)(1992-5#1)(1993-1#6)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#3)(1995-12#2)(1995-3#1)(1995-5#1)(1996-3#1)(1997-3#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#10)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-6#2)(2011-2#9)(2012-12#4)(2012-3#3)(2013-1#3)
return-based##2##1##(2008-8#2)
returned for a##2##3##(1997-2#1)(2008-4#1)
returned for##4##2##(1997-2#1)(2008-4#1)(2011-2#2)
returned questionnaires##2##2##(2012-2#1)(2013-1#1)
returned the questionnaires##2##3##(1997-3#1)(2008-11#1)
returned to baseline levels##2##4##(1990-10#1)(2012-2#1)
returned to baseline##6##3##(1990-10#1)(1993-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
returned to control levels##3##4##(1996-12#2)(2010-5#1)
returned to control##4##3##(1994-5#1)(1996-12#2)(2010-5#1)
returned to independent living##2##4##(2008-12#1)(2009-10#1)
returned to normal##7##3##(1993-1#1)(1993-3#1)(2008-10#2)(2008-12#1)(2012-2#1)(2013-1#1)
returned to the hospital##3##4##(1996-5#1)(2011-2#1)(2012-12#1)
returned to the##13##3##(1991-6#1)(1994-5#1)(1996-5#1)(1997-7#2)(2008-10#1)(2008-5#1)(2008-6#2)(2008-8#2)(2011-2#1)(2012-12#1)
returned to##44##2##(1990-10#1)(1991-6#2)(1993-1#2)(1993-3#1)(1994-2#1)(1994-5#2)(1995-12#1)(1996-12#2)(1996-5#1)(1997-7#2)(2008-1#1)(2008-10#6)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
returned##63##1##(1990-10#1)(1991-2#1)(1991-6#2)(1993-1#2)(1993-3#1)(1994-2#1)(1994-5#2)(1995-12#1)(1996-12#2)(1996-3#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
returning to baseline##2##3##(1994-3#1)(2013-1#1)
returning to normal##2##3##(2009-11#1)(2013-1#1)
returning to the##3##3##(1993-1#1)(2008-11#1)(2012-12#1)
returning to##11##2##(1993-1#1)(1994-3#1)(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#3)
returning travelers##3##2##(2010-12#1)(2011-2#2)
returning##25##1##(1991-3#1)(1993-1#1)(1994-3#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#4)
returns from##2##2##(2008-3#1)(2008-8#1)
returns to the##3##3##(2008-10#2)(2011-2#1)
returns to##5##2##(1991-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
returns##16##1##(1991-2#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2013-1#1)
reunification##2##1##(1995-1#1)(2008-11#1)
reuptake inhibitor##8##2##(2008-4#4)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#1)
reuptake inhibitors##13##2##(1997-8#3)(2008-11#1)(2008-6#3)(2012-3#5)(2013-1#1)
reuptake##24##1##(1997-8#3)(2008-11#1)(2008-4#4)(2008-6#4)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#7)(2013-1#2)
reusability of the##3##3##(2008-10#2)(2010-4#1)
reusability##6##1##(2008-10#3)(2008-6#1)(2009-12#1)(2010-4#1)
reusable##7##1##(1992-12#1)(1995-2#1)(2008-10#5)
reuse of##2##2##(2010-5#1)(2012-3#1)
reuse##7##1##(1992-3#1)(2008-10#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#2)
reused for##4##2##(2008-10#4)
reused##12##1##(2008-10#12)
revascularization and##2##2##(2008-9#1)(2013-8#1)
revascularization of##2##2##(1992-9#1)(2011-3#1)
revascularization procedures##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
revascularization##31##1##(1992-9#1)(1993-12#1)(1995-12#1)(1996-3#1)(1997-8#1)(2008-11#4)(2008-12#5)(2008-5#2)(2008-9#6)(2009-12#1)(2011-3#1)(2012-3#2)(2013-8#5)
revascularization?##2##1##(2009-10#1)(2012-2#1)
reveal a##18##2##(1991-5#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
reveal an##6##2##(1992-9#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2010-8#1)
reveal and##2##2##(2008-3#2)
reveal any##14##2##(1992-1#1)(1993-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2013-1#1)(2013-8#1)
reveal different##2##2##(2008-10#2)
reveal evidence of##2##3##(2009-7#1)(2012-3#1)
reveal important##2##2##(1992-12#1)(1996-2#1)
reveal low##2##2##(2010-7#1)(2011-1#1)
reveal sequence##2##2##(1993-9#1)(1997-9#1)
reveal that the##16##3##(1991-12#1)(1994-1#1)(1994-5#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2012-2#1)
reveal that##50##2##(1990-11#1)(1990-6#2)(1991-12#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-5#3)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
reveal the importance of##2##4##(2008-3#1)(2011-1#1)
reveal the##24##2##(1994-6#1)(1997-5#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-6#1)(2009-8#3)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#2)(2013-8#1)
reveal##181##1##(1990-11#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#1)(1997-9#2)(2007-12#2)(2008-1#1)(2008-10#40)(2008-11#10)(2008-12#3)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-9#5)(2009-10#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#5)(2013-8#2)
revealed a 4 cm##2##4##(2008-12#1)(2010-3#1)
revealed a characteristic##2##3##(2008-5#1)(2012-12#1)
revealed a clear##2##3##(2008-5#1)(2012-2#1)
revealed a close relationship##2##4##(2008-10#2)
revealed a good##2##3##(1991-8#1)(2008-10#1)
revealed a great##2##3##(2008-10#1)(2009-7#1)
revealed a high degree of##2##5##(1993-2#1)(2008-10#1)
revealed a large mass##2##4##(2008-11#2)
revealed a large##8##3##(2008-11#2)(2008-12#2)(2008-7#1)(2009-3#1)(2011-1#1)(2013-1#1)
revealed a low level of##2##5##(2008-10#2)
revealed a low##3##3##(2008-10#3)
revealed a mass##2##3##(2010-11#1)(2011-2#1)
revealed a moderate##2##3##(1997-4#1)(2008-10#1)
revealed a number of##3##4##(2008-11#1)(2010-10#1)(2011-2#1)
revealed a significant reduction in##2##5##(2008-10#2)
revealed a significant##8##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)
revealed a significantly##2##3##(2008-10#1)(2009-12#1)
revealed a similar pattern##2##4##(1997-2#1)(2008-10#1)
revealed a similar##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
revealed a single##7##3##(1990-11#1)(1990-2#1)(1994-11#1)(1995-2#1)(1996-12#1)(2008-10#1)(2009-9#1)
revealed a total##2##3##(2008-10#1)(2008-12#1)
revealed a typical##2##3##(1993-8#1)(2010-6#1)
revealed a very high##2##4##(1994-2#1)(2008-10#1)
revealed a very##3##3##(1994-2#1)(2008-10#2)
revealed a wide##4##3##(2008-10#2)(2008-5#1)(2010-10#1)
revealed a##175##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#3)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#4)(1996-12#2)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#36)(2008-11#8)(2008-12#10)(2008-2#1)(2008-5#6)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#2)(2011-2#13)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#6)(2013-8#1)
revealed an increase in##4##4##(1996-3#1)(2008-10#2)(2012-2#1)
revealed an increase##5##3##(1996-3#1)(2008-10#2)(2010-2#1)(2012-2#1)
revealed an increased##3##3##(1994-3#1)(1995-2#1)(2012-12#1)
revealed an open reading frame of##2##6##(1992-3#1)(1997-2#1)
revealed an open reading frame##3##5##(1991-9#1)(1992-3#1)(1997-2#1)
revealed an overall##2##3##(2008-11#1)(2008-8#1)
revealed an##39##2##(1991-6#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-3#2)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
revealed as##2##2##(2010-11#1)(2011-2#1)
revealed at##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
revealed between##2##2##(1990-5#1)(2013-8#1)
revealed bilateral##4##2##(1997-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
revealed bone##2##2##(1995-9#1)(2008-12#1)
revealed both##3##2##(2008-10#3)
revealed by comparative##2##3##(2010-12#1)(2012-3#1)
revealed by the##6##3##(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
revealed by##48##2##(1990-5#1)(1991-10#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
revealed close##2##2##(2008-10#1)(2008-8#1)
revealed comparable##2##2##(1994-12#1)(2013-1#1)
revealed differences##4##2##(1997-2#2)(2008-10#2)
revealed different##2##2##(1995-12#1)(2008-10#1)
revealed differential##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
revealed diffuse##4##2##(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
revealed direct##2##2##(2008-10#2)
revealed distinct##2##2##(1991-5#1)(2008-10#1)
revealed extensive##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
revealed factors affecting##2##3##(1994-3#1)(2009-5#1)
revealed features##2##2##(2008-10#1)(2008-5#1)
revealed five##2##2##(2008-10#1)(2009-6#1)
revealed four##5##2##(2008-10#3)(2009-5#1)(2010-4#1)
revealed good selectivity##3##3##(2008-10#3)
revealed good##7##2##(2008-10#7)
revealed greater than##2##3##(2008-10#2)
revealed high levels of##2##4##(2008-10#1)(2009-11#1)
revealed high##3##2##(2008-10#1)(2008-11#1)(2009-11#1)
revealed in the##6##3##(1996-9#1)(2008-12#2)(2008-3#1)(2013-1#2)
revealed in##12##2##(1990-5#1)(1991-1#1)(1991-11#1)(1996-9#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2013-1#2)
revealed increased##4##2##(1992-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
revealed inflammation##2##2##(2008-10#1)(2011-2#1)
revealed inhibition of##2##3##(2008-11#1)(2008-7#1)
revealed its##4##2##(2008-9#1)(2009-1#1)(2011-2#2)
revealed less##2##2##(2008-10#1)(2012-2#1)
revealed little##2##2##(2008-10#1)(2008-8#1)
revealed major##2##2##(2008-10#1)(2008-7#1)
revealed multiple##5##2##(1993-8#1)(2008-10#2)(2010-7#1)(2011-2#1)
revealed new##2##2##(2008-10#1)(2013-1#1)
revealed nine##3##2##(2008-10#2)(2008-12#1)
revealed no significant differences##2##4##(1993-11#1)(2011-2#1)
revealed no significant##5##3##(1993-11#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
revealed no##22##2##(1991-4#1)(1993-11#1)(1993-3#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-9#2)(2011-2#2)(2012-3#1)(2012-5#1)(2013-8#1)
revealed normal##2##2##(1991-3#1)(2010-5#1)
revealed numerous##2##2##(2008-5#1)(2008-7#1)
revealed one##4##2##(1996-11#1)(1996-2#1)(2008-10#1)(2009-11#1)
revealed only a##2##3##(2008-12#1)(2010-5#1)
revealed only one##3##3##(1990-3#1)(2008-10#1)(2008-12#1)
revealed only##10##2##(1990-3#1)(1990-5#1)(1991-7#1)(1995-1#1)(2008-10#1)(2008-12#3)(2010-5#1)(2011-2#1)
revealed over##2##2##(2008-10#2)
revealed polymorphism in##2##3##(1993-6#1)(2008-10#1)
revealed positive##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
revealed reduced##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
revealed relatively##2##2##(2008-10#2)
revealed resolution of##2##3##(2008-10#1)(2013-8#1)
revealed reversible##2##2##(1993-6#1)(2008-10#1)
revealed several##7##2##(1993-12#2)(1995-12#1)(1997-7#1)(2008-10#1)(2009-5#1)(2013-1#1)
revealed severe##2##2##(1993-12#1)(2013-1#1)
revealed significant differences##2##3##(2008-10#1)(2008-12#1)
revealed significant homology to##2##4##(1995-12#1)(1997-2#1)
revealed significant##12##2##(1995-12#1)(1997-2#1)(2008-10#5)(2008-12#2)(2008-8#1)(2012-3#1)(2013-8#1)
revealed significantly##2##2##(1995-12#1)(2009-11#1)
revealed similar##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
revealed similarities##2##2##(2008-10#1)(2010-1#1)
revealed solid##3##2##(2008-5#1)(2008-8#1)(2012-3#1)
revealed some##2##2##(2008-10#1)(2011-2#1)
revealed striking differences in the extent of##2##7##(2008-10#2)
revealed striking##3##2##(2007-12#1)(2008-10#2)
revealed strong##4##2##(2008-10#3)(2008-11#1)
revealed that F##2##3##(2008-10#1)(2008-5#1)
revealed that SA##2##3##(2009-8#2)
revealed that a##6##3##(1995-2#1)(2008-10#3)(2008-12#1)(2010-1#1)
revealed that all##7##3##(1992-4#1)(2008-10#5)(2008-12#1)
revealed that at least##3##4##(1996-12#1)(2008-10#1)(2008-11#1)
revealed that both##13##3##(1990-5#1)(1993-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#2)(2009-3#1)(2012-3#1)
revealed that bromination##2##3##(2008-10#2)
revealed that cell##2##3##(1997-1#1)(2008-5#1)
revealed that in##5##3##(1995-12#1)(1997-8#1)(2008-7#1)(2008-9#1)(2010-10#1)
revealed that isolates of##2##4##(2008-10#2)
revealed that isolates##4##3##(2008-10#4)
revealed that it##4##3##(1992-12#1)(1992-3#1)(2008-8#1)(2008-9#1)
revealed that many##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
revealed that most of the##2##5##(2008-9#1)(2011-2#1)
revealed that most of##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
revealed that most##8##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#1)
revealed that neither##2##3##(2008-10#1)(2008-8#1)
revealed that one of##2##4##(2008-10#1)(2008-8#1)
revealed that one##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
revealed that only##3##3##(1994-12#1)(1996-2#1)(2008-10#1)
revealed that several##3##3##(1996-8#1)(2008-10#2)
revealed that some of the##2##5##(2008-10#1)(2008-12#1)
revealed that some##4##3##(2008-10#2)(2008-12#1)(2012-2#1)
revealed that students##2##3##(1996-1#1)(2008-12#1)
revealed that the 8-bp sequence##2##5##(1995-6#2)
revealed that the ability of##2##5##(2008-10#2)
revealed that the different##2##4##(1993-8#1)(2008-10#1)
revealed that the expression##2##4##(2008-10#1)(2013-1#1)
revealed that the method##2##4##(2008-10#2)
revealed that the performance of##2##5##(2008-10#1)(2008-12#1)
revealed that the presence of##2##5##(2008-10#1)(2008-11#1)
revealed that the proposed procedure##2##5##(2008-10#2)
revealed that the surface##2##4##(2008-10#1)(2013-1#1)
revealed that the##142##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-8#3)(1994-12#1)(1994-3#2)(1995-12#1)(1995-6#4)(1995-9#1)(1996-12#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#3)(2007-12#2)(2008-10#53)(2008-11#11)(2008-12#7)(2008-3#1)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#7)
revealed that their##2##3##(2008-11#1)(2008-9#1)
revealed that there was no##2##5##(2008-10#2)
revealed that there were##3##4##(1996-12#1)(2008-10#1)(2008-9#1)
revealed that there##8##3##(1994-11#1)(1996-12#2)(2008-10#3)(2008-9#2)
revealed that these##5##3##(1997-8#2)(2008-10#2)(2010-2#1)
revealed that they##3##3##(1993-8#1)(1997-3#1)(2008-10#1)
revealed that this##9##3##(1994-11#1)(1994-12#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-9#1)
revealed that two of##2##4##(1994-11#1)(2008-9#1)
revealed that two##4##3##(1994-11#1)(2008-10#2)(2008-9#1)
revealed that##467##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#5)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-6#11)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-7#5)(1997-8#9)(2007-12#2)(2008-1#1)(2008-10#159)(2008-11#32)(2008-12#15)(2008-3#1)(2008-4#2)(2008-5#13)(2008-6#6)(2008-7#5)(2008-8#18)(2008-9#17)(2009-10#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#13)(2012-12#1)(2012-2#10)(2012-3#8)(2013-1#11)(2013-8#2)
revealed the accumulation##2##3##(2008-10#1)(2008-11#1)
revealed the existence of a##2##5##(1995-8#1)(2008-10#1)
revealed the existence of two##2##5##(2008-10#1)(2008-11#1)
revealed the existence of##11##4##(1994-11#1)(1995-8#1)(1997-3#1)(2008-10#4)(2008-11#2)(2010-6#1)(2010-7#1)
revealed the following##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
revealed the formation of##3##4##(2008-10#2)(2013-1#1)
revealed the formation##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
revealed the genomic##2##3##(1995-8#1)(2008-10#1)
revealed the presence of a consensus##2##6##(1993-2#1)(2008-10#1)
revealed the presence of a##11##5##(1991-11#1)(1993-2#1)(1994-8#1)(2008-10#4)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
revealed the presence of the##5##5##(1994-6#1)(1996-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
revealed the presence of two##2##5##(1990-5#1)(2008-10#1)
revealed the presence of##42##4##(1990-5#1)(1991-11#1)(1993-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
revealed the##113##2##(1990-5#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-7#1)(2007-8#1)(2008-10#40)(2008-11#10)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#2)(2010-1#1)(2010-6#2)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#3)
revealed their##2##2##(2008-10#1)(2012-12#1)
revealed three clades##2##3##(2008-10#2)
revealed three distinct##3##3##(2008-10#2)(2012-3#1)
revealed three##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
revealed to be##2##3##(2008-5#1)(2008-8#1)
revealed to have##2##3##(1997-4#1)(2008-11#1)
revealed to##6##2##(1990-5#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
revealed two distinct##2##3##(2008-10#1)(2009-9#1)
revealed two independent##2##3##(1991-3#1)(2008-10#1)
revealed two main##3##3##(2008-10#3)
revealed two##20##2##(1991-3#1)(1992-3#1)(1997-4#1)(2008-10#10)(2008-12#1)(2008-7#1)(2009-6#1)(2009-9#2)(2010-4#1)(2010-6#1)
revealed unique##2##2##(2007-12#1)(2008-11#1)
revealed##1301##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#9)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#5)(1993-12#6)(1993-2#5)(1993-3#7)(1993-6#5)(1993-8#13)(1994-11#10)(1994-12#8)(1994-2#3)(1994-3#8)(1994-5#3)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#3)(1995-12#13)(1995-2#7)(1995-5#2)(1995-6#17)(1995-8#5)(1995-9#3)(1996-1#1)(1996-11#4)(1996-12#13)(1996-2#3)(1996-3#7)(1996-5#4)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#7)(1997-3#8)(1997-4#3)(1997-6#1)(1997-7#9)(1997-8#14)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#397)(2008-11#80)(2008-12#53)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#33)(2008-6#9)(2008-7#33)(2008-8#35)(2008-9#31)(2009-1#3)(2009-10#5)(2009-11#3)(2009-12#1)(2009-3#7)(2009-4#2)(2009-5#7)(2009-6#5)(2009-7#8)(2009-8#9)(2009-9#7)(2010-1#8)(2010-10#7)(2010-11#7)(2010-12#4)(2010-2#6)(2010-3#3)(2010-4#3)(2010-5#7)(2010-6#9)(2010-7#4)(2010-9#4)(2011-1#7)(2011-2#62)(2012-12#12)(2012-2#31)(2012-3#26)(2012-5#1)(2013-1#43)(2013-8#16)
revealing a##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)
revealing an##2##2##(2007-8#1)(2011-2#1)
revealing its##2##2##(2008-5#1)(2013-1#1)
revealing that the##2##3##(1995-6#1)(2008-5#1)
revealing that##4##2##(1995-6#1)(2008-5#1)(2010-3#1)(2010-8#1)
revealing the##6##2##(1997-8#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
revealing##43##1##(1990-6#1)(1991-11#2)(1992-3#1)(1995-6#1)(1997-6#1)(1997-8#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#4)(2008-7#1)(2008-9#2)(2009-11#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
reveals a##17##2##(1990-8#1)(1992-10#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-4#2)(2008-10#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-3#1)(2012-2#2)
reveals an##6##2##(2007-12#1)(2008-8#2)(2009-8#1)(2013-1#1)(2013-8#1)
reveals differences##2##2##(2008-10#1)(2008-8#1)
reveals good##2##2##(2008-10#2)
reveals high##2##2##(1996-12#1)(2011-2#1)
reveals how##2##2##(2008-11#1)(2008-8#1)
reveals large##3##2##(1995-6#1)(2008-3#1)(2008-7#1)
reveals no##2##2##(1992-3#1)(2012-2#1)
reveals some##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)
reveals structural##2##2##(1993-3#1)(1993-8#1)
reveals that it is##2##4##(1995-8#1)(2012-3#1)
reveals that it##3##3##(1994-9#1)(1995-8#1)(2012-3#1)
reveals that some##2##3##(1993-3#1)(1997-9#1)
reveals that the two##2##4##(2008-11#1)(2008-8#1)
reveals that the##20##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1995-1#1)(1995-2#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#2)(2012-2#1)
reveals that there is##2##4##(2008-10#1)(2008-11#1)
reveals that there##3##3##(2008-10#2)(2008-11#1)
reveals that##57##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-3#1)(1997-8#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#3)(2009-1#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
reveals the following##2##3##(1995-12#1)(1996-3#1)
reveals the presence of##4##4##(1990-11#1)(1995-12#1)(2008-11#2)
reveals the presence##5##3##(1990-11#1)(1993-3#1)(1995-12#1)(2008-11#2)
reveals the##18##2##(1990-11#1)(1993-2#1)(1993-3#1)(1995-12#2)(1995-8#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#1)
reveals##160##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-3#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1997-4#2)(1997-8#2)(1997-9#1)(2007-12#4)(2008-1#1)(2008-10#21)(2008-11#12)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#9)(2013-8#2)
revenue and##2##2##(1991-3#1)(1995-3#1)
revenue generation activities##2##3##(1991-12#2)
revenue generation##5##2##(1991-12#5)
revenue##23##1##(1991-1#1)(1991-12#5)(1991-3#4)(1992-12#4)(1992-2#1)(1994-1#1)(1994-2#2)(1995-3#1)(1996-2#2)(1996-3#1)(2008-11#1)
revenues and profits##2##3##(1991-3#1)(2008-11#1)
revenues and##3##2##(1991-3#1)(1992-12#1)(2008-11#1)
revenues grew more##2##3##(1993-3#2)
revenues##13##1##(1991-3#1)(1992-12#3)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#2)(1995-2#1)(2008-11#2)
reverberation activity##2##2##(2008-11#2)
reverberation##3##1##(2008-11#3)
reversal in##2##2##(1990-8#1)(2008-10#1)
reversal of the##4##3##(1992-10#1)(1995-3#1)(2008-3#1)(2010-8#1)
reversal of tolerance##3##3##(1996-2#3)
reversal of##17##2##(1990-12#1)(1990-2#2)(1992-10#1)(1995-3#1)(1996-2#3)(1997-2#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-8#1)(2012-12#1)
reversal times##2##2##(2008-10#2)
reversal##41##1##(1990-12#1)(1990-2#2)(1990-8#1)(1992-10#1)(1993-3#3)(1993-6#1)(1995-3#1)(1996-2#3)(1997-2#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2010-8#1)(2012-12#1)(2013-8#3)
reversals in##2##2##(2008-8#2)
reversals##9##1##(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-8#2)(2008-9#1)
reverse and forward##2##3##(2007-12#1)(2008-10#1)
reverse dot blot system##2##4##(2008-10#2)
reverse dot blot##3##3##(2008-10#3)
reverse flow injection analysis##2##4##(2008-10#2)
reverse flow injection method##2##4##(2008-10#2)
reverse flow injection##5##3##(2008-10#5)
reverse flow##7##2##(2008-10#7)
reverse flow-injection##2##2##(2008-10#2)
reverse genetics##2##2##(2011-1#1)(2012-3#1)
reverse latissimus dorsi##2##3##(2008-7#2)
reverse micellar##2##2##(1995-3#1)(2008-10#1)
reverse oblique fractures##3##3##(2013-1#3)
reverse oblique##5##2##(2013-1#5)
reverse order##3##2##(1993-2#1)(2008-10#2)
reverse phase HPLC##3##3##(1990-12#1)(2008-10#1)(2008-8#1)
reverse phase liquid chromatography##2##4##(2008-10#2)
reverse phase##11##2##(1990-12#1)(1995-3#1)(2008-10#8)(2008-8#1)
reverse reaction##4##2##(1991-9#2)(1995-6#1)(2008-3#1)
reverse the##11##2##(1991-3#1)(1992-8#1)(1992-9#1)(1994-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(2008-7#2)(2013-1#1)
reverse transcriptase (RT)##2##3##(1991-9#1)(2013-1#1)
reverse transcriptase inhibitors##7##3##(2011-2#4)(2011-3#3)
reverse transcriptase##31##2##(1991-9#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-5#1)(2011-2#8)(2011-3#8)(2013-1#1)
reverse transcriptase-activity##2##2##(2008-11#2)
reverse transcriptase-polymerase chain reaction##7##4##(1994-11#1)(1995-12#1)(1996-12#1)(1997-9#1)(2008-10#2)(2012-3#1)
reverse transcription PCR##3##3##(2008-8#1)(2010-5#1)(2011-2#1)
reverse transcription and polymerase chain reaction##2##6##(1995-12#1)(2011-2#1)
reverse transcription and##4##3##(1993-8#1)(1995-12#1)(2010-5#1)(2011-2#1)
reverse transcription polymerase chain reaction (RT-PCR)##3##6##(1995-11#1)(1996-12#1)(2008-9#1)
reverse transcription polymerase chain reaction##7##5##(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-9#1)(2013-8#1)
reverse transcription##16##2##(1993-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#2)(2011-2#2)(2012-12#1)(2013-8#1)
reverse transcription-PCR##6##2##(1993-12#1)(1995-8#1)(1996-12#1)(2008-9#1)(2010-11#1)(2013-8#1)
reverse transcription-polymerase chain reaction (RT-PCR) and##2##6##(1994-11#1)(2008-10#1)
reverse transcription-polymerase chain reaction (RT-PCR) in##2##6##(2008-10#2)
reverse transcription-polymerase chain reaction (RT-PCR) was used##2##7##(2008-10#2)
reverse transcription-polymerase chain reaction (RT-PCR)##15##5##(1993-12#1)(1994-11#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-9#1)(2010-1#1)
reverse transcription-polymerase chain reaction and##2##5##(1995-12#1)(2008-10#1)
reverse transcription-polymerase chain reaction procedure##2##5##(2008-10#2)
reverse transcription-polymerase chain reaction with##2##5##(2008-10#2)
reverse transcription-polymerase chain reaction##36##4##(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1997-1#1)(1997-7#1)(2008-10#21)(2008-11#2)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#2)(2013-1#1)
reverse transcription-polymerase chain##37##3##(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1997-1#1)(1997-7#1)(2008-10#22)(2008-11#2)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#2)(2013-1#1)
reverse##220##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-2#1)(1995-11#1)(1995-12#3)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#3)(1997-1#3)(1997-2#1)(1997-7#2)(1997-9#2)(2007-12#2)(2008-1#1)(2008-10#68)(2008-11#13)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#10)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#12)(2011-3#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#12)(2013-8#3)
reverse-correlation##6##1##(2008-11#1)(2013-8#5)
reverse-flow injection analysis##2##3##(2008-10#2)
reverse-flow injection##3##2##(2008-10#3)
reverse-phase HPLC##3##2##(1994-5#1)(2008-10#2)
reverse-phase chromatography##2##2##(2008-10#2)
reverse-phase high performance liquid chromatography##2##5##(2008-10#2)
reverse-phase##10##1##(1990-2#1)(1991-3#1)(1994-5#1)(2008-10#7)
reverse-transcriptase##3##1##(2008-10#2)(2008-9#1)
reverse-transcription polymerase chain reaction (RT-PCR)##3##5##(2008-10#3)
reverse-transcription polymerase chain reaction##11##4##(2008-10#10)(2008-5#1)
reversed by NAC##2##3##(2009-9#2)
reversed by##11##2##(1990-5#1)(1992-8#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#2)(2013-7#1)(2013-8#1)
reversed flow##4##2##(1991-3#2)(1993-3#1)(2008-10#1)
reversed in the##2##3##(1991-3#1)(2012-3#1)
reversed in##3##2##(1991-3#1)(2008-12#1)(2012-3#1)
reversed micellar##3##2##(1990-5#2)(2008-10#1)
reversed micelles as##3##3##(2008-10#3)
reversed micelles of##2##3##(1995-3#1)(2008-10#1)
reversed micelles##8##2##(1990-5#1)(1995-3#2)(2008-10#5)
reversed phase and##4##3##(2008-10#3)(2011-2#1)
reversed phase chromatography##4##3##(2008-10#4)
reversed phase high performance liquid chromatography##4##6##(1990-8#1)(2008-10#3)
reversed phase high performance liquid##5##5##(1990-8#1)(2008-10#4)
reversed phase liquid chromatography (RPLC)##4##5##(2008-10#4)
reversed phase liquid chromatography##9##4##(2008-10#9)
reversed phase##33##2##(1990-8#1)(1992-8#1)(2008-10#28)(2008-5#1)(2010-11#1)(2011-2#1)
reversed the##9##2##(1990-11#1)(1993-8#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
reversed this##3##2##(1991-2#2)(2008-11#1)
reversed##123##1##(1990-11#1)(1990-5#6)(1990-6#1)(1990-8#1)(1991-2#3)(1991-3#3)(1991-5#1)(1992-8#2)(1993-3#1)(1993-8#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-7#1)(2007-11#2)(2008-10#54)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-9#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-4#1)(2013-7#2)(2013-8#2)
reversed-phase HPLC method##3##3##(2008-10#3)
reversed-phase HPLC##25##2##(1990-5#2)(1993-8#1)(1996-12#2)(1997-2#3)(2008-10#14)(2008-5#1)(2008-8#1)(2011-2#1)
reversed-phase chromatographic separation##2##3##(2008-10#2)
reversed-phase chromatographic##3##2##(2008-10#3)
reversed-phase column##2##2##(1993-11#1)(2008-10#1)
reversed-phase columns##2##2##(2008-10#2)
reversed-phase high performance liquid##5##4##(2008-10#4)(2008-11#1)
reversed-phase high-performance liquid chromatographic##2##4##(2008-10#2)
reversed-phase high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
reversed-phase high-performance liquid chromatography and##2##5##(1992-6#1)(2008-10#1)
reversed-phase high-performance liquid chromatography with##3##5##(2008-10#3)
reversed-phase high-performance liquid chromatography##20##4##(1991-12#1)(1992-6#2)(1995-11#1)(1997-2#2)(2008-10#14)
reversed-phase high-performance liquid##22##3##(1991-12#1)(1992-6#2)(1995-11#1)(1997-2#2)(2008-10#16)
reversed-phase high-performance##23##2##(1991-12#1)(1992-6#2)(1995-11#1)(1997-2#2)(2008-10#17)
reversed-phase ion-pair##3##2##(2008-10#3)
reversed-phase liquid chromatographic separation of##2##5##(2008-10#2)
reversed-phase liquid chromatography##6##3##(2008-10#4)(2008-5#2)
reversed-phase liquid##8##2##(2008-10#6)(2008-5#2)
reversed-phase##93##1##(1990-5#2)(1991-12#1)(1992-11#1)(1992-6#2)(1993-11#1)(1993-8#1)(1995-11#1)(1996-12#2)(1997-2#5)(2008-10#71)(2008-11#1)(2008-5#3)(2008-8#1)(2011-2#1)
reverses the##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
reverses##6##1##(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
reversibility and##3##2##(2008-10#2)(2011-2#1)
reversibility of the##7##3##(2008-10#7)
reversibility of##12##2##(1992-10#1)(2008-10#10)(2009-4#1)
reversibility##23##1##(1992-10#1)(1992-5#1)(2008-10#18)(2008-2#1)(2009-4#1)(2011-2#1)
reversible addition fragmentation chain transfer (RAFT)##2##6##(2008-12#1)(2009-10#1)
reversible and the##2##3##(2008-10#2)
reversible and##13##2##(1990-12#1)(1990-8#1)(1996-5#1)(2008-10#7)(2008-7#1)(2008-8#1)(2011-2#1)
reversible chemical##2##2##(1993-6#1)(2008-10#1)
reversible decrease##2##2##(2008-11#1)(2008-8#1)
reversible encephalopathy syndrome##2##3##(2010-12#1)(2013-1#1)
reversible in##2##2##(2008-10#2)
reversible interconversion between the high##2##5##(2008-10#2)
reversible nature##2##2##(1990-2#1)(2008-10#1)
reversible or##2##2##(2011-2#1)(2012-3#1)
reversible redox##4##2##(2008-10#4)
reversible sensing##2##2##(2008-10#2)
reversible waves##3##2##(2009-9#3)
reversible with##2##2##(2010-5#1)(2013-7#1)
reversible within##2##2##(1996-11#1)(2008-10#1)
reversible##128##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#2)(1990-9#2)(1991-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-6#6)(1993-8#1)(1994-11#2)(1994-8#3)(1995-12#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#1)(2008-10#48)(2008-11#5)(2008-12#2)(2008-4#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#3)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)
reversibly##14##1##(1993-1#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-11#2)(2011-2#1)
reversing the##5##2##(1992-12#1)(1995-6#1)(2008-10#2)(2008-11#1)
reversing##7##1##(1992-12#1)(1995-6#1)(1997-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
reversion##8##1##(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
revert to##2##2##(2008-10#2)
revert##4##1##(2008-10#3)(2008-9#1)
revertant##4##1##(1995-5#4)
revertants##5##1##(1995-5#2)(2008-10#2)(2008-9#1)
reverted by##2##2##(1997-1#1)(2012-3#1)
reverted##5##1##(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
review a##4##2##(1997-3#1)(2008-11#2)(2013-8#1)
review addresses##5##2##(2008-11#1)(2008-6#1)(2008-8#1)(2011-7#1)(2013-8#1)
review and update##2##3##(2012-3#1)(2013-1#1)
review and##29##2##(1992-1#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
review article##19##2##(2008-1#1)(2008-10#4)(2008-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#2)(2012-2#4)(2012-3#1)(2013-1#3)
review based on##3##3##(1995-12#1)(2008-10#1)(2009-10#1)
review basic##2##2##(2012-3#1)(2013-1#1)
review briefly##2##2##(2009-1#1)(2009-5#1)
review by the##4##3##(1993-6#1)(1995-6#1)(2010-3#1)(2012-12#1)
review by##5##2##(1993-6#1)(1995-6#2)(2010-3#1)(2012-12#1)
review can##2##2##(1990-11#1)(2008-11#1)
review comparing##3##2##(2012-12#2)(2013-1#1)
review concludes that##2##3##(2008-11#1)(2010-8#1)
review concludes##4##2##(2008-11#1)(2010-11#1)(2010-5#1)(2010-8#1)
review covers##6##2##(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#2)
review current##4##2##(2008-11#1)(2010-1#1)(2011-2#1)(2013-1#1)
review data##2##2##(1991-2#1)(2008-10#1)
review deals with the##2##4##(2008-10#1)(2008-11#1)
review deals with##5##3##(2008-10#4)(2008-11#1)
review deals##6##2##(2008-10#5)(2008-11#1)
review different##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
review discusses the##12##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-6#1)(2011-2#2)(2013-1#2)(2013-8#1)
review discusses##24##2##(1993-3#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
review examines the##3##3##(2010-7#1)(2010-9#1)(2013-1#1)
review examines##6##2##(2008-10#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
review existing##2##2##(2008-10#1)(2013-1#1)
review explores the##3##3##(2008-10#1)(2008-11#2)
review explores##4##2##(2008-10#1)(2008-11#3)
review focuses on the recent advances##2##6##(2012-2#1)(2012-3#1)
review focuses on the##14##4##(1991-7#1)(1994-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
review focuses on##19##3##(1991-7#1)(1994-1#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#4)(2013-1#1)
review focuses upon##2##3##(1997-2#1)(2008-7#1)
review focuses##24##2##(1991-7#1)(1994-1#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
review from##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
review gives##3##2##(2010-11#2)(2012-2#1)
review highlights the##3##3##(2010-12#1)(2010-7#1)(2011-2#1)
review highlights##6##2##(2010-12#1)(2010-7#2)(2011-2#2)(2012-2#1)
review how##3##2##(2008-8#1)(2012-3#1)(2013-8#1)
review in##6##2##(1992-1#1)(2008-11#2)(2010-6#1)(2011-2#1)(2013-8#1)
review is aimed at##2##4##(2009-3#1)(2012-2#1)
review is focused on##5##4##(1992-6#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
review is not to##2##4##(2008-7#1)(2010-7#1)
review is to discuss the##3##5##(2008-8#1)(2012-2#1)(2013-1#1)
review is to evaluate the##2##5##(2008-10#1)(2008-3#1)
review is to summarize##2##4##(2008-10#1)(2010-1#1)
review is to##21##3##(2008-10#2)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#2)(2010-1#1)(2010-12#1)(2010-5#1)(2011-3#2)(2012-2#4)(2013-1#2)(2013-8#1)
review is##44##2##(1992-1#1)(1992-6#1)(1994-3#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#1)
review it##2##2##(2008-10#1)(2013-1#1)
review its##2##2##(1992-12#1)(2008-11#1)
review makes##2##2##(2008-10#1)(2010-7#1)
review of 1##2##3##(1997-8#1)(2012-2#1)
review of a##6##3##(1990-12#1)(1992-12#1)(2008-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
review of all##2##3##(2008-9#1)(2012-2#1)
review of available##2##3##(2008-12#1)(2009-5#1)
review of cell##2##3##(2008-10#2)
review of clinical##4##3##(1994-3#1)(1995-9#1)(1997-2#1)(2011-2#1)
review of current##4##3##(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
review of data##2##3##(2008-1#1)(2013-1#1)
review of its##2##3##(1992-12#1)(2012-12#1)
review of literature and##2##4##(2008-11#1)(2010-7#1)
review of literature is presented##2##5##(2010-11#1)(2010-8#1)
review of literature##24##3##(1992-5#1)(1993-6#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
review of literature]##2##3##(2009-5#1)(2012-3#1)
review of patient##2##3##(2008-12#1)(2010-2#1)
review of published##2##3##(2008-10#1)(2008-9#1)
review of recent##4##3##(1993-3#1)(1996-1#1)(2008-11#1)(2012-12#1)
review of statistical##2##3##(1995-1#1)(1997-6#1)
review of the English-language literature was undertaken##2##7##(2012-12#2)
review of the current literature##3##5##(2010-12#1)(2010-5#1)(2011-2#1)
review of the current##9##4##(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-2#1)
review of the effectiveness of##2##5##(2013-1#2)
review of the literature and##7##5##(1990-3#1)(1991-1#1)(1991-3#1)(2006-5#1)(2008-10#1)(2012-3#1)(2013-1#1)
review of the literature concerning the##2##6##(2010-9#1)(2011-2#1)
review of the literature is##3##5##(1991-3#1)(2008-1#1)(2010-12#1)
review of the literature of##2##5##(2012-3#2)
review of the literature on the##4##6##(1996-12#1)(2008-11#1)(2009-6#1)(2013-1#1)
review of the literature on this##3##6##(1993-6#1)(2008-5#1)(2010-8#1)
review of the literature on##9##5##(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
review of the literature revealed only##2##6##(1995-1#1)(2008-12#1)
review of the literature shows that##3##6##(2008-10#1)(2011-3#1)(2012-3#1)
review of the literature with##2##5##(2008-10#1)(2009-3#1)
review of the literature##102##4##(1990-3#1)(1991-1#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-12#2)(1997-5#1)(2006-5#1)(2008-1#1)(2008-10#11)(2008-11#9)(2008-12#8)(2008-5#2)(2008-7#6)(2008-9#2)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#9)(2011-3#1)(2012-2#5)(2012-3#6)(2013-1#10)(2013-7#1)
review of the literature]##6##4##(1990-5#1)(1992-5#1)(1992-9#1)(1993-6#1)(2012-3#1)(2013-1#1)
review of the main##2##4##(2008-10#2)
review of the medical literature##2##5##(1992-12#1)(2012-3#1)
review of the medical##3##4##(1992-12#1)(2008-9#1)(2012-3#1)
review of the most recent##2##5##(1991-2#1)(2008-11#1)
review of the relevant##3##4##(2010-11#1)(2012-2#1)(2013-1#1)
review of the results##2##4##(1993-1#1)(2008-4#1)
review of the##182##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#3)(1992-3#1)(1992-5#2)(1992-9#2)(1993-1#2)(1993-3#1)(1993-6#3)(1994-3#2)(1994-8#1)(1995-1#2)(1995-11#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-5#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#23)(2008-11#16)(2008-12#11)(2008-4#1)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#18)(2013-7#1)
review of these##2##3##(1995-3#1)(2008-10#1)
review of this##2##3##(2008-10#2)
review of##351##2##(1990-12#2)(1990-3#2)(1990-5#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#5)(1992-3#3)(1992-5#3)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#4)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-1#4)(2008-10#39)(2008-11#32)(2008-12#16)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#15)(2008-8#5)(2008-9#7)(2009-3#4)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#23)(2011-3#1)(2011-7#2)(2012-12#11)(2012-2#14)(2012-3#14)(2013-1#34)(2013-7#1)(2013-8#4)
review on the##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
review on##11##2##(1991-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
review outlines##2##2##(2008-7#1)(2012-3#1)
review process to##2##3##(1995-12#1)(2008-8#1)
review process##4##2##(1995-12#1)(2008-11#1)(2008-8#1)(2010-5#1)
review provides##14##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
review recent progress in##2##4##(2008-11#1)(2010-12#1)
review recent##12##2##(2008-10#1)(2008-11#3)(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
review reports##2##2##(2008-10#1)(2013-1#1)
review several##2##2##(2008-10#1)(2011-2#1)
review shows that##2##3##(2010-7#1)(2013-8#1)
review shows##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
review some of the##3##4##(2008-11#1)(2008-12#1)(2008-4#1)
review some##5##2##(1994-8#2)(2008-11#1)(2008-12#1)(2008-4#1)
review suggests that##2##3##(2010-6#1)(2013-8#1)
review summarizes the current##3##4##(2008-11#1)(2008-7#2)
review summarizes the##11##3##(2008-10#2)(2008-11#1)(2008-7#2)(2009-10#1)(2010-11#1)(2011-2#2)(2011-9#1)(2012-12#1)
review summarizes##21##2##(2008-10#5)(2008-11#4)(2008-7#2)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
review that##2##2##(2008-10#1)(2008-6#1)
review the current state of##2##5##(2008-11#1)(2010-9#1)
review the current status of##4##5##(2008-10#1)(2010-12#1)(2010-4#1)(2013-1#1)
review the current##10##3##(2008-1#1)(2008-10#2)(2008-11#2)(2010-12#1)(2010-4#1)(2010-9#2)(2013-1#1)
review the development of##2##4##(1996-6#1)(2008-11#1)
review the development##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
review the evidence##3##3##(2008-7#2)(2008-8#1)
review the literature on the##2##5##(2009-1#1)(2011-2#1)
review the literature on##5##4##(1990-2#1)(2009-1#1)(2011-2#3)
review the literature##9##3##(1990-2#1)(1996-9#1)(2009-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
review the main##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
review the most common##2##4##(2009-12#1)(2010-7#1)
review the most##4##3##(2008-10#1)(2009-12#1)(2010-7#1)(2012-3#1)
review the pathogenesis of##2##4##(1993-2#1)(2009-1#1)
review the pathophysiology of##2##4##(2008-11#1)(2012-3#1)
review the possible##2##3##(2008-7#1)(2008-8#1)
review the published##4##3##(1995-2#1)(2008-12#1)(2008-3#1)(2009-7#1)
review the recent##3##3##(2008-3#1)(2009-1#1)(2009-12#1)
review the relevant##2##3##(1994-12#1)(2009-7#1)
review the state of the art##2##6##(1993-3#1)(2008-5#1)
review the##112##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#2)(1995-2#2)(1996-6#1)(1996-9#1)(1997-1#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#9)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-1#3)(2009-10#1)(2009-12#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#12)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#6)(2013-2#1)(2013-8#3)
review these issues and##2##4##(2008-11#1)(2008-7#1)
review these##4##2##(1995-1#1)(2008-11#1)(2008-7#1)(2010-4#1)
review to##3##2##(2008-10#1)(2013-1#2)
review using##2##2##(1993-1#1)(2013-8#1)
review was made of##2##4##(1996-1#1)(2012-12#1)
review was made##3##3##(1996-1#1)(2012-12#2)
review was performed on##2##4##(2009-10#1)(2013-1#1)
review was performed to##2##4##(2008-10#1)(2012-3#1)
review was performed##6##3##(2008-10#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
review was to##6##3##(1996-6#1)(2008-11#1)(2009-11#1)(2010-6#1)(2013-1#2)
review was##22##2##(1995-6#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-6#1)(2011-2#2)(2012-12#5)(2012-3#1)(2013-1#5)
review we##26##2##(1992-5#1)(2008-10#1)(2008-11#3)(2008-7#3)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#2)
review were##3##2##(2009-1#1)(2011-2#1)(2013-1#1)
review will address the##2##4##(2008-10#1)(2008-7#1)
review will focus on##11##4##(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)
review will provide a##3##4##(2008-11#1)(2009-12#1)(2009-5#1)
review will provide##4##3##(2008-11#1)(2009-12#1)(2009-4#1)(2009-5#1)
review will summarize##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
review will##36##2##(1994-3#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
review with##4##2##(1995-12#1)(2008-10#2)(2008-7#1)
review##1311##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#3)(1991-1#7)(1991-12#3)(1991-2#5)(1991-3#5)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#7)(1992-12#8)(1992-2#1)(1992-3#3)(1992-5#5)(1992-6#1)(1992-9#2)(1993-1#3)(1993-12#5)(1993-2#8)(1993-3#4)(1993-6#6)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#8)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#5)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#2)(1996-6#2)(1996-9#2)(1997-1#4)(1997-2#9)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#3)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#14)(2008-10#165)(2008-11#125)(2008-12#39)(2008-3#10)(2008-4#7)(2008-5#14)(2008-6#8)(2008-7#55)(2008-8#22)(2008-9#16)(2009-1#9)(2009-10#10)(2009-11#1)(2009-12#12)(2009-3#7)(2009-4#7)(2009-5#9)(2009-6#5)(2009-7#10)(2009-8#8)(2009-9#5)(2010-1#10)(2010-10#11)(2010-11#17)(2010-12#20)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#13)(2010-6#13)(2010-7#25)(2010-8#8)(2010-9#7)(2011-1#11)(2011-10#1)(2011-2#102)(2011-3#9)(2011-7#7)(2011-9#1)(2012-12#43)(2012-2#67)(2012-3#48)(2013-1#101)(2013-2#1)(2013-7#3)(2013-8#42)
review)##3##1##(1994-12#1)(1995-11#1)(2009-10#1)
review]##12##1##(1990-12#1)(1991-3#1)(1993-8#1)(2009-9#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
reviewed a##2##2##(1992-12#1)(2008-12#1)
reviewed after##2##2##(1994-2#1)(2009-3#1)
reviewed and the##4##3##(1993-8#1)(2008-5#1)(2008-7#1)(2010-8#1)
reviewed and##16##2##(1991-3#1)(1992-2#1)(1993-2#1)(1993-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-8#1)(2013-1#1)
reviewed as##3##2##(2008-11#1)(2008-8#1)(2010-9#1)
reviewed by##4##2##(1996-1#1)(2008-7#1)(2011-2#2)
reviewed for##3##2##(1995-12#1)(1996-11#1)(2008-9#1)
reviewed from##3##2##(1991-8#1)(2008-11#1)(2013-1#1)
reviewed here##7##2##(2008-10#2)(2008-4#2)(2008-7#1)(2011-2#1)(2013-1#1)
reviewed in terms of##2##4##(1991-2#1)(2008-10#1)
reviewed in##11##2##(1991-2#1)(1992-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-2#1)(2012-3#1)
reviewed literature##2##2##(2008-7#1)(2010-11#1)
reviewed our##2##2##(1994-12#1)(2012-3#1)
reviewed retrospectively##2##2##(1991-2#1)(1993-8#1)
reviewed the literature##4##3##(1996-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
reviewed the medical records of##2##5##(1990-2#1)(2012-12#1)
reviewed the##25##2##(1990-2#1)(1990-9#1)(1991-9#1)(1992-5#1)(1995-12#1)(1995-5#1)(1996-6#2)(1997-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
reviewed to##4##2##(1991-3#1)(1993-1#1)(2012-2#1)(2012-3#1)
reviewed with emphasis on the##2##5##(2008-10#2)
reviewed with##6##2##(1990-3#1)(1991-3#1)(1996-6#1)(2008-10#2)(2008-11#1)
reviewed##275##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#4)(1994-12#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#3)(2007-11#1)(2008-1#1)(2008-10#34)(2008-11#19)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#18)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#3)(2010-9#5)(2011-1#3)(2011-2#14)(2011-3#2)(2012-12#3)(2012-2#9)(2012-3#9)(2013-1#14)(2013-7#1)(2013-8#3)
reviewer##2##1##(2008-11#1)(2012-3#1)
reviewers##18##1##(1993-12#2)(1997-8#1)(2008-10#5)(2008-12#1)(2009-6#1)(2010-12#1)(2012-12#4)(2013-1#3)
reviewing research##2##2##(1993-12#1)(2009-4#1)
reviewing the results of##2##4##(1996-12#1)(2008-6#1)
reviewing the##11##2##(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
reviewing##28##1##(1990-8#1)(1993-1#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#1)(2009-4#2)(2010-1#1)(2010-4#3)(2010-5#1)(2010-7#1)(2012-12#2)(2013-1#2)
reviews -##4##2##(2011-2#4)
reviews and##2##2##(1992-2#1)(2008-11#1)
reviews available##2##2##(2008-4#1)(2011-10#1)
reviews existing##3##2##(1996-2#1)(2008-11#2)
reviews have##2##2##(2008-10#2)
reviews how##2##2##(2008-9#1)(2009-9#1)
reviews of the##3##3##(1993-12#2)(2012-2#1)
reviews of##9##2##(1993-12#4)(1996-3#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
reviews on##2##2##(2008-11#1)(2011-2#1)
reviews previous##2##2##(2008-10#1)(2008-11#1)
reviews recent developments in the##2##5##(1994-9#1)(2008-10#1)
reviews recent##9##2##(1994-9#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)
reviews some of the##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
reviews some##6##2##(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)
reviews the current state of##2##5##(1997-4#1)(2011-2#1)
reviews the current##8##3##(1997-4#1)(2008-11#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#1)
reviews the development##2##3##(1993-3#1)(2008-10#1)
reviews the literature and##2##4##(1997-2#1)(2013-1#1)
reviews the literature on the effects##2##6##(1996-3#1)(2008-7#1)
reviews the literature on the##3##5##(1996-3#1)(2008-12#1)(2008-7#1)
reviews the literature on##5##4##(1996-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
reviews the literature##8##3##(1996-3#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
reviews the major##2##3##(1994-3#1)(2012-2#1)
reviews the management of##2##4##(2012-2#1)(2013-8#1)
reviews the##85##2##(1991-2#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#2)(2008-2#1)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-2#8)(2013-1#8)(2013-8#4)
reviews these##2##2##(2008-11#1)(2008-6#1)
reviews what is known about##2##5##(2008-11#1)(2008-9#1)
reviews##199##1##(1990-3#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#2)(1993-12#10)(1993-3#2)(1994-2#3)(1994-3#2)(1994-6#2)(1994-9#1)(1995-2#3)(1996-1#2)(1996-11#1)(1996-2#4)(1996-3#2)(1997-1#2)(1997-2#5)(1997-4#1)(2008-1#1)(2008-10#15)(2008-11#24)(2008-12#2)(2008-2#1)(2008-4#13)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#5)(2009-12#2)(2009-7#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#16)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#12)(2013-8#9)
revise##4##1##(1996-2#1)(1997-2#1)(2008-10#1)(2012-3#1)
revised and updated##2##3##(1994-12#1)(2013-1#1)
revised and##6##2##(1994-12#1)(1994-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
revised model of##2##3##(1991-9#2)
revised model##4##2##(1991-9#2)(2008-10#1)(2008-3#1)
revised system##2##2##(1992-2#1)(2008-1#1)
revised to##4##2##(1992-1#1)(1996-5#1)(2008-1#1)(2008-11#1)
revised##55##1##(1991-2#1)(1991-9#2)(1992-1#3)(1992-2#2)(1993-6#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-3#2)(2008-5#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#1)
revision for##2##2##(2013-1#2)
revision is##2##2##(1994-2#1)(1997-2#1)
revision of the##10##3##(1992-9#1)(1993-6#1)(2008-10#4)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
revision of##11##2##(1992-9#1)(1993-6#1)(2008-10#4)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
revision stem##2##2##(2013-1#2)
revision surgery and##2##3##(2011-2#1)(2012-3#1)
revision surgery for##3##3##(2008-9#1)(2009-7#1)(2012-3#1)
revision surgery##14##2##(2008-9#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)
revision was##2##2##(2010-5#1)(2013-1#1)
revision##61##1##(1992-2#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#5)(2008-9#1)(2009-10#2)(2009-7#1)(2010-5#1)(2011-2#5)(2011-3#2)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#18)(2013-8#1)
revisions to##2##2##(2008-10#1)(2009-10#1)
revisions##7##1##(2008-10#3)(2008-11#1)(2009-10#1)(2011-1#1)(2012-2#1)
revisit the##2##2##(2008-3#1)(2010-10#1)
revisit##9##1##(1991-1#1)(1997-8#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#1)(2012-2#1)
revisited##21##1##(1991-12#1)(1992-9#1)(1993-8#1)(1993-9#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-7#1)(2013-1#1)
revitalization of##3##2##(1992-3#1)(1995-12#1)(2008-10#1)
revitalization##5##1##(1992-3#1)(1994-2#1)(1995-12#1)(2008-10#1)(2009-10#1)
revitalize##2##1##(1996-3#1)(2013-1#1)
revival##2##1##(1990-12#1)(2010-3#1)
revived##2##1##(2008-10#1)(2012-3#1)
revolution in##5##2##(1990-8#1)(1997-8#1)(2008-5#1)(2010-12#1)(2011-2#1)
revolution##13##1##(1990-8#1)(1992-11#1)(1993-12#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
revolutionary changes##2##2##(1994-3#1)(1996-2#1)
revolutionary##7##1##(1994-3#1)(1996-1#1)(1996-2#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-7#1)
revolutionized the##4##2##(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)
revolutionized##8##1##(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-2#1)
revolves around a##2##3##(1996-3#1)(1996-9#1)
revolves around##3##2##(1996-3#1)(1996-9#1)(2008-4#1)
reward and recognition##2##3##(1991-3#2)
reward and##9##2##(1991-3#2)(1993-6#2)(1994-2#1)(1994-8#1)(2008-4#1)(2008-7#1)(2013-8#1)
reward circuitry##2##2##(2012-12#1)(2013-8#1)
reward correlates)##2##2##(1994-2#2)
reward systems##2##2##(1994-1#1)(1996-3#1)
reward##50##1##(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#5)(1992-7#1)(1993-6#4)(1994-1#1)(1994-2#3)(1994-8#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#2)(2008-11#2)(2008-4#4)(2008-7#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-9#1)(2012-12#2)(2013-8#6)
reward-related##6##1##(1993-6#3)(1994-2#1)(2013-8#2)
reward-relevant axons##2##2##(1992-12#2)
rewarded for##2##2##(1997-1#1)(2012-3#1)
rewarded##4##1##(1993-6#1)(1997-1#1)(2008-6#1)(2012-3#1)
rewarding##10##1##(1991-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-5#1)(2010-7#1)
rewards of##3##2##(2010-9#2)(2013-1#1)
rewards##8##1##(1992-12#1)(1994-12#1)(1996-1#1)(1997-1#1)(2010-4#1)(2010-9#2)(2013-1#1)
rewarming is indicated for##2##4##(2011-2#2)
rewarming is##3##2##(2011-2#3)
rewarming##6##1##(1990-9#1)(2011-2#5)
reweighted least-squares##3##2##(2008-10#3)
rewiring##2##1##(2008-11#1)(2010-10#1)
rhAT III##4##2##(2008-7#4)
rhBMP-2##2##1##(2011-2#2)
rhEPO in##2##2##(2008-8#2)
rhEPO##3##1##(2008-8#3)
rhFKBP12##5##1##(2008-9#5)
rhIL-1##2##1##(1990-12#2)
rhIL-2##2##1##(2008-11#2)
rhKGF##4##1##(1994-11#4)
rhPC##4##1##(2008-12#4)
rhTNF##2##1##(1990-12#1)(2008-8#1)
rhTSH patients##3##2##(2013-1#3)
rhTSH##4##1##(2013-1#4)
rhabdoms##2##1##(2007-12#2)
rhabdomyolysis and acute renal##2##4##(2011-2#1)(2013-8#1)
rhabdomyolysis and##3##2##(2011-2#2)(2013-8#1)
rhabdomyolysis due to##2##3##(2011-2#2)
rhabdomyolysis in a##2##3##(2007-12#1)(2013-8#1)
rhabdomyolysis in##3##2##(1997-5#1)(2007-12#1)(2013-8#1)
rhabdomyolysis##20##1##(1992-2#1)(1997-5#1)(2007-12#1)(2008-10#3)(2011-2#8)(2013-1#3)(2013-8#3)
rhabdomyosarcoma of##3##2##(2010-11#1)(2013-1#2)
rhabdomyosarcoma##7##1##(2008-10#1)(2010-11#4)(2013-1#2)
rhabdovirus##4##1##(2008-10#1)(2008-8#3)
rhabdoviruses##2##1##(2008-8#2)
rhamnogalacturonase##2##1##(1990-9#2)
rhamnoides##4##1##(2008-10#3)(2012-8#1)
rhamnolipids##7##1##(2009-6#3)(2012-2#4)
rhamnose##5##1##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
rhamnoside##4##1##(2008-5#4)
rhamnosus##3##1##(2008-7#1)(2009-12#2)
rhein##3##1##(2008-10#3)
rheological and##2##2##(2008-10#1)(2010-4#1)
rheological behavior of##2##3##(2008-5#1)(2008-8#1)
rheological behavior##4##2##(2008-5#2)(2008-8#1)(2011-3#1)
rheological behaviour##3##2##(2008-5#3)
rheological parameters##2##2##(1994-8#2)
rheological properties of##3##3##(2008-5#2)(2011-2#1)
rheological properties##6##2##(2008-5#4)(2011-2#2)
rheological##20##1##(1994-8#2)(2008-10#1)(2008-5#11)(2008-8#1)(2010-4#1)(2011-2#3)(2011-3#1)
rheology and##2##2##(2008-5#1)(2010-12#1)
rheology of creams##2##3##(2008-5#2)
rheology of##5##2##(2008-5#5)
rheology##11##1##(1997-1#1)(2008-11#1)(2008-5#8)(2010-12#1)
rhesus macaques##2##2##(1990-11#1)(2012-3#1)
rhesus monkey##4##2##(1991-1#2)(1995-11#1)(2008-9#1)
rhesus monkeys##13##2##(1990-11#2)(1991-1#3)(1991-9#1)(1996-2#4)(2008-4#2)(2008-5#1)
rhesus##20##1##(1990-11#3)(1991-1#5)(1991-9#1)(1995-11#2)(1996-2#4)(2008-4#2)(2008-5#1)(2008-9#1)(2012-3#1)
rhetoric and##2##2##(1994-1#1)(2008-11#1)
rhetoric##5##1##(1994-1#2)(1995-12#1)(2008-11#1)(2010-5#1)
rheumatic diseases##6##2##(1991-2#1)(1991-3#1)(1991-8#1)(1993-11#1)(1993-3#1)(2011-2#1)
rheumatic fever##5##2##(1996-11#1)(1996-12#4)
rheumatic##20##1##(1991-2#2)(1991-3#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-2#1)(1996-11#1)(1996-12#5)(2008-10#1)(2008-11#1)(2011-2#5)
rheumatica and temporal arteritis##8##4##(1994-9#3)(1997-8#5)
rheumatica##14##1##(1994-11#2)(1994-9#5)(1997-8#5)(2008-7#2)
rheumatoid arthritis (RA)##6##3##(2008-10#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
rheumatoid arthritis a##2##3##(1993-11#1)(2013-1#1)
rheumatoid arthritis and degenerative arthritis##2##5##(2013-1#2)
rheumatoid arthritis and##8##3##(1992-5#1)(1997-5#1)(1997-8#1)(2009-1#1)(2012-3#1)(2013-1#3)
rheumatoid arthritis patients of Shen deficiency##2##6##(2013-8#2)
rheumatoid arthritis patients##3##3##(2008-8#1)(2013-8#2)
rheumatoid arthritis##55##2##(1990-2#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1995-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#6)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2010-1#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#6)(2013-1#7)(2013-8#6)
rheumatoid##59##1##(1990-2#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#2)(1995-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#7)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2010-1#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#6)(2013-1#7)(2013-8#6)
rheumatologic##2##1##(1997-8#1)(2012-3#1)
rheumatologist##4##1##(1997-4#4)
rheumatology##5##1##(1991-11#1)(1997-3#1)(1997-4#1)(2009-5#1)(2012-2#1)
rhinitis (AR)##4##2##(2008-7#1)(2011-2#1)(2012-12#2)
rhinitis and##3##2##(1991-2#1)(2010-6#1)(2012-12#1)
rhinitis##25##1##(1990-3#1)(1991-2#1)(2007-11#1)(2008-5#4)(2008-7#2)(2010-6#1)(2011-2#2)(2012-12#11)(2012-3#1)(2013-1#1)
rhinobronchitis##2##1##(2008-7#2)
rhinocerebral mucormycosis##2##2##(2011-2#2)
rhinoceros beetles##2##2##(2008-8#2)
rhinorrhea and##2##2##(2008-12#1)(2012-3#1)
rhinorrhea##4##1##(2008-12#2)(2012-12#1)(2012-3#1)
rhinosinusitis (CRS)##2##2##(2011-2#1)(2013-8#1)
rhinosinusitis##4##1##(2011-2#2)(2013-8#2)
rhizo-sphere##2##1##(2008-10#2)
rhizobacteria##15##1##(2008-10#15)
rhizobacterial##3##1##(2008-10#3)
rhizobia##2##1##(2011-2#2)
rhizobial##2##1##(2008-10#1)(2011-2#1)
rhizoctonia##3##1##(2008-10#3)
rhizolysis##2##1##(2011-2#2)
rhizoma##2##1##(2012-3#2)
rhizomania##10##1##(2008-10#10)
rhizomes of##2##2##(2008-11#1)(2008-12#1)
rhizoplane##3##1##(2008-10#3)
rhizosphere abundance of##3##3##(2008-10#3)
rhizosphere and##4##2##(2008-10#4)
rhizosphere bacterium##2##2##(2008-10#2)
rhizosphere colonization by##2##3##(2008-10#2)
rhizosphere colonization was##2##3##(2008-10#2)
rhizosphere colonization##5##2##(2008-10#5)
rhizosphere competence##3##2##(2008-10#3)
rhizosphere densities of##2##3##(2008-10#2)
rhizosphere microorganisms for their ability to induce systemic resistance##2##9##(2008-10#2)
rhizosphere population densities of##2##4##(2008-10#2)
rhizosphere population##4##2##(2008-10#4)
rhizosphere populations of Phytophthora parasitica##3##5##(2008-10#3)
rhizosphere populations of##5##3##(2008-10#5)
rhizosphere priming may##3##3##(2013-8#3)
rhizosphere priming##5##2##(2013-8#5)
rhizosphere soil##4##2##(2008-10#3)(2010-3#1)
rhizosphere were##3##2##(2008-10#3)
rhizosphere##72##1##(2008-10#63)(2008-12#2)(2009-8#1)(2010-3#1)(2013-8#5)
rho 1 receptor function##2##4##(1995-11#2)
rho 1##4##2##(1995-11#4)
rho##20##1##(1992-11#1)(1992-3#1)(1995-11#4)(1995-8#1)(2008-10#10)(2010-10#1)(2010-5#1)(2011-2#1)
rho(t##4##1##(2008-10#4)
rhodamine 123##5##2##(1994-2#1)(2008-10#3)(2008-7#1)
rhodamine 6G##10##2##(2008-10#10)
rhodamine B and##2##3##(2008-10#2)
rhodamine B hydrazide##4##3##(2008-10#4)
rhodamine B isothiocyanate##2##3##(2008-10#2)
rhodamine B##19##2##(2008-10#18)(2008-12#1)
rhodamine S##5##2##(2008-10#5)
rhodamine dyes##2##2##(2008-10#2)
rhodamine##47##1##(1990-12#1)(1994-2#1)(2008-10#43)(2008-12#1)(2008-7#1)
rhodanese##4##1##(1992-12#4)
rhodium has##3##2##(2008-10#3)
rhodium on##2##2##(2008-10#2)
rhodium permanent##2##2##(2008-10#2)
rhodium##34##1##(2008-10#34)
rhododendron##2##1##(2008-10#2)
rhodopsin##2##1##(2009-8#1)(2012-3#1)
rhubarbs##2##1##(2008-10#2)
rhumatoid factor##2##2##(2007-8#2)
rhumatoid##3##1##(2007-8#3)
rhythm and##3##2##(1990-3#1)(1990-5#1)(2008-5#1)
rhythm disturbances##2##2##(2008-10#1)(2009-10#1)
rhythm in##6##2##(1994-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
rhythm is##3##2##(2008-5#1)(2008-6#1)(2010-12#1)
rhythm of the##2##3##(1992-2#1)(2008-10#1)
rhythm of##4##2##(1992-2#1)(1993-11#1)(2008-10#1)(2008-12#1)
rhythm reversal##3##2##(2008-6#3)
rhythm was##2##2##(2008-11#1)(2011-2#1)
rhythm##53##1##(1990-3#1)(1990-5#1)(1990-9#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-2#2)(1995-11#1)(1997-2#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-5#8)(2008-6#5)(2008-7#2)(2008-8#2)(2009-10#2)(2010-12#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
rhythmic bladder contractions were##2##4##(1992-3#2)
rhythmic bladder contractions##3##3##(1992-3#3)
rhythmic##7##1##(1992-3#3)(1997-4#2)(2012-2#1)(2013-8#1)
rhythmical jaw movements##2##3##(1990-9#2)
rhythmical jaw##3##2##(1990-9#3)
rhythmical##6##1##(1990-9#4)(1991-2#1)(1992-12#1)
rhythmically##2##1##(1994-11#1)(1995-12#1)
rhythms and##3##2##(1990-5#1)(1996-2#1)(2013-1#1)
rhythms in the##2##3##(2013-7#1)(2013-8#1)
rhythms in##4##2##(1990-3#1)(2008-5#1)(2013-7#1)(2013-8#1)
rhythms##18##1##(1990-3#1)(1990-5#4)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#2)(2013-1#1)(2013-7#2)(2013-8#2)
rib##11##1##(1997-3#1)(2008-2#1)(2008-3#2)(2012-3#3)(2013-1#4)
ribavirin in##4##2##(1994-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
ribavirin with##2##2##(2008-10#1)(2009-8#1)
ribavirin##19##1##(1990-10#3)(1994-6#2)(1994-8#1)(2008-10#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-2#2)(2013-1#2)(2013-7#1)
ribbon-like inclusions maps to##2##4##(2008-10#2)
ribbon-like inclusions##4##2##(2008-10#4)
ribicola was##2##2##(2008-10#2)
ribicola##18##1##(2008-10#18)
riboflavin##25##1##(1992-9#1)(2008-10#12)(2008-9#8)(2012-2#1)(2012-3#2)(2013-1#1)
riboflavine and 0##2##3##(2008-10#2)
riboflavine and##3##2##(2008-10#3)
ribonuclear protein##2##2##(2008-11#1)(2011-2#1)
ribonuclease A##2##2##(1997-6#1)(2008-10#1)
ribonuclease protection assay##3##3##(2008-10#2)(2008-4#1)
ribonuclease protection##4##2##(2008-10#3)(2008-4#1)
ribonuclease##10##1##(1992-4#1)(1997-6#1)(2008-10#5)(2008-4#1)(2008-7#1)(2012-3#1)
ribonucleic##2##1##(1995-12#1)(2008-10#1)
ribonucleoprotein particles##2##2##(1994-11#2)
ribonucleoprotein##7##1##(1993-8#1)(1994-11#2)(2008-8#2)(2008-9#1)(2011-2#1)
ribonucleoside##2##1##(1994-5#1)(2008-4#1)
ribonucleosides##12##1##(1997-2#3)(2008-4#9)
ribonucleotide reductase##3##2##(1991-12#1)(1992-10#2)
ribonucleotide synthetase##3##2##(1993-12#3)
ribonucleotide##8##1##(1991-12#1)(1992-10#2)(1993-12#4)(2011-1#1)
riboprobes and##2##2##(1996-12#2)
riboprobes##5##1##(1996-12#3)(1996-2#1)(2008-10#1)
ribose##6##1##(1993-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#2)
riboside##2##1##(1994-8#2)
ribosomal (r)DNA##2##2##(2008-10#2)
ribosomal DNA (rDNA)##5##3##(2008-10#4)(2008-9#1)
ribosomal DNA internal transcribed spacer region##2##6##(2008-10#2)
ribosomal DNA internal transcribed spacer##5##5##(2008-10#5)
ribosomal DNA##29##2##(2008-10#25)(2008-12#2)(2008-9#1)(2010-3#1)
ribosomal RNA (rRNA)##3##3##(2008-10#2)(2011-2#1)
ribosomal RNA gene (rDNA)##2##4##(2008-10#1)(2008-8#1)
ribosomal RNA gene##7##3##(2008-10#3)(2008-8#1)(2011-2#2)(2013-1#1)
ribosomal RNA genes##4##3##(1992-3#1)(2008-10#3)
ribosomal RNA in Drosophila melanogaster##2##5##(1997-7#2)
ribosomal RNA##21##2##(1992-3#1)(1997-7#4)(2008-10#9)(2008-8#1)(2010-4#1)(2011-2#4)(2013-1#1)
ribosomal cistron##2##2##(1993-12#2)
ribosomal frameshifting##5##2##(1995-9#5)
ribosomal gene##2##2##(2008-10#2)
ribosomal genes##3##2##(2008-10#3)
ribosomal intergenic spacer analysis##2##4##(2008-10#2)
ribosomal intergenic spacer##3##3##(2008-10#3)
ribosomal internal transcribed spacer (ITS)##2##5##(2008-10#1)(2008-9#1)
ribosomal internal transcribed spacer region##3##5##(2008-10#3)
ribosomal internal transcribed spacer##5##4##(2008-10#4)(2008-9#1)
ribosomal protein S14##3##3##(1996-6#3)
ribosomal protein S3a##2##3##(2008-11#2)
ribosomal protein S6##3##3##(1993-2#1)(1996-2#2)
ribosomal protein gene##2##3##(2008-10#1)(2008-8#1)
ribosomal protein genes##3##3##(1996-3#1)(2008-11#1)(2009-8#1)
ribosomal protein operons##2##3##(2008-8#2)
ribosomal protein##30##2##(1991-5#1)(1991-6#1)(1991-7#2)(1992-8#1)(1993-2#1)(1995-6#2)(1996-2#2)(1996-3#1)(1996-6#3)(1997-2#1)(2008-10#2)(2008-11#4)(2008-8#6)(2009-8#2)(2013-8#1)
ribosomal proteins##4##2##(1992-8#1)(2008-8#2)(2013-8#1)
ribosomal subunits##2##2##(2011-2#1)(2012-2#1)
ribosomal##120##1##(1991-5#1)(1991-6#2)(1991-7#2)(1992-3#2)(1992-8#3)(1993-12#3)(1993-2#1)(1993-6#1)(1995-6#2)(1995-9#5)(1996-2#2)(1996-3#1)(1996-6#3)(1997-2#1)(1997-7#4)(2008-10#54)(2008-11#5)(2008-12#2)(2008-8#10)(2008-9#2)(2009-8#2)(2010-3#2)(2010-4#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#2)
ribosome and##2##2##(1994-11#1)(1995-3#1)
ribosome binding sequence##2##3##(2008-10#1)(2010-6#1)
ribosome binding##3##2##(2008-10#1)(2010-6#2)
ribosome biogenesis##4##2##(2011-2#4)
ribosome##21##1##(1991-6#1)(1991-9#2)(1994-11#1)(1995-3#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-9#2)(2010-6#2)(2011-2#5)(2012-3#1)(2013-8#1)
ribosome-activated ATPase activity of EF-3##3##5##(1996-2#3)
ribosome-activated ATPase activity##4##3##(1996-2#4)
ribosome-binding site##3##2##(1991-9#1)(1993-9#2)
ribosome-inactivating protein##4##2##(1993-2#2)(2008-10#2)
ribosome-inactivating##6##1##(1990-12#2)(1993-2#2)(2008-10#2)
ribosomes##8##1##(1992-8#1)(1995-9#2)(2008-10#1)(2008-7#3)(2008-9#1)
ribozyme in vitro and in vivo##2##6##(2008-9#2)
ribozyme in##5##2##(1993-9#2)(2008-9#3)
ribozyme##27##1##(1993-9#7)(1994-11#6)(1995-3#1)(2008-11#1)(2008-9#12)
ribozymes##3##1##(2008-11#1)(2008-9#2)
ribs##7##1##(1991-11#1)(1993-12#2)(1994-12#1)(1997-3#2)(2013-1#1)
rice (Oryza sativa L##8##4##(1994-11#1)(2008-10#2)(2008-9#5)
rice (Oryza sativa##11##3##(1994-11#1)(2008-10#2)(2008-9#6)(2009-10#2)
rice (Oryza sativa)##3##3##(2008-10#2)(2009-10#1)
rice (Oryza##16##2##(1994-11#1)(1996-12#1)(2008-10#4)(2008-9#6)(2009-10#4)
rice 5460S##2##2##(2008-8#2)
rice GTs##2##2##(2009-10#2)
rice MADS box##2##3##(1997-8#1)(2008-8#1)
rice Pi21##2##2##(2012-2#2)
rice SVP-group MADS-box proteins##2##4##(2009-8#2)
rice U-box##2##2##(2009-10#2)
rice allergenic protein##2##3##(2008-11#2)
rice and Arabidopsis U-box proteins##3##5##(2009-10#3)
rice and Arabidopsis##4##3##(2009-10#4)
rice and St##3##3##(2008-10#3)
rice and barley gene expression databases##2##6##(2009-10#2)
rice and barley##3##3##(2009-10#3)
rice and maize##2##3##(2008-8#1)(2009-10#1)
rice and wheat##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
rice and##27##2##(2008-10#8)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#1)(2009-10#11)(2011-3#1)(2013-8#1)
rice bacterial artificial chromosome (BAC) library##2##6##(2008-8#2)
rice bacterial blight##3##3##(2008-10#3)
rice bacterial##5##2##(2008-10#3)(2008-8#2)
rice blast caused by##2##4##(2008-10#2)
rice blast fungus##5##3##(2008-10#5)
rice blast in the##2##4##(2008-10#2)
rice blast in##3##3##(2008-10#2)(2012-2#1)
rice blast resistance##2##3##(2008-10#2)
rice blast##24##2##(2008-10#23)(2012-2#1)
rice breeding##2##2##(2008-10#1)(2008-8#1)
rice by##3##2##(2008-10#2)(2008-9#1)
rice cDNA##4##2##(1996-8#1)(2008-10#1)(2008-9#2)
rice chromosome 4##2##3##(2009-10#2)
rice chromosome##4##2##(1995-6#1)(2008-8#1)(2009-10#2)
rice chromosomes##7##2##(1996-12#3)(1997-2#2)(2008-8#1)(2008-9#1)
rice cultivar##5##2##(2008-10#4)(2008-9#1)
rice cultivars##7##2##(2008-10#6)(2009-10#1)
rice cv##4##2##(2008-10#2)(2008-9#2)
rice epsps cDNA##2##3##(2008-9#2)
rice epsps##4##2##(2008-9#4)
rice flour##7##2##(2008-10#7)
rice from##2##2##(2008-10#2)
rice genome and##2##3##(2008-9#1)(2009-10#1)
rice genome by##2##3##(2008-8#1)(2009-10#1)
rice genome##17##2##(1996-8#2)(2008-8#4)(2008-9#8)(2009-10#3)
rice genomic DNA##2##3##(1996-12#1)(2008-8#1)
rice genomic library##3##3##(2008-8#1)(2008-9#2)
rice genomic##5##2##(1996-12#1)(2008-8#2)(2008-9#2)
rice grain##3##2##(2013-1#3)
rice grains##2##2##(1995-3#1)(2008-10#1)
rice growth stages##2##3##(2008-10#2)
rice growth##3##2##(2008-10#2)(2008-9#1)
rice hull##3##2##(2008-12#3)
rice hybrid##2##2##(2008-9#2)
rice hybrids##2##2##(2008-10#1)(2009-10#1)
rice in the United States##2##5##(2008-10#1)(2013-8#1)
rice in##6##2##(2008-10#3)(2013-1#1)(2013-8#2)
rice leaves##5##2##(2008-10#5)
rice line##3##2##(2008-10#2)(2008-9#1)
rice lines##3##2##(2008-10#2)(2008-9#1)
rice pest management##2##3##(2008-10#2)
rice plant##3##2##(2008-10#2)(2009-8#1)
rice plants were##2##3##(2008-10#2)
rice plants##12##2##(2008-10#9)(2008-8#1)(2008-9#1)(2013-8#1)
rice plus canola oil##3##4##(2008-10#3)
rice production in##2##3##(2008-10#2)
rice production##3##2##(2008-10#3)
rice resistance to blast##2##4##(2008-10#1)(2012-2#1)
rice root##7##2##(2008-9#7)
rice samples##3##2##(2008-10#3)
rice seed##2##2##(2008-10#2)
rice seedlings##3##2##(2008-10#3)
rice seeds##2##2##(2008-9#2)
rice starch 4##2##3##(2008-5#2)
rice starch##3##2##(2008-5#3)
rice tungro spherical virus##2##4##(2008-10#2)
rice tungro##3##2##(2008-10#3)
rice varieties##6##2##(1996-8#3)(2008-10#1)(2008-8#2)
rice variety##3##2##(2008-9#3)
rice yellow mottle virus##2##4##(2008-10#2)
rice yellow stunt rhabdovirus##2##4##(2008-8#2)
rice yellow##5##2##(2008-10#3)(2008-8#2)
rice yield was##2##3##(2008-12#2)
rice yield##3##2##(2008-12#2)(2013-8#1)
rice##415##1##(1994-11#2)(1995-3#1)(1995-6#2)(1996-12#6)(1996-8#7)(1997-2#3)(1997-8#2)(2008-10#162)(2008-11#7)(2008-12#9)(2008-3#2)(2008-5#3)(2008-8#52)(2008-9#73)(2009-10#57)(2009-8#4)(2011-3#3)(2012-2#5)(2013-1#8)(2013-8#7)
rice)##2##1##(2008-10#2)
rice-M##2##1##(2009-10#1)(2012-2#1)
rice-diverged##2##1##(2009-10#2)
rich and##4##2##(1991-6#1)(2008-11#1)(2008-12#1)(2008-3#1)
rich data##2##2##(2010-7#1)(2011-2#1)
rich in acidic residues##2##4##(1992-7#1)(1995-6#1)
rich in fat##2##3##(1995-2#1)(1997-8#1)
rich in##34##2##(1990-5#1)(1991-12#1)(1992-7#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-6#2)(1997-5#1)(1997-8#5)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2009-1#1)(2010-1#1)(2010-4#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
rich information##2##2##(2008-10#1)(2012-3#1)
rich region##5##2##(1993-3#2)(1997-2#1)(2008-8#2)
rich repeat##3##2##(2008-9#2)(2010-10#1)
rich source of##3##3##(1992-12#1)(2008-5#1)(2008-9#1)
rich sources of##2##3##(1992-3#1)(2008-5#1)
rich##102##1##(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#5)(2007-12#1)(2008-10#14)(2008-11#9)(2008-12#4)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-1#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
richest##3##1##(2008-10#1)(2008-5#1)(2011-3#1)
richly##2##1##(1997-4#1)(2013-1#1)
richness and altitude##2##3##(2008-8#2)
richness and complexity##3##3##(2008-10#2)(2008-12#1)
richness and##16##2##(2008-10#3)(2008-12#1)(2008-8#9)(2008-9#1)(2012-2#1)(2013-8#1)
richness increased##2##2##(2008-8#2)
richness is##8##2##(2008-10#1)(2008-8#6)(2008-9#1)
richness of##5##2##(2008-11#1)(2008-8#1)(2008-9#2)(2010-10#1)
richness##64##1##(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#41)(2008-9#10)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
ricin and abrin##3##3##(1994-5#3)
ricin##8##1##(1990-12#1)(1993-11#2)(1994-5#5)
ricini##3##1##(2008-6#1)(2008-8#2)
rickettsial##2##1##(1995-12#1)(1996-1#1)
ridge gourd##2##2##(2013-8#2)
ridge tillage##6##2##(2008-10#6)
ridge##14##1##(1994-11#1)(2008-10#6)(2008-7#4)(2013-1#1)(2013-8#2)
ridges of##2##2##(1994-11#1)(2008-5#1)
ridges with##2##2##(2011-2#1)(2013-1#1)
ridges##12##1##(1994-11#2)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#5)(2013-8#1)
rifampicin and##4##2##(2008-10#4)
rifampicin##10##1##(2008-1#1)(2008-10#7)(2008-12#1)(2011-2#1)
rifampin##2##1##(2011-2#2)
rifamycin B production##2##3##(1994-8#2)
rifamycin B##3##2##(1994-8#3)
right MCA##2##2##(1997-6#1)(2008-12#1)
right accessory##2##2##(2008-11#1)(2008-7#1)
right and left lobes of the thyroid gland##2##8##(2013-1#2)
right and left lobes##3##4##(2013-1#3)
right and left##11##3##(1993-12#1)(1996-2#1)(2008-10#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-1#5)
right and##15##2##(1993-1#1)(1993-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#5)
right arm and leg##2##4##(2010-9#2)
right arm##10##2##(1995-9#1)(1996-3#2)(1996-6#4)(2010-9#2)(2011-2#1)
right atrial pressure##2##3##(1997-5#1)(2008-11#1)
right atrial##5##2##(1997-2#1)(1997-5#1)(2008-11#1)(2012-12#2)
right brain##2##2##(1995-8#1)(1996-2#1)
right bundle branch block##2##4##(2008-12#2)
right coronary artery##2##3##(2008-12#1)(2013-2#1)
right ear##2##2##(2010-6#1)(2011-2#1)
right eye and##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
right eye##12##2##(2008-11#1)(2010-10#2)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#2)
right femoral##2##2##(2008-12#1)(2009-4#1)
right femur##2##2##(2008-12#1)(2011-2#1)
right foot##4##2##(2008-12#1)(2008-5#1)(2010-3#1)(2013-1#1)
right for##3##2##(1992-2#1)(1993-1#1)(2013-1#1)
right forelimb lameness##2##3##(2012-3#1)(2013-8#1)
right forelimb##3##2##(2012-3#1)(2013-8#2)
right heart##8##2##(1996-3#2)(1997-1#1)(2010-10#2)(2011-2#2)(2012-12#1)
right hemiparesis##3##2##(2008-7#1)(2010-9#1)(2013-8#1)
right hemisphere brain damage##2##4##(2012-3#2)
right hemisphere is##2##3##(2008-11#2)
right hemisphere##9##2##(1991-11#1)(1996-2#4)(2008-11#2)(2012-3#2)
right hepatic artery##2##3##(2012-2#1)(2013-1#1)
right hepatic##3##2##(1991-6#1)(2012-2#1)(2013-1#1)
right kidney##6##2##(1990-9#1)(1994-5#1)(2008-10#1)(2011-2#2)(2013-1#1)
right lateral##2##2##(2012-3#1)(2013-1#1)
right lobe##5##2##(1993-6#1)(2008-11#1)(2008-12#1)(2012-2#2)
right lower##4##2##(1991-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
right lungs##2##2##(1996-3#1)(2008-10#1)
right middle##11##2##(1996-2#1)(1996-3#2)(2008-11#1)(2008-12#2)(2008-7#3)(2013-1#1)(2013-8#1)
right or##4##2##(1994-1#2)(2008-5#1)(2013-8#1)
right parietal##2##2##(2009-1#1)(2013-8#1)
right subclavian artery##3##3##(2008-11#2)(2010-5#1)
right subclavian##4##2##(2008-11#3)(2010-5#1)
right superior parietal##2##3##(2008-11#1)(2013-8#1)
right superior##4##2##(1996-9#1)(2008-11#1)(2011-2#1)(2013-8#1)
right temporal##2##2##(1992-12#1)(2013-8#1)
right testis##3##2##(1997-3#1)(2008-10#2)
right thigh##2##2##(2012-3#2)
right to abortion##2##3##(1992-6#1)(1993-3#1)
right to left##2##3##(2009-10#2)
right to life##5##3##(1995-12#1)(2011-2#4)
right to privacy##3##3##(1996-9#1)(1997-5#1)(2008-12#1)
right to refuse treatment##3##4##(1995-12#2)(1995-2#1)
right to refuse##4##3##(1990-11#1)(1995-12#2)(1995-2#1)
right to seek##2##3##(1990-12#1)(1997-7#1)
right to self-determination##4##3##(1991-2#2)(1997-8#2)
right to##38##2##(1990-11#1)(1990-12#1)(1991-2#2)(1992-6#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-12#8)(1995-2#2)(1995-6#1)(1996-5#1)(1996-9#1)(1997-5#2)(1997-7#1)(1997-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2009-10#2)(2011-2#4)(2013-1#1)
right transradial approach##4##3##(2008-11#3)(2011-2#1)
right up##2##2##(1990-11#1)(2008-5#1)
right upper extremity##2##3##(2008-12#1)(2010-9#1)
right upper##7##2##(2008-12#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
right ventricular##12##2##(1996-11#1)(1996-3#3)(2008-12#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-2#1)
right vertebral artery##2##3##(1991-8#1)(2013-8#1)
right visual field##2##3##(1996-2#2)
right with##2##2##(1994-11#1)(2008-11#1)
right##412##1##(1990-11#4)(1990-12#2)(1990-6#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#5)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#3)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-5#1)(1994-8#4)(1995-1#2)(1995-12#9)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#11)(1996-3#14)(1996-5#1)(1996-6#4)(1996-9#9)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#5)(1997-6#2)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#1)(2008-1#3)(2008-10#15)(2008-11#33)(2008-12#21)(2008-5#8)(2008-7#14)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#8)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#5)(2010-8#2)(2010-9#6)(2011-1#1)(2011-2#40)(2012-12#8)(2012-2#9)(2012-3#19)(2013-1#27)(2013-2#4)(2013-7#5)(2013-8#17)
right&quot##10##1##(1993-2#1)(1993-3#1)(1994-2#4)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)
right-brain-damaged patients##2##2##(2009-10#2)
right-handed##4##1##(1996-2#2)(2009-8#1)(2012-2#1)
right-pawed##2##1##(1997-2#2)
right-side##4##1##(2007-8#2)(2013-7#2)
right-sided##12##1##(1991-11#1)(1991-3#1)(2008-11#2)(2010-7#2)(2011-2#6)
right-to-left##2##1##(1990-11#1)(2011-2#1)
rights and##4##2##(1990-6#2)(2008-11#1)(2013-8#1)
rights for##3##2##(1992-12#1)(2008-12#1)(2008-5#1)
rights in##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
rights of##3##2##(1996-5#1)(2008-11#1)(2009-11#1)
rights to##5##2##(1994-8#1)(1997-8#2)(2008-11#1)(2008-5#1)
rights##43##1##(1990-2#1)(1990-6#3)(1991-2#1)(1991-3#1)(1992-12#2)(1993-9#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#2)(1996-5#1)(1997-7#1)(1997-8#2)(2008-11#8)(2008-12#1)(2008-5#3)(2008-8#1)(2009-11#1)(2013-8#8)
rightward bisection error##2##3##(2009-10#2)
rightward##5##1##(1990-5#1)(1994-8#1)(2008-5#1)(2009-10#2)
rigid sagittal deformity##2##3##(2008-8#2)
rigid##33##1##(1991-2#2)(1991-5#1)(1992-1#1)(1993-12#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#4)(2009-7#1)(2011-2#1)(2012-12#2)(2012-3#1)
rigidity and##5##2##(2008-10#1)(2008-12#2)(2009-11#2)
rigidity of the##3##3##(1995-8#1)(2008-10#2)
rigidity of##8##2##(1995-2#1)(1995-8#1)(2008-10#3)(2008-12#2)(2013-1#1)
rigidity##26##1##(1995-2#1)(1995-8#2)(2008-10#6)(2008-12#7)(2008-5#1)(2008-7#2)(2009-11#4)(2012-12#1)(2013-1#2)
rigor##3##1##(1992-12#1)(2010-4#1)(2011-2#1)
rigorous and##2##2##(1992-1#1)(2008-8#1)
rigorous electromagnetic##2##2##(2008-2#1)(2008-3#1)
rigorous methods##2##2##(2008-10#1)(2011-2#1)
rigorous study##3##2##(2008-10#1)(2012-3#2)
rigorous##44##1##(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-9#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-5#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
rigorously controlled##2##2##(2008-10#1)(2013-1#1)
rigorously##13##1##(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
rigors##3##1##(1990-10#1)(2007-12#2)
rigour##2##1##(2008-11#2)
rim of the##2##3##(1996-5#1)(1996-9#1)
rim##8##1##(1996-5#3)(1996-9#1)(2007-12#2)(2008-10#1)(2008-11#1)
rims##4##1##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
rind##2##1##(2008-10#2)
rinderpest##6##1##(1990-3#4)(2011-2#2)
ring analogues and derivatives of##2##5##(1993-1#2)
ring and##3##2##(2008-10#2)(2011-1#1)
ring annuloplasty##2##2##(2008-10#2)
ring cavity##4##2##(2008-2#1)(2008-3#3)
ring formation##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
ring from##2##2##(2008-8#1)(2010-7#1)
ring in the##3##3##(1991-3#1)(1995-11#1)(2008-8#1)
ring is##4##2##(1994-12#1)(1994-5#1)(2008-10#2)
ring laser gyroscopes##2##3##(2008-3#2)
ring laser##3##2##(2008-3#3)
ring nematodes##2##2##(2008-10#2)
ring of the##5##3##(1992-1#1)(1994-5#1)(2008-10#3)
ring of##13##2##(1992-1#1)(1992-3#1)(1994-5#1)(1996-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)
ring opening##3##2##(1994-5#1)(2008-8#2)
ring sinus##4##2##(2011-2#4)
ring structure##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
ring structures##2##2##(2008-11#1)(2008-7#1)
ring study##2##2##(2008-10#2)
ring system and the##2##4##(1993-12#2)
ring system and##3##3##(1993-12#3)
ring system##6##2##(1991-3#1)(1993-12#5)
ring to##2##2##(1991-3#1)(2008-11#1)
ring were##2##2##(1992-10#1)(2008-11#1)
ring##143##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-1#2)(1992-10#1)(1992-3#2)(1993-1#4)(1993-12#5)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#4)(1994-5#4)(1995-1#1)(1995-11#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#45)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#13)(2008-7#2)(2008-8#5)(2008-9#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-2#1)(2012-5#1)(2013-1#2)
ring-closing##2##1##(1990-9#1)(2008-11#1)
ring-disc electrode##4##2##(2008-10#4)
ring-disk dual##2##2##(2008-10#2)
ring-disk working electrode##2##3##(2008-10#2)
ring-disk##5##1##(2008-10#5)
ring-opening##3##1##(1990-9#2)(1996-5#1)
ringdown spectral photography##2##3##(2008-3#2)
ringdown spectroscopy##12##2##(2007-12#1)(2008-2#2)(2008-3#9)
ringdown##23##1##(2007-12#2)(2008-2#3)(2008-3#18)
ringed seals##2##2##(2008-10#2)
ringed##4##1##(2008-10#4)
ringing##3##1##(2011-1#3)
rings have##3##2##(1996-5#1)(2008-10#2)
rings in the##2##3##(1990-3#1)(2008-10#1)
rings were##5##2##(1993-8#1)(2008-10#1)(2008-11#2)(2011-2#1)
rings##28##1##(1990-3#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#1)(1996-5#1)(2008-10#9)(2008-11#4)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-1#1)
rings)##2##1##(2008-10#1)(2013-8#1)
ringspot virus##18##2##(2008-10#18)
ringspot##24##1##(2008-10#24)
ringworm##2##1##(2008-5#2)
ringwulst##2##1##(2011-2#2)
rinse##4##1##(2008-10#2)(2013-1#2)
rinsed with##2##2##(2008-10#1)(2013-1#1)
rinsing of the##2##3##(2008-10#2)
rinsing with##2##2##(2008-10#1)(2008-5#1)
rinsing##10##1##(1991-6#1)(2008-10#7)(2008-3#1)(2008-5#1)
ripe fleshy fruits##2##3##(2008-9#2)
ripe##5##1##(2008-10#2)(2008-9#2)(2013-1#1)
ripened honey##2##2##(2008-10#2)
ripened##4##1##(2008-10#2)(2012-2#2)
ripeness##2##1##(2008-10#2)
ripening fruits##2##2##(2008-10#2)
ripening state##2##2##(2008-10#2)
ripening##16##1##(2008-10#8)(2009-11#1)(2011-2#5)(2012-2#2)
ripple structure##2##2##(2008-3#2)
rise as##3##2##(1990-11#1)(1994-5#1)(2008-10#1)
rise in [Ca2+]i in##2##4##(1992-6#1)(1994-2#1)
rise in [Ca2+]i##3##3##(1992-6#1)(1994-2#1)(1994-3#1)
rise in current##2##3##(1990-5#2)
rise in incidence##4##3##(1991-12#1)(1995-2#2)(2008-10#1)
rise in the##10##3##(1992-1#1)(1994-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
rise in##61##2##(1990-10#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-3#2)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#3)
rise induced by##2##3##(1994-5#1)(1995-11#1)
rise of the##3##3##(1994-3#1)(1994-6#1)(2008-11#1)
rise of##10##2##(1990-2#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-1#1)
rise time of##2##3##(2008-10#1)(2008-2#1)
rise to a##21##3##(1991-9#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2013-8#1)
rise to an##4##3##(2008-10#2)(2008-12#1)(2008-7#1)
rise to chromosome##2##3##(2008-11#1)(2012-3#1)
rise to many##3##3##(1992-3#1)(2008-5#1)(2009-1#1)
rise to new##4##3##(1992-6#1)(2009-12#1)(2009-8#1)(2012-2#1)
rise to the##12##3##(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
rise to##99##2##(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#12)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#6)
rise was##2##2##(1991-12#1)(1997-8#1)
rise with##3##2##(1993-3#1)(2008-9#1)(2013-1#1)
rise##205##1##(1990-10#2)(1990-11#2)(1990-2#2)(1990-5#3)(1990-7#1)(1991-12#2)(1991-3#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1993-3#2)(1993-5#2)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-3#2)(1997-6#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#30)(2008-11#19)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#9)
risen##6##1##(1994-1#1)(1995-1#1)(1997-7#1)(2008-12#1)(2008-3#2)
rises in##2##2##(1994-6#1)(1994-8#1)
rises##7##1##(1993-1#1)(1994-6#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-3#1)
rising costs##5##2##(1991-12#2)(1992-12#1)(2011-7#1)(2012-3#1)
rising health care costs##2##4##(1997-1#1)(2012-2#1)
rising to##2##2##(1993-11#1)(2008-7#1)
rising##39##1##(1991-12#3)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#1)
risk =##2##2##(1991-2#1)(1997-8#1)
risk adjustment for##2##3##(1997-1#2)
risk adjustment of##2##3##(1995-2#1)(2010-12#1)
risk adjustment##11##2##(1995-2#3)(1995-3#2)(1997-1#3)(2008-11#1)(2008-7#1)(2010-12#1)
risk among##9##2##(1994-6#1)(1996-3#1)(2008-11#1)(2008-12#2)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
risk analysis approach##2##3##(2008-10#1)(2012-2#1)
risk analysis in##2##3##(1997-4#1)(2008-10#1)
risk analysis of##3##3##(2008-11#1)(2012-2#2)
risk analysis##17##2##(1990-11#1)(1997-4#1)(2008-10#3)(2008-11#2)(2009-10#3)(2009-7#1)(2012-2#6)
risk and##40##2##(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1995-11#1)(1995-9#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-6#2)(2008-7#2)(2009-10#3)(2009-9#1)(2010-1#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#2)
risk appraisal##2##2##(2010-7#2)
risk are still##2##3##(1990-6#1)(2008-1#1)
risk are##6##2##(1990-6#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-8#1)
risk assessment and##7##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#2)(2013-1#1)
risk assessment are##2##3##(1997-3#1)(2008-10#1)
risk assessment for##3##3##(2008-10#2)(2011-2#1)
risk assessment in the##2##4##(2008-10#1)(2008-5#1)
risk assessment in##5##3##(2008-10#2)(2008-5#1)(2008-7#2)
risk assessment of pharmaceutical residues##2##5##(2008-10#2)
risk assessment of plant protection products##2##6##(2008-11#2)
risk assessment of##12##3##(1995-9#1)(1996-3#1)(1997-4#1)(2008-10#3)(2008-11#5)(2008-9#1)
risk assessment process##2##3##(2008-10#1)(2008-5#1)
risk assessment##76##2##(1991-12#2)(1993-1#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#25)(2008-11#10)(2008-12#1)(2008-5#5)(2008-7#3)(2008-9#4)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-2#7)(2013-1#1)(2013-8#2)
risk assessments and##3##3##(2008-10#2)(2010-4#1)
risk assessments of##2##3##(2008-10#2)
risk assessments##14##2##(1997-8#1)(2008-10#7)(2008-5#1)(2010-4#1)(2011-2#4)
risk associated with##5##3##(1991-12#1)(2008-1#1)(2008-10#2)(2011-2#1)
risk associated##6##2##(1991-12#1)(2008-1#1)(2008-10#2)(2009-10#1)(2011-2#1)
risk averse##2##2##(2011-2#2)
risk because of##2##3##(1991-12#1)(2008-7#1)
risk behavior##9##2##(2008-12#4)(2010-7#1)(2013-1#3)(2013-8#1)
risk behaviors among##2##3##(2013-1#1)(2013-8#1)
risk behaviors and##3##3##(1991-1#1)(2008-12#1)(2008-4#1)
risk behaviors in##5##3##(2008-4#1)(2008-8#1)(2013-1#3)
risk behaviors##22##2##(1991-1#1)(1995-12#1)(1997-3#1)(2008-12#1)(2008-4#5)(2008-8#1)(2009-5#1)(2010-7#1)(2013-1#6)(2013-8#4)
risk behaviour##2##2##(2008-10#1)(2012-12#1)
risk category##2##2##(2008-1#1)(2010-11#1)
risk classification##7##2##(1993-12#2)(1994-12#1)(1995-1#1)(2011-2#3)
risk communication##2##2##(2010-11#1)(2013-1#1)
risk compared##2##2##(2008-3#1)(2013-8#1)
risk conditions##5##2##(1994-1#1)(2009-10#4)
risk difference##2##2##(1994-9#1)(2008-11#1)
risk distribution##3##2##(1992-12#3)
risk due to the##2##4##(2008-11#1)(2010-12#1)
risk due to##8##3##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-12#1)(2011-2#1)
risk during##2##2##(2012-3#1)(2013-8#1)
risk emphasis##2##2##(2012-2#2)
risk estimates##4##2##(1990-6#1)(1996-3#2)(2011-2#1)
risk estimation##3##2##(1992-6#1)(2008-10#1)(2013-8#1)
risk evaluation##2##2##(2009-5#1)(2012-3#1)
risk factor control##2##3##(2011-2#2)
risk factor evaluation##2##3##(2010-9#1)(2012-2#1)
risk factor for coronary##2##4##(1997-8#1)(2008-6#1)
risk factor for developing##2##4##(2008-6#1)(2012-5#1)
risk factor for development of venous##2##6##(1997-3#2)
risk factor for development of##3##5##(1997-3#2)(2011-2#1)
risk factor for falls##2##4##(2008-7#1)(2011-2#1)
risk factor for the##3##4##(2011-2#1)(2012-12#1)(2012-3#1)
risk factor for##46##3##(1990-8#1)(1993-2#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-1#1)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#4)(2013-8#1)
risk factor levels##2##3##(1991-6#2)
risk factor of##3##3##(1994-12#1)(2008-8#1)(2010-8#1)
risk factor##77##2##(1990-6#2)(1990-8#1)(1991-6#3)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-12#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-5#2)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2010-1#1)(2010-8#1)(2010-9#2)(2011-2#14)(2012-12#1)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#4)(2013-8#1)
risk factors and##22##3##(1991-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1996-12#1)(2008-11#2)(2008-7#5)(2009-7#1)(2010-2#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
risk factors are more##2##4##(2008-1#1)(2008-9#1)
risk factors are##10##3##(1992-12#1)(1996-11#1)(2008-1#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)
risk factors associated with the##2##5##(2009-5#1)(2011-2#1)
risk factors associated with##9##4##(1993-11#1)(2008-1#2)(2009-5#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
risk factors associated##10##3##(1993-11#1)(2007-8#1)(2008-1#2)(2009-5#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
risk factors do not##2##4##(1992-9#1)(2010-9#1)
risk factors for HIV infection##2##5##(2007-12#1)(2008-5#1)
risk factors for coronary##3##4##(1993-2#1)(2008-12#2)
risk factors for pulmonary##2##4##(2010-10#1)(2011-2#1)
risk factors for the##4##4##(2011-2#1)(2013-1#2)(2013-7#1)
risk factors for this##2##4##(2008-10#1)(2008-7#1)
risk factors for##62##3##(1993-2#1)(1993-3#2)(1996-2#2)(1997-5#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-5#1)(2008-7#6)(2009-8#1)(2010-10#4)(2010-8#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
risk factors in a##4##4##(2010-4#2)(2012-2#1)(2013-8#1)
risk factors in the##2##4##(2008-10#1)(2010-1#1)
risk factors in##13##3##(1996-6#1)(2008-10#2)(2010-1#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
risk factors may##4##3##(2010-9#1)(2012-3#1)(2013-1#2)
risk factors measured at##3##4##(2008-7#3)
risk factors of cardiovascular diseases##2##5##(2008-11#1)(2009-10#1)
risk factors of##21##3##(1994-12#2)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#2)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#2)(2013-1#1)
risk factors on##2##3##(1990-6#1)(1992-9#1)
risk factors such as##4##4##(2008-11#2)(2008-7#1)(2010-12#1)
risk factors that##2##3##(1992-1#1)(2008-7#1)
risk factors to##2##3##(1993-3#1)(2013-8#1)
risk factors was##3##3##(1991-6#1)(1996-8#1)(2011-2#1)
risk factors were##6##3##(1991-6#1)(2008-1#1)(2009-3#1)(2010-7#2)(2012-2#1)
risk factors##248##2##(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#6)(1993-9#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-5#2)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#8)(2008-10#9)(2008-11#20)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#22)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#1)(2010-10#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#4)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#27)(2011-3#1)(2012-12#6)(2012-2#10)(2012-3#10)(2013-1#17)(2013-3#2)(2013-7#1)(2013-8#8)
risk for Alzheimer's##2##3##(2009-10#1)(2011-2#1)
risk for HIV##3##3##(1996-5#1)(2009-12#1)(2013-1#1)
risk for MS##2##3##(2011-2#2)
risk for a##6##3##(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
risk for breast cancer##2##4##(1995-9#1)(2011-2#1)
risk for cardiovascular events and##2##5##(2012-2#1)(2013-8#1)
risk for cardiovascular events##3##4##(2012-2#1)(2013-1#1)(2013-8#1)
risk for cardiovascular##5##3##(2010-6#2)(2012-2#1)(2013-1#1)(2013-8#1)
risk for complications##3##3##(1990-11#1)(2011-2#1)(2012-2#1)
risk for developing##9##3##(1993-1#1)(2008-1#1)(2008-12#2)(2008-2#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
risk for development of##2##4##(2008-7#1)(2011-2#1)
risk for infection##2##3##(2008-10#1)(2011-2#1)
risk for physical##2##3##(1995-1#1)(2008-12#1)
risk for poor##2##3##(1996-12#1)(2008-12#1)
risk for the##7##3##(1991-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-10#1)
risk for those##2##3##(1993-12#1)(2011-2#1)
risk for##136##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#18)(2008-12#10)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-6#2)(2011-1#1)(2011-2#14)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#9)(2013-8#2)
risk from##6##2##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#3)
risk group for##2##3##(2008-11#1)(2011-2#1)
risk group##5##2##(2008-11#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
risk groups##8##2##(1990-3#1)(1995-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
risk in a##3##3##(2008-9#1)(2011-2#2)
risk in the##8##3##(1991-3#1)(1992-2#1)(1997-5#1)(2008-10#1)(2008-11#2)(2009-11#1)(2009-12#1)
risk in women##2##3##(2010-12#2)
risk in##42##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
risk include##2##2##(2009-12#1)(2010-7#1)
risk increase##2##2##(2009-10#2)
risk indicators##2##2##(2008-7#1)(2010-9#1)
risk infants##2##2##(1993-12#1)(2008-11#1)
risk is##13##2##(1990-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
risk lesions)##2##2##(1994-6#1)(2011-2#1)
risk level##3##2##(1991-6#2)(2008-10#1)
risk levels of latent infection##2##5##(2008-10#2)
risk levels##3##2##(1995-9#1)(2008-10#2)
risk management and##2##3##(1994-2#1)(2013-1#1)
risk management policies##2##3##(2012-3#1)(2013-1#1)
risk management strategies##2##3##(1990-11#1)(2013-1#1)
risk management##22##2##(1990-11#1)(1991-12#1)(1993-2#2)(1994-12#1)(1994-2#2)(1996-1#1)(1997-2#2)(2008-11#1)(2008-9#1)(2009-4#2)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#4)
risk manager's##3##2##(1995-1#1)(1996-1#1)(1997-1#1)
risk managers##3##2##(1991-3#1)(1996-1#1)(1996-2#1)
risk may be##2##3##(2010-12#1)(2011-2#1)
risk may##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
risk model##5##2##(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
risk models##6##2##(1992-12#1)(2008-10#1)(2008-7#4)
risk of HCC in patients taking the drugs##2##8##(2008-11#2)
risk of HCC in##3##4##(2008-11#3)
risk of HIV infection##2##4##(1995-6#1)(1996-5#1)
risk of HIV transmission##2##4##(1995-6#1)(2009-5#1)
risk of HIV##4##3##(1995-6#2)(1996-5#1)(2009-5#1)
risk of Parkinson's disease##2##4##(2008-7#1)(2008-8#1)
risk of Parkinson's##3##3##(2008-7#2)(2008-8#1)
risk of a##5##3##(1992-3#1)(1992-6#1)(1997-4#1)(2009-4#1)(2012-2#1)
risk of acquiring##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
risk of acute##5##3##(2009-1#1)(2009-12#1)(2013-1#2)(2013-7#1)
risk of adverse effects##2##4##(2007-11#1)(2008-10#1)
risk of adverse##3##3##(2007-11#1)(2008-10#1)(2010-6#1)
risk of an##4##3##(1992-6#1)(2008-11#1)(2012-3#1)(2013-1#1)
risk of atherosclerosis##3##3##(2008-6#3)
risk of becoming##2##3##(1997-6#1)(2008-12#1)
risk of bleeding##4##3##(2008-5#1)(2008-7#1)(2013-1#2)
risk of bowel##2##3##(1994-2#1)(1996-6#1)
risk of breast cancer##6##4##(1990-8#1)(1991-2#1)(1993-11#1)(1994-2#1)(1994-9#1)(2012-3#1)
risk of breast##7##3##(1990-8#1)(1991-2#1)(1993-11#1)(1994-2#1)(1994-9#1)(2008-11#1)(2012-3#1)
risk of cancer##12##3##(1990-8#1)(1994-2#2)(1994-9#1)(2008-11#2)(2008-7#1)(2012-2#1)(2013-1#4)
risk of cardiovascular disease##3##4##(1992-8#1)(2011-2#1)(2013-8#1)
risk of cardiovascular disease]##2##4##(1993-9#1)(2013-8#1)
risk of cardiovascular##6##3##(1992-8#1)(1993-11#1)(1993-9#1)(2011-2#1)(2013-8#2)
risk of cerebral embolism##2##4##(2013-1#2)
risk of cerebral##3##3##(2008-7#1)(2013-1#2)
risk of colorectal cancer##2##4##(2009-8#1)(2010-6#1)
risk of complications##10##3##(1990-11#1)(1990-3#1)(1991-6#1)(1996-11#1)(1996-6#1)(2007-11#1)(2011-2#1)(2013-1#3)
risk of congenital malformations##2##4##(2013-1#2)
risk of contamination##7##3##(2008-10#6)(2008-11#1)
risk of coronary heart disease events##2##6##(2008-12#2)
risk of coronary heart disease##4##5##(1991-8#1)(2008-12#3)
risk of coronary heart##5##4##(1991-8#1)(2008-12#3)(2013-1#1)
risk of death##8##3##(1995-2#1)(1997-3#1)(2008-11#1)(2010-11#1)(2011-2#1)(2011-3#2)(2012-3#1)
risk of developing PCOS##2##4##(2008-4#2)
risk of developing TLS is##2##5##(2008-7#2)
risk of developing breast cancer##4##5##(1991-2#1)(1995-9#1)(2008-12#2)
risk of developing skin##2##4##(1991-6#1)(2012-3#1)
risk of developing the##3##4##(1996-6#1)(2008-11#1)(2008-4#1)
risk of developing##38##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-12#1)(1994-9#1)(1995-9#1)(1996-6#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#3)(2012-3#5)
risk of development##2##3##(2012-3#1)(2013-1#1)
risk of diabetes##2##3##(2008-10#1)(2013-8#1)
risk of disease##5##3##(1997-8#1)(2008-10#2)(2013-1#1)(2013-8#1)
risk of early##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
risk of exposure to##2##4##(1991-12#1)(2009-12#1)
risk of extinction##2##3##(2008-9#1)(2010-8#1)
risk of failure##3##3##(1996-3#1)(2009-7#1)(2012-12#1)
risk of fracture##4##3##(2008-11#2)(2011-2#1)(2013-1#1)
risk of fractures##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
risk of gastric cancer in patients with##3##7##(2008-12#3)
risk of gastric cancer##7##4##(1997-1#1)(2008-12#5)(2011-2#1)
risk of growth rate suppression##2##5##(2007-11#2)
risk of growth##3##3##(2007-11#3)
risk of haemorrhage##3##3##(1992-6#1)(1996-6#1)(1996-9#1)
risk of having a##2##4##(2008-11#1)(2008-8#1)
risk of hepatocellular carcinoma##2##4##(2008-11#1)(2010-12#1)
risk of hospitalization##2##3##(1995-2#2)
risk of human##3##3##(2008-8#1)(2010-11#1)(2011-2#1)
risk of hypertension##3##3##(2008-11#2)(2008-5#1)
risk of infection in##2##4##(1994-6#1)(2008-10#1)
risk of infection with##3##4##(1996-6#1)(2009-12#1)(2011-2#1)
risk of infection##11##3##(1990-3#1)(1994-6#2)(1996-6#1)(2008-10#3)(2008-8#1)(2009-12#1)(2011-2#2)
risk of injury##2##3##(1996-6#1)(2008-8#1)
risk of intracranial##2##3##(1992-6#1)(2011-2#1)
risk of ischemic##2##3##(2008-3#1)(2010-4#1)
risk of losing##3##3##(1992-5#1)(1996-11#1)(2008-10#1)
risk of lymph node metastasis##2##5##(2009-12#1)(2011-2#1)
risk of major##5##3##(2008-10#1)(2008-11#1)(2010-1#1)(2010-3#1)(2013-7#1)
risk of malignant transformation##5##4##(2009-12#1)(2009-8#2)(2012-12#1)(2013-1#1)
risk of mortality##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
risk of nicotine dependence##2##4##(2011-2#2)
risk of other##2##3##(2009-12#1)(2010-1#1)
risk of ovarian##2##3##(1994-9#1)(2012-12#1)
risk of postoperative##5##3##(1992-5#1)(2007-8#1)(2008-7#1)(2009-5#1)(2012-2#1)
risk of pregnancy##2##3##(1990-6#1)(2008-11#1)
risk of preterm##2##3##(1996-11#1)(2011-2#1)
risk of primary##2##3##(1994-6#1)(2008-6#1)
risk of progression##3##3##(2008-9#1)(2013-1#1)(2013-8#1)
risk of puncture or rupture##2##5##(2012-2#2)
risk of raised ICP##3##4##(2010-5#3)
risk of recurrence##5##3##(1992-1#1)(1996-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
risk of redisplacement##2##3##(2011-2#2)
risk of relapse##3##3##(1990-11#1)(1993-1#1)(2009-11#1)
risk of rupture##3##3##(1994-1#1)(2011-2#1)(2013-8#1)
risk of serious bacterial##2##4##(1994-9#1)(2008-11#1)
risk of serious##4##3##(1994-9#2)(2008-11#2)
risk of severe##3##3##(1995-5#1)(2008-7#1)(2010-12#1)
risk of stroke##7##3##(2008-8#3)(2008-9#2)(2011-2#1)(2012-3#1)
risk of the disease##2##4##(1994-9#1)(2012-12#1)
risk of the##4##3##(1990-9#1)(1994-9#1)(2008-4#1)(2012-12#1)
risk of using a##2##4##(2008-11#1)(2011-2#1)
risk of venous thromboembolism##2##4##(1996-11#1)(2010-11#1)
risk of venous##3##3##(1996-11#1)(1996-3#1)(2010-11#1)
risk of vitamin A deficiency##2##5##(1991-8#2)
risk of##502##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#4)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#3)(1991-7#1)(1991-8#5)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-2#4)(1994-3#4)(1994-6#3)(1994-9#11)(1995-1#1)(1995-2#4)(1995-5#1)(1995-6#3)(1995-9#1)(1996-11#7)(1996-3#6)(1996-5#1)(1996-6#7)(1996-9#3)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2006-5#2)(2007-11#5)(2007-8#1)(2008-1#4)(2008-10#35)(2008-11#37)(2008-12#17)(2008-3#2)(2008-4#7)(2008-5#4)(2008-6#7)(2008-7#18)(2008-8#21)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#11)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#3)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#46)(2011-3#5)(2012-12#6)(2012-2#12)(2012-3#15)(2013-1#39)(2013-7#2)(2013-8#19)
risk or harm reduction##2##4##(2009-7#2)
risk or##8##2##(1994-12#1)(1995-9#1)(1997-3#1)(2008-7#2)(2009-7#2)(2013-1#1)
risk pattern during the period##2##5##(1991-6#2)
risk pattern##4##2##(1991-6#2)(1992-2#1)(2011-1#1)
risk perception in##2##3##(2008-11#2)
risk perception##4##2##(2008-11#4)
risk plans##2##2##(1996-3#2)
risk pool##2##2##(1993-12#2)
risk profile##6##2##(1993-11#1)(1993-2#1)(2010-4#1)(2010-6#1)(2011-2#2)
risk profiles of##2##3##(2008-10#1)(2008-11#1)
risk program##2##2##(1994-3#2)
risk ratio##3##2##(1994-9#1)(1995-2#1)(2008-11#1)
risk reduction of##4##3##(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
risk reduction##9##2##(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#1)
risk remains##2##2##(2008-7#1)(2011-2#1)
risk research##2##2##(2010-12#2)
risk score##4##2##(1991-6#3)(2010-10#1)
risk scores##2##2##(2012-2#2)
risk selection##2##2##(1994-3#1)(1995-1#1)
risk spreading##2##2##(2008-8#2)
risk status##3##2##(1995-9#2)(2012-3#1)
risk stratification in##2##3##(2010-5#1)(2010-9#1)
risk stratification of##4##3##(2011-2#2)(2012-2#1)(2012-3#1)
risk stratification##13##2##(2008-3#2)(2009-1#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)
risk taking##4##2##(1995-2#1)(2008-11#3)
risk than##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
risk that##6##2##(1992-9#1)(2008-10#2)(2011-2#2)(2013-8#1)
risk threshold##3##2##(2008-10#3)
risk through##2##2##(2008-10#1)(2012-12#1)
risk to the patient##2##4##(1995-11#1)(2012-3#1)
risk to the##4##3##(1995-11#1)(1995-2#1)(2012-3#1)(2013-8#1)
risk to##14##2##(1990-9#1)(1991-12#2)(1995-11#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
risk tolerance##4##2##(2011-2#4)
risk using##2##2##(1995-9#1)(2010-6#1)
risk was found##2##3##(1991-2#1)(2011-2#1)
risk was##7##2##(1991-2#2)(1991-3#1)(1991-6#1)(2009-10#2)(2011-2#1)
risk will be##2##3##(1992-3#1)(1997-3#1)
risk will##3##2##(1992-2#1)(1992-3#1)(1997-3#1)
risk with##5##2##(1997-8#2)(2008-7#2)(2009-12#1)
risk##1757##1##(1990-11#7)(1990-12#2)(1990-2#2)(1990-3#7)(1990-6#9)(1990-8#6)(1990-9#4)(1991-1#4)(1991-11#1)(1991-12#17)(1991-2#8)(1991-3#10)(1991-6#19)(1991-7#1)(1991-8#9)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#18)(1992-2#6)(1992-3#6)(1992-5#4)(1992-6#5)(1992-8#1)(1992-9#11)(1993-1#6)(1993-11#7)(1993-12#11)(1993-2#13)(1993-3#9)(1993-8#1)(1993-9#3)(1994-1#3)(1994-12#9)(1994-2#8)(1994-3#12)(1994-5#1)(1994-6#6)(1994-9#13)(1995-1#8)(1995-11#2)(1995-12#3)(1995-2#13)(1995-3#4)(1995-5#4)(1995-6#4)(1995-9#17)(1996-1#3)(1996-11#16)(1996-12#6)(1996-2#6)(1996-3#20)(1996-5#2)(1996-6#10)(1996-8#4)(1996-9#4)(1997-1#9)(1997-2#2)(1997-3#17)(1997-4#5)(1997-5#7)(1997-6#2)(1997-8#12)(2006-5#3)(2007-11#7)(2007-12#6)(2007-8#3)(2008-1#22)(2008-10#137)(2008-11#131)(2008-12#52)(2008-2#2)(2008-3#13)(2008-4#23)(2008-5#19)(2008-6#17)(2008-7#80)(2008-8#46)(2008-9#30)(2009-1#2)(2009-10#27)(2009-11#2)(2009-12#20)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#11)(2009-6#3)(2009-7#12)(2009-8#9)(2009-9#3)(2010-1#9)(2010-10#16)(2010-11#10)(2010-12#28)(2010-2#2)(2010-3#5)(2010-4#5)(2010-5#8)(2010-6#16)(2010-7#19)(2010-8#7)(2010-9#13)(2011-1#9)(2011-2#174)(2011-3#7)(2011-7#1)(2012-12#27)(2012-2#52)(2012-3#55)(2012-5#1)(2013-1#104)(2013-3#3)(2013-7#3)(2013-8#50)
risk)##3##1##(2008-3#1)(2008-7#1)(2012-12#1)
risk-adjusted##2##1##(1995-2#1)(2008-11#1)
risk-adjustment##2##1##(1996-2#1)(1997-1#1)
risk-based##5##1##(1991-3#1)(2008-7#3)(2012-2#1)
risk-benefit##5##1##(2008-7#1)(2010-6#1)(2012-2#1)(2013-1#2)
risk-level cut scores##2##3##(2008-12#2)
risk-level##3##1##(2008-12#3)
risk-reducing recommendations##2##2##(1993-12#2)
risk-reducing##5##1##(1993-12#5)
risk-reduction##2##1##(2010-7#1)(2013-1#1)
risk-taking##3##1##(2008-11#1)(2012-2#1)(2013-8#1)
risk/benefit##3##1##(1991-3#1)(2011-1#1)(2013-1#1)
risk?##7##1##(1992-2#1)(1994-12#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-12#1)
risk]##4##1##(1993-3#1)(1994-2#1)(1994-6#1)(2008-11#1)
riskier##2##1##(2011-2#2)
risking##4##1##(2008-10#2)(2008-11#1)(2011-2#1)
risks and benefits of##7##4##(2008-10#1)(2008-11#3)(2010-12#2)(2011-2#1)
risks and benefits##8##3##(2008-10#1)(2008-11#3)(2009-12#1)(2010-12#2)(2011-2#1)
risks and hazards##2##3##(1991-12#1)(2013-1#1)
risks and##22##2##(1990-11#1)(1991-12#1)(1991-3#1)(1993-6#1)(1994-1#1)(1995-12#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2009-12#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
risks are##3##2##(2008-11#1)(2008-3#1)(2012-12#1)
risks associated with their use##2##5##(2011-3#1)(2013-1#1)
risks associated with##20##3##(1991-3#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#3)(2013-8#3)
risks can be minimized and maximum safety maintained##2##8##(2012-2#2)
risks can be##3##3##(2011-2#1)(2012-2#2)
risks can##4##2##(2008-11#1)(2011-2#1)(2012-2#2)
risks could be##2##3##(2008-7#1)(2013-1#1)
risks for##9##2##(1996-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-4#1)(2013-1#1)(2013-8#1)
risks from##4##2##(1991-3#1)(1996-11#1)(2008-11#1)(2008-9#1)
risks in##6##2##(1990-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
risks involved##3##2##(1992-3#1)(1996-2#1)(2010-5#1)
risks may be##2##3##(1992-2#1)(2008-11#1)
risks of cancer##2##3##(2008-11#1)(2008-7#1)
risks of these##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
risks of##56##2##(1991-12#1)(1991-8#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-6#4)(1996-6#1)(1996-9#1)(1997-5#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#9)
risks that##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
risks to the##3##3##(1993-2#1)(2008-9#1)(2013-8#1)
risks to##7##2##(1993-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
risks were##5##2##(1991-3#1)(1994-2#2)(1996-11#1)(2011-3#1)
risks##209##1##(1990-11#1)(1990-6#1)(1991-12#2)(1991-3#4)(1991-8#2)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#3)(1993-6#1)(1994-1#1)(1994-2#2)(1994-6#4)(1995-1#1)(1995-12#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-8#1)(2008-1#2)(2008-10#16)(2008-11#23)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#9)(2008-8#4)(2008-9#5)(2009-12#5)(2009-4#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#3)(2011-1#7)(2011-2#12)(2011-3#2)(2011-9#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#21)(2013-8#7)
risks]##4##1##(1994-6#1)(1995-12#1)(1996-2#1)(2011-3#1)
risky behavior##2##2##(1996-2#1)(2011-2#1)
risky behaviors##2##2##(2010-9#1)(2013-8#1)
risky decision-making##2##2##(2013-8#2)
risky injection##2##2##(2013-8#2)
risky sexual##2##2##(2013-8#2)
risky##25##1##(1990-2#1)(1992-1#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#7)
risque##6##1##(2008-11#3)(2013-1#3)
ritonavir##5##1##(2011-3#5)
ritual circumcision##2##2##(1991-8#2)
ritual##10##1##(1991-8#2)(2008-11#1)(2009-10#5)(2013-1#1)(2013-8#1)
rituals##3##1##(2008-11#1)(2009-10#2)
rituximab in##2##2##(2013-1#2)
rituximab##10##1##(2008-11#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-3#1)(2013-1#4)(2013-8#1)
rival##9##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#2)(2010-7#1)(2012-2#1)
rivals##3##1##(2008-11#1)(2009-6#1)(2012-2#1)
rivanol##5##1##(2008-10#5)
rivastigmine##10##1##(2011-2#10)
river and sea##2##3##(2008-10#2)
river and seawater samples##2##4##(2008-10#2)
river and seawater##5##3##(2008-10#5)
river and tap water and##2##5##(2008-10#2)
river and tap water samples##3##5##(2008-10#3)
river and tap water##5##4##(2008-10#5)
river and##23##2##(2008-10#23)
river at##2##2##(2008-10#2)
river humic substances (HS)##2##4##(2008-10#2)
river humic substances##4##3##(2008-10#4)
river kilometre##2##2##(2010-8#2)
river samples##2##2##(2008-10#2)
river sediment##3##2##(2008-10#3)
river sediments##4##2##(2008-10#4)
river water and##7##3##(2008-10#7)
river water samples##22##3##(2008-10#22)
river water spiked with##2##4##(2008-10#2)
river water using##2##3##(2008-10#2)
river water was##2##3##(2008-10#2)
river water##79##2##(2008-10#79)
river waters by##2##3##(2008-10#2)
river waters##15##2##(2008-10#15)
river##168##1##(1991-2#1)(1993-3#1)(1996-6#1)(2008-10#156)(2008-12#1)(2008-8#3)(2009-7#1)(2010-8#3)(2013-8#1)
riverine##2##1##(2008-10#2)
rivers in the State of Selangor##2##6##(2008-10#2)
rivers##10##1##(2008-10#9)(2008-9#1)
rkm##2##1##(2010-8#2)
rms deviation##2##2##(1992-4#1)(2008-8#1)
rms deviations##2##2##(1994-5#1)(2008-8#1)
rms##12##1##(1992-4#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#2)
road accidents##2##2##(2009-10#2)
road maps for##2##3##(2010-8#2)
road maps##4##2##(2010-8#4)
road safety##3##2##(2008-10#1)(2011-2#2)
road to##3##2##(1993-3#1)(1995-1#1)(2009-12#1)
road traffic and##2##3##(2010-11#2)
road traffic injuries##2##3##(2008-10#2)
road traffic##13##2##(2008-10#4)(2008-11#1)(2010-11#8)
road##47##1##(1992-2#2)(1993-3#1)(1995-1#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#7)(2009-12#1)(2009-7#2)(2010-11#9)(2010-12#1)(2010-8#4)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
roadmap##3##1##(2008-9#1)(2010-8#2)
roadside soil##2##2##(2008-10#1)(2008-11#1)
roadside soils##3##2##(2008-10#3)
roadside##6##1##(2008-10#4)(2008-11#1)(2013-1#1)
roasted coffee beans##2##3##(2008-10#2)
roasted coffee##3##2##(2008-10#3)
roasted##6##1##(2008-10#5)(2008-11#1)
robert C##2##2##(2008-3#2)
robin and##2##2##(2008-9#2)
robin##4##1##(2008-10#2)(2008-9#2)
robot##5##1##(2008-6#2)(2009-12#1)(2012-2#2)
robotic##5##1##(2008-10#2)(2008-11#1)(2010-7#1)(2013-1#1)
robots##5##1##(2008-11#2)(2012-2#3)
robur##6##1##(2008-10#1)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-8#1)
robust against##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
robust and reliable##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
robust and sensitive##2##3##(2008-10#2)
robust and##15##2##(2008-10#6)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
robust clinical##2##2##(2008-12#1)(2010-6#1)
robust design##2##2##(1993-3#2)
robust enough##2##2##(2008-10#1)(2011-1#1)
robust estimators##2##2##(2008-10#2)
robust evidence##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
robust flow injection##2##3##(2008-10#2)
robust method for the##2##4##(2008-1#1)(2008-10#1)
robust method for##3##3##(2008-1#1)(2008-10#2)
robust method##6##2##(2008-1#1)(2008-10#4)(2008-2#1)
robust methods##2##2##(2008-10#2)
robust process##2##2##(2012-2#1)(2013-1#1)
robust regression method##2##3##(2008-10#2)
robust regression##4##2##(2008-10#4)
robust to##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
robust##155##1##(1992-9#1)(1993-3#3)(1995-11#1)(1997-7#1)(2008-1#2)(2008-10#71)(2008-11#12)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#6)(2009-11#2)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#3)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#2)
robusta##6##1##(2008-10#5)(2013-8#1)
robustly##4##1##(2008-11#1)(2010-4#1)(2010-7#1)(2013-1#1)
robustness and##5##2##(1995-11#1)(2008-10#3)(2008-11#1)
robustness are##2##2##(2008-10#1)(2013-8#1)
robustness of our##2##3##(2010-8#1)(2013-1#1)
robustness of the method##3##4##(2008-10#3)
robustness of the proposed method##2##5##(2008-10#2)
robustness of the proposed##5##4##(2008-10#3)(2012-2#2)
robustness of the##16##3##(1993-3#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-2#2)
robustness of this procedure##2##4##(2008-10#1)(2008-11#1)
robustness of this##7##3##(2008-10#2)(2008-11#2)(2008-3#1)(2010-10#1)(2011-2#1)
robustness of##34##2##(1993-3#1)(1994-9#1)(2008-10#14)(2008-11#7)(2008-3#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
robustness to##2##2##(1994-9#1)(2008-3#1)
robustness was##2##2##(2008-10#2)
robustness with##2##2##(2008-10#2)
robustness##60##1##(1993-3#1)(1994-9#2)(1995-11#1)(2008-10#33)(2008-11#9)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
rock has##2##2##(2008-10#1)(2013-8#1)
rock sample##6##2##(2008-10#3)(2013-8#3)
rock samples##7##2##(2008-10#6)(2013-8#1)
rock##31##1##(2008-10#16)(2008-5#1)(2011-2#1)(2013-8#13)
rocket exhausts##2##2##(2008-3#2)
rocket propellant fuel##2##3##(2008-10#2)
rocket##6##1##(2008-10#3)(2008-11#1)(2008-3#2)
rocking##4##1##(2008-11#1)(2008-5#3)
rocking-chair##2##1##(2010-4#2)
rocks and##2##2##(2008-10#2)
rocks##10##1##(2008-10#6)(2008-3#1)(2010-7#1)(2010-8#1)(2013-1#1)
rockwool slabs##2##2##(2008-10#2)
rockwool to##2##2##(2008-10#2)
rockwool##25##1##(2008-10#25)
rocuronium##7##1##(2011-2#7)
rod outer segments##2##3##(1993-8#1)(1997-1#1)
rod outer##3##2##(1993-8#1)(1997-1#2)
rod system##2##2##(2008-12#1)(2012-2#1)
rod was##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
rod with an##2##3##(2008-2#2)
rod with##5##2##(2008-2#5)
rod##39##1##(1992-9#1)(1993-8#1)(1997-1#2)(1997-2#3)(2008-10#4)(2008-12#1)(2008-2#14)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
rod-shaped##5##1##(2008-10#3)(2008-7#1)(2012-2#1)
rodent and human mammary explant##2##5##(1995-9#2)
rodent and human##6##3##(1994-12#1)(1995-9#2)(1997-7#1)(2008-11#1)(2008-4#1)
rodent and##11##2##(1992-12#1)(1994-12#1)(1995-9#2)(1997-7#1)(2008-11#1)(2008-4#2)(2010-11#2)(2010-6#1)
rodent brain##3##2##(1994-2#1)(1996-12#1)(2008-7#1)
rodent cell lines##5##3##(1993-12#1)(1996-2#1)(2008-11#3)
rodent cell##6##2##(1993-12#1)(1995-9#1)(1996-2#1)(2008-11#3)
rodent guilds##2##2##(2008-8#2)
rodent models for##2##3##(2008-4#1)(2012-3#1)
rodent models##6##2##(2008-10#2)(2008-4#3)(2012-3#1)
rodent ventricular##2##2##(2008-11#2)
rodent##52##1##(1990-5#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-12#3)(1994-12#1)(1994-2#1)(1995-12#1)(1995-9#5)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#7)(2008-4#5)(2008-7#1)(2008-8#2)(2008-9#5)(2010-11#3)(2010-6#1)(2012-2#1)(2012-3#2)
rodentium##5##1##(2011-1#5)
rodents and primates##2##3##(2008-10#1)(2013-8#1)
rodents and##5##2##(1993-3#1)(2008-10#2)(2009-7#1)(2013-8#1)
rodents from##2##2##(2012-2#1)(2013-1#1)
rodents that##2##2##(2008-4#1)(2011-2#1)
rodents##44##1##(1990-3#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#12)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-7#1)(2010-4#1)(2011-2#3)(2012-2#5)(2013-1#1)(2013-8#1)
rods and##2##2##(2008-7#1)(2009-8#1)
rods are##2##2##(2008-7#1)(2012-2#1)
rods of##2##2##(2008-2#1)(2008-8#1)
rods with##3##2##(2008-2#1)(2009-5#1)(2011-2#1)
rods##21##1##(1997-1#1)(2007-12#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-2#1)
rods)##2##1##(1991-3#1)(2008-8#1)
roentgenogram showed##2##2##(1991-12#1)(1993-6#1)
rofecoxib##4##1##(2011-2#4)
roguing##3##1##(2008-10#3)
rolC##4##1##(2008-9#4)
role and contribution##2##3##(1997-8#1)(2011-2#1)
role and responsibility##2##3##(2008-11#1)(2011-2#1)
role and##29##2##(1990-12#2)(1992-12#2)(1992-3#1)(1992-9#1)(1993-1#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#6)
role are##2##2##(1990-12#1)(1994-2#1)
role as a##12##3##(1995-6#1)(2008-10#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#3)(2013-1#1)
role as well##2##3##(1992-9#1)(2008-11#1)
role as##25##2##(1992-1#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-3#1)(1995-6#2)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-5#1)(2011-2#4)(2013-1#1)
role at##3##2##(1994-9#1)(1997-1#1)(2009-8#1)
role conflict and professional attitude of##2##6##(1990-2#2)
role conflict and professional attitude##3##5##(1990-2#3)
role conflict and##4##3##(1990-2#4)
role conflict##5##2##(1990-2#5)
role development##2##2##(2008-11#2)
role during##9##2##(1991-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
role even##2##2##(2008-3#1)(2011-2#1)
role for a##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
role for the##15##3##(1992-3#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#2)(1997-6#1)(2007-12#1)(2009-10#1)(2009-4#1)(2012-2#2)
role for these##6##3##(1990-3#1)(1990-8#1)(1994-11#1)(1997-8#1)(2006-6#1)(2012-3#1)
role for this enzyme in##2##5##(1994-8#1)(2008-5#1)
role for this##7##3##(1990-8#1)(1991-1#1)(1994-8#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-5#1)
role for##122##2##(1990-11#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#4)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#7)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-6#1)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#3)
role in RNA##2##3##(1993-12#1)(2012-3#1)
role in a##4##3##(1990-2#1)(1994-11#1)(2008-5#1)(2011-2#1)
role in activating##2##3##(1995-12#1)(2008-11#1)
role in affecting##2##3##(2008-10#1)(2013-8#1)
role in an##2##3##(1992-1#1)(1997-7#1)
role in apoptotic cell death##2##5##(2008-7#1)(2012-2#1)
role in apoptotic##3##3##(2008-7#2)(2012-2#1)
role in blood##2##3##(2008-10#1)(2011-2#1)
role in both##3##3##(2011-2#2)(2013-1#1)
role in breast##2##3##(2008-12#1)(2009-2#1)
role in causing##3##3##(2008-10#1)(2011-2#1)(2011-3#1)
role in cell growth##2##4##(1992-12#1)(2011-2#1)
role in cell##3##3##(1992-12#1)(2008-9#1)(2011-2#1)
role in cellular redox homeostasis##2##5##(2009-6#1)(2009-9#1)
role in cellular##4##3##(1991-5#1)(2008-11#1)(2009-6#1)(2009-9#1)
role in cholesterol##2##3##(1995-6#1)(2008-11#1)
role in chronic##2##3##(2008-1#1)(2011-2#1)
role in clinical##4##3##(2008-12#1)(2008-7#1)(2010-2#2)
role in community##2##3##(2008-9#2)
role in control of##3##4##(1997-7#2)(2009-6#1)
role in controlling the##2##4##(2008-10#1)(2009-11#1)
role in controlling##7##3##(1997-1#1)(2008-10#3)(2008-9#1)(2009-11#1)(2010-8#1)
role in determining the##6##4##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)
role in determining##7##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2013-1#1)
role in development##2##3##(1993-8#1)(2008-8#1)
role in disease##5##3##(1991-12#1)(2008-10#3)(2010-12#1)
role in early##3##3##(1993-3#1)(2008-9#1)(2011-2#1)
role in enhancing##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
role in eukaryotic##3##3##(1993-8#1)(2008-4#1)(2008-8#1)
role in female##2##3##(2009-10#1)(2010-8#1)
role in health and##2##4##(2010-10#1)(2011-2#1)
role in health##3##3##(1996-3#1)(2010-10#1)(2011-2#1)
role in host defense##3##4##(2008-10#1)(2008-4#1)(2009-10#1)
role in how##3##3##(2008-11#1)(2010-1#2)
role in human##5##3##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)
role in identifying##2##3##(2008-11#1)(2008-12#1)
role in immunity##2##3##(2009-6#1)(2010-3#1)
role in implementing##2##3##(1994-1#1)(2010-4#1)
role in in vivo##2##4##(2008-11#2)
role in increasing the##2##4##(2008-11#1)(2013-1#1)
role in infection##2##3##(2008-10#1)(2009-8#1)
role in inflammation##3##3##(1990-9#1)(2013-8#2)
role in its##5##3##(1994-8#1)(2008-10#1)(2008-8#2)(2010-8#1)
role in maintaining the##3##4##(2009-10#1)(2009-8#1)(2012-2#1)
role in maintaining##10##3##(1994-11#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-11#2)(2011-2#2)(2012-2#1)
role in many aspects of##2##5##(1996-6#1)(2008-11#1)
role in many##4##3##(1996-6#1)(2008-11#1)(2008-6#1)(2008-8#1)
role in mediating the##3##4##(1993-6#1)(1996-5#1)(1997-2#1)
role in mediating##6##3##(1993-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-9#1)(2011-2#1)
role in modern##2##3##(1994-3#1)(2011-2#1)
role in modulating the##2##4##(2008-11#1)(2013-7#1)
role in modulating##6##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-7#1)
role in normal##3##3##(1992-3#1)(2008-5#1)(2009-10#1)
role in plant growth##2##4##(2008-10#1)(2008-9#1)
role in plant##4##3##(2008-10#2)(2008-9#1)(2009-6#1)
role in promoting##2##3##(2008-4#1)(2011-2#1)
role in protection against##2##4##(2009-6#1)(2013-8#1)
role in providing##3##3##(1994-2#1)(2008-5#1)(2009-5#1)
role in public health##2##4##(1996-2#1)(2008-5#1)
role in public##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
role in radiation##2##3##(1995-6#1)(2013-8#1)
role in reducing##5##3##(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
role in regulating the##5##4##(1994-11#1)(1997-8#1)(2008-11#2)(2012-3#1)
role in regulating##14##3##(1994-11#2)(1995-12#1)(1995-2#1)(1997-8#1)(1997-9#1)(2008-11#2)(2009-10#1)(2009-8#1)(2011-10#1)(2012-3#2)(2013-1#1)
role in regulation of##2##4##(2008-1#1)(2013-1#1)
role in renal##3##3##(2011-2#2)(2013-8#1)
role in resistance to##2##4##(2008-10#2)
role in resistance##5##3##(1992-7#1)(2008-10#4)
role in respiratory##2##3##(2011-2#2)
role in signal transduction##2##4##(1994-12#1)(1997-8#1)
role in the binding of##2##5##(1991-8#1)(2008-10#1)
role in the binding##4##4##(1991-8#1)(2008-10#2)(2010-7#1)
role in the cell##2##4##(2008-2#1)(2011-2#1)
role in the cellular##2##4##(1995-8#1)(2011-2#1)
role in the control of##4##5##(1994-2#1)(1996-3#1)(2008-7#1)(2013-8#1)
role in the detection##2##4##(2008-2#1)(2010-12#1)
role in the development and##2##5##(1996-2#1)(2008-11#1)
role in the development of chronic##2##6##(2010-10#1)(2011-2#1)
role in the development of these##2##6##(2008-11#1)(2011-2#1)
role in the development of##23##5##(1994-12#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2009-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-10#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
role in the development##25##4##(1994-12#1)(1996-2#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2009-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-10#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
role in the diagnosis and##3##5##(2008-5#1)(2010-12#1)(2012-2#1)
role in the diagnosis of##3##5##(2008-11#1)(2009-11#1)(2012-2#1)
role in the diagnosis##6##4##(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#1)(2012-2#2)
role in the early##4##4##(1994-11#1)(1997-3#1)(2011-2#1)(2013-1#1)
role in the epidemiology of##2##5##(2008-10#2)
role in the etiology##2##4##(1990-11#1)(1990-8#1)
role in the evolution of##5##5##(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
role in the expression of##2##5##(1993-3#1)(2008-11#1)
role in the genesis of##2##5##(1995-8#1)(2012-2#1)
role in the health##2##4##(1993-11#1)(1993-12#1)
role in the improvement of##2##5##(2008-10#1)(2011-7#1)
role in the induction of##2##5##(1991-12#1)(2012-3#1)
role in the initiation of##2##5##(1994-11#1)(2008-8#1)
role in the initiation##3##4##(1994-11#1)(2008-8#1)(2013-1#1)
role in the intracellular##2##4##(1992-5#1)(2008-11#1)
role in the maintenance of##3##5##(1997-1#1)(2008-5#1)(2011-2#1)
role in the mechanism of##2##5##(1993-6#1)(2008-10#1)
role in the neural##2##4##(1990-11#1)(1997-4#1)
role in the occurrence of##2##5##(1997-3#1)(2012-2#1)
role in the pathogenesis of the##2##6##(1992-6#1)(2008-1#1)
role in the pathogenesis of##10##5##(1992-6#1)(1997-8#1)(2008-1#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-3#1)
role in the recognition of##2##5##(1995-2#1)(2009-3#1)
role in the regulation of the##2##6##(1992-11#1)(2008-8#1)
role in the regulation of##18##5##(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-8#1)(1995-11#1)(1995-2#2)(1995-8#1)(1997-2#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
role in the response##2##4##(1990-5#1)(2012-7#1)
role in the rise of health care costs##2##8##(1994-2#2)
role in the signal transduction##2##5##(1990-12#1)(2008-8#1)
role in the sorption##2##4##(2008-10#2)
role in the structure and function of##2##7##(2008-4#1)(2008-8#1)
role in the transmission of##3##5##(2008-10#1)(2010-1#2)
role in the treatment of##6##5##(1995-11#1)(2008-7#1)(2011-2#1)(2011-3#2)(2013-1#1)
role in the treatment##7##4##(1995-11#1)(2008-7#2)(2011-2#1)(2011-3#2)(2013-1#1)
role in the##280##3##(1990-11#2)(1990-12#1)(1990-5#5)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-6#4)(1995-8#6)(1996-12#5)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-1#4)(2008-10#34)(2008-11#16)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#10)(2008-8#12)(2008-9#8)(2009-1#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#2)(2011-1#3)(2011-10#1)(2011-2#21)(2011-3#2)(2011-7#2)(2012-2#13)(2012-3#6)(2012-7#1)(2013-1#11)(2013-3#1)(2013-7#1)(2013-8#3)
role in their##3##3##(1992-6#1)(1996-12#1)(2008-8#1)
role in these##3##3##(2007-12#1)(2011-1#1)(2011-3#1)
role in this area##2##4##(1996-1#1)(2008-7#1)
role in this process##3##4##(1993-11#1)(2009-7#1)(2011-2#1)
role in this##10##3##(1993-11#1)(1994-2#1)(1996-1#1)(1996-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)
role in thyroid homeostasis##2##4##(2013-1#2)
role in thyroid##3##3##(2013-1#3)
role in tumorigenesis##2##3##(2008-9#1)(2011-2#1)
role in understanding the##2##4##(2010-1#1)(2012-2#1)
role in understanding##3##3##(2008-8#1)(2010-1#1)(2012-2#1)
role in various##2##3##(1992-6#1)(2009-3#1)
role in vesicle##2##3##(2008-11#1)(2009-8#1)
role in which##2##3##(1994-2#1)(2008-12#1)
role in##767##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#8)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#1)(1991-11#2)(1991-12#4)(1991-5#5)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#3)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#6)(1993-6#2)(1993-8#4)(1994-1#2)(1994-11#9)(1994-12#5)(1994-2#7)(1994-3#1)(1994-5#1)(1994-8#4)(1995-1#1)(1995-11#3)(1995-12#6)(1995-2#12)(1995-5#1)(1995-6#8)(1995-8#7)(1996-1#2)(1996-12#10)(1996-2#7)(1996-3#4)(1996-5#1)(1996-6#2)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#7)(1997-8#4)(1997-9#2)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#7)(2008-10#89)(2008-11#47)(2008-12#9)(2008-2#5)(2008-3#2)(2008-4#5)(2008-5#15)(2008-6#4)(2008-7#28)(2008-8#31)(2008-9#27)(2009-1#4)(2009-10#11)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#7)(2009-7#9)(2009-8#11)(2009-9#2)(2010-1#7)(2010-10#6)(2010-11#7)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#4)(2011-1#11)(2011-10#3)(2011-2#63)(2011-3#5)(2011-7#2)(2012-12#5)(2012-2#32)(2012-3#12)(2012-7#2)(2013-1#33)(2013-3#1)(2013-7#2)(2013-8#14)
role is to##2##3##(1994-2#1)(1997-2#1)
role is##13##2##(1991-6#1)(1993-3#1)(1994-2#1)(1995-5#1)(1996-6#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-1#1)(2009-10#1)(2012-2#1)
role model##2##2##(2008-12#1)(2008-8#1)
role modelling##5##2##(2008-12#5)
role models had##2##3##(2008-11#1)(2009-7#1)
role models to##2##3##(1991-2#1)(2008-12#1)
role models##12##2##(1991-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-7#4)(2009-8#1)
role of Cys-138##2##3##(1993-8#2)
role of ECM in##2##4##(2009-10#2)
role of IRF-8 in the cross talk between melanoma##2##9##(2013-1#2)
role of LMP2 as##2##4##(2012-2#2)
role of MTs in the##2##5##(2013-7#2)
role of MTs in##3##4##(2008-11#1)(2013-7#2)
role of NGF in##2##4##(2010-8#2)
role of TSPO##3##3##(2012-2#3)
role of XBP1 in##3##4##(2011-2#3)
role of Zn in##2##4##(2012-2#2)
role of a##6##3##(1990-12#1)(1991-9#1)(1994-5#1)(2008-10#2)(2008-11#1)
role of advanced##2##3##(2011-2#1)(2013-1#1)
role of affective##2##3##(2008-1#2)
role of an##7##3##(1990-9#1)(1994-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-4#1)
role of atypical##3##3##(2008-8#3)
role of calcium##2##3##(1995-11#1)(1995-8#1)
role of cell##2##3##(2008-11#2)
role of citrate complexes in preventing urolithiasis##2##7##(1992-9#2)
role of classroom##2##3##(2008-12#2)
role of different##5##3##(2008-10#1)(2008-5#1)(2009-8#2)(2011-2#1)
role of endogenous cytokines in host resistance against an intragastric infection with##2##12##(1996-12#2)
role of endogenous cytokines##3##4##(1996-12#3)
role of endogenous##6##3##(1995-12#1)(1995-2#1)(1996-12#3)(1996-2#1)
role of environmental##2##3##(2008-1#1)(2009-8#1)
role of evidence##2##3##(1993-12#1)(2008-11#1)
role of functional##2##3##(2008-1#1)(2009-9#1)
role of genetic factors##2##4##(1997-8#1)(2013-8#1)
role of genetic##3##3##(1997-8#1)(2008-8#1)(2013-8#1)
role of health##3##3##(1993-12#1)(1997-2#1)(2008-11#1)
role of host##3##3##(2008-10#3)
role of inhibition##2##3##(2008-7#1)(2010-7#1)
role of intracellular MIF in##2##5##(2009-6#2)
role of intracellular##5##3##(1994-11#1)(1995-8#2)(2009-6#2)
role of iron##2##3##(1993-11#1)(2012-2#1)
role of magnetic resonance##2##4##(2011-2#1)(2012-2#1)
role of maternal##2##3##(2008-9#1)(2011-2#1)
role of membrane##2##3##(1995-2#1)(2008-8#1)
role of natural##3##3##(2009-1#1)(2010-4#1)(2010-5#1)
role of oncogenes in drug resistance##3##6##(2008-11#3)
role of oospores in##2##4##(2008-10#2)
role of oxidative stress in##2##5##(2008-11#1)(2010-12#1)
role of p53 in##2##4##(2008-9#1)(2011-2#1)
role of pancreatic##2##3##(2010-10#1)(2013-7#1)
role of phenolics##2##3##(2008-10#2)
role of platelets in##2##4##(2006-6#1)(2008-1#1)
role of prostaglandin E2##2##4##(1996-2#1)(1997-2#1)
role of protein kinase C##2##5##(1992-8#1)(2013-8#1)
role of protein##3##3##(1992-8#1)(2008-11#1)(2013-8#1)
role of public health##3##4##(1996-2#1)(1997-3#2)
role of purinergic signaling##2##4##(2013-8#2)
role of radiotherapy##3##3##(1993-9#1)(1994-8#1)(2009-1#1)
role of senior##2##3##(1993-12#1)(1994-2#1)
role of serine##2##3##(1993-3#1)(1994-5#1)
role of serotonin (5-HT) in##2##5##(1993-3#1)(2008-6#1)
role of spirituality in##2##4##(2008-12#2)
role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and##2##18##(2011-3#2)
role of structural##3##3##(2008-7#1)(2011-3#2)
role of the adventitia in##2##5##(1997-8#2)
role of the family##2##4##(1991-2#2)
role of the immune system in##2##6##(2011-2#1)(2012-3#1)
role of the lecturer practitioner##2##5##(2008-12#2)
role of the lecturer##3##4##(2008-11#1)(2008-12#2)
role of the low##2##4##(1992-12#1)(2008-2#1)
role of the medical##3##4##(1995-11#1)(2013-1#2)
role of the nurse##3##4##(2008-11#2)(2008-6#1)
role of the peptide in the##2##6##(1992-6#2)
role of the visual input in the##2##7##(1991-2#2)
role of the##138##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#4)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#16)(2008-11#15)(2008-12#4)(2008-2#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#1)(2010-10#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-2#5)(2012-3#4)(2013-1#2)
role of these##28##3##(1991-2#1)(1992-12#1)(1992-3#1)(1993-9#1)(1995-2#3)(1995-6#1)(2008-10#8)(2008-11#2)(2008-8#1)(2009-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#2)
role of this phenomenon##2##4##(2008-12#1)(2013-1#1)
role of this##6##3##(1994-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2013-1#2)
role of traditional##2##3##(2009-6#1)(2013-1#1)
role of tumor suppressor##2##4##(1990-12#1)(1995-6#1)
role of tumor##3##3##(1990-12#1)(1995-6#1)(2009-12#1)
role of viral##2##3##(1994-1#1)(2008-11#1)
role of vitamin##2##3##(2010-1#1)(2013-1#1)
role of women in##2##4##(1992-12#1)(1996-9#1)
role of women##3##3##(1992-12#1)(1993-6#1)(1996-9#1)
role of x-rays in the treatment of gas gangrene##2##9##(2013-1#2)
role of##855##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#3)(1992-12#7)(1992-2#3)(1992-3#5)(1992-5#4)(1992-6#5)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#7)(1993-12#7)(1993-2#4)(1993-3#7)(1993-6#7)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#8)(1994-12#4)(1994-2#7)(1994-3#3)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#1)(1995-1#2)(1995-11#5)(1995-12#10)(1995-2#13)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#7)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#5)(1996-2#10)(1996-3#3)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#3)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#7)(2006-6#3)(2007-12#1)(2008-1#10)(2008-10#97)(2008-11#67)(2008-12#23)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#23)(2008-8#22)(2008-9#12)(2009-1#3)(2009-10#12)(2009-11#3)(2009-12#8)(2009-2#1)(2009-4#2)(2009-6#8)(2009-7#8)(2009-8#14)(2009-9#5)(2010-1#6)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#1)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#8)(2011-10#1)(2011-2#56)(2011-3#8)(2011-7#1)(2011-9#2)(2012-12#2)(2012-2#35)(2012-3#19)(2012-4#1)(2013-1#35)(2013-2#1)(2013-7#8)(2013-8#28)
role on##5##2##(1995-2#1)(1996-12#1)(2008-10#2)(2013-1#1)
role or##2##2##(2008-10#1)(2013-8#1)
role played by the##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
role played by##14##3##(1997-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#2)(2011-2#1)(2013-8#1)
role plays##7##2##(2009-11#7)
role than##4##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-9#1)
role that##15##2##(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2013-8#1)
role they##2##2##(2008-12#1)(2010-1#1)
role to play in the##4##5##(1992-3#1)(2008-11#1)(2008-5#1)(2012-12#1)
role to play in##8##4##(1992-3#1)(1997-2#1)(2008-11#3)(2008-5#1)(2010-10#1)(2012-12#1)
role to play##11##3##(1992-3#1)(1993-12#1)(1997-2#1)(2008-11#3)(2008-5#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
role to##18##2##(1992-3#1)(1993-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
role transition##3##2##(1995-1#1)(2008-11#2)
role was##5##2##(1991-2#1)(2008-11#3)(2010-11#1)
role when##2##2##(2008-2#1)(2008-3#1)
role within the##4##3##(1997-7#1)(2008-11#1)(2010-6#1)(2011-2#1)
role within##6##2##(1995-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)
role##2102##1##(1990-11#6)(1990-12#10)(1990-2#7)(1990-3#1)(1990-5#12)(1990-6#4)(1990-7#1)(1990-8#6)(1990-9#7)(1991-1#8)(1991-10#1)(1991-11#4)(1991-12#8)(1991-2#11)(1991-3#4)(1991-5#9)(1991-6#6)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#7)(1992-10#5)(1992-11#2)(1992-12#15)(1992-2#6)(1992-3#13)(1992-5#7)(1992-6#12)(1992-7#2)(1992-8#2)(1992-9#9)(1993-1#3)(1993-11#11)(1993-12#22)(1993-2#7)(1993-3#14)(1993-6#11)(1993-8#11)(1993-9#3)(1994-1#3)(1994-11#19)(1994-12#12)(1994-2#17)(1994-3#7)(1994-5#7)(1994-6#4)(1994-8#11)(1994-9#3)(1995-1#6)(1995-10#1)(1995-11#10)(1995-12#21)(1995-2#30)(1995-3#4)(1995-5#3)(1995-6#17)(1995-8#16)(1995-9#5)(1996-1#5)(1996-11#3)(1996-12#20)(1996-2#27)(1996-3#9)(1996-5#2)(1996-6#7)(1996-9#1)(1997-1#15)(1997-2#20)(1997-3#9)(1997-4#3)(1997-5#5)(1997-6#4)(1997-7#12)(1997-8#16)(1997-9#3)(2006-6#5)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#23)(2008-10#226)(2008-11#169)(2008-12#60)(2008-2#9)(2008-3#13)(2008-4#10)(2008-5#36)(2008-6#9)(2008-7#64)(2008-8#60)(2008-9#48)(2009-1#10)(2009-10#28)(2009-11#14)(2009-12#11)(2009-2#2)(2009-3#3)(2009-4#7)(2009-5#1)(2009-6#20)(2009-7#22)(2009-8#34)(2009-9#9)(2010-1#16)(2010-10#14)(2010-11#14)(2010-12#14)(2010-2#3)(2010-3#2)(2010-4#10)(2010-5#9)(2010-6#5)(2010-7#7)(2010-8#12)(2010-9#2)(2011-1#23)(2011-10#4)(2011-2#149)(2011-3#13)(2011-7#3)(2011-9#2)(2012-12#10)(2012-2#73)(2012-3#39)(2012-4#1)(2012-7#2)(2013-1#78)(2013-2#1)(2013-3#1)(2013-7#15)(2013-8#46)
role(s) for##3##2##(1991-5#1)(1992-12#1)(1995-6#1)
role(s) of##2##2##(1993-8#1)(2008-11#1)
role(s)##6##1##(1991-5#1)(1992-12#1)(1993-8#1)(1995-6#1)(2008-11#2)
role-physical##2##1##(2008-8#2)
role-play as a##2##3##(2008-11#2)
role-play as an##2##3##(2008-11#2)
role-play as##4##2##(2008-11#4)
role-play##6##1##(2008-11#6)
roles and responsibilities##4##3##(1994-1#1)(1995-12#1)(2010-5#1)(2013-1#1)
roles and##12##2##(1991-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-1#1)(2008-11#1)(2009-7#1)(2010-2#1)(2010-5#2)(2013-1#1)
roles are##3##2##(1992-12#1)(2008-12#1)(2012-3#1)
roles as##6##2##(1995-6#1)(2008-10#3)(2010-7#1)(2013-8#1)
roles during##3##2##(2008-6#1)(2009-6#1)(2010-8#1)
roles for the##4##3##(1994-9#1)(1996-3#1)(2009-10#1)(2012-2#1)
roles for##24##2##(1992-8#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
roles have been##2##3##(2011-1#1)(2011-2#1)
roles have##4##2##(2008-11#1)(2011-1#2)(2011-2#1)
roles in biological systems##2##4##(2008-10#1)(2008-9#1)
roles in cell##2##3##(2009-8#1)(2011-2#1)
roles in health care##2##4##(1992-1#1)(2008-12#1)
roles in health##3##3##(1992-1#1)(2008-10#1)(2008-12#1)
roles in many##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
roles in neural development##2##4##(1996-12#1)(2009-9#1)
roles in neuronal##2##3##(2008-7#1)(2013-8#1)
roles in plant##4##3##(2008-9#2)(2009-8#1)(2012-3#1)
roles in regulating the##2##4##(2009-8#1)(2011-2#1)
roles in regulating##4##3##(1995-2#1)(2008-11#1)(2009-8#1)(2011-2#1)
roles in regulation of##2##4##(2008-10#1)(2009-4#1)
roles in the regulation of##4##5##(1993-12#1)(2008-5#1)(2009-8#1)(2013-1#1)
roles in the##29##3##(1993-12#1)(1995-11#2)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)
roles in tissue##2##3##(2010-9#1)(2012-2#1)
roles in##113##2##(1992-1#1)(1992-10#1)(1993-12#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#3)(2006-6#2)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#9)(2009-10#4)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-2#8)(2012-3#2)(2013-1#7)(2013-8#3)
roles is##2##2##(2009-7#1)(2011-2#1)
roles of CNG channels in##2##5##(2009-10#2)
roles of a##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
roles of kappa-opioid and NMDA##2##5##(1997-2#2)
roles of the##8##3##(2008-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#2)(2012-2#1)
roles of these##5##3##(1994-5#1)(1995-3#1)(2008-7#1)(2010-12#1)(2012-2#1)
roles of this##2##3##(1995-6#1)(2010-8#1)
roles of##91##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-12#2)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#3)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
roles on##2##2##(1990-2#1)(2008-8#1)
roles played by##4##3##(1994-12#1)(2008-12#1)(2008-5#1)(2009-8#1)
roles that##4##2##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
roles within##2##2##(2008-11#1)(2008-9#1)
roles##323##1##(1990-12#1)(1990-2#2)(1990-9#1)(1991-1#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-6#2)(1992-8#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-6#2)(2008-1#3)(2008-10#21)(2008-11#31)(2008-12#10)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#10)(2008-9#18)(2009-10#8)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#6)(2009-7#4)(2009-8#12)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#6)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#19)(2012-12#1)(2012-2#20)(2012-3#5)(2013-1#13)(2013-8#7)
rolfsii and##3##2##(2008-10#3)
rolfsii sclerotia##2##2##(2008-10#2)
rolfsii were##2##2##(2008-10#2)
rolfsii##27##1##(2008-10#27)
roll##4##1##(2008-10#2)(2008-11#1)(2010-8#1)
roll-off##3##1##(2008-3#1)(2008-7#2)
roll-over##2##1##(2013-1#2)
roller bottles##5##2##(2008-11#5)
roller coaster##2##2##(1994-2#1)(1996-3#1)
roller##10##1##(1994-2#1)(1996-3#1)(2008-11#8)
rolling with different reduction##2##4##(2013-8#2)
rolling with##3##2##(2013-8#3)
rolling##11##1##(1993-8#1)(1997-6#2)(2008-11#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#3)
rolling-circle##2##1##(1997-6#2)
romance##3##1##(2012-2#3)
romantic relationship distress##3##3##(2008-12#3)
romantic relationship##4##2##(2008-12#4)
romantic##5##1##(2008-12#5)
romifidine##5##1##(2012-3#5)
room air##5##2##(1993-1#1)(1996-3#1)(2008-3#1)(2010-7#2)
room and##2##2##(2008-7#1)(2010-12#1)
room for improvement in##2##4##(1996-2#1)(2012-12#1)
room for improvement##3##3##(1996-2#1)(2012-12#1)(2012-3#1)
room for##11##2##(1991-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
room temperature fluorimetry for##2##4##(2008-10#2)
room temperature fluorimetry##3##3##(2008-10#3)
room temperature for##5##3##(2008-10#4)(2008-5#1)
room temperature is##3##3##(2007-11#1)(2008-10#2)
room temperature or##3##3##(2008-10#1)(2008-5#2)
room temperature phosphorescence (RTP)##4##4##(2008-10#4)
room temperature phosphorescence of##2##4##(2008-10#2)
room temperature phosphorescence##14##3##(2008-10#14)
room temperature to##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
room temperature##113##2##(1993-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#68)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#5)(2008-8#3)(2009-11#1)(2009-5#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
room with##2##2##(2010-12#1)(2013-8#1)
room##181##1##(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#1)(2007-11#2)(2007-12#5)(2008-10#74)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#4)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#4)
room-temperature laser##2##2##(2008-2#1)(2008-3#1)
room-temperature phosphorescence (RTP)##2##3##(2008-10#2)
room-temperature phosphorescence of##2##3##(2008-10#2)
room-temperature phosphorescence##4##2##(2008-10#4)
room-temperature phosphorimetric##2##2##(2008-10#2)
room-temperature phosphorimetry##2##2##(2008-10#2)
room-temperature##21##1##(2007-12#1)(2008-10#11)(2008-2#2)(2008-3#5)(2012-2#2)
rooms##5##1##(1996-2#1)(2008-10#3)(2008-11#1)
root and apical meristem##2##4##(2008-12#2)
root and crown rot##2##4##(2008-10#2)
root and crown##3##3##(2008-10#3)
root and shoot dry weights##2##5##(2008-10#2)
root and shoot##3##3##(2008-10#3)
root and stem rot##3##4##(2008-10#3)
root and stem##5##3##(2008-10#5)
root and the##2##3##(2008-10#2)
root and##29##2##(2008-10#20)(2008-12#2)(2008-9#2)(2009-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
root apical meristem##3##3##(2008-10#1)(2009-8#2)
root at##2##2##(2008-10#1)(2010-10#1)
root bark of Calotropis gigantea##2##5##(2008-12#2)
root bark of Oroxylum indicum##2##5##(2008-10#2)
root bark of##6##3##(2008-10#3)(2008-11#1)(2008-12#2)
root canal filling##4##3##(1991-3#1)(2013-1#3)
root canal treatment##2##3##(2013-1#2)
root canal##10##2##(1991-3#1)(2012-12#1)(2013-1#8)
root canals##3##2##(2012-12#1)(2012-3#2)
root cap cells##2##3##(2008-10#2)
root cap was divested##2##4##(2008-9#2)
root cap was##3##3##(2008-9#3)
root cap##10##2##(2008-10#3)(2008-9#5)(2009-8#2)
root carbohydrate concentrations decreased##2##4##(2008-10#2)
root caries##3##2##(2008-1#2)(2008-5#1)
root colonization by##5##3##(2008-10#5)
root colonization##12##2##(2008-10#12)
root compression##2##2##(2011-2#1)(2012-3#1)
root coverage##6##2##(2013-1#6)
root culture##2##2##(2008-10#2)
root damage##2##2##(2008-10#1)(2012-3#1)
root dip##2##2##(2008-10#2)
root disease severity##3##3##(2008-10#3)
root disease##10##2##(2008-10#10)
root epidermis and##3##3##(2008-10#3)
root extracts##2##2##(2008-10#1)(2013-1#1)
root exudates##5##2##(2008-10#5)
root galling of cucumber seedlings##2##5##(2008-10#2)
root galling##4##2##(2008-10#4)
root growth to inoculum##3##4##(2008-10#3)
root growth##13##2##(2008-10#9)(2008-12#1)(2008-8#1)(2009-8#2)
root hair area##2##3##(2008-10#2)
root hair##3##2##(2008-10#3)
root hairs##2##2##(2008-10#2)
root in##2##2##(2008-10#1)(2011-2#1)
root infection by##4##3##(2008-10#4)
root infection##7##2##(2008-10#7)
root length##10##2##(2008-10#8)(2008-12#2)
root lesions##2##2##(2008-10#2)
root mean square deviation##2##4##(1994-5#1)(2008-9#1)
root mean square error of prediction (RMSEP)##3##7##(2008-10#3)
root mean square error of prediction##5##6##(2008-10#5)
root mean square error of##7##5##(2008-10#7)
root mean square error##8##4##(2008-10#7)(2011-2#1)
root mean square##14##3##(1992-4#1)(1994-5#2)(2008-10#8)(2008-9#1)(2010-9#1)(2011-2#1)
root mean squared error##2##4##(2008-10#2)
root mean##16##2##(1992-4#1)(1994-5#2)(2008-10#10)(2008-9#1)(2010-9#1)(2011-2#1)
root necrosis##8##2##(2008-10#8)
root nodules##2##2##(2008-11#1)(2011-2#1)
root of the##11##3##(1994-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-11#1)(2011-2#1)
root of##25##2##(1990-11#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
root pathogen##2##2##(2008-10#2)
root perforation##2##2##(2013-1#2)
root populations##2##2##(2008-10#2)
root powder##3##2##(2008-10#3)
root production##6##2##(2008-10#6)
root resorption##2##2##(2013-1#2)
root rot and##5##3##(2008-10#5)
root rot caused by##2##4##(2008-10#2)
root rot complex##2##3##(2008-10#2)
root rot disease##3##3##(2008-10#3)
root rot in##5##3##(2008-10#5)
root rot of apple##3##4##(2008-10#3)
root rot of sugarcane##2##4##(2008-10#2)
root rot of##16##3##(2008-10#16)
root rot severity##7##3##(2008-10#7)
root rot symptoms##3##3##(2008-10#3)
root rot##63##2##(2008-10#63)
root samples from##2##3##(2008-10#2)
root samples##6##2##(2008-10#5)(2012-6#1)
root surface##6##2##(2008-10#4)(2013-1#2)
root symbiosis##2##2##(2010-10#1)(2012-8#1)
root symptoms##2##2##(2008-10#2)
root system##5##2##(2008-10#5)
root systems of##2##3##(2008-10#2)
root systems##6##2##(2008-10#6)
root tip exudates##3##3##(2008-10#3)
root tip##5##2##(2008-10#5)
root tips were##2##3##(2008-10#1)(2008-9#1)
root tips##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
root tissue##16##2##(2008-10#15)(2008-8#1)
root tissues in##2##3##(2008-10#2)
root tissues of##2##3##(2008-10#2)
root tissues##13##2##(2008-10#12)(2009-8#1)
root was##5##2##(2008-11#1)(2008-12#1)(2008-9#2)(2013-1#1)
root weight##2##2##(2008-10#2)
root were##2##2##(2008-9#2)
root##504##1##(1990-11#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#333)(2008-11#6)(2008-12#11)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#6)(2008-8#8)(2008-9#30)(2009-10#1)(2009-6#1)(2009-8#16)(2010-10#3)(2010-11#2)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#7)(2012-6#1)(2012-8#3)(2013-1#25)(2013-8#7)
root)##3##1##(2008-10#3)
root-colonizing##3##1##(2008-10#3)
root-galling##2##1##(2008-10#2)
root-knot and cyst##2##3##(2008-10#2)
root-knot nematode Meloidogyne incognita##2##4##(2008-10#2)
root-knot nematode Meloidogyne##7##3##(2008-10#7)
root-knot nematode##14##2##(2008-10#14)
root-knot nematodes##7##2##(2008-10#7)
root-knot##25##1##(2008-10#25)
root-lesion nematodes##2##2##(2008-10#2)
root-lesion##4##1##(2008-10#4)
root-mean-square##5##1##(2008-10#2)(2008-3#1)(2008-8#2)
root-resistant##2##1##(2008-10#2)
root-tip cells##2##2##(2008-11#1)(2008-9#1)
root-to-root spread##4##2##(2008-10#4)
rooted in the##3##3##(1993-11#1)(2008-10#1)(2009-6#1)
rooted##10##1##(1993-11#1)(1995-5#1)(2008-10#6)(2008-11#1)(2009-6#1)
rooting##2##1##(1992-12#1)(2008-4#1)
rootlets##2##1##(2008-10#2)
roots and hypocotyls##2##3##(2008-10#2)
roots and leaves##5##3##(2008-12#3)(2012-7#1)(2013-8#1)
roots and shoots##4##3##(2008-10#1)(2008-12#3)
roots and stems##3##3##(2008-10#3)
roots and the##3##3##(2008-10#2)(2008-11#1)
roots and##34##2##(2008-10#19)(2008-11#2)(2008-12#7)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)(2012-7#1)(2013-8#1)
roots are##2##2##(2008-10#1)(2008-7#1)
roots as##2##2##(2008-10#1)(2008-9#1)
roots at the##2##3##(2008-10#2)
roots at##3##2##(2008-10#3)
roots but##2##2##(2008-10#2)
roots by##13##2##(2008-10#13)
roots collected##2##2##(2008-10#2)
roots did not##2##3##(2008-10#2)
roots for the treatment##2##4##(2008-9#2)
roots from##6##2##(2008-10#6)
roots grown##2##2##(2008-10#1)(2010-10#1)
roots in a##2##3##(2008-10#2)
roots in the##4##3##(1993-2#1)(1997-2#1)(2008-10#1)(2008-9#1)
roots in which##2##3##(2008-10#2)
roots in##13##2##(1993-2#1)(1997-2#1)(2008-10#10)(2008-9#1)
roots increased##2##2##(2008-10#2)
roots inoculated with##2##3##(2008-10#2)
roots occurred##2##2##(2008-10#2)
roots of Brugmansia candida##2##4##(2008-6#2)
roots of apple seedlings grown in##2##6##(2008-10#2)
roots of apple seedlings##3##4##(2008-10#3)
roots of tomato##2##3##(2008-10#2)
roots of##54##2##(2008-10#37)(2008-11#1)(2008-12#3)(2008-6#2)(2008-9#2)(2009-8#2)(2010-3#1)(2010-6#2)(2011-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
roots or##4##2##(2008-10#4)
roots prior to##2##3##(2008-10#2)
roots produced on##2##3##(2008-10#2)
roots resulted in##2##3##(1995-9#1)(2008-10#1)
roots revealed##2##2##(2008-10#2)
roots showed##3##2##(2008-10#3)
roots that were##2##3##(2008-10#2)
roots that##4##2##(2008-10#4)
roots to the##2##3##(2008-10#1)(2008-11#1)
roots to##6##2##(2008-10#4)(2008-11#1)(2008-9#1)
roots was##14##2##(2008-10#12)(2008-12#1)(2008-9#1)
roots were infected for Genghis and Savannah##2##7##(2008-10#2)
roots were infected##4##3##(2008-10#4)
roots were##22##2##(2008-10#21)(2008-12#1)
roots with increasing##2##3##(2008-10#1)(2008-12#1)
roots with##8##2##(2008-10#7)(2008-12#1)
roots##340##1##(1993-2#1)(1995-9#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#255)(2008-11#7)(2008-12#18)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#14)(2009-11#1)(2009-8#7)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-10#4)(2011-2#3)(2012-3#1)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#4)(2013-8#3)
roots)##3##1##(2008-10#3)
rootstock##5##1##(2008-10#5)
rootstocks##8##1##(2008-10#8)
ropinirole##3##1##(2008-7#3)
ropivacain (5##2##2##(2012-3#2)
ropivacain 5##2##2##(2012-3#2)
ropivacain##6##1##(2012-3#6)
rosa##7##1##(1990-5#5)(1993-6#2)
rose from##3##2##(1991-12#1)(1994-2#1)(1995-3#1)
rose significantly##4##2##(1992-1#1)(2008-10#1)(2008-12#1)(2010-7#1)
rose steadily##2##2##(1997-7#1)(2008-10#1)
rose to##4##2##(1992-12#1)(2008-9#1)(2009-6#1)(2011-2#1)
rose wines##3##2##(2008-10#3)
rose##33##1##(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1994-2#1)(1995-3#1)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-7#2)(2011-2#1)
rosea IK726##4##2##(2008-10#4)
rosea##10##1##(2008-10#10)
roses##5##1##(2008-10#5)
rosette assistor virus (GRAV)##2##4##(2008-10#2)
rosette assistor virus##3##3##(2008-10#3)
rosette infections##2##2##(2008-10#2)
rosette leaves of Tsu-0 plants##2##5##(2008-10#2)
rosette leaves##3##2##(2008-10#2)(2008-8#1)
rosette virus (GRV)##2##3##(2008-10#2)
rosette##18##1##(2008-10#15)(2008-8#2)(2009-8#1)
rosettes##2##1##(2008-10#1)(2011-2#1)
roseum##8##1##(2008-10#5)(2008-5#3)
roseus)##3##1##(2008-10#3)
rosiglitazone and##2##2##(2010-10#2)
rosiglitazone##5##1##(2008-11#1)(2008-5#1)(2010-10#2)(2010-7#1)
rosmarinic acid production##2##3##(2013-1#2)
rosmarinic acid##8##2##(2008-10#1)(2013-1#7)
rostellar hooks##2##2##(2011-2#2)
rostochiensis and G##4##3##(2008-10#4)
rostral ventrolateral medulla##2##3##(1997-2#2)
rostral##11##1##(1990-9#1)(1993-3#1)(1996-12#1)(1997-2#2)(2008-11#3)(2008-7#3)
rostratum##7##1##(2008-10#7)
rostro-caudal##2##1##(1992-12#1)(2013-8#1)
rosuvastatin##2##1##(2010-12#2)
rot and##19##2##(2008-10#19)
rot are caused by##2##4##(2008-10#2)
rot caused by##5##3##(2008-10#5)
rot development on##2##3##(2008-10#2)
rot fungal##2##2##(2008-10#1)(2009-9#1)
rot fungi##3##2##(2008-10#2)(2009-9#1)
rot fungus##3##2##(2008-10#1)(2008-6#1)(2009-9#1)
rot in different##2##3##(2008-10#2)
rot in the##2##3##(2008-10#2)
rot in##23##2##(2008-10#23)
rot incidence##4##2##(2008-10#4)
rot is a##2##3##(2008-10#2)
rot is likely##2##3##(2008-10#2)
rot is##5##2##(2008-10#5)
rot isolates##2##2##(2008-10#2)
rot of citrus##2##3##(2008-10#2)
rot of corn##3##3##(2008-10#3)
rot of##36##2##(2008-10#36)
rot on##6##2##(2008-10#6)
rot pathogen##2##2##(2008-10#2)
rot pathogens##2##2##(2008-10#2)
rot severity by##3##3##(2008-10#3)
rot severity were##2##3##(2008-10#2)
rot severity##11##2##(2008-10#11)
rot symptoms in##2##3##(2008-10#2)
rot symptoms##7##2##(2008-10#7)
rot was##8##2##(2008-10#8)
rot were##3##2##(2008-10#3)
rot when##2##2##(2008-10#2)
rot##241##1##(1996-12#1)(2008-10#236)(2008-6#1)(2009-9#3)
rot)##2##1##(2008-10#2)
rotamer##2##1##(1990-5#2)
rotarod test##3##2##(1997-2#3)
rotarod##5##1##(1997-2#4)(2008-7#1)
rotary cultivator##5##2##(2008-10#5)
rotary##11##1##(2008-10#9)(2008-7#1)(2008-8#1)
rotatable##3##1##(2010-12#1)(2012-2#2)
rotate##4##1##(2008-10#1)(2008-3#2)(2008-7#1)
rotated in##2##2##(2008-10#1)(2008-11#1)
rotated##14##1##(1993-6#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-8#3)
rotates the##2##2##(2008-2#1)(2008-3#1)
rotates##4##1##(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
rotating bioreactor##3##2##(2008-10#3)
rotating biosensor##4##2##(2008-10#4)
rotating disc electrode##2##3##(2008-10#2)
rotating disk electrode measurements##2##4##(2008-10#2)
rotating disk electrode##3##3##(2008-10#3)
rotating disk##10##2##(2008-10#8)(2008-3#2)
rotating glassy carbon##2##3##(2008-10#2)
rotating magnetic field##2##3##(2008-10#2)
rotating magnetic##3##2##(2008-10#3)
rotating##44##1##(1990-12#2)(1991-2#1)(1994-2#1)(1996-2#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-3#5)(2008-8#4)(2010-12#1)
rotating-disc##2##1##(2008-10#2)
rotating-wall vessel##2##2##(2008-11#2)
rotating-wall##3##1##(2008-11#3)
rotation and##10##2##(1996-5#2)(2008-10#2)(2008-12#3)(2008-6#1)(2008-8#1)(2009-3#1)
rotation between the two helices##2##5##(1993-1#2)
rotation between##4##2##(1993-1#3)(2008-9#1)
rotation by##2##2##(2008-3#1)(2008-7#1)
rotation for##3##2##(2007-12#1)(2008-11#2)
rotation in##6##2##(1997-3#1)(2007-11#1)(2008-12#2)(2008-6#1)(2008-9#1)
rotation is a##3##3##(2008-10#2)(2011-2#1)
rotation is##6##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
rotation of the##11##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-3#4)(2011-2#1)(2012-2#1)(2012-3#1)
rotation of##14##2##(1992-12#1)(1993-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
rotation rate of##2##3##(2008-11#1)(2008-8#1)
rotation rate##3##2##(2008-11#2)(2008-8#1)
rotation significantly increased##2##3##(2008-12#2)
rotation##100##1##(1992-1#1)(1992-12#1)(1992-9#1)(1993-1#3)(1993-3#1)(1993-8#1)(1996-2#3)(1996-5#4)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#12)(2008-12#12)(2008-3#12)(2008-6#4)(2008-7#3)(2008-8#4)(2008-9#3)(2009-3#1)(2010-12#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#2)
rotation-invariant##2##1##(2008-6#2)
rotational (lacking##2##2##(2008-10#2)
rotational Raman##5##2##(2008-10#1)(2008-3#4)
rotational diffusion##2##2##(1997-6#1)(2008-10#1)
rotational fine structure##2##3##(2008-10#2)
rotational state##2##2##(2008-2#2)
rotational thrombectomy##2##2##(2011-2#2)
rotational##42##1##(1990-12#2)(1991-5#1)(1997-2#1)(1997-6#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#10)(2009-12#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
rotationally##3##1##(2008-2#1)(2008-3#2)
rotations of##2##2##(2008-10#1)(2008-11#1)
rotations with##3##2##(2008-10#3)
rotations##11##1##(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2012-2#1)
rotator cuff##5##2##(2008-12#1)(2012-2#2)(2013-1#2)
rotator##7##1##(2007-11#1)(2008-12#1)(2008-3#1)(2012-2#2)(2013-1#2)
rotators##3##1##(2010-9#2)(2013-1#1)
rotavirus##4##1##(1994-9#1)(2008-5#1)(2012-3#1)(2013-8#1)
rotenoid##2##1##(2008-11#2)
rotenone##8##1##(1990-5#4)(1995-11#3)(2008-11#1)
rotors##2##1##(2008-7#2)
rots and fumonisin##2##3##(2008-10#2)
rots and##4##2##(2008-10#4)
rots##7##1##(2008-10#7)
rotted##2##1##(2008-10#2)
rotting of##2##2##(1991-6#1)(2008-10#1)
rotting##4##1##(1991-6#1)(2008-10#3)
rotundifolia##2##1##(2008-10#2)
rotundus##3##1##(2008-12#1)(2011-2#2)
rough and##2##2##(1991-2#1)(2013-1#1)
rough endoplasmic reticulum and##2##4##(2007-12#1)(2008-5#1)
rough endoplasmic reticulum##8##3##(1992-12#1)(2007-12#1)(2008-5#1)(2008-7#5)
rough lemon##7##2##(2008-10#7)
rough mapping##2##2##(2008-11#2)
rough rice##3##2##(2013-1#3)
rough surfaces##3##2##(2008-2#1)(2008-3#2)
rough##38##1##(1991-2#1)(1992-12#1)(1992-2#1)(1994-5#1)(1994-9#1)(1997-1#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#5)(2008-9#1)(2011-2#2)(2013-1#5)
roughened##2##1##(2008-5#1)(2008-7#1)
roughly 1##2##2##(2008-10#2)
roughly monitored by counting the numbers of##2##7##(1997-6#1)(1997-8#1)
roughly proportional to##2##3##(1992-12#1)(2008-11#1)
roughly##25##1##(1991-2#1)(1992-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-3#1)
roughness and##4##2##(2008-10#1)(2008-3#2)(2009-7#1)
roughness of 0##2##3##(2012-2#2)
roughness of the##3##3##(2008-3#3)
roughness of##6##2##(2008-10#1)(2008-3#3)(2012-2#2)
roughness##21##1##(2008-10#4)(2008-3#6)(2008-5#1)(2008-7#1)(2009-7#4)(2012-2#4)(2013-1#1)
round and##5##2##(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#1)
round mucous##2##2##(2008-6#2)
round nuclei and##2##3##(1991-8#1)(2008-5#1)
round of##12##2##(1995-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#2)(2013-1#1)
round or##2##2##(1997-3#1)(2010-6#1)
round robin test##2##3##(2008-10#2)
round spermatids##2##2##(2008-9#1)(2012-2#1)
round window##2##2##(2008-9#2)
round##55##1##(1991-3#1)(1991-6#3)(1991-8#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-12#3)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-8#1)(2008-9#4)(2009-5#1)(2010-12#2)(2010-6#3)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#2)
round-bottom 96-well polystyrene plate coated with##2##6##(2008-11#2)
rounded##5##1##(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-9#1)
rounding##4##1##(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
roundness##2##1##(2008-11#1)(2012-5#1)
rounds of selection against##2##4##(2008-10#2)
rounds of selection##3##3##(2008-10#2)(2008-4#1)
rounds of##18##2##(1995-12#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#2)(2009-6#2)(2013-1#1)
rounds##26##1##(1991-6#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-9#2)(2009-6#2)(2013-1#1)
roundtable##2##1##(1993-3#1)(2008-6#1)
route for the##2##3##(1996-5#1)(2012-2#1)
route for##8##2##(1992-12#1)(1992-2#1)(1993-6#1)(1996-5#1)(2008-10#3)(2012-2#1)
route in##3##2##(1994-9#1)(1997-1#1)(2011-2#1)
route is the##2##3##(1990-3#1)(1997-1#1)
route is##5##2##(1990-3#1)(1997-1#1)(1997-3#1)(2010-6#1)(2012-2#1)
route may##2##2##(1993-11#1)(2008-10#1)
route of administration##3##3##(1993-11#1)(1997-1#1)(2011-2#1)
route of infection##3##3##(2008-10#1)(2008-9#1)(2009-6#1)
route of##22##2##(1993-11#2)(1994-2#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-11#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
route or##2##2##(2008-11#1)(2008-9#1)
route to the##6##3##(1991-1#1)(1994-9#1)(1996-5#1)(2008-10#2)(2008-11#1)
route to##12##2##(1991-1#1)(1994-9#1)(1996-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)
route was##3##2##(1994-2#1)(1995-12#1)(2008-7#1)
route##95##1##(1990-3#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#3)(1993-6#1)(1994-2#2)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#4)(1997-1#4)(1997-3#2)(2007-9#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
routed##2##1##(1995-2#1)(2008-3#1)
routes and##4##2##(2009-8#1)(2011-2#3)
routes for##3##2##(1992-12#1)(2008-10#2)
routes in southern Somalia##2##4##(2011-2#2)
routes in##3##2##(1992-3#1)(2011-2#2)
routes of administration##2##3##(1991-1#1)(1995-5#1)
routes of##10##2##(1991-1#1)(1994-5#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
routes to##3##2##(2008-11#1)(2008-8#1)(2010-7#1)
routes##46##1##(1991-1#1)(1992-11#1)(1992-12#3)(1992-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-12#2)(1997-3#2)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#11)(2012-12#1)(2013-8#1)
routine EEG##4##2##(2008-7#4)
routine EEGs##2##2##(2008-7#2)
routine administration of##4##3##(2011-2#1)(2012-12#3)
routine analyses of pharmaceuticals##2##4##(2008-10#2)
routine analyses of##5##3##(2008-10#4)(2008-5#1)
routine analyses##7##2##(2008-10#5)(2008-5#2)
routine analysis of##13##3##(2008-10#12)(2008-11#1)
routine analysis##28##2##(2008-10#27)(2008-11#1)
routine analytical##2##2##(2008-10#2)
routine and##2##2##(2008-11#1)(2012-2#1)
routine application of##2##3##(2008-10#1)(2008-6#1)
routine application##3##2##(2008-10#2)(2008-6#1)
routine assay##2##2##(2008-10#2)
routine auditory stimulation##3##3##(1991-12#3)
routine blood level##2##3##(1991-11#2)
routine blood##3##2##(1991-11#2)(1997-3#1)
routine chest##2##2##(1990-6#1)(1997-3#1)
routine clinical practice##4##3##(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
routine clinical##11##2##(1997-7#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
routine control##4##2##(2008-10#3)(2008-5#1)
routine detection of##2##3##(2008-10#2)
routine detection##3##2##(2008-10#3)
routine determination of##3##3##(2008-10#3)
routine diagnostic##2##2##(1992-2#1)(2008-12#1)
routine examination of##2##3##(2008-12#1)(2008-9#1)
routine examination##3##2##(1990-8#1)(2008-12#1)(2008-9#1)
routine forensic##2##2##(2008-12#2)
routine health##3##2##(1994-6#1)(2010-9#2)
routine identification##2##2##(2008-10#2)
routine in##6##2##(1991-6#1)(1996-3#1)(2008-9#2)(2010-5#1)(2012-3#1)
routine laboratories##4##2##(1994-1#1)(2008-10#3)
routine laboratory tests##3##3##(2011-2#2)(2012-3#1)
routine laboratory##9##2##(1990-2#1)(1994-1#1)(2008-10#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-3#1)
routine measurement##2##2##(2008-10#1)(2008-7#1)
routine method##2##2##(2008-10#2)
routine monitoring of##2##3##(2008-10#2)
routine monitoring##5##2##(2008-10#3)(2013-8#2)
routine of##2##2##(2013-1#2)
routine operation##2##2##(1991-6#1)(2008-9#1)
routine practice##2##2##(1996-12#1)(1997-6#1)
routine screening##3##2##(1991-7#1)(1997-8#1)(2008-10#1)
routine tasks##2##2##(1996-1#1)(2008-11#1)
routine use in##2##3##(2008-10#1)(2011-2#1)
routine use of##8##3##(1990-6#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#4)
routine use##17##2##(1990-6#1)(1991-6#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-11#1)(2011-2#6)
routine##281##1##(1990-12#1)(1990-2#1)(1990-6#5)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#5)(1991-6#3)(1991-7#2)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-1#2)(1994-3#1)(1994-6#3)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#2)(2008-10#96)(2008-11#10)(2008-12#6)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#17)(2009-1#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-9#4)(2011-1#1)(2011-2#20)(2012-12#4)(2012-2#10)(2012-3#7)(2013-1#10)(2013-8#4)
routinely and##4##2##(1994-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
routinely be##3##2##(1992-6#1)(2008-10#1)(2008-8#1)
routinely collected##3##2##(2010-8#1)(2012-12#1)(2013-8#1)
routinely monitored##2##2##(2008-10#1)(2011-1#1)
routinely obtained##2##2##(2008-10#2)
routinely used for##2##3##(2008-5#1)(2009-12#1)
routinely used in##2##3##(2008-10#1)(2011-2#1)
routinely used to##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
routinely used##11##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#2)(2009-12#1)(2011-2#2)(2012-2#1)
routinely##59##1##(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-5#2)(1992-6#1)(1993-8#1)(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#6)(2009-12#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
routines and##3##2##(1990-9#1)(2008-11#1)(2010-6#1)
routines##16##1##(1990-9#1)(1993-3#1)(1994-6#1)(1994-8#1)(1997-8#1)(2008-11#2)(2008-12#1)(2009-2#2)(2010-6#1)(2010-9#4)(2011-2#1)
row and##2##2##(2008-10#2)
row centering##2##2##(2008-10#2)
row of##5##2##(1994-2#2)(2007-12#1)(2008-10#1)(2011-2#1)
row##20##1##(1994-2#2)(1995-9#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-3#2)(2009-10#1)(2011-2#1)(2013-1#1)
rows and##3##2##(2008-10#1)(2008-12#2)
rows of##3##2##(2008-10#3)
rows##24##1##(2008-10#19)(2008-12#5)
royal jelly##3##2##(2008-10#2)(2011-2#1)
royal##5##1##(2008-10#2)(2008-11#2)(2011-2#1)
royalisin was##2##2##(2011-2#2)
royalisin##5##1##(2011-2#5)
rp subgroup##2##2##(2008-10#2)
rp##3##1##(2008-10#3)
rpGH##3##1##(2008-9#3)
rpm##16##1##(2008-10#4)(2008-11#9)(2008-5#1)(2008-7#1)(2011-2#1)
rpm)##6##1##(2008-11#5)(2011-2#1)
rpoB##2##1##(2009-6#2)
rps1##4##1##(2008-10#4)
rps14##3##1##(1996-6#3)
rpsA##3##1##(1997-2#3)
rsd##3##1##(2008-10#3)
rsp1##2##1##(2008-10#2)
rsp2##2##1##(2008-10#2)
rtA181T##3##1##(2013-1#3)
rtA181V and rtA181T##2##3##(2013-1#2)
rtN236T mutant virus showed similar##2##5##(2013-1#2)
rtN236T mutant viruses##2##3##(2013-1#2)
rtN236T mutant##4##2##(2013-1#4)
rtN236T##16##1##(2013-1#16)
rtp##4##1##(1993-9#4)
rub##3##1##(2008-10#2)(2008-5#1)
rubber gloves##2##2##(1995-6#2)
rubber##8##1##(1995-6#2)(2008-10#3)(2008-7#1)(2011-2#1)(2013-8#1)
rubbing##2##1##(2008-10#1)(2011-2#1)
rubella##6##1##(1992-5#1)(1995-3#1)(2011-2#4)
ruber##7##1##(2009-8#1)(2011-2#6)
rubidate##7##1##(2008-10#7)
rubidium##15##1##(2008-10#10)(2008-2#1)(2008-3#4)
rubisco activase in the presence of##2##6##(1991-9#2)
rubisco activase##7##2##(1991-9#7)
rubisco##9##1##(1991-9#9)
rubrerythrin from Desulfovibrio vulgaris##2##4##(1991-12#2)
rubrerythrin##5##1##(1991-12#5)
rubripes##4##1##(1995-2#3)(2008-11#1)
rubrum was##2##2##(2008-5#2)
rubrum##11##1##(2008-11#2)(2008-5#8)(2012-3#1)
rudimentary horn##3##2##(2013-1#3)
rudimentary##7##1##(1991-2#1)(1997-1#1)(2008-10#1)(2010-7#1)(2013-1#3)
rue##2##1##(1991-8#1)(2013-8#1)
ruelene and trichlorfon##2##3##(2008-10#2)
ruelene##3##1##(2008-10#3)
ruffs##2##1##(2008-8#2)
rugged and##3##2##(2008-10#2)(2008-3#1)
rugged##7##1##(1997-2#1)(2008-10#2)(2008-3#4)
ruggedness##6##1##(2008-10#5)(2010-7#1)
rugosa##3##1##(1994-11#2)(2008-7#1)
rugose##2##1##(2008-10#2)
rule and##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
rule in##3##2##(1997-3#1)(2008-8#2)
rule of##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
rule out the##2##3##(2011-2#1)(2012-12#1)
rule out##17##2##(1995-5#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
rule##73##1##(1990-11#1)(1991-6#1)(1992-12#1)(1993-3#2)(1995-11#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-5#1)(1997-3#1)(2007-12#6)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
rule&quot##3##1##(2008-8#3)
rule-based##2##1##(2008-10#1)(2013-1#1)
rule-breaking behavior##2##2##(2008-11#2)
ruled out as##2##3##(1995-6#1)(2008-10#1)
ruled out by##2##3##(1990-3#1)(1996-6#1)
ruled out##16##2##(1990-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
ruled that the##4##3##(1995-12#2)(1995-6#1)(1996-5#1)
ruled that##9##2##(1995-12#6)(1995-6#2)(1996-5#1)
ruled##26##1##(1990-3#1)(1995-12#7)(1995-2#1)(1995-6#4)(1995-8#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
rules and the##2##3##(1997-3#1)(2011-3#1)
rules and##5##2##(1993-12#1)(1996-3#1)(1997-3#1)(2008-8#1)(2011-3#1)
rules are##2##2##(2008-6#1)(2008-9#1)
rules for##15##2##(1991-6#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-2#2)
rules governing##5##2##(1995-5#1)(2008-8#3)(2008-9#1)
rules of thumb##3##3##(2008-8#2)(2009-10#1)
rules of##9##2##(1993-12#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-10#1)(2011-2#2)
rules that##3##2##(1993-3#1)(2011-2#1)(2013-8#1)
rules to##2##2##(1993-2#1)(2011-2#1)
rules were##2##2##(2008-4#1)(2013-8#1)
rules##70##1##(1990-8#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#4)(1997-8#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-8#10)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2011-2#6)(2011-3#1)(2012-2#3)(2013-8#2)
ruling out##5##2##(2006-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
ruling##14##1##(1995-12#3)(1995-6#2)(1996-2#1)(1996-5#1)(1997-6#1)(2006-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
rulings##3##1##(1990-6#1)(1992-11#1)(1994-1#1)
rumen##5##1##(2011-2#4)(2013-1#1)
ruminant##2##1##(2011-2#2)
ruminantium##5##1##(1996-12#4)(2010-1#1)
ruminants in##3##2##(1997-7#1)(2011-2#1)(2012-2#1)
ruminants##7##1##(1997-7#3)(2011-2#2)(2012-2#1)(2013-1#1)
rumination##13##1##(2009-11#7)(2010-10#5)(2010-6#1)
run and##2##2##(1997-1#1)(2008-3#1)
run at##2##2##(2013-1#2)
run buffer##7##2##(2008-10#7)
run by the##2##3##(1996-5#1)(2011-2#1)
run by##6##2##(1991-2#1)(1996-5#1)(2008-2#1)(2011-2#3)
run in##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
run increased risk of developing##2##5##(1990-9#1)(1994-9#1)
run increased risk of##3##4##(1990-9#1)(1994-9#2)
run on##4##2##(1990-3#1)(2008-10#1)(2008-4#1)(2013-1#1)
run the risk of##2##4##(1992-12#1)(2008-8#1)
run the##3##2##(1992-12#1)(2008-4#1)(2008-8#1)
run time##2##2##(2008-10#2)
run was##3##2##(1991-8#1)(1995-3#1)(2008-10#1)
run with##4##2##(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
run##96##1##(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-8#1)(1994-3#2)(1994-9#3)(1995-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#33)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
run-in##2##1##(1995-12#1)(2013-1#1)
run-on##5##1##(1995-6#2)(2008-8#1)(2012-3#2)
run-to-run##2##1##(2008-10#1)(2008-3#1)
runaway youths##2##2##(2008-9#2)
runaway##4##1##(2008-9#3)(2011-2#1)
runner hyphae##2##2##(2008-11#2)
runner##8##1##(2008-10#2)(2008-11#2)(2011-2#3)(2013-8#1)
runners during the##2##3##(2013-8#2)
runners##5##1##(2013-8#5)
running a##5##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-9#1)
running at##2##2##(2008-9#1)(2013-1#1)
running buffer (pH##2##3##(2008-10#2)
running buffer##12##2##(2008-10#11)(2010-7#1)
running in##2##2##(2008-10#1)(2008-11#1)
running the##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
running through##2##2##(2008-10#1)(2013-8#1)
running##58##1##(1991-3#1)(1992-2#2)(1993-2#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(2008-10#26)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)(2010-7#2)(2012-3#1)(2013-1#2)(2013-8#1)
runoff by cotton wicks##2##4##(2008-10#2)
runoff##8##1##(2008-10#8)
runs analysis##8##2##(2008-10#8)
runs of the##2##3##(2008-10#1)(2011-2#1)
runs of##3##2##(2008-10#2)(2011-2#1)
runs posteriorly##2##2##(2008-5#2)
runs the##2##2##(2007-12#1)(2012-2#1)
runs##32##1##(1990-3#1)(2007-12#1)(2008-10#17)(2008-11#3)(2008-5#2)(2008-7#2)(2009-6#1)(2011-2#3)(2012-2#1)(2013-1#1)
rupestris stem-pitting disease##2##3##(2008-10#2)
rupestris##5##1##(2008-10#5)
rupintrivir##5##1##(2008-10#5)
rupture and##5##2##(1996-5#1)(2012-2#1)(2012-3#1)(2013-8#2)
rupture in a patient##2##4##(1992-2#1)(2010-3#1)
rupture in a##3##3##(1992-2#1)(2009-10#1)(2010-3#1)
rupture in##8##2##(1992-2#2)(1995-12#1)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#1)
rupture is a##3##3##(1997-8#1)(2009-10#1)(2012-2#1)
rupture is##6##2##(1997-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
rupture of a##2##3##(2011-2#2)
rupture of an anterior communicating artery aneurysm##2##7##(1996-3#2)
rupture of an##4##3##(1991-6#1)(1996-3#2)(2008-7#1)
rupture of hydatid cyst##2##4##(2008-12#2)
rupture of intracranial##2##3##(2010-9#1)(2011-2#1)
rupture of the aneurysm##2##4##(2008-7#1)(2011-2#1)
rupture of the cyst##2##4##(1990-6#1)(1991-8#1)
rupture of the##17##3##(1990-11#1)(1990-6#1)(1991-8#2)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-4#1)(2009-9#1)(2011-2#3)(2012-2#1)(2012-3#1)
rupture of##36##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-6#2)(1991-8#2)(1992-2#1)(1996-1#1)(1996-3#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#3)(2009-4#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#3)(2013-1#1)
rupture was##4##2##(1996-3#1)(2009-4#1)(2011-1#1)(2011-3#1)
rupture with##2##2##(1997-8#1)(2008-10#1)
rupture##103##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-6#2)(1991-8#2)(1992-2#5)(1994-1#1)(1994-3#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-3#6)(1996-5#1)(1996-6#1)(1997-8#3)(2008-10#3)(2008-11#2)(2008-12#5)(2008-7#6)(2009-10#3)(2009-4#6)(2009-5#1)(2009-9#3)(2010-3#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#16)(2011-3#2)(2012-2#6)(2012-3#8)(2013-1#2)(2013-8#3)
ruptured aneurysm##3##2##(1997-3#1)(1997-8#1)(2013-8#1)
ruptured basilar tip##2##3##(2008-7#2)
ruptured into the##2##3##(1991-6#1)(2008-12#1)
ruptured intracranial##2##2##(2008-7#2)
ruptured##25##1##(1991-5#1)(1991-6#1)(1995-12#1)(1997-3#3)(1997-8#1)(2008-10#1)(2008-12#3)(2008-7#7)(2010-5#2)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
ruptures of the##2##3##(2008-7#1)(2013-1#1)
ruptures##3##1##(2008-7#1)(2013-1#2)
rural AFDC##2##2##(1996-3#2)
rural Alaska hospitals##2##3##(1996-12#2)
rural and urban areas##2##4##(1994-2#1)(2009-7#1)
rural and urban beneficiaries##3##4##(1994-2#2)(1996-3#1)
rural and urban##8##3##(1994-2#4)(1996-3#1)(2009-10#1)(2009-7#1)(2012-2#1)
rural areas are##2##3##(1994-2#1)(2013-1#1)
rural areas in##2##3##(1991-6#1)(1994-3#1)
rural areas##25##2##(1991-1#1)(1991-3#1)(1991-6#1)(1994-1#2)(1994-2#2)(1994-3#2)(1994-9#1)(1996-3#3)(1996-5#1)(1997-2#2)(2008-11#1)(2008-3#1)(2010-1#1)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#2)
rural beneficiaries##4##2##(1992-12#3)(1996-3#1)
rural communities in##2##3##(1994-9#1)(2008-10#1)
rural communities##3##2##(1994-9#1)(2008-10#1)(2010-7#1)
rural community##8##2##(1994-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-6#2)(2010-9#1)(2012-2#1)
rural counties are##2##3##(1996-3#2)
rural counties##7##2##(1996-3#7)
rural dogs##3##2##(2008-12#3)
rural health care##5##3##(1992-12#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#1)
rural health##11##2##(1991-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-3#1)(2008-9#1)(2012-12#1)
rural hospital##7##2##(1991-1#3)(1996-3#4)
rural hospitals are##3##3##(1991-1#1)(1993-12#1)(1996-3#1)
rural hospitals in##3##3##(1992-2#2)(1996-3#1)
rural hospitals##19##2##(1991-1#2)(1992-12#3)(1992-2#2)(1992-8#1)(1993-12#5)(1996-3#4)(2008-11#2)
rural hospitals?##2##2##(1992-12#1)(1996-3#1)
rural residents##2##2##(1995-12#1)(1997-2#1)
rural smokers##4##2##(2013-1#4)
rural state##2##2##(2010-5#2)
rural states##4##2##(1994-1#4)
rural##182##1##(1991-1#9)(1991-3#1)(1991-6#1)(1992-12#11)(1992-2#3)(1992-8#1)(1993-12#8)(1993-2#3)(1993-3#1)(1993-5#2)(1994-1#11)(1994-2#9)(1994-3#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#29)(1996-5#1)(1997-2#4)(1997-3#1)(1997-7#2)(2008-10#5)(2008-11#8)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#1)(2010-9#3)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#1)
rush##2##1##(1993-1#1)(2008-3#1)
rust (Puccinia##4##2##(2008-10#4)
rust (Uromyces##2##2##(2008-10#2)
rust and anthracnose on the##2##5##(2008-10#2)
rust and stripe rust##6##4##(2008-10#6)
rust and##15##2##(2008-10#15)
rust by##2##2##(2008-10#2)
rust caused by##4##3##(2008-10#4)
rust epidemics##7##2##(2008-10#7)
rust fungi##4##2##(2008-10#4)
rust fungus Puccinia##3##3##(2008-10#3)
rust fungus##12##2##(2008-10#12)
rust in##14##2##(2008-10#14)
rust infection##5##2##(2008-10#5)
rust is##3##2##(2008-10#3)
rust isolates##5##2##(2008-10#5)
rust lesions##3##2##(2008-10#3)
rust occurs in##2##3##(2008-10#2)
rust of##9##2##(2008-10#9)
rust on##5##2##(2008-10#5)
rust pathogen##5##2##(2008-10#5)
rust pathogens##3##2##(2008-10#3)
rust pathosystem##5##2##(2008-10#5)
rust population in##2##3##(2008-10#2)
rust populations##2##2##(2008-10#2)
rust races##5##2##(2008-10#5)
rust ratings##2##2##(2008-10#2)
rust resistance and##2##3##(2008-10#2)
rust resistance gene Lr34##2##4##(2008-10#2)
rust resistance gene in##2##4##(2008-10#2)
rust resistance gene##15##3##(2008-10#15)
rust resistance genes in##2##4##(2008-10#2)
rust resistance genes##12##3##(2008-10#12)
rust resistance in the##4##4##(2008-10#4)
rust resistance in##11##3##(2008-10#11)
rust resistance##59##2##(2008-10#59)
rust severity and##5##3##(2008-10#5)
rust severity##15##2##(2008-10#15)
rust uredospore production and##2##4##(2008-10#2)
rust uredospore production##3##3##(2008-10#3)
rust was detected##2##3##(2008-10#2)
rust was##9##2##(2008-10#9)
rust were##3##2##(2008-10#3)
rust##317##1##(2008-10#317)
rustica##2##1##(2008-10#1)(2008-9#1)
rusts in##2##2##(2008-10#2)
rusts##11##1##(2008-10#11)
rusty##2##1##(2008-10#1)(2008-9#1)
ruthenium (III)##2##2##(2008-10#2)
ruthenium and##5##2##(2008-10#4)(2010-7#1)
ruthenium as##2##2##(2008-10#2)
ruthenium complex##3##2##(2008-10#3)
ruthenium complexes##3##2##(2008-10#3)
ruthenium concentration##2##2##(2008-10#2)
ruthenium in##4##2##(2008-10#4)
ruthenium with##3##2##(2008-10#3)
ruthenium##43##1##(2008-10#38)(2008-12#1)(2009-8#1)(2010-7#3)
ruthenium(II) complex##2##2##(2008-10#2)
ruthenium(II) complexes containing##2##3##(2008-10#2)
ruthenium(II) complexes##4##2##(2008-10#4)
ruthenium(II)##13##1##(2008-10#13)
rutin and quercetin##2##3##(2008-9#2)
rutin and##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
rutin##23##1##(2008-10#18)(2008-11#2)(2008-9#3)
rvWF/106 cells x day##3##4##(2008-11#3)
ryanodine receptors##3##2##(2008-8#1)(2008-9#1)(2010-11#1)
ryanodine sensitive ion channel##3##4##(1994-8#3)
ryanodine##12##1##(1990-2#1)(1994-8#5)(1996-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2013-8#1)
rye B medium##2##3##(2008-10#2)
rye and barley##2##3##(1991-12#2)
rye and##3##2##(1991-12#2)(2008-8#1)
rye##18##1##(1990-3#1)(1991-12#2)(1997-5#1)(2008-10#9)(2008-12#1)(2008-8#3)(2011-2#1)
rye-vetch green manure##3##3##(2008-10#3)
ryegrass (Lolium perenne)##3##3##(2008-10#3)
ryegrass (Lolium##4##2##(2008-10#4)
ryegrass##29##1##(2008-10#29)
r = 0##6##1##(2012-5#6)
résection du dôme saillant##2##4##(2011-2#2)
résection##3##1##(2011-2#3)
s =##2##2##(2008-5#1)(2009-7#1)
s accumulation time##2##3##(2008-10#2)
s accumulation##3##2##(2008-10#3)
s after the reactants##2##4##(2008-10#2)
s after the##3##3##(2008-10#3)
s after##6##2##(1990-2#1)(1990-5#1)(2008-10#4)
s and a##4##3##(2008-10#3)(2008-11#1)
s and can be used for at least 3 months without any##2##12##(2008-10#2)
s and can be used for at least##6##8##(2008-10#6)
s and can be used for##8##6##(2008-10#8)
s and the detection limit##2##5##(2008-10#2)
s and the membrane##2##4##(2008-10#2)
s and the##5##3##(2008-10#5)
s and##25##2##(1992-6#1)(2008-10#23)(2008-11#1)
s are##2##2##(2008-10#1)(2008-2#1)
s at##2##2##(2008-10#2)
s circulation period)##2##3##(1997-2#2)
s for the##2##3##(2008-10#2)
s for##6##2##(2008-10#6)
s from##2##2##(2008-10#1)(2008-11#1)
s in a##3##3##(2008-10#3)
s in##5##2##(1993-8#1)(2008-10#3)(2008-7#1)
s of##10##2##(2008-10#7)(2012-3#3)
s or##2##2##(2008-10#1)(2013-1#1)
s preconcentration time##8##3##(2008-10#8)
s preconcentration##11##2##(2008-10#11)
s to##2##2##(2008-10#2)
s under##2##2##(2008-10#2)
s without##2##2##(2008-10#1)(2008-3#1)
s##269##1##(1990-2#1)(1990-5#4)(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-6#12)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#2)(1996-2#7)(1996-9#1)(1997-1#1)(1997-2#6)(1997-4#1)(2007-12#1)(2008-10#160)(2008-11#8)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#7)(2009-7#2)(2010-1#2)(2010-3#3)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#3)(2012-6#1)(2013-1#6)(2013-8#1)
s(-1) and##7##2##(2008-10#5)(2008-9#1)(2009-7#1)
s(-1) at##2##2##(2008-10#2)
s(-1) for##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)
s(-1)##55##1##(1997-7#1)(2008-10#36)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-8#2)
s(-1))##12##1##(2008-10#10)(2008-9#1)(2009-8#1)
s(b)##2##1##(2008-10#2)
s(r##6##1##(2008-10#6)
s(r)##2##1##(2008-10#2)
s) and a##2##3##(2008-10#2)
s) and high##2##3##(2008-10#2)
s) and##6##2##(2008-10#5)(2013-1#1)
s) of##3##2##(2008-10#3)
s)##23##1##(2008-10#20)(2008-3#1)(2009-8#1)(2013-1#1)
s-1 and##4##2##(1991-5#1)(1991-9#1)(1993-8#1)(1995-6#1)
s-1##31##1##(1991-5#9)(1991-9#2)(1993-8#5)(1993-9#3)(1994-5#5)(1995-11#1)(1995-6#2)(1995-8#3)(2008-10#1)
s-1) approximately beta-erythro-2-pentulofuranose (0##2##4##(1990-9#2)
s-1) approximately##4##2##(1990-9#4)
s-1) greater than alpha-erythrofuranose##2##4##(1990-9#2)
s-1) greater than alpha-threo-2-pentulofuranose (0##2##5##(1990-9#2)
s-1) greater than alpha-threofuranose##2##4##(1990-9#2)
s-1) greater than##10##3##(1990-9#10)
s-1)##20##1##(1990-9#16)(1995-11#1)(1995-6#3)
s-triazines##2##1##(2008-10#2)
s/mm2##2##1##(2009-11#2)
sAPP695##2##1##(1994-11#2)
sAPP770##2##1##(1994-11#2)
sCysC in SLE##3##3##(2013-1#3)
sCysC##7##1##(2013-1#7)
sEMG##3##1##(2013-8#3)
sGAG-storage##2##1##(1993-12#2)
sGnRH##5##1##(1994-8#5)
sIL-1R I##3##2##(2008-10#3)
sIL-1R##10##1##(1995-2#7)(2008-10#3)
sIL-6R##4##1##(1997-7#4)
sRNA##3##1##(2008-9#3)
sRNAs##2##1##(2008-9#2)
sTRAIL##4##1##(2009-3#4)
saCBMFX##6##1##(2008-11#6)
sac and##5##2##(1993-8#1)(2007-12#1)(2009-12#2)(2012-3#1)
sac during##3##2##(2008-11#2)(2011-3#1)
sac is##3##2##(2007-12#1)(2012-12#2)
sac of##3##2##(2007-12#1)(2008-5#1)(2009-12#1)
sac##41##1##(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#2)(1997-3#2)(2007-12#5)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#2)(2009-12#3)(2009-6#1)(2009-8#3)(2011-3#3)(2012-12#3)(2012-3#1)
sacB[BamP]##2##1##(1990-11#2)
saccades##2##1##(2010-5#2)
sacchari##2##1##(2008-10#2)
saccharide composition##2##2##(1991-7#2)
saccharide##4##1##(1991-7#2)(1995-2#1)(2008-10#1)
saccharides##4##1##(1991-7#4)
saccharin aversion##3##2##(2008-5#3)
saccharin preference##2##2##(2008-2#1)(2008-5#1)
saccharin##11##1##(2008-2#1)(2008-5#10)
saccharina##3##1##(2008-10#3)
saccharose##3##1##(2008-10#2)(2008-2#1)
saccular aneurysm##4##2##(2008-7#3)(2013-8#1)
saccular##8##1##(1995-11#1)(2008-7#3)(2010-9#1)(2013-8#3)
sacculus##2##1##(1997-8#1)(2007-12#1)
sachalinensis##2##1##(2008-11#2)
sack##2##1##(1990-5#1)(2012-3#1)
sacral fractures##2##2##(2008-12#2)
sacral##15##1##(2008-10#1)(2008-12#4)(2008-7#5)(2008-8#1)(2010-6#1)(2013-8#3)
sacrifice the##2##2##(1995-5#1)(2008-12#1)
sacrifice##9##1##(1995-12#1)(1995-5#1)(1996-2#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-3#1)
sacrificed 24 h##2##3##(1994-2#1)(1996-12#1)
sacrificed and##2##2##(2008-7#2)
sacrificed at##7##2##(1994-2#1)(1995-11#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-3#1)(2013-1#1)
sacrificed##20##1##(1992-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(1996-12#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-1#1)(2012-3#2)(2013-1#1)
sacrificial##2##1##(2009-10#1)(2009-9#1)
sacroiliac joints in patients with##2##5##(2011-2#2)
sacroiliac joints in##3##3##(2011-2#3)
sacroiliac##4##1##(2011-2#4)
sacrum##7##1##(1991-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2013-8#1)
sacs of##4##2##(2007-12#1)(2008-11#2)(2008-9#1)
sacs##10##1##(2007-12#3)(2008-10#1)(2008-11#4)(2008-9#2)
sad##3##1##(2008-11#2)(2013-8#1)
saddle##3##1##(2008-12#1)(2013-8#2)
sadness##2##1##(2008-11#1)(2009-9#1)
safe alternative to##2##3##(2008-10#1)(2011-2#1)
safe alternative##4##2##(2008-10#1)(2008-11#1)(2011-2#2)
safe and cost-effective##2##3##(1997-8#1)(2012-2#1)
safe and effective in##3##4##(2008-11#1)(2009-3#1)(2011-2#1)
safe and effective treatment##2##4##(1993-3#1)(2012-12#1)
safe and effective when used##2##5##(1996-12#1)(2008-11#1)
safe and effective when##3##4##(1996-12#1)(2008-11#1)(2010-12#1)
safe and effective##23##3##(1990-8#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#3)
safe and efficacious##2##3##(1993-1#1)(1996-1#1)
safe and efficient##2##3##(1992-6#1)(1994-5#1)
safe and secure environment for##2##5##(1992-2#1)(1992-3#1)
safe and secure##4##3##(1992-2#1)(1992-3#1)(1996-12#1)(2010-10#1)
safe and that##2##3##(1994-3#1)(2008-9#1)
safe and##69##2##(1990-11#1)(1990-6#1)(1990-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
safe delivery of##2##3##(2010-5#1)(2013-1#1)
safe for##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
safe harbors##3##2##(1991-1#1)(1993-1#2)
safe in the##3##3##(2008-11#1)(2010-12#2)
safe in##8##2##(1995-5#1)(1997-2#1)(2008-1#1)(2008-11#1)(2010-12#3)(2012-3#1)
safe management of##2##3##(1996-6#1)(2008-11#1)
safe method for##2##3##(1990-11#1)(1993-1#1)
safe method##3##2##(1990-11#1)(1993-1#1)(2008-10#1)
safe procedure##2##2##(1995-1#1)(2011-2#1)
safe sex practices##3##3##(1997-6#2)(2009-5#1)
safe sex##6##2##(1997-6#5)(2009-5#1)
safe technique##3##2##(1996-3#1)(1996-9#1)(2012-3#1)
safe to use##2##3##(2008-12#1)(2012-3#1)
safe to##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
safe use of##5##3##(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
safe##200##1##(1990-11#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#3)(1992-2#3)(1992-3#2)(1992-6#1)(1993-1#5)(1993-12#2)(1993-3#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#3)(1997-2#1)(1997-4#2)(1997-6#7)(1997-8#2)(2008-1#3)(2008-10#19)(2008-11#19)(2008-12#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-1#1)(2009-12#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-5#2)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#22)(2012-12#4)(2012-2#3)(2012-3#8)(2013-1#11)(2013-8#1)
safe-sex##2##1##(2010-7#2)
safe?##2##1##(2008-11#1)(2011-2#1)
safeguard against##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
safeguard##7##1##(1993-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
safeguarding##2##1##(1990-9#1)(2011-2#1)
safeguards##2##1##(2010-8#1)(2011-2#1)
safely and effectively##4##3##(1991-1#2)(1992-2#1)(2010-6#1)
safely and##8##2##(1991-1#2)(1991-3#1)(1992-2#1)(1996-11#1)(2008-6#1)(2010-6#1)(2012-3#1)
safely be##2##2##(1994-8#1)(2008-10#1)
safely in##3##2##(2008-9#1)(2010-12#1)(2012-12#1)
safely##32##1##(1991-1#2)(1991-3#2)(1992-2#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-11#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
safer sex##2##2##(2008-12#2)
safer to##3##2##(2008-9#1)(2012-3#2)
safer##25##1##(1993-12#1)(1996-1#1)(1996-9#1)(1997-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)
safety and effectiveness##4##3##(2008-10#1)(2008-8#1)(2010-6#1)(2012-3#1)
safety and efficacy of##14##4##(1994-5#1)(1996-3#1)(2008-11#6)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-3#1)
safety and efficacy##23##3##(1992-3#1)(1994-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-11#6)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2011-2#5)(2012-3#1)
safety and health##2##3##(1993-3#1)(2008-7#1)
safety and security##3##3##(1992-2#1)(1996-12#2)
safety and the##2##3##(2008-10#1)(2008-11#1)
safety and##59##2##(1990-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-11#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#10)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#8)(2012-3#2)(2013-1#2)
safety are##2##2##(1996-2#1)(2007-12#1)
safety assessment##5##2##(2008-10#1)(2008-7#1)(2010-11#3)
safety assessments##3##2##(2009-10#1)(2010-11#2)
safety at##4##2##(1991-3#1)(2007-12#1)(2008-11#2)
safety benefits##2##2##(2008-11#1)(2008-8#1)
safety between##2##2##(2008-11#1)(2011-1#1)
safety concerns##5##2##(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
safety considerations##3##2##(1992-3#1)(1994-5#1)(2008-10#1)
safety data##3##2##(2008-11#2)(2008-5#1)
safety due##2##2##(2012-12#1)(2013-1#1)
safety during##3##2##(2010-12#2)(2012-3#1)
safety evaluation##2##2##(2008-11#2)
safety features##2##2##(2011-2#1)(2013-1#1)
safety in the##4##3##(1996-3#1)(2007-12#2)(2008-4#1)
safety in##12##2##(1996-3#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2013-1#1)
safety is a##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
safety is##6##2##(1994-3#2)(2008-10#1)(2008-11#1)(2011-2#2)
safety issues##11##2##(1991-12#1)(1993-2#1)(1993-3#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-8#1)
safety margins##2##2##(1995-2#1)(2009-10#1)
safety measures##3##2##(1996-3#1)(2007-11#1)(2009-10#1)
safety net##3##2##(1996-12#1)(1997-5#1)(2008-4#1)
safety of a##6##3##(1990-11#1)(2008-10#2)(2008-8#1)(2012-3#1)(2013-1#1)
safety of both##2##3##(1991-1#1)(2012-3#1)
safety of the##8##3##(1991-3#1)(1996-9#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
safety of this drug##2##4##(2008-11#2)
safety of this##6##3##(1992-2#1)(1997-3#2)(2008-11#2)(2008-5#1)
safety of##82##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1995-5#1)(1996-9#2)(1997-3#2)(2008-10#10)(2008-11#8)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#10)(2013-8#3)
safety practices##2##2##(1996-5#1)(2013-1#1)
safety precautions##2##2##(1993-2#1)(1996-3#1)
safety profile of##3##3##(2008-10#1)(2008-8#2)
safety profile##13##2##(1996-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#4)(2012-3#2)(2013-1#1)
safety standards##3##2##(1993-3#3)
safety system##3##2##(2008-3#1)(2011-1#1)(2013-1#1)
safety testing##5##2##(1992-3#2)(2008-5#2)(2010-11#1)
safety##404##1##(1990-11#3)(1990-12#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#5)(1992-2#2)(1992-3#7)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#5)(1993-3#12)(1993-6#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#7)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#6)(1996-5#3)(1996-9#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#35)(2008-11#48)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#7)(2008-8#15)(2008-9#6)(2009-10#14)(2009-12#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#11)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#8)(2011-2#32)(2011-3#2)(2012-12#8)(2012-2#10)(2012-3#14)(2013-1#28)(2013-8#5)
safflower seedlings##2##2##(2008-10#2)
safflower##5##1##(2008-10#4)(2013-1#1)
saffron##2##1##(2008-12#2)
safranine##2##1##(2008-10#2)
saga##2##1##(1990-6#1)(1991-2#1)
sagging in the cheeks##2##4##(2008-5#2)
sagging in the##3##3##(2008-5#3)
sagging##6##1##(2008-5#6)
sagittal and##3##2##(1995-5#1)(1997-6#1)(2008-3#1)
sagittal plane##4##2##(2008-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
sagittal sinus pressure##2##3##(1993-1#2)
sagittal sinus##8##2##(1993-1#2)(1997-3#3)(2008-7#1)(2013-8#2)
sagittal##25##1##(1993-1#2)(1993-3#1)(1995-5#1)(1997-3#3)(1997-6#1)(1997-8#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#4)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#3)(2013-8#2)
said he##3##2##(1995-12#1)(1996-5#1)(2008-10#1)
said it##2##2##(1993-3#1)(1995-6#1)
said that they##2##3##(1996-1#1)(2013-8#1)
said that##9##2##(1990-2#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
said the##3##2##(1992-8#1)(1995-6#1)(2010-12#1)
said to be##2##3##(1997-8#1)(2013-8#1)
said to##3##2##(1996-2#1)(1997-8#1)(2013-8#1)
said##43##1##(1990-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-6#5)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#2)
saikogenin E##3##2##(2008-11#3)
saikosaponin c was##3##3##(2008-11#3)
saikosaponin c##5##2##(2008-11#5)
saitoana to##2##2##(2008-10#2)
saitoana##15##1##(2008-10#15)
sake at 2 x 10(6) CFU ml(-1)##2##7##(2008-10#2)
sake at 2 x 10(6)##3##5##(2008-10#3)
sake at 2 x##4##4##(2008-10#4)
sake of##6##2##(1994-12#1)(2008-10#4)(2008-12#1)
sake##22##1##(1994-12#1)(2008-10#18)(2008-11#1)(2008-12#1)(2011-1#1)
salaries##8##1##(1991-2#2)(1991-3#2)(1992-1#1)(1992-3#1)(1994-1#1)(1995-1#1)
salary survey##2##2##(1991-3#1)(1995-1#1)
salary##13##1##(1990-9#1)(1991-12#1)(1991-3#4)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(2008-9#1)(2012-12#1)
salbutamol sulfate##2##2##(2008-10#2)
salbutamol##25##1##(1994-12#1)(1996-1#5)(1996-2#2)(2008-10#15)(2008-11#2)
sale of##3##2##(1992-11#1)(1992-8#1)(1996-11#1)
sale##5##1##(1992-11#1)(1992-8#1)(1994-6#1)(1996-11#1)(2010-7#1)
sales##12##1##(1992-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-11#1)(1997-3#1)(2008-11#3)(2008-5#2)(2009-7#1)
salexigens flavodoxin and##2##3##(1994-5#2)
salicylaldehyde thiosemicarbazone##2##2##(2008-10#2)
salicylaldehyde##5##1##(2008-10#5)
salicylamide##3##1##(2008-10#3)
salicylate (SA)##2##2##(2008-10#2)
salicylate and iodide##2##3##(2008-10#2)
salicylate and##4##2##(2008-10#4)
salicylate hydroxylase##3##2##(2008-10#3)
salicylate in##4##2##(2008-10#4)
salicylate ions##2##2##(2008-10#2)
salicylate##34##1##(2008-10#30)(2008-5#4)
salicylate) (CAS RN##2##3##(2008-5#2)
salicylates##3##1##(1991-8#1)(1993-11#1)(2008-10#1)
salicylic Acid##2##2##(2008-10#2)
salicylic acid (SA) in##2##4##(2008-10#1)(2009-8#1)
salicylic acid (SA)##9##3##(2008-10#7)(2009-8#2)
salicylic acid and acetylsalicylic acid##2##5##(2008-10#2)
salicylic acid and##9##3##(1993-11#3)(2008-10#6)
salicylic acid in##4##3##(2008-10#3)(2008-5#1)
salicylic acid##52##2##(1993-11#5)(2008-10#39)(2008-5#4)(2008-8#1)(2009-8#2)(2011-10#1)
salicylic acid-dependent##2##2##(2008-10#1)(2009-6#1)
salicylic##59##1##(1993-11#5)(2008-10#45)(2008-5#4)(2008-8#1)(2009-6#1)(2009-8#2)(2011-10#1)
salience of##2##2##(1997-3#1)(2011-1#1)
salience##3##1##(1997-3#2)(2011-1#1)
saliency##2##1##(2008-11#2)
salient feature of##2##3##(1993-2#1)(2010-5#1)
salient features##2##2##(1993-8#1)(2008-11#1)
salient themes##2##2##(1993-3#1)(2013-1#1)
salient##16##1##(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-3#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2013-1#1)
salina##4##1##(2007-12#4)
saline (0##3##2##(1997-4#1)(2011-2#1)(2012-3#1)
saline (n =##2##3##(2010-6#1)(2012-3#1)
saline and##2##2##(2008-10#1)(2008-11#1)
saline are##2##2##(2010-12#1)(2012-3#1)
saline controls##3##2##(1995-12#2)(2010-5#1)
saline in##2##2##(2008-5#1)(2013-1#1)
saline is##2##2##(1997-1#1)(2010-1#1)
saline matrices##6##2##(2008-10#6)
saline matrix##3##2##(2008-10#3)
saline media##3##2##(2008-10#3)
saline or##5##2##(1993-1#1)(1994-2#2)(2008-10#2)
saline soil##2##2##(2009-8#1)(2011-2#1)
saline solution##3##2##(1994-9#1)(2008-10#1)(2010-12#1)
saline solutions##3##2##(2008-10#3)
saline vehicle##2##2##(1994-8#1)(2013-1#1)
saline water##12##2##(2008-10#10)(2012-5#2)
saline waters##2##2##(2008-10#2)
saline##113##1##(1991-6#2)(1993-1#2)(1994-11#3)(1994-2#3)(1994-5#1)(1994-8#4)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#2)(2008-10#46)(2008-11#1)(2008-5#3)(2008-8#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-5#1)(2010-6#2)(2010-7#4)(2011-2#5)(2012-2#1)(2012-3#5)(2012-5#2)(2013-1#7)(2013-8#2)
saline-instilled##2##1##(2008-10#2)
salinities##2##1##(2008-10#1)(2012-2#1)
salinity and alkalinity##2##3##(2013-8#2)
salinity and##4##2##(2008-10#1)(2008-2#1)(2013-8#2)
salinity stress##2##2##(2008-11#1)(2008-8#1)
salinity tolerance##2##2##(2011-1#1)(2012-5#1)
salinity##21##1##(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#1)(2008-8#1)(2009-8#2)(2011-1#1)(2012-2#1)(2012-5#2)(2013-8#2)
saliva and urine samples##2##4##(2008-10#2)
saliva and urine##3##3##(2008-10#2)(2009-9#1)
saliva and##6##2##(2008-10#3)(2008-12#1)(2009-9#1)(2013-8#1)
saliva by capillary isotachophoresis##2##4##(2008-10#2)
saliva by##3##2##(2008-10#3)
saliva for##2##2##(2008-10#2)
saliva in##2##2##(2008-10#1)(2009-6#1)
saliva of##3##2##(2008-10#1)(2008-12#1)(2010-12#1)
saliva osmolality##2##2##(2013-8#2)
saliva production##3##2##(2007-11#3)
saliva samples##5##2##(2008-10#4)(2013-1#1)
saliva##63##1##(1990-5#1)(1991-1#1)(1995-11#1)(1996-12#1)(1996-5#1)(2007-11#3)(2008-10#36)(2008-12#2)(2008-8#1)(2009-6#3)(2009-9#1)(2010-11#1)(2010-12#2)(2013-1#3)(2013-8#6)
salivarius##2##1##(2008-5#2)
salivary IgA##2##2##(2013-8#2)
salivary biomarkers##2##2##(2010-12#2)
salivary duct##2##2##(2007-12#1)(2008-10#1)
salivary gland cells##3##3##(2008-10#2)(2008-11#1)
salivary gland of Chironomus##3##4##(2008-11#3)
salivary gland of##5##3##(2008-11#3)(2013-1#2)
salivary gland tissue##2##3##(1991-11#1)(2007-11#1)
salivary gland##29##2##(1990-5#3)(1991-11#1)(1993-9#1)(1995-11#3)(1995-8#1)(1997-5#1)(2007-11#2)(2008-10#5)(2008-11#4)(2008-8#1)(2009-1#1)(2009-3#2)(2013-1#4)
salivary glands and##2##3##(2008-10#2)
salivary glands of##10##3##(1990-11#2)(1991-11#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#1)
salivary glands##39##2##(1990-11#3)(1990-6#2)(1991-11#1)(2007-12#2)(2008-10#23)(2008-4#4)(2008-8#2)(2011-2#2)
salivary immunoglobulin A##2##3##(2013-1#1)(2013-8#1)
salivary α-amylase##2##2##(2013-8#2)
salivary##96##1##(1990-11#3)(1990-5#3)(1990-6#3)(1991-11#2)(1993-9#1)(1995-11#3)(1995-8#1)(1997-5#1)(2007-11#2)(2007-12#4)(2008-10#34)(2008-11#4)(2008-4#4)(2008-8#3)(2009-1#1)(2009-3#2)(2009-6#1)(2010-12#4)(2011-2#2)(2013-1#9)(2013-8#9)
salivas have##2##2##(2008-10#2)
salivas##3##1##(2008-10#3)
salivation##4##1##(2008-10#3)(2008-7#1)
salmeterol and fluticasone propionate (FP)##2##5##(1996-2#2)
salmeterol and##4##2##(1996-1#2)(1996-2#2)
salmeterol##9##1##(1996-1#4)(1996-2#4)(2008-10#1)
salmon (Oncorhynchus##2##2##(1993-3#1)(1995-11#1)
salmon GnRH##2##2##(1994-8#1)(1995-11#1)
salmon Oncorhynchus nerka##2##3##(2010-8#2)
salmon egg cell cytoplasm was diluted five-fold with 0##2##9##(2008-10#2)
salmon egg cell cytoplasm was##3##5##(2008-10#3)
salmon egg cell cytoplasm##5##4##(2008-10#5)
salmon genome##2##2##(1993-3#2)
salmon##33##1##(1991-8#1)(1992-6#3)(1992-9#1)(1993-3#4)(1994-8#1)(1995-11#5)(1997-4#1)(2008-10#6)(2008-11#1)(2008-8#4)(2009-6#4)(2010-8#2)
salmonella##3##1##(1993-8#1)(1995-9#1)(1997-3#1)
salmonellosis##4##1##(1991-3#1)(1993-8#1)(1997-3#2)
salmonid##4##1##(1995-11#1)(2008-11#1)(2008-8#1)(2013-1#1)
salmonids##7##1##(2008-10#3)(2008-7#2)(2009-6#2)
salmoninarum##6##1##(2009-6#6)
salpingectomy##3##1##(1991-3#1)(1993-12#1)(2010-12#1)
salpingitis##3##1##(1994-2#3)
salpingo-oophorectomy##3##1##(2012-3#1)(2013-8#2)
salpingostomy##2##1##(1993-12#1)(1993-3#1)
salsalate in##4##2##(2008-10#4)
salsalate##7##1##(2008-10#7)
salt and sodium##2##3##(2008-10#1)(2008-4#1)
salt and##18##2##(1997-8#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)
salt bridge##5##2##(1990-8#1)(2008-10#3)(2008-8#1)
salt can##2##2##(1990-6#1)(2008-10#1)
salt concentration##7##2##(1990-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#2)(2008-7#1)
salt concentrations##5##2##(1990-5#1)(2008-10#2)(2010-4#1)(2011-2#1)
salt of the##2##3##(2008-10#2)
salt of##15##2##(1991-11#1)(1997-2#1)(1997-4#1)(2008-10#10)(2011-2#1)(2012-2#1)
salt solutions##6##2##(2008-10#5)(2012-3#1)
salt stress and nonstress##2##4##(2008-9#2)
salt stress in##2##3##(2008-11#1)(2009-8#1)
salt stress responses in Arabidopsis##2##5##(1997-8#2)
salt stress##18##2##(1997-7#1)(1997-8#3)(2008-11#2)(2008-8#1)(2008-9#5)(2009-8#6)
salt stress-inducible ESTs##2##3##(1997-8#2)
salt technique##2##2##(2013-1#2)
salt tolerance in##2##3##(2008-9#2)
salt tolerance##5##2##(2008-9#4)(2011-2#1)
salt tolerant##2##2##(2008-12#1)(2013-1#1)
salt was##2##2##(2008-10#2)
salt##196##1##(1990-5#3)(1990-6#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-9#1)(1993-6#2)(1993-8#3)(1994-11#1)(1995-11#1)(1996-3#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#6)(2008-10#98)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#13)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#10)(2009-8#7)(2010-4#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
salt) and##2##2##(2008-10#2)
salt)##6##1##(2008-10#6)
salt-free shampoo##2##2##(2008-5#2)
salt-free##4##1##(2008-5#4)
salt-stress##2##1##(2008-9#1)(2009-8#1)
salt-stressed barley##2##2##(2008-9#2)
salt-tolerant##2##1##(2008-8#1)(2009-8#1)
saltation##2##1##(2012-3#2)
salted out##2##2##(1990-5#2)
salted##3##1##(1990-5#2)(2008-10#1)
salting out##2##2##(2008-10#1)(2013-1#1)
salting##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
salting-out##5##1##(1990-5#3)(2008-10#2)
salts and##5##2##(2008-10#3)(2008-12#1)(2011-2#1)
salts are##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
salts as##2##2##(2008-10#1)(2010-6#1)
salts at##3##2##(2008-10#2)(2011-2#1)
salts in solution##2##3##(2008-10#2)
salts in##5##2##(2008-10#5)
salts of##9##2##(1997-2#1)(2008-10#7)(2008-11#1)
salts on the##2##3##(1994-5#1)(2008-10#1)
salts such as##2##3##(2008-10#2)
salts to##2##2##(1992-8#1)(2008-11#1)
salts upon##2##2##(2008-10#2)
salts was##2##2##(1997-2#1)(2008-10#1)
salts##99##1##(1990-5#2)(1991-9#1)(1992-8#1)(1994-5#4)(1995-5#1)(1996-5#1)(1997-2#3)(2008-10#61)(2008-11#8)(2008-12#1)(2008-5#4)(2008-7#3)(2009-8#2)(2010-6#1)(2011-2#5)(2012-7#1)
salts)##2##1##(1997-5#1)(2008-11#1)
salvage chemotherapy in heavily pretreated##2##5##(1992-2#2)
salvage chemotherapy in##3##3##(1992-2#3)
salvage resection##2##2##(2012-3#2)
salvage surgery##2##2##(1990-6#1)(2008-8#1)
salvage##26##1##(1990-6#3)(1991-6#1)(1991-8#1)(1992-2#3)(1992-8#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#2)(2009-1#2)(2011-2#2)(2011-3#2)(2012-12#1)(2012-3#4)
salvational process##2##2##(2009-11#2)
salvianolic acid##2##2##(2008-10#2)
salvianolic acids from##2##3##(2008-10#2)
salvianolic acids##4##2##(2008-10#4)
salvianolic##6##1##(2008-10#6)
samarium hydroxide##3##2##(2008-10#3)
samarium iodide##3##2##(2008-10#3)
samarium##14##1##(2008-10#13)(2012-2#1)
samarium(III)##2##1##(2008-10#2)
samarium-cobalt magnet##3##2##(2008-10#3)
sambucinum##3##1##(2008-10#3)
same VCG##2##2##(2008-10#2)
same active##2##2##(2008-10#1)(2008-5#1)
same affinity##2##2##(1990-11#1)(2008-10#1)
same age control plants at 14##2##6##(2008-10#2)
same age control##3##3##(2008-10#3)
same age##16##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#2)(1991-9#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
same amount of##7##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)
same amount##9##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)
same animals were##2##3##(1993-3#1)(1993-6#1)
same antibody##3##2##(1997-2#1)(2007-12#1)(2008-7#1)
same approach##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
same as##44##2##(1990-5#1)(1991-5#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
same bacterial##2##2##(2008-10#1)(2011-2#1)
same behavior##2##2##(2008-10#1)(2011-2#1)
same cell##7##2##(1993-6#1)(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-12#1)
same characteristics##3##2##(1994-9#1)(2008-5#1)(2013-1#1)
same compounds##3##2##(1991-5#1)(2008-10#2)
same conditions##27##2##(1990-2#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#2)
same developmental##3##2##(1994-12#1)(2007-12#1)(2008-9#1)
same dose of##2##3##(1994-8#1)(2012-3#1)
same dose##5##2##(1992-6#1)(1994-3#1)(1994-8#1)(2008-6#1)(2012-3#1)
same enzyme##4##2##(1990-11#1)(1994-8#1)(1995-6#1)(2008-11#1)
same experimental conditions##4##3##(1997-2#1)(2008-10#3)
same experimental##7##2##(1997-2#1)(2008-10#5)(2013-8#1)
same four##3##2##(1997-5#1)(2008-10#2)
same gene##9##2##(1990-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(2008-10#5)
same group##6##2##(2008-10#3)(2010-11#1)(2011-2#1)(2013-8#1)
same high##2##2##(2008-10#1)(2008-8#1)
same input##2##2##(2008-10#1)(2008-11#1)
same is##3##2##(2008-10#3)
same method##2##2##(1995-2#1)(2013-8#1)
same mouse##2##2##(1995-2#1)(2008-10#1)
same or##13##2##(1991-2#1)(1993-1#1)(1996-2#2)(2008-10#3)(2008-12#1)(2008-4#2)(2008-8#2)(2011-2#1)
same patient##9##2##(1994-12#1)(1996-3#2)(2008-10#1)(2008-8#1)(2010-12#1)(2013-1#2)(2013-8#1)
same pattern of response##2##4##(1990-6#1)(2008-10#1)
same pattern of##4##3##(1990-6#1)(1995-12#1)(2008-10#1)(2008-11#1)
same pattern##8##2##(1990-6#1)(1994-9#1)(1995-12#1)(1997-7#1)(2008-10#3)(2008-11#1)
same patterns##2##2##(2008-11#1)(2008-7#1)
same population##8##2##(1992-2#1)(2008-10#5)(2008-8#1)(2012-12#1)
same procedure was##2##3##(2008-10#1)(2012-12#1)
same procedure##4##2##(1996-3#1)(2008-10#1)(2008-8#1)(2012-12#1)
same procedures##2##2##(2008-5#1)(2008-9#1)
same rats##3##2##(1993-3#1)(1993-6#2)
same result##2##2##(1990-11#1)(1994-11#1)
same results##8##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)(2012-2#2)
same sample##11##2##(1995-5#1)(2008-10#10)
same samples##9##2##(2008-10#8)(2008-3#1)
same sex##3##2##(2008-11#1)(2008-9#2)
same side##5##2##(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
same site##10##2##(1990-5#3)(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#2)
same size##7##2##(1994-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-1#1)(2013-8#1)
same specificity##2##2##(1990-5#1)(2008-10#1)
same step##2##2##(2008-10#2)
same system##4##2##(1996-1#1)(2008-10#2)(2010-5#1)
same three##2##2##(2008-10#2)
same time period##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
same time##83##2##(1990-11#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-12#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#22)(2008-11#5)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#2)(2009-8#1)(2010-12#2)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#4)
same volume of##2##3##(2012-3#2)
same volume##3##2##(2008-3#1)(2012-3#2)
same was found##2##3##(2008-10#1)(2011-2#1)
same was##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
same wheat##3##2##(2008-10#2)(2008-9#1)
same year##4##2##(1991-2#1)(2008-10#2)(2008-8#1)
same##1439##1##(1990-11#10)(1990-12#5)(1990-2#10)(1990-3#2)(1990-5#14)(1990-6#5)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#5)(1991-12#7)(1991-2#8)(1991-3#4)(1991-5#10)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#4)(1992-10#1)(1992-12#4)(1992-2#7)(1992-3#4)(1992-4#1)(1992-6#6)(1992-7#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#3)(1993-6#14)(1993-8#11)(1993-9#2)(1994-1#6)(1994-11#7)(1994-12#8)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#13)(1994-9#4)(1995-1#5)(1995-11#6)(1995-12#10)(1995-2#12)(1995-3#3)(1995-5#4)(1995-6#8)(1995-8#5)(1995-9#3)(1996-1#4)(1996-11#3)(1996-12#5)(1996-2#9)(1996-3#9)(1996-5#2)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#8)(1997-7#4)(1997-8#7)(2006-6#1)(2007-11#2)(2007-12#7)(2008-1#3)(2008-10#506)(2008-11#99)(2008-12#18)(2008-2#10)(2008-3#29)(2008-4#7)(2008-5#41)(2008-6#8)(2008-7#29)(2008-8#53)(2008-9#44)(2009-1#4)(2009-10#11)(2009-11#3)(2009-12#3)(2009-3#1)(2009-5#4)(2009-6#5)(2009-7#4)(2009-8#10)(2009-9#1)(2010-1#5)(2010-10#4)(2010-11#3)(2010-12#7)(2010-3#3)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#8)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#39)(2011-3#2)(2011-7#1)(2012-12#10)(2012-2#16)(2012-3#18)(2012-4#2)(2013-1#22)(2013-7#1)(2013-8#21)
same-ethnic##3##1##(2009-7#3)
same-sex helpers##2##2##(2008-9#2)
same-sex##5##1##(2008-12#1)(2008-8#1)(2008-9#2)(2010-7#1)
samfR gene##2##2##(2008-8#2)
samfR##4##1##(2008-8#4)
sample (100##2##2##(2008-10#2)
sample (N =##2##3##(2008-1#1)(2012-2#1)
sample (i##2##2##(2008-11#1)(2009-10#1)
sample (or##2##2##(2008-10#2)
sample acidification##2##2##(2008-10#2)
sample acidity##3##2##(2008-10#3)
sample after the##2##3##(2008-10#2)
sample aliquot##4##2##(2008-10#4)
sample aliquots##2##2##(2008-10#2)
sample amount##2##2##(2008-10#2)
sample amounts##2##2##(2008-10#2)
sample analysis and##2##3##(2008-10#2)
sample analysis were##2##3##(2008-10#2)
sample analysis##13##2##(2008-10#12)(2008-9#1)
sample and a##2##3##(2008-10#2)
sample and eluent##5##3##(2008-10#5)
sample and organic##2##3##(2008-10#2)
sample and reagent consumption##2##4##(2008-10#2)
sample and reagent volumes##2##4##(2008-10#2)
sample and reagent zones##2##4##(2008-10#2)
sample and reagent##13##3##(2008-10#13)
sample and reagents are##2##4##(2008-10#2)
sample and reagents##8##3##(2008-10#7)(2010-7#1)
sample and standard##2##3##(2008-10#1)(2008-4#1)
sample and the sample##3##4##(2008-10#3)
sample and the##14##3##(2008-10#14)
sample and then##2##3##(2008-10#2)
sample and to##2##3##(2008-10#1)(2012-2#1)
sample and##103##2##(1992-6#1)(1997-2#1)(2008-10#93)(2008-11#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-8#1)
sample and/or reagent##2##3##(2008-10#2)
sample and/or##6##2##(2008-10#5)(2008-12#1)
sample are##5##2##(2008-10#5)
sample aspiration##2##2##(2008-10#1)(2008-11#1)
sample at the##2##3##(2008-10#2)
sample at##8##2##(2008-10#6)(2008-11#1)(2008-5#1)
sample breakthrough volume##2##3##(2008-10#2)
sample by the##2##3##(2008-10#2)
sample by##11##2##(2008-10#10)(2011-2#1)
sample can be##6##3##(2008-10#6)
sample carryover##3##2##(2008-10#3)
sample cell##3##2##(2008-3#3)
sample clean-up##4##2##(1997-2#1)(2008-10#3)
sample cleanup##6##2##(2008-10#6)
sample collection##13##2##(2008-10#13)
sample combustion##2##2##(2008-10#2)
sample comprises##2##2##(1995-1#1)(2013-1#1)
sample concentration and##4##3##(2008-10#4)
sample concentration##9##2##(2008-10#9)
sample concentrations##2##2##(2008-10#2)
sample consisted of##13##3##(1994-1#1)(1994-6#1)(1995-1#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
sample consumed##3##2##(2008-10#3)
sample consumption##4##2##(2008-10#4)
sample contained##2##2##(1990-9#1)(2008-8#1)
sample containing##17##2##(2008-10#17)
sample contamination##2##2##(2008-10#2)
sample detected by the method is in good agreement with the certified value##2##13##(2008-10#2)
sample determined##2##2##(2008-10#2)
sample digestion and##3##3##(2008-10#3)
sample digestion##12##2##(2008-10#12)
sample dilution##2##2##(2008-10#2)
sample dissolution##5##2##(2008-10#5)
sample due to the##2##4##(2008-10#2)
sample during##3##2##(1990-5#1)(2008-10#2)
sample enrichment##2##2##(2008-10#2)
sample extraction##9##2##(2008-10#9)
sample extracts##2##2##(2008-10#2)
sample flow rate and##4##4##(2008-10#4)
sample flow rate##22##3##(2008-10#22)
sample flow##25##2##(2008-10#25)
sample for##7##2##(2008-10#7)
sample free from sulphur dioxide##2##5##(2008-10#2)
sample frequency of 27 samples per##2##6##(2008-10#2)
sample frequency of##11##3##(2008-10#11)
sample frequency##14##2##(2008-10#14)
sample from a##7##3##(2008-10#4)(2008-12#1)(2010-2#1)(2013-1#1)
sample from the##5##3##(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
sample from##19##2##(2008-1#1)(2008-10#8)(2008-12#5)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
sample group##4##2##(1993-11#1)(2008-10#2)(2009-11#1)
sample groups##3##2##(2008-10#2)(2009-11#1)
sample h(-1)##3##2##(2008-10#3)
sample had##2##2##(2008-10#1)(2008-11#1)
sample handling and##2##3##(2008-10#2)
sample handling##15##2##(1997-6#1)(2008-10#11)(2008-11#1)(2008-9#2)
sample has##2##2##(2008-10#1)(2009-5#1)
sample in the##6##3##(2008-10#6)
sample in##23##2##(1991-2#2)(2008-10#16)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
sample included##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2009-7#1)
sample including##3##2##(2008-10#1)(2008-7#1)(2009-7#1)
sample injection and##4##3##(1995-3#1)(2008-10#3)
sample injection is##2##3##(2008-10#2)
sample injection of##2##3##(2008-10#2)
sample injection volume##4##3##(2008-10#4)
sample injection##24##2##(1995-3#1)(2008-10#23)
sample injections##4##2##(2008-10#4)
sample insertion##2##2##(2008-10#2)
sample into a##3##3##(2008-10#3)
sample into the##3##3##(2008-10#3)
sample into##8##2##(2008-10#8)
sample introduction in##2##3##(2008-10#2)
sample introduction system##6##3##(2008-10#6)
sample introduction techniques##2##3##(2008-10#2)
sample introduction##33##2##(2008-10#32)(2010-7#1)
sample is directly##3##3##(2008-10#2)(2008-2#1)
sample is fused with##2##4##(2008-10#2)
sample is injected##2##3##(2008-10#2)
sample is introduced##2##3##(2008-10#2)
sample is the##2##3##(2008-10#2)
sample is treated with##2##4##(2008-10#2)
sample is##58##2##(1995-12#1)(2008-10#48)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2013-1#1)
sample loading and##2##3##(2008-10#2)
sample loading flow rate##5##4##(2008-10#5)
sample loading time of##2##4##(2008-10#2)
sample loading time##3##3##(2008-10#3)
sample loading volume##2##3##(2008-10#2)
sample loading##14##2##(2008-10#14)
sample loop of##3##3##(2008-10#3)
sample loop##9##2##(2008-10#9)
sample loss##2##2##(2008-10#1)(2008-11#1)
sample manipulation##4##2##(2008-10#4)
sample mass##8##2##(2008-10#8)
sample materials##2##2##(2008-10#2)
sample matrices##4##2##(2008-10#4)
sample matrix and##2##3##(2008-10#2)
sample matrix was##5##3##(2008-10#5)
sample matrix##28##2##(2008-10#28)
sample may be stored##2##4##(2008-10#2)
sample may##5##2##(2008-10#2)(2008-9#1)(2013-8#2)
sample measurement frequency##4##3##(2008-10#4)
sample measurement##6##2##(2008-10#6)
sample number##2##2##(2008-10#2)
sample of 0##2##3##(2008-10#2)
sample of 1##4##3##(1993-2#1)(1996-6#1)(2008-10#1)(2011-2#1)
sample of 10##2##3##(1993-3#1)(2008-11#1)
sample of 2##4##3##(1992-12#1)(1993-12#1)(2008-4#1)(2012-2#1)
sample of 20##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
sample of 3##2##3##(1994-1#1)(2013-8#1)
sample of 37##3##3##(2008-12#1)(2010-6#1)(2013-8#1)
sample of 40##2##3##(1993-2#1)(2009-12#1)
sample of 43##2##3##(1993-12#1)(2009-11#1)
sample of a##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
sample of healthy individuals##2##4##(2008-7#1)(2009-10#1)
sample of nurses##2##3##(2008-11#1)(2010-11#1)
sample of subjects##2##3##(1994-9#1)(2008-7#1)
sample of the##6##3##(1992-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
sample of women aged##2##4##(1990-8#1)(1992-1#1)
sample of women##3##3##(1990-8#1)(1992-1#1)(2011-2#1)
sample of##208##2##(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-8#3)(1992-1#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#3)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#3)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(2007-12#4)(2008-1#2)(2008-10#37)(2008-11#18)(2008-12#14)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#4)(2009-7#6)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#4)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#5)
sample or##5##2##(2008-10#4)(2009-10#1)
sample pH and##4##3##(2008-10#4)
sample pH##13##2##(2008-10#12)(2008-9#1)
sample passes##2##2##(2008-10#2)
sample per##2##2##(2008-10#2)
sample period##2##2##(2008-10#2)
sample periods##3##2##(2008-10#3)
sample plan##3##2##(1993-3#1)(2008-10#2)
sample plug##5##2##(2008-10#5)
sample population##3##2##(2008-10#2)(2012-3#1)
sample positioning##2##2##(2008-10#2)
sample pre-concentration##2##2##(2008-10#2)
sample pre-treatment and##2##3##(2008-10#2)
sample pre-treatment##14##2##(2008-10#14)
sample pre-treatments##2##2##(2008-10#2)
sample preconcentration##4##2##(2008-10#3)(2010-7#1)
sample preparation and determination##2##4##(2008-10#2)
sample preparation and##9##3##(2008-10#6)(2008-5#1)(2008-9#1)(2010-7#1)
sample preparation for##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
sample preparation in##2##3##(2008-10#2)
sample preparation instead of intensive treatments inherent with the##3##9##(2008-10#3)
sample preparation is##5##3##(2008-10#4)(2008-4#1)
sample preparation method based on##3##5##(2008-10#3)
sample preparation method##8##3##(2008-10#7)(2008-9#1)
sample preparation methods##3##3##(2008-10#3)
sample preparation procedure for##2##4##(2008-10#2)
sample preparation procedure##5##3##(2008-10#5)
sample preparation procedures##3##3##(2008-10#3)
sample preparation process##2##3##(2008-10#2)
sample preparation was##3##3##(2008-10#3)
sample preparation##79##2##(2008-10#66)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#3)(2010-11#2)(2010-7#1)
sample preparations##3##2##(2008-10#2)(2010-11#1)
sample pretreatment and##2##3##(2008-10#2)
sample pretreatment for##2##3##(2008-10#2)
sample pretreatment steps##2##3##(2008-10#1)(2010-11#1)
sample pretreatment using##2##3##(2008-10#2)
sample pretreatment##20##2##(2008-10#19)(2010-11#1)
sample prior to##3##3##(2008-10#2)(2008-11#1)
sample processing and##2##3##(2008-10#2)
sample processing##9##2##(2008-10#7)(2008-11#2)
sample rate##2##2##(2008-10#2)
sample should##2##2##(2008-10#2)
sample showed##2##2##(2008-10#1)(2008-11#1)
sample size and##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
sample size estimate##2##3##(1994-9#1)(2010-4#1)
sample size for##4##3##(1994-9#1)(1995-9#1)(2008-10#2)
sample size formula##2##3##(1992-9#1)(1996-3#1)
sample size formulae##2##3##(2012-3#2)
sample size of##2##3##(2013-1#2)
sample size reassessment##2##3##(2012-2#2)
sample size required to##2##4##(1992-9#1)(1995-9#1)
sample size was##2##3##(2008-10#1)(2012-2#1)
sample size##60##2##(1992-3#1)(1992-9#3)(1994-9#4)(1995-5#1)(1995-9#3)(1996-3#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#4)
sample sizes differ##2##3##(2008-10#2)
sample sizes in##3##3##(1992-9#1)(2008-10#2)
sample sizes##18##2##(1991-12#1)(1992-9#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
sample solution and eluent##4##4##(2008-10#4)
sample solution and##9##3##(2008-10#9)
sample solution by##2##3##(2008-10#2)
sample solution can be determined##2##5##(2008-10#2)
sample solution containing##6##3##(2008-10#6)
sample solution for##2##3##(2008-10#2)
sample solution in##3##3##(2008-10#3)
sample solution is injected into the##2##6##(2008-10#2)
sample solution is##8##3##(2008-10#8)
sample solution was injected##5##4##(2008-10#5)
sample solution was introduced into the##2##6##(2008-10#2)
sample solution was##13##3##(2008-10#13)
sample solution were##5##3##(2008-10#5)
sample solution##110##2##(2008-10#110)
sample solutions by##3##3##(2008-10#3)
sample solutions containing##2##3##(2008-10#2)
sample solutions using##2##3##(2008-10#2)
sample solutions were##3##3##(2008-10#3)
sample solutions##16##2##(2008-10#16)
sample stabilization##3##2##(2008-10#3)
sample stacking for##2##3##(2008-10#2)
sample stacking##7##2##(2008-10#7)
sample storage protocols##2##3##(2008-10#2)
sample storage##3##2##(2008-10#3)
sample stream##4##2##(2008-10#4)
sample surface##8##2##(1994-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-7#1)(2012-2#1)
sample surveys##2##2##(2011-2#1)(2012-2#1)
sample taken##2##2##(2008-10#1)(2008-12#1)
sample temperature##3##2##(2008-10#1)(2008-9#2)
sample that is##2##3##(2008-10#2)
sample that##3##2##(2008-10#3)
sample the##7##2##(2008-10#5)(2008-6#1)(2009-4#1)
sample then##2##2##(2008-10#2)
sample through##4##2##(2008-10#4)
sample throughput and##3##3##(2008-10#3)
sample throughput is##3##3##(2008-10#3)
sample throughput of##25##3##(2008-10#25)
sample throughput was##10##3##(2008-10#10)
sample throughput##64##2##(1992-11#1)(2008-10#62)(2010-11#1)
sample to##17##2##(2007-12#1)(2008-10#16)
sample treated##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
sample treatment and##6##3##(2008-10#6)
sample treatment for the##2##4##(2008-10#2)
sample treatment for##3##3##(2008-10#3)
sample treatment is##2##3##(2008-10#2)
sample treatment##29##2##(2008-10#29)
sample treatments##2##2##(2008-10#2)
sample tube length##2##3##(2008-10#2)
sample tube##4##2##(2008-10#4)
sample type##3##2##(2008-10#3)
sample types##6##2##(2008-10#5)(2008-3#1)
sample under##3##2##(2008-10#1)(2008-3#2)
sample using a##3##3##(2008-10#3)
sample using##10##2##(2008-10#10)
sample volume and##4##3##(2008-10#4)
sample volume are##2##3##(2008-10#2)
sample volume injected##2##3##(2008-10#2)
sample volume of 100 ml##3##5##(2008-10#3)
sample volume of 100##4##4##(2008-10#4)
sample volume of##19##3##(2008-10#19)
sample volume up to##2##4##(2008-10#2)
sample volume were##2##3##(2008-10#2)
sample volume with##2##3##(2008-10#1)(2008-2#1)
sample volume##74##2##(1990-12#1)(2008-10#70)(2008-12#1)(2008-2#1)(2008-3#1)
sample volumes and##2##3##(2008-10#2)
sample volumes##12##2##(2008-10#12)
sample was &lt##2##3##(2008-10#2)
sample was added##2##3##(1997-2#1)(2008-10#1)
sample was also##3##3##(2008-10#3)
sample was determined with##2##4##(2008-10#2)
sample was divided into##3##4##(2008-12#1)(2013-1#2)
sample was injected into##3##4##(2008-10#3)
sample was injected##4##3##(2008-10#4)
sample was measured##2##3##(2008-10#2)
sample was taken##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
sample was used##3##3##(2008-10#3)
sample was##65##2##(1994-12#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#47)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
sample weight##2##2##(2008-10#2)
sample were also##3##3##(2008-10#3)
sample were##19##2##(2008-10#17)(2008-11#1)(2008-12#1)
sample while##2##2##(2008-10#2)
sample with a##5##3##(2008-10#5)
sample with the##5##3##(2008-10#4)(2008-5#1)
sample with##24##2##(1991-12#1)(2008-10#21)(2008-5#1)(2008-9#1)
sample without##2##2##(2008-10#2)
sample zone was##2##3##(2008-10#2)
sample zone##14##2##(2008-10#14)
sample##2167##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#7)(1991-3#2)(1991-6#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#4)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1994-1#3)(1994-12#3)(1994-3#5)(1994-6#2)(1994-9#9)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#2)(1995-9#6)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#9)(2008-1#5)(2008-10#1641)(2008-11#51)(2008-12#34)(2008-2#2)(2008-3#19)(2008-4#17)(2008-5#12)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#24)(2009-10#10)(2009-11#7)(2009-12#6)(2009-4#2)(2009-5#8)(2009-6#2)(2009-7#9)(2009-8#3)(2009-9#5)(2010-1#5)(2010-10#4)(2010-11#12)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#10)(2010-8#5)(2010-9#2)(2011-1#2)(2011-2#23)(2012-12#6)(2012-2#22)(2012-3#11)(2013-1#23)(2013-3#1)(2013-8#20)
sample's##3##1##(2007-11#1)(2008-3#1)(2010-7#1)
sample) and##5##2##(1992-9#1)(2008-10#4)
sample)##22##1##(1991-12#1)(1992-9#1)(2008-10#16)(2008-11#1)(2009-4#1)(2009-5#1)(2012-3#1)
sample-handling##2##1##(2008-10#2)
sample-preparation techniques##2##2##(2010-11#1)(2010-7#1)
sample-preparation##4##1##(2008-10#1)(2008-4#1)(2010-11#1)(2010-7#1)
sample-to-sample##2##1##(2008-10#1)(2012-2#1)
sample/reagent##3##1##(2008-10#3)
sample/standard##3##1##(2008-10#3)
sampled (p&lt##2##2##(2008-4#2)
sampled and analyzed##2##3##(2008-10#2)
sampled and##10##2##(1994-3#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)
sampled at##5##2##(2008-10#5)
sampled by##3##2##(2008-10#2)(2008-3#1)
sampled during##3##2##(2008-10#3)
sampled either##2##2##(2008-2#1)(2008-5#1)
sampled for##2##2##(2008-10#2)
sampled from RL##3##3##(2008-10#3)
sampled from a##2##3##(2008-10#1)(2008-11#1)
sampled from different##4##3##(2008-10#4)
sampled from nine##2##3##(2008-10#2)
sampled from one##2##3##(2008-10#1)(2009-7#1)
sampled from the##6##3##(1990-5#1)(2008-10#3)(2008-11#1)(2012-2#1)
sampled from two##2##3##(2008-10#2)
sampled from wheat##2##3##(2008-10#2)
sampled from##43##2##(1990-5#1)(2008-10#37)(2008-11#2)(2008-8#1)(2009-7#1)(2012-2#1)
sampled in a##4##3##(2008-10#4)
sampled in the##6##3##(2008-10#6)
sampled in##18##2##(2008-10#18)
sampled on a##2##3##(2008-10#2)
sampled on the##2##3##(2008-10#2)
sampled on##4##2##(2008-10#4)
sampled over time##2##3##(2008-10#2)
sampled over##4##2##(2008-10#4)
sampled points##2##2##(2008-10#2)
sampled seedlings##2##2##(2008-10#2)
sampled were##3##2##(2008-10#3)
sampled##165##1##(1990-5#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#132)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
sampler for##5##2##(2008-10#4)(2010-5#1)
sampler is##2##2##(2008-10#2)
sampler method##2##2##(2008-10#1)(2010-5#1)
sampler technique##3##2##(2008-10#3)
sampler##35##1##(1994-9#1)(2008-10#26)(2008-11#3)(2008-5#1)(2010-5#3)(2012-7#1)
samplers##15##1##(2008-10#10)(2008-11#2)(2008-5#3)
samples (0##7##2##(2008-10#6)(2013-1#1)
samples (30##2##2##(2008-10#2)
samples (n =##3##3##(2012-3#3)
samples according to##2##3##(2008-10#2)
samples after a simple##2##4##(2008-10#2)
samples after a##3##3##(2008-10#3)
samples after adsorption of its##3##5##(2008-10#3)
samples after preconcentration##3##3##(2008-10#3)
samples after##19##2##(2008-10#19)
samples against##2##2##(1990-12#1)(2008-10#1)
samples analysed##4##2##(2008-10#3)(2012-12#1)
samples analysis##4##2##(2008-10#4)
samples analyzed were##2##3##(2008-10#2)
samples analyzed##11##2##(2008-10#10)(2008-11#1)
samples and a##7##3##(2008-10#7)
samples and also##2##3##(2008-10#2)
samples and calibration##2##3##(2008-10#2)
samples and chromium##2##3##(2008-10#2)
samples and compared##2##3##(2008-10#1)(2013-8#1)
samples and for##3##3##(1997-6#1)(2008-10#2)
samples and from##2##3##(2008-10#1)(2008-11#1)
samples and good##2##3##(2008-10#2)
samples and in##7##3##(1995-12#1)(2008-10#6)
samples and it##2##3##(2008-10#2)
samples and its##3##3##(2008-10#3)
samples and on##2##3##(2008-10#2)
samples and other##2##3##(2008-10#2)
samples and several##2##3##(2008-10#2)
samples and spiked##2##3##(2008-10#2)
samples and standard##3##3##(2008-10#3)
samples and the results obtained##2##5##(2008-10#2)
samples and the results were##2##5##(2008-10#2)
samples and the results##5##4##(2008-10#5)
samples and the##16##3##(2008-10#16)
samples and three##3##3##(2008-10#3)
samples and waters##2##3##(2008-10#2)
samples and##159##2##(1990-8#1)(1993-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#137)(2008-11#3)(2008-12#2)(2008-6#1)(2008-8#2)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
samples are analysed##2##3##(2008-10#2)
samples are described##2##3##(2008-10#2)
samples are examined##2##3##(2008-2#1)(2012-2#1)
samples are obtained##3##3##(2008-10#2)(2010-6#1)
samples are presented##3##3##(2008-10#3)
samples are reviewed##3##3##(2008-10#3)
samples are usually##2##3##(2008-10#1)(2010-11#1)
samples are##66##2##(2008-10#57)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-6#1)(2012-2#1)
samples as well as in##2##5##(2008-10#1)(2008-11#1)
samples as well as##5##4##(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
samples as##11##2##(2008-10#6)(2008-11#2)(2008-9#1)(2009-12#1)(2012-3#1)
samples at a##2##3##(2008-10#1)(2011-2#1)
samples at concentration levels between##2##5##(2008-10#2)
samples at the##4##3##(2008-10#3)(2008-12#1)
samples at trace##2##3##(2008-10#2)
samples at##20##2##(1992-3#1)(1993-11#1)(2008-10#16)(2008-12#1)(2011-2#1)
samples based on the use of##2##6##(2008-10#2)
samples based on##5##3##(2008-10#4)(2012-2#1)
samples before##5##2##(2008-10#4)(2008-5#1)
samples belonged to##2##3##(2008-10#2)
samples but not##2##3##(2008-10#2)
samples but##3##2##(2008-10#3)
samples by a##2##3##(2008-10#2)
samples by electrothermal atomic absorption spectrometry using##3##7##(2008-10#3)
samples by electrothermal atomic absorption spectrometry##7##6##(2008-10#7)
samples by electrothermal atomic absorption##8##5##(2008-10#8)
samples by electrothermal##10##3##(2008-10#10)
samples by extraction##2##3##(2008-10#2)
samples by flame AAS##2##4##(2008-10#2)
samples by flame atomic absorption spectrometry##3##6##(2008-10#3)
samples by flame atomic absorption##4##5##(2008-10#4)
samples by flame##6##3##(2008-10#6)
samples by flow-injection##3##3##(2008-10#3)
samples by gas chromatography with##2##5##(2008-10#2)
samples by gas chromatography##4##4##(2008-10#4)
samples by gas##5##3##(2008-10#5)
samples by graphite furnace atomic absorption spectrometry (GFAAS)##2##8##(2008-10#2)
samples by graphite furnace atomic absorption spectrometry after##3##8##(2008-10#3)
samples by graphite furnace atomic absorption spectrometry##7##7##(2008-10#7)
samples by graphite furnace atomic##8##5##(2008-10#8)
samples by hydride generation-four-channel##2##4##(2008-10#2)
samples by hydride##6##3##(2008-10#6)
samples by inductively coupled plasma atomic emission spectrometry##2##8##(1992-3#1)(2008-10#1)
samples by inductively coupled plasma atomic emission##3##7##(1992-3#1)(2008-10#2)
samples by inductively coupled plasma##5##5##(1992-3#1)(2008-10#4)
samples by inductively coupled##6##4##(1992-3#1)(2008-10#5)
samples by liquid##2##3##(2008-10#2)
samples by solid-phase##2##3##(2008-10#2)
samples by the proposed##2##4##(2008-10#2)
samples by the standard addition method##2##6##(2008-10#2)
samples by the##11##3##(2008-10#11)
samples by this method were##2##5##(2008-10#2)
samples by this method##3##4##(2008-10#3)
samples by this##4##3##(2008-10#4)
samples by using a##3##4##(2008-10#3)
samples by using the##2##4##(2008-10#2)
samples by using##8##3##(2008-10#8)
samples by##144##2##(1992-3#1)(1996-12#1)(2008-10#137)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-12#1)
samples can be analyzed per hour with a relative standard deviation of less than##2##14##(2008-10#2)
samples can be analyzed per hour with a relative##3##9##(2008-10#3)
samples can be analyzed per hour##4##6##(2008-10#4)
samples can be analyzed##6##4##(2008-10#6)
samples can be##19##3##(2008-10#15)(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)
samples collected at##2##3##(2008-10#2)
samples collected by##3##3##(2008-10#3)
samples collected from 6##2##4##(2008-9#1)(2013-8#1)
samples collected from an##3##4##(2008-10#3)
samples collected from the##5##4##(2008-10#4)(2009-12#1)
samples collected from##26##3##(1996-12#2)(2008-10#19)(2008-11#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-8#1)
samples collected in the##4##4##(2008-10#4)
samples collected in##9##3##(2008-10#9)
samples collected##44##2##(1996-12#2)(2008-10#35)(2008-11#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
samples coming from the##2##4##(2008-10#2)
samples coming from##3##3##(2008-10#3)
samples compared well with those found by##2##7##(2008-10#2)
samples compared well with those##3##5##(2008-10#3)
samples compared##4##2##(2008-10#4)
samples contain##2##2##(2008-10#1)(2008-2#1)
samples containing a##2##3##(2008-10#2)
samples containing both##2##3##(2008-10#2)
samples containing different concentrations of##2##5##(2008-10#2)
samples containing high##4##3##(2008-10#3)(2009-8#1)
samples containing low concentrations of##2##5##(2008-10#2)
samples containing##37##2##(1991-12#1)(2008-10#32)(2008-11#2)(2009-8#1)(2010-4#1)
samples corresponding to##3##3##(2008-10#3)
samples could be##10##3##(2008-10#9)(2011-2#1)
samples could##12##2##(2008-10#11)(2011-2#1)
samples demonstrated that the##2##4##(2008-10#2)
samples demonstrated##4##2##(2008-10#4)
samples determined##2##2##(2008-10#1)(2008-12#1)
samples did not##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
samples displaying##2##2##(1990-2#1)(2008-10#1)
samples elaborated##2##2##(2008-10#2)
samples examined##2##2##(2008-12#1)(2012-3#1)
samples extracted##2##2##(2008-10#2)
samples for subsequent##2##3##(2008-10#2)
samples for the determination of##3##5##(2008-10#3)
samples for the##5##3##(2008-10#4)(2008-7#1)
samples for which the##2##4##(2008-10#1)(2008-3#1)
samples for##35##2##(1991-11#1)(1991-3#1)(1996-12#2)(1997-2#1)(2008-10#23)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#1)
samples fortified##3##2##(2008-10#3)
samples found##2##2##(1992-12#1)(2008-10#1)
samples from a##6##3##(2008-10#6)
samples from an##7##3##(2008-10#5)(2008-12#1)(2011-2#1)
samples from different##8##3##(2008-10#8)
samples from groups of##2##4##(1991-3#1)(1996-12#1)
samples from healthy adults##2##4##(2008-10#1)(2009-8#1)
samples from healthy##6##3##(2008-10#2)(2008-4#1)(2009-8#1)(2011-2#2)
samples from items of the cultural heritage of Valencia (Spain)##2##10##(2008-10#2)
samples from local markets##2##4##(2008-10#2)
samples from patients with##2##4##(2011-2#1)(2012-3#1)
samples from patients##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
samples from rural domestic##2##4##(2013-1#2)
samples from several##5##3##(2008-10#5)
samples from the##14##3##(1995-11#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-9#1)(2010-6#2)
samples from three##2##3##(2008-10#2)
samples from which##2##3##(2008-10#2)
samples from##152##2##(1990-2#1)(1991-3#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#5)(1997-3#1)(2008-10#102)(2008-11#4)(2008-12#5)(2008-4#1)(2008-5#4)(2008-9#3)(2009-8#1)(2010-1#1)(2010-4#1)(2010-6#3)(2011-10#1)(2011-2#6)(2012-3#2)(2013-1#3)(2013-8#2)
samples gave##4##2##(2008-10#4)
samples h(-1) were##2##3##(2008-10#2)
samples h(-1)##33##2##(2008-10#33)
samples h(-1))##4##2##(2008-10#4)
samples had no##2##3##(2008-10#1)(2008-11#1)
samples had##3##2##(2008-10#2)(2008-11#1)
samples has been carried out##2##5##(2008-10#2)
samples has been determined##2##4##(2008-10#2)
samples has been##17##3##(1997-2#1)(2008-10#16)
samples has##22##2##(1997-2#1)(2008-10#20)(2011-2#1)
samples have been collected##2##4##(2008-11#1)(2008-12#1)
samples have been##9##3##(2008-10#7)(2008-11#1)(2008-12#1)
samples have##12##2##(2008-10#9)(2008-11#1)(2008-12#1)(2009-4#1)
samples having##3##2##(2008-10#2)(2012-2#1)
samples heated at 1100 degrees C##2##6##(2010-4#2)
samples in a##7##3##(2008-10#3)(2008-11#2)(2008-6#1)(2010-11#1)
samples in aqueous##2##3##(2008-10#2)
samples in order to##4##4##(2008-10#2)(2008-4#1)(2008-5#1)
samples in the range##3##4##(2008-10#3)
samples in the##11##3##(1992-9#1)(2008-10#10)
samples in##63##2##(1992-9#1)(1993-2#1)(2008-10#45)(2008-11#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-2#1)
samples including##3##2##(2008-10#3)
samples indicated that##2##3##(2008-10#1)(2008-12#1)
samples indicates that##2##3##(2008-10#1)(2008-3#1)
samples infected##2##2##(2008-10#1)(2008-12#1)
samples into a##2##3##(2008-10#1)(2008-9#1)
samples into##4##2##(2008-10#3)(2008-9#1)
samples is demonstrated##4##3##(2008-10#4)
samples is described##14##3##(2008-10#14)
samples is illustrated##2##3##(2008-10#2)
samples is not##2##3##(2008-10#2)
samples is presented##4##3##(2008-10#4)
samples is proposed##5##3##(2008-10#5)
samples is successful##3##3##(2008-10#3)
samples is##55##2##(2008-10#55)
samples like##2##2##(2008-10#2)
samples may be##2##3##(2008-10#1)(2010-11#1)
samples may##3##2##(2008-10#2)(2010-11#1)
samples must be##2##3##(2008-10#2)
samples must##3##2##(2008-10#3)
samples need##2##2##(2008-10#1)(2008-5#1)
samples needed##2##2##(2008-10#2)
samples obtained by##4##3##(1994-1#1)(2008-10#3)
samples obtained from hospitalized##2##4##(1992-3#1)(2008-10#1)
samples obtained from##12##3##(1992-3#2)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#7)
samples obtained##19##2##(1991-2#1)(1992-3#2)(1994-1#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#11)(2012-12#1)
samples of &quot##2##3##(2008-10#2)
samples of 0##2##3##(2008-10#2)
samples of N##2##3##(2008-10#2)
samples of a##4##3##(2008-10#3)(2008-11#1)
samples of animal##2##3##(2008-10#1)(2013-8#1)
samples of commercial##2##3##(2008-10#2)
samples of different types of##2##5##(2008-10#2)
samples of different types##3##4##(2008-10#3)
samples of different##8##3##(2008-10#8)
samples of distilled##2##3##(2008-10#2)
samples of each##2##3##(2008-10#1)(2008-5#1)
samples of fish##2##3##(2008-10#2)
samples of healthy##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
samples of human##2##3##(1990-12#1)(2008-10#1)
samples of interest##2##3##(1995-2#1)(2008-10#1)
samples of natural water##3##4##(2008-10#3)
samples of natural##5##3##(2008-10#5)
samples of normal##2##3##(1992-3#1)(2008-5#1)
samples of patients##2##3##(2008-10#1)(2011-2#1)
samples of river##2##3##(2008-10#2)
samples of small##2##3##(1996-6#1)(2008-10#1)
samples of the##14##3##(1991-1#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)
samples of##193##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-6#1)(2008-10#130)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#9)(2008-7#4)(2008-9#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#3)
samples on a##2##3##(2008-10#2)
samples on the##6##3##(2008-10#5)(2011-1#1)
samples on##12##2##(2008-10#10)(2008-11#1)(2011-1#1)
samples or##5##2##(2008-10#4)(2008-12#1)
samples originating from##2##3##(2008-10#2)
samples over##3##2##(2008-10#2)(2008-6#1)
samples per h and the##2##5##(2008-10#2)
samples per h and##3##4##(2008-10#3)
samples per h with a##3##5##(2008-10#3)
samples per h##13##3##(2008-10#13)
samples per hour analyzed by##2##5##(2008-10#2)
samples per hour and##6##4##(2008-10#6)
samples per hour could be##2##5##(2008-10#2)
samples per hour was achieved##2##5##(2008-10#2)
samples per hour was obtained##2##5##(2008-10#2)
samples per hour was##4##4##(2008-10#4)
samples per hour with a relative standard deviation##2##8##(2008-10#2)
samples per hour with a##3##5##(2008-10#3)
samples per hour##47##3##(2008-10#47)
samples per##63##2##(2008-10#63)
samples preparation##2##2##(2008-10#2)
samples prepared from##2##3##(2008-10#2)
samples prepared in##5##3##(2008-10#5)
samples prepared using the##2##4##(2008-5#2)
samples prepared using##3##3##(2008-5#3)
samples prepared##15##2##(2008-10#11)(2008-5#4)
samples prior to the##2##4##(2008-10#2)
samples prior to##5##3##(2008-10#5)
samples produced##2##2##(1991-12#1)(2008-10#1)
samples provided##5##2##(2008-10#3)(2008-12#2)
samples range from##2##3##(2008-10#2)
samples ranged from 95##2##4##(2008-10#2)
samples ranged from 97##2##4##(2008-10#2)
samples ranged from 99##3##4##(2008-10#3)
samples ranged from##12##3##(2008-10#11)(2013-1#1)
samples ranged##13##2##(2008-10#12)(2013-1#1)
samples remained##2##2##(1996-12#1)(2008-5#1)
samples reported##2##2##(2008-10#1)(2011-2#1)
samples resulted in##2##3##(2008-10#2)
samples revealed that the##2##4##(2008-10#2)
samples revealed##5##2##(2008-10#4)(2009-3#1)
samples show##2##2##(2008-10#2)
samples showed that##2##3##(2008-10#1)(2008-12#1)
samples showed##8##2##(2008-10#6)(2008-12#1)(2008-5#1)
samples simultaneously##3##2##(1997-6#1)(2008-10#2)
samples since the##2##3##(2008-10#2)
samples solubilized##2##2##(2008-10#2)
samples spiked at##2##3##(2008-10#1)(2011-2#1)
samples spiked with known amounts of##2##6##(2008-10#2)
samples spiked with the target##2##5##(2008-10#2)
samples spiked with##27##3##(2008-10#27)
samples spiked##29##2##(2008-10#28)(2011-2#1)
samples studied##9##2##(1991-12#1)(1991-5#1)(1996-12#1)(2008-10#5)(2011-2#1)
samples subjected##2##2##(2008-10#1)(2009-7#1)
samples successfully##2##2##(2008-10#2)
samples such as urine##2##4##(2008-10#2)
samples such as water##2##4##(2008-10#2)
samples such as##16##3##(2008-10#16)
samples taken from an##3##4##(2008-10#3)
samples taken from the##2##4##(2008-10#1)(2008-5#1)
samples taken from##11##3##(1990-8#1)(1990-9#1)(2008-10#8)(2008-5#1)
samples taken##13##2##(1990-8#1)(1990-9#1)(1991-9#1)(2008-10#8)(2008-12#1)(2008-5#1)
samples tested##2##2##(2008-10#1)(2010-5#1)
samples that are##3##3##(2008-10#3)
samples that contain##2##3##(2008-10#2)
samples that have##2##3##(2008-10#2)
samples that were##2##3##(2008-10#1)(2012-3#1)
samples that##19##2##(1997-2#1)(2008-10#16)(2008-12#1)(2012-3#1)
samples the##8##2##(2008-10#6)(2010-12#1)(2010-5#1)
samples through##4##2##(2008-10#4)
samples to be analyzed##2##4##(2008-10#1)(2008-4#1)
samples to be##7##3##(2008-10#3)(2008-12#1)(2008-4#1)(2011-2#2)
samples to determine##4##3##(2008-10#3)(2008-5#1)
samples to the##2##3##(2008-10#1)(2010-6#1)
samples to##25##2##(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
samples treated##3##2##(2008-10#3)
samples under study##2##3##(2008-10#1)(2009-8#1)
samples under ultrasonic effect has been described##2##7##(2008-10#2)
samples under##7##2##(2008-10#5)(2009-8#1)(2013-1#1)
samples underwent##2##2##(2008-12#1)(2011-2#1)
samples used##2##2##(2008-10#2)
samples using a flow injection##2##5##(2008-10#2)
samples using a##6##3##(2008-10#6)
samples using electrothermal atomic absorption spectrometry with##2##7##(2008-10#2)
samples using flow injection##3##4##(2008-10#3)
samples using inductively coupled plasma##2##5##(2008-10#2)
samples using octadecyl##2##3##(2008-10#2)
samples using on-line##2##3##(2008-10#2)
samples using standard##2##3##(2008-10#2)
samples using the proposed##3##4##(2008-10#3)
samples using the##12##3##(2008-10#11)(2013-8#1)
samples using##69##2##(1993-2#1)(1997-2#1)(2008-10#62)(2008-12#1)(2008-5#1)(2009-12#1)(2010-7#1)(2013-8#1)
samples varied##3##2##(2008-10#3)
samples was 0##2##3##(2008-10#2)
samples was also##8##3##(2008-10#7)(2009-8#1)
samples was carried out by##2##5##(2008-10#2)
samples was carried out##5##4##(2008-10#5)
samples was demonstrated##2##3##(2008-10#2)
samples was determined by##3##4##(2008-10#3)
samples was determined##6##3##(2008-10#6)
samples was developed by##2##4##(2008-10#2)
samples was developed##9##3##(2008-10#9)
samples was evaluated##2##3##(2008-10#2)
samples was found to##2##4##(2008-10#2)
samples was found##3##3##(2008-10#3)
samples was investigated##3##3##(2008-10#3)
samples was made##2##3##(2008-10#2)
samples was measured##2##3##(2008-10#2)
samples was performed##4##3##(2008-10#4)
samples was studied##2##3##(2008-10#2)
samples was used##3##3##(2008-10#3)
samples was##96##2##(1990-12#1)(1990-2#1)(1996-12#1)(2008-10#90)(2008-7#1)(2009-11#1)(2009-8#1)
samples were 0##4##3##(2008-10#3)(2008-5#1)
samples were 1##2##3##(2008-10#2)
samples were 4##2##3##(2008-10#2)
samples were almost##2##3##(2008-10#2)
samples were also tested##2##4##(2008-10#2)
samples were also##9##3##(2008-10#9)
samples were analysed by##2##4##(2008-10#2)
samples were analysed with##3##4##(2008-10#2)(2008-11#1)
samples were analysed##9##3##(2008-10#7)(2008-11#1)(2012-6#1)
samples were analyzed by##4##4##(2008-10#2)(2011-2#2)
samples were analyzed for the##2##5##(1997-2#1)(2008-10#1)
samples were analyzed for##5##4##(1997-2#1)(2008-10#4)
samples were analyzed##16##3##(1997-2#1)(2008-10#13)(2011-2#2)
samples were between##6##3##(2008-10#5)(2008-5#1)
samples were classified##2##3##(2008-10#2)
samples were collected for##2##4##(2008-10#1)(2008-12#1)
samples were collected from five##2##5##(2008-10#2)
samples were collected from##12##4##(2008-10#4)(2008-12#2)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)
samples were collected in##2##4##(1996-12#1)(2008-10#1)
samples were collected until##2##4##(2008-10#2)
samples were collected##31##3##(1990-12#1)(1991-6#2)(1993-11#1)(1996-12#1)(1997-2#1)(2008-10#10)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#3)
samples were determined by##4##4##(2008-10#4)
samples were determined with satisfactory results##2##6##(2008-10#2)
samples were determined with##4##4##(2008-10#4)
samples were determined##11##3##(2008-10#11)
samples were digested by##2##4##(2008-10#2)
samples were digested##5##3##(2008-10#5)
samples were diluted##2##3##(2008-10#2)
samples were drawn at baseline##2##5##(2012-3#1)(2013-8#1)
samples were drawn##5##3##(1991-6#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
samples were examined by##2##4##(2011-2#1)(2013-1#1)
samples were examined##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
samples were extracted from##2##4##(2008-10#1)(2011-2#1)
samples were extracted with##3##4##(2008-10#3)
samples were extracted##8##3##(2008-10#6)(2011-2#1)(2011-3#1)
samples were found to contain##2##5##(2008-10#2)
samples were found to##3##4##(2008-10#3)
samples were found##6##3##(2008-10#6)
samples were higher than##2##4##(2008-10#1)(2008-12#1)
samples were in the range##2##5##(2008-10#2)
samples were in##5##3##(2008-10#5)
samples were inoculated##2##3##(2008-5#1)(2012-2#1)
samples were investigated##2##3##(2008-10#1)(2009-7#1)
samples were irradiated##2##3##(2008-10#1)(2008-5#1)
samples were lower than##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
samples were obtained by##2##4##(2008-10#1)(2012-2#1)
samples were obtained from##3##4##(2008-10#2)(2008-12#1)
samples were obtained##11##3##(1995-2#1)(2008-10#6)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
samples were performed##2##3##(2008-10#2)
samples were placed in##2##4##(2008-10#2)
samples were plated in##2##4##(2008-12#1)(2013-1#1)
samples were plated##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
samples were pre-treated with##2##4##(2008-10#2)
samples were prepared using##2##4##(1990-2#1)(2008-10#1)
samples were prepared##4##3##(1990-2#1)(2008-10#3)
samples were quantitative##3##3##(2008-10#3)
samples were spiked with known##3##5##(2008-10#3)
samples were spiked with##4##4##(2008-10#4)
samples were studied##2##3##(2008-10#1)(2008-3#1)
samples were suspended##2##3##(2008-10#2)
samples were taken at##2##4##(2008-10#1)(2013-1#1)
samples were taken for##3##4##(2008-10#1)(2010-1#1)(2012-3#1)
samples were taken from##4##4##(1997-5#1)(2008-10#2)(2011-2#1)
samples were taken##14##3##(1997-5#1)(2008-10#5)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
samples were tested for##3##4##(2008-1#1)(2008-10#1)(2008-5#1)
samples were treated##3##3##(2008-10#3)
samples were used as a##2##5##(2008-10#1)(2008-11#1)
samples were used as##4##4##(2008-10#3)(2008-11#1)
samples were used to##3##4##(2008-10#3)
samples were used##9##3##(1996-12#1)(2008-10#6)(2008-11#1)(2012-12#1)
samples were##307##2##(1990-12#2)(1990-2#1)(1991-6#3)(1992-12#1)(1993-11#1)(1995-2#1)(1996-12#4)(1997-2#3)(1997-5#1)(2008-1#3)(2008-10#213)(2008-11#5)(2008-12#11)(2008-2#1)(2008-3#2)(2008-5#7)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-4#3)(2010-6#3)(2010-8#1)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#8)(2013-8#6)
samples when##4##2##(1996-12#1)(2008-10#2)(2008-3#1)
samples whereas##2##2##(2008-10#1)(2010-5#1)
samples which##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
samples while##2##2##(2008-10#2)
samples with a recovery range of##2##6##(2008-10#2)
samples with a recovery##3##4##(2008-10#3)
samples with a##20##3##(2008-10#17)(2008-11#1)(2008-5#1)(2012-2#1)
samples with an##2##3##(2008-10#2)
samples with and without##2##4##(2008-10#1)(2008-5#1)
samples with different##6##3##(2008-10#6)
samples with respect to##2##4##(2008-10#1)(2010-12#1)
samples with satisfactory results##22##4##(2008-10#22)
samples with satisfactory##24##3##(2008-10#24)
samples with satisfied results##2##4##(2008-10#2)
samples with the##3##3##(2008-10#2)(2008-11#1)
samples with this##2##3##(2008-10#2)
samples with unknown##2##3##(2008-10#1)(2008-11#1)
samples with very##2##3##(1994-11#1)(2008-10#1)
samples with##126##2##(1990-2#1)(1994-11#1)(1997-2#1)(2008-10#106)(2008-11#4)(2008-4#2)(2008-5#3)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
samples within the##2##3##(2008-10#1)(2008-6#1)
samples without any##3##3##(2008-10#3)
samples without previous##2##3##(2008-10#2)
samples without##10##2##(2008-10#10)
samples##3430##1##(1990-12#7)(1990-2#6)(1990-3#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#8)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#3)(1991-9#2)(1992-11#2)(1992-12#4)(1992-3#6)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#5)(1994-1#1)(1994-11#2)(1994-5#4)(1994-8#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-8#1)(1996-12#29)(1996-2#2)(1996-6#2)(1997-2#11)(1997-3#2)(1997-5#1)(1997-6#2)(2008-1#5)(2008-10#2781)(2008-11#60)(2008-12#52)(2008-2#4)(2008-3#8)(2008-4#23)(2008-5#59)(2008-6#7)(2008-7#9)(2008-8#5)(2008-9#29)(2009-11#4)(2009-12#7)(2009-3#2)(2009-4#9)(2009-6#3)(2009-7#6)(2009-8#6)(2010-1#4)(2010-10#1)(2010-11#5)(2010-12#4)(2010-4#11)(2010-5#4)(2010-6#10)(2010-7#3)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#53)(2011-3#5)(2012-12#10)(2012-2#25)(2012-3#14)(2012-6#1)(2013-1#37)(2013-8#24)
samples) was##2##2##(2008-10#1)(2011-2#1)
samples)##17##1##(2008-10#13)(2010-12#3)(2011-2#1)
samples/h##5##1##(2008-10#5)
samplesh(-1)##6##1##(2008-10#6)
sampling ETAAS method##2##3##(2008-10#2)
sampling ETAAS##6##2##(2008-10#6)
sampling a##3##2##(2008-10#3)
sampling and analysis##2##3##(2008-10#2)
sampling and the##4##3##(1996-3#1)(2008-10#3)
sampling and washing##5##3##(2008-10#5)
sampling and##36##2##(1992-12#1)(1995-2#1)(1996-3#2)(2008-10#28)(2008-11#1)(2008-3#1)(2011-2#2)
sampling approach##2##2##(2008-10#1)(2011-2#1)
sampling are##4##2##(2008-10#3)(2008-11#1)
sampling arm##5##2##(2008-10#5)
sampling at##4##2##(2008-10#1)(2009-1#1)(2010-8#1)(2013-1#1)
sampling bias##2##2##(1993-9#1)(2008-10#1)
sampling bout##5##2##(2008-10#2)(2008-8#3)
sampling bouts##3##2##(2008-8#3)
sampling by##3##2##(2008-10#3)
sampling date##6##2##(1996-12#1)(2008-10#4)(2012-8#1)
sampling dates##7##2##(2008-10#6)(2013-8#1)
sampling design in##2##3##(1996-3#1)(2008-10#1)
sampling design##4##2##(1996-3#1)(2008-10#2)(2011-2#1)
sampling designs##2##2##(2008-10#1)(2010-11#1)
sampling device##3##2##(2008-10#2)(2012-2#1)
sampling distribution##3##2##(2008-10#3)
sampling electrothermal atomic absorption spectrometry##5##5##(2008-10#5)
sampling electrothermal atomic absorption##6##4##(2008-10#6)
sampling electrothermal##9##2##(2008-10#9)
sampling for##9##2##(1996-12#1)(2008-10#8)
sampling frequency is##5##3##(2008-10#4)(2012-2#1)
sampling frequency of 30 h(-1)##2##5##(2008-10#2)
sampling frequency of 40h(-1)##2##4##(2008-10#2)
sampling frequency of 50##2##4##(2008-10#2)
sampling frequency of 60 h(-1)##2##5##(2008-10#2)
sampling frequency of the system was##2##6##(2008-10#2)
sampling frequency of##33##3##(2008-10#31)(2010-9#1)(2013-1#1)
sampling frequency was##8##3##(2008-10#8)
sampling frequency##55##2##(2008-10#52)(2010-9#1)(2012-2#1)(2013-1#1)
sampling from##5##2##(1995-2#1)(2008-10#3)(2013-8#1)
sampling graphite furnace atomic absorption spectrometry##3##6##(2008-10#3)
sampling in##7##2##(1996-3#1)(2008-10#3)(2008-2#1)(2011-3#1)(2013-1#1)
sampling interval##2##2##(2008-3#1)(2011-2#1)
sampling is##9##2##(1990-2#1)(1996-3#2)(2008-10#3)(2008-8#1)(2010-11#2)
sampling loop##2##2##(2008-10#2)
sampling method used##2##3##(2008-1#1)(2008-10#1)
sampling method##5##2##(2008-1#1)(2008-10#3)(2013-1#1)
sampling methods for##5##3##(2008-10#3)(2009-4#1)(2010-11#1)
sampling methods##16##2##(1992-12#1)(2008-10#11)(2008-5#1)(2009-4#1)(2010-11#1)(2013-8#1)
sampling models##2##2##(2008-10#2)
sampling of a##3##3##(2008-10#2)(2008-8#1)
sampling of the##3##3##(1996-12#1)(2008-10#2)
sampling of##32##2##(1995-8#1)(1996-12#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#2)
sampling period##3##2##(2008-10#3)
sampling periods##3##2##(2008-10#2)(2008-12#1)
sampling plan##2##2##(2008-10#2)
sampling points##2##2##(2008-10#2)
sampling procedure##6##2##(2008-10#5)(2010-5#1)
sampling procedures##3##2##(2008-10#3)
sampling programs##2##2##(2008-10#2)
sampling protocol was##2##3##(2008-10#2)
sampling pulse##2##2##(2008-2#2)
sampling rate for##2##3##(2008-10#1)(2012-2#1)
sampling rate of 120##2##4##(2008-10#2)
sampling rate of 30##3##4##(2008-10#3)
sampling rate of 40##2##4##(2008-10#2)
sampling rate of 60##4##4##(2008-10#4)
sampling rate of about##5##4##(2008-10#5)
sampling rate of##29##3##(2008-10#29)
sampling rate was about##2##4##(2008-10#2)
sampling rate was##11##3##(2008-10#11)
sampling rate##53##2##(2007-12#2)(2008-10#50)(2012-2#1)
sampling rates of##3##3##(2008-10#3)
sampling rates##8##2##(2008-10#8)
sampling scheme##3##2##(2008-10#2)(2010-3#1)
sampling schemes##4##2##(2008-10#4)
sampling seasons##3##2##(2008-10#3)
sampling site##4##2##(2008-10#3)(2008-11#1)
sampling sites##7##2##(2008-10#6)(2011-2#1)
sampling spinning rates##2##3##(2008-10#2)
sampling strategies##3##2##(2008-10#2)(2008-6#1)
sampling strategy##2##2##(2008-10#1)(2013-8#1)
sampling system##7##2##(2008-10#5)(2008-12#1)(2008-8#1)
sampling systems##3##2##(2008-10#1)(2008-11#2)
sampling technique##7##2##(2008-10#6)(2013-1#1)
sampling techniques##5##2##(1992-2#1)(2008-10#4)
sampling the##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
sampling time and##2##3##(2008-10#2)
sampling time##9##2##(2008-10#9)
sampling times##6##2##(2008-10#4)(2010-1#1)(2013-8#1)
sampling to##5##2##(1995-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
sampling unit##5##2##(2008-10#5)
sampling units observed in each##2##5##(2008-10#2)
sampling units were##2##3##(2008-10#1)(2011-2#1)
sampling units##19##2##(2008-10#18)(2011-2#1)
sampling using##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
sampling variance##5##2##(2008-10#4)(2008-8#1)
sampling volume##7##2##(2008-10#4)(2008-3#3)
sampling was performed##3##3##(2008-5#3)
sampling was used to##2##4##(2008-10#1)(2012-12#1)
sampling was##10##2##(1996-12#1)(2008-10#2)(2008-5#3)(2011-2#1)(2012-12#2)(2013-1#1)
sampling with a##2##3##(2008-10#1)(2012-7#1)
sampling with##4##2##(1991-10#1)(2008-10#2)(2012-7#1)
sampling year##2##2##(2008-10#2)
sampling zone##2##2##(2008-11#2)
sampling##644##1##(1990-2#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-11#1)(1993-9#1)(1994-9#1)(1995-2#2)(1995-8#1)(1995-9#3)(1996-12#8)(1996-3#12)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#473)(2008-11#16)(2008-12#5)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#15)(2008-9#2)(2009-1#1)(2009-4#2)(2010-1#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#3)(2012-7#1)(2012-8#2)(2013-1#10)(2013-8#6)
sampling-electrothermal##2##1##(2008-10#2)
sampling-graphite furnace atomic absorption spectrometry##2##5##(2008-10#2)
sampling-unit##4##1##(2008-10#4)
samplings##5##1##(2008-10#5)
san##2##1##(1990-11#1)(1995-11#1)
sanA is##3##2##(2008-9#3)
sanA##6##1##(2008-9#6)
sanctions that##2##2##(1991-2#2)
sanctions##6##1##(1991-1#1)(1991-2#3)(1992-1#1)(2008-11#1)
sand + silt + leaf mold##2##6##(2008-12#2)
sand + silt##3##3##(2008-12#3)
sand +##4##2##(2008-12#4)
sand and##2##2##(2008-10#2)
sand flies##10##2##(2008-12#6)(2013-1#4)
sand fly##3##2##(2008-12#1)(2010-1#1)(2012-2#1)
sand sample##2##2##(2008-10#1)(2008-3#1)
sand soil##2##2##(2008-10#2)
sand##45##1##(1991-12#1)(2007-12#1)(2008-10#17)(2008-12#12)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)(2013-1#4)
sandgobies##2##1##(2008-8#2)
sandwich ELISA##4##2##(1992-12#1)(2008-11#1)(2010-12#2)
sandwich assay##2##2##(2008-10#2)
sandwich enzyme-linked immunosorbent assay##7##4##(1995-11#2)(2008-10#5)
sandwich hybridization assay##2##3##(2008-10#2)
sandwich immunoassay##2##2##(2008-10#2)
sandwich##37##1##(1992-12#1)(1993-2#1)(1995-11#2)(2008-10#30)(2008-11#1)(2010-12#2)
sandwich-enzyme-linked immunosorbent assay##2##3##(2008-10#2)
sandwich-type##5##1##(2008-10#4)(2008-6#1)
sandwiched between##2##2##(1993-3#1)(1995-8#1)
sandwiched by##2##2##(1994-5#1)(2008-10#1)
sandwiched##4##1##(1993-3#1)(1994-5#1)(1995-8#1)(2008-10#1)
sandy loam field soil were larger##2##6##(2008-10#2)
sandy loam##7##2##(2008-10#6)(2011-1#1)
sandy soils##3##2##(2008-10#3)
sandy##18##1##(2008-10#14)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
sandyi##2##1##(2008-10#2)
sanguinalis and##2##2##(2008-10#2)
sanguinarine##7##1##(2008-10#3)(2011-2#4)
sanguinea##2##1##(2008-10#2)
sanguis##4##1##(2006-6#2)(2008-5#2)
sanitary workers##2##2##(2009-12#2)
sanitary##7##1##(2009-12#3)(2011-2#2)(2012-12#2)
sanitation and##2##2##(2008-10#1)(2013-8#1)
sanitation practices##2##2##(2008-10#2)
sanitation##15##1##(1994-9#1)(2008-10#9)(2008-7#1)(2009-12#1)(2010-1#1)(2012-2#1)(2013-8#1)
sanofi##2##1##(2013-1#2)
sans##4##1##(1997-6#3)(2013-1#1)
sap inoculation from infected##2##4##(2008-10#2)
sap##9##1##(2007-12#1)(2008-10#5)(2008-11#1)(2009-8#1)(2012-8#1)
saphenofemoral##2##1##(2013-1#2)
saphenous vein##5##2##(1990-9#1)(1991-6#1)(2006-6#1)(2008-7#1)(2011-2#1)
saphenous##9##1##(1990-9#1)(1991-6#2)(1997-3#2)(2006-6#1)(2008-7#1)(2011-2#2)
sapinea DNA##2##2##(2008-10#2)
sapinea infections in##2##3##(2008-10#2)
sapinea##11##1##(2008-10#11)
sapling crown##2##2##(2008-9#2)
sapling##4##1##(2008-9#4)
saplings##5##1##(2008-9#1)(2012-5#3)(2012-9#1)
saponification by lead salts##2##4##(2008-10#2)
saponification##4##1##(2008-10#3)(2008-5#1)
saponified##2##1##(2008-10#2)
saponin##7##1##(1995-8#3)(2006-6#1)(2008-10#1)(2008-11#2)
saponins##11##1##(2008-10#1)(2008-11#4)(2008-5#1)(2010-2#1)(2011-3#2)(2013-8#2)
sapphire laser in##2##3##(2008-2#1)(2008-3#1)
sapphire laser##10##2##(2007-11#1)(2008-2#4)(2008-3#5)
sapphire##25##1##(1991-1#1)(1993-1#2)(2007-11#1)(2008-10#2)(2008-2#5)(2008-3#13)(2008-7#1)
sapphire-fiber##3##1##(2008-10#3)
sapphyrin##2##1##(2008-10#2)
saprophyte##3##1##(2008-10#2)(2008-9#1)
saprophytes and nonpathogens##2##3##(2008-10#2)
saprophytes and##3##2##(2008-10#3)
saprophytes##6##1##(2008-10#6)
saprophytic ability##2##2##(2008-10#2)
saprophytic fungal##2##2##(2008-10#2)
saprophytic phase##2##2##(2008-10#2)
saprophytic##20##1##(2008-10#18)(2008-9#1)(2011-2#1)
saprophytically##2##1##(2008-10#2)
sapstain fungi##2##2##(2008-10#2)
sapstain fungus##2##2##(2008-10#2)
sapstain##12##1##(2008-10#12)
sapstaining##2##1##(2008-10#2)
sapwood##6##1##(2008-10#6)
sarcoid##2##1##(2008-11#1)(2008-7#1)
sarcoidosis##9##1##(1994-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-6#3)(2012-3#1)
sarcoiliac joint##2##2##(2010-1#2)
sarcolemmal vesicles##2##2##(1991-5#2)
sarcolemmal##3##1##(1991-5#3)
sarcoma and##3##2##(1992-12#1)(2011-2#1)(2011-3#1)
sarcoma in##2##2##(2011-2#1)(2013-1#1)
sarcoma of the breast##3##4##(1992-2#3)
sarcoma of the##11##3##(1990-2#1)(1991-11#1)(1992-12#1)(1992-2#3)(1993-8#1)(2011-2#2)(2013-1#2)
sarcoma of##14##2##(1990-2#1)(1991-11#1)(1992-12#1)(1992-2#3)(1993-8#1)(2008-1#1)(2009-5#1)(2011-2#2)(2013-1#3)
sarcoma virus##6##2##(1995-6#2)(1997-8#1)(2008-11#2)(2008-9#1)
sarcoma with myxoid##2##3##(1993-2#2)
sarcoma with##3##2##(1990-6#1)(1993-2#2)
sarcoma##53##1##(1990-11#1)(1990-2#2)(1990-6#2)(1990-8#3)(1991-11#2)(1991-8#2)(1992-12#6)(1992-2#3)(1993-2#3)(1993-8#1)(1994-12#1)(1995-6#2)(1997-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-9#2)(2009-5#1)(2011-2#7)(2011-3#1)(2012-3#2)(2013-1#7)
sarcoma-like##2##1##(1993-2#1)(2012-3#1)
sarcomas##12##1##(1990-12#1)(1991-11#1)(1992-12#3)(1992-9#1)(1993-9#1)(1994-6#1)(2010-12#1)(2011-2#2)(2013-1#1)
sarcomatoid##3##1##(2011-2#1)(2012-3#2)
sarcomatous##4##1##(1994-5#1)(1994-6#1)(2011-2#2)
sarcomere length##2##2##(2010-4#1)(2013-1#1)
sarcomere##3##1##(2008-6#1)(2010-4#1)(2013-1#1)
sarcomeric##2##1##(2008-7#1)(2008-9#1)
sarcoplasmic reticulum (SR)##5##3##(1994-8#1)(1995-6#1)(2008-11#1)(2008-8#2)
sarcoplasmic reticulum##14##2##(1990-2#2)(1991-9#1)(1994-8#1)(1995-6#2)(2008-11#1)(2008-8#4)(2009-7#2)(2013-8#1)
sardous plots##2##2##(2008-10#2)
sardous##5##1##(2008-10#5)
sarin##3##1##(2008-11#3)
sarkosyl treatment##2##2##(1990-7#2)
sarkosyl##3##1##(1990-7#3)
sarson##2##1##(2011-1#2)
satDNA##2##1##(2008-10#2)
satRNA variants##2##2##(2008-10#2)
satRNA##9##1##(2008-10#9)
satRNA-free##2##1##(2008-10#2)
satRNAs from##2##2##(2008-10#2)
satRNAs##13##1##(2008-10#13)
satellite DNA##9##2##(1997-6#2)(2008-10#1)(2008-8#2)(2010-8#4)
satellite DNAs##3##2##(2008-10#2)(2010-8#1)
satellite RNA##6##2##(2008-10#6)
satellite RNAs##3##2##(2008-10#3)
satellite cell##2##2##(1993-3#1)(2008-7#1)
satellite cells##7##2##(1993-3#2)(1995-12#2)(2008-11#2)(2008-7#1)
satellite##60##1##(1993-12#2)(1993-3#3)(1994-1#2)(1995-12#2)(1997-3#1)(1997-6#3)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#10)(2008-7#3)(2008-8#3)(2010-8#5)(2012-3#1)
satellites and##3##2##(2008-8#3)
satellites##9##1##(2008-10#1)(2008-7#1)(2008-8#7)
satiating##2##1##(2012-2#2)
satin##2##1##(2008-8#2)
satisfaction among##5##2##(1992-1#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
satisfaction and efficacy##3##3##(1995-2#3)
satisfaction and psychological##2##3##(2008-11#1)(2011-2#1)
satisfaction and the##2##3##(1991-2#1)(2008-11#1)
satisfaction and##27##2##(1991-2#2)(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#3)(1996-1#2)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-2#4)(2013-1#3)
satisfaction data##3##2##(1996-1#1)(1997-2#1)(1997-3#1)
satisfaction during##2##2##(2010-2#2)
satisfaction for##2##2##(1990-12#1)(2011-2#1)
satisfaction in##6##2##(1993-11#1)(1993-12#2)(1997-1#1)(2008-9#1)(2010-10#1)
satisfaction is##6##2##(1994-12#2)(2008-11#1)(2008-7#1)(2010-10#2)
satisfaction measures##2##2##(1997-2#1)(2010-2#1)
satisfaction of the##3##3##(1991-1#1)(1992-1#1)(1994-5#1)
satisfaction of##9##2##(1991-1#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-5#1)(1994-5#1)(1995-3#1)(2010-11#1)(2010-2#1)
satisfaction survey##2##2##(1993-1#1)(1995-3#1)
satisfaction surveys##3##2##(1994-12#1)(1994-3#1)(1996-2#1)
satisfaction than##2##2##(1997-1#1)(2013-1#1)
satisfaction was##5##2##(1995-3#1)(1996-3#1)(2008-11#1)(2009-5#1)(2012-2#1)
satisfaction were found##2##3##(2008-11#1)(2010-10#1)
satisfaction were##8##2##(1992-1#1)(1992-3#1)(1996-3#1)(2008-11#1)(2009-3#1)(2009-5#1)(2010-10#1)(2013-1#1)
satisfaction with care##4##3##(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#1)
satisfaction with cessation##2##3##(2010-2#2)
satisfaction with clinical##2##3##(2008-11#2)
satisfaction with pain treatment##2##4##(2009-12#2)
satisfaction with radiology##2##3##(1993-1#1)(2012-2#1)
satisfaction with the TEMPO+##2##4##(2008-9#2)
satisfaction with the##9##3##(1993-12#1)(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-10#1)(2013-1#1)(2013-8#1)
satisfaction with##39##2##(1993-1#1)(1993-12#4)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#5)(2009-12#3)(2010-10#1)(2010-2#3)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
satisfaction##208##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#7)(1991-3#2)(1992-1#7)(1992-12#1)(1992-3#3)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#11)(1993-2#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#6)(1995-2#8)(1995-3#4)(1996-1#5)(1996-2#7)(1996-3#4)(1997-1#5)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#4)(2008-11#17)(2008-12#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#4)(2009-3#1)(2009-5#5)(2009-6#1)(2010-10#9)(2010-11#3)(2010-2#11)(2010-8#3)(2011-2#9)(2012-12#1)(2012-2#8)(2013-1#11)(2013-8#3)
satisfaction)##2##1##(2008-7#1)(2013-1#1)
satisfaction]##2##1##(1994-6#1)(1996-11#1)
satisfactorily applied for the##4##4##(2008-10#4)
satisfactorily applied to the determination of##12##6##(2008-10#12)
satisfactorily applied to the##15##4##(2008-10#15)
satisfactorily applied to##19##3##(2008-10#19)
satisfactorily applied##24##2##(2008-10#24)
satisfactorily for the determination of##2##5##(2008-10#2)
satisfactorily for##4##2##(2008-10#4)
satisfactorily in the##4##3##(2008-10#3)(2011-2#1)
satisfactorily in##6##2##(1995-6#1)(2008-10#4)(2011-2#1)
satisfactorily predicted##2##2##(2008-10#1)(2008-7#1)
satisfactorily to##16##2##(2008-10#16)
satisfactorily used##3##2##(2008-10#3)
satisfactorily with those##2##3##(2008-10#2)
satisfactorily with##3##2##(2008-10#3)
satisfactorily##88##1##(1990-11#1)(1991-1#1)(1993-3#1)(1995-6#1)(1997-3#2)(2008-10#75)(2008-11#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
satisfactory accuracy and precision in the presence of excess##2##9##(2008-10#2)
satisfactory accuracy and precision in the presence of##3##8##(2008-10#3)
satisfactory accuracy and precision##5##4##(2008-10#5)
satisfactory agreement##5##2##(2008-10#4)(2008-3#1)
satisfactory and##5##2##(2008-10#2)(2012-2#2)(2013-1#1)
satisfactory clinical##2##2##(2011-2#1)(2013-1#1)
satisfactory evolution##2##2##(1991-11#1)(2013-8#1)
satisfactory for the##3##3##(1992-3#1)(2008-10#2)
satisfactory for##10##2##(1992-3#1)(2008-10#8)(2008-7#1)
satisfactory in two (10%)##3##4##(1996-9#3)
satisfactory in##11##2##(1991-2#1)(1996-11#1)(1996-9#3)(1997-8#1)(2008-10#2)(2008-7#1)(2011-2#2)
satisfactory performance##3##2##(2008-10#3)
satisfactory precision##4##2##(2008-10#4)
satisfactory recovery##4##2##(2008-10#4)
satisfactory reproducibility##2##2##(2008-10#2)
satisfactory result##3##2##(2008-10#3)
satisfactory results and##3##3##(2008-10#3)
satisfactory results in##6##3##(1994-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2010-12#1)
satisfactory results on##2##3##(2008-10#2)
satisfactory results were obtained##2##4##(2008-10#2)
satisfactory results were##3##3##(2008-10#2)(2011-2#1)
satisfactory results with##2##3##(1992-9#1)(2008-10#1)
satisfactory results##105##2##(1990-12#1)(1992-9#1)(1994-3#1)(1997-4#1)(2007-8#1)(2008-10#90)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#1)
satisfactory separation of##2##3##(2008-10#2)
satisfactory to##3##2##(2008-10#3)
satisfactory with##3##2##(1991-11#1)(2008-10#2)
satisfactory##269##1##(1990-12#1)(1990-5#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#2)(1995-2#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#4)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#191)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#7)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
satisfactory&quot##2##1##(1993-2#2)
satisfied by the##2##3##(1992-3#1)(2008-11#1)
satisfied by##4##2##(1990-6#1)(1992-3#1)(2008-11#2)
satisfied customers##2##2##(1992-1#1)(1993-1#1)
satisfied for##2##2##(2008-10#1)(2008-8#1)
satisfied than the##2##3##(1996-2#1)(2009-11#1)
satisfied than##5##2##(1996-2#2)(2009-11#1)(2012-2#2)
satisfied with the treatment##2##4##(2008-9#1)(2013-1#1)
satisfied with the##11##3##(1991-1#1)(1991-2#1)(1994-1#1)(1995-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#1)(2013-1#1)
satisfied with their bodies##3##4##(2009-5#2)(2010-10#1)
satisfied with their##4##3##(1996-2#1)(2009-5#2)(2010-10#1)
satisfied with this##2##3##(1990-2#1)(1991-1#1)
satisfied with##19##2##(1990-2#1)(1991-1#2)(1991-2#1)(1994-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-11#1)(2009-5#2)(2010-10#1)(2011-2#2)(2013-1#1)
satisfied##44##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-2#2)(1992-1#1)(1992-3#2)(1993-1#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#3)(2009-11#2)(2009-5#2)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
satisfies the##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2013-1#1)
satisfies##9##1##(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
satisfy the##13##2##(1994-12#1)(1994-2#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-8#2)(2012-2#1)(2013-1#1)
satisfy##23##1##(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
satisfying the##3##2##(1993-12#1)(2008-7#1)(2008-9#1)
satisfying##9##1##(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
sativa L##26##2##(1994-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-8#3)(2008-9#13)(2012-3#1)
sativa ssp##4##2##(2008-9#1)(2009-10#3)
sativa##46##1##(1994-11#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-8#3)(2008-9#20)(2009-10#6)(2012-3#1)
sativa)##13##1##(2008-10#12)(2009-10#1)
sativum##4##1##(2008-10#3)(2011-2#1)
sativum) and##2##2##(2008-1#1)(2008-10#1)
sativum)##4##1##(2008-1#1)(2008-10#3)
sativus L##2##2##(2008-10#1)(2008-12#1)
sativus and##5##2##(2008-10#5)
sativus isolates##2##2##(2008-10#2)
sativus##24##1##(2008-10#23)(2008-12#1)
sativus)##9##1##(2008-10#8)(2011-2#1)
saturable absorber##7##2##(2007-12#1)(2008-3#6)
saturable and reversible##2##3##(1990-11#1)(1990-8#1)
saturable and##7##2##(1990-11#1)(1990-8#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)
saturable##28##1##(1990-11#2)(1990-8#2)(1991-12#1)(1992-3#3)(1993-1#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-2#1)(2007-12#2)(2008-3#8)
saturable-absorber mirror##2##2##(2008-3#2)
saturate##5##1##(1992-10#1)(2008-10#1)(2008-3#3)
saturated absorption##2##2##(2008-3#2)
saturated calomel electrode##2##3##(2008-10#2)
saturated calomel reference electrode##3##4##(2008-10#3)
saturated calomel##5##2##(2008-10#5)
saturated esters on##2##3##(2008-10#2)
saturated fat##2##2##(2008-10#1)(2010-4#1)
saturated fatty acid##2##3##(1990-8#1)(1995-11#1)
saturated fatty acids was##2##4##(2008-11#2)
saturated fatty acids were##2##4##(1994-8#1)(2009-8#1)
saturated fatty acids##5##3##(1991-12#1)(1994-8#1)(2008-11#2)(2009-8#1)
saturated fatty##8##2##(1990-8#1)(1991-12#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#2)(2009-8#1)
saturated with##4##2##(1996-3#1)(2008-10#2)(2008-2#1)
saturated##65##1##(1990-8#1)(1991-12#1)(1992-3#1)(1994-8#2)(1995-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#28)(2008-11#5)(2008-2#1)(2008-3#9)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#4)
saturates##4##1##(2008-10#1)(2008-3#2)(2013-8#1)
saturating##8##1##(1990-10#1)(1990-2#1)(1991-5#1)(1993-6#1)(1995-11#1)(2008-3#1)(2008-8#2)
saturation (SpO2)##2##2##(1993-1#2)
saturation and excited-state absorption##2##4##(2008-3#2)
saturation and predominant in the##2##5##(1990-5#2)
saturation and##5##2##(1990-5#2)(1995-12#1)(2008-3#2)
saturation as##2##2##(2008-3#1)(2008-8#1)
saturation capacity##2##2##(2008-10#2)
saturation during##2##2##(1993-1#1)(1997-8#1)
saturation experiments##2##2##(1993-6#1)(1996-2#1)
saturation fluence##2##2##(2008-3#2)
saturation in##5##2##(2008-3#3)(2008-7#1)(2010-10#1)
saturation intensity##2##2##(2008-3#2)
saturation is##3##2##(1994-5#1)(1997-6#1)(2008-3#1)
saturation mutagenesis##2##2##(2011-1#2)
saturation of the##5##3##(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#1)
saturation of##11##2##(1994-5#1)(2008-10#4)(2008-3#2)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
saturation on the##3##3##(2008-3#3)
saturation was##2##2##(1991-5#1)(2008-11#1)
saturation##92##1##(1990-5#2)(1990-8#2)(1991-5#2)(1991-6#1)(1992-3#3)(1993-1#3)(1993-6#1)(1994-5#4)(1995-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-3#22)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#1)(2010-10#6)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#2)
saturatus##2##1##(2010-3#2)
saturnus##2##1##(1993-12#2)
sauce##5##1##(2008-10#2)(2010-4#3)
sausages##4##1##(2008-10#1)(2010-4#3)
savastanoi##7##1##(2008-10#7)
save money for##2##3##(1994-3#1)(2008-6#1)
save money##3##2##(1994-3#1)(1995-1#1)(2008-6#1)
save the patient's life##2##4##(1990-5#1)(2010-5#1)
save the##8##2##(1990-5#1)(1997-7#1)(2008-11#1)(2008-9#2)(2010-5#1)(2010-8#1)(2011-2#1)
save women's##2##2##(1997-5#1)(2008-11#1)
save##28##1##(1990-5#1)(1991-8#1)(1994-2#2)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-5#1)(2010-8#2)(2011-2#1)
saved by##2##2##(2008-6#1)(2008-8#1)
saved##10##1##(1992-2#1)(1993-8#1)(1997-3#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#2)
saves##2##1##(1994-12#1)(2008-10#1)
saving of##3##2##(1992-3#1)(2008-10#2)
saving the##2##2##(1990-3#1)(2008-12#1)
saving##16##1##(1990-11#1)(1990-3#1)(1992-3#1)(1994-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
savings and##2##2##(1992-2#1)(1994-2#1)
savings are##2##2##(1992-2#1)(1995-2#1)
savings for##3##2##(1991-1#1)(1995-2#1)(1997-2#1)
savings from##3##2##(1992-2#1)(2008-11#2)
savings in##6##2##(1991-1#1)(1994-9#1)(1997-2#1)(2008-10#2)(2008-11#1)
savings of##7##2##(1992-2#1)(1994-12#1)(1994-9#1)(1995-2#1)(2008-10#3)
savings on##2##2##(1992-1#1)(1992-2#1)
savings targets##2##2##(1995-1#2)
savings through##2##2##(1995-1#1)(1995-2#1)
savings to##2##2##(1993-12#1)(1994-6#1)
savings##51##1##(1991-1#2)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#9)(1992-8#1)(1993-12#2)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-1#3)(1995-2#6)(1996-1#2)(1997-1#1)(1997-2#2)(2008-1#2)(2008-10#6)(2008-11#4)(2008-5#1)(2013-1#1)
saw the##3##2##(1992-1#1)(1993-2#1)(1997-2#1)
saw##14##1##(1990-11#1)(1992-1#1)(1993-2#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)
sawB##6##1##(2008-8#6)
sawdust##7##1##(2008-12#4)(2008-9#1)(2013-1#2)
sawmills##2##1##(2008-10#1)(2008-12#1)
say a##2##2##(1992-11#2)
say that##4##2##(1991-3#1)(1997-6#1)(2008-7#1)(2012-3#1)
say the##2##2##(1996-5#1)(2011-2#1)
say##18##1##(1991-3#1)(1991-6#1)(1992-11#2)(1992-8#2)(1995-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
saying##6##1##(1992-2#1)(1993-2#1)(1994-1#1)(1995-6#2)(1996-5#1)
says that##2##2##(2009-10#2)
says the author##6##3##(1991-3#1)(1993-2#2)(1994-12#2)(1994-2#1)
says##20##1##(1991-3#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#1)(1996-12#2)(1996-5#1)(2008-1#1)(2008-11#1)(2009-10#2)(2010-12#1)
sb=0##2##1##(2013-1#2)
sc##4##1##(1990-8#2)(2008-10#2)
scFv M97 transfection##2##3##(2008-8#2)
scFv M97##3##2##(2008-8#3)
scFv fusion proteins were##3##4##(2008-10#3)
scFv fusion proteins##4##3##(2008-10#4)
scFv in##2##2##(2008-10#2)
scFv is##2##2##(2008-10#1)(2009-9#1)
scFv were##3##2##(2008-10#3)
scFv##22##1##(1993-8#1)(2008-10#16)(2008-4#1)(2008-8#3)(2009-9#1)
scFvC(L) fusion proteins##3##3##(2008-10#3)
scFvC(L)##4##1##(2008-10#4)
scFvs##2##1##(2008-10#2)
scab (Venturia inaequalis)##2##3##(2008-10#2)
scab and##3##2##(2008-10#3)
scab development##2##2##(2008-10#2)
scab in the##2##3##(2008-10#2)
scab in##4##2##(2008-10#4)
scab is a##2##3##(2008-10#2)
scab is##3##2##(2008-10#3)
scab lesions##4##2##(1991-11#1)(2008-10#3)
scab on##2##2##(2008-10#2)
scab pathogen)##2##2##(2008-10#2)
scab resistance genes##3##3##(2008-10#3)
scab resistance##12##2##(2008-10#12)
scab severity##5##2##(2008-10#5)
scab symptoms##2##2##(2008-10#2)
scab##63##1##(1991-11#1)(2008-10#61)(2008-11#1)
scab-causing streptomycetes##2##2##(2008-10#2)
scabbed##2##1##(2008-10#2)
scabies ATCC##2##2##(2008-10#2)
scabies in##4##2##(1997-5#1)(2008-12#1)(2010-6#2)
scabies##26##1##(1991-2#1)(1996-12#4)(1997-5#1)(2008-10#12)(2008-12#3)(2010-2#1)(2010-6#4)
scabra 'Fitzroy'##2##2##(2008-10#2)
scabra##5##1##(2008-10#4)(2010-2#1)
scaffold fabrication##4##2##(2010-9#4)
scaffold for##5##2##(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)
scaffold of##2##2##(2007-12#1)(2009-7#1)
scaffold that##2##2##(2009-8#1)(2012-2#1)
scaffold to enhance##2##3##(2008-9#1)(2009-12#1)
scaffold to##3##2##(2008-9#1)(2009-12#2)
scaffold##37##1##(1995-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#2)(2009-7#7)(2009-8#2)(2010-9#6)(2011-2#2)(2012-2#5)(2013-1#2)
scaffold-associated region (SAR)##2##3##(2008-8#2)
scaffold-free##3##1##(2011-2#3)
scaffolding material##2##2##(2009-12#1)(2009-7#1)
scaffolding##8##1##(1993-2#1)(2008-11#2)(2009-12#1)(2009-7#3)(2013-1#1)
scaffolds and##4##2##(2010-9#1)(2012-4#1)(2012-5#1)(2013-1#1)
scaffolds for##2##2##(2009-7#2)
scaffolds have##2##2##(2009-7#2)
scaffolds in##2##2##(2009-7#1)(2011-2#1)
scaffolds is##2##2##(2010-9#1)(2011-2#1)
scaffolds seeded using the##2##4##(2011-2#2)
scaffolds that##2##2##(2008-11#1)(2009-7#1)
scaffolds were##6##2##(2009-7#1)(2011-2#1)(2012-2#4)
scaffolds##48##1##(2008-11#2)(2008-9#1)(2009-12#1)(2009-7#17)(2010-10#1)(2010-9#3)(2011-2#9)(2011-3#1)(2012-2#9)(2012-3#1)(2012-4#1)(2012-5#1)(2013-1#1)
scalability##3##1##(2008-11#1)(2008-3#1)(2012-3#1)
scalable##7##1##(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-10#1)
scalar##5##1##(2008-3#5)
scald##6##1##(2008-10#6)
scale (e##3##2##(2008-10#2)(2013-1#1)
scale (proportion of sampling units with one or more diseased##2##10##(2008-10#2)
scale according to##2##3##(2008-10#1)(2012-3#1)
scale and that the##2##4##(2008-8#1)(2012-2#1)
scale and the##7##3##(2008-10#3)(2008-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
scale and##24##2##(1996-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-2#1)(2012-2#2)(2013-1#2)
scale are##3##2##(2008-10#2)(2009-8#1)
scale at which##2##3##(2008-10#1)(2009-10#1)
scale at##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
scale can be##2##3##(1993-12#1)(2008-10#1)
scale cell##3##2##(2008-11#3)
scale counts##2##2##(2008-8#2)
scale cultures##2##2##(2008-11#2)
scale did not##2##3##(2008-10#1)(2012-2#1)
scale experiments##4##2##(1997-2#1)(2008-11#3)
scale for assessing##2##3##(2011-8#1)(2013-1#1)
scale for##7##2##(1993-12#1)(1997-5#1)(2008-10#1)(2011-8#1)(2012-12#1)(2013-1#2)
scale from##3##2##(1995-8#1)(2008-10#1)(2008-9#1)
scale hollow##2##2##(2008-11#2)
scale in##8##2##(1994-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-5#2)(2012-3#1)
scale insects)##2##2##(2007-12#2)
scale is##6##2##(2008-10#3)(2008-3#1)(2012-2#1)(2013-1#1)
scale isometrically with##2##3##(2007-12#1)(2008-8#1)
scale model##2##2##(2012-2#2)
scale of an##2##3##(2008-8#1)(2012-2#1)
scale of operation##3##3##(2008-11#3)
scale of the##13##3##(1993-2#1)(2007-12#1)(2008-10#6)(2008-3#2)(2008-8#3)
scale of##49##2##(1990-2#2)(1991-2#1)(1992-1#1)(1993-2#1)(1994-8#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-3#4)(2008-7#2)(2008-8#6)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
scale production##4##2##(2008-11#3)(2011-2#1)
scale ranging from##2##3##(2008-9#1)(2010-10#1)
scale scores##3##2##(2008-8#1)(2009-11#1)(2009-4#1)
scale the##2##2##(2008-3#1)(2009-7#1)
scale to##5##2##(2008-10#2)(2008-11#1)(2010-10#1)(2012-2#1)
scale under##2##2##(2009-12#1)(2013-1#1)
scale up of antibody production from##2##6##(2008-11#2)
scale up of##3##3##(2008-11#2)(2008-7#1)
scale up##15##2##(2008-11#9)(2008-7#5)(2009-8#1)
scale was 0##2##3##(2008-10#1)(2011-2#1)
scale was not##2##3##(2008-10#2)
scale was##12##2##(1997-8#2)(2008-1#1)(2008-10#3)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#2)
scale were##2##2##(2008-10#2)
scale when##2##2##(2008-8#1)(2009-12#1)
scale with a##2##3##(1994-3#1)(2012-2#1)
scale with##3##2##(1994-3#1)(2012-2#1)(2012-3#1)
scale##448##1##(1990-12#1)(1990-2#4)(1990-3#1)(1990-8#3)(1991-2#5)(1991-3#1)(1992-1#3)(1992-11#1)(1992-2#1)(1992-5#2)(1992-8#1)(1993-12#2)(1993-2#4)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#4)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#4)(1997-1#2)(1997-2#2)(1997-5#1)(1997-8#2)(2007-12#5)(2008-1#2)(2008-10#112)(2008-11#65)(2008-12#8)(2008-2#1)(2008-3#13)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#23)(2008-8#20)(2008-9#17)(2009-10#1)(2009-11#5)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#4)(2011-1#3)(2011-2#10)(2011-3#1)(2011-8#1)(2012-12#2)(2012-2#20)(2012-3#13)(2013-1#21)(2013-8#1)
scale)##6##1##(2008-10#2)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
scale-tunable##2##1##(2008-3#2)
scale-up of##6##2##(2008-11#3)(2008-7#1)(2010-11#1)(2011-2#1)
scale-up##19##1##(1992-12#1)(2008-11#12)(2008-7#2)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
scaleable##4##1##(2008-11#3)(2008-8#1)
scaled up##3##2##(2008-11#2)(2008-7#1)
scaled##9##1##(1991-12#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)
scaled-up##2##1##(2008-11#2)
scales and##10##2##(1991-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)
scales are##3##2##(1990-5#1)(2008-6#1)(2008-8#1)
scales for each##2##3##(2008-3#1)(2008-5#1)
scales for##8##2##(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
scales have been##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
scales in##3##2##(1990-3#1)(2008-10#1)(2013-8#1)
scales may##2##2##(1993-2#1)(2008-8#1)
scales of spatial##2##3##(2008-10#1)(2008-8#1)
scales of the##4##3##(2008-10#2)(2008-2#1)(2008-9#1)
scales of##17##2##(1990-2#1)(1991-6#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#2)
scales that##2##2##(2008-10#1)(2009-11#1)
scales to##4##2##(1990-5#1)(1991-3#1)(2008-10#2)
scales were##3##2##(2008-10#1)(2008-5#1)(2009-12#1)
scales##149##1##(1990-2#1)(1990-3#1)(1990-5#3)(1990-8#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1993-2#4)(1993-3#1)(1995-5#1)(2008-1#1)(2008-10#43)(2008-11#5)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#22)(2008-9#6)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-8#1)(2012-2#10)(2012-3#2)(2012-5#1)(2013-1#8)(2013-8#2)
scaliness##3##1##(2008-5#3)
scaling and##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
scaling exponents##2##2##(1993-5#1)(2008-8#1)
scaling factor##2##2##(2008-3#2)
scaling in the##2##3##(1993-5#1)(1995-5#1)
scaling in##3##2##(1993-5#1)(1995-5#1)(2009-9#1)
scaling law##2##2##(2008-3#2)
scaling of the##2##3##(1993-5#1)(1995-9#1)
scaling relationships##2##2##(2008-8#2)
scaling symptoms##2##2##(2008-10#2)
scaling##48##1##(1993-5#3)(1995-5#4)(1995-9#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#8)(2008-5#3)(2008-6#2)(2008-8#7)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2012-2#5)(2012-3#1)
scallop##4##1##(2013-8#4)
scalp and##3##2##(2008-5#1)(2013-1#1)(2013-8#1)
scalp condition##2##2##(2008-5#2)
scalp hair samples##2##3##(2008-10#2)
scalp hair##3##2##(2008-10#3)
scalp##29##1##(2008-10#3)(2008-11#2)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#5)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
scaly##4##1##(2008-5#2)(2012-3#2)
scan (p = 0##2##2##(2011-2#1)(2012-2#1)
scan after##3##2##(1990-6#1)(2012-3#1)(2013-1#1)
scan and##9##2##(1990-12#1)(1992-12#1)(2008-10#3)(2008-7#1)(2010-6#1)(2013-8#2)
scan in the##2##3##(2008-10#1)(2008-3#1)
scan in##6##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
scan increment of##2##3##(2008-10#2)
scan increment##3##2##(2008-10#3)
scan may be##2##3##(1992-3#1)(2011-2#1)
scan mode##2##2##(2008-10#2)
scan of the##4##3##(2008-10#1)(2008-12#1)(2010-3#1)(2012-2#1)
scan of##7##2##(1995-10#1)(2008-10#2)(2008-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
scan offers##2##2##(2007-11#1)(2008-10#1)
scan rate and##4##3##(2008-10#4)
scan rate in##2##3##(2008-10#2)
scan rate of 100 mV s(-1)##3##6##(2008-10#3)
scan rate of##9##3##(2008-10#9)
scan rate were optimized##2##4##(2008-10#2)
scan rate##34##2##(2008-10#34)
scan revealed##4##2##(1996-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
scan showed a##4##3##(1990-6#1)(1997-3#1)(2009-8#1)(2010-1#1)
scan showed##11##2##(1990-6#1)(1997-3#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2013-1#3)
scan suggested##2##2##(2008-10#1)(2009-6#1)
scan was##5##2##(2008-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
scan##173##1##(1990-12#2)(1990-3#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#4)(1995-10#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#76)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#7)(2008-9#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-6#3)(2011-2#11)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#2)
scandium##3##1##(2008-10#3)
scandium(III) and yttrium(III) from##2##4##(2008-10#2)
scandium(III) and yttrium(III)##4##3##(2008-10#4)
scanned and##2##2##(2008-10#1)(2008-3#1)
scanned by both##2##3##(1996-1#2)
scanned by##3##2##(1996-1#2)(2008-10#1)
scanned in##2##2##(2008-10#1)(2008-3#1)
scanned with##2##2##(2008-3#1)(2008-8#1)
scanned##17##1##(1996-1#2)(2008-10#8)(2008-3#5)(2008-8#1)(2013-8#1)
scanner##11##1##(2008-11#1)(2008-3#4)(2008-7#1)(2010-12#1)(2011-2#1)(2011-7#2)(2012-12#1)
scanners and the##2##3##(2008-3#1)(2010-9#1)
scanners with##2##2##(2008-10#1)(2008-3#1)
scanners##11##1##(2008-10#3)(2008-3#5)(2008-9#1)(2010-9#2)
scanning and transmission electron microscopy##8##5##(2007-12#4)(2008-10#2)(2008-11#1)(2008-7#1)
scanning and transmission electron##9##4##(2007-12#5)(2008-10#2)(2008-11#1)(2008-7#1)
scanning and transmission##11##3##(2007-12#5)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)
scanning and##15##2##(1993-8#1)(2007-12#5)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2009-7#1)(2012-2#1)
scanning calorimetry (DSC)##8##3##(1992-10#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-3#1)
scanning calorimetry##17##2##(1991-5#1)(1992-10#1)(1993-8#3)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
scanning device##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
scanning electron micrographs##3##3##(2008-10#3)
scanning electron microscope (SEM)##4##4##(2008-10#1)(2008-5#1)(2009-11#1)(2009-3#1)
scanning electron microscope##12##3##(2008-10#4)(2008-3#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-3#1)(2012-3#1)
scanning electron microscopic##2##3##(1995-8#1)(2008-10#1)
scanning electron microscopy (SEM) and X-ray##2##6##(2008-10#1)(2009-7#1)
scanning electron microscopy (SEM) and##7##5##(2008-10#2)(2008-7#1)(2009-7#3)(2010-4#1)
scanning electron microscopy (SEM)##24##4##(1992-2#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#3)(2010-4#1)(2013-1#1)(2013-8#1)
scanning electron microscopy and electrochemical method##2##6##(2008-10#2)
scanning electron microscopy and##5##4##(2008-10#5)
scanning electron microscopy coupled##2##4##(2008-10#1)(2008-5#1)
scanning electron microscopy of##3##4##(2008-10#1)(2010-4#1)(2011-2#1)
scanning electron microscopy to##3##4##(2007-12#1)(2008-12#1)(2009-7#1)
scanning electron microscopy##67##3##(1992-2#2)(1996-3#1)(2007-12#2)(2008-10#33)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#4)(2010-4#2)(2010-6#1)(2011-2#3)(2013-1#4)(2013-8#1)
scanning electron##87##2##(1992-2#2)(1995-8#1)(1996-3#1)(2007-12#2)(2008-10#44)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#4)(2010-4#2)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
scanning fluorescence##2##2##(2008-3#1)(2008-9#1)
scanning holography##3##2##(2008-3#3)
scanning is##5##2##(1991-3#2)(2008-3#1)(2010-3#1)(2011-2#1)
scanning laser##2##2##(2008-9#1)(2011-7#1)
scanning microscope##3##2##(2008-8#1)(2008-9#2)
scanning microscopy and##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
scanning microscopy##14##2##(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#4)(2010-8#1)
scanning of##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
scanning optical microscope##2##3##(2007-12#2)
scanning permittivity measurements##2##3##(2008-11#2)
scanning potentiometry##4##2##(2008-10#4)
scanning probe##2##2##(2008-7#1)(2010-7#1)
scanning the potential in##2##4##(2008-10#2)
scanning the potential##4##3##(2008-10#4)
scanning the##6##2##(2008-10#4)(2008-3#1)(2008-4#1)
scanning tunneling microscope##5##3##(1990-11#1)(2007-12#3)(2010-7#1)
scanning tunneling##8##2##(1990-11#1)(1990-12#1)(2007-12#3)(2008-10#1)(2010-7#2)
scanning was##2##2##(1991-3#1)(2008-7#1)
scanning while##2##2##(2008-11#1)(2013-8#1)
scanning with##2##2##(1995-12#1)(2008-3#1)
scanning##255##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#5)(1991-5#1)(1992-10#1)(1992-2#2)(1992-9#1)(1993-8#5)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-1#2)(1996-3#1)(1996-9#1)(1997-2#1)(2007-12#14)(2008-10#83)(2008-11#15)(2008-12#1)(2008-2#2)(2008-3#20)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#14)(2008-8#7)(2008-9#15)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#5)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2011-7#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
scanning)##2##1##(2008-10#1)(2011-2#1)
scans after##2##2##(1992-12#1)(2008-7#1)
scans and##3##2##(1992-3#1)(2008-11#1)(2009-11#1)
scans at a##4##3##(1992-3#2)(2008-10#1)(2008-3#1)
scans have##3##2##(1993-6#1)(2011-2#2)
scans in##3##2##(2008-10#2)(2010-1#1)
scans of##2##2##(1996-11#1)(2013-8#1)
scans per##2##2##(2008-10#2)
scans performed##2##2##(2011-2#2)
scans revealed##2##2##(2008-11#1)(2011-2#1)
scans showed##2##2##(2008-7#1)(2011-2#1)
scans was##2##2##(2009-8#1)(2011-2#1)
scans were performed##2##3##(2009-11#1)(2013-1#1)
scans were##5##2##(2009-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
scans##61##1##(1990-12#1)(1992-12#1)(1992-3#3)(1993-6#1)(1995-5#2)(1996-11#1)(2007-11#1)(2008-10#11)(2008-11#3)(2008-3#3)(2008-7#8)(2008-9#1)(2009-11#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
scanty##5##1##(2008-1#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
scaphoid fracture##3##2##(2008-9#3)
scaphoid##6##1##(2008-9#5)(2013-1#1)
scapholunate##2##1##(2013-1#2)
scapular aneurysmal bone cyst in a child##2##7##(2012-12#2)
scapular upward rotators during##2##4##(2010-9#2)
scapular##6##1##(2010-9#2)(2012-12#2)(2012-2#1)(2012-3#1)
scapularis##6##1##(2008-11#6)
scar and##3##2##(1990-8#1)(2009-10#1)(2013-8#1)
scar fibroblasts treated with##2##4##(2008-9#2)
scar on##2##2##(2011-2#1)(2013-1#1)
scar tissue and##2##3##(1997-3#2)
scar tissue##5##2##(1992-12#1)(1997-3#4)
scar##33##1##(1990-8#1)(1990-9#1)(1992-12#1)(1997-3#4)(2008-10#1)(2008-9#9)(2009-10#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#7)(2013-1#3)(2013-8#1)
scarce and##2##2##(2008-10#1)(2012-3#1)
scarce##17##1##(1990-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-7#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
scarcely##6##1##(1995-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2012-12#1)
scarcity of##5##2##(1996-3#1)(2008-8#1)(2011-2#1)(2011-3#2)
scarcity##8##1##(1993-3#1)(1996-3#1)(2008-12#1)(2008-8#1)(2011-2#1)(2011-3#2)(2012-5#1)
scare##2##1##(2008-11#1)(2008-9#1)
scarlet gilia##2##2##(2008-9#2)
scarlet##3##1##(2008-10#1)(2008-9#2)
scarring and##2##2##(1997-8#1)(2013-8#1)
scarring in the group##2##4##(1991-2#1)(1997-3#1)
scarring in##4##2##(1991-2#2)(1997-3#1)(2008-10#1)
scarring of the##3##3##(1991-12#1)(2008-11#1)(2008-7#1)
scarring were##2##2##(1991-12#2)
scarring##20##1##(1990-3#1)(1991-12#4)(1991-2#2)(1996-1#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
scars and##2##2##(2008-9#2)
scars##16##1##(1991-11#1)(1991-2#1)(1995-2#1)(2008-10#1)(2008-9#8)(2009-1#1)(2009-4#2)(2013-1#1)
scatter##10##1##(1991-5#1)(1995-8#1)(1995-9#1)(2006-6#1)(2008-10#1)(2008-3#3)(2008-9#2)
scattered from##2##2##(1993-5#1)(2008-3#1)
scattered in##3##2##(1992-12#1)(2008-5#1)(2012-12#1)
scattered light##9##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)
scattered radiation##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
scattered##41##1##(1992-12#1)(1992-3#1)(1993-5#1)(1995-12#1)(1995-8#1)(1996-12#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#3)(2009-10#1)(2009-11#1)(2010-6#2)(2012-12#1)
scatterer##3##1##(1995-6#1)(2008-3#2)
scatterers has been##2##3##(2008-3#2)
scatterers##7##1##(1995-6#1)(2008-3#6)
scattering (DW-RLS)##2##2##(2008-10#2)
scattering and absorbing##3##3##(2008-3#3)
scattering and absorption by##2##4##(2008-2#1)(2008-3#1)
scattering and absorption##7##3##(2008-2#1)(2008-3#6)
scattering and the##2##3##(2008-10#1)(2008-3#1)
scattering and##25##2##(2008-10#3)(2008-2#2)(2008-3#18)(2010-7#1)(2011-2#1)
scattering are##3##2##(2008-3#3)
scattering as a##3##3##(1992-8#1)(2008-10#1)(2008-3#1)
scattering at##4##2##(2008-3#3)(2009-11#1)
scattering by a##3##3##(2008-3#3)
scattering by an##2##3##(2008-3#2)
scattering by##18##2##(1993-5#1)(2008-2#4)(2008-3#13)
scattering coefficient##2##2##(2008-2#1)(2008-3#1)
scattering component##3##2##(2008-2#1)(2008-3#2)
scattering detection##4##2##(2008-10#4)
scattering effect##2##2##(2008-10#2)
scattering experiments##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
scattering from the##2##3##(2008-3#2)
scattering from##10##2##(2008-3#10)
scattering in a##3##3##(2008-3#3)
scattering in the##2##3##(1994-3#1)(2008-10#1)
scattering in##14##2##(1990-12#1)(1994-3#2)(2008-10#1)(2008-3#10)
scattering intensity at##2##3##(2008-10#2)
scattering intensity##4##2##(2008-10#4)
scattering is##6##2##(2008-2#1)(2008-3#4)(2008-4#1)
scattering layers##3##2##(2008-3#3)
scattering lidars##3##2##(2008-3#3)
scattering media##9##2##(1992-8#1)(2008-2#1)(2008-3#7)
scattering method for the##2##4##(2008-10#2)
scattering method##4##2##(2008-10#4)
scattering object##2##2##(2008-3#2)
scattering of a##2##3##(2008-3#1)(2009-10#1)
scattering of light by##3##4##(2008-2#1)(2008-3#2)
scattering of light##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
scattering of##16##2##(2008-10#7)(2008-2#3)(2008-3#4)(2009-10#2)
scattering on##4##2##(2008-2#2)(2008-3#2)
scattering pattern##4##2##(2008-3#4)
scattering properties of##3##3##(2008-3#3)
scattering properties##4##2##(2008-3#4)
scattering signals##3##2##(2008-10#3)
scattering studies##2##2##(1995-3#1)(2008-11#1)
scattering study##2##2##(2008-10#2)
scattering techniques##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
scattering with##2##2##(2008-10#1)(2011-7#1)
scattering##324##1##(1990-12#2)(1992-3#1)(1992-8#3)(1993-5#1)(1994-2#1)(1994-3#2)(1995-3#3)(1995-6#2)(2007-12#3)(2008-10#97)(2008-11#2)(2008-2#33)(2008-3#154)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2010-7#4)(2011-2#4)(2011-7#1)
scavenge##6##1##(1992-9#1)(1995-8#1)(2008-11#3)(2008-7#1)
scavenged##2##1##(2008-10#1)(2008-8#1)
scavenger activity##4##2##(2008-5#3)(2011-2#1)
scavenger of##3##2##(1995-2#1)(2008-11#2)
scavenger##31##1##(1992-9#1)(1993-6#2)(1993-8#4)(1995-11#1)(1995-2#2)(1995-8#3)(1996-2#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-5#6)(2011-2#1)
scavengers and##4##2##(1996-2#1)(2008-11#2)(2008-5#1)
scavengers in the##2##3##(2009-12#1)(2012-2#1)
scavengers were##2##2##(1993-8#1)(2008-6#1)
scavengers##16##1##(1992-9#1)(1993-8#2)(1996-2#2)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-2#1)
scavenges##2##1##(2008-10#1)(2008-11#1)
scavenging abilities of##2##3##(2008-10#1)(2008-5#1)
scavenging activities in##2##3##(2013-1#1)(2013-8#1)
scavenging activities##6##2##(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
scavenging activity##6##2##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)
scavenging effect of##2##3##(1993-6#1)(2008-11#1)
scavenging effect##3##2##(1993-6#1)(2008-11#2)
scavenging of##2##2##(2008-11#1)(2011-2#1)
scavenging superoxide anion##2##3##(2008-10#1)(2013-8#1)
scavenging##35##1##(1993-1#2)(1993-6#1)(1995-6#1)(1996-2#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-5#4)(2008-6#1)(2008-9#3)(2009-3#1)(2011-2#2)(2013-1#2)(2013-8#2)
scenario analysis##2##2##(1992-9#1)(1997-3#1)
scenario and##2##2##(2007-11#1)(2008-11#1)
scenario in##2##2##(2008-11#1)(2008-8#1)
scenario of##7##2##(2008-1#1)(2008-10#4)(2009-10#1)(2010-8#1)
scenario##40##1##(1992-9#1)(1993-12#1)(1993-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#2)(2011-3#1)(2012-12#2)(2012-5#1)(2013-8#1)
scenario-based design##3##2##(2010-8#3)
scenario-based##5##1##(2008-11#2)(2010-8#3)
scenarios based on##2##3##(2010-12#1)(2010-3#1)
scenarios for##2##2##(2008-11#1)(2010-8#1)
scenarios generated##2##2##(2009-10#2)
scenarios in##4##2##(2008-1#1)(2008-11#1)(2009-10#1)(2012-3#1)
scenarios of##6##2##(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
scenarios triggered by fire##2##4##(2009-10#2)
scenarios were##4##2##(2008-11#1)(2009-10#1)(2010-8#1)(2013-1#1)
scenarios where the##2##3##(2008-11#1)(2008-6#1)
scenarios where##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
scenarios##55##1##(1996-12#1)(1996-3#2)(2008-1#1)(2008-10#5)(2008-11#8)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#13)(2009-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
scene##19##1##(1991-8#1)(1993-12#1)(1994-12#1)(1995-11#2)(1996-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#2)(2009-12#1)
scenes##8##1##(2008-10#5)(2008-2#1)(2008-3#2)
scent##4##1##(2007-12#1)(2008-4#1)(2012-2#2)
schachtii J2##2##2##(2008-10#2)
schachtii and##2##2##(2008-10#1)(2008-12#1)
schachtii cysts##3##2##(2008-10#3)
schachtii multiplied##2##2##(2008-10#2)
schachtii population densities##2##3##(2008-10#2)
schachtii population##3##2##(2008-10#3)
schachtii##30##1##(2008-10#27)(2008-12#3)
schedule and##3##2##(1994-1#1)(1995-5#1)(2008-6#1)
schedule for##5##2##(1990-6#1)(1991-11#1)(1993-11#1)(2008-12#1)(2013-8#1)
schedule is##2##2##(1991-12#1)(2008-6#1)
schedule of male##3##3##(2008-6#3)
schedule of reproductive effort##2##4##(2008-8#2)
schedule of##12##2##(1990-2#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-6#2)(2008-6#4)(2008-8#2)
schedule or##2##2##(1991-8#1)(1993-11#1)
schedule was##2##2##(1991-8#1)(1993-6#1)
schedule with##2##2##(1994-8#1)(1995-5#1)
schedule##67##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#3)(1991-8#3)(1992-2#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#4)(1994-1#9)(1994-12#1)(1994-6#1)(1994-8#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-3#4)(1996-9#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#6)(2008-8#2)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
schedule-induced polydipsia##2##2##(1993-6#2)
scheduled for elective surgery##2##4##(1995-1#1)(2010-7#1)
scheduled for elective##4##3##(1995-1#1)(2007-8#1)(2010-7#1)(2011-2#1)
scheduled for mitral valve repair##2##5##(2011-2#2)
scheduled for##18##2##(1991-2#1)(1993-1#1)(1994-2#1)(1995-1#1)(1996-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-7#2)(2011-2#5)
scheduled to be##2##3##(1992-1#1)(2011-4#1)
scheduled to##4##2##(1992-1#1)(1993-3#1)(2011-2#1)(2011-4#1)
scheduled##31##1##(1991-2#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-7#2)(2011-2#6)(2011-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
schedules of##4##2##(1992-12#1)(1995-5#1)(2008-10#1)(2008-5#1)
schedules##19##1##(1991-12#2)(1992-12#1)(1993-3#3)(1993-9#1)(1995-5#4)(2008-1#1)(2008-10#2)(2008-5#3)(2008-9#1)(2010-5#1)
scheduling process##3##2##(1991-2#1)(1996-1#2)
scheduling##22##1##(1991-2#4)(1994-2#2)(1994-3#1)(1995-6#1)(1996-1#5)(1996-12#1)(1996-2#4)(1997-3#1)(2008-5#1)(2009-3#1)(2010-10#1)
schema##4##1##(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
schemas##2##1##(2008-7#1)(2010-7#1)
schematic##3##1##(2008-4#1)(2009-4#2)
schematically##2##1##(2008-4#1)(2008-5#1)
scheme allows##2##2##(2008-10#1)(2008-3#1)
scheme and##5##2##(2008-10#2)(2008-3#1)(2009-12#1)(2012-3#1)
scheme are##3##2##(1991-12#1)(1996-8#1)(2008-2#1)
scheme based on##2##3##(2008-3#1)(2009-3#1)
scheme for the##2##3##(1991-5#1)(2008-10#1)
scheme for##20##2##(1991-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(2007-12#1)(2008-10#9)(2008-3#6)
scheme has been developed for##3##5##(2008-10#1)(2008-3#2)
scheme has been developed##4##4##(2008-10#2)(2008-3#2)
scheme has been##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
scheme has##8##2##(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
scheme in##3##2##(1996-8#1)(2008-11#1)(2008-9#1)
scheme involving##2##2##(2007-12#1)(2008-10#1)
scheme is based on the##2##5##(2007-11#1)(2008-10#1)
scheme is##15##2##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#4)(2012-2#3)
scheme of##7##2##(1995-11#1)(2008-10#5)(2008-5#1)
scheme offers a##2##3##(2007-11#1)(2008-10#1)
scheme that##4##2##(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
scheme to##4##2##(2008-10#2)(2008-11#1)(2008-2#1)
scheme used for##2##3##(2007-12#1)(2008-2#1)
scheme was developed##2##3##(2008-10#2)
scheme was##6##2##(2008-10#5)(2008-9#1)
scheme with##5##2##(1992-4#1)(2008-10#1)(2008-2#2)(2008-3#1)
scheme##138##1##(1991-12#1)(1991-3#1)(1991-5#1)(1992-4#1)(1993-6#1)(1994-12#1)(1995-11#2)(1995-6#2)(1996-6#1)(1996-8#4)(1997-2#1)(2007-11#3)(2007-12#3)(2008-10#48)(2008-11#7)(2008-12#1)(2008-2#10)(2008-3#26)(2008-5#3)(2008-6#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#2)
schemes and the##3##3##(1993-12#2)(2008-10#1)
schemes and##4##2##(1993-12#2)(2008-10#2)
schemes are##3##2##(2008-10#3)
schemes in##2##2##(2008-11#1)(2013-7#1)
schemes of##2##2##(1991-3#1)(2008-10#1)
schemes##45##1##(1990-3#1)(1991-12#1)(1991-3#1)(1993-12#2)(1994-12#1)(1996-11#1)(1996-8#2)(1997-3#1)(1997-7#1)(2008-10#23)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-7#1)(2013-7#1)
schistosomes##3##1##(2013-1#2)(2013-8#1)
schistosomiasis##3##1##(1996-8#2)(2008-10#1)
schizoaffective disorder##3##2##(2008-8#3)
schizoaffective##5##1##(2008-8#4)(2011-2#1)
schizophrenia and##10##2##(2008-4#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-1#2)(2010-9#1)(2011-1#1)(2011-3#1)
schizophrenia brain##2##2##(1993-9#2)
schizophrenia have##2##2##(2009-6#1)(2010-1#1)
schizophrenia in the elderly##2##4##(2008-8#2)
schizophrenia in##4##2##(1994-12#1)(2008-8#2)(2009-6#1)
schizophrenia is##5##2##(1990-11#1)(1993-9#2)(1995-12#1)(2008-4#1)
schizophrenia was##2##2##(1993-9#1)(2011-2#1)
schizophrenia##70##1##(1990-11#1)(1990-2#1)(1991-2#1)(1993-9#11)(1994-12#1)(1995-12#3)(1995-5#3)(2008-1#2)(2008-11#2)(2008-4#2)(2008-8#4)(2009-12#4)(2009-6#4)(2009-7#5)(2010-1#8)(2010-9#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#3)(2013-8#3)
schizophrenic patients and##2##3##(1995-5#2)
schizophrenic patients##6##2##(1995-12#1)(1995-5#4)(2011-2#1)
schizophrenic##11##1##(1990-11#2)(1993-2#1)(1995-12#1)(1995-5#5)(2008-11#1)(2011-2#1)
schizotypal traits##3##2##(2008-1#3)
schizotypal##4##1##(2008-1#4)
scholarly##6##1##(2010-2#1)(2010-4#2)(2010-7#2)(2012-12#1)
scholars##4##1##(1996-2#1)(2009-5#1)(2010-4#1)(2013-8#1)
school adolescents##2##2##(2011-1#2)
school and university##2##3##(2010-2#1)(2012-12#1)
school and##6##2##(1994-12#1)(2008-11#2)(2009-7#1)(2010-2#1)(2012-12#1)
school based##2##2##(2012-2#2)
school children in##6##3##(1994-12#1)(2008-10#3)(2011-2#2)
school children##14##2##(1991-9#3)(1994-12#1)(2008-10#3)(2008-12#1)(2009-7#1)(2011-2#4)(2012-12#1)
school classes##3##2##(2010-1#3)
school classrooms##2##2##(2009-7#1)(2010-8#1)
school curricula##2##2##(1994-1#1)(2012-3#1)
school curriculum##2##2##(2008-1#1)(2008-3#1)
school engagement##6##2##(2009-7#6)
school entry##2##2##(2008-11#1)(2011-1#1)
school environments##3##2##(1996-3#1)(2010-1#1)(2010-5#1)
school health personnel##2##3##(2008-10#2)
school health##4##2##(1990-6#2)(2008-10#2)
school in##6##2##(1993-1#1)(2011-2#2)(2013-8#3)
school maintenance##2##2##(1991-12#2)
school nutrition##2##2##(2012-2#2)
school of nursing##2##3##(2008-11#1)(2008-12#1)
school of##8##2##(1993-5#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2013-1#1)
school or##3##2##(2008-11#1)(2009-9#1)(2011-2#1)
school outcomes##3##2##(2008-12#1)(2009-7#1)(2012-2#1)
school performance##2##2##(2008-11#1)(2009-7#1)
school readiness##4##2##(2008-11#1)(2008-12#3)
school settings##2##2##(1996-3#1)(2012-2#1)
school students in##6##3##(2008-12#2)(2013-1#4)
school students##13##2##(1990-12#1)(1990-2#1)(1993-3#1)(2008-12#2)(2009-5#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
school teachers##4##2##(1991-12#4)
school year##5##2##(2008-12#4)(2010-1#1)
school years##2##2##(2008-11#1)(2008-12#1)
school##215##1##(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#4)(1991-12#11)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-8#1)(1993-1#3)(1993-11#1)(1993-3#1)(1993-5#1)(1994-1#3)(1994-12#3)(1994-6#2)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(2008-1#3)(2008-10#8)(2008-11#17)(2008-12#28)(2008-2#2)(2008-3#3)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#19)(2009-9#1)(2010-1#10)(2010-10#2)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#7)(2012-2#13)(2012-3#4)(2013-1#13)(2013-8#5)
school's##2##1##(1996-1#1)(2008-12#1)
school) and##2##2##(1997-4#1)(2010-1#1)
school-age children 7-14 years##2##4##(2011-2#2)
school-age children anticipating##2##3##(1995-1#2)
school-age children##9##2##(1991-2#2)(1995-1#2)(2009-9#1)(2011-2#4)
school-age##10##1##(1991-2#3)(1995-1#2)(2009-9#1)(2011-2#4)
school-aged children##6##2##(1992-2#2)(1993-3#1)(2009-4#1)(2010-5#1)(2012-12#1)
school-aged##7##1##(1992-2#2)(1993-3#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
school-based##11##1##(1993-1#1)(1995-12#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-2#2)(2013-1#2)
school-level##2##1##(2009-7#2)
school-related##2##1##(1991-2#1)(2008-12#1)
schoolchildren##6##1##(1992-6#1)(1993-11#1)(1994-12#1)(1994-6#1)(2008-1#1)(2011-2#1)
schooling##4##1##(2009-10#1)(2009-12#1)(2009-9#1)(2011-1#1)
schools and##4##2##(1991-8#1)(1994-12#1)(1997-3#1)(2010-5#1)
schools have##2##2##(1994-1#1)(2008-12#1)
schools in the##4##3##(2009-10#1)(2009-7#2)(2013-1#1)
schools in##15##2##(1991-12#2)(1991-6#1)(1996-1#1)(2008-10#2)(2009-10#2)(2009-7#2)(2010-1#2)(2011-2#1)(2013-1#2)
schools of medicine##2##3##(1991-1#1)(2008-12#1)
schools of nursing are##3##4##(2008-12#2)(2010-8#1)
schools of nursing##6##3##(2008-11#1)(2008-12#4)(2010-8#1)
schools of public health##11##4##(1996-1#3)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)
schools of##24##2##(1991-1#1)(1991-8#1)(1996-1#3)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)(2008-11#1)(2008-12#5)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
schools to##3##2##(2008-12#1)(2010-5#1)(2012-2#1)
schools with##2##2##(1991-8#1)(2009-7#1)
schools##103##1##(1991-1#1)(1991-12#5)(1991-2#3)(1991-6#1)(1991-8#3)(1993-1#1)(1993-11#2)(1994-1#1)(1994-12#3)(1995-12#1)(1996-1#4)(1996-2#1)(1996-3#2)(1997-2#5)(1997-3#4)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#13)(2008-7#1)(2008-8#1)(2009-10#2)(2009-6#1)(2009-7#7)(2010-1#3)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#1)
schools'##2##1##(2012-2#2)
schwannoma is##2##2##(2008-7#1)(2013-1#1)
schwannoma of the##4##3##(1997-8#2)(2011-2#1)(2012-3#1)
schwannoma with##3##2##(2011-2#3)
schwannoma##21##1##(1994-6#3)(1997-8#2)(2008-7#2)(2011-2#8)(2012-3#3)(2013-1#3)
schwannomas are##2##2##(2011-2#2)
schwannomas most commonly##2##3##(2011-2#1)(2013-1#1)
schwannomas##9##1##(1997-8#2)(2008-7#1)(2011-2#4)(2013-1#2)
schwerinii##4##1##(2012-3#4)
sciatic myelinated##2##2##(1997-3#2)
sciatic nerve##8##2##(1990-5#1)(1995-12#2)(1996-2#2)(2008-8#3)
sciatic neuropathy and##2##3##(2008-8#2)
sciatic##16##1##(1990-5#1)(1995-12#2)(1996-2#2)(1997-3#5)(2008-8#6)
sciatica##4##1##(1991-11#1)(1996-9#1)(2012-12#2)
scid mice##3##2##(1994-3#3)
scid##7##1##(1994-3#4)(1995-2#2)(1996-2#1)
science and technology##2##3##(1994-12#1)(2010-1#1)
science and the##2##3##(1993-11#1)(2010-1#1)
science and##18##2##(1990-2#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-1#2)(2012-2#1)(2013-1#1)
science continues to##2##3##(2008-10#1)(2009-3#1)
science during##2##2##(2008-11#2)
science has##2##2##(1995-1#1)(2013-1#1)
science of##14##2##(1990-3#1)(1993-12#1)(1993-3#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#2)
science on whole grains##2##4##(2010-1#2)
science research##6##2##(1995-2#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
science##128##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#4)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#1)(2008-10#16)(2008-11#14)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2010-1#6)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#3)(2010-9#3)(2011-2#5)(2012-2#9)(2012-3#2)(2013-1#8)(2013-8#2)
science&quot##2##1##(2009-6#1)(2013-1#1)
science-based##3##1##(1997-1#1)(2008-3#1)(2008-6#1)
science-oriented##2##1##(1994-12#2)
sciences and##4##2##(1994-12#1)(2008-11#1)(2009-12#1)(2011-2#1)
sciences in##4##2##(1994-12#1)(2008-11#1)(2010-7#1)(2012-2#1)
sciences##51##1##(1991-12#2)(1994-11#1)(1994-12#8)(1994-3#2)(1996-1#1)(1996-2#1)(1996-6#1)(1997-3#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#2)(2010-7#6)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#3)
scientific and practical##2##3##(1996-6#1)(2008-8#1)
scientific and##12##2##(1991-3#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-7#1)(2013-7#1)(2013-8#1)
scientific articles##2##2##(1991-11#1)(2010-12#1)
scientific basis##2##2##(2008-7#2)
scientific community has##2##3##(2008-10#1)(2012-2#1)
scientific community have##2##3##(2008-12#2)
scientific community##10##2##(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#2)
scientific disciplines##2##2##(2012-2#1)(2012-3#1)
scientific discoveries##3##2##(2008-11#2)(2013-1#1)
scientific discovery##3##2##(2012-2#3)
scientific evaluation of the hazards of##2##6##(2008-11#2)
scientific evaluation##3##2##(2008-11#2)(2013-1#1)
scientific evidence is##3##3##(1993-12#1)(2013-1#2)
scientific evidence on##2##3##(2008-4#1)(2012-2#1)
scientific evidence supporting##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
scientific evidence##17##2##(1993-12#2)(1997-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
scientific fields##2##2##(2008-10#1)(2010-5#1)
scientific foundation and##2##3##(2008-10#2)
scientific foundation##3##2##(2008-10#2)(2010-5#1)
scientific impact##2##2##(2012-2#2)
scientific information##5##2##(1993-12#1)(2008-10#2)(2010-5#1)(2011-2#1)
scientific investigation##2##2##(1992-3#1)(1996-1#1)
scientific journals##2##2##(2010-1#1)(2012-12#1)
scientific knowledge##6##2##(1994-6#1)(2009-10#1)(2010-1#1)(2011-2#2)(2013-8#1)
scientific literature is##2##3##(2008-11#1)(2011-2#1)
scientific literature##13##2##(1993-12#1)(1997-2#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
scientific meeting##4##2##(2008-7#3)(2009-9#1)
scientific output##2##2##(2012-2#2)
scientific papers##3##2##(1993-6#1)(2012-3#1)(2013-1#1)
scientific problems##3##2##(1990-11#3)
scientific progress##2##2##(2010-12#1)(2012-2#1)
scientific publications##3##2##(2008-11#1)(2012-12#2)
scientific rationale##4##2##(2008-10#1)(2008-3#1)(2010-12#2)
scientific sessions##2##2##(2009-5#1)(2009-6#1)
scientific societies##2##2##(1992-12#1)(2008-10#1)
scientific study of##2##3##(1993-3#1)(2008-11#1)
scientific study##3##2##(1992-1#1)(1993-3#1)(2008-11#1)
scientific##202##1##(1990-11#3)(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#2)(1994-12#5)(1994-6#2)(1994-8#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#22)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#4)(2009-11#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#4)(2011-1#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#15)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#3)
scientifically proven##2##2##(2008-6#1)(2009-7#1)
scientifically supported##2##2##(2010-1#1)(2012-3#1)
scientifically##15##1##(1994-12#1)(2008-10#2)(2008-12#2)(2008-6#2)(2009-10#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
scientist##16##1##(1990-3#1)(1990-8#1)(1994-12#1)(2008-12#5)(2008-4#1)(2008-5#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#3)
scientists and clinicians##2##3##(2008-10#1)(2008-11#1)
scientists and engineers##2##3##(2009-11#1)(2009-12#1)
scientists and##12##2##(2008-10#3)(2008-11#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
scientists had##2##2##(2008-11#1)(2010-1#1)
scientists in the##2##3##(2008-9#1)(2013-1#1)
scientists in##5##2##(1997-2#1)(2008-11#1)(2008-9#2)(2013-1#1)
scientists of##2##2##(2008-12#1)(2013-7#1)
scientists to##3##2##(2008-9#1)(2009-9#1)(2013-8#1)
scientists who##3##2##(1992-12#1)(2008-10#1)(2013-8#1)
scientists with##2##2##(2008-10#1)(2012-2#1)
scientists worldwide##2##2##(2008-11#1)(2011-2#1)
scientists##74##1##(1992-1#1)(1992-12#3)(1993-12#1)(1994-12#2)(1996-5#1)(1996-9#2)(1997-2#1)(2008-10#6)(2008-11#10)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#9)(2013-7#1)(2013-8#3)
scientists'##2##1##(2013-1#2)
scintigrams##2##1##(1990-12#2)
scintigraphic activity##5##2##(2011-2#5)
scintigraphic control was##2##3##(2013-1#2)
scintigraphic renal lesions##2##3##(2013-1#2)
scintigraphic##15##1##(1990-12#1)(2011-2#7)(2012-2#1)(2013-1#6)
scintigraphy and##3##2##(1991-2#1)(2008-7#1)(2010-10#1)
scintigraphy in patients with##2##4##(1997-8#1)(2007-11#1)
scintigraphy in##6##2##(1990-12#2)(1997-8#2)(2007-11#2)
scintigraphy to##2##2##(1997-8#1)(2009-10#1)
scintigraphy with##2##2##(1992-5#1)(2009-4#1)
scintigraphy##27##1##(1990-12#3)(1991-2#2)(1992-5#1)(1996-3#1)(1997-1#1)(1997-8#3)(2007-11#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#5)(2013-1#3)
scintillant##2##1##(2008-4#2)
scintillating microplate##2##2##(2008-11#2)
scintillation counting##5##2##(2008-10#2)(2008-11#2)(2008-8#1)
scintillation index##2##2##(2007-12#2)
scintillation proximity assay##2##3##(2008-11#1)(2013-1#1)
scintillation##16##1##(1992-2#1)(1992-3#1)(1994-5#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-3#4)(2008-8#1)(2013-1#1)
scintillations##4##1##(2008-3#4)
scintillator##3##1##(1996-2#1)(2013-1#2)
scion circumference##2##2##(2008-10#2)
scion vigor##2##2##(2008-10#2)
scion##6##1##(2008-10#6)
scions##3##1##(2008-10#3)
scirrhous carcinoma##3##2##(2008-10#3)
scirtid-O##2##1##(2008-12#2)
scirtids##5##1##(2008-12#5)
scission##2##1##(1990-5#1)(2008-4#1)
scissoring##4##1##(2008-10#4)
sclerectomy##2##1##(2013-8#2)
sclerites and##2##2##(2008-7#2)
sclerites##4##1##(2008-7#4)
scleroderma and##2##2##(1992-8#1)(2011-2#1)
scleroderma##14##1##(1992-8#5)(1993-9#1)(2008-10#1)(2011-2#6)(2013-1#1)
sclerosing agent##3##2##(1990-9#1)(1997-8#2)
sclerosing cholangitis##3##2##(1997-6#1)(2009-8#1)(2010-12#1)
sclerosing##12##1##(1990-3#1)(1990-9#1)(1994-12#1)(1997-6#1)(1997-8#2)(2009-8#1)(2010-12#1)(2011-2#4)
sclerosis (MS)##12##2##(1995-12#2)(2008-11#1)(2008-5#1)(2010-12#2)(2010-2#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)
sclerosis and lichen ruber planus##2##5##(2011-2#2)
sclerosis and##5##2##(1995-12#1)(1997-8#1)(2010-12#1)(2011-2#2)
sclerosis is##3##2##(1995-12#1)(2010-12#1)(2013-1#1)
sclerosis or##2##2##(2011-2#2)
sclerosis with##2##2##(2011-2#1)(2012-12#1)
sclerosis##89##1##(1991-11#1)(1991-3#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-9#1)(1995-12#5)(1996-3#1)(1996-5#1)(1996-8#3)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#3)(2010-10#2)(2010-12#12)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#18)(2011-7#2)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#5)(2013-8#2)
sclerosis]##4##1##(1991-3#1)(1994-12#1)(1996-3#1)(2008-11#1)
sclerotherapy for##2##2##(2008-8#1)(2013-1#1)
sclerotherapy##9##1##(1995-10#1)(2008-8#2)(2013-1#6)
sclerotia and the##3##3##(2008-10#3)
sclerotia and##8##2##(2008-10#8)
sclerotia buried##2##2##(2008-10#2)
sclerotia from##3##2##(2008-10#3)
sclerotia in##4##2##(2008-10#4)
sclerotia increased##2##2##(2008-10#2)
sclerotia occurred##2##2##(2008-10#2)
sclerotia of Sclerotinia sclerotiorum##2##4##(2008-10#2)
sclerotia of##8##2##(2008-10#8)
sclerotia on##2##2##(2008-10#2)
sclerotia per square centimeter##2##4##(2008-10#2)
sclerotia produced in vitro##2##4##(2008-10#2)
sclerotia produced##4##2##(2008-10#4)
sclerotia to##2##2##(2008-10#2)
sclerotia viability and##3##3##(2008-10#3)
sclerotia was##3##2##(2008-10#3)
sclerotia were##5##2##(2008-10#5)
sclerotia within##2##2##(2008-10#2)
sclerotia##86##1##(2008-10#86)
sclerotial development in##2##3##(2008-10#2)
sclerotial development##4##2##(2008-10#4)
sclerotial size##3##2##(2008-10#3)
sclerotial##13##1##(2008-10#13)
sclerotinia stem rot in##2##4##(2008-10#2)
sclerotinia stem rot##5##3##(2008-10#5)
sclerotinia##8##1##(2008-10#8)
sclerotiorum Sclerotia##2##2##(2008-10#2)
sclerotiorum from##3##2##(2008-10#3)
sclerotiorum in the##2##3##(2008-10#2)
sclerotiorum in##7##2##(2008-10#7)
sclerotiorum isolates##3##2##(2008-10#3)
sclerotiorum populations##2##2##(2008-10#2)
sclerotiorum sclerotia was##2##3##(2008-10#2)
sclerotiorum sclerotia##5##2##(2008-10#5)
sclerotiorum was##6##2##(2008-10#6)
sclerotiorum##62##1##(2008-10#61)(2013-8#1)
sclerotized##3##1##(2007-12#3)
sclerotome induction##2##2##(1994-12#2)
sclerotome##6##1##(1994-12#6)
sclerotomy##5##1##(2013-8#5)
scolaire##3##1##(2008-11#3)
scoliosis##11##1##(1997-3#1)(1997-4#1)(2007-8#5)(2008-8#2)(2009-3#1)(2012-2#1)
scolopale rods##2##2##(2008-7#2)
scolopale##5##1##(2008-7#5)
scolopidia##4##1##(2008-7#4)
scope and##9##2##(1992-12#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2011-2#1)(2013-1#1)
scope for##2##2##(2008-10#2)
scope of practice##3##3##(2008-12#2)(2008-7#1)
scope of the##11##3##(1991-5#1)(1996-5#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
scope of##31##2##(1990-8#1)(1991-1#1)(1991-5#1)(1993-1#1)(1994-12#1)(1996-12#1)(1996-5#1)(1997-2#3)(1997-3#1)(2008-11#3)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-8#1)
scope##55##1##(1990-8#1)(1991-1#2)(1991-3#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
scopolamine (0##4##2##(1991-7#3)(1994-8#1)
scopolamine##14##1##(1991-7#4)(1992-12#1)(1994-8#4)(2008-10#5)
scopoletin and##2##2##(2008-10#2)
scopoletin##6##1##(2008-10#6)
scorch##3##1##(2008-10#3)
score &gt##2##2##(2008-7#1)(2011-2#1)
score &lt##4##2##(1994-3#1)(2008-7#1)(2010-11#1)(2011-2#1)
score (p=0##2##2##(2008-7#2)
score and in##2##3##(2008-10#1)(2011-2#1)
score and##12##2##(1992-2#1)(2008-10#2)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
score at##2##2##(1997-8#1)(2013-1#1)
score decreased##3##2##(2008-7#2)(2009-12#1)
score for each##2##3##(1993-12#1)(1994-9#1)
score for the##4##3##(1990-2#2)(1991-6#1)(2008-10#1)
score for##9##2##(1990-2#2)(1991-2#2)(1991-6#2)(1993-12#1)(1994-9#1)(2008-10#1)
score from##2##2##(2008-8#1)(2010-10#1)
score improved from##2##3##(2008-7#1)(2009-3#1)
score improved##3##2##(2008-7#1)(2009-3#1)(2010-11#1)
score in the##5##3##(1994-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
score in##11##2##(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#5)(2013-1#2)(2013-8#1)
score increased to##2##3##(2008-7#1)(2013-1#1)
score is a##2##3##(1994-9#1)(2011-2#1)
score is##5##2##(1994-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
score less than##2##3##(2011-2#2)
score less##4##2##(2011-2#2)(2012-3#2)
score of 0##2##3##(2008-7#1)(2010-8#1)
score of 3##2##3##(1997-5#2)
score of##21##2##(1991-12#1)(1992-1#1)(1997-5#3)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#5)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
score on the##3##3##(2008-7#2)(2011-2#1)
score on##5##2##(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#1)
score than##2##2##(2011-2#1)(2012-2#1)
score to##2##2##(1994-3#1)(1994-9#1)
score was 14##2##3##(1990-12#1)(2013-1#1)
score was 3##2##3##(1990-2#1)(2012-3#1)
score was##18##2##(1990-12#2)(1990-2#2)(1991-6#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-3#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
score##195##1##(1990-12#3)(1990-2#4)(1991-11#1)(1991-12#1)(1991-2#4)(1991-6#4)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-12#3)(1994-3#4)(1994-9#4)(1995-9#1)(1996-3#1)(1996-6#1)(1997-5#6)(1997-8#1)(2008-10#10)(2008-11#6)(2008-12#3)(2008-5#5)(2008-6#3)(2008-7#23)(2008-8#3)(2009-10#2)(2009-12#1)(2009-3#5)(2009-5#1)(2009-7#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#4)(2011-1#3)(2011-2#27)(2011-3#3)(2012-2#6)(2012-3#10)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#3)
score)##4##1##(2010-10#2)(2011-2#2)
scorecard approach##2##2##(1995-12#2)
scorecard##5##1##(1995-12#3)(2008-11#2)
scorecards##5##1##(2008-11#5)
scored by##2##2##(2008-5#2)
scored for##7##2##(1997-8#1)(2008-10#3)(2008-7#1)(2011-2#2)
scored in##2##2##(2008-8#1)(2010-10#1)
scored lower##2##2##(2010-10#1)(2011-2#1)
scored on##3##2##(1993-1#1)(2008-10#2)
scored positive for##2##3##(2008-10#2)
scored significantly##3##2##(2008-9#1)(2010-8#2)
scored using a##2##3##(1997-3#1)(2013-1#1)
scored using##3##2##(1997-3#2)(2013-1#1)
scored##45##1##(1991-2#1)(1993-1#1)(1994-3#1)(1997-3#2)(1997-8#3)(2008-10#12)(2008-11#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#1)(2010-10#2)(2010-8#2)(2011-2#3)(2013-1#2)
scores and the##2##3##(2010-3#1)(2012-3#1)
scores and##19##2##(1991-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-3#1)(2011-2#3)(2012-3#1)
scores are##3##2##(1992-2#1)(2010-3#1)(2012-2#1)
scores as##2##2##(2008-8#1)(2012-2#1)
scores at##3##2##(2008-12#1)(2011-2#2)
scores averaged##2##2##(2008-9#1)(2012-2#1)
scores did not##2##3##(2010-10#1)(2010-11#1)
scores for children##2##3##(2012-2#2)
scores for pain##2##3##(2008-12#1)(2011-2#1)
scores for the##3##3##(2008-7#1)(2011-1#2)
scores for##18##2##(1995-12#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#2)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#1)
scores from##3##2##(1995-3#1)(2009-11#1)(2010-9#1)
scores had##4##2##(1992-1#1)(2011-2#3)
scores in the##3##3##(2008-7#1)(2010-5#1)(2011-2#1)
scores in##10##2##(2008-11#2)(2008-7#2)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#2)(2013-1#1)
scores is##3##2##(2008-10#2)(2008-11#1)
scores of a##2##3##(2008-10#1)(2008-7#1)
scores of pain (p=0##2##4##(2008-10#2)
scores of the##3##3##(2008-10#3)
scores of##17##2##(1992-1#3)(2008-1#1)(2008-10#8)(2008-7#3)(2013-1#2)
scores on the##3##3##(1992-2#1)(2008-12#1)(2012-5#1)
scores on##8##2##(1992-2#1)(2008-1#1)(2008-12#4)(2010-7#1)(2012-5#1)
scores over##3##2##(1994-9#1)(2008-12#2)
scores than the##2##3##(2010-10#1)(2013-1#1)
scores that##2##2##(2010-9#1)(2012-2#1)
scores was##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
scores were lower##2##3##(2008-4#1)(2013-1#1)
scores were significantly##4##3##(2008-5#1)(2008-7#1)(2008-9#2)
scores were##19##2##(1993-1#1)(1996-1#1)(1996-9#2)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#5)(2009-1#1)(2013-1#2)
scores##227##1##(1991-12#2)(1991-2#4)(1992-1#5)(1992-2#3)(1993-1#6)(1993-2#3)(1994-1#1)(1994-12#1)(1994-3#2)(1994-9#2)(1995-12#3)(1995-3#3)(1996-1#2)(1996-9#2)(2008-1#3)(2008-10#26)(2008-11#7)(2008-12#19)(2008-2#2)(2008-4#5)(2008-5#8)(2008-7#12)(2008-8#4)(2008-9#13)(2009-1#2)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#3)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#14)(2012-12#3)(2012-2#13)(2012-3#2)(2012-5#2)(2013-1#19)(2013-8#1)
scoring and ranking system for##4##5##(2008-11#4)
scoring and ranking##5##3##(2008-11#5)
scoring and##9##2##(2008-11#5)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
scoring for##2##2##(1995-12#1)(2008-10#1)
scoring function##4##2##(2011-3#4)
scoring matrices##4##2##(2008-11#1)(2008-9#3)
scoring of the##2##3##(2008-11#1)(2009-4#1)
scoring of##7##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2009-4#1)
scoring scale##2##2##(1997-5#1)(2011-2#1)
scoring system##8##2##(2007-8#1)(2008-10#2)(2008-5#2)(2010-3#1)(2012-3#1)(2013-1#1)
scoring systems##8##2##(2010-11#3)(2012-2#1)(2013-1#4)
scoring was performed using##2##4##(2008-5#1)(2011-2#1)
scoring was##5##2##(2008-10#2)(2008-5#1)(2010-8#1)(2011-2#1)
scoring##67##1##(1994-12#1)(1995-12#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#12)(2008-4#1)(2008-5#6)(2008-7#1)(2008-9#9)(2009-4#1)(2009-5#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#3)(2011-3#4)(2012-2#3)(2012-3#1)(2013-1#7)
scorpion##3##1##(1993-6#2)(2008-9#1)
scotopic##2##1##(2011-2#2)
scourge##2##1##(1995-2#1)(2008-9#1)
scrX##5##1##(2008-8#5)
scrap##4##1##(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
scraped##2##1##(1995-11#1)(2008-10#1)
scrapie##2##1##(1990-6#1)(1994-6#1)
scraping##3##1##(1991-5#1)(2008-5#1)(2010-6#1)
scrapings of##2##2##(1992-9#1)(2008-10#1)
scrapings##3##1##(1992-9#1)(2008-10#1)(2008-5#1)
scratch assay##2##2##(2013-8#2)
scratch##4##1##(1990-3#1)(2013-8#3)
scratching##3##1##(2008-8#1)(2011-2#2)
screen and##2##2##(1995-6#1)(2008-10#1)
screen for##20##2##(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
screen in##2##2##(2011-2#2)
screen of##5##2##(1992-12#1)(2008-11#1)(2008-9#1)(2011-2#2)
screen time and##3##3##(2013-1#3)
screen time##6##2##(2008-11#1)(2010-8#2)(2013-1#3)
screen to##2##2##(1992-12#1)(2008-10#1)
screen was found to be##2##5##(1992-12#1)(1994-5#1)
screen was##3##2##(1992-12#1)(1994-5#1)(2008-9#1)
screen##89##1##(1991-6#1)(1992-12#5)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-8#1)(2008-1#4)(2008-10#17)(2008-11#6)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#5)(2008-9#12)(2010-10#3)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
screen-based sedentary behavior and##3##4##(2013-1#3)
screen-based sedentary##4##2##(2013-1#4)
screen-based##6##1##(2013-1#6)
screen-printed amperometric biosensor##2##3##(2008-10#2)
screen-printed amperometric##3##2##(2008-10#3)
screen-printed biosensor##3##2##(2008-10#3)
screen-printed carbon electrode##7##3##(2008-10#7)
screen-printed carbon electrodes (SPCEs)##2##4##(2008-10#2)
screen-printed carbon electrodes##6##3##(2008-10#6)
screen-printed carbon##14##2##(2008-10#14)
screen-printed electrode (SPE)##4##3##(2008-10#4)
screen-printed electrode##15##2##(2008-10#15)
screen-printed electrodes for##2##3##(2008-10#2)
screen-printed electrodes##6##2##(2008-10#6)
screen-printed sensor##2##2##(2008-10#2)
screen-printed##50##1##(2008-10#50)
screen-printing##6##1##(2008-10#6)
screen-time##2##1##(2013-1#2)
screened a##2##2##(1993-2#1)(2008-8#1)
screened against##3##2##(1992-6#1)(2008-10#2)
screened and##7##2##(1992-12#1)(1994-11#1)(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)
screened by##5##2##(2008-10#2)(2008-9#2)(2010-1#1)
screened for resistance to##3##4##(2008-10#3)
screened for the presence of##3##5##(1994-11#1)(1996-12#1)(2008-10#1)
screened for the##5##3##(1994-11#1)(1996-12#1)(2008-10#3)
screened for##42##2##(1990-2#1)(1990-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
screened from a##2##3##(1995-6#1)(2008-8#1)
screened from##3##2##(1995-6#1)(1996-2#1)(2008-8#1)
screened in a##2##3##(1994-5#1)(2008-5#1)
screened in the##2##3##(1991-6#1)(2008-9#1)
screened in##8##2##(1991-6#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
screened the##5##2##(2008-10#1)(2008-8#2)(2011-2#1)(2012-3#1)
screened to##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2011-3#1)
screened using a##2##3##(1992-3#1)(2009-6#1)
screened using##7##2##(1992-3#1)(1992-6#1)(2008-10#1)(2008-8#2)(2009-6#1)(2013-1#1)
screened with a##3##3##(1990-8#1)(1991-6#1)(2008-10#1)
screened with##8##2##(1990-8#2)(1991-6#2)(2008-10#2)(2008-8#1)(2011-1#1)
screened##129##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-6#3)(1992-12#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#43)(2008-11#5)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#11)(2008-9#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#4)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#3)
screening a##4##2##(1993-12#1)(1994-11#1)(2008-8#1)(2008-9#1)
screening and analysis of##3##4##(2008-10#3)
screening and analysis##4##3##(2008-10#4)
screening and brief intervention##3##4##(2008-11#3)
screening and brief##4##3##(2008-11#4)
screening and treatment##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
screening and##46##2##(1991-9#1)(1992-2#1)(1993-12#2)(1995-11#1)(1996-12#1)(1996-2#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-5#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
screening approach##2##2##(2008-10#1)(2010-10#1)
screening assay##3##2##(2008-10#1)(2008-12#1)(2011-3#1)
screening assays##4##2##(2008-11#1)(2008-9#1)(2012-12#2)
screening based on##2##3##(1997-1#1)(2008-10#1)
screening by##3##2##(1994-3#1)(2008-9#1)(2010-8#1)
screening can be##2##3##(1997-6#1)(2008-11#1)
screening can##3##2##(1997-6#1)(2008-11#1)(2011-2#1)
screening center##2##2##(2008-10#1)(2010-8#1)
screening database##2##2##(1991-6#1)(2010-8#1)
screening for breast and##2##4##(1990-6#1)(1990-8#1)
screening for breast##3##3##(1990-2#1)(1990-6#1)(1990-8#1)
screening for drugs of abuse##2##5##(2008-10#2)
screening for resistance##3##3##(2008-10#3)
screening for the##4##3##(1990-6#1)(1991-3#1)(1991-8#1)(2008-7#1)
screening for##57##2##(1990-2#1)(1990-6#4)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#4)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-4#2)(2008-7#6)(2009-5#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
screening guidelines##2##2##(1995-9#1)(2012-2#1)
screening has been##2##3##(1990-12#1)(1992-2#1)
screening has##3##2##(1990-12#1)(1992-2#1)(1996-8#1)
screening healthcare information system##2##4##(2010-8#2)
screening in a##2##3##(2008-11#1)(2013-1#1)
screening in women##2##3##(1995-9#1)(2008-1#1)
screening in##14##2##(1990-2#1)(1990-9#1)(1992-3#1)(1995-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#2)
screening is##10##2##(1991-1#1)(1991-6#1)(1992-2#1)(1995-9#1)(1997-1#1)(2008-5#1)(2009-12#1)(2010-10#1)(2010-8#1)(2013-1#1)
screening mammography##5##2##(1991-3#2)(1993-2#1)(1996-11#1)(1997-1#1)
screening method for##7##3##(2008-10#6)(2008-11#1)
screening method is##2##3##(2008-10#1)(2012-2#1)
screening method##14##2##(2008-10#11)(2008-11#1)(2012-2#1)(2012-3#1)
screening methods for##4##3##(2008-10#4)
screening methods in##2##3##(2008-10#1)(2008-12#1)
screening methods##12##2##(2008-10#8)(2008-12#1)(2008-8#1)(2010-11#1)(2013-1#1)
screening models##3##2##(2008-9#1)(2011-3#2)
screening nurseries##3##2##(2008-10#3)
screening of a##3##3##(1990-12#1)(1992-9#1)(2008-10#1)
screening of large##2##3##(2008-10#1)(2013-1#1)
screening of organophosphorus pesticides##2##4##(2008-10#2)
screening of the##10##3##(1990-6#1)(1994-6#1)(1996-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-8#1)
screening of water##2##3##(2008-10#2)
screening of##68##2##(1990-12#1)(1990-6#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1996-11#2)(1996-12#1)(1996-8#1)(1997-2#1)(2008-10#21)(2008-11#9)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#1)
screening platform##4##2##(2008-10#1)(2008-11#3)
screening procedure##7##2##(1991-3#1)(2008-10#6)
screening procedures##3##2##(2008-11#1)(2010-8#2)
screening process##4##2##(1993-9#1)(2008-11#2)(2010-11#1)
screening program in Bogotá##2##4##(2012-12#2)
screening program in##4##3##(1992-2#1)(1993-2#1)(2012-12#2)
screening program##8##2##(1991-6#2)(1992-2#1)(1993-2#1)(1996-2#1)(2008-10#1)(2012-12#2)
screening programmes##2##2##(1995-12#1)(2012-12#1)
screening programs in##2##3##(1990-3#1)(2008-11#1)
screening programs##6##2##(1990-3#1)(1990-6#1)(1997-1#1)(2008-11#1)(2009-12#2)
screening purposes##11##2##(1990-6#2)(1995-12#1)(1997-1#1)(2008-10#6)(2008-4#1)
screening recommendations##3##2##(1990-8#1)(2008-4#1)(2009-12#1)
screening results##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
screening services##4##2##(1996-2#2)(1997-1#1)(2008-10#1)
screening sites##2##2##(2008-10#2)
screening studies##6##2##(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
screening study##3##2##(1990-8#1)(1995-12#1)(2008-1#1)
screening survey##2##2##(1995-12#2)
screening system##4##2##(2008-10#3)(2010-8#1)
screening systems for antioxidants##2##4##(2008-10#2)
screening systems##4##2##(2008-10#4)
screening technique for##3##3##(1993-3#1)(2008-10#1)(2008-9#1)
screening techniques##2##2##(2008-10#2)
screening test##8##2##(1990-6#1)(1992-3#1)(1997-2#2)(2008-10#2)(2008-5#1)(2012-3#1)
screening tests can##2##3##(1993-3#1)(2008-11#1)
screening tests for##3##3##(1990-2#1)(1992-3#1)(1993-2#1)
screening tests were##2##3##(2010-8#1)(2012-12#1)
screening tests##15##2##(1990-2#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-5#2)(2010-8#1)(2012-12#1)
screening that##2##2##(2008-10#1)(2011-7#1)
screening the##7##2##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#2)(2013-1#2)
screening tool for the##3##4##(2008-10#3)
screening tool for##7##3##(1993-12#1)(2008-10#3)(2008-8#1)(2010-9#1)(2013-1#1)
screening tool to##2##3##(1992-12#1)(2009-10#1)
screening tool##12##2##(1992-12#1)(1993-12#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
screening tools##4##2##(2008-10#2)(2008-11#1)(2010-10#1)
screening using##2##2##(1996-12#1)(2011-1#1)
screening was##4##2##(1990-2#1)(1990-8#1)(1992-2#1)(2008-8#1)
screening were##4##2##(1990-2#1)(1992-2#1)(2008-10#1)(2012-12#1)
screening with the##3##3##(1993-2#1)(1997-8#1)(2008-10#1)
screening with##7##2##(1993-2#2)(1997-8#1)(2008-10#1)(2009-10#1)(2009-5#1)(2013-1#1)
screening##607##1##(1990-12#6)(1990-2#7)(1990-3#2)(1990-6#11)(1990-8#5)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-6#13)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#8)(1992-3#3)(1992-5#4)(1992-9#2)(1993-12#7)(1993-2#6)(1993-3#3)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#3)(1995-10#1)(1995-11#1)(1995-12#11)(1995-2#1)(1995-6#1)(1995-9#10)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#5)(1997-1#13)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#4)(2008-1#6)(2008-10#158)(2008-11#49)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#14)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#17)(2009-1#1)(2009-10#3)(2009-12#4)(2009-4#1)(2009-5#7)(2009-8#2)(2010-10#4)(2010-11#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#16)(2010-9#2)(2011-1#4)(2011-2#24)(2011-3#7)(2011-7#1)(2012-12#15)(2012-2#8)(2012-3#11)(2013-1#24)(2013-8#5)
screenings##8##1##(1991-6#5)(1992-2#1)(1993-3#1)(2013-8#1)
screens for##4##2##(2008-10#1)(2008-9#1)(2012-3#1)(2012-4#1)
screens of##2##2##(2008-10#1)(2010-8#1)
screens to##3##2##(1993-12#1)(1997-7#1)(2012-3#1)
screens##17##1##(1992-3#1)(1993-12#1)(1994-2#2)(1997-7#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2012-4#1)
screw and##4##2##(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
screw diameter##3##2##(2007-11#3)
screw fixation for##2##3##(2011-2#1)(2012-12#1)
screw fixation in the##2##4##(2009-3#1)(2013-1#1)
screw fixation in##3##3##(2009-3#1)(2012-12#1)(2013-1#1)
screw fixation##9##2##(2009-1#1)(2009-3#3)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
screw placement##5##2##(2008-8#1)(2012-12#3)(2012-3#1)
screw##46##1##(2007-11#11)(2008-10#1)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#3)(2009-3#5)(2010-8#1)(2010-9#2)(2011-2#2)(2012-12#8)(2012-3#2)(2013-1#3)
screw-retained implant-supported single-tooth crowns##2##4##(2013-1#2)
screw-retained implant-supported##3##2##(2013-1#3)
screw-retained##4##1##(2013-1#4)
screwless fixation##4##2##(2009-3#4)
screws and##4##2##(2008-12#2)(2008-7#1)(2008-8#1)
screws for##2##2##(2011-2#1)(2012-12#1)
screws was##2##2##(2007-11#1)(2011-2#1)
screws were used##2##3##(2009-3#1)(2011-2#1)
screws were##4##2##(2007-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
screws##32##1##(1991-9#2)(2007-11#6)(2008-10#1)(2008-12#4)(2008-7#3)(2008-8#1)(2009-3#2)(2011-2#5)(2012-12#1)(2012-3#4)(2013-1#3)
screws)##2##1##(2008-8#1)(2013-1#1)
screws]##2##1##(1991-9#1)(2013-1#1)
script event##4##2##(1996-2#4)
script##8##1##(1995-12#1)(1996-2#6)(2008-9#1)
scrotal wall##2##2##(2008-10#2)
scrotal##5##1##(1994-8#1)(2008-10#3)(2012-12#1)
scrotum##6##1##(1994-1#1)(2008-10#3)(2012-3#1)(2013-1#1)
scrutinised##2##1##(2008-10#1)(2010-11#1)
scrutinize the##2##2##(2008-9#1)(2012-3#1)
scrutinized##3##1##(1991-12#1)(1991-5#1)(2008-10#1)
scrutiny by##2##2##(1992-12#1)(2008-11#1)
scrutiny in##2##2##(2008-10#1)(2013-1#1)
scrutiny of##5##2##(1991-6#1)(1997-1#1)(2008-11#2)(2011-2#1)
scrutiny##22##1##(1991-6#1)(1992-12#1)(1993-12#1)(1994-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
scuba diving##2##2##(2010-3#2)
scuba##4##1##(1996-2#1)(2010-3#3)
sculpting##2##1##(2009-12#1)(2010-4#1)
scutellar##2##1##(2008-10#2)
sd-t(t) gene##2##2##(2008-9#2)
sd-t(t)##5##1##(2008-9#5)
se##20##1##(1990-2#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#4)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#3)
sea and##6##2##(2008-10#5)(2008-3#1)
sea bream##3##2##(2010-5#3)
sea of##2##2##(1995-12#1)(2013-1#1)
sea pansy##3##2##(2008-7#3)
sea urchin##8##2##(1990-5#1)(1995-6#1)(2008-11#1)(2008-8#2)(2011-2#1)(2012-2#2)
sea water and##7##3##(2008-10#7)
sea water samples by ETAAS##2##5##(2008-10#2)
sea water samples##12##3##(2008-10#12)
sea water using##2##3##(2008-10#2)
sea water##39##2##(2008-10#39)
sea waters##3##2##(2008-10#3)
sea##92##1##(1990-5#1)(1994-11#1)(1995-12#1)(1995-6#1)(2008-10#52)(2008-11#4)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-8#1)(2010-1#1)(2010-5#3)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
sea-going##2##1##(2008-11#2)
sea-water and waste-water##2##3##(2008-10#2)
sea-water samples##2##2##(2008-10#2)
sea-water##6##1##(2008-10#6)
seabream##3##1##(2008-11#1)(2010-5#2)
seafood products##4##2##(2008-10#2)(2011-2#2)
seafood##9##1##(2008-10#4)(2008-11#1)(2010-9#1)(2011-2#3)
seal##12##1##(1991-3#2)(1995-6#1)(1996-6#1)(2008-10#4)(2008-7#1)(2013-1#3)
sealant materials##2##2##(2013-1#2)
sealant##9##1##(1992-3#1)(2009-6#1)(2012-3#2)(2013-1#5)
sealed using##2##2##(2008-10#2)
sealed##16##1##(1996-1#2)(1996-5#1)(2008-10#10)(2008-3#1)(2008-7#1)(2013-1#1)
sealer##2##1##(2013-1#2)
sealing the##2##2##(2008-10#1)(2013-1#1)
sealing##13##1##(2008-10#1)(2010-7#4)(2011-2#2)(2012-3#5)(2013-1#1)
seals on##2##2##(2008-10#1)(2012-2#1)
seals##10##1##(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(2008-10#4)(2011-2#1)(2012-2#1)
seamen##5##1##(1991-12#5)
seamless##5##1##(2008-11#4)(2010-8#1)
search a##4##2##(1997-6#1)(2008-12#1)(2008-9#2)
search algorithms for##2##3##(2008-1#1)(2011-2#1)
search and retrieval##3##3##(2008-11#3)
search and##4##2##(2008-11#3)(2012-12#1)
search based on##2##3##(2008-8#1)(2012-3#1)
search for answers##2##3##(2008-9#1)(2012-3#1)
search for new##8##3##(1997-7#1)(2008-1#1)(2008-10#2)(2010-7#1)(2012-3#1)(2013-1#2)
search for other##2##3##(2008-10#1)(2013-1#1)
search for the cause of##2##5##(2008-11#1)(2010-3#1)
search for the##15##3##(1995-12#2)(1996-8#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#2)(2010-3#1)(2013-1#1)
search for##77##2##(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#2)(1995-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#3)(2008-1#1)(2008-10#10)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2010-1#1)(2010-3#1)(2010-7#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#1)
search in##2##2##(2008-12#1)(2008-9#1)
search is##4##2##(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
search of a##2##3##(2009-9#1)(2010-2#1)
search of all##2##3##(2008-8#1)(2013-1#1)
search of the##10##3##(1990-2#1)(1994-2#1)(1996-2#1)(2008-11#2)(2008-8#1)(2010-5#1)(2012-3#2)(2013-8#1)
search of##27##2##(1990-2#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
search on##7##2##(1992-12#1)(1994-3#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-7#1)
search procedure##2##2##(1992-9#1)(2008-3#1)
search process##2##2##(1991-2#1)(1997-1#1)
search program##2##2##(2008-10#1)(2008-4#1)
search results##2##2##(1992-12#2)
search revealed##2##2##(1990-2#1)(2008-10#1)
search strategies##4##2##(1995-12#1)(2008-11#1)(2008-8#2)
search strategy##3##2##(2010-12#1)(2010-4#1)(2011-2#1)
search the OMIM database##2##4##(2008-4#2)
search the##9##2##(1991-12#2)(1993-8#1)(1997-6#1)(2008-4#2)(2008-8#1)(2011-1#1)(2013-1#1)
search to##3##2##(1996-6#1)(2008-10#1)(2012-3#1)
search using##2##2##(2008-10#1)(2009-10#1)
search was conducted##2##3##(1996-12#1)(2013-1#1)
search was performed##5##3##(1994-9#1)(2008-1#2)(2010-6#1)(2013-1#1)
search was##11##2##(1994-9#1)(1996-12#1)(2008-1#2)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)
search##231##1##(1990-2#2)(1991-12#4)(1991-2#4)(1991-3#1)(1992-1#2)(1992-12#5)(1992-2#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#3)(1994-3#6)(1994-5#1)(1994-9#1)(1995-12#5)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#3)(1997-7#3)(1997-8#1)(2008-1#5)(2008-10#25)(2008-11#14)(2008-12#7)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#19)(2008-9#8)(2009-10#5)(2009-11#1)(2009-12#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#6)(2012-3#7)(2013-1#18)(2013-8#4)
searched electronic databases##2##3##(2011-2#1)(2012-12#1)
searched for##20##2##(1991-5#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2009-10#2)(2009-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)
searched in##2##2##(2010-9#1)(2013-1#1)
searched to##4##2##(2011-2#1)(2012-12#3)
searched##41##1##(1991-2#1)(1991-5#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-8#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-7#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
searcher##2##1##(1991-1#1)(1994-3#1)
searchers##2##1##(1991-2#1)(1992-12#1)
searches and##3##2##(1996-2#1)(2008-11#1)(2012-2#1)
searches are##2##2##(1991-3#1)(2008-11#1)
searches for##5##2##(1991-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
searches of##2##2##(2013-1#2)
searches were##3##2##(1991-1#1)(1992-12#2)
searches##39##1##(1991-1#2)(1991-11#1)(1991-3#2)(1992-1#2)(1992-12#3)(1996-2#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#4)(2008-8#1)(2008-9#3)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
searching and##4##2##(1991-3#1)(2008-11#1)(2008-8#1)(2008-9#1)
searching for##7##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-3#1)
searching in##2##2##(2008-4#1)(2008-8#1)
searching is##3##2##(2008-8#2)(2008-9#1)
searching the##4##2##(1992-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
searching was##2##2##(1991-3#1)(1996-2#1)
searching##54##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#8)(1992-1#3)(1992-12#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#1)(2008-8#8)(2008-9#7)(2009-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
seas##4##1##(1990-11#1)(2008-10#1)(2008-11#2)
season and##9##2##(2008-10#6)(2011-2#1)(2012-7#1)(2013-1#1)
season are##2##2##(2008-10#2)
season for##2##2##(1996-12#1)(2012-3#1)
season from##2##2##(2008-10#1)(2010-8#1)
season in the##3##3##(1991-12#1)(2008-10#2)
season in##13##2##(1991-12#1)(2008-10#8)(2008-8#2)(2008-9#1)(2013-8#1)
season of##7##2##(2008-10#5)(2008-3#1)(2008-8#1)
season progressed##2##2##(2008-10#2)
season resulted in high##2##4##(2008-10#2)
season to##2##2##(2008-10#1)(2010-8#1)
season was##2##2##(2008-10#2)
season were##2##2##(2008-10#1)(2012-3#1)
season##177##1##(1991-12#1)(1991-8#1)(1992-6#2)(1994-9#2)(1996-12#2)(2008-10#112)(2008-11#3)(2008-3#1)(2008-5#2)(2008-8#18)(2008-9#3)(2009-8#1)(2010-12#1)(2010-8#7)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#5)(2012-5#2)(2012-6#1)(2012-7#3)(2013-1#2)(2013-8#1)
season)##2##1##(2008-10#1)(2012-5#1)
seasonal allergens##5##2##(2011-2#5)
seasonal and daily variations##2##4##(2008-5#2)
seasonal and daily##3##3##(2008-10#1)(2008-5#2)
seasonal and##4##2##(2008-10#2)(2008-5#2)
seasonal ascospore##4##2##(2008-10#4)
seasonal change##2##2##(2008-5#1)(2008-9#1)
seasonal changes in##3##3##(1990-11#1)(2008-8#1)(2008-9#1)
seasonal changes##4##2##(1990-11#1)(1993-6#1)(2008-8#1)(2008-9#1)
seasonal environments##2##2##(2008-9#2)
seasonal pattern##3##2##(2008-10#3)
seasonal variation in##2##3##(2008-10#1)(2010-8#1)
seasonal variation##9##2##(2008-10#3)(2008-5#1)(2010-8#2)(2012-2#1)(2012-3#2)
seasonal variations in##2##3##(1991-8#1)(2008-10#1)
seasonal variations##4##2##(1991-8#1)(2008-10#2)(2008-11#1)
seasonal weather##4##2##(2008-10#1)(2012-3#3)
seasonal##77##1##(1990-11#1)(1991-8#4)(1993-6#1)(1994-9#1)(2008-10#29)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#7)(2008-8#3)(2008-9#6)(2009-7#1)(2009-8#2)(2010-8#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#5)(2012-5#1)(2012-7#1)
seasonality##5##1##(1993-2#1)(1994-12#1)(2008-10#2)(2008-9#1)
seasonally##4##1##(1995-5#1)(2008-8#1)(2010-3#1)(2011-3#1)
seasons and##3##2##(2008-8#3)
seasons by##2##2##(2008-10#2)
seasons from##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
seasons in the##2##3##(2008-10#1)(2012-12#1)
seasons in##6##2##(2008-10#4)(2012-12#2)
seasons of##6##2##(1994-3#1)(2008-10#3)(2008-12#1)(2010-1#1)
seasons were##2##2##(2008-10#2)
seasons##73##1##(1992-6#1)(1994-3#1)(1996-1#1)(1996-12#1)(2008-10#52)(2008-11#1)(2008-12#2)(2008-8#4)(2008-9#1)(2009-7#1)(2010-1#1)(2012-12#4)(2012-2#2)(2012-8#1)
seat##4##1##(1990-5#2)(1993-3#1)(2013-1#1)
seated##3##1##(2010-3#3)
seawater and##5##2##(2008-10#5)
seawater by##7##2##(2008-10#7)
seawater in##2##2##(2008-10#2)
seawater is##3##2##(2008-10#2)(2008-3#1)
seawater matrix##2##2##(2008-10#2)
seawater pH##2##2##(2008-10#2)
seawater sample##5##2##(2008-10#4)(2009-6#1)
seawater samples containing##2##3##(2008-10#2)
seawater samples from##2##3##(2008-10#2)
seawater samples##19##2##(2008-10#19)
seawater using flow injection##2##4##(2008-10#2)
seawater using the##2##3##(2008-10#2)
seawater using##10##2##(2008-10#10)
seawater was##3##2##(2008-10#2)(2008-2#1)
seawater were##4##2##(2008-10#4)
seawater with##4##2##(2008-10#3)(2008-2#1)
seawater##124##1##(1990-11#1)(2008-10#110)(2008-2#4)(2008-3#3)(2008-5#1)(2009-6#3)(2011-2#1)(2012-5#1)
seaweed##10##1##(2008-10#7)(2008-11#3)
seaweeds##4##1##(2008-11#4)
sebacate##2##1##(2008-10#2)
sebaceous glands##2##2##(2008-5#1)(2008-9#1)
sebaceous##3##1##(2008-5#2)(2008-9#1)
seborrheic dermatitis##2##2##(2008-5#2)
seborrheic keratosis##4##2##(2007-8#2)(2011-2#1)(2012-12#1)
seborrheic##6##1##(2007-8#2)(2008-5#2)(2011-2#1)(2012-12#1)
seborrhoeic##2##1##(1991-2#1)(2008-5#1)
sebum content##2##2##(2008-5#2)
sebum##10##1##(2008-5#10)
sec##14##1##(1990-2#2)(1992-12#1)(1992-2#1)(1994-12#1)(1995-2#1)(1997-5#1)(2008-5#1)(2010-7#3)(2011-2#1)(2013-1#1)(2013-8#1)
sec)##5##1##(2008-4#1)(2008-5#4)
sec18##2##1##(1994-12#1)(1997-1#1)
sec7##3##1##(1997-1#3)
secalis in##3##2##(2008-10#3)
secalis populations##2##2##(2008-10#2)
secalis were##2##2##(2008-10#2)
secalis##26##1##(2008-10#26)
seclusion##2##1##(2009-6#2)
second (FEV1)##3##2##(2008-1#1)(2011-2#1)(2012-3#1)
second F(2) population##2##3##(2008-10#2)
second alkane-inducible cytochrome P450-encoding gene##2##5##(1991-9#2)
second analysis##3##2##(2008-10#3)
second and third line##2##4##(1993-1#2)
second and third##11##3##(1993-1#2)(1993-12#2)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#2)
second antibody##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
second application##2##2##(1997-4#1)(2008-11#1)
second approach##5##2##(1995-2#1)(2008-10#2)(2008-3#2)
second article##2##2##(1994-1#1)(2012-2#1)
second attachment site##2##3##(1995-6#2)
second basic##2##2##(1995-6#1)(2008-4#1)
second birth##2##2##(2009-10#1)(2010-11#1)
second case of##4##3##(1993-2#1)(2007-8#1)(2010-3#1)(2013-1#1)
second case##10##2##(1993-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
second cause##3##2##(1991-11#1)(2010-12#1)(2011-3#1)
second class##2##2##(1994-11#1)(2008-11#1)
second codon##2##2##(1993-8#1)(1997-2#1)
second course##3##2##(2008-10#2)(2008-11#1)
second cycle##2##2##(2008-10#1)(2008-11#1)
second day##7##2##(2008-12#2)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
second derivative spectra##3##3##(2008-10#3)
second derivative spectrophotometric method##3##4##(2008-10#3)
second derivative spectrophotometry##3##3##(2008-10#3)
second derivative##14##2##(2008-10#14)
second dimension##3##2##(2008-10#2)(2009-10#1)
second dissociation reactions of the##2##5##(2008-10#2)
second dissociation##6##2##(2008-10#6)
second ed##3##2##(2008-11#1)(2008-12#2)
second edition##4##2##(2008-10#2)(2010-5#1)(2013-8#1)
second example##3##2##(2008-10#2)(2008-8#1)
second experiment##10##2##(1996-12#2)(2008-10#7)(2008-3#1)
second factor##2##2##(2008-10#1)(2009-11#1)
second flavodoxin gene##2##3##(1997-7#2)
second gene##2##2##(1992-6#1)(2009-8#1)
second generation of##2##3##(1991-5#1)(2008-10#1)
second generation##9##2##(1990-2#1)(1991-5#1)(1991-6#2)(1997-3#1)(2008-10#2)(2009-6#1)(2012-2#1)
second group of##4##3##(1990-5#1)(2011-2#1)(2012-3#2)
second group##19##2##(1990-2#2)(1990-5#1)(1991-5#1)(2007-8#3)(2008-10#4)(2008-9#1)(2011-2#2)(2012-3#4)(2013-1#1)
second half##7##2##(1991-6#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
second harmonic##6##2##(2007-12#1)(2008-10#2)(2008-3#3)
second hour post##2##3##(2012-2#2)
second in##2##2##(1997-1#1)(2008-12#1)
second injection##3##2##(1996-12#2)(2013-8#1)
second intron of the##2##4##(1993-8#1)(2012-3#1)
second is##12##2##(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2012-2#1)(2012-3#1)
second kind##2##2##(2008-10#1)(2009-10#1)
second largest##2##2##(1995-12#1)(2008-10#1)
second level##2##2##(1993-3#1)(2008-8#1)
second line chemotherapy##2##3##(1990-2#1)(1994-2#1)
second line therapy##3##3##(1990-2#1)(1997-7#1)(2008-5#1)
second line##7##2##(1990-2#2)(1993-1#1)(1994-2#1)(1997-4#1)(1997-7#1)(2008-5#1)
second manifold##2##2##(2008-10#2)
second messenger in##2##3##(1993-6#1)(1995-8#1)
second messenger##13##2##(1992-3#1)(1993-6#3)(1994-11#1)(1994-5#2)(1995-11#1)(1995-8#2)(1996-2#1)(2008-11#1)(2009-6#1)
second messengers in##2##3##(1995-8#1)(2008-11#1)
second messengers##13##2##(1991-3#2)(1992-8#1)(1993-6#1)(1995-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#2)(2013-1#1)
second method is##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
second method was##3##3##(2008-10#2)(2010-8#1)
second method##16##2##(2008-10#9)(2008-3#3)(2008-4#1)(2008-7#1)(2010-8#1)(2012-2#1)
second most frequently##2##3##(1996-8#1)(2013-1#1)
second most##13##2##(1996-11#1)(1996-8#1)(2007-12#1)(2008-11#2)(2008-5#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
second on##2##2##(2008-11#1)(2008-6#1)
second one##13##2##(1991-3#1)(1994-11#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)
second one)##2##2##(1990-2#1)(1993-2#1)
second only to##2##3##(2008-9#1)(2012-2#1)
second or third##2##3##(1993-1#1)(2008-10#1)
second order derivative##3##3##(2008-10#3)
second order##12##2##(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)
second pair of##2##3##(2008-8#1)(2012-3#1)
second part of the##2##4##(2008-11#1)(2013-8#1)
second part of##5##3##(1994-3#1)(1997-4#1)(1997-6#1)(2008-11#1)(2013-8#1)
second part##13##2##(1994-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-5#1)(2009-6#1)(2013-8#2)
second patient##5##2##(2008-1#1)(2008-9#1)(2009-1#1)(2010-7#1)(2013-1#1)
second peak##4##2##(1997-3#1)(2008-10#2)(2008-11#1)
second period##6##2##(1996-3#2)(2011-2#3)(2013-1#1)
second phase##4##2##(2008-10#1)(2008-4#1)(2008-6#1)(2009-7#1)
second primary##3##2##(1990-8#1)(1991-6#1)(2011-2#1)
second principal##2##2##(2008-10#1)(2008-6#1)
second procedure##2##2##(1996-9#1)(2008-4#1)
second round of##3##3##(1997-7#1)(2008-10#1)(2008-3#1)
second round##4##2##(1991-6#1)(1997-7#1)(2008-10#1)(2008-3#1)
second sample##2##2##(2008-10#2)
second section##9##2##(1991-1#1)(1992-6#1)(2008-10#2)(2008-4#2)(2010-11#1)(2012-2#2)
second series##2##2##(1992-6#1)(2008-5#1)
second set of##5##3##(1993-12#1)(2008-10#1)(2010-10#1)(2013-1#2)
second set##6##2##(1993-12#1)(2008-10#2)(2010-10#1)(2013-1#2)
second site##3##2##(1995-6#1)(2008-8#1)(2011-2#1)
second stage juvenile##2##3##(2008-12#2)
second stage of##2##3##(2012-3#1)(2013-8#1)
second stage##7##2##(1990-12#1)(2008-10#1)(2008-12#3)(2012-3#1)(2013-8#1)
second step##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)
second study##4##2##(1991-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
second substrates of the enzyme##2##5##(2008-10#2)
second test##2##2##(1990-6#1)(2012-3#1)
second time##5##2##(1991-8#1)(1992-12#1)(1996-12#1)(2008-10#1)(2013-1#1)
second to##4##2##(1990-8#1)(1992-6#1)(2008-10#2)
second toe##3##2##(1996-8#1)(2010-11#2)
second trimester##5##2##(1991-6#1)(1993-3#1)(1994-3#1)(1997-7#1)(2013-1#1)
second type##5##2##(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)
second was##3##2##(1994-2#1)(2008-10#1)(2009-8#1)
second week##7##2##(1992-3#2)(2008-10#3)(2008-8#1)(2009-12#1)
second year of the##2##4##(1995-5#1)(2008-10#1)
second year of##3##3##(1995-5#1)(1996-11#1)(2008-10#1)
second year##13##2##(1991-8#1)(1995-5#1)(1996-11#1)(1996-12#4)(2008-10#2)(2008-12#4)
second##816##1##(1990-11#3)(1990-12#6)(1990-2#7)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#7)(1991-5#3)(1991-6#6)(1991-8#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#5)(1992-4#1)(1992-6#4)(1992-8#2)(1993-1#5)(1993-12#6)(1993-2#5)(1993-3#4)(1993-6#5)(1993-8#5)(1994-1#1)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#12)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#13)(1996-2#5)(1996-3#5)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#9)(1997-4#3)(1997-6#1)(1997-7#8)(1997-8#1)(2007-11#1)(2007-12#6)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#218)(2008-11#38)(2008-12#21)(2008-2#5)(2008-3#25)(2008-4#10)(2008-5#15)(2008-6#8)(2008-7#15)(2008-8#32)(2008-9#11)(2009-1#3)(2009-10#4)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#7)(2009-7#4)(2009-8#7)(2009-9#1)(2010-10#4)(2010-11#8)(2010-12#5)(2010-3#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#6)(2011-2#36)(2011-3#1)(2012-12#6)(2012-2#13)(2012-3#17)(2013-1#29)(2013-7#1)(2013-8#12)
second-derivative spectroscopy##2##2##(1993-8#2)
second-derivative##12##1##(1993-8#2)(2008-10#9)(2008-3#1)
second-generation process##2##2##(2008-11#2)
second-generation##8##1##(1991-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-12#1)(2011-2#1)
second-harmonic generation of##2##3##(2008-2#1)(2008-3#1)
second-harmonic generation##13##2##(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#3)
second-harmonic light##2##2##(2007-11#1)(2008-2#1)
second-harmonic##27##1##(2007-11#3)(2007-12#8)(2008-2#9)(2008-3#7)
second-line agents##2##2##(2008-2#1)(2012-3#1)
second-line therapy##3##2##(1992-12#1)(1994-12#1)(2010-12#1)
second-line##13##1##(1992-12#2)(1993-11#1)(1994-12#1)(2008-2#1)(2010-12#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
second-look##2##1##(1992-2#1)(1992-3#1)
second-order advantage##4##2##(2008-10#4)
second-order data##2##2##(2008-10#2)
second-order fear conditioning##2##3##(1997-7#2)
second-order nonlinearity##3##2##(2008-2#1)(2008-3#2)
second-order rate constant##4##3##(1990-5#1)(1993-8#1)(1994-5#1)(2008-4#1)
second-order rate##6##2##(1990-5#1)(1993-8#1)(1994-5#1)(2008-10#2)(2008-4#1)
second-order reaction##3##2##(1993-8#1)(2008-10#2)
second-order##42##1##(1990-5#1)(1993-8#2)(1994-5#1)(1997-7#3)(2007-11#4)(2008-10#21)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)
second-order-pumped fiber Raman amplifiers##2##4##(2007-11#2)
second-phase Ca2+ response##2##3##(1990-2#2)
second-phase##3##1##(1990-2#2)(1991-5#1)
second-stage juveniles (J2)##4##3##(2008-10#4)
second-stage juveniles per##2##3##(2008-10#2)
second-stage juveniles##10##2##(2008-10#10)
second-stage##14##1##(2008-10#12)(2012-3#2)
secondarily##7##1##(2008-10#2)(2008-7#1)(2008-9#3)(2012-3#1)
secondary aliphatic##3##2##(1996-5#2)(2008-10#1)
secondary amines##3##2##(1996-5#1)(2008-10#2)
secondary analysis of data##2##4##(2008-12#1)(2012-12#1)
secondary analysis##4##2##(2008-10#1)(2008-12#1)(2010-10#1)(2012-12#1)
secondary and tertiary structure of##2##5##(2008-10#1)(2008-9#1)
secondary and tertiary structure##5##4##(2008-10#1)(2008-4#3)(2008-9#1)
secondary and tertiary##9##3##(1990-6#1)(1993-2#1)(1994-5#1)(1995-12#1)(2008-10#1)(2008-4#3)(2008-9#1)
secondary and##10##2##(1990-6#1)(1993-2#1)(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#1)
secondary anti-apoptotic##2##2##(2011-2#2)
secondary antibodies##2##2##(1990-12#2)
secondary antibody responses##2##3##(2008-10#2)
secondary antibody##9##2##(1991-3#1)(2008-10#4)(2008-4#2)(2008-9#2)
secondary axis##3##2##(2008-6#3)
secondary center of diversity of##2##5##(2008-10#2)
secondary complications##2##2##(1993-11#1)(2008-1#1)
secondary conidia and##2##3##(2008-10#2)
secondary conidia on##2##3##(2008-10#2)
secondary conidia##9##2##(2008-10#9)
secondary conidiation##2##2##(2008-10#2)
secondary data##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
secondary diagnosis##2##2##(1991-3#1)(1991-8#1)
secondary dispersal##2##2##(2010-4#2)
secondary droplets##2##2##(1995-3#1)(2008-5#1)
secondary education##3##2##(2009-10#1)(2011-2#2)
secondary effects of##2##3##(2006-6#1)(2009-12#1)
secondary female##2##2##(2008-8#2)
secondary foci##2##2##(2008-10#2)
secondary germ tubes and a haustorium##2##6##(2008-10#2)
secondary germ tubes##3##3##(2008-10#3)
secondary growth and##2##3##(2012-5#2)
secondary growth##3##2##(2008-10#1)(2012-5#2)
secondary headspot cells##5##3##(2007-12#5)
secondary hyperparathyroidism##7##2##(1991-11#3)(1991-8#1)(1993-3#2)(2011-2#1)
secondary hypertension##3##2##(1997-2#1)(2008-12#1)(2011-2#1)
secondary hyphae##5##2##(2008-10#5)
secondary infection##9##2##(2008-1#1)(2008-10#8)
secondary infections##2##2##(2008-10#2)
secondary inoculum##4##2##(2008-10#4)
secondary ion mass spectrometry (S-SIMS) for the##2##7##(2008-10#2)
secondary ion mass spectrometry (SIMS)##2##5##(2008-10#1)(2012-12#1)
secondary ion mass spectrometry##6##4##(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)
secondary ion##7##2##(2008-10#4)(2008-2#1)(2008-5#1)(2012-12#1)
secondary metabolite biosynthesis##2##3##(2008-10#2)
secondary metabolite production##2##3##(2008-10#2)
secondary metabolite##6##2##(2008-10#4)(2008-7#1)(2011-2#1)
secondary metabolites##8##2##(2008-10#4)(2008-9#2)(2011-1#1)(2011-2#1)
secondary osteoarthritis##4##2##(2013-1#4)
secondary prevention of##4##3##(2007-8#1)(2008-11#1)(2010-1#1)(2010-2#1)
secondary prevention##14##2##(1990-2#1)(1993-3#1)(1994-2#1)(1997-1#1)(2007-8#1)(2008-11#1)(2010-1#1)(2010-2#1)(2010-7#3)(2011-2#1)(2011-3#1)(2013-1#1)
secondary products##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
secondary reactions##2##2##(2008-10#1)(2009-8#1)
secondary roots##3##2##(2008-10#3)
secondary school students##2##3##(1990-2#1)(2013-1#1)
secondary school##4##2##(1990-2#1)(1996-6#1)(2008-10#1)(2013-1#1)
secondary schools in##2##3##(2008-10#1)(2009-7#1)
secondary schools##5##2##(2008-10#2)(2009-7#2)(2013-1#1)
secondary sexual characters in##2##4##(1995-2#2)
secondary sexual characters##4##3##(1995-2#4)
secondary sexual##10##2##(1995-2#4)(2007-12#1)(2008-9#4)(2010-9#1)
secondary sources##2##2##(2012-12#1)(2012-3#1)
secondary sporidia##4##2##(2008-10#4)
secondary spread of the##2##4##(2008-10#2)
secondary spread of##4##3##(2008-10#4)
secondary spread##12##2##(2008-10#12)
secondary structure and##2##3##(1992-4#1)(2011-2#1)
secondary structure in##2##3##(1991-9#1)(1994-3#1)
secondary structure of the##2##4##(1992-6#1)(2008-10#1)
secondary structure of##7##3##(1992-6#1)(1992-8#1)(1993-8#1)(2008-10#3)(2008-9#1)
secondary structure predicted##2##3##(1995-12#1)(2008-10#1)
secondary structure##30##2##(1990-4#3)(1990-5#1)(1991-5#1)(1991-9#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-8#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-10#7)(2008-4#3)(2008-9#1)(2011-2#1)(2011-3#1)
secondary structures##16##2##(1990-5#1)(1991-5#1)(1992-3#1)(1993-3#1)(1995-9#1)(1997-6#2)(2008-10#1)(2008-4#1)(2008-8#2)(2010-7#1)(2011-2#1)(2011-3#3)
secondary to a##11##3##(1990-3#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
secondary to an##6##3##(1995-5#1)(2008-7#2)(2010-10#1)(2010-6#1)(2013-1#1)
secondary to hypertension##2##3##(2008-12#1)(2013-1#1)
secondary to the##7##3##(1991-3#1)(1992-1#1)(1995-8#1)(2008-1#1)(2008-7#2)(2013-1#1)
secondary to trauma##2##3##(2008-7#1)(2011-2#1)
secondary to##82##2##(1990-12#2)(1990-3#1)(1991-3#3)(1992-1#1)(1992-9#2)(1994-8#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#13)(2008-9#3)(2009-12#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-2#1)(2010-6#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#5)
secondary xylem##2##2##(2008-10#2)
secondary##474##1##(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#3)(1991-2#2)(1991-3#7)(1991-5#2)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-2#1)(1996-3#4)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-6#4)(1997-8#3)(2006-6#1)(2007-12#8)(2007-8#2)(2008-1#5)(2008-10#130)(2008-11#11)(2008-12#8)(2008-2#3)(2008-4#14)(2008-5#4)(2008-6#3)(2008-7#19)(2008-8#5)(2008-9#22)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#5)(2010-9#2)(2011-1#3)(2011-2#28)(2011-3#7)(2012-12#6)(2012-2#6)(2012-3#7)(2012-5#2)(2013-1#20)(2013-7#1)(2013-8#7)
secondly the##2##2##(2008-11#1)(2008-12#1)
secondly##13##1##(1995-5#1)(2008-10#4)(2008-11#4)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
secondment to##2##2##(2008-11#1)(2010-1#1)
seconds##22##1##(1990-2#1)(1991-5#2)(1993-6#1)(1994-5#1)(1997-4#1)(2007-9#1)(2008-10#5)(2008-3#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
secret##5##1##(1994-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-11#1)
secretagogues##4##1##(1990-12#2)(1994-12#1)(1997-1#1)
secrete a##2##2##(2007-12#1)(2008-10#1)
secrete insulin##3##2##(2010-10#1)(2010-11#2)
secrete pancreatic##2##2##(2008-1#1)(2009-7#1)
secrete the##2##2##(2008-10#2)
secrete##42##1##(1991-5#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-5#2)(1997-7#1)(2007-12#1)(2008-1#6)(2008-10#5)(2008-11#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#2)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
secreted EPO##2##2##(2008-11#2)
secreted IgG##2##2##(2008-7#2)
secreted alkaline phosphatase (SEAP)##2##4##(2008-7#1)(2011-2#1)
secreted alkaline phosphatase##3##3##(1993-6#1)(2008-7#1)(2011-2#1)
secreted an##2##2##(2008-10#1)(2010-6#1)
secreted and##3##2##(1991-6#1)(1992-10#1)(1997-6#1)
secreted at##2##2##(1990-5#1)(1993-3#1)
secreted by activated##2##3##(1994-5#1)(2008-4#1)
secreted by the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
secreted by##27##2##(1992-12#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-6#1)(2011-2#1)
secreted form of##3##3##(1992-12#1)(2008-11#2)
secreted form##4##2##(1992-12#1)(1997-1#1)(2008-11#2)
secreted from the cells##2##4##(2008-11#1)(2008-8#1)
secreted from the##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
secreted from##8##2##(1993-12#1)(1993-3#1)(2008-11#4)(2008-4#1)(2008-8#1)
secreted human##2##2##(2008-11#2)
secreted in a##3##3##(1997-2#1)(2008-7#1)(2012-2#1)
secreted in##7##2##(1990-12#1)(1992-8#1)(1995-8#1)(1997-2#1)(2008-7#1)(2012-2#2)
secreted into the medium##2##4##(1992-3#1)(1993-3#1)
secreted into the##7##3##(1992-3#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(2008-5#1)
secreted into##9##2##(1990-12#1)(1992-3#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(2008-11#1)(2008-5#1)
secreted molecules##2##2##(2008-4#1)(2008-7#1)
secreted protein##6##2##(1995-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)
secreted to the##2##3##(2008-8#1)(2009-3#1)
secreted##128##1##(1990-12#2)(1990-5#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#6)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#3)(1997-2#1)(1997-6#1)(2008-10#13)(2008-11#24)(2008-12#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-2#4)
secretes##4##1##(1994-8#1)(1997-1#1)(2008-10#1)(2011-1#1)
secretin in##2##2##(1994-3#2)
secretin##4##1##(1994-3#2)(2009-7#1)(2013-8#1)
secreting an##2##2##(2008-10#1)(2013-7#1)
secreting cells##2##2##(2008-11#1)(2008-4#1)
secreting monoclonal antibodies##2##3##(2008-10#1)(2008-11#1)
secreting monoclonal antibody##2##3##(2008-11#2)
secreting monoclonal##4##2##(2008-10#1)(2008-11#3)
secreting recombinant##2##2##(2008-11#2)
secreting##29##1##(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#15)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2013-7#1)
secretion and mucosal##2##3##(1997-1#1)(2012-2#1)
secretion and##29##2##(1991-7#1)(1992-6#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#2)(1997-1#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#2)(2008-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
secretion as##3##2##(1994-3#1)(1996-12#1)(2010-11#1)
secretion assay##4##2##(2008-11#3)(2008-4#1)
secretion at##3##2##(1994-12#1)(1995-11#1)(1997-2#1)
secretion by##16##2##(1991-5#1)(1994-8#1)(1995-11#3)(1995-8#2)(2006-6#1)(2008-11#3)(2008-12#3)(2009-3#1)(2009-5#1)
secretion during##2##2##(1990-5#1)(1997-2#1)
secretion dynamics##2##2##(2008-11#2)
secretion efficiency##2##2##(1991-6#2)
secretion for##3##2##(2008-11#3)
secretion from Bacillus subtilis of a 34-amino acid##2##8##(1991-6#2)
secretion from naive##2##3##(2008-11#2)
secretion from the##3##3##(1990-11#1)(2008-6#1)(2012-2#1)
secretion from##24##2##(1990-11#1)(1991-6#2)(1992-6#1)(1994-8#3)(1995-11#1)(1995-8#5)(1996-12#1)(2008-10#1)(2008-11#6)(2008-6#1)(2008-7#1)(2012-2#1)
secretion in bovine##2##3##(1995-11#2)
secretion in rats##3##3##(1992-6#1)(1994-11#2)
secretion in response to##2##4##(1995-8#1)(2010-11#1)
secretion in the presence of##3##5##(1994-11#1)(1995-11#1)(2008-11#1)
secretion in the##7##3##(1991-9#1)(1993-12#2)(1994-11#1)(1995-11#1)(1995-8#1)(2008-11#1)
secretion in##27##2##(1990-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1995-11#3)(1995-8#7)(1997-1#1)(2008-11#1)(2010-11#1)(2013-1#1)
secretion induced by##2##3##(1995-8#2)
secretion into##2##2##(1994-11#1)(2008-11#1)
secretion is not dependent on##2##5##(1994-8#1)(1995-11#1)
secretion is stimulated##2##3##(1991-6#1)(1997-1#1)
secretion is##14##2##(1991-5#1)(1991-6#1)(1994-12#1)(1994-8#1)(1995-11#2)(1997-1#3)(2007-12#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
secretion observed in##2##3##(1992-8#1)(1996-2#1)
secretion observed##4##2##(1992-8#2)(1996-2#1)(2008-11#1)
secretion of ANP and BNP##2##5##(1991-5#2)
secretion of IL-12 p70##2##4##(2008-8#2)
secretion of TGF-beta from IECs##2##5##(2008-11#2)
secretion of active##2##3##(1995-6#1)(1997-1#1)
secretion of an##2##3##(1995-6#1)(2008-11#1)
secretion of beta-endorphin in##2##4##(1990-12#2)
secretion of insulin##2##3##(2010-11#2)
secretion of proinflammatory cytokines such as##2##6##(2008-11#2)
secretion of proinflammatory cytokines##4##4##(2008-11#4)
secretion of the##6##3##(1990-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)
secretion of transforming growth factor beta##2##6##(2008-11#2)
secretion of##78##2##(1990-12#2)(1990-5#1)(1990-9#1)(1991-5#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-1#2)(1997-7#1)(2006-6#2)(2007-12#2)(2008-10#2)(2008-11#26)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-12#1)(2010-11#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#2)
secretion on the##2##3##(2008-11#1)(2009-8#1)
secretion or##2##2##(2006-6#1)(2008-7#1)
secretion patterns##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
secretion profile##2##2##(2008-11#2)
secretion profiles##2##2##(2008-11#1)(2011-2#1)
secretion rate of##2##3##(2008-11#2)
secretion rate##3##2##(2008-11#3)
secretion rates were##2##3##(2013-8#2)
secretion rates##3##2##(2013-8#3)
secretion system##5##2##(2008-11#2)(2008-9#1)(2009-8#1)(2011-2#1)
secretion that##2##2##(1990-5#1)(2007-12#1)
secretion to the##2##3##(2008-10#2)
secretion to##4##2##(1993-2#1)(2008-10#2)(2008-7#1)
secretion via##2##2##(1997-1#2)
secretion was not##2##3##(1995-11#1)(2008-11#1)
secretion was##9##2##(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-8#1)(2008-11#1)(2008-7#1)(2012-5#1)
secretion were also##2##3##(2006-6#1)(2011-2#1)
secretion were##4##2##(2006-6#1)(2008-11#1)(2008-5#1)(2011-2#1)
secretion when##2##2##(2008-11#2)
secretion with##3##2##(1994-11#1)(1996-2#1)(2013-1#1)
secretion##391##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#4)(1990-9#1)(1991-5#5)(1991-6#5)(1991-7#4)(1991-9#3)(1992-6#4)(1992-8#4)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#11)(1994-12#4)(1994-3#6)(1994-5#3)(1994-8#8)(1995-11#16)(1995-2#2)(1995-6#4)(1995-8#21)(1996-12#3)(1996-2#7)(1997-1#22)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2006-6#6)(2007-12#14)(2008-1#3)(2008-10#12)(2008-11#81)(2008-12#6)(2008-4#12)(2008-5#6)(2008-6#6)(2008-7#17)(2008-8#6)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#7)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#6)(2013-7#2)(2013-8#5)
secretion)##2##1##(2008-4#1)(2009-12#1)
secretion-affinity fusion system##2##3##(2008-7#2)
secretions and##4##2##(1993-3#1)(1994-8#1)(1997-1#1)(2008-5#1)
secretions from the##2##3##(1990-11#1)(2007-12#1)
secretions from##4##2##(1990-11#1)(1991-11#1)(1997-1#1)(2007-12#1)
secretions in##2##2##(2008-1#1)(2008-11#1)
secretions of the##2##3##(1991-5#1)(2008-12#1)
secretions of##3##2##(1991-5#1)(2008-12#1)(2008-5#1)
secretions##38##1##(1990-11#2)(1991-11#6)(1991-5#1)(1991-6#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-8#2)(1996-2#1)(1997-1#3)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#9)(2012-2#1)
secretogranin II##6##2##(1992-12#6)
secretory activity##3##2##(1997-1#1)(2007-12#1)(2008-7#1)
secretory cell##2##2##(2007-12#1)(2008-6#1)
secretory cells##6##2##(2007-12#4)(2008-6#1)(2008-7#1)
secretory cycle##3##2##(2008-7#3)
secretory function and##2##3##(2007-11#1)(2010-10#1)
secretory function##8##2##(1992-6#1)(1994-12#1)(2007-11#1)(2007-12#1)(2010-10#4)
secretory granule##3##2##(1992-6#1)(2010-11#2)
secretory granules in##2##3##(1992-12#1)(1997-7#1)
secretory granules with##2##3##(1992-12#1)(2008-7#1)
secretory granules##16##2##(1992-12#5)(1992-2#1)(1995-8#3)(1997-7#2)(2007-12#1)(2008-7#3)(2010-11#1)
secretory machinery##2##2##(1991-5#2)
secretory pathway and##2##3##(2009-8#1)(2012-2#1)
secretory pathway##10##2##(1997-1#3)(2008-11#2)(2008-7#3)(2009-8#1)(2012-2#1)
secretory pathways##3##2##(1992-12#2)(1993-5#1)
secretory patterns##2##2##(1995-8#1)(1997-1#1)
secretory portions##4##2##(2007-12#4)
secretory product##2##2##(2007-12#2)
secretory profiles##2##2##(2007-11#1)(2013-1#1)
secretory protein##2##2##(1995-2#1)(1997-8#1)
secretory response to##2##3##(1990-12#1)(1990-5#1)
secretory response##3##2##(1990-12#1)(1990-5#1)(1995-8#1)
secretory small GTPase Rab27B##2##4##(2011-2#2)
secretory spines##2##2##(2007-12#2)
secretory tissues##3##2##(2012-2#3)
secretory units##2##2##(2007-12#1)(2008-7#1)
secretory vesicles from##2##3##(1992-12#1)(2008-11#1)
secretory vesicles##7##2##(1992-12#2)(1997-7#1)(2007-12#1)(2008-11#2)(2008-7#1)
secretory##126##1##(1990-12#1)(1990-5#3)(1991-5#3)(1991-6#1)(1991-7#1)(1992-12#9)(1992-2#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#5)(1996-12#1)(1997-1#6)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#22)(2008-1#2)(2008-10#2)(2008-11#9)(2008-6#3)(2008-7#16)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#4)(2010-11#5)(2011-2#3)(2012-2#4)(2013-1#3)
secrets##4##1##(1993-1#1)(1995-9#1)(1996-3#1)(2011-2#1)
section Flavi##2##2##(2008-10#2)
section and##4##2##(2008-3#3)(2008-5#1)
section deals with##2##3##(2008-10#1)(2008-4#1)
section discusses##4##2##(1994-3#1)(2008-4#2)(2011-2#1)
section followed by##2##3##(2008-7#1)(2013-1#1)
section for##4##2##(1995-12#1)(2008-2#1)(2008-3#2)
section in##4##2##(2008-10#2)(2008-3#1)(2012-3#1)
section is##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
section of a##4##3##(1992-12#1)(1997-3#1)(2008-10#1)(2008-3#1)
section of the##9##3##(1993-12#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-2#2)
section of##26##2##(1990-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1996-5#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#4)(2008-8#3)(2011-2#2)(2013-1#2)
section on##7##2##(1991-2#1)(1992-2#1)(1997-2#1)(2008-3#1)(2008-4#1)(2012-2#2)
section to##2##2##(2008-3#1)(2011-2#1)
section using##2##2##(2008-10#1)(2008-11#1)
section was##2##2##(2011-2#1)(2013-1#1)
section with##2##2##(2008-3#1)(2013-1#1)
section##133##1##(1990-2#2)(1991-1#1)(1991-2#4)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#3)(1995-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#20)(2008-4#8)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-5#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#9)
sectional study##4##2##(2008-7#1)(2011-2#2)(2012-2#1)
sectional##9##1##(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
sectioned at##3##2##(1992-12#1)(2009-4#1)(2011-2#1)
sectioned in##2##2##(2008-9#1)(2009-12#1)
sectioned##11##1##(1990-2#1)(1992-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2011-2#2)(2013-1#1)
sectioning with a##2##3##(2008-4#2)
sectioning##12##1##(1997-8#1)(2007-12#1)(2008-4#5)(2008-9#2)(2011-2#2)(2013-8#1)
sections and##5##2##(1991-11#1)(1991-2#1)(2008-10#1)(2008-7#1)(2010-11#1)
sections at##3##2##(1994-3#1)(1997-2#1)(2008-4#1)
sections from##6##2##(1990-12#3)(1991-9#1)(2008-3#1)(2008-7#1)
sections of a##2##3##(2008-2#1)(2012-3#1)
sections of brain##2##3##(1994-11#1)(2010-11#1)
sections of the##8##3##(1990-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
sections of##34##2##(1990-11#1)(1990-5#1)(1991-2#1)(1994-11#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-2#4)(2012-3#1)
sections revealed##2##2##(1997-2#1)(2008-10#1)
sections show##2##2##(1990-5#1)(2007-12#1)
sections stained##2##2##(2008-5#1)(2013-1#1)
sections to##4##2##(1993-11#1)(1996-2#1)(1997-2#1)(2008-4#1)
sections was##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
sections were cut##2##3##(1997-2#1)(2012-3#1)
sections were##9##2##(1993-12#1)(1997-2#3)(2011-2#2)(2012-3#3)
sections##130##1##(1990-11#1)(1990-12#3)(1990-5#2)(1991-11#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-2#6)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#21)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#8)(2008-5#5)(2008-7#7)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#1)(2009-7#1)(2010-11#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#9)(2012-2#5)(2012-3#8)(2013-1#1)
sector and##6##2##(1992-2#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)
sector are##3##2##(1991-12#1)(1996-3#1)(2008-11#1)
sector employment##3##2##(1994-12#1)(1996-2#2)
sector has##2##2##(1995-3#1)(2013-8#1)
sector in##4##2##(1993-3#1)(2008-12#1)(2010-10#1)(2012-3#1)
sector is##3##2##(1997-2#1)(2011-2#2)
sector of the##2##3##(1995-8#1)(1996-3#1)
sector should##2##2##(2008-11#1)(2011-2#1)
sector##97##1##(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#1)(1995-3#6)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#2)(1997-1#5)(1997-2#5)(1997-5#5)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#4)(2009-10#1)(2009-3#1)(2010-10#2)(2010-7#1)(2011-2#4)(2012-2#4)(2012-3#6)(2013-8#1)
sector-field##2##1##(2008-10#2)
sectors and##2##2##(1991-2#1)(2008-12#1)
sectors in##2##2##(1994-1#1)(2010-12#1)
sectors of the##2##3##(2008-11#1)(2009-4#1)
sectors of##5##2##(1990-12#1)(1991-3#1)(2008-11#1)(2009-4#1)(2012-2#1)
sectors to##3##2##(1996-2#1)(1997-3#1)(2008-11#1)
sectors##32##1##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1994-1#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#2)(1997-3#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-5#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
secular##5##1##(2008-11#2)(2008-12#1)(2008-8#1)(2013-1#1)
secundum atrial septal##2##3##(2008-11#1)(2009-10#1)
secure##28##1##(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-5#2)(2010-8#1)(2013-1#2)
secured interrupted stitch##2##3##(1991-2#2)
secured stitch##2##2##(1991-2#2)
secured##7##1##(1991-2#4)(2008-11#1)(2008-9#2)
securing a##2##2##(1991-3#1)(2008-7#1)
securing the##2##2##(2010-7#1)(2011-2#1)
securing##12##1##(1991-3#1)(1995-3#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
security and safety##2##3##(1991-3#1)(1993-2#1)
security and##12##2##(1991-3#1)(1992-2#2)(1993-2#1)(2008-10#2)(2009-10#1)(2010-8#3)(2010-9#2)
security checkpoints##2##2##(2008-10#2)
security department##6##2##(1993-12#2)(1993-2#2)(1994-12#1)(1996-12#1)
security directors##3##2##(1991-3#1)(1992-12#2)
security guards##3##2##(1995-6#2)(1996-12#1)
security in##4##2##(1991-12#1)(2008-10#1)(2010-8#2)
security must be##2##3##(1991-1#1)(1992-12#1)
security needs##2##2##(1992-12#1)(1992-2#1)
security of Electronic Health##2##4##(2010-8#2)
security of the##2##3##(1992-2#1)(1994-3#1)
security of##10##2##(1992-2#1)(1994-12#1)(1994-3#2)(1996-12#1)(2008-11#1)(2010-8#3)(2012-3#1)
security officer##3##2##(1992-2#1)(1993-2#2)
security officers##8##2##(1991-1#1)(1992-12#1)(1992-2#2)(1993-2#2)(1996-12#2)
security personnel##2##2##(1991-12#1)(1991-3#1)
security plan##2##2##(1995-12#1)(2008-9#1)
security practices##2##2##(1991-12#1)(1992-2#1)
security program##7##2##(1991-1#4)(1992-12#1)(1994-12#1)(1994-2#1)
security requirements##4##2##(2010-8#4)
security setting##2##2##(1992-12#1)(1993-2#1)
security training program##2##3##(1991-12#2)
security training##3##2##(1991-12#2)(1992-12#1)
security##160##1##(1991-1#10)(1991-12#5)(1991-3#7)(1991-9#1)(1992-12#18)(1992-2#13)(1993-12#9)(1993-2#18)(1994-12#8)(1994-2#4)(1994-3#2)(1994-6#1)(1995-12#3)(1995-6#2)(1996-12#11)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-9#4)(2009-10#1)(2009-6#2)(2010-8#17)(2010-9#2)(2012-12#1)(2012-3#1)
sedation and##3##2##(1992-3#1)(2008-7#1)(2011-2#1)
sedation in##3##2##(1990-3#1)(1990-6#1)(1993-1#1)
sedation##22##1##(1990-3#1)(1990-6#1)(1992-3#1)(1993-1#7)(1995-11#1)(1996-6#1)(2008-12#1)(2008-7#2)(2009-6#1)(2010-7#3)(2011-2#2)(2013-1#1)
sedation/analgesia##2##1##(2008-4#2)
sedative##6##1##(1996-3#1)(2008-10#1)(2010-4#1)(2010-7#2)(2013-8#1)
sedentary behavior and health indicators##2##5##(2013-1#2)
sedentary behavior and##5##3##(2013-1#5)
sedentary behavior##13##2##(2012-2#1)(2013-1#12)
sedentary##30##1##(1991-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-2#2)(2012-3#1)(2013-1#17)(2013-8#1)
sediment and##6##2##(2008-10#5)(2008-11#1)
sediment certified reference material##2##4##(2008-10#2)
sediment certified reference##4##3##(2008-10#4)
sediment certified##5##2##(2008-10#5)
sediment extracts##4##2##(2008-10#4)
sediment in the##2##3##(2008-10#2)
sediment material##2##2##(2008-10#2)
sediment pore waters##3##3##(2008-10#3)
sediment pore##4##2##(2008-10#4)
sediment reference##4##2##(2008-10#4)
sediment samples collected from##2##4##(2008-10#2)
sediment samples from##2##3##(2008-10#2)
sediment samples has been##2##4##(2008-10#2)
sediment samples were##3##3##(2008-10#3)
sediment samples with##2##3##(2008-10#2)
sediment samples##22##2##(2008-10#22)
sediment slurries##3##2##(2008-10#2)(2008-11#1)
sediment slurry samples by##2##4##(2008-10#2)
sediment using##2##2##(2008-10#2)
sediment were##2##2##(1996-12#1)(2008-11#1)
sediment with##2##2##(2008-10#2)
sediment##102##1##(1996-12#1)(2008-10#93)(2008-11#3)(2008-5#1)(2008-9#2)(2013-8#2)
sedimentary##3##1##(2008-10#2)(2010-7#1)
sedimentation and##2##2##(1990-9#1)(1993-8#1)
sedimentation rate and##2##3##(1990-9#1)(2008-10#1)
sedimentation rate##8##2##(1990-9#1)(1993-2#1)(1993-8#1)(1997-8#2)(2008-10#3)
sedimentation velocity experiments##2##3##(2008-4#2)
sedimentation velocity##3##2##(2008-4#3)
sedimentation##25##1##(1990-9#3)(1993-2#1)(1993-8#3)(1996-12#1)(1996-2#1)(1997-8#2)(2008-10#8)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#1)
sedimented##4##1##(1990-12#1)(2008-10#2)(2008-11#1)
sedimenting##3##1##(1996-1#1)(2008-4#1)(2008-9#1)
sediments after##2##2##(2008-10#2)
sediments and fish##2##3##(2008-10#2)
sediments and sludges using electrothermal atomic absorption spectrometry##2##8##(2008-10#2)
sediments and##9##2##(2008-10#9)
sediments are##4##2##(2008-10#3)(2013-8#1)
sediments by##5##2##(2008-10#5)
sediments collected in##2##3##(2008-10#2)
sediments during##2##2##(2008-10#2)
sediments from##2##2##(2008-10#2)
sediments has been##2##3##(2008-10#2)
sediments is##4##2##(2008-10#4)
sediments using##5##2##(2008-10#5)
sediments with a##2##3##(2008-10#2)
sediments##80##1##(2008-10#77)(2008-9#1)(2010-5#1)(2013-8#1)
see a##4##2##(1990-6#1)(1996-12#1)(2008-5#1)(2009-12#1)
see if##6##2##(1995-12#2)(2008-10#1)(2008-11#2)(2008-7#1)
see text] )##2##3##(2008-10#2)
see text] SE##2##3##(2008-8#2)
see text] The##2##3##(1992-12#1)(1995-6#1)
see text] for##2##3##(2013-1#2)
see text] of##2##3##(2013-1#2)
see text]##30##2##(1992-12#2)(1992-4#2)(1995-6#1)(2008-10#4)(2008-11#3)(2008-8#11)(2012-2#1)(2013-1#6)
see text]HCl##2##2##(2008-11#2)
see that##6##2##(1994-12#1)(1994-9#1)(2008-11#2)(2009-4#2)
see the##10##2##(1992-3#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#3)
see this##3##2##(1992-3#1)(2009-10#1)(2012-3#1)
see##106##1##(1990-6#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-4#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#9)(2008-11#13)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#15)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-9#1)(2011-2#9)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#1)
see&quot##2##1##(1993-2#2)
seed and soil treatments with##2##5##(2008-10#2)
seed and soil##3##3##(2008-10#3)
seed and##13##2##(2008-10#13)
seed bank##4##2##(2008-8#4)
seed by##2##2##(2008-10#2)
seed coat##17##2##(2008-10#10)(2013-8#7)
seed crops##4##2##(2008-10#3)(2013-8#1)
seed densities##2##2##(2008-7#2)
seed development and##2##3##(1995-6#1)(2009-8#1)
seed development##3##2##(1995-6#1)(2008-10#1)(2009-8#1)
seed dispersal##6##2##(2008-12#1)(2008-9#5)
seed embryos were##2##3##(2008-10#2)
seed embryos##3##2##(2008-10#3)
seed extract##5##2##(2008-10#2)(2012-2#3)
seed formation##2##2##(2008-10#1)(2009-10#1)
seed from##3##2##(2008-10#2)(2011-2#1)
seed germination and##2##3##(2008-12#1)(2008-7#1)
seed germination##16##2##(2008-10#4)(2008-12#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#2)(2012-3#1)
seed had##2##2##(2008-10#2)
seed health testing##2##3##(2008-10#2)
seed health##3##2##(2008-10#3)
seed in the##3##3##(2008-10#2)(2008-12#1)
seed in##4##2##(2008-10#3)(2008-12#1)
seed infection by##2##3##(2008-10#2)
seed infection##7##2##(2008-10#7)
seed infestation by A##2##4##(2008-10#2)
seed infestation by##3##3##(2008-10#3)
seed lot##8##2##(2008-10#8)
seed lots were##2##3##(2008-10#2)
seed lots##10##2##(2008-10#10)
seed mass##2##2##(2008-8#2)
seed meal amendment##5##3##(2008-10#5)
seed meal amendments##4##3##(2008-10#4)
seed meal at a rate of##2##6##(2008-10#2)
seed meal type##2##3##(2008-10#2)
seed meal##21##2##(2008-10#21)
seed meals##2##2##(2008-10#2)
seed of##9##2##(2008-10#7)(2008-12#1)(2013-8#1)
seed oil##3##2##(2008-11#1)(2009-10#1)(2009-3#1)
seed oils##4##2##(2008-11#4)
seed parents##3##2##(2008-10#3)
seed particles##2##2##(2008-10#1)(2008-3#1)
seed plant species##3##3##(2008-8#3)
seed plant##5##2##(2008-8#4)(2010-5#1)
seed predators##2##2##(2008-8#1)(2008-9#1)
seed production fields##3##3##(2008-10#3)
seed production##12##2##(2008-10#5)(2008-8#4)(2008-9#3)
seed shattering##2##2##(2009-10#2)
seed source##3##2##(2008-10#2)(2012-9#1)
seed train##2##2##(2008-11#2)
seed transmission of##3##3##(2008-10#3)
seed transmission##7##2##(2008-10#7)
seed treated with##2##3##(2008-10#2)
seed treatment and##3##3##(2008-10#3)
seed treatment with##3##3##(2008-10#3)
seed treatment##14##2##(2008-10#14)
seed treatments in##2##3##(2008-10#2)
seed treatments##5##2##(2008-10#5)
seed tubers##6##2##(2008-10#6)
seed was##5##2##(2008-10#4)(2008-8#1)
seed weight##3##2##(2008-10#1)(2013-8#2)
seed were##3##2##(2008-10#3)
seed with##3##2##(2008-10#2)(2008-12#1)
seed yield was##2##3##(2008-10#2)
seed yield##9##2##(2008-10#9)
seed yields##2##2##(2008-10#2)
seed##358##1##(1991-8#1)(1994-11#3)(1995-3#1)(1995-6#2)(1997-5#1)(2007-12#1)(2008-10#237)(2008-11#10)(2008-12#10)(2008-2#4)(2008-3#2)(2008-7#5)(2008-8#23)(2008-9#20)(2009-10#8)(2009-3#1)(2009-8#4)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#1)(2012-9#1)(2013-8#16)
seed)##2##1##(2008-10#2)
seed-borne##3##1##(2008-10#3)
seed-coat##2##1##(2008-10#2)
seed-eating##2##1##(2008-8#2)
seed-size selection##2##2##(2008-8#2)
seed-train##2##1##(2008-11#2)
seed-transmitted endophytes##4##2##(2008-8#4)
seed-transmitted##9##1##(2008-10#5)(2008-8#4)
seedborne in##2##2##(2008-10#2)
seedborne inoculum##2##2##(2008-10#2)
seedborne isolates##2##2##(2008-10#2)
seedborne##18##1##(2008-10#18)
seeded at##2##2##(2008-11#1)(2008-3#1)
seeded on the##2##3##(2008-10#1)(2008-11#1)
seeded on##3##2##(1990-8#1)(2008-10#1)(2008-11#1)
seeded scaffolds##2##2##(2011-2#2)
seeded with sugar beet##2##4##(2008-10#2)
seeded with##5##2##(2008-10#3)(2012-2#2)
seeded##23##1##(1990-8#1)(1994-8#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#4)(2012-2#3)(2012-3#1)(2012-4#1)
seeding and##3##2##(2008-10#1)(2009-12#1)(2011-2#1)
seeding density##3##2##(2008-10#1)(2008-11#2)
seeding efficiency##2##2##(2011-2#2)
seeding in##2##2##(2008-8#1)(2011-2#1)
seeding method##2##2##(2011-2#2)
seeding methods##2##2##(2011-2#2)
seeding of##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
seeding##43##1##(1990-6#1)(1994-11#1)(2008-10#13)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2011-2#14)
seedling and adult##2##3##(2008-10#2)
seedling and##7##2##(2008-10#7)
seedling blight##5##2##(2008-10#5)
seedling damping-off##2##2##(2008-10#2)
seedling death##2##2##(2008-10#2)
seedling disease##5##2##(2008-10#5)
seedling dry weight##3##3##(2008-12#3)
seedling emergence##5##2##(2008-10#5)
seedling explants##2##2##(2008-12#2)
seedling genes##2##2##(2008-10#2)
seedling growth##8##2##(2008-10#1)(2008-12#5)(2008-8#2)
seedling leaves of##2##3##(2008-10#2)
seedling resistance when##2##3##(2008-10#2)
seedling resistance##3##2##(2008-10#3)
seedling root##2##2##(2008-10#2)
seedling stand##4##2##(2008-10#3)(2008-12#1)
seedling##89##1##(2008-10#71)(2008-12#12)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#1)
seedlings and adult plants##2##4##(2008-10#2)
seedlings and the##3##3##(2008-10#2)(2008-8#1)
seedlings and##11##2##(2008-10#9)(2008-8#1)(2011-10#1)
seedlings at##2##2##(2008-10#2)
seedlings by strain 4/4##2##4##(2008-10#2)
seedlings by##5##2##(2008-10#5)
seedlings caused by##2##3##(2008-10#2)
seedlings derived from##2##3##(2008-10#2)
seedlings did develop##2##3##(2008-10#2)
seedlings did##3##2##(2008-10#3)
seedlings followed##2##2##(2008-10#2)
seedlings for##2##2##(2008-10#2)
seedlings grown in these##2##4##(2008-10#2)
seedlings grown in##8##3##(2008-10#8)
seedlings had##2##2##(2008-10#1)(2011-2#1)
seedlings in a##2##3##(2008-10#2)
seedlings in the greenhouse##2##4##(2008-10#2)
seedlings in the##4##3##(2008-10#4)
seedlings in##11##2##(2008-10#11)
seedlings inoculated with the##3##4##(2008-10#3)
seedlings inoculated with##6##3##(2008-10#5)(2008-11#1)
seedlings inoculated##7##2##(2008-10#6)(2008-11#1)
seedlings of the##3##3##(2008-10#3)
seedlings of##21##2##(2008-10#16)(2008-11#1)(2008-8#3)(2012-8#1)
seedlings over##2##2##(2008-10#2)
seedlings that were inoculated##2##4##(2008-10#2)
seedlings that were##6##3##(2008-10#6)
seedlings that##9##2##(2008-10#9)
seedlings treated with both types of CWP##2##7##(2008-10#2)
seedlings was##6##2##(2008-10#6)
seedlings were challenged with##2##4##(2008-10#2)
seedlings were grown in##2##4##(2008-10#2)
seedlings were inoculated##3##3##(2008-10#3)
seedlings were##21##2##(2008-10#17)(2008-11#1)(2008-12#1)(2011-10#2)
seedlings with##7##2##(2008-10#7)
seedlings##219##1##(1990-11#2)(2008-10#189)(2008-11#3)(2008-12#3)(2008-8#9)(2008-9#2)(2009-8#2)(2011-10#5)(2011-2#3)(2012-8#1)
seeds and its##2##3##(2008-10#1)(2008-11#1)
seeds and seedlings##2##3##(2008-10#2)
seeds and##9##2##(2008-10#7)(2008-11#1)(2008-8#1)
seeds for##2##2##(2010-5#1)(2011-2#1)
seeds from##2##2##(2008-10#1)(2012-9#1)
seeds had##2##2##(2008-10#1)(2011-2#1)
seeds in##3##2##(2008-5#1)(2008-8#1)(2009-8#1)
seeds of a##2##3##(2008-10#1)(2008-8#1)
seeds of##13##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-8#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-8#1)
seeds per##2##2##(2008-10#2)
seeds to##2##2##(1992-8#1)(2008-10#1)
seeds was##4##2##(2008-10#3)(2008-11#1)
seeds were planted##2##3##(2008-10#2)
seeds were##4##2##(2008-10#4)
seeds with##2##2##(2008-10#1)(2009-12#1)
seeds##111##1##(1992-8#2)(1995-6#2)(2008-10#55)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#10)(2008-9#12)(2009-12#2)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-9#1)(2013-8#1)
seeds)##2##1##(2008-8#1)(2011-2#1)
seeing##8##1##(1991-12#1)(1997-3#1)(2008-3#2)(2008-8#1)(2008-9#1)(2013-7#1)(2013-8#1)
seek a##4##2##(1997-7#1)(2008-7#1)(2008-8#1)(2010-7#1)
seek to identify the##2##4##(2008-8#1)(2013-1#1)
seek to improve the##2##4##(2008-3#1)(2013-1#1)
seek to##8##2##(1991-6#1)(1991-7#1)(2008-3#1)(2008-8#2)(2013-1#2)(2013-8#1)
seek##39##1##(1990-12#1)(1990-6#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-8#1)(1993-1#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#3)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
seeking medical care##2##3##(2012-12#2)
seeking to promote##3##3##(2011-2#1)(2013-1#2)
seeking to##8##2##(1995-6#1)(2008-12#1)(2008-9#1)(2010-10#2)(2011-2#1)(2013-1#2)
seeking treatment for##2##3##(2009-9#1)(2011-2#1)
seeking treatment##3##2##(2008-1#1)(2009-9#1)(2011-2#1)
seeking##48##1##(1992-1#1)(1992-5#1)(1993-3#2)(1994-2#1)(1994-3#2)(1995-12#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-1#4)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#5)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#3)
seeks to expand##2##3##(1995-12#1)(2008-11#1)
seeks to foster##2##3##(2008-11#1)(2008-6#1)
seeks to##19##2##(1992-11#2)(1995-12#2)(1996-1#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-11#6)(2008-12#2)(2008-6#1)(2013-8#2)
seeks##24##1##(1991-9#1)(1992-11#2)(1993-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-3#2)(1997-7#1)(2008-11#6)(2008-12#2)(2008-6#1)(2013-8#2)
seem particularly##2##2##(2008-11#1)(2008-7#1)
seem to affect##2##3##(2008-11#1)(2008-5#1)
seem to be a##2##4##(2008-11#1)(2011-2#1)
seem to be free##2##4##(1993-12#1)(2008-10#1)
seem to be involved in##2##5##(1996-12#1)(2008-11#1)
seem to be more##2##4##(1990-2#2)
seem to be related##2##4##(1991-6#1)(1993-8#1)
seem to be the most##2##5##(1994-12#1)(2012-3#1)
seem to be the##3##4##(1994-12#1)(2009-8#1)(2012-3#1)
seem to be useful##2##4##(1992-2#1)(2012-2#1)
seem to be##44##3##(1990-2#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-7#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#1)
seem to have a##4##4##(1990-8#1)(2008-12#1)(2008-5#1)(2009-6#1)
seem to have##10##3##(1990-8#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-10#1)(2009-6#1)
seem to interact directly with the basal transcription##2##8##(1995-6#2)
seem to interact##3##3##(1995-6#2)(2008-10#1)
seem to play##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
seem to possess##2##3##(1990-5#1)(1995-1#1)
seem to represent##2##3##(2008-5#1)(2009-4#1)
seem to##104##2##(1990-2#3)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#22)(2008-11#10)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#6)(2008-9#2)(2009-10#3)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#5)(2012-4#1)(2012-5#1)(2013-1#3)
seem useful##2##2##(2008-10#2)
seem##132##1##(1990-2#3)(1990-5#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#25)(2008-11#15)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#9)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#3)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#6)(2012-4#1)(2012-5#1)(2013-1#3)
seemed that##2##2##(2008-8#2)
seemed to be a##2##4##(2008-10#1)(2008-11#1)
seemed to be different from##2##5##(2008-10#1)(2008-11#1)
seemed to be more##2##4##(1996-3#1)(2008-10#1)
seemed to be##28##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-6#1)(1995-5#1)(1996-3#1)(2008-10#8)(2008-11#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2012-2#1)
seemed to have##4##3##(1991-2#1)(1997-3#1)(2008-10#1)(2013-8#1)
seemed to increase##2##3##(1992-6#1)(1996-6#1)
seemed to induce##3##3##(2008-10#2)(2011-2#1)
seemed to##52##2##(1990-3#1)(1990-9#1)(1991-2#2)(1991-8#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#15)(2008-11#7)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
seemed##62##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#2)(1991-2#2)(1991-8#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#16)(2008-11#8)(2008-7#3)(2008-8#3)(2008-9#3)(2009-7#2)(2010-10#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
seemingly contradictory findings##2##3##(1993-3#1)(2008-11#1)
seemingly normal##2##2##(2008-7#1)(2009-3#1)
seemingly unrelated##3##2##(1991-2#1)(1997-8#1)(2011-2#1)
seemingly##18##1##(1990-12#1)(1991-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-3#1)(2009-6#1)(2011-2#4)(2012-3#1)
seems a##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
seems an##3##2##(1991-3#1)(2008-10#1)(2011-2#1)
seems appropriate##2##2##(2008-10#2)
seems at##2##2##(2010-7#1)(2012-3#1)
seems likely##4##2##(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)
seems not to##2##3##(1994-8#1)(1997-1#1)
seems possible##5##2##(1997-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
seems that the##8##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
seems that there are##2##4##(2008-2#1)(2012-3#1)
seems that##24##2##(1990-12#3)(1993-12#1)(1995-12#1)(1995-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
seems to act##2##3##(2008-10#1)(2012-2#1)
seems to be a##15##4##(1993-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-5#2)(2009-8#1)(2010-12#1)
seems to be an effective##2##5##(2008-12#1)(2008-7#1)
seems to be an##6##4##(1990-8#1)(1992-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
seems to be associated with a##2##6##(2008-7#1)(2013-1#1)
seems to be due to the##2##6##(2008-10#1)(2008-11#1)
seems to be more##2##4##(2008-10#1)(2008-7#1)
seems to be related to##2##5##(1994-8#1)(2006-6#1)
seems to be related##3##4##(1994-8#1)(1995-11#1)(2006-6#1)
seems to be that##3##4##(1994-6#1)(2008-5#1)(2011-2#1)
seems to be the best##2##5##(2008-10#2)
seems to be the##8##4##(1990-6#1)(2007-8#1)(2008-10#4)(2009-8#1)(2010-10#1)
seems to be very##2##4##(2008-10#1)(2011-2#1)
seems to be##85##3##(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#2)(1992-3#1)(1992-5#1)(1993-3#1)(1994-6#2)(1994-8#1)(1995-11#3)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-10#14)(2008-11#8)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)
seems to depend on##2##4##(1992-5#1)(2008-7#1)
seems to have##11##3##(1991-9#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-2#1)(2008-10#2)(2008-7#1)(2012-12#1)(2013-1#1)
seems to improve##2##3##(2008-10#1)(2011-2#1)
seems to indicate that##2##4##(2008-10#1)(2010-12#1)
seems to prevent##2##3##(2008-7#1)(2013-1#1)
seems to##136##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-11#4)(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#3)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#3)(1995-12#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-8#1)(2008-10#28)(2008-11#12)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
seems##215##1##(1990-12#4)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#4)(1991-3#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#2)(1995-11#3)(1995-12#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#2)(1997-9#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#16)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#2)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#5)(2013-8#1)
seen a##3##2##(2008-11#1)(2010-11#1)(2011-2#1)
seen after##10##2##(1991-8#1)(1994-5#1)(1995-12#2)(1996-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-3#1)
seen an##2##2##(2009-10#1)(2013-1#1)
seen and##2##2##(1990-9#1)(2008-8#1)
seen as a##11##3##(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2011-2#1)(2013-1#1)
seen as an opportunity to##2##5##(2008-10#1)(2008-12#1)
seen as an##4##3##(2008-10#2)(2008-12#1)(2012-12#1)
seen as part of##2##4##(2008-12#1)(2010-11#1)
seen as the##5##3##(1994-1#1)(2008-11#2)(2008-8#1)(2013-1#1)
seen as##31##2##(1992-3#2)(1993-12#1)(1994-1#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#4)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
seen at the##3##3##(2008-10#1)(2010-3#1)(2011-2#1)
seen at##12##2##(1990-5#1)(1991-11#1)(1991-2#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-9#1)(2010-3#1)(2011-2#1)
seen between##6##2##(1997-6#1)(2008-10#1)(2008-5#3)(2012-3#1)
seen by the##3##3##(1993-12#1)(1994-6#1)(2009-7#1)
seen by##7##2##(1993-12#1)(1994-6#1)(2008-11#1)(2009-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
seen during the##4##3##(1990-12#1)(1990-5#1)(1994-6#1)(2012-3#1)
seen during##8##2##(1990-12#1)(1990-5#1)(1992-12#2)(1994-6#1)(2008-7#1)(2012-3#1)(2013-8#1)
seen following##3##2##(1991-3#1)(1993-6#1)(2008-10#1)
seen for##8##2##(1991-12#1)(1993-8#1)(1995-2#1)(2008-10#3)(2009-9#1)(2013-1#1)
seen from##2##2##(1990-8#1)(2008-3#1)
seen in 100%##2##3##(1991-2#1)(2012-3#1)
seen in a##2##3##(1991-11#1)(2010-10#1)
seen in all##4##3##(2008-10#2)(2010-1#1)(2011-2#1)
seen in both##3##3##(1996-12#2)(2008-10#1)
seen in children##4##3##(1996-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
seen in diabetic##2##3##(1994-12#1)(2012-3#1)
seen in male##4##3##(1996-11#1)(2008-9#2)(2012-3#1)
seen in our##3##3##(1991-11#1)(2013-1#1)(2013-7#1)
seen in patients with##4##4##(1992-5#1)(2008-11#1)(2009-1#1)(2012-3#1)
seen in patients##6##3##(1991-11#1)(1992-5#1)(1995-12#1)(2008-11#1)(2009-1#1)(2012-3#1)
seen in previously reported models##2##5##(1994-5#2)
seen in rat##2##3##(1993-3#1)(1995-11#1)
seen in rats##3##3##(1995-11#1)(1996-1#1)(2011-2#1)
seen in response to##2##4##(1997-1#1)(2008-11#1)
seen in the field##2##4##(2008-10#1)(2008-8#1)
seen in the frontal##2##4##(1996-12#1)(2008-7#1)
seen in the##44##3##(1990-12#1)(1991-10#1)(1991-12#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-8#2)(1996-12#5)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-5#6)(2008-7#4)(2008-8#1)(2010-11#1)(2011-2#3)(2012-3#3)(2013-8#1)
seen in this##3##3##(2008-7#1)(2008-8#1)(2010-5#1)
seen in##180##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#6)(1994-8#3)(1995-11#5)(1995-12#5)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#8)(1996-2#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#3)(2008-1#3)(2008-10#24)(2008-11#9)(2008-12#8)(2008-3#1)(2008-4#2)(2008-5#7)(2008-7#10)(2008-8#4)(2008-9#4)(2009-1#2)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#10)(2013-1#2)(2013-7#1)(2013-8#1)
seen more##2##2##(2008-12#1)(2013-1#1)
seen much##2##2##(2008-11#2)
seen on follow-up MR##2##4##(1996-6#2)
seen on the##5##3##(1991-6#1)(1992-12#1)(1996-2#1)(2008-1#1)(2011-2#1)
seen on ultrasound##2##3##(2012-2#2)
seen on##17##2##(1991-6#1)(1992-12#1)(1995-12#1)(1996-2#1)(1996-6#2)(1997-8#2)(2006-6#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#3)
seen only##2##2##(1994-11#1)(1996-1#1)
seen that the##2##3##(2008-10#1)(2008-3#1)
seen that##8##2##(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2011-2#1)
seen the##4##2##(1993-6#1)(1995-12#1)(2008-11#1)(2008-9#1)
seen to be a##2##4##(1992-1#1)(2008-10#1)
seen to be##6##3##(1992-1#1)(2008-10#2)(2008-11#3)
seen to have a##2##4##(2008-12#1)(2008-5#1)
seen to have##4##3##(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
seen to increase##2##3##(2008-10#1)(2011-2#1)
seen to##19##2##(1991-12#1)(1992-1#1)(1994-8#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
seen when##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
seen with the##3##3##(1995-11#1)(2008-10#2)
seen with##26##2##(1991-1#1)(1993-12#1)(1994-11#2)(1995-11#1)(1995-2#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
seen within the##2##3##(1997-3#1)(2008-10#1)
seen within##5##2##(1993-2#1)(1997-3#1)(1997-5#1)(2008-10#1)(2009-11#1)
seen##437##1##(1990-12#3)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#9)(1991-2#3)(1991-3#2)(1991-6#3)(1991-8#1)(1992-1#2)(1992-12#4)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-5#8)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#7)(1995-12#10)(1995-2#2)(1995-3#1)(1995-8#3)(1996-1#2)(1996-11#4)(1996-12#10)(1996-2#4)(1996-3#1)(1996-6#6)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#10)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#7)(2006-6#1)(2008-1#5)(2008-10#63)(2008-11#38)(2008-12#18)(2008-3#5)(2008-4#2)(2008-5#17)(2008-6#1)(2008-7#18)(2008-8#11)(2008-9#8)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#4)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#23)(2012-12#4)(2012-2#8)(2012-3#15)(2013-1#11)(2013-7#1)(2013-8#4)
sees##5##1##(1993-2#1)(1995-8#1)(2008-11#1)(2008-9#2)
segment 61-69##2##2##(1992-4#2)
segment adjacent to the##2##4##(2008-10#1)(2009-10#1)
segment and##4##2##(1996-6#2)(2008-11#1)(2011-2#1)
segment between##2##2##(1992-4#1)(2008-4#1)
segment by##2##2##(2008-2#1)(2011-2#1)
segment disease (ASD)##3##3##(2012-12#1)(2012-3#2)
segment disease##6##2##(2012-12#3)(2012-3#3)
segment elevation##3##2##(2008-12#1)(2008-3#1)(2012-3#1)
segment from the##2##3##(1996-6#1)(2008-10#1)
segment from##3##2##(1995-9#1)(1996-6#1)(2008-10#1)
segment in the##3##3##(1995-6#1)(1996-8#1)(2007-12#1)
segment in##7##2##(1995-6#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)
segment is##3##2##(2008-2#1)(2008-7#1)(2013-8#1)
segment of the left##2##4##(1991-3#1)(2013-8#1)
segment of the population##3##4##(1992-1#1)(2008-10#1)(2012-3#1)
segment of the##21##3##(1991-3#1)(1991-9#1)(1992-1#1)(1993-8#1)(1994-3#2)(1995-8#1)(2006-6#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-1#1)(2011-7#3)(2012-3#3)(2013-8#2)
segment of##39##2##(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-8#1)(1994-3#2)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(2006-6#1)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-1#1)(2011-7#3)(2012-3#3)(2013-8#4)
segment polarity gene hedgehog##3##4##(1993-12#2)(1994-12#1)
segment polarity gene##5##3##(1993-12#3)(1994-12#1)(2007-12#1)
segment substitution##2##2##(2008-10#1)(2009-10#1)
segment was long and##2##4##(2007-12#2)
segment was##8##2##(1997-2#1)(2007-12#2)(2008-8#1)(2009-10#2)(2011-2#1)(2012-3#1)
segment with##2##2##(2011-2#1)(2013-1#1)
segment##166##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#3)(1992-6#2)(1993-12#3)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-3#4)(1996-5#1)(1996-6#4)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-12#10)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#10)(2008-8#5)(2008-9#4)(2009-10#8)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#13)(2011-7#4)(2012-12#4)(2012-3#12)(2013-1#3)(2013-8#7)
segment-polarity gene##2##2##(1993-2#2)
segmental changes##2##2##(2009-7#1)(2011-2#1)
segmental duplication##3##2##(2009-10#2)(2012-3#1)
segmental glomerulosclerosis##2##2##(2008-1#1)(2012-2#1)
segmental motion##2##2##(2012-12#2)
segmental##33##1##(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-12#3)(2008-1#1)(2008-7#1)(2009-10#4)(2009-12#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#1)
segmentation algorithms##2##2##(1995-5#1)(2008-6#1)
segmentation and##7##2##(2008-10#1)(2008-6#3)(2009-10#1)(2011-7#2)
segmentation in##2##2##(2007-12#1)(2008-6#1)
segmentation of##6##2##(2008-3#1)(2008-7#2)(2009-12#1)(2010-8#1)(2011-7#1)
segmentation##32##1##(1995-5#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#11)(2008-7#2)(2008-8#1)(2009-10#3)(2009-11#1)(2009-12#1)(2010-8#3)(2011-7#3)(2012-3#1)
segmented assimilation##2##2##(2009-7#2)
segmented flow analysis (SFA)##3##4##(2008-10#3)
segmented flow analysis##5##3##(2008-10#5)
segmented flow##8##2##(2008-10#8)
segmented##14##1##(2008-10#10)(2008-5#1)(2009-10#1)(2009-7#2)
segments and##11##2##(1991-5#1)(1991-6#2)(1992-5#1)(1996-3#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)
segments are##4##2##(1991-5#1)(1993-9#1)(2007-12#1)(2008-10#1)
segments between##2##2##(1997-8#1)(2008-4#1)
segments from##5##2##(1991-2#1)(1994-5#1)(2008-10#3)
segments in##2##2##(2008-12#1)(2008-5#1)
segments including##2##2##(2008-5#1)(2013-8#1)
segments incubated in continuous##2##4##(2008-10#2)
segments incubated in##3##3##(2008-10#3)
segments incubated##4##2##(2008-10#4)
segments into##2##2##(1997-7#1)(2008-7#1)
segments of DNA##2##3##(2008-11#1)(2008-9#1)
segments of the##11##3##(1991-12#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-8#1)(2010-4#1)(2010-8#1)
segments of##31##2##(1990-5#1)(1991-12#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-3#1)(2013-1#1)
segments was##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
segments were##6##2##(1997-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)
segments with##5##2##(1992-2#1)(1995-2#1)(1997-6#1)(1997-8#1)(2009-5#1)
segments##146##1##(1990-5#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#3)(1997-9#2)(2007-12#5)(2008-10#40)(2008-11#5)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#3)(2013-3#1)(2013-8#1)
segregant analysis (BSA)##2##3##(2008-10#1)(2008-9#1)
segregant analysis using##3##3##(2008-10#3)
segregant analysis##16##2##(1995-6#2)(2008-10#13)(2008-9#1)
segregant##17##1##(1995-6#3)(2008-10#13)(2008-9#1)
segregate##5##1##(2008-10#5)
segregated 1##2##2##(2008-10#2)
segregated for##6##2##(2008-10#4)(2012-3#2)
segregated in Mendelian##2##3##(2008-10#2)
segregated in a 1##4##4##(2008-10#4)
segregated in a##6##3##(2008-10#5)(2008-8#1)
segregated in##10##2##(2008-10#9)(2008-8#1)
segregated into##4##2##(1994-5#1)(2008-10#1)(2008-8#2)
segregated##33##1##(1994-5#1)(1995-2#1)(2008-10#21)(2008-12#1)(2008-8#3)(2011-2#4)(2012-3#2)
segregates##5##1##(1993-2#1)(1995-2#1)(2008-10#2)(2009-10#1)
segregating F(2)##2##2##(2008-10#2)
segregating for##5##2##(2008-10#4)(2010-10#1)
segregating in##2##2##(2008-10#2)
segregating with##2##2##(1997-7#1)(2008-9#1)
segregating##28##1##(1991-3#1)(1997-7#1)(2008-10#20)(2008-8#1)(2008-9#1)(2010-10#1)(2012-3#3)
segregation analysis##5##2##(2008-10#4)(2008-11#1)
segregation and##2##2##(2009-8#1)(2013-1#1)
segregation for##5##2##(2008-10#5)
segregation in##7##2##(2008-10#2)(2008-11#3)(2008-12#2)
segregation of a single##2##4##(2008-10#2)
segregation of the##2##3##(1995-8#1)(2008-10#1)
segregation of##21##2##(1995-8#1)(2008-10#13)(2008-12#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#2)
segregation##58##1##(1995-8#1)(2008-10#31)(2008-11#4)(2008-12#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-10#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
seismic##3##1##(1990-11#1)(1995-3#2)
seizure activity##4##2##(1990-5#1)(1997-3#1)(2009-11#1)(2010-2#1)
seizure attacks of P77PMC rat##2##5##(2008-8#2)
seizure control##3##2##(1997-3#2)(2008-7#1)
seizure disorder##2##2##(2008-11#1)(2008-4#1)
seizure disorders##3##2##(1993-3#1)(1997-3#1)(2012-3#1)
seizure generation##4##2##(1990-5#1)(2009-8#3)
seizure in a##2##3##(2008-11#1)(2010-1#1)
seizure in##3##2##(2008-11#1)(2008-8#1)(2010-1#1)
seizure intensity##4##2##(1992-12#4)
seizure susceptibility of these animals##2##5##(1996-12#2)
seizure susceptibility##3##2##(1990-5#1)(1996-12#2)
seizure##58##1##(1990-5#6)(1992-12#4)(1992-3#1)(1993-3#2)(1994-2#3)(1996-12#5)(1997-3#7)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-8#4)(2009-9#1)(2010-1#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
seizure-naive##4##1##(1996-12#4)
seizures and##5##2##(1995-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-5#1)
seizures in a##2##3##(2008-10#1)(2008-11#1)
seizures in children##2##3##(1997-2#1)(2008-4#1)
seizures in the##2##3##(1994-2#1)(2011-1#1)
seizures in##9##2##(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
seizures of##2##2##(2008-10#1)(2008-4#1)
seizures were##3##2##(1994-2#1)(1997-3#1)(2008-4#1)
seizures##66##1##(1990-5#1)(1992-12#1)(1994-2#11)(1995-5#1)(1996-12#2)(1996-9#1)(1997-2#2)(1997-3#6)(2006-5#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
seldom been##2##2##(1991-12#1)(2008-7#1)
seldom##17##1##(1990-11#1)(1990-9#1)(1991-12#1)(1992-5#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2013-1#2)
select a##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#1)
select and##2##2##(2011-3#1)(2012-2#1)
select for##8##2##(1997-7#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-1#2)
select group of##3##3##(1995-3#1)(2009-3#1)(2013-1#1)
select patients##3##2##(2011-2#3)
select the most##5##3##(1990-12#1)(2008-10#3)(2013-1#1)
select the##28##2##(1990-12#1)(1992-12#1)(1993-11#1)(1997-6#1)(2008-10#13)(2008-11#1)(2008-5#1)(2009-12#1)(2011-3#1)(2012-3#2)(2013-1#4)(2013-8#1)
select##106##1##(1990-12#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-3#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#35)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#2)
selectable marker gene##2##3##(2008-10#2)
selectable marker##9##2##(1997-8#1)(2008-10#4)(2008-11#2)(2008-4#2)
selectable markers##2##2##(1997-7#1)(2008-10#1)
selectable##11##1##(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-4#2)
selected Hispanic health beliefs and practices##2##6##(2008-9#2)
selected PCBs##3##2##(2008-11#3)
selected a##3##2##(1995-12#1)(2008-5#2)
selected according to##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
selected after##2##2##(2008-10#1)(2012-2#1)
selected among##2##2##(2008-10#1)(2009-8#1)
selected anaplerotic##2##2##(2008-7#2)
selected and an##2##3##(1994-12#1)(2008-10#1)
selected and##12##2##(1992-9#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2009-6#1)(2013-1#1)
selected areas of##2##3##(2008-10#1)(2012-2#1)
selected areas##4##2##(1996-6#1)(1997-3#1)(2008-10#1)(2012-2#1)
selected as a##4##3##(1996-1#1)(2008-10#3)
selected as the most##2##4##(2008-10#1)(2012-2#1)
selected as the##8##3##(2008-10#6)(2008-5#1)(2012-2#1)
selected as##27##2##(1996-1#1)(2008-10#23)(2008-5#1)(2011-2#1)(2012-2#1)
selected at random from##2##4##(2008-10#1)(2012-3#1)
selected at random##3##3##(2008-10#2)(2012-3#1)
selected at##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)
selected blood##2##2##(2008-12#2)
selected by the##5##3##(2008-10#2)(2008-8#1)(2013-1#2)
selected by##29##2##(1990-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1997-6#1)(2008-10#8)(2008-7#1)(2008-8#3)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#3)(2013-1#5)
selected cases of##3##3##(1990-9#1)(1993-11#1)(1997-8#1)
selected cases##9##2##(1990-9#1)(1991-2#1)(1993-11#1)(1995-3#1)(1997-8#2)(2007-11#1)(2008-1#1)(2010-12#1)
selected children##2##2##(1996-1#1)(2008-10#1)
selected compounds##2##2##(2008-10#1)(2011-2#1)
selected conditions for##2##3##(2008-10#2)
selected conditions##12##2##(2008-10#12)
selected dental##2##2##(2008-5#1)(2013-1#1)
selected differentially##2##2##(2010-8#1)(2011-3#1)
selected donor##2##2##(2008-10#2)
selected elements##4##2##(2008-10#4)
selected examples##2##2##(2010-11#1)(2011-2#1)
selected experimental conditions##2##3##(2008-10#2)
selected five##2##2##(1996-12#1)(2011-2#1)
selected for a##2##3##(1990-2#1)(1992-2#1)
selected for analysis##2##3##(2008-10#1)(2008-11#1)
selected for clinical##3##3##(1992-12#1)(1996-9#1)(2010-11#1)
selected for each##2##3##(1996-12#1)(2012-2#1)
selected for further analysis##2##4##(2008-11#1)(2008-9#1)
selected for further study##2##4##(1997-3#1)(2008-10#1)
selected for further##5##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
selected for increased aggressiveness##2##4##(2008-10#2)
selected for increased##4##3##(2008-10#2)(2008-8#2)
selected for more##2##3##(2008-10#1)(2013-1#1)
selected for resistance to##2##4##(2008-10#2)
selected for resistance##4##3##(2008-10#4)
selected for the determination of##4##5##(2008-10#4)
selected for the study##2##4##(1990-3#1)(2013-8#1)
selected for the##20##3##(1990-3#1)(2008-10#16)(2009-12#1)(2011-2#1)(2013-8#1)
selected for their##3##3##(2008-10#3)
selected for this##2##3##(2008-10#2)
selected for##84##2##(1990-2#1)(1990-3#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#44)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#3)(2008-9#2)(2009-12#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
selected from 6##2##3##(2011-1#1)(2013-1#1)
selected from a##6##3##(1997-8#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
selected from the##7##3##(1997-8#1)(2008-10#4)(2011-2#1)(2013-8#1)
selected from two##2##3##(2008-10#1)(2010-3#1)
selected from##26##2##(1997-8#2)(2008-10#13)(2008-7#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
selected fungal##2##2##(2008-10#1)(2010-5#1)
selected gene##2##2##(2013-8#2)
selected genes##3##2##(2008-10#2)(2010-11#1)
selected germ plasm##2##3##(2008-10#2)
selected in order to avoid##2##5##(2008-10#2)
selected in order to##3##4##(2008-10#3)
selected in##12##2##(1993-9#1)(2008-10#8)(2008-11#2)(2012-3#1)
selected ion monitoring (SIM) mode##3##5##(2008-10#3)
selected ion monitoring (SIM)##5##4##(2008-10#5)
selected ion monitoring mode##6##4##(2008-10#5)(2008-11#1)
selected ion monitoring##14##3##(2008-10#13)(2008-11#1)
selected isolates of##2##3##(2008-10#2)
selected isolates##6##2##(2008-10#6)
selected lines that##2##3##(1994-2#1)(2008-10#1)
selected lines##6##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)
selected multivariate##2##2##(2008-10#2)
selected on the basis of##7##5##(1990-11#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-3#1)
selected on##8##2##(1990-11#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-3#1)
selected patient##2##2##(1996-11#1)(2011-3#1)
selected patients with##2##3##(1992-6#1)(2008-11#1)
selected patients##12##2##(1991-9#1)(1992-6#1)(1994-6#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2011-3#1)(2013-8#1)
selected phage##2##2##(2008-1#1)(2008-10#1)
selected population##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
selected populations##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
selected procedures##2##2##(2008-4#1)(2008-9#1)
selected randomly from##3##3##(1993-1#1)(1994-3#1)(2008-10#1)
selected regions##2##2##(1996-12#1)(2010-7#1)
selected resistant##2##2##(2008-10#2)
selected samples##4##2##(2008-10#3)(2012-2#1)
selected stress behaviors##2##3##(1991-12#2)
selected that##2##2##(2008-10#1)(2012-2#1)
selected the##3##2##(2008-10#2)(2009-10#1)
selected through##2##2##(2008-10#1)(2011-2#1)
selected tissues##2##2##(1994-5#1)(2010-5#1)
selected to represent the##2##4##(2008-10#2)
selected to represent##3##3##(1991-12#1)(2008-10#2)
selected to##27##2##(1991-12#2)(1991-2#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2012-2#2)(2012-9#1)(2013-1#1)(2013-8#1)
selected variables##2##2##(2008-10#2)
selected virulent populations##2##3##(2008-10#2)
selected virulent##3##2##(2008-10#3)
selected wastewater protozoa##2##3##(2008-12#2)
selected with##3##2##(2008-10#1)(2008-11#2)
selected##671##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#4)(1991-5#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#3)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#6)(2006-5#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-10#304)(2008-11#28)(2008-12#9)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#16)(2008-6#1)(2008-7#7)(2008-8#19)(2008-9#12)(2009-10#5)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#7)(2011-1#4)(2011-2#28)(2011-3#6)(2012-12#6)(2012-2#12)(2012-3#11)(2012-9#1)(2013-1#25)(2013-8#10)
selected-ion monitoring (SIM)##2##3##(2008-10#1)(2008-5#1)
selecting a group of##2##4##(2008-10#1)(2012-3#1)
selecting a suitable##3##3##(2008-4#1)(2008-7#1)(2012-5#1)
selecting a##10##2##(1995-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-3#1)(2012-5#1)
selecting an appropriate##3##3##(2008-9#2)(2011-2#1)
selecting an##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)
selecting and implementing##2##3##(1994-12#1)(2010-8#1)
selecting and##4##2##(1994-12#1)(2008-4#1)(2010-8#1)(2011-2#1)
selecting patients for##3##3##(2008-7#1)(2009-4#1)(2012-3#1)
selecting patients##4##2##(2008-7#1)(2008-8#1)(2009-4#1)(2012-3#1)
selecting the appropriate##2##3##(2008-10#1)(2008-8#1)
selecting the best##2##3##(2008-3#1)(2013-1#1)
selecting the most suitable##2##4##(2008-10#1)(2008-12#1)
selecting the most##3##3##(1990-5#1)(2008-10#1)(2008-12#1)
selecting the type of##2##4##(1996-1#1)(2013-8#1)
selecting the##20##2##(1990-5#1)(1992-12#1)(1992-2#1)(1994-3#2)(1995-12#1)(1996-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-7#1)(2013-1#1)(2013-8#1)
selecting##75##1##(1990-5#1)(1991-12#2)(1992-12#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-12#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#1)(2013-8#1)
selection (MAS)##4##2##(2008-10#2)(2012-3#1)(2013-8#1)
selection acting##3##2##(2008-8#1)(2010-4#1)(2012-3#1)
selection against##3##2##(2008-10#3)
selection and a##2##3##(2008-4#1)(2008-8#1)
selection and retention##2##3##(1995-3#1)(2009-12#1)
selection and the##8##3##(2008-8#3)(2008-9#2)(2010-1#1)(2012-3#2)
selection and##61##2##(1991-12#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-8#1)(2008-10#8)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#5)(2009-12#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-2#5)(2011-3#1)(2012-3#5)(2013-1#2)(2013-8#1)
selection are not##2##3##(2008-12#1)(2011-3#1)
selection are##10##2##(1991-2#2)(1995-2#1)(2008-12#1)(2008-8#2)(2009-12#1)(2011-3#1)(2012-3#1)(2013-8#1)
selection as well as##2##4##(1991-2#1)(2008-8#1)
selection as##3##2##(1991-2#1)(1996-3#1)(2008-8#1)
selection at##5##2##(2008-8#3)(2010-4#1)(2012-2#1)
selection based on##9##3##(1994-12#1)(1996-6#1)(2008-10#4)(2008-8#3)
selection between the##2##3##(2008-8#1)(2010-8#1)
selection bias in##2##3##(1995-2#1)(2013-1#1)
selection bias##4##2##(1995-2#1)(1996-1#1)(2008-1#1)(2013-1#1)
selection by the host##2##4##(2008-10#2)
selection by two##2##3##(2008-8#2)
selection by##12##2##(1990-8#1)(2008-10#7)(2008-3#1)(2008-8#2)(2010-11#1)
selection can##2##2##(2008-10#1)(2008-8#1)
selection cannot##2##2##(1995-5#1)(2008-8#1)
selection could##2##2##(2008-10#1)(2008-8#1)
selection criteria##9##2##(1990-9#1)(1994-9#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-12#1)
selection criterion##2##2##(2008-10#1)(2008-8#1)
selection differed##2##2##(2008-8#1)(2012-3#1)
selection experiments##3##2##(2008-10#1)(2008-8#2)
selection favoring##3##2##(2008-8#1)(2009-8#2)
selection for quantitative resistance to Sclerotinia trifoliorum in alfalfa also##2##10##(2008-10#2)
selection for resistance to##2##4##(2008-10#2)
selection for resistance##6##3##(2008-10#6)
selection for the##2##3##(2008-10#1)(2010-7#1)
selection for these##2##3##(2008-8#1)(2012-2#1)
selection for##39##2##(1992-12#1)(1993-9#1)(1997-4#1)(2008-10#15)(2008-7#1)(2008-8#6)(2008-9#7)(2009-10#2)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
selection forces##2##2##(2013-8#2)
selection gradients##6##2##(2008-8#6)
selection has been##2##3##(2008-8#1)(2012-3#1)
selection has##8##2##(1995-2#1)(2008-10#1)(2008-8#2)(2012-2#1)(2012-3#3)
selection in a##2##3##(2008-8#1)(2008-9#1)
selection in breeding programs##2##4##(2008-10#1)(2012-3#1)
selection in natural populations##2##4##(2008-8#1)(2012-3#1)
selection in plants##3##3##(1995-2#3)
selection in the##6##3##(1995-5#1)(2008-10#2)(2008-8#2)(2010-5#1)
selection in##33##2##(1995-2#4)(1995-5#1)(2008-10#6)(2008-8#9)(2008-9#5)(2010-2#1)(2010-4#2)(2010-5#1)(2012-3#3)(2013-1#1)
selection intensity##2##2##(2008-10#1)(2008-8#1)
selection is also##2##3##(1995-2#1)(2010-4#1)
selection is reduced if dose is##2##6##(2008-10#2)
selection is##16##2##(1995-2#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#4)(2008-9#2)(2010-4#1)(2010-6#1)(2010-8#1)(2012-2#1)
selection marker##6##2##(1997-4#1)(2008-11#5)
selection method##2##2##(2008-1#1)(2008-4#1)
selection models##2##2##(2008-10#1)(2008-9#1)
selection of a suitable##2##4##(2008-5#2)
selection of a##7##3##(1993-1#1)(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
selection of appropriate##2##3##(2008-10#1)(2008-12#1)
selection of aptamers##2##3##(2008-4#1)(2010-5#1)
selection of candidate##2##3##(2008-10#1)(2010-5#1)
selection of full-length cDNA by##2##5##(1997-2#2)
selection of genes##2##3##(2008-10#1)(2010-11#1)
selection of internal##2##3##(2008-10#2)
selection of patients for##2##4##(1994-2#1)(2008-10#1)
selection of patients who##3##4##(2007-8#1)(2008-7#1)(2012-3#1)
selection of patients##11##3##(1991-3#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#1)
selection of resistant##2##3##(2008-10#1)(2013-1#1)
selection of specific##2##3##(2008-11#2)
selection of the most##2##4##(2008-10#1)(2011-2#1)
selection of the##33##3##(1991-3#1)(1993-8#2)(1997-9#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#3)(2012-12#1)(2012-3#1)
selection of these##2##3##(2008-11#2)
selection of variables##5##3##(1995-9#1)(2008-10#4)
selection of##171##2##(1991-11#1)(1991-12#1)(1991-3#2)(1992-12#1)(1993-1#1)(1993-12#2)(1993-8#3)(1994-1#2)(1994-2#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-2#4)(1997-3#2)(1997-9#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#58)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#9)(2009-11#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#10)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#6)
selection on a heritable##2##4##(2008-8#2)
selection on a##4##3##(2008-8#3)(2008-9#1)
selection on attractive traits##3##4##(2008-8#3)
selection on resistance##2##3##(2008-8#2)
selection on the##6##3##(1993-8#1)(2008-11#1)(2008-8#3)(2012-3#1)
selection on##44##2##(1993-8#1)(2008-11#2)(2008-8#30)(2008-9#6)(2010-4#2)(2012-3#3)
selection or##4##2##(1990-8#1)(1995-2#1)(2008-4#1)(2012-3#1)
selection pressure and that##2##4##(2008-10#1)(2013-1#1)
selection pressure for##3##3##(2008-10#1)(2010-7#2)
selection pressure##12##2##(1997-6#1)(2008-10#7)(2008-11#1)(2010-7#2)(2013-1#1)
selection pressures##6##2##(2008-10#1)(2008-11#1)(2008-8#2)(2012-3#2)
selection process of##2##3##(2008-10#1)(2012-3#1)
selection process##6##2##(1996-3#1)(1997-1#2)(2008-10#1)(2012-2#1)(2012-3#1)
selection should##2##2##(2008-9#1)(2011-2#1)
selection strategies##2##2##(2008-8#1)(2012-3#1)
selection systems##2##2##(2008-11#1)(2013-8#1)
selection through##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
selection to##6##2##(2008-10#2)(2008-8#2)(2008-9#1)(2010-4#1)
selection using##6##2##(1993-6#1)(2008-4#3)(2008-6#1)(2013-1#1)
selection valve in##2##3##(2008-10#2)
selection valve##8##2##(2008-10#8)
selection via##2##2##(2008-8#2)
selection was also##3##3##(2008-10#2)(2013-1#1)
selection was##17##2##(1990-8#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-8#6)(2008-9#1)(2012-3#1)(2013-1#1)
selection were##4##2##(2008-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
selection when##2##2##(1996-3#1)(2012-3#1)
selection with##3##2##(1995-8#1)(2008-9#1)(2012-3#1)
selection within##2##2##(2008-10#2)
selection##776##1##(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1992-1#1)(1992-12#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#14)(1995-3#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#4)(1996-6#3)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#2)(2007-12#1)(2007-8#1)(2008-1#5)(2008-10#181)(2008-11#31)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#21)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#165)(2008-9#53)(2009-10#3)(2009-11#3)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#5)(2010-11#2)(2010-12#4)(2010-2#3)(2010-4#17)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#8)(2011-1#3)(2011-10#1)(2011-2#23)(2011-3#6)(2012-12#2)(2012-2#10)(2012-3#54)(2012-8#1)(2013-1#16)(2013-8#11)
selection&quot##2##1##(2008-8#2)
selections for##2##2##(2008-10#1)(2008-3#1)
selections of##3##2##(2008-10#3)
selections to##2##2##(2008-10#2)
selections with##2##2##(2008-10#1)(2008-9#1)
selections##15##1##(1991-2#1)(1997-3#2)(2008-10#10)(2008-3#1)(2008-9#1)
selective AMPA receptor antagonist##2##4##(1994-2#2)
selective COX-2 inhibitor##3##3##(2008-10#1)(2008-12#2)
selective COX-2 inhibitors##2##3##(2008-10#2)
selective COX-2##6##2##(2008-10#4)(2008-12#2)
selective NMDA receptor antagonist##2##4##(1997-2#1)(2008-8#1)
selective adsorption of heavy metal ions##2##6##(2008-10#2)
selective adsorption##3##2##(2008-10#3)
selective advantage of##3##3##(2008-8#2)(2012-3#1)
selective advantage##9##2##(1993-2#1)(1997-3#1)(2008-10#2)(2008-8#4)(2012-3#1)
selective and non-selective##4##3##(2008-10#1)(2011-2#3)
selective and nonselective##4##3##(2008-10#2)(2008-12#2)
selective and rapid method for the determination of##2##8##(2008-10#2)
selective and rapid method##3##4##(2008-10#3)
selective and rapid##5##3##(2008-10#4)(2011-3#1)
selective and reproducible##2##3##(2008-10#2)
selective and sensitive assay of##2##5##(2008-10#2)
selective and sensitive determination of##4##5##(2008-10#4)
selective and sensitive fluorescence##3##4##(2008-10#1)(2008-12#2)
selective and sensitive fluorescent##2##4##(2008-10#2)
selective and sensitive method for the determination of##2##8##(2008-10#2)
selective and sensitive method for the##3##6##(2008-10#3)
selective and sensitive method##5##4##(2008-10#5)
selective and sensitive##28##3##(2008-10#26)(2008-12#2)
selective and simple##5##3##(2008-10#5)
selective and##67##2##(1995-11#2)(2008-10#56)(2008-12#5)(2011-2#3)(2011-3#1)
selective angiography##2##2##(2011-2#2)
selective assay of proteins##2##4##(2008-10#2)
selective binding##4##2##(1990-12#1)(1992-8#1)(2008-10#2)
selective brain cooling##3##3##(2010-1#3)
selective cells##3##2##(2008-8#3)
selective chromogenic##4##2##(2008-10#4)
selective cytotoxicity##2##2##(1997-7#1)(2008-11#1)
selective deposition##2##2##(1994-12#2)
selective destruction of##2##3##(2008-4#1)(2008-5#1)
selective detection of##6##3##(2008-10#6)
selective detection##10##2##(2008-10#10)
selective detector for##2##3##(2008-10#2)
selective detector##3##2##(2008-10#3)
selective determination of Fe(III) in the presence of Fe(II)##2##9##(2008-10#2)
selective determination of trace amounts of metal##2##7##(2008-10#2)
selective determination of uric acid in##2##6##(2008-10#2)
selective determination of##24##3##(1997-2#1)(2008-10#23)
selective determination##26##2##(1997-2#1)(2008-10#25)
selective displacement##5##2##(2008-7#5)
selective double excision##2##3##(1992-2#2)
selective dysfunction of##2##3##(1991-2#2)
selective effect of##2##3##(1993-6#1)(2008-10#1)
selective electrochemical##2##2##(2008-10#2)
selective electrode based on##5##4##(2008-10#5)
selective electrode is##2##3##(2008-10#2)
selective electrode##27##2##(2008-10#26)(2008-5#1)
selective electrodes##18##2##(2008-10#17)(2008-6#1)
selective enrichment##2##2##(2008-10#1)(2008-7#1)
selective extraction and determination of##2##5##(2008-10#2)
selective extraction and##6##3##(2008-10#5)(2008-8#1)
selective extraction of##10##3##(2008-10#10)
selective extraction##21##2##(2008-10#20)(2008-8#1)
selective flow injection##6##3##(2008-10#6)
selective fluorescence quenching agent for discriminating between alternant versus nonalternant polycyclic aromatic hydrocarbons##2##13##(2008-10#2)
selective fluorescence quenching agent for##3##5##(2008-10#3)
selective fluorescence quenching agent##4##4##(2008-10#4)
selective fluorescence quenching##5##3##(2008-10#5)
selective fluorescence##6##2##(2008-10#6)
selective for the##7##3##(1995-11#1)(2008-10#4)(2008-5#1)(2010-1#1)
selective for##26##2##(1990-8#1)(1991-7#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1997-2#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-1#1)
selective forces##4##2##(2008-8#4)
selective illumination of##2##3##(1993-3#2)
selective in the##2##3##(2008-10#2)
selective inhibitor of##3##3##(1990-8#1)(1993-8#1)(2008-5#1)
selective ion monitoring##2##3##(2008-10#2)
selective ion##4##2##(2008-10#4)
selective laser##2##2##(2009-7#1)(2011-2#1)
selective ligands##2##2##(1993-8#1)(2009-7#1)
selective measurement##2##2##(2008-10#1)(2008-5#1)
selective measurements of##2##3##(2008-10#2)
selective media for isolation of##2##5##(2008-10#2)
selective media##8##2##(2008-10#7)(2008-12#1)
selective medium##10##2##(2008-10#9)(2008-7#1)
selective membrane potentiometric sensor##2##4##(2008-10#2)
selective membrane potentiometric##3##3##(2008-10#3)
selective membrane##9##2##(1995-6#1)(2008-10#8)
selective membranes##2##2##(2008-10#2)
selective method for the determination of##6##6##(2008-10#6)
selective method for the##9##4##(2008-10#9)
selective method for##12##3##(2008-10#12)
selective method was##3##3##(2008-10#3)
selective method##30##2##(2008-10#29)(2008-5#1)
selective methods##4##2##(2008-10#4)
selective mu-opioid receptor##2##3##(1996-2#2)
selective oxidation of##2##3##(2008-10#2)
selective oxidation##3##2##(2008-10#3)
selective pecking##2##2##(2008-6#2)
selective polymeric membrane##2##3##(2008-10#2)
selective pre-concentration and differential pulse anodic stripping voltammetry##2##8##(2008-10#2)
selective preconcentration##2##2##(2008-10#2)
selective pressure##6##2##(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
selective pressures##7##2##(1997-9#1)(2008-8#4)(2008-9#1)(2009-8#1)
selective protein##2##2##(1992-12#1)(2008-9#1)
selective proteolysis##2##2##(2008-7#1)(2009-7#1)
selective quencher##3##2##(2008-10#3)
selective quenching##2##2##(2008-10#2)
selective reagents##3##2##(2008-10#2)(2012-2#1)
selective reduction##2##2##(1995-12#1)(2008-10#1)
selective regime##2##2##(2008-8#2)
selective removal of##2##3##(2008-10#2)
selective sensor##2##2##(2008-10#2)
selective sensors##2##2##(2008-10#2)
selective separation of##3##3##(2008-10#3)
selective separation##7##2##(2008-10#6)(2008-7#1)
selective sequential extractions##2##3##(2008-10#2)
selective sequential##3##2##(2008-10#3)
selective serotonin reuptake inhibitor##3##4##(2008-4#1)(2010-2#1)(2012-3#1)
selective serotonin reuptake inhibitors (SSRIs)##2##5##(2008-11#1)(2012-3#1)
selective serotonin reuptake inhibitors##7##4##(1997-8#3)(2008-11#1)(2008-6#2)(2012-3#1)
selective serotonin reuptake##10##3##(1997-8#3)(2008-11#1)(2008-4#1)(2008-6#2)(2010-2#1)(2012-3#2)
selective serotonin##11##2##(1997-8#3)(2008-11#1)(2008-4#1)(2008-6#2)(2010-2#1)(2012-3#3)
selective silver staining##2##3##(1997-3#2)
selective solid phase##2##3##(2008-10#2)
selective solid##3##2##(2008-10#3)
selective spectrofluorimetric determination of##2##4##(2008-10#2)
selective spectrophotometric method for##2##4##(2008-10#2)
selective spectrophotometric method##3##3##(2008-10#3)
selective spectrophotometric##6##2##(2008-10#6)
selective system##2##2##(2008-10#1)(2008-11#1)
selective to##16##2##(2008-10#16)
selective towards##4##2##(1995-11#1)(2008-10#3)
selective##714##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#4)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-5#2)(1994-8#7)(1995-11#9)(1995-12#2)(1995-6#2)(1996-2#5)(1996-3#1)(1996-5#4)(1996-6#1)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2008-10#466)(2008-11#17)(2008-12#9)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#11)(2008-6#8)(2008-7#17)(2008-8#26)(2008-9#6)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#4)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#14)(2011-3#2)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#2)(2013-8#1)
selectively activated##2##2##(1990-9#1)(2008-11#1)
selectively affect##2##2##(1990-11#1)(2012-2#1)
selectively amplified##3##2##(2008-10#3)
selectively and sensitively detected by##2##5##(2008-10#2)
selectively and##8##2##(1994-5#1)(2008-10#6)(2009-12#1)
selectively bind##2##2##(2008-10#1)(2010-7#1)
selectively blocked##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
selectively detected##4##2##(2008-10#4)
selectively determined##2##2##(2008-10#2)
selectively extracted##2##2##(2008-10#2)
selectively from##2##2##(2008-11#1)(2013-1#1)
selectively in##3##2##(1990-5#1)(2008-10#2)
selectively increased##3##2##(2011-2#3)
selectively inhibit##2##2##(1993-11#1)(2012-3#1)
selectively killed by##2##3##(2008-10#1)(2012-2#1)
selectively monitored at##2##3##(2008-10#2)
selectively neutral##2##2##(1997-6#1)(2008-10#1)
selectively on##2##2##(1993-6#1)(2008-10#1)
selectively promoted growth and stability of differentiated phenotype in##2##9##(1995-11#2)
selectively quenches##2##2##(2008-10#2)
selectively retain##2##2##(2008-10#2)
selectively to a##2##3##(2008-10#1)(2008-4#1)
selectively to##5##2##(1993-11#1)(2008-10#3)(2008-4#1)
selectively##143##1##(1990-11#2)(1990-2#1)(1990-5#2)(1990-9#1)(1991-5#2)(1992-3#1)(1992-6#3)(1993-11#2)(1993-6#3)(1994-2#1)(1994-5#3)(1994-8#1)(1995-11#3)(1996-12#3)(1996-2#2)(1996-5#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#69)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2009-12#2)(2009-3#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#3)
selectivities for##6##2##(1994-8#1)(2008-10#5)
selectivities of ISEs##2##3##(2008-10#2)
selectivities of##3##2##(2008-10#3)
selectivities##21##1##(1994-8#1)(2008-10#17)(2008-6#1)(2010-11#1)(2010-7#1)
selectivity against##2##2##(2008-10#2)
selectivity and a##2##3##(2008-10#2)
selectivity and in the presence of this cation the host fluorescence intensity was##2##13##(2008-10#2)
selectivity and reproducibility##3##3##(2008-10#3)
selectivity and sensitivity of##4##4##(2008-10#4)
selectivity and sensitivity##20##3##(1997-6#1)(2008-10#17)(2008-11#1)(2010-7#1)
selectivity and stability##2##3##(2008-10#2)
selectivity and the##4##3##(2008-10#3)(2008-8#1)
selectivity and##45##2##(1991-5#2)(1997-6#1)(2008-10#36)(2008-11#1)(2008-5#1)(2008-8#3)(2010-7#1)
selectivity are##5##2##(2008-10#5)
selectivity as well as##2##4##(2008-10#1)(2008-3#1)
selectivity as##3##2##(2008-10#2)(2008-3#1)
selectivity can be##4##3##(2008-10#3)(2008-11#1)
selectivity can##5##2##(1994-12#1)(2008-10#3)(2008-11#1)
selectivity coefficient for##2##3##(2008-10#2)
selectivity coefficient values as determined by##3##6##(2008-10#3)
selectivity coefficient values##5##3##(2008-10#5)
selectivity coefficient##12##2##(2008-10#12)
selectivity coefficients and##3##3##(2008-10#3)
selectivity coefficients for##5##3##(2008-10#5)
selectivity coefficients of a##2##4##(2008-10#2)
selectivity coefficients of ion-selective electrodes##2##5##(2008-10#2)
selectivity coefficients of ion-selective##3##4##(2008-10#3)
selectivity coefficients of##10##3##(2008-10#10)
selectivity coefficients towards##2##3##(2008-10#2)
selectivity coefficients##25##2##(2008-10#25)
selectivity control##2##2##(2008-10#2)
selectivity factor and##2##3##(2008-10#2)
selectivity factors##2##2##(2008-10#2)
selectivity for Ag(+)##2##3##(2008-10#2)
selectivity for Cu(2+)##2##3##(2008-10#2)
selectivity for Cu(II)##2##3##(2008-10#2)
selectivity for Mg(2+) over##2##4##(2008-10#2)
selectivity for Pb(2+) over##2##4##(2008-10#2)
selectivity for Pb(II) over##2##4##(2008-10#2)
selectivity for U(VI) over Fe(III)##2##5##(2008-10#2)
selectivity for cesium ion over##2##5##(2008-10#2)
selectivity for cesium over##2##4##(2008-10#2)
selectivity for cesium##5##3##(2008-10#5)
selectivity for headgroup##2##3##(1994-5#2)
selectivity for primary-tertiary alkylammonium cations##2##5##(2008-10#2)
selectivity for sodium and potassium picrates##2##6##(2008-10#2)
selectivity for the##6##3##(2008-10#6)
selectivity for##78##2##(1990-8#3)(1991-3#1)(1994-11#1)(1994-5#2)(1994-8#1)(2008-10#70)
selectivity in the##5##3##(2008-10#5)
selectivity in##22##2##(1992-3#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-8#1)(2009-12#3)(2011-2#1)
selectivity is##9##2##(2008-10#5)(2008-11#1)(2008-9#1)(2010-12#1)(2010-7#1)
selectivity obtained##2##2##(2008-10#2)
selectivity of a##2##3##(2008-10#2)
selectivity of liquid##2##3##(2008-10#2)
selectivity of organic##2##3##(2008-10#2)
selectivity of the developed##2##4##(2008-10#2)
selectivity of the electrode##2##4##(2008-10#2)
selectivity of the method##4##4##(2008-10#4)
selectivity of the proposed method##3##5##(2008-10#3)
selectivity of the proposed##4##4##(2008-10#4)
selectivity of the sensor##3##4##(2008-10#3)
selectivity of the##33##3##(2008-10#32)(2008-11#1)
selectivity of this##7##3##(1995-11#1)(2008-10#6)
selectivity of##85##2##(1995-11#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#2)(2008-10#70)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-7#1)
selectivity over K(+)##2##3##(2008-10#2)
selectivity over##6##2##(2008-10#6)
selectivity pattern with##3##3##(2008-10#3)
selectivity pattern##4##2##(2008-10#4)
selectivity properties of##2##3##(2008-10#2)
selectivity relative to##2##3##(2008-10#2)
selectivity than##2##2##(2008-10#2)
selectivity to##9##2##(2008-10#9)
selectivity toward##10##2##(2008-10#7)(2008-7#1)(2009-12#1)(2013-1#1)
selectivity towards the##2##3##(2008-10#1)(2008-11#1)
selectivity towards##11##2##(2008-10#10)(2008-11#1)
selectivity using##3##2##(2008-10#3)
selectivity was improved##2##3##(2008-10#2)
selectivity was observed##2##3##(2008-10#2)
selectivity was##13##2##(1992-3#1)(1996-5#1)(2008-10#10)(2008-11#1)
selectivity were##4##2##(1996-5#1)(2008-10#3)
selectivity when##3##2##(2008-10#2)(2011-2#1)
selectivity with##3##2##(2008-10#3)
selectivity##493##1##(1990-8#3)(1991-3#1)(1991-5#3)(1992-3#3)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#4)(1994-8#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-6#1)(2008-10#408)(2008-11#11)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#7)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
selector in the##2##3##(2008-10#2)
selector in##4##2##(2008-10#4)
selector##18##1##(2008-10#17)(2009-10#1)
selects for##2##2##(1990-8#1)(2008-8#1)
selects the##3##2##(2008-3#2)(2008-8#1)
selects##10##1##(1990-8#1)(1997-3#1)(2008-1#1)(2008-3#2)(2008-8#3)(2009-6#1)(2010-1#1)
selenate (Se(VI))##2##2##(2008-10#2)
selenate##9##1##(1997-4#1)(2008-10#8)
selenide##3##1##(2010-11#1)(2012-2#2)
selenious acid##2##2##(2008-10#2)
selenite (Se(IV))##3##2##(2008-10#3)
selenite and##3##2##(1995-11#1)(2008-10#2)
selenite ion selective##2##3##(2008-10#2)
selenite ion##4##2##(2008-10#4)
selenite##27##1##(1993-12#2)(1995-11#1)(2008-10#23)(2010-11#1)
selenium (IV)##6##2##(2008-10#6)
selenium (Se)##3##2##(2008-10#2)(2012-2#1)
selenium and lead##2##3##(2008-10#2)
selenium and##7##2##(2008-10#5)(2008-11#1)(2010-11#1)
selenium compounds##4##2##(2008-10#2)(2010-11#2)
selenium content in##3##3##(1993-12#1)(2008-10#2)
selenium content of##2##3##(2008-10#2)
selenium content##6##2##(1993-12#1)(2008-10#5)
selenium could##2##2##(2008-10#1)(2008-6#1)
selenium determination in##3##3##(2008-10#3)
selenium determination##4##2##(2008-10#4)
selenium determination/speciation##2##2##(2008-10#2)
selenium from the##2##3##(2008-10#2)
selenium hydride generation##2##3##(2008-10#2)
selenium in natural water##2##4##(2008-10#2)
selenium in the atmosphere##3##4##(2008-10#3)
selenium in the##7##3##(2008-10#6)(2012-2#1)
selenium in urine##2##3##(2008-10#2)
selenium in##31##2##(2008-10#29)(2010-11#1)(2012-2#1)
selenium is##6##2##(2008-10#6)
selenium levels and##2##3##(1993-12#2)
selenium levels##4##2##(1993-12#3)(2008-10#1)
selenium present in##2##3##(2008-10#2)
selenium present##3##2##(2008-10#3)
selenium speciation##5##2##(2008-10#5)
selenium species in human urine##2##5##(2008-10#2)
selenium species in##5##3##(2008-10#5)
selenium species##23##2##(2008-10#21)(2010-11#2)
selenium was found##2##3##(1993-12#1)(2008-10#1)
selenium was##7##2##(1993-12#1)(2008-10#5)(2010-11#1)
selenium with the##2##3##(2008-10#2)
selenium with##3##2##(1993-12#1)(2008-10#2)
selenium##191##1##(1993-12#8)(1997-8#2)(2008-10#148)(2008-11#1)(2008-4#1)(2008-6#9)(2009-10#4)(2009-5#1)(2010-11#12)(2012-2#4)(2013-1#1)
selenium(IV + VI)##2##3##(2008-10#2)
selenium(IV) and (IV + VI)##2##5##(2008-10#2)
selenium(IV) and (VI)##2##3##(2008-10#2)
selenium(IV) and molybdenum(VI)##3##3##(2008-10#3)
selenium(IV) and##9##2##(2008-10#9)
selenium(IV) in##2##2##(2008-10#2)
selenium(IV)##17##1##(2008-10#17)
selenium-containing phycocyanin from##2##3##(2008-8#2)
selenium-containing##6##1##(1995-3#1)(2008-10#2)(2008-8#2)(2012-2#1)
selenium-enriched plants##2##2##(2008-10#2)
selenium-rich algae (Spirulina platensis)##2##4##(2008-8#2)
selenoamino acids##4##2##(2008-10#4)
selenocompounds##3##1##(2008-10#3)
selenocysteine (Sec)##2##2##(2008-10#1)(2012-2#1)
selenocysteine##8##1##(2008-10#4)(2008-9#1)(2010-11#1)(2012-2#2)
selenocystine##4##1##(2008-10#3)(2010-11#1)
selenomethionine (SeMet)##2##2##(2008-10#2)
selenomethionine and##2##2##(2008-10#2)
selenomethionine##9##1##(2008-10#9)
selenophosphate##2##1##(2012-2#2)
selenoprotein mRNA##3##2##(2012-2#3)
selenoprotein transcripts##2##2##(2012-2#2)
selenoprotein##13##1##(2009-10#2)(2012-2#11)
selenoproteins##4##1##(2009-10#1)(2010-11#2)(2012-2#1)
selenospecies##5##1##(2008-10#4)(2010-11#1)
selenoxide##2##1##(2008-10#2)
self and non-self##2##3##(2008-1#1)(2008-9#1)
self and peer assessment and##2##5##(2008-11#2)
self and peer assessment##4##4##(2008-11#4)
self and##9##2##(2008-1#1)(2008-11#6)(2008-12#1)(2008-9#1)
self assembled##2##2##(2008-10#2)
self from##2##2##(2008-11#1)(2009-8#1)
self in##2##2##(2008-11#1)(2008-12#1)
self is##2##2##(2008-11#2)
self monitoring##6##2##(2008-10#6)
self or##2##2##(2008-4#1)(2013-8#1)
self reflection##2##2##(1993-2#1)(2008-11#1)
self##68##1##(1990-11#1)(1990-3#1)(1990-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#1)(2008-1#1)(2008-10#11)(2008-11#25)(2008-12#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#3)(2012-2#2)(2013-1#2)(2013-8#2)
self-##2##1##(2008-11#1)(2013-1#1)
self-absorption##2##1##(2008-10#1)(2012-2#1)
self-administered questionnaire##3##2##(1992-1#1)(1993-2#1)(2008-11#1)
self-administered questionnaires##2##2##(2008-10#1)(2011-2#1)
self-administered##11##1##(1992-1#1)(1993-2#1)(2008-10#2)(2008-11#2)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#2)
self-administration in##4##2##(1993-6#1)(2012-3#3)
self-administration of##2##2##(1993-6#1)(2008-10#1)
self-administration##18##1##(1991-1#3)(1993-6#7)(1997-2#1)(2008-10#1)(2009-7#1)(2012-3#5)
self-amputated colonic##2##2##(2008-10#2)
self-assemble##3##1##(1995-5#1)(2008-11#1)(2009-11#1)
self-assembled aminoethanethiol monolayer##2##3##(2008-10#2)
self-assembled bilayers##3##2##(2008-10#3)
self-assembled electrode##4##2##(2008-10#4)
self-assembled monolayer (SAM) modified gold##2##5##(2008-10#2)
self-assembled monolayer (SAM) of##3##4##(2008-10#3)
self-assembled monolayer (SAM)##8##3##(2008-10#8)
self-assembled monolayer film##2##3##(2008-8#2)
self-assembled monolayer modified gold##2##4##(2008-10#2)
self-assembled monolayer modified##3##3##(2008-10#3)
self-assembled monolayer of##4##3##(2008-10#4)
self-assembled monolayer on##2##3##(2008-10#2)
self-assembled monolayer##23##2##(2008-10#21)(2008-8#2)
self-assembled monolayers (SAMs)##3##3##(2008-10#3)
self-assembled monolayers surface##2##3##(2008-10#2)
self-assembled monolayers##12##2##(2008-10#11)(2010-7#1)
self-assembled on##3##2##(2008-10#3)
self-assembled##57##1##(1995-3#1)(2008-10#51)(2008-7#1)(2008-8#2)(2009-11#1)(2010-7#1)
self-assembly of##3##2##(2008-10#2)(2010-9#1)
self-assembly##16##1##(2008-10#8)(2009-5#1)(2010-9#1)(2013-8#6)
self-assessed skills##2##2##(2007-12#2)
self-assessed##3##1##(2007-12#3)
self-assessment##10##1##(1995-3#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
self-assessments##2##1##(1992-3#2)
self-awareness##9##1##(2008-11#3)(2008-12#4)(2012-3#1)(2013-1#1)
self-blame##3##1##(2008-11#1)(2010-1#2)
self-care self-efficacy##3##2##(2010-2#3)
self-care##10##1##(1995-3#1)(2008-12#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-2#3)(2010-7#1)
self-catheterisation##2##1##(2008-6#1)(2008-7#1)
self-competence and intrinsic value for math and English##2##8##(2009-7#2)
self-competence##3##1##(2009-7#3)
self-complementary##2##1##(1992-6#1)(2008-10#1)
self-concept of##2##2##(2008-11#1)(2009-7#1)
self-concept##13##1##(2008-11#2)(2009-7#11)
self-consistent##2##1##(2008-10#1)(2008-3#1)
self-contained##6##1##(1992-3#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
self-control##7##1##(2008-12#7)
self-cured##2##1##(1996-12#1)(2013-1#1)
self-cycling fermentation##2##2##(2008-7#2)
self-defense##3##1##(2008-10#2)(2010-11#1)
self-directed learning##3##2##(2008-11#1)(2008-12#2)
self-directed work teams##7##3##(1993-12#5)(1994-1#1)(1994-3#1)
self-directed##13##1##(1993-12#5)(1994-1#1)(1994-3#1)(1996-2#1)(2008-11#3)(2008-12#2)
self-efficacy and##5##2##(1992-1#1)(2008-11#1)(2008-12#1)(2010-9#2)
self-efficacy in##3##2##(2012-2#2)(2012-3#1)
self-efficacy of##2##2##(2008-12#1)(2010-9#1)
self-efficacy##35##1##(1992-1#1)(2008-11#1)(2008-12#8)(2008-4#3)(2009-3#2)(2009-7#1)(2010-2#5)(2010-9#4)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#3)
self-esteem and cognitive coping##2##4##(2008-11#2)
self-esteem and##8##2##(1994-12#1)(1995-2#1)(2008-11#4)(2008-5#1)(2010-7#1)
self-esteem is##2##2##(1993-3#2)
self-esteem of##3##2##(1990-2#1)(1993-3#1)(2008-11#1)
self-esteem was##3##2##(1995-2#1)(2008-11#1)(2012-2#1)
self-esteem##35##1##(1990-2#1)(1993-3#4)(1994-12#2)(1995-2#2)(2008-11#9)(2008-12#3)(2008-5#1)(2009-11#1)(2009-7#4)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#2)
self-evaluation##4##1##(1990-2#1)(1994-6#2)(2008-5#1)
self-expandable##3##1##(2013-1#3)
self-fertile##2##1##(2008-10#2)
self-fertilization##7##1##(2008-8#4)(2008-9#3)
self-focus##4##1##(2010-10#4)
self-focused##2##1##(2008-11#1)(2009-5#1)
self-focusing in##3##2##(2007-12#2)(2008-3#1)
self-focusing##5##1##(2007-12#3)(2008-2#1)(2008-3#1)
self-frequency##2##1##(2007-11#1)(2007-12#1)
self-frequency-doubling##2##1##(2007-12#1)(2008-2#1)
self-generated##3##1##(2008-11#2)(2009-8#1)
self-healing##2##1##(1991-11#1)(2010-12#1)
self-help groups and##3##3##(1994-1#1)(1996-3#1)(2008-4#1)
self-help groups##11##2##(1994-1#2)(1994-12#1)(1995-1#2)(1996-3#2)(2008-4#4)
self-help networks##2##2##(1994-1#2)
self-help##28##1##(1994-1#9)(1994-12#2)(1995-1#2)(1995-3#1)(1996-3#9)(2008-4#4)(2010-10#1)
self-identified lesbian and bisexual##2##4##(2008-12#2)
self-identified##4##1##(1996-3#1)(2008-12#2)(2010-7#1)
self-image and##3##2##(2008-7#1)(2009-1#1)(2011-2#1)
self-image##4##1##(1991-2#1)(2008-7#1)(2009-1#1)(2011-2#1)
self-imaging##2##1##(2007-12#1)(2008-3#1)
self-improvement##2##1##(1997-1#2)
self-injury##4##1##(2008-11#4)
self-insured##3##1##(1994-12#1)(1995-12#1)(1997-2#1)
self-limited##4##1##(1991-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
self-limiting##5##1##(1992-2#1)(2007-12#1)(2008-8#1)(2010-5#1)(2012-3#1)
self-management of##2##2##(2013-1#2)
self-management##5##1##(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#2)
self-medication##4##1##(1995-2#1)(1997-4#1)(2008-10#1)(2009-7#1)
self-mode locking##3##2##(2008-3#3)
self-monitored##2##1##(2008-1#1)(2008-11#1)
self-monitoring##6##1##(1990-3#1)(2008-11#2)(2008-9#3)
self-ordered ring##2##2##(2008-10#2)
self-organization##5##1##(2008-8#2)(2008-9#2)(2011-2#1)
self-organizing emergence of##2##3##(2008-8#2)
self-organizing##5##1##(1997-6#1)(2008-8#2)(2009-10#1)(2009-6#1)
self-paced reading##3##2##(2013-1#3)
self-paced##7##1##(2008-7#1)(2013-1#5)(2013-8#1)
self-perception after##2##2##(2013-1#2)
self-perception##5##1##(2009-6#1)(2012-2#1)(2013-1#3)
self-processing##2##1##(1995-6#1)(2008-11#1)
self-protective##2##1##(2010-12#1)(2012-2#1)
self-pumped##4##1##(2008-2#4)
self-rated health##2##2##(2009-11#1)(2013-8#1)
self-rated##3##1##(2009-11#1)(2012-3#1)(2013-8#1)
self-rating##3##1##(1992-2#1)(2008-7#1)(2012-3#1)
self-reference##6##1##(2008-10#1)(2008-9#5)
self-referential##2##1##(2008-11#1)(2013-8#1)
self-reflection and##2##2##(2008-11#2)
self-reflection##4##1##(2008-11#4)
self-regenerating##2##1##(2008-10#2)
self-regulate##2##1##(2013-8#2)
self-regulation##8##1##(2008-12#3)(2012-3#5)
self-renewal and senescence##3##3##(2013-1#3)
self-renewal and##4##2##(1990-5#1)(2013-1#3)
self-renewal divisions##2##2##(2009-12#1)(2012-2#1)
self-renewal in##2##2##(2008-8#1)(2009-12#1)
self-renewal##14##1##(1990-5#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-12#3)(2012-2#1)(2013-1#4)
self-renewing##5##1##(1995-11#1)(2013-1#4)
self-report data##2##2##(2010-7#1)(2013-1#1)
self-report measures##6##2##(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#2)
self-report scales##2##2##(2012-2#2)
self-report##18##1##(2008-12#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#3)(2013-1#5)(2013-8#1)
self-reported adverse##2##2##(1991-1#1)(2008-11#1)
self-reported function##2##2##(2008-12#1)(2013-1#1)
self-reported health##3##2##(1993-1#1)(2008-10#1)(2008-11#1)
self-reported physical##3##2##(2008-4#1)(2013-1#2)
self-reported##36##1##(1991-1#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-6#2)(2007-12#1)(2008-10#2)(2008-11#6)(2008-12#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-3#3)(2013-1#5)
self-reporting##2##1##(1993-3#1)(2013-1#1)
self-reports of##2##2##(2008-4#1)(2009-11#1)
self-reports##3##1##(2008-10#1)(2008-4#1)(2009-11#1)
self-reproducing##2##1##(2008-8#1)(2008-9#1)
self-retaining##2##1##(1991-2#1)(1992-1#1)
self-selected##2##1##(2008-8#1)(2011-2#1)
self-selection##2##1##(1990-6#1)(2008-8#1)
self-similar##2##1##(1992-11#1)(2008-11#1)
self-similarity##2##1##(2008-11#1)(2008-8#1)
self-sorted##2##1##(2008-10#2)
self-sorting and##2##2##(2008-10#2)
self-specific##4##1##(2013-8#4)
self-starting##2##1##(2008-3#2)
self-stimulation##9##1##(1991-2#2)(1993-6#5)(1996-2#2)
self-stretching##3##1##(2010-9#3)
self-sufficiency##3##1##(1992-12#1)(1994-2#2)
self-supporting##2##1##(1994-2#1)(1996-3#1)
self-sustaining##5##1##(2008-10#4)(2008-8#1)
self-tanning formulations##2##2##(2008-5#2)
self-tanning##4##1##(2008-5#4)
self-trapped##2##1##(1992-8#1)(2007-12#1)
self-weighted alternating trilinear decomposition (SWATLD)##2##5##(2008-10#2)
selfed##4##1##(2008-10#3)(2008-8#1)
selfing rate##2##2##(2008-8#2)
selfing rates##3##2##(2008-8#3)
selfing##16##1##(2008-10#4)(2008-8#7)(2008-9#5)
selfish##7##1##(2008-8#2)(2008-9#3)(2009-6#1)(2012-3#1)
selfishness is##3##2##(2008-9#3)
selfishness##6##1##(2008-9#5)(2010-2#1)
sella##11##1##(1991-11#1)(1991-6#1)(1997-3#1)(2011-2#4)(2013-1#4)
sellar volume##3##2##(2011-2#3)
sellar##10##1##(2011-2#3)(2012-3#5)(2013-1#2)
selling##5##1##(1992-2#1)(1996-1#1)(2008-12#1)(2008-9#1)(2012-12#1)
selon##2##1##(2013-1#2)
sema##3##1##(1993-12#3)
semagenesis##2##1##(2009-8#2)
semantic differential##4##2##(1991-2#1)(1993-2#1)(1993-3#1)(2012-2#1)
semantic intervention##3##2##(2011-1#3)
semantic processing##3##2##(1990-8#1)(1991-2#1)(1996-2#1)
semantic##23##1##(1990-8#2)(1991-2#4)(1993-2#1)(1993-3#1)(1996-2#3)(2008-9#1)(2010-12#2)(2010-4#1)(2011-1#6)(2012-2#1)(2012-3#1)
semantically##2##1##(2009-10#1)(2010-10#1)
semantics##3##1##(2009-11#1)(2010-4#1)(2013-8#1)
semantics)##2##1##(2013-8#2)
semen and##2##2##(2009-10#1)(2011-1#1)
semen##14##1##(1992-6#1)(1994-8#1)(1996-9#1)(2008-12#6)(2008-6#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
semeniperda##7##1##(2008-10#7)
semester of##2##2##(2009-3#1)(2012-3#1)
semester##8##1##(2008-10#1)(2008-11#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-3#2)
semesters##2##1##(1996-1#1)(2010-3#1)
semi-arid##2##1##(2010-10#1)(2012-9#1)
semi-automated##7##1##(2008-10#6)(2010-12#1)
semi-automatic##3##1##(2008-10#1)(2008-9#1)(2012-2#1)
semi-batch##4##1##(2008-10#3)(2009-10#1)
semi-definite tensors##2##2##(2013-1#2)
semi-dwarf##3##1##(2008-9#3)
semi-dwarfing##2##1##(2008-10#2)
semi-empirical##3##1##(1992-4#1)(1994-12#1)(2011-3#1)
semi-infinite##2##1##(2008-10#1)(2008-3#1)
semi-liquid core microcapsules##2##3##(2008-11#2)
semi-preparative scale##2##2##(2008-10#2)
semi-preparative##5##1##(1990-8#1)(2008-10#3)(2008-5#1)
semi-quantitative PCR##2##2##(1994-11#1)(2011-2#1)
semi-quantitative RT-PCR and##2##3##(2008-8#1)(2011-3#1)
semi-quantitative RT-PCR##5##2##(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)
semi-quantitative analysis of##2##3##(2008-10#1)(2008-2#1)
semi-quantitative calibration##2##2##(2008-10#2)
semi-quantitative##20##1##(1994-11#1)(1994-2#1)(2008-10#10)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#4)(2011-3#1)
semi-static and PGA-alginate##3##3##(2011-2#3)
semi-static and##4##2##(2011-2#4)
semi-static seeding##2##2##(2011-2#2)
semi-static##6##1##(2011-2#6)
semi-structured interview##4##2##(2008-1#1)(2010-6#1)(2012-3#2)
semi-structured interviews were conducted with##2##5##(2008-12#1)(2013-1#1)
semi-structured interviews were##3##3##(2008-1#1)(2008-12#1)(2013-1#1)
semi-structured interviews with##6##3##(1996-1#1)(2008-12#2)(2009-10#1)(2013-1#2)
semi-structured interviews##13##2##(1991-6#1)(1996-1#1)(2008-1#2)(2008-12#3)(2009-10#1)(2009-12#1)(2012-3#1)(2013-1#3)
semi-structured##23##1##(1991-6#1)(1996-1#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#3)(2009-10#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-3#3)(2013-1#4)
semi-supervised learning based method##2##4##(2010-7#2)
semi-supervised learning##4##2##(2010-7#4)
semi-thin##2##1##(1997-2#2)
semi-urban##2##1##(2008-3#1)(2011-2#1)
semiarid##5##1##(2008-8#3)(2008-9#1)(2013-8#1)
semicarbazide and hydrazine in##3##4##(2008-10#3)
semicarbazide and hydrazine##6##3##(2008-10#6)
semicarbazide##8##1##(2008-10#8)
semicircular##2##1##(1992-4#1)(2008-9#1)
semiconducting##2##1##(2008-10#1)(2008-7#1)
semiconductor guiding layer##2##3##(2008-3#2)
semiconductor industry##2##2##(2008-10#1)(2008-7#1)
semiconductor laser radar##2##3##(2008-3#2)
semiconductor laser with an##2##4##(2008-3#2)
semiconductor laser with##3##3##(2008-3#3)
semiconductor laser##12##2##(2008-10#2)(2008-2#2)(2008-3#8)
semiconductor lasers##4##2##(2007-12#2)(2008-3#2)
semiconductor optical##3##2##(2007-11#2)(2008-3#1)
semiconductor quantum dots##2##3##(1995-3#1)(2008-10#1)
semiconductor sensor for##2##3##(2008-10#2)
semiconductor sensor##4##2##(2008-10#4)
semiconductor transducer##2##2##(2008-10#2)
semiconductor##50##1##(1990-11#1)(1990-12#1)(1995-3#1)(2007-11#2)(2007-12#2)(2008-10#13)(2008-2#3)(2008-3#17)(2008-7#2)(2008-8#4)(2012-2#4)
semiconductors##6##1##(1992-8#1)(2008-3#3)(2008-9#1)(2012-2#1)
semicontinuous##4##1##(1992-8#1)(2008-11#1)(2008-6#1)(2008-7#1)
semidominant##2##1##(2008-10#2)
semiempirical##5##1##(1996-5#1)(2008-10#3)(2008-11#1)
semilaevis##4##1##(2010-8#3)(2013-8#1)
semilobar##2##1##(2011-1#2)
semimechanistic models##2##2##(2008-9#2)
seminal RNase##4##2##(1990-5#4)
seminal gamma-GTP##3##2##(1995-11#3)
seminal plasma##4##2##(1990-5#2)(1994-3#2)
seminal vesicle##8##2##(2008-11#4)(2011-2#4)
seminal vesicles##4##2##(1997-8#2)(2012-12#2)
seminal##37##1##(1990-5#6)(1994-3#3)(1995-11#6)(1997-8#4)(2008-10#1)(2008-11#4)(2008-12#1)(2008-9#3)(2010-7#1)(2011-2#6)(2012-12#2)
seminar##6##1##(1990-2#1)(1994-2#1)(2008-1#1)(2008-12#2)(2010-1#1)
seminars and##2##2##(1992-3#1)(1994-12#1)
seminars##6##1##(1991-2#1)(1992-3#1)(1994-12#3)(2010-8#1)
seminiferous epithelium##23##2##(2009-10#14)(2012-2#9)
seminiferous tubule##3##2##(2009-10#2)(2012-2#1)
seminiferous tubules##5##2##(1995-6#2)(2008-7#1)(2009-10#2)
seminiferous##37##1##(1995-6#3)(2008-7#1)(2009-10#20)(2012-2#13)
semiparametric model##3##2##(1996-2#1)(2010-11#2)
semiparametric##6##1##(1996-2#1)(2008-11#1)(2010-11#2)(2010-5#2)
semipenetrans and##2##2##(2008-10#2)
semipenetrans##3##1##(2008-10#3)
semiquantitative##9##1##(1993-12#1)(1995-11#1)(1995-12#1)(2008-10#3)(2008-7#1)(2012-3#1)(2013-8#1)
semiquantitatively##2##1##(1996-12#1)(2008-5#1)
semiquinone##3##1##(1993-8#1)(2008-10#2)
semiselective agar medium##3##3##(2008-10#3)
semiselective medium##6##2##(2008-10#6)
semiselective##12##1##(2008-10#12)
semisolid##5##1##(2008-10#1)(2008-5#4)
semistructured interviews##4##2##(2009-5#1)(2010-11#1)(2010-8#1)(2013-1#1)
semistructured##8##1##(1993-3#1)(2009-5#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
semisynthetic##5##1##(1993-8#2)(1994-8#1)(2008-10#2)
semitaeniatus and T##2##3##(2008-7#2)
semitaeniatus and##3##2##(2008-7#3)
semithin##2##1##(1993-11#1)(2011-2#1)
semitransparent##4##1##(2008-3#4)
semivariance##2##1##(2008-10#2)
semivariogram analysis##2##2##(2008-10#1)(2008-11#1)
semivariogram parameters##2##2##(2008-10#2)
semivariogram##5##1##(2008-10#4)(2008-11#1)
semivolatile compounds##2##2##(2008-10#2)
semivolatile##4##1##(2008-10#4)
semivolatiles##3##1##(2008-10#3)
send##6##1##(1990-12#1)(1991-3#1)(1995-1#1)(1997-5#1)(2008-1#1)(2011-2#1)
senders##2##1##(2013-1#2)
sending##2##1##(1991-10#1)(2013-1#1)
sends signals##2##2##(2008-11#2)
sends##6##1##(2008-11#2)(2009-1#3)(2009-10#1)
senesced##4##1##(2008-10#3)(2013-1#1)
senescence accelerated##2##2##(2008-7#2)
senescence and##6##2##(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
senescence in##5##2##(1990-5#1)(1997-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
senescence is##3##2##(2008-11#2)(2008-9#1)
senescence pathways##4##2##(2012-3#2)(2013-1#2)
senescence##68##1##(1990-5#2)(1992-9#2)(1993-12#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-3#1)(1997-7#4)(2008-10#5)(2008-11#13)(2008-7#2)(2008-8#6)(2008-9#8)(2009-8#1)(2011-2#3)(2012-3#7)(2013-1#8)(2013-7#1)
senescence?##2##1##(1996-3#1)(2008-9#1)
senescent cells##4##2##(1997-7#2)(2008-11#1)(2013-7#1)
senescent rats##6##2##(1991-2#3)(2013-7#3)
senescent##19##1##(1991-2#3)(1992-9#2)(1993-12#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2013-7#7)
senescing##2##1##(2008-10#2)
senile lentigo represents a##2##4##(2011-2#2)
senile lentigo##3##2##(2011-2#3)
senile osteoporosis##2##2##(2008-7#2)
senile plaques and##2##3##(2008-7#2)
senile plaques##4##2##(1991-7#1)(2008-7#3)
senile##11##1##(1991-7#1)(1992-12#1)(2008-7#6)(2011-2#3)
senior administrators##2##2##(1993-12#1)(1994-2#1)
senior and##2##2##(1996-1#1)(2011-2#1)
senior managers##3##2##(1992-3#1)(1993-2#1)(1997-2#1)
senior student nurses##2##3##(2008-11#2)
senior volunteerism##4##2##(1994-2#4)
senior##38##1##(1990-3#2)(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#2)(1994-2#6)(1995-12#1)(1996-1#1)(1997-2#1)(2008-11#2)(2008-12#5)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
seniority##5##1##(1991-12#1)(2008-10#2)(2011-2#2)
seniors##4##1##(1993-2#1)(1994-2#1)(1994-3#1)(1997-2#1)
senology##2##1##(1990-2#2)
sensation and##4##2##(1992-3#1)(2008-12#1)(2010-6#1)(2011-2#1)
sensation in##2##2##(2010-9#1)(2013-1#1)
sensation of##3##2##(1995-8#1)(1996-6#1)(2011-2#1)
sensation##19##1##(1990-5#1)(1991-3#1)(1992-3#1)(1995-8#1)(1996-6#2)(2008-11#1)(2008-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
sensations##2##1##(2008-10#1)(2009-10#1)
sense and antisense EDRF1 constructs were prepared and transfected into K562 cells##2##12##(2008-8#1)(2008-9#1)
sense and antisense##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
sense and##7##2##(2008-10#1)(2008-8#3)(2008-9#2)(2009-9#1)
sense of being##2##3##(2008-11#2)
sense of control##2##3##(1993-12#1)(1995-3#1)
sense of self##3##3##(2008-11#2)(2010-6#1)
sense of smell##5##3##(2008-7#1)(2012-2#1)(2013-1#3)
sense of taste##2##3##(2008-7#2)
sense of the word##2##4##(1995-5#2)
sense of the##5##3##(1995-5#2)(2008-11#1)(2010-11#1)(2011-2#1)
sense of well-being##3##3##(2008-7#2)(2011-2#1)
sense of##42##2##(1991-12#1)(1992-1#1)(1993-12#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-1#1)(1997-1#1)(2008-11#8)(2008-12#2)(2008-4#1)(2008-7#7)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#1)
sense primers##2##2##(2008-10#2)
sense to##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
sense##104##1##(1990-5#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-1#1)(2008-10#12)(2008-11#12)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#8)(2009-10#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
sensed by the detector##2##4##(2008-10#2)
sensed by the##3##3##(2008-10#3)
sensed by##5##2##(1994-6#1)(2008-10#4)
sensed##15##1##(1994-6#1)(2008-10#10)(2008-3#3)(2009-11#1)
senses##4##1##(1995-2#1)(1995-6#1)(2007-12#1)(2011-1#1)
sensibilities##2##1##(2008-11#1)(2008-8#1)
sensibility to auxin##3##3##(2008-8#3)
sensibility##8##1##(2008-10#3)(2008-8#4)(2008-9#1)
sensible and##2##2##(2008-10#1)(2011-2#1)
sensible##9##1##(1991-3#1)(2008-10#3)(2008-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
sensibly##3##1##(1990-5#1)(2008-10#1)(2010-8#1)
sensilla and##3##2##(2007-12#3)
sensilla basiconica II##3##3##(2007-12#3)
sensilla basiconica##5##2##(2007-12#5)
sensilla of the##3##3##(2007-12#1)(2008-7#2)
sensilla of##4##2##(2007-12#1)(2008-7#3)
sensilla##33##1##(2007-12#20)(2008-7#7)(2008-8#6)
sensillum styloconicum##5##2##(2008-8#5)
sensillum##11##1##(2007-12#4)(2008-7#2)(2008-8#5)
sensing agent##2##2##(2008-10#2)
sensing and##6##2##(2008-10#3)(2009-8#1)(2010-8#2)
sensing applications##2##2##(2008-10#2)
sensing approach##2##2##(2008-10#2)
sensing by##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
sensing characteristics##4##2##(2008-10#4)
sensing device for##2##3##(2008-10#2)
sensing device##6##2##(2008-10#6)
sensing devices##4##2##(2008-10#2)(2010-6#1)(2010-7#1)
sensing elements##3##2##(2008-10#3)
sensing film##12##2##(2008-10#12)
sensing in##4##2##(2008-10#4)
sensing is##6##2##(2008-10#3)(2008-3#1)(2010-11#1)(2012-2#1)
sensing layer##2##2##(1995-3#1)(2008-10#1)
sensing material is successfully developed##2##5##(2008-10#2)
sensing material##10##2##(2008-10#10)
sensing materials and##2##3##(2008-10#2)
sensing materials##3##2##(2008-10#3)
sensing mechanism##3##2##(2008-10#3)
sensing membrane##8##2##(2008-10#8)
sensing membranes##3##2##(2008-10#3)
sensing method##4##2##(2008-10#3)(2008-3#1)
sensing molecules##5##2##(2008-10#1)(2013-8#4)
sensing of dopamine at the surface of##2##7##(2008-10#2)
sensing of dopamine##4##3##(2008-10#4)
sensing of nitric oxide##2##4##(2008-10#2)
sensing of##24##2##(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#9)
sensing parts##2##2##(2008-10#2)
sensing phase##5##2##(2008-10#5)
sensing platform##2##2##(2008-10#2)
sensing properties of##2##3##(2008-10#2)
sensing properties##5##2##(2008-10#5)
sensing surface##2##2##(2008-10#2)
sensing system for##2##3##(2008-10#2)
sensing system has##2##3##(2008-10#2)
sensing system was developed using##2##5##(2008-10#2)
sensing system was##5##3##(2008-10#5)
sensing system##16##2##(2008-10#14)(2008-3#2)
sensing systems##2##2##(1995-2#2)
sensing technique##3##2##(2008-10#2)(2008-3#1)
sensing technologies##2##2##(2008-10#2)
sensing tip##2##2##(2008-10#2)
sensing using a##2##3##(2008-10#2)
sensing using##3##2##(2008-10#2)(2013-1#1)
sensing was obtained for the electrode membrane containing##2##8##(2008-10#2)
sensing zone##4##2##(2008-10#4)
sensing##249##1##(1995-2#3)(1995-3#1)(2007-12#3)(2008-10#184)(2008-11#4)(2008-2#4)(2008-3#26)(2008-7#1)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#4)
sensitised guinea-pigs##2##2##(1994-11#2)
sensitised##3##1##(1994-11#2)(2009-9#1)
sensitiser and##2##2##(2008-10#2)
sensitive (0##2##2##(1990-2#1)(2008-10#1)
sensitive (detection limit##2##3##(2008-10#2)
sensitive A(549)##2##2##(2008-9#2)
sensitive CL##2##2##(2008-10#2)
sensitive FI-ECL response##2##3##(2008-10#2)
sensitive adsorptive##3##2##(2008-10#3)
sensitive amperometric sensor for##2##4##(2008-10#2)
sensitive amperometric##3##2##(2008-10#3)
sensitive analysis of##2##3##(2008-10#2)
sensitive analytical##2##2##(2008-10#2)
sensitive and accurate method##2##4##(2008-10#2)
sensitive and accurate##6##3##(2008-10#6)
sensitive and convenient##4##3##(1994-11#1)(2008-10#3)
sensitive and effective##3##3##(1994-11#1)(2008-10#1)(2010-10#1)
sensitive and efficient##2##3##(2008-10#2)
sensitive and free##2##3##(2008-10#1)(2012-2#1)
sensitive and highly##2##3##(2008-10#2)
sensitive and rapid##9##3##(2008-10#8)(2010-6#1)
sensitive and reliable detection##2##4##(2008-11#1)(2013-8#1)
sensitive and reliable method for##3##5##(1997-7#1)(2008-10#2)
sensitive and reliable##10##3##(1997-7#1)(2008-10#7)(2008-11#1)(2013-8#1)
sensitive and reproducible##2##3##(2008-10#1)(2008-11#1)
sensitive and resistant##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
sensitive and robust##3##3##(2008-10#3)
sensitive and selective chemiluminescence (CL) method##2##6##(2008-10#2)
sensitive and selective flow injection##3##5##(2008-10#3)
sensitive and selective method for the determination of##3##8##(2008-10#3)
sensitive and selective method for the##4##6##(2008-10#4)
sensitive and selective method has been developed for##2##8##(2008-10#2)
sensitive and selective method has been##3##6##(2008-10#3)
sensitive and selective method is described for the determination of##2##10##(2008-10#2)
sensitive and selective method is described for##3##7##(2008-10#3)
sensitive and selective method is##7##5##(2008-10#7)
sensitive and selective method##16##4##(2008-10#15)(2008-5#1)
sensitive and selective methods##2##4##(2008-10#2)
sensitive and selective spectrophotometric##3##4##(2008-10#3)
sensitive and selective##52##3##(2008-10#51)(2008-5#1)
sensitive and simple method for##3##5##(2008-10#3)
sensitive and simple method##4##4##(2008-10#4)
sensitive and simple##8##3##(2008-10#8)
sensitive and simultaneous##2##3##(2008-10#2)
sensitive and specific diagnostic##2##4##(2011-2#1)(2012-3#1)
sensitive and specific identification##2##4##(1996-12#1)(2008-9#1)
sensitive and specific method for##3##5##(2008-10#2)(2011-3#1)
sensitive and specific##17##3##(1990-12#1)(1990-2#1)(1992-6#1)(1993-2#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-9#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)
sensitive and the##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
sensitive and##169##2##(1990-12#2)(1990-2#1)(1992-6#1)(1993-2#1)(1994-11#2)(1996-12#1)(1997-2#1)(1997-7#2)(2008-1#1)(2008-10#132)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-6#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
sensitive anodic stripping##2##3##(2008-10#2)
sensitive as##3##2##(1992-3#1)(2008-10#2)
sensitive assay for##4##3##(2008-10#3)(2008-7#1)
sensitive assay of##3##3##(1991-2#1)(2008-10#2)
sensitive assay##9##2##(1991-2#1)(1995-11#1)(2008-10#5)(2008-11#1)(2008-7#1)
sensitive assays##2##2##(2008-10#1)(2008-4#1)
sensitive automatic##2##2##(2008-10#2)
sensitive biosensor based on##2##4##(2008-10#2)
sensitive catalytic##2##2##(2008-10#2)
sensitive cells##5##2##(1990-2#3)(2008-8#2)
sensitive chemiluminescent##2##2##(2008-10#2)
sensitive chromium speciation procedure##2##4##(2008-10#2)
sensitive colorimetric##2##2##(2008-10#2)
sensitive derivative spectrophotometric method##2##4##(2008-10#2)
sensitive detection of##16##3##(1994-11#1)(2008-10#13)(2010-12#1)(2012-2#1)
sensitive detection##25##2##(1994-11#1)(2008-10#20)(2008-3#1)(2010-12#1)(2010-7#1)(2012-2#1)
sensitive determination of##17##3##(2008-10#17)
sensitive determination##18##2##(2008-10#18)
sensitive diagnostic technique##2##3##(2008-10#1)(2012-12#1)
sensitive differential##2##2##(2008-10#2)
sensitive direct##2##2##(2008-10#2)
sensitive electrochemical##2##2##(2008-10#2)
sensitive enough to detect##3##4##(1995-12#1)(1996-2#1)(2008-10#1)
sensitive enough##4##2##(1995-12#1)(1996-2#1)(2008-10#2)
sensitive field##2##2##(2008-10#2)
sensitive flow injection chemiluminescence##3##4##(2008-10#3)
sensitive flow injection method with##2##5##(2008-10#2)
sensitive flow injection method##3##4##(2008-10#3)
sensitive flow injection##9##3##(2008-10#9)
sensitive flow##13##2##(1990-12#2)(2008-10#10)(2008-9#1)
sensitive flow-injection method##2##3##(2008-10#2)
sensitive flow-injection##5##2##(2008-10#5)
sensitive fluorescence quenching method##2##4##(2008-10#2)
sensitive fluorescence##9##2##(2008-10#6)(2008-12#2)(2008-9#1)
sensitive fluorescent dye##2##3##(1992-6#1)(2009-12#1)
sensitive fluorescent##7##2##(1992-6#1)(2008-10#4)(2008-9#1)(2009-12#1)
sensitive fluorimetric method for the determination of##3##7##(2008-10#3)
sensitive for the##2##3##(2008-10#2)
sensitive for##12##2##(1992-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#1)
sensitive genotypes##2##2##(2008-10#2)
sensitive high performance liquid##2##4##(2008-10#2)
sensitive high-resolution##2##2##(2007-12#1)(2008-3#1)
sensitive immunoassay##3##2##(2008-10#3)
sensitive in##4##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-5#1)
sensitive index of##2##3##(1994-8#1)(2008-5#1)
sensitive indicator of##2##3##(2008-7#1)(2012-2#1)
sensitive indicator strain in tomato leaf##2##6##(2008-10#2)
sensitive indicator strain in##3##4##(2008-10#3)
sensitive indicator##5##2##(2008-10#3)(2008-7#1)(2012-2#1)
sensitive indirect spectrophotometric method##2##4##(2008-10#2)
sensitive isolates##5##2##(2008-10#5)
sensitive marker of##2##3##(1990-2#1)(2011-2#1)
sensitive mass response##2##3##(2008-10#2)
sensitive method for determination of##2##5##(2008-10#2)
sensitive method for the determination of trace##3##7##(2008-10#3)
sensitive method for the determination of##14##6##(2008-10#14)
sensitive method for the quantitative determination of##2##7##(2008-10#2)
sensitive method for the quantitative##3##5##(2008-10#2)(2010-1#1)
sensitive method for the spectrophotometric determination of##2##7##(2008-10#2)
sensitive method for the##31##4##(1993-2#1)(2008-10#27)(2008-5#1)(2010-1#1)(2010-4#1)
sensitive method for##37##3##(1993-2#1)(2008-10#32)(2008-5#1)(2010-1#1)(2010-12#1)(2010-4#1)
sensitive method is described for the determination of##4##8##(2008-10#4)
sensitive method is described for the##5##6##(2008-10#5)
sensitive method is##8##3##(2008-10#8)
sensitive method of##4##3##(2008-10#4)
sensitive method was developed for the##2##6##(2008-10#2)
sensitive method was developed for##3##5##(2008-10#3)
sensitive method was developed##4##4##(2008-10#3)(2011-1#1)
sensitive method was##5##3##(2008-10#4)(2011-1#1)
sensitive method##62##2##(1991-3#1)(1993-2#1)(2008-10#54)(2008-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
sensitive methods##2##2##(2008-10#2)
sensitive optical humidity probe##2##4##(2008-10#2)
sensitive optical##4##2##(2008-10#4)
sensitive or resistant to##3##4##(1992-7#1)(2008-10#2)
sensitive or##4##2##(1992-7#1)(2008-10#2)(2010-1#1)
sensitive populations##2##2##(2008-10#2)
sensitive procedure for the determination of##3##6##(2008-10#3)
sensitive procedure for the##4##4##(2008-10#4)
sensitive procedure for##7##3##(2008-10#7)
sensitive procedure##9##2##(2008-10#9)
sensitive procedures for##2##3##(1992-9#1)(2008-4#1)
sensitive response##3##2##(2008-10#3)
sensitive sequential injection##3##3##(2008-10#3)
sensitive spectrophotometric determination of##2##4##(2008-10#2)
sensitive spectrophotometric method for##5##4##(2008-10#5)
sensitive spectrophotometric method##8##3##(2008-10#8)
sensitive spectrophotometric##17##2##(2008-10#17)
sensitive strains##4##2##(2008-10#4)
sensitive system##2##2##(2008-10#2)
sensitive technique for the##2##4##(2008-10#2)
sensitive technique for##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
sensitive technique##6##2##(1996-12#1)(2007-11#1)(2008-10#3)(2008-3#1)
sensitive than##28##2##(1990-3#1)(1991-8#1)(1994-12#1)(1996-8#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#1)
sensitive to benomyl at##2##4##(2008-10#2)
sensitive to both##3##3##(1992-4#1)(2008-9#1)(2009-7#1)
sensitive to change##2##3##(2008-10#1)(2009-11#1)
sensitive to changes in the##2##5##(2008-8#1)(2010-4#1)
sensitive to changes in##7##4##(1994-2#1)(1996-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-4#1)
sensitive to guanine nucleotide##2##4##(1993-9#2)
sensitive to ionizing radiation##2##4##(1995-12#1)(1997-7#1)
sensitive to ionizing##3##3##(1995-12#1)(1995-5#1)(1997-7#1)
sensitive to its##3##3##(1997-2#1)(2008-11#1)(2008-4#1)
sensitive to measure##2##3##(2008-10#2)
sensitive to metalaxyl##4##3##(2008-10#4)
sensitive to mismatches##3##3##(2008-4#2)(2008-9#1)
sensitive to nonionic surfactants##2##4##(2008-10#2)
sensitive to several##2##3##(2008-10#1)(2008-11#1)
sensitive to temperature##2##3##(2008-9#2)
sensitive to the numerical##2##4##(2008-10#1)(2008-3#1)
sensitive to the##37##3##(1991-2#1)(1991-5#1)(1993-1#1)(1994-5#1)(1994-6#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-3#6)(2008-8#4)(2008-9#2)(2009-5#2)(2010-1#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
sensitive to treatment##2##3##(2008-10#1)(2011-2#1)
sensitive to vinclozolin (R(T)S(V))##2##4##(2008-10#2)
sensitive to##210##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#4)(1991-5#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#70)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#11)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#10)(2008-9#9)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#4)(2012-4#1)(2013-1#3)
sensitive tool for the detection##2##5##(2008-10#2)
sensitive tool for##3##3##(2008-10#2)(2012-2#1)
sensitive tool to##2##3##(2008-10#1)(2008-9#1)
sensitive tool##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
sensitive voltammetric##4##2##(2008-10#4)
sensitive wheat genotypes##2##3##(2008-10#2)
sensitive yeasts##2##2##(1993-12#2)
sensitive##1079##1##(1990-11#1)(1990-12#9)(1990-2#8)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-2#6)(1991-3#4)(1991-5#3)(1991-6#1)(1991-8#1)(1992-12#4)(1992-2#4)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-8#3)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#6)(1996-2#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#4)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#698)(2008-11#33)(2008-12#10)(2008-2#3)(2008-3#20)(2008-4#7)(2008-5#15)(2008-6#6)(2008-7#11)(2008-8#14)(2008-9#25)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#17)(2011-3#4)(2012-12#2)(2012-2#15)(2012-3#5)(2012-4#1)(2012-5#1)(2013-1#8)(2013-8#3)
sensitively by##2##2##(2008-10#2)
sensitively detected##3##2##(2008-10#3)
sensitively on the##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
sensitively with##3##2##(2008-10#3)
sensitively##19##1##(2008-10#12)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-3#1)(2013-8#1)
sensitivities and##5##2##(1997-7#1)(2008-10#3)(2012-12#1)
sensitivities for##7##2##(2008-10#4)(2008-12#1)(2008-3#1)(2012-12#1)
sensitivities of the##5##3##(2008-10#4)(2008-3#1)
sensitivities of##13##2##(1994-11#1)(2008-10#9)(2008-3#3)
sensitivities to##5##2##(2008-10#5)
sensitivities were##2##2##(2008-10#2)
sensitivities##45##1##(1994-11#1)(1997-7#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2011-2#2)(2012-12#2)(2012-3#1)
sensitivity (em =##2##3##(2008-10#2)
sensitivity C-reactive protein##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
sensitivity about##2##2##(2008-10#2)
sensitivity after##3##2##(2008-10#2)(2013-1#1)
sensitivity analysis to##2##3##(1995-12#1)(2013-1#1)
sensitivity analysis##16##2##(1994-1#1)(1995-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2010-10#1)(2012-3#1)(2013-1#2)
sensitivity and 100% specificity##2##4##(2009-8#1)(2010-8#1)
sensitivity and a##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
sensitivity and accuracy##2##3##(2008-10#1)(2008-12#1)
sensitivity and adequate##2##3##(2008-10#2)
sensitivity and detection##2##3##(2008-10#2)
sensitivity and limit of detection of##2##6##(2008-10#2)
sensitivity and limit of detection##3##5##(2008-10#3)
sensitivity and limited##2##3##(2008-3#1)(2008-4#1)
sensitivity and limits of detection##3##5##(2008-10#3)
sensitivity and linearity##3##3##(1996-2#1)(2008-10#2)
sensitivity and low##2##3##(2008-10#2)
sensitivity and reproducibility##4##3##(2008-10#3)(2008-4#1)
sensitivity and robustness##2##3##(1993-3#1)(2008-10#1)
sensitivity and selectivity in the##2##5##(2008-10#2)
sensitivity and selectivity of the##3##5##(2008-10#3)
sensitivity and selectivity of##4##4##(2008-10#4)
sensitivity and selectivity was##2##4##(2008-10#2)
sensitivity and selectivity##24##3##(2008-10#22)(2008-3#1)(2008-9#1)
sensitivity and simplicity##2##3##(2008-10#2)
sensitivity and specificity for##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
sensitivity and specificity of the##5##5##(1993-6#1)(2008-10#2)(2008-11#1)(2012-2#1)
sensitivity and specificity of##11##4##(1990-9#1)(1991-2#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
sensitivity and specificity##25##3##(1990-9#1)(1991-2#1)(1993-3#1)(1993-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)
sensitivity and stability##6##3##(2008-10#6)
sensitivity and the##5##3##(1995-12#1)(2008-10#3)(2010-6#1)
sensitivity and##157##2##(1990-9#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-3#2)(1995-12#1)(1996-2#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#97)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#7)(2012-12#4)(2012-2#2)(2012-3#5)
sensitivity are##7##2##(2008-10#6)(2010-10#1)
sensitivity as##5##2##(1991-6#1)(2008-10#3)(2009-5#1)
sensitivity at the##2##3##(2008-10#2)
sensitivity at##4##2##(2008-10#3)(2012-2#1)
sensitivity between##3##2##(2008-10#2)(2008-3#1)
sensitivity by##8##2##(1993-3#1)(2008-10#7)
sensitivity can be##3##3##(1995-2#1)(1997-6#1)(2008-10#1)
sensitivity can##4##2##(1995-2#1)(1997-6#1)(2008-10#2)
sensitivity compared with##2##3##(2008-10#2)
sensitivity demonstrated##2##2##(2008-5#1)(2009-5#1)
sensitivity drift##3##2##(2008-10#3)
sensitivity during##2##2##(2008-10#1)(2008-11#1)
sensitivity enhancement in##2##3##(2008-10#2)
sensitivity enhancement of##3##3##(2008-10#3)
sensitivity enhancement##9##2##(2008-10#8)(2008-3#1)
sensitivity for all##2##3##(2008-10#2)
sensitivity for detecting##2##3##(1995-5#1)(2008-1#1)
sensitivity for hydrazine##2##3##(2008-10#2)
sensitivity for low##2##3##(2008-10#2)
sensitivity for the determination of##3##5##(2008-10#3)
sensitivity for the##8##3##(2008-10#8)
sensitivity for##44##2##(1990-5#1)(1995-2#1)(1995-5#1)(1996-8#1)(2008-1#1)(2008-10#29)(2008-3#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
sensitivity has been developed for##2##5##(2008-10#2)
sensitivity has been##5##3##(2008-10#4)(2008-7#1)
sensitivity in the##9##3##(2008-10#4)(2008-3#2)(2011-2#2)(2013-8#1)
sensitivity in vitro##2##3##(2008-10#1)(2008-5#1)
sensitivity in##30##2##(1992-2#1)(1997-1#1)(1997-7#1)(2008-10#14)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#2)(2013-8#1)
sensitivity increase##2##2##(2008-10#2)
sensitivity is achieved by##2##4##(2008-10#2)
sensitivity is achieved##3##3##(2008-10#2)(2008-9#1)
sensitivity is required##2##3##(2008-10#1)(2010-11#1)
sensitivity is##24##2##(1990-2#1)(1990-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)
sensitivity of 0##4##3##(2008-10#3)(2008-3#1)
sensitivity of 1##5##3##(2008-10#4)(2010-4#1)
sensitivity of 3##2##3##(2008-10#2)
sensitivity of a##6##3##(2008-10#4)(2008-3#1)(2011-2#1)
sensitivity of all##2##3##(2008-10#2)
sensitivity of detection##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
sensitivity of human##3##3##(1994-8#1)(1997-7#1)(2008-5#1)
sensitivity of the ELISA was##2##5##(1990-2#1)(2011-2#1)
sensitivity of the biosensor##2##4##(2008-10#2)
sensitivity of the complex##2##4##(2008-10#2)
sensitivity of the determination of##2##5##(2008-10#2)
sensitivity of the electrode##3##4##(2008-10#3)
sensitivity of the method as##2##5##(2008-10#2)
sensitivity of the method can be increased##2##7##(2008-10#2)
sensitivity of the method was##2##5##(2008-10#2)
sensitivity of the method##18##4##(1990-12#1)(2008-10#17)
sensitivity of the methods##2##4##(2008-10#2)
sensitivity of the proposed method##2##5##(2008-10#2)
sensitivity of the proposed##3##4##(2008-10#2)(2008-2#1)
sensitivity of the sensor##3##4##(2008-10#3)
sensitivity of the##105##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1992-4#1)(1993-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#73)(2008-11#4)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#1)(2008-9#3)(2010-10#1)(2011-2#4)(2012-3#1)
sensitivity of these##4##3##(1994-11#1)(2008-10#3)
sensitivity of this##9##3##(2008-10#5)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
sensitivity of tumors##2##3##(2008-5#1)(2013-7#1)
sensitivity of##280##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-4#1)(1993-1#2)(1993-2#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#4)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#3)(2007-12#1)(2008-1#2)(2008-10#148)(2008-11#16)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#5)(2008-8#5)(2008-9#11)(2009-10#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#3)
sensitivity on##2##2##(2007-12#1)(2008-10#1)
sensitivity required##3##2##(2008-10#2)(2008-11#1)
sensitivity study##2##2##(2008-3#2)
sensitivity than##6##2##(2008-10#5)(2008-11#1)
sensitivity that corresponds to##2##4##(2008-10#1)(2008-2#1)
sensitivity that##7##2##(2008-10#6)(2008-2#1)
sensitivity to 2##2##3##(2008-10#2)
sensitivity to growth stimulation by estrogen##2##6##(2008-11#2)
sensitivity to growth##3##3##(2008-11#3)
sensitivity to insulin##2##3##(1991-7#1)(1996-11#1)
sensitivity to low##2##3##(2007-12#1)(2009-8#1)
sensitivity to metalaxyl##4##3##(2008-10#4)
sensitivity to nicotine-induced seizures##2##4##(1996-12#2)
sensitivity to nicotine-induced##3##3##(1996-12#3)
sensitivity to propiconazole increased##2##4##(2008-10#2)
sensitivity to propiconazole##3##3##(2008-10#3)
sensitivity to temperature##3##3##(2008-3#1)(2008-7#1)(2012-6#1)
sensitivity to the fungicide mefenoxam##2##5##(2008-10#2)
sensitivity to the##16##3##(1992-2#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)
sensitivity to this##2##3##(2008-10#2)
sensitivity to##132##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-3#2)(1994-5#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#6)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#53)(2008-11#7)(2008-12#3)(2008-3#3)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#2)
sensitivity toward prolactin##2##3##(1994-11#2)
sensitivity toward##3##2##(1994-11#2)(1997-1#1)
sensitivity towards##4##2##(2008-10#3)(2008-11#1)
sensitivity was 0##2##3##(1992-6#1)(2008-10#1)
sensitivity was determined##2##3##(2008-3#1)(2011-2#1)
sensitivity was improved##3##3##(2008-10#2)(2012-3#1)
sensitivity was obtained by##2##4##(2008-10#2)
sensitivity was obtained##4##3##(2008-10#4)
sensitivity was shown##2##3##(2008-10#2)
sensitivity was##43##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-12#1)(1996-2#1)(1997-8#1)(2008-10#25)(2008-11#1)(2008-3#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
sensitivity were##13##2##(1992-2#1)(2008-10#12)
sensitivity with##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
sensitivity without##2##2##(2008-10#1)(2009-11#1)
sensitivity##1179##1##(1990-11#1)(1990-12#8)(1990-2#6)(1990-3#2)(1990-5#4)(1990-6#1)(1990-9#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#7)(1991-7#2)(1991-8#1)(1992-11#2)(1992-2#7)(1992-3#2)(1992-4#1)(1992-6#3)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#6)(1993-6#1)(1993-8#1)(1994-1#3)(1994-11#4)(1994-12#5)(1994-3#3)(1994-5#2)(1994-8#1)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-11#1)(1996-12#11)(1996-2#5)(1996-8#1)(1997-1#5)(1997-2#3)(1997-3#6)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#7)(2007-11#1)(2007-12#5)(2008-1#6)(2008-10#672)(2008-11#43)(2008-12#9)(2008-2#5)(2008-3#43)(2008-4#11)(2008-5#15)(2008-6#2)(2008-7#13)(2008-8#13)(2008-9#31)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#6)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#39)(2012-12#12)(2012-2#14)(2012-3#17)(2012-6#2)(2013-1#11)(2013-7#1)(2013-8#8)
sensitivity)##3##1##(2008-10#2)(2013-8#1)
sensitization and##2##2##(2008-8#1)(2008-9#1)
sensitization in##4##2##(2008-10#4)
sensitization of the##2##3##(2008-10#1)(2008-9#1)
sensitization of##7##2##(1993-8#1)(1996-12#1)(2008-10#3)(2008-9#2)
sensitization potential##4##2##(2008-10#4)
sensitization to##6##2##(1990-3#1)(1991-12#1)(1993-6#2)(2013-1#2)
sensitization##44##1##(1990-3#1)(1991-12#1)(1993-6#2)(1993-8#2)(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#19)(2008-11#3)(2008-5#4)(2008-8#1)(2008-9#3)(2011-2#1)(2013-1#4)
sensitize##2##1##(2009-12#1)(2009-8#1)
sensitized and##3##2##(1992-3#1)(2008-10#2)
sensitized by hypocrellin B##2##4##(2008-8#2)
sensitized by hypocrellin##4##3##(2008-8#4)
sensitized by##14##2##(1993-8#1)(2008-10#8)(2008-8#5)
sensitized fluorescence##2##2##(2008-10#2)
sensitized modified##2##2##(2008-10#2)
sensitized ormosil-modified electrodes##2##3##(2008-10#2)
sensitized the##2##2##(2008-10#1)(2010-2#1)
sensitized with##4##2##(1992-1#1)(1997-5#1)(2008-11#2)
sensitized##44##1##(1992-1#1)(1992-3#1)(1993-8#1)(1995-11#1)(1997-5#1)(2007-11#1)(2008-10#26)(2008-11#2)(2008-3#2)(2008-8#5)(2010-2#1)(2010-5#1)(2011-2#1)
sensitizer##5##1##(1991-3#1)(1992-1#1)(2008-10#3)
sensitizers##5##1##(2008-10#4)(2008-8#1)
sensitizes##3##1##(1993-11#1)(2008-10#1)(2011-2#1)
sensitizing dose##2##2##(2008-10#2)
sensitizing effect of##5##3##(2008-10#5)
sensitizing effect##6##2##(2008-10#6)
sensitizing potency##7##2##(2008-5#7)
sensitizing potential##2##2##(1995-11#1)(2008-10#1)
sensitizing##28##1##(1995-11#1)(2008-10#14)(2008-11#1)(2008-5#11)(2010-11#1)
sensor achieved##2##2##(2008-10#2)
sensor also##2##2##(2008-10#2)
sensor and a##3##3##(2008-10#3)
sensor and the##3##3##(2008-10#3)
sensor and##15##2##(2008-10#13)(2008-3#1)(2012-3#1)
sensor applications##5##2##(2008-10#5)
sensor are##2##2##(2008-10#1)(2008-3#1)
sensor array with##2##3##(2008-10#2)
sensor array##12##2##(2008-10#12)
sensor as a##2##3##(2008-10#2)
sensor at##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
sensor based on 2##2##4##(2008-10#2)
sensor based on a##4##4##(2008-10#4)
sensor based on an##2##4##(2008-10#2)
sensor based on the##6##4##(2008-10#6)
sensor based on##37##3##(2008-10#35)(2008-2#2)
sensor by##3##2##(2008-10#3)
sensor can be used to##2##5##(2008-10#2)
sensor can be used##4##4##(2008-10#4)
sensor can be##7##3##(2008-10#7)
sensor can##10##2##(2008-10#9)(2008-2#1)
sensor chip surface##2##3##(2008-10#1)(2008-4#1)
sensor chip##11##2##(2008-10#9)(2008-4#1)(2008-9#1)
sensor construction##2##2##(2008-10#2)
sensor contains##2##2##(2008-10#2)
sensor could be##4##3##(2008-10#4)
sensor could##5##2##(2008-10#5)
sensor data##2##2##(2008-10#2)
sensor design##2##2##(2007-11#1)(2010-4#1)
sensor designed for##2##3##(2008-7#1)(2010-7#1)
sensor device##2##2##(2008-10#2)
sensor displayed##3##2##(2008-10#3)
sensor displays##2##2##(2008-10#2)
sensor electrode##2##2##(2008-10#2)
sensor element##3##2##(2008-10#1)(2011-2#2)
sensor exhibited a##2##3##(2008-10#2)
sensor exhibited high selectivity and##2##5##(2008-10#2)
sensor exhibited##6##2##(2008-10#6)
sensor exhibits a linear response##2##5##(2008-10#2)
sensor exhibits a linear##3##4##(2008-10#3)
sensor exhibits a##10##3##(2008-10#10)
sensor exhibits##16##2##(2008-10#16)
sensor for Hg(II)##3##3##(2008-10#3)
sensor for copper##2##3##(2008-10#2)
sensor for detection of##2##4##(2008-10#2)
sensor for glucose##2##3##(2008-10#2)
sensor for hydrogen##2##3##(2008-10#2)
sensor for isoniazid##2##3##(2008-10#2)
sensor for mercury(II)##2##3##(2008-10#2)
sensor for nitrite using a glassy carbon electrode modified with##2##10##(2008-10#2)
sensor for the detection of##3##5##(2008-10#3)
sensor for the determination of##8##5##(2008-10#8)
sensor for the potentiometric##2##4##(2008-10#2)
sensor for the##21##3##(2008-10#20)(2008-3#1)
sensor for##90##2##(1996-5#1)(2008-10#85)(2008-3#4)
sensor has a##4##3##(2008-10#4)
sensor has been successfully##2##4##(2008-10#2)
sensor has been used##5##4##(2008-10#5)
sensor has been##15##3##(2008-10#15)
sensor has##24##2##(2008-10#24)
sensor in a##2##3##(2008-10#2)
sensor in the##2##3##(2008-10#2)
sensor in##7##2##(2008-10#7)
sensor incorporates##2##2##(2008-10#2)
sensor is based on the##4##5##(2008-10#4)
sensor is based on##8##4##(2008-10#7)(2008-3#1)
sensor is described##2##3##(2008-10#2)
sensor is simple##2##3##(2008-10#1)(2008-2#1)
sensor is used##3##3##(2008-10#3)
sensor is##54##2##(2008-10#52)(2008-2#1)(2008-3#1)
sensor membrane##2##2##(2008-10#2)
sensor modified with##2##3##(2008-10#2)
sensor of the##2##3##(2008-10#1)(2008-9#1)
sensor of##9##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#2)(2009-8#1)(2013-8#1)
sensor on a chip for##3##5##(2008-10#3)
sensor on##4##2##(2008-10#4)
sensor over##2##2##(2008-10#2)
sensor performance##8##2##(2008-10#5)(2011-1#3)
sensor presented##2##2##(2008-10#2)
sensor provides##2##2##(2008-10#2)
sensor responds to##4##3##(2008-10#4)
sensor responds##6##2##(2008-10#6)
sensor response is##2##3##(2008-10#2)
sensor response##16##2##(2008-10#16)
sensor responses##2##2##(2008-10#2)
sensor revealed a##2##3##(2008-10#2)
sensor revealed##3##2##(2008-10#3)
sensor showed##5##2##(2008-10#5)
sensor shows a linear response##2##5##(2008-10#2)
sensor shows a linear##3##4##(2008-10#3)
sensor shows excellent##2##3##(2008-10#2)
sensor shows##16##2##(2008-10#16)
sensor signal##4##2##(2008-10#4)
sensor signals##6##2##(2008-10#6)
sensor suitable for use##2##4##(2008-10#2)
sensor surface##7##2##(2008-10#6)(2008-11#1)
sensor system for the##2##4##(2008-10#2)
sensor system for##3##3##(2008-10#3)
sensor system is##3##3##(2008-10#3)
sensor system to##2##3##(2008-10#2)
sensor system was##5##3##(2008-10#4)(2008-7#1)
sensor system##24##2##(2008-10#22)(2008-7#1)(2010-8#1)
sensor that##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
sensor to determine##2##3##(2008-10#2)
sensor to measure##3##3##(2007-12#1)(2008-3#2)
sensor to the##2##3##(2008-10#2)
sensor to##18##2##(2007-12#1)(2008-10#14)(2008-3#2)(2013-1#1)
sensor using a##5##3##(2008-10#5)
sensor using##14##2##(2008-10#14)
sensor was applied for##3##4##(2008-10#3)
sensor was applied to##3##4##(2008-10#3)
sensor was applied##7##3##(2008-10#7)
sensor was developed for##2##4##(2008-10#2)
sensor was developed##6##3##(2008-10#5)(2008-7#1)
sensor was evaluated##4##3##(2008-10#4)
sensor was fabricated by##2##4##(2008-10#2)
sensor was fabricated##3##3##(2008-10#3)
sensor was found to##4##4##(2008-10#4)
sensor was prepared by##2##4##(2008-10#2)
sensor was successfully applied to##2##5##(2008-10#2)
sensor was successfully applied##3##4##(2008-10#3)
sensor was successfully##5##3##(2008-10#5)
sensor was tested in##2##4##(2008-10#1)(2008-7#1)
sensor was used for##2##4##(2008-10#2)
sensor was used to monitor##2##5##(2008-10#1)(2008-7#1)
sensor was used to##3##4##(2008-10#2)(2008-7#1)
sensor was used##6##3##(2008-10#5)(2008-7#1)
sensor was##65##2##(2008-10#61)(2008-7#4)
sensor were found to##2##4##(2008-10#2)
sensor were investigated##2##3##(2008-10#2)
sensor were##12##2##(2008-10#12)
sensor with PPy-calcion##2##3##(2008-10#2)
sensor with a##3##3##(2008-10#3)
sensor with##16##2##(2008-10#14)(2008-2#1)(2008-7#1)
sensor without##2##2##(2008-10#2)
sensor works well##3##3##(2008-10#3)
sensor works##4##2##(2008-10#4)
sensor##783##1##(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#713)(2008-11#4)(2008-2#7)(2008-3#20)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-9#3)(2009-5#2)(2009-6#1)(2009-8#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
sensor-to-sensor reproducibility##2##2##(2008-10#2)
sensorial functioning##2##2##(2011-2#2)
sensorial##10##1##(2008-5#4)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)
sensorimotor##10##1##(1992-12#2)(1994-6#1)(1996-2#2)(2008-11#1)(2008-7#1)(2009-12#1)(2013-8#2)
sensorineural deafness##3##2##(2008-7#1)(2008-9#1)(2011-1#1)
sensorineural hearing impairment##2##3##(2008-9#2)
sensorineural hearing loss##4##3##(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
sensorineural hearing##6##2##(2008-9#3)(2011-1#1)(2012-3#1)(2013-1#1)
sensorineural##9##1##(2008-7#1)(2008-9#4)(2011-1#2)(2012-3#1)(2013-1#1)
sensors 1##3##2##(2008-10#3)
sensors and##12##2##(2008-10#11)(2009-1#1)
sensors are based##2##3##(2008-10#1)(2011-1#1)
sensors are presented##2##3##(2008-10#2)
sensors are used##3##3##(2008-10#3)
sensors are##14##2##(2008-10#11)(2008-3#1)(2010-4#1)(2011-1#1)
sensors as##3##2##(2008-10#3)
sensors based on chemically modified##2##5##(2008-10#2)
sensors based on##20##3##(2008-10#20)
sensors by##3##2##(2008-10#3)
sensors can be##2##3##(2008-10#2)
sensors can##3##2##(2008-10#3)
sensors exhibit##4##2##(2008-10#4)
sensors for some##2##3##(2008-10#2)
sensors for the analysis of##2##5##(2008-10#2)
sensors for the determination of##4##5##(2008-10#4)
sensors for the##8##3##(2008-10#8)
sensors for##37##2##(1990-8#1)(2008-10#35)(2008-3#1)
sensors have##2##2##(2008-10#1)(2013-1#1)
sensors in the##2##3##(2008-10#2)
sensors in##7##2##(2008-10#5)(2011-2#1)(2013-1#1)
sensors is##6##2##(2008-10#6)
sensors of##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2009-3#1)
sensors or##2##2##(2008-10#2)
sensors responsive to##2##3##(2008-10#2)
sensors sensitive##2##2##(2008-10#2)
sensors show##2##2##(2008-10#2)
sensors showed##2##2##(2008-10#2)
sensors that##2##2##(2008-10#2)
sensors to##3##2##(2008-10#2)(2013-1#1)
sensors using##6##2##(2008-10#6)
sensors was##2##2##(2008-10#2)
sensors were##12##2##(2008-10#12)
sensors will##2##2##(2008-10#2)
sensors with##11##2##(2008-10#11)
sensors##274##1##(1990-8#2)(2008-10#237)(2008-11#2)(2008-2#2)(2008-3#9)(2008-6#1)(2009-1#1)(2009-3#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#4)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)
sensory analysis##3##2##(2009-9#1)(2011-2#2)
sensory and motor neuron##2##4##(2013-1#2)
sensory and motor##3##3##(2008-7#1)(2013-1#2)
sensory and##7##2##(1993-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#2)
sensory apparatus##2##2##(1990-5#1)(1997-3#1)
sensory areas##4##2##(2008-11#2)(2008-5#2)
sensory assessment##4##2##(2008-5#4)
sensory attributes##6##2##(2008-10#2)(2010-4#1)(2011-2#3)
sensory capacity##2##2##(2008-10#2)
sensory cell##2##2##(2007-12#1)(2008-7#1)
sensory cells of##2##3##(2008-7#1)(2011-2#1)
sensory cells##7##2##(2007-12#3)(2008-7#3)(2011-2#1)
sensory changes##2##2##(2008-10#1)(2010-4#1)
sensory cue##2##2##(2009-8#2)
sensory deficit##2##2##(1990-12#1)(2012-12#1)
sensory experience##2##2##(2008-4#1)(2009-12#1)
sensory hair cells##2##3##(2009-8#1)(2009-9#1)
sensory information into##2##3##(1990-5#2)
sensory information##5##2##(1990-5#2)(1995-1#2)(2013-8#1)
sensory input##4##2##(1997-3#1)(2008-11#1)(2009-12#2)
sensory inputs##4##2##(2008-7#1)(2008-9#2)(2013-1#1)
sensory loss##2##2##(1994-9#1)(2013-1#1)
sensory modulation##2##2##(2009-8#2)
sensory nerve##3##2##(1992-6#1)(1994-9#1)(2007-12#1)
sensory nerves##4##2##(1992-6#3)(1997-1#1)
sensory neurons and##2##3##(1995-2#1)(2008-5#1)
sensory neurons in##2##3##(1992-6#1)(2007-12#1)
sensory neurons##10##2##(1992-6#2)(1995-2#1)(1996-12#2)(2007-12#2)(2008-11#2)(2008-5#1)
sensory or motor##3##3##(1991-6#1)(2012-12#1)(2013-1#1)
sensory predictions##2##2##(2013-8#2)
sensory processing##7##2##(1993-6#1)(2008-11#1)(2008-5#1)(2009-12#2)(2009-8#1)(2013-8#1)
sensory properties of##3##3##(2008-10#1)(2011-2#2)
sensory properties##5##2##(2008-10#1)(2010-4#2)(2011-2#2)
sensory responses##2##2##(2008-12#2)
sensory stimulation##3##2##(1992-6#1)(2008-11#1)(2008-7#1)
sensory stimuli##4##2##(1995-8#1)(2008-4#1)(2013-1#2)
sensory system is##2##3##(2008-10#1)(2009-8#1)
sensory system##7##2##(1996-2#1)(2008-10#4)(2009-8#1)(2013-8#1)
sensory units##4##2##(2007-12#3)(2013-8#1)
sensory##191##1##(1990-12#1)(1990-3#1)(1990-5#4)(1990-9#1)(1991-6#1)(1992-6#10)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-9#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#5)(2007-12#12)(2007-8#1)(2008-10#13)(2008-11#11)(2008-12#5)(2008-2#1)(2008-4#2)(2008-5#10)(2008-7#9)(2008-8#5)(2008-9#8)(2009-12#5)(2009-8#13)(2009-9#2)(2010-1#1)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#17)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#9)
sensu lato##10##2##(2008-10#7)(2011-2#1)(2012-12#2)
sensu stricto with##2##3##(2008-10#1)(2012-12#1)
sensu stricto##8##2##(2008-10#5)(2008-5#1)(2012-12#2)
sensu##21##1##(2008-10#13)(2008-5#1)(2011-2#3)(2012-12#4)
sent by the##2##3##(1992-2#1)(2012-12#1)
sent by##3##2##(1992-2#1)(1997-3#1)(2012-12#1)
sent to a##7##3##(1993-2#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
sent to all##5##3##(1992-1#1)(1997-8#1)(2008-11#1)(2012-2#2)
sent to the##4##3##(1994-1#1)(2008-10#2)(2010-10#1)
sent to##30##2##(1990-2#1)(1990-6#1)(1992-1#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#3)
sent##39##1##(1990-2#1)(1990-6#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-11#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#2)(2013-1#3)
senta##4##1##(2010-8#4)
sentence##18##1##(1996-5#1)(1997-8#1)(2007-12#2)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#5)(2010-7#1)(2011-1#3)
sentenced##3##1##(1996-5#3)
sentences##10##1##(2007-12#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-7#2)(2012-3#2)(2013-8#1)
sentinel lymph node##5##3##(2010-12#1)(2011-2#2)(2012-12#2)
sentinel lymph nodes##3##3##(2012-12#3)
sentinel lymph##8##2##(2010-12#1)(2011-2#2)(2012-12#5)
sentinel marker data##2##3##(2008-1#2)
sentinel node##2##2##(2008-10#1)(2010-7#1)
sentinel##23##1##(1991-12#1)(1994-2#1)(1994-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-9#4)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#6)
sentinels##7##1##(2008-9#7)
separable##7##1##(1990-2#1)(1992-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
separata##6##1##(1992-6#1)(2008-11#5)
separate analysis##2##2##(2008-11#1)(2011-2#1)
separate and##13##2##(1993-3#1)(1997-2#1)(2008-10#9)(2008-6#2)
separate bureaus##2##2##(1992-1#2)
separate cluster##2##2##(2008-10#2)
separate compartments##2##2##(2008-10#1)(2013-1#1)
separate components##3##2##(1995-5#2)(2008-10#1)
separate days##2##2##(2008-12#1)(2013-1#1)
separate effects##2##2##(2008-10#1)(2008-9#1)
separate evolutionary##2##2##(2009-6#1)(2011-2#1)
separate experiments##11##2##(1990-5#1)(1994-2#1)(1995-11#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-7#1)
separate from the##2##3##(2008-10#1)(2009-7#1)
separate from##8##2##(2008-10#4)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
separate genera##2##2##(2007-12#1)(2008-6#1)
separate genes##4##2##(1992-6#2)(1993-9#1)(1997-7#1)
separate groups of##2##3##(2008-10#1)(2008-11#1)
separate in##2##2##(1995-6#1)(2009-10#1)
separate mechanisms of##2##3##(1995-8#1)(1996-12#1)
separate mechanisms##3##2##(1995-8#2)(1996-12#1)
separate mental health##2##3##(1994-1#2)
separate populations##3##2##(2008-10#2)(2008-8#1)
separate processes##2##2##(1996-12#1)(2008-9#1)
separate regions##2##2##(1995-2#1)(2008-10#1)
separate samples##2##2##(2008-10#1)(2008-12#1)
separate sets##2##2##(2008-10#1)(2009-8#1)
separate solutions##2##2##(2008-10#2)
separate species##4##2##(2008-10#4)
separate the cells##2##3##(2011-2#2)
separate the presacral##2##3##(1994-3#2)
separate the##20##2##(1994-3#2)(1997-2#1)(2008-10#9)(2008-3#1)(2008-4#2)(2010-12#1)(2011-1#1)(2011-2#2)(2013-7#1)
separate##260##1##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#4)(1992-12#3)(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)(1997-7#2)(2007-12#1)(2008-10#115)(2008-11#13)(2008-12#7)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#1)
separated Al species##2##3##(2008-10#2)
separated P##2##2##(2008-10#2)
separated after##3##2##(2008-10#1)(2008-5#1)(2010-11#1)
separated and determined##2##3##(2008-10#2)
separated and quantified by##2##4##(1991-12#1)(2008-10#1)
separated and quantified##3##3##(1991-12#1)(1997-2#1)(2008-10#1)
separated and##13##2##(1991-12#1)(1993-8#1)(1997-2#1)(2008-10#9)(2008-12#1)
separated at##2##2##(1991-3#1)(2008-10#1)
separated by 1##3##3##(2008-10#1)(2010-10#1)(2013-8#1)
separated by HPLC##3##3##(2008-10#2)(2008-8#1)
separated by SDS-PAGE##2##3##(1990-11#1)(2008-5#1)
separated by a##13##3##(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#2)(2009-7#1)(2011-1#1)(2013-1#2)
separated by an interval of##2##5##(1993-11#1)(1996-8#1)
separated by an##4##3##(1993-11#1)(1993-2#1)(1996-8#1)(2008-10#1)
separated by applying##2##3##(1995-8#1)(2008-10#1)
separated by capillary electrophoresis##3##4##(2008-10#3)
separated by capillary zone electrophoresis (CZE)##2##6##(2008-10#2)
separated by capillary zone electrophoresis##3##5##(2008-10#3)
separated by capillary##6##3##(2008-10#6)
separated by high performance liquid chromatography (HPLC)##2##7##(2008-10#2)
separated by high performance liquid chromatography##3##6##(2008-10#3)
separated by high-performance##2##3##(1997-2#1)(2008-10#1)
separated by the##2##3##(2011-2#1)(2013-8#1)
separated by##88##2##(1990-10#1)(1990-11#2)(1990-5#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-10#41)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-11#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#2)
separated completely##2##2##(2008-10#2)
separated for##4##2##(1991-12#1)(1995-11#1)(2008-10#2)
separated fractions##4##2##(2008-10#4)
separated from Cr(III)##4##3##(2008-10#4)
separated from a##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
separated from each other by##2##5##(1992-6#1)(2008-10#1)
separated from each other##3##4##(1992-6#1)(2008-10#2)
separated from the aqueous phase##2##5##(2008-10#2)
separated from the aqueous##4##4##(2008-10#4)
separated from the bulk##2##4##(2008-10#2)
separated from the solution by##2##5##(2008-10#2)
separated from the solution##3##4##(2008-10#3)
separated from the##24##3##(1995-5#1)(2008-10#20)(2008-11#1)(2010-8#1)(2012-3#1)
separated from their##2##3##(1991-2#1)(2008-9#1)
separated from##67##2##(1991-2#1)(1992-11#1)(1992-6#1)(1995-2#1)(1995-5#1)(2008-10#50)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
separated in##17##2##(2008-10#16)(2008-12#1)
separated into different##2##3##(2008-10#1)(2008-12#1)
separated into two groups##3##4##(1991-9#1)(2008-10#2)
separated into two##6##3##(1991-9#1)(2008-10#5)
separated into##22##2##(1991-9#1)(1992-11#1)(1994-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2009-7#1)
separated on a reversed-phase##2##4##(2008-10#2)
separated on a##9##3##(2008-10#7)(2008-4#1)(2008-5#1)
separated on the##8##3##(2008-10#7)(2008-4#1)
separated on##17##2##(2008-10#14)(2008-4#2)(2008-5#1)
separated on-line from##2##3##(2008-10#2)
separated peaks##2##2##(2008-10#2)
separated the effects of##2##4##(2008-8#2)
separated the two species##2##4##(2008-10#1)(2008-9#1)
separated the two##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
separated the##14##2##(2008-10#8)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
separated using##3##2##(2008-10#3)
separated via##2##2##(2008-10#1)(2008-5#1)
separated well##2##2##(2008-10#2)
separated with a##3##3##(2008-10#2)(2013-8#1)
separated with##11##2##(2008-10#9)(2008-7#1)(2013-8#1)
separated within##10##2##(2008-10#10)
separated without any##2##3##(2008-10#2)
separated without##4##2##(2008-10#4)
separated##371##1##(1990-10#1)(1990-11#2)(1990-5#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-6#4)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(2006-6#1)(2007-11#1)(2008-10#254)(2008-11#12)(2008-12#5)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#6)(2009-11#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#3)
separately and together##3##3##(2008-10#3)
separately and##7##2##(1991-2#1)(1994-5#1)(2008-10#5)
separately for##7##2##(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)
separately from##3##2##(2008-10#2)(2012-12#1)
separately in the##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
separately in##5##2##(1996-2#1)(2008-10#2)(2008-5#1)(2010-8#1)
separately or##2##2##(2008-10#1)(2011-2#1)
separately under##2##2##(2008-10#1)(2010-5#1)
separately with##2##2##(1990-5#1)(2008-9#1)
separately##81##1##(1990-5#1)(1990-9#1)(1991-2#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-5#1)(1995-5#3)(1996-2#2)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#3)(2009-8#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#1)
separates as##2##2##(1990-11#2)
separates##10##1##(1990-11#2)(1991-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
separating and determining##2##3##(2008-10#2)
separating and##6##2##(2008-10#6)
separating the two##2##3##(1991-12#1)(2008-12#1)
separating the##7##2##(1991-12#1)(1991-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-8#1)
separating them##2##2##(2008-10#1)(2008-11#1)
separating##45##1##(1991-12#1)(1991-5#1)(1994-11#1)(2008-10#23)(2008-11#3)(2008-12#3)(2008-4#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-3#1)
separation and a##2##3##(2008-10#2)
separation and detection of##13##4##(2008-10#12)(2011-1#1)
separation and detection processes were examined and##3##7##(2008-10#3)
separation and detection processes were##4##5##(2008-10#4)
separation and detection processes##5##4##(2008-10#5)
separation and detection system##2##4##(2008-10#2)
separation and detection were investigated##2##5##(2008-10#2)
separation and detection##30##3##(2008-10#28)(2008-12#1)(2011-1#1)
separation and determination of##26##4##(2008-10#25)(2009-8#1)
separation and determination##29##3##(2008-10#28)(2009-8#1)
separation and direct detection of##2##5##(2008-10#2)
separation and enrichment of##2##4##(2008-10#2)
separation and enrichment##3##3##(2008-10#3)
separation and estimation of##3##4##(2008-10#3)
separation and identification##2##3##(2008-12#1)(2010-9#1)
separation and pre-concentration of inorganic arsenic##2##6##(2008-10#2)
separation and pre-concentration of##5##4##(2008-10#5)
separation and preconcentration of inorganic##2##5##(2008-10#2)
separation and preconcentration of trace##3##5##(2008-10#3)
separation and preconcentration of##25##4##(2008-10#25)
separation and preconcentration technique##2##4##(2008-10#2)
separation and preconcentration##37##3##(2008-10#37)
separation and purification of##5##4##(1997-2#2)(2008-10#3)
separation and resolution##2##3##(2008-10#2)
separation and the##3##3##(2008-10#3)
separation and to##2##3##(2008-10#2)
separation and##163##2##(1997-2#2)(1997-5#1)(2008-10#149)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
separation at##5##2##(2007-12#1)(2008-10#3)(2008-7#1)
separation between the##6##3##(2008-10#4)(2008-6#1)(2009-2#1)
separation between##11##2##(1990-12#1)(2008-10#7)(2008-3#1)(2008-6#1)(2009-2#1)
separation by IP-RPHPLC##2##3##(2008-10#2)
separation by ion##2##3##(2008-10#2)
separation by##13##2##(1990-12#1)(2008-10#11)(2008-11#1)
separation capillary##4##2##(2008-10#4)
separation cell##2##2##(2008-10#2)
separation chamber##3##2##(2008-10#2)(2008-11#1)
separation channel##6##2##(2008-10#6)
separation condition##2##2##(2008-10#2)
separation conditions for##2##3##(2008-10#2)
separation conditions were##3##3##(2008-10#3)
separation conditions##12##2##(2008-10#12)
separation device##3##2##(2008-10#1)(2008-11#2)
separation distance between##2##3##(2008-2#1)(2013-1#1)
separation distance##4##2##(2008-2#2)(2013-1#2)
separation efficiencies##2##2##(2008-10#2)
separation efficiency of##2##3##(1997-2#1)(2008-10#1)
separation efficiency##7##2##(1997-2#1)(2008-10#6)
separation factor (alpha)##2##3##(2008-10#2)
separation factor##7##2##(2008-10#7)
separation factors##7##2##(1997-2#1)(2008-10#6)
separation for all##2##3##(2008-10#2)
separation for the##2##3##(1990-12#1)(2008-10#1)
separation for##8##2##(1990-12#1)(2008-10#6)(2013-1#1)
separation from the##2##3##(2008-10#2)
separation from water##2##3##(2008-10#2)
separation from##11##2##(1990-3#1)(2008-10#9)(2012-3#1)
separation has been##2##3##(2008-10#2)
separation in a##2##3##(1997-2#1)(2010-7#1)
separation in the##3##3##(2008-10#2)(2013-8#1)
separation in##9##2##(1995-5#1)(1997-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-7#1)(2013-8#1)
separation into##3##2##(2008-10#2)(2010-4#1)
separation is##17##2##(1997-2#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
separation length##3##2##(2008-10#3)
separation mechanisms##3##2##(2008-10#3)
separation method based on a novel reversed-phase sequential injection chromatography (SIC)##2##11##(2008-10#2)
separation method##6##2##(2008-10#6)
separation methods##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
separation mode##3##2##(2008-10#2)(2010-7#1)
separation of Cu##2##3##(2008-10#2)
separation of DNA fragments##3##4##(2008-10#2)(2008-4#1)
separation of Fe(III)##3##3##(2008-10#3)
separation of Hf##4##3##(2008-10#4)
separation of K(+)##2##3##(2008-10#2)
separation of PEG##2##3##(2008-10#2)
separation of a complex mixture of##2##6##(2008-10#2)
separation of a mixture of##3##5##(2008-10#3)
separation of a mixture##4##4##(2008-10#4)
separation of a set of##2##5##(2008-10#2)
separation of a##12##3##(2008-10#12)
separation of actinides and##2##4##(2008-10#2)
separation of amino##2##3##(1991-12#1)(2008-7#1)
separation of anions##3##3##(2008-10#3)
separation of both##2##3##(2008-10#2)
separation of bound##2##3##(1995-11#1)(2008-11#1)
separation of cadmium##2##3##(2008-10#2)
separation of chromium##2##3##(2008-10#2)
separation of different##3##3##(2008-10#3)
separation of enantiomers of##2##4##(2008-10#2)
separation of extract from aqueous phase##2##6##(2008-10#2)
separation of five##2##3##(2008-10#2)
separation of four##2##3##(2008-10#2)
separation of gallium##3##3##(2008-10#3)
separation of inorganic##4##3##(2008-10#4)
separation of iron(III)##2##3##(2008-10#2)
separation of metal ions##5##4##(2008-10#5)
separation of metal##6##3##(2008-10#6)
separation of micron##2##3##(2008-10#2)
separation of p-sulfonated calix[n]arenes##2##4##(2008-10#2)
separation of palladium(II) from##2##4##(2008-10#2)
separation of platinum##2##3##(2008-10#2)
separation of platinum(IV) from##2##4##(2008-10#2)
separation of seven##2##3##(2008-10#2)
separation of six##4##3##(2008-10#4)
separation of solasodine glycosides##2##4##(2008-11#2)
separation of tellurium(IV) from##2##4##(2008-10#2)
separation of the formed##2##4##(2008-10#2)
separation of the same compounds##2##5##(2008-10#2)
separation of the three##4##4##(2008-10#4)
separation of the##50##3##(1990-12#2)(1991-6#1)(1996-5#1)(2008-10#41)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)
separation of these##5##3##(2008-10#4)(2012-2#1)
separation of trace##7##3##(2008-10#7)
separation of trivalent##3##3##(2008-10#3)
separation of two##2##3##(2008-10#1)(2009-12#1)
separation of uranium##3##3##(2008-10#3)
separation of zinc compounds##2##4##(2008-10#2)
separation of zinc from##2##4##(2008-10#2)
separation of zinc traces from##2##5##(2008-10#2)
separation of zinc##7##3##(2008-10#7)
separation of##338##2##(1990-12#2)(1991-12#1)(1991-6#2)(1992-6#2)(1993-8#1)(1995-11#1)(1996-5#1)(1997-2#3)(1997-6#1)(2007-11#1)(2008-10#292)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-7#2)(2011-2#3)(2012-2#2)(2013-1#1)
separation on a##2##3##(2008-10#2)
separation on the##3##3##(2008-10#1)(2009-2#1)(2012-2#1)
separation on##9##2##(2008-10#7)(2009-2#1)(2012-2#1)
separation or##2##2##(2008-10#1)(2010-11#1)
separation parameters##2##2##(2008-10#2)
separation principle is##2##3##(2010-7#2)
separation procedure##7##2##(2008-10#7)
separation procedures##5##2##(2008-10#5)
separation process##4##2##(2008-10#4)
separation result##2##2##(2008-10#1)(2009-12#1)
separation selectivity##3##2##(2008-10#3)
separation step##7##2##(2008-10#7)
separation steps##7##2##(2008-10#5)(2008-11#1)(2008-4#1)
separation surgery##3##2##(2010-7#3)
separation system was used##2##4##(2008-10#2)
separation system##4##2##(2008-10#3)(2008-7#1)
separation systems##2##2##(2008-10#2)
separation technique for##2##3##(2008-10#2)
separation technique##6##2##(2008-10#6)
separation techniques such as##2##4##(2008-10#2)
separation techniques##6##2##(2008-10#6)
separation time##2##2##(2008-10#2)
separation under##2##2##(2008-10#2)
separation using##3##2##(2008-10#2)(2008-4#1)
separation voltage and##4##3##(2008-10#4)
separation voltage of##8##3##(2008-10#8)
separation voltage##14##2##(2008-10#14)
separation was accomplished##2##3##(2008-10#2)
separation was achieved on##4##4##(2008-10#4)
separation was achieved with##2##4##(2008-10#2)
separation was achieved##8##3##(2008-10#8)
separation was carried out##6##4##(2008-10#6)
separation was observed##2##3##(2008-10#2)
separation was performed on a##2##5##(2008-10#1)(2011-3#1)
separation was performed using a##2##5##(2008-10#2)
separation was performed##6##3##(2008-10#5)(2011-3#1)
separation was##34##2##(1992-6#1)(2008-10#31)(2008-11#1)(2011-3#1)
separation were##5##2##(2008-10#5)
separation with Amberlite##2##3##(2008-10#2)
separation with a##3##3##(2008-10#3)
separation with##16##2##(2008-10#16)
separation##960##1##(1990-12#5)(1990-3#1)(1990-8#1)(1991-12#1)(1991-6#2)(1992-6#3)(1993-8#1)(1994-5#1)(1995-11#1)(1995-3#2)(1995-5#1)(1996-5#1)(1997-2#11)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#808)(2008-11#20)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#2)(2009-6#1)(2009-8#2)(2010-11#2)(2010-4#1)(2010-7#12)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-2#8)(2012-3#1)(2013-1#4)(2013-8#1)
separation)##2##1##(2008-10#2)
separation-of-variables##3##1##(2008-3#3)
separation/preconcentration##4##1##(2008-10#4)
separations and##2##2##(2008-10#1)(2010-11#1)
separations are##2##2##(2008-10#1)(2008-4#1)
separations between##2##2##(2008-10#1)(2008-7#1)
separations in##4##2##(2008-10#3)(2008-4#1)
separations of neuromediators##2##3##(2008-10#2)
separations of organic compounds##2##4##(2008-10#2)
separations of##15##2##(2008-10#14)(2008-2#1)
separations using##4##2##(2008-10#2)(2008-7#2)
separations were performed on##2##4##(2008-10#2)
separations were##5##2##(2008-10#5)
separations with##2##2##(2008-10#2)
separations##52##1##(2008-10#42)(2008-2#1)(2008-4#2)(2008-7#5)(2010-11#1)(2010-7#1)
separative##2##1##(2008-10#2)
separator and##5##2##(2008-10#5)
separator to##2##2##(2008-10#2)
separator##25##1##(2008-10#23)(2010-12#1)(2011-2#1)
separators##5##1##(2008-10#2)(2008-11#1)(2011-2#2)
sepiolite and determined by flame atomic absorption##2##7##(2008-10#2)
sepiolite and##3##2##(2008-10#3)
sepiolite##8##1##(2008-10#8)
sepsis (p &lt##2##3##(2009-6#2)
sepsis (p##3##2##(2009-6#3)
sepsis and meningitis##3##3##(2009-12#3)
sepsis and##14##2##(1992-12#1)(1994-6#1)(1996-3#1)(2009-12#3)(2011-1#1)(2011-2#5)(2013-1#1)(2013-8#1)
sepsis are##2##2##(2008-12#1)(2012-3#1)
sepsis in the##2##3##(2011-2#1)(2012-3#1)
sepsis in##4##2##(2008-1#1)(2009-6#1)(2011-2#1)(2012-3#1)
sepsis is##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
sepsis was##2##2##(2007-12#1)(2008-7#1)
sepsis##84##1##(1990-3#2)(1991-3#4)(1992-12#1)(1993-6#1)(1993-9#1)(1994-6#1)(1996-3#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-5#7)(2008-7#2)(2008-8#2)(2009-12#3)(2009-5#1)(2009-6#8)(2009-8#2)(2009-9#1)(2010-12#2)(2010-7#3)(2011-1#2)(2011-2#20)(2011-3#1)(2012-3#6)(2013-1#4)(2013-8#4)
sepsis)##2##1##(2008-7#1)(2013-8#1)
septa##8##1##(2008-7#5)(2010-10#1)(2012-12#1)(2012-2#1)
septal defect##13##2##(2008-11#11)(2012-12#2)
septal defects##7##2##(1997-8#3)(2008-11#2)(2009-10#1)(2012-3#1)
septal occluder##2##2##(1997-8#1)(2009-10#1)
septal##36##1##(1991-3#1)(1994-2#2)(1996-12#2)(1997-8#4)(2008-11#14)(2009-10#2)(2009-5#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
septate junctions##7##2##(2008-7#7)
septate##11##1##(2008-10#1)(2008-7#7)(2013-1#3)
septated##2##1##(2011-2#1)(2012-2#1)
septaurelia##4##1##(2008-12#4)
septentrionalis##3##1##(2012-2#3)
septic arthritis and##2##3##(2010-12#1)(2013-8#1)
septic arthritis##6##2##(1991-3#1)(2010-12#1)(2011-2#1)(2013-8#3)
septic cardiomyopathy##2##2##(2008-7#2)
septic complications##4##2##(2007-11#1)(2007-8#2)(2010-12#1)
septic shock and##3##3##(2009-5#1)(2011-1#1)(2011-2#1)
septic shock##21##2##(1996-3#3)(2006-5#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#11)(2013-1#1)(2013-8#1)
septic##43##1##(1991-3#1)(1994-11#1)(1996-3#4)(1997-8#1)(2006-5#1)(2007-11#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#12)(2013-1#1)(2013-8#5)
septicaemia##9##1##(1990-9#1)(1991-8#1)(1994-3#1)(2008-5#4)(2008-7#1)(2013-1#1)
septicemia##6##1##(1994-9#3)(2009-6#1)(2010-2#1)(2011-2#1)
septicemia]##2##1##(1990-9#1)(1996-3#1)
septo-hippocampal cell cultures##3##3##(1996-12#1)(1996-2#2)
septo-hippocampal##4##1##(1996-12#1)(1996-2#3)
septo-optic dysplasia##2##2##(1997-3#2)
septohippocampal##3##1##(1996-12#1)(2013-8#2)
septoria speckled leaf blotch##3##4##(2008-10#3)
septoria##5##1##(2008-10#5)
septosporum and##2##2##(2008-10#2)
septosporum##4##1##(2008-10#4)
septum and##4##2##(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)
septum in##2##2##(2008-10#1)(2008-11#1)
septum##23##1##(1991-8#1)(1994-2#3)(1994-8#1)(1995-2#1)(1996-12#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2012-12#1)(2012-3#4)(2013-1#1)
sequel##5##1##(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
sequela of##2##2##(2008-12#1)(2008-7#1)
sequela##3##1##(2008-12#1)(2008-7#2)
sequelae and##2##2##(1997-2#1)(2010-12#1)
sequelae but##2##2##(1990-12#1)(2011-2#1)
sequelae cause##2##2##(1996-11#1)(2013-1#1)
sequelae of##8##2##(1990-12#1)(1991-3#1)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
sequelae##40##1##(1990-12#4)(1990-9#1)(1991-3#2)(1992-9#1)(1993-11#1)(1994-6#2)(1994-9#2)(1995-5#1)(1995-9#1)(1996-11#1)(1997-2#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#4)(2008-9#1)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#2)
sequence (&gt##3##2##(1997-9#1)(2008-10#2)
sequence (1 copy/every##2##3##(1997-2#2)
sequence (an 1##2##3##(2008-11#2)
sequence against a##2##3##(2008-4#1)(2011-2#1)
sequence alignment of##2##3##(1994-5#1)(2008-10#1)
sequence alignment##10##2##(1993-12#1)(1994-5#1)(2008-10#4)(2008-4#2)(2008-9#1)(2009-8#1)
sequence alignments##5##2##(2008-10#1)(2008-4#2)(2010-4#1)(2013-8#1)
sequence also contains a##2##4##(1993-3#1)(1995-9#1)
sequence also##4##2##(1992-9#1)(1993-3#1)(1995-6#1)(1995-9#1)
sequence alterations##2##2##(1992-3#1)(2008-10#1)
sequence amplified##2##2##(1996-8#1)(2008-10#1)
sequence analyses and##2##3##(1996-6#1)(2008-10#1)
sequence analyses of the##3##4##(1993-12#1)(2008-10#2)
sequence analyses of##5##3##(1993-12#1)(2008-10#4)
sequence analyses##13##2##(1993-12#1)(1996-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2013-1#1)
sequence analysis and expression##2##4##(1993-2#1)(2008-8#1)
sequence analysis and##9##3##(1990-8#1)(1993-12#1)(1993-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#1)
sequence analysis indicated that##2##4##(2008-10#1)(2008-9#1)
sequence analysis indicated##3##3##(2008-10#2)(2008-9#1)
sequence analysis indicates that##2##4##(2008-6#1)(2008-9#1)
sequence analysis of a##4##4##(1993-12#1)(1993-2#1)(1993-3#1)(1997-4#1)
sequence analysis of the internal transcribed spacer (ITS)##2##8##(2008-10#2)
sequence analysis of the internal transcribed spacer region 1 (ITS1)##2##10##(2008-10#2)
sequence analysis of the internal transcribed spacer##4##7##(2008-10#4)
sequence analysis of the##19##4##(1992-8#1)(1994-11#1)(1994-5#1)(1997-3#1)(2008-10#15)
sequence analysis of##39##3##(1990-8#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#23)(2008-8#1)(2008-9#1)
sequence analysis revealed that##4##4##(1990-2#1)(1992-6#1)(2008-10#1)(2008-8#1)
sequence analysis revealed##5##3##(1990-2#1)(1992-6#1)(2008-10#2)(2008-8#1)
sequence analysis showed that the##2##5##(1990-11#1)(1993-3#1)
sequence analysis showed that##3##4##(1990-11#1)(1993-3#1)(1997-8#1)
sequence analysis showed##5##3##(1990-11#1)(1993-3#1)(1997-8#1)(2008-10#2)
sequence analysis##96##2##(1990-11#1)(1990-2#1)(1990-8#3)(1991-5#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#3)(1994-11#2)(1994-5#1)(1995-8#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#44)(2008-11#2)(2008-2#2)(2008-4#3)(2008-6#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-6#1)(2012-2#3)
sequence and a##6##3##(1991-10#1)(1992-3#1)(1993-6#1)(1997-7#2)(2008-11#1)
sequence and annotation##11##3##(2011-2#11)
sequence and expression of##2##4##(1992-9#1)(1993-12#1)
sequence and expression##6##3##(1990-8#1)(1992-9#1)(1993-12#2)(1996-8#1)(2012-2#1)
sequence and is##3##3##(1992-8#1)(1993-6#1)(1994-12#1)
sequence and structural##2##3##(1991-6#1)(2008-10#1)
sequence and the##6##3##(1992-6#1)(1993-8#1)(2008-10#2)(2008-4#1)(2010-6#1)
sequence and was##2##3##(1993-2#1)(1996-12#1)
sequence and##69##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#4)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-8#1)(1997-7#2)(2008-10#9)(2008-11#5)(2008-4#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-6#2)(2011-2#12)(2012-2#2)(2013-8#1)
sequence are located##2##3##(1995-8#1)(2008-9#1)
sequence are##6##2##(1992-3#1)(1995-8#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#1)
sequence as a probe##2##4##(1992-3#1)(1993-2#1)
sequence as a##3##3##(1992-10#1)(1992-3#1)(1993-2#1)
sequence as##7##2##(1991-10#1)(1992-10#1)(1992-3#1)(1993-2#1)(2008-10#2)(2013-1#1)
sequence at position##2##3##(2008-8#1)(2011-2#1)
sequence at the NH2 terminus##2##5##(1992-9#1)(1993-3#1)
sequence at the##6##3##(1992-9#1)(1993-3#1)(1993-9#1)(2008-10#2)(2008-5#1)
sequence at##9##2##(1992-9#1)(1993-3#1)(1993-9#1)(1997-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
sequence base##3##2##(1996-6#2)(2008-10#1)
sequence between the##2##3##(2008-11#1)(2013-8#1)
sequence between##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
sequence but##2##2##(2008-10#1)(2008-9#1)
sequence by##5##2##(1991-5#1)(1993-3#1)(1997-9#1)(2008-10#1)(2008-8#1)
sequence can be##2##3##(2008-10#1)(2008-4#1)
sequence changes##3##2##(1997-3#1)(2008-9#2)
sequence characterized amplified region (SCAR) marker##2##6##(2008-10#2)
sequence characterized amplified region (SCAR)##4##5##(2008-10#4)
sequence comparison##5##2##(1991-6#2)(2008-10#3)
sequence comparisons between##2##3##(1995-2#1)(2008-9#1)
sequence comparisons indicated that the##2##5##(2008-10#2)
sequence comparisons##14##2##(1992-6#1)(1993-2#1)(1995-2#1)(2008-10#9)(2008-9#2)
sequence conservation between##2##3##(1993-6#1)(2012-3#1)
sequence conservation##5##2##(1993-6#2)(1995-12#1)(2011-1#1)(2012-3#1)
sequence contained##2##2##(1993-12#1)(2011-2#1)
sequence contains several##2##3##(1993-2#1)(1993-6#1)
sequence contains##6##2##(1993-2#1)(1993-6#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-8#1)
sequence context##2##2##(1995-12#1)(2008-4#1)
sequence could be##2##3##(2008-11#1)(2008-9#1)
sequence data and##3##3##(1997-6#1)(1997-8#1)(2008-10#1)
sequence data for##2##3##(1991-10#1)(2008-10#1)
sequence data from the##3##4##(2008-10#3)
sequence data from##7##3##(1996-3#1)(2008-10#4)(2010-4#1)(2013-1#1)
sequence data of the##4##4##(1995-12#1)(2008-10#2)(2008-5#1)
sequence data of##7##3##(1995-12#3)(1997-6#1)(2008-10#2)(2008-5#1)
sequence data revealed##2##3##(2008-10#2)
sequence data##46##2##(1991-10#1)(1991-9#1)(1995-12#3)(1995-2#1)(1995-8#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#6)(1997-8#1)(2008-10#17)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#1)(2010-3#2)(2010-4#1)(2013-1#1)(2013-8#1)
sequence database for sequences that are similar to a query##2##10##(2008-9#2)
sequence databases##4##2##(1996-8#1)(2008-11#1)(2008-5#1)(2010-11#1)
sequence derived from##4##3##(1993-6#1)(1994-5#1)(1995-5#1)(2008-10#1)
sequence determination of the##3##4##(1996-6#1)(2008-10#1)(2010-6#1)
sequence determination of##4##3##(1996-6#1)(2008-10#1)(2010-6#2)
sequence determination##6##2##(1993-8#1)(1996-6#1)(2008-10#1)(2008-8#1)(2010-6#2)
sequence determined##2##2##(1996-8#1)(1997-7#1)
sequence difference##2##2##(2008-10#1)(2011-2#1)
sequence differences between##2##3##(1993-6#1)(2008-9#1)
sequence differences##6##2##(1993-6#1)(2008-10#2)(2008-9#3)
sequence divergence##4##2##(2008-10#4)
sequence diversity##3##2##(2008-10#2)(2009-6#1)
sequence does not##2##3##(2008-11#2)
sequence elements of##2##3##(1991-6#1)(1996-3#1)
sequence elements##3##2##(1991-6#1)(1996-3#1)(2013-1#1)
sequence encoded##2##2##(1992-9#1)(2008-9#1)
sequence encodes a##2##3##(1990-11#1)(1996-2#1)
sequence encodes##3##2##(1990-11#1)(1995-9#1)(1996-2#1)
sequence encoding the##2##3##(1992-10#1)(2008-10#1)
sequence encoding##3##2##(1992-10#1)(2008-10#1)(2008-8#1)
sequence features##4##2##(1996-8#2)(1997-8#1)(2010-5#1)
sequence for the##5##3##(1992-10#1)(1993-6#1)(1997-3#1)(2008-11#1)(2008-4#1)
sequence for##20##2##(1991-5#1)(1992-10#2)(1993-6#3)(1997-3#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2011-10#1)(2011-2#2)
sequence from a different##2##4##(2008-4#2)
sequence from a member of the family##2##7##(2011-2#2)
sequence from a member of the##3##6##(2011-2#3)
sequence from a##8##3##(1991-7#1)(1995-12#1)(2008-4#2)(2011-2#3)(2012-2#1)
sequence from the##7##3##(1991-7#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#2)
sequence from##26##2##(1991-7#2)(1993-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#2)(2011-2#4)(2012-2#1)
sequence had##2##2##(1994-11#1)(2013-1#1)
sequence has been##3##3##(1996-12#1)(2011-2#2)
sequence homologies with##3##3##(1994-11#1)(2008-10#1)(2010-4#1)
sequence homologous to the##2##4##(2007-12#1)(2008-10#1)
sequence homologous to##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
sequence homologous##5##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
sequence homology between##2##3##(1997-8#1)(2008-8#1)
sequence homology of##4##3##(1992-3#1)(1997-6#1)(2008-8#2)
sequence homology to##4##3##(1991-5#1)(1993-3#1)(1995-12#1)(1995-2#1)
sequence homology with##8##3##(1992-6#1)(1993-12#1)(1994-11#1)(1997-3#1)(1997-7#1)(2008-9#2)(2010-5#1)
sequence homology##30##2##(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#2)(1995-2#2)(1996-12#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#3)(2008-8#4)(2008-9#3)(2010-5#1)(2011-2#1)
sequence identities with##2##3##(2008-10#2)
sequence identities##10##2##(1990-7#1)(1997-3#1)(2008-10#7)(2008-11#1)
sequence identity between##4##3##(1991-5#1)(2008-10#2)(2012-3#1)
sequence identity in the##3##4##(1993-6#1)(2008-10#2)
sequence identity in##4##3##(1993-6#1)(2008-10#3)
sequence identity to their##2##4##(1997-7#1)(2008-10#1)
sequence identity to##4##3##(1997-7#1)(2008-10#3)
sequence identity with the maize-type viruses##2##6##(2008-10#2)
sequence identity with the##5##4##(1995-11#2)(2008-10#3)
sequence identity with##10##3##(1995-11#2)(2008-10#7)(2010-5#1)
sequence identity##40##2##(1991-5#1)(1992-4#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-11#2)(1996-6#1)(1997-7#1)(2008-10#27)(2010-5#1)(2010-6#1)(2012-3#1)
sequence in a##3##3##(1993-8#1)(2008-10#2)
sequence in the##15##3##(1991-9#1)(1993-12#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-7#2)(2008-9#2)(2009-9#2)(2011-2#2)
sequence in##30##2##(1991-9#1)(1993-12#2)(1993-8#1)(1995-11#1)(1995-6#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-7#2)(1997-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#4)(2009-9#2)(2010-7#1)(2011-2#4)(2013-8#1)
sequence includes##2##2##(1990-5#1)(2008-10#1)
sequence including##2##2##(2008-8#1)(2008-9#1)
sequence information for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
sequence information of##3##3##(1995-8#1)(1997-8#1)(2008-10#1)
sequence information on##3##3##(1995-6#1)(2008-4#1)(2012-2#1)
sequence information##17##2##(1993-2#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-6#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
sequence into##2##2##(1991-10#1)(2008-7#1)
sequence involved in##2##3##(1992-8#1)(1995-6#1)
sequence is highly homologous to##2##5##(1993-12#1)(1993-6#1)
sequence is highly##3##3##(1993-12#1)(1993-6#1)(2008-10#1)
sequence is##28##2##(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-6#4)(1996-12#1)(1996-6#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#2)(2012-2#1)(2012-3#1)
sequence level##2##2##(1993-2#1)(1997-2#1)
sequence may have##2##3##(1993-6#1)(2008-9#1)
sequence may##4##2##(1993-6#2)(1996-12#1)(2008-9#1)
sequence motif##5##2##(1992-6#1)(1994-3#1)(1995-6#3)
sequence motifs##4##2##(1993-8#1)(1996-2#1)(1997-7#1)(2008-9#1)
sequence of 1##4##3##(1995-8#1)(1996-6#1)(1997-8#1)(2008-8#1)
sequence of 2##2##3##(1991-5#1)(2008-9#1)
sequence of DNaseI hypersensitive site 2##2##6##(2008-8#2)
sequence of MARs##2##3##(2008-8#2)
sequence of Synechocystis sp##2##4##(1996-12#1)(1996-8#1)
sequence of TMV-B##2##3##(2008-8#2)
sequence of a member of the genus##5##7##(2011-2#5)
sequence of a member of the##12##6##(2011-2#12)
sequence of a member##13##4##(2011-2#13)
sequence of a##48##3##(1990-11#2)(1990-2#1)(1990-5#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-6#1)(1995-9#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-8#2)(1997-4#1)(2008-10#9)(2008-7#1)(2008-9#2)(2009-3#1)(2011-2#15)
sequence of an 11##2##4##(1995-9#2)
sequence of an##5##3##(1995-9#2)(1996-8#1)(2008-10#2)
sequence of events leading to##2##5##(1991-5#1)(2008-12#1)
sequence of events leading##3##4##(1990-9#1)(1991-5#1)(2008-12#1)
sequence of events##10##3##(1990-9#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-6#2)(2012-3#1)(2013-8#1)
sequence of human##8##3##(1991-6#1)(1993-3#1)(1996-2#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
sequence of matrix attachment##2##4##(2008-8#2)
sequence of multiple##3##3##(1990-5#2)(2009-6#1)
sequence of one##2##3##(1990-5#1)(1993-12#1)
sequence of several##2##3##(1993-12#1)(1993-6#1)
sequence of the 3##2##4##(1996-2#1)(2008-8#1)
sequence of the Escherichia coli K-12 genome corresponding to the##7##10##(1996-12#4)(1996-6#3)
sequence of the Xenopus##2##4##(1993-12#1)(1997-7#1)
sequence of the beta subunit##2##5##(1992-9#1)(1994-11#1)
sequence of the cloned##2##4##(1991-9#1)(2008-10#1)
sequence of the entire##2##4##(1991-6#1)(1996-8#1)
sequence of the four##2##4##(1992-3#1)(2008-8#1)
sequence of the genomic##2##4##(2008-10#2)
sequence of the genus##5##4##(2011-2#5)
sequence of the human##4##4##(1990-8#1)(1994-11#1)(1996-8#1)(1997-7#1)
sequence of the internal transcribed spacer (ITS)##2##7##(2008-10#2)
sequence of the overlapping##2##4##(1996-12#1)(2008-10#1)
sequence of the protein##3##4##(1993-2#1)(1993-8#1)(2008-4#1)
sequence of the reductase was##2##5##(1996-3#1)(2008-11#1)
sequence of the##130##3##(1990-5#3)(1990-8#2)(1991-10#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#6)(1993-2#5)(1993-3#3)(1993-8#3)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#7)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#4)(1997-1#1)(1997-2#2)(1997-7#3)(1997-8#2)(2008-10#28)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#1)(2011-2#11)
sequence of this##12##3##(1990-2#1)(1990-5#1)(1993-12#1)(1993-2#2)(1994-11#1)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#2)(2008-8#1)
sequence of two##2##3##(1993-2#1)(2013-8#1)
sequence of##396##2##(1990-11#5)(1990-12#1)(1990-2#4)(1990-5#11)(1990-8#3)(1990-9#1)(1991-10#3)(1991-12#2)(1991-3#1)(1991-5#5)(1991-6#3)(1991-9#1)(1992-10#3)(1992-12#1)(1992-3#5)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#12)(1993-2#10)(1993-3#7)(1993-6#8)(1993-8#4)(1993-9#2)(1994-11#10)(1994-12#3)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-6#7)(1995-8#4)(1995-9#4)(1996-12#11)(1996-2#5)(1996-3#5)(1996-6#7)(1996-8#9)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#5)(1997-8#4)(2007-12#1)(2008-10#73)(2008-11#9)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#24)(2008-9#13)(2009-10#2)(2009-3#1)(2009-6#3)(2009-8#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#60)(2012-2#1)(2012-3#1)(2013-8#3)
sequence on##4##2##(1995-10#1)(1995-2#1)(2008-9#1)(2010-10#1)
sequence or##6##2##(1993-12#1)(1994-11#1)(1995-12#1)(2008-4#1)(2010-5#1)(2011-1#1)
sequence patterns surrounding##2##3##(1997-2#2)
sequence polymorphisms##3##2##(1996-6#1)(2008-10#2)
sequence provides##2##2##(1996-12#1)(2008-10#1)
sequence published##2##2##(1993-6#1)(2008-12#1)
sequence reads##2##2##(2011-2#1)(2012-3#1)
sequence repeat markers##3##3##(2008-10#3)
sequence repeat##14##2##(2008-10#11)(2008-9#2)(2010-10#1)
sequence repeats##6##2##(1996-8#2)(2008-10#4)
sequence represents##2##2##(1990-8#1)(2008-10#1)
sequence respectively##3##2##(2008-8#1)(2010-7#2)
sequence resulted in##2##3##(1991-10#1)(1993-12#1)
sequence revealed that this##2##4##(1994-12#1)(1996-12#1)
sequence revealed that##4##3##(1990-2#1)(1994-12#1)(1996-12#1)(2008-10#1)
sequence revealed the##2##3##(1996-6#1)(1997-7#1)
sequence revealed##10##2##(1990-2#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#2)
sequence segments##2##2##(2008-10#1)(2008-9#1)
sequence sets##3##2##(1997-6#1)(2008-4#2)
sequence showed a high degree of##2##6##(1996-2#1)(1997-1#1)
sequence showed a high##3##4##(1996-2#1)(1996-3#1)(1997-1#1)
sequence showed a##4##3##(1996-2#1)(1996-3#1)(1997-1#1)(2008-5#1)
sequence showed##8##2##(1993-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
sequence shows##6##2##(1993-12#2)(1993-2#3)(1995-11#1)
sequence similar to##2##3##(1991-5#1)(2008-10#1)
sequence similarities to##2##3##(1992-9#1)(1995-8#1)
sequence similarities with the##2##4##(1992-6#1)(2008-10#1)
sequence similarities with##3##3##(1992-6#1)(1995-2#1)(2008-10#1)
sequence similarities##8##2##(1990-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1995-2#1)(1995-8#1)(2008-10#2)
sequence similarity among##2##3##(2008-10#2)
sequence similarity and##2##3##(2011-1#1)(2011-2#1)
sequence similarity between the##2##4##(1991-6#1)(2008-10#1)
sequence similarity to##5##3##(1993-8#1)(1995-8#1)(2008-10#2)(2012-3#1)
sequence similarity with##3##3##(1994-11#1)(1995-6#1)(2008-10#1)
sequence similarity##28##2##(1991-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-8#1)(2008-10#11)(2008-6#1)(2008-9#1)(2009-10#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
sequence so##2##2##(2011-2#2)
sequence space##3##2##(1997-6#3)
sequence specific##5##2##(1996-2#1)(2008-12#2)(2008-9#1)(2009-7#1)
sequence surrounding the##4##3##(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)
sequence tag (EST)##3##3##(1997-6#1)(2008-11#1)(2008-9#1)
sequence tagged##2##2##(1995-6#1)(2008-10#1)
sequence tags##12##2##(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#2)(1997-6#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#2)(2013-8#1)
sequence that is##4##3##(1993-12#1)(1993-2#1)(1997-7#1)(2008-11#1)
sequence that provides##2##3##(2008-10#2)
sequence that##14##2##(1991-10#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-6#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
sequence through##2##2##(1995-8#1)(2008-11#1)
sequence to##15##2##(1991-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-9#1)(2010-6#1)(2011-2#2)
sequence types##2##2##(2008-12#2)
sequence unique##2##2##(1995-6#1)(2009-9#1)
sequence variability##2##2##(2008-10#2)
sequence variants in##3##3##(2008-4#3)
sequence variants##15##2##(1993-9#1)(2008-10#10)(2008-4#3)(2011-2#1)
sequence variation in##2##3##(2008-12#1)(2008-6#1)
sequence variation##9##2##(1992-8#1)(1993-2#1)(1997-9#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-10#1)(2012-3#1)
sequence was cloned into##2##4##(1993-6#1)(2008-8#1)
sequence was determined to be##2##5##(2008-10#2)
sequence was determined##9##3##(1990-5#1)(1993-12#2)(1993-9#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-8#1)
sequence was found##3##3##(1993-12#1)(1995-6#1)(2008-9#1)
sequence was isolated##2##3##(1993-12#1)(2008-10#1)
sequence was obtained##3##3##(1993-6#1)(2008-10#1)(2008-9#1)
sequence was used to##2##4##(1992-9#1)(2008-10#1)
sequence was##58##2##(1990-5#1)(1991-10#3)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#6)(1993-6#2)(1993-9#1)(1994-11#1)(1995-6#5)(1996-12#1)(1996-6#4)(1997-2#2)(1997-4#1)(1997-7#1)(2008-10#14)(2008-11#4)(2008-8#4)(2008-9#2)(2010-7#1)(2012-12#1)
sequence were##6##2##(1992-6#1)(1993-6#1)(1996-8#1)(2008-10#2)(2010-4#1)
sequence which is##2##3##(1995-2#1)(2008-8#1)
sequence which##6##2##(1990-5#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-8#2)
sequence with##8##2##(1993-12#1)(2008-10#5)(2008-4#1)(2008-9#1)
sequence within the##2##3##(2008-10#1)(2011-2#1)
sequence within##3##2##(1993-9#1)(2008-10#1)(2011-2#1)
sequence##1708##1##(1990-11#9)(1990-12#1)(1990-2#6)(1990-5#16)(1990-7#2)(1990-8#10)(1990-9#2)(1991-10#18)(1991-12#4)(1991-3#1)(1991-5#16)(1991-6#16)(1991-7#4)(1991-9#9)(1992-10#12)(1992-12#4)(1992-3#15)(1992-4#2)(1992-6#14)(1992-7#1)(1992-8#7)(1992-9#11)(1993-12#48)(1993-2#33)(1993-3#19)(1993-6#41)(1993-8#19)(1993-9#16)(1994-11#20)(1994-12#8)(1994-2#3)(1994-3#2)(1994-5#7)(1994-6#3)(1994-8#4)(1994-9#2)(1995-10#1)(1995-11#6)(1995-12#11)(1995-2#17)(1995-5#1)(1995-6#43)(1995-8#23)(1995-9#9)(1996-12#29)(1996-2#12)(1996-3#12)(1996-5#7)(1996-6#24)(1996-8#20)(1997-1#4)(1997-2#18)(1997-3#10)(1997-4#4)(1997-6#23)(1997-7#20)(1997-8#21)(1997-9#11)(2006-6#3)(2007-12#3)(2008-1#2)(2008-10#409)(2008-11#53)(2008-12#14)(2008-2#2)(2008-3#4)(2008-4#45)(2008-5#10)(2008-6#10)(2008-7#7)(2008-8#82)(2008-9#73)(2009-10#10)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#10)(2009-7#3)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#9)(2010-5#6)(2010-6#11)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#8)(2011-10#1)(2011-2#124)(2011-3#2)(2012-12#1)(2012-2#15)(2012-3#8)(2013-1#7)(2013-8#13)
sequence-based##11##1##(2008-10#8)(2011-1#2)(2012-3#1)
sequence-characterized amplified##2##2##(2008-10#2)
sequence-characterized##3##1##(2008-10#3)
sequence-dependent##4##1##(1991-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
sequence-independent DNA binding proteins in##2##5##(2008-8#2)
sequence-selective##3##1##(2008-10#3)
sequence-specific DNA##2##2##(1994-11#1)(2008-4#1)
sequence-specific and##2##2##(1995-8#1)(2008-9#1)
sequence-specific proteases##2##2##(2008-4#2)
sequence-specific##15##1##(1992-3#1)(1994-11#1)(1995-6#1)(1995-8#2)(2008-10#1)(2008-4#4)(2008-8#1)(2008-9#3)(2011-2#1)
sequence-tagged site (STS) markers##4##4##(1996-12#2)(1997-8#1)(2008-10#1)
sequence-tagged##5##1##(1995-6#1)(1996-12#2)(1997-8#1)(2008-10#1)
sequenced LCAT cDNA##2##3##(1993-6#2)
sequenced a##2##2##(1991-6#1)(2008-5#1)
sequenced and assembled##2##3##(1996-2#1)(2012-3#1)
sequenced and characterized##2##3##(1991-9#1)(2008-5#1)
sequenced and compared##3##3##(1990-11#1)(2008-10#1)(2009-10#1)
sequenced and expressed in##2##4##(1990-11#1)(2008-9#1)
sequenced and found to be##2##5##(1996-12#1)(2008-10#1)
sequenced and the##2##3##(2008-10#1)(2008-8#1)
sequenced and##25##2##(1990-11#2)(1991-9#1)(1992-3#1)(1993-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#1)
sequenced by##3##2##(1991-5#1)(1995-12#2)
sequenced for each##2##3##(2008-10#2)
sequenced for##4##2##(2008-10#4)
sequenced from##3##2##(2008-10#2)(2008-12#1)
sequenced genome##2##2##(2008-10#1)(2008-7#1)
sequenced genomes##2##2##(2009-10#1)(2011-1#1)
sequenced in this study##2##4##(1997-8#1)(2008-10#1)
sequenced in##5##2##(1997-8#1)(2008-10#3)(2008-8#1)
sequenced open reading##2##3##(1996-6#1)(2008-10#1)
sequenced regions##3##2##(1997-6#1)(1997-8#2)
sequenced the##11##2##(1990-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-7#2)(1997-8#1)(2011-2#1)
sequenced to##6##2##(1993-9#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-10#1)(2012-2#1)
sequenced##182##1##(1990-11#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#4)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#4)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#4)(1997-8#4)(1997-9#2)(2007-12#1)(2008-10#67)(2008-11#1)(2008-12#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#4)(2009-10#3)(2009-6#2)(2010-10#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#4)
sequences (0##2##2##(2008-10#1)(2013-1#1)
sequences 5' to the##2##4##(1991-6#1)(1993-12#1)
sequences after##2##2##(2008-9#1)(2011-2#1)
sequences among##4##2##(1993-12#1)(1995-8#1)(2008-10#2)
sequences analyzed##2##2##(2008-10#2)
sequences and a##2##3##(1997-2#1)(1997-8#1)
sequences and##34##2##(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#9)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-3#1)
sequences and/or##2##2##(1995-8#1)(2008-7#1)
sequences are##19##2##(1990-8#1)(1992-10#1)(1992-3#1)(1993-6#1)(1993-9#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-8#1)(2009-10#1)(2012-2#2)
sequences around##2##2##(1991-5#1)(1994-11#1)
sequences as##2##2##(1996-6#1)(2008-4#1)
sequences at##5##2##(1993-12#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#1)
sequences between##4##2##(1994-11#1)(2008-10#2)(2008-4#1)
sequences by##4##2##(1993-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
sequences can be##3##3##(2008-10#1)(2008-9#1)(2009-12#1)
sequences coding##2##2##(1996-6#1)(1997-6#1)
sequences contained##2##2##(1997-2#1)(2008-10#1)
sequences containing##3##2##(1991-6#1)(1992-9#1)(2008-10#1)
sequences could be##2##3##(2008-10#1)(2011-2#1)
sequences could##3##2##(2008-10#1)(2011-2#2)
sequences during##2##2##(2008-10#2)
sequences encoded##2##2##(1993-6#1)(1993-9#1)
sequences encoding the##2##3##(1993-9#1)(2008-9#1)
sequences encoding##5##2##(1992-6#1)(1993-9#1)(2008-9#1)(2010-5#1)(2012-3#1)
sequences exhibited##2##2##(2008-10#1)(2009-6#1)
sequences flanking the##2##3##(1995-2#1)(2008-10#1)
sequences for the##4##3##(1995-6#1)(1997-8#1)(2009-10#1)(2010-12#1)
sequences for##16##2##(1991-5#1)(1991-6#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-8#1)(2009-10#1)(2010-12#1)(2012-3#1)
sequences found in##2##3##(1992-6#1)(2008-10#1)
sequences from a##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
sequences from all##2##3##(2008-10#2)
sequences from the nuclear##2##4##(2008-10#2)
sequences from the##10##3##(1995-6#1)(2008-10#8)(2008-12#1)
sequences from##38##2##(1990-5#1)(1993-2#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#22)(2008-11#1)(2008-12#1)(2009-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
sequences had##3##2##(1997-9#1)(2008-9#1)(2010-4#1)
sequences has##2##2##(2008-10#1)(2008-7#1)
sequences have been##5##3##(1992-6#1)(1993-12#1)(1993-6#2)(2008-9#1)
sequences have##9##2##(1992-6#1)(1993-12#1)(1993-6#2)(1997-6#1)(2008-10#2)(2008-6#1)(2008-9#1)
sequences homologous to##3##3##(1991-6#1)(1993-12#1)(1996-6#1)
sequences in the databases##2##4##(1997-3#1)(2008-10#1)
sequences in the##17##3##(1991-9#1)(1993-8#1)(1994-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
sequences in two##2##3##(1993-12#1)(2008-9#1)
sequences in##39##2##(1991-9#1)(1992-6#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#5)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
sequences indicated that##3##3##(1995-8#1)(2008-10#2)
sequences indicated##5##2##(1995-8#1)(2008-10#4)
sequences into##3##2##(1997-7#1)(2008-10#2)
sequences is##5##2##(1996-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)
sequences located in the##2##4##(1993-2#1)(2008-10#1)
sequences may##3##2##(1993-12#1)(1996-12#1)(2008-10#1)
sequences nor##2##2##(1994-11#1)(1997-3#1)
sequences obtained##2##2##(2008-10#1)(2010-3#1)
sequences of 40##5##3##(1995-8#2)(1996-2#3)
sequences of PVV##2##3##(2008-10#2)
sequences of a##5##3##(1994-11#3)(2008-10#1)(2008-5#1)
sequences of all four##2##4##(1993-6#1)(1995-6#1)
sequences of all##3##3##(1993-6#1)(1995-6#1)(2008-10#1)
sequences of different##2##3##(1996-6#1)(2008-6#1)
sequences of groups I and II##2##6##(2008-10#2)
sequences of groups I##3##4##(2008-10#3)
sequences of interest##2##3##(2008-10#1)(2008-2#1)
sequences of other##2##3##(1991-10#1)(2008-8#1)
sequences of the 16S rRNA genes##2##6##(2008-10#2)
sequences of the RNA##2##4##(2008-10#2)
sequences of the Rep##2##4##(2008-10#2)
sequences of the cloned##2##4##(2008-10#1)(2008-11#1)
sequences of the coat protein (CP)##2##6##(2008-10#2)
sequences of the complete##2##4##(2008-10#1)(2008-6#1)
sequences of the genes encoding##2##5##(1993-12#1)(2010-7#1)
sequences of the genes##3##4##(1993-12#1)(2008-11#1)(2010-7#1)
sequences of the human##2##4##(1992-3#1)(2010-5#1)
sequences of the intergenic##2##4##(2008-10#2)
sequences of the internal transcribed spacer (ITS) region of##2##9##(2008-10#2)
sequences of the internal transcribed spacer (ITS)##3##7##(2008-10#3)
sequences of the internal transcribed spacer##5##6##(2008-10#5)
sequences of the mitochondrial##2##4##(1991-6#1)(2008-6#1)
sequences of the same##2##4##(2008-9#1)(2011-2#1)
sequences of the##79##3##(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-6#2)(1996-8#3)(1997-7#1)(2008-10#40)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#4)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#2)
sequences of these##4##3##(1993-6#1)(1997-8#1)(2008-10#2)
sequences of two##3##3##(1991-6#2)(1993-6#1)
sequences of##206##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#2)(1993-6#5)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#5)(1996-2#7)(1996-3#1)(1996-6#3)(1996-8#5)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#3)(2008-10#83)(2008-11#6)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#10)(2008-9#8)(2009-10#1)(2010-4#1)(2010-5#2)(2010-7#3)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#4)
sequences on the basis of##2##5##(1996-6#1)(2008-9#1)
sequences on the##4##3##(1995-6#1)(1996-6#1)(2008-9#1)(2012-2#1)
sequences on##5##2##(1992-4#1)(1995-6#1)(1996-6#1)(2008-9#1)(2012-2#1)
sequences or##2##2##(2008-4#1)(2008-8#1)
sequences reported##3##2##(1991-5#1)(1993-2#1)(2008-11#1)
sequences required##2##2##(1994-12#1)(1997-3#1)
sequences revealed that##3##3##(1993-8#1)(2008-10#2)
sequences revealed##6##2##(1993-8#1)(1994-11#1)(2008-10#4)
sequences showed that##3##3##(1990-5#1)(2008-10#1)(2008-12#1)
sequences showed##4##2##(1990-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
sequences strongly##2##2##(1993-8#1)(2008-10#1)
sequences such##2##2##(2013-8#2)
sequences surrounding##2##2##(1991-5#1)(1995-6#1)
sequences that are similar to##3##5##(1995-2#1)(2008-9#2)
sequences that are##9##3##(1992-9#1)(1993-12#1)(1993-2#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-9#2)
sequences that can##2##3##(2009-12#1)(2012-2#1)
sequences that##18##2##(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#2)(1995-8#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#2)(2009-12#1)(2012-2#1)(2012-3#1)
sequences the##2##2##(2008-4#1)(2008-8#1)
sequences to a##2##3##(1994-11#1)(2008-10#1)
sequences to the##2##3##(1991-5#1)(2008-10#1)
sequences to##12##2##(1991-5#1)(1993-8#1)(1994-11#1)(2008-10#5)(2009-12#1)(2009-8#1)(2010-7#1)(2011-1#1)
sequences using network BLAST searches##2##5##(2008-4#1)(2008-9#1)
sequences using the##2##3##(1997-7#1)(2008-9#1)
sequences using##7##2##(1997-7#1)(2008-11#1)(2008-4#2)(2008-9#2)(2012-2#1)
sequences was found##2##3##(1993-2#1)(1995-6#1)
sequences was used to##2##4##(2008-10#1)(2010-3#1)
sequences was##11##2##(1993-2#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#5)(2010-3#1)
sequences were compared with##3##4##(1991-5#1)(2008-10#1)(2013-8#1)
sequences were compared##5##3##(1991-5#1)(2008-10#3)(2013-8#1)
sequences were detected as showing##2##5##(2008-9#2)
sequences were detected##3##3##(2008-9#2)(2011-2#1)
sequences were determined by##2##4##(1994-11#1)(2008-8#1)
sequences were determined##6##3##(1994-11#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-8#2)
sequences were identical##2##3##(2008-12#1)(2011-2#1)
sequences were identified from##2##4##(2008-10#1)(2008-9#1)
sequences were identified##3##3##(2008-10#1)(2008-9#1)(2010-10#1)
sequences were obtained for##2##4##(1993-6#1)(2008-10#1)
sequences were obtained##5##3##(1993-2#1)(1993-6#1)(1997-3#1)(2008-10#1)(2013-8#1)
sequences were used to##2##4##(2008-10#1)(2012-2#1)
sequences were used##3##3##(1997-9#1)(2008-10#1)(2012-2#1)
sequences were##51##2##(1991-5#1)(1993-2#1)(1993-6#1)(1994-11#2)(1995-2#3)(1995-6#2)(1995-8#1)(1996-8#2)(1997-3#1)(1997-6#1)(1997-8#1)(1997-9#2)(2008-10#11)(2008-12#3)(2008-8#2)(2008-9#4)(2010-10#1)(2010-4#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
sequences which##8##2##(1991-6#1)(1993-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#2)(2010-7#1)
sequences with the##3##3##(1992-6#1)(1993-6#1)(1996-8#1)
sequences with those of##3##4##(1991-12#1)(1995-2#1)(2008-10#1)
sequences with##14##2##(1991-12#1)(1992-6#1)(1993-6#2)(1995-2#1)(1996-8#1)(2008-10#4)(2008-12#1)(2008-4#2)(2011-3#1)
sequences within the##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
sequences within##9##2##(1990-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
sequences##890##1##(1990-11#3)(1990-5#6)(1990-8#4)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#11)(1991-6#10)(1991-7#1)(1991-9#2)(1992-10#3)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#11)(1992-9#3)(1993-1#2)(1993-12#26)(1993-2#12)(1993-3#2)(1993-6#17)(1993-8#11)(1993-9#6)(1994-1#1)(1994-11#20)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#6)(1995-2#13)(1995-5#2)(1995-6#17)(1995-8#16)(1995-9#3)(1996-12#10)(1996-2#12)(1996-3#3)(1996-5#1)(1996-6#14)(1996-8#12)(1997-2#8)(1997-3#9)(1997-4#1)(1997-6#11)(1997-7#14)(1997-8#13)(1997-9#5)(2007-12#1)(2008-1#1)(2008-10#247)(2008-11#25)(2008-12#11)(2008-2#2)(2008-3#3)(2008-4#33)(2008-5#7)(2008-6#13)(2008-7#9)(2008-8#33)(2008-9#49)(2009-10#8)(2009-12#4)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#25)(2011-3#2)(2012-2#13)(2012-3#10)(2013-1#9)(2013-3#1)(2013-8#14)
sequences)##4##1##(1993-12#1)(1993-8#1)(2008-10#1)(2008-4#1)
sequencing analysis##2##2##(1992-8#1)(1997-9#1)
sequencing and assembly##2##3##(2008-4#1)(2012-3#1)
sequencing and##21##2##(1990-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
sequencing are##2##2##(2008-10#1)(2011-2#1)
sequencing by##2##2##(1991-2#1)(2009-9#1)
sequencing data##4##2##(2008-8#1)(2008-9#1)(2011-2#2)
sequencing effort##2##2##(2008-5#1)(2012-3#1)
sequencing efforts##3##2##(2008-10#1)(2011-10#1)(2012-3#1)
sequencing for##2##2##(1997-7#1)(2012-2#1)
sequencing have##2##2##(1995-12#1)(2010-10#1)
sequencing in##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
sequencing is##2##2##(1995-8#1)(2010-10#1)
sequencing method##3##2##(1992-8#1)(1995-12#1)(1995-6#1)
sequencing of 16S rDNA##2##4##(2008-10#2)
sequencing of 16S##3##3##(2008-10#2)(2012-2#1)
sequencing of a##7##3##(1995-12#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-9#1)
sequencing of peptides##2##3##(1990-5#1)(1994-11#1)
sequencing of the entire##2##4##(1995-12#1)(1996-2#1)
sequencing of the genomes of##2##5##(2008-4#1)(2008-7#1)
sequencing of the##21##3##(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-7#1)(2008-10#7)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#2)
sequencing of##51##2##(1990-2#1)(1990-5#1)(1991-6#1)(1993-12#2)(1993-3#1)(1994-11#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-7#2)(2008-10#16)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)
sequencing or##2##2##(1991-6#1)(2008-11#1)
sequencing procedure##2##2##(1990-5#1)(2011-2#1)
sequencing projects##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
sequencing protocol##2##2##(1995-6#2)
sequencing reads##2##2##(2011-2#1)(2013-8#1)
sequencing revealed##2##2##(1992-3#1)(2012-3#1)
sequencing techniques##2##2##(1997-8#1)(2013-1#1)
sequencing technologies##2##2##(2009-6#1)(2011-2#1)
sequencing the##8##2##(1990-8#1)(1992-9#1)(1997-7#1)(2008-10#3)(2011-2#1)(2012-3#1)
sequencing##223##1##(1990-11#2)(1990-2#1)(1990-5#8)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#3)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#3)(1994-3#1)(1994-8#2)(1995-12#6)(1995-2#1)(1995-6#10)(1995-8#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#4)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#6)(1997-8#1)(1997-9#1)(2008-10#45)(2008-11#3)(2008-12#5)(2008-4#10)(2008-5#3)(2008-7#1)(2008-8#12)(2008-9#7)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#5)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#19)(2012-2#9)(2012-3#8)(2013-1#2)(2013-8#5)
sequential analysis of Cd and Zn on the same##2##9##(2008-10#2)
sequential analysis of##4##3##(2008-10#4)
sequential analysis##6##2##(2008-10#6)
sequential and##4##2##(1990-6#1)(1992-3#1)(2008-10#2)
sequential application of##2##3##(2008-10#2)
sequential arm movements##2##3##(2008-7#2)
sequential determination of cadmium and lead##2##6##(2008-10#2)
sequential determination of copper and mercury ions in river-water samples##2##10##(2008-10#2)
sequential determination of##11##3##(2008-10#11)
sequential determination##12##2##(2008-10#12)
sequential determinations##2##2##(2008-10#2)
sequential elution##3##2##(2008-10#3)
sequential extraction procedure (SEP)##3##4##(2008-10#3)
sequential extraction procedure for##6##4##(2008-10#6)
sequential extraction procedure##16##3##(2008-10#16)
sequential extraction protocol##2##3##(2008-10#2)
sequential extraction test##3##3##(2008-10#3)
sequential extraction##36##2##(2008-10#36)
sequential flow injection##2##3##(2008-10#2)
sequential flow##4##2##(2008-10#4)
sequential inductively coupled plasma atomic emission##2##6##(2008-10#2)
sequential inductively coupled plasma##3##4##(2008-10#3)
sequential injection (SI)##7##3##(2008-10#7)
sequential injection (SIA)##3##3##(2008-10#3)
sequential injection analysis (SIA) and##3##5##(2008-10#3)
sequential injection analysis (SIA) methodology for the fluorimetric determination of##2##10##(2008-10#2)
sequential injection analysis (SIA) system is proposed for the determination of##2##11##(2008-10#2)
sequential injection analysis (SIA) system is##4##6##(2008-10#4)
sequential injection analysis (SIA) system##8##5##(2008-10#8)
sequential injection analysis (SIA) technique##2##5##(2008-10#2)
sequential injection analysis (SIA) was##2##5##(2008-10#2)
sequential injection analysis (SIA)##27##4##(2008-10#27)
sequential injection analysis for##2##4##(2008-10#2)
sequential injection analysis system##6##4##(2008-10#6)
sequential injection analysis technique##2##4##(2008-10#2)
sequential injection analysis using##2##4##(2008-10#2)
sequential injection analysis was##2##4##(2008-10#2)
sequential injection analysis##59##3##(2008-10#59)
sequential injection chromatography (SIC)##3##4##(2008-10#3)
sequential injection chromatography##5##3##(2008-10#5)
sequential injection determination of##2##4##(2008-10#2)
sequential injection extraction##2##3##(2008-10#2)
sequential injection lab-on-valve (SI-LOV) system##2##5##(2008-10#2)
sequential injection method##3##3##(2008-10#3)
sequential injection mode##2##3##(2008-10#2)
sequential injection spectrophotometric determination of##2##5##(2008-10#2)
sequential injection spectrophotometric method for the assay of##2##8##(2008-10#2)
sequential injection spectrophotometric method for the determination of##2##8##(2008-10#2)
sequential injection spectrophotometric method for the##4##6##(2008-10#4)
sequential injection spectrophotometric method##5##4##(2008-10#5)
sequential injection spectrophotometric##8##3##(2008-10#8)
sequential injection system for the##4##5##(2008-10#4)
sequential injection system for trace mercury determination##2##7##(2008-10#2)
sequential injection system for##8##4##(2008-10#8)
sequential injection system##20##3##(2008-10#20)
sequential injection systems##3##3##(2008-10#3)
sequential injection technique##3##3##(2008-10#3)
sequential injection titration system##2##4##(2008-10#2)
sequential injection titration##4##3##(2008-10#4)
sequential injection##149##2##(2008-10#149)
sequential leaching##4##2##(2008-10#4)
sequential method##2##2##(1992-3#1)(2008-10#1)
sequential sampling##4##2##(2008-10#4)
sequential separation##4##2##(2008-10#4)
sequential simplex optimization##2##3##(2008-10#2)
sequential simplex##4##2##(2008-10#4)
sequential steps##2##2##(1991-9#1)(2008-10#1)
sequential use of a##2##4##(2008-10#1)(2008-12#1)
sequential##350##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-9#2)(1992-12#2)(1992-3#3)(1992-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#4)(1995-12#1)(1995-2#3)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#286)(2008-11#9)(2008-12#2)(2008-2#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#2)
sequential-injection analysis##3##2##(2008-10#3)
sequential-injection system##2##2##(2008-10#2)
sequential-injection##5##1##(2008-10#5)
sequential-stage ultrafiltration##3##2##(2008-10#3)
sequentially in##2##2##(2008-10#1)(2008-11#1)
sequentially inserted as##2##3##(2008-10#1)(2008-9#1)
sequentially##37##1##(1991-5#1)(1994-5#1)(1994-6#1)(1995-8#1)(1997-2#1)(2008-10#18)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
sequester##5##1##(2008-10#3)(2009-12#1)(2010-6#1)
sequestered by##4##2##(1990-2#1)(1997-6#1)(2008-10#2)
sequestered##9##1##(1990-2#1)(1991-6#1)(1992-6#1)(1994-11#1)(1994-8#1)(1997-6#1)(2008-10#3)
sequestering resin was##2##3##(2008-10#2)
sequestering##10##1##(2008-10#7)(2008-11#1)(2009-7#1)(2012-2#1)
sequesters the##2##2##(1991-9#1)(2008-11#1)
sequesters##3##1##(1991-9#2)(2008-11#1)
sequestration in##2##2##(1997-1#1)(2013-8#1)
sequestration of##3##2##(2008-5#1)(2009-12#1)(2012-12#1)
sequestration with##2##2##(2013-1#2)
sequestration##13##1##(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
sera (n =##2##3##(1990-8#1)(1996-12#1)
sera and##4##2##(1991-5#1)(2008-10#2)(2008-11#1)
sera diluted##2##2##(2008-10#1)(2010-4#1)
sera for##2##2##(2008-11#1)(2011-2#1)
sera from patients with##3##4##(1990-5#1)(1993-2#2)
sera from patients##5##3##(1990-5#1)(1991-12#1)(1993-2#2)(2008-5#1)
sera from##20##2##(1990-5#1)(1991-12#1)(1992-11#3)(1993-2#2)(1993-8#1)(1994-3#2)(1996-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2009-6#1)(2012-5#1)(2013-8#1)
sera obtained##3##2##(1992-3#1)(2008-11#2)
sera of patients with##3##4##(1990-12#1)(1993-1#1)(1993-2#1)
sera of##8##2##(1990-12#1)(1992-3#1)(1993-1#2)(1993-2#1)(1994-3#2)(1996-3#1)
sera recognize##2##2##(1995-2#2)
sera showed##2##2##(1996-12#1)(2008-11#1)
sera to##2##2##(1997-5#1)(2012-3#1)
sera using##2##2##(1990-12#1)(2008-10#1)
sera were##3##2##(1990-12#1)(1996-12#1)(2008-12#1)
sera##93##1##(1990-12#7)(1990-5#1)(1990-8#5)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#3)(1992-12#1)(1992-3#4)(1993-1#3)(1993-2#3)(1993-8#2)(1994-3#4)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#6)(1996-3#1)(1997-5#4)(2008-10#14)(2008-11#12)(2008-12#1)(2008-5#3)(2008-8#3)(2009-6#1)(2010-4#2)(2011-2#2)(2012-3#1)(2012-5#1)(2013-8#1)
serial CT scans##2##3##(1990-12#1)(2010-1#1)
serial assessment of##2##3##(2009-10#1)(2012-5#1)
serial deletants and chimeras of##2##5##(2008-8#2)
serial passage in##2##3##(2008-10#2)
serial passage##3##2##(1990-5#1)(2008-10#2)
serial passages in##2##3##(2008-10#1)(2013-1#1)
serial passages##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
serial sections##5##2##(1997-3#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
serial subtraction##2##2##(2008-7#2)
serial##65##1##(1990-12#1)(1990-5#1)(1991-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#2)(2010-11#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
serially connected##2##2##(2008-10#2)
serially##8##1##(1991-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2011-2#2)
sericin was##2##2##(2008-11#2)
sericin##10##1##(2008-11#10)
series and the##2##3##(1995-11#1)(2008-10#1)
series and##4##2##(1995-11#1)(2008-10#2)(2009-6#1)
series as##3##2##(1996-9#1)(2008-10#1)(2013-8#1)
series at##2##2##(1995-8#1)(2008-10#1)
series for##2##2##(1990-6#1)(2008-10#1)
series in##3##2##(2011-2#2)(2013-1#1)
series is##3##2##(2008-10#2)(2008-7#1)
series of 1##2##3##(2008-10#1)(2008-11#1)
series of 10##3##3##(1994-8#1)(2008-10#2)
series of 150##3##3##(1990-12#2)(1996-2#1)
series of 20##3##3##(2008-7#2)(2008-9#1)
series of 250##2##3##(2008-7#1)(2012-5#1)
series of acyclic##2##3##(2008-10#2)
series of aqueous solutions##2##4##(2008-10#1)(2008-5#1)
series of arecoline##2##3##(1992-10#2)
series of compounds##4##3##(1991-5#1)(1994-8#1)(2008-10#1)(2010-11#1)
series of events##4##3##(1992-8#1)(1997-1#1)(2008-10#1)(2008-8#1)
series of experiments were conducted##2##5##(2008-10#1)(2008-11#1)
series of experiments##13##3##(1992-6#1)(1993-3#1)(1993-8#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
series of field##3##3##(2008-10#1)(2008-12#1)(2011-8#1)
series of greenhouse##2##3##(2008-10#1)(2008-12#1)
series of microarray##2##3##(2010-1#1)(2012-3#1)
series of new##5##3##(1992-9#1)(2008-8#1)(2012-2#1)(2012-3#2)
series of normal##2##3##(1997-3#1)(2006-6#1)
series of papers##3##3##(2008-10#3)
series of patients##3##3##(1993-6#1)(1996-9#1)(2012-2#1)
series of potential##2##3##(2008-10#2)
series of protocols##2##3##(2008-9#2)
series of samples##5##3##(2008-10#5)
series of six##3##3##(2008-10#3)
series of techniques##2##3##(2008-8#1)(2008-9#1)
series of ten##3##3##(1991-5#1)(2008-10#1)(2009-8#1)
series of tests##3##3##(2008-10#3)
series of the##2##3##(2008-10#1)(2011-2#1)
series of##350##2##(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-12#4)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-2#3)(1994-5#6)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-6#2)(1997-8#1)(2006-6#1)(2007-12#2)(2008-10#110)(2008-11#25)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#13)(2008-8#13)(2008-9#14)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#9)(2011-3#1)(2011-4#2)(2011-8#1)(2012-2#8)(2012-3#7)(2012-5#1)(2013-1#5)(2013-8#4)
series on##3##2##(1992-12#1)(2010-9#2)
series performed##2##2##(1996-3#1)(2011-2#1)
series was##6##2##(1990-2#1)(1992-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
series were##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
series with a##2##3##(2008-11#1)(2010-11#1)
series with##6##2##(2008-10#3)(2008-11#1)(2010-11#1)(2013-1#1)
series##522##1##(1990-12#6)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-12#6)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-5#6)(1994-6#1)(1994-8#3)(1995-11#6)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#4)(1997-6#3)(1997-8#2)(2006-6#1)(2007-12#3)(2008-10#146)(2008-11#31)(2008-12#14)(2008-2#5)(2008-3#7)(2008-4#9)(2008-5#13)(2008-6#2)(2008-7#17)(2008-8#20)(2008-9#19)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#3)(2010-1#3)(2010-11#5)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#4)(2011-2#19)(2011-3#1)(2011-4#2)(2011-8#1)(2012-12#5)(2012-2#12)(2012-3#13)(2012-5#1)(2013-1#15)(2013-7#1)(2013-8#5)
series]##2##1##(1993-6#1)(2009-8#1)
serine and##9##2##(1992-10#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)
serine as##2##2##(1994-5#1)(2008-11#1)
serine binding to##2##3##(1994-5#2)
serine binding##3##2##(1994-5#3)
serine isotopomers##2##2##(1997-1#2)
serine protease inhibitors##2##3##(1997-7#1)(2006-6#1)
serine protease##7##2##(1992-6#1)(1994-11#1)(1995-3#1)(1997-7#1)(2006-6#1)(2008-11#2)
serine proteases and their##3##4##(2008-4#3)
serine proteases##10##2##(1995-2#1)(1995-6#1)(2008-4#6)(2008-5#1)(2008-9#1)
serine proteinase##3##2##(1993-3#1)(1995-6#1)(2008-10#1)
serine proteinases##5##2##(1991-5#1)(1993-3#2)(2012-3#2)
serine receptor of##2##3##(1994-5#2)
serine receptor##3##2##(1994-5#3)
serine residues##7##2##(1991-5#1)(1992-6#1)(1993-8#2)(1994-11#1)(2011-2#2)
serine synthesis##2##2##(1992-10#1)(1997-1#1)
serine to##2##2##(1994-5#1)(1997-1#1)
serine##98##1##(1991-5#2)(1992-10#3)(1992-6#2)(1993-12#1)(1993-3#3)(1993-8#4)(1994-11#5)(1994-5#11)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#1)(1997-1#15)(1997-7#1)(1997-8#1)(2006-6#2)(2008-10#11)(2008-11#6)(2008-4#9)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)
serine-143##3##1##(1994-5#3)
serine/threonine kinase##7##2##(1995-2#2)(1996-2#2)(2008-4#1)(2008-9#1)(2009-8#1)
serine/threonine kinases that##2##3##(1995-2#1)(2013-1#1)
serine/threonine kinases##3##2##(1993-3#1)(1995-2#1)(2013-1#1)
serine/threonine phosphatases##3##2##(1994-11#1)(1995-8#1)(2009-9#1)
serine/threonine protein##2##2##(1994-11#1)(1996-2#1)
serine/threonine##18##1##(1993-3#1)(1994-11#3)(1995-2#4)(1995-8#2)(1996-2#3)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2013-1#1)
serious adverse drug reactions##2##4##(2011-2#1)(2013-8#1)
serious adverse event##2##3##(2007-11#1)(2010-12#1)
serious adverse events are##2##4##(2008-10#1)(2008-8#1)
serious adverse events##8##3##(1996-1#1)(2007-11#1)(2008-10#2)(2008-8#4)
serious adverse##15##2##(1996-1#1)(1997-1#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-8#4)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
serious and life-threatening##2##3##(1995-12#1)(2011-2#1)
serious and##9##2##(1992-3#1)(1995-12#1)(2008-10#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
serious bacterial##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
serious cause of##2##3##(2008-11#1)(2009-9#1)
serious complication of##4##3##(1991-11#1)(1991-8#1)(2010-5#2)
serious complication##8##2##(1991-11#1)(1991-8#1)(2010-5#2)(2011-2#1)(2012-3#1)(2013-1#2)
serious complications in##2##3##(1990-2#1)(2013-1#1)
serious complications of##2##3##(2011-3#1)(2012-2#1)
serious complications that##2##3##(1991-3#1)(2009-3#1)
serious complications##13##2##(1990-11#1)(1990-2#1)(1991-3#1)(2008-11#1)(2009-3#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
serious condition with##2##3##(2011-2#1)(2012-12#1)
serious condition##3##2##(2011-2#2)(2012-12#1)
serious consequences##4##2##(2008-1#1)(2008-5#1)(2010-1#1)(2013-1#1)
serious damage##2##2##(2008-10#1)(2008-11#1)
serious disease##12##2##(2008-10#10)(2011-2#1)(2012-2#1)
serious disorder##2##2##(1991-6#1)(2010-1#1)
serious health problems##2##3##(2010-1#1)(2010-7#1)
serious health##6##2##(1991-6#1)(1997-1#1)(2010-1#1)(2010-7#1)(2013-1#2)
serious illness##2##2##(2008-11#1)(2010-8#1)
serious in##2##2##(1993-12#2)
serious infections##6##2##(2008-7#3)(2011-2#2)(2013-1#1)
serious interference was##2##3##(2008-10#2)
serious interference##5##2##(2008-10#5)
serious limitations##2##2##(1995-2#1)(2008-10#1)
serious medical##2##2##(2011-2#1)(2012-3#1)
serious mental illness##3##3##(2009-6#3)
serious mental##5##2##(1991-1#1)(1997-3#1)(2009-6#3)
serious or##2##2##(2008-11#1)(2012-2#1)
serious problem in##5##3##(1995-5#1)(2008-7#1)(2012-3#1)(2013-1#2)
serious problem##14##2##(1991-2#1)(1991-3#1)(1995-5#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
serious risk##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
serious side effects##6##3##(1993-11#1)(1995-5#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
serious##246##1##(1990-11#3)(1990-2#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#3)(1991-6#3)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#59)(2008-11#14)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#7)(2008-8#5)(2008-9#1)(2009-3#2)(2009-6#3)(2009-7#1)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-2#26)(2011-3#1)(2012-12#6)(2012-2#5)(2012-3#8)(2012-6#1)(2013-1#19)(2013-8#5)
seriously by##2##2##(2008-10#1)(2008-4#1)
seriously ill##2##2##(1995-2#1)(2012-12#1)
seriously limits##2##2##(2008-5#1)(2010-10#1)
seriously##28##1##(1991-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-5#1)(2010-1#1)(2010-10#1)(2012-12#1)(2013-1#2)
seriousness##4##1##(1990-3#1)(1991-6#1)(2008-7#1)(2012-3#1)
sero-survey##2##1##(2011-2#2)
seroconversion for##2##2##(1990-9#1)(2009-8#1)
seroconversion##10##1##(1990-3#3)(1990-9#1)(1997-8#1)(2008-11#1)(2009-12#1)(2009-8#2)(2010-3#1)
serodiagnosis of##2##2##(1996-12#2)
serogroup C##2##2##(1997-5#1)(2008-5#1)
serogroup##19##1##(1992-5#1)(1997-5#1)(2008-10#8)(2008-12#3)(2008-5#3)(2011-2#1)(2012-2#2)
serogroups##9##1##(2008-10#4)(2008-5#1)(2012-2#3)(2013-1#1)
serologic reactions##2##2##(2008-5#2)
serologic study##2##2##(1994-5#1)(1996-12#1)
serologic tests for##3##3##(1992-1#1)(1995-5#2)
serologic tests##11##2##(1991-12#1)(1992-1#1)(1995-5#5)(2008-5#1)(2012-3#3)
serologic##31##1##(1990-3#1)(1991-12#1)(1992-1#1)(1994-5#1)(1994-9#2)(1995-5#7)(1996-12#2)(1996-9#1)(1997-8#2)(2008-10#1)(2008-5#4)(2011-2#4)(2012-3#3)(2013-8#1)
serological and##4##2##(1995-12#1)(2008-10#2)(2011-2#1)
serological assays##2##2##(2008-10#2)
serological comparisons and##2##3##(2008-10#2)
serological detection of##3##3##(2008-10#3)
serological methods##2##2##(1995-12#1)(2013-8#1)
serological properties##4##2##(2008-10#4)
serological techniques##2##2##(1996-12#1)(2008-10#1)
serological test##2##2##(1996-12#1)(2011-2#1)
serological tests##5##2##(1991-2#1)(1997-4#1)(2008-10#1)(2011-2#2)
serological##50##1##(1990-3#1)(1991-2#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-12#2)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#30)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#5)(2013-8#1)
serologically distinct from##3##3##(2008-10#3)
serologically distinct##4##2##(2008-10#4)
serologically related to##2##3##(2008-10#2)
serologically related##3##2##(2008-10#3)
serologically##14##1##(1996-12#2)(2006-6#1)(2008-10#9)(2008-5#1)(2012-2#1)
serology was##2##2##(1996-8#1)(2007-12#1)
serology##14##1##(1993-11#1)(1993-9#1)(1996-8#1)(2007-12#1)(2008-10#5)(2008-4#2)(2008-5#1)(2011-2#2)
seronegative individuals##2##2##(2013-8#2)
seronegative##9##1##(1990-2#1)(1990-9#1)(1995-9#2)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
seropositive individuals##3##2##(2013-8#3)
seropositive##21##1##(1990-2#1)(1990-6#1)(1993-8#1)(1995-1#1)(1997-5#1)(2008-11#1)(2008-5#1)(2009-11#2)(2010-12#1)(2010-7#4)(2011-2#2)(2012-3#1)(2013-8#4)
seropositivity was##2##2##(1996-3#2)
seropositivity##13##1##(1991-1#1)(1993-11#2)(1996-11#1)(1996-3#3)(2008-1#1)(2008-5#3)(2013-8#2)
seroprevalence data##3##2##(1994-9#3)
seroprevalence in##3##2##(2011-2#3)
seroprevalence of trypanozoon infection##2##4##(2011-2#2)
seroprevalence of##4##2##(2011-2#4)
seroprevalence were##2##2##(2011-2#2)
seroprevalence##15##1##(1994-9#3)(2011-2#12)
serosa##3##1##(1991-5#1)(2007-12#2)
serotonergic and##2##2##(2008-7#2)
serotonergic innervation##3##2##(2007-12#3)
serotonergic neurons##3##2##(1996-12#1)(2008-6#1)(2008-7#1)
serotonergic signaling##6##2##(2012-3#6)
serotonergic##33##1##(1991-7#2)(1993-1#1)(1993-2#1)(1993-3#3)(1994-2#1)(1996-12#2)(2007-12#3)(2008-5#4)(2008-6#1)(2008-7#5)(2012-12#1)(2012-3#8)(2013-8#1)
serotonin (5-HT)##7##2##(1992-1#1)(1993-3#1)(1994-2#2)(2008-5#1)(2008-6#1)(2008-8#1)
serotonin and##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
serotonin content in the##2##4##(2008-5#1)(2008-6#1)
serotonin neurotransmission##2##2##(2012-3#2)
serotonin receptor##2##2##(1996-12#2)
serotonin reuptake inhibitors (SSRIs)##4##4##(2008-11#1)(2008-6#1)(2012-3#1)(2013-1#1)
serotonin reuptake inhibitors##11##3##(1997-8#3)(2008-11#1)(2008-6#3)(2012-3#3)(2013-1#1)
serotonin reuptake##15##2##(1997-8#3)(2008-11#1)(2008-4#1)(2008-6#4)(2010-2#1)(2012-3#4)(2013-1#1)
serotonin transporter##4##2##(1996-12#2)(2012-3#2)
serotonin##61##1##(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1993-1#2)(1993-2#1)(1993-3#4)(1994-2#2)(1995-12#1)(1996-12#8)(1997-8#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#5)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#11)(2013-1#2)(2013-7#1)
serotype 1##4##2##(1996-12#3)(2008-5#1)
serotype A##2##2##(2008-5#2)
serotype B##2##2##(2008-5#2)
serotype of C##2##3##(2008-5#2)
serotype of infectious bronchitis virus##2##5##(2008-5#2)
serotype of the##2##3##(1994-9#1)(2008-10#1)
serotype of##7##2##(1994-9#1)(2008-10#2)(2008-5#4)
serotype was##2##2##(2008-5#1)(2013-8#1)
serotype##40##1##(1992-5#1)(1994-9#1)(1995-5#1)(1996-12#4)(2007-12#2)(2008-10#7)(2008-5#18)(2009-6#4)(2011-2#1)(2013-8#1)
serotypes 1##4##2##(1996-12#4)
serotypes and##2##2##(1995-5#1)(1996-12#1)
serotypes differed in##2##3##(2008-10#2)
serotypes of##4##2##(2008-10#3)(2013-8#1)
serotypes were##4##2##(1994-9#1)(1996-12#1)(2013-8#2)
serotypes##34##1##(1994-9#1)(1995-5#3)(1996-12#7)(1997-3#4)(2008-10#11)(2008-7#1)(2010-6#1)(2013-8#6)
serotyping of staphylocoagulase##2##3##(2010-6#2)
serotyping##6##1##(2008-5#1)(2010-6#3)(2012-3#2)
serous and##3##2##(2008-7#2)(2011-2#1)
serous carcinomas##3##2##(2012-12#3)
serous detachment associated with latanoprost/timolol fixed combination##2##7##(2013-1#2)
serous##18##1##(1992-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2011-2#1)(2012-12#3)(2013-1#3)(2013-8#1)
serovar##13##1##(1990-5#1)(2008-10#2)(2008-11#2)(2008-5#6)(2012-3#2)
serovars##5##1##(1990-5#1)(1993-9#3)(2011-2#1)
serpentine##3##1##(2008-10#3)
serpin##2##1##(1995-6#1)(2008-4#1)
serpins##3##1##(1995-6#1)(2008-4#2)
serrata##3##1##(2008-9#3)
serrated adenoma##2##2##(2009-12#2)
serrated##8##1##(2009-12#8)
serratus anterior##3##2##(2010-9#3)
serum 25(OH)D##3##2##(2011-1#2)(2011-2#1)
serum BDNF levels##2##3##(2011-2#2)
serum CA-125 level##2##3##(2008-10#1)(2012-3#1)
serum CA-125##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
serum CRP##2##2##(2008-10#1)(2008-7#1)
serum EC-SOD in Group##2##4##(1992-11#2)
serum EC-SOD##3##2##(1992-11#3)
serum HBV DNA levels after##2##5##(2009-8#2)
serum IGF-I##3##2##(2008-9#1)(2012-3#1)(2013-1#1)
serum IgE##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
serum IgG##4##2##(2008-10#2)(2008-11#2)
serum IgM##2##2##(1992-12#1)(2008-10#1)
serum Lp(a)##2##2##(1991-12#2)
serum NSE##3##2##(1990-6#3)
serum PEDF##2##2##(2012-5#2)
serum PSA##2##2##(1990-9#1)(2009-5#1)
serum T during##2##3##(2013-8#2)
serum T levels##2##3##(2013-8#2)
serum T##5##2##(2013-8#5)
serum T4 and T3##2##4##(1990-3#2)
serum TBARS##2##2##(2008-10#2)
serum TSH##2##2##(2008-6#2)
serum adiponectin##4##2##(2011-1#4)
serum albumen##3##2##(2008-10#3)
serum albumin (BSA)##30##3##(1995-12#1)(2008-10#24)(2008-11#3)(2008-3#1)(2008-7#1)
serum albumin and##8##3##(2008-10#6)(2008-11#1)(2008-7#1)
serum albumin as a##2##4##(2008-10#1)(2009-9#1)
serum albumin as the##2##4##(1991-12#1)(2008-10#1)
serum albumin as##5##3##(1991-12#1)(2008-10#2)(2008-11#1)(2009-9#1)
serum albumin conjugate##3##3##(1990-12#1)(2008-11#2)
serum albumin in the olfactory bulb of##2##7##(2008-7#2)
serum albumin in the##3##4##(2008-7#3)
serum albumin in##4##3##(2008-11#1)(2008-7#3)
serum albumin##101##2##(1990-11#2)(1990-12#2)(1990-8#1)(1991-12#1)(1993-2#1)(1993-8#2)(1994-8#1)(1995-11#1)(1995-12#3)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#60)(2008-11#8)(2008-3#2)(2008-5#1)(2008-7#8)(2008-9#1)(2009-9#1)(2011-2#2)(2013-8#1)
serum amylase##2##2##(2010-1#1)(2013-1#1)
serum amyloid A##2##3##(2009-10#1)(2009-8#1)
serum amyloid##3##2##(2009-10#1)(2009-8#1)(2010-12#1)
serum analysis##2##2##(2008-10#1)(2009-9#1)
serum and animal##2##3##(2008-11#2)
serum and pharmaceutical formulations##3##4##(2008-10#3)
serum and pharmaceutical##5##3##(2008-10#5)
serum and plasma##2##3##(1995-2#1)(2010-11#1)
serum and the##4##3##(1997-5#1)(2008-11#1)(2008-7#2)
serum and urine of##2##4##(2008-10#2)
serum and urine samples##4##4##(2008-10#4)
serum and urine##13##3##(1990-2#1)(1991-12#1)(1992-11#1)(2008-10#10)
serum and##67##2##(1990-12#1)(1990-2#1)(1991-12#2)(1991-9#1)(1992-11#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-8#2)(2008-10#34)(2008-11#12)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
serum anti-PRP antibody##2##3##(1995-5#2)
serum antibodies##2##2##(2008-10#2)
serum antibody##6##2##(1991-12#3)(1995-5#2)(2008-10#1)
serum as##2##2##(2008-10#2)
serum aspartate aminotransferase##2##3##(1997-3#1)(2013-8#1)
serum at a##2##3##(2008-10#1)(2008-11#1)
serum at##4##2##(2008-10#3)(2008-11#1)
serum based##2##2##(2008-10#1)(2008-6#1)
serum bile acids##2##3##(1995-9#1)(2013-1#1)
serum bilirubin##2##2##(2011-2#1)(2013-1#1)
serum biochemical##4##2##(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
serum blocking factors##2##3##(1991-12#2)
serum by a##2##3##(2008-10#2)
serum by using##2##3##(2008-10#2)
serum by##16##2##(1991-5#1)(1992-3#1)(1995-12#1)(2008-10#12)(2008-4#1)
serum c-erbB-2 protein##3##3##(1993-1#3)
serum calcium levels##2##3##(1991-8#1)(2008-12#1)
serum calcium##3##2##(1991-8#1)(1996-9#1)(2008-12#1)
serum cholesterol and##2##3##(1991-6#2)
serum cholesterol level##3##3##(1991-6#1)(2008-7#1)(2010-3#1)
serum cholesterol levels##2##3##(1991-6#2)
serum cholesterol was##3##3##(1991-6#2)(2008-10#1)
serum cholesterol##19##2##(1991-6#10)(1993-5#1)(2008-10#1)(2008-3#2)(2008-7#3)(2010-3#1)(2013-8#1)
serum collagenase##2##2##(1994-3#2)
serum components##2##2##(2008-11#2)
serum concentration of##3##3##(1995-3#1)(2008-11#1)(2011-2#1)
serum concentration##8##2##(1995-3#1)(2008-10#1)(2008-11#3)(2008-9#2)(2011-2#1)
serum concentrations of##7##3##(1990-3#1)(1991-8#1)(1992-12#1)(1995-2#1)(1997-5#1)(2008-10#1)(2009-5#1)
serum concentrations##9##2##(1990-3#1)(1991-2#1)(1991-8#1)(1992-12#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-7#1)(2009-5#1)
serum containing medium##6##3##(2008-11#6)
serum containing##10##2##(1993-12#1)(2008-11#9)
serum corticosterone##3##2##(2008-10#3)
serum cortisol##3##2##(2011-2#2)(2013-1#1)
serum could be##2##3##(1994-8#1)(2011-2#1)
serum creatine kinase##2##3##(1990-2#1)(1994-12#1)
serum creatine##3##2##(1990-2#1)(1994-12#1)(2008-3#1)
serum creatinine and##3##3##(1994-12#1)(2008-10#1)(2013-8#1)
serum creatinine##15##2##(1990-12#1)(1994-12#1)(2008-1#3)(2008-10#2)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
serum culture##2##2##(2008-11#2)
serum depletion##2##2##(1992-9#1)(2008-11#1)
serum deprivation##2##2##(2008-11#1)(2008-9#1)
serum ferritin##3##2##(2008-1#1)(2009-8#1)(2012-12#1)
serum for##6##2##(1994-8#1)(1995-5#1)(1996-2#1)(2008-11#3)
serum free media##2##3##(2008-11#2)
serum free medium##4##3##(2008-11#4)
serum free##13##2##(1990-5#1)(1995-12#1)(2008-11#9)(2008-6#1)(2012-3#1)
serum from##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
serum fructosamine##3##2##(1991-12#3)
serum gamma-glutamyl transferase##2##3##(2006-6#2)
serum glucose and##2##3##(2010-2#1)(2012-5#1)
serum homocysteine levels##2##3##(2008-11#2)
serum homocysteine##4##2##(2008-11#3)(2010-1#1)
serum in##9##2##(1991-5#1)(1992-3#1)(1995-8#1)(2008-11#5)(2013-1#1)
serum insulin##2##2##(1994-12#1)(2010-10#1)
serum is described##2##3##(2008-10#2)
serum is##7##2##(2008-10#7)
serum lactate dehydrogenase activity##2##4##(2012-2#2)
serum level of##2##3##(1990-8#1)(2008-9#1)
serum level##7##2##(1990-8#2)(1993-2#1)(2008-12#1)(2008-9#1)(2013-1#1)(2013-7#1)
serum levels of##14##3##(1990-9#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#3)(2012-3#1)
serum levels were##5##3##(1993-3#1)(2008-10#3)(2008-7#1)
serum levels##25##2##(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-3#2)(1994-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#3)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)
serum lipid profiles##2##3##(2008-3#1)(2009-12#1)
serum lipid##6##2##(2008-10#1)(2008-3#2)(2008-9#2)(2009-12#1)
serum lipids and##3##3##(2011-2#1)(2013-1#2)
serum lipids##5##2##(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
serum lipoprotein##2##2##(1992-11#1)(2008-3#1)
serum lipoproteins##3##2##(1990-8#1)(2008-10#1)(2010-12#1)
serum magnesium and hs-CRP##2##4##(2011-2#2)
serum magnesium##6##2##(2011-2#6)
serum markers of##2##3##(2008-3#1)(2011-2#1)
serum markers##4##2##(1991-12#1)(1992-9#1)(2008-3#1)(2011-2#1)
serum matrix##2##2##(2008-10#2)
serum neopterin##4##2##(1990-2#3)(2009-12#1)
serum neutralisation test##2##3##(1991-3#2)
serum neutralisation##4##2##(1991-3#4)
serum nitrate level##2##3##(2009-8#2)
serum nitrate##4##2##(2009-8#4)
serum of patients with##3##4##(1990-6#1)(1992-9#1)(1996-10#1)
serum of patients##5##3##(1990-6#1)(1992-9#1)(1996-10#1)(2013-1#2)
serum of##17##2##(1990-2#1)(1990-6#1)(1992-9#1)(1993-2#1)(1996-10#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#4)
serum on##4##2##(2008-10#1)(2008-11#2)(2013-8#1)
serum or##7##2##(1990-2#2)(1993-11#1)(2008-11#4)
serum p53 Abs were##2##4##(2011-2#2)
serum p53 Abs##5##3##(2011-2#5)
serum p53##6##2##(2011-2#6)
serum phospholipids##3##2##(2008-3#3)
serum protein##5##2##(1991-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
serum removal##2##2##(1995-6#2)
serum sample##6##2##(2008-10#6)
serum samples after##2##3##(2008-10#2)
serum samples by##4##3##(2008-10#4)
serum samples collected from##2##4##(1996-12#1)(2008-10#1)
serum samples collected##4##3##(1996-12#1)(2008-10#2)(2011-2#1)
serum samples could##2##3##(2008-10#2)
serum samples from##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
serum samples of##4##3##(2008-10#1)(2008-5#3)
serum samples was illustrated##2##4##(2008-10#2)
serum samples were determined##2##4##(2008-10#2)
serum samples were spiked with known amount of##2##8##(2008-10#2)
serum samples were##8##3##(2008-10#7)(2011-2#1)
serum samples with##2##3##(1990-2#1)(2008-10#1)
serum samples##67##2##(1990-12#1)(1990-2#1)(1996-12#3)(1997-2#1)(2008-10#52)(2008-5#5)(2011-2#3)(2013-1#1)
serum sickness arteritis in##2##4##(1997-8#2)
serum sickness##3##2##(1997-8#3)
serum specimens##2##2##(1994-3#1)(2008-10#1)
serum starvation of donor cells##2##5##(2008-9#2)
serum starvation of##3##3##(2008-9#3)
serum starvation##4##2##(2008-9#4)
serum stimulation##3##2##(1997-1#3)
serum thyroid##2##2##(1990-3#1)(2008-6#1)
serum thyroxine##3##2##(2008-11#2)(2008-7#1)
serum total##2##2##(1990-8#1)(2013-1#1)
serum triglyceride##8##2##(1991-12#4)(2008-11#1)(2008-3#3)
serum using##5##2##(2008-10#5)
serum vitamin B12 levels were##2##5##(1990-3#2)
serum was##16##2##(1995-12#1)(2008-10#13)(2008-11#2)
serum weaning##2##2##(2008-11#2)
serum were##5##2##(1995-8#1)(2008-10#2)(2008-7#2)
serum with a##2##3##(1992-3#1)(2008-10#1)
serum with##5##2##(1992-3#1)(2008-10#4)
serum zinc level##2##3##(2010-6#2)
serum zinc##4##2##(1990-8#2)(2010-6#2)
serum##990##1##(1990-11#2)(1990-12#8)(1990-2#15)(1990-3#6)(1990-5#1)(1990-6#5)(1990-8#12)(1990-9#4)(1991-11#1)(1991-12#23)(1991-2#2)(1991-3#4)(1991-5#5)(1991-6#12)(1991-8#5)(1991-9#5)(1992-11#9)(1992-12#6)(1992-3#4)(1992-6#2)(1992-9#5)(1993-1#4)(1993-11#2)(1993-12#3)(1993-2#15)(1993-3#4)(1993-5#1)(1993-8#3)(1994-12#5)(1994-3#5)(1994-8#5)(1995-1#1)(1995-11#2)(1995-12#8)(1995-2#6)(1995-3#6)(1995-5#7)(1995-6#2)(1995-8#6)(1995-9#1)(1996-10#1)(1996-12#5)(1996-2#5)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-5#6)(1997-8#5)(2006-6#4)(2008-1#8)(2008-10#333)(2008-11#121)(2008-12#6)(2008-3#16)(2008-4#5)(2008-5#12)(2008-6#7)(2008-7#32)(2008-8#6)(2008-9#14)(2009-10#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#11)(2009-9#3)(2010-1#6)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-6#4)(2010-7#1)(2011-1#11)(2011-2#47)(2012-12#4)(2012-2#5)(2012-3#11)(2012-5#4)(2013-1#26)(2013-7#2)(2013-8#20)
serum)##6##1##(2008-10#4)(2008-11#2)
serum-cholesterol measurements in##2##3##(1990-6#2)
serum-cholesterol##9##1##(1990-6#9)
serum-containing media##3##2##(2008-11#3)
serum-containing medium##7##2##(2008-11#7)
serum-containing##15##1##(2008-11#15)
serum-containingmedium##3##1##(2008-11#3)
serum-fed SMC##2##2##(1994-11#2)
serum-free Vero##2##2##(2008-11#2)
serum-free and##2##2##(2008-11#2)
serum-free cell line McCoy-Plovdiv##3##4##(2008-11#3)
serum-free cell##4##2##(2008-11#4)
serum-free conditions##6##2##(1993-3#1)(2008-11#5)
serum-free culture media##2##3##(2008-11#2)
serum-free culture##8##2##(2008-11#8)
serum-free media in##2##3##(2008-11#2)
serum-free media##18##2##(2008-11#16)(2008-7#2)
serum-free medium (SFM)##2##3##(2008-11#1)(2008-7#1)
serum-free medium and##3##3##(2008-11#3)
serum-free medium was##3##3##(2008-11#3)
serum-free medium##36##2##(1990-11#1)(2008-11#33)(2008-7#1)(2008-9#1)
serum-free process##2##2##(2008-11#2)
serum-free suspension process##2##3##(2008-11#2)
serum-free suspension##9##2##(2008-11#9)
serum-free##114##1##(1990-11#1)(1993-3#1)(1995-11#1)(2008-11#103)(2008-4#1)(2008-7#6)(2008-9#1)
serum-independent##4##1##(2008-11#4)
serum-induced##2##1##(1992-8#1)(1995-2#1)
serum-supplemented medium##6##2##(2008-11#6)
serum-supplemented##10##1##(2008-11#10)
serum/plasma##2##1##(1990-11#1)(1996-3#1)
serum]##2##1##(1997-8#1)(2013-8#1)
serve a variety of functions##2##5##(2008-11#1)(2012-2#1)
serve a##6##2##(1990-11#1)(1990-2#1)(1992-12#1)(1995-3#1)(2008-11#1)(2012-2#1)
serve as a guide##2##4##(1991-12#1)(2011-1#1)
serve as a guideline##2##4##(2008-3#1)(2008-6#1)
serve as a model for##2##5##(1991-9#1)(2008-11#1)
serve as a new##2##4##(2008-10#1)(2008-11#1)
serve as a potential##2##4##(2008-10#1)(2008-11#1)
serve as a reservoir##2##4##(1995-2#1)(1997-5#1)
serve as a source of##2##5##(2008-10#1)(2008-9#1)
serve as a suitable##2##4##(2008-10#1)(2008-5#1)
serve as a surrogate##2##4##(2009-11#1)(2013-8#1)
serve as a useful##3##4##(1995-5#1)(2008-9#1)(2009-11#1)
serve as a valuable##2##4##(1991-6#1)(2008-12#1)
serve as a##67##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-8#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-11#2)(2010-11#1)(2010-12#1)(2010-8#4)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
serve as an alternative to##3##5##(2008-10#1)(2008-8#1)(2012-3#1)
serve as an important##3##4##(2008-11#1)(2011-2#2)
serve as an##15##3##(1991-2#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#2)(2012-3#1)
serve as biomarkers##2##3##(2008-6#1)(2012-2#1)
serve as either##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
serve as good##2##3##(1994-8#1)(2009-5#1)
serve as potential##2##3##(2010-12#1)(2012-3#1)
serve as precursors##2##3##(1992-6#1)(1995-3#1)
serve as targets for##2##4##(1997-7#1)(2011-2#1)
serve as the basis##2##4##(1993-12#1)(2012-3#1)
serve as the##5##3##(1993-12#1)(1995-12#1)(2008-11#1)(2012-3#1)(2013-8#1)
serve as##137##2##(1990-5#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#28)(2008-11#12)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#1)(2010-11#2)(2010-12#2)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#6)
serve both##3##2##(1996-2#1)(1997-6#1)(2008-10#1)
serve in the##2##3##(2008-5#2)
serve in##4##2##(1994-2#1)(2007-12#1)(2008-5#2)
serve the##2##2##(1997-1#1)(2011-2#1)
serve to concentrate##2##3##(1997-7#2)
serve to##19##2##(1991-12#1)(1991-2#1)(1994-12#1)(1994-5#1)(1997-7#2)(2008-1#1)(2008-11#3)(2008-8#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
serve##196##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#2)(1994-12#2)(1994-2#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#14)(2012-12#1)(2012-2#9)(2012-3#7)(2013-1#3)(2013-8#7)
served as a model system for##2##6##(2008-10#1)(2011-1#1)
served as a protective##2##4##(2009-12#1)(2013-1#1)
served as a##15##3##(1993-8#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
served as an##6##3##(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)
served as both##2##3##(2008-10#2)
served as controls##4##3##(1990-5#1)(1991-8#1)(2008-10#1)(2008-7#1)
served as the control group##3##5##(1991-8#1)(1993-1#1)(1994-5#1)
served as the##9##3##(1991-8#1)(1993-1#1)(1994-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)
served as##53##2##(1990-5#1)(1991-8#2)(1993-1#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-1#1)(2010-11#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
served by a##2##3##(1991-2#1)(1997-2#1)
served by the##4##3##(1991-11#1)(1991-6#1)(1993-3#1)(2012-2#1)
served by##10##2##(1991-11#1)(1991-2#1)(1991-6#1)(1993-3#1)(1995-3#1)(1996-3#2)(1997-2#2)(2012-2#1)
served for##2##2##(1993-2#1)(2008-10#1)
served to##7##2##(1992-12#1)(1992-6#1)(1997-3#1)(2008-1#1)(2008-10#3)
served##87##1##(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
server for##2##2##(2008-1#1)(2008-4#1)
server##6##1##(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#1)
serves an important##2##3##(1995-12#1)(2012-2#1)
serves an##3##2##(1995-12#1)(1997-2#1)(2012-2#1)
serves as a bridge##2##4##(2011-2#1)(2012-3#1)
serves as a negative##2##4##(1994-8#1)(2013-1#1)
serves as a##32##3##(1992-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-8#1)(1997-9#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
serves as an##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
serves as the##3##3##(1995-2#1)(2008-3#1)(2008-7#1)
serves as##40##2##(1991-5#1)(1992-10#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-8#1)(1997-9#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
serves for##2##2##(2008-10#2)
serves to reinforce##2##3##(1994-2#1)(2008-12#1)
serves to##14##2##(1990-5#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-6#1)(2013-1#1)
serves##65##1##(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#2)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#2)(2010-6#1)(2010-7#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
service agencies##3##2##(1992-12#1)(1992-3#1)(1995-3#1)
service and the##3##3##(1991-1#1)(1996-11#1)(1997-8#1)
service and##11##2##(1991-1#2)(1995-12#1)(1996-11#1)(1997-3#2)(1997-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
service are##2##2##(1993-3#1)(1995-2#1)
service areas##8##2##(1992-12#2)(1996-3#6)
service as well as##2##4##(1995-2#1)(2008-6#1)
service as##5##2##(1995-12#1)(1995-2#2)(1997-5#1)(2008-6#1)
service delivery system##2##3##(1992-1#1)(2008-6#1)
service delivery systems##2##3##(1994-2#1)(1996-1#1)
service delivery to##2##3##(1996-3#1)(2008-1#1)
service delivery##31##2##(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-3#1)(1994-1#2)(1994-2#2)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#1)(2010-10#1)
service facilities##2##2##(1994-12#1)(1997-8#1)
service firms##3##2##(1992-3#1)(1993-1#2)
service for##5##2##(1990-6#1)(1994-2#1)(1997-8#1)(2008-11#1)(2009-12#1)
service in the##2##3##(1991-2#1)(1996-2#1)
service in##10##2##(1990-3#1)(1991-2#1)(1993-3#1)(1996-2#1)(1997-8#1)(2008-12#1)(2008-3#1)(2013-1#1)(2013-8#2)
service integration##2##2##(1996-12#2)
service is##5##2##(1994-1#2)(1995-2#1)(2008-1#2)
service limitation##3##2##(1993-12#3)
service management##2##2##(1994-1#1)(1997-2#1)
service managers##4##2##(1992-1#3)(1997-2#1)
service members##4##2##(1995-6#3)(1996-5#1)
service needs and##2##3##(1992-3#1)(1994-12#1)
service needs##7##2##(1992-1#1)(1992-3#1)(1994-1#2)(1994-12#1)(2008-1#1)(2013-1#1)
service networks##2##2##(1995-1#1)(1996-3#1)
service of a##2##3##(1994-5#1)(2010-8#1)
service of##9##2##(1991-1#1)(1991-6#1)(1994-5#1)(1996-6#1)(2008-1#1)(2008-11#1)(2010-6#1)(2010-8#1)(2012-12#1)
service organizations manage their funding##2##5##(1991-12#2)
service organizations##11##2##(1991-12#3)(1993-12#2)(1994-12#2)(1995-1#1)(1996-2#1)(1996-3#2)
service patterns were##2##3##(1991-1#1)(2011-2#1)
service provider##4##2##(1995-6#1)(1996-5#1)(2008-11#1)(2011-2#1)
service providers and##3##3##(2008-11#2)(2008-12#1)
service providers in the##2##4##(1995-3#1)(2008-11#1)
service providers##15##2##(1993-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-11#6)(2008-12#1)(2012-2#1)
service provision for##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
service provision##7##2##(1992-1#1)(1996-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2012-2#1)
service quality in##2##3##(1993-12#1)(1995-2#1)
service quality##12##2##(1992-3#1)(1993-1#1)(1993-12#2)(1994-12#1)(1995-2#7)
service redeployment##5##2##(1993-1#3)(1995-1#1)(1995-2#1)
service system##4##2##(1994-1#1)(1995-3#1)(1997-5#1)(2013-8#1)
service systems##3##2##(1994-1#2)(2008-12#1)
service to the##3##3##(1997-2#1)(2008-11#1)(2009-3#1)
service to##7##2##(1994-1#2)(1997-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-3#1)
service use patterns##3##3##(1991-1#1)(2012-3#2)
service use##16##2##(1991-1#5)(1991-3#2)(1992-1#1)(1993-1#1)(1997-2#1)(2011-1#1)(2012-2#1)(2012-3#4)
service user and carer##2##4##(2008-12#1)(2009-6#1)
service user and##3##3##(2008-12#2)(2009-6#1)
service user involvement##3##3##(2008-12#3)
service user##6##2##(2008-12#5)(2009-6#1)
service users and carers##3##4##(2009-6#3)
service users and their carers##2##5##(2008-11#1)(2008-12#1)
service users and##6##3##(2008-11#1)(2008-12#2)(2009-6#3)
service users as##3##3##(2008-12#2)(2012-3#1)
service users in##6##3##(2008-12#5)(2012-3#1)
service users##19##2##(2008-11#1)(2008-12#11)(2009-6#4)(2012-3#3)
service utilization and##2##3##(1994-2#2)
service utilization##3##2##(1994-2#3)
service volume##2##2##(1992-12#1)(1994-12#1)
service was##2##2##(1997-8#1)(2008-11#1)
service workers##2##2##(1993-1#1)(2008-10#1)
service##381##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#11)(1991-12#5)(1991-2#2)(1991-3#9)(1991-6#2)(1991-8#1)(1992-1#11)(1992-12#6)(1992-2#4)(1992-3#7)(1992-8#1)(1993-1#15)(1993-12#11)(1993-2#4)(1993-3#5)(1993-6#1)(1993-8#1)(1994-1#18)(1994-12#9)(1994-2#11)(1994-5#1)(1995-1#10)(1995-12#7)(1995-2#18)(1995-3#6)(1995-6#4)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#15)(1996-5#3)(1996-6#1)(1997-1#3)(1997-2#8)(1997-3#4)(1997-5#2)(1997-8#6)(2007-12#1)(2008-1#8)(2008-10#4)(2008-11#23)(2008-12#27)(2008-2#1)(2008-3#5)(2008-6#3)(2008-7#1)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#6)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#16)(2012-12#1)(2012-2#5)(2012-3#13)(2013-1#8)(2013-8#4)
service'##2##1##(1994-12#1)(2008-11#1)
service-learning##3##1##(2008-1#3)
service-oriented##3##1##(1992-12#1)(1993-1#1)(2010-8#1)
services administration education##4##3##(1993-1#1)(1993-2#1)(1994-2#1)(1997-2#1)
services administration programs must##2##4##(1997-2#2)
services administration programs##3##3##(1996-3#1)(1997-2#2)
services administration##13##2##(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-2#3)(1997-3#1)
services and examine##2##3##(1992-12#1)(1993-12#1)
services and health care##2##4##(1994-1#1)(1995-2#1)
services and health##4##3##(1991-2#1)(1994-1#1)(1995-2#1)(1996-3#1)
services and the##7##3##(1991-2#1)(1992-1#1)(1992-5#1)(1994-1#1)(1996-11#1)(2008-1#1)(2009-6#1)
services and to##2##3##(1991-2#1)(2008-11#1)
services and##48##2##(1991-12#1)(1991-2#3)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#3)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-3#1)(2009-6#2)(2010-8#1)(2012-2#1)
services are discussed##3##3##(1991-2#2)(1997-1#1)
services are##10##2##(1991-1#1)(1991-2#2)(1992-12#1)(1993-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-11#1)(2012-2#1)
services as well as##2##4##(1991-3#1)(1994-1#1)
services as##3##2##(1991-3#1)(1991-9#1)(1994-1#1)
services at##4##2##(1991-2#1)(1992-3#1)(1993-12#1)(2008-11#1)
services available to##2##3##(1995-12#1)(2008-11#1)
services available##3##2##(1995-12#1)(2008-1#1)(2008-11#1)
services by the elderly##2##4##(1995-12#1)(1995-3#1)
services by the##3##3##(1992-2#1)(1995-12#1)(1995-3#1)
services by##11##2##(1992-2#2)(1992-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(2010-9#1)
services can be##2##3##(1995-12#1)(1995-2#1)
services can##3##2##(1995-12#1)(1995-2#1)(2009-6#1)
services delivered##2##2##(1997-2#2)
services during the##2##3##(1993-3#1)(1995-1#1)
services following##2##2##(1994-1#1)(1996-3#1)
services for children and##2##4##(1992-1#1)(1995-2#1)
services for children##3##3##(1992-1#1)(1995-12#1)(1995-2#1)
services for people with##2##4##(1993-1#1)(1996-1#1)
services for the elderly##2##4##(1991-3#1)(1994-1#1)
services for the##11##3##(1991-3#1)(1992-1#1)(1994-1#2)(1997-5#5)(1997-8#1)(2009-6#1)
services for their children with##2##5##(1993-3#1)(1996-1#1)
services for their##3##3##(1993-3#1)(1995-1#1)(1996-1#1)
services for women##2##3##(1997-1#1)(2011-2#1)
services for##41##2##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#5)(1997-7#1)(1997-8#1)(2008-1#1)(2009-6#1)(2011-2#1)(2013-1#1)
services from the##2##3##(1991-6#1)(2011-1#1)
services from##4##2##(1991-6#1)(1994-12#1)(1994-2#1)(2011-1#1)
services has been##2##3##(1996-5#1)(1997-5#1)
services has##5##2##(1991-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-5#1)
services have##4##2##(1992-2#1)(2008-1#1)(2009-6#1)(2011-2#1)
services if##3##2##(1992-2#1)(1995-12#2)
services in a##4##3##(1990-3#1)(1993-12#2)(1995-12#1)
services in an##3##3##(1994-3#1)(1997-3#1)(2008-11#1)
services in the##8##3##(1991-2#1)(1993-1#1)(1994-1#2)(1994-8#1)(1995-12#1)(1996-1#1)(1997-8#1)
services in this##2##3##(1991-2#1)(1993-12#1)
services in##42##2##(1990-11#1)(1990-3#1)(1991-2#4)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-1#3)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-11#2)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
services increased##2##2##(1991-2#1)(1994-1#1)
services into the##2##3##(1991-2#1)(1997-2#1)
services is##8##2##(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-11#1)
services management##7##2##(1992-1#4)(1994-2#1)(1995-12#1)(1996-1#1)
services must be##2##3##(1996-12#1)(2013-8#1)
services of the##2##3##(1994-1#1)(2008-9#1)
services of##6##2##(1994-1#2)(1995-3#1)(2008-9#3)
services offered##2##2##(1993-12#1)(2012-12#1)
services on##2##2##(1993-12#1)(2008-12#1)
services or##2##2##(1994-3#1)(2008-5#1)
services over##3##2##(1995-3#1)(1996-2#1)(1997-1#1)
services program##2##2##(1991-3#1)(1994-2#1)
services provided by##2##3##(1992-2#1)(1996-1#1)
services provided in##3##3##(1994-12#1)(1994-3#2)
services provided to##2##3##(1991-3#1)(1992-2#1)
services provided##11##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1994-12#1)(1994-3#2)(1995-3#1)(1996-1#1)
services received by##3##3##(1992-2#1)(1994-2#1)(1995-12#1)
services research##5##2##(1991-1#1)(1992-3#2)(1993-12#1)(1996-2#1)
services should be##2##3##(1991-6#1)(1995-1#1)
services should not be##2##4##(1995-1#1)(1997-1#1)
services should##5##2##(1991-6#1)(1995-1#2)(1997-1#1)(1997-8#1)
services than##4##2##(1991-1#1)(1993-2#1)(1994-1#1)(1996-3#1)
services that are##2##3##(2008-11#1)(2009-6#1)
services that can##2##3##(1992-1#1)(1996-3#1)
services that##12##2##(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#2)(1994-12#1)(1996-3#1)(2008-11#2)(2009-6#2)
services through##2##2##(1994-2#1)(1996-3#1)
services to Medicare beneficiaries##3##4##(1991-3#2)(1992-2#1)
services to meet the needs of##2##6##(1993-1#1)(1994-1#1)
services to offenders##2##3##(2008-11#1)(2010-6#1)
services to people with##2##4##(1996-3#1)(2011-1#1)
services to the elderly##2##4##(1994-1#2)
services to the##8##3##(1991-1#1)(1994-1#2)(1995-12#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
services to##34##2##(1991-1#1)(1991-3#2)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#4)(1994-3#3)(1995-1#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-11#4)(2008-6#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
services under Medicare##2##3##(1991-2#1)(1991-3#1)
services under##6##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#1)(1997-2#2)
services used by##3##3##(1991-3#1)(1995-12#1)(1997-3#1)
services was##3##2##(1992-2#1)(2013-1#2)
services were identified##2##3##(2008-1#1)(2010-8#1)
services were provided to##2##4##(1995-3#1)(1996-1#1)
services were##13##2##(1992-3#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-6#1)(2008-1#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)
services which##3##2##(1992-2#1)(1996-3#1)(1997-2#1)
services will be##2##3##(1993-3#1)(1995-12#1)
services will##4##2##(1993-3#1)(1995-12#1)(1997-1#1)(2012-2#1)
services with the##2##3##(1994-12#1)(1996-3#1)
services with##7##2##(1993-3#1)(1994-1#3)(1994-12#1)(1996-3#1)(2011-2#1)
services within##2##2##(1996-2#1)(2010-12#1)
services would##2##2##(1995-1#1)(2012-3#1)
services##713##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#18)(1991-10#1)(1991-12#7)(1991-2#30)(1991-3#19)(1991-6#11)(1991-8#1)(1991-9#3)(1992-1#22)(1992-12#9)(1992-2#20)(1992-3#16)(1992-5#2)(1992-8#1)(1993-1#14)(1993-11#3)(1993-12#18)(1993-2#13)(1993-3#16)(1993-6#1)(1994-1#36)(1994-12#13)(1994-2#18)(1994-3#21)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#7)(1995-12#26)(1995-2#13)(1995-3#22)(1995-6#1)(1996-1#22)(1996-11#3)(1996-12#6)(1996-2#20)(1996-3#30)(1996-5#1)(1996-6#3)(1997-1#9)(1997-2#27)(1997-3#10)(1997-4#3)(1997-5#7)(1997-7#2)(1997-8#9)(2008-1#10)(2008-10#2)(2008-11#33)(2008-12#10)(2008-4#1)(2008-5#5)(2008-6#7)(2008-7#2)(2008-9#7)(2009-11#1)(2009-3#3)(2009-5#1)(2009-6#13)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#3)(2010-8#11)(2010-9#1)(2011-1#4)(2011-2#10)(2012-12#8)(2012-2#14)(2012-3#6)(2013-1#7)(2013-8#4)
services? The##2##2##(1994-8#1)(1995-12#1)
services?##3##1##(1994-8#1)(1995-12#1)(2012-2#1)
services]##6##1##(1992-5#1)(1994-6#1)(1996-11#1)(1997-4#1)(1997-5#2)
servicing##3##1##(1991-12#1)(2011-2#2)
serving Medicaid##2##2##(1996-2#1)(1997-6#1)
serving as a##3##3##(2008-10#2)(2008-8#1)
serving as the##6##3##(1991-3#1)(1996-1#1)(2008-10#3)(2011-3#1)
serving as##16##2##(1991-3#1)(1993-12#1)(1996-1#1)(1996-12#1)(2008-10#9)(2008-8#1)(2010-1#1)(2011-3#1)
serving children##2##2##(1994-1#1)(2013-1#1)
serving specific needs that traditional excipients are unable to provide and for which safety studies are necessary to support a novel excipient for marketing applications##2##25##(2012-2#2)
serving##41##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-6#1)(2008-1#2)(2008-10#9)(2008-8#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#2)
servings of##5##2##(1994-2#1)(1997-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
servings##7##1##(1994-2#1)(1997-1#1)(2010-1#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
servlet##2##1##(2008-9#2)
seryl##2##1##(1990-2#1)(2012-2#1)
sesame##3##1##(1991-8#1)(2008-10#1)(2008-11#1)
sesamoid bone##2##2##(2011-2#1)(2012-2#1)
sesamoid##3##1##(2011-2#1)(2012-2#2)
sesquiterpene##8##1##(1991-6#1)(2008-10#2)(2008-11#2)(2008-8#3)
sesquiterpenes##7##1##(2008-10#3)(2008-11#1)(2011-10#2)(2013-8#1)
sessile##4##1##(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)
session &quot##2##2##(2008-10#1)(2009-6#1)
session and##3##2##(2008-11#1)(2008-9#2)
session consisted of##2##3##(2013-1#1)(2013-8#1)
session of##6##2##(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)
session on pediatric nurses' perspectives toward providing spiritual care##2##9##(2011-1#2)
session on##5##2##(1994-2#1)(1995-12#1)(2008-5#1)(2011-1#2)
session was##5##2##(1991-2#1)(1994-1#1)(2010-12#1)(2013-1#2)
session##61##1##(1991-11#1)(1991-12#3)(1991-2#2)(1993-6#3)(1994-1#1)(1994-2#1)(1994-8#3)(1995-12#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-6#1)(2010-1#2)(2010-12#3)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#4)(2012-2#1)(2013-1#7)(2013-8#2)
sessions and##4##2##(1993-6#1)(2008-12#1)(2013-1#1)(2013-8#1)
sessions in the##2##3##(2008-10#1)(2009-9#1)
sessions in##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2009-9#1)
sessions to##2##2##(2008-12#1)(2008-9#1)
sessions was##2##2##(2009-11#1)(2010-12#1)
sessions with##2##2##(1992-1#1)(2008-12#1)
sessions##54##1##(1991-3#1)(1992-1#1)(1993-12#1)(1993-6#2)(1994-2#1)(1996-11#1)(2008-10#6)(2008-11#5)(2008-12#5)(2008-5#1)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#11)(2013-8#4)
sessions)##2##1##(1996-11#1)(2009-9#1)
set (n =##2##3##(2008-10#1)(2013-8#1)
set a##2##2##(2008-11#1)(2012-12#1)
set and its##2##3##(2008-10#2)
set and##11##2##(1990-11#1)(2008-10#9)(2010-4#1)
set are##7##2##(1990-2#1)(2008-10#1)(2008-8#1)(2010-8#4)
set aside for##2##3##(2008-10#1)(2008-12#1)
set aside##3##2##(1995-6#1)(2008-10#1)(2008-12#1)
set at a##3##3##(1992-3#1)(1996-12#1)(2012-2#1)
set at p &lt##2##4##(2011-2#1)(2013-1#1)
set at##18##2##(1991-2#1)(1992-3#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
set by the##2##3##(1996-2#1)(2008-11#1)
set by##8##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
set consisting of##3##3##(2008-10#3)
set containing##3##2##(2008-10#3)
set for the##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
set for##9##2##(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2012-2#1)(2013-1#1)
set forth in the##2##4##(1997-5#1)(2007-12#1)
set forth##6##2##(1993-3#1)(1994-12#1)(1997-5#1)(2007-12#1)(2009-11#1)(2010-9#1)
set from##2##2##(2008-10#1)(2008-5#1)
set goals and##2##3##(1994-12#1)(1997-1#1)
set in##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#1)(2012-12#1)
set is##4##2##(2007-12#1)(2008-10#2)(2008-11#1)
set of 11##2##3##(2008-10#2)
set of 16##2##3##(2008-10#2)
set of 5##2##3##(2009-1#1)(2009-3#1)
set of absorption spectra##2##4##(2008-10#1)(2008-3#1)
set of absorption##3##3##(2008-10#2)(2008-3#1)
set of analytical##3##3##(2008-10#2)(2008-9#1)
set of challenges##2##3##(2008-12#1)(2013-1#1)
set of conditions##3##3##(2008-10#2)(2008-11#1)
set of criteria for##2##4##(2008-10#1)(2008-3#1)
set of criteria##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
set of cultivars##2##3##(2008-10#1)(2012-4#1)
set of data##5##3##(1993-11#1)(2008-10#2)(2008-11#1)(2010-10#1)
set of equations##2##3##(2008-10#1)(2008-7#1)
set of experimental##2##3##(2008-8#1)(2013-8#1)
set of experiments##4##3##(2008-10#1)(2008-8#1)(2009-10#1)(2011-3#1)
set of genes##3##3##(1996-12#1)(2008-5#1)(2012-3#1)
set of glasses##2##3##(2008-10#2)
set of greenhouse isolates##2##4##(2008-10#2)
set of guiding##2##3##(2008-11#2)
set of images was##2##4##(2013-1#2)
set of indicators##3##3##(1996-2#1)(2007-12#1)(2008-11#1)
set of management##2##3##(1996-3#1)(2010-6#1)
set of molecular##3##3##(2008-10#3)
set of parameters##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
set of performance##2##3##(1994-2#1)(1995-12#1)
set of primers##4##3##(1993-12#1)(1995-8#1)(2008-10#1)(2008-5#1)
set of proteins##2##3##(2011-3#2)
set of reagents &quot##2##4##(2013-1#2)
set of recommendations for##2##4##(1993-12#1)(1996-6#1)
set of six##2##3##(2008-3#1)(2008-8#1)
set of size##2##3##(2008-10#2)
set of standards##3##3##(2008-10#3)
set of studies##2##3##(2010-10#1)(2010-12#1)
set of the##5##3##(1995-12#1)(2008-10#3)(2008-6#1)
set of wheat differentials##2##4##(2008-10#2)
set of##302##2##(1991-2#1)(1991-3#1)(1992-2#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-12#4)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#2)(1997-2#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#105)(2008-11#18)(2008-12#5)(2008-2#2)(2008-3#10)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#12)(2008-9#11)(2009-1#1)(2009-10#8)(2009-11#4)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#3)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#7)(2011-3#3)(2012-2#4)(2012-3#7)(2012-4#1)(2013-1#12)(2013-8#8)
set on the##2##3##(2008-10#1)(2008-9#1)
set on##3##2##(2008-10#2)(2008-9#1)
set out in##2##3##(2008-10#1)(2008-11#1)
set out to##7##3##(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#1)(2012-3#1)(2012-5#1)
set out##11##2##(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-10#1)(2009-6#1)(2012-3#1)(2012-5#1)(2013-8#1)
set ranged between##2##3##(2008-10#2)
set samples##2##2##(2008-10#2)
set sequences##2##2##(2008-10#1)(2008-9#1)
set shifting tasks##2##3##(2008-11#2)
set shifting##4##2##(2008-11#4)
set the stage for##4##4##(1997-2#1)(2008-11#1)(2010-4#1)(2011-2#1)
set the##9##2##(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
set to 0##2##3##(2008-10#2)
set to##11##2##(2008-10#4)(2008-2#1)(2008-9#2)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
set up a##3##3##(2008-5#1)(2012-2#2)
set up and##6##3##(1996-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2013-8#1)
set up at##2##3##(2008-1#1)(2008-10#1)
set up based on##2##4##(2008-10#2)
set up for the##2##4##(2008-10#2)
set up in##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
set up##41##2##(1991-3#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#1)(2011-2#1)(2012-2#2)(2013-8#2)
set used##3##2##(2008-10#3)
set was randomly##2##3##(1995-9#1)(2008-10#1)
set was used for##3##4##(1995-9#1)(1996-5#1)(2008-10#1)
set was##14##2##(1995-9#2)(1996-5#1)(2008-10#11)
set were##5##2##(2008-10#3)(2008-12#1)(2013-1#1)
set with##2##2##(2008-10#2)
set##615##1##(1990-11#3)(1990-2#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#5)(1994-2#1)(1994-3#1)(1995-12#4)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#5)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#7)(2008-1#2)(2008-10#258)(2008-11#39)(2008-12#17)(2008-2#3)(2008-3#16)(2008-4#10)(2008-5#7)(2008-6#6)(2008-7#13)(2008-8#14)(2008-9#22)(2009-1#1)(2009-10#10)(2009-11#7)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#6)(2010-10#4)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#2)(2011-2#13)(2011-3#3)(2012-12#3)(2012-2#9)(2012-3#9)(2012-4#1)(2012-5#1)(2013-1#19)(2013-8#13)
set)##2##1##(2008-10#2)
set-up and the##3##3##(2008-10#1)(2008-11#2)
set-up and##4##2##(2008-10#2)(2008-11#2)
set-up has been##2##3##(2008-10#2)
set-up was##2##2##(2008-10#1)(2012-2#1)
set-up##21##1##(1993-9#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
setae on##2##2##(2007-12#1)(2008-5#1)
setae##6##1##(2007-12#5)(2008-5#1)
setosus##5##1##(2008-10#5)
sets and##9##2##(2008-10#4)(2008-12#1)(2008-7#1)(2010-5#1)(2012-2#1)(2012-3#1)
sets are##5##2##(1992-3#1)(2008-10#3)(2008-9#1)
sets could##2##2##(2008-10#2)
sets examined##2##2##(2008-9#1)(2012-3#1)
sets exhibited##2##2##(2008-10#1)(2008-11#1)
sets for##9##2##(1996-2#1)(2008-10#4)(2008-12#1)(2010-7#1)(2010-9#1)(2012-2#1)
sets of PCR##2##3##(1993-12#1)(2008-10#1)
sets of behavioral##2##3##(2008-8#2)
sets of conditions##4##3##(2008-10#3)(2008-4#1)
sets of data##3##3##(2008-10#1)(2008-11#1)(2011-3#1)
sets of genes##2##3##(1995-2#1)(2009-8#1)
sets of models##2##3##(2008-10#2)
sets of primers##4##3##(2008-10#4)
sets of random##2##3##(2008-10#1)(2008-3#1)
sets of samples##2##3##(2008-10#2)
sets of the##2##3##(2008-3#1)(2011-2#1)
sets of##86##2##(1990-5#1)(1991-3#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-8#3)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#30)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#7)(2009-1#2)(2009-10#1)(2009-12#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-5#1)(2011-2#2)(2011-3#1)(2013-8#2)
sets out to review##2##4##(2008-11#1)(2010-11#1)
sets out##4##2##(2008-11#1)(2010-11#1)(2012-12#1)(2013-8#1)
sets per##2##2##(2008-10#1)(2012-3#1)
sets the stage for##2##4##(2008-7#1)(2012-3#1)
sets was##4##2##(2008-10#4)
sets were designed##3##3##(2008-10#3)
sets were##10##2##(2008-10#7)(2008-11#1)(2012-2#1)(2013-1#1)
sets with##4##2##(2008-10#1)(2010-7#1)(2010-9#1)(2012-3#1)
sets##246##1##(1990-5#1)(1991-3#2)(1992-12#1)(1992-3#2)(1993-12#2)(1993-5#1)(1993-8#3)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#111)(2008-11#15)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#11)(2009-1#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#4)(2010-9#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#2)(2013-8#3)
setting and that##2##3##(1993-12#1)(2008-9#1)
setting and##13##2##(1992-1#1)(1993-12#1)(1994-1#2)(1994-12#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2010-10#1)(2013-1#1)
setting are##3##2##(1996-2#1)(2008-11#1)(2010-7#1)
setting by##4##2##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
setting for##6##2##(1991-1#1)(1994-12#2)(2012-2#2)(2013-8#1)
setting has##2##2##(2008-10#1)(2011-2#1)
setting in##3##2##(1993-1#1)(1993-2#1)(2011-2#1)
setting is##4##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
setting must##4##2##(1993-2#1)(1994-3#2)(2012-3#1)
setting of the branch cuts##2##5##(2008-3#2)
setting of the##4##3##(1991-6#2)(2008-3#2)
setting of##31##2##(1991-2#1)(1991-6#2)(1992-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#2)
setting or##2##2##(1995-2#1)(2008-8#1)
setting the##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)
setting to##2##2##(2008-12#1)(2013-1#1)
setting up a##4##3##(1992-1#1)(2008-10#2)(2013-8#1)
setting up and##2##3##(2008-11#1)(2008-4#1)
setting up##12##2##(1990-2#1)(1992-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#1)
setting was##2##2##(2008-10#1)(2011-2#1)
setting with##2##2##(2008-12#1)(2011-2#1)
setting##281##1##(1990-2#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-1#4)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#2)(1992-9#1)(1993-1#2)(1993-12#4)(1993-2#9)(1993-3#1)(1993-9#1)(1994-1#5)(1994-12#6)(1994-2#3)(1994-3#5)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-8#2)(2006-5#2)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#32)(2008-12#12)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#10)(2009-1#2)(2009-10#3)(2009-11#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#17)(2011-7#3)(2012-12#5)(2012-2#12)(2012-3#5)(2013-1#18)(2013-8#5)
settings and##11##2##(1991-1#1)(1994-2#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-10#1)(2010-9#2)(2012-2#1)(2013-8#1)
settings are##4##2##(2008-11#3)(2013-1#1)
settings by##3##2##(1996-12#1)(2008-10#1)(2013-1#1)
settings for the##2##3##(2008-10#1)(2012-2#1)
settings for##4##2##(2008-10#1)(2009-6#1)(2009-7#1)(2012-2#1)
settings in which##3##3##(1991-12#1)(2007-11#1)(2009-6#1)
settings in##8##2##(1991-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2009-6#1)(2012-2#1)
settings is##4##2##(1994-3#1)(2008-11#1)(2008-7#1)(2009-8#1)
settings of##2##2##(2011-2#1)(2012-3#1)
settings such as##2##3##(1996-3#1)(2007-12#1)
settings that##3##2##(2008-1#1)(2010-11#1)(2011-2#1)
settings to##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
settings was##2##2##(1996-12#1)(2008-11#1)
settings will be##2##3##(1997-2#1)(2010-8#1)
settings with one##2##3##(2008-8#1)(2013-1#1)
settings with##5##2##(1993-1#1)(2008-8#2)(2009-6#1)(2013-1#1)
settings without##2##2##(1993-1#1)(2011-2#1)
settings##173##1##(1990-2#1)(1991-1#2)(1991-12#2)(1992-12#3)(1992-2#1)(1993-1#2)(1993-12#2)(1993-5#1)(1994-2#2)(1994-3#3)(1995-11#1)(1996-1#2)(1996-12#4)(1996-3#2)(1996-8#1)(1997-1#3)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#7)(2008-11#31)(2008-12#10)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#4)(2010-9#3)(2011-2#12)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#6)
settle in patches of##2##4##(2008-8#1)(2008-9#1)
settle in##4##2##(2008-8#2)(2008-9#1)(2013-1#1)
settle##11##1##(1990-6#1)(1991-9#1)(1995-6#1)(1996-5#1)(2008-5#1)(2008-8#4)(2008-9#1)(2013-1#1)
settled##4##1##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
settlement and##2##2##(2010-8#2)
settlement of the##2##3##(1990-12#1)(2008-10#1)
settlement of##6##2##(1990-12#2)(2008-10#2)(2008-8#1)(2010-1#1)
settlement##24##1##(1990-12#2)(1995-12#3)(1995-6#2)(1996-5#2)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-8#4)(2011-2#1)(2013-8#1)
settlements##3##1##(1995-6#1)(2008-12#1)(2008-4#1)
settlers##4##1##(2008-11#1)(2008-9#3)
settling particle samples##2##3##(2008-10#2)
settling##9##1##(1995-12#1)(1996-2#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-4#1)
setup and##5##2##(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-4#1)
setup are##3##2##(2008-3#1)(2008-9#1)(2010-12#1)
setup for the##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
setup for##4##2##(2008-10#1)(2009-2#1)(2010-12#1)(2013-8#1)
setup is##4##2##(2008-10#1)(2008-3#2)(2010-12#1)
setup of##2##2##(2010-10#1)(2013-8#1)
setup that##3##2##(2008-2#2)(2008-3#1)
setup##45##1##(1993-12#1)(1993-9#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#10)(2008-4#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-12#6)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
setups##7##1##(1994-2#1)(1997-6#1)(2008-11#2)(2010-11#1)(2011-2#1)(2013-1#1)
sevelamer##2##1##(2012-12#2)
seven (47%)##2##2##(2008-5#2)
seven advisors##2##2##(1995-12#2)
seven barley##2##2##(2008-10#2)
seven cases of##2##3##(1997-5#1)(2008-12#1)
seven cases##7##2##(1990-9#1)(1991-2#1)(1991-6#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-9#1)
seven commercial##2##2##(2008-10#1)(2008-7#1)
seven compounds##3##2##(2008-10#2)(2008-12#1)
seven consecutive measurements##2##3##(2008-10#2)
seven consecutive##4##2##(2008-10#4)
seven cultivars##2##2##(2008-10#2)
seven days after the first##2##5##(1996-9#1)(2008-7#1)
seven days##7##2##(1990-3#1)(1994-5#1)(1996-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
seven different##11##2##(1997-6#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-6#1)
seven distinct##2##2##(2008-10#1)(2008-5#1)
seven elements##2##2##(2008-3#1)(2013-8#1)
seven field trials##3##3##(2008-10#3)
seven field##5##2##(2008-10#5)
seven fragments##2##2##(1997-2#1)(2008-10#1)
seven genes##2##2##(1991-6#1)(1996-6#1)
seven group##2##2##(2008-10#1)(2013-1#1)
seven introns##2##2##(1993-12#1)(1997-4#1)
seven isolates##6##2##(1997-8#1)(2008-10#5)
seven items##2##2##(2012-2#2)
seven locations in##3##3##(2008-10#3)
seven management and planning tools##3##5##(1994-1#1)(1994-2#2)
seven new##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
seven of the 13##2##4##(1991-12#1)(2008-9#1)
seven of the eight##2##4##(1994-9#1)(1997-3#1)
seven of the##6##3##(1991-12#1)(1994-9#1)(1997-3#1)(2008-10#2)(2008-9#1)
seven of them##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
seven of these##3##3##(1990-5#1)(1993-2#1)(2013-8#1)
seven of which##2##3##(1995-9#1)(2008-8#1)
seven of##18##2##(1990-5#1)(1991-12#1)(1991-2#1)(1993-2#1)(1994-9#2)(1995-9#1)(1996-9#1)(1997-3#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
seven orders##2##2##(2008-10#1)(2010-8#1)
seven other##2##2##(2008-10#1)(2008-6#1)
seven out of##3##3##(1996-12#1)(2008-5#1)(2008-8#1)
seven participants##3##2##(2010-10#3)
seven patients who##2##3##(1996-6#1)(2008-1#1)
seven patients with##3##3##(1991-2#1)(1993-3#2)
seven patients##12##2##(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#2)(1996-1#1)(1996-6#2)(2008-1#1)(2011-2#2)(2013-8#1)
seven percent##2##2##(1997-2#1)(2013-1#1)
seven putative##2##2##(1990-5#1)(2008-8#1)
seven replicate##3##2##(2008-10#3)
seven replicates##5##2##(2008-10#5)
seven samples##3##2##(2008-10#3)
seven sampling##2##2##(2008-10#2)
seven species of##2##3##(2008-10#1)(2008-8#1)
seven species##3##2##(2008-10#1)(2008-8#2)
seven squabs##2##2##(2008-5#2)
seven states and##2##3##(2008-10#1)(2013-1#1)
seven strains were##2##3##(2008-10#2)
seven strains##3##2##(2008-10#3)
seven times##3##2##(2008-10#1)(2012-12#1)(2013-8#1)
seven to##3##2##(1995-6#1)(1996-11#1)(2008-8#1)
seven variables##2##2##(2008-10#2)
seven week##2##2##(2008-11#1)(2008-12#1)
seven weeks##2##2##(1997-5#1)(2013-8#1)
seven women##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
seven years of##2##3##(1996-3#1)(2008-9#1)
seven years##6##2##(1995-12#1)(1996-12#1)(1996-3#1)(2008-9#1)(2010-12#1)(2013-1#1)
seven##354##1##(1990-3#1)(1990-5#2)(1990-9#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-6#2)(1991-9#1)(1992-5#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#5)(1995-3#3)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#5)(1996-8#1)(1996-9#3)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-8#1)(2008-1#3)(2008-10#144)(2008-11#10)(2008-12#8)(2008-3#2)(2008-5#14)(2008-6#3)(2008-7#5)(2008-8#13)(2008-9#8)(2009-6#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2010-8#4)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#8)(2012-5#1)(2013-1#9)(2013-8#6)
seven-item##3##1##(2012-2#2)(2013-1#1)
seven-year##4##1##(1996-12#1)(1996-3#1)(2011-3#2)
seventeen##7##1##(1990-8#1)(1991-12#1)(1995-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2012-3#1)
seventeenth-century New Spain##2##3##(2008-11#2)
seventh generation##2##2##(2008-10#2)
seventh##16##1##(1993-8#1)(1994-11#1)(1995-8#1)(2007-12#1)(2008-10#5)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
seventies##2##1##(1993-3#1)(1997-8#1)
seventy six##2##2##(2008-9#1)(2013-8#1)
seventy##5##1##(2008-12#1)(2008-7#1)(2008-9#2)(2013-8#1)
seventy-six##2##1##(2008-10#1)(2008-8#1)
seventy-two##3##1##(1996-8#1)(2008-7#1)(2012-2#1)
several Brassica spp##2##3##(2008-10#2)
several DNA##2##2##(2011-3#2)
several active##2##2##(2008-10#2)
several additional##6##2##(1993-8#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-3#1)
several advantages over conventional##4##4##(2008-10#3)(2011-2#1)
several advantages over the##2##4##(2008-10#2)
several advantages over##7##3##(2008-10#6)(2011-2#1)
several advantages##10##2##(2008-10#7)(2008-7#1)(2011-2#1)(2012-3#1)
several animal##2##2##(1994-5#1)(2008-10#1)
several apple varieties##2##3##(2008-10#2)
several applications of##3##3##(2008-10#3)
several applications##4##2##(2008-10#4)
several approaches to##3##3##(1992-12#1)(2008-4#1)(2008-7#1)
several approaches##5##2##(1992-12#1)(1994-12#1)(2008-4#1)(2008-7#1)(2010-4#1)
several areas of##3##3##(2008-10#1)(2008-6#1)(2011-3#1)
several areas##6##2##(1993-3#1)(2008-10#2)(2008-6#1)(2009-4#1)(2011-3#1)
several aspects of the##2##4##(1996-9#1)(2008-10#1)
several aspects of##6##3##(1996-9#1)(1997-1#1)(2008-10#3)(2008-11#1)
several aspects##8##2##(1996-9#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-5#1)
several authors##4##2##(1993-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
several bands##2##2##(2008-10#1)(2008-12#1)
several barriers##3##2##(1994-1#2)(2011-2#1)
several benefits##2##2##(2008-11#1)(2013-8#1)
several biological##2##2##(2008-10#1)(2008-5#1)
several cancer##3##2##(2008-11#2)(2009-12#1)
several carbohydrates##3##2##(2008-10#3)
several carcinomas##3##2##(2008-12#1)(2009-4#1)(2012-2#1)
several cases##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)
several cell types##2##3##(1992-12#1)(2008-4#1)
several cell##4##2##(1992-12#1)(1992-6#1)(2008-4#1)(2013-8#1)
several cellular##2##2##(1997-3#1)(2008-8#1)
several certified reference materials##4##4##(2008-10#4)
several characteristic##2##2##(1993-11#1)(2013-1#1)
several characteristics that##3##3##(1996-12#1)(2008-8#1)(2012-3#1)
several characteristics##5##2##(1991-11#1)(1996-12#1)(2008-8#1)(2012-12#1)(2012-3#1)
several chemical##2##2##(2008-10#2)
several chronic##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
several clinical##6##2##(1994-12#1)(1996-3#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
several clusters of##3##3##(2008-10#2)(2008-11#1)
several commercial##3##2##(2008-10#2)(2008-5#1)
several common##4##2##(2008-10#3)(2010-10#1)
several complex##2##2##(2011-1#1)(2012-2#1)
several components of##4##3##(2008-10#3)(2012-3#1)
several components##10##2##(2008-10#4)(2008-8#1)(2009-10#1)(2009-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
several compounds##5##2##(1995-8#1)(2008-10#4)
several conditions##2##2##(1994-9#1)(2008-6#1)
several conserved##2##2##(1993-12#1)(2008-10#1)
several countries##3##2##(1993-2#1)(2008-5#1)(2013-1#1)
several criteria##2##2##(1992-12#1)(2012-12#1)
several cultivars##2##2##(2008-10#2)
several cytokines##2##2##(2008-8#1)(2011-2#1)
several days after inoculation##2##4##(2008-10#2)
several days after##3##3##(2008-10#2)(2013-1#1)
several days or##2##3##(1991-3#1)(2013-1#1)
several days##13##2##(1991-3#1)(2007-12#2)(2008-10#7)(2008-7#1)(2013-1#2)
several decades and##2##3##(2008-10#1)(2010-5#1)
several decades##7##2##(1997-8#1)(2008-10#2)(2010-5#1)(2011-2#2)(2012-2#1)
several different locations##2##3##(2008-10#1)(2011-1#1)
several different types of##2##4##(2008-10#2)
several different##35##2##(1991-5#1)(1992-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#4)
several dimensions##2##2##(2010-7#1)(2013-8#1)
several diseases##4##2##(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
several distinct##3##2##(2008-10#3)
several distinctive##2##2##(2011-1#1)(2011-2#1)
several drawbacks##2##2##(2008-5#1)(2012-3#1)
several economic##2##2##(1991-12#1)(2008-11#1)
several elements##4##2##(1992-1#1)(2008-10#3)
several environmental##3##2##(2008-10#3)
several enzymes active against##2##4##(2010-3#2)
several enzymes##4##2##(2008-10#1)(2008-7#1)(2010-3#2)
several examples of##2##3##(2008-10#1)(2008-4#1)
several examples##6##2##(2008-10#2)(2008-11#1)(2008-4#1)(2012-2#1)(2013-8#1)
several experimental parameters##2##3##(2008-10#2)
several experimental##5##2##(2008-10#4)(2008-5#1)
several factors were##2##3##(2008-3#1)(2011-2#1)
several factors##14##2##(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
several features of##3##3##(1994-5#1)(2008-8#1)(2013-8#1)
several features##5##2##(1994-5#1)(2008-8#1)(2010-11#1)(2011-10#1)(2013-8#1)
several fish species##3##3##(2008-10#1)(2010-8#2)
several forms of##3##3##(1997-7#1)(2008-10#1)(2010-12#1)
several fragments##2##2##(2007-12#1)(2008-10#1)
several functional##2##2##(2008-10#1)(2009-5#1)
several functions of##2##3##(1992-3#1)(2008-9#1)
several functions##3##2##(1992-3#1)(2008-9#1)(2011-3#1)
several fungi##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
several gene##2##2##(1992-9#1)(2010-5#1)
several generations##3##2##(2008-10#2)(2008-8#1)
several genes that##3##3##(1993-3#1)(1997-7#1)(2010-4#1)
several genes##6##2##(1993-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
several genetic##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
several groups##7##2##(1992-6#1)(1997-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2011-7#1)
several highly##2##2##(1991-6#1)(1997-8#1)
several host species##3##3##(2008-8#2)(2008-9#1)
several hosts##5##2##(2008-10#5)
several hours##5##2##(1997-6#1)(2007-12#1)(2008-10#3)
several human cancer cell lines##3##5##(2010-6#1)(2011-2#1)(2011-3#1)
several human##10##2##(1990-5#1)(1991-6#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2011-3#1)
several hundred##10##2##(1993-12#1)(1997-6#1)(2008-10#4)(2008-4#1)(2010-7#1)(2013-1#1)(2013-8#1)
several hundreds of##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
several hypotheses##2##2##(2008-9#1)(2009-10#1)
several important##11##2##(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)
several improvements##2##2##(1997-1#1)(2008-4#1)
several in vitro##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
several incidents##2##2##(2008-10#1)(2010-5#1)
several independent##3##2##(2008-10#2)(2008-8#1)
several instrumental##2##2##(2008-10#2)
several intensities##2##2##(2008-10#1)(2008-2#1)
several interfering ions##2##3##(2008-10#2)
several interfering##3##2##(2008-10#3)
several isolates of##2##3##(2008-10#2)
several issues##3##2##(1997-2#1)(2010-5#1)(2010-7#1)
several key##3##2##(1994-2#1)(2008-1#1)(2008-9#1)
several kinds of##3##3##(2008-11#1)(2008-8#1)(2010-6#1)
several laboratories##4##2##(1995-12#1)(1996-2#1)(2008-10#2)
several layers##3##2##(1995-5#1)(2008-5#1)(2011-2#1)
several leading##2##2##(1993-3#1)(2011-2#1)
several levels##3##2##(2008-10#2)(2012-12#1)
several limitations##2##2##(2008-10#1)(2013-1#1)
several lines of evidence indicate that##2##6##(2008-7#2)
several lines of evidence##3##4##(2008-7#2)(2012-3#1)
several lines of##5##3##(2008-10#1)(2008-11#1)(2008-7#2)(2012-3#1)
several locations##2##2##(2008-10#2)
several major##2##2##(2008-10#1)(2010-5#1)
several males##3##2##(2008-8#3)
several mammalian##3##2##(1996-6#1)(2008-10#1)(2008-11#1)
several mechanisms of##2##3##(2008-10#1)(2008-6#1)
several mechanisms that##2##3##(2008-7#1)(2011-2#1)
several mechanisms##11##2##(1990-11#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)
several medical##3##2##(1994-12#1)(2009-1#1)(2013-8#1)
several members of the##2##4##(1997-4#1)(2008-11#1)
several members of##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
several members##4##2##(1997-4#1)(2008-10#2)(2008-11#1)
several metabolic##2##2##(2008-7#1)(2013-8#1)
several metal ions##2##3##(2008-10#1)(2008-8#1)
several methods for##5##3##(1995-9#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
several methods of##3##3##(2008-12#1)(2008-7#2)
several methods##10##2##(1995-9#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
several minutes##6##2##(1997-6#1)(2008-10#2)(2008-8#1)(2010-7#1)(2013-8#1)
several mixtures of##2##3##(2008-10#2)
several mixtures##3##2##(2008-10#3)
several model##2##2##(2008-10#2)
several models of##2##3##(1995-12#1)(2008-7#1)
several models##3##2##(1995-12#1)(2008-2#1)(2008-7#1)
several molecular##2##2##(2008-10#1)(2008-3#1)
several months after##3##3##(1992-2#1)(2008-1#1)(2008-9#1)
several months##12##2##(1991-8#1)(1992-2#1)(1996-12#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-12#3)(2010-6#1)
several mutants##2##2##(1993-8#1)(2008-10#1)
several neuropsychiatric disorders##2##3##(2012-12#1)(2013-8#1)
several neurotransmitters##2##2##(2008-11#1)(2008-7#1)
several new##6##2##(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)
several novel##3##2##(2008-8#1)(2009-12#1)(2013-1#1)
several of the##13##3##(1990-11#1)(1993-8#1)(1995-6#1)(1996-5#2)(2008-10#4)(2008-11#1)(2012-2#2)(2012-3#1)
several of them##2##3##(1991-9#1)(1996-12#1)
several of these mines##2##4##(2008-10#2)
several of these##6##3##(2008-10#4)(2008-11#1)(2008-12#1)
several of which##2##3##(1996-5#1)(2010-5#1)
several of##25##2##(1990-11#1)(1991-9#1)(1993-8#1)(1995-6#1)(1996-12#1)(1996-5#3)(2008-10#8)(2008-11#2)(2008-12#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#1)
several operational parameters##2##3##(2008-10#2)
several operational##3##2##(2008-10#2)(2008-11#1)
several orders of magnitude higher than##2##6##(2008-10#2)
several orders of magnitude##9##4##(1994-5#2)(2007-11#1)(2008-10#4)(2008-11#1)(2010-8#1)
several organs##4##2##(2008-10#2)(2010-10#1)(2010-11#1)
several other##25##2##(1992-11#1)(1993-12#1)(1994-1#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
several pH##2##2##(2008-10#2)
several papers##3##2##(2012-3#1)(2013-1#2)
several parameters of##2##3##(2008-10#1)(2013-1#1)
several parameters such as macroscopic##2##5##(2008-5#2)
several parameters such as##3##4##(2008-10#1)(2008-5#2)
several parameters##7##2##(2008-10#3)(2008-5#2)(2008-7#1)(2013-1#1)
several passages##2##2##(1990-5#1)(2008-10#1)
several pathological##2##2##(2010-10#1)(2010-12#1)
several percent##3##2##(2008-10#2)(2008-3#1)
several physiological processes##2##3##(1995-2#1)(2009-12#1)
several physiological##4##2##(1995-2#1)(2008-12#1)(2009-12#1)(2013-1#1)
several plant##4##2##(2008-10#3)(2008-7#1)
several points##2##2##(1992-6#1)(2010-6#1)
several positive##2##2##(1993-6#1)(2008-8#1)
several possible##3##2##(2008-10#2)(2008-8#1)
several potential##7##2##(1993-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-7#1)
several previously##2##2##(2008-10#1)(2008-3#1)
several problems##2##2##(1994-3#1)(2008-7#1)
several protein bands##2##3##(2008-11#2)
several protein##5##2##(1994-5#1)(2008-10#2)(2008-11#2)
several proteins##2##2##(1991-5#1)(2008-10#1)
several putative##3##2##(1993-2#1)(1997-8#1)(2008-10#1)
several reasons##6##2##(1991-8#1)(1997-3#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-6#1)
several recent studies##3##3##(2008-1#1)(2008-3#1)(2009-10#1)
several recent##4##2##(2008-1#1)(2008-3#1)(2008-8#1)(2009-10#1)
several recombinant##2##2##(1993-6#1)(2008-10#1)
several reference##3##2##(2008-10#2)(2011-2#1)
several regions of the##2##4##(2008-10#1)(2008-4#1)
several regions of##3##3##(2008-10#2)(2008-4#1)
several regions##4##2##(1995-2#1)(2008-10#2)(2008-4#1)
several regulatory##3##2##(1996-12#1)(1997-7#1)(2011-2#1)
several reports##5##2##(1997-8#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
several research groups##3##3##(1991-6#1)(2008-7#1)(2010-10#1)
several research##5##2##(1991-6#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)
several river##2##2##(2008-10#2)
several routes##2##2##(1992-11#1)(2008-11#1)
several samples##4##2##(2008-10#4)
several scales##2##2##(1990-5#1)(2008-10#1)
several seconds##2##2##(2008-10#1)(2012-2#1)
several similar##2##2##(1992-6#1)(2008-10#1)
several simple##2##2##(2008-10#1)(2008-11#1)
several sites##2##2##(2008-8#1)(2008-9#1)
several skin##2##2##(2008-10#1)(2008-5#1)
several small##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
several soil##3##2##(2008-10#3)
several solid##2##2##(2008-10#2)
several sources##2##2##(1990-2#1)(2008-10#1)
several species of##8##3##(1990-3#1)(2008-10#5)(2008-7#1)(2012-3#1)
several species##13##2##(1990-3#1)(1992-10#1)(1992-6#1)(2008-10#7)(2008-7#1)(2009-6#1)(2012-3#1)
several specific##2##2##(1996-3#1)(2008-5#1)
several stages##4##2##(1992-12#1)(1996-2#1)(2010-9#1)(2013-1#1)
several states##2##2##(2008-10#1)(2008-11#1)
several steps##2##2##(1995-2#1)(2008-10#1)
several strains of mice##2##4##(2008-12#1)(2008-4#1)
several strains of##7##3##(2008-10#5)(2008-12#1)(2008-4#1)
several strains##8##2##(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#1)
several structural##2##2##(1993-1#1)(2008-10#1)
several studies have##5##3##(1994-6#1)(2008-12#1)(2010-12#1)(2013-1#2)
several studies##14##2##(1994-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-1#3)
several substances##3##2##(2008-10#2)(2013-1#1)
several successful##3##2##(2008-10#2)(2011-1#1)
several synthetic##8##2##(2008-10#8)
several systems##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
several taxa##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
several techniques##3##2##(1992-12#1)(2008-2#1)(2008-4#1)
several theories##2##2##(2010-6#1)(2013-1#1)
several therapies##2##2##(1993-2#1)(2009-7#1)
several time##4##2##(1995-12#1)(2008-10#2)(2008-7#1)
several times in##2##3##(1992-12#1)(1996-5#1)
several times##14##2##(1990-5#1)(1992-12#1)(1993-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
several tissues##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
several trace##2##2##(2008-10#1)(2008-11#1)
several tumor##2##2##(2009-3#1)(2013-1#1)
several types of##18##3##(1994-3#1)(1995-6#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-7#1)(2013-8#1)
several typical##2##2##(1993-2#1)(2012-3#1)
several unknown##2##2##(2008-10#1)(2008-11#1)
several urine##2##2##(2008-10#2)
several variables##10##2##(1997-3#1)(2008-10#8)(2008-8#1)
several varieties of##2##3##(2008-10#2)
several viral##2##2##(1995-2#1)(2011-2#1)
several weeks##14##2##(1994-3#1)(1996-11#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
several wild##2##2##(1990-5#1)(2008-10#1)
several years of##2##3##(2008-10#1)(2012-3#1)
several years##30##2##(1991-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#3)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#2)
several##1474##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#8)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#6)(1991-6#6)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#4)(1992-3#7)(1992-6#7)(1992-8#1)(1992-9#2)(1993-1#5)(1993-11#3)(1993-12#10)(1993-2#7)(1993-3#7)(1993-6#5)(1993-8#6)(1993-9#1)(1994-1#5)(1994-11#4)(1994-12#7)(1994-2#5)(1994-3#6)(1994-5#8)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#9)(1995-2#10)(1995-3#3)(1995-5#3)(1995-6#6)(1995-8#5)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#8)(1996-2#10)(1996-3#8)(1996-5#9)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#14)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#7)(1997-8#11)(1997-9#1)(2007-11#1)(2007-12#7)(2008-1#7)(2008-10#524)(2008-11#75)(2008-12#18)(2008-2#9)(2008-3#20)(2008-4#25)(2008-5#35)(2008-6#8)(2008-7#38)(2008-8#46)(2008-9#28)(2009-1#2)(2009-10#6)(2009-11#3)(2009-12#13)(2009-3#6)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#6)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#9)(2010-6#13)(2010-7#11)(2010-8#5)(2010-9#3)(2011-1#8)(2011-10#1)(2011-2#60)(2011-3#9)(2011-7#2)(2012-12#8)(2012-2#35)(2012-3#37)(2012-4#1)(2012-5#3)(2013-1#43)(2013-8#16)
severalfold##4##1##(1992-5#1)(1995-2#1)(2008-11#1)(2008-7#1)
severe acute asthma##3##3##(1992-3#1)(1997-1#1)(2008-8#1)
severe acute pancreatitis##2##3##(2009-8#2)
severe acute respiratory syndrome (SARS)##2##5##(2008-10#1)(2010-2#1)
severe acute##9##2##(1990-12#1)(1992-3#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-8#2)(2010-2#1)(2011-2#1)
severe adverse##2##2##(2008-11#1)(2008-9#1)
severe allergic##2##2##(2010-1#1)(2010-6#1)
severe and sometimes##2##3##(1996-11#1)(2008-11#1)
severe and##12##2##(1994-5#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
severe anemia##4##2##(2007-12#1)(2010-11#1)(2012-12#1)(2012-3#1)
severe aortic regurgitation##6##3##(1997-5#1)(1997-8#4)(2008-11#1)
severe aplastic anemia##2##3##(2012-3#2)
severe black##2##2##(2008-10#2)
severe burns##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
severe cases##8##2##(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#3)(2013-8#2)
severe chronic##3##2##(1994-6#1)(1996-1#1)(2010-10#1)
severe clinical##2##2##(1991-3#1)(1992-5#1)
severe combined##2##2##(2008-11#1)(2012-12#1)
severe complications##4##2##(1992-9#1)(2009-12#1)(2010-1#1)(2011-3#1)
severe condition##2##2##(1993-3#1)(2008-10#1)
severe consequences##2##2##(1996-11#1)(2010-11#1)
severe coronary##2##2##(2008-12#1)(2011-2#1)
severe curly top virus##2##4##(2008-10#2)
severe damage##2##2##(2008-10#2)
severe depression##6##2##(2008-10#1)(2008-7#1)(2009-11#1)(2012-3#1)(2013-8#2)
severe disease and##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
severe disease on##2##3##(2008-10#2)
severe disease##16##2##(2006-6#1)(2008-10#7)(2011-2#5)(2013-1#2)(2013-8#1)
severe effects on##2##3##(2008-12#1)(2008-9#1)
severe epidemics##8##2##(2008-10#8)
severe fibrosis (T4-T5)##2##3##(2013-8#2)
severe fibrosis##6##2##(2013-1#2)(2013-8#4)
severe form of##2##3##(2009-7#1)(2011-1#1)
severe functional##2##2##(1991-6#1)(1995-2#1)
severe grades##4##2##(2011-2#2)(2012-2#2)
severe head injury##3##3##(2008-7#1)(2013-8#2)
severe headache##2##2##(2008-7#1)(2012-12#1)
severe hemorrhage##2##2##(1994-2#1)(2012-3#1)
severe homocyst(e)inemia##2##2##(1995-2#2)
severe human##3##2##(2008-4#1)(2008-8#1)(2013-8#1)
severe hydrocephalus##2##2##(2008-12#1)(2011-2#1)
severe hypertension##6##2##(1990-12#1)(1991-6#1)(1993-8#1)(2011-2#2)(2013-8#1)
severe hypotension##2##2##(1990-8#2)
severe hypothermia##4##2##(2011-2#4)
severe hypothyroidism##4##2##(2011-1#4)
severe impairment of##2##3##(1990-9#1)(1996-1#1)
severe impairments##2##2##(1993-3#1)(1997-2#1)
severe in the##2##3##(2008-10#1)(2008-5#1)
severe in##10##2##(1994-5#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
severe infections##2##2##(1994-5#1)(2012-3#1)
severe injury##2##2##(1990-6#1)(2009-6#1)
severe interference##2##2##(2008-10#2)
severe interferences##2##2##(2008-10#2)
severe ischemia##2##2##(1996-12#2)
severe levels of##2##3##(1991-1#1)(2008-10#1)
severe levels##3##2##(1991-1#1)(1994-9#1)(2008-10#1)
severe loss of##3##3##(1995-12#1)(2008-1#1)(2010-12#1)
severe malnutrition##2##2##(2013-1#1)(2013-8#1)
severe neurological##3##2##(1996-11#1)(2008-7#1)(2012-12#1)
severe neutropenia and##2##3##(2008-10#1)(2008-5#1)
severe neutropenia##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
severe pain and##2##3##(2008-12#1)(2010-11#1)
severe pain but##2##3##(2008-7#1)(2013-1#1)
severe pain##6##2##(2008-12#1)(2008-7#2)(2010-11#1)(2012-3#1)(2013-1#1)
severe pelvic endometriosis##3##3##(1991-3#3)
severe periodontitis##5##2##(2008-10#5)
severe plucking##2##2##(1990-9#2)
severe pre-capillary##2##2##(2010-10#2)
severe pruritus##2##2##(1993-3#1)(2010-6#1)
severe pulmonary##3##2##(2008-11#2)(2010-10#1)
severe renal##2##2##(2012-12#1)(2013-1#1)
severe respiratory##4##2##(1994-6#3)(2012-12#1)
severe rigidity and altered sensorium##2##5##(2009-11#2)
severe sepsis (p##2##3##(2009-6#2)
severe sepsis and septic shock##4##5##(2011-2#4)
severe sepsis##17##2##(2008-5#1)(2009-5#1)(2009-6#7)(2009-9#1)(2011-2#7)
severe septic shock##2##3##(1996-3#1)(2013-1#1)
severe strain of##2##3##(2008-10#2)
severe strain##4##2##(2008-10#4)
severe surgical##2##2##(1991-6#1)(2011-2#1)
severe symptoms in##2##3##(2008-10#2)
severe symptoms##6##2##(2008-10#5)(2013-8#1)
severe than##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
severe to profound##2##3##(2008-9#2)
severe toxicity##3##2##(1990-12#1)(2008-12#1)(2008-7#1)
severe##563##1##(1990-11#1)(1990-12#5)(1990-3#3)(1990-6#1)(1990-8#3)(1990-9#6)(1991-1#1)(1991-11#3)(1991-2#3)(1991-3#6)(1991-6#4)(1991-8#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#5)(1993-6#2)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#5)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-5#1)(1996-1#3)(1996-11#4)(1996-12#3)(1996-3#2)(1996-6#2)(1997-1#3)(1997-2#5)(1997-3#4)(1997-5#1)(1997-8#5)(2006-6#2)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#113)(2008-11#21)(2008-12#11)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#23)(2008-8#11)(2008-9#16)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#3)(2009-5#3)(2009-6#8)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#4)(2010-10#6)(2010-11#4)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#4)(2011-1#8)(2011-10#1)(2011-2#48)(2011-3#3)(2012-12#17)(2012-2#6)(2012-3#17)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#30)(2013-8#22)
severed##3##1##(1995-11#1)(2008-9#1)(2011-3#1)
severely affect the##2##3##(2008-10#1)(2008-8#1)
severely affected##7##2##(2008-10#4)(2008-7#1)(2008-8#1)(2011-2#1)
severely damaged by##2##3##(2008-10#2)
severely damaged##8##2##(1997-2#1)(2008-10#5)(2008-11#1)(2010-10#1)
severely depressed##2##2##(2008-10#1)(2008-8#1)
severely disabled##2##2##(1995-1#1)(1997-3#1)
severely diseased##3##2##(2008-10#3)
severely ill##2##2##(1992-3#1)(2008-11#1)
severely impaired##7##2##(1994-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
severely inhibited##4##2##(1991-12#1)(1993-8#1)(1994-8#1)(2009-6#1)
severely limit##2##2##(1997-2#1)(2008-10#1)
severely limited##2##2##(1996-2#1)(2010-8#1)
severely reduced##3##2##(1990-3#1)(2008-7#1)(2009-7#1)
severely##83##1##(1990-11#2)(1990-3#1)(1990-5#2)(1991-12#2)(1992-3#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#2)(1997-3#1)(2008-1#2)(2008-10#28)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
severities of##5##2##(2008-10#1)(2008-7#1)(2008-9#3)
severities##11##1##(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#3)(2012-2#1)
severity (P##2##2##(2008-10#2)
severity (i##3##2##(1997-3#1)(2008-10#2)
severity after##2##2##(2008-10#2)
severity and soil##2##3##(2008-10#2)
severity and yield##2##3##(2008-10#2)
severity and##34##2##(1990-12#1)(1992-2#1)(1995-1#1)(2008-10#24)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#2)
severity as##4##2##(2008-10#4)
severity at##6##2##(2008-10#6)
severity between##3##2##(2008-10#3)
severity by##7##2##(2008-10#7)
severity can be##2##3##(2008-10#1)(2013-8#1)
severity can##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
severity caused by##2##3##(2008-10#2)
severity classes##2##2##(2008-10#2)
severity compared with##4##3##(2008-10#4)
severity data##2##2##(1995-2#1)(2008-10#1)
severity factor##4##2##(2013-8#4)
severity for##5##2##(2008-10#4)(2008-11#1)
severity from a##2##3##(2008-10#1)(2008-2#1)
severity from##3##2##(2008-10#2)(2008-2#1)
severity in the##4##3##(2008-10#3)(2010-11#1)
severity in##24##2##(2008-10#22)(2010-11#1)(2013-8#1)
severity increased##5##2##(2008-10#5)
severity index##2##2##(2008-10#1)(2009-8#1)
severity indicated that##2##3##(2008-10#2)
severity is##2##2##(1990-9#1)(1997-5#1)
severity of Fusarium wilt##4##4##(2008-10#4)
severity of Fusarium##6##3##(2008-10#6)
severity of asthma##2##3##(1997-1#1)(2010-8#1)
severity of atherosclerosis##2##3##(1991-9#2)
severity of disease##6##3##(1994-9#1)(1996-12#1)(2008-10#2)(2008-8#1)(2012-3#1)
severity of fruit russet##2##4##(2008-10#2)
severity of hepatocyte cytoplasmic vacuolization##2##5##(2008-9#2)
severity of illness##7##3##(1993-12#3)(1994-12#2)(1995-2#1)(2012-2#1)
severity of panicle##2##3##(2008-10#2)
severity of symptoms##7##3##(2008-10#5)(2011-2#2)
severity of the disease in##2##5##(1990-9#1)(2008-10#1)
severity of the disease is##2##5##(2010-6#1)(2011-2#1)
severity of the disease##10##4##(1990-9#1)(1991-2#1)(1997-6#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-2#2)(2012-3#1)
severity of the##29##3##(1990-9#1)(1991-2#1)(1993-1#1)(1997-2#2)(1997-6#3)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#6)(2012-3#2)(2013-1#1)
severity of these##3##3##(1991-12#1)(2008-7#1)(2012-7#1)
severity of this##5##3##(2008-10#2)(2010-1#1)(2011-2#1)(2013-1#1)
severity of translation##2##3##(2011-2#2)
severity of##171##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#3)(1993-3#2)(1993-8#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-1#2)(1997-2#2)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#2)(2008-10#58)(2008-11#3)(2008-12#4)(2008-2#1)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#16)(2012-12#3)(2012-2#2)(2012-3#6)(2012-7#1)(2013-1#9)(2013-8#1)
severity on the##4##3##(2008-10#2)(2010-6#1)(2012-2#1)
severity on##13##2##(1995-2#1)(2008-10#10)(2010-6#1)(2012-2#1)
severity or##7##2##(1990-5#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-3#1)
severity ratings##2##2##(1990-5#1)(2008-10#1)
severity score##3##2##(1994-9#1)(2008-10#2)
severity scores for##2##3##(2010-1#2)
severity scores##4##2##(1994-9#1)(2010-1#2)(2010-6#1)
severity showed##2##2##(2008-10#2)
severity significantly##2##2##(2008-10#2)
severity system##2##2##(1994-12#1)(1995-2#1)
severity than did plants##2##4##(2008-10#2)
severity than##4##2##(2008-10#3)(2010-2#1)
severity values##4##2##(2008-10#4)
severity varied##2##2##(2008-10#2)
severity was associated with##2##4##(2008-10#1)(2013-8#1)
severity was estimated##2##3##(2008-10#2)
severity was reduced##3##3##(2008-10#3)
severity was significantly reduced##2##4##(2008-10#2)
severity was significantly##4##3##(2008-10#4)
severity was##30##2##(1996-12#1)(2008-10#27)(2010-6#1)(2013-8#1)
severity were##10##2##(2008-10#10)
severity with##2##2##(2011-2#1)(2013-1#1)
severity##540##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-5#1)(1996-12#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#2)(2008-10#330)(2008-11#8)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#14)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-6#5)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#23)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#10)(2012-7#1)(2013-1#16)(2013-8#13)
severity) were##2##2##(2008-10#2)
severity)##5##1##(2008-10#5)
sevoflurane##4##1##(2010-7#1)(2011-2#2)(2012-3#1)
sevrage de la ventilation mécanique##2##5##(2013-1#2)
sevrage##5##1##(2013-1#5)
sewage and##2##2##(2009-12#1)(2013-8#1)
sewage effluent##2##2##(2008-10#2)
sewage samples##4##2##(2008-10#4)
sewage sludge amended soil##2##4##(2008-10#2)
sewage sludge##12##2##(2008-10#7)(2008-11#1)(2008-12#4)
sewage sludges and##2##3##(2008-11#2)
sewage sludges##4##2##(2008-10#1)(2008-11#3)
sewage treatment##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
sewage##40##1##(1991-7#1)(1994-9#1)(2007-12#1)(2008-10#25)(2008-11#4)(2008-12#6)(2009-12#1)(2013-8#1)
sex allocation##11##2##(2008-8#8)(2008-9#3)
sex and age##4##3##(1991-6#1)(1993-1#1)(1995-12#1)(2012-2#1)
sex and the##2##3##(2008-7#1)(2009-11#1)
sex and##22##2##(1990-2#1)(1991-6#2)(1993-1#1)(1995-12#1)(1997-1#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-11#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
sex biases##2##2##(1997-3#2)
sex change##5##2##(2008-8#1)(2010-5#3)(2010-8#1)
sex chromosome system##4##3##(2008-12#1)(2010-8#3)
sex chromosome##10##2##(2008-12#2)(2010-5#4)(2010-8#3)(2012-3#1)
sex chromosomes##7##2##(2008-12#2)(2008-8#1)(2010-5#3)(2010-8#1)
sex determination##4##2##(2008-8#2)(2010-5#1)(2012-12#1)
sex difference in the##2##4##(2008-9#1)(2010-6#1)
sex difference in##4##3##(1994-2#1)(2008-4#1)(2008-9#1)(2010-6#1)
sex differences and similarities##3##4##(2008-7#2)(2009-7#1)
sex differences and##4##3##(1994-8#1)(2008-7#2)(2009-7#1)
sex differences in depressive symptoms and delinquent behavior##2##8##(2009-7#2)
sex differences in immune##3##4##(2008-8#1)(2008-9#2)
sex differences in##16##3##(2008-11#1)(2008-4#3)(2008-8#4)(2008-9#6)(2009-7#2)
sex differences were##2##3##(1994-2#1)(2008-12#1)
sex differences##25##2##(1994-2#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#3)(2008-8#4)(2008-9#6)(2009-7#3)(2012-3#1)
sex differentiation##3##2##(2010-5#2)(2012-3#1)
sex education##3##2##(1990-9#1)(1991-1#1)(1995-12#1)
sex glands##2##2##(2008-10#2)
sex glandular##2##2##(2008-10#2)
sex hormone-binding globulin##2##3##(1990-2#1)(2008-3#1)
sex hormone-dependent##2##2##(2008-11#2)
sex hormones##6##2##(2008-11#1)(2008-7#3)(2010-6#2)
sex in##3##2##(1997-7#1)(2008-10#1)(2008-12#1)
sex is##2##2##(1997-7#1)(2012-3#1)
sex linkage of##2##3##(2012-3#2)
sex of##3##2##(1991-8#2)(2008-8#1)
sex on the##2##3##(1996-5#1)(2008-7#1)
sex on##3##2##(1996-5#1)(1997-7#1)(2008-7#1)
sex or##2##2##(1994-8#1)(2008-5#1)
sex partners##7##2##(2008-12#3)(2009-5#2)(2013-1#2)
sex pheromone components##3##3##(2008-10#3)
sex pheromone gland##2##3##(2008-10#2)
sex pheromone of##2##3##(2008-10#2)
sex pheromone##14##2##(1990-8#1)(2007-12#2)(2008-10#10)(2013-8#1)
sex pheromones##2##2##(1990-8#1)(2008-10#1)
sex ratio distortion##3##3##(2008-8#3)
sex ratio was##2##3##(2008-7#1)(2010-8#1)
sex ratio##32##2##(1991-11#1)(1997-7#1)(1997-8#1)(2008-7#1)(2008-8#18)(2008-9#6)(2010-8#1)(2011-2#1)(2012-3#2)
sex ratios of##2##3##(1997-7#1)(2010-8#1)
sex ratios##8##2##(1997-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#3)
sex regulatory##2##2##(2007-12#2)
sex related##3##2##(1994-2#1)(2008-7#1)(2012-3#1)
sex steroid##2##2##(1990-11#1)(2008-3#1)
sex steroids##4##2##(1990-11#1)(1990-2#1)(1995-12#1)(2009-6#1)
sex were##5##2##(2007-8#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
sex with##12##2##(1996-5#2)(2009-5#7)(2011-2#1)(2013-1#2)
sex##340##1##(1990-11#2)(1990-2#3)(1990-3#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#5)(1991-8#3)(1992-12#1)(1992-2#1)(1992-7#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-2#4)(1994-6#1)(1994-8#2)(1995-12#4)(1996-3#1)(1996-5#5)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-6#6)(1997-7#8)(1997-8#1)(2007-12#4)(2007-8#1)(2008-10#22)(2008-11#12)(2008-12#14)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#18)(2008-8#48)(2008-9#27)(2009-11#1)(2009-5#11)(2009-6#4)(2009-7#4)(2009-8#1)(2010-4#1)(2010-5#13)(2010-6#3)(2010-7#5)(2010-8#7)(2010-9#1)(2011-2#12)(2012-12#1)(2012-2#3)(2012-3#16)(2013-1#16)(2013-8#9)
sex-##2##1##(2008-10#1)(2008-12#1)
sex-biased##2##1##(1997-3#1)(2012-3#1)
sex-changing fish##2##2##(2010-8#2)
sex-changing##4##1##(2008-8#1)(2010-8#3)
sex-linked##6##1##(1993-9#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
sex-ratio##7##1##(1994-8#4)(2008-8#1)(2012-3#2)
sex-related differences in liver##3##4##(1995-12#3)
sex-related differences##4##2##(1995-12#4)
sex-specific##10##1##(1994-2#1)(2008-11#2)(2010-5#2)(2012-3#3)(2013-8#2)
sex-typed##3##1##(2013-8#3)
sexangularis##3##1##(2008-10#3)
sexes and##4##2##(1991-6#1)(2008-8#2)(2012-3#1)
sexes in##5##2##(1991-6#1)(1997-4#1)(2008-10#1)(2008-8#1)(2012-3#1)
sexes of##4##2##(2007-12#1)(2008-10#1)(2010-8#1)(2013-8#1)
sexes was##2##2##(1995-8#1)(2012-3#1)
sexes were##2##2##(2008-7#1)(2008-8#1)
sexes##57##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-6#5)(1992-12#1)(1993-8#2)(1994-2#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#8)(2008-8#6)(2009-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
sexting behavior##2##2##(2013-1#2)
sexting##21##1##(2013-1#21)
sexual IPV##2##2##(2008-12#2)
sexual abuse and##3##3##(2009-7#1)(2009-9#1)(2010-4#1)
sexual abuse can##2##3##(2009-9#1)(2010-10#1)
sexual abuse in a##2##4##(1992-1#1)(1996-11#1)
sexual abuse in##3##3##(1992-1#1)(1996-11#1)(2009-9#1)
sexual abuse of##4##3##(1995-5#1)(1996-11#2)(2009-9#1)
sexual abuse##35##2##(1992-1#6)(1995-5#2)(1996-1#1)(1996-11#5)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#10)(2010-10#4)(2010-4#4)
sexual activity##13##2##(1997-1#1)(1997-6#1)(2008-7#1)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#7)
sexual aggression##3##2##(2008-10#1)(2009-10#1)(2010-11#1)
sexual and asexual##5##3##(2008-10#5)
sexual and natural selection##3##4##(2012-3#3)
sexual and nonsexual##2##3##(2008-9#2)
sexual and reproductive health##9##4##(2008-11#3)(2012-12#4)(2012-2#1)(2013-8#1)
sexual and reproductive##10##3##(2008-11#3)(2012-12#5)(2012-2#1)(2013-8#1)
sexual and##24##2##(2008-10#5)(2008-11#4)(2008-9#3)(2010-2#1)(2012-12#5)(2012-2#1)(2012-3#4)(2013-8#1)
sexual assault##9##2##(1996-5#1)(2008-10#1)(2008-12#2)(2009-5#2)(2012-3#3)
sexual behavior and##2##3##(2008-4#1)(2013-1#1)
sexual behavior##17##2##(1992-12#3)(1993-8#2)(1994-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#2)(2013-1#4)(2013-8#1)
sexual behaviors##3##2##(2013-1#1)(2013-8#2)
sexual behaviour of male rats##2##5##(2008-11#2)
sexual behaviour of##4##3##(1990-9#1)(1996-11#1)(2008-11#2)
sexual behaviour##7##2##(1990-9#1)(1993-9#2)(1996-11#1)(1996-6#1)(2008-11#2)
sexual changes##4##2##(2008-7#4)
sexual characters##7##2##(1995-2#5)(2012-3#2)
sexual coercion##2##2##(2009-11#1)(2012-2#1)
sexual concerns##3##2##(2008-7#3)
sexual conflict##5##2##(2008-8#4)(2012-3#1)
sexual cross##2##2##(2008-10#2)
sexual cycle of##2##3##(2008-10#1)(2012-2#1)
sexual debut##3##2##(1990-9#2)(2013-8#1)
sexual differentiation of the##2##4##(1990-11#1)(1994-2#1)
sexual differentiation##7##2##(1990-11#1)(1994-2#1)(1997-3#1)(2007-12#2)(2012-3#2)
sexual dimorphism was found in##2##5##(2007-12#1)(2012-3#1)
sexual dimorphism##7##2##(2007-12#1)(2008-8#3)(2012-3#3)
sexual division of leadership in volunteer emergency medical service##2##9##(1996-3#2)
sexual division of leadership in##3##5##(1996-3#3)
sexual experiences##2##2##(2009-12#1)(2009-5#1)
sexual fruiting##2##2##(2008-10#1)(2008-8#1)
sexual function##3##2##(2008-7#1)(2010-8#1)(2013-8#1)
sexual health##10##2##(1990-12#1)(2008-11#2)(2008-12#1)(2009-5#3)(2012-12#2)(2012-2#1)
sexual hormone binding globulin##2##4##(1991-3#2)
sexual identity##3##2##(2008-12#1)(2009-5#2)
sexual intercourse with##2##3##(2008-12#1)(2012-2#1)
sexual intercourse##6##2##(2008-12#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#2)
sexual isolation between##2##3##(2008-9#2)
sexual isolation##4##2##(2008-8#1)(2008-9#3)
sexual maturity##3##2##(2008-8#2)(2010-8#1)
sexual minority##3##2##(2008-12#3)
sexual or parasexual##2##3##(2008-10#2)
sexual or##3##2##(2008-10#3)
sexual orientation and##2##3##(1995-12#1)(1996-5#1)
sexual orientation##5##2##(1995-12#2)(1996-5#1)(2010-8#1)(2012-2#1)
sexual ornaments##2##2##(2008-8#2)
sexual partner##2##2##(1993-9#1)(2012-2#1)
sexual partners##11##2##(1993-9#1)(2008-11#1)(2008-5#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-1#4)
sexual practices##2##2##(1996-5#1)(2012-2#1)
sexual problems##3##2##(1996-11#1)(2008-8#2)
sexual recombination between##2##3##(2008-10#2)
sexual recombination##15##2##(2008-10#15)
sexual reproduction and##2##3##(2008-10#1)(2008-9#1)
sexual reproduction between##2##3##(2008-10#2)
sexual reproduction##27##2##(2008-10#16)(2008-8#2)(2008-9#3)(2009-5#1)(2012-3#5)
sexual risk and##2##3##(2008-12#1)(2013-1#1)
sexual risk behavior##5##3##(2008-12#3)(2013-1#2)
sexual risk behaviors and##2##4##(2008-12#1)(2008-4#1)
sexual risk behaviors in##2##4##(2008-4#1)(2008-8#1)
sexual risk behaviors##10##3##(2008-12#1)(2008-4#5)(2008-8#1)(2010-7#1)(2013-1#2)
sexual risk##21##2##(2008-12#7)(2008-4#5)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#5)
sexual risks##2##2##(2013-1#1)(2013-8#1)
sexual selection and the##3##4##(2008-8#2)(2012-3#1)
sexual selection and##4##3##(2008-8#3)(2012-3#1)
sexual selection are##2##3##(1995-2#1)(2012-3#1)
sexual selection in plants##2##4##(1995-2#2)
sexual selection in##5##3##(1995-2#2)(2008-8#2)(2008-9#1)
sexual selection is##3##3##(1995-2#1)(2008-9#2)
sexual selection on signals of health##3##6##(2008-8#3)
sexual selection on##6##3##(2008-8#6)
sexual selection was##3##3##(2008-8#2)(2012-3#1)
sexual selection##47##2##(1995-2#5)(2008-8#28)(2008-9#7)(2012-3#7)
sexual situations with##2##3##(2008-12#2)
sexual species##3##2##(2008-8#3)
sexual stage##5##2##(2008-10#5)
sexual trait expression##3##3##(2012-3#3)
sexual trait##6##2##(2008-9#1)(2012-3#5)
sexual traits##5##2##(2008-8#1)(2008-9#1)(2012-3#3)
sexual transmission##4##2##(1996-2#1)(2008-9#3)
sexual versus##2##2##(2008-9#1)(2009-5#1)
sexual violence##3##2##(2009-5#3)
sexual##451##1##(1990-11#1)(1990-12#2)(1990-9#3)(1991-3#2)(1991-6#2)(1992-1#6)(1992-12#3)(1992-9#2)(1993-3#1)(1993-8#2)(1993-9#4)(1994-2#3)(1995-12#4)(1995-2#10)(1995-5#3)(1996-1#1)(1996-11#7)(1996-2#1)(1996-3#4)(1996-5#5)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#4)(2008-1#1)(2008-10#64)(2008-11#12)(2008-12#22)(2008-4#6)(2008-5#1)(2008-7#15)(2008-8#61)(2008-9#29)(2009-10#3)(2009-11#3)(2009-12#3)(2009-4#1)(2009-5#21)(2009-6#1)(2009-7#1)(2009-9#10)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#5)(2010-7#1)(2010-8#4)(2010-9#1)(2011-2#7)(2011-3#1)(2012-12#9)(2012-2#12)(2012-3#39)(2013-1#19)(2013-8#15)
sexuality##9##1##(1996-9#1)(1997-7#2)(2009-10#2)(2009-5#3)(2013-1#1)
sexually abused children##2##3##(1995-5#1)(2010-10#1)
sexually abused##6##2##(1990-11#1)(1995-5#2)(1996-11#1)(2009-9#1)(2010-10#1)
sexually active young##2##3##(2008-11#1)(2012-2#1)
sexually active##11##2##(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#6)
sexually antagonistic##2##2##(2008-8#2)
sexually dimorphic##6##2##(1992-3#4)(1993-8#1)(2008-8#1)
sexually selected##5##2##(2008-8#1)(2008-9#2)(2012-3#2)
sexually transmitted disease##2##3##(2008-4#1)(2012-3#1)
sexually transmitted diseases##6##3##(1990-3#1)(1993-9#1)(1996-6#1)(1996-9#1)(1997-6#1)(2009-12#1)
sexually transmitted infections and unwanted pregnancies##2##6##(2008-11#1)(2012-2#1)
sexually transmitted infections##10##3##(2008-11#2)(2008-12#1)(2009-5#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
sexually transmitted##26##2##(1990-3#1)(1993-9#1)(1995-11#1)(1996-6#2)(1996-9#1)(1997-6#1)(2008-11#3)(2008-12#2)(2008-4#1)(2009-12#1)(2009-5#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
sexually##78##1##(1990-11#1)(1990-3#2)(1992-3#4)(1993-8#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-11#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-6#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-4#2)(2008-8#7)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#3)(2009-9#1)(2010-10#1)(2011-2#9)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#1)
sgcD is##3##2##(2008-9#3)
sgcD##8##1##(2008-9#8)
shAIC##4##1##(2012-2#4)
shRNA##4##1##(2013-1#4)
shade and##3##2##(2008-10#1)(2009-8#2)
shade avoidance##2##2##(2009-8#2)
shade##10##1##(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#4)(2013-1#1)
shaded##5##1##(2008-10#2)(2008-9#3)
shadow##8##1##(1991-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)
shadows##7##1##(1991-12#1)(1992-1#1)(1996-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-1#1)
shaft##11##1##(2007-12#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-8#1)(2010-11#2)(2013-1#1)
shake flasks##5##2##(2008-11#2)(2008-12#1)(2011-2#2)
shake##10##1##(1996-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2011-2#2)
shake-flask culture##2##2##(2008-11#1)(2008-7#1)
shake-flask##6##1##(2008-11#2)(2008-12#1)(2008-7#3)
shaken##4##1##(2008-10#3)(2011-2#1)
shaker##3##1##(2008-10#1)(2008-11#2)
shaker-Schott##2##1##(2008-11#2)
shaking time after addition of##2##5##(2008-10#2)
shaking time and##2##3##(2008-10#2)
shaking time##12##2##(2008-10#12)
shaking with##3##2##(2008-10#3)
shaking##23##1##(1996-12#2)(2008-10#19)(2008-7#2)
shall be##2##2##(1991-3#1)(1997-8#1)
shall##6##1##(1991-3#1)(1997-8#1)(2008-10#1)(2009-11#1)(2013-1#2)
shallot##2##1##(2008-10#2)
shallow and##3##2##(1994-1#1)(2008-10#1)(2008-9#1)
shallow##12##1##(1991-2#1)(1994-1#1)(2008-10#5)(2008-9#2)(2013-1#1)(2013-8#2)
sham ECS##2##2##(1996-12#2)
sham and SCLP or CLP##2##5##(2012-3#2)
sham and##4##2##(1995-11#2)(2012-3#2)
sham##25##1##(1993-3#1)(1993-6#1)(1994-2#1)(1995-11#4)(1996-12#2)(2008-12#1)(2011-2#3)(2012-2#2)(2012-3#5)(2013-1#5)
sham-irradiated rings##2##2##(2008-11#2)
sham-irradiated##3##1##(2008-11#3)
sham-operated and lesioned rats##2##4##(1994-8#2)
sham-operated controls##2##2##(1993-6#1)(1997-2#1)
sham-operated##6##1##(1993-6#1)(1994-8#3)(1996-12#1)(1997-2#1)
shame and##2##2##(2008-1#1)(2008-11#1)
shame##3##1##(2008-1#1)(2008-11#2)
shame-proneness##2##1##(2009-11#2)
shampoo and##3##2##(2008-10#2)(2008-5#1)
shampoo containing##2##2##(2008-5#2)
shampoo formulations##3##2##(2008-5#3)
shampoo in##2##2##(2008-5#2)
shampoo products##2##2##(2008-5#2)
shampoo was##2##2##(2008-5#2)
shampoo with##2##2##(2008-5#2)
shampoo##42##1##(1991-2#1)(2008-10#7)(2008-5#33)(2012-3#1)
shampoo)##2##1##(2008-10#1)(2008-5#1)
shampooing##2##1##(2008-10#1)(2011-1#1)
shampoos and##3##2##(2008-10#1)(2008-5#2)
shampoos are##3##2##(2008-5#3)
shampoos using##2##2##(2008-5#2)
shampoos were##3##2##(2008-5#3)
shampoos with##2##2##(2008-10#1)(2008-5#1)
shampoos##33##1##(2008-10#4)(2008-5#29)
shank##3##1##(2008-10#3)
shape after##2##2##(2008-11#2)
shape and a##2##3##(2008-5#1)(2008-7#1)
shape and intensity##2##3##(2008-3#1)(2008-5#1)
shape and location of integrin clusters##2##6##(2010-10#2)
shape and reflection##2##3##(2008-3#2)
shape and size of##2##4##(2010-3#1)(2010-8#1)
shape and size##8##3##(2007-12#1)(2009-5#3)(2010-3#1)(2010-8#2)(2011-2#1)
shape and the##3##3##(2008-3#1)(2008-6#1)(2010-3#1)
shape and##36##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#3)(2009-8#1)(2010-10#2)(2010-3#2)(2010-8#3)(2010-9#1)(2011-2#2)(2012-2#2)
shape are##2##2##(2008-11#1)(2008-9#1)
shape between##2##2##(2011-2#1)(2012-3#1)
shape change##4##2##(2009-5#2)(2009-9#2)
shape classification accuracy was##2##4##(2008-6#2)
shape during the##2##3##(2011-2#1)(2012-2#1)
shape function##3##2##(1995-9#3)
shape invariant model##2##3##(1995-9#2)
shape is##7##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2010-6#1)
shape memory alloy##2##3##(2009-7#2)
shape memory##4##2##(2009-7#4)
shape of the##32##3##(1994-8#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2012-2#1)(2012-3#1)(2013-8#1)
shape of##50##2##(1991-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#15)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2012-2#2)(2012-3#1)(2013-8#1)
shape or##2##2##(2010-8#1)(2011-2#1)
shape parameters##2##2##(2008-10#2)
shape that##3##2##(2008-10#1)(2009-5#1)(2012-2#1)
shape the##9##2##(1991-2#1)(2008-11#1)(2008-12#3)(2008-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
shape to##2##2##(2008-6#1)(2009-10#1)
shape variation##3##2##(2012-3#3)
shape with##4##2##(1994-2#1)(2008-10#1)(2008-6#1)(2009-10#1)
shape##228##1##(1991-2#2)(1992-1#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-5#1)(1995-9#7)(1996-3#2)(1996-5#1)(1997-3#2)(1997-6#1)(2007-11#1)(2007-12#6)(2008-10#33)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#35)(2008-4#3)(2008-5#8)(2008-6#13)(2008-7#6)(2008-8#5)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#2)(2009-5#7)(2009-7#6)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-2#8)(2012-2#8)(2012-3#7)(2013-1#2)(2013-8#2)
shaped and##3##2##(2008-10#2)(2009-5#1)
shaped by##7##2##(2008-10#1)(2008-11#2)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
shaped the##3##2##(1994-1#1)(2008-12#1)(2010-1#1)
shaped##42##1##(1994-1#1)(1997-3#2)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
shapes and sizes##2##3##(2008-10#1)(2009-8#1)
shapes and the##2##3##(2008-4#1)(2008-9#1)
shapes and##12##2##(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)
shapes in##5##2##(2008-10#1)(2008-3#3)(2008-6#1)
shapes of objects##2##3##(2008-2#1)(2009-10#1)
shapes of the fitness gain functions##2##6##(2008-9#2)
shapes of the##3##3##(2008-10#1)(2008-9#2)
shapes of##11##2##(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-6#1)
shapes with##2##2##(2008-6#2)
shapes##61##1##(1991-7#1)(1992-6#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#14)(2008-4#1)(2008-6#6)(2008-7#2)(2008-9#7)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
shaping of##5##2##(2008-11#2)(2008-2#1)(2008-3#2)
shaping the##6##2##(1997-1#1)(2008-8#2)(2009-6#1)(2011-2#1)(2011-3#1)
shaping##29##1##(1994-1#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-8#4)(2009-6#2)(2009-8#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
shards##3##1##(2008-10#3)
share a common##12##3##(1992-7#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-3#1)(2008-8#3)(2008-9#1)
share a high degree of##2##5##(1994-11#1)(2008-10#1)
share a high##3##3##(1994-11#1)(1997-6#1)(2008-10#1)
share a##23##2##(1992-7#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#1)(2010-11#1)(2010-7#1)
share an##2##2##(1995-6#1)(2013-1#1)
share and##2##2##(1993-1#1)(2008-12#1)
share approximately##2##2##(2008-10#2)
share common##7##2##(1994-11#1)(2008-10#2)(2011-2#2)(2012-3#1)(2013-1#1)
share homology with##2##3##(1991-12#1)(1993-9#1)
share identical##2##2##(2009-12#1)(2011-2#1)
share low amino acid identities##2##5##(2008-10#2)
share many features##2##3##(1997-3#2)
share many##6##2##(1997-3#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
share of gross domestic product##2##5##(1991-2#1)(1992-12#1)
share of health##3##3##(1995-3#1)(1997-2#1)(1997-3#1)
share of the Nation's##2##4##(1992-12#1)(1995-3#1)
share of the##6##3##(1992-12#1)(1994-1#1)(1995-3#1)(1997-2#2)(2008-8#1)
share of total##3##3##(1991-2#1)(1996-2#1)(2008-10#1)
share of##22##2##(1991-12#1)(1991-2#2)(1992-12#2)(1992-2#1)(1993-11#1)(1994-1#2)(1995-1#1)(1995-3#3)(1996-2#1)(1997-2#3)(1997-3#1)(2008-10#1)(2008-8#1)(2010-12#1)(2013-1#1)
share our##2##2##(2008-12#2)
share relatively##3##2##(1995-11#1)(2011-2#2)
share responsibility for the##2##4##(1992-3#1)(1992-5#1)
share several##4##2##(1997-3#1)(2009-10#1)(2010-10#1)(2011-2#1)
share significant##3##2##(1993-12#1)(1995-2#1)(2009-8#1)
share similar##3##2##(1995-2#1)(2008-1#1)(2009-9#1)
share the same##6##3##(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
share the##13##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#2)
share their##4##2##(2008-11#3)(2011-2#1)
share with##2##2##(1994-1#1)(2007-12#1)
share##142##1##(1991-12#2)(1991-2#3)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#2)(1997-2#4)(1997-3#4)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#6)(2008-2#1)(2008-3#1)(2008-6#3)(2008-8#10)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#10)(2011-4#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#5)
shared 98##3##2##(2010-4#1)(2010-5#2)
shared a##4##2##(1990-11#1)(1993-8#1)(2008-10#2)
shared among##4##2##(2008-10#3)(2008-8#1)
shared between##2##2##(1997-9#1)(2010-5#1)
shared by all##3##3##(1997-9#1)(2008-10#1)(2013-8#1)
shared by both##2##3##(2007-12#1)(2011-2#1)
shared by##21##2##(1992-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-10#5)(2008-8#3)(2008-9#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
shared components##2##2##(2008-11#1)(2010-5#1)
shared genetic##2##2##(2011-2#1)(2012-3#1)
shared highest nucleotide sequence identity with##3##6##(2008-10#3)
shared highest nucleotide sequence##4##4##(2008-10#4)
shared identical##2##2##(2008-10#2)
shared in##2##2##(2008-10#2)
shared similar##3##2##(2008-10#1)(2008-9#1)(2009-6#1)
shared the##3##2##(2008-10#2)(2013-8#1)
shared with the##4##3##(1993-2#1)(2008-6#2)(2013-1#1)
shared with##5##2##(1993-2#1)(2008-6#2)(2012-3#1)(2013-1#1)
shared##119##1##(1990-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-11#2)(1996-2#1)(1997-2#1)(1997-7#2)(1997-8#1)(1997-9#2)(2007-12#2)(2008-10#29)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#5)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#5)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
shares 92##2##2##(1993-2#1)(2008-10#1)
shares a common##2##3##(1991-6#1)(2008-10#1)
shares a most recent common ancestor with##2##7##(2008-10#2)
shares a##12##2##(1991-6#1)(1995-6#1)(1996-6#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
shares amino acid##2##3##(2008-10#1)(2011-1#1)
shares features with##2##3##(2008-7#1)(2009-8#1)
shares many##2##2##(2008-6#1)(2011-2#1)
shares no##2##2##(1994-12#1)(1997-7#1)
shares sequence##2##2##(1995-2#1)(1997-3#1)
shares some##3##2##(1995-9#1)(1997-7#1)(2013-8#1)
shares the##3##2##(2008-12#1)(2008-8#1)(2008-9#1)
shares with##2##2##(2008-8#1)(2009-9#1)
shares##55##1##(1991-6#1)(1992-2#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-1#4)(1994-12#1)(1995-2#1)(1995-6#3)(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#2)(2008-10#12)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
sharing a##5##2##(2008-10#2)(2008-8#1)(2012-2#2)
sharing in the##2##3##(1992-2#1)(1996-3#1)
sharing in##4##2##(1992-2#1)(1994-3#1)(1996-3#1)(1997-3#1)
sharing of##12##2##(1993-12#1)(1994-12#1)(1996-1#1)(2008-11#3)(2008-12#1)(2008-8#1)(2010-8#2)(2011-2#1)(2013-8#1)
sharing that##2##2##(2008-10#1)(2011-2#1)
sharing the same##3##3##(1990-5#1)(2008-10#1)(2009-6#1)
sharing##61##1##(1990-5#1)(1991-1#1)(1992-2#2)(1993-12#3)(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#3)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-9#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#2)
shark##4##1##(1994-11#3)(2008-11#1)
sharks##4##1##(2010-8#4)
sharp contrast to the##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
sharp contrast##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
sharp decline in##2##3##(2008-7#1)(2009-6#1)
sharp decline##4##2##(1991-3#1)(2008-11#1)(2008-7#1)(2009-6#1)
sharp dissection##2##2##(1993-12#1)(2008-7#1)
sharp edges##4##2##(2007-12#1)(2008-3#3)
sharp increase##2##2##(2008-10#2)
sharp peak##2##2##(2008-10#2)
sharp peaks##2##2##(1995-3#1)(2008-5#1)
sharp##51##1##(1990-3#1)(1991-12#2)(1991-3#2)(1992-1#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)
sharpening##2##1##(2008-10#1)(2008-3#1)
sharper##3##1##(2008-10#2)(2008-3#1)
sharply##19##1##(1992-2#1)(1994-12#1)(1995-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-2#1)
sharpshooter##4##1##(2007-12#2)(2008-10#2)
shattering##3##1##(2009-10#2)(2013-1#1)
shaved##2##1##(2008-5#2)
shaving##9##1##(2008-5#9)
she developed##2##2##(1991-11#1)(2012-3#1)
she experienced##2##2##(2009-12#1)(2010-3#1)
she had a##2##3##(1993-6#1)(2011-2#1)
she had##8##2##(1993-6#1)(1995-11#1)(1995-2#1)(1997-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
she has##3##2##(2012-3#2)(2013-1#1)
she practiced##2##2##(2010-7#1)(2011-2#1)
she presented with##2##3##(2008-1#1)(2013-1#1)
she returned##2##2##(1996-5#1)(2008-4#1)
she underwent##5##2##(1992-12#1)(2009-3#1)(2010-10#1)(2010-6#1)(2013-1#1)
she was diagnosed##2##3##(2010-6#1)(2011-2#1)
she was taken##2##3##(1995-12#1)(1996-12#1)
she was##18##2##(1995-11#1)(1995-12#2)(1996-12#1)(1996-5#1)(2008-12#3)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
she##71##1##(1990-2#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-6#2)(1994-12#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#5)(1997-3#2)(2008-1#1)(2008-12#3)(2008-4#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-6#4)(2010-7#1)(2011-2#8)(2012-2#1)(2012-3#6)(2013-1#8)(2013-8#1)
shear conditions##2##2##(2006-6#2)
shear flow##3##2##(2008-8#1)(2012-2#1)(2013-1#1)
shear flows##2##2##(2013-1#2)
shear force##5##2##(2008-11#2)(2009-11#1)(2010-4#1)(2013-1#1)
shear rate##7##2##(2008-5#1)(2008-9#3)(2009-10#1)(2013-1#2)
shear sensitive insect##2##3##(2008-11#2)
shear stress and##3##3##(2008-11#1)(2010-10#1)(2010-9#1)
shear stress on the##2##4##(1990-8#1)(2008-11#1)
shear stress##22##2##(1990-8#1)(1994-8#1)(2008-11#10)(2009-7#2)(2010-1#4)(2010-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
shear thinning##3##2##(2008-5#3)
shear wave##2##2##(2008-5#1)(2009-5#1)
shear##79##1##(1990-11#1)(1990-8#1)(1994-8#1)(1997-6#1)(2006-6#5)(2008-10#1)(2008-11#23)(2008-3#1)(2008-5#9)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-1#4)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#8)
shear-induced platelet##2##2##(2006-6#2)
shears##2##1##(2008-12#1)(2012-3#1)
sheath and##2##2##(2008-10#1)(2008-5#1)
sheath blight development##2##3##(2008-10#2)
sheath blight##14##2##(2008-10#13)(2008-9#1)
sheath is##3##2##(2007-12#1)(2008-7#1)(2010-5#1)
sheath of the##2##3##(2008-10#1)(2011-2#1)
sheath of##5##2##(2008-10#3)(2009-6#1)(2011-2#1)
sheath##51##1##(1997-8#1)(2007-12#6)(2008-10#29)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-5#3)(2011-2#2)
sheaths in##3##2##(2007-12#2)(2009-6#1)
sheaths##11##1##(2007-12#3)(2008-10#3)(2009-6#1)(2010-3#1)(2011-2#2)(2013-8#1)
shed and##2##2##(1996-3#1)(2009-9#1)
shed from leukocytes##2##3##(1992-12#2)
shed from##3##2##(1992-12#2)(2009-6#1)
shed light on the##7##4##(1994-1#1)(1997-9#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-12#1)(2012-2#1)
shed light on##12##3##(1991-9#1)(1994-1#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2012-2#1)
shed light##14##2##(1991-9#1)(1994-1#1)(1997-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
shed more light on##2##4##(1992-9#1)(2008-8#1)
shed new light on the##3##5##(2008-9#1)(2012-2#2)
shed new light on##4##4##(2008-9#1)(2009-3#1)(2012-2#2)
shed some light##2##3##(2008-11#1)(2011-2#1)
shed##41##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-9#1)(1992-12#3)(1992-9#1)(1994-1#1)(1995-5#1)(1996-3#1)(1997-9#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
shedding and##2##2##(1994-6#1)(2008-5#1)
shedding at intake##2##3##(2013-8#2)
shedding could##2##2##(2008-5#1)(2012-2#1)
shedding of revertant virus##3##4##(1995-5#3)
shedding of##9##2##(1995-5#5)(2008-5#2)(2009-6#1)(2012-9#1)
shedding was##4##2##(1995-5#1)(2008-10#1)(2008-5#1)(2009-6#1)
shedding##37##1##(1994-6#1)(1995-5#7)(1996-12#2)(1997-2#1)(2008-10#1)(2008-5#8)(2009-6#3)(2010-5#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-8#9)
sheds light on the##3##4##(2010-1#1)(2012-2#1)(2013-1#1)
sheds some light on this##2##5##(2008-8#1)(2012-2#1)
sheds##6##1##(1994-12#1)(2008-8#1)(2010-1#1)(2012-2#2)(2013-1#1)
sheep (n =##2##3##(1996-12#1)(1997-1#1)
sheep and goats##4##3##(2008-12#3)(2011-2#1)
sheep and##6##2##(2008-12#3)(2008-8#1)(2011-2#2)
sheep by##2##2##(1991-11#1)(1991-8#1)
sheep erythrocytes##2##2##(2008-10#2)
sheep in##2##2##(1991-8#1)(2008-12#1)
sheep liver mitochondria##2##3##(2008-5#2)
sheep liver##3##2##(2008-5#3)
sheep over a##2##3##(1996-12#1)(2011-2#1)
sheep red blood cells (SRBC)##6##5##(2008-10#4)(2008-4#1)(2008-7#1)
sheep red blood cells##16##4##(1993-12#2)(2008-10#11)(2008-4#1)(2008-7#2)
sheep red blood##17##3##(1993-12#2)(2008-10#12)(2008-4#1)(2008-7#2)
sheep to##3##2##(1991-12#1)(1996-12#2)
sheep was significantly different##2##4##(2008-12#2)
sheep was##3##2##(2008-12#2)(2008-8#1)
sheep with##3##2##(1997-5#2)(2012-12#1)
sheep##88##1##(1990-5#6)(1990-6#1)(1991-11#1)(1991-12#1)(1991-8#2)(1993-12#2)(1996-12#10)(1997-1#1)(1997-3#1)(1997-5#4)(1997-7#1)(2008-10#24)(2008-11#1)(2008-12#7)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#4)(2010-4#3)(2010-6#1)(2011-2#6)(2012-12#2)(2012-2#1)
sheet and##2##2##(1995-6#1)(2008-3#1)
sheet bed##6##2##(2008-11#6)
sheet##26##1##(1991-6#1)(1992-9#1)(1995-6#1)(1997-9#3)(2008-10#4)(2008-11#8)(2008-3#2)(2008-7#2)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
sheets##12##1##(1990-2#2)(1990-5#1)(1995-8#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#3)
shelf life of##2##3##(2008-10#1)(2010-7#1)
shelf life##9##2##(2008-10#5)(2010-7#2)(2011-2#2)
shelf##15##1##(2008-10#5)(2010-7#2)(2010-8#6)(2011-2#2)
shelf-life of##2##2##(2008-5#2)
shelf-life##9##1##(1994-3#1)(2008-10#2)(2008-5#2)(2010-7#1)(2012-2#1)(2013-1#2)
shell and##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
shell gland##2##2##(2008-12#2)
shell with##2##2##(2008-8#1)(2012-2#1)
shell##39##1##(1991-5#1)(1992-11#1)(1992-8#1)(1994-2#1)(1995-2#1)(2008-10#7)(2008-12#3)(2008-7#1)(2008-8#7)(2009-10#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#5)(2013-1#4)
shellac than when applied by##2##5##(2008-10#2)
shellac than when##3##3##(2008-10#3)
shellac##4##1##(2008-10#4)
shellacked fruit##2##2##(2008-10#2)
shellfish##3##1##(2008-10#1)(2008-11#1)(2010-9#1)
shells of##3##2##(2008-11#1)(2008-12#2)
shells##13##1##(1994-3#2)(2008-10#4)(2008-11#1)(2008-12#5)(2009-7#1)
shelter##5##1##(1996-12#1)(2008-10#1)(2009-5#1)(2013-8#2)
sheltered##3##1##(2008-10#3)
shelters##3##1##(1996-3#1)(2008-9#1)(2012-3#1)
sherds##2##1##(2008-10#2)
shh in##2##2##(1993-12#2)
shh##3##1##(1993-12#3)
shibatae##6##1##(2008-9#6)
shield was##2##2##(2009-11#2)
shield##10##1##(2008-10#1)(2008-11#1)(2009-11#7)(2011-2#1)
shielded by##2##2##(2008-10#1)(2008-8#1)
shielded##3##1##(2008-10#1)(2008-3#1)(2008-8#1)
shielding##6##1##(1993-8#1)(2008-3#1)(2009-7#1)(2010-4#1)(2010-7#1)(2013-1#1)
shields##4##1##(2008-10#3)(2009-11#1)
shift analysis##3##2##(1993-8#1)(2008-9#2)
shift and scale##2##3##(1995-9#1)(1996-3#1)
shift and the##3##3##(2007-12#2)(2008-10#1)
shift and##9##2##(1991-2#1)(1995-9#1)(1996-3#1)(2007-12#2)(2008-10#3)(2008-3#1)
shift assay##13##2##(1993-6#1)(1993-8#2)(1995-8#1)(2008-11#4)(2008-4#1)(2008-9#3)(2011-2#1)
shift assays##8##2##(1995-6#2)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
shift assignments of the##2##4##(2009-7#2)
shift assignments of##5##3##(2009-7#5)
shift assignments##10##2##(2009-7#10)
shift away from##2##3##(1993-12#1)(2010-4#1)
shift between##2##2##(2008-11#1)(2008-3#1)
shift by##2##2##(2008-11#1)(2008-9#1)
shift curves##3##2##(2008-10#3)
shift for the##2##3##(2009-5#1)(2010-1#1)
shift from a##4##3##(1993-12#1)(1995-11#1)(2008-10#1)(2008-11#1)
shift from inpatient to outpatient services##2##6##(1992-2#1)(1993-1#1)
shift from the##3##3##(1993-1#1)(2008-11#1)(2009-3#1)
shift from##19##2##(1992-2#1)(1993-1#2)(1993-12#2)(1993-2#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)
shift has##2##2##(2008-7#1)(2008-8#1)
shift in baseline##2##3##(2008-10#2)
shift in our##2##3##(2010-7#1)(2013-1#1)
shift in the##17##3##(1990-5#1)(1991-3#1)(1993-8#1)(1994-11#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2009-2#1)(2011-2#1)
shift in virulence##2##3##(2008-10#2)
shift in##46##2##(1990-5#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#1)
shift is##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
shift occurred##2##2##(2008-7#1)(2008-9#1)
shift of equilibrium between the two fluorescent forms of a synthetic##2##11##(2008-10#2)
shift of pH##2##3##(2008-10#2)
shift of temperature##2##3##(2008-11#2)
shift of the maximum##2##4##(2008-10#2)
shift of the##12##3##(1991-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)
shift of##38##2##(1991-12#1)(1991-5#1)(1994-5#1)(1995-2#1)(2008-10#16)(2008-11#5)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-11#3)(2009-5#3)(2010-1#1)(2011-2#1)
shift reagent##2##2##(1994-3#1)(2008-10#1)
shift the##11##2##(1992-4#1)(1994-2#2)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-8#1)
shift to a##2##3##(2008-11#1)(2008-7#1)
shift to the##3##3##(1994-5#1)(2007-12#1)(2008-5#1)
shift to##14##2##(1994-5#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)
shift toward##4##2##(1993-12#1)(1996-2#1)(2008-10#1)(2011-2#1)
shift was##4##2##(2008-10#2)(2009-5#1)(2010-10#1)
shift work##4##2##(1990-2#1)(2010-7#3)
shift##282##1##(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-11#1)(1992-2#2)(1992-4#1)(1993-1#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#4)(1994-11#1)(1994-2#3)(1994-3#2)(1994-5#6)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#1)(1995-9#2)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#3)(1997-2#2)(1997-7#1)(2007-12#5)(2008-1#1)(2008-10#61)(2008-11#29)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#8)(2008-9#14)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#8)(2009-6#1)(2009-7#10)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#7)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#8)(2013-1#2)(2013-8#2)
shift-multiplexed holographic##3##2##(2008-3#3)
shifted by##3##2##(1990-9#1)(1997-7#1)(2008-10#1)
shifted from##6##2##(1994-3#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
shifted linearly##2##2##(2008-10#2)
shifted over the past##2##4##(1995-12#1)(2011-2#1)
shifted the##5##2##(1993-8#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-2#1)
shifted to##17##2##(1990-12#1)(1991-2#1)(1991-9#1)(1993-8#1)(1994-5#2)(1995-8#2)(2007-11#1)(2008-10#3)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
shifted toward##3##2##(2008-10#2)(2008-9#1)
shifted##63##1##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-3#1)(1993-8#3)(1994-3#2)(1994-5#2)(1995-12#1)(1995-5#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#2)(2008-9#3)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-8#2)
shifter##4##1##(2008-10#1)(2008-3#3)
shifting of the##3##3##(1994-11#1)(2007-11#1)(2008-10#1)
shifting the##12##2##(1992-3#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-6#1)(2011-2#1)
shifting to##3##2##(1992-2#1)(1993-6#1)(2008-8#1)
shifting##38##1##(1992-2#2)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-6#1)(1997-3#1)(2007-11#1)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#5)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
shifts and##6##2##(1992-4#1)(1993-2#1)(1995-3#1)(2010-1#1)(2010-7#1)(2010-8#1)
shifts as##2##2##(2008-11#1)(2012-2#1)
shifts between##2##2##(1991-5#1)(1992-2#1)
shifts for##2##2##(1994-5#1)(2010-7#1)
shifts from##4##2##(2008-12#1)(2008-9#2)(2012-2#1)
shifts in reimbursement##2##3##(1992-1#1)(1995-3#1)
shifts in the##4##3##(2008-10#1)(2008-2#1)(2011-2#1)(2012-6#1)
shifts in their##2##3##(1997-7#1)(2009-10#1)
shifts in women's##2##3##(2008-11#2)
shifts in##23##2##(1992-1#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-6#2)
shifts is##3##2##(1992-2#1)(2008-11#1)(2008-3#1)
shifts observed for##2##3##(1993-8#2)
shifts of the##6##3##(1994-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
shifts of these##2##3##(2008-10#1)(2008-9#1)
shifts of##13##2##(1994-2#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)
shifts that##2##2##(1994-8#1)(2007-12#1)
shifts the##5##2##(1995-6#1)(2008-10#2)(2008-8#2)
shifts to more##2##3##(2008-10#2)
shifts to##8##2##(1992-12#1)(2008-10#6)(2010-12#1)
shifts were##6##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-6#2)
shifts##121##1##(1991-5#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-2#3)(1994-5#2)(1994-8#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-12#3)(2008-10#27)(2008-11#16)(2008-12#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#2)(2010-1#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2012-6#2)(2013-8#1)
shiga toxin##7##2##(2008-8#6)(2013-1#1)
shiitake##5##1##(2008-10#5)
shikimic and quinic##2##3##(2008-10#2)
shikimic##3##1##(2008-10#3)
shimming by##2##2##(2012-3#2)
shimming##7##1##(2012-3#7)
ship##3##1##(1991-12#1)(2008-10#1)(2008-3#1)
shipboard##3##1##(2008-10#3)
shipping##2##1##(1993-6#1)(2008-11#1)
ships and##2##2##(2008-11#2)
ships##7##1##(2008-10#1)(2008-11#6)
shipyard##3##1##(1991-12#1)(2008-10#1)(2011-2#1)
shipyards##2##1##(2008-10#1)(2008-11#1)
shivering##11##1##(2010-7#11)
shoal##2##1##(2010-8#2)
shock absorption##2##2##(2011-2#1)(2013-1#1)
shock and##7##2##(1996-3#1)(1997-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
shock element##3##2##(1993-8#2)(1994-8#1)
shock in##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
shock protein (HSP)##2##3##(1993-8#1)(2008-7#1)
shock protein##22##2##(1990-11#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-6#2)(1996-12#4)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
shock proteins##3##2##(1990-11#1)(1997-4#1)(2008-7#1)
shock syndrome##4##2##(1993-3#2)(2011-2#2)
shock wave lithotripsy##5##3##(1990-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
shock wave##8##2##(1990-11#1)(1997-6#2)(2008-10#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
shock with##3##2##(1991-8#1)(2008-8#1)(2013-1#1)
shock##137##1##(1990-11#3)(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-3#3)(1993-8#6)(1994-5#3)(1994-8#6)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#6)(1996-2#3)(1996-3#5)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#5)(2006-5#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#22)(2012-12#1)(2012-3#4)(2013-1#8)(2013-8#3)
shock-probe##7##1##(1993-3#5)(1994-2#2)
shock-wave##2##1##(2007-12#1)(2008-10#1)
shocked##5##1##(1995-12#3)(2008-6#2)
shocking##2##1##(2008-2#1)(2010-8#1)
shocks##7##1##(1994-3#1)(1997-1#1)(2011-1#1)(2011-2#4)
shockwave lithotripsy##4##2##(2013-1#4)
shockwave##5##1##(1997-6#1)(2013-1#4)
shoe##4##1##(1990-6#1)(1997-4#2)(2013-1#1)
shoe-surface##5##1##(2013-1#5)
shoes and##2##2##(1990-6#1)(2010-11#1)
shoes##4##1##(1990-6#1)(2008-10#1)(2010-11#1)(2013-1#1)
shoot and root stem##2##4##(2009-8#2)
shoot and root##5##3##(2008-10#1)(2009-8#4)
shoot and##6##2##(2008-10#2)(2009-8#4)
shoot apical meristem (SAM)##2##4##(2009-8#2)
shoot apical meristem##3##3##(2009-8#3)
shoot blight##8##2##(2008-10#8)
shoot buds##3##2##(2013-1#3)
shoot competition##3##2##(2008-9#3)
shoot dieback##2##2##(2008-10#2)
shoot growth or##2##3##(2008-10#1)(2008-11#1)
shoot growth##3##2##(2008-10#2)(2008-11#1)
shoot tip and##2##3##(2008-10#1)(2008-12#1)
shoot tip meristems##2##3##(2008-8#1)(2008-9#1)
shoot tip##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
shoot tips##5##2##(2008-10#1)(2008-8#4)
shoot##76##1##(2008-10#40)(2008-11#1)(2008-12#3)(2008-8#8)(2008-9#8)(2009-8#9)(2012-3#1)(2013-1#6)
shoot)##2##1##(2008-10#2)
shoot/root ratio##2##2##(2008-10#1)(2008-12#1)
shooting##6##1##(1991-3#1)(1995-11#2)(2008-12#2)(2011-2#1)
shoots and roots##3##3##(2008-10#2)(2008-12#1)
shoots and##8##2##(2008-10#5)(2008-12#1)(2009-8#2)
shoots are##2##2##(2008-10#1)(2008-12#1)
shoots as##3##2##(2008-10#2)(2008-9#1)
shoots by##3##2##(2008-10#3)
shoots contained##2##2##(2008-10#2)
shoots for##3##2##(2008-10#3)
shoots in the##2##3##(2008-10#1)(2008-12#1)
shoots increased##2##2##(2008-10#1)(2008-12#1)
shoots was##6##2##(2008-10#3)(2008-11#1)(2009-8#1)(2012-8#1)
shoots were##4##2##(2008-10#3)(2008-12#1)
shoots##68##1##(2008-10#49)(2008-11#1)(2008-12#10)(2008-9#1)(2009-10#1)(2009-8#3)(2012-8#1)(2013-1#2)
shoots)##4##1##(2008-10#1)(2011-2#1)(2013-1#2)
shop##2##1##(1992-3#1)(1994-1#1)
shopper##2##1##(1994-1#1)(1996-5#1)
shopping##5##1##(1994-9#1)(1996-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
shore flies##2##2##(2008-10#2)
shore##3##1##(1994-11#1)(2008-10#2)
shoreline##2##1##(2008-10#2)
shores##2##1##(2008-10#1)(2010-1#1)
short (6##2##2##(2008-10#1)(2008-7#1)
short (approximately##2##2##(2008-3#1)(2009-8#1)
short CDSs##4##2##(1996-12#4)
short DNA and fibrous DNA##2##5##(2008-11#2)
short DNA##7##2##(2008-10#1)(2008-11#5)(2010-7#1)
short analysis time##4##3##(2008-10#4)
short analysis##5##2##(2008-10#5)
short and long term##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
short and long-term##2##3##(2008-11#1)(2012-2#1)
short and medium-term##2##3##(2011-2#2)
short and##13##2##(1991-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#3)(2012-2#1)
short and/or##2##2##(1997-3#1)(2007-12#1)
short arm##25##2##(1996-2#1)(1997-2#1)(2008-10#14)(2008-12#1)(2008-4#1)(2008-9#4)(2009-10#1)(2012-3#2)
short arms##3##2##(2008-12#1)(2008-7#1)(2009-10#1)
short bowel syndrome##4##3##(1991-12#3)(1994-3#1)
short but##2##2##(1995-1#1)(2008-7#1)
short calls##2##2##(1994-8#1)(2008-8#1)
short capillary and##2##3##(2008-10#2)
short cattle tendons##3##3##(2008-5#3)
short chain fatty##2##3##(1990-6#1)(2008-7#1)
short chain##3##2##(1990-6#1)(2008-7#1)(2009-6#1)
short cut##2##2##(2010-4#1)(2010-8#1)
short deletions##2##2##(1993-2#1)(1997-7#1)
short distances##5##2##(2008-10#4)(2013-8#1)
short duration of##2##3##(2009-10#1)(2012-2#1)
short duration##5##2##(1995-11#1)(2008-11#1)(2009-10#1)(2012-2#2)
short exposure to##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
short exposure##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
short exposures##2##2##(2008-10#1)(2008-7#1)
short fibers##2##2##(2008-3#1)(2009-7#1)
short for##2##2##(1990-12#1)(2008-10#1)
short galls##2##2##(2008-10#2)
short gaps##2##2##(2011-2#2)
short generation times##2##3##(2008-10#1)(2008-8#1)
short generation##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
short glass fibers##2##3##(2009-7#2)
short hairpin RNA##2##3##(2011-2#1)(2013-1#1)
short half-life##3##2##(2008-11#1)(2009-11#1)(2010-7#1)
short homologies##2##2##(1993-6#2)
short laser##2##2##(2007-11#1)(2008-10#1)
short lasting##2##2##(1992-6#1)(1994-2#1)
short latency##4##2##(1996-2#2)(1996-5#2)
short lengths of stay##2##4##(1992-3#1)(1995-1#1)
short linear##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
short of##4##2##(1991-3#1)(1995-2#1)(2008-11#2)
short or##4##2##(1992-5#1)(1994-2#1)(2008-5#1)(2013-1#1)
short peptides##2##2##(2008-10#1)(2011-3#1)
short period of time##8##4##(1993-3#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#1)
short period of##13##3##(1993-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-11#1)(2013-1#3)
short period##18##2##(1990-8#1)(1993-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
short periods##2##2##(1996-3#1)(2013-1#1)
short plasma half-life##4##3##(1993-8#1)(2008-5#2)(2012-2#1)
short pulses##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
short range##2##2##(2008-10#1)(2008-3#1)
short reaction##3##2##(2008-10#2)(2008-9#1)
short response time##11##3##(2008-10#11)
short review of##2##3##(2008-10#1)(2012-12#1)
short review##7##2##(2008-10#2)(2008-11#1)(2008-7#2)(2009-3#1)(2012-12#1)
short rods##2##2##(2008-7#1)(2011-2#1)
short solarization##2##2##(2008-10#2)
short stature##14##2##(1996-6#1)(2010-6#1)(2011-1#4)(2012-2#1)(2012-3#2)(2013-1#5)
short stretches of##2##3##(1993-6#1)(2008-4#1)
short supply##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
short survival##2##2##(1994-6#1)(2008-9#1)
short tandem repeat (STR) loci##3##5##(1995-11#1)(2008-12#2)
short tandem repeat (STR)##6##4##(1995-11#1)(2008-12#5)
short tandem repeat##9##3##(1994-9#1)(1995-11#1)(2008-11#1)(2008-12#6)
short tandem##10##2##(1994-9#1)(1995-11#1)(2008-11#1)(2008-12#7)
short term event##3##3##(2013-1#3)
short term memory status in##3##5##(2012-2#3)
short term##17##2##(1992-2#1)(1993-3#1)(1993-6#2)(2008-10#1)(2010-1#1)(2011-1#1)(2012-2#4)(2013-1#5)(2013-8#1)
short time and##2##3##(2008-10#1)(2008-11#1)
short time period##2##3##(2008-10#1)(2008-11#1)
short time##23##2##(1990-9#1)(1991-3#1)(1995-11#2)(2008-10#8)(2008-11#6)(2008-9#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-8#1)
short treatment##3##2##(2008-12#1)(2008-5#1)(2010-11#1)
short volatile##2##2##(2008-7#2)
short##449##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-3#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#5)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#1)(1995-2#5)(1995-5#1)(1996-1#3)(1996-12#6)(1996-2#4)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#1)(1997-7#2)(1997-9#1)(2007-11#2)(2007-12#10)(2008-1#2)(2008-10#105)(2008-11#30)(2008-12#14)(2008-2#6)(2008-3#13)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#16)(2008-8#7)(2008-9#16)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#17)(2011-3#2)(2012-12#2)(2012-2#18)(2012-3#6)(2013-1#26)(2013-8#4)
short&quot##3##1##(2008-4#3)
short)##3##1##(2008-5#2)(2008-8#1)
short- and long-term##10##3##(1991-6#1)(1993-12#1)(1995-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#4)
short- and##15##2##(1991-6#1)(1993-12#2)(1995-8#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#4)
short- or long-term##2##3##(2011-2#1)(2012-5#1)
short-##19##1##(1991-6#1)(1993-12#2)(1995-8#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-5#1)(2013-1#4)
short-acting versus long-acting##2##3##(2009-9#2)
short-acting##4##1##(1997-4#2)(2009-9#2)
short-chain and##2##2##(1991-5#1)(1994-8#1)
short-chain##11##1##(1991-5#3)(1993-8#1)(1994-8#1)(1995-6#1)(2008-10#4)(2008-5#1)
short-distance##4##1##(1990-11#1)(2008-10#2)(2011-2#1)
short-form##2##1##(2008-10#1)(2011-2#1)
short-lasting##2##1##(1990-5#1)(1994-2#1)
short-lived##8##1##(1991-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#1)(2012-12#1)(2012-3#1)(2012-4#1)
short-pulse##3##1##(1993-5#1)(2008-3#2)
short-range##4##1##(2008-10#2)(2008-3#1)(2008-8#1)
short-run##2##1##(1992-2#1)(1994-12#1)
short-stay hospital inpatient##2##3##(1991-1#1)(1991-3#1)
short-stay hospital services##3##3##(1991-1#1)(1991-3#1)(1992-2#1)
short-stay hospital##6##2##(1991-1#2)(1991-3#2)(1992-2#2)
short-stay hospitals##2##2##(1992-2#2)
short-stay##8##1##(1991-1#2)(1991-3#2)(1992-2#4)
short-term and long-term##6##3##(2008-1#1)(2008-11#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
short-term and##7##2##(2008-1#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
short-term assays##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
short-term chaos##2##2##(2008-9#2)
short-term colony assays##2##3##(2008-11#2)
short-term control##2##2##(2008-8#1)(2013-8#1)
short-term effects of##2##3##(1995-12#1)(1997-1#1)
short-term efficacy of##2##3##(2011-2#2)
short-term feeding##2##2##(1992-9#1)(1996-2#1)
short-term goals##2##2##(1993-12#1)(2008-11#1)
short-term longitudinal##2##2##(2009-7#2)
short-term memory and##2##3##(1991-10#1)(2009-8#1)
short-term memory##3##2##(1991-10#1)(2008-11#1)(2009-8#1)
short-term or##2##2##(1996-3#1)(2012-12#1)
short-term outcomes##3##2##(2008-12#1)(2009-7#1)(2012-3#1)
short-term pain##2##2##(2013-1#2)
short-term results##2##2##(1993-3#1)(2011-2#1)
short-term standard##2##2##(2008-10#1)(2012-3#1)
short-term survival##3##2##(1992-9#3)
short-term##115##1##(1990-2#1)(1991-10#1)(1992-1#2)(1992-3#1)(1992-9#4)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#5)(1995-12#6)(1995-2#1)(1995-5#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-8#1)(2008-1#2)(2008-10#13)(2008-11#13)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#5)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#4)
short-wavelength##5##1##(1991-9#1)(2007-12#1)(2008-3#3)
shortage in##2##2##(2008-10#1)(2008-11#1)
shortage of##19##2##(1991-2#1)(1992-1#1)(1993-2#1)(1993-6#1)(1995-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-5#1)
shortage##31##1##(1991-1#1)(1991-2#2)(1992-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-7#1)(2009-3#1)(2010-10#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-5#1)(2012-7#1)
shortages##2##1##(1997-1#1)(2008-11#1)
shortcomings in##3##2##(1994-12#1)(2008-12#1)(2013-7#1)
shortcomings##13##1##(1991-1#1)(1993-1#1)(1993-11#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2012-2#2)(2012-4#1)(2013-1#1)(2013-7#1)
shorten the##6##2##(1991-1#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-2#1)
shorten time to##2##3##(2007-9#1)(2012-3#1)
shorten##14##1##(1990-5#1)(1991-1#1)(1992-1#1)(2007-9#1)(2008-10#4)(2008-12#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
shortened by##2##2##(2008-10#1)(2010-8#1)
shortened the time##2##3##(2008-10#1)(2008-9#1)
shortened the##4##2##(2008-10#3)(2008-9#1)
shortened##26##1##(1993-12#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#4)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
shortening of the##3##3##(1995-6#1)(1997-8#1)(2012-7#1)
shortening of##5##2##(1995-6#1)(1997-8#1)(2008-11#1)(2012-7#1)(2013-8#1)
shortening the##4##2##(2008-10#2)(2008-2#1)(2012-12#1)
shortening##29##1##(1993-9#1)(1995-6#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2012-12#2)(2012-2#4)(2012-7#1)(2013-1#7)(2013-8#2)
shortens the##3##2##(1992-3#1)(2010-6#1)(2011-2#1)
shortens##5##1##(1992-3#1)(2008-12#1)(2008-9#1)(2010-6#1)(2011-2#1)
shorter RNA molecules##2##3##(2008-7#2)
shorter analysis time##4##3##(2008-10#4)
shorter and less##2##3##(2008-5#1)(2008-9#1)
shorter and lighter##2##3##(2008-11#1)(2010-6#1)
shorter and##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)
shorter at##2##2##(1995-8#1)(2008-10#1)
shorter duration of##3##3##(2008-7#1)(2008-9#1)(2010-4#1)
shorter duration##5##2##(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)
shorter in##4##2##(2008-5#1)(2008-7#1)(2011-2#2)
shorter periods##3##2##(1994-6#1)(2008-10#1)(2008-3#1)
shorter than that of##3##4##(1991-3#1)(2010-4#1)(2010-8#1)
shorter than the##3##3##(1991-12#1)(2008-10#1)(2010-10#1)
shorter than##14##2##(1991-12#1)(1991-3#1)(1993-2#1)(1995-12#1)(2008-10#5)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2013-8#1)
shorter time##5##2##(1991-3#1)(1996-2#1)(1996-3#1)(2008-9#1)(2011-2#1)
shorter times##2##2##(2008-10#2)
shorter##115##1##(1990-2#1)(1990-8#1)(1991-12#2)(1991-3#3)(1992-3#2)(1993-11#1)(1993-2#3)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-2#3)(1995-6#2)(1995-8#3)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#1)(2007-12#1)(2008-10#24)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#4)(2009-3#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
shorter-lived##2##1##(2008-10#1)(2013-8#1)
shortest##10##1##(1991-2#1)(1992-12#2)(1996-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
shortfall##2##1##(2008-12#1)(2008-8#1)
shortly after the##4##3##(2008-10#2)(2010-12#1)(2011-2#1)
shortly after##20##2##(1991-12#1)(1995-2#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
shortly##27##1##(1991-12#1)(1993-8#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
shortness of breath##8##3##(2007-12#1)(2008-7#3)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
shot noise##4##2##(2008-3#3)(2008-4#1)
shot wounds##2##2##(1995-11#1)(2013-1#1)
shot##15##1##(1995-11#3)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
shot-to-shot##2##1##(2008-2#1)(2008-3#1)
shotgun metagenomics##2##2##(2011-2#2)
shotgun sequencing##2##2##(1996-6#1)(2011-2#1)
shotgun##5##1##(1996-6#1)(2010-12#1)(2011-2#3)
shots in##2##2##(1995-11#1)(2011-2#1)
shots with a##2##3##(2011-2#2)
shots##10##1##(1995-11#1)(1995-5#1)(2008-3#3)(2011-2#5)
shots)##2##1##(2008-10#1)(2011-2#1)
should adopt##2##2##(1993-11#1)(1996-12#1)
should alert##2##2##(1996-2#1)(2008-12#1)
should allow##6##2##(1992-3#1)(1993-12#1)(1995-2#1)(1997-8#1)(2008-10#2)
should also be applicable to##2##5##(2008-10#1)(2008-11#1)
should also be##11##3##(1994-6#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-7#1)
should also##21##2##(1994-3#1)(1994-6#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-7#1)(2012-3#2)(2013-8#1)
should always be considered when##2##5##(2008-10#1)(2011-2#1)
should always be considered##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
should always be##13##3##(1990-2#1)(1996-6#1)(2008-10#3)(2008-5#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)
should always##16##2##(1990-2#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
should apply to##2##3##(2008-10#1)(2008-3#1)
should apply##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
should assist##5##2##(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
should avoid##3##2##(1993-1#1)(2008-10#1)(2010-12#1)
should be a##16##3##(1992-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#6)(2012-12#1)(2012-2#1)(2013-1#1)
should be able to##8##4##(1992-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)
should be added to the##3##5##(1996-1#1)(2009-1#1)(2011-2#1)
should be added##4##3##(1996-1#1)(2009-1#1)(2011-2#1)(2012-12#1)
should be addressed##4##3##(1992-12#1)(2012-2#2)(2012-3#1)
should be adequately##2##3##(2008-11#1)(2012-5#1)
should be adjusted##3##3##(1997-4#1)(2008-10#1)(2008-7#1)
should be administered##2##3##(1996-3#1)(2008-3#1)
should be advised##2##3##(1994-3#1)(1996-11#1)
should be also##2##3##(1990-3#1)(1991-3#1)
should be always##2##3##(2008-5#1)(2009-4#1)
should be amenable to##2##4##(1997-7#1)(2008-10#1)
should be an important part of##2##6##(2013-1#2)
should be an important##3##4##(2008-8#1)(2013-1#2)
should be an##9##3##(1991-9#1)(2008-10#2)(2008-8#2)(2011-2#1)(2013-1#3)
should be analyzed##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
should be applicable to a range of##2##7##(2008-10#2)
should be applicable to##5##4##(1991-5#1)(2008-10#3)(2010-12#1)
should be applicable##7##3##(1991-5#1)(1994-3#1)(1996-8#1)(2008-10#3)(2010-12#1)
should be applied##5##3##(1992-12#1)(2008-5#1)(2008-9#2)(2010-8#1)
should be as##2##3##(1995-2#1)(2008-10#1)
should be assessed##2##3##(2008-11#1)(2010-12#1)
should be attractive##2##3##(2008-10#2)
should be available##2##3##(1994-3#1)(2008-8#1)
should be avoided##8##3##(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
should be aware of the##3##5##(2009-8#1)(2011-2#1)(2012-12#1)
should be aware of this##2##5##(2008-12#2)
should be aware of##11##4##(1991-2#1)(2008-10#2)(2008-12#2)(2009-8#1)(2010-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
should be aware that##2##4##(2010-9#1)(2012-2#1)
should be aware##15##3##(1991-2#1)(1992-2#1)(2008-10#2)(2008-12#2)(2009-8#1)(2010-1#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
should be based on a combination of##2##7##(2008-7#1)(2011-2#1)
should be based on a##4##5##(1992-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
should be based on the##6##5##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-12#1)
should be based on##14##4##(1991-7#1)(1992-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
should be careful##2##3##(1992-3#1)(2008-5#1)
should be carefully considered##2##4##(1995-12#1)(2008-7#1)
should be carefully evaluated##2##4##(2008-1#1)(2013-1#1)
should be carefully followed##2##4##(1991-2#1)(2008-7#1)
should be carefully monitored##2##4##(2011-1#1)(2012-2#1)
should be carefully##8##3##(1991-2#1)(1995-12#1)(2008-1#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#1)
should be carried out##4##4##(1992-5#1)(1994-6#1)(2011-1#1)(2011-2#1)
should be cautioned##2##3##(1996-3#1)(2013-1#1)
should be cautious##2##3##(2008-10#1)(2008-5#1)
should be changed##2##3##(1991-6#1)(2008-10#1)
should be classified as##2##4##(1993-1#1)(2008-10#1)
should be classified##4##3##(1993-1#1)(2008-10#2)(2011-2#1)
should be combined with##6##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
should be conducted to##2##4##(2009-12#1)(2010-8#1)
should be considered a##5##4##(1993-1#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
should be considered an##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
should be considered as a possible##2##6##(2008-12#1)(2012-12#1)
should be considered as a##5##5##(2008-12#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-12#1)
should be considered as an alternative to##2##7##(2011-2#2)
should be considered as##9##4##(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#4)(2012-12#1)
should be considered at##2##4##(2009-7#1)(2012-6#1)
should be considered for a##2##5##(1993-11#1)(2008-10#1)
should be considered for##8##4##(1993-11#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
should be considered if##2##4##(1996-6#1)(2009-12#1)
should be considered in cases##2##5##(2008-7#1)(2011-1#1)
should be considered in the differential diagnosis of##6##8##(2008-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
should be considered in the differential diagnosis##9##7##(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
should be considered in the##11##5##(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#2)(2013-8#1)
should be considered in young##2##5##(1990-3#1)(2011-2#1)
should be considered in##28##4##(1990-3#1)(1991-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
should be considered when##8##4##(1993-6#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2013-8#1)
should be considered with##2##4##(1993-1#1)(2008-10#1)
should be considered##85##3##(1990-3#1)(1990-6#1)(1991-8#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-1#1)(1995-1#2)(1996-3#1)(1996-6#1)(1997-3#2)(2008-10#13)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#14)(2012-12#2)(2012-3#3)(2012-6#1)(2013-1#3)(2013-8#3)
should be defined##3##3##(1991-12#1)(2008-8#2)
should be determined##2##3##(2008-10#1)(2008-8#1)
should be developed to##2##4##(1992-12#1)(2013-1#1)
should be developed##6##3##(1992-12#1)(1995-5#1)(2008-5#1)(2011-2#2)(2013-1#1)
should be differentiated##2##3##(1991-2#1)(2010-6#1)
should be directed##4##3##(1996-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
should be discouraged##2##3##(1992-3#2)
should be distinguished from##2##4##(1992-2#1)(2013-1#1)
should be done##9##3##(1996-11#2)(1997-3#2)(2008-10#2)(2012-2#2)(2013-1#1)
should be effective##2##3##(2008-10#2)
should be emphasized##3##3##(1993-12#1)(1996-3#1)(2008-4#1)
should be employed##5##3##(1990-12#1)(1991-3#1)(1991-6#1)(1997-2#1)(2008-4#1)
should be encouraged to##3##4##(1993-2#1)(2008-11#1)(2012-3#1)
should be encouraged##6##3##(1993-2#1)(1996-3#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#1)
should be enrolled in##2##4##(1994-2#1)(2008-11#1)
should be established##2##3##(1990-6#1)(2011-2#1)
should be evaluated in##2##4##(1992-2#1)(2008-10#1)
should be evaluated##8##3##(1992-2#1)(1997-8#1)(2006-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
should be expanded to include##2##5##(1991-9#1)(2013-1#1)
should be expanded##4##3##(1991-9#1)(1993-1#1)(2010-7#1)(2013-1#1)
should be familiar##2##3##(1994-5#1)(2012-12#1)
should be focused on##2##4##(1996-3#1)(2008-10#1)
should be followed by##3##4##(1994-2#1)(2008-10#1)(2008-9#1)
should be followed up##2##4##(1997-8#1)(2008-10#1)
should be followed##8##3##(1994-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-9#1)
should be further investigated##2##4##(1990-8#1)(2008-11#1)
should be further##4##3##(1990-8#1)(2008-11#1)(2012-2#1)(2013-8#1)
should be given to##5##4##(1990-11#1)(1994-9#1)(1997-2#1)(2008-9#1)(2011-1#1)
should be given##16##3##(1990-11#1)(1992-5#1)(1994-9#2)(1996-11#2)(1997-2#1)(1997-8#2)(2007-11#1)(2008-11#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#1)
should be helpful in##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
should be helpful##4##3##(1992-12#1)(2008-10#2)(2011-2#1)
should be highly##3##3##(2008-11#1)(2008-8#1)(2011-1#1)
should be identified##2##3##(2008-10#1)(2009-8#1)
should be implemented##2##3##(1995-5#1)(1996-12#1)
should be important in##2##4##(2008-11#1)(2008-8#1)
should be important##3##3##(2008-11#1)(2008-8#1)(2010-6#1)
should be improved by##2##4##(1993-1#1)(2010-7#1)
should be improved##3##3##(1993-1#1)(2008-5#1)(2010-7#1)
should be in##2##3##(1991-2#1)(2008-11#1)
should be included in the differential diagnosis of##2##8##(1997-7#1)(2013-1#1)
should be included in the differential diagnosis##3##7##(1997-7#1)(2010-11#1)(2013-1#1)
should be included in the##8##5##(1996-6#1)(1997-7#1)(2008-10#2)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
should be included in##11##4##(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
should be included##13##3##(1995-5#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
should be incorporated##2##3##(1992-12#1)(2012-12#1)
should be informed##2##3##(2008-6#1)(2008-8#1)
should be initiated immediately in##2##5##(1994-9#1)(2008-10#1)
should be initiated##5##3##(1994-9#1)(2008-10#1)(2010-10#1)(2011-2#2)
should be integrated##3##3##(1993-6#1)(1995-12#1)(2008-6#1)
should be intensified##2##3##(1994-2#1)(2009-7#1)
should be interpreted cautiously##2##4##(1995-5#1)(2008-8#1)
should be interpreted with caution##3##5##(1994-12#1)(1997-1#1)(2011-1#1)
should be interpreted##9##3##(1994-12#1)(1995-5#1)(1997-1#2)(2008-5#1)(2008-8#2)(2010-3#1)(2011-1#1)
should be investigated##3##3##(1992-5#1)(2009-12#1)(2012-3#1)
should be involved##2##3##(2008-11#1)(2008-8#1)
should be kept in mind##4##5##(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
should be kept##6##3##(1996-6#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
should be limited to##3##4##(1991-6#1)(1991-9#1)(2008-11#1)
should be made between##2##4##(2008-9#1)(2011-1#1)
should be made to##3##4##(2008-9#1)(2009-5#1)(2013-1#1)
should be made##14##3##(1992-9#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
should be maintained##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
should be measured##2##3##(1994-9#1)(2008-8#1)
should be monitored in##2##4##(2008-8#1)(2013-8#1)
should be monitored##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
should be more##5##3##(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)
should be noted that the##4##5##(2008-10#2)(2008-11#1)(2010-6#1)
should be noted that##6##4##(2008-10#3)(2008-11#1)(2010-6#1)(2011-2#1)
should be observed##3##3##(1993-2#2)(2008-9#1)
should be of great##2##4##(1997-2#1)(2008-9#1)
should be offered##3##3##(1994-3#1)(1994-9#1)(2013-1#1)
should be on##2##3##(1992-2#1)(1997-2#1)
should be one of##2##4##(1996-1#1)(2008-7#1)
should be one##3##3##(1996-1#1)(2008-7#1)(2012-2#1)
should be paid to##4##4##(1992-12#1)(1995-3#1)(2008-11#1)(2011-2#1)
should be paid##5##3##(1992-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
should be part of##2##4##(1997-3#1)(2009-1#1)
should be particularly useful to##2##5##(1993-3#1)(2008-2#1)
should be particularly useful##3##4##(1993-3#1)(2008-10#1)(2008-2#1)
should be performed for##3##4##(2008-7#1)(2010-3#1)(2012-12#1)
should be performed in##4##4##(1990-12#1)(1990-2#1)(2008-7#1)(2011-2#1)
should be performed only##3##4##(1994-3#1)(2008-7#1)(2012-2#1)
should be performed regularly##2##4##(2007-11#1)(2010-10#1)
should be performed to##3##4##(2008-12#1)(2009-8#1)(2012-12#1)
should be performed##21##3##(1990-12#1)(1990-2#1)(1994-3#1)(1996-11#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
should be possible to##7##4##(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)
should be preferred##2##3##(2010-12#1)(2012-12#1)
should be present##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
should be promptly##2##3##(1993-12#1)(2012-12#1)
should be provided##5##3##(1992-3#1)(1994-12#1)(1995-9#1)(2008-10#1)(2008-11#1)
should be pursued##2##3##(2010-4#1)(2013-1#1)
should be put in place##2##5##(1991-3#1)(2012-12#1)
should be quantified##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
should be raised##2##3##(1997-8#1)(2008-9#1)
should be recognized##2##3##(2009-8#1)(2011-2#1)
should be referred to##3##4##(1990-6#1)(2008-7#1)(2011-2#1)
should be regarded as##4##4##(1996-12#1)(1997-4#1)(2008-10#2)
should be regarded##5##3##(1990-2#1)(1996-12#1)(1997-4#1)(2008-10#2)
should be regularly##2##3##(2013-1#2)
should be replaced with##2##4##(1994-12#1)(2010-7#1)
should be replaced##3##3##(1994-12#1)(2008-11#1)(2010-7#1)
should be reported##2##3##(2008-11#1)(2010-6#1)
should be reserved for patients with##2##6##(2011-2#1)(2012-3#1)
should be reserved for##3##4##(2008-8#1)(2011-2#1)(2012-3#1)
should be revised##3##3##(1994-2#1)(1996-3#1)(1996-5#1)
should be routinely##2##3##(2008-10#1)(2012-2#1)
should be safe##2##3##(1996-12#1)(2010-7#1)
should be screened##2##3##(2008-11#1)(2011-2#1)
should be separated##3##3##(1991-3#1)(2008-10#2)
should be seriously considered as##2##5##(1991-2#1)(1994-6#1)
should be seriously considered##3##4##(1991-2#1)(1994-6#1)(2010-1#1)
should be specifically##2##3##(1996-6#1)(2008-11#1)
should be started##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
should be stopped##3##3##(2008-8#1)(2009-5#1)(2013-1#1)
should be studied##3##3##(2008-11#2)(2011-2#1)
should be suspected##4##3##(1997-4#1)(2008-11#1)(2010-10#1)(2013-1#1)
should be taken into account in##5##6##(1994-12#1)(2007-12#1)(2008-10#2)(2013-1#1)
should be taken into account##8##5##(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-1#1)(2013-1#1)(2013-8#1)
should be taken into consideration when##3##6##(2008-10#1)(2010-8#1)(2013-1#1)
should be taken into consideration##4##5##(2008-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
should be taken into##13##4##(1991-12#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-1#1)(2010-8#1)(2013-1#2)(2013-8#2)
should be taken seriously##2##4##(1996-6#1)(2008-4#1)
should be taken to##3##4##(1994-3#1)(1995-12#1)(2008-10#1)
should be taken##24##3##(1991-12#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#3)
should be targeted##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
should be tested##2##3##(1990-3#1)(1994-8#1)
should be the first##3##4##(1990-2#1)(1993-6#1)(2010-11#1)
should be the goal of##2##5##(1992-3#1)(2013-1#1)
should be the##15##3##(1990-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-1#1)(2008-11#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
should be to##2##3##(2008-11#1)(2010-12#1)
should be treated by##2##4##(1997-4#1)(1997-8#1)
should be treated with##9##4##(1991-6#1)(1996-11#1)(2008-3#1)(2008-8#2)(2009-4#1)(2011-2#2)(2013-1#1)
should be treated##14##3##(1990-2#1)(1991-3#1)(1991-6#1)(1993-2#1)(1996-11#1)(1997-4#1)(1997-8#1)(2008-3#1)(2008-8#2)(2009-4#1)(2011-2#2)(2013-1#1)
should be undertaken at##2##4##(1996-6#1)(2008-5#1)
should be undertaken##3##3##(1996-6#1)(2008-5#1)(2012-3#1)
should be used as##3##4##(2008-2#1)(2008-9#1)(2010-1#1)
should be used for##3##4##(1990-2#1)(2008-10#1)(2013-1#1)
should be used in the##2##5##(1990-11#1)(2010-11#1)
should be used in##6##4##(1990-11#2)(1991-2#1)(1996-6#1)(2010-11#1)(2011-1#1)
should be used only##2##4##(1993-2#1)(1994-12#1)
should be used to##2##4##(1997-7#1)(2008-10#1)
should be used with caution##2##5##(2011-2#1)(2013-1#1)
should be used##25##3##(1990-11#2)(1990-2#1)(1991-2#1)(1992-12#1)(1993-2#1)(1994-12#1)(1996-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#3)(2013-1#2)
should be useful for##6##4##(1992-1#1)(1995-2#1)(2008-10#3)(2008-11#1)
should be useful in the##3##5##(1993-12#1)(2008-10#1)(2010-4#1)
should be useful in##13##4##(1993-12#2)(1993-6#1)(1993-8#1)(1996-8#1)(2008-10#5)(2008-5#1)(2010-4#2)
should be useful to##2##4##(2008-10#1)(2008-8#1)
should be useful##22##3##(1991-9#1)(1992-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1995-2#1)(1996-8#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#2)
should be valuable##2##3##(1995-12#1)(2008-9#1)
should be very useful for##3##5##(1997-2#1)(1997-8#1)(2008-10#1)
should be very##4##3##(1997-2#1)(1997-8#1)(2008-10#2)
should be weighed##2##3##(2008-10#1)(2011-2#1)
should be well##2##3##(1997-8#1)(2008-9#1)
should be##895##2##(1990-11#5)(1990-12#2)(1990-2#5)(1990-3#3)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#7)(1991-3#8)(1991-5#1)(1991-6#8)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#2)(1992-11#1)(1992-12#12)(1992-2#5)(1992-3#7)(1992-5#3)(1992-9#1)(1993-1#6)(1993-11#1)(1993-12#5)(1993-2#7)(1993-3#2)(1993-6#6)(1993-8#1)(1994-1#3)(1994-12#7)(1994-2#6)(1994-3#11)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#7)(1995-1#2)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#5)(1995-9#1)(1996-1#5)(1996-11#11)(1996-12#3)(1996-2#1)(1996-3#10)(1996-5#1)(1996-6#9)(1996-8#2)(1997-1#4)(1997-2#6)(1997-3#8)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#16)(2006-5#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#6)(2008-10#128)(2008-11#49)(2008-12#14)(2008-2#3)(2008-3#8)(2008-4#13)(2008-5#20)(2008-6#5)(2008-7#32)(2008-8#29)(2008-9#36)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#1)(2009-4#7)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#10)(2010-1#6)(2010-10#4)(2010-11#11)(2010-12#11)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#12)(2011-2#63)(2011-3#1)(2011-4#1)(2011-7#1)(2011-8#1)(2012-12#21)(2012-2#16)(2012-3#11)(2012-5#1)(2012-6#1)(2013-1#41)(2013-8#16)
should become a##2##3##(2008-10#1)(2013-1#1)
should become##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
should begin##5##2##(1993-2#1)(1994-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
should benefit from##2##3##(1996-6#1)(2010-5#1)
should benefit##4##2##(1996-6#1)(2008-10#1)(2008-3#1)(2010-5#1)
should carry##2##2##(1994-5#1)(2008-11#1)
should consider the##3##3##(2008-10#2)(2012-2#1)
should consider##18##2##(1992-3#1)(1995-3#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
should consist of##3##3##(1997-2#1)(2008-12#1)(2008-5#1)
should continue to##3##3##(2008-11#1)(2009-4#1)(2013-8#1)
should continue##5##2##(2008-10#1)(2008-11#2)(2009-4#1)(2013-8#1)
should contribute##2##2##(1991-5#1)(2012-2#1)
should decrease##2##2##(2008-5#1)(2008-8#1)
should enable##2##2##(2008-10#1)(2011-2#1)
should encourage##4##2##(1994-2#1)(1996-2#1)(2013-1#2)
should enhance##2##2##(1992-2#1)(2008-8#1)
should ensure that##3##3##(2008-8#1)(2010-9#1)(2011-2#1)
should facilitate the##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
should facilitate##9##2##(1993-2#2)(1995-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-8#1)
should favor##4##2##(2008-8#1)(2008-9#2)(2012-3#1)
should find a wide range of##2##6##(2008-10#2)
should find##4##2##(2008-10#3)(2008-11#1)
should focus on the##2##4##(2010-11#1)(2012-2#1)
should focus on##8##3##(1995-11#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-11#1)(2012-2#1)
should focus##10##2##(1995-11#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
should follow##4##2##(1997-1#1)(2009-7#1)(2010-12#1)(2013-1#1)
should greatly##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
should have a##8##3##(1995-5#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)
should have in##2##3##(1993-12#1)(1996-6#1)
should have positive##2##3##(2008-7#1)(2011-1#1)
should have the##3##3##(1993-11#1)(1997-3#1)(2008-8#1)
should have##29##2##(1990-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#1)(2010-10#2)(2010-7#1)(2011-1#3)(2011-2#2)(2013-1#1)
should help to##6##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
should help##10##2##(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
should improve##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
should in##2##2##(2008-11#1)(2008-8#1)
should include a##2##3##(2009-12#1)(2010-7#1)
should include an##2##3##(1997-5#1)(2008-10#1)
should include both##2##3##(1997-8#1)(2008-10#1)
should include the##3##3##(1994-5#1)(2008-7#1)(2011-2#1)
should include##18##2##(1990-3#1)(1991-1#1)(1994-3#1)(1994-5#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-12#2)(2008-7#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)
should incorporate##5##2##(1994-3#1)(2008-1#1)(2008-11#1)(2010-6#1)(2013-1#1)
should increase##3##2##(2008-10#1)(2008-8#1)(2010-3#1)
should induce##2##2##(1995-5#1)(2009-4#1)
should initially be##3##3##(1990-11#1)(1990-3#1)(2011-2#1)
should keep##3##2##(2010-6#1)(2012-12#1)(2013-8#1)
should know##4##2##(1996-11#3)(2008-4#1)
should lead to a##3##4##(2008-5#2)(2012-2#1)
should lead to the##2##4##(2008-10#2)
should lead to##10##3##(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#3)(2012-2#1)
should look##2##2##(1994-12#1)(2008-7#1)
should make standardizing CS a high priority for targeted funding##2##10##(2013-1#2)
should make##4##2##(1995-1#1)(2008-10#1)(2013-1#2)
should meet##2##2##(1997-8#1)(2011-2#1)
should not be confused with##3##5##(1997-3#1)(1997-4#1)(1997-8#1)
should not be considered a##2##5##(2008-10#1)(2008-11#1)
should not be considered##5##4##(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
should not be the##2##4##(2008-10#1)(2011-2#1)
should not be used##3##4##(1994-3#1)(2008-10#1)(2012-12#1)
should not be##47##3##(1990-11#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
should not only##2##3##(1993-11#1)(2009-9#1)
should not##66##2##(1990-11#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
should now be##2##3##(1997-7#1)(2010-12#1)
should only be applied##2##4##(2008-10#1)(2013-1#1)
should only be##6##3##(2008-10#1)(2008-8#1)(2010-11#1)(2012-2#2)(2013-1#1)
should pay##2##2##(2008-9#1)(2010-1#1)
should perform##4##2##(1995-11#3)(2011-2#1)
should preferably be##2##3##(1993-2#1)(1993-6#1)
should preferably##5##2##(1991-2#1)(1993-2#1)(1993-6#1)(2008-8#2)
should probably be##2##3##(1996-3#1)(2008-10#1)
should produce##2##2##(1993-3#1)(2008-8#1)
should prompt##5##2##(1997-3#1)(2009-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
should protect##2##2##(1997-5#1)(2008-5#1)
should prove useful as a##2##5##(2008-10#2)
should prove useful for##2##4##(2008-10#2)
should prove useful##7##3##(1992-12#1)(2008-10#4)(2008-3#1)(2012-2#1)
should prove##9##2##(1992-12#1)(1993-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2012-2#1)
should provide a##2##3##(2008-10#1)(2008-11#1)
should provide further##2##3##(1993-12#1)(2008-7#1)
should provide##16##2##(1991-2#1)(1993-12#1)(1996-1#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
should receive greater##3##3##(1997-8#1)(2013-1#2)
should receive##7##2##(1993-12#1)(1994-9#1)(1997-8#2)(2008-11#1)(2013-1#2)
should reduce##2##2##(2008-10#1)(2008-8#1)
should rely on##2##3##(2008-8#1)(2010-7#1)
should remain##3##2##(1992-3#1)(1997-8#1)(2008-12#1)
should remove##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
should result in##5##3##(1995-5#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-3#1)
should serve##2##2##(2012-2#1)(2013-8#1)
should start##3##2##(1993-2#1)(2008-11#1)(2011-2#1)
should stop##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
should take##8##2##(1994-1#2)(1996-6#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)
should the##5##2##(1991-3#1)(1992-1#1)(1995-2#1)(1997-4#1)(2008-11#1)
should therefore be##4##3##(1993-11#1)(1996-11#1)(1997-3#1)(2009-5#1)
should therefore##6##2##(1993-11#1)(1996-11#1)(1997-3#1)(2008-10#1)(2009-5#1)(2010-7#1)
should they##2##2##(1991-12#1)(2012-3#1)
should thus##2##2##(1994-2#1)(2006-6#1)
should undergo##2##2##(2010-2#1)(2011-8#1)
should use##3##2##(2008-12#1)(2008-8#1)(2012-2#1)
should usually be##2##3##(2006-5#1)(2008-8#1)
should vary##2##2##(1994-1#1)(2008-9#1)
should we##6##2##(1993-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#2)
should##1486##1##(1990-11#8)(1990-12#2)(1990-2#7)(1990-3#5)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#10)(1991-2#10)(1991-3#12)(1991-5#2)(1991-6#9)(1991-7#1)(1991-8#6)(1991-9#6)(1992-1#3)(1992-11#1)(1992-12#17)(1992-2#6)(1992-3#11)(1992-5#4)(1992-9#1)(1993-1#7)(1993-11#8)(1993-12#11)(1993-2#14)(1993-3#6)(1993-6#7)(1993-8#2)(1994-1#6)(1994-11#1)(1994-12#10)(1994-2#11)(1994-3#19)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#8)(1995-1#4)(1995-11#4)(1995-12#9)(1995-2#6)(1995-3#3)(1995-5#9)(1995-6#2)(1995-9#2)(1996-1#10)(1996-11#18)(1996-12#6)(1996-2#4)(1996-3#14)(1996-5#3)(1996-6#16)(1996-8#3)(1996-9#2)(1997-1#8)(1997-2#12)(1997-3#14)(1997-4#6)(1997-5#8)(1997-6#2)(1997-7#7)(1997-8#26)(2006-5#2)(2006-6#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-1#10)(2008-10#204)(2008-11#92)(2008-12#27)(2008-2#3)(2008-3#15)(2008-4#20)(2008-5#27)(2008-6#5)(2008-7#45)(2008-8#69)(2008-9#54)(2009-1#3)(2009-10#2)(2009-11#3)(2009-12#5)(2009-3#1)(2009-4#9)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#12)(2009-9#1)(2010-1#8)(2010-10#9)(2010-11#15)(2010-12#20)(2010-2#4)(2010-3#5)(2010-4#7)(2010-5#3)(2010-6#8)(2010-7#9)(2010-8#9)(2010-9#2)(2011-1#19)(2011-2#101)(2011-3#3)(2011-4#1)(2011-7#1)(2011-8#2)(2012-12#26)(2012-2#30)(2012-3#24)(2012-5#1)(2012-6#1)(2013-1#71)(2013-8#26)
shoulder abduction loading##3##3##(2010-7#3)
shoulder abduction##4##2##(2010-7#3)(2013-1#1)
shoulder and##5##2##(1990-12#1)(1997-5#1)(1997-8#1)(2008-7#1)(2009-7#1)
shoulder during##3##2##(2009-1#1)(2009-3#1)(2013-1#1)
shoulder flexion##6##2##(2010-9#6)
shoulder function##5##2##(2008-9#4)(2013-1#1)
shoulder girdle##2##2##(2012-2#2)
shoulder in##2##2##(1997-6#1)(2008-10#1)
shoulder muscles in##2##3##(2010-9#1)(2012-2#1)
shoulder muscles##6##2##(2008-12#1)(2010-9#2)(2012-2#3)
shoulder pain##6##2##(2008-12#2)(2008-8#1)(2009-1#1)(2009-3#1)(2010-9#1)
shoulder##69##1##(1990-12#1)(1994-8#1)(1995-3#3)(1997-5#4)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#5)(2008-7#1)(2008-8#2)(2008-9#6)(2009-1#3)(2009-3#2)(2009-7#1)(2010-7#3)(2010-9#10)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#9)
shoulders##6##1##(2008-10#1)(2008-12#2)(2008-7#1)(2010-9#1)(2011-1#1)
show a clear##2##3##(1990-5#1)(2008-12#1)
show a consistent##2##3##(1994-2#1)(2008-5#1)
show a decline##2##3##(2008-7#1)(2009-12#1)
show a decrease in##2##4##(1996-11#1)(2008-10#1)
show a high degree of##2##5##(1990-11#1)(1993-3#1)
show a high prevalence of##2##5##(2008-11#1)(2011-1#1)
show a high##7##3##(1990-11#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
show a higher incidence of##2##5##(1990-5#1)(2011-2#1)
show a higher##3##3##(1990-5#1)(1997-8#1)(2011-2#1)
show a highly##2##3##(1995-12#1)(2008-10#1)
show a homology##2##3##(1992-5#1)(2008-11#1)
show a linear##2##3##(2008-10#1)(2011-2#1)
show a low##3##3##(1990-6#1)(2008-10#1)(2008-9#1)
show a maximum##3##3##(1994-5#1)(2008-10#2)
show a more##2##3##(2008-4#1)(2012-3#1)
show a significant change in##2##5##(2008-11#1)(2011-2#1)
show a significant##11##3##(1993-1#1)(1994-12#1)(1996-12#2)(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#1)(2012-5#1)
show a strong##2##3##(2008-3#1)(2009-12#1)
show a sufficient antimicrobial effect##3##5##(2008-5#3)
show a wide##2##3##(2011-2#2)
show a##107##2##(1990-11#2)(1990-5#2)(1990-6#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-6#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#20)(2008-11#9)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#2)
show additional##2##2##(1993-8#1)(2009-8#1)
show an association between##2##4##(1990-8#1)(2011-2#1)
show an association##3##3##(1990-8#1)(2011-2#1)(2012-2#1)
show an important##2##3##(1995-12#1)(2008-10#1)
show an increase##2##3##(2008-10#1)(2008-3#1)
show an overall##2##3##(2008-10#1)(2010-12#1)
show an##27##2##(1990-8#1)(1991-2#1)(1992-10#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-12#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
show any##29##2##(1990-2#2)(1990-6#1)(1992-6#1)(1994-5#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-5#2)(2009-10#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
show by##4##2##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
show consistent##2##2##(2010-10#2)
show differences in##2##3##(1997-3#1)(2008-10#1)
show differences##3##2##(1997-3#1)(2008-10#2)
show different##6##2##(2008-10#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)
show distinct##2##2##(2008-5#1)(2012-2#1)
show dramatic##3##2##(1992-12#1)(1996-3#1)(2013-1#1)
show either##4##2##(1996-3#1)(1997-1#1)(2008-10#1)(2008-9#1)
show enhanced##2##2##(1994-3#1)(2008-9#1)
show evidence of##2##3##(1997-3#1)(2008-10#1)
show excellent##7##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
show for the first time##3##5##(1995-11#1)(2011-2#1)(2012-2#1)
show for##4##2##(1992-10#1)(1995-11#1)(2011-2#1)(2012-2#1)
show good agreement of##2##4##(2008-10#1)(2008-3#1)
show good agreement with the##2##5##(1996-12#1)(2008-10#1)
show good agreement with##4##4##(1996-12#1)(2008-10#2)(2008-3#1)
show good agreement##9##3##(1996-12#1)(2008-10#4)(2008-2#2)(2008-3#2)
show good##12##2##(1996-12#1)(2008-10#7)(2008-2#2)(2008-3#2)
show great##2##2##(1994-12#1)(2008-7#1)
show greater##2##2##(2008-11#1)(2008-5#1)
show high##2##2##(2008-10#1)(2010-6#1)
show higher##4##2##(2008-10#1)(2008-5#2)(2008-8#1)
show how a##3##3##(1996-3#1)(2008-8#1)(2008-9#1)
show how migration##2##3##(2008-8#2)
show how the##8##3##(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)(2012-2#2)
show how these##4##3##(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
show how this##3##3##(2008-11#1)(2008-9#2)
show how to use##2##4##(1993-12#1)(1997-3#1)
show how to##8##3##(1993-12#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)
show how##44##2##(1991-3#1)(1993-12#1)(1993-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#5)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#6)(2008-9#3)(2010-1#1)(2010-11#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
show increased##8##2##(1992-8#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-11#2)(2010-11#1)(2011-10#1)
show large##2##2##(1994-2#1)(2013-8#1)
show less##4##2##(1995-12#1)(2008-10#1)(2009-8#1)(2011-2#1)
show more##2##2##(2008-10#1)(2008-11#1)
show much##3##2##(1990-11#1)(2008-10#1)(2012-2#1)
show negligible##3##2##(1990-8#1)(2008-10#2)
show no##13##2##(1990-2#1)(1994-12#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
show non-linear##2##2##(2008-10#1)(2008-7#1)
show potential##2##2##(2008-10#1)(2009-1#1)
show promise##2##2##(2008-7#1)(2010-5#1)
show relative standard deviations##2##4##(1997-2#1)(2008-10#1)
show resistance to##2##3##(2008-10#1)(2011-1#1)
show severe##2##2##(1997-2#1)(2008-11#1)
show significant changes##2##3##(1992-3#1)(2012-2#1)
show significant##15##2##(1992-3#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#2)
show similar patterns of##2##4##(1996-12#1)(2012-3#1)
show similar##7##2##(1992-6#1)(1995-11#1)(1996-12#1)(2008-5#1)(2012-3#1)(2012-8#1)(2013-1#1)
show similarity##3##2##(1995-2#1)(1995-5#1)(1995-6#1)
show some##7##2##(1990-8#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
show spontaneous resolution##2##3##(2008-12#2)
show spontaneous##3##2##(2008-11#1)(2008-12#2)
show strong##2##2##(1995-2#1)(2008-10#1)
show that 2##2##3##(2008-8#1)(2011-2#1)
show that CBF-C##2##3##(1995-2#2)
show that CsA##2##3##(1994-8#2)
show that G##2##3##(1992-9#1)(2008-3#1)
show that GC7##2##3##(1997-1#2)
show that T##3##3##(1996-2#1)(2008-10#1)(2013-8#1)
show that a critical##2##4##(1994-2#1)(2010-7#1)
show that a reduction##2##4##(2008-9#1)(2011-2#1)
show that a single##3##4##(1990-11#1)(2006-6#1)(2008-7#1)
show that a##27##3##(1990-11#2)(1994-2#1)(1997-3#1)(1997-9#1)(2006-6#2)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
show that all##2##3##(2007-12#1)(2009-8#1)
show that an##8##3##(1990-5#1)(1994-3#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
show that at##4##3##(1992-3#1)(2008-3#1)(2012-3#1)(2013-8#1)
show that beta-CD reacts with##2##5##(2008-10#2)
show that both##9##3##(1991-9#1)(1993-8#1)(1994-8#1)(1997-3#1)(2008-10#4)(2012-12#1)
show that by##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
show that certain##2##3##(2008-12#1)(2008-5#1)
show that different##2##3##(2011-1#1)(2012-3#1)
show that for a##2##4##(2008-3#1)(2013-8#1)
show that for##5##3##(2007-12#1)(2008-3#2)(2008-9#1)(2013-8#1)
show that high##2##3##(2008-10#1)(2008-11#1)
show that human##2##3##(2008-5#1)(2009-12#1)
show that if##3##3##(2008-5#1)(2009-12#1)(2010-7#1)
show that in the##3##4##(1994-8#1)(2008-2#1)(2008-9#1)
show that in##17##3##(1990-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)
show that increases in##2##4##(2008-10#1)(2011-2#1)
show that individuals with##2##4##(2010-2#1)(2012-2#1)
show that it is##4##4##(1990-5#1)(2008-12#1)(2011-2#1)(2013-1#1)
show that it##8##3##(1990-5#1)(1990-6#1)(1993-9#1)(1995-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
show that its##2##3##(2009-5#1)(2010-5#1)
show that low##2##3##(2008-3#1)(2008-7#1)
show that neither##2##3##(1991-3#1)(1993-12#1)
show that our##4##3##(2008-10#1)(2008-6#1)(2011-3#1)(2012-3#1)
show that positive##3##3##(1994-12#1)(2008-9#1)(2012-3#1)
show that rat##2##3##(1993-3#1)(1993-8#1)
show that some##3##3##(2008-10#1)(2008-9#2)
show that spatial##4##3##(2008-10#1)(2008-8#3)
show that species##2##3##(2009-8#1)(2012-6#1)
show that the STELLS algorithm is##2##6##(2012-3#2)
show that the analysis of##2##5##(2008-10#2)
show that the application of##2##5##(2008-11#1)(2008-3#1)
show that the delivered##2##4##(1996-2#1)(2008-11#1)
show that the effects##2##4##(2008-3#1)(2008-8#1)
show that the evolution of##2##5##(2008-8#1)(2012-3#1)
show that the interaction##2##4##(1994-6#1)(2008-8#1)
show that the main##2##4##(2008-10#1)(2008-3#1)
show that the method is##2##5##(2008-10#2)
show that the model##2##4##(2008-3#1)(2013-8#1)
show that the number##2##4##(1995-12#1)(2008-3#1)
show that the optimal##2##4##(2008-10#1)(2008-3#1)
show that the presence of##2##5##(2008-10#1)(2011-2#1)
show that the previously##2##4##(1990-5#1)(1995-9#1)
show that the proposed##2##4##(1995-9#1)(2013-8#1)
show that the ratio of##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
show that the selectivity of the##2##6##(2008-10#2)
show that the use of##3##5##(1992-2#1)(2011-3#1)(2013-1#1)
show that the##261##3##(1990-11#1)(1990-5#4)(1991-1#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#4)(1996-12#3)(1996-2#2)(1996-5#1)(1997-2#3)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#70)(2008-11#19)(2008-12#2)(2008-2#3)(2008-3#33)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#21)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-2#7)(2012-3#6)(2013-1#6)(2013-8#10)
show that there are two##3##5##(2008-3#1)(2008-8#1)(2011-3#1)
show that there are##6##4##(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-3#1)
show that there is a##6##5##(1991-9#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
show that there is no##3##5##(2008-10#1)(2008-3#1)(2012-3#1)
show that there is##13##4##(1991-9#1)(1994-5#1)(1997-1#1)(2008-10#3)(2008-3#3)(2008-9#1)(2012-2#1)(2012-3#2)
show that there##22##3##(1991-12#1)(1991-9#1)(1994-5#1)(1997-1#1)(2008-10#4)(2008-12#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-3#1)(2012-2#1)(2012-3#2)
show that these##14##3##(1993-2#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-10#3)(2008-11#1)(2009-8#1)(2011-2#1)(2012-3#1)
show that they##2##3##(2008-10#1)(2012-3#1)
show that this is##3##4##(1993-1#1)(2008-10#1)(2012-3#1)
show that this model##2##4##(2008-10#1)(2013-8#1)
show that this procedure##2##4##(2009-8#1)(2012-2#1)
show that this##26##3##(1991-5#1)(1992-9#1)(1993-1#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
show that transmission##2##3##(2008-10#1)(2008-3#1)
show that treatment of##2##4##(2008-10#2)
show that when##2##3##(2008-12#1)(2008-3#1)
show that while##2##3##(1990-5#1)(2012-3#1)
show that with##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
show that##833##2##(1990-11#4)(1990-2#3)(1990-3#1)(1990-5#12)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#3)(1991-5#4)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#5)(1993-12#5)(1993-2#4)(1993-3#2)(1993-6#3)(1993-8#6)(1993-9#1)(1994-1#3)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#5)(1994-6#2)(1994-8#9)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#13)(1995-5#2)(1995-6#5)(1995-8#5)(1995-9#4)(1996-1#2)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#5)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#4)(1997-6#1)(1997-7#9)(1997-8#1)(1997-9#1)(2006-6#3)(2007-11#3)(2007-12#10)(2008-1#1)(2008-10#164)(2008-11#46)(2008-12#13)(2008-2#6)(2008-3#67)(2008-4#1)(2008-5#20)(2008-6#4)(2008-7#19)(2008-8#61)(2008-9#30)(2009-10#5)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#10)(2009-9#6)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#3)(2011-1#2)(2011-2#27)(2011-3#3)(2012-12#2)(2012-2#17)(2012-3#23)(2012-6#1)(2012-7#1)(2013-1#18)(2013-8#23)
show the effect of##2##4##(2008-11#1)(2012-2#1)
show the effectiveness of##3##4##(1996-12#1)(2010-4#1)(2012-2#1)
show the existence of##5##4##(1991-11#1)(2008-10#2)(2010-10#1)(2013-8#1)
show the feasibility of##2##4##(2008-10#2)
show the feasibility##3##3##(2008-10#3)
show the importance of##4##4##(1997-3#1)(2008-10#1)(2008-5#1)(2010-10#1)
show the influence of##2##4##(2008-10#1)(2008-8#1)
show the need for##2##4##(2008-10#1)(2008-8#1)
show the potential##3##3##(2008-10#3)
show the relative##2##3##(2008-10#2)
show the same##2##3##(2008-10#2)
show the usefulness##2##3##(2008-10#1)(2008-3#1)
show the##94##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#3)(2008-10#30)(2008-11#5)(2008-12#1)(2008-3#5)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-3#1)(2013-8#2)
show there is##2##3##(2008-10#1)(2012-3#1)
show there##3##2##(2008-10#2)(2012-3#1)
show this##3##2##(1997-3#1)(2008-5#1)(2008-8#1)
show two##2##2##(2008-10#2)
show up##4##2##(1992-5#1)(2008-1#1)(2008-5#1)(2008-7#1)
show variable##2##2##(2008-5#1)(2011-2#1)
show very##5##2##(2008-10#2)(2008-9#1)(2010-6#1)(2012-2#1)
show##1471##1##(1990-11#10)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#17)(1990-6#4)(1990-8#4)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#6)(1991-2#4)(1991-3#6)(1991-5#7)(1991-6#2)(1991-9#3)(1992-1#1)(1992-10#3)(1992-12#3)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#8)(1993-1#8)(1993-12#7)(1993-2#6)(1993-3#5)(1993-6#6)(1993-8#11)(1993-9#1)(1994-1#3)(1994-11#8)(1994-12#8)(1994-2#6)(1994-3#7)(1994-5#10)(1994-6#3)(1994-8#10)(1994-9#3)(1995-1#2)(1995-11#8)(1995-12#11)(1995-2#15)(1995-3#1)(1995-5#3)(1995-6#9)(1995-8#6)(1995-9#5)(1996-1#2)(1996-11#2)(1996-12#10)(1996-2#8)(1996-3#8)(1996-5#7)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#10)(1997-3#13)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#12)(1997-8#5)(1997-9#1)(2006-6#4)(2007-11#4)(2007-12#18)(2008-1#3)(2008-10#296)(2008-11#87)(2008-12#24)(2008-2#10)(2008-3#91)(2008-4#5)(2008-5#51)(2008-6#10)(2008-7#35)(2008-8#79)(2008-9#45)(2009-1#2)(2009-10#10)(2009-11#2)(2009-12#7)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#6)(2009-7#3)(2009-8#14)(2009-9#8)(2010-1#4)(2010-10#11)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#5)(2010-4#5)(2010-5#6)(2010-6#7)(2010-7#5)(2010-8#5)(2011-1#5)(2011-10#1)(2011-2#58)(2011-3#6)(2012-12#4)(2012-2#39)(2012-3#33)(2012-5#1)(2012-6#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#30)(2013-3#1)(2013-7#2)(2013-8#34)
showed 99%##2##2##(1993-12#1)(2008-10#1)
showed NP##2##2##(2013-8#2)
showed a 50-kDa protein##2##4##(1993-6#2)
showed a better##3##3##(1990-9#1)(2011-2#1)(2013-1#1)
showed a big##2##3##(1997-8#1)(2008-10#1)
showed a clear##5##3##(1993-3#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
showed a close##2##3##(2008-10#1)(2008-11#1)
showed a complete##2##3##(1990-2#1)(2012-3#1)
showed a correlation##2##3##(2008-10#2)
showed a decrease in the##3##5##(1994-8#2)(2008-5#1)
showed a decrease in##6##4##(1994-8#2)(2008-10#2)(2008-12#1)(2008-5#1)
showed a decrease of##2##4##(1994-8#1)(1996-6#1)
showed a decrease##10##3##(1991-1#1)(1994-8#3)(1996-6#1)(2008-10#2)(2008-12#1)(2008-5#2)
showed a decreasing##2##3##(1996-3#1)(2008-10#1)
showed a dramatic##2##3##(2008-10#1)(2013-1#1)
showed a good agreement##4##4##(2008-10#4)
showed a good linearity##2##4##(2008-10#1)(2011-3#1)
showed a good##20##3##(1993-8#1)(1994-8#1)(1996-9#1)(2008-10#11)(2008-11#2)(2008-5#1)(2009-4#1)(2010-4#1)(2011-3#1)
showed a great##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
showed a greater##2##3##(1993-11#1)(2011-10#1)
showed a high affinity for the##2##6##(1994-11#1)(1995-11#1)
showed a high degree of homology##2##6##(1997-1#1)(2008-10#1)
showed a high degree of similarity##2##6##(1993-9#1)(2008-10#1)
showed a high degree of##8##5##(1993-9#1)(1996-2#1)(1997-1#1)(2008-10#4)(2010-12#1)
showed a high##18##3##(1993-9#1)(1994-11#1)(1995-11#2)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#8)(2010-12#1)(2010-4#1)(2011-2#1)
showed a higher frequency##2##4##(1997-8#1)(2008-7#1)
showed a higher prevalence of##2##5##(1996-12#1)(2008-12#1)
showed a higher rate of##2##5##(1997-8#1)(2012-12#1)
showed a higher##17##3##(1991-12#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-8#1)
showed a highly##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
showed a homogeneous##2##3##(2008-5#1)(2008-7#1)
showed a large##2##3##(1990-6#1)(2008-7#1)
showed a larger##2##3##(2008-11#1)(2008-7#1)
showed a lesion##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
showed a linear range of##2##5##(2008-10#2)
showed a linear response##4##4##(2008-10#4)
showed a linear##12##3##(1990-11#1)(2008-10#11)
showed a little##2##3##(2008-10#1)(2008-11#1)
showed a low##5##3##(1991-11#1)(1991-8#1)(1993-6#1)(2008-9#1)(2011-3#1)
showed a lower##8##3##(1991-3#1)(1991-6#1)(2008-10#3)(2008-11#1)(2012-5#1)(2013-8#1)
showed a major##2##3##(1992-12#1)(1993-1#1)
showed a marked##3##3##(1990-12#1)(1994-8#1)(2012-2#1)
showed a moderate##2##3##(2008-5#1)(2010-1#1)
showed a much stronger##2##4##(2008-10#1)(2011-1#1)
showed a near-Nernstian response over the##2##6##(2008-10#2)
showed a negative correlation##2##4##(1991-11#1)(2011-2#1)
showed a negative##3##3##(1991-11#1)(2008-11#1)(2011-2#1)
showed a normal##3##3##(1997-3#1)(2008-9#1)(2011-2#1)
showed a pair of well-defined##2##5##(2008-10#2)
showed a positive##3##3##(1991-2#1)(2010-1#1)(2013-1#1)
showed a precision##2##3##(2008-10#2)
showed a progressive##2##3##(1995-8#1)(2011-1#1)
showed a range of##4##4##(1997-3#1)(2008-10#2)(2008-7#1)
showed a reduced##2##3##(2008-10#1)(2008-9#1)
showed a reduction in##3##4##(1993-3#1)(1994-12#1)(2009-10#1)
showed a reduction##5##3##(1993-3#1)(1994-12#1)(1995-2#1)(2008-10#1)(2009-10#1)
showed a relative standard deviation of##2##6##(2008-10#2)
showed a relatively##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
showed a remarkable increase##2##4##(2008-8#1)(2012-3#1)
showed a significant correlation##2##4##(2008-8#1)(2010-4#1)
showed a significant decrease in total##2##6##(1992-2#1)(2008-12#1)
showed a significant decrease of the##2##6##(1992-6#1)(2008-1#1)
showed a significant decrease of##3##5##(1992-6#1)(2008-1#1)(2009-6#1)
showed a significant decrease##5##4##(1992-2#1)(1992-6#1)(2008-1#1)(2008-12#1)(2009-6#1)
showed a significant difference##3##4##(1990-12#1)(2008-10#1)(2013-8#1)
showed a significant improvement of##2##5##(2008-10#1)(2013-1#1)
showed a significant improvement##3##4##(1991-8#1)(2008-10#1)(2013-1#1)
showed a significant increase in the##3##6##(2008-3#1)(2008-6#1)(2013-7#1)
showed a significant increase in##6##5##(1994-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-7#1)
showed a significant increase##9##4##(1994-2#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2013-7#1)
showed a significant negative##2##4##(2011-2#1)(2012-2#1)
showed a significant##39##3##(1990-12#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-6#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
showed a significantly higher level of##2##6##(2008-10#2)
showed a significantly higher##4##4##(2008-10#2)(2008-7#1)(2011-2#1)
showed a similar pattern of##2##5##(1996-12#1)(2011-2#1)
showed a similar pattern##4##4##(1990-12#1)(1996-12#1)(2011-2#2)
showed a similar##11##3##(1990-12#1)(1990-6#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-8#1)(2011-2#3)
showed a single##2##3##(2008-10#2)
showed a slightly better##2##4##(2008-10#1)(2013-1#1)
showed a slightly##3##3##(1995-3#1)(2008-10#1)(2013-1#1)
showed a smaller##3##3##(2008-5#1)(2008-7#1)(2011-1#1)
showed a stable##2##3##(2008-11#1)(2013-1#1)
showed a statistically significant difference between##2##6##(2008-12#1)(2010-12#1)
showed a statistically significant##4##4##(2008-12#1)(2010-12#1)(2012-12#1)(2013-1#1)
showed a strong##7##3##(1996-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-2#1)(2013-8#1)
showed a substantial##2##3##(2008-10#1)(2013-1#1)
showed a tendency towards##2##4##(1993-3#1)(2011-2#1)
showed a tendency##4##3##(1991-1#1)(1993-3#1)(1993-8#1)(2011-2#1)
showed a trend towards##2##4##(2008-7#1)(2009-3#1)
showed a trend##3##3##(2008-7#1)(2009-3#1)(2011-2#1)
showed a typical##5##3##(1994-8#2)(2008-10#2)(2008-11#1)
showed a very high##2##4##(2008-10#1)(2012-6#1)
showed a very##5##3##(2008-10#3)(2011-2#1)(2012-6#1)
showed a##434##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#4)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#3)(1992-12#2)(1992-2#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#5)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#9)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-8#5)(2007-8#1)(2008-1#2)(2008-10#115)(2008-11#38)(2008-12#6)(2008-2#1)(2008-3#3)(2008-5#12)(2008-6#3)(2008-7#14)(2008-8#8)(2008-9#9)(2009-1#3)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#8)(2010-1#5)(2010-10#2)(2010-12#4)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#6)(2011-10#1)(2011-2#23)(2011-3#3)(2012-12#5)(2012-2#7)(2012-3#7)(2012-5#1)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#12)
showed abnormal##2##2##(2008-5#1)(2008-8#1)
showed abundant##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
showed active##2##2##(2012-12#1)(2013-1#1)
showed activity##3##2##(1995-6#1)(2008-11#1)(2008-7#1)
showed altered##2##2##(2008-10#2)
showed an apparent##4##3##(1997-2#1)(2008-10#2)(2008-11#1)
showed an average##5##3##(1992-3#1)(2008-10#1)(2010-8#1)(2011-2#2)
showed an enhanced##2##3##(2008-10#1)(2008-11#1)
showed an excellent##2##3##(2008-10#1)(2009-4#1)
showed an improvement in##2##4##(2008-10#1)(2011-2#1)
showed an improvement##3##3##(2008-10#2)(2011-2#1)
showed an increase in the##2##5##(2008-10#1)(2013-8#1)
showed an increase in##7##4##(2008-10#4)(2008-11#2)(2013-8#1)
showed an increase of##2##4##(1993-3#1)(2008-3#1)
showed an increase##12##3##(1991-1#1)(1993-3#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#1)(2013-8#1)
showed an increased##2##3##(1990-11#1)(1994-8#1)
showed an initial##2##3##(2008-10#1)(2008-11#1)
showed an intact##2##3##(2008-8#1)(2013-1#1)
showed an interesting##2##3##(1996-1#1)(2012-2#1)
showed an optimum##2##3##(2008-10#2)
showed an overall##2##3##(2008-11#2)
showed an##82##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#2)(1992-3#1)(1992-8#1)(1993-3#1)(1994-8#2)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#2)(1997-3#1)(2008-10#25)(2008-11#11)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
showed any significant##2##3##(1990-11#1)(1993-11#1)
showed any##5##2##(1990-11#1)(1993-11#2)(2008-10#1)(2008-7#1)
showed better##9##2##(1997-8#2)(2008-10#6)(2010-8#1)
showed bilateral##5##2##(1990-3#1)(1997-3#1)(2008-10#1)(2010-11#1)(2011-2#1)
showed both##5##2##(1991-9#1)(2008-10#2)(2011-2#2)
showed changes in##2##3##(2008-10#1)(2009-6#1)
showed changes##3##2##(1995-12#1)(2008-10#1)(2009-6#1)
showed clear##4##2##(2008-10#3)(2008-11#1)
showed comparable##4##2##(1991-6#1)(1994-6#1)(2008-10#1)(2008-11#1)
showed complete##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
showed considerable##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
showed consistent##2##2##(2008-7#1)(2008-8#1)
showed continuous##2##2##(1991-3#1)(2010-4#1)
showed correlation##2##2##(2008-10#1)(2011-2#1)
showed cytotoxicity against K562 cells##2##5##(2008-11#2)
showed cytotoxicity against##3##3##(2008-11#2)(2011-3#1)
showed decreased##3##2##(1991-1#1)(1996-2#1)(2008-5#1)
showed decreases##2##2##(2008-5#1)(2013-1#1)
showed dense##2##2##(2008-11#2)
showed differences##3##2##(1993-12#2)(2008-11#1)
showed different levels of##2##4##(2008-10#2)
showed different##10##2##(1994-8#1)(2006-6#1)(2008-10#7)(2013-1#1)
showed differential expression##2##3##(2010-12#1)(2013-8#1)
showed differential##4##2##(2008-10#1)(2010-12#1)(2012-3#1)(2013-8#1)
showed diffuse##5##2##(1991-12#1)(1997-8#1)(2008-7#1)(2010-12#1)(2013-1#1)
showed distinct##2##2##(2008-8#1)(2009-8#1)
showed elevated eIF4E in##2##4##(1997-7#2)
showed elevated##3##2##(1993-6#1)(1997-7#2)
showed enhanced##6##2##(2008-10#3)(2008-11#2)(2010-11#1)
showed evidence of##7##3##(1997-6#1)(2008-8#1)(2011-2#2)(2012-12#2)(2013-1#1)
showed excellent electrocatalytic##2##3##(2008-10#2)
showed excellent linearity##3##3##(2008-10#2)(2011-3#1)
showed excellent sensitivity##2##3##(2008-10#1)(2012-2#1)
showed excellent##21##2##(1991-2#1)(1993-1#1)(1995-12#1)(2008-10#12)(2008-7#2)(2011-1#1)(2011-3#1)(2012-2#2)
showed extensive##2##2##(1994-12#1)(2008-10#1)
showed for the first time##2##5##(1992-12#1)(2012-2#1)
showed for##6##2##(1992-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
showed four##2##2##(2011-2#1)(2012-3#1)
showed free##2##2##(1993-6#1)(2008-11#1)
showed genotypic##2##2##(2008-10#2)
showed good agreement between the##2##5##(2008-10#2)
showed good agreement between##4##4##(2008-10#3)(2008-5#1)
showed good agreement with the certified value##2##7##(2008-10#2)
showed good agreement with the certified##3##6##(2008-10#3)
showed good agreement with##5##4##(2008-10#5)
showed good agreement##14##3##(2008-10#13)(2008-5#1)
showed good correlation in the concentration##2##6##(2008-10#2)
showed good correlation##4##3##(2008-10#4)
showed good linearity in the concentration range##2##7##(2008-10#2)
showed good linearity##4##3##(2008-10#4)
showed good response##2##3##(2008-10#2)
showed good sensitivity##4##3##(2008-10#3)(2012-2#1)
showed good##52##2##(1990-6#1)(1995-5#1)(2008-10#41)(2008-11#2)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
showed greater##13##2##(1991-12#1)(1994-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-5#2)(2010-4#1)(2012-2#1)
showed growth##4##2##(2008-10#1)(2008-11#2)(2009-6#1)
showed here that##2##3##(2008-11#2)
showed high affinity##4##3##(1994-11#1)(1994-8#1)(2008-10#1)(2009-6#1)
showed high homology to##4##4##(1990-5#1)(1993-12#1)(1996-8#1)(1997-2#1)
showed high homology with##3##4##(1993-8#1)(2008-10#1)(2008-8#1)
showed high homology##8##3##(1990-5#1)(1993-12#1)(1993-8#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
showed high levels of##2##4##(2011-10#1)(2013-1#1)
showed high reliability##2##3##(2008-10#1)(2013-1#1)
showed high selectivity##2##3##(2008-10#2)
showed high sensitivity and##2##4##(2008-10#2)
showed high sensitivity##3##3##(2008-10#3)
showed high##39##2##(1990-5#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#15)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
showed higher expression##2##3##(2008-11#1)(2010-7#1)
showed higher##17##2##(1994-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
showed highest##4##2##(1994-8#1)(2008-10#1)(2011-2#2)
showed homology##2##2##(1996-3#1)(1997-2#1)
showed improved##2##2##(2008-10#1)(2008-11#1)
showed in##7##2##(2008-10#1)(2008-11#2)(2008-12#3)(2011-2#1)
showed increase##2##2##(2012-3#1)(2013-1#1)
showed increased##13##2##(1990-9#1)(1994-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-7#1)(2011-2#4)
showed inhibition##2##2##(2008-11#1)(2008-5#1)
showed it to##2##3##(2008-10#2)
showed lesions##3##2##(2008-7#1)(2013-1#2)
showed less than##2##3##(2008-10#1)(2008-5#1)
showed less##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2012-2#1)
showed linear calibration within##2##4##(2008-10#2)
showed linear calibration##3##3##(2008-10#3)
showed linear response##2##3##(2008-10#2)
showed linear##9##2##(1993-8#1)(2008-10#8)
showed linearity in the range of##2##6##(2008-10#2)
showed little or no##4##4##(1990-11#1)(1991-2#2)(2008-10#1)
showed little variation in##2##4##(1990-9#1)(2008-9#1)
showed little##14##2##(1990-11#1)(1990-9#1)(1991-2#2)(1993-6#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-11#1)(2012-3#1)
showed low##12##2##(1996-12#1)(2008-10#6)(2008-11#1)(2010-12#1)(2011-1#1)(2012-9#1)(2013-8#1)
showed lower levels of##2##4##(2008-10#1)(2012-5#1)
showed lower sleep efficiency##2##4##(2012-3#2)
showed lower##16##2##(1990-12#1)(1996-2#1)(2008-10#4)(2008-7#1)(2009-7#2)(2010-6#1)(2011-2#1)(2012-3#3)(2012-5#1)(2013-1#1)
showed malignant lymphoma##2##3##(2008-10#1)(2009-1#1)
showed many##2##2##(2008-10#1)(2009-8#1)
showed marked dilation of the##2##5##(2010-10#2)
showed marked##13##2##(1990-5#1)(1994-8#1)(2008-10#2)(2008-6#1)(2008-7#2)(2010-10#2)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
showed maximal##2##2##(2008-11#2)
showed maximum##3##2##(1993-11#1)(2008-10#1)(2010-3#1)
showed mediastinal##2##2##(2008-7#1)(2013-1#1)
showed mild##2##2##(2008-10#1)(2008-7#1)
showed minimal##4##2##(1992-3#1)(2008-11#1)(2008-12#1)(2013-1#1)
showed moderate##5##2##(1990-12#1)(1994-5#1)(2008-10#3)
showed more potent##2##3##(2008-11#1)(2008-5#1)
showed more than##3##3##(2008-9#1)(2010-1#1)(2010-5#1)
showed more##10##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
showed most##2##2##(2007-8#1)(2008-10#1)
showed much##4##2##(2008-10#3)(2008-8#1)
showed multiple nodular##2##3##(1990-2#1)(2013-8#1)
showed multiple##4##2##(1990-2#1)(2008-7#1)(2013-8#2)
showed negative##2##2##(1996-12#1)(2008-5#1)
showed no apparent##3##3##(1995-8#1)(2008-11#2)
showed no change in##2##4##(1990-3#1)(2008-11#1)
showed no change##4##3##(1990-3#1)(2008-11#1)(2010-1#1)(2011-1#1)
showed no changes in##2##4##(1990-11#1)(2008-10#1)
showed no clear##2##3##(2008-10#2)
showed no difference in##3##4##(1995-5#1)(1997-6#1)(2008-5#1)
showed no differences between##2##4##(2008-10#2)
showed no effect on##4##4##(1993-2#1)(1994-3#1)(2008-10#2)
showed no effect##5##3##(1993-2#1)(1994-3#1)(2008-10#2)(2008-11#1)
showed no evidence of##5##4##(2008-10#3)(2012-3#1)(2013-1#1)
showed no interference##2##3##(2008-10#2)
showed no negative##2##3##(2008-9#2)
showed no reflux##2##3##(2008-10#2)
showed no significant difference in##4##5##(1991-8#1)(1994-11#1)(2008-11#1)(2008-12#1)
showed no significant difference##5##4##(1991-8#1)(1994-11#1)(2008-11#1)(2008-12#2)
showed no significant differences in the##2##6##(2008-10#1)(2008-12#1)
showed no significant differences##4##4##(2008-10#2)(2008-12#1)(2013-1#1)
showed no significant##17##3##(1991-8#1)(1993-8#1)(1994-11#2)(1995-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
showed no##91##2##(1990-11#2)(1990-3#2)(1991-3#2)(1991-5#1)(1991-8#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#26)(2008-11#8)(2008-12#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#4)
showed normal##5##2##(1993-3#1)(1997-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
showed numerous##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
showed only a##3##3##(1994-2#1)(2008-10#1)(2010-6#1)
showed only one##2##3##(2008-10#1)(2012-3#1)
showed only##14##2##(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-8#1)(2010-6#1)(2012-3#1)
showed partial##5##2##(1990-6#1)(1997-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
showed polymorphism##2##2##(2008-10#1)(2013-8#1)
showed poor##2##2##(1995-8#2)
showed positive##7##2##(1992-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
showed potent##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
showed presence of##2##3##(2008-10#1)(2012-2#1)
showed progression of##2##3##(1994-8#1)(2008-7#1)
showed progression##3##2##(1994-8#1)(2008-7#1)(2011-2#1)
showed proliferation of##2##3##(2011-2#1)(2013-8#1)
showed prolonged##2##2##(2008-7#1)(2010-6#1)
showed promising results##2##3##(2010-7#1)(2013-8#1)
showed protection##2##2##(2008-11#1)(2008-5#1)
showed reduced pathogenicity##2##3##(2008-10#2)
showed reduced##7##2##(1993-6#1)(2008-10#2)(2008-11#2)(2009-11#1)(2012-3#1)
showed reductions in##2##3##(2008-10#1)(2012-3#1)
showed relatively##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#1)
showed residual##2##2##(1993-2#1)(2009-11#1)
showed resistance to the##2##4##(2008-10#1)(2008-9#1)
showed resistance to##9##3##(2008-10#6)(2008-9#1)(2011-2#1)(2012-3#1)
showed resistance##10##2##(2008-10#7)(2008-9#1)(2011-2#1)(2012-3#1)
showed satisfactory##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
showed several clusters of##2##4##(2008-10#1)(2008-11#1)
showed several##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2010-4#1)
showed severe toxicity##2##3##(2008-12#1)(2008-7#1)
showed severe##7##2##(1997-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-6#1)
showed significant association between##2##4##(2008-10#1)(2011-2#1)
showed significant association##3##3##(2008-10#2)(2011-2#1)
showed significant correlations##2##3##(2008-10#1)(2008-11#1)
showed significant decrease in##2##4##(2008-12#1)(2012-2#1)
showed significant difference in##2##4##(2008-12#1)(2011-2#1)
showed significant difference##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
showed significant differences##3##3##(1995-8#1)(2008-5#1)(2010-9#1)
showed significant homology to##2##4##(1997-7#1)(2008-10#1)
showed significant homology##3##3##(1997-7#1)(2008-10#2)
showed significant improvement in##2##4##(2008-10#1)(2013-1#1)
showed significant improvement##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
showed significant increases##2##3##(1995-12#1)(2008-12#1)
showed significant positive correlations with##3##5##(2010-10#1)(2011-1#2)
showed significant positive correlations##4##4##(2010-10#1)(2010-8#1)(2011-1#2)
showed significant positive##5##3##(2010-10#1)(2010-8#1)(2011-1#2)(2012-2#1)
showed significant##56##2##(1991-5#2)(1995-12#2)(1995-5#1)(1995-8#2)(1997-7#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#3)
showed significantly greater##2##3##(2008-10#1)(2008-8#1)
showed significantly higher levels of##3##5##(2008-10#1)(2009-12#1)(2010-3#1)
showed significantly higher##8##3##(2008-10#3)(2008-5#1)(2008-8#1)(2009-12#1)(2010-3#2)
showed significantly less##2##3##(2008-7#1)(2013-1#1)
showed significantly lower##3##3##(1997-8#1)(2008-10#1)(2012-3#1)
showed significantly##21##2##(1990-12#1)(1991-12#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-1#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#1)
showed signs of##5##3##(1991-6#2)(1994-3#1)(2008-10#1)(2013-1#1)
showed similar behavior##2##3##(1991-2#1)(1991-6#1)
showed similar results##2##3##(1994-12#1)(2011-2#1)
showed similar##32##2##(1991-2#1)(1991-6#1)(1993-8#1)(1994-12#1)(1994-8#2)(1996-1#1)(1996-2#2)(1997-1#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#3)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#3)(2013-8#2)
showed similarity to##2##3##(1996-6#2)
showed slight##3##2##(1997-8#1)(2008-10#2)
showed some differences in##2##4##(2008-10#2)
showed some differences##3##3##(2008-10#2)(2008-5#1)
showed some##12##2##(1994-12#1)(1995-8#1)(1997-2#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)
showed statistically significant differences##2##4##(2008-12#1)(2008-7#1)
showed statistically significant##4##3##(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
showed strong positive##2##3##(2008-10#1)(2012-3#1)
showed strong##14##2##(1995-2#1)(2008-10#7)(2008-11#2)(2008-9#1)(2011-3#1)(2012-3#1)(2013-1#1)
showed stronger##2##2##(2008-11#1)(2011-2#1)
showed strongest##2##2##(1991-3#1)(2008-5#1)
showed sufficient##2##2##(2008-5#1)(2008-7#1)
showed superior extractability of uranium##2##5##(2008-10#2)
showed superior extraction##2##3##(2008-10#2)
showed superior##6##2##(2008-10#6)
showed symptoms##3##2##(2008-10#3)
showed that 19##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
showed that DNA##2##3##(1995-11#1)(2008-11#1)
showed that FSTRAP##2##3##(2008-8#2)
showed that P##2##3##(2008-10#2)
showed that T##2##3##(2008-10#2)
showed that YY1 was##2##4##(2008-11#2)
showed that a##16##3##(1990-5#1)(1990-9#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
showed that after##5##3##(2008-11#2)(2008-9#1)(2009-3#1)(2013-8#1)
showed that all of##2##4##(2008-10#1)(2008-5#1)
showed that all the##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
showed that all##14##3##(1993-8#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
showed that almost all##2##4##(1993-6#1)(2012-2#1)
showed that approximately##2##3##(2008-10#1)(2008-12#1)
showed that at##5##3##(2006-6#1)(2008-10#2)(2008-4#1)(2008-8#1)
showed that axons##2##3##(2008-11#1)(2011-2#1)
showed that beta-amylase##2##3##(2008-9#2)
showed that both the##5##4##(1991-6#1)(2008-10#1)(2008-7#1)(2008-9#2)
showed that both##18##3##(1991-6#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2010-10#1)
showed that by##2##3##(1993-11#1)(2008-10#1)
showed that cell##3##3##(2008-11#3)
showed that cigarette##2##3##(2008-12#1)(2008-5#1)
showed that deletion of##2##4##(1997-3#1)(2012-2#1)
showed that each of##2##4##(1991-7#1)(2008-7#1)
showed that each##5##3##(1991-7#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-7#1)
showed that expression levels of##2##5##(2008-11#1)(2008-9#1)
showed that expression##3##3##(1997-1#1)(2008-11#1)(2008-9#1)
showed that for##5##3##(2008-10#3)(2008-8#1)(2013-8#1)
showed that human##2##3##(2008-11#2)
showed that in##9##3##(1993-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
showed that increasing##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
showed that irradiation##2##3##(1995-6#1)(2008-10#1)
showed that isolates##2##3##(2008-10#2)
showed that it contained##2##4##(1991-9#1)(1995-12#1)
showed that it is##5##4##(1991-10#1)(1994-12#1)(1995-12#1)(2008-10#2)
showed that it was##2##4##(2008-10#2)
showed that it##13##3##(1990-12#1)(1990-5#1)(1991-10#1)(1991-9#1)(1994-12#1)(1995-12#2)(2008-10#5)(2009-7#1)
showed that most of##2##4##(1997-2#1)(2008-10#1)
showed that most##7##3##(1990-2#1)(1992-9#1)(1995-6#1)(1997-2#1)(2008-10#3)
showed that no##3##3##(2008-10#2)(2008-9#1)
showed that one of##2##4##(1990-5#1)(2009-8#1)
showed that one##5##3##(1990-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
showed that only##7##3##(1993-11#1)(2008-10#6)
showed that patients##2##3##(2008-11#1)(2011-2#1)
showed that performance##2##3##(1992-12#1)(2009-4#1)
showed that plants##2##3##(2008-10#1)(2012-7#1)
showed that propranolol##2##3##(2008-10#1)(2009-8#1)
showed that purified##2##3##(1990-11#1)(2012-2#1)
showed that several##4##3##(1991-6#1)(1991-9#1)(2008-3#1)(2011-2#1)
showed that single##2##3##(2008-10#2)
showed that some##6##3##(1994-2#1)(2008-10#1)(2008-12#1)(2008-9#2)(2013-8#1)
showed that species of##2##4##(2008-10#1)(2008-12#1)
showed that specimens##2##3##(2008-10#2)
showed that such a##2##4##(2008-11#1)(2009-10#1)
showed that the 2##2##4##(2008-10#2)
showed that the activity##2##4##(1993-2#1)(2008-9#1)
showed that the area##2##4##(2008-10#1)(2008-11#1)
showed that the average##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
showed that the binding##2##4##(2008-10#1)(2008-8#1)
showed that the effects##2##4##(1997-1#1)(2008-5#1)
showed that the enzyme##3##4##(1991-5#1)(1994-11#1)(2008-7#1)
showed that the expression##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
showed that the fungus##2##4##(2008-10#2)
showed that the growth of##2##5##(2008-10#1)(2008-8#1)
showed that the highest##2##4##(2008-10#1)(2008-12#1)
showed that the isolates##2##4##(1996-12#1)(2008-10#1)
showed that the level of##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
showed that the major##2##4##(2008-10#1)(2008-6#1)
showed that the mean##2##4##(2008-10#1)(2010-7#1)
showed that the most##2##4##(2008-10#1)(2011-2#1)
showed that the number of##3##5##(2008-1#1)(2008-8#1)(2013-8#1)
showed that the optimal##2##4##(1994-11#1)(2008-8#1)
showed that the optimum##2##4##(2008-10#2)
showed that the presence of##2##5##(2008-10#1)(2012-12#1)
showed that the proposed method could##2##6##(2008-10#2)
showed that the proposed method##3##5##(2008-10#3)
showed that the proposed##5##4##(2008-10#5)
showed that the purified##2##4##(1990-10#1)(2008-9#1)
showed that the response##2##4##(2008-10#1)(2008-11#1)
showed that the retention##2##4##(2008-10#2)
showed that the three##3##4##(2008-5#1)(2008-9#1)(2009-12#1)
showed that the transgene##2##4##(2008-10#1)(2008-12#1)
showed that the use of##2##5##(2008-10#1)(2008-5#1)
showed that the##295##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-10#1)(1992-12#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-2#2)(1994-8#2)(1995-2#2)(1995-6#3)(1995-8#2)(1996-12#3)(1996-2#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#2)(2006-6#1)(2007-12#1)(2008-1#3)(2008-10#98)(2008-11#18)(2008-12#5)(2008-3#2)(2008-5#13)(2008-6#2)(2008-7#10)(2008-8#31)(2008-9#16)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-6#2)(2010-7#2)(2011-10#1)(2011-2#11)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#5)(2013-8#6)
showed that there are two##2##5##(1992-3#1)(2008-8#1)
showed that there are##4##4##(1992-3#1)(2008-5#1)(2008-8#2)
showed that there was a##3##5##(1997-3#1)(2008-12#1)(2008-9#1)
showed that there was an##2##5##(1997-8#1)(2013-8#1)
showed that there was no##3##5##(2008-12#1)(2008-8#1)(2009-7#1)
showed that there was##8##4##(1997-3#1)(1997-8#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
showed that there were no##2##5##(2008-10#1)(2008-12#1)
showed that there were significant differences between##2##7##(2008-10#1)(2008-12#1)
showed that there were##5##4##(2008-10#3)(2008-12#2)
showed that there##18##3##(1992-3#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-12#4)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-7#1)(2013-8#1)
showed that these compounds##2##4##(2008-10#2)
showed that these##11##3##(1994-11#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#2)(2009-6#1)
showed that they##5##3##(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)
showed that this new##2##4##(2008-5#1)(2008-8#1)
showed that this##12##3##(1995-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)
showed that trophic##2##3##(2008-8#1)(2010-8#1)
showed that virus replication was##2##5##(1997-3#1)(2008-10#1)
showed that virus##3##3##(1997-3#1)(2008-10#2)
showed that when##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
showed that while##2##3##(2008-8#1)(2009-7#1)
showed that with##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
showed that##958##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#6)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#4)(1991-7#2)(1991-9#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#3)(1993-1#2)(1993-11#3)(1993-2#4)(1993-3#2)(1993-6#6)(1993-8#5)(1994-11#4)(1994-12#2)(1994-2#5)(1994-8#3)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-6#7)(1995-8#4)(1995-9#1)(1996-1#2)(1996-12#10)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#4)(1997-3#7)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#5)(2006-6#3)(2007-12#2)(2008-1#4)(2008-10#306)(2008-11#68)(2008-12#28)(2008-3#5)(2008-4#1)(2008-5#30)(2008-6#7)(2008-7#26)(2008-8#80)(2008-9#72)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#7)(2009-7#7)(2009-8#8)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#3)(2011-1#1)(2011-10#2)(2011-2#30)(2011-3#9)(2012-12#3)(2012-2#10)(2012-3#14)(2012-7#1)(2012-8#1)(2013-1#16)(2013-7#1)(2013-8#22)
showed the ability to##2##4##(2008-10#1)(2012-2#1)
showed the best##5##3##(2008-10#5)
showed the distribution of##2##4##(2008-10#2)
showed the expected##3##3##(2008-10#1)(2009-8#2)
showed the formation of##2##4##(1994-8#1)(2011-2#1)
showed the greatest##4##3##(1992-9#1)(1995-12#1)(2008-10#2)
showed the highest level of##3##5##(2008-10#1)(2008-8#1)(2010-3#1)
showed the highest rate##2##4##(2011-2#1)(2013-1#1)
showed the highest sensitivity##2##4##(2008-10#1)(2008-11#1)
showed the highest##28##3##(2008-10#11)(2008-11#1)(2008-12#2)(2008-5#2)(2008-8#1)(2009-6#2)(2009-7#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#4)
showed the largest##2##3##(2008-10#1)(2011-2#1)
showed the lowest##4##3##(2009-7#1)(2010-5#1)(2013-1#2)
showed the most##6##3##(1996-2#1)(2008-10#2)(2011-1#1)(2012-3#1)(2013-8#1)
showed the opposite##2##3##(1993-8#1)(2009-10#1)
showed the possibility##2##3##(2008-10#1)(2008-5#1)
showed the presence of a##3##5##(1997-1#1)(2008-10#2)
showed the presence of##13##4##(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#7)(2008-5#1)(2009-10#1)(2013-7#1)
showed the same pattern of##2##5##(2008-10#1)(2008-11#1)
showed the same##10##3##(1990-12#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
showed the typical##2##3##(1995-8#1)(2007-12#1)
showed the##157##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1992-9#1)(1993-1#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#3)(2008-10#69)(2008-11#8)(2008-12#4)(2008-3#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-6#3)(2009-7#2)(2009-8#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#3)
showed these##4##2##(1994-11#1)(2008-10#2)(2008-9#1)
showed to be##6##3##(2008-10#6)
showed two distinct##2##3##(1991-8#1)(2008-10#1)
showed two##7##2##(1991-8#1)(1993-6#1)(2008-10#4)(2012-12#1)
showed typical##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
showed unique##2##2##(2008-11#1)(2012-3#1)
showed unusual##2##2##(2008-12#1)(2012-3#1)
showed up as significant##2##4##(2008-10#2)
showed up to##2##3##(1992-12#1)(2008-11#1)
showed up##4##2##(1992-12#1)(2008-10#2)(2008-11#1)
showed values of##2##3##(1993-3#1)(2008-10#1)
showed variations##2##2##(2008-11#1)(2011-2#1)
showed various##2##2##(2008-10#1)(2008-7#1)
showed varying degrees of##2##4##(2008-10#1)(2013-8#1)
showed varying##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
showed very good##2##3##(2008-10#1)(2008-5#1)
showed very##7##2##(2008-10#5)(2008-5#1)(2008-7#1)
showed weak##6##2##(1990-11#1)(1994-8#1)(1995-8#1)(2008-10#2)(2011-2#1)
showed##2822##1##(1990-10#3)(1990-11#13)(1990-12#13)(1990-2#8)(1990-3#5)(1990-5#10)(1990-6#10)(1990-8#2)(1990-9#5)(1991-1#6)(1991-10#2)(1991-11#3)(1991-12#9)(1991-2#9)(1991-3#8)(1991-5#7)(1991-6#10)(1991-7#2)(1991-8#5)(1991-9#3)(1992-10#1)(1992-12#9)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#7)(1993-1#5)(1993-11#7)(1993-12#8)(1993-2#6)(1993-3#9)(1993-6#16)(1993-8#15)(1993-9#1)(1994-1#1)(1994-11#18)(1994-12#8)(1994-2#10)(1994-3#6)(1994-5#3)(1994-6#1)(1994-8#31)(1995-11#8)(1995-12#15)(1995-2#8)(1995-3#3)(1995-5#4)(1995-6#12)(1995-8#16)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#22)(1996-2#11)(1996-3#6)(1996-5#1)(1996-6#7)(1996-8#2)(1996-9#2)(1997-1#10)(1997-2#13)(1997-3#23)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#6)(1997-8#22)(2006-6#6)(2007-11#1)(2007-12#9)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#886)(2008-11#212)(2008-12#67)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#100)(2008-6#17)(2008-7#99)(2008-8#115)(2008-9#103)(2009-1#6)(2009-10#7)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#8)(2009-4#4)(2009-5#2)(2009-6#17)(2009-7#13)(2009-8#23)(2009-9#1)(2010-1#11)(2010-10#9)(2010-11#7)(2010-12#14)(2010-2#3)(2010-3#8)(2010-4#12)(2010-5#9)(2010-6#12)(2010-7#6)(2010-8#11)(2010-9#1)(2011-1#19)(2011-10#4)(2011-2#134)(2011-3#17)(2012-12#22)(2012-2#41)(2012-3#54)(2012-5#2)(2012-6#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#103)(2013-7#4)(2013-8#59)
shower##2##1##(2008-5#2)
showers##6##1##(1995-6#1)(2008-10#5)
showing CGE##2##2##(2010-4#2)
showing a good##2##3##(2008-10#1)(2012-3#1)
showing a##25##2##(1993-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-7#1)(1997-8#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-3#1)(2013-1#1)
showing an increase##2##3##(1992-6#1)(1994-2#1)
showing an##9##2##(1990-2#1)(1992-2#1)(1992-6#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-5#1)
showing at the##2##3##(1993-8#1)(1994-9#1)
showing at##3##2##(1993-8#1)(1994-9#1)(1996-1#1)
showing direct##2##2##(1990-5#1)(1997-4#1)
showing either##3##2##(2008-10#3)
showing enhanced##2##2##(2008-9#2)
showing good repeatability##2##3##(2008-10#2)
showing greater##2##2##(2008-10#2)
showing high##2##2##(1993-1#1)(2008-8#1)
showing how the##3##3##(1997-2#1)(2008-12#1)(2008-7#1)
showing how##5##2##(1997-2#2)(2008-12#1)(2008-7#1)(2012-2#1)
showing increased##2##2##(1996-12#1)(2008-5#1)
showing its##2##2##(2008-10#1)(2010-6#1)
showing no significant##2##3##(2008-10#1)(2008-5#1)
showing no##6##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2013-1#1)
showing reduced##2##2##(2008-11#1)(2011-2#1)
showing severe##2##2##(2008-10#1)(2012-3#1)
showing some##2##2##(1990-11#1)(2010-6#1)
showing strong##2##2##(2008-10#1)(2011-3#1)
showing that the##10##3##(1991-2#1)(1991-3#1)(1992-3#1)(1993-6#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
showing that these##2##3##(2009-8#1)(2011-2#1)
showing that this##2##3##(1996-12#1)(2008-10#1)
showing that treatment##2##3##(1997-5#1)(2008-10#1)
showing that##45##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)
showing the most significant effect##2##5##(2008-10#1)(2008-11#1)
showing the most significant##3##4##(2008-1#1)(2008-10#1)(2008-11#1)
showing the most##4##3##(2008-1#1)(2008-10#1)(2008-11#2)
showing the##36##2##(1991-11#1)(1992-12#1)(1992-6#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
showing their##2##2##(2008-10#1)(2008-7#1)
showing typical##3##2##(2008-10#2)(2009-8#1)
showing##267##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#3)(1995-2#3)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#73)(2008-11#17)(2008-12#8)(2008-3#1)(2008-5#15)(2008-7#12)(2008-8#3)(2008-9#12)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#1)(2011-10#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#2)
shown a positive correlation##3##4##(1995-9#1)(2008-12#1)(2011-2#1)
shown a positive##4##3##(1993-3#1)(1995-9#1)(2008-12#1)(2011-2#1)
shown a##16##2##(1991-12#1)(1992-12#1)(1993-3#1)(1994-8#1)(1995-9#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2011-2#1)
shown an appreciable##2##3##(2008-10#2)
shown an##4##2##(1991-6#1)(2008-10#3)
shown and##3##2##(1991-8#1)(2008-3#1)(2008-8#1)
shown any##3##2##(2008-10#1)(2012-3#2)
shown as##2##2##(2008-10#1)(2008-8#1)
shown at##4##2##(2008-10#2)(2008-11#2)
shown between the##2##3##(2008-10#2)
shown between##3##2##(2008-10#2)(2011-1#1)
shown both##3##2##(2008-12#1)(2008-7#1)(2010-1#1)
shown by 1-day-old chicks##2##4##(2008-5#2)
shown by FTIR##2##3##(2008-10#2)
shown by a##4##3##(1990-5#1)(2008-10#3)
shown by immunoelectron microscopy##2##4##(1996-3#1)(2011-1#1)
shown by studies##2##3##(1995-5#1)(2011-2#1)
shown by the##14##3##(1990-12#2)(1990-2#1)(1990-9#1)(1991-6#1)(1995-12#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-2#2)
shown by##67##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-9#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-5#1)(2013-1#1)
shown enormous potential in##2##4##(2008-10#1)(2009-7#1)
shown for the##3##3##(1990-11#1)(2008-10#2)
shown for##10##2##(1990-11#1)(1996-3#1)(2008-10#6)(2008-11#1)(2011-2#1)
shown here that##4##3##(1992-3#1)(2008-10#2)(2008-3#1)
shown here##6##2##(1992-3#1)(2008-10#3)(2008-3#1)(2009-8#1)
shown how##6##2##(2008-10#1)(2008-11#1)(2008-6#2)(2008-8#1)(2010-4#1)
shown in a##2##3##(1996-3#1)(2008-10#1)
shown in the##6##3##(1993-2#1)(1995-3#1)(2008-10#3)(2008-7#1)
shown in this##2##3##(2008-10#2)
shown in##26##2##(1990-5#1)(1991-1#1)(1991-12#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
shown not##2##2##(1990-12#1)(2011-2#1)
shown on##2##2##(1997-3#1)(2008-12#1)
shown previously##4##2##(1994-8#1)(1995-2#1)(2008-10#1)(2009-8#1)
shown promise##3##2##(2008-10#1)(2010-10#1)(2010-4#1)
shown some##4##2##(2008-10#2)(2008-11#2)
shown that (i)##2##3##(1993-8#1)(2008-8#1)
shown that a##21##3##(1990-3#1)(1994-11#1)(1994-8#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2010-12#1)(2011-2#3)(2012-3#1)
shown that an optimal##2##4##(2008-11#1)(2008-3#1)
shown that an##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
shown that both##5##3##(1995-1#1)(2008-10#2)(2008-11#1)(2013-8#1)
shown that in the##5##4##(1990-5#1)(1994-8#1)(2008-10#2)(2013-7#1)
shown that in##9##3##(1990-5#1)(1994-8#1)(2008-10#4)(2008-11#1)(2011-1#1)(2013-7#1)
shown that it is##3##4##(2008-11#1)(2008-3#1)(2011-1#1)
shown that it##4##3##(2008-11#1)(2008-3#1)(2011-1#1)(2013-8#1)
shown that loss of##3##4##(2013-1#2)(2013-7#1)
shown that one##2##3##(2008-3#1)(2013-1#1)
shown that only##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
shown that oral##2##3##(2008-11#1)(2008-5#1)
shown that polar##2##3##(2008-10#1)(2009-8#1)
shown that several##2##3##(2008-10#1)(2011-2#1)
shown that the different##2##4##(2008-11#2)
shown that the method##4##4##(2008-10#2)(2008-3#1)(2010-6#1)
shown that the presence of##3##5##(2008-1#1)(2009-1#1)(2013-1#1)
shown that the##97##3##(1990-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#30)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#4)(2009-1#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
shown that there is##3##4##(1991-3#1)(2008-7#1)(2008-9#1)
shown that these##7##3##(1995-2#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-11#1)
shown that this##11##3##(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2011-2#2)
shown that three##2##3##(2008-12#1)(2008-3#1)
shown that women##2##3##(2008-12#1)(2008-4#1)
shown that##396##2##(1990-11#2)(1990-3#1)(1990-5#3)(1991-3#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#5)(1994-2#1)(1994-5#4)(1994-6#1)(1994-8#6)(1995-1#1)(1995-12#3)(1995-2#4)(1995-5#3)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#2)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-1#7)(2008-10#93)(2008-11#29)(2008-12#5)(2008-2#10)(2008-3#29)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#18)(2008-9#6)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#6)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#17)(2012-2#6)(2012-3#7)(2013-1#10)(2013-7#2)(2013-8#8)
shown the best selectivity##2##4##(2008-10#2)
shown the best##3##3##(2008-10#3)
shown the##14##2##(1992-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
shown these##2##2##(2008-11#1)(2011-2#1)
shown through##2##2##(1995-11#1)(2008-10#1)
shown to accumulate##2##3##(2008-11#1)(2012-3#1)
shown to acquire##2##3##(2008-10#2)
shown to activate##8##3##(1992-4#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#2)(2011-2#1)
shown to agree##3##3##(2008-3#3)
shown to alter the##3##4##(2008-11#1)(2008-7#1)(2010-12#1)
shown to alter##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)
shown to be a powerful##2##5##(2008-10#1)(2008-3#1)
shown to be a useful##2##5##(1994-12#1)(2010-7#1)
shown to be a##24##4##(1990-11#1)(1990-8#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-12#1)
shown to be an important##2##5##(1992-1#1)(2008-10#1)
shown to be an##6##4##(1992-1#1)(1997-1#1)(2008-10#4)
shown to be associated with##2##5##(2008-10#1)(2011-1#1)
shown to be capable of separating##2##6##(2008-10#1)(2008-11#1)
shown to be capable of##6##5##(2008-10#4)(2008-11#1)(2011-2#1)
shown to be dependent on##4##5##(1991-5#1)(1995-9#1)(2008-10#1)(2008-11#1)
shown to be effective as##2##5##(2008-10#1)(2008-11#1)
shown to be effective##6##4##(2008-10#1)(2008-11#4)(2009-10#1)
shown to be equal to##2##5##(1991-5#1)(2008-10#1)
shown to be equivalent to##2##5##(2008-10#2)
shown to be essential for##4##5##(1993-12#1)(2008-11#1)(2008-5#2)
shown to be essential##5##4##(1993-12#1)(2008-11#1)(2008-5#2)(2010-7#1)
shown to be expressed in##3##5##(1995-6#1)(2010-5#2)
shown to be highly specific for##2##6##(1990-2#1)(1996-2#1)
shown to be highly##4##4##(1990-2#1)(1993-3#1)(1996-2#1)(2012-3#1)
shown to be increased##2##4##(1994-8#1)(2008-5#1)
shown to be involved in the##3##6##(2008-10#2)(2010-10#1)
shown to be involved in##4##5##(1994-5#1)(2008-10#2)(2010-10#1)
shown to be mediated by##2##5##(1996-12#1)(1997-1#1)
shown to be more##4##4##(2008-11#1)(2008-2#1)(2009-8#1)(2012-2#1)
shown to be necessary for##2##5##(1993-9#1)(2008-9#1)
shown to be one of##2##5##(1997-3#1)(2013-1#1)
shown to be preferable##2##4##(2008-10#2)
shown to be present as##2##5##(1991-5#1)(1995-2#1)
shown to be present##5##4##(1991-5#2)(1995-2#1)(1996-8#1)(2008-4#1)
shown to be quite##2##4##(2008-11#1)(2010-11#1)
shown to be regulated##4##4##(1993-8#1)(1997-2#1)(2010-3#1)(2011-2#1)
shown to be related to the##2##6##(1994-5#1)(2008-10#1)
shown to be released##2##4##(1997-4#1)(2008-10#1)
shown to be reliable##2##4##(1992-3#2)
shown to be the##6##4##(1991-6#1)(2008-10#1)(2008-11#3)(2008-7#1)
shown to be tolerant##2##4##(2008-10#1)(2008-8#1)
shown to be useful for##3##5##(2008-10#2)(2011-1#1)
shown to be useful in##2##5##(2008-10#1)(2008-8#1)
shown to be useful##5##4##(2008-10#3)(2008-8#1)(2011-1#1)
shown to be very##2##4##(1997-8#1)(2008-10#1)
shown to be##214##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#5)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#1)(2008-10#62)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-5#2)(2010-7#3)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
shown to belong to the##2##5##(2008-10#1)(2008-5#1)
shown to belong to##3##4##(2008-10#2)(2008-5#1)
shown to bind to##4##4##(1994-5#1)(1995-12#1)(2008-5#1)(2008-6#1)
shown to bind##7##3##(1990-10#1)(1991-5#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-5#1)(2008-6#1)
shown to contain##6##3##(1991-10#1)(1991-2#1)(1992-12#1)(2008-10#2)(2012-12#1)
shown to correlate with##4##4##(1996-12#1)(2009-11#1)(2009-12#1)(2011-1#1)
shown to decrease##4##3##(1992-6#1)(2008-10#1)(2009-7#1)(2010-11#1)
shown to depend on the##3##5##(1992-12#1)(1994-11#1)(2008-10#1)
shown to differ##2##3##(1991-5#1)(1996-12#1)
shown to display##2##3##(1990-12#1)(2008-10#1)
shown to encode a##2##4##(1993-12#1)(1997-4#1)
shown to encode##3##3##(1993-12#1)(1997-4#1)(2008-11#1)
shown to enhance the##2##4##(2009-4#1)(2012-12#1)
shown to enhance##3##3##(2008-11#1)(2009-4#1)(2012-12#1)
shown to exist in##4##4##(1993-8#1)(1995-11#1)(2008-9#2)
shown to exist##6##3##(1993-8#1)(1995-11#1)(1995-8#1)(2008-8#1)(2008-9#2)
shown to form##2##3##(2008-10#1)(2010-11#1)
shown to give##3##3##(1995-5#1)(2008-10#2)
shown to have a##6##4##(1993-3#1)(1994-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-7#1)
shown to have an##3##4##(1990-12#1)(1997-1#1)(2009-7#1)
shown to have no##2##4##(1993-8#1)(2008-10#1)
shown to have strong##2##4##(2008-10#1)(2008-8#1)
shown to have##23##3##(1990-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1997-1#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-7#3)
shown to improve the##5##4##(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
shown to improve##8##3##(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
shown to increase the percentage of##2##6##(2008-1#1)(2008-10#1)
shown to increase the##5##4##(1996-2#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-3#1)
shown to increase##10##3##(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-3#1)
shown to induce##7##3##(1993-12#1)(1995-12#1)(1995-5#2)(1997-3#1)(2008-11#1)(2013-1#1)
shown to inhibit##5##3##(1995-2#1)(1995-8#2)(2008-11#1)(2010-11#1)
shown to interact with##5##4##(1993-8#1)(1994-5#1)(1995-2#2)(2008-10#1)
shown to interact##6##3##(1993-8#1)(1994-5#1)(1995-2#2)(2008-10#1)(2008-4#1)
shown to involve the##2##4##(1995-6#1)(1997-8#1)
shown to lyse##2##3##(1994-3#1)(2009-6#1)
shown to markedly##3##3##(1991-5#1)(2008-12#1)(2013-8#1)
shown to occur in##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
shown to occur##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
shown to operate##2##3##(2008-10#1)(2008-3#1)
shown to play##7##3##(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)
shown to possess the##3##4##(1993-8#1)(2008-10#2)
shown to predict##3##3##(1995-12#1)(2008-8#1)(2008-9#1)
shown to produce a##2##4##(1997-7#1)(2008-10#1)
shown to produce##4##3##(1997-7#1)(2007-12#1)(2008-10#1)(2011-1#1)
shown to provide a##3##4##(1994-12#1)(2008-10#2)
shown to provide##12##3##(1994-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-10#2)(2010-12#1)
shown to reduce the##2##4##(1992-4#1)(2008-10#1)
shown to reduce##8##3##(1992-4#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-3#1)
shown to remain##2##3##(2008-10#1)(2008-7#1)
shown to result from##2##4##(1994-5#1)(2008-10#1)
shown to result##4##3##(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)
shown to significantly##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
shown to stimulate the##2##4##(1991-6#1)(1997-1#1)
shown to stimulate##3##3##(1991-6#1)(1997-1#2)
shown to suppress##3##3##(2008-10#2)(2010-7#1)
shown to transmit##2##3##(2008-10#2)
shown to work##2##3##(1991-1#1)(2008-10#1)
shown to##512##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#3)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#10)(1991-6#3)(1991-9#2)(1992-1#1)(1992-12#3)(1992-3#3)(1992-4#2)(1992-6#3)(1992-9#1)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#5)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#8)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#1)(1995-5#4)(1995-6#11)(1995-8#4)(1995-9#1)(1996-12#7)(1996-2#6)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#7)(1997-2#4)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#3)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#124)(2008-11#40)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#11)(2008-6#4)(2008-7#16)(2008-8#11)(2008-9#14)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#5)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#5)(2009-8#6)(2010-1#1)(2010-10#6)(2010-11#7)(2010-12#3)(2010-3#2)(2010-5#4)(2010-7#4)(2010-9#1)(2011-1#5)(2011-2#13)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#7)(2013-8#6)
shown unchanged##2##2##(2008-10#1)(2008-9#1)
shown with##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
shown##1209##1##(1990-10#1)(1990-11#6)(1990-12#9)(1990-2#5)(1990-3#1)(1990-5#7)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#13)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#2)(1992-3#8)(1992-4#2)(1992-6#5)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#8)(1993-2#4)(1993-3#7)(1993-6#4)(1993-8#8)(1993-9#4)(1994-11#7)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#14)(1994-6#2)(1994-8#11)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#11)(1995-2#14)(1995-3#2)(1995-5#8)(1995-6#11)(1995-8#7)(1995-9#3)(1996-12#9)(1996-2#12)(1996-3#6)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#14)(1997-2#11)(1997-3#8)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#5)(2006-6#1)(2007-11#4)(2007-12#6)(2007-8#1)(2007-9#1)(2008-1#11)(2008-10#305)(2008-11#89)(2008-12#16)(2008-2#12)(2008-3#45)(2008-4#7)(2008-5#29)(2008-6#13)(2008-7#32)(2008-8#38)(2008-9#26)(2009-1#2)(2009-10#11)(2009-11#2)(2009-12#7)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#9)(2009-8#18)(2009-9#2)(2010-1#5)(2010-10#8)(2010-11#10)(2010-12#11)(2010-3#6)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#12)(2011-2#43)(2012-12#6)(2012-2#15)(2012-3#17)(2012-5#1)(2013-1#22)(2013-7#2)(2013-8#20)
shows 84% identity##2##3##(1993-3#1)(1996-12#1)
shows Na(+)##2##2##(2008-10#2)
shows a decrease##2##3##(2008-10#1)(2008-3#1)
shows a fast response##2##4##(2008-10#2)
shows a fast##3##3##(2008-10#3)
shows a few##2##3##(2008-10#1)(2008-9#1)
shows a good stability##2##4##(2008-10#2)
shows a good##7##3##(2008-10#7)
shows a high##7##3##(1993-2#1)(1995-11#1)(1996-3#1)(1997-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
shows a higher##2##3##(1992-6#1)(2008-11#1)
shows a linear range between##4##5##(2008-10#4)
shows a linear response for##3##5##(2008-10#3)
shows a linear response##5##4##(2008-10#5)
shows a linear variation##2##4##(2008-10#2)
shows a linear##14##3##(2008-10#14)
shows a maximum##2##3##(2008-10#2)
shows a significant##2##3##(2008-10#1)(2008-5#1)
shows a strong dependence##2##4##(2008-10#1)(2008-3#1)
shows a strong##5##3##(2008-10#3)(2008-3#1)(2008-8#1)
shows a very##2##3##(1997-8#1)(2008-10#1)
shows a##102##2##(1990-11#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-3#2)(1992-6#2)(1993-2#2)(1993-6#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#52)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#3)
shows an absorption maximum at##2##5##(2008-10#2)
shows an##12##2##(1990-11#1)(1991-9#1)(1994-11#1)(1996-12#1)(2007-12#1)(2008-10#6)(2012-2#1)
shows better##2##2##(2008-10#2)
shows both##2##2##(2008-12#1)(2008-4#1)
shows considerable##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
shows cooperativity in O2 binding##2##5##(1991-10#2)
shows excellent##5##2##(2008-10#5)
shows good agreement with##2##4##(1995-3#1)(2008-3#1)
shows good performance##2##3##(2008-10#2)
shows good repeatability##2##3##(2008-10#2)
shows good selectivity for##5##4##(2008-10#5)
shows good sensitivity##2##3##(2008-10#2)
shows good stability##2##3##(2008-10#2)
shows good##23##2##(1995-3#1)(2008-10#20)(2008-3#1)(2013-1#1)
shows great potential##2##3##(2008-10#1)(2010-4#1)
shows greater##2##2##(1996-12#1)(2009-10#1)
shows high##6##2##(1993-12#1)(1997-2#1)(2008-10#2)(2012-12#1)(2012-2#1)
shows how##9##2##(1993-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-3#1)(2013-8#1)
shows improved##2##2##(2008-10#2)
shows its##2##2##(2008-10#2)
shows large##2##2##(1996-8#1)(2008-3#1)
shows low##2##2##(2008-10#2)
shows maximum absorbance at##3##4##(2008-10#3)
shows no significant##3##3##(1990-2#1)(1992-9#1)(2008-10#1)
shows no##11##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-3#1)(1992-9#1)(1996-5#1)(2008-10#3)(2008-3#1)(2013-8#1)
shows only##5##2##(1990-8#1)(1991-12#1)(1992-5#1)(2008-10#1)(2012-3#1)
shows patterns of##2##3##(1992-6#1)(2008-11#1)
shows promise##2##2##(1997-2#1)(2008-11#1)
shows satisfactory##2##2##(2008-10#1)(2008-3#1)
shows significant improvement##2##3##(2008-3#2)
shows significant##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
shows some##2##2##(1993-8#1)(2008-6#1)
shows strong##5##2##(1993-2#1)(1996-6#1)(2008-10#2)(2012-3#1)
shows substantial##2##2##(2008-10#1)(2013-8#1)
shows that a##5##3##(1994-12#1)(1995-6#1)(2008-10#1)(2008-12#1)(2010-6#1)
shows that an##2##3##(2008-10#1)(2013-1#1)
shows that by##3##3##(2008-12#1)(2009-3#1)(2010-3#1)
shows that each of##2##4##(2008-10#1)(2008-11#1)
shows that for##2##3##(2011-2#1)(2013-8#1)
shows that it is possible to##2##6##(2008-11#1)(2008-3#1)
shows that it is##6##4##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
shows that many##2##3##(2010-12#1)(2013-8#1)
shows that most##2##3##(1993-3#1)(2008-11#1)
shows that the host shift##2##5##(2008-8#2)
shows that the size##2##4##(1992-8#1)(2008-10#1)
shows that the##55##3##(1990-11#1)(1990-5#2)(1991-8#1)(1992-1#1)(1992-8#2)(1993-12#1)(1994-3#2)(1994-5#1)(1995-2#2)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-3#4)(2008-5#5)(2008-7#1)(2008-8#5)(2008-9#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
shows that there##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
shows that these##3##3##(1993-2#1)(1994-1#1)(2008-10#1)
shows that they##2##3##(1997-8#1)(2008-10#1)
shows that##210##2##(1990-11#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#4)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#2)(1995-2#4)(1995-3#1)(1995-6#2)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#4)(1997-9#1)(2007-11#1)(2008-1#1)(2008-10#40)(2008-11#14)(2008-12#5)(2008-3#8)(2008-5#12)(2008-7#2)(2008-8#19)(2008-9#8)(2009-3#1)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#2)(2013-8#6)
shows the importance of##3##4##(2007-12#1)(2008-8#2)
shows the presence of##3##4##(1990-8#1)(2008-10#1)(2008-3#1)
shows the results##2##3##(2008-10#1)(2008-9#1)
shows the same##4##3##(1990-5#1)(1991-9#1)(2008-10#1)(2008-11#1)
shows the##42##2##(1990-5#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-8#1)(2010-8#1)(2013-1#1)
shows two##2##2##(1993-2#1)(2008-10#1)
shows very high##2##3##(2008-10#2)
shows very little##3##3##(1995-11#1)(1995-6#1)(2008-10#1)
shows very##6##2##(1995-11#1)(1995-6#1)(2008-10#4)
shows why##3##2##(1991-3#1)(1991-9#1)(1992-2#1)
shows##593##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#4)(1990-6#2)(1990-8#5)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#4)(1993-2#9)(1993-3#3)(1993-6#1)(1993-8#3)(1994-1#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#3)(1995-1#2)(1995-11#3)(1995-2#6)(1995-3#3)(1995-6#3)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#8)(1997-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#203)(2008-11#29)(2008-12#9)(2008-2#1)(2008-3#20)(2008-4#1)(2008-5#17)(2008-6#3)(2008-7#9)(2008-8#38)(2008-9#12)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#2)(2009-8#8)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#18)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#8)(2012-3#6)(2012-7#1)(2012-9#1)(2013-1#8)(2013-8#10)
shrimp##16##1##(2007-12#4)(2008-10#1)(2008-12#3)(2008-3#1)(2008-8#2)(2008-9#2)(2010-4#3)
shrink film##2##2##(2008-10#2)
shrink##5##1##(1994-8#1)(1997-8#1)(2008-10#2)(2012-3#1)
shrinkage due to##2##3##(2010-10#1)(2012-2#1)
shrinkage of##4##2##(1994-8#1)(2009-3#1)(2012-2#2)
shrinkage was##2##2##(2009-3#1)(2012-2#1)
shrinkage##15##1##(1994-8#1)(1995-9#1)(2007-12#1)(2009-3#2)(2010-10#3)(2012-2#7)
shrinking##6##1##(1991-5#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-8#1)
shrub##2##1##(2008-8#1)(2008-9#1)
shrubs##6##1##(2008-10#3)(2008-8#1)(2008-9#2)
shuffling##2##1##(1997-9#1)(2011-1#1)
shunt and##2##2##(1996-3#1)(2008-11#1)
shunt at##2##2##(2008-11#1)(2008-7#1)
shunt by##2##2##(1991-11#1)(1993-3#1)
shunt catheter##2##2##(2012-2#2)
shunt in##3##2##(1991-11#1)(2008-7#2)
shunt was##2##2##(2011-2#2)
shunt##32##1##(1991-11#3)(1991-6#1)(1993-3#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#2)(2008-11#2)(2008-7#9)(2009-8#1)(2009-9#1)(2011-2#4)(2012-2#3)(2012-3#1)
shunt)##2##1##(1995-10#1)(1996-3#1)
shunting and##2##2##(2009-10#1)(2013-1#1)
shunting in the##2##3##(1997-6#1)(2011-2#1)
shunting##9##1##(1990-11#1)(1996-9#2)(1997-6#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
shunts in the##2##3##(2008-7#2)
shunts##18##1##(1990-11#1)(1993-6#1)(1995-11#1)(1996-11#1)(1996-3#2)(1996-9#5)(2008-11#1)(2008-7#3)(2009-9#2)(2010-10#1)
shutting##2##1##(2008-11#1)(2009-8#1)
shuttle between the##2##3##(2008-10#1)(2011-2#1)
shuttle cloning vectors##2##3##(1993-12#2)
shuttle plasmid##5##2##(1995-5#1)(2008-11#2)(2008-8#2)
shuttle vector##4##2##(1995-6#1)(2008-4#1)(2008-8#1)(2008-9#1)
shuttle##19##1##(1993-12#3)(1995-5#2)(1995-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#6)(2008-9#1)(2011-2#1)
shuttling in##2##2##(2011-2#2)
shuttling##4##1##(1991-3#1)(1995-2#1)(2011-2#2)
shyness and##3##2##(2008-1#1)(2008-4#2)
shyness##6##1##(2008-1#1)(2008-4#5)
siRNA##11##1##(2008-11#1)(2009-4#1)(2009-9#1)(2010-1#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
siRNA-mediated##2##1##(2008-11#1)(2013-1#1)
sialic acid plasma level##2##4##(2008-12#2)
sialic acid residues##3##3##(1994-11#2)(2008-11#1)
sialic acid##20##2##(1990-12#2)(1990-5#1)(1993-1#2)(1994-11#4)(2008-11#6)(2008-12#3)(2008-5#1)(2008-7#1)
sialic acids to IFN##2##4##(2008-11#2)
sialic acids##6##2##(1997-2#1)(2008-11#4)(2008-7#1)
sialic##27##1##(1990-12#2)(1990-5#1)(1993-1#2)(1994-11#5)(1997-2#1)(2008-11#10)(2008-12#3)(2008-5#1)(2008-7#2)
sialidase and the##2##3##(2008-11#2)
sialidase release and##2##3##(2008-11#2)
sialidase##6##1##(1994-11#1)(2008-11#5)
sialidases##2##1##(1994-11#1)(2008-11#1)
sialoliths##3##1##(2008-10#3)
sialometaplasia of the##2##3##(1991-11#1)(2009-1#1)
sialometaplasia##5##1##(1991-11#3)(2009-1#2)
sialylation of##3##2##(2008-11#1)(2008-7#2)
sialylation was observed at##2##4##(2008-7#2)
sialylation was##4##2##(2008-7#3)(2008-8#1)
sialylation##17##1##(2008-11#9)(2008-7#7)(2008-8#1)
sibiricus##2##1##(2008-10#2)
siblicide in##2##2##(2008-9#2)
siblicide##3##1##(2008-9#3)
sibling jealousy##2##2##(2008-12#2)
sibling pathogens with##3##3##(2008-10#3)
sibling pathogens##6##2##(2008-10#6)
sibling species##5##2##(2008-10#3)(2008-9#1)(2012-3#1)
sibling##30##1##(1995-2#1)(1995-3#1)(1996-6#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#5)(2008-9#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#2)
siblings in##3##2##(2008-8#1)(2008-9#1)(2010-5#1)
siblings of##2##2##(1995-3#1)(2008-8#1)
siblings##26##1##(1995-2#1)(1995-3#1)(1995-6#2)(1997-7#3)(1997-8#1)(2008-10#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-5#1)(2010-5#1)(2010-9#3)(2011-1#2)(2013-1#1)
siblings' fertility##2##2##(2011-2#2)
siblings'##5##1##(2008-9#1)(2011-2#3)(2013-7#1)
siboglinid##3##1##(2009-8#3)
siboglinids##3##1##(2009-8#3)
sibships with##2##2##(2008-8#2)
sick##11##1##(1990-2#1)(1991-3#1)(1991-9#2)(1992-3#1)(1994-6#2)(1996-1#1)(2008-8#1)(2012-3#2)
sick-listed##2##1##(1991-11#1)(1991-9#1)
sickle cell disease##4##3##(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
sickle cell##9##2##(2008-11#1)(2008-8#2)(2012-12#3)(2013-1#3)
sickle##10##1##(1992-9#1)(2008-11#1)(2008-8#2)(2012-12#3)(2013-1#3)
sickle-cell disease##4##2##(2006-5#1)(2008-10#2)(2008-4#1)
sickle-cell##5##1##(2006-5#1)(2008-10#2)(2008-4#1)(2013-1#1)
sickness and##2##2##(1994-6#1)(2010-1#1)
sickness funds##2##2##(1992-12#1)(1995-1#1)
sickness##15##1##(1991-2#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1994-6#1)(1995-1#1)(1997-8#3)(2010-1#4)
sickness]##2##1##(1991-6#1)(2010-12#1)
side and##12##2##(1993-12#1)(1993-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
side bands##2##2##(2008-10#2)
side branch##3##2##(2008-11#3)
side by side with the##2##5##(2008-8#1)(2013-8#1)
side by side##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2013-8#1)
side chain in##4##3##(1995-11#2)(2008-9#2)
side chain of##5##3##(1992-1#1)(1993-2#1)(1994-5#1)(2008-10#1)(2008-8#1)
side chain resonances##2##3##(2009-7#2)
side chain##25##2##(1991-6#1)(1992-1#2)(1992-3#1)(1993-2#1)(1993-8#2)(1994-5#3)(1995-11#3)(1997-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#2)(2009-7#5)
side chains of##3##3##(1992-4#1)(1993-8#1)(2008-10#1)
side chains##19##2##(1991-6#1)(1992-4#1)(1993-12#3)(1993-8#2)(1993-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-11#1)(2009-8#2)
side effect of##7##3##(1990-6#1)(1993-11#1)(2008-10#1)(2008-7#1)(2011-10#1)(2011-2#1)(2012-12#1)
side effect profiles##3##3##(2010-12#1)(2011-10#2)
side effect##21##2##(1990-6#1)(1993-11#1)(1997-3#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-7#1)(2010-12#1)(2011-10#3)(2011-2#2)(2012-12#2)
side effects and the##2##4##(1997-1#1)(1997-8#1)
side effects and##11##3##(1992-3#1)(1993-2#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-11#1)(2010-1#2)(2012-12#1)(2013-1#1)
side effects and/or events##2##4##(1993-2#2)
side effects and/or##3##3##(1993-2#2)(2008-7#1)
side effects are##4##3##(2008-10#1)(2008-7#1)(2009-7#1)(2009-9#1)
side effects associated with the##2##5##(1997-8#1)(2010-10#1)
side effects associated with##4##4##(1997-3#1)(1997-8#1)(2008-10#1)(2010-10#1)
side effects from##2##3##(2008-7#1)(2011-2#1)
side effects has been##2##4##(2008-10#1)(2008-8#1)
side effects in the##2##4##(2009-7#1)(2010-7#1)
side effects in##5##3##(1992-11#1)(2008-10#1)(2009-7#1)(2010-7#1)(2011-2#1)
side effects of drugs##2##4##(1995-12#1)(1997-3#1)
side effects of immunosuppressive##2##4##(1994-5#1)(2011-3#1)
side effects of##16##3##(1991-6#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-5#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#1)
side effects on##3##3##(2008-9#2)(2011-2#1)
side effects or##3##3##(1995-8#1)(2008-7#1)(2008-8#1)
side effects such as##2##4##(2008-7#1)(2009-7#1)
side effects that##4##3##(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
side effects were##10##3##(1990-11#1)(1991-3#1)(1991-8#2)(1993-2#1)(1996-11#2)(1996-8#1)(2012-3#1)(2013-1#1)
side effects##132##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#3)(1991-3#4)(1991-6#4)(1991-8#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-2#6)(1993-6#3)(1994-5#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-8#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#9)(2008-8#6)(2008-9#2)(2009-12#4)(2009-7#7)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-7#2)(2011-2#8)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
side in##2##2##(1996-3#1)(2007-12#1)
side of the membrane##2##4##(1991-5#1)(2008-10#1)
side of the subesophageal ganglion##2##5##(2008-5#2)
side of the triquinacene framework##2##5##(1996-5#2)
side of the##50##3##(1991-5#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-12#3)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-2#1)
side of##73##2##(1991-3#1)(1991-5#4)(1992-3#2)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#3)(1995-6#1)(1996-1#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#12)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#3)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-2#1)
side population (SP)##2##3##(2008-9#1)(2010-6#1)
side population cells are##2##4##(2010-6#2)
side population cells##8##3##(2010-6#8)
side population##12##2##(2008-9#2)(2010-6#10)
side product##2##2##(2009-12#2)
side reaction of##2##3##(2008-10#2)
side reaction##5##2##(2008-10#4)(2008-12#1)
side reactions##6##2##(2008-10#1)(2008-4#2)(2011-1#1)(2012-2#2)
side was##3##2##(1991-2#2)(2013-1#1)
side were##2##2##(1993-3#1)(2013-1#1)
side when the knee was##2##5##(1997-8#2)
side##416##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#7)(1991-3#7)(1991-5#5)(1991-6#6)(1991-8#3)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#7)(1993-3#2)(1993-6#6)(1993-8#4)(1993-9#1)(1994-1#1)(1994-2#3)(1994-5#8)(1995-11#4)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#3)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#6)(1997-4#2)(1997-8#4)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#52)(2008-11#12)(2008-12#8)(2008-3#3)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#19)(2008-8#14)(2008-9#16)(2009-10#1)(2009-12#6)(2009-6#1)(2009-7#13)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#8)(2010-4#1)(2010-5#2)(2010-6#10)(2010-7#4)(2010-9#2)(2011-1#1)(2011-10#3)(2011-2#22)(2011-3#2)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#15)(2013-2#1)(2013-7#2)(2013-8#8)
side) of##2##2##(1993-6#1)(2010-12#1)
side)##4##1##(1993-6#1)(2010-12#1)(2010-5#1)(2010-9#1)
side-by-side##5##1##(1995-2#1)(2008-10#1)(2008-5#2)(2008-6#1)
side-chain##10##1##(1990-11#2)(1992-3#1)(1994-5#2)(1995-3#1)(2008-4#1)(2008-8#1)(2009-7#2)
side-effect##3##1##(1993-1#1)(2008-12#1)(2008-9#1)
side-effects in##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
side-effects that##2##2##(2008-7#2)
side-effects were##2##2##(1994-12#1)(2008-11#1)
side-effects##29##1##(1990-2#2)(1994-12#1)(1996-12#1)(1997-3#1)(2008-11#4)(2008-5#5)(2008-7#8)(2008-9#2)(2010-1#1)(2011-2#3)(2013-8#1)
side-pumped solid-state laser##3##3##(2008-3#3)
side-pumped solid-state lasers##2##3##(2008-3#2)
side-pumped solid-state##5##2##(2008-3#5)
side-pumped##7##1##(2008-2#2)(2008-3#5)
side-to-side##3##1##(1990-5#1)(2012-2#1)(2012-3#1)
sidebands##3##1##(2008-10#1)(2008-3#2)
sidechain##3##1##(1994-11#1)(2008-9#1)(2009-7#1)
sided##5##1##(1997-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
sidelobe##2##1##(2008-3#1)(2012-3#1)
siderophore complexation##2##2##(2013-1#2)
siderophore production##3##2##(2008-10#2)(2013-1#1)
siderophore##17##1##(2008-10#9)(2011-2#3)(2013-1#5)
siderophores##2##1##(2008-10#1)(2013-1#1)
siderosis of the central nervous system secondary to a thalamic hamartoma##2##11##(2008-7#2)
siderosis##3##1##(2008-7#3)
sides at##2##2##(2008-10#1)(2013-1#1)
sides of the root system##2##5##(2008-10#2)
sides of the root##3##4##(2008-10#3)
sides of the##15##3##(1990-2#1)(2007-12#1)(2008-10#6)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-4#1)(2013-8#1)
sides of##16##2##(1990-2#1)(2007-12#1)(2008-10#7)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-4#1)(2013-8#1)
sides##32##1##(1990-2#1)(1993-3#2)(1995-1#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-6#1)(2008-7#1)(2009-1#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
sidewall##2##1##(2008-3#2)
sidewalls##2##1##(2008-10#1)(2008-3#1)
sideways##4##1##(1994-9#1)(2008-10#2)(2008-11#1)
sieve elements##4##2##(2008-10#4)
sieve##12##1##(2008-10#10)(2008-11#2)
sieved##3##1##(2008-10#3)
sieving##7##1##(2008-10#6)(2008-7#1)
sight and##2##2##(2010-8#1)(2011-2#1)
sight in##2##2##(1993-11#1)(2011-2#1)
sight of the##2##3##(2008-3#1)(2008-5#1)
sight of##5##2##(1993-6#3)(2008-3#1)(2008-5#1)
sight##19##1##(1990-3#1)(1991-2#1)(1992-1#1)(1993-11#1)(1993-6#3)(1995-8#1)(1996-3#1)(1997-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-8#1)(2011-2#3)(2013-1#1)
sigma 1##2##2##(1990-8#2)
sigma 35##2##2##(1993-12#2)
sigma 70##2##2##(1993-12#1)(1995-2#1)
sigma 70-dependent##2##2##(1995-2#2)
sigma A##2##2##(1993-9#2)
sigma B2 has##2##3##(1996-3#2)
sigma B2##4##2##(1996-3#4)
sigma H##4##2##(1990-12#4)
sigma factor##5##2##(1990-12#1)(1993-12#3)(2012-2#1)
sigma##39##1##(1990-12#6)(1990-8#2)(1991-6#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-12#9)(1993-8#1)(1993-9#2)(1995-2#4)(1995-6#2)(1996-3#5)(2008-10#2)(2012-2#1)
sigma(0)##3##1##(2008-5#3)
sigmoid colon fistula##2##3##(2012-12#2)
sigmoid colon##9##2##(1991-6#1)(2008-12#2)(2010-12#2)(2011-2#2)(2012-12#2)
sigmoid sinus##3##2##(1996-6#1)(1996-9#1)(2008-7#1)
sigmoid##24##1##(1991-6#2)(1996-6#1)(1996-9#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-7#2)(2008-9#1)(2009-1#1)(2010-12#3)(2010-8#2)(2011-2#2)(2012-12#2)(2013-1#1)
sigmoidal##7##1##(1990-5#1)(2008-10#4)(2013-8#2)
sigmoidectomy##3##1##(2009-1#3)
sign and##3##2##(1991-8#1)(2008-10#1)(2008-8#1)
sign in##2##2##(2008-11#1)(2012-12#1)
sign is##3##2##(2012-12#1)(2013-1#1)(2013-7#1)
sign language##3##2##(2010-5#2)(2011-2#1)
sign of recurrence##2##3##(2011-2#1)(2012-3#1)
sign of the##5##3##(2007-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
sign of##34##2##(1990-11#1)(1990-12#1)(1991-11#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-11#2)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#2)(2010-10#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
sign to##2##2##(1995-3#1)(2008-9#1)
sign was##3##2##(1991-8#1)(2013-7#2)
sign##67##1##(1990-11#1)(1990-12#1)(1991-11#2)(1991-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-11#2)(1995-3#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#2)(2010-10#1)(2010-5#3)(2010-6#2)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#1)
signal amplification##9##2##(1996-2#1)(2008-10#3)(2008-4#2)(2008-9#3)
signal amplitude##4##2##(1990-5#1)(1996-2#1)(2008-3#1)(2009-11#1)
signal and a##2##3##(2008-3#1)(2011-2#1)
signal and coding##2##3##(1997-7#1)(2013-1#1)
signal and##16##2##(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
signal at##13##2##(1993-8#1)(1995-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#4)
signal based##2##2##(2008-10#2)
signal beam##3##2##(2008-3#3)
signal behavior##2##2##(1997-8#1)(2008-3#1)
signal by##2##2##(2008-3#1)(2008-9#1)
signal can be##2##3##(2008-10#2)
signal can##4##2##(2008-10#2)(2008-8#1)(2010-6#1)
signal change##2##2##(2008-10#1)(2012-12#1)
signal changes##4##2##(2008-10#1)(2012-12#2)(2013-8#1)
signal collected##2##2##(2008-10#1)(2012-2#1)
signal contamination##2##2##(2008-3#2)
signal correction (OSC)##2##3##(2008-10#2)
signal cost is inversely related to the##2##7##(2008-9#2)
signal could be##2##3##(2008-7#1)(2008-9#1)
signal could##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
signal decreased##2##2##(2008-10#2)
signal depends on##2##3##(2008-10#2)
signal depends##3##2##(2008-10#3)
signal detected##3##2##(2008-10#2)(2008-11#1)
signal detection##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
signal deterioration##2##2##(2008-10#2)
signal during##3##2##(2008-10#2)(2008-11#1)
signal enhancement##2##2##(2008-10#2)
signal evolution##2##2##(1995-5#1)(2008-9#1)
signal for the##4##3##(2008-10#3)(2008-9#1)
signal for##24##2##(1991-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-7#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-9#1)(2009-8#1)
signal from the sample##3##4##(2007-12#1)(2008-10#2)
signal from the##7##3##(1990-12#1)(2007-12#1)(2008-10#4)(2008-11#1)
signal from##16##2##(1990-12#1)(1994-12#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2009-6#1)(2012-2#1)
signal function##2##2##(2008-8#1)(2008-9#1)
signal generated by the##2##4##(1991-3#1)(2008-10#1)
signal generation##3##2##(2008-11#1)(2009-8#1)(2010-9#1)
signal has been investigated##2##4##(2008-10#1)(2008-3#1)
signal has been##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
signal has##4##2##(2008-10#1)(2008-3#1)(2010-7#1)(2010-8#1)
signal height##4##2##(1993-8#1)(2008-10#3)
signal in the##8##3##(2007-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2011-1#1)
signal in##23##2##(1993-6#1)(1995-2#2)(2007-11#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#2)(2008-8#3)(2011-1#1)(2013-1#1)
signal increase##3##2##(1996-2#1)(1997-8#1)(2008-10#1)
signal induced by##2##3##(1994-3#1)(2008-10#1)
signal integration##2##2##(2008-3#1)(2009-8#1)
signal intensities are##2##3##(2008-3#2)
signal intensities##6##2##(2008-10#2)(2008-3#2)(2009-11#1)(2012-3#1)
signal intensity (SI) on different pulse sequences##2##7##(1997-8#1)(2012-2#1)
signal intensity and##3##3##(1992-3#1)(2008-3#1)(2013-1#1)
signal intensity at b = 0##2##6##(2009-11#2)
signal intensity in the##3##4##(1991-11#2)(2009-3#1)
signal intensity in##4##3##(1991-11#2)(2009-3#1)(2013-8#1)
signal intensity on T1-weighted##2##4##(1991-11#1)(2012-2#1)
signal intensity on##9##3##(1991-11#2)(1997-8#3)(2009-11#2)(2011-2#1)(2012-2#1)
signal intensity was##2##3##(2008-10#1)(2008-2#1)
signal intensity##40##2##(1991-11#6)(1992-3#1)(1996-2#1)(1997-8#4)(2008-10#6)(2008-2#2)(2008-3#5)(2008-7#1)(2009-11#5)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
signal is a##2##3##(2008-10#2)
signal is detected##2##3##(2007-12#1)(2008-3#1)
signal is directly##3##3##(2008-10#2)(2008-11#1)
signal is##24##2##(1994-11#1)(1994-5#3)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#2)
signal levels##2##2##(2008-3#2)
signal magnitude##2##2##(2008-10#2)
signal may##2##2##(2008-8#1)(2009-6#1)
signal measurements##3##2##(2008-10#3)
signal molecules##2##2##(2008-10#1)(2008-9#1)
signal noise##2##2##(2008-10#1)(2010-8#1)
signal obtained##2##2##(1996-2#1)(2008-10#1)
signal of the##11##3##(2008-10#8)(2008-3#1)(2010-9#1)(2013-1#1)
signal of##35##2##(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#23)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2013-1#1)
signal on the##2##3##(2008-10#1)(2012-3#1)
signal on##6##2##(1997-8#1)(2008-10#2)(2008-9#1)(2010-8#1)(2012-3#1)
signal pathway in##4##3##(2011-2#2)(2011-3#2)
signal pathway##9##2##(2008-8#1)(2010-9#1)(2011-2#2)(2011-3#4)(2013-8#1)
signal pathways##2##2##(1996-2#1)(2013-7#1)
signal peptidase I##2##3##(1997-7#2)
signal peptidase##5##2##(1991-10#1)(1993-12#1)(1997-7#2)(2008-10#1)
signal peptide and##6##3##(2008-11#2)(2008-4#1)(2008-8#1)(2010-5#1)(2010-6#1)
signal peptide of##3##3##(1992-8#1)(1993-2#1)(2008-8#1)
signal peptide polymorphism##2##3##(1997-8#2)
signal peptide sequence##2##3##(2010-6#2)
signal peptide##22##2##(1990-12#1)(1990-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-6#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#2)(2010-5#1)(2010-6#4)
signal peptides##4##2##(1994-11#1)(1995-2#1)(1997-6#1)(2008-10#1)
signal power##3##2##(2008-3#3)
signal processing##9##2##(2008-10#2)(2008-3#1)(2008-9#3)(2010-10#1)(2011-7#1)(2012-3#1)
signal produced by the##3##4##(1994-12#1)(2008-10#2)
signal produced by##4##3##(1994-12#1)(1995-2#1)(2008-10#2)
signal profiles##2##2##(2008-10#2)
signal quality##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
signal range##2##2##(2008-10#2)
signal recognition particle receptor##2##4##(1995-6#2)
signal recognition particle##5##3##(1994-11#1)(1995-6#2)(2009-7#2)
signal recognition##6##2##(1994-11#1)(1995-6#3)(2009-7#2)
signal response##4##2##(1996-2#1)(2008-10#3)
signal sequence and a##3##4##(1997-7#2)(2008-11#1)
signal sequence and##6##3##(1991-6#1)(1997-7#2)(2008-11#3)
signal sequence that##2##3##(1991-10#1)(1993-2#1)
signal sequence##25##2##(1990-11#1)(1991-10#6)(1991-6#4)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1997-7#2)(2008-11#5)(2008-5#1)(2008-8#1)
signal sequences##2##2##(1993-6#1)(1997-7#1)
signal showed a##3##3##(2008-10#3)
signal strength##2##2##(2008-10#1)(2008-3#1)
signal suppression##2##2##(2008-10#2)
signal that##5##2##(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
signal the##3##2##(2008-10#2)(2008-11#1)
signal to be##2##3##(2008-10#1)(2008-3#1)
signal to noise ratio of##2##5##(2008-10#2)
signal to noise ratio##5##4##(2008-10#4)(2008-9#1)
signal to noise##6##3##(2008-10#4)(2008-9#1)(2010-8#1)
signal to the##4##3##(2007-12#1)(2008-10#3)
signal to##24##2##(1991-3#1)(1993-8#1)(1994-11#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#12)(2008-3#2)(2008-8#2)(2008-9#1)(2010-8#1)
signal transducer and activator of transcription##2##6##(2008-8#1)(2012-3#1)
signal transducer##6##2##(1996-2#2)(2008-11#1)(2008-8#1)(2009-8#1)(2012-3#1)
signal transducers and activators of transcription (STAT)##2##7##(2011-2#1)(2012-3#1)
signal transducers and activators of transcription##3##6##(1996-2#1)(2011-2#1)(2012-3#1)
signal transducers##7##2##(1996-12#3)(1996-2#1)(2010-4#1)(2011-2#1)(2012-3#1)
signal transducing##3##2##(1993-8#1)(1994-11#1)(2009-4#1)
signal transduction and##4##3##(2008-11#2)(2008-9#2)
signal transduction by##2##3##(1992-12#1)(1994-12#1)
signal transduction cascades##2##3##(1996-2#1)(2009-12#1)
signal transduction in response to##2##5##(1996-2#1)(2010-1#1)
signal transduction in##9##3##(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-5#1)(2013-1#1)
signal transduction leading to the##2##5##(1990-12#1)(1995-6#1)
signal transduction leading to##3##4##(1990-12#1)(1995-2#1)(1995-6#1)
signal transduction mechanisms##2##3##(1993-8#1)(1995-11#1)
signal transduction molecules and##2##4##(1993-8#1)(2008-11#1)
signal transduction networks##2##3##(2011-3#2)
signal transduction of##2##3##(2008-4#1)(2010-5#1)
signal transduction pathway##13##3##(1994-11#1)(1994-3#1)(1995-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2009-4#1)(2011-3#1)
signal transduction pathways by leptin in colorectal cancer##2##8##(2012-3#2)
signal transduction pathways by leptin##3##5##(2012-3#3)
signal transduction pathways by##4##4##(1994-11#1)(2012-3#3)
signal transduction pathways triggered by##2##5##(2008-11#1)(2008-9#1)
signal transduction pathways##16##3##(1994-11#1)(1995-2#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#3)
signal transduction##84##2##(1990-12#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-8#3)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#1)(1995-2#5)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#8)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#2)(2009-4#1)(2009-8#2)(2010-1#1)(2010-5#2)(2010-7#1)(2011-2#2)(2011-3#4)(2012-3#3)(2013-1#1)
signal transfer##2##2##(2008-8#1)(2012-3#1)
signal transmission##6##2##(1992-10#1)(1993-9#1)(1994-11#1)(2008-11#2)(2011-7#1)
signal using##3##2##(2008-10#3)
signal was found to##2##4##(2008-10#1)(2009-8#1)
signal was found##3##3##(1993-12#1)(2008-10#1)(2009-8#1)
signal was observed and##2##4##(2008-10#2)
signal was observed in##3##4##(2008-10#1)(2008-11#2)
signal was observed##6##3##(2008-10#4)(2008-11#2)
signal was obtained for##4##4##(1996-12#1)(2008-10#3)
signal was obtained##5##3##(1996-12#1)(2008-10#3)(2008-3#1)
signal was##34##2##(1993-12#1)(1994-3#1)(1996-12#1)(1997-8#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#2)(2009-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
signal wave in##2##3##(2008-3#2)
signal wave##4##2##(2008-3#4)
signal were##4##2##(2008-10#4)
signal when##2##2##(2008-10#2)
signal which##2##2##(1993-3#1)(2010-8#1)
signal with only a##2##4##(2008-10#1)(2008-2#1)
signal with##6##2##(2008-10#3)(2008-2#1)(2008-3#2)
signal without##2##2##(2008-11#1)(2008-3#1)
signal##848##1##(1990-11#1)(1990-12#3)(1990-5#3)(1990-8#1)(1991-10#8)(1991-11#6)(1991-3#2)(1991-5#1)(1991-6#6)(1992-10#1)(1992-12#2)(1992-3#2)(1992-8#3)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#7)(1993-9#2)(1994-11#13)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#5)(1994-6#2)(1995-11#3)(1995-12#3)(1995-2#11)(1995-5#1)(1995-6#6)(1995-8#3)(1996-12#9)(1996-2#14)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#10)(1997-8#13)(2007-11#4)(2007-12#8)(2008-1#1)(2008-10#293)(2008-11#48)(2008-12#3)(2008-2#11)(2008-3#79)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#30)(2008-9#37)(2009-10#2)(2009-11#7)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#6)(2009-7#2)(2009-8#15)(2010-1#1)(2010-10#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#6)(2010-7#5)(2010-8#13)(2010-9#5)(2011-1#6)(2011-2#12)(2011-3#8)(2011-7#2)(2012-12#4)(2012-2#7)(2012-3#13)(2013-1#6)(2013-7#1)(2013-8#4)
signal)##3##1##(2008-10#3)
signal-anchor sequence##2##2##(1991-10#1)(1996-3#1)
signal-anchor##4##1##(1991-10#3)(1996-3#1)
signal-regulated kinases##2##2##(1995-6#1)(2013-8#1)
signal-regulated##9##1##(1995-6#1)(2009-8#1)(2010-12#1)(2011-2#3)(2013-1#2)(2013-8#1)
signal-related##3##1##(1991-6#2)(2008-7#1)
signal-to-background ratio##2##2##(1997-6#1)(2008-10#1)
signal-to-background##3##1##(1997-6#1)(2008-10#2)
signal-to-noise characteristics##2##2##(2008-10#2)
signal-to-noise level##2##2##(2008-10#2)
signal-to-noise ratio (SNR)##3##3##(2008-3#2)(2013-8#1)
signal-to-noise ratio of 3##9##4##(2008-10#8)(2008-3#1)
signal-to-noise ratio of##16##3##(2008-10#13)(2008-3#3)
signal-to-noise ratio with##2##3##(2008-3#2)
signal-to-noise ratio##39##2##(1991-2#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-3#14)(2008-4#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-8#1)
signal-to-noise ratios##5##2##(2008-10#2)(2008-3#1)(2008-4#1)(2012-2#1)
signal-to-noise##54##1##(1991-2#1)(1997-8#1)(2007-12#1)(2008-10#28)(2008-3#16)(2008-4#2)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
signal-transduction##3##1##(1994-8#1)(2008-4#1)(2008-9#1)
signal/noise##2##1##(1990-12#1)(2008-10#1)
signaled##2##1##(2008-10#1)(2010-4#1)
signaler##4##1##(2008-9#4)
signalers##4##1##(2008-8#4)
signaling and the##2##3##(2008-9#1)(2012-2#1)
signaling and##7##2##(2008-10#2)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
signaling at##2##2##(2008-10#1)(2009-9#1)
signaling by##7##2##(1997-7#1)(2008-7#1)(2008-9#1)(2009-8#2)(2012-2#1)(2013-1#1)
signaling cascade##5##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#2)
signaling cascades##6##2##(2008-1#1)(2008-11#2)(2008-7#2)(2009-8#1)
signaling components##3##2##(2008-11#1)(2009-10#1)(2009-8#1)
signaling during##4##2##(2008-9#1)(2009-8#2)(2010-1#1)
signaling equilibrium##2##2##(2008-9#2)
signaling event##3##2##(2008-10#1)(2011-1#2)
signaling events##14##2##(1991-3#2)(1991-5#1)(1994-12#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#3)(2009-9#1)(2011-2#3)
signaling functions##2##2##(2009-6#1)(2011-2#1)
signaling in postsynaptic##2##3##(2008-11#1)(2009-8#1)
signaling in the##3##3##(2008-5#1)(2009-12#1)(2013-1#1)
signaling in##15##2##(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
signaling is##10##2##(1995-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
signaling leads##2##2##(2011-2#1)(2013-1#1)
signaling may##2##2##(2009-8#1)(2012-12#1)
signaling mechanisms that##3##3##(2008-10#2)(2010-11#1)
signaling mechanisms##7##2##(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)(2012-2#1)
signaling molecule##3##2##(2009-6#1)(2010-4#1)(2011-2#1)
signaling molecules are##2##3##(1994-12#1)(2013-8#1)
signaling molecules in##3##3##(2009-10#1)(2010-1#1)(2010-7#1)
signaling molecules##17##2##(1993-3#1)(1994-12#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#2)(2010-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
signaling network##3##2##(2008-11#1)(2009-8#2)
signaling of##6##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-5#1)
signaling pathway and##4##3##(1994-11#1)(2008-11#2)(2013-1#1)
signaling pathway in##3##3##(1994-11#1)(2012-12#1)(2013-8#1)
signaling pathway is##3##3##(2009-8#1)(2012-2#1)(2013-1#1)
signaling pathway may be##2##4##(2009-6#1)(2013-1#1)
signaling pathway might##2##3##(2008-11#1)(2011-2#1)
signaling pathway of apoptosis##2##4##(2008-11#1)(2009-9#1)
signaling pathway of##3##3##(1994-11#1)(2008-11#1)(2009-9#1)
signaling pathway to##2##3##(1997-1#1)(2009-10#1)
signaling pathway##38##2##(1993-3#1)(1994-11#5)(1997-1#1)(1997-2#1)(1997-7#1)(2008-11#6)(2008-9#1)(2009-10#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#4)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
signaling pathways and##3##3##(1991-9#1)(1996-12#1)(1997-7#1)
signaling pathways are##2##3##(2008-10#1)(2008-11#1)
signaling pathways in##7##3##(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#3)(2013-1#1)
signaling pathways including##2##3##(1995-2#1)(2013-7#1)
signaling pathways involved##2##3##(2008-10#1)(2008-4#1)
signaling pathways that##3##3##(2008-7#1)(2008-9#1)(2009-3#1)
signaling pathways to##2##3##(2009-8#1)(2012-2#1)
signaling pathways##66##2##(1991-9#1)(1994-12#1)(1995-2#2)(1996-12#1)(1997-1#1)(1997-7#2)(2008-1#1)(2008-10#5)(2008-11#10)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#2)(2009-3#2)(2009-6#2)(2009-8#5)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
signaling process##2##2##(2008-10#1)(2008-8#1)
signaling processes##2##2##(2008-10#1)(2008-5#1)
signaling promotes##2##2##(2008-11#1)(2011-1#1)
signaling system##3##2##(2008-10#3)
signaling systems in##2##3##(2009-8#1)(2012-2#1)
signaling systems##5##2##(1996-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
signaling via##2##2##(2008-1#1)(2009-8#1)
signaling##358##1##(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#2)(1993-1#2)(1993-12#1)(1993-3#2)(1994-11#5)(1994-12#4)(1994-5#1)(1995-11#1)(1995-2#4)(1995-6#2)(1996-12#4)(1997-1#2)(1997-2#1)(1997-7#4)(2008-1#6)(2008-10#31)(2008-11#35)(2008-3#1)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#11)(2008-9#21)(2009-10#8)(2009-12#6)(2009-3#3)(2009-6#10)(2009-7#1)(2009-8#41)(2009-9#7)(2010-1#5)(2010-11#2)(2010-12#8)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#5)(2011-1#4)(2011-2#22)(2012-12#3)(2012-2#19)(2012-3#8)(2013-1#20)(2013-7#1)(2013-8#12)
signallers##2##1##(1995-5#2)
signalling a##2##2##(2008-9#2)
signalling and##4##2##(1993-8#1)(2008-7#1)(2011-2#2)
signalling cascades##3##2##(1996-2#1)(2009-3#1)(2011-2#1)
signalling events##3##2##(1995-8#1)(2008-1#1)(2009-6#1)
signalling in##3##2##(1994-2#1)(2011-2#2)
signalling is##2##2##(1995-5#1)(2010-10#1)
signalling molecules##5##2##(1995-8#1)(1996-2#1)(2010-7#1)(2012-6#2)
signalling pathway and##2##3##(1996-3#1)(2011-10#1)
signalling pathway##9##2##(1995-8#2)(1996-2#1)(1996-3#2)(1997-2#1)(2011-10#1)(2011-2#2)
signalling pathways are##3##3##(1994-11#1)(1996-2#1)(2009-3#1)
signalling pathways##8##2##(1994-11#2)(1996-2#3)(2009-3#1)(2009-6#1)(2013-8#1)
signalling proteins which##2##3##(1996-2#2)
signalling proteins##3##2##(1996-2#2)(2009-7#1)
signalling system##3##2##(1994-11#1)(1995-8#1)(2010-10#1)
signalling##76##1##(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-6#2)(1995-5#2)(1995-8#7)(1996-2#10)(1996-3#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-3#3)(2009-6#3)(2009-7#3)(2009-8#2)(2010-10#7)(2010-7#1)(2011-10#2)(2011-2#11)(2012-2#1)(2012-6#2)(2013-7#1)(2013-8#2)
signals acquired##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
signals and the##2##3##(2008-10#1)(2012-3#1)
signals and##10##2##(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-8#1)(2009-6#1)(2012-3#1)
signals are##15##2##(2008-10#3)(2008-11#3)(2008-3#2)(2009-8#2)(2010-5#1)(2010-7#1)(2010-8#2)(2012-3#1)
signals at##7##2##(2008-10#4)(2008-3#2)(2010-1#1)
signals but##2##2##(2008-3#1)(2010-6#1)
signals by##5##2##(1992-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(2009-8#1)
signals can be##4##3##(2008-10#2)(2008-4#1)(2012-2#1)
signals can##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
signals caused by##3##3##(2008-10#3)
signals characterized at##2##3##(2008-10#2)
signals derived from##2##3##(1994-12#1)(2007-11#1)
signals detected##2##2##(2008-10#1)(2008-3#1)
signals for the##3##3##(2008-10#2)(2008-3#1)
signals for##17##2##(1994-12#1)(1995-12#1)(1996-12#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)
signals from a##4##3##(2008-10#1)(2008-3#3)
signals from clouds##2##3##(2008-10#1)(2008-3#1)
signals from multiple##2##3##(2008-3#1)(2009-8#1)
signals from the##11##3##(1994-3#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#1)
signals from##32##2##(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-8#3)(2010-1#1)(2010-8#1)
signals generated by##2##3##(2008-10#1)(2013-1#1)
signals have a##2##3##(2008-3#1)(2010-7#1)
signals have been##2##3##(2008-10#2)
signals have##4##2##(2008-10#2)(2008-3#1)(2010-7#1)
signals in a##2##3##(2008-9#1)(2013-1#1)
signals in the##5##3##(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)
signals in these##2##3##(2008-11#1)(2011-2#1)
signals in wavelength-modulation spectrometry##2##4##(2008-3#2)
signals in##26##2##(2007-11#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#4)(2008-8#2)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
signals induced by##2##3##(1994-6#2)
signals is##8##2##(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#1)(2009-8#1)(2011-1#1)
signals may##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)
signals obtained from##2##3##(2008-10#2)
signals obtained##6##2##(2008-10#5)(2008-4#1)
signals of LHR mRNA##2##4##(2008-8#2)
signals of the##5##3##(1993-2#1)(1994-5#1)(2008-10#3)
signals of##30##2##(1993-2#1)(1994-5#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-8#7)(2008-9#3)(2009-8#1)
signals on##2##2##(2008-11#1)(2012-2#1)
signals received##2##2##(2008-11#1)(2008-3#1)
signals such as##2##3##(2010-3#1)(2013-7#1)
signals that are##5##3##(1990-5#1)(1995-5#1)(2008-11#1)(2008-3#1)(2010-8#1)
signals that control##2##3##(2008-10#1)(2008-5#1)
signals that##12##2##(1990-5#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-8#1)
signals through##4##2##(1995-11#1)(1995-2#1)(2008-11#1)(2008-9#1)
signals to the##5##3##(1994-11#1)(1997-6#3)(2008-11#1)
signals to##9##2##(1994-11#1)(1997-6#3)(2008-11#2)(2008-3#1)(2010-6#1)(2012-2#1)
signals was##2##2##(2008-10#1)(2008-3#1)
signals were detected##3##3##(2008-8#3)
signals were observed in##3##4##(2008-10#2)(2010-8#1)
signals were observed##4##3##(2008-10#2)(2008-11#1)(2010-8#1)
signals were obtained for##2##4##(1996-12#1)(2008-10#1)
signals were obtained##3##3##(1996-12#1)(2008-10#2)
signals were recorded##2##3##(2008-11#1)(2012-2#1)
signals were##28##2##(1996-12#2)(2008-10#18)(2008-11#2)(2008-8#3)(2010-5#1)(2010-8#1)(2012-2#1)
signals when##5##2##(1991-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-7#1)
signals with the##2##3##(2008-10#2)
signals with##4##2##(2008-10#4)
signals within##2##2##(2008-10#1)(2009-12#1)
signals##447##1##(1990-2#2)(1990-5#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#4)(1994-12#3)(1994-3#2)(1994-5#4)(1994-6#3)(1995-11#1)(1995-12#3)(1995-2#5)(1995-5#3)(1995-8#1)(1996-11#1)(1996-12#4)(1997-3#3)(1997-6#3)(1997-7#2)(2007-11#4)(2007-12#4)(2008-10#159)(2008-11#37)(2008-2#3)(2008-3#45)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#24)(2008-9#19)(2009-12#2)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#19)(2010-1#2)(2010-10#2)(2010-3#2)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#14)(2011-1#2)(2011-2#4)(2012-2#6)(2012-3#4)(2012-9#1)(2013-1#2)(2013-7#6)(2013-8#5)
signature chemicals##5##2##(2008-10#5)
signature of##3##2##(2008-3#1)(2010-1#1)(2011-2#1)
signature##22##1##(1990-12#1)(2008-10#7)(2008-3#2)(2008-4#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#2)
signatures as##2##2##(2009-6#1)(2010-11#1)
signatures from##3##2##(1997-2#1)(2008-10#1)(2010-11#1)
signatures of##4##2##(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
signatures to##2##2##(2009-6#1)(2012-2#1)
signatures were##2##2##(2008-10#1)(2008-3#1)
signatures##28##1##(1995-9#1)(1997-2#1)(2008-10#5)(2008-3#1)(2009-3#2)(2009-4#1)(2009-6#4)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
signed into law##6##3##(1991-12#2)(1991-3#1)(1993-1#1)(1994-3#1)(1996-5#1)
signed the##4##2##(1994-1#1)(1996-1#1)(1996-5#1)(2009-4#1)
signed##16##1##(1991-12#2)(1991-3#1)(1993-1#1)(1994-1#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-5#2)(1997-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2010-6#1)
signers##2##1##(2010-5#2)
significance (P &lt##2##3##(2008-10#1)(2012-3#1)
significance (P##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
significance and##10##2##(1991-2#1)(1997-2#1)(2008-10#5)(2008-4#1)(2010-7#1)(2013-2#1)
significance as##5##2##(1996-8#1)(2007-12#1)(2009-4#1)(2013-1#2)
significance because##2##2##(2008-7#1)(2011-2#1)
significance between##2##2##(1990-12#1)(1993-2#1)
significance for the##4##3##(1990-11#1)(1990-3#1)(1990-9#1)(2011-3#1)
significance for##13##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#1)
significance in##8##2##(1990-12#1)(1991-11#1)(1991-8#1)(1993-2#1)(1994-8#1)(2008-7#1)(2008-9#1)(2010-7#1)
significance level##5##2##(2008-10#3)(2008-12#1)(2013-1#1)
significance of difficulties in mobility##2##5##(2008-7#2)
significance of each##2##3##(2008-10#1)(2010-6#1)
significance of flow##2##3##(1993-1#2)
significance of several##2##3##(2008-10#1)(2011-2#1)
significance of the##28##3##(1991-2#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-7#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
significance of these results##2##4##(2008-10#2)
significance of these##4##3##(2008-10#2)(2008-7#1)(2009-10#1)
significance of this##12##3##(1990-11#1)(1993-1#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)
significance of##131##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#2)(1991-9#1)(1993-1#3)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#22)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#11)(2008-9#3)(2009-1#3)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#5)(2012-3#9)(2013-1#4)(2013-8#3)
significance should not be##2##4##(1997-4#1)(2010-6#1)
significance threshold##2##2##(2008-10#1)(2012-2#1)
significance to##6##2##(1992-2#1)(2008-10#3)(2008-8#2)
significance was##8##2##(1993-11#1)(1993-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
significance##264##1##(1990-11#2)(1990-12#3)(1990-3#1)(1990-4#1)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#46)(2008-11#15)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#16)(2008-8#5)(2008-9#8)(2009-1#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#14)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#11)(2013-1#13)(2013-2#1)(2013-8#5)
significant (P &lt##19##3##(1993-12#2)(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#11)(2008-5#1)(2012-2#2)
significant (P = 0##10##4##(2008-10#9)(2008-8#1)
significant (P##30##2##(1993-12#2)(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#21)(2008-5#1)(2008-8#1)(2012-2#2)
significant (P&gt##3##2##(2008-7#1)(2009-3#2)
significant (P&lt##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
significant (p &gt##2##3##(2008-12#2)
significant (p &lt##6##3##(1996-8#1)(2008-10#1)(2008-12#2)(2010-7#1)(2011-2#1)
significant (p = 0##4##4##(1993-1#1)(2008-1#1)(2013-1#2)
significant (p =##5##3##(1993-1#1)(2008-1#1)(2010-10#1)(2013-1#2)
significant (p##15##2##(1991-11#1)(1993-1#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-12#4)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
significant (p&lt##2##2##(2012-12#1)(2013-1#1)
significant accumulation of##2##3##(1991-5#1)(1997-1#1)
significant accumulation##3##2##(1991-5#1)(1997-1#1)(2012-2#1)
significant activity in##2##3##(2009-3#1)(2010-11#1)
significant activity##4##2##(1994-5#1)(2008-11#1)(2009-3#1)(2010-11#1)
significant additive##2##2##(2008-10#1)(2011-2#1)
significant advances in the##3##4##(1990-11#1)(2008-11#1)(2009-3#1)
significant advances in##5##3##(1990-11#1)(2008-11#1)(2009-3#1)(2011-1#1)(2013-7#1)
significant advances##7##2##(1990-11#1)(2008-10#1)(2008-11#2)(2009-3#1)(2011-1#1)(2013-7#1)
significant advantage over##3##3##(2008-10#2)(2008-9#1)
significant advantage##5##2##(2008-10#3)(2008-9#1)(2009-1#1)
significant advantages##3##2##(2008-10#3)
significant adverse effect##2##3##(2008-4#1)(2011-2#1)
significant adverse##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
significant after adjusting for##2##4##(2012-5#2)
significant after##3##2##(1992-12#1)(2012-5#2)
significant alterations##2##2##(1996-12#1)(2008-5#1)
significant amino acid##2##3##(2008-10#2)
significant among##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
significant amount of##7##3##(1991-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
significant amounts of##9##3##(1993-11#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-7#2)(2011-2#1)
significant amounts##11##2##(1990-11#1)(1993-11#1)(1995-2#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-7#2)(2011-2#1)
significant and comparable##2##3##(1995-3#1)(2013-1#1)
significant and insignificant##3##3##(2008-10#3)
significant and##24##2##(1993-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#9)(2008-12#1)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
significant antagonistic effect##2##3##(2008-10#1)(2008-7#1)
significant antibacterial##2##2##(2008-12#1)(2012-3#1)
significant association between the##2##4##(2011-2#1)(2013-8#1)
significant association between##9##3##(1996-12#1)(2008-10#2)(2009-6#1)(2011-2#4)(2013-8#1)
significant association of##2##3##(2008-10#2)
significant association was##2##3##(1991-6#1)(2011-2#1)
significant association with##5##3##(1992-2#1)(1994-12#1)(2008-10#1)(2010-6#1)(2012-2#1)
significant association##20##2##(1990-8#1)(1991-6#1)(1992-2#1)(1994-12#1)(1996-12#1)(2008-10#5)(2008-5#1)(2009-6#1)(2010-6#1)(2011-2#5)(2012-2#1)(2013-8#1)
significant associations between##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-1#1)(2012-3#1)
significant associations were found between##2##5##(2010-2#1)(2012-5#1)
significant associations were found##3##4##(2009-5#1)(2010-2#1)(2012-5#1)
significant associations were##4##3##(2009-5#1)(2010-2#1)(2012-5#1)(2013-8#1)
significant associations##12##2##(2008-10#2)(2008-12#1)(2008-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
significant at P&lt##2##3##(2008-12#1)(2008-7#1)
significant at##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#2)
significant background##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
significant because##2##2##(2008-11#1)(2010-7#1)
significant benefits##3##2##(2008-5#1)(2009-3#1)(2010-8#1)
significant bias##2##2##(2008-10#2)
significant body of##2##3##(2008-8#1)(2009-6#1)
significant body##3##2##(2008-5#1)(2008-8#1)(2009-6#1)
significant but##6##2##(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
significant by##2##2##(1995-12#1)(2008-9#1)
significant cell##3##2##(1993-8#1)(2010-11#1)(2011-2#1)
significant challenges##5##2##(1995-12#1)(2008-12#1)(2008-6#1)(2009-10#1)(2013-8#1)
significant change in the##13##4##(1991-2#1)(1995-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#2)
significant change in##27##3##(1991-2#1)(1993-8#1)(1995-3#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#3)(2013-8#1)
significant change was observed in##2##5##(1993-12#1)(2010-5#1)
significant change was##3##3##(1991-1#1)(1993-12#1)(2010-5#1)
significant change##34##2##(1991-1#1)(1991-2#1)(1993-12#1)(1993-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
significant changes between##2##3##(2008-10#1)(2012-2#1)
significant changes from baseline##2##4##(1993-1#1)(2011-2#1)
significant changes in the##7##4##(1992-6#1)(1995-6#1)(1996-12#1)(2008-11#1)(2010-6#1)(2010-8#1)(2011-2#1)
significant changes in##35##3##(1991-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)
significant changes occurred in the##2##5##(1992-12#1)(2008-11#1)
significant changes were##8##3##(1991-12#1)(1994-3#1)(1996-2#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
significant changes with##2##3##(2008-7#1)(2009-8#1)
significant changes##57##2##(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#5)(2012-3#2)(2013-1#1)
significant clinical##4##2##(1994-1#1)(2008-7#1)(2008-9#1)(2010-12#1)
significant complication##2##2##(2011-2#1)(2013-1#1)
significant complications##3##2##(1993-1#1)(2008-7#1)(2013-1#1)
significant concentration##2##2##(2008-10#2)
significant consequences##2##2##(1996-2#1)(2013-1#1)
significant contributions##2##2##(2008-10#1)(2013-1#1)
significant contributor##2##2##(2008-10#1)(2011-3#1)
significant coronary artery##2##3##(2008-11#1)(2013-1#1)
significant correlation between the##4##4##(1994-3#1)(1997-2#1)(1997-8#1)(2008-10#1)
significant correlation between##20##3##(1990-5#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-12#1)(2010-1#1)(2010-4#1)(2013-1#2)(2013-8#1)
significant correlation of##3##3##(2008-10#2)(2011-2#1)
significant correlation was found between##3##5##(2008-10#2)(2013-1#1)
significant correlation was found##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
significant correlation was observed between##3##5##(1991-6#1)(2008-10#1)(2008-5#1)
significant correlation was observed##4##4##(1991-6#1)(1995-6#1)(2008-10#1)(2008-5#1)
significant correlation was##10##3##(1990-5#1)(1991-6#1)(1995-6#1)(2008-10#4)(2008-5#1)(2011-2#1)(2013-1#1)
significant correlation##38##2##(1990-5#2)(1991-6#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#13)(2008-12#2)(2008-5#1)(2008-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#2)(2013-1#3)(2013-8#1)
significant correlations between the##3##4##(1992-2#1)(2008-10#1)(2011-2#1)
significant correlations between##6##3##(1992-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
significant correlations were##2##3##(2008-8#1)(2011-1#1)
significant correlations##12##2##(1992-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
significant damage to##2##3##(2008-10#2)
significant decrease in the##5##4##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
significant decrease in total##3##4##(1992-2#1)(1993-6#1)(2008-12#1)
significant decrease in##41##3##(1991-6#1)(1992-2#1)(1993-1#1)(1993-6#2)(1994-3#2)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(2008-10#5)(2008-11#4)(2008-12#3)(2008-5#3)(2009-11#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#2)
significant decrease of##9##3##(1992-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-6#1)(2012-3#1)
significant decrease##55##2##(1991-6#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-6#2)(1994-2#1)(1994-3#2)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#4)(2008-5#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-8#3)
significant decreases in the##2##4##(1993-6#1)(1994-2#1)
significant decreases in##7##3##(1993-6#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-5#1)(2010-12#1)(2010-6#1)
significant decreases##8##2##(1993-6#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-5#2)(2010-12#1)(2010-6#1)
significant decreasing##2##2##(2008-10#1)(2012-12#1)
significant degree##5##2##(1990-5#1)(1994-8#1)(2008-11#1)(2008-4#1)(2011-2#1)
significant deviation from##2##3##(2008-10#1)(2013-8#1)
significant deviation##3##2##(1996-5#1)(2008-10#1)(2013-8#1)
significant difference (p &lt##3##4##(2008-5#2)(2013-1#1)
significant difference among the##3##4##(1994-3#1)(2008-10#2)
significant difference among##5##3##(1994-3#1)(2008-10#3)(2013-1#1)
significant difference at 95% confidence level was observed##2##8##(2008-10#2)
significant difference at 95% confidence level##4##6##(2008-10#4)
significant difference at the 95% confidence level was observed##3##9##(2008-10#3)
significant difference at##8##3##(2008-10#8)
significant difference between groups regarding##2##5##(2008-12#1)(2013-1#1)
significant difference between patients##2##4##(1995-5#1)(2011-2#1)
significant difference between the two##4##5##(2008-12#2)(2008-7#1)(2008-9#1)
significant difference between the##19##4##(1992-11#1)(1992-2#1)(1997-8#2)(1997-9#1)(2008-10#4)(2008-12#2)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)(2011-3#1)(2012-3#1)
significant difference between##38##3##(1991-8#1)(1992-11#1)(1992-2#1)(1993-2#1)(1995-5#1)(1995-8#1)(1997-8#2)(1997-9#1)(2007-12#1)(2008-10#8)(2008-12#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#2)
significant difference for##3##3##(2008-10#2)(2008-12#1)
significant difference in the##25##4##(1991-2#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-7#1)(2009-3#1)(2011-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
significant difference in##64##3##(1990-12#1)(1991-2#2)(1991-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#3)(2008-5#2)(2008-7#3)(2008-9#2)(2009-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-3#4)(2012-6#1)(2013-1#4)(2013-8#1)
significant difference observed##3##3##(2008-12#1)(2013-1#2)
significant difference of the##2##4##(2008-10#1)(2008-9#1)
significant difference of##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
significant difference was found among##2##5##(2008-7#1)(2013-1#1)
significant difference was found between the##3##6##(1993-2#1)(2008-12#1)(2011-2#1)
significant difference was found between##7##5##(1990-8#1)(1993-2#1)(2008-10#2)(2008-12#1)(2011-2#2)
significant difference was found in##2##5##(2008-10#1)(2008-11#1)
significant difference was found##12##4##(1990-8#1)(1993-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
significant difference was observed##4##4##(1993-1#1)(1993-11#1)(2009-11#1)(2013-1#1)
significant difference was##19##3##(1990-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#2)(2013-1#3)
significant difference##157##2##(1990-12#1)(1990-8#1)(1991-2#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#2)(1993-2#3)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-8#3)(1997-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#37)(2008-11#7)(2008-12#10)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#1)(2012-3#6)(2012-6#1)(2013-1#16)(2013-8#3)
significant differences (P &lt##2##4##(2008-5#2)
significant differences among##7##3##(1993-2#1)(2008-10#5)(2013-8#1)
significant differences between groups##4##4##(2011-2#1)(2013-1#3)
significant differences between men and women##2##6##(1993-2#2)
significant differences between the groups##2##5##(1995-1#1)(2009-12#1)
significant differences between the proposed##2##5##(2008-10#2)
significant differences between the two groups##3##6##(2008-9#1)(2013-1#2)
significant differences between the two##6##5##(1991-3#1)(1993-8#1)(1995-8#1)(2008-9#1)(2013-1#2)
significant differences between the##16##4##(1991-3#1)(1991-9#1)(1993-8#1)(1995-1#1)(1995-8#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#2)
significant differences between##39##3##(1991-3#1)(1991-9#1)(1992-2#1)(1993-2#2)(1993-8#1)(1995-1#2)(1995-8#1)(1997-7#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#6)
significant differences in allele frequencies##2##5##(2008-10#2)
significant differences in allele##3##4##(2008-10#2)(2008-12#1)
significant differences in diagnostic##2##4##(1991-8#1)(2012-2#1)
significant differences in the frequency of##2##6##(2008-10#1)(2012-3#1)
significant differences in the size##2##5##(1991-12#1)(2010-9#1)
significant differences in the##13##4##(1991-12#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
significant differences in##64##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-3#1)(2008-10#18)(2008-11#2)(2008-12#5)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#3)
significant differences were found among##3##5##(1993-2#1)(2008-10#1)(2012-3#1)
significant differences were found between the##3##6##(1992-3#1)(1993-2#1)(2008-10#1)
significant differences were found between##8##5##(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#2)(2010-6#1)(2011-3#1)(2013-1#1)
significant differences were found in##7##5##(1992-12#1)(1997-3#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
significant differences were found##19##4##(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#2)(1997-3#1)(2008-10#6)(2008-7#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
significant differences were observed between the##2##6##(2008-10#1)(2011-2#1)
significant differences were observed in the##2##6##(1995-11#1)(2012-3#1)
significant differences were observed in##3##5##(1995-11#1)(2008-10#1)(2012-3#1)
significant differences were observed##9##4##(1995-11#1)(2008-10#6)(2011-2#1)(2012-3#1)
significant differences were seen in##3##5##(2008-12#1)(2008-5#2)
significant differences were##39##3##(1990-5#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#2)(1994-1#1)(1994-2#1)(1995-11#1)(1997-3#1)(2008-10#15)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#2)
significant differences when##2##3##(2008-8#1)(2013-1#1)
significant differences##181##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#2)(1993-2#6)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#2)(1997-7#2)(2008-1#1)(2008-10#57)(2008-11#3)(2008-12#8)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-10#1)(2011-2#8)(2011-3#2)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#17)(2013-8#5)
significant different##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
significant disease control##2##3##(2008-10#2)
significant disease##6##2##(2008-10#5)(2013-1#1)
significant diversity##2##2##(2008-10#1)(2010-12#1)
significant down-regulation of##2##3##(1992-6#1)(2013-1#1)
significant ecological##2##2##(2008-8#1)(2008-9#1)
significant economic losses##2##3##(2008-10#2)
significant economic##4##2##(1994-12#1)(2008-10#2)(2008-11#1)
significant effect in##4##3##(1991-8#2)(2008-11#1)(2012-12#1)
significant effect of the##3##4##(1996-12#1)(2008-11#1)(2013-8#1)
significant effect of##13##3##(1996-12#2)(2006-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
significant effect on LAT cell viability##2##6##(1990-6#2)
significant effect on the rate of 3H-thymidine##2##7##(1995-3#2)
significant effect on the rate of##3##6##(1995-3#2)(2008-10#1)
significant effect on the##28##4##(1990-5#1)(1991-6#1)(1993-1#1)(1993-11#1)(1994-5#2)(1995-3#2)(1996-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-1#1)(2011-2#1)(2011-3#1)(2013-1#2)
significant effect on##54##3##(1990-5#1)(1990-6#3)(1991-6#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-5#2)(1995-12#1)(1995-3#2)(1996-12#2)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-5#1)(2011-2#1)(2011-3#2)(2012-2#2)(2013-1#3)
significant effect was##2##3##(1993-6#1)(2008-10#1)
significant effect##91##2##(1990-5#1)(1990-6#3)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-3#2)(1996-12#4)(1996-2#1)(1997-1#1)(2006-6#1)(2007-11#1)(2008-10#31)(2008-11#5)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
significant effects on the##4##4##(1991-9#1)(2008-11#2)(2013-8#1)
significant effects on##14##3##(1991-9#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-9#1)(2009-5#1)(2013-8#1)
significant effects##18##2##(1991-9#1)(1996-12#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
significant efficacy##2##2##(2008-9#1)(2011-2#1)
significant elevation##2##2##(1990-8#1)(2012-2#1)
significant enhancement of the##5##4##(2008-10#4)(2008-11#1)
significant enhancement of##7##3##(2008-10#5)(2008-11#1)(2008-5#1)
significant enhancement##9##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)
significant error##2##2##(2008-10#1)(2008-6#1)
significant evidence for##3##3##(1994-12#1)(2008-7#1)(2008-9#1)
significant evidence##4##2##(1994-12#1)(2008-7#2)(2008-9#1)
significant expression##2##2##(1996-12#1)(2008-11#1)
significant extent##2##2##(1991-6#1)(2012-3#1)
significant factor##5##2##(1994-3#1)(2008-10#3)(2008-8#1)
significant factors for total inorganic##2##5##(2008-10#2)
significant factors for##4##3##(2008-10#3)(2012-3#1)
significant factors were##2##3##(2008-10#1)(2011-2#1)
significant factors##11##2##(1997-2#1)(2008-10#8)(2011-2#1)(2012-3#1)
significant finding##5##2##(1997-1#1)(1997-6#1)(2008-12#1)(2008-9#1)(2013-1#1)
significant fit##2##2##(2012-2#1)(2012-3#1)
significant for the##2##3##(2011-2#1)(2012-3#1)
significant for##15##2##(1990-2#2)(1991-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
significant gains##2##2##(2008-12#1)(2008-9#1)
significant gastrointestinal##2##2##(1996-8#1)(2011-2#1)
significant gender differences in##2##4##(2008-12#1)(2008-5#1)
significant gender differences##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
significant gender##4##2##(2008-11#2)(2008-12#1)(2008-5#1)
significant genetic differentiation among##2##4##(2008-10#2)
significant genetic differentiation##3##3##(2008-10#3)
significant genetic##7##2##(2008-10#4)(2008-12#1)(2012-3#1)(2013-8#1)
significant group differences in##2##4##(1993-3#1)(2012-2#1)
significant growth in##2##3##(1997-2#1)(2011-2#1)
significant growth was##2##3##(2012-3#2)
significant growth##8##2##(1993-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#3)
significant health##5##2##(1996-12#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-1#1)
significant hemodynamic##2##2##(2009-8#2)
significant heterogeneity##3##2##(2008-10#2)(2010-2#1)
significant higher##2##2##(1990-8#1)(2011-2#1)
significant homologies##2##2##(1990-11#1)(1991-9#1)
significant homology to known proteins##2##5##(1995-12#1)(1995-9#1)
significant homology to##7##3##(1993-12#1)(1995-12#1)(1995-9#1)(1997-2#1)(1997-7#2)(2008-10#1)
significant homology with##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
significant homology##12##2##(1990-5#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-2#1)(1997-7#2)(2008-10#3)(2008-8#1)
significant impact of##3##3##(2008-1#1)(2008-10#2)
significant impact on the##7##4##(1996-1#1)(2008-1#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#1)
significant impact on##18##3##(1993-2#1)(1994-12#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
significant impact##22##2##(1993-2#1)(1994-12#1)(1996-1#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
significant impacts##3##2##(1991-12#2)(2008-10#1)
significant impairment of##2##3##(2012-2#2)
significant implications for##2##3##(2008-7#1)(2009-12#1)
significant implications in the##2##4##(2008-10#2)
significant implications##4##2##(2008-10#2)(2008-7#1)(2009-12#1)
significant improvement in clinical##2##4##(1994-12#1)(2011-2#1)
significant improvement in the##5##4##(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#2)
significant improvement in##25##3##(1990-2#2)(1991-3#1)(1991-8#1)(1994-12#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#2)(2009-1#1)(2011-2#2)(2012-2#1)(2013-1#6)
significant improvement of the##3##4##(2008-10#2)(2013-1#1)
significant improvement of##9##3##(2008-10#5)(2008-11#1)(2010-12#1)(2013-1#2)
significant improvement over time##2##4##(2008-9#1)(2011-2#1)
significant improvement over##5##3##(1994-1#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)
significant improvement##45##2##(1990-2#2)(1991-3#1)(1991-8#1)(1994-1#1)(1994-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#2)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#8)
significant improvements in the##2##4##(1991-2#1)(1996-3#1)
significant improvements in##7##3##(1991-2#1)(1993-1#1)(1996-2#1)(1996-3#1)(2010-11#1)(2012-2#1)(2013-1#1)
significant improvements##12##2##(1991-2#2)(1993-1#1)(1996-2#1)(1996-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
significant in both##2##3##(2008-10#1)(2008-7#1)
significant in the##5##3##(2008-10#2)(2010-1#1)(2010-3#1)(2010-7#1)
significant in##18##2##(1990-11#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
significant increase (by about##2##4##(2009-8#2)
significant increase after##2##3##(1995-12#1)(2013-1#1)
significant increase in comet tail length##2##6##(2010-5#2)
significant increase in the level of##2##6##(2009-8#2)
significant increase in the##19##4##(1993-1#1)(1994-2#1)(1994-5#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-8#3)(2011-2#1)(2012-2#1)(2013-7#1)
significant increase in##57##3##(1991-5#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-1#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#1)(2009-6#1)(2009-8#7)(2010-1#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#1)
significant increase of intracellular##2##4##(1995-8#1)(2008-8#1)
significant increase of the signal intensity##2##6##(2008-10#1)(2008-3#1)
significant increase of the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
significant increase of##15##3##(1990-9#1)(1995-8#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#1)
significant increase was##3##3##(1995-8#1)(2008-7#1)(2013-1#1)
significant increase##85##2##(1990-6#1)(1990-9#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-8#2)(1996-12#1)(1997-1#2)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#10)(2010-1#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#1)
significant increases in##16##3##(1990-3#1)(1995-11#1)(1996-12#3)(1997-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-12#2)(2010-6#1)(2013-1#2)
significant increases of##2##3##(2011-2#1)(2013-8#1)
significant increases##20##2##(1990-3#1)(1995-11#1)(1995-12#1)(1996-12#3)(1997-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
significant independent##2##2##(2010-4#1)(2011-2#1)
significant influence of##2##3##(2008-10#1)(2012-6#1)
significant influence on the##5##4##(1990-2#1)(2008-5#2)(2011-2#1)(2011-3#1)
significant influence on##13##3##(1990-2#1)(2008-10#4)(2008-11#1)(2008-5#3)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
significant influence##15##2##(1990-2#1)(2008-10#5)(2008-11#1)(2008-5#3)(2011-2#1)(2011-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
significant inhibition of##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
significant inhibition##6##2##(1990-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
significant inhibitory effects##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
significant inhibitory##5##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
significant interaction between the##2##4##(1993-3#1)(2008-10#1)
significant interaction between##5##3##(1993-3#1)(2008-10#2)(2008-11#1)(2012-4#1)
significant interaction by##2##3##(2011-2#1)(2013-1#1)
significant interaction for##2##3##(2008-10#1)(2008-12#1)
significant interaction of##2##3##(2008-10#2)
significant interaction##12##2##(1993-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-4#1)(2013-1#1)
significant interactions##4##2##(2008-10#3)(2008-11#1)
significant interference from##3##3##(1990-2#1)(2008-10#2)
significant interference##8##2##(1990-2#2)(2008-10#6)
significant interferences##3##2##(1990-2#1)(2008-10#2)
significant intracranial hypertension##2##3##(2010-5#2)
significant lag positions discontinuous from##2##5##(2008-10#2)
significant level of##3##3##(1994-8#1)(2009-10#1)(2010-4#1)
significant levels of genetic differentiation##2##5##(2008-10#2)
significant levels of##9##3##(1996-1#1)(1997-2#1)(2008-10#5)(2008-7#1)(2013-1#1)
significant levels##13##2##(1996-1#1)(1997-2#1)(2008-10#7)(2008-7#1)(2008-8#2)(2013-1#1)
significant loss of##5##3##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
significant loss##6##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
significant lower##3##2##(1991-6#2)(2011-2#1)
significant main effects##2##3##(2008-10#1)(2013-1#1)
significant main##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
significant maternal and##2##3##(2008-7#1)(2012-3#1)
significant maternal##3##2##(2008-7#1)(2010-8#1)(2012-3#1)
significant model##2##2##(2008-8#1)(2009-3#1)
significant morbidity and mortality##4##4##(2008-7#2)(2010-10#1)(2011-2#1)
significant morbidity and##5##3##(1997-3#1)(2008-7#2)(2010-10#1)(2011-2#1)
significant morbidity to##2##3##(2008-7#1)(2013-1#1)
significant morbidity##11##2##(1997-3#1)(2008-7#4)(2008-8#1)(2010-10#1)(2011-2#3)(2013-1#1)
significant mortality##2##2##(2008-7#1)(2013-8#1)
significant negative correlation between##4##4##(1994-2#1)(2008-10#1)(2011-2#1)(2012-6#1)
significant negative correlation##9##3##(1994-2#1)(2008-10#3)(2008-7#1)(2011-2#2)(2012-6#1)(2013-1#1)
significant negative##15##2##(1992-3#1)(1994-2#1)(2008-10#4)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#1)
significant nonrandom##2##2##(2008-10#2)
significant number of patients##2##4##(2008-7#1)(2011-2#1)
significant number of##8##3##(1990-5#1)(1996-1#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
significant number##9##2##(1990-5#1)(1993-8#1)(1996-1#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
significant or##2##2##(2008-10#1)(2008-9#1)
significant population##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
significant positive association##2##3##(2012-2#2)
significant positive correlation between##3##4##(2008-11#1)(2008-8#1)(2012-3#1)
significant positive correlation##4##3##(1991-12#1)(2008-11#1)(2008-8#1)(2012-3#1)
significant positive effect##2##3##(2008-11#1)(2011-1#1)
significant positive##20##2##(1991-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#3)(2012-2#2)(2012-3#2)(2013-8#1)
significant potential##4##2##(1995-2#1)(2008-10#1)(2010-6#1)(2011-2#1)
significant predictor of##6##3##(1991-3#1)(1996-3#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
significant predictor##8##2##(1991-3#1)(1993-1#1)(1996-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
significant predictors of mortality##3##4##(2008-7#3)
significant predictors of##10##3##(1996-1#1)(1996-3#1)(2008-11#2)(2008-7#3)(2011-2#2)(2012-2#1)
significant predictors##13##2##(1996-1#1)(1996-3#1)(2008-11#3)(2008-12#1)(2008-7#3)(2011-2#3)(2012-2#1)
significant problem##7##2##(1996-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-11#1)
significant progress has been made in##2##6##(2009-12#1)(2009-8#1)
significant progress has been made##3##5##(2009-12#1)(2009-8#1)(2013-8#1)
significant progress has##4##3##(2009-12#1)(2009-8#1)(2011-1#1)(2013-8#1)
significant progress in##3##3##(2010-10#2)(2012-3#1)
significant progress##8##2##(2009-12#1)(2009-8#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
significant prolongation of the CSP duration##2##6##(2011-2#2)
significant proportion of the##6##4##(1993-3#2)(2008-10#2)(2008-11#1)(2011-2#1)
significant proportion of##14##3##(1993-3#2)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
significant protection against##3##3##(1991-2#1)(1995-5#1)(2008-11#1)
significant protection##5##2##(1991-2#1)(1995-5#1)(2008-10#2)(2008-11#1)
significant quantities of##2##3##(1990-5#1)(1996-1#1)
significant reduction in the##10##4##(1991-3#1)(1992-9#2)(1994-6#1)(1996-1#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-6#1)
significant reduction in##30##3##(1991-3#1)(1992-9#2)(1993-1#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#10)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-10#1)(2012-2#2)(2013-1#2)
significant reduction of the##6##4##(1992-1#1)(1996-1#1)(2008-3#1)(2011-2#3)
significant reduction of##20##3##(1992-1#1)(1993-3#1)(1996-1#1)(1996-12#1)(2008-10#6)(2008-3#2)(2008-6#1)(2010-12#1)(2011-10#1)(2011-2#3)(2012-2#2)
significant reduction##53##2##(1991-3#1)(1992-1#1)(1992-9#2)(1993-1#2)(1993-3#1)(1994-6#1)(1995-2#1)(1996-1#2)(1996-12#2)(1996-2#1)(2008-10#16)(2008-3#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-10#2)(2011-2#3)(2012-2#5)(2013-1#3)
significant reductions in the##3##4##(1995-1#1)(1997-2#1)(2008-10#1)
significant reductions in yield##2##4##(2008-10#2)
significant reductions in##10##3##(1995-1#1)(1997-2#1)(2008-10#8)
significant reductions of##5##3##(1993-3#1)(1995-5#1)(2008-10#2)(2013-1#1)
significant reductions##16##2##(1993-3#1)(1995-1#1)(1995-5#1)(1997-2#1)(2008-10#11)(2013-1#1)
significant relation##2##2##(1992-3#1)(2008-10#1)
significant relationship among the##2##4##(2010-9#1)(2011-2#1)
significant relationship between the##2##4##(1997-8#1)(2008-8#1)
significant relationship between##9##3##(1995-2#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
significant relationship##15##2##(1992-2#1)(1995-2#1)(1996-12#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#2)
significant relationships between##2##3##(2008-9#1)(2012-2#1)
significant relationships were##2##3##(1991-2#1)(2008-10#1)
significant relationships##5##2##(1991-2#1)(2008-10#2)(2008-9#1)(2012-2#1)
significant renal##2##2##(2008-10#2)
significant research##2##2##(2008-11#1)(2012-3#1)
significant response##2##2##(2008-10#1)(2008-8#1)
significant results##5##2##(1994-3#1)(2008-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
significant rise in the##2##4##(2011-2#1)(2012-2#1)
significant rise in##7##3##(1996-3#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
significant rise##8##2##(1996-3#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
significant risk factor for##7##4##(1997-3#1)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
significant risk factors##2##3##(2008-8#1)(2013-8#1)
significant risk of##4##3##(1996-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
significant risk##14##2##(1996-9#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
significant role for reduced##2##4##(2008-10#2)
significant role for##4##3##(1993-12#1)(2008-10#2)(2008-7#1)
significant role of##3##3##(1995-6#1)(2008-10#1)(2013-8#1)
significant role##34##2##(1993-12#1)(1995-2#1)(1995-6#2)(2008-10#9)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-10#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
significant roles in##3##3##(1994-8#1)(1995-2#1)(2008-9#1)
significant roles##4##2##(1994-8#2)(1995-2#1)(2008-9#1)
significant savings of##2##3##(1994-12#1)(2008-10#1)
significant selectivity##2##2##(1994-5#1)(1997-2#1)
significant sequence identity##2##3##(1992-4#1)(1994-12#1)
significant sequence##5##2##(1992-4#1)(1994-12#1)(1995-8#1)(1996-12#1)(2008-10#1)
significant side##2##2##(2011-10#1)(2013-8#1)
significant similarity to any##4##4##(1996-12#2)(1996-6#1)(2008-10#1)
significant similarity to##8##3##(1991-6#1)(1995-2#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-7#1)(2008-10#1)
significant similarity##11##2##(1991-6#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-7#1)(2008-10#1)(2009-8#1)
significant sources of##2##3##(2008-10#2)
significant standing height##2##3##(2010-3#2)
significant statistical difference was found##3##5##(1994-3#1)(2010-8#1)(2013-8#1)
significant statistical difference##4##3##(1994-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
significant statistical differences between the##2##5##(2008-1#1)(2008-7#1)
significant statistical##6##2##(1994-3#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
significant stenosis##2##2##(1993-8#1)(2011-2#1)
significant stimulation of##2##3##(2008-10#1)(2008-7#1)
significant structural##4##2##(1991-3#1)(1993-8#1)(1996-2#1)(2012-2#1)
significant suppression of##3##3##(1994-2#1)(2011-2#1)(2012-2#1)
significant suppression##4##2##(1994-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
significant survival##4##2##(2008-11#1)(2008-7#1)(2013-1#2)
significant symptoms of depression##2##4##(2010-7#2)
significant technological##2##2##(2008-10#1)(2011-2#1)
significant than##2##2##(1992-3#1)(2008-9#1)
significant time##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
significant titers of##2##3##(1996-11#1)(2012-3#1)
significant to##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
significant variability##4##2##(1990-2#1)(2008-10#1)(2010-9#1)(2011-3#1)
significant variables##5##2##(2008-10#3)(2010-1#1)(2011-2#1)
significant variation in the##2##4##(2008-10#1)(2008-11#1)
significant variation in##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
significant variation of##2##3##(2008-10#2)
significant variation##6##2##(2008-10#3)(2008-11#1)(2012-3#1)(2013-1#1)
significant variations in##2##3##(2008-10#1)(2008-5#1)
significant variations##5##2##(1991-12#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
significant visual loss##2##3##(2011-2#1)(2013-8#1)
significant way##2##2##(2008-11#1)(2012-3#1)
significant when##4##2##(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
significant with##3##2##(2007-11#1)(2008-10#2)
significant yield losses##2##3##(2008-10#2)
significant##2290##1##(1990-10#1)(1990-11#9)(1990-12#1)(1990-2#10)(1990-3#3)(1990-4#1)(1990-5#11)(1990-6#7)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#4)(1991-12#8)(1991-2#12)(1991-3#8)(1991-5#3)(1991-6#9)(1991-8#6)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#10)(1992-2#13)(1992-3#6)(1992-4#3)(1992-6#5)(1992-7#2)(1992-9#5)(1993-1#15)(1993-11#6)(1993-12#8)(1993-2#13)(1993-3#10)(1993-6#6)(1993-8#9)(1993-9#2)(1994-1#6)(1994-11#5)(1994-12#14)(1994-2#15)(1994-3#16)(1994-5#11)(1994-6#3)(1994-8#11)(1994-9#1)(1995-1#7)(1995-11#3)(1995-12#12)(1995-2#11)(1995-3#7)(1995-5#6)(1995-6#4)(1995-8#8)(1995-9#3)(1996-1#12)(1996-11#1)(1996-12#28)(1996-2#9)(1996-3#11)(1996-5#2)(1996-6#3)(1996-8#5)(1996-9#1)(1997-1#10)(1997-2#13)(1997-3#8)(1997-5#1)(1997-6#3)(1997-7#7)(1997-8#11)(1997-9#2)(2006-6#2)(2007-11#7)(2007-12#1)(2007-8#4)(2008-1#11)(2008-10#590)(2008-11#119)(2008-12#68)(2008-2#3)(2008-3#26)(2008-4#9)(2008-5#55)(2008-6#14)(2008-7#81)(2008-8#45)(2008-9#46)(2009-1#4)(2009-10#7)(2009-11#6)(2009-12#6)(2009-2#1)(2009-3#14)(2009-4#2)(2009-5#5)(2009-6#9)(2009-7#5)(2009-8#27)(2009-9#1)(2010-1#14)(2010-10#13)(2010-11#6)(2010-12#21)(2010-2#5)(2010-3#6)(2010-4#9)(2010-5#11)(2010-6#13)(2010-7#10)(2010-8#13)(2010-9#5)(2011-1#16)(2011-10#4)(2011-2#143)(2011-3#12)(2011-7#1)(2012-12#14)(2012-2#65)(2012-3#60)(2012-4#1)(2012-5#8)(2012-6#3)(2013-1#126)(2013-7#4)(2013-8#51)
significant&quot##3##1##(1993-12#2)(1993-2#1)
significantly (P &gt##4##3##(2008-10#3)(2012-2#1)
significantly (P &lt##43##3##(1993-1#1)(1994-8#1)(1996-6#1)(2006-6#1)(2008-10#29)(2008-11#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-7#1)(2012-3#2)(2013-1#2)
significantly (P = 0##6##4##(1996-8#1)(2008-10#5)
significantly (P =##7##3##(1996-8#1)(2008-10#5)(2008-8#1)
significantly (P less than 0##2##5##(1990-11#2)
significantly (P##56##2##(1990-11#2)(1993-1#1)(1994-8#1)(1996-6#1)(1996-8#1)(2006-6#1)(2008-10#37)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#2)
significantly (P&lt##10##2##(2008-10#5)(2008-12#1)(2008-5#1)(2010-4#2)(2012-3#1)
significantly (p &lt##10##3##(1993-3#1)(1997-4#2)(2008-11#2)(2008-12#2)(2008-9#1)(2009-9#1)(2011-2#1)
significantly (p = 0##2##4##(2008-12#2)
significantly (p##13##2##(1991-3#1)(1993-3#1)(1997-4#2)(2008-11#2)(2008-12#4)(2008-9#1)(2009-9#1)(2011-2#1)
significantly (p&lt##4##2##(2008-10#1)(2013-1#3)
significantly affect the##7##3##(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-8#1)(2012-2#1)
significantly affect##13##2##(1991-1#1)(1994-11#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-8#1)(2010-8#1)(2012-2#1)
significantly affected (P &gt##2##3##(2010-11#2)
significantly affected by gypsum application##2##5##(2008-12#2)
significantly affected by the##3##4##(1995-12#1)(1996-12#1)(2008-10#1)
significantly affected by##21##3##(1990-5#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#1)(2010-2#1)(2010-4#1)
significantly affected the##6##3##(1997-5#1)(2008-10#2)(2008-12#1)(2010-8#1)(2013-1#1)
significantly affected##41##2##(1990-5#1)(1992-2#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#17)(2008-11#2)(2008-12#4)(2008-5#1)(2008-6#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
significantly affects the##2##3##(1997-6#1)(2012-3#1)
significantly affects##3##2##(1997-6#1)(2008-12#1)(2012-3#1)
significantly after##7##2##(1991-3#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-5#1)
significantly alter##8##2##(1991-3#1)(1993-11#1)(1993-6#1)(1995-11#2)(1997-2#1)(1997-4#1)(2011-2#1)
significantly altered in##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
significantly altered##9##2##(1992-1#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-2#1)
significantly among##5##2##(1997-8#1)(2008-10#4)
significantly and positively##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
significantly and the##4##3##(2008-1#1)(2008-8#2)(2008-9#1)
significantly and##11##2##(1994-2#1)(2008-1#2)(2008-10#4)(2008-8#2)(2008-9#1)(2013-8#1)
significantly as##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
significantly associated with a##3##4##(1997-4#1)(2008-12#1)(2013-8#1)
significantly associated with fewer##2##4##(2012-2#2)
significantly associated with##37##3##(1990-9#2)(1997-4#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-5#2)(2010-11#2)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#3)
significantly associated##43##2##(1990-9#2)(1991-6#1)(1997-4#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-5#2)(2010-11#2)(2011-2#3)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#3)
significantly at##9##2##(1995-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#3)
significantly attenuated the##4##3##(1994-11#1)(1995-8#1)(2008-7#1)(2011-2#1)
significantly attenuated##7##2##(1994-11#2)(1995-8#1)(2008-5#1)(2008-7#2)(2011-2#1)
significantly augmented##4##2##(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#1)
significantly below the##2##3##(2007-12#1)(2011-2#1)
significantly below##3##2##(1997-2#1)(2007-12#1)(2011-2#1)
significantly better than the##2##4##(2008-10#1)(2009-9#1)
significantly better than##5##3##(2008-10#3)(2009-9#1)(2013-8#1)
significantly better##16##2##(1991-3#1)(1991-8#1)(1997-7#1)(2008-10#8)(2008-2#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-8#1)
significantly between age groups##2##4##(2008-7#1)(2012-3#1)
significantly between the##5##3##(1997-7#2)(2008-8#1)(2009-10#1)(2011-2#1)
significantly between##14##2##(1997-7#2)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
significantly by the##3##3##(2008-10#2)(2008-4#1)
significantly by##15##2##(1991-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
significantly canceled the stimulatory actions of L-leucine and KIC on protein synthesis##2##12##(2008-11#2)
significantly change##5##2##(1994-5#1)(1995-1#1)(1996-6#1)(2008-2#2)
significantly changed##8##2##(1992-6#1)(1995-6#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-11#1)(2012-3#1)
significantly compared with the##2##4##(2008-10#1)(2011-3#1)
significantly compared with##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
significantly contributed to##2##3##(1991-2#1)(2012-3#1)
significantly correlated with geographic distance##2##5##(2008-10#2)
significantly correlated with the##8##4##(1993-3#1)(2008-10#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-8#1)
significantly correlated with##24##3##(1991-8#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(2008-10#8)(2008-7#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-5#2)(2013-8#2)
significantly correlated##31##2##(1990-8#1)(1991-8#1)(1992-12#2)(1993-3#1)(1994-12#1)(1994-3#1)(2008-10#10)(2008-7#3)(2010-2#1)(2011-1#1)(2011-2#4)(2012-3#1)(2012-5#2)(2013-8#2)
significantly declined##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
significantly decrease the##3##3##(1990-5#1)(2008-9#1)(2009-3#1)
significantly decrease##8##2##(1990-12#1)(1990-5#1)(1994-12#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
significantly decreased (p &lt##2##4##(2008-11#1)(2008-12#1)
significantly decreased after##4##3##(1994-2#1)(1995-12#1)(2011-2#1)(2013-1#1)
significantly decreased and##2##3##(2008-10#1)(2008-5#1)
significantly decreased at##3##3##(1995-12#1)(2008-8#1)(2013-1#1)
significantly decreased compared##2##3##(1993-1#1)(1995-6#1)
significantly decreased in both##2##4##(2008-10#1)(2013-1#1)
significantly decreased in patients with##2##5##(2007-11#1)(2008-7#1)
significantly decreased in the##2##4##(2008-10#2)
significantly decreased in##13##3##(1993-3#2)(2007-11#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#2)(2009-6#1)(2013-1#1)
significantly decreased the##9##3##(1994-5#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-9#1)(2009-1#1)(2011-2#1)
significantly decreased with##2##3##(1994-8#1)(2008-11#1)
significantly decreased##53##2##(1991-12#1)(1993-1#1)(1993-3#3)(1993-8#1)(1994-2#4)(1994-5#2)(1994-8#3)(1995-12#2)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#2)(2013-1#4)
significantly decreases##3##2##(1990-9#1)(1994-3#1)(2007-12#1)
significantly delayed in##2##3##(2011-2#1)(2012-12#1)
significantly delayed##5##2##(1997-3#1)(2008-10#1)(2011-2#1)(2012-12#2)
significantly depressed##2##2##(1994-11#1)(2011-1#1)
significantly different (P = 0##2##5##(2008-10#2)
significantly different (P##4##3##(2008-10#4)
significantly different (p&lt##3##3##(2008-12#2)(2013-1#1)
significantly different among concentrations for##2##5##(2008-10#2)
significantly different among the four##2##5##(2008-7#1)(2010-4#1)
significantly different among the##3##4##(2008-10#1)(2008-7#1)(2010-4#1)
significantly different among##10##3##(2008-10#5)(2008-7#1)(2008-9#2)(2010-4#1)(2010-7#1)
significantly different between the##3##4##(2007-12#1)(2008-10#2)
significantly different between##9##3##(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#4)(2011-2#1)(2013-8#1)
significantly different from a binomial distribution (P##2##7##(2008-10#2)
significantly different from each other##2##5##(1993-3#1)(2008-10#1)
significantly different from that##4##4##(2008-10#4)
significantly different from the##10##4##(1992-11#1)(1993-1#1)(1993-8#1)(1995-3#1)(2008-10#4)(2012-3#1)(2013-1#1)
significantly different from those of##3##5##(1993-8#1)(2010-8#1)(2011-2#1)
significantly different from those##4##4##(1990-12#1)(1993-8#1)(2010-8#1)(2011-2#1)
significantly different from zero (P &lt##2##6##(2008-10#2)
significantly different from zero##3##4##(2008-10#3)
significantly different from##39##3##(1990-12#1)(1991-12#1)(1992-11#1)(1993-1#1)(1993-3#1)(1993-8#2)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#24)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
significantly different in the##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
significantly different in##7##3##(1992-3#1)(2008-10#3)(2008-11#1)(2008-12#2)
significantly different than##2##3##(2008-10#1)(2013-1#1)
significantly different to##2##3##(1996-12#1)(2008-10#1)
significantly different##116##2##(1990-12#1)(1990-6#1)(1991-12#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-8#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(2007-12#2)(2008-10#53)(2008-11#2)(2008-12#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
significantly diminished in##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
significantly down-regulated##2##2##(2008-10#1)(2008-11#1)
significantly during the first##3##4##(2008-9#1)(2012-3#1)(2013-1#1)
significantly during the##8##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
significantly during treatment##2##3##(2012-3#2)
significantly during##16##2##(1997-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)
significantly elevated in the##3##4##(1996-12#1)(2008-10#2)
significantly elevated in##4##3##(1996-12#2)(2008-10#2)
significantly elevated##15##2##(1993-12#1)(1995-12#1)(1996-12#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
significantly enhance the##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2013-1#1)
significantly enhance##8##2##(1997-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2011-2#1)(2013-1#1)
significantly enhanced by##3##3##(2008-10#1)(2008-11#2)
significantly enhanced resistance##2##3##(2008-10#2)
significantly enhanced response towards##2##4##(2008-10#2)
significantly enhanced the##5##3##(1997-4#1)(2008-10#2)(2008-7#1)(2011-2#1)
significantly enhanced##29##2##(1994-11#1)(1994-8#2)(1997-4#1)(2008-10#16)(2008-11#4)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)
significantly enhances##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
significantly extends the##2##3##(2008-10#1)(2012-3#1)
significantly faster in##2##3##(2008-11#1)(2008-8#1)
significantly faster##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
significantly fewer##15##2##(1991-3#1)(1995-12#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-7#1)
significantly following##2##2##(2008-10#1)(2010-7#1)
significantly for RAPD##2##3##(2008-10#2)
significantly for##6##2##(1991-12#1)(1994-5#1)(2008-10#4)
significantly from a##3##3##(2008-10#2)(2013-1#1)
significantly from one##2##3##(2008-10#2)
significantly from that of##4##4##(1994-2#1)(2008-10#1)(2008-8#1)(2009-10#1)
significantly from that##5##3##(1994-2#1)(1994-5#1)(2008-10#1)(2008-8#1)(2009-10#1)
significantly from the##7##3##(1991-6#1)(1997-2#1)(2008-10#4)(2009-4#1)
significantly from those##4##3##(1996-3#1)(2008-8#2)(2013-8#1)
significantly from##35##2##(1991-6#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#11)(2008-12#4)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-9#1)(2012-3#2)(2013-1#2)(2013-8#2)
significantly greater (P &lt##2##4##(2008-10#2)
significantly greater in mulch##2##4##(2008-10#2)
significantly greater in##14##3##(1992-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#4)(2011-2#1)(2013-1#1)
significantly greater than 0 (P &lt##2##6##(2008-10#2)
significantly greater than that of##2##5##(2008-10#1)(2009-7#1)
significantly greater than that##3##4##(2008-10#1)(2008-5#1)(2009-7#1)
significantly greater than the##3##4##(1996-3#1)(2008-10#1)(2010-9#1)
significantly greater than those of##2##5##(2008-5#1)(2010-4#1)
significantly greater than##15##3##(1993-3#1)(1994-3#1)(1996-3#1)(2008-10#5)(2008-5#2)(2008-9#1)(2009-7#1)(2010-4#1)(2010-9#1)(2013-1#1)
significantly greater##58##2##(1991-2#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-9#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#6)
significantly high levels##2##3##(2008-10#1)(2008-11#1)
significantly high##9##2##(2008-10#3)(2008-11#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
significantly higher (p##2##3##(1993-11#1)(2011-2#1)
significantly higher amounts of##2##4##(2008-10#1)(2008-11#1)
significantly higher cell##2##3##(1994-2#1)(2008-10#1)
significantly higher during##2##3##(1995-11#1)(2008-11#1)
significantly higher for##6##3##(1992-12#1)(2008-10#2)(2008-9#1)(2009-1#1)(2011-2#1)
significantly higher in patients with##5##5##(1992-12#1)(1993-11#1)(2010-4#1)(2013-1#2)
significantly higher in patients##6##4##(1991-6#1)(1992-12#1)(1993-11#1)(2010-4#1)(2013-1#2)
significantly higher in the resistant##2##5##(2008-10#2)
significantly higher in the##16##4##(1992-12#1)(1992-3#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
significantly higher in##63##3##(1991-6#1)(1992-12#3)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-6#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#7)(2012-5#1)(2013-1#3)
significantly higher incidence##2##3##(1996-8#2)
significantly higher levels in##2##4##(2008-10#1)(2010-7#1)
significantly higher levels of##7##4##(1992-2#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-6#1)(2011-2#1)
significantly higher levels##9##3##(1992-2#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)
significantly higher mean age##2##4##(2008-10#1)(2013-8#1)
significantly higher mean##3##3##(1993-11#1)(2008-10#1)(2013-8#1)
significantly higher number of##3##4##(2009-8#1)(2010-10#1)(2013-1#1)
significantly higher on##4##3##(2008-10#2)(2008-5#1)(2012-9#1)
significantly higher percentage of##6##4##(1991-2#1)(2008-10#4)(2008-5#1)
significantly higher scores##4##3##(2008-12#1)(2008-8#1)(2009-4#1)(2013-1#1)
significantly higher serum##2##3##(2008-11#1)(2011-1#1)
significantly higher than in the##2##5##(1997-8#1)(2011-2#1)
significantly higher than in##9##4##(1990-11#1)(1991-5#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
significantly higher than that in##2##5##(2008-10#1)(2008-9#1)
significantly higher than that##7##4##(1994-11#1)(1997-7#1)(2008-10#2)(2008-9#1)(2011-2#1)(2011-3#1)
significantly higher than the##6##4##(1993-3#1)(2008-10#2)(2009-10#1)(2010-8#1)(2011-2#1)
significantly higher than##45##3##(1990-11#1)(1991-5#1)(1993-11#1)(1993-2#2)(1993-3#3)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-8#3)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
significantly higher total##2##3##(2008-12#1)(2008-5#1)
significantly higher under##2##3##(2008-10#2)
significantly higher with##2##3##(2008-9#1)(2010-12#1)
significantly higher##227##2##(1990-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#4)(1993-3#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#56)(2008-11#12)(2008-12#5)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#23)(2011-3#1)(2012-2#4)(2012-3#10)(2012-5#2)(2012-9#1)(2013-1#11)(2013-8#4)
significantly highest with##2##3##(2008-12#2)
significantly impact on##2##3##(2008-1#1)(2013-1#1)
significantly impact##3##2##(2008-1#1)(2008-8#1)(2013-1#1)
significantly impaired##7##2##(1992-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(2008-10#1)(2013-1#1)
significantly improve the##2##3##(1997-1#1)(2008-8#1)
significantly improve##5##2##(1995-2#1)(1997-1#1)(2008-8#1)(2013-1#1)(2013-8#1)
significantly improved the##4##3##(2008-10#2)(2009-2#1)(2012-12#1)
significantly improved##23##2##(1991-8#1)(2008-10#8)(2008-11#2)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
significantly improves##4##2##(1991-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
significantly in both##2##3##(2009-3#1)(2011-2#1)
significantly in the presence of##2##5##(2008-10#1)(2008-9#1)
significantly in the##10##3##(2008-10#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
significantly in##30##2##(1993-8#1)(1994-1#1)(1994-2#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#2)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
significantly increase the##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
significantly increase##7##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
significantly increased after##3##3##(1991-6#1)(2011-2#1)(2012-3#1)
significantly increased and##2##3##(1996-6#1)(2008-7#1)
significantly increased at##4##3##(1995-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
significantly increased by##8##3##(1992-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2012-6#1)(2013-1#2)
significantly increased during##3##3##(1992-12#2)(1995-5#1)
significantly increased from 1##2##4##(2008-10#1)(2009-11#1)
significantly increased from##5##3##(1994-3#1)(2008-10#2)(2009-11#1)(2011-2#1)
significantly increased in 256 mg/kg males at##2##7##(2008-9#2)
significantly increased in 800 mg/L##2##5##(2008-9#2)
significantly increased in all##3##4##(1995-11#1)(2008-9#2)
significantly increased in both##3##4##(1994-11#1)(2008-10#1)(2008-9#1)
significantly increased in the##7##4##(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-6#1)
significantly increased in those##2##4##(2008-11#1)(2011-2#1)
significantly increased in##36##3##(1990-2#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#12)(2011-2#3)(2012-6#1)
significantly increased on day##2##4##(1994-5#2)
significantly increased over##2##3##(2008-10#1)(2012-2#1)
significantly increased resistance to M##2##5##(2008-10#2)
significantly increased risk of##2##4##(2008-1#1)(2011-2#1)
significantly increased risk##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
significantly increased the maximum##2##4##(2013-1#2)
significantly increased the number of##2##5##(2008-10#1)(2008-6#1)
significantly increased the##21##3##(1990-5#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-6#1)(2012-3#2)(2013-1#2)
significantly increased##154##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#5)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-3#1)(1994-5#3)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#26)(2008-11#9)(2008-12#6)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#19)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2012-6#2)(2013-1#8)
significantly increases##3##2##(2008-10#1)(2010-1#1)(2012-3#1)
significantly induced in##2##3##(2008-10#1)(2008-9#1)
significantly induced the##2##3##(2011-10#1)(2011-3#1)
significantly induced##7##2##(2008-10#3)(2008-9#1)(2011-10#2)(2011-3#1)
significantly influence the##6##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)
significantly influence##10##2##(1991-2#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-2#1)
significantly influenced by the##5##4##(1990-11#1)(1992-5#1)(2008-10#1)(2011-2#2)
significantly influenced by##8##3##(1990-11#1)(1992-5#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#2)(2012-2#1)
significantly influenced the##3##3##(1992-2#1)(1995-5#1)(2008-10#1)
significantly influenced##13##2##(1990-11#1)(1992-2#1)(1992-5#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-11#1)(2010-8#1)(2011-2#2)(2012-2#1)
significantly influences##2##2##(1990-8#1)(2009-5#1)
significantly inhibit##5##2##(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#1)
significantly inhibited the##5##3##(1991-9#1)(1994-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
significantly inhibited##21##2##(1991-9#1)(1992-3#1)(1994-2#1)(1995-11#2)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)
significantly larger than that##2##4##(2008-9#1)(2009-2#1)
significantly larger than##4##3##(1995-3#1)(2008-10#1)(2008-9#1)(2009-2#1)
significantly larger##16##2##(1992-3#2)(1993-11#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
significantly less disease##4##3##(2008-10#4)
significantly less effective in##2##4##(2008-10#2)
significantly less frequent in##2##4##(2011-2#2)
significantly less frequently##2##3##(2008-12#1)(2011-2#1)
significantly less in##4##3##(1996-3#1)(2008-10#2)(2010-7#1)
significantly less than the##2##4##(2008-10#1)(2009-7#1)
significantly less than##10##3##(1991-11#1)(1994-12#1)(1995-12#1)(2008-10#6)(2009-7#1)
significantly less##51##2##(1991-1#1)(1991-11#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-3#1)(1997-4#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-7#1)(2011-2#4)(2013-1#1)
significantly longer than the##2##4##(2008-10#1)(2013-8#1)
significantly longer##8##2##(1993-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
significantly low##2##2##(1994-8#2)
significantly lower at##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
significantly lower compared with##2##4##(2011-2#2)
significantly lower disease##2##3##(2008-10#2)
significantly lower flux##2##3##(2008-7#2)
significantly lower for##8##3##(1990-12#2)(1993-11#1)(2008-10#4)(2011-2#1)
significantly lower fraction of##2##4##(1991-11#2)
significantly lower in the##3##4##(2008-10#1)(2009-8#1)(2013-7#1)
significantly lower in##16##3##(1992-3#1)(1995-5#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
significantly lower incidence of##2##4##(2008-10#2)
significantly lower levels of##4##4##(1995-2#1)(2008-10#1)(2010-6#1)(2013-8#1)
significantly lower on##3##3##(2008-10#1)(2010-8#2)
significantly lower than in the##2##5##(2008-8#1)(2011-2#1)
significantly lower than in##8##4##(1990-11#1)(1991-11#1)(1993-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)
significantly lower than that in##2##5##(1995-8#1)(2013-1#1)
significantly lower than that of##3##5##(1994-8#1)(2008-10#1)(2008-9#1)
significantly lower than that##9##4##(1993-8#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-9#1)(2009-10#1)(2013-1#1)
significantly lower than the calculated##2##5##(2008-10#2)
significantly lower than the##9##4##(1991-11#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-7#1)
significantly lower than those##3##4##(2008-10#2)(2011-2#1)
significantly lower than##32##3##(1990-11#1)(1991-11#2)(1991-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
significantly lower##124##2##(1990-11#1)(1990-12#2)(1991-11#4)(1991-6#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#2)(2008-1#1)(2008-10#39)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
significantly lowered##7##2##(1994-8#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
significantly modified the relationship between##2##5##(2009-7#2)
significantly modified##5##2##(1991-9#1)(2008-10#2)(2009-7#2)
significantly modify the##3##3##(1994-5#1)(2008-8#1)(2011-10#1)
significantly more and##2##3##(1990-8#1)(2012-2#1)
significantly more common in##4##4##(2008-7#2)(2010-12#1)(2010-4#1)
significantly more common##5##3##(2008-7#2)(2010-12#1)(2010-4#1)(2012-3#1)
significantly more effective##5##3##(1992-2#1)(2008-10#3)(2013-1#1)
significantly more efficient##3##3##(2008-10#2)(2011-2#1)
significantly more frequent than##2##4##(1994-3#1)(2012-2#1)
significantly more likely to##3##4##(2008-12#1)(2008-9#1)(2009-5#1)
significantly more likely##4##3##(2008-12#1)(2008-9#1)(2009-5#1)(2013-1#1)
significantly more resistant to##2##4##(2008-10#1)(2009-4#1)
significantly more than##4##3##(2008-10#2)(2011-2#2)
significantly more##78##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-11#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
significantly negatively##2##2##(2010-1#1)(2012-3#1)
significantly on the##2##3##(2008-11#1)(2008-12#1)
significantly on##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
significantly only##2##2##(2008-10#1)(2008-7#1)
significantly over time##4##3##(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
significantly over##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
significantly poorer##3##2##(1991-2#1)(1994-3#1)(2008-11#1)
significantly potentiated##3##2##(1990-12#1)(1996-2#2)
significantly predict##2##2##(2008-12#1)(2009-6#1)
significantly prevented increases in the urinary excretion of protein##2##9##(1994-5#2)
significantly prevented the##2##3##(1994-5#1)(2013-1#1)
significantly prevented##5##2##(1994-5#3)(1996-12#1)(2013-1#1)
significantly prolonged the##2##3##(1996-2#1)(2008-8#1)
significantly prolonged##4##2##(1992-3#1)(1995-2#1)(1996-2#1)(2008-8#1)
significantly raised##2##2##(1991-12#1)(1992-12#1)
significantly reduce the##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
significantly reduce##11##2##(1995-8#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2009-7#1)(2010-9#1)(2011-2#1)
significantly reduced after##2##3##(1990-9#1)(2008-10#1)
significantly reduced at##3##3##(2008-10#2)(2008-7#1)
significantly reduced by##13##3##(1992-12#1)(1995-11#1)(1996-12#2)(1996-2#1)(2008-10#5)(2008-11#1)(2010-10#1)(2012-3#1)
significantly reduced compared with the##2##5##(2008-10#1)(2008-3#1)
significantly reduced disease##3##3##(2008-10#3)
significantly reduced in the##4##4##(1995-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
significantly reduced in##25##3##(1990-5#1)(1995-11#2)(1995-8#1)(1996-12#4)(1997-2#1)(2008-10#9)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
significantly reduced pain##2##3##(2008-7#1)(2013-1#1)
significantly reduced the development of lesions caused by##2##8##(2008-10#2)
significantly reduced the incidence of##3##5##(2008-10#2)(2008-6#1)
significantly reduced the infarct size##2##5##(2011-2#2)
significantly reduced the number of##3##5##(1993-11#1)(2008-10#2)
significantly reduced the severity of##2##5##(2008-10#2)
significantly reduced the##26##3##(1991-12#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-12#1)(2008-10#16)(2008-6#1)(2010-7#1)(2011-2#3)
significantly reduced to##2##3##(2008-5#1)(2012-2#1)
significantly reduced##140##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#3)(1992-12#2)(1993-1#1)(1993-11#1)(1993-8#3)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-8#1)(1996-12#8)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#63)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-9#3)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-10#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
significantly reduces the##3##3##(1992-9#1)(1995-11#1)(2008-10#1)
significantly reduces##5##2##(1992-9#1)(1995-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
significantly reducing##4##2##(1996-9#1)(2008-10#3)
significantly related to Medicaid##2##4##(1996-1#2)
significantly related to##11##3##(1991-8#1)(1996-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
significantly retarded##3##2##(2008-10#3)
significantly shorter##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-7#1)(2011-2#2)
significantly similar to##2##3##(2008-10#2)
significantly since##2##2##(2008-7#1)(2011-3#1)
significantly slower##4##2##(2008-10#3)(2008-9#1)
significantly smaller in##2##3##(1991-11#1)(1997-2#1)
significantly smaller than that of##2##5##(2008-10#1)(2008-11#1)
significantly smaller than that##3##4##(2008-10#2)(2008-11#1)
significantly smaller than##5##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
significantly smaller##12##2##(1991-11#1)(1995-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-7#1)(2012-3#1)
significantly superior##3##2##(2008-5#2)(2011-2#1)
significantly suppress##2##2##(2008-10#1)(2008-11#1)
significantly suppressed the##3##3##(1994-2#1)(1994-8#1)(2008-10#1)
significantly suppressed##11##2##(1994-2#2)(1994-8#3)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)(2012-3#1)
significantly the##19##2##(1994-2#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-8#1)(2011-2#1)(2013-1#3)(2013-8#2)
significantly to the##12##3##(1993-6#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
significantly to##21##2##(1993-2#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
significantly under##3##2##(2008-10#2)(2008-11#1)
significantly upon##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
significantly upregulated##3##2##(2008-10#2)(2013-1#1)
significantly when##3##2##(1991-3#1)(2008-10#1)(2008-11#1)
significantly with age##5##3##(1990-3#2)(1991-9#1)(2008-7#2)
significantly with the##6##3##(1991-2#1)(2008-10#2)(2008-12#2)(2008-6#1)
significantly with##31##2##(1990-3#2)(1990-6#1)(1991-2#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-4#1)(2013-8#2)
significantly##2098##1##(1990-11#5)(1990-12#9)(1990-2#2)(1990-3#2)(1990-5#6)(1990-6#4)(1990-8#4)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#11)(1991-2#8)(1991-3#6)(1991-5#4)(1991-6#6)(1991-8#4)(1991-9#5)(1992-1#2)(1992-11#1)(1992-12#18)(1992-2#4)(1992-3#11)(1992-5#2)(1992-6#3)(1992-9#2)(1993-1#7)(1993-11#9)(1993-12#4)(1993-2#9)(1993-3#21)(1993-6#4)(1993-8#10)(1993-9#1)(1994-1#1)(1994-11#11)(1994-12#8)(1994-2#14)(1994-3#11)(1994-5#13)(1994-8#19)(1995-1#3)(1995-11#12)(1995-12#20)(1995-2#9)(1995-3#4)(1995-5#4)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#25)(1996-2#13)(1996-3#6)(1996-6#9)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#17)(1997-3#7)(1997-4#9)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#9)(1997-9#1)(2006-6#1)(2007-11#3)(2007-12#5)(2008-1#9)(2008-10#644)(2008-11#108)(2008-12#57)(2008-2#7)(2008-3#17)(2008-4#6)(2008-5#35)(2008-6#11)(2008-7#69)(2008-8#53)(2008-9#69)(2009-1#2)(2009-10#9)(2009-11#6)(2009-12#4)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#5)(2009-6#8)(2009-7#13)(2009-8#8)(2009-9#3)(2010-1#8)(2010-10#10)(2010-11#7)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#13)(2010-5#3)(2010-6#4)(2010-7#16)(2010-8#16)(2010-9#5)(2011-1#16)(2011-10#4)(2011-2#112)(2011-3#10)(2012-12#9)(2012-2#40)(2012-3#53)(2012-4#2)(2012-5#7)(2012-6#2)(2012-9#1)(2013-1#87)(2013-7#2)(2013-8#38)
significative##2##1##(1990-9#1)(2008-10#1)
signify##2##1##(1993-12#1)(2013-8#1)
signing##9##1##(1996-1#1)(1996-3#1)(2008-9#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)
signouts##2##1##(1991-12#1)(1993-12#1)
signs and symptoms and##3##4##(1991-8#1)(1997-8#1)(2008-7#1)
signs and symptoms of##6##4##(1992-1#1)(1997-8#1)(2007-11#1)(2008-5#2)(2011-2#1)
signs and symptoms##23##3##(1991-8#1)(1992-1#1)(1997-2#1)(1997-8#3)(2007-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
signs and##24##2##(1991-8#1)(1992-1#1)(1992-5#1)(1997-2#1)(1997-8#3)(2007-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
signs for##2##2##(1995-1#1)(2012-12#1)
signs from##2##2##(2008-10#1)(2009-9#1)
signs in patients with malaria##2##5##(2012-12#2)
signs in patients with##3##4##(2012-12#2)(2013-1#1)
signs in##7##2##(1995-2#1)(2008-5#1)(2010-11#1)(2012-12#2)(2013-1#2)
signs included##2##2##(1997-3#1)(1997-5#1)
signs of a##2##3##(1994-6#1)(2013-1#1)
signs of acute##3##3##(1991-11#2)(2013-1#1)
signs of depression##2##3##(2008-7#1)(2013-1#1)
signs of infection##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
signs of left##2##3##(2008-3#1)(2008-7#1)
signs of local##2##3##(1993-1#1)(2009-4#1)
signs of recurrence##2##3##(1991-9#1)(2012-12#1)
signs of the##4##3##(1996-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
signs of##90##2##(1990-5#1)(1990-9#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-5#1)(1993-1#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-8#1)(2006-6#1)(2007-9#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#8)(2008-9#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#10)(2011-3#1)(2012-12#4)(2012-3#4)(2013-1#10)(2013-8#1)
signs or symptoms of##2##4##(1991-8#1)(2008-7#1)
signs or symptoms##3##3##(1991-8#1)(2008-7#1)(2011-2#1)
signs or##4##2##(1991-8#1)(2008-7#1)(2010-6#1)(2011-2#1)
signs to##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
signs were##7##2##(2007-9#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
signs##196##1##(1990-3#4)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#2)(1993-1#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-5#2)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#1)(1997-8#6)(2006-6#1)(2007-11#1)(2007-9#2)(2008-10#12)(2008-11#8)(2008-12#4)(2008-3#3)(2008-5#9)(2008-7#18)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#11)(2012-2#1)(2012-3#9)(2013-1#19)(2013-8#2)
silage##10##1##(1990-6#2)(2008-10#6)(2013-1#2)
silane film##4##2##(2008-10#4)
silane##13##1##(2008-10#8)(2008-3#1)(2009-7#4)
silanized##4##1##(2008-10#4)
silanol##3##1##(2008-10#2)(2009-5#1)
silanols##2##1##(2008-10#2)
silastic tube##2##2##(2008-7#2)
silastic##3##1##(1996-3#1)(2008-7#2)
sildenafil##7##1##(2008-10#4)(2008-11#2)(2009-10#1)
silence##4##1##(2011-1#2)(2012-2#1)(2012-3#1)
silenced##9##1##(2008-9#3)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
silencer elements##2##2##(1995-8#2)
silencing and##2##2##(2008-9#1)(2011-2#1)
silencing of the##2##3##(2011-1#2)
silencing of##9##2##(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#2)(2011-2#3)(2012-3#1)
silencing triggering##3##2##(2011-1#3)
silencing##51##1##(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#14)(2011-2#9)(2012-2#2)(2012-3#6)(2013-1#3)
silent ST segment depression##2##4##(2008-7#2)
silent behavior##2##2##(2009-8#2)
silent mutations##2##2##(1997-9#1)(2008-10#1)
silent myocardial ischemia##2##3##(1992-6#1)(2008-7#1)
silent myocardial##3##2##(1992-6#1)(2008-12#1)(2008-7#1)
silent##28##1##(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-4#1)(2009-8#3)(2010-12#1)(2011-2#2)(2012-3#1)
silent&quot##3##1##(1990-11#2)(1992-3#1)
silica and##9##2##(2008-10#5)(2008-12#1)(2008-3#1)(2009-12#1)(2010-7#1)
silica as the##2##3##(2008-10#2)
silica as##3##2##(2008-10#3)
silica based##2##2##(2008-10#2)
silica beads##3##2##(2008-10#3)
silica capillaries##2##2##(2008-10#2)
silica capillary and##2##3##(2008-10#2)
silica capillary##4##2##(2008-10#4)
silica cartridge##2##2##(2008-10#2)
silica chromatography##3##2##(2008-10#3)
silica column##6##2##(2008-10#6)
silica columns##2##2##(2008-10#2)
silica content##3##2##(2008-10#3)
silica exposure##3##2##(2008-10#3)
silica fillers##3##2##(2009-7#3)
silica fume##3##2##(2008-10#3)
silica gel and estimated##2##4##(2008-10#2)
silica gel and##14##3##(2008-10#12)(2011-2#1)(2013-8#1)
silica gel as a solid##2##5##(2008-10#2)
silica gel as a##4##4##(2008-10#4)
silica gel as##5##3##(2008-10#5)
silica gel chemically modified with zirconium##2##6##(2008-10#2)
silica gel column chromatography##2##4##(2008-11#1)(2008-5#1)
silica gel column##5##3##(2008-10#2)(2008-11#1)(2008-5#2)
silica gel for the##2##4##(2008-10#2)
silica gel for##4##3##(2008-10#4)
silica gel has been##2##4##(2008-10#2)
silica gel in##2##3##(2008-10#2)
silica gel modified with##6##4##(2008-10#6)
silica gel phases##4##3##(2008-10#4)
silica gel stationary phase##9##4##(2008-10#9)
silica gel surface##2##3##(2008-10#2)
silica gel was investigated##2##4##(2008-10#2)
silica gel was##8##3##(2008-10#8)
silica gel with##3##3##(2008-10#3)
silica gel##126##2##(1992-12#1)(2008-10#115)(2008-11#3)(2008-5#2)(2009-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
silica gel)##2##2##(2008-10#2)
silica gels modified with##2##4##(2008-10#2)
silica gels##11##2##(2008-10#11)
silica in aqueous##2##3##(2008-10#2)
silica in##7##2##(2008-10#7)
silica is##3##2##(2008-10#3)
silica matrix##2##2##(2008-10#2)
silica membrane disks modified with##5##5##(2008-10#5)
silica membrane disks modified##10##4##(2008-10#10)
silica membrane##11##2##(2008-10#11)
silica modified by organofunctional silane##2##5##(2009-7#2)
silica modified with N-propylsalicylaldimine##2##4##(2008-10#2)
silica modified with##3##3##(2008-10#3)
silica modified##5##2##(2008-10#3)(2009-7#2)
silica monoliths##3##2##(2008-10#3)
silica or##2##2##(2007-12#1)(2008-10#1)
silica slabs##2##2##(2008-3#2)
silica sol-gel modified##2##3##(2008-10#2)
silica sol-gel##4##2##(2008-10#4)
silica sol-gels##2##2##(2010-7#2)
silica support##3##2##(1997-2#1)(2008-10#2)
silica surface were obtained##2##4##(2008-10#2)
silica surface were##3##3##(2008-10#3)
silica surface##12##2##(1997-2#1)(2008-10#11)
silica surfaces##3##2##(2008-10#2)(2010-7#1)
silica was##4##2##(2008-10#4)
silica with##2##2##(2008-10#2)
silica##342##1##(1992-12#1)(1995-2#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#296)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#2)(2009-12#3)(2009-6#1)(2009-7#8)(2010-4#2)(2010-7#4)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
silica-based##6##1##(1997-2#2)(2008-10#4)
silica-coated##4##1##(2008-10#4)
silica-immobilized##2##1##(2008-10#2)
silicagel##3##1##(2008-10#2)(2008-5#1)
silicalite##2##1##(2008-10#2)
silicate film##3##2##(2008-10#3)
silicate in##2##2##(2008-10#2)
silicate interference in##2##3##(2008-10#2)
silicate interference##4##2##(2008-10#4)
silicate##28##1##(1995-6#1)(2008-10#24)(2008-6#1)(2009-7#2)
silicates in##2##2##(2008-10#2)
silicates##4##1##(2008-10#4)
siliceous##2##1##(2008-10#2)
silico##13##1##(2008-10#2)(2008-4#1)(2008-7#2)(2010-11#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#1)
silicon (Si)##4##2##(2008-10#3)(2008-9#1)
silicon and alkali##2##3##(2013-8#2)
silicon and##6##2##(2008-10#2)(2008-11#2)(2013-8#2)
silicon content##3##2##(2008-10#3)
silicon layers##2##2##(2008-10#2)
silicon nanowires##3##2##(2008-7#1)(2010-3#2)
silicon oil##3##2##(2008-10#3)
silicon on##2##2##(2008-10#1)(2008-9#1)
silicon oxide##3##2##(2008-10#3)
silicon substrate##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
silicon tethers##2##2##(2008-8#2)
silicon tetrafluoride##3##2##(2008-10#3)
silicon wafer##2##2##(2008-10#2)
silicon wafers##2##2##(2008-4#1)(2012-2#1)
silicon were##3##2##(2008-10#3)
silicon##119##1##(1991-9#1)(1992-11#2)(1994-2#1)(1997-6#1)(2008-10#87)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-3#2)(2011-2#1)(2012-2#1)(2013-8#2)
silicon-based##2##1##(2008-10#1)(2012-2#1)
silicon-treated plants##3##2##(2008-10#3)
silicone and##2##2##(2008-10#1)(2011-2#1)
silicone catheter##4##2##(2013-1#4)
silicone oil##4##2##(2008-10#3)(2008-3#1)
silicone rubber##2##2##(2008-10#1)(2008-7#1)
silicone##26##1##(1996-12#1)(2008-10#11)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
silicones##5##1##(1996-3#1)(2008-5#3)(2013-1#1)
silicosis and##3##2##(2009-12#3)
silicotungstic acid##4##2##(2008-10#4)
silk emergence##2##2##(2008-10#2)
silk fibroin##3##2##(2008-11#2)(2012-2#1)
silk##24##1##(1990-9#2)(1991-2#1)(2007-12#4)(2008-10#4)(2008-11#2)(2008-7#5)(2008-9#1)(2012-2#5)
silk-producing##3##1##(2007-12#3)
silks were inoculated##2##3##(2008-10#2)
silks##6##1##(2008-10#6)
silkworm larvae##2##2##(1997-3#1)(2008-11#1)
silkworm##15##1##(1995-11#5)(1997-3#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-9#2)(2012-2#1)
sill values##2##2##(2008-10#2)
sill##4##1##(2008-10#4)
silorane##2##1##(2011-2#2)
siloxane##2##1##(2008-10#1)(2009-5#1)
silt (0##2##2##(2008-10#2)
silt + leaf mold##3##4##(2008-12#3)
silt loam soil##3##3##(2008-10#3)
silt loam##7##2##(2008-10#7)
silt##16##1##(2008-10#11)(2008-12#5)
silty clay loam##3##3##(2008-10#3)
silty##4##1##(2008-10#4)
silvanus##3##1##(2011-2#3)
silver and copper##2##3##(2008-10#2)
silver and manganese##3##3##(2008-10#3)
silver and##8##2##(2008-10#7)(2008-3#1)
silver as##3##2##(2008-10#3)
silver at##3##2##(2008-10#3)
silver by##2##2##(2008-10#2)
silver chloride activated surface-silver##2##4##(2008-10#2)
silver chloride##4##2##(2008-10#4)
silver colloidal##2##2##(2008-10#2)
silver deposits##2##2##(2008-7#2)
silver diethyldithiocarbamate##4##2##(2008-10#4)
silver electrode##7##2##(2008-10#7)
silver enhancement##2##2##(2008-10#2)
silver halide sensitized gelatin##2##4##(2007-11#1)(2008-3#1)
silver halide##5##2##(2007-11#1)(2008-3#4)
silver impregnation and sequence specific fluorochromes CMA3 and DAPI##2##9##(2008-12#2)
silver impregnation##3##2##(2008-12#2)(2008-7#1)
silver in environmental samples##2##4##(2008-10#2)
silver in environmental##3##3##(2008-10#3)
silver in##11##2##(2008-10#11)
silver ion##6##2##(2008-10#6)
silver ions##11##2##(2008-10#11)
silver mottle virus##9##3##(2008-10#9)
silver nanoparticles in##2##3##(2008-10#1)(2011-2#1)
silver nanoparticles##10##2##(2008-10#5)(2011-2#5)
silver nitrate and##2##3##(2008-10#2)
silver nitrate##5##2##(2008-10#5)
silver oxide##3##2##(2008-10#3)
silver particles##2##2##(2008-10#2)
silver preconcentration##2##2##(2008-10#2)
silver sea bream##2##3##(2010-5#2)
silver staining##14##2##(1992-8#1)(1995-12#1)(1997-3#2)(2008-10#1)(2008-4#4)(2008-7#2)(2008-8#3)
silver stains##2##2##(1991-1#2)
silver surface##2##2##(2008-10#2)
silver were##3##2##(2008-10#3)
silver##176##1##(1991-1#2)(1992-8#1)(1995-12#1)(1997-3#2)(2007-11#1)(2008-10#133)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#5)(2008-7#5)(2008-8#4)(2009-5#1)(2010-5#2)(2011-2#7)(2012-5#1)(2013-1#1)(2013-7#1)
silver(I) and##3##2##(2008-10#3)
silver(I) at##2##2##(2008-10#2)
silver(I) by##2##2##(2008-10#2)
silver(I) was##2##2##(2008-10#2)
silver(I)##23##1##(2008-10#23)
silylated##6##1##(1996-5#5)(2008-5#1)
silylation##6##1##(1996-5#1)(2008-10#3)(2008-5#1)(2010-11#1)
simazine##7##1##(2008-10#7)
simian immunodeficiency virus (SIV)##2##4##(1992-6#1)(1997-3#1)
simian immunodeficiency virus protease##2##4##(1991-9#1)(1992-6#1)
simian immunodeficiency virus##5##3##(1991-9#1)(1992-6#2)(1997-3#2)
simian immunodeficiency##6##2##(1991-9#1)(1992-6#2)(1997-3#2)(1997-6#1)
simian virus 40##6##3##(1995-2#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-11#2)
simian##16##1##(1991-9#1)(1992-6#2)(1995-11#1)(1995-2#1)(1995-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-9#1)(2012-12#1)
simii in a##3##3##(2008-5#3)
simii##5##1##(2008-5#5)
similar P##2##2##(2008-10#1)(2012-3#1)
similar according to##2##3##(2010-12#1)(2013-1#1)
similar across##4##2##(1991-3#1)(1997-2#1)(2008-1#1)(2013-8#1)
similar activity##2##2##(1996-2#1)(2008-5#1)
similar affinities##2##2##(1994-2#1)(1995-6#1)
similar affinity##2##2##(1992-6#1)(1993-8#1)
similar age##2##2##(1994-11#1)(2009-12#1)
similar amino acids##2##3##(1995-9#2)
similar among the##2##3##(1994-11#1)(2008-10#1)
similar among##7##2##(1994-11#1)(2008-10#3)(2008-11#2)(2013-8#1)
similar amounts of##4##3##(1994-8#1)(2008-11#2)(2008-5#1)
similar and the##2##3##(1996-3#1)(2008-10#1)
similar and##13##2##(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
similar antibody##2##2##(1996-12#1)(2011-2#1)
similar approach##2##2##(1993-11#1)(2008-3#1)
similar approaches##3##2##(2008-8#1)(2010-6#1)(2011-2#1)
similar behavior##3##2##(1991-2#1)(1991-6#1)(2008-11#1)
similar between treatment groups##2##4##(2010-4#1)(2012-12#1)
similar between treatment##3##3##(2010-4#1)(2012-12#1)(2012-3#1)
similar between##13##2##(1992-12#1)(1994-11#1)(1995-8#2)(2007-12#1)(2008-10#4)(2010-4#1)(2012-12#1)(2012-3#1)(2012-5#1)
similar binding##2##2##(1991-5#1)(2008-10#1)
similar biological properties##2##3##(1993-8#1)(2008-5#1)
similar biological##3##2##(1991-2#1)(1993-8#1)(2008-5#1)
similar but##5##2##(1994-5#1)(1995-1#1)(2008-10#2)(2008-7#1)
similar case reports##2##3##(2008-7#1)(2011-2#1)
similar cases in the##2##4##(1997-3#1)(2012-12#1)
similar cases in##3##3##(1997-3#1)(2012-12#2)
similar cases##4##2##(1997-3#1)(2008-12#1)(2012-12#2)
similar cell##2##2##(2008-11#2)
similar change in##2##3##(1990-3#1)(1994-5#1)
similar change##3##2##(1990-3#1)(1994-3#1)(1994-5#1)
similar changes to##2##3##(1991-6#1)(2013-1#1)
similar changes##5##2##(1991-6#1)(1995-2#1)(2010-12#1)(2013-1#1)(2013-8#1)
similar characteristics##3##2##(1990-2#1)(1992-6#1)(2009-9#1)
similar chemical##3##2##(2008-10#3)
similar composition##2##2##(2008-10#2)
similar conclusions##2##2##(2008-5#1)(2008-7#1)
similar conditions##13##2##(1990-9#1)(1995-2#1)(2008-10#7)(2008-8#1)(2009-7#2)(2010-12#1)
similar criteria##2##2##(1995-6#1)(2008-7#1)
similar data##2##2##(1991-12#1)(1996-2#1)
similar disease##4##2##(1991-2#1)(2008-10#3)
similar distribution patterns##2##3##(2008-9#1)(2010-1#1)
similar distribution##4##2##(1991-10#1)(2008-9#1)(2010-1#1)(2013-1#1)
similar dose##2##2##(2006-6#1)(2008-11#1)
similar educational##2##2##(2008-9#2)
similar effect##5##2##(1991-5#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-2#1)
similar effects on morning peak##2##5##(1996-1#1)(1996-2#1)
similar effects on##3##3##(1996-1#1)(1996-2#1)(2008-8#1)
similar effects##5##2##(1995-2#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-8#1)
similar efficacy##4##2##(1994-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
similar experimental##2##2##(1990-2#1)(2008-11#1)
similar experiments##2##2##(1995-8#1)(2008-8#1)
similar expression##2##2##(1996-12#1)(2008-8#1)
similar extent##4##2##(1990-8#1)(1994-5#1)(1995-11#1)(2013-8#1)
similar fashion##8##2##(1990-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
similar features##2##2##(2008-10#1)(2012-8#1)
similar findings##2##2##(1997-3#1)(2012-3#1)
similar for all##7##3##(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)
similar for both##11##3##(1991-1#1)(1995-8#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-11#1)(2010-12#1)
similar for the three##2##4##(2008-10#1)(2008-8#1)
similar for the##4##3##(2008-10#3)(2008-8#1)
similar for##35##2##(1990-2#1)(1991-1#1)(1992-12#1)(1995-8#1)(1996-1#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-12#1)(2011-10#1)(2011-2#1)(2012-12#2)(2013-8#1)
similar frequencies##2##2##(2008-10#1)(2012-2#1)
similar frequency##3##2##(1996-6#1)(2008-10#1)(2012-2#1)
similar gene##2##2##(2008-10#1)(2010-5#1)
similar genetic##3##2##(1996-8#1)(2008-10#2)
similar group of##2##3##(1990-6#1)(2009-10#1)
similar improvement in##2##3##(2007-12#1)(2008-7#1)
similar in all##3##3##(2008-10#2)(2008-7#1)
similar in both groups##7##4##(1991-12#1)(1994-12#1)(1997-2#1)(2008-5#2)(2009-3#1)(2011-2#1)
similar in both##16##3##(1990-3#1)(1991-12#1)(1992-4#1)(1994-12#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#2)
similar in composition to##2##4##(2008-10#1)(2008-11#1)
similar in magnitude##2##3##(2008-9#1)(2011-2#1)
similar in many##2##3##(1991-5#1)(2008-11#1)
similar in terms of##4##4##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
similar in the two groups##3##5##(1992-3#1)(2011-1#1)(2012-2#1)
similar in the two##5##4##(1991-11#1)(1992-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
similar in the##15##3##(1991-11#2)(1992-2#1)(1992-3#1)(2008-10#6)(2010-12#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
similar in their##2##3##(2010-10#1)(2011-2#1)
similar in##80##2##(1990-3#1)(1991-11#2)(1991-12#2)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#22)(2008-11#4)(2008-5#3)(2008-7#4)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
similar lesion##2##2##(1993-3#1)(2008-10#1)
similar lesions##3##2##(1995-2#1)(2009-12#1)(2012-3#1)
similar level of##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
similar levels in##2##3##(1991-6#1)(2008-10#1)
similar levels of##6##3##(1995-8#2)(1997-1#1)(2008-10#2)(2009-12#1)
similar levels##10##2##(1991-6#1)(1995-8#2)(1997-1#1)(2008-10#3)(2008-11#1)(2009-12#1)(2011-2#1)
similar magnitude and##2##3##(1997-4#1)(2008-10#1)
similar magnitude##5##2##(1997-4#1)(2008-10#2)(2008-11#2)
similar mechanisms of##3##3##(1991-9#1)(2008-10#2)
similar mechanisms##6##2##(1991-9#1)(1997-2#1)(2008-10#2)(2008-9#1)(2011-1#1)
similar molecular##2##2##(1990-12#1)(2008-10#1)
similar morphological##2##2##(2008-10#1)(2008-9#1)
similar numbers##2##2##(1991-12#2)
similar or##8##2##(1991-5#1)(1995-5#1)(2008-10#3)(2008-11#1)(2009-3#1)(2012-12#1)
similar over##2##2##(2008-3#1)(2011-2#1)
similar pattern of##6##3##(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#1)(2011-2#1)
similar pattern##12##2##(1990-12#1)(1990-8#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-10#2)(2011-2#2)
similar patterns of##3##3##(1996-12#1)(2008-5#1)(2012-3#1)
similar patterns##8##2##(1996-12#1)(2008-5#1)(2008-8#4)(2008-9#1)(2012-3#1)
similar performance to##2##3##(2008-10#1)(2013-1#1)
similar phenomena##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)
similar positions##2##2##(1997-3#1)(2008-11#1)
similar potency and##3##3##(1993-8#2)(1997-1#1)
similar potency to##3##3##(1994-8#1)(2008-5#1)(2008-9#1)
similar potency##8##2##(1991-3#1)(1993-8#2)(1994-8#1)(1997-1#1)(2008-12#1)(2008-5#1)(2008-9#1)
similar pregnancy rates##2##3##(1991-12#1)(1991-3#1)
similar problems##2##2##(1997-3#1)(2009-3#1)
similar properties##3##2##(1994-8#1)(2008-10#2)
similar rates of##2##3##(2008-8#1)(2013-1#1)
similar rates##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
similar reduction##2##2##(1993-12#1)(1994-8#1)
similar regions##2##2##(2008-4#1)(2010-3#1)
similar response##3##2##(2008-10#2)(2009-5#1)
similar responses##2##2##(2008-10#1)(2013-8#1)
similar results and##2##3##(2008-10#1)(2008-3#1)
similar results in##3##3##(1996-2#1)(2011-2#1)(2012-12#1)
similar results were obtained with##2##5##(2008-10#2)
similar results were obtained##4##4##(2008-10#3)(2008-11#1)
similar results were##5##3##(2008-10#3)(2008-11#1)(2013-1#1)
similar results##22##2##(1991-5#1)(1994-12#1)(1994-9#1)(1996-2#1)(1996-3#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#2)(2013-1#2)
similar sample##2##2##(2008-10#2)
similar set of##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
similar size##7##2##(1993-12#1)(1994-11#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-10#1)
similar species##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
similar stimulation##2##2##(1990-5#1)(1995-8#1)
similar structural##2##2##(2008-10#2)
similar studies##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
similar symptoms##5##2##(1993-8#1)(1997-3#1)(2008-10#3)
similar time##3##2##(1995-2#1)(2008-3#1)(2013-1#1)
similar to F##2##3##(2008-10#2)
similar to P##2##3##(2008-10#1)(2010-3#1)
similar to V##2##3##(2008-10#2)
similar to a##7##3##(1991-7#1)(1995-2#1)(2008-10#1)(2008-9#3)(2010-9#1)
similar to an##5##3##(1994-6#1)(2008-10#3)(2008-2#1)
similar to and##2##3##(1994-6#1)(2008-10#1)
similar to control##2##3##(1997-2#1)(2012-6#1)
similar to conventional##2##3##(2008-3#1)(2009-12#1)
similar to each other and##2##5##(2008-10#2)
similar to each other##10##4##(1993-6#1)(1997-8#1)(2008-10#7)(2008-9#1)
similar to either##2##3##(2008-10#1)(2008-5#1)
similar to gunshot residue##2##4##(2012-2#2)
similar to its##3##3##(2008-10#3)
similar to known##2##3##(2008-10#2)
similar to one another##2##4##(1995-6#1)(2008-10#1)
similar to or##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
similar to other##16##3##(1990-11#1)(1990-7#1)(1994-12#1)(1994-9#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
similar to previously reported##2##4##(1993-1#1)(2008-10#1)
similar to that associated with##2##5##(2008-10#1)(2008-2#1)
similar to that described for the##2##6##(1990-5#1)(2008-10#1)
similar to that for##3##4##(1993-8#1)(2008-10#1)(2008-9#1)
similar to that found##3##4##(1991-3#1)(2007-11#1)(2012-12#1)
similar to that in##4##4##(2008-10#2)(2008-7#1)(2010-11#1)
similar to that induced by##2##5##(1995-9#1)(2008-10#1)
similar to that observed for##2##5##(2008-10#1)(2008-7#1)
similar to that observed in the##2##6##(1995-12#1)(2008-10#1)
similar to that observed in##9##5##(1991-12#1)(1993-8#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-7#1)(2013-1#1)
similar to that observed##14##4##(1991-12#1)(1993-8#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-10#5)(2008-7#2)(2009-5#1)(2013-1#1)
similar to that obtained##3##4##(2008-10#3)
similar to that of a##2##5##(2008-10#1)(2008-3#1)
similar to that of chicken##2##5##(1993-2#1)(2008-5#1)
similar to that of other##5##5##(1993-2#1)(1997-3#1)(2008-10#1)(2010-8#1)(2012-2#1)
similar to that of the control##2##6##(1994-8#1)(2008-9#1)
similar to that of the##21##5##(1991-7#1)(1991-9#1)(1992-6#2)(1993-3#1)(1993-6#2)(1994-8#1)(1995-2#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#3)
similar to that of##67##4##(1990-12#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#3)(1994-8#1)(1995-2#2)(1996-12#3)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-5#4)(2008-6#2)(2008-8#4)(2008-9#7)(2009-10#1)(2010-7#1)(2010-8#1)(2011-10#1)(2012-2#1)
similar to that reported for##2##5##(2008-11#1)(2008-7#1)
similar to that reported##3##4##(1990-2#1)(2008-11#1)(2008-7#1)
similar to that seen in patients with##2##7##(2008-11#1)(2012-3#1)
similar to that seen in##5##5##(1994-5#2)(2008-10#1)(2008-11#1)(2012-3#1)
similar to that seen##6##4##(1994-5#2)(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
similar to that##127##3##(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#5)(1994-5#3)(1994-8#1)(1995-12#2)(1995-2#2)(1995-9#1)(1996-12#3)(1996-2#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-10#32)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
similar to the control##2##4##(2008-11#2)
similar to the distribution##2##4##(1997-2#1)(2008-5#1)
similar to the hypersensitive##2##4##(2008-10#1)(2008-11#1)
similar to the one##2##4##(1992-1#1)(2010-7#1)
similar to the ones##2##4##(2008-11#1)(2008-4#1)
similar to the original##2##4##(2008-11#1)(2013-1#1)
similar to the other##2##4##(1990-12#1)(2008-10#1)
similar to the previously identified##2##5##(1996-12#1)(2008-10#1)
similar to the primary##2##4##(2008-8#1)(2013-8#1)
similar to the value##2##4##(1995-11#1)(1996-12#1)
similar to the##94##3##(1990-11#2)(1990-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#3)(1996-6#1)(1997-2#2)(2008-10#27)(2008-11#10)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
similar to those caused by##2##5##(2008-10#2)
similar to those found in##4##5##(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
similar to those found##5##4##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
similar to those in##3##4##(1993-12#1)(1993-6#1)(2008-10#1)
similar to those induced by##3##5##(2008-10#2)(2011-2#1)
similar to those observed in the field##3##7##(2008-10#3)
similar to those observed in the##4##6##(1997-8#1)(2008-10#3)
similar to those observed in##11##5##(1994-5#1)(1997-8#2)(2008-10#7)(2011-2#1)
similar to those observed##15##4##(1992-12#1)(1994-5#1)(1997-8#2)(2008-10#8)(2008-5#1)(2008-9#1)(2011-2#1)
similar to those obtained by the##2##6##(2008-10#2)
similar to those obtained by##3##5##(2008-10#3)
similar to those obtained in##3##5##(1990-5#1)(2008-10#2)
similar to those obtained with##2##5##(2008-10#2)
similar to those obtained##9##4##(1990-5#1)(1993-8#1)(2008-10#7)
similar to those of other##2##5##(1994-5#1)(2008-10#1)
similar to those of the 25 degrees C-grown C##2##9##(2008-5#2)
similar to those of the wild-type##2##6##(1990-10#1)(1993-8#1)
similar to those of the##14##5##(1990-10#1)(1991-5#1)(1993-12#1)(1993-8#1)(2007-12#1)(2008-12#1)(2008-5#2)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#1)
similar to those of##47##4##(1990-10#1)(1990-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#6)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
similar to those seen##2##4##(1995-12#1)(2008-5#1)
similar to those that##2##4##(1994-2#1)(2008-10#1)
similar to those used for##2##5##(1990-11#1)(2011-2#1)
similar to those##110##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#37)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#1)(2008-9#10)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#4)(2013-1#1)
similar to what is##2##4##(1995-12#1)(2008-8#1)
similar to what##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
similar to##525##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#3)(1992-9#3)(1993-1#2)(1993-12#4)(1993-2#5)(1993-3#3)(1993-6#7)(1993-8#11)(1994-12#3)(1994-2#1)(1994-5#8)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#7)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#10)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#5)(1997-3#3)(1997-7#3)(1997-8#3)(2007-11#2)(2007-12#2)(2008-10#168)(2008-11#24)(2008-12#5)(2008-2#4)(2008-3#11)(2008-4#3)(2008-5#20)(2008-6#4)(2008-7#15)(2008-8#17)(2008-9#30)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#13)(2012-12#1)(2012-2#8)(2012-3#7)(2012-6#1)(2013-1#7)(2013-8#4)
similar topologies##3##2##(2008-10#3)
similar trials##2##2##(2008-5#1)(2010-1#1)
similar under##2##2##(1991-2#1)(2008-10#1)
similar values##2##2##(2008-10#1)(2013-1#1)
similar with respect to##2##4##(1991-2#1)(2008-10#1)
similar with##6##2##(1990-2#1)(1991-2#1)(1997-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
similar within##2##2##(2008-10#1)(2012-2#1)
similar yields##2##2##(2008-11#1)(2008-7#1)
similar##1480##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#8)(1990-3#3)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#10)(1991-2#9)(1991-3#8)(1991-5#11)(1991-6#7)(1991-7#4)(1991-9#2)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#7)(1992-4#1)(1992-6#5)(1992-9#4)(1993-1#4)(1993-11#2)(1993-12#7)(1993-2#5)(1993-3#5)(1993-6#11)(1993-8#22)(1993-9#1)(1994-1#3)(1994-11#8)(1994-12#10)(1994-2#3)(1994-3#5)(1994-5#16)(1994-6#2)(1994-8#10)(1994-9#2)(1995-1#1)(1995-11#12)(1995-12#7)(1995-2#18)(1995-3#1)(1995-5#8)(1995-6#9)(1995-8#9)(1995-9#3)(1996-1#7)(1996-11#1)(1996-12#24)(1996-2#15)(1996-3#6)(1996-5#5)(1996-6#5)(1996-8#2)(1997-1#6)(1997-2#16)(1997-3#13)(1997-4#1)(1997-7#5)(1997-8#7)(2006-6#1)(2007-11#3)(2007-12#8)(2008-1#3)(2008-10#442)(2008-11#82)(2008-12#19)(2008-2#7)(2008-3#22)(2008-4#10)(2008-5#42)(2008-6#6)(2008-7#47)(2008-8#49)(2008-9#56)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#5)(2009-3#3)(2009-5#4)(2009-6#6)(2009-7#5)(2009-8#10)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#3)(2010-12#10)(2010-3#5)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#6)(2011-10#2)(2011-2#48)(2011-3#1)(2012-12#11)(2012-2#15)(2012-3#23)(2012-5#1)(2012-6#2)(2012-8#1)(2013-1#38)(2013-7#1)(2013-8#21)
similarities and differences between the##2##5##(2008-10#1)(2008-11#1)
similarities and differences between##5##4##(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)
similarities and differences##9##3##(1991-3#1)(1993-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2012-5#1)
similarities and##13##2##(1991-3#1)(1993-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-5#1)
similarities between the##5##3##(1991-5#1)(1993-3#1)(2008-11#1)(2009-12#1)(2009-3#1)
similarities between##14##2##(1990-4#1)(1991-1#1)(1991-5#1)(1992-9#1)(1993-3#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-7#1)
similarities for##2##2##(1991-6#1)(2008-10#1)
similarities in##8##2##(1991-5#1)(1992-7#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)
similarities include the##2##3##(1993-3#1)(2008-5#1)
similarities of##3##2##(1997-3#1)(2008-10#1)(2010-12#1)
similarities or##2##2##(1997-1#1)(2008-11#1)
similarities to human##2##3##(1995-9#1)(2008-9#1)
similarities to the##4##3##(1992-9#1)(1996-6#1)(2008-10#1)(2009-4#1)
similarities to##19##2##(1990-5#1)(1992-9#1)(1993-8#1)(1995-8#3)(1995-9#1)(1996-2#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-9#1)
similarities were found between the##2##5##(2008-10#1)(2010-5#1)
similarities were found between##3##4##(2008-10#2)(2010-5#1)
similarities were##5##2##(2008-10#4)(2010-5#1)
similarities with the##3##3##(1992-6#1)(2008-10#1)(2008-3#1)
similarities with##10##2##(1992-6#1)(1995-2#1)(1995-9#2)(1996-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
similarities within the##2##3##(1993-2#1)(2008-10#1)
similarities##95##1##(1990-4#1)(1990-5#2)(1991-1#1)(1991-3#1)(1991-5#3)(1991-6#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#5)(1993-8#1)(1995-2#1)(1995-8#3)(1995-9#3)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2008-10#20)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-5#1)(2012-9#1)(2013-1#1)(2013-8#2)
similarity (&gt##2##2##(2008-10#1)(2010-6#1)
similarity among isolates of##2##4##(2008-10#2)
similarity among##7##2##(2008-10#5)(2008-3#1)(2008-8#1)
similarity and##7##2##(1996-6#1)(2008-10#2)(2008-9#2)(2011-1#1)(2011-2#1)
similarity at##2##2##(1995-6#1)(2008-10#1)
similarity between EAS and ENA##2##5##(2008-8#2)
similarity between EAS##3##3##(2008-8#3)
similarity between the##4##3##(1990-4#1)(1991-6#1)(2008-10#2)
similarity between##18##2##(1990-4#1)(1991-6#1)(1993-2#1)(1993-3#1)(1996-6#1)(2008-10#6)(2008-8#5)(2009-10#1)(2011-2#1)
similarity coefficient##2##2##(2008-10#2)
similarity for two##2##3##(1996-6#1)(2008-10#1)
similarity in properties##2##3##(2008-10#1)(2008-8#1)
similarity in the##3##3##(1995-2#1)(2008-10#2)
similarity in##13##2##(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(2008-10#5)(2008-8#3)(2013-8#1)
similarity of the##8##3##(1994-6#1)(2008-10#4)(2008-9#1)(2009-8#1)(2012-2#1)
similarity of##27##2##(1991-5#1)(1991-6#1)(1991-9#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-6#1)(2007-12#1)(2008-10#10)(2008-12#3)(2008-9#3)(2009-8#1)(2012-2#1)(2012-3#1)
similarity searching##2##2##(2008-9#1)(2013-8#1)
similarity to a##3##3##(1994-5#1)(1996-6#1)(2008-10#1)
similarity to any##6##3##(1995-8#1)(1996-12#2)(1996-6#2)(2008-10#1)
similarity to human skin##2##4##(2008-5#2)
similarity to known genes were also predicted##2##7##(1997-6#1)(1997-8#1)
similarity to known genes##3##4##(1995-12#1)(1997-6#1)(1997-8#1)
similarity to known##6##3##(1995-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)
similarity to sequences##2##3##(2008-10#2)
similarity to that of the yeast##2##6##(1991-6#1)(1996-2#1)
similarity to that of##3##4##(1991-6#1)(1993-12#1)(1996-2#1)
similarity to the##11##3##(1991-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(2008-10#2)(2012-3#1)
similarity to those of##2##4##(1991-5#1)(1995-6#1)
similarity to##54##2##(1991-5#1)(1991-6#2)(1992-6#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#6)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#14)(2008-5#2)(2011-2#1)(2012-3#2)
similarity values##2##2##(2008-10#1)(2011-3#1)
similarity was found##3##3##(1994-5#2)(2008-10#1)
similarity was##4##2##(1994-5#2)(2008-10#2)
similarity with a##2##3##(1994-11#1)(2008-10#1)
similarity with amino acid sequences##2##5##(1994-11#1)(1995-9#1)
similarity with isolates from##2##4##(2008-10#2)
similarity with strains##2##3##(2008-10#1)(2008-5#1)
similarity with the##2##3##(1995-6#2)
similarity with##19##2##(1994-11#2)(1995-6#2)(1995-9#1)(1997-7#1)(2008-10#10)(2008-5#1)(2010-4#1)(2012-12#1)
similarity##215##1##(1990-4#1)(1990-8#1)(1991-5#2)(1991-6#4)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-5#3)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#7)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#12)(1996-8#1)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#73)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#13)(2008-9#11)(2009-10#3)(2009-8#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-8#3)
similarly as##2##2##(2008-10#2)
similarly high##3##2##(1997-2#1)(2008-12#1)(2012-3#1)
similarly reduced the##2##3##(1996-2#1)(2008-10#1)
similarly tested##2##2##(2009-7#1)(2012-3#1)
similarly to a##3##3##(1994-5#1)(2008-11#1)(2009-9#1)
similarly to the##2##3##(1996-5#1)(2008-10#1)
similarly to those##2##3##(1997-4#1)(2008-10#1)
similarly to##19##2##(1990-11#1)(1993-2#1)(1994-5#2)(1996-5#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-3#1)
similarly##77##1##(1990-11#3)(1991-1#1)(1991-3#2)(1991-5#3)(1992-1#1)(1992-10#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-5#3)(1995-8#2)(1995-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#3)(2013-1#5)
similis##3##1##(2008-10#3)
simple DNA##2##2##(2008-10#1)(2008-4#1)
simple RT##3##2##(2008-7#1)(2010-1#2)
simple adaptive##2##2##(2008-11#1)(2010-4#1)
simple addition of##2##3##(2008-10#1)(2008-7#1)
simple analytical technique##2##3##(2008-10#2)
simple analytical##5##2##(2008-10#5)
simple and can be##3##4##(2008-10#2)(2008-3#1)
simple and complex##3##3##(2010-1#1)(2010-12#1)(2011-2#1)
simple and convenient##3##3##(2008-10#2)(2008-11#1)
simple and direct##2##3##(2008-10#2)
simple and easy to##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
simple and easy##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
simple and economical##2##3##(2008-10#2)
simple and effective##2##3##(2008-10#2)
simple and efficient##8##3##(2008-10#4)(2008-3#1)(2008-9#2)(2009-5#1)
simple and fast method for the##3##6##(2008-10#3)
simple and fast method for##5##5##(2008-10#4)(2008-11#1)
simple and fast method is proposed##2##6##(2008-10#2)
simple and fast method##7##4##(2008-10#6)(2008-11#1)
simple and fast procedure##2##4##(2008-10#1)(2008-6#1)
simple and fast##20##3##(2008-10#17)(2008-11#1)(2008-5#1)(2008-6#1)
simple and general##3##3##(1996-5#1)(2008-4#1)(2008-8#1)
simple and highly selective##3##4##(2008-10#3)
simple and highly##5##3##(2008-10#5)
simple and inexpensive##6##3##(1991-6#1)(2007-12#1)(2008-10#3)(2008-11#1)
simple and low-cost##3##3##(2008-10#3)
simple and non-invasive##2##3##(1996-2#1)(2006-6#1)
simple and practical##2##3##(2008-10#1)(2008-3#1)
simple and rapid method for the##2##6##(2008-10#2)
simple and rapid method for##5##5##(2008-10#5)
simple and rapid method##8##4##(2008-10#7)(2008-5#1)
simple and rapid procedure##4##4##(1994-8#1)(1996-12#1)(2008-10#2)
simple and rapid spectrophotometric##3##4##(2008-10#3)
simple and rapid##33##3##(1990-12#1)(1994-8#1)(1996-12#1)(2008-10#25)(2008-11#2)(2008-5#1)(2008-9#1)(2012-2#1)
simple and relatively##2##3##(2008-10#2)
simple and reliable method for the##2##6##(2008-10#2)
simple and reliable method for##4##5##(2008-10#4)
simple and reliable method##7##4##(2008-10#6)(2008-9#1)
simple and reliable##11##3##(2008-10#9)(2008-3#1)(2008-9#1)
simple and reproducible##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
simple and robust##4##3##(2008-10#4)
simple and safe##2##3##(2008-10#1)(2008-7#1)
simple and selective method for##3##5##(2008-10#3)
simple and selective method##5##4##(2008-10#5)
simple and selective##7##3##(2008-10#7)
simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells##2##18##(1990-12#2)
simple and sensitive flow##4##4##(1990-12#2)(2008-10#2)
simple and sensitive fluorometric method##2##5##(2008-10#2)
simple and sensitive method for the##4##6##(2008-10#4)
simple and sensitive method of nonaqueous capillary electrophoresis with laser-induced native fluorescence##2##12##(2008-10#2)
simple and sensitive method##10##4##(1991-3#1)(2008-10#8)(2011-1#1)
simple and sensitive spectrophotometric##2##4##(2008-10#2)
simple and sensitive visible spectrophotometric methods##3##6##(2008-10#3)
simple and sensitive##39##3##(1990-12#2)(1991-3#1)(2008-10#34)(2008-9#1)(2011-1#1)
simple and straightforward##3##3##(2008-10#2)(2008-11#1)
simple and the##2##3##(2008-10#2)
simple and useful##2##3##(1997-3#1)(2008-10#1)
simple and versatile##2##3##(2008-10#2)
simple and##210##2##(1990-11#1)(1990-12#3)(1991-3#1)(1991-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-6#1)(2007-12#2)(2008-10#151)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#1)
simple application of##2##3##(2008-10#2)
simple approach to the##2##4##(2008-11#1)(2012-2#1)
simple approach to##3##3##(1994-3#1)(2008-11#1)(2012-2#1)
simple aqueous##5##2##(2008-10#4)(2008-8#1)
simple bead injection##2##3##(2008-10#2)
simple bromophenols in fish meat##2##5##(2008-10#2)
simple bromophenols in##3##3##(2008-10#3)
simple but##3##2##(2008-10#2)(2013-8#1)
simple calibration##2##2##(2008-10#2)
simple cell##3##2##(2008-5#1)(2008-8#2)
simple cells in##4##3##(1996-2#1)(2008-11#1)(2008-8#2)
simple cells##6##2##(1996-2#1)(2008-11#1)(2008-8#4)
simple chemical##2##2##(1995-5#1)(2008-10#1)
simple classification system of##2##4##(2008-12#2)
simple classification##4##2##(2008-12#2)(2008-7#2)
simple communities##2##2##(2008-10#1)(2008-8#1)
simple design##3##2##(2008-10#2)(2008-2#1)
simple determination of##4##3##(1992-3#1)(2008-10#3)
simple device##2##2##(2008-10#2)
simple dilution of##2##3##(2008-10#2)
simple dilution##4##2##(2008-10#4)
simple disjoining solid-state##2##3##(2008-10#2)
simple equation##2##2##(2008-10#1)(2011-2#1)
simple example##2##2##(2008-10#1)(2013-8#1)
simple explanation##2##2##(2008-2#1)(2008-9#1)
simple exposure##3##2##(2008-4#3)
simple extraction procedure and##2##4##(2008-10#2)
simple extraction##3##2##(2008-10#3)
simple fabrication##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
simple flow injection (FI)##2##4##(2008-10#2)
simple flow injection##9##3##(2008-10#9)
simple flow##11##2##(2008-10#10)(2011-2#1)
simple form of##3##3##(1995-12#1)(2008-9#1)(2009-6#1)
simple formulas##2##2##(2007-12#1)(2008-3#1)
simple harvest##2##2##(2008-11#2)
simple in##2##2##(2008-10#1)(2008-4#1)
simple interrupted##2##2##(1991-2#2)
simple kinetic method##2##3##(2008-10#2)
simple linear regression##2##3##(2008-10#1)(2012-3#1)
simple linear##3##2##(2008-10#2)(2012-3#1)
simple mathematical##3##2##(2008-10#1)(2008-3#1)(2009-8#1)
simple means for##2##3##(2006-6#1)(2008-8#1)
simple means##4##2##(2006-6#1)(2008-10#1)(2008-8#1)(2010-11#1)
simple measures##2##2##(2008-7#1)(2009-9#1)
simple mechanical##3##2##(2007-12#1)(2008-10#2)
simple method for determining the##2##5##(2008-10#2)
simple method for rapid##2##4##(2008-10#2)
simple method for the##11##4##(1995-3#1)(2008-10#9)(2008-2#1)
simple method for##25##3##(1995-3#1)(2008-10#19)(2008-2#1)(2008-3#2)(2010-6#1)(2012-2#1)
simple method has been developed for the##3##7##(2008-10#3)
simple method has been developed for##4##6##(2008-10#4)
simple method is proposed for##2##5##(2008-10#2)
simple method of##6##3##(2008-10#4)(2008-3#1)(2008-6#1)
simple method to detect##2##4##(2008-12#1)(2008-5#1)
simple method to##9##3##(1997-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
simple method was developed for the##3##6##(2008-10#3)
simple method was developed##4##4##(2008-10#4)
simple method was##5##3##(2008-10#5)
simple method##55##2##(1995-3#1)(1997-7#1)(2008-10#40)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
simple methodology to##2##3##(1996-3#1)(2008-10#1)
simple methodology##4##2##(1996-3#1)(2008-10#2)(2008-7#1)
simple model of##6##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-8#1)
simple model that##2##3##(2008-7#1)(2008-8#1)
simple model##21##2##(1992-4#1)(1992-9#1)(1993-8#1)(2008-10#6)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-8#1)
simple models##3##2##(2008-10#1)(2008-8#2)
simple molecular##3##2##(1994-5#1)(2012-2#2)
simple network##2##2##(2008-11#1)(2013-8#1)
simple organisms##2##2##(2008-10#2)
simple patch##2##2##(2008-5#1)(2008-8#1)
simple pathotypes##2##2##(2008-10#2)
simple photoreceptors##2##2##(2008-9#2)
simple physical##2##2##(1996-12#1)(2008-10#1)
simple preparation##2##2##(2008-10#2)
simple procedure for the determination of##3##6##(2008-10#3)
simple procedure for the##4##4##(2008-10#4)
simple procedure is##3##3##(2008-10#3)
simple procedure##13##2##(1993-3#1)(2008-10#9)(2008-2#1)(2008-4#2)
simple procedures for##2##3##(2008-2#1)(2008-4#1)
simple procedures##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
simple protocol for##2##3##(2008-10#1)(2008-11#1)
simple protocol##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
simple quantitative##3##2##(2008-10#2)(2008-5#1)
simple repeat##2##2##(2008-6#2)
simple rules##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
simple sample##2##2##(2008-10#2)
simple sequence repeat (SSR) markers in##2##6##(2008-10#1)(2008-9#1)
simple sequence repeat (SSR) markers##5##5##(2008-10#3)(2008-9#2)
simple sequence repeat (SSR)##6##4##(2008-10#4)(2008-9#2)
simple sequence repeat markers##2##4##(2008-10#2)
simple sequence repeat##13##3##(2008-10#10)(2008-9#2)(2010-10#1)
simple sequence repeats (SSRs)##2##4##(1996-8#1)(2008-10#1)
simple sequence repeats##4##3##(1996-8#2)(2008-10#2)
simple sequence##19##2##(1992-6#1)(1996-5#1)(1996-8#2)(2008-10#12)(2008-9#2)(2010-10#1)
simple spectrophotometer##2##2##(2008-10#2)
simple spectrophotometric method##2##3##(2008-10#2)
simple spectrophotometric##4##2##(2008-10#4)
simple strategy for##2##3##(2008-10#2)
simple sugars##3##2##(2008-10#3)
simple synchronous fluorimetric method##2##4##(2008-10#2)
simple system##4##2##(1997-6#1)(2008-10#1)(2008-5#2)
simple taste analyzing system##2##4##(2008-10#2)
simple technique for##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
simple technique##7##2##(1994-3#1)(2008-10#3)(2008-3#1)(2009-2#1)(2011-2#1)
simple techniques##2##2##(1997-4#1)(2008-4#1)
simple theoretical##4##2##(1990-12#1)(2008-10#1)(2008-3#2)
simple to be##2##3##(2008-10#1)(2010-8#1)
simple to implement##2##3##(2008-10#1)(2008-3#1)
simple to##14##2##(1990-2#1)(1993-1#1)(1993-6#1)(1996-2#1)(1997-2#1)(2008-10#6)(2008-3#1)(2009-10#1)(2010-8#1)
simple tool for##3##3##(2008-10#2)(2011-2#1)
simple transcriptional##2##2##(1993-2#1)(2008-11#1)
simple visual##2##2##(2008-10#2)
simple way to##10##3##(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)
simple way##11##2##(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)
simple##1102##1##(1990-11#2)(1990-12#9)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#2)(1996-5#5)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#4)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#620)(2008-11#46)(2008-12#7)(2008-2#9)(2008-3#49)(2008-4#21)(2008-5#17)(2008-6#10)(2008-7#18)(2008-8#42)(2008-9#35)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#14)(2012-12#2)(2012-2#15)(2012-3#5)(2013-1#7)(2013-8#7)
simple-repeat##2##1##(2008-10#2)
simpler and more##2##3##(2008-3#1)(2011-2#1)
simpler and##6##2##(2008-10#3)(2008-3#1)(2010-12#1)(2011-2#1)
simpler for##2##2##(2008-10#1)(2008-9#1)
simpler than the##3##3##(2008-10#2)(2008-9#1)
simpler than##7##2##(2008-10#3)(2008-11#2)(2008-9#1)(2009-8#1)
simpler##38##1##(1991-3#1)(1993-11#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
simples##3##1##(2008-5#1)(2011-2#1)(2013-1#1)
simplest##23##1##(1990-5#1)(1993-1#1)(1995-5#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-8#1)(2013-8#1)
simplex algorithm was##2##3##(2008-10#2)
simplex algorithm##4##2##(2008-10#3)(2008-3#1)
simplex and##2##2##(2008-10#1)(2011-2#1)
simplex in##2##2##(1997-7#1)(2008-10#1)
simplex method to##2##3##(2008-10#2)
simplex method was used##2##4##(2008-10#1)(2008-5#1)
simplex method were##2##3##(2008-10#2)
simplex method##12##2##(2008-10#11)(2008-5#1)
simplex optimization##3##2##(2008-10#3)
simplex virus (HSV)##2##3##(1996-12#1)(2008-11#1)
simplex virus type##4##3##(2008-11#2)(2008-9#1)(2013-1#1)
simplex virus##13##2##(1995-2#3)(1996-12#2)(2008-10#1)(2008-11#5)(2008-9#1)(2013-1#1)
simplex##60##1##(1991-12#2)(1994-11#1)(1995-2#5)(1996-12#2)(1997-7#1)(2007-12#3)(2008-10#31)(2008-11#5)(2008-3#1)(2008-5#3)(2008-9#1)(2011-2#3)(2013-1#2)
simplicity and high sensitivity##2##4##(2008-10#2)
simplicity and rapidity##2##3##(2008-10#2)
simplicity and##15##2##(1990-2#1)(2008-10#10)(2008-11#2)(2010-12#1)(2010-8#1)
simplicity of preparation##2##3##(2008-10#2)
simplicity of the##7##3##(1995-5#1)(2008-10#5)(2011-2#1)
simplicity of this##3##3##(2008-10#3)
simplicity of##16##2##(1995-5#1)(1997-7#1)(2008-10#12)(2009-9#1)(2011-2#1)
simplicity##64##1##(1990-2#1)(1990-5#1)(1995-5#1)(1997-7#1)(2008-10#44)(2008-11#5)(2008-4#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#1)
simplification##5##1##(1992-9#1)(2008-2#1)(2009-8#1)(2011-2#2)
simplified chemical##2##2##(1995-6#1)(2008-10#1)
simplified procedure##2##2##(2008-11#1)(2008-4#1)
simplified version of the##2##4##(2008-3#1)(2008-8#1)
simplified##40##1##(1990-12#1)(1991-12#1)(1992-12#1)(1994-2#2)(1994-3#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
simplifies the##6##2##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#2)
simplifies##10##1##(1995-5#1)(2008-10#3)(2008-2#1)(2008-3#4)(2011-2#1)
simplify the##6##2##(1994-9#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-11#1)
simplify##17##1##(1993-12#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-6#1)(2011-2#3)
simplifying the##5##2##(1991-2#1)(2008-10#2)(2011-2#2)
simplifying##10##1##(1991-2#1)(2008-10#5)(2008-3#1)(2008-8#1)(2011-2#2)
simply a##4##2##(2008-10#1)(2008-11#1)(2011-2#2)
simply an##2##2##(1996-3#1)(2009-7#1)
simply and rapidly##3##3##(2008-10#3)
simply and##6##2##(2008-10#5)(2011-2#1)
simply as##2##2##(2008-10#1)(2010-1#1)
simply be##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
simply by##6##2##(1992-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)
simply reflect the##2##3##(2008-10#1)(2009-4#1)
simply##84##1##(1991-12#3)(1992-9#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(2006-6#1)(2008-10#32)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#5)
simulans##8##1##(2012-3#8)
simulant##3##1##(2008-10#2)(2010-1#1)
simulants##3##1##(2008-10#3)
simulate different##2##2##(1995-3#1)(2008-8#1)
simulate the##18##2##(1994-1#1)(2008-10#4)(2008-11#5)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
simulate##44##1##(1990-11#1)(1991-11#1)(1994-1#1)(1994-12#1)(1995-3#1)(2008-10#10)(2008-11#8)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#2)(2010-5#2)(2011-2#2)(2013-8#1)
simulated action potential of the##2##5##(2008-11#2)
simulated and experimental data##3##4##(2008-10#1)(2008-3#1)(2009-7#1)
simulated and experimental##5##3##(2008-10#1)(2008-3#3)(2009-7#1)
simulated and real##3##3##(2008-10#3)
simulated and##10##2##(2008-10#4)(2008-3#4)(2009-7#1)(2012-2#1)
simulated annealing##6##2##(1994-5#3)(2008-3#3)
simulated by##7##2##(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)
simulated data##7##2##(2008-10#2)(2008-11#1)(2008-3#3)(2010-2#1)
simulated field temperatures##2##3##(2008-10#2)
simulated in##2##2##(2008-10#1)(2009-3#1)
simulated ischemia##6##2##(1994-2#6)
simulated microgravity##7##2##(2008-9#7)
simulated rain##3##2##(2008-10#3)
simulated rainfall##2##2##(2008-10#2)
simulated samples##2##2##(2008-10#2)
simulated solar##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
simulated sunlight##4##2##(2008-11#3)(2008-5#1)
simulated temperature##2##2##(1996-12#1)(2008-10#1)
simulated the##4##2##(1990-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
simulated under##2##2##(2008-7#1)(2008-9#1)
simulated using a##4##3##(2008-10#3)(2013-1#1)
simulated using##6##2##(2008-10#3)(2013-1#2)(2013-8#1)
simulated with##4##2##(1996-2#1)(2008-3#2)(2013-1#1)
simulated##165##1##(1990-12#1)(1990-6#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-2#7)(1994-5#3)(1995-1#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#56)(2008-11#17)(2008-12#2)(2008-3#20)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#12)(2009-1#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#7)(2013-8#1)
simulates a##4##2##(1996-3#1)(2008-10#2)(2011-2#1)
simulates the##5##2##(2008-10#3)(2008-8#1)(2009-10#1)
simulates##13##1##(1996-3#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-10#2)(2011-2#1)(2013-8#2)
simulating a##4##2##(1993-2#1)(1997-8#1)(2008-10#1)(2008-12#1)
simulating the##5##2##(1993-3#1)(1994-3#1)(2008-10#2)(2011-2#1)
simulating##24##1##(1990-3#2)(1991-9#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
simulation and a##2##3##(2008-3#1)(2008-9#1)
simulation and experimental results##2##4##(2008-3#1)(2008-7#1)
simulation and experimental##3##3##(2008-3#2)(2008-7#1)
simulation and##12##2##(2008-10#1)(2008-3#5)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
simulation experiments##6##2##(1995-9#1)(2008-10#4)(2008-8#1)
simulation for the##2##3##(2008-10#1)(2008-3#1)
simulation in##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
simulation is##5##2##(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)(2013-8#1)
simulation methods##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
simulation model for##2##3##(2012-12#2)
simulation model to##2##3##(2008-9#1)(2010-8#1)
simulation model##14##2##(2008-10#3)(2008-8#5)(2008-9#3)(2010-8#1)(2012-12#2)
simulation models##2##2##(2008-8#1)(2008-9#1)
simulation of a##3##3##(1996-12#1)(2008-10#1)(2008-4#1)
simulation of the##5##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)
simulation of##27##2##(1992-8#1)(1994-8#2)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#4)(2008-4#2)(2009-11#1)(2009-7#1)(2009-8#1)(2013-1#1)
simulation output##2##2##(2008-10#2)
simulation results##7##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-8#1)(2012-3#1)
simulation studies##7##2##(2008-10#2)(2008-8#1)(2009-10#1)(2009-12#1)(2013-1#2)
simulation study##8##2##(1992-9#1)(1995-9#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
simulation technologies##2##2##(2008-11#2)
simulation that##2##2##(2008-10#1)(2008-11#1)
simulation to##2##2##(2008-10#1)(2008-11#1)
simulation training##2##2##(2008-11#2)
simulation using a##2##3##(2009-12#1)(2011-2#1)
simulation was##3##2##(1995-1#1)(2011-2#1)(2013-1#1)
simulation with##2##2##(2008-3#1)(2008-8#1)
simulation##175##1##(1990-12#2)(1992-4#1)(1992-8#1)(1992-9#2)(1994-8#2)(1995-1#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-3#1)(1997-6#2)(2007-11#2)(2007-12#2)(2008-10#40)(2008-11#20)(2008-12#3)(2008-2#1)(2008-3#21)(2008-4#4)(2008-6#1)(2008-7#4)(2008-8#16)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#2)(2010-8#4)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#3)
simulation-based##3##1##(2012-2#2)(2013-8#1)
simulations and##11##2##(1994-9#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-8#1)(2010-1#1)(2012-3#3)(2013-1#1)
simulations are able to##2##4##(2008-11#1)(2013-8#1)
simulations are used##2##3##(1992-2#1)(2008-3#1)
simulations are##9##2##(1992-2#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#2)
simulations based on##4##3##(2008-3#3)(2008-7#1)
simulations can be##2##3##(2008-12#1)(2008-8#1)
simulations for##4##2##(2008-10#1)(2013-1#2)(2013-8#1)
simulations has been##2##3##(2008-10#1)(2008-12#1)
simulations indicate that##5##3##(2008-11#1)(2008-3#2)(2008-7#1)(2012-12#1)
simulations of a##2##3##(2012-2#1)(2013-8#1)
simulations of the##6##3##(1991-9#1)(1992-9#1)(1995-6#1)(2008-3#3)
simulations of##26##2##(1991-9#1)(1992-9#1)(1993-12#1)(1993-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-3#6)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
simulations show that##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
simulations showed that##2##3##(2008-3#1)(2008-8#1)
simulations suggest that##3##3##(2008-12#1)(2012-2#1)(2013-8#1)
simulations to##7##2##(1994-9#1)(2008-2#1)(2008-3#2)(2008-6#1)(2011-2#1)(2011-3#1)
simulations using##2##2##(2008-10#1)(2008-2#1)
simulations was##2##2##(2008-10#1)(2008-11#1)
simulations were judged to be##2##5##(2008-11#2)
simulations were##4##2##(2008-10#1)(2008-11#2)(2012-3#1)
simulations with the##2##3##(2008-10#1)(2008-8#1)
simulations with##6##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#2)
simulations##151##1##(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#18)(2008-11#13)(2008-12#5)(2008-2#4)(2008-3#29)(2008-6#1)(2008-7#3)(2008-8#11)(2008-9#2)(2009-5#2)(2009-7#1)(2009-8#5)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#13)(2013-8#10)
simulator for the##2##3##(1994-12#1)(2008-10#1)
simulator##11##1##(1994-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
simulators are##2##2##(2008-11#2)
simultaneous addition of##6##3##(1995-11#1)(2008-10#3)(2008-5#1)(2009-8#1)
simultaneous administration of##5##3##(1991-1#1)(1991-3#1)(1991-5#1)(1992-6#1)(1995-5#1)
simultaneous administration##6##2##(1991-1#1)(1991-3#1)(1991-5#1)(1992-6#1)(1995-5#2)
simultaneous analysis of several##2##4##(2008-10#1)(2008-4#1)
simultaneous analysis of three##2##4##(2008-10#2)
simultaneous analysis of##20##3##(2008-10#17)(2008-3#1)(2008-4#1)(2008-9#1)
simultaneous analysis##21##2##(2008-10#18)(2008-3#1)(2008-4#1)(2008-9#1)
simultaneous and quantitative##2##3##(2008-10#1)(2008-5#1)
simultaneous and##7##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
simultaneous atomic absorption spectrometry (SIMAAS)##2##5##(2008-10#2)
simultaneous atomic absorption spectrometry##3##4##(2008-10#3)
simultaneous detection of the##2##4##(2008-10#2)
simultaneous detection of##20##3##(2007-12#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-9#2)(2010-11#1)(2013-8#1)
simultaneous detection##24##2##(2007-12#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-9#3)(2010-11#1)(2013-8#1)
simultaneous determination method##2##3##(2008-10#2)
simultaneous determination of 19##2##4##(2008-10#2)
simultaneous determination of As##5##4##(2008-10#5)
simultaneous determination of Fe(II)##5##4##(2008-10#5)
simultaneous determination of Fe(III) and Fe(II)##2##6##(2008-10#2)
simultaneous determination of Pb(2+) and Cd(2+)##2##6##(2008-10#2)
simultaneous determination of V(V) and##2##5##(2008-10#2)
simultaneous determination of all##3##4##(2008-10#3)
simultaneous determination of ammonium##4##4##(2008-10#4)
simultaneous determination of both organic and inorganic anions in##2##9##(2008-10#2)
simultaneous determination of both##5##4##(2008-10#5)
simultaneous determination of caffeine##3##4##(2008-10#3)
simultaneous determination of cobalt##2##4##(2008-10#2)
simultaneous determination of copper and iron##2##6##(2008-10#2)
simultaneous determination of copper and##3##5##(2008-10#3)
simultaneous determination of cyclosporine A##2##5##(2008-10#2)
simultaneous determination of direct and total##2##6##(2008-10#2)
simultaneous determination of four##5##4##(2008-10#5)
simultaneous determination of honokiol and magnolol in rat plasma##2##9##(2008-10#2)
simultaneous determination of iron and##3##5##(2008-10#3)
simultaneous determination of iron##4##4##(2008-10#4)
simultaneous determination of iron(III) and copper(II) and of iron(III) and palladium(II) based on##2##13##(2008-10#2)
simultaneous determination of iron(III) and##3##5##(2008-10#3)
simultaneous determination of nitrite and nitrate##7##6##(2008-10#7)
simultaneous determination of nitroaniline isomers##2##5##(2008-10#2)
simultaneous determination of nitroaniline##3##4##(2008-10#3)
simultaneous determination of organic##2##4##(2008-10#2)
simultaneous determination of oxidizable amino acids##2##6##(2008-10#2)
simultaneous determination of periodate-bromate and iodate-bromate##2##6##(2008-10#2)
simultaneous determination of selenium(IV) and##2##5##(2008-10#2)
simultaneous determination of some##4##4##(2008-10#4)
simultaneous determination of the compounds##2##5##(2008-10#2)
simultaneous determination of the##12##4##(2008-10#12)
simultaneous determination of these##3##4##(2008-10#3)
simultaneous determination of three##4##4##(2008-10#4)
simultaneous determination of trace##7##4##(2008-10#7)
simultaneous determination of two##2##4##(2008-10#2)
simultaneous determination of##219##3##(1995-3#2)(2008-10#214)(2009-6#1)(2011-3#1)(2012-2#1)
simultaneous determination##226##2##(1995-3#2)(2008-10#221)(2009-6#1)(2011-3#1)(2012-2#1)
simultaneous determinations of##2##3##(2008-10#2)
simultaneous determinations##4##2##(2008-10#4)
simultaneous dilution##2##2##(2008-10#2)
simultaneous direct##2##2##(2008-10#2)
simultaneous estimation##3##2##(2008-10#3)
simultaneous extraction##2##2##(2008-10#2)
simultaneous flow injection##2##3##(2008-10#2)
simultaneous handling of##2##3##(2008-10#2)
simultaneous identification and##4##3##(2008-10#1)(2008-5#2)(2008-9#1)
simultaneous kinetic##2##2##(2008-10#2)
simultaneous measurement of##5##3##(2007-11#1)(2008-3#2)(2008-4#2)
simultaneous measurements of##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
simultaneous measurements##7##2##(2008-10#3)(2008-2#1)(2008-3#3)
simultaneous monitoring of##2##3##(2008-10#2)
simultaneous multielement determination of##2##4##(2008-10#2)
simultaneous multielement determination##3##3##(2008-10#3)
simultaneous multielement flame atomic absorption spectrometry##2##6##(2008-10#2)
simultaneous multielement##5##2##(2008-10#5)
simultaneous multiple##2##2##(2008-10#2)
simultaneous operation##2##2##(2008-10#1)(2008-11#1)
simultaneous preconcentration##2##2##(2008-10#2)
simultaneous presence of##2##3##(1991-8#1)(2008-11#1)
simultaneous quantification of##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
simultaneous quantitation of##3##3##(2008-10#2)(2008-9#1)
simultaneous quantitative##2##2##(2008-10#2)
simultaneous saccharification and fermentation##2##4##(2013-1#2)
simultaneous scores monitoring and residuals tracking (SMART)##2##7##(2008-10#2)
simultaneous separation and determination of different##2##6##(2008-10#2)
simultaneous separation and determination of##3##5##(2008-10#3)
simultaneous separation and##5##3##(2008-10#5)
simultaneous separation of##4##3##(2008-10#4)
simultaneous separation##10##2##(2008-10#10)
simultaneous spectrophotometric determination of copper(II) and nickel(II) in##2##8##(2008-10#2)
simultaneous spectrophotometric determination of trace amounts of##2##7##(2008-10#2)
simultaneous spectrophotometric determination of##18##4##(2008-10#18)
simultaneous spectrophotometric##19##2##(2008-10#19)
simultaneous system##2##2##(2008-10#2)
simultaneous thermal lens and beam deflection phenomena##2##7##(2008-3#2)
simultaneous thermal##3##2##(2008-3#2)(2011-2#1)
simultaneous triple ENBD insertion##2##4##(2013-1#2)
simultaneous triple ENBD##3##3##(2013-1#3)
simultaneous triple##4##2##(2013-1#4)
simultaneous use of##2##3##(2008-10#2)
simultaneous visualization of##2##3##(2008-7#1)(2011-2#1)
simultaneous visualization##3##2##(2008-7#1)(2009-11#1)(2011-2#1)
simultaneous##541##1##(1990-12#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#3)(1996-1#1)(1996-2#1)(1996-3#2)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#391)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#4)(2010-4#1)(2010-5#1)(2011-2#5)(2011-3#3)(2012-12#1)(2012-2#4)(2013-1#11)(2013-8#4)
simultaneously and##6##2##(2007-12#1)(2008-10#3)(2008-11#1)(2012-2#1)
simultaneously as##2##2##(2008-10#1)(2008-3#1)
simultaneously at##6##2##(2008-10#3)(2008-5#1)(2008-9#1)(2012-2#1)
simultaneously by the##2##3##(2008-10#2)
simultaneously by##8##2##(2008-10#7)(2008-3#1)
simultaneously detect##3##2##(2008-10#2)(2013-8#1)
simultaneously detected##2##2##(2008-10#2)
simultaneously determined by##4##3##(2008-10#4)
simultaneously determined in##5##3##(2008-10#5)
simultaneously determined##11##2##(1996-8#1)(2008-10#10)
simultaneously determining##2##2##(1994-3#1)(2008-10#1)
simultaneously employs##2##2##(2008-3#1)(2010-8#1)
simultaneously extracted##2##2##(2008-10#2)
simultaneously for##2##2##(2008-10#2)
simultaneously from the##3##3##(1996-2#1)(2008-3#2)
simultaneously from##6##2##(1991-12#1)(1996-2#1)(2008-10#1)(2008-3#3)
simultaneously in a##2##3##(2008-10#1)(2008-3#1)
simultaneously in the same##4##4##(1995-5#1)(2008-10#2)(2008-9#1)
simultaneously in the##5##3##(1995-5#1)(2008-10#3)(2008-9#1)
simultaneously in##13##2##(1995-5#1)(1995-6#1)(2008-10#6)(2008-3#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)
simultaneously into##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
simultaneously measured##3##2##(2008-10#1)(2011-2#2)
simultaneously monitored##2##2##(2008-10#2)
simultaneously observed##3##2##(1995-9#1)(2008-10#1)(2008-8#1)
simultaneously obtained##3##2##(2008-10#2)(2008-8#1)
simultaneously on a##2##3##(2008-10#2)
simultaneously on the##2##3##(2008-10#1)(2008-4#1)
simultaneously on##6##2##(2008-10#5)(2008-4#1)
simultaneously over##2##2##(2008-10#1)(2008-2#1)
simultaneously the##4##2##(1995-5#1)(2008-10#3)
simultaneously to##2##2##(2008-10#2)
simultaneously using##2##2##(2008-10#2)
simultaneously with a##3##3##(1995-2#1)(2008-1#1)(2008-2#1)
simultaneously with an##2##3##(1990-12#1)(2008-10#1)
simultaneously with the##7##3##(1993-2#1)(2008-10#6)
simultaneously with##28##2##(1990-12#1)(1991-3#1)(1993-2#1)(1995-2#2)(2008-1#1)(2008-10#15)(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-7#1)(2013-7#1)
simultaneously##279##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-2#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#4)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#2)(1997-6#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#131)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#21)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#12)(2009-10#1)(2009-12#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#2)(2010-7#3)(2010-8#2)(2011-2#7)(2012-12#1)(2012-2#9)(2012-3#3)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#3)
sinapic acid##3##2##(2008-5#1)(2013-1#2)
since 1970 has##2##3##(1990-11#2)
since 1970##5##2##(1990-11#2)(1992-2#1)(1995-3#1)(2010-8#1)
since 1974##2##2##(2007-8#1)(2008-10#1)
since 1975##3##2##(1990-9#1)(1992-2#1)(1997-5#1)
since 1979##2##2##(1992-3#1)(1995-2#1)
since 1980##6##2##(1992-3#1)(1994-3#1)(1994-9#1)(2008-10#2)(2013-1#1)
since 1981##2##2##(1990-12#1)(1991-1#1)
since 1985##6##2##(1990-2#2)(1991-3#1)(1992-12#1)(1992-9#1)(1997-3#1)
since 1988##2##2##(1992-11#1)(2008-10#1)
since 1990##5##2##(1994-1#1)(1996-2#1)(1997-5#1)(2008-10#1)(2011-2#1)
since 1991##2##2##(2008-1#1)(2008-9#1)
since 1992##5##2##(1996-3#2)(2008-10#2)(2008-3#1)
since 2000##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
since 2004##2##2##(2012-3#1)(2013-8#1)
since 2007##2##2##(2012-3#1)(2013-8#1)
since 2012##2##2##(2013-8#2)
since August##3##2##(1995-6#1)(1996-8#1)(2012-12#1)
since March##2##2##(1995-2#1)(2013-8#1)
since September##2##2##(1991-2#1)(1996-3#1)
since a##10##2##(1990-6#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
since all##2##2##(1995-6#1)(2008-10#1)
since ancient times##2##3##(2008-9#1)(2013-1#1)
since been##4##2##(1996-3#1)(2008-1#1)(2008-9#1)(2012-3#1)
since birth##4##2##(2008-10#1)(2008-12#1)(2010-3#1)(2010-6#1)
since both##2##2##(1995-5#1)(2008-10#1)
since childhood##2##2##(2012-2#1)(2013-1#1)
since early##2##2##(1993-2#1)(2012-2#1)
since environmental##2##2##(2008-7#1)(2010-11#1)
since in the##2##3##(1990-9#1)(1995-11#1)
since in##5##2##(1990-9#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-11#1)
since it can be##3##4##(1992-2#1)(2013-1#1)(2013-8#1)
since it can##4##3##(1992-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
since it is##10##3##(1994-12#2)(1997-8#2)(2008-10#3)(2008-4#1)(2010-3#1)(2011-2#1)
since it may be##2##4##(2010-7#1)(2013-1#1)
since it may##3##3##(2008-5#1)(2010-7#1)(2013-1#1)
since it provides##2##3##(2008-10#2)
since it was reversed##2##4##(1994-2#1)(1997-7#1)
since it was##6##3##(1992-2#1)(1994-2#1)(1995-2#1)(1997-7#1)(2008-10#1)(2010-12#1)
since it##37##2##(1990-6#1)(1992-2#2)(1994-12#2)(1994-2#1)(1995-2#1)(1997-1#1)(1997-7#1)(1997-8#2)(2008-10#10)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
since its first##2##3##(1990-9#1)(2008-10#1)
since its##9##2##(1990-3#1)(1990-9#1)(1996-3#1)(2008-10#4)(2008-11#1)(2009-3#1)
since long##2##2##(2008-10#1)(2012-3#1)
since many##3##2##(1990-9#1)(1994-2#1)(2008-10#1)
since most##3##2##(1992-2#1)(2008-10#1)(2012-3#1)
since neither##3##2##(1994-11#1)(1994-5#1)(1995-12#1)
since no statistical differences were found after applying the paired t-test at the 95%##2##14##(2008-10#2)
since no##4##2##(1994-8#1)(2008-10#2)(2012-12#1)
since one##2##2##(2007-12#1)(2008-10#1)
since remained##2##2##(1996-11#1)(2013-8#1)
since some##2##2##(1994-3#1)(2008-11#1)
since the 1960s##2##3##(2010-10#1)(2010-5#1)
since the 1970s##3##3##(1994-12#1)(2008-10#2)
since the 1990s##3##3##(2010-8#1)(2013-8#2)
since the early##2##3##(2007-8#1)(2008-10#1)
since the first##3##3##(1992-5#1)(1993-6#1)(1997-8#1)
since the inception of##2##4##(1995-12#1)(2011-2#1)
since the introduction of the##2##5##(1997-5#1)(2011-1#1)
since the introduction of##7##4##(1991-9#1)(1997-5#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-1#1)(2012-3#1)
since the latter is##2##4##(1990-3#1)(2008-10#1)
since the original##2##3##(2008-11#1)(2008-12#1)
since the remaining##2##3##(1994-5#1)(2011-2#1)
since the##114##2##(1990-11#3)(1990-12#1)(1990-3#1)(1991-11#1)(1991-12#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2007-8#1)(2008-10#28)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
since their##8##2##(1993-1#1)(2007-11#1)(2008-10#2)(2009-7#1)(2010-3#1)(2010-5#1)(2012-3#1)
since then##4##2##(2008-10#1)(2008-12#1)(2012-2#1)(2013-7#1)
since there##4##2##(1990-11#1)(1993-1#1)(1995-5#1)(2008-10#1)
since these are##2##3##(2008-10#2)
since these variables##2##3##(1993-1#1)(2013-1#1)
since these##14##2##(1990-8#1)(1991-6#1)(1992-10#1)(1993-1#1)(2008-10#4)(2008-7#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-1#2)
since they exhibit##2##3##(2008-11#1)(2013-1#1)
since they have##2##3##(1997-6#1)(2010-11#1)
since they may##2##3##(1992-1#1)(1992-6#1)
since they##20##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#2)(2011-2#1)(2013-1#1)
since this is##4##3##(1994-3#1)(1997-1#1)(2008-10#2)
since this##12##2##(1990-5#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
since we##2##2##(1997-3#1)(2009-8#1)
since##493##1##(1990-11#7)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#6)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#4)(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#9)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#2)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#3)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#6)(1996-5#4)(1996-6#4)(1996-8#2)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#4)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#6)(2008-10#106)(2008-11#19)(2008-12#10)(2008-3#4)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#7)(2009-10#2)(2009-3#4)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#6)(2010-1#5)(2010-10#4)(2010-11#5)(2010-12#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#6)(2011-1#4)(2011-2#18)(2011-3#4)(2012-12#3)(2012-2#7)(2012-3#11)(2013-1#16)(2013-7#3)(2013-8#11)
sincere##2##1##(1992-2#1)(2008-11#1)
sindbis##2##1##(1997-8#2)
sine wave##2##2##(2011-2#2)
sine##4##1##(2008-11#1)(2008-3#1)(2011-2#2)
sinensis##6##1##(2008-10#2)(2008-8#2)(2011-2#1)(2013-8#1)
sinensis)##6##1##(2008-10#6)
sing##2##1##(1991-3#1)(1991-8#1)
singing males##2##2##(2008-8#2)
singing##4##1##(2008-8#3)(2008-9#1)
single African##2##2##(1994-3#2)
single Cys##2##2##(1994-5#2)
single DNA molecule##2##3##(2008-10#1)(2008-12#1)
single DNA##5##2##(2008-10#2)(2008-12#1)(2008-9#2)
single P##3##2##(2008-10#3)
single QTL##3##2##(2008-10#2)(2012-3#1)
single U##2##2##(2008-10#1)(2011-2#1)
single access retroperitoneoscopic adrenalectomy##2##4##(2012-12#2)
single access retroperitoneoscopic##4##3##(2012-12#4)
single administration##2##2##(1990-7#1)(2012-2#1)
single agent in pretreated##2##4##(1991-6#1)(1994-8#1)
single agent in##4##3##(1991-6#2)(1994-8#2)
single agent##8##2##(1991-6#2)(1994-8#3)(2008-10#1)(2009-12#1)(2010-10#1)
single agents##2##2##(2008-10#1)(2009-12#1)
single amino acid change in the##2##6##(2008-10#1)(2012-3#1)
single amino acid change##3##4##(1995-2#1)(2008-10#1)(2012-3#1)
single amino acid substitution##3##4##(1991-12#1)(2008-10#1)(2008-8#1)
single amino acid##7##3##(1991-12#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-8#1)(2012-3#1)
single amino##8##2##(1991-12#1)(1994-5#1)(1995-2#1)(2008-10#3)(2008-8#1)(2012-3#1)
single analysis##3##2##(1994-9#1)(2008-10#1)(2009-11#1)
single and double##2##3##(1990-5#1)(1991-9#1)
single and mixed##4##3##(1996-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
single and multiple##3##3##(1992-8#1)(2009-12#1)(2011-1#1)
single and##19##2##(1990-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-12#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
single application of##6##3##(2008-10#5)(2013-1#1)
single application##7##2##(2008-10#6)(2013-1#1)
single assay##3##2##(1992-3#1)(2008-10#2)
single bacterial##2##2##(1995-2#1)(2008-10#1)
single band in##2##3##(1993-2#1)(2008-10#1)
single band##10##2##(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-11#2)(2008-10#2)
single bead string##3##3##(2008-10#3)
single bead##4##2##(2008-10#3)(2008-11#1)
single cancer##2##2##(2009-12#1)(2010-12#1)
single case study##2##3##(2008-9#1)(2013-1#1)
single case##8##2##(1990-6#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-9#1)(2013-1#3)
single cause##2##2##(1992-6#1)(2008-11#1)
single cell analysis##2##3##(2007-12#1)(2009-12#1)
single cell##20##2##(1993-6#1)(1994-8#2)(1996-2#1)(1997-7#1)(2007-12#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-8#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
single cells##18##2##(1991-5#1)(1992-12#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#7)(2008-9#1)(2009-12#2)
single chain antibodies##2##3##(2008-10#2)
single chain antibody to vascular endothelial growth factor##2##8##(2008-8#2)
single chain antibody##5##3##(1992-6#2)(2008-8#3)
single chain insulin##6##3##(2008-9#6)
single chain##15##2##(1992-6#2)(2008-10#2)(2008-11#1)(2008-8#4)(2008-9#6)
single channel##9##2##(1994-12#1)(1995-2#1)(1996-2#1)(2008-10#2)(2009-8#1)(2011-3#2)(2012-3#1)
single colonies##3##2##(1994-11#1)(2008-10#2)
single component##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
single components in##2##3##(2008-10#2)
single components##3##2##(2008-10#3)
single compound##7##2##(2008-10#1)(2008-11#4)(2008-5#1)(2009-8#1)
single copy##18##2##(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-5#1)(1996-8#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#4)(2009-10#1)(2012-2#1)
single crown##3##2##(1990-5#1)(2013-1#2)
single crystals##3##2##(2008-10#1)(2008-3#1)(2009-5#1)
single cystosorus isolates##2##3##(2008-10#2)
single cystosorus##3##2##(2008-10#3)
single daily dose##4##3##(1990-11#2)(1991-11#1)(2008-11#1)
single difference##2##2##(2008-3#1)(2009-6#1)
single dominant avirulence genes##2##4##(2008-10#2)
single dominant avirulence##3##3##(2008-10#3)
single dominant gene##17##3##(2008-10#17)
single dominant##27##2##(2008-10#27)
single dose of##6##3##(1990-6#1)(1992-12#1)(1995-11#1)(1997-5#1)(2010-1#1)(2012-2#1)
single dose##12##2##(1990-6#1)(1992-12#2)(1995-11#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-1#1)(2012-2#1)
single ectopic ureteric##2##3##(2008-10#2)
single ectopic ureters with hypoplastic bladder##3##6##(2008-10#3)
single ectopic##5##2##(2008-10#5)
single element##3##2##(2008-10#1)(2008-9#1)(2009-5#1)
single eukaryotic##2##2##(1995-9#1)(2009-12#1)
single extract of##2##3##(2008-10#2)
single extraction##8##2##(2008-10#8)
single factor##3##2##(2008-10#1)(2008-11#2)
single fiber optic sensor##2##4##(2008-10#2)
single fiber##4##2##(2007-12#1)(2008-10#3)
single fields##3##2##(2008-10#3)
single fraction 8Gy##3##3##(2008-10#3)
single fraction##5##2##(1990-2#1)(2008-10#4)
single frequency##2##2##(2008-10#1)(2008-2#1)
single gene control of##3##4##(2008-10#3)
single gene disorders##2##3##(2008-8#2)
single gene##24##2##(1993-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#15)(2008-8#3)(2012-2#1)(2012-3#1)
single genes##3##2##(2008-10#2)(2008-6#1)
single genotype stands##2##3##(2008-10#2)
single genotype##5##2##(2008-10#5)
single genotypes##2##2##(2008-10#1)(2008-12#1)
single genotypic infections##2##3##(2008-12#2)
single genotypic##3##2##(2008-12#3)
single habitat##2##2##(2008-8#1)(2008-9#1)
single haplotype##2##2##(2008-10#2)
single image##2##2##(2008-10#1)(2008-6#1)
single implants inserted##2##3##(2013-1#2)
single implants##4##2##(2013-1#4)
single individual##3##2##(2008-10#2)(2013-1#1)
single infection##2##2##(2008-10#1)(2008-11#1)
single injection of##4##3##(1995-11#1)(2008-10#2)(2008-8#1)
single injection##6##2##(1995-11#1)(1997-3#1)(2008-10#2)(2008-8#1)(2010-8#1)
single isolate##5##2##(2008-10#5)
single joint##2##2##(2008-7#1)(2013-1#1)
single large##4##2##(1993-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
single laser##4##2##(2008-3#4)
single layer##6##2##(2008-10#4)(2008-11#1)(2008-12#1)
single line##2##2##(2008-10#2)
single lineage##2##2##(2008-10#1)(2008-6#1)
single linear##2##2##(2008-10#1)(2009-10#1)
single locus##5##2##(2008-10#4)(2008-8#1)
single lung##2##2##(2011-3#2)
single major##5##2##(1995-12#1)(2008-10#4)
single mandibular##3##2##(2013-1#3)
single measure##2##2##(2010-11#1)(2011-2#1)
single mirror##2##2##(2007-11#1)(2008-6#1)
single mode and##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
single model##3##2##(1995-2#1)(2008-11#1)(2010-6#1)
single molecule##11##2##(1992-3#1)(1997-6#1)(2008-10#1)(2009-5#2)(2010-5#3)(2010-6#1)(2010-7#1)(2012-3#1)
single molecules and##2##3##(2008-4#1)(2008-7#1)
single molecules##4##2##(2008-4#1)(2008-7#3)
single mutant receptors##2##3##(1995-6#2)
single mutant##6##2##(1993-9#1)(1995-6#3)(2011-2#1)(2013-8#1)
single mutation##2##2##(1997-3#1)(2008-11#1)
single neurons##4##2##(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)
single nucleotide polymorphism (SNP)##5##4##(2009-7#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
single nucleotide polymorphism##7##3##(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
single nucleotide polymorphisms (SNPs) and##2##5##(2008-10#1)(2013-1#1)
single nucleotide polymorphisms (SNPs)##8##4##(2008-10#2)(2008-12#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
single nucleotide polymorphisms and##2##4##(2010-6#1)(2013-8#1)
single nucleotide polymorphisms##15##3##(1997-9#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-8#2)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
single nucleotide##28##2##(1996-12#1)(1997-9#1)(2008-10#5)(2008-12#1)(2008-8#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-6#2)(2011-2#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#1)
single or few##2##3##(2008-10#1)(2008-2#1)
single or in##2##3##(2008-12#1)(2008-8#1)
single or multiple##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2011-1#1)
single or##17##2##(1994-2#1)(1995-6#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
single oral administration of##2##4##(2008-10#1)(2010-11#1)
single oral##3##2##(2008-10#2)(2010-11#1)
single parameter##3##2##(1994-9#1)(2008-10#1)(2008-9#1)
single particle analysis##3##3##(2008-10#3)
single particle##10##2##(1990-12#1)(2008-10#7)(2008-3#1)(2009-8#1)
single particles##2##2##(2008-10#1)(2008-5#1)
single peak##5##2##(1996-12#1)(2008-10#3)(2008-8#1)
single phase##2##2##(2008-5#1)(2009-11#1)
single photon emission computed tomography##4##5##(1994-1#1)(1996-12#1)(2008-7#1)(2010-12#1)
single photon emission##6##3##(1994-1#1)(1996-12#1)(2008-12#1)(2008-7#2)(2010-12#1)
single photon##7##2##(1994-1#1)(1995-6#1)(1996-12#1)(2008-12#1)(2008-7#2)(2010-12#1)
single plants##2##2##(2008-10#2)
single point mutation##2##3##(2008-10#2)
single point##10##2##(1995-12#1)(1997-6#1)(2008-10#7)(2008-6#1)
single polypeptide chain##2##3##(2008-10#1)(2008-11#1)
single polypeptide##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2010-5#1)
single population##4##2##(1990-8#1)(1996-2#1)(2008-10#1)(2011-2#1)
single primary##2##2##(2008-10#1)(2013-1#1)
single pulse##2##2##(1997-4#1)(2008-5#1)
single pyramidal cells in the hippocampal CA1##2##7##(2008-11#2)
single pyramidal cells##4##3##(2008-11#4)
single recessive gene##7##3##(2008-10#5)(2008-8#1)(2008-9#1)
single recessive##9##2##(2008-10#7)(2008-8#1)(2008-9#1)
single resistance##5##2##(2008-10#5)
single run##3##2##(2008-10#2)(2008-11#1)
single scan##3##2##(2008-10#2)(2012-2#1)
single scattering##5##2##(2008-2#1)(2008-3#3)(2009-11#1)
single secretory##2##2##(1997-7#1)(2008-6#1)
single seed##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
single sensory##2##2##(1996-12#1)(2007-12#1)
single social##2##2##(2010-10#1)(2010-2#1)
single source##3##2##(1992-1#1)(1993-2#1)(2008-10#1)
single species of##2##3##(1995-12#1)(1996-12#1)
single species##12##2##(1993-12#1)(1995-12#1)(1996-12#1)(2008-10#8)(2011-2#1)
single stage##2##2##(2008-8#1)(2011-2#1)
single standard addition##2##3##(2008-10#2)
single standard##3##2##(2008-10#3)
single step##13##2##(1992-11#1)(1993-6#1)(1995-11#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-3#1)(2013-8#1)
single strain##4##2##(2008-10#2)(2009-6#1)(2012-3#1)
single strand##6##2##(1993-12#1)(2008-10#2)(2008-12#2)(2008-8#1)
single stranded DNA##2##3##(2008-10#2)
single stranded##5##2##(2008-10#4)(2011-2#1)
single study##2##2##(2008-8#1)(2009-10#1)
single subcutaneous injection of##2##4##(1993-1#1)(2008-7#1)
single surgical##2##2##(1994-8#1)(2008-11#1)
single telia##2##2##(2008-10#2)
single test##4##2##(1997-6#1)(2008-10#1)(2009-12#1)(2012-2#1)
single topical application of##2##4##(1992-8#2)
single treatment##3##2##(1995-12#1)(2008-12#1)(2010-9#1)
single trees##3##2##(2008-10#3)
single tropocollagen##2##2##(2009-7#2)
single unit##2##2##(1994-2#1)(2008-10#1)
single units##2##2##(1996-2#1)(2008-8#1)
single versus multiple##4##3##(2008-10#3)(2012-3#1)
single wavelength modulation##2##3##(2008-10#2)
single wavelength##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
single zoospore isolates##6##3##(2008-10#6)
single##1342##1##(1990-11#4)(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-11#2)(1992-12#7)(1992-3#7)(1992-4#1)(1992-6#5)(1992-8#5)(1993-1#3)(1993-12#7)(1993-2#10)(1993-3#4)(1993-6#7)(1993-8#6)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#6)(1994-5#10)(1994-6#3)(1994-8#9)(1994-9#2)(1995-11#6)(1995-12#10)(1995-2#11)(1995-3#1)(1995-5#3)(1995-6#15)(1995-8#2)(1995-9#3)(1996-1#2)(1996-12#15)(1996-2#7)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#9)(1997-8#1)(1997-9#1)(2006-6#2)(2007-11#3)(2007-12#11)(2008-1#3)(2008-10#488)(2008-11#67)(2008-12#25)(2008-2#12)(2008-3#39)(2008-4#10)(2008-5#18)(2008-6#8)(2008-7#29)(2008-8#48)(2008-9#43)(2009-1#1)(2009-10#10)(2009-11#5)(2009-12#14)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#10)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#6)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#6)(2010-6#6)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#46)(2011-3#6)(2011-7#1)(2012-12#9)(2012-2#21)(2012-3#18)(2012-5#1)(2012-6#2)(2013-1#39)(2013-2#1)(2013-7#2)(2013-8#21)
single- and##3##2##(2008-3#2)(2008-9#1)
single- or##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
single-##10##1##(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)
single-base mismatch in##2##3##(2008-10#2)
single-base##12##1##(1990-8#2)(1992-3#1)(1997-2#1)(2008-10#5)(2008-9#3)
single-blind##3##1##(2008-8#1)(2012-2#1)(2013-1#1)
single-blinded##2##1##(2012-12#1)(2013-1#1)
single-carbon metabolism##2##2##(1992-10#2)
single-case##2##1##(2013-1#1)(2013-8#1)
single-cell level##2##2##(2008-10#1)(2008-11#1)
single-cell reproduction##2##2##(2008-8#2)
single-cell suspension##2##2##(2008-11#1)(2008-9#1)
single-cell suspensions##3##2##(2008-4#2)(2008-9#1)
single-cell##13##1##(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#2)(2008-9#3)(2009-12#2)(2012-12#1)
single-celled##2##1##(1995-2#1)(2012-3#1)
single-center experience##2##2##(2008-11#1)(2011-2#1)
single-center##3##1##(2008-11#1)(2011-2#2)
single-chain Fv##2##2##(1993-8#1)(2008-10#1)
single-chain antibodies (scFvs)##2##3##(2008-10#1)(2008-4#1)
single-chain antibody##3##2##(1993-8#1)(2008-4#1)(2008-8#1)
single-chain variable fragment antibodies (scFv) that bind##2##7##(2008-10#2)
single-chain variable fragment antibodies##3##4##(2008-10#3)
single-chain variable##4##2##(2008-10#4)
single-chain##20##1##(1991-7#1)(1992-10#1)(1992-6#1)(1993-8#2)(1995-3#1)(1995-6#1)(2008-10#7)(2008-4#2)(2008-8#4)
single-channel##5##1##(1994-11#1)(1997-6#2)(2008-3#1)(2008-9#1)
single-charged##6##1##(2008-10#6)
single-color##2##1##(1997-6#1)(2008-4#1)
single-copy DNA##2##2##(2008-10#2)
single-copy restriction fragment length polymorphism##2##5##(2008-10#2)
single-copy##13##1##(1993-12#1)(1993-6#1)(1993-9#1)(1995-6#1)(1996-6#1)(2008-10#6)(2008-8#1)(2008-9#1)
single-domain##2##1##(1993-12#1)(2008-2#1)
single-dose##5##1##(1992-9#1)(1997-5#1)(2008-10#1)(2011-2#2)
single-drop microextraction (SDME)##4##3##(2008-10#4)
single-drop microextraction##6##2##(2008-10#6)
single-drop##9##1##(2008-10#9)
single-electron reduction##3##2##(1995-8#3)
single-electron##5##1##(1995-8#3)(1996-5#1)(2008-11#1)
single-electron-transferring##2##1##(1995-8#2)
single-frequency green output##2##3##(2008-3#2)
single-frequency##11##1##(2008-2#4)(2008-3#7)
single-gene##7##1##(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#2)(2010-7#1)
single-genotype plots##4##2##(2008-10#4)
single-genotype##5##1##(2008-10#5)
single-group##3##1##(1993-1#1)(2010-7#1)(2013-1#1)
single-hTREK1-channel##2##1##(2012-2#2)
single-ion##3##1##(2008-10#1)(2010-7#1)(2012-2#1)
single-joint strength##2##2##(2010-7#2)
single-joint##3##1##(2008-7#1)(2010-7#2)
single-knob tuning##2##2##(2008-2#2)
single-laser##3##1##(2008-3#1)(2008-9#2)
single-laser-shot##2##1##(2008-2#1)(2008-3#1)
single-layer viscous##2##2##(2009-10#2)
single-level C-ADR with##2##3##(2012-12#2)
single-level C-ADR##4##2##(2012-12#4)
single-level##10##1##(2010-1#2)(2012-12#7)(2012-3#1)
single-line##2##1##(2008-10#2)
single-mode behavior##2##2##(2007-11#1)(2008-2#1)
single-mode continuous-wave##2##2##(2008-3#2)
single-mode fiber coupling##2##3##(2008-2#1)(2008-3#1)
single-mode fiber depolarizer##2##3##(2008-2#2)
single-mode fiber##7##2##(2008-2#3)(2008-3#4)
single-mode optical##2##2##(2008-3#2)
single-mode##25##1##(2007-11#2)(2008-2#6)(2008-3#17)
single-molecule fluorescence##3##2##(2007-12#1)(2008-10#2)
single-molecule##7##1##(1997-6#1)(2007-12#1)(2008-10#2)(2010-10#1)(2012-2#1)(2013-8#1)
single-neuron##2##1##(1994-2#1)(2009-8#1)
single-nucleotide polymorphism##2##2##(2008-10#1)(2011-2#1)
single-nucleotide##6##1##(1993-6#1)(2008-10#2)(2008-9#1)(2010-4#1)(2011-2#1)
single-parent families##2##2##(2008-11#1)(2008-9#1)
single-particle##2##1##(2008-3#2)
single-pass##9##1##(1997-2#1)(2008-3#6)(2011-3#2)
single-phase extraction##2##2##(2008-10#2)
single-phase solution##2##2##(2008-10#2)
single-phase##5##1##(2008-10#4)(2010-4#1)
single-photon emission computed tomography##2##4##(1995-5#1)(2012-2#1)
single-photon##4##1##(1995-5#1)(2008-3#2)(2012-2#1)
single-point##4##1##(1993-8#1)(2008-9#2)(2013-1#1)
single-pulse##5##1##(2008-2#1)(2008-3#4)
single-round##2##1##(2008-10#2)
single-scattering albedo at##2##3##(2008-3#2)
single-scattering albedo of the hexagonal column##2##6##(2008-3#2)
single-scattering albedo of##4##3##(2008-3#4)
single-scattering albedo##9##2##(2008-3#9)
single-scattering##10##1##(2008-3#10)
single-shot##8##1##(2007-12#1)(2008-3#7)
single-spore isolates##3##2##(2008-10#3)
single-spore##4##1##(2008-10#4)
single-spot multianalyte##2##2##(2008-10#2)
single-stage##5##1##(2008-10#3)(2008-2#1)(2012-3#1)
single-step##5##1##(1995-6#1)(2008-10#3)(2008-4#1)
single-strand breaks were##2##3##(1993-8#1)(2008-11#1)
single-strand breaks##7##2##(1993-8#1)(1994-8#4)(2008-11#2)
single-strand conformation polymorphism (SSCP) analysis##2##5##(2008-10#2)
single-strand conformation polymorphism##4##3##(2008-10#3)(2011-2#1)
single-strand conformational polymorphism##2##3##(2008-10#2)
single-strand##14##1##(1993-8#1)(1994-8#4)(2008-10#5)(2008-11#2)(2011-2#1)(2013-1#1)
single-stranded DNA (ssDNA)##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
single-stranded DNA binding protein##4##4##(1992-3#1)(1992-6#1)(1997-3#2)
single-stranded DNA virus##2##3##(2008-10#1)(2008-9#1)
single-stranded DNA##16##2##(1991-3#1)(1991-5#2)(1992-3#1)(1992-6#2)(1995-2#1)(1997-3#3)(2008-10#3)(2008-9#1)(2012-3#2)
single-stranded RNA molecules##2##3##(2008-10#1)(2011-2#1)
single-stranded RNA##8##2##(2008-10#5)(2008-4#1)(2011-2#1)(2012-2#1)
single-stranded and double-stranded DNA##2##4##(2008-10#1)(2008-9#1)
single-stranded and##3##2##(2008-10#2)(2008-9#1)
single-stranded deoxyribonucleic acid##2##3##(2008-10#2)
single-stranded nucleic##3##2##(1991-5#1)(2008-10#1)(2008-9#1)
single-stranded nucleotides##2##2##(1993-1#2)
single-stranded##56##1##(1990-5#1)(1991-3#1)(1991-5#4)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-8#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-3#3)(1997-7#1)(2008-10#22)(2008-11#1)(2008-4#3)(2008-9#4)(2011-2#1)(2012-2#1)(2012-3#2)
single-subject##2##1##(2009-9#1)(2011-2#1)
single-tooth##5##1##(1996-3#1)(2013-1#4)
single-uredinial isolates##2##2##(2008-10#2)
single-uredinial##3##1##(2008-10#3)
single-use phosphorimetric##2##2##(2008-10#2)
single-use##4##1##(2008-10#4)
single-wall carbon nanotubes##2##3##(2008-10#2)
single-walled carbon nanotubes##2##3##(2008-7#1)(2013-1#1)
single-walled carbon##3##2##(2008-7#2)(2013-1#1)
single-walled##5##1##(2008-7#4)(2013-1#1)
single-zoospore progeny##2##2##(2008-10#2)
single-zoospore##3##1##(2008-10#3)
singlehood##2##1##(2011-2#2)
singlet oxygen##6##2##(2008-10#1)(2008-2#1)(2008-5#3)(2010-4#1)
singlet##12##1##(1992-9#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-5#3)(2010-4#1)
singly and in combination##2##4##(1990-6#1)(2012-6#1)
singly and in##5##3##(1990-6#1)(2008-10#2)(2008-5#1)(2012-6#1)
singly and##7##2##(1990-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2012-6#1)
singly immunoprecipitated##2##2##(2008-2#2)
singly or##2##2##(1995-6#1)(2010-1#1)
singly resonant##3##2##(2007-12#2)(2008-3#1)
singly##23##1##(1990-5#1)(1990-6#1)(1995-11#1)(1995-6#1)(2007-12#3)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-6#1)
singular value decomposition##7##3##(1990-8#1)(2008-10#5)(2010-10#1)
singular##17##1##(1990-8#1)(1994-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
singularities##4##1##(2007-11#3)(2008-2#1)
singularity##4##1##(2008-10#1)(2008-6#1)(2009-10#1)(2013-1#1)
singularly perturbed##2##2##(2013-8#2)
sinica##4##1##(2008-10#4)
sink for##3##2##(2008-10#1)(2008-11#2)
sink populations##2##2##(2013-1#2)
sink##30##1##(1995-6#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#14)(2008-9#1)(2013-1#2)
sinking phytoplankton species##2##3##(2008-8#2)
sinking phytoplankton##4##2##(2008-8#4)
sinking##7##1##(2008-10#1)(2008-8#6)
sinks planted to##2##3##(2008-10#2)
sinks planted##4##2##(2008-10#4)
sinks to##2##2##(2008-10#1)(2008-9#1)
sinks##13##1##(1995-3#1)(2008-10#6)(2008-11#2)(2008-8#3)(2008-9#1)
sinoatrial blocks##4##2##(1996-3#4)
sinomenine##2##1##(1994-8#2)
sinonasal symptoms following##2##3##(2011-2#2)
sinonasal symptoms##3##2##(2011-2#3)
sinonasal##7##1##(1990-6#1)(2008-11#1)(2009-1#1)(2011-2#4)
sintered##3##1##(2009-7#3)
sintering##7##1##(2008-3#4)(2009-7#3)
sinus and##12##2##(1990-12#1)(1996-6#1)(1996-9#2)(2008-7#1)(2008-9#1)(2011-2#4)(2012-3#1)(2013-1#1)
sinus are##2##2##(2008-7#1)(2013-1#1)
sinus beats##2##2##(1996-6#2)
sinus dural##3##2##(1996-9#1)(2008-7#2)
sinus in##2##2##(1996-6#1)(2008-5#1)
sinus is an##2##3##(1996-9#1)(2013-1#1)
sinus is##7##2##(1996-9#2)(2008-7#2)(2013-1#3)
sinus lift##2##2##(2010-5#2)
sinus mucocele##2##2##(2013-1#2)
sinus of##4##2##(1997-5#3)(2011-2#1)
sinus or##3##2##(2011-2#1)(2011-7#1)(2012-3#1)
sinus rhythm##10##2##(1990-3#1)(1990-9#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-12#3)(2013-1#1)
sinus system##2##2##(1996-9#1)(2011-2#1)
sinus thrombosis##9##2##(1997-3#1)(1997-6#2)(2008-7#5)(2012-3#1)
sinus was##2##2##(1996-6#1)(1996-9#1)
sinus with##3##2##(1996-9#1)(2008-7#1)(2013-1#1)
sinus##154##1##(1990-12#3)(1990-3#1)(1990-5#2)(1990-9#1)(1991-10#1)(1992-6#1)(1993-1#3)(1993-9#2)(1996-6#7)(1996-9#27)(1997-3#4)(1997-5#3)(1997-6#2)(2008-10#1)(2008-11#4)(2008-5#3)(2008-6#4)(2008-7#27)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#3)(2010-5#2)(2010-6#1)(2011-2#25)(2011-7#1)(2012-12#1)(2012-3#5)(2013-1#14)(2013-8#3)
sinuses and##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
sinuses are##2##2##(1996-9#2)
sinuses##22##1##(1990-6#1)(1991-6#1)(1996-9#4)(2008-11#2)(2008-5#2)(2008-7#4)(2011-2#4)(2011-7#1)(2012-2#2)(2013-8#1)
sinusitis##16##1##(1991-6#4)(1993-2#2)(1996-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-5#1)(2010-6#1)(2011-2#4)
sinusoidal GSH##4##2##(1995-2#4)
sinusoidal gratings##3##2##(1996-2#1)(2007-12#1)(2008-8#1)
sinusoidal##17##1##(1992-6#1)(1992-9#1)(1995-2#5)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2013-1#1)
sinusoidally##2##1##(1995-12#1)(2008-3#1)
sinusoids##4##1##(2008-10#1)(2008-11#2)(2008-7#1)
sired by##3##2##(2008-8#1)(2010-8#2)
siring##2##1##(2008-8#1)(2008-9#1)
siroheme##3##1##(1993-8#3)
sirolimus##4##1##(2008-11#1)(2013-1#3)
sirolimus-eluting##2##1##(2008-11#2)
sirtuin##2##1##(2010-1#1)(2010-12#1)
sirtuins are##2##2##(2008-10#2)
sirtuins##5##1##(2008-10#5)
sister chromatid exchange##2##3##(1993-12#1)(2008-11#1)
sister chromatid exchanges (SCEs)##2##4##(1997-7#1)(2008-11#1)
sister chromatid exchanges in human##2##5##(2008-11#2)
sister chromatid exchanges##6##3##(1993-12#1)(1997-7#2)(2008-11#3)
sister chromatid##9##2##(1993-12#2)(1997-7#2)(2008-11#4)(2012-2#1)
sister clades##2##2##(2008-8#2)
sister group##2##2##(2008-10#1)(2008-8#1)
sister who##2##2##(1996-6#1)(2011-2#1)
sister##25##1##(1993-12#2)(1996-5#1)(1996-6#1)(1997-7#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
sisters with##2##2##(2008-9#1)(2011-2#1)
sisters##10##1##(1991-12#1)(1996-5#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#5)
sit in a##2##3##(2010-4#1)(2011-7#1)
sit##4##1##(1990-3#1)(2010-4#1)(2011-2#1)(2011-7#1)
site (STS) markers##5##3##(1996-12#2)(1997-8#1)(2008-10#2)
site 2##3##2##(2008-8#3)
site 8 O-acetylated sialomucins##3##4##(1990-2#3)
site I##3##2##(1991-5#1)(2008-10#2)
site II##3##2##(2008-10#3)
site after##2##2##(1990-6#1)(2011-2#1)
site and in##2##3##(2008-7#1)(2010-6#1)
site and the##3##3##(1994-5#1)(2008-12#1)(2008-9#1)
site and##24##2##(1990-5#1)(1990-8#1)(1992-10#1)(1994-5#2)(1995-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-6#1)(2010-8#1)(2012-3#1)(2012-5#1)(2013-8#2)
site as the##2##3##(1990-5#1)(1996-12#1)
site as##8##2##(1990-5#3)(1995-6#1)(1996-12#2)(2008-10#1)(2008-9#1)
site at##5##2##(1992-10#1)(1992-12#1)(1995-11#1)(2008-10#2)
site between##3##2##(1995-11#1)(1995-6#1)(2008-8#1)
site by##7##2##(1991-6#1)(1995-6#1)(2008-10#4)(2013-8#1)
site characterization##3##2##(2008-10#3)
site complications but##3##3##(2011-2#2)(2013-1#1)
site complications##7##2##(2011-2#5)(2013-1#2)
site directed##2##2##(1992-3#1)(2011-2#1)
site fidelity##2##2##(2010-4#2)
site for a##4##3##(1993-8#1)(1995-11#1)(1997-6#1)(2008-10#1)
site for the##8##3##(1990-5#2)(1993-12#1)(1993-3#2)(2008-10#1)(2009-8#1)(2010-7#1)
site for##34##2##(1990-2#1)(1990-5#2)(1991-5#1)(1991-6#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-7#1)(2011-2#3)(2012-2#1)
site gastric cancer after##3##4##(2008-12#3)
site had##3##2##(2008-10#2)(2012-12#1)
site in a##3##3##(1990-5#2)(1991-9#1)
site in the##16##3##(1990-5#2)(1990-8#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-8#1)(1996-2#1)(2008-10#5)(2008-11#1)(2009-8#1)
site in##38##2##(1990-5#4)(1990-8#2)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#14)(2008-11#1)(2008-9#1)(2009-8#1)(2010-5#1)(2013-8#1)
site infection##4##2##(2009-3#1)(2010-12#2)(2012-3#1)
site is located in the##2##5##(1995-2#1)(2008-11#1)
site is located##5##3##(1990-7#1)(1991-12#1)(1993-8#1)(1995-2#1)(2008-11#1)
site is the##2##3##(1991-3#1)(1997-4#1)
site is##24##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-2#3)(1995-6#3)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
site ligands were##2##3##(1995-11#2)
site ligands##5##2##(1991-12#1)(1995-11#4)
site located at##2##3##(2008-10#2)
site located##3##2##(2008-10#2)(2008-11#1)
site may be##2##3##(1995-2#2)
site near##2##2##(1993-9#1)(2008-10#1)
site observed##2##2##(1993-6#1)(1995-11#1)
site of S##2##3##(2008-12#1)(2011-2#1)
site of a##5##3##(1993-2#1)(1995-3#1)(1995-8#1)(2010-6#2)
site of action##5##3##(1990-11#1)(1991-2#1)(1994-2#1)(2008-10#1)(2011-2#1)
site of infection and##2##4##(2008-10#1)(2011-1#1)
site of infection##12##3##(1996-8#1)(1997-1#1)(2008-10#4)(2009-8#1)(2010-6#1)(2011-1#1)(2012-12#3)
site of insulin resistance in Type 2##2##7##(2008-1#2)
site of metastatic##2##3##(2008-1#2)
site of origin##3##3##(2008-11#1)(2009-9#1)(2012-2#1)
site of stimulation##2##3##(1992-12#2)
site of the mutation##2##4##(1993-8#1)(1994-11#1)
site of the##32##3##(1990-9#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#3)(1994-5#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#2)(2006-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
site of their##2##3##(1996-6#1)(2008-9#1)
site of transcription##2##3##(1991-5#1)(1997-7#1)
site of##161##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#3)(1992-12#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-8#2)(1993-9#1)(1994-11#5)(1994-2#1)(1994-3#1)(1994-5#14)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#4)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#2)(1997-8#2)(2006-6#1)(2007-12#1)(2008-1#4)(2008-10#19)(2008-11#6)(2008-12#2)(2008-5#7)(2008-7#4)(2008-8#4)(2008-9#7)(2009-8#2)(2009-9#1)(2010-12#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#1)
site on the##5##3##(1990-7#1)(1994-11#1)(1994-5#1)(2008-11#1)(2009-8#1)
site on##12##2##(1990-7#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)
site or##2##2##(1997-6#1)(2008-10#1)
site reactions##4##2##(1996-8#1)(2008-8#3)
site selection##3##2##(1995-8#1)(2008-12#1)(2008-8#1)
site sequence##3##2##(1993-6#1)(2008-8#1)(2009-9#1)
site that had been##2##4##(2008-10#2)
site that##9##2##(1993-8#1)(1994-5#2)(1995-6#1)(2008-10#3)(2008-11#1)(2011-2#1)
site to##12##2##(1992-6#1)(1994-5#2)(2008-10#3)(2008-11#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-2#1)
site variation##2##2##(2008-10#1)(2008-5#1)
site was identified##3##3##(1991-7#2)(2008-8#1)
site was localized##2##3##(1994-11#1)(1995-6#1)
site was##19##2##(1991-10#1)(1991-12#1)(1991-7#3)(1994-11#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#3)
site were measured##2##3##(2008-10#1)(2008-9#1)
site were obtained##2##3##(1991-3#1)(2008-10#1)
site were##10##2##(1990-6#1)(1991-3#1)(1994-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2012-3#1)
site where##2##2##(1992-3#1)(2008-4#1)
site which##3##2##(1991-5#1)(1994-3#1)(1997-7#1)
site with##6##2##(1991-5#1)(1992-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
site within the##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
site within##4##2##(1997-7#1)(2008-10#2)(2008-8#1)
site##836##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#7)(1990-5#16)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#4)(1991-10#5)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#9)(1991-5#10)(1991-6#9)(1991-7#4)(1991-9#4)(1992-10#3)(1992-12#3)(1992-2#4)(1992-3#12)(1992-4#3)(1992-6#10)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#4)(1993-6#7)(1993-8#11)(1993-9#4)(1994-11#9)(1994-2#2)(1994-3#6)(1994-5#34)(1994-8#3)(1994-9#1)(1995-11#15)(1995-12#6)(1995-2#14)(1995-3#3)(1995-5#3)(1995-6#25)(1995-8#11)(1995-9#1)(1996-12#8)(1996-2#9)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#7)(2006-6#1)(2007-12#2)(2008-1#4)(2008-10#165)(2008-11#34)(2008-12#15)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#23)(2008-7#18)(2008-8#31)(2008-9#17)(2009-10#3)(2009-2#1)(2009-3#4)(2009-4#2)(2009-6#1)(2009-7#4)(2009-8#7)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#6)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#44)(2012-12#8)(2012-2#20)(2012-3#18)(2012-5#1)(2012-9#1)(2013-1#12)(2013-7#2)(2013-8#7)
site(s)##8##1##(1993-6#1)(1994-8#1)(1995-11#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-5#1)(2012-2#1)
site) of the##2##3##(1993-12#1)(1995-6#1)
site)##11##1##(1990-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-6#1)(1997-3#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)(2012-9#1)
site-binding##2##1##(1994-5#1)(2008-10#1)
site-directed mutagenesis and##2##3##(1992-3#1)(1994-5#1)
site-directed mutagenesis at##2##3##(1992-1#1)(2008-9#1)
site-directed mutagenesis was##2##3##(1995-2#1)(2008-9#1)
site-directed mutagenesis##28##2##(1990-5#2)(1991-10#1)(1991-5#2)(1992-1#2)(1992-3#2)(1992-6#1)(1993-8#1)(1994-5#4)(1994-8#1)(1995-2#2)(1995-8#1)(2008-10#2)(2008-9#6)(2010-5#1)
site-directed mutants of##3##3##(1994-11#1)(1995-6#1)(1997-9#1)
site-directed mutants##5##2##(1994-11#1)(1995-2#1)(1995-6#2)(1997-9#1)
site-directed mutation of##2##3##(2008-8#2)
site-directed mutation##3##2##(1997-3#1)(2008-8#2)
site-directed mutations##3##2##(1991-5#1)(1995-2#1)(1995-6#1)
site-directed##47##1##(1990-5#2)(1991-10#1)(1991-5#3)(1992-1#2)(1992-3#2)(1992-6#1)(1993-8#3)(1994-11#1)(1994-5#4)(1994-8#1)(1995-2#5)(1995-6#4)(1995-8#1)(1997-3#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#3)(2008-9#6)(2010-5#1)
site-specific cancers##2##2##(2010-1#1)(2011-2#1)
site-specific mutagenesis##2##2##(1991-10#1)(2008-8#1)
site-specific recombination##4##2##(1995-2#1)(2008-4#1)(2008-8#1)(2012-2#1)
site-specific##27##1##(1991-10#1)(1994-3#1)(1995-2#1)(2008-10#6)(2008-11#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2010-1#3)(2011-2#1)(2012-2#2)
site-years##2##1##(2008-10#2)
sited##2##1##(2008-10#1)(2008-7#1)
siteof##2##1##(2008-11#1)(2009-8#1)
sites (D2##2##2##(1993-9#2)
sites among##2##2##(2008-10#1)(2008-11#1)
sites and an##2##3##(2008-10#1)(2013-1#1)
sites and in##2##3##(2008-10#2)
sites and that##2##3##(1995-6#1)(2008-11#1)
sites and the##6##3##(1990-12#1)(1994-2#1)(2008-10#3)(2008-9#1)
sites and were##2##3##(1991-3#1)(2008-10#1)
sites and##38##2##(1990-12#3)(1990-2#1)(1990-5#1)(1991-3#1)(1992-1#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-2#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
sites are found##2##3##(1995-11#1)(2008-8#1)
sites are located in the##2##5##(1993-8#1)(2008-10#1)
sites are of the##3##4##(1994-5#2)(1995-8#1)
sites are present in##2##4##(1994-11#1)(2008-11#1)
sites are##28##2##(1990-5#1)(1991-5#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-8#2)(1994-11#1)(1994-5#2)(1995-11#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#2)(2009-6#1)(2011-2#1)(2012-3#1)
sites as##2##2##(1997-2#1)(2008-5#1)
sites at the##2##3##(2008-9#1)(2013-8#1)
sites at which##2##3##(1993-6#1)(2008-5#1)
sites at##8##2##(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-8#1)
sites but##2##2##(1994-5#1)(2008-10#1)
sites by##3##2##(1995-6#1)(2008-10#2)
sites can##3##2##(1995-6#1)(2008-9#1)(2011-2#1)
sites containing wild##2##3##(2008-10#2)
sites containing##3##2##(1995-8#1)(2008-10#2)
sites covered##2##2##(2008-10#2)
sites during##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
sites for SH2##2##3##(1995-6#1)(1996-2#1)
sites for the##3##3##(1991-5#1)(1993-8#1)(2008-10#1)
sites for two##2##3##(1991-5#1)(1992-10#1)
sites for##41##2##(1990-8#3)(1990-9#1)(1991-5#4)(1991-6#2)(1992-1#1)(1992-10#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)
sites found##2##2##(1991-9#1)(2008-10#1)
sites from##4##2##(1990-8#1)(2008-10#1)(2008-7#1)(2012-6#1)
sites had##2##2##(1991-3#1)(2008-11#1)
sites have##2##2##(1994-2#1)(2008-9#1)
sites in a##2##3##(1993-12#1)(2008-11#1)
sites in significant##2##3##(2012-5#2)
sites in the genome##2##4##(1997-3#1)(2008-10#1)
sites in the##29##3##(1990-2#2)(1992-6#1)(1993-2#1)(1996-12#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-3#2)(2013-1#2)(2013-8#1)
sites in various##2##3##(1990-5#1)(2012-2#1)
sites in##83##2##(1990-2#2)(1990-5#2)(1991-5#2)(1992-6#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#31)(2008-11#8)(2008-7#3)(2008-8#2)(2008-9#3)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#3)(2011-3#2)(2012-2#2)(2012-3#1)(2012-5#2)(2013-1#2)(2013-8#1)
sites including##3##2##(1993-6#1)(2008-12#1)(2010-4#1)
sites indicated that##2##3##(2008-10#1)(2008-8#1)
sites indicated##3##2##(2008-10#2)(2008-8#1)
sites is##9##2##(1992-12#1)(1993-3#1)(1993-8#1)(1995-8#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-3#1)(2013-1#1)
sites may##2##2##(1990-12#1)(2011-2#1)
sites of DNA##2##3##(2012-3#1)(2013-1#1)
sites of action##2##3##(1994-5#1)(2008-11#1)
sites of both##2##3##(1993-8#1)(2008-10#1)
sites of disease##2##3##(2008-11#1)(2012-2#1)
sites of high affinity##2##4##(1992-6#1)(1995-12#1)
sites of human##2##3##(1993-8#1)(2008-11#1)
sites of infection##2##3##(2008-10#1)(2013-1#1)
sites of potential pathogen##2##4##(2008-10#2)
sites of potential##5##3##(2008-10#5)
sites of tau##2##3##(1995-12#2)
sites of the##15##3##(1994-11#1)(1994-5#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-6#1)(2009-9#2)(2011-1#1)
sites of thrombosis##2##3##(2008-7#2)
sites of vascular injury##2##4##(1992-12#1)(1994-5#1)
sites of##102##2##(1990-11#1)(1990-5#2)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#4)(1994-8#1)(1995-12#3)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#4)(1997-7#1)(1997-8#2)(1997-9#1)(2008-10#26)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2009-6#2)(2009-7#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
sites on the##10##3##(1991-3#1)(1994-5#1)(1995-11#2)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)
sites on##18##2##(1990-5#1)(1990-7#1)(1991-3#1)(1992-4#1)(1994-5#1)(1995-11#2)(1996-12#1)(1996-8#1)(1997-2#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-5#1)(2010-8#1)
sites per##5##2##(1992-3#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-4#1)
sites represented##3##2##(1994-2#2)(2008-10#1)
sites revealed##2##2##(2008-7#1)(2008-8#1)
sites such as##2##3##(1994-11#1)(2011-2#1)
sites that are##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
sites that##7##2##(1993-8#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-8#1)
sites throughout##4##2##(1994-9#1)(1996-12#1)(2008-10#2)
sites to##7##2##(1995-12#1)(1995-2#1)(1997-9#1)(2008-10#1)(2008-4#1)(2009-5#1)(2013-1#1)
sites using the##2##3##(2008-4#1)(2008-9#1)
sites using##4##2##(1996-2#1)(2008-4#2)(2008-9#1)
sites was##8##2##(1992-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#1)(2011-1#2)(2012-12#1)
sites were analyzed##2##3##(1993-12#1)(2008-10#1)
sites were detected##2##3##(1993-3#1)(1994-2#1)
sites were identified##2##3##(2008-11#2)
sites were not##2##3##(1995-6#1)(1997-6#1)
sites were predominant##2##3##(1994-2#2)
sites were##31##2##(1990-8#1)(1991-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#5)(1994-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-6#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#2)(2008-9#1)(2013-1#1)
sites when##2##2##(2008-10#2)
sites where disease pressure was##2##5##(2008-10#2)
sites where##10##2##(1992-12#1)(1997-3#1)(2008-10#5)(2008-11#1)(2009-10#1)(2011-1#1)
sites which##3##2##(1991-9#1)(1996-2#1)(2012-2#1)
sites with different##2##3##(2008-10#1)(2008-8#1)
sites with high##2##3##(1993-1#1)(2008-10#1)
sites with##17##2##(1990-8#1)(1993-1#1)(1993-8#1)(1995-11#1)(1995-8#2)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
sites within an##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
sites within the##4##3##(2007-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
sites within##13##2##(1994-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
sites##838##1##(1990-11#3)(1990-12#4)(1990-2#4)(1990-5#8)(1990-6#1)(1990-7#2)(1990-8#11)(1990-9#2)(1991-12#5)(1991-3#5)(1991-5#7)(1991-6#5)(1991-7#2)(1991-9#2)(1992-1#2)(1992-10#2)(1992-12#7)(1992-2#4)(1992-3#5)(1992-4#4)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#3)(1993-12#8)(1993-2#7)(1993-3#3)(1993-6#12)(1993-8#14)(1993-9#3)(1994-1#1)(1994-11#13)(1994-12#2)(1994-2#14)(1994-3#3)(1994-5#11)(1994-8#4)(1994-9#1)(1995-11#8)(1995-12#9)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#19)(1995-8#8)(1996-1#2)(1996-12#6)(1996-2#17)(1996-3#4)(1996-6#1)(1996-8#5)(1997-2#6)(1997-3#5)(1997-6#10)(1997-7#6)(1997-8#3)(1997-9#3)(2007-12#2)(2008-1#1)(2008-10#236)(2008-11#46)(2008-12#5)(2008-2#1)(2008-4#10)(2008-5#16)(2008-6#1)(2008-7#17)(2008-8#31)(2008-9#20)(2009-10#5)(2009-11#2)(2009-3#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#4)(2010-12#1)(2010-3#1)(2010-4#4)(2010-5#5)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#19)(2011-3#3)(2012-12#7)(2012-2#21)(2012-3#11)(2012-5#2)(2012-6#1)(2013-1#20)(2013-7#2)(2013-8#7)
sites) was##2##2##(1991-5#1)(2010-11#1)
sites)##4##1##(1991-5#1)(1992-4#1)(2008-8#1)(2010-11#1)
sites/cell##2##1##(1994-8#1)(1995-8#1)
sitting and##2##2##(2010-3#1)(2013-1#1)
sitting in##2##2##(2008-10#1)(2008-8#1)
sitting on##2##2##(2008-10#1)(2008-11#1)
sitting position##6##2##(2010-9#1)(2011-2#1)(2012-3#4)
sitting positions##3##2##(2011-2#3)
sitting##26##1##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#3)(2010-9#3)(2011-2#4)(2012-3#5)(2013-1#6)
situ combustion##2##2##(2008-3#2)
situ determination of##3##3##(2008-10#2)(2008-11#1)
situ generated##2##2##(2008-10#2)
situ hybridisation##5##2##(1995-12#1)(1996-12#2)(2008-12#2)
situ hybridization (FISH)##9##3##(1993-12#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-8#1)
situ hybridization analysis##3##3##(1991-5#1)(1996-12#1)(2008-9#1)
situ hybridization and##7##3##(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#1)(2008-11#1)
situ hybridization of the##2##4##(1995-11#1)(1996-12#1)
situ hybridization of##5##3##(1995-11#1)(1996-12#3)(2008-10#1)
situ hybridization studies##3##3##(1996-12#1)(2008-4#1)(2009-8#1)
situ hybridization technique##2##3##(2008-11#1)(2008-8#1)
situ hybridization to##2##3##(1997-7#1)(2008-4#1)
situ hybridization using##2##3##(1991-5#1)(2008-10#1)
situ hybridization##97##2##(1991-5#3)(1992-12#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#19)(1996-2#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#2)(1997-8#2)(2008-10#5)(2008-11#4)(2008-4#7)(2008-5#1)(2008-6#2)(2008-8#7)(2008-9#13)(2009-1#1)(2009-7#1)(2009-8#3)(2010-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
situ hybridization)##2##2##(2008-8#1)(2008-9#1)
situ images of##2##3##(2007-11#2)
situ measurements of##3##3##(2008-10#1)(2008-3#2)
situ nick##4##2##(2008-4#3)(2008-9#1)
situ prepared BiFE##2##3##(2008-10#2)
situ##354##1##(1990-12#1)(1990-2#2)(1990-8#1)(1991-3#2)(1991-5#3)(1991-9#1)(1992-12#2)(1992-6#2)(1993-12#4)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-6#3)(1996-12#23)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#4)(1997-3#4)(1997-7#2)(1997-8#3)(2007-11#3)(2008-10#113)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#31)(2008-4#13)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#17)(2008-9#24)(2009-1#1)(2009-12#1)(2009-7#1)(2009-8#4)(2010-1#3)(2010-10#1)(2010-6#5)(2010-7#1)(2010-8#2)(2011-2#6)(2011-3#3)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
situated at##2##2##(2007-11#1)(2008-10#1)
situated in the##9##3##(1991-3#1)(1993-8#1)(1997-2#1)(1997-9#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)
situated in##11##2##(1991-3#1)(1993-8#1)(1997-2#1)(1997-9#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
situated within##2##2##(1996-8#1)(2008-12#1)
situated##27##1##(1990-3#1)(1991-3#1)(1993-8#1)(1994-2#1)(1996-8#1)(1997-2#1)(1997-9#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
situation and##8##2##(1990-11#1)(1990-12#3)(1991-3#1)(1993-1#1)(2008-10#1)(2008-5#1)
situation for##3##2##(1991-5#1)(1994-12#1)(1997-5#1)
situation in the##2##3##(1991-11#1)(1996-3#1)
situation in##13##2##(1991-11#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-6#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
situation is##7##2##(1995-11#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-8#2)
situation model##3##2##(2013-1#3)
situation of the##3##3##(1996-9#1)(2011-2#1)(2012-2#1)
situation of##12##2##(1992-3#1)(1996-2#1)(1996-9#2)(2008-1#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
situation that is##2##3##(1995-3#1)(2008-8#1)
situation that##6##2##(1995-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)
situation the##3##2##(1990-6#1)(1995-5#1)(2008-10#1)
situation when##2##2##(2008-10#1)(2008-8#1)
situation where##2##2##(2008-8#1)(2012-2#1)
situation with##2##2##(2010-10#1)(2012-2#1)
situation##147##1##(1990-11#1)(1990-12#12)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#3)(1992-1#1)(1992-2#1)(1992-3#4)(1992-5#2)(1992-8#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-9#2)(1997-4#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#15)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#7)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#3)
situational##6##1##(1997-8#1)(2008-12#2)(2009-7#2)(2013-8#1)
situations and##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2010-11#1)(2010-5#1)
situations are##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
situations as##3##2##(2009-6#1)(2013-1#2)
situations in the##2##3##(1990-9#1)(1991-1#1)
situations in which##6##3##(2008-3#1)(2008-4#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
situations in##13##2##(1990-9#1)(1991-1#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
situations of##4##2##(1990-3#1)(1993-12#1)(2012-3#2)
situations or##2##2##(1993-11#1)(2008-12#1)
situations that##2##2##(2010-11#1)(2011-2#1)
situations were##2##2##(1990-12#1)(2008-10#1)
situations where a##2##3##(2008-10#1)(2010-7#1)
situations where##9##2##(1997-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#2)(2010-7#1)
situations with##5##2##(2008-10#1)(2008-12#2)(2008-9#1)(2009-8#1)
situations##138##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-5#1)(2008-10#21)(2008-11#17)(2008-12#6)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#6)(2009-10#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-10#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#7)(2013-8#1)
situations]##2##1##(1990-12#1)(1993-2#1)
situs inversus##3##2##(2009-8#3)
sive non specificata)##2##3##(1990-12#2)
six (20%)##2##2##(2011-2#2)
six (9%)##2##2##(1994-6#1)(2008-10#1)
six Cys residues##2##3##(1991-6#1)(1993-2#1)
six active##2##2##(2008-10#1)(2008-5#1)
six additional##3##2##(1992-7#1)(2008-10#2)
six alkaloids##2##2##(2008-10#1)(2011-3#1)
six amplified fragment length polymorphism markers##2##6##(2008-10#2)
six and##4##2##(1996-12#1)(1997-1#1)(2008-10#2)
six animals##3##2##(1994-8#1)(1996-12#1)(1996-3#1)
six areas##3##2##(1991-12#1)(1993-3#1)(2008-10#1)
six cases of##3##3##(2007-8#1)(2008-7#1)(2008-9#1)
six cases##8##2##(1991-11#1)(1994-3#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
six children##3##2##(1997-3#1)(2008-11#1)(2008-9#1)
six classes##2##2##(2008-10#1)(2008-5#1)
six clinical isolates##2##3##(2008-5#2)
six clusters##2##2##(1991-5#1)(2008-5#1)
six critical points of intervention##2##5##(1997-2#2)
six cultivars##2##2##(2008-10#2)
six days after##2##3##(1996-5#1)(2012-3#1)
six days of##2##3##(1993-2#1)(2008-11#1)
six days##4##2##(1993-2#1)(1996-5#1)(2008-11#1)(2012-3#1)
six different commercial##2##3##(2008-10#2)
six different##14##2##(1995-3#1)(2008-10#8)(2008-5#2)(2008-7#2)(2013-8#1)
six dimensions of##2##3##(1992-3#1)(2010-3#1)
six dimensions##4##2##(1991-3#2)(1992-3#1)(2010-3#1)
six donors##2##2##(2008-11#1)(2012-2#1)
six genes##2##2##(1996-6#1)(2012-3#1)
six genotypes##2##2##(2008-10#2)
six had##2##2##(1995-12#1)(2011-2#1)
six hours##2##2##(1991-11#1)(1991-6#1)
six in##2##2##(2008-10#2)
six indigenous communities residing in the city of Cali##2##9##(2012-12#2)
six indigenous communities residing in##3##5##(2012-12#3)
six isolates##5##2##(2008-10#4)(2008-5#1)
six key##4##2##(1993-12#1)(1994-2#1)(2010-4#1)(2012-2#1)
six known##2##2##(2008-10#1)(2008-4#1)
six major##2##2##(2008-10#1)(2008-12#1)
six media##4##2##(2008-12#4)
six methods##2##2##(2008-10#2)
six mismatched##2##2##(2010-11#2)
six month##3##2##(2008-12#1)(2008-6#1)(2012-12#1)
six months after an##2##4##(2013-1#2)
six months after embolisation##2##4##(1997-3#2)
six months after surgery##2##4##(1993-3#2)
six months after the event##2##5##(1991-3#1)(2013-8#1)
six months after the procedure##2##5##(2008-11#1)(2011-2#1)
six months after the##6##4##(1991-3#1)(2008-11#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
six months after##14##3##(1991-3#1)(1993-3#2)(1997-3#2)(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#1)(2013-1#4)(2013-8#1)
six months and##2##3##(1991-11#1)(2008-11#1)
six months in##2##3##(1993-2#1)(2008-1#1)
six months of age##3##4##(1991-11#1)(1991-6#1)(2008-10#1)
six months of treatment##2##4##(2008-5#1)(2013-1#1)
six months of##7##3##(1991-11#1)(1991-6#1)(1996-11#1)(2008-10#1)(2008-5#1)(2013-1#2)
six months##47##2##(1990-12#1)(1991-11#5)(1991-2#1)(1991-3#1)(1991-6#2)(1993-2#1)(1993-3#3)(1993-6#1)(1996-11#1)(1997-3#2)(1997-4#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#7)(2013-8#4)
six more##3##2##(1997-8#1)(2008-10#2)
six multimember VCGs##2##3##(2008-10#2)
six multimember##3##2##(2008-10#3)
six new##4##2##(1996-3#1)(1997-3#1)(2008-10#1)(2012-3#1)
six of the##6##3##(1990-12#1)(1996-9#1)(2008-10#1)(2008-11#2)(2011-2#1)
six of these##2##3##(1996-3#1)(2008-7#1)
six of##15##2##(1990-12#1)(1991-2#1)(1996-3#1)(1996-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)
six open reading frames##2##4##(1995-9#2)
six or##2##2##(1990-5#1)(2008-6#1)
six organic##2##2##(2008-10#1)(2013-8#1)
six other members of the SCMV subgroup##2##7##(2008-10#2)
six other##4##2##(1996-6#1)(2008-10#3)
six patients treated##2##3##(1991-3#1)(2008-10#1)
six patients with##2##3##(2008-7#1)(2011-2#1)
six patients##10##2##(1991-3#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-9#1)(2011-2#1)(2013-8#1)
six putative##2##2##(1997-9#1)(2008-10#1)
six pyrethroids##3##2##(2008-10#3)
six races##2##2##(2008-10#2)
six regions##2##2##(2008-10#2)
six replicate##4##2##(2008-10#4)
six replicates##3##2##(2008-10#3)
six samples##4##2##(2008-10#4)
six sections##2##2##(2012-3#2)
six series of six samples were analyzed along 5 months##2##10##(2008-10#2)
six series of##3##3##(2008-10#2)(2008-8#1)
six species##6##2##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#3)
six states##4##2##(1995-12#1)(2008-10#2)(2012-2#1)
six structural##2##2##(1994-5#1)(2008-10#1)
six students##2##2##(1997-2#1)(2008-11#1)
six successive##2##2##(2008-10#2)
six times##10##2##(1993-1#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)
six to eight copies##2##4##(2008-10#2)
six to eight##3##3##(2008-10#3)
six to##6##2##(1991-12#1)(2008-1#1)(2008-10#4)
six transmembrane##2##2##(1996-12#1)(2009-9#1)
six types of##2##3##(2008-10#1)(2011-2#1)
six variables##2##2##(1995-1#1)(2008-7#1)
six weeks and three months##2##5##(1991-11#2)
six weeks of##2##3##(1997-5#1)(2011-1#1)
six weeks##10##2##(1991-11#3)(1991-2#1)(1997-5#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-3#2)
six were##2##2##(1991-2#1)(2008-5#1)
six years##10##2##(1991-2#1)(1995-5#1)(2008-10#2)(2008-7#2)(2011-3#1)(2012-3#1)(2013-1#2)
six##568##1##(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#10)(1991-12#4)(1991-2#8)(1991-3#4)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-12#2)(1993-2#4)(1993-3#4)(1993-6#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1995-1#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#9)(1996-2#3)(1996-3#7)(1996-5#1)(1996-6#2)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#6)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#3)(1997-9#1)(2007-12#3)(2007-8#3)(2008-1#8)(2008-10#191)(2008-11#21)(2008-12#13)(2008-3#4)(2008-4#1)(2008-5#22)(2008-6#4)(2008-7#15)(2008-8#16)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#19)(2011-3#4)(2012-12#4)(2012-2#9)(2012-3#11)(2013-1#14)(2013-7#1)(2013-8#15)
six-month survival##2##2##(1994-12#2)
six-month##4##1##(1994-12#2)(1996-11#1)(1997-3#1)
six-monthly##2##1##(2008-6#1)(2008-9#1)
six-way valve##2##2##(2008-10#2)
six-year-old boy##2##2##(1997-7#1)(2008-11#1)
sixfold##7##1##(1993-9#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-8#1)
sixteen##7##1##(1991-5#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
sixteenth-century##5##1##(2008-11#4)(2012-2#1)
sixth##20##1##(1990-12#1)(1993-8#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
sixty (65%)##2##2##(1997-3#2)
sixty patients##2##2##(2011-2#2)
sixty##10##1##(1991-12#1)(1997-3#2)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
sixty-five##2##1##(2008-11#1)(2008-7#1)
sizable##3##1##(1995-2#1)(2008-10#2)
size (8##2##2##(1993-9#1)(2008-10#1)
size (diameter)##2##2##(2008-10#1)(2008-11#1)
size N##2##2##(2008-10#1)(2008-8#1)
size a##2##2##(1993-12#1)(2012-3#1)
size affected##2##2##(2008-10#1)(2009-8#1)
size analysis##3##2##(2008-10#2)(2008-12#1)
size and a##2##3##(2008-10#1)(2008-3#1)
size and charge distribution##2##4##(1997-2#1)(2008-10#1)
size and charge##4##3##(1992-8#1)(1997-2#1)(2008-10#2)
size and composition##2##3##(2009-8#2)
size and concentration of##2##4##(1995-3#1)(2008-10#1)
size and concentration##5##3##(1995-3#1)(2008-10#1)(2008-3#2)(2011-2#1)
size and density##2##3##(2008-10#1)(2008-4#1)
size and expression level##2##4##(1997-8#1)(2008-10#1)
size and initial##2##3##(2008-10#1)(2008-11#1)
size and mature height##2##4##(2008-9#2)
size and number of##6##4##(2008-10#4)(2008-7#1)(2008-8#1)
size and number##10##3##(1991-5#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#2)
size and rate##2##3##(2008-7#1)(2011-2#1)
size and sample##3##3##(2008-10#2)(2010-4#1)
size and shape of the##2##5##(2008-5#1)(2013-8#1)
size and shape of##4##4##(1995-5#1)(2008-10#1)(2008-5#1)(2013-8#1)
size and shape##9##3##(1995-5#1)(2008-10#5)(2008-5#1)(2010-7#1)(2013-8#1)
size and that##3##3##(2008-8#2)(2008-9#1)
size and the##13##3##(1996-3#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-8#1)(2011-2#2)
size and##164##2##(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#47)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#18)(2008-9#10)(2009-10#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#8)(2012-3#4)(2013-1#4)(2013-8#3)
size are##5##2##(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#2)
size as a##3##3##(2008-11#1)(2008-7#1)(2011-1#1)
size as the##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
size as##10##2##(1992-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
size asymmetric##2##2##(2008-8#2)
size asymmetry of competition##3##4##(2008-8#3)
size asymmetry##5##2##(2008-8#5)
size at maturity##5##3##(2008-9#5)
size at##11##2##(2008-1#1)(2008-3#1)(2008-8#3)(2008-9#6)
size based##3##2##(1995-9#1)(2008-10#2)
size below which##2##3##(2008-10#2)
size below##4##2##(2008-10#2)(2008-8#2)
size between##2##2##(1993-9#1)(2011-1#1)
size bias in##2##3##(2008-8#2)
size bias##4##2##(2008-8#4)
size but##4##2##(1993-12#1)(2008-10#1)(2012-3#1)(2013-7#1)
size by##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
size can##2##2##(2008-10#1)(2008-8#1)
size classes##5##2##(1996-12#2)(2008-10#3)
size could##2##2##(1995-3#1)(2008-10#1)
size dependent##2##2##(1991-2#1)(1997-1#1)
size determination##3##2##(1995-9#1)(2008-10#1)(2008-3#1)
size differences##2##2##(2007-12#1)(2008-8#1)
size distribution is##3##3##(2008-3#1)(2008-7#1)(2008-9#1)
size distribution of the##2##4##(1992-2#1)(2008-10#1)
size distribution of##6##3##(1991-12#1)(1992-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)
size distribution##44##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#10)(2008-11#1)(2008-3#9)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-11#2)(2009-5#1)(2011-2#1)(2013-1#1)
size distributions are##2##3##(1994-12#1)(2008-10#1)
size distributions of##3##3##(1992-3#1)(1997-2#1)(2008-3#1)
size distributions##16##2##(1992-3#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-3#9)(2008-9#3)
size due to##2##3##(2008-10#1)(2008-11#1)
size during the##3##3##(2008-7#1)(2008-8#1)(2010-8#1)
size during##4##2##(1995-9#1)(2008-7#1)(2008-8#1)(2010-8#1)
size effect##2##2##(2008-10#1)(2010-7#1)
size effects##4##2##(1993-5#1)(2008-8#3)
size estimate of##2##3##(1990-8#1)(2010-4#1)
size estimate##3##2##(1990-8#1)(1994-9#1)(2010-4#1)
size evolution##3##2##(2012-3#3)
size exclusion chromatography (SEC) with##2##5##(2008-10#2)
size exclusion chromatography (SEC)##3##4##(2008-10#3)
size exclusion chromatography##7##3##(2008-10#6)(2011-2#1)
size exclusion##9##2##(2008-10#8)(2011-2#1)
size for a##2##3##(1995-9#1)(2008-8#1)
size for the##2##3##(1996-3#1)(2009-11#1)
size for##10##2##(1994-9#1)(1995-9#1)(1996-3#1)(2008-10#4)(2008-8#1)(2009-11#1)(2013-1#1)
size formulae##3##2##(2012-3#3)
size fractionation of##4##3##(2008-10#4)
size fractionation##5##2##(2008-10#5)
size from 4##2##3##(1991-5#1)(2008-10#1)
size from##8##2##(1990-12#1)(1991-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#2)
size had##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
size have been##2##3##(2008-10#1)(2009-5#1)
size in the##2##3##(2008-10#2)
size in##26##2##(1991-11#1)(1991-5#2)(1992-3#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-7#2)(2008-8#6)(2008-9#4)(2009-5#1)(2011-1#1)(2012-3#3)
size increase##4##2##(1995-9#2)(2008-8#1)(2008-9#1)
size increased##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
size increases##2##2##(2008-10#2)
size is determined##2##3##(2008-10#1)(2008-8#1)
size is more closely related to host size##2##8##(2008-9#2)
size is the##3##3##(2008-10#1)(2008-11#2)
size is##29##2##(2008-10#4)(2008-11#3)(2008-3#1)(2008-8#11)(2008-9#4)(2009-8#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
size may be##2##3##(2008-7#1)(2008-8#1)
size may##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
size measurements##2##2##(2008-10#1)(2011-2#1)
size of 1##3##3##(1990-6#1)(2008-8#1)(2009-2#1)
size of 20##2##3##(1993-12#1)(2008-5#1)
size of 3##2##3##(2008-5#1)(2011-1#1)
size of P##3##3##(2008-10#3)
size of a##8##3##(1994-11#1)(1994-3#2)(2007-12#1)(2008-3#1)(2008-8#2)(2013-1#1)
size of about##2##3##(2008-5#1)(2008-8#1)
size of approximately##2##3##(1993-6#1)(2008-9#1)
size of both##2##3##(1996-5#1)(2008-9#1)
size of cells##2##3##(2008-10#1)(2008-11#1)
size of detectable populations of##2##5##(2008-10#2)
size of detectable populations##3##4##(2008-10#3)
size of more than##2##4##(2008-7#1)(2008-8#1)
size of pancreas##2##3##(2012-3#2)
size of the inoculum##2##4##(1991-11#1)(2008-5#1)
size of the referred pain area##2##6##(2010-9#2)
size of the##105##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-11#4)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#3)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
size of this##2##3##(1991-2#1)(2010-4#1)
size of##221##2##(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-11#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#6)(1997-6#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#63)(2008-11#6)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#9)(2008-8#13)(2008-9#6)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#5)(2010-9#3)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#3)
size on the##2##3##(2008-8#1)(2009-2#1)
size on##11##2##(2008-10#4)(2008-3#1)(2008-8#2)(2008-9#3)(2009-2#1)
size or##9##2##(1995-1#1)(2008-10#4)(2008-8#4)
size parameter of##2##3##(2008-3#2)
size parameter##4##2##(2008-3#4)
size parameters##9##2##(2008-2#1)(2008-3#8)
size phenotype##2##2##(2008-3#2)
size polymorphism##2##2##(1993-2#1)(2008-10#1)
size range of##6##3##(1995-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
size range##11##2##(1994-11#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)
size ranges##2##2##(1997-2#1)(2008-10#1)
size ratio##2##2##(2008-9#1)(2011-2#1)
size reduction##4##2##(2008-10#1)(2008-7#2)(2012-3#1)
size smaller than##3##3##(2008-10#2)(2008-5#1)
size standards##2##2##(2008-4#2)
size structuring##2##2##(2008-8#2)
size that##6##2##(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-6#1)
size through##2##2##(2007-12#1)(2008-8#1)
size to be##2##3##(1997-2#1)(2008-8#1)
size to the##2##3##(1992-10#1)(2008-10#1)
size to##14##2##(1992-10#1)(1993-12#1)(1997-2#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
size variants##2##2##(1995-11#2)
size variation and##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
size variation in##2##3##(2008-8#2)
size variation within##2##3##(2008-8#2)
size variation##12##2##(2008-10#1)(2008-7#1)(2008-8#8)(2009-5#1)(2010-5#1)
size was calculated##3##3##(2008-10#2)(2008-11#1)
size was not##3##3##(1992-2#1)(1993-8#1)(2008-10#1)
size was significantly##2##3##(1993-11#1)(2008-10#1)
size was##28##2##(1991-1#1)(1992-2#1)(1993-11#1)(1993-8#1)(2008-10#14)(2008-11#2)(2008-7#1)(2008-8#3)(2009-2#1)(2010-12#2)(2012-2#1)
size were##7##2##(2008-10#5)(2009-10#1)(2012-3#1)
size when##6##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)
size while##2##2##(2008-10#1)(2008-9#1)
size will##4##2##(1996-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
size with##7##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-5#1)
size ≥50 mm##2##2##(2011-2#2)
size##1282##1##(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#9)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#10)(1992-5#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#6)(1993-2#6)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#5)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#6)(1995-1#2)(1995-11#6)(1995-12#1)(1995-2#4)(1995-3#9)(1995-5#4)(1995-6#1)(1995-8#5)(1995-9#9)(1996-1#4)(1996-12#11)(1996-2#9)(1996-3#12)(1996-5#1)(1996-6#4)(1996-8#1)(1997-1#6)(1997-2#17)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#6)(1997-9#1)(2006-6#1)(2007-12#13)(2008-1#5)(2008-10#343)(2008-11#43)(2008-12#9)(2008-2#7)(2008-3#65)(2008-4#11)(2008-5#30)(2008-6#4)(2008-7#56)(2008-8#151)(2008-9#82)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#6)(2009-2#3)(2009-5#7)(2009-6#1)(2009-7#1)(2009-8#10)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#6)(2010-8#19)(2010-9#6)(2011-1#10)(2011-2#39)(2012-12#3)(2012-2#14)(2012-3#30)(2012-5#4)(2012-9#2)(2013-1#23)(2013-7#3)(2013-8#13)
size) and##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
size) in##2##2##(1996-6#1)(2008-11#1)
size)##15##1##(1993-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-8#4)(2008-9#1)(2011-2#1)(2012-12#2)
size-abundance relationships among##3##3##(2008-9#3)
size-asymmetric##3##1##(2008-8#3)
size-dependent##5##1##(2008-10#2)(2008-8#2)(2010-8#1)
size-exclusion and##2##2##(1991-9#1)(2008-10#1)
size-exclusion chromatography (SEC)##2##3##(2008-10#1)(2008-8#1)
size-exclusion chromatography##7##2##(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
size-exclusion##10##1##(1991-9#1)(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)
size-fractionated by##2##2##(1994-8#1)(1995-8#1)
size-fractionated##5##1##(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#2)
size-related##3##1##(1996-12#1)(2010-8#2)
size/BMR##2##1##(2008-8#2)
sizeable##3##1##(1995-11#1)(1996-3#1)(2010-12#1)
sized particles##2##2##(2008-10#2)
sized##19##1##(1992-3#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
sizer##3##1##(1993-2#2)(2008-3#1)
sizes and##22##2##(1995-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
sizes are##5##2##(1994-5#1)(1997-8#1)(2008-8#1)(2010-10#1)(2012-3#1)
sizes as##2##2##(2008-8#2)
sizes can be##2##3##(1995-5#1)(2009-5#1)
sizes for##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
sizes in the##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
sizes in this##2##3##(2008-10#1)(2008-9#1)
sizes in##16##2##(1992-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
sizes is##2##2##(1993-9#1)(2008-12#1)
sizes of 0##2##3##(2008-10#1)(2008-6#1)
sizes of Eh252##2##3##(2008-10#2)
sizes of the##12##3##(2008-10#8)(2008-7#1)(2009-11#1)(2010-7#1)(2013-8#1)
sizes of these##2##3##(2008-10#2)
sizes of##38##2##(1997-2#2)(2007-12#1)(2008-10#26)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-11#1)(2010-7#1)(2010-8#1)(2013-8#1)
sizes or##2##2##(2008-3#1)(2008-8#1)
sizes ranged from##2##3##(2008-10#1)(2011-1#1)
sizes ranging from##2##3##(2008-10#1)(2013-1#1)
sizes tested##5##2##(2008-10#5)
sizes that##2##2##(2008-10#1)(2011-2#1)
sizes up to##4##3##(1997-2#1)(2008-10#2)(2008-7#1)
sizes were##11##2##(1995-8#1)(2008-10#4)(2008-6#1)(2008-7#2)(2010-6#1)(2011-2#2)
sizes##201##1##(1991-12#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#2)(1996-6#1)(1997-2#5)(1997-3#2)(1997-6#2)(1997-8#1)(2007-12#5)(2008-10#79)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#21)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#6)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
sizes)##2##1##(2008-10#1)(2013-8#1)
sizing systems##2##2##(1992-3#2)
sizing##13##1##(1992-3#3)(1995-3#2)(1996-6#1)(2008-2#1)(2008-3#5)(2011-2#1)
skate Leucoraja##2##2##(2010-8#2)
skate##8##1##(2008-11#1)(2010-8#7)
skeletal abnormalities##2##2##(2011-1#1)(2012-2#1)
skeletal and cardiac muscle development##2##5##(2010-7#2)
skeletal and cardiac muscle##3##4##(2010-7#2)(2012-3#1)
skeletal and##7##2##(1990-2#1)(1991-2#1)(2010-7#2)(2012-3#2)(2013-1#1)
skeletal anomalies were##2##3##(1993-12#2)
skeletal anomalies##3##2##(1993-12#3)
skeletal bones##2##2##(2008-12#1)(2011-1#1)
skeletal defects##3##2##(2009-7#1)(2010-6#2)
skeletal development and##2##3##(2008-11#1)(2012-2#1)
skeletal development##3##2##(2008-11#2)(2012-2#1)
skeletal disease##2##2##(2011-1#1)(2012-2#1)
skeletal dysplasia was##2##3##(2011-1#2)
skeletal dysplasia##7##2##(2008-11#1)(2011-1#6)
skeletal muscle and testis##2##4##(1994-11#1)(1997-8#1)
skeletal muscle and##4##3##(1990-2#1)(1994-11#1)(1996-12#1)(1997-8#1)
skeletal muscle by##2##3##(1992-6#1)(2008-4#1)
skeletal muscle cells##4##3##(2008-11#2)(2008-9#2)
skeletal muscle differentiation##2##3##(1994-11#1)(2013-1#1)
skeletal muscle during##2##3##(1991-2#2)
skeletal muscle fibers##2##3##(2009-8#1)(2010-1#1)
skeletal muscle insulin resistance in##2##5##(2008-1#1)(2008-3#1)
skeletal muscle is##4##3##(1990-8#1)(1991-9#1)(2008-1#2)
skeletal muscle nebulin##2##3##(2008-6#2)
skeletal muscle sodium channel gene##3##5##(1991-12#1)(1992-3#2)
skeletal muscle##80##2##(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#3)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#6)(2008-10#1)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#4)(2008-8#4)(2008-9#7)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
skeletal muscle-specific##4##2##(1993-12#1)(1995-2#2)(2008-8#1)
skeletal muscles of##2##3##(1995-8#1)(2008-11#1)
skeletal muscles##11##2##(1990-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#3)(1995-8#2)(2008-11#1)(2011-2#1)
skeletal survey##3##2##(2011-1#3)
skeletal system##2##2##(2007-8#2)
skeletal##159##1##(1990-11#2)(1990-2#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-9#3)(1992-3#2)(1992-6#2)(1992-9#1)(1993-12#8)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#5)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#6)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-8#4)(2008-1#7)(2008-10#2)(2008-11#11)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#4)(2008-8#5)(2008-9#8)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#4)(2010-7#2)(2011-1#14)(2011-2#4)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#2)
skeleton and##3##2##(1991-11#1)(2012-2#2)
skeleton##28##1##(1991-11#1)(1992-4#1)(1996-5#3)(2008-10#2)(2008-11#1)(2008-8#6)(2009-7#1)(2010-6#4)(2011-2#4)(2012-2#2)(2012-3#3)
skeletons##2##1##(2008-10#1)(2009-3#1)
skepticism##6##1##(1991-12#1)(1995-2#1)(2009-1#1)(2009-10#1)(2011-2#2)
sketch##2##1##(2008-11#1)(2010-10#1)
skew foot deformity in a patient with##2##7##(2012-3#2)
skew foot deformity##3##3##(2012-3#3)
skew in##5##2##(2008-8#3)(2008-9#2)
skew models##4##2##(2008-8#3)(2008-9#1)
skew or##2##2##(2008-8#1)(2008-9#1)
skew was associated with##2##4##(2008-9#2)
skew##31##1##(2008-10#1)(2008-8#20)(2008-9#7)(2012-3#3)
skewed toward##3##2##(2008-10#3)
skewed##9##1##(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
skewing##3##1##(2008-3#3)
skews##2##1##(2008-8#2)
skiing##2##1##(1992-6#1)(2013-1#1)
skill acquisition##2##2##(1994-2#1)(2008-11#1)
skill and##6##2##(1990-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2010-4#1)(2011-2#1)
skill for##3##2##(2008-11#2)(2008-12#1)
skill in##2##2##(2008-11#2)
skill level##2##2##(1996-12#1)(2009-2#1)
skill mix##3##2##(1995-2#1)(1997-2#2)
skill of##5##2##(2008-11#4)(2010-4#1)
skill set##4##2##(2007-12#4)
skill that##4##2##(2008-11#1)(2008-12#2)(2013-1#1)
skill##63##1##(1990-12#2)(1990-3#1)(1991-3#2)(1992-2#1)(1994-12#1)(1994-2#2)(1995-2#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(2007-12#6)(2008-10#4)(2008-11#16)(2008-12#5)(2008-7#1)(2008-8#2)(2009-2#1)(2010-1#1)(2010-4#2)(2010-8#1)(2011-2#5)(2013-1#3)
skilled and##5##2##(1995-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
skilled nursing facilities##3##3##(1991-2#1)(1992-2#1)(2012-3#1)
skilled nursing facility (SNF)##3##4##(1994-12#1)(1994-2#1)(1995-3#1)
skilled nursing facility##7##3##(1991-1#2)(1994-12#1)(1994-2#2)(1995-3#2)
skilled nursing##12##2##(1991-1#2)(1991-2#1)(1992-2#1)(1994-12#2)(1994-2#3)(1995-3#2)(2012-3#1)
skilled##26##1##(1991-1#2)(1991-2#1)(1992-2#1)(1994-12#2)(1994-2#3)(1995-3#2)(1995-5#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-1#1)(2012-2#1)(2012-3#1)
skillful##3##1##(1991-2#1)(1994-6#1)(1997-1#1)
skills acquisition##3##2##(2008-11#2)(2011-2#1)
skills and abilities##2##3##(1993-1#1)(2008-12#1)
skills and attitudes##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
skills and confidence##2##3##(2008-11#1)(2008-12#1)
skills and knowledge of##2##4##(2008-10#1)(2011-2#1)
skills and knowledge##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
skills and the##3##3##(1992-3#1)(2008-11#1)(2011-2#1)
skills and##42##2##(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(2008-10#1)(2008-11#13)(2008-12#6)(2008-7#1)(2009-10#1)(2011-2#4)(2012-2#2)(2013-8#1)
skills are##7##2##(1993-12#1)(1996-1#1)(2008-11#2)(2008-12#1)(2010-5#1)(2012-3#1)
skills as a##2##3##(2008-11#1)(2009-10#1)
skills as##5##2##(1992-12#1)(2008-11#3)(2009-10#1)
skills at##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
skills by##3##2##(2008-11#2)(2008-12#1)
skills course##2##2##(2008-11#1)(2013-1#1)
skills for people who will##2##5##(1994-1#2)
skills for##9##2##(1990-12#1)(1992-12#1)(1994-1#2)(1997-3#1)(2008-12#4)
skills have##2##2##(1997-3#1)(2012-2#1)
skills in standard and non-standard entry diploma students##2##8##(2008-11#2)
skills in the##4##3##(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)
skills in##29##2##(1993-12#2)(1995-1#2)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#11)(2008-12#5)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
skills into##2##2##(2008-11#1)(2008-12#1)
skills may##2##2##(2008-11#1)(2011-2#1)
skills needed for##3##3##(1993-12#1)(2008-12#1)(2012-3#1)
skills needed##4##2##(1993-12#1)(2008-12#1)(2012-12#1)(2012-3#1)
skills of##18##2##(1992-3#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-11#5)(2008-12#1)(2008-9#5)(2011-2#3)
skills required for##2##3##(1991-1#1)(2008-11#1)
skills that##3##2##(2007-12#1)(2008-11#2)
skills to a##2##3##(2008-11#2)
skills to##12##2##(1990-11#1)(1994-1#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#5)(2008-4#1)
skills training to##2##3##(2008-11#1)(2013-1#1)
skills training##4##2##(1996-2#1)(2008-11#1)(2013-1#2)
skills was##3##2##(1994-3#1)(2009-10#1)(2012-2#1)
skills were##5##2##(2008-11#1)(2008-12#3)(2008-9#1)
skills##278##1##(1990-11#1)(1990-12#1)(1991-1#2)(1991-12#1)(1992-1#1)(1992-12#3)(1992-2#3)(1992-3#4)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#5)(1995-1#3)(1996-1#3)(1996-2#1)(1996-3#8)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(2007-12#10)(2008-10#4)(2008-11#80)(2008-12#43)(2008-4#1)(2008-7#2)(2008-9#15)(2009-10#4)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#13)(2012-12#2)(2012-2#11)(2012-3#4)(2013-1#9)(2013-8#3)
skills-based##4##1##(2008-11#1)(2008-6#2)(2012-2#1)
skills?##3##1##(1992-2#1)(2008-11#1)(2009-11#1)
skim milk##2##2##(2008-10#1)(2013-1#1)
skim##3##1##(2008-10#1)(2013-1#2)
skimmed##2##1##(2008-10#1)(2008-11#1)
skimmer interface and ion attachment mass spectrometry##2##7##(2008-10#2)
skimmer interface and##3##3##(2008-10#3)
skimmer interface##6##2##(2008-10#6)
skimmer##8##1##(2008-10#8)
skimping##2##1##(1993-1#2)
skin -##3##2##(2008-5#1)(2012-3#2)
skin against##2##2##(2008-5#2)
skin ageing##6##2##(2008-5#6)
skin aging##5##2##(2008-5#1)(2009-9#2)(2011-2#2)
skin and a##2##3##(2008-5#2)
skin and hair##2##3##(2008-5#1)(2008-9#1)
skin and measuring##2##3##(2008-5#2)
skin and the##9##3##(1991-8#1)(2008-10#1)(2008-5#5)(2011-3#2)
skin and##45##2##(1991-11#1)(1991-8#1)(1992-6#3)(1993-3#1)(1997-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#24)(2008-6#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)
skin are##5##2##(2007-11#1)(2008-11#1)(2008-5#3)
skin as a##2##3##(1993-3#1)(2008-5#1)
skin as well as##2##4##(2008-10#1)(2012-2#1)
skin as##4##2##(1993-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
skin barrier function##3##3##(2008-5#3)
skin barrier##9##2##(2008-5#9)
skin biopsy##3##2##(2007-9#1)(2010-6#1)(2011-2#1)
skin blood##2##2##(1992-3#1)(2008-5#1)
skin but##3##2##(1991-6#1)(1992-6#1)(2008-5#1)
skin by##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
skin can##3##2##(1995-11#1)(2008-5#1)(2008-9#1)
skin cancer and##2##3##(1994-5#1)(2012-3#1)
skin cancer##16##2##(1991-6#3)(1994-5#1)(2008-4#2)(2008-8#1)(2010-6#1)(2011-2#4)(2012-3#4)
skin cancers##6##2##(2011-2#2)(2011-3#1)(2012-3#3)
skin care formulation##2##3##(2008-5#2)
skin care##5##2##(2008-5#5)
skin cells##3##2##(2012-3#3)
skin changes##2##2##(2010-6#1)(2011-2#1)
skin characteristics##2##2##(2008-5#2)
skin chronic##2##2##(2012-3#2)
skin coloration##3##2##(2008-5#1)(2008-6#2)
skin colour##3##2##(1991-6#1)(2008-5#2)
skin compatibility of##3##3##(2008-10#1)(2008-5#2)
skin compatibility##6##2##(2008-10#2)(2008-5#4)
skin condition##4##2##(2008-5#3)(2011-2#1)
skin conductance level##2##3##(2008-7#2)
skin damage##5##2##(1995-11#1)(2008-5#2)(2009-9#1)(2011-2#1)
skin delivery##2##2##(2008-5#1)(2012-2#1)
skin disease##4##2##(1995-1#1)(1997-8#1)(2008-6#1)(2013-8#1)
skin diseases##3##2##(1991-6#1)(2011-1#1)(2011-2#1)
skin disorders in##2##3##(2011-2#2)
skin disorders##7##2##(2008-11#1)(2008-12#1)(2008-5#2)(2011-2#3)
skin effects##4##2##(2008-10#1)(2008-5#3)
skin elasticity##4##2##(2008-5#4)
skin equivalent model##6##3##(2008-5#6)
skin equivalent##8##2##(2008-5#8)
skin equivalents##3##2##(2008-5#3)
skin eruption##2##2##(2008-8#1)(2012-3#1)
skin erythemal response##2##3##(2008-5#2)
skin exposure to##2##3##(2008-5#2)
skin fibroblast and##2##3##(1995-3#1)(2012-3#1)
skin fibroblast cells##2##3##(2008-11#1)(2008-9#1)
skin fibroblast##5##2##(1995-3#1)(2008-11#1)(2008-9#2)(2012-3#1)
skin fibroblasts and the##2##4##(2008-5#2)
skin fibroblasts and##6##3##(1991-12#1)(1995-3#1)(2008-5#3)(2008-8#1)
skin fibroblasts from##2##3##(1993-3#1)(1995-8#1)
skin fibroblasts##24##2##(1991-12#2)(1992-8#1)(1993-3#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-5#13)(2008-7#1)(2008-8#3)
skin fold thickness (r = -0##2##6##(2012-2#2)
skin fold thickness##3##3##(2012-2#3)
skin for##3##2##(2008-5#3)
skin from the##2##3##(2008-10#1)(2008-5#1)
skin from##5##2##(2008-10#1)(2008-5#3)(2011-2#1)
skin graft##6##2##(2008-9#3)(2009-1#1)(2009-6#1)(2013-8#1)
skin grafting##3##2##(2008-9#1)(2013-8#2)
skin grafts##2##2##(2009-1#1)(2012-2#1)
skin has been##2##3##(2008-5#2)
skin has##3##2##(2008-5#3)
skin have##2##2##(2008-5#2)
skin hydration##6##2##(2008-10#1)(2008-5#5)
skin impedance at##2##3##(2008-10#2)
skin impedance##6##2##(2008-10#6)
skin improvement##5##2##(2008-5#5)
skin in##11##2##(1995-11#1)(1996-12#1)(2008-10#1)(2008-5#7)(2011-3#1)
skin incision##2##2##(1991-12#1)(2008-10#1)
skin infection##7##2##(1997-3#1)(2008-12#3)(2008-5#1)(2008-9#2)
skin infections##3##2##(1991-6#1)(2008-5#1)(2011-2#1)
skin inflammation##2##2##(2008-10#1)(2008-5#1)
skin irritation##7##2##(2008-10#2)(2008-5#5)
skin is##15##2##(1994-5#1)(2008-5#9)(2008-9#1)(2011-2#3)(2013-8#1)
skin layers##8##2##(2008-10#1)(2008-11#5)(2008-5#2)
skin lesion##3##2##(2008-9#1)(2011-2#2)
skin lesions are##2##3##(1997-8#1)(2012-3#1)
skin lesions in##3##3##(2011-2#2)(2012-3#1)
skin lesions##22##2##(1991-6#1)(1992-6#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-5#1)(2010-6#3)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#1)
skin loss##2##2##(2007-8#1)(2013-8#1)
skin lotion##2##2##(2008-5#2)
skin markers can be##2##4##(2013-1#2)
skin markers for##2##3##(2011-2#1)(2013-1#1)
skin markers##6##2##(2011-2#1)(2013-1#5)
skin melanoma in##3##3##(1994-12#1)(1994-8#1)(2011-2#1)
skin microflora##3##2##(2012-3#3)
skin model##7##2##(2008-5#6)(2012-2#1)
skin moisture and##2##3##(2008-5#2)
skin moisturisation##4##2##(2008-5#4)
skin moisturization##3##2##(2008-5#3)
skin necrosis and sloughing##3##4##(1991-8#3)
skin necrosis##4##2##(1991-8#3)(2009-1#1)
skin of an operator##2##4##(2008-5#2)
skin of the##9##3##(1990-6#1)(1994-5#1)(2008-12#1)(2008-5#4)(2008-7#1)(2011-2#1)
skin of##24##2##(1990-6#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)(2008-10#2)(2008-12#1)(2008-5#8)(2008-7#1)(2008-9#2)(2011-2#1)(2011-3#1)(2013-1#1)
skin on the##2##3##(1995-11#1)(2008-5#1)
skin or##9##2##(1992-6#1)(1993-11#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-5#3)
skin over time##2##3##(2008-10#1)(2008-5#1)
skin over##3##2##(2008-10#1)(2008-5#2)
skin penetration##4##2##(2008-5#3)(2013-1#1)
skin photoprotection##2##2##(2008-5#2)
skin photoreceptors##2##2##(1993-3#2)
skin phototype##2##2##(2008-5#2)
skin physiology##3##2##(2008-5#2)(2009-8#1)
skin pigmentation##6##2##(1997-3#1)(2008-5#3)(2008-9#2)
skin prick test (SPT)##2##4##(2008-10#1)(2012-3#1)
skin prick##4##2##(2008-10#2)(2012-12#1)(2012-3#1)
skin problems##2##2##(2008-5#1)(2009-12#1)
skin rash##4##2##(1997-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
skin reaction was##2##3##(1992-12#1)(2008-5#1)
skin reaction##5##2##(1992-12#1)(1994-1#1)(2008-5#3)
skin reactions##2##2##(2008-7#1)(2010-8#1)
skin response to##2##3##(2008-5#2)
skin response##5##2##(2008-5#3)(2012-3#2)
skin scaliness##2##2##(2008-5#2)
skin segmentation##2##2##(2008-6#2)
skin sensitivity##2##2##(2008-5#2)
skin sensitization##5##2##(1997-2#1)(2008-10#1)(2008-5#3)
skin sensitizing potency of##4##4##(2008-5#4)
skin sensitizing potency##5##3##(2008-5#5)
skin surface is##2##3##(2008-5#2)
skin surface pH and##2##4##(2008-5#2)
skin surface pH are##3##4##(2008-5#3)
skin surface pH##11##3##(2008-5#11)
skin surface##36##2##(2008-10#1)(2008-5#35)
skin temperature##2##2##(2008-5#2)
skin test##5##2##(1990-6#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-5#1)
skin tests##3##2##(1990-3#1)(1991-4#1)(2013-1#1)
skin that##2##2##(2008-5#1)(2011-2#1)
skin tissue##5##2##(1995-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
skin to##8##2##(2008-11#1)(2008-5#5)(2011-2#1)(2012-3#1)
skin tone bias##2##3##(2008-11#2)
skin tone##5##2##(2008-11#5)
skin tumor promotion##3##3##(1992-8#2)(1993-8#1)
skin tumor##4##2##(1992-8#2)(1993-3#1)(1993-8#1)
skin tumors##3##2##(1991-6#1)(1992-8#1)(2011-2#1)
skin tumour##2##2##(2008-5#2)
skin tumours##2##2##(2008-8#1)(2011-2#1)
skin type##9##2##(2008-4#1)(2008-5#7)(2011-2#1)
skin types##6##2##(2008-5#5)(2011-2#1)
skin using##6##2##(2008-5#4)(2008-6#1)(2012-2#1)
skin was analyzed##2##3##(2008-5#1)(2012-3#1)
skin was investigated##2##3##(2008-10#1)(2008-11#1)
skin was observed##2##3##(2008-5#1)(2011-3#1)
skin was##14##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#8)(2011-3#2)(2012-3#1)
skin water##2##2##(2008-3#1)(2008-5#1)
skin were##6##2##(2008-11#1)(2008-12#1)(2008-5#4)
skin whitening agents##2##3##(2008-5#2)
skin whitening##5##2##(2008-5#5)
skin with##5##2##(2008-5#3)(2008-9#1)(2012-2#1)
skin##951##1##(1990-2#1)(1990-3#2)(1990-6#3)(1991-11#2)(1991-12#4)(1991-2#1)(1991-4#1)(1991-6#15)(1991-8#6)(1992-12#1)(1992-3#3)(1992-6#11)(1992-8#6)(1993-11#1)(1993-3#9)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#4)(1994-8#1)(1995-1#3)(1995-11#7)(1995-12#1)(1995-3#6)(1995-8#1)(1996-1#1)(1996-12#3)(1996-6#2)(1997-2#3)(1997-3#9)(1997-4#1)(1997-7#2)(1997-8#6)(2007-11#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#47)(2008-11#25)(2008-12#7)(2008-3#2)(2008-4#5)(2008-5#489)(2008-6#10)(2008-7#9)(2008-8#8)(2008-9#30)(2009-1#4)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-3#3)(2010-5#2)(2010-6#11)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#64)(2011-3#10)(2012-12#1)(2012-2#16)(2012-3#40)(2013-1#12)(2013-8#12)
skin&quot##2##1##(2008-10#1)(2008-5#1)
skin)##3##1##(1993-3#1)(2008-5#1)(2008-9#1)
skin-associated##2##1##(2008-10#1)(2012-2#1)
skin-care##2##1##(2008-5#2)
skin-lightening##3##1##(2008-5#3)
skin-resident bacteria##2##2##(2008-5#2)
skinning##3##1##(1997-5#3)
skins of##2##2##(2008-10#1)(2011-3#1)
skins##4##1##(2008-10#1)(2008-7#1)(2010-8#1)(2011-3#1)
skipped##2##1##(1993-8#2)
skipping the##3##2##(1993-6#1)(1993-8#2)
skipping##7##1##(1993-6#2)(1993-8#4)(2011-2#1)
skull and##2##2##(1994-3#1)(2010-12#1)
skull base are##2##3##(2008-7#1)(2011-2#1)
skull base fracture##2##3##(2008-9#1)(2011-2#1)
skull base in##3##3##(2008-1#2)(2011-2#1)
skull base lesions##2##3##(2011-2#1)(2013-1#1)
skull base malignancies##2##3##(2011-2#2)
skull base model##3##3##(2011-2#3)
skull base surgery##9##3##(2011-2#8)(2012-3#1)
skull base tumors##2##3##(2011-2#1)(2012-3#1)
skull base##43##2##(2008-1#4)(2008-7#4)(2008-9#1)(2011-2#30)(2012-3#2)(2013-1#1)(2013-7#1)
skull fracture##5##2##(1992-6#1)(2008-11#1)(2008-12#1)(2013-1#2)
skull##70##1##(1992-6#2)(1994-2#1)(1994-3#2)(2008-1#4)(2008-11#3)(2008-12#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-12#2)(2011-1#1)(2011-2#33)(2012-12#4)(2012-3#3)(2013-1#6)(2013-7#1)
skull-base##2##1##(2008-9#1)(2011-2#1)
skulls##4##1##(1995-9#1)(2013-1#3)
sky radiance##2##2##(2008-3#2)
sky##17##1##(2007-12#3)(2008-2#5)(2008-3#9)
skyrocketing##2##1##(1996-12#1)(2010-7#1)
slab gel##2##2##(2008-4#2)
slab optical waveguide (SOWG)##3##4##(2008-10#3)
slab optical waveguide spectroscopy##2##4##(2008-10#2)
slab optical waveguide##6##3##(2008-10#6)
slab waveguide##3##2##(2007-12#3)
slab##18##1##(1995-6#4)(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#2)(2013-8#1)
slabs##4##1##(2008-10#2)(2008-3#2)
slag samples##3##2##(2008-10#3)
slag##11##1##(2008-10#11)
slalom chromatography##4##2##(2008-10#4)
slash and burn##2##3##(2010-7#2)
slash and loblolly pine##2##4##(2008-10#2)
slash and loblolly##3##3##(2008-10#3)
slash and##5##2##(2008-10#3)(2010-7#2)
slash##8##1##(2008-10#6)(2010-7#2)
slaughter##5##1##(1996-8#1)(1997-5#2)(2008-12#1)(2008-5#1)
slaughtered at##2##2##(1996-12#1)(2010-4#1)
slaughtered pigs in##2##3##(2011-2#2)
slaughtered##10##1##(1996-12#2)(1997-5#1)(2008-12#2)(2008-9#1)(2010-4#1)(2011-2#3)
slaughterhouse##4##1##(2008-12#2)(2010-4#1)(2013-1#1)
slave##2##1##(1991-3#1)(2008-3#1)
sleep EEG##5##2##(2009-8#3)(2010-8#2)
sleep and its##2##3##(2008-7#1)(2009-8#1)
sleep and##9##2##(1991-9#1)(1993-3#1)(1994-8#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-8#1)(2012-2#1)(2013-1#1)
sleep apnea (OSA) and##2##4##(2009-9#1)(2010-5#1)
sleep apnea##5##2##(2009-9#2)(2010-5#2)(2013-1#1)
sleep at##2##2##(1990-5#1)(2010-7#1)
sleep disorders in##2##3##(2008-11#1)(2013-8#1)
sleep disturbances in##2##3##(2008-7#1)(2009-9#1)
sleep disturbances##6##2##(2008-7#3)(2009-7#1)(2009-9#1)(2012-3#1)
sleep fragmentation##2##2##(2010-5#1)(2012-3#1)
sleep in the##2##3##(1994-8#1)(2008-11#1)
sleep in##3##2##(1994-8#1)(2008-11#1)(2013-1#1)
sleep onset time##2##3##(1990-5#2)
sleep onset##4##2##(1990-5#3)(2010-7#1)
sleep patterns##2##2##(2008-7#1)(2009-8#1)
sleep problems##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
sleep quality##4##2##(2009-11#1)(2009-3#3)
sleep spindles and##2##3##(2009-8#2)
sleep spindles##3##2##(2009-8#3)
sleep stage##2##2##(2009-8#2)
sleep stages##4##2##(1997-4#1)(2010-8#3)
sleep states##2##2##(2009-8#2)
sleep##119##1##(1990-5#6)(1991-1#1)(1991-9#4)(1993-3#1)(1994-8#10)(1997-3#1)(1997-4#2)(1997-8#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-7#7)(2008-9#1)(2009-11#2)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#17)(2009-9#4)(2010-5#3)(2010-6#2)(2010-7#8)(2010-8#7)(2011-10#1)(2011-2#3)(2012-2#1)(2012-3#9)(2013-1#6)(2013-8#6)
sleepiness and##3##2##(2010-7#3)
sleepiness##8##1##(2008-7#1)(2010-7#7)
sleeping sickness##4##2##(2010-1#4)
sleeping time##3##2##(1995-12#2)(2008-12#1)
sleeping##11##1##(1995-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2010-1#4)(2010-6#1)(2012-2#1)
sleeve##5##1##(1991-12#2)(2008-11#2)(2010-4#1)
slender##2##1##(2008-10#1)(2009-8#1)
slice preparation##3##2##(1996-2#1)(2008-4#1)(2008-7#1)
slice preparations##3##2##(2008-4#2)(2008-7#1)
slice thickness##2##2##(1995-5#1)(1997-8#1)
slice was##2##2##(2008-6#1)(2013-1#1)
slice##16##1##(1995-11#2)(1995-5#2)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-6#2)(2008-7#2)(2013-1#1)
sliced##2##1##(2008-11#1)(2010-1#1)
slices and##3##2##(1995-5#1)(2008-12#1)(2008-5#1)
slices by##2##2##(1993-6#1)(1994-5#1)
slices from##3##2##(1995-11#1)(1995-2#1)(2008-11#1)
slices of##3##2##(1995-12#3)
slices was##2##2##(1994-5#1)(1997-1#1)
slices were##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
slices##45##1##(1990-12#2)(1993-6#1)(1994-11#2)(1994-5#3)(1995-11#4)(1995-12#5)(1995-2#2)(1995-5#1)(1996-2#1)(1997-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-9#2)(2010-8#1)(2011-3#2)(2011-7#1)(2012-3#1)(2013-1#1)
slicing##3##1##(2008-10#1)(2012-2#2)
slide and##3##2##(2008-11#1)(2008-9#2)
slide##18##1##(1990-12#1)(1993-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#3)(2008-9#2)(2009-12#1)
slides was##2##2##(2008-10#2)
slides with##3##2##(2008-10#1)(2008-4#2)
slides##19##1##(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#5)(2008-9#2)(2009-12#1)(2011-2#1)
sliding and##2##2##(2009-7#1)(2010-11#1)
sliding##10##1##(1990-9#1)(1993-9#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-2#3)
slight and##2##2##(1990-2#1)(1996-2#1)
slight but significant##2##3##(2008-7#1)(2012-3#1)
slight decrease of the##2##4##(2008-10#1)(2008-7#1)
slight decrease##5##2##(1994-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
slight difference##2##2##(2008-10#1)(2013-8#1)
slight differences##2##2##(1991-2#1)(2008-10#1)
slight excess##2##2##(1996-3#1)(2008-10#1)
slight improvement##2##2##(2008-10#1)(2008-6#1)
slight interference##2##2##(2008-10#2)
slight or##2##2##(2008-10#1)(2008-7#1)
slight reduction##3##2##(1993-12#1)(1997-2#1)(2008-10#1)
slight##82##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#3)(1991-9#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#2)
slightly acidic##4##2##(2008-10#4)
slightly better for##2##3##(2008-10#1)(2008-11#1)
slightly better##9##2##(2008-10#6)(2008-11#1)(2011-2#1)(2013-1#1)
slightly but##3##2##(1993-6#1)(2008-10#2)
slightly decreased##4##2##(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)
slightly different from##4##3##(1996-6#1)(2008-10#2)(2008-11#1)
slightly different##9##2##(1991-8#1)(1994-11#1)(1996-6#1)(2008-10#4)(2008-11#1)(2010-7#1)
slightly elevated##3##2##(1990-9#1)(2008-10#1)(2010-3#1)
slightly from##2##2##(2008-10#2)
slightly greater than##2##3##(2008-10#1)(2008-7#1)
slightly greater##4##2##(2008-10#2)(2008-7#1)(2009-4#1)
slightly higher in the##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
slightly higher in##6##3##(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
slightly higher than the##2##4##(1993-6#1)(2008-2#1)
slightly higher than those##2##4##(1994-8#1)(2008-10#1)
slightly higher than##9##3##(1993-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-3#1)
slightly higher##29##2##(1991-12#1)(1992-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
slightly improved##4##2##(1995-9#1)(2008-11#2)(2008-3#1)
slightly in##2##2##(2008-10#2)
slightly increased in the##2##4##(2008-10#1)(2013-1#1)
slightly increased##9##2##(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-10#1)(2012-3#1)(2012-5#1)(2013-1#1)
slightly larger##2##2##(1995-3#1)(2012-3#1)
slightly less##7##2##(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
slightly lower in##2##3##(1994-2#1)(1996-12#1)
slightly lower than that##2##4##(2008-10#1)(2008-11#1)
slightly lower than##5##3##(1997-8#1)(2008-10#2)(2008-11#1)(2009-9#1)
slightly lower##13##2##(1994-2#1)(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#2)(2009-9#1)(2011-2#2)(2012-12#1)
slightly modified##2##2##(2008-11#1)(2008-7#1)
slightly more effective than##5##4##(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
slightly more##12##2##(1990-12#1)(1992-5#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-5#1)
slightly on##2##2##(2008-3#2)
slightly reduced##5##2##(1996-6#1)(2008-10#3)(2008-5#1)
slightly shifted##2##2##(2008-10#2)
slightly shorter##2##2##(1991-3#1)(2008-8#1)
slightly smaller##2##2##(1992-2#1)(2012-3#1)
slightly soluble##2##2##(2008-10#2)
slightly stimulated##2##2##(2008-11#2)
slightly the##3##2##(1996-2#1)(2008-10#2)
slightly with##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
slightly##214##1##(1990-12#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#2)(1997-2#1)(1997-5#2)(1997-7#2)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#74)(2008-11#22)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#4)(2012-5#2)(2013-1#6)(2013-8#1)
slime molds##3##2##(1993-2#1)(2008-8#2)
slime production##2##2##(1991-3#2)
slime##12##1##(1991-3#3)(1993-2#1)(1995-6#1)(2008-10#2)(2008-8#2)(2012-2#3)
slime-producing##2##1##(1991-3#2)
slip##6##1##(1990-11#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)
slipped##2##1##(2008-8#2)
slit##8##1##(2008-10#2)(2008-2#2)(2008-3#2)(2013-1#1)(2013-8#1)
slits##2##1##(1995-12#1)(2008-2#1)
slope =##2##2##(2008-10#2)
slope analysis##2##2##(2008-10#2)
slope and intercept for##2##4##(2008-10#2)
slope and intercept were 0##2##5##(2008-10#2)
slope and intercept were##3##4##(2008-10#3)
slope and intercept##7##3##(2008-10#7)
slope and##11##2##(2008-10#10)(2008-7#1)
slope area##2##2##(2010-8#2)
slope at##2##2##(1995-3#1)(2008-10#1)
slope efficiency of##9##3##(2007-12#2)(2008-2#5)(2008-3#2)
slope efficiency##15##2##(2007-12#2)(2008-2#9)(2008-3#4)
slope equal to##2##3##(2008-10#1)(2008-9#1)
slope from the##2##3##(2008-10#2)
slope in##3##2##(1990-9#1)(2008-10#1)(2008-3#1)
slope of -55##2##3##(2008-10#2)
slope of -59##2##3##(2008-10#2)
slope of 0##5##3##(2008-10#5)
slope of 19##4##3##(2008-10#4)
slope of 28##4##3##(2008-10#4)
slope of 29 mV##3##4##(2008-10#3)
slope of 29##12##3##(2008-10#12)
slope of 30##2##3##(2008-10#2)
slope of 30+/-1 mV per decade##2##6##(2008-10#2)
slope of 56##4##3##(2008-10#4)
slope of 57##2##3##(2008-10#2)
slope of the electrode##2##4##(2008-10#2)
slope of the linear portion##2##5##(2008-10#2)
slope of the survival curve##2##5##(1995-3#2)
slope of the##26##3##(1995-3#2)(1997-2#1)(2007-12#1)(2008-10#18)(2008-8#3)(2008-9#1)
slope of##115##2##(1991-2#1)(1991-5#1)(1995-3#2)(1996-2#2)(1997-2#1)(2007-12#1)(2008-10#101)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)
slope or##2##2##(1994-9#1)(2008-10#1)
slope was##5##2##(1995-8#1)(2008-10#4)
slope##203##1##(1990-9#1)(1991-2#1)(1991-5#1)(1994-9#1)(1995-3#5)(1995-8#2)(1996-2#2)(1997-2#1)(2007-12#4)(2008-10#152)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#2)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
slopes and##2##2##(2008-10#1)(2013-1#1)
slopes of the##7##3##(2008-10#6)(2012-3#1)
slopes of##18##2##(2008-10#13)(2008-8#3)(2008-9#1)(2012-3#1)
slopes were##3##2##(2008-10#3)
slopes##37##1##(2008-10#26)(2008-3#1)(2008-8#4)(2008-9#4)(2012-3#1)(2013-1#1)
sloppy##2##1##(1996-5#1)(2008-9#1)
slot of##2##2##(1996-2#1)(2007-8#1)
slot or##2##2##(1996-2#1)(2008-4#1)
slot##5##1##(1996-2#2)(2007-8#2)(2008-4#1)
slough##2##1##(2008-10#1)(2010-11#1)
sloughed##3##1##(2008-10#3)
slovaca##3##1##(1995-12#3)
slow and##8##2##(1990-7#1)(2008-10#2)(2008-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
slow down the process of##2##5##(2008-12#1)(2008-9#1)
slow down the##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)
slow down##8##2##(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
slow flow##2##2##(1996-9#1)(2013-8#1)
slow growing##3##2##(2008-10#1)(2008-9#2)
slow growth in##2##3##(1992-12#1)(1997-3#1)
slow growth##5##2##(1992-12#1)(1997-3#1)(2010-12#1)(2010-8#1)(2013-8#1)
slow in##2##2##(1996-1#1)(2008-10#1)
slow phase##3##2##(1995-12#1)(2008-11#1)(2008-5#1)
slow process##2##2##(2008-10#1)(2009-8#1)
slow rate##7##2##(1997-1#1)(2008-10#1)(2008-7#1)(2008-9#3)(2012-3#1)
slow rates##4##2##(2008-8#3)(2008-9#1)
slow reaction##2##2##(2008-10#2)
slow rusting resistance to leaf rust##2##6##(2008-10#2)
slow skeletal muscles##2##3##(1995-2#2)
slow the growth of##2##4##(1992-2#1)(2012-2#1)
slow the growth##3##3##(1992-2#2)(2012-2#1)
slow the##5##2##(1992-2#2)(1996-9#1)(2008-10#1)(2012-2#1)
slow to##5##2##(1993-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
slow wave activity##2##3##(1991-2#1)(2008-7#1)
slow wave##3##2##(1991-2#1)(1991-9#1)(2008-7#1)
slow waves##2##2##(1991-9#1)(2009-8#1)
slow##148##1##(1990-7#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#3)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#39)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#11)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#5)(2010-10#1)(2010-12#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#4)
slow-canker-growth (SCG)##2##2##(2008-10#2)
slow-growing##8##1##(1993-9#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-3#2)(2012-3#1)
slow-grown##2##1##(1996-12#2)
slow-release##2##1##(1996-12#1)(2008-11#1)
slow-rusting resistance to leaf rust in wheat##2##7##(2008-10#2)
slow-rusting resistance to leaf rust##3##5##(2008-10#3)
slow-rusting resistance##4##2##(2008-10#4)
slow-rusting##5##1##(2008-10#5)
slow-wave activity##2##2##(1992-12#1)(1994-8#1)
slow-wave##4##1##(1992-12#1)(1994-8#1)(2008-11#1)(2012-3#1)
slowed down the##2##3##(1997-2#1)(2008-11#1)
slowed down##7##2##(1991-2#1)(1997-2#1)(2008-11#2)(2010-1#1)(2012-2#2)
slowed##22##1##(1991-12#1)(1991-2#1)(1992-1#1)(1994-11#1)(1996-2#1)(1996-3#1)(1997-2#3)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#2)
slower in##6##2##(1990-11#1)(2008-10#3)(2008-11#1)(2012-3#1)
slower than the##3##3##(2008-10#1)(2008-7#1)(2010-10#1)
slower than##11##2##(1995-2#1)(1995-6#1)(2008-10#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-3#1)
slower to##3##2##(1993-6#1)(2008-10#1)(2012-3#1)
slower with##2##2##(1990-9#1)(2008-10#1)
slower##46##1##(1990-11#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-8#1)(1993-6#2)(1993-8#1)(1995-2#1)(1995-6#2)(2008-10#16)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)
slower)##2##1##(2008-10#2)
slowest##7##1##(1997-3#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
slowing down the##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
slowing down##6##2##(2008-10#1)(2008-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
slowing in##2##2##(1995-3#1)(2008-7#1)
slowing of the##2##3##(1991-11#1)(2008-11#1)
slowing of##6##2##(1991-11#2)(1993-6#1)(1994-3#1)(2008-11#1)(2008-7#1)
slowing the##5##2##(1991-12#1)(1992-2#1)(1996-11#1)(2008-10#1)(2011-2#1)
slowing##25##1##(1991-11#2)(1991-12#2)(1992-2#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#5)(2009-8#2)(2011-2#3)(2012-2#1)(2013-1#1)
slowly and##2##2##(2008-10#1)(2011-2#1)
slowly but##2##2##(2008-10#2)
slowly growing##4##2##(1997-2#1)(2008-10#1)(2011-2#2)
slowly in the##2##3##(2008-10#2)
slowly in##4##2##(2008-10#3)(2008-5#1)
slowly increased##2##2##(2008-10#2)
slowly migrating species##2##3##(1993-12#2)
slowly on##3##2##(2008-10#2)(2008-9#1)
slowly over a##2##3##(1991-2#1)(2010-8#1)
slowly over the##2##3##(1991-2#1)(2008-11#1)
slowly over##4##2##(1991-2#2)(2008-11#1)(2010-8#1)
slowly progressive CES##2##3##(2012-3#2)
slowly progressive##6##2##(1997-3#1)(1997-8#1)(2008-7#1)(2012-3#3)
slowly to##2##2##(1991-5#1)(1991-6#1)
slowly until##2##2##(2008-11#1)(2011-2#1)
slowly##72##1##(1990-6#1)(1991-2#3)(1991-5#2)(1991-6#1)(1992-3#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-8#2)(1996-2#2)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#4)(2013-1#1)
slowness##2##1##(1991-12#1)(2012-12#1)
slows##6##1##(1994-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-8#1)
sludge and##2##2##(2008-12#1)(2010-12#1)
sludge was##2##2##(2008-12#1)(2012-3#1)
sludge##40##1##(2008-10#14)(2008-11#4)(2008-12#14)(2008-6#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-3#3)
sludges##8##1##(2008-10#5)(2008-11#3)
slug##4##1##(2008-10#1)(2008-6#2)(2008-7#1)
slum##2##1##(2009-10#1)(2012-2#1)
slump test##3##2##(2008-12#3)
slump##6##1##(1992-11#1)(2008-12#4)(2011-2#1)
slurried in##2##2##(2008-10#2)
slurried##5##1##(2008-10#5)
slurries (2%##2##2##(2008-10#2)
slurries and##2##2##(2008-10#2)
slurries of##4##2##(2008-10#4)
slurries were prepared by##3##4##(2008-10#3)
slurries were##7##2##(2008-10#7)
slurries##23##1##(2008-10#22)(2008-11#1)
slurry analysis##3##2##(2008-10#3)
slurry and##3##2##(2008-10#3)
slurry formation##3##2##(2008-10#3)
slurry preparation##4##2##(2008-10#4)
slurry sample introduction##2##3##(2008-10#2)
slurry sample##3##2##(2008-10#3)
slurry samples##6##2##(2008-10#6)
slurry sampling ETAAS##3##3##(2008-10#3)
slurry sampling and##2##3##(2008-10#2)
slurry sampling electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
slurry sampling electrothermal atomic absorption##3##5##(2008-10#3)
slurry sampling electrothermal vaporisation##2##4##(2008-10#2)
slurry sampling electrothermal##6##3##(2008-10#6)
slurry sampling##27##2##(2008-10#27)
slurry technique##3##2##(2008-10#3)
slurry was##6##2##(2008-10#5)(2008-3#1)
slurry##79##1##(2008-10#73)(2008-3#2)(2008-7#3)(2013-1#1)
small (&lt##7##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
small DNA##3##2##(2008-10#2)(2008-7#1)
small GTP-binding proteins by##2##4##(1992-3#1)(1995-8#1)
small GTP-binding proteins##5##3##(1992-3#1)(1994-11#1)(1994-6#1)(1995-8#1)(1997-1#1)
small GTP-binding##6##2##(1992-3#1)(1994-11#2)(1994-6#1)(1995-8#1)(1997-1#1)
small GTPases and##2##3##(1997-7#1)(2008-11#1)
small GTPases##6##2##(1997-7#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
small PTTH##2##2##(1995-11#2)
small PTTH-stimulated ecdysteroid secretion##2##4##(1995-11#2)
small RNA and##2##3##(2008-10#1)(2010-5#1)
small RNA##5##2##(2008-10#3)(2008-8#1)(2010-5#1)
small RNAs##3##2##(2008-9#2)(2013-1#1)
small amount of##21##3##(1991-9#1)(1994-5#1)(1995-2#1)(1996-9#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#2)(2008-9#1)(2013-8#1)
small amounts of a##3##4##(2008-10#1)(2010-4#2)
small amounts of##22##3##(1990-5#1)(1993-6#1)(1993-8#1)(2008-10#13)(2008-11#1)(2008-6#1)(2008-8#1)(2010-4#2)(2013-8#1)
small amounts##24##2##(1990-5#1)(1993-6#1)(1993-8#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#2)(2013-8#1)
small analyte##3##2##(2008-4#1)(2008-7#2)
small analytes##2##2##(2008-10#2)
small and isolated patches##2##4##(2008-9#2)
small and large subunits##2##4##(1990-11#2)
small and large##5##3##(1990-11#2)(1994-11#1)(1996-2#1)(2008-11#1)
small and medium##2##3##(1996-12#1)(1997-3#1)
small and the##4##3##(1995-9#1)(2008-10#1)(2008-6#1)(2012-3#1)
small and##33##2##(1990-11#2)(1992-3#1)(1994-1#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-10#1)(2012-3#2)(2013-1#1)(2013-7#1)
small angle X-ray##2##3##(2008-11#1)(2008-5#1)
small angle neutron scattering##2##4##(2008-10#2)
small angle##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
small animal model system##2##4##(2008-11#2)
small animal##4##2##(1996-12#2)(2008-11#2)
small animals##6##2##(1990-12#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)
small antral follicles##3##3##(2008-8#2)(2008-9#1)
small areas of##2##3##(2008-10#2)
small areas##3##2##(1990-8#1)(2008-10#2)
small arteries and##2##3##(1996-8#1)(2007-9#1)
small arteries##4##2##(1996-8#1)(2007-9#2)(2009-1#1)
small artery##3##2##(2009-1#2)(2013-8#1)
small as##8##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)
small biological networks##2##3##(2008-11#1)(2010-10#1)
small biological##3##2##(2008-11#1)(2010-10#2)
small bowel lesions##2##3##(2010-12#2)
small bowel obstruction##4##3##(2008-12#2)(2009-8#1)(2013-1#1)
small bowel##38##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-12#1)(1995-10#1)(1995-12#2)(1996-8#1)(1997-8#1)(2008-10#1)(2008-12#3)(2009-1#1)(2009-8#1)(2010-12#11)(2011-2#4)(2012-12#2)(2012-3#4)(2013-1#1)
small but significant increases in##2##5##(1990-3#1)(2008-10#1)
small but significant##6##3##(1990-3#1)(1991-6#1)(1994-2#1)(1995-8#1)(2008-10#1)(2008-11#1)
small but##11##2##(1990-3#1)(1991-6#1)(1992-2#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-10#2)(2008-11#1)
small case##2##2##(2008-11#1)(2013-1#1)
small cell carcinoma of the bladder##2##6##(1992-12#2)
small cell carcinoma of the##3##5##(1992-12#2)(1997-5#1)
small cell carcinoma##6##3##(1992-12#2)(1997-5#1)(2008-1#1)(2009-1#2)
small cell lung cancer##6##4##(1993-2#1)(1996-2#1)(2008-10#2)(2009-1#2)
small cell lung carcinoma cell line##2##6##(1994-8#1)(1996-12#1)
small cell lung carcinoma##4##4##(1994-8#2)(1996-12#2)
small cell lung##10##3##(1993-2#1)(1994-8#2)(1996-12#2)(1996-2#1)(2008-10#2)(2009-1#2)
small cell##20##2##(1992-12#2)(1993-2#1)(1994-8#2)(1996-12#2)(1996-2#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-1#4)(2011-2#1)(2012-3#1)
small changes in the##3##4##(2008-8#1)(2010-7#1)(2013-1#1)
small changes in##5##3##(2008-8#3)(2010-7#1)(2013-1#1)
small changes##6##2##(2008-8#3)(2010-7#1)(2013-1#2)
small children with##2##3##(2008-1#1)(2008-10#1)
small children##8##2##(1990-11#1)(1994-2#1)(1996-11#1)(1996-3#1)(2008-1#2)(2008-10#1)(2012-12#1)
small communities##3##2##(2008-10#1)(2010-9#2)
small compared to##2##3##(2008-10#1)(2008-2#1)
small compared with##4##3##(1995-3#1)(2008-10#2)(2008-3#1)
small compared##6##2##(1995-3#1)(2008-10#3)(2008-2#1)(2008-3#1)
small concentration##2##2##(2008-10#2)
small decrease in##2##3##(2008-10#1)(2008-7#1)
small decrease##3##2##(2008-10#2)(2008-7#1)
small deletion##2##2##(1993-8#1)(2008-9#1)
small dense##5##2##(2008-3#4)(2011-1#1)
small dependence on##2##3##(1993-8#1)(1997-6#1)
small difference in##2##3##(2012-3#1)(2013-8#1)
small differences between##2##3##(2008-11#1)(2011-2#1)
small differences in##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
small differences##7##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
small dimensions##2##2##(2008-10#2)
small dispersal rates##2##3##(2008-8#2)
small doses##2##2##(2008-5#1)(2008-7#1)
small droplets##2##2##(1994-12#1)(2008-10#1)
small effect on##3##3##(1995-3#2)(2008-8#1)
small effect##7##2##(1995-3#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)
small effects##2##2##(1991-12#1)(2008-10#1)
small enough to##5##3##(1994-1#1)(1994-2#1)(1997-6#1)(2008-10#1)(2008-3#1)
small fiber##2##2##(2010-1#1)(2012-3#1)
small foci of##2##3##(2008-11#1)(2011-2#1)
small for gestational age (SGA)##3##5##(1994-3#1)(2011-1#1)(2013-1#1)
small for##4##2##(1994-3#1)(2008-3#1)(2011-1#1)(2013-1#1)
small fraction of##7##3##(1991-12#1)(1991-5#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
small fragment##2##2##(2008-8#1)(2012-3#1)
small genetic##2##2##(2008-10#2)
small genomic##2##2##(2009-7#1)(2013-1#1)
small geographical##3##2##(2008-10#2)(2012-3#1)
small grains##4##2##(2008-10#3)(2008-9#1)
small group of##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
small group process##2##3##(2008-12#2)
small group##7##2##(1995-12#1)(2008-10#1)(2008-12#2)(2013-1#1)(2013-8#2)
small groups of##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
small groups##5##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
small heat##2##2##(2013-1#2)
small heat-shock protein##3##3##(1993-6#3)
small hospitals##2##2##(1991-12#1)(1991-6#1)
small in##6##2##(1993-8#1)(2008-10#3)(2010-7#1)(2010-8#1)
small inclination##4##2##(2008-3#4)
small inclined angle##2##3##(2008-3#2)
small increase in the##2##4##(1997-8#1)(2008-10#1)
small increase in##4##3##(1990-12#1)(1997-8#1)(2008-10#1)(2008-7#1)
small increase##5##2##(1990-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
small influence##2##2##(1993-8#1)(2008-5#1)
small interference##2##2##(2008-10#2)
small interfering RNAs (siRNAs)##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
small interfering RNAs##4##3##(2008-10#2)(2011-2#1)(2012-2#1)
small interfering##5##2##(2008-10#2)(2010-5#1)(2011-2#1)(2012-2#1)
small intestinal##8##2##(1990-2#1)(1990-8#2)(1992-6#1)(1996-6#1)(2008-5#1)(2013-1#2)
small intestine and colon##2##4##(1991-12#1)(2012-2#1)
small intestine and##5##3##(1991-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
small intestine metastases##2##3##(1995-12#2)
small intestine##28##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-5#2)(1995-11#2)(1995-12#2)(2008-10#1)(2008-5#3)(2008-8#1)(2009-1#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#6)
small lesions##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
small loss##2##2##(2008-7#1)(2013-1#1)
small metal##2##2##(1992-8#1)(2008-9#1)
small molecular##2##2##(2008-10#1)(2011-3#1)
small molecule##17##2##(1992-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
small molecules for##2##3##(2008-4#1)(2011-2#1)
small molecules have##2##3##(1992-9#1)(2008-9#1)
small molecules in the##2##4##(2008-8#1)(2010-11#1)
small molecules that##3##3##(2008-4#1)(2009-4#1)(2009-7#1)
small molecules##24##2##(1992-9#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-8#2)
small neutral amino##2##3##(1994-5#2)
small nuclear RNA##3##3##(1990-5#1)(1993-8#1)(1996-3#1)
small nuclear##6##2##(1990-5#1)(1993-8#2)(1996-3#1)(1997-3#1)(2008-10#1)
small number of samples##2##4##(2008-10#1)(2008-11#1)
small number of##27##3##(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)
small number##31##2##(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1994-6#1)(1994-9#1)(1995-5#2)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)
small numbers of##6##3##(1993-12#1)(1995-9#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-2#1)
small numbers##9##2##(1991-12#1)(1993-12#1)(1994-6#1)(1995-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
small objects##2##2##(2008-2#1)(2008-7#1)
small open reading##2##3##(1993-12#1)(2008-9#1)
small open##3##2##(1993-12#1)(2008-9#1)(2013-7#1)
small or large##2##3##(1994-11#1)(2008-9#1)
small or moderate##2##3##(1995-9#1)(2008-8#1)
small or##5##2##(1994-11#1)(1995-9#1)(2008-8#1)(2008-9#2)
small organic molecules##4##3##(1997-6#2)(2009-11#2)
small part of the##2##4##(1994-12#1)(2010-5#1)
small part of##3##3##(1994-12#1)(1997-6#1)(2010-5#1)
small particle size##2##3##(2008-5#2)
small particles##7##2##(1991-12#1)(1995-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-5#1)
small peptides##7##2##(1991-5#1)(1994-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#1)
small percentage of the##2##4##(1991-3#1)(1993-3#1)
small percentage of##5##3##(1991-3#1)(1993-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
small percentage##6##2##(1991-3#1)(1992-9#1)(1993-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
small piece of##2##3##(1992-3#1)(2008-12#1)
small population##6##2##(1991-12#1)(2008-10#2)(2008-7#2)(2008-8#1)
small populations##3##2##(2008-1#1)(2008-9#2)
small portion of##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
small portion##4##2##(2008-10#2)(2008-4#1)(2010-3#1)
small proportion of the##7##4##(1991-12#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
small proportion of##13##3##(1991-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
small proportion##15##2##(1991-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
small proteins##2##2##(2008-10#2)
small quantities of##6##3##(2008-10#4)(2008-11#1)(2008-9#1)
small quantities##9##2##(2008-10#6)(2008-11#2)(2008-9#1)
small quantity of##2##3##(1996-1#1)(2008-10#1)
small radial diameters##2##3##(2011-2#2)
small radial##3##2##(2011-2#3)
small reaction##2##2##(2008-10#2)
small round##3##2##(2007-12#1)(2008-12#1)(2010-6#1)
small rural hospitals##4##3##(1991-1#1)(1992-2#1)(1996-3#1)(2008-11#1)
small rural##5##2##(1991-1#1)(1992-2#1)(1996-3#1)(2008-11#1)(2010-5#1)
small sample size##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
small sample sizes##3##3##(2008-10#2)(2008-11#1)
small sample##16##2##(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
small samples##6##2##(2008-10#5)(2008-12#1)
small scale##10##2##(2008-11#6)(2008-12#1)(2010-5#1)(2010-8#1)(2011-2#1)
small segments##2##2##(2008-10#1)(2010-8#1)
small series##2##2##(1996-9#1)(2011-2#1)
small size of the##3##4##(1991-5#1)(1992-12#1)(2008-12#1)
small size of##6##3##(1991-5#1)(1992-12#1)(2008-10#2)(2008-12#1)(2011-2#1)
small size##10##2##(1991-5#1)(1992-12#1)(2008-10#6)(2008-12#1)(2011-2#1)
small solid##2##2##(2008-3#1)(2012-12#1)
small spatial##3##2##(2008-3#1)(2008-9#1)(2010-6#1)
small spectral##2##2##(2008-3#2)
small studies##2##2##(1995-12#1)(2013-8#1)
small study##4##2##(1990-11#1)(1990-2#1)(2008-11#2)
small subset of##4##3##(1995-5#1)(1997-1#1)(1997-7#1)(2012-12#1)
small subunit##10##2##(1990-11#1)(1993-12#2)(2008-10#5)(2008-8#1)(2013-8#1)
small to##7##2##(1990-8#1)(1991-3#2)(1994-12#1)(1994-9#1)(2008-10#2)
small trials##2##2##(1993-12#2)
small unilamellar vesicles##3##3##(1994-5#1)(2008-10#2)
small unilamellar##4##2##(1993-8#1)(1994-5#1)(2008-10#2)
small variation##2##2##(1990-8#1)(2008-9#1)
small variations in##2##3##(1995-5#1)(2013-8#1)
small vesicles##2##2##(1992-12#1)(2007-12#1)
small vessel disease##3##3##(2008-8#2)(2009-10#1)
small vessel##8##2##(1997-8#2)(2008-10#1)(2008-8#2)(2009-10#1)(2011-2#1)(2013-8#1)
small vessels##2##2##(2008-8#1)(2013-1#1)
small volume of##13##3##(2008-10#13)
small volume##17##2##(2008-10#16)(2008-11#1)
small volumes of##5##3##(2008-10#4)(2008-9#1)
small volumes##10##2##(1996-1#1)(2008-10#6)(2008-9#1)(2009-7#2)
small with##2##2##(2009-7#1)(2009-8#1)
small##1132##1##(1990-11#9)(1990-12#3)(1990-2#6)(1990-3#2)(1990-5#6)(1990-6#4)(1990-8#9)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#15)(1991-3#3)(1991-5#5)(1991-6#7)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#8)(1992-2#4)(1992-3#5)(1992-5#3)(1992-6#1)(1992-8#4)(1992-9#3)(1993-12#9)(1993-2#4)(1993-3#1)(1993-6#4)(1993-8#11)(1994-1#4)(1994-11#6)(1994-12#4)(1994-2#7)(1994-3#1)(1994-5#6)(1994-6#3)(1994-8#5)(1994-9#3)(1995-10#1)(1995-11#11)(1995-12#10)(1995-2#1)(1995-3#6)(1995-5#4)(1995-6#1)(1995-8#4)(1995-9#3)(1996-1#2)(1996-11#3)(1996-12#11)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#8)(1997-7#3)(1997-8#6)(2007-12#8)(2007-9#2)(2008-1#7)(2008-10#283)(2008-11#64)(2008-12#23)(2008-2#9)(2008-3#41)(2008-4#15)(2008-5#19)(2008-6#5)(2008-7#31)(2008-8#43)(2008-9#38)(2009-1#10)(2009-10#4)(2009-11#4)(2009-12#4)(2009-4#1)(2009-5#3)(2009-7#7)(2009-8#9)(2010-1#5)(2010-10#3)(2010-11#5)(2010-12#18)(2010-3#2)(2010-4#8)(2010-5#6)(2010-6#5)(2010-7#9)(2010-8#7)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#45)(2011-3#2)(2012-12#7)(2012-2#10)(2012-3#20)(2013-1#39)(2013-7#4)(2013-8#19)
small-angle X-ray scattering##2##3##(2008-10#2)
small-angle X-ray##3##2##(2008-10#2)(2008-5#1)
small-angle approximation to##2##3##(2008-3#2)
small-angle approximation##4##2##(2008-3#4)
small-angle##8##1##(2008-10#2)(2008-3#4)(2008-5#1)(2011-2#1)
small-animal imaging##2##2##(2012-2#2)
small-breasted patients##2##2##(2013-1#2)
small-breasted##3##1##(2013-1#3)
small-caliber##2##1##(2011-3#2)
small-cell carcinoma##2##2##(1992-12#1)(1997-1#1)
small-cell lung##2##2##(1997-8#1)(2008-7#1)
small-cell##4##1##(1992-12#1)(1997-1#1)(1997-8#1)(2008-7#1)
small-diameter##6##1##(1991-2#2)(2008-10#1)(2008-3#2)(2010-1#1)
small-molecule##2##1##(2008-12#1)(2013-1#1)
small-scale##23##1##(1994-8#2)(1995-6#1)(2007-12#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-9#2)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#2)
small-signal##2##1##(2007-12#1)(2008-3#1)
small-size##2##1##(1990-5#1)(2008-10#1)
small-world##4##1##(2008-11#4)
smaller and more##2##3##(1996-2#1)(2008-4#1)
smaller and##8##2##(1996-2#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
smaller breeds##2##2##(1996-12#2)
smaller but##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
smaller difference between##2##3##(2008-10#1)(2011-1#1)
smaller for##2##2##(2008-10#1)(2012-3#1)
smaller geographic areas##2##3##(1994-3#1)(2008-10#1)
smaller hospitals##3##2##(1990-11#1)(1992-6#1)(1993-6#1)
smaller in##7##2##(1991-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
smaller increases in##2##3##(1993-3#1)(2008-12#1)
smaller lesions##2##2##(2008-10#2)
smaller numbers##2##2##(1990-12#1)(1991-12#1)
smaller ones##3##2##(1995-12#1)(2007-12#1)(2008-10#1)
smaller particles##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
smaller propagule size##2##3##(2008-8#2)
smaller proportion of the##2##4##(1994-3#1)(2008-10#1)
smaller protein##2##2##(1993-12#1)(2008-9#1)
smaller sample##3##2##(2008-10#3)
smaller than 1##3##3##(2008-10#3)
smaller than at pH##2##4##(2008-10#2)
smaller than in##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
smaller than one##2##3##(1997-1#1)(2008-10#1)
smaller than that in##2##4##(1993-8#1)(2008-10#1)
smaller than that obtained##2##4##(2008-10#2)
smaller than that of the##4##5##(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
smaller than that of##7##4##(1995-6#1)(2008-10#4)(2008-11#1)(2008-6#1)
smaller than that##14##3##(1993-8#1)(1995-11#1)(1995-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-6#1)
smaller than the ligand##2##4##(2008-10#2)
smaller than the##10##3##(1992-10#1)(2008-10#3)(2008-3#1)(2009-5#1)(2010-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
smaller than those of##2##4##(1994-5#1)(2008-3#1)
smaller than those##6##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
smaller than##66##2##(1992-10#1)(1992-5#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#31)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#3)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
smaller volumes##2##2##(2008-10#1)(2009-7#1)
smaller##242##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#3)(1991-6#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#1)(2007-12#3)(2008-10#84)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#8)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#6)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#4)
smallest chromosome##2##2##(2008-10#2)
smallest##31##1##(1991-9#1)(1996-2#1)(1997-2#2)(2007-12#2)(2008-10#11)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#2)(2011-2#3)(2013-1#2)
smallpox##2##1##(1994-9#1)(1996-12#1)
smart##9##1##(1994-1#2)(1996-3#2)(2008-7#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
smear of##2##2##(1996-12#1)(2008-5#1)
smear##18##1##(1990-3#1)(1990-6#1)(1990-8#3)(1991-2#1)(1992-1#2)(1992-3#4)(1996-12#2)(2008-10#1)(2008-5#1)(2012-3#2)
smear-positive PTB cases##2##3##(2013-8#2)
smear-positive##3##1##(2013-8#3)
smears and##3##2##(1990-12#1)(1992-3#1)(2008-9#1)
smears of##2##2##(1996-12#1)(2008-7#1)
smears were##2##2##(1990-6#1)(1992-3#1)
smears##14##1##(1990-12#2)(1990-6#4)(1990-8#1)(1991-11#1)(1992-3#3)(1996-12#1)(2008-7#1)(2008-9#1)
smectite##2##1##(2008-10#2)
smell##9##1##(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#6)
smelting##3##1##(2008-10#3)
smoke and##6##2##(1993-8#1)(1996-3#1)(2008-1#2)(2008-10#1)(2008-5#1)
smoke caused##3##2##(2008-5#3)
smoke control##3##2##(1996-12#3)
smoke in##3##2##(1993-8#1)(1996-12#1)(2008-11#1)
smoke production##2##2##(1993-12#1)(1996-12#1)
smoke toxicity testing##2##3##(1996-12#2)
smoke toxicity##5##2##(1996-12#5)
smoke while##2##2##(1991-11#1)(2010-5#1)
smoke##70##1##(1991-11#4)(1991-3#1)(1991-4#1)(1993-11#1)(1993-12#1)(1993-8#4)(1994-3#1)(1996-12#22)(1996-3#2)(1997-1#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-3#1)(2008-5#11)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#2)(2013-1#3)(2013-8#1)
smoke-free##2##1##(1990-6#1)(1996-12#1)
smoked more##2##2##(1991-11#1)(1993-11#1)
smoked##11##1##(1991-1#1)(1991-11#3)(1993-11#1)(2008-10#1)(2011-2#3)(2013-1#1)(2013-8#1)
smokeless powders##2##2##(2008-10#2)
smokeless tobacco use##2##3##(2008-4#2)
smokeless tobacco using patients enrolled)##2##5##(2008-4#2)
smokeless tobacco##7##2##(2008-4#7)
smokeless##9##1##(2008-10#2)(2008-4#7)
smoker (n =##2##3##(2008-12#2)
smoker##14##1##(1994-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-12#4)(2012-12#1)(2012-3#1)(2013-1#2)
smokers and non-smokers##2##3##(2008-10#1)(2008-12#1)
smokers and nonsmokers##2##3##(2008-10#2)
smokers and##9##2##(2008-10#6)(2008-11#1)(2008-12#1)(2013-1#1)
smokers are##3##2##(1996-3#1)(1996-9#1)(2008-12#1)
smokers continue to##2##3##(2010-2#1)(2013-1#1)
smokers had##3##2##(2008-10#1)(2008-12#1)(2010-7#1)
smokers in the##2##3##(2008-10#1)(2010-11#1)
smokers in##3##2##(2008-10#1)(2010-11#1)(2013-1#1)
smokers than non-smokers##3##3##(1992-9#1)(2008-10#2)
smokers using##2##2##(2009-7#1)(2010-11#1)
smokers were##2##2##(1994-6#1)(2010-11#1)
smokers who##3##2##(2013-1#3)
smokers##82##1##(1990-2#1)(1990-6#2)(1991-1#1)(1992-9#5)(1993-11#1)(1993-2#4)(1994-6#6)(1995-12#1)(1996-3#7)(1996-8#2)(1996-9#1)(2007-12#4)(2008-10#15)(2008-11#2)(2008-12#4)(2009-5#1)(2009-7#2)(2010-11#5)(2010-2#2)(2010-7#1)(2011-2#3)(2013-1#11)(2013-8#1)
smoking abstinence##4##2##(2010-11#3)(2013-1#1)
smoking among##6##2##(1991-11#3)(2009-7#1)(2013-1#2)
smoking and its##2##3##(2009-5#1)(2013-1#1)
smoking and lung cancer##4##4##(1996-3#1)(2013-1#3)
smoking and the risk of##2##5##(2008-12#1)(2011-2#1)
smoking and the##3##3##(2008-12#1)(2009-5#1)(2011-2#1)
smoking and##16##2##(1991-11#1)(1991-9#1)(1992-6#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#2)(2010-5#1)(2011-2#1)(2013-1#5)
smoking are##3##2##(1994-6#1)(2011-2#1)(2013-8#1)
smoking at Wave 1 were##2##5##(2013-8#2)
smoking at##6##2##(1991-11#1)(1991-9#1)(1997-3#1)(2010-11#1)(2013-8#2)
smoking by doctors##2##3##(2008-10#2)
smoking cessation and##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
smoking cessation in##2##3##(2009-7#2)
smoking cessation interventions##4##3##(2009-7#1)(2011-2#2)(2013-1#1)
smoking cessation rate##2##3##(1991-11#1)(2008-11#1)
smoking cessation rates##2##3##(2008-11#2)
smoking cessation training##2##3##(2011-2#2)
smoking cessation##33##2##(1991-11#1)(1991-12#1)(1995-3#1)(2007-12#2)(2008-11#4)(2008-7#1)(2008-8#1)(2009-7#6)(2010-2#1)(2011-2#5)(2013-1#10)
smoking during##2##2##(1991-11#2)
smoking habits##8##2##(1990-2#3)(1991-11#1)(1993-2#1)(1996-3#1)(2012-12#1)(2013-1#1)
smoking histories##2##2##(1991-12#1)(1992-6#1)
smoking history##4##2##(1993-1#1)(1996-3#2)(2009-4#1)
smoking in the##2##3##(2008-1#1)(2013-1#1)
smoking in##8##2##(1990-6#1)(1996-1#1)(1996-8#1)(2008-1#1)(2008-10#2)(2010-6#1)(2013-1#1)
smoking initiation##2##2##(2008-8#1)(2010-11#1)
smoking is##7##2##(2008-12#1)(2008-8#1)(2011-2#2)(2013-1#3)
smoking maintenance##2##2##(2010-2#2)
smoking on##6##2##(1990-6#1)(1996-3#1)(2008-10#2)(2008-12#1)(2009-12#1)
smoking prevalence##8##2##(1994-6#3)(1996-3#3)(2011-2#2)
smoking rates##2##2##(2013-1#1)(2013-8#1)
smoking status and##2##3##(2011-2#1)(2013-1#1)
smoking status##9##2##(2008-11#1)(2008-12#1)(2011-2#5)(2012-12#1)(2013-1#1)
smoking was##8##2##(1994-6#1)(1996-3#1)(1997-2#1)(2010-2#2)(2011-2#1)(2013-1#2)
smoking were##5##2##(1996-3#1)(2010-11#1)(2010-2#2)(2013-8#1)
smoking##235##1##(1990-12#1)(1990-2#5)(1990-6#6)(1990-9#1)(1991-1#3)(1991-11#12)(1991-12#8)(1991-6#1)(1991-9#3)(1992-2#1)(1992-6#5)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-6#1)(1994-3#1)(1994-6#7)(1995-3#1)(1996-1#2)(1996-3#12)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#3)(2008-1#5)(2008-10#13)(2008-11#8)(2008-12#5)(2008-6#1)(2008-7#4)(2008-8#4)(2009-12#2)(2009-4#1)(2009-5#4)(2009-7#9)(2010-11#6)(2010-12#1)(2010-2#11)(2010-5#2)(2010-6#2)(2011-2#21)(2012-12#3)(2012-2#1)(2013-1#38)(2013-8#8)
smoking]##5##1##(1995-12#1)(1996-3#2)(2008-10#1)(2013-8#1)
smooth and##3##2##(2007-12#1)(2008-6#1)(2008-7#1)
smooth as##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
smooth endoplasmic reticulum and##2##4##(2007-12#2)
smooth muscle actin and##2##4##(2008-11#1)(2010-12#1)
smooth muscle actin##6##3##(1994-12#1)(2008-11#2)(2010-12#1)(2011-2#1)(2013-8#1)
smooth muscle and##3##3##(1990-8#1)(1991-8#1)(1997-4#1)
smooth muscle are##2##3##(1994-8#1)(2010-1#1)
smooth muscle by##3##3##(1990-8#1)(1993-6#1)(1994-11#1)
smooth muscle cell proliferation##2##4##(2008-10#1)(2010-12#1)
smooth muscle cell##8##3##(1992-8#1)(1992-9#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
smooth muscle cells and fibroblasts##3##5##(1990-2#2)(1997-1#1)
smooth muscle cells and##4##4##(1990-2#2)(1995-2#1)(1997-1#1)
smooth muscle cells from##3##4##(1990-2#1)(1994-11#1)(1995-11#1)
smooth muscle cells is##3##4##(1990-12#1)(1990-8#1)(1992-9#1)
smooth muscle cells was##2##4##(1994-11#1)(2008-11#1)
smooth muscle cells were##3##4##(1990-8#2)(1992-8#1)
smooth muscle cells##49##3##(1990-12#2)(1990-2#3)(1990-8#5)(1991-5#1)(1992-8#3)(1992-9#1)(1993-2#1)(1993-3#2)(1994-11#7)(1995-11#2)(1995-12#1)(1995-2#7)(1997-1#2)(1997-4#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-1#1)(2009-7#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-8#1)
smooth muscle is##2##3##(1994-8#1)(1995-8#1)
smooth muscle myosin light chain kinase##2##6##(1993-8#2)
smooth muscle of##4##3##(1993-8#2)(1997-4#1)(2012-3#1)
smooth muscle relaxation##3##3##(1992-6#2)(1993-6#1)
smooth muscle##119##2##(1990-12#3)(1990-2#3)(1990-8#8)(1991-5#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-6#3)(1992-8#4)(1992-9#5)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#4)(1994-11#9)(1994-12#1)(1994-6#3)(1994-8#6)(1995-11#2)(1995-12#1)(1995-2#7)(1995-8#1)(1996-1#2)(1997-1#4)(1997-3#1)(1997-4#4)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-1#2)(2010-12#5)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
smooth pursuit##3##2##(2008-7#1)(2009-8#2)
smooth septate junctions##4##3##(2008-7#4)
smooth surface##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
smooth tongue sole##2##3##(2013-8#2)
smooth transition##2##2##(2008-6#1)(2013-1#1)
smooth##168##1##(1990-12#3)(1990-2#3)(1990-8#8)(1991-5#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-6#3)(1992-8#4)(1992-9#5)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#4)(1994-11#9)(1994-12#1)(1994-6#3)(1994-8#6)(1995-11#2)(1995-12#2)(1995-2#7)(1995-8#1)(1996-1#3)(1996-12#1)(1997-1#4)(1997-3#1)(1997-4#5)(1997-8#1)(2006-6#1)(2007-12#3)(2008-1#2)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#6)(2008-7#7)(2008-8#3)(2008-9#1)(2009-1#1)(2009-7#3)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#5)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#4)
smoother##4##1##(1993-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
smoothing factor gamma##2##3##(2008-2#2)
smoothing##15##1##(2008-10#3)(2008-2#3)(2008-3#3)(2008-5#1)(2009-7#3)(2010-5#1)(2013-1#1)
smoothly##5##1##(2008-3#1)(2008-6#1)(2010-1#1)(2010-4#1)(2012-3#1)
smoothness and##2##2##(2008-6#2)
smoothness of##2##2##(2008-10#1)(2010-6#1)
smoothness##7##1##(2008-10#1)(2008-5#1)(2008-6#3)(2010-6#1)(2011-2#1)
smut fungi##3##2##(2008-10#3)
smut##12##1##(2008-10#11)(2009-8#1)
sn-glycerol-3-phosphate##2##1##(1990-5#1)(1995-6#1)
snRNA##2##1##(2008-9#1)(2013-8#1)
snRNP##4##1##(1993-6#1)(1993-8#1)(1997-9#1)(2013-8#1)
snRNPs##4##1##(1993-8#3)(2013-8#1)
snail##12##1##(1991-5#1)(2008-10#1)(2008-11#5)(2008-12#3)(2009-8#1)(2011-2#1)
snails Helix##2##2##(2008-12#2)
snails were##2##2##(2008-11#1)(2008-12#1)
snails##21##1##(2008-11#4)(2008-12#10)(2010-4#3)(2011-2#2)(2012-2#1)(2013-8#1)
snake muscle fructose-1##3##3##(2008-9#3)
snake venom##3##2##(1993-3#3)
snake##15##1##(1991-6#1)(1993-3#3)(1996-12#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-8#1)(2013-1#1)
snakes fed##2##2##(1996-12#2)
snakes##11##1##(1996-12#7)(2008-7#1)(2008-8#2)(2010-8#1)
snap and dry bean##2##4##(2008-10#2)
snap bean##11##2##(2008-10#11)
snap##16##1##(2008-10#15)(2012-3#1)
snapper##2##1##(2008-10#1)(2010-8#1)
snapping##2##1##(2009-10#2)
snapshot of the##2##3##(2011-2#1)(2012-3#1)
snapshot##3##1##(1997-6#1)(2011-2#1)(2012-3#1)
sneezing##3##1##(2008-5#1)(2011-2#1)(2012-12#1)
snoRNA gene##4##2##(2008-8#4)
snoRNA genes##2##2##(2008-8#2)
snoRNA##9##1##(1997-8#1)(2008-8#8)
snorted cocaine##2##2##(2013-8#2)
snow cover##6##2##(2008-10#4)(2008-3#2)
snow molds##6##2##(2008-10#6)
snow##17##1##(2008-10#14)(2008-3#2)(2012-6#1)
so a##5##2##(1996-3#1)(2008-10#2)(2010-3#1)(2011-2#1)
so are the##2##3##(1997-8#1)(2008-3#1)
so are##3##2##(1997-8#1)(2008-3#1)(2013-8#1)
so as not to##2##4##(1992-6#1)(2008-12#1)
so as to avoid##3##4##(1996-11#1)(2008-3#1)(2013-8#1)
so as to have##3##4##(2006-6#1)(2008-12#1)(2010-8#1)
so as to##33##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-11#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-12#5)(2008-3#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
so as##36##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-11#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-12#6)(2008-3#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-8#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-7#1)(2013-8#1)
so at 12 months##2##4##(2012-2#2)
so at##3##2##(2008-9#1)(2012-2#2)
so called &quot##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2011-3#1)(2013-1#1)
so called##11##2##(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
so common##2##2##(2009-3#1)(2011-2#1)
so created##2##2##(2008-11#1)(2011-2#1)
so does the##2##3##(1994-1#1)(2008-10#1)
so far and##2##3##(2008-11#1)(2008-9#1)
so far as##3##3##(1990-9#1)(1997-6#1)(2009-8#1)
so far been##8##3##(1990-11#1)(1991-12#1)(1991-6#1)(1993-2#1)(2008-11#1)(2009-8#1)(2009-9#1)(2011-2#1)
so far developed##2##3##(1993-3#1)(2008-10#1)
so far have##2##3##(1996-12#1)(2013-8#1)
so far in the literature##2##5##(2012-12#1)(2013-1#1)
so far in the##4##4##(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
so far investigated##2##3##(2008-12#1)(2011-1#1)
so far proposed##2##3##(1996-11#1)(2008-8#1)
so far the##2##3##(1990-5#1)(2008-10#1)
so far##83##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-6#2)(1991-8#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#6)(2008-12#3)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#6)(2013-7#1)(2013-8#3)
so high that##2##3##(2008-10#2)
so important##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
so in the##3##3##(1994-2#1)(2012-12#1)(2013-1#1)
so in##6##2##(1994-2#1)(1997-1#1)(2008-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
so it can##2##3##(2008-10#2)
so it is##4##3##(1994-9#1)(2008-8#1)(2010-11#1)(2010-6#1)
so it may##2##3##(2010-8#1)(2013-1#1)
so it##17##2##(1994-9#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
so long as##2##3##(1992-3#1)(1993-8#1)
so many##8##2##(1992-2#2)(1993-1#2)(1994-12#2)(2008-10#1)(2008-11#1)
so may##2##2##(2008-7#1)(2010-10#1)
so more quickly##2##3##(2008-11#1)(2008-9#1)
so much##4##2##(1991-6#1)(1993-3#1)(1996-3#1)(2008-4#1)
so obtained##3##2##(2008-10#3)
so on##10##2##(2008-10#4)(2008-7#1)(2008-9#1)(2009-10#1)(2011-3#1)(2011-4#1)(2012-3#1)
so strongly##3##2##(2008-10#1)(2008-8#2)
so that a##9##3##(1996-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
so that all##2##3##(2008-10#1)(2008-5#1)
so that in##2##3##(2008-11#2)
so that it becomes##2##4##(2008-10#1)(2008-11#1)
so that it##7##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-3#1)(2010-6#1)
so that long-term##2##3##(1992-11#1)(2008-11#1)
so that more##4##3##(2009-11#1)(2010-7#1)(2012-2#1)(2013-8#1)
so that no##2##3##(2008-11#1)(2011-2#1)
so that possible##2##3##(1990-9#1)(1992-11#1)
so that quantitative##2##3##(2008-10#2)
so that some##2##3##(1994-2#1)(2008-10#1)
so that the##32##3##(1991-1#1)(1993-11#1)(1994-11#1)(1995-9#1)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#11)(2008-11#1)(2008-3#4)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
so that their##2##3##(2012-2#1)(2013-8#1)
so that these##2##3##(2008-10#1)(2008-7#1)
so that they can be##3##5##(1994-3#1)(2008-9#1)(2011-2#1)
so that they can##4##4##(1994-3#1)(2008-9#2)(2011-2#1)
so that they will be more##2##6##(1997-3#1)(1997-7#1)
so that they##9##3##(1994-3#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-9#2)(2010-4#2)(2011-2#1)
so that##141##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#35)(2008-11#10)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#3)
so thatthe##2##2##(2008-11#2)
so the##21##2##(1991-12#1)(1993-2#1)(1996-2#1)(2008-10#4)(2008-2#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2010-9#1)(2011-2#3)(2013-1#1)
so their##2##2##(1995-2#1)(2008-2#1)
so they##3##2##(1997-2#1)(2008-7#1)(2013-8#1)
so this##3##2##(1996-1#1)(2008-9#1)(2009-6#1)
so to##5##2##(1990-12#1)(1993-3#1)(1994-2#1)(2008-10#1)(2010-10#1)
so too##2##2##(1996-1#2)
so was##3##2##(2008-10#1)(2008-9#2)
so we##4##2##(2008-10#1)(2008-8#1)(2010-7#1)(2013-7#1)
so well##2##2##(1991-6#1)(2008-11#1)
so when##5##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
so##565##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#5)(1993-6#3)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#6)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#4)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#115)(2008-11#40)(2008-12#13)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#21)(2008-8#23)(2008-9#23)(2009-1#3)(2009-10#9)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#26)(2011-3#3)(2011-4#1)(2012-12#4)(2012-2#9)(2012-3#7)(2012-4#1)(2012-6#1)(2012-7#1)(2013-1#18)(2013-7#4)(2013-8#14)
so-called &quot##9##2##(1991-3#2)(1993-3#1)(1993-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#2)
so-called DNA##2##2##(1995-5#1)(2010-8#1)
so-called hairy length##2##3##(2008-7#2)
so-called##72##1##(1990-12#1)(1991-3#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1997-6#1)(2007-12#3)(2008-1#1)(2008-10#14)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#4)(2009-5#1)(2009-8#2)(2010-1#2)(2010-8#1)(2011-2#2)(2012-2#3)(2012-5#1)
soaked in a##3##3##(2008-10#3)
soaked in##4##2##(1993-8#1)(2008-10#3)
soaked##11##1##(1993-8#1)(2008-10#8)(2011-2#1)(2012-3#1)
soaking##5##1##(2008-10#4)(2013-1#1)
soap and water##2##3##(2007-12#1)(2008-5#1)
soap and##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
soap##11##1##(2007-12#1)(2008-10#6)(2008-5#4)
soapnut##5##1##(2009-3#5)
soaps##5##1##(2008-10#2)(2008-5#3)
soapy##2##1##(1990-3#1)(2008-5#1)
soccer players##2##2##(1996-6#1)(2010-3#1)
soccer##12##1##(1996-6#7)(2010-1#1)(2010-3#1)(2011-2#2)(2012-3#1)
sociability##3##1##(2008-1#1)(2008-5#1)(2011-2#1)
social Hymenoptera##3##2##(2008-8#3)
social action in##2##3##(1996-1#1)(2009-11#1)
social and academic##4##3##(2008-12#4)
social and communication##2##3##(2008-6#1)(2012-2#1)
social and cultural##4##3##(1990-3#1)(1993-11#1)(2008-11#1)(2011-2#1)
social and economic##8##3##(1991-3#1)(1992-12#1)(1994-9#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
social and economical practice opportunity benefits associated with our rural location##2##11##(1994-1#2)
social and emotional##3##3##(2008-11#1)(2009-10#1)(2013-8#1)
social and environmental##2##3##(2008-11#2)
social and physical##2##3##(2012-2#2)
social and political##2##3##(1993-11#1)(2008-11#1)
social and##44##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-12#1)(1993-11#2)(1994-1#2)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-11#7)(2008-12#5)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#3)(2012-2#3)(2013-8#1)
social anxiety##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
social aspects##2##2##(1993-11#1)(2012-12#1)
social awareness##2##2##(2008-12#1)(2013-1#1)
social behavior in##2##3##(1992-6#1)(2008-8#1)
social behavior is##2##3##(2008-10#1)(2008-8#1)
social behavior##15##2##(1992-6#1)(1995-12#1)(2008-10#2)(2008-11#4)(2008-8#3)(2009-9#1)(2010-3#1)(2012-12#1)(2012-3#1)
social benefits to##2##3##(2008-9#1)(2010-7#1)
social care##12##2##(1996-8#1)(2008-11#8)(2008-12#3)
social climate##2##2##(2008-7#1)(2009-7#1)
social cognition##5##2##(2008-11#5)
social cognitive##2##2##(2008-11#2)
social competence and self-regulation##2##4##(2008-12#2)
social competence and##4##3##(2008-12#2)(2010-11#2)
social competence##8##2##(2008-11#1)(2008-12#3)(2008-9#1)(2010-11#3)
social conditions##2##2##(1994-6#1)(1995-11#1)
social consequences of##2##3##(2012-2#1)(2013-1#1)
social consequences##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
social contact##2##2##(1997-1#1)(2011-2#1)
social context of##2##3##(1993-1#1)(2008-11#1)
social context##9##2##(1992-1#1)(1993-1#1)(2008-11#2)(2009-10#1)(2009-6#1)(2010-10#1)(2010-8#2)
social contract&quot##2##2##(1995-1#1)(2008-9#1)
social contracts##2##2##(2008-9#2)
social control##5##2##(1996-1#1)(2009-7#1)(2010-7#1)(2011-2#2)
social cost##2##2##(2010-11#1)(2010-5#1)
social development and##3##3##(2009-9#2)(2012-2#1)
social development##5##2##(2009-9#4)(2012-2#1)
social dominance is##2##3##(2008-8#2)
social dominance##7##2##(2008-11#1)(2008-8#5)(2010-1#1)
social environment##4##2##(2008-10#1)(2009-6#1)(2009-9#1)(2010-11#1)
social environments##2##2##(2008-1#1)(2008-9#1)
social evolution and##2##3##(2008-8#1)(2010-4#1)
social evolution in##2##3##(2008-8#2)
social evolution##9##2##(2008-8#5)(2010-4#1)(2012-3#3)
social experiences##2##2##(2008-11#1)(2012-2#1)
social factors such as religion##2##5##(2009-6#2)
social factors##6##2##(1995-9#1)(2008-7#1)(2008-8#1)(2009-6#2)(2009-7#1)
social function##2##2##(2008-11#1)(2013-8#1)
social functioning of##2##3##(2011-2#1)(2013-1#1)
social functioning##6##2##(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
social groups##5##2##(2008-11#1)(2008-8#2)(2010-4#1)(2013-1#1)
social health maintenance organization##3##4##(1991-3#1)(1992-1#1)(1997-1#1)
social health maintenance##4##3##(1991-3#2)(1992-1#1)(1997-1#1)
social hierarchy##2##2##(2008-11#2)
social impact##2##2##(2008-8#1)(2009-5#1)
social insect colonies##2##3##(2008-8#2)
social insects##3##2##(2008-8#2)(2008-9#1)
social intelligence##3##2##(2010-1#3)
social interaction##12##2##(1996-11#1)(1996-2#1)(2008-11#2)(2008-4#1)(2011-2#3)(2012-2#1)(2012-3#3)
social interactions##15##2##(1996-2#1)(2008-11#5)(2008-12#1)(2008-8#3)(2009-10#1)(2010-10#1)(2012-3#2)(2013-8#1)
social isolation##5##2##(1991-2#1)(1994-12#1)(2008-11#1)(2009-5#1)(2011-2#1)
social life##3##2##(2009-10#1)(2010-11#1)(2011-2#1)
social marketing techniques##2##3##(1997-3#2)
social marketing##3##2##(1997-3#2)(2012-3#1)
social media technologies##2##3##(2012-2#2)
social media##3##2##(2012-2#3)
social memory/recognition##3##2##(1994-3#3)
social network##7##2##(1995-1#1)(2010-1#2)(2010-10#1)(2012-3#2)(2013-1#1)
social networks and##2##3##(2009-5#1)(2010-10#1)
social networks##4##2##(2008-11#1)(2009-5#1)(2010-10#1)(2013-8#1)
social norms##2##2##(1993-3#1)(2013-1#1)
social or##2##2##(2008-12#1)(2009-6#1)
social organization in##2##3##(2008-11#1)(2012-2#1)
social organization##6##2##(2007-12#1)(2008-11#1)(2008-9#1)(2010-1#1)(2012-2#2)
social outcome following paediatric traumatic brain injury##2##7##(2009-10#2)
social outcome##6##2##(2009-10#6)
social participation##2##2##(2008-12#1)(2013-8#1)
social partners##3##2##(2008-8#1)(2012-3#2)
social perception##3##2##(2008-11#1)(2013-8#2)
social phenotypes##3##2##(2008-11#3)
social phobia and##2##3##(2008-4#2)
social phobia subtypes##2##3##(2008-4#1)(2010-2#1)
social phobia##27##2##(2008-4#18)(2010-2#6)(2012-2#2)(2013-1#1)
social policy##5##2##(1996-12#1)(1997-2#2)(2008-1#1)(2008-11#1)
social practice##2##2##(2012-3#2)
social problem##2##2##(2008-11#1)(2009-10#1)
social problem-solving skills##3##3##(2009-10#3)
social problem-solving##4##2##(2008-11#1)(2009-10#3)
social problems##2##2##(1990-11#1)(2009-7#1)
social programs##2##2##(1994-2#1)(1997-2#1)
social rank##2##2##(2008-11#2)
social recognition##2##2##(2008-11#2)
social relations##2##2##(1995-3#2)
social relationships##2##2##(2010-1#1)(2011-2#1)
social representation##5##2##(2011-2#4)(2012-3#1)
social representations##2##2##(2011-2#1)(2012-3#1)
social risk factors##2##3##(1993-3#2)
social risk##3##2##(1993-3#3)
social science##4##2##(1995-2#1)(1996-3#1)(2010-1#1)(2010-10#1)
social sciences##6##2##(1996-6#1)(2008-12#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
social selection##6##2##(2008-8#2)(2012-3#4)
social service organizations##2##3##(1991-12#2)
social service##5##2##(1991-12#2)(1994-2#1)(1995-3#1)(1996-3#1)
social services##14##2##(1994-1#1)(1995-3#2)(1996-1#1)(1996-3#4)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#1)
social situation##2##2##(1995-5#1)(2008-11#1)
social skills##6##2##(2008-11#2)(2008-12#1)(2009-12#1)(2013-1#2)
social spacing##2##2##(2010-8#2)
social species##4##2##(2008-8#2)(2008-9#2)
social spider##3##2##(2008-9#3)
social status##7##2##(1994-6#1)(2008-11#2)(2008-12#2)(2008-8#1)(2011-2#1)
social structure##3##2##(2008-12#3)
social support and##13##3##(1992-3#3)(2009-7#4)(2010-1#2)(2010-10#1)(2010-3#2)(2013-8#1)
social support for##5##3##(1995-1#1)(2008-6#1)(2010-10#1)(2010-11#1)(2011-2#1)
social support from##4##3##(1992-3#1)(2009-7#3)
social support in##3##3##(1992-3#2)(2009-7#1)
social support networks of##2##4##(1992-3#2)
social support networks##3##3##(1992-3#2)(2009-5#1)
social support##62##2##(1991-1#1)(1992-1#3)(1992-2#2)(1992-3#13)(1993-1#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#4)(1996-3#3)(2008-6#2)(2009-10#1)(2009-5#4)(2009-7#11)(2010-1#3)(2010-10#2)(2010-11#1)(2010-3#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
social systems##6##2##(2008-8#1)(2010-5#1)(2012-2#4)
social validity##2##2##(2009-11#2)
social welfare##4##2##(1994-1#1)(1995-3#1)(2008-11#1)(2011-2#1)
social work##9##2##(1991-12#1)(2008-1#1)(2008-12#1)(2010-10#2)(2012-12#3)(2013-1#1)
social worker##4##2##(1993-12#1)(1995-11#1)(2012-3#1)(2013-1#1)
social workers##4##2##(1994-3#1)(1995-11#1)(2010-11#1)(2012-3#1)
social##654##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-6#3)(1992-1#8)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#13)(1992-6#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-3#5)(1994-1#4)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#3)(1994-9#1)(1995-1#6)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#8)(1995-5#3)(1995-9#1)(1996-1#4)(1996-11#4)(1996-12#2)(1996-2#7)(1996-3#10)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#11)(2008-10#7)(2008-11#87)(2008-12#39)(2008-4#21)(2008-6#6)(2008-7#7)(2008-8#45)(2008-9#20)(2009-10#18)(2009-11#5)(2009-12#2)(2009-5#7)(2009-6#7)(2009-7#17)(2009-8#2)(2009-9#6)(2010-1#18)(2010-10#11)(2010-11#11)(2010-2#7)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#5)(2011-2#34)(2012-12#10)(2012-2#26)(2012-3#31)(2013-1#17)(2013-8#12)
social-cognitive processing##2##2##(2008-11#2)
social-cognitive##3##1##(2008-11#3)
social-emotional growth fostering##2##3##(1990-12#2)
social/health maintenance organization##2##3##(1995-2#2)
social/health maintenance##3##2##(1993-12#1)(1995-2#2)
sociality##9##1##(2008-8#9)
socialization and##2##2##(2008-12#1)(2010-10#1)
socialization of##2##2##(1991-3#1)(2010-10#1)
socialization process##2##2##(2008-5#1)(2010-10#1)
socialization##11##1##(1991-3#1)(2008-12#1)(2008-5#1)(2010-10#6)(2011-2#1)(2012-3#1)
socially##24##1##(1991-2#1)(1994-2#1)(1995-11#1)(1995-5#2)(2008-1#2)(2008-11#6)(2008-4#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-7#1)(2012-12#1)
societal##11##1##(2008-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-6#1)(2010-10#2)(2010-12#2)(2011-2#1)(2012-2#1)
societies is##3##2##(2008-10#1)(2009-12#1)(2010-12#1)
societies##30##1##(1992-1#1)(1992-12#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-8#5)(2009-12#3)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-3#1)(2011-4#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
society and##6##2##(1995-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
society as##3##2##(1995-5#1)(2008-12#1)(2009-6#1)
society by##2##2##(2008-11#1)(2008-8#1)
society for##2##2##(2008-11#1)(2013-8#1)
society is##2##2##(2010-10#1)(2011-2#1)
society of##9##2##(1994-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-2#2)(2012-3#1)
society##87##1##(1990-6#1)(1991-3#3)(1991-6#1)(1992-3#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-5#3)(1996-1#2)(1996-11#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#3)(2008-10#15)(2008-11#6)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#3)
society's##4##1##(1992-1#1)(1993-12#1)(2012-2#2)
society]##2##1##(1993-3#1)(1996-6#1)
socio-cultural##3##1##(2008-11#1)(2012-3#2)
socio-demographic##7##1##(2008-10#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-1#1)
socio-economic and##3##2##(2008-10#1)(2010-6#2)
socio-economic status##6##2##(1992-2#1)(2008-1#1)(2010-11#1)(2010-6#2)(2012-3#1)
socio-economic##22##1##(1992-2#1)(2008-1#3)(2008-10#1)(2008-12#4)(2008-7#2)(2010-11#3)(2010-6#4)(2012-12#1)(2012-3#1)(2013-1#2)
socio-economical model##2##2##(1994-1#2)
socio-economical##3##1##(1990-12#1)(1994-1#2)
socio-emotional##2##1##(2008-11#1)(2009-11#1)
socio-political##2##1##(2008-11#2)
sociobiology##4##1##(2010-4#4)
sociocultural##5##1##(1991-8#1)(2008-11#1)(2009-10#1)(2011-1#1)(2013-1#1)
sociodemographic and psychosocial##2##3##(2011-2#2)
sociodemographic and##5##2##(2009-5#1)(2011-2#3)(2013-1#1)
sociodemographic characteristics of##2##3##(2011-2#1)(2012-3#1)
sociodemographic characteristics##5##2##(1994-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
sociodemographic factors##3##2##(1997-4#1)(2011-2#2)
sociodemographic##21##1##(1994-1#1)(1997-4#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-2#8)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
socioeconomic and demographic##2##3##(1992-12#1)(2012-12#1)
socioeconomic and##7##2##(1992-12#1)(1996-3#1)(1997-3#1)(2008-1#1)(2009-5#1)(2012-12#1)(2013-1#1)
socioeconomic burden##2##2##(2010-10#1)(2012-12#1)
socioeconomic change##3##2##(2008-12#3)
socioeconomic classes##2##2##(2008-10#1)(2013-7#1)
socioeconomic conditions##2##2##(1994-6#1)(1997-5#1)
socioeconomic factors##3##2##(2011-2#1)(2012-12#2)
socioeconomic groups##5##2##(1995-1#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-1#1)
socioeconomic level##2##2##(1997-5#1)(2013-8#1)
socioeconomic status (SES)##2##3##(2011-1#1)(2012-2#1)
socioeconomic status##16##2##(1991-6#1)(1991-8#1)(1994-6#2)(2008-1#1)(2009-10#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
socioeconomic strata##2##2##(2008-1#1)(2009-12#1)
socioeconomic##62##1##(1991-6#1)(1991-8#1)(1992-12#2)(1994-6#4)(1995-1#1)(1996-3#2)(1997-3#1)(1997-5#2)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#5)(2008-6#1)(2009-10#1)(2009-12#1)(2009-5#3)(2010-1#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
socioeconomically##2##1##(2013-1#1)(2013-8#1)
sociological##4##1##(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
sociologists##6##1##(2008-12#6)
sociology and##2##2##(1996-1#1)(2008-12#1)
sociology of##2##2##(2008-12#2)
sociology##6##1##(1993-2#1)(1996-1#1)(2008-12#4)
sociometric popularity##2##2##(2010-1#2)
sociometric##4##1##(2010-1#2)(2013-1#2)
sociotechnical systems theory and##2##4##(1993-12#2)
sociotechnical systems##3##2##(1993-12#2)(2010-8#1)
socket##3##1##(2008-10#1)(2013-1#2)
sod-2 was##2##2##(1996-6#2)
soda##5##1##(2008-10#5)
sodalites##7##1##(2008-10#7)
sodium (Na(+))##2##2##(2010-7#1)(2012-2#1)
sodium acetate buffer##3##3##(2008-10#3)
sodium acetate##9##2##(1990-9#1)(1991-7#1)(2008-10#6)(2012-2#1)
sodium acetate-acetic acid buffer##2##4##(2008-10#2)
sodium and potassium picrates##4##4##(2008-10#4)
sodium and potassium sensing##2##4##(2008-10#2)
sodium and potassium##12##3##(1995-8#1)(2008-10#11)
sodium and##20##2##(1990-6#1)(1995-8#1)(2008-10#16)(2008-2#1)(2013-8#1)
sodium arsenite##2##2##(1994-11#1)(1995-11#1)
sodium at##2##2##(2008-10#2)
sodium azide##6##2##(1993-8#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
sodium benzoate##4##2##(2008-10#1)(2008-6#1)(2012-2#2)
sodium bicarbonate##2##2##(1991-1#1)(2008-10#1)
sodium borate##5##2##(1990-3#3)(2008-10#2)
sodium borohydride flow##2##3##(2008-10#2)
sodium borohydride reduction##3##3##(2008-10#2)(2010-6#1)
sodium borohydride##10##2##(2008-10#9)(2010-6#1)
sodium bromate in##4##3##(2008-9#4)
sodium bromate##15##2##(2008-10#1)(2008-9#14)
sodium bromide##2##2##(1994-5#1)(2008-9#1)
sodium butyrate##6##2##(1990-6#1)(2008-11#5)
sodium carbonate##3##2##(2008-10#3)
sodium caseinates##2##2##(2010-4#2)
sodium channel alpha-subunit mRNAs##2##4##(1996-12#2)
sodium channel mRNA##2##3##(1996-12#2)
sodium channel mRNAs##2##3##(1996-12#2)
sodium channel##20##2##(1991-12#2)(1992-3#3)(1996-12#9)(2008-12#3)(2008-5#1)(2008-7#2)
sodium chloride at##2##3##(2008-10#2)
sodium chloride concentration##3##3##(2008-10#2)(2011-2#1)
sodium chloride in##3##3##(2008-10#2)(2011-2#1)
sodium chloride was##2##3##(2008-10#2)
sodium chloride##34##2##(1991-12#1)(1992-10#1)(1994-5#2)(1994-8#1)(1996-3#3)(2008-10#19)(2008-12#5)(2011-2#2)
sodium citrate##7##2##(2008-10#4)(2011-2#2)(2012-2#1)
sodium concentration##4##2##(1994-3#1)(1995-8#1)(2010-1#2)
sodium content##2##2##(1994-3#1)(2008-10#1)
sodium currents##2##2##(1996-12#1)(2008-11#1)
sodium deoxycholate##4##2##(1993-8#1)(2008-10#3)
sodium dichloroisocyanurate##2##2##(2008-10#2)
sodium diethyldithiocarbamate##6##2##(2008-10#6)
sodium dodecyl sulfate (SDS) micellar##2##5##(2008-10#2)
sodium dodecyl sulfate (SDS)##17##4##(1990-11#1)(2008-10#14)(2008-4#1)(2012-2#1)
sodium dodecyl sulfate polyacrylamide gel electrophoresis##3##6##(1990-10#1)(2008-10#1)(2012-2#1)
sodium dodecyl sulfate to##2##4##(1991-3#1)(2008-10#1)
sodium dodecyl sulfate##35##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-3#1)(1996-12#1)(1996-5#1)(2008-10#24)(2008-11#1)(2008-4#1)(2010-11#1)(2012-2#2)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis of##4##6##(2008-10#4)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis##13##5##(1990-10#1)(1992-12#1)(2008-10#10)(2008-11#1)
sodium dodecyl sulphate (SDS)##3##4##(2008-10#3)
sodium dodecyl sulphate##8##3##(1993-3#1)(2008-10#6)(2008-5#1)
sodium dodecyl##63##2##(1990-10#2)(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-3#1)(1996-12#1)(1996-5#1)(2008-10#45)(2008-11#3)(2008-4#1)(2008-5#1)(2010-11#1)(2012-2#2)
sodium dodecylsulfate (SDS) and##2##4##(2008-10#2)
sodium dodecylsulfate (SDS) in##2##4##(2008-10#2)
sodium dodecylsulfate (SDS)##7##3##(2008-10#7)
sodium dodecylsulfate##12##2##(1991-12#1)(2008-10#11)
sodium efflux##3##2##(1992-12#3)
sodium fluoride (NaF)##4##3##(2008-10#3)(2013-1#1)
sodium fluoride pollution##2##3##(2008-12#2)
sodium fluoride##14##2##(1991-11#2)(2008-10#6)(2008-11#1)(2008-12#4)(2013-1#1)
sodium hexadecane-sulfonate##2##2##(2008-10#2)
sodium hydroxide and##7##3##(2008-10#7)
sodium hydroxide in##3##3##(2008-10#2)(2009-5#1)
sodium hydroxide solution##5##3##(2008-10#5)
sodium hydroxide##27##2##(1991-7#1)(2008-10#25)(2009-5#1)
sodium hypochlorite (NaOCl)##2##3##(2013-1#2)
sodium hypochlorite solution##3##3##(2008-10#3)
sodium hypochlorite##7##2##(2008-10#5)(2013-1#2)
sodium in##10##2##(1994-3#1)(2008-10#9)
sodium influx##2##2##(1992-12#2)
sodium intake when injected##2##4##(1997-4#2)
sodium intake##4##2##(1997-4#4)
sodium ion##7##2##(2008-10#7)
sodium ions##4##2##(1992-3#1)(2008-10#3)
sodium lauryl ether sulfate##2##4##(2008-10#1)(2008-5#1)
sodium lauryl ether sulphate##2##4##(2008-5#2)
sodium lauryl ether##4##3##(2008-10#1)(2008-5#3)
sodium lauryl sulphate##2##3##(2008-5#2)
sodium lauryl##7##2##(2008-10#2)(2008-5#5)
sodium metabisulfite##3##2##(2008-10#3)
sodium metaperiodate##2##2##(2008-10#2)
sodium molybdate##2##2##(2008-10#2)
sodium n-vanadate##3##2##(2008-8#3)
sodium nitrate in##2##3##(2008-10#2)
sodium nitrate##6##2##(2008-10#6)
sodium nitrilotriacetate##2##2##(2008-10#2)
sodium nitrite##2##2##(2008-10#2)
sodium nitroprusside (SNP)##3##3##(2008-10#1)(2008-11#2)
sodium nitroprusside##10##2##(1995-8#3)(2008-10#3)(2008-11#3)(2012-3#1)
sodium or potassium##2##3##(2008-10#2)
sodium or##3##2##(1993-8#1)(2008-10#2)
sodium orthovanadate##2##2##(1994-11#1)(2008-10#1)
sodium oxalate##3##2##(2008-10#3)
sodium pentanesulphonate##3##2##(2008-10#3)
sodium perchlorate solutions##2##3##(2008-10#2)
sodium perchlorate##5##2##(2008-10#5)
sodium phosphate buffer##2##3##(2008-10#2)
sodium phosphate##8##2##(1991-1#1)(1992-3#1)(2008-10#5)(2009-8#1)
sodium polypectate##2##2##(2008-10#2)
sodium polystyrenesulfonate (NaPSS)##2##3##(2008-10#2)
sodium potassium##2##2##(1995-8#1)(2008-10#1)
sodium salicylate##2##2##(2008-10#2)
sodium salt##6##2##(1990-6#1)(1993-8#2)(2008-10#2)(2008-11#1)
sodium salts of##2##3##(2008-10#1)(2008-11#1)
sodium salts##5##2##(1994-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-7#1)
sodium selenite and##2##3##(1995-11#1)(2008-10#1)
sodium selenite##4##2##(1995-11#1)(2008-10#2)(2010-11#1)
sodium signal##2##2##(1994-3#2)
sodium sulfide##3##2##(2008-10#3)
sodium sulfite as##2##3##(2008-10#2)
sodium sulfite##7##2##(2008-10#7)
sodium sulphate##5##2##(2008-10#5)
sodium tartrate##4##2##(2008-10#4)
sodium tetrahydroborate##9##2##(2008-10#9)
sodium tetrahydroborate(III)##2##2##(2008-10#2)
sodium tetrakis (4-fluorophenyl) borate##2##4##(2008-10#2)
sodium tetraphenyl borate##3##3##(2008-10#3)
sodium tetraphenylborate (NaTPB) as##4##4##(2008-10#4)
sodium tetraphenylborate (NaTPB)##5##3##(2008-10#5)
sodium tetraphenylborate##10##2##(2008-10#10)
sodium thiocyanate in##2##3##(2008-10#2)
sodium thiocyanate##3##2##(2008-10#3)
sodium to##2##2##(2007-12#1)(2008-10#1)
sodium transport##2##2##(1992-12#1)(2008-7#1)
sodium was##2##2##(2008-10#2)
sodium##619##1##(1990-10#2)(1990-11#1)(1990-3#3)(1990-5#2)(1990-6#3)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#5)(1991-3#2)(1991-7#2)(1992-10#1)(1992-11#1)(1992-12#7)(1992-3#5)(1993-3#1)(1993-8#5)(1994-11#2)(1994-3#8)(1994-5#7)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#8)(1996-12#12)(1996-3#3)(1996-5#1)(1997-2#2)(1997-4#6)(1997-5#1)(2007-12#3)(2008-10#397)(2008-11#20)(2008-12#14)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#20)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#3)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#7)(2011-3#2)(2012-2#8)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#1)
sodium)##4##1##(1991-3#1)(2008-10#3)
sodium-dependent and##2##2##(1992-3#2)
sodium-dependent##5##1##(1992-3#2)(1994-8#1)(1995-11#1)(2008-11#1)
sodium-depleted rats##2##2##(1997-4#2)
sodiumindependent##2##1##(2008-11#2)
soft agar##6##2##(1990-5#1)(1995-2#1)(2008-11#3)(2008-8#1)
soft and##4##2##(1991-2#2)(2008-10#1)(2011-2#1)
soft dough stage##2##3##(2008-10#2)
soft dough##3##2##(2008-10#3)
soft drink powders##2##3##(2008-10#2)
soft drink sample##2##3##(2008-10#2)
soft drink samples##2##3##(2008-10#2)
soft drink##9##2##(2008-10#9)
soft drinks##14##2##(2008-10#14)
soft ice cream##3##3##(2011-2#3)
soft independent modeling of class##2##5##(2008-10#2)
soft independent modelling of class analogy (SIMCA)##2##7##(2008-10#2)
soft independent modelling of class analogy##4##6##(2008-10#4)
soft independent##6##2##(2008-10#6)
soft ionization##2##2##(2008-10#1)(2010-7#1)
soft modeling##2##2##(2008-10#2)
soft palate is##2##3##(1991-2#1)(1991-3#1)
soft palate##3##2##(1990-6#1)(1991-2#1)(1991-3#1)
soft part sarcoma##2##3##(1990-2#2)
soft rot##4##2##(2008-10#4)
soft sensors##2##2##(2013-1#2)
soft tissue and##3##3##(2008-12#2)(2010-6#1)
soft tissue defect##3##3##(2008-9#2)(2011-2#1)
soft tissue defects##2##3##(2010-6#1)(2012-12#1)
soft tissue dissection##2##3##(2011-2#1)(2012-2#1)
soft tissue infections##3##3##(2008-10#1)(2013-1#2)
soft tissue inflammation of##2##4##(2008-12#2)
soft tissue lesions##3##3##(2012-2#3)
soft tissue sarcomas##5##3##(1992-12#3)(1993-9#1)(2011-2#1)
soft tissue tumors##3##3##(1994-6#1)(2011-2#2)
soft tissue tumours##2##3##(2012-2#2)
soft tissue##72##2##(1991-2#1)(1992-1#1)(1992-12#4)(1992-2#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#10)(2008-7#1)(2008-8#1)(2008-9#6)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#4)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#8)(2013-1#7)(2013-7#2)(2013-8#2)
soft tissues and##3##3##(2012-2#2)(2013-1#1)
soft tissues in##2##3##(2008-12#1)(2012-2#1)
soft tissues of the##4##4##(2008-12#2)(2010-6#1)(2010-9#1)
soft tissues##25##2##(2008-10#1)(2008-12#5)(2008-7#1)(2008-9#3)(2009-4#1)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#1)(2012-12#1)(2012-2#3)(2013-1#4)
soft##184##1##(1990-2#2)(1990-5#1)(1990-6#1)(1991-2#5)(1991-3#1)(1992-1#1)(1992-12#4)(1992-2#2)(1993-11#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-11#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#55)(2008-11#4)(2008-12#15)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#9)(2009-3#2)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#9)(2012-12#4)(2012-2#14)(2013-1#14)(2013-7#2)(2013-8#3)
soft-tissue thickening##2##2##(2011-2#1)(2013-7#1)
soft-tissue##10##1##(1992-6#1)(1994-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
soft-x-ray##3##1##(2008-3#3)
softening##7##1##(1993-5#1)(2008-10#2)(2009-5#1)(2009-7#1)(2011-2#2)
softer##3##1##(2008-5#1)(2008-8#1)(2008-9#1)
software and hardware##2##3##(1994-3#1)(2012-2#1)
software and the##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
software and##13##2##(1991-2#1)(1994-3#1)(2008-10#5)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
software applications##2##2##(2007-12#1)(2009-12#1)
software based on##2##3##(2007-8#1)(2012-3#1)
software compensation##3##2##(2008-9#3)
software developed in##2##3##(2008-10#2)
software developed##3##2##(2008-10#3)
software for the##4##3##(2008-10#3)(2008-5#1)
software for##12##2##(1992-9#1)(1994-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)
software has##2##2##(1991-2#1)(2008-3#1)
software in##3##2##(1992-3#1)(2008-10#1)(2012-3#1)
software is##4##2##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
software of##2##2##(2010-8#1)(2011-2#1)
software package##7##2##(1991-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)
software packages##2##2##(2008-10#1)(2008-4#1)
software platform to support##2##4##(1994-2#1)(1994-3#1)
software program##4##2##(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
software programs##3##2##(2008-4#1)(2008-9#1)(2009-3#1)
software requirements##2##2##(1994-2#1)(2008-4#1)
software that##6##2##(1991-12#1)(1992-12#1)(1994-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
software to##8##2##(1992-3#1)(1992-9#1)(1996-1#1)(1996-12#1)(2008-10#1)(2009-12#1)(2010-9#1)(2012-3#1)
software tools##3##2##(2010-10#1)(2010-11#1)(2011-3#1)
software used in##2##3##(2008-10#1)(2012-2#1)
software version##2##2##(2008-4#1)(2011-2#1)
software was used for##2##4##(2008-10#2)
software was used in order to##2##6##(2008-10#1)(2008-12#1)
software was used to##2##4##(2008-1#1)(2008-10#1)
software was used##6##3##(2008-1#1)(2008-10#4)(2008-12#1)
software was##9##2##(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)
software written in##2##3##(2008-10#2)
software##192##1##(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1992-12#2)(1992-3#2)(1992-9#2)(1993-1#1)(1994-2#8)(1994-3#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#47)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#11)(2009-1#1)(2009-11#1)(2009-12#3)(2009-3#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#11)(2011-3#2)(2011-7#1)(2012-2#5)(2012-3#8)(2013-1#8)(2013-8#6)
software-based##3##1##(1994-1#1)(2008-4#1)(2008-6#1)
soil (P &lt##2##3##(2008-10#2)
soil 2##2##2##(2008-10#1)(2008-11#1)
soil acidification##2##2##(2008-10#2)
soil amended with##2##3##(2008-10#2)
soil amendment##2##2##(2008-10#2)
soil and a##2##3##(2008-10#2)
soil and airborne##2##3##(2008-10#1)(2008-11#1)
soil and fruit##2##3##(2008-10#2)
soil and infected##2##3##(2008-10#2)
soil and on##2##3##(2008-10#2)
soil and plant##4##3##(2008-10#3)(2008-11#1)
soil and root##2##3##(2008-10#2)
soil and sediment certified##2##4##(2008-10#2)
soil and sediment samples##4##4##(2008-10#4)
soil and sediment##13##3##(2008-10#13)
soil and the##4##3##(2008-10#4)
soil and vegetation##2##3##(2008-10#1)(2008-9#1)
soil and water##7##3##(2008-10#4)(2008-11#2)(2008-9#1)
soil and##81##2##(2008-10#70)(2008-11#6)(2008-12#1)(2008-9#2)(2012-9#1)(2013-1#1)
soil applications of##2##3##(2008-10#1)(2008-12#1)
soil applications##3##2##(2008-10#2)(2008-12#1)
soil are##2##2##(2008-10#2)
soil as well as##2##4##(2008-10#2)
soil as##6##2##(2008-10#6)
soil at 5##2##3##(2008-10#2)
soil at the##2##3##(2008-10#2)
soil at##14##2##(2008-10#14)
soil bacteria##3##2##(2008-10#1)(2009-3#1)(2012-3#1)
soil block##4##2##(2008-10#4)
soil but##4##2##(2008-10#3)(2008-12#1)
soil by##10##2##(2008-10#9)(2008-11#1)
soil can##2##2##(2008-10#1)(2008-11#1)
soil caused##3##2##(2008-10#3)
soil characteristics##2##2##(2008-10#1)(2012-2#1)
soil chemical##4##2##(2008-10#4)
soil compared with##3##3##(2008-10#3)
soil compartment##2##2##(2008-10#1)(2008-11#1)
soil compounds##3##2##(2010-3#3)
soil conditioners##2##2##(2008-10#2)
soil conditions##3##2##(2008-10#3)
soil containing##3##2##(2008-10#2)(2008-11#1)
soil cores##2##2##(2008-10#2)
soil disinfestation##2##2##(2008-10#2)
soil drought##6##2##(2012-5#2)(2012-6#3)(2012-8#1)
soil during##2##2##(2008-10#2)
soil extract containing##2##3##(2008-10#2)
soil extract##3##2##(2008-10#3)
soil extracts and##2##3##(2008-10#2)
soil extracts using##3##3##(2008-10#3)
soil extracts was##2##3##(2008-10#2)
soil extracts##24##2##(2008-10#24)
soil factors##3##2##(2008-10#3)
soil fertility##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)
soil fractions##3##2##(2008-10#3)
soil from the##5##3##(2008-10#4)(2008-11#1)
soil from##13##2##(2008-10#12)(2008-11#1)
soil fulvic acid##2##3##(2008-10#2)
soil fumigant##2##2##(2008-10#2)
soil fumigants##2##2##(2008-10#2)
soil fungi##3##2##(2008-10#3)
soil had significantly##2##3##(2008-10#2)
soil had##6##2##(2008-10#6)
soil in a##2##3##(2008-10#2)
soil in the##4##3##(2008-10#4)
soil in##18##2##(2008-10#15)(2008-5#1)(2011-2#2)
soil infestation##4##2##(2008-10#4)
soil infested with T##2##4##(2008-10#2)
soil infested with##7##3##(2008-10#7)
soil is##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
soil isolates##2##2##(2008-10#2)
soil layers##4##2##(2008-10#4)
soil leachates##3##2##(2008-10#3)
soil management##2##2##(2008-10#1)(2010-7#1)
soil material##2##2##(2008-11#2)
soil matric potential##2##3##(2008-10#2)
soil matrices##2##2##(2008-10#2)
soil microbes were##2##3##(2008-10#1)(2008-11#1)
soil microbes##6##2##(2008-10#3)(2008-11#3)
soil microbial communities##3##3##(2008-10#3)
soil microbial community structure##2##4##(2008-10#2)
soil microbial community##7##3##(2008-10#7)
soil microbial##14##2##(2008-10#14)
soil microcosm experiments##3##3##(2008-10#3)
soil microflora##6##2##(2008-10#6)
soil mixtures##2##2##(2008-10#2)
soil moisture and temperature##4##4##(2008-10#4)
soil moisture and##8##3##(2008-10#6)(2008-9#1)(2012-7#1)
soil moisture content##4##3##(2008-10#1)(2008-12#1)(2012-7#2)
soil moisture##22##2##(1995-3#1)(2008-10#15)(2008-12#1)(2008-9#1)(2011-1#1)(2012-7#3)
soil of##6##2##(2008-10#4)(2008-5#1)(2010-3#1)
soil on##4##2##(2008-10#3)(2008-11#1)
soil or##6##2##(2008-10#5)(2008-11#1)
soil organisms##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
soil pH##11##2##(1995-3#1)(2008-10#8)(2008-12#1)(2012-6#1)
soil particles##2##2##(2008-10#2)
soil pasteurization##2##2##(2008-10#2)
soil pollution##2##2##(2008-10#1)(2008-11#1)
soil population##2##2##(2008-10#2)
soil populations of Pythium spp##2##5##(2008-10#2)
soil populations of##6##3##(2008-10#6)
soil populations##12##2##(2008-10#12)
soil prior to##2##3##(2008-10#2)
soil properties and##2##3##(2008-10#2)
soil properties in##2##3##(2008-10#2)
soil properties##5##2##(2008-10#5)
soil reduced the##2##3##(2008-10#2)
soil reference materials##3##3##(2008-10#3)
soil respiration##2##2##(2008-11#2)
soil sample with##2##3##(2008-10#2)
soil sample##8##2##(2008-10#8)
soil samples by##5##3##(2008-10#5)
soil samples collected from##5##4##(2008-10#5)
soil samples collected##6##3##(2008-10#6)
soil samples from an intensive horticulture area##2##7##(2008-10#2)
soil samples from##4##3##(2008-10#4)
soil samples of##3##3##(2008-10#1)(2008-11#2)
soil samples taken from an##2##5##(2008-10#2)
soil samples that##3##3##(2008-10#3)
soil samples using##2##3##(2008-10#2)
soil samples was developed##2##4##(2008-10#2)
soil samples was##3##3##(2008-10#3)
soil samples were collected##2##4##(2008-10#1)(2008-12#1)
soil samples were##9##3##(2008-10#8)(2008-12#1)
soil samples with##2##3##(2008-10#2)
soil samples##73##2##(2008-10#68)(2008-11#4)(2008-12#1)
soil solarization##2##2##(2008-10#2)
soil solution##5##2##(2008-10#4)(2008-11#1)
soil surface of##2##3##(2008-10#2)
soil surface##12##2##(2008-10#11)(2008-11#1)
soil suspensions##2##2##(2008-10#2)
soil temperature and##3##3##(2008-10#3)
soil temperature##7##2##(2008-10#7)
soil temperatures##4##2##(2008-10#4)
soil texture##8##2##(2008-10#8)
soil than in##3##3##(2008-10#3)
soil than##4##2##(2008-10#3)(2008-11#1)
soil that##4##2##(2008-10#4)
soil to##12##2##(2008-10#12)
soil transplant experiment##2##3##(2008-9#2)
soil treatments and##2##3##(2008-10#2)
soil treatments##8##2##(2008-10#8)
soil type##9##2##(2008-10#4)(2012-6#1)(2012-9#4)
soil types of##2##3##(2008-10#1)(2012-9#1)
soil types##6##2##(2008-10#3)(2012-5#1)(2012-9#2)
soil using##4##2##(2008-10#4)
soil was inoculated with##2##4##(2008-10#2)
soil was##31##2##(2008-10#26)(2008-11#3)(2008-12#1)(2010-3#1)
soil water content##2##3##(2012-8#2)
soil water potential##2##3##(2008-10#2)
soil water##7##2##(2008-10#3)(2012-5#1)(2012-6#1)(2012-8#2)
soil were not##2##3##(2008-10#2)
soil were##15##2##(2008-10#14)(2008-11#1)
soil with##15##2##(2008-10#14)(2008-12#1)
soil within##2##2##(2008-10#1)(2008-11#1)
soil##998##1##(1991-7#1)(1995-3#4)(2008-10#826)(2008-11#68)(2008-12#15)(2008-5#2)(2008-7#3)(2008-9#11)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#8)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#7)(2012-2#3)(2012-3#1)(2012-5#4)(2012-6#10)(2012-7#3)(2012-8#3)(2012-9#8)(2013-1#2)(2013-8#5)
soil)##12##1##(2008-10#11)(2008-12#1)
soil-to-solvent ratios##2##2##(2008-10#2)
soilborne disease of##2##3##(2008-10#2)
soilborne disease##4##2##(2008-10#4)
soilborne diseases##2##2##(2008-10#2)
soilborne fungal pathogens##2##3##(2008-10#2)
soilborne fungus##4##2##(2008-10#4)
soilborne pathogen##6##2##(2008-10#6)
soilborne pathogens under##2##3##(2008-10#2)
soilborne pathogens##15##2##(2008-10#15)
soilborne pests in fresh market vegetable production systems##2##8##(2008-10#2)
soilborne pests##4##2##(2008-10#4)
soilborne plant pathogen##2##3##(2008-10#2)
soilborne plant pathogens##6##3##(2008-10#6)
soilborne plant##9##2##(2008-10#9)
soilborne##59##1##(2008-10#59)
soiled##3##1##(1996-12#1)(1997-5#2)
soiling##4##1##(1990-3#1)(1997-5#2)(2011-2#1)
soilless container##2##2##(2008-10#2)
soilless##8##1##(2008-10#8)
soils after##2##2##(2008-10#2)
soils amended with##6##3##(2008-10#6)
soils and sediments##6##3##(2008-10#6)
soils and the##3##3##(2008-10#2)(2008-11#1)
soils and vegetation##2##3##(2008-10#2)
soils and wastes##2##3##(2008-10#2)
soils and##31##2##(2008-10#30)(2008-11#1)
soils are##3##2##(2008-10#1)(2008-11#2)
soils by##6##2##(2008-10#5)(2008-12#1)
soils containing the##2##3##(2008-10#2)
soils exhibited##2##2##(2008-10#2)
soils from##11##2##(2008-10#11)
soils had##2##2##(2008-10#2)
soils in a##2##3##(2008-10#2)
soils in which##2##3##(2008-10#2)
soils in##11##2##(2008-10#10)(2012-6#1)
soils infested with##5##3##(2008-10#5)
soils is##3##2##(2008-10#3)
soils may be##2##3##(2008-10#1)(2008-11#1)
soils of##2##2##(2008-10#1)(2008-12#1)
soils prior to planting##2##4##(2008-10#2)
soils prior to##3##3##(2008-10#3)
soils tested##2##2##(2008-10#2)
soils under##2##2##(2008-10#2)
soils was##6##2##(2008-10#6)
soils were infested with##2##4##(2008-10#2)
soils were infested##3##3##(2008-10#3)
soils were##11##2##(2008-10#11)
soils with different##2##3##(2008-10#2)
soils with##15##2##(1995-3#1)(2008-10#13)(2012-6#1)
soils##278##1##(1995-3#1)(2008-10#258)(2008-11#8)(2008-12#2)(2008-9#3)(2009-8#1)(2010-7#1)(2012-6#3)(2013-8#1)
soils)##3##1##(2008-10#1)(2009-8#1)(2012-6#1)
sojae and##2##2##(2008-10#2)
sojae from##2##2##(2008-10#2)
sojae in soil##2##3##(2008-10#2)
sojae in the##2##3##(2008-10#2)
sojae in##8##2##(2008-10#8)
sojae is##3##2##(2008-10#3)
sojae isolates were##2##3##(2008-10#2)
sojae isolates##4##2##(2008-10#4)
sojae was##4##2##(2008-10#4)
sojae were##2##2##(2008-10#2)
sojae##40##1##(2008-10#40)
sol is##2##2##(2008-10#2)
sol was##2##2##(2008-10#2)
sol##11##1##(2008-10#9)(2008-8#2)
sol-gel carbon composite##2##3##(2008-10#2)
sol-gel carbon##3##2##(2008-10#3)
sol-gel chemistry##2##2##(2008-10#1)(2010-7#1)
sol-gel coating##2##2##(2008-10#2)
sol-gel derived##4##2##(2008-10#4)
sol-gel film with##2##3##(2008-10#2)
sol-gel film##8##2##(2008-10#8)
sol-gel glass##4##2##(2008-10#4)
sol-gel material##2##2##(2008-10#2)
sol-gel matrix##3##2##(2008-10#3)
sol-gel membranes##2##2##(2008-10#2)
sol-gel method and characterized by##2##5##(2008-10#2)
sol-gel method and##3##3##(2008-10#3)
sol-gel method##7##2##(2008-10#7)
sol-gel process##2##2##(2008-10#2)
sol-gel technique is##2##3##(2008-10#2)
sol-gel technique##7##2##(2008-10#7)
sol-gel was##3##2##(2008-10#3)
sol-gel##74##1##(2008-10#73)(2010-7#1)
sol-gel-imprinted##2##1##(2008-10#2)
sol-gels##3##1##(2008-10#1)(2010-7#2)
solanacearum 1609##3##2##(2008-10#3)
solanacearum biovar 2##2##3##(2008-10#2)
solanacearum growth##2##2##(2008-10#2)
solanacearum is##4##2##(2008-10#4)
solanacearum population##3##2##(2008-10#3)
solanacearum strains from ginger in Hawaii##2##6##(2008-10#2)
solanacearum strains from##3##3##(2008-10#3)
solanacearum strains##6##2##(2008-10#6)
solanacearum##60##1##(2008-10#60)
solanaceous crops##2##2##(2008-10#1)(2008-6#1)
solanaceous hosts##2##2##(2008-10#2)
solanaceous species##2##2##(2008-10#2)
solanaceous##8##1##(2008-10#7)(2008-6#1)
solani AG-3##3##2##(2008-10#3)
solani AG-4##2##2##(2008-10#2)
solani AG-5##3##2##(2008-10#3)
solani AG1-1A##2##2##(2008-10#2)
solani AGs##2##2##(2008-10#2)
solani anastomosis group##8##3##(2008-10#8)
solani and##8##2##(2008-10#8)
solani at##2##2##(2008-10#2)
solani by##4##2##(2008-10#4)
solani cutinase##2##2##(2008-7#2)
solani f##25##2##(2008-10#25)
solani from##2##2##(2008-10#2)
solani in##7##2##(2008-10#7)
solani is##2##2##(2008-10#2)
solani isolates from coffee##2##4##(2008-10#2)
solani isolates from##3##3##(2008-10#3)
solani isolates##4##2##(2008-10#4)
solani on soybean##2##3##(2008-10#2)
solani on the surface of##2##5##(2008-10#2)
solani on##7##2##(2008-10#7)
solani only##2##2##(2008-10#2)
solani or##3##2##(2008-10#3)
solani pisi##3##2##(1995-3#1)(2008-7#2)
solani resulted in##2##3##(2008-10#2)
solani showed##2##2##(2008-10#2)
solani was##4##2##(2008-10#4)
solani were##6##2##(2008-10#6)
solani##180##1##(1992-8#1)(1995-3#1)(2008-10#174)(2008-7#4)
solar UV radiation##2##3##(2008-10#1)(2013-8#1)
solar UV##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
solar absorption##3##2##(2008-3#3)
solar cells##3##2##(2008-10#1)(2011-2#2)
solar elevation##2##2##(2008-3#2)
solar irradiance##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)
solar radiation and cancer mortality##2##5##(2010-1#2)
solar radiation and##3##3##(2008-10#1)(2010-1#2)
solar radiation on##3##3##(2008-10#1)(2010-1#2)
solar radiation##23##2##(1990-9#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#2)(2010-1#7)(2011-2#1)
solar simulator##2##2##(2008-10#1)(2008-11#1)
solar spectra##2##2##(2008-3#2)
solar spectral irradiance##2##3##(2008-3#2)
solar spectral##3##2##(2008-3#3)
solar transmittance##2##2##(2008-3#2)
solar zenith angle##2##3##(2008-3#2)
solar zenith angles##2##3##(2008-3#2)
solar zenith##4##2##(2008-3#4)
solar##82##1##(1990-9#1)(1992-11#1)(2008-10#17)(2008-11#6)(2008-2#1)(2008-3#32)(2008-5#2)(2008-7#4)(2008-8#1)(2010-1#7)(2011-2#9)(2013-8#1)
solar-blind##2##1##(2007-12#2)
solarization for##2##2##(2008-10#2)
solarization of##2##2##(2008-10#2)
solarization was##2##2##(2008-10#2)
solarization##12##1##(2008-10#12)
solasodine glycosides##4##2##(2008-11#4)
sold##4##1##(1990-6#1)(1991-9#1)(1996-2#1)(2008-1#1)
soldiers##7##1##(1993-2#2)(1995-6#1)(2011-2#1)(2012-12#3)
sole carbon source and##2##4##(2008-10#1)(2011-1#1)
sole carbon source##11##3##(2008-10#6)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
sole##55##1##(1990-9#1)(1991-12#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-5#2)(1997-7#1)(2008-10#17)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2010-5#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
solely by##5##2##(1997-8#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
solely from##5##2##(1994-2#1)(1994-8#1)(2008-10#2)(2011-2#1)
solely in##4##2##(2008-10#3)(2008-11#1)
solely on the basis of##2##5##(1995-6#1)(2008-9#1)
solely on the##3##3##(1995-6#1)(2008-9#2)
solely on##13##2##(1994-12#1)(1994-3#1)(1995-6#2)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-9#1)(2012-12#1)(2012-2#1)
solely responsible for the##2##4##(1997-9#1)(2008-5#1)
solely the##2##2##(2013-1#2)
solely to##6##2##(1990-9#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
solely##58##1##(1990-12#1)(1990-9#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-8#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
solenoid valves and##3##3##(2008-10#3)
solenoid valves assembled to##3##4##(2008-10#3)
solenoid valves for##2##3##(2008-10#2)
solenoid valves##13##2##(2008-10#13)
solenoid##15##1##(2008-10#15)
soles and##2##2##(1997-3#1)(2008-5#1)
soles##5##1##(1997-3#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-3#1)
soleus muscles##2##2##(1991-2#1)(1995-12#1)
soleus##6##1##(1991-2#1)(1995-12#4)(2013-8#1)
solgel silica lasers##2##3##(2008-3#2)
solgel silica##3##2##(2008-3#3)
solgel waveguide##2##2##(2008-3#2)
solgel##5##1##(2008-3#5)
solicit##2##1##(1995-3#1)(2007-12#1)
solicitation##2##1##(1993-12#1)(2010-12#1)
solid acid##2##2##(2008-10#2)
solid adsorbents##2##2##(2008-10#2)
solid amalgam electrode##3##3##(2008-10#3)
solid amalgam##5##2##(2008-10#5)
solid and liquid##4##3##(2008-10#4)
solid and the##2##3##(2008-10#1)(2010-4#1)
solid and##11##2##(2008-10#9)(2008-12#1)(2010-4#1)
solid arthrodesis from##2##3##(2008-8#2)
solid contact electrodes##4##3##(2008-10#4)
solid contact sensor for the determination of doxycycline hydrochloride##2##9##(2008-10#2)
solid contact were##2##3##(2008-10#2)
solid contact##11##2##(2008-10#11)
solid dispersion##3##2##(2012-2#3)
solid dispersions##3##2##(2012-2#3)
solid electrodes##2##2##(2008-10#2)
solid explosive##2##2##(2008-10#2)
solid fermentation##3##2##(2008-10#3)
solid fusion##2##2##(2012-3#2)
solid iodine##2##2##(2008-10#2)
solid mass##6##2##(2008-10#6)
solid material##2##2##(2008-10#2)
solid materials##3##2##(2008-10#3)
solid matrices##3##2##(2008-10#2)(2008-9#1)
solid matrix##4##2##(2008-10#4)
solid media##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
solid medium##3##2##(1993-9#1)(1997-2#1)(2008-7#1)
solid mercury##2##2##(2008-10#2)
solid mixture##3##2##(2008-10#3)
solid or liquid media##2##4##(2008-10#2)
solid or liquid particles##2##4##(1992-3#2)
solid or liquid##4##3##(1992-3#2)(2008-10#2)
solid or##5##2##(1992-3#2)(2008-10#3)
solid organ##2##2##(2008-10#1)(2010-12#1)
solid particles##2##2##(1996-3#1)(2008-10#1)
solid phase and##2##3##(1990-12#1)(2008-10#1)
solid phase degradation of l-ascorbic acid##4##6##(2008-10#4)
solid phase extractant for##2##4##(2008-10#2)
solid phase extractant##4##3##(2008-10#4)
solid phase extraction (SPE) and##3##5##(2008-10#2)(2008-11#1)
solid phase extraction (SPE) cartridges##2##5##(2008-10#2)
solid phase extraction (SPE) method##2##5##(2008-10#2)
solid phase extraction (SPE)##27##4##(2008-10#26)(2008-11#1)
solid phase extraction and##4##4##(2008-10#4)
solid phase extraction cartridges##2##4##(2008-10#2)
solid phase extraction followed by##2##5##(2008-10#2)
solid phase extraction of##8##4##(2008-10#8)
solid phase extraction procedure##2##4##(2008-10#2)
solid phase extraction system##2##4##(2008-10#2)
solid phase extraction using##2##4##(2008-10#2)
solid phase extraction##73##3##(2008-10#71)(2008-11#1)(2009-8#1)
solid phase extractive preconcentration##2##4##(2008-10#2)
solid phase extractor for##3##4##(2008-10#3)
solid phase extractor##4##3##(2008-10#4)
solid phase micro extraction##2##4##(2008-10#2)
solid phase micro-extraction##3##3##(2008-10#3)
solid phase microextraction (HSSPME)##2##4##(2008-10#2)
solid phase microextraction (SPME) to##2##5##(2008-10#2)
solid phase microextraction (SPME)##7##4##(2008-10#7)
solid phase microextraction coupled##2##4##(2008-10#2)
solid phase microextraction##16##3##(2008-10#16)
solid phase spectrophotometric##3##3##(2008-10#3)
solid phase spectrophotometry##3##3##(2008-10#3)
solid phase##163##2##(1990-12#4)(1990-6#1)(1991-5#1)(1992-9#1)(1993-2#2)(2008-10#150)(2008-11#2)(2008-7#1)(2009-8#1)
solid propellants##2##2##(2008-10#2)
solid sample##8##2##(2008-10#8)
solid samples and##4##3##(2008-10#4)
solid samples by##2##3##(2008-10#2)
solid samples has##2##3##(2008-10#2)
solid samples using the##2##4##(2008-10#2)
solid samples was##3##3##(2008-10#3)
solid samples were##2##3##(2008-10#2)
solid samples##25##2##(2008-10#25)
solid sampling electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
solid sampling##7##2##(2008-10#7)
solid sensing zone##2##3##(2008-10#2)
solid sensing##3##2##(2008-10#3)
solid solution##6##2##(2007-11#1)(2008-10#4)(2012-2#1)
solid sorbents##3##2##(2008-10#3)
solid state (13)C NMR##3##4##(2008-10#3)
solid state bioprocessing of##2##4##(1997-2#2)
solid state bioprocessing##3##3##(1997-2#3)
solid state##13##2##(1997-2#4)(2008-10#9)
solid substrate inoculum##2##3##(2008-10#2)
solid substrate##11##2##(1997-2#1)(2008-10#8)(2008-5#1)(2008-7#1)
solid substrate-room temperature phosphorimetry##2##4##(2008-10#2)
solid substrates##5##2##(2008-10#3)(2008-4#1)(2009-6#1)
solid support and##3##3##(2008-10#1)(2008-4#2)
solid support is##2##3##(2008-10#2)
solid support##28##2##(2008-10#23)(2008-4#3)(2008-6#1)(2009-12#1)
solid supports##3##2##(2008-10#3)
solid surface fluorescence##2##3##(2008-10#2)
solid surface fluorescence-based sensing##2##4##(2008-10#2)
solid surface is##2##3##(2008-10#2)
solid surface##9##2##(2008-10#8)(2008-11#1)
solid surfaces##4##2##(2008-4#1)(2008-7#1)(2009-11#1)(2010-7#1)
solid tumor##7##2##(1993-6#1)(1994-12#1)(1994-3#1)(1995-9#1)(2008-11#1)(2008-9#1)(2010-7#1)
solid tumors by##2##3##(2008-9#1)(2011-2#1)
solid tumors##19##2##(1992-10#1)(1996-10#1)(2008-11#5)(2008-5#1)(2008-7#4)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#3)
solid tumour##2##2##(2008-1#1)(2008-11#1)
solid waste disposal##2##3##(2008-12#2)
solid waste##8##2##(2008-10#4)(2008-12#4)
solid##526##1##(1990-12#5)(1990-6#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-3#2)(1992-9#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-3#2)(1997-1#1)(1997-2#7)(1997-3#1)(2007-11#2)(2008-1#1)(2008-10#391)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#8)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#12)(2013-8#1)
solid&quot##3##1##(1994-5#2)(2008-10#1)
solid-contact##3##1##(2008-10#3)
solid-liquid extraction of##2##3##(2008-10#2)
solid-liquid extraction##12##2##(2008-10#12)
solid-liquid##17##1##(2008-10#16)(2008-7#1)
solid-matrix luminescence##3##2##(2008-10#3)
solid-matrix phosphorescence##2##2##(2008-10#2)
solid-matrix##6##1##(2008-10#6)
solid-phase PbO(2)##2##2##(2008-10#2)
solid-phase extraction (SPE)##12##3##(1997-2#1)(2008-10#11)
solid-phase extraction and gas chromatography-mass spectrometry##2##6##(2008-10#2)
solid-phase extraction and gas chromatography-mass##3##5##(2008-10#3)
solid-phase extraction and##13##3##(1992-11#1)(1997-2#2)(2008-10#9)(2008-11#1)
solid-phase extraction by##2##3##(2008-10#2)
solid-phase extraction device##2##3##(1997-2#2)
solid-phase extraction of##7##3##(1997-2#1)(2008-10#6)
solid-phase extraction support##2##3##(2008-10#2)
solid-phase extraction system##2##3##(2008-10#2)
solid-phase extraction technique##2##3##(1992-11#1)(2013-8#1)
solid-phase extraction using##4##3##(2008-10#4)
solid-phase extraction was##2##3##(2008-10#2)
solid-phase extraction with##4##3##(2008-10#4)
solid-phase extraction##67##2##(1992-11#4)(1997-2#9)(2008-10#52)(2008-11#1)(2013-8#1)
solid-phase method##2##2##(1995-6#1)(2008-9#1)
solid-phase microextraction (HS-SPME)##3##3##(2008-10#3)
solid-phase microextraction (SPME) fiber##2##4##(2008-10#2)
solid-phase microextraction (SPME) with##2##4##(2008-10#2)
solid-phase microextraction (SPME)##14##3##(2008-10#14)
solid-phase microextraction and##3##3##(2008-10#3)
solid-phase microextraction coupled with high-performance liquid chromatography##2##7##(2008-10#2)
solid-phase microextraction coupled##3##3##(2008-10#3)
solid-phase microextraction using calix[4]arene fiber##2##5##(2008-10#2)
solid-phase microextraction with##2##3##(2008-10#2)
solid-phase microextraction##41##2##(1997-2#1)(2008-10#39)(2012-12#1)
solid-phase reactor##2##2##(2008-10#2)
solid-phase spectrofluorimetry##2##2##(2008-10#2)
solid-phase spectrophotometric##2##2##(2008-10#2)
solid-phase spectrophotometry##3##2##(2008-10#3)
solid-phase synthesis of##3##3##(2008-4#3)
solid-phase##157##1##(1990-12#2)(1991-3#1)(1992-11#4)(1992-3#1)(1992-6#2)(1995-6#2)(1995-8#1)(1997-2#11)(2008-10#124)(2008-11#1)(2008-4#4)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
solid-state and##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
solid-state contact##3##2##(2008-10#3)
solid-state electrochemiluminescence##2##2##(2008-10#2)
solid-state electrodes##3##2##(2008-10#3)
solid-state fermentation##2##2##(2011-2#2)
solid-state lasers##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
solid-state##41##1##(1992-1#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-2#2)(2008-3#7)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
solid-support assisted on-line derivatization##2##4##(2008-10#2)
solid-support assisted##3##2##(2008-10#3)
solid-surface fluorescence##2##2##(2008-10#2)
solid-surface##4##1##(2008-10#4)
solidified wastes##2##2##(2008-10#2)
solidified##4##1##(2008-10#3)(2008-5#1)
solidifying##3##1##(2008-12#1)(2008-5#2)
solids and##2##2##(2008-10#1)(2008-3#1)
solids have been##2##3##(2008-10#2)
solids##29##1##(1994-12#1)(2008-10#21)(2008-12#1)(2008-3#1)(2010-5#2)(2011-2#2)(2012-2#1)
solitarily##2##1##(2008-8#1)(2008-9#1)
solitary and##3##2##(1997-1#1)(2008-9#1)(2012-3#1)
solitary cells##2##2##(1994-6#1)(2008-10#1)
solitary extramedullary plasmacytoma##2##3##(2009-3#2)
solitary foragers##2##2##(2008-9#2)
solitary kidney##3##2##(2012-12#3)
solitary metastases##2##2##(1990-8#1)(1992-12#1)
solitary nodules##2##2##(2012-3#2)
solitary nonparasitic cyst of the##2##5##(1991-3#2)
solitary plasmacytoma##2##2##(2012-12#2)
solitary solid##2##2##(1993-6#1)(2013-1#1)
solitary##50##1##(1990-12#1)(1990-8#3)(1991-3#4)(1991-9#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-6#1)(1996-1#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-3#2)(2009-8#1)(2010-4#2)(2010-6#3)(2011-2#1)(2012-12#6)(2012-3#3)(2013-1#4)
soliton collisions##2##2##(2007-12#2)
soliton generation##2##2##(2007-12#2)
soliton##6##1##(1992-11#1)(2007-12#5)
solitons in##2##2##(2007-12#2)
solitons##12##1##(1994-2#1)(2007-11#2)(2007-12#9)
solstitialis##2##1##(2008-10#2)
solubilisation##3##1##(2008-10#2)(2010-4#1)
solubilities and##2##2##(2008-10#2)
solubilities##7##1##(2008-10#7)
solubility and##6##2##(2008-10#4)(2008-4#1)(2010-4#1)
solubility constant##2##2##(2008-10#2)
solubility in molten##2##3##(2008-10#2)
solubility in the##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
solubility in water##6##3##(2008-10#5)(2008-9#1)
solubility in##13##2##(1991-12#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-9#1)
solubility is##2##2##(1991-12#1)(2008-10#1)
solubility of furosemide##2##3##(2012-2#2)
solubility of the##7##3##(2008-10#6)(2013-1#1)
solubility of toluene##3##3##(2008-10#3)
solubility of##28##2##(1994-8#1)(2008-10#20)(2008-11#1)(2008-4#1)(2008-5#2)(2012-2#2)(2013-1#1)
solubility on##2##2##(2008-10#2)
solubility parameter##3##2##(2008-10#3)
solubility parameters##5##2##(2008-10#5)
solubility product##2##2##(2008-10#2)
solubility properties##2##2##(1997-2#1)(2008-10#1)
solubility was##3##2##(2008-11#1)(2012-2#2)
solubility##111##1##(1991-12#2)(1993-1#1)(1993-8#1)(1994-8#1)(1997-1#4)(1997-2#1)(2008-10#67)(2008-11#4)(2008-4#4)(2008-5#7)(2008-7#1)(2008-9#1)(2010-4#4)(2011-2#1)(2012-2#6)(2013-1#6)
solubility)##2##1##(2008-10#1)(2008-5#1)
solubilization and##4##2##(2008-11#1)(2008-4#1)(2008-5#2)
solubilization in##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
solubilization of##5##2##(2008-10#4)(2008-4#1)
solubilization##26##1##(1994-5#1)(2008-10#8)(2008-11#6)(2008-4#6)(2008-5#2)(2012-2#2)(2013-1#1)
solubilize##3##1##(2008-10#1)(2009-10#2)
solubilized and##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
solubilized enzyme##2##2##(1990-5#1)(1994-8#1)
solubilized in##4##2##(1990-2#1)(1995-11#1)(2008-10#2)
solubilized tonoplast proteins##2##3##(2008-11#2)
solubilized with##3##2##(1990-2#1)(2008-10#2)
solubilized##26##1##(1990-2#2)(1990-5#1)(1991-10#1)(1991-5#2)(1992-3#1)(1994-11#1)(1994-8#3)(1995-11#1)(1996-12#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-6#2)
solubilizing the##2##2##(2008-10#1)(2008-11#1)
solubilizing##4##1##(2008-10#2)(2008-11#1)(2013-1#1)
soluble Cr##3##2##(2008-10#3)
soluble IL-6 receptor##2##3##(1997-7#2)
soluble Mn (IV)-formaldehyde-indomethacin##2##3##(2008-10#2)
soluble and insoluble##5##3##(1996-1#1)(2008-10#3)(2008-4#1)
soluble and microsomal b5##2##4##(1992-6#2)
soluble and microsomal##4##3##(1992-6#4)
soluble and##14##2##(1992-6#4)(1994-11#1)(1995-2#1)(1996-1#1)(2008-10#5)(2008-4#1)(2009-7#1)
soluble antigens##5##2##(1997-9#1)(2008-11#3)(2008-9#1)
soluble complexes##3##2##(2008-10#3)
soluble cytokines##2##2##(2008-9#2)
soluble even##2##2##(2008-10#2)
soluble extract##3##2##(1990-2#2)(1990-5#1)
soluble factors##6##2##(2007-11#1)(2008-4#1)(2009-12#1)(2012-4#1)(2013-1#1)(2013-8#1)
soluble form##5##2##(1994-8#1)(2008-10#1)(2008-7#1)(2012-2#2)
soluble forms##2##2##(1995-12#1)(2008-10#1)
soluble fraction##2##2##(1990-2#1)(2008-10#1)
soluble fractions##3##2##(1990-11#3)
soluble glucose oxidase##2##3##(2008-10#2)
soluble human##2##2##(2008-11#2)
soluble in a##2##3##(2008-10#2)
soluble in the##6##3##(1997-7#1)(2008-10#3)(2008-7#1)(2008-9#1)
soluble in water##3##3##(2008-10#2)(2008-5#1)
soluble in##16##2##(1996-1#1)(1997-7#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-9#1)
soluble magnesium##2##2##(2008-10#2)
soluble manganese(IV)##2##2##(2008-10#2)
soluble mediators##2##2##(1990-9#1)(1995-2#1)
soluble oxalate##2##2##(2012-2#2)
soluble phenolic compounds##4##3##(2008-10#4)
soluble protein##10##2##(1990-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-4#1)(2012-9#1)
soluble proteins##3##2##(1992-6#1)(1995-2#1)(1997-1#1)
soluble recombinant##2##2##(1995-11#1)(2013-8#1)
soluble salts##2##2##(1990-5#1)(2008-10#1)
soluble solids##2##2##(2008-10#1)(2011-2#1)
soluble species of##2##3##(2008-10#2)
soluble type##2##2##(1993-3#1)(2008-11#1)
soluble##218##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#5)(1990-5#2)(1990-9#2)(1991-10#1)(1992-6#8)(1992-7#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#5)(1996-1#2)(1996-2#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-7#3)(1997-9#1)(2006-6#2)(2007-11#1)(2007-12#1)(2008-10#93)(2008-11#18)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#4)(2012-4#1)(2012-9#1)(2013-1#1)(2013-8#5)
solublized##2##1##(2008-10#1)(2008-11#1)
soluflazine##2##1##(1994-8#2)
solute and##4##2##(2008-10#4)
solute dielectric##2##2##(2008-4#1)(2013-1#1)
solute is##2##2##(2008-10#1)(2013-1#1)
solute retention and##2##3##(2008-10#2)
solute##31##1##(1991-6#1)(2008-10#22)(2008-3#1)(2008-4#2)(2011-2#1)(2012-7#1)(2013-1#3)
solute-solvent interactions##3##2##(2008-10#3)
solutes are##2##2##(2008-10#2)
solutes in##2##2##(2008-10#1)(2012-7#1)
solutes on##2##2##(2008-10#2)
solutes were##2##2##(2008-10#2)
solutes##28##1##(1990-5#2)(1997-2#1)(2008-10#17)(2008-12#1)(2008-7#3)(2011-2#2)(2012-7#2)
solution (0##5##2##(2008-10#5)
solution (1##2##2##(2008-10#2)
solution (2##3##2##(2008-10#3)
solution (5##2##2##(2008-10#2)
solution (NaNO(3) 0##2##3##(2008-10#2)
solution (in##2##2##(1993-8#1)(2008-10#1)
solution (pH 4##7##3##(2008-10#6)(2008-3#1)
solution (pH 7##4##3##(2008-10#4)
solution (pH 8##2##3##(2008-10#1)(2008-11#1)
solution (pH##26##2##(2008-10#24)(2008-11#1)(2008-3#1)
solution 0##2##2##(2008-10#2)
solution acidity##4##2##(2008-10#4)
solution adjusted to pH##3##4##(2008-10#3)
solution after each##2##3##(2008-10#2)
solution after##7##2##(2008-10#6)(2009-7#1)
solution and a##5##3##(2008-10#5)
solution and in##6##3##(2008-10#6)
solution and subsequently##2##3##(2008-10#2)
solution and the##17##3##(2008-10#15)(2008-3#1)(2008-9#1)
solution and then##2##3##(2008-10#2)
solution and to##4##3##(2008-10#3)(2008-5#1)
solution and were##2##3##(2008-10#1)(2008-12#1)
solution and##109##2##(1990-5#1)(1991-3#2)(1995-6#1)(1997-2#1)(2008-10#93)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#3)(2010-3#1)(2013-1#1)(2013-8#1)
solution are##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
solution as a titrant##2##4##(2008-10#2)
solution as a##6##3##(2008-10#6)
solution as eluent##2##3##(2008-10#2)
solution as mobile phase##2##4##(2008-10#2)
solution as##18##2##(2008-10#16)(2008-5#1)(2008-9#1)
solution at a flow-rate of##2##5##(2008-10#2)
solution at a##8##3##(2008-10#8)
solution at an##2##3##(2008-10#2)
solution at different##2##3##(2008-10#2)
solution at pH 3##3##4##(2008-10#3)
solution at pH 5##2##4##(2008-10#2)
solution at pH 6##3##4##(2008-10#3)
solution at pH 7##3##4##(2008-10#3)
solution at pH 8##3##4##(2008-10#3)
solution at pH##17##3##(2008-10#17)
solution at the##2##3##(1994-3#1)(2008-10#1)
solution at##41##2##(1991-6#1)(1994-3#1)(2008-10#39)
solution between##2##2##(2008-10#2)
solution by means of##3##4##(2008-10#3)
solution by the##2##3##(2008-10#2)
solution by using##2##3##(2008-10#2)
solution by##19##2##(1991-3#1)(1994-5#1)(2008-10#17)
solution calorimetry##5##2##(2008-10#5)
solution can be##6##3##(1991-3#1)(2008-10#5)
solution can##9##2##(1991-3#1)(2008-10#8)
solution carrier##2##2##(2008-10#2)
solution casting##2##2##(2008-10#2)
solution caused##2##2##(2008-10#1)(2008-8#1)
solution chemistry##2##2##(1993-12#1)(2008-5#1)
solution composition##2##2##(2008-10#2)
solution concentration##3##2##(2008-10#2)(2009-7#1)
solution conditions##3##2##(1997-2#1)(2008-10#2)
solution containing 0##10##3##(2008-10#9)(2008-12#1)
solution containing 1##2##3##(2008-10#1)(2008-8#1)
solution containing 2##3##3##(2008-10#3)
solution containing 7##2##3##(2008-10#2)
solution containing a##3##3##(2008-10#3)
solution containing both##2##3##(2008-10#2)
solution containing the##3##3##(2008-10#3)
solution containing##74##2##(1997-6#1)(2008-10#67)(2008-12#2)(2008-8#2)(2008-9#1)(2011-2#1)
solution culture##2##2##(2008-8#1)(2008-9#1)
solution decreased##2##2##(1996-2#1)(2008-10#1)
solution depends on##2##3##(1997-2#1)(2011-2#1)
solution does not##2##3##(1996-3#1)(2008-10#1)
solution during##2##2##(2008-10#2)
solution equilibria of##3##3##(2008-10#3)
solution followed by##3##3##(2008-10#2)(2008-11#1)
solution for a##3##3##(2008-10#2)(2008-11#1)
solution for the##9##3##(2008-10#5)(2008-2#1)(2008-3#1)(2009-7#1)(2011-7#1)
solution for##36##2##(1990-3#1)(1992-9#1)(1993-8#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-7#1)(2011-7#1)
solution from the##3##3##(2008-10#3)
solution from##6##2##(2008-10#6)
solution gave a mean absorbance of 0##2##7##(2008-10#2)
solution gave a mean##3##4##(2008-10#3)
solution gave a##5##3##(2008-10#5)
solution generated##2##2##(2008-10#2)
solution had##3##2##(2008-10#3)
solution has been described##2##4##(2008-10#2)
solution has been investigated##2##4##(2008-10#2)
solution has been##8##3##(2008-10#7)(2008-3#1)
solution have been##5##3##(1990-9#1)(1995-6#1)(2008-10#2)(2008-5#1)
solution have##6##2##(1990-9#1)(1995-6#1)(2008-10#3)(2008-5#1)
solution hybridisation-RNase protection assay##3##4##(1996-12#3)
solution hybridisation-RNase protection##4##3##(1996-12#4)
solution hybridization##2##2##(1995-8#1)(2008-10#1)
solution in a##9##3##(2008-10#8)(2009-9#1)
solution in order to##3##4##(2008-10#3)
solution in the presence of##3##5##(2008-10#3)
solution in the##11##3##(1991-1#1)(1995-3#2)(2008-10#8)
solution in which the##2##4##(2008-10#1)(2008-8#1)
solution in##44##2##(1991-1#1)(1994-5#1)(1995-3#2)(2007-8#1)(2008-10#35)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)
solution including##2##2##(2008-10#2)
solution increased##2##2##(1990-5#1)(2008-11#1)
solution instead of##2##3##(2008-10#1)(2008-11#1)
solution into a##3##3##(2008-10#3)
solution into the##4##3##(2008-10#4)
solution into##8##2##(2008-10#8)
solution is added to##2##4##(2008-10#2)
solution is determined##2##3##(2008-10#2)
solution is injected into##3##4##(2008-10#3)
solution is mixed##2##3##(2008-10#2)
solution is presented##2##3##(2008-10#1)(2008-3#1)
solution is required##2##3##(2008-10#2)
solution is to##2##3##(1994-3#1)(2011-2#1)
solution is used to##2##4##(2008-10#1)(2008-2#1)
solution is used##4##3##(2008-10#3)(2008-2#1)
solution is##55##2##(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#42)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-8#1)(2010-12#1)(2011-2#1)
solution leaving##2##2##(2008-10#2)
solution measurements##2##2##(1993-8#1)(2008-10#1)
solution must be##2##3##(2008-10#2)
solution obtained by##2##3##(2008-10#1)(2011-2#1)
solution obtained##3##2##(2008-10#2)(2011-2#1)
solution of 0##9##3##(2008-10#9)
solution of 2##3##3##(2008-10#3)
solution of a##3##3##(2008-10#1)(2008-2#1)(2009-10#1)
solution of light scattering##2##4##(2008-3#2)
solution of pH 8##2##4##(2008-10#2)
solution of pH##5##3##(2008-10#5)
solution of potassium phosphate dibasic (pH 7##2##7##(2008-10#2)
solution of sodium##3##3##(2008-10#3)
solution of the reagent##2##4##(2008-10#2)
solution of the##22##3##(1991-11#1)(1991-9#1)(1997-2#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-10#1)
solution of##116##2##(1990-3#1)(1991-11#1)(1991-2#1)(1991-9#1)(1994-9#1)(1997-2#1)(2008-10#86)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)
solution on the##8##3##(2008-10#8)
solution on##13##2##(2008-10#10)(2010-7#1)(2013-1#1)(2013-7#1)
solution only##2##2##(2008-10#1)(2008-12#1)
solution onto##3##2##(2008-10#2)(2008-11#1)
solution or##11##2##(1990-5#1)(1994-9#1)(2008-10#9)
solution orientation##2##2##(2011-2#2)
solution over##2##2##(2008-10#2)
solution pH and##3##3##(2008-10#3)
solution pH on the##3##4##(2008-10#2)(2008-5#1)
solution pH##24##2##(2008-10#23)(2008-5#1)
solution phase sensing##2##3##(2008-10#2)
solution phase##8##2##(2008-10#8)
solution preparation##2##2##(2008-10#1)(2008-9#1)
solution procedure##2##2##(1992-6#1)(2009-10#1)
solution results in##2##3##(1990-2#1)(1996-5#1)
solution samples##11##2##(2008-10#11)
solution should be##2##3##(2008-10#1)(2013-1#1)
solution showed##2##2##(2008-10#2)
solution shows##2##2##(2008-10#1)(2008-3#1)
solution structure of a##2##4##(1992-4#1)(1995-8#1)
solution structure of##8##3##(1992-4#1)(1994-5#5)(1995-8#1)(2011-2#1)
solution structure##13##2##(1992-4#1)(1994-5#8)(1995-8#1)(2009-7#2)(2011-2#1)
solution temperature##3##2##(2008-10#3)
solution than##2##2##(2008-10#2)
solution that contained##2##3##(2008-10#2)
solution that##6##2##(2008-10#3)(2008-3#2)(2010-8#1)
solution the##3##2##(2008-10#3)
solution through the##3##3##(2008-10#3)
solution through##5##2##(2008-10#4)(2008-11#1)
solution to an##2##3##(2008-10#2)
solution to form##2##3##(2008-10#2)
solution to give##2##3##(2008-10#2)
solution to the problem##5##4##(1994-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
solution to the##11##3##(1990-5#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-7#1)
solution to this##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
solution to##44##2##(1990-5#1)(1993-11#1)(1994-9#1)(1995-1#1)(1997-5#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#3)(2010-11#1)(2010-7#1)(2013-1#1)
solution under##6##2##(1995-2#1)(2008-10#5)
solution upon##2##2##(2008-10#2)
solution used for##2##3##(2008-10#1)(2009-9#1)
solution used##5##2##(2008-10#4)(2009-9#1)
solution using a##2##3##(2008-10#1)(2008-11#1)
solution using the##2##3##(1996-12#1)(2010-3#1)
solution using##8##2##(1996-12#1)(2008-10#5)(2008-11#1)(2010-3#1)
solution was 0##5##3##(2008-10#5)
solution was also##2##3##(2008-10#2)
solution was analyzed##2##3##(2008-10#1)(2011-3#1)
solution was carried out##2##4##(2008-10#2)
solution was carried##3##3##(2008-10#3)
solution was determined##2##3##(2008-10#2)
solution was directly##3##3##(2008-10#3)
solution was found to be##2##5##(2008-10#1)(2012-2#1)
solution was found##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
solution was injected in to##2##5##(2008-10#2)
solution was injected into the##2##5##(2008-10#2)
solution was injected into##3##4##(2008-10#2)(2008-9#1)
solution was injected##10##3##(2008-10#9)(2008-9#1)
solution was linear##2##3##(2008-10#2)
solution was measured##4##3##(2008-10#3)(2013-1#1)
solution was obtained##3##3##(2008-10#3)
solution was passed through##2##4##(2008-10#2)
solution was performed by##2##4##(2008-10#2)
solution was performed##3##3##(2008-10#3)
solution was studied##3##3##(2008-10#3)
solution was used as a##2##5##(2008-10#2)
solution was used as##5##4##(2008-10#5)
solution was used##7##3##(2008-10#7)
solution was##108##2##(1996-12#1)(1996-5#1)(2008-10#93)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-3#2)(2011-3#1)(2012-2#2)(2013-1#1)
solution were carried out##2##4##(1991-5#1)(2008-10#1)
solution were determined##2##3##(2008-10#2)
solution were introduced##2##3##(2008-10#2)
solution were investigated##2##3##(2008-10#1)(2008-5#1)
solution were obtained##3##3##(2008-10#3)
solution were studied##3##3##(2008-10#3)
solution were##35##2##(1991-5#1)(2008-10#31)(2008-11#1)(2008-5#1)(2008-8#1)
solution which was##2##3##(2008-10#2)
solution which##5##2##(1992-3#1)(2008-10#4)
solution while##2##2##(2008-10#1)(2009-10#1)
solution with a correlation coefficient of 0##3##7##(2008-10#3)
solution with a detection limit of##2##6##(2008-10#2)
solution with a detection limit##3##5##(2008-10#3)
solution with a##9##3##(2008-10#9)
solution with pH##2##3##(2008-10#2)
solution with the##5##3##(2008-10#5)
solution with##35##2##(1990-12#1)(1992-3#1)(1995-11#1)(2008-10#30)(2008-7#1)(2013-1#1)
solution within the##3##3##(1990-5#1)(2008-10#2)
solution without##4##2##(2008-10#3)(2008-12#1)
solution yielding a##2##3##(2008-10#2)
solution##1702##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#7)(1990-9#2)(1991-1#2)(1991-11#2)(1991-2#2)(1991-3#5)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#6)(1994-12#2)(1994-3#2)(1994-5#10)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#2)(1996-12#7)(1996-2#5)(1996-3#4)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#9)(1997-3#1)(1997-5#1)(1997-6#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1360)(2008-11#25)(2008-12#10)(2008-2#7)(2008-3#25)(2008-4#6)(2008-5#17)(2008-6#5)(2008-7#9)(2008-8#10)(2008-9#26)(2009-10#5)(2009-4#1)(2009-7#7)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-2#17)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#1)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#2)
solution) were##3##2##(2008-10#2)(2008-5#1)
solution)##12##1##(1994-2#1)(2008-10#9)(2008-12#1)(2008-5#1)
solution?##4##1##(1995-1#2)(1995-2#1)(2008-10#1)
solutions (0##2##2##(2008-10#2)
solutions after##4##2##(2008-10#3)(2011-3#1)
solutions and for##2##3##(2008-10#2)
solutions and in the##3##4##(2008-10#2)(2008-11#1)
solutions and in##9##3##(2008-10#7)(2008-11#1)(2008-8#1)
solutions and its##2##3##(2008-10#2)
solutions and the##3##3##(2008-10#3)
solutions and##43##2##(2008-10#36)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
solutions are described##2##3##(1992-11#1)(2008-10#1)
solutions are##15##2##(1992-11#1)(2008-10#11)(2008-3#2)(2008-8#1)
solutions as##5##2##(2008-10#5)
solutions at pH##2##3##(2008-10#2)
solutions at##13##2##(2008-10#12)(2008-6#1)
solutions based on##4##3##(2008-10#4)
solutions by##11##2##(2008-10#11)
solutions can be##3##3##(2008-10#2)(2008-6#1)
solutions containing 0##2##3##(2008-10#2)
solutions containing a##3##3##(2008-10#3)
solutions containing acetic##2##3##(2008-10#2)
solutions containing both##2##3##(2008-10#2)
solutions containing up to##2##4##(2008-10#2)
solutions containing##47##2##(2008-10#43)(2008-5#1)(2008-8#1)(2011-2#2)
solutions did not##2##3##(2008-10#2)
solutions due to##2##3##(2008-10#1)(2011-2#1)
solutions due##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
solutions exist##2##2##(2008-10#1)(2008-11#1)
solutions for a##2##3##(2010-4#1)(2013-8#1)
solutions for all##2##3##(2008-10#1)(2013-8#1)
solutions for the##2##3##(2008-3#1)(2013-8#1)
solutions for##18##2##(1996-12#1)(2008-10#3)(2008-12#1)(2008-3#4)(2008-6#1)(2008-9#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-8#4)
solutions from##3##2##(2008-10#2)(2010-11#1)
solutions has been investigated##2##4##(2008-10#2)
solutions has been studied using##2##5##(2008-10#2)
solutions has been##7##3##(2008-10#7)
solutions have been##2##3##(2008-10#1)(2008-12#1)
solutions have##6##2##(2008-10#4)(2008-12#2)
solutions in the##10##3##(1991-1#1)(1992-2#1)(1994-2#1)(2008-10#7)
solutions in view of##2##4##(2008-10#2)
solutions in##26##2##(1991-1#1)(1992-2#1)(1994-2#1)(2008-10#21)(2010-8#1)(2012-3#1)
solutions including##3##2##(2008-10#3)
solutions into a##2##3##(2008-10#2)
solutions into##5##2##(2008-10#5)
solutions is described##2##3##(2008-10#2)
solutions is proposed##3##3##(2008-10#3)
solutions is##13##2##(1997-5#1)(2008-10#11)(2008-2#1)
solutions needed for##2##3##(2008-10#1)(2008-9#1)
solutions obtained from##2##3##(2008-10#2)
solutions obtained##6##2##(2008-10#6)
solutions of 0##3##3##(2008-10#3)
solutions of 10##2##3##(2008-10#2)
solutions of 2##2##3##(2008-10#2)
solutions of 5##2##3##(2008-10#2)
solutions of As(III)##2##3##(2008-10#2)
solutions of different##3##3##(2008-10#3)
solutions of mixed salts##2##4##(2008-10#2)
solutions of pH##3##3##(2008-10#3)
solutions of sodium##2##3##(2008-10#2)
solutions of the single molecule magnet Ni(4)##2##7##(2009-5#2)
solutions of the##13##3##(1993-5#1)(2008-10#9)(2008-4#1)(2009-5#2)
solutions of various##5##3##(2008-10#4)(2008-5#1)
solutions of##94##2##(1990-12#1)(1991-5#1)(1993-5#1)(1994-8#1)(1995-11#1)(2008-10#76)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#2)(2010-1#1)(2013-8#1)
solutions on the##2##3##(2008-10#2)
solutions on##6##2##(1993-1#1)(2008-10#4)(2013-1#1)
solutions or for##2##3##(2008-10#2)
solutions or##4##2##(1994-2#1)(2008-10#3)
solutions over##3##2##(2008-10#3)
solutions prepared in##3##3##(1992-11#2)(2008-10#1)
solutions prepared##4##2##(1992-11#3)(2008-10#1)
solutions previously##3##2##(2008-10#3)
solutions resulted in##2##3##(2008-10#2)
solutions resulting from##2##3##(2008-10#1)(2009-9#1)
solutions show##2##2##(2008-10#2)
solutions showed##2##2##(2008-10#2)
solutions that are##2##3##(2008-10#1)(2011-2#1)
solutions that##12##2##(2008-10#5)(2008-11#2)(2008-3#1)(2010-7#1)(2011-2#2)(2013-1#1)
solutions to the##3##3##(1996-1#1)(1997-7#1)(2008-8#1)
solutions to these##4##3##(1990-2#1)(2011-1#1)(2011-2#2)
solutions to##33##2##(1990-2#1)(1994-6#1)(1995-3#2)(1996-1#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#2)(2010-11#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
solutions under##2##2##(2008-10#2)
solutions using a##2##3##(2008-10#2)
solutions using##9##2##(2008-10#8)(2012-2#1)
solutions was determined##2##3##(2008-10#2)
solutions was developed##3##3##(2008-10#3)
solutions was##20##2##(1993-1#1)(2008-10#18)(2008-5#1)
solutions were determined##2##3##(2008-10#2)
solutions were introduced##2##3##(2008-10#2)
solutions were mixed and##2##4##(2008-10#1)(2009-9#1)
solutions were observed##2##3##(2008-10#2)
solutions were studied##2##3##(2008-10#2)
solutions were used##3##3##(2008-10#2)(2011-2#1)
solutions were##37##2##(1991-5#1)(2008-10#33)(2009-9#1)(2011-2#2)
solutions when##2##2##(2008-10#1)(2011-1#1)
solutions with different##2##3##(2008-10#2)
solutions with low##2##3##(2008-10#2)
solutions with##20##2##(2008-10#19)(2008-5#1)
solutions without##3##2##(2008-10#2)(2008-5#1)
solutions##767##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-11#5)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#4)(1996-1#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#586)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#15)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#8)(2009-10#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#3)(2010-11#5)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#15)(2011-3#1)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#6)
solutions)##4##1##(2008-10#3)(2008-11#1)
solvated##3##1##(2008-10#3)
solvating##6##1##(1992-9#1)(2008-10#5)
solvation and the##3##3##(2008-10#2)(2008-4#1)
solvation and##4##2##(2008-10#3)(2008-4#1)
solvation energy##2##2##(2008-10#1)(2011-3#1)
solvation of the##2##3##(1990-5#1)(2008-10#1)
solvation##19##1##(1990-5#1)(2008-10#8)(2008-4#3)(2009-9#1)(2010-7#5)(2011-3#1)
solve a##4##2##(1992-12#1)(1994-12#1)(2008-6#1)(2010-7#1)
solve some##2##2##(2008-10#2)
solve the problem of##4##4##(1992-9#1)(2008-10#2)(2008-3#1)
solve the problem##6##3##(1992-9#1)(2008-10#4)(2008-3#1)
solve the##21##2##(1992-9#2)(1997-3#1)(2008-10#8)(2008-3#6)(2008-6#1)(2008-9#2)(2011-2#1)
solve these problems##3##3##(2008-10#2)(2008-5#1)
solve this problem##4##3##(1997-1#1)(2008-5#1)(2009-10#1)(2013-8#1)
solve##49##1##(1990-12#1)(1992-12#1)(1992-9#2)(1994-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#7)(2008-5#4)(2008-6#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-8#1)
solved by a##2##3##(1992-9#1)(2011-2#1)
solved by##7##2##(1992-12#1)(1992-4#1)(1992-9#1)(2008-10#2)(2008-3#1)(2011-2#1)
solved for##2##2##(1990-2#1)(2008-3#1)
solved the##4##2##(2008-10#1)(2010-1#2)(2011-2#1)
solved using##3##2##(1991-6#1)(2008-7#1)(2009-12#1)
solved with the##2##3##(2008-11#1)(2010-10#1)
solved with##6##2##(1996-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-3#1)
solved##42##1##(1990-2#2)(1991-6#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-1#3)(2010-10#1)(2011-2#3)(2011-3#1)(2013-8#1)
solvent access to##2##3##(1992-4#2)
solvent and the##6##3##(1996-5#1)(2008-10#5)
solvent and##23##2##(1996-5#1)(2008-10#19)(2008-4#1)(2008-8#1)(2012-2#1)
solvent are##4##2##(2008-10#4)
solvent composition##4##2##(2008-10#4)
solvent concentration##2##2##(2008-10#1)(2008-4#1)
solvent consumption and##3##3##(2008-10#3)
solvent consumption##9##2##(2008-10#9)
solvent content##2##2##(1992-9#1)(2008-10#1)
solvent dependence##2##2##(2008-10#1)(2008-7#1)
solvent effect on##3##3##(2008-10#2)(2008-7#1)
solvent effects##2##2##(2008-10#2)
solvent exchange##2##2##(2008-10#2)
solvent extraction and##7##3##(2008-10#7)
solvent extraction combined with solid-phase microextraction##2##6##(2008-10#2)
solvent extraction in##2##3##(2008-10#1)(2008-7#1)
solvent extraction method and##2##4##(2008-10#2)
solvent extraction method##4##3##(2008-10#4)
solvent extraction of##8##3##(2008-10#8)
solvent extraction or##2##3##(2008-10#2)
solvent extraction step##2##3##(2008-10#2)
solvent extraction techniques##2##3##(2008-10#2)
solvent extraction using##2##3##(2008-10#2)
solvent extraction##59##2##(1995-2#1)(2008-10#54)(2008-5#2)(2008-7#1)(2008-9#1)
solvent extracts of##2##3##(2008-10#1)(2013-8#1)
solvent flow##2##2##(2008-10#2)
solvent for the##3##3##(2008-10#2)(2008-3#1)
solvent for##11##2##(2008-10#9)(2008-3#1)(2008-5#1)
solvent from##2##2##(2008-10#2)
solvent has been developed##2##4##(2008-10#2)
solvent has been##4##3##(2008-10#3)(2010-11#1)
solvent has##5##2##(2008-10#3)(2008-11#1)(2010-11#1)
solvent in##6##2##(2008-10#6)
solvent media and##2##3##(2008-10#2)
solvent media##7##2##(2008-10#7)
solvent mediator##4##2##(2008-10#4)
solvent mediators##5##2##(2008-10#5)
solvent microextraction##5##2##(2008-10#5)
solvent mixture##9##2##(1992-4#1)(2008-10#8)
solvent mixtures##5##2##(2008-10#5)
solvent molecules##5##2##(2008-10#4)(2010-7#1)
solvent of##4##2##(2008-10#4)
solvent on the##3##3##(2008-10#3)
solvent or##3##2##(1997-2#1)(2008-11#1)(2008-5#1)
solvent polymeric membrane electrodes##2##4##(2008-10#2)
solvent polymeric membrane##4##3##(2008-10#4)
solvent polymeric membranes##3##3##(2008-10#3)
solvent polymeric##11##2##(2008-10#11)
solvent precipitation##3##2##(2008-10#3)
solvent properties of##2##3##(2010-5#1)(2012-2#1)
solvent properties##3##2##(1991-5#1)(2010-5#1)(2012-2#1)
solvent relaxation##4##2##(2013-1#4)
solvent sublation##3##2##(2008-10#3)
solvent system##10##2##(2008-10#10)
solvent systems##4##2##(2008-10#4)
solvent to##3##2##(1994-8#1)(2008-10#2)
solvent under##2##2##(1996-5#1)(2008-10#1)
solvent used##4##2##(2008-10#3)(2008-7#1)
solvent vapor##2##2##(2008-10#1)(2008-7#1)
solvent volume and##2##3##(2008-10#2)
solvent volume##7##2##(2008-10#7)
solvent was optimized##2##3##(2008-10#2)
solvent was##9##2##(2008-10#9)
solvent water##2##2##(1992-4#1)(2009-8#1)
solvent were##3##2##(2008-10#3)
solvent with##2##2##(2008-7#1)(2012-2#1)
solvent##413##1##(1990-5#3)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-4#5)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#3)(1997-1#1)(1997-2#1)(2008-10#335)(2008-11#5)(2008-3#2)(2008-4#4)(2008-5#9)(2008-7#11)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-2#8)(2013-1#7)(2013-8#1)
solvent)##5##1##(2008-10#4)(2011-2#1)
solvent-accessible surface area##2##3##(1994-5#1)(1997-2#1)
solvent-accessible##3##1##(1994-5#2)(1997-2#1)
solvent-based##4##1##(2008-10#3)(2008-5#1)
solvent-free##5##1##(2008-10#3)(2008-5#1)(2011-2#1)
solvent-soluble conducting##2##2##(2008-10#2)
solventless##3##1##(2008-10#2)(2012-3#1)
solvents and##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2011-1#1)
solvents compared with##2##3##(2008-10#2)
solvents for the##2##3##(2008-10#1)(2011-2#1)
solvents for##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
solvents have been##2##3##(2008-10#2)
solvents in the##2##3##(2008-10#2)
solvents in##3##2##(2008-10#3)
solvents of##2##2##(2008-10#2)
solvents on the##5##3##(2008-10#3)(2008-3#1)(2011-1#1)
solvents on##6##2##(2008-10#4)(2008-3#1)(2011-1#1)
solvents revealed##2##2##(2008-10#2)
solvents such as##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
solvents that##4##2##(2008-3#3)(2008-7#1)
solvents to##3##2##(2008-10#3)
solvents using##2##2##(1991-5#1)(2008-10#1)
solvents were##7##2##(1991-1#1)(2008-10#5)(2008-3#1)
solvents with##2##2##(2008-10#1)(2011-1#1)
solvents##158##1##(1990-2#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-5#1)(1992-4#1)(1994-8#3)(1995-3#1)(1996-5#1)(2008-10#111)(2008-11#5)(2008-3#7)(2008-5#5)(2008-7#7)(2009-9#1)(2011-1#4)(2011-2#2)(2012-2#2)(2013-8#1)
solvents)##2##1##(1993-8#1)(2008-10#1)
solves the problem of##2##4##(1995-6#1)(2012-2#1)
solves the##3##2##(1995-6#1)(2009-12#1)(2012-2#1)
solving a##3##2##(2008-6#1)(2010-7#1)(2010-8#1)
solving and##3##2##(2008-11#1)(2008-6#1)(2010-10#1)
solving the problem of##2##4##(2008-12#1)(2009-10#1)
solving the##8##2##(1996-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-10#1)
solving##41##1##(1991-2#1)(1992-1#1)(1992-2#1)(1993-5#1)(1994-12#1)(1996-12#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-12#4)(2008-2#1)(2008-4#1)(2008-6#4)(2009-10#2)(2009-12#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
soma##4##1##(1991-10#1)(1991-12#1)(1997-2#1)(2008-11#1)
somata and##2##2##(1997-3#1)(2008-9#1)
somata showed##2##2##(1995-12#2)
somata were##3##2##(1997-3#2)(2008-7#1)
somata##16##1##(1995-12#7)(1996-12#2)(1997-3#3)(2008-5#1)(2008-7#2)(2008-9#1)
somatic cell count##2##3##(1992-2#1)(1996-8#1)
somatic cell##8##2##(1992-2#1)(1994-11#1)(1996-3#1)(1996-8#1)(1997-9#1)(2008-11#1)(2008-9#1)(2009-10#1)
somatic cells and##3##3##(1994-11#1)(2009-10#2)
somatic cells##17##2##(1993-6#2)(1994-11#3)(2007-12#1)(2008-11#3)(2008-9#3)(2009-10#3)(2010-7#1)(2011-2#1)
somatic compatibility##2##2##(2008-10#2)
somatic complaints##4##2##(1996-2#1)(2008-10#1)(2008-7#2)
somatic embryo##4##2##(2008-9#3)(2009-8#1)
somatic embryogenesis##5##2##(2008-12#2)(2008-9#1)(2009-8#2)
somatic embryos##2##2##(2008-10#1)(2008-12#1)
somatic gene therapy##2##3##(1994-5#1)(2008-8#1)
somatic health##2##2##(1996-6#2)
somatic hybridization between##2##3##(2008-8#1)(2008-9#1)
somatic incompatibility types##3##3##(2008-10#3)
somatic mutations in##2##3##(2010-5#1)(2012-2#1)
somatic mutations##9##2##(1995-12#1)(2008-10#2)(2008-9#2)(2009-8#1)(2010-5#1)(2012-2#2)
somatic nucleus##2##2##(2008-9#2)
somatic sexual differentiation##2##3##(2007-12#2)
somatic symptoms##5##2##(1990-2#1)(1995-5#1)(2009-6#2)(2009-9#1)
somatic treatments##2##2##(2008-4#1)(2008-7#1)
somatic##105##1##(1990-12#1)(1990-2#1)(1992-2#1)(1993-12#1)(1993-6#2)(1994-11#4)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-9#1)(2007-12#5)(2008-10#10)(2008-11#8)(2008-12#3)(2008-4#2)(2008-7#5)(2008-8#5)(2008-9#22)(2009-10#4)(2009-11#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#1)
somatodendritic 5-HT release##2##3##(2008-7#2)
somatodendritic##4##1##(2008-7#3)(2012-3#1)
somatoform disorders##2##2##(1997-8#2)
somatoform##3##1##(1997-8#3)
somatosensory area##2##2##(1994-3#1)(1995-8#1)
somatosensory cortex##6##2##(1994-3#2)(1996-2#1)(1997-2#1)(1997-3#1)(2008-5#1)
somatosensory##17##1##(1991-2#1)(1993-6#1)(1994-3#3)(1994-8#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-5#5)(2010-7#1)
somatostatin analogs##2##2##(1994-11#1)(2012-3#1)
somatostatin analogue RC-160##2##3##(1995-2#2)
somatostatin and##2##2##(1990-5#1)(1997-4#1)
somatostatin gene in##2##3##(1995-8#2)
somatostatin gene##5##2##(1995-8#5)
somatostatin or##2##2##(1993-1#1)(1997-4#1)
somatostatin receptor subtypes##3##3##(1994-11#1)(1995-2#2)
somatostatin receptor##7##2##(1994-11#3)(1995-2#2)(1997-8#1)(2012-3#1)
somatostatin##37##1##(1990-5#1)(1992-6#1)(1993-1#1)(1994-11#7)(1995-2#4)(1995-8#5)(1997-1#1)(1997-2#1)(1997-4#8)(1997-8#3)(2011-2#1)(2012-3#3)(2013-1#1)
somatostatin-14##2##1##(1995-2#2)
somatotopic##5##1##(1997-3#3)(2009-8#2)
somatotropes##3##1##(1992-6#3)
some &quot##2##2##(1995-3#2)
some 70##2##2##(2008-11#2)
some G##2##2##(1997-1#1)(2010-8#1)
some additional##4##2##(2008-10#2)(2009-8#1)(2013-8#1)
some advantages over##2##3##(1993-3#1)(2008-10#1)
some advantages##6##2##(1993-3#1)(2008-10#5)
some alcoholic##2##2##(2008-10#1)(2009-7#1)
some alternative##2##2##(1990-9#1)(2008-10#1)
some amines##2##2##(2008-10#2)
some amino-alcohols##2##2##(2008-10#2)
some analytes##2##2##(2008-10#2)
some analytical##6##2##(2008-10#6)
some animal protein sources##2##4##(2008-10#2)
some antioxidants##2##2##(1993-2#1)(2008-10#1)
some applications##4##2##(1992-9#1)(2008-10#3)
some are more##2##3##(2008-5#1)(2008-9#1)
some are##9##2##(1991-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-3#1)
some aromatic amino acids##2##4##(2008-10#2)
some aromatic##7##2##(2008-10#6)(2011-3#1)
some as##3##2##(1990-6#2)(2008-11#1)
some aspect of##2##3##(2008-10#1)(2008-4#1)
some aspects of the##3##4##(2008-10#2)(2008-11#1)
some aspects of##16##3##(1995-12#1)(1996-11#2)(2008-10#4)(2008-11#1)(2008-12#2)(2009-10#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#1)
some assistance##2##2##(1991-12#1)(1994-1#1)
some attention##2##2##(1991-1#1)(2012-3#1)
some authors have##2##3##(1990-5#1)(2013-1#1)
some authors##8##2##(1990-5#1)(1992-2#1)(1994-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
some bacterial##2##2##(2008-10#1)(2010-7#1)
some basic##4##2##(1994-5#1)(1996-3#1)(2008-7#1)(2010-5#1)
some benefits##2##2##(2007-11#1)(2012-3#1)
some biological fluids##2##3##(2008-10#2)
some biological##8##2##(2008-10#6)(2008-8#1)(2010-12#1)
some biologically important##2##3##(2008-10#1)(2008-12#1)
some biologically##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
some cancer##2##2##(1990-12#1)(2008-11#1)
some cancers and##2##3##(2008-5#1)(2013-8#1)
some cancers##6##2##(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
some cardiovascular##2##2##(1994-3#1)(2008-7#1)
some case##2##2##(1995-2#1)(2008-11#1)
some cases for##3##3##(1990-2#1)(2008-10#1)(2011-2#1)
some cases of##3##3##(1997-6#1)(2008-4#1)(2011-1#1)
some cases the##5##3##(1991-2#1)(1991-8#1)(2008-10#3)
some cases##69##2##(1990-2#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-12#2)(1994-12#1)(1995-12#1)(1995-3#2)(1996-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
some cell lines##3##3##(2008-11#2)(2008-8#1)
some cell##5##2##(1996-12#1)(2008-11#2)(2008-8#1)(2011-2#1)
some cells in##2##3##(1992-6#1)(2008-8#1)
some cells##5##2##(1992-6#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-8#1)
some challenges##2##2##(2008-11#2)
some changes in##2##3##(1992-2#1)(1994-3#1)
some changes##3##2##(1992-2#1)(1994-3#1)(2013-8#1)
some characteristics of##2##3##(1990-11#1)(1997-3#1)
some characteristics##4##2##(1990-11#1)(1997-3#1)(2011-2#2)
some children##2##2##(2008-12#1)(2013-8#1)
some circumstances##5##2##(1996-1#1)(2008-10#1)(2010-10#1)(2011-1#1)(2012-3#1)
some clinical##5##2##(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-12#1)
some clinically##2##2##(2008-11#1)(2013-8#1)
some combination of##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2010-11#1)
some combinations of##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
some commercial##3##2##(2008-10#3)
some common##8##2##(1992-11#1)(1995-2#1)(2008-10#4)(2010-12#1)(2013-1#1)
some components of the##3##4##(1996-12#2)(2008-10#1)
some components of##4##3##(1996-12#2)(2008-10#2)
some components##6##2##(1994-3#1)(1996-12#2)(2008-10#3)
some concerns##2##2##(2008-3#1)(2010-11#1)
some conditions##2##2##(1992-3#1)(2008-10#1)
some confusion in##2##3##(1997-3#1)(2008-10#1)
some confusion##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
some considerations##2##2##(1990-2#1)(2010-11#1)
some cosmetic##2##2##(2008-5#2)
some costs##2##2##(2008-11#1)(2012-3#1)
some countries##5##2##(1993-11#1)(1996-2#1)(2008-11#1)(2011-2#1)(2012-12#1)
some critical##3##2##(1991-3#1)(2008-11#2)
some data##3##2##(1991-12#1)(1994-12#1)(2008-10#1)
some degree of recovery##2##4##(2008-10#1)(2008-7#1)
some degree of##6##3##(1995-1#1)(2008-10#2)(2008-7#1)(2010-5#1)(2013-1#1)
some degree##11##2##(1995-1#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)
some differences between##2##3##(2012-12#1)(2013-1#1)
some differences in##5##3##(1991-6#1)(1993-3#1)(2008-10#2)(2008-5#1)
some differences##9##2##(1991-6#1)(1993-3#1)(2008-10#2)(2008-5#2)(2008-9#1)(2012-12#1)(2013-1#1)
some dipeptides##3##2##(2008-10#3)
some diseases##3##2##(1993-2#1)(2008-11#1)(2013-1#1)
some distinct##2##2##(1992-2#1)(1993-8#1)
some drug##3##2##(2008-10#1)(2011-3#2)
some drugs##7##2##(1991-1#2)(2008-10#3)(2008-7#1)(2013-1#1)
some dyes##2##2##(2008-10#2)
some empirical##2##2##(2008-6#1)(2012-2#1)
some environmental samples##2##3##(2008-10#2)
some environmental##4##2##(1990-6#1)(2008-10#3)
some epidemiological##2##2##(2008-10#1)(2011-2#1)
some essential##5##2##(1993-8#2)(2008-10#2)(2008-7#1)
some evidence of##4##3##(1991-1#1)(2008-10#1)(2010-8#1)(2011-2#1)
some evidence that the##3##4##(1994-5#1)(2008-10#1)(2008-5#1)
some evidence that##6##3##(1990-2#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
some evidence##11##2##(1990-2#1)(1991-1#1)(1994-5#1)(1996-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)
some examples of such##2##4##(2012-2#1)(2013-1#1)
some examples of the##2##4##(2008-8#1)(2009-10#1)
some examples of##6##3##(2008-10#2)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
some examples##8##2##(2008-10#3)(2008-4#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
some experimental##6##2##(1990-2#1)(2008-10#4)(2008-8#1)
some experiments##6##2##(1994-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
some explanatory variables##2##3##(2008-10#2)
some extent##15##2##(1990-5#1)(1993-8#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2011-3#1)
some factors##4##2##(2008-10#3)(2008-6#1)
some features##3##2##(1992-2#1)(2008-10#1)(2008-3#1)
some findings##2##2##(1997-3#1)(1997-8#1)
some form of##12##3##(1991-3#1)(1992-12#1)(1994-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-11#1)(2012-3#1)
some form##13##2##(1991-3#1)(1992-12#1)(1994-1#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-11#1)(2012-3#1)
some forms of##2##3##(2008-11#1)(2008-7#1)
some functional##3##2##(2008-10#1)(2008-5#2)
some fungal##2##2##(2008-10#1)(2012-2#1)
some general guidelines for##2##4##(1993-12#1)(2008-9#1)
some general##4##2##(1991-2#1)(1993-12#1)(1996-6#1)(2008-9#1)
some genes##3##2##(2009-10#1)(2009-8#1)(2011-2#1)
some groups##3##2##(2008-10#1)(2009-5#1)(2010-7#1)
some hard and soft metals##2##5##(2008-10#2)
some have##8##2##(1991-9#1)(1996-11#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-3#2)
some health##2##2##(2008-10#2)
some heavy metal ions##3##4##(2008-10#3)
some heavy metals##2##3##(2008-10#2)
some heavy##5##2##(2008-10#5)
some heteropoly##3##2##(2008-10#3)
some highlights##2##2##(1997-7#1)(2008-11#1)
some hospital##2##2##(1991-2#1)(2012-2#1)
some hospitals##2##2##(1993-12#1)(2008-10#1)
some host##2##2##(2008-10#2)
some ideas on##2##3##(1995-2#1)(2009-10#1)
some ideas##4##2##(1992-2#1)(1995-2#1)(2009-10#1)(2011-3#1)
some implications of##2##3##(1991-1#1)(2008-11#1)
some important##12##2##(1991-12#1)(1992-3#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2009-12#1)(2012-2#1)
some in vitro##2##3##(2008-10#2)
some indication##2##2##(2008-9#2)
some individual##5##2##(1992-12#1)(1995-9#1)(2008-10#2)(2008-12#1)
some individuals##9##2##(1992-11#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)
some industrial waste waters##2##4##(2008-10#2)
some industrial##4##2##(2008-10#3)(2008-3#1)
some inorganic##2##2##(2008-10#2)
some insight into##2##3##(1993-12#1)(2008-10#1)
some insights##2##2##(1992-9#1)(2013-1#1)
some instances##11##2##(1995-12#1)(1995-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#2)(2011-1#1)
some instrumental parameters##2##3##(2008-10#2)
some instrumental##4##2##(2008-10#4)
some interesting##3##2##(2008-2#1)(2008-5#1)(2010-11#1)
some investigators##2##2##(1994-3#1)(2008-8#1)
some ions##3##2##(2008-10#3)
some isolates of V##2##4##(2008-10#2)
some isolates of##3##3##(2008-10#3)
some isolates##9##2##(2008-10#9)
some issues##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
some key issues##2##3##(2008-12#1)(2012-2#1)
some key lessons##3##3##(1995-12#1)(2008-12#2)
some key##8##2##(1994-3#1)(1995-12#1)(1995-3#1)(2008-12#4)(2012-2#1)
some kind of##4##3##(1993-3#1)(2008-10#1)(2008-12#1)(2008-8#1)
some lanthanide metal ions##2##4##(2008-10#2)
some large##2##2##(1991-3#1)(2008-10#1)
some lead##2##2##(2008-10#1)(2012-3#1)
some level of##2##3##(2008-10#1)(2008-9#1)
some ligands##2##2##(2010-11#1)(2012-2#1)
some light on the##2##4##(2008-10#1)(2008-11#1)
some light on##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
some light##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
some limitations##2##2##(2008-11#2)
some lines##3##2##(2008-10#2)(2008-9#1)
some locations##2##2##(2008-10#2)
some loss of##3##3##(2008-10#3)
some major##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
some malignant##2##2##(2010-1#1)(2011-2#1)
some measure of##3##3##(1993-3#1)(1995-5#1)(2008-12#1)
some members##3##2##(1993-3#1)(1997-3#1)(2009-10#1)
some metal ions and##3##4##(2008-10#3)
some metal ions##11##3##(2008-10#11)
some metals##7##2##(2008-10#6)(2008-12#1)
some methods of##2##3##(1994-9#1)(2008-10#1)
some methods##4##2##(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
some might##2##2##(1991-6#2)
some migration##2##2##(2008-8#1)(2008-9#1)
some minor##2##2##(1995-2#1)(2008-2#1)
some molecules##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
some months##2##2##(1991-11#1)(1994-6#1)
some natural compounds##2##3##(2011-3#2)
some natural##6##2##(2008-10#4)(2011-3#2)
some ncRNAs##2##2##(2012-3#2)
some neurons##4##2##(1996-12#1)(2008-8#1)(2009-10#2)
some new##6##2##(1991-9#1)(2008-10#3)(2008-9#1)(2012-3#1)
some of its##7##3##(1994-3#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-8#1)
some of our##2##3##(2008-12#1)(2012-2#1)
some of the basic##3##4##(2008-4#2)(2008-6#1)
some of the causes##2##4##(1991-6#1)(1996-2#1)
some of the challenges##3##4##(1996-2#1)(2008-11#1)(2008-12#1)
some of the current##3##4##(2008-11#2)(2012-3#1)
some of the difficulties##2##4##(2008-7#1)(2008-9#1)
some of the effects of##2##5##(2008-3#1)(2009-12#1)
some of the existing##2##4##(2008-5#1)(2009-1#1)
some of the factors that##2##5##(1997-1#1)(2008-4#1)
some of the factors##3##4##(1991-3#1)(1997-1#1)(2008-4#1)
some of the first##2##4##(2008-10#1)(2008-9#1)
some of the genes##2##4##(2008-10#1)(2008-9#1)
some of the important##2##4##(2008-4#1)(2010-7#1)
some of the issues##4##4##(1991-12#1)(2008-4#2)(2013-8#1)
some of the key##5##4##(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
some of the limitations##4##4##(2008-1#1)(2008-10#2)(2013-1#1)
some of the main##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
some of the major problems##2##5##(1997-2#1)(2008-12#1)
some of the major##3##4##(1997-2#1)(2008-11#1)(2008-12#1)
some of the methods##2##4##(2008-10#1)(2008-11#1)
some of the more common##3##5##(2008-9#1)(2009-9#1)(2012-2#1)
some of the more##5##4##(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)(2012-2#1)
some of the most common##2##5##(2008-10#1)(2008-11#1)
some of the most important##3##5##(2008-10#1)(2008-4#1)(2010-10#1)
some of the most##12##4##(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-10#1)(2010-7#1)(2011-2#1)
some of the other##2##4##(2008-9#1)(2010-3#1)
some of the participating##2##4##(2008-11#1)(2008-12#1)
some of the potential##2##4##(2008-10#1)(2008-11#1)
some of the problems##2##4##(1992-12#1)(2008-11#1)
some of the properties of##2##5##(2008-10#1)(2008-7#1)
some of the real##2##4##(1997-7#1)(2008-3#1)
some of the reasons for the##2##6##(1996-2#1)(2013-1#1)
some of the reasons##3##4##(1996-2#1)(2012-2#1)(2013-1#1)
some of the unique##2##4##(1991-1#1)(2008-11#1)
some of the##224##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-4#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#2)(1997-1#2)(1997-2#5)(1997-3#1)(1997-7#2)(2008-1#2)(2008-10#35)(2008-11#26)(2008-12#12)(2008-3#5)(2008-4#12)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#8)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2011-2#8)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#2)
some of their##6##3##(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
some of them may##2##4##(2011-1#1)(2013-1#1)
some of them##17##3##(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-4#2)(2008-7#3)(2011-1#1)(2012-3#1)(2013-1#2)
some of these are##2##4##(1996-3#1)(2009-12#1)
some of these problems##2##4##(2008-10#1)(2008-11#1)
some of these products##2##4##(2008-10#2)
some of these##35##3##(1990-5#1)(1990-6#1)(1994-6#1)(1995-1#1)(1996-3#2)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
some of those##2##3##(1991-3#1)(2009-8#1)
some of which are currently##2##5##(2008-12#1)(2008-5#1)
some of which are##9##4##(1991-12#1)(1992-6#1)(1993-11#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)(2010-8#1)
some of which were##2##4##(2009-4#1)(2013-1#1)
some of which##20##3##(1991-12#1)(1991-8#1)(1992-6#1)(1993-11#1)(1996-8#1)(2008-10#4)(2008-12#2)(2008-5#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
some of##326##2##(1990-12#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-7#3)(2007-12#2)(2008-1#2)(2008-10#58)(2008-11#32)(2008-12#17)(2008-3#5)(2008-4#15)(2008-5#13)(2008-6#2)(2008-7#15)(2008-8#7)(2008-9#9)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#10)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#11)(2013-8#5)
some older##2##2##(1996-2#1)(2013-1#1)
some operons##2##2##(2008-8#2)
some or all##2##3##(2007-12#1)(2008-10#1)
some organic compounds of##2##4##(2008-10#1)(2011-2#1)
some organic compounds##3##3##(2008-10#2)(2011-2#1)
some organic##10##2##(1990-9#1)(2008-10#8)(2011-2#1)
some other##21##2##(1992-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)
some others##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
some overall##2##2##(2008-10#1)(2010-9#1)
some parallels##2##2##(2008-6#1)(2012-2#1)
some parameters such as##2##4##(2008-10#2)
some parameters##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
some patients with##6##3##(1992-6#1)(1994-11#1)(1996-2#1)(1997-8#1)(2010-8#1)(2011-2#1)
some patients##24##2##(1991-1#2)(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#2)(1996-2#2)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-3#2)
some peculiarities##2##2##(2008-3#1)(2008-7#1)
some people##2##2##(2009-12#1)(2013-8#1)
some pharmaceutical formulations##2##3##(2008-10#2)
some pharmaceutical##7##2##(2008-10#6)(2008-11#1)
some physiological##4##2##(2008-12#2)(2008-7#1)(2012-2#1)
some pigments##2##2##(2008-10#2)
some plant##2##2##(2008-10#1)(2008-11#1)
some plants##4##2##(2008-10#4)
some point##6##2##(1991-12#1)(2008-9#1)(2009-5#2)(2013-1#2)
some polymeric##3##2##(2008-10#1)(2008-11#2)
some positive##2##2##(2010-2#1)(2013-1#1)
some possible##3##2##(1992-12#1)(1994-3#1)(2008-6#1)
some potential for##2##3##(2008-10#1)(2008-7#1)
some potential##6##2##(1994-8#1)(2008-10#3)(2008-7#1)(2008-8#1)
some practical##2##2##(1995-5#1)(2008-11#1)
some previous reports##2##3##(1991-3#1)(1991-8#1)
some previous##5##2##(1991-3#1)(1991-8#1)(2008-11#1)(2008-12#1)(2008-6#1)
some prior##2##2##(1991-12#1)(2008-10#1)
some problems in##3##3##(2008-10#1)(2013-1#2)
some problems##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
some products##2##2##(2008-11#1)(2008-5#1)
some properties##4##2##(1990-6#1)(2008-10#2)(2008-11#1)
some proteins##4##2##(1995-6#1)(2008-10#3)
some psychological##3##2##(2008-11#1)(2008-12#1)(2010-8#1)
some purposes##2##2##(1997-8#1)(2008-1#1)
some questions##2##2##(1992-2#1)(2013-1#1)
some recent developments##3##3##(1991-2#1)(2008-10#1)(2009-10#1)
some recent results##2##3##(2008-10#2)
some recent##11##2##(1991-2#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-8#1)(2009-10#1)(2011-2#1)
some recently synthesized##4##3##(2008-10#4)
some regions##4##2##(1990-5#1)(1994-2#1)(2008-8#1)(2011-2#1)
some related##3##2##(1993-6#1)(2008-10#1)(2010-7#1)
some research##2##2##(1991-2#1)(2010-7#1)
some residual##3##2##(1993-2#1)(2006-6#1)(2008-11#1)
some resistant##2##2##(2008-10#2)
some results of##2##3##(2009-8#1)(2013-1#1)
some risk##3##2##(1995-11#1)(2008-1#1)(2009-4#1)
some role in##3##3##(2008-7#2)(2008-8#1)
some rural areas##2##3##(1991-6#1)(2013-1#1)
some samples with##2##3##(2008-10#2)
some samples##7##2##(2008-10#6)(2011-2#1)
some scientific##2##2##(1994-8#1)(2013-8#1)
some sequence##2##2##(2008-10#1)(2008-8#1)
some short##2##2##(2011-3#1)(2013-1#1)
some similarities to known genes##2##5##(1995-8#1)(1996-2#1)
some similarities to##3##3##(1993-8#1)(1995-8#1)(1996-2#1)
some similarities##4##2##(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#1)
some simple##2##2##(1997-4#1)(2008-8#1)
some situations##5##2##(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)
some skin##2##2##(1992-6#1)(2013-1#1)
some small##3##2##(1993-12#1)(2008-8#1)(2008-9#1)
some soils##2##2##(2008-10#2)
some sort##2##2##(2008-10#1)(2012-12#1)
some species of##3##3##(1995-3#1)(2008-8#1)(2011-2#1)
some species##6##2##(1995-3#2)(2008-10#1)(2008-8#2)(2011-2#1)
some specific##11##2##(1990-6#1)(1995-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-3#1)(2012-2#1)
some standard##6##2##(2008-10#3)(2013-1#3)
some strains##7##2##(1991-3#1)(2008-10#4)(2008-5#1)(2012-3#1)
some strategies##2##2##(1991-1#1)(2008-10#1)
some structural##2##2##(2008-9#1)(2009-4#1)
some students##2##2##(2008-11#1)(2012-3#1)
some studies have##2##3##(2008-11#1)(2008-12#1)
some studies##8##2##(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-2#1)
some suggestions##2##2##(1991-2#1)(2012-3#1)
some surfactants##2##2##(2008-10#2)
some synthetic##4##2##(2008-10#4)
some systems##2##2##(2008-10#1)(2013-8#1)
some taxonomic##2##2##(2008-6#1)(2011-2#1)
some ten##2##2##(1990-6#1)(1997-4#1)
some time after##2##3##(2008-10#1)(2011-2#1)
some time##13##2##(1992-3#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)
some tissues of##2##3##(2008-12#2)
some tissues##3##2##(1992-9#1)(2008-12#2)
some transition metal ions##3##4##(2008-10#3)
some transition##6##2##(2008-10#6)
some tumors##2##2##(1993-8#1)(2008-9#1)
some types of samples##2##4##(2008-10#2)
some types of##7##3##(2008-10#4)(2008-7#1)(2009-10#1)(2011-3#1)
some types##8##2##(2008-10#4)(2008-7#1)(2009-10#1)(2011-2#1)(2011-3#1)
some typical##2##2##(2008-10#2)
some uncertainty##2##2##(1996-11#1)(2008-10#1)
some unresolved##2##2##(1996-1#1)(2011-3#1)
some unusual##2##2##(2008-10#1)(2008-11#1)
some users##2##2##(1991-3#1)(2009-5#1)
some variation##2##2##(2008-10#2)
some variations##2##2##(2008-10#1)(2008-7#1)
some very##3##2##(1993-12#1)(2008-10#1)(2013-8#1)
some viruses##4##2##(2008-10#1)(2008-11#2)(2010-1#1)
some way##3##2##(1991-6#1)(2008-11#1)(2008-8#1)
some weeks##2##2##(1991-3#1)(1991-8#1)
some well##2##2##(2008-10#2)
some were##2##2##(1997-2#1)(2008-9#1)
some what##2##2##(1990-5#1)(2008-8#1)
some with##2##2##(2008-11#1)(2013-1#1)
some years##5##2##(1997-5#1)(2008-10#3)(2011-2#1)
some##2069##1##(1990-11#5)(1990-12#3)(1990-2#7)(1990-5#7)(1990-6#9)(1990-8#2)(1990-9#3)(1991-1#11)(1991-10#2)(1991-11#2)(1991-12#18)(1991-2#13)(1991-3#12)(1991-5#1)(1991-6#7)(1991-8#5)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#12)(1992-2#9)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#2)(1992-9#7)(1993-1#7)(1993-11#3)(1993-12#12)(1993-2#7)(1993-3#10)(1993-6#5)(1993-8#10)(1994-1#4)(1994-11#6)(1994-12#7)(1994-2#8)(1994-3#11)(1994-5#5)(1994-6#5)(1994-8#6)(1994-9#4)(1995-1#4)(1995-11#1)(1995-12#13)(1995-2#9)(1995-3#15)(1995-5#6)(1995-6#6)(1995-8#4)(1995-9#4)(1996-1#3)(1996-11#6)(1996-12#11)(1996-2#14)(1996-3#7)(1996-5#6)(1996-6#7)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#11)(1997-3#17)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#9)(1997-8#5)(1997-9#2)(2006-6#5)(2007-11#2)(2007-12#7)(2007-8#2)(2008-1#12)(2008-10#645)(2008-11#132)(2008-12#64)(2008-2#6)(2008-3#19)(2008-4#31)(2008-5#56)(2008-6#17)(2008-7#54)(2008-8#71)(2008-9#75)(2009-1#2)(2009-10#21)(2009-11#2)(2009-12#12)(2009-3#3)(2009-4#4)(2009-5#8)(2009-6#6)(2009-7#2)(2009-8#12)(2009-9#3)(2010-1#12)(2010-10#8)(2010-11#13)(2010-12#15)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#8)(2010-6#3)(2010-7#13)(2010-8#12)(2010-9#3)(2011-1#10)(2011-2#67)(2011-3#15)(2012-12#9)(2012-2#31)(2012-3#35)(2012-7#1)(2013-1#57)(2013-7#4)(2013-8#26)
someone else##3##2##(2008-11#1)(2010-11#1)(2012-12#1)
someone##8##1##(1994-2#1)(1995-9#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-10#1)(2010-11#1)(2012-12#1)
something that##2##2##(2008-12#1)(2008-5#1)
something to##2##2##(1996-11#1)(1997-2#1)
something##11##1##(1991-1#1)(1991-3#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-12#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-1#2)
sometime##3##1##(1990-3#1)(2008-10#1)(2013-1#1)
sometimes also##2##2##(1997-4#1)(1997-8#1)
sometimes be##8##2##(1993-11#1)(2008-10#2)(2009-6#1)(2011-2#2)(2013-1#2)
sometimes the##4##2##(1991-6#1)(2007-8#1)(2008-5#1)(2008-8#1)
sometimes were##2##2##(2008-10#2)
sometimes with##2##2##(2008-8#1)(2009-10#1)
sometimes##101##1##(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#6)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#11)(2012-2#3)(2013-1#5)
somewhat different##5##2##(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2010-6#1)
somewhat larger##2##2##(1991-6#1)(2008-10#1)
somewhat less##4##2##(1995-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
somewhat lower##3##2##(1997-8#1)(2008-10#2)
somewhat more##2##2##(1991-1#1)(2008-11#1)
somewhat reduced##2##2##(1997-2#1)(2008-11#1)
somewhat##52##1##(1990-12#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#2)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
somewhere##2##1##(2008-10#1)(2008-8#1)
somite##4##1##(1993-12#1)(1994-12#3)
somites##5##1##(1994-12#4)(1995-8#1)
somitic mesoderm##2##2##(1994-12#2)
somnolence##3##1##(1991-2#1)(1994-3#1)(2008-8#1)
son##9##1##(1992-3#1)(1994-12#1)(1995-6#1)(2008-12#2)(2008-7#2)(2013-1#2)
sonar##2##1##(2009-8#2)
song rate##4##2##(2008-9#4)
song sparrows##4##2##(2008-8#2)(2008-9#2)
song was highly##2##3##(2008-9#2)
song##20##1##(1996-3#1)(2008-8#8)(2008-9#9)(2011-1#2)
songbirds##5##1##(1995-3#1)(2008-8#1)(2008-9#3)
songs of C##2##3##(2008-8#2)
songs of##3##2##(2008-8#3)
songs##11##1##(2008-8#11)
sonic hedgehog##2##2##(1993-12#1)(2013-1#1)
sonic##4##1##(1993-12#1)(2008-3#1)(2013-1#2)
sonicated in##2##2##(2008-10#2)
sonicated##9##1##(1994-5#3)(2008-10#5)(2008-11#1)
sonicating##2##1##(2008-10#2)
sonication amplitude##3##2##(2008-10#3)
sonication and##5##2##(1993-12#1)(2008-10#4)
sonication for##2##2##(2008-10#2)
sonication in##2##2##(2008-10#2)
sonication time##11##2##(2008-10#11)
sonication were##3##2##(2008-10#2)(2011-2#1)
sonication##45##1##(1993-12#1)(2008-10#41)(2008-5#2)(2011-2#1)
sonication-assisted##2##1##(2008-10#2)
sonnei strain##2##2##(2008-9#2)
sonnei##6##1##(2008-10#1)(2008-9#4)(2012-2#1)
sonogel-carbon electrode is##2##3##(2008-10#2)
sonogel-carbon electrode##4##2##(2008-10#4)
sonographic findings##2##2##(1991-8#1)(2012-2#1)
sonographic##6##1##(1991-8#1)(2012-2#5)
sonography and##4##2##(1990-6#1)(1991-3#1)(1997-8#1)(2011-2#1)
sonography in the##2##3##(1994-3#1)(2011-2#1)
sonography in##5##2##(1991-3#1)(1994-3#1)(1997-8#1)(2011-2#2)
sonography is##2##2##(2010-5#1)(2012-12#1)
sonography or##2##2##(1990-12#1)(2010-5#1)
sonography revealed##2##2##(2012-12#1)(2013-1#1)
sonography##28##1##(1990-12#1)(1990-6#1)(1991-3#2)(1993-6#3)(1994-3#1)(1996-6#1)(1997-8#7)(2008-10#1)(2010-5#2)(2011-2#4)(2012-12#4)(2013-1#1)
sonolinear sweep voltammetry##2##3##(2008-10#2)
sonoluminescence##2##1##(1994-2#2)
sons or##2##2##(1995-1#2)
sons that they##2##3##(2008-8#2)
sons##8##1##(1995-1#2)(1997-3#1)(2008-8#3)(2012-3#2)
sont des##3##2##(2011-2#1)(2013-1#2)
sont##12##1##(2008-11#1)(2011-2#4)(2013-1#7)
soon after the##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
soon after##14##2##(1993-12#1)(2008-10#3)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#1)
soon as the##4##3##(1990-9#1)(2008-10#2)(2009-8#1)
soon as##24##2##(1990-9#2)(1991-12#1)(1991-6#1)(1994-3#1)(1996-1#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#2)(2013-1#2)
soon be##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
soon become##2##2##(2008-10#1)(2011-2#1)
soon##55##1##(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)
sooner than##3##2##(2008-10#1)(2008-9#2)
sooner##7##1##(2008-10#2)(2008-9#2)(2012-12#2)(2013-8#1)
soot##16##1##(2008-10#5)(2008-11#3)(2008-3#8)
sooty##4##1##(2008-10#3)(2008-3#1)
sophisticated and##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
sophisticated mechanisms##2##2##(2011-1#1)(2011-10#1)
sophisticated##40##1##(1991-12#1)(1991-3#2)(1992-3#3)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#6)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
sophistication##4##1##(1995-2#1)(1996-2#1)(2008-11#1)(2009-10#1)
sophomore##2##1##(2008-12#2)
sophoridine##2##1##(2008-10#2)
sorbed on the##3##3##(2008-10#3)
sorbed on##6##2##(2008-10#6)
sorbed onto activated##2##3##(2008-10#2)
sorbed onto the resin##2##4##(2008-10#2)
sorbed onto the##3##3##(2008-10#3)
sorbed onto##8##2##(2008-10#8)
sorbed##30##1##(2008-10#30)
sorbent and##2##2##(2008-10#2)
sorbent column##2##2##(2008-10#2)
sorbent extraction preconcentration system##2##4##(2008-10#2)
sorbent extraction preconcentration##4##3##(2008-10#4)
sorbent extraction##8##2##(2008-10#8)
sorbent for the##2##3##(2008-10#2)
sorbent for##8##2##(2008-10#8)
sorbent has been developed for##2##5##(2008-10#2)
sorbent has been developed##3##4##(2008-10#3)
sorbent has##4##2##(2008-10#4)
sorbent material##3##2##(2008-10#3)
sorbent phase##2##2##(2008-10#2)
sorbent tube for##2##3##(2008-10#2)
sorbent was##7##2##(2008-10#7)
sorbent with##2##2##(2008-10#1)(2009-8#1)
sorbent##85##1##(1997-2#1)(2008-10#83)(2009-8#1)
sorbents for##4##2##(2008-10#4)
sorbents##13##1##(2008-10#13)
sorbic acid##9##2##(2008-10#6)(2011-2#3)
sorbic##10##1##(2008-10#6)(2011-2#4)
sorbing solids##2##2##(2008-10#2)
sorbing##4##1##(2008-10#3)(2008-11#1)
sorbinil##5##1##(1994-8#5)
sorbitol and##3##2##(1996-2#1)(2008-12#1)(2011-1#1)
sorbitol or##2##2##(1994-8#1)(2008-11#1)
sorbitol##14##1##(1994-8#1)(1996-2#5)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)(2011-1#1)(2012-7#1)
sore##4##1##(1992-6#1)(2008-10#1)(2008-12#1)(2008-9#1)
sorghi and##2##2##(2008-10#2)
sorghi##14##1##(2008-10#14)
sorghum and millet##3##3##(2008-10#3)
sorghum ergot##3##2##(2008-10#3)
sorghum mosaic virus##3##3##(2008-10#2)(2008-9#1)
sorghum pathogen##3##2##(2008-10#3)
sorghum was##2##2##(2008-10#2)
sorghum##43##1##(2008-10#35)(2008-9#4)(2009-10#4)
sorokiniana conidia on##2##3##(2008-10#2)
sorokiniana conidia##3##2##(2008-10#3)
sorokiniana on##2##2##(2008-10#2)
sorokiniana##24##1##(2008-10#24)
sorption and preconcentration for the off-line determination of##2##8##(2008-10#2)
sorption and recovery of##2##4##(2008-10#2)
sorption and##9##2##(2008-10#6)(2008-5#1)(2013-1#2)
sorption capacities##2##2##(2008-10#2)
sorption capacity of the impregnated resin##2##6##(2008-10#2)
sorption capacity of the##9##4##(2008-10#9)
sorption capacity of##13##3##(2008-10#13)
sorption capacity values##2##3##(2008-10#2)
sorption capacity was##2##3##(2008-10#2)
sorption capacity##26##2##(2008-10#26)
sorption characteristics##2##2##(2008-10#1)(2010-4#1)
sorption conditions##2##2##(2008-10#2)
sorption data##4##2##(2008-10#4)
sorption efficiency##2##2##(2008-10#2)
sorption equilibria##3##2##(2008-10#3)
sorption is##3##2##(2008-10#3)
sorption isotherms##4##2##(2008-10#1)(2010-4#3)
sorption kinetics##4##2##(2008-10#4)
sorption mechanism##2##2##(2008-10#2)
sorption of Hg(II)##2##3##(2008-10#2)
sorption of Pb(II)##2##3##(2008-10#2)
sorption of metal ions##2##4##(2008-10#2)
sorption of metal##3##3##(2008-10#3)
sorption of silver ions onto PUF##2##6##(2008-10#2)
sorption of silver##3##3##(2008-10#3)
sorption of the##4##3##(2008-10#4)
sorption of##46##2##(2008-10#46)
sorption on a##6##3##(2008-10#6)
sorption on activated carbon##2##4##(2008-10#2)
sorption on octadecyl silica membrane disks modified with##2##8##(2008-10#2)
sorption on##12##2##(2008-10#12)
sorption onto##4##2##(2008-10#4)
sorption preconcentration##5##2##(2008-10#5)
sorption properties of##2##3##(2008-10#2)
sorption properties##4##2##(2008-10#4)
sorption rate##2##2##(2008-10#2)
sorption was##3##2##(2008-10#3)
sorption were##2##2##(2008-10#1)(2010-4#1)
sorption with##5##2##(2008-10#5)
sorption##192##1##(2008-10#181)(2008-12#1)(2008-5#2)(2010-4#6)(2013-1#2)
sorption-spectroscopic##2##1##(2008-10#2)
sorptive##4##1##(2008-10#4)
sorrow##4##1##(1993-11#1)(2009-9#3)
sort of##4##2##(1992-3#1)(2008-11#1)(2008-7#1)(2012-12#1)
sort##10##1##(1991-12#1)(1992-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)(2012-12#1)
sorted chromosomes##2##2##(2008-9#2)
sorted into##4##2##(1992-12#2)(2008-10#1)(2012-3#1)
sorted##9##1##(1992-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
sorting and##4##2##(2008-7#1)(2008-9#2)(2012-3#1)
sorting by##2##2##(2010-6#1)(2012-3#1)
sorting defect##3##2##(1990-5#3)
sorting of##9##2##(1995-8#2)(2008-7#1)(2008-9#4)(2011-2#1)(2013-8#1)
sorting system##2##2##(2008-8#1)(2008-9#1)
sorting##38##1##(1990-5#4)(1992-6#1)(1993-9#1)(1995-8#2)(1996-2#1)(2008-11#3)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#9)(2010-6#1)(2011-2#4)(2012-12#1)(2012-3#3)(2013-8#1)
sorts##5##1##(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)
sotalol##2##1##(1992-3#1)(2008-10#1)
sought in##2##2##(2008-1#1)(2011-2#1)
sought solutions to##2##3##(2011-2#1)(2012-2#1)
sought to determine if##2##4##(1994-2#1)(2008-10#1)
sought to determine whether##3##4##(1991-2#1)(2008-11#1)(2010-2#1)
sought to determine##8##3##(1991-2#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-2#1)(2012-3#1)
sought to develop##3##3##(2008-12#1)(2013-1#2)
sought to evaluate the##3##4##(2010-1#1)(2011-2#1)(2012-3#1)
sought to explore##2##3##(2008-11#1)(2010-10#1)
sought to identify##4##3##(2008-10#1)(2008-9#2)(2011-1#1)
sought to##44##2##(1991-2#1)(1992-12#1)(1993-12#1)(1994-2#1)(1996-12#1)(2007-9#1)(2008-10#3)(2008-11#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2010-1#2)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#3)
sought##70##1##(1991-2#1)(1992-12#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#11)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)
soul##2##1##(2008-11#1)(2013-8#1)
sound and##4##2##(2008-11#1)(2008-3#3)
sound arguments##2##2##(2012-2#2)
sound clinical##2##2##(2008-12#1)(2010-10#1)
sound condition##2##2##(2013-8#2)
sound condition)##2##2##(2013-8#2)
sound decisions##2##2##(1993-3#1)(2010-1#1)
sound evidence##3##2##(1993-12#2)(2010-12#1)
sound is##4##2##(2008-3#2)(2008-8#1)(2012-3#1)
sound on fishes##2##3##(2010-8#2)
sound##70##1##(1993-12#2)(1993-3#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#5)(2008-8#6)(2008-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#1)(2011-8#1)(2012-2#4)(2012-3#1)(2013-8#10)
sounder##6##1##(2008-2#3)(2008-3#3)
sounding board##2##2##(1992-2#1)(2010-4#1)
sounding##6##1##(1992-2#1)(2008-3#3)(2008-8#1)(2010-4#1)
sounds by##2##2##(2008-11#2)
sounds##15##1##(2008-11#5)(2008-9#3)(2009-9#1)(2010-8#3)(2011-1#1)(2013-1#1)(2013-8#1)
sour orange##7##2##(2008-10#7)
sour##9##1##(2008-10#9)
source analysis##3##2##(2008-11#2)(2008-3#1)
source and a##6##3##(2008-10#6)
source and is##2##3##(1993-6#1)(1996-1#1)
source and the##7##3##(2008-10#5)(2008-8#1)(2012-2#1)
source and##30##2##(1993-6#1)(1996-1#1)(2008-10#20)(2008-11#1)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
source are##3##2##(2008-2#1)(2008-3#2)
source areas##2##2##(2008-10#2)
source by##3##2##(2008-10#2)(2011-2#1)
source can be##2##3##(2010-1#1)(2013-8#1)
source control##3##2##(2011-2#3)
source emitting##2##2##(2007-12#1)(2008-3#1)
source for a##2##3##(2008-11#1)(2008-3#1)
source for the##8##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2010-12#1)(2013-1#1)
source for##37##2##(1991-12#1)(1994-12#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-9#1)(2013-1#2)
source in a##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
source in the##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
source in##11##2##(1993-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#1)(2013-1#1)
source is not##2##3##(2008-3#1)(2011-2#1)
source is##9##2##(2008-10#4)(2008-3#3)(2011-2#1)(2012-3#1)
source located##2##2##(2008-3#2)
source of C##2##3##(1990-3#1)(2010-3#1)
source of a##2##3##(2008-3#1)(2013-1#1)
source of asbestos exposure##2##4##(1991-12#2)
source of cells for##2##4##(2008-9#1)(2013-1#1)
source of data##2##3##(1995-2#1)(2008-4#1)
source of error##3##3##(2008-10#2)(2008-3#1)
source of gender differences in##2##5##(2008-12#2)
source of health##3##3##(2008-10#3)
source of infection##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
source of information##2##3##(2011-2#1)(2012-3#1)
source of inoculum for##3##4##(2008-10#3)
source of inoculum##7##3##(2008-10#7)
source of morbidity##2##3##(2010-6#1)(2012-3#1)
source of noise##2##3##(2008-3#1)(2010-10#1)
source of organic carbon##2##4##(2008-10#2)
source of primary inoculum##5##4##(2008-10#5)
source of recurrent##2##3##(1994-5#1)(2011-2#1)
source of resistance##4##3##(2008-10#4)
source of stem rust resistance in oat breeding##2##8##(2008-10#2)
source of stem##3##3##(2008-10#2)(2008-9#1)
source of the##15##3##(1991-12#1)(1995-11#1)(1996-5#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-9#1)
source of variation##2##3##(2008-10#2)
source of##187##2##(1990-3#1)(1990-5#1)(1991-12#3)(1991-2#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-3#2)(1997-4#1)(2007-12#3)(2008-10#60)(2008-11#12)(2008-12#9)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-2#7)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#2)
source or##2##2##(2008-10#1)(2010-11#1)
source phase##3##2##(2008-10#3)
source plant##4##2##(2008-10#4)
source plants 21##2##3##(2008-10#2)
source plants displaying##2##3##(2008-10#2)
source plants##12##2##(2008-10#12)
source population##4##2##(2008-10#3)(2013-1#1)
source populations in##2##3##(1995-3#1)(2008-8#1)
source that##2##2##(2008-3#2)
source tissue##2##2##(2008-10#2)
source to##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
source used##2##2##(1995-9#1)(2008-3#1)
source was used##2##3##(2011-3#2)
source was##10##2##(2008-10#4)(2008-5#1)(2011-2#2)(2011-3#2)(2013-1#1)
source were##2##2##(2008-10#1)(2008-3#1)
source which##2##2##(2008-10#1)(2012-2#1)
source with##2##2##(2008-3#2)
source##542##1##(1990-3#1)(1990-5#1)(1991-12#4)(1991-2#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-9#2)(1996-1#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#3)(1997-3#2)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#236)(2008-11#30)(2008-12#11)(2008-2#7)(2008-3#55)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#11)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#20)(2011-3#3)(2011-7#1)(2012-2#11)(2012-3#7)(2012-9#1)(2013-1#16)(2013-7#1)(2013-8#5)
source)##2##1##(2008-10#1)(2011-2#1)
source-sink dynamics##4##2##(2008-8#4)
source-sink##10##1##(2008-8#8)(2008-9#2)
sources (e##3##2##(2008-10#1)(2008-4#2)
sources and methods##2##3##(1991-2#1)(2013-1#1)
sources and sinks##4##3##(2008-11#2)(2008-8#1)(2008-9#1)
sources and##19##2##(1991-2#1)(1995-5#1)(2008-10#8)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-3#1)(2013-1#1)
sources are used##2##3##(2008-10#1)(2008-3#1)
sources are##8##2##(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)
sources as##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
sources at##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
sources for##15##2##(1995-2#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-1#1)
sources from##4##2##(1990-11#1)(1997-6#1)(2008-10#1)(2010-1#1)
sources have##4##2##(2008-10#3)(2009-10#1)
sources in the##6##3##(1991-9#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2011-7#1)
sources in##9##2##(1991-9#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-5#2)(2010-10#1)(2011-7#1)(2012-12#1)
sources including##2##2##(2008-11#1)(2008-5#1)
sources is##2##2##(2008-10#1)(2008-3#1)
sources of bias##2##3##(2008-10#2)
sources of contamination##3##3##(1994-3#1)(2008-10#1)(2012-2#1)
sources of data##3##3##(2008-1#2)(2011-3#1)
sources of funding##5##3##(1993-2#2)(1995-3#1)(1997-2#1)(1997-3#1)
sources of infection##2##3##(2008-10#1)(2008-7#1)
sources of information about##2##4##(1996-11#1)(2008-1#1)
sources of information##8##3##(1990-2#1)(1995-2#1)(1996-11#1)(1997-3#1)(2008-1#1)(2008-11#2)(2009-7#1)
sources of inoculum and##2##4##(2008-10#2)
sources of inoculum for##3##4##(2008-10#3)
sources of inoculum##11##3##(2008-10#11)
sources of input##2##3##(1991-3#1)(2008-9#1)
sources of leaf rust resistance##2##5##(2008-10#2)
sources of noise##2##3##(2008-3#1)(2008-4#1)
sources of perceived##2##3##(2010-1#2)
sources of resistance and##2##4##(2008-10#2)
sources of resistance to##2##4##(2008-10#2)
sources of resistance##6##3##(2008-10#6)
sources of support##2##3##(2010-1#1)(2010-10#1)
sources of the##2##3##(1992-3#1)(2008-10#1)
sources of variability##2##3##(2008-10#1)(2008-4#1)
sources of##126##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-2#2)(1993-6#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-3#1)(1997-2#2)(1997-3#2)(2008-1#3)(2008-10#44)(2008-11#8)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-3#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
sources on the##2##3##(2008-10#1)(2012-3#1)
sources on##3##2##(2008-10#2)(2012-3#1)
sources previously##2##2##(2008-10#2)
sources that##2##2##(2008-3#1)(2013-1#1)
sources to identify##2##3##(2010-11#1)(2011-8#1)
sources to##9##2##(1991-3#1)(1992-1#1)(1995-1#1)(2007-12#1)(2008-10#1)(2009-10#1)(2010-11#1)(2011-2#1)(2011-8#1)
sources used to##2##3##(1991-2#1)(2010-11#1)
sources used##3##2##(1991-2#1)(2010-11#1)(2012-12#1)
sources was##3##2##(2008-10#2)(2013-1#1)
sources were determined##3##3##(2008-10#2)(2008-8#1)
sources were##8##2##(1992-1#1)(1995-1#1)(1996-2#1)(2008-10#3)(2008-8#1)(2010-2#1)
sources which##2##2##(1992-1#1)(1995-9#1)
sources with##2##2##(1991-8#1)(1997-6#1)
sources##344##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#3)(1997-3#3)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#123)(2008-11#29)(2008-12#4)(2008-2#1)(2008-3#13)(2008-4#7)(2008-5#10)(2008-7#2)(2008-8#6)(2008-9#15)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#5)(2010-10#2)(2010-11#3)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#4)(2011-7#2)(2011-8#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#10)(2013-8#3)
sources)##2##1##(2008-4#1)(2010-10#1)
sourcing##2##1##(2008-11#2)
south India##2##2##(1992-11#1)(2010-10#1)
south London##3##2##(1996-8#3)
south of the##4##3##(2008-10#3)(2009-5#1)
south of##14##2##(1990-12#2)(2008-10#9)(2009-5#1)(2013-1#1)(2013-8#1)
south than in##2##3##(2008-10#2)
south to##3##2##(2008-10#2)(2008-9#1)
south##34##1##(1990-12#2)(1992-11#1)(1994-3#1)(1996-8#3)(2008-10#17)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#2)(2013-8#2)
south-west##3##1##(2010-3#1)(2010-8#1)(2011-2#1)
southeast Asia##2##2##(1994-9#1)(2008-6#1)
southeast##6##1##(1994-9#1)(2008-10#2)(2008-6#1)(2010-1#1)(2012-2#1)
southeastern Spain##2##2##(2008-10#2)
southeastern##14##1##(1993-1#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-5#1)(2011-2#1)
southern Africa##4##2##(2008-10#1)(2010-1#2)(2011-2#1)
southern Arizona##4##2##(2008-10#1)(2008-9#1)(2009-8#2)
southern California##2##2##(2008-10#2)
southern Egypt##2##2##(1994-9#1)(2008-10#1)
southern Europe##3##2##(2010-1#1)(2011-2#2)
southern Somalia##4##2##(2011-2#4)
southern Spain##8##2##(2008-10#8)
southern United States##2##3##(2008-10#1)(2008-11#1)
southern and northern##3##3##(2008-8#2)(2013-1#1)
southern and##7##2##(2008-10#3)(2008-11#1)(2008-8#2)(2013-1#1)
southern blight##4##2##(2008-10#4)
southern corn##2##2##(2008-10#2)
southern division meeting##8##3##(2008-11#8)
southern ocean islands##3##3##(2008-8#1)(2008-9#2)
southern##116##1##(1990-6#1)(1991-6#2)(1994-11#1)(1994-9#1)(1995-6#1)(1996-8#2)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#48)(2008-11#10)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-8#3)(2010-1#4)(2010-8#5)(2011-2#11)(2012-3#3)(2013-1#5)(2013-8#3)
southernmost##2##1##(2008-5#1)(2009-8#1)
southward##3##1##(2008-10#2)(2010-1#1)
southwest France##2##2##(2008-10#2)
southwest of##2##2##(2008-12#1)(2008-9#1)
southwest##12##1##(2008-10#8)(2008-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
southwestern##12##1##(1990-8#3)(2008-10#7)(2008-12#1)(2008-9#1)
souvent##4##1##(2011-2#3)(2013-1#1)
sowing and##2##2##(2008-10#2)
sowing date##9##2##(2008-10#9)
sowing distances##7##2##(2008-12#7)
sowing##21##1##(2008-10#14)(2008-12#7)
sowings##3##1##(2008-10#2)(2012-7#1)
sown##4##1##(2008-10#4)
sows##4##1##(1991-11#1)(2008-8#3)
soxhlet extraction##2##2##(2008-10#2)
soy hydrolysate##4##2##(2008-11#4)
soy isoflavones##2##2##(2008-10#2)
soy protein##2##2##(2010-4#1)(2012-2#1)
soy sauce and hot-pepper paste##2##5##(2010-4#2)
soy sauce and##3##3##(2008-10#1)(2010-4#2)
soy sauce##4##2##(2008-10#1)(2010-4#3)
soy##23##1##(2008-10#6)(2008-11#5)(2010-1#2)(2010-4#4)(2012-2#2)(2013-1#4)
soya bean##3##2##(1990-3#2)(2008-5#1)
soya beans##2##2##(2008-3#2)
soya biopeptide##3##2##(2008-5#3)
soya peptide##2##2##(2008-5#2)
soya##16##1##(1990-3#2)(1997-2#1)(2008-10#3)(2008-3#2)(2008-5#7)(2013-8#1)
soybean (Glycine max) plants##2##4##(2008-10#2)
soybean (Glycine max)##6##3##(2008-10#5)(2008-11#1)
soybean (Glycine##8##2##(1990-5#1)(2008-10#5)(2008-11#1)(2010-11#1)
soybean Sclerotinia stem rot (SSR)##2##5##(2008-10#2)
soybean agglutinin##4##2##(1995-11#4)
soybean and the##2##3##(2008-10#2)
soybean and##10##2##(2008-10#9)(2008-11#1)
soybean by##3##2##(2008-10#3)
soybean cultivar response to S##2##5##(2008-10#2)
soybean cultivar##3##2##(2008-10#3)
soybean cultivars##3##2##(2008-10#3)
soybean cvs##2##2##(2008-10#2)
soybean cyst nematode##2##3##(2008-10#2)
soybean dwarf##2##2##(2008-10#2)
soybean fields in##4##3##(2008-10#4)
soybean fields##7##2##(2008-10#7)
soybean genotypes carrying##2##3##(2008-10#2)
soybean genotypes##3##2##(2008-10#3)
soybean is##3##2##(2008-10#2)(2011-2#1)
soybean leaves##2##2##(2008-10#2)
soybean oil##4##2##(2008-10#3)(2008-5#1)
soybean plants in##2##3##(2008-10#2)
soybean plants were##2##3##(2008-10#2)
soybean plants##12##2##(2008-10#11)(2010-11#1)
soybean production##3##2##(2008-10#3)
soybean roots##3##2##(2008-10#3)
soybean rust epidemics##2##3##(2008-10#2)
soybean rust##12##2##(2008-10#12)
soybean seed##3##2##(2008-10#3)
soybean seedlings##5##2##(2008-10#3)(2008-8#2)
soybean stem##5##2##(2008-10#5)
soybean stems##4##2##(2008-10#4)
soybean tissue##4##2##(2008-10#4)
soybean varieties##2##2##(2008-12#1)(2008-8#1)
soybean variety##2##2##(2008-12#2)
soybean were##2##2##(2008-10#2)
soybean##187##1##(1990-5#3)(1995-11#4)(1995-3#1)(1995-8#2)(1997-7#1)(2008-10#150)(2008-11#4)(2008-12#6)(2008-5#1)(2008-6#1)(2008-8#6)(2009-10#1)(2010-10#2)(2010-11#2)(2010-3#1)(2011-10#1)(2011-2#1)
soybeans##11##1##(2008-10#10)(2009-10#1)
sp##458##1##(1993-3#2)(1995-12#2)(1995-3#3)(1995-6#4)(1995-8#2)(1996-12#3)(1996-6#5)(1996-8#2)(1997-2#1)(1997-6#2)(2007-12#1)(2008-10#366)(2008-11#2)(2008-12#10)(2008-5#9)(2008-7#5)(2008-8#6)(2008-9#2)(2009-6#5)(2010-10#1)(2010-3#2)(2010-8#1)(2011-2#11)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
space acquisition##3##2##(2008-8#2)(2008-9#1)
space analysis##2##2##(2008-5#1)(2009-8#1)
space and in##2##3##(1992-2#1)(2008-3#1)
space and the##4##3##(2008-1#1)(2008-7#1)(2013-8#2)
space and time##12##3##(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2013-1#4)(2013-8#1)
space and##32##2##(1991-12#1)(1992-2#1)(1993-6#1)(1994-3#2)(1994-9#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-7#1)(2010-8#1)(2011-7#1)(2013-1#4)(2013-8#5)
space are##2##2##(2007-12#1)(2008-11#1)
space as##2##2##(1991-12#1)(2013-8#1)
space at##4##2##(2008-5#1)(2008-8#1)(2012-3#2)
space available##2##2##(2008-9#1)(2011-2#1)
space between the##2##3##(1997-3#1)(2008-10#1)
space between##4##2##(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
space by##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
space can##2##2##(2008-11#1)(2013-1#1)
space exploration##4##2##(2012-3#4)
space for##2##2##(2008-11#1)(2008-9#1)
space group##11##2##(1992-11#1)(1992-12#1)(1993-8#2)(1996-5#1)(2008-8#3)(2008-9#3)
space in##7##2##(1990-5#1)(1991-2#1)(1997-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-8#1)
space into##2##2##(2008-11#1)(2008-8#1)
space is##4##2##(1991-2#1)(1992-11#1)(1997-6#1)(2008-12#1)
space models##6##2##(2008-11#6)
space of the##7##3##(1990-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2013-8#1)
space of##11##2##(1990-12#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-10#1)(2009-8#1)(2013-8#1)
space other than##2##3##(2008-8#1)(2011-2#1)
space structure of##3##3##(2008-8#3)
space that##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
space to##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
space use of##2##3##(2008-8#1)(2008-9#1)
space use patterns##2##3##(2008-8#1)(2008-9#1)
space use##6##2##(2008-8#3)(2008-9#2)(2012-2#1)
space whose##2##2##(2009-6#1)(2011-2#1)
space with##2##2##(1994-2#1)(2008-12#1)
space within##2##2##(2008-6#1)(2012-2#1)
space without##2##2##(2008-10#1)(2008-7#1)
space##271##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#5)(1991-2#9)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#8)(2007-12#5)(2008-1#4)(2008-10#18)(2008-11#24)(2008-12#3)(2008-3#5)(2008-5#4)(2008-6#5)(2008-7#10)(2008-8#38)(2008-9#25)(2009-10#5)(2009-11#4)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#12)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#16)(2013-1#10)(2013-8#10)
space-based##4##1##(2008-3#4)
space-charge##3##1##(2008-3#1)(2012-2#2)
space-dependent rate equation##3##3##(2008-3#3)
space-filling curve##2##2##(2008-6#2)
space-occupying##4##1##(1991-3#1)(2008-4#1)(2008-8#1)(2010-12#1)
space-time##3##1##(2007-12#1)(2008-3#1)(2008-8#1)
spaceborne lidar##2##2##(2008-3#2)
spaceborne##7##1##(2008-3#7)
spacecraft##2##1##(2008-3#1)(2012-3#1)
spaced polyps and##2##3##(2009-8#2)
spaced##14##1##(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#2)(2012-3#1)
spaceflight##5##1##(1991-2#2)(2012-3#3)
spacer and##2##2##(2008-10#2)
spacer between##2##2##(2008-10#2)
spacer layer##3##2##(2008-3#1)(2009-11#2)
spacer of the##3##3##(2008-10#3)
spacer of##4##2##(2008-10#4)
spacer rDNA##2##2##(2008-10#2)
spacer region between##2##3##(2008-10#2)
spacer region of##3##3##(2008-10#3)
spacer region were##3##3##(2008-10#3)
spacer region##27##2##(2008-10#25)(2008-9#1)(2011-2#1)
spacer regions of##4##3##(2008-10#4)
spacer regions##6##2##(2008-10#6)
spacer##142##1##(1993-12#1)(1995-8#1)(1996-1#3)(1996-2#3)(1997-7#1)(2007-11#2)(2008-10#116)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#3)(2009-11#2)(2011-1#1)(2011-2#2)
spacers##7##1##(1992-3#2)(2008-10#4)(2008-8#1)
spaces and the##2##3##(2008-8#1)(2012-3#1)
spaces and##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
spaces from##2##2##(2008-11#1)(2009-5#1)
spaces of##7##2##(2008-10#6)(2009-6#1)
spaces##37##1##(1993-2#1)(1995-11#1)(1997-6#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-5#5)(2009-6#1)(2010-12#1)(2010-6#2)(2012-3#1)(2013-1#1)
spacing in the##2##3##(2010-8#1)(2012-2#1)
spacing in##3##2##(1992-3#1)(2010-8#1)(2012-2#1)
spacing of##5##2##(2008-3#4)(2008-9#1)
spacing to##2##2##(1994-11#1)(2008-9#1)
spacing##29##1##(1992-3#1)(1994-11#1)(1996-2#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#10)(2008-7#1)(2008-8#2)(2008-9#3)(2010-8#2)(2011-2#1)(2012-2#2)
spacings of##2##2##(2008-5#1)(2010-11#1)
span and##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
span of the##5##3##(1991-5#1)(1993-8#1)(2007-12#1)(2008-10#2)
span of##16##2##(1991-5#1)(1993-8#3)(1995-6#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#3)(2008-9#1)(2010-4#1)(2011-2#1)
span the range of##2##4##(1996-2#1)(2008-10#1)
span the##7##2##(1993-8#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-3#1)
span##65##1##(1990-3#4)(1991-5#1)(1992-2#1)(1993-8#4)(1994-11#1)(1995-6#3)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#11)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#6)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
spanned##4##1##(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#1)
spanning from##4##2##(1992-3#1)(2008-11#1)(2008-3#1)(2010-4#1)
spanning several##2##2##(1994-5#1)(2009-11#1)
spanning the##11##2##(1990-8#1)(1992-1#1)(1994-5#1)(1995-6#1)(1996-6#1)(2008-10#6)
spanning##35##1##(1990-8#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)(1996-8#1)(1997-7#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
spans##12##1##(1991-5#1)(1993-12#2)(1993-3#1)(1994-11#1)(1996-6#1)(1997-8#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
spare##3##1##(2008-10#1)(2008-11#1)(2008-8#1)
spared##6##1##(1993-3#1)(1994-8#1)(1995-8#1)(2009-10#1)(2010-6#1)(2013-1#1)
sparfloxacin##2##1##(2008-7#2)
sparge##2##1##(2008-10#1)(2008-11#1)
sparing of brain##2##3##(2008-11#2)
sparing of##6##2##(1992-12#1)(1992-3#1)(2008-11#2)(2008-7#1)(2008-9#1)
sparing the##3##2##(1990-6#1)(1994-2#1)(2012-3#1)
sparing##20##1##(1990-6#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-9#1)(2009-4#1)(2012-2#2)(2012-3#2)(2013-1#1)
sparingly soluble and insoluble Cr(VI) from##2##6##(2008-10#2)
sparingly soluble##5##2##(2008-10#5)
sparingly##7##1##(2008-10#7)
spark ablation vessel##3##3##(2008-10#3)
spark ablation##7##2##(2008-10#7)
spark source##3##2##(2008-10#3)
spark##14##1##(2008-10#14)
sparked an##2##2##(1995-1#1)(1997-1#1)
sparked##4##1##(1994-11#1)(1995-1#1)(1997-1#1)(2011-2#1)
sparkling wines##4##2##(2008-10#4)
sparkling##5##1##(2008-10#5)
sparks##2##1##(1996-3#1)(2009-10#1)
sparrows (Passer##3##2##(2008-5#3)
sparrows##9##1##(2008-5#5)(2008-8#2)(2008-9#2)
sparse##24##1##(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
sparsely##4##1##(1991-1#1)(1994-8#1)(2008-11#1)(2012-3#1)
sparseness of##2##2##(2008-10#1)(2008-11#1)
spasm and##5##2##(1992-6#2)(2008-7#2)(2011-2#1)
spasm during##2##2##(2011-2#1)(2012-2#1)
spasm##22##1##(1991-3#1)(1992-6#3)(2008-12#2)(2008-7#5)(2011-1#1)(2011-2#8)(2012-2#1)(2012-3#1)
spasmodic##3##1##(1996-2#3)
spasms and##2##2##(2009-11#1)(2011-2#1)
spasms##9##1##(1990-9#1)(2008-12#1)(2009-11#5)(2011-2#2)
spastic foot drop##2##3##(2009-11#2)
spastic##7##1##(1996-2#2)(1997-6#1)(2008-7#1)(2009-11#2)(2011-2#1)
spasticity and##2##2##(2009-9#1)(2011-2#1)
spasticity in##2##2##(2010-8#1)(2010-9#1)
spasticity##9##1##(2008-7#1)(2009-4#1)(2009-9#2)(2010-8#1)(2010-9#1)(2011-2#3)
spat##2##1##(1995-3#1)(2010-11#1)
spataceum##2##1##(2012-2#2)
spatial abilities##2##2##(2008-11#2)
spatial ability##5##2##(1994-8#1)(2008-11#3)(2008-7#1)
spatial adaptation##3##2##(2013-8#3)
spatial aggregation##6##2##(2008-10#4)(2008-8#2)
spatial analysis by distance indices (SADIE)##2##6##(2008-10#2)
spatial analysis by distance indices##3##5##(2008-10#3)
spatial analysis##4##2##(2008-10#4)
spatial and contextual learning##2##4##(1993-12#2)
spatial and contextual##3##3##(1993-12#2)(2011-2#1)
spatial and temporal changes in##2##5##(2008-11#1)(2010-4#1)
spatial and temporal characteristics##2##4##(2008-8#2)
spatial and temporal dynamics##2##4##(2008-9#1)(2009-8#1)
spatial and temporal patterns##2##4##(2008-10#2)
spatial and temporal resolution in##2##5##(2008-11#1)(2011-2#1)
spatial and temporal##26##3##(1996-6#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
spatial and##36##2##(1993-12#2)(1994-2#2)(1996-6#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
spatial architecture##2##2##(2008-8#2)
spatial arrangement of##4##3##(1993-8#1)(1994-9#1)(2008-10#2)
spatial arrangement##5##2##(1993-8#1)(1994-9#1)(2008-10#3)
spatial aspects of disease incidence data##2##6##(2008-10#2)
spatial assimilation##2##2##(2011-2#2)
spatial autocorrelation##9##2##(2008-10#7)(2008-8#2)
spatial beam profile##2##3##(2008-3#2)
spatial beam##3##2##(2007-12#1)(2008-3#2)
spatial coherence##3##2##(2008-3#3)
spatial conformation of the##2##4##(2008-8#2)
spatial conformation##3##2##(2008-8#3)
spatial correlation##5##2##(2008-10#3)(2008-8#2)
spatial covariance##2##2##(2008-8#2)
spatial delayed##3##2##(1991-2#1)(1993-3#1)(1994-8#1)
spatial dependence##6##2##(2008-10#4)(2008-3#1)(2009-7#1)
spatial dependence)##2##2##(2008-10#2)
spatial distribution of the##4##4##(1995-3#1)(2008-10#1)(2008-8#1)(2013-8#1)
spatial distribution of##15##3##(1994-9#1)(1995-3#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-8#2)(2013-8#1)
spatial distribution##22##2##(1994-9#1)(1995-3#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2013-8#2)
spatial distributions##2##2##(2008-10#2)
spatial dynamics of the##2##4##(2008-10#2)
spatial dynamics of##8##3##(1995-5#1)(2008-10#6)(2011-2#1)
spatial dynamics##10##2##(1995-5#1)(2008-10#6)(2008-8#2)(2011-2#1)
spatial expression of##2##3##(2008-10#1)(2012-2#1)
spatial expression##4##2##(1993-2#1)(1996-12#1)(2008-10#1)(2012-2#1)
spatial filter##2##2##(2007-12#1)(2008-3#1)
spatial frame##2##2##(2012-2#2)
spatial frequency of##3##3##(2008-3#1)(2008-8#1)(2009-10#1)
spatial frequency##5##2##(2008-3#1)(2008-8#2)(2009-10#2)
spatial heterodyne##2##2##(2013-8#2)
spatial heterogeneity in##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
spatial heterogeneity of##5##3##(1996-2#1)(2008-10#4)
spatial heterogeneity##14##2##(1996-2#1)(2008-10#6)(2008-3#1)(2008-8#4)(2008-9#2)
spatial hierarchy##6##2##(2008-10#6)
spatial hole burning##3##3##(2008-3#3)
spatial information##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-9#1)
spatial issues##2##2##(2008-8#2)
spatial learning and memory##2##4##(2011-2#1)(2012-2#1)
spatial learning and##3##3##(1991-7#1)(2011-2#1)(2012-2#1)
spatial learning##13##2##(1991-7#4)(1993-3#1)(1994-3#1)(1994-8#2)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
spatial light modulator##2##3##(2008-3#2)
spatial location##2##2##(2008-10#1)(2010-5#1)
spatial memory##4##2##(2008-11#1)(2008-7#1)(2011-2#2)
spatial model##2##2##(2008-8#2)
spatial models##2##2##(2008-8#2)
spatial modes of lasers##2##4##(2008-3#2)
spatial modes##3##2##(2008-3#3)
spatial navigation##2##2##(1994-3#1)(2008-11#1)
spatial or temporal##2##3##(2008-9#1)(2009-10#1)
spatial or##3##2##(1994-2#1)(2008-9#1)(2009-10#1)
spatial organisation##3##2##(2010-10#3)
spatial organization of##3##3##(1991-2#1)(2009-5#2)
spatial organization##4##2##(1991-2#1)(1995-6#1)(2009-5#2)
spatial pattern of disease##2##4##(2008-10#1)(2008-8#1)
spatial pattern of spore deposition##2##5##(2008-10#2)
spatial pattern of##16##3##(2008-10#13)(2008-8#3)
spatial pattern##29##2##(2008-10#18)(2008-11#1)(2008-8#10)
spatial patterns at##2##3##(2008-10#1)(2008-8#1)
spatial patterns of ACC##2##4##(2008-10#2)
spatial patterns of##14##3##(1996-12#1)(2008-10#13)
spatial patterns##22##2##(1996-12#1)(2008-10#16)(2008-8#4)(2008-9#1)
spatial point##2##2##(2008-10#1)(2013-8#1)
spatial population structure##2##3##(2008-8#2)
spatial population##3##2##(2008-8#3)
spatial power##2##2##(2008-3#1)(2010-7#1)
spatial problems##2##2##(1991-2#1)(2008-8#1)
spatial processes##2##2##(2008-10#1)(2008-8#1)
spatial quality##2##2##(2007-11#1)(2007-12#1)
spatial reasoning##2##2##(2008-11#2)
spatial redistribution of surface water##2##5##(2008-8#2)
spatial redistribution of##3##3##(1995-6#1)(2008-8#2)
spatial redistribution##4##2##(1995-6#1)(2008-8#3)
spatial relationships##5##2##(1997-3#1)(2008-10#1)(2008-9#2)(2011-7#1)
spatial representation##3##2##(1995-5#1)(2009-8#1)(2013-8#1)
spatial resolution and##4##3##(2008-8#1)(2009-1#1)(2010-12#1)(2012-2#1)
spatial resolution in optical diffusion tomography##2##6##(2008-3#2)
spatial resolution in##3##3##(2008-3#3)
spatial resolution of##8##3##(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-7#1)(2011-2#1)
spatial resolution##35##2##(1995-11#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#11)(2008-5#1)(2008-8#2)(2009-1#2)(2009-5#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-8#1)
spatial reversal##2##2##(1993-3#2)
spatial scale of the##2##4##(2008-8#2)
spatial scale of##4##3##(2008-8#4)
spatial scale##12##2##(2008-10#4)(2008-8#7)(2010-6#1)
spatial scales##16##2##(2008-10#5)(2008-8#6)(2008-9#4)(2013-1#1)
spatial segregation of##2##3##(2010-10#1)(2013-8#1)
spatial smoothing##2##2##(2009-7#2)
spatial spread of##6##3##(2008-10#5)(2011-3#1)
spatial spread##7##2##(2008-10#5)(2008-9#1)(2011-3#1)
spatial statistics of##4##3##(2008-10#1)(2008-3#3)
spatial statistics##6##2##(2008-10#1)(2008-3#3)(2008-8#2)
spatial structure and##2##3##(2008-10#1)(2008-11#1)
spatial structure of the##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
spatial structure of##8##3##(2008-10#2)(2008-11#2)(2008-8#4)
spatial structure##15##2##(2008-10#4)(2008-11#3)(2008-8#8)
spatial structures##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
spatial terms##2##2##(2009-7#2)
spatial variance in fitness##2##4##(2008-8#2)
spatial variation in habitat quality##2##5##(2008-8#2)
spatial variation in##7##3##(2008-8#4)(2010-8#2)(2012-3#1)
spatial variation of##2##3##(2008-10#1)(2009-8#1)
spatial variation##12##2##(2008-10#2)(2008-5#2)(2008-8#4)(2009-8#1)(2010-8#2)(2012-3#1)
spatial working memory##2##3##(2008-11#2)
spatial working##3##2##(2008-11#3)
spatial##543##1##(1991-2#4)(1991-5#1)(1991-7#4)(1992-4#1)(1993-12#2)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#1)(1994-2#4)(1994-3#3)(1994-8#9)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#2)(1996-12#3)(1996-2#1)(1996-6#1)(1997-3#1)(2007-11#2)(2007-12#9)(2008-10#157)(2008-11#26)(2008-2#6)(2008-3#54)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#10)(2008-8#103)(2008-9#15)(2009-1#2)(2009-10#7)(2009-11#1)(2009-5#3)(2009-7#8)(2009-8#9)(2010-1#1)(2010-10#5)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-2#11)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#3)(2013-8#20)
spatially aggregated within##2##3##(2008-10#2)
spatially aggregated##4##2##(2008-10#4)
spatially and temporally regulated##3##4##(1994-2#1)(2009-8#1)(2011-2#1)
spatially and temporally##7##3##(1994-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#1)
spatially autocorrelated##2##2##(2008-10#1)(2008-8#1)
spatially characterized##2##2##(2008-5#2)
spatially continuous##2##2##(2008-8#2)
spatially correlated##10##2##(2008-10#3)(2008-11#1)(2008-8#4)(2008-9#2)
spatially discrete##2##2##(2008-8#2)
spatially distant##2##2##(2010-3#1)(2012-2#1)
spatially distributed##2##2##(1995-11#1)(2007-12#1)
spatially explicit models##3##3##(2008-8#1)(2008-9#2)
spatially explicit##12##2##(2008-10#2)(2008-8#6)(2008-9#3)(2013-8#1)
spatially heterogeneous##5##2##(2008-10#3)(2008-8#1)(2013-1#1)
spatially homogeneous##6##2##(2008-8#6)
spatially incoherent##2##2##(2008-3#2)
spatially integrated##2##2##(2011-2#2)
spatially localized##2##2##(2008-3#1)(2013-1#1)
spatially realistic metapopulation model##2##4##(2008-8#1)(2008-9#1)
spatially resolved##6##2##(1997-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-2#1)
spatially separated##3##2##(2008-10#2)(2008-7#1)
spatially structured##3##2##(2008-8#2)(2008-9#1)
spatially variable pest management##2##4##(2008-10#2)
spatially variable##5##2##(2008-10#2)(2008-8#2)(2009-8#1)
spatially varying##3##2##(2008-3#1)(2008-9#1)(2013-1#1)
spatially##129##1##(1992-4#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#28)(2008-11#3)(2008-2#4)(2008-3#11)(2008-5#3)(2008-7#1)(2008-8#36)(2008-9#10)(2009-7#1)(2009-8#6)(2010-10#1)(2010-3#2)(2010-4#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
spatially-resolved##2##1##(1997-6#1)(2008-10#1)
spatio-temporal organization##2##2##(1995-6#1)(2011-2#1)
spatio-temporal##13##1##(1992-12#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
spatiotemporal dynamics of##4##3##(2008-10#2)(2008-11#2)
spatiotemporal maps##2##2##(2008-10#2)
spatiotemporal patterns of activity##2##4##(1990-5#1)(2009-8#1)
spatiotemporal patterns##3##2##(1990-5#1)(1996-2#1)(2009-8#1)
spatiotemporal resolution##2##2##(1994-3#1)(2009-7#1)
spatiotemporal variation##2##2##(2008-8#2)
spatiotemporal##36##1##(1990-5#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#10)(2008-11#7)(2008-3#1)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#3)(2011-2#2)(2013-1#2)
spatula##2##1##(2008-7#1)(2009-6#1)
spawned##2##1##(1995-1#1)(2010-8#1)
spawners##3##1##(2008-8#2)(2010-8#1)
spawning habitat##2##2##(2010-8#2)
spawning number##3##2##(2010-8#3)
spawning##26##1##(2008-11#1)(2008-7#2)(2008-8#1)(2010-8#22)
spawnings##6##1##(2010-8#6)
speak to##2##2##(1993-12#1)(2008-11#1)
speak##8##1##(1991-2#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-3#1)
speaker from prosody##2##3##(2009-10#2)
speaker from##3##2##(2009-10#2)(2011-1#1)
speaker sounded##2##2##(2009-10#2)
speaker##14##1##(2008-11#2)(2008-2#2)(2009-10#6)(2010-5#1)(2011-1#2)(2012-2#1)
speaker's##4##1##(2008-11#1)(2008-2#1)(2009-10#1)(2011-1#1)
speakers and##2##2##(2008-11#1)(2008-2#1)
speakers who stammer##3##3##(2008-2#3)
speakers##14##1##(1995-12#2)(1995-6#1)(1997-4#1)(2008-11#1)(2008-2#4)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)
speaking the##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
speaking##15##1##(1991-6#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#1)
speaks##2##1##(1993-1#1)(2011-2#1)
special attention to##10##3##(1997-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-3#1)
special attention##13##2##(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
special care nursery##2##3##(1993-3#2)
special care##6##2##(1993-3#2)(1994-3#1)(1997-8#1)(2008-10#1)(2008-3#1)
special case of the##2##4##(2008-8#1)(2008-9#1)
special case of##5##3##(2008-3#1)(2008-8#3)(2008-9#1)
special case##10##2##(2008-3#2)(2008-8#7)(2008-9#1)
special cases##5##2##(1997-4#1)(2008-10#2)(2008-8#1)(2012-2#1)
special characteristics##2##2##(2008-11#1)(2008-6#1)
special circumstances##2##2##(2008-12#1)(2009-8#1)
special clinics##2##2##(1995-2#2)
special considerations in Asia##2##4##(2012-3#2)
special considerations in##3##3##(2010-6#1)(2012-3#2)
special considerations##4##2##(2008-4#1)(2010-6#1)(2012-3#2)
special edition##2##2##(1997-1#1)(2008-12#1)
special education##4##2##(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)
special emphasis on the##6##4##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
special emphasis on##17##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#2)
special emphasis##18##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#2)
special experiences##2##2##(2012-2#2)
special features##2##2##(1991-1#1)(1994-3#1)
special focus on##4##3##(1990-6#1)(2009-7#1)(2011-2#2)
special focus##6##2##(1990-6#1)(1994-3#2)(2009-7#1)(2011-2#2)
special health care needs##10##4##(1995-12#4)(1995-3#2)(1997-2#2)(2010-11#2)
special health##12##2##(1992-2#1)(1994-3#1)(1995-12#4)(1995-3#2)(1997-2#2)(2010-11#2)
special interest because of##3##4##(1997-3#1)(2011-2#2)
special interest for##3##3##(2008-10#1)(2011-2#2)
special interest in##2##3##(2011-1#1)(2013-1#1)
special interest##15##2##(1990-9#1)(1991-3#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2011-1#1)(2011-2#6)(2013-1#1)
special issue on##2##3##(2008-8#1)(2013-1#1)
special issue##5##2##(1993-6#1)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
special list health journals##3##4##(1991-12#3)
special needs and##2##3##(1996-3#1)(2012-3#1)
special needs##10##2##(1995-1#2)(1996-3#1)(1997-2#3)(1997-8#1)(2012-3#3)
special populations##4##2##(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#1)
special probe##2##2##(2008-9#2)
special quadrature scheme##2##3##(2008-3#2)
special reactor##2##2##(2008-11#2)
special reference to##7##3##(1993-8#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
special regard to the##4##4##(1991-6#1)(2008-10#2)(2013-8#1)
special regard to##5##3##(1991-6#1)(2007-11#1)(2008-10#2)(2013-8#1)
special relativity effects##2##3##(2008-3#2)
special relativity##3##2##(2008-3#3)
special role##2##2##(1991-6#1)(2009-12#1)
special section##4##2##(2011-2#2)(2012-2#2)
special tests are##2##3##(2008-12#2)
special treatment##2##2##(1992-12#1)(2011-2#1)
special##276##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#4)(1992-12#1)(1992-2#3)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#5)(1994-6#2)(1995-1#4)(1995-12#7)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#4)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#42)(2008-11#16)(2008-12#9)(2008-3#12)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#12)(2008-9#8)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-11#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#20)(2011-3#1)(2012-2#7)(2012-3#7)(2013-1#9)(2013-8#6)
special-needs children##2##2##(1994-3#2)
special-needs##3##1##(1994-3#3)
specialised##5##1##(1992-9#1)(2007-12#1)(2008-11#2)(2011-3#1)
specialist and##3##2##(1996-11#1)(2008-8#1)(2009-8#1)
specialist education in##2##3##(2010-10#2)
specialist education##4##2##(2010-10#4)
specialist health##2##2##(1993-6#2)
specialist in endocrinology##2##3##(2013-1#2)
specialist in##7##2##(1992-2#1)(1993-2#1)(1993-5#1)(1995-6#1)(2008-11#1)(2013-1#2)
specialist practice##2##2##(2008-11#2)
specialist services##2##2##(1991-6#1)(1993-12#1)
specialist to##2##2##(1993-12#2)
specialist training##2##2##(1991-3#1)(1993-6#1)
specialist##67##1##(1990-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-5#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#4)(1995-12#1)(1995-6#1)(1996-11#1)(1997-8#2)(2007-12#3)(2008-11#6)(2008-7#3)(2008-8#6)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-10#4)(2010-11#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
specialists and##4##2##(1993-6#1)(2011-2#2)(2011-3#1)
specialists in##10##2##(1991-12#1)(1993-2#1)(1993-6#1)(1995-11#1)(1996-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2010-12#1)(2013-1#1)
specialists to##2##2##(2008-5#1)(2012-3#1)
specialists##41##1##(1990-12#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-2#2)(1993-3#1)(1993-6#3)(1994-1#1)(1995-11#1)(1996-1#2)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#5)(2008-9#3)(2010-12#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
specialities##3##1##(2008-11#2)(2009-4#1)
speciality##5##1##(1990-2#1)(2008-11#1)(2008-2#1)(2009-10#1)(2012-2#1)
specialization (such as##2##3##(2008-8#2)
specialization and##6##2##(1993-6#1)(2008-10#1)(2008-8#4)
specialization in##9##2##(1993-2#1)(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
specialization is##3##2##(1995-5#1)(2008-8#2)
specialization of the##2##3##(1996-12#1)(2008-10#1)
specialization of##6##2##(1996-12#1)(2008-10#1)(2008-8#3)(2008-9#1)
specialization within the##2##3##(2008-10#1)(2008-12#1)
specialization##56##1##(1993-2#1)(1993-6#1)(1994-12#2)(1995-5#1)(1996-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#19)(2008-9#6)(2009-10#1)(2012-2#4)(2012-3#1)
specializations in the##2##3##(2007-12#2)
specializations##8##1##(1995-6#1)(2007-12#3)(2008-9#3)(2009-10#1)
specialized and##2##2##(2008-11#1)(2009-8#1)
specialized care##2##2##(1992-12#1)(1993-12#1)
specialized centres##2##2##(1992-6#2)
specialized feeding##2##2##(2008-10#2)
specialized for##5##2##(2007-12#1)(2008-11#4)
specialized health care##3##3##(1993-1#1)(2008-11#2)
specialized host races##2##3##(2008-9#2)
specialized in the##2##3##(1995-12#1)(2008-7#1)
specialized infection##3##2##(2008-10#3)
specialized knowledge##2##2##(1993-12#1)(2008-11#1)
specialized laboratories##2##2##(2011-2#1)(2013-1#1)
specialized metabolism##2##2##(2011-2#2)
specialized metabolites##3##2##(2011-2#3)
specialized on##2##2##(2008-10#1)(2008-9#1)
specialized retinal##2##2##(2008-5#1)(2011-2#1)
specialized services##3##2##(1996-1#3)
specialized structures##3##2##(1990-5#1)(2008-11#2)
specialized to##4##2##(2008-10#3)(2013-1#1)
specialized training##3##2##(1994-12#1)(1996-11#1)(2010-8#1)
specialized units##2##2##(1995-11#1)(2008-11#1)
specialized##105##1##(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#2)(1992-1#2)(1992-12#1)(1992-6#2)(1993-1#2)(1993-12#2)(1994-11#1)(1994-12#3)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-11#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#12)(2008-11#15)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#9)(2009-10#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#11)(2012-2#2)(2012-3#1)(2013-1#4)
specializing in##3##2##(1992-8#1)(1996-1#1)(2008-12#1)
specializing on the##2##3##(2008-9#2)
specializing on##3##2##(2008-8#1)(2008-9#2)
specializing##6##1##(1992-8#1)(1996-1#1)(2008-12#1)(2008-8#1)(2008-9#2)
specially adapted##3##2##(2008-10#1)(2008-3#1)(2010-2#1)
specially designed for##2##3##(2008-10#1)(2008-5#1)
specially designed##17##2##(1993-2#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-3#1)(2010-8#1)
specially prepared##2##2##(2008-10#1)(2008-4#1)
specially##40##1##(1993-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)
specialties and##9##2##(1991-11#2)(1991-6#1)(1992-4#2)(1993-6#1)(1994-1#2)(2013-1#1)
specialties##27##1##(1991-11#2)(1991-6#5)(1992-4#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-1#2)(1994-12#3)(1996-1#1)(2008-10#2)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
specialty and##3##2##(1993-6#2)(2010-12#1)
specialty boards##4##2##(1994-12#1)(2008-4#3)
specialty health##2##2##(1993-2#1)(1994-3#1)
specialty ingredients##2##2##(2010-7#2)
specialty physician##3##2##(1994-1#2)(1997-1#1)
specialty services##2##2##(1991-2#1)(1994-3#1)
specialty##47##1##(1991-2#1)(1991-6#4)(1992-3#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#5)(1994-12#2)(1994-3#2)(1995-3#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#3)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#1)(2012-12#1)(2013-1#1)
speciated and##2##2##(2008-6#1)(2008-7#1)
speciated simultaneously##2##2##(2008-10#2)
speciated##7##1##(2008-10#4)(2008-6#1)(2008-7#2)
speciation analysis is##2##3##(2008-10#2)
speciation analysis of iron in##2##5##(2008-10#2)
speciation analysis of this element##2##5##(2008-10#2)
speciation analysis of##9##3##(2008-10#8)(2010-11#1)
speciation analysis##21##2##(2008-10#20)(2010-11#1)
speciation and determination##3##3##(2008-10#3)
speciation and##9##2##(2008-10#8)(2008-9#1)
speciation approaches##2##2##(2008-10#2)
speciation as a function of##2##5##(2008-10#2)
speciation by##8##2##(2008-10#7)(2008-9#1)
speciation calculations##2##2##(2008-10#2)
speciation continuum##2##2##(2013-1#2)
speciation in aqueous solutions##2##4##(2008-10#2)
speciation in environmental samples##4##4##(2008-10#4)
speciation in environmental##6##3##(2008-10#6)
speciation in water by##2##4##(2008-10#2)
speciation in water##3##3##(2008-10#3)
speciation in##27##2##(2008-10#27)
speciation measurements##2##2##(2008-10#2)
speciation method##4##2##(2008-10#4)
speciation methods##2##2##(2008-10#2)
speciation of As(III) and As(V)##3##5##(2008-10#3)
speciation of Cr(VI)##2##3##(2008-10#2)
speciation of Fe(II) and Fe(III)##2##5##(2008-10#2)
speciation of arsenic in environmental and biological samples##2##8##(2008-10#2)
speciation of arsenic in##6##4##(2008-10#6)
speciation of arsenic##13##3##(2008-10#13)
speciation of chromium in##7##4##(2008-10#7)
speciation of chromium##13##3##(2008-10#13)
speciation of different forms using##2##5##(2008-10#2)
speciation of inorganic##7##3##(2008-10#7)
speciation of mercury##2##3##(2008-10#2)
speciation of selenium in##2##4##(2008-10#2)
speciation of selenium##3##3##(2008-10#3)
speciation of the##2##3##(2008-10#2)
speciation of this group##2##4##(2008-10#1)(2008-9#1)
speciation of##89##2##(2008-10#87)(2008-9#2)
speciation or##2##2##(2008-10#1)(2008-8#1)
speciation scheme##2##2##(2008-10#2)
speciation studies##4##2##(2008-10#4)
speciation study in##2##3##(2008-10#2)
speciation study of##2##3##(2008-10#2)
speciation study##4##2##(2008-10#4)
speciation was assessed by performing multiple analyses of the spiked samples##2##11##(2008-10#2)
speciation was##8##2##(2008-10#7)(2010-11#1)
speciation##250##1##(2008-10#229)(2008-6#2)(2008-8#2)(2008-9#7)(2010-11#3)(2012-3#4)(2013-1#3)
specie##5##1##(2008-10#2)(2010-11#1)(2011-2#1)(2013-1#1)
species (Q##4##2##(2012-5#3)(2012-6#1)
species (e##2##2##(2008-10#1)(2012-3#1)
species (i##3##2##(2008-10#2)(2012-9#1)
species (the##2##2##(2008-10#1)(2012-3#1)
species B##2##2##(2008-10#2)
species C##3##2##(2008-10#3)
species X##2##2##(2008-10#2)
species abundance distribution##2##3##(2008-8#2)
species abundance distributions##3##3##(2008-8#3)
species abundance##8##2##(2008-8#8)
species after##4##2##(2008-10#3)(2013-1#1)
species also##2##2##(2008-10#1)(2008-9#1)
species analysis##5##2##(2008-10#5)
species and a##3##3##(1996-2#1)(2008-8#1)(2011-3#1)
species and between##2##3##(2008-10#1)(2008-9#1)
species and one##2##3##(2008-10#1)(2013-1#1)
species and other morphologically##2##4##(2008-10#1)(2011-2#1)
species and subspecies##2##3##(2008-10#1)(2008-12#1)
species and that##2##3##(2008-10#1)(2008-8#1)
species and the##7##3##(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)
species and their hybrids##2##4##(2008-10#1)(2008-9#1)
species and their##4##3##(2008-10#3)(2008-9#1)
species and this##2##3##(1993-3#1)(1997-9#1)
species and two##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
species and##116##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#54)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#9)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2012-6#2)(2013-1#1)(2013-8#3)
species are determined by##2##4##(2008-10#2)
species are determined##3##3##(2008-10#3)
species are discussed##2##3##(2008-12#1)(2010-8#1)
species are formed##3##3##(2008-10#3)
species are found##2##3##(2008-10#1)(2011-2#1)
species are not##3##3##(2008-8#2)(2013-1#1)
species are present in the##2##5##(2008-10#2)
species are present##3##3##(2008-10#3)
species are separated##2##3##(2008-10#2)
species are the##2##3##(2008-8#1)(2009-8#1)
species are very##3##3##(2008-10#2)(2008-7#1)
species are##65##2##(1994-8#1)(2007-12#1)(2008-10#30)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-5#1)(2013-1#2)
species as a function##2##4##(2008-10#2)
species as well as the##2##5##(2008-10#2)
species as well as##8##4##(1993-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-7#1)
species as##16##2##(1993-8#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-8#2)(2010-7#1)(2011-2#1)
species associated with##2##3##(2008-10#1)(2011-2#1)
species at a##3##3##(2008-8#1)(2008-9#2)
species at the##2##3##(2008-10#2)
species at##11##2##(2008-10#8)(2008-8#1)(2008-9#2)
species based on##3##3##(2008-10#3)
species because##2##2##(2008-10#1)(2008-9#1)
species belong to##2##3##(2008-8#1)(2011-2#1)
species belonging to the##2##4##(2008-10#1)(2008-11#1)
species belonging to##6##3##(2008-10#4)(2008-11#1)(2008-12#1)
species both##2##2##(1997-1#1)(2008-10#1)
species but not##3##3##(2008-10#1)(2008-9#1)(2010-11#1)
species but remain##2##3##(2008-10#2)
species but##10##2##(1997-6#1)(2008-10#3)(2008-8#2)(2008-9#2)(2010-11#1)(2010-8#1)
species by##20##2##(1996-12#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-4#1)(2012-2#1)
species can be##7##3##(2008-10#4)(2008-5#2)(2008-8#1)
species can##11##2##(2008-10#5)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)
species capable of##2##3##(2008-10#2)
species causing##3##2##(2008-10#2)(2008-5#1)
species coexistence##3##2##(2008-8#2)(2008-9#1)
species collected in##2##3##(2008-10#1)(2008-8#1)
species complex##6##2##(2008-10#4)(2008-12#1)(2010-10#1)
species composition of##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
species composition##6##2##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#3)
species concepts##2##2##(2008-8#1)(2010-3#1)
species could be##4##3##(1993-8#1)(2008-10#3)
species could##6##2##(1993-8#1)(2008-10#4)(2008-5#1)
species delimitation##3##2##(2012-3#3)
species dependent##2##2##(2008-10#2)
species detected in##2##3##(2008-10#1)(2010-11#1)
species detected##4##2##(2008-10#3)(2010-11#1)
species detection##2##2##(2008-10#2)
species determination##4##2##(2008-10#4)
species did not##3##3##(1991-7#1)(2008-10#2)
species difference##2##2##(1997-7#1)(2008-8#1)
species differences in##2##3##(1990-6#1)(2008-9#1)
species differences##3##2##(1990-6#1)(2008-9#1)(2012-2#1)
species differentiation##2##2##(2008-10#2)
species divergence##2##2##(2012-3#2)
species diversity and##2##3##(2008-8#1)(2008-9#1)
species diversity in##3##3##(2008-8#2)(2012-3#1)
species diversity of fruit flies##2##5##(2013-8#2)
species diversity of##3##3##(2012-3#1)(2013-8#2)
species diversity##15##2##(2008-8#6)(2008-9#4)(2012-3#3)(2013-8#2)
species do not##2##3##(1997-3#1)(2008-8#1)
species dominant under##2##3##(2008-8#2)
species during the##2##3##(2008-10#2)
species during##4##2##(2008-10#3)(2008-5#1)
species examined##4##2##(1993-12#1)(1993-2#1)(2008-10#2)
species except##2##2##(2008-10#2)
species exhibit##2##2##(2008-8#1)(2008-9#1)
species exhibited an##2##3##(2008-10#1)(2010-8#1)
species exhibited##5##2##(1993-12#1)(2008-10#2)(2008-8#1)(2010-8#1)
species existing in##2##3##(2008-10#2)
species for the##4##3##(2008-10#2)(2008-12#1)(2009-8#1)
species for##16##2##(1990-2#1)(1995-2#1)(2008-10#8)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
species formed by##2##3##(2008-10#2)
species formed##13##2##(2008-10#11)(2008-6#1)(2009-9#1)
species found in##2##3##(2008-12#1)(2011-2#1)
species found##4##2##(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
species from a##2##3##(2008-10#1)(2008-9#1)
species from five##2##3##(2011-2#1)(2012-3#1)
species from the##8##3##(2008-10#4)(2008-8#1)(2011-2#1)(2012-3#2)
species from##39##2##(1995-2#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-8#4)(2008-9#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2012-9#1)(2013-1#2)
species groups##2##2##(2010-4#2)
species growing in the##2##4##(2008-10#1)(2008-9#1)
species growing in##3##3##(2008-10#1)(2008-9#1)(2012-5#1)
species growing##4##2##(2008-10#1)(2008-9#1)(2012-5#1)(2012-6#1)
species had a##2##3##(1993-8#1)(2008-8#1)
species had##5##2##(1993-8#1)(2008-12#1)(2008-7#1)(2008-8#2)
species has been##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
species has##14##2##(1992-10#1)(2008-10#5)(2008-11#1)(2008-8#4)(2010-4#1)(2010-7#1)(2011-2#1)
species have been determined##2##4##(2008-10#2)
species have been##13##3##(1996-2#1)(2007-12#1)(2008-10#10)(2013-1#1)
species have##26##2##(1996-2#1)(2007-12#1)(2008-10#14)(2008-12#2)(2008-8#2)(2008-9#3)(2011-2#1)(2013-1#2)
species identification and##2##3##(2010-4#1)(2011-2#1)
species identification##4##2##(2008-10#1)(2010-3#1)(2010-4#1)(2011-2#1)
species identified in##2##3##(2008-10#1)(2011-2#1)
species identified##5##2##(1996-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
species in a##14##3##(2008-10#6)(2008-12#1)(2008-3#1)(2008-8#5)(2008-9#1)
species in aqueous##2##3##(2008-10#2)
species in both##4##3##(1996-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
species in deep##2##3##(2008-10#1)(2008-8#1)
species in each of##2##4##(1991-5#1)(2008-10#1)
species in environmental samples##2##4##(2008-10#2)
species in environmental##5##3##(2008-10#5)
species in fish##2##3##(2008-10#2)
species in human##3##3##(2008-10#2)(2009-11#1)
species in natural waters##3##4##(2008-10#3)
species in natural##5##3##(2008-10#5)
species in response to drought##2##5##(2012-8#2)
species in river##2##3##(2008-10#2)
species in solution##3##3##(2008-10#3)
species in spiked##2##3##(2008-10#2)
species in the family##2##4##(2008-10#2)
species in the genus Tospovirus##2##5##(2008-10#2)
species in the genus##9##4##(2008-10#6)(2008-8#1)(2011-2#2)
species in the##42##3##(1991-6#1)(1995-3#1)(2008-10#26)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#3)
species in these##2##3##(2008-8#2)
species in this##4##3##(2008-10#3)(2012-5#1)
species in water samples##3##4##(2008-10#3)
species in water##5##3##(2008-10#5)
species in which##5##3##(2008-10#1)(2008-8#3)(2013-1#1)
species in##174##2##(1991-5#1)(1991-6#1)(1991-8#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#107)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#23)(2008-9#4)(2009-10#1)(2009-11#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-8#2)(2013-1#1)(2013-8#2)
species include##3##2##(2007-12#1)(2008-12#1)(2012-3#1)
species including##9##2##(1997-2#1)(2008-10#7)(2010-1#1)
species indicates that##2##3##(1993-12#1)(1993-6#1)
species indicates##3##2##(1993-12#1)(1993-6#1)(2008-10#1)
species infected with##2##3##(2008-10#1)(2012-3#1)
species infecting##3##2##(2008-10#3)
species inhabiting##2##2##(2008-8#1)(2011-2#1)
species interactions##8##2##(2008-8#1)(2008-9#7)
species into##4##2##(2008-10#4)
species investigated##4##2##(2008-10#1)(2008-11#1)(2010-4#1)(2012-5#1)
species involved in the##3##4##(1993-6#1)(1994-11#1)(2008-10#1)
species involved##7##2##(1993-6#1)(1994-11#1)(2008-10#5)
species is a##2##3##(2008-8#1)(2011-2#1)
species is also##2##3##(2008-10#2)
species is characterized by a##2##5##(2008-8#1)(2011-2#1)
species is not##2##3##(2008-10#1)(2012-3#1)
species is of##3##3##(2008-11#1)(2011-2#2)
species is possible by##2##4##(2008-10#2)
species is the##3##3##(2008-10#2)(2013-1#1)
species is##66##2##(1990-11#2)(1995-12#1)(1996-1#1)(2008-10#35)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2008-8#7)(2008-9#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#4)(2012-3#1)(2012-6#1)(2013-1#1)
species isolated from##4##3##(1996-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
species isolated in##2##3##(2008-10#1)(2008-5#1)
species isolated##7##2##(1993-8#1)(1996-3#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
species lacking##2##2##(1995-12#1)(2008-11#1)
species level##10##2##(2008-10#3)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#2)(2012-6#1)
species life history##2##3##(2008-8#2)
species may be##7##3##(2008-10#3)(2008-8#1)(2009-11#1)(2009-8#2)
species may have been##2##4##(2008-10#2)
species may##13##2##(1995-12#1)(2008-10#6)(2008-8#1)(2009-11#1)(2009-8#3)(2012-2#1)
species mixtures##2##2##(2008-10#2)
species native to##2##3##(2008-10#1)(2008-8#1)
species not##4##2##(2008-10#2)(2008-9#1)(2009-8#1)
species occur##2##2##(1992-9#1)(2008-10#1)
species occurs##2##2##(2008-8#1)(2011-2#1)
species of &quot##2##3##(2011-2#2)
species of Drosophila##3##3##(1993-12#1)(2008-8#1)(2012-3#1)
species of Fusarium##2##3##(2008-10#2)
species of Gracilaria##2##3##(2008-11#2)
species of Hypocrea##2##3##(2008-10#2)
species of Mentha##2##3##(2013-1#2)
species of Nicotiana##2##3##(2008-10#2)
species of Phytophthora##6##3##(2008-10#6)
species of Trichoderma##2##3##(2008-10#2)
species of approximately##3##3##(2008-10#3)
species of bacteria##2##3##(2006-6#1)(2011-2#1)
species of birds##3##3##(2008-8#1)(2008-9#2)
species of bitterling##2##3##(2010-8#2)
species of cerebroside sulfate##2##4##(1993-8#2)
species of copper(II)##2##3##(2008-10#2)
species of cyanobacteria##2##3##(1996-12#1)(2008-10#1)
species of different##2##3##(2008-10#1)(2008-8#1)
species of fish##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)
species of fungi##3##3##(2008-10#2)(2008-5#1)
species of pathogens##2##3##(2008-10#2)
species of plants##2##3##(2008-10#2)
species of poikilothermic vertebrates##2##4##(2008-7#2)
species of sand flies##2##4##(2013-1#2)
species of serogroup IV##2##4##(2008-10#2)
species of skate (Rajidae)##2##4##(2010-8#2)
species of tRNA genes##2##4##(1995-8#1)(2008-9#1)
species of the Paramecium aurelia complex##3##6##(2008-12#3)
species of the family##2##4##(2008-10#2)
species of the genus##31##4##(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#3)(2010-8#2)(2011-2#19)(2013-8#1)
species of the order##2##4##(2008-5#1)(2008-8#1)
species of the##51##3##(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-5#3)(2008-6#4)(2008-8#1)(2008-9#1)(2010-8#2)(2011-2#22)(2012-3#1)(2013-8#1)
species of this##2##3##(2008-10#2)
species of##254##2##(1990-2#1)(1990-3#1)(1991-5#2)(1992-10#1)(1993-12#2)(1993-2#1)(1993-8#4)(1994-11#2)(1995-12#4)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-6#1)(2007-12#7)(2008-10#97)(2008-11#7)(2008-12#12)(2008-5#5)(2008-6#7)(2008-7#4)(2008-8#14)(2008-9#10)(2009-8#3)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#8)(2011-2#34)(2012-12#1)(2012-3#4)(2013-1#7)(2013-8#4)
species on the##4##3##(2008-10#4)
species on##17##2##(2008-10#13)(2008-5#1)(2012-2#1)(2012-6#2)
species only##3##2##(2008-10#2)(2008-8#1)
species or##14##2##(1991-3#1)(2008-10#8)(2008-11#1)(2008-8#4)
species other than##2##3##(2008-10#1)(2011-2#1)
species over a##2##3##(2008-10#2)
species over##4##2##(2008-10#3)(2008-8#1)
species present in these samples##2##5##(2008-10#2)
species present in these##3##4##(1990-2#1)(2008-10#2)
species present in##7##3##(1990-2#1)(2008-10#6)
species present##10##2##(1990-2#1)(2008-10#8)(2008-4#1)
species provide##2##2##(2008-8#2)
species rather than##2##3##(2008-8#1)(2009-8#1)
species responded to##2##3##(2008-7#1)(2008-8#1)
species responded##3##2##(2008-7#1)(2008-8#2)
species responsible for##2##3##(2010-11#1)(2011-2#1)
species retained on##2##3##(2008-10#2)
species reveal##2##2##(2008-10#1)(2011-1#1)
species revealed that##3##3##(1997-7#1)(2008-8#1)(2008-9#1)
species revealed##4##2##(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
species richness along##2##3##(2008-8#2)
species richness and plant functional group richness had##2##8##(2008-8#2)
species richness and plant functional group richness##3##7##(2008-8#3)
species richness and plant functional group##4##6##(2008-8#4)
species richness and##6##3##(2008-8#5)(2008-9#1)
species richness is##5##3##(2008-8#4)(2008-9#1)
species richness of##3##3##(2008-8#1)(2008-9#2)
species richness##38##2##(2008-8#28)(2008-9#10)
species sampled##2##2##(2008-10#2)
species separation##3##2##(2008-10#3)
species show a##2##3##(2008-12#1)(2012-5#1)
species show##3##2##(1993-12#1)(2008-12#1)(2012-5#1)
species showed a##2##3##(2012-5#1)(2013-1#1)
species showed that##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)
species showed##12##2##(1993-12#1)(1995-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-5#1)(2013-1#1)
species shows##4##2##(2008-10#2)(2008-8#2)
species so far##2##3##(2008-10#1)(2013-7#1)
species specific primer-probe##2##3##(2010-4#2)
species specific##6##2##(2008-10#3)(2010-4#2)(2012-3#1)
species specificity of##2##3##(2008-10#2)
species specificity##4##2##(2008-10#3)(2008-12#1)
species studied were##2##3##(2008-10#1)(2013-8#1)
species studied##7##2##(2007-12#1)(2008-10#2)(2008-8#1)(2010-5#1)(2012-5#1)(2013-8#1)
species such as ascorbic acid##2##5##(2008-10#2)
species such as the##2##4##(1994-11#1)(1997-8#1)
species such as##18##3##(1992-10#1)(1992-12#1)(1994-11#1)(1997-8#1)(2008-10#11)(2008-3#1)(2008-8#1)(2009-12#1)
species suggest that##2##3##(2008-10#1)(2008-9#1)
species suggests that##2##3##(2008-9#1)(2010-8#1)
species tested were##2##3##(2008-10#2)
species tested##8##2##(2008-10#8)
species than##3##2##(1990-8#1)(2008-10#2)
species that are##8##3##(1992-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)
species that causes##2##3##(2008-10#2)
species that have##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
species that probably##2##3##(1993-3#1)(2008-6#1)
species that vary in##2##4##(2008-12#1)(2008-8#1)
species that were##3##3##(2008-10#1)(2010-1#1)(2012-2#1)
species that##47##2##(1992-10#3)(1993-3#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#16)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#1)
species the##4##2##(1994-12#1)(2008-10#2)(2008-12#1)
species through##2##2##(2008-8#1)(2008-9#1)
species to be##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
species to neighbors##2##3##(2008-8#2)
species to the##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
species to##35##2##(1990-2#1)(1993-3#1)(1995-2#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#8)(2008-9#1)(2009-8#3)(2010-8#1)(2011-2#2)(2012-2#4)(2012-6#1)(2013-8#1)
species tree inference##2##3##(2012-3#2)
species tree##4##2##(2012-3#4)
species trees##3##2##(2008-4#1)(2012-3#2)
species used##5##2##(2008-10#2)(2010-11#3)
species using##11##2##(1994-11#1)(2008-10#9)(2012-3#1)
species usually##2##2##(2008-10#1)(2008-8#1)
species via##2##2##(2008-10#1)(2012-2#1)
species was carried out##2##4##(2008-10#1)(2010-3#1)
species was demonstrated##2##3##(2008-10#2)
species was detected##2##3##(2008-10#1)(2010-11#1)
species was determined##2##3##(2008-10#2)
species was estimated##2##3##(2008-10#2)
species was first##2##3##(2011-2#2)
species was found to##2##4##(2008-12#1)(2011-2#1)
species was found##3##3##(2008-12#1)(2011-2#1)(2012-12#1)
species was not##2##3##(2008-10#1)(2012-12#1)
species was performed##3##3##(1996-12#1)(2008-10#2)
species was studied##2##3##(2008-10#1)(2008-12#1)
species was the##2##3##(2008-10#2)
species was##62##2##(1991-7#1)(1992-10#1)(1993-12#1)(1996-12#1)(1997-2#1)(2008-10#38)(2008-12#3)(2008-5#1)(2008-8#4)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-5#1)(2012-6#1)(2013-8#1)
species we##2##2##(2008-8#1)(2009-8#1)
species were analyzed##2##3##(2008-10#1)(2008-11#1)
species were carried##2##3##(2008-5#1)(2013-8#1)
species were chosen##2##3##(2007-12#1)(2008-10#1)
species were determined in##2##4##(2008-10#2)
species were determined##5##3##(2008-10#5)
species were found to be##3##5##(2008-10#3)
species were found to##4##4##(2008-10#4)
species were found##6##3##(2008-10#5)(2012-2#1)
species were identified##5##3##(1996-2#1)(2008-10#2)(2008-12#1)(2013-1#1)
species were isolated##2##3##(2008-10#2)
species were measured##2##3##(2008-10#2)
species were more##2##3##(2008-11#1)(2008-8#1)
species were not##3##3##(2008-10#1)(2008-9#1)(2010-12#1)
species were observed##5##3##(1991-7#1)(2008-10#2)(2008-12#1)(2012-6#1)
species were placed in##2##4##(2008-10#2)
species were placed##3##3##(2008-10#2)(2008-8#1)
species were reduced##2##3##(2008-10#1)(2012-6#1)
species were separated from##2##4##(2008-10#2)
species were separated##4##3##(2008-10#4)
species were shown to##2##4##(2008-10#2)
species were studied by##2##4##(2008-10#1)(2008-12#1)
species were studied##3##3##(2008-10#2)(2008-12#1)
species were tested and in##2##5##(2008-8#2)
species were tested for##2##4##(2008-10#2)
species were tested##4##3##(2008-10#2)(2008-8#2)
species were used##2##3##(2008-10#1)(2008-8#1)
species were very##2##3##(2008-10#1)(2012-8#1)
species were##105##2##(1991-7#1)(1991-8#1)(1993-12#1)(1993-8#2)(1996-2#1)(2007-12#1)(2008-10#62)(2008-11#3)(2008-12#7)(2008-5#3)(2008-6#1)(2008-8#6)(2008-9#2)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-6#2)(2012-8#1)(2012-9#1)(2013-1#1)(2013-8#1)
species when##4##2##(2008-10#3)(2008-8#1)
species which were##2##3##(2008-10#2)
species which##4##2##(2008-10#2)(2011-2#2)
species whose##2##2##(2008-10#1)(2008-8#1)
species will##2##2##(2008-9#1)(2013-1#1)
species with a##2##3##(2008-10#1)(2009-12#1)
species with different##2##3##(2008-8#2)
species with low##2##3##(2008-9#2)
species with the highest##2##4##(2008-10#2)
species with the##4##3##(2008-10#4)
species with##42##2##(1990-5#1)(1994-8#1)(1997-3#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-8#8)(2008-9#4)(2009-12#2)(2010-8#1)(2011-2#1)(2012-3#1)(2012-8#1)
species within a##2##3##(2008-8#2)
species within the family##2##4##(2008-10#2)
species within the##8##3##(1997-6#1)(2008-10#6)(2010-3#1)
species within##13##2##(1997-6#1)(2008-10#6)(2008-8#3)(2010-10#2)(2010-3#1)
species without##3##2##(2008-10#3)
species##2760##1##(1990-11#3)(1990-2#5)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#5)(1991-12#3)(1991-3#2)(1991-5#6)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#1)(1992-10#10)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#2)(1993-12#15)(1993-2#6)(1993-3#3)(1993-6#4)(1993-8#12)(1994-11#9)(1994-12#3)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#4)(1995-11#2)(1995-12#8)(1995-2#7)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#5)(1996-1#2)(1996-12#7)(1996-2#9)(1996-3#1)(1996-6#4)(1997-1#2)(1997-2#8)(1997-3#4)(1997-6#6)(1997-7#5)(1997-8#1)(1997-9#2)(2006-6#1)(2007-12#25)(2008-1#2)(2008-10#1251)(2008-11#65)(2008-12#66)(2008-2#3)(2008-3#14)(2008-4#13)(2008-5#48)(2008-6#18)(2008-7#30)(2008-8#326)(2008-9#149)(2009-10#6)(2009-11#2)(2009-12#4)(2009-3#2)(2009-5#2)(2009-6#6)(2009-8#40)(2009-9#1)(2010-1#6)(2010-10#8)(2010-11#15)(2010-12#7)(2010-3#22)(2010-4#14)(2010-5#5)(2010-7#3)(2010-8#36)(2011-1#5)(2011-10#2)(2011-2#121)(2011-3#6)(2012-12#13)(2012-2#39)(2012-3#73)(2012-5#20)(2012-6#17)(2012-7#1)(2012-8#5)(2012-9#10)(2013-1#28)(2013-7#2)(2013-8#25)
species' range##2##2##(2008-10#1)(2008-9#1)
species' ranges##2##2##(2008-8#2)
species' responses to disturbance##4##4##(2008-8#4)
species'##18##1##(2008-10#1)(2008-8#12)(2008-9#4)(2009-8#1)
species)##16##1##(1994-5#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#2)(2012-2#1)(2012-5#1)(2012-9#2)(2013-8#1)
species- and##2##2##(1990-8#1)(2012-5#1)
species-area##5##1##(2008-8#4)(2008-9#1)
species-groups##4##1##(2008-10#4)
species-specific differences in##2##3##(2010-4#1)(2011-10#1)
species-specific differences##3##2##(2008-10#1)(2010-4#1)(2011-10#1)
species-specific polymerase chain reaction (PCR)##2##5##(2008-10#2)
species-specific primer pair##3##3##(2008-10#3)
species-specific primer##4##2##(1995-12#1)(2008-10#3)
species-specific primers and##2##3##(2008-10#2)
species-specific primers for##2##3##(2008-10#1)(2008-12#1)
species-specific primers##10##2##(2008-10#9)(2008-12#1)
species-specific##48##1##(1993-2#1)(1995-12#2)(2007-12#1)(2008-10#30)(2008-12#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-8#1)
specific 1H##2##2##(2009-7#2)
specific AT receptors##2##3##(1993-8#2)
specific CAT activity##2##3##(2008-7#2)
specific DNA fragment##2##3##(2008-10#1)(2008-8#1)
specific DNA sequence##2##3##(1997-2#1)(2008-8#1)
specific DNA##11##2##(1993-9#1)(1995-11#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#2)(2012-3#1)(2013-1#1)
specific IgE##4##2##(1990-3#1)(2008-10#3)
specific Low-density lipoprotein##2##3##(1990-2#2)
specific PCR##6##2##(1996-8#1)(1997-3#1)(2008-10#4)
specific [3H]5-HT##2##2##(1994-2#2)
specific actions##2##2##(1994-1#1)(1996-11#1)
specific activities##8##2##(1992-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1997-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
specific activity and##2##3##(1993-8#1)(2008-5#1)
specific activity of the##2##4##(2008-10#2)
specific activity of##8##3##(1991-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-7#1)(2008-9#1)
specific activity##22##2##(1990-11#1)(1991-12#1)(1992-12#1)(1993-8#3)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-6#2)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
specific adhesion##2##2##(1990-2#1)(1996-12#1)
specific adsorption of##2##3##(2008-10#2)
specific adsorption##3##2##(2008-10#3)
specific analysis##2##2##(2008-9#2)
specific and irreversible##2##3##(1990-2#1)(2008-11#1)
specific and not##2##3##(1995-11#1)(2008-5#1)
specific and sensitive##5##3##(1997-3#1)(2008-10#4)
specific and showed##2##3##(1994-8#1)(2008-10#1)
specific and##44##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#2)(1992-6#1)(1993-8#1)(1994-8#2)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#2)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
specific antibodies against##2##3##(1997-9#1)(2008-4#1)
specific antibodies##11##2##(1990-12#2)(1990-5#1)(1992-7#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-7#1)
specific antibody was##2##3##(1996-12#1)(2008-10#1)
specific antibody##14##2##(1993-8#1)(1996-12#2)(1997-1#1)(2008-10#2)(2008-11#5)(2008-8#1)(2008-9#1)(2012-2#1)
specific antigen (PSA)##3##3##(1994-12#1)(2008-12#1)(2011-2#1)
specific antigen##6##2##(1994-12#2)(1995-12#1)(2008-12#1)(2011-2#1)(2013-8#1)
specific antigens##3##2##(2006-6#1)(2008-4#2)
specific antisera##2##2##(2008-10#1)(2008-5#1)
specific as##2##2##(2008-4#1)(2008-5#1)
specific aspects of the##2##4##(1992-2#2)
specific aspects of##8##3##(1991-3#1)(1992-2#2)(1996-6#1)(2008-11#1)(2009-7#1)(2010-3#1)(2010-9#1)
specific aspects##9##2##(1991-3#1)(1992-2#2)(1996-6#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-9#1)
specific attachment##2##2##(2008-10#1)(2008-8#1)
specific band##2##2##(2008-8#1)(2013-1#1)
specific behaviors that##2##3##(2010-11#1)(2011-2#1)
specific behaviors##3##2##(2010-11#1)(2010-8#1)(2011-2#1)
specific binding of##8##3##(1990-12#1)(1992-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-9#1)(2010-7#1)
specific binding sites for [3H]-staurosporine on##2##6##(1990-8#2)
specific binding sites in##2##4##(1990-5#2)
specific binding sites##7##3##(1990-5#2)(1990-8#2)(1993-8#2)(1996-3#1)
specific binding to##5##3##(1993-6#1)(1995-11#1)(1995-12#1)(2008-10#1)(2009-7#1)
specific binding##26##2##(1990-12#1)(1990-5#2)(1990-8#2)(1992-3#1)(1993-3#1)(1993-6#2)(1993-8#2)(1995-11#3)(1995-12#3)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-7#1)(2010-7#1)
specific bioassay##2##2##(1990-12#1)(2008-10#1)
specific biological activity##4##3##(1990-12#2)(1990-8#1)(2011-2#1)
specific biological##6##2##(1990-12#2)(1990-8#1)(2008-11#1)(2010-12#1)(2011-2#1)
specific brain##6##2##(1994-2#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-7#1)
specific capacity##3##2##(2008-10#3)
specific causal##2##2##(2008-11#1)(2011-2#1)
specific causes##2##2##(2009-3#1)(2010-4#1)
specific cell types##3##3##(2008-11#1)(2008-4#2)
specific cell##7##2##(2008-11#3)(2008-4#2)(2008-9#1)(2009-12#1)
specific cellular##4##2##(1991-2#1)(2009-5#1)(2009-9#1)(2012-2#1)
specific changes in the##2##4##(2008-10#2)
specific changes##3##2##(2008-10#2)(2008-11#1)
specific characteristics and##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
specific characteristics of##5##3##(1990-11#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-8#1)
specific characteristics##10##2##(1990-11#1)(1991-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#2)(2013-8#2)
specific class of##2##3##(1994-12#1)(2008-10#1)
specific classes of##2##3##(2008-10#2)
specific cleavage##2##2##(2008-9#2)
specific clinical##7##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)
specific combinations of##2##3##(2008-10#1)(2008-3#1)
specific complications##2##2##(2007-8#1)(2013-1#1)
specific compounds##3##2##(2008-10#2)(2008-11#1)
specific computer##2##2##(1996-2#1)(2008-12#1)
specific conditions##5##2##(1996-2#1)(2008-11#1)(2008-6#1)(2011-3#1)(2013-1#1)
specific contribution of##2##3##(2008-11#1)(2013-1#1)
specific criteria##2##2##(1991-2#1)(2011-7#1)
specific defects##2##2##(2007-11#1)(2012-12#1)
specific detection of P##2##4##(2008-10#2)
specific detection of the##2##4##(2008-10#2)
specific detection of##5##3##(2008-10#5)
specific detection##8##2##(2008-10#7)(2013-8#1)
specific determination of hydrogen peroxide##2##5##(2008-10#2)
specific determination of l-ascorbic acid##2##5##(2008-10#2)
specific determination of##5##3##(2008-10#5)
specific developmental##2##2##(2008-9#2)
specific diagnostic##6##2##(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
specific differences##2##2##(1995-11#1)(2013-1#1)
specific diseases##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
specific domains##3##2##(1992-6#1)(1993-12#1)(2011-1#1)
specific drug delivery##2##3##(2008-11#2)
specific drug##5##2##(2008-11#3)(2011-3#1)(2013-8#1)
specific duties##2##2##(1992-1#1)(2008-11#1)
specific effect##2##2##(2008-5#1)(2012-2#1)
specific energy dissipation rate##9##4##(2008-7#9)
specific energy dissipation rates##2##4##(2008-7#2)
specific energy dissipation##12##3##(2008-7#12)
specific enolase (NSE) in##2##4##(1990-2#1)(1990-6#1)
specific enolase##4##2##(1990-2#3)(1990-6#1)
specific environmental##5##2##(1995-9#1)(2008-10#1)(2008-11#2)(2011-1#1)
specific enzymatic activity##2##3##(1995-6#1)(2008-11#1)
specific enzymatic##3##2##(1995-6#1)(1997-7#1)(2008-11#1)
specific enzyme##4##2##(1990-12#1)(1992-3#1)(1992-9#1)(2008-7#1)
specific enzymes##2##2##(2008-5#1)(2013-8#1)
specific example##2##2##(2008-10#1)(2008-4#1)
specific examples##3##2##(2008-1#1)(2008-4#1)(2011-2#1)
specific exercise##3##2##(2008-12#3)
specific expectations of##2##3##(2013-1#2)
specific expression and##2##3##(2008-11#1)(2012-3#1)
specific expression of##2##3##(1994-11#1)(1995-2#1)
specific expression##6##2##(1994-11#1)(1995-2#1)(2008-11#2)(2011-2#1)(2012-3#1)
specific extraction##2##2##(2008-10#2)
specific factors##4##2##(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
specific features of the##2##4##(2008-10#2)
specific features of##7##3##(2008-10#3)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)
specific features##9##2##(2008-10#3)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
specific findings##2##2##(2013-1#2)
specific for P##5##3##(2008-10#5)
specific for a##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
specific for each##5##3##(2008-10#5)
specific for either##3##3##(2008-10#1)(2013-8#2)
specific for glycoprotein IIb-IIIa##2##4##(1990-5#2)
specific for human##2##3##(1997-6#1)(2008-4#1)
specific for individual##2##3##(2008-10#2)
specific for the##24##3##(1990-12#1)(1991-5#1)(1994-11#1)(1995-12#2)(1995-2#3)(1996-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-8#2)
specific for these##2##3##(1995-12#1)(2008-10#1)
specific for##104##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#4)(1991-12#1)(1991-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-2#1)(1995-11#1)(1995-12#4)(1995-2#5)(1996-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#40)(2008-11#8)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#3)(2009-11#1)(2010-11#1)(2010-4#2)(2011-1#1)(2012-2#1)(2013-8#5)
specific frequency##2##2##(1993-2#1)(2010-8#1)
specific functional##4##2##(1996-2#1)(1997-7#1)(2008-8#2)
specific functions##5##2##(1994-8#2)(1996-12#1)(2008-11#2)
specific gene##5##2##(1995-11#2)(2008-10#2)(2008-8#1)
specific genes##6##2##(1994-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)
specific genetic##3##2##(2008-7#2)(2013-1#1)
specific genomic regions##2##3##(2008-10#1)(2011-2#1)
specific geographical##2##2##(2008-10#1)(2012-5#1)
specific glucose consumption rate##3##4##(2008-11#3)
specific glucose consumption##4##3##(2008-11#4)
specific glucose##6##2##(2008-11#4)(2008-7#2)
specific goals##2##2##(1994-3#1)(1995-5#1)
specific gravity##2##2##(1991-1#2)
specific growth and##2##3##(2008-11#1)(2008-7#1)
specific growth rate (mu)##2##4##(2008-11#2)
specific growth rate and##2##4##(2008-11#2)
specific growth rate of 0##4##5##(2008-11#3)(2011-2#1)
specific growth rate of##9##4##(1995-9#1)(2008-11#4)(2008-7#2)(2010-11#1)(2011-2#1)
specific growth rate was##2##4##(2008-11#1)(2010-11#1)
specific growth rate##30##3##(1995-9#2)(2008-10#1)(2008-11#14)(2008-7#9)(2008-9#1)(2010-11#2)(2011-2#1)
specific growth rates##5##3##(2008-11#4)(2008-7#1)
specific growth##40##2##(1995-9#2)(2008-10#1)(2008-11#21)(2008-7#11)(2008-9#2)(2010-11#2)(2011-2#1)
specific guidelines##2##2##(2008-11#1)(2008-12#1)
specific hMab productivity in##2##4##(2008-11#2)
specific hMab productivity##3##3##(2008-11#3)
specific health##3##2##(1995-3#1)(2010-10#1)(2010-4#1)
specific hospital##2##2##(1994-12#1)(2008-11#1)
specific host##2##2##(2008-10#2)
specific human monoclonal##2##3##(2008-11#2)
specific human##6##2##(2008-11#5)(2008-8#1)
specific identification##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
specific imaging##2##2##(2007-11#1)(2010-6#1)
specific immune responses##2##3##(2008-10#1)(2008-9#1)
specific immune##8##2##(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#2)(2012-3#1)
specific immunoassay##2##2##(2008-10#2)
specific in the##2##3##(2009-8#1)(2011-2#1)
specific in##7##2##(1992-3#1)(2008-10#2)(2009-8#1)(2011-2#1)(2013-1#2)
specific indications##3##2##(1996-9#1)(1997-6#1)(2010-6#1)
specific inhibition##2##2##(2008-10#1)(2008-11#1)
specific inhibitor of protein##2##4##(1994-11#1)(1997-7#1)
specific inhibitor of##8##3##(1990-5#1)(1993-3#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-2#1)(1997-7#1)
specific inhibitor##9##2##(1990-5#1)(1993-3#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-2#1)(1997-7#1)(2009-6#1)
specific inhibitors of##5##3##(1995-2#1)(1996-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
specific inhibitors##10##2##(1995-2#1)(1996-2#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-3#1)(2012-2#2)(2013-1#1)
specific input##2##2##(2008-11#1)(2008-3#1)
specific interaction between##2##3##(2008-10#2)
specific interaction with##2##3##(2008-10#1)(2008-7#1)
specific interaction##7##2##(1993-3#1)(2008-10#5)(2008-7#1)
specific interactions##2##2##(2008-12#1)(2008-5#1)
specific intervention##2##2##(2011-2#1)(2013-8#1)
specific ion interaction##2##3##(2008-10#2)
specific issues##2##2##(2010-6#1)(2013-1#1)
specific labeling of##2##3##(1991-12#1)(1996-12#1)
specific labeling##4##2##(1991-12#1)(1994-8#1)(1996-12#1)(2008-7#1)
specific labelling of the##2##4##(2009-8#2)
specific leaf##4##2##(2008-10#2)(2008-8#1)(2012-5#1)
specific ligand of##2##3##(1995-8#1)(2008-9#1)
specific ligand##3##2##(1995-8#1)(2008-9#1)(2010-1#1)
specific limitations##2##2##(2008-7#1)(2009-10#1)
specific local##2##2##(1994-1#1)(2013-1#1)
specific localization##2##2##(1990-12#1)(1996-12#1)
specific locations##4##2##(2008-10#2)(2008-5#1)(2011-1#1)
specific mRNA##2##2##(1990-8#1)(2008-8#1)
specific manner##6##2##(1993-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)
specific marker for##3##3##(1996-12#1)(1997-7#1)(2008-12#1)
specific marker##4##2##(1994-11#1)(1996-12#1)(1997-7#1)(2008-12#1)
specific markers for##3##3##(2008-10#1)(2008-9#2)
specific markers##6##2##(2008-10#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
specific mechanisms##2##2##(2008-10#2)
specific medical##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
specific medication##2##2##(2008-12#1)(2008-4#1)
specific membrane markers##2##3##(2013-1#2)
specific method for the determination of##2##6##(2008-10#2)
specific method for the##3##4##(2008-10#3)
specific method for##7##3##(2008-10#6)(2011-3#1)
specific method##9##2##(2008-10#7)(2011-3#1)(2013-1#1)
specific methods##2##2##(2008-10#1)(2008-3#1)
specific molecular##6##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2013-1#1)
specific molecules##4##2##(2008-1#1)(2008-3#1)(2008-4#2)
specific monoclonal antibodies##4##3##(1992-9#1)(2008-11#1)(2008-9#1)(2012-3#1)
specific monoclonal antibody production##4##4##(2008-11#4)
specific monoclonal antibody##6##3##(1993-8#1)(2008-10#1)(2008-11#4)
specific monoclonal##10##2##(1992-9#1)(1993-8#1)(2008-10#1)(2008-11#5)(2008-9#1)(2012-3#1)
specific morphological##2##2##(1994-3#1)(2008-9#1)
specific mutations##2##2##(2008-4#1)(2011-1#1)
specific nature##2##2##(2008-11#1)(2010-2#1)
specific needs##4##2##(1995-1#1)(2008-11#1)(2012-2#2)
specific nuclease##2##2##(1991-7#1)(1997-7#1)
specific nucleotide##2##2##(1995-8#1)(2008-10#1)
specific oligonucleotide primers##2##3##(2008-10#2)
specific oligonucleotide probe##2##3##(1996-2#1)(1997-8#1)
specific oligonucleotide##7##2##(1996-2#1)(1997-8#3)(2008-10#3)
specific or##3##2##(2008-10#1)(2008-5#1)(2010-6#1)
specific organic##2##2##(1995-9#1)(2008-10#1)
specific oxygen uptake##2##3##(2008-11#2)
specific parameters##2##2##(1991-5#1)(2008-10#1)
specific parasitism##2##2##(2008-10#2)
specific parts of##2##3##(2008-11#1)(2008-5#1)
specific pathogen free hens##2##4##(1991-11#2)
specific pathogen##3##2##(1991-11#2)(2008-10#1)
specific patient##2##2##(1996-3#1)(2010-6#1)
specific patients##2##2##(2008-7#1)(2010-8#1)
specific pattern of##2##3##(2009-1#1)(2011-2#1)
specific patterns of##2##3##(2008-8#1)(2010-2#1)
specific peptide##2##2##(2008-4#2)
specific perfusion rates##4##3##(2008-11#4)
specific perfusion##5##2##(2008-11#5)
specific physical##2##2##(2008-11#1)(2013-8#1)
specific physiological##2##2##(1995-6#1)(2008-7#1)
specific points in##2##3##(1995-6#1)(2008-11#1)
specific polyclonal antibodies##3##3##(1995-12#2)(2008-10#1)
specific polyclonal##5##2##(1995-12#2)(2008-10#3)
specific polymerase chain reaction##2##4##(2008-10#2)
specific practice##2##2##(2008-11#1)(2011-2#1)
specific predictions##3##2##(2008-11#1)(2008-8#2)
specific primer sets##2##3##(2008-10#2)
specific primer##4##2##(2008-10#4)
specific primers for##4##3##(1994-11#1)(2008-10#2)(2008-7#1)
specific primers were designed##2##4##(2008-10#1)(2013-8#1)
specific primers were##4##3##(2008-10#3)(2013-8#1)
specific primers##19##2##(1994-11#1)(1997-8#1)(2008-10#10)(2008-12#2)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
specific probes##3##2##(1991-5#1)(1993-6#1)(1997-7#1)
specific problems##4##2##(1994-2#1)(2008-10#1)(2008-5#1)(2010-11#1)
specific production rate##3##3##(2008-11#2)(2011-2#1)
specific production##6##2##(2008-10#1)(2008-11#4)(2011-2#1)
specific productivity of##6##3##(2008-11#5)(2008-7#1)
specific productivity##15##2##(2008-11#13)(2008-7#2)
specific promoter##3##2##(2008-11#3)
specific properties##2##2##(2008-10#1)(2008-7#1)
specific protein##9##2##(1990-8#1)(1992-6#1)(1996-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
specific proteins##7##2##(1996-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)
specific questions are##2##3##(1996-3#1)(2012-2#1)
specific questions##4##2##(1996-3#2)(2012-2#2)
specific radioactivity##4##2##(1990-12#3)(1991-3#1)
specific rat##2##2##(1995-11#2)
specific rates of##3##3##(2008-11#3)
specific rates##4##2##(2008-11#4)
specific reagents##2##2##(2008-10#1)(2008-9#1)
specific receptor##5##2##(1990-5#1)(1993-8#1)(2008-5#1)(2009-8#1)(2010-4#1)
specific receptors##4##2##(2008-5#1)(2008-8#2)(2013-7#1)
specific recognition of the##2##4##(1991-9#1)(2008-10#1)
specific recognition of##4##3##(1991-9#1)(2008-10#3)
specific recognition##5##2##(1991-9#1)(2008-10#4)
specific recombinant##3##2##(2008-11#2)(2013-8#1)
specific recommendations##2##2##(1990-6#1)(2009-11#1)
specific reference to##4##3##(1991-3#1)(1992-12#1)(1993-1#1)(2008-10#1)
specific region of##2##3##(1994-11#1)(2011-2#1)
specific region##6##2##(1993-3#1)(1993-9#1)(1994-11#1)(1996-1#1)(2011-2#1)(2013-8#1)
specific regions of the genome##2##5##(2008-4#1)(2008-9#1)
specific regions of the##4##4##(1993-6#1)(1996-12#1)(2008-4#1)(2008-9#1)
specific regions of##5##3##(1993-6#1)(1996-12#1)(2008-4#1)(2008-6#1)(2008-9#1)
specific regions##6##2##(1993-6#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
specific requirements##2##2##(1991-12#1)(2008-4#1)
specific research##6##2##(1996-1#1)(1996-2#1)(2008-4#1)(2008-7#1)(2012-2#2)
specific resistance##6##2##(2008-10#6)
specific response of##2##3##(1995-8#1)(2008-10#1)
specific response##4##2##(1990-5#1)(1992-10#1)(1995-8#1)(2008-10#1)
specific risk##2##2##(2009-10#1)(2009-8#1)
specific role in##2##3##(1997-2#1)(2008-11#1)
specific role##8##2##(1991-9#1)(1997-2#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
specific roles of##2##3##(1993-8#1)(1996-2#1)
specific roles##5##2##(1993-8#1)(1996-2#1)(2008-11#2)(2013-8#1)
specific scoring##2##2##(2008-11#2)
specific secretory##2##2##(1990-5#1)(2013-1#1)
specific sensitivity##2##2##(2008-11#1)(2011-2#1)
specific sequence##4##2##(2008-10#1)(2008-11#1)(2009-9#1)(2010-1#1)
specific sets of##3##3##(1990-5#1)(1995-2#1)(2009-12#1)
specific signal##3##2##(2007-12#1)(2008-9#1)(2010-4#1)
specific signaling##2##2##(2009-3#1)(2011-2#1)
specific signatures##2##2##(2012-2#1)(2012-3#1)
specific sites##3##2##(1994-12#1)(1996-2#1)(2008-10#1)
specific situation##3##2##(2009-11#1)(2010-12#1)(2011-2#1)
specific soluble antigen##2##3##(2008-11#2)
specific somatic##2##2##(2008-4#1)(2008-9#1)
specific spatial##2##2##(2008-7#1)(2013-8#1)
specific spectral##2##2##(2008-10#1)(2008-7#1)
specific stages##3##2##(2008-6#1)(2010-5#1)(2012-2#1)
specific stem##2##2##(2008-10#1)(2008-11#1)
specific steps##3##2##(2008-11#1)(2011-3#1)(2012-2#1)
specific strains of##2##3##(2008-10#2)
specific strategies##2##2##(2008-7#1)(2010-12#1)
specific structural##2##2##(1994-5#1)(2012-3#1)
specific structure##2##2##(2008-10#1)(2012-2#1)
specific substrates##3##2##(2006-6#1)(2008-9#1)(2010-12#1)
specific surface area was synthesized##2##5##(2008-10#2)
specific surface##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
specific symptoms##2##2##(1997-2#1)(2010-12#1)
specific target##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
specific targets##2##2##(2012-3#1)(2013-8#1)
specific test##2##2##(1996-3#1)(2011-2#1)
specific tests##2##2##(1993-2#1)(2008-5#1)
specific therapeutic##2##2##(2008-10#1)(2012-3#1)
specific therapies to##2##3##(2009-1#1)(2010-7#1)
specific therapies##3##2##(2009-1#1)(2009-4#1)(2010-7#1)
specific therapy##2##2##(2008-10#1)(2010-1#1)
specific time##2##2##(2008-10#2)
specific tissues##5##2##(1993-12#1)(1994-5#1)(2008-11#1)(2010-5#1)(2011-2#1)
specific to DRB1*0406##2##3##(1997-8#2)
specific to V##3##3##(2008-10#2)(2009-8#1)
specific to the particular##2##4##(1995-8#1)(2008-10#1)
specific to the##18##3##(1990-7#1)(1992-6#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2009-8#1)(2011-2#1)(2013-1#1)
specific to this##2##3##(2008-10#1)(2008-11#1)
specific to##61##2##(1990-7#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#21)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
specific training##2##2##(1991-12#1)(2012-12#1)
specific treatment for##3##3##(1994-9#1)(1996-11#1)(2013-1#1)
specific treatment##14##2##(1993-1#1)(1993-2#1)(1994-9#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
specific treatments##3##2##(1995-12#1)(2009-4#1)(2013-1#1)
specific type##2##2##(1990-8#1)(1991-5#1)
specific tyrosine-phosphorylated peptides##3##3##(2008-1#2)(2008-4#1)
specific virulence on##2##3##(2008-10#2)
specific virulence##6##2##(2008-10#6)
specific ways##3##2##(2008-10#2)(2008-11#1)
specific wheat cultivars##2##3##(2008-10#2)
specific##1844##1##(1990-11#7)(1990-12#17)(1990-2#13)(1990-3#1)(1990-5#17)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#1)(1991-1#2)(1991-11#4)(1991-12#8)(1991-2#9)(1991-3#6)(1991-5#11)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#4)(1992-10#2)(1992-12#6)(1992-2#3)(1992-3#6)(1992-6#6)(1992-7#2)(1992-9#7)(1993-1#6)(1993-11#3)(1993-12#6)(1993-2#8)(1993-3#7)(1993-6#12)(1993-8#20)(1993-9#2)(1994-1#7)(1994-11#14)(1994-12#7)(1994-2#12)(1994-3#8)(1994-5#5)(1994-6#4)(1994-8#15)(1994-9#2)(1995-1#3)(1995-11#20)(1995-12#21)(1995-2#14)(1995-3#4)(1995-5#1)(1995-6#10)(1995-8#8)(1995-9#8)(1996-1#3)(1996-11#4)(1996-12#19)(1996-2#16)(1996-3#9)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#13)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#13)(1997-8#10)(1997-9#1)(2006-6#2)(2007-11#4)(2007-12#8)(2007-8#1)(2008-1#9)(2008-10#377)(2008-11#237)(2008-12#28)(2008-2#6)(2008-3#11)(2008-4#42)(2008-5#37)(2008-6#8)(2008-7#77)(2008-8#42)(2008-9#58)(2009-1#3)(2009-10#11)(2009-11#4)(2009-12#5)(2009-3#4)(2009-4#5)(2009-5#4)(2009-6#5)(2009-7#9)(2009-8#14)(2009-9#4)(2010-1#8)(2010-10#2)(2010-11#13)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#13)(2010-5#4)(2010-6#11)(2010-7#6)(2010-8#13)(2010-9#3)(2011-1#10)(2011-10#1)(2011-2#75)(2011-3#7)(2011-7#1)(2011-9#1)(2012-12#9)(2012-2#46)(2012-3#23)(2012-5#2)(2012-7#2)(2013-1#48)(2013-7#1)(2013-8#35)
specific-pathogen-free##3##1##(2008-5#3)
specifically affect the##2##3##(2008-11#1)(2008-7#1)
specifically affect##3##2##(1995-6#1)(2008-11#1)(2008-7#1)
specifically against##2##2##(1996-12#1)(2012-3#1)
specifically amplified##3##2##(1993-12#1)(2008-10#2)
specifically and##4##2##(1993-8#1)(1997-2#1)(2008-10#1)(2010-1#1)
specifically associated with##3##3##(1990-8#1)(2011-2#1)(2013-8#1)
specifically bind the##2##3##(1993-6#1)(2008-10#1)
specifically bind to##2##3##(1992-6#1)(2008-10#1)
specifically bind##4##2##(1992-6#1)(1993-6#1)(2008-10#2)
specifically binds to##5##3##(1993-3#1)(1995-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
specifically binds##7##2##(1990-12#1)(1993-3#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-5#1)(2008-9#1)
specifically bound to the##3##4##(1993-6#1)(2008-11#1)(2008-8#1)
specifically bound to##5##3##(1993-3#1)(1993-6#1)(2008-11#1)(2008-8#2)
specifically bound##7##2##(1993-3#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#2)
specifically by##4##2##(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
specifically cleaved##2##2##(1991-5#1)(1994-8#1)
specifically competed##2##2##(1993-6#1)(1996-12#1)
specifically designed for##5##3##(1991-1#1)(2008-10#2)(2008-11#1)(2008-4#1)
specifically designed to##7##3##(1995-2#1)(1996-1#1)(1997-1#1)(2008-4#1)(2009-11#1)(2011-2#1)(2012-2#1)
specifically designed##12##2##(1991-1#1)(1995-2#1)(1996-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-11#1)(2011-2#1)(2012-2#1)
specifically detected##4##2##(2008-10#4)
specifically developed##3##2##(2008-10#1)(2008-3#1)(2009-10#1)
specifically examined##2##2##(2008-11#2)
specifically expressed in testis##2##4##(1995-6#1)(2008-8#1)
specifically expressed in the##2##4##(2008-11#1)(2008-8#1)
specifically expressed in##12##3##(1995-6#1)(2008-11#4)(2008-8#4)(2008-9#1)(2009-8#1)(2010-7#1)
specifically expressed##15##2##(1991-5#1)(1995-6#1)(2008-11#4)(2008-8#5)(2008-9#2)(2009-8#1)(2010-7#1)
specifically for##14##2##(1990-11#1)(1995-6#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)
specifically from##4##2##(1995-2#1)(2008-10#3)
specifically in the testis##2##4##(1993-12#1)(1995-6#1)
specifically in the##9##3##(1993-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(2007-12#2)(2008-11#1)(2008-7#1)
specifically in##23##2##(1990-11#1)(1990-8#1)(1993-12#2)(1993-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
specifically inhibit##2##2##(1991-7#1)(2009-12#1)
specifically interact with##3##3##(1994-12#1)(1997-7#1)(2009-6#1)
specifically on the##3##3##(1991-12#1)(1994-12#1)(2008-8#1)
specifically on##6##2##(1991-12#1)(1993-3#1)(1994-12#1)(2008-6#1)(2008-8#1)(2011-1#1)
specifically recognize##2##2##(2008-10#2)
specifically recognized a single##2##4##(1991-9#1)(1995-6#1)
specifically recognized a##3##3##(1991-9#1)(1995-6#1)(2008-11#1)
specifically recognized the##2##3##(1995-8#1)(1996-2#1)
specifically recognized##9##2##(1991-9#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#3)
specifically related to##3##3##(1995-8#1)(2008-11#1)(2009-11#1)
specifically stimulated##2##2##(1993-1#1)(2008-11#1)
specifically target##4##2##(2008-12#1)(2010-5#1)(2010-6#1)(2010-8#1)
specifically targeting the##2##3##(2010-7#1)(2012-3#1)
specifically the##8##2##(2008-11#3)(2008-12#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
specifically through the##2##3##(1997-7#1)(2008-10#1)
specifically to address##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
specifically to##20##2##(1990-2#2)(1991-12#1)(1992-6#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-9#3)(2009-10#1)(2009-12#1)(2012-2#2)(2013-1#1)
specifically with the##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
specifically with##11##2##(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(2008-10#4)(2008-5#1)(2008-9#1)(2012-3#1)
specifically##311##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#7)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#2)(1993-9#2)(1994-12#4)(1994-2#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#10)(1995-5#1)(1995-6#8)(1995-8#2)(1996-1#2)(1996-12#3)(1996-2#3)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#54)(2008-11#31)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#11)(2008-9#13)(2009-10#3)(2009-11#2)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#3)(2011-2#12)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#7)(2013-8#6)
specification and##3##2##(1994-12#1)(2010-8#1)(2013-1#1)
specification in##2##2##(1994-9#1)(2009-4#1)
specification is##2##2##(1994-3#1)(2013-8#1)
specification of the##7##3##(1995-2#1)(2008-2#1)(2008-7#1)(2009-8#2)(2010-5#1)(2013-1#1)
specification of##13##2##(1991-1#1)(1994-3#1)(1995-2#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-5#1)(2012-2#1)(2013-1#1)
specification##24##1##(1991-1#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-8#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
specifications are##2##2##(1993-3#1)(2008-10#1)
specifications##13##1##(1991-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(2008-10#6)(2011-2#1)(2012-2#1)
specificities of##5##2##(1991-2#1)(1994-8#1)(2008-11#1)(2011-2#2)
specificities towards##2##2##(2008-10#1)(2012-2#1)
specificities##22##1##(1991-2#2)(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-9#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
specificity 91##2##2##(1997-4#1)(2011-2#1)
specificity 95%)##2##2##(1997-8#2)
specificity against##2##2##(1997-7#1)(2008-10#1)
specificity and accuracy of##2##4##(2011-2#1)(2013-8#1)
specificity and sensitivity of##3##4##(2008-10#2)(2008-11#1)
specificity and sensitivity##7##3##(1997-2#1)(2008-10#5)(2008-11#1)
specificity and##26##2##(1992-6#1)(1993-5#1)(1993-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#2)
specificity by##2##2##(2008-10#1)(2008-11#1)
specificity during##2##2##(2008-6#1)(2012-2#1)
specificity for DNA##2##3##(2008-11#2)
specificity for aspartate##2##3##(1995-6#1)(2008-4#1)
specificity for##22##2##(1990-11#1)(1990-5#1)(1992-9#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
specificity in the##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
specificity in##11##2##(1992-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2011-2#2)(2012-3#1)
specificity is##2##2##(1991-5#1)(1997-2#1)
specificity of a##4##3##(1992-9#1)(2008-10#2)(2013-1#1)
specificity of the immobilized##2##4##(2008-10#1)(2008-7#1)
specificity of the##40##3##(1990-11#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-2#3)(2008-10#13)(2008-11#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#3)(2012-2#3)(2013-8#1)
specificity of this##5##3##(1990-9#1)(1996-3#1)(2008-10#2)(2008-11#1)
specificity of##101##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-3#1)(1995-11#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#3)(1997-8#2)(2008-10#27)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#8)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
specificity on##3##2##(2008-10#3)
specificity remains##2##2##(2008-11#1)(2012-2#1)
specificity to the##3##3##(1991-9#1)(2008-10#1)(2011-2#1)
specificity to##7##2##(1990-2#1)(1991-9#1)(1997-1#1)(2008-10#2)(2008-8#1)(2011-2#1)
specificity was##14##2##(1992-3#1)(1995-12#1)(1996-12#3)(2008-10#3)(2008-8#2)(2010-6#1)(2011-2#3)
specificity were##2##2##(1990-6#1)(2008-10#1)
specificity with##2##2##(2011-1#1)(2012-12#1)
specificity##341##1##(1990-11#3)(1990-2#3)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#7)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-6#3)(1996-12#4)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#5)(2008-1#2)(2008-10#101)(2008-11#19)(2008-12#4)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#11)(2008-9#9)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#6)(2011-2#31)(2012-12#8)(2012-2#13)(2012-3#6)(2013-1#4)(2013-8#4)
specificity?##3##1##(1992-11#1)(1994-6#1)(2008-12#1)
specifics##2##1##(2008-10#1)(2011-1#1)
specified a##2##2##(2008-10#1)(2013-1#1)
specified as##2##2##(2008-11#1)(2009-10#1)
specified by a##2##3##(1995-6#1)(2008-10#1)
specified by the##2##3##(2008-10#1)(2011-2#1)
specified by##6##2##(1994-12#1)(1995-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
specified conditions##2##2##(2008-10#2)
specified for##3##2##(1991-12#1)(2008-10#1)(2013-1#1)
specified in the##2##3##(2011-2#1)(2012-12#1)
specified time##3##2##(2008-10#1)(2008-12#2)
specified##57##1##(1990-2#1)(1991-12#1)(1991-6#1)(1992-9#2)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
specifies the##3##2##(1991-9#1)(2008-11#1)(2009-10#1)
specifies##4##1##(1991-9#1)(2008-10#1)(2008-11#1)(2009-10#1)
specify a##2##2##(2008-10#1)(2011-1#1)
specify the relationship between##2##4##(1997-1#1)(2010-11#1)
specify the##8##2##(1994-12#1)(1995-2#1)(1997-1#1)(2008-10#2)(2009-10#1)(2010-11#1)(2013-8#1)
specify##15##1##(1990-8#1)(1991-5#1)(1992-3#1)(1994-12#1)(1995-2#1)(1997-1#1)(2008-10#5)(2009-10#1)(2010-11#1)(2011-1#1)(2013-8#1)
specifying the##3##2##(1992-9#1)(1994-12#1)(2008-6#1)
specifying##7##1##(1991-1#1)(1992-9#1)(1994-12#1)(1996-12#1)(2008-6#1)(2010-10#1)(2013-8#1)
specimen of##3##2##(2008-10#2)(2011-2#1)
specimen revealed##3##2##(2010-6#1)(2011-2#1)(2013-1#1)
specimen showed##4##2##(2007-9#1)(2008-10#1)(2009-5#1)(2011-2#1)
specimen volume##3##2##(2009-7#3)
specimen was##7##2##(2008-10#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-12#1)
specimen were##3##2##(1991-1#1)(2008-11#1)(2012-3#1)
specimen##59##1##(1991-1#1)(1991-6#1)(1996-1#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-5#2)(2008-9#1)(2009-3#2)(2009-5#1)(2009-7#10)(2010-11#2)(2010-12#1)(2010-6#4)(2010-9#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
specimens and##8##2##(1992-12#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2012-7#1)
specimens at##2##2##(1993-8#1)(2008-11#1)
specimens by##5##2##(2008-10#4)(2011-2#1)
specimens can be##2##3##(2008-9#2)
specimens examined##2##2##(1994-8#1)(2008-5#1)
specimens from##17##2##(1992-9#1)(1994-3#1)(1996-12#2)(1997-3#1)(2008-10#2)(2008-12#3)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#2)(2012-9#1)
specimens in##2##2##(2008-5#1)(2010-12#1)
specimens obtained##2##2##(1994-3#1)(1997-8#1)
specimens of Pimelodus##2##3##(2008-12#2)
specimens of patients##2##3##(2008-12#1)(2010-11#1)
specimens of the##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
specimens of##19##2##(1996-10#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
specimens received##2##2##(2008-12#1)(2012-3#1)
specimens was##2##2##(2008-7#1)(2009-7#1)
specimens were collected##2##3##(1991-7#1)(2011-2#1)
specimens were randomly##2##3##(2013-1#2)
specimens were subjected to##2##4##(2013-1#2)
specimens were used##3##3##(1994-12#1)(2008-12#1)(2013-1#1)
specimens were##24##2##(1990-2#1)(1991-7#1)(1994-12#1)(1996-12#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2011-2#3)(2013-1#7)
specimens with##2##2##(2008-10#2)
specimens##178##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#4)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#4)(1994-8#1)(1995-3#1)(1996-10#1)(1996-12#4)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#3)(2007-12#2)(2008-10#24)(2008-11#4)(2008-12#12)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#15)(2009-7#10)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2011-2#16)(2011-3#1)(2012-2#5)(2012-3#7)(2012-7#1)(2012-9#1)(2013-1#17)(2013-8#6)
speciosa##2##1##(2008-12#1)(2013-8#1)
speck of tomato##2##3##(2008-10#2)
speck##12##1##(2008-10#12)
speckle field##2##2##(2007-12#1)(2008-3#1)
speckle pattern interferometry##2##3##(2008-3#1)(2009-7#1)
speckle##16##1##(2007-12#1)(2008-1#2)(2008-3#11)(2009-7#1)(2013-1#1)
speckle-tracking echocardiography##2##2##(2011-2#2)
speckled leaf blotch##6##3##(2008-10#6)
speckled##8##1##(1995-6#1)(2008-1#1)(2008-10#6)
speckles##2##1##(2008-3#1)(2013-1#1)
spectabilis##2##1##(2010-3#2)
spectacle corrected visual##2##3##(2011-2#1)(2012-3#1)
spectacle independence##2##2##(2011-2#2)
spectacle##4##1##(2011-2#3)(2012-3#1)
spectacles##2##1##(1993-11#1)(2011-2#1)
spectacular##4##1##(1996-1#1)(2008-3#1)(2009-5#1)(2011-2#1)
spectra and a##2##3##(2008-10#2)
spectra and electrochemical properties of##2##5##(1996-5#1)(2008-8#1)
spectra and the##3##3##(2008-10#3)
spectra and their##4##3##(2008-10#4)
spectra and##31##2##(1992-1#1)(1994-5#1)(1996-5#2)(1997-7#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-8#2)(2010-4#1)(2011-2#2)(2013-8#1)
spectra are recorded##3##3##(1997-2#1)(2008-3#1)(2012-2#1)
spectra are used##2##3##(2008-3#2)
spectra are##17##2##(1997-2#1)(2008-10#6)(2008-3#4)(2008-4#2)(2011-2#1)(2012-12#1)(2012-2#2)
spectra as well as##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
spectra as##8##2##(2008-10#5)(2008-3#2)(2011-2#1)
spectra at##2##2##(2008-10#1)(2008-3#1)
spectra between##4##2##(2008-10#3)(2008-3#1)
spectra by##5##2##(2008-10#2)(2008-3#3)
spectra can be##2##3##(2008-10#1)(2008-3#1)
spectra can##3##2##(2008-10#2)(2008-3#1)
spectra derivative##6##2##(2008-10#6)
spectra do not##2##3##(2008-3#1)(2008-5#1)
spectra due to##3##3##(2008-10#2)(2012-2#1)
spectra for the##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
spectra for##11##2##(1990-8#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)
spectra from a##2##3##(1990-8#1)(2008-8#1)
spectra from##4##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
spectra has been##2##3##(2008-10#2)
spectra have been##2##3##(1990-8#1)(2008-10#1)
spectra have##3##2##(1990-8#1)(2008-10#2)
spectra in##8##2##(2008-10#4)(2008-3#4)
spectra indicated that##2##3##(2008-10#1)(2013-8#1)
spectra indicated##3##2##(2008-10#2)(2013-8#1)
spectra is demonstrated##2##3##(2008-10#1)(2008-3#1)
spectra is##9##2##(2008-10#4)(2008-3#4)(2008-4#1)
spectra measured##2##2##(2008-3#2)
spectra obtained from##2##3##(2008-10#1)(2008-2#1)
spectra obtained##7##2##(2008-10#6)(2008-2#1)
spectra of 12##2##3##(2008-10#2)
spectra of a##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
spectra of aqueous##3##3##(2008-10#2)(2008-3#1)
spectra of biological##2##3##(1995-12#1)(2008-10#1)
spectra of individual##2##3##(2008-10#2)
spectra of mixtures##3##3##(2008-10#3)
spectra of n-component solid mixtures##2##5##(2008-10#2)
spectra of pure chlorophenols##2##4##(2008-10#2)
spectra of pure##3##3##(2008-10#3)
spectra of six##2##3##(2008-10#2)
spectra of the analytes##2##4##(2008-10#2)
spectra of the complex##2##4##(1994-11#1)(2008-10#1)
spectra of the##34##3##(1991-5#1)(1993-8#1)(1994-11#2)(2008-10#24)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)
spectra of their##2##3##(2008-10#2)
spectra of these compounds##3##4##(2008-10#3)
spectra of these##7##3##(2008-10#6)(2009-10#1)
spectra of##128##2##(1990-5#1)(1991-5#2)(1992-12#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-5#2)(1995-12#1)(2007-12#1)(2008-10#87)(2008-2#1)(2008-3#9)(2008-5#2)(2008-8#1)(2008-9#11)(2009-10#1)(2009-3#1)(2013-8#2)
spectra on the##2##3##(2008-10#2)
spectra on##3##2##(2008-10#2)(2008-3#1)
spectra produced##2##2##(2008-10#1)(2008-8#1)
spectra recorded at##2##3##(2008-10#1)(2008-3#1)
spectra recorded##5##2##(2008-10#1)(2008-3#3)(2008-7#1)
spectra revealed##2##2##(2008-10#2)
spectra show that##2##3##(2008-10#2)
spectra show##3##2##(2008-10#3)
spectra showed the##2##3##(2008-10#2)
spectra showed##6##2##(1994-2#2)(2008-10#3)(2013-8#1)
spectra to be##2##3##(2008-3#2)
spectra to##4##2##(2008-10#1)(2008-3#3)
spectra using##3##2##(2008-10#3)
spectra was##2##2##(2008-10#2)
spectra were acquired##2##3##(2008-10#1)(2008-2#1)
spectra were analysed by principal component analysis (PCA) and the relevant principal components (PCs) were used for constructing multivariate Shewhart##2##20##(2008-10#2)
spectra were analysed##3##3##(2008-10#3)
spectra were measured for##2##4##(1996-5#1)(2008-2#1)
spectra were obtained##2##3##(2008-10#2)
spectra were recorded at various##2##5##(2008-10#2)
spectra were recorded for##2##4##(2008-10#2)
spectra were recorded##7##3##(2008-10#7)
spectra were##29##2##(1995-2#1)(1996-5#1)(2008-10#24)(2008-2#2)(2008-3#1)
spectra with##4##2##(2008-10#4)
spectra without##2##2##(2008-10#2)
spectra##472##1##(1990-5#1)(1990-8#3)(1990-9#1)(1991-5#2)(1992-1#1)(1992-10#1)(1992-12#2)(1993-12#2)(1993-5#1)(1993-8#1)(1994-11#3)(1994-2#2)(1994-5#4)(1995-12#1)(1995-2#1)(1996-5#4)(1997-2#3)(1997-7#1)(2007-12#2)(2008-10#308)(2008-11#4)(2008-2#8)(2008-3#64)(2008-4#5)(2008-5#4)(2008-7#4)(2008-8#6)(2008-9#12)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-8#6)
spectra)##7##1##(2008-10#7)
spectral EEG characteristics of##3##4##(2008-7#3)
spectral analysis and##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
spectral analysis is##2##3##(2008-10#1)(2011-2#1)
spectral analysis of##3##3##(1990-5#1)(2008-3#1)(2012-2#1)
spectral analysis##13##2##(1990-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-2#1)(2011-3#1)(2012-2#2)
spectral and spatial##2##3##(2008-3#2)
spectral and##5##2##(1994-3#1)(2008-10#2)(2008-3#2)
spectral band##5##2##(2008-10#1)(2008-3#2)(2008-7#2)
spectral bands of##2##3##(2008-10#2)
spectral bands##6##2##(2008-10#3)(2008-3#2)(2008-7#1)
spectral behavior##2##2##(2008-10#2)
spectral broadening##2##2##(2007-12#2)
spectral characteristics of##2##3##(2008-10#1)(2013-8#1)
spectral characteristics##7##2##(2008-10#3)(2008-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
spectral characterization of##2##3##(2007-12#1)(2008-2#1)
spectral classification library##2##3##(2013-8#2)
spectral classification##6##2##(2013-8#6)
spectral correction##3##2##(2008-10#3)
spectral data obtained##2##3##(2008-10#2)
spectral data##25##2##(1991-1#1)(2008-10#18)(2008-11#2)(2008-3#1)(2011-2#1)(2012-2#2)
spectral deconvolution##3##2##(2008-10#2)(2011-2#1)
spectral dispersion##2##2##(2008-3#2)
spectral distribution of the Raman-scattering##2##5##(2008-2#2)
spectral distribution##3##2##(2008-10#1)(2008-2#2)
spectral domain##3##2##(2008-3#3)
spectral extinction and backscatter##2##4##(2008-3#2)
spectral extinction##6##2##(2008-3#6)
spectral feature##3##2##(2008-10#1)(2008-3#2)
spectral features of##2##3##(2008-10#2)
spectral features##8##2##(1994-5#1)(2008-10#5)(2008-3#2)
spectral filters that##2##3##(2007-12#1)(2008-6#1)
spectral hole-burning##3##2##(2007-12#1)(2008-3#2)
spectral image##2##2##(2008-3#1)(2008-5#1)
spectral imager operates based on##2##5##(2013-8#2)
spectral imager##5##2##(2008-3#1)(2013-8#4)
spectral images##4##2##(2013-8#4)
spectral information##3##2##(2008-10#2)(2008-9#1)
spectral interference##2##2##(2008-10#2)
spectral interferences of##2##3##(2008-10#2)
spectral interferences##10##2##(2008-10#10)
spectral interfering elements##2##3##(2008-10#2)
spectral interval##2##2##(2008-3#2)
spectral library##2##2##(2008-10#1)(2011-2#1)
spectral lines##4##2##(2008-3#3)(2011-2#1)
spectral measurements##3##2##(2007-12#2)(2008-11#1)
spectral model##2##2##(2008-2#2)
spectral overlap was##3##3##(2008-10#3)
spectral overlap##9##2##(2008-10#9)
spectral overlapping of##2##3##(2008-10#2)
spectral overlapping##6##2##(2008-10#6)
spectral parameters##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
spectral peak##2##2##(2008-10#1)(2008-8#1)
spectral profiles##5##2##(2007-11#1)(2008-10#4)
spectral properties of the##2##4##(1992-1#1)(2008-10#1)
spectral properties of##7##3##(1992-1#1)(1994-11#1)(2008-10#2)(2008-3#2)(2012-2#1)
spectral properties were evaluated##2##4##(2008-10#2)
spectral properties##14##2##(1992-1#2)(1994-11#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#1)
spectral purity##2##2##(2008-3#2)
spectral range was##2##3##(2008-10#1)(2008-3#1)
spectral range##16##2##(2008-10#9)(2008-3#6)(2009-12#1)
spectral ranges##3##2##(2007-11#1)(2008-3#1)(2009-12#1)
spectral reflectance##3##2##(2008-10#1)(2008-5#2)
spectral region and number of factors##2##6##(2008-10#2)
spectral region##15##2##(1991-5#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#6)(2009-12#1)
spectral regions##8##2##(2008-10#2)(2008-3#6)
spectral resolution##11##2##(1991-5#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-9#1)(2012-2#1)(2013-8#1)
spectral response linewidth##2##3##(2008-3#2)
spectral response##4##2##(2007-12#1)(2008-3#3)
spectral sensitivity##2##2##(2008-8#2)
spectral shape##3##2##(2008-3#3)
spectral shifts##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
spectral structure##2##2##(2008-3#2)
spectral studies##2##2##(2008-10#2)
spectral transmission##3##2##(2008-3#1)(2008-5#2)
spectral transmittance##2##2##(2008-3#1)(2008-5#1)
spectral width of the##2##4##(2007-12#1)(2008-3#1)
spectral##365##1##(1990-5#1)(1991-1#1)(1991-5#2)(1992-1#3)(1994-11#1)(1994-3#1)(1994-5#1)(2007-11#6)(2007-12#14)(2008-10#139)(2008-11#5)(2008-12#1)(2008-2#16)(2008-3#95)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#3)(2009-7#2)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#12)(2011-3#1)(2012-2#7)(2013-1#1)(2013-8#17)
spectral-curvature algorithms##2##2##(2008-3#2)
spectral-domain OCT in the diagnosis and management of##2##8##(2011-7#2)
spectral-domain OCT##7##2##(2011-7#6)(2013-1#1)
spectral-domain##11##1##(2008-3#2)(2011-7#8)(2013-1#1)
spectrally encoded##2##2##(2008-2#2)
spectrally resolved fluorescence##2##3##(2008-2#1)(2008-3#1)
spectrally resolved##3##2##(2008-2#1)(2008-3#2)
spectrally##12##1##(1995-3#1)(1997-7#1)(2007-11#1)(2008-2#4)(2008-3#4)(2008-4#1)
spectre##2##1##(1991-6#1)(2013-1#1)
spectrin and##2##2##(1990-5#1)(1996-12#1)
spectrin is##2##2##(1990-5#2)
spectrin##6##1##(1990-5#4)(1996-12#2)
spectroelectrochemical cell##3##2##(2008-10#3)
spectroelectrochemical characterization of##2##3##(2008-10#2)
spectroelectrochemical##11##1##(2008-10#11)
spectroelectrochemistry##2##1##(2008-10#1)(2009-9#1)
spectrofluorimeter##6##1##(2008-10#6)
spectrofluorimetric determination of acetylsalicylic acid##2##5##(2008-10#2)
spectrofluorimetric determination of the##2##4##(2008-10#2)
spectrofluorimetric determination of trace##4##4##(2008-10#4)
spectrofluorimetric determination of##24##3##(2008-10#24)
spectrofluorimetric method for the determination of##9##6##(2008-10#9)
spectrofluorimetric method for the##11##4##(2008-10#11)
spectrofluorimetric method for##13##3##(2008-10#13)
spectrofluorimetric method##21##2##(2008-10#21)
spectrofluorimetric system is##2##3##(2008-10#2)
spectrofluorimetric##56##1##(2008-10#56)
spectrofluorimetrically##4##1##(2008-10#4)
spectrofluorimetry of ultra trace##2##4##(2008-10#2)
spectrofluorimetry of##3##2##(2008-10#3)
spectrofluorimetry##23##1##(2008-10#22)(2008-11#1)
spectrofluorometer##7##1##(2008-10#7)
spectrofluorometric##5##1##(2008-10#3)(2008-11#2)
spectrograms and##2##2##(2008-10#1)(2008-9#1)
spectrograph and##2##2##(2008-10#2)
spectrograph##4##1##(2008-10#3)(2008-3#1)
spectrometer (ICP-MS)##4##2##(2008-10#4)
spectrometer and##4##2##(1992-3#1)(2008-1#1)(2008-10#2)
spectrometer are##2##2##(2008-10#1)(2008-3#1)
spectrometer based on##3##3##(2008-10#1)(2013-8#2)
spectrometer equipped with a##2##4##(2008-10#2)
spectrometer equipped with##3##3##(2008-10#2)(2011-3#1)
spectrometer for##9##2##(2008-10#6)(2008-3#2)(2010-6#1)
spectrometer has been##3##3##(2008-10#3)
spectrometer in##2##2##(2008-10#2)
spectrometer is used##2##3##(2008-10#2)
spectrometer is##8##2##(2008-10#4)(2008-3#1)(2010-7#1)(2013-8#2)
spectrometer systems##2##2##(2008-10#2)
spectrometer to##2##2##(2008-10#2)
spectrometer was##6##2##(2008-10#5)(2010-9#1)
spectrometer with a##5##3##(2008-10#4)(2008-3#1)
spectrometer with##11##2##(2008-10#9)(2008-3#2)
spectrometer##159##1##(1992-3#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#116)(2008-2#2)(2008-3#25)(2010-6#1)(2010-7#3)(2010-9#2)(2011-3#1)(2013-8#4)
spectrometer's##3##1##(2008-10#2)(2008-3#1)
spectrometer]##2##1##(2013-8#2)
spectrometers are##2##2##(2008-10#1)(2013-8#1)
spectrometers for##2##2##(2008-10#2)
spectrometers is##2##2##(2008-10#2)
spectrometers##21##1##(2008-1#1)(2008-10#8)(2008-3#6)(2010-7#2)(2011-2#2)(2013-8#2)
spectrometric analysis of##2##3##(2008-10#2)
spectrometric analysis##4##2##(2008-10#3)(2008-11#1)
spectrometric data##2##2##(2008-10#1)(2008-9#1)
spectrometric detection has been developed##3##5##(2008-10#3)
spectrometric detection in the##3##4##(2008-10#3)
spectrometric detection##23##2##(2008-10#23)
spectrometric detector##3##2##(2008-10#3)
spectrometric determination of trace##2##4##(2008-10#2)
spectrometric determination of##28##3##(2008-10#28)
spectrometric determination##30##2##(2008-10#30)
spectrometric determinations##5##2##(2008-10#5)
spectrometric identification##3##2##(2008-10#3)
spectrometric measurements##3##2##(2008-10#2)(2010-11#1)
spectrometric method##8##2##(2008-10#8)
spectrometric methods##3##2##(2008-10#2)(2013-1#1)
spectrometric microtitration set up##2##4##(2008-10#2)
spectrometric microtitration##4##2##(2008-10#4)
spectrometric procedure##5##2##(2008-10#5)
spectrometric techniques is##3##3##(2008-10#2)(2008-3#1)
spectrometric techniques##6##2##(2008-10#5)(2008-3#1)
spectrometric##125##1##(1993-8#1)(2008-10#115)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#2)
spectrometrically##2##1##(2008-10#2)
spectrometry (ESI-MS)##5##2##(2008-10#3)(2008-5#1)(2011-1#1)
spectrometry (FAAS##2##2##(2008-10#2)
spectrometry (GC-MS)##19##2##(1990-5#1)(2008-10#17)(2008-5#1)
spectrometry (GC/MS)##5##2##(1995-11#1)(2008-10#4)
spectrometry (ICP-MS) and##2##3##(2008-10#2)
spectrometry (ICP-MS)##32##2##(2008-10#32)
spectrometry (LA-ICP-MS)##5##2##(2008-10#3)(2010-11#2)
spectrometry (LC-MS)##2##2##(2008-10#2)
spectrometry (LOQ=0##2##2##(2008-10#2)
spectrometry after##18##2##(2008-10#18)
spectrometry analysis##5##2##(2008-10#3)(2010-6#1)(2013-1#1)
spectrometry and cyclic voltammetry##2##4##(2008-10#2)
spectrometry and temperature-constrained cascade correlation networks##2##6##(2008-10#2)
spectrometry and the##2##3##(2008-10#2)
spectrometry and##37##2##(1997-2#2)(2008-10#23)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-7#1)(2012-2#1)(2013-8#2)
spectrometry as an alternative##2##4##(2008-10#2)
spectrometry as an##3##3##(2008-10#3)
spectrometry as##10##2##(1997-2#1)(2008-10#9)
spectrometry at##6##2##(2008-10#4)(2008-5#2)
spectrometry can be used##2##4##(2008-10#2)
spectrometry coupled with##3##3##(2008-10#3)
spectrometry detection##11##2##(2008-10#11)
spectrometry determination of Malathion in pesticide##2##6##(2008-10#2)
spectrometry determination of##6##3##(2008-10#6)
spectrometry determination##8##2##(2008-10#8)
spectrometry for determination of##2##4##(2008-10#2)
spectrometry for the determination of##4##5##(2008-10#4)
spectrometry for the##13##3##(2008-10#12)(2010-9#1)
spectrometry for trace##2##3##(2008-10#2)
spectrometry for##27##2##(2008-10#25)(2008-3#1)(2010-9#1)
spectrometry has become##2##3##(2008-10#2)
spectrometry has been##8##3##(1990-12#1)(1997-2#1)(2008-10#6)
spectrometry has##11##2##(1990-12#1)(1997-2#1)(2008-10#9)
spectrometry in terms of##2##4##(2008-3#1)(2010-7#1)
spectrometry in the##2##3##(2008-10#2)
spectrometry in##20##2##(1992-3#1)(2008-10#16)(2008-3#1)(2010-7#2)
spectrometry is described##7##3##(1992-3#1)(2008-10#5)(2008-11#1)
spectrometry is##19##2##(1992-3#1)(2008-10#16)(2008-11#1)(2008-9#1)
spectrometry method for##3##3##(2008-10#3)
spectrometry method was developed##2##4##(2008-10#2)
spectrometry method##7##2##(2008-10#7)
spectrometry of##8##2##(1992-6#1)(2008-10#5)(2008-9#1)(2010-7#1)
spectrometry techniques##3##2##(2008-10#3)
spectrometry to##5##2##(2008-10#3)(2010-6#1)(2010-7#1)
spectrometry using a##5##3##(2008-10#5)
spectrometry using solid##2##3##(2008-10#2)
spectrometry using the##2##3##(2008-10#2)
spectrometry using##23##2##(2008-10#22)(2008-5#1)
spectrometry was used for the##3##5##(2008-10#3)
spectrometry was used for##5##4##(2008-10#5)
spectrometry was used to##4##4##(2008-10#4)
spectrometry was used##11##3##(2008-10#11)
spectrometry was##19##2##(2008-10#18)(2011-3#1)
spectrometry were##6##2##(2008-10#6)
spectrometry with a##3##3##(2008-10#3)
spectrometry with high performance liquid chromatography for the analysis of##2##10##(2008-10#2)
spectrometry with##27##2##(1994-2#1)(2008-10#25)(2008-3#1)
spectrometry##1117##1##(1990-12#2)(1990-5#2)(1990-8#2)(1991-12#1)(1991-5#1)(1992-3#3)(1992-6#1)(1993-8#1)(1994-2#1)(1994-5#3)(1995-11#2)(1995-3#1)(1996-12#1)(1997-2#11)(2008-1#1)(2008-10#999)(2008-11#12)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#10)(2008-7#1)(2008-8#7)(2008-9#2)(2010-11#4)(2010-6#3)(2010-7#12)(2010-9#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#5)
spectrometry)##4##1##(2008-10#3)(2008-12#1)
spectrometry-based##5##1##(2008-10#2)(2010-5#1)(2010-7#2)
spectrophotometer and##3##2##(2008-10#2)(2008-3#1)
spectrophotometer assay##3##2##(2008-10#3)
spectrophotometer at##2##2##(1994-3#1)(2008-10#1)
spectrophotometer for##3##2##(2008-10#3)
spectrophotometer to##2##2##(2008-10#2)
spectrophotometer was##2##2##(2008-10#2)
spectrophotometer with##2##2##(2008-10#2)
spectrophotometer##47##1##(1994-3#1)(1997-4#1)(2008-10#41)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
spectrophotometeric##2##1##(2008-10#2)
spectrophotometers##2##1##(2008-3#1)(2008-5#1)
spectrophotometric FI system with a column##2##6##(2008-10#2)
spectrophotometric FI##3##2##(2008-10#3)
spectrophotometric analyses##2##2##(2008-10#1)(2008-5#1)
spectrophotometric analysis of##3##3##(2008-10#3)
spectrophotometric analysis##4##2##(2008-10#4)
spectrophotometric and inductively coupled plasma atomic emission##2##7##(2008-10#2)
spectrophotometric and spectrofluorimetric analysis##2##4##(2008-10#2)
spectrophotometric and spectrofluorimetric determination of##2##5##(2008-10#2)
spectrophotometric and spectrofluorimetric##4##3##(2008-10#4)
spectrophotometric and##18##2##(2008-10#18)
spectrophotometric assay##5##2##(2008-10#5)
spectrophotometric assays##2##2##(2008-10#2)
spectrophotometric data in##3##3##(2008-10#3)
spectrophotometric data##12##2##(1993-8#1)(2008-10#10)(2008-3#1)
spectrophotometric detection at##3##3##(2008-10#3)
spectrophotometric detection has been developed for the##2##7##(2008-10#2)
spectrophotometric detection in##2##3##(2008-10#2)
spectrophotometric detection is proposed##2##4##(2008-10#2)
spectrophotometric detection is##3##3##(2008-10#3)
spectrophotometric detection of##3##3##(2008-10#3)
spectrophotometric detection was##3##3##(2008-10#3)
spectrophotometric detection##37##2##(2008-10#37)
spectrophotometric determination method##2##3##(2008-10#2)
spectrophotometric determination of Fe and Ni##2##6##(2008-10#2)
spectrophotometric determination of Fe##3##4##(2008-10#3)
spectrophotometric determination of Fe(II) and Fe(III)##2##6##(2008-10#2)
spectrophotometric determination of ascorbic acid based on##2##7##(2008-10#2)
spectrophotometric determination of ascorbic acid##5##5##(2008-10#5)
spectrophotometric determination of boron in##4##5##(2008-10#4)
spectrophotometric determination of boron##5##4##(2008-10#5)
spectrophotometric determination of calcium using murexide##2##6##(2008-10#2)
spectrophotometric determination of calcium##3##4##(2008-10#3)
spectrophotometric determination of captopril##2##4##(2008-10#2)
spectrophotometric determination of chromium (VI) with diphenylcarbazide##2##7##(2008-10#2)
spectrophotometric determination of chromium##3##4##(2008-10#3)
spectrophotometric determination of chromium(VI) in##2##5##(2008-10#2)
spectrophotometric determination of chromium(VI)##3##4##(2008-10#3)
spectrophotometric determination of cobalt##3##4##(2008-10#3)
spectrophotometric determination of cobalt(II)##2##4##(2008-10#2)
spectrophotometric determination of copper and iron##2##6##(2008-10#2)
spectrophotometric determination of copper##4##4##(2008-10#4)
spectrophotometric determination of copper(II) in##2##5##(2008-10#2)
spectrophotometric determination of copper(II)##6##4##(2008-10#6)
spectrophotometric determination of europium##2##4##(2008-10#2)
spectrophotometric determination of free chlorine##2##5##(2008-10#2)
spectrophotometric determination of hydrazine##2##4##(2008-10#2)
spectrophotometric determination of hydrosoluble vitamins##2##5##(2008-10#2)
spectrophotometric determination of iron##2##4##(2008-10#2)
spectrophotometric determination of manganese##4##4##(2008-10#4)
spectrophotometric determination of molybdenum in##2##5##(2008-10#2)
spectrophotometric determination of molybdenum##3##4##(2008-10#3)
spectrophotometric determination of nickel in##3##5##(2008-10#3)
spectrophotometric determination of nickel##7##4##(2008-10#7)
spectrophotometric determination of nitrite##4##4##(2008-10#4)
spectrophotometric determination of the##4##4##(2008-10#4)
spectrophotometric determination of total##4##4##(2008-10#4)
spectrophotometric determination of trace amount of##2##6##(2008-10#2)
spectrophotometric determination of trace amounts of copper##2##7##(2008-10#2)
spectrophotometric determination of trace amounts of##7##6##(2008-10#7)
spectrophotometric determination of trace##13##4##(2008-10#13)
spectrophotometric determination of tungsten##2##4##(2008-10#2)
spectrophotometric determination of vanillin##3##4##(2008-10#3)
spectrophotometric determination of zinc in##2##5##(2008-10#2)
spectrophotometric determination of zinc##3##4##(2008-10#3)
spectrophotometric determination of##192##3##(2008-10#191)(2009-8#1)
spectrophotometric determination##203##2##(2008-10#202)(2009-8#1)
spectrophotometric determinations of##3##3##(2008-10#3)
spectrophotometric determinations##4##2##(2008-10#4)
spectrophotometric estimation##2##2##(2008-10#2)
spectrophotometric flow injection##3##3##(2008-10#3)
spectrophotometric flow-injection method is##2##4##(2008-10#2)
spectrophotometric flow-injection##3##2##(2008-10#3)
spectrophotometric measurement##5##2##(2008-10#5)
spectrophotometric measurements##6##2##(2008-10#6)
spectrophotometric method and##2##3##(2008-10#2)
spectrophotometric method based on the##2##5##(2008-10#2)
spectrophotometric method based on##5##4##(2008-10#5)
spectrophotometric method for determination of acidity constants##2##7##(2008-10#2)
spectrophotometric method for determination of##7##5##(2008-10#7)
spectrophotometric method for the determination of hydrogen peroxide##2##8##(2008-10#2)
spectrophotometric method for the determination of trace##3##7##(2008-10#3)
spectrophotometric method for the determination of##23##6##(2008-10#23)
spectrophotometric method for the simultaneous##2##5##(2008-10#2)
spectrophotometric method for the##31##4##(2008-10#31)
spectrophotometric method for##48##3##(2008-10#48)
spectrophotometric method has been developed for the determination of##5##9##(2008-10#5)
spectrophotometric method has been developed for the##8##7##(2008-10#8)
spectrophotometric method has been developed##9##5##(2008-10#9)
spectrophotometric method in the##2##4##(2008-10#2)
spectrophotometric method in##3##3##(2008-10#3)
spectrophotometric method is described for the determination of trace amounts of##2##11##(2008-10#2)
spectrophotometric method is described for the determination of##4##8##(2008-10#4)
spectrophotometric method is described for##5##5##(2008-10#5)
spectrophotometric method is proposed for the determination of##3##8##(2008-10#3)
spectrophotometric method is proposed for the simultaneous determination of##2##9##(2008-10#2)
spectrophotometric method is proposed for the##6##6##(2008-10#6)
spectrophotometric method is##13##3##(2008-10#13)
spectrophotometric method of##3##3##(2008-10#2)(2008-5#1)
spectrophotometric method using##3##3##(2008-10#3)
spectrophotometric method was developed for the determination of##2##8##(2008-10#2)
spectrophotometric method was proposed for the determination of##2##8##(2008-10#2)
spectrophotometric method was proposed for##3##5##(2008-10#3)
spectrophotometric method was##9##3##(2008-10#9)
spectrophotometric method##135##2##(1991-2#1)(1996-12#1)(2008-10#132)(2008-5#1)
spectrophotometric methodology##2##2##(2008-10#2)
spectrophotometric methods are described for the##2##6##(2008-10#2)
spectrophotometric methods are described##3##4##(2008-10#3)
spectrophotometric methods are##4##3##(1996-12#1)(2008-10#3)
spectrophotometric methods for the determination of##3##6##(2008-10#3)
spectrophotometric methods for the##4##4##(2008-10#4)
spectrophotometric methods##20##2##(1996-12#1)(2008-10#19)
spectrophotometric monitoring of the##3##4##(2008-10#3)
spectrophotometric monitoring of##4##3##(2008-10#4)
spectrophotometric monitoring##5##2##(2008-10#5)
spectrophotometric multicomponent analysis of##2##4##(2008-10#2)
spectrophotometric procedure for DNA assay##2##5##(2008-10#2)
spectrophotometric procedure for##5##3##(2008-10#5)
spectrophotometric procedure is proposed for the determination of##2##8##(2008-10#2)
spectrophotometric procedure is proposed for##3##5##(2008-10#3)
spectrophotometric procedure##14##2##(2008-10#14)
spectrophotometric procedures##2##2##(2008-10#2)
spectrophotometric reaction##2##2##(2008-10#2)
spectrophotometric reagent##4##2##(2008-10#4)
spectrophotometric reference method##4##3##(2008-10#4)
spectrophotometric studies##3##2##(2008-10#3)
spectrophotometric study on##2##3##(2008-10#2)
spectrophotometric study##4##2##(2008-10#4)
spectrophotometric system##2##2##(2008-10#2)
spectrophotometric technique for the##2##4##(1990-2#1)(2008-10#1)
spectrophotometric technique##3##2##(1990-2#1)(2008-10#2)
spectrophotometric##548##1##(1990-2#1)(1991-2#1)(1993-8#1)(1996-12#2)(2008-10#539)(2008-3#1)(2008-5#2)(2009-8#1)
spectrophotometrically and##2##2##(2008-10#2)
spectrophotometrically as##3##2##(2008-10#3)
spectrophotometrically at##20##2##(2008-10#20)
spectrophotometrically by##12##2##(2008-10#12)
spectrophotometrically in aqueous##2##3##(2008-10#2)
spectrophotometrically using##3##2##(2008-10#3)
spectrophotometrically with##3##2##(2008-10#3)
spectrophotometrically##70##1##(2008-10#70)
spectrophotometry and by##2##3##(2008-10#2)
spectrophotometry and flame atomic absorption spectrometry##2##6##(2008-10#2)
spectrophotometry and multivariate calibration##2##4##(2008-10#2)
spectrophotometry and##21##2##(1993-1#1)(2008-10#20)
spectrophotometry for determination of##2##4##(2008-10#2)
spectrophotometry for##9##2##(2008-10#8)(2009-5#1)
spectrophotometry has been developed##2##4##(2008-10#2)
spectrophotometry has been##3##3##(2008-10#3)
spectrophotometry has the advantage of high sensitivity than normal##2##9##(2008-10#2)
spectrophotometry has##5##2##(2008-10#5)
spectrophotometry in##4##2##(2008-10#4)
spectrophotometry is##4##2##(2008-10#4)
spectrophotometry of##3##2##(2008-10#3)
spectrophotometry using##5##2##(2008-10#5)
spectrophotometry was used to##2##4##(2008-10#2)
spectrophotometry was used##4##3##(2008-10#4)
spectrophotometry was##5##2##(2008-10#5)
spectrophotometry were##2##2##(2008-10#2)
spectrophotometry with flow injection##2##4##(2008-10#2)
spectrophotometry with##9##2##(2008-10#9)
spectrophotometry##161##1##(1993-1#1)(2008-10#159)(2009-5#1)
spectropolarimetric##4##1##(1994-5#1)(2008-10#1)(2008-3#2)
spectroscopic analysis##6##2##(2008-10#5)(2010-6#1)
spectroscopic and##8##2##(1994-5#1)(2008-10#4)(2008-5#1)(2010-7#1)(2012-12#1)
spectroscopic characterization of##2##3##(2008-10#1)(2008-3#1)
spectroscopic data##7##2##(1995-6#1)(2008-10#4)(2011-2#1)(2013-1#1)
spectroscopic detection of##2##3##(2008-10#1)(2008-3#1)
spectroscopic detection##6##2##(2008-10#5)(2008-3#1)
spectroscopic determination of##3##3##(2008-10#3)
spectroscopic ellipsometry##3##2##(2008-3#3)
spectroscopic measurements##5##2##(1997-6#1)(2008-10#3)(2008-5#1)
spectroscopic method for##2##3##(2008-10#2)
spectroscopic method was##2##3##(2008-10#2)
spectroscopic method##8##2##(2008-10#8)
spectroscopic methods##4##2##(2008-10#4)
spectroscopic parameters##3##2##(2008-10#1)(2008-3#2)
spectroscopic probe##2##2##(2008-10#1)(2010-4#1)
spectroscopic probes##2##2##(2008-10#1)(2008-12#1)
spectroscopic properties##5##2##(1994-11#1)(2008-10#3)(2008-3#1)
spectroscopic studies of##2##3##(2008-10#1)(2012-12#1)
spectroscopic studies##4##2##(1995-6#1)(2008-10#2)(2012-12#1)
spectroscopic study of##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
spectroscopic study##6##2##(1994-8#1)(2008-10#3)(2008-3#1)(2008-8#1)
spectroscopic techniques##11##2##(1997-2#1)(2008-10#8)(2008-11#1)(2008-9#1)
spectroscopic##116##1##(1991-5#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-6#2)(1997-2#1)(1997-6#1)(2008-10#75)(2008-11#1)(2008-12#1)(2008-3#14)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
spectroscopical##2##1##(2008-10#2)
spectroscopically##5##1##(1992-8#1)(1994-5#1)(2008-10#2)(2008-5#1)
spectroscopies##4##1##(1992-8#1)(2008-10#2)(2010-7#1)
spectroscopy (CRDS)##2##2##(2008-2#1)(2010-7#1)
spectroscopy (EDS)##3##2##(2008-10#1)(2008-11#2)
spectroscopy (FTIR) and##3##3##(2008-10#3)
spectroscopy (FTIR)##7##2##(2008-10#7)
spectroscopy (LIBS)##2##2##(2008-10#2)
spectroscopy (NIRS) technology together with a remote reflectance fibre-optic probe##2##10##(2008-10#2)
spectroscopy (NIRS) was##2##3##(2008-10#2)
spectroscopy (NIRS)##8##2##(2008-10#8)
spectroscopy and X-ray##4##3##(1994-3#1)(1996-5#1)(2008-10#2)
spectroscopy and imaging##2##3##(1993-3#1)(2008-11#1)
spectroscopy and multivariate calibration##5##4##(2008-10#5)
spectroscopy and multivariate control charts##3##5##(2008-10#3)
spectroscopy and multivariate##9##3##(2008-10#9)
spectroscopy and the##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
spectroscopy and##57##2##(1992-4#1)(1993-3#1)(1994-11#1)(1994-3#3)(1995-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#38)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#1)
spectroscopy are##3##2##(2008-2#1)(2008-3#1)(2010-11#1)
spectroscopy as a##3##3##(2008-10#1)(2009-12#1)(2010-11#1)
spectroscopy as##6##2##(2008-10#4)(2009-12#1)(2010-11#1)
spectroscopy at##5##2##(1990-9#1)(2008-10#3)(2008-3#1)
spectroscopy can##2##2##(2008-10#1)(2008-7#1)
spectroscopy coupled to multivariate##2##4##(2008-10#2)
spectroscopy coupled to##3##3##(2008-10#3)
spectroscopy coupled##4##2##(2008-10#4)
spectroscopy determinations##2##2##(2008-10#2)
spectroscopy for in situ##3##4##(2008-10#3)
spectroscopy for the##5##3##(2008-10#4)(2008-3#1)
spectroscopy for##14##2##(2008-10#9)(2008-3#3)(2012-12#2)
spectroscopy has been used to study##2##6##(1991-12#1)(1994-8#1)
spectroscopy has been used to##3##5##(1991-12#1)(1994-5#1)(1994-8#1)
spectroscopy has been##6##3##(1991-12#1)(1994-5#1)(1994-8#1)(2008-10#2)(2008-3#1)
spectroscopy has##9##2##(1991-12#1)(1994-5#1)(1994-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
spectroscopy have been##4##3##(1992-3#1)(2008-10#2)(2008-3#1)
spectroscopy in order to##2##4##(2008-10#2)
spectroscopy in the##3##3##(2008-10#3)
spectroscopy in##21##2##(1990-5#1)(1990-9#1)(1997-6#1)(2008-10#14)(2008-3#2)(2008-7#1)(2010-7#1)
spectroscopy is an important tool##2##5##(2008-4#1)(2010-12#1)
spectroscopy is##12##2##(2008-10#6)(2008-3#4)(2008-4#1)(2010-12#1)
spectroscopy measurements##2##2##(2008-3#1)(2012-2#1)
spectroscopy method for##2##3##(2008-10#1)(2008-3#1)
spectroscopy method##3##2##(2008-10#2)(2008-3#1)
spectroscopy methods##3##2##(2008-10#2)(2008-9#1)
spectroscopy of the skin##2##4##(2008-5#2)
spectroscopy of the##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)
spectroscopy of##20##2##(1990-9#1)(1991-9#1)(1992-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)
spectroscopy or##2##2##(2008-10#1)(2008-3#1)
spectroscopy technique##4##2##(2008-10#2)(2008-3#2)
spectroscopy techniques##8##2##(2008-10#4)(2008-11#1)(2008-3#2)(2012-12#1)
spectroscopy the##2##2##(2008-10#2)
spectroscopy to the##2##3##(2008-10#2)
spectroscopy to##12##2##(1991-5#1)(1994-11#1)(1994-2#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-3#1)
spectroscopy using##6##2##(1994-5#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#1)
spectroscopy was used to investigate the##2##6##(2008-10#1)(2008-8#1)
spectroscopy was used to##6##4##(1994-11#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
spectroscopy was##9##2##(1994-11#1)(1994-5#1)(2008-10#5)(2008-11#1)(2008-8#1)
spectroscopy were##2##2##(2008-10#2)
spectroscopy with a 1##2##4##(2008-2#1)(2008-3#1)
spectroscopy with a##7##3##(2008-10#2)(2008-2#3)(2008-3#2)
spectroscopy with##10##2##(2008-10#3)(2008-2#3)(2008-3#4)
spectroscopy##524##1##(1990-5#2)(1990-9#5)(1991-1#1)(1991-12#2)(1991-3#2)(1991-5#3)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-2#2)(1994-3#3)(1994-5#5)(1994-8#3)(1995-2#3)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-6#4)(2007-12#3)(2008-10#318)(2008-11#11)(2008-2#11)(2008-3#53)(2008-4#2)(2008-5#10)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#2)(2009-3#2)(2009-9#1)(2010-11#5)(2010-12#4)(2010-4#1)(2010-7#6)(2010-8#1)(2011-2#7)(2012-12#3)(2012-2#5)(2013-1#5)(2013-8#4)
spectroscopy) to##2##2##(2008-3#2)
spectroscopy)##5##1##(2008-10#1)(2008-3#3)(2010-7#1)
spectrum analysis##2##2##(2009-8#1)(2013-8#1)
spectrum and##11##2##(1991-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#1)(2013-8#2)
spectrum are##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
spectrum at##3##2##(2008-10#3)
spectrum beta##2##2##(2008-3#1)(2012-2#1)
spectrum by##2##2##(2008-10#1)(2008-4#1)
spectrum can##2##2##(2008-10#1)(2013-1#1)
spectrum could##2##2##(2008-8#1)(2013-8#1)
spectrum disorder##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
spectrum disorders##5##2##(2008-11#3)(2012-2#2)
spectrum displays four peaks##2##4##(2008-8#2)
spectrum from##2##2##(2008-3#1)(2008-8#1)
spectrum in the##2##3##(2008-11#1)(2008-3#1)
spectrum in##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
spectrum is acquired##2##3##(2008-10#2)
spectrum is presented##2##3##(2008-10#1)(2008-2#1)
spectrum is##14##2##(1995-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)
spectrum of a single##2##4##(2008-10#1)(2010-7#1)
spectrum of a##5##3##(2008-10#4)(2010-7#1)
spectrum of action##2##3##(2010-6#1)(2013-8#1)
spectrum of activity and##2##4##(2008-10#2)
spectrum of activity##7##3##(2008-10#4)(2008-5#2)(2011-2#1)
spectrum of antibiotics##2##3##(2008-10#1)(2011-2#1)
spectrum of congenital##2##3##(2008-11#1)(2008-8#1)
spectrum of differential##2##3##(1993-8#1)(2008-12#1)
spectrum of each##4##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
spectrum of resistance to##2##4##(2008-10#1)(2011-2#1)
spectrum of symptoms##2##3##(2008-7#2)
spectrum of the##16##3##(1993-8#1)(1994-3#1)(2008-10#8)(2008-3#1)(2008-8#2)(2011-2#2)(2012-2#1)
spectrum of##137##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#2)(1993-8#5)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1997-1#1)(1997-3#2)(1997-8#2)(2008-10#36)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#8)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
spectrum ranging from##2##3##(1995-1#1)(2008-5#1)
spectrum resolution of the##2##4##(2013-8#2)
spectrum resolution##4##2##(2013-8#4)
spectrum was##6##2##(2008-10#6)
spectrum were##2##2##(2008-10#1)(2013-8#1)
spectrum with##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
spectrum##315##1##(1990-12#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-3#2)(1993-8#7)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#5)(1994-6#1)(1995-1#2)(1995-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#3)(2007-12#1)(2007-8#1)(2008-10#98)(2008-11#19)(2008-12#3)(2008-2#5)(2008-3#31)(2008-4#6)(2008-5#10)(2008-7#6)(2008-8#13)(2008-9#3)(2009-12#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#3)(2011-2#21)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#22)
specular microscope##2##2##(2011-2#2)
specular##8##1##(2008-3#6)(2011-2#2)
speculate on the possible##2##4##(2007-12#1)(2008-11#1)
speculate on the##4##3##(1996-3#1)(2007-12#1)(2008-11#1)(2012-3#1)
speculate on##9##2##(1994-2#1)(1996-3#1)(2007-12#1)(2008-11#3)(2008-3#1)(2011-2#1)(2012-3#1)
speculate that the##3##3##(1994-2#1)(2008-10#2)
speculate that this##2##3##(2008-11#1)(2012-3#1)
speculate that##16##2##(1994-2#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
speculate##29##1##(1994-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-8#1)
speculated that a##2##3##(2008-9#1)(2009-6#1)
speculated that the##2##3##(1996-2#1)(2008-10#1)
speculated that##13##2##(1992-3#2)(1995-11#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#1)
speculated to be##4##3##(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)
speculated##18##1##(1992-3#2)(1995-11#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
speculation that##2##2##(2008-4#1)(2013-8#1)
speculation##4##1##(2008-11#1)(2008-4#2)(2013-8#1)
speculations about##3##2##(1992-3#1)(1996-9#1)(2012-2#1)
speculations##6##1##(1992-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
speculative##4##1##(1990-11#1)(2008-12#1)(2013-1#2)
speech and language##4##3##(2008-9#3)(2011-1#1)
speech and phonological awareness##2##4##(2011-1#2)
speech and##10##2##(2008-9#4)(2011-1#6)
speech intelligibility##2##2##(2008-9#2)
speech perception and##2##3##(2008-11#1)(2008-9#1)
speech perception in adult##2##4##(2008-9#2)
speech perception performance##3##3##(2008-9#3)
speech perception##17##2##(2008-11#2)(2008-9#15)
speech processor##11##2##(2008-9#11)
speech production##6##2##(2008-9#4)(2011-1#2)
speech recognition in noise##2##4##(2008-9#2)
speech recognition in##3##3##(2008-9#3)
speech recognition##8##2##(2008-9#8)
speech sounds##3##2##(2008-9#3)
speech##105##1##(1990-12#1)(1991-3#1)(1994-1#3)(1994-3#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-9#61)(2009-10#6)(2010-4#1)(2010-8#1)(2011-1#22)(2011-2#1)
speed and accuracy##3##3##(2008-11#1)(2009-12#1)(2011-2#1)
speed and the##2##3##(2008-10#1)(2008-8#1)
speed and time##6##3##(2008-10#1)(2008-5#5)
speed and##28##2##(1990-5#1)(1993-6#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#2)(2009-12#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
speed in##5##2##(1994-8#1)(2008-12#2)(2008-7#1)(2011-2#1)
speed is required##2##3##(2008-3#2)
speed is##3##2##(2008-3#3)
speed of analysis##3##3##(2008-10#2)(2008-9#1)
speed of sound##5##3##(2008-3#5)
speed of the##5##3##(1990-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#1)
speed of##44##2##(1990-12#1)(1994-5#1)(1994-8#2)(1997-7#1)(2008-10#12)(2008-12#1)(2008-3#6)(2008-5#3)(2008-6#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
speed on##2##2##(1994-8#1)(2008-7#1)
speed to##2##2##(1991-3#1)(2008-10#1)
speed up##9##2##(1990-11#1)(1994-9#1)(1997-2#1)(2008-10#3)(2008-3#3)
speed was##4##2##(2008-10#2)(2013-1#2)
speed were##4##2##(2008-12#2)(2008-3#1)(2011-2#1)
speed##172##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-5#1)(1994-8#8)(1994-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#50)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#19)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#6)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#10)(2011-7#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#2)
speeds of##5##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)
speeds revealed differences from##2##4##(1997-2#2)
speeds##22##1##(1992-12#1)(1993-9#1)(1995-1#1)(1997-2#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-1#2)
speedy##5##1##(2008-10#1)(2008-11#1)(2010-6#1)(2012-12#1)(2013-1#1)
spelling##5##1##(1990-8#1)(2008-11#1)(2008-12#1)(2011-1#2)
speltoides##9##1##(2008-10#9)
spend compared to##2##3##(2009-4#2)
spend more time in##2##4##(2008-7#1)(2012-2#1)
spend more time##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
spend on##4##2##(1990-2#2)(1995-6#1)(2009-4#1)
spend their##2##2##(1997-1#1)(2009-10#1)
spend##25##1##(1990-2#2)(1991-2#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#5)(2011-2#4)(2012-2#1)(2013-8#1)
spend-down##2##1##(1994-2#2)
spending and##4##2##(1993-3#1)(1995-1#1)(2008-11#1)(2012-3#1)
spending by state##2##3##(1995-12#1)(1997-3#1)
spending by##4##2##(1994-1#2)(1995-12#1)(1997-3#1)
spending for##5##2##(1991-2#3)(1995-3#1)(1997-3#1)
spending growth##2##2##(1993-1#1)(1996-2#1)
spending is##2##2##(2012-3#1)(2013-8#1)
spending more time##3##3##(2008-11#1)(2009-8#1)(2011-1#1)
spending more##4##2##(1991-3#1)(2008-11#1)(2009-8#1)(2011-1#1)
spending on##2##2##(1991-12#1)(1992-2#1)
spending per##2##2##(1994-1#1)(1996-3#1)
spending time##2##2##(1991-2#2)
spending to##2##2##(1995-3#1)(1996-1#1)
spending##83##1##(1991-12#2)(1991-2#6)(1991-3#2)(1992-11#1)(1992-12#2)(1992-2#6)(1993-1#1)(1993-2#1)(1993-3#3)(1994-1#9)(1994-2#2)(1995-1#5)(1995-12#4)(1995-2#2)(1995-3#3)(1995-6#1)(1996-1#1)(1996-2#3)(1996-3#2)(1996-5#2)(1997-2#4)(1997-3#5)(2008-11#10)(2009-8#1)(2011-1#1)(2012-3#3)(2013-8#1)
spends##2##1##(1990-2#1)(1991-2#1)
spent CAPD fluids by##2##4##(2008-10#2)
spent CAPD fluids##4##3##(2008-10#4)
spent CAPD##5##2##(2008-10#5)
spent in the##3##3##(1993-2#1)(2008-9#1)(2011-2#1)
spent in##9##2##(1993-2#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-2#2)(2013-1#1)
spent ion exchange##2##3##(2008-10#2)
spent male and female buffalo meat##2##6##(2010-4#2)
spent male and##3##3##(2010-4#3)
spent male##4##2##(2010-4#4)
spent medium was##2##3##(2008-11#2)
spent medium##3##2##(2008-11#3)
spent on the##2##3##(2008-10#1)(2008-11#1)
spent on##7##2##(1990-2#1)(1992-2#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-4#1)
spent##63##1##(1990-2#1)(1990-3#1)(1991-12#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-12#2)(1995-6#1)(1996-2#1)(1997-2#2)(1997-3#2)(2008-10#15)(2008-11#9)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#2)(2010-4#5)(2010-8#4)(2011-2#4)(2012-3#1)(2013-1#2)
spent-sulfidic caustic##3##2##(2008-6#3)
sperm DNA##14##2##(2008-10#12)(2008-9#2)
sperm acrosome##5##2##(1995-6#1)(2008-8#4)
sperm and microbes##2##3##(1996-9#2)
sperm and##6##2##(1996-9#3)(2008-8#1)(2009-10#1)(2011-2#1)
sperm are##3##2##(1994-8#1)(2008-8#2)
sperm binding to ZP and##2##5##(2013-1#2)
sperm can##2##2##(1994-5#1)(1994-8#1)
sperm cell##3##2##(2007-12#2)(2008-12#1)
sperm cells and##2##3##(2008-12#2)
sperm cells of##2##3##(2007-12#1)(2008-8#1)
sperm cells##14##2##(1997-6#3)(2007-12#2)(2008-12#6)(2008-8#1)(2009-8#1)(2012-2#1)
sperm competition##6##2##(2008-6#1)(2008-8#4)(2009-6#1)
sperm from##3##2##(1996-11#1)(2007-12#1)(2008-6#1)
sperm head##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
sperm in##4##2##(1994-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
sperm insemination##2##2##(1996-9#1)(2012-3#1)
sperm limitation and polyspermy##2##4##(2008-8#2)
sperm limitation##4##2##(2008-8#4)
sperm maturation##2##2##(1997-6#2)
sperm movement##2##2##(2007-12#1)(2008-12#1)
sperm parameters##3##2##(2008-12#3)
sperm penetration##2##2##(2013-1#2)
sperm production##4##2##(1992-12#2)(1994-8#1)(2009-10#1)
sperm quality and##2##3##(2008-12#1)(2009-10#1)
sperm quality##3##2##(2008-12#1)(2009-10#1)(2013-8#1)
sperm release##2##2##(2008-8#1)(2009-10#1)
sperm storage and##2##3##(2007-12#2)
sperm storage organs##3##3##(2007-12#3)
sperm storage##7##2##(2007-12#6)(2008-6#1)
sperm to##2##2##(2008-8#1)(2013-1#1)
sperm were##2##2##(2008-12#2)
sperm when stimulated with##2##4##(2008-8#2)
sperm##165##1##(1991-5#1)(1992-12#2)(1994-5#4)(1994-8#9)(1995-2#1)(1995-6#4)(1996-11#1)(1996-9#6)(1997-6#6)(2007-12#13)(2008-10#13)(2008-11#1)(2008-12#21)(2008-6#6)(2008-7#5)(2008-8#37)(2008-9#7)(2009-10#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#1)
sperm)##2##1##(1997-8#1)(2008-8#1)
sperm-ZP interactions##3##2##(2013-1#3)
sperm-egg membrane fusion##2##3##(2008-8#2)
sperm-egg##5##1##(2008-6#1)(2008-8#4)
spermathecae##7##1##(2007-12#4)(2008-12#1)(2008-8#2)
spermathecal ducts##3##2##(2007-12#1)(2008-8#2)
spermathecal sperm##3##2##(2008-8#3)
spermathecal##7##1##(2007-12#2)(2008-8#5)
spermatia##2##1##(2008-10#2)
spermatic cord torsion##3##3##(2008-10#3)
spermatic cord##4##2##(2008-10#4)
spermatic##6##1##(1990-9#2)(2008-10#4)
spermatid differentiation##2##2##(2008-7#2)
spermatid##11##1##(2008-7#4)(2009-12#1)(2012-2#6)
spermatids and##2##2##(2008-7#2)
spermatids that##2##2##(2008-7#1)(2012-2#1)
spermatids##17##1##(1992-12#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-7#5)(2008-9#1)(2009-10#3)(2012-2#4)
spermatocystes##2##1##(2008-12#2)
spermatocyte##6##1##(2008-7#1)(2009-10#3)(2011-2#1)(2012-2#1)
spermatocytes and##3##2##(2009-10#1)(2010-5#1)(2012-2#1)
spermatocytes##12##1##(2008-7#2)(2009-10#2)(2009-7#1)(2010-5#2)(2012-2#5)
spermatogenesis and male fertility##2##4##(2009-10#1)(2012-2#1)
spermatogenesis and##5##2##(2008-8#1)(2009-10#2)(2012-2#2)
spermatogenesis are##4##2##(2009-10#1)(2010-5#1)(2012-2#2)
spermatogenesis in the##2##3##(2010-5#1)(2013-7#1)
spermatogenesis in##4##2##(2009-7#1)(2010-5#1)(2012-2#1)(2013-7#1)
spermatogenesis##53##1##(1992-12#4)(1993-12#2)(1996-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#17)(2009-7#1)(2010-5#4)(2012-2#17)(2012-3#1)(2013-7#1)
spermatogenic cells##2##2##(2009-10#1)(2012-2#1)
spermatogenic##12##1##(2008-9#1)(2009-10#3)(2012-2#8)
spermatogonia and##3##2##(2008-9#1)(2009-10#1)(2013-7#1)
spermatogonia##15##1##(2008-7#1)(2008-9#1)(2009-10#4)(2009-7#1)(2010-5#2)(2012-2#5)(2013-7#1)
spermatogonial and spermatocyte##2##3##(2009-10#1)(2011-2#1)
spermatogonial stem cell##2##3##(2012-2#2)
spermatogonial stem##3##2##(2009-10#1)(2012-2#2)
spermatogonial##11##1##(2008-7#2)(2009-10#2)(2011-2#1)(2012-2#6)
spermatozoa from##2##2##(2008-12#1)(2013-1#1)
spermatozoa is##2##2##(2007-12#1)(2008-6#1)
spermatozoa of the rove beetle Aleochara bilineata##2##7##(2008-7#2)
spermatozoa of the##3##3##(2008-7#3)
spermatozoa of##7##2##(2008-7#6)(2008-8#1)
spermatozoa to##2##2##(2013-1#2)
spermatozoa were##3##2##(2008-12#1)(2008-8#2)
spermatozoa##43##1##(1996-9#1)(2007-12#3)(2008-10#1)(2008-12#3)(2008-6#1)(2008-7#12)(2008-8#10)(2009-10#2)(2010-5#1)(2012-2#3)(2013-1#6)
spermatozoon##4##1##(2008-7#2)(2008-8#2)
spermiation##5##1##(2012-2#5)
spermidine and spermine##2##3##(2008-10#2)
spermidine and##6##2##(2008-10#4)(2009-6#2)
spermidine importer##2##2##(2009-6#2)
spermidine##14##1##(2008-10#7)(2008-8#1)(2009-6#4)(2013-8#2)
spermidine/spermine N1-acetyltransferase##4##2##(1991-9#2)(1992-10#2)
spermine and##2##2##(1990-7#1)(1991-5#1)
spermine##23##1##(1990-3#6)(1990-7#4)(1991-5#3)(1993-8#1)(1994-11#1)(1996-2#3)(2008-10#5)
spermiogenesis and spermiation##3##3##(2012-2#3)
spermiogenesis and##4##2##(2012-2#4)
spermiogenesis in two##2##3##(2007-12#1)(2008-7#1)
spermiogenesis in##3##2##(2007-12#1)(2008-7#2)
spermiogenesis##15##1##(2007-12#3)(2008-7#4)(2008-9#1)(2012-2#7)
spermogonia##4##1##(2008-10#4)
sperms are##2##2##(2007-12#1)(2008-8#1)
sperms##5##1##(2007-12#2)(2008-8#2)(2012-2#1)
sphagnum peat mix##2##3##(2008-10#2)
sphagnum peat##4##2##(2008-10#4)
spheno-clival region##3##2##(2011-2#3)
sphenoid ridge##2##2##(2008-7#2)
sphenoid sinus and##2##3##(2011-2#1)(2012-3#1)
sphenoid sinus##9##2##(2008-7#3)(2011-2#3)(2012-3#3)
sphenoid##13##1##(2008-7#5)(2011-2#4)(2012-3#3)(2013-1#1)
sphenoparietal sinus##4##2##(1996-9#4)
sphere##12##1##(1990-3#1)(2008-2#1)(2008-3#6)(2008-6#1)(2012-3#1)(2013-1#2)
spheres containing##3##2##(2008-11#2)(2008-3#1)
spheres of##3##2##(2008-11#2)(2008-3#1)
spheres with a##2##3##(2008-3#2)
spheres with the##2##3##(2008-3#2)
spheres with##5##2##(2008-3#5)
spheres##35##1##(1990-2#2)(1994-12#1)(2008-11#7)(2008-2#4)(2008-3#21)
spherical aberration##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
spherical ceramic##2##2##(2010-11#2)
spherical drop##2##2##(2008-10#2)
spherical end##2##2##(2008-10#2)
spherical interference##3##2##(2008-3#3)
spherical macroporous epoxy-dicyandiamide chelating resin##2##5##(2008-10#2)
spherical micelles##3##2##(2008-10#3)
spherical multicellular aggregates (spheroids)##2##4##(2008-11#2)
spherical particle##2##2##(2008-2#1)(2011-2#1)
spherical particles##3##2##(2008-2#1)(2008-3#2)
spherical shape##2##2##(2008-10#1)(2009-5#1)
spherical surface##2##2##(2008-3#2)
spherical vesicles##3##2##(1990-2#1)(1997-2#1)(2008-10#1)
spherical virus##3##2##(2008-10#3)
spherical##70##1##(1990-2#1)(1992-12#2)(1996-1#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#16)(2008-11#4)(2008-2#3)(2008-3#21)(2008-7#4)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#2)(2011-2#4)(2012-2#2)(2013-1#2)
spherically##2##1##(2008-3#2)
spheroid culture##4##2##(2008-11#4)
spheroid cultures##2##2##(2008-11#2)
spheroid##13##1##(2008-11#11)(2008-3#2)
spheroidal##2##1##(2008-3#1)(2008-7#1)
spheroids formed##2##2##(2008-11#2)
spheroids of##2##2##(1995-12#1)(2008-11#1)
spheroids on a##2##3##(2008-11#2)
spheroids were##2##2##(2008-11#2)
spheroids with##4##2##(2008-3#4)
spheroids##30##1##(1995-12#2)(2008-11#21)(2008-3#4)(2011-2#3)
spheroplasts##2##1##(2008-4#2)
spherule recovered from##2##3##(2008-10#2)
sphincter mechanism##2##2##(1996-11#2)
sphincter##11##1##(1990-3#1)(1990-9#1)(1992-6#1)(1992-9#1)(1996-11#2)(2008-10#3)(2011-2#1)(2012-3#1)
sphincterotomy was##2##2##(2007-8#2)
sphincterotomy##12##1##(1990-2#1)(1990-3#4)(1991-3#1)(1993-2#1)(2007-8#4)(2013-1#1)
sphinganine##2##1##(2008-10#1)(2008-5#1)
sphingolipid metabolism##2##2##(2009-9#2)
sphingolipid##4##1##(1997-7#1)(2008-10#1)(2009-9#2)
sphingomyelin##8##1##(1994-5#3)(1995-12#2)(1995-8#1)(1996-2#1)(2008-10#1)
sphingomyelinase##4##1##(1995-12#2)(2008-6#1)(2009-9#1)
sphingosine levels##2##2##(1994-3#2)
sphingosine production##3##2##(1994-3#3)
sphingosine treatment##2##2##(1994-3#2)
sphingosine##12##1##(1993-8#1)(1994-3#9)(2009-9#2)
sphingosine)##2##1##(2008-5#2)
sphingosine-1-phosphate##2##1##(2009-9#2)
sphingosine-dependent##2##1##(1994-3#2)
sphygmomanometer##2##1##(2008-1#1)(2008-11#1)
spi gene in##2##3##(1997-7#2)
spi gene##3##2##(1997-7#3)
spica##4##1##(2008-9#3)(2013-7#1)
spices##3##1##(2008-10#2)(2011-2#1)
spicifera##3##1##(2008-11#3)
spicules##2##1##(1992-3#1)(2008-1#1)
spider mite##2##2##(2008-8#2)
spider silk##2##2##(2008-7#2)
spider##21##1##(1990-5#2)(2007-12#2)(2008-10#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-9#2)(2012-3#2)(2013-8#1)
spiders##10##1##(2007-12#3)(2008-9#2)(2009-9#1)(2012-3#4)
spiders)##2##1##(2008-9#2)
spike activity##2##2##(1996-2#1)(2008-11#1)
spike characteristics##2##2##(2008-10#2)
spike gene##5##2##(1997-3#5)
spike in##2##2##(2008-8#1)(2011-2#1)
spike of##3##2##(1994-6#1)(2008-7#2)
spike protein##2##2##(2008-5#2)
spike recovery##3##2##(2008-10#3)
spike train##6##2##(2008-11#2)(2009-8#3)(2013-8#1)
spike trains##10##2##(2008-11#5)(2009-8#3)(2013-8#2)
spike was##2##2##(2008-10#2)
spike##69##1##(1994-2#1)(1994-6#1)(1995-12#1)(1996-2#2)(1997-3#5)(2008-10#22)(2008-11#14)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#8)(2011-2#1)(2012-3#1)(2013-8#4)
spike) and##2##2##(2008-10#2)
spike)##3##1##(2008-10#3)
spike-burst##3##1##(2008-11#3)
spiked and unspiked##2##3##(2008-10#2)
spiked and##4##2##(2008-10#4)
spiked artificial##2##2##(2008-10#2)
spiked at##3##2##(2008-10#2)(2011-2#1)
spiked human urine and serum##2##5##(2008-10#2)
spiked human urine and##4##4##(2008-10#4)
spiked human urine##6##3##(2008-10#6)
spiked human##9##2##(2008-10#9)
spiked in a##2##3##(2008-10#2)
spiked in##3##2##(2008-10#3)
spiked into##4##2##(2008-10#3)(2011-2#1)
spiked matrices and##2##3##(2008-10#2)
spiked matrices##3##2##(2008-10#3)
spiked natural water##3##3##(2008-10#3)
spiked natural##5##2##(2008-10#5)
spiked on the surface of the##2##6##(2008-10#2)
spiked plasma samples##4##3##(2008-10#4)
spiked samples are##2##3##(2008-10#2)
spiked samples of##3##3##(2008-10#3)
spiked samples were over##2##4##(2008-10#2)
spiked samples were##8##3##(2008-10#8)
spiked samples##32##2##(2008-10#32)
spiked seawater samples##2##3##(2008-10#2)
spiked serum##2##2##(2008-10#2)
spiked tap water##2##3##(2008-10#2)
spiked tap##4##2##(2008-10#4)
spiked urine samples##3##3##(2008-10#3)
spiked urine##5##2##(2008-10#5)
spiked vegetable##2##2##(2008-10#2)
spiked water and##3##3##(2008-10#3)
spiked water samples##7##3##(2008-10#7)
spiked water##12##2##(2008-10#12)
spiked with 1##2##3##(2008-10#2)
spiked with 10##2##3##(2008-10#2)
spiked with Au##2##3##(2008-10#2)
spiked with Hg(II)##2##3##(2008-10#2)
spiked with a mixture of##2##5##(2008-10#2)
spiked with a##3##3##(2008-10#3)
spiked with different concentrations of##2##5##(2008-10#2)
spiked with different##5##3##(2008-10#5)
spiked with known amounts of##4##5##(2008-10#4)
spiked with known##7##3##(2008-10#7)
spiked with the##3##3##(2008-10#3)
spiked with##60##2##(2008-10#58)(2008-11#1)(2012-12#1)
spiked##229##1##(1997-2#1)(2008-10#223)(2008-11#1)(2009-8#1)(2011-2#2)(2012-12#1)
spiked)##2##1##(2008-10#2)
spikelet differentiation in rice##2##4##(2008-9#2)
spikelet differentiation##4##2##(2008-9#4)
spikelet##10##1##(2008-10#2)(2008-8#4)(2008-9#4)
spikelets##11##1##(2008-10#10)(2008-9#1)
spikes added to the##2##4##(2008-10#2)
spikes are##2##2##(2008-4#1)(2009-8#1)
spikes can##3##2##(2008-10#1)(2008-11#2)
spikes in##2##2##(1995-2#1)(2008-11#1)
spikes that##2##2##(2008-10#1)(2008-11#1)
spikes were##3##2##(2008-10#2)(2008-3#1)
spikes##36##1##(1991-5#1)(1994-6#1)(1995-2#1)(1996-2#1)(2008-10#18)(2008-11#5)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#5)(2012-4#1)
spiking activity in##2##3##(2009-8#1)(2013-8#1)
spiking activity##4##2##(2009-8#3)(2013-8#1)
spiking level##2##2##(2008-10#2)
spiking procedure##3##2##(2008-10#3)
spiking with##2##2##(2008-10#2)
spiking##35##1##(1991-5#1)(2008-10#24)(2008-11#4)(2009-8#3)(2011-2#1)(2013-8#2)
spill##5##1##(2008-10#2)(2008-11#2)(2009-7#1)
spilled##3##1##(2008-10#2)(2012-2#1)
spillovers##2##1##(1997-1#2)
spills##3##1##(2008-11#3)
spin coating method##2##3##(2008-10#2)
spin coating##4##2##(2008-10#4)
spin delocalization##2##2##(2010-7#2)
spin density##3##2##(1993-8#1)(1994-5#2)
spin echo##2##2##(2008-1#1)(2011-2#1)
spin filter perfusion##2##3##(2008-11#2)
spin filter##3##2##(2008-11#3)
spin labels##4##2##(1993-8#4)
spin probe##3##2##(2008-10#3)
spin resonance##11##2##(2008-10#9)(2008-8#1)(2008-9#1)
spin trapping##2##2##(2008-10#1)(2008-5#1)
spin##46##1##(1992-11#1)(1993-8#6)(1994-5#2)(2007-11#2)(2008-1#1)(2008-10#18)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-5#3)(2010-7#3)(2011-2#1)(2012-12#1)
spin-coated films##2##2##(2008-10#2)
spin-coated##4##1##(2008-10#4)
spin-labeled##3##1##(1994-5#3)
spin-lattice relaxation time##4##3##(1994-11#1)(2008-10#2)(2008-9#1)
spin-lattice relaxation##6##2##(1991-5#1)(1994-11#1)(2008-10#3)(2008-9#1)
spin-trapping##2##1##(2008-5#1)(2008-8#1)
spin-traps##2##1##(1993-6#2)
spina bifida and##2##3##(1990-9#1)(2012-2#1)
spina bifida##4##2##(1990-9#1)(1997-3#1)(2008-10#1)(2012-2#1)
spina##5##1##(1990-9#1)(1996-12#1)(1997-3#1)(2008-10#1)(2012-2#1)
spinach (Spinacia oleracea) tissue##2##4##(2008-10#2)
spinach and##3##2##(2008-10#3)
spinach leaves##4##2##(1990-5#1)(1994-11#2)(2008-10#1)
spinach tissue homogenate##2##3##(2008-10#2)
spinach##30##1##(1990-5#2)(1991-9#1)(1994-11#2)(1997-7#1)(2008-10#19)(2008-9#4)(2012-2#1)
spinaciae in##2##2##(2008-10#2)
spinaciae##4##1##(2008-10#4)
spinal AVMs##2##2##(2008-7#2)
spinal accessory nerve##2##3##(2008-7#1)(2008-9#1)
spinal and##2##2##(1992-12#1)(2007-8#1)
spinal anesthesia for##2##3##(2011-2#1)(2012-12#1)
spinal anesthesia in##3##3##(2012-3#3)
spinal anesthesia with isobaric bypivacain##2##5##(2012-3#2)
spinal anesthesia##12##2##(2011-2#3)(2012-12#1)(2012-3#8)
spinal arteriovenous malformation##3##3##(2008-7#2)(2013-1#1)
spinal arteriovenous malformations##3##3##(2008-7#3)
spinal arteriovenous##7##2##(1995-11#1)(2008-7#5)(2013-1#1)
spinal canal##6##2##(2007-11#1)(2008-12#1)(2008-7#2)(2009-3#1)(2011-2#1)
spinal column##2##2##(2008-11#1)(2008-7#1)
spinal cord and RT##2##4##(1990-11#2)
spinal cord and##13##3##(1990-11#2)(1992-1#1)(1992-12#1)(1995-12#2)(1996-12#1)(1996-2#2)(2008-7#2)(2013-7#1)(2013-8#1)
spinal cord arteriovenous malformations (SCAVMs)##2##5##(1995-11#1)(1997-6#1)
spinal cord compression in pregnancy##2##5##(2008-7#2)
spinal cord compression##13##3##(1991-9#2)(1992-12#4)(1993-9#1)(2008-7#5)(2012-3#1)
spinal cord in##2##3##(1990-5#1)(1996-5#1)
spinal cord injuries##5##3##(1991-6#3)(2008-11#1)(2012-2#1)
spinal cord injury##11##3##(1991-12#1)(1993-2#1)(2008-10#1)(2008-7#3)(2012-2#1)(2013-1#4)
spinal cord##128##2##(1990-11#3)(1990-5#3)(1991-12#1)(1991-5#5)(1991-6#7)(1991-9#2)(1992-1#2)(1992-12#5)(1992-6#1)(1993-2#2)(1993-6#1)(1993-9#2)(1994-2#1)(1995-11#1)(1995-12#3)(1996-12#4)(1996-2#7)(1996-5#3)(1996-9#1)(1997-2#5)(1997-3#4)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-4#2)(2008-7#22)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#4)(2010-5#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#1)
spinal deformities##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
spinal deformity##2##2##(2008-8#2)
spinal dorsal horn##2##3##(1992-6#1)(1994-2#1)
spinal dural arteriovenous##2##3##(2008-7#2)
spinal dysraphism##2##2##(2012-2#1)(2013-1#1)
spinal epidural haematoma##3##3##(2008-7#3)
spinal epidural hematoma##2##3##(2008-7#2)
spinal epidural##10##2##(1992-12#2)(2007-8#1)(2008-7#5)(2011-2#1)(2012-3#1)
spinal fixation##2##2##(2008-8#1)(2012-3#1)
spinal fluid##2##2##(1997-3#1)(2008-7#1)
spinal fusion with##3##3##(2008-8#3)
spinal fusion##11##2##(2008-8#4)(2012-3#7)
spinal instability##2##2##(2008-7#1)(2012-12#1)
spinal instrumentation##2##2##(2008-8#2)
spinal manipulative therapy##2##3##(2013-1#2)
spinal metastasis##2##2##(2008-7#2)
spinal needle##2##2##(2012-3#2)
spinal nerve##2##2##(2011-2#1)(2013-1#1)
spinal pain and related disorders##3##5##(2008-12#3)
spinal pain and related##5##4##(2008-12#5)
spinal pain##6##2##(2008-12#6)
spinal reconstruction##2##2##(2008-7#2)
spinal segments##2##2##(2008-7#1)(2008-9#1)
spinal subdural hematoma##2##3##(2012-12#2)
spinal surgery##4##2##(2008-8#1)(2012-12#1)(2012-3#2)
spinal##283##1##(1990-11#4)(1990-5#3)(1990-9#1)(1991-12#1)(1991-5#5)(1991-6#8)(1991-9#2)(1992-1#2)(1992-12#8)(1992-6#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#4)(1995-11#2)(1995-12#6)(1996-12#5)(1996-2#8)(1996-3#1)(1996-5#3)(1996-9#1)(1997-2#5)(1997-3#6)(1997-6#2)(1997-8#5)(2007-11#3)(2007-8#3)(2008-10#2)(2008-11#5)(2008-12#13)(2008-4#2)(2008-7#59)(2008-8#11)(2008-9#4)(2009-11#2)(2009-3#1)(2009-5#3)(2009-8#1)(2010-12#6)(2010-3#1)(2010-5#3)(2011-1#2)(2011-2#16)(2012-12#7)(2012-2#4)(2012-3#28)(2013-1#15)(2013-7#1)(2013-8#1)
spinally##2##1##(1992-12#1)(1992-3#1)
spindle cell carcinoma and apocrine carcinoma##2##6##(2008-10#2)
spindle cell carcinoma##5##3##(2008-10#5)
spindle cell lipoma##2##3##(1990-12#2)
spindle cell neoplasm##2##3##(2010-12#1)(2011-2#1)
spindle cell nodules##3##3##(2008-11#3)
spindle cell##17##2##(1990-12#3)(1991-8#1)(2008-10#6)(2008-11#3)(2010-12#1)(2011-2#3)
spindle cells##9##2##(1990-12#1)(2010-6#3)(2012-12#1)(2012-2#2)(2013-8#2)
spindle poles##2##2##(2009-10#1)(2011-2#1)
spindle shaped##2##2##(2008-10#1)(2008-11#1)
spindle streak mosaic virus (WSSMV)##2##5##(2008-10#1)(2008-8#1)
spindle##49##1##(1990-12#4)(1991-12#2)(1991-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-8#3)(2008-9#1)(2009-10#5)(2009-5#1)(2010-12#1)(2010-5#2)(2010-6#3)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
spindle-shaped cells##2##2##(1991-8#1)(1994-6#1)
spindle-shaped##3##1##(1991-8#1)(1994-6#1)(2011-2#1)
spindled##2##1##(2008-11#1)(2010-12#1)
spindles and##3##2##(1997-3#1)(2009-8#2)
spindles##7##1##(1991-9#1)(1997-3#1)(2009-10#1)(2009-8#3)(2011-2#1)
spine and##7##2##(1991-11#2)(1995-11#1)(1997-3#1)(2008-8#2)(2010-1#1)
spine curve##6##2##(2007-8#6)
spine for##2##2##(2008-7#1)(2012-3#1)
spine fusion##3##2##(2008-8#2)(2012-3#1)
spine in##5##2##(1991-11#1)(2008-12#1)(2009-10#1)(2011-2#2)
spine is a rare##2##4##(2011-2#2)
spine is##3##2##(2008-8#1)(2011-2#2)
spine morphologies##2##2##(2008-11#2)
spine of##2##2##(1991-6#1)(1995-8#1)
spine revealed a##2##3##(2009-3#1)(2012-2#1)
spine revealed##3##2##(2009-3#2)(2012-2#1)
spine surgery##14##2##(2008-7#3)(2008-8#1)(2012-12#3)(2012-2#3)(2012-3#4)
spine synostosis##2##2##(2013-1#2)
spine##118##1##(1991-11#4)(1991-6#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#1)(2007-8#9)(2008-11#7)(2008-12#11)(2008-7#6)(2008-8#9)(2009-10#1)(2009-3#3)(2009-9#1)(2010-1#3)(2010-12#4)(2010-3#5)(2010-6#1)(2011-2#9)(2012-12#12)(2012-2#5)(2012-3#10)(2013-1#7)(2013-8#1)
spinel-type manganese oxide##2##3##(2008-10#2)
spinel-type##4##1##(2008-10#4)
spines##13##1##(1995-8#2)(1997-2#1)(2007-12#2)(2008-11#7)(2012-3#1)
spinfilter##8##1##(2008-11#8)
spinner bottle##2##2##(2008-11#2)
spinner culture##3##2##(2008-11#3)
spinner flask to##2##3##(2008-11#2)
spinner flask##9##2##(2008-11#9)
spinner flasks##2##2##(2008-11#2)
spinner##20##1##(2008-11#19)(2008-3#1)
spinning nuclear magnetic resonance##2##4##(2008-10#2)
spinning rates##3##2##(2008-10#3)
spinning##9##1##(2008-10#8)(2008-7#1)
spinocerebellar##2##1##(1997-8#1)(2008-7#1)
spinous##3##1##(2008-5#1)(2011-2#1)(2013-1#1)
spiny##6##1##(2007-12#2)(2008-11#2)(2013-8#2)
spiraecola##2##1##(2008-10#2)
spiral CT##3##2##(1997-8#1)(2012-2#2)
spiral cell##3##2##(2008-10#3)
spiral ganglion##2##2##(2008-9#2)
spiral##17##1##(1997-8#1)(2008-10#7)(2008-7#1)(2008-9#2)(2009-1#1)(2010-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
spiralin##4##1##(2008-10#4)
spiralis (T1)##2##2##(1996-12#2)
spiralis##3##1##(1990-12#1)(1996-12#2)
spiramycin##3##1##(1990-9#1)(2008-10#2)
spirit of##4##2##(1992-12#1)(1996-1#1)(2009-10#1)(2012-2#1)
spirit##11##1##(1992-12#1)(1996-1#1)(2008-12#2)(2009-10#2)(2010-7#1)(2012-2#2)(2012-3#2)
spirits##4##1##(2008-10#3)(2009-7#1)
spiritual belief##2##2##(2010-2#2)
spiritual care in Hong Kong##4##5##(2010-11#4)
spiritual care in##6##3##(2009-11#1)(2010-11#5)
spiritual care##13##2##(2009-11#2)(2010-11#8)(2011-1#3)
spiritual education session##2##3##(2011-1#2)
spiritual experience##3##2##(2009-11#2)(2010-2#1)
spiritual needs##5##2##(2008-11#3)(2011-1#2)
spiritual##45##1##(1995-5#2)(1997-2#1)(2008-11#3)(2008-12#5)(2009-11#7)(2010-11#8)(2010-2#5)(2011-1#8)(2011-2#1)(2013-8#5)
spirituality and spiritual care in Hong Kong##2##7##(2010-11#2)
spirituality and##4##2##(2008-12#1)(2010-11#2)(2011-1#1)
spirituality in##3##2##(2008-12#2)(2013-1#1)
spirituality to##2##2##(1997-2#1)(2009-11#1)
spirituality##21##1##(1997-2#2)(2008-11#3)(2008-12#7)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#3)(2011-1#1)(2013-1#1)(2013-8#1)
spiritually##3##1##(2009-11#1)(2010-10#2)
spirituous beverages##4##2##(2008-10#4)
spirituous##5##1##(2008-10#5)
spiro##4##1##(1996-5#1)(2008-10#2)(2008-11#1)
spirobenzylisoquinoline##2##1##(2008-11#2)
spirochetal##2##1##(2008-9#1)(2011-2#1)
spirochete##2##1##(1990-2#1)(2011-2#1)
spirochetes##4##1##(1990-2#2)(2008-9#2)
spirodioxanyl oligosaccharides##2##2##(1992-12#2)
spirodioxanyl##3##1##(1992-12#3)
spirometer##3##1##(2009-11#1)(2012-2#1)(2012-3#1)
spirometric parameters##3##2##(2008-1#2)(2008-7#1)
spirometric##4##1##(1997-3#1)(2008-1#2)(2008-7#1)
spirometry and##2##2##(1990-9#1)(1996-1#1)
spirometry in##2##2##(2008-1#2)
spirometry parameters##2##2##(2007-8#2)
spirometry##11##1##(1990-9#1)(1996-1#2)(2007-8#2)(2008-1#3)(2008-7#2)(2012-3#1)
spironolactone##7##1##(2008-10#7)
spiroplas-mas##2##1##(2008-10#2)
spiroplasma membrane##2##2##(2008-10#2)
spiroplasma##11##1##(2008-10#11)
spiroplasmas to##2##2##(2008-10#2)
spiroplasmas with##2##2##(2008-10#2)
spiroplasmas##6##1##(2008-10#6)
spite of a##4##3##(1990-5#1)(2008-10#2)(2010-10#1)
spite of high##2##3##(1996-12#1)(2008-8#1)
spite of its##8##3##(1992-9#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-7#1)
spite of many##3##3##(2008-10#2)(2008-8#1)
spite of numerous##2##3##(1992-12#1)(1993-2#1)
spite of remarkable##2##3##(2008-1#1)(2008-12#1)
spite of the fact that##5##5##(1991-2#1)(2008-10#1)(2008-11#3)
spite of the##26##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1996-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
spite of##74##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#3)(1993-2#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-2#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)
spite##75##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#3)(1993-2#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-2#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)
splanchnic##4##1##(1996-3#2)(2008-6#1)(2012-2#1)
splash dispersal of three##2##4##(2008-10#2)
splash dispersal of##4##3##(2008-10#4)
splash dispersal##12##2##(2008-10#12)
splash##17##1##(2008-10#17)
splash-dispersed##2##1##(2008-10#2)
splashing##5##1##(2008-10#5)
spleen and bone##2##3##(1995-11#1)(2008-5#1)
spleen and liver##4##3##(1994-5#1)(2008-10#2)(2008-5#1)
spleen and testis##2##3##(2008-8#2)
spleen and##21##2##(1990-3#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(2008-10#7)(2008-5#2)(2008-8#2)(2009-9#1)(2012-3#1)
spleen in##3##2##(1990-5#1)(1992-2#1)(2010-8#1)
spleen mass##2##2##(2008-9#2)
spleen or##2##2##(1996-12#1)(2008-10#1)
spleen weight##2##2##(1991-6#1)(2008-10#1)
spleen were significantly##2##3##(1993-3#1)(1995-12#1)
spleen were##4##2##(1993-3#1)(1995-12#1)(2008-5#1)(2010-7#1)
spleen##93##1##(1990-12#1)(1990-3#1)(1990-5#4)(1990-9#2)(1991-6#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#6)(1996-12#4)(1996-2#1)(1997-8#1)(1997-9#1)(2007-8#1)(2008-10#14)(2008-11#7)(2008-5#10)(2008-8#4)(2008-9#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2012-2#3)(2012-3#1)
spleen)##2##1##(2008-9#1)(2009-8#1)
spleens of immunized##2##3##(1995-2#1)(2008-4#1)
spleens of##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
spleens##6##1##(1990-12#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-4#1)
splenectomized individuals##2##2##(1994-9#2)
splenectomized patients##4##2##(1990-9#2)(1994-9#2)
splenectomized##11##1##(1990-9#2)(1994-9#8)(2012-3#1)
splenectomy with##2##2##(2012-12#1)(2012-2#1)
splenectomy##10##1##(1994-9#3)(1997-8#1)(2010-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
splenic CD4 T cells##3##4##(2008-11#3)
splenic DCs##3##2##(2008-11#3)
splenic T-cells##2##2##(2008-10#2)
splenic T-lymphocytes##3##2##(2008-10#3)
splenic artery aneurysm##4##3##(2011-2#4)
splenic artery##5##2##(2011-2#5)
splenic cellularity##2##2##(2008-10#2)
splenic cyst##6##2##(1997-8#5)(2007-12#1)
splenic flexure##2##2##(2008-12#2)
splenic hematoma##3##2##(2011-2#3)
splenic metastasis##3##2##(1992-2#1)(2007-8#2)
splenic rupture in##3##3##(1992-2#2)(2011-2#1)
splenic rupture##6##2##(1992-2#4)(2011-2#2)
splenic##62##1##(1992-2#6)(1993-12#4)(1995-12#2)(1997-8#5)(2007-12#1)(2007-8#3)(2008-10#11)(2008-11#9)(2008-12#2)(2009-9#1)(2010-12#1)(2011-2#12)(2012-2#1)(2012-3#3)(2013-1#1)
splenocyte proliferation##4##2##(2008-10#4)
splenocyte##10##1##(1993-12#1)(1996-12#1)(2008-10#8)
splenocytes immunized with##2##3##(2008-11#2)
splenocytes of##2##2##(1990-2#1)(2008-8#1)
splenocytes was##3##2##(1995-12#1)(2008-10#2)
splenocytes with##3##2##(1991-1#1)(2008-11#2)
splenocytes##18##1##(1990-2#1)(1990-5#1)(1991-1#2)(1995-12#1)(1996-12#2)(2008-10#4)(2008-11#4)(2008-8#1)(2008-9#1)(2013-1#1)
splenomegaly and##2##2##(2008-10#2)
splenomegaly was##2##2##(2008-5#1)(2012-2#1)
splenomegaly##11##1##(1990-6#1)(1994-11#1)(2007-12#2)(2008-10#3)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
splice site##7##2##(1991-5#2)(1993-6#1)(1993-8#1)(1995-12#2)(2008-8#1)
splice sites##3##2##(1992-6#1)(1993-6#1)(2008-4#1)
splice variant##2##2##(1996-12#1)(1997-1#1)
splice variants in##2##3##(2012-2#2)
splice variants##7##2##(1996-12#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-2#3)
splice##26##1##(1991-5#3)(1992-6#2)(1993-11#1)(1993-6#2)(1993-8#1)(1994-11#1)(1995-12#2)(1996-12#3)(1997-1#1)(2008-4#2)(2008-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#3)
splice-site##5##1##(1993-6#5)
spliced out in##2##3##(1993-8#1)(1995-12#1)
spliced##13##1##(1990-8#2)(1992-6#1)(1993-12#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-8#1)(2011-3#1)
spliceosome##3##1##(2008-2#3)
spliceosomes##2##1##(2008-2#1)(2013-8#1)
splicing and##5##2##(1993-2#1)(1994-8#1)(1996-2#1)(2008-11#1)(2009-7#1)
splicing by##2##2##(1991-5#1)(1993-12#1)
splicing events##4##2##(1992-6#1)(1993-8#1)(2010-12#2)
splicing factor##3##2##(1993-8#1)(1995-6#2)
splicing in the##2##3##(1992-6#1)(2008-12#1)
splicing is##2##2##(1993-12#1)(1993-8#1)
splicing of purified precursor##2##4##(1993-12#2)
splicing of the##3##3##(1991-5#1)(1993-6#1)(1993-8#1)
splicing of##12##2##(1991-5#3)(1993-12#2)(1993-6#1)(1993-8#3)(1994-11#1)(1995-6#2)
splicing or##2##2##(1993-12#1)(2008-9#1)
splicing##65##1##(1991-5#4)(1992-6#3)(1993-12#8)(1993-2#1)(1993-6#2)(1993-8#9)(1994-11#1)(1994-8#1)(1995-12#2)(1995-6#11)(1995-8#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-12#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-7#1)(2010-12#6)(2011-3#1)(2013-8#1)
spline wavelet##4##2##(2008-10#4)
spline##7##1##(1995-9#2)(2008-10#5)
splines##5##1##(2008-11#1)(2008-6#4)
splint##5##1##(2008-10#2)(2010-6#3)
splints in##2##2##(2008-10#2)
splints##5##1##(2008-10#3)(2010-6#2)
split CFTR##2##2##(2011-3#2)
split by a##2##3##(2008-10#1)(2008-3#1)
split by##4##2##(2008-10#3)(2008-3#1)
split common fixed point problem##2##5##(2011-2#2)
split from##2##2##(2008-6#1)(2009-10#1)
split into two##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2013-8#1)
split into##9##2##(1995-9#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
split of the##2##3##(1995-3#1)(2010-5#1)
split of##4##2##(1995-3#1)(2007-12#1)(2009-10#1)(2010-5#1)
split rice spikelet##3##3##(2008-8#3)
split root##2##2##(2008-10#2)
split##52##1##(1993-6#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2009-10#2)(2009-4#1)(2010-5#1)(2011-10#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#2)(2013-8#3)
split-mouth##5##1##(2012-12#1)(2013-1#4)
split-root tests##2##2##(2008-10#2)
split-thickness##2##1##(2008-11#1)(2008-9#1)
splits##4##1##(1994-12#1)(2008-4#2)(2010-4#1)
splitting and##3##2##(2008-3#3)
splitting of the##2##3##(2008-10#1)(2008-5#1)
splitting of##5##2##(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#2)
splitting ratio##2##2##(2008-2#2)
splitting##19##1##(1994-5#4)(1997-8#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-5#3)(2012-3#1)(2013-8#1)
splénectomie##2##1##(2011-2#2)
splénique##4##1##(2011-2#4)
spoil##2##1##(2008-7#1)(2009-9#1)
spoilage and##3##2##(2011-2#3)
spoilage microorganisms##2##2##(2008-10#1)(2012-2#1)
spoilage##18##1##(2008-10#7)(2011-2#10)(2012-2#1)
spoiled##5##1##(1997-8#4)(2008-10#1)
spoke channels##3##2##(2007-12#1)(2008-7#2)
spoke##9##1##(1990-6#1)(1993-12#2)(2007-12#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-2#1)
spoken language##2##2##(2008-9#1)(2009-10#1)
spoken word recognition in Spanish##2##5##(2008-11#2)
spoken word recognition##3##3##(2008-11#3)
spoken##11##1##(1995-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-10#1)(2013-1#1)
spokesman##3##1##(1995-6#3)
spokespersons##2##1##(1997-3#2)
spondyloarthropathies##2##1##(2011-2#2)
spondylodiscitis##4##1##(1996-8#1)(2007-8#1)(2012-3#2)
spondylolisthesis##2##1##(1996-6#1)(2007-11#1)
sponge##4##1##(1994-3#1)(2008-10#1)(2009-11#1)(2012-12#1)
sponge-like mycelial mass was##2##4##(2008-10#2)
sponge-like mycelial mass##3##3##(2008-10#3)
sponges##7##1##(1994-3#4)(2010-7#2)(2012-3#1)
spongiform encephalopathy##7##2##(1992-5#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-5#1)(2011-2#2)
spongiform##11##1##(1992-5#1)(1996-3#1)(1997-8#1)(2008-11#3)(2008-5#2)(2010-12#1)(2011-2#2)
spongy##3##1##(2008-10#2)(2012-2#1)
sponsor##6##1##(1991-12#1)(1991-3#1)(1994-1#2)(1995-5#1)(2008-6#1)
sponsored by the##5##3##(1990-2#1)(1997-2#2)(1997-8#1)(2008-11#1)
sponsored by##8##2##(1990-2#1)(1992-3#1)(1997-2#2)(1997-8#1)(2008-11#1)(2008-5#1)(2012-12#1)
sponsored##10##1##(1990-2#1)(1992-3#1)(1997-2#2)(1997-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#2)
sponsoring##3##1##(1992-2#1)(2008-11#1)(2013-1#1)
sponsors##3##1##(1992-1#1)(2008-11#1)(2013-8#1)
sponsorship##3##1##(1995-12#1)(2012-2#2)
spontaneous abortion rate##3##3##(1994-3#1)(2008-10#2)
spontaneous abortion##5##2##(1991-2#1)(1994-3#2)(2008-10#2)
spontaneous abortions and##4##3##(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#1)
spontaneous abortions##5##2##(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#2)
spontaneous activity in the absence of##2##6##(1996-2#1)(2013-8#1)
spontaneous activity in the##3##4##(1996-2#1)(2008-11#1)(2013-8#1)
spontaneous activity in##5##3##(1996-2#1)(2008-11#2)(2013-8#2)
spontaneous activity##15##2##(1996-2#2)(2008-11#6)(2008-8#1)(2013-1#1)(2013-8#5)
spontaneous alternation##2##2##(1994-8#1)(2012-2#1)
spontaneous and cytokine-dependent##2##3##(2006-6#2)
spontaneous and induced##2##3##(2008-7#1)(2013-1#1)
spontaneous and intentional trait inferences##2##5##(2008-11#2)
spontaneous and intentional##3##3##(2008-11#3)
spontaneous and##8##2##(2006-6#2)(2008-11#3)(2008-7#2)(2013-1#1)
spontaneous asymptomatic urinoma##2##3##(2008-10#2)
spontaneous bacterial peritonitis and##2##4##(2011-2#2)
spontaneous bacterial peritonitis##3##3##(2009-8#1)(2011-2#2)
spontaneous bloody##2##2##(1990-11#2)
spontaneous calcium oscillations##2##3##(1994-11#2)
spontaneous cancer##2##2##(2008-7#1)(2011-2#1)
spontaneous emission##3##2##(1993-5#1)(2008-2#1)(2008-3#1)
spontaneous emulsion##2##2##(2008-5#2)
spontaneous evolution of##3##3##(1996-9#1)(1997-8#1)(2008-7#1)
spontaneous haemothorax##3##2##(2011-2#2)(2013-7#1)
spontaneous inferences##2##2##(2008-11#2)
spontaneous lung##2##2##(1990-8#1)(2008-11#1)
spontaneous motor activity##3##3##(1994-2#1)(2008-12#2)
spontaneous motor##4##2##(1994-2#1)(2008-12#2)(2008-4#1)
spontaneous or radiation-induced##2##3##(2008-7#2)
spontaneous or##4##2##(2008-11#1)(2008-7#2)(2012-12#1)
spontaneous oscillations##2##2##(1994-11#2)
spontaneous rearrangement##2##2##(2008-10#2)
spontaneous recovery##2##2##(1996-6#1)(1997-2#1)
spontaneous reports##2##2##(1996-11#1)(2008-11#1)
spontaneous resolution##3##2##(2008-10#1)(2008-12#2)
spontaneous seizures##2##2##(2008-4#1)(2009-8#1)
spontaneous splenic rupture in##2##4##(1992-2#1)(2011-2#1)
spontaneous splenic rupture##3##3##(1992-2#2)(2011-2#1)
spontaneous##182##1##(1990-11#3)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#4)(1994-2#1)(1994-3#4)(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#2)(2007-12#1)(2008-1#2)(2008-10#21)(2008-11#26)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#14)(2008-8#4)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#15)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#6)
spontaneously and##3##2##(1996-1#1)(1996-3#1)(2008-11#1)
spontaneously detach##2##2##(2011-2#2)
spontaneously develop##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
spontaneously developed##2##2##(1997-3#2)
spontaneously diabetic##2##2##(1994-12#2)
spontaneously hypertensive rats##7##3##(1991-5#1)(1991-6#1)(1994-2#2)(1995-11#2)(1997-2#1)
spontaneously hypertensive##10##2##(1991-5#1)(1991-6#1)(1994-2#2)(1994-8#1)(1995-11#2)(1997-2#2)(2013-8#1)
spontaneously immortalized##2##2##(1997-7#1)(2008-11#1)
spontaneously in the##2##3##(1997-5#1)(2013-8#1)
spontaneously in##4##2##(1995-2#1)(1997-5#1)(2008-10#1)(2013-8#1)
spontaneously or##4##2##(1997-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
spontaneously resolved##2##2##(2008-10#1)(2008-7#1)
spontaneously##75##1##(1990-2#1)(1990-5#3)(1991-5#1)(1991-6#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(2008-10#8)(2008-11#11)(2008-4#1)(2008-6#1)(2008-7#7)(2009-3#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
sporadic and##3##2##(2009-12#1)(2013-1#2)
sporadic cases##2##2##(2008-7#1)(2011-2#1)
sporadic##29##1##(1990-12#1)(1991-8#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-12#2)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
sporadically##5##1##(2008-1#1)(2008-10#2)(2008-8#1)(2012-3#1)
sporangia and mycelia##3##3##(2008-10#3)
sporangia and##11##2##(2008-10#11)
sporangia of##5##2##(2008-10#5)
sporangia on##2##2##(2008-10#2)
sporangia production##2##2##(2008-10#2)
sporangia released##2##2##(2008-10#2)
sporangia was##3##2##(2008-10#3)
sporangia##52##1##(2008-10#51)(2010-3#1)
sporangiiferum##2##1##(2008-10#2)
sporangiophores and sporangia##2##3##(2008-10#2)
sporangiophores##5##1##(2008-10#5)
spore adhesion##5##2##(2008-10#5)
spore attachment##3##2##(2008-10#3)
spore coat##3##2##(2008-10#3)
spore concentrations##3##2##(2008-5#2)(2010-5#1)
spore densities##2##2##(2008-10#2)
spore density##4##2##(2008-10#4)
spore deposition of G##2##4##(2008-10#2)
spore deposition##8##2##(2008-10#8)
spore dispersal gradient##4##3##(2008-10#4)
spore dispersal##10##2##(2008-10#10)
spore efficacy on##2##3##(2008-10#2)
spore efficacy##5##2##(2008-10#5)
spore formation##2##2##(2008-8#1)(2012-2#1)
spore germination and germ tube growth of##2##7##(2008-10#2)
spore germination and outgrowth##3##4##(2011-2#3)
spore germination and##8##3##(2008-10#5)(2011-2#3)
spore germination fluid##2##3##(2008-10#2)
spore germination frequency##2##3##(2008-10#2)
spore germination in##4##3##(2008-10#3)(2011-2#1)
spore germination##27##2##(1997-7#1)(2008-10#19)(2011-2#7)
spore maturation##2##2##(2008-10#1)(2012-2#1)
spore movement##2##2##(2008-10#2)
spore outgrowth##2##2##(2011-2#2)
spore precipitator in##2##3##(2008-10#2)
spore precipitator##4##2##(2008-10#4)
spore production per lesion##2##4##(2008-10#2)
spore production per##3##3##(2008-10#3)
spore production was##2##3##(2008-10#2)
spore production##13##2##(2008-10#12)(2012-3#1)
spore release of##3##3##(2008-10#3)
spore release##9##2##(2008-10#9)
spore samplers##3##2##(2008-10#3)
spore suspension and irrigation water samples##2##6##(2008-10#2)
spore suspension##8##2##(2008-10#8)
spore suspensions##2##2##(2008-10#2)
spore traps##4##2##(2008-10#3)(2010-5#1)
spore types##3##2##(2008-10#3)
spore##171##1##(1995-3#1)(1995-6#1)(1996-8#1)(1997-7#1)(2008-10#133)(2008-5#4)(2008-8#1)(2010-1#1)(2010-5#2)(2011-2#23)(2012-2#2)(2012-3#1)
spore-forming bacteria and##3##3##(2011-2#3)
spore-forming bacteria##8##2##(2011-2#8)
spore-forming##10##1##(2011-2#10)
spores and the##2##3##(2011-2#2)
spores and##8##2##(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#3)
spores are##3##2##(2008-10#1)(2008-5#2)
spores by##2##2##(2011-2#2)
spores can##2##2##(2008-10#1)(2011-2#1)
spores has been##2##3##(2011-2#2)
spores have##2##2##(2010-5#1)(2011-2#1)
spores in##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
spores is##4##2##(2008-10#3)(2010-1#1)
spores m(-3) day(-1)) was##2##4##(2010-5#2)
spores m(-3)##3##2##(2008-5#1)(2010-5#2)
spores of A##2##3##(2008-10#2)
spores of the##2##3##(2008-10#1)(2011-2#1)
spores of##16##2##(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#5)
spores on##2##2##(2008-10#2)
spores per##4##2##(2008-10#4)
spores produced at##2##3##(2011-2#2)
spores produced##3##2##(2008-10#1)(2011-2#2)
spores to##2##2##(2010-1#1)(2011-2#1)
spores was##2##2##(2008-10#2)
spores were##12##2##(2008-10#7)(2010-5#4)(2011-2#1)
spores with##3##2##(2008-10#1)(2010-10#2)
spores##139##1##(1994-9#1)(2008-10#76)(2008-5#8)(2008-8#5)(2008-9#2)(2009-8#1)(2010-1#3)(2010-10#4)(2010-3#1)(2010-5#8)(2011-2#30)
sporidia##5##1##(2008-10#5)
sporocysts of S##2##3##(1996-12#2)
sporocysts of##3##2##(1996-12#3)
sporocysts##4##1##(1996-12#4)
sporopollenin##5##1##(2011-2#5)
sport and##2##2##(2010-7#1)(2011-2#1)
sport orientation##3##2##(2009-7#3)
sport participation##4##2##(2009-7#1)(2010-1#1)(2010-7#2)
sport##23##1##(2008-6#1)(2009-1#2)(2009-11#3)(2009-3#1)(2009-7#4)(2009-9#1)(2010-1#1)(2010-11#2)(2010-7#4)(2011-2#2)(2013-1#2)
sport-related concussion##3##2##(2010-1#3)
sporting##2##1##(1991-3#1)(1993-3#1)
sports and##4##2##(1995-5#1)(2009-7#2)(2013-1#1)
sports injuries and illnesses##2##4##(1993-3#2)
sports injuries##5##2##(1993-3#2)(2010-1#2)(2013-1#1)
sports medicine##4##2##(1993-3#1)(1994-3#2)(2013-1#1)
sports participation##2##2##(2009-7#1)(2010-7#1)
sports##27##1##(1990-9#1)(1991-6#1)(1993-3#4)(1994-3#2)(1995-5#1)(1996-6#4)(2009-7#3)(2010-1#3)(2010-7#1)(2012-2#1)(2013-1#6)
sporulated##5##1##(2008-10#4)(2011-2#1)
sporulating lesions on##2##3##(2008-10#2)
sporulating lesions##4##2##(2008-10#4)
sporulating surface area##2##3##(2008-10#2)
sporulating surface##3##2##(2008-10#3)
sporulating##14##1##(2008-10#14)
sporulation and##6##2##(2008-10#4)(2011-2#2)
sporulation capacity on##2##3##(2008-10#2)
sporulation capacity##6##2##(2008-10#6)
sporulation curve##5##2##(2008-10#5)
sporulation from##2##2##(2008-10#2)
sporulation in##5##2##(1995-9#1)(2008-10#3)(2008-8#1)
sporulation occurred##2##2##(2008-10#2)
sporulation of B##2##3##(2008-10#2)
sporulation of the##5##3##(2008-10#5)
sporulation of##11##2##(2008-10#11)
sporulation on necrotic##2##3##(2008-10#2)
sporulation on##3##2##(2008-10#3)
sporulation rate##4##2##(2008-10#4)
sporulation was observed##2##3##(2008-10#2)
sporulation was##8##2##(2008-10#8)
sporulation##99##1##(1990-12#1)(1993-12#1)(1995-6#2)(1995-9#4)(2008-10#83)(2008-8#1)(2011-2#5)(2012-2#2)
spot analysis##2##2##(1997-6#1)(2013-1#1)
spot and Stagonospora blotch##2##4##(2008-10#2)
spot and##10##2##(2008-10#10)
spot blotch disease##2##3##(2008-10#2)
spot blotch resistance##3##3##(2008-10#3)
spot blotch##7##2##(2008-10#7)
spot caused by##2##3##(2008-10#2)
spot disease of##2##3##(2008-10#2)
spot disease on##2##3##(2008-10#2)
spot disease##12##2##(2008-10#11)(2010-3#1)
spot in##6##2##(2008-10#4)(2008-4#1)(2011-2#1)
spot incidence##3##2##(2008-10#3)
spot is##5##2##(2008-10#5)
spot lesions on##3##3##(2008-10#3)
spot lesions##6##2##(2008-10#6)
spot of wheat##4##3##(2008-10#4)
spot of##36##2##(2008-10#34)(2008-3#1)(2008-9#1)
spot on##11##2##(1995-2#1)(2008-10#9)(2008-9#1)
spot pathogen##5##2##(2008-10#5)
spot resistance##8##2##(2008-10#8)
spot size##5##2##(2008-10#4)(2010-1#1)
spot test analysis##2##3##(2008-10#2)
spot test##7##2##(2008-10#6)(2012-2#1)
spot virus and##2##3##(2008-10#2)
spot virus##24##2##(2008-10#24)
spot was##3##2##(2008-10#2)(2008-11#1)
spot were##2##2##(2008-10#2)
spot with##2##2##(2008-10#1)(2008-3#1)
spot##258##1##(1995-2#1)(1995-8#1)(1996-1#1)(1997-6#1)(2008-10#232)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-9#2)(2010-1#2)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
spot)##7##1##(1991-5#2)(2008-10#5)
spot-resistant##2##1##(2008-10#2)
spotlight on##2##2##(2008-11#1)(2010-5#1)
spotlight##6##1##(1995-2#1)(1995-3#1)(1997-2#1)(2008-11#1)(2009-7#1)(2010-5#1)
spots and##2##2##(2008-10#1)(2010-3#1)
spots for##3##2##(2008-10#2)(2009-10#1)
spots of##2##2##(2008-10#2)
spots on the##2##3##(2008-10#1)(2011-3#1)
spots on##8##2##(2007-12#1)(2008-10#3)(2008-9#1)(2009-6#1)(2010-3#1)(2011-3#1)
spots or##4##2##(1991-8#1)(2008-10#2)(2008-5#1)
spots was##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
spots were##6##2##(1996-8#1)(2008-10#3)(2010-12#1)(2010-8#1)
spots##71##1##(1990-5#1)(1991-2#2)(1991-8#1)(1992-12#1)(1993-11#1)(1996-8#1)(1997-6#2)(2007-12#3)(2008-10#35)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#3)(2010-12#4)(2010-3#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
spotted wilt tospovirus (TSWV)##3##4##(2008-10#3)
spotted wilt virus (TSWV)##16##4##(2008-10#16)
spotted wilt virus##30##3##(2008-10#30)
spotted wilt##34##2##(2008-10#34)
spotted##43##1##(1994-12#1)(1995-12#1)(2007-12#1)(2008-10#38)(2008-7#1)(2012-3#1)
spotting##9##1##(1994-12#4)(2008-10#4)(2010-4#1)
spotty##2##1##(1990-5#1)(2008-7#1)
spouse##8##1##(1994-2#1)(1995-2#1)(1996-11#1)(2009-5#2)(2010-4#1)(2011-2#1)(2012-12#1)
spouses##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
spouses'##2##1##(2011-2#2)
spp and##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
spp##481##1##(1996-12#4)(2007-12#1)(2008-10#383)(2008-11#1)(2008-12#1)(2008-5#11)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#4)(2009-6#1)(2009-8#4)(2010-6#1)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#15)(2012-12#16)(2012-2#10)(2012-3#2)(2012-5#4)(2013-1#10)(2013-8#1)
spray and##5##2##(2007-11#1)(2008-10#4)
spray by##2##2##(2008-10#1)(2008-3#1)
spray drying##2##2##(2008-10#2)
spray inoculation##3##2##(2008-10#3)
spray of##2##2##(1996-2#1)(2008-10#1)
spray or##2##2##(2008-10#2)
spray pyrolysis##2##2##(2008-11#2)
spray to##2##2##(1992-2#1)(2008-10#1)
spray##65##1##(1991-12#1)(1992-2#2)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#47)(2008-11#2)(2008-3#4)(2008-5#5)(2008-7#1)
spray-inoculated onto##3##2##(2008-10#3)
sprayed and##2##2##(2008-10#2)
sprayed with a##3##3##(2008-10#3)
sprayed with##9##2##(2008-10#7)(2008-8#1)(2011-2#1)
sprayed##18##1##(2008-10#16)(2008-8#1)(2011-2#1)
spraying the##2##2##(2008-10#1)(2008-9#1)
spraying##12##1##(1997-7#1)(2008-10#9)(2008-9#2)
sprays is##2##2##(2008-10#2)
sprays of the##2##3##(2008-10#2)
sprays of##3##2##(1996-2#1)(2008-10#2)
sprays with##4##2##(2008-10#4)
sprays##21##1##(1996-2#1)(2008-10#19)(2008-5#1)
spread all over the##2##4##(1996-6#1)(2008-10#1)
spread and##11##2##(1991-6#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
spread as##2##2##(2008-10#1)(2012-2#1)
spread by##4##2##(2008-10#4)
spread from the##2##3##(2008-10#1)(2011-2#1)
spread from##5##2##(2008-10#4)(2011-2#1)
spread in the##5##3##(1992-9#1)(2008-1#1)(2008-10#2)(2012-3#1)
spread in##21##2##(1991-12#1)(1992-9#1)(1996-10#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-3#1)(2013-8#1)
spread into##4##2##(2008-10#3)(2008-7#1)
spread is##2##2##(1992-9#1)(2012-2#1)
spread of HIV##7##3##(1996-11#3)(1997-6#3)(2008-1#1)
spread of P##2##3##(2008-10#2)
spread of SMV strain G-5##2##5##(2008-10#2)
spread of SMV strain##3##4##(2008-10#3)
spread of SMV##5##3##(2008-10#5)
spread of TSWV##3##3##(2008-10#3)
spread of a##3##3##(2008-10#1)(2008-9#2)
spread of blueberry shock ilarvirus##2##5##(2008-10#2)
spread of disease##9##3##(2008-10#8)(2008-8#1)
spread of infection##4##3##(2009-6#1)(2010-6#1)(2011-2#1)(2012-3#1)
spread of infectious diseases##2##4##(2010-3#1)(2013-8#1)
spread of soybean mosaic virus##2##5##(2008-10#2)
spread of the disease##3##4##(2008-10#3)
spread of the fungus##2##4##(2008-10#2)
spread of the infection##2##4##(2011-2#2)
spread of the pathogen##4##4##(2008-10#4)
spread of the##22##3##(1990-6#1)(1993-8#1)(1994-6#1)(2007-12#1)(2008-10#14)(2011-2#4)
spread of these##2##3##(1997-3#1)(2008-9#1)
spread of this##2##3##(2008-10#2)
spread of##140##2##(1990-11#3)(1990-3#1)(1990-6#2)(1993-8#1)(1993-9#1)(1994-6#1)(1996-11#3)(1996-3#1)(1997-3#1)(1997-6#6)(2007-12#2)(2008-1#1)(2008-10#77)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-6#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#10)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
spread on##2##2##(2008-10#1)(2008-9#1)
spread out##2##2##(2008-11#1)(2009-10#1)
spread over##6##2##(2008-10#4)(2008-11#1)(2008-3#1)
spread rapidly##4##2##(1990-3#1)(1996-11#1)(1997-6#1)(2008-11#1)
spread systemically##2##2##(2008-10#2)
spread the word##4##3##(1993-1#1)(1993-2#1)(1993-3#1)(2008-4#1)
spread the##5##2##(1993-1#1)(1993-2#1)(1993-3#1)(1997-6#1)(2008-4#1)
spread through##4##2##(1992-5#1)(2008-10#2)(2013-8#1)
spread throughout the##2##3##(2008-10#2)
spread throughout##3##2##(2008-10#3)
spread to other##3##3##(2008-12#2)(2008-9#1)
spread to the##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
spread to##16##2##(1994-12#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
spread was possible##2##3##(2008-10#2)
spread was##4##2##(1990-8#1)(2008-10#3)
spread when##2##2##(2008-10#1)(2008-8#1)
spread within the##3##3##(2008-10#3)
spread within##6##2##(2008-10#6)
spread##334##1##(1990-11#3)(1990-3#2)(1990-6#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-10#1)(1996-11#6)(1996-3#2)(1996-6#1)(1997-3#1)(1997-6#8)(1997-8#2)(2007-12#4)(2008-1#7)(2008-10#187)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#8)(2009-10#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-3#1)(2010-6#1)(2010-7#2)(2011-2#18)(2011-3#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#7)
spreaders##2##1##(2012-2#2)
spreading from the##2##3##(2012-3#2)
spreading of the##2##3##(1991-3#1)(2007-12#1)
spreading of##7##2##(1990-12#1)(1991-3#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-10#1)
spreading panicle was##2##3##(2009-10#2)
spreading panicle##6##2##(2009-10#6)
spreading##46##1##(1990-12#2)(1990-2#1)(1991-3#1)(1991-5#2)(1993-3#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#3)(2008-9#3)(2009-10#7)(2009-12#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#4)(2012-5#1)
spreads epidemically##2##2##(2008-10#2)
spreads to##2##2##(1991-6#1)(2008-9#1)
spreads##7##1##(1991-6#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-12#1)
spreadsheet##4##1##(1993-1#1)(2008-11#2)(2013-1#1)
spring 1999##2##2##(2008-10#2)
spring and autumn##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
spring and fall##4##3##(2008-10#4)
spring and summer season##2##4##(2012-3#2)
spring and summer##4##3##(2008-9#1)(2011-2#1)(2012-3#2)
spring and the##2##3##(2008-10#2)
spring and winter barley##2##4##(2008-10#2)
spring and winter##3##3##(2008-10#2)(2008-12#1)
spring and##18##2##(2008-10#11)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
spring barley cv##2##3##(2008-10#2)
spring barley##9##2##(2008-10#4)(2008-12#5)
spring cotton and fall corn every year##2##7##(2008-10#2)
spring cotton and fall corn##3##5##(2008-10#3)
spring crop##2##2##(2008-10#2)
spring in##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
spring infections##4##2##(2008-10#4)
spring of##12##2##(1996-2#1)(2008-10#6)(2008-11#2)(2010-8#1)(2011-9#1)(2012-3#1)
spring season##4##2##(2008-10#3)(2012-3#1)
spring water##8##2##(1991-11#1)(2008-10#7)
spring wheat##6##2##(2008-10#6)
spring##120##1##(1990-8#1)(1991-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(2008-10#76)(2008-11#3)(2008-12#12)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#4)(2011-2#3)(2011-9#1)(2012-12#2)(2012-3#7)(2013-1#2)
springiness##2##1##(2011-2#2)
springs associated with the##2##4##(1990-8#2)
sprinkler irrigation##2##2##(2008-10#2)
sprinters##3##1##(2011-2#3)
sprout##3##1##(1997-3#3)
sprouting of##2##2##(1997-3#1)(2008-5#1)
sprouting was##2##2##(1997-3#2)
sprouting##13##1##(1996-12#1)(1997-3#4)(2008-10#1)(2008-5#1)(2008-9#5)(2011-2#1)
spruce (Picea##3##2##(2008-10#2)(2012-2#1)
spruce seedlings##4##2##(2008-10#4)
spruce wood##5##2##(2008-10#1)(2012-2#1)(2013-1#3)
spruce##20##1##(2008-10#15)(2012-2#2)(2013-1#3)
spun##2##1##(1990-12#1)(2008-8#1)
spur##4##1##(1990-11#1)(1997-2#1)(2012-2#1)(2013-1#1)
spurious##5##1##(2008-10#1)(2008-3#2)(2009-8#2)
spurred##5##1##(1990-8#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-7#1)
sputtered##6##1##(2008-10#1)(2008-12#2)(2008-5#1)(2009-5#1)(2010-4#1)
sputtering##4##1##(2008-10#1)(2009-5#2)(2012-2#1)
sputum and##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
sputum from##2##2##(1997-1#2)
sputum in##2##2##(2008-1#1)(2008-5#1)
sputum##21##1##(1991-11#1)(1992-5#1)(1997-1#8)(2008-1#2)(2008-11#1)(2008-5#3)(2011-2#3)(2013-8#2)
squads##3##1##(1996-3#3)
squalane##3##1##(2008-10#3)
squalene##6##1##(1995-5#1)(2008-10#2)(2008-5#3)
squamometry index##2##2##(2008-5#2)
squamometry tests##2##2##(2008-5#2)
squamometry##11##1##(2008-5#11)
squamosa##2##1##(2008-10#1)(2008-8#1)
squamosissimus##3##1##(2008-7#3)
squamous cell carcinoma (OSCC)##3##4##(2010-12#1)(2013-1#2)
squamous cell carcinoma and##4##4##(1991-8#2)(1993-8#1)(2010-12#1)
squamous cell carcinoma arising##2##4##(2010-7#1)(2013-8#1)
squamous cell carcinoma of the head and neck##2##8##(1990-6#1)(2007-11#1)
squamous cell carcinoma of the##7##5##(1990-6#1)(1991-6#1)(1992-3#1)(1993-8#1)(1993-9#1)(2007-11#1)(2009-5#1)
squamous cell carcinoma##35##3##(1990-6#1)(1991-6#2)(1991-8#2)(1992-3#1)(1993-8#2)(1993-9#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#6)(2013-8#4)
squamous cell carcinomas of the##3##5##(1991-8#1)(2012-3#2)
squamous cell carcinomas##9##3##(1991-11#1)(1991-8#1)(1992-3#1)(1993-9#1)(1997-3#2)(2012-3#3)
squamous cell lung cancer##3##4##(2012-2#3)
squamous cell lung##4##3##(2012-2#4)
squamous cell papillomas at##2##4##(2008-9#2)
squamous cell##55##2##(1990-6#1)(1991-11#1)(1991-6#2)(1991-8#3)(1992-3#2)(1993-8#2)(1993-9#2)(1997-3#3)(1997-7#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#4)
squamous cells##2##2##(1997-5#1)(2008-11#1)
squamous epithelium##2##2##(1990-6#1)(2013-1#1)
squamous intraepithelial lesions##2##3##(1994-1#1)(1994-12#1)
squamous intraepithelial##3##2##(1994-1#1)(1994-12#1)(2008-11#1)
squamous lesions##2##2##(1994-1#2)
squamous##71##1##(1990-6#3)(1991-11#1)(1991-2#2)(1991-6#2)(1991-8#3)(1992-3#2)(1993-8#2)(1993-9#2)(1994-1#3)(1994-12#1)(1997-3#3)(1997-5#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#2)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#4)
squamous-cell carcinoma##2##2##(1990-8#1)(1991-12#1)
squamous-cell##3##1##(1990-8#1)(1991-12#1)(1992-12#1)
squaraine##2##1##(2008-10#2)
square analysis##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
square and##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
square centimeter##6##2##(1991-5#1)(2008-10#5)
square error of prediction##7##4##(2008-10#7)
square error of##9##3##(2008-10#9)
square error##11##2##(2008-10#10)(2011-2#1)
square fit##2##2##(2008-10#1)(2012-2#1)
square of the##3##3##(2008-10#2)(2008-3#1)
square of##5##2##(2008-10#3)(2008-3#1)(2012-3#1)
square root of the##5##4##(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#1)
square root of##9##3##(1994-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
square wave adsorptive stripping voltammetry##7##5##(2008-10#7)
square wave adsorptive stripping##8##4##(2008-10#8)
square wave and##2##3##(2008-10#2)
square wave anodic stripping voltammetry##4##5##(2008-10#4)
square wave cathodic stripping voltammetry (SWCSV)##2##6##(2008-10#2)
square wave cathodic stripping voltammetry##4##5##(2008-10#4)
square wave pattern##2##3##(2011-2#2)
square wave voltammetric##11##3##(2008-10#11)
square wave voltammetry (SWV) with##2##5##(2008-10#2)
square wave voltammetry (SWV)##6##4##(2008-10#6)
square wave voltammetry was##2##4##(2008-10#1)(2008-8#1)
square wave voltammetry with##2##4##(2008-10#2)
square wave voltammetry##26##3##(2008-10#24)(2008-8#2)
square wave##65##2##(2008-10#61)(2008-8#2)(2011-2#2)
square##148##1##(1990-3#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#105)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#5)(2008-9#2)(2010-9#1)(2011-2#5)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)
square-wave (SW)##4##2##(2008-10#4)
square-wave adsorptive cathodic stripping voltammetric procedure was##2##7##(2008-10#2)
square-wave adsorptive cathodic stripping##3##4##(2008-10#3)
square-wave adsorptive stripping##2##3##(2008-10#2)
square-wave adsorptive##5##2##(2008-10#5)
square-wave and adsorptive stripping square-wave##2##5##(2008-10#2)
square-wave and##4##2##(2008-10#4)
square-wave anodic stripping voltammetry##8##4##(2008-10#8)
square-wave anodic##9##2##(2008-10#9)
square-wave stripping voltammetry (SWSV)##2##4##(2008-10#2)
square-wave stripping voltammetry##4##3##(2008-10#4)
square-wave techniques##2##2##(2008-10#2)
square-wave voltammetric (SWV) method##2##4##(2008-10#2)
square-wave voltammetric scan##3##3##(2008-10#3)
square-wave voltammetric##6##2##(2008-10#6)
square-wave voltammetry##8##2##(2008-10#8)
square-wave was 2##2##3##(2008-10#2)
square-wave##49##1##(2008-10#48)(2008-3#1)
squared##4##1##(2008-10#2)(2008-7#1)(2011-3#1)
squares of##3##2##(1995-12#1)(2008-8#1)(2013-1#1)
squares regression analysis##4##3##(1993-12#1)(2008-10#2)(2008-11#1)
squares regression##24##2##(1993-12#1)(2008-10#21)(2008-11#2)
squares##130##1##(1993-12#1)(1995-12#1)(1995-2#1)(2008-10#115)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2013-1#1)
squarylium dye##2##2##(2008-10#2)
squash and melon plants##2##4##(2008-10#2)
squash and##4##2##(2008-10#4)
squash leaf curl virus##2##4##(2008-10#2)
squash leaf curl##3##3##(2008-10#3)
squash plants##2##2##(2008-10#2)
squash##21##1##(2008-10#21)
squid##5##1##(2008-12#3)(2008-7#1)(2013-8#1)
squirrel monkeys##2##2##(1991-1#1)(2012-3#1)
squirrel##15##1##(1990-5#3)(1991-1#1)(2008-7#1)(2008-8#9)(2012-3#1)
src##2##1##(1990-12#1)(1990-8#1)
srebf1a##5##1##(2012-2#5)
srs-1 gene##3##2##(2008-8#3)
srs-1##6##1##(2008-8#6)
ss##2##1##(2007-11#1)(2011-2#1)
ss-DNA probe##2##2##(2008-10#2)
ss-DNA##3##1##(2008-10#3)
ssDNA and dsDNA##2##3##(2008-10#2)
ssDNA and##3##2##(1995-2#1)(2008-10#2)
ssDNA##26##1##(1991-5#9)(1995-2#1)(2008-10#11)(2008-4#2)(2012-3#3)
ssRNA##3##1##(1991-5#1)(2008-10#2)
ssh7a and ssh7b##2##3##(2008-9#2)
ssp##12##1##(2008-11#2)(2008-9#7)(2009-10#3)
stab wounds##2##2##(1990-2#2)
stabilisation of the##3##3##(1991-5#1)(1997-5#1)(2007-8#1)
stabilisation of##5##2##(1991-5#1)(1997-5#1)(2007-8#1)(2008-10#1)(2009-1#1)
stabilisation##12##1##(1991-5#1)(1997-5#1)(2007-8#1)(2008-10#6)(2008-7#1)(2009-1#1)(2010-12#1)
stabilised##2##1##(2008-10#1)(2011-2#1)
stabiliser##3##1##(2008-10#3)
stabilising##2##1##(1992-9#1)(2008-10#1)
stabilities of##2##2##(2008-10#2)
stabilities##10##1##(2008-10#6)(2008-11#1)(2012-3#3)
stability against##2##2##(2008-10#1)(2008-5#1)
stability analysis of##2##3##(2008-3#1)(2008-9#1)
stability analysis##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-8#1)
stability and a##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
stability and ability to##2##4##(2008-10#1)(2011-2#1)
stability and its##2##3##(2008-10#1)(2008-5#1)
stability and long-life##2##3##(2008-10#2)
stability and reproducibility##12##3##(2008-10#11)(2008-12#1)
stability and selectivity##2##3##(2008-10#2)
stability and the##4##3##(1991-1#1)(2008-10#3)
stability and to##2##3##(2008-10#1)(2008-5#1)
stability and##82##2##(1990-10#1)(1991-1#1)(1992-11#1)(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#41)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-7#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
stability are##2##2##(1991-6#1)(2008-8#1)
stability as##2##2##(2008-10#2)
stability at##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
stability because of the##2##4##(2008-10#2)
stability between##2##2##(2008-10#1)(2008-8#1)
stability but##4##2##(1994-8#1)(2008-4#1)(2008-5#1)(2012-2#1)
stability by##3##2##(2008-10#2)(2010-4#1)
stability constant for##3##3##(2008-10#3)
stability constant of##7##3##(2008-10#7)
stability constant values##2##3##(2008-10#2)
stability constant##19##2##(2008-10#19)
stability constants for metal-ligand complexes##2##5##(2008-10#2)
stability constants for the##3##4##(2008-10#2)(2008-5#1)
stability constants for##10##3##(2008-10#9)(2008-5#1)
stability constants of Fe(II)##2##4##(2008-10#2)
stability constants of complexes##3##4##(2008-10#3)
stability constants of praseodymium carbonate complexes##2##6##(2008-10#2)
stability constants of the complexes##2##5##(2008-10#2)
stability constants of the##15##4##(2008-10#15)
stability constants of##34##3##(1992-9#1)(2008-10#33)
stability constants were##2##3##(2008-10#2)
stability constants##78##2##(1992-9#1)(2008-10#74)(2008-5#3)
stability for at least 3 months##2##6##(2008-10#2)
stability for at least##3##4##(2008-10#3)
stability for up to##2##4##(2008-10#2)
stability for##13##2##(2008-10#11)(2008-11#1)(2008-2#1)
stability has been##3##3##(1996-3#1)(2008-10#2)
stability in aqueous##2##3##(2008-10#1)(2008-5#1)
stability in the##5##3##(1992-12#1)(2008-10#1)(2008-3#1)(2008-5#2)
stability in##22##2##(1992-12#1)(1992-2#1)(1993-12#1)(1994-8#1)(1996-6#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#4)(2008-8#1)(2009-3#1)(2009-7#1)(2010-8#1)(2010-9#1)
stability indicating##5##2##(2008-10#5)
stability is##6##2##(2008-10#6)
stability level##2##2##(2008-3#2)
stability of a##5##3##(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)
stability of adriamycin##2##3##(2008-10#2)
stability of complexes formed##2##4##(2008-10#2)
stability of recombinant##2##3##(1994-11#1)(2011-2#1)
stability of such##3##3##(1992-2#1)(2008-5#2)
stability of the PB##3##4##(2008-10#3)
stability of the complex##3##4##(2008-10#3)
stability of the electrode##3##4##(2008-10#3)
stability of the film##2##4##(2008-10#2)
stability of the product##2##4##(1995-5#1)(2008-10#1)
stability of the protein##2##4##(1994-5#1)(2008-5#1)
stability of the system is##2##5##(2008-11#1)(2008-8#1)
stability of the system##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
stability of the##86##3##(1993-6#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#51)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)
stability of these##9##3##(1991-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
stability of this##4##3##(2008-10#3)(2008-8#1)
stability of##214##2##(1990-9#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-2#3)(1995-5#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#101)(2008-11#14)(2008-12#3)(2008-3#6)(2008-4#2)(2008-5#11)(2008-7#1)(2008-8#9)(2008-9#8)(2009-12#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
stability on##3##2##(2008-11#1)(2008-12#2)
stability over##4##2##(2008-10#4)
stability studies##5##2##(2008-10#5)
stability study##2##2##(2008-5#2)
stability tests##4##2##(2008-10#2)(2008-6#1)(2012-12#1)
stability to##6##2##(1994-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-8#1)
stability under##4##2##(1992-12#1)(2008-5#3)
stability upon##2##2##(2008-10#1)(2008-11#1)
stability was found##2##3##(2008-10#1)(2008-5#1)
stability was observed##2##3##(2008-10#1)(2008-5#1)
stability was##10##2##(2008-10#6)(2008-5#4)
stability were##6##2##(2008-10#6)
stability when##3##2##(2008-10#2)(2008-4#1)
stability which measures##2##3##(1991-6#1)(2013-8#1)
stability will##2##2##(2008-9#1)(2013-8#1)
stability with##2##2##(2008-5#1)(2008-6#1)
stability##709##1##(1990-10#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-6#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#4)(1995-1#1)(1995-11#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#4)(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-10#383)(2008-11#30)(2008-12#9)(2008-2#4)(2008-3#13)(2008-4#7)(2008-5#49)(2008-6#5)(2008-7#7)(2008-8#19)(2008-9#26)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#4)(2010-4#5)(2010-5#2)(2010-7#4)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#18)(2012-12#2)(2012-2#9)(2012-3#7)(2012-9#1)(2013-1#13)(2013-8#7)
stability-diversity relationships##2##2##(2008-9#2)
stability-diversity##3##1##(2008-9#3)
stability-indicating##2##1##(2008-10#2)
stabilization and##6##2##(2008-10#2)(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#1)
stabilization effect##4##2##(1994-11#3)(2008-10#1)
stabilization mechanism##2##2##(2008-10#1)(2008-3#1)
stabilization of infrequently used##2##4##(1994-8#2)
stabilization of neural circuitry##2##4##(1994-8#2)
stabilization of tellurium in##3##4##(2008-10#3)
stabilization of the##9##3##(1991-6#1)(1993-3#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
stabilization of this##2##3##(1991-5#1)(1994-11#1)
stabilization of##35##2##(1991-5#2)(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-11#1)(1996-3#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-8#1)(2009-9#1)(2012-3#1)
stabilization with##2##2##(2012-2#1)(2013-1#1)
stabilization##74##1##(1991-5#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-11#4)(1994-5#2)(1994-8#4)(1994-9#1)(1995-11#1)(1996-3#1)(2007-11#2)(2008-10#19)(2008-12#6)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-7#1)(2012-2#2)(2012-3#4)(2013-1#3)
stabilize the##13##2##(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#3)(2012-3#1)(2013-8#1)
stabilize this##2##2##(2011-2#1)(2011-3#1)
stabilize##35##1##(1991-6#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-2#1)(1997-6#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-5#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-8#1)
stabilized at##2##2##(2008-10#1)(2013-1#1)
stabilized by a##2##3##(2008-11#1)(2011-2#1)
stabilized by the##6##3##(1991-3#1)(1994-11#1)(1997-4#1)(2008-3#1)(2008-4#1)(2013-8#1)
stabilized by##21##2##(1990-5#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-6#2)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2013-8#1)
stabilized in the##2##3##(2008-2#1)(2008-4#1)
stabilized in##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
stabilized phosphate##2##2##(2008-10#2)
stabilized the##2##2##(1990-5#1)(1992-6#1)
stabilized to##2##2##(2008-2#1)(2011-1#1)
stabilized with a cervical plate##2##5##(2009-10#2)
stabilized with##5##2##(2008-10#1)(2009-10#2)(2011-2#1)(2013-1#1)
stabilized##68##1##(1990-5#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#5)(2012-4#1)(2013-1#3)(2013-8#1)
stabilizer of the##2##3##(1994-8#1)(2008-9#1)
stabilizer of##3##2##(1994-8#1)(2008-7#1)(2008-9#1)
stabilizer##7##1##(1994-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
stabilizers in##2##2##(2008-10#2)
stabilizers##10##1##(2007-8#2)(2008-10#5)(2008-7#2)(2011-2#1)
stabilizes and##2##2##(1997-2#1)(2011-2#1)
stabilizes the##2##2##(2008-10#2)
stabilizes##11##1##(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#2)(2013-8#1)
stabilizing effect of##2##3##(1990-5#1)(1993-8#1)
stabilizing effect##3##2##(1990-5#1)(1993-8#1)(2008-10#1)
stabilizing or destabilizing influences##2##4##(2008-8#1)(2008-9#1)
stabilizing selection##10##2##(2008-10#1)(2008-8#9)
stabilizing the##6##2##(1993-6#1)(1993-8#1)(2008-10#1)(2008-9#1)(2010-4#1)(2013-8#1)
stabilizing##41##1##(1990-5#1)(1991-7#2)(1992-6#1)(1993-6#1)(1993-8#2)(1995-8#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#11)(2008-9#5)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
stable (II##2##2##(2012-3#2)
stable 1##2##2##(2008-10#1)(2008-5#1)
stable 100% control##3##3##(2012-2#3)
stable BC1F4 line (denominated##2##4##(2008-10#2)
stable Chinese hamster ovary##2##4##(2008-11#2)
stable after##2##2##(2008-11#1)(2008-8#1)
stable amperometric##2##2##(2008-10#2)
stable and highly productive##3##4##(2008-11#3)
stable and homogeneous##3##3##(2008-10#2)(2008-4#1)
stable and reproducible##3##3##(2008-10#3)
stable and showed##2##3##(2008-10#2)
stable and unstable##2##3##(2008-3#1)(2012-3#1)
stable and##41##2##(1990-9#1)(1994-11#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
stable angina##3##2##(2008-10#2)(2013-8#1)
stable at##10##2##(1993-3#1)(2008-10#4)(2008-11#3)(2008-7#1)(2011-1#1)
stable biosensor for##2##3##(2008-10#2)
stable but##2##2##(1997-6#1)(2008-4#1)
stable carbon##3##2##(2008-10#2)(2012-9#1)
stable cell lines##4##3##(2008-11#3)(2008-7#1)
stable cell##6##2##(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)
stable chelating resin was##2##4##(2008-10#2)
stable chelating resin##3##3##(2008-10#3)
stable coating##2##2##(2008-10#1)(2008-3#1)
stable complex with##3##3##(2008-10#2)(2008-8#1)
stable complex##6##2##(1990-12#1)(2008-10#4)(2008-8#1)
stable complexes with##6##3##(2008-10#5)(2010-11#1)
stable cyclic##2##2##(1994-2#1)(2008-10#1)
stable dioxin-responsive cell line##2##4##(2008-11#2)
stable disease##11##2##(1990-2#3)(1991-6#1)(1991-8#1)(1992-12#3)(1994-8#1)(2008-10#1)(2011-2#1)
stable during##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
stable enough to be##2##4##(2008-10#1)(2013-8#1)
stable enzyme##2##2##(1994-11#1)(2008-10#1)
stable equilibria##4##2##(1995-3#1)(2008-8#3)
stable equilibrium##5##2##(2008-8#4)(2008-9#1)
stable expression of##3##3##(2008-11#3)
stable expression##4##2##(1992-9#1)(2008-11#3)
stable flow##3##2##(2008-10#3)
stable for 24 h##3##4##(2008-10#3)
stable for 3##3##3##(2008-10#2)(2010-4#1)
stable for at least 2##2##5##(2008-10#2)
stable for at least 24h##2##5##(2008-10#2)
stable for at least##9##4##(1993-8#1)(2008-10#7)(2008-8#1)
stable for more than 2##2##5##(2008-10#1)(2008-11#1)
stable for more than##6##4##(2008-10#5)(2008-11#1)
stable for one##2##3##(1993-2#1)(1997-6#1)
stable for##39##2##(1993-2#2)(1993-8#1)(1997-6#1)(1997-8#1)(2008-10#26)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#1)
stable in the presence of##2##5##(2008-10#2)
stable in the##7##3##(1992-6#1)(2008-10#4)(2008-11#1)(2013-8#1)
stable in##20##2##(1991-2#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-2#1)(2008-10#7)(2008-11#3)(2008-5#3)(2011-2#1)(2013-8#1)
stable integration of##2##3##(1995-5#1)(2008-11#1)
stable intramedullary##3##2##(2009-3#1)(2011-2#2)
stable isotope##5##2##(1990-5#1)(1991-5#1)(2008-6#2)(2010-8#1)
stable metabolite of##2##3##(1991-5#1)(2008-10#1)
stable on##2##2##(2008-10#2)
stable only if##2##3##(2008-8#2)
stable or##3##2##(1994-8#1)(1995-12#1)(2012-4#1)
stable over a wide pH range##2##6##(2008-10#2)
stable over a wide##3##4##(2008-10#2)(2008-8#1)
stable over a##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)
stable over the##2##3##(2008-10#1)(2013-1#1)
stable over##13##2##(1997-2#1)(2008-10#7)(2008-11#2)(2008-8#1)(2009-11#1)(2013-1#1)
stable patients##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
stable population##2##2##(2008-11#1)(2008-9#1)
stable resonator##2##2##(2008-2#1)(2008-3#1)
stable response##4##2##(2008-10#4)
stable secondary##2##2##(2008-10#1)(2011-2#1)
stable species with##2##3##(2008-10#2)
stable than##9##2##(1994-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
stable through##2##2##(2008-10#1)(2008-11#1)
stable throughout the##2##3##(2008-8#1)(2009-8#1)
stable to##7##2##(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2011-1#1)
stable transfectants##2##2##(2008-11#2)
stable transfection of##2##3##(1992-7#1)(1997-1#1)
stable transfection##3##2##(1992-7#1)(1997-1#1)(2008-11#1)
stable transformants##3##2##(1993-12#1)(1997-8#1)(2008-10#1)
stable transgenic##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
stable under##3##2##(1995-6#1)(2008-10#1)(2009-9#1)
stable up to##2##3##(2008-10#1)(2010-8#1)
stable when##2##2##(1997-1#1)(2008-9#1)
stable with##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
stable within##2##2##(2008-8#1)(2009-1#1)
stable##565##1##(1990-11#1)(1990-12#4)(1990-2#4)(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#4)(1991-5#3)(1991-6#1)(1991-8#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-6#5)(1997-7#3)(1997-8#3)(2007-12#1)(2008-10#202)(2008-11#52)(2008-12#4)(2008-2#8)(2008-3#12)(2008-4#10)(2008-5#18)(2008-6#4)(2008-7#7)(2008-8#40)(2008-9#26)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#5)(2011-1#2)(2011-2#13)(2011-3#1)(2012-2#6)(2012-3#9)(2012-4#3)(2012-9#1)(2013-1#9)(2013-8#11)
stably and##2##2##(2008-11#1)(2008-8#1)
stably coexist##3##2##(2008-8#3)
stably express##2##2##(2008-11#1)(2008-9#1)
stably expressing the##2##3##(1995-11#1)(2008-8#1)
stably expressing##5##2##(1992-8#1)(1995-11#1)(2008-11#1)(2008-8#1)(2013-1#1)
stably maintained##4##2##(1993-9#1)(2008-7#1)(2008-8#1)(2012-2#1)
stably transfected by##2##3##(2008-9#2)
stably transfected with##3##3##(2008-11#2)(2012-3#1)
stably transfected##13##2##(1994-2#1)(1995-2#1)(1997-7#1)(2008-11#5)(2008-8#1)(2008-9#2)(2010-11#1)(2012-3#1)
stably transformed with##2##3##(1993-2#1)(2008-10#1)
stably transformed##4##2##(1993-2#2)(2008-10#1)(2008-11#1)
stably##49##1##(1992-8#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#13)(2008-7#1)(2008-8#9)(2008-9#8)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
stachyose##6##1##(2008-10#6)
stack of##3##2##(2007-11#1)(2008-3#2)
stack##11##1##(1993-1#1)(2007-11#1)(2008-10#1)(2008-3#4)(2008-4#1)(2012-2#3)
stacked stems##2##2##(2008-10#2)
stacked##11##1##(1991-5#1)(1993-8#1)(2008-10#5)(2008-4#1)(2008-7#3)
stacking in##2##2##(1991-5#1)(1993-8#1)
stacking##20##1##(1991-5#4)(1993-8#2)(2008-10#11)(2008-8#1)(2009-11#1)(2009-12#1)
stacks of##2##2##(2008-5#1)(2009-10#1)
stacks##6##1##(2008-10#2)(2008-5#1)(2008-7#2)(2009-10#1)
stadium##2##1##(1992-8#1)(2011-3#1)
staff about##2##2##(1995-12#1)(2008-11#1)
staff and may##2##3##(2008-12#1)(2013-1#1)
staff and patients##3##3##(1992-3#1)(1993-2#1)(2011-2#1)
staff and students##2##3##(2008-12#2)
staff and the##3##3##(1997-3#1)(2008-11#2)
staff and##35##2##(1991-12#2)(1991-2#2)(1991-3#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-3#3)(1997-3#1)(2008-11#2)(2008-12#6)(2008-6#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
staff at##3##2##(1993-12#1)(2008-11#2)
staff can##4##2##(1992-2#1)(1994-2#1)(2008-6#1)(2011-2#1)
staff development##5##2##(1994-1#2)(2008-11#2)(2008-9#1)
staff for##3##2##(1993-3#1)(1996-1#1)(2008-11#1)
staff from##3##2##(1995-3#1)(2008-11#1)(2008-12#1)
staff had##3##2##(2008-11#2)(2010-10#1)
staff has##2##2##(1995-1#1)(2010-11#1)
staff in a##2##3##(2008-11#1)(2010-10#1)
staff in the##4##3##(1994-6#1)(2008-11#1)(2010-8#1)(2013-1#1)
staff in##14##2##(1991-12#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-6#1)(2008-11#4)(2010-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
staff incentive program##2##3##(1992-3#2)
staff involved in##2##3##(1992-3#1)(2012-2#1)
staff is##3##2##(1991-2#1)(2008-11#1)(2008-12#1)
staff may be##2##3##(1991-12#1)(1995-2#1)
staff members can##2##3##(1996-1#1)(2008-9#1)
staff members in##2##3##(1995-1#1)(2010-10#1)
staff members regarding the##2##4##(1991-12#1)(1994-12#1)
staff members##11##2##(1991-12#1)(1994-12#1)(1995-1#1)(1996-1#1)(2008-9#2)(2010-10#3)(2010-11#1)(2013-1#1)
staff members'##6##2##(2008-11#1)(2010-10#5)
staff must##2##2##(1991-12#1)(1992-2#1)
staff need##2##2##(1997-5#1)(2011-2#1)
staff nurse##3##2##(2010-11#1)(2013-8#2)
staff of##2##2##(1991-12#1)(1991-2#1)
staff on##2##2##(1996-12#1)(2008-12#1)
staff regarding##2##2##(2010-10#1)(2012-3#1)
staff support##4##2##(1991-12#1)(2008-11#1)(2008-9#1)(2010-2#1)
staff to##6##2##(1996-1#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-9#1)
staff training and##2##3##(2008-12#1)(2008-6#1)
staff use##2##2##(1993-12#1)(2010-10#1)
staff were##4##2##(1994-12#1)(2008-12#1)(2010-10#1)(2012-12#1)
staff who##6##2##(2008-1#1)(2008-11#4)(2010-8#1)
staff##271##1##(1990-3#1)(1991-1#2)(1991-12#12)(1991-2#6)(1991-3#4)(1991-9#1)(1992-1#5)(1992-12#2)(1992-2#6)(1992-3#6)(1993-1#4)(1993-12#3)(1993-2#2)(1993-3#4)(1994-1#2)(1994-12#6)(1994-2#4)(1994-3#8)(1994-6#2)(1995-1#3)(1995-12#3)(1995-2#3)(1995-3#2)(1996-1#9)(1996-12#4)(1996-2#1)(1996-3#9)(1997-1#2)(1997-2#6)(1997-3#2)(1997-5#2)(1997-8#1)(2008-1#2)(2008-10#5)(2008-11#37)(2008-12#20)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#6)(2009-11#1)(2009-3#3)(2010-10#19)(2010-11#6)(2010-2#2)(2010-5#1)(2010-8#5)(2011-1#1)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#5)
staff's##4##1##(1993-12#1)(1993-2#1)(1993-3#1)(2010-10#1)
staff)##3##1##(1990-3#1)(2008-1#1)(2013-1#1)
staff?##3##1##(1991-3#1)(1994-12#1)(2011-2#1)
staffing and##4##2##(1994-12#1)(1996-1#2)(2013-8#1)
staffing in##2##2##(1990-3#1)(1994-3#1)
staffing levels in##2##3##(2008-11#1)(2008-7#1)
staffing levels##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
staffing patterns##4##2##(1993-1#3)(1996-3#1)
staffing##31##1##(1990-2#1)(1990-3#1)(1991-1#3)(1992-1#1)(1992-8#2)(1993-1#3)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#2)(1996-2#1)(1996-3#3)(2008-11#5)(2008-7#1)(2009-6#1)(2012-2#2)(2013-8#2)
staffs##5##1##(1991-12#1)(1994-12#1)(1994-2#1)(1994-3#2)
stage (P##2##2##(2009-11#1)(2013-1#1)
stage (n =##2##3##(1990-5#2)
stage (p = 0##2##4##(2011-2#2)
stage 2##4##2##(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
stage 3##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
stage 5##3##2##(1996-12#1)(2008-10#1)(2010-4#1)
stage I##6##2##(1990-6#1)(1991-8#1)(1993-11#1)(1994-12#1)(2012-12#1)(2012-3#1)
stage II or IIIa patients##2##5##(1993-11#2)
stage II##6##2##(1990-6#1)(1993-11#2)(1997-7#1)(2009-10#2)
stage III non small cell lung cancer##2##7##(1993-2#1)(2008-10#1)
stage III##13##2##(1990-6#1)(1990-9#1)(1991-8#2)(1993-2#1)(1994-8#1)(1997-3#1)(1997-5#1)(2008-10#3)(2008-8#2)
stage III-IV##2##2##(1990-6#2)
stage IIIA-IIIB non-small-cell lung cancer##2##5##(1992-12#2)
stage IIa##2##2##(2008-8#2)
stage IIb##2##2##(2008-8#2)
stage IV and##2##3##(1991-8#1)(2008-1#1)
stage IV##9##2##(1990-6#1)(1991-11#1)(1991-8#1)(1995-12#1)(2008-1#3)(2009-3#1)(2012-2#1)
stage Ia##2##2##(1991-2#1)(2007-8#1)
stage V##3##2##(2011-1#1)(2012-2#2)
stage and a##3##3##(1992-3#1)(2008-10#1)(2008-12#1)
stage and may##2##3##(1997-6#1)(2008-11#1)
stage and the##4##3##(1997-8#1)(2008-1#1)(2008-10#1)(2009-8#1)
stage and##39##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-2#1)(1995-3#1)(1996-11#1)(1997-6#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
stage are##2##2##(1995-1#1)(2008-8#1)
stage at diagnosis##4##3##(1990-12#3)(2012-3#1)
stage at##8##2##(1990-12#3)(2008-10#4)(2012-3#1)
stage chronic renal failure##2##4##(1991-11#1)(2008-1#1)
stage chronic renal##3##3##(1991-11#1)(2008-1#1)(2008-10#1)
stage distribution##2##2##(1994-8#1)(2012-12#1)
stage embryos##2##2##(2008-5#1)(2008-9#1)
stage following##2##2##(2008-10#1)(2013-1#1)
stage for the##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
stage for##10##2##(1990-9#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
stage grouping##2##2##(2011-2#2)
stage has##2##2##(1991-8#1)(1997-7#1)
stage in the##4##3##(2008-10#3)(2008-8#1)
stage in##14##2##(1990-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#2)
stage is##6##2##(2008-10#3)(2010-7#1)(2011-2#1)(2013-1#1)
stage of a##2##3##(2008-10#2)
stage of advanced CHF##2##4##(2009-10#2)
stage of an##2##3##(2008-10#1)(2008-11#1)
stage of change##2##3##(2008-11#1)(2013-1#1)
stage of development of##2##4##(1996-8#1)(2008-10#1)
stage of development##11##3##(1991-1#1)(1996-2#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-3#1)
stage of exercise##2##3##(2008-10#1)(2013-1#1)
stage of flower##2##3##(1997-8#1)(2008-8#1)
stage of fruit development##2##4##(2008-10#1)(2008-9#1)
stage of infection##2##3##(2008-5#2)
stage of kernel development##2##4##(2008-10#2)
stage of lag##2##3##(2011-2#2)
stage of life##3##3##(1993-12#1)(2010-1#2)
stage of organ##2##3##(2008-7#1)(2008-9#1)
stage of the disease##6##4##(1991-8#1)(1993-2#1)(1995-2#1)(1995-9#1)(2012-2#1)(2013-1#1)
stage of the program##2##4##(1991-12#2)
stage of the##31##3##(1990-8#1)(1991-12#2)(1991-8#1)(1992-12#1)(1993-2#2)(1995-2#1)(1995-6#1)(1995-9#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#2)(2010-8#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
stage of their##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
stage of this##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
stage of weaning##2##3##(2013-1#2)
stage of##149##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-8#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#3)(1994-3#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#2)(2007-12#1)(2007-9#1)(2008-10#32)(2008-11#9)(2008-12#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#3)(2012-8#1)(2013-1#11)(2013-8#6)
stage or##3##2##(1991-6#1)(2008-10#1)(2008-8#1)
stage renal disease and##2##4##(2010-11#1)(2013-1#1)
stage renal disease patients##2##4##(2008-1#1)(2010-7#1)
stage renal disease##14##3##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(2008-1#4)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
stage renal failure##3##3##(1997-8#2)(2008-1#1)
stage renal##17##2##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-8#2)(2008-1#5)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
stage specific embryonic##2##3##(2008-11#2)
stage specific##4##2##(2008-11#2)(2008-9#1)(2009-10#1)
stage structure##4##2##(2008-8#4)
stage that##2##2##(2007-12#1)(2011-3#1)
stage the##3##2##(1990-3#1)(2008-10#1)(2008-9#1)
stage through##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
stage to##8##2##(2008-10#4)(2008-11#1)(2008-5#1)(2009-11#1)(2011-2#1)
stage tumours##2##2##(2011-2#2)
stage using a##2##3##(1993-9#1)(2011-2#1)
stage was##13##2##(1991-8#1)(1994-11#1)(2008-10#6)(2008-12#2)(2008-8#1)(2010-11#1)(2011-2#1)
stage were##3##2##(1990-12#1)(1990-3#1)(2008-10#1)
stage when the##2##3##(2008-11#1)(2008-6#1)
stage when##3##2##(2008-11#1)(2008-6#1)(2010-7#1)
stage with##2##2##(1997-3#1)(2008-3#1)
stage##639##1##(1990-12#10)(1990-2#1)(1990-3#5)(1990-5#6)(1990-6#6)(1990-8#3)(1990-9#6)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#3)(1991-6#2)(1991-8#13)(1991-9#1)(1992-12#5)(1992-3#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#3)(1993-11#4)(1993-12#4)(1993-2#5)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#3)(1995-1#5)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#6)(2006-6#1)(2007-12#10)(2007-8#2)(2007-9#1)(2008-1#12)(2008-10#148)(2008-11#31)(2008-12#14)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#9)(2008-6#9)(2008-7#14)(2008-8#37)(2008-9#16)(2009-10#7)(2009-11#2)(2009-12#1)(2009-3#2)(2009-7#4)(2009-8#4)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#1)(2011-2#34)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#18)(2012-8#1)(2013-1#33)(2013-8#12)
stage) and##3##2##(1992-12#1)(2008-10#2)
stage)##11##1##(1990-6#1)(1991-6#1)(1992-12#1)(2008-10#6)(2008-6#1)(2010-2#1)
stage-dependent##3##1##(1990-12#1)(2012-2#2)
stage-related##2##1##(2008-8#1)(2008-9#1)
stage-specific manner##2##2##(1995-12#1)(2008-8#1)
stage-specific##6##1##(1995-12#1)(2008-8#2)(2008-9#1)(2009-6#1)(2012-2#1)
stage-structured##2##1##(2008-8#2)
staged according to##2##3##(1990-8#1)(2012-3#1)
staged operation##2##2##(2008-10#1)(2008-7#1)
staged operations##2##2##(2008-7#2)
staged surgery##3##2##(2008-7#3)
staged therapy##2##2##(2012-3#2)
staged with##2##2##(1992-6#1)(2012-2#1)
staged##31##1##(1990-8#1)(1992-6#1)(1993-12#1)(1996-3#1)(1997-3#3)(2008-10#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-4#2)(2010-11#1)(2010-6#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
stages 2##2##2##(2008-10#1)(2008-11#1)
stages I and##2##3##(1990-8#1)(2008-1#1)
stages I##4##2##(1990-8#1)(1997-4#1)(2008-1#2)
stages and in##2##3##(1993-6#1)(1997-7#1)
stages and the##3##3##(2008-10#2)(2008-4#1)
stages and##24##2##(1993-6#1)(1995-1#1)(1997-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
stages are##3##2##(1995-1#1)(2008-10#1)(2012-12#1)
stages by##2##2##(1993-6#1)(2010-8#1)
stages can##2##2##(2008-11#1)(2011-3#1)
stages for##3##2##(1993-6#1)(2008-4#1)(2010-8#1)
stages from##2##2##(2008-10#2)
stages in the life cycles of these pathogens##2##8##(2008-10#2)
stages in the##7##3##(1991-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
stages in##11##2##(1991-2#1)(1994-11#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2010-8#1)(2011-2#1)
stages increased##2##2##(2008-10#1)(2008-9#1)
stages of Alzheimer's##2##3##(1992-12#2)
stages of biofilm formation##2##4##(2013-8#2)
stages of both##2##3##(2008-10#1)(2008-9#1)
stages of cell##2##3##(2008-11#1)(2008-8#1)
stages of change##2##3##(2008-12#1)(2008-4#1)
stages of colonization##2##3##(2008-10#1)(2008-8#1)
stages of development ranging from##2##5##(1991-7#1)(2008-10#1)
stages of development##10##3##(1990-5#1)(1991-7#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
stages of diabetic##2##3##(1997-8#2)
stages of disease development##2##4##(2008-10#2)
stages of epidemics##2##3##(2008-10#2)
stages of follicular atresia##2##4##(2008-7#2)
stages of germ##2##3##(2008-7#1)(2009-10#1)
stages of growth##3##3##(2008-1#1)(2008-10#1)(2010-7#1)
stages of human##2##3##(1997-8#1)(2010-8#1)
stages of infection##6##3##(2008-10#3)(2008-2#1)(2010-6#1)(2011-10#1)
stages of lag##2##3##(2011-2#2)
stages of life##2##3##(2009-5#1)(2013-1#1)
stages of mammalian##2##3##(2008-10#1)(2008-9#1)
stages of physical activity##3##4##(2013-1#3)
stages of plant development##3##4##(2008-10#3)
stages of reward##2##3##(2013-8#2)
stages of the disease##6##4##(1990-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
stages of the##25##3##(1990-11#1)(1993-9#1)(1996-1#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#2)(2011-2#1)(2011-3#3)
stages of their##3##3##(2008-5#1)(2009-10#1)(2009-8#1)
stages of treatment##2##3##(1997-4#1)(2012-3#1)
stages of tumor##2##3##(2009-6#1)(2012-2#1)
stages of##194##2##(1990-11#1)(1990-5#3)(1991-12#1)(1991-7#1)(1992-12#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-12#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#4)(1997-8#4)(2006-6#1)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#42)(2008-11#4)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#5)(2009-10#5)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#4)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#1)(2011-10#1)(2011-2#10)(2011-3#3)(2012-2#6)(2012-3#5)(2012-7#1)(2013-1#10)(2013-8#4)
stages on##2##2##(2008-10#2)
stages or##2##2##(2008-10#1)(2008-3#1)
stages was##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
stages were##2##2##(2007-12#1)(2008-10#1)
stages with a##2##3##(2008-10#2)
stages with##4##2##(2008-10#3)(2008-12#1)
stages##415##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-8#2)(1991-12#2)(1991-2#1)(1991-7#1)(1992-12#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#4)(1993-9#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#4)(2006-6#1)(2007-12#10)(2007-8#2)(2008-1#7)(2008-10#109)(2008-11#14)(2008-12#14)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#7)(2008-6#8)(2008-7#6)(2008-8#18)(2008-9#10)(2009-1#1)(2009-10#9)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#6)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#14)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#24)(2011-3#5)(2012-12#2)(2012-2#12)(2012-3#8)(2012-7#1)(2012-8#1)(2013-1#15)(2013-8#10)
stages)##2##1##(2008-10#1)(2011-2#1)
staggered##2##1##(2008-8#1)(2009-12#1)
staghorn##2##1##(2008-10#1)(2013-1#1)
staging and##5##2##(1990-3#1)(1995-1#1)(2008-2#1)(2011-2#2)
staging of##8##2##(1992-9#1)(2008-1#2)(2008-2#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
staging procedure##3##2##(1990-12#1)(1994-12#1)(1997-8#1)
staging system and##2##3##(2011-2#2)
staging system##5##2##(1990-8#1)(2011-2#3)(2012-3#1)
staging##39##1##(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-1#1)(1997-8#1)(2008-1#3)(2008-2#4)(2009-12#1)(2009-5#1)(2010-12#5)(2010-7#2)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#1)
stagnant##3##1##(1992-1#1)(2008-10#1)(2008-5#1)
stagnation##2##1##(1992-1#1)(1997-7#1)
stagonospora##2##1##(2008-10#2)
stain and##3##2##(1992-2#1)(1995-12#1)(2012-3#1)
stain of##2##2##(2011-2#2)
stain was##2##2##(1992-2#1)(2008-12#1)
stain##29##1##(1990-2#1)(1990-3#2)(1991-1#1)(1992-2#3)(1995-12#2)(2007-11#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2011-2#5)(2012-3#1)
stained and the##3##3##(2008-5#3)
stained and##7##2##(1990-2#1)(2008-11#1)(2008-5#3)(2008-9#1)(2011-3#1)
stained by the##2##3##(2008-10#2)
stained by##8##2##(1996-12#1)(2008-10#3)(2008-7#1)(2008-9#2)(2012-3#1)
stained cells##2##2##(2008-9#1)(2013-1#1)
stained for##3##2##(1992-6#1)(2008-10#1)(2011-2#1)
stained nuclei##2##2##(1996-2#1)(2008-11#1)
stained positive for##2##3##(1997-8#1)(2012-3#1)
stained positively##2##2##(1996-12#1)(2008-7#1)
stained with hematoxylin and eosin##2##5##(2011-2#1)(2013-1#1)
stained with one##2##3##(1990-12#1)(2008-5#1)
stained with the##3##3##(1991-5#1)(2008-11#1)(2008-9#1)
stained with##18##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#2)
stained##73##1##(1990-11#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1994-11#1)(1995-12#1)(1996-12#4)(1996-2#2)(1997-2#3)(1997-8#1)(2007-12#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#7)(2008-7#6)(2008-8#1)(2008-9#5)(2010-12#1)(2011-2#5)(2011-3#1)(2012-3#2)(2013-1#3)
staining after##2##2##(2008-11#1)(2010-6#1)
staining and confocal##2##3##(2007-12#1)(2011-2#1)
staining and flow cytometry##2##4##(2008-10#2)
staining and##20##2##(1992-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-3#1)
staining cells##2##2##(2008-11#1)(2008-9#1)
staining for##16##2##(1995-12#3)(1997-3#2)(1997-7#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#3)
staining in both telomeres##2##4##(2008-12#2)
staining in the##2##3##(1992-8#1)(2012-3#1)
staining in##8##2##(1992-8#1)(1995-6#1)(2008-12#2)(2008-8#1)(2008-9#1)(2012-3#2)
staining intensity##4##2##(1991-5#2)(1996-2#1)(2009-4#1)
staining is##4##2##(2008-5#1)(2008-9#3)
staining method##2##2##(2007-12#1)(2008-11#1)
staining methods##2##2##(1997-3#1)(2007-12#1)
staining of DNA and##2##4##(2008-11#1)(2008-9#1)
staining of the device##2##4##(2010-7#2)
staining of the##6##3##(1991-5#1)(1992-1#1)(2008-4#1)(2010-7#2)(2011-2#1)
staining of##28##2##(1991-5#1)(1992-1#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#5)(2010-7#2)(2011-2#2)(2012-2#1)
staining on##2##2##(1990-12#1)(2008-8#1)
staining procedures for##2##3##(2008-9#2)
staining protocol##2##2##(2008-9#2)
staining reagents##2##2##(2008-4#1)(2013-8#1)
staining technique##2##2##(2008-7#1)(2008-9#1)
staining was seen in##2##4##(1995-8#1)(1997-2#1)
staining was seen##3##3##(1995-8#1)(1997-2#2)
staining was##8##2##(1990-5#1)(1995-8#1)(1996-2#1)(1997-2#2)(2008-11#1)(2008-12#1)(2008-5#1)
staining were##2##2##(2008-11#1)(2011-2#1)
staining with 4'##2##3##(2008-10#1)(2008-11#1)
staining with a second fluorochrome (propidium iodide) after incubation of effector and target cells##2##14##(1990-12#2)
staining with a##4##3##(1990-12#2)(2008-11#1)(2008-5#1)
staining with##25##2##(1990-12#2)(1993-12#1)(1994-2#3)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)
staining##229##1##(1990-12#3)(1990-5#1)(1991-5#3)(1991-7#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#3)(1993-3#2)(1994-2#4)(1995-12#6)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#3)(1996-6#1)(1997-2#4)(1997-3#4)(1997-4#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-12#4)(2008-10#18)(2008-11#32)(2008-12#13)(2008-4#14)(2008-5#10)(2008-7#9)(2008-8#14)(2008-9#33)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
staining)##2##1##(2008-10#1)(2008-11#1)
stainings##2##1##(1996-12#1)(1997-8#1)
stainless steel housing##2##3##(2008-7#2)
stainless steel welding fume##2##4##(2008-10#2)
stainless steel welding##3##3##(2008-10#3)
stainless steel wire##2##3##(2008-10#1)(2009-3#1)
stainless steel##25##2##(1992-1#1)(2008-10#15)(2008-7#2)(2009-3#1)(2011-2#2)(2012-2#2)(2013-8#2)
stainless##26##1##(1992-1#1)(2008-10#15)(2008-7#2)(2009-3#1)(2011-2#3)(2012-2#2)(2013-8#2)
stainless-steel cone pinhole##2##3##(2008-3#2)
stains and##2##2##(2008-9#1)(2013-1#1)
stains##22##1##(1991-1#2)(1992-2#1)(1993-6#1)(1996-11#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
stair##3##1##(2013-1#3)
staircase procedure##3##2##(1990-11#3)
staircase##5##1##(1990-11#4)(2013-1#1)
stairs##3##1##(2008-7#2)(2013-1#1)
stake##2##1##(1993-5#1)(1995-2#1)
stakeholder alignment##3##2##(2013-1#3)
stakeholder management##2##2##(1991-3#1)(1993-3#1)
stakeholder##10##1##(1991-3#2)(1993-2#1)(1993-3#1)(2009-4#1)(2012-2#1)(2013-1#4)
stakeholders and##2##2##(2008-12#1)(2013-1#1)
stakeholders from##2##2##(2008-10#1)(2008-12#1)
stakeholders in the##2##3##(2008-12#1)(2011-2#1)
stakeholders in##7##2##(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#3)
stakeholders involved##2##2##(1992-1#1)(1997-2#1)
stakeholders##31##1##(1991-1#1)(1991-3#1)(1992-1#1)(1993-12#1)(1994-1#1)(1995-3#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#5)(2011-2#2)(2012-2#1)(2013-1#8)(2013-8#1)
stakeholders'##3##1##(1994-1#1)(1995-3#1)(2008-11#1)
stalk pieces##3##2##(2008-10#3)
stalk##22##1##(1995-6#1)(1997-3#3)(1997-8#2)(2008-10#6)(2008-11#1)(2008-8#2)(2009-9#2)(2011-2#1)(2013-8#4)
stalker##2##1##(2009-9#2)
stalking##2##1##(2009-9#2)
stalks##7##1##(2007-12#1)(2008-10#6)
stall##3##1##(1991-9#1)(1997-3#1)(2011-2#1)
stalled##4##1##(1991-9#1)(1993-3#1)(1995-2#1)(2011-2#1)
stalling##2##1##(2011-2#2)
stamens and##2##2##(2008-8#2)
staminate ear tip##3##3##(2012-3#3)
staminate ear tips##2##3##(2012-3#2)
staminate ear##5##2##(2012-3#5)
staminate##9##1##(2012-3#9)
stammering##2##1##(2008-2#2)
stance on##3##2##(2008-11#1)(2008-12#2)
stance phase##2##2##(2013-1#2)
stance##12##1##(1991-12#1)(1993-3#2)(1994-9#1)(2008-11#2)(2008-12#3)(2010-9#1)(2013-1#2)
stand against##2##2##(1990-6#1)(2012-3#1)
stand establishment##2##2##(2008-10#1)(2008-12#1)
stand for##2##2##(2008-10#2)
stand in##2##2##(1990-2#1)(2008-11#1)
stand##25##1##(1990-2#1)(1990-6#1)(1995-6#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-8#1)(2011-3#1)(2012-3#1)
stand-alone##5##1##(1993-2#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
stand-by therapy##3##2##(1993-8#3)
standard &quot##2##2##(2008-8#1)(2011-2#1)
standard DNA##2##2##(2008-10#2)
standard LPA using PBMC##2##4##(2011-2#2)
standard LPA using##3##3##(2011-2#3)
standard LPA##4##2##(2011-2#4)
standard Papanicolaou smear##2##3##(1992-1#2)
standard acid##2##2##(2008-10#2)
standard addition and##5##3##(2008-10#5)
standard addition approach##2##3##(2008-10#2)
standard addition calibration##6##3##(2008-10#6)
standard addition method and##4##4##(2008-10#4)
standard addition method for##2##4##(2008-10#2)
standard addition method or##2##4##(2008-10#2)
standard addition method to##2##4##(2008-10#2)
standard addition method was##3##4##(2008-10#3)
standard addition method were##2##4##(2008-10#2)
standard addition method##55##3##(2008-10#55)
standard addition methodology##5##3##(2008-10#5)
standard addition technique was##2##4##(2008-10#2)
standard addition technique##9##3##(1991-12#1)(2008-10#8)
standard addition##96##2##(1991-12#1)(2008-10#95)
standard additions method##15##3##(2008-10#15)
standard additions methods##3##3##(2008-10#3)
standard additions##31##2##(2008-10#31)
standard alloy##2##2##(2008-10#2)
standard alloys and environmental samples##3##5##(2008-10#3)
standard alloys and##5##3##(2008-10#5)
standard alloys##9##2##(2008-10#9)
standard and the##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
standard and##23##2##(2008-10#13)(2008-11#3)(2008-5#1)(2008-7#1)(2011-3#1)(2012-3#1)(2013-8#3)
standard approach in##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
standard approach##6##2##(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
standard approaches##2##2##(2010-6#1)(2013-1#1)
standard at##2##2##(2008-10#2)
standard bacteriological##3##2##(2008-12#2)(2012-3#1)
standard benefits##2##2##(1994-12#1)(1997-3#1)
standard calibration technique##2##3##(2008-10#2)
standard calibration##4##2##(2008-10#4)
standard care##4##2##(2008-4#1)(2010-4#3)
standard cell culture##2##3##(1993-12#1)(2008-11#1)
standard cell##3##2##(1993-12#1)(2008-11#1)(2011-1#1)
standard clinical##2##2##(2008-10#1)(2009-10#1)
standard coals##2##2##(2008-10#2)
standard colorimetric##2##2##(2008-10#2)
standard commercial##3##2##(2008-10#2)(2008-2#1)
standard compounds##2##2##(2008-10#2)
standard criteria##3##2##(2008-5#1)(2010-11#1)(2011-1#1)
standard curve##7##2##(1996-12#1)(2008-10#6)
standard curves##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
standard derivative##2##2##(2008-10#2)
standard derivatives##2##2##(2008-10#2)
standard deviation (R##80##3##(2008-10#80)
standard deviation (S##5##3##(2008-10#5)
standard deviation (n=10)##6##3##(2008-10#6)
standard deviation (n=6) was##2##4##(2008-10#2)
standard deviation (n=6)##3##3##(2008-10#3)
standard deviation =##2##3##(2008-10#2)
standard deviation and the##2##4##(2008-10#1)(2013-1#1)
standard deviation and##4##3##(2008-10#3)(2013-1#1)
standard deviation being##2##3##(2008-10#2)
standard deviation between##4##3##(2008-10#3)(2013-8#1)
standard deviation in the##2##4##(2008-10#2)
standard deviation in##4##3##(2008-10#4)
standard deviation is##19##3##(2008-10#19)
standard deviation less than##2##4##(2008-10#2)
standard deviation of +/-0##4##4##(2008-10#4)
standard deviation of 0##10##4##(2008-10#8)(2008-3#1)(2009-2#1)
standard deviation of 10##2##4##(2008-10#2)
standard deviation of 5##2##4##(2008-10#2)
standard deviation of the blank signal##2##6##(2008-10#2)
standard deviation of the blank##7##5##(2008-10#7)
standard deviation of the mean##2##5##(2008-3#2)
standard deviation of the method was##2##6##(2008-10#2)
standard deviation of the method##4##5##(2008-10#4)
standard deviation of the proposed method##2##6##(2008-10#2)
standard deviation of the proposed##4##5##(2008-10#4)
standard deviation of the##35##4##(2008-10#29)(2008-3#6)
standard deviation of three independent##2##5##(2008-10#2)
standard deviation of three##3##4##(2008-10#3)
standard deviation of##142##3##(1996-8#1)(2008-10#132)(2008-3#8)(2009-2#1)
standard deviation score (SDS)##2##4##(2011-1#2)
standard deviation was 5##3##4##(2008-10#3)
standard deviation was##38##3##(2008-10#38)
standard deviation##457##2##(1995-12#1)(1996-8#1)(2007-11#3)(2008-10#429)(2008-11#1)(2008-3#9)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
standard deviation)##11##2##(2008-10#6)(2008-11#1)(2008-12#1)(2011-2#2)(2013-8#1)
standard deviations (R##18##3##(2008-10#18)
standard deviations for##18##3##(2008-10#17)(2008-5#1)
standard deviations of the results##2##5##(2008-10#2)
standard deviations of the##12##4##(2008-10#11)(2008-12#1)
standard deviations of##34##3##(1992-1#1)(2008-10#32)(2008-12#1)
standard deviations were less than##2##5##(2008-10#2)
standard deviations were lower than##3##5##(2008-10#3)
standard deviations were##23##3##(2008-10#21)(2011-2#2)
standard deviations##130##2##(1992-1#1)(1997-2#1)(2008-10#119)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-1#1)(2011-2#2)
standard drink##4##2##(2009-7#4)
standard drinks##3##2##(2009-7#3)
standard drug##2##2##(2008-10#1)(2012-2#1)
standard dural##2##2##(2012-3#1)(2013-8#1)
standard electrode##2##2##(2008-10#1)(2008-9#1)
standard error (R##3##3##(2008-10#3)
standard error for##3##3##(2008-10#2)(2008-3#1)
standard error of prediction##2##4##(2008-10#2)
standard error of##8##3##(2008-10#6)(2010-12#1)(2013-1#1)
standard error##18##2##(2008-10#15)(2008-3#1)(2010-12#1)(2013-1#1)
standard errors of prediction##2##4##(2008-10#2)
standard errors of the##2##4##(2008-10#2)
standard errors of##4##3##(2008-10#4)
standard errors##7##2##(1995-9#1)(2008-10#5)(2008-8#1)
standard ethanolic deodorant##2##3##(2008-5#2)
standard for the##7##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)
standard for##25##2##(1993-5#1)(1996-12#3)(1996-9#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#2)(2010-8#2)(2011-2#2)(2012-3#1)(2013-8#1)
standard free##2##2##(2008-10#2)
standard in##9##2##(2008-10#3)(2008-4#1)(2011-2#3)(2011-3#1)(2012-12#1)
standard iodine solution##2##3##(2008-10#2)
standard is##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
standard laboratory##3##2##(1993-6#1)(2008-10#2)
standard laparoscopic##2##2##(2008-10#2)
standard length (L(S))##2##3##(2010-8#2)
standard length##3##2##(2010-8#3)
standard liquid##2##2##(1994-5#1)(2008-9#1)
standard material##2##2##(2008-10#2)
standard materials##3##2##(2008-10#3)
standard medical##2##2##(2009-10#1)(2012-2#1)
standard metal##2##2##(2008-10#2)
standard method and##2##3##(2008-10#2)
standard method for##2##3##(2008-3#1)(2010-12#1)
standard method in##2##3##(1996-3#1)(2008-10#1)
standard method of##2##3##(2011-2#1)(2013-1#1)
standard method##28##2##(1992-12#1)(1993-3#1)(1996-3#1)(2008-10#19)(2008-3#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
standard methodology for##3##3##(1992-12#1)(1996-6#1)(2008-10#1)
standard methods of analysis##2##4##(1994-9#1)(2008-10#1)
standard methods of##4##3##(1994-9#1)(2008-10#2)(2008-4#1)
standard methods##17##2##(1994-3#1)(1994-9#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#2)(2010-7#1)
standard mixtures of##2##3##(2008-10#2)
standard mixtures##6##2##(2008-10#6)
standard multidish##2##2##(2008-11#2)
standard of care and##2##4##(1993-2#1)(2012-3#1)
standard of care in##2##4##(2008-10#1)(2010-12#1)
standard of care##11##3##(1991-12#1)(1993-2#1)(2008-10#1)(2008-6#1)(2009-12#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)
standard of society##2##3##(1995-5#2)
standard of the##2##3##(2008-11#1)(2011-2#1)
standard of##26##2##(1991-12#1)(1993-2#2)(1995-5#2)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
standard on the##2##3##(1993-2#1)(2008-10#1)
standard on##3##2##(1993-2#1)(2008-10#2)
standard operating##3##2##(2009-12#1)(2011-2#2)
standard operation procedure##2##3##(2008-10#2)
standard or##4##2##(2008-10#3)(2009-8#1)
standard osmolality##2##2##(2008-11#2)
standard pellet diet##3##3##(2013-1#3)
standard phase-sensitive detection##2##3##(2008-3#2)
standard potential##2##2##(2008-10#1)(2008-8#1)
standard practice##4##2##(2008-10#1)(2008-11#1)(2009-11#1)(2013-1#1)
standard preparation##3##2##(1992-9#1)(2008-4#1)(2008-7#1)
standard procedure##7##2##(2008-10#4)(2008-11#1)(2008-12#1)(2012-3#1)
standard procedures##8##2##(1990-12#1)(1995-5#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
standard reference material and##3##4##(2008-10#3)
standard reference material##17##3##(2008-10#17)
standard reference materials and##4##4##(2008-10#4)
standard reference materials##30##3##(2008-10#30)
standard reference serum##2##3##(2011-2#2)
standard reference##58##2##(2008-1#1)(2008-10#54)(2010-3#1)(2011-2#2)
standard sample and##2##3##(2008-10#2)
standard sample##3##2##(2008-10#3)
standard samples of##2##3##(2008-10#2)
standard samples##10##2##(2008-10#10)
standard screening##2##2##(1990-8#1)(2008-10#1)
standard set of##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
standard set##4##2##(2008-10#1)(2008-4#1)(2012-2#2)
standard setting##6##2##(2011-2#2)(2012-2#4)
standard slurries were##3##3##(2008-10#3)
standard slurries##4##2##(2008-10#4)
standard solution and in##2##4##(2008-10#2)
standard solution and##5##3##(2008-10#5)
standard solution containing##5##3##(2008-10#5)
standard solution of##5##3##(2008-10#5)
standard solution was##2##3##(2008-10#2)
standard solution##33##2##(2008-10#33)
standard solutions and##2##3##(2008-10#2)
standard solutions containing##3##3##(2008-10#3)
standard solutions in##2##3##(2008-10#2)
standard solutions of##6##3##(2008-10#6)
standard solutions was##2##3##(2008-10#2)
standard solutions were##4##3##(2008-10#4)
standard solutions##37##2##(2008-10#37)
standard spectrophotometric procedure##2##3##(2008-10#2)
standard spectrophotometric##3##2##(2008-10#3)
standard strains##2##2##(2008-10#1)(2008-12#1)
standard techniques##2##2##(2008-10#1)(2010-7#1)
standard ten##2##2##(2013-1#2)
standard testing procedures##2##3##(2008-12#1)(2008-5#1)
standard tests##2##2##(2012-2#1)(2013-1#1)
standard that##2##2##(1991-3#1)(1992-2#1)
standard therapy for##2##3##(1994-12#1)(2011-2#1)
standard therapy##4##2##(1994-12#1)(2010-7#1)(2011-2#2)
standard tissue culture plasticware##2##4##(2008-11#2)
standard to##11##2##(1995-10#1)(2008-10#8)(2008-9#1)(2010-8#1)
standard treatment is##3##3##(1990-2#1)(1995-9#1)(1997-5#1)
standard treatment##11##2##(1990-2#1)(1991-8#1)(1995-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-8#1)
standard uncertainty of##2##3##(2008-2#2)
standard values##3##2##(2008-10#2)(2008-5#1)
standard was##8##2##(1992-12#1)(1993-2#1)(2008-10#5)(2008-5#1)
standard wheat##2##2##(2008-10#1)(2010-8#1)
standard with##2##2##(2008-10#1)(2009-6#1)
standard##1688##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-3#2)(1991-5#1)(1991-8#2)(1992-1#3)(1992-11#1)(1992-12#7)(1992-2#1)(1992-4#2)(1992-9#2)(1993-12#2)(1993-2#5)(1993-3#2)(1993-5#1)(1993-6#2)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#4)(1995-5#4)(1995-8#2)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-8#2)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1179)(2008-11#50)(2008-12#21)(2008-2#6)(2008-3#21)(2008-4#11)(2008-5#23)(2008-6#1)(2008-7#17)(2008-8#12)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#8)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#7)(2010-8#13)(2010-9#1)(2011-1#7)(2011-2#44)(2011-3#4)(2011-7#1)(2012-12#7)(2012-2#17)(2012-3#20)(2012-5#1)(2013-1#39)(2013-8#17)
standard&quot##9##1##(1992-3#1)(1993-2#1)(1995-5#1)(2008-10#2)(2009-3#1)(2011-2#1)(2012-2#1)(2012-4#1)
standard)##5##1##(2008-10#4)(2011-3#1)
standard/sample##2##1##(2008-10#2)
standard?##2##1##(1992-3#1)(2008-10#1)
standardisation of##3##2##(1991-2#1)(1992-3#1)(2008-10#1)
standardisation##7##1##(1990-3#1)(1991-2#1)(1992-3#1)(1997-7#1)(2008-10#3)
standardised methods##2##2##(2008-10#1)(2008-11#1)
standardised##10##1##(2008-10#4)(2008-11#3)(2008-12#2)(2010-6#1)
standardization and##3##2##(2008-10#2)(2008-12#1)
standardization for##3##2##(2008-10#2)(2012-3#1)
standardization of the##2##3##(2006-6#1)(2008-10#1)
standardization of##11##2##(1993-3#1)(1996-2#1)(2006-6#1)(2008-10#4)(2008-8#1)(2012-2#1)(2013-1#2)
standardization##39##1##(1993-1#1)(1993-3#1)(1994-12#1)(1996-2#1)(2006-6#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
standardize our##2##2##(2008-3#2)
standardize the##4##2##(1997-3#1)(2008-9#1)(2010-4#1)(2012-2#1)
standardize##10##1##(1997-3#1)(2008-11#2)(2008-3#2)(2008-9#2)(2010-4#1)(2012-2#2)
standardized and##4##2##(1993-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
standardized area under DII progress curve##2##6##(2008-10#2)
standardized area under DII progress##3##5##(2008-10#3)
standardized area under##4##3##(2008-10#4)
standardized data##2##2##(2008-11#1)(2010-8#1)
standardized mean square##2##3##(2012-2#2)
standardized procedure##2##2##(1995-2#1)(2008-12#1)
standardized protocol for##2##3##(1997-1#1)(2008-11#1)
standardized protocol##3##2##(1997-1#2)(2008-11#1)
standardized protocols##2##2##(1997-8#1)(2013-8#1)
standardized questionnaire##3##2##(1994-12#1)(1996-11#1)(2008-11#1)
standardized test scores##2##3##(2008-12#1)(2009-7#1)
standardized test##3##2##(2008-12#2)(2009-7#1)
standardized tests##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
standardized to##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
standardized tool##2##2##(2008-6#1)(2013-1#1)
standardized##117##1##(1991-11#2)(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-5#1)(1997-8#1)(2008-10#19)(2008-11#13)(2008-12#7)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-11#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#5)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#12)(2013-8#3)
standardizing the##2##2##(2008-10#2)
standardizing##9##1##(1997-3#1)(2008-10#3)(2008-9#1)(2013-1#4)
standardless FP method##2##3##(2008-10#2)
standards and from##2##3##(1992-11#1)(2008-10#1)
standards and samples##2##3##(2008-10#2)
standards and##23##2##(1992-11#2)(1993-3#1)(1994-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
standards are##5##2##(1993-3#1)(1997-1#1)(2008-12#1)(2010-11#1)(2011-2#1)
standards can be##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
standards containing##2##2##(2008-10#2)
standards could##2##2##(2008-10#1)(2013-8#1)
standards for the##6##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-8#1)
standards for##28##2##(1991-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
standards from##2##2##(2008-4#1)(2013-1#1)
standards have been##2##3##(1996-1#1)(2012-3#1)
standards in papers published in##2##5##(2013-1#2)
standards in the##4##3##(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)
standards in##14##2##(1996-2#1)(1996-8#1)(2008-10#4)(2008-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#2)
standards is##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
standards of practice##2##3##(2008-12#1)(2012-12#1)
standards of##20##2##(1991-3#1)(1991-8#1)(1994-3#2)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2012-12#2)
standards on##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
standards such as##2##3##(2008-11#1)(2012-3#1)
standards to##5##2##(2008-10#4)(2013-1#1)
standards was##2##2##(2008-10#2)
standards well##2##2##(2008-10#2)
standards were used##2##3##(2008-10#2)
standards were##13##2##(2008-10#11)(2010-10#1)(2013-1#1)
standards which##2##2##(2008-11#1)(2013-1#1)
standards will##2##2##(1995-1#1)(2008-3#1)
standards##246##1##(1991-12#2)(1991-3#3)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#4)(1994-12#1)(1994-3#4)(1995-1#1)(1995-12#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#3)(2008-10#115)(2008-11#16)(2008-12#9)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-5#3)(2010-8#4)(2011-2#9)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#8)(2013-1#10)(2013-8#2)
standards)##2##1##(2008-10#2)
standing height changes##2##3##(2010-3#2)
standing height gains##2##3##(2010-3#2)
standing height##4##2##(2010-3#4)
standing horses##2##2##(2013-8#2)
standing in##4##2##(2008-10#1)(2010-9#1)(2013-1#2)
standing spore crop was##2##4##(2008-10#2)
standing spore crop##3##3##(2008-10#3)
standing##43##1##(1992-3#1)(1992-8#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-7#3)(2010-10#2)(2010-3#6)(2010-9#2)(2012-2#1)(2013-1#10)(2013-8#2)
standpoint##9##1##(1990-2#1)(1991-6#1)(1995-12#1)(2008-10#1)(2008-8#1)(2010-11#1)(2011-2#3)
stands and##8##2##(2008-10#8)
stands for##6##2##(2008-10#4)(2012-3#1)(2013-8#1)
stands in southern##2##3##(2008-10#2)
stands in##4##2##(2008-10#3)(2010-8#1)
stands of##7##2##(2008-10#5)(2008-12#2)
stands with##4##2##(2008-10#4)
stands##44##1##(1995-3#1)(2008-10#38)(2008-12#2)(2010-8#1)(2012-3#1)(2013-8#1)
standstill##2##1##(1993-6#1)(1997-5#1)
stannous chloride##4##2##(2008-10#4)
stapedius##5##1##(2008-9#5)
staphylocoagulase##3##1##(2010-6#3)
staphylococcal enterotoxin##2##2##(1993-3#1)(2008-10#1)
staphylococcal plasmids##4##2##(2012-3#4)
staphylococcal##12##1##(1990-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#2)(2010-6#1)(2012-3#4)
staphylococci isolated##2##2##(2008-7#1)(2012-3#1)
staphylococci##11##1##(1990-6#1)(2006-6#1)(2008-7#3)(2010-12#1)(2010-4#3)(2012-3#2)
staphylococcus aureus##2##2##(2010-8#1)(2013-1#1)
staphylococcus##3##1##(1991-3#1)(2010-8#1)(2013-1#1)
staple##5##1##(1991-12#2)(2008-9#1)(2009-10#1)(2009-12#1)
stapler##4##1##(1992-9#2)(1995-1#1)(1995-3#1)
stapling device##2##2##(1993-12#1)(1995-3#1)
stapling##4##1##(1991-12#1)(1993-12#1)(1995-3#2)
star##8##1##(1994-2#1)(2007-12#2)(2008-3#4)(2013-8#1)
starch 4##4##2##(2008-5#4)
starch accumulation##2##2##(2008-10#2)
starch and##3##2##(2008-10#1)(2009-12#1)(2013-8#1)
starch breakdown##2##2##(2008-9#2)
starch concentrations##2##2##(2008-10#1)(2008-9#1)
starch degradation##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
starch granules##4##2##(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
starch hydrolysis##3##2##(2008-10#2)(2008-9#1)
starch in##7##2##(2008-10#2)(2008-5#2)(2008-8#2)(2010-8#1)
starch with##2##2##(2008-10#1)(2010-8#1)
starch##68##1##(1991-12#2)(1993-6#2)(1995-6#1)(1997-5#2)(2008-10#20)(2008-11#1)(2008-5#16)(2008-8#5)(2008-9#5)(2009-10#2)(2009-12#1)(2009-8#2)(2010-8#3)(2011-2#1)(2013-1#1)(2013-8#4)
stark contrast##2##2##(2011-2#1)(2013-1#1)
starlings##4##1##(2008-8#2)(2008-9#2)
stars##8##1##(1991-1#1)(1996-3#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#3)
start codon##4##2##(1991-6#2)(2008-8#1)(2008-9#1)
start in##2##2##(1993-2#1)(2008-11#1)
start of the study##3##4##(1992-5#1)(2008-5#1)(2012-2#1)
start of the##15##3##(1991-5#1)(1991-6#1)(1992-5#1)(1993-8#1)(1994-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
start of##38##2##(1990-9#1)(1991-5#1)(1991-6#3)(1992-5#2)(1992-9#1)(1993-6#1)(1993-8#1)(1994-12#2)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#1)
start performance##3##2##(2011-2#3)
start site was##3##3##(1991-7#2)(1994-11#1)
start site##15##2##(1991-5#1)(1991-7#2)(1992-10#1)(1992-8#1)(1994-11#1)(1995-11#2)(1995-2#2)(1995-6#2)(1996-12#1)(1997-8#1)(2008-11#1)
start sites##5##2##(1993-8#1)(1994-11#3)(2008-4#1)
start smoking##2##2##(1990-2#2)
start their##2##2##(2009-12#1)(2011-2#1)
start to be##2##3##(2008-7#1)(2011-2#1)
start to##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
start up##2##2##(1992-1#1)(2008-10#1)
start with##3##2##(1994-12#1)(2008-3#1)(2010-6#1)
start##124##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#3)(1991-6#6)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#3)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-6#2)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
start-up##7##1##(1991-12#1)(1991-3#4)(1997-2#1)(2008-7#1)
started and##2##2##(2008-12#1)(2011-1#1)
started immediately after##2##3##(2008-10#1)(2008-7#1)
started in##8##2##(1990-2#1)(1991-12#1)(1992-5#1)(1996-6#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
started on##5##2##(2007-12#1)(2008-12#1)(2009-11#1)(2011-1#1)(2012-3#1)
started the##2##2##(2010-1#1)(2010-11#1)
started to be##3##3##(2008-11#2)(2010-8#1)
started to decrease##2##3##(2008-10#1)(2008-11#1)
started to##18##2##(1994-1#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#6)(2008-12#2)(2010-8#1)(2010-9#1)(2011-3#1)
started with##5##2##(1991-2#2)(1991-6#1)(1995-2#1)(2011-1#1)
started within 24 h##2##4##(2011-2#2)
started within 24##3##3##(2011-2#3)
started within##4##2##(1992-2#1)(2011-2#3)
started##86##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-5#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#8)(2008-12#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#6)
starter##2##1##(2008-3#1)(2010-4#1)
starting and##3##2##(2008-10#3)
starting at a##2##3##(1993-6#1)(2011-2#1)
starting at the##2##3##(2008-10#1)(2008-5#1)
starting at##13##2##(1991-6#1)(1993-6#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
starting compound for##2##3##(2008-11#1)(2008-5#1)
starting concentrations##2##2##(1994-5#1)(2012-2#1)
starting from the##3##3##(1996-2#1)(1996-5#1)(2010-10#1)
starting from##11##2##(1990-8#1)(1993-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#1)
starting hemodialysis##2##2##(1991-11#1)(2012-3#1)
starting in the##3##3##(1993-8#1)(1996-3#1)(2012-3#1)
starting in##10##2##(1993-8#1)(1994-12#1)(1994-3#1)(1996-3#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-2#2)(2012-3#1)
starting material and##2##3##(2008-10#1)(2008-5#1)
starting material for##2##3##(2008-11#1)(2008-9#1)
starting material##12##2##(1996-5#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#2)
starting materials##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)
starting molar##3##2##(2008-10#3)
starting on##3##2##(1991-2#1)(2007-8#1)(2010-7#1)
starting point for the##2##4##(2008-10#1)(2008-11#1)
starting point for##10##3##(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#1)(2010-11#1)(2013-1#1)
starting point is##2##3##(1994-12#1)(2008-11#1)
starting point##19##2##(1994-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
starting points for##2##3##(1997-8#1)(2008-4#1)
starting the##4##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
starting time##4##2##(2008-10#1)(2010-8#2)(2011-2#1)
starting to##3##2##(1994-3#1)(2010-12#1)(2013-8#1)
starting treatment with##3##3##(1993-2#1)(2011-2#1)(2012-3#1)
starting treatment##4##2##(1991-9#1)(1993-2#1)(2011-2#1)(2012-3#1)
starting values for##3##3##(2008-10#1)(2008-2#2)
starting values##5##2##(1993-8#1)(2008-10#1)(2008-2#3)
starting with##7##2##(1993-3#1)(1994-11#1)(2008-4#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
starting##148##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#5)(1997-3#1)(1997-6#1)(1997-8#4)(2007-8#1)(2008-1#1)(2008-10#37)(2008-11#10)(2008-12#1)(2008-2#3)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#2)
startle response##5##2##(1996-2#2)(1996-5#1)(2008-11#2)
startle responses##2##2##(1996-2#2)
startle##18##1##(1996-2#5)(1996-5#2)(2008-11#11)
starts by##4##2##(1997-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
starts from the##2##3##(2008-7#1)(2009-10#1)
starts in the##2##3##(1994-11#1)(2013-8#1)
starts the##2##2##(2008-10#2)
starts to##6##2##(1994-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)
starts with the##2##3##(2008-7#1)(2010-11#1)
starts with##5##2##(1994-1#1)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)
starts##28##1##(1991-3#1)(1992-10#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
startup##5##1##(2008-11#4)(2010-8#1)
starvation##17##1##(2008-10#1)(2008-11#6)(2008-7#5)(2008-9#4)(2010-10#1)
starved##4##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
starving##2##1##(2009-8#1)(2011-2#1)
stasis in##2##2##(1994-3#1)(2013-1#1)
stasis ulcers##5##2##(2013-1#5)
stasis##13##1##(1994-3#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#7)(2013-8#2)
state Medicaid programs##2##3##(1995-12#1)(1997-2#1)
state activities##2##2##(1997-3#1)(1997-7#1)
state agencies##4##2##(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)
state analog##2##2##(1991-5#2)
state and federal##4##3##(1995-2#1)(1996-1#1)(1997-3#1)(2010-9#1)
state and local health##3##4##(1996-3#1)(1997-3#1)(2011-9#1)
state and local public health##5##5##(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)
state and local##13##3##(1995-12#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-2#3)(1997-3#1)(2011-9#3)
state and the##7##3##(1996-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
state and##57##2##(1990-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-2#2)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-9#3)(2013-1#2)(2013-8#2)
state anxiety##2##2##(2010-6#2)
state are##2##2##(1996-2#1)(2008-7#1)
state as##4##2##(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
state at pH##4##3##(1990-8#2)(1993-8#2)
state at##7##2##(1990-8#2)(1993-8#2)(1995-12#1)(2008-10#1)(2008-11#1)
state attorneys general##2##3##(2008-11#2)
state by##4##2##(1990-11#1)(2008-10#1)(2010-12#1)(2011-2#1)
state can be##2##3##(1990-2#1)(1997-2#1)
state during##2##2##(2010-12#1)(2012-3#1)
state examination (MMSE)##2##3##(2008-7#2)
state fluorescence##3##2##(1995-3#1)(2008-10#2)
state following##2##2##(1990-11#1)(1991-2#1)
state for##3##2##(1997-3#1)(2008-11#1)(2009-5#1)
state from##2##2##(2008-10#1)(2008-3#1)
state government##3##2##(1994-12#1)(1997-1#1)(1997-3#1)
state governments##2##2##(1996-1#1)(1997-3#1)
state health agencies to##3##4##(1997-1#3)
state health agencies##5##3##(1995-12#1)(1997-1#4)
state health agency##3##3##(1996-2#1)(1997-1#1)(1997-2#1)
state health departments##3##3##(1996-3#1)(1997-2#1)(1997-3#1)
state health reform##2##3##(1994-2#1)(1997-3#1)
state health services commissions##2##4##(1997-2#2)
state health##20##2##(1994-2#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#5)(1997-2#4)(1997-3#3)(2013-8#1)
state hospital##2##2##(1996-9#1)(2008-11#1)
state in the##4##3##(1996-3#1)(1997-2#1)(2008-10#1)(2008-7#1)
state in vivo##2##3##(1995-12#1)(2008-9#1)
state in##24##2##(1990-3#2)(1991-9#1)(1995-11#1)(1995-12#2)(1996-3#1)(1997-2#1)(1997-3#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
state is##11##2##(1991-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
state law##3##2##(1996-5#1)(1997-7#1)(2008-4#1)
state legislation##4##2##(2008-11#4)
state legislators##2##2##(2008-11#2)
state may##2##2##(1992-8#1)(2008-9#1)
state mental health##2##3##(1995-2#2)
state mental##4##2##(1995-2#3)(1996-9#1)
state name##2##2##(1990-11#2)
state nursing##2##2##(1996-3#1)(2012-3#1)
state of São Paulo##3##4##(1996-12#1)(2008-10#2)
state of a##4##3##(1991-9#1)(2008-1#1)(2008-2#1)(2008-3#1)
state of art##3##3##(1993-2#1)(2008-11#1)(2013-1#1)
state of health##4##3##(1992-3#1)(1993-11#1)(1994-9#1)(1997-1#1)
state of knowledge on##2##4##(1990-8#1)(2012-2#1)
state of knowledge##8##3##(1990-8#1)(1991-3#1)(2008-10#3)(2008-11#1)(2012-2#1)(2012-3#1)
state of polarization##6##3##(2008-2#2)(2008-3#4)
state of rebalance##2##3##(2013-1#2)
state of the art##12##4##(1993-3#2)(1994-8#1)(1995-2#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-9#1)(2012-2#2)
state of the cell##3##4##(1993-8#1)(1995-9#1)(2012-3#1)
state of the science##3##4##(2009-5#2)(2010-9#1)
state of the##58##3##(1990-2#1)(1990-8#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-3#1)(2012-2#2)(2012-3#1)
state of##178##2##(1990-2#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(2007-12#2)(2008-1#3)(2008-10#38)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#2)(2009-7#4)(2010-12#3)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#4)(2011-2#9)(2011-3#1)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#3)
state on##2##2##(1990-8#1)(2008-7#1)
state or local##2##3##(1995-2#1)(2011-9#1)
state or##5##2##(1995-2#1)(2008-11#1)(2008-2#1)(2011-9#1)(2013-8#1)
state policy##2##2##(2008-12#1)(2013-1#1)
state public health##3##3##(1995-2#2)(1997-3#1)
state regulations##2##2##(1995-2#2)
state response##2##2##(1997-3#1)(2008-10#1)
state space models in##2##4##(2008-11#2)
state space models##5##3##(2008-11#5)
state space##11##2##(2008-11#8)(2008-8#1)(2008-9#2)
state than##2##2##(1994-8#1)(2008-10#1)
state that##9##2##(1994-1#1)(1994-2#1)(1995-9#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-7#1)(2012-2#1)(2013-8#1)
state to##8##2##(1992-5#1)(1995-12#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-8#1)
state using##2##2##(2008-10#1)(2010-6#1)
state variables##3##2##(2008-11#3)
state was##9##2##(1991-6#1)(1992-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2012-2#1)
state with##5##2##(1991-3#1)(2008-7#2)(2010-7#1)(2012-12#1)
state##738##1##(1990-11#9)(1990-12#4)(1990-2#4)(1990-3#4)(1990-5#2)(1990-8#10)(1990-9#1)(1991-12#1)(1991-2#5)(1991-3#4)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-2#3)(1992-3#1)(1992-5#2)(1992-8#4)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-8#5)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#15)(1995-2#16)(1995-3#7)(1995-6#7)(1995-8#1)(1995-9#2)(1996-1#9)(1996-11#1)(1996-12#8)(1996-2#8)(1996-3#20)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#15)(1997-2#23)(1997-3#21)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#2)(2008-1#7)(2008-10#133)(2008-11#59)(2008-12#6)(2008-2#8)(2008-3#17)(2008-4#8)(2008-5#10)(2008-6#3)(2008-7#32)(2008-8#12)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#6)(2009-8#7)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#8)(2010-4#3)(2010-5#2)(2010-6#8)(2010-7#3)(2010-8#2)(2010-9#5)(2011-1#1)(2011-2#23)(2011-3#1)(2011-9#5)(2012-12#3)(2012-2#16)(2012-3#9)(2013-1#14)(2013-8#15)
state&quot##3##1##(1995-3#1)(2008-9#2)
state's##7##1##(1991-8#1)(1992-8#1)(1995-6#1)(1996-5#1)(1996-9#1)(2010-5#1)(2011-2#1)
state)##4##1##(1995-3#1)(2008-10#1)(2010-5#1)(2013-1#1)
state-of-the-art of##2##2##(2008-10#1)(2011-7#1)
state-of-the-art##19##1##(1991-1#1)(1992-11#1)(1992-2#1)(1996-1#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-7#1)(2012-12#1)(2012-2#1)
stated by##3##2##(1991-6#2)(1992-2#1)
stated in##2##2##(1995-2#1)(2007-11#1)
stated that the##5##3##(1990-11#1)(1993-3#1)(1995-6#1)(1997-8#1)(2008-11#1)
stated that their##2##3##(1996-1#1)(2010-6#1)
stated that they had##2##4##(2008-11#1)(2011-2#1)
stated that they##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
stated that##23##2##(1990-11#1)(1992-11#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1997-8#1)(2008-1#2)(2008-11#2)(2009-8#2)(2010-10#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-2#1)
stated##44##1##(1990-11#1)(1991-6#2)(1992-11#1)(1992-2#4)(1993-3#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2009-8#2)(2010-10#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-2#1)
statement by the##2##3##(1996-3#1)(2012-12#1)
statement for the##2##3##(2008-12#1)(2010-6#1)
statement for##3##2##(1996-8#1)(2008-12#1)(2010-6#1)
statement of the##4##3##(2007-9#2)(2008-3#1)(2009-11#1)
statement on the##3##3##(1991-3#1)(2009-8#2)
statement on##13##2##(1991-3#1)(1993-3#2)(1994-9#1)(1995-11#2)(1995-12#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-3#1)(2009-8#2)
statement to##2##2##(1993-11#1)(2008-6#1)
statement were##2##2##(2008-10#1)(2009-8#1)
statement##42##1##(1991-3#1)(1992-3#1)(1993-11#1)(1993-3#2)(1994-1#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-5#1)(1996-3#2)(1996-8#1)(1997-5#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#3)(2009-11#1)(2009-6#1)(2009-8#3)(2010-6#1)(2012-12#1)(2013-1#4)
statements and##2##2##(1992-12#1)(2008-10#1)
statements regarding##2##2##(1997-1#1)(2008-11#1)
statements that##4##2##(2008-11#2)(2011-2#2)
statements##23##1##(1990-11#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#2)(1997-1#2)(1997-3#2)(2008-10#1)(2008-11#3)(2008-9#1)(2009-4#1)(2011-2#4)(2013-1#3)
states (the##2##2##(2008-8#1)(2009-8#1)
states and the##4##3##(2009-1#1)(2009-6#1)(2010-5#1)(2013-1#1)
states and##20##2##(1993-5#1)(1995-5#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#3)(2008-7#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2013-1#1)
states and/or##2##2##(2008-11#1)(2010-7#1)
states are##6##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-8#1)
states but also##2##3##(2008-12#1)(2009-10#1)
states during##2##2##(1991-6#1)(2009-5#1)
states for##4##2##(1991-9#1)(1996-5#1)(2008-10#1)(2009-8#1)
states in a##2##3##(1995-3#1)(2007-11#1)
states in the##5##3##(2008-10#2)(2010-10#1)(2013-1#1)(2013-8#1)
states in##18##2##(1993-12#1)(1994-12#1)(1995-3#1)(1996-2#2)(1997-3#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
states is##4##2##(1994-1#2)(2008-3#1)(2008-7#1)
states of fac-Re(CO)(3)(dpknph)Cl##2##3##(2008-10#2)
states of interest##2##3##(2008-11#1)(2011-2#1)
states of the neurons##2##4##(2008-11#1)(2009-8#1)
states of the##9##3##(1991-6#1)(1994-3#1)(1995-2#1)(2008-10#3)(2008-11#1)(2009-8#1)(2013-8#1)
states of##33##2##(1990-2#1)(1990-8#1)(1991-6#1)(1991-9#1)(1993-5#1)(1994-11#1)(1994-3#2)(1995-2#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-10#12)(2008-11#3)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-8#1)
states that##16##2##(1993-2#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
states to##6##2##(1995-12#1)(1997-1#2)(1997-3#1)(2008-4#1)(2012-2#1)
states under##3##2##(2006-6#1)(2008-11#1)(2011-2#1)
states was##3##2##(1996-5#1)(2008-10#1)(2008-7#1)
states were##7##2##(1994-6#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
states which##2##2##(1996-1#1)(2008-7#1)
states with the##2##3##(2008-10#1)(2008-7#1)
states with##8##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2012-2#1)
states##280##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-9#3)(1992-11#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#3)(1993-8#3)(1994-1#4)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#1)(1997-1#6)(1997-2#3)(1997-3#5)(1997-5#1)(1997-8#1)(2006-6#1)(2007-11#5)(2008-1#2)(2008-10#53)(2008-11#21)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#2)(2008-7#19)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#4)(2009-12#2)(2009-5#3)(2009-6#2)(2009-8#6)(2010-10#3)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#9)(2012-12#2)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#6)(2013-8#7)
states'##4##1##(1997-1#2)(2008-11#1)(2012-3#1)
states)##3##1##(1993-1#1)(2008-10#1)(2009-5#1)
statewide##14##1##(1991-2#1)(1994-12#1)(1995-1#1)(1995-12#2)(1996-1#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(2008-9#1)(2012-2#1)
static SDME##2##2##(2008-10#2)
static and dynamic modes##2##4##(2008-10#1)(2010-7#1)
static and dynamic##12##3##(1994-3#1)(1995-3#1)(2008-10#6)(2008-3#2)(2010-7#1)(2011-2#1)
static and##16##2##(1992-3#1)(1994-3#1)(1995-3#1)(2008-10#7)(2008-3#2)(2009-1#2)(2010-7#1)(2011-2#1)
static extraction time##2##3##(2008-10#2)
static extraction##4##2##(2008-10#4)
static headspace (HS)##2##3##(2008-10#2)
static headspace gas chromatographic##2##4##(2008-10#2)
static headspace gas##3##3##(2008-10#3)
static headspace##5##2##(2008-10#5)
static images##4##2##(2013-1#4)
static imaging method##2##3##(2008-10#2)
static imaging##3##2##(2008-10#3)
static mercury drop electrode (SMDE)##4##5##(2008-10#4)
static mercury drop electrode##10##4##(2008-10#10)
static mode sampling##2##3##(2008-10#2)
static mode##3##2##(2008-10#3)
static or##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
static quenching effect##2##3##(2008-10#2)
static quenching##3##2##(2008-10#3)
static seeding##3##2##(2011-2#3)
static time##2##2##(2008-10#2)
static ultrasonic##3##2##(2008-10#3)
static##121##1##(1991-6#1)(1992-3#2)(1992-6#2)(1993-9#1)(1994-3#2)(1995-3#1)(1996-12#1)(1997-1#1)(2008-10#54)(2008-11#10)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#3)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#8)
statically##3##1##(1990-8#1)(2008-10#1)(2011-2#1)
statin therapy##7##2##(2008-11#1)(2008-3#1)(2010-12#2)(2013-8#3)
statin##12##1##(2008-11#1)(2008-3#2)(2010-12#4)(2013-8#5)
stating that##3##2##(1995-6#2)(1996-5#1)
stating##5##1##(1995-6#2)(1996-5#2)(2009-12#1)
statins and##4##2##(2008-10#1)(2008-12#1)(2009-6#1)(2013-8#1)
statins##16##1##(2008-10#1)(2008-12#1)(2008-6#1)(2009-6#3)(2010-12#1)(2010-2#1)(2013-1#6)(2013-8#2)
station of the##2##3##(2008-10#1)(2010-1#1)
station##14##1##(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
stationary phase Chromosorb 105##2##4##(2008-10#2)
stationary phase and a##2##4##(2008-10#2)
stationary phase and##10##3##(2008-10#8)(2008-4#1)(2008-7#1)
stationary phase at##3##3##(2008-10#2)(2008-11#1)
stationary phase by HPLC##3##4##(2008-10#3)
stationary phase by##4##3##(2008-10#4)
stationary phase for the##2##4##(2008-10#2)
stationary phase for##6##3##(2008-10#6)
stationary phase in the##3##4##(2008-10#3)
stationary phase in##5##3##(2008-10#5)
stationary phase of##5##3##(2008-10#4)(2008-11#1)
stationary phase surface##2##3##(2008-10#1)(2008-11#1)
stationary phase was##6##3##(2008-10#5)(2008-7#1)
stationary phase with##2##3##(2008-10#2)
stationary phase##114##2##(2008-10#93)(2008-11#8)(2008-4#1)(2008-5#1)(2008-7#6)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
stationary phases and##3##3##(2008-10#3)
stationary phases for steroids were##2##5##(2008-10#2)
stationary phases for##6##3##(2008-10#6)
stationary phases were##5##3##(2008-10#3)(2008-11#1)(2010-11#1)
stationary phases with the##2##4##(2008-10#2)
stationary phases##30##2##(2008-10#26)(2008-11#2)(2009-8#1)(2010-11#1)
stationary signal wave##2##3##(2008-3#2)
stationary##170##1##(1995-3#1)(2007-12#1)(2008-10#125)(2008-11#16)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#7)(2008-9#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)
stations in##6##2##(1991-12#1)(1993-3#1)(2008-10#3)(2008-11#1)
stations##21##1##(1990-3#1)(1991-12#1)(1993-3#1)(2008-10#15)(2008-11#2)(2009-4#1)
statistic for##3##2##(1996-3#1)(2008-12#1)(2012-3#1)
statistic is##3##2##(1992-9#1)(1996-3#1)(2008-10#1)
statistic that##2##2##(2008-10#1)(2008-8#1)
statistic was##2##2##(2008-10#2)
statistic##33##1##(1992-9#2)(1993-12#1)(1994-9#3)(1995-9#1)(1996-3#6)(2008-10#12)(2008-12#1)(2008-3#2)(2008-8#2)(2009-8#1)(2011-2#1)(2012-3#1)
statistical agreement with##2##3##(2008-10#2)
statistical agreement##3##2##(2008-10#3)
statistical analyses are##2##3##(1992-12#1)(2010-7#1)
statistical analyses##5##2##(1992-12#1)(2008-1#1)(2008-12#1)(2008-9#1)(2010-7#1)
statistical analysis is##2##3##(1990-5#1)(2008-2#1)
statistical analysis of the data##2##5##(2008-10#2)
statistical analysis of the results##2##5##(2008-10#2)
statistical analysis of the##9##4##(1990-9#1)(2008-10#4)(2008-11#2)(2008-9#1)(2013-1#1)
statistical analysis of##12##3##(1990-9#1)(1995-5#1)(2008-10#6)(2008-11#2)(2008-9#1)(2013-1#1)
statistical analysis was performed using##2##5##(2011-2#2)
statistical analysis was##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
statistical analysis##32##2##(1990-5#1)(1990-9#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
statistical and##4##2##(1993-12#1)(2007-12#1)(2008-11#1)(2008-8#1)
statistical applications##2##2##(2008-10#2)
statistical approach##2##2##(2008-10#1)(2008-5#1)
statistical approaches##2##2##(2008-10#1)(2008-9#1)
statistical association##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
statistical averaging##3##2##(2008-9#3)
statistical comparison of##2##3##(2008-10#1)(2013-1#1)
statistical comparison##5##2##(2008-10#3)(2010-11#1)(2013-1#1)
statistical correlation between##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
statistical correlation##5##2##(1992-12#1)(2008-10#1)(2008-7#1)(2012-4#1)(2013-1#1)
statistical data##4##2##(1995-1#1)(1997-8#1)(2008-10#1)(2008-7#1)
statistical design##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
statistical difference in the##2##4##(2011-1#1)(2011-2#1)
statistical difference in##3##3##(1990-12#1)(2011-1#1)(2011-2#1)
statistical difference was##4##3##(1994-3#1)(2008-10#1)(2010-8#1)(2013-8#1)
statistical difference##15##2##(1990-12#1)(1994-3#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
statistical differences between##3##3##(2008-1#1)(2008-7#1)(2012-2#1)
statistical differences in##4##3##(2012-12#1)(2013-1#3)
statistical differences##11##2##(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#3)
statistical distribution##2##2##(2008-3#1)(2009-10#1)
statistical evaluation of the##2##4##(2008-10#1)(2011-3#1)
statistical evaluation of##3##3##(1994-2#1)(2008-10#1)(2011-3#1)
statistical evaluation##8##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
statistical geometry##3##2##(1997-6#3)
statistical inevitability##2##2##(2008-9#2)
statistical inference##2##2##(2008-10#1)(2008-11#1)
statistical measures##2##2##(2008-10#2)
statistical method##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
statistical methodology##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
statistical methods to##2##3##(2008-10#1)(2008-3#1)
statistical methods##17##2##(1990-2#1)(1990-9#1)(1993-11#1)(1997-1#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)
statistical model for##2##3##(1995-12#1)(2008-10#1)
statistical model##8##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-11#1)
statistical models for##2##3##(1996-3#1)(2010-1#1)
statistical models##4##2##(1996-3#1)(2008-10#2)(2010-1#1)
statistical parameters##4##2##(2008-10#3)(2008-12#1)
statistical power##4##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
statistical procedures for##2##3##(1996-6#1)(2008-10#1)
statistical process control (SPC)##2##4##(1996-1#1)(2008-10#1)
statistical process control##3##3##(1995-2#1)(1996-1#1)(2008-10#1)
statistical properties of##5##3##(2007-12#1)(2008-11#1)(2008-3#2)(2010-10#1)
statistical properties##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-10#1)
statistical regression##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
statistical relevance##2##2##(1991-2#1)(2011-2#1)
statistical significance (P=0##2##3##(2008-11#1)(2008-7#1)
statistical significance in##2##3##(1990-12#1)(1991-8#1)
statistical significance was##5##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
statistical significance##30##2##(1990-12#2)(1991-2#2)(1991-8#1)(1993-3#1)(1994-12#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-2#2)(2009-4#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
statistical significant decrease##2##3##(2013-8#2)
statistical software##4##2##(2007-12#1)(2008-10#2)(2011-2#1)
statistical study of##2##3##(2008-10#1)(2008-6#1)
statistical study##5##2##(2008-1#1)(2008-10#3)(2008-6#1)
statistical support##4##2##(1997-7#1)(2008-8#2)(2012-3#1)
statistical techniques##4##2##(1996-3#1)(2008-10#3)
statistical test##2##2##(2008-10#1)(2008-4#1)
statistical tests##4##2##(1994-1#1)(2008-10#3)
statistical theory##3##2##(2008-10#3)
statistical tools##4##2##(1993-3#1)(2008-10#2)(2010-8#1)
statistical treatment of##2##3##(2008-10#2)
statistical treatment##3##2##(2008-10#3)
statistical##314##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-9#2)(1991-2#3)(1991-5#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#3)(1996-3#3)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2006-6#1)(2007-12#4)(2008-1#4)(2008-10#99)(2008-11#22)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#18)(2009-10#2)(2009-2#2)(2009-4#1)(2009-7#1)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#6)(2012-4#1)(2013-1#13)(2013-8#6)
statistically analysed##2##2##(2008-10#1)(2008-9#1)
statistically analyzed##5##2##(2008-10#1)(2010-5#1)(2010-8#1)(2012-3#2)
statistically and##2##2##(2008-10#1)(2012-2#1)
statistically by##3##2##(2008-10#2)(2013-1#1)
statistically comparable##3##2##(2008-10#3)
statistically compared with those##2##4##(2008-10#2)
statistically compared with##5##3##(2008-10#5)
statistically compared##6##2##(2008-10#6)
statistically different##13##2##(1990-3#1)(1994-2#1)(1997-8#1)(2008-10#5)(2009-1#1)(2011-2#1)(2012-3#3)
statistically equivalent to##3##3##(2008-10#3)
statistically evaluated for its accuracy and precision##2##7##(2008-10#2)
statistically evaluated using##2##3##(2008-12#2)
statistically evaluated##8##2##(2008-10#4)(2008-12#2)(2008-7#1)(2009-1#1)
statistically higher##5##2##(1995-12#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#1)
statistically important influence##2##3##(2008-5#2)
statistically in##2##2##(1997-8#1)(2008-10#1)
statistically independent##2##2##(1996-12#1)(2008-12#1)
statistically indistinguishable##2##2##(2008-10#2)
statistically insignificant##2##2##(1993-6#1)(2008-2#1)
statistically related to##2##3##(1992-2#1)(2008-9#1)
statistically satisfactory##2##2##(2008-10#2)
statistically separated##2##2##(2008-10#2)
statistically significant (P &lt##4##4##(1994-12#1)(1996-12#1)(2008-10#1)(2008-5#1)
statistically significant (P##5##3##(1994-12#1)(1996-12#1)(2008-10#2)(2008-5#1)
statistically significant (p &lt##4##4##(1996-8#1)(2008-12#1)(2010-7#1)(2011-2#1)
statistically significant (p = 0##2##5##(2008-1#1)(2013-1#1)
statistically significant (p##7##3##(1996-8#1)(2008-1#1)(2008-12#2)(2010-7#1)(2011-2#1)(2013-1#1)
statistically significant and##2##3##(2008-10#1)(2008-8#1)
statistically significant association##2##3##(2008-5#1)(2011-2#1)
statistically significant associations##2##3##(2012-5#1)(2013-1#1)
statistically significant between##2##3##(2011-2#2)
statistically significant changes##2##3##(2008-11#1)(2011-2#1)
statistically significant correlation between##3##4##(1994-3#1)(1996-8#1)(2013-1#1)
statistically significant correlation##4##3##(1994-3#1)(1996-8#1)(2008-5#1)(2013-1#1)
statistically significant difference (p&gt##2##4##(2013-1#2)
statistically significant difference between the##4##5##(1992-11#1)(2008-12#2)(2012-3#1)
statistically significant difference between##6##4##(1992-11#1)(2007-12#1)(2008-12#2)(2010-12#1)(2012-3#1)
statistically significant difference in the##3##5##(2008-11#1)(2013-1#1)(2013-8#1)
statistically significant difference in##5##4##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
statistically significant difference was observed##2##5##(2009-11#1)(2013-1#1)
statistically significant difference was##4##4##(2009-11#1)(2011-2#1)(2013-1#2)
statistically significant difference##21##3##(1992-11#1)(1993-2#1)(2007-12#1)(2008-11#1)(2008-12#3)(2009-11#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
statistically significant differences between the##3##5##(2008-10#1)(2013-1#2)
statistically significant differences between##8##4##(1997-7#1)(2008-10#1)(2010-12#2)(2011-2#1)(2013-1#3)
statistically significant differences in the##2##5##(2008-7#1)(2012-3#1)
statistically significant differences in##6##4##(1996-12#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#2)
statistically significant differences were##5##4##(1992-12#1)(2008-10#2)(2008-8#1)(2012-3#1)
statistically significant differences##24##3##(1992-12#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-12#2)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#7)
statistically significant effect on##2##4##(2008-7#1)(2009-1#1)
statistically significant effect##4##3##(2008-10#1)(2008-7#1)(2009-1#1)(2009-3#1)
statistically significant for##3##3##(1990-2#2)(1991-1#1)
statistically significant improvement##3##3##(1994-12#1)(2008-12#1)(2013-1#1)
statistically significant improvements in##2##4##(1991-2#1)(1993-1#1)
statistically significant improvements##4##3##(1991-2#2)(1993-1#1)(2008-7#1)
statistically significant in##2##3##(2010-1#1)(2011-2#1)
statistically significant increase in the##2##5##(2009-8#2)
statistically significant increase in##4##4##(1992-2#1)(2009-8#3)
statistically significant increase##5##3##(1992-2#1)(2009-8#3)(2013-1#1)
statistically significant pre- to post-intervention##2##5##(2008-12#2)
statistically significant relationship between##2##4##(2008-11#1)(2011-2#1)
statistically significant relationship##3##3##(2008-11#1)(2010-9#1)(2011-2#1)
statistically significant results##2##3##(2008-10#1)(2012-12#1)
statistically significant##183##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#3)(1996-8#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#12)(2008-5#5)(2008-7#4)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#1)(2009-3#5)(2009-6#1)(2009-8#4)(2010-1#1)(2010-12#4)(2010-7#2)(2010-9#1)(2011-2#21)(2011-7#1)(2012-12#6)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#26)(2013-8#2)
statistically significant)##2##2##(2008-9#1)(2013-1#1)
statistically significantly different##2##3##(2010-10#1)(2011-2#1)
statistically significantly higher##3##3##(2008-12#1)(2013-1#2)
statistically significantly##7##2##(1997-5#1)(2008-12#1)(2010-10#1)(2011-2#2)(2013-1#2)
statistically similar to##2##3##(2008-10#1)(2013-1#1)
statistically similar##5##2##(2008-10#1)(2013-1#4)
statistically that the##2##3##(2008-1#1)(2008-8#1)
statistically the most significant##2##4##(2008-10#1)(2009-3#1)
statistically##305##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-8#1)(1991-1#1)(1991-2#3)(1992-11#1)(1992-12#1)(1992-2#4)(1992-4#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#3)(1996-8#2)(1997-5#2)(1997-7#1)(1997-8#3)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#74)(2008-11#10)(2008-12#16)(2008-2#1)(2008-5#8)(2008-7#5)(2008-8#9)(2008-9#7)(2009-1#3)(2009-11#1)(2009-3#6)(2009-6#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-12#5)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-2#26)(2011-7#1)(2012-12#6)(2012-2#4)(2012-3#10)(2012-5#1)(2013-1#40)(2013-8#2)
statisticians##2##1##(2008-10#1)(2010-1#1)
statistics also##2##2##(1996-3#1)(2008-9#1)
statistics and##7##2##(1991-3#1)(1992-9#1)(1995-9#1)(2008-10#2)(2008-4#1)(2010-5#1)
statistics are##6##2##(1992-2#1)(2008-3#3)(2008-9#1)(2010-7#1)
statistics for##5##2##(1992-2#1)(1992-9#1)(1995-1#1)(2008-10#1)(2011-3#1)
statistics in the##2##3##(1990-11#1)(2008-8#1)
statistics in##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
statistics of the##2##3##(2008-10#1)(2008-3#1)
statistics of##9##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2010-3#1)(2012-2#1)
statistics on##2##2##(2008-11#1)(2010-7#1)
statistics that##2##2##(1992-6#1)(2011-1#1)
statistics to##2##2##(2008-10#1)(2008-9#1)
statistics were calculated##2##3##(2008-10#1)(2008-11#1)
statistics were used##3##3##(2012-12#1)(2013-1#2)
statistics were##7##2##(1993-12#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#2)
statistics##119##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-2#3)(1992-6#2)(1992-9#3)(1993-12#1)(1993-2#3)(1994-12#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#3)(2008-1#1)(2008-10#22)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#14)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-12#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
stature with##2##2##(2013-1#2)
stature##20##1##(1996-6#1)(2008-10#2)(2008-7#1)(2010-6#1)(2011-1#4)(2012-2#1)(2012-3#2)(2013-1#8)
status (SES)##3##2##(2010-11#1)(2011-1#1)(2012-2#1)
status after##2##2##(2008-9#1)(2009-11#1)
status among immediately adjacent trees##2##5##(2008-10#2)
status among##6##2##(1992-12#1)(1996-6#1)(2008-10#2)(2011-2#2)
status and future##4##3##(1997-3#1)(2008-11#1)(2010-12#1)(2012-3#1)
status and risk factors##2##4##(2011-1#1)(2013-1#1)
status and risk##3##3##(1993-11#1)(2011-1#1)(2013-1#1)
status and the##5##3##(1997-1#1)(2008-11#2)(2008-7#2)
status and##63##2##(1990-6#1)(1991-6#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#3)(2008-7#5)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
status are##2##2##(2009-10#1)(2011-1#1)
status as##3##2##(1995-2#1)(1997-3#1)(2012-12#1)
status assessment##2##2##(1992-9#1)(2008-3#1)
status at##3##2##(1991-6#1)(1994-1#1)(2013-1#1)
status between##4##2##(1994-1#1)(2008-1#1)(2008-6#1)(2012-12#1)
status did not##2##3##(1995-12#1)(2008-11#1)
status for##5##2##(1993-2#1)(1994-1#1)(2008-10#1)(2011-2#1)(2011-3#1)
status from##4##2##(1996-11#1)(1996-5#1)(2008-9#1)(2012-2#1)
status in a##2##3##(1992-9#1)(2008-12#1)
status in the elderly##2##4##(2008-10#1)(2008-7#1)
status in the##4##3##(1996-5#1)(2008-10#1)(2008-7#1)(2009-9#1)
status in##25##2##(1992-9#1)(1993-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#2)(2009-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
status information##2##2##(1996-1#1)(2008-10#1)
status is a##2##3##(1996-5#1)(2010-10#1)
status is##9##2##(1991-12#1)(1996-5#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#2)(2011-2#1)
status may##2##2##(1994-6#1)(2013-8#1)
status of Medicare##2##3##(1993-3#1)(1997-2#1)
status of a##3##3##(1996-3#1)(2008-10#2)
status of an##2##3##(2008-11#1)(2011-2#1)
status of children##3##3##(1996-1#1)(2008-11#1)(2010-6#1)
status of displaced persons##2##4##(1994-9#2)
status of patients in##2##4##(1992-3#1)(1995-3#1)
status of patients with##2##4##(1992-3#1)(2012-3#1)
status of patients##5##3##(1992-3#2)(1995-3#1)(2009-5#1)(2012-3#1)
status of the##43##3##(1990-8#2)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
status of these##5##3##(1994-1#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
status of##154##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#2)(1992-3#4)(1993-1#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#4)(2007-12#1)(2008-1#3)(2008-10#23)(2008-11#16)(2008-12#3)(2008-5#4)(2008-7#4)(2008-9#5)(2009-12#1)(2009-5#2)(2009-8#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-4#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#11)(2013-8#2)
status on##6##2##(1993-12#1)(1993-2#1)(2008-11#1)(2009-9#1)(2010-4#1)(2011-2#1)
status or##3##2##(1990-12#1)(2008-12#1)(2008-4#1)
status than##2##2##(2010-6#1)(2013-8#1)
status to##4##2##(1992-9#1)(1995-12#1)(2010-10#1)(2013-1#1)
status was assessed by##2##4##(1993-3#1)(2008-7#1)
status was assessed##4##3##(1991-12#1)(1991-2#1)(1993-3#1)(2008-7#1)
status was determined by##2##4##(1993-11#1)(2008-8#1)
status was determined##3##3##(1993-11#1)(2008-11#1)(2008-8#1)
status was evaluated##2##3##(2008-10#1)(2011-1#1)
status was not##2##3##(2008-10#1)(2013-8#1)
status was##17##2##(1991-12#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
status with##5##2##(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-2#1)
status within##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
status##556##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-6#5)(1991-8#1)(1992-12#4)(1992-2#4)(1992-3#4)(1992-9#7)(1993-1#7)(1993-11#5)(1993-12#5)(1993-2#3)(1993-3#6)(1993-6#2)(1994-1#5)(1994-12#9)(1994-2#1)(1994-3#9)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#8)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#2)(1996-5#6)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#6)(1997-5#2)(1997-7#5)(1997-8#7)(2007-12#1)(2008-1#9)(2008-10#56)(2008-11#40)(2008-12#17)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#18)(2008-8#5)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#5)(2009-6#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#12)(2010-11#2)(2010-12#6)(2010-2#5)(2010-4#4)(2010-5#2)(2010-6#6)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#31)(2011-3#2)(2011-7#2)(2012-12#15)(2012-2#23)(2012-3#11)(2013-1#32)(2013-8#15)
status)##6##1##(1992-12#1)(1993-3#1)(2008-6#1)(2008-8#1)(2010-1#1)(2013-1#1)
status]##2##1##(1991-3#1)(1993-11#1)
statute and##2##2##(1993-1#1)(1994-2#1)
statute of limitations##2##3##(1996-5#2)
statute of##3##2##(1996-5#3)
statute##16##1##(1993-1#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-6#2)(1996-5#5)(1997-1#1)(1997-6#1)(1997-7#2)
statutes##3##1##(1994-1#2)(1997-6#1)
statutory health insurance##2##3##(1992-12#1)(2008-11#1)
statutory##13##1##(1992-12#1)(1992-2#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-11#4)(2012-3#1)(2013-8#1)
staufen##4##1##(1994-12#4)
staurosporine##13##1##(1990-12#2)(1990-8#3)(1993-3#2)(1993-6#2)(1995-11#1)(2008-10#1)(2008-11#2)
stavudine##5##1##(2008-10#3)(2008-7#2)
stay and##5##2##(1996-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
stay for##6##2##(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#2)
stay in hospital##5##3##(1992-5#1)(1997-4#2)(1997-8#1)(2013-1#1)
stay in##7##2##(1991-12#1)(1992-5#1)(1994-12#1)(1997-4#2)(1997-8#1)(2013-1#1)
stay of the##2##3##(1990-9#1)(1997-6#1)
stay of##8##2##(1990-9#1)(1991-1#1)(1991-12#1)(1992-12#1)(1997-6#1)(2011-2#2)(2013-1#1)
stay on##3##2##(1994-3#1)(1997-2#1)(2013-1#1)
stay was##2##2##(1992-12#1)(2012-2#1)
stay were##3##2##(1990-9#1)(1994-1#1)(1996-3#1)
stay##111##1##(1990-9#2)(1991-1#1)(1991-12#8)(1991-3#1)(1992-1#2)(1992-12#11)(1992-2#3)(1992-3#2)(1992-5#1)(1993-1#3)(1993-12#8)(1993-2#4)(1993-3#1)(1994-1#2)(1994-12#4)(1994-3#6)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2011-2#8)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#2)
stayed in##2##2##(2008-10#1)(2012-3#1)
stayed##10##1##(1997-8#1)(2008-10#3)(2008-5#2)(2012-2#1)(2012-3#2)(2013-1#1)
staying in the##2##3##(2008-10#1)(2009-12#1)
staying in##5##2##(2008-10#1)(2009-12#1)(2010-10#2)(2013-1#1)
staying##9##1##(2008-10#1)(2008-12#1)(2008-8#2)(2009-12#1)(2010-10#2)(2011-3#1)(2013-1#1)
stays are##3##2##(1993-1#1)(2010-8#2)
stays in##3##2##(2008-11#1)(2010-8#1)(2013-1#1)
stays##20##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#2)(1994-1#1)(1996-1#2)(1996-2#1)(1996-3#2)(2008-11#1)(2008-12#1)(2010-8#4)(2012-3#1)(2013-1#1)
steadily from 2##2##3##(1994-12#1)(2008-10#1)
steadily increased##2##2##(1995-3#1)(2008-10#1)
steadily increasing##2##2##(1997-6#1)(2011-2#1)
steadily with##2##2##(1993-6#1)(1997-7#1)
steadily##20##1##(1990-5#2)(1993-12#2)(1993-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-5#1)(2011-2#2)
steady and unsteady##4##3##(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
steady in##2##2##(2008-11#2)
steady increase in the##2##4##(2009-7#1)(2012-2#1)
steady increase in##4##3##(2008-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
steady state and##5##3##(2008-10#3)(2008-7#2)
steady state conditions##2##3##(2008-10#2)
steady state fluorescence##2##3##(1995-3#1)(2008-10#1)
steady state fluxes##2##3##(2008-7#2)
steady state is##3##3##(2008-10#2)(2008-7#1)
steady state isotopomer##2##3##(2008-7#2)
steady state##43##2##(1990-2#1)(1991-5#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-7#1)(2008-10#15)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#10)(2010-11#1)(2011-2#1)(2013-8#2)
steady states##2##2##(1992-11#1)(1992-8#1)
steady swimming##2##2##(2010-8#2)
steady##79##1##(1990-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-3#3)(1997-7#1)(2008-10#19)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#7)
steady-state DO concentration##3##3##(2008-10#3)
steady-state Young's relaxation modulus##2##4##(2009-7#2)
steady-state concentration##2##2##(2008-10#2)
steady-state fluorescence##5##2##(1991-5#1)(2008-10#4)
steady-state growth##4##2##(1993-9#2)(2008-11#1)(2008-7#1)
steady-state kinetic##3##2##(1994-5#1)(1995-2#1)(1995-6#1)
steady-state level of##5##3##(1992-1#1)(1993-6#1)(1997-1#2)(2008-10#1)
steady-state level##6##2##(1992-1#1)(1993-6#1)(1997-1#2)(2008-10#1)(2008-7#1)
steady-state levels of##5##3##(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-8#1)
steady-state mRNA levels##3##3##(1992-10#1)(1992-9#1)(1997-7#1)
steady-state mRNA##4##2##(1992-10#1)(1992-9#1)(1997-7#1)(2008-8#1)
steady-state##68##1##(1991-5#1)(1991-7#2)(1992-1#1)(1992-10#1)(1992-9#1)(1993-6#1)(1993-9#2)(1994-5#2)(1995-12#1)(1995-2#2)(1995-6#1)(1997-1#3)(1997-7#2)(2008-10#22)(2008-11#5)(2008-3#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-7#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
steal##2##1##(1993-3#1)(2010-5#1)
steam generator##3##2##(2008-10#1)(2009-10#2)
steam##12##1##(2008-10#8)(2008-7#1)(2009-10#2)(2011-2#1)
steamed potting mix##2##3##(2008-10#2)
steaming and Al##2##3##(2008-10#2)
stearate##3##1##(2008-10#2)(2008-5#1)
stearic acid##7##2##(1991-3#2)(2008-10#5)
stearic##12##1##(1991-3#2)(1994-8#2)(2008-10#8)
stearothermophilus##2##1##(2008-7#1)(2011-2#1)
steatocystoma multiplex##2##2##(2012-3#2)
steatohepatitis##3##1##(2007-8#2)(2013-1#1)
steatosis##5##1##(2007-8#1)(2009-8#1)(2012-2#2)(2012-3#1)
steel and brass##2##3##(2008-10#2)
steel and##6##2##(2008-10#6)
steel pin##2##2##(2008-10#1)(2012-2#1)
steel production##2##2##(2008-10#2)
steel sample##3##2##(2008-10#3)
steel samples##6##2##(2008-10#6)
steel standards##2##2##(2008-10#2)
steel wire and##3##3##(2009-3#3)
steel wire##5##2##(2008-10#1)(2009-3#4)
steel##66##1##(1990-11#1)(1991-12#1)(1992-1#1)(2008-10#49)(2008-4#1)(2008-7#2)(2009-3#4)(2011-2#3)(2012-2#2)(2013-8#2)
steel)##3##1##(2008-10#2)(2011-2#1)
steelmaking##2##1##(2008-10#2)
steels is##2##2##(2008-10#2)
steels##11##1##(2008-10#11)
steels)##4##1##(2008-10#4)
steep decrease in##2##3##(2008-3#1)(2008-8#1)
steep learning##2##2##(2008-11#2)
steep trajectory##2##2##(1995-12#2)
steep##15##1##(1995-12#3)(1995-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
steeper than##2##2##(2008-8#2)
steeper##6##1##(1993-8#1)(2008-10#1)(2008-11#1)(2008-8#3)
steeply##4##1##(2008-11#1)(2008-8#1)(2008-9#2)
steering committee for##2##3##(1993-3#1)(1995-12#1)
steering committee##3##2##(1993-3#1)(1995-12#1)(1997-3#1)
steering##5##1##(1993-3#1)(1995-12#1)(1997-3#1)(2008-12#1)(2008-5#1)
steers##4##1##(1996-12#2)(1997-5#1)(2013-1#1)
stele##4##1##(2008-10#4)
stellar##2##1##(1997-8#1)(2008-3#1)
stellate cell##3##2##(2008-11#3)
stellate cells##8##2##(1997-3#1)(2008-11#5)(2009-7#1)(2013-8#1)
stellate##13##1##(1997-3#1)(2008-11#9)(2008-7#1)(2009-7#1)(2013-8#1)
stem (ES) cells##7##3##(1997-8#1)(2008-11#4)(2008-9#1)(2009-12#1)
stem (ES)##9##2##(1997-8#1)(2008-11#6)(2008-9#1)(2009-12#1)
stem and leaf##2##3##(2008-10#2)
stem and loop##2##3##(2008-8#1)(2011-3#1)
stem and progenitor cells##2##4##(2008-9#2)
stem and progenitor##3##3##(2008-4#1)(2008-9#2)
stem and##17##2##(1990-9#1)(2008-10#7)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-3#1)
stem base tissue##2##3##(2008-10#2)
stem base##4##2##(2008-10#4)
stem can be##2##3##(2008-10#2)
stem canker of##4##3##(2008-10#4)
stem canker##6##2##(2008-10#6)
stem cell banks##2##3##(2008-11#2)
stem cell biology and##2##4##(2008-11#1)(2009-12#1)
stem cell biology##5##3##(2008-11#4)(2009-12#1)
stem cell culture##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
stem cell differentiation##6##3##(2008-11#4)(2011-2#1)(2013-7#1)
stem cell fate##4##3##(2008-11#4)
stem cell is##2##3##(2008-10#1)(2010-8#1)
stem cell line##3##3##(2008-11#2)(2013-1#1)
stem cell lines##4##3##(1994-12#1)(2008-8#2)(2008-9#1)
stem cell maintenance and##2##4##(2009-8#1)(2013-8#1)
stem cell marker##2##3##(2009-10#1)(2012-5#1)
stem cell niche##3##3##(2009-12#1)(2009-8#1)(2012-2#1)
stem cell population in the##2##5##(2008-11#1)(2010-7#1)
stem cell population##9##3##(2008-11#6)(2010-7#3)
stem cell populations##3##3##(2008-11#1)(2009-8#1)(2010-6#1)
stem cell research##8##3##(2008-10#1)(2008-11#3)(2008-9#3)(2013-8#1)
stem cell therapy##5##3##(2008-10#1)(2010-12#1)(2010-3#1)(2012-4#1)(2013-1#1)
stem cell transplant##2##3##(2010-11#1)(2012-12#1)
stem cell transplantation in##3##4##(2008-10#1)(2010-11#1)(2012-12#1)
stem cell transplantation##17##3##(1997-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-11#5)(2011-2#2)(2012-12#3)(2013-1#1)
stem cell types##2##3##(2008-9#1)(2012-5#1)
stem cell##137##2##(1992-12#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-11#1)(1997-8#1)(2008-10#8)(2008-11#48)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#2)(2009-12#4)(2009-3#1)(2009-8#5)(2010-10#2)(2010-11#6)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#4)(2010-8#3)(2011-2#9)(2012-12#6)(2012-2#3)(2012-4#1)(2012-5#5)(2013-1#6)(2013-7#1)(2013-8#2)
stem cell-derived##2##2##(2011-2#2)
stem cell-like##2##2##(2012-5#1)(2013-1#1)
stem cells (ESC)##3##3##(2008-10#1)(2008-11#2)
stem cells (HSCs)##4##3##(1993-8#1)(2008-10#1)(2008-4#1)(2009-12#1)
stem cells and their##2##4##(2011-2#1)(2012-4#1)
stem cells and##6##3##(2008-11#2)(2010-12#1)(2011-2#1)(2012-4#1)(2013-1#1)
stem cells are##7##3##(2008-11#4)(2008-8#1)(2008-9#1)(2010-10#1)
stem cells both##2##3##(2008-11#2)
stem cells can be##3##4##(2008-11#2)(2008-9#1)
stem cells can##6##3##(2008-10#1)(2008-11#2)(2008-9#1)(2009-12#2)
stem cells for the treatment of##2##6##(2008-11#1)(2010-6#1)
stem cells for##4##3##(2008-11#2)(2010-6#1)(2012-5#1)
stem cells from human cord blood##2##6##(2008-9#2)
stem cells from##8##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-9#4)(2013-8#1)
stem cells have##4##3##(2008-11#2)(2010-6#1)(2011-2#1)
stem cells in a##2##4##(2008-11#1)(2010-10#1)
stem cells in the##2##4##(2010-6#1)(2013-8#1)
stem cells in##11##3##(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-6#1)(2012-3#1)(2012-5#1)(2013-8#2)
stem cells into##5##3##(2008-11#5)
stem cells is##2##3##(2008-9#1)(2012-2#1)
stem cells or##3##3##(2008-11#1)(2008-9#1)(2010-10#1)
stem cells to##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
stem cells were##3##3##(2008-11#1)(2009-12#1)(2010-6#1)
stem cells will##3##3##(2008-11#2)(2010-12#1)
stem cells with a##2##4##(2008-11#2)
stem cells##194##2##(1991-11#1)(1993-2#2)(1993-8#2)(1994-11#3)(1994-5#1)(1995-2#3)(1997-8#1)(2008-10#11)(2008-11#70)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#27)(2009-10#3)(2009-11#1)(2009-12#6)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#4)(2010-3#2)(2010-6#4)(2010-7#1)(2010-8#2)(2011-2#12)(2012-10#1)(2012-2#4)(2012-3#2)(2012-4#2)(2012-5#5)(2013-1#6)(2013-7#1)(2013-8#5)
stem colonization##2##2##(2008-10#2)
stem diameter##6##2##(2008-10#5)(2008-9#1)
stem elongation##2##2##(2008-10#2)
stem for##2##2##(2008-10#1)(2013-1#1)
stem from the##2##3##(1991-2#1)(2011-3#1)
stem from##7##2##(1990-11#1)(1991-2#1)(1993-12#1)(2008-10#2)(2008-11#1)(2011-3#1)
stem gall##9##2##(2008-10#9)
stem girdling##2##2##(2008-10#2)
stem grooving##3##2##(2008-10#3)
stem hydration##2##2##(2008-10#2)
stem in##3##2##(2008-10#1)(2013-1#2)
stem infection##5##2##(2008-10#5)
stem infections##2##2##(2008-10#2)
stem inoculation##2##2##(2008-10#2)
stem lesions##3##2##(2008-10#2)(2008-7#1)
stem necrosis##2##2##(2008-10#2)
stem of##4##2##(1995-6#1)(2008-10#2)(2008-9#1)
stem pieces##3##2##(2008-10#3)
stem pitting virus##4##3##(2008-10#4)
stem pitting##6##2##(2008-10#6)
stem rot caused by##2##4##(2008-10#2)
stem rot in##5##3##(2008-10#5)
stem rot of soybean##4##4##(2008-10#4)
stem rot of soybeans##2##4##(2008-10#2)
stem rot of##7##3##(2008-10#7)
stem rot or##2##3##(2008-10#2)
stem rot prevalence##2##3##(2008-10#2)
stem rot was##6##3##(2008-10#6)
stem rot##40##2##(2008-10#40)
stem rust races##2##3##(2008-10#2)
stem rust resistance genes##2##4##(2008-10#2)
stem rust resistance in the##2##5##(2008-10#2)
stem rust resistance in##4##4##(2008-10#4)
stem rust resistance##9##3##(2008-10#9)
stem rust##21##2##(2008-10#21)
stem samples##6##2##(2008-10#6)
stem segments##2##2##(2008-10#2)
stem tissue##4##2##(2008-10#3)(2008-11#1)
stem tissues##4##2##(2008-10#4)
stem to##4##2##(2008-10#4)
stem##614##1##(1990-11#1)(1990-5#1)(1990-9#3)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#4)(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-5#1)(1995-2#3)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-8#3)(2007-12#1)(2008-10#212)(2008-11#130)(2008-12#5)(2008-4#4)(2008-5#3)(2008-7#7)(2008-8#7)(2008-9#39)(2009-10#5)(2009-11#1)(2009-12#11)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#5)(2010-3#4)(2010-6#5)(2010-7#5)(2010-8#5)(2011-2#25)(2011-3#2)(2012-10#1)(2012-12#6)(2012-2#7)(2012-3#3)(2012-4#3)(2012-5#14)(2013-1#25)(2013-7#2)(2013-8#9)
stem-loop##7##1##(1994-12#1)(1995-12#1)(1997-6#2)(2008-10#2)(2013-1#1)
stem-pitting##3##1##(2008-10#3)
stem/progenitor##2##1##(2008-11#2)
stemmed from a##2##3##(1990-11#1)(1990-9#1)
stemming from the##3##3##(1991-3#1)(2009-12#1)(2011-2#1)
stemming from##7##2##(1991-3#2)(2008-11#1)(2009-11#1)(2009-12#1)(2010-4#1)(2011-2#1)
stemming##8##1##(1991-3#2)(2008-11#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-4#1)(2011-2#1)
stems after##2##2##(2008-10#1)(2011-10#1)
stems and leaves##2##3##(2008-10#1)(2013-8#1)
stems and roots##3##3##(2008-10#1)(2011-10#2)
stems and##9##2##(2008-10#6)(2011-10#2)(2013-8#1)
stems as##3##2##(2008-10#2)(2008-7#1)
stems from##4##2##(1990-6#1)(1996-3#1)(2008-8#1)(2012-2#1)
stems is##2##2##(2008-10#1)(2008-11#1)
stems of##12##2##(2008-10#9)(2008-11#2)(2011-2#1)
stems were##4##2##(2008-10#4)
stems with##2##2##(2008-10#2)
stems##87##1##(1990-6#1)(1991-7#1)(1996-3#1)(2008-10#62)(2008-11#5)(2008-7#1)(2008-8#2)(2009-4#5)(2011-10#4)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
stenophagy##6##1##(2012-3#6)
stenoses of##3##2##(1990-8#1)(2008-10#1)(2010-9#1)
stenoses##8##1##(1990-5#1)(1990-8#1)(1993-6#1)(1996-6#1)(2008-10#2)(2010-9#1)(2012-2#1)
stenoses]##2##1##(1991-3#1)(1994-9#1)
stenosing##4##1##(2012-3#1)(2013-1#3)
stenosis (n =##2##3##(1993-8#2)
stenosis and##12##2##(1993-8#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#3)(2012-3#1)
stenosis by##2##2##(2012-2#1)(2013-1#1)
stenosis has##2##2##(2008-11#1)(2011-2#1)
stenosis in the##3##3##(1997-8#1)(2008-8#1)(2011-2#1)
stenosis in##9##2##(1993-8#1)(1997-8#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)
stenosis is##4##2##(2008-1#1)(2008-12#1)(2008-8#1)(2013-1#1)
stenosis of the##6##3##(1991-8#1)(1993-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
stenosis of##8##2##(1991-8#1)(1993-3#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#2)
stenosis or##4##2##(2008-1#1)(2008-11#1)(2008-8#1)(2010-5#1)
stenosis was##4##2##(1993-8#1)(1997-8#1)(2013-1#2)
stenosis were##2##2##(1993-8#1)(2011-2#1)
stenosis##98##1##(1990-3#4)(1990-9#3)(1991-8#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#7)(1997-8#5)(2007-8#1)(2008-1#7)(2008-10#2)(2008-11#7)(2008-12#6)(2008-7#5)(2008-8#6)(2009-10#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#13)
stenosis)##2##1##(2012-3#1)(2013-8#1)
stenosis]##2##1##(1990-8#1)(1990-9#1)
stenotic lesions of##2##3##(1994-5#1)(2008-7#1)
stenotic lesions##3##2##(1994-5#1)(2008-12#1)(2008-7#1)
stenotic##6##1##(1994-5#1)(1996-6#1)(1997-8#1)(2008-12#1)(2008-7#1)(2013-1#1)
stent for##2##2##(2013-1#2)
stent graft##3##2##(2010-12#2)(2011-3#1)
stent grafts##4##2##(2010-12#3)(2011-2#1)
stent implantation##6##2##(2008-11#4)(2011-2#2)
stent in##2##2##(1990-8#1)(2008-11#1)
stent material##2##2##(2009-7#2)
stent placement and##2##3##(2008-12#1)(2008-2#1)
stent placement##4##2##(2008-12#1)(2008-2#1)(2008-5#1)(2009-1#1)
stent thrombosis##3##2##(2008-11#2)(2013-8#1)
stent was##2##2##(2008-11#2)
stent##69##1##(1990-8#3)(2008-10#1)(2008-11#21)(2008-12#6)(2008-2#1)(2008-5#1)(2009-1#1)(2009-7#5)(2010-12#7)(2010-5#2)(2011-2#10)(2011-3#1)(2012-2#2)(2013-1#6)(2013-8#2)
stent-assisted coiling##2##2##(2011-2#1)(2012-3#1)
stent-assisted##4##1##(2011-2#1)(2012-3#2)(2013-8#1)
stented##3##1##(2008-12#1)(2008-4#1)(2013-1#1)
stentgraft##2##1##(2011-3#2)
stenting of the##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
stenting of##4##2##(2008-1#1)(2008-11#2)(2013-1#1)
stenting or##2##2##(2008-11#1)(2012-3#1)
stenting prior to coronary artery bypass##2##6##(2008-11#2)
stenting##22##1##(2008-1#1)(2008-10#1)(2008-11#9)(2008-12#2)(2009-10#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
stents and##3##2##(2008-5#1)(2011-2#2)
stents are##2##2##(2008-11#1)(2013-1#1)
stents has##2##2##(2008-11#1)(2008-12#1)
stents have##3##2##(2008-11#2)(2008-12#1)
stents in##8##2##(1990-8#1)(2008-11#3)(2008-12#1)(2012-2#3)
stents were##2##2##(1990-8#2)
stents##49##1##(1990-8#4)(1994-9#1)(2008-11#18)(2008-12#7)(2008-5#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-2#3)(2013-1#5)(2013-8#2)
step and the##3##3##(2008-10#3)
step and##11##2##(1997-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2012-3#1)
step are##2##2##(2008-10#2)
step associated with##2##3##(1991-9#1)(2008-10#1)
step at the##2##3##(2008-10#1)(2012-2#1)
step at##4##2##(2008-10#3)(2012-2#1)
step before##2##2##(1997-3#1)(2008-10#1)
step by##6##2##(2008-10#4)(2008-11#1)(2008-8#1)
step closer to##3##3##(2007-9#1)(2008-10#1)(2008-6#1)
step consisting of##2##3##(1990-12#1)(2008-10#1)
step followed by##2##3##(2008-10#2)
step following the##2##3##(2008-10#1)(2008-3#1)
step for the##4##3##(1992-6#1)(1994-11#1)(2008-11#1)(2011-2#1)
step for##18##2##(1992-6#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
step forward in##3##3##(2008-5#1)(2009-3#1)(2010-11#1)
step from a##2##3##(1991-9#1)(2008-10#1)
step from##3##2##(1991-9#1)(2008-10#2)
step gradient##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
step has been##2##3##(1992-9#1)(2008-10#1)
step height##2##2##(2008-3#2)
step in a##4##3##(1995-12#1)(2008-10#2)(2008-9#1)
step in colonization##2##3##(2008-5#1)(2008-9#1)
step in cytokinesis##2##3##(2009-8#2)
step in the development of##2##5##(1994-12#1)(1996-6#1)
step in the development##3##4##(1994-12#1)(1996-6#1)(2009-7#1)
step in the preparation of##2##5##(1992-3#1)(2008-7#1)
step in the process of##2##5##(1994-1#1)(2010-4#1)
step in the##25##3##(1990-5#2)(1991-9#1)(1992-3#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#1)(2013-8#1)
step in this##4##3##(1992-8#1)(2007-8#1)(2008-11#2)
step in##73##2##(1990-5#2)(1990-7#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#8)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-7#1)(2009-8#5)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
step includes an##2##3##(2008-10#2)
step is the##2##3##(1995-2#1)(1996-5#1)
step is##13##2##(1995-2#1)(1996-5#1)(2008-10#10)(2008-11#1)
step of a##2##3##(1995-2#1)(2008-10#1)
step of chiral inversion##2##4##(1994-8#2)
step of chiral##3##3##(1994-8#3)
step of hepatic##2##3##(1993-8#1)(2008-6#1)
step of the reaction##2##4##(2008-10#2)
step of the##10##3##(1992-5#1)(1992-8#1)(2008-10#5)(2008-11#1)(2008-9#1)(2013-8#1)
step of##44##2##(1992-12#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#16)(2008-11#1)(2008-6#1)(2008-9#3)(2009-3#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
step on##2##2##(1992-11#1)(2009-11#1)
step or##4##2##(1991-9#1)(2008-10#1)(2008-5#1)(2008-9#1)
step potential##2##2##(2008-10#2)
step prior to##3##3##(2008-10#3)
step process##2##2##(2008-1#1)(2008-5#1)
step purification##2##2##(1992-12#1)(2008-7#1)
step sequential extraction procedure##3##4##(2008-10#3)
step size##3##2##(2008-3#1)(2009-2#2)
step that##2##2##(2008-3#1)(2008-4#1)
step to##18##2##(1992-12#1)(1993-2#1)(1995-6#1)(2007-12#1)(2008-10#8)(2008-11#3)(2010-10#1)(2011-2#1)(2013-1#1)
step toward identifying##2##3##(1997-2#1)(2008-11#1)
step toward the##3##3##(1997-3#1)(2009-1#1)(2009-7#1)
step toward##16##2##(1991-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-12#1)(2012-3#1)
step towards the##2##3##(2008-10#2)
step towards##6##2##(1994-11#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
step was carried out using##3##5##(2008-10#3)
step was carried out##5##4##(2008-10#5)
step was performed##3##3##(1996-5#1)(2008-10#2)
step was##16##2##(1990-12#1)(1996-5#1)(2008-10#13)(2008-7#1)
step were##2##2##(2008-10#2)
step with the##3##3##(2008-10#2)(2008-9#1)
step with##8##2##(1996-3#1)(2008-10#6)(2008-9#1)
step##454##1##(1990-12#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#6)(1992-1#1)(1992-11#4)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#3)(1994-1#3)(1994-11#5)(1994-12#3)(1994-3#6)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#5)(1995-6#6)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#7)(1997-3#3)(1997-5#2)(1997-7#2)(1997-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#205)(2008-11#30)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#9)(2008-8#2)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#6)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#9)(2012-3#6)(2013-1#8)(2013-8#5)
step(s)##3##1##(1997-1#2)(2008-10#1)
step)##2##1##(2008-10#2)
step-by-step##19##1##(1992-1#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)
step-gradient##2##1##(2011-3#2)
step-index POF's##2##2##(2008-3#2)
step-index fiber##2##2##(2008-2#1)(2008-3#1)
step-index##9##1##(2007-12#1)(2008-2#2)(2008-3#6)
step-wise##3##1##(2008-10#2)(2010-7#1)
stepless##2##1##(2011-2#2)
stepper motor##3##2##(2008-10#1)(2008-3#2)
stepping##2##1##(1993-12#1)(1997-2#1)
stepping-stone##2##1##(2008-11#1)(2008-9#1)
steps and the##6##3##(1994-5#1)(2008-10#2)(2008-4#1)(2009-3#1)(2010-1#1)
steps and##13##2##(1994-5#1)(2008-10#4)(2008-4#2)(2008-9#2)(2009-3#1)(2010-1#1)(2011-2#1)(2013-1#1)
steps are required##2##3##(2008-10#1)(2010-11#1)
steps are##11##2##(1991-12#1)(2008-10#8)(2008-4#1)(2010-11#1)
steps based on##2##3##(2008-10#2)
steps for##8##2##(1997-7#1)(2008-10#3)(2008-4#1)(2010-8#1)(2010-9#1)(2012-3#1)
steps from##3##2##(1993-12#1)(2008-10#1)(2012-2#1)
steps in a##2##3##(2008-10#1)(2011-3#1)
steps in the process##2##4##(1993-12#1)(2008-9#1)
steps in the##14##3##(1993-12#1)(1995-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
steps in##25##2##(1993-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-8#1)
steps involve##2##2##(1991-6#1)(1997-7#1)
steps involved in##3##3##(2008-10#3)
steps involved##4##2##(2008-10#4)
steps of the##9##3##(1995-9#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)
steps of##33##2##(1991-2#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-4#3)(2008-9#1)(2009-6#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)
steps taken##4##2##(1993-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
steps that##4##2##(2008-11#2)(2008-8#1)(2012-3#1)
steps to##12##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)(2012-2#1)
steps toward##2##2##(1996-1#1)(2008-11#1)
steps using##3##2##(2008-10#3)
steps were also##2##3##(1993-3#1)(2008-10#1)
steps were required##2##3##(2008-10#2)
steps were##16##2##(1993-3#2)(2008-10#13)(2011-2#1)
steps##235##1##(1991-12#3)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-7#3)(2008-10#90)(2008-11#14)(2008-12#2)(2008-2#1)(2008-4#12)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#14)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#5)(2013-1#5)(2013-8#1)
steps/day##2##1##(2013-1#2)
stepwise evolution##2##2##(2008-10#1)(2010-4#1)
stepwise increase in##2##3##(2008-11#1)(2011-2#1)
stepwise increase##3##2##(2008-11#2)(2011-2#1)
stepwise linear discriminant analysis##2##4##(2008-10#2)
stepwise linear discriminant##3##3##(2008-10#3)
stepwise linear##4##2##(2008-10#3)(2008-11#1)
stepwise logistic regression analysis##2##4##(2008-10#1)(2012-2#1)
stepwise logistic regression##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
stepwise manner##2##2##(2008-10#2)
stepwise pattern##3##2##(2008-10#3)
stepwise regression##2##2##(2008-10#1)(2008-9#1)
stepwise##47##1##(1992-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-5#1)(1997-3#1)(2008-10#22)(2008-11#7)(2008-4#3)(2008-7#2)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
stereo vision##3##2##(2008-3#2)(2008-9#1)
stereo##7##1##(1994-8#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-9#1)
stereochemical course of##2##3##(1992-7#1)(1996-5#1)
stereochemical##3##1##(1992-7#1)(1996-5#2)
stereochemically##3##1##(1990-6#1)(1992-12#1)(1992-4#1)
stereochemistry of##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
stereochemistry##6##1##(1993-8#1)(1996-5#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
stereodefined PS-oligos##3##2##(2008-4#3)
stereodefined##4##1##(2008-4#4)
stereoisomers##2##1##(1992-9#1)(2008-8#1)
stereological##8##1##(1995-5#1)(1995-8#1)(2007-12#1)(2008-12#1)(2008-5#3)(2011-2#1)
stereology##2##1##(1992-12#1)(1995-5#1)
stereomicroscopy##3##1##(2008-10#2)(2013-1#1)
stereoscopic##4##1##(1990-8#1)(2008-3#1)(2011-2#1)(2011-7#1)
stereoselective##9##1##(1994-5#1)(1994-8#2)(1996-5#5)(2008-10#1)
stereoselectivity##6##1##(1990-6#1)(1992-12#1)(1992-7#1)(1996-5#1)(2008-10#1)(2009-5#1)
stereospecific##4##1##(1994-5#1)(1995-8#1)(2008-10#1)(2008-11#1)
stereospecificity##2##1##(1991-5#1)(1996-5#1)
stereotactic radiosurgery##4##2##(2011-2#4)
stereotactic##9##1##(1993-9#1)(1997-6#1)(2008-7#2)(2010-12#1)(2011-2#4)
stereotaxic##2##1##(1997-4#1)(2008-7#1)
stereotype group was exposed to##2##5##(2008-11#2)
stereotype group was##3##3##(2008-11#3)
stereotype group##4##2##(2008-11#4)
stereotype of a##2##3##(2012-3#2)
stereotype of##3##2##(2008-11#1)(2012-3#2)
stereotype##11##1##(1993-2#1)(2008-11#8)(2012-3#2)
stereotyped##3##1##(1996-2#1)(2008-5#1)(2008-9#1)
stereotypes of##2##2##(1990-2#1)(2012-3#1)
stereotypes##10##1##(1990-2#1)(1994-12#1)(2008-11#2)(2011-2#2)(2012-3#4)
stereotypies##3##1##(2008-11#3)
stereotypy performance##3##2##(2008-11#3)
stereovision##2##1##(2008-6#1)(2011-2#1)
steric accessibility##2##2##(2008-10#2)
steric and##2##2##(1992-10#1)(2010-12#1)
steric effects##2##2##(2008-10#2)
steric hindrance##4##2##(2008-10#4)
steric influence on the##2##4##(1994-5#1)(2008-10#1)
steric repulsions##2##2##(2008-10#1)(2010-5#1)
steric restriction##2##2##(2008-10#2)
steric##28##1##(1991-5#2)(1992-10#1)(1994-5#2)(1996-5#1)(1997-2#1)(2008-10#16)(2008-11#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#1)
sterically demanding##2##2##(1996-5#1)(2008-11#1)
sterically hindered##2##2##(1996-5#1)(2008-10#1)
sterically##4##1##(1996-5#2)(2008-10#1)(2008-11#1)
sterile and##3##2##(2007-12#1)(2008-8#2)
sterile anther##3##2##(2008-8#3)
sterile because##2##2##(2012-2#1)(2012-3#1)
sterile distilled water##2##3##(2008-10#1)(2008-5#1)
sterile fungus StFCh1-1##3##3##(2008-12#3)
sterile fungus##4##2##(2008-10#1)(2008-12#3)
sterile production##3##2##(2012-2#3)
sterile##42##1##(1994-12#1)(1996-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#6)(2008-5#2)(2008-8#6)(2008-9#1)(2011-2#3)(2012-2#8)(2012-3#1)(2013-1#2)
sterility and##2##2##(1993-8#1)(2012-3#1)
sterility mosaic disease##2##3##(2008-10#2)
sterility mosaic##4##2##(2008-10#4)
sterility of the final product##2##5##(2012-2#2)
sterility of the##4##3##(2008-11#1)(2012-2#3)
sterility of##5##2##(2008-11#1)(2008-9#1)(2012-2#3)
sterility testing##2##2##(2012-2#2)
sterility##31##1##(1990-2#1)(1993-8#1)(1994-12#3)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#6)(2011-2#1)(2012-2#8)(2012-3#1)
sterilization of##2##2##(1992-12#1)(1997-2#1)
sterilization procedure##2##2##(1991-3#1)(1995-1#1)
sterilization status##2##2##(2013-8#2)
sterilization##29##1##(1991-3#5)(1992-12#3)(1993-3#2)(1995-1#6)(1996-3#4)(1997-2#1)(2008-11#1)(2010-7#2)(2011-2#2)(2012-12#1)(2013-8#2)
sterilized##11##1##(1990-3#1)(1991-3#1)(1995-3#1)(2008-10#5)(2008-11#1)(2012-2#1)(2013-1#1)
sterilizing pathogens##3##2##(2008-8#3)
sterilizing##4##1##(2008-8#3)(2010-7#1)
steriod##2##1##(1990-11#1)(1997-1#1)
sternal##2##1##(1994-2#1)(2012-2#1)
sternoclavicular##2##1##(2009-6#1)(2012-2#1)
sternocleidomastoid##3##1##(2010-9#2)(2011-2#1)
sternotomy##2##1##(1993-3#1)(2008-11#1)
steroid - TSPO interactions##2##4##(2012-2#2)
steroid 5##4##2##(1990-11#3)(1995-9#1)
steroid 9alpha-hydroxylase##4##2##(2008-11#4)
steroid binding##4##2##(1990-12#1)(1991-12#3)
steroid drugs##2##2##(2008-10#2)
steroid hormone##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
steroid hormones are##2##3##(1995-2#1)(2008-3#1)
steroid hormones##7##2##(1990-11#1)(1994-6#1)(1995-2#1)(2008-3#1)(2008-7#2)(2012-3#1)
steroid in##2##2##(1990-11#1)(2008-10#1)
steroid nucleus##2##2##(2008-11#2)
steroid production##2##2##(1995-12#1)(2012-2#1)
steroid receptor##3##2##(1993-2#1)(1994-6#1)(2011-2#1)
steroid receptors##2##2##(1991-12#1)(1997-4#1)
steroid secretion and##2##3##(2008-12#1)(2010-8#1)
steroid secretion by##2##3##(2008-12#2)
steroid secretion##4##2##(2008-12#3)(2010-8#1)
steroid structure##2##2##(1996-2#1)(2008-10#1)
steroid substrates##2##2##(1990-11#2)
steroid therapy##6##2##(1994-6#1)(2008-1#1)(2011-2#3)(2013-1#1)
steroid was##2##2##(1990-11#1)(2008-10#1)
steroid##99##1##(1990-11#15)(1990-12#2)(1991-12#4)(1991-5#2)(1993-1#1)(1993-2#1)(1994-6#4)(1995-12#3)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#3)(1996-6#1)(1997-1#3)(1997-4#1)(2008-1#2)(2008-10#10)(2008-11#11)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#3)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#4)(2012-2#7)(2012-3#2)(2013-1#1)(2013-8#1)
steroid-binding domain##3##2##(1990-11#3)
steroid-binding##4##1##(1990-11#4)
steroid-dependent##2##1##(2010-12#2)
steroid-induced##2##1##(2008-7#2)
steroid-sparing##2##1##(2010-12#1)(2012-3#1)
steroidal saponins##3##2##(2008-11#3)
steroidal##10##1##(1990-11#1)(1990-9#1)(1991-8#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-11#3)
steroidogenesis##9##1##(1991-3#2)(1995-12#1)(2012-2#6)
steroidogenic acute regulatory##2##3##(1995-12#2)
steroidogenic##6##1##(1990-11#1)(1991-3#1)(1995-12#2)(1995-2#1)(2012-2#1)
steroids and a##2##3##(1991-12#1)(1995-10#1)
steroids and other##2##3##(1990-11#1)(1991-3#1)
steroids and tamoxifen##2##3##(2011-2#2)
steroids and##12##2##(1990-11#1)(1991-12#1)(1991-3#1)(1995-10#1)(1995-12#1)(2011-2#4)(2012-2#2)(2013-1#1)
steroids at the##2##3##(1995-10#1)(2008-7#1)
steroids for##2##2##(2010-12#1)(2010-2#1)
steroids having##2##2##(1997-1#2)
steroids in##8##2##(1995-12#1)(1996-3#1)(1997-1#1)(1997-8#2)(2008-10#2)(2012-3#1)
steroids or##2##2##(2010-4#1)(2011-2#1)
steroids tested##3##2##(1990-11#2)(1996-2#1)
steroids to##5##2##(1990-11#1)(1997-1#2)(2009-6#1)(2012-2#1)
steroids were found in##2##4##(1990-11#2)
steroids were found##3##3##(1990-11#2)(1991-5#1)
steroids were##7##2##(1990-11#3)(1991-5#1)(2008-10#2)(2008-11#1)
steroids with##3##2##(1990-11#2)(1997-1#1)
steroids##89##1##(1990-11#12)(1990-2#1)(1991-12#2)(1991-3#2)(1991-5#1)(1992-3#1)(1992-5#2)(1994-2#1)(1995-10#2)(1995-12#4)(1995-2#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-1#6)(1997-8#4)(2008-10#7)(2008-11#8)(2008-12#1)(2008-4#1)(2008-7#3)(2009-6#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#5)(2012-3#4)(2013-1#3)
sterol and##3##2##(2008-10#1)(2008-6#1)(2009-3#1)
sterol demethylation inhibitors (DMIs)##2##4##(2008-10#2)
sterol demethylation##3##2##(2008-10#3)
sterol of##2##2##(1997-2#2)
sterol##20##1##(1990-12#1)(1991-5#1)(1992-3#4)(1993-6#1)(1997-2#2)(2008-10#7)(2008-6#1)(2009-3#1)(2010-11#1)(2011-2#1)
sterols having##2##2##(1992-3#2)
sterols in the##2##3##(1997-2#1)(2008-10#1)
sterols in##3##2##(1997-2#1)(2008-10#2)
sterols##12##1##(1992-3#2)(1997-2#4)(2008-10#6)
stethoscope##2##1##(2009-6#1)(2010-8#1)
stethoscopes##4##1##(2009-6#4)
stevia##2##1##(2008-10#2)
stewardship in##7##2##(2012-2#3)(2013-1#4)
stewardship programs (ASPs)##3##3##(2013-1#3)
stewardship programs##6##2##(2013-1#6)
stewardship##27##1##(2009-8#2)(2012-2#6)(2013-1#19)
stewartii ranged from 0##3##4##(2008-10#3)
stewartii##6##1##(2008-10#6)
stewartii-infested corn flea beetles##2##4##(2008-10#2)
stewartii-infested corn flea##3##3##(2008-10#3)
stewartii-infested##5##1##(2008-10#5)
stibine generation##2##2##(2008-10#2)
stibine##4##1##(2008-10#4)
stick insect##2##2##(2007-12#2)
stick##8##1##(1995-8#1)(2007-12#2)(2008-10#2)(2008-5#3)
sticky platelet syndrome##2##3##(1997-6#2)
sticky platelet##4##2##(1997-6#3)(2010-3#1)
sticky##5##1##(1997-6#3)(2008-5#1)(2010-3#1)
stiff##5##1##(1997-5#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-4#1)
stiffening##2##1##(2009-5#1)(2012-2#1)
stiffer tissue##2##2##(2009-8#1)(2010-8#1)
stiffer##4##1##(2008-5#2)(2009-8#1)(2010-8#1)
stiffness and##3##2##(2008-5#1)(2009-7#1)(2010-7#1)
stiffness coefficient##2##2##(2013-1#2)
stiffness is##2##2##(2008-9#1)(2013-7#1)
stiffness of the##2##3##(2008-12#1)(2009-7#1)
stiffness of##3##2##(2008-12#1)(2009-7#1)(2013-7#1)
stiffness##33##1##(2008-11#1)(2008-12#1)(2008-5#3)(2008-9#4)(2009-3#3)(2009-7#5)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-3#2)(2013-7#5)(2013-8#1)
stifle##4##1##(1996-1#1)(2012-3#3)
stigma and##5##2##(2008-10#2)(2008-12#1)(2010-2#1)(2012-2#1)
stigma##17##1##(1996-5#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-6#1)(2009-5#1)(2010-2#1)(2011-10#1)(2012-2#1)(2012-3#1)
stigmas and##2##2##(2008-10#2)
stigmas of detached crab apple blossoms##2##6##(2008-10#2)
stigmas##10##1##(2008-10#10)
stigmasterol and beta-sitosterol##2##3##(2008-12#2)
stigmasterol##3##1##(2008-11#1)(2008-12#2)
stigmata were inoculated##2##3##(2008-10#2)
stigmata##8##1##(1991-12#1)(1991-2#1)(2008-10#5)(2010-6#1)
stigmatic##2##1##(2008-10#2)
stigmatized##2##1##(2012-2#2)
stilbene oxidase##2##2##(2008-10#2)
stilbene##4##1##(2008-10#4)
still a##22##2##(1990-8#1)(1991-12#1)(1995-5#1)(1996-11#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
still able to##4##3##(1993-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
still alive##10##2##(1990-6#1)(1990-9#1)(1992-9#1)(1995-2#1)(1997-4#1)(1997-5#1)(2008-7#1)(2011-2#2)(2013-8#1)
still apparent##2##2##(1994-2#1)(1996-12#1)
still at##2##2##(1991-3#1)(2008-11#1)
still be##9##2##(1996-11#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#1)
still been##2##2##(1996-3#1)(2008-11#1)
still being##6##2##(1991-8#1)(1997-5#1)(2008-11#2)(2010-1#2)
still birth##2##2##(1996-11#1)(2012-3#1)
still clearly##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
still considered##2##2##(1995-2#1)(1995-5#1)
still contained##2##2##(1992-10#1)(1997-7#1)
still controversial##4##2##(1992-6#1)(1995-2#1)(2008-11#1)(2008-7#1)
still dependent##2##2##(1993-12#1)(1994-11#1)
still did##2##2##(2012-2#2)
still discussed##2##2##(1993-6#1)(2009-1#1)
still do not##2##3##(2008-12#1)(2010-12#1)
still engage in##2##3##(2010-7#1)(2011-2#1)
still evident##2##2##(2008-10#1)(2013-1#1)
still exhibited##2##2##(2008-10#1)(2012-3#1)
still exists##4##2##(1994-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
still face##3##2##(1997-3#1)(2013-8#2)
still had##3##2##(1991-9#1)(1995-9#1)(2008-7#1)
still have a##3##3##(1996-8#1)(2008-9#1)(2009-6#1)
still have to be##2##4##(2012-2#2)
still have##9##2##(1994-9#1)(1996-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#2)(2013-1#1)
still high##2##2##(1996-11#1)(2011-1#1)
still higher than##3##3##(1997-5#1)(2008-8#1)(2010-12#1)
still highly##2##2##(1990-10#1)(1996-12#1)
still in its infancy##3##4##(1995-5#1)(1996-2#1)(2008-10#1)
still in##8##2##(1990-11#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-10#1)(2010-7#1)
still incompletely##2##2##(2011-2#1)(2012-2#1)
still increasing##3##2##(1990-12#1)(1997-8#1)(2011-2#1)
still is##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
still lacking##4##2##(1997-8#1)(2008-10#1)(2010-1#1)(2012-3#1)
still largely##5##2##(1990-6#1)(1996-12#1)(2008-9#1)(2010-12#1)(2010-6#1)
still leave##2##2##(1991-2#1)(1995-12#1)
still markedly##2##2##(1992-8#1)(1993-3#1)
still more##2##2##(1994-1#1)(2012-3#1)
still much##4##2##(1990-9#1)(1996-2#1)(2008-11#1)(2009-1#1)
still need to##3##3##(1995-9#1)(2008-12#1)(2008-9#1)
still need##4##2##(1995-9#1)(2008-12#1)(2008-9#1)(2009-6#1)
still needs to be##2##4##(2011-2#1)(2013-7#1)
still needs##4##2##(2008-1#1)(2011-2#1)(2011-3#1)(2013-7#1)
still not completely elucidated##3##4##(2008-10#1)(2009-12#1)(2010-7#1)
still not fully understood##5##4##(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2009-3#1)
still not known##2##3##(2008-12#1)(2013-1#1)
still not##26##2##(1993-6#1)(1994-11#1)(1996-5#1)(1997-8#1)(2006-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
still obtained##2##2##(2008-10#1)(2008-2#1)
still occurs##2##2##(1996-5#1)(2008-10#1)
still on##2##2##(1994-6#1)(1995-2#1)
still over##3##2##(2008-10#3)
still plays##2##2##(2012-3#1)(2013-1#1)
still present in the##5##4##(1995-2#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-9#1)
still present in##6##3##(1991-3#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-9#1)
still present##9##2##(1991-3#1)(1995-2#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-12#1)(2012-9#1)
still relatively##3##2##(2008-4#1)(2008-9#1)(2010-12#1)
still remain about##2##3##(2008-11#1)(2012-12#1)
still remain##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-3#1)(2012-12#1)
still remains##7##2##(2008-1#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
still represent the##2##3##(2008-10#1)(2010-11#1)
still represents##2##2##(1993-3#1)(2008-11#1)
still require##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
still required to##3##3##(2009-10#1)(2010-11#1)(2011-2#1)
still required##5##2##(1997-1#1)(2009-10#1)(2010-11#1)(2011-2#2)
still retain a##2##3##(2008-10#1)(2008-11#1)
still significant##4##2##(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
still significantly##2##2##(1994-5#1)(2008-4#1)
still some##3##2##(1996-11#1)(2008-10#1)(2011-3#1)
still subject to##2##3##(2008-5#1)(2010-10#1)
still the##7##2##(1990-5#1)(1991-10#1)(1997-4#1)(1997-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
still to be##3##3##(1993-3#1)(1997-8#1)(2010-12#1)
still to##4##2##(1993-3#1)(1997-8#1)(2008-10#1)(2010-12#1)
still uncertain##3##2##(2011-2#1)(2013-1#2)
still unclear##13##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
still under##4##2##(1992-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
still unknown##14##2##(1991-3#1)(1992-3#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#2)(2009-6#1)(2012-3#1)(2013-8#1)
still valid##4##2##(1992-9#1)(2008-3#1)(2008-9#2)
still very##6##2##(1991-1#1)(1994-2#1)(1997-7#1)(2008-10#2)(2011-2#1)
still widely##2##2##(2008-10#1)(2008-12#1)
still##507##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#6)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#4)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#6)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#6)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#9)(2006-6#1)(2007-11#1)(2008-1#5)(2008-10#74)(2008-11#44)(2008-12#8)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#17)(2008-8#16)(2008-9#16)(2009-1#3)(2009-10#2)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#7)(2010-11#7)(2010-12#12)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#36)(2011-3#7)(2011-7#1)(2012-12#5)(2012-2#13)(2012-3#16)(2012-9#1)(2013-1#21)(2013-7#2)(2013-8#8)
stillbirth##3##1##(1996-11#1)(2008-12#1)(2013-1#1)
stimulant effects##2##2##(1991-5#1)(1993-6#1)
stimulant medication##3##2##(1995-1#1)(1996-6#2)
stimulant##8##1##(1991-5#1)(1993-6#1)(1995-1#1)(1996-6#2)(2008-10#3)
stimulants in##3##2##(2008-10#3)
stimulants were##2##2##(2008-10#1)(2013-8#1)
stimulants##13##1##(2008-10#7)(2008-11#2)(2008-8#2)(2009-7#1)(2013-8#1)
stimulate DNA synthesis##3##3##(1990-11#1)(1992-3#1)(2009-8#1)
stimulate a##4##2##(1993-6#1)(1995-2#1)(2008-10#1)(2008-11#1)
stimulate ascospore##2##2##(2008-10#2)
stimulate both##4##2##(1992-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
stimulate further##2##2##(2009-3#1)(2013-1#1)
stimulate glucose uptake##2##3##(2008-11#1)(2008-8#1)
stimulate glucose##3##2##(1994-8#1)(2008-11#1)(2008-8#1)
stimulate growth of normal##2##4##(2008-11#2)
stimulate or##3##2##(1994-8#1)(1995-2#1)(2008-9#1)
stimulate plant##2##2##(2008-10#2)
stimulate the growth##2##3##(2008-4#1)(2011-2#1)
stimulate the immune##2##3##(1997-2#1)(2008-7#1)
stimulate the phosphorylation of the##2##5##(1990-10#1)(1996-2#1)
stimulate the phosphorylation of##3##4##(1990-10#1)(1996-2#2)
stimulate the proliferation of##4##4##(2008-11#1)(2008-4#2)(2008-8#1)
stimulate the proliferation##5##3##(1995-2#1)(2008-11#1)(2008-4#2)(2008-8#1)
stimulate the##39##2##(1990-10#1)(1990-12#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-8#2)(1996-2#2)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-8#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
stimulate transcription##4##2##(1993-8#1)(1994-2#1)(1996-2#1)(2011-1#1)
stimulate##146##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-5#4)(1991-6#1)(1992-10#2)(1992-12#1)(1992-3#3)(1992-7#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-2#7)(1995-6#1)(1995-8#4)(1996-12#2)(1996-2#3)(1997-1#6)(1997-2#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#16)(2008-12#3)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-8#3)(2010-1#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
stimulated GTH-II release##2##3##(1994-8#2)
stimulated Raman scattering and##2##4##(2008-2#1)(2010-7#1)
stimulated Raman scattering##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2010-7#2)
stimulated T##2##2##(1997-8#1)(2008-4#1)
stimulated a##4##2##(1994-11#1)(1995-2#1)(2008-4#1)(2012-2#1)
stimulated an##6##2##(1996-12#1)(2008-10#1)(2011-2#4)
stimulated by a##3##3##(1995-8#2)(2008-5#1)
stimulated by all##2##3##(1995-12#1)(1997-1#1)
stimulated by tetrachlorohydroquinone##2##3##(2009-3#2)
stimulated by the##6##3##(1990-5#1)(1993-3#1)(1994-3#2)(2008-11#1)(2010-1#1)
stimulated by##51##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#3)(1991-3#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#6)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#1)(2012-2#1)
stimulated for##3##2##(1993-6#1)(1994-6#1)(1997-3#1)
stimulated glucose##2##2##(1997-1#1)(2008-1#1)
stimulated in the##3##3##(1990-12#1)(2008-6#1)(2008-9#1)
stimulated in##5##2##(1990-12#1)(1990-8#1)(2008-5#1)(2008-6#1)(2008-9#1)
stimulated inositol trisphosphate production##2##4##(1990-8#1)(1993-3#1)
stimulated insulin##2##2##(1991-7#1)(1995-8#1)
stimulated luminescence##2##2##(2008-10#2)
stimulated muscle##2##2##(1995-3#1)(1995-8#1)
stimulated phosphorylation of##2##3##(1993-1#1)(1993-3#1)
stimulated protein synthesis##3##3##(2008-11#3)
stimulated protein##4##2##(1995-11#1)(2008-11#3)
stimulated the expression of##2##4##(1997-2#1)(2008-11#1)
stimulated the production of##2##4##(2008-10#2)
stimulated the proliferation##3##3##(2008-11#3)
stimulated the##24##2##(1993-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#9)(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
stimulated through##2##2##(2008-4#2)
stimulated to##6##2##(1990-12#1)(1991-6#2)(1992-2#1)(1995-12#1)(2008-10#1)
stimulated with hVEGF(165)##2##3##(2008-8#2)
stimulated with phorbol##2##3##(1994-6#1)(1994-8#1)
stimulated with the##5##3##(1991-5#1)(2008-5#1)(2008-8#2)(2012-12#1)
stimulated with##27##2##(1991-2#2)(1991-3#1)(1991-5#2)(1992-6#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-8#5)(2011-2#1)(2012-12#1)
stimulated##249##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#6)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#5)(1993-1#1)(1993-12#1)(1993-3#4)(1993-6#4)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#4)(1994-8#7)(1995-11#7)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#10)(1996-12#2)(1996-2#5)(1996-5#1)(1997-1#7)(1997-2#3)(1997-3#2)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#27)(2008-11#31)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#1)(2008-8#9)(2008-9#7)(2009-3#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#7)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#4)(2013-8#1)
stimulates DNA synthesis in##3##4##(1994-3#1)(1995-11#1)(1997-1#1)
stimulates human##2##2##(1994-11#1)(1995-2#1)
stimulates proliferation##2##2##(2008-11#1)(2008-6#1)
stimulates protein##2##2##(1995-11#1)(1997-8#1)
stimulates pyruvate kinase activity in confluent-phase##2##6##(1995-12#2)
stimulates the activity of##2##4##(1994-8#1)(1996-2#1)
stimulates the phosphorylation of##2##4##(1996-2#1)(2009-3#1)
stimulates the secretion of##2##4##(1990-12#1)(1996-12#1)
stimulates the##18##2##(1990-12#1)(1990-5#1)(1991-5#1)(1993-3#2)(1994-11#2)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#2)(1997-8#1)(2008-8#2)(2009-3#1)(2010-1#1)(2011-2#1)
stimulates tyrosine phosphorylation of##2##4##(1992-10#2)
stimulates##72##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#2)(1992-10#2)(1992-3#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-11#6)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#3)(1995-11#5)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#2)(1997-1#3)(1997-2#1)(1997-7#2)(1997-8#2)(2007-11#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-10#1)(2009-3#2)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
stimulating activity of##3##3##(1991-5#1)(2008-11#2)
stimulating effect of ET-1##2##4##(1994-8#2)
stimulating effect of##5##3##(1992-12#1)(1994-8#2)(1996-2#1)(2008-11#1)
stimulating effect on antibody production##2##5##(2008-11#2)
stimulating effect on##4##3##(1995-11#1)(1997-2#1)(2008-11#2)
stimulating effect##10##2##(1992-12#1)(1994-8#2)(1995-11#1)(1996-2#1)(1997-2#1)(2008-11#3)(2012-3#1)
stimulating effects##4##2##(1994-2#1)(1996-5#1)(1997-3#1)(2012-3#1)
stimulating factor (M-CSF)##2##3##(1991-5#1)(2008-11#1)
stimulating factor##5##2##(1991-5#1)(1992-3#1)(2008-11#2)(2011-2#1)
stimulating factors##2##2##(2008-10#1)(2008-11#1)
stimulating glucose##2##2##(1993-8#1)(2008-11#1)
stimulating hormone##4##2##(1993-11#2)(2007-7#1)(2008-6#1)
stimulating sound-pulses##4##2##(2008-8#4)
stimulating the##9##2##(1992-10#1)(1996-11#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-7#1)
stimulating##87##1##(1990-8#1)(1991-5#3)(1992-10#1)(1992-12#5)(1992-3#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#14)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2010-10#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
stimulation (P&lt##2##2##(2009-10#2)
stimulation and inhibition of##2##4##(2008-11#1)(2008-8#1)
stimulation and##18##2##(1991-2#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1995-2#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#1)(2012-2#1)
stimulation assays##2##2##(2008-4#2)
stimulation by##14##2##(1990-5#1)(1990-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-8#2)(1996-2#1)(2008-11#5)(2010-12#1)
stimulation causes##2##2##(1992-12#1)(1997-1#1)
stimulation decreased##2##2##(1993-3#1)(2009-10#1)
stimulation for##4##2##(2008-7#1)(2009-8#1)(2010-7#1)(2013-1#1)
stimulation in a##2##3##(1994-5#1)(1994-6#1)
stimulation in##20##2##(1990-5#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-2#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
stimulation increased##3##2##(1993-3#1)(2009-6#1)(2011-2#1)
stimulation index (SI)##2##3##(2008-5#1)(2011-2#1)
stimulation index of##2##3##(2008-10#2)
stimulation index##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
stimulation is##5##2##(1993-12#1)(1995-11#1)(2009-8#1)(2010-7#1)(2013-1#1)
stimulation may##2##2##(1991-12#1)(2013-8#1)
stimulation of Ca2+##2##3##(1996-2#2)
stimulation of GTH-II and GH release##2##6##(1994-8#2)
stimulation of NAT##2##3##(1994-2#2)
stimulation of PLD##2##3##(1995-8#2)
stimulation of T##2##3##(1995-5#1)(2008-11#1)
stimulation of a##2##3##(1996-2#1)(2008-10#1)
stimulation of acetylcholine##2##3##(1992-3#1)(2013-1#1)
stimulation of antibody production##3##4##(2008-11#3)
stimulation of both##2##3##(1993-3#1)(2010-1#1)
stimulation of cell growth##2##4##(2008-11#2)
stimulation of cell##4##3##(2008-11#4)
stimulation of collagen synthesis##2##4##(2008-5#2)
stimulation of collagen##3##3##(2008-5#3)
stimulation of cultured##2##3##(2008-11#2)
stimulation of ecdysteroid secretion##2##4##(1995-11#2)
stimulation of expression##2##3##(2011-1#2)
stimulation of glucose transport into L6##2##6##(1994-11#2)
stimulation of glucose##5##3##(1994-11#2)(1994-8#3)
stimulation of human##2##3##(1994-11#1)(1997-1#1)
stimulation of immunity by##2##4##(2008-7#2)
stimulation of mu-opioid receptors##2##4##(1997-2#2)
stimulation of platelets##2##3##(1992-6#1)(2008-8#1)
stimulation of the activity of##2##5##(1997-2#1)(2008-8#1)
stimulation of the##39##3##(1990-5#3)(1990-8#1)(1990-9#1)(1991-2#1)(1992-3#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#4)(1997-2#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-6#1)(2010-7#3)(2012-2#1)
stimulation of##160##2##(1990-5#6)(1990-8#3)(1990-9#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-6#3)(1993-3#3)(1993-8#1)(1994-11#8)(1994-2#6)(1994-3#3)(1994-5#3)(1994-8#10)(1995-11#4)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#5)(1996-12#1)(1996-2#8)(1996-5#1)(1997-1#2)(1997-2#4)(1997-7#4)(1997-8#1)(2008-10#5)(2008-11#21)(2008-12#1)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
stimulation on##8##2##(1994-2#2)(1995-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-2#1)
stimulation or##4##2##(1994-2#1)(2008-12#1)(2008-8#1)(2010-7#1)
stimulation produced##2##2##(2011-2#2)
stimulation rate##4##2##(2008-9#4)
stimulation resulted in##2##3##(1997-3#1)(2008-5#1)
stimulation test##4##2##(2008-9#2)(2012-3#1)(2013-1#1)
stimulation testing##2##2##(2008-4#1)(2012-3#1)
stimulation tests##2##2##(1996-11#2)
stimulation that##2##2##(2008-10#1)(2010-6#1)
stimulation through##2##2##(2008-10#1)(2008-7#1)
stimulation to the##3##3##(1993-8#1)(2008-9#1)(2010-7#1)
stimulation to##5##2##(1993-8#1)(2008-10#2)(2008-9#1)(2010-7#1)
stimulation under##2##2##(2008-9#1)(2011-1#1)
stimulation was used##2##3##(2008-7#2)
stimulation was##19##2##(1990-5#2)(1992-3#1)(1993-3#3)(1994-2#1)(1995-11#2)(1995-2#1)(1995-8#1)(2008-10#1)(2008-7#6)(2012-2#1)
stimulation were##4##2##(1993-1#1)(2008-7#3)
stimulation with a##2##3##(1992-6#1)(1994-3#1)
stimulation with the##3##3##(2008-5#1)(2008-9#1)(2013-8#1)
stimulation with##27##2##(1991-5#1)(1992-6#3)(1993-6#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
stimulation##517##1##(1990-5#13)(1990-8#4)(1990-9#1)(1991-12#6)(1991-2#4)(1991-3#4)(1991-5#4)(1991-6#2)(1992-10#2)(1992-11#1)(1992-12#9)(1992-3#5)(1992-6#10)(1992-8#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#9)(1993-6#5)(1993-8#4)(1994-11#10)(1994-2#13)(1994-3#5)(1994-5#4)(1994-6#2)(1994-8#14)(1995-11#12)(1995-12#6)(1995-2#6)(1995-5#2)(1995-6#5)(1995-8#12)(1996-11#3)(1996-12#6)(1996-2#14)(1996-5#2)(1996-6#1)(1997-1#7)(1997-2#8)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#6)(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#21)(2008-11#42)(2008-12#3)(2008-4#5)(2008-5#14)(2008-7#23)(2008-8#5)(2008-9#28)(2009-1#1)(2009-10#8)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#7)(2009-9#3)(2010-1#4)(2010-10#4)(2010-12#5)(2010-5#2)(2010-6#2)(2010-7#26)(2010-8#4)(2011-1#5)(2011-2#16)(2012-2#16)(2012-3#9)(2013-1#10)(2013-7#1)(2013-8#11)
stimulation-induced##3##1##(1992-3#1)(1997-1#1)(2008-9#1)
stimulation?##2##1##(2008-11#1)(2010-7#1)
stimulations and##2##2##(1994-3#1)(2008-4#1)
stimulations of##2##2##(1993-8#1)(2008-11#1)
stimulations were##2##2##(1993-3#1)(1995-8#1)
stimulations##10##1##(1993-3#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
stimulative effects##2##2##(1995-8#1)(2008-11#1)
stimulator of##5##2##(1995-12#1)(1997-1#1)(1997-2#1)(2008-6#1)(2008-7#1)
stimulator was##2##2##(2012-3#2)
stimulator##19##1##(1995-11#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-6#1)(2008-7#3)(2010-1#2)(2010-12#1)(2010-7#1)(2012-3#5)
stimulators##7##1##(1994-3#1)(2008-10#3)(2008-7#1)(2010-1#1)(2013-1#1)
stimulatory ability##5##2##(2008-8#5)
stimulatory action of L-histidine on protein synthesis in L6 myotubes##2##10##(2008-11#2)
stimulatory action of L-histidine on protein synthesis##3##7##(2008-11#3)
stimulatory actions of L-leucine and KIC on protein synthesis##4##9##(2008-11#4)
stimulatory actions of L-leucine and KIC##5##6##(2008-11#5)
stimulatory actions of L-leucine and##6##5##(2008-11#6)
stimulatory actions##8##2##(2008-11#8)
stimulatory and##2##2##(1994-3#1)(1996-2#1)
stimulatory effect of##8##3##(1992-6#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-8#1)
stimulatory effect on##4##3##(1993-12#1)(1994-2#1)(1997-7#1)(1997-8#1)
stimulatory effect##13##2##(1992-6#1)(1993-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-7#1)(1997-8#2)(2008-11#1)
stimulatory effects of##2##3##(2008-6#1)(2008-7#1)
stimulatory effects##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
stimulatory##53##1##(1990-12#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-12#4)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#3)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#4)(2008-11#13)(2008-6#1)(2008-7#2)(2008-8#5)(2011-2#1)(2013-1#1)
stimuli and the##2##3##(2008-9#1)(2009-9#1)
stimuli and##17##2##(1990-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-6#1)(2009-9#1)(2010-1#1)(2013-8#1)
stimuli are##3##2##(2008-10#1)(2008-9#1)(2009-4#1)
stimuli comprised of##2##3##(2013-8#2)
stimuli in##9##2##(1990-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(2008-7#2)(2011-2#2)(2012-2#1)
stimuli of##3##2##(1996-2#1)(2010-8#1)(2013-8#1)
stimuli on the##3##3##(2008-4#1)(2008-8#1)(2009-4#1)
stimuli on##4##2##(1996-12#1)(2008-4#1)(2008-8#1)(2009-4#1)
stimuli such as##2##3##(1993-6#1)(2008-10#1)
stimuli that##6##2##(1995-12#1)(1995-8#1)(1997-1#2)(2008-8#1)(2011-9#1)
stimuli to##4##2##(1993-6#1)(1997-7#1)(2008-11#2)
stimuli was##3##2##(2008-11#1)(2008-8#2)
stimuli were applied##2##3##(2008-8#1)(2008-9#1)
stimuli were##9##2##(1990-11#1)(1990-5#1)(1993-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-4#1)
stimuli with##2##2##(2008-11#1)(2013-8#1)
stimuli##173##1##(1990-11#8)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-5#1)(1992-6#1)(1993-3#4)(1993-6#9)(1994-11#1)(1994-2#3)(1994-3#2)(1995-12#2)(1995-8#4)(1996-12#3)(1996-2#9)(1997-1#4)(1997-2#1)(1997-3#1)(1997-7#2)(2008-10#9)(2008-11#15)(2008-4#8)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#11)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#6)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-9#2)(2012-2#5)(2013-1#2)(2013-8#11)
stimulus (e##2##2##(2008-5#2)
stimulus and##2##2##(1992-12#1)(1993-3#1)
stimulus configuration##2##2##(2008-9#2)
stimulus duration and##2##3##(2008-9#2)
stimulus features##2##2##(1990-5#1)(2008-11#1)
stimulus for##3##2##(1993-1#1)(2009-6#1)(2013-8#1)
stimulus intensity##3##2##(2008-7#3)
stimulus is##3##2##(1995-12#1)(1997-4#1)(2008-11#1)
stimulus may##2##2##(1994-2#1)(1997-2#1)
stimulus of##2##2##(1995-8#1)(2010-4#1)
stimulus preexposure##3##2##(2008-10#2)(2008-4#1)
stimulus rate##3##2##(2008-9#3)
stimulus to##2##2##(1994-12#1)(2013-8#1)
stimulus was##6##2##(1990-5#1)(1996-2#1)(1997-2#1)(2008-5#3)
stimulus##101##1##(1990-5#4)(1990-9#2)(1991-3#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#4)(1995-12#1)(1995-8#1)(1996-12#2)(1996-2#6)(1996-5#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-7#3)(2008-10#4)(2008-11#13)(2008-4#2)(2008-5#13)(2008-7#4)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#5)
stimulus--reward learning##2##2##(1993-6#2)
stimulus--reward##3##1##(1993-6#3)
stimulus-induced activity##3##2##(2013-8#3)
stimulus-induced##4##1##(2010-12#1)(2013-8#3)
stingray##2##1##(1995-12#1)(2011-2#1)
stipes and apothecia##2##3##(2008-10#2)
stipes##4##1##(2008-10#4)
stirred at##2##2##(2008-10#1)(2008-11#1)
stirred bioreactors##2##2##(2008-11#1)(2008-7#1)
stirred reactor##2##2##(2008-10#1)(2008-11#1)
stirred tank bioreactor##10##3##(2008-11#10)
stirred tank reactor##4##3##(1997-2#1)(2008-11#1)(2008-7#2)
stirred tank##17##2##(1997-2#1)(2008-11#13)(2008-7#3)
stirred tankreactor##2##2##(2008-11#2)
stirred##49##1##(1996-3#1)(1997-2#1)(2008-10#9)(2008-11#30)(2008-7#6)(2011-2#1)(2013-1#1)
stirred-tank reactor##2##2##(2008-10#1)(2008-11#1)
stirrer##3##1##(2008-10#1)(2008-11#2)
stirring for##3##2##(2008-10#3)
stirring of##2##2##(2008-10#2)
stirring rate##7##2##(2008-10#7)
stirring rates##2##2##(2008-11#2)
stirring speed##3##2##(2008-10#1)(2008-11#2)
stirring time from##2##3##(2008-10#2)
stirring time of##2##3##(2008-10#2)
stirring time##11##2##(2008-10#11)
stirring##42##1##(2006-6#1)(2008-10#34)(2008-11#6)(2008-5#1)
stitch##7##1##(1991-2#6)(2013-1#1)
stitches##2##1##(1996-3#1)(1997-7#1)
stochastic differential equations##2##3##(2008-6#2)
stochastic effects##3##2##(2008-8#1)(2009-5#1)(2012-2#1)
stochastic extinction##3##2##(2008-8#3)
stochastic harvesting in##2##3##(2008-8#2)
stochastic juvenile survival##2##3##(2008-8#2)
stochastic kinetic models##2##3##(2010-7#1)(2011-2#1)
stochastic model for##2##3##(2008-10#1)(2008-9#1)
stochastic model##5##2##(2008-10#4)(2008-9#1)
stochastic models of##3##3##(2008-8#2)(2013-8#1)
stochastic models##5##2##(1995-5#1)(2008-11#1)(2008-8#2)(2013-8#1)
stochastic processes##2##2##(2009-8#2)
stochastic resonance##2##2##(2008-10#2)
stochastic simulations##2##2##(2008-10#1)(2008-8#1)
stochastic##69##1##(1992-9#1)(1995-5#2)(1995-6#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#2)(2008-7#2)(2008-8#24)(2008-9#3)(2009-5#1)(2009-8#2)(2010-10#2)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-8#3)
stochasticity and##2##2##(2008-8#1)(2008-9#1)
stochasticity in##2##2##(2008-8#1)(2008-9#1)
stochasticity##12##1##(2008-8#6)(2008-9#5)(2013-8#1)
stock and##5##2##(2007-12#1)(2008-10#1)(2008-9#2)(2010-1#1)
stock for##2##2##(2008-10#1)(2008-9#1)
stock of##3##2##(1996-12#1)(1997-2#1)(2008-12#1)
stock solutions of##2##3##(2008-10#1)(2008-4#1)
stock types##2##2##(2008-10#2)
stock##30##1##(1994-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2008-9#4)(2009-7#1)(2010-1#2)(2011-2#2)
stocking rate##10##2##(1996-12#10)
stocking##11##1##(1996-12#10)(2011-3#1)
stocks##19##1##(2008-10#7)(2008-11#2)(2008-4#1)(2008-9#2)(2010-8#1)(2010-9#1)(2012-2#2)(2012-3#2)(2013-1#1)
stoichiometric LiTaO(3)##2##2##(2007-12#2)
stoichiometric data##2##2##(1994-3#1)(2008-10#1)
stoichiometric model##2##2##(2008-11#1)(2008-7#1)
stoichiometric ratio##3##2##(2008-10#2)(2008-11#1)
stoichiometric##36##1##(1992-3#1)(1993-9#1)(1994-3#2)(1995-6#1)(1996-2#2)(2007-12#4)(2008-10#17)(2008-11#7)(2008-7#1)
stoichiometrically##3##1##(1991-5#1)(2008-10#2)
stoichiometries and##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
stoichiometries##8##1##(2008-10#6)(2008-4#1)(2011-1#1)
stoichiometry and distance##2##3##(2010-5#2)
stoichiometry and##8##2##(1994-5#1)(2008-10#4)(2008-11#1)(2010-5#2)
stoichiometry in##3##2##(1992-3#2)(2008-10#1)
stoichiometry of the complex##3##4##(2008-10#3)
stoichiometry of the species##2##4##(2008-10#2)
stoichiometry of the##12##3##(1993-8#1)(2008-10#10)(2008-7#1)
stoichiometry of##22##2##(1991-5#1)(1993-8#1)(1995-11#1)(1997-2#1)(2008-10#15)(2008-4#2)(2008-7#1)
stoichiometry was##3##2##(1991-5#1)(1992-3#1)(2008-10#1)
stoichiometry were##2##2##(2008-10#2)
stoichiometry with##2##2##(1995-11#1)(2008-10#1)
stoichiometry##58##1##(1991-3#1)(1991-5#3)(1992-3#4)(1993-8#1)(1994-5#1)(1995-11#2)(1996-2#2)(1997-2#1)(2008-10#35)(2008-11#2)(2008-4#2)(2008-7#1)(2010-5#3)
stolbur phytoplasma##4##2##(2008-10#4)
stolbur##5##1##(2008-10#5)
stolon connections##2##2##(2009-8#2)
stolon regression and##2##3##(2009-8#2)
stolon regression##4##2##(2009-8#4)
stolon##8##1##(2009-8#8)
stolonifer##2##1##(2008-5#2)
stolons of##2##2##(2008-10#2)
stolons##3##1##(2008-10#2)(2009-8#1)
stoma##2##1##(1993-6#1)(2008-10#1)
stomach and##10##2##(1990-9#1)(1992-5#1)(1996-12#2)(1997-1#1)(2008-12#1)(2008-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
stomach cancer cells##3##3##(2008-8#1)(2009-9#2)
stomach cancer##10##2##(1990-12#1)(1990-9#1)(1992-12#1)(1995-9#1)(2008-8#1)(2009-9#2)(2012-12#2)(2012-3#1)
stomach compartment##2##2##(2011-2#2)
stomach contents##3##2##(1992-12#1)(1995-11#1)(2008-12#1)
stomach is##3##2##(1997-1#1)(2008-5#1)(2012-3#1)
stomach lavage and cloacal##2##4##(1996-12#2)
stomach lavage##3##2##(1996-12#3)
stomach samples##3##2##(1996-12#3)
stomach##90##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#2)(1990-9#3)(1991-2#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-5#3)(1992-6#3)(1992-9#3)(1993-6#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#8)(1997-1#6)(1997-4#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-6#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)
stomachs##4##1##(2008-12#3)(2010-8#1)
stomata were##2##2##(2008-10#1)(2011-10#1)
stomata##15##1##(2008-10#14)(2011-10#1)
stomatal aperture##2##2##(2008-10#2)
stomatal closure and##2##3##(2008-10#2)
stomatal closure##3##2##(2008-10#2)(2012-6#1)
stomatal conductance##2##2##(2008-10#1)(2012-7#1)
stomatal movement##4##2##(2008-8#4)
stomatal opening##4##2##(2008-10#1)(2008-8#2)(2012-6#1)
stomatal##21##1##(2008-10#11)(2008-8#6)(2009-8#1)(2012-6#2)(2012-7#1)
stomatitis##6##1##(1991-6#1)(1992-2#1)(1993-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
stomatopod##4##1##(2007-12#4)
stone disease##2##2##(1997-8#1)(2012-12#1)
stone formation##4##2##(1992-9#3)(1996-3#1)
stone formers##6##2##(1991-12#6)
stone fruit trees##3##3##(2008-10#3)
stone fruit##10##2##(2008-10#10)
stone fruits##4##2##(2008-10#4)
stone in##2##2##(2008-10#1)(2011-2#1)
stone##46##1##(1990-12#1)(1991-12#6)(1992-9#3)(1993-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-3#1)(1997-8#1)(2008-10#16)(2008-2#1)(2008-3#2)(2009-1#1)(2010-12#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#3)
stone-fruit-growing##2##1##(2008-10#2)
stones and##4##2##(1991-9#1)(2010-8#1)(2013-8#2)
stones in##4##2##(1991-3#1)(1994-6#1)(2010-12#1)(2013-8#1)
stones was##2##2##(1994-5#1)(2010-12#1)
stones were##2##2##(1991-3#1)(2013-8#1)
stones##34##1##(1990-5#1)(1991-3#4)(1991-9#1)(1994-5#1)(1994-6#1)(1996-3#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2010-12#4)(2010-8#1)(2011-2#4)(2013-1#1)(2013-8#8)
stones)##2##1##(2008-10#1)(2011-2#1)
stood##2##1##(2008-10#1)(2011-2#1)
stool as##2##2##(1993-3#1)(2011-2#1)
stool bed cuttings##2##3##(2008-10#2)
stool samples##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
stool##18##1##(1991-3#1)(1993-3#1)(1995-10#1)(2008-10#4)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-8#2)
stools##5##1##(1991-6#1)(2009-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
stop at##2##2##(1994-12#1)(2011-2#1)
stop codon##8##2##(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-9#2)(2013-1#1)
stop codons##2##2##(1993-12#1)(1993-2#1)
stop smoking##3##2##(1990-6#1)(1996-8#1)(2011-2#1)
stop##41##1##(1990-6#1)(1991-12#2)(1991-2#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-4#1)(2008-8#3)(2008-9#4)(2009-8#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
stopped after the##2##3##(1996-11#1)(2008-10#1)
stopped and##3##2##(1993-1#1)(2010-12#1)(2011-3#1)
stopped before##2##2##(2008-1#1)(2009-5#1)
stopped flow##7##2##(2008-10#7)
stopped for##2##2##(1996-3#1)(2008-8#1)
stopped smoking##2##2##(1996-8#1)(1997-3#1)
stopped the##2##2##(2008-12#1)(2008-8#1)
stopped##41##1##(1993-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-7#3)(2008-8#4)(2009-5#1)(2010-1#2)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#2)
stopped-FI##3##1##(2008-10#3)
stopped-flow fluorescence polarization immunoassay##2##4##(2008-10#2)
stopped-flow fluorescence##3##2##(1994-5#1)(2008-10#2)
stopped-flow injection##4##2##(2008-10#4)
stopped-flow mixing technique##7##3##(2008-10#7)
stopped-flow technique##2##2##(2008-10#2)
stopped-flow##28##1##(1994-5#1)(2008-10#26)(2008-4#1)
stopping the##4##2##(1992-3#1)(2008-10#1)(2008-7#1)(2010-2#1)
stopping##11##1##(1992-3#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-12#1)
stops##4##1##(1997-6#1)(2008-5#1)(2010-1#2)
storage and##20##2##(1991-5#1)(1992-3#1)(1994-3#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-2#1)
storage area at Vikuge##2##4##(2008-10#2)
storage at 4 degrees C##4##5##(2008-10#4)
storage at room temperature and##2##5##(2008-10#1)(2008-5#1)
storage at room temperature##4##4##(2008-10#2)(2008-12#1)(2008-5#1)
storage at##16##2##(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)
storage because##2##2##(1995-6#1)(2010-8#1)
storage by##2##2##(1995-6#1)(2008-8#1)
storage capacity of##2##3##(2008-3#2)
storage capacity##5##2##(2008-3#5)
storage densities##2##2##(2008-3#2)
storage density of##2##3##(2008-3#2)
storage density##4##2##(2008-3#4)
storage disease##5##2##(1992-10#1)(2010-8#3)(2012-2#1)
storage diseases##2##2##(2008-10#1)(2012-2#1)
storage disorder##3##2##(1990-8#1)(1996-8#1)(2008-10#1)
storage due to##2##3##(2007-12#1)(2008-10#1)
storage facility##2##2##(2008-10#1)(2008-9#1)
storage for##5##2##(1995-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)
storage in a##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
storage in the##5##3##(1992-3#1)(1995-12#1)(2007-12#1)(2008-10#1)(2012-5#1)
storage in##18##2##(1992-3#1)(1995-12#1)(2007-12#1)(2008-10#5)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-5#1)
storage medium##4##2##(2013-1#4)
storage of samples##3##3##(1992-3#1)(2008-10#2)
storage of the##4##3##(1990-9#1)(2008-10#2)(2008-9#1)
storage of##28##2##(1990-9#1)(1991-3#1)(1992-3#1)(1993-12#3)(1994-3#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#3)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
storage or##3##2##(1994-8#1)(2008-10#2)
storage pixels##2##2##(2008-3#2)
storage protein##3##2##(1993-11#1)(2008-10#1)(2008-9#1)
storage proteins##3##2##(1991-12#1)(2008-10#1)(2010-4#1)
storage protocols##4##2##(2008-10#4)
storage roots##2##2##(2008-10#2)
storage sites##2##2##(1994-8#1)(2008-7#1)
storage stability of the##3##4##(2008-10#2)(2008-5#1)
storage stability of##6##3##(2008-10#5)(2008-5#1)
storage stability##19##2##(2008-10#17)(2008-5#1)(2008-6#1)
storage system##3##2##(1994-3#2)(2008-10#1)
storage time of##2##3##(2008-10#1)(2008-3#1)
storage time##5##2##(2008-10#4)(2008-3#1)
storage##271##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-10#1)(1992-3#4)(1992-9#1)(1993-11#1)(1993-12#4)(1994-3#10)(1994-8#2)(1995-12#2)(1995-2#1)(1995-6#3)(1996-8#1)(2007-12#12)(2008-10#106)(2008-11#8)(2008-12#1)(2008-3#27)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#15)(2009-10#1)(2009-7#4)(2010-11#2)(2010-12#1)(2010-4#2)(2010-8#8)(2011-2#11)(2011-3#1)(2012-2#5)(2012-5#1)(2013-1#7)(2013-8#1)
store and##2##2##(1993-8#1)(2010-11#1)
store employee##2##2##(1996-5#2)
store information##2##2##(2008-11#1)(2008-4#1)
store the##3##2##(2008-10#2)(2008-3#1)
store their##2##2##(2008-7#2)
store##27##1##(1990-2#1)(1990-3#1)(1993-8#2)(1994-3#1)(1996-5#4)(1997-6#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)
store-operated##2##1##(1996-12#2)
stored LH##2##2##(1996-2#2)
stored and##2##2##(2008-10#1)(2011-9#1)
stored apples##2##2##(2008-10#2)
stored as##5##2##(2008-10#2)(2008-3#2)(2008-7#1)
stored at 20##2##3##(2008-10#2)
stored at 4 degrees C##5##5##(1990-12#1)(1991-11#1)(1993-8#1)(2008-10#2)
stored at room temperature##2##4##(2008-10#1)(2010-9#1)
stored at##15##2##(1990-12#1)(1991-11#1)(1993-8#1)(2008-10#10)(2010-7#1)(2010-9#1)
stored for##5##2##(1990-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
stored in a##4##3##(1994-6#1)(2008-11#1)(2008-7#1)(2010-8#1)
stored in the##7##3##(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2013-1#1)
stored in##24##2##(1993-1#1)(1994-6#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
stored sperm##2##2##(1994-8#1)(2008-6#1)
stored under##2##2##(2008-10#2)
stored##83##1##(1990-12#2)(1991-11#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-2#2)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#30)(2008-11#5)(2008-12#2)(2008-3#6)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-7#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#3)(2011-9#1)(2012-3#1)(2013-1#1)
stores and##3##2##(1996-5#2)(2008-3#1)
stores in##2##2##(1996-5#1)(2008-1#1)
stores##18##1##(1992-3#1)(1994-11#1)(1994-8#2)(1996-12#1)(1996-5#4)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)
stories about##2##2##(2010-10#1)(2012-2#1)
stories and##2##2##(2008-11#1)(2009-3#1)
stories##13##1##(1993-1#1)(2008-11#4)(2008-12#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-10#2)(2012-2#2)
storing data##2##2##(2008-3#1)(2008-4#1)
storing##6##1##(1996-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-10#1)
storm##6##1##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#3)
story of a##2##3##(2008-11#1)(2012-2#1)
story of##6##2##(1997-9#1)(2008-11#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-8#1)
story##25##1##(1991-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-9#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-1#1)(2011-1#2)(2011-3#1)(2012-2#1)(2013-8#4)
storytelling and narrative##3##3##(2008-11#3)
storytelling as a##2##3##(2008-11#2)
storytelling##6##1##(2008-11#6)
stover##3##1##(2008-10#1)(2011-2#2)
straight line##8##2##(1991-5#1)(2008-10#7)
straight when the knee was##2##5##(1997-8#2)
straight##29##1##(1991-5#1)(1993-12#2)(1996-6#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-10#12)(2008-6#2)(2008-9#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
straight-line##2##1##(2008-10#2)
straightforward and##2##2##(2008-10#2)
straightforward procedure##2##2##(2008-9#1)(2011-2#1)
straightforward to##2##2##(2008-8#1)(2009-7#1)
straightforward##36##1##(1990-12#1)(1992-9#1)(1995-9#1)(1996-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
strain (ATCC##2##2##(2008-12#1)(2011-2#1)
strain 10##2##2##(2008-10#2)
strain 1295-22##3##2##(2008-10#3)
strain 1609##3##2##(2008-10#3)
strain 2##2##2##(2008-10#2)
strain 2308##4##2##(1996-12#4)
strain 4/4 was##2##3##(2008-10#2)
strain 4/4##4##2##(2008-10#4)
strain 70T01 was##2##3##(2008-10#2)
strain 70T01##9##2##(2008-10#9)
strain 90-166##3##2##(2008-10#3)
strain A1##2##2##(2011-2#2)
strain A506##10##2##(2008-10#10)
strain AAV-2##4##2##(2008-8#4)
strain AF2240##2##2##(2008-11#2)
strain ATCC##2##2##(2008-10#1)(2011-2#1)
strain BK18 of##2##3##(2008-10#2)
strain BK18##3##2##(2008-10#3)
strain BV-15##4##2##(2008-10#4)
strain C##2##2##(2008-10#2)
strain C3 produces##2##3##(2008-10#2)
strain C3##8##2##(2008-10#8)
strain DC3000##2##2##(2008-10#2)
strain E278Ar##2##2##(2008-10#2)
strain Fo47##5##2##(2008-10#5)
strain G-5##3##2##(2008-10#3)
strain H46A##2##2##(2012-2#2)
strain IFO##2##2##(1993-12#2)
strain JJ45##2##2##(2009-6#2)
strain K##7##2##(2008-10#7)
strain K84##4##2##(2008-10#4)
strain Liaoning##2##2##(2008-9#2)
strain M##2##2##(2008-10#2)
strain MKB 158##4##3##(2008-10#4)
strain MKB##5##2##(2008-10#5)
strain PAV##2##2##(2008-10#2)
strain PCC 6301##2##3##(1996-6#2)
strain PCC 6803##2##3##(1996-12#2)
strain PCC##4##2##(1996-12#2)(1996-6#2)
strain PCC6803 by amino-terminal##2##4##(1996-8#1)(1997-6#1)
strain PCC6803 by##3##3##(1996-8#1)(1997-6#2)
strain PCC6803##14##2##(1995-12#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-6#2)
strain Q2-87##2##2##(2008-10#2)
strain Q8r1-96##3##2##(2008-10#3)
strain RT37-1##2##2##(2008-10#2)
strain SHZH98##3##2##(2008-8#3)
strain SSB17##2##2##(2008-10#2)
strain T32##2##2##(2008-9#2)
strain W260##2##2##(2008-10#2)
strain and its associated factors among lecturers##2##7##(2008-10#2)
strain and its##5##3##(2008-10#5)
strain and the##3##3##(2008-9#2)(2013-8#1)
strain and##23##2##(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-7#2)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
strain at 60##2##3##(1990-8#1)(1994-11#1)
strain at##5##2##(1990-8#1)(1994-11#1)(1995-12#1)(2008-10#1)(2009-11#1)
strain but##2##2##(2008-10#1)(2011-2#1)
strain can##2##2##(2008-9#1)(2011-2#1)
strain caused by the##2##4##(1996-5#1)(2009-1#1)
strain clustered##2##2##(2008-10#1)(2013-8#1)
strain compared##2##2##(1996-12#1)(2008-10#1)
strain constitutes##2##2##(1991-2#1)(2008-10#1)
strain could##3##2##(1993-8#1)(2012-2#1)(2013-8#1)
strain decreased##2##2##(2008-10#1)(2009-8#1)
strain did not##2##3##(2010-9#1)(2011-2#1)
strain differences##2##2##(1994-8#2)
strain distribution##2##2##(2008-12#1)(2010-8#1)
strain distributions##5##2##(2007-12#1)(2009-7#2)(2013-1#2)
strain diversity##2##2##(2008-10#1)(2008-9#1)
strain expressing##2##2##(2008-8#1)(2011-2#1)
strain failed to##5##3##(2008-10#3)(2008-8#1)(2012-3#1)
strain for##4##2##(2008-10#3)(2013-1#1)
strain from##5##2##(1991-2#1)(1996-12#1)(2008-10#3)
strain group##2##2##(2008-10#2)
strain had##2##2##(2008-10#1)(2013-8#1)
strain has##2##2##(2011-2#1)(2012-3#1)
strain in the##3##3##(1994-11#1)(2008-9#1)(2009-7#1)
strain in##16##2##(1993-12#1)(1993-9#1)(1994-11#1)(2008-10#9)(2008-9#1)(2009-7#1)(2010-7#1)(2013-8#1)
strain is##8##2##(2008-10#3)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)
strain isolated from a commercial##2##5##(2012-2#2)
strain isolated from##7##3##(2008-10#3)(2012-2#3)(2013-8#1)
strain isolated in##2##3##(2013-8#2)
strain isolated##9##2##(2008-10#3)(2012-2#3)(2013-8#3)
strain isolates##13##2##(2008-10#13)
strain lacking##3##2##(1992-10#1)(2009-10#1)(2009-8#1)
strain m6418##2##2##(2008-10#2)
strain maintained##2##2##(2008-10#1)(2013-8#1)
strain of A##4##3##(2008-10#4)
strain of B##2##3##(2008-10#2)
strain of BYDV##2##3##(2008-10#2)
strain of C##3##3##(2008-10#3)
strain of E##2##3##(2008-10#1)(2008-5#1)
strain of P##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
strain of Pseudomonas##2##3##(2012-2#2)
strain of S##5##3##(1996-12#1)(1996-6#1)(2006-6#1)(2008-10#2)
strain of a##2##3##(2008-10#1)(2011-2#1)
strain of group##2##3##(2008-8#1)(2012-2#1)
strain of mice##3##3##(1993-12#1)(1997-8#1)(2008-12#1)
strain of the##11##3##(1993-3#1)(1995-2#1)(2008-10#4)(2008-9#2)(2010-1#1)(2011-2#2)
strain of virus##2##3##(2008-5#2)
strain of yeast##2##3##(1994-6#1)(2008-8#1)
strain of##91##2##(1992-3#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#50)(2008-11#1)(2008-12#1)(2008-5#7)(2008-6#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#1)(2010-1#1)(2011-2#3)(2012-2#4)(2013-8#2)
strain on##9##2##(1996-6#1)(1997-2#1)(2008-10#4)(2009-1#1)(2009-6#1)(2011-2#1)
strain profile##2##2##(2007-12#2)
strain rate and##2##3##(2009-7#2)
strain rate##5##2##(2009-10#1)(2009-7#4)
strain rates##2##2##(2009-7#2)
strain specific##3##2##(2008-10#2)(2011-2#1)
strain stimulates##2##2##(1994-11#2)
strain structure can##2##3##(2008-8#2)
strain structure##3##2##(2008-8#3)
strain subgroups##2##2##(2008-10#2)
strain that##4##2##(1994-9#1)(2008-10#2)(2008-7#1)
strain to##4##2##(1992-5#1)(1993-9#1)(2008-10#1)(2011-2#1)
strain under##2##2##(1997-1#1)(2008-10#1)
strain was also##2##3##(2008-10#2)
strain was isolated##2##3##(2008-10#1)(2011-2#1)
strain was significantly##2##3##(2008-10#1)(2009-7#1)
strain was##32##2##(1991-3#1)(1995-12#1)(1996-12#1)(2008-10#13)(2008-12#2)(2008-7#1)(2008-8#1)(2009-6#2)(2009-7#2)(2009-8#1)(2011-2#2)(2012-2#2)(2013-8#3)
strain were##10##2##(1991-9#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
strain when##3##2##(2008-10#2)(2009-7#1)
strain which##3##2##(1991-7#1)(2008-10#1)(2011-3#1)
strain##914##1##(1990-2#2)(1990-8#1)(1991-2#4)(1991-3#2)(1991-7#1)(1991-9#5)(1992-10#1)(1992-3#2)(1992-5#2)(1993-12#11)(1993-3#2)(1993-8#1)(1993-9#9)(1994-11#7)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#5)(1995-2#4)(1995-6#3)(1995-8#2)(1996-12#14)(1996-2#1)(1996-5#1)(1996-6#8)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#6)(2006-6#1)(2007-12#11)(2008-10#453)(2008-11#12)(2008-12#12)(2008-2#2)(2008-3#1)(2008-5#18)(2008-6#3)(2008-7#10)(2008-8#38)(2008-9#24)(2009-1#2)(2009-10#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#11)(2009-7#25)(2009-8#4)(2009-9#1)(2010-1#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#79)(2011-3#3)(2012-2#19)(2012-3#14)(2013-1#15)(2013-8#28)
strain)##6##1##(2008-10#2)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
strain-based plasticity##2##2##(2013-1#2)
strain-based##4##1##(2013-1#4)
strain-dependent##2##1##(1994-2#1)(2008-10#1)
strain-induced##4##1##(1994-11#1)(1995-2#3)
strain-specific monoclonal antibodies##2##3##(2008-10#2)
strain-specific monoclonal##3##2##(2008-10#3)
strain-specific##17##1##(1996-12#1)(2008-10#9)(2008-12#3)(2008-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
strained##3##1##(1990-8#2)(2008-3#1)
strains (F##2##2##(2008-10#2)
strains ER##2##2##(2008-10#2)
strains able to##2##3##(1991-3#1)(2008-10#1)
strains after##3##2##(2008-10#2)(2008-11#1)
strains against##2##2##(2008-10#1)(2012-2#1)
strains also##3##2##(2008-10#2)(2013-8#1)
strains among##2##2##(2008-10#1)(2011-2#1)
strains and a##2##3##(2008-10#2)
strains and in##2##3##(2008-10#2)
strains and isolates##3##3##(2008-10#2)(2008-5#1)
strains and other##2##3##(2008-10#2)
strains and the##4##3##(2008-10#3)(2013-1#1)
strains and their##4##3##(2008-12#4)
strains and##43##2##(1993-12#1)(1994-8#1)(2008-10#28)(2008-11#1)(2008-12#4)(2008-5#3)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#2)
strains are able to##2##4##(2008-10#2)
strains are discussed##2##3##(1993-9#1)(1995-12#1)
strains are##18##2##(1993-12#1)(1993-9#1)(1995-12#1)(2008-10#10)(2008-8#1)(2010-3#1)(2011-2#2)(2012-3#1)
strains as X##2##3##(2008-10#2)
strains as well as##2##4##(2008-10#1)(2008-12#1)
strains as##9##2##(2008-10#8)(2008-12#1)
strains associated with diseased##2##4##(2008-10#2)
strains associated with##3##3##(2008-10#3)
strains at##3##2##(2008-10#2)(2012-2#1)
strains based on##3##3##(2008-10#2)(2013-1#1)
strains became##2##2##(2008-10#1)(2010-7#1)
strains belonged to##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
strains belonging to genomospecies 1##2##5##(2008-10#2)
strains belonging to genomospecies##3##4##(2008-10#3)
strains belonging to##4##3##(2008-10#4)
strains but##2##2##(2008-10#2)
strains by##9##2##(1997-3#1)(2008-10#6)(2008-9#1)(2012-2#1)
strains can##5##2##(2008-10#4)(2008-5#1)
strains carry multiple##2##3##(2008-10#1)(2012-3#1)
strains carry##3##2##(1996-6#1)(2008-10#1)(2012-3#1)
strains carrying##3##2##(1990-11#1)(1992-10#1)(2008-10#1)
strains caused##3##2##(2008-10#3)
strains causing##2##2##(2008-12#1)(2013-8#1)
strains clearly##2##2##(2008-10#1)(2008-5#1)
strains clustered##3##2##(2008-10#2)(2013-8#1)
strains collected from##3##3##(2008-10#3)
strains collected##6##2##(2008-10#6)
strains containing##4##2##(1993-9#1)(2008-10#2)(2011-2#1)
strains could be##3##3##(2008-10#3)
strains could##6##2##(2008-10#4)(2008-5#1)(2013-8#1)
strains derived from##2##3##(2008-10#2)
strains did not##5##3##(2008-10#4)(2008-5#1)
strains displaying##2##2##(2008-10#2)
strains examined##3##2##(2008-10#3)
strains exhibited##3##2##(2008-10#3)
strains expressing##2##2##(2010-11#1)(2012-3#1)
strains for##5##2##(1996-12#1)(2008-10#2)(2010-7#1)(2011-2#1)
strains formed a##2##3##(1996-12#1)(2008-10#1)
strains from a##2##3##(2008-10#2)
strains from all other##2##4##(2008-10#2)
strains from all##6##3##(2008-10#6)
strains from cantaloupe and##2##4##(2008-10#2)
strains from citrus##2##3##(2008-10#2)
strains from different geographical##2##4##(2008-10#2)
strains from different##6##3##(2008-10#6)
strains from ginger##4##3##(2008-10#4)
strains from hazelnut##3##3##(2008-10#3)
strains from other##3##3##(2008-10#3)
strains from the##3##3##(2008-10#2)(2008-5#1)
strains from tomato##2##3##(2008-10#2)
strains from various##2##3##(1993-3#1)(2011-2#1)
strains from##65##2##(1993-3#1)(2008-10#58)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
strains grew##4##2##(2008-10#3)(2010-4#1)
strains had##6##2##(2008-10#3)(2008-5#1)(2010-4#1)(2013-8#1)
strains has##2##2##(1995-9#1)(2008-10#1)
strains have been obtained##2##4##(2008-10#1)(2008-8#1)
strains have been##6##3##(1996-12#1)(2008-10#3)(2008-8#1)(2012-3#1)
strains have not##2##3##(2008-10#1)(2008-5#1)
strains have##13##2##(1996-12#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
strains identified##2##2##(2008-10#2)
strains in a##4##3##(2008-10#3)(2011-2#1)
strains in cucurbits##2##3##(2008-10#2)
strains in culture##2##3##(1991-2#1)(2008-10#1)
strains in the##10##3##(2007-12#1)(2008-10#4)(2008-5#1)(2008-9#3)(2013-8#1)
strains in##40##2##(1991-2#1)(2007-12#1)(2008-10#26)(2008-12#1)(2008-5#1)(2008-9#5)(2009-7#1)(2011-2#1)(2013-8#3)
strains increased##3##2##(2008-10#3)
strains induced##2##2##(2008-10#2)
strains infecting##2##2##(2008-10#2)
strains into three##3##3##(2008-10#3)
strains into two distinct groups##2##5##(2008-10#2)
strains into##11##2##(2008-10#10)(2012-3#1)
strains is a##2##3##(1996-6#1)(2008-9#1)
strains is##5##2##(1996-6#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)
strains isolated from the##2##4##(2008-10#1)(2008-5#1)
strains isolated from##28##3##(2008-10#20)(2008-12#2)(2008-5#3)(2009-6#1)(2013-1#1)(2013-8#1)
strains isolated in the##2##4##(1990-2#1)(2008-12#1)
strains isolated in##4##3##(1990-2#1)(2008-10#1)(2008-12#2)
strains isolated##37##2##(1990-2#1)(2008-10#22)(2008-12#4)(2008-5#6)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
strains lacking##2##2##(1992-10#1)(2009-10#1)
strains may##2##2##(2008-10#1)(2008-5#1)
strains not##2##2##(2008-10#1)(2008-12#1)
strains of Bacillus##2##3##(2008-10#2)
strains of C##3##3##(2008-10#2)(2009-10#1)
strains of E##5##3##(2008-10#3)(2008-12#1)(2012-3#1)
strains of F##5##3##(2008-10#4)(2013-1#1)
strains of Fusarium oxysporum##2##4##(2008-10#2)
strains of H contortus##2##4##(1991-8#2)
strains of H##6##3##(1990-5#1)(1991-8#2)(2008-12#1)(2008-5#1)(2008-7#1)
strains of Helicobacter pylori##2##4##(1997-8#1)(2008-12#1)
strains of P##7##3##(2008-10#5)(2008-5#1)(2010-3#1)
strains of Pantoea agglomerans##2##4##(2008-10#2)
strains of Pseudomonas##4##3##(2008-10#3)(2008-7#1)
strains of R##3##3##(2008-10#3)
strains of S##9##3##(2008-10#5)(2008-7#2)(2012-3#2)
strains of SCMV and SrMV##2##5##(2008-10#2)
strains of Salmonella##2##3##(1995-5#1)(2013-8#1)
strains of Trichoderma##2##3##(2008-10#2)
strains of X##9##3##(2008-10#9)
strains of Xanthomonas axonopodis pv##3##5##(2008-10#3)
strains of Xanthomonas campestris pv##2##5##(2008-10#2)
strains of Xanthomonas oryzae pv##2##5##(2008-10#2)
strains of Xanthomonas##11##3##(2008-10#10)(2008-8#1)
strains of Xylella fastidiosa##3##4##(2008-10#3)
strains of a##2##3##(2008-10#2)
strains of bacteria##3##3##(1990-5#1)(2008-10#1)(2008-12#1)
strains of beet##2##3##(2008-10#2)
strains of coagulase-negative staphylococci##2##4##(2008-7#1)(2010-4#1)
strains of each species##2##4##(2008-10#1)(2008-12#1)
strains of infectious bronchitis virus isolated from the##2##8##(2008-5#2)
strains of infectious bronchitis virus##3##5##(1996-11#1)(2008-5#2)
strains of mice##10##3##(1993-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2013-1#1)
strains of other##3##3##(2008-10#3)
strains of plant growth-promoting rhizobacteria (PGPR)##2##6##(2008-10#2)
strains of rat##2##3##(1994-2#1)(2008-11#1)
strains of rats##2##3##(1993-12#1)(2008-10#1)
strains of the bacterial##2##4##(2008-10#2)
strains of the pathogen##6##4##(2008-10#6)
strains of the same##3##4##(2008-10#2)(2008-4#1)
strains of the species##3##4##(2008-10#3)
strains of the##28##3##(1993-12#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
strains of##193##2##(1990-5#3)(1991-8#2)(1993-12#3)(1993-9#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#124)(2008-11#3)(2008-12#11)(2008-4#2)(2008-5#11)(2008-7#5)(2008-8#2)(2009-10#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#7)(2013-1#3)(2013-8#1)
strains on the basis of##2##5##(2008-10#2)
strains on the##3##3##(2008-10#2)(2011-2#1)
strains on##11##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
strains or##3##2##(2008-10#2)(2008-9#1)
strains pathogenic to##3##3##(2008-10#3)
strains pathogenic##4##2##(2008-10#4)
strains persisted##2##2##(2008-10#1)(2008-5#1)
strains produced##7##2##(2008-10#7)
strains producing##3##2##(2008-10#2)(2008-5#1)
strains represent##2##2##(2008-10#2)
strains representing the##2##3##(2008-10#2)
strains required##2##2##(2008-10#1)(2012-3#1)
strains revealed##5##2##(2008-10#2)(2008-5#1)(2009-6#2)
strains sensitive##3##2##(2008-10#3)
strains showed##8##2##(2008-10#5)(2008-12#1)(2008-5#2)
strains significantly reduced##2##3##(2008-10#2)
strains tested##8##2##(2008-10#6)(2008-5#1)(2011-2#1)
strains that are##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
strains that differ in##2##4##(1996-12#1)(2008-10#1)
strains that might##2##3##(1992-12#1)(2011-2#1)
strains that were##7##3##(2008-10#6)(2008-12#1)
strains that##28##2##(1992-12#1)(1993-9#1)(1996-12#1)(2008-10#19)(2008-12#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
strains to##8##2##(1993-12#1)(2008-10#6)(2011-2#1)
strains used##2##2##(2008-10#2)
strains using##6##2##(2008-10#5)(2011-2#1)
strains varied significantly##2##3##(2008-10#1)(2008-12#1)
strains was found##2##3##(2008-10#1)(2008-12#1)
strains was revealed by RFLP##2##5##(2008-10#2)
strains was##20##2##(1991-3#2)(2008-10#16)(2008-12#1)(2012-3#1)
strains were also##3##3##(1991-3#1)(1996-12#1)(2008-10#1)
strains were compared##3##3##(2008-10#3)
strains were divided into two##2##5##(2008-10#2)
strains were divided into##3##4##(2008-10#3)
strains were evaluated##2##3##(2008-10#2)
strains were examined##2##3##(2008-10#1)(2008-5#1)
strains were further##2##3##(2008-10#2)
strains were grouped##3##3##(2008-10#3)
strains were highly pathogenic on Andean##2##6##(2008-10#2)
strains were highly pathogenic on##3##5##(2008-10#3)
strains were identified as##4##4##(2008-10#3)(2009-6#1)
strains were identified##9##3##(2008-10#7)(2008-11#1)(2009-6#1)
strains were inoculated##2##3##(2008-10#2)
strains were isolated from##6##4##(2008-10#5)(2008-5#1)
strains were isolated##7##3##(2008-10#5)(2008-5#1)(2011-2#1)
strains were more##2##3##(2008-10#2)
strains were not##4##3##(2008-10#3)(2008-5#1)
strains were pathogenic on##2##4##(2008-10#2)
strains were placed in##2##4##(2008-10#2)
strains were placed##3##3##(2008-10#3)
strains were present##2##3##(2008-10#2)
strains were separated##2##3##(2008-10#2)
strains were significantly##2##3##(2008-10#1)(2008-12#1)
strains were tested for##2##4##(2008-10#2)
strains were the most##2##4##(2008-10#1)(2011-2#1)
strains were then##2##3##(2008-10#1)(2011-2#1)
strains were used to##2##4##(2008-10#2)
strains were##112##2##(1991-3#1)(1996-12#2)(1997-8#1)(2008-10#91)(2008-11#1)(2008-12#3)(2008-5#3)(2009-6#1)(2009-7#1)(2010-7#1)(2011-2#5)(2013-8#2)
strains with##18##2##(1991-12#2)(1993-8#1)(1993-9#1)(2008-10#7)(2008-2#1)(2008-8#3)(2011-1#2)(2012-3#1)
strains within this##2##3##(2008-10#1)(2008-5#1)
strains within##6##2##(2008-10#5)(2008-5#1)
strains without##3##2##(2008-10#3)
strains##1248##1##(1990-11#1)(1990-2#2)(1990-5#7)(1991-12#2)(1991-2#1)(1991-3#7)(1991-8#2)(1992-10#3)(1992-12#1)(1993-12#12)(1993-3#1)(1993-8#1)(1993-9#9)(1994-2#4)(1994-5#1)(1994-8#5)(1995-12#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-11#1)(1996-12#14)(1996-6#4)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#4)(1997-9#2)(2006-6#1)(2007-12#1)(2008-10#818)(2008-11#11)(2008-12#36)(2008-2#5)(2008-4#2)(2008-5#58)(2008-7#10)(2008-8#20)(2008-9#22)(2009-10#4)(2009-12#1)(2009-6#6)(2009-7#3)(2010-11#1)(2010-3#2)(2010-4#5)(2010-6#2)(2010-7#7)(2011-1#8)(2011-2#38)(2011-3#1)(2012-2#15)(2012-3#37)(2013-1#12)(2013-8#26)
strains) and##2##2##(2008-10#2)
strains)##8##1##(1996-12#1)(2008-10#6)(2008-7#1)
stramonium SPDS1##2##2##(2013-8#2)
stramonium##7##1##(2008-10#4)(2008-7#1)(2013-8#2)
strand break##3##2##(1996-2#2)(2013-1#1)
strand breaks##10##2##(1993-12#1)(1993-9#1)(2008-4#1)(2008-7#1)(2008-9#4)(2011-2#1)(2012-3#1)
strand cDNA##2##2##(1994-11#1)(2008-9#1)
strand encodes a protein of##2##5##(2008-10#2)
strand in##2##2##(2008-4#1)(2011-2#1)
strand of the##5##3##(1997-9#1)(2008-10#3)(2008-11#1)
strand of##9##2##(1997-7#1)(1997-9#1)(2008-10#4)(2008-11#3)
strand##61##1##(1990-5#3)(1990-7#1)(1992-3#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-2#2)(1997-6#1)(1997-7#1)(1997-9#1)(2008-10#15)(2008-11#6)(2008-12#2)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#7)(2009-10#1)(2011-2#3)(2012-3#1)(2013-1#1)
strand-specific##2##1##(2008-10#1)(2012-3#1)
stranded DNA##7##2##(1990-12#1)(2008-10#5)(2013-8#1)
stranded in##2##2##(2012-2#2)
stranded oligonucleotides##2##2##(2008-10#2)
stranded##23##1##(1990-12#1)(1990-5#1)(1994-8#1)(2008-10#14)(2008-11#1)(2011-2#1)(2012-2#3)(2013-8#1)
strands and##2##2##(2008-10#1)(2012-2#1)
strands are##2##2##(2008-4#1)(2010-7#1)
strands of##4##2##(1996-6#1)(1997-3#1)(1997-6#1)(2008-9#1)
strands##20##1##(1992-3#1)(1992-4#1)(1992-6#2)(1993-8#2)(1996-6#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-4#3)(2008-9#2)(2010-7#1)(2012-2#3)
strange##3##1##(1990-11#2)(2013-1#1)
strata and##2##2##(1991-6#1)(2013-8#1)
strata of##2##2##(1994-6#1)(2008-1#1)
strata##11##1##(1990-8#1)(1991-6#1)(1994-6#1)(1995-9#1)(2008-1#3)(2008-5#1)(2009-12#1)(2012-12#1)(2013-8#1)
strategic and##3##2##(2008-11#2)(2008-12#1)
strategic choices##4##2##(1995-12#1)(1996-3#2)(1997-1#1)
strategic considerations##2##2##(1997-1#1)(2012-3#1)
strategic decision##2##2##(1997-3#1)(2013-1#1)
strategic goals##4##2##(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)
strategic management of##2##3##(1992-12#1)(2011-2#1)
strategic management##6##2##(1992-12#1)(1993-12#3)(1997-3#1)(2011-2#1)
strategic objectives##2##2##(1995-12#1)(1995-3#1)
strategic or##2##2##(1994-3#1)(1997-1#1)
strategic plan##5##2##(1991-2#2)(1994-1#1)(1994-2#2)
strategic planning and##4##3##(1994-1#1)(1994-12#1)(1994-2#1)(2008-10#1)
strategic planning in##3##3##(1991-1#1)(1992-1#1)(2008-11#1)
strategic planning process##10##3##(1991-2#2)(1994-2#6)(1994-3#1)(1996-1#1)
strategic planning##30##2##(1991-1#2)(1991-2#3)(1992-1#1)(1994-1#1)(1994-12#1)(1994-2#10)(1994-3#2)(1996-1#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
strategic plans##2##2##(1994-2#1)(1995-1#1)
strategic quality planning##2##3##(1994-2#2)
strategic response##2##2##(1996-3#1)(1997-2#1)
strategic use of##2##3##(1991-8#2)
strategic##111##1##(1991-1#2)(1991-2#5)(1991-3#1)(1991-8#3)(1992-1#1)(1992-12#2)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#4)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#18)(1994-3#6)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#3)(1996-2#3)(1996-3#5)(1997-1#7)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#9)(2008-12#3)(2008-6#1)(2008-9#4)(2009-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
strategically##4##1##(1996-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
strategies (i##2##2##(2008-8#1)(2011-2#1)
strategies adopted##3##2##(2012-3#1)(2013-1#2)
strategies against##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
strategies and tactics to##2##4##(1994-12#1)(2013-1#1)
strategies and the##2##3##(2009-12#1)(2010-11#1)
strategies and their##2##3##(2008-7#1)(2012-3#1)
strategies and to##2##3##(1995-9#1)(2008-8#1)
strategies and##33##2##(1992-3#2)(1994-1#1)(1994-12#1)(1995-12#2)(1995-9#1)(1996-1#1)(1997-7#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-10#1)(2012-12#1)(2012-3#1)(2013-1#2)
strategies are available for##2##4##(2010-11#1)(2012-2#1)
strategies are based on##2##4##(1996-11#1)(2010-11#1)
strategies are discussed##6##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
strategies are##34##2##(1992-1#1)(1992-3#1)(1994-3#2)(1996-11#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-12#1)(2010-11#2)(2010-12#1)(2011-2#3)(2012-2#2)(2013-1#1)
strategies as well as##2##4##(2010-8#1)(2011-2#1)
strategies based on##2##3##(1991-8#1)(2011-2#1)
strategies based##3##2##(1991-8#1)(2008-8#1)(2011-2#1)
strategies can be##6##3##(1993-11#1)(1997-6#1)(2008-11#1)(2008-9#1)(2009-12#1)(2012-4#1)
strategies can##9##2##(1993-11#1)(1997-6#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-4#1)
strategies employed in##3##3##(2008-1#1)(2008-11#1)(2012-2#1)
strategies employed to facilitate the detection##2##6##(2008-10#2)
strategies employed to##3##3##(2008-10#2)(2011-2#1)
strategies employed##6##2##(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
strategies for communicating##2##3##(1997-3#1)(2010-4#1)
strategies for future##3##3##(1991-1#1)(2008-10#2)
strategies for implementing##2##3##(1994-1#2)
strategies for improving##4##3##(1993-2#1)(2008-11#1)(2008-7#1)(2009-10#1)
strategies for integrating##2##3##(2008-10#1)(2008-6#1)
strategies for management##2##3##(1994-1#1)(2008-10#1)
strategies for the treatment of##3##5##(2011-2#1)(2013-1#1)(2013-8#1)
strategies for the##14##3##(2008-10#5)(2008-11#1)(2008-3#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
strategies for their##2##3##(2008-8#1)(2009-10#1)
strategies for treatment##2##3##(2008-4#1)(2010-5#1)
strategies for##116##2##(1991-1#1)(1992-2#2)(1993-1#1)(1993-2#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#5)(2009-4#1)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#4)(2011-10#1)(2011-2#8)(2011-9#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#7)(2013-8#1)
strategies from##2##2##(1995-5#1)(2008-8#1)
strategies have been##10##3##(1990-6#1)(2008-10#3)(2008-12#2)(2008-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
strategies have##13##2##(1990-6#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
strategies in a##2##3##(1994-3#1)(2010-12#1)
strategies in order to##3##4##(2008-11#2)(2012-3#1)
strategies in the##8##3##(1993-2#1)(1993-3#1)(1994-1#1)(2008-11#1)(2008-6#1)(2008-9#2)(2010-12#1)
strategies in which current investments##2##5##(2008-8#2)
strategies in##37##2##(1990-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
strategies include##2##2##(2008-10#1)(2008-11#1)
strategies into##2##2##(2008-11#1)(2008-12#1)
strategies is##8##2##(1991-6#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2013-8#1)
strategies may##3##2##(2012-2#2)(2012-3#1)
strategies must##2##2##(2008-10#1)(2010-3#1)
strategies of measurement instruments and their validity as adopted in##4##10##(2013-1#4)
strategies of the##4##3##(1990-8#1)(1996-9#1)(2009-8#1)(2010-8#1)
strategies of##22##2##(1990-8#1)(1993-3#1)(1996-9#1)(2008-10#2)(2008-8#3)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
strategies on the##4##3##(1993-1#2)(2013-1#2)
strategies should be##2##3##(1991-6#1)(2008-11#1)
strategies should##5##2##(1991-6#1)(1995-3#1)(2008-1#1)(2008-11#2)
strategies such as##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
strategies support##2##2##(2008-12#1)(2011-2#1)
strategies targeting##2##2##(1994-2#1)(2013-1#1)
strategies than##2##2##(2008-11#1)(2008-8#1)
strategies that can##2##3##(1997-2#1)(2008-9#1)
strategies that have been evaluated##2##5##(1992-2#1)(2009-1#1)
strategies that have been##3##4##(1992-2#1)(2009-1#1)(2010-7#1)
strategies that may##2##3##(2008-10#1)(2013-8#1)
strategies that##29##2##(1992-2#1)(1996-2#2)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-5#1)(2010-11#1)(2010-7#2)(2012-3#1)(2013-1#2)(2013-8#2)
strategies these pathogens##2##3##(2012-2#2)
strategies to deal with##2##4##(2008-11#1)(2008-8#1)
strategies to enhance##2##3##(1997-8#1)(2008-11#1)
strategies to help##3##3##(1991-1#1)(2008-10#1)(2010-1#1)
strategies to identify##2##3##(2008-10#1)(2008-7#1)
strategies to improve the##2##4##(1991-11#1)(2008-10#1)
strategies to improve##6##3##(1991-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
strategies to increase##2##3##(2008-4#1)(2011-2#1)
strategies to minimize the##2##4##(1996-9#1)(2011-2#1)
strategies to minimize##3##3##(1996-9#1)(2008-7#1)(2011-2#1)
strategies to optimize##2##3##(2008-10#1)(2009-8#1)
strategies to prevent or##2##4##(2008-5#1)(2010-10#1)
strategies to prevent##4##3##(2008-10#1)(2008-5#1)(2010-10#1)(2012-3#1)
strategies to protect##2##3##(1994-3#1)(1996-12#1)
strategies to reduce##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
strategies to##60##2##(1991-1#1)(1991-11#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#3)(1997-6#1)(1997-8#1)(2008-10#8)(2008-11#12)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
strategies used by the##2##4##(2008-7#1)(2010-11#1)
strategies used by##4##3##(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
strategies used to##2##3##(2008-10#1)(2008-12#1)
strategies used##9##2##(2008-10#2)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
strategies using##2##2##(2008-11#1)(2009-8#1)
strategies were##10##2##(1995-1#1)(1997-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-12#2)(2011-2#1)
strategies which##4##2##(1991-6#1)(2008-10#1)(2008-11#2)
strategies will be##2##3##(1992-3#1)(2011-3#1)
strategies with##2##2##(1991-3#1)(2008-9#1)
strategies within##2##2##(1996-3#1)(2008-10#1)
strategies##626##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#5)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#4)(1994-1#5)(1994-12#3)(1994-2#5)(1994-3#8)(1994-5#3)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#4)(1995-5#3)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#2)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#1)(1997-6#7)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#5)(2008-10#91)(2008-11#76)(2008-12#20)(2008-2#2)(2008-3#4)(2008-4#7)(2008-5#4)(2008-6#9)(2008-7#16)(2008-8#36)(2008-9#18)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#9)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#5)(2010-1#3)(2010-10#7)(2010-11#13)(2010-12#9)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#11)(2010-8#3)(2011-1#3)(2011-10#2)(2011-2#37)(2011-3#5)(2011-9#1)(2012-12#5)(2012-2#15)(2012-3#19)(2012-4#1)(2013-1#34)(2013-8#9)
strategy allowed##2##2##(2008-10#2)
strategy and precisely located on the physical map of chromosome 5##2##11##(1997-6#1)(1997-8#1)
strategy and##14##2##(1991-6#1)(1992-9#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2013-8#1)
strategy are##3##2##(2008-11#2)(2008-12#1)
strategy based on the##2##4##(2008-10#2)
strategy based on##6##3##(2008-10#4)(2008-7#1)(2011-1#1)
strategy by##2##2##(1995-3#1)(2008-10#1)
strategy can##3##2##(2008-7#2)(2009-12#1)
strategy could be##3##3##(2010-10#1)(2011-3#1)(2012-12#1)
strategy designed##2##2##(2008-12#1)(2008-7#1)
strategy during##2##2##(1997-8#1)(2008-12#1)
strategy entailed##2##2##(1996-3#1)(2008-10#1)
strategy for developing##2##3##(2008-10#1)(2008-9#1)
strategy for effective##2##3##(1992-1#1)(1993-12#1)
strategy for improving the##2##4##(2008-10#1)(2013-1#1)
strategy for improving##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
strategy for preventing##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
strategy for prevention##2##3##(2011-2#2)
strategy for reducing the##2##4##(2008-10#1)(2008-11#1)
strategy for reducing##3##3##(2008-10#2)(2008-11#1)
strategy for the determination of##2##5##(2008-10#2)
strategy for the##17##3##(1990-12#1)(1992-9#1)(1995-3#1)(2008-10#6)(2008-11#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#3)
strategy for##104##2##(1990-12#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-1#1)(1996-3#2)(1997-1#2)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#26)(2008-11#10)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#4)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
strategy from##5##2##(2008-10#1)(2008-11#2)(2009-6#1)(2013-1#1)
strategy has been developed##2##4##(2008-10#1)(2008-11#1)
strategy has been##5##3##(1994-9#1)(1997-2#1)(2008-10#1)(2008-11#2)
strategy has##8##2##(1994-9#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2009-10#1)
strategy if##2##2##(2008-10#1)(2008-8#1)
strategy in a##2##3##(1991-2#1)(2008-11#1)
strategy in the##5##3##(1993-3#1)(1994-9#1)(2008-10#2)(2013-8#1)
strategy in this##2##3##(2011-3#1)(2012-3#1)
strategy in##23##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-8#2)
strategy involving##2##2##(2008-12#1)(2011-1#1)
strategy is also##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
strategy is based on the##2##5##(2008-5#1)(2008-6#1)
strategy is based on##3##4##(1991-6#1)(2008-5#1)(2008-6#1)
strategy is proposed##2##3##(1997-7#1)(2012-12#1)
strategy is the##2##3##(2008-9#1)(2011-2#1)
strategy is##21##2##(1991-6#1)(1992-9#1)(1997-7#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
strategy of gene##3##3##(2008-8#2)(2008-9#1)
strategy of the##2##3##(2008-7#2)
strategy of##30##2##(1990-6#1)(1991-1#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
strategy on##2##2##(2008-8#1)(2011-2#1)
strategy represents##2##2##(2008-8#1)(2010-5#1)
strategy that can be used##2##5##(2008-12#1)(2012-2#1)
strategy that can be##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
strategy that combines##2##3##(2008-6#1)(2012-12#1)
strategy that##21##2##(1993-12#1)(1993-2#1)(1994-3#3)(1995-6#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
strategy to a##2##3##(1997-4#1)(2010-11#1)
strategy to control##2##3##(1991-3#1)(2008-10#1)
strategy to enhance##2##3##(2008-7#1)(2013-8#1)
strategy to identify##3##3##(1995-1#1)(2008-10#1)(2009-5#1)
strategy to improve the##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
strategy to improve##7##3##(1991-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#2)
strategy to increase##2##3##(2008-11#1)(2008-12#1)
strategy to integrate##2##3##(1993-1#1)(2008-10#1)
strategy to prevent##4##3##(2008-1#2)(2011-2#1)(2013-8#1)
strategy to##53##2##(1991-1#1)(1991-3#2)(1993-1#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
strategy used##2##2##(2008-9#1)(2012-3#1)
strategy using##2##2##(2008-2#1)(2008-9#1)
strategy was proposed##3##3##(2008-10#2)(2013-1#1)
strategy was used to##2##4##(2008-10#1)(2009-11#1)
strategy was used##3##3##(1995-2#1)(2008-10#1)(2009-11#1)
strategy was##17##2##(1993-8#1)(1995-11#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-9#2)(2009-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
strategy we##2##2##(2008-11#1)(2010-12#1)
strategy were##2##2##(2008-10#1)(2008-9#1)
strategy which##2##2##(1993-2#1)(2011-2#1)
strategy with##4##2##(1992-3#1)(1993-12#1)(2008-10#1)(2008-5#1)
strategy would allow the##2##4##(2008-3#1)(2008-7#1)
strategy would##3##2##(1993-1#1)(2008-3#1)(2008-7#1)
strategy##525##1##(1990-12#1)(1990-6#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-6#5)(1992-1#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#8)(1993-2#5)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#5)(1994-3#5)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#7)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#4)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#95)(2008-11#62)(2008-12#23)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#16)(2008-8#29)(2008-9#26)(2009-10#2)(2009-11#1)(2009-12#5)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#3)(2010-10#5)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#5)(2010-7#10)(2011-1#4)(2011-2#26)(2011-3#4)(2012-12#9)(2012-2#13)(2012-3#14)(2013-1#18)(2013-8#10)
stratification and##4##2##(2008-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
stratification is##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
stratification of the##3##3##(1994-9#1)(2008-3#1)(2010-12#1)
stratification of##10##2##(1994-9#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
stratification with##2##2##(2012-3#1)(2013-8#1)
stratification##33##1##(1992-12#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-8#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
stratified as##2##2##(1995-11#1)(2007-12#1)
stratified by the##2##3##(1995-2#1)(2013-1#1)
stratified by##9##2##(1992-3#1)(1995-2#2)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2011-9#1)(2013-1#1)
stratified epithelium##2##2##(2010-3#1)(2010-7#1)
stratified into##6##2##(2010-12#2)(2011-2#3)(2012-2#1)
stratified random##2##2##(1997-3#1)(2013-1#1)
stratified sample##2##2##(2008-10#1)(2010-1#1)
stratified##44##1##(1990-11#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-9#2)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#5)(2011-9#2)(2012-2#1)(2012-5#1)(2013-1#2)
stratify##6##1##(1994-3#1)(1995-12#1)(2008-11#2)(2012-2#1)(2013-1#1)
stratifying by##2##2##(2011-2#2)
stratifying##6##1##(2008-3#1)(2011-2#5)
stratosphere from##2##2##(2008-3#2)
stratosphere##9##1##(1991-5#4)(1991-6#1)(2008-3#4)
stratospheric ozone##4##2##(1995-3#1)(1996-1#1)(2008-10#2)
stratospheric sulfuric##2##2##(2008-3#2)
stratospheric##16##1##(1991-5#3)(1995-3#1)(1996-1#2)(2008-10#2)(2008-11#1)(2008-3#7)
stratum corneum (SC)##6##3##(2008-10#1)(2008-5#5)
stratum corneum and##2##3##(2008-5#2)
stratum corneum barrier function##2##4##(2008-5#2)
stratum corneum lipid##3##3##(2008-10#1)(2008-5#2)
stratum corneum lipids##5##3##(2008-5#5)
stratum corneum maturation##2##3##(2008-5#2)
stratum corneum water barrier##2##4##(2008-5#2)
stratum corneum were##3##3##(2008-5#3)
stratum corneum##74##2##(2008-10#3)(2008-5#71)
stratum granulosum##2##2##(2008-5#2)
stratum radiatum##2##2##(1994-2#1)(2008-7#1)
stratum##82##1##(1994-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#74)(2008-7#1)(2008-9#1)
straw##9##1##(2008-10#4)(2008-11#1)(2011-1#1)(2013-8#3)
strawberry and##7##2##(2008-10#7)
strawberry fields##4##2##(2008-10#4)
strawberry isolates##4##2##(2008-10#4)
strawberry leaf blight##3##3##(2008-10#3)
strawberry leaf##4##2##(2008-10#4)
strawberry leaflets##4##2##(2008-10#4)
strawberry leaves and##2##3##(2008-10#2)
strawberry leaves##9##2##(2008-10#9)
strawberry plants##3##2##(2008-10#3)
strawberry production fields##2##3##(2008-10#2)
strawberry production##5##2##(2008-10#5)
strawberry tree honey##2##3##(2008-10#2)
strawberry was##3##2##(2008-10#3)
strawberry##91##1##(2008-10#90)(2008-8#1)
stray##5##1##(1996-12#3)(2008-12#1)(2013-8#1)
streak disease##2##2##(2008-10#2)
streak method##2##2##(2008-11#1)(2012-2#1)
streak mosaic virus##3##3##(2008-10#2)(2008-8#1)
streak mosaic##4##2##(2008-10#3)(2008-8#1)
streak virus (MSV)##3##3##(2008-10#3)
streak virus Isolates from##2##4##(2008-10#2)
streak virus##11##2##(2008-10#11)
streak##23##1##(2008-10#17)(2008-11#1)(2008-2#3)(2008-8#1)(2012-2#1)
streaks##7##1##(2008-10#7)
stream and passed through the##2##5##(2008-10#2)
stream and the##3##3##(2008-10#3)
stream and##6##2##(2008-10#6)
stream at##2##2##(2008-10#1)(2008-6#1)
stream containing 0##4##3##(2008-10#4)
stream containing##9##2##(2008-10#9)
stream flow##2##2##(2008-10#1)(2011-2#1)
stream formation##2##2##(2009-8#2)
stream in##2##2##(2008-10#2)
stream into##2##2##(1995-3#1)(2008-10#1)
stream is##4##2##(2008-10#3)(2013-8#1)
stream of N(2)##2##3##(2008-10#2)
stream of sodium##2##3##(2008-10#2)
stream of##35##2##(1995-2#1)(2007-12#1)(2008-10#27)(2008-11#1)(2010-10#4)(2011-2#1)
stream sediment##4##2##(2008-10#4)
stream that##2##2##(2008-7#1)(2008-8#1)
stream then returns to the reservoir##2##6##(2008-10#2)
stream to be##3##3##(2008-10#3)
stream to##6##2##(2008-10#6)
stream was monitored##2##3##(2008-10#2)
stream was##9##2##(2008-10#9)
stream water##3##2##(2008-10#3)
stream with a##2##3##(2008-10#2)
stream with##3##2##(2008-10#3)
stream##150##1##(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#126)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#5)(2009-8#3)(2010-10#4)(2011-2#2)(2012-2#2)(2013-8#1)
stream)##2##1##(1992-5#1)(2008-10#1)
streaming##5##1##(1994-9#2)(2008-11#1)(2008-6#2)
streamlined##6##1##(1997-3#1)(2008-11#1)(2009-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
streamlining the##2##2##(1997-2#2)
streamlining##4##1##(1992-8#1)(1997-2#2)(2012-3#1)
streams and##4##2##(1996-2#1)(2008-10#2)(2008-11#1)
streams of##9##2##(1997-3#1)(2008-10#5)(2008-8#2)(2009-8#1)
streams that##2##2##(2012-2#2)
streams with##3##2##(2008-10#2)(2008-8#1)
streams##41##1##(1994-9#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-10#21)(2008-11#1)(2008-8#5)(2008-9#1)(2009-8#3)(2012-2#4)
streamwater##3##1##(2008-10#3)
street air##2##2##(2008-11#2)
street children##2##2##(1997-6#2)
street dust samples##2##3##(2008-10#2)
street dust##3##2##(2008-10#3)
street##12##1##(1996-5#1)(1997-6#2)(2008-10#3)(2008-11#2)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
street-involved youth##3##2##(2013-1#3)
strength (quadriceps##2##2##(2013-1#2)
strength and function##3##3##(2013-1#3)
strength and functional##2##3##(2010-1#1)(2013-1#1)
strength and##50##2##(1993-3#1)(1994-8#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-3#2)(2008-8#1)(2009-1#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
strength by##3##2##(2008-10#2)(2010-12#1)
strength has##2##2##(1992-3#1)(1992-4#1)
strength in##8##2##(1997-6#1)(2008-10#1)(2009-3#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
strength is reported##2##3##(2008-3#1)(2008-9#1)
strength is##6##2##(2008-10#1)(2008-3#1)(2008-9#2)(2013-8#2)
strength of a##2##3##(1991-2#1)(2013-1#1)
strength of evidence##6##3##(2012-12#6)
strength of experimentally filled resins##2##5##(2009-7#2)
strength of local density regulation##2##5##(2008-8#2)
strength of selection on##3##4##(2008-8#1)(2008-9#2)
strength of selection##7##3##(2008-8#4)(2008-9#2)(2010-4#1)
strength of the##28##3##(1991-2#1)(1993-1#1)(1993-12#1)(1997-1#1)(1997-2#1)(1997-8#3)(2008-10#6)(2008-11#2)(2008-3#5)(2009-3#1)(2009-7#2)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
strength of##94##2##(1991-2#2)(1993-1#1)(1993-12#1)(1994-8#2)(1995-2#1)(1995-5#1)(1997-1#2)(1997-2#1)(1997-8#4)(2007-11#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#13)(2008-9#6)(2009-3#1)(2009-7#7)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
strength on##5##2##(2008-10#3)(2008-9#1)(2010-9#1)
strength or##2##2##(2008-10#1)(2009-3#1)
strength test was performed##2##4##(2009-7#1)(2013-1#1)
strength training##3##2##(2010-1#1)(2013-8#2)
strength values of the##2##4##(2008-10#1)(2008-5#1)
strength values##6##2##(2008-10#1)(2008-5#2)(2009-3#1)(2009-7#1)(2013-1#1)
strength was##10##2##(1997-2#2)(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#3)(2011-2#1)(2013-1#1)
strength were##6##2##(2008-10#3)(2008-9#2)(2012-2#1)
strength when##3##2##(2009-3#1)(2013-1#2)
strength with##2##2##(2008-10#1)(2009-11#1)
strength##347##1##(1990-11#1)(1990-5#2)(1991-2#2)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-5#4)(1994-8#3)(1995-2#2)(1995-5#1)(1997-1#2)(1997-2#6)(1997-6#1)(1997-8#4)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#98)(2008-11#6)(2008-12#10)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#15)(2008-9#22)(2009-1#1)(2009-11#2)(2009-3#7)(2009-7#25)(2009-9#3)(2010-1#4)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-2#10)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#37)(2013-8#10)
strength)##5##1##(1992-3#1)(2008-10#4)
strengthen the public health##3##4##(1995-12#1)(1996-2#1)(1997-2#1)
strengthen the##14##2##(1995-12#1)(1996-2#1)(1997-2#1)(2008-11#3)(2008-12#1)(2008-5#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
strengthen their##2##2##(1991-2#1)(1992-3#1)
strengthen##28##1##(1991-2#1)(1992-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
strengthened##7##1##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-6#1)(2013-8#2)
strengthening Shen'##2##2##(2013-8#2)
strengthening and##2##2##(2009-6#1)(2013-1#1)
strengthening of the##2##3##(1997-8#1)(2008-10#1)
strengthening of##4##2##(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)
strengthening the hypothesis that##2##4##(2008-10#2)
strengthening the##6##2##(1991-3#1)(2008-10#3)(2008-4#1)(2012-12#1)
strengthening##28##1##(1991-3#1)(1994-3#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-7#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#5)
strengthens its##2##2##(1991-2#1)(1992-6#1)
strengthens the##2##2##(1993-1#1)(2012-12#1)
strengthens##5##1##(1991-2#1)(1992-6#1)(1993-1#1)(2008-12#1)(2012-12#1)
strengths and limitations of##4##4##(1993-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
strengths and weaknesses and##2##4##(1996-2#1)(2008-9#1)
strengths and weaknesses of##5##4##(1992-12#1)(1997-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
strengths and weaknesses within##2##4##(1994-1#1)(2008-11#1)
strengths and weaknesses##12##3##(1992-12#1)(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#1)
strengths and##27##2##(1992-12#1)(1993-1#1)(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
strengths in##6##2##(1991-12#1)(2008-10#3)(2013-1#1)(2013-8#1)
strengths of the##6##3##(1995-2#1)(1996-2#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-1#1)
strengths of##14##2##(1995-2#2)(1996-1#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
strengths ranging from 0##2##4##(2008-10#1)(2009-7#1)
strengths than##2##2##(2008-11#1)(2009-7#1)
strengths##71##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-2#2)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-6#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-7#2)(2009-9#1)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
strenuous##5##1##(2008-7#1)(2009-3#1)(2013-1#2)(2013-8#1)
streptavidin was##2##2##(1993-6#1)(2008-10#1)
streptavidin##18##1##(1990-12#1)(1993-6#1)(1995-2#2)(1995-8#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#3)
streptavidin-biotin##4##1##(1995-2#2)(2008-10#1)(2011-2#1)
streptavidin-coated magnetic beads##3##3##(1995-6#3)
streptavidin-coated##4##1##(1995-6#3)(2008-9#1)
streptococcal infection##3##2##(2011-2#3)
streptococcal##11##1##(1991-8#2)(2008-10#1)(2011-1#3)(2011-2#5)
streptococci##4##1##(1990-12#1)(2006-6#2)(2011-2#1)
streptococcus mutans##2##2##(2013-1#2)
streptococcus##7##1##(1991-2#1)(1995-5#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
streptokinase and##2##2##(1995-6#1)(2012-2#1)
streptokinase by##2##2##(2012-2#2)
streptokinase##15##1##(1993-8#2)(1994-12#1)(1994-6#1)(1995-6#1)(2012-2#10)
streptomycetes were##2##2##(2008-10#2)
streptomycetes##4##1##(2008-10#3)(2011-1#1)
streptomycin or##2##2##(2008-10#2)
streptomycin sulfate##7##2##(2008-10#6)(2008-8#1)
streptomycin##19##1##(1993-12#1)(2008-10#17)(2008-8#1)
streptomycin-resistant##2##1##(2008-10#2)
streptozotocin (STZ)##2##2##(2010-11#1)(2011-3#1)
streptozotocin##10##1##(1990-2#1)(2008-10#4)(2008-12#1)(2010-11#1)(2010-2#1)(2011-2#1)(2011-3#1)
streptozotocin-induced##5##1##(1994-11#1)(2011-3#3)(2012-3#1)
stress adaptation##2##2##(2009-6#1)(2011-2#1)
stress among##2##2##(2008-11#1)(2010-10#1)
stress and burnout##2##3##(1996-2#1)(2010-7#1)
stress and coping model##2##4##(1995-1#2)
stress and coping##5##3##(1995-1#2)(2008-11#1)(2012-2#2)
stress and strain distributions##2##4##(2013-1#2)
stress and the##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
stress and##62##2##(1990-5#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-1#2)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#3)(2012-5#2)(2012-6#1)(2013-1#6)(2013-7#1)(2013-8#1)
stress anisotropy##2##2##(2008-3#2)
stress are##2##2##(2008-12#1)(2009-8#1)
stress associated with##3##3##(2008-8#3)
stress at##2##2##(1997-8#1)(2008-11#1)
stress behaviors##3##2##(1991-12#3)
stress by##6##2##(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
stress can##6##2##(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)
stress caused##2##2##(2008-10#1)(2011-10#1)
stress conditions##7##2##(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#2)(2012-7#1)
stress could##2##2##(2008-10#1)(2011-10#1)
stress defense##2##2##(2009-8#1)(2010-11#1)
stress disorder (PTSD)##6##3##(2008-6#1)(2009-11#1)(2010-10#1)(2012-12#2)(2013-8#1)
stress disorder and##2##3##(1991-2#1)(2013-8#1)
stress disorder##15##2##(1991-2#1)(2008-11#1)(2008-6#2)(2009-11#2)(2010-10#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#4)
stress distribution##2##2##(2008-11#1)(2013-1#1)
stress experienced by##4##3##(1991-12#1)(1992-2#1)(2008-11#1)(2009-8#1)
stress exposure and##2##3##(2009-7#1)(2012-3#1)
stress factors##2##2##(1990-6#1)(2008-10#1)
stress field##2##2##(2009-7#2)
stress for##2##2##(2008-11#1)(2009-6#1)
stress fractures of the##3##4##(1991-11#3)
stress fractures##6##2##(1991-11#5)(2007-11#1)
stress has been##2##3##(2008-10#1)(2012-3#1)
stress hormones##2##2##(2008-10#1)(2013-1#1)
stress in the##9##3##(1994-2#1)(2008-11#3)(2009-10#1)(2009-7#1)(2010-11#2)(2010-12#1)
stress in##31##2##(1990-8#1)(1991-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#7)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#1)(2011-2#1)(2012-5#1)(2012-7#1)(2013-1#2)
stress incontinence##2##2##(1994-3#2)
stress induced by##3##3##(2008-3#1)(2009-7#1)(2012-2#1)
stress induced##7##2##(2008-10#1)(2008-3#1)(2009-7#1)(2012-2#2)(2012-3#2)
stress is laid on##2##4##(1990-3#2)
stress is one##2##3##(2008-12#1)(2009-9#1)
stress is##8##2##(1990-3#2)(1990-5#1)(1994-2#1)(1995-6#1)(2008-12#1)(2008-7#1)(2009-9#1)
stress management##3##2##(1996-2#1)(2010-7#1)(2013-1#1)
stress markers in##2##3##(2009-6#1)(2010-5#1)
stress markers##5##2##(2009-6#1)(2010-5#2)(2012-5#2)
stress may##2##2##(1992-12#1)(2008-9#1)
stress measures##2##2##(2009-7#1)(2012-3#1)
stress of the##2##3##(2008-7#2)
stress of##10##2##(1995-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#2)(2010-1#1)
stress on the##4##3##(1990-8#1)(1997-4#1)(2008-11#2)
stress on##17##2##(1990-8#1)(1997-4#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-6#2)(2012-2#1)(2012-3#4)
stress or##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
stress produced##2##2##(2009-8#2)
stress proteins##5##2##(1992-5#3)(1995-6#1)(2008-11#1)
stress resistance##3##2##(2008-8#1)(2011-2#2)
stress response behaviors##2##3##(2008-7#2)
stress response by##2##3##(2008-7#2)
stress response in##2##3##(2008-7#1)(2011-2#1)
stress response protein##3##3##(1997-7#2)(2011-2#1)
stress response to##6##3##(1995-8#3)(1997-2#1)(2008-11#2)
stress response##35##2##(1992-12#1)(1995-8#3)(1997-2#3)(1997-7#2)(2008-10#4)(2008-11#2)(2008-7#6)(2008-8#1)(2009-8#4)(2010-11#1)(2011-2#3)(2012-2#3)(2012-3#2)
stress responses##9##2##(1997-8#2)(2008-10#1)(2008-9#1)(2009-10#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
stress symptoms##4##2##(2008-11#1)(2009-11#2)(2010-5#1)
stress tensor##3##2##(2008-3#1)(2009-10#2)
stress than##3##2##(2008-4#2)(2012-7#1)
stress that the##2##3##(2009-9#1)(2013-1#1)
stress that##3##2##(2009-9#1)(2012-3#1)(2013-1#1)
stress the importance of##2##4##(1990-9#1)(2008-11#1)
stress the need##2##3##(2008-10#1)(2008-7#1)
stress the##8##2##(1990-9#2)(1992-5#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
stress to##4##2##(1996-2#1)(2008-12#1)(2009-8#1)(2011-2#1)
stress tolerance##5##2##(2008-10#3)(2008-11#1)(2012-7#1)
stress ulcer##2##2##(2012-3#2)
stress urinary incontinence##2##3##(2008-10#1)(2011-2#1)
stress using##3##2##(2008-11#1)(2008-9#1)(2009-10#1)
stress was studied in##2##4##(2008-12#1)(2008-8#1)
stress was##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
stress were##3##2##(1990-5#1)(2008-9#1)(2011-3#1)
stress##645##1##(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#5)(1991-12#8)(1991-2#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-5#7)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#9)(1994-3#2)(1994-8#2)(1995-1#5)(1995-12#2)(1995-5#1)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#6)(1996-3#1)(1996-6#1)(1997-2#3)(1997-4#6)(1997-6#2)(1997-7#4)(1997-8#4)(2007-11#1)(2008-1#2)(2008-10#60)(2008-11#94)(2008-12#15)(2008-3#8)(2008-4#6)(2008-5#23)(2008-6#5)(2008-7#31)(2008-8#18)(2008-9#18)(2009-1#2)(2009-10#12)(2009-11#5)(2009-5#2)(2009-6#6)(2009-7#21)(2009-8#26)(2009-9#2)(2010-1#4)(2010-10#6)(2010-11#4)(2010-12#4)(2010-2#2)(2010-4#11)(2010-5#8)(2010-6#1)(2010-7#5)(2010-9#2)(2011-1#5)(2011-10#2)(2011-2#31)(2011-3#2)(2012-12#3)(2012-2#24)(2012-3#19)(2012-5#5)(2012-6#2)(2012-7#5)(2013-1#23)(2013-7#2)(2013-8#9)
stress)##3##1##(2008-11#1)(2008-7#1)(2008-9#1)
stress-based##2##1##(2013-1#2)
stress-induced ABA accumulation##5##3##(2008-8#5)
stress-induced anxiety##2##2##(2011-2#1)(2013-8#1)
stress-induced birefringence##3##2##(2008-3#3)
stress-induced changes in##2##3##(2008-11#1)(2008-7#1)
stress-induced##26##1##(1994-2#2)(1995-12#1)(1997-4#1)(1997-8#1)(2008-11#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#5)(2009-8#1)(2011-2#3)(2012-3#1)(2013-8#2)
stress-inducible protein##2##2##(1997-7#2)
stress-inducible##7##1##(1997-7#3)(1997-8#2)(2009-6#2)
stress-related hormone##2##2##(2008-10#1)(2009-8#1)
stress-related parameters in##2##3##(2010-12#2)
stress-related parameters##3##2##(2010-12#3)
stress-related symptoms##2##2##(1991-2#2)
stress-related##12##1##(1991-2#2)(1992-1#1)(2008-10#3)(2008-6#1)(2009-8#2)(2010-12#3)
stress-response##3##1##(2010-12#1)(2011-1#1)(2012-12#1)
stress-responsive##3##1##(1996-2#1)(2008-9#1)(2009-10#1)
stress]##2##1##(1991-6#1)(2012-3#1)
stressed that##5##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
stressed the need##2##3##(2008-11#1)(2009-4#1)
stressed the##3##2##(2008-11#1)(2009-4#1)(2010-10#1)
stressed volumes##2##2##(2009-7#2)
stressed##33##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1997-7#1)(2008-10#5)(2008-11#10)(2008-4#1)(2009-10#1)(2009-4#1)(2009-7#3)(2010-10#1)(2011-2#1)(2012-2#1)
stresses and##5##2##(1996-9#1)(2008-7#1)(2009-7#2)(2011-2#1)
stresses how##2##2##(1992-2#1)(1995-12#1)
stresses in##2##2##(2009-8#1)(2010-10#1)
stresses on##2##2##(2009-3#1)(2009-7#1)
stresses the need for##2##4##(2008-11#1)(2011-2#1)
stresses the##3##2##(2008-11#2)(2011-2#1)
stresses##54##1##(1991-1#2)(1991-12#1)(1991-5#1)(1992-2#1)(1995-12#1)(1996-2#2)(1996-9#1)(2008-10#6)(2008-11#6)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-7#6)(2009-8#2)(2010-10#4)(2010-5#1)(2011-2#9)(2012-5#1)(2013-1#1)(2013-8#1)
stressful and##2##2##(2008-11#2)
stressful events having a negative impact##2##6##(1992-1#2)
stressful events##4##2##(1992-1#3)(1996-12#1)
stressful##20##1##(1992-1#3)(1992-2#2)(1994-2#1)(1996-12#1)(2008-11#6)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#3)(2013-1#1)
stressing the need for##2##4##(2008-10#1)(2008-11#1)
stressing the##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
stressing##5##1##(1995-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
stressor of##2##2##(2008-2#1)(2010-2#1)
stressor##18##1##(2008-10#1)(2008-11#10)(2008-2#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
stressors and distress##2##3##(2012-3#2)
stressors and##6##2##(2008-10#1)(2009-8#2)(2012-3#2)(2013-8#1)
stressors compared to##2##3##(2008-4#2)
stressors in##2##2##(2010-4#1)(2012-3#1)
stressors is##2##2##(2008-4#1)(2010-12#1)
stressors##32##1##(1996-12#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#5)(2008-7#2)(2009-11#1)(2009-8#4)(2010-12#2)(2010-4#2)(2012-3#5)(2012-6#1)(2013-8#1)
stressosome##7##1##(2009-8#7)
stretch and##2##2##(2008-12#1)(2012-2#1)
stretch of##5##2##(1993-6#1)(1995-8#2)(1996-3#1)(1997-3#1)
stretch##23##1##(1990-2#1)(1990-8#5)(1993-12#1)(1993-2#1)(1993-6#1)(1995-8#2)(1996-3#1)(1997-3#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-7#2)(2010-10#1)(2012-2#2)
stretched##12##1##(1990-8#1)(1992-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#2)(2013-8#1)
stretches of##4##2##(1993-6#1)(1994-5#1)(2008-4#1)(2008-8#1)
stretches##7##1##(1990-11#1)(1993-6#1)(1994-5#1)(2008-10#2)(2008-4#1)(2008-8#1)
stretching and##2##2##(2008-10#1)(2008-2#1)
stretching band##4##2##(2008-10#4)
stretching bands##3##2##(2008-10#3)
stretching exercises##2##2##(2009-1#2)
stretching mode##3##2##(1990-8#1)(2008-10#1)(2010-10#1)
stretching of the##5##3##(2008-10#1)(2008-12#1)(2009-3#1)(2009-7#2)
stretching of##10##2##(1990-8#1)(1994-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-3#1)(2009-7#3)
stretching techniques##2##2##(2009-1#2)
stretching vibration mode##2##3##(2008-10#2)
stretching vibration of##2##3##(2008-10#2)
stretching vibration##6##2##(2008-10#5)(2008-2#1)
stretching##47##1##(1990-8#2)(1994-11#1)(1995-8#2)(2008-10#20)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#7)(2009-3#1)(2009-7#5)(2010-10#1)(2013-1#1)
stria vascularis##2##2##(2009-8#2)
stria##4##1##(1994-2#1)(2008-9#1)(2009-8#2)
striae##2##1##(2008-10#1)(2011-2#1)
striatal dopamine transporter##4##3##(1996-2#4)
striatal dopamine##9##2##(1994-8#1)(1995-2#2)(1996-2#4)(2008-11#1)(2008-7#1)
striatal dopaminergic##2##2##(2008-7#1)(2013-8#1)
striatal hyperactivity##2##2##(2013-8#2)
striatal interactions##2##2##(1993-6#2)
striatal neurons##2##2##(1991-6#1)(2008-5#1)
striatal projection##2##2##(1996-12#1)(1996-2#1)
striatal synaptosomes##3##2##(1995-11#2)(1996-2#1)
striatal##39##1##(1990-7#3)(1991-6#2)(1993-6#2)(1994-2#1)(1994-8#2)(1995-11#3)(1995-12#1)(1995-2#2)(1996-12#2)(1996-2#7)(1997-2#3)(2008-11#1)(2008-5#2)(2008-7#4)(2013-8#4)
striate cortical cells in the monkey##2##6##(2008-8#2)
striate##5##1##(2008-10#2)(2008-11#1)(2008-8#2)
striated muscle myosin of Xenopus laevis##2##6##(1995-12#2)
striated muscle##3##2##(1992-6#1)(1995-12#2)
striated##5##1##(1992-6#1)(1995-12#3)(2010-6#1)
striations##2##1##(2008-5#2)
striatum after dopamine##2##3##(1996-12#1)(1996-2#1)
striatum and motor cortex##3##4##(1991-6#3)
striatum and spinal cord##2##4##(1996-2#1)(1997-2#1)
striatum and##9##2##(1991-6#3)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#2)
striatum of the##2##3##(1993-6#1)(2008-10#1)
striatum of##4##2##(1993-6#1)(1997-2#1)(2008-10#1)(2009-8#1)
striatum##65##1##(1990-9#1)(1991-4#1)(1991-6#5)(1993-6#7)(1993-9#1)(1994-2#7)(1995-11#3)(1995-2#1)(1995-6#1)(1996-12#8)(1996-2#8)(1997-2#6)(1997-3#2)(2008-10#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-8#1)(2013-8#7)
striatum)##2##1##(1996-12#1)(2012-2#1)
strict control of##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
strict genetic##2##2##(2008-11#1)(2008-6#1)
strict requirements##3##2##(2008-10#1)(2008-11#1)(2009-3#1)
strict selection##2##2##(1996-6#1)(1996-8#1)
strict specificity##2##2##(2008-4#1)(2008-8#1)
strict temporal##2##2##(2012-2#1)(2012-3#1)
strict##36##1##(1990-2#1)(1991-1#1)(1991-5#1)(1992-9#1)(1996-6#1)(1996-8#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
stricter##2##1##(1992-12#1)(1995-6#1)
strictly anaerobic##4##2##(2011-2#4)
strictly clonal##3##2##(2008-10#3)
strictly conserved##2##2##(1991-5#1)(2008-10#1)
strictly controlled##7##2##(1995-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
strictly limited##2##2##(1997-3#1)(2008-11#1)
strictly related to##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-7#1)
strictly##53##1##(1990-9#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
stricture and##2##2##(1996-3#1)(2009-1#1)
stricture is not a##2##4##(2008-11#1)(2013-1#1)
stricture of##2##2##(2010-12#1)(2013-1#1)
stricture was##2##2##(2010-12#1)(2013-1#1)
stricture##18##1##(1995-10#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-1#1)(2010-12#2)(2013-1#7)(2013-7#1)(2013-8#1)
strictures##12##1##(1993-2#1)(2008-10#1)(2010-12#4)(2012-3#1)(2013-1#5)
stride length##3##2##(2008-7#1)(2010-8#1)(2013-1#1)
stride##5##1##(1994-8#1)(2008-7#1)(2010-8#1)(2013-1#2)
strides have been made in##3##5##(1995-12#1)(2008-11#1)(2013-1#1)
strides have been made##4##4##(1995-12#1)(2008-11#2)(2013-1#1)
strides in##2##2##(1997-1#1)(2008-8#1)
strides##7##1##(1995-12#1)(1997-1#1)(2008-11#2)(2008-8#1)(2012-3#1)(2013-1#1)
striga emergence##4##2##(2008-10#4)
striga per host plant##2##4##(2008-10#2)
striga##14##1##(2008-10#14)
striiformis f##21##2##(2008-10#21)
striiformis in##2##2##(2008-10#2)
striiformis##31##1##(2008-10#31)
strike slip##2##2##(1990-11#2)
strike the##2##2##(1996-5#1)(2010-1#1)
strike##8##1##(1990-11#2)(1991-11#1)(1993-12#1)(1996-5#2)(2008-10#1)(2010-1#1)
strikes##4##1##(1992-9#1)(2010-12#1)(2010-8#1)(2012-3#1)
striking difference between##2##3##(2008-10#2)
striking difference##3##2##(2008-10#2)(2008-11#1)
striking differences in##3##3##(2008-10#2)(2012-3#1)
striking feature of##2##3##(1994-5#1)(2008-10#1)
striking feature##4##2##(1991-5#1)(1994-5#1)(1996-6#1)(2008-10#1)
striking reduction in##2##3##(1993-11#1)(2011-2#1)
striking similarity to a##2##4##(1994-5#1)(1996-6#1)
striking similarity##3##2##(1994-5#1)(1996-6#1)(2007-12#1)
striking##47##1##(1991-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
strikingly different##3##2##(1992-3#1)(2008-11#2)
strikingly increased##2##2##(1990-5#1)(1993-2#1)
strikingly similar##5##2##(1994-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)
strikingly##17##1##(1990-5#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-3#1)(2013-8#1)
string quartets##2##2##(2013-1#2)
string##13##1##(2008-10#3)(2008-7#7)(2008-9#1)(2013-1#2)
stringency of##2##2##(1996-2#1)(2010-12#1)
stringency##4##1##(1995-2#1)(1996-2#1)(2008-10#1)(2010-12#1)
stringent in##2##2##(1995-6#1)(2008-11#1)
stringent##25##1##(1991-12#1)(1991-6#1)(1992-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#1)(2012-3#1)
strings of##3##2##(1990-8#1)(1997-6#1)(2008-5#1)
strings##12##1##(1990-8#1)(1997-6#1)(2008-5#7)(2008-7#3)
strip agent##2##2##(2008-10#2)
strip electrode##2##2##(2008-10#2)
strip of##2##2##(2008-10#2)
strip tillage##3##2##(2008-10#3)
strip##20##1##(2008-10#18)(2008-3#1)(2008-5#1)
stripe rust in##2##3##(2008-10#2)
stripe rust resistance gene##2##4##(2008-10#2)
stripe rust resistance##6##3##(2008-10#6)
stripe rust severity and infection type##2##6##(2008-10#2)
stripe rust severity##5##3##(2008-10#5)
stripe rust was##4##3##(2008-10#4)
stripe rust##33##2##(2008-10#33)
stripe width of##2##3##(2008-3#2)
stripe##45##1##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#39)(2008-3#3)
striped##2##1##(2008-10#1)(2011-2#1)
stripes##5##1##(1993-2#1)(2011-2#4)
striping##3##1##(2008-10#3)
stripped from organic phase with##2##5##(2008-10#2)
stripped from the organic phase with##2##6##(2008-10#2)
stripped from the##9##3##(1993-1#1)(2008-10#8)
stripped from##11##2##(1993-1#1)(2008-10#10)
stripped##17##1##(1993-1#1)(2008-10#15)(2008-5#1)
stripping analysis (PSA)##2##3##(2008-10#2)
stripping analysis##8##2##(2008-10#8)
stripping and##6##2##(2008-10#3)(2008-11#1)(2008-5#2)
stripping chronopotentiometric##3##2##(2008-10#3)
stripping current##4##2##(2008-10#4)
stripping differential pulse voltammetry##2##4##(2008-10#2)
stripping differential pulse##4##3##(2008-10#4)
stripping method for the##2##4##(2008-10#2)
stripping method##3##2##(2008-10#3)
stripping mode with an accumulation time##2##6##(2008-10#2)
stripping mode##3##2##(2008-10#3)
stripping of the##4##3##(2008-10#4)
stripping of##9##2##(2008-10#9)
stripping peak current##3##3##(2008-10#3)
stripping peak was##2##3##(2008-10#2)
stripping peak##7##2##(2008-10#7)
stripping peaks##2##2##(2008-10#2)
stripping performance##2##2##(2008-10#2)
stripping potentiometry##3##2##(2008-10#3)
stripping procedure for##2##3##(2008-10#2)
stripping response is##2##3##(2008-10#2)
stripping response##5##2##(2008-10#5)
stripping square-wave voltammetry##3##3##(2008-10#3)
stripping square-wave##6##2##(2008-10#6)
stripping step##3##2##(2008-10#3)
stripping technique##4##2##(2008-10#4)
stripping voltammetric assay of##2##4##(2008-10#2)
stripping voltammetric detection##4##3##(2008-10#4)
stripping voltammetric determination of the##2##5##(2008-10#2)
stripping voltammetric determination of##12##4##(2008-10#12)
stripping voltammetric determination##13##3##(2008-10#13)
stripping voltammetric measurement##2##3##(2008-10#2)
stripping voltammetric measurements##3##3##(2008-10#3)
stripping voltammetric method for the##2##5##(2008-10#2)
stripping voltammetric method is##2##4##(2008-10#2)
stripping voltammetric method##4##3##(2008-10#4)
stripping voltammetric procedure for##2##4##(2008-10#2)
stripping voltammetric procedure##7##3##(2008-10#7)
stripping voltammetric##44##2##(2008-10#44)
stripping voltammetry (CSV)##3##3##(2008-10#3)
stripping voltammetry (DPASV)##5##3##(2008-10#5)
stripping voltammetry and##4##3##(2008-10#4)
stripping voltammetry at a##2##4##(2008-10#2)
stripping voltammetry at##6##3##(2008-10#6)
stripping voltammetry in##2##3##(2008-10#2)
stripping voltammetry is##2##3##(2008-10#2)
stripping voltammetry of cysteine##2##4##(2008-10#2)
stripping voltammetry of##10##3##(2008-10#10)
stripping voltammetry on a##4##4##(2008-10#4)
stripping voltammetry on##6##3##(2008-10#6)
stripping voltammetry using##7##3##(2008-10#7)
stripping voltammetry with a mercury##2##5##(2008-10#2)
stripping voltammetry with a##5##4##(2008-10#5)
stripping voltammetry with##10##3##(2008-10#10)
stripping voltammetry##138##2##(2008-10#138)
stripping was##2##2##(2008-10#2)
stripping with##3##2##(2008-10#2)(2008-5#1)
stripping##303##1##(2008-10#294)(2008-11#1)(2008-5#8)
strips of##3##2##(1994-11#1)(2008-11#1)(2008-3#1)
strips##16##1##(1991-5#1)(1992-6#1)(1994-11#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#2)(2009-7#1)
strive to##3##2##(1994-3#2)(2008-9#1)
strive##4##1##(1994-3#2)(2008-10#1)(2008-9#1)
strives##2##1##(1994-1#1)(2013-7#1)
striving for##2##2##(1997-2#1)(2010-9#1)
striving to improve##2##3##(2010-8#1)(2011-2#1)
striving to##3##2##(2008-11#1)(2010-8#1)(2011-2#1)
striving##7##1##(1997-2#1)(2008-11#1)(2008-12#1)(2010-8#1)(2010-9#2)(2011-2#1)
strobilurin resistance in##2##3##(2008-10#2)
strobilurin##4##1##(2008-10#4)
strobus##2##1##(2008-10#2)
stroke and to##2##3##(2008-8#1)(2010-12#1)
stroke and##20##2##(1993-2#1)(1994-12#1)(2008-10#2)(2008-7#2)(2008-8#5)(2009-11#2)(2010-10#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
stroke are##2##2##(2008-8#2)
stroke center##2##2##(2007-9#1)(2013-8#1)
stroke centers##2##2##(2007-9#2)
stroke event##2##2##(2008-9#1)(2009-10#1)
stroke in patients with##2##4##(2007-7#1)(2008-8#1)
stroke in the##2##3##(2009-7#1)(2013-1#1)
stroke in##9##2##(1991-6#1)(2007-7#1)(2008-8#3)(2009-7#1)(2012-3#1)(2013-1#2)
stroke is##4##2##(2008-9#3)(2009-11#1)
stroke number##2##2##(2008-7#2)
stroke or##5##2##(1993-12#1)(2007-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
stroke patients##5##2##(2008-8#2)(2010-3#1)(2011-2#1)(2012-12#1)
stroke prevention##6##2##(1993-9#1)(1994-9#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
stroke rehabilitation##2##2##(2011-2#1)(2013-1#1)
stroke risk##2##2##(2008-8#2)
stroke treatment##2##2##(2007-9#1)(2008-8#1)
stroke units##5##2##(2011-1#5)
stroke volume##3##2##(2012-2#2)(2012-3#1)
stroke##200##1##(1991-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(2007-7#2)(2007-9#11)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#19)(2008-8#43)(2008-9#10)(2009-1#3)(2009-10#4)(2009-11#12)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-7#3)(2011-1#7)(2011-2#13)(2012-12#10)(2012-2#4)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#9)
stroke)##2##1##(2008-7#1)(2009-11#1)
stroke?##3##1##(2008-8#1)(2009-10#1)(2010-12#1)
strokectomy##3##1##(2012-3#3)
strokes in##2##2##(2008-7#1)(2011-2#1)
strokes##9##1##(1990-11#1)(2008-7#4)(2009-10#1)(2009-11#1)(2010-10#1)(2011-2#1)
stroma and##4##2##(2008-11#1)(2013-1#2)(2013-8#1)
stroma with##2##2##(2010-12#1)(2011-2#1)
stroma##31##1##(1991-8#1)(1992-2#1)(1993-2#1)(1993-3#1)(2008-10#4)(2008-11#4)(2008-12#5)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
stromal cell line##6##3##(2008-10#1)(2008-11#4)(2008-8#1)
stromal cell##13##2##(2008-10#1)(2008-11#6)(2008-8#3)(2009-10#1)(2010-3#1)(2012-3#1)
stromal cells or##2##3##(2008-11#1)(2008-4#1)
stromal cells##22##2##(1993-11#1)(1995-12#2)(2008-11#6)(2008-4#1)(2008-8#5)(2009-10#1)(2009-3#2)(2010-3#1)(2011-2#3)
stromal fibroblast##2##2##(1995-11#1)(2013-1#1)
stromal fibroblasts##6##2##(2013-1#6)
stromal tumor##5##2##(2008-10#1)(2009-7#2)(2010-12#1)(2012-12#1)
stromal tumors##9##2##(1992-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
stromal vascular##2##2##(2008-11#2)
stromal##69##1##(1992-9#1)(1993-11#1)(1995-11#1)(1995-12#2)(2008-10#2)(2008-11#17)(2008-4#1)(2008-8#8)(2009-10#2)(2009-3#2)(2009-7#2)(2010-12#1)(2010-3#2)(2011-2#6)(2012-12#2)(2012-3#4)(2013-1#14)(2013-8#1)
stromata##5##1##(2008-10#5)
stromaticum##8##1##(2008-10#8)
stromatoporoids##3##1##(1990-11#3)
strong RTP##2##2##(2008-10#2)
strong Raman##2##2##(2008-10#2)
strong absorption##3##2##(2008-10#2)(2008-3#1)
strong acid##7##2##(1990-6#1)(2008-10#6)
strong acidic##6##2##(2008-10#5)(2008-11#1)
strong acids##3##2##(2008-10#3)
strong activation of##2##3##(2008-11#1)(2008-4#1)
strong adsorption of##3##3##(2008-10#3)
strong affinity for the##2##4##(2008-10#2)
strong affinity for##3##3##(2008-10#3)
strong affinity of##2##3##(2008-10#1)(2011-2#1)
strong affinity##6##2##(1995-8#1)(2008-10#4)(2011-2#1)
strong alkaline##2##2##(2008-10#2)
strong and stable electrocatalytic##2##4##(2008-10#2)
strong and##9##2##(1994-2#1)(1995-3#1)(1996-12#1)(2008-10#5)(2012-3#1)
strong anion exchanger##2##3##(2008-10#2)
strong anion##5##2##(1991-7#1)(2008-10#4)
strong antioxidant##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
strong association##5##2##(1990-8#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)
strong associations##3##2##(1990-8#1)(1997-2#1)(2013-8#1)
strong base##3##2##(2008-10#3)
strong bootstrap support##3##3##(2008-10#3)
strong but##5##2##(1997-2#1)(2008-10#1)(2008-8#2)(2009-8#1)
strong candidates##3##2##(1996-8#1)(2008-11#1)(2008-7#1)
strong cation##2##2##(1991-7#1)(2008-10#1)
strong cell-mediated immune responses##2##4##(1995-2#1)(2013-8#1)
strong clinical suspicion##2##3##(2009-11#1)(2013-1#1)
strong clinical##4##2##(1997-2#1)(2009-11#1)(2010-10#1)(2013-1#1)
strong competition for##2##3##(2008-7#1)(2008-8#1)
strong contribution##2##2##(2008-11#1)(2008-3#1)
strong contributions##2##2##(2008-12#1)(2008-8#1)
strong correlated##2##2##(2008-8#2)
strong correlation between the##2##4##(1991-6#1)(2013-1#1)
strong correlation between##10##3##(1991-6#1)(1994-6#1)(1997-1#1)(2007-8#2)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
strong correlation##20##2##(1991-6#1)(1994-6#1)(1994-8#1)(1997-1#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
strong decrease##2##2##(2008-10#1)(2009-8#1)
strong dependence of##2##3##(2008-2#2)
strong dependence##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
strong effect on##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2011-3#1)
strong effect##6##2##(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-3#1)(2013-8#1)
strong effects##3##2##(2008-8#1)(2010-4#1)(2012-3#1)
strong emphasis##2##2##(2011-2#1)(2013-8#1)
strong enhancement##2##2##(2008-10#1)(2013-1#1)
strong enough to##3##3##(2008-7#1)(2012-2#2)
strong enough##4##2##(2008-10#1)(2008-7#1)(2012-2#2)
strong environmental##2##2##(2008-8#1)(2008-9#1)
strong evidence for##4##3##(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
strong evidence that##9##3##(1990-2#1)(1994-9#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-8#3)(2012-3#1)
strong evidence##18##2##(1990-2#1)(1992-2#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-8#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
strong expression of##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
strong expression##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
strong fluorescence##5##2##(2008-10#5)
strong functional##2##2##(1993-12#1)(2012-3#1)
strong genetic##2##2##(2008-10#1)(2013-1#1)
strong growth##2##2##(1992-12#1)(2008-11#1)
strong homology##4##2##(1993-2#1)(1996-6#2)(1997-7#1)
strong hybridization signals##2##3##(1991-6#1)(2008-8#1)
strong hybridization##3##2##(1991-12#1)(1991-6#1)(2008-8#1)
strong hydrophobicity##2##2##(2008-10#1)(2008-8#1)
strong implications##3##2##(2010-10#1)(2011-2#1)(2013-1#1)
strong in##2##2##(1996-12#1)(2008-8#1)
strong increase in##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
strong increase##5##2##(1991-9#1)(2008-10#2)(2008-11#1)(2008-7#1)
strong influence of the##2##4##(2008-3#1)(2009-7#1)
strong influence of##5##3##(2008-10#1)(2008-11#1)(2008-3#2)(2009-7#1)
strong influence on the##4##4##(2008-10#3)(2012-8#1)
strong influence on##8##3##(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2012-8#1)
strong influence##13##2##(2008-10#5)(2008-11#2)(2008-3#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-8#1)
strong inhibition##3##2##(2008-10#1)(2008-8#2)
strong inhibitory activities##3##3##(2011-3#3)
strong inhibitory##6##2##(1994-11#1)(2008-10#2)(2011-3#3)
strong interaction##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
strong intermolecular##2##2##(2008-10#1)(2008-5#1)
strong inverse##2##2##(2008-11#1)(2008-3#1)
strong is##2##2##(2008-8#1)(2011-2#1)
strong leadership##2##2##(1997-3#1)(2008-12#1)
strong light scattering##2##3##(2008-10#2)
strong light##3##2##(2008-10#2)(2008-9#1)
strong matrix##2##2##(2008-10#2)
strong metabolic##2##2##(2008-10#1)(2012-3#1)
strong negative##8##2##(1994-12#2)(1994-3#1)(2008-10#1)(2009-8#1)(2010-1#1)(2010-6#1)(2012-2#1)
strong positive##8##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
strong predictor of##4##3##(1996-8#1)(2007-12#1)(2008-9#1)(2012-2#1)
strong promoter##2##2##(2008-9#2)
strong psychometric properties##2##3##(2010-10#1)(2010-9#1)
strong reaction##2##2##(1993-6#1)(2008-8#1)
strong relation##2##2##(1994-6#1)(2008-12#1)
strong resistance to##3##3##(2008-10#2)(2012-2#1)
strong retention of##2##3##(2008-10#2)
strong selective##2##2##(2008-8#2)
strong short-term##2##2##(2008-9#2)
strong spectral##3##2##(2008-10#3)
strong support for the##2##4##(2008-11#1)(2012-3#1)
strong support for##5##3##(1991-1#1)(1992-2#1)(2008-1#1)(2008-11#1)(2012-3#1)
strong support to the##2##4##(1990-11#1)(2012-3#1)
strong support##7##2##(1990-11#1)(1991-1#1)(1992-2#1)(2008-1#1)(2008-11#1)(2012-3#2)
strong synergistic##2##2##(1993-8#1)(2008-10#1)
strong visible##2##2##(2008-8#1)(2011-2#1)
strong##582##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#3)(1992-12#2)(1992-2#4)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#5)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#1)(1996-6#4)(1996-8#4)(1997-1#1)(1997-2#4)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#4)(2008-10#182)(2008-11#38)(2008-12#9)(2008-2#2)(2008-3#23)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#11)(2008-8#49)(2008-9#22)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#3)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#13)(2011-3#6)(2012-12#2)(2012-2#10)(2012-3#10)(2012-6#1)(2012-8#1)(2012-9#1)(2013-1#15)(2013-7#1)(2013-8#6)
stronger affinity for##2##3##(1997-1#1)(2008-10#1)
stronger and##4##2##(2008-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
stronger delayed absorbable suture materials##2##5##(1991-1#2)
stronger effect on the action threshold##2##6##(2008-4#2)
stronger effect on##3##3##(2008-4#2)(2008-8#1)
stronger for##3##2##(2008-10#1)(2010-1#1)(2013-1#1)
stronger in the##2##3##(1995-11#1)(2011-2#1)
stronger in##5##2##(1995-11#1)(2008-9#2)(2010-10#1)(2011-2#1)
stronger or##2##2##(2008-8#1)(2008-9#1)
stronger signal##2##2##(2008-3#1)(2013-8#1)
stronger than that of##4##4##(1996-2#1)(2008-10#1)(2008-8#1)(2009-8#1)
stronger than that##5##3##(1996-2#1)(2008-10#1)(2008-8#2)(2009-8#1)
stronger than the##3##3##(2008-10#2)(2008-3#1)
stronger than##16##2##(1993-5#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#4)(2009-8#1)(2010-9#1)
stronger when##2##2##(2008-9#1)(2009-10#1)
stronger with##2##2##(2008-10#2)
stronger##113##1##(1991-1#2)(1991-12#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-8#1)(2008-10#28)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#10)(2008-9#6)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#5)
strongest in##2##2##(2008-10#1)(2008-11#1)
strongest##40##1##(1990-7#1)(1991-3#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
strongly absorbing##4##2##(2008-3#4)
strongly acidic resins##2##3##(2008-10#2)
strongly acidic solution##3##3##(2008-10#3)
strongly acidic##10##2##(2008-10#10)
strongly adsorbed##2##2##(2008-10#2)
strongly affected by the##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
strongly affected by##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
strongly affected the##2##3##(2008-10#1)(2008-9#1)
strongly affected##9##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
strongly aggregated##2##2##(2008-10#2)
strongly and irreversibly##2##3##(2008-10#2)
strongly and##7##2##(1992-4#1)(1994-11#1)(2008-10#3)(2010-3#1)(2013-1#1)
strongly associated with the##2##4##(1995-2#1)(2008-3#1)
strongly associated with##15##3##(1995-2#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#1)
strongly associated##17##2##(1991-6#1)(1995-2#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#1)
strongly attached##2##2##(2008-11#2)
strongly blocked##2##2##(1990-12#1)(2008-11#1)
strongly bound##2##2##(2010-7#1)(2011-2#1)
strongly competing species##2##3##(2008-8#2)
strongly coordinates with the##2##4##(2008-10#2)
strongly correlated with the##3##4##(1990-2#1)(2008-9#1)(2009-3#1)
strongly correlated with##9##3##(1990-2#1)(1991-8#1)(2008-10#2)(2008-9#1)(2009-3#1)(2012-3#3)
strongly correlated##13##2##(1990-2#1)(1991-8#1)(2008-10#4)(2008-8#2)(2008-9#1)(2009-3#1)(2012-3#3)
strongly decreased##4##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
strongly depend on the##2##4##(2008-10#1)(2008-5#1)
strongly dependent on the##14##4##(1995-8#1)(2008-10#6)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#1)
strongly dependent on##19##3##(1994-9#1)(1995-8#1)(2008-10#7)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#2)
strongly dependent upon##2##3##(2008-10#2)
strongly dependent##21##2##(1994-9#1)(1995-8#1)(2008-10#9)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#2)
strongly depends on the##2##4##(2008-6#1)(2009-3#1)
strongly differed between##2##3##(2008-11#1)(2008-8#1)
strongly enhance##2##2##(1995-2#1)(2008-10#1)
strongly enhanced by##2##3##(2008-10#2)
strongly enhanced##3##2##(2008-10#2)(2008-8#1)
strongly expressed in##2##3##(1996-2#1)(2012-2#1)
strongly expressed##3##2##(1996-2#1)(2008-9#1)(2012-2#1)
strongly in##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
strongly increased##2##2##(1995-3#1)(2013-1#1)
strongly indicate##2##2##(1993-8#1)(2008-10#1)
strongly indicates that##2##3##(1990-2#1)(2011-2#1)
strongly indicates##3##2##(1990-2#1)(2008-8#1)(2011-2#1)
strongly indicating that##2##3##(2008-10#2)
strongly induced##2##2##(2008-10#2)
strongly influence the##5##3##(2008-10#2)(2008-3#1)(2008-9#2)
strongly influence##7##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2009-5#1)
strongly influenced by the##2##4##(2008-11#1)(2008-8#1)
strongly influenced by##9##3##(2008-10#4)(2008-11#1)(2008-8#3)(2013-1#1)
strongly influenced##10##2##(2008-10#5)(2008-11#1)(2008-8#3)(2013-1#1)
strongly inhibited by##4##3##(1991-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
strongly inhibited growth##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
strongly inhibited the growth of##2##5##(1992-8#1)(2010-6#1)
strongly inhibited the##3##3##(1992-8#2)(2010-6#1)
strongly inhibited##21##2##(1991-5#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#4)(2010-6#1)(2011-2#1)(2013-1#1)
strongly interacting##2##2##(1990-12#1)(2008-9#1)
strongly linked to##2##3##(1991-12#1)(2010-5#1)
strongly on the##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
strongly on##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)
strongly overlapped##2##2##(2008-10#2)
strongly overlapping##2##2##(2008-10#2)
strongly positive##2##2##(2008-10#1)(2008-5#1)
strongly recommended##4##2##(2008-11#2)(2008-7#2)
strongly reduced by##2##3##(2008-5#1)(2008-8#1)
strongly reduced##6##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-8#1)
strongly reduces##2##2##(2008-10#1)(2008-8#1)
strongly reducing##3##2##(2008-10#3)
strongly related to the##6##4##(1991-12#1)(2008-10#4)(2008-12#1)
strongly related to##10##3##(1991-12#1)(2008-10#5)(2008-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
strongly stabilizing##2##2##(1991-7#1)(2008-9#1)
strongly stimulated##3##2##(1993-8#1)(1994-8#1)(1997-2#1)
strongly suggest that Si##2##4##(2008-10#2)
strongly suggest that the##3##4##(1994-6#1)(1996-5#1)(2008-8#1)
strongly suggest that##14##3##(1991-12#1)(1994-6#1)(1995-12#1)(1996-5#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-8#1)
strongly suggest the##4##3##(1994-5#1)(2008-10#1)(2008-7#1)(2010-11#1)
strongly suggest##20##2##(1991-12#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-5#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-3#1)
strongly suggested that##3##3##(1990-5#1)(2008-10#1)(2010-12#1)
strongly suggested##5##2##(1990-5#1)(2008-10#2)(2008-9#1)(2010-12#1)
strongly suggests that the##4##4##(1993-6#1)(1995-5#1)(1995-8#1)(2008-5#1)
strongly suggests that these##2##4##(1995-2#1)(2008-12#1)
strongly suggests that##8##3##(1993-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
strongly suggests##10##2##(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
strongly support the##7##3##(1992-3#1)(1997-7#2)(1997-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
strongly support##8##2##(1992-3#1)(1997-7#2)(1997-8#1)(2008-10#2)(2008-5#1)(2012-3#1)
strongly supported##6##2##(1993-2#1)(2008-10#2)(2008-9#1)(2012-3#1)(2013-8#1)
strongly suppressed##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
strongly that##3##2##(1992-3#1)(2008-7#1)(2008-8#1)
strongly the##3##2##(2008-10#2)(2008-5#1)
strongly to the##2##3##(2008-10#1)(2008-8#1)
strongly to##5##2##(2008-10#2)(2008-11#1)(2008-8#2)
strongly turbid suspensions##2##3##(2008-3#2)
strongly with the##2##3##(2008-10#2)
strongly with##20##2##(1993-2#2)(1994-5#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#2)(2009-10#1)(2010-2#2)(2011-2#1)(2012-4#1)
strongly##423##1##(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#5)(1994-11#2)(1994-12#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#141)(2008-11#31)(2008-12#5)(2008-2#1)(2008-3#15)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#30)(2008-9#18)(2009-10#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-8#2)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#17)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#10)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#5)(2013-8#5)
strontium and lanthanum##2##3##(2008-10#2)
strontium ion##4##2##(2008-10#4)
strontium or lanthanum was##2##4##(2008-10#2)
strontium or lanthanum##4##3##(2008-10#4)
strontium##26##1##(2008-10#24)(2008-3#1)(2012-2#1)
strontium(II)##2##1##(2008-10#2)
structural RNA##2##2##(1995-8#1)(2013-1#1)
structural abnormalities##3##2##(1996-2#1)(2008-11#1)(2010-1#1)
structural alignments##2##2##(2011-3#2)
structural alteration##2##2##(1995-2#1)(2013-8#1)
structural alterations##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
structural analysis of the Yersinia##2##5##(2013-8#2)
structural analysis of the##3##4##(2008-11#1)(2013-8#2)
structural analysis##8##2##(1997-9#2)(2008-11#1)(2008-4#1)(2010-11#1)(2010-7#1)(2013-8#2)
structural and functional analyses##2##4##(1995-6#1)(2012-2#1)
structural and functional analysis##2##4##(1993-6#1)(2008-10#1)
structural and functional properties of##2##5##(2008-5#1)(2008-8#1)
structural and functional properties##3##4##(2008-5#1)(2008-8#1)(2009-10#1)
structural and functional##16##3##(1993-6#2)(1995-12#1)(1995-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
structural and##30##2##(1991-6#1)(1993-6#2)(1995-12#1)(1995-6#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
structural anomalies##2##2##(2008-1#1)(2008-2#1)
structural aspects##2##2##(2008-8#1)(2009-12#1)
structural change##10##2##(1991-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#3)(2009-5#1)(2011-2#1)
structural changes in the##5##4##(1991-12#1)(1992-3#1)(2008-10#2)(2013-1#1)
structural changes in##7##3##(1991-12#1)(1992-3#1)(2008-10#3)(2008-7#1)(2013-1#1)
structural changes of##3##3##(1992-3#1)(2008-10#1)(2009-8#1)
structural changes that##2##3##(1997-1#1)(2012-12#1)
structural changes##26##2##(1991-12#1)(1991-3#2)(1991-5#2)(1992-3#2)(1993-8#2)(1994-5#1)(1995-2#1)(1997-1#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-8#1)(2012-12#1)(2013-1#1)
structural characteristics of the##2##4##(2008-11#1)(2008-8#1)
structural characteristics of##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
structural characteristics##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
structural characterization of the##6##4##(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-4#1)
structural characterization of##7##3##(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-4#1)
structural characterization##9##2##(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#5)(2008-4#1)
structural classes##3##2##(1993-6#1)(2008-11#1)(2008-4#1)
structural component##5##2##(1995-2#1)(2008-7#1)(2013-1#1)(2013-8#2)
structural components of the##2##4##(1997-8#1)(2008-8#1)
structural components##4##2##(1997-8#1)(2008-8#1)(2009-10#1)(2009-6#1)
structural constraints##2##2##(1994-5#2)
structural damage##2##2##(2013-8#2)
structural database##2##2##(2008-10#2)
structural defense responses##2##3##(2008-10#2)
structural defense##3##2##(2008-10#3)
structural detail##3##2##(1994-5#1)(1997-2#1)(2008-7#1)
structural determinants##2##2##(1992-12#2)
structural determination##2##2##(1994-5#1)(1997-7#1)
structural differences between##2##3##(2008-10#1)(2008-5#1)
structural differences##5##2##(1997-8#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)
structural diversity of##2##3##(1992-6#1)(2008-5#1)
structural diversity##3##2##(1992-6#1)(2008-5#1)(2011-3#1)
structural domains##3##2##(1995-6#2)(2009-7#1)
structural dynamics##5##2##(1990-8#1)(2008-10#2)(2008-4#2)
structural effects##2##2##(1994-3#1)(2008-10#1)
structural elements of##2##3##(1992-4#1)(1994-5#1)
structural elements##4##2##(1992-4#1)(1994-5#1)(2008-9#1)(2009-3#1)
structural elucidation of##2##3##(2008-10#1)(2011-2#1)
structural elucidation##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
structural equation modeling approach##2##4##(2013-8#2)
structural equation modeling##9##3##(2008-11#1)(2008-12#1)(2009-11#1)(2010-2#2)(2010-6#1)(2012-3#1)(2013-8#2)
structural equation##11##2##(2008-11#1)(2008-12#2)(2009-11#1)(2010-2#2)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#2)
structural factors##3##2##(1990-9#1)(2008-10#1)(2009-3#1)
structural features of##4##3##(1992-10#1)(1993-1#1)(2008-10#1)(2012-2#1)
structural features##15##2##(1990-10#1)(1991-6#2)(1992-10#1)(1993-1#1)(1994-5#2)(2008-10#5)(2008-5#1)(2011-1#1)(2012-2#1)
structural gene of##3##3##(1995-6#1)(2008-8#2)
structural gene##12##2##(1990-5#1)(1992-3#1)(1993-2#1)(1993-6#2)(1995-6#2)(2008-10#1)(2008-5#1)(2008-8#3)
structural genes were isolated##2##4##(1990-11#1)(2008-8#1)
structural genes were##3##3##(1990-11#1)(1993-9#1)(2008-8#1)
structural genes##8##2##(1990-11#2)(1990-5#1)(1993-9#1)(2008-8#2)(2008-9#2)
structural genomics##2##2##(2008-4#1)(2010-11#1)
structural heterogeneity##2##2##(2008-11#1)(2010-11#1)
structural information on##2##3##(2008-10#1)(2008-11#1)
structural information##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
structural integrity of##2##3##(2008-4#1)(2008-7#1)
structural integrity##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
structural model of PBS##2##4##(2008-8#2)
structural model##5##2##(1992-9#1)(1994-5#1)(2008-8#2)(2012-2#1)
structural modification##2##2##(1992-3#1)(2008-9#1)
structural modifications##3##2##(2008-10#1)(2008-7#2)
structural motif##2##2##(1993-2#1)(1995-6#1)
structural motifs##3##2##(1995-6#1)(1997-8#1)(1997-9#1)
structural or##2##2##(1997-3#1)(2008-4#1)
structural organization of the##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
structural organization of##7##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)
structural organization##10##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-8#1)
structural parameters for the##2##4##(2008-10#2)
structural parameters##6##2##(1990-4#1)(2008-10#4)(2008-3#1)
structural properties##5##2##(1991-6#1)(1993-12#1)(2007-8#1)(2008-10#1)(2010-11#1)
structural protein Gag and##3##4##(2011-3#3)
structural protein##12##2##(1993-12#2)(1993-9#1)(1995-2#1)(2008-10#2)(2009-7#1)(2010-5#1)(2011-2#1)(2011-3#3)
structural proteins of##2##3##(2008-10#1)(2008-8#1)
structural proteins##6##2##(2008-10#2)(2008-5#1)(2008-8#1)(2009-7#1)(2012-2#1)
structural relaxation##2##2##(1995-3#1)(2008-10#1)
structural reorganization of the##2##4##(2011-2#1)(2013-1#1)
structural requirements for##3##3##(1990-5#1)(1992-9#1)(2011-2#1)
structural requirements##4##2##(1990-5#1)(1992-9#1)(1994-5#1)(2011-2#1)
structural response##2##2##(2008-10#2)
structural role in the##2##4##(1993-8#1)(2008-10#1)
structural role in##3##3##(1993-8#1)(1995-6#1)(2008-10#1)
structural role##7##2##(1993-8#1)(1995-6#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)
structural similarities##2##2##(2008-10#1)(2009-4#1)
structural similarity to##2##3##(1992-6#1)(1996-2#1)
structural similarity##7##2##(1990-4#1)(1991-6#1)(1992-5#1)(1992-6#1)(1996-2#1)(2008-10#1)(2011-1#1)
structural solarization##4##2##(2008-10#4)
structural stability##5##2##(1993-12#1)(2008-10#2)(2008-11#1)(2009-8#1)
structural studies##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
structural study##2##2##(1991-12#1)(2009-8#1)
structural support##2##2##(2010-6#1)(2012-2#1)
structural##444##1##(1990-10#1)(1990-11#2)(1990-4#3)(1990-5#3)(1990-8#2)(1990-9#2)(1991-12#2)(1991-3#4)(1991-5#3)(1991-6#5)(1992-10#2)(1992-12#2)(1992-3#7)(1992-4#4)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#6)(1993-8#10)(1993-9#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#14)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-6#9)(1995-8#3)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#4)(1997-9#6)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#86)(2008-11#18)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#13)(2008-5#10)(2008-6#2)(2008-7#19)(2008-8#21)(2008-9#10)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#5)(2010-1#2)(2010-11#6)(2010-2#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#13)(2011-3#8)(2012-12#2)(2012-2#18)(2012-3#4)(2012-9#1)(2013-1#5)(2013-8#13)
structural-functional##2##1##(2010-8#1)(2011-7#1)
structurally and functionally##3##3##(1993-3#1)(2008-11#1)(2009-9#1)
structurally and##5##2##(1993-3#1)(1996-2#1)(2008-11#1)(2009-9#1)(2010-10#1)
structurally characterized##3##2##(1994-5#3)
structurally different##4##2##(2007-12#2)(2009-12#2)
structurally dissimilar##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
structurally distinct##4##2##(1990-8#1)(1995-2#1)(1996-2#1)(2009-12#1)
structurally normal heart##3##3##(2008-12#2)(2011-2#1)
structurally related to##2##3##(1997-8#1)(2008-11#1)
structurally related##7##2##(1993-12#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#2)
structurally similar##7##2##(1990-5#1)(1990-8#1)(1993-8#1)(1994-11#1)(2008-10#2)(2011-1#1)
structurally unique##3##2##(1995-11#1)(1995-6#1)(2010-7#1)
structurally##64##1##(1990-5#1)(1990-8#2)(1991-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#2)(1997-8#1)(2007-12#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#3)(2009-9#1)(2010-10#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#5)(2013-1#2)
structure according to##2##3##(2008-10#2)
structure across##3##2##(1992-6#1)(2012-3#1)(2013-1#1)
structure allows##2##2##(1992-12#1)(2008-8#1)
structure analysis of##4##3##(1993-8#1)(1996-5#1)(2011-2#1)(2013-8#1)
structure analysis##9##2##(1993-8#1)(1996-5#2)(2008-10#2)(2008-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
structure and a##2##3##(1992-12#1)(2013-1#1)
structure and an##2##3##(1991-6#1)(2008-7#1)
structure and characteristics of a##2##5##(1993-3#1)(2008-10#1)
structure and chemical##2##3##(2009-7#1)(2012-2#1)
structure and composition##3##3##(1997-2#1)(2010-7#1)(2012-2#1)
structure and distribution##2##3##(2007-12#1)(2008-11#1)
structure and dynamics of##2##4##(2008-10#2)
structure and dynamics##5##3##(2008-10#2)(2008-9#1)(2009-8#1)(2012-3#1)
structure and expression of the##2##5##(1992-6#1)(1993-12#1)
structure and expression##4##3##(1992-6#1)(1993-12#1)(1997-7#1)(1997-9#1)
structure and function in the##3##5##(1995-2#1)(2009-5#2)
structure and function in##5##4##(1995-2#1)(2009-1#1)(2009-5#2)(2012-12#1)
structure and function of the##3##5##(1996-2#1)(2008-10#1)(2008-7#1)
structure and function of##12##4##(1992-11#1)(1995-6#2)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#4)(2008-8#1)(2012-2#1)
structure and function##34##3##(1991-1#1)(1992-11#1)(1993-8#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-1#1)(2009-5#2)(2009-7#2)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
structure and hydration##2##3##(1994-3#2)
structure and its##2##3##(2011-1#1)(2012-2#1)
structure and sequence of##3##4##(1991-6#1)(1993-6#2)
structure and sequence##5##3##(1991-6#1)(1993-6#3)(2008-10#1)
structure and the##14##3##(1990-8#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#1)
structure and##167##2##(1990-12#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-12#3)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#3)(1997-9#1)(2007-12#4)(2008-10#22)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#1)(2009-5#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#2)(2010-4#2)(2010-5#2)(2010-7#3)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
structure are important##2##3##(2008-10#2)
structure are##5##2##(1993-8#1)(2008-10#2)(2008-4#1)(2012-3#1)
structure around##2##2##(1991-6#1)(2008-10#1)
structure as the##2##3##(1990-2#1)(2008-11#1)
structure as well as##2##4##(2008-9#1)(2011-2#1)
structure as##6##2##(1990-2#1)(1993-6#1)(2008-11#1)(2008-9#1)(2009-7#1)(2011-2#1)
structure at##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
structure based on##2##3##(1992-5#1)(2008-10#1)
structure between##4##2##(1991-5#1)(1992-9#1)(1993-12#1)(2008-11#1)
structure by##6##2##(1991-5#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
structure can be##5##3##(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)
structure can##11##2##(2008-2#2)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#1)(2012-3#1)
structure consistent with##2##3##(2008-10#1)(2012-12#1)
structure consisting of a##2##4##(1993-2#1)(2007-12#1)
structure consisting of##3##3##(1993-2#1)(2007-12#1)(2008-11#1)
structure determination of the##2##4##(1993-8#1)(2009-7#1)
structure determination of##3##3##(1993-8#1)(2008-9#1)(2009-7#1)
structure determination##8##2##(1993-8#2)(2008-9#2)(2009-7#3)(2010-7#1)
structure does not##2##3##(1995-5#1)(2008-8#1)
structure due to##2##3##(2008-8#2)
structure during##2##2##(1997-9#1)(2008-11#1)
structure elucidation of small molecules##2##5##(2011-2#2)
structure elucidation of##3##3##(1997-2#1)(2011-2#2)
structure elucidation##4##2##(1997-2#1)(2009-7#1)(2011-2#2)
structure following##2##2##(1994-8#1)(1995-2#1)
structure for the##7##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)
structure for##16##2##(1993-12#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#2)
structure formation##3##2##(1995-2#1)(2008-10#1)(2013-8#1)
structure from##3##2##(1993-8#1)(2008-3#1)(2008-4#1)
structure has been determined for##2##5##(1993-3#1)(1994-5#1)
structure has been determined##3##4##(1992-4#1)(1993-3#1)(1994-5#1)
structure has been##6##3##(1992-4#1)(1993-3#1)(1994-5#1)(2008-4#1)(2008-5#1)(2012-3#1)
structure has##8##2##(1992-4#1)(1992-5#1)(1993-3#1)(1994-5#1)(2008-4#1)(2008-5#1)(2009-12#1)(2012-3#1)
structure have been##2##3##(2008-3#1)(2008-4#1)
structure have##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
structure in the##18##3##(1991-9#1)(1992-4#1)(1994-2#1)(1994-5#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-2#1)
structure in which##3##3##(1994-12#1)(1995-6#1)(1997-6#1)
structure in##45##2##(1991-9#1)(1992-4#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-6#1)(2007-12#3)(2008-10#9)(2008-11#6)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#2)
structure is a##2##3##(1994-12#1)(2008-10#1)
structure is not##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
structure is presented##2##3##(1991-7#1)(2008-11#1)
structure is similar##3##3##(1992-12#1)(1992-4#1)(1993-8#1)
structure is very similar to that##2##6##(1993-8#1)(1994-5#1)
structure is very##3##3##(1993-8#1)(1994-5#1)(1997-2#1)
structure is##40##2##(1990-2#1)(1991-7#1)(1992-12#2)(1992-4#2)(1993-2#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#3)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#3)(2010-11#1)(2011-2#2)(2013-1#1)
structure may##2##2##(1996-12#1)(2008-8#1)
structure of A##2##3##(2008-10#1)(2013-8#1)
structure of DNA##2##3##(2008-10#1)(2011-2#1)
structure of Heterobasidion annosum##2##4##(2008-10#2)
structure of P##3##3##(2008-10#2)(2011-2#1)
structure of PBS##2##3##(2008-8#2)
structure of Phytophthora infestans##3##4##(2008-10#3)
structure of S##3##3##(2008-10#3)
structure of X##4##3##(1993-6#1)(2008-10#3)
structure of a##21##3##(1991-9#1)(1992-2#1)(1992-4#1)(1992-9#1)(1995-8#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-8#2)
structure of an##4##3##(1990-9#1)(1991-12#1)(2008-10#1)(2009-5#1)
structure of biological##2##3##(1994-5#1)(2010-4#1)
structure of brazzein##2##3##(2008-9#2)
structure of compounds##2##3##(2008-10#2)
structure of eukaryotic##2##3##(2008-10#1)(2008-8#1)
structure of goat##4##3##(2010-4#4)
structure of horse heart ferrocytochrome c##2##6##(1994-5#2)
structure of human##3##3##(1991-2#1)(1995-8#1)(2008-6#1)
structure of membrane##3##3##(2008-8#3)
structure of natural##2##3##(2008-8#1)(2012-3#1)
structure of neural##2##3##(1990-5#1)(2008-10#1)
structure of oxidized##3##3##(1993-9#1)(1994-5#2)
structure of populations of##4##4##(2008-10#3)(2011-2#1)
structure of populations##6##3##(2008-10#5)(2011-2#1)
structure of rat##2##3##(1992-8#1)(1993-12#1)
structure of the Peruvian scallop Argopecten purpuratus##2##7##(2013-8#2)
structure of the azobenzene arsonic acid compound##2##7##(2008-10#2)
structure of the chicken##2##4##(1991-6#1)(1993-2#1)
structure of the complexes##2##4##(2008-10#2)
structure of the fungal##2##4##(2008-10#2)
structure of the gene and##2##5##(1996-2#1)(1996-8#1)
structure of the inner##3##4##(2008-8#2)(2013-8#1)
structure of the mammalian##2##4##(1990-7#1)(2008-11#1)
structure of the molecule##3##4##(1990-5#1)(2008-10#1)(2008-4#1)
structure of the planarian CNS##2##5##(2008-5#2)
structure of the protein##5##4##(2008-10#2)(2008-11#1)(2008-9#2)
structure of the trp operator##2##5##(1994-3#2)
structure of the trp##3##4##(1994-3#3)
structure of the##140##3##(1990-5#4)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-4#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#4)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(2007-12#4)(2008-10#30)(2008-11#11)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#5)
structure of these##7##3##(1996-12#1)(1997-6#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-2#1)(2012-3#1)
structure of this##5##3##(1992-3#1)(1992-8#1)(1997-3#1)(2009-3#1)(2011-2#1)
structure of viral##2##3##(2008-10#2)
structure of##409##2##(1990-4#1)(1990-5#6)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#5)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#9)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#9)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#5)(1995-9#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2007-12#7)(2008-10#108)(2008-11#23)(2008-12#8)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#7)(2008-8#36)(2008-9#10)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-4#7)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#23)(2011-3#1)(2012-2#6)(2012-3#5)(2013-1#3)(2013-8#12)
structure on the##6##3##(1994-11#1)(2008-10#4)(2013-1#1)
structure on##14##2##(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
structure or function##2##3##(1991-5#1)(2012-2#1)
structure or the##2##3##(1994-11#1)(2008-10#1)
structure or##7##2##(1991-5#1)(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
structure parameter##2##2##(2008-2#2)
structure parameters##3##2##(2008-10#2)(2013-8#1)
structure prediction##2##2##(1990-4#1)(2008-8#1)
structure reveals##2##2##(1991-12#1)(1995-8#1)
structure showed##2##2##(2008-8#1)(2008-9#1)
structure similar to that of the##2##6##(1992-6#1)(2008-5#1)
structure similar to that of##4##5##(1992-6#1)(2008-10#1)(2008-5#1)(2008-6#1)
structure similar to##8##3##(1990-11#1)(1992-6#1)(2008-10#4)(2008-5#1)(2008-6#1)
structure suggests##2##2##(1997-7#1)(2008-6#1)
structure termed##2##2##(2008-7#1)(2008-8#1)
structure than##4##2##(2008-10#2)(2008-4#1)(2012-2#1)
structure that is##5##3##(1993-12#1)(1994-5#1)(2008-3#1)(2009-9#1)(2011-2#1)
structure that##20##2##(1991-9#2)(1993-12#1)(1994-1#1)(1994-5#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
structure they##2##2##(2007-12#1)(2008-10#1)
structure through##2##2##(2008-8#2)
structure to facilitate##2##3##(1996-1#1)(2010-10#1)
structure to produce##2##3##(2008-5#1)(2008-9#1)
structure to##12##2##(1994-12#1)(1994-2#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#1)(2012-3#1)(2012-5#1)
structure underlying##2##2##(2006-6#1)(2008-11#1)
structure using##5##2##(1991-9#1)(2008-10#2)(2008-7#1)(2008-9#1)
structure was determined by##2##4##(1996-5#1)(2008-8#1)
structure was examined##2##3##(2008-10#1)(2013-1#1)
structure was produced##2##3##(2008-10#2)
structure was##27##2##(1992-12#1)(1993-8#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-4#1)(2013-1#1)
structure were investigated##2##3##(2008-10#1)(2008-12#1)
structure were##9##2##(2008-10#4)(2008-12#2)(2009-7#1)(2012-3#1)(2013-8#1)
structure when##6##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)
structure which##5##2##(2008-11#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-7#1)
structure with a##3##3##(2008-5#1)(2009-11#1)(2013-1#1)
structure with the##2##3##(2008-11#1)(2008-8#1)
structure with##15##2##(1991-6#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#2)(2013-1#1)
structure##1310##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-4#5)(1990-5#9)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#4)(1991-5#12)(1991-6#8)(1991-7#2)(1991-9#5)(1992-1#3)(1992-11#2)(1992-12#9)(1992-2#2)(1992-3#2)(1992-4#10)(1992-5#5)(1992-6#7)(1992-8#2)(1992-9#5)(1993-1#2)(1993-12#9)(1993-2#7)(1993-3#5)(1993-5#1)(1993-6#10)(1993-8#26)(1993-9#4)(1994-1#3)(1994-11#7)(1994-12#9)(1994-2#6)(1994-3#10)(1994-5#25)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#9)(1995-3#5)(1995-5#5)(1995-6#11)(1995-8#8)(1995-9#2)(1996-1#2)(1996-12#14)(1996-2#7)(1996-3#3)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#4)(1997-6#4)(1997-7#8)(1997-8#3)(1997-9#4)(2006-6#1)(2007-11#3)(2007-12#22)(2008-1#1)(2008-10#282)(2008-11#65)(2008-12#16)(2008-2#8)(2008-3#29)(2008-4#38)(2008-5#40)(2008-6#9)(2008-7#31)(2008-8#102)(2008-9#53)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#7)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#19)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#2)(2010-2#1)(2010-4#12)(2010-5#9)(2010-7#9)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#53)(2011-3#4)(2012-12#2)(2012-2#25)(2012-3#16)(2012-5#2)(2013-1#24)(2013-7#1)(2013-8#23)
structure&quot##2##1##(1996-9#1)(2008-9#1)
structure's##2##1##(2008-2#1)(2009-7#1)
structure)##3##1##(1990-5#2)(2008-10#1)
structure-activity relationship##7##2##(1994-3#1)(1994-5#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-12#1)(2011-3#1)
structure-activity relationships##11##2##(1991-3#1)(1992-6#1)(1993-12#2)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#2)(2013-1#1)
structure-activity##19##1##(1991-3#1)(1992-6#1)(1993-12#2)(1994-11#1)(1994-3#1)(1994-5#1)(2008-10#3)(2008-11#2)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#1)
structure-function relationships##3##2##(1990-5#1)(2008-11#2)
structure-function studies##2##2##(2008-11#1)(2008-8#1)
structure-function##7##1##(1990-5#1)(2008-11#4)(2008-8#1)(2011-2#1)
structure-property relationship study##2##3##(2008-10#2)
structure-property relationship##4##2##(2008-10#3)(2009-7#1)
structure-property##5##1##(2008-10#3)(2009-7#1)(2013-1#1)
structure-retention relationship (QSRR)##3##3##(2008-10#3)
structure/function##2##1##(1990-5#1)(1992-4#1)
structured and##4##2##(1993-12#1)(1995-2#1)(2010-8#1)(2011-1#1)
structured arrays##2##2##(2008-9#1)(2009-10#1)
structured assessments##2##2##(2008-11#2)
structured by##2##2##(2008-5#1)(2008-8#1)
structured in##2##2##(1991-1#1)(2009-4#1)
structured interview on##2##3##(2008-1#1)(2011-2#1)
structured interview##3##2##(2008-1#1)(2011-2#1)(2012-3#1)
structured interviews##4##2##(2010-3#1)(2013-1#2)(2013-8#1)
structured into##2##2##(2008-10#1)(2008-8#1)
structured metapopulation models##2##3##(2008-8#2)
structured populations##3##2##(2008-8#3)
structured questionnaire##6##2##(1995-10#1)(2008-11#2)(2010-1#1)(2013-1#1)(2013-7#1)
structured questionnaires##2##2##(2010-2#1)(2012-12#1)
structured student tutorial support##3##4##(2008-11#3)
structured to##5##2##(1992-2#1)(1994-3#2)(2008-11#1)(2008-8#1)
structured tutorial support##2##3##(2008-11#2)
structured vocabularies##3##2##(2008-9#3)
structured##89##1##(1991-1#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-1#2)(1995-10#1)(1995-2#1)(1996-3#2)(1997-4#2)(2008-1#2)(2008-10#4)(2008-11#19)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#13)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
structures among##2##2##(2008-11#1)(2010-1#1)
structures and experiments##2##3##(2010-7#2)
structures and processes##3##3##(2008-12#2)(2008-6#1)
structures and the##4##3##(2008-10#1)(2008-12#1)(2009-7#1)(2011-2#1)
structures and their##2##3##(1995-3#1)(2008-10#1)
structures and##43##2##(1990-6#1)(1992-12#1)(1993-12#1)(1993-3#2)(1995-3#2)(1996-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#4)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#1)
structures are a##2##3##(1990-11#1)(2008-11#1)
structures are used##2##3##(1997-6#1)(2008-12#1)
structures are##20##2##(1990-11#2)(1990-5#1)(1993-6#1)(1994-1#1)(1997-5#2)(1997-6#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#3)(2009-9#1)(2011-2#1)(2012-2#1)
structures associated with##2##3##(1995-3#1)(2008-10#1)
structures at the##4##3##(2008-11#1)(2011-2#2)(2013-1#1)
structures at##7##2##(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#2)(2013-1#1)
structures based on##2##3##(2008-10#1)(2009-3#1)
structures by##9##2##(1994-8#2)(2008-10#1)(2008-3#1)(2008-4#3)(2011-2#1)(2013-1#1)
structures can be##3##3##(1990-11#1)(2009-12#1)(2010-7#1)
structures can##6##2##(1990-11#1)(1992-9#1)(1997-3#1)(2009-12#1)(2009-5#1)(2010-7#1)
structures composed of##4##3##(1990-5#1)(2008-3#1)(2008-8#1)(2009-7#1)
structures containing##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)
structures derived##2##2##(2009-10#1)(2012-2#1)
structures embedded in##2##3##(2008-2#1)(2008-3#1)
structures for##9##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-2#1)
structures from##3##2##(2008-10#1)(2008-4#1)(2010-10#1)
structures have been elucidated##3##4##(1995-9#1)(2008-10#1)(2012-2#1)
structures have been##4##3##(1995-9#1)(2008-10#1)(2009-7#1)(2012-2#1)
structures in a##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
structures in the##9##3##(2008-10#2)(2008-2#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
structures in##33##2##(1992-3#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
structures increased##2##2##(2008-10#2)
structures involved##2##2##(2008-11#1)(2011-2#1)
structures is a##2##3##(1991-2#1)(2008-10#1)
structures is##6##2##(1991-2#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
structures like##2##2##(1997-6#1)(2009-8#1)
structures may##3##2##(1995-2#1)(2008-10#1)(2011-1#1)
structures must##2##2##(2008-11#2)
structures observed in the##2##4##(1992-4#1)(2008-8#1)
structures observed in##3##3##(1992-4#1)(1995-3#1)(2008-8#1)
structures of all##3##3##(1991-6#1)(2010-6#1)(2012-2#1)
structures of both##2##3##(1992-9#1)(2008-10#1)
structures of the isolated##2##4##(1994-5#1)(2008-11#1)
structures of the##21##3##(1990-9#1)(1991-12#2)(1993-2#1)(1994-5#2)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-5#1)(2011-3#2)(2013-1#1)(2013-8#1)
structures of##75##2##(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#5)(1994-8#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#3)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#3)(2011-3#2)(2012-2#3)(2013-1#1)(2013-8#3)
structures on the surface of##2##5##(2008-5#2)
structures on the##3##3##(2008-5#2)(2008-8#1)
structures on##7##2##(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#2)(2013-8#1)
structures or##3##2##(1992-2#1)(1994-2#1)(1995-3#1)
structures resembling##3##2##(1990-11#1)(2008-10#1)(2009-8#1)
structures significantly##2##2##(1993-6#1)(2012-2#1)
structures such as##7##3##(1995-11#1)(1996-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-12#1)
structures that are##2##3##(2008-7#1)(2012-2#1)
structures that##8##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)
structures to##8##2##(1991-2#1)(1996-1#1)(2007-12#1)(2008-11#2)(2008-3#1)(2009-7#1)(2011-2#1)
structures was##5##2##(1993-3#1)(1997-3#1)(1997-8#1)(2010-4#1)(2013-1#1)
structures were confirmed##2##3##(2010-2#1)(2011-3#1)
structures were determined##3##3##(1997-2#1)(2008-12#1)(2010-6#1)
structures were elucidated##3##3##(2008-10#1)(2011-2#1)(2011-3#1)
structures were found##2##3##(2008-10#1)(2008-8#1)
structures were##27##2##(1990-6#1)(1991-7#1)(1994-5#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2010-2#1)(2010-6#1)(2011-2#2)(2011-3#2)(2012-3#1)
structures which##2##2##(1994-5#1)(2008-10#1)
structures with a##2##3##(2008-9#1)(2013-1#1)
structures with##13##2##(1994-5#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#2)(2013-1#2)
structures within the##2##3##(1996-12#1)(2008-12#1)
structures within##3##2##(1996-12#1)(2008-12#2)
structures##535##1##(1990-11#5)(1990-12#2)(1990-5#5)(1990-6#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#4)(1991-6#2)(1991-7#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#3)(1993-12#5)(1993-2#1)(1993-3#5)(1993-6#4)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#5)(1994-5#13)(1994-8#4)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#6)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#2)(1997-9#1)(2007-12#13)(2008-1#2)(2008-10#79)(2008-11#39)(2008-12#15)(2008-2#4)(2008-3#16)(2008-4#14)(2008-5#7)(2008-6#5)(2008-7#25)(2008-8#19)(2008-9#6)(2009-10#3)(2009-12#4)(2009-3#1)(2009-5#5)(2009-7#7)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#9)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#34)(2011-3#8)(2011-7#1)(2012-12#1)(2012-2#21)(2012-3#5)(2013-1#11)(2013-8#11)
structures)##2##1##(2008-8#1)(2010-7#1)
structuring of##2##2##(1993-12#1)(2008-10#1)
structuring##16##1##(1991-1#1)(1993-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#3)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
struggle for##2##2##(1995-2#1)(2008-6#1)
struggle to##2##2##(1996-1#1)(2008-6#1)
struggle with##3##2##(1997-6#1)(2008-10#1)(2008-9#1)
struggle##10##1##(1993-11#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#1)
struggles##2##1##(1996-1#1)(2008-9#1)
struma ovarii##2##2##(1994-12#2)
strut bone##2##2##(2012-3#2)
strychnine-insensitive glycine receptors##2##3##(1995-11#2)
stubble##6##1##(2008-10#6)
stuck in##2##2##(2008-10#1)(2010-9#1)
stuck##4##1##(2008-10#3)(2010-9#1)
student achievement##2##2##(2008-12#1)(2009-7#1)
student at##2##2##(2010-8#1)(2013-1#1)
student attitudes##2##2##(2008-11#1)(2012-12#1)
student evaluation##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
student experience of##2##3##(2008-11#1)(2013-1#1)
student experience##7##2##(2008-11#6)(2013-1#1)
student group##2##2##(2008-11#1)(2008-12#1)
student in##2##2##(1994-3#1)(2008-11#1)
student journal club##3##3##(2008-12#3)
student learning##10##2##(2008-11#4)(2008-12#6)
student midwives##3##2##(2008-11#3)
student nurse education##2##3##(2008-12#1)(2013-8#1)
student nurse##9##2##(2008-11#6)(2008-12#2)(2013-8#1)
student nurses and##2##3##(2008-11#1)(2008-12#1)
student nurses at##2##3##(2008-11#2)
student nurses on##4##3##(2008-11#1)(2008-12#3)
student nurses to##5##3##(2008-11#3)(2008-12#1)(2013-8#1)
student nurses who##5##3##(2008-11#4)(2010-3#1)
student nurses##42##2##(2008-11#27)(2008-12#9)(2010-3#4)(2013-8#2)
student nurses'##2##2##(2008-11#2)
student performance##2##2##(2008-11#1)(2008-12#1)
student population##2##2##(2008-11#1)(2008-12#1)
student psychiatric nurses##2##3##(2008-11#1)(2008-12#1)
student psychiatric nurses'##2##3##(2008-11#1)(2008-12#1)
student psychiatric##4##2##(2008-11#2)(2008-12#2)
student research##2##2##(2010-9#1)(2013-1#1)
student responses##2##2##(2008-11#1)(2008-12#1)
student stress##4##2##(2008-11#4)
student support##5##2##(2008-11#4)(2008-12#1)
student survey##2##2##(1996-1#1)(2008-12#1)
student to##3##2##(2008-11#2)(2008-12#1)
student##187##1##(1990-12#2)(1991-1#1)(1992-3#1)(1993-1#2)(1994-3#1)(1996-1#4)(1996-2#2)(1997-2#2)(1997-3#1)(2008-10#3)(2008-11#104)(2008-12#42)(2008-8#1)(2009-7#1)(2009-8#1)(2010-3#4)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#3)
student's##16##1##(2008-11#11)(2008-8#1)(2008-9#1)(2009-7#2)(2012-3#1)
student-centered##2##1##(2008-12#2)
student-centred##2##1##(2008-11#2)
student-focused##2##1##(2011-2#2)
students about their##2##3##(2008-11#2)
students about##6##2##(1995-12#2)(2008-11#2)(2009-8#1)(2012-3#1)
students and Practice Nurses##2##4##(2008-11#2)
students and academics##2##3##(2008-11#2)
students and factory workers##2##4##(2008-11#2)
students and faculty##2##3##(2008-11#1)(2008-12#1)
students and lecturers##2##3##(2008-11#2)
students and nurse##3##3##(2008-11#2)(2008-12#1)
students and staff##3##3##(1993-1#1)(2008-12#1)(2008-9#1)
students and teachers##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-9#1)
students and their##2##3##(2008-11#1)(2009-7#1)
students and##46##2##(1990-12#1)(1991-6#1)(1993-1#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#18)(2008-12#10)(2008-9#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
students are also##2##3##(2008-11#1)(2008-12#1)
students are##15##2##(1996-1#1)(1997-3#1)(1997-5#1)(2008-11#9)(2008-12#3)
students as##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
students at the##4##3##(1996-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
students at##12##2##(1991-6#1)(1992-3#1)(1996-1#2)(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2011-2#1)
students attending##2##2##(2008-5#2)
students completed an##2##3##(1991-9#1)(2013-8#1)
students completed##4##2##(1991-9#1)(1997-2#1)(2008-12#1)(2013-8#1)
students delivered between##3##3##(2013-1#3)
students delivered##4##2##(2013-1#4)
students developed##2##2##(2008-12#2)
students due to##2##3##(2010-12#1)(2010-3#1)
students during##2##2##(2008-11#2)
students enrolled in##3##3##(1992-1#1)(1996-1#1)(2008-11#1)
students for##2##2##(2008-12#1)(2010-10#1)
students found##4##2##(1996-1#1)(2008-11#1)(2008-12#1)(2010-10#1)
students from non-English speaking backgrounds##3##5##(2008-11#1)(2008-12#2)
students from the##2##3##(1990-2#1)(2008-10#1)
students from##20##2##(1990-2#1)(1997-2#1)(2008-10#1)(2008-11#5)(2008-12#6)(2009-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
students had a positive##2##4##(1997-2#1)(2008-11#1)
students had##9##2##(1991-9#1)(1997-2#1)(2008-11#5)(2011-2#1)(2013-1#1)
students has been##2##3##(2008-11#2)
students has##4##2##(2008-11#4)
students have##9##2##(1996-1#1)(1997-2#2)(2008-1#1)(2008-11#3)(2012-12#1)(2013-8#1)
students identified##2##2##(2008-11#2)
students in India##3##3##(2013-1#3)
students in Years##2##3##(2008-12#1)(2011-1#1)
students in a##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
students in the##17##3##(1991-1#1)(1996-1#1)(2008-11#5)(2008-12#4)(2008-4#1)(2012-2#1)(2013-1#3)(2013-7#1)
students in this study##2##4##(2008-11#1)(2013-8#1)
students in##48##2##(1991-1#1)(1996-1#1)(2008-11#13)(2008-12#11)(2008-4#1)(2009-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#10)(2013-7#1)(2013-8#2)
students is##2##2##(2008-11#2)
students learn##5##2##(1992-12#1)(2008-11#3)(2013-8#1)
students must be##2##3##(2008-11#1)(2008-12#1)
students must##3##2##(1996-1#1)(2008-11#1)(2008-12#1)
students need to achieve##2##4##(2008-11#2)
students need to##4##3##(1996-1#1)(2008-11#3)
students need##5##2##(1996-1#1)(2008-11#3)(2008-12#1)
students of nursing to##2##4##(2008-12#2)
students of nursing##4##3##(2008-11#1)(2008-12#3)
students of the##3##3##(2012-3#1)(2013-1#1)(2013-8#1)
students of##18##2##(1994-5#1)(1997-3#1)(2008-11#2)(2008-12#3)(2008-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
students perceived##2##2##(2008-11#1)(2012-3#1)
students receive##2##2##(2008-11#2)
students reported that##2##3##(1993-3#1)(2008-11#1)
students reported##8##2##(1991-9#1)(1993-3#1)(2008-11#1)(2008-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
students should be##2##3##(2008-11#1)(2008-6#1)
students that##3##2##(2008-10#2)(2008-11#1)
students to apply##2##3##(1996-1#1)(2008-11#1)
students to be##2##3##(2008-11#1)(2008-3#1)
students to develop##4##3##(1991-3#1)(2008-11#3)
students to##38##2##(1991-3#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-1#2)(1996-1#1)(1997-2#1)(2008-11#21)(2008-12#5)(2008-3#1)(2009-8#1)(2013-1#1)(2013-8#1)
students undertaking a##3##3##(2008-11#3)
students undertaking##7##2##(2008-11#6)(2008-12#1)
students used##2##2##(2009-12#1)(2013-1#1)
students volunteered to##2##3##(2008-11#1)(2008-12#1)
students was##3##2##(2011-2#1)(2013-1#2)
students were asked to##2##4##(2008-11#1)(2008-12#1)
students were randomly assigned to##3##5##(1992-12#1)(2008-12#1)(2009-11#1)
students were##28##2##(1992-12#1)(1997-2#1)(2008-11#7)(2008-12#11)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
students whilst##2##2##(2008-11#1)(2008-12#1)
students who are##5##3##(1996-2#1)(2008-11#1)(2008-12#1)(2011-2#2)
students who failed##2##3##(2008-11#2)
students who had just completed##2##5##(2008-11#2)
students who had##5##3##(1992-1#1)(2008-11#3)(2013-1#1)
students who have##3##3##(1996-1#1)(2008-11#1)(2009-5#1)
students who##26##2##(1992-1#1)(1996-1#1)(1996-2#1)(2008-1#1)(2008-11#14)(2008-12#2)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
students with dyslexia##3##3##(2008-12#3)
students with limited##2##3##(1996-2#1)(2008-12#1)
students with similar records of achievement##2##6##(2008-12#2)
students with the##3##3##(2008-11#1)(2013-1#2)
students with##21##2##(1996-2#2)(1997-2#1)(2008-11#3)(2008-12#9)(2008-5#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
students would##2##2##(2008-11#2)
students##620##1##(1990-12#1)(1990-2#3)(1990-9#1)(1991-1#1)(1991-3#2)(1991-6#2)(1991-9#3)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#3)(1992-7#1)(1993-1#3)(1993-2#2)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#3)(1996-1#17)(1996-2#7)(1997-2#13)(1997-3#2)(1997-5#2)(2008-1#2)(2008-10#8)(2008-11#224)(2008-12#135)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-9#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#2)(2010-1#5)(2010-10#6)(2010-12#1)(2010-3#2)(2010-7#1)(2010-9#5)(2011-1#4)(2011-2#23)(2012-12#7)(2012-2#14)(2012-3#9)(2013-1#42)(2013-7#2)(2013-8#25)
students' ability to##2##3##(2008-11#1)(2008-12#1)
students' access to##2##3##(2008-11#1)(2008-12#1)
students' and##3##2##(2008-11#1)(2009-7#1)(2013-8#1)
students' approaches to learning##3##4##(2011-1#2)(2011-2#1)
students' clinical learning##2##3##(2008-11#1)(2008-12#1)
students' clinical##3##2##(2008-11#1)(2008-12#2)
students' competence and confidence##2##4##(2008-11#1)(2008-12#1)
students' competence##4##2##(1993-1#1)(2008-11#2)(2008-12#1)
students' experiences of##2##3##(2008-11#1)(2008-12#1)
students' experiences##7##2##(2008-11#3)(2008-12#3)(2009-8#1)
students' learning##3##2##(2008-10#1)(2008-11#2)
students' needs##3##2##(2008-12#2)(2012-3#1)
students' perceptions and##2##3##(2008-11#1)(2009-7#1)
students' perceptions of ethical behavior in##2##6##(2008-12#2)
students' perceptions of their##2##4##(2008-11#2)
students' perceptions of##9##3##(2008-11#5)(2008-12#2)(2012-3#2)
students' perceptions##11##2##(2008-11#6)(2008-12#2)(2009-7#1)(2012-3#2)
students' perspectives on##2##3##(2008-11#1)(2012-2#1)
students' perspectives##3##2##(2008-11#2)(2012-2#1)
students' self-esteem##2##2##(2008-11#1)(2008-12#1)
students' theoretical##2##2##(2008-11#1)(2010-10#1)
students'##99##1##(1993-1#1)(1996-1#1)(2008-10#2)(2008-11#37)(2008-12#29)(2009-12#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-3#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#5)(2013-8#5)
students)##3##1##(2008-12#1)(2012-12#1)(2012-3#1)
studied 60##2##2##(1997-8#1)(2010-7#1)
studied a##5##2##(1997-3#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-6#1)
studied and a##4##3##(1990-11#1)(2008-10#2)(2008-11#1)
studied and compared to##2##4##(2008-10#1)(2011-2#1)
studied and compared with those of##2##6##(2008-10#1)(2008-3#1)
studied and compared with those##3##5##(2008-10#2)(2008-3#1)
studied and compared with##5##4##(2008-10#3)(2008-3#1)(2008-7#1)
studied and compared##11##3##(2008-10#7)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
studied and correlated with##2##4##(1990-12#1)(2008-10#1)
studied and evaluated##3##3##(2008-10#3)
studied and it was##2##4##(2008-10#2)
studied and optimized##12##3##(2008-10#12)
studied and reported##2##3##(2008-10#2)
studied and the##14##3##(2008-10#13)(2008-12#1)
studied and##83##2##(1990-11#1)(1990-12#1)(1991-12#1)(1994-2#2)(1995-5#1)(2008-10#64)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#3)(2009-11#1)(2010-7#1)(2011-2#2)(2011-3#1)
studied are##7##2##(2008-10#2)(2008-3#2)(2008-9#1)(2010-10#1)(2012-5#1)
studied as a function of the##2##6##(2008-10#2)
studied as a function of##5##5##(1990-5#1)(2008-10#3)(2008-3#1)
studied as a##12##3##(1990-5#1)(2008-10#9)(2008-3#1)(2008-4#1)
studied as##24##2##(1990-5#1)(1995-6#1)(2008-10#17)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2013-1#1)
studied at 1##4##3##(2008-10#3)(2010-5#1)
studied at 25 degrees C##3##5##(2008-10#3)
studied at a##3##3##(2008-10#3)
studied at the##6##3##(2007-12#1)(2008-10#3)(2011-10#1)(2012-3#1)
studied at##31##2##(1990-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#18)(2008-7#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-10#1)(2012-2#1)(2012-3#1)
studied because of##2##3##(1990-12#1)(2008-10#1)
studied by ID##2##3##(2008-5#2)
studied by X-ray##3##3##(2008-10#2)(2013-8#1)
studied by a##2##3##(2008-10#2)
studied by applying##3##3##(2008-10#3)
studied by comparing the##2##4##(1994-5#1)(2010-4#1)
studied by comparing##3##3##(1994-5#1)(2008-10#1)(2010-4#1)
studied by cyclic voltammetry (CV)##4##5##(2008-10#4)
studied by cyclic voltammetry##9##4##(2008-10#9)
studied by cyclic##10##3##(2008-10#10)
studied by differential scanning calorimetry##3##5##(1993-8#2)(2011-2#1)
studied by liquid chromatography##2##4##(2008-10#2)
studied by means of the##2##5##(2008-10#2)
studied by means of##5##4##(2008-10#5)
studied by measurement of##2##4##(2008-2#1)(2008-5#1)
studied by measuring##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
studied by molecular##2##3##(2008-10#1)(2008-8#1)
studied by spectrofluorimetry##2##3##(2008-10#2)
studied by spectrophotometry##3##3##(2008-10#3)
studied by the##7##3##(1990-5#1)(2008-10#6)
studied by use of##2##4##(1993-8#1)(2008-2#1)
studied by using a##2##4##(2008-10#2)
studied by using##12##3##(2008-10#8)(2008-11#1)(2008-8#2)(2008-9#1)
studied by##169##2##(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-8#5)(1994-11#1)(1994-5#2)(1995-11#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#103)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#9)(2008-9#4)(2010-4#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
studied can##2##2##(2008-10#2)
studied cases##4##2##(1993-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
studied compounds were##2##3##(2008-10#2)
studied compounds##6##2##(2008-10#6)
studied could be##2##3##(2008-10#1)(2011-1#1)
studied countries##2##2##(2010-8#2)
studied directly##2##2##(1994-11#1)(2007-12#1)
studied drug in##2##3##(2008-10#2)
studied drug##5##2##(2008-10#5)
studied drugs in##3##3##(2008-10#3)
studied drugs##6##2##(2008-10#6)
studied during the##2##3##(1994-12#1)(2008-5#1)
studied during##5##2##(1994-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
studied elements##2##2##(2008-10#2)
studied employing##2##2##(1991-10#1)(2008-10#1)
studied even##2##2##(2008-10#2)
studied experimentally##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
studied extensively as##2##3##(2008-10#1)(2010-5#1)
studied extensively##10##2##(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-2#2)
studied following##2##2##(1994-11#1)(2008-10#1)
studied for a##2##3##(2008-10#1)(2008-11#1)
studied for comparison##2##3##(1994-8#1)(2008-10#1)
studied for the first time##5##5##(1993-2#1)(2008-10#2)(2008-12#1)(2010-4#1)
studied for the##16##3##(1990-8#1)(1992-3#1)(1993-2#1)(2008-10#10)(2008-12#1)(2009-2#1)(2010-4#1)
studied for their##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
studied for##48##2##(1990-8#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-8#2)(1995-12#2)(2006-6#1)(2008-10#31)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)
studied from##6##2##(1991-8#1)(2007-12#1)(2008-10#4)
studied have been##2##3##(2008-10#2)
studied have##4##2##(2008-10#3)(2008-11#1)
studied here##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
studied histopathologically##2##2##(1994-12#1)(2011-2#1)
studied in 15##2##3##(2008-10#1)(2010-6#1)
studied in a##18##3##(1991-8#1)(1993-11#1)(1994-5#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-12#1)
studied in an##6##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
studied in aqueous solution##3##4##(2008-10#3)
studied in aqueous##5##3##(2008-10#5)
studied in batch##3##3##(2008-10#2)(2008-11#1)
studied in cultured##3##3##(1994-6#1)(1995-11#1)(2008-11#1)
studied in detail by##2##4##(2008-10#2)
studied in detail to optimize the conditions for##6##8##(2008-10#6)
studied in detail##29##3##(1991-12#1)(1992-3#1)(2008-10#25)(2008-11#1)(2008-5#1)
studied in order to##5##4##(2008-10#5)
studied in rats##3##3##(1991-5#1)(1993-2#1)(1994-5#1)
studied in relation to##7##4##(1995-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-11#1)
studied in solution by##2##4##(1994-5#1)(2008-10#1)
studied in terms of##3##4##(2008-10#2)(2009-9#1)
studied in the field and##2##5##(2008-10#1)(2008-5#1)
studied in the field##3##4##(2008-10#2)(2008-5#1)
studied in the liver of##2##5##(1990-3#1)(2008-5#1)
studied in the past##2##4##(2008-1#1)(2012-7#1)
studied in the presence and absence of##2##7##(2008-10#2)
studied in the presence of##3##5##(2008-10#3)
studied in the presence##5##4##(2008-10#5)
studied in the range of##2##5##(2008-10#2)
studied in the rat##3##4##(1996-12#2)(1996-2#1)
studied in the##39##3##(1990-11#1)(1990-3#1)(1990-5#2)(1992-12#1)(1993-12#1)(1994-2#1)(1995-8#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#2)(2011-2#1)(2012-7#1)
studied in this##4##3##(2008-10#3)(2010-7#1)
studied in three##2##3##(1996-2#1)(2010-8#1)
studied in two##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
studied in vitro##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
studied in##241##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#4)(1991-12#3)(1991-2#1)(1991-5#3)(1991-6#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-6#1)(1995-8#4)(1996-12#3)(1996-2#5)(1997-1#1)(1997-2#2)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#105)(2008-11#16)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#9)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2012-5#1)(2012-7#1)
studied include the##2##3##(2008-10#2)
studied included##3##2##(1992-3#1)(1994-3#1)(2008-10#1)
studied including##2##2##(2008-9#1)(2013-1#1)
studied is##4##2##(1994-8#1)(2008-10#2)(2008-7#1)
studied its##5##2##(1991-6#1)(2008-9#2)(2012-3#2)
studied mainly##2##2##(2008-10#1)(2010-5#1)
studied methods##2##2##(2008-10#2)
studied more##3##2##(2008-10#2)(2009-3#1)
studied on a##5##3##(2008-10#5)
studied on five##2##3##(2008-10#1)(2009-8#1)
studied on##20##2##(1990-8#1)(1994-8#1)(2008-10#13)(2008-11#1)(2009-12#1)(2009-8#1)(2011-10#1)(2011-2#1)
studied only in##2##3##(1997-7#1)(2010-1#1)
studied over a##2##3##(1991-6#1)(2008-3#1)
studied over##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
studied pH range##2##3##(2008-10#2)
studied parameters##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
studied patients##2##2##(2008-1#1)(2013-1#1)
studied population##3##2##(2008-10#1)(2009-1#1)(2013-1#1)
studied potentiometrically (H(+)-glass electrode)##3##4##(2008-10#3)
studied potentiometrically##6##2##(2008-10#6)
studied previously##2##2##(1990-5#1)(2008-7#1)
studied prospectively##3##2##(1994-1#1)(2008-10#1)(2008-11#1)
studied quantitatively##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
studied retrospectively##2##2##(1997-8#1)(2008-1#1)
studied separately##2##2##(1996-2#1)(2009-8#1)
studied so far##2##3##(1997-6#1)(2008-7#1)
studied soils##2##2##(2008-10#2)
studied species##2##2##(2008-12#1)(2008-7#1)
studied spectrophotometrically##6##2##(2008-10#6)
studied systematically##2##2##(2008-10#2)
studied the association##2##3##(2008-10#1)(2008-11#1)
studied the effect of a##2##5##(1992-6#1)(1997-8#1)
studied the effect of##16##4##(1990-8#1)(1992-6#1)(1993-1#1)(1994-11#3)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-7#1)
studied the effects of##11##4##(1990-11#1)(1993-1#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-12#1)(2011-10#1)(2013-1#1)
studied the effects##12##3##(1990-11#1)(1993-1#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-12#1)(2011-10#1)(2013-1#1)
studied the evolution of##2##4##(2008-9#1)(2012-3#1)
studied the expression of##3##4##(1996-12#1)(2008-9#2)
studied the influence of##4##4##(1994-8#1)(2008-3#1)(2008-5#2)
studied the role of##3##4##(1992-5#1)(1995-12#1)(1996-12#1)
studied the##96##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-5#1)(1994-8#3)(1995-11#2)(1995-12#3)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#2)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#1)(2008-3#4)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#3)(2009-8#2)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#3)
studied their##2##2##(2008-10#1)(2008-9#1)
studied to date##2##3##(1993-2#1)(2012-3#1)
studied to determine the##2##4##(2008-10#1)(2008-7#1)
studied to determine##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
studied to ensure##2##3##(2008-10#2)
studied to test##2##3##(2008-10#2)
studied to##27##2##(1991-8#1)(1992-3#1)(1993-2#1)(1995-10#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
studied under different##3##3##(2008-10#3)
studied under the##3##3##(2008-10#1)(2008-9#1)(2009-5#1)
studied under##16##2##(1992-8#1)(1996-6#1)(1997-2#1)(2008-10#7)(2008-12#2)(2008-9#1)(2009-5#1)(2010-11#1)(2012-3#1)
studied using a bioluminescent strain##2##5##(2008-10#2)
studied using a##9##3##(2008-10#7)(2008-9#1)(2010-10#1)
studied using cyclic##2##3##(2008-10#2)
studied using the##6##3##(1993-3#1)(2008-10#3)(2008-11#1)(2008-8#1)
studied using##78##2##(1990-5#1)(1991-12#2)(1991-6#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#2)(2008-1#1)(2008-10#45)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
studied was##4##2##(1991-12#1)(2008-10#3)
studied were the##2##3##(1994-5#1)(2008-10#1)
studied were##20##2##(1994-5#1)(1996-12#1)(2008-10#14)(2008-11#1)(2008-5#1)(2010-7#1)(2013-8#1)
studied when##2##2##(1990-9#1)(2008-10#1)
studied with a##3##3##(1997-4#1)(2007-12#1)(2008-10#1)
studied with respect to##2##4##(1993-6#1)(2008-10#1)
studied with the##9##3##(2008-10#2)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
studied with##34##2##(1990-5#1)(1991-11#1)(1991-3#1)(1993-6#1)(1994-6#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#13)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
studied##1805##1##(1990-11#5)(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#13)(1990-6#4)(1990-7#1)(1990-8#6)(1990-9#3)(1991-10#1)(1991-11#4)(1991-12#10)(1991-2#3)(1991-3#3)(1991-5#7)(1991-6#6)(1991-8#3)(1991-9#3)(1992-12#5)(1992-2#3)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#6)(1993-11#2)(1993-12#9)(1993-2#9)(1993-3#4)(1993-6#3)(1993-8#9)(1993-9#1)(1994-1#1)(1994-11#10)(1994-12#3)(1994-2#7)(1994-3#4)(1994-5#12)(1994-6#3)(1994-8#11)(1995-1#1)(1995-10#2)(1995-11#8)(1995-12#10)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#7)(1996-1#1)(1996-11#1)(1996-12#14)(1996-2#13)(1996-3#2)(1996-5#2)(1996-6#3)(1997-1#6)(1997-2#10)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#9)(2006-6#2)(2007-11#3)(2007-12#7)(2008-1#12)(2008-10#943)(2008-11#62)(2008-12#30)(2008-2#3)(2008-3#31)(2008-4#3)(2008-5#45)(2008-6#3)(2008-7#43)(2008-8#47)(2008-9#41)(2009-1#2)(2009-10#1)(2009-11#5)(2009-12#3)(2009-2#1)(2009-3#4)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#11)(2009-9#1)(2010-1#4)(2010-10#6)(2010-11#6)(2010-12#3)(2010-3#4)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#8)(2010-8#7)(2011-1#3)(2011-10#4)(2011-2#41)(2011-3#5)(2012-12#8)(2012-2#18)(2012-3#27)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#14)(2013-8#15)
studies (i##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
studies (up to##2##3##(2008-10#1)(2011-2#1)
studies a##3##2##(2008-10#2)(2013-1#1)
studies about the##2##3##(2008-10#1)(2012-3#1)
studies about##5##2##(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)
studies addressing##2##2##(2008-8#1)(2010-10#1)
studies aimed at understanding the##2##5##(1995-6#1)(2008-7#1)
studies aimed at##7##3##(1991-5#1)(1995-6#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2013-8#1)
studies also##11##2##(1996-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
studies and clinical trials##2##4##(1993-11#1)(2010-8#1)
studies and clinical##4##3##(1993-11#1)(1997-1#1)(2010-8#1)(2012-3#1)
studies and in##3##3##(2008-10#1)(2008-9#1)(2009-7#1)
studies and the##6##3##(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
studies and##80##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#2)
studies are also##2##3##(2009-8#1)(2012-3#1)
studies are carried out##2##4##(2009-12#1)(2010-11#1)
studies are consistent with the##2##5##(1997-1#1)(2008-10#1)
studies are consistent with##3##4##(1995-12#1)(1997-1#1)(2008-10#1)
studies are discussed##2##3##(2008-9#1)(2011-1#1)
studies are in progress##2##4##(1993-11#1)(2008-12#1)
studies are in##4##3##(1991-9#1)(1993-11#1)(2008-12#1)(2008-9#1)
studies are necessary to##5##4##(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
studies are necessary##7##3##(2009-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
studies are needed to clarify##2##5##(1991-3#1)(2012-3#1)
studies are needed to confirm##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
studies are needed to establish##3##5##(2008-5#1)(2012-2#1)(2012-3#1)
studies are needed to##12##4##(1991-3#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
studies are needed##17##3##(1991-12#1)(1991-3#1)(1995-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
studies are often##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
studies are presented##3##3##(1990-5#1)(1995-5#1)(2011-2#1)
studies are reported for##2##4##(2008-10#2)
studies are reported##4##3##(2008-10#3)(2008-12#1)
studies are required to##4##4##(1990-6#1)(1993-2#1)(2011-2#1)(2012-2#1)
studies are required##8##3##(1990-6#1)(1993-2#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
studies are the##2##3##(1995-5#1)(2008-5#1)
studies are used##2##3##(1990-3#1)(2010-5#1)
studies are warranted to##3##4##(2008-5#1)(2008-7#2)
studies are##102##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-5#3)(1995-6#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#2)(2010-11#3)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#5)(2013-8#2)
studies as a##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
studies as well as##2##4##(1996-6#1)(2008-11#1)
studies as well##4##3##(1995-9#1)(1996-6#1)(2008-11#1)(2013-1#1)
studies as##10##2##(1995-9#1)(1996-6#1)(2008-10#1)(2008-11#3)(2009-12#1)(2010-8#1)(2012-5#1)(2013-1#1)
studies at##6##2##(2008-10#4)(2008-9#1)(2011-2#1)
studies based on the##3##4##(2008-1#1)(2008-10#1)(2008-5#1)
studies based on##7##3##(1992-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)
studies between##3##2##(2008-10#2)(2010-9#1)
studies by##8##2##(1994-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-11#2)(2008-3#1)(2008-8#1)
studies can be applied##2##4##(2008-10#1)(2008-11#1)
studies can be##8##3##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
studies can##9##2##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
studies carried out in the##2##5##(2008-10#1)(2008-7#1)
studies carried out in##3##4##(2008-10#2)(2008-7#1)
studies carried out through##2##4##(2008-10#1)(2012-2#1)
studies carried out to##2##4##(2008-10#2)
studies carried out##9##3##(1990-5#1)(2008-10#6)(2008-7#1)(2012-2#1)
studies compared##2##2##(2012-12#2)
studies comparing##5##2##(1990-2#1)(1992-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
studies conducted in the##2##4##(1990-8#1)(1994-9#1)
studies conducted in##6##3##(1990-8#1)(1994-9#1)(1996-1#1)(2008-10#1)(2008-7#1)(2009-1#1)
studies conducted with##2##3##(2008-5#2)
studies conducted##17##2##(1990-8#1)(1994-9#1)(1995-9#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2013-1#1)
studies confirm that##3##3##(1993-6#1)(1995-2#1)(2010-1#1)
studies confirm##6##2##(1993-2#1)(1993-6#1)(1995-2#1)(2008-5#1)(2008-7#1)(2010-1#1)
studies confirmed##3##2##(1994-11#1)(1997-8#1)(2008-10#1)
studies demonstrate that the##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
studies demonstrate that##12##3##(1991-12#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#2)
studies demonstrate the##2##3##(2008-10#1)(2008-4#1)
studies demonstrate##17##2##(1991-12#1)(1994-6#1)(1995-2#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#2)
studies demonstrated a high##2##4##(2008-10#1)(2010-11#1)
studies demonstrated a##4##3##(2006-6#1)(2008-10#1)(2010-11#1)(2013-1#1)
studies demonstrated that the##4##4##(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
studies demonstrated that##13##3##(1991-3#1)(1993-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
studies demonstrated the##3##3##(1994-2#1)(2011-2#1)(2012-3#1)
studies demonstrated##24##2##(1991-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-6#1)(1997-6#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
studies demonstrating that##2##3##(2008-11#1)(2008-12#1)
studies demonstrating##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
studies described##3##2##(1994-8#1)(1996-1#1)(2008-11#1)
studies describing##3##2##(2008-11#1)(2012-3#2)
studies designed to##2##3##(2008-5#1)(2012-3#1)
studies did not##2##3##(2011-2#1)(2013-1#1)
studies directly##2##2##(1995-2#1)(2008-3#1)
studies do not##3##3##(1991-12#1)(2008-11#1)(2012-2#1)
studies during##3##2##(1995-5#1)(2008-7#2)
studies employing##3##2##(2010-10#1)(2010-7#1)(2011-2#1)
studies established##2##2##(1994-8#1)(1996-8#1)
studies evaluating##5##2##(1995-1#1)(1995-12#1)(2010-1#2)(2013-1#1)
studies examined musculoskeletal injuries in the##2##6##(2013-1#2)
studies examined musculoskeletal injuries##3##4##(2013-1#3)
studies examining##7##2##(2008-10#2)(2008-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2013-1#1)
studies exploring the##2##3##(2010-2#1)(2011-1#1)
studies failed to##2##3##(2008-7#1)(2011-1#1)
studies focused on##2##3##(2008-11#1)(2010-11#1)
studies for tebuconazole effect on##2##5##(2008-10#2)
studies for the##3##3##(2008-10#2)(2012-2#1)
studies for##17##2##(1992-9#1)(1996-1#1)(2008-10#8)(2008-4#1)(2009-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
studies found that##2##3##(2013-7#1)(2013-8#1)
studies found##6##2##(2011-2#4)(2013-7#1)(2013-8#1)
studies from this laboratory##3##4##(1990-11#1)(1991-3#1)(1995-12#1)
studies from##14##2##(1990-11#1)(1991-3#1)(1992-1#1)(1993-11#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
studies further##3##2##(1996-12#1)(2013-1#1)(2013-8#1)
studies has##4##2##(1994-1#1)(2008-1#1)(2008-7#1)(2009-10#1)
studies have also##2##3##(2008-10#2)
studies have been carried out in##2##6##(1994-5#1)(2008-11#1)
studies have been carried out##5##5##(1994-5#1)(2008-10#1)(2008-11#2)(2010-7#1)
studies have been conducted in##2##5##(2013-1#2)
studies have been conducted##4##4##(2008-10#1)(2011-2#1)(2013-1#2)
studies have been performed##2##4##(2008-11#1)(2012-2#1)
studies have been published##2##4##(1997-6#1)(2008-2#1)
studies have been reported##2##4##(1990-11#1)(2008-5#1)
studies have been##23##3##(1990-11#1)(1994-5#1)(1995-5#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-5#2)(2010-1#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#3)
studies have begun to##2##4##(2008-10#1)(2011-2#1)
studies have compared##2##3##(1991-3#1)(2008-8#1)
studies have confirmed the##2##4##(2008-1#1)(2011-2#1)
studies have confirmed##3##3##(1995-2#1)(2008-1#1)(2011-2#1)
studies have demonstrated that the##2##5##(2008-7#1)(2011-3#1)
studies have demonstrated that##10##4##(1996-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)
studies have demonstrated the##5##4##(1992-1#1)(2008-11#1)(2008-5#2)(2012-2#1)
studies have demonstrated##15##3##(1992-1#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)
studies have described##2##3##(2008-12#1)(2008-9#1)
studies have established##2##3##(2008-5#1)(2010-12#1)
studies have evaluated##2##3##(2008-4#1)(2010-8#1)
studies have examined the##4##4##(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
studies have examined##6##3##(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
studies have explored the##2##4##(2009-10#1)(2010-1#1)
studies have failed to##2##4##(1994-2#1)(2008-7#1)
studies have focused on##5##4##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
studies have found##5##3##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2013-1#1)
studies have identified the##2##4##(2008-10#1)(2008-6#1)
studies have identified##10##3##(1995-6#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
studies have implicated##2##3##(2008-11#1)(2013-1#1)
studies have indicated that##10##4##(1992-12#1)(1993-12#1)(1995-11#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
studies have indicated the##2##4##(2008-11#1)(2013-1#1)
studies have indicated##16##3##(1992-12#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
studies have investigated the##2##4##(2008-12#1)(2013-1#1)
studies have investigated##3##3##(2008-12#1)(2012-3#1)(2013-1#1)
studies have not##3##3##(1991-2#1)(2008-11#1)(2008-9#1)
studies have now demonstrated that##2##5##(1997-1#1)(2008-11#1)
studies have now##3##3##(1993-2#1)(1997-1#1)(2008-11#1)
studies have provided##4##3##(1992-9#1)(2008-9#1)(2011-2#1)(2013-8#1)
studies have reported that the##2##5##(2008-11#1)(2009-11#1)
studies have reported that##3##4##(2008-11#1)(2009-11#1)(2013-1#1)
studies have reported the##2##4##(2008-11#1)(2013-8#1)
studies have reported##14##3##(2008-10#1)(2008-11#5)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
studies have revealed that##8##4##(1992-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)
studies have revealed##12##3##(1992-10#1)(1996-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)
studies have shown that a##3##5##(1994-8#1)(2011-2#2)
studies have shown that the##10##5##(1993-8#1)(1994-5#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
studies have shown that this##3##5##(1993-6#1)(2011-2#2)
studies have shown that##43##4##(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
studies have shown the##2##4##(1992-2#1)(2008-2#1)
studies have shown##54##3##(1992-2#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
studies have suggested a possible##2##5##(2013-1#2)
studies have suggested a##4##4##(2008-5#1)(2013-1#3)
studies have suggested that##6##4##(1992-2#1)(1994-6#1)(2009-10#1)(2010-12#1)(2010-8#1)(2013-1#1)
studies have suggested##10##3##(1992-2#1)(1994-6#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-8#1)(2013-1#4)
studies have tested##2##3##(2008-11#1)(2008-9#1)
studies have##240##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#13)(2008-11#25)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#15)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#23)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#5)(2013-1#20)(2013-8#6)
studies identified##2##2##(2012-2#1)(2013-1#1)
studies illustrate##2##2##(2008-10#1)(2008-7#1)
studies in a##3##3##(2008-10#1)(2008-9#1)(2010-5#1)
studies in animal models##3##4##(2006-6#1)(2010-10#1)(2012-3#1)
studies in bovine##2##3##(2008-10#1)(2008-11#1)
studies in different##2##3##(2008-12#1)(2013-1#1)
studies in humans##2##3##(2008-7#1)(2009-8#1)
studies in order to##2##4##(2008-11#1)(2013-1#1)
studies in our##3##3##(1991-2#1)(2008-7#1)(2009-6#1)
studies in patients with##2##4##(2008-10#1)(2010-11#1)
studies in rats##3##3##(1991-12#1)(1997-1#1)(2008-5#1)
studies in the##13##3##(1992-2#1)(1994-1#1)(1994-8#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2009-10#1)(2009-12#1)(2012-2#1)
studies in this area##2##4##(2008-11#1)(2012-12#1)
studies in this##4##3##(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
studies in vivo##2##3##(1995-9#1)(2008-5#1)
studies in which the##2##4##(2008-7#1)(2013-1#1)
studies in which##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
studies in##91##2##(1991-12#1)(1991-2#1)(1991-7#1)(1992-2#2)(1992-3#1)(1994-1#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-6#2)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#13)(2008-11#8)(2008-12#5)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#2)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
studies including a##2##3##(1991-11#1)(2008-1#1)
studies including##7##2##(1991-11#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
studies indicate a##2##3##(2008-1#1)(2009-12#1)
studies indicate that both##2##4##(1991-5#1)(1995-11#1)
studies indicate that the##6##4##(1990-11#1)(1993-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
studies indicate that##29##3##(1990-11#1)(1991-12#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-7#2)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2013-8#1)
studies indicate##32##2##(1990-11#1)(1991-12#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2013-8#1)
studies indicated that the##3##4##(1993-12#1)(1996-12#1)(2008-9#1)
studies indicated that##14##3##(1990-11#1)(1993-12#1)(1996-12#2)(2008-10#6)(2008-8#1)(2008-9#2)(2013-1#1)
studies indicated##15##2##(1990-11#1)(1993-12#1)(1996-12#2)(2008-10#7)(2008-8#1)(2008-9#2)(2013-1#1)
studies indicating that##2##3##(1994-5#1)(2011-2#1)
studies into the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
studies into##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
studies investigating the##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
studies investigating##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
studies involving the##4##3##(2008-10#3)(2008-5#1)
studies involving##15##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
studies is the##3##3##(2008-10#2)(2008-7#1)
studies is##11##2##(1990-8#1)(1995-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)
studies leading to##2##3##(2008-8#1)(2010-7#1)
studies may be##2##3##(1991-6#1)(2008-1#1)
studies may##7##2##(1991-6#1)(1995-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)
studies met##3##2##(2012-12#1)(2013-1#2)
studies need to be##2##4##(2008-9#1)(2010-12#1)
studies of a##4##3##(1992-12#1)(1996-6#1)(2008-10#1)(2008-8#1)
studies of cancer##2##3##(2009-4#1)(2012-12#1)
studies of complex##2##3##(1992-4#1)(2008-10#1)
studies of dichloroacetic acid##2##4##(2008-9#2)
studies of different##3##3##(1996-6#1)(2008-10#2)
studies of human##2##3##(1995-6#1)(2008-11#1)
studies of its##2##3##(2008-10#1)(2008-7#1)
studies of many##2##3##(2008-10#1)(2008-9#1)
studies of methylphenidate##2##3##(1995-11#2)
studies of natural##2##3##(2008-10#1)(2008-9#1)
studies of nickel and chromium in wastewater from##2##8##(2008-10#2)
studies of other##2##3##(1991-5#1)(2008-5#1)
studies of reverse-correlation have##2##4##(2013-8#2)
studies of six##2##3##(1991-12#2)
studies of sodium bromate##2##4##(2008-9#2)
studies of the binary and ternary complexes involving##2##8##(2008-10#2)
studies of the biosensor##4##4##(2008-10#4)
studies of the development of##2##5##(1992-12#1)(2008-11#1)
studies of the effect of##3##5##(2008-10#2)(2008-9#1)
studies of the interaction##2##4##(2008-10#2)
studies of the##69##3##(1990-9#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-3#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#5)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
studies of these##3##3##(1993-12#1)(1994-9#1)(2008-8#1)
studies of this pathogen##3##4##(2008-10#3)
studies of this##9##3##(1991-12#1)(1994-11#1)(2008-10#5)(2008-5#2)
studies of utilization##2##3##(1995-1#1)(2012-12#1)
studies of ventricular brain CSF in assorted psychiatric and##2##9##(1993-1#2)
studies of##319##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1993-1#3)(1993-12#3)(1993-3#2)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-6#2)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#92)(2008-11#28)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#7)(2008-7#8)(2008-8#15)(2008-9#23)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#8)(2011-3#2)(2011-7#1)(2012-12#3)(2012-2#5)(2012-3#7)(2012-4#1)(2012-9#1)(2013-1#1)(2013-8#4)
studies on human##2##3##(1995-8#1)(2008-11#1)
studies on natural##3##3##(2008-10#3)
studies on other##2##3##(2008-10#1)(2009-6#1)
studies on social support##2##4##(1992-3#2)
studies on the development of##2##5##(2008-10#1)(2009-6#1)
studies on the effects of##2##5##(2008-11#1)(2008-5#1)
studies on the role of##2##5##(2008-7#1)(2009-8#1)
studies on the##53##3##(1990-5#1)(1992-3#1)(1993-8#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#2)
studies on this issue##2##4##(2008-11#2)
studies on this##4##3##(1997-8#1)(2008-11#2)(2011-2#1)
studies on virus##2##3##(2007-12#1)(2008-10#1)
studies on##139##2##(1990-5#2)(1991-5#1)(1991-8#1)(1992-3#4)(1993-1#1)(1993-2#2)(1993-8#2)(1994-2#2)(1994-6#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#11)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
studies or##4##2##(1992-6#1)(2008-4#1)(2010-5#1)(2013-1#1)
studies performed with##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
studies performed##8##2##(1994-6#1)(2008-10#4)(2008-7#1)(2012-12#1)(2013-8#1)
studies predict##2##2##(2008-10#1)(2008-8#1)
studies presented##4##2##(1995-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
studies proved that the##2##4##(1992-2#1)(2008-10#1)
studies proved##3##2##(1992-2#1)(2008-10#1)(2008-9#1)
studies provide##7##2##(1991-9#1)(2008-10#3)(2009-7#1)(2011-2#1)(2013-8#1)
studies provided##2##2##(2008-10#1)(2009-10#1)
studies published##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
studies regarding the##2##3##(2008-11#1)(2008-7#1)
studies regarding##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
studies related to##3##3##(2008-10#3)
studies report##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
studies reported here##2##3##(1995-8#1)(2008-10#1)
studies reported to date##2##4##(1991-12#1)(2011-2#1)
studies reported##8##2##(1990-5#1)(1991-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
studies reporting long-term (≥ 48 months)##2##6##(2012-12#2)
studies reporting##4##2##(2008-10#1)(2008-7#1)(2012-12#2)
studies reveal a##2##3##(1996-2#1)(2012-12#1)
studies reveal that##3##3##(1994-5#1)(2008-11#2)
studies reveal##6##2##(1990-8#1)(1994-5#1)(1996-2#1)(2008-11#2)(2012-12#1)
studies revealed a##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
studies revealed that both##2##4##(1995-8#1)(2012-3#1)
studies revealed that the##6##4##(2007-12#1)(2008-10#5)
studies revealed that##18##3##(1993-8#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2009-4#1)(2012-2#1)(2012-3#2)
studies revealed the presence of##2##5##(1994-8#1)(2008-7#1)
studies revealed the##4##3##(1994-8#1)(2008-10#1)(2008-7#2)
studies revealed##32##2##(1992-1#1)(1993-8#2)(1994-8#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#4)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
studies should be##5##3##(1990-6#1)(1994-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
studies should##10##2##(1990-6#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-8#3)(2011-2#2)(2012-3#1)
studies show a##3##3##(2008-11#2)(2011-2#1)
studies show that the##7##4##(2008-10#5)(2008-8#1)(2011-2#1)
studies show that##25##3##(1992-4#1)(1994-6#1)(1995-6#2)(1996-3#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#2)(2010-6#1)(2011-2#1)(2012-2#1)
studies show##36##2##(1992-3#1)(1992-4#1)(1994-6#1)(1995-6#2)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-6#1)(2009-8#2)(2010-6#1)(2011-2#4)(2012-2#2)(2013-1#1)
studies showed a##7##3##(1990-11#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-2#1)
studies showed that the##5##4##(2008-10#3)(2008-5#1)(2008-7#1)
studies showed that##25##3##(1990-11#1)(1993-8#1)(2008-10#9)(2008-11#3)(2008-5#2)(2008-7#4)(2008-9#2)(2009-10#1)(2010-12#1)(2013-1#1)
studies showed##42##2##(1990-11#2)(1990-5#1)(1993-8#1)(1995-5#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-5#4)(2008-7#5)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-3#2)(2013-1#1)
studies showing that##2##3##(1993-6#1)(2012-3#1)
studies showing##3##2##(1993-6#1)(2008-9#1)(2012-3#1)
studies suggest that the##4##4##(1992-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
studies suggest that these##3##4##(1990-8#1)(1995-2#1)(2010-5#1)
studies suggest that##37##3##(1990-5#1)(1990-8#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-6#2)(1994-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
studies suggest##40##2##(1990-5#2)(1990-8#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-6#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
studies suggested that##2##3##(2008-11#1)(2013-1#1)
studies suggested##4##2##(2008-11#1)(2011-2#2)(2013-1#1)
studies suggesting that##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
studies suggesting##4##2##(2007-12#1)(2008-4#1)(2008-7#1)(2009-3#1)
studies support the notion that##2##5##(2008-5#1)(2011-2#1)
studies support the notion##3##4##(2008-5#1)(2011-1#1)(2011-2#1)
studies support the##6##3##(2008-2#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)
studies support##8##2##(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#2)
studies supporting##2##2##(1990-12#1)(2010-5#1)
studies that compare##3##3##(2008-10#1)(2010-12#1)(2010-6#1)
studies that describe##2##3##(2009-6#1)(2013-1#1)
studies that examine the##4##4##(2008-11#1)(2008-7#2)(2012-2#1)
studies that examine##5##3##(2008-11#1)(2008-7#2)(2009-9#1)(2012-2#1)
studies that found##2##3##(2011-2#2)
studies that have##6##3##(2008-10#1)(2008-11#1)(2008-7#2)(2010-10#1)(2013-1#1)
studies that##47##2##(1991-2#1)(1993-11#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#6)(2008-8#4)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
studies the##9##2##(1994-2#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#2)
studies to assess the##2##4##(2008-10#1)(2008-5#1)
studies to assess##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
studies to date##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
studies to determine##5##3##(1991-11#1)(1994-12#1)(1997-5#1)(2008-10#2)
studies to evaluate##3##3##(1993-8#1)(1994-3#1)(2010-12#1)
studies to examine##2##3##(1992-6#1)(2013-1#1)
studies to##37##2##(1991-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
studies under##3##2##(2008-10#2)(2008-11#1)
studies using the##4##3##(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)
studies using##33##2##(1990-2#1)(1990-5#1)(1991-1#1)(1993-6#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#13)(2008-11#3)(2008-3#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
studies utilizing##5##2##(2008-10#2)(2008-11#1)(2010-11#1)(2012-2#1)
studies was##6##2##(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)
studies we have##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
studies we##5##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
studies were carried out on##4##5##(1994-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
studies were carried out to##3##5##(2008-10#2)(2008-5#1)
studies were carried out##9##4##(1994-5#1)(2008-10#5)(2008-12#1)(2008-5#1)(2011-2#1)
studies were compared##2##3##(2008-7#1)(2010-1#1)
studies were conducted by##2##4##(2008-10#1)(2008-11#1)
studies were conducted in##3##4##(2008-1#1)(2008-9#2)
studies were conducted to##3##4##(2008-10#3)
studies were conducted##12##3##(2008-1#1)(2008-10#5)(2008-11#1)(2008-9#2)(2009-12#1)(2012-2#1)(2013-1#1)
studies were done##2##3##(1996-12#1)(2008-10#1)
studies were identified##4##3##(2008-11#1)(2013-1#3)
studies were included##4##3##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
studies were performed by##2##4##(2008-10#1)(2008-5#1)
studies were performed in##3##4##(1997-8#1)(2008-10#1)(2008-7#1)
studies were performed to determine##3##5##(1997-1#1)(1997-6#1)(2008-10#1)
studies were performed to##6##4##(1997-1#1)(1997-6#1)(2008-10#3)(2011-2#1)
studies were performed with##2##4##(1994-5#1)(2008-10#1)
studies were performed##17##3##(1994-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#9)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
studies were undertaken to##3##4##(1993-11#1)(1994-11#1)(1994-6#1)
studies were used to##2##4##(1994-11#1)(2008-10#1)
studies were##80##2##(1990-6#1)(1991-12#2)(1991-3#1)(1993-11#1)(1993-12#1)(1994-11#2)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#1)
studies where##2##2##(2012-3#1)(2013-8#1)
studies which have##3##3##(1994-2#1)(1997-1#1)(1997-8#1)
studies which##8##2##(1994-2#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)
studies will allow##2##3##(2010-4#1)(2012-2#1)
studies will be##3##3##(1991-12#1)(2008-4#1)(2009-8#1)
studies will##12##2##(1991-12#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-2#2)(2012-3#1)
studies with a##7##3##(1995-12#1)(1995-5#1)(1997-8#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
studies with long-term follow-up##2##4##(2012-12#2)
studies with the##6##3##(1990-12#1)(2008-10#2)(2009-3#2)(2013-8#1)
studies with##80##2##(1990-12#1)(1991-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-1#2)(1997-6#1)(1997-8#2)(1997-9#1)(2006-6#1)(2008-10#23)(2008-11#4)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-8#2)
studies would be##2##3##(1992-2#1)(2011-3#1)
studies would##3##2##(1992-2#1)(2010-12#1)(2011-3#1)
studies##2571##1##(1990-11#8)(1990-12#3)(1990-2#3)(1990-3#3)(1990-5#10)(1990-6#5)(1990-8#7)(1990-9#1)(1991-1#5)(1991-11#5)(1991-12#21)(1991-2#11)(1991-3#7)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#6)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#8)(1992-3#18)(1992-4#3)(1992-5#3)(1992-6#5)(1992-9#8)(1993-1#7)(1993-11#10)(1993-12#10)(1993-2#9)(1993-3#5)(1993-6#8)(1993-8#15)(1993-9#1)(1994-1#4)(1994-11#5)(1994-12#8)(1994-2#12)(1994-3#6)(1994-5#14)(1994-6#10)(1994-8#10)(1994-9#4)(1995-1#4)(1995-11#14)(1995-12#12)(1995-2#17)(1995-3#2)(1995-5#14)(1995-6#15)(1995-8#6)(1995-9#8)(1996-1#8)(1996-10#1)(1996-11#4)(1996-12#19)(1996-2#12)(1996-3#5)(1996-5#2)(1996-6#7)(1996-8#1)(1996-9#4)(1997-1#16)(1997-2#8)(1997-3#4)(1997-4#5)(1997-5#5)(1997-6#8)(1997-7#7)(1997-8#13)(1997-9#2)(2006-5#1)(2006-6#3)(2007-11#4)(2007-12#6)(2008-1#22)(2008-10#539)(2008-11#207)(2008-12#47)(2008-2#11)(2008-3#18)(2008-4#33)(2008-5#87)(2008-6#10)(2008-7#93)(2008-8#87)(2008-9#114)(2009-1#4)(2009-10#17)(2009-11#4)(2009-12#12)(2009-3#7)(2009-4#5)(2009-5#1)(2009-6#10)(2009-7#18)(2009-8#32)(2009-9#7)(2010-1#16)(2010-10#14)(2010-11#17)(2010-12#20)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#20)(2010-6#5)(2010-7#11)(2010-8#9)(2010-9#5)(2011-1#17)(2011-10#1)(2011-2#146)(2011-3#6)(2011-7#1)(2011-8#1)(2012-12#48)(2012-2#71)(2012-3#60)(2012-4#2)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#113)(2013-7#3)(2013-8#48)
studies) and##3##2##(2008-9#2)(2012-2#1)
studies)##9##1##(2008-3#1)(2008-8#1)(2008-9#5)(2012-2#2)
studies?##3##1##(1991-3#1)(1993-11#1)(2007-11#1)
studies]##4##1##(1990-3#2)(2012-3#1)(2013-8#1)
study (N =##2##3##(2010-10#1)(2013-8#1)
study (n =##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
study a##18##2##(1993-11#1)(1995-5#1)(1996-6#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#2)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
study about##4##2##(2009-1#1)(2009-5#1)(2013-1#2)
study addresses the##3##3##(1992-1#1)(2008-9#1)(2009-4#1)
study addresses##5##2##(1992-1#1)(1994-1#2)(2008-9#1)(2009-4#1)
study adds##2##2##(2010-5#1)(2011-2#1)
study aimed at investigating the##2##5##(2012-3#1)(2013-8#1)
study aimed at##7##3##(1992-9#1)(2008-10#1)(2008-5#1)(2012-3#3)(2013-8#1)
study aimed to describe##3##4##(2010-7#1)(2012-3#1)(2013-1#1)
study aimed to evaluate the##4##5##(2008-11#1)(2011-2#2)(2012-3#1)
study aimed to evaluate##5##4##(2008-11#1)(2011-1#1)(2011-2#2)(2012-3#1)
study aimed to identify##4##4##(2011-2#1)(2012-3#2)(2012-8#1)
study aimed to##33##3##(2008-10#3)(2008-11#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-1#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#10)(2012-6#1)(2012-8#1)(2013-1#2)
study aimed##40##2##(1992-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-1#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#13)(2012-6#1)(2012-8#1)(2013-1#2)(2013-8#1)
study aims at##4##3##(1994-6#1)(2009-11#1)(2009-12#1)(2013-8#1)
study aims to assess##2##4##(2010-6#1)(2013-8#1)
study aims to identify##2##4##(2010-10#1)(2013-1#1)
study aims to##15##3##(2008-10#1)(2008-11#2)(2008-9#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
study aims##19##2##(1994-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
study allowed##3##2##(2008-5#1)(2010-4#1)(2012-3#1)
study also demonstrates that##3##4##(2008-10#2)(2008-3#1)
study also describes the experimental conditions and the##2##8##(2008-10#2)
study also indicates##2##3##(2008-10#1)(2008-9#1)
study also##28##2##(1991-12#2)(1992-12#1)(1994-8#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-3#1)
study among##2##2##(1995-1#1)(2011-2#1)
study analysed##2##2##(2008-12#1)(2011-2#1)
study analyzed the##3##3##(2013-1#3)
study analyzed##6##2##(1995-12#1)(2010-6#1)(2013-1#4)
study analyzes##4##2##(1995-2#1)(1996-3#2)(2011-2#1)
study and a##3##3##(1990-9#1)(1995-3#1)(2010-1#1)
study and analysis of##3##4##(2008-10#2)(2012-3#1)
study and analytical applications of##2##5##(2008-10#2)
study and application of##2##4##(2008-10#2)
study and report##2##3##(1993-2#1)(2011-2#1)
study and the##8##3##(1991-12#1)(1993-12#1)(2008-10#3)(2008-5#2)(2012-3#1)
study and were##4##3##(1991-2#1)(2008-11#1)(2011-2#2)
study and##66##2##(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#17)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#2)(2009-2#1)(2010-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
study applies##2##2##(2008-10#2)
study are discussed##2##3##(1993-1#1)(2013-8#1)
study are encouraging##2##3##(1996-12#1)(2010-12#1)
study are presented##2##3##(1992-2#1)(2008-11#1)
study are##27##2##(1992-2#1)(1993-1#1)(1993-3#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
study area##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
study areas##4##2##(1995-3#1)(2008-10#2)(2013-1#1)
study as a##6##3##(1997-5#1)(2008-11#3)(2008-9#1)(2011-2#1)
study as well##2##3##(2008-5#1)(2012-3#1)
study as##10##2##(1997-5#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
study assessed the effects of##2##5##(1993-3#1)(1996-2#1)
study assessed the##10##3##(1993-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#3)
study assessed##15##2##(1993-3#1)(1995-2#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#2)(2010-10#1)(2010-8#1)(2011-2#3)
study assesses the##4##3##(2008-11#2)(2008-3#1)(2012-2#1)
study assesses##5##2##(1997-3#1)(2008-11#2)(2008-3#1)(2012-2#1)
study at a##2##3##(1991-11#1)(1995-2#1)
study at the##4##3##(1991-12#1)(2008-10#2)(2008-12#1)
study at##10##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1995-2#1)(2008-10#4)(2008-12#1)
study attempted to##4##3##(1990-2#1)(1993-2#1)(2008-10#1)(2008-5#1)
study attempts to##4##3##(1992-1#1)(2008-9#1)(2010-5#1)(2011-2#1)
study based on the##2##4##(2008-10#2)
study based on##7##3##(1991-8#1)(1996-12#1)(1996-2#1)(2008-10#2)(2010-12#1)(2012-3#1)
study because##4##2##(2008-10#1)(2008-9#1)(2010-1#1)(2013-1#1)
study before and##2##3##(2008-10#2)
study between##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
study by the##3##3##(1992-1#1)(2008-11#1)(2008-9#1)
study by##13##2##(1992-1#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)
study can provide a##2##4##(2008-11#1)(2013-1#1)
study can##5##2##(1995-9#1)(2008-11#1)(2008-12#2)(2013-1#1)
study carried out on 16##2##5##(2008-11#1)(2008-5#1)
study carried out on##3##4##(1991-6#1)(2008-11#1)(2008-5#1)
study carried out##5##3##(1991-6#1)(1993-3#1)(2008-11#1)(2008-5#2)
study characterized the##3##3##(2010-1#1)(2010-11#1)(2013-1#1)
study characterized##4##2##(2008-10#1)(2010-1#1)(2010-11#1)(2013-1#1)
study clearly##7##2##(2008-10#3)(2008-11#3)(2012-2#1)
study clinical##2##2##(2007-8#1)(2012-3#1)
study compared a##2##3##(2009-11#1)(2012-12#1)
study compared the effects of##2##5##(1993-3#1)(2010-1#1)
study compared the efficacy##2##4##(1993-1#1)(2012-3#1)
study compared the results of##2##5##(2009-3#1)(2011-2#1)
study compared the##13##3##(1993-1#1)(1993-3#1)(1996-1#1)(2009-3#3)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
study compared##24##2##(1993-1#1)(1993-3#2)(1996-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-3#4)(2010-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
study compares the##4##3##(1993-12#1)(1996-12#1)(1997-3#1)(2009-4#1)
study compares##7##2##(1992-12#1)(1993-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2009-4#1)(2009-7#1)
study comparing the##3##3##(1994-3#1)(1996-1#1)(2008-10#1)
study comparing##7##2##(1994-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)
study concerning##2##2##(1990-3#1)(1990-5#1)
study concerns##3##2##(1994-6#1)(1996-1#1)(2008-11#1)
study concluded that##3##3##(2008-11#2)(2010-9#1)
study concludes that##4##3##(1991-2#1)(2008-11#1)(2012-3#1)(2013-1#1)
study concludes##5##2##(1991-2#1)(1995-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
study conducted in##4##3##(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#1)
study conducted##9##2##(1990-6#1)(1991-11#1)(1994-12#1)(2008-10#1)(2009-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
study confirmed that##2##3##(1993-12#1)(2011-2#1)
study confirmed the##3##3##(1993-2#1)(2008-10#1)(2012-12#1)
study confirmed##5##2##(1993-12#1)(1993-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
study confirms that##3##3##(1990-2#1)(2008-10#2)
study confirms the##4##3##(1995-2#1)(2008-10#2)(2008-7#1)
study confirms##8##2##(1990-2#1)(1994-3#1)(1995-2#1)(2008-10#4)(2008-7#1)
study consisted of##6##3##(2008-10#1)(2008-11#1)(2010-1#2)(2011-2#1)(2013-8#1)
study contributes##2##2##(2008-10#1)(2010-10#1)
study could##6##2##(2008-10#2)(2010-7#1)(2011-3#1)(2013-1#2)
study current##2##2##(1996-2#1)(2008-8#1)
study data##4##2##(2008-11#2)(2010-5#1)(2012-2#1)
study deals with a##2##4##(1995-12#1)(2008-10#1)
study deals with the##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
study deals with##7##3##(1995-12#1)(2008-10#3)(2008-5#1)(2012-2#2)
study deals##8##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-2#2)
study demonstrate that##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
study demonstrate##5##2##(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)
study demonstrated that the##4##4##(2008-10#1)(2008-11#1)(2011-2#2)
study demonstrated that##19##3##(1990-5#1)(1994-3#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#5)(2013-8#1)
study demonstrated the##5##3##(1997-1#1)(2008-10#1)(2008-6#1)(2009-1#1)(2013-1#1)
study demonstrated##26##2##(1990-5#1)(1994-3#1)(1995-11#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2009-1#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#6)(2013-1#1)(2013-8#1)
study demonstrates a##5##3##(1990-11#1)(1995-12#1)(1996-3#1)(2008-10#2)
study demonstrates that the##3##4##(1994-11#1)(2008-10#1)(2008-11#1)
study demonstrates that this##2##4##(2013-1#1)(2013-8#1)
study demonstrates that##19##3##(1992-6#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-2#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
study demonstrates the##15##3##(1990-5#1)(1992-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-7#1)
study demonstrates##42##2##(1990-11#1)(1990-5#1)(1992-1#1)(1992-6#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-3#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
study described##3##2##(1991-2#1)(2008-11#1)(2013-1#1)
study describes a##6##3##(2008-10#4)(2008-11#1)(2009-6#1)
study describes the##12##3##(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)
study describes##28##2##(1991-12#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#3)
study design and##6##3##(1992-3#1)(2008-11#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
study design is##2##3##(2008-11#1)(2011-2#1)
study design was used##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
study design was##4##3##(1994-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
study design##25##2##(1992-3#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#5)(2012-2#2)(2013-1#4)(2013-8#1)
study designed to##3##3##(1990-12#1)(2008-11#2)
study designs##3##2##(1995-9#1)(1996-3#1)(2013-1#1)
study determined the##2##3##(2012-5#1)(2013-1#1)
study determined##5##2##(1997-7#1)(2008-10#1)(2010-6#1)(2012-5#1)(2013-1#1)
study did not show any##2##5##(1997-8#1)(2010-8#1)
study did not##5##3##(1992-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2010-8#1)
study do not##2##3##(2008-11#1)(2008-7#1)
study documents##2##2##(1993-9#1)(2012-3#1)
study does not support the##2##5##(1993-3#1)(2008-9#1)
study does not support##3##4##(1991-8#1)(1993-3#1)(2008-9#1)
study does not##4##3##(1991-8#1)(1992-12#1)(1993-3#1)(2008-9#1)
study done##2##2##(1996-11#1)(2013-1#1)
study end##2##2##(2007-11#1)(2008-10#1)
study evaluated the use##2##4##(2008-10#1)(2013-1#1)
study evaluated the##15##3##(1993-1#1)(1995-12#2)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)
study evaluated whether##2##3##(2009-11#1)(2013-1#1)
study evaluated##25##2##(1993-1#1)(1995-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#2)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#6)
study evaluates the effect of##2##5##(2008-7#1)(2013-8#1)
study evaluates the##7##3##(1993-3#1)(1996-2#1)(1997-2#1)(2008-7#2)(2010-2#1)(2013-8#1)
study evaluates##10##2##(1993-3#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-2#1)(2013-8#1)
study evaluating##2##2##(2010-12#1)(2011-2#1)
study examined how##2##3##(1997-8#1)(2010-10#1)
study examined the effect of##4##5##(1991-2#2)(2011-2#1)(2013-1#1)
study examined the effects of##7##5##(1990-9#1)(1994-8#1)(1996-12#1)(2008-12#1)(2009-3#1)(2010-6#1)(2011-1#1)
study examined the relationship between##4##5##(2009-11#1)(2010-7#1)(2010-9#1)(2011-2#1)
study examined the##41##3##(1990-9#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-11#2)(2009-3#1)(2009-5#1)(2010-1#3)(2010-10#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
study examined whether##5##3##(1996-5#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
study examined##74##2##(1990-9#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-5#1)(2008-9#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#4)(2010-10#3)(2010-2#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
study examines how##3##3##(2008-12#1)(2008-8#1)(2009-7#1)
study examines the impact of##2##5##(1994-2#1)(2008-11#1)
study examines the relationship between the##2##6##(1997-3#1)(2009-5#1)
study examines the relationship between##3##5##(1995-12#1)(1997-3#1)(2009-5#1)
study examines the##21##3##(1992-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-7#1)(2010-8#2)(2012-3#1)(2013-1#1)
study examines whether##3##3##(1993-3#1)(1994-12#1)(2010-7#1)
study examines##37##2##(1992-12#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-5#1)(2008-8#1)(2009-3#1)(2009-5#2)(2009-7#3)(2010-11#1)(2010-7#2)(2010-8#2)(2012-3#2)(2013-1#2)(2013-8#1)
study explored the perceptions##2##4##(2010-11#1)(2010-9#1)
study explored the##8##3##(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)
study explored##11##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
study explores how##2##3##(2010-9#1)(2013-8#1)
study explores the##5##3##(1996-2#1)(1997-1#1)(2008-1#1)(2008-12#1)(2008-8#1)
study explores##14##2##(1994-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-8#1)(2010-10#1)(2010-9#1)(2013-8#2)
study exploring the##3##3##(2008-11#3)
study exploring##4##2##(2008-11#3)(2013-8#1)
study extends previous##3##3##(1994-3#1)(2010-2#1)(2013-8#1)
study extends##6##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2013-8#1)
study findings##7##2##(1991-12#2)(1991-2#1)(1993-1#1)(1993-12#1)(1995-1#1)(2009-5#1)
study finds##2##2##(1994-2#1)(2008-11#1)
study focused on the##5##4##(2008-10#1)(2010-4#1)(2013-1#3)
study focused on##7##3##(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#4)
study focuses on the##4##4##(1990-6#1)(2008-10#1)(2008-11#2)
study focuses on##7##3##(1990-6#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-11#3)
study followed the##2##3##(2008-9#1)(2013-1#1)
study followed##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
study for each##2##3##(2008-10#1)(2008-7#1)
study for the analysis of##2##5##(2008-10#1)(2010-6#1)
study for the##8##3##(1993-3#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
study for##26##2##(1993-3#1)(1997-3#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#2)(2011-3#1)(2013-8#1)
study found no##2##3##(1997-8#1)(2008-7#1)
study found that##4##3##(2008-11#1)(2009-9#1)(2012-12#1)(2013-8#1)
study found##9##2##(1995-3#1)(1997-8#1)(2008-11#2)(2008-7#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
study from a##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
study from the##2##3##(1993-6#1)(1995-3#1)
study from##12##2##(1993-6#1)(1995-3#1)(2008-10#2)(2008-11#2)(2009-3#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
study further revealed##2##3##(1993-6#1)(2009-8#1)
study further##5##2##(1993-6#1)(1994-8#1)(2008-7#1)(2009-8#1)(2012-3#1)
study gives##2##2##(2008-10#2)
study group and##2##3##(2011-1#1)(2011-2#1)
study group comprised##3##3##(1991-12#1)(2009-6#1)(2013-1#1)
study group##18##2##(1990-11#1)(1991-12#1)(1992-11#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#4)
study groups##4##2##(1991-11#1)(1991-8#1)(2008-7#1)(2010-4#1)
study had##6##2##(1990-6#1)(1991-5#1)(1992-2#1)(1994-3#1)(2013-1#1)(2013-8#1)
study has been carried out##5##5##(1990-9#1)(2008-10#2)(2008-3#2)
study has been##13##3##(1990-9#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#2)(2011-2#1)
study has demonstrated##2##3##(2011-2#2)
study has found##2##3##(1997-2#1)(2011-2#1)
study has provided##2##3##(2008-9#1)(2013-1#1)
study has revealed that##2##4##(1993-11#1)(1997-1#1)
study has revealed##3##3##(1993-11#1)(1997-1#1)(1997-3#1)
study has shown that##5##4##(1997-4#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)
study has##49##2##(1990-9#1)(1991-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
study have shown that the##2##5##(2008-1#1)(2008-10#1)
study have shown that##3##4##(2008-1#2)(2008-10#1)
study have##13##2##(2008-1#2)(2008-10#5)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
study highlights the importance of##3##5##(2008-10#2)(2008-5#1)
study highlights the##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
study highlights##9##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
study hospitals##2##2##(1991-3#1)(1996-3#1)
study how##5##2##(1994-11#1)(2008-10#2)(2008-8#2)
study identified##5##2##(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
study identifies##2##2##(1996-1#1)(1997-2#1)
study illustrates##2##2##(2008-9#1)(2013-1#1)
study in Korea##2##3##(2009-8#1)(2010-6#1)
study in a##4##3##(1990-11#1)(1993-5#1)(2008-7#1)(2011-2#1)
study in patients with##2##4##(1997-8#1)(2008-7#1)
study in patients##3##3##(1997-8#1)(2008-7#1)(2012-12#1)
study in the##5##3##(1995-12#1)(2008-10#3)(2008-5#1)
study in three##2##3##(1995-3#1)(2008-10#1)
study in which we##2##4##(2008-6#1)(2010-9#1)
study in which##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-10#1)(2010-9#1)
study in##82##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-3#1)(1991-6#4)(1991-8#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-3#1)(1997-8#2)(2008-1#1)(2008-10#13)(2008-11#6)(2008-2#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#3)(2010-10#3)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#4)
study include##3##2##(2008-12#1)(2008-8#2)
study included 100##2##3##(1993-11#1)(2008-11#1)
study included a##2##3##(1991-1#1)(2013-1#1)
study included##28##2##(1990-2#1)(1991-1#1)(1991-6#1)(1992-2#1)(1993-11#1)(1994-1#1)(1994-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-12#2)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
study includes##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
study indicate that the##6##4##(1996-3#1)(2006-6#1)(2008-10#2)(2008-12#1)(2009-7#1)
study indicate that##19##3##(1990-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#6)(2008-12#2)(2009-7#1)(2011-2#1)(2013-1#1)
study indicate the##2##3##(2008-11#1)(2008-12#1)
study indicate##21##2##(1990-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-12#3)(2009-7#1)(2011-2#1)(2013-1#1)
study indicated that the##7##4##(1994-3#1)(2008-10#3)(2008-6#1)(2008-9#2)
study indicated that##14##3##(1993-8#1)(1994-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#3)(2012-3#1)
study indicated##17##2##(1993-8#1)(1994-3#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#3)(2010-8#1)(2012-3#1)
study indicates that the##2##4##(1996-12#1)(2013-1#1)
study indicates that##17##3##(1993-2#1)(1994-12#1)(1996-12#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
study indicates the##2##3##(1990-2#1)(1995-11#1)
study indicates##22##2##(1990-2#1)(1993-2#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-6#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
study investigated the##25##3##(1991-9#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-7#3)(2010-10#1)(2010-11#1)(2010-9#1)(2011-10#1)(2011-2#3)(2013-1#2)
study investigated whether##5##3##(1994-8#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-2#1)
study investigated##42##2##(1991-2#1)(1991-7#1)(1991-9#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-10#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
study investigates the##9##3##(1991-12#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
study investigates##12##2##(1991-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
study investigating the##2##3##(2008-11#1)(2010-7#1)
study investigating##3##2##(2008-11#1)(2009-7#1)(2010-7#1)
study involved##10##2##(1991-9#1)(1996-1#1)(1996-9#1)(2008-11#3)(2009-9#1)(2011-2#2)(2012-4#1)
study involves the##2##3##(1997-2#1)(2011-3#1)
study involves##3##2##(1997-2#1)(2008-5#1)(2011-3#1)
study involving##6##2##(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#2)
study is a retrospective##2##4##(2008-7#1)(2011-2#1)
study is a##7##3##(2008-1#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
study is an##7##3##(1997-3#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2013-1#2)
study is based on##2##4##(1991-12#1)(2010-10#1)
study is focused on##2##4##(1994-5#1)(2008-11#1)
study is limited by##2##4##(1991-3#1)(2008-12#1)
study is made##2##3##(2008-10#2)
study is needed to##3##4##(2008-9#1)(2010-10#1)(2012-3#1)
study is needed##4##3##(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
study is part of a##2##5##(1992-1#1)(2008-10#1)
study is presented##2##3##(1997-5#1)(2008-10#1)
study is required to##2##4##(1992-12#1)(2011-2#1)
study is required##3##3##(1992-12#1)(2011-2#2)
study is that##5##3##(1997-8#1)(2008-3#1)(2009-6#1)(2013-1#1)(2013-8#1)
study is the first to show##2##6##(2011-2#1)(2013-3#1)
study is the first to##5##5##(1993-1#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-3#1)
study is the first##7##4##(1993-1#1)(2008-11#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-3#1)
study is the##13##3##(1993-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-5#1)(2013-3#1)
study is to analyze the##2##5##(2011-7#1)(2013-1#1)
study is to assess the##5##5##(2008-11#2)(2008-5#1)(2012-3#2)
study is to assess##7##4##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-3#2)
study is to compare efficiency and safety of##2##8##(2012-3#2)
study is to compare##3##4##(2008-10#1)(2012-3#2)
study is to describe the##3##5##(1993-1#1)(2010-7#1)(2011-2#1)
study is to describe##4##4##(1993-1#1)(2008-11#1)(2010-7#1)(2011-2#1)
study is to determine the##2##5##(2008-11#1)(2013-1#1)
study is to determine##4##4##(2008-11#1)(2011-2#2)(2013-1#1)
study is to evaluate##8##4##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#3)(2013-1#2)
study is to examine##4##4##(2008-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
study is to explore the##2##5##(2008-11#1)(2011-3#1)
study is to investigate the effects##2##6##(2008-10#1)(2011-3#1)
study is to investigate the##5##5##(2008-10#1)(2008-5#1)(2010-12#1)(2011-3#2)
study is to investigate##8##4##(2008-10#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-3#2)(2012-3#1)
study is to present##4##4##(1996-1#1)(1997-3#1)(2011-2#1)(2012-12#1)
study is to show##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
study is to##75##3##(1992-2#1)(1993-1#1)(1993-3#1)(1996-1#1)(1997-3#1)(2008-10#10)(2008-11#6)(2008-12#2)(2008-5#3)(2008-7#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#5)(2011-7#1)(2012-12#2)(2012-3#8)(2013-1#7)(2013-8#4)
study is##164##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-3#1)(1994-5#1)(1996-1#2)(1997-3#2)(1997-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#11)(2008-12#3)(2008-3#4)(2008-5#6)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#2)(2011-2#17)(2011-3#6)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#12)(2012-5#1)(2013-1#14)(2013-3#1)(2013-8#8)
study it##5##2##(1994-11#1)(1996-12#1)(2008-1#1)(2008-11#1)(2012-2#1)
study its##6##2##(1994-9#1)(1995-8#1)(2008-10#2)(2008-8#1)(2013-7#1)
study may be used##2##4##(2008-10#1)(2013-1#1)
study may be##4##3##(1996-2#1)(2008-10#2)(2013-1#1)
study may##10##2##(1996-2#1)(2008-10#3)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
study measured the effect of##2##5##(1995-1#1)(2008-12#1)
study measured the##3##3##(1995-1#1)(1996-2#1)(2008-12#1)
study measured##5##2##(1995-1#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-9#1)
study methodology##2##2##(2008-12#1)(2009-9#1)
study of 10##2##3##(1994-3#1)(2008-10#1)
study of 2##2##3##(1992-6#1)(1993-6#1)
study of 30##2##3##(2008-10#1)(2008-8#1)
study of 38##2##3##(2008-7#1)(2011-2#1)
study of 4771 patients##2##4##(2008-6#2)
study of 70##2##3##(1990-2#1)(1996-3#1)
study of Cd(II)##2##3##(2008-10#2)
study of QTLs##2##3##(2008-9#2)
study of a school-based##2##4##(2010-12#1)(2012-2#1)
study of a##23##3##(1991-2#1)(1992-12#1)(1994-1#1)(1994-5#1)(1997-2#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-9#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)
study of adaptive radiations##2##4##(2008-8#2)
study of all##4##3##(1995-1#1)(2007-12#1)(2010-3#1)(2012-2#1)
study of an##9##3##(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-3#1)(2013-1#1)(2013-8#2)
study of apoptosis##2##3##(2008-9#1)(2013-1#1)
study of cell##2##3##(1995-11#1)(2008-9#1)
study of clinical##2##3##(1994-12#1)(2007-8#1)
study of critical##2##3##(2008-11#2)
study of different##2##3##(2008-10#2)
study of diispropylcarbodiimide##2##3##(2008-9#2)
study of eight##2##3##(2008-11#1)(2011-2#1)
study of four##3##3##(2008-7#2)(2010-12#1)
study of human##5##3##(2007-12#1)(2008-10#1)(2012-2#1)(2012-3#2)
study of interferences##2##3##(2008-10#2)
study of interfering##2##3##(2008-10#2)
study of its##3##3##(1992-3#1)(1994-11#1)(2008-10#1)
study of normal##2##3##(1996-11#1)(1997-5#1)
study of nursing##3##3##(1990-2#1)(2008-12#1)(2010-10#1)
study of patients##2##3##(1992-9#1)(1993-11#1)
study of plant##2##3##(2008-10#1)(2008-11#1)
study of pretreatment methods for the determination of##2##8##(2008-10#2)
study of proteinaceous binding media##2##5##(2008-10#2)
study of reaction between##2##4##(2008-10#2)
study of robustness##2##3##(2008-10#2)
study of some##2##3##(2008-10#1)(2008-12#1)
study of specific##2##3##(1995-11#1)(2008-7#1)
study of synaptic plasticity in##2##5##(2008-4#2)
study of synaptic plasticity##3##4##(2008-4#3)
study of the adsorption##3##4##(2008-10#3)
study of the analytical##3##4##(2008-10#3)
study of the characteristics##2##4##(2008-10#1)(2008-7#1)
study of the development of##2##5##(2008-10#1)(2008-12#1)
study of the development##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
study of the effect of##7##5##(1991-2#1)(2008-10#3)(2008-7#1)(2011-2#1)(2011-3#1)
study of the effects##3##4##(1995-2#1)(2008-10#1)(2011-1#1)
study of the enzyme##2##4##(1995-6#1)(2008-10#1)
study of the experiences of##3##5##(2008-11#1)(2008-9#1)(2013-1#1)
study of the inclusion##2##4##(2008-10#2)
study of the interaction of##2##5##(2008-10#2)
study of the interaction##3##4##(2008-10#3)
study of the main##3##4##(2008-10#3)
study of the molecular##4##4##(1997-7#1)(2008-10#2)(2009-3#1)
study of the oxidation##2##4##(2008-10#2)
study of the physiological##2##4##(2008-5#2)
study of the reaction##2##4##(2008-10#2)
study of the reduction of##2##5##(2008-10#2)
study of the reduction##3##4##(2008-10#2)(2008-8#1)
study of the relationship between##2##5##(2008-7#1)(2011-10#1)
study of the relationship##3##4##(2008-10#1)(2008-7#1)(2011-10#1)
study of the simultaneous##2##4##(2008-10#1)(2009-7#1)
study of the use of##2##5##(2008-10#1)(2009-3#1)
study of the##183##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#87)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#7)(2009-3#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-10#2)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)
study of thermal##2##3##(2008-10#2)
study of these##7##3##(1993-9#1)(2008-10#3)(2008-11#1)(2009-8#1)(2013-1#1)
study of treatment##2##3##(1990-2#1)(1993-2#1)
study of tumor##2##3##(1995-10#1)(2008-11#1)
study of two##4##3##(1991-12#1)(2008-10#2)(2011-2#1)
study of various##4##3##(2008-10#3)(2008-7#1)
study of##724##2##(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-6#2)(1992-9#2)(1993-1#5)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#5)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#3)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#2)(1995-1#4)(1995-10#3)(1995-11#4)(1995-2#3)(1995-5#2)(1995-6#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#7)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(2006-6#1)(2007-12#6)(2007-8#2)(2008-1#3)(2008-10#235)(2008-11#40)(2008-12#11)(2008-2#5)(2008-3#15)(2008-4#10)(2008-5#16)(2008-6#4)(2008-7#23)(2008-8#16)(2008-9#25)(2009-1#4)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#1)(2011-10#2)(2011-2#20)(2011-3#7)(2012-12#6)(2012-2#13)(2012-3#23)(2013-1#15)(2013-8#13)
study offers a##2##3##(1996-6#1)(2012-2#1)
study on a##7##3##(1993-6#1)(2008-10#2)(2008-8#2)(2009-3#1)(2013-1#1)
study on primary##2##3##(2008-8#1)(2013-8#1)
study on the determination of##2##5##(2008-10#2)
study on the effect of##4##5##(1990-12#1)(2008-10#1)(2010-3#1)(2012-3#1)
study on the interaction of##3##5##(2008-10#2)(2008-9#1)
study on the interaction##4##4##(2008-10#3)(2008-9#1)
study on the##49##3##(1990-12#2)(1990-2#2)(1990-5#1)(1991-2#1)(1994-5#1)(1995-9#1)(1996-12#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#3)(2013-1#2)
study on their##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
study on##127##2##(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-8#1)(2008-10#27)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#5)(2008-7#5)(2008-8#14)(2008-9#6)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#5)(2013-1#7)(2013-8#3)
study opens##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
study or##3##2##(1991-1#1)(1997-7#1)(2010-11#1)
study over##2##2##(1996-11#1)(2008-10#1)
study participants##10##2##(1994-2#1)(2008-12#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
study participants'##2##2##(2011-2#1)(2012-3#1)
study participation##3##2##(2008-3#1)(2009-4#1)(2013-1#1)
study patients##6##2##(1993-12#1)(2008-1#2)(2010-12#1)(2013-1#2)
study performed##4##2##(1990-9#1)(2008-12#1)(2008-5#2)
study period##25##2##(1992-5#1)(1994-12#1)(1997-5#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#1)
study periods##2##2##(2010-11#1)(2011-2#1)
study population of##2##3##(1990-2#1)(2011-2#1)
study population was##4##3##(2008-1#1)(2008-7#1)(2010-1#1)(2013-1#1)
study population##16##2##(1990-2#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
study populations##3##2##(2008-11#1)(2008-8#1)(2009-7#1)
study presented##2##2##(1995-3#1)(2008-12#1)
study presents a##5##3##(2008-10#2)(2009-8#1)(2010-10#1)(2011-2#1)
study presents the##3##3##(1991-3#1)(2011-2#1)(2013-8#1)
study presents##11##2##(1991-3#1)(1997-3#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
study proposed a##2##3##(2011-2#1)(2013-1#1)
study proposed##3##2##(2010-11#1)(2011-2#1)(2013-1#1)
study proposes##2##2##(2008-10#1)(2009-10#1)
study protocol##3##2##(1997-5#1)(2011-2#1)(2013-1#1)
study provide##3##2##(2008-10#2)(2008-12#1)
study provided##8##2##(2008-1#1)(2008-5#1)(2008-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)
study provides a##5##3##(2008-10#2)(2010-12#1)(2010-8#1)(2012-3#1)
study provides evidence for##3##4##(1994-8#1)(2013-1#1)(2013-8#1)
study provides evidence that##2##4##(2008-10#1)(2008-9#1)
study provides evidence##6##3##(1994-8#1)(2008-10#2)(2008-9#1)(2013-1#1)(2013-8#1)
study provides for the first time##2##6##(2011-2#1)(2012-2#1)
study provides novel##2##3##(2008-10#1)(2013-1#1)
study provides##31##2##(1994-8#2)(2008-10#11)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
study questions##2##2##(1994-2#1)(2011-2#1)
study recommends##2##2##(2008-10#1)(2008-11#1)
study reported here##3##3##(2008-12#1)(2010-5#1)(2013-8#1)
study reported##7##2##(1997-2#1)(2008-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
study reports a##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
study reports on the##3##4##(1994-2#1)(2008-7#1)(2008-9#1)
study reports##18##2##(1991-2#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2012-7#1)(2013-1#3)
study results##11##2##(1992-12#1)(1993-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#2)(2010-7#1)
study revealed a##3##3##(1994-12#1)(2008-11#1)(2008-12#1)
study revealed that the##3##4##(2008-10#1)(2008-3#1)(2009-7#1)
study revealed that##16##3##(1995-12#1)(1996-1#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2012-2#1)
study revealed the##2##3##(2008-7#1)(2012-3#1)
study revealed##27##2##(1994-12#1)(1995-12#1)(1996-1#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#2)(2009-7#1)(2012-2#2)(2012-3#2)
study reveals a##2##3##(2008-10#1)(2012-2#1)
study reveals that the##3##4##(1991-3#1)(2008-1#1)(2009-5#1)
study reveals that##6##3##(1991-3#1)(2008-1#1)(2008-10#1)(2009-5#1)(2013-1#2)
study reveals##11##2##(1991-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#1)(2012-2#2)(2013-1#3)
study reviews##4##2##(1995-2#1)(1996-1#1)(2012-2#2)
study seeks to##2##3##(1995-12#1)(2013-8#1)
study several##2##2##(2008-10#1)(2009-11#1)
study should be##5##3##(1991-12#1)(1995-5#1)(1996-8#1)(2008-10#1)(2010-4#1)
study should prove useful##2##4##(2008-10#1)(2012-2#1)
study should##10##2##(1991-12#1)(1995-5#1)(1996-8#1)(2008-10#2)(2008-12#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
study show that##6##3##(1994-3#1)(2008-10#2)(2008-12#1)(2010-7#1)(2013-1#1)
study show##7##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-7#1)(2013-1#1)
study showed a##6##3##(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-6#1)(2013-1#1)
study showed no##2##3##(2008-10#1)(2008-11#1)
study showed that both##2##4##(2008-5#1)(2008-7#1)
study showed that the##15##4##(1990-11#1)(2008-1#2)(2008-10#5)(2008-5#2)(2011-2#3)(2013-8#2)
study showed that##42##3##(1990-11#1)(1990-2#1)(2008-1#2)(2008-10#11)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-3#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#4)
study showed##65##2##(1990-11#1)(1990-2#1)(1990-6#1)(1992-12#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#3)(2013-8#5)
study showing##2##2##(2008-10#1)(2010-5#1)
study shows a##2##3##(1996-3#1)(2012-12#1)
study shows how##2##3##(1993-2#1)(2008-7#1)
study shows that a##2##4##(2008-10#1)(2010-6#1)
study shows that by##2##4##(2008-12#1)(2009-3#1)
study shows that the##5##4##(2008-1#1)(2008-5#2)(2008-7#1)(2012-3#1)
study shows that##29##3##(1990-8#1)(1991-12#2)(1992-12#1)(1993-1#1)(1993-2#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#3)(2012-3#2)(2013-1#2)
study shows the##2##3##(2008-7#1)(2008-9#1)
study shows##39##2##(1990-8#1)(1991-12#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#2)(1996-3#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-7#4)(2008-9#2)(2009-3#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
study sites##6##2##(2008-10#2)(2008-12#2)(2009-5#1)(2012-12#1)
study sought to##12##3##(2008-11#4)(2008-5#1)(2008-9#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-3#2)
study subjects##3##2##(2008-12#1)(2011-2#2)
study suggest that the##2##4##(1992-12#1)(1994-2#1)
study suggest that##27##3##(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#1)
study suggested that##6##3##(1992-2#1)(1995-8#1)(2008-6#1)(2011-3#1)(2013-1#1)(2013-8#1)
study suggested##7##2##(1992-2#1)(1995-8#1)(2008-6#1)(2009-5#1)(2011-3#1)(2013-1#1)(2013-8#1)
study suggests that a##2##4##(2008-1#1)(2008-10#1)
study suggests that the##12##4##(1991-3#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-8#2)(2011-2#3)(2013-1#1)
study suggests that##31##3##(1990-12#1)(1990-8#1)(1991-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
study suggests##33##2##(1990-12#1)(1990-8#1)(1991-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
study supports the##4##3##(2008-11#1)(2008-7#1)(2010-10#1)(2012-3#1)
study supports##7##2##(1996-2#1)(2008-11#1)(2008-7#2)(2010-10#1)(2010-3#1)(2012-3#1)
study takes##2##2##(2008-3#1)(2011-2#1)
study tested the##4##3##(1993-6#1)(1995-12#1)(2009-10#1)(2010-2#1)
study tested##6##2##(1993-6#1)(1995-12#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#1)
study tests##3##2##(1995-2#1)(2008-9#1)(2010-10#1)
study that the##2##3##(1995-12#1)(2011-2#1)
study that##20##2##(1990-11#1)(1991-1#1)(1994-8#1)(1995-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
study the consequences of##2##4##(2008-10#1)(2008-8#1)
study the effect of a##2##5##(1991-6#1)(2008-9#1)
study the effect of##22##4##(1991-6#1)(1992-3#1)(1993-8#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#7)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
study the effects of##14##4##(1992-6#1)(1993-1#1)(1997-3#1)(2006-6#1)(2008-10#5)(2008-5#1)(2010-5#1)(2011-3#1)(2012-2#1)(2012-3#1)
study the effects##15##3##(1992-6#1)(1993-1#1)(1993-12#1)(1997-3#1)(2006-6#1)(2008-10#5)(2008-5#1)(2010-5#1)(2011-3#1)(2012-2#1)(2012-3#1)
study the efficacy of##2##4##(2008-12#1)(2008-5#1)
study the evolution of##2##4##(2008-8#2)
study the expression##2##3##(2008-9#2)
study the feasibility##2##3##(2008-10#1)(2008-8#1)
study the frequency##2##3##(2007-12#1)(2008-10#1)
study the function of##4##4##(1995-8#1)(2008-8#1)(2008-9#2)
study the gene##2##3##(2008-10#1)(2008-9#1)
study the genetic##2##3##(2008-10#1)(2010-4#1)
study the influence of##8##4##(1991-8#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
study the molecular##4##3##(1991-6#1)(1997-2#1)(2008-10#2)
study the origin and##2##4##(1995-11#1)(2008-10#1)
study the physiology##2##3##(1992-9#1)(2008-9#1)
study the possible mechanism of##2##5##(2008-10#1)(2009-12#1)
study the possible##3##3##(1991-9#1)(2008-10#1)(2009-12#1)
study the relationship between the##2##5##(2008-10#1)(2008-6#1)
study the relationship between##4##4##(1991-11#1)(2008-10#2)(2008-6#1)
study the relationship##7##3##(1991-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#2)
study the role of##9##4##(1993-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
study the use of##2##4##(2008-10#2)
study the##261##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#6)(1994-11#1)(1994-5#4)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#87)(2008-11#17)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#15)(2008-9#15)(2009-1#1)(2009-12#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-10#1)(2011-2#6)(2011-3#3)(2011-7#1)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#6)
study their##3##2##(1996-3#1)(2008-10#2)
study these##3##2##(2008-11#1)(2008-3#1)(2009-7#1)
study this##10##2##(1991-12#1)(1993-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-12#1)(2013-1#1)
study thus##4##2##(1994-8#1)(1995-11#1)(2008-10#2)
study to assess the effect of##2##6##(2009-6#1)(2012-3#1)
study to assess the##5##4##(2009-12#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
study to assess##7##3##(2008-10#1)(2008-5#1)(2009-12#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
study to be##2##3##(2008-10#2)
study to determine##6##3##(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)
study to evaluate the##6##4##(2008-5#2)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
study to evaluate##11##3##(1990-2#1)(2008-10#1)(2008-5#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#3)
study to examine##2##3##(2008-12#1)(2008-8#1)
study to identify##3##3##(1990-11#1)(2008-10#1)(2010-11#1)
study to test##2##3##(1997-3#1)(2008-11#1)
study to##56##2##(1990-11#1)(1990-2#1)(1991-7#1)(1992-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#1)
study undertaken##2##2##(2008-11#1)(2008-7#1)
study used a mixed method##2##5##(2013-1#2)
study used a##5##3##(2008-11#1)(2008-12#1)(2009-4#1)(2013-1#2)
study used##12##2##(1990-6#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-4#1)(2013-1#3)
study uses a##2##3##(2009-5#1)(2010-7#1)
study uses##9##2##(1995-2#2)(1997-3#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-7#1)
study using a##4##3##(1995-2#1)(2008-10#1)(2008-5#1)(2009-8#1)
study using focus groups was##2##5##(2008-11#1)(2008-12#1)
study using focus##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
study using##21##2##(1994-8#1)(1995-2#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)
study utilized##2##2##(1993-2#1)(1994-2#1)
study utilizing##4##2##(1993-3#1)(2008-10#1)(2008-11#1)(2010-9#1)
study was a##5##3##(2008-9#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
study was aimed at##3##4##(1994-2#1)(1994-8#1)(2011-2#1)
study was aimed to##5##4##(1991-6#1)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
study was aimed##8##3##(1991-6#1)(1994-2#1)(1994-8#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
study was also##4##3##(1994-8#1)(2008-10#2)(2011-2#1)
study was based on a##2##5##(1990-9#1)(2010-11#1)
study was based on##4##4##(1990-9#1)(2008-11#1)(2008-5#1)(2010-11#1)
study was carried out in##4##5##(2012-12#2)(2012-3#1)(2013-8#1)
study was carried out on##7##5##(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#2)
study was carried out to determine##3##6##(1994-3#1)(2008-7#1)(2011-2#1)
study was carried out to evaluate##2##6##(1990-11#1)(1990-2#1)
study was carried out to investigate the##2##7##(1991-6#1)(2008-12#1)
study was carried out to investigate##3##6##(1991-6#1)(2008-11#1)(2008-12#1)
study was carried out to##12##5##(1990-11#1)(1990-2#1)(1991-6#1)(1994-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
study was carried out using##2##5##(2008-11#1)(2012-2#1)
study was carried out##35##4##(1990-11#1)(1990-2#1)(1991-6#1)(1991-8#2)(1992-12#1)(1994-3#1)(1996-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#3)(2010-4#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#2)
study was closed##2##3##(1990-12#1)(1992-2#1)
study was completed##3##3##(1991-12#1)(1994-3#1)(2008-11#1)
study was comprised of##3##4##(2008-10#2)(2013-1#1)
study was conducted at the##2##5##(1994-1#1)(2008-12#1)
study was conducted in a##3##5##(2009-12#1)(2009-5#1)(2012-2#1)
study was conducted in##10##4##(1992-2#1)(1993-1#1)(1997-7#1)(2008-5#1)(2009-12#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
study was conducted on##4##4##(2008-10#1)(2011-2#1)(2012-2#1)(2012-5#1)
study was conducted to assess##2##5##(2008-10#2)
study was conducted to compare the##2##6##(2012-12#1)(2012-2#1)
study was conducted to determine the##2##6##(1995-1#1)(2008-11#1)
study was conducted to determine##4##5##(1995-1#1)(1995-8#1)(2008-10#1)(2008-11#1)
study was conducted to evaluate the##5##6##(2008-10#2)(2008-11#1)(2010-4#1)(2012-2#1)
study was conducted to evaluate##7##5##(2008-10#2)(2008-11#1)(2008-7#2)(2010-4#1)(2012-2#1)
study was conducted to examine##2##5##(2008-10#1)(2008-11#1)
study was conducted to explore##2##5##(2008-11#1)(2009-5#1)
study was conducted to identify the##2##6##(1995-10#1)(2008-10#1)
study was conducted to identify##3##5##(1995-10#1)(2008-10#1)(2010-11#1)
study was conducted to investigate the effect of##2##8##(2008-12#1)(2011-2#1)
study was conducted to investigate the##4##6##(2008-10#1)(2008-12#1)(2011-2#2)
study was conducted to provide##2##5##(1990-12#1)(2008-10#1)
study was conducted to test the hypothesis##2##7##(1991-2#1)(2012-2#1)
study was conducted to test##3##5##(1991-2#1)(2008-10#1)(2012-2#1)
study was conducted to##39##4##(1990-12#1)(1991-2#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-2#1)(2008-10#11)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)
study was conducted using a##2##5##(2008-10#1)(2013-1#1)
study was conducted using##4##4##(2008-10#2)(2009-5#1)(2013-1#1)
study was conducted##65##3##(1990-12#1)(1991-2#1)(1992-2#1)(1993-1#1)(1994-1#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#17)(2008-11#5)(2008-12#4)(2008-5#2)(2008-7#2)(2009-12#1)(2009-5#3)(2010-11#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#3)(2013-7#1)
study was designed as a##2##5##(2010-3#1)(2013-1#1)
study was designed to compare the##5##6##(1991-12#1)(1996-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
study was designed to compare##6##5##(1991-12#1)(1996-3#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
study was designed to determine the##2##6##(1990-5#1)(2012-3#1)
study was designed to determine##3##5##(1990-5#1)(1994-2#1)(2012-3#1)
study was designed to examine the##3##6##(1992-2#1)(1992-8#1)(2008-10#1)
study was designed to examine##4##5##(1992-2#1)(1992-8#1)(1993-12#1)(2008-10#1)
study was designed to investigate the##6##6##(2008-10#1)(2009-8#1)(2011-2#3)(2012-12#1)
study was designed to investigate##7##5##(2008-10#1)(2009-8#1)(2011-2#4)(2012-12#1)
study was designed to##35##4##(1990-5#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#2)(2009-8#1)(2010-3#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#5)(2013-8#1)
study was designed##40##3##(1990-5#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-3#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
study was developed##2##3##(2008-10#1)(2012-3#1)
study was done in##2##4##(1997-8#1)(2011-2#1)
study was done to##3##4##(2008-12#1)(2008-5#1)(2010-7#1)
study was done##7##3##(1995-3#1)(1997-8#1)(2008-12#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
study was initiated##3##3##(2008-10#3)
study was made on the##2##5##(2008-10#1)(2008-8#1)
study was made on##3##4##(2008-10#2)(2008-8#1)
study was made##9##3##(1990-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
study was performed in##4##4##(1996-5#1)(2008-5#1)(2008-7#1)(2009-7#1)
study was performed on##4##4##(1990-6#1)(2008-10#2)(2008-12#1)
study was performed to evaluate the##2##6##(2008-1#1)(2008-10#1)
study was performed to##7##4##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-8#1)(2013-1#1)
study was performed##24##3##(1990-6#1)(1992-12#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-7#4)(2009-1#1)(2009-7#1)(2010-5#1)(2010-8#1)(2013-1#1)
study was planned as##2##4##(1990-6#1)(2010-7#1)
study was planned##4##3##(1990-6#1)(2010-7#1)(2012-3#1)(2013-1#1)
study was started##2##3##(1991-6#1)(2008-11#1)
study was the##5##3##(2007-11#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
study was therefore to##2##4##(1990-5#1)(2009-6#1)
study was therefore##4##3##(1990-5#1)(1994-12#1)(2009-6#1)(2010-10#1)
study was to analyse##4##4##(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
study was to analyze the##6##5##(1995-8#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-3#1)
study was to analyze##10##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#3)(2012-3#2)
study was to assess the##14##5##(1992-12#1)(2008-12#1)(2008-5#4)(2008-7#3)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
study was to assess##22##4##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#4)(2009-2#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
study was to characterize and##2##5##(2008-11#1)(2008-5#1)
study was to characterize##4##4##(1993-1#1)(2008-11#2)(2008-5#1)
study was to compare the##9##5##(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)
study was to compare##20##4##(1990-2#1)(1994-12#1)(1994-2#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#3)(2013-1#3)
study was to describe the##6##5##(2008-11#1)(2009-3#1)(2010-10#1)(2010-5#1)(2013-1#2)
study was to describe##9##4##(2008-11#1)(2008-12#1)(2009-3#1)(2010-10#1)(2010-5#2)(2011-7#1)(2013-1#2)
study was to determine if a##3##6##(1997-3#1)(2008-12#1)(2008-9#1)
study was to determine if##6##5##(1997-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-6#1)
study was to determine the effect of##4##7##(1991-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
study was to determine the effects of##5##7##(2008-10#1)(2008-5#1)(2010-4#1)(2010-6#1)(2013-8#1)
study was to determine the influence of##2##7##(2011-2#2)
study was to determine the##42##5##(1991-11#1)(1991-8#1)(1994-5#1)(2008-1#1)(2008-10#6)(2008-12#4)(2008-5#3)(2008-9#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#3)(2013-3#1)(2013-8#3)
study was to determine whether##12##5##(1990-8#1)(1994-11#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-3#2)
study was to determine which##3##5##(2008-11#1)(2012-2#1)(2013-1#1)
study was to determine##67##4##(1990-8#1)(1991-11#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#4)(2013-3#1)(2013-8#4)
study was to develop a##4##5##(2008-10#1)(2008-5#2)(2012-4#1)
study was to develop##15##4##(2008-10#4)(2008-11#4)(2008-5#3)(2010-9#1)(2011-2#1)(2012-2#1)(2012-4#1)
study was to establish a##2##5##(2010-6#1)(2013-1#1)
study was to establish##4##4##(2008-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
study was to evaluate effects of##2##6##(2008-12#1)(2010-7#1)
study was to evaluate the effect of##3##7##(2008-1#1)(2012-2#1)(2013-1#1)
study was to evaluate the effectiveness of##2##7##(2008-9#1)(2013-1#1)
study was to evaluate the##39##5##(1990-11#1)(1991-3#1)(1997-8#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#4)(2008-9#2)(2009-11#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#12)
study was to evaluate whether##4##5##(2008-11#1)(2008-7#1)(2010-11#1)(2013-1#1)
study was to evaluate##59##4##(1990-11#1)(1991-3#1)(1993-6#1)(1997-8#5)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-5#4)(2008-7#2)(2008-9#2)(2009-11#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#13)(2013-8#1)
study was to examine the effects of##3##7##(1991-12#1)(2013-8#2)
study was to examine the##25##5##(1991-12#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#3)
study was to examine##31##4##(1991-12#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-11#4)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
study was to explore the##3##5##(2008-12#1)(2010-11#1)(2011-2#1)
study was to explore##9##4##(2008-11#1)(2008-12#3)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
study was to further##3##4##(1992-12#1)(2008-11#1)(2011-2#1)
study was to identify the##8##5##(1994-5#1)(2008-1#1)(2008-12#1)(2009-1#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#1)
study was to identify##15##4##(1990-2#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-1#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#2)(2013-1#1)
study was to investigate the effect of##5##7##(2008-12#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)
study was to investigate the effectiveness of##2##7##(2013-1#2)
study was to investigate the effects of##5##7##(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
study was to investigate the effects##6##6##(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
study was to investigate the influence of##2##7##(2008-12#1)(2011-2#1)
study was to investigate the relationship between the##2##8##(2008-8#1)(2009-7#1)
study was to investigate the relationship between##5##7##(2008-8#1)(2009-7#2)(2013-1#1)(2013-8#1)
study was to investigate the##41##5##(1994-12#1)(1997-3#1)(2008-10#6)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
study was to investigate whether##3##5##(2008-11#1)(2011-2#1)(2013-1#1)
study was to investigate##59##4##(1993-2#1)(1994-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-12#4)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#7)(2013-8#1)
study was to localize the##2##5##(1993-8#1)(1995-2#1)
study was to measure the##2##5##(2008-5#1)(2010-10#1)
study was to provide##2##4##(1995-2#1)(2011-2#1)
study was to quantify##3##4##(1996-6#1)(2008-10#1)(2009-5#1)
study was to test##4##4##(1990-8#1)(1993-12#1)(2008-11#1)(2012-3#1)
study was to verify##4##4##(1996-3#1)(2008-10#1)(2008-7#1)(2010-9#1)
study was to##408##3##(1990-11#1)(1990-2#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-3#4)(1997-8#10)(2007-8#2)(2008-1#3)(2008-10#44)(2008-11#28)(2008-12#29)(2008-3#1)(2008-4#1)(2008-5#27)(2008-7#15)(2008-8#3)(2008-9#18)(2009-1#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#40)(2011-7#1)(2012-12#3)(2012-2#11)(2012-3#13)(2012-4#1)(2012-6#1)(2013-1#39)(2013-3#1)(2013-8#10)
study was undertaken on##2##4##(2012-2#1)(2012-3#1)
study was undertaken to compare##3##5##(1992-3#1)(2008-5#1)(2011-2#1)
study was undertaken to determine whether##2##6##(2008-10#1)(2008-6#1)
study was undertaken to determine##3##5##(2008-10#1)(2008-12#1)(2008-6#1)
study was undertaken to establish##3##5##(2008-10#1)(2012-2#2)
study was undertaken to evaluate the##3##6##(1996-1#1)(2008-11#1)(2008-12#1)
study was undertaken to investigate the##3##6##(1994-12#1)(2008-7#1)(2012-2#1)
study was undertaken to##24##4##(1991-12#1)(1992-3#1)(1994-12#1)(1996-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#3)(2012-2#3)
study was undertaken##29##3##(1990-12#1)(1991-12#1)(1992-3#1)(1994-12#1)(1996-1#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2011-2#3)(2012-2#4)(2012-3#1)
study was##712##2##(1990-11#2)(1990-12#3)(1990-2#5)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#3)(1992-1#1)(1992-12#4)(1992-2#4)(1992-3#2)(1992-8#1)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#4)(1994-3#3)(1994-5#2)(1994-8#3)(1995-1#2)(1995-10#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#3)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#3)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#11)(2007-11#2)(2007-8#2)(2008-1#5)(2008-10#104)(2008-11#44)(2008-12#43)(2008-3#2)(2008-4#1)(2008-5#41)(2008-6#2)(2008-7#28)(2008-8#5)(2008-9#19)(2009-1#3)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#10)(2010-11#7)(2010-12#1)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#3)(2010-6#6)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#6)(2011-2#72)(2011-7#1)(2012-12#10)(2012-2#27)(2012-3#31)(2012-4#1)(2012-5#1)(2012-6#1)(2013-1#50)(2013-3#1)(2013-7#1)(2013-8#13)
study we compared the##3##4##(1993-11#1)(1995-11#1)(2008-7#1)
study we conducted##2##3##(2008-11#1)(2012-2#1)
study we evaluated the##4##4##(1992-12#1)(1994-8#1)(1997-2#1)(2013-1#1)
study we examined the effects of##3##6##(1995-8#1)(1996-12#1)(2009-7#1)
study we examined##4##3##(1995-8#1)(1996-12#1)(2009-7#1)(2010-7#1)
study we have used##3##4##(1996-12#2)(2008-7#1)
study we have##15##3##(1992-10#1)(1994-2#1)(1995-12#2)(1996-12#2)(2008-11#2)(2008-7#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
study we identified##2##3##(2008-10#1)(2012-3#1)
study we investigated whether##2##4##(1995-8#1)(2010-6#1)
study we investigated##10##3##(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-7#1)(2013-8#1)
study we present##2##3##(1997-3#1)(2008-5#1)
study we show that##4##4##(1990-5#1)(1993-8#1)(1995-9#1)(2008-7#1)
study we used##4##3##(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#1)
study we wanted to compare##2##5##(2011-2#1)(2013-1#1)
study we wanted to##4##4##(2008-10#1)(2011-2#2)(2013-1#1)
study we##79##2##(1990-11#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#7)(2008-12#3)(2008-5#2)(2008-7#5)(2009-7#2)(2009-8#2)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#4)(2013-8#1)
study were similar to those of the vehicle control groups##2##10##(2008-9#2)
study were to evaluate the repeatability (r) and reproducibility (R) when different laboratories conduct the test##2##16##(2008-10#2)
study were to evaluate the##4##5##(2008-10#2)(2008-12#1)(2012-3#1)
study were to evaluate##6##4##(2008-10#3)(2008-12#1)(2009-8#1)(2012-3#1)
study were to examine the##3##5##(2008-11#1)(2010-11#1)(2012-2#1)
study were to identify##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
study were to##35##3##(2008-10#10)(2008-11#4)(2008-12#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#6)
study were##70##2##(1991-1#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1996-1#1)(1997-8#2)(2008-10#21)(2008-11#9)(2008-12#3)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#8)
study when##2##2##(2008-3#1)(2013-1#1)
study where##3##2##(1991-12#1)(2008-5#1)(2011-2#1)
study which##11##2##(1993-1#1)(1993-12#1)(1996-1#1)(1997-8#1)(2008-11#4)(2012-12#1)(2012-3#1)(2013-8#1)
study will be##2##3##(2008-10#1)(2010-11#1)
study will show that##3##4##(1994-3#2)(2008-5#1)
study will##17##2##(1994-3#3)(1994-8#1)(1996-3#1)(2008-10#4)(2008-5#3)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#1)
study with a##4##3##(1990-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
study with emphasis on##2##4##(1990-12#1)(2013-1#1)
study with healthy##2##3##(1991-8#2)
study with the##3##3##(1994-5#1)(2008-1#1)(2008-11#1)
study with##43##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#3)(1991-9#1)(1992-12#1)(1993-12#1)(1994-5#1)(1994-6#1)(1996-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
study would##4##2##(1993-2#1)(1994-5#1)(2009-10#1)(2011-7#1)
study##5748##1##(1990-11#16)(1990-12#16)(1990-2#24)(1990-3#8)(1990-5#11)(1990-6#18)(1990-8#11)(1990-9#14)(1991-1#14)(1991-11#11)(1991-12#33)(1991-2#32)(1991-3#22)(1991-4#1)(1991-5#4)(1991-6#15)(1991-7#4)(1991-8#20)(1991-9#8)(1992-1#11)(1992-10#2)(1992-11#2)(1992-12#28)(1992-2#18)(1992-3#11)(1992-4#2)(1992-5#2)(1992-6#8)(1992-8#2)(1992-9#10)(1993-1#26)(1993-11#9)(1993-12#25)(1993-2#24)(1993-3#28)(1993-5#1)(1993-6#13)(1993-8#17)(1993-9#5)(1994-1#12)(1994-11#17)(1994-12#25)(1994-2#29)(1994-3#31)(1994-5#16)(1994-6#11)(1994-8#33)(1994-9#2)(1995-1#19)(1995-10#4)(1995-11#14)(1995-12#31)(1995-2#37)(1995-3#12)(1995-5#7)(1995-6#8)(1995-8#18)(1995-9#8)(1996-1#25)(1996-10#1)(1996-11#6)(1996-12#33)(1996-2#26)(1996-3#26)(1996-5#4)(1996-6#13)(1996-8#6)(1996-9#5)(1997-1#8)(1997-2#24)(1997-3#36)(1997-4#9)(1997-5#6)(1997-6#1)(1997-7#10)(1997-8#35)(2006-6#3)(2007-11#8)(2007-12#18)(2007-8#9)(2008-1#42)(2008-10#1181)(2008-11#433)(2008-12#192)(2008-2#13)(2008-3#62)(2008-4#33)(2008-5#180)(2008-6#30)(2008-7#156)(2008-8#114)(2008-9#171)(2009-1#16)(2009-10#31)(2009-11#23)(2009-12#23)(2009-2#5)(2009-3#28)(2009-4#11)(2009-5#30)(2009-6#18)(2009-7#31)(2009-8#45)(2009-9#15)(2010-1#42)(2010-10#59)(2010-11#34)(2010-12#31)(2010-2#13)(2010-3#21)(2010-4#21)(2010-5#25)(2010-6#41)(2010-7#42)(2010-8#45)(2010-9#22)(2011-1#39)(2011-10#5)(2011-2#346)(2011-3#24)(2011-7#5)(2012-12#66)(2012-2#143)(2012-3#192)(2012-4#3)(2012-5#8)(2012-6#3)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#331)(2013-3#2)(2013-7#5)(2013-8#120)
study's findings##2##2##(1995-1#1)(2008-11#1)
study's##8##1##(1993-2#1)(1995-1#2)(2008-11#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#1)
study) and##2##2##(2008-10#1)(2013-1#1)
study)##14##1##(1991-3#1)(1992-2#1)(1995-12#1)(2008-10#3)(2008-7#1)(2008-9#3)(2009-3#1)(2011-2#1)(2013-1#2)
study]##24##1##(1990-3#2)(1990-5#1)(1990-9#1)(1991-3#3)(1992-5#1)(1993-2#1)(1994-6#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
studying cell##2##2##(1990-5#1)(2008-11#1)
studying changes in##2##3##(2008-10#1)(2008-8#1)
studying gene##2##2##(1993-9#1)(2008-4#1)
studying human##2##2##(1993-6#1)(2008-11#1)
studying its##2##2##(2008-10#2)
studying population dynamics##2##3##(2008-10#1)(2008-8#1)
studying the biological##2##3##(2008-4#1)(2008-9#1)
studying the effect of##5##4##(1991-8#1)(1995-11#1)(2008-10#3)
studying the effects of##4##4##(1995-2#1)(2008-11#1)(2008-6#1)(2012-12#1)
studying the impact of##2##4##(2012-12#1)(2012-3#1)
studying the regulation of##2##4##(1991-6#1)(1993-6#1)
studying the##67##2##(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-11#1)(1995-11#3)(1995-12#1)(1995-2#2)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#17)(2008-11#6)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#4)(2009-12#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
studying##152##1##(1990-5#3)(1991-6#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#5)(1996-12#1)(1996-2#3)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#37)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#12)(2008-9#8)(2009-12#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#4)(2013-8#1)
stuff##2##1##(1994-1#1)(2008-10#1)
stumbling##2##1##(2009-9#1)(2012-3#1)
stump of##2##2##(1991-6#1)(2008-12#1)
stump##9##1##(1991-6#3)(1992-9#2)(2008-10#2)(2008-12#2)
stumps##7##1##(2008-10#6)(2008-9#1)
stung##2##1##(1991-6#1)(2012-3#1)
stunned myocardium&quot##2##2##(1991-3#1)(2013-1#1)
stunned##3##1##(1991-3#1)(2013-1#2)
stunning##7##1##(1990-9#3)(1991-3#3)(2008-10#1)
stunning&quot##3##1##(1990-9#1)(1991-3#2)
stunt viroid##4##2##(2008-10#4)
stunt virus (PSV)##3##3##(2008-10#3)
stunt virus##17##2##(2008-10#17)
stunt##25##1##(2008-10#23)(2008-8#2)
stunted growth##2##2##(2008-10#2)
stunted##7##1##(2008-10#3)(2010-6#3)(2011-1#1)
stunting and##5##2##(2008-10#4)(2010-6#1)
stunting##20##1##(2008-10#16)(2009-8#1)(2010-6#2)(2011-1#1)
stupor##2##1##(1996-11#1)(1996-6#1)
sturdy##2##1##(1991-7#1)(1993-5#1)
style and##7##2##(1992-2#1)(2008-10#1)(2009-8#1)(2010-10#3)(2012-3#1)
style of##3##2##(1992-1#1)(2008-10#1)(2008-7#1)
style that##3##2##(1992-11#1)(2008-6#1)(2012-2#1)
style to##2##2##(1993-12#1)(2008-9#1)
style was##3##2##(2010-1#1)(2012-2#1)(2012-3#1)
style##58##1##(1991-1#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#5)(1993-12#2)(1994-1#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#11)(2010-10#7)(2010-5#1)(2012-2#4)(2012-3#2)
styles and##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2009-7#1)
styles of##4##2##(1997-6#1)(2008-10#2)(2009-11#1)
styles##28##1##(1990-9#1)(1992-2#1)(1996-12#1)(1997-3#2)(1997-6#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-4#1)(2008-9#1)(2009-11#3)(2009-7#3)(2009-8#1)(2013-1#2)
stylet##8##1##(2007-12#2)(2008-10#6)
stylets##3##1##(2007-12#2)(2008-10#1)
styling##4##1##(2008-5#4)
styloconicum##6##1##(2008-8#6)
styrene##18##1##(1994-8#1)(1996-5#3)(2008-10#6)(2008-11#1)(2008-12#5)(2008-3#2)
styrene-divinylbenzene copolymer##2##2##(2008-10#2)
styrene-divinylbenzene##4##1##(2008-10#4)
stysi##4##1##(2013-8#4)
su(f)##2##1##(1995-6#2)
sub group##3##2##(2007-8#1)(2008-11#2)
sub groups##2##2##(1997-1#1)(2008-11#1)
sub mug l(-1)##2##3##(2008-10#2)
sub##16##1##(1990-12#1)(1994-9#1)(1997-1#1)(2007-8#2)(2008-10#6)(2008-11#3)(2013-1#1)(2013-8#1)
sub-10-fs##2##1##(2007-11#2)
sub-Nernstian##3##1##(2008-10#3)
sub-Saharan Africa##8##2##(1995-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-2#1)(2013-1#1)
sub-Saharan##9##1##(1995-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-2#2)(2013-1#1)
sub-acute##2##1##(2008-10#2)
sub-boiling distillation##3##2##(2008-10#3)
sub-cellular##2##1##(2009-12#1)(2012-2#1)
sub-formulations##2##1##(2008-5#2)
sub-group of##2##2##(1995-11#1)(2008-10#1)
sub-groups##3##1##(2008-10#2)(2008-11#1)
sub-injection##2##1##(2008-10#2)
sub-isoforms##3##1##(2008-10#3)
sub-lethal##2##1##(1996-12#1)(2007-12#1)
sub-microgram##2##1##(1990-2#1)(1993-8#1)
sub-micron##2##1##(2008-10#1)(2010-4#1)
sub-nanogram levels##3##2##(2008-10#3)
sub-nanogram per liter##3##3##(2008-10#3)
sub-nanogram per##4##2##(2008-10#4)
sub-nanogram##9##1##(2008-10#9)
sub-nanogram/gram##2##1##(2008-10#2)
sub-ng##3##1##(2008-10#3)
sub-optimal##2##1##(2008-11#2)
sub-physiological##3##1##(2008-11#3)
sub-population##3##1##(2008-11#2)(2013-1#1)
sub-populations##7##1##(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#1)
sub-sample##11##1##(2008-10#7)(2008-12#1)(2010-8#1)(2013-1#2)
sub-samples##2##1##(2008-10#2)
sub-scale##2##1##(1992-1#1)(2008-11#1)
subacromial##2##1##(2008-12#1)(2010-9#1)
subacute and chronic occlusions##2##4##(2011-2#2)
subacute and chronic##3##3##(2011-2#3)
subacute##19##1##(1991-11#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2010-9#1)(2011-2#4)(2012-3#1)(2013-1#1)
subadult##3##1##(1997-9#1)(2010-4#2)
subadventitial layer of##3##3##(2011-2#3)
subapical##3##1##(1995-2#1)(2008-10#2)
subarachnoid haemorrhage (SAH)##5##3##(2008-7#5)
subarachnoid haemorrhage and##3##3##(2008-7#3)
subarachnoid haemorrhage##20##2##(1996-9#3)(1997-3#1)(2008-7#16)
subarachnoid hemorrhage (SAH)##3##3##(2012-3#2)(2013-8#1)
subarachnoid hemorrhage##15##2##(1991-8#1)(1995-11#4)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#5)(2013-8#1)
subarachnoid##50##1##(1991-8#1)(1995-11#5)(1996-9#3)(1997-3#1)(2007-8#1)(2008-12#1)(2008-7#26)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#6)(2013-8#1)
subband##2##1##(1997-8#2)
subcapsular hematoma##3##2##(2010-11#2)(2012-3#1)
subcapsular##8##1##(1990-5#1)(2010-11#2)(2011-2#1)(2012-2#2)(2012-3#2)
subcategories##3##1##(1990-12#2)(1991-12#1)
subcategory##4##1##(1990-12#2)(1991-12#1)(2010-5#1)
subcellular compartments##2##2##(1990-5#1)(2008-9#1)
subcellular fractionation##5##2##(1990-5#2)(1995-6#2)(2008-4#1)
subcellular fractions##3##2##(1990-5#1)(1993-8#1)(1995-8#1)
subcellular localization of##6##3##(1992-6#1)(1994-9#1)(1996-2#1)(2008-7#1)(2009-8#1)(2011-2#1)
subcellular localization##13##2##(1992-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-6#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)
subcellular##38##1##(1990-5#4)(1992-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-2#2)(1996-6#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#4)(2008-7#2)(2008-9#4)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#3)
subchondral erosions in##2##3##(2011-2#2)
subchondral erosions##3##2##(2011-2#3)
subchondral##5##1##(2011-2#5)
subchronic##2##1##(2008-10#1)(2013-8#1)
subclades##2##1##(2008-10#2)
subclass##9##1##(1991-5#1)(1993-12#1)(1993-6#1)(1997-1#1)(2008-3#3)(2009-4#1)(2011-2#1)
subclasses of##2##2##(1996-2#1)(2008-11#1)
subclasses##5##1##(1996-2#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-6#1)
subclavian artery aneurysm##2##3##(2010-5#2)
subclavian artery##15##2##(1993-3#3)(1997-8#1)(2008-11#3)(2008-7#5)(2010-5#2)(2010-7#1)
subclavian##22##1##(1993-3#3)(1997-8#1)(2008-11#4)(2008-12#3)(2008-7#6)(2010-5#2)(2010-7#1)(2011-2#2)
subclinical cryptosporidiosis##4##2##(1996-12#4)
subclinical hypothyroidism (TSH##2##3##(2012-3#2)
subclinical##21##1##(1996-12#5)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-7#1)(2009-10#1)(2011-2#3)(2012-3#2)(2013-1#2)
subcloned into the expression vector pT7-7##2##6##(1994-5#2)
subcloned into the##4##3##(1994-5#2)(2008-10#1)(2008-11#1)
subcloned into##6##2##(1994-5#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
subcloned##9##1##(1990-5#1)(1991-9#1)(1992-3#1)(1994-5#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
subclones##6##1##(1993-1#1)(2008-10#1)(2008-11#3)(2008-8#1)
subcloning##4##1##(1991-12#1)(1997-7#1)(2008-10#1)(2008-4#1)
subclusters##4##1##(2008-10#2)(2008-5#1)(2013-8#1)
subcommittee##3##1##(1995-12#1)(1995-6#1)(1997-3#1)
subcomplexes##2##1##(2011-2#2)
subcomponent of the##2##3##(1997-3#1)(2008-11#1)
subconjunctival application##3##2##(2008-12#3)
subconjunctival##4##1##(2008-12#3)(2012-3#1)
subcontinent##5##1##(1996-8#1)(2008-10#3)(2011-2#1)
subcortical##12##1##(1996-3#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-12#1)
subcritical water extraction##3##3##(2008-10#3)
subcritical water##4##2##(2008-10#4)
subcritical##6##1##(1994-2#1)(2008-10#4)(2010-10#1)
subcultivation##3##1##(2008-11#3)
subculture##10##1##(1991-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-10#1)(2013-1#2)(2013-8#1)
subcultured in##2##2##(2008-10#1)(2013-8#1)
subcultured on##2##2##(2008-10#2)
subcultured##9##1##(2008-10#8)(2013-8#1)
subcultures and##2##2##(1991-1#1)(2008-10#1)
subcultures##4##1##(1991-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
subculturing##5##1##(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
subcutaneous administration of##3##3##(1992-3#1)(1995-2#1)(2012-2#1)
subcutaneous administration##4##2##(1992-3#1)(1995-2#1)(1996-2#1)(2012-2#1)
subcutaneous alemtuzumab##3##2##(2009-12#3)
subcutaneous and##2##2##(2008-11#1)(2008-7#1)
subcutaneous atrophy##3##2##(2011-2#3)
subcutaneous continuous infusion##2##3##(2012-3#2)
subcutaneous fat##10##2##(1996-3#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#5)(2012-4#1)
subcutaneous implantation##2##2##(2008-11#2)
subcutaneous infusion##3##2##(1990-3#1)(2011-2#2)
subcutaneous injection of##5##3##(1993-1#1)(1994-2#1)(2008-10#1)(2008-7#1)(2013-7#1)
subcutaneous injection##7##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-7#1)
subcutaneous interleukin-2##2##2##(1991-6#1)(1994-12#1)
subcutaneous mass in the##2##4##(1994-8#1)(2013-1#1)
subcutaneous nodules##6##2##(1990-2#2)(2013-1#3)(2013-8#1)
subcutaneous tissues##2##2##(1990-12#1)(2010-2#1)
subcutaneous##78##1##(1990-12#1)(1990-2#2)(1990-3#1)(1991-1#1)(1991-6#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-8#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#2)(2009-12#3)(2009-5#2)(2010-2#1)(2010-6#2)(2011-2#7)(2012-12#1)(2012-2#10)(2012-3#2)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#1)
subcutaneously into nude mice##2##4##(2008-11#1)(2008-8#1)
subcutaneously with##4##2##(1991-6#1)(1995-11#1)(1996-12#1)(2012-3#1)
subcutaneously##13##1##(1991-6#1)(1992-12#1)(1992-2#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-5#1)(2010-6#2)(2012-3#1)
subcuticular hyphae##2##2##(2008-10#2)
subcuticular##3##1##(2007-12#1)(2008-10#2)
subcutis##2##1##(2010-6#2)
subdivided by##2##2##(2007-12#1)(2008-10#1)
subdivided into four##2##3##(2008-11#1)(2013-1#1)
subdivided into two##2##3##(2008-10#1)(2008-12#1)
subdivided into##12##2##(1992-9#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
subdivided##18##1##(1992-9#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
subdivision among all##2##3##(2008-10#2)
subdivision of##3##2##(2008-10#2)(2008-8#1)
subdivision##12##1##(2008-10#6)(2008-8#3)(2008-9#3)
subdivisions##4##1##(1994-2#1)(1997-2#3)
subdomain of the CPAP protein##2##5##(2009-7#2)
subdomain##3##1##(1992-4#1)(2009-7#2)
subdomains##2##1##(2008-10#2)
subduction zone##3##2##(1990-11#3)
subduction##4##1##(1990-11#3)(1995-6#1)
subdural electrode##2##2##(2008-11#1)(2010-7#1)
subdural hematoma on the##2##4##(2008-7#2)
subdural hematoma##12##2##(1996-11#1)(2008-7#9)(2012-12#2)
subdural##16##1##(1996-11#1)(1997-6#1)(2008-11#1)(2008-7#9)(2009-9#1)(2010-7#1)(2012-12#2)
subendocardial##2##1##(1991-3#2)
subependymal##2##1##(1996-3#1)(2008-11#1)
subepidermal##4##1##(2008-10#2)(2008-8#1)(2009-6#1)
subepithelial lymphocytic infiltrates##2##3##(2013-1#2)
subepithelial##6##1##(1997-1#1)(2008-11#1)(2009-8#1)(2013-1#3)
suberized##2##1##(2008-10#2)
subesophageal##3##1##(2008-5#3)
subfamilies##6##1##(1993-9#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)
subfamily in##3##2##(1994-8#1)(1995-8#1)(2011-2#1)
subfamily of##5##2##(1993-2#1)(1994-5#1)(1995-6#1)(1996-12#2)
subfamily##21##1##(1991-5#1)(1993-2#1)(1994-5#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
subfield of##2##2##(1995-3#1)(2008-12#1)
subfield##5##1##(1990-5#2)(1995-3#1)(2008-12#1)(2013-1#1)
subfields CA##2##2##(1995-3#2)
subfields##5##1##(1995-3#5)
subfragment 1##3##2##(1992-4#2)(1994-5#1)
subgenera##2##1##(2008-6#1)(2011-2#1)
subgenogroup B5##3##2##(2008-12#3)
subgenogroup##4##1##(2008-12#4)
subgenogroups (C1##2##2##(2008-12#2)
subgenogroups##3##1##(2008-12#3)
subgenomic RNA##3##2##(2008-10#3)
subgenomic library##2##2##(1997-8#1)(2008-10#1)
subgenomic##8##1##(1995-2#1)(1997-8#1)(2008-10#5)(2013-1#1)
subgenus##4##1##(2008-6#2)(2011-2#1)(2013-8#1)
subgingival##2##1##(2008-12#1)(2008-5#1)
subglutinans from##2##2##(2008-10#2)
subglutinans in##2##2##(2008-10#2)
subglutinans##12##1##(2008-10#12)
subgroup 16SrI-A phytoplasma strains##2##4##(2008-10#2)
subgroup 16SrI-A##4##2##(2008-10#4)
subgroup 16SrI-B##2##2##(2008-10#2)
subgroup C##2##2##(2008-5#2)
subgroup I strains##3##3##(2008-10#3)
subgroup I##11##2##(2008-10#11)
subgroup II strains##2##3##(2008-10#2)
subgroup II##12##2##(2008-10#12)
subgroup III##4##2##(2008-10#3)(2008-9#1)
subgroup analyses##3##2##(2008-4#1)(2011-2#2)
subgroup and the other##2##4##(2008-10#2)
subgroup and the##3##3##(1990-5#1)(2008-10#2)
subgroup and##6##2##(1990-5#1)(2008-10#3)(2009-12#1)(2010-12#1)
subgroup are##2##2##(2008-10#2)
subgroup in the##2##3##(2008-10#2)
subgroup of the##2##3##(1997-7#1)(2013-8#1)
subgroup of##12##2##(1990-2#1)(1993-1#1)(1997-7#1)(2007-12#2)(2008-10#3)(2009-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
subgroup specific##2##2##(2008-10#2)
subgroup that##3##2##(2008-10#3)
subgroup within##3##2##(2008-10#3)
subgroup##102##1##(1990-2#1)(1990-5#3)(1993-1#1)(1995-12#2)(1997-7#1)(2007-12#2)(2008-10#74)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#5)(2013-8#1)
subgroups A and B##2##4##(2008-5#2)
subgroups I and II##4##4##(2008-10#4)
subgroups I##5##2##(2008-10#5)
subgroups according to the##3##4##(1993-2#1)(2008-10#1)(2011-2#1)
subgroups according to##4##3##(1993-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
subgroups based on##2##3##(2008-10#1)(2008-12#1)
subgroups is##2##2##(1997-1#2)
subgroups of patients##3##3##(1991-3#1)(1994-3#1)(2008-10#1)
subgroups of the population##2##4##(1994-9#1)(1997-1#1)
subgroups of the##3##3##(1994-9#1)(1996-2#1)(1997-1#1)
subgroups of##12##2##(1991-3#2)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-7#1)(2013-1#1)
subgroups that are##2##3##(1995-12#1)(2008-10#1)
subgroups that##3##2##(1995-12#1)(2008-10#1)(2013-8#1)
subgroups were##3##2##(1990-8#1)(2008-10#2)
subgroups with##4##2##(1996-9#1)(2008-12#3)
subgroups within the##3##3##(1996-3#1)(2008-10#2)
subgroups within##4##2##(1996-3#1)(2008-10#3)
subgroups##103##1##(1990-8#2)(1991-3#2)(1991-6#2)(1992-9#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#5)(1995-5#1)(1996-2#2)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#1)(2008-10#44)(2008-12#7)(2008-5#4)(2008-7#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#5)(2013-8#1)
subiculum##8##1##(1991-10#1)(1991-12#1)(1993-6#5)(1994-2#1)
subisolates obtained##2##2##(2008-10#2)
subisolates##3##1##(2008-10#3)
subjacent##3##1##(1992-12#1)(1995-2#1)(2008-1#1)
subject and##4##2##(1993-11#1)(1994-12#1)(2008-11#1)(2008-9#1)
subject area##2##2##(2008-11#1)(2008-9#1)
subject has##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
subject in##3##2##(1994-9#1)(2008-11#1)(2008-5#1)
subject is##4##2##(1996-12#1)(2008-9#1)(2009-6#1)(2013-8#1)
subject matter##2##2##(2008-10#1)(2008-11#1)
subject of a##2##3##(2008-10#1)(2008-11#1)
subject of the##6##3##(1993-6#1)(1997-3#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
subject of##28##2##(1990-2#1)(1993-6#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
subject or##2##2##(1996-5#1)(2010-8#1)
subject to a precipitation/dissolution process##2##5##(2008-10#2)
subject to a##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
subject to an##2##3##(2008-12#1)(2013-1#1)
subject to both##2##3##(2010-5#1)(2012-3#1)
subject to certain##2##3##(1992-2#1)(2008-5#1)
subject to interference from##2##4##(2008-10#2)
subject to the##2##3##(2009-8#1)(2013-1#1)
subject to##61##2##(1991-7#1)(1992-12#1)(1992-2#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#4)(2013-1#2)
subject was##8##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
subject who##2##2##(1991-3#1)(2008-10#1)
subject with##4##2##(1992-9#1)(1995-8#2)(2011-1#1)
subject##188##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-3#2)(1997-5#2)(1997-8#1)(2007-12#1)(2008-10#24)(2008-11#24)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#8)(2008-7#7)(2008-8#3)(2008-9#9)(2009-1#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#6)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#3)
subject's##10##1##(1992-1#1)(1992-2#1)(1997-5#2)(2008-11#1)(2008-4#2)(2008-7#1)(2010-7#1)(2013-8#1)
subjected to SDS-PAGE##2##3##(2008-10#1)(2008-12#1)
subjected to a##17##3##(1995-5#2)(1995-6#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-9#1)(2010-1#1)(2010-7#1)(2013-1#2)
subjected to acid##4##3##(2008-10#4)
subjected to an##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-7#1)
subjected to different##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#2)
subjected to four##2##3##(2008-10#1)(2008-12#1)
subjected to one of##2##4##(2009-7#1)(2012-9#1)
subjected to rigorous##3##3##(1992-1#1)(2012-3#2)
subjected to the##11##3##(1993-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)
subjected to##173##2##(1990-11#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#4)(1993-6#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-5#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#52)(2008-11#20)(2008-12#7)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-12#1)(2009-7#6)(2009-8#2)(2010-1#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#5)(2012-7#1)(2012-9#1)(2013-1#13)(2013-8#2)
subjected##177##1##(1990-11#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#5)(1993-6#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-5#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#55)(2008-11#20)(2008-12#7)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-12#1)(2009-7#6)(2009-8#2)(2010-1#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#5)(2012-7#1)(2012-9#1)(2013-1#13)(2013-8#2)
subjecting##2##1##(1995-12#1)(2008-10#1)
subjective and objective##4##3##(1992-9#2)(2008-3#1)(2013-1#1)
subjective and##8##2##(1991-1#1)(1992-9#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2013-1#1)
subjective health##4##2##(2008-7#2)(2010-4#1)(2013-1#1)
subjective knee##2##2##(2013-1#2)
subjective night##4##2##(1994-2#1)(2008-5#3)
subjective perception during landing##2##4##(2011-2#2)
subjective perception##5##2##(2011-2#4)(2013-1#1)
subjective results were##2##3##(1996-9#2)
subjective results##3##2##(1996-9#2)(2012-2#1)
subjective symptoms##3##2##(1990-8#1)(1991-6#1)(2010-1#1)
subjective well-being##4##2##(1990-2#2)(2008-12#2)
subjective##91##1##(1990-2#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-12#3)(1992-9#2)(1993-12#2)(1994-2#1)(1996-11#1)(1996-9#2)(1997-1#1)(2007-11#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#9)(2008-7#4)(2008-9#7)(2009-10#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#10)(2011-3#1)(2012-2#4)(2013-1#8)(2013-8#1)
subjectively##5##1##(1995-1#1)(2007-12#1)(2008-8#1)(2010-8#1)(2013-8#1)
subjectivity##3##1##(2008-11#1)(2008-5#1)(2012-3#1)
subjects (11##2##2##(1995-5#2)
subjects (19##2##2##(1992-3#1)(2013-1#1)
subjects (P##2##2##(1994-12#1)(1994-3#1)
subjects (mean age##2##3##(2008-12#1)(2008-7#1)
subjects (n =##4##3##(1995-5#1)(2008-10#1)(2009-8#1)(2013-8#1)
subjects after##3##2##(1992-6#1)(1996-1#1)(2008-10#1)
subjects aged##5##2##(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
subjects and patients with##3##4##(2008-10#1)(2010-12#2)
subjects and patients##4##3##(1996-1#1)(2008-10#1)(2010-12#2)
subjects and the##4##3##(1991-2#1)(1996-1#1)(2011-2#2)
subjects and##30##2##(1991-2#1)(1991-6#1)(1992-12#1)(1994-6#1)(1996-1#4)(2006-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-12#4)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
subjects are##8##2##(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-3#1)
subjects as##4##2##(2008-11#1)(2009-1#2)(2009-4#1)
subjects at##6##2##(2008-10#3)(2008-7#1)(2010-9#1)(2012-3#1)
subjects belonging to##2##3##(2008-1#1)(2009-12#1)
subjects can##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
subjects completed##2##2##(2008-4#1)(2013-8#1)
subjects did not perform any##2##5##(2009-1#1)(2009-3#1)
subjects did not##3##3##(2008-5#1)(2009-1#1)(2009-3#1)
subjects exposed##2##2##(1992-3#1)(2013-1#1)
subjects following##2##2##(1995-9#1)(2011-2#1)
subjects for##6##2##(1990-6#1)(1991-2#1)(1996-3#1)(1997-8#1)(2010-7#1)(2011-2#1)
subjects from Crikvenica##2##3##(2011-2#2)
subjects from Kostrena##2##3##(2011-2#2)
subjects from a##2##3##(2008-11#1)(2008-12#1)
subjects from##7##2##(2008-11#1)(2008-12#1)(2011-2#4)(2011-3#1)
subjects had##10##2##(1994-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-1#1)(2011-2#1)
subjects have##3##2##(1992-12#1)(1992-3#1)(2008-3#1)
subjects in a##3##3##(1995-5#1)(1995-9#1)(2008-10#1)
subjects in the##7##3##(1992-3#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-4#2)(2011-2#1)
subjects in##13##2##(1992-3#1)(1995-5#3)(1995-9#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-9#1)(2011-2#1)
subjects is##2##2##(1995-9#1)(1997-1#1)
subjects not##2##2##(2008-12#1)(2013-1#1)
subjects of the##2##3##(1991-1#1)(1991-8#1)
subjects of##10##2##(1991-1#1)(1991-11#1)(1991-8#1)(2008-11#2)(2008-5#2)(2012-3#2)(2013-7#1)
subjects on a##2##3##(2008-5#1)(2011-2#1)
subjects on the##3##3##(1991-6#1)(1996-3#1)(2008-7#1)
subjects on##7##2##(1991-6#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)
subjects participated in##2##3##(2010-10#1)(2013-1#1)
subjects performed##5##2##(2008-11#1)(2008-7#2)(2009-8#1)(2013-8#1)
subjects received##2##2##(2008-11#1)(2008-6#1)
subjects receiving##2##2##(2008-11#1)(2011-2#1)
subjects showed a##3##3##(1992-6#1)(2008-5#1)(2008-7#1)
subjects such as##2##3##(1996-1#2)
subjects tend to##2##3##(2008-11#1)(2009-11#1)
subjects the##2##2##(1993-1#1)(2008-10#1)
subjects to##3##2##(1990-5#1)(1994-12#1)(1997-5#1)
subjects treated##2##2##(1991-1#1)(1991-6#1)
subjects under the effect of##2##5##(2013-8#2)
subjects under the##3##3##(1991-12#1)(2013-8#2)
subjects under##4##2##(1991-12#1)(2011-2#1)(2013-8#2)
subjects undergoing##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
subjects underwent##4##2##(2008-7#1)(2011-2#3)
subjects until##2##2##(1995-9#1)(1996-3#1)
subjects used##2##2##(1992-2#1)(2008-11#1)
subjects using cochlear implants##2##4##(2008-9#2)
subjects using##4##2##(1992-2#1)(1996-2#1)(2008-9#2)
subjects was found##2##3##(2008-7#1)(2012-3#1)
subjects was##8##2##(1992-6#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
subjects were examined##4##3##(2008-7#2)(2012-3#1)(2013-1#1)
subjects were found to be##2##5##(1996-2#1)(2008-7#1)
subjects were found##3##3##(1996-2#1)(2008-7#2)
subjects were randomly assigned to##3##5##(2008-11#1)(2008-12#1)(2011-2#1)
subjects were tested##2##3##(2008-12#1)(2008-7#1)
subjects were##54##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#3)(1996-1#1)(1996-2#2)(1997-8#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#7)(2010-1#2)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
subjects who had##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)
subjects who##13##2##(1994-3#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-1#1)(2013-1#1)(2013-8#1)
subjects whose##2##2##(2008-7#1)(2010-11#1)
subjects with Type 2 diabetes##2##5##(1994-12#2)
subjects with chronic##3##3##(2009-8#1)(2011-2#1)(2012-3#1)
subjects with clinically##2##3##(1996-12#1)(2008-7#1)
subjects with diabetes##2##3##(2012-3#2)
subjects with different##2##3##(2008-7#1)(2010-10#1)
subjects with normal skin##2##4##(2008-5#2)
subjects with normal##4##3##(1992-11#1)(1996-2#1)(2008-5#2)
subjects with xerotic skin##2##4##(2008-5#2)
subjects with##59##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1994-12#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(2008-10#4)(2008-11#4)(2008-5#5)(2008-7#10)(2008-9#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
subjects without##4##2##(2008-12#1)(2008-7#1)(2012-3#2)
subjects##601##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-11#1)(1991-12#6)(1991-2#14)(1991-3#2)(1991-6#5)(1991-7#1)(1991-8#4)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#6)(1992-6#4)(1992-9#3)(1993-1#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#15)(1994-2#2)(1994-3#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#18)(1995-6#1)(1995-8#3)(1995-9#6)(1996-1#10)(1996-11#1)(1996-12#3)(1996-2#8)(1996-3#5)(1996-6#1)(1996-8#3)(1997-1#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#5)(2006-6#1)(2007-12#1)(2008-1#4)(2008-10#38)(2008-11#47)(2008-12#27)(2008-3#6)(2008-4#6)(2008-5#27)(2008-6#2)(2008-7#64)(2008-8#2)(2008-9#14)(2009-1#5)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#9)(2009-8#8)(2010-1#7)(2010-10#3)(2010-11#3)(2010-12#9)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#1)(2011-2#35)(2011-3#1)(2012-12#2)(2012-2#14)(2012-3#22)(2013-1#30)(2013-7#1)(2013-8#17)
subjects'##4##1##(2009-4#1)(2013-1#2)(2013-8#1)
subjects)##7##1##(1994-12#2)(1995-5#2)(1996-1#1)(2011-3#1)(2012-2#1)
subjugated##2##1##(2008-11#1)(2008-12#1)
sublethal concentrations##2##2##(2008-7#1)(2011-1#1)
sublethal##9##1##(1993-12#1)(1994-5#1)(2008-10#3)(2008-7#3)(2011-1#1)
sublethally injured##2##2##(2008-10#1)(2009-6#1)
subline##3##1##(1990-2#2)(2008-11#1)
sublineolum##5##1##(2008-10#5)
sublineolum)##2##1##(2008-10#2)
sublines##7##1##(2008-11#6)(2008-9#1)
sublingual##2##1##(1991-1#1)(2008-3#1)
submandibular gland##2##2##(1996-2#1)(2011-2#1)
submandibular salivary gland##4##3##(1990-5#3)(1995-11#1)
submandibular##7##1##(1990-5#3)(1995-11#1)(1996-2#1)(2011-2#2)
submaximal sustained##2##2##(2013-8#2)
submaximal##8##1##(1994-3#1)(1995-8#1)(2008-11#1)(2011-2#1)(2013-8#4)
submerged##8##1##(1994-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#3)
submicromolar##4##1##(1994-11#1)(2008-10#3)
submicroscopic##4##1##(1997-3#2)(2008-1#1)(2012-12#1)
submillimeter radiometer##2##2##(2008-3#2)
submillimeter##5##1##(2008-2#1)(2008-3#4)
submission of##2##2##(2008-11#1)(2008-5#1)
submission##7##1##(1992-3#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#2)
submissive##2##1##(2008-11#2)
submit##6##1##(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
submitted for##9##2##(1992-3#1)(1992-5#1)(1994-2#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-4#1)
submitted to a##7##3##(1991-12#1)(1993-6#1)(1994-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
submitted to an##2##3##(2008-10#1)(2008-11#1)
submitted to the##6##3##(1992-2#1)(2008-10#1)(2008-11#2)(2010-6#1)(2011-2#1)
submitted to three##2##3##(2008-10#1)(2013-1#1)
submitted to##48##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1996-6#1)(1997-2#1)(2008-10#8)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-6#2)(2011-2#4)(2012-3#1)(2013-1#4)
submitted##71##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-2#3)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-2#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#2)(2011-2#4)(2012-3#1)(2013-1#5)
submitting data##2##2##(2008-4#1)(2008-7#1)
submitting##3##1##(2008-1#1)(2008-4#1)(2008-7#1)
submucosa##2##1##(1990-9#1)(2011-2#1)
submucosal hematoma of the esophagus##3##5##(2011-2#3)
submucosal tumor##6##2##(2008-12#5)(2012-2#1)
submucosal tumors##2##2##(1992-9#1)(2013-1#1)
submucosal##20##1##(1990-5#1)(1992-9#1)(1993-8#1)(1994-2#1)(1997-4#1)(2008-12#5)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
submucous leiomyomas##4##2##(1991-2#4)
submucous##6##1##(1991-2#5)(2009-6#1)
subnanomolar##2##1##(1995-2#1)(2008-10#1)
suboccipital craniotomy##3##2##(2008-7#2)(2012-3#1)
suboccipital muscles##2##2##(2010-9#2)
suboccipital##10##1##(2008-7#4)(2010-9#2)(2011-2#2)(2012-3#1)(2013-1#1)
suboptimal##11##1##(1991-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
suborder##3##1##(1993-3#1)(2011-2#2)
subordinate male##3##2##(1992-1#1)(2008-8#2)
subordinate to##2##2##(2008-11#1)(2008-8#1)
subordinate##14##1##(1992-1#2)(2008-11#1)(2008-8#7)(2008-9#1)(2010-8#3)
subordinates##8##1##(1992-1#2)(2008-8#4)(2010-8#2)
subperiosteal##2##1##(1991-11#1)(2011-2#1)
subperitoneal space##3##2##(2008-1#3)
subphase##5##1##(1991-3#1)(1994-5#1)(1997-2#2)(2012-2#1)
subpicosecond##2##1##(1996-2#1)(2008-2#1)
subplots##5##1##(2008-10#3)(2008-12#1)(2008-9#1)
subpopulation (clusters##2##2##(2008-10#2)
subpopulation of##11##2##(1995-11#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2011-2#1)(2012-3#1)
subpopulation that##3##2##(2008-4#1)(2011-2#2)
subpopulation##42##1##(1991-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(2008-10#20)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#4)(2012-3#1)(2013-1#1)
subpopulations and##2##2##(2008-10#2)
subpopulations from##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
subpopulations have##2##2##(2008-7#2)
subpopulations in##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
subpopulations of the##3##3##(1991-12#1)(2008-10#2)
subpopulations of##15##2##(1991-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-3#1)(2008-10#6)(2008-11#2)(2009-8#1)
subpopulations were##7##2##(2008-10#5)(2008-11#1)(2008-9#1)
subpopulations with##2##2##(2008-11#1)(2008-4#1)
subpopulations within##4##2##(2008-10#4)
subpopulations##94##1##(1991-1#1)(1991-12#1)(1993-8#1)(1994-8#1)(1995-12#6)(1995-6#1)(1995-9#1)(1997-3#1)(2008-1#1)(2008-10#50)(2008-11#9)(2008-4#2)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#1)(2009-8#1)(2011-2#2)(2013-1#1)
subregion##3##1##(2008-3#1)(2008-5#1)(2008-8#1)
subregions##8##1##(1996-12#1)(2008-3#4)(2008-7#1)(2008-8#2)
subretinal fluid##2##2##(2011-7#1)(2013-8#1)
subretinal##4##1##(2011-7#3)(2013-8#1)
subsample of##4##2##(2008-10#2)(2008-4#1)(2013-8#1)
subsample##5##1##(2008-10#3)(2008-4#1)(2013-8#1)
subsamples##3##1##(2008-10#2)(2009-12#1)
subsarcolemmal##2##1##(1995-12#1)(2009-7#1)
subscale##8##1##(2008-12#1)(2008-7#1)(2009-12#1)(2010-6#1)(2010-8#2)(2012-2#1)(2013-1#1)
subscales and##2##2##(2008-11#1)(2010-6#1)
subscales of the##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
subscales##15##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-11#2)(2010-6#1)(2010-7#1)(2012-2#5)
subscriber##4##1##(1994-12#2)(1996-3#1)(2011-3#1)
subscription##2##1##(1991-12#2)
subsequent CT##2##2##(1994-2#1)(2012-3#1)
subsequent DHAA reduction##2##3##(1993-3#2)
subsequent activation##3##2##(1994-6#1)(2009-8#1)(2012-2#1)
subsequent age group##2##3##(1991-6#2)
subsequent age##3##2##(1990-6#1)(1991-6#2)
subsequent analysis of##2##3##(2008-10#1)(2008-9#1)
subsequent analysis##9##2##(2008-10#4)(2008-11#1)(2008-4#2)(2008-9#1)(2011-2#1)
subsequent attachment of##3##3##(1993-6#1)(2008-10#2)
subsequent changes in##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
subsequent chromium##2##2##(2008-10#2)
subsequent clinical##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
subsequent complex formation##2##3##(2008-10#2)
subsequent day##2##2##(1994-8#1)(2010-3#1)
subsequent decrease in##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
subsequent detection of##2##3##(2008-10#1)(2008-3#1)
subsequent detection##4##2##(2008-10#3)(2008-3#1)
subsequent determination by##4##3##(2008-10#4)
subsequent determination of##2##3##(2008-10#2)
subsequent determination##8##2##(2008-10#8)
subsequent development of##7##3##(1991-12#1)(1993-6#1)(2008-10#5)
subsequent development##8##2##(1991-12#1)(1993-6#1)(1994-11#1)(2008-10#5)
subsequent elution of##4##3##(2008-10#4)
subsequent elution##5##2##(2008-10#5)
subsequent exams##2##2##(1991-3#2)
subsequent experiments##2##2##(2008-10#1)(2008-5#1)
subsequent expression of##2##3##(1992-3#1)(2008-10#1)
subsequent generations##2##2##(1992-2#1)(2010-4#1)
subsequent germination##2##2##(2008-10#2)
subsequent health##3##2##(1993-1#1)(2009-5#2)
subsequent inhibition of the##2##4##(1993-6#1)(2010-12#1)
subsequent isolation of##2##3##(2008-10#1)(2008-9#1)
subsequent leaching##2##2##(2008-10#1)(2008-11#1)
subsequent maintenance of##2##3##(1996-12#1)(2008-10#1)
subsequent measurement by##2##3##(2008-10#2)
subsequent measurement of##2##3##(2008-10#1)(2008-4#1)
subsequent measurement##4##2##(2008-10#3)(2008-4#1)
subsequent medical##2##2##(1993-11#1)(2008-12#1)
subsequent oxidation##3##2##(2008-10#3)
subsequent papers##2##2##(2008-10#2)
subsequent pseudothecium##2##2##(2008-10#2)
subsequent rapid##2##2##(2008-10#2)
subsequent reaction with##3##3##(2008-10#3)
subsequent reaction##5##2##(2008-10#5)
subsequent reactions##2##2##(1991-3#1)(2008-10#1)
subsequent space use##2##3##(2008-9#2)
subsequent steps of##2##3##(1995-3#1)(2008-10#1)
subsequent steps##4##2##(1991-12#1)(1992-5#1)(1995-3#1)(2008-10#1)
subsequent surgery##2##2##(2008-9#1)(2013-1#1)
subsequent to the##5##3##(1990-5#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-5#1)
subsequent to##13##2##(1990-5#1)(1990-9#1)(1991-2#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-8#1)
subsequent treatment##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-6#1)
subsequent use##2##2##(2008-10#1)(2011-1#1)
subsequent years##2##2##(2008-10#1)(2011-2#1)
subsequent##438##1##(1990-12#3)(1990-2#1)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#3)(1992-1#2)(1992-10#2)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#4)(1993-6#4)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#3)(1994-6#2)(1994-8#2)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#149)(2008-11#22)(2008-12#10)(2008-2#3)(2008-3#1)(2008-4#12)(2008-5#9)(2008-7#12)(2008-8#5)(2008-9#21)(2009-10#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#14)(2011-3#1)(2012-12#8)(2012-2#5)(2012-3#10)(2013-1#9)(2013-7#1)(2013-8#6)
subsequently analysed by##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
subsequently analyzed##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
subsequently be##2##2##(2008-10#1)(2013-8#1)
subsequently became##2##2##(2008-10#1)(2010-1#1)
subsequently been##3##2##(1995-8#1)(2010-12#1)(2011-2#1)
subsequently confirmed##2##2##(2008-7#1)(2012-3#1)
subsequently delivered##2##2##(1994-3#1)(2008-10#1)
subsequently detected##2##2##(1994-5#1)(2008-10#1)
subsequently determined by##2##3##(2008-10#2)
subsequently determined with##2##3##(2008-10#2)
subsequently determined##5##2##(2008-10#5)
subsequently developed##6##2##(2008-10#2)(2008-7#2)(2011-2#1)(2013-1#1)
subsequently eluted with##4##3##(2008-10#4)
subsequently eluted##5##2##(2008-10#5)
subsequently examined##2##2##(1995-6#1)(1997-3#1)
subsequently had##2##2##(1995-8#1)(2009-6#1)
subsequently measured##4##2##(2007-11#1)(2008-10#2)(2008-9#1)
subsequently modified by##2##3##(1997-2#1)(2008-10#1)
subsequently placed##2##2##(2008-11#1)(2011-2#1)
subsequently received##2##2##(1993-6#1)(2010-1#1)
subsequently released##2##2##(2008-10#1)(2011-2#1)
subsequently shown to##2##3##(1991-2#1)(2008-10#1)
subsequently shown##3##2##(1991-2#1)(1992-6#1)(2008-10#1)
subsequently subjected to##2##3##(2008-10#1)(2013-1#1)
subsequently the##3##2##(2008-8#1)(2008-9#1)(2010-6#1)
subsequently to##5##2##(1991-8#1)(1991-9#1)(2008-9#1)(2009-12#1)(2010-10#1)
subsequently treated with##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2010-7#1)
subsequently treated##6##2##(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#1)(2010-7#1)
subsequently underwent a##2##3##(1994-12#1)(2008-9#1)
subsequently underwent##6##2##(1994-12#1)(1995-11#1)(2008-9#2)(2013-1#2)
subsequently used to##2##3##(2008-10#2)
subsequently used##3##2##(2008-10#2)(2010-6#1)
subsequently was##2##2##(1996-8#1)(2008-10#1)
subsequently with##3##2##(2008-10#3)
subsequently##197##1##(1991-11#1)(1991-2#3)(1991-8#1)(1991-9#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(2007-11#1)(2008-10#73)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#4)(2008-9#7)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#3)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#2)
subserve##2##1##(1993-3#1)(2008-11#1)
subserving##5##1##(1992-12#1)(1993-3#1)(1993-6#1)(1995-8#1)(2008-11#1)
subset composition##2##2##(2008-11#2)
subset of T cells##2##4##(2008-4#1)(2012-2#1)
subset of patients##5##3##(1995-5#1)(1997-1#1)(2008-12#1)(2010-12#1)(2011-2#1)
subset of the##10##3##(2008-10#3)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
subset of these##4##3##(1995-5#1)(1995-8#1)(2008-10#2)
subset of##69##2##(1990-8#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-5#2)(1995-8#2)(1997-1#2)(1997-7#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
subset selection##2##2##(2008-11#1)(2008-6#1)
subset##91##1##(1990-8#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-2#4)(1995-5#3)(1995-8#2)(1997-1#2)(1997-7#1)(2008-10#20)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#6)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#3)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
subsets in##4##2##(1991-6#1)(1993-8#1)(2008-9#1)(2012-2#1)
subsets of AG-2 were##2##4##(2008-10#2)
subsets of AG-2##4##3##(2008-10#4)
subsets of neurons##2##3##(1993-12#1)(1997-3#1)
subsets of the##2##3##(1995-12#1)(2009-8#1)
subsets of##24##2##(1993-12#2)(1994-3#1)(1995-12#1)(1997-2#3)(1997-3#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-3#1)(2012-3#1)
subsets##59##1##(1991-6#3)(1993-12#2)(1993-8#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-2#3)(1997-3#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#9)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#4)
subsided##2##1##(2012-2#1)(2013-1#1)
subsidiary##3##1##(1990-2#1)(2008-10#1)(2008-5#1)
subsidies##10##1##(1992-12#1)(1994-2#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-7#1)(2008-8#2)(2010-5#1)(2013-8#1)
subsiding##2##1##(1992-11#1)(1997-4#1)
subsidized##3##1##(1991-12#1)(1997-5#1)(2012-12#1)
subsidy##4##1##(1994-2#1)(1996-2#2)(2008-11#1)
subsistence##4##1##(2008-1#1)(2008-10#2)(2010-6#1)
subsite##4##1##(1991-6#2)(1992-12#1)(2010-12#1)
subsonic##2##1##(2008-3#2)
subsp##72##1##(1990-5#2)(1993-12#2)(2008-10#60)(2008-5#1)(2008-7#1)(2010-6#1)(2012-3#5)
subspecialists##2##1##(2008-11#1)(2013-1#1)
subspecialties##3##1##(1991-6#1)(1994-12#1)(2008-11#1)
subspecialty##3##1##(1993-12#1)(1994-12#1)(2012-3#1)
subspecies##15##1##(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#1)(2010-8#1)(2012-3#1)
subspecies-specific##2##1##(2008-10#2)
subspecific##3##1##(2008-10#3)
substance P in##2##3##(1994-8#1)(2009-11#1)
substance P##16##2##(1994-8#8)(1995-11#2)(1997-1#1)(1997-3#1)(1997-4#1)(2008-4#1)(2009-11#1)(2013-8#1)
substance P-##2##2##(1994-8#1)(1997-3#1)
substance abuse and comorbid##2##4##(2008-6#1)(2009-5#1)
substance abuse and##6##3##(2008-6#1)(2009-5#1)(2009-9#1)(2013-8#3)
substance abuse patients##2##3##(1991-1#1)(2008-6#1)
substance abuse treatment and##3##4##(2008-6#2)(2010-6#1)
substance abuse treatment##6##3##(2008-6#2)(2010-11#3)(2010-6#1)
substance abuse##39##2##(1991-1#1)(1991-2#1)(1992-1#2)(1993-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-4#2)(2008-6#11)(2008-9#1)(2009-5#1)(2009-9#3)(2010-11#3)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#4)
substance abusers##2##2##(1991-1#2)
substance and volume loss were##2##5##(2011-2#2)
substance and volume loss##3##4##(2011-2#3)
substance and##4##2##(2007-12#1)(2011-2#3)
substance as##2##2##(2008-10#2)
substance by##2##2##(2008-10#1)(2008-5#1)
substance code##2##2##(2010-8#2)
substance dependence##5##2##(1991-1#1)(2012-2#2)(2013-8#2)
substance did not##2##3##(1997-6#1)(2008-10#1)
substance have been##2##3##(2008-10#2)
substance in the##2##3##(2008-11#1)(2008-9#1)
substance in##6##2##(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)
substance inhibited##2##2##(1993-3#1)(1997-6#1)
substance is##2##2##(2008-10#1)(2010-5#1)
substance of##4##2##(1993-12#1)(2008-10#2)(2013-1#1)
substance that appears to##2##4##(2008-11#2)
substance that##3##2##(1997-6#1)(2008-11#2)
substance use and##3##3##(2010-7#1)(2013-1#1)(2013-8#1)
substance use disorder in##2##4##(2012-12#1)(2012-3#1)
substance use disorder##4##3##(2009-11#2)(2012-12#1)(2012-3#1)
substance use##21##2##(2008-11#1)(2008-4#1)(2008-6#2)(2009-11#3)(2009-7#2)(2010-6#1)(2010-7#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#2)
substance was##5##2##(1990-5#1)(1990-6#1)(2008-11#2)(2008-5#1)
substance were##2##2##(2008-11#1)(2008-5#1)
substance##185##1##(1990-5#1)(1990-6#3)(1991-1#5)(1991-2#1)(1991-3#1)(1992-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#9)(1995-11#3)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(2007-12#1)(2008-10#28)(2008-11#24)(2008-12#1)(2008-4#5)(2008-5#10)(2008-6#15)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#4)(2009-5#1)(2009-7#4)(2009-9#3)(2010-11#3)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#6)(2013-8#9)
substance(s)##2##1##(2008-10#2)
substances (HS) and##2##3##(2008-10#2)
substances (HS)##5##2##(2008-10#5)
substances and the##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
substances and their##3##3##(2008-10#3)
substances and##19##2##(1990-11#1)(1992-1#1)(1992-3#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-7#2)(2013-8#1)
substances are responsible for##2##4##(2008-10#1)(2008-11#1)
substances are##7##2##(1991-3#1)(1993-11#1)(1994-9#1)(2008-10#1)(2008-11#1)(2009-7#2)
substances as##2##2##(2008-11#1)(2009-10#1)
substances by##3##2##(2008-10#3)
substances for the##4##3##(2008-11#3)(2013-1#1)
substances for##6##2##(2008-11#3)(2008-5#1)(2012-12#1)(2013-1#1)
substances from the##3##3##(2007-12#1)(2008-7#2)
substances from##4##2##(1997-1#1)(2007-12#1)(2008-7#2)
substances have##3##2##(1995-12#1)(1997-4#1)(2008-5#1)
substances having a##2##3##(2008-10#1)(2008-11#1)
substances in human##2##3##(2008-10#1)(2010-11#1)
substances in plasma##3##3##(1992-3#1)(2008-10#2)
substances in the##7##3##(1994-8#1)(2008-10#3)(2008-7#1)(2013-8#2)
substances in##27##2##(1992-3#1)(1994-8#1)(2008-10#15)(2008-11#3)(2008-7#2)(2010-11#2)(2013-8#3)
substances is##2##2##(1995-11#1)(2013-1#1)
substances of##3##2##(1994-8#1)(2007-12#1)(2008-10#1)
substances present in the##2##4##(1994-3#1)(2008-10#1)
substances present in##3##3##(1994-3#1)(2008-10#2)
substances produced by##2##3##(2010-1#1)(2010-7#1)
substances such as##6##3##(1992-9#1)(1997-1#1)(2008-10#4)
substances that are##2##3##(2008-10#1)(2008-5#1)
substances that##9##2##(1991-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
substances to##2##2##(2008-10#1)(2008-5#1)
substances used for##2##3##(2008-10#1)(2008-7#1)
substances used##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
substances was studied##2##3##(2008-10#1)(2008-8#1)
substances was##5##2##(2008-10#4)(2008-8#1)
substances were##8##2##(2008-10#6)(2008-11#1)(2013-1#1)
substances which can##2##3##(2008-10#1)(2013-8#1)
substances which##5##2##(1996-1#1)(2008-10#1)(2008-11#2)(2013-8#1)
substances with##3##2##(2008-10#3)
substances##256##1##(1990-11#1)(1991-12#2)(1991-3#3)(1991-9#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#4)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#2)(1996-1#1)(1997-1#2)(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#128)(2008-11#34)(2008-4#1)(2008-5#16)(2008-7#9)(2008-8#1)(2009-10#2)(2009-4#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#6)(2013-8#7)
substantia nigra and##5##3##(1996-12#2)(2008-7#3)
substantia nigra has##2##3##(1990-5#2)
substantia nigra##25##2##(1990-5#4)(1991-12#1)(1994-2#2)(1995-2#4)(1995-8#1)(1996-12#6)(1997-3#1)(2008-7#5)(2012-2#1)
substantial advances##2##2##(1995-5#1)(2011-2#1)
substantial amount of##3##3##(1995-1#1)(1997-3#1)(2008-11#1)
substantial amounts of##3##3##(1991-12#2)(1991-5#1)
substantial benefit##2##2##(2010-12#1)(2012-3#1)
substantial change##2##2##(1994-12#1)(2013-8#1)
substantial changes in##3##3##(1997-1#1)(2008-10#1)(2010-1#1)
substantial changes of##2##3##(2008-10#2)
substantial changes##5##2##(1997-1#1)(2008-10#3)(2010-1#1)
substantial decrease in##2##3##(1991-6#1)(2008-10#1)
substantial differences##2##2##(1995-3#1)(2009-10#1)
substantial effects on##2##3##(2008-10#1)(2012-2#1)
substantial effort##2##2##(2011-2#2)
substantial evidence that##2##3##(1992-5#1)(2008-11#1)
substantial improvement in the##3##4##(1995-12#1)(2007-12#1)(2008-10#1)
substantial improvement##4##2##(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)
substantial improvements in##2##3##(1994-12#1)(2013-1#1)
substantial increase in the##4##4##(1992-2#1)(2008-10#2)(2011-2#1)
substantial increase in##8##3##(1992-2#1)(1994-12#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-1#1)
substantial increase##11##2##(1991-6#1)(1992-2#1)(1994-12#1)(2008-10#4)(2008-11#2)(2011-2#1)(2013-1#1)
substantial increases in##2##3##(2008-8#1)(2012-2#1)
substantial numbers of##3##3##(1995-12#1)(1996-9#1)(2008-12#1)
substantial part of the##2##4##(1995-1#1)(2008-7#1)
substantial part of##3##3##(1995-1#1)(2008-7#1)(2011-2#1)
substantial part##4##2##(1995-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
substantial public health##2##3##(1993-12#1)(2013-8#1)
substantial reduction in##2##3##(2008-10#1)(2008-11#1)
substantial reduction##3##2##(1991-8#1)(2008-10#1)(2008-11#1)
substantial reductions in##3##3##(1992-2#1)(2008-10#1)(2011-3#1)
substantial variation in##2##3##(1992-12#1)(2008-10#1)
substantial##171##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#4)(1994-3#1)(1994-6#1)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-7#1)(1997-8#3)(2007-12#1)(2008-10#26)(2008-11#13)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#3)(2010-10#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#6)
substantially at##2##2##(1990-5#1)(2008-9#1)
substantially better##2##2##(1991-6#1)(2011-2#1)
substantially between##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
substantially decreased##2##2##(1995-11#1)(2009-10#1)
substantially delayed##2##2##(1997-3#2)
substantially different##2##2##(1992-12#1)(2008-10#1)
substantially from##6##2##(1994-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
substantially greater than##2##3##(1994-3#1)(2010-10#1)
substantially higher##5##2##(1993-1#1)(1993-12#1)(1995-2#1)(1995-8#1)(1996-12#1)
substantially in recent##2##3##(1994-6#1)(2012-2#1)
substantially increased##4##2##(2008-10#2)(2008-11#2)
substantially less##2##2##(1994-5#1)(2008-8#1)
substantially lower than##2##3##(1993-3#1)(2008-10#1)
substantially lower##6##2##(1993-3#1)(1994-6#1)(1997-2#1)(2008-10#2)(2008-3#1)
substantially more##3##2##(1990-12#1)(1993-12#1)(2008-10#1)
substantially on##2##2##(2008-10#1)(2010-8#1)
substantially reduce the##2##3##(2008-10#1)(2008-8#1)
substantially reduced##11##2##(1994-3#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
substantially reducing##2##2##(1992-9#1)(2008-10#1)
substantially the##4##2##(1993-3#1)(1994-9#1)(2008-8#1)(2012-2#1)
substantially to##2##2##(1991-8#1)(2008-7#1)
substantially with##2##2##(1991-3#1)(1994-6#1)
substantially##117##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1994-1#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-9#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2008-10#28)(2008-11#6)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#3)(2009-10#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
substantiate the##3##2##(2008-11#2)(2008-7#1)
substantiate##5##1##(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)
substantiated by##7##2##(1990-5#1)(1994-11#1)(1994-2#1)(1995-3#1)(2008-10#3)
substantiated##11##1##(1990-5#1)(1991-10#1)(1994-11#1)(1994-2#1)(1995-3#1)(2008-10#4)(2008-5#1)(2012-2#1)
substantiates the##3##2##(1994-12#1)(2008-10#2)
substantive##5##1##(1996-1#1)(1996-3#1)(2008-5#1)(2009-11#1)(2009-12#1)
substantivity##3##1##(2008-5#3)
substituent at the##2##3##(1995-2#1)(2009-8#1)
substituent at##3##2##(1995-2#1)(1996-5#1)(2009-8#1)
substituent in##2##2##(2008-10#2)
substituent is##2##2##(1996-5#1)(2008-10#1)
substituent was##2##2##(2008-10#2)
substituent##17##1##(1994-5#1)(1995-2#1)(1996-5#3)(2008-10#10)(2009-8#1)(2010-8#1)
substituent's##2##1##(2008-10#2)
substituents are##2##2##(1993-12#1)(2008-10#1)
substituents at##2##2##(2009-10#2)
substituents in##3##2##(1992-8#1)(2008-10#2)
substituents on the##2##3##(1992-8#1)(2009-10#1)
substituents##18##1##(1991-5#1)(1992-8#2)(1993-12#1)(1994-5#1)(1994-8#1)(1996-5#2)(2008-10#5)(2009-10#3)(2010-4#1)(2012-3#1)
substitutable##3##1##(1996-3#1)(2008-8#2)
substitute for a##2##3##(2008-10#1)(2008-3#1)
substitute for inpatient##2##3##(1991-1#1)(1996-3#1)
substitute for the##2##3##(1993-3#1)(2008-10#1)
substitute for##19##2##(1991-1#1)(1991-3#1)(1993-12#1)(1993-3#1)(1995-2#3)(1995-3#1)(1996-3#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2013-1#1)
substitute the##3##2##(2008-11#2)(2008-8#1)
substitute##36##1##(1991-1#1)(1991-3#1)(1993-12#1)(1993-3#1)(1995-2#3)(1995-3#1)(1996-3#2)(1997-1#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)
substituted amino acid##2##3##(1996-5#1)(2011-2#1)
substituted at position##2##3##(1994-11#1)(1996-5#1)
substituted benzamides##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
substituted benzenes##2##2##(2008-10#2)
substituted by a##2##3##(1996-9#1)(2008-10#1)
substituted by##9##2##(1995-6#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-8#2)
substituted consent##3##2##(1995-2#3)
substituted for the##3##3##(1990-12#1)(2008-10#2)
substituted for##7##2##(1990-12#1)(1993-8#1)(2008-10#2)(2011-2#3)
substituted in the##2##3##(1997-2#1)(2008-7#1)
substituted with a##2##3##(1994-5#1)(1995-11#1)
substituted with##5##2##(1994-5#1)(1995-11#1)(2008-10#2)(2011-2#1)
substituted##80##1##(1990-12#2)(1990-5#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-6#3)(1996-2#1)(1996-5#4)(1996-9#1)(1997-2#2)(2008-10#31)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#9)(2010-6#2)(2011-2#5)(2012-3#1)
substitutes for##5##2##(2008-11#2)(2008-8#1)(2012-3#2)
substitutes in##2##2##(1994-3#1)(2008-11#1)
substitutes the##2##2##(1994-12#1)(2008-10#1)
substitutes##23##1##(1991-2#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(2008-10#2)(2008-11#7)(2008-7#1)(2008-8#1)(2009-7#2)(2010-6#1)(2012-2#1)(2012-3#2)
substituting the##3##2##(2008-10#2)(2012-3#1)
substituting##9##1##(1994-5#1)(1995-6#1)(2008-10#4)(2010-8#1)(2012-2#1)(2012-3#1)
substitution and##4##2##(1991-7#1)(2008-7#2)(2011-1#1)
substitution has##2##2##(1990-12#1)(2008-10#1)
substitution in the##7##3##(1991-2#1)(1993-3#1)(2008-10#3)(2008-6#1)(2008-9#1)
substitution in##11##2##(1991-2#1)(1992-3#1)(1993-3#1)(2008-10#4)(2008-6#1)(2008-9#2)(2010-4#1)
substitution line##7##2##(2008-10#5)(2008-8#2)
substitution lines##2##2##(2008-10#2)
substitution of a##4##3##(1991-12#1)(1993-8#1)(2008-10#1)(2011-2#1)
substitution of the##5##3##(1990-8#1)(1994-5#1)(2008-10#1)(2008-11#2)
substitution of##32##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-8#2)(1994-11#4)(1994-5#2)(1995-6#1)(2008-10#6)(2008-11#3)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#3)(2013-1#1)
substitution on##3##2##(2008-10#1)(2008-8#2)
substitution pattern##3##2##(1996-5#1)(2008-10#2)
substitution process##3##2##(1991-2#3)
substitution rates##2##2##(1997-6#1)(2008-8#1)
substitution reaction in metallic complex##2##5##(2008-10#2)
substitution reaction##4##2##(2008-10#4)
substitution to##2##2##(1992-3#1)(2008-4#1)
substitution were##2##2##(2008-10#1)(2008-7#1)
substitution##128##1##(1990-12#2)(1990-8#1)(1991-12#4)(1991-2#4)(1991-5#1)(1991-7#3)(1992-11#1)(1992-3#5)(1992-4#1)(1993-12#2)(1993-3#1)(1993-8#4)(1994-11#4)(1994-5#3)(1995-6#2)(1996-5#1)(1997-6#2)(1997-7#1)(2006-6#1)(2008-10#41)(2008-11#4)(2008-12#1)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#4)(2009-10#1)(2009-7#1)(2010-4#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
substitutional##2##1##(2008-10#1)(2009-3#1)
substitutions and##4##2##(1994-5#1)(1995-6#2)(2008-10#1)
substitutions at##3##2##(1995-8#1)(1997-8#1)(2008-10#1)
substitutions between##2##2##(1993-6#1)(2008-6#1)
substitutions in the##4##3##(1993-6#1)(2008-10#2)(2013-8#1)
substitutions in##7##2##(1993-12#1)(1993-6#1)(1994-12#1)(2008-10#2)(2011-1#1)(2013-8#1)
substitutions of##4##2##(1992-3#1)(2008-10#1)(2008-6#1)(2010-5#1)
substitutions were##3##2##(1997-9#1)(2008-10#1)(2008-5#1)
substitutions##48##1##(1990-8#1)(1992-3#3)(1992-4#1)(1993-12#2)(1993-2#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-6#2)(1995-8#1)(1997-2#1)(1997-8#1)(1997-9#3)(2008-10#11)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
substitutive##2##1##(1991-11#1)(1992-3#1)
substoichiometric##2##1##(2008-10#2)
substomatal chambers##2##2##(2008-10#2)
substomatal##4##1##(2008-10#4)
substrain##2##1##(1995-8#2)
substrata and##2##2##(1994-8#2)
substrata##10##1##(1994-8#6)(2008-10#2)(2008-7#1)(2010-8#1)
substrate (e##2##2##(2008-10#1)(2008-5#1)
substrate RC3/neurogranin##2##2##(1997-2#2)
substrate analogue##2##2##(1992-6#1)(2008-4#1)
substrate and metabolite##2##3##(1991-3#1)(2008-11#1)
substrate and##31##2##(1990-5#2)(1991-3#1)(1993-8#1)(1994-5#3)(1994-6#1)(1995-2#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
substrate are##2##2##(1992-3#1)(2008-3#1)
substrate as##2##2##(1995-2#1)(2008-10#1)
substrate at##4##2##(2008-10#2)(2011-2#2)
substrate binding site##2##3##(1992-3#1)(1994-5#1)
substrate binding##10##2##(1991-5#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-5#4)(1995-6#2)
substrate colonization##3##2##(2008-10#3)
substrate concentration and##2##3##(2008-7#1)(2010-10#1)
substrate concentration##7##2##(1992-3#1)(2008-5#2)(2008-7#3)(2010-10#1)
substrate concentrations##6##2##(1993-8#1)(1996-5#1)(2008-10#1)(2008-7#2)(2011-1#1)
substrate consumption rate##2##3##(2008-7#2)
substrate consumption##7##2##(2008-11#1)(2008-7#6)
substrate deprivation and simulated ischemia##2##5##(1994-2#2)
substrate discrimination##2##2##(2011-1#2)
substrate during##4##2##(1992-3#1)(2008-2#1)(2008-5#1)(2008-7#1)
substrate exposed to##2##3##(2008-10#1)(2008-11#1)
substrate for protein##3##3##(1994-11#1)(2008-7#1)(2009-9#1)
substrate for the##8##3##(1991-5#3)(2008-10#5)
substrate for tyrosine##2##3##(1992-7#1)(1993-9#1)
substrate for##41##2##(1991-5#5)(1992-1#1)(1992-3#1)(1992-7#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#1)
substrate in a##3##3##(1990-5#1)(1995-2#1)(2011-2#1)
substrate in the##5##3##(1990-10#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
substrate in##15##2##(1990-10#1)(1990-5#1)(1993-8#1)(1994-5#2)(1995-2#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
substrate is##10##2##(1992-3#2)(1992-6#1)(1993-8#1)(1994-5#1)(1995-2#2)(2008-10#1)(2008-3#1)(2012-3#1)
substrate material##2##2##(2008-10#2)
substrate molecules and##2##3##(1992-3#2)
substrate molecules##5##2##(1992-3#5)
substrate of the##2##3##(1994-8#1)(2008-10#1)
substrate of##12##2##(1990-10#1)(1990-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
substrate or##3##2##(1993-6#1)(2008-3#1)(2008-7#1)
substrate properties of##2##3##(1994-8#2)
substrate protein##2##2##(1990-10#1)(2008-4#1)
substrate proteins##3##2##(1995-2#1)(2009-6#1)(2009-7#1)
substrate reaction##2##2##(1990-8#1)(1992-3#1)
substrate recognition by##2##3##(1992-3#1)(1995-6#1)
substrate recognition##3##2##(1992-3#1)(1992-6#1)(1995-6#1)
substrate recycling##2##2##(2008-10#2)
substrate resulted in a##2##4##(2011-2#2)
substrate solution##2##2##(2008-10#2)
substrate specificities and##2##3##(2010-3#1)(2011-2#1)
substrate specificities##4##2##(2008-4#1)(2010-3#2)(2011-2#1)
substrate specificity and##2##3##(1995-2#1)(2008-10#1)
substrate specificity of the##2##4##(1992-3#1)(1996-2#1)
substrate specificity of##7##3##(1990-5#1)(1990-8#1)(1992-3#1)(1996-2#1)(2008-7#2)(2013-1#1)
substrate specificity##23##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-3#1)(1995-2#2)(1995-6#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-7#2)(2011-1#1)(2011-2#2)(2013-1#1)
substrate to form a##2##4##(2008-10#2)
substrate to##7##2##(1994-5#1)(1995-2#1)(2008-10#4)(2008-7#1)
substrate used##2##2##(2008-10#2)
substrate using##2##2##(2008-10#1)(2008-11#1)
substrate utilisation##2##2##(2008-10#2)
substrate utilization and##2##3##(2008-10#1)(2008-7#1)
substrate utilization patterns##3##3##(2008-10#2)(2008-7#1)
substrate utilization##9##2##(2008-10#6)(2008-7#2)(2008-8#1)
substrate was##8##2##(1990-10#1)(1993-3#1)(2008-10#4)(2008-11#1)(2011-1#1)
substrate will give##2##3##(2008-5#1)(2009-7#1)
substrate with##5##2##(1997-2#1)(2008-10#1)(2008-3#2)(2011-2#1)
substrate within##2##2##(1993-1#1)(2008-10#1)
substrate##506##1##(1990-10#5)(1990-11#1)(1990-2#1)(1990-5#8)(1990-8#3)(1990-9#3)(1991-3#1)(1991-5#6)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#23)(1992-6#5)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-3#4)(1993-6#5)(1993-8#14)(1993-9#1)(1994-11#6)(1994-2#4)(1994-5#22)(1994-6#1)(1994-8#6)(1994-9#1)(1995-2#14)(1995-6#9)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#8)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#129)(2008-11#28)(2008-12#3)(2008-2#5)(2008-3#18)(2008-4#9)(2008-5#17)(2008-7#58)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-9#1)(2010-10#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#9)(2011-2#17)(2012-2#13)(2012-3#1)(2013-1#2)(2013-8#1)
substrate)##3##1##(1991-9#1)(2008-10#1)(2008-8#1)
substrate-GFP fusion protein##2##3##(2008-4#2)
substrate-binding##3##1##(1991-9#1)(1995-3#2)
substrate-bound##2##1##(1994-5#2)
substrates and inhibitors##4##3##(1991-5#1)(1994-8#2)(1995-8#1)
substrates and##20##2##(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-8#2)(1995-8#1)(1996-12#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-7#1)(2009-4#1)
substrates are##5##2##(1993-3#1)(1993-8#1)(2008-10#2)(2008-7#1)
substrates at##2##2##(2011-2#1)(2012-2#1)
substrates because of##2##3##(2008-11#1)(2008-2#1)
substrates by thermolysin##2##3##(1994-5#2)
substrates by##6##2##(1994-5#2)(2008-10#3)(2012-2#1)
substrates capable of##2##3##(1990-5#1)(1994-5#1)
substrates containing##2##2##(1992-3#1)(1994-5#1)
substrates for the##5##3##(1994-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)
substrates for##29##2##(1991-9#2)(1992-6#1)(1992-8#1)(1993-2#1)(1994-5#2)(1994-8#3)(1995-8#1)(1997-3#2)(2008-10#7)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-7#1)(2012-2#2)(2013-8#1)
substrates in a##3##3##(1994-5#2)(2008-7#1)
substrates in cactophilic Drosophila mojavensis##2##5##(2008-8#1)(2008-9#1)
substrates in##12##2##(1992-10#1)(1993-3#1)(1994-5#2)(1997-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)
substrates is of##2##3##(2008-7#1)(2012-3#1)
substrates is##6##2##(1994-5#1)(2008-10#1)(2008-7#3)(2012-3#1)
substrates of the##3##3##(1997-2#1)(2008-10#2)
substrates of##11##2##(1994-8#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-6#1)(2009-9#1)(2012-2#1)
substrates on##2##2##(1992-11#1)(2010-3#1)
substrates or##3##2##(1994-5#1)(2008-7#1)(2011-1#1)
substrates such as glucose##2##4##(2008-10#1)(2011-1#1)
substrates such as##6##3##(2008-10#3)(2008-4#1)(2008-7#1)(2011-1#1)
substrates tested##2##2##(2008-10#1)(2008-11#1)
substrates that##5##2##(2008-10#3)(2008-8#1)(2010-3#1)
substrates to the##2##3##(1994-5#1)(1994-6#1)
substrates to##8##2##(1991-5#1)(1994-5#3)(1994-6#1)(1996-5#1)(2009-11#1)(2009-12#1)
substrates was##6##2##(1992-6#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-7#1)
substrates were &quot##2##3##(1991-9#2)
substrates were tested##2##3##(2008-11#1)(2011-2#1)
substrates were##12##2##(1991-9#2)(1992-6#1)(2008-10#6)(2008-11#1)(2008-7#1)(2011-2#1)
substrates with##4##2##(2008-10#2)(2008-7#1)(2010-7#1)
substrates##264##1##(1990-10#1)(1990-11#3)(1990-5#4)(1990-8#2)(1991-3#1)(1991-5#3)(1991-9#13)(1992-10#3)(1992-11#1)(1992-3#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#4)(1993-9#1)(1994-3#1)(1994-5#24)(1994-6#2)(1994-8#8)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#4)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#65)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#4)(2008-7#20)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-9#2)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#1)
substrates)##2##1##(1990-11#1)(2012-2#1)
substratum##7##1##(1994-8#1)(1995-8#1)(2008-11#4)(2008-9#1)
substructure and##2##2##(2008-12#1)(2013-1#1)
substructure##7##1##(2008-12#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
substructuring##2##1##(2008-10#2)
subsurface drip irrigation##7##3##(2008-10#7)
subsurface drip##9##2##(2008-10#9)
subsurface soil##2##2##(2008-10#2)
subsurface##14##1##(2008-10#12)(2008-3#2)
subsurface-drip irrigation##5##2##(2008-10#5)
subsurface-drip##6##1##(2008-10#6)
subsystem##2##1##(2008-10#2)
subsystems and the analysis of##2##5##(2008-11#2)
subsystems##10##1##(2008-10#4)(2008-11#3)(2008-2#2)(2010-8#1)
subtalar dislocation##3##2##(2008-12#2)(2010-3#1)
subtalar##7##1##(2008-12#3)(2010-3#3)(2012-2#1)
subtelomere##2##1##(1996-3#1)(2009-10#1)
subtelomeric DNA sequence probe were observed at the telomeres of HSA##2##11##(1997-6#2)
subtelomeric DNA##5##2##(1991-7#1)(1997-6#4)
subtelomeric region##3##2##(2008-10#1)(2009-10#1)(2012-3#1)
subtelomeric repeat##2##2##(1997-6#2)
subtelomeric##11##1##(1991-7#2)(1997-6#6)(2008-10#1)(2009-10#1)(2012-3#1)
subtending##2##1##(2008-10#1)(2009-8#1)
subterranea f##8##2##(2008-10#8)
subterranea##14##1##(2008-10#14)
subterranea-specific##2##1##(2008-10#2)
subterranean##6##1##(2008-10#2)(2011-2#1)(2012-3#3)
subterraneus##3##1##(2012-3#3)
subtests##2##1##(2008-9#1)(2009-10#1)
subthalamic nuclei##2##2##(1996-12#2)
subthalamic##4##1##(1996-12#2)(2010-12#1)(2012-2#1)
subthreshold##3##1##(1990-5#1)(2008-11#1)(2009-8#1)
subtilis GB03##2##2##(2008-10#2)
subtilis MBI 600##4##3##(2008-10#4)
subtilis and##5##2##(1995-3#1)(1996-6#1)(1997-2#1)(2009-3#1)(2011-2#1)
subtilis strains##3##2##(2008-10#2)(2011-2#1)
subtilis##60##1##(1990-11#3)(1990-12#3)(1991-6#2)(1993-12#3)(1993-9#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-6#1)(1996-8#2)(1997-2#3)(1997-7#2)(2008-10#19)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#3)(2010-1#1)(2011-1#2)(2011-2#5)
subtilis)##4##1##(2008-10#3)(2008-5#1)
subtilisin##6##1##(1992-11#2)(1992-4#1)(1994-5#1)(1995-3#1)(2008-7#1)
subtle changes in##3##3##(1993-8#1)(2008-5#1)(2011-2#1)
subtle differences in their##2##4##(2008-10#1)(2008-7#1)
subtle differences in##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#1)
subtle differences##8##2##(1994-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#2)(2013-8#1)
subtle##33##1##(1991-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-10#2)(2009-11#2)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#3)(2013-8#2)
subtotal and##2##2##(1990-6#1)(2008-7#1)
subtotal occlusion##2##2##(1997-3#1)(2013-1#1)
subtotal parathyroidectomy##2##2##(1993-3#2)
subtotal resection##2##2##(2008-7#1)(2011-2#1)
subtotal vertebrectomy##2##2##(2008-7#2)
subtotal##20##1##(1990-6#2)(1991-8#2)(1993-3#2)(1994-12#1)(1997-3#1)(1997-6#1)(2008-7#6)(2010-12#2)(2011-2#2)(2013-1#1)
subtracted fragments##2##2##(2008-10#2)
subtracted from##2##2##(2008-10#1)(2008-3#1)
subtracted##5##1##(2008-10#3)(2008-3#2)
subtracting the##2##2##(2008-8#1)(2009-12#1)
subtracting##5##1##(2008-10#3)(2008-8#1)(2009-12#1)
subtraction and odour detection##2##4##(2008-7#2)
subtraction angiography##8##2##(1993-8#2)(2008-12#1)(2008-7#3)(2011-2#2)
subtraction of##4##2##(2008-3#2)(2008-5#1)(2013-8#1)
subtraction##25##1##(1990-4#1)(1993-8#2)(1994-11#1)(1995-12#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#2)(2011-2#3)(2013-8#1)
subtractive enrichment of##2##3##(1995-12#2)
subtractive hybridization (SSH)##2##3##(2008-10#1)(2010-4#1)
subtractive hybridization##6##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-4#1)
subtractive##12##1##(1995-11#1)(1995-12#2)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)
subtractor##3##1##(2008-3#3)
subtrochanteric femoral##3##2##(2013-1#3)
subtrochanteric##5##1##(2009-3#1)(2013-1#4)
subtropical##10##1##(2008-10#6)(2008-11#1)(2008-8#2)(2010-5#1)
subtype and##2##2##(2008-10#1)(2013-1#1)
subtype of cystosarcoma phyllodes##2##4##(2011-3#2)
subtype of##19##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#1)
subtype##61##1##(1992-11#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-8#3)(1995-11#8)(1995-12#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#7)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#7)
subtype-selective##2##1##(1995-11#1)(2008-11#1)
subtypes and##2##2##(1995-12#1)(2013-1#1)
subtypes are##2##2##(1995-12#1)(2011-2#1)
subtypes have been described##3##4##(2010-6#1)(2011-2#1)(2011-3#1)
subtypes have been##4##3##(1995-11#1)(2010-6#1)(2011-2#1)(2011-3#1)
subtypes in##2##2##(1996-2#1)(2010-12#1)
subtypes of neuronal nicotinic acetylcholine receptors##2##6##(1995-11#2)
subtypes of the##2##3##(2013-1#1)(2013-8#1)
subtypes of##17##2##(1994-12#1)(1995-11#2)(1997-8#1)(2008-11#2)(2008-12#1)(2008-8#2)(2009-8#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
subtypes with##2##2##(2007-12#1)(2008-8#1)
subtypes##60##1##(1991-2#1)(1991-8#1)(1994-11#1)(1994-12#1)(1995-11#5)(1995-12#2)(1995-2#2)(1996-2#2)(1997-1#1)(1997-8#3)(2007-11#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-6#2)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#8)(2013-8#2)
subtyping##3##1##(1997-8#1)(2011-2#2)
subumbilical incision##3##2##(2011-2#3)
subungual##5##1##(2008-9#3)(2010-6#2)
subunit I of cytochrome##3##4##(1993-2#1)(1997-7#2)
subunit I of##5##3##(1993-2#2)(1995-2#1)(1997-7#2)
subunit I##6##2##(1993-2#2)(1995-2#1)(1997-7#2)(2010-4#1)
subunit alone##3##2##(1993-9#1)(1995-2#1)(2008-9#1)
subunit and the##2##3##(1993-8#1)(1995-8#1)
subunit and##14##2##(1990-5#1)(1991-12#1)(1992-9#1)(1993-8#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#1)(2008-11#1)(2008-8#2)(2010-12#1)(2013-8#1)
subunit by##2##2##(2006-6#1)(2008-8#1)
subunit combination Pb2+##2##3##(1995-11#2)
subunit combination##3##2##(1995-11#3)
subunit composition##3##2##(1990-5#1)(1991-10#1)(1995-11#1)
subunit from##5##2##(1991-6#1)(1993-12#1)(1993-8#2)(2008-11#1)
subunit gene##9##2##(1992-10#1)(1992-9#1)(1995-6#2)(1996-2#2)(2008-10#1)(2008-8#2)
subunit genes##2##2##(1996-2#1)(2008-8#1)
subunit has been##2##3##(1992-9#1)(1996-2#1)
subunit homologue##2##2##(1993-12#1)(1996-12#1)
subunit in the##5##3##(1993-8#1)(1995-12#3)(1997-7#1)
subunit in##11##2##(1993-8#2)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#1)(1997-7#2)
subunit interactions##3##2##(1994-5#1)(1995-2#1)(2008-9#1)
subunit is##9##2##(1991-12#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-8#3)
subunit mRNA levels##2##3##(1996-12#2)
subunit mRNAs##2##2##(1996-12#2)
subunit molecular##2##2##(1991-9#1)(1994-8#1)
subunit of the human platelet fibrinogen receptor##2##7##(2006-6#2)
subunit of the human##3##4##(1995-11#1)(2006-6#2)
subunit of the##17##3##(1993-12#1)(1994-2#1)(1994-5#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#3)(1997-7#1)(2006-6#2)(2008-10#1)(2009-7#2)
subunit of##52##2##(1990-2#1)(1991-12#3)(1993-12#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#6)(1995-6#5)(1995-8#3)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#2)(2006-6#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-8#1)(2012-2#2)
subunit protein##3##2##(1990-5#1)(1992-8#1)(1995-5#1)
subunit recombination##3##2##(1991-3#3)
subunit ribosomal##3##2##(1991-6#1)(2008-10#1)(2010-4#1)
subunit vaccine against##2##3##(1995-12#1)(1995-2#1)
subunit vaccines##2##2##(1995-5#1)(2009-8#1)
subunit was##6##2##(1990-2#1)(1990-5#1)(1992-9#2)(1993-8#1)(1995-2#1)
subunit with##2##2##(1993-8#1)(1995-11#1)
subunit α##4##2##(2010-11#1)(2010-12#3)
subunit##279##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#6)(1990-5#9)(1991-10#1)(1991-12#5)(1991-3#5)(1991-6#3)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#15)(1993-12#9)(1993-2#4)(1993-3#1)(1993-8#11)(1993-9#3)(1994-11#8)(1994-12#2)(1994-2#1)(1994-5#7)(1994-8#2)(1995-11#14)(1995-12#9)(1995-2#20)(1995-5#2)(1995-6#17)(1995-8#15)(1996-12#11)(1996-2#9)(1997-1#1)(1997-2#2)(1997-7#8)(2006-6#4)(2008-10#11)(2008-11#5)(2008-6#1)(2008-7#2)(2008-8#14)(2008-9#6)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#5)(2010-4#2)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
subunit)##3##1##(1991-5#1)(1995-6#1)(2008-9#1)
subunits and##9##2##(1991-12#1)(1993-6#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-8#1)(2008-9#2)
subunits are##3##2##(1995-11#1)(2008-10#1)(2012-3#1)
subunits by##2##2##(1992-6#1)(2009-7#1)
subunits encoded##2##2##(1995-6#1)(1997-7#1)
subunits from##3##2##(1993-8#1)(1996-2#1)(2008-8#1)
subunits have##3##2##(1992-3#1)(1995-6#1)(2013-8#1)
subunits in##9##2##(1991-10#1)(1991-12#1)(1993-8#1)(1995-6#1)(1996-2#1)(2008-8#1)(2008-9#3)
subunits occurred in##2##3##(1990-5#1)(2008-8#1)
subunits of the enzyme##2##4##(1990-11#1)(1992-6#1)
subunits of the##7##3##(1990-11#1)(1990-2#1)(1992-6#1)(1992-9#1)(1995-2#1)(1997-4#1)(2008-10#1)
subunits of##36##2##(1990-11#1)(1990-2#2)(1991-10#2)(1992-10#1)(1992-6#3)(1992-9#3)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-8#3)(2008-9#1)(2009-8#2)(2011-2#1)(2013-8#1)
subunits to##3##2##(1991-3#1)(1992-6#1)(2008-1#1)
subunits were##4##2##(1990-5#1)(2008-10#1)(2008-8#2)
subunits with##2##2##(1997-2#1)(2008-8#1)
subunits##144##1##(1990-11#2)(1990-2#3)(1990-5#4)(1990-7#1)(1990-8#2)(1991-10#8)(1991-12#5)(1991-3#1)(1991-7#3)(1992-10#1)(1992-2#1)(1992-3#3)(1992-6#8)(1992-9#5)(1993-12#1)(1993-2#2)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#1)(1995-11#8)(1995-2#3)(1995-6#11)(1995-8#2)(1996-1#1)(1996-2#6)(1996-8#1)(1997-2#4)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#6)(2008-4#1)(2008-8#14)(2008-9#10)(2009-7#1)(2009-8#2)(2010-5#3)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#3)
suburban##5##1##(1997-5#1)(2008-10#1)(2008-11#2)(2013-1#1)
subventricular##2##1##(1995-12#1)(2008-9#1)
subverted##2##1##(2008-11#1)(2013-1#1)
subwavelength gratings##2##2##(2008-3#2)
subwavelength##5##1##(2007-12#1)(2008-3#4)
succeed in##9##2##(1994-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
succeed##12##1##(1994-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-8#2)(2011-2#2)(2013-1#1)
succeeded in##10##2##(1992-12#1)(1995-5#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)
succeeded##17##1##(1992-12#1)(1995-5#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
succeeding##3##1##(1993-1#1)(2008-1#1)(2008-10#1)
succeeds in predicting mothers'##2##4##(2011-1#2)
success and safety##2##3##(2008-7#2)
success and the##2##3##(1997-6#1)(2008-9#1)
success and##16##2##(1994-3#1)(1996-1#1)(1997-6#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-11#1)(2010-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
success as##3##2##(1994-2#1)(2008-8#1)(2012-3#1)
success at the##2##3##(1996-12#1)(2008-8#1)
success at##4##2##(1996-1#1)(1996-12#1)(2008-8#1)(2008-9#1)
success but##2##2##(2008-8#1)(2013-1#1)
success factors##4##2##(1993-2#1)(1994-2#2)(2010-8#1)
success for##4##2##(1992-11#1)(2008-10#3)
success has##4##2##(2010-10#1)(2011-3#1)(2012-12#1)(2013-8#1)
success in a##2##3##(1995-2#1)(2007-8#1)
success in##19##2##(1992-2#1)(1995-2#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#3)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#2)
success is the##2##3##(1994-9#1)(2008-7#1)
success is##6##2##(1994-2#1)(1994-3#1)(1994-9#1)(2008-11#1)(2008-7#1)(2008-8#1)
success may##2##2##(1997-3#1)(2008-8#1)
success of a health care##2##5##(1995-1#1)(2013-1#1)
success of a##6##3##(1991-2#1)(1994-2#1)(1995-1#1)(2008-12#1)(2013-1#2)
success of percutaneous##2##3##(2008-11#1)(2008-12#1)
success of the##15##3##(1994-2#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
success of their##3##3##(1991-8#1)(1992-3#1)(2012-2#1)
success of these##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
success of this approach##2##4##(2008-1#1)(2008-11#1)
success of this##10##3##(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-2#1)(2013-8#1)
success of treatment##2##3##(2008-11#1)(2008-6#1)
success of##94##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#2)(1994-12#1)(1994-2#3)(1994-9#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#10)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#6)(2010-1#1)(2010-10#2)(2010-11#1)(2010-7#1)(2010-8#3)(2011-2#3)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#5)(2013-8#3)
success or##3##2##(2008-10#2)(2008-8#1)
success rate and##2##3##(1996-11#1)(2010-7#1)
success rate for##2##3##(1991-12#1)(2013-1#1)
success rate in##5##3##(1994-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
success rate of##11##3##(1991-3#1)(1994-5#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-12#1)(2010-7#2)(2012-12#1)(2013-1#1)
success rate##33##2##(1991-12#1)(1991-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-4#1)(2008-10#4)(2008-11#4)(2008-12#3)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
success rates##11##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
success story##2##2##(2008-10#1)(2009-12#1)
success through##2##2##(1993-3#1)(1997-1#1)
success was##9##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
success will be##2##3##(1996-1#1)(1996-3#1)
success with##4##2##(1994-1#1)(1996-12#1)(2008-7#1)(2010-8#1)
success##328##1##(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-9#2)(1993-2#3)(1993-3#3)(1993-9#1)(1994-1#3)(1994-12#6)(1994-2#9)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#7)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#9)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#31)(2008-12#8)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#37)(2008-9#22)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#1)(2010-7#5)(2010-8#10)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#5)(2012-2#12)(2012-3#17)(2012-7#1)(2013-1#15)(2013-8#8)
successes and failures##2##3##(1994-3#1)(2008-5#1)
successes and##3##2##(1994-12#1)(1994-3#1)(2008-5#1)
successes##8##1##(1990-3#1)(1993-3#1)(1994-12#1)(1994-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2012-2#1)
successful adaptation##2##2##(1995-5#1)(2008-12#1)
successful amplification of##2##3##(2008-10#1)(2008-9#1)
successful and##5##2##(1994-1#1)(2008-10#1)(2010-10#1)(2012-2#1)(2013-8#1)
successful application of a##2##4##(1995-11#1)(2008-9#1)
successful application of##6##3##(1995-11#1)(2008-10#2)(2008-9#2)(2012-3#1)
successful at##3##2##(1990-3#1)(1997-2#1)(2008-10#1)
successful attempt##3##2##(2008-10#3)
successful clinical##3##2##(2008-9#1)(2010-10#1)(2010-11#1)
successful closed reduction of##2##4##(2013-7#2)
successful closed reduction##4##3##(2013-7#4)
successful completion of##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
successful condom use##2##3##(2008-11#2)
successful condom users were more likely to##2##7##(2008-11#2)
successful condom users##3##3##(2008-11#3)
successful condom##5##2##(2008-11#5)
successful defense of##2##3##(1991-1#1)(1993-12#1)
successful establishment of##2##3##(2008-10#1)(2008-11#1)
successful exploitation##2##2##(2008-11#1)(2008-8#1)
successful for the determination of the enantiopurity of Mtx as raw material##2##12##(2008-10#2)
successful for the##3##3##(2008-10#3)
successful for##7##2##(2008-10#4)(2008-3#1)(2008-9#1)(2010-5#1)
successful hospital##2##2##(1991-2#1)(1996-2#1)
successful implementation of##5##3##(1992-1#1)(1993-12#1)(2008-10#1)(2008-7#1)(2010-12#1)
successful implementation##6##2##(1992-1#1)(1993-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-8#1)
successful in all##2##3##(1991-2#1)(2011-2#1)
successful in many##2##3##(2008-10#1)(2013-1#1)
successful in preventing fungal ingress##2##5##(2008-10#2)
successful in reducing##4##3##(2008-11#3)(2012-2#1)
successful in the##2##3##(2008-10#1)(2012-2#1)
successful in##41##2##(1991-2#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-9#2)(1996-3#1)(1997-2#2)(1997-8#2)(2008-10#10)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#1)
successful isolation of##2##3##(2008-10#2)
successful management of##6##3##(1994-3#1)(2008-10#1)(2010-7#1)(2011-2#3)
successful management##8##2##(1994-3#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#3)
successful medical##2##2##(1995-8#1)(2008-10#1)
successful operation##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
successful outcome##8##2##(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(2007-11#1)(2008-11#1)(2008-12#1)(2012-2#1)
successful past##2##2##(2008-8#1)(2011-2#1)
successful practice##2##2##(1991-1#1)(1993-1#1)
successful pregnancy##3##2##(1991-3#1)(2010-8#1)(2012-3#1)
successful rehabilitation##2##2##(1992-3#1)(2008-9#1)
successful resection of##2##3##(2008-10#1)(2011-2#1)
successful restructuring##2##2##(1994-3#1)(1995-1#1)
successful results##2##2##(2013-1#2)
successful surgical##2##2##(2011-2#1)(2013-1#1)
successful than##2##2##(1993-2#1)(1996-3#1)
successful therapeutic##2##2##(1996-11#1)(2013-1#1)
successful therapy##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
successful to##2##2##(2008-10#1)(2008-11#1)
successful transmission##2##2##(2008-10#2)
successful treatment by##3##3##(2008-7#1)(2009-5#1)(2010-12#1)
successful treatment of##6##3##(1991-4#1)(1994-6#1)(2008-10#1)(2009-7#1)(2010-3#1)(2013-8#1)
successful treatment##13##2##(1991-4#1)(1993-2#1)(1994-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
successful use of##4##3##(2008-10#2)(2008-11#2)
successful users to##2##3##(2008-11#2)
successful with##3##2##(1993-9#1)(2008-11#1)(2008-9#1)
successful##402##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#5)(1992-2#4)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#6)(1993-12#4)(1993-2#4)(1993-3#3)(1993-8#1)(1993-9#2)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#6)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-5#1)(1997-6#2)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#88)(2008-11#39)(2008-12#8)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#18)(2009-10#1)(2009-3#4)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#5)(2010-11#2)(2010-12#3)(2010-3#3)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#2)(2012-12#4)(2012-2#8)(2012-3#13)(2013-1#12)(2013-7#5)(2013-8#8)
successfully amplified by##2##3##(2008-10#2)
successfully analyzed##5##2##(2008-10#5)
successfully and##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
successfully applied for determination of##3##5##(2008-10#3)
successfully applied for simultaneous determination of##2##6##(2008-10#2)
successfully applied for the analysis of##3##6##(2008-10#3)
successfully applied for the assay of##3##6##(2008-10#3)
successfully applied for the determination of trace##2##7##(2008-10#2)
successfully applied for the determination of##16##6##(2008-10#16)
successfully applied for the##34##4##(2008-10#32)(2009-6#1)(2009-8#1)
successfully applied for##48##3##(2008-10#46)(2009-6#1)(2009-8#1)
successfully applied in##9##3##(2008-10#8)(2011-3#1)
successfully applied to analysis of##2##5##(2008-10#2)
successfully applied to determination of the##2##6##(2008-10#2)
successfully applied to determination of##5##5##(2008-10#5)
successfully applied to determine the##2##5##(2008-10#2)
successfully applied to determine##12##4##(2008-10#12)
successfully applied to different##2##4##(2008-10#2)
successfully applied to on-line##2##4##(2008-10#2)
successfully applied to real##2##4##(2008-10#2)
successfully applied to the analysis of##11##6##(2008-10#11)
successfully applied to the determination of atrazine in##2##8##(2008-10#2)
successfully applied to the determination of chromium in##2##8##(2008-10#2)
successfully applied to the determination of glucose in##2##8##(2008-10#2)
successfully applied to the determination of lead in##3##8##(2008-10#3)
successfully applied to the determination of nickel in##2##8##(2008-10#2)
successfully applied to the determination of nickel##3##7##(2008-10#3)
successfully applied to the determination of nitrite in##2##8##(2008-10#2)
successfully applied to the determination of the drug in##2##9##(2008-10#2)
successfully applied to the determination of the##4##7##(2008-10#4)
successfully applied to the determination of these##2##7##(2008-10#2)
successfully applied to the determination of trace amount of##3##9##(2008-10#3)
successfully applied to the determination of trace##7##7##(2008-10#7)
successfully applied to the determination of vanadium in##4##8##(2008-10#4)
successfully applied to the determination of##85##6##(2008-10#85)
successfully applied to the determination##86##5##(2008-10#86)
successfully applied to the pharmacokinetic study of##2##7##(2008-10#2)
successfully applied to the simultaneous determination of##12##7##(2008-10#12)
successfully applied to the simultaneous##15##5##(2008-10#14)(2008-5#1)
successfully applied to the##135##4##(2008-10#134)(2008-5#1)
successfully applied to##186##3##(2008-10#180)(2008-11#1)(2008-3#1)(2008-5#2)(2012-12#1)(2012-2#1)
successfully applied##249##2##(2008-10#238)(2008-11#1)(2008-3#2)(2008-5#2)(2009-6#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
successfully as##2##2##(2008-10#2)
successfully be##2##2##(2008-10#2)
successfully been##3##2##(2008-10#2)(2008-7#1)
successfully by##4##2##(1990-9#1)(1994-3#1)(2008-10#1)(2011-2#1)
successfully completed##4##2##(2008-10#3)(2011-2#1)
successfully conducting a##2##3##(1992-12#1)(1992-3#1)
successfully contained the growth of public expenditures on##2##8##(1994-2#2)
successfully coupled with##2##3##(2008-1#1)(2008-10#1)
successfully demonstrated for##2##3##(2008-10#2)
successfully demonstrated the##2##3##(2008-10#1)(2008-2#1)
successfully demonstrated##5##2##(2008-10#4)(2008-2#1)
successfully detect##3##2##(2008-10#2)(2011-2#1)
successfully detected##4##2##(1996-12#1)(2008-10#3)
successfully determined by##3##3##(2008-10#3)
successfully determined##6##2##(2008-10#6)
successfully developed a##2##3##(2009-7#1)(2012-3#1)
successfully developed##6##2##(2008-10#3)(2008-11#1)(2009-7#1)(2012-3#1)
successfully employed for the##3##4##(2008-10#3)
successfully employed for##5##3##(2008-10#4)(2012-12#1)
successfully employed in the##3##4##(1990-12#1)(2008-10#2)
successfully employed##14##2##(1990-12#1)(2008-10#9)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#1)
successfully established##2##2##(2008-10#1)(2008-11#1)
successfully for the analysis of##2##5##(1997-2#1)(2008-10#1)
successfully for the##10##3##(1997-2#1)(2008-10#8)(2009-11#1)
successfully for##14##2##(1997-2#1)(2008-10#10)(2008-2#1)(2009-11#1)(2009-3#1)
successfully from##2##2##(2008-10#1)(2008-8#1)
successfully generate##2##2##(2008-10#1)(2012-3#1)
successfully implement##2##2##(1994-1#1)(2008-10#1)
successfully in the determination of##2##5##(2008-10#2)
successfully in the##3##3##(2008-10#2)(2009-10#1)
successfully in##9##2##(2008-10#6)(2008-4#1)(2009-10#1)(2010-11#1)
successfully incorporated into a##2##4##(2008-10#1)(2009-12#1)
successfully incorporated into##5##3##(1996-1#1)(2008-10#2)(2009-12#1)(2012-2#1)
successfully inserted##2##2##(1997-6#1)(2010-7#1)
successfully introduced##2##2##(2008-11#1)(2013-8#1)
successfully isolated##3##2##(1997-3#1)(2008-11#1)(2008-8#1)
successfully managed##3##2##(2010-10#1)(2011-2#1)(2013-1#1)
successfully mapped##2##2##(1995-8#1)(2008-8#1)
successfully obtained##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
successfully performed in##2##3##(2008-7#1)(2012-3#1)
successfully performed##8##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-3#1)
successfully plan##2##2##(2010-7#1)(2013-8#1)
successfully recovered##2##2##(2008-10#2)
successfully separated##4##2##(2008-10#4)
successfully tested for##3##3##(2008-10#3)
successfully tested in##2##3##(1991-1#1)(2008-3#1)
successfully tested##8##2##(1991-1#1)(2008-10#5)(2008-3#1)(2011-2#1)
successfully to##33##2##(2008-10#30)(2008-11#1)(2008-5#1)(2012-2#1)
successfully transduced##2##2##(1994-5#1)(2008-9#1)
successfully transferred##2##2##(2008-10#1)(2008-8#1)
successfully treat##2##2##(2008-11#1)(2008-6#1)
successfully treated by##5##3##(1991-8#1)(2008-12#1)(2008-7#2)(2013-1#1)
successfully treated patients##2##3##(2008-11#1)(2010-10#1)
successfully treated with a##2##4##(2013-1#2)
successfully treated with itraconazole##2##4##(2008-5#2)
successfully treated with##21##3##(1990-8#1)(2008-10#4)(2008-5#2)(2008-7#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#5)(2013-1#2)(2013-8#1)
successfully treated##33##2##(1990-8#1)(1991-8#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#3)(2010-10#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#6)(2013-1#3)(2013-8#1)
successfully underwent##3##2##(2008-11#2)(2008-8#1)
successfully used as a##2##4##(2008-10#1)(2009-10#1)
successfully used as an indicator electrode in the potentiometric titration of##2##11##(2008-10#2)
successfully used as an indicator electrode in##3##7##(2008-10#3)
successfully used as##6##3##(2008-10#5)(2009-10#1)
successfully used for determination of##2##5##(2008-10#2)
successfully used for the assay of##2##6##(2008-10#2)
successfully used for the separation##2##5##(2008-10#2)
successfully used for the##11##4##(2008-10#10)(2008-5#1)
successfully used for##19##3##(2008-10#16)(2008-11#1)(2008-5#1)(2011-2#1)
successfully used in a##2##4##(2008-10#2)
successfully used in the##2##4##(2008-10#2)
successfully used in##9##3##(1990-9#1)(2008-10#6)(2008-3#1)(2011-3#1)
successfully used to determine##4##4##(2008-10#3)(2012-2#1)
successfully used to##18##3##(2008-10#9)(2008-11#4)(2008-5#1)(2010-4#1)(2012-2#2)(2013-1#1)
successfully used##55##2##(1990-9#1)(2008-10#37)(2008-11#6)(2008-3#1)(2008-5#2)(2009-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
successfully using a##2##3##(1993-3#1)(2008-10#1)
successfully utilized for##3##3##(2008-10#3)
successfully utilized##4##2##(1997-8#1)(2008-10#3)
successfully with##7##2##(1995-2#1)(2008-11#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-5#1)(2013-1#1)
successfully##682##1##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#3)(1991-1#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#3)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-2#3)(1994-3#2)(1994-5#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(2007-12#3)(2008-1#2)(2008-10#442)(2008-11#35)(2008-12#8)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#2)(2011-1#1)(2011-2#21)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#11)(2013-8#6)
succession of##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
succession##9##1##(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#4)
successive additions of##3##3##(1993-8#1)(2008-10#2)
successive cultures of human##2##4##(2008-11#2)
successive cultures##3##2##(2008-11#3)
successive cycles of##3##3##(2008-10#3)
successive cycles##4##2##(2008-10#4)
successive days##2##2##(1993-6#1)(2008-10#1)
successive determination of##5##3##(2008-10#5)
successive determinations of##2##3##(2008-10#2)
successive determinations##3##2##(2008-10#3)
successive generations##3##2##(2008-10#2)(2008-9#1)
successive increase##2##2##(2011-2#1)(2013-1#1)
successive injections of##3##3##(2008-10#2)(2012-12#1)
successive injections##7##2##(2008-10#6)(2012-12#1)
successive measurements##2##2##(2008-10#2)
successive reaction##2##2##(1995-6#1)(1996-5#1)
successive years##6##2##(2008-10#5)(2010-4#1)
successive##96##1##(1991-11#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#49)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#2)
successively##19##1##(1993-6#1)(1993-8#1)(1997-6#1)(2008-10#9)(2008-11#3)(2008-2#1)(2009-8#1)(2011-3#1)(2013-1#1)
successor##5##1##(2008-11#1)(2008-9#3)(2013-1#1)
succinate##7##1##(1996-8#1)(2008-10#6)
succinct overview of##2##3##(2008-10#1)(2013-8#1)
succinctly##2##1##(1996-12#1)(2011-2#1)
succinic acid##2##2##(1990-5#1)(2008-10#1)
succinic##8##1##(1990-5#1)(1995-11#1)(2008-10#6)
succinimidyl ester##2##2##(2008-9#1)(2012-3#1)
succinoyl trehalose##3##2##(2008-11#3)
succinyl concanavalin A##4##3##(1995-11#4)
succinyl dehydrogenase##2##2##(2012-2#2)
succinyl##6##1##(1995-11#4)(2012-2#2)
such &quot##2##2##(2008-10#1)(2012-2#1)
such a bias##2##3##(2013-1#2)
such a case##4##3##(2009-10#1)(2010-6#1)(2012-3#1)(2013-8#1)
such a change##2##3##(1994-2#1)(2008-10#1)
such a combined##3##3##(1990-6#1)(1992-9#2)
such a device##2##3##(2006-6#1)(2007-12#1)
such a distinction##2##3##(1991-2#1)(1992-9#1)
such a level##2##3##(2008-12#1)(2008-3#1)
such a method##3##3##(2008-10#2)(2008-7#1)
such a model##2##3##(2008-11#1)(2008-8#1)
such a procedure##2##3##(2008-10#1)(2008-7#1)
such a process##2##3##(1996-2#1)(2012-2#1)
such a program##3##3##(1992-12#2)(1992-3#1)
such a setting##3##3##(1992-1#1)(1993-1#1)(2009-6#1)
such a signal##2##3##(2008-2#1)(2008-8#1)
such a system##6##3##(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(2008-2#1)(2008-3#1)
such a test##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
such a type##2##3##(2008-10#2)
such a way##18##3##(1990-12#1)(1997-5#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
such a wide range of##2##5##(1990-11#1)(2008-10#1)
such a##165##2##(1990-11#2)(1990-12#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-9#4)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#2)(2006-6#1)(2007-12#4)(2008-10#29)(2008-11#15)(2008-12#9)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#3)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#4)
such activities##5##2##(1991-12#2)(2008-11#2)(2010-8#1)
such algorithms##2##2##(2008-3#1)(2008-6#1)
such alterations##2##2##(2009-7#1)(2011-2#1)
such an approach##3##3##(1995-2#1)(2008-3#1)(2013-1#1)
such an assessment##3##3##(1995-11#1)(2008-11#2)
such an event##2##3##(1991-2#1)(2008-11#1)
such an##39##2##(1990-11#1)(1990-6#1)(1991-2#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#2)(2009-8#1)(2010-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
such analyses##4##2##(1996-12#1)(2008-10#1)(2008-8#1)(2010-11#1)
such analysis##3##2##(1995-5#1)(2008-11#1)(2011-3#1)
such analytes##2##2##(2008-10#2)
such approaches##3##2##(2008-1#1)(2008-11#1)(2013-8#1)
such as &quot##4##3##(2008-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
such as 1##2##3##(2008-10#2)
such as 2##2##3##(2008-10#1)(2008-3#1)
such as Al##2##3##(2008-10#1)(2009-8#1)
such as Alzheimer's disease##2##4##(1996-12#1)(2008-11#1)
such as BrdU##2##3##(2008-9#2)
such as Crohn's disease##2##4##(2008-11#1)(2009-8#1)
such as Cu(II)##4##3##(2008-10#4)
such as DNA and##2##4##(2008-10#1)(2009-5#1)
such as DNA##3##3##(2008-10#1)(2008-9#1)(2009-5#1)
such as EDTA##2##3##(2008-10#2)
such as Escherichia coli##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
such as Fe##2##3##(2008-12#1)(2013-8#1)
such as MR##2##3##(2010-12#2)
such as MRI##2##3##(2012-2#1)(2013-1#1)
such as Mg(II)##2##3##(2008-10#2)
such as Mg2+##2##3##(1995-2#1)(2008-6#1)
such as Mycobacterium##2##3##(2008-7#1)(2011-1#1)
such as NH(3)##2##3##(2008-10#2)
such as Na(+)##2##3##(2008-10#2)
such as Pythium##2##3##(2008-10#2)
such as R##2##3##(2008-10#1)(2012-2#1)
such as a##21##3##(1990-8#1)(1994-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-1#1)(2009-10#1)(2012-12#1)(2013-8#1)
such as accuracy##3##3##(2008-10#2)(2013-1#1)
such as acetylsalicylic acid##2##4##(2008-10#2)
such as acidity##3##3##(2008-10#3)
such as age and##3##4##(1994-3#1)(2012-12#1)(2013-8#1)
such as age##8##3##(1990-8#1)(1994-3#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
such as air##2##3##(2008-11#1)(2008-8#1)
such as alcohol##2##3##(2010-5#1)(2013-8#1)
such as an##7##3##(1995-11#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-4#1)(2011-2#1)
such as antibiotics##3##3##(1992-3#1)(2008-11#1)(2011-1#1)
such as antibodies or##2##4##(2008-11#1)(2008-4#1)
such as anxiety##2##3##(2008-11#2)
such as apoptosis##2##3##(2008-11#1)(2012-2#1)
such as applied##2##3##(2008-10#2)
such as are##2##3##(1997-3#1)(2008-9#1)
such as aromatic##2##3##(2008-10#1)(2010-7#1)
such as arthritis##2##3##(2008-4#1)(2008-5#1)
such as ascorbate##2##3##(2008-10#2)
such as ascorbic acid and##2##5##(1993-2#1)(2008-10#1)
such as ascorbic acid##3##4##(1993-2#1)(2008-10#2)
such as asthma##2##3##(1994-11#1)(2010-12#1)
such as atherosclerosis and##2##4##(2010-5#1)(2012-12#1)
such as atherosclerosis##5##3##(2008-10#1)(2010-5#1)(2012-12#1)(2012-2#2)
such as bcl-2##3##3##(2008-11#2)(2008-7#1)
such as being##2##3##(2010-5#1)(2013-1#1)
such as benzene and##2##4##(2008-10#2)
such as blood##5##3##(2008-10#3)(2010-4#1)(2012-2#1)
such as body mass index##2##5##(2008-7#2)
such as body##3##3##(2008-7#2)(2010-5#1)
such as bone##2##3##(2008-9#1)(2011-7#1)
such as bovine##2##3##(2008-10#1)(2008-11#1)
such as brain##5##3##(2008-10#1)(2008-6#1)(2011-2#2)(2012-12#1)
such as breast cancer##3##4##(1997-3#1)(1997-8#1)(2012-2#1)
such as cadmium##2##3##(2008-10#2)
such as cancer##2##3##(2011-2#1)(2012-2#1)
such as cardiovascular##2##3##(2008-10#1)(2010-7#1)
such as cell signaling##2##4##(2008-9#1)(2011-2#1)
such as cell##8##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-5#1)
such as chemical##2##3##(1994-5#1)(1995-11#1)
such as chest pain##2##4##(2010-1#1)(2012-3#1)
such as chestnut blight##2##4##(2008-10#2)
such as chloride##2##3##(1994-5#2)
such as citrate##2##3##(2008-10#1)(2010-4#1)
such as clinical##2##3##(1994-12#1)(2008-11#1)
such as cluster##2##3##(2008-10#2)
such as cognitive##2##3##(2008-5#1)(2011-2#1)
such as commercial##2##3##(2008-10#2)
such as competition##3##3##(2008-10#1)(2008-9#2)
such as computed tomography and magnetic resonance imaging##2##8##(2008-2#1)(2008-7#1)
such as concentration of##2##4##(2008-10#2)
such as crude oil##2##4##(2008-10#2)
such as cucumber##2##3##(2008-10#1)(2013-8#1)
such as deep##2##3##(1994-3#1)(2012-3#1)
such as depression and##2##4##(2008-11#1)(2012-2#1)
such as depression##3##3##(2008-11#1)(2010-12#1)(2012-2#1)
such as diabetes##3##3##(1995-2#1)(2011-3#1)(2012-2#1)
such as direct##2##3##(1997-3#1)(2008-6#1)
such as disease##4##3##(1995-12#1)(2008-10#2)(2011-2#1)
such as dopamine##4##3##(1995-11#1)(2008-10#3)
such as drug##2##3##(2009-5#1)(2011-2#1)
such as dual##2##3##(2008-1#1)(2013-8#1)
such as egg##2##3##(2008-8#1)(2008-9#1)
such as elevated##2##3##(2008-7#1)(2010-4#1)
such as energy##2##3##(2008-8#1)(2013-8#1)
such as enhanced##3##3##(2008-8#1)(2009-6#1)(2012-2#1)
such as environmental##2##3##(2008-10#2)
such as exercise##2##3##(2008-1#1)(2011-2#1)
such as facial##2##3##(2008-12#1)(2008-9#1)
such as family##2##3##(1992-1#1)(2012-2#1)
such as film##2##3##(2008-10#2)
such as flavonoids##2##3##(2008-10#1)(2011-2#1)
such as flow cytometry and##2##5##(2008-9#1)(2010-7#1)
such as flow injection analysis (FIA)##2##6##(2008-10#2)
such as flow##7##3##(2008-10#5)(2008-9#1)(2010-7#1)
such as fluorescence##2##3##(2007-12#1)(2010-7#1)
such as freshwater##2##3##(2008-12#1)(2008-8#1)
such as fructose and##2##4##(1995-11#1)(2008-7#1)
such as gastrointestinal##2##3##(2010-12#1)(2013-7#1)
such as gene expression##2##4##(2010-11#1)(2011-3#1)
such as gene therapy##2##4##(2008-11#1)(2013-8#1)
such as gene##4##3##(2008-11#1)(2010-11#1)(2011-3#1)(2013-8#1)
such as genetic##3##3##(1995-1#1)(2008-11#1)(2008-8#1)
such as glucose##3##3##(1992-12#1)(2008-10#1)(2011-1#1)
such as glutathione##3##3##(1992-9#1)(2008-5#2)
such as health##2##3##(2008-11#1)(2010-12#1)
such as healthy##2##3##(2008-10#1)(2011-2#1)
such as heart attack##2##4##(2008-5#1)(2013-8#1)
such as heart##4##3##(2008-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
such as hemoglobin##2##3##(1990-8#1)(2008-1#1)
such as high##7##3##(2008-10#3)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
such as honey##2##3##(2008-10#2)
such as hospital##2##3##(1993-2#1)(2012-12#1)
such as hospitals##2##3##(2007-12#1)(2012-12#1)
such as host##2##3##(1997-7#1)(2008-10#1)
such as human##7##3##(1992-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
such as hydrogen##3##3##(2008-10#2)(2010-5#1)
such as hydrophobic interaction##2##4##(2008-10#2)
such as hypertension and diabetes##3##5##(1996-11#1)(2007-8#1)(2008-1#1)
such as hypertension##6##3##(1996-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2012-2#1)
such as image##2##3##(2008-6#2)
such as improved##3##3##(1997-2#1)(2008-10#1)(2013-1#1)
such as in the##3##4##(2008-10#2)(2011-2#1)
such as in##9##3##(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2011-2#1)
such as increased##3##3##(2008-8#1)(2010-1#1)(2012-12#1)
such as infection##2##3##(2008-10#1)(2012-12#1)
such as influenza##2##3##(2008-8#1)(2013-8#1)
such as injection##2##3##(2008-10#2)
such as internal##2##3##(1994-12#1)(2011-2#1)
such as ischemic##2##3##(1992-9#1)(2008-7#1)
such as its##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
such as learning##2##3##(1995-1#1)(2008-10#1)
such as leukotriene modifiers##2##4##(2010-1#2)
such as leukotriene##3##3##(2010-1#2)(2012-12#1)
such as ligand##2##3##(2008-4#1)(2008-5#1)
such as linear discriminant analysis##2##5##(2008-10#2)
such as linearity##2##3##(2008-10#1)(2009-8#1)
such as long##2##3##(2008-10#1)(2012-3#1)
such as loss##2##3##(2008-11#2)
such as low##2##3##(2008-10#2)
such as lower##2##3##(2008-10#1)(2010-9#1)
such as lupus erythematosus##2##4##(1992-5#1)(2011-2#1)
such as macrophages##2##3##(1995-5#1)(2008-10#1)
such as mass##2##3##(2008-10#1)(2011-2#1)
such as meat and##2##4##(2008-10#2)
such as mechanical##2##3##(1994-3#1)(2009-12#1)
such as medical##2##3##(2008-11#1)(2013-1#1)
such as metabolic##2##3##(2010-1#1)(2011-2#1)
such as metal##2##3##(2008-10#2)
such as metalaxyl##2##3##(2008-10#2)
such as methanol content##3##4##(2008-10#3)
such as mitochondria##2##3##(2008-7#1)(2009-8#1)
such as molecular##3##3##(2008-3#1)(2010-4#1)(2010-7#1)
such as monitoring##2##3##(2008-3#1)(2008-7#1)
such as morphine##2##3##(2008-11#1)(2008-7#1)
such as multiple sclerosis##3##4##(2011-2#2)(2012-3#1)
such as multiple##5##3##(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
such as muscle##4##3##(1992-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
such as myocardial infarction##2##4##(1997-5#1)(2013-8#1)
such as natural##2##3##(2008-10#2)
such as neural##2##3##(1990-11#1)(2011-2#1)
such as neurons##2##3##(2008-11#2)
such as nitrate##2##3##(2008-10#2)
such as number of##2##4##(2008-9#1)(2012-9#1)
such as nutrients and##2##4##(2008-10#1)(2009-8#1)
such as organic##2##3##(2008-10#2)
such as osteoblasts and##2##4##(2008-11#2)
such as oxygen##2##3##(2008-10#1)(2010-4#1)
such as oxytocin##2##3##(2008-4#2)
such as pH and the##2##5##(2008-10#2)
such as pH and##5##4##(2008-10#4)(2011-1#1)
such as pH of##2##4##(2008-10#2)
such as pH value##2##4##(2008-10#2)
such as pH##27##3##(2008-10#26)(2011-1#1)
such as partial##2##3##(2008-10#2)
such as physical##2##3##(1994-8#1)(2008-11#1)
such as poor##2##3##(2008-11#1)(2012-3#1)
such as population##2##3##(2008-11#1)(2008-8#1)
such as pork##2##3##(2007-12#1)(2008-10#1)
such as potassium##3##3##(2008-10#3)
such as predation##2##3##(2008-9#1)(2012-3#1)
such as presence of##2##4##(2009-12#1)(2011-2#1)
such as prevention of##2##4##(2013-7#1)(2013-8#1)
such as primary##2##3##(1992-12#1)(2010-12#1)
such as principal component analysis##2##5##(2008-10#1)(2013-1#1)
such as principal##3##3##(2008-10#2)(2013-1#1)
such as propylene glycol##2##4##(1991-5#1)(2008-5#1)
such as protein##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
such as proteins##4##3##(2008-10#2)(2008-12#1)(2009-8#1)
such as providing##2##3##(2012-12#1)(2012-3#1)
such as psoriasis##2##3##(2011-2#1)(2013-1#1)
such as public##3##3##(1991-12#1)(1996-1#1)(1996-3#1)
such as pyridine##2##3##(2009-9#1)(2012-12#1)
such as rats##2##3##(2009-10#2)
such as reagent##2##3##(2008-10#2)
such as reduced##2##3##(2008-10#1)(2013-1#1)
such as reproducibility##3##3##(2008-10#3)
such as rheumatoid arthritis##2##4##(1993-11#1)(2013-1#1)
such as sample volume##2##4##(2008-10#2)
such as sample##6##3##(2008-10#6)
such as scanning electron microscopy (SEM) and##2##7##(2008-10#1)(2009-7#1)
such as scanning##3##3##(2008-10#2)(2009-7#1)
such as schizophrenia##2##3##(1991-2#1)(2009-6#1)
such as seawater##2##3##(2008-10#2)
such as selection##2##3##(1992-12#1)(2008-10#1)
such as selective##2##3##(1990-3#1)(2008-10#1)
such as sensitivity##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
such as shape##2##3##(1992-2#1)(2008-3#1)
such as skin##3##3##(2008-5#3)
such as sleep##4##3##(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)
such as social##2##3##(2008-11#1)(2012-2#1)
such as sodium##6##3##(2008-10#2)(2008-11#1)(2010-4#1)(2010-7#1)(2012-2#1)
such as solution pH##2##4##(2008-10#2)
such as sonication time##3##4##(2008-10#3)
such as superoxide dismutase##2##4##(1992-9#1)(2008-10#1)
such as superoxide##3##3##(1992-12#1)(1992-9#1)(2008-10#1)
such as systemic##2##3##(2008-12#1)(2013-1#1)
such as temperature##7##3##(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2013-8#1)
such as the European##2##4##(1995-6#1)(2008-10#1)
such as the International##2##4##(2008-10#1)(2010-11#1)
such as the chemical##2##4##(2008-10#1)(2008-8#1)
such as the concentration##2##4##(2008-10#2)
such as the detection of##2##5##(1997-6#1)(2008-10#1)
such as the formation of##2##5##(1992-12#1)(2012-2#1)
such as the orbitofrontal cortex and amygdala that##2##8##(2009-10#2)
such as the pH value##2##5##(2008-10#2)
such as the pH##4##4##(2008-10#4)
such as the potential##2##4##(1997-2#1)(2009-12#1)
such as the presence of##3##5##(1996-3#1)(2008-10#1)(2008-11#1)
such as the selection of##2##5##(2008-10#1)(2009-8#1)
such as the skin##2##4##(1994-3#1)(2008-10#1)
such as the use of##4##5##(2008-10#4)
such as the##182##3##(1990-11#1)(1990-12#1)(1991-12#2)(1991-8#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#3)(2008-10#54)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#2)(2009-5#1)(2009-7#2)(2009-8#3)(2010-1#2)(2010-11#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#2)(2011-4#1)(2012-12#4)(2012-2#5)(2012-3#1)(2012-9#1)(2013-1#4)(2013-8#1)
such as these##3##3##(2008-11#1)(2008-8#1)(2010-11#1)
such as this##2##3##(2008-11#1)(2008-8#1)
such as those in the##2##5##(1991-12#1)(2010-1#1)
such as those of##2##4##(2008-11#1)(2013-1#1)
such as those with##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
such as those##15##3##(1991-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-1#1)(2012-2#3)(2013-1#2)
such as time##3##3##(2008-11#2)(2010-9#1)
such as to##3##3##(1993-11#1)(2008-11#1)(2008-6#1)
such as tobacco##2##3##(1992-9#1)(2008-10#1)
such as transcription factors##2##4##(2008-11#1)(2011-2#1)
such as transcription##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
such as transepidermal water loss##2##5##(2008-5#2)
such as trauma##3##3##(1991-2#1)(2009-5#1)(2010-9#1)
such as treatment of##2##4##(2011-2#2)
such as treatment##3##3##(2011-2#2)(2012-2#1)
such as types of##4##4##(1994-12#2)(2008-10#2)
such as understanding##2##3##(1997-3#1)(2007-12#1)
such as vascular endothelial growth factor (VEGF)##2##7##(2008-1#1)(2010-7#1)
such as ventricular##2##3##(2010-6#1)(2010-8#1)
such as viscosity##2##3##(2008-7#1)(2011-2#1)
such as water##4##3##(2008-10#3)(2008-3#1)
such as working##2##3##(1991-12#1)(2008-10#1)
such as##1924##2##(1990-11#8)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#2)(1990-8#4)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#4)(1991-3#4)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#8)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#10)(1993-1#2)(1993-11#4)(1993-12#4)(1993-2#8)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#7)(1994-12#6)(1994-2#2)(1994-3#15)(1994-5#10)(1994-6#2)(1994-8#11)(1994-9#3)(1995-1#2)(1995-11#9)(1995-12#8)(1995-2#7)(1995-3#4)(1995-5#5)(1995-6#2)(1996-1#6)(1996-11#5)(1996-12#9)(1996-2#7)(1996-3#5)(1996-5#7)(1996-9#2)(1997-1#12)(1997-2#8)(1997-3#9)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#7)(2006-6#1)(2007-12#11)(2007-8#1)(2008-1#14)(2008-10#606)(2008-11#141)(2008-12#33)(2008-2#11)(2008-3#39)(2008-4#26)(2008-5#53)(2008-6#23)(2008-7#45)(2008-8#46)(2008-9#47)(2009-1#3)(2009-10#11)(2009-11#4)(2009-12#8)(2009-3#2)(2009-4#2)(2009-5#11)(2009-6#6)(2009-7#13)(2009-8#36)(2009-9#5)(2010-1#13)(2010-10#3)(2010-11#11)(2010-12#23)(2010-3#5)(2010-4#12)(2010-5#11)(2010-6#8)(2010-7#18)(2010-8#15)(2010-9#6)(2011-1#13)(2011-2#91)(2011-3#18)(2011-4#1)(2011-7#3)(2012-12#30)(2012-2#52)(2012-3#32)(2012-5#2)(2012-9#2)(2013-1#49)(2013-7#5)(2013-8#26)
such assays##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
such association##3##2##(2008-10#2)(2008-9#1)
such behavior##2##2##(2008-3#1)(2008-8#1)
such behaviour##2##2##(1996-11#1)(2008-11#1)
such biological##2##2##(2011-2#1)(2013-1#1)
such case##5##2##(2008-11#1)(2008-7#1)(2010-5#1)(2010-6#1)(2013-1#1)
such cases have##3##3##(2010-6#2)(2013-1#1)
such cases is##3##3##(1996-11#1)(2010-12#1)(2013-1#1)
such cases##25##2##(1990-9#1)(1991-11#1)(1996-11#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#4)
such cells##3##2##(2008-10#1)(2008-11#2)
such children##2##2##(2008-10#1)(2012-12#1)
such circumstances##2##2##(2008-8#1)(2010-8#1)
such combination##2##2##(2008-10#1)(2011-2#1)
such common##3##2##(1995-12#1)(2008-10#2)
such complex##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
such compounds##2##2##(1993-12#1)(2008-11#1)
such conditions##5##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-8#1)
such correlations were##2##3##(2008-10#2)
such correlations##3##2##(2008-10#2)(2013-8#1)
such damage##3##2##(1991-2#1)(1995-6#1)(2008-10#1)
such data##10##2##(1991-12#2)(1996-11#1)(1997-2#1)(2008-10#3)(2011-3#1)(2012-2#1)(2013-1#1)
such deaths in##2##3##(1997-8#1)(2010-1#1)
such determinations##2##2##(1993-3#1)(2008-10#1)
such developments##2##2##(2009-8#1)(2013-8#1)
such devices##2##2##(1997-1#1)(2008-10#1)
such difference##2##2##(1996-3#1)(2008-5#1)
such differences##3##2##(2008-10#1)(2009-7#1)(2013-1#1)
such diverse##3##2##(2008-10#1)(2009-8#1)(2010-7#1)
such drugs##2##2##(1992-11#1)(2010-12#1)
such effects##8##2##(1996-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#1)
such events##2##2##(2009-10#1)(2013-7#1)
such examples##3##2##(2008-11#1)(2009-11#1)(2013-8#1)
such experimental##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
such factors as the##2##4##(1990-2#1)(2008-8#1)
such factors as##4##3##(1990-2#1)(2008-11#1)(2008-8#1)(2013-1#1)
such films##2##2##(2008-10#1)(2011-2#1)
such findings##3##2##(1992-12#1)(1995-11#1)(2008-8#1)
such food##2##2##(2008-10#1)(2008-11#1)
such functions##2##2##(1990-11#1)(1992-9#1)
such gene##2##2##(1997-3#1)(1997-7#1)
such groups##3##2##(1991-3#1)(1993-3#1)(2008-8#1)
such images##2##2##(2008-6#1)(2012-2#1)
such important##2##2##(1995-5#1)(1996-1#1)
such infections##2##2##(1996-12#1)(2013-8#1)
such information is##2##3##(2008-4#1)(2013-1#1)
such information##4##2##(1997-3#1)(2008-11#1)(2008-4#1)(2013-1#1)
such injuries##5##2##(1990-2#1)(1990-9#1)(1993-3#1)(2009-3#1)(2013-1#1)
such interactions##6##2##(1995-6#1)(2008-10#4)(2010-10#1)
such interventions##4##2##(2008-11#1)(2008-2#1)(2010-5#1)(2012-2#1)
such investigations##4##2##(2008-12#1)(2008-8#1)(2008-9#1)(2013-7#1)
such issues##2##2##(2008-9#1)(2009-5#1)
such lasers##2##2##(2008-3#1)(2008-9#1)
such lesions##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
such libraries##2##2##(2008-4#2)
such lines##2##2##(2008-11#2)
such low##4##2##(2008-10#2)(2008-8#1)(2013-7#1)
such materials##2##2##(2008-10#2)
such measures##2##2##(2009-6#1)(2013-1#1)
such mechanism##2##2##(2008-8#1)(2012-3#1)
such methods##5##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
such model##2##2##(2008-9#1)(2013-1#1)
such models are##2##3##(2008-7#2)
such models##6##2##(2008-7#2)(2008-8#2)(2009-4#1)(2010-1#1)
such modifications##2##2##(2009-5#1)(2013-8#1)
such new##2##2##(1997-1#1)(2008-10#1)
such observations##2##2##(2008-8#1)(2012-2#1)
such online health communities##2##4##(2011-2#2)
such parameters##2##2##(2008-10#1)(2008-11#1)
such particle##2##2##(2008-3#1)(2012-2#1)
such patients with##3##3##(2008-7#2)(2011-2#1)
such patients##21##2##(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#1)
such peptide##2##2##(2008-10#1)(2009-6#1)
such phenotypes##2##2##(2008-10#1)(2012-3#1)
such predictions##2##2##(2008-11#1)(2013-8#1)
such problems##2##2##(2008-10#1)(2013-1#1)
such processing##3##2##(1990-8#1)(2008-11#2)
such programs are##2##3##(1992-3#1)(1996-1#1)
such programs##12##2##(1992-1#2)(1992-3#1)(1992-9#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(2012-12#4)
such proteins is##2##3##(1993-9#1)(2009-8#1)
such proteins##3##2##(1993-9#1)(2008-4#1)(2009-8#1)
such purposes##2##2##(2008-10#2)
such samples##6##2##(2008-10#2)(2008-11#3)(2008-12#1)
such services##2##2##(1992-3#1)(2011-2#1)
such signals##3##2##(2008-9#1)(2010-7#1)(2013-8#1)
such simulations##2##2##(2012-12#1)(2013-1#1)
such situations##2##2##(2008-10#1)(2008-12#1)
such solutions##2##2##(2008-10#1)(2008-5#1)
such species##3##2##(2008-10#2)(2008-9#1)
such strains##2##2##(2008-10#2)
such strategies are##2##3##(1994-3#1)(2008-8#1)
such studies have##2##3##(2008-4#1)(2013-1#1)
such studies##9##2##(1994-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#2)
such substances##2##2##(1994-9#1)(2008-10#1)
such support##2##2##(2008-11#1)(2011-2#1)
such system##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
such systems is##2##3##(2008-9#1)(2013-8#1)
such systems##10##2##(1993-3#1)(1996-1#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-8#1)
such techniques##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
such technologies##2##2##(2008-11#1)(2012-2#1)
such testing##2##2##(2012-12#1)(2013-8#1)
such tests##2##2##(2008-10#1)(2008-12#1)
such that a##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2013-7#1)
such that it##2##3##(2008-8#1)(2012-12#1)
such that the overall##2##4##(2012-2#2)
such that the##11##3##(1994-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-5#1)(2012-2#2)
such that##51##2##(1994-5#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#1)
such training##2##2##(1991-1#1)(2010-10#1)
such traits##3##2##(2007-12#1)(2008-8#2)
such treatment have not##2##4##(2008-7#1)(2012-2#1)
such treatment##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
such trials##3##2##(1994-9#1)(2008-11#1)(2013-7#1)
such variables##2##2##(2009-8#1)(2013-8#1)
such##2998##1##(1990-11#14)(1990-12#3)(1990-2#8)(1990-3#2)(1990-5#3)(1990-6#2)(1990-8#5)(1990-9#2)(1991-1#4)(1991-10#1)(1991-11#5)(1991-12#17)(1991-2#10)(1991-3#7)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#3)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#12)(1992-2#8)(1992-3#8)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#19)(1993-1#4)(1993-11#4)(1993-12#7)(1993-2#11)(1993-3#10)(1993-6#2)(1993-8#4)(1993-9#2)(1994-1#4)(1994-11#8)(1994-12#13)(1994-2#11)(1994-3#20)(1994-5#12)(1994-6#4)(1994-8#15)(1994-9#8)(1995-1#2)(1995-11#12)(1995-12#11)(1995-2#15)(1995-3#8)(1995-5#15)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#12)(1996-11#10)(1996-12#13)(1996-2#10)(1996-3#12)(1996-5#8)(1996-6#3)(1996-9#3)(1997-1#15)(1997-2#12)(1997-3#16)(1997-4#5)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#9)(2006-6#2)(2007-11#3)(2007-12#19)(2007-8#2)(2008-1#20)(2008-10#796)(2008-11#249)(2008-12#64)(2008-2#19)(2008-3#76)(2008-4#39)(2008-5#75)(2008-6#32)(2008-7#78)(2008-8#94)(2008-9#78)(2009-1#3)(2009-10#22)(2009-11#5)(2009-12#14)(2009-3#4)(2009-4#4)(2009-5#16)(2009-6#15)(2009-7#16)(2009-8#49)(2009-9#9)(2010-1#19)(2010-10#9)(2010-11#14)(2010-12#28)(2010-3#8)(2010-4#14)(2010-5#17)(2010-6#14)(2010-7#28)(2010-8#20)(2010-9#6)(2011-1#15)(2011-2#127)(2011-3#23)(2011-4#1)(2011-7#3)(2012-12#44)(2012-2#81)(2012-3#47)(2012-5#3)(2012-8#1)(2012-9#2)(2013-1#95)(2013-7#11)(2013-8#60)
sucking the##2##2##(2008-7#2)
sucking##4##1##(1995-12#1)(2008-10#1)(2008-7#2)
suckling to##2##2##(2013-1#2)
suckling##4##1##(2008-8#1)(2013-1#3)
sucralfate##2##1##(1991-3#1)(2007-11#1)
sucrose (2%)##2##2##(2013-1#2)
sucrose and raffinose##2##3##(1997-2#1)(2008-10#1)
sucrose and##13##2##(1997-2#1)(2008-10#8)(2008-8#1)(2011-2#3)
sucrose biosensor##2##2##(2008-10#2)
sucrose density gradient##3##3##(1994-8#1)(1997-3#1)(2010-12#1)
sucrose density gradients##2##3##(1995-6#1)(2008-4#1)
sucrose density##5##2##(1994-8#1)(1995-6#1)(1997-3#1)(2008-4#1)(2010-12#1)
sucrose in##6##2##(1990-11#1)(2008-10#4)(2011-2#1)
sucrose is##2##2##(2008-10#2)
sucrose or##2##2##(1996-12#1)(2008-4#1)
sucrose reinforcement##2##2##(1993-6#2)
sucrose synthase##3##2##(1995-3#1)(2011-2#2)
sucrose##79##1##(1990-11#1)(1991-5#1)(1993-6#3)(1994-8#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-4#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2010-11#2)(2010-12#1)(2011-2#9)(2012-7#1)(2013-1#4)
sucrose)##2##1##(2010-11#2)
suction##18##1##(1990-11#1)(1991-3#5)(1992-12#2)(1995-8#2)(2008-10#1)(2008-5#1)(2011-2#5)(2013-1#1)
sudangrass##3##1##(2008-10#3)
sudden and unexpected##2##3##(1990-11#1)(2008-12#1)
sudden and##5##2##(1990-11#2)(2008-12#1)(2010-11#1)(2011-2#1)
sudden cardiac death in young##2##5##(2008-12#1)(2012-3#1)
sudden cardiac death##7##3##(2008-11#2)(2008-12#2)(2009-10#1)(2011-2#1)(2012-3#1)
sudden cardiac##8##2##(2008-11#2)(2008-12#2)(2009-10#1)(2010-1#1)(2011-2#1)(2012-3#1)
sudden deafness##4##2##(1994-9#3)(2011-2#1)
sudden death in##3##3##(2008-1#1)(2008-12#2)
sudden death syndrome##4##3##(2008-10#4)
sudden death##16##2##(2008-1#1)(2008-10#6)(2008-12#2)(2010-12#1)(2011-2#2)(2012-12#3)(2013-8#1)
sudden gains##6##2##(2009-11#6)
sudden increase in##2##3##(1991-12#1)(2013-1#1)
sudden infant death syndrome (SIDS) and##2##6##(1991-11#1)(1993-12#1)
sudden infant death syndrome (SIDS)##4##5##(1991-11#3)(1993-12#1)
sudden infant death syndrome##11##4##(1991-11#5)(1991-9#3)(1993-12#2)(2009-8#1)
sudden infant death##13##3##(1991-11#5)(1991-9#4)(1993-12#2)(1996-9#1)(2009-8#1)
sudden infant##14##2##(1991-11#5)(1991-9#5)(1993-12#2)(1996-9#1)(2009-8#1)
sudden loss of##2##3##(1995-3#1)(2012-12#1)
sudden oak death##5##3##(2008-10#5)
sudden onset of##6##3##(2007-12#1)(2008-10#1)(2008-7#3)(2009-12#1)
sudden onset##9##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-7#4)(2009-12#1)(2013-1#1)
sudden##93##1##(1990-11#4)(1991-11#6)(1991-12#1)(1991-9#5)(1992-12#1)(1993-12#2)(1993-8#1)(1994-9#4)(1995-3#1)(1996-11#1)(1996-9#1)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#7)(2008-5#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#6)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#7)(2012-12#5)(2012-3#1)(2013-1#2)(2013-8#1)
suddenly and##2##2##(1991-9#1)(2008-5#1)
suddenly##4##1##(1991-9#1)(2008-5#1)(2010-7#1)(2012-12#1)
sue the##3##2##(1995-12#1)(1996-5#1)(2008-11#1)
sue##6##1##(1995-12#2)(1996-5#3)(2008-11#1)
suecica##2##1##(2011-2#2)
sued##8##1##(1995-12#3)(1995-6#3)(2008-1#1)(2008-11#1)
suf-1##2##1##(1995-6#2)
sufentanil and nitrous oxide##2##4##(1996-6#2)
suffer a##3##2##(2008-11#1)(2008-7#1)(2009-8#1)
suffer from a##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
suffer from chronic##3##3##(1997-2#1)(2008-11#1)(2012-2#1)
suffer from this##2##3##(2008-10#1)(2008-7#1)
suffer from##37##2##(1990-11#1)(1990-5#1)(1992-3#1)(1993-3#1)(1995-9#1)(1996-5#1)(1996-6#2)(1997-2#2)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
suffer##52##1##(1990-11#1)(1990-5#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-9#1)(1996-5#1)(1996-6#2)(1997-2#3)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-5#1)(2008-7#5)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
suffered a fracture##2##3##(2008-11#1)(2008-12#1)
suffered a##13##2##(1990-9#1)(1993-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#3)(2009-10#1)(2010-7#1)(2013-1#1)
suffered an##3##2##(1991-3#1)(1995-12#1)(2013-8#1)
suffered from a malignant##3##4##(1991-8#1)(1993-2#1)(1995-12#1)
suffered from a##5##3##(1991-8#1)(1993-2#1)(1993-6#1)(1995-12#1)(2008-7#1)
suffered from acute##2##3##(1991-8#1)(2013-1#1)
suffered from##30##2##(1990-3#1)(1991-6#1)(1991-8#3)(1993-2#1)(1993-6#1)(1993-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-3#1)(1996-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-1#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#1)
suffered##66##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#4)(1993-2#2)(1993-6#1)(1993-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-3#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#6)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#1)(2010-1#2)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#3)(2012-9#1)(2013-1#5)(2013-8#2)
sufferers##5##1##(1996-1#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-8#1)
suffering for##2##2##(1995-5#1)(2008-11#1)
suffering from MMD and##2##4##(2013-1#2)
suffering from a##4##3##(2007-11#1)(2008-10#1)(2012-12#1)(2012-3#1)
suffering from acute##3##3##(1992-9#1)(2010-1#1)(2011-2#1)
suffering from chronic renal##2##4##(2008-10#1)(2013-1#1)
suffering from chronic##6##3##(1991-2#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
suffering from clinical depression##2##4##(1991-2#1)(2008-10#1)
suffering from recurrent##2##3##(2008-12#1)(2010-6#1)
suffering from rheumatoid arthritis##2##4##(2013-1#2)
suffering from surgical diseases##2##4##(1990-5#1)(1991-3#1)
suffering from the##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
suffering from##83##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#4)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-3#1)(1996-9#1)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#12)
suffering in##2##2##(2009-7#1)(2012-3#1)
suffering of##2##2##(1991-8#1)(2010-8#1)
suffering##115##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#4)(1991-8#4)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-1#2)(1996-3#1)(1996-9#1)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#13)(2013-8#3)
suffers from the##2##3##(2008-5#1)(2008-6#1)
suffers from##9##2##(1991-1#1)(1992-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)
suffers##14##1##(1991-1#1)(1992-10#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
suffice to##2##2##(1990-11#1)(1995-2#1)
suffice##3##1##(1990-11#1)(1991-2#1)(1995-2#1)
suffices##2##1##(1990-11#1)(2008-10#1)
sufficiency##2##1##(1990-4#1)(1996-12#1)
sufficient amounts of##6##3##(1990-5#1)(2008-10#1)(2008-11#3)(2011-2#1)
sufficient amounts##7##2##(1990-5#1)(2008-10#1)(2008-11#4)(2011-2#1)
sufficient and##6##2##(1993-1#1)(1994-5#1)(2008-10#2)(2008-4#1)(2008-9#1)
sufficient concentrations##2##2##(2008-3#1)(2010-10#1)
sufficient data##2##2##(1994-12#1)(2013-1#1)
sufficient evidence for##2##3##(2008-1#1)(2008-11#1)
sufficient evidence##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
sufficient follow-up##2##2##(1993-11#1)(2008-10#1)
sufficient for a##2##3##(2007-12#1)(2008-3#1)
sufficient for management of##2##4##(2009-12#1)(2013-1#1)
sufficient for the##8##3##(1991-2#2)(1993-11#1)(1995-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
sufficient for##36##2##(1990-11#1)(1991-2#2)(1991-3#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-11#1)(1995-2#2)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#2)(2009-10#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
sufficient interactions##2##2##(1993-6#1)(2013-8#1)
sufficient levels of##2##3##(2008-11#1)(2008-5#1)
sufficient levels##3##2##(1997-7#1)(2008-11#1)(2008-5#1)
sufficient numbers of##2##3##(2008-11#1)(2008-9#1)
sufficient numbers##3##2##(2008-11#2)(2008-9#1)
sufficient quantities of##2##3##(2008-10#1)(2008-11#1)
sufficient rats##2##2##(1994-5#2)
sufficient selectivity##3##2##(2008-10#3)
sufficient sensitivity##3##2##(2008-10#2)(2008-3#1)
sufficient time##2##2##(1994-12#1)(2012-3#1)
sufficient to account for the##2##5##(1991-3#1)(2008-7#1)
sufficient to account for##3##4##(1991-3#1)(2008-11#1)(2008-7#1)
sufficient to allow##3##3##(1992-12#1)(2008-10#1)(2010-7#1)
sufficient to cause##3##3##(1993-12#1)(2010-10#1)(2011-2#1)
sufficient to confer##2##3##(1995-5#1)(1997-3#1)
sufficient to elicit##2##3##(1991-2#1)(1996-12#1)
sufficient to identify##2##3##(1993-12#1)(2008-10#1)
sufficient to induce##4##3##(1991-5#1)(1997-7#1)(2008-10#1)(2010-11#1)
sufficient to promote##2##3##(2008-5#1)(2013-1#1)
sufficient to raise##2##3##(1996-12#1)(2008-7#1)
sufficient to##65##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-3#1)(1993-12#2)(1994-11#3)(1994-5#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-12#2)(1997-3#2)(1997-6#1)(1997-7#1)(2008-10#14)(2008-11#7)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#2)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#1)
sufficient##231##1##(1990-11#1)(1990-5#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#1)(1992-12#2)(1992-3#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-5#9)(1995-11#1)(1995-12#2)(1995-2#5)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#60)(2008-11#27)(2008-12#4)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#10)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
sufficiently flexible to##2##3##(2008-10#1)(2008-11#1)
sufficiently high##6##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-8#3)
sufficiently large##5##2##(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)
sufficiently low to allow##2##4##(2008-10#1)(2008-3#1)
sufficiently low to##4##3##(2008-10#3)(2008-3#1)
sufficiently low##5##2##(2008-10#4)(2008-3#1)
sufficiently reliable##3##2##(1990-9#1)(2008-10#1)(2013-1#1)
sufficiently sensitive##4##2##(2008-10#2)(2008-11#2)
sufficiently similar##2##2##(1995-5#1)(2008-3#1)
sufficiently stable##2##2##(2008-10#1)(2008-11#1)
sufficiently to##3##2##(1997-2#1)(2008-10#2)
sufficiently##64##1##(1990-9#1)(1992-12#1)(1993-12#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#27)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-7#2)(2010-4#2)(2010-7#1)(2012-2#2)(2013-1#1)
suffocation##2##1##(2008-10#1)(2008-11#1)
suffruticosa##2##1##(2008-10#1)(2011-1#1)
sugar and##5##2##(2008-10#2)(2008-12#1)(2010-6#1)(2013-1#1)
sugar beet (Beta##2##3##(2008-10#1)(2012-3#1)
sugar beet and wheat##3##4##(2008-10#3)
sugar beet and##4##3##(2008-10#4)
sugar beet cv##2##3##(2008-12#2)
sugar beet cyst nematode##2##4##(2008-10#1)(2008-12#1)
sugar beet genotypes##2##3##(2008-12#2)
sugar beet plant##2##3##(2008-12#2)
sugar beet plants##3##3##(2008-10#1)(2008-12#2)
sugar beet seedlings##3##3##(2008-10#3)
sugar beet##41##2##(2008-10#27)(2008-12#12)(2012-3#2)
sugar beets and##2##3##(2008-10#2)
sugar beets##4##2##(2008-10#4)
sugar bound pK(a)##2##3##(2008-10#2)
sugar cane juices using##2##4##(2008-10#2)
sugar cane##3##2##(2008-10#3)
sugar chain##2##2##(2008-11#2)
sugar content##6##2##(2008-10#3)(2010-7#1)(2013-1#2)
sugar cultivars##2##2##(2011-2#2)
sugar in##2##2##(1990-2#1)(2008-10#1)
sugar level##2##2##(1994-8#1)(2008-10#1)
sugar levels##3##2##(1993-11#1)(2008-1#1)(2008-10#1)
sugar moiety##4##2##(1992-6#1)(1993-6#1)(1995-12#1)(1996-5#1)
sugar retention##2##2##(2008-10#2)
sugar spheres##6##2##(2008-11#6)
sugar##128##1##(1990-2#2)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#62)(2008-11#9)(2008-12#16)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-10#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#4)
sugarcane and##2##2##(2008-10#2)
sugarcane cultivars##3##2##(2008-10#1)(2011-2#2)
sugarcane in##2##2##(2008-10#2)
sugarcane mosaic virus##3##3##(2008-10#1)(2008-9#2)
sugarcane mosaic##4##2##(2008-10#2)(2008-9#2)
sugarcane rust##2##2##(2008-10#2)
sugarcane##37##1##(2007-12#2)(2008-10#29)(2008-9#2)(2011-2#4)
sugars and##9##2##(2008-10#8)(2008-6#1)
sugars are##2##2##(2008-10#1)(2008-5#1)
sugars for##2##2##(2008-10#1)(2011-1#1)
sugars in the##3##3##(1990-2#1)(2008-10#2)
sugars in##7##2##(1990-2#1)(2008-10#5)(2011-1#1)
sugars or##3##2##(1990-2#1)(1992-12#1)(2008-7#1)
sugars to##2##2##(1990-2#1)(2008-10#1)
sugars##64##1##(1990-2#3)(1990-9#1)(1992-12#3)(1993-8#1)(1995-8#1)(1996-5#1)(2008-1#2)(2008-10#32)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
sugary drinks##2##2##(2010-8#2)
sugary##4##1##(1997-6#1)(2010-8#3)
suggest a complex##2##3##(2009-11#1)(2009-12#1)
suggest a crucial role of##2##5##(2008-11#1)(2010-5#1)
suggest a model##2##3##(1995-2#1)(2009-8#1)
suggest a possible mechanism##2##4##(1993-6#1)(2011-2#1)
suggest a possible##7##3##(1990-8#1)(1991-1#1)(1991-5#1)(1993-6#1)(1995-2#1)(2011-2#1)(2013-1#1)
suggest a role for##7##4##(1990-6#1)(1992-6#1)(1994-11#1)(1997-1#1)(2008-10#1)(2009-10#1)(2012-3#1)
suggest a role of the##2##5##(1992-6#1)(2010-4#1)
suggest a role##9##3##(1990-6#1)(1992-6#2)(1994-11#1)(1997-1#1)(2008-10#1)(2009-10#1)(2010-4#1)(2012-3#1)
suggest a##71##2##(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-6#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-3#3)(1994-5#1)(1995-2#2)(1995-6#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#3)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
suggest an involvement of##2##4##(2008-11#2)
suggest an##13##2##(1990-8#1)(1991-12#1)(1992-2#1)(1994-3#1)(1994-8#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-4#1)
suggest any##2##2##(1990-12#1)(2008-9#1)
suggest direct##2##2##(1992-6#1)(2011-2#1)
suggest how##3##2##(2008-12#1)(2008-8#1)(2010-3#1)
suggest increased##2##2##(2008-10#2)
suggest it##3##2##(2008-10#2)(2008-8#1)
suggest its possible##2##3##(2008-12#1)(2013-1#1)
suggest its##5##2##(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#2)
suggest possible##2##2##(2009-10#1)(2012-3#1)
suggest some##3##2##(1990-6#1)(1992-2#1)(2008-11#1)
suggest that (1)##2##3##(1994-5#1)(2011-2#1)
suggest that (a)##2##3##(1997-8#1)(2008-2#1)
suggest that B##2##3##(2008-10#2)
suggest that CC-516##2##3##(2008-5#2)
suggest that L-PHP may##2##4##(2013-7#2)
suggest that L-PHP##3##3##(2013-7#3)
suggest that M##2##3##(2008-10#2)
suggest that NO##2##3##(1992-12#1)(1995-11#1)
suggest that P##6##3##(2008-10#4)(2008-12#1)(2012-12#1)
suggest that PKC##3##3##(1990-5#1)(1993-3#1)(1995-2#1)
suggest that a high##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
suggest that a low##2##4##(1993-8#1)(2008-7#1)
suggest that a single##4##4##(1996-2#1)(2008-10#2)(2009-10#1)
suggest that a##29##3##(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-7#3)(2008-8#1)(2009-10#2)(2010-11#1)(2012-3#2)(2013-1#2)(2013-8#1)
suggest that activation of##2##4##(1991-2#1)(2008-3#1)
suggest that activation##3##3##(1991-2#1)(2008-3#1)(2008-9#1)
suggest that all##2##3##(2008-12#1)(2008-8#1)
suggest that although##2##3##(1991-10#1)(2010-3#1)
suggest that an##8##3##(1990-2#1)(1990-9#1)(1994-5#1)(2008-10#1)(2008-11#1)(2012-2#2)(2013-8#1)
suggest that artificial turf##2##4##(2013-1#2)
suggest that at least##3##4##(1991-3#1)(1991-5#1)(2008-10#1)
suggest that at##4##3##(1991-3#1)(1991-5#1)(1995-12#1)(2008-10#1)
suggest that binding of##2##4##(1993-1#1)(1995-6#1)
suggest that both the##2##4##(1994-3#1)(2013-1#1)
suggest that both##14##3##(1990-12#1)(1993-12#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-7#1)(2013-1#1)
suggest that bullying##2##3##(2009-7#2)
suggest that cAMP##2##3##(1991-3#1)(1994-11#1)
suggest that certain##5##3##(1994-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
suggest that combination therapy##2##4##(2010-10#1)(2011-2#1)
suggest that concomitant##2##3##(2011-2#1)(2012-12#1)
suggest that different##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
suggest that early##2##3##(2008-12#1)(2009-1#1)
suggest that exposure to##2##4##(1997-1#1)(2008-10#1)
suggest that extracellular##2##3##(1994-11#1)(2008-8#1)
suggest that factors##2##3##(2008-8#1)(2011-2#1)
suggest that for##2##3##(1996-12#1)(2008-7#1)
suggest that functional##3##3##(1995-2#1)(2008-11#1)(2008-5#1)
suggest that further studies##2##4##(1990-12#1)(2009-8#1)
suggest that further##6##3##(1990-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
suggest that genetic##3##3##(2008-10#3)
suggest that high##2##3##(2008-8#1)(2013-8#1)
suggest that human##3##3##(1994-2#1)(2008-2#1)(2008-8#1)
suggest that in the absence of##2##6##(1990-2#1)(2009-8#1)
suggest that in the##3##4##(1990-2#1)(1990-5#1)(2009-8#1)
suggest that in##14##3##(1990-2#1)(1990-5#1)(1993-1#1)(1993-3#1)(1993-8#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#2)(2013-8#1)
suggest that increased##4##3##(1992-3#1)(1995-11#1)(2009-12#1)(2011-2#1)
suggest that individual differences##2##4##(2008-11#1)(2013-8#1)
suggest that induced resistance is the##2##6##(2008-10#2)
suggest that induced##4##3##(2008-10#3)(2008-8#1)
suggest that inoculum##2##3##(2008-10#2)
suggest that intracellular##3##3##(1993-6#1)(1995-8#1)(2008-10#1)
suggest that it is##3##4##(1994-11#1)(1996-12#1)(2008-10#1)
suggest that it may be##4##5##(1993-2#1)(2008-10#1)(2008-3#1)(2009-10#1)
suggest that it may##5##4##(1993-2#1)(2008-10#2)(2008-3#1)(2009-10#1)
suggest that it##12##3##(1993-2#1)(1994-11#1)(1996-12#1)(1996-3#1)(2008-10#5)(2008-3#1)(2009-10#1)(2011-2#1)
suggest that local##4##3##(2008-9#1)(2009-10#1)(2011-2#2)
suggest that low##2##3##(2008-11#1)(2008-8#1)
suggest that many##2##3##(2008-9#1)(2009-10#1)
suggest that maternal##2##3##(1996-11#1)(2010-8#1)
suggest that molecular##2##3##(2008-9#1)(2012-2#1)
suggest that multiple##4##3##(1991-6#1)(1992-6#1)(1997-3#1)(2008-10#1)
suggest that other##3##3##(1990-2#1)(2013-1#1)(2013-8#1)
suggest that our##2##3##(2008-10#1)(2008-8#1)
suggest that parental##2##3##(2008-11#1)(2010-1#1)
suggest that patients with##2##4##(1993-11#1)(2011-2#1)
suggest that patients##3##3##(1993-11#1)(2008-10#1)(2011-2#1)
suggest that poor##3##3##(2008-11#1)(2009-5#1)(2013-1#1)
suggest that previous##2##3##(1994-2#1)(2013-8#1)
suggest that problem-solving therapies##2##4##(1993-2#2)
suggest that protein##2##3##(1993-8#1)(1995-6#1)
suggest that rather than##2##4##(2008-10#2)
suggest that regulation of##2##4##(1995-11#1)(1995-12#1)
suggest that regulation##3##3##(1995-11#1)(1995-12#1)(2009-10#1)
suggest that schools of nursing##2##5##(2008-11#1)(2010-8#1)
suggest that selection##2##3##(2008-10#2)
suggest that sexting is##2##4##(2013-1#2)
suggest that signal##2##3##(1997-8#1)(2008-10#1)
suggest that similar##2##3##(2008-4#1)(2008-8#1)
suggest that some of the##3##5##(1996-6#1)(2008-7#1)(2008-9#1)
suggest that some##4##3##(1996-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
suggest that stimulation of##2##4##(1994-2#1)(1997-7#1)
suggest that such##4##3##(1993-3#1)(1997-3#1)(2008-11#1)(2008-12#1)
suggest that sugarcane##2##3##(2008-10#2)
suggest that suppression of##2##4##(2008-10#1)(2008-11#1)
suggest that surfactant##2##3##(1994-5#1)(2008-10#1)
suggest that the &quot##2##4##(2008-10#1)(2008-11#1)
suggest that the ability to##2##5##(1990-11#1)(1992-10#1)
suggest that the ability##3##4##(1990-11#1)(1992-10#1)(2008-10#1)
suggest that the activation of the##2##6##(1995-2#1)(1997-2#1)
suggest that the altered##2##4##(1997-1#1)(2008-10#1)
suggest that the early##3##4##(1996-12#1)(2008-9#1)(2013-8#1)
suggest that the effect of##2##5##(1994-11#1)(1994-3#1)
suggest that the formation of##2##5##(1994-8#1)(2008-5#1)
suggest that the functional##2##4##(2008-10#1)(2012-2#1)
suggest that the gene##2##4##(2008-11#1)(2008-9#1)
suggest that the human##2##4##(1993-6#1)(2008-11#1)
suggest that the increased##2##4##(2008-11#1)(2008-9#1)
suggest that the mechanisms of##2##5##(2008-5#1)(2011-2#1)
suggest that the medial##2##4##(2008-11#1)(2008-7#1)
suggest that the most##2##4##(2008-10#1)(2008-9#1)
suggest that the observed##3##4##(1992-12#1)(2008-7#1)(2013-7#1)
suggest that the presence of##5##5##(1990-5#1)(1992-9#1)(2008-10#2)(2013-7#1)
suggest that the prevalence of##2##5##(2007-12#1)(2008-8#1)
suggest that the proposed##2##4##(2008-10#1)(2013-1#1)
suggest that the release of##2##5##(1992-6#1)(2008-10#1)
suggest that the resistance of##3##5##(2008-10#3)
suggest that the role of##3##5##(1991-5#1)(1996-12#1)(2010-1#1)
suggest that the synthesis##2##4##(1990-11#1)(1995-11#1)
suggest that the two##4##4##(1990-6#1)(2008-10#1)(2008-11#2)
suggest that the use of##3##5##(2008-11#1)(2008-9#1)(2013-8#1)
suggest that the##269##3##(1990-11#3)(1990-2#3)(1990-5#3)(1990-6#1)(1991-1#1)(1991-2#2)(1991-5#3)(1991-6#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#4)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#3)(1995-12#2)(1995-2#4)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#4)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#4)(2008-10#47)(2008-11#28)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#12)(2008-9#16)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#13)(2012-2#7)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#4)
suggest that their##3##3##(1991-9#1)(1995-3#1)(2008-10#1)
suggest that there are some##2##5##(1992-3#1)(2008-11#1)
suggest that there are##7##4##(1992-3#1)(1993-2#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
suggest that there is a##3##5##(2008-3#1)(2009-12#1)(2010-12#1)
suggest that there is no##3##5##(2008-10#1)(2008-11#2)
suggest that there is##9##4##(2008-10#3)(2008-11#2)(2008-3#1)(2009-1#1)(2009-12#1)(2010-12#1)
suggest that there may be##4##5##(1995-12#1)(2008-12#1)(2011-2#1)(2013-8#1)
suggest that there may##5##4##(1995-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
suggest that there##23##3##(1992-3#1)(1993-2#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#2)
suggest that these two##3##4##(1990-8#1)(1995-11#1)(2008-9#1)
suggest that these##15##3##(1990-8#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-7#1)(2008-10#2)(2008-9#1)(2009-10#1)(2010-5#1)
suggest that they##2##3##(1997-1#1)(2008-10#1)
suggest that this##24##3##(1990-11#1)(1990-5#1)(1993-1#1)(1993-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-6#1)(2010-11#1)(2011-7#1)(2012-2#1)(2012-3#2)
suggest that treatment with##2##4##(1996-12#1)(2008-11#1)
suggest that urinary##2##3##(1991-12#1)(1992-3#1)
suggest that use of##4##4##(2008-10#3)(2010-7#1)
suggest that virus##2##3##(2008-10#2)
suggest that visual##2##3##(1996-2#1)(2011-1#1)
suggest that vitamin##2##3##(2008-11#1)(2008-8#1)
suggest that we##2##3##(2008-9#1)(2012-2#1)
suggest that when##5##3##(1992-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
suggest that zinc##2##3##(2008-10#1)(2013-7#1)
suggest that##1171##2##(1990-11#6)(1990-12#5)(1990-2#10)(1990-3#1)(1990-5#12)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#6)(1991-6#3)(1991-7#1)(1991-9#3)(1992-1#2)(1992-10#2)(1992-12#9)(1992-2#2)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#8)(1992-8#2)(1992-9#2)(1993-1#6)(1993-11#4)(1993-12#9)(1993-2#6)(1993-3#13)(1993-6#11)(1993-8#16)(1993-9#2)(1994-1#1)(1994-11#21)(1994-12#9)(1994-2#7)(1994-3#8)(1994-5#5)(1994-6#5)(1994-8#7)(1994-9#3)(1995-11#17)(1995-12#10)(1995-2#13)(1995-3#4)(1995-5#1)(1995-6#7)(1995-8#5)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#15)(1996-2#14)(1996-3#5)(1996-5#5)(1996-6#2)(1997-1#10)(1997-2#12)(1997-3#5)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#5)(2007-11#1)(2007-12#9)(2008-1#1)(2008-10#215)(2008-11#108)(2008-12#17)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#21)(2008-6#10)(2008-7#25)(2008-8#50)(2008-9#52)(2009-1#5)(2009-10#12)(2009-12#4)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#4)(2009-7#8)(2009-8#14)(2009-9#2)(2010-1#4)(2010-10#6)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#4)(2011-1#7)(2011-10#1)(2011-2#47)(2011-7#2)(2012-12#8)(2012-2#21)(2012-3#20)(2012-5#2)(2013-1#28)(2013-7#7)(2013-8#20)
suggest the existence of##4##4##(1990-8#1)(1996-12#1)(2008-11#1)(2008-9#1)
suggest the following##2##3##(1994-5#1)(1996-12#1)
suggest the involvement of##2##4##(1997-1#1)(2008-10#1)
suggest the need for##4##4##(1995-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
suggest the need to##2##4##(1991-3#1)(2010-4#1)
suggest the need##6##3##(1991-3#1)(1995-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)
suggest the possibility of##5##4##(1990-5#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-7#1)
suggest the possibility that##5##4##(1994-11#1)(1994-3#1)(1996-12#1)(2008-11#1)(2012-2#1)
suggest the possibility##10##3##(1990-5#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
suggest the possible use of##2##5##(2008-10#1)(2008-5#1)
suggest the possible##5##3##(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
suggest the potential##5##3##(1993-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
suggest the presence of a##4##5##(1991-2#1)(1994-11#1)(2008-10#1)(2008-9#1)
suggest the presence of##7##4##(1991-2#1)(1994-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
suggest the##70##2##(1990-5#2)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-12#3)(1997-1#1)(2006-6#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#5)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
suggest their##2##2##(2007-12#1)(2009-10#1)
suggest there is a##2##4##(1995-11#1)(2008-10#1)
suggest there##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
suggest these##2##2##(2009-12#1)(2013-1#1)
suggest they##2##2##(1994-11#1)(2008-10#1)
suggest this##3##2##(2008-10#1)(2012-3#2)
suggest two##2##2##(2012-2#1)(2012-3#1)
suggest using##2##2##(1996-2#1)(2008-10#1)
suggest##1444##1##(1990-11#6)(1990-12#6)(1990-2#10)(1990-3#2)(1990-5#16)(1990-6#6)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#8)(1991-2#6)(1991-3#5)(1991-5#7)(1991-6#4)(1991-7#1)(1991-9#3)(1992-1#2)(1992-10#3)(1992-12#10)(1992-2#5)(1992-3#11)(1992-4#2)(1992-5#1)(1992-6#12)(1992-8#3)(1992-9#3)(1993-1#7)(1993-11#5)(1993-12#11)(1993-2#6)(1993-3#17)(1993-6#13)(1993-8#18)(1993-9#2)(1994-1#1)(1994-11#25)(1994-12#10)(1994-2#7)(1994-3#14)(1994-5#8)(1994-6#5)(1994-8#9)(1994-9#3)(1995-1#1)(1995-11#19)(1995-12#10)(1995-2#17)(1995-3#4)(1995-5#1)(1995-6#9)(1995-8#6)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#22)(1996-2#16)(1996-3#8)(1996-5#5)(1996-6#2)(1997-1#12)(1997-2#12)(1997-3#10)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#6)(2006-6#1)(2007-11#1)(2007-12#11)(2008-1#3)(2008-10#251)(2008-11#128)(2008-12#25)(2008-2#3)(2008-3#8)(2008-4#9)(2008-5#25)(2008-6#11)(2008-7#33)(2008-8#57)(2008-9#62)(2009-1#5)(2009-10#16)(2009-11#1)(2009-12#6)(2009-3#1)(2009-4#8)(2009-5#1)(2009-6#5)(2009-7#10)(2009-8#15)(2009-9#2)(2010-1#5)(2010-10#6)(2010-11#8)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#7)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#4)(2011-1#7)(2011-10#1)(2011-2#55)(2011-7#2)(2012-12#10)(2012-2#32)(2012-3#27)(2012-5#2)(2013-1#35)(2013-7#7)(2013-8#26)
suggested a possible involvement of##2##5##(1997-2#2)
suggested a possible##4##3##(1997-2#2)(2013-1#2)
suggested a role for##2##4##(2008-5#1)(2008-8#1)
suggested a role##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
suggested a##36##2##(1991-5#1)(1996-11#2)(1997-2#2)(1997-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#5)(2013-8#2)
suggested aggregation of##2##3##(2008-10#2)
suggested an##2##2##(1991-5#1)(2009-6#1)
suggested and##5##2##(2008-10#1)(2008-9#1)(2010-11#1)(2012-12#2)
suggested approach##2##2##(1990-5#1)(1997-2#1)
suggested as a##10##3##(1997-3#1)(2008-10#6)(2008-11#1)(2008-9#1)(2012-2#1)
suggested as##19##2##(1990-11#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
suggested based on##2##3##(1994-6#1)(2011-2#1)
suggested by Vitruvius (De Architectura)##2##5##(2008-10#2)
suggested by a##2##3##(1992-6#1)(2013-1#1)
suggested by its##2##3##(1990-5#1)(2009-12#1)
suggested by the##9##3##(1992-12#1)(1992-9#1)(1993-8#1)(1996-5#1)(1997-5#1)(2008-10#2)(2009-9#1)(2011-2#1)
suggested by##34##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#2)(2012-4#1)(2013-1#2)(2013-8#1)
suggested earlier##2##2##(1991-11#1)(2009-12#1)
suggested for##15##2##(1993-6#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)
suggested in this##2##3##(1991-11#1)(2008-12#1)
suggested in##5##2##(1991-11#1)(2008-10#1)(2008-12#2)(2012-2#1)
suggested method uses##2##3##(2008-10#2)
suggested method##4##2##(2008-10#3)(2010-8#1)
suggested on##2##2##(1994-12#1)(2008-10#1)
suggested that a single##3##4##(1992-1#1)(2008-10#2)
suggested that a##10##3##(1991-2#1)(1992-1#1)(2008-10#4)(2009-10#1)(2009-9#1)(2013-1#2)
suggested that active##2##3##(1991-5#1)(2008-10#1)
suggested that all##3##3##(1992-3#1)(2008-10#2)
suggested that an important##2##4##(1992-2#1)(2010-12#1)
suggested that an##4##3##(1992-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
suggested that at##2##3##(2008-10#2)
suggested that both##3##3##(1991-12#1)(2008-10#1)(2008-9#1)
suggested that chromosome##2##3##(1996-6#1)(2008-10#1)
suggested that health##2##3##(2008-11#1)(2010-7#1)
suggested that in##3##3##(2008-11#1)(2010-6#1)(2013-1#1)
suggested that it is##2##4##(1992-3#1)(2008-10#1)
suggested that it was##2##4##(1994-11#1)(2011-2#1)
suggested that it##7##3##(1990-6#1)(1992-3#1)(1994-11#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
suggested that not##2##3##(2008-10#2)
suggested that one##2##3##(2008-10#1)(2008-11#1)
suggested that patients##2##3##(1997-8#1)(2008-11#1)
suggested that resistance##4##3##(2008-10#4)
suggested that some##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
suggested that students##2##3##(2008-11#1)(2009-7#1)
suggested that the cell##2##4##(1997-3#1)(2008-11#1)
suggested that the conformation of##2##5##(2008-10#1)(2008-8#1)
suggested that the efe gene##2##5##(2008-10#2)
suggested that the initial##2##4##(2008-10#1)(2008-12#1)
suggested that the##98##3##(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#3)(2006-6#1)(2008-10#19)(2008-11#12)(2008-12#3)(2008-5#2)(2008-6#2)(2008-8#8)(2008-9#4)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#5)
suggested that there##6##3##(1991-12#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-12#1)
suggested that these findings##2##4##(2008-10#1)(2011-1#1)
suggested that these##8##3##(1991-3#1)(1991-5#1)(1992-3#1)(1996-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)
suggested that they##4##3##(1992-12#1)(1996-2#1)(2010-8#1)(2011-2#1)
suggested that this combination##2##4##(1997-7#1)(2013-1#1)
suggested that this virus##2##4##(2008-10#2)
suggested that this##18##3##(1990-2#1)(1990-5#3)(1993-6#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-12#2)(2008-8#1)(2010-1#1)(2013-1#1)
suggested that three##2##3##(2008-10#1)(2012-3#1)
suggested that##371##2##(1990-2#1)(1990-5#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#4)(1991-6#1)(1992-1#1)(1992-12#5)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#3)(1994-11#4)(1994-2#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#3)(1996-12#7)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#3)(1997-8#6)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#88)(2008-11#40)(2008-12#6)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#27)(2008-9#17)(2009-10#4)(2009-3#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#11)(2011-3#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#20)(2013-7#1)(2013-8#4)
suggested the existence of##2##4##(2008-11#1)(2012-7#1)
suggested the following##2##3##(2008-10#1)(2008-9#1)
suggested the possibility##2##3##(2009-5#1)(2011-2#1)
suggested the presence of##7##4##(1992-6#1)(1993-2#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
suggested the##29##2##(1991-5#1)(1992-6#1)(1993-2#1)(1995-6#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
suggested to be a##3##4##(1995-3#1)(2008-9#1)(2010-12#1)
suggested to be involved in##4##5##(1995-6#1)(2008-10#1)(2009-9#1)(2011-2#1)
suggested to be responsible for##2##5##(2008-7#1)(2011-2#1)
suggested to be##22##3##(1990-11#1)(1991-2#1)(1993-1#1)(1994-8#1)(1995-3#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#2)
suggested to contribute to##2##4##(1994-11#1)(2008-10#1)
suggested to occur via##3##4##(1990-5#1)(2013-1#2)
suggested to play##3##3##(1993-12#1)(2008-11#1)(2009-8#1)
suggested to##45##2##(1990-11#1)(1990-5#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#3)
suggested##674##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#7)(1990-6#2)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#4)(1991-5#7)(1991-6#1)(1992-1#2)(1992-12#7)(1992-2#2)(1992-3#6)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#4)(1993-8#5)(1994-11#5)(1994-12#2)(1994-2#4)(1994-6#3)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#3)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#2)(1997-2#8)(1997-3#7)(1997-5#2)(1997-7#3)(1997-8#11)(2006-6#1)(2007-11#3)(2007-12#2)(2008-10#173)(2008-11#62)(2008-12#14)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#13)(2008-6#4)(2008-7#19)(2008-8#33)(2008-9#26)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#24)(2011-3#4)(2011-4#1)(2011-7#1)(2012-12#5)(2012-2#11)(2012-3#2)(2012-4#1)(2012-7#1)(2013-1#34)(2013-7#1)(2013-8#7)
suggestedthat the##2##2##(2008-11#2)
suggesting a common##2##3##(1990-5#1)(2008-10#1)
suggesting a direct action of the drug##2##7##(1990-11#1)(1994-8#1)
suggesting a possible role for##2##5##(2008-10#2)
suggesting a possible##5##3##(1997-3#1)(2008-10#3)(2008-11#1)
suggesting a potential##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
suggesting a role for##4##4##(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#1)
suggesting a##51##2##(1990-11#1)(1990-5#2)(1991-10#1)(1991-8#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#14)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
suggesting an increased flux##2##4##(2008-11#2)
suggesting an involvement of phosphatidylinositol degradation and activation of protein kinase C##2##12##(2008-11#2)
suggesting an##13##2##(1991-6#1)(1995-2#2)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-3#1)
suggesting different##2##2##(1991-5#1)(2008-11#1)
suggesting either that##2##3##(2008-10#2)
suggesting it##4##2##(1995-6#1)(1996-6#1)(2008-10#1)(2013-8#1)
suggesting its##6##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
suggesting no involvement of arachidonic acid metabolism##2##7##(2008-11#2)
suggesting no##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
suggesting possible##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
suggesting similar##2##2##(1997-2#1)(2009-8#1)
suggesting that a single##2##4##(2008-10#2)
suggesting that a##12##3##(1991-2#1)(1992-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-6#1)(2011-2#1)
suggesting that an##2##3##(2008-10#1)(2008-3#1)
suggesting that at least##2##4##(1992-10#1)(2008-10#1)
suggesting that at##3##3##(1992-10#1)(1994-5#1)(2008-10#1)
suggesting that both##2##3##(2008-10#1)(2011-2#1)
suggesting that different##2##3##(1993-8#1)(2011-2#1)
suggesting that it may play##2##5##(2008-10#2)
suggesting that it may##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
suggesting that it##7##3##(1993-6#1)(2008-10#3)(2008-11#1)(2011-2#2)
suggesting that migration##2##3##(2008-10#2)
suggesting that new##2##3##(1995-2#1)(2008-10#1)
suggesting that no##2##3##(1994-8#1)(1996-12#1)
suggesting that one##2##3##(1993-8#1)(2008-10#1)
suggesting that other##3##3##(1992-7#1)(1995-2#1)(2010-12#1)
suggesting that protein##2##3##(1991-5#1)(1997-1#1)
suggesting that some##4##3##(1993-6#1)(1997-3#1)(2008-10#2)
suggesting that the effect##2##4##(2008-11#1)(2010-8#1)
suggesting that the interaction##2##4##(2008-8#1)(2008-9#1)
suggesting that the resistance##2##4##(2008-10#2)
suggesting that the two##3##4##(1995-6#1)(2008-10#1)(2008-11#1)
suggesting that the various##2##4##(1994-8#1)(1995-6#1)
suggesting that the##91##3##(1990-5#2)(1991-5#2)(1992-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#3)(1995-6#5)(1995-8#1)(1995-9#1)(1997-1#1)(1997-9#1)(2007-12#1)(2008-10#21)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#4)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
suggesting that their##2##3##(2008-8#1)(2010-4#1)
suggesting that there is##2##4##(1996-2#1)(1997-9#1)
suggesting that there##5##3##(1996-2#1)(1997-9#1)(2008-8#2)(2008-9#1)
suggesting that these##6##3##(1992-2#1)(1993-8#1)(2008-10#2)(2008-11#2)
suggesting that they are##2##4##(2008-7#1)(2008-9#1)
suggesting that they were derived from##2##6##(2008-10#2)
suggesting that they##7##3##(1995-2#1)(1997-1#1)(2008-10#3)(2008-7#1)(2008-9#1)
suggesting that this##12##3##(1991-11#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-9#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-2#1)
suggesting that##351##2##(1990-5#4)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#3)(1992-7#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#8)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#6)(1995-11#2)(1995-12#3)(1995-2#9)(1995-6#7)(1995-8#5)(1995-9#2)(1996-12#2)(1996-2#3)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#2)(2007-12#4)(2008-10#93)(2008-11#28)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#18)(2008-9#9)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#3)(2011-10#1)(2011-2#13)(2012-2#3)(2012-3#10)(2013-1#5)(2013-7#2)(2013-8#2)
suggesting the existence of##5##4##(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)
suggesting the importance of the##2##5##(2008-10#1)(2010-6#1)
suggesting the importance of##6##4##(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-2#1)
suggesting the involvement of a##2##5##(1994-3#1)(2008-11#1)
suggesting the involvement of##6##4##(1994-3#1)(1994-5#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)
suggesting the need##2##3##(1991-3#1)(2009-6#1)
suggesting the occurrence of##2##4##(2008-10#2)
suggesting the possibility that the##2##5##(1995-9#1)(2011-2#1)
suggesting the possible involvement##2##4##(1994-8#1)(2008-11#1)
suggesting the potential for##2##4##(2008-10#2)
suggesting the potential##3##3##(2008-10#2)(2008-11#1)
suggesting the presence of##6##4##(1994-11#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-6#1)
suggesting the##51##2##(1990-11#1)(1990-4#1)(1991-3#1)(1992-10#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-7#1)(1997-8#2)(2008-10#13)(2008-11#6)(2008-5#4)(2008-7#2)(2008-8#1)(2009-6#1)(2010-5#2)(2010-6#2)(2011-2#1)(2012-2#2)(2013-8#1)
suggesting##550##1##(1990-11#2)(1990-4#1)(1990-5#7)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#3)(1992-7#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#12)(1994-11#8)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#8)(1995-11#2)(1995-12#4)(1995-2#11)(1995-3#1)(1995-6#9)(1995-8#5)(1995-9#3)(1996-12#7)(1996-2#4)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#3)(1997-9#2)(2007-12#6)(2008-10#142)(2008-11#51)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#18)(2008-6#6)(2008-7#14)(2008-8#24)(2008-9#11)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#3)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#14)(2013-1#10)(2013-7#2)(2013-8#5)
suggestion is made##2##3##(2008-10#1)(2009-10#1)
suggestion is##3##2##(2008-10#1)(2009-10#1)(2012-3#1)
suggestion that the##3##3##(1993-12#1)(1995-6#1)(1996-2#1)
suggestion that##12##2##(1991-10#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-8#1)(2010-12#1)
suggestion##19##1##(1991-10#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-3#1)
suggestions for a##2##3##(2008-10#1)(2011-2#1)
suggestions for future research##4##4##(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)
suggestions for##24##2##(1990-2#1)(1991-2#2)(1992-12#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#2)(2010-2#1)(2011-2#1)(2012-3#1)
suggestions from##2##2##(1994-3#1)(1997-3#1)
suggestions that##3##2##(1997-3#1)(2008-7#1)(2009-8#1)
suggestions were##2##2##(2010-8#1)(2012-3#1)
suggestions##42##1##(1990-2#1)(1991-2#2)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)
suggestive for a relationship between increased##2##6##(2013-8#2)
suggestive for an inverse relationship between##2##6##(2013-8#2)
suggestive for##5##2##(2013-8#5)
suggestive of a##6##3##(1992-2#1)(1994-8#1)(1997-8#1)(2008-11#1)(2009-1#1)(2010-8#1)
suggestive of##32##2##(1990-6#1)(1991-2#1)(1992-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-7#3)(2008-8#1)(2009-1#2)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
suggestive##44##1##(1990-6#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#2)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#7)
suggests a general##2##3##(1996-1#1)(2008-10#1)
suggests a mechanism##2##3##(1991-9#1)(1995-9#1)
suggests a possible role in##2##5##(1993-12#1)(1996-3#1)
suggests a possible role##4##4##(1992-6#1)(1993-12#1)(1996-3#1)(2011-2#1)
suggests a possible##6##3##(1992-6#1)(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
suggests a potential##4##3##(1996-2#1)(2008-10#1)(2008-12#1)(2013-7#1)
suggests a relationship between##2##4##(1994-11#1)(2013-8#1)
suggests a role##2##3##(1992-6#1)(2009-6#1)
suggests a##46##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-6#2)(1993-12#2)(1993-8#2)(1994-11#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
suggests an##4##2##(1997-8#1)(2008-11#1)(2009-10#1)(2010-7#1)
suggests different##2##2##(1995-12#1)(1997-3#1)
suggests it##2##2##(2008-6#1)(2013-8#1)
suggests that S##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
suggests that a##7##3##(1997-2#1)(2008-1#1)(2008-10#2)(2008-9#1)(2012-2#1)(2013-8#1)
suggests that an##4##3##(1993-2#1)(1995-6#1)(2008-12#1)(2011-3#1)
suggests that both##3##3##(2008-10#1)(2008-8#1)(2010-1#1)
suggests that further##3##3##(1996-8#1)(2008-9#1)(2009-5#1)
suggests that genetic##3##3##(2008-10#2)(2008-11#1)
suggests that horizontal##2##3##(2008-10#1)(2009-6#1)
suggests that in the##2##4##(2008-10#1)(2008-8#1)
suggests that in##4##3##(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
suggests that increasing altitude##2##4##(2009-5#2)
suggests that it is##6##4##(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
suggests that it may##3##4##(1991-5#1)(1992-12#1)(2009-9#1)
suggests that it##12##3##(1991-12#1)(1991-5#1)(1992-12#1)(1993-6#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-9#1)(2012-2#1)
suggests that many##2##3##(2008-11#1)(2011-1#1)
suggests that most##2##3##(1996-2#1)(2008-5#1)
suggests that natural##3##3##(2008-11#1)(2008-8#2)
suggests that no##2##3##(1992-3#1)(2008-11#1)
suggests that one##2##3##(2008-10#1)(2009-10#1)
suggests that only##3##3##(1991-7#1)(1992-4#1)(2008-8#1)
suggests that other##3##3##(1997-3#1)(2012-2#1)(2012-3#1)
suggests that several##2##3##(2008-10#1)(2008-11#1)
suggests that sexual reproduction##2##4##(2008-10#2)
suggests that some##3##3##(2008-8#2)(2013-1#1)
suggests that the effects of##2##5##(2008-10#1)(2008-8#1)
suggests that the genetic##3##4##(1991-2#1)(2008-10#1)(2009-8#1)
suggests that the increase in##2##5##(1993-6#1)(1995-6#1)
suggests that the pathogen##2##4##(2008-10#2)
suggests that the rate##2##4##(2008-10#1)(2013-1#1)
suggests that the two##2##4##(1991-2#1)(2008-4#1)
suggests that the##97##3##(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-6#3)(1994-2#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-12#2)(2008-10#17)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#2)(2013-7#1)
suggests that there are##5##4##(1992-8#1)(2008-10#1)(2008-12#1)(2008-8#2)
suggests that there is a##3##5##(2008-6#1)(2010-5#1)(2011-2#1)
suggests that there is##4##4##(1994-5#1)(2008-6#1)(2010-5#1)(2011-2#1)
suggests that there##10##3##(1992-8#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-2#1)
suggests that these##15##3##(1990-12#1)(1995-11#1)(1995-12#1)(1995-2#2)(2008-10#3)(2008-12#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)
suggests that they are##3##4##(1991-5#1)(1997-2#1)(2008-7#1)
suggests that they have##2##4##(2008-10#2)
suggests that they may be##2##5##(1993-8#1)(2008-11#1)
suggests that they may##3##4##(1993-8#1)(2008-11#1)(2008-7#1)
suggests that they##11##3##(1990-2#1)(1991-5#1)(1993-8#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#2)
suggests that this protein might##2##5##(1996-12#1)(2008-10#1)
suggests that this##14##3##(1992-8#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2013-1#1)
suggests that##424##2##(1990-12#4)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#3)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#5)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#8)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#4)(1996-1#3)(1996-12#8)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-7#3)(1997-8#2)(1997-9#2)(2007-12#6)(2008-1#5)(2008-10#68)(2008-11#35)(2008-12#10)(2008-3#1)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#31)(2008-9#14)(2009-10#2)(2009-12#2)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#6)(2012-6#1)(2013-1#12)(2013-7#3)(2013-8#5)
suggests the existence of##3##4##(1992-6#1)(1994-11#1)(2011-2#1)
suggests the involvement of##2##4##(1995-2#1)(2008-10#1)
suggests the potential##2##3##(1995-6#1)(2012-3#1)
suggests the usefulness of##2##4##(1994-12#1)(2008-10#1)
suggests the##25##2##(1991-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2009-8#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-8#1)
suggests this##3##2##(2008-9#1)(2009-9#1)(2013-1#1)
suggests two##2##2##(1993-6#1)(2013-1#1)
suggests ways##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
suggests##570##1##(1990-12#4)(1990-2#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-5#5)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#3)(1992-6#3)(1992-8#2)(1993-1#1)(1993-12#5)(1993-2#3)(1993-3#3)(1993-6#6)(1993-8#5)(1994-11#5)(1994-12#3)(1994-2#10)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#7)(1995-8#4)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#9)(1996-2#5)(1996-3#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#4)(1997-6#1)(1997-7#3)(1997-8#4)(1997-9#2)(2006-6#1)(2007-12#9)(2008-1#5)(2008-10#87)(2008-11#47)(2008-12#12)(2008-3#1)(2008-4#4)(2008-5#11)(2008-6#4)(2008-7#10)(2008-8#35)(2008-9#18)(2009-10#3)(2009-11#2)(2009-12#2)(2009-5#3)(2009-6#5)(2009-7#3)(2009-8#10)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#6)(2010-8#2)(2011-1#2)(2011-2#17)(2011-3#1)(2012-12#4)(2012-2#18)(2012-3#9)(2012-6#1)(2013-1#19)(2013-7#5)(2013-8#10)
suicidal behavior in a##2##4##(2010-7#1)(2013-1#1)
suicidal behavior##5##2##(2010-7#1)(2013-1#4)
suicidal hanging##2##2##(2010-7#2)
suicidal ideation##5##2##(1992-1#2)(2008-11#1)(2010-6#2)
suicidal thoughts and behaviors##2##4##(2008-11#2)
suicidal thoughts and##3##3##(2008-11#2)(2009-7#1)
suicidal thoughts##4##2##(2008-11#2)(2008-6#1)(2009-7#1)
suicidal##35##1##(1992-1#5)(1992-5#1)(1993-2#2)(1995-11#2)(2008-11#4)(2008-6#1)(2009-7#1)(2010-6#11)(2010-7#4)(2013-1#4)
suicide attempt##5##2##(1992-1#1)(1995-11#1)(2010-7#2)(2013-1#1)
suicide attempts and##2##3##(2010-6#1)(2013-1#1)
suicide attempts##3##2##(2010-6#1)(2013-1#2)
suicide cases##2##2##(1996-1#2)
suicide in older##3##3##(2009-5#3)
suicide in##10##2##(1996-1#2)(1997-3#1)(2008-11#1)(2009-5#4)(2010-6#1)(2011-2#1)
suicide is##2##2##(2010-6#1)(2013-1#1)
suicide prevention measures among##2##4##(2011-2#2)
suicide prevention##3##2##(2009-5#1)(2011-2#2)
suicide rates##4##2##(1990-6#1)(1996-1#1)(2009-5#1)(2011-2#1)
suicide was##3##2##(1991-8#2)(1992-1#1)
suicide##78##1##(1990-6#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#9)(1992-1#5)(1993-3#1)(1993-9#3)(1995-11#1)(1996-1#10)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#2)(2009-5#8)(2010-5#1)(2010-6#6)(2010-7#2)(2010-9#1)(2011-2#6)(2012-3#1)(2013-1#6)(2013-8#1)
suicides##2##1##(1995-11#1)(2011-2#1)
suillus##4##1##(2011-2#4)
suing##2##1##(1994-2#1)(1996-5#1)
suis serotype 2##4##3##(2009-6#4)
suis##12##1##(1996-12#2)(2007-12#1)(2009-6#9)
suit against##3##2##(1993-12#1)(1995-12#2)
suit over##3##2##(1996-2#1)(1996-5#2)
suit##26##1##(1993-12#3)(1994-3#1)(1995-12#8)(1995-6#5)(1996-2#1)(1996-5#4)(1996-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
suitability as##3##2##(2008-10#2)(2009-7#1)
suitability for##12##2##(1995-11#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)
suitability of potential##2##3##(2008-8#2)
suitability of the##17##3##(1997-6#1)(2008-10#11)(2008-11#2)(2008-9#1)(2009-8#1)(2010-4#1)
suitability of##42##2##(1994-9#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#21)(2008-11#5)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#2)(2013-8#1)
suitability to##2##2##(2008-10#2)
suitability##67##1##(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#35)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
suitable alternative##9##2##(1993-1#1)(1996-1#3)(2008-10#2)(2008-3#1)(2008-5#1)(2010-7#1)
suitable amount of##2##3##(2008-10#2)
suitable analytical##3##2##(2008-10#3)
suitable and##2##2##(2008-10#2)
suitable approach for##3##3##(2008-10#2)(2008-11#1)
suitable as a##2##3##(2008-10#1)(2011-2#1)
suitable as##4##2##(2008-10#3)(2011-2#1)
suitable conditions for##2##3##(2008-10#2)
suitable conditions##4##2##(2008-10#3)(2010-1#1)
suitable detection##2##2##(2008-10#1)(2012-2#1)
suitable for a variety of##2##5##(2008-4#2)
suitable for a##5##3##(2008-10#2)(2008-3#1)(2008-4#2)
suitable for analysis of##3##4##(1997-2#1)(2008-10#1)(2010-12#1)
suitable for analysis##4##3##(1997-2#1)(2008-10#1)(2008-9#1)(2010-12#1)
suitable for application in skin and##2##6##(2008-5#2)
suitable for application in##5##4##(2008-10#3)(2008-5#2)
suitable for application##7##3##(2008-10#5)(2008-5#2)
suitable for applications in##2##4##(2007-12#1)(2008-11#1)
suitable for applications##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
suitable for automatic and continuous analysis##4##6##(2008-10#4)
suitable for biomimetic bone tissue engineering##2##6##(2009-7#2)
suitable for clinical##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
suitable for determination of the##2##5##(2008-10#2)
suitable for determination of##4##4##(2008-10#4)
suitable for field##2##3##(2008-10#2)
suitable for industrial##3##3##(1991-5#1)(2008-10#1)(2011-2#1)
suitable for measuring##3##3##(2008-10#3)
suitable for most##2##3##(2008-10#1)(2011-2#1)
suitable for neonatal screening##2##4##(1991-2#2)
suitable for qualitative##2##3##(2008-10#1)(2012-3#1)
suitable for quantification of##2##4##(2008-10#2)
suitable for quantitating iodate##2##4##(2008-10#2)
suitable for rapid##2##3##(2008-11#1)(2008-9#1)
suitable for routine##5##3##(2008-10#4)(2008-5#1)
suitable for screening##3##3##(2008-10#2)(2011-2#1)
suitable for studying##2##3##(2008-10#1)(2008-11#1)
suitable for the assay of##2##5##(2008-10#2)
suitable for the assay##3##4##(2008-10#2)(2008-11#1)
suitable for the detection of##2##5##(1990-12#1)(2008-10#1)
suitable for the determination of##11##5##(2008-10#10)(2009-8#1)
suitable for the expression of##2##5##(2008-8#2)
suitable for the identification##2##4##(2008-10#1)(2011-2#1)
suitable for the salivary gland##2##5##(2008-11#2)
suitable for the separation##2##4##(2008-10#2)
suitable for the simultaneous##4##4##(2008-10#4)
suitable for the##57##3##(1990-12#1)(1990-2#1)(1991-2#1)(1996-2#1)(1996-3#1)(2008-10#35)(2008-11#8)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
suitable for their##2##3##(2008-10#1)(2012-12#1)
suitable for use in##5##4##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
suitable for use with##5##4##(2008-10#2)(2008-6#1)(2008-9#1)(2013-1#1)
suitable for use##14##3##(1990-12#1)(1996-12#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
suitable for##244##2##(1990-12#2)(1990-2#2)(1991-12#1)(1991-2#4)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#128)(2008-11#23)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#4)(2009-7#3)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
suitable habitat##2##2##(2008-10#1)(2008-11#1)
suitable in##3##2##(2008-10#1)(2009-10#1)(2010-12#1)
suitable material for##3##3##(2008-10#2)(2008-4#1)
suitable mathematical##2##2##(2008-1#1)(2008-10#1)
suitable medium for##2##3##(2008-10#2)
suitable method for##4##3##(2008-10#4)
suitable method##7##2##(2008-10#6)(2008-5#1)
suitable methodology##2##2##(2008-10#2)
suitable model##6##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
suitable models##2##2##(1991-5#1)(2013-1#1)
suitable or##2##2##(2008-10#1)(2008-9#1)
suitable pH for##2##3##(2008-10#2)
suitable pH##3##2##(2008-10#3)
suitable substrate for##2##3##(2008-10#1)(2012-2#1)
suitable substrates##3##2##(1991-9#1)(2008-10#1)(2009-11#1)
suitable technique##3##2##(2008-10#2)(2009-12#1)
suitable to##8##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
suitable tool for##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
suitable tool##5##2##(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
suitable##477##1##(1990-12#3)(1990-2#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-9#2)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#245)(2008-11#48)(2008-12#5)(2008-2#3)(2008-3#12)(2008-4#9)(2008-5#17)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-4#2)(2010-6#2)(2010-7#3)(2010-8#3)(2011-2#12)(2011-3#2)(2012-12#3)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#8)
suitably packed medications##2##3##(2012-12#2)
suitably##17##1##(1990-11#1)(1992-12#1)(2007-11#1)(2008-10#7)(2008-3#2)(2008-4#1)(2009-7#1)(2010-6#1)(2012-12#2)
suite of##10##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#2)
suite##15##1##(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#4)(2010-11#1)(2012-3#1)(2013-1#3)
suited as##2##2##(1990-8#1)(2008-10#1)
suited for the analysis of##2##5##(2008-10#2)
suited for the##11##3##(1990-12#1)(1990-8#1)(1997-6#1)(2008-10#7)(2011-1#1)
suited for this##3##3##(1995-2#1)(2008-10#2)
suited for##43##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#1)(1995-2#1)(1997-6#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-9#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)
suited to study##2##3##(2008-7#1)(2012-12#1)
suited to the##6##3##(1990-9#1)(1993-12#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-9#1)
suited to##30##2##(1990-9#1)(1991-12#1)(1993-12#1)(1993-2#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
suited##75##1##(1990-11#1)(1990-12#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-9#1)(1993-12#1)(1993-2#1)(1995-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#26)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#6)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
suites of##2##2##(2007-12#1)(2008-9#1)
suites##4##1##(2007-12#1)(2008-9#1)(2013-1#2)
suits##4##1##(1996-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
sujet âgé##2##2##(2013-1#2)
sulcus and##3##2##(2008-11#1)(2010-5#1)(2013-1#1)
sulcus hemorrhage##3##2##(2013-1#3)
sulcus##12##1##(1991-3#1)(1994-8#1)(2008-11#3)(2008-7#1)(2009-10#1)(2010-5#1)(2013-1#4)
sulfabenzamide##2##1##(2008-10#2)
sulfadiazine##5##1##(2008-10#5)
sulfadimethoxine##4##1##(2008-10#4)
sulfaguanidine##8##1##(2008-10#8)
sulfamate derivatives##2##2##(1993-1#2)
sulfamate##4##1##(1993-1#3)(2008-10#1)
sulfamerazine##7##1##(2008-10#7)
sulfamethazine##4##1##(2008-10#4)
sulfamethoxazole##4##1##(2008-10#3)(2010-12#1)
sulfamonomethoxine##4##1##(2008-10#4)
sulfanilamide and##3##2##(2008-10#3)
sulfanilamide##5##1##(2008-10#4)(2011-3#1)
sulfanilic acid##5##2##(2008-10#5)
sulfapyridine##3##1##(2008-10#3)
sulfaquinoxaline##2##1##(2008-10#2)
sulfasalazine##5##1##(2008-10#3)(2010-12#2)
sulfatase##6##1##(2012-2#4)(2013-8#2)
sulfate (SLES)##2##2##(2008-10#1)(2008-5#1)
sulfate and ammonium##2##3##(2008-10#1)(2008-8#1)
sulfate and##15##2##(1992-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#9)(2008-8#1)(2010-6#1)
sulfate as##2##2##(2008-10#1)(2008-5#1)
sulfate droplets##2##2##(2008-3#2)
sulfate groups##4##2##(2008-10#4)
sulfate in the##2##3##(2008-10#2)
sulfate in##5##2##(1995-12#2)(2008-10#3)
sulfate ion and##2##3##(2008-10#2)
sulfate ion in##2##3##(2008-10#2)
sulfate ion##9##2##(2008-10#9)
sulfate ion-selective##2##2##(2008-10#2)
sulfate ions in##2##3##(2008-10#2)
sulfate ions##4##2##(2008-10#4)
sulfate is##3##2##(2008-10#2)(2008-8#1)
sulfate on##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
sulfate reduction##2##2##(2008-10#1)(2013-8#1)
sulfate to##4##2##(1991-3#1)(2008-10#2)(2008-11#1)
sulfate was##3##2##(2008-10#2)(2011-2#1)
sulfate with##2##2##(1993-8#1)(1996-2#1)
sulfate##200##1##(1990-10#2)(1990-11#2)(1990-5#1)(1991-12#2)(1991-3#1)(1991-7#1)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-2#1)(1993-8#5)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-6#2)(1996-12#2)(1996-2#11)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#112)(2008-11#6)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
sulfate)##8##1##(1995-12#1)(2008-10#7)
sulfate-carbon##2##1##(2008-3#2)
sulfate-reducing bacteria##2##2##(1994-5#1)(2011-1#1)
sulfated Asn-linked oligosaccharides##2##3##(1992-10#2)
sulfated GAGs##2##2##(1993-12#2)
sulfated##13##1##(1992-10#4)(1992-12#2)(1993-12#5)(1995-2#1)(2008-11#1)
sulfathiazole and##2##2##(2008-10#2)
sulfathiazole##7##1##(2008-10#7)
sulfation##3##1##(1993-12#1)(1995-2#1)(2008-11#1)
sulfentrazone##2##1##(2008-10#2)
sulfhydryl and amino groups##2##4##(2008-7#1)(2009-8#1)
sulfhydryl compounds##2##2##(1992-9#1)(1994-8#1)
sulfhydryl group##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
sulfhydryl groups##2##2##(1991-5#1)(2013-1#1)
sulfhydryl##18##1##(1991-5#1)(1992-12#1)(1992-9#1)(1994-8#1)(1995-8#3)(2006-6#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
sulfide and mercaptans##2##3##(2008-10#1)(2008-6#1)
sulfide and nitrite##2##3##(1993-8#1)(2008-10#1)
sulfide and##9##2##(1993-8#1)(2008-10#6)(2008-11#1)(2008-6#1)
sulfide at##2##2##(2008-10#2)
sulfide based on##2##3##(2008-10#2)
sulfide by##2##2##(2008-10#2)
sulfide can##2##2##(2008-10#1)(2012-2#1)
sulfide concentration##2##2##(2008-10#2)
sulfide determination in##3##3##(2008-10#3)
sulfide determination##6##2##(2008-10#6)
sulfide in different##2##3##(2008-10#2)
sulfide in environmental##2##3##(2008-10#2)
sulfide in##15##2##(1996-5#1)(2008-10#14)
sulfide is determined by##2##4##(2008-10#2)
sulfide is##3##2##(2008-10#3)
sulfide on##2##2##(2008-10#1)(2013-8#1)
sulfide solution##2##2##(2008-10#2)
sulfide with##3##2##(2008-10#3)
sulfide##99##1##(1993-8#1)(1995-3#1)(1996-5#3)(2008-10#85)(2008-11#1)(2008-2#1)(2008-6#3)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
sulfides to##2##2##(2008-10#1)(2008-6#1)
sulfides##11##1##(2008-10#9)(2008-6#2)
sulfidic##2##1##(2008-10#2)
sulfisoxazole##7##1##(2008-10#1)(2008-12#6)
sulfite and sulfide##3##3##(2008-10#3)
sulfite and##5##2##(1993-8#1)(2008-10#4)
sulfite in##6##2##(2008-10#6)
sulfite ions in##2##3##(2008-10#2)
sulfite ions##5##2##(2008-10#5)
sulfite is used##2##3##(2008-10#2)
sulfite is##3##2##(2008-10#3)
sulfite reductase##2##2##(1993-8#2)
sulfite solution##3##2##(2008-10#3)
sulfite##45##1##(1993-8#4)(2008-10#41)
sulfonamide compounds in a mixture##2##5##(2008-10#2)
sulfonamide compounds##3##2##(2008-10#3)
sulfonamide##11##1##(1996-2#1)(2008-10#7)(2009-3#2)(2009-8#1)
sulfonamides and quinolones##4##3##(2008-10#4)
sulfonamides and##5##2##(2008-10#4)(2011-2#1)
sulfonamides##19##1##(2008-10#16)(2009-8#1)(2010-6#1)(2011-2#1)
sulfonate (SDBS)##2##2##(2008-10#2)
sulfonate and##2##2##(2008-10#2)
sulfonate##16##1##(1994-5#1)(2008-10#14)(2010-12#1)
sulfonate)##6##1##(2008-10#5)(2008-12#1)
sulfonated##5##1##(2008-10#5)
sulfonates in##2##2##(2008-10#2)
sulfonates##6##1##(2008-10#6)
sulfonephthalein##2##1##(2008-10#2)
sulfonic acid##7##2##(2008-10#7)
sulfonic acids##3##2##(2008-10#3)
sulfonic##12##1##(2008-10#12)
sulfonium##3##1##(1994-8#3)
sulfonyl##3##1##(1990-5#1)(2008-10#1)(2008-5#1)
sulfonylurea agents on##2##3##(1994-8#2)
sulfonylurea herbicides##2##2##(2008-10#2)
sulfonylurea##7##1##(1991-7#1)(1992-3#2)(1994-8#2)(2008-10#2)
sulfonylureas##8##1##(1991-12#2)(1992-3#6)
sulforhodamine B##2##2##(2008-10#2)
sulfotransferase##3##1##(1992-10#1)(1993-12#2)
sulfoxide (DMSO)##6##2##(1994-8#1)(2008-10#5)
sulfoxide and##4##2##(1993-3#2)(2008-10#2)
sulfoxide##18##1##(1990-9#1)(1993-3#2)(1994-8#1)(1996-12#1)(1996-5#1)(2008-10#11)(2010-1#1)
sulfur amino acids##2##3##(2008-10#1)(2011-2#1)
sulfur and##6##2##(2008-10#5)(2008-9#1)
sulfur atom##2##2##(1992-12#1)(2010-2#1)
sulfur by##2##2##(2008-10#1)(2008-11#1)
sulfur colloid##2##2##(1994-2#1)(1997-1#1)
sulfur compounds in##3##3##(2008-10#3)
sulfur compounds##11##2##(2008-10#11)
sulfur containing diesel fuels##2##4##(2008-10#2)
sulfur containing##3##2##(2008-10#3)
sulfur content##2##2##(2008-10#2)
sulfur dioxide in air by##2##5##(2008-10#2)
sulfur dioxide in air##3##4##(2008-10#3)
sulfur dioxide in##9##3##(2008-10#9)
sulfur dioxide##18##2##(1996-12#1)(2008-10#17)
sulfur in the##2##3##(2008-10#2)
sulfur in##4##2##(2008-10#4)
sulfur solids##2##2##(2008-10#2)
sulfur to##2##2##(2008-10#1)(2010-7#1)
sulfur##94##1##(1992-12#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-10#76)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)
sulfur-containing##3##1##(1990-8#1)(2008-10#2)
sulfuric acid and##2##3##(2008-10#2)
sulfuric acid media##4##3##(2008-10#4)
sulfuric acid medium##9##3##(2008-10#9)
sulfuric acid solution##3##3##(2008-10#3)
sulfuric acid with##2##3##(2008-10#2)
sulfuric acid##38##2##(1991-12#1)(2008-10#34)(2008-3#3)
sulfuric acid-assisted continuous twin screw-driven reactor##2##6##(2013-1#2)
sulfuric##43##1##(1991-12#1)(2008-10#36)(2008-3#4)(2013-1#2)
sulfuric-acid-water##2##1##(2008-3#2)
sulfurreducens##3##1##(2011-1#3)
sulindac##2##1##(1995-9#1)(2009-12#1)
sulisobenzone was##2##2##(2008-5#2)
sulisobenzone##5##1##(2008-5#5)
sulpha-drug##2##1##(2008-10#2)
sulphadiazine##2##1##(2011-2#1)(2013-7#1)
sulphamidase gene##3##2##(1996-8#3)
sulphamidase##4##1##(1996-8#4)
sulphanilic acid to##2##3##(2008-10#2)
sulphanilic acid##3##2##(2008-10#3)
sulphate (SDS)##5##2##(2008-10#4)(2008-5#1)
sulphate and chloride##2##3##(2008-10#2)
sulphate and sodium##2##3##(2008-5#2)
sulphate and sulphite reduction##2##4##(2008-7#2)
sulphate and##11##2##(2008-10#6)(2008-5#3)(2008-7#2)
sulphate as##2##2##(2008-10#1)(2013-1#1)
sulphate conversion##2##2##(2008-7#2)
sulphate hydrate##2##2##(2008-10#2)
sulphate in##5##2##(2008-10#5)
sulphate ion##3##2##(2008-10#2)(2012-7#1)
sulphate matrix##3##2##(2008-10#3)
sulphate media##2##2##(2008-10#2)
sulphate was##2##2##(1995-9#1)(2008-5#1)
sulphate with##3##2##(2008-10#2)(2013-1#1)
sulphate##75##1##(1990-11#1)(1990-12#1)(1990-5#5)(1993-2#2)(1993-3#1)(1995-9#1)(1996-12#1)(1996-8#1)(2006-6#1)(2008-10#44)(2008-5#9)(2008-7#4)(2012-7#2)(2013-1#2)
sulphate)##3##1##(1994-12#1)(2008-10#2)
sulphated##3##1##(1993-6#1)(1994-8#1)(2011-10#1)
sulphates##3##1##(2008-10#2)(2008-5#1)
sulphide and##2##2##(1997-4#1)(2008-10#1)
sulphide at##3##2##(2008-10#3)
sulphide in##2##2##(2008-10#2)
sulphide is##2##2##(2008-10#2)
sulphide##27##1##(1997-4#2)(2008-10#24)(2008-7#1)
sulphides##5##1##(2008-10#5)
sulphite##7##1##(2008-10#4)(2008-7#3)
sulphonate formaldehyde##2##2##(2008-10#2)
sulphonate##3##1##(2008-10#3)
sulphonated azo dyes in##2##4##(2008-10#2)
sulphonated azo dyes##3##3##(2008-10#3)
sulphonated##5##1##(2008-10#5)
sulphonic acid)##2##2##(2008-10#2)
sulphonic##5##1##(2008-10#5)
sulphonylurea##5##1##(1994-12#2)(1994-8#3)
sulphonylureas##4##1##(1994-8#4)
sulphotransferase##4##1##(1994-11#4)
sulphur and##3##2##(2008-10#3)
sulphur compounds##6##2##(1997-4#1)(2008-10#5)
sulphur content##3##2##(2008-10#2)(2008-11#1)
sulphur dioxide in ambient air##2##5##(2008-10#2)
sulphur dioxide in##3##3##(2008-10#3)
sulphur dioxide were##2##3##(2008-10#2)
sulphur dioxide##11##2##(2008-10#11)
sulphur in##6##2##(2008-10#6)
sulphur is##2##2##(2008-10#2)
sulphur were##3##2##(2008-10#3)
sulphur##51##1##(1997-4#2)(2008-10#47)(2008-11#1)(2008-8#1)
sulphur-containing compounds##4##2##(1997-4#2)(2008-10#2)
sulphur-containing##6##1##(1997-4#3)(2008-10#2)(2008-11#1)
sulphureum and##2##2##(2008-10#2)
sulphureum##6##1##(2008-10#6)
sulphuric acid and permanganate##2##4##(2008-10#2)
sulphuric acid and##4##3##(2008-10#4)
sulphuric acid concentration##3##3##(2008-10#3)
sulphuric acid media was##2##4##(2008-10#2)
sulphuric acid media##3##3##(2008-10#3)
sulphuric acid medium##4##3##(2008-10#4)
sulphuric acid to##2##3##(2008-10#2)
sulphuric acid with##2##3##(2008-10#2)
sulphuric acid##30##2##(2008-10#30)
sulphuric##34##1##(2008-10#34)
sulphydryl##3##1##(1993-2#1)(2008-10#2)
sulpiride##4##1##(1991-1#1)(1996-2#1)(2008-10#2)
sultone##2##1##(2008-10#2)
sultopride##2##1##(2008-10#2)
sum of squares of##2##4##(1995-12#1)(2013-1#1)
sum of squares##4##3##(1995-12#1)(2008-10#2)(2013-1#1)
sum of the##20##3##(1990-12#1)(1990-6#1)(1991-12#2)(1995-12#1)(1996-6#1)(2008-10#9)(2008-3#1)(2008-8#1)(2009-10#2)(2010-8#1)
sum of##50##2##(1990-12#4)(1990-6#1)(1991-12#3)(1993-2#1)(1995-12#2)(1996-6#1)(2008-10#24)(2008-11#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-10#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
sum##61##1##(1990-12#4)(1990-6#1)(1991-12#3)(1993-12#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-12#2)(1996-6#1)(2008-10#28)(2008-11#3)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
sum-frequency generation##2##2##(2008-3#2)
sum-frequency##3##1##(2008-3#3)
summaries of##6##2##(1991-12#1)(1993-12#1)(1994-3#1)(1996-6#1)(2008-10#1)(2010-11#1)
summaries##12##1##(1991-12#2)(1993-12#1)(1993-2#2)(1994-3#1)(1996-6#1)(2008-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
summarise##2##1##(2008-11#1)(2008-8#1)
summarised and##2##2##(2008-11#2)
summarised in this##2##3##(2008-7#1)(2011-3#1)
summarised##8##1##(1994-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)
summarises the##4##2##(2008-10#2)(2011-10#1)(2011-2#1)
summarises##10##1##(1994-3#1)(2008-10#3)(2008-11#1)(2011-10#1)(2011-2#3)(2012-2#1)
summarize our##5##2##(2008-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
summarize recent##6##2##(2008-1#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#2)
summarize some of the##3##4##(2008-11#1)(2008-4#1)(2009-10#1)
summarize some##4##2##(2008-11#1)(2008-4#1)(2009-10#2)
summarize the current##2##3##(2010-12#1)(2011-2#1)
summarize the evidence on##2##4##(1995-5#1)(2013-1#1)
summarize the evidence##3##3##(1995-5#1)(2010-1#1)(2013-1#1)
summarize the##21##2##(1994-9#1)(1995-5#1)(2008-10#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)
summarize these##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
summarize##58##1##(1993-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
summarized and compared to the##2##5##(1993-2#1)(1995-12#1)
summarized and compared##3##3##(1993-2#1)(1995-12#1)(2008-10#1)
summarized and##4##2##(1993-2#1)(1995-12#1)(2008-10#1)(2008-11#1)
summarized as follows##3##3##(1995-9#2)(2008-11#1)
summarized as##4##2##(1995-9#2)(2008-11#1)(2012-2#1)
summarized by##2##2##(1992-9#1)(2008-10#1)
summarized in this review##2##4##(1995-5#1)(2008-10#1)
summarized in this##4##3##(1995-5#1)(2008-10#2)(2008-5#1)
summarized in##8##2##(1995-5#1)(2008-10#5)(2008-4#1)(2008-5#1)
summarized the##4##2##(1996-12#1)(2008-5#1)(2011-3#1)(2012-3#1)
summarized##54##1##(1991-12#2)(1992-9#1)(1993-2#1)(1995-12#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-10#14)(2008-11#7)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-3#1)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
summarizes a##3##2##(2008-10#2)(2012-2#1)
summarizes aspects##2##2##(2008-11#1)(2008-4#1)
summarizes findings##3##2##(1994-9#1)(2009-8#1)(2012-2#1)
summarizes key##2##2##(2008-11#1)(2010-4#1)
summarizes our##2##2##(2008-10#1)(2008-11#1)
summarizes several examples##2##3##(2008-10#2)
summarizes the evidence supporting##2##4##(2009-10#1)(2009-12#1)
summarizes the literature##2##3##(1992-12#1)(2009-5#1)
summarizes the most##2##3##(2008-10#2)
summarizes the##29##2##(1992-12#2)(1993-12#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-2#4)(2011-9#1)(2012-12#1)(2013-1#1)
summarizes these##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
summarizes##74##1##(1990-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-9#3)(1995-2#1)(1995-3#2)(1996-3#2)(1996-6#1)(1997-1#2)(2008-10#13)(2008-11#6)(2008-4#4)(2008-6#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-4#1)(2011-2#5)(2011-9#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#3)
summarizing the##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
summarizing##8##1##(1996-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#1)
summary measure of##2##3##(2008-9#1)(2013-1#1)
summary of recent##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
summary of the##25##3##(1991-3#2)(1992-3#1)(1993-1#1)(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-12#2)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#1)
summary of##40##2##(1990-2#1)(1991-1#2)(1991-2#1)(1991-3#2)(1992-3#1)(1993-1#1)(1994-1#1)(1994-2#1)(1997-3#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#2)
summary statistic##3##2##(1994-9#3)
summary statistics##3##2##(1992-9#3)
summary##127##1##(1990-2#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#4)(1992-1#1)(1992-3#3)(1992-6#2)(1992-9#3)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-9#3)(1995-1#2)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-11#12)(2008-12#2)(2008-3#1)(2008-4#4)(2008-7#5)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
summation of the##2##3##(1990-5#1)(2007-11#1)
summation of##8##2##(1990-5#1)(2007-11#1)(2008-10#3)(2009-8#1)(2010-9#1)(2013-1#1)
summation operatorDDT##2##2##(2008-10#2)
summation operatorHCH##2##2##(2008-10#2)
summation##20##1##(1990-5#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#6)(2009-8#1)(2010-9#1)(2013-1#2)
summed##6##1##(1994-8#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-3#1)
summer and autumn##2##3##(2008-10#2)
summer and winter##2##3##(1994-12#1)(2008-5#1)
summer and##6##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#2)
summer months##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
summer of##7##2##(1990-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2011-2#1)
summer season##3##2##(2012-2#1)(2012-3#2)
summer to##2##2##(2008-10#1)(2008-8#1)
summer##59##1##(1990-11#1)(1990-9#1)(1991-8#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#4)(2008-8#5)(2008-9#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)
summer)##3##1##(2008-10#1)(2008-12#1)(2012-2#1)
summers##2##1##(2008-11#1)(2008-8#1)
summing##5##1##(1995-11#1)(2008-10#3)(2008-8#1)
summit##2##1##(1991-9#1)(2008-11#1)
sump##2##1##(1991-3#1)(1996-6#1)
sums##3##1##(1996-11#1)(2008-10#1)(2009-4#1)
sun damage##3##2##(2011-2#3)
sun dried##2##2##(2008-10#2)
sun exposure##10##2##(2008-10#1)(2008-5#1)(2011-2#8)
sun glint contamination##3##3##(2008-3#3)
sun glint correction##3##3##(2008-3#3)
sun glint##11##2##(2008-3#11)
sun protection factor (SPF)##2##4##(2008-5#2)
sun protection factor##4##3##(1991-6#1)(2008-5#3)
sun protection factors (SPF) of##2##5##(2008-5#2)
sun protection factors (SPF)##3##4##(2008-5#3)
sun protection factors##6##3##(2008-5#6)
sun protection##13##2##(1991-6#1)(2008-4#1)(2008-5#9)(2011-2#2)
sun radiation##6##2##(2011-2#6)
sun reactive skin type##2##4##(2008-5#2)
sun reactive skin##3##3##(1991-6#1)(2008-5#2)
sun##70##1##(1991-6#10)(1994-3#2)(2008-10#5)(2008-3#11)(2008-4#1)(2008-5#15)(2011-2#26)
sun-exposed areas of the##2##4##(2010-6#1)(2011-2#1)
sun-exposed areas##3##2##(2010-6#2)(2011-2#1)
sun-exposed skin##2##2##(2011-2#2)
sun-exposed##5##1##(2010-6#2)(2011-2#3)
sunburn##7##1##(1991-6#1)(1992-6#1)(2008-4#1)(2008-5#4)
sunburns##4##1##(2011-2#4)
suncare products##2##2##(2008-10#2)
suncare##3##1##(2008-10#3)
sunflower (Helianthus annuus)##2##3##(2008-10#2)
sunflower (Helianthus##3##2##(2008-10#3)
sunflower and##2##2##(2008-10#2)
sunflower oil##4##2##(2008-10#2)(2013-1#2)
sunflower stem##4##2##(2008-10#4)
sunflower##33##1##(1991-5#3)(2008-10#28)(2013-1#2)
sunflowers (Helianthus##3##2##(2008-10#1)(2008-8#2)
sunflowers##4##1##(2008-10#1)(2008-8#3)
sunitinib##4##1##(2013-1#4)
sunken##3##1##(2008-10#3)
sunlight and##3##2##(2008-5#1)(2011-2#2)
sunlight in##2##2##(2008-10#1)(2011-2#1)
sunlight intensity was##2##3##(2008-6#2)
sunlight intensity##8##2##(2008-6#7)(2008-8#1)
sunlight##48##1##(1994-1#1)(1997-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-5#9)(2008-6#8)(2008-8#3)(2011-2#14)
sunny##7##1##(1997-6#1)(2008-10#4)(2008-11#1)(2012-3#1)
sunrise and##2##2##(2008-10#2)
sunrise##6##1##(2008-10#6)
sunscreen agents in##2##3##(2008-10#2)
sunscreen agents##3##2##(2008-10#2)(2008-5#1)
sunscreen and##2##2##(2008-5#2)
sunscreen application##2##2##(2008-5#2)
sunscreen derived from Chinese herbs##2##5##(2008-5#2)
sunscreen derived from natural Chinese herbs##2##6##(2008-5#2)
sunscreen derived from##4##3##(2008-5#4)
sunscreen films##6##2##(2008-5#6)
sunscreen formulation##3##2##(2008-5#3)
sunscreen formulations##4##2##(2008-5#4)
sunscreen from##2##2##(2008-5#2)
sunscreen lotions containing##3##3##(2008-10#1)(2008-5#2)
sunscreen lotions##6##2##(2008-10#1)(2008-5#5)
sunscreen preparations##2##2##(2008-5#2)
sunscreen products in the##2##4##(2008-5#2)
sunscreen products in##3##3##(2008-5#3)
sunscreen products##11##2##(2008-10#1)(2008-5#10)
sunscreen system##2##2##(2008-5#2)
sunscreen##79##1##(2008-10#6)(2008-4#1)(2008-5#71)(2008-8#1)
sunscreening##4##1##(1991-6#1)(2008-5#3)
sunscreens should be##2##3##(2008-5#2)
sunscreens##25##1##(1991-6#3)(2008-5#22)
sunset to##2##2##(2008-10#2)
sunset yellow FCF##2##3##(2008-10#2)
sunset yellow##5##2##(2008-10#5)
sunset##8##1##(2008-10#7)(2011-2#1)
sunshine##2##1##(2008-10#1)(2013-8#1)
super family##3##2##(1996-12#1)(2009-10#1)(2009-8#1)
super high-yielding##2##2##(2008-9#2)
super modified simplex##3##3##(2008-10#3)
super splines##2##2##(2008-6#2)
super##19##1##(1991-12#1)(1992-10#1)(1996-12#1)(2008-10#5)(2008-6#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#2)
super&quot##2##1##(1991-12#2)
super-Gaussian intensity##2##2##(2008-3#2)
super-Gaussian##5##1##(2008-2#2)(2008-3#3)
superabsorbent polymers##2##2##(2008-11#2)
superantigen##3##1##(1993-3#2)(1994-12#1)
superb##3##1##(2008-10#1)(2010-5#1)(2010-6#1)
superchannel##2##1##(2011-2#2)
supercoiled DNA-modified mercury##2##3##(2008-10#2)
supercoiled and##2##2##(1993-8#1)(2008-9#1)
supercoiled##6##1##(1993-8#1)(2008-10#3)(2008-9#2)
supercoiling factor##3##2##(1995-6#3)
supercoiling##7##1##(1994-5#1)(1995-6#4)(2008-8#1)(2008-9#1)
supercoils##3##1##(1995-6#1)(2008-9#2)
superconducting quantum interference device##2##4##(2008-7#2)
superconducting##9##1##(1990-12#1)(1992-8#3)(2008-10#1)(2008-7#3)(2010-7#1)
superconductors##9##1##(1992-8#3)(1993-5#1)(1994-9#1)(2008-10#4)
supercritical CO(2)##10##2##(2008-10#10)
supercritical carbon dioxide (SC-CO(2))##2##4##(2008-10#1)(2010-4#1)
supercritical carbon dioxide has been##2##5##(2008-10#2)
supercritical carbon dioxide##18##3##(2008-10#15)(2008-7#1)(2010-4#2)
supercritical fluid CO(2)##2##3##(2008-10#2)
supercritical fluid and##2##3##(2008-10#2)
supercritical fluid chromatography (SFC)##3##4##(2008-10#3)
supercritical fluid chromatography##9##3##(2008-10#9)
supercritical fluid extraction (SFE) has##2##5##(2008-10#2)
supercritical fluid extraction (SFE)##9##4##(2008-10#9)
supercritical fluid extraction of##3##4##(2008-10#2)(2012-3#1)
supercritical fluid extraction##17##3##(2008-10#15)(2008-11#1)(2012-3#1)
supercritical fluid extractor##2##3##(2008-10#2)
supercritical fluid##40##2##(2008-10#37)(2008-11#1)(2012-2#1)(2012-3#1)
supercritical fluids and their##2##4##(2012-2#2)
supercritical fluids##5##2##(2008-10#2)(2012-2#3)
supercritical##77##1##(2008-10#65)(2008-11#1)(2008-7#1)(2010-10#1)(2010-4#2)(2012-2#5)(2012-3#1)(2013-1#1)
superfamily and##2##2##(2008-5#1)(2011-2#1)
superfamily of proteins##2##3##(1993-12#1)(1995-6#1)
superfamily of##10##2##(1993-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-11#4)(2010-5#1)
superfamily were##2##2##(1997-6#1)(2011-1#1)
superfamily##38##1##(1993-12#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-2#5)(1995-6#1)(1995-8#1)(1996-2#2)(1997-6#1)(1997-7#1)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#3)(2011-2#1)
superficial and##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
superficial bladder cancer##2##3##(1993-11#1)(2008-11#1)
superficial bladder tumours##3##3##(1991-6#3)
superficial bladder##5##2##(1991-6#3)(1993-11#1)(2008-11#1)
superficial categorical##2##2##(2008-11#2)
superficial cervical plexus##2##3##(2010-7#1)(2012-3#1)
superficial fascia##2##2##(2009-9#2)
superficial femoral vein##2##3##(2011-3#2)
superficial femoral##3##2##(2011-2#1)(2011-3#2)
superficial layers of the stratum corneum##2##6##(2008-5#2)
superficial layers of the##3##4##(2008-5#3)
superficial layers of##4##3##(2008-11#1)(2008-5#3)
superficial layers##10##2##(1997-2#1)(2008-11#2)(2008-5#6)(2013-1#1)
superficial mycoses##2##2##(2008-5#2)
superficial porokeratosis##2##2##(2010-6#2)
superficial siderosis##2##2##(2008-7#2)
superficial temporal##2##2##(2008-12#1)(2012-3#1)
superficial to##2##2##(2008-9#1)(2013-8#1)
superficial vein##2##2##(2013-8#2)
superficial veins##2##2##(2008-9#1)(2013-8#1)
superficial##79##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#3)(1993-11#1)(1993-9#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-5#17)(2008-7#2)(2008-9#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-6#2)(2010-7#1)(2011-2#6)(2011-3#4)(2012-3#6)(2013-1#1)(2013-8#4)
superficially##4##1##(1996-2#1)(2007-8#2)(2008-10#1)
superfluous##4##1##(1991-6#1)(1996-9#1)(2007-12#1)(2008-9#1)
superfused carp retina##2##3##(2008-8#1)(2008-9#1)
superfused##5##1##(1994-3#1)(1995-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
superfusion##2##1##(1995-11#1)(2008-11#1)
superheated hexane extraction##2##3##(2008-10#2)
superheated hexane##3##2##(2008-10#3)
superheated water extraction and##2##4##(2008-10#2)
superheated water extraction##5##3##(2008-10#5)
superheated water##8##2##(2008-10#8)
superheated##12##1##(2008-10#12)
superhigh-yield rice##3##2##(2008-9#3)
superimposed on the##3##3##(2008-2#1)(2008-3#2)
superimposed on##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)
superimposed preeclampsia##2##2##(1997-8#1)(2008-11#1)
superimposed##17##1##(1993-12#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-12#1)(2010-12#1)(2013-1#2)
superinfection##5##1##(1991-6#1)(1993-8#1)(2008-8#2)(2013-1#1)
superinfections##3##1##(1991-2#1)(2008-8#2)
superior ability##3##2##(2008-10#2)(2008-8#1)
superior and inferior##2##3##(2008-6#1)(2008-8#1)
superior competitor##4##2##(2008-8#4)
superior efficacy and tolerability of##2##5##(2012-3#2)
superior efficacy##3##2##(2011-2#1)(2012-3#2)
superior for##3##2##(1995-3#1)(2008-10#2)
superior frontal##2##2##(1996-12#2)
superior in terms of##4##4##(2008-10#2)(2009-2#1)(2011-2#1)
superior in##9##2##(2008-10#5)(2008-5#1)(2009-2#1)(2011-2#1)(2013-8#1)
superior mesenteric artery##7##3##(2008-11#1)(2013-1#6)
superior mesenteric##9##2##(2008-11#2)(2012-3#1)(2013-1#6)
superior oblique muscle##2##3##(2010-9#1)(2011-2#1)
superior oblique##4##2##(2010-9#3)(2011-2#1)
superior outcomes##3##2##(1992-11#1)(1995-3#1)(2010-6#1)
superior pancreaticoduodenal##2##2##(1991-6#2)
superior parietal cortex##2##3##(2013-8#2)
superior parietal lobule##2##3##(1996-2#1)(2008-11#1)
superior parietal##4##2##(1996-2#1)(2008-11#1)(2013-8#2)
superior results##2##2##(2008-10#1)(2008-7#1)
superior sagittal sinus##4##3##(1997-3#3)(2008-7#1)
superior sagittal##5##2##(1997-3#3)(1997-6#1)(2008-7#1)
superior temporal and##2##3##(2008-10#1)(2008-9#1)
superior temporal gyrus##4##3##(1996-2#2)(2008-11#2)
superior temporal sulcus##4##3##(2008-11#3)(2009-10#1)
superior temporal##13##2##(1996-2#2)(2008-10#1)(2008-11#6)(2008-9#1)(2009-10#2)(2012-12#1)
superior to a##2##3##(2008-3#1)(2012-2#1)
superior to both##3##3##(1993-12#1)(2008-10#2)
superior to conventional##2##3##(2008-1#1)(2008-10#1)
superior to other##3##3##(1992-9#1)(2008-10#1)(2010-6#1)
superior to that for##2##4##(1994-5#1)(2008-10#1)
superior to that of##4##4##(1996-2#1)(2008-10#1)(2008-11#2)
superior to that##8##3##(1993-2#1)(1994-5#1)(1996-2#1)(2008-10#3)(2008-11#2)
superior to the conventional##2##4##(1997-8#1)(2011-2#1)
superior to the##18##3##(1992-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
superior to those##2##3##(2008-10#2)
superior to##66##2##(1990-12#1)(1991-7#1)(1992-1#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-12#2)(1996-2#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#9)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-1#1)
superior vena cava##5##3##(2008-1#2)(2008-11#1)(2008-12#2)
superior##206##1##(1990-12#1)(1991-6#2)(1991-7#1)(1992-1#3)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#2)(1995-5#3)(1996-12#5)(1996-2#7)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#7)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#51)(2008-11#23)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#3)(2010-9#3)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#5)(2012-8#1)(2012-9#1)(2013-1#11)(2013-8#3)
superior-posterior radiograms in##2##3##(2007-8#2)
superior-posterior radiograms##3##2##(2007-8#3)
superiority of the##4##3##(1995-5#2)(1997-2#1)(2008-10#1)
superiority of##12##2##(1990-9#1)(1993-3#1)(1995-5#2)(1997-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
superiority over##2##2##(1992-9#1)(2008-10#1)
superiority##19##1##(1990-9#1)(1992-12#1)(1992-9#1)(1993-3#1)(1995-5#2)(1997-2#1)(2008-10#3)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
superlattices##3##1##(1991-9#1)(1993-5#1)(1994-9#1)
supernatant and##6##2##(2008-10#2)(2008-11#4)
supernatant containing##3##2##(2008-11#2)(2012-2#1)
supernatant from##2##2##(2008-10#1)(2008-11#1)
supernatant is##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
supernatant of human##2##3##(1992-12#1)(2008-11#1)
supernatant of the##2##3##(2008-10#1)(2012-2#1)
supernatant of##7##2##(1992-12#1)(2008-10#1)(2008-11#2)(2008-9#2)(2012-2#1)
supernatant solutions##2##2##(2008-11#2)
supernatant was##9##2##(1990-2#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)
supernatant##56##1##(1990-2#1)(1990-8#1)(1992-12#2)(1993-9#1)(1994-11#2)(1994-8#1)(1996-2#1)(2008-10#13)(2008-11#21)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2012-2#2)
supernatants from the##2##3##(2008-10#1)(2011-3#1)
supernatants from##3##2##(1997-3#1)(2008-10#1)(2011-3#1)
supernatants of##7##2##(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
supernatants were##2##2##(2008-11#1)(2011-3#1)
supernatants##22##1##(1990-12#1)(1990-2#1)(1995-2#1)(1997-3#3)(2008-10#6)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-3#2)(2012-2#1)
supernumerary spleen##3##2##(1990-5#3)
supernumerary##13##1##(1990-5#3)(2008-10#1)(2008-3#4)(2010-3#1)(2012-3#1)(2013-1#3)
supernutritional Se##2##2##(2012-2#2)
superoxide and hydrogen peroxide##2##4##(2011-2#2)
superoxide anion (O2-)##2##3##(1994-8#1)(1996-2#1)
superoxide anion and##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
superoxide anion by##2##3##(1993-6#1)(2008-9#1)
superoxide anion radical (O(2)(-))##2##4##(2008-10#2)
superoxide anion radical##6##3##(2008-10#6)
superoxide anion##28##2##(1992-11#2)(1993-6#3)(1994-11#1)(1994-8#3)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#12)(2008-11#2)(2008-9#1)(2013-8#1)
superoxide dismutase (SOD) activity##3##4##(2008-10#2)(2008-11#1)
superoxide dismutase (SOD)##9##3##(2008-10#5)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
superoxide dismutase and##3##3##(1992-7#1)(1995-6#1)(2007-11#1)
superoxide dismutase##36##2##(1990-3#2)(1992-12#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-6#4)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#2)(2007-11#1)(2008-10#8)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
superoxide generation by##2##3##(1993-6#1)(1994-11#1)
superoxide generation in##3##3##(1993-6#1)(1994-11#2)
superoxide generation##9##2##(1993-6#5)(1994-11#4)
superoxide radical anion##2##3##(2008-10#1)(2008-5#1)
superoxide radical##3##2##(1992-12#1)(2008-10#1)(2008-5#1)
superoxide##86##1##(1990-3#2)(1990-5#1)(1992-11#2)(1992-12#3)(1992-7#1)(1992-9#1)(1993-6#9)(1993-8#1)(1994-11#5)(1994-8#3)(1995-6#6)(1995-8#2)(1996-2#2)(1996-5#1)(1996-6#2)(2007-11#1)(2008-10#24)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
superparamagnetic iron oxide nanoparticles##4##4##(2012-12#2)(2012-2#1)(2013-1#1)
superparamagnetic iron oxide##5##3##(2012-12#2)(2012-2#2)(2013-1#1)
superparamagnetic##6##1##(2012-12#2)(2012-2#3)(2013-1#1)
superposed##3##1##(1991-8#1)(2008-10#1)(2008-7#1)
superposition of##5##2##(1997-6#1)(2008-10#1)(2008-3#2)(2011-2#1)
superposition##8##1##(1995-3#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-2#1)
superresolution##5##1##(2008-3#5)
supersaturation of##2##2##(1992-9#1)(2008-10#1)
supersaturation##4##1##(1990-11#2)(1992-9#1)(2008-10#1)
superseded by##5##2##(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
superseded##7##1##(1990-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#2)
supersedes##2##1##(2008-11#1)(2010-11#1)
superselective##2##1##(1997-3#1)(1997-6#1)
supersonic##3##1##(2008-10#2)(2010-7#1)
superstructure##3##1##(1995-6#1)(2008-3#1)(2013-1#1)
supervised by the##2##3##(1994-12#1)(2010-1#1)
supervised learning##4##2##(2008-10#3)(2008-11#1)
supervised##13##1##(1994-12#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2010-1#1)
supervision and##3##2##(1996-1#1)(2008-7#1)(2010-10#1)
supervision from##2##2##(2008-11#1)(2012-2#1)
supervision in##2##2##(1997-2#1)(2008-4#1)
supervision of##4##2##(1991-2#1)(2008-11#1)(2008-12#1)(2012-12#1)
supervision##25##1##(1991-2#2)(1991-3#1)(1994-3#1)(1996-1#2)(1997-2#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-6#3)(2008-7#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-2#2)
supervisor##5##1##(1995-6#2)(2008-7#2)(2009-10#1)
supervisors##4##1##(1992-3#1)(1996-1#1)(2008-11#1)(2012-2#1)
supervisors)##2##1##(1990-12#1)(2008-11#1)
supervisory##2##1##(1993-2#1)(1996-1#1)
supine position with##2##3##(2011-2#1)(2012-3#1)
supine position##8##2##(2011-2#4)(2012-3#4)
supine##15##1##(1993-12#1)(1994-3#1)(2008-7#1)(2011-2#5)(2012-3#6)(2013-1#1)
supplement and##2##2##(2009-11#1)(2013-8#1)
supplement at##3##2##(2013-8#3)
supplement conventional##2##2##(1997-2#1)(1997-4#1)
supplement for##2##2##(2008-11#2)
supplement in serum-free##2##3##(2008-11#2)
supplement in##4##2##(2008-11#2)(2010-7#1)(2013-1#1)
supplement of##2##2##(1991-6#1)(2008-10#1)
supplement on##2##2##(2008-10#1)(2010-12#1)
supplement the##5##2##(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-8#1)
supplement to the##2##3##(1991-6#1)(1997-3#1)
supplement to##6##2##(1990-2#1)(1990-9#1)(1991-6#1)(1994-6#1)(1997-3#1)(2008-10#1)
supplement use and##2##3##(2008-10#2)
supplement use##4##2##(2008-10#4)
supplement##55##1##(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#2)(1994-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-8#1)(2009-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#4)(2013-8#8)
supplemental insurance##2##2##(1994-1#2)
supplemental oxygen and##2##3##(1993-1#2)
supplemental oxygen##4##2##(1993-1#4)
supplemental water##2##2##(2008-10#2)
supplemental##13##1##(1992-9#2)(1993-1#4)(1994-1#2)(1995-2#1)(1997-3#1)(2008-10#2)(2012-12#1)
supplementary insurance##3##2##(1996-2#1)(1996-3#2)
supplementary##27##1##(1991-12#1)(1991-2#1)(1993-2#2)(1996-2#1)(1996-3#3)(1997-6#1)(2008-12#1)(2010-1#2)(2010-10#4)(2011-2#3)(2012-2#5)(2012-3#2)(2013-1#1)
supplementation and##3##2##(1996-12#1)(2009-8#1)(2011-2#1)
supplementation at the##2##3##(2008-11#1)(2013-1#1)
supplementation during##4##2##(2008-11#1)(2011-2#2)(2012-3#1)
supplementation in pregnancy and its##2##5##(2012-3#2)
supplementation in##8##2##(2008-1#2)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-3#2)
supplementation is##4##2##(1997-1#1)(2008-1#1)(2013-1#2)
supplementation of Euphorbia heterophylla on##2##5##(2013-1#2)
supplementation of zymosan with morphine##2##5##(2008-12#2)
supplementation of##12##2##(2008-11#5)(2008-12#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
supplementation on##3##2##(2008-11#1)(2008-7#1)(2010-1#1)
supplementation with a##2##3##(2008-11#1)(2011-2#1)
supplementation with##10##2##(1991-12#1)(1991-6#1)(1996-6#1)(2008-10#1)(2008-11#4)(2010-1#1)(2011-2#1)
supplementation##80##1##(1990-5#1)(1991-12#1)(1991-6#1)(1992-9#3)(1993-1#1)(1996-12#1)(1996-6#2)(1997-1#1)(2008-1#4)(2008-10#3)(2008-11#21)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-8#2)(2010-1#4)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#1)
supplemented by the##2##3##(1990-5#1)(2008-10#1)
supplemented by##6##2##(1990-5#1)(1996-11#1)(2008-10#2)(2008-11#1)(2013-8#1)
supplemented in##2##2##(2008-11#2)
supplemented medium##3##2##(2008-11#3)
supplemented the##2##2##(1996-6#1)(2013-1#1)
supplemented to##2##2##(2008-11#1)(2008-5#1)
supplemented with 1##3##3##(1995-6#1)(2008-11#1)(2008-12#1)
supplemented with 1%##2##3##(2008-11#1)(2008-5#1)
supplemented with 10%##2##3##(2008-11#2)
supplemented with 2##2##3##(2008-7#1)(2008-8#1)
supplemented with a##2##3##(2008-10#1)(2011-2#1)
supplemented with different##2##3##(2008-12#1)(2013-1#1)
supplemented with glucose##5##3##(2008-10#1)(2008-11#4)
supplemented with other##2##3##(2008-10#1)(2010-8#1)
supplemented with sodium selenite##2##4##(2008-10#1)(2010-11#1)
supplemented with the##2##3##(2008-11#2)
supplemented with##68##2##(1991-10#1)(1991-2#1)(1992-9#1)(1993-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-10#14)(2008-11#26)(2008-12#2)(2008-5#3)(2008-7#4)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#3)
supplemented##93##1##(1990-5#1)(1991-10#1)(1991-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(2008-10#16)(2008-11#36)(2008-12#2)(2008-5#4)(2008-7#4)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#5)(2013-8#1)
supplementing the##2##2##(2008-11#1)(2011-2#1)
supplementing##5##1##(1993-8#1)(1995-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
supplements and##6##2##(1992-9#1)(2008-10#3)(2008-11#1)(2010-3#1)
supplements as well##2##3##(2008-10#1)(2011-2#1)
supplements for##2##2##(2008-11#1)(2011-2#1)
supplements to##2##2##(1991-2#1)(2012-2#1)
supplements were##3##2##(1995-11#1)(2008-11#1)(2013-7#1)
supplements##33##1##(1991-2#2)(1992-9#3)(1995-11#2)(2008-1#1)(2008-10#7)(2008-11#7)(2008-8#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#2)
supplied by##2##2##(2008-10#1)(2011-2#1)
supplied from the##2##3##(1992-1#1)(2011-2#1)
supplied in##2##2##(2008-10#1)(2008-11#1)
supplied to a##2##3##(2008-10#2)
supplied to the##3##3##(1995-3#1)(2008-10#2)
supplied to##6##2##(1995-3#1)(2008-10#4)(2008-9#1)
supplied with##7##2##(1990-11#1)(1997-3#1)(2008-11#2)(2011-1#2)(2011-2#1)
supplied##34##1##(1990-11#2)(1992-1#1)(1994-11#1)(1995-3#1)(1997-3#1)(2008-10#9)(2008-11#6)(2008-5#1)(2008-7#3)(2008-9#3)(2011-1#2)(2011-2#4)
supplier##7##1##(1992-1#2)(1994-1#1)(1994-12#1)(1994-3#1)(2008-10#1)(2011-2#1)
suppliers and##2##2##(1993-12#1)(1994-1#1)
suppliers##7##1##(1993-12#1)(1994-1#1)(1994-3#1)(2008-11#1)(2008-12#1)(2011-2#2)
supplies a##2##2##(1997-1#1)(2008-9#1)
supplies the##2##2##(2011-2#2)
supplies##18##1##(1991-12#1)(1993-1#1)(1993-3#1)(1996-6#3)(1997-1#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#3)(2012-2#1)
supply and##3##2##(1992-1#1)(2008-11#1)(2008-12#1)
supply by##3##2##(1995-6#1)(2008-7#1)(2008-8#1)
supply in##3##2##(2008-11#1)(2009-3#1)(2013-8#1)
supply is##3##2##(1996-3#2)(2008-11#1)
supply of charity##2##3##(1992-3#2)
supply of doctors##2##3##(1991-2#2)
supply of volunteer labor##2##4##(1994-3#2)
supply of##30##2##(1991-2#3)(1991-3#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-1#1)(1994-3#4)(1994-6#1)(1994-9#1)(1996-11#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
supply ratios##3##2##(2008-8#3)
supply the##4##2##(1997-1#2)(2007-12#1)(2008-11#1)
supply to plants##2##3##(2013-8#2)
supply to the##6##3##(1993-1#1)(1997-8#1)(2008-9#1)(2009-10#1)(2011-2#2)
supply to##10##2##(1993-1#1)(1997-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-8#2)
supply tubing##2##2##(2011-1#2)
supply##139##1##(1991-2#4)(1991-3#1)(1992-1#1)(1992-3#5)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#5)(1996-9#3)(1997-1#3)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#21)(2008-12#3)(2008-2#1)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-6#1)(2011-1#3)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#3)
supplying##4##1##(1996-6#1)(2010-11#1)(2010-3#1)(2011-2#1)
support a role for##4##4##(1997-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
support a single##2##3##(1994-3#2)
support a##30##2##(1991-6#1)(1993-11#1)(1993-12#2)(1994-1#2)(1994-3#2)(1995-8#1)(1997-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)
support after##3##2##(2009-5#3)
support an##7##2##(1995-2#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-8#1)
support and guidance##2##3##(2008-12#2)
support and its##3##3##(1992-3#1)(2008-10#1)(2010-3#1)
support and networks##2##3##(2010-10#2)
support and participation##2##3##(2008-10#1)(2013-1#1)
support and perceived##2##3##(2009-7#1)(2010-2#1)
support and psychological##2##3##(2010-1#1)(2010-2#1)
support and the##6##3##(1995-1#1)(1997-4#1)(2008-10#1)(2008-11#2)(2009-7#1)
support and well-being##2##3##(1992-3#2)
support and##56##2##(1992-12#1)(1992-3#4)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-11#6)(2008-12#4)(2008-4#2)(2008-9#1)(2009-5#1)(2009-7#4)(2010-1#2)(2010-10#2)(2010-2#2)(2010-3#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
support are##3##2##(1992-1#1)(2008-12#1)(2008-5#1)
support as a##2##3##(1992-3#1)(1996-3#1)
support as well as##2##4##(2008-11#2)
support as##4##2##(1992-3#1)(1996-3#1)(2008-11#2)
support at the##2##3##(1993-9#1)(2010-5#1)
support at##4##2##(1992-1#1)(1993-9#1)(2010-5#2)
support available##2##2##(1992-2#1)(2008-12#1)
support breeding##2##2##(2008-10#2)
support can##2##2##(1994-3#1)(2008-10#1)
support cell growth in##2##4##(1996-2#1)(2008-11#1)
support cell growth##3##3##(1996-2#1)(2008-11#2)
support cell##4##2##(1996-2#1)(2008-11#2)(2009-7#1)
support cells##2##2##(2008-7#1)(2008-9#1)
support could be##2##3##(2008-10#1)(2011-2#1)
support device##2##2##(2008-11#1)(2013-1#1)
support devices##2##2##(1991-3#1)(2008-11#1)
support during##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
support early##3##2##(1997-1#1)(2008-9#2)
support for a##4##3##(1994-3#1)(2008-1#1)(2008-12#1)(2008-9#1)
support for the concept##2##4##(1995-12#1)(1995-2#1)
support for the hypothesis##3##4##(1994-8#1)(2008-10#1)(2013-1#1)
support for the##33##3##(1991-2#1)(1991-9#1)(1992-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#2)(2008-8#2)(2009-4#1)(2010-1#1)(2012-3#4)(2013-1#2)
support for your##2##3##(1991-1#1)(1993-2#1)
support for##84##2##(1990-11#1)(1991-1#2)(1991-2#2)(1991-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-1#3)(2008-10#10)(2008-11#13)(2008-12#4)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2011-2#6)(2012-12#1)(2012-3#5)(2013-1#2)(2013-8#1)
support from classmates and##2##4##(2009-7#2)
support from friends and family##2##5##(1994-1#1)(2008-6#1)
support from the##3##3##(1991-12#1)(1996-3#1)(2010-10#1)
support from##20##2##(1991-12#1)(1992-12#1)(1992-3#2)(1994-1#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-7#5)(2010-10#1)(2010-2#1)(2011-1#1)
support group for adolescents with##2##5##(1993-3#2)
support group for##4##3##(1991-12#2)(1993-3#2)
support group##7##2##(1991-12#3)(1993-3#2)(2008-11#2)
support groups and##4##3##(1994-3#1)(1996-3#3)
support groups##13##2##(1991-12#1)(1994-3#1)(1996-1#1)(1996-3#6)(2008-12#1)(2009-5#2)(2012-2#1)
support growth##2##2##(2011-2#1)(2012-3#1)
support has been##4##3##(2008-10#2)(2010-10#1)(2010-3#1)
support have##2##2##(2008-10#1)(2010-6#1)
support in an##2##3##(1992-3#1)(2008-10#1)
support in the##5##3##(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)
support in##19##2##(1992-3#4)(1994-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
support interventions##2##2##(1996-3#2)
support is used##2##3##(2008-10#2)
support is##6##2##(1992-3#1)(2008-10#5)
support its use##2##3##(1997-5#1)(2013-8#1)
support its##5##2##(1995-5#1)(1997-5#1)(2008-11#1)(2009-8#1)(2013-8#1)
support material##5##2##(2008-10#5)
support may##4##2##(2008-11#1)(2009-7#1)(2010-12#1)(2010-6#1)
support mechanism for##2##3##(2008-11#2)
support membrane##2##2##(2008-4#2)
support network##4##2##(2008-11#2)(2011-2#2)
support networks##7##2##(1992-3#2)(2008-11#1)(2009-5#2)(2009-6#1)(2011-2#1)
support of a##2##3##(1991-2#1)(2008-8#1)
support of the##17##3##(1991-1#1)(1991-5#1)(1994-12#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)
support of this hypothesis##2##4##(1990-11#1)(2008-7#1)
support of this##7##3##(1990-11#1)(1992-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-6#1)
support of##43##2##(1990-11#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-4#1)(1994-12#2)(1994-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-8#1)
support on##5##2##(1996-2#1)(2008-10#2)(2008-11#1)(2010-2#1)
support our##3##2##(2008-10#1)(2008-9#1)(2012-5#1)
support previous##2##2##(2008-10#2)
support protocol for##2##3##(2008-4#2)
support protocol##10##2##(2008-4#9)(2008-9#1)
support protocols provide##2##3##(2008-4#1)(2008-9#1)
support protocols##8##2##(2008-4#6)(2008-9#2)
support provided by##2##3##(2008-11#1)(2010-4#1)
support provided##3##2##(2008-11#1)(2010-4#1)(2011-2#1)
support recent##2##2##(2009-8#1)(2010-7#1)
support resources and##2##3##(1995-1#2)
support roles##4##2##(2008-11#3)(2008-8#1)
support services##5##2##(1993-1#2)(1994-2#1)(1996-1#1)(2008-6#1)
support some previous##2##3##(2008-11#1)(2008-6#1)
support staff##6##2##(1991-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(2008-12#2)
support system##9##2##(1991-1#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-6#1)(2010-8#1)(2012-2#1)
support systems for##2##3##(2010-6#1)(2010-8#1)
support systems in##2##3##(1993-2#1)(1997-3#1)
support systems##15##2##(1993-2#1)(1996-3#1)(1997-3#1)(2008-11#5)(2009-7#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)
support that##7##2##(1995-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)
support the argument that females can gain paternal investment##2##9##(2008-8#2)
support the assumption of##2##4##(1995-12#1)(2013-8#1)
support the concept##2##3##(1997-8#1)(2008-7#1)
support the conclusion that##6##4##(1992-3#1)(1995-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
support the contention that##2##4##(2008-9#1)(2011-2#1)
support the development of##2##4##(2012-3#1)(2013-1#1)
support the development##3##3##(1994-2#1)(2012-3#1)(2013-1#1)
support the feasibility##2##3##(2009-7#1)(2013-8#1)
support the formation of##2##4##(2008-10#1)(2008-11#1)
support the growth of##2##4##(2008-11#2)
support the growth##3##3##(2008-11#3)
support the hypothesis of##2##4##(1991-12#1)(2008-10#1)
support the hypothesis that IAA-producing bacteria cause cranberry stem gall##2##10##(2008-10#2)
support the hypothesis that the##5##5##(1991-2#1)(1993-3#1)(2008-10#3)
support the hypothesis that##23##4##(1991-2#1)(1991-9#1)(1992-6#3)(1992-7#1)(1993-3#1)(1993-8#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-8#1)(2011-2#1)(2013-1#1)
support the hypothesis##28##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#3)(1992-7#1)(1993-3#1)(1993-8#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
support the idea that##8##4##(1997-6#1)(1997-7#1)(2008-10#3)(2008-9#1)(2009-8#1)(2009-9#1)
support the idea##9##3##(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2009-9#1)
support the model##2##3##(1992-12#1)(1995-2#1)
support the need for##2##4##(2011-2#1)(2013-1#1)
support the new##2##3##(1992-5#1)(2008-10#1)
support the notion that##6##4##(1990-2#1)(1993-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
support the notion##7##3##(1990-2#1)(1993-3#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
support the premise that##2##4##(1992-6#1)(2008-8#1)
support the proposal that##2##4##(1990-10#1)(2009-4#1)
support the role of##2##4##(2010-4#1)(2011-2#1)
support the role##3##3##(2008-11#1)(2010-4#1)(2011-2#1)
support the systemic##2##3##(2008-10#2)
support the use of##8##4##(2008-10#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
support the view that##5##4##(1993-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
support the well-being of##2##4##(2010-11#1)(2010-5#1)
support the##176##2##(1990-10#1)(1990-2#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-9#2)(1993-12#1)(1993-3#3)(1993-8#2)(1994-2#1)(1994-3#2)(1995-12#3)(1995-2#1)(1995-8#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#4)(2008-10#38)(2008-11#15)(2008-12#1)(2008-2#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#6)(2013-8#4)
support their##3##2##(1993-12#1)(1993-3#1)(2010-5#1)
support these##7##2##(1995-1#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)
support this hypothesis##2##3##(1991-3#1)(2008-8#1)
support this##11##2##(1991-3#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2009-6#1)(2013-1#2)
support to a role for##2##5##(1992-7#1)(1995-8#1)
support to a##3##3##(1992-7#1)(1995-12#1)(1995-8#1)
support to facilitate the##2##4##(2008-11#2)
support to the hypothesis that##3##5##(1991-6#1)(2008-8#1)(2012-3#1)
support to the##13##3##(1990-11#1)(1990-5#1)(1991-6#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-1#1)(2012-3#2)
support to##45##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-7#1)(1994-12#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#2)(2012-3#2)(2013-1#1)(2013-8#1)
support vector machines##2##3##(2008-11#1)(2009-12#1)
support vector##4##2##(2008-11#1)(2009-12#1)(2010-7#2)
support was a robust unique predictor##2##6##(2010-1#2)
support was provided##2##3##(1997-2#1)(2008-11#1)
support was##12##2##(1993-8#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-5#1)(2010-1#2)(2011-2#1)
support were##4##2##(1994-3#1)(1995-1#1)(2008-10#1)(2013-1#1)
support which##2##2##(1993-8#1)(2013-8#1)
support with##5##2##(2008-10#3)(2009-7#1)(2010-1#1)
support##1047##1##(1990-10#1)(1990-11#3)(1990-2#4)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#6)(1991-12#8)(1991-2#6)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#5)(1992-12#5)(1992-2#5)(1992-3#31)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#2)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#9)(1993-2#2)(1993-3#7)(1993-8#5)(1993-9#1)(1994-1#9)(1994-12#6)(1994-2#7)(1994-3#14)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#15)(1995-12#9)(1995-2#10)(1995-5#2)(1995-8#4)(1996-1#5)(1996-11#3)(1996-2#8)(1996-3#19)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#6)(1997-3#8)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#1)(1997-9#1)(2007-12#4)(2007-8#1)(2008-1#4)(2008-10#169)(2008-11#122)(2008-12#32)(2008-2#2)(2008-3#1)(2008-4#28)(2008-5#14)(2008-6#12)(2008-7#21)(2008-8#20)(2008-9#23)(2009-10#5)(2009-11#3)(2009-12#6)(2009-3#2)(2009-4#3)(2009-5#14)(2009-6#9)(2009-7#26)(2009-8#6)(2009-9#3)(2010-1#14)(2010-10#7)(2010-11#4)(2010-12#6)(2010-2#6)(2010-3#5)(2010-4#6)(2010-5#12)(2010-6#12)(2010-7#7)(2010-8#8)(2010-9#1)(2011-1#7)(2011-2#44)(2011-3#2)(2011-9#1)(2012-12#8)(2012-2#11)(2012-3#26)(2012-5#1)(2013-1#34)(2013-8#13)
support) and##2##2##(2009-7#2)
support)##5##1##(2008-10#1)(2009-5#1)(2009-7#3)
supported a##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
supported an##3##2##(2008-11#1)(2009-10#1)(2009-8#1)
supported both##2##2##(1995-2#1)(2009-4#1)
supported by a##9##3##(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-11#1)(2013-1#1)
supported by field##2##3##(2008-1#1)(2008-3#1)
supported by restriction analysis of##2##5##(1996-6#1)(2008-10#1)
supported by results##2##3##(1990-12#1)(1991-11#1)
supported by the results of##2##5##(2008-10#2)
supported by the##23##3##(1993-12#1)(1993-6#1)(1996-5#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
supported by##88##2##(1990-12#1)(1991-11#1)(1991-12#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
supported capillary membrane sampling-gas chromatography##2##5##(2008-10#2)
supported in the##4##3##(1994-3#1)(2008-1#1)(2008-12#1)(2012-2#1)
supported in##7##2##(1993-12#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
supported liquid membrane (SLM)##2##4##(2008-10#2)
supported liquid membrane containing##2##4##(2008-10#2)
supported liquid membrane##11##3##(2008-10#11)
supported liquid membranes (SLMs)##2##4##(2008-10#2)
supported liquid membranes##3##3##(2008-10#3)
supported liquid##14##2##(2008-10#14)
supported on a##2##3##(2008-10#2)
supported on poly(ethylene-co-vinyl-acetate)##2##3##(2008-10#2)
supported on##8##2##(2008-10#8)
supported only##3##2##(1990-3#1)(2008-10#1)(2010-6#1)
supported our##2##2##(1990-12#1)(2008-10#1)
supported the development##2##3##(2008-10#1)(2008-11#1)
supported the hypothesis##2##3##(2008-10#2)
supported the validity of##2##4##(2008-10#1)(2009-12#1)
supported the##33##2##(1992-12#1)(1996-12#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-8#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)
supported their learning##2##3##(2008-11#2)
supported##247##1##(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(2007-12#2)(2008-1#3)(2008-10#103)(2008-11#25)(2008-12#6)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#3)(2009-10#2)(2009-12#4)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#6)(2012-3#7)(2013-1#9)(2013-8#3)
supporters##2##1##(2008-10#1)(2011-2#1)
supporting Sertoli cells##2##3##(2009-10#1)(2010-5#1)
supporting Sertoli##3##2##(2009-10#2)(2010-5#1)
supporting a##6##2##(1995-5#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
supporting electrolyte and oxygen removing agent##2##6##(2008-10#2)
supporting electrolyte and##5##3##(2008-10#5)
supporting electrolyte in the##2##4##(2008-10#2)
supporting electrolyte on the##2##4##(2008-10#2)
supporting electrolyte was##3##3##(2008-10#3)
supporting electrolyte##39##2##(2008-10#39)
supporting electrolytes##7##2##(2008-10#7)
supporting evidence##4##2##(1991-6#1)(1992-10#1)(2008-10#1)(2012-2#1)
supporting growth of##4##3##(1995-11#1)(2008-11#3)
supporting growth##5##2##(1995-11#1)(2008-11#4)
supporting information##2##2##(1997-3#1)(2008-9#1)
supporting its##2##2##(2008-10#1)(2010-5#1)
supporting our##2##2##(2008-11#1)(2008-3#1)
supporting students##2##2##(2008-11#1)(2008-12#1)
supporting that##2##2##(1990-12#1)(2012-12#1)
supporting the hypothesis that the##2##5##(1997-7#1)(2009-3#1)
supporting the hypothesis that##7##4##(1990-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#1)(2009-7#1)
supporting the hypothesis##8##3##(1990-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-3#1)(2009-7#1)
supporting the involvement of##2##4##(2008-7#1)(2011-2#1)
supporting the role of##3##4##(1997-3#1)(2011-2#2)
supporting the use of##4##4##(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
supporting the##44##2##(1990-5#2)(1992-2#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#2)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
supporting these##2##2##(1994-1#1)(1996-2#1)
supporting this##4##2##(1991-6#1)(2008-12#1)(2008-2#1)(2011-2#1)
supporting##176##1##(1990-12#1)(1990-5#2)(1991-1#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-3#2)(1997-7#1)(2007-8#1)(2008-10#68)(2008-11#20)(2008-12#6)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-7#2)(2010-5#2)(2010-8#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
supportive acts##2##2##(1992-2#2)
supportive care##6##2##(1990-2#1)(1991-8#1)(2008-11#1)(2008-7#2)(2013-1#1)
supportive environment##2##2##(2008-12#1)(2010-9#1)
supportive evidence for the##2##4##(2008-10#1)(2013-1#1)
supportive evidence##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
supportive of adoption of##2##4##(2010-11#2)
supportive of##6##2##(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2010-11#2)
supportive oral care##2##3##(2008-7#2)
supportive processes##2##2##(2008-11#1)(2009-4#1)
supportive role##2##2##(1996-1#1)(2013-1#1)
supportive therapy##3##2##(1994-6#1)(2008-7#1)(2012-3#1)
supportive treatment##3##2##(2009-1#1)(2012-12#1)(2013-8#1)
supportive##59##1##(1990-2#1)(1991-2#1)(1991-8#1)(1992-2#2)(1992-3#1)(1993-1#1)(1994-2#2)(1994-6#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-2#1)(2008-10#4)(2008-11#8)(2008-12#3)(2008-7#6)(2008-8#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#3)(2010-1#2)(2010-11#2)(2010-6#1)(2010-9#1)(2012-12#1)(2012-3#3)(2013-1#5)(2013-8#1)
supportiveness##2##1##(2008-10#1)(2010-9#1)
supports a role for##2##4##(1996-2#1)(1997-1#1)
supports a##8##2##(1992-10#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2010-9#1)(2013-1#1)
supports an##2##2##(1991-5#1)(1994-2#1)
supports and##5##2##(1996-1#1)(2008-10#2)(2008-7#1)(2010-8#1)
supports previous##3##2##(1994-2#1)(1997-3#1)(2007-12#1)
supports that##3##2##(1993-3#1)(2008-9#1)(2013-1#1)
supports the conclusion that##2##4##(2008-10#1)(2008-9#1)
supports the fact that##2##4##(1997-4#1)(2011-2#1)
supports the hypothesis of##2##4##(2008-10#1)(2012-3#1)
supports the hypothesis that the##2##5##(1997-1#1)(2008-8#1)
supports the hypothesis that##11##4##(1990-11#1)(1997-1#1)(1997-2#1)(1997-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
supports the hypothesis##13##3##(1990-11#1)(1997-1#1)(1997-2#1)(1997-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
supports the idea that##5##4##(1990-11#1)(1997-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
supports the idea##6##3##(1990-11#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
supports the interpretation##2##3##(1997-9#1)(2009-11#1)
supports the possibility##2##3##(1993-1#1)(2008-10#1)
supports the role of##2##4##(1990-12#1)(2008-8#1)
supports the use of##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
supports the view that##2##4##(2008-7#1)(2013-7#1)
supports the##63##2##(1990-11#2)(1990-12#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-9#2)(2008-10#11)(2008-11#6)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#2)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
supports this##2##2##(1991-5#1)(1992-9#1)
supports was##2##2##(2008-10#2)
supports##129##1##(1990-11#2)(1990-12#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#3)(1994-3#2)(1994-5#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(1997-9#2)(2007-12#1)(2008-10#29)(2008-11#11)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
suppose that##3##2##(1990-5#1)(2008-10#2)
suppose##4##1##(1990-5#1)(1993-6#1)(2008-10#2)
supposed that##2##2##(2008-10#2)
supposed to be##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
supposed to##9##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-12#1)(2012-2#2)(2013-1#1)
supposed##14##1##(1990-12#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
supposedly##2##1##(1993-11#1)(1996-3#1)
supposition##2##1##(2008-11#1)(2008-9#1)
suppress ascospore germination##2##3##(2008-10#2)
suppress or##3##2##(1993-6#1)(2009-8#1)(2012-2#1)
suppress populations of##2##3##(2008-10#2)
suppress the growth of##2##4##(2008-5#1)(2008-9#1)
suppress the internalization of ADH-I##2##5##(2008-11#2)
suppress the severity of##2##4##(2008-10#2)
suppress the##26##2##(1992-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#10)(2008-11#6)(2008-5#2)(2008-9#2)(2009-8#1)(2010-7#1)
suppress##85##1##(1990-6#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#41)(2008-11#7)(2008-3#4)(2008-5#3)(2008-8#1)(2008-9#2)(2009-8#3)(2010-7#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
suppressed P##2##2##(2008-10#2)
suppressed and##5##2##(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#2)
suppressed at##3##2##(2008-10#2)(2008-11#1)
suppressed both the##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
suppressed both##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
suppressed by a##4##3##(1993-8#1)(1994-8#1)(1995-11#1)(2012-3#1)
suppressed by the addition of##2##5##(2008-10#2)
suppressed by the simultaneous##2##4##(1992-6#1)(2007-12#1)
suppressed by the##10##3##(1990-11#1)(1992-6#1)(1993-6#1)(1994-11#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)
suppressed by##36##2##(1990-11#1)(1990-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
suppressed conductivity##2##2##(2008-10#2)
suppressed damping-off##2##2##(2008-10#2)
suppressed disease##4##2##(2008-10#3)(2012-2#1)
suppressed during##2##2##(2009-10#1)(2013-8#1)
suppressed growth of##2##3##(2008-10#1)(2008-11#1)
suppressed in all##3##3##(2008-10#2)(2011-2#1)
suppressed in lactating mothers##2##4##(2011-2#2)
suppressed in the##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
suppressed in##16##2##(1993-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#3)(2013-8#1)
suppressed mycelial##2##2##(2008-10#2)
suppressed numbers of##2##3##(2008-10#1)(2008-5#1)
suppressed only##2##2##(1994-2#1)(2008-10#1)
suppressed secondary axis formation##2##4##(2008-6#2)
suppressed the development of##2##4##(1994-2#1)(2008-10#1)
suppressed the disease##3##3##(2008-10#3)
suppressed the invasion of##2##4##(2008-11#2)
suppressed the uptake of Pb by##2##6##(2008-10#2)
suppressed the uptake of##3##4##(2008-10#3)
suppressed the##40##2##(1990-12#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#2)(2008-10#13)(2008-11#6)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
suppressed when##3##2##(2008-10#2)(2008-12#1)
suppressed##223##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#2)(1994-11#1)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#6)(1995-11#6)(1995-2#2)(1995-8#2)(1996-12#2)(1996-2#4)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#72)(2008-11#32)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#3)(2009-10#2)(2009-8#2)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
suppresses and delays the##2##4##(1994-8#2)
suppresses the growth of##2##4##(2008-7#1)(2012-3#1)
suppresses the##9##2##(1992-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
suppresses tumor##2##2##(2011-2#1)(2013-1#1)
suppresses##37##1##(1991-1#1)(1991-9#1)(1992-6#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-6#1)(1997-1#2)(1997-8#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
suppressing cell growth##2##3##(2008-11#2)
suppressing cell##3##2##(2008-11#2)(2013-1#1)
suppressing the##9##2##(1994-2#1)(2008-10#3)(2008-11#2)(2009-10#1)(2013-1#1)(2013-8#1)
suppressing##39##1##(1991-1#1)(1994-11#1)(1994-2#1)(1994-8#2)(1997-2#1)(1997-7#1)(2008-10#12)(2008-11#8)(2008-3#1)(2009-10#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
suppression and##7##2##(1994-8#1)(2008-10#3)(2008-11#1)(2009-10#1)(2012-3#1)
suppression at##5##2##(1995-6#1)(2008-10#2)(2008-3#1)(2008-8#1)
suppression by the##3##3##(2008-10#3)
suppression by##16##2##(1993-8#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-9#1)(2009-9#1)(2011-2#1)
suppression effect of##2##3##(2008-10#2)
suppression have##2##2##(2008-10#1)(2013-8#1)
suppression in##12##2##(2007-11#1)(2008-10#6)(2008-11#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
suppression is##2##2##(2007-11#1)(2008-10#1)
suppression may be##2##3##(2007-11#1)(2008-8#1)
suppression of Botrytis cinerea##6##4##(2008-10#6)
suppression of Fusarium crown and root rot of asparagus##2##9##(2008-10#2)
suppression of Fusarium wilt of flax##2##6##(2008-10#2)
suppression of Fusarium wilt##4##4##(2008-10#4)
suppression of Fusarium##6##3##(2008-10#6)
suppression of I(gaba)##2##3##(2008-8#2)
suppression of a##2##3##(2008-10#1)(2008-11#1)
suppression of cell##3##3##(2008-10#1)(2008-11#2)
suppression of damping-off##3##3##(2008-10#3)
suppression of disease##4##3##(1997-8#1)(2008-10#3)
suppression of fire blight##2##4##(2008-10#2)
suppression of growth##3##3##(1992-10#1)(2008-10#1)(2008-8#1)
suppression of maturation##2##3##(2008-5#2)
suppression of plant pathogens##4##4##(2008-10#4)
suppression of plant##5##3##(2008-10#5)
suppression of plasmin##2##3##(2011-2#2)
suppression of soilborne##2##3##(2008-10#2)
suppression of the antibody response##2##5##(2008-10#2)
suppression of the##17##3##(1993-12#2)(1995-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#2)(2010-11#1)
suppression of##145##2##(1990-12#1)(1990-5#1)(1992-10#1)(1993-11#1)(1993-12#2)(1994-2#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#69)(2008-11#15)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#7)(2008-9#4)(2009-8#4)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#5)(2012-2#4)(2013-1#3)(2013-7#1)
suppression only##2##2##(2008-10#2)
suppression or enhancement##2##3##(2008-10#1)(2010-11#1)
suppression or##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
suppression subtractive hybridization##2##3##(2008-11#1)(2010-4#1)
suppression using##3##2##(2008-10#3)
suppression was not##2##3##(2008-10#1)(2010-11#1)
suppression was##16##2##(2008-10#12)(2008-11#1)(2008-3#1)(2010-11#1)(2013-1#1)
suppression were##2##2##(2008-10#2)
suppression with##3##2##(1994-2#1)(2008-10#2)
suppression##302##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#5)(1994-6#2)(1994-8#3)(1995-11#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#3)(1997-2#1)(1997-7#1)(1997-8#2)(2007-11#5)(2007-12#1)(2008-1#2)(2008-10#156)(2008-11#26)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#10)(2008-9#7)(2009-10#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-11#4)(2010-4#3)(2011-2#10)(2012-2#5)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#1)
suppressive and##2##2##(2008-10#2)
suppressive effect of##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
suppressive effect on##3##3##(1994-2#1)(2008-11#1)(2009-8#1)
suppressive effect##9##2##(1994-2#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
suppressive effects of##2##3##(2008-10#2)
suppressive effects##4##2##(2008-10#3)(2013-8#1)
suppressive or conducive##2##3##(2008-10#2)
suppressive soil had##3##3##(2008-10#3)
suppressive soil##11##2##(2008-10#11)
suppressive soils##3##2##(2008-10#3)
suppressive to##9##2##(2008-10#9)
suppressive##59##1##(1994-11#1)(1994-2#1)(1994-6#1)(2008-10#44)(2008-11#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
suppressiveness against##3##2##(2008-10#3)
suppressiveness in the different##2##4##(2008-10#2)
suppressiveness in##3##2##(2008-10#3)
suppressiveness of soils to##2##4##(2008-10#2)
suppressiveness of soils##4##3##(2008-10#4)
suppressiveness of the##2##3##(2008-10#2)
suppressiveness of##10##2##(2008-10#10)
suppressiveness to##2##2##(2008-10#2)
suppressiveness##28##1##(2008-10#28)
suppressor activity##3##2##(1993-11#1)(1995-6#1)(1997-8#1)
suppressor cells##3##2##(1991-6#2)(2013-1#1)
suppressor function##2##2##(1991-5#2)
suppressor gene##21##2##(1990-12#1)(1991-10#1)(1994-9#1)(1997-7#1)(1997-8#1)(1997-9#2)(2008-10#1)(2008-9#4)(2009-9#2)(2011-2#5)(2013-1#2)
suppressor genes##14##2##(1990-12#1)(1993-12#1)(1997-2#1)(1997-8#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#6)(2013-1#1)
suppressor macrophages##2##2##(2008-8#2)
suppressor of##5##2##(1995-6#2)(1995-8#1)(2008-10#1)(2012-12#1)
suppressor proteins##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
suppressor##80##1##(1990-12#2)(1991-10#1)(1991-5#2)(1991-6#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#6)(1995-8#1)(1997-2#1)(1997-7#2)(1997-8#3)(1997-9#2)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-4#1)(2009-8#1)(2009-9#2)(2011-2#16)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#1)
suppressors of##4##2##(1993-6#1)(2011-2#1)(2012-3#2)
suppressors##7##1##(1990-5#1)(1993-6#1)(2008-10#2)(2011-2#1)(2012-3#2)
suppuration##2##1##(2011-2#1)(2013-1#1)
suppurative otitis media##3##3##(2008-9#3)
suppurative##15##1##(1991-8#2)(1993-8#1)(1994-12#4)(1996-3#1)(1997-1#1)(2008-12#1)(2008-9#3)(2010-12#1)(2013-8#1)
supra- and##4##2##(2008-7#3)(2013-1#1)
supra-annual##2##1##(2008-9#2)
supracervical (subtotal) hysterectomy (LASH)##2##4##(1994-2#2)
supracervical##3##1##(1994-2#3)
supraclavicular lymph nodes##2##3##(1997-8#2)
supraclavicular##7##1##(1994-12#1)(1997-8#2)(2008-7#2)(2012-2#2)
supraconducive temperatures##2##2##(2008-10#2)
supraconducive##4##1##(2008-10#4)
supracondylar fracture##2##2##(2010-11#1)(2013-1#1)
supracondylar humerus fractures in children##2##5##(2009-3#1)(2013-1#1)
supracondylar humerus fractures in##3##4##(2009-3#1)(2013-1#2)
supracondylar humerus fractures##4##3##(2009-3#2)(2013-1#2)
supracondylar##7##1##(2009-3#2)(2010-11#1)(2013-1#4)
supramaximal inhibition##3##2##(1992-8#3)
supramaximal##7##1##(1992-8#3)(2013-8#4)
suprameatal approach##3##2##(2008-9#2)(2011-2#1)
supramolecular catalytic kinetic##2##3##(2008-10#2)
supramolecular liquid crystals##2##3##(2008-7#2)
supramolecular system##3##2##(2008-10#3)
supramolecular##19##1##(1993-12#1)(1993-8#1)(2008-10#15)(2008-7#2)
supranuclear palsy##2##2##(2012-12#2)
supraoptic nucleus##3##2##(1990-5#1)(1994-8#1)(2008-8#1)
supraoptic##5##1##(1990-5#1)(1994-8#1)(1996-12#2)(2008-8#1)
suprapubic##5##1##(2008-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
suprarenal##2##1##(1991-6#1)(2010-12#1)
suprasellar variant superior##2##3##(2012-3#2)
suprasellar##4##1##(2011-2#1)(2012-3#3)
supratentorial primitive neuroectodermal tumor with glioblastomatous differentiation##2##7##(2009-1#2)
supratentorial primitive neuroectodermal tumor with##3##5##(2009-1#3)
supratentorial##10##1##(1996-6#1)(2007-9#1)(2008-7#2)(2009-1#3)(2012-3#3)
suprathreshold 0##2##2##(2011-2#2)
suprathreshold tests##3##2##(2008-9#3)
suprathreshold##5##1##(2008-9#3)(2011-2#2)
supraventricular extrasystoles##3##2##(1996-6#3)
supraventricular tachycardia##2##2##(1993-2#2)
supraventricular##9##1##(1991-11#1)(1993-2#2)(1996-6#5)(2010-5#1)
supravesical hernia##2##2##(2008-12#2)
supravesical##3##1##(2008-12#2)(2011-2#1)
sur le##2##2##(2011-2#1)(2013-1#1)
sur les données de##2##4##(2013-1#2)
sur les##3##2##(2013-1#3)
sur##10##1##(2008-11#1)(2011-2#3)(2013-1#6)
suramin and##2##2##(1995-11#1)(2008-11#1)
sure that the##6##3##(1993-1#2)(1995-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
sure that##11##2##(1993-1#3)(1993-3#2)(1995-9#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)
sure##20##1##(1990-8#1)(1993-1#3)(1993-3#2)(1994-2#1)(1994-6#1)(1995-6#1)(1995-9#1)(2008-10#4)(2008-11#2)(2010-5#1)(2011-1#1)(2011-2#2)
surely##4##1##(1991-3#1)(1993-12#1)(2008-8#1)(2009-6#1)
surface (0##3##2##(2008-10#3)
surface EMG recording in##3##4##(2011-2#3)
surface EMG recording##4##3##(2011-2#4)
surface EMG##6##2##(2011-2#4)(2012-2#2)
surface FcepsilonRI expression was##3##4##(2008-11#3)
surface FcepsilonRI expression##4##3##(2008-11#4)
surface H and##2##3##(2008-10#2)
surface acoustic wave (SAW) devices##3##5##(2008-10#3)
surface acoustic wave (SAW)##5##4##(2007-12#1)(2008-10#4)
surface acoustic wave##9##3##(2007-12#2)(2008-10#6)(2009-5#1)
surface acoustic##10##2##(2007-12#2)(2008-10#7)(2009-5#1)
surface active##5##2##(2008-10#5)
surface activity reduction due to##2##5##(2008-10#2)
surface activity##9##2##(1994-5#2)(2008-10#6)(2008-5#1)
surface after##2##2##(2008-10#1)(2008-11#1)
surface allows the##2##3##(2008-10#2)
surface allows##3##2##(2008-10#3)
surface and a##2##3##(1995-2#1)(2008-2#1)
surface and in##2##3##(2008-10#2)
surface and intracellular antigens##3##4##(1990-12#2)(2008-9#1)
surface and intracellular##4##3##(1990-12#2)(2008-4#1)(2008-9#1)
surface and middle of##2##4##(2008-9#2)
surface and the##7##3##(2008-10#3)(2008-3#2)(2008-7#1)(2011-1#1)
surface and to##2##3##(2008-10#2)
surface and was##2##3##(2008-10#2)
surface and wastewaters##3##3##(2008-10#3)
surface and##61##2##(1990-12#2)(1991-12#1)(1995-2#2)(1997-1#1)(1997-2#1)(2006-6#2)(2008-10#30)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#4)(2009-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
surface antigen (HBsAg) and##2##4##(2008-8#1)(2012-3#1)
surface antigen (HBsAg)##8##3##(1994-11#1)(1995-2#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
surface antigen##22##2##(1994-11#2)(1995-2#1)(2008-10#2)(2008-11#6)(2008-8#4)(2008-9#2)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
surface antigens that are##2##4##(1995-6#1)(2008-4#1)
surface antigens##9##2##(1995-6#1)(2008-10#2)(2008-4#3)(2008-8#1)(2008-9#2)
surface appearance##2##2##(2008-5#1)(2010-6#1)
surface area and##6##3##(2008-10#2)(2008-7#2)(2010-7#1)(2012-3#1)
surface area by##2##3##(2008-10#1)(2013-1#1)
surface area in##3##3##(2008-11#2)(2013-1#1)
surface area of 3##2##4##(2013-1#2)
surface area of the##7##4##(1994-5#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
surface area of##18##3##(1993-12#1)(1994-5#1)(1997-1#1)(1997-2#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#3)
surface area to##2##3##(2008-10#1)(2008-11#1)
surface area was##3##3##(2008-10#2)(2009-11#1)
surface area##67##2##(1990-8#1)(1993-12#1)(1994-5#1)(1994-9#1)(1997-1#1)(1997-2#3)(2007-12#1)(2008-10#21)(2008-11#7)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-7#1)(2010-5#1)(2010-7#2)(2011-2#5)(2012-3#1)(2013-1#7)
surface areas of##3##3##(1996-12#1)(2008-3#1)(2013-1#1)
surface areas##9##2##(1996-12#1)(2008-10#5)(2008-3#2)(2013-1#1)
surface as a##2##3##(2008-10#1)(2008-11#1)
surface as##6##2##(2008-10#3)(2008-11#1)(2008-6#1)(2012-2#1)
surface at##9##2##(2008-10#6)(2008-11#1)(2008-3#2)
surface attachment##2##2##(2008-10#1)(2008-11#1)
surface between##2##2##(2008-8#1)(2013-1#1)
surface binding##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
surface by the##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
surface by##17##2##(1990-11#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
surface can be##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
surface characteristics of the##4##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
surface characteristics of##6##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
surface characteristics##10##2##(1992-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)
surface charge and##2##3##(1994-5#1)(2008-10#1)
surface charge density##4##3##(2008-4#1)(2008-9#1)(2009-8#2)
surface charge development##2##3##(2008-10#2)
surface charge##14##2##(1994-5#2)(1997-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#2)(2010-6#1)(2013-1#1)
surface chemistry##4##2##(2008-10#3)(2008-3#1)
surface coating##2##2##(2008-10#1)(2008-3#1)
surface coil##2##2##(1992-3#2)
surface coils##2##2##(1997-8#2)
surface components##4##2##(1991-12#3)(2008-10#1)
surface concentration of##2##3##(2008-10#1)(2008-9#1)
surface concentration##4##2##(2008-10#3)(2008-9#1)
surface contamination##3##2##(2008-10#3)
surface could be##2##3##(2008-10#2)
surface coverage##7##2##(2008-10#7)
surface deformation##2##2##(2008-3#1)(2008-8#1)
surface deformations##2##2##(2008-6#1)(2009-7#1)
surface does not##2##3##(2008-10#1)(2008-11#1)
surface drip system##2##3##(2008-10#2)
surface during##4##2##(2008-10#3)(2009-12#1)
surface ectoderm and##2##3##(1994-12#2)
surface electrodes##5##2##(2012-2#5)
surface electromyography can be used as a tool to##2##9##(2010-6#2)
surface electromyography##4##2##(2010-6#4)
surface enhanced resonance Raman scattering (SERRS)##2##6##(2008-10#2)
surface enhanced resonance Raman scattering##3##5##(2008-10#3)
surface enhanced##5##2##(2008-10#4)(2011-2#1)
surface epithelium##3##2##(1995-12#1)(1997-1#1)(2011-2#1)
surface expression of FcepsilonRI##4##4##(2008-11#4)
surface expression of HLA class I##2##6##(1994-5#1)(1997-9#1)
surface expression of##9##3##(1994-11#1)(1994-5#1)(1997-9#1)(2008-11#5)(2008-9#1)
surface expression##10##2##(1994-11#1)(1994-5#1)(1997-9#1)(2008-10#1)(2008-11#5)(2008-9#1)
surface followed by##3##3##(1997-8#1)(2008-10#2)
surface for the##4##3##(2008-10#3)(2009-5#1)
surface for##8##2##(2008-10#6)(2009-5#1)(2013-1#1)
surface from##4##2##(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
surface functional groups##2##3##(2008-10#1)(2009-7#1)
surface glycoprotein##3##2##(1992-6#1)(1996-12#1)(2011-2#1)
surface glycoproteins##2##2##(1994-5#1)(2008-9#1)
surface grown cultures of##2##4##(2008-7#2)
surface hydrophobicity##4##2##(1996-12#2)(2008-10#1)(2010-4#1)
surface in a##2##3##(2008-10#2)
surface in the##2##3##(2008-5#1)(2009-2#1)
surface in##13##2##(1990-11#1)(1995-2#1)(2008-10#7)(2008-5#1)(2008-6#1)(2009-2#1)(2013-1#1)
surface integrals is##2##3##(2008-3#2)
surface integration##3##2##(2008-3#3)
surface is described##2##3##(2008-3#1)(2008-4#1)
surface is presented##2##3##(2008-10#2)
surface is the##2##3##(2008-5#2)
surface is##21##2##(1990-6#1)(1992-2#1)(1993-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2009-11#1)(2010-10#1)
surface layer##5##2##(2008-10#2)(2008-5#2)(2013-8#1)
surface layers##6##2##(2008-3#1)(2008-5#2)(2008-7#1)(2012-2#2)
surface lipids##2##2##(2008-5#2)
surface marker##4##2##(2008-11#2)(2011-2#1)(2012-4#1)
surface markers has##2##3##(2008-9#1)(2013-1#1)
surface markers##6##2##(2008-10#1)(2008-9#3)(2011-2#1)(2013-1#1)
surface mastoidotomy##2##2##(2008-7#2)
surface materials on marble##2##4##(2008-10#2)
surface materials##3##2##(2008-10#2)(2008-3#1)
surface methodology##2##2##(2008-10#2)
surface modification##7##2##(2008-10#5)(2010-3#2)
surface molecules##7##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)
surface morphologies##2##2##(2008-10#1)(2009-7#1)
surface morphology of##2##3##(2008-5#1)(2008-7#1)
surface morphology##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#2)
surface not only##2##3##(2007-12#1)(2008-10#1)
surface occurs##2##2##(2008-10#1)(2008-7#1)
surface of CCPE##3##3##(2008-10#3)
surface of a quartz crystal##2##5##(2008-10#2)
surface of a##28##3##(1990-12#1)(1990-5#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)
surface of an##4##3##(2008-10#4)
surface of inoculated##2##3##(2008-10#2)
surface of the chorion##2##4##(2008-12#2)
surface of the electrode##6##4##(2008-10#6)
surface of the sample##3##4##(2008-10#2)(2008-3#1)
surface of the##103##3##(1990-8#1)(1992-11#1)(1992-6#1)(1994-11#3)(1996-9#1)(1997-7#1)(2008-10#55)(2008-11#9)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
surface of these two##2##4##(2008-11#1)(2008-5#1)
surface of these##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
surface of##233##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#5)(1995-2#3)(1995-6#2)(1995-8#2)(1996-9#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#133)(2008-11#19)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#11)(2008-7#3)(2008-8#7)(2008-9#3)(2009-3#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
surface on the##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
surface on##4##2##(2008-10#2)(2010-6#1)(2011-2#1)
surface or buried##2##3##(2008-10#2)
surface or##6##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#2)
surface orientation##2##2##(2008-6#2)
surface pH and##3##3##(2008-5#3)
surface pH##12##2##(2008-5#12)
surface pK(a)##2##2##(2008-10#2)
surface plasmon resonance (SPR) biosensor##5##5##(2008-10#3)(2008-11#1)(2008-4#1)
surface plasmon resonance (SPR) sensor##4##5##(2008-10#4)
surface plasmon resonance (SPR)##16##4##(2008-10#13)(2008-11#1)(2008-4#1)(2008-9#1)
surface plasmon resonance biosensor##7##4##(2008-10#7)
surface plasmon resonance sensor with##2##5##(2008-10#2)
surface plasmon resonance sensor##4##4##(2008-10#4)
surface plasmon resonance##40##3##(1992-11#1)(1995-12#1)(2008-10#32)(2008-11#1)(2008-4#2)(2008-9#1)(2009-12#1)(2013-1#1)
surface plasmon##41##2##(1992-11#1)(1995-12#1)(2008-10#32)(2008-11#1)(2008-4#2)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
surface plasmons##4##2##(2007-12#1)(2008-11#1)(2012-2#2)
surface potential##5##2##(1991-3#1)(1994-5#1)(2008-10#3)
surface pressure##5##2##(1997-2#2)(2008-10#3)
surface pressures##2##2##(2008-10#2)
surface pretreatment##2##2##(1997-2#1)(2008-10#1)
surface probability##3##2##(1990-4#3)
surface profiles##2##2##(2008-2#1)(2008-3#1)
surface properties##5##2##(2008-10#2)(2008-3#2)(2009-7#1)
surface protein##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
surface proteins##3##2##(1994-11#1)(2011-1#1)(2012-2#1)
surface rather than##4##3##(1993-8#1)(2008-10#3)
surface receptor##9##2##(1992-12#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-5#2)(1995-2#1)(1996-2#1)(2010-8#1)
surface receptors##9##2##(1994-11#1)(1995-2#2)(1996-2#1)(1997-7#1)(2008-10#2)(2009-9#1)(2011-2#1)
surface reconstruction##3##2##(2008-6#3)
surface reflectance##5##2##(2008-3#5)
surface residues##5##2##(2008-10#5)
surface roughness of##2##3##(2008-10#1)(2012-2#1)
surface roughness##10##2##(2008-10#2)(2008-3#1)(2008-7#1)(2009-7#4)(2012-2#2)
surface science##2##2##(2008-10#2)
surface seawater##2##2##(2008-10#2)
surface sediments##2##2##(2008-10#2)
surface shape##2##2##(2008-3#2)
surface soil##3##2##(2008-10#2)(2008-11#1)
surface structure of##2##3##(1997-6#1)(2008-10#1)
surface structure##5##2##(1997-6#1)(2008-10#3)(2008-7#1)
surface structures##2##2##(1990-11#1)(1992-2#1)
surface temperature##3##2##(2008-5#1)(2008-7#2)
surface temperatures##3##2##(1997-2#1)(2008-3#1)(2008-9#1)
surface tension and##2##3##(2008-3#1)(2010-4#1)
surface tension lowering##4##3##(2008-10#4)
surface tension measurements##2##3##(2008-10#2)
surface tension of the##2##4##(1995-3#1)(1996-3#1)
surface tension of##3##3##(1995-3#1)(1996-3#1)(2008-10#1)
surface tension##40##2##(1994-5#2)(1995-3#1)(1996-3#1)(2008-10#28)(2008-3#2)(2008-5#5)(2010-4#1)
surface texture##3##2##(2008-10#1)(2008-5#2)
surface that##3##2##(1992-2#1)(2008-3#1)(2008-5#1)
surface through##3##2##(2008-10#2)(2008-3#1)
surface to develop##2##3##(2008-10#2)
surface to the##5##3##(2008-10#2)(2008-3#1)(2008-6#1)(2009-7#1)
surface to##11##2##(2008-10#6)(2008-3#1)(2008-6#1)(2009-7#1)(2013-1#1)(2013-8#1)
surface treatment##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
surface under the##2##3##(2008-10#1)(2008-3#1)
surface under##6##2##(1997-2#1)(2008-10#4)(2008-3#1)
surface using a##2##3##(2008-10#2)
surface using##4##2##(2008-10#3)(2013-8#1)
surface was monitored##2##3##(2008-10#2)
surface was optimized##2##3##(2008-10#2)
surface was performed##2##3##(2008-10#1)(2008-11#1)
surface was used##2##3##(2008-10#2)
surface was##23##2##(1990-2#1)(2008-10#17)(2008-11#4)(2011-2#1)
surface water and##2##3##(2008-10#2)
surface water in##2##3##(2008-11#1)(2012-2#1)
surface water samples##7##3##(2008-10#7)
surface water##28##2##(2008-10#22)(2008-11#1)(2008-12#1)(2008-8#3)(2012-2#1)
surface waters and sediments##2##4##(2008-10#2)
surface waters and##3##3##(2008-10#3)
surface waters##6##2##(2008-10#6)
surface were##9##2##(2008-10#6)(2008-11#1)(2008-5#1)(2009-7#1)
surface wetness##2##2##(2008-10#2)
surface where##2##2##(2008-5#1)(2009-9#1)
surface which is##3##3##(2008-10#2)(2013-8#1)
surface which##5##2##(2008-10#2)(2008-5#1)(2009-8#1)(2013-8#1)
surface with##12##2##(1994-8#1)(1995-2#1)(2008-10#7)(2008-4#1)(2008-5#2)
surface##1538##1##(1990-11#4)(1990-12#6)(1990-2#2)(1990-4#3)(1990-5#5)(1990-6#2)(1990-8#2)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#1)(1992-6#3)(1992-8#1)(1993-1#2)(1993-12#4)(1993-6#1)(1993-8#2)(1994-11#13)(1994-12#4)(1994-3#3)(1994-5#16)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#17)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#5)(1996-12#6)(1996-2#3)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#7)(1997-2#15)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#3)(1997-9#1)(2006-6#2)(2007-12#12)(2008-10#743)(2008-11#83)(2008-12#10)(2008-2#6)(2008-3#74)(2008-4#17)(2008-5#93)(2008-6#17)(2008-7#34)(2008-8#28)(2008-9#34)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#18)(2009-8#6)(2009-9#6)(2010-10#4)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#8)(2010-7#4)(2010-8#1)(2011-1#4)(2011-2#30)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#29)(2012-3#8)(2012-4#1)(2012-5#1)(2013-1#36)(2013-8#16)
surface)##2##1##(2008-10#1)(2008-5#1)
surface-active##6##1##(2008-10#5)(2008-5#1)
surface-associated##3##1##(1996-12#2)(2012-2#1)
surface-confined Ru(bpy)(3)(2+)##2##2##(2008-10#2)
surface-disinfested##3##1##(2008-10#3)
surface-enhanced Raman scattering (SERS)##3##4##(2008-10#3)
surface-enhanced Raman scattering##8##3##(2008-10#8)
surface-enhanced Raman spectroscopy (SERS)##2##4##(2008-10#2)
surface-enhanced Raman spectroscopy##3##3##(2008-10#3)
surface-enhanced Raman##11##2##(2008-10#11)
surface-enhanced##13##1##(2008-10#13)
surface-mediated reactions##2##2##(2008-10#2)
surface-mulched plots amended with##2##4##(2008-10#2)
surface-plasmon polariton##2##2##(2008-3#2)
surface-plasmon##4##1##(2008-3#4)
surface-relief##3##1##(2008-2#1)(2008-3#2)
surfaced##3##1##(2008-7#1)(2011-2#2)
surfaces after##2##2##(1996-12#1)(2008-10#1)
surfaces and matrices is##2##4##(1990-2#2)
surfaces and matrices##3##3##(1990-2#3)
surfaces and the##2##3##(2008-10#1)(2008-11#1)
surfaces and##14##2##(1990-2#3)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2009-8#1)
surfaces are##3##2##(2008-10#1)(2008-5#1)(2010-10#1)
surfaces at##2##2##(2008-10#1)(2012-2#1)
surfaces by##6##2##(2008-10#5)(2013-8#1)
surfaces can be##2##3##(1990-11#1)(2008-7#1)
surfaces for##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
surfaces have##2##2##(2008-3#1)(2013-1#1)
surfaces in accelerated ageing##2##4##(2008-10#2)
surfaces in the##3##3##(2008-10#2)(2008-3#1)
surfaces in##8##2##(2008-10#4)(2008-3#1)(2009-12#1)(2010-10#1)(2013-1#1)
surfaces is described##2##3##(2008-10#1)(2008-3#1)
surfaces is presented##2##3##(2008-10#1)(2008-2#1)
surfaces is##9##2##(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
surfaces of the##8##3##(1996-12#1)(2007-12#1)(2008-10#6)
surfaces of##27##2##(1990-12#1)(1996-12#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-8#1)
surfaces to form##2##3##(2008-10#1)(2008-7#1)
surfaces to##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
surfaces using##2##2##(2008-10#2)
surfaces was initially##2##3##(2010-10#2)
surfaces was##7##2##(2008-10#3)(2010-10#4)
surfaces were##7##2##(1995-2#1)(2008-10#2)(2008-3#1)(2009-12#1)(2009-7#1)(2013-1#1)
surfaces with##8##2##(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-5#1)
surfaces##259##1##(1990-11#1)(1990-12#1)(1990-2#8)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-6#1)(2007-12#4)(2008-10#106)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#21)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#9)(2010-6#1)(2010-7#5)(2011-2#4)(2012-2#5)(2012-3#2)(2012-5#2)(2013-1#14)(2013-8#8)
surfactant (Curosurf)##2##2##(1990-11#2)
surfactant Triton X-100##2##3##(2008-10#2)
surfactant Triton##3##2##(2008-10#3)
surfactant aggregates##3##2##(2008-10#3)
surfactant and##7##2##(1997-1#2)(2008-10#4)(2008-5#1)
surfactant can##2##2##(1997-1#1)(2011-2#1)
surfactant concentration and##2##3##(2008-10#2)
surfactant concentration##11##2##(1996-5#1)(2008-10#8)(2008-5#2)
surfactant in the##3##3##(2008-10#2)(2008-5#1)
surfactant in##5##2##(2008-10#4)(2008-5#1)
surfactant is##4##2##(1997-1#1)(2008-10#3)
surfactant micelles##7##2##(2008-10#7)
surfactant mixtures##3##2##(2008-10#2)(2008-5#1)
surfactant or##3##2##(1994-5#1)(2008-10#1)(2008-5#1)
surfactant phase##2##2##(2008-10#2)
surfactant phospholipid##2##2##(1994-5#2)
surfactant reduced##2##2##(1990-11#1)(1997-1#1)
surfactant sodium##4##2##(2008-10#3)(2010-11#1)
surfactant solution##3##2##(2008-10#1)(2008-5#2)
surfactant solutions##2##2##(2008-10#2)
surfactant solvent media##2##3##(2008-10#2)
surfactant system##2##2##(1997-1#1)(2008-10#1)
surfactant to##2##2##(2008-10#1)(2008-5#1)
surfactant used##3##2##(2008-10#2)(2008-5#1)
surfactant was##3##2##(1994-5#1)(2008-10#2)
surfactant with##2##2##(1994-5#1)(2008-10#1)
surfactant##208##1##(1990-11#4)(1993-2#2)(1994-3#1)(1994-5#10)(1996-5#1)(1997-1#15)(1997-2#5)(2008-10#133)(2008-5#24)(2008-8#3)(2009-10#1)(2010-11#2)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
surfactant)##3##1##(2008-10#3)
surfactant-based products##3##2##(2008-5#3)
surfactant-rich phase##9##2##(2008-10#7)(2008-7#2)
surfactant-rich##10##1##(2008-10#8)(2008-7#2)
surfactant-selective##2##1##(2008-10#2)
surfactants and the##2##3##(2008-10#2)
surfactants and##9##2##(1996-1#1)(2008-10#8)
surfactants are##4##2##(1996-1#1)(2008-10#3)
surfactants as##2##2##(2008-10#1)(2008-5#1)
surfactants at##2##2##(2008-10#2)
surfactants by##2##2##(2008-10#2)
surfactants in the##5##3##(2008-10#4)(2008-5#1)
surfactants in##14##2##(2008-10#12)(2008-5#2)
surfactants is##3##2##(2008-10#3)
surfactants of##4##2##(2008-10#4)
surfactants on the##4##3##(2008-10#2)(2008-5#2)
surfactants on##6##2##(2008-10#3)(2008-5#3)
surfactants was##2##2##(2008-5#2)
surfactants were##6##2##(2008-10#4)(2008-5#2)
surfactants with##2##2##(2008-10#1)(2008-5#1)
surfactants##118##1##(1996-1#3)(1996-2#1)(1997-1#1)(2008-10#86)(2008-5#25)(2008-7#2)
surge of##2##2##(1990-9#1)(2012-2#1)
surge##5##1##(1990-9#1)(2008-10#1)(2008-11#1)(2009-3#1)(2012-2#1)
surgeon and##3##2##(2011-2#2)(2013-1#1)
surgeon in##2##2##(1990-9#1)(2008-8#1)
surgeon is##3##2##(1992-1#1)(1993-11#1)(1996-1#1)
surgeon should be##2##3##(2008-9#1)(2013-1#1)
surgeon should##4##2##(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
surgeon to##5##2##(1992-12#2)(1993-12#1)(2010-7#1)(2012-12#1)
surgeon##44##1##(1990-9#1)(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#2)(1993-1#2)(1993-11#1)(1993-12#1)(1995-12#2)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#1)
surgeon's##8##1##(1990-5#1)(1991-9#1)(1995-1#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
surgeonfish is##2##2##(2008-5#2)
surgeonfish##5##1##(2008-5#5)
surgeons and##3##2##(1993-12#1)(2008-4#1)(2008-9#1)
surgeons in the##2##3##(2008-10#1)(2010-8#1)
surgeons in##3##2##(2008-10#1)(2010-8#1)(2012-12#1)
surgeons should be##2##3##(1991-3#1)(2008-8#1)
surgeons should##5##2##(1991-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
surgeons to##3##2##(2008-9#1)(2013-1#2)
surgeons were##4##2##(1995-1#1)(1996-3#1)(2008-9#2)
surgeons##51##1##(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-1#2)(1995-9#1)(1996-3#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#9)(2009-1#1)(2009-10#1)(2009-3#2)(2010-12#1)(2010-8#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
surgeons'##2##1##(1991-9#1)(2008-9#1)
surgeries were##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
surgeries##15##1##(1990-9#1)(1992-11#1)(2008-8#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)
surgery after##4##2##(1990-6#2)(2008-7#1)(2012-3#1)
surgery alone##6##2##(1990-8#1)(1995-5#1)(2012-3#3)(2013-1#1)
surgery and 1##2##3##(1995-2#1)(2012-12#1)
surgery and adjuvant##2##3##(1992-12#1)(2008-11#1)
surgery and anesthesia##2##3##(1993-1#1)(2012-3#1)
surgery and chemotherapy for##2##4##(2012-12#1)(2013-1#1)
surgery and chemotherapy##6##3##(1990-8#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
surgery and the##6##3##(1993-3#1)(1997-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
surgery and with##2##3##(1993-1#1)(2013-1#1)
surgery and##65##2##(1990-11#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-6#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#4)(2013-8#1)
surgery and/or##2##2##(1991-9#1)(2008-7#1)
surgery are discussed##2##3##(2013-1#2)
surgery are##10##2##(1991-1#1)(2008-7#2)(2008-8#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)
surgery as compared with##2##4##(1990-9#1)(1996-3#1)
surgery as##3##2##(1990-9#1)(1996-3#1)(2011-2#1)
surgery at the##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
surgery at##7##2##(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
surgery because of the##2##4##(2011-2#1)(2012-12#1)
surgery because of##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
surgery because##5##2##(1991-9#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
surgery between##2##2##(2011-2#1)(2013-8#1)
surgery but##2##2##(2012-3#2)
surgery by a##2##3##(2011-2#1)(2013-1#1)
surgery by##3##2##(1992-3#1)(2011-2#1)(2013-1#1)
surgery can be performed##2##4##(1990-2#1)(1991-3#1)
surgery can be##5##3##(1990-2#1)(1991-3#1)(2008-7#1)(2008-8#1)(2010-10#1)
surgery can##8##2##(1990-2#1)(1991-3#1)(1992-5#1)(1994-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
surgery due to##2##3##(1993-6#1)(2013-1#1)
surgery during the##2##3##(2011-3#1)(2012-2#1)
surgery followed by chemotherapy##2##4##(2007-8#1)(2013-8#1)
surgery for a large##2##4##(2008-7#2)
surgery for a##5##3##(1992-2#1)(2008-7#2)(2008-8#1)(2009-1#1)
surgery for benign esophageal##2##4##(2013-1#2)
surgery for cerebral##3##3##(1996-6#1)(1996-9#1)(2008-7#1)
surgery for craniopharyngioma##2##3##(1995-5#1)(2008-7#1)
surgery for their##2##3##(1991-3#1)(2008-7#1)
surgery for treating##2##3##(2008-11#1)(2008-9#1)
surgery for##54##2##(1990-9#2)(1991-3#2)(1991-8#1)(1992-2#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#2)(2008-11#5)(2008-7#9)(2008-8#2)(2008-9#3)(2009-1#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
surgery has become##3##3##(1990-2#1)(2012-12#1)(2013-1#1)
surgery has been##3##3##(1991-11#1)(1992-3#1)(2012-3#1)
surgery has##12##2##(1990-2#1)(1991-11#1)(1991-3#1)(1992-3#2)(2008-10#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#3)
surgery have been##2##3##(2008-10#1)(2012-3#1)
surgery in breast cancer##2##4##(1993-11#2)
surgery in breast##4##3##(1991-2#2)(1993-11#2)
surgery in patients##2##3##(1994-3#1)(2009-8#1)
surgery in the##6##3##(1991-6#1)(1995-5#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
surgery in this##2##3##(2008-7#1)(2012-3#1)
surgery in##44##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-6#1)(1993-11#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1997-8#2)(2008-10#2)(2008-11#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#5)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#1)
surgery is a##2##3##(2012-3#2)
surgery is not##4##3##(2008-1#1)(2013-1#2)(2013-8#1)
surgery is often##2##3##(1992-9#1)(2012-2#1)
surgery is still the##2##4##(1990-5#1)(2008-11#1)
surgery is still##3##3##(1990-5#1)(2008-11#1)(2011-2#1)
surgery is##28##2##(1990-5#1)(1990-9#2)(1992-12#1)(1992-9#2)(1993-3#1)(1996-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
surgery may##3##2##(2011-2#2)(2012-3#1)
surgery of the##3##3##(1992-9#1)(2008-9#1)(2013-1#1)
surgery of##14##2##(1990-9#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-8#1)(1997-8#1)(2008-7#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
surgery on##9##2##(1990-5#1)(1993-12#1)(2008-10#2)(2010-8#1)(2012-3#4)
surgery or embolization##2##3##(2008-7#2)
surgery or endovascular##2##3##(1995-11#1)(2008-7#1)
surgery or##16##2##(1990-5#1)(1991-8#2)(1994-12#1)(1995-11#1)(1997-4#1)(2008-10#2)(2008-7#5)(2008-9#1)(2011-2#1)(2012-3#1)
surgery performed##2##2##(1991-2#1)(2008-11#1)
surgery practice##3##2##(2008-9#1)(2013-1#2)
surgery provided that##2##3##(1990-11#1)(2008-7#1)
surgery requiring##3##2##(2010-7#1)(2011-2#1)(2012-3#1)
surgery seems to be##2##4##(2008-7#2)
surgery should be##2##3##(1997-3#1)(1997-8#1)
surgery since##2##2##(1990-9#1)(1996-3#1)
surgery the##6##2##(1992-9#1)(1993-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
surgery time##3##2##(1993-12#2)(2012-12#1)
surgery to##8##2##(1994-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
surgery under general anaesthesia##2##4##(2010-7#2)
surgery under##4##2##(1991-1#1)(1993-1#1)(2010-7#2)
surgery using a##4##3##(1992-9#1)(2010-3#1)(2013-1#2)
surgery using##6##2##(1990-9#1)(1992-9#1)(2010-3#1)(2010-8#1)(2013-1#2)
surgery was done##2##3##(1993-6#1)(1997-3#1)
surgery was performed##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
surgery was the##3##3##(1997-3#1)(2010-12#1)(2010-8#1)
surgery was##27##2##(1991-1#1)(1993-6#1)(1994-12#1)(1997-3#2)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
surgery were evaluated##2##3##(1997-3#1)(2011-2#1)
surgery were randomly##2##3##(2007-8#1)(2011-2#1)
surgery were##16##2##(1990-6#1)(1991-6#1)(1993-12#1)(1997-3#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#1)
surgery with a##3##3##(1992-12#1)(2008-7#1)(2012-2#1)
surgery with extracorporeal circulation##2##4##(2012-3#2)
surgery with extracorporeal##3##3##(2012-3#3)
surgery with##18##2##(1991-2#1)(1992-12#1)(1993-1#3)(1997-3#1)(2008-12#1)(2008-7#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)
surgery without any##2##3##(2011-2#2)
surgery without##7##2##(1990-2#1)(2011-2#4)(2012-3#1)(2013-8#1)
surgery##898##1##(1990-11#3)(1990-12#2)(1990-2#7)(1990-3#3)(1990-5#3)(1990-6#9)(1990-8#4)(1990-9#19)(1991-1#10)(1991-11#1)(1991-12#1)(1991-2#10)(1991-3#13)(1991-6#4)(1991-8#5)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#5)(1992-3#13)(1992-5#10)(1992-9#12)(1993-1#14)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#10)(1993-6#4)(1994-1#2)(1994-11#1)(1994-12#9)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#9)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#4)(1995-5#4)(1996-1#1)(1996-11#4)(1996-3#11)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#11)(1997-4#4)(1997-5#1)(1997-7#4)(1997-8#7)(2006-6#1)(2007-8#4)(2008-1#2)(2008-10#24)(2008-11#26)(2008-12#13)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#62)(2008-8#15)(2008-9#21)(2009-1#5)(2009-10#2)(2009-12#5)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#16)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#4)(2010-7#14)(2010-8#9)(2010-9#3)(2011-1#4)(2011-2#92)(2011-3#7)(2011-7#2)(2012-12#42)(2012-2#23)(2012-3#71)(2012-5#1)(2013-1#75)(2013-7#2)(2013-8#15)
surgery) were##2##2##(1990-11#1)(2012-3#1)
surgery)##6##1##(1990-11#1)(1990-6#1)(1991-3#1)(1993-3#1)(2008-10#1)(2012-3#1)
surgery-related##2##1##(1994-12#1)(2010-12#1)
surgery]##28##1##(1990-5#2)(1990-9#1)(1991-3#2)(1992-3#3)(1992-6#1)(1992-9#2)(1993-3#1)(1994-3#1)(1994-8#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2009-5#1)(2011-3#1)(2012-3#5)(2013-8#3)
surgical access##2##2##(2009-4#1)(2013-1#1)
surgical alternative for##2##3##(1991-2#1)(2008-7#1)
surgical and medical complications##2##4##(2008-9#2)
surgical and medical##3##3##(2008-9#2)(2013-1#1)
surgical and##17##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#2)(1994-3#1)(1995-12#1)(2008-7#1)(2008-9#2)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#2)
surgical approach for the##2##4##(2011-2#2)
surgical approach in the##2##4##(1993-6#1)(2011-3#1)
surgical approach to##2##3##(1990-12#1)(2008-10#1)
surgical approach was##3##3##(1991-6#1)(2008-7#1)(2013-1#1)
surgical approach##26##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-5#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-7#4)(2008-8#1)(2011-2#4)(2011-3#1)(2012-3#4)(2013-1#2)
surgical approaches to##2##3##(2008-7#1)(2013-1#1)
surgical approaches##8##2##(1991-3#1)(1993-3#1)(2008-7#1)(2011-2#2)(2013-1#3)
surgical aspects of##3##3##(1990-9#1)(2008-10#1)(2008-9#1)
surgical biopsy of##2##3##(1990-6#1)(2012-3#1)
surgical biopsy##3##2##(1990-6#1)(2008-5#1)(2012-3#1)
surgical blood##2##2##(1996-9#2)
surgical care##7##2##(1992-6#1)(1993-12#1)(1995-2#1)(2008-4#1)(2008-6#1)(2009-12#1)(2013-1#1)
surgical cases##3##2##(1993-12#2)(2008-8#1)
surgical center##2##2##(1997-1#2)
surgical challenges##2##2##(2008-9#1)(2012-3#1)
surgical clipping##2##2##(1997-6#1)(2013-8#1)
surgical complication##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
surgical complications##8##2##(1993-3#1)(1994-12#1)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#3)
surgical correction##3##2##(2010-10#1)(2011-2#1)(2012-2#1)
surgical debridement##4##2##(1995-2#1)(2007-11#1)(2010-6#2)
surgical decompression is##3##3##(2011-2#2)(2012-12#1)
surgical decompression##4##2##(2008-7#1)(2011-2#2)(2012-12#1)
surgical delay##3##2##(2013-1#3)
surgical drainage##3##2##(2011-2#3)
surgical emergency##2##2##(2009-4#1)(2011-2#1)
surgical excision of##2##3##(2011-2#1)(2013-1#1)
surgical excision was##2##3##(2012-3#1)(2013-1#1)
surgical excision##13##2##(1993-1#1)(2008-10#1)(2010-11#1)(2011-2#5)(2012-3#3)(2013-1#2)
surgical exeresis##2##2##(1990-3#1)(1991-11#1)
surgical exploration and##2##3##(2008-7#1)(2010-7#1)
surgical exploration is##2##3##(2008-7#1)(2012-3#1)
surgical exploration of the neck##2##5##(2010-12#1)(2011-2#1)
surgical exploration##8##2##(1991-3#1)(1993-3#1)(2008-7#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
surgical exposure##3##2##(1990-5#1)(2008-4#1)(2013-1#1)
surgical field##3##2##(1996-1#1)(2008-9#1)(2012-3#1)
surgical findings##2##2##(2008-10#1)(2008-9#1)
surgical glove##3##2##(1993-6#1)(1995-3#2)
surgical intervention and##2##3##(2008-7#1)(2013-1#1)
surgical intervention is##4##3##(1991-3#1)(2008-8#1)(2012-2#1)(2013-8#1)
surgical intervention##29##2##(1990-2#1)(1991-3#1)(1992-9#1)(1994-6#1)(2007-11#1)(2008-12#2)(2008-7#3)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
surgical interventions##4##2##(1991-3#1)(1994-5#1)(2011-2#1)(2013-8#1)
surgical literature##2##2##(1992-1#1)(2011-2#1)
surgical management is##4##3##(2008-7#1)(2011-2#1)(2013-1#2)
surgical management of##17##3##(1994-12#2)(1994-3#1)(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#3)
surgical management with##2##3##(1993-3#1)(2008-12#1)
surgical management##28##2##(1991-3#1)(1992-1#1)(1993-3#1)(1994-12#2)(1994-3#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#5)
surgical margins may##2##3##(1997-7#2)
surgical margins##4##2##(1997-7#2)(2011-2#2)
surgical methods##3##2##(1997-5#1)(2007-8#1)(2008-9#1)
surgical navigation##2##2##(2008-9#2)
surgical nurses' experiences in caring for patients with postoperative pain##2##10##(2010-7#2)
surgical oncology##2##2##(2008-10#1)(2012-3#1)
surgical operations##2##2##(1992-11#1)(2010-6#1)
surgical options##2##2##(2008-8#1)(2008-9#1)
surgical or##2##2##(2011-2#1)(2013-1#1)
surgical orientation##2##2##(2008-9#1)(2011-2#1)
surgical outcome##4##2##(1991-2#1)(2008-7#2)(2013-8#1)
surgical outcomes##3##2##(1993-12#1)(2008-10#1)(2013-1#1)
surgical patients and##2##3##(1993-12#1)(2009-12#1)
surgical patients##9##2##(1991-6#1)(1993-12#2)(2008-1#1)(2008-12#3)(2009-12#1)(2013-8#1)
surgical planning##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
surgical practice##6##2##(2008-11#1)(2008-9#3)(2010-8#1)(2011-2#1)
surgical procedure is##2##3##(1994-8#1)(2011-2#1)
surgical procedure was##2##3##(2008-7#1)(2010-7#1)
surgical procedure with##3##3##(1991-3#1)(2008-9#1)(2012-3#1)
surgical procedure##24##2##(1991-3#1)(1993-3#1)(1994-12#1)(1994-8#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-7#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#3)
surgical procedures and##3##3##(1992-2#1)(1994-3#1)(2007-8#1)
surgical procedures are##2##3##(1990-3#1)(2008-9#1)
surgical procedures for##2##3##(1996-9#1)(2008-12#1)
surgical procedures in##2##3##(2008-7#1)(2013-1#1)
surgical procedures that##2##3##(1992-5#1)(1993-3#1)
surgical procedures were##3##3##(1991-8#1)(2012-12#1)(2012-3#1)
surgical procedures##43##2##(1990-3#2)(1990-5#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-9#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)
surgical removal of the##7##4##(1992-12#1)(1995-12#1)(2008-4#1)(2008-7#2)(2011-2#2)
surgical removal of##9##3##(1992-12#1)(1995-12#1)(1996-9#1)(2008-4#1)(2008-7#2)(2011-2#3)
surgical removal##10##2##(1992-12#1)(1995-12#1)(1996-9#1)(2008-4#1)(2008-7#3)(2011-2#3)
surgical repair of##4##3##(1993-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
surgical repair##13##2##(1993-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
surgical resection and adjuvant##2##4##(1990-9#1)(2011-3#1)
surgical resection and##4##3##(1990-9#1)(2008-11#1)(2011-2#1)(2011-3#1)
surgical resection is indicated##2##4##(1997-3#1)(2009-12#1)
surgical resection is##4##3##(1997-3#1)(2008-1#1)(2008-7#1)(2009-12#1)
surgical resection of##3##3##(2010-7#1)(2011-2#2)
surgical resection or##2##3##(1996-3#1)(2013-1#1)
surgical resection##27##2##(1990-9#1)(1991-12#1)(1991-2#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#5)(2009-12#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
surgical results##2##2##(2008-7#1)(2010-3#1)
surgical risk##3##2##(1991-3#1)(2008-12#1)(2011-2#1)
surgical salvage##2##2##(1991-8#1)(2012-3#1)
surgical site complications##2##3##(2013-1#2)
surgical site infection##3##3##(2010-12#2)(2012-3#1)
surgical site infections in##2##4##(2009-3#2)
surgical site infections##5##3##(2009-3#2)(2012-3#3)
surgical site##13##2##(2009-3#2)(2010-12#2)(2010-3#1)(2010-6#1)(2012-3#5)(2013-1#2)
surgical specialty##2##2##(2010-3#1)(2010-8#1)
surgical specimen##4##2##(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
surgical specimens of##2##3##(1996-10#1)(2010-11#1)
surgical specimens##4##2##(1995-3#1)(1996-10#1)(2008-9#1)(2010-11#1)
surgical stabilization consisting of##2##4##(2012-3#2)
surgical stabilization##3##2##(2012-3#3)
surgical strategy##2##2##(1992-9#1)(2011-2#1)
surgical stress##3##2##(1992-5#1)(2008-12#1)(2013-1#1)
surgical team##2##2##(2008-7#1)(2011-3#1)
surgical technique and##3##3##(1995-3#1)(2012-2#1)(2013-1#1)
surgical technique##24##2##(1990-9#3)(1991-3#1)(1992-9#1)(1995-3#1)(2008-7#4)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#3)(2011-7#1)(2012-2#2)(2013-1#4)
surgical techniques and##2##3##(1994-5#1)(2011-3#1)
surgical techniques for##2##3##(2011-2#2)
surgical techniques have been##2##4##(2009-10#1)(2011-3#1)
surgical techniques have##3##3##(1994-3#1)(2009-10#1)(2011-3#1)
surgical techniques##22##2##(1992-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-9#2)(2009-10#1)(2010-7#1)(2011-2#4)(2011-3#2)(2012-3#3)(2013-1#1)
surgical terminology##2##2##(1997-8#2)
surgical therapies##2##2##(2010-6#1)(2013-1#1)
surgical therapy and##4##3##(1990-5#2)(1992-5#1)(2011-2#1)
surgical therapy of##5##3##(1990-9#1)(1992-3#1)(2008-7#1)(2011-3#2)
surgical therapy##14##2##(1990-5#2)(1990-9#2)(1991-6#1)(1992-3#1)(1992-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-3#3)(2013-1#1)
surgical time##2##2##(1994-2#1)(2011-2#1)
surgical trauma##4##2##(1993-1#1)(2008-12#1)(2012-12#2)
surgical treatment and##2##3##(1990-5#1)(2008-11#1)
surgical treatment for##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
surgical treatment in##2##3##(1993-3#1)(2013-1#1)
surgical treatment is indicated##2##4##(2008-9#1)(2010-3#1)
surgical treatment is##7##3##(1992-9#1)(1993-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)
surgical treatment of the urinary bladder##2##6##(2011-2#2)
surgical treatment of the##3##4##(1991-6#1)(2011-2#2)
surgical treatment of##24##3##(1990-3#2)(1990-5#1)(1990-9#2)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#2)
surgical treatment was##3##3##(1990-3#1)(1994-12#1)(2012-3#1)
surgical treatment were##2##3##(1990-9#1)(2011-2#1)
surgical treatment with##2##3##(1991-6#1)(2008-10#1)
surgical treatment##87##2##(1990-12#1)(1990-3#3)(1990-5#3)(1990-6#1)(1990-9#6)(1991-2#2)(1991-3#2)(1991-6#2)(1991-8#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#4)(1993-3#3)(1993-6#2)(1994-12#2)(1995-2#1)(1996-3#1)(1996-6#1)(1997-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#5)
surgical treatments##2##2##(2008-11#1)(2012-3#1)
surgical##709##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#8)(1990-5#11)(1990-6#5)(1990-9#15)(1991-1#5)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#18)(1991-6#8)(1991-8#3)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#6)(1992-6#3)(1992-9#8)(1993-1#5)(1993-12#6)(1993-2#2)(1993-3#11)(1993-6#8)(1994-12#9)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#4)(1996-6#1)(1996-9#7)(1997-1#2)(1997-3#1)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#7)(2007-11#2)(2007-8#3)(2008-1#4)(2008-10#19)(2008-11#15)(2008-12#15)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#51)(2008-8#12)(2008-9#29)(2009-1#1)(2009-10#1)(2009-12#7)(2009-3#4)(2009-4#3)(2009-5#1)(2009-8#4)(2010-10#1)(2010-11#6)(2010-12#10)(2010-3#6)(2010-5#3)(2010-6#7)(2010-7#11)(2010-8#2)(2011-1#1)(2011-2#91)(2011-3#12)(2011-7#2)(2012-12#14)(2012-2#12)(2012-3#41)(2013-1#73)(2013-8#13)
surgically and##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
surgically correctable##2##2##(2008-11#1)(2008-7#1)
surgically excised##3##2##(1997-8#1)(2012-3#1)(2013-1#1)
surgically implanted##2##2##(2008-5#1)(2010-6#1)
surgically in##2##2##(2007-8#1)(2008-7#1)
surgically removed##4##2##(1991-2#1)(1997-5#1)(2008-7#1)(2011-2#1)
surgically resected##4##2##(2008-11#1)(2008-7#2)(2010-12#1)
surgically treated by##2##3##(1994-6#1)(2008-7#1)
surgically treated cases##2##3##(2008-7#1)(2011-2#1)
surgically treated in##2##3##(1996-11#1)(2012-3#1)
surgically treated patients##2##3##(2008-7#2)
surgically treated##15##2##(1990-9#1)(1992-9#2)(1994-6#1)(1996-11#1)(2008-7#5)(2011-2#3)(2012-3#1)(2013-1#1)
surgically##71##1##(1990-12#2)(1990-2#2)(1990-6#1)(1990-9#1)(1991-2#1)(1992-9#2)(1993-2#1)(1994-6#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#17)(2008-8#1)(2009-1#1)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#8)(2012-2#1)(2012-3#4)(2013-1#8)(2013-8#1)
surimi samples##2##2##(2011-2#2)
surimi seafood products##2##3##(2011-2#2)
surimi##4##1##(2011-2#4)
surpass##3##1##(1995-12#1)(2011-2#1)(2013-8#1)
surpassed##6##1##(1991-5#1)(1994-12#1)(2008-10#2)(2008-9#1)(2012-2#1)
surprise##5##1##(1990-11#2)(1990-3#1)(2009-8#1)(2011-1#1)
surprising that##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
surprising##14##1##(1991-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
surprisingly high##4##2##(1991-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
surprisingly little##3##2##(2008-11#1)(2009-4#1)(2012-3#1)
surprisingly similar##2##2##(1995-11#1)(2008-8#1)
surprisingly##23##1##(1991-8#1)(1993-12#1)(1995-11#2)(1995-3#1)(1997-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#3)(2008-9#2)(2009-4#1)(2011-2#3)(2012-2#1)(2012-3#1)
surrender##2##1##(2010-12#1)(2011-2#1)
surrogate decision makers##2##3##(1995-12#1)(2010-4#1)
surrogate endpoints##2##2##(1994-9#1)(2008-11#1)
surrogate marker##2##2##(2009-6#1)(2011-7#1)
surrogate markers##3##2##(2008-6#1)(2009-6#1)(2013-1#1)
surrogate serologic tests##3##3##(1995-5#3)
surrogate standard##2##2##(2008-10#2)
surrogate test##2##2##(1995-1#2)
surrogate##34##1##(1992-3#1)(1993-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-5#3)(1995-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-4#2)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
surrogates##5##1##(1995-5#1)(2008-10#3)(2010-4#1)
surround##4##1##(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
surrounded by a##8##3##(1991-11#1)(1991-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-8#1)
surrounded by an area of##3##5##(1991-11#1)(2008-10#1)(2011-2#1)
surrounded by an##7##3##(1991-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2011-2#1)
surrounded by##28##2##(1991-11#2)(1991-8#1)(1993-9#1)(2007-12#4)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
surrounded##32##1##(1991-11#2)(1991-8#1)(1993-9#1)(2007-12#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2010-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
surrounding a##4##2##(1991-5#1)(1994-11#1)(2008-3#1)(2008-9#1)
surrounding areas##2##2##(2008-11#1)(2009-10#1)
surrounding environment##4##2##(2008-10#1)(2008-7#1)(2013-1#2)
surrounding muscles##2##2##(2008-12#1)(2013-8#1)
surrounding normal##3##2##(2008-12#1)(2008-7#1)(2010-12#1)
surrounding soft tissues##2##3##(2008-9#1)(2012-12#1)
surrounding soft##3##2##(2008-9#1)(2010-6#1)(2012-12#1)
surrounding soil##2##2##(2008-12#2)
surrounding solvent##3##2##(1993-8#1)(2008-10#2)
surrounding structures and##3##3##(2011-2#2)(2013-1#1)
surrounding structures##6##2##(1993-6#1)(2008-10#1)(2011-2#3)(2013-1#1)
surrounding the nucleus##2##3##(2008-10#1)(2009-10#1)
surrounding the potential##2##3##(2008-11#2)
surrounding the translation initiation sites on##2##6##(1996-8#1)(1997-2#1)
surrounding the translation initiation sites##6##5##(1996-8#3)(1997-2#2)(1997-6#1)
surrounding the##49##2##(1991-10#1)(1991-5#1)(1991-7#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#4)(1997-2#5)(1997-5#1)(1997-6#1)(1997-9#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-7#1)(2009-10#2)(2009-12#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
surrounding tissue##3##2##(1990-11#1)(1991-2#1)(1997-4#1)
surrounding tissues##6##2##(1990-6#1)(1993-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
surrounding##171##1##(1990-11#1)(1990-2#1)(1990-6#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-8#4)(1997-2#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#13)(2008-12#9)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#11)(2008-9#4)(2009-10#3)(2009-12#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-10#1)(2011-2#11)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
surroundings of the##2##3##(2008-5#1)(2009-7#1)
surroundings of##3##2##(1995-2#1)(2008-5#1)(2009-7#1)
surroundings to##2##2##(1992-2#1)(2008-10#1)
surroundings##11##1##(1992-2#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2009-7#1)(2013-8#1)
surrounds the##3##2##(1996-5#1)(2007-12#1)(2008-7#1)
surrounds##5##1##(1996-5#1)(2007-12#2)(2008-7#2)
surtout##2##1##(2008-11#1)(2011-2#1)
surveillance and assessment activities##2##4##(1997-3#2)
surveillance and assessment##3##3##(1997-3#3)
surveillance and information systems##2##4##(1997-3#2)
surveillance and management##3##3##(2009-12#1)(2012-3#2)
surveillance and public health information systems##3##6##(1997-3#3)
surveillance and public health##4##4##(1997-3#3)(2010-8#1)
surveillance and the##2##3##(2009-12#1)(2011-2#1)
surveillance and##28##2##(1990-3#2)(1997-1#1)(1997-2#2)(1997-3#8)(2008-10#1)(2008-7#1)(2009-12#2)(2009-8#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-8#1)
surveillance data for##2##3##(1995-3#1)(2013-8#1)
surveillance data##8##2##(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#3)(2013-8#2)
surveillance definition##3##2##(1992-9#3)
surveillance for##11##2##(1997-3#5)(2008-1#1)(2008-10#1)(2009-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
surveillance from##2##2##(1996-11#1)(2011-2#1)
surveillance in##6##2##(1997-3#3)(2011-2#1)(2012-12#1)(2013-8#1)
surveillance is##2##2##(1997-3#2)
surveillance network##2##2##(2011-9#2)
surveillance of the##3##3##(1991-11#1)(1997-5#1)(2009-12#1)
surveillance of these##2##3##(1991-11#1)(2009-12#1)
surveillance of##17##2##(1991-11#2)(1991-12#1)(1995-2#1)(1996-2#1)(1997-5#1)(2007-12#1)(2008-10#3)(2009-12#2)(2011-2#1)(2012-12#3)(2013-8#1)
surveillance on##2##2##(2011-2#1)(2013-8#1)
surveillance programs##5##2##(1991-12#2)(2008-10#1)(2012-12#2)
surveillance results##2##2##(2011-2#2)
surveillance strategies##2##2##(2008-1#1)(2011-2#1)
surveillance study in##2##3##(1991-11#1)(2008-7#1)
surveillance study##4##2##(1991-11#2)(1993-2#1)(2008-7#1)
surveillance system for##2##3##(1997-3#1)(2012-12#1)
surveillance system##15##2##(1991-12#1)(1991-8#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-3#4)(2012-12#5)
surveillance systems and##2##3##(1997-3#2)
surveillance systems were##2##3##(1994-9#1)(1997-3#1)
surveillance systems will##2##3##(1997-3#2)
surveillance systems##20##2##(1994-9#1)(1997-3#12)(2008-7#5)(2012-12#1)(2013-1#1)
surveillance to##3##2##(2008-7#1)(2010-11#1)(2011-2#1)
surveillance using a##3##3##(1997-3#1)(2013-1#2)
surveillance was##2##2##(2010-12#1)(2011-2#1)
surveillance will##2##2##(1997-3#1)(2008-12#1)
surveillance##213##1##(1990-3#2)(1991-11#4)(1991-12#6)(1991-8#1)(1992-2#1)(1992-6#2)(1992-9#3)(1993-2#2)(1993-3#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#55)(1997-5#1)(2007-12#1)(2008-1#10)(2008-10#9)(2008-11#2)(2008-12#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-12#9)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-8#3)(2011-2#18)(2011-3#2)(2011-9#5)(2012-12#19)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#7)
surveillance)##3##1##(2008-10#1)(2009-12#1)(2010-3#1)
survenue##4##1##(2011-2#1)(2013-1#3)
survey also##3##2##(1994-12#1)(2008-6#1)(2010-5#1)
survey among##3##2##(1992-3#1)(2008-12#1)(2012-3#1)
survey and administrative data##2##4##(1995-2#1)(1995-3#1)
survey and in##2##3##(2008-8#1)(2011-1#1)
survey and##10##2##(1991-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-8#1)(2011-1#1)(2012-2#1)
survey conducted in##4##3##(1991-3#1)(1996-9#1)(2008-1#1)(2008-10#1)
survey conducted##6##2##(1991-3#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
survey data and##2##3##(1997-3#1)(2008-10#1)
survey data from the##2##4##(1993-3#1)(1997-3#1)
survey data from##3##3##(1992-12#1)(1993-3#1)(1997-3#1)
survey data##12##2##(1992-12#1)(1993-3#1)(1996-3#1)(1997-3#3)(2008-10#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
survey for##8##2##(1991-5#1)(1994-3#2)(1995-12#1)(2008-10#3)(2013-1#1)
survey has##3##2##(1991-11#1)(1996-1#1)(1997-8#1)
survey in a##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
survey in the##2##3##(1991-6#1)(1994-3#1)
survey in##19##2##(1990-6#1)(1991-6#1)(1993-11#1)(1994-1#1)(1994-3#2)(1994-8#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
survey included##2##2##(2008-1#1)(2008-11#1)
survey indicated##2##2##(1995-1#1)(2008-10#1)
survey instrument##2##2##(1996-1#1)(1996-3#1)
survey instruments##2##2##(1996-2#1)(2013-8#1)
survey is##5##2##(1995-1#1)(1997-8#1)(2008-10#1)(2008-11#2)
survey method##2##2##(1991-3#1)(2008-11#1)
survey methods##3##2##(1995-2#1)(2009-4#1)(2010-1#1)
survey of 200##3##3##(1997-2#1)(2008-12#1)(2009-4#1)
survey of Canadian##2##3##(1994-12#1)(2008-11#1)
survey of a##2##3##(2008-10#1)(2009-11#1)
survey of all##5##3##(1990-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2008-1#1)
survey of excipients used in approved injectable products##2##8##(2012-2#2)
survey of members##3##3##(1994-3#1)(1995-1#1)(1995-2#1)
survey of the##6##3##(1992-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2012-2#1)
survey of trypanozoon infection in horses##2##6##(2011-2#2)
survey of users##2##3##(1991-1#2)
survey of##105##2##(1990-12#1)(1991-1#2)(1991-3#2)(1991-6#1)(1991-8#2)(1992-1#2)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-3#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2008-1#1)(2008-10#20)(2008-11#7)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#3)(2010-10#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)
survey on indoor##2##3##(2008-10#2)
survey on##6##2##(1990-8#1)(1994-12#1)(1994-3#1)(2008-10#3)
survey questionnaire##3##2##(1991-8#1)(1993-12#1)(2012-2#1)
survey responses##2##2##(1994-12#1)(2013-1#1)
survey results##8##2##(1991-3#1)(1994-3#1)(2008-11#2)(2011-10#1)(2013-1#2)(2013-8#1)
survey revealed that##3##3##(1994-3#1)(2008-10#2)
survey revealed##4##2##(1994-3#1)(2008-10#3)
survey sampling##2##2##(2008-10#1)(2008-7#1)
survey showed that##3##3##(1993-6#1)(2008-10#2)
survey showed##4##2##(1993-6#1)(1997-1#1)(2008-10#2)
survey suggests that##2##3##(1994-12#1)(1996-1#1)
survey that##2##2##(1993-11#1)(2013-1#1)
survey to assess##2##3##(1995-12#1)(2012-12#1)
survey to##5##2##(1995-12#1)(1996-12#1)(2008-11#1)(2012-12#1)(2013-1#1)
survey tool##2##2##(2012-12#1)(2013-1#1)
survey undertaken##2##2##(1996-12#1)(2008-10#1)
survey using##3##2##(1997-1#1)(2008-10#1)(2011-1#1)
survey was administered to##2##4##(2008-12#1)(2008-9#1)
survey was carried out in##2##5##(2008-9#1)(2010-5#1)
survey was carried out##5##4##(1997-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)
survey was conducted in##6##4##(1991-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
survey was conducted to##5##4##(1997-1#1)(2008-10#1)(2011-2#1)(2013-1#2)
survey was conducted using a##2##5##(1991-12#1)(2010-8#1)
survey was conducted##18##3##(1991-12#1)(1991-3#1)(1996-1#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#4)
survey was sent to##4##4##(1993-1#1)(2011-2#2)(2012-2#1)
survey was sent##5##3##(1993-1#1)(2007-12#1)(2011-2#2)(2012-2#1)
survey was to##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
survey was##43##2##(1991-12#2)(1991-3#1)(1992-1#1)(1993-1#1)(1993-3#1)(1994-1#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#3)(2010-1#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#4)
survey were##5##2##(1991-12#1)(1992-1#1)(1995-12#1)(2008-10#1)(2011-2#1)
survey##435##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#8)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#5)(1992-12#1)(1992-3#4)(1992-7#1)(1993-1#5)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#6)(1993-6#2)(1994-1#4)(1994-12#12)(1994-2#2)(1994-3#13)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-12#5)(1995-2#6)(1995-3#3)(1995-5#1)(1996-1#9)(1996-12#5)(1996-2#3)(1996-3#6)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#8)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#5)(2007-12#2)(2008-1#5)(2008-10#65)(2008-11#31)(2008-12#13)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#2)(2009-4#5)(2009-8#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-10#2)(2011-2#18)(2012-12#7)(2012-2#14)(2012-3#4)(2013-1#30)(2013-8#6)
survey]##5##1##(1993-11#2)(1993-2#1)(1994-5#1)(1997-3#1)
surveyed for##5##2##(1996-12#1)(1997-4#1)(2008-10#2)(2010-8#1)
surveyed in##10##2##(1992-3#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#2)
surveyed##68##1##(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#3)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#3)(2008-10#15)(2008-11#5)(2008-9#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
surveying##4##1##(1993-1#1)(1995-2#1)(1996-2#1)(2012-2#1)
surveys and##8##2##(1994-1#1)(1994-12#1)(2008-10#5)(2012-12#1)
surveys are##2##2##(1997-3#1)(2008-8#1)
surveys assessing##2##2##(2009-5#1)(2010-8#1)
surveys at##3##2##(1994-2#1)(2013-1#2)
surveys conducted by##2##3##(1996-2#1)(1997-1#1)
surveys conducted##4##2##(1996-2#1)(1997-1#1)(2008-10#1)(2010-9#1)
surveys in##4##2##(1995-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
surveys indicate that##2##3##(1994-3#1)(2010-8#1)
surveys of##6##2##(1993-9#1)(1996-11#1)(1996-12#1)(1997-4#1)(2008-10#1)(2012-2#1)
surveys on##2##2##(2008-10#2)
surveys the##2##2##(1991-1#1)(1992-3#1)
surveys to##5##2##(1991-9#1)(1992-1#1)(2008-1#1)(2008-10#1)(2010-1#1)
surveys using##2##2##(2009-4#1)(2009-8#1)
surveys were##7##2##(1991-9#1)(1994-9#1)(1996-3#1)(2008-10#1)(2009-5#1)(2010-11#1)(2010-8#1)
surveys##86##1##(1990-6#1)(1991-1#1)(1991-3#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#2)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#3)
survivability##3##1##(1996-12#2)(2008-11#1)
survival (P##2##2##(2012-3#1)(2013-1#1)
survival ability##2##2##(2008-10#2)
survival advantage was found with##2##5##(2008-7#2)
survival advantage##3##2##(2008-7#2)(2012-3#1)
survival after##5##2##(1993-8#1)(1997-5#1)(2008-10#1)(2008-9#1)(2012-3#1)
survival age##3##2##(1996-2#3)
survival among##2##2##(1990-8#1)(2009-1#1)
survival analysis##6##2##(1997-4#1)(2008-10#4)(2008-6#1)
survival and breeding##2##3##(2008-8#2)
survival and differentiation of##2##4##(1996-12#1)(2010-11#1)
survival and differentiation##5##3##(1996-12#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-8#1)
survival and growth of##2##4##(2008-10#1)(2008-11#1)
survival and growth##4##3##(2008-10#2)(2008-11#2)
survival and insufficient neuronal differentiation##2##5##(2009-10#2)
survival and progression##2##3##(2008-10#1)(2012-12#1)
survival and proliferation of##2##4##(2008-9#1)(2011-2#1)
survival and the##4##3##(2008-10#1)(2008-8#1)(2012-3#2)
survival and##57##2##(1990-12#1)(1991-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-6#2)(1996-11#1)(1996-12#1)(1996-3#1)(2006-6#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#3)(2009-8#1)(2010-1#1)(2010-11#3)(2010-7#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#1)
survival and/or##2##2##(1994-12#1)(1996-12#1)
survival at 5 years of##2##5##(1991-2#1)(1994-6#1)
survival at##6##2##(1990-5#1)(1991-2#1)(1994-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
survival benefit in##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
survival benefit##8##2##(1993-1#1)(2008-10#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#3)
survival by##2##2##(2008-9#2)
survival compared##2##2##(2008-7#2)
survival curves##7##2##(1995-1#2)(1995-3#3)(2013-1#1)(2013-8#1)
survival data##3##2##(1990-2#1)(1992-2#1)(1995-12#1)
survival depends on##2##3##(2008-8#1)(2011-3#1)
survival distribution##4##2##(1995-12#1)(1995-9#3)
survival due to##2##3##(1991-12#1)(2012-3#1)
survival during the##2##3##(1994-2#1)(2010-11#1)
survival during##8##2##(1994-2#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-3#1)
survival factor##3##2##(2008-11#1)(2009-8#1)(2010-11#1)
survival following##2##2##(2008-10#1)(2011-2#1)
survival for patients##2##3##(1990-8#1)(2008-10#1)
survival for the##2##3##(2008-1#1)(2008-8#1)
survival for##7##2##(1990-6#1)(1990-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
survival from##2##2##(1993-1#1)(2008-7#1)
survival improvement##2##2##(2007-11#1)(2013-1#1)
survival in a##3##3##(1994-12#1)(1995-2#1)(2008-10#1)
survival in patients with##3##4##(1997-5#1)(2010-11#1)(2011-2#1)
survival in patients##4##3##(1997-5#1)(2010-11#1)(2011-2#2)
survival in the##2##3##(2008-11#1)(2008-7#1)
survival in vitro##4##3##(2008-10#1)(2008-5#1)(2012-2#2)
survival in##30##2##(1994-12#2)(1995-2#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-1#1)(2010-11#1)(2011-2#5)(2011-3#1)(2012-2#2)(2013-1#1)
survival index##5##2##(2008-10#5)
survival is##12##2##(1990-6#1)(1990-9#1)(1993-1#1)(1994-12#2)(1995-9#1)(1996-3#1)(2008-7#1)(2008-8#1)(2011-3#3)
survival level at the end of irradiation##2##7##(2008-9#2)
survival mechanism##2##2##(2008-10#1)(2011-2#1)
survival model##2##2##(1996-12#2)
survival of Fusarium##2##3##(2008-10#2)
survival of P##3##3##(2008-10#3)
survival of Verticillium dahliae##2##4##(2008-12#2)
survival of a##2##3##(2008-10#2)
survival of cells##2##3##(1993-8#1)(2008-9#1)
survival of microsclerotia##2##3##(2008-10#2)
survival of patients with##6##4##(1994-6#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-2#1)(2012-3#1)
survival of patients##8##3##(1994-6#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-3#1)
survival of the cells##3##4##(2008-11#3)
survival of the pathogen##2##4##(2008-10#1)(2011-2#1)
survival of the##21##3##(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-8#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
survival of this##2##3##(1994-12#1)(2011-1#1)
survival of##114##2##(1990-2#2)(1991-3#1)(1991-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#2)(2007-11#1)(2008-1#1)(2008-10#32)(2008-11#6)(2008-12#2)(2008-2#1)(2008-5#7)(2008-7#1)(2008-8#7)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#3)(2011-1#2)(2011-2#9)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#5)(2013-8#3)
survival on##2##2##(2010-8#1)(2012-2#1)
survival or##5##2##(1992-2#1)(1995-2#1)(2008-8#2)(2008-9#1)
survival outcomes##2##2##(2012-3#1)(2013-1#1)
survival pathway##5##2##(2009-7#2)(2011-2#3)
survival predictions##2##2##(1992-9#2)
survival rate after##2##3##(1990-12#1)(1993-8#1)
survival rate and##3##3##(1997-7#1)(2012-12#1)(2013-1#1)
survival rate in##2##3##(1995-2#1)(2011-2#1)
survival rate nor##3##3##(1990-8#1)(1997-7#2)
survival rate of##6##3##(2008-11#2)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
survival rate was 88%##2##4##(1991-2#1)(1991-6#1)
survival rate was##14##3##(1990-6#1)(1990-9#1)(1991-2#2)(1991-6#1)(1993-11#1)(1997-7#4)(2008-7#1)(2011-2#3)
survival rate##46##2##(1990-12#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-3#1)(1997-7#9)(2008-10#3)(2008-11#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
survival rates for##2##3##(2008-10#1)(2010-11#1)
survival rates of##2##3##(2008-11#1)(2008-7#1)
survival rates were##2##3##(1990-8#1)(1991-8#1)
survival rates##22##2##(1990-8#1)(1990-9#1)(1991-8#1)(1994-12#2)(2008-10#3)(2008-11#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
survival significantly##2##2##(2008-10#2)
survival strategies##2##2##(2008-11#1)(2008-5#1)
survival substantially##2##2##(2008-8#1)(2009-10#1)
survival time after##3##3##(1990-9#1)(2012-3#2)
survival time for##2##3##(1997-4#2)
survival time of##4##3##(1990-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
survival time was##4##3##(1990-9#1)(1994-8#1)(2008-10#1)(2013-8#1)
survival time##19##2##(1990-12#1)(1990-9#3)(1992-9#1)(1994-8#1)(1995-12#3)(1997-4#2)(2008-10#2)(2008-7#2)(2008-8#1)(2012-3#2)(2013-8#1)
survival times##3##2##(2008-10#1)(2013-8#2)
survival to##8##2##(1993-8#1)(2008-8#2)(2008-9#1)(2010-7#2)(2011-9#1)(2012-3#1)
survival under##4##2##(2008-11#1)(2008-9#1)(2010-7#1)(2012-3#1)
survival was investigated##2##3##(1992-12#1)(2008-7#1)
survival was##41##2##(1990-12#2)(1990-8#1)(1991-2#1)(1991-6#4)(1991-8#3)(1992-12#5)(1992-5#1)(1993-1#1)(1993-6#1)(1995-2#1)(1997-5#1)(2008-10#4)(2008-7#3)(2008-9#5)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
survival were##6##2##(1990-12#1)(1996-12#1)(2008-10#2)(2012-3#1)(2013-1#1)
survival with##3##2##(1992-9#1)(1993-2#1)(2011-2#1)
survival##700##1##(1990-10#1)(1990-12#7)(1990-2#3)(1990-5#2)(1990-6#6)(1990-8#8)(1990-9#6)(1991-12#3)(1991-2#7)(1991-3#2)(1991-6#6)(1991-8#10)(1992-12#5)(1992-2#3)(1992-3#1)(1992-5#1)(1992-9#8)(1993-1#11)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-12#14)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#8)(1994-8#1)(1995-1#3)(1995-12#10)(1995-2#7)(1995-3#8)(1995-9#8)(1996-11#2)(1996-12#9)(1996-2#5)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#5)(1997-7#9)(1997-9#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#5)(2008-10#108)(2008-11#34)(2008-12#3)(2008-2#3)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#46)(2008-8#36)(2008-9#25)(2009-1#2)(2009-10#8)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#6)(2010-1#1)(2010-10#1)(2010-11#7)(2010-12#4)(2010-4#1)(2010-7#6)(2010-8#9)(2011-1#2)(2011-2#53)(2011-3#11)(2011-9#2)(2012-12#5)(2012-2#8)(2012-3#36)(2012-5#2)(2012-7#1)(2013-1#28)(2013-7#1)(2013-8#13)
survival)##2##1##(2008-10#1)(2008-8#1)
survival/proliferation##2##1##(2009-10#1)(2009-3#1)
survival?##2##1##(1995-3#1)(2008-7#1)
survive and thrive##2##3##(1994-12#1)(1997-1#1)
survive and##7##2##(1992-3#1)(1994-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2013-1#2)
survive as##2##2##(2008-10#2)
survive for##6##2##(2007-12#1)(2008-7#1)(2008-8#2)(2009-6#1)(2013-1#1)
survive in the##3##3##(2008-10#2)(2011-2#1)
survive in##8##2##(1992-12#1)(1996-12#1)(2008-10#2)(2009-12#2)(2011-2#1)(2013-8#1)
survive longer##2##2##(2008-10#2)
survive the##2##2##(2011-2#2)
survive##53##1##(1991-11#1)(1991-3#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1997-1#1)(2007-12#2)(2008-10#14)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#6)(2012-3#1)(2013-1#3)(2013-8#1)
survived a##2##2##(1996-12#1)(2008-10#1)
survived after##4##2##(1994-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
survived at##4##2##(1995-2#1)(2008-10#2)(2008-11#1)
survived for more than 1##2##5##(2008-10#1)(2011-2#1)
survived for more than three months##2##6##(1990-12#2)
survived for more than##5##4##(1990-12#2)(1991-8#1)(2008-10#1)(2011-2#1)
survived for##7##2##(1990-12#2)(1991-8#1)(2008-10#2)(2008-8#1)(2011-2#1)
survived in the##2##3##(2008-10#2)
survived in##3##2##(2008-10#3)
survived more than##2##3##(1990-6#1)(2008-11#1)
survived the##3##2##(1990-2#1)(2008-10#1)(2008-7#1)
survived to##2##2##(2008-11#1)(2008-9#1)
survived well in##2##3##(1996-12#1)(2008-8#1)
survived with##4##2##(1990-12#1)(1990-9#2)(2013-1#1)
survived without##2##2##(1992-5#1)(1994-9#1)
survived##64##1##(1990-12#3)(1990-2#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#2)(1996-12#2)(2008-1#1)(2008-10#19)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2011-2#5)(2011-3#1)(2013-1#3)
survivin and##2##2##(2011-2#2)
survivin in##5##2##(2010-1#1)(2011-2#4)
survivin protein##3##2##(2011-2#3)
survivin##19##1##(2010-1#3)(2011-2#16)
surviving children##2##2##(1994-3#2)
surviving in##3##2##(1996-8#1)(2008-10#1)(2008-7#1)
surviving patients##2##2##(1993-1#1)(2012-3#1)
surviving the##2##2##(1996-12#1)(2010-4#1)
surviving##36##1##(1992-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#2)(1996-12#1)(1996-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#6)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#2)
survivor##11##1##(1991-12#1)(1997-3#2)(2008-10#1)(2011-2#1)(2012-3#2)(2013-1#4)
survivors and##3##2##(2008-11#2)(2010-7#1)
survivors of violence##4##3##(2008-11#4)
survivors of##11##2##(1991-6#1)(1995-11#1)(1995-6#1)(2008-11#7)(2008-7#1)
survivors##47##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-9#1)(1993-1#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-3#1)(2008-11#9)(2008-5#2)(2008-7#3)(2008-8#1)(2009-6#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#5)(2013-1#2)
survivors'##3##1##(2010-2#1)(2010-4#1)(2012-3#1)
survivorship of##3##2##(2013-1#3)
survivorship was##2##2##(2009-4#1)(2013-1#1)
survivorship##24##1##(2008-11#1)(2008-8#2)(2008-9#4)(2009-4#2)(2012-3#6)(2013-1#9)
susceptibilities of##2##2##(2008-7#2)
susceptibilities to##2##2##(1997-3#1)(2008-11#1)
susceptibilities##6##1##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2013-8#1)
susceptibility and a##2##3##(2008-10#2)
susceptibility and##7##2##(2008-10#5)(2008-7#1)(2012-3#1)
susceptibility between##2##2##(2008-10#1)(2011-3#1)
susceptibility effects##2##2##(2012-2#2)
susceptibility for##2##2##(2008-10#1)(2008-7#1)
susceptibility gene##3##2##(1994-9#1)(1995-12#1)(1997-8#1)
susceptibility genes##6##2##(1994-9#1)(1995-8#1)(1997-7#1)(2008-7#1)(2008-8#1)(2008-9#1)
susceptibility in##5##2##(1991-9#1)(1997-7#1)(2007-12#1)(2011-2#1)(2012-2#1)
susceptibility is##2##2##(2011-2#2)
susceptibility locus##3##2##(1994-12#1)(1994-9#1)(2011-2#1)
susceptibility of peach to##2##4##(2008-10#2)
susceptibility of the chickpea cultivar##2##5##(2008-10#2)
susceptibility of the##7##3##(2008-10#5)(2008-3#1)(2011-2#1)
susceptibility of these##3##3##(1994-5#1)(1996-12#2)
susceptibility of##41##2##(1990-12#1)(1992-9#1)(1994-5#1)(1994-8#1)(1996-12#2)(2008-10#19)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
susceptibility pattern of##2##3##(2010-8#1)(2012-3#1)
susceptibility pattern##4##2##(1995-11#1)(2010-8#1)(2012-3#2)
susceptibility patterns of##2##3##(2008-12#1)(2008-5#1)
susceptibility patterns##5##2##(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
susceptibility period of##2##3##(2008-10#2)
susceptibility period##3##2##(2008-10#3)
susceptibility should##2##2##(1991-12#1)(2008-10#1)
susceptibility testing was##2##3##(2008-7#1)(2012-3#1)
susceptibility testing##12##2##(1996-10#1)(2008-7#3)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#3)
susceptibility to antibiotics##2##3##(1997-4#1)(2009-6#1)
susceptibility to bacterial canker##4##4##(2008-10#4)
susceptibility to colitis-associated##2##3##(2011-2#2)
susceptibility to disease##2##3##(2008-10#1)(2008-9#1)
susceptibility to essential hypertension in Han Chinese##2##7##(2008-9#2)
susceptibility to human##2##3##(2011-2#1)(2013-8#1)
susceptibility to infection##4##3##(1995-5#1)(2008-10#3)
susceptibility to infections##4##3##(2007-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
susceptibility to lysis by##2##4##(1992-2#1)(2008-9#1)
susceptibility to the##6##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
susceptibility to##102##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-8#6)(2007-8#1)(2008-10#41)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#3)(2008-9#4)(2009-6#1)(2011-10#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
susceptibility was##2##2##(1992-2#1)(2008-10#1)
susceptibility were##2##2##(2008-10#2)
susceptibility with##2##2##(2008-10#1)(2013-8#1)
susceptibility##278##1##(1990-12#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#2)(1997-4#1)(1997-7#3)(1997-8#8)(2007-12#4)(2007-8#2)(2008-10#106)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#15)(2008-7#13)(2008-8#7)(2008-9#10)(2009-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#25)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#10)(2013-1#8)(2013-8#4)
susceptible B##2##2##(2008-10#2)
susceptible accessions##2##2##(2008-10#2)
susceptible and a resistant##2##4##(2008-10#2)
susceptible and partially resistant cultivars##2##5##(2008-10#2)
susceptible and resistant cultivars##5##4##(2008-10#5)
susceptible and resistant roots##2##4##(2008-10#2)
susceptible and resistant##16##3##(1996-12#1)(2008-10#14)(2011-10#1)
susceptible and##29##2##(1996-12#1)(2008-10#27)(2011-10#1)
susceptible at##3##2##(2008-10#3)
susceptible barley cultivars##2##3##(2008-10#2)
susceptible barley##3##2##(2008-10#3)
susceptible berries##2##2##(2008-10#2)
susceptible control##2##2##(2008-10#2)
susceptible controls##4##2##(2008-10#4)
susceptible crops##8##2##(2008-10#8)
susceptible cultivar was##4##3##(2008-10#4)
susceptible cultivar##26##2##(2008-10#26)
susceptible cultivars and##4##3##(2008-10#4)
susceptible cultivars##26##2##(2008-10#24)(2011-10#2)
susceptible cv##15##2##(2008-10#15)
susceptible cvs##5##2##(2008-10#5)
susceptible ecotype N913##3##3##(2008-10#3)
susceptible families##3##2##(2008-10#2)(2011-10#1)
susceptible flag leaves##2##3##(2008-10#2)
susceptible genotypes##11##2##(2008-10#11)
susceptible host tissue##3##3##(2008-10#3)
susceptible host##11##2##(2008-10#9)(2008-8#1)(2013-8#1)
susceptible hosts as##2##3##(2008-10#2)
susceptible hosts##4##2##(2008-10#4)
susceptible in##2##2##(2008-10#1)(2011-2#1)
susceptible inbred##5##2##(2008-10#5)
susceptible individuals##2##2##(2008-10#2)
susceptible leaves##3##2##(2008-10#3)
susceptible line##4##2##(2008-10#4)
susceptible lines##4##2##(2008-10#4)
susceptible maize##2##2##(2008-10#2)
susceptible oat##2##2##(2008-10#2)
susceptible ones##5##2##(2008-10#4)(2008-12#1)
susceptible only##2##2##(2008-10#1)(2008-5#1)
susceptible or resistant##3##3##(1996-12#1)(2008-10#2)
susceptible or##5##2##(1996-12#1)(2008-10#3)(2011-2#1)
susceptible parent##10##2##(2008-10#10)
susceptible plants##13##2##(2008-10#11)(2009-8#2)
susceptible potato cv##3##3##(2008-10#3)
susceptible potato##5##2##(2008-10#5)
susceptible reactions##2##2##(2008-10#2)
susceptible roots##2##2##(2008-10#2)
susceptible sorghum cultivar##2##3##(2008-10#2)
susceptible sorghum##3##2##(2008-10#3)
susceptible than##3##2##(2008-10#2)(2012-2#1)
susceptible to A##3##3##(2008-10#3)
susceptible to S##4##3##(2008-10#4)
susceptible to all races##2##4##(2008-10#2)
susceptible to all##4##3##(2008-10#3)(2008-5#1)
susceptible to apoptosis##2##3##(1995-2#1)(2008-11#1)
susceptible to bacterial##2##3##(1991-3#1)(2008-10#1)
susceptible to both pathogens##3##4##(2008-10#3)
susceptible to both##8##3##(1993-6#1)(2008-10#5)(2008-11#2)
susceptible to infection by##3##4##(2008-10#3)
susceptible to infection##17##3##(2008-10#15)(2008-9#1)(2011-2#1)
susceptible to injury from##2##4##(1995-11#2)
susceptible to isolates##2##3##(2008-10#2)
susceptible to leaf##3##3##(2008-10#3)
susceptible to several##2##3##(2008-10#2)
susceptible to the pathogen##2##4##(2008-10#2)
susceptible to the##11##3##(1993-2#1)(1996-12#1)(2008-10#7)(2008-5#1)(2009-8#1)
susceptible to##136##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-2#1)(1996-12#1)(2006-5#1)(2007-12#1)(2008-10#87)(2008-11#6)(2008-3#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-10#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)
susceptible tomato##4##2##(2008-10#4)
susceptible wheat##3##2##(2008-10#3)
susceptible when##2##2##(2008-10#2)
susceptible zucchini##2##2##(2008-10#2)
susceptible##519##1##(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#2)(1996-12#7)(1997-1#1)(2006-5#1)(2007-12#1)(2008-10#427)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#10)(2008-8#3)(2008-9#2)(2009-8#3)(2010-7#1)(2011-1#1)(2011-10#8)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
suspect##11##1##(1993-1#1)(1995-11#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
suspected acute PE##2##3##(2011-2#2)
suspected acute##3##2##(2011-2#3)
suspected and##2##2##(1996-1#1)(2013-1#1)
suspected as##2##2##(2010-4#1)(2013-1#1)
suspected cases##5##2##(1990-12#1)(2008-12#1)(2010-10#1)(2011-1#1)(2013-8#1)
suspected in a##3##3##(1996-12#1)(2009-8#1)(2012-12#1)
suspected in##7##2##(1990-2#1)(1996-12#1)(1997-2#1)(2008-10#1)(2009-8#1)(2010-10#1)(2012-12#1)
suspected lesions##2##2##(1990-6#1)(2008-9#1)
suspected of being##2##3##(1996-1#1)(2008-10#1)
suspected of having##3##3##(2008-10#1)(2010-12#1)(2012-12#1)
suspected of##12##2##(1990-12#1)(1993-12#1)(1996-1#1)(1997-8#2)(2008-10#4)(2008-5#1)(2010-12#1)(2012-12#1)
suspected on the##3##3##(1990-3#1)(2008-7#1)(2009-9#1)
suspected on##6##2##(1990-3#2)(2008-7#1)(2009-9#1)(2012-2#2)
suspected pulmonary##2##2##(1991-11#1)(1991-3#1)
suspected skeletal dysplasia##3##3##(2011-1#3)
suspected to be a##3##4##(1991-12#1)(2008-5#1)(2010-6#1)
suspected to be##6##3##(1991-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-8#1)
suspected to##9##2##(1991-12#1)(1994-5#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-8#1)
suspected when##2##2##(1997-8#1)(2013-1#1)
suspected##135##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-6#6)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#5)(1992-2#1)(1992-3#1)(1993-12#1)(1994-5#1)(1994-9#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-4#2)(1997-8#5)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#10)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#3)
suspecting##2##1##(2010-11#1)(2011-2#1)
suspended carriers in##2##3##(2008-7#2)
suspended carriers##3##2##(2008-7#3)
suspended cells##2##2##(2008-11#2)
suspended from##2##2##(2008-3#1)(2011-2#1)
suspended in non-alcoholic beer##2##4##(2012-2#2)
suspended in the##2##3##(2008-10#1)(2008-11#1)
suspended in##19##2##(1992-2#1)(1996-1#1)(2008-10#7)(2008-11#2)(2008-5#3)(2008-7#1)(2012-2#4)
suspended matter##3##2##(2008-10#3)
suspended on##2##2##(2008-10#2)
suspended particles##2##2##(2008-10#2)
suspended particulate matter##2##3##(2008-10#2)
suspended solids##6##2##(2008-10#4)(2010-5#2)
suspended##54##1##(1992-2#1)(1996-1#1)(2007-12#1)(2008-10#23)(2008-11#6)(2008-3#5)(2008-5#3)(2008-7#5)(2009-7#1)(2010-5#2)(2011-2#1)(2012-2#4)(2012-4#1)
suspending agents##2##2##(1992-3#2)
suspending##7##1##(1992-3#2)(1993-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
suspensa##3##1##(2007-12#3)
suspension and monolayer##3##3##(2008-11#3)
suspension and##13##2##(2008-10#4)(2008-11#9)
suspension bioreactor##2##2##(2008-11#2)
suspension cell culture##2##3##(2008-10#1)(2008-11#1)
suspension cell##4##2##(2008-10#2)(2008-11#2)
suspension cells and##2##3##(2008-8#2)
suspension cells using##2##3##(2008-11#1)(2008-8#1)
suspension cells##11##2##(1991-5#1)(2008-11#5)(2008-8#4)(2008-9#1)
suspension culture of##3##3##(2008-11#2)(2008-9#1)
suspension culture was##3##3##(2008-11#3)
suspension culture##33##2##(1997-1#1)(2008-11#28)(2008-9#3)(2009-6#1)
suspension cultured##2##2##(2008-11#1)(2008-8#1)
suspension cultures in##3##3##(2008-11#2)(2008-7#1)
suspension cultures of##5##3##(2008-11#5)
suspension cultures##18##2##(2008-11#14)(2008-7#3)(2008-9#1)
suspension galvanic cells##2##3##(2008-10#2)
suspension growth##3##2##(2008-11#3)
suspension in a##3##3##(2008-10#1)(2008-11#2)
suspension in the##2##3##(2008-10#1)(2008-11#1)
suspension in##9##2##(1996-1#1)(2008-10#3)(2008-11#5)
suspension into##2##2##(2008-10#2)
suspension of P##3##3##(2008-10#3)
suspension of##17##2##(2008-10#12)(2008-12#1)(2008-5#1)(2008-7#3)
suspension on the##2##3##(2008-10#1)(2008-11#1)
suspension or##5##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)
suspension to##2##2##(1990-12#1)(2008-10#1)
suspension was##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
suspension with##2##2##(2008-10#1)(2008-11#1)
suspension##203##1##(1990-12#3)(1991-5#1)(1994-8#2)(1996-1#2)(1996-2#1)(1997-1#1)(2008-10#55)(2008-11#107)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#7)(2008-9#8)(2009-6#1)
suspensions and##2##2##(2008-10#1)(2008-7#1)
suspensions are prepared by weighing##2##5##(2008-10#2)
suspensions are##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
suspensions is also##2##3##(2008-4#2)
suspensions of##25##2##(1994-2#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#1)
suspensions to##4##2##(1994-2#2)(2008-10#2)
suspensions were##3##2##(1993-8#1)(1994-11#1)(2008-10#1)
suspensions with##3##2##(2008-10#2)(2008-3#1)
suspensions##69##1##(1990-12#1)(1991-2#1)(1993-8#1)(1994-11#1)(1994-2#3)(2008-10#39)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2010-8#1)(2012-2#1)(2013-1#1)
suspensor cells##2##2##(2009-8#2)
suspensor##4##1##(2009-8#4)
suspensory fixation##2##2##(2013-1#2)
suspicion and the##2##3##(1991-6#1)(2010-7#1)
suspicion and##4##2##(1991-6#1)(2009-11#1)(2010-7#1)(2011-2#1)
suspicion for##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
suspicion is##3##2##(1995-10#1)(2010-1#1)(2011-2#1)
suspicion of an##3##3##(2008-12#1)(2008-7#1)(2010-12#1)
suspicion of malignancy##2##3##(1991-2#1)(1994-12#1)
suspicion of##15##2##(1991-2#1)(1992-5#1)(1994-12#2)(1995-5#1)(2008-12#3)(2008-3#3)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
suspicion##35##1##(1990-3#1)(1991-2#1)(1991-6#1)(1992-5#1)(1994-12#2)(1995-10#1)(1995-5#2)(1997-2#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#7)(2013-1#3)(2013-8#1)
suspicious cases##2##2##(1990-6#1)(2012-12#1)
suspicious of##2##2##(1991-6#1)(1997-2#1)
suspicious##13##1##(1990-6#1)(1991-6#2)(1994-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
suspiciousof##2##1##(2009-8#2)
sustain a healthy##2##3##(2012-2#1)(2013-7#1)
sustain a##4##2##(2008-11#1)(2008-8#1)(2012-2#1)(2013-7#1)
sustain long-lasting in vitro hematopoiesis##2##5##(2009-12#2)
sustain their##2##2##(2008-1#1)(2010-5#1)
sustain##27##1##(1990-2#1)(1991-2#1)(1993-6#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-8#1)(2009-12#2)(2009-8#1)(2010-10#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
sustainability and##3##2##(2008-12#1)(2009-5#1)(2010-7#1)
sustainability of the##2##3##(2008-10#1)(2008-11#1)
sustainability of##8##2##(1997-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#3)
sustainability##21##1##(1997-7#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#4)(2009-8#1)(2010-7#1)(2012-2#4)(2013-1#2)
sustainable and##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
sustainable development##4##2##(1996-5#1)(2008-11#3)
sustainable environmental##2##2##(2008-10#1)(2008-11#1)
sustainable management##2##2##(2008-10#2)
sustainable##39##1##(1994-9#1)(1996-1#1)(1996-5#1)(1997-7#4)(2008-10#8)(2008-11#6)(2008-12#5)(2008-8#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-7#2)(2011-2#1)(2012-9#1)(2013-8#3)
sustained a##7##2##(2008-12#1)(2009-10#1)(2010-1#1)(2012-3#2)(2013-1#2)
sustained activation of##3##3##(1994-6#1)(1997-7#1)(2012-2#1)
sustained activation##4##2##(1994-6#1)(1997-7#1)(2010-4#1)(2012-2#1)
sustained an##2##2##(2008-12#1)(2012-2#1)
sustained and transient ON signals of##2##6##(2008-9#2)
sustained and transient##3##3##(2008-9#3)
sustained and##4##2##(2008-9#3)(2011-2#1)
sustained blockade of##2##3##(1995-2#2)
sustained by##2##2##(2007-11#1)(2008-10#1)
sustained contractions##2##2##(2013-8#2)
sustained for##6##2##(1990-10#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
sustained growth##2##2##(1995-8#1)(2008-11#1)
sustained improvement in##2##3##(2011-2#1)(2012-3#1)
sustained improvement##3##2##(1994-12#1)(2011-2#1)(2012-3#1)
sustained increase in##6##3##(1991-6#1)(1992-6#1)(1997-1#1)(1997-2#1)(2012-12#1)(2013-8#1)
sustained increase##7##2##(1991-6#1)(1992-6#2)(1997-1#1)(1997-2#1)(2012-12#1)(2013-8#1)
sustained oscillations##2##2##(1996-6#1)(2010-10#1)
sustained phase##2##2##(1991-5#2)
sustained release##6##2##(2008-11#4)(2012-2#1)(2013-1#1)
sustained remission##2##2##(2008-1#1)(2011-2#1)
sustained the##4##2##(1995-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
sustained ventricular tachycardia##4##3##(1990-3#4)
sustained##131##1##(1990-10#1)(1990-12#1)(1990-3#5)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-2#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#10)(2008-12#4)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#2)(2009-4#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#2)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#12)(2013-8#5)
sustained-release##3##1##(1993-1#1)(2011-2#1)(2012-2#1)
sustaining the##2##2##(2008-11#1)(2013-8#1)
sustaining##15##1##(1990-11#1)(1991-2#1)(1992-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
sustains##6##1##(2008-10#3)(2008-11#1)(2008-12#1)(2009-11#1)
suture techniques##3##2##(1992-1#1)(1993-12#1)(2013-8#1)
suture##31##1##(1990-3#1)(1991-1#4)(1991-12#2)(1991-2#2)(1992-1#3)(1992-2#4)(1993-11#1)(1993-12#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-9#2)(2011-3#1)(2012-2#1)(2012-3#5)(2013-8#1)
sutured##3##1##(1992-3#1)(1993-11#1)(2008-12#1)
sutures##10##1##(1994-2#1)(1995-1#1)(2008-10#1)(2008-9#1)(2010-10#2)(2011-1#2)(2012-3#1)(2013-1#1)
suturing##5##1##(1992-3#1)(1995-1#1)(1996-3#1)(2008-10#1)(2012-3#1)
sw/B/98##2##1##(2011-2#2)
sw/IA/04##4##1##(2011-2#4)
swab was##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
swab##13##1##(1996-12#2)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#4)(2013-1#1)
swabs and##3##2##(2008-5#1)(2011-2#2)
swabs taken from the##2##4##(2008-12#1)(2009-6#1)
swabs taken##3##2##(2008-12#2)(2009-6#1)
swabs were##4##2##(2008-5#1)(2011-2#1)(2013-8#2)
swabs##21##1##(2008-10#2)(2008-12#2)(2008-5#5)(2008-9#1)(2009-6#1)(2011-2#8)(2013-8#2)
swainsoni##4##1##(2013-8#4)
swallow##2##1##(2008-7#1)(2008-9#1)
swallowed##3##1##(1990-6#1)(1995-11#1)(2008-10#1)
swallowing##7##1##(1991-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
swallows##3##1##(2008-8#2)(2008-9#1)
swarming##5##1##(2009-6#5)
sway##2##1##(2010-10#1)(2012-3#1)
sweat and##5##2##(2008-5#5)
sweat components##2##2##(2008-10#2)
sweat glands##3##2##(2008-5#3)
sweat pH of##3##3##(2008-5#3)
sweat pH##5##2##(2008-5#5)
sweat rate##4##2##(1992-3#1)(2008-5#3)
sweat the##2##2##(2013-8#2)
sweat##34##1##(1992-3#2)(2008-10#5)(2008-5#25)(2013-8#2)
sweating was##7##2##(2008-5#7)
sweating##15##1##(1992-3#1)(2008-5#13)(2009-5#1)
sweats##3##1##(1993-9#1)(1997-4#1)(2008-11#1)
sweep and##2##2##(2008-10#2)
sweep rate##2##2##(2008-10#2)
sweep voltammetric##3##2##(2008-10#3)
sweep voltammetry##14##2##(2008-10#14)
sweep##41##1##(2007-12#1)(2008-10#38)(2008-3#2)
sweeping##8##1##(1991-12#1)(1992-1#1)(1993-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)
sweet Spanish onions we studied had##2##6##(1993-12#2)
sweet cherry fruit##2##3##(2008-10#2)
sweet cherry##4##2##(2008-10#4)
sweet corn##3##2##(2008-10#3)
sweet orange grafted on Rangpur lime##2##6##(2008-10#2)
sweet orange##10##2##(2008-10#10)
sweet pepper ferredoxin-I protein##2##4##(2008-10#2)
sweet pepper##3##2##(2008-10#3)
sweet potato (Ipomoea batatas)##2##4##(2008-10#2)
sweet potato (Ipomoea##3##3##(2008-10#3)
sweet potato feathery mottle##3##4##(2008-10#3)
sweet potato##9##2##(2008-10#9)
sweet taste##2##2##(2008-2#2)
sweet wine##2##2##(2008-10#2)
sweet wines##2##2##(2008-10#2)
sweet##46##1##(1993-12#2)(2008-10#39)(2008-2#3)(2008-5#1)(2008-9#1)
sweetened beverages##2##2##(2012-2#2)
sweetener##8##1##(2008-2#3)(2008-5#5)
sweetener-preferring strain##2##2##(2008-2#2)
sweeteners##5##1##(2008-10#2)(2008-2#3)
sweetness##9##1##(2008-10#1)(2008-2#1)(2008-5#5)(2011-2#2)
sweetpotato##6##1##(2008-10#6)
swell in##2##2##(2008-9#1)(2010-6#1)
swell##4##1##(1992-12#1)(2008-10#1)(2008-9#1)(2010-6#1)
swelled##3##1##(1995-1#1)(2008-10#1)(2008-8#1)
swelling and pain##2##3##(2012-12#2)
swelling and##12##2##(1990-2#1)(1991-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-6#1)(2012-12#2)(2013-1#1)
swelling in the##3##3##(2008-10#1)(2008-12#1)(2010-11#1)
swelling in##5##2##(2008-1#1)(2008-10#2)(2008-12#1)(2010-11#1)
swelling of the##8##3##(1991-3#1)(1991-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
swelling of##14##2##(1991-3#1)(1991-5#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-5#1)(2011-2#2)(2013-1#1)
swelling on the##2##3##(2010-3#1)(2013-1#1)
swelling was##2##2##(2008-12#1)(2010-11#1)
swelling##62##1##(1990-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1995-12#1)(1997-5#1)(2008-1#2)(2008-10#13)(2008-12#4)(2008-5#5)(2008-7#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-3#2)(2010-4#1)(2011-2#6)(2012-12#3)(2012-3#3)(2013-1#8)
swellings were##2##2##(1995-12#1)(2008-10#1)
swellings##4##1##(1995-12#1)(2008-10#2)(2013-1#1)
swells##2##1##(2008-10#1)(2008-5#1)
swept by##2##2##(2008-10#2)
swept into a##3##3##(2008-10#3)
swept##9##1##(1992-1#1)(2008-10#7)(2008-3#1)
swim stress##2##2##(1997-4#2)
swim##13##1##(1990-8#1)(1997-4#2)(2008-11#4)(2008-12#4)(2008-7#1)(2013-8#1)
swim-to-platform##2##1##(1992-12#2)
swimming in the##2##3##(1990-11#1)(2012-3#1)
swimming performance##2##2##(2010-8#2)
swimming##25##1##(1990-11#2)(1990-5#1)(1993-3#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#4)(2010-8#5)(2012-3#1)(2013-1#1)(2013-8#1)
swine farms##2##2##(1996-12#1)(2013-1#1)
swine influenza##4##2##(2011-2#3)(2013-8#1)
swine manure##8##2##(2008-10#8)
swine##30##1##(1992-1#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2011-2#11)(2013-1#1)(2013-8#2)
swing beds##4##2##(1991-1#2)(1994-2#2)
swing##10##1##(1991-1#2)(1993-3#2)(1994-2#2)(2008-10#1)(2010-3#1)(2011-2#2)
swing-bed program##2##2##(1991-1#1)(1994-2#1)
swing-bed##3##1##(1991-1#2)(1994-2#1)
swiss needle cast##2##3##(2008-10#2)
swiss##5##1##(1992-6#1)(2008-10#2)(2008-12#1)(2010-1#1)
switch and##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
switch at##2##2##(2008-10#1)(2013-1#1)
switch between##3##2##(2008-10#2)(2009-8#1)
switch for##2##2##(2008-2#1)(2009-6#1)
switch from##5##2##(1992-9#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-8#1)
switch in##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
switch of##3##2##(2008-5#1)(2008-8#1)(2011-1#1)
switch to##4##2##(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
switch##50##1##(1992-12#1)(1992-9#1)(1993-12#2)(1994-12#1)(1995-2#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#7)(2008-9#1)(2009-6#3)(2009-8#3)(2010-6#1)(2011-1#1)(2011-2#4)(2013-1#4)(2013-8#3)
switched from##2##2##(2008-2#1)(2008-5#1)
switched magnetic fields##2##3##(1992-3#2)
switched on##2##2##(1997-7#1)(2008-9#1)
switched to##3##2##(2008-7#1)(2010-9#1)(2013-1#1)
switched##17##1##(1992-3#3)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#1)(2013-8#1)
switches and##2##2##(2008-3#2)
switches##12##1##(1990-8#2)(1997-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-4#1)(2011-1#1)(2013-8#3)
switchgrass##5##1##(2011-2#5)
switching and image storage##2##4##(1995-6#2)
switching and##4##2##(1995-6#2)(2007-12#1)(2008-10#1)
switching between##3##2##(2008-11#1)(2008-3#1)(2008-4#1)
switching from##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2013-1#1)
switching in##2##2##(2007-11#1)(2008-3#1)
switching is##3##2##(2008-3#3)
switching of##3##2##(2008-11#1)(2008-3#2)
switching to##2##2##(2008-10#1)(2008-11#1)
switching valve##4##2##(2008-10#4)
switching voltage##2##2##(2007-11#1)(2008-2#1)
switching##47##1##(1992-11#1)(1995-6#2)(2007-11#3)(2007-12#1)(2008-10#12)(2008-11#5)(2008-2#2)(2008-3#10)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2013-1#2)
swollen lamellar gel network phase##2##5##(2008-5#2)
swollen lamellar##3##2##(2008-5#3)
swollen##22##1##(1992-11#1)(1992-9#1)(1997-5#2)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#4)(2008-7#1)(2009-5#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
sword##3##1##(2008-8#1)(2011-2#1)(2012-2#1)
swords##3##1##(2008-8#2)(2009-8#1)
swordtails##2##1##(2008-8#2)
sycamore##3##1##(2008-10#3)
syllable structure##2##2##(2008-8#1)(2008-9#1)
sylvatica##2##1##(2008-10#1)(2013-8#1)
sylvaticum##3##1##(2008-10#3)
sylvestrene##3##1##(2008-11#3)
sylvestris and##2##2##(2008-11#1)(2011-10#1)
sylvestris##3##1##(2008-11#1)(2011-10#2)
symbiont population##2##2##(2007-12#2)
symbiont##5##1##(2007-12#2)(2008-10#1)(2008-8#1)(2013-8#1)
symbionts##2##1##(2007-12#1)(2008-10#1)
symbioses##7##1##(2008-10#1)(2008-8#2)(2009-8#2)(2012-8#1)(2013-1#1)
symbiosis and##2##2##(2008-11#1)(2008-8#1)
symbiosis of##3##2##(1996-2#1)(2009-6#1)(2009-8#1)
symbiosis with##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
symbiosis##18##1##(1996-2#1)(2008-11#4)(2008-5#1)(2008-8#5)(2009-6#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-8#2)
symbiotic events##2##2##(2011-2#2)
symbiotic microbes##2##2##(2009-6#2)
symbiotic##24##1##(2007-12#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-8#2)(2009-6#3)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-8#2)
symbol Rpc1##2##2##(2008-10#2)
symbol##7##1##(2008-10#2)(2008-4#1)(2008-7#2)(2010-5#1)(2011-2#1)
symbolic##7##1##(1994-3#1)(2008-11#1)(2010-4#1)(2011-3#2)(2013-8#2)
symbolism##2##1##(2009-10#2)
symbols##2##1##(1992-2#1)(2008-4#1)
symmetric about##2##2##(2008-10#1)(2008-8#1)
symmetric and asymmetric fusion##3##4##(2008-8#3)
symmetric and asymmetric##6##3##(2008-10#2)(2008-8#4)
symmetric and##10##2##(2008-10#3)(2008-12#1)(2008-8#6)
symmetric intervals##2##2##(2008-10#2)
symmetric stretching band##2##3##(2008-10#2)
symmetric stretching##5##2##(1994-11#1)(2008-10#4)
symmetric##44##1##(1991-3#1)(1993-12#1)(1993-8#4)(1994-11#1)(1994-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-6#1)(2008-8#7)(2009-7#1)(2013-1#1)(2013-8#1)
symmetrical and unsymmetrical##2##3##(2008-10#2)
symmetrical and##3##2##(2008-10#2)(2010-3#1)
symmetrical peak and with##2##4##(2008-10#2)
symmetrical peak and##3##3##(2008-10#3)
symmetrical##28##1##(1991-11#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#2)
symmetrically##3##1##(2008-10#1)(2008-3#1)(2012-3#1)
symmetries are##2##2##(2010-8#2)
symmetries in##4##2##(2008-3#1)(2010-8#2)(2013-1#1)
symmetries##12##1##(2008-3#4)(2008-6#1)(2009-8#1)(2010-8#5)(2013-1#1)
symmetry and##6##2##(1992-9#1)(1994-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
symmetry differences in##2##3##(2008-8#2)
symmetry differences##3##2##(2008-8#3)
symmetry in##3##2##(1992-11#1)(2008-3#1)(2013-1#1)
symmetry is##2##2##(2008-3#1)(2008-6#1)
symmetry of the##3##3##(2008-3#1)(2008-7#1)(2009-12#1)
symmetry of##5##2##(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-8#1)
symmetry##49##1##(1990-11#1)(1990-12#1)(1992-11#1)(1992-9#3)(1994-3#1)(1996-5#1)(2007-12#2)(2008-10#2)(2008-3#3)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#14)(2008-9#3)(2009-12#1)(2010-4#1)(2010-6#1)(2012-12#2)(2013-1#2)(2013-8#3)
sympathetic activation##2##2##(2010-5#1)(2013-8#1)
sympathetic activity in##2##3##(2012-2#2)
sympathetic activity##3##2##(2008-7#1)(2012-2#2)
sympathetic and parasympathetic##4##3##(2008-10#1)(2010-5#1)(2012-2#2)
sympathetic nerve##7##2##(1993-1#1)(2008-7#1)(2008-9#4)(2012-2#1)
sympathetic nervous system activity##2##4##(2008-7#2)
sympathetic nervous system##4##3##(1997-2#1)(2008-7#2)(2012-2#1)
sympathetic nervous##5##2##(1997-2#1)(2008-5#1)(2008-7#2)(2012-2#1)
sympathetic sprouting in the DRG and##2##6##(2008-9#2)
sympathetic sprouting in the##3##4##(2008-9#3)
sympathetic sprouting in##5##3##(2008-9#5)
sympathetic##43##1##(1992-6#1)(1993-1#1)(1994-9#1)(1995-5#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#10)(2009-11#1)(2010-5#3)(2010-7#1)(2011-2#1)(2012-2#11)(2013-8#1)
sympathomimetic amines##2##2##(2008-10#2)
sympathomimetic##3##1##(1995-2#1)(2008-10#2)
sympathovagal balance##2##2##(2009-11#1)(2012-2#1)
sympathovagal imbalance in##2##3##(2012-2#2)
sympathovagal imbalance##3##2##(2012-2#3)
sympathovagal##6##1##(2009-11#1)(2012-2#4)(2013-8#1)
sympathy##4##1##(2012-2#4)
sympatric locations##3##2##(2008-8#3)
sympatric species##5##2##(2008-10#1)(2008-8#2)(2012-3#1)(2013-1#1)
sympatric##16##1##(2008-10#5)(2008-8#7)(2012-3#3)(2013-1#1)
sympatry and allopatry##2##3##(2008-10#2)
sympatry##14##1##(2008-10#7)(2008-8#6)(2012-3#1)
symphysis##7##1##(1994-3#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
symplastic##2##1##(1992-12#1)(2008-11#1)
symposia##2##1##(2008-11#1)(2008-5#1)
symposium on##2##2##(2008-10#1)(2013-1#1)
symposium##19##1##(1992-2#1)(1992-3#2)(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#1)(2010-7#1)(2013-1#3)
symptom and##4##2##(2008-10#1)(2011-2#3)
symptom area##2##2##(2008-10#2)
symptom complex##4##2##(1991-11#1)(1996-1#1)(1997-2#1)(2008-7#1)
symptom control##3##2##(2010-12#2)(2011-2#1)
symptom criteria##2##2##(1991-1#1)(2011-2#1)
symptom descriptors##2##2##(2008-10#2)
symptom development by##2##3##(2008-10#2)
symptom development of##2##3##(2008-10#2)
symptom development on##2##3##(2008-10#2)
symptom development was##3##3##(2008-10#2)(2008-9#1)
symptom development##22##2##(2008-10#20)(2008-9#1)(2012-9#1)
symptom expression and##4##3##(2008-10#4)
symptom expression##16##2##(2008-10#16)
symptom free##2##2##(2010-5#1)(2012-12#1)
symptom in##2##2##(1997-6#1)(2008-7#1)
symptom is##2##2##(1996-9#1)(2008-7#1)
symptom management##2##2##(2009-9#1)(2010-11#1)
symptom of##9##2##(1991-8#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-6#1)(2011-2#2)(2013-8#1)
symptom onset##3##2##(2008-9#1)(2010-11#1)(2011-2#1)
symptom or sign##2##3##(1991-8#2)
symptom or##4##2##(1991-8#2)(2008-10#1)(2008-7#1)
symptom phenotype##2##2##(2008-10#2)
symptom reduction##3##2##(2009-1#2)(2009-11#1)
symptom severity in##2##3##(2008-10#2)
symptom severity score##2##3##(2008-10#2)
symptom severity##12##2##(2008-10#8)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
symptom type##2##2##(2008-10#2)
symptom was##5##2##(1990-9#2)(2008-10#1)(2008-12#1)(2011-2#1)
symptom##150##1##(1990-12#3)(1990-3#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-8#3)(1994-6#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#67)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#12)(2008-9#3)(2009-1#2)(2009-11#2)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#2)(2011-1#1)(2011-10#1)(2011-2#15)(2011-8#1)(2012-12#1)(2012-9#1)(2013-7#1)(2013-8#2)
symptom-days##3##1##(2013-1#3)
symptom-free after##2##2##(1997-8#1)(2012-3#1)
symptom-free##5##1##(1997-8#1)(2008-10#1)(2011-2#1)(2012-3#2)
symptomatic ASD##2##2##(2012-12#1)(2012-3#1)
symptomatic and asymptomatic##2##3##(2008-10#2)
symptomatic and##6##2##(1996-8#1)(2008-10#3)(2008-7#1)(2009-8#1)
symptomatic and/or##2##2##(2010-12#1)(2012-12#1)
symptomatic benefit##2##2##(2010-12#2)
symptomatic berries##2##2##(2008-10#2)
symptomatic bone metastases##3##3##(2008-7#3)
symptomatic carotid stenosis##3##3##(1993-1#1)(2008-8#2)
symptomatic control##2##2##(2008-7#1)(2010-7#1)
symptomatic improvement##6##2##(1993-1#1)(2008-11#1)(2008-7#2)(2011-2#2)
symptomatic leaves##2##2##(2008-10#2)
symptomatic patient##3##2##(2008-10#1)(2011-2#2)
symptomatic patients##4##2##(1991-3#1)(1993-11#1)(2009-10#1)(2009-4#1)
symptomatic plants##6##2##(2008-10#6)
symptomatic relief##2##2##(1991-3#1)(2008-7#1)
symptomatic samples##4##2##(2008-10#4)
symptomatic treatment of##3##3##(1996-11#1)(2008-7#1)(2010-7#1)
symptomatic treatment##7##2##(1991-2#1)(1996-11#2)(1997-4#1)(2008-7#1)(2010-7#1)(2012-3#1)
symptomatic trees were##2##3##(2008-10#2)
symptomatic trees##7##2##(2008-10#7)
symptomatic uterine fibroids##2##3##(1993-12#2)
symptomatic vertebrobasilar artery stenosis##2##4##(2012-3#2)
symptomatic vines##2##2##(2008-10#2)
symptomatic##146##1##(1990-8#1)(1991-2#3)(1991-3#2)(1991-6#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1996-11#2)(1996-3#1)(1996-6#2)(1996-8#1)(1997-4#1)(2008-1#1)(2008-10#50)(2008-11#3)(2008-7#14)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#5)(2010-7#2)(2011-2#14)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#9)(2013-1#6)(2013-8#1)
symptomatological##2##1##(1990-9#1)(2013-1#1)
symptomatology and##3##2##(2008-4#1)(2008-7#1)(2012-3#1)
symptomatology by##2##2##(1993-3#1)(2008-7#1)
symptomatology in##2##2##(1996-9#1)(2008-10#1)
symptomatology of##5##2##(1994-3#1)(1997-8#1)(2008-10#2)(2013-1#1)
symptomatology was##4##2##(1996-9#2)(2008-7#1)(2013-8#1)
symptomatology were##2##2##(1990-9#1)(2008-10#1)
symptomatology##39##1##(1990-11#1)(1990-9#2)(1991-1#1)(1991-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-3#1)(1996-9#3)(1997-8#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-7#5)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
symptomless Austrian##2##2##(2008-10#2)
symptomless infections##2##2##(2008-10#2)
symptomless pine shoots##3##3##(2008-10#3)
symptomless plants from##2##3##(2008-10#2)
symptomless plants##5##2##(2008-10#5)
symptomless##28##1##(2008-10#28)
symptoms 6##2##2##(1991-8#1)(2008-10#1)
symptoms after##7##2##(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
symptoms and functional##2##3##(2008-7#1)(2011-8#1)
symptoms and has##2##3##(1997-1#1)(2008-7#1)
symptoms and life##2##3##(1991-8#1)(2008-10#1)
symptoms and signs of##4##4##(1995-2#1)(2008-10#1)(2008-11#1)(2011-3#1)
symptoms and signs##11##3##(1995-2#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#2)(2010-12#1)(2011-3#1)
symptoms and the need for##2##5##(2010-10#1)(2011-2#1)
symptoms and the##9##3##(1990-3#1)(1996-11#1)(2008-10#2)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
symptoms and treatment##3##3##(2008-7#1)(2010-3#1)(2012-12#1)
symptoms and##105##2##(1990-3#2)(1990-6#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-5#1)(1993-12#1)(1995-2#2)(1996-11#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#3)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#3)(2008-7#10)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#3)(2009-9#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#2)(2011-8#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#3)
symptoms appear##3##2##(1993-3#1)(2009-9#1)(2013-8#1)
symptoms appeared##4##2##(1990-3#1)(2008-10#3)
symptoms appearing##2##2##(1997-8#1)(2008-10#1)
symptoms are a##2##3##(1993-6#1)(2008-4#1)
symptoms are reported##2##3##(1990-12#1)(1991-6#1)
symptoms are similar to##2##4##(2008-10#1)(2010-8#1)
symptoms are usually##2##3##(2008-11#1)(2012-3#1)
symptoms are##22##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1993-6#1)(1996-11#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2012-3#2)(2013-1#2)
symptoms as##5##2##(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
symptoms associated with##7##3##(1992-1#1)(2008-10#3)(2008-8#1)(2010-4#1)(2011-2#1)
symptoms at discharge##3##3##(2011-2#3)
symptoms at the##2##3##(1997-8#1)(2008-10#1)
symptoms at##8##2##(1997-8#1)(2008-10#2)(2008-12#1)(2011-2#3)(2013-8#1)
symptoms began##2##2##(2008-10#1)(2012-12#1)
symptoms but##5##2##(1995-5#1)(2008-10#3)(2008-7#1)
symptoms by##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
symptoms can be##2##3##(2008-12#1)(2011-2#1)
symptoms can##3##2##(2008-12#1)(2009-9#1)(2011-2#1)
symptoms caused by the##2##4##(2008-10#2)
symptoms caused by##6##3##(2008-10#6)
symptoms described##2##2##(1994-3#1)(2008-12#1)
symptoms developed in##2##3##(2008-10#1)(2008-5#1)
symptoms developed##6##2##(2008-10#4)(2008-5#1)(2012-3#1)
symptoms did not##2##3##(2008-7#1)(2011-2#1)
symptoms disappeared##4##2##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
symptoms do not##2##3##(1995-11#1)(2008-10#1)
symptoms during##4##2##(1990-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
symptoms even though##2##3##(2008-10#1)(2012-2#1)
symptoms even##3##2##(1997-4#1)(2008-10#1)(2012-2#1)
symptoms five years later##2##4##(2012-2#2)
symptoms following##4##2##(1990-12#1)(2011-2#2)(2013-1#1)
symptoms has been##2##3##(1997-6#1)(2011-2#1)
symptoms has##3##2##(1997-6#1)(2008-11#1)(2011-2#1)
symptoms improved##3##2##(2008-1#1)(2008-7#1)(2013-8#1)
symptoms in Parkinson's disease (PD)##2##5##(2010-12#1)(2013-8#1)
symptoms in a##3##3##(2008-10#2)(2008-8#1)
symptoms in bean##2##3##(2008-10#2)
symptoms in both##2##3##(2008-10#2)
symptoms in patients with##2##4##(1997-8#1)(2009-12#1)
symptoms in patients##3##3##(1997-8#1)(2009-12#1)(2011-2#1)
symptoms in response to##3##4##(2008-10#3)
symptoms in susceptible##2##3##(2008-10#2)
symptoms in the##9##3##(2008-10#7)(2008-9#1)(2011-2#1)
symptoms in tomato##5##3##(2008-10#5)
symptoms in two cases##2##4##(1997-8#1)(2007-12#1)
symptoms in two##3##3##(1997-8#1)(2007-12#1)(2008-10#1)
symptoms in##77##2##(1990-2#2)(1995-2#1)(1997-1#1)(1997-8#2)(2007-12#1)(2008-10#44)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
symptoms include##2##2##(2008-10#1)(2012-3#1)
symptoms included##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
symptoms including##3##2##(1991-4#1)(2008-10#1)(2013-1#1)
symptoms induced by##2##3##(2008-10#2)
symptoms induced##3##2##(2008-10#3)
symptoms initially##2##2##(2008-10#2)
symptoms is##4##2##(2008-10#2)(2009-9#1)(2013-1#1)
symptoms may appear##2##3##(2008-11#1)(2010-8#1)
symptoms may##7##2##(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
symptoms must##2##2##(2008-10#1)(2008-8#1)
symptoms of acute##2##3##(2008-7#1)(2011-2#1)
symptoms of anthracnose##2##3##(2008-10#2)
symptoms of chronic fatigue##2##4##(2008-10#2)
symptoms of citrus variegated chlorosis##2##5##(2008-10#2)
symptoms of citrus##3##3##(2008-10#3)
symptoms of dementia##2##3##(2008-5#1)(2011-2#1)
symptoms of depression##6##3##(2008-4#1)(2010-12#1)(2010-7#2)(2011-2#1)(2013-1#1)
symptoms of disease##2##3##(2008-10#2)
symptoms of the common cold##2##5##(2008-10#2)
symptoms of the common##3##4##(2008-10#3)
symptoms of the disease##5##4##(2008-10#4)(2008-7#1)
symptoms of the##11##3##(1995-5#1)(2008-10#8)(2008-7#1)(2013-1#1)
symptoms of these##2##3##(2010-2#1)(2013-8#1)
symptoms of this##3##3##(1990-9#1)(1993-3#1)(2008-7#1)
symptoms of##114##2##(1990-9#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-5#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#2)(2007-11#1)(2008-1#2)(2008-10#37)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#4)(2008-7#6)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#4)(2012-2#1)(2012-7#1)(2013-1#5)(2013-8#1)
symptoms often##2##2##(1991-6#1)(2008-8#1)
symptoms on the##4##3##(2008-10#4)
symptoms on##23##2##(2008-10#22)(2008-12#1)
symptoms or##10##2##(1991-9#1)(2007-12#1)(2008-10#5)(2008-7#1)(2012-2#1)(2013-1#1)
symptoms over time##2##3##(2008-10#1)(2010-5#1)
symptoms potentially indicative of##2##4##(2008-12#2)
symptoms prior to##2##3##(1990-6#1)(2007-12#1)
symptoms produced by##2##3##(2008-10#2)
symptoms ranging from##2##3##(2008-7#1)(2011-2#1)
symptoms related to##2##3##(2008-9#1)(2010-12#1)
symptoms resolved##5##2##(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
symptoms revealed##2##2##(2008-4#1)(2012-2#1)
symptoms showed##2##2##(2008-7#1)(2011-2#1)
symptoms similar to those observed in##2##6##(2008-10#2)
symptoms similar to those##5##4##(2008-10#5)
symptoms similar to##7##3##(2008-10#7)
symptoms such as##6##3##(2008-10#1)(2008-12#1)(2008-7#2)(2010-1#1)(2011-1#1)
symptoms suggestive of##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
symptoms than##6##2##(2008-10#3)(2008-9#1)(2009-11#1)(2009-7#1)
symptoms that##7##2##(1991-6#1)(1996-6#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
symptoms to##5##2##(2008-10#1)(2010-10#1)(2010-12#1)(2013-1#2)
symptoms typical of##3##3##(2008-10#2)(2008-12#1)
symptoms under##2##2##(2008-10#1)(2012-3#1)
symptoms was the##2##3##(2008-10#1)(2012-12#1)
symptoms was##15##2##(1997-8#1)(2008-10#6)(2008-7#4)(2010-10#1)(2012-12#1)(2013-1#2)
symptoms were not##2##3##(2008-10#2)
symptoms were observed on##2##4##(2008-10#2)
symptoms were observed##4##3##(1990-2#1)(2008-10#2)(2008-5#1)
symptoms were visible by 3 days after inoculation with the pathogen##2##11##(2008-10#2)
symptoms were##43##2##(1990-2#2)(1990-8#1)(1990-9#2)(1991-3#1)(1992-2#2)(1992-9#1)(2008-10#18)(2008-5#2)(2008-7#4)(2009-11#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
symptoms when##10##2##(1996-6#1)(2008-10#5)(2009-11#1)(2011-10#1)(2013-1#2)
symptoms with##6##2##(2008-10#2)(2008-12#1)(2010-1#1)(2010-12#1)(2013-1#1)
symptoms within##3##2##(1990-6#1)(1991-4#1)(2013-8#1)
symptoms##936##1##(1990-12#3)(1990-2#5)(1990-3#3)(1990-6#6)(1990-8#1)(1990-9#5)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#3)(1991-6#8)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#3)(1992-12#1)(1992-2#5)(1992-3#2)(1992-5#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#4)(1996-11#3)(1996-3#1)(1996-6#3)(1996-8#2)(1996-9#4)(1997-1#6)(1997-2#4)(1997-3#4)(1997-4#3)(1997-6#2)(1997-8#12)(2007-11#4)(2007-12#6)(2008-1#7)(2008-10#334)(2008-11#15)(2008-12#24)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#10)(2008-7#56)(2008-8#14)(2008-9#6)(2009-1#3)(2009-10#2)(2009-11#8)(2009-12#5)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#8)(2009-8#3)(2009-9#12)(2010-1#7)(2010-10#13)(2010-11#4)(2010-12#16)(2010-2#6)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#4)(2011-1#6)(2011-10#3)(2011-2#56)(2011-3#4)(2011-8#1)(2012-12#20)(2012-2#17)(2012-3#18)(2012-7#1)(2013-1#47)(2013-7#1)(2013-8#24)
symptoms&quot##2##1##(2011-2#2)
symptoms)##5##1##(2008-10#3)(2010-11#1)(2013-1#1)
symptoms/diseases##2##1##(2008-11#2)
symptoms]##4##1##(1992-5#1)(1994-8#1)(1995-11#1)(2013-8#1)
syn##3##1##(1996-5#2)(2008-10#1)
synapomorphies##2##1##(2011-2#2)
synapse##11##1##(1992-6#1)(1995-12#1)(1997-7#1)(2008-7#1)(2009-8#4)(2009-9#2)(2012-2#1)
synapses formed with##2##3##(1997-3#2)
synapses on##5##2##(1994-2#1)(1997-2#2)(1997-7#1)(2012-2#1)
synapses were##2##2##(1997-2#1)(1997-3#1)
synapses with##6##2##(1997-3#1)(2008-7#1)(2011-2#4)
synapses##38##1##(1992-6#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-2#6)(1997-3#7)(1997-7#5)(2008-11#1)(2008-7#3)(2009-8#2)(2009-9#2)(2011-2#4)(2012-2#2)
synaptic activity##5##2##(1995-2#1)(1996-12#2)(2008-11#1)(2013-8#1)
synaptic and non-synaptic##2##3##(1992-3#1)(2008-7#1)
synaptic and##3##2##(1992-3#1)(2008-11#1)(2008-7#1)
synaptic connections##5##2##(1997-2#1)(2008-11#1)(2008-4#1)(2009-8#2)
synaptic currents##2##2##(1995-2#2)
synaptic depression##2##2##(1997-7#1)(2008-11#1)
synaptic drive##2##2##(1996-2#1)(2008-11#1)
synaptic efficacy##3##2##(1993-12#1)(1994-8#1)(2008-6#1)
synaptic events##3##2##(1990-9#1)(2008-7#1)(2012-2#1)
synaptic expression of##2##3##(2008-7#2)
synaptic functions##2##2##(2009-9#2)
synaptic homeostasis##6##2##(2009-9#6)
synaptic impairment##2##2##(2012-3#1)(2013-8#1)
synaptic input##3##2##(1994-2#1)(2008-4#2)
synaptic inputs##2##2##(1994-2#1)(1995-2#1)
synaptic modification is##2##3##(1997-7#1)(2008-11#1)
synaptic modification##3##2##(1997-7#1)(2008-11#1)(2009-10#1)
synaptic plasticity and##4##3##(2008-11#2)(2008-7#1)(2013-8#1)
synaptic plasticity in the nervous system##2##6##(1996-12#1)(2008-7#1)
synaptic plasticity in the##4##4##(1996-12#1)(2008-7#3)
synaptic plasticity in##6##3##(1996-12#1)(2008-4#2)(2008-7#3)
synaptic plasticity might##3##3##(2008-7#2)(2012-2#1)
synaptic plasticity##29##2##(1993-12#3)(1995-2#1)(1996-12#1)(1997-7#2)(2008-11#2)(2008-4#3)(2008-7#10)(2009-9#1)(2011-2#1)(2012-2#3)(2013-8#2)
synaptic proteins##3##2##(1996-12#2)(2007-12#1)
synaptic strength and learning rules##2##5##(2008-11#2)
synaptic strength and##3##3##(2008-1#1)(2008-11#2)
synaptic strength##5##2##(1995-2#1)(2008-1#1)(2008-11#2)(2009-9#1)
synaptic terminals##5##2##(1994-8#1)(1997-2#1)(1997-3#3)
synaptic transmission and plasticity##2##4##(2008-11#1)(2009-9#1)
synaptic transmission and##3##3##(2008-11#1)(2009-8#1)(2009-9#1)
synaptic transmission in the##3##4##(1993-12#1)(2008-5#1)(2013-8#1)
synaptic transmission in##4##3##(1993-12#1)(1995-2#1)(2008-5#1)(2013-8#1)
synaptic transmission##20##2##(1993-12#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-7#2)(2008-11#1)(2008-5#2)(2009-8#1)(2009-9#2)(2013-8#1)
synaptic vesicle##4##2##(1996-12#1)(1997-1#1)(2008-7#1)(2013-8#1)
synaptic vesicles and##2##3##(1993-12#1)(1995-12#1)
synaptic vesicles##6##2##(1993-12#2)(1995-12#1)(1997-2#1)(1997-7#2)
synaptic weights##2##2##(1996-2#1)(2008-11#1)
synaptic##155##1##(1990-12#1)(1990-9#1)(1992-3#1)(1992-6#1)(1993-12#9)(1994-2#3)(1994-8#4)(1995-12#2)(1995-2#8)(1995-6#3)(1996-12#8)(1996-2#6)(1996-5#1)(1997-1#4)(1997-2#5)(1997-3#5)(1997-7#9)(2007-12#1)(2008-1#1)(2008-11#18)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#20)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#4)(2009-9#13)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#8)
synaptogenesis of##2##2##(1996-2#2)
synaptogenesis##3##1##(1996-2#2)(2008-7#1)
synaptophysin##3##1##(1991-8#1)(1992-2#1)(2011-2#1)
synaptosomal and##2##2##(1993-8#2)
synaptosomal##4##1##(1992-3#1)(1993-8#2)(1995-11#1)
synaptosomes with arachidonic acid##2##4##(1995-11#2)
synaptosomes##11##1##(1995-11#7)(1996-2#4)
synchronization and##2##2##(2008-11#2)
synchronization in##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)
synchronization of the##2##3##(1996-2#1)(2008-7#1)
synchronization of##7##2##(1996-2#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
synchronization##26##1##(1995-9#1)(1996-2#3)(2007-12#1)(2008-10#2)(2008-11#9)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#5)
synchronization-1st derivative fluorescence##2##3##(2008-10#2)
synchronize##5##1##(2008-10#1)(2008-11#2)(2009-8#2)
synchronized dual wavelength modulation##2##4##(2008-10#2)
synchronized##19##1##(1993-9#1)(1994-3#1)(1994-5#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#3)(2013-8#2)
synchronizing##2##1##(2009-8#1)(2010-9#1)
synchronous activity##2##2##(2013-8#2)
synchronous derivative fluorimetry##2##3##(2008-10#2)
synchronous fluorescence spectra##2##3##(2008-10#2)
synchronous fluorescence spectrometry##5##3##(2008-10#5)
synchronous fluorescence spectroscopy##3##3##(2008-10#3)
synchronous fluorescence##17##2##(2008-10#17)
synchronous luminescence analysis##2##3##(2008-10#2)
synchronous luminescence##5##2##(2008-10#5)
synchronous scanning##2##2##(1993-8#2)
synchronous spectrofluorimetry##5##2##(2008-10#5)
synchronous##66##1##(1990-6#4)(1991-2#1)(1991-6#1)(1993-8#3)(1995-9#1)(1996-2#1)(1996-8#2)(1997-2#1)(2008-1#1)(2008-10#38)(2008-11#4)(2008-2#1)(2008-9#1)(2009-1#2)(2009-12#1)(2009-6#1)(2013-1#1)(2013-8#2)
synchronously pumped##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
synchronously##14##1##(1992-5#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)
synchrony between the##3##3##(2013-8#3)
synchrony in the##2##3##(2008-11#1)(2013-8#1)
synchrony in##5##2##(2008-11#1)(2009-8#3)(2013-8#1)
synchrony##17##1##(2008-11#6)(2008-8#1)(2009-8#4)(2013-8#6)
synchrotron radiation in##2##3##(2008-10#2)
synchrotron radiation##7##2##(1995-6#1)(2008-10#5)(2008-5#1)
synchrotron sources##2##2##(2008-10#1)(2008-11#1)
synchrotron##14##1##(1995-6#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#4)
syncopal##3##1##(2008-11#1)(2008-12#1)(2008-2#1)
syncope and##3##2##(2008-11#1)(2008-12#2)
syncope##5##1##(2008-11#1)(2008-12#2)(2012-12#1)(2013-1#1)
syncytia##3##1##(1990-8#1)(2008-10#1)(2008-12#1)
syncytial##8##1##(1994-6#3)(1995-5#1)(1996-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
syncytiotrophoblast##2##1##(1990-12#2)
syncytium##3##1##(1993-6#1)(2008-7#1)(2010-11#1)
syndecan-1 is expressed in##2##4##(2008-5#2)
syndesmosis##3##1##(2009-1#1)(2012-12#2)
syndesmotic##3##1##(2009-3#2)(2012-3#1)
syndet surfactants##2##2##(2008-5#2)
syndrome (AIDS)##15##2##(1990-6#1)(1991-12#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#1)(2011-2#1)(2011-3#1)
syndrome (CBS)##2##2##(2011-2#2)
syndrome (DS)##3##2##(1991-1#1)(1996-2#1)(2012-2#1)
syndrome (MDS)##3##2##(1997-3#1)(2010-8#1)(2011-2#1)
syndrome (VCFS)##2##2##(2012-12#2)
syndrome (n = 3)##2##4##(1994-6#1)(2012-12#1)
syndrome (n =##5##3##(1994-6#1)(2008-11#1)(2008-3#1)(2012-12#2)
syndrome X patients##2##3##(2008-12#2)
syndrome X##5##2##(2008-12#5)
syndrome after##5##2##(2012-12#1)(2012-3#3)(2013-1#1)
syndrome and chronic##2##3##(2010-10#1)(2012-3#1)
syndrome and in##2##3##(1990-2#1)(2008-1#1)
syndrome and multiple##2##3##(1997-1#1)(2008-12#1)
syndrome and other##5##3##(1990-3#2)(1997-8#1)(2010-12#1)(2010-4#1)
syndrome and the##3##3##(1994-5#1)(1995-2#1)(2012-12#1)
syndrome and##53##2##(1990-2#1)(1990-3#2)(1992-1#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#2)(1997-8#2)(2007-11#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#3)
syndrome are##11##2##(1991-12#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#1)
syndrome as a##4##3##(1995-2#1)(2008-1#1)(2008-3#1)(2012-3#1)
syndrome as well as##2##4##(2008-7#1)(2011-2#1)
syndrome as##8##2##(1995-2#1)(2008-1#2)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)
syndrome associated with##4##3##(2008-11#1)(2010-7#1)(2011-1#1)(2012-12#1)
syndrome at the##2##3##(2008-11#1)(2008-9#1)
syndrome based on##2##3##(2011-2#1)(2013-1#1)
syndrome by proxy##4##3##(1995-5#2)(1996-2#1)(2010-12#1)
syndrome by##11##2##(1990-6#1)(1995-5#2)(1996-2#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-12#1)(2013-8#3)
syndrome can##4##2##(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)
syndrome caused by a##2##4##(2008-7#1)(2008-8#1)
syndrome caused by##3##3##(1997-5#1)(2008-7#1)(2008-8#1)
syndrome characterized by##7##3##(2008-11#1)(2008-4#2)(2009-11#1)(2009-3#1)(2012-3#1)(2013-1#1)
syndrome confirmed by##2##3##(2011-2#1)(2012-12#1)
syndrome de glissement&quot##2##3##(2010-6#2)
syndrome de sevrage à la nicotine##2##6##(2013-1#2)
syndrome de sevrage##3##3##(2013-1#3)
syndrome de##5##2##(2010-6#2)(2013-1#3)
syndrome due to##2##3##(2008-12#1)(2011-2#1)
syndrome during##4##2##(2008-12#2)(2011-3#1)(2012-3#1)
syndrome had##3##2##(1990-9#1)(1994-3#1)(2008-11#1)
syndrome has been##2##3##(2008-10#1)(2008-6#1)
syndrome has recently##2##3##(2008-11#1)(2011-2#1)
syndrome has##7##2##(1990-9#1)(1991-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
syndrome have a##3##3##(1997-3#1)(1997-6#1)(2010-5#1)
syndrome have##6##2##(1997-3#2)(1997-6#1)(2008-10#1)(2010-5#1)(2011-2#1)
syndrome in Parkinson's disease##2##4##(2009-11#2)
syndrome in a##7##3##(1993-3#1)(2008-12#1)(2008-3#2)(2011-2#2)(2013-7#1)
syndrome in adults##4##3##(1996-11#1)(2008-7#2)(2012-3#1)
syndrome in the##5##3##(2008-3#3)(2008-7#1)(2013-1#1)
syndrome in which##3##3##(1996-11#1)(2008-10#1)(2009-10#1)
syndrome in##52##2##(1992-5#1)(1993-3#1)(1996-11#2)(1996-2#2)(2008-1#1)(2008-10#6)(2008-12#4)(2008-3#7)(2008-7#5)(2009-10#1)(2009-11#2)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)
syndrome involves##2##2##(2008-12#1)(2013-8#1)
syndrome is a rare autosomal recessive##2##6##(1997-8#1)(2011-1#1)
syndrome is a rare complication##2##5##(2009-11#1)(2011-2#1)
syndrome is a rare##6##4##(1997-8#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
syndrome is a##13##3##(1996-6#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
syndrome is characterized by##5##4##(1991-3#1)(1994-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
syndrome is the most common##2##5##(2009-12#1)(2010-11#1)
syndrome is the##6##3##(2008-7#2)(2009-12#1)(2010-11#1)(2011-3#1)(2012-2#1)
syndrome is##45##2##(1990-11#1)(1990-9#1)(1991-3#1)(1994-12#2)(1996-6#1)(1997-3#1)(1997-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#2)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
syndrome may be##2##3##(2008-1#2)
syndrome may##4##2##(2008-1#2)(2008-7#1)(2009-6#1)
syndrome mutation##2##2##(2011-2#1)(2012-3#1)
syndrome occurs##2##2##(2008-7#1)(2010-6#1)
syndrome of the battered##2##4##(1995-5#2)
syndrome of the##3##3##(1995-5#2)(2008-12#1)
syndrome of##21##2##(1990-12#1)(1991-8#1)(1992-9#1)(1994-12#1)(1995-5#2)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2010-3#1)(2011-2#3)(2013-1#3)(2013-8#1)
syndrome or##4##2##(1997-1#1)(1997-3#1)(2011-1#1)(2013-1#1)
syndrome patients##4##2##(2008-11#3)(2008-7#1)
syndrome reactions##2##2##(2008-8#2)
syndrome region##2##2##(1996-2#1)(1997-3#1)
syndrome reported##2##2##(1991-2#1)(2008-1#1)
syndrome should##2##2##(2008-10#1)(2011-2#1)
syndrome that##5##2##(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
syndrome type##4##2##(1997-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
syndrome using##2##2##(2008-1#1)(2010-8#1)
syndrome was diagnosed in##2##4##(1992-5#1)(1997-8#1)
syndrome was diagnosed##4##3##(1992-5#1)(1997-8#1)(2008-11#1)(2013-8#1)
syndrome was##14##2##(1990-6#1)(1992-5#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
syndrome were##3##2##(1993-1#1)(2008-7#1)(2012-3#1)
syndrome which##2##2##(2008-10#1)(2008-7#1)
syndrome with a##2##3##(2009-1#1)(2010-5#1)
syndrome with lactic acidosis and cerebral##2##6##(1990-3#2)
syndrome with##19##2##(1990-3#3)(1992-2#1)(1992-9#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-1#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
syndrome without##2##2##(2008-10#1)(2008-11#1)
syndrome##861##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#7)(1990-6#3)(1990-9#9)(1991-1#2)(1991-10#1)(1991-11#9)(1991-12#10)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#2)(1991-9#4)(1992-1#1)(1992-12#4)(1992-2#1)(1992-5#4)(1992-9#3)(1993-1#3)(1993-12#3)(1993-2#3)(1993-3#3)(1993-9#1)(1994-12#9)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#7)(1995-5#7)(1996-1#1)(1996-11#2)(1996-2#7)(1996-3#2)(1996-6#9)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#4)(1997-3#24)(1997-5#1)(1997-6#3)(1997-8#10)(2007-11#4)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#26)(2008-10#40)(2008-11#43)(2008-12#44)(2008-2#2)(2008-3#40)(2008-4#18)(2008-5#5)(2008-6#7)(2008-7#55)(2008-8#21)(2008-9#15)(2009-1#8)(2009-10#12)(2009-11#9)(2009-12#3)(2009-3#2)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#6)(2010-10#4)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#7)(2010-6#8)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#11)(2011-2#69)(2011-3#5)(2011-9#1)(2012-12#12)(2012-2#9)(2012-3#46)(2012-5#1)(2013-1#60)(2013-7#3)(2013-8#25)
syndrome&quot##6##1##(1993-3#1)(1997-6#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-2#1)
syndrome'##3##1##(2010-5#2)(2013-8#1)
syndrome) and##2##2##(2008-11#1)(2011-2#1)
syndrome)##13##1##(1990-3#1)(1994-3#1)(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
syndrome--a case report]##2##3##(2008-11#1)(2012-3#1)
syndrome-associated##2##1##(2008-11#1)(2008-7#1)
syndrome?##6##1##(1997-3#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-3#1)
syndrome]##26##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-5#3)(1996-9#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
syndromes and##7##2##(1992-12#2)(2008-11#1)(2008-4#1)(2009-10#1)(2010-1#1)(2010-11#1)
syndromes are##8##2##(1995-5#1)(1996-11#1)(2008-10#1)(2009-12#1)(2011-2#4)
syndromes associated with##2##3##(2009-12#1)(2012-2#1)
syndromes in##4##2##(1996-11#1)(2008-7#2)(2013-1#1)
syndromes include##2##2##(1996-6#1)(2008-3#1)
syndromes is##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
syndromes may##2##2##(2008-11#1)(2012-3#1)
syndromes of##2##2##(2008-2#1)(2010-12#1)
syndromes or##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
syndromes##125##1##(1990-12#1)(1990-8#1)(1991-12#1)(1992-12#2)(1993-11#2)(1994-9#1)(1995-5#1)(1996-11#6)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#8)(2008-12#8)(2008-2#1)(2008-3#14)(2008-4#7)(2008-7#9)(2008-8#3)(2008-9#4)(2009-10#4)(2009-12#8)(2009-3#1)(2009-7#3)(2010-1#3)(2010-11#5)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#13)(2012-2#1)(2012-3#5)(2013-1#3)
syndromic##7##1##(2008-1#1)(2009-10#2)(2011-2#1)(2011-9#1)(2013-1#2)
synergetic effect of##2##3##(2008-10#1)(2008-12#1)
synergetic##3##1##(2008-10#2)(2008-12#1)
synergic effect##3##2##(2008-10#2)(2008-11#1)
synergic##5##1##(2008-10#3)(2008-11#1)(2011-3#1)
synergid##3##1##(2008-11#2)(2009-8#1)
synergies##3##1##(1992-9#1)(2010-10#2)
synergism with##3##2##(1990-2#1)(1994-11#1)(2008-4#1)
synergism##9##1##(1990-2#1)(1993-11#1)(1994-11#2)(2008-10#3)(2008-4#1)(2009-3#1)
synergist##2##1##(2008-10#2)
synergistic activity##2##2##(2008-10#1)(2011-3#1)
synergistic effect of##6##3##(1993-6#1)(2008-10#3)(2008-11#2)
synergistic effect on the##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
synergistic effect on##5##3##(1997-8#1)(2008-10#1)(2008-11#2)(2010-10#1)
synergistic effect##20##2##(1993-3#1)(1993-6#1)(1997-8#1)(2008-10#9)(2008-11#5)(2008-5#2)(2010-10#1)
synergistic effects##6##2##(1995-5#1)(1996-12#1)(2008-10#3)(2013-8#1)
synergistic extraction##3##2##(2008-10#3)
synergistic interaction between##2##3##(1993-8#1)(2008-10#1)
synergistic interaction##4##2##(1993-8#1)(2008-10#3)
synergistic interactions##2##2##(2008-9#1)(2009-3#1)
synergistic or antagonistic##2##3##(2008-10#2)
synergistic relationships between##2##3##(2008-10#1)(2008-11#1)
synergistic with##2##2##(1993-11#1)(2008-10#1)
synergistic##67##1##(1990-2#1)(1990-8#1)(1991-8#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#32)(2008-11#7)(2008-5#2)(2008-9#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-8#1)
synergistically mediate the gene transfer into primary rat hepatocytes##2##9##(2008-9#2)
synergistically to enhance##2##3##(2008-5#1)(2009-7#1)
synergistically to increase##2##3##(1993-6#1)(2008-10#1)
synergistically to##6##2##(1991-12#1)(1993-6#1)(2008-10#2)(2008-5#1)(2009-7#1)
synergistically##20##1##(1991-12#1)(1991-5#1)(1993-6#1)(1994-11#2)(1995-8#1)(1997-1#2)(2006-6#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2012-12#1)
synergize with##5##2##(1993-12#1)(1995-8#1)(2009-12#3)
synergy between##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2011-3#1)
synergy with##3##2##(1992-8#1)(1994-3#1)(2009-6#1)
synergy##11##1##(1992-8#1)(1993-8#1)(1994-3#2)(2008-10#1)(2008-11#2)(2008-5#1)(2009-6#1)(2011-3#2)
syngeneic lymphocytes##2##2##(1990-12#2)
syngeneic##9##1##(1990-12#2)(1990-8#1)(1995-12#2)(2008-4#2)(2013-1#2)
synonymized##2##1##(2011-2#2)
synonymous with##4##2##(2008-1#1)(2010-3#1)(2010-4#1)(2010-7#1)
synonymous##10##1##(1993-11#2)(2008-1#1)(2008-10#3)(2010-3#1)(2010-4#1)(2010-7#1)(2012-5#1)
synonyms##3##1##(2008-10#2)(2011-2#1)
synopsis of the##2##3##(2008-10#1)(2010-12#1)
synopsis of##5##2##(2008-10#2)(2008-11#2)(2010-12#1)
synopsis##6##1##(1991-3#1)(2008-10#2)(2008-11#2)(2010-12#1)
synoptic##2##1##(2008-10#1)(2008-2#1)
synovectomy##2##1##(2010-7#1)(2013-1#1)
synovial cells##2##2##(2007-11#1)(2008-5#1)
synovial estradiol and##2##3##(1992-3#2)
synovial estradiol level was##2##4##(1992-3#2)
synovial estradiol##4##2##(1992-3#4)
synovial fluid##10##2##(1990-2#1)(1992-8#1)(1993-6#1)(1994-8#2)(2008-12#1)(2010-10#1)(2011-1#2)(2013-8#1)
synovial membrane of a knee joint##2##6##(2013-1#2)
synovial membrane##3##2##(2013-1#3)
synovial osteochondromatosis##2##2##(2010-5#2)
synovial reaction##2##2##(2011-2#2)
synovial sarcoma of the##2##4##(2013-1#2)
synovial sarcoma##4##2##(2013-1#4)
synovial tissue##2##2##(2012-2#1)(2013-1#1)
synovial##40##1##(1990-2#1)(1992-3#6)(1992-8#1)(1993-2#1)(1993-6#1)(1994-8#2)(1996-9#1)(2007-11#2)(2008-12#2)(2008-5#2)(2010-10#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
synoviocytes##4##1##(2008-10#3)(2013-8#1)
synovitis##4##1##(2010-3#2)(2012-3#1)(2013-1#1)
synovium##2##1##(2007-11#1)(2008-5#1)
syntactic and##2##2##(2008-7#1)(2008-9#1)
syntactic categories in##2##3##(2008-2#2)
syntactic categories##5##2##(2008-2#5)
syntactic##10##1##(2008-11#1)(2008-2#5)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
syntax##8##1##(1997-3#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-9#1)(2013-8#1)
syntax)##2##1##(2013-8#2)
syntenic region##2##2##(2008-10#1)(2012-3#1)
syntenic##4##1##(2008-10#3)(2012-3#1)
synthase (NOS)##6##2##(1992-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(2009-10#1)(2009-7#1)
synthase A##2##2##(2008-9#2)
synthase activity##4##2##(1992-6#1)(1996-2#2)(1996-6#1)
synthase and a##2##3##(1992-12#1)(1995-2#1)
synthase and##6##2##(1992-10#1)(1992-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(2010-10#1)
synthase cDNA##2##2##(1991-5#1)(1995-2#1)
synthase catalyzes the##2##3##(1991-5#1)(1997-8#1)
synthase catalyzes##3##2##(1991-5#1)(1994-5#1)(1997-8#1)
synthase from##4##2##(1995-3#1)(1996-6#1)(2008-8#1)(2008-9#1)
synthase gene and##2##3##(1995-12#1)(2008-9#1)
synthase gene##15##2##(1995-12#1)(1995-2#3)(1996-12#1)(1997-4#1)(1997-8#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
synthase in##9##2##(1993-2#1)(1995-11#3)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-5#1)
synthase inhibitor##3##2##(1994-8#2)(1995-11#1)
synthase is##2##2##(2008-10#1)(2008-8#1)
synthase kinase##2##2##(1995-12#1)(2008-7#1)
synthase of##3##2##(1997-4#2)(1997-8#1)
synthase was##2##2##(1990-5#1)(1995-11#1)
synthase were##3##2##(1990-5#1)(1994-5#1)(2008-10#1)
synthase with##2##2##(1994-5#1)(1997-1#1)
synthase##154##1##(1990-5#3)(1991-5#4)(1992-10#5)(1992-12#6)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#4)(1993-2#5)(1994-11#1)(1994-5#5)(1994-8#3)(1995-11#11)(1995-12#3)(1995-2#9)(1995-3#1)(1995-9#1)(1996-12#4)(1996-2#3)(1996-6#4)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#4)(1997-8#10)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#11)(2008-9#6)(2009-10#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#1)(2013-8#1)
synthase)##4##1##(1994-8#1)(1997-8#1)(2008-10#1)(2008-9#1)
synthase-1 in##2##2##(1992-3#1)(2012-2#1)
synthase-1##5##1##(1992-3#4)(2012-2#1)
synthases##13##1##(1992-10#1)(1993-2#2)(1995-11#1)(1995-6#4)(1997-1#1)(2013-1#3)(2013-8#1)
syntheses of the##2##3##(1997-4#1)(2008-10#1)
syntheses of##6##2##(1991-6#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-12#1)
syntheses##14##1##(1991-6#1)(1992-12#2)(1992-6#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-12#1)
synthesis and a##3##3##(1993-12#1)(1995-11#1)(2009-7#1)
synthesis and accumulation of##2##4##(1995-11#1)(2008-8#1)
synthesis and antimicrobial evaluation of##2##5##(2012-3#2)
synthesis and applications as##2##4##(2008-10#2)
synthesis and breakdown of##2##4##(1993-8#1)(2011-2#1)
synthesis and cell##6##3##(1991-2#1)(1992-8#1)(1993-8#1)(1995-11#2)(1996-2#1)
synthesis and characterization of##6##4##(1994-8#1)(2008-10#1)(2008-4#3)(2010-4#1)
synthesis and degradation of##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
synthesis and deposition##2##3##(2009-8#2)
synthesis and evaluation##2##3##(2008-10#2)
synthesis and release of##3##4##(1995-11#1)(1996-2#1)(2013-7#1)
synthesis and release##5##3##(1995-11#1)(1996-2#1)(2011-1#1)(2013-7#2)
synthesis and secretion##3##3##(1990-2#1)(1994-8#1)(2008-11#1)
synthesis and the##3##3##(1995-6#1)(2008-10#1)(2008-5#1)
synthesis and##82##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-8#3)(1995-11#6)(1995-2#1)(1995-6#1)(1996-2#3)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#16)(2008-11#3)(2008-4#6)(2008-5#4)(2008-7#1)(2008-8#4)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
synthesis are##5##2##(2008-11#1)(2008-4#2)(2008-5#1)(2011-1#1)
synthesis as##2##2##(1992-10#1)(1995-2#1)
synthesis at the##2##3##(1992-3#1)(2008-10#1)
synthesis at##6##2##(1991-2#1)(1992-3#1)(1994-11#1)(1995-2#2)(2008-10#1)
synthesis by the##4##3##(1995-2#1)(2008-4#2)(2008-6#1)
synthesis by##18##2##(1990-11#1)(1992-8#2)(1995-11#1)(1995-2#1)(1997-1#4)(1997-3#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-9#1)(2013-8#1)
synthesis from##3##2##(1995-8#1)(1996-5#1)(2011-1#1)
synthesis gene##2##2##(1992-10#1)(2008-4#1)
synthesis has##2##2##(2008-9#2)
synthesis in a##3##3##(1995-11#1)(1995-12#1)(2008-10#1)
synthesis in hepatocytes##3##3##(1993-3#2)(1995-8#1)
synthesis in human##2##3##(1997-1#1)(2008-9#1)
synthesis in the retina##2##4##(2008-5#2)
synthesis in the##9##3##(1995-11#1)(1996-12#1)(2008-12#2)(2008-5#3)(2011-2#1)(2013-1#1)
synthesis in vitro and in vivo##2##6##(2008-5#2)
synthesis in vitro##3##3##(1996-2#1)(2008-5#2)
synthesis in vivo##2##3##(1992-10#1)(1992-11#1)
synthesis in##58##2##(1990-11#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#2)(1995-11#6)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-1#3)(2008-10#3)(2008-11#7)(2008-12#2)(2008-5#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
synthesis inhibitor##4##2##(1993-3#2)(1996-6#1)(2008-9#1)
synthesis inhibitors##5##2##(1991-2#1)(1991-5#3)(2008-11#1)
synthesis is dependent##2##3##(1995-11#1)(2009-8#1)
synthesis is##11##2##(1991-3#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-8#1)(2011-1#1)(2011-2#2)
synthesis may##3##2##(1990-12#1)(1993-9#1)(1997-1#1)
synthesis of a##12##3##(1992-6#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2009-12#1)(2012-2#1)
synthesis of amino##2##3##(2008-11#1)(2008-7#1)
synthesis of both subunits##2##4##(1996-2#2)
synthesis of chiral##2##3##(1992-11#1)(2009-10#1)
synthesis of nascent##2##3##(2008-10#1)(2008-9#1)
synthesis of phosphatidylinositol##2##3##(1997-1#1)(1997-8#1)
synthesis of salinosporamide A##2##4##(2010-7#2)
synthesis of several##3##3##(1992-8#1)(1993-8#1)(2008-11#1)
synthesis of some##2##3##(1996-5#1)(2008-10#1)
synthesis of the##20##3##(1990-11#2)(1990-5#1)(1991-10#1)(1992-12#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2009-6#1)(2009-8#1)(2011-1#1)
synthesis of these##2##3##(2008-12#1)(2011-2#1)
synthesis of this##2##3##(1993-3#1)(2008-10#1)
synthesis of##203##2##(1990-11#2)(1990-5#4)(1991-10#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#3)(1992-12#4)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#15)(1997-1#4)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#35)(2008-11#10)(2008-12#3)(2008-2#1)(2008-4#17)(2008-5#6)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#6)(2009-12#2)(2009-6#3)(2009-8#4)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#2)(2011-1#3)(2011-2#5)(2011-3#2)(2012-2#4)(2012-3#5)(2012-7#2)(2013-7#1)
synthesis or a##2##3##(1993-8#1)(2008-7#1)
synthesis or##5##2##(1990-5#1)(1993-8#1)(1994-2#1)(1996-2#1)(2008-7#1)
synthesis process##5##2##(2008-10#4)(2011-2#1)
synthesis rate##2##2##(1992-8#1)(1994-5#1)
synthesis to##4##2##(1996-5#1)(2008-10#1)(2008-9#1)(2010-7#1)
synthesis using##2##2##(1994-3#1)(2008-6#1)
synthesis via##2##2##(1992-10#1)(1997-1#1)
synthesis was investigated##2##3##(1997-1#1)(2008-7#1)
synthesis was##20##2##(1990-5#3)(1990-8#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-12#1)(1997-1#2)(2008-10#3)(2008-5#2)(2008-7#1)
synthesis were##4##2##(1996-12#1)(2008-11#2)(2013-1#1)
synthesis with##2##2##(1991-5#1)(1994-3#1)
synthesis##660##1##(1990-11#7)(1990-12#3)(1990-2#1)(1990-5#12)(1990-8#1)(1991-10#1)(1991-2#7)(1991-3#1)(1991-5#7)(1991-6#1)(1992-1#1)(1992-10#5)(1992-11#5)(1992-12#5)(1992-3#6)(1992-4#1)(1992-6#5)(1992-7#1)(1992-8#6)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#8)(1993-3#5)(1993-6#2)(1993-8#9)(1993-9#4)(1994-11#10)(1994-2#1)(1994-3#7)(1994-5#7)(1994-6#1)(1994-8#8)(1995-11#21)(1995-12#10)(1995-2#12)(1995-3#5)(1995-5#2)(1995-6#5)(1995-8#6)(1995-9#1)(1996-11#1)(1996-12#11)(1996-2#12)(1996-5#19)(1996-6#2)(1997-1#19)(1997-2#8)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#98)(2008-11#47)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#39)(2008-5#21)(2008-6#3)(2008-7#20)(2008-8#9)(2008-9#12)(2009-10#7)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#10)(2009-9#1)(2010-11#2)(2010-12#2)(2010-4#5)(2010-5#1)(2010-7#3)(2011-1#18)(2011-2#23)(2011-3#3)(2012-2#13)(2012-3#9)(2012-7#2)(2013-1#3)(2013-7#4)(2013-8#4)
synthesised and tested##2##3##(2008-10#1)(2011-2#1)
synthesised by##3##2##(2008-10#2)(2013-7#1)
synthesised in our##2##3##(2008-10#2)
synthesised in##3##2##(1992-8#1)(2008-10#2)
synthesised##16##1##(1990-11#1)(1992-8#1)(2008-10#11)(2008-11#1)(2011-2#1)(2013-7#1)
synthesize and secrete##3##3##(1993-3#1)(2008-7#1)(2013-1#1)
synthesize and##5##2##(1993-3#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
synthesize the##5##2##(1996-6#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)
synthesize##35##1##(1990-5#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#4)(2009-10#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
synthesized a##2##2##(2010-6#1)(2012-2#1)
synthesized and characterized##7##3##(1993-8#1)(1994-8#1)(2008-10#5)
synthesized and evaluated as##2##4##(1993-1#1)(2008-10#1)
synthesized and evaluated##3##3##(1992-12#1)(1993-1#1)(2008-10#1)
synthesized and investigated##2##3##(2008-10#1)(2008-12#1)
synthesized and its##3##3##(2008-10#3)
synthesized and released##2##3##(1992-6#1)(2009-10#1)
synthesized and studied##2##3##(1995-3#1)(2008-10#1)
synthesized and tested in##2##4##(2008-8#1)(2011-2#1)
synthesized and tested##4##3##(1993-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
synthesized and the##2##3##(1992-8#1)(2008-10#1)
synthesized and used as##3##4##(2008-10#3)
synthesized and used##6##3##(2008-10#6)
synthesized and##50##2##(1991-7#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#2)(1995-3#1)(1996-2#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-4#2)(2008-8#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
synthesized as a##3##3##(1990-8#1)(2008-10#2)
synthesized as##10##2##(1990-8#1)(1991-5#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
synthesized at the##2##3##(2008-10#1)(2008-12#1)
synthesized at##4##2##(2008-10#3)(2008-12#1)
synthesized brood food proteins##2##4##(2008-6#2)
synthesized by osteoblasts##2##3##(1997-1#2)
synthesized by solid-phase##2##3##(1992-3#1)(2008-9#1)
synthesized by suspension polymerization##2##4##(2008-10#2)
synthesized by the##5##3##(1992-6#1)(1995-2#1)(2008-10#3)
synthesized by using##4##3##(1991-3#1)(2008-10#3)
synthesized by##37##2##(1991-3#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-1#2)(2008-10#19)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2013-1#1)
synthesized cell wall materials##2##4##(2008-10#2)
synthesized compounds have##2##3##(2012-2#1)(2012-3#1)
synthesized compounds were##3##3##(2008-11#1)(2008-5#2)
synthesized compounds##6##2##(2008-11#1)(2008-5#2)(2012-2#2)(2012-3#1)
synthesized for##5##2##(1996-5#1)(2008-10#3)(2012-12#1)
synthesized from an##2##3##(2008-10#2)
synthesized from the##2##3##(1996-5#1)(2008-5#1)
synthesized from##14##2##(1993-8#1)(1994-11#1)(1996-5#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2012-2#1)
synthesized in Escherichia coli##2##4##(1992-6#1)(1993-12#1)
synthesized in our laboratory##3##4##(1993-1#1)(2008-10#2)
synthesized in the##6##3##(1992-10#1)(1993-12#1)(1994-11#2)(2008-10#1)(2008-6#1)
synthesized in##31##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-11#2)(1995-6#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)
synthesized on##4##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-11#1)
synthesized through##2##2##(1992-6#1)(2008-10#1)
synthesized under##2##2##(2008-10#1)(2008-9#1)
synthesized using##6##2##(2008-1#1)(2008-10#5)
synthesized with a##2##3##(1990-5#1)(2008-5#1)
synthesized with##4##2##(1990-5#1)(1994-5#1)(2008-10#1)(2008-5#1)
synthesized##325##1##(1990-11#2)(1990-12#1)(1990-5#3)(1990-8#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#7)(1992-8#2)(1993-1#2)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#5)(1994-11#4)(1994-3#2)(1994-5#2)(1994-8#7)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-2#2)(1996-5#4)(1997-1#5)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#143)(2008-11#17)(2008-12#4)(2008-4#7)(2008-5#12)(2008-6#5)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#5)(2009-3#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-5#5)(2010-6#2)(2011-1#2)(2011-2#4)(2011-3#3)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
synthesizers##2##1##(2008-3#1)(2008-4#1)
synthesizes the##2##2##(1994-9#1)(2012-3#1)
synthesizes##4##1##(1994-9#1)(1996-2#1)(2008-9#1)(2012-3#1)
synthesizing a##2##2##(2008-4#1)(2011-2#1)
synthesizing enzymes##2##2##(1996-12#2)
synthesizing research results##2##3##(2008-10#2)
synthesizing the##3##2##(2008-4#1)(2008-9#1)(2013-8#1)
synthesizing##20##1##(1992-8#1)(1994-11#2)(1994-8#1)(1996-12#3)(2008-10#2)(2008-11#1)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
synthetase activity##2##2##(1995-6#1)(2008-11#1)
synthetase and##2##2##(2008-11#1)(2012-2#1)
synthetase in the##2##3##(1995-9#1)(1996-12#1)
synthetase in##3##2##(1995-9#1)(1996-12#1)(2008-11#1)
synthetase##40##1##(1990-7#3)(1993-12#3)(1993-8#2)(1995-6#3)(1995-9#2)(1996-12#6)(1997-1#2)(2008-11#11)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#4)
synthetases##6##1##(1990-7#2)(1993-8#1)(2012-2#3)
synthetic DI RNA##2##3##(1997-3#2)
synthetic DNA##2##2##(2008-10#1)(2008-4#1)
synthetic HA##2##2##(2008-10#2)
synthetic RNA##2##2##(2008-10#1)(2008-4#1)
synthetic SIV protease##2##3##(1992-6#2)
synthetic activity of##2##3##(1994-11#1)(1994-8#1)
synthetic activity##3##2##(1994-11#1)(1994-8#1)(2011-2#1)
synthetic analogues##2##2##(1994-11#2)
synthetic and natural photosensitising agents##2##5##(2008-11#2)
synthetic and natural##4##3##(2008-10#2)(2008-11#2)
synthetic and real samples##5##4##(2008-10#5)
synthetic and real##8##3##(2008-10#8)
synthetic and water samples##2##4##(2008-10#2)
synthetic and##21##2##(1990-10#1)(2008-10#17)(2008-11#2)(2012-2#1)
synthetic antioxidant##3##2##(2008-10#2)(2009-3#1)
synthetic aperture infrared laser radar##2##5##(2008-3#2)
synthetic aperture radar##5##3##(2008-3#4)(2008-6#1)
synthetic aperture##9##2##(2008-3#8)(2008-6#1)
synthetic approach##2##2##(2008-8#1)(2010-5#1)
synthetic biology##3##2##(2009-5#2)(2012-2#1)
synthetic ceramides##2##2##(1995-12#2)
synthetic chemicals##2##2##(2008-11#1)(2012-2#1)
synthetic chromone derivatives was##2##4##(2009-3#2)
synthetic compounds##3##2##(1993-8#1)(2008-11#2)
synthetic data##3##2##(2008-2#1)(2008-3#2)
synthetic diamond##2##2##(2008-10#2)
synthetic emergence inhibitors##2##3##(2008-10#2)
synthetic enzymes##2##2##(1992-8#1)(1997-3#1)
synthetic extensions of##2##3##(1994-11#2)
synthetic fertilizers##4##2##(2008-10#4)
synthetic gene##3##2##(1991-5#1)(2008-11#2)
synthetic human##2##2##(1993-6#1)(2012-3#1)
synthetic intermediates for the preparation of##2##6##(1996-5#1)(2011-1#1)
synthetic iron hydroxide##2##3##(2008-10#2)
synthetic kitchen waste (KW)##2##4##(2013-1#2)
synthetic ligands##2##2##(2008-10#1)(2008-9#1)
synthetic medium##2##2##(2008-10#1)(2008-5#1)
synthetic metal-doped##2##2##(2008-10#2)
synthetic method##2##2##(2008-10#1)(2008-12#1)
synthetic mixture##6##2##(2008-10#6)
synthetic mixtures and mineral sample##2##5##(2008-10#2)
synthetic mixtures and##10##3##(2008-10#10)
synthetic mixtures containing##4##3##(2008-10#4)
synthetic mixtures of the##2##4##(2008-10#2)
synthetic mixtures of##8##3##(2008-10#8)
synthetic mixtures##32##2##(2008-10#32)
synthetic molecular machines##2##3##(2008-7#2)
synthetic near-field##2##2##(2008-3#2)
synthetic oligonucleotides##3##2##(1995-12#1)(2008-10#1)(2008-4#1)
synthetic peptide##15##2##(1991-9#1)(1992-7#1)(1993-3#1)(1994-5#2)(1995-2#3)(1995-6#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)
synthetic peptides representing##2##3##(1993-8#1)(2008-10#1)
synthetic peptides##14##2##(1990-4#2)(1992-6#1)(1993-8#1)(1994-3#1)(2008-10#2)(2008-4#7)
synthetic playing surfaces##3##3##(2013-1#3)
synthetic polymers##2##2##(2008-11#1)(2010-6#1)
synthetic polynucleotides##2##2##(1994-8#1)(2008-10#1)
synthetic process##2##2##(2008-10#1)(2008-11#1)
synthetic psoralen##2##2##(2008-11#2)
synthetic pyrethroids##3##2##(2008-10#3)
synthetic replicators##2##2##(1992-6#2)
synthetic route##4##2##(1996-5#1)(2008-10#1)(2008-11#1)(2010-2#1)
synthetic saliva##3##2##(2008-10#3)
synthetic sample solutions by##2##4##(2008-10#2)
synthetic sample##5##2##(2008-10#5)
synthetic samples in##2##3##(2008-10#2)
synthetic samples prepared with##3##4##(2008-10#3)
synthetic samples prepared##5##3##(2008-10#5)
synthetic samples were##3##3##(2008-10#3)
synthetic samples with##4##3##(2008-10#4)
synthetic samples##36##2##(2008-10#36)
synthetic sea water##2##3##(2008-10#2)
synthetic seawater##3##2##(2008-10#2)(2008-2#1)
synthetic serum and pharmaceutical##2##4##(2008-10#2)
synthetic serum and##3##3##(2008-10#3)
synthetic serum samples##2##3##(2008-10#2)
synthetic serum##5##2##(2008-10#5)
synthetic solution##3##2##(2008-10#3)
synthetic solutions##4##2##(2008-10#3)(2013-1#1)
synthetic strategies for##3##3##(2009-10#3)
synthetic strategies##4##2##(2009-10#3)(2012-3#1)
synthetic sunscreen##6##2##(2008-5#6)
synthetic target##2##2##(2008-10#2)
synthetic telomeres##2##2##(1991-7#2)
synthetic wastewater##2##2##(2008-10#1)(2011-2#1)
synthetic##426##1##(1990-10#1)(1990-2#1)(1990-4#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#6)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#6)(1994-3#1)(1994-5#3)(1994-8#3)(1995-12#3)(1995-2#6)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#4)(1997-1#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-10#212)(2008-11#19)(2008-12#1)(2008-2#2)(2008-3#13)(2008-4#15)(2008-5#16)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#2)(2009-3#5)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#8)(2011-3#2)(2012-2#4)(2012-3#6)(2013-1#8)
synthetics##2##1##(2008-11#2)
synthetized##2##1##(1992-3#1)(1995-6#1)
syphilis and##3##2##(2011-2#2)(2013-8#1)
syphilis##19##1##(1994-9#1)(1995-2#1)(1997-5#3)(1997-6#1)(1997-7#2)(2008-10#4)(2011-2#6)(2013-8#1)
syphilitic##2##1##(1997-5#1)(2010-3#1)
syrB gene##5##2##(2008-10#5)
syrB##8##1##(2008-10#8)
syringae B728a##2##2##(2008-10#2)
syringae Cit7 was the most effective##2##6##(2008-10#2)
syringae Cit7##3##2##(2008-10#3)
syringae and C##2##3##(2008-10#2)
syringae and##7##2##(2008-10#7)
syringae in the##2##3##(2008-10#2)
syringae pathovars##4##2##(2008-10#4)
syringae pv##75##2##(2008-10#75)
syringae pvs##5##2##(2008-10#5)
syringae strain##3##2##(2008-10#2)(2009-8#1)
syringae strains##4##2##(2008-10#4)
syringae was##2##2##(2008-10#2)
syringae were##2##2##(2008-10#2)
syringae##157##1##(2008-10#154)(2009-8#3)
syringae)##2##1##(2008-10#2)
syringaldazine##5##1##(2008-10#5)
syringe and##3##2##(2008-10#3)
syringe filled with##2##3##(2008-10#2)
syringe pump##8##2##(2008-10#7)(2011-2#1)
syringe pumps##2##2##(2008-10#1)(2011-2#1)
syringe##28##1##(1995-5#1)(2008-10#24)(2008-11#1)(2011-2#2)
syringes and##2##2##(2008-10#1)(2012-2#1)
syringes##5##1##(1996-11#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-8#1)
syringic acid##5##2##(2008-10#1)(2008-11#1)(2011-1#3)
syringic##6##1##(2008-10#1)(2008-11#1)(2011-1#3)(2011-2#1)
syringomatous features##2##2##(1990-6#2)
syringomycin##2##1##(2008-10#2)
syringyl lignin##2##2##(2009-8#2)
syrup##6##1##(1995-11#1)(2008-10#5)
syrups by##2##2##(2008-10#2)
syrups##7##1##(2008-10#7)
system (IL-1##2##2##(1996-12#2)
system (e##2##2##(1997-2#1)(2011-2#1)
system (the##2##2##(2008-10#2)
system BqsS-BqsR##2##2##(2009-6#2)
system a##3##2##(1996-6#1)(2008-10#2)
system activity##4##2##(2008-4#1)(2008-7#3)
system adapted to##2##3##(2008-10#2)
system after##5##2##(1993-3#1)(2008-10#3)(2008-9#1)
system allow##2##2##(2008-10#1)(2008-12#1)
system allowed determination of##2##4##(2008-10#2)
system allowed for##2##3##(2008-10#1)(2009-9#1)
system allowed the##3##3##(2008-10#3)
system allowed##8##2##(2008-10#7)(2009-9#1)
system allowing##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
system allows##6##2##(1990-5#1)(2008-10#4)(2008-11#1)
system and 0##2##3##(2008-10#2)
system and a##6##3##(1990-5#1)(1991-3#1)(1997-7#1)(2008-10#3)
system and for##2##3##(1995-12#1)(2010-4#1)
system and in##2##3##(2008-10#1)(2008-7#1)
system and its application to##3##5##(2008-10#3)
system and its##5##3##(1994-3#1)(2008-10#3)(2012-3#1)
system and may##2##3##(2008-10#2)
system and obtained##2##3##(1997-7#1)(2008-8#1)
system and the amounts of##2##5##(2008-10#2)
system and the##29##3##(1991-2#1)(1993-11#1)(1993-12#3)(1995-12#1)(1996-1#1)(2008-10#14)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
system and then##2##3##(1992-1#1)(2008-10#1)
system and those obtained##2##4##(2008-10#2)
system and those##3##3##(2008-10#2)(2009-11#1)
system and thus##2##3##(1996-2#1)(2009-8#1)
system and to##6##3##(1996-2#1)(2008-10#3)(2008-3#1)(2009-6#1)
system and was##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
system and##173##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#72)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#4)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
system applied to##2##3##(2008-10#1)(2008-7#1)
system are described##2##3##(2008-10#2)
system are discussed##3##3##(2008-10#3)
system are##29##2##(1991-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#11)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
system around##2##2##(1997-2#1)(2008-5#1)
system as a##4##3##(2008-10#2)(2009-9#1)(2010-11#1)
system as an##2##3##(2008-9#1)(2010-7#1)
system as it##2##3##(1994-1#1)(2012-3#1)
system as well as the##2##5##(2008-10#1)(2008-11#1)
system as well as##4##4##(2008-10#2)(2008-11#1)(2012-2#1)
system as##18##2##(1991-2#1)(1994-1#1)(2008-10#7)(2008-11#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#1)
system at the##3##3##(1993-12#1)(1996-12#1)(2010-6#1)
system at##9##2##(1993-12#1)(1996-12#1)(2008-10#4)(2008-3#2)(2010-6#1)
system automatically##2##2##(1995-12#1)(2008-11#1)
system based on a##3##4##(2008-10#2)(2008-3#1)
system based on an array of##2##6##(2008-10#2)
system based on the##5##4##(1991-3#1)(2008-10#4)
system based on##29##3##(1991-3#1)(1995-2#1)(1996-6#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
system based##31##2##(1991-3#1)(1995-2#1)(1996-6#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2011-3#1)
system by the##3##3##(2008-10#2)(2008-7#1)
system by using##2##3##(2008-11#1)(2008-3#1)
system by##26##2##(1990-11#1)(1992-10#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-8#1)(2011-2#1)
system called##2##2##(2008-10#1)(2008-3#1)
system can also be used##2##5##(2010-8#1)(2011-1#1)
system can also be##3##4##(2008-10#1)(2010-8#1)(2011-1#1)
system can be easily##2##4##(2008-10#1)(2008-3#1)
system can be used to##2##5##(1996-12#1)(2008-10#1)
system can be used##3##4##(1996-12#1)(2008-10#1)(2010-1#1)
system can be##23##3##(1990-2#1)(1994-11#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-7#1)(2010-1#1)(2011-2#1)
system can provide##2##3##(1993-2#1)(2008-10#1)
system can recognize##2##3##(2008-3#1)(2008-4#1)
system can##42##2##(1990-2#1)(1993-2#1)(1994-11#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
system capable of##3##3##(1993-9#1)(1996-12#1)(2008-10#1)
system capable##4##2##(1993-9#1)(1996-12#1)(2008-10#2)
system combined with##3##3##(2008-10#3)
system combined##5##2##(2008-10#5)
system compared to##2##3##(2008-9#1)(2010-8#1)
system compared with that##2##4##(2008-10#1)(2012-2#1)
system compared##4##2##(2008-10#1)(2008-9#1)(2010-8#1)(2012-2#1)
system components##3##2##(1996-12#1)(2008-3#1)(2008-9#1)
system composed of a##2##4##(2008-10#1)(2008-3#1)
system composed of the##2##4##(1990-5#1)(2008-5#1)
system composed of##4##3##(1990-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
system comprising##2##2##(2008-10#1)(2009-8#1)
system conforms to##2##3##(2008-10#2)
system consisted of##4##3##(2008-10#4)
system consisting of a##3##4##(2008-10#2)(2008-3#1)
system consisting of##10##3##(1990-5#1)(1991-5#1)(1993-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#1)
system consists of a##4##4##(2008-10#3)(2008-11#1)
system consists of##9##3##(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
system consists##10##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
system containing a##3##3##(1993-9#1)(2008-10#2)
system containing both##2##3##(1996-3#1)(2008-5#1)
system containing##15##2##(1993-9#1)(1996-3#1)(2008-10#11)(2008-5#2)
system correlates##2##2##(2008-11#1)(2013-8#1)
system could be##6##3##(2008-10#2)(2008-3#1)(2009-6#1)(2010-7#1)(2011-2#1)
system could##12##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)
system coupled to a flame atomic absorption spectrometer##2##8##(2008-10#2)
system coupled to a##3##4##(2008-10#3)
system coupled to##9##3##(2008-10#9)
system coupled with a##3##4##(2008-10#3)
system coupled with##4##3##(2008-10#4)
system coupled##13##2##(2008-10#13)
system coupling##2##2##(2008-10#2)
system covering##2##2##(2008-10#1)(2012-12#1)
system damage##3##2##(1991-3#1)(1992-5#1)(1993-3#1)
system data##2##2##(1995-5#1)(2012-5#1)
system demonstrated##2##2##(2008-10#1)(2010-8#1)
system depends on##3##3##(1993-3#1)(2008-10#1)(2009-10#1)
system described in this##2##4##(2008-10#1)(2008-4#1)
system described##5##2##(1994-2#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
system design for##2##3##(2008-10#2)
system design##5##2##(1994-1#1)(2008-10#3)(2008-3#1)
system designed##3##2##(1995-2#1)(2008-10#2)
system detects##2##2##(2008-10#2)
system developed and implemented by##2##5##(1996-12#1)(2013-1#1)
system developed for##2##3##(1997-1#1)(2008-10#1)
system developed is##2##3##(2008-10#2)
system developed##11##2##(1996-12#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2013-1#1)
system development##4##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
system did not##2##3##(2008-8#1)(2009-6#1)
system disorders##2##2##(2008-9#1)(2013-1#1)
system disturbances##2##2##(2008-12#2)
system does not##4##3##(1994-3#1)(2008-3#2)(2011-2#1)
system due to##2##3##(2008-10#1)(2008-7#1)
system during##2##2##(1995-5#1)(2008-5#1)
system employing##3##2##(2008-10#3)
system employs##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
system enables the##2##3##(2008-10#1)(2008-11#1)
system enables##6##2##(1996-12#1)(2008-10#2)(2008-11#2)(2009-10#1)
system enhances##2##2##(2008-10#1)(2013-8#1)
system equipped with##4##3##(2008-10#3)(2008-11#1)
system exhibited##3##2##(2008-10#3)
system exhibits##2##2##(1991-3#1)(2008-10#1)
system exploiting multicommutation##2##3##(2008-10#2)
system expressing##2##2##(2008-11#1)(2008-8#1)
system following##2##2##(2008-10#1)(2013-1#1)
system for a##6##3##(1996-3#1)(2008-10#2)(2008-12#1)(2010-7#1)(2010-8#1)
system for ambulatory##4##3##(1991-1#2)(1994-3#2)
system for assessing##2##3##(2008-11#1)(2008-5#1)
system for automated dissolution testing##2##5##(2008-10#2)
system for automated##4##3##(2008-10#4)
system for automatic determination of chemical oxygen demand##2##8##(2008-10#2)
system for copper##3##3##(2008-10#3)
system for detection of##2##4##(2008-10#1)(2010-8#1)
system for determination of ascorbic acid##2##6##(2008-10#2)
system for determination of##7##4##(2008-10#7)
system for determination##9##3##(2008-10#8)(2010-8#1)
system for determining##2##3##(2008-10#2)
system for efficient##3##3##(2008-11#2)(2011-1#1)
system for lead##2##3##(2008-10#2)
system for measuring##2##3##(1996-12#1)(2008-10#1)
system for on-line preconcentration and determination of##2##7##(2008-10#2)
system for on-line##4##3##(2008-10#4)
system for physician##2##3##(1992-1#1)(2013-1#1)
system for protein##2##3##(1991-5#1)(2008-4#1)
system for recombinant##2##3##(2008-11#1)(2008-9#1)
system for separation of##2##4##(2008-10#1)(2008-7#1)
system for separation##3##3##(2008-10#2)(2008-7#1)
system for simultaneous##5##3##(2007-12#1)(2008-10#4)
system for spectrophotometric determination of##3##5##(2008-10#3)
system for study on adaptive mutations##2##6##(2008-9#2)
system for studying##4##3##(1996-2#1)(2008-10#1)(2009-12#1)(2009-8#1)
system for surveillance##2##3##(2008-10#1)(2011-2#1)
system for the detection of##4##5##(2008-10#1)(2008-3#2)(2013-8#1)
system for the detection##5##4##(2008-10#2)(2008-3#2)(2013-8#1)
system for the determination of copper##2##6##(2008-10#2)
system for the determination of fish freshness##2##7##(2008-10#2)
system for the determination of mercury by##2##7##(2008-10#2)
system for the determination of the##2##6##(2008-10#2)
system for the determination of total##2##6##(2008-10#2)
system for the determination of trace boron in iron and##2##10##(2008-10#2)
system for the determination of trace##4##6##(2008-10#4)
system for the determination of##31##5##(2008-10#31)
system for the determination##32##4##(2008-10#32)
system for the evaluation of##2##5##(2008-5#1)(2009-11#1)
system for the management of##2##5##(2008-12#1)(2011-2#1)
system for the on-line##3##4##(2008-10#3)
system for the production of##2##5##(2008-11#1)(2011-2#1)
system for the selective##2##4##(2008-10#2)
system for the simultaneous determination of##2##6##(2008-10#2)
system for the simultaneous##4##4##(2008-10#3)(2008-2#1)
system for the spectrophotometric determination of##7##6##(2008-10#7)
system for the##106##3##(1990-5#1)(1992-3#1)(1993-1#1)(1995-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#72)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
system for##332##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#5)(1992-3#5)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-12#2)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#185)(2008-11#21)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#8)(2009-11#1)(2009-12#2)(2009-8#3)(2010-7#2)(2010-8#6)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
system from which##2##3##(1993-12#1)(2008-10#1)
system from##9##2##(1993-12#1)(1996-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
system function in##2##3##(2008-10#1)(2009-8#1)
system gave##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
system gives a##2##3##(2008-8#1)(2013-8#1)
system gives##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
system greatly##2##2##(2008-10#1)(2008-9#1)
system had a##4##3##(2008-10#3)(2008-11#1)
system had##5##2##(2008-10#4)(2008-11#1)
system handles about 65 samples per hour##2##7##(2008-10#2)
system handles about##3##3##(2008-10#3)
system handles##4##2##(2008-10#4)
system has a detection limit of 0##2##7##(2008-10#2)
system has a##7##3##(1992-12#1)(2008-10#6)
system has also been investigated##2##5##(2008-10#2)
system has also been##3##4##(1995-5#1)(2008-10#2)
system has been applied to the analysis of##2##8##(2008-10#2)
system has been applied to##3##5##(2008-10#2)(2010-5#1)
system has been applied##5##4##(2008-10#4)(2010-5#1)
system has been developed for the##3##6##(2008-10#3)
system has been developed for##5##5##(2008-10#5)
system has been developed##7##4##(2008-10#7)
system has been established##2##4##(2008-10#1)(2010-6#1)
system has been explored for##2##5##(2008-10#2)
system has been studied##2##4##(1992-9#1)(2008-10#1)
system has been successfully##2##4##(2008-10#2)
system has been suggested##2##4##(1994-6#1)(2009-9#1)
system has been tested##4##4##(2008-10#4)
system has been used for##3##5##(2008-10#2)(2008-11#1)
system has been used to##2##5##(1993-6#1)(2008-8#1)
system has been used##6##4##(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
system has been##49##3##(1992-12#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-6#1)(1997-5#1)(2008-10#28)(2008-11#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2012-2#1)(2012-3#1)
system has found##2##3##(1991-9#1)(2008-11#1)
system has made it possible##2##5##(2008-7#1)(2010-12#1)
system has the##2##3##(2008-10#2)
system has##80##2##(1990-11#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-5#1)(2008-10#44)(2008-11#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
system have been##4##3##(2008-10#1)(2008-3#2)(2008-7#1)
system have##10##2##(1991-2#1)(1991-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2013-8#1)
system in a##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
system in both##4##3##(1997-8#1)(2008-10#2)(2008-7#1)
system in cancer cells##2##4##(1994-11#1)(2008-4#1)
system in cancer##3##3##(1994-11#1)(2008-4#1)(2013-1#1)
system in heart failure##2##4##(2008-7#1)(2012-2#1)
system in many diseases##2##4##(2008-10#1)(2008-5#1)
system in patients with##2##4##(1997-1#1)(2013-1#1)
system in regulating##2##3##(2008-11#1)(2011-2#1)
system in the presence of##3##5##(2008-10#3)
system in the##21##3##(1992-12#1)(1993-1#1)(1993-6#1)(1995-11#1)(1997-2#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-8#1)(2013-1#1)
system in this##2##3##(2008-7#1)(2008-8#1)
system in vivo##2##3##(1990-5#1)(1995-2#1)
system in which the##5##4##(1991-9#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-3#1)
system in which to study the##2##6##(1995-2#1)(1997-3#1)
system in which to##4##4##(1995-2#1)(1997-3#1)(2009-8#1)(2012-3#1)
system in which##17##3##(1991-9#1)(1992-10#1)(1993-3#1)(1994-12#2)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-3#1)
system in##139##2##(1990-12#1)(1990-2#1)(1990-5#3)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-8#2)(2007-12#2)(2008-10#26)(2008-11#12)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#4)(2008-9#5)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-8#4)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#4)(2013-2#1)(2013-8#1)
system includes a##3##3##(2008-10#3)
system includes##5##2##(2008-10#4)(2008-3#1)
system including the##2##3##(1993-6#1)(1996-9#1)
system including##8##2##(1993-6#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
system incorporating##5##2##(2008-10#4)(2011-2#1)
system injury##2##2##(2007-8#1)(2011-2#1)
system involves##2##2##(2008-10#2)
system involving##6##2##(1990-2#1)(2008-10#5)
system is 0##2##3##(2008-10#2)
system is a##15##3##(1992-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-7#1)(2013-8#1)
system is able to detect##2##5##(2008-11#1)(2008-3#1)
system is able to##8##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)
system is also##2##3##(2008-3#1)(2011-1#1)
system is an##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
system is based on a##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
system is based on the##3##5##(1995-5#1)(2008-10#1)(2008-9#1)
system is based on##10##4##(1995-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
system is capable of##2##4##(2008-10#1)(2008-3#1)
system is demonstrated##2##3##(2008-10#2)
system is described for the determination of##2##7##(2008-10#2)
system is described in this paper##2##6##(2008-10#2)
system is described in##3##4##(1994-5#1)(2008-10#2)
system is described##11##3##(1994-5#1)(2008-10#8)(2008-11#1)(2008-3#1)
system is designed##3##3##(1991-1#1)(2008-10#1)(2011-2#1)
system is discussed##2##3##(2008-10#1)(2008-11#1)
system is highly##2##3##(1992-12#1)(2008-10#1)
system is in##3##3##(2008-10#2)(2012-2#1)
system is involved in the##2##5##(1996-2#1)(2008-7#1)
system is involved in##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
system is likely##2##3##(2008-8#1)(2009-8#1)
system is prepared##2##3##(2008-10#2)
system is presented##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
system is proposed for the determination of##4##7##(2008-10#4)
system is proposed for the##7##5##(2008-10#7)
system is proposed for##10##4##(2008-10#10)
system is proposed##14##3##(1991-5#1)(2008-10#13)
system is suitable for##4##4##(2008-10#4)
system is the##7##3##(2008-10#6)(2008-9#1)
system is to##2##3##(1994-2#1)(2013-8#1)
system is used##7##3##(1991-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-6#1)
system is very##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
system is##195##2##(1991-1#1)(1991-2#2)(1991-5#1)(1992-12#2)(1992-3#3)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#3)(1997-3#2)(2007-11#1)(2008-10#101)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-5#1)(2009-6#1)(2009-8#6)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
system leading to##2##3##(1992-3#1)(2008-10#1)
system made up##3##3##(2008-10#3)
system made##4##2##(2008-10#4)
system maintained##2##2##(2008-10#1)(2008-11#1)
system making##2##2##(2008-5#1)(2010-6#1)
system may be##11##3##(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
system may##17##2##(1992-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-3#1)
system mediated by##2##3##(1992-8#1)(2011-2#1)
system might##3##2##(2008-11#1)(2008-9#1)(2009-6#1)
system modelling##2##2##(2008-11#1)(2010-10#1)
system more than##2##3##(2008-11#1)(2013-1#1)
system more##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
system must##3##2##(1993-12#1)(1997-1#1)(2008-12#1)
system needs##2##2##(2009-12#1)(2013-8#1)
system not only##4##3##(2007-12#1)(2008-10#2)(2010-8#1)
system not##5##2##(2007-12#1)(2008-1#1)(2008-10#2)(2010-8#1)
system obeys Beer's law in the range##3##7##(2008-10#3)
system obeys Beer's law##5##4##(2008-10#5)
system of Neisseria gonorrhoeae##2##4##(1993-9#2)
system of Tb-TMA-beta-CD##2##3##(2008-10#2)
system of a##5##3##(2008-10#4)(2008-3#1)
system of care##3##3##(1997-1#1)(2009-10#1)(2010-12#1)
system of choice##3##3##(1996-1#1)(1996-2#1)(2008-11#1)
system of differential equations##2##4##(2010-11#1)(2013-8#1)
system of local##2##3##(2008-3#1)(2008-8#1)
system of medicine in India##2##5##(2008-10#2)
system of medicine##4##3##(2008-10#3)(2013-1#1)
system of partial differential equations##2##5##(2013-8#2)
system of performance intervention zones##2##5##(2008-12#2)
system of the lamprey##2##4##(1997-3#2)
system of the##22##3##(1992-12#2)(1992-6#1)(1995-3#1)(1997-3#2)(2007-12#2)(2008-10#6)(2008-11#2)(2008-4#3)(2010-11#1)(2011-2#1)(2012-3#1)
system of two##6##3##(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
system of##167##2##(1990-5#2)(1991-2#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#2)(1994-1#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1997-1#2)(1997-3#2)(1997-5#1)(2007-12#9)(2008-1#1)(2008-10#45)(2008-11#13)(2008-12#9)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#9)(2009-10#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#4)(2013-1#1)(2013-8#7)
system offered improved##2##3##(2008-10#2)
system offered##4##2##(2008-10#4)
system offers a##2##3##(1995-3#1)(2008-10#1)
system offers the##4##3##(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
system offers##8##2##(1995-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
system on a##2##3##(2008-10#2)
system on the##7##3##(1996-2#2)(2008-10#3)(2010-6#2)
system on##15##2##(1991-9#1)(1992-1#1)(1994-8#1)(1995-11#1)(1996-2#2)(1996-5#1)(2008-10#5)(2010-6#2)(2013-1#1)
system or the##2##3##(1993-12#1)(2008-9#1)
system or##8##2##(1990-12#1)(1993-12#1)(2008-10#2)(2008-8#1)(2008-9#2)(2012-12#1)
system over the##3##3##(2008-10#3)
system over##5##2##(2008-10#4)(2008-11#1)
system parameters##4##2##(2008-3#3)(2008-7#1)
system performance##8##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2013-8#2)
system permits##3##2##(2008-11#1)(2008-2#2)
system permitted##2##2##(2008-10#1)(2008-11#1)
system plays a##2##3##(2008-5#1)(2009-7#1)
system plays##5##2##(1993-12#1)(2007-8#1)(2008-5#1)(2009-7#1)(2010-3#1)
system presented an analytical##2##4##(2008-10#2)
system presented##5##2##(2008-10#4)(2008-11#1)
system presents##2##2##(1997-2#1)(2012-3#1)
system produced##2##2##(2008-10#1)(2008-3#1)
system produces##3##2##(2008-10#2)(2008-3#1)
system proposed##2##2##(1990-8#1)(2010-8#1)
system proved to be##3##4##(1995-11#1)(2008-10#2)
system provided a##2##3##(2008-10#1)(2008-9#1)
system provided excellent##2##3##(1995-12#1)(2008-3#1)
system provided##6##2##(1995-12#1)(2008-10#3)(2008-3#1)(2008-9#1)
system provides a##4##3##(1994-3#2)(2008-10#2)
system provides##8##2##(1994-3#2)(2008-10#4)(2008-11#1)(2008-9#1)
system reached##2##2##(1996-3#1)(1997-8#1)
system reduced##2##2##(2008-10#1)(2008-5#1)
system reform##10##2##(1993-12#4)(1993-3#2)(1995-12#1)(1995-2#1)(2009-3#1)(2012-12#1)
system remains##2##2##(1992-12#1)(2008-7#1)
system represents##3##2##(1996-9#1)(2008-10#1)(2008-11#1)
system required##2##2##(2008-10#1)(2008-11#1)
system requirements##2##2##(1991-1#1)(1996-3#1)
system requires only##2##3##(2008-11#1)(2010-6#1)
system requires##3##2##(2008-11#2)(2010-6#1)
system response##2##2##(2012-6#1)(2013-1#1)
system resulted in##2##3##(2008-10#1)(2008-7#1)
system results in##4##3##(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
system revealed##3##2##(1995-6#1)(2008-11#1)(2013-1#1)
system review##2##2##(2013-1#1)(2013-8#1)
system safety##2##2##(1990-11#2)
system should be useful for##2##5##(1992-1#1)(2008-11#1)
system should be##6##3##(1992-1#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#1)
system should not be##2##4##(2008-10#1)(2013-8#1)
system should##10##2##(1992-1#1)(1996-2#1)(2008-10#4)(2008-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
system showed good##4##3##(2008-10#4)
system showed that##5##3##(1993-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
system showed##9##2##(1993-11#1)(1997-2#1)(2008-10#5)(2008-11#1)(2011-2#1)
system shows##2##2##(2008-10#1)(2010-8#1)
system since##2##2##(1994-1#1)(2008-10#1)
system size##2##2##(2012-2#1)(2013-8#1)
system so that##2##3##(2008-10#1)(2008-3#1)
system states##2##2##(2008-11#1)(2009-10#1)
system such as##2##3##(1995-2#1)(2008-10#1)
system suggests that##2##3##(1996-12#1)(2009-10#1)
system suitability##2##2##(2008-10#1)(2012-2#1)
system technology##2##2##(2008-10#1)(2008-11#1)
system than##3##2##(1997-3#1)(2008-10#2)
system that allows us to##2##5##(2010-5#2)
system that can##5##3##(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)
system that combines the##2##4##(1993-3#1)(2008-12#1)
system that combines##3##3##(1993-3#1)(2008-10#1)(2008-12#1)
system that does not##3##4##(1996-2#1)(2008-10#1)(2008-9#1)
system that has been##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
system that includes##2##3##(1993-6#1)(2008-1#1)
system that is able to##2##5##(1995-11#1)(2008-5#1)
system that is##6##3##(1995-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
system that regulates##2##3##(1995-8#1)(2009-6#1)
system that uses a##2##4##(2008-3#2)
system that was developed##3##4##(1994-3#1)(1995-2#1)(2008-10#1)
system that we##2##3##(2008-11#1)(2008-5#1)
system that##62##2##(1990-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
system through a##3##3##(1993-8#2)(2008-10#1)
system through the##3##3##(1997-7#1)(2008-9#2)
system through##6##2##(1993-8#2)(1997-7#1)(2008-10#1)(2008-9#2)
system thus##2##2##(2008-10#1)(2008-11#1)
system to a##3##3##(1995-11#1)(1996-1#1)(2008-10#1)
system to analyze##2##3##(2008-10#1)(2011-2#1)
system to avoid##2##3##(2008-10#2)
system to be##2##3##(2009-8#1)(2010-11#1)
system to characterize the##2##4##(1997-3#1)(2008-10#1)
system to control##2##3##(2008-11#1)(2011-2#1)
system to determine##2##3##(2008-10#2)
system to evaluate the##2##4##(2008-10#1)(2013-8#1)
system to evaluate##3##3##(1996-3#1)(2008-10#1)(2013-8#1)
system to express##3##3##(1992-10#1)(2008-10#1)(2008-11#1)
system to generate##2##3##(2008-9#1)(2012-3#1)
system to identify##2##3##(2008-11#1)(2008-9#1)
system to increase##2##3##(1997-8#1)(2008-10#1)
system to investigate##3##3##(1994-6#1)(2008-11#1)(2008-9#1)
system to measure##3##3##(2008-10#1)(2008-3#2)
system to meet##2##3##(1992-1#1)(1994-1#1)
system to study##6##3##(1995-9#1)(1996-3#1)(2008-10#2)(2008-11#2)
system to the##2##3##(2008-10#1)(2008-11#1)
system to##97##2##(1990-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#3)(1997-3#3)(1997-8#1)(2008-10#35)(2008-11#10)(2008-12#1)(2008-3#4)(2008-8#2)(2008-9#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
system under the##2##3##(2010-12#1)(2010-8#1)
system under##8##2##(1994-12#1)(2008-10#5)(2010-12#1)(2010-8#1)
system used in##3##3##(1996-12#1)(2008-10#1)(2010-6#1)
system used##8##2##(1990-11#1)(1993-3#1)(1996-12#1)(2008-10#2)(2010-6#1)(2011-2#2)
system uses a##2##3##(1994-12#1)(2008-10#1)
system uses##4##2##(1994-12#1)(2008-10#2)(2008-3#1)
system using a##12##3##(2008-10#12)
system using an##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
system using the##3##3##(2008-10#2)(2008-5#1)
system using##48##2##(1990-11#1)(1994-11#1)(1996-12#1)(2008-10#35)(2008-11#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
system utilizing##2##2##(2008-10#1)(2008-7#1)
system was able to##2##4##(2008-10#2)
system was also##5##3##(2008-10#5)
system was applied for the determination of##2##7##(2008-10#2)
system was applied to the determination of##4##7##(2008-10#4)
system was applied to the##8##5##(2008-10#8)
system was applied to##12##4##(2008-10#11)(2011-3#1)
system was applied##14##3##(2008-10#13)(2011-3#1)
system was ascertained by analyzing a set of##3##8##(2008-10#3)
system was assembled with a##2##5##(2008-10#2)
system was assembled##4##3##(2008-10#4)
system was calibrated in the range##2##6##(2008-10#2)
system was calibrated##4##3##(2008-10#4)
system was carried out by##2##5##(2008-10#2)
system was carried out##3##4##(2008-10#3)
system was constructed by using##2##5##(2008-11#1)(2011-3#1)
system was constructed##6##3##(2008-10#3)(2008-11#2)(2011-3#1)
system was controlled##2##3##(2008-10#2)
system was demonstrated##5##3##(2008-10#5)
system was designed and##2##4##(2008-11#1)(2008-8#1)
system was designed##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
system was detected##2##3##(1995-8#1)(2008-10#1)
system was developed for the determination of##3##7##(2008-10#3)
system was developed for the##5##5##(2008-10#5)
system was developed for##8##4##(2008-10#8)
system was developed to##3##4##(2008-10#2)(2008-11#1)
system was developed using##3##4##(2008-10#3)
system was developed##21##3##(1993-8#1)(1997-3#1)(2008-10#16)(2008-11#1)(2008-7#2)
system was employed to##3##4##(2008-10#3)
system was employed##4##3##(2008-10#4)
system was established##3##3##(1991-12#1)(2008-8#2)
system was evaluated by##2##4##(1993-1#1)(2008-10#1)
system was evaluated for the##2##5##(2008-10#2)
system was evaluated for##3##4##(2008-10#3)
system was evaluated##5##3##(1993-1#1)(2008-10#4)
system was found to##5##4##(2008-10#4)(2008-5#1)
system was found##6##3##(2008-10#5)(2008-5#1)
system was higher than##2##4##(2008-11#1)(2008-9#1)
system was implemented to##2##4##(1997-1#1)(2008-10#1)
system was implemented##3##3##(1997-1#1)(2008-10#1)(2010-2#1)
system was investigated by##2##4##(2008-10#1)(2008-11#1)
system was investigated in##2##4##(2008-10#1)(2011-2#1)
system was investigated##8##3##(2008-10#6)(2008-11#1)(2011-2#1)
system was linear##2##3##(2008-10#2)
system was more##2##3##(1993-12#1)(2008-10#1)
system was not##2##3##(1997-8#1)(2008-10#1)
system was obtained##2##3##(2008-10#2)
system was optimised##2##3##(2008-10#2)
system was optimized and##3##4##(2008-10#3)
system was optimized##5##3##(2008-10#4)(2008-11#1)
system was reported##2##3##(2008-12#1)(2008-2#1)
system was successfully applied to##3##5##(2008-10#3)
system was successfully applied##4##4##(2008-10#4)
system was successfully##5##3##(2008-10#5)
system was tested by##2##4##(2008-10#1)(2013-8#1)
system was tested##4##3##(2008-10#3)(2013-8#1)
system was the##2##3##(2008-10#2)
system was used as##2##4##(2008-10#2)
system was used for the##3##5##(2008-10#3)
system was used for##6##4##(2008-10#5)(2010-12#1)
system was used to determine the##2##6##(1993-8#1)(2008-10#1)
system was used to##9##4##(1993-8#2)(1994-5#1)(2008-10#5)(2008-12#1)
system was used##19##3##(1993-8#2)(1994-5#1)(2008-10#13)(2008-12#1)(2009-11#1)(2010-12#1)
system was##219##2##(1990-11#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#3)(1993-9#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-1#2)(1997-3#1)(1997-8#1)(2008-10#160)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#5)
system we have##2##3##(2008-11#2)
system we##5##2##(1996-2#1)(1997-8#1)(2008-11#2)(2011-1#1)
system were also evaluated##2##4##(2008-10#2)
system were also##4##3##(1991-2#1)(2008-10#3)
system were compared##2##3##(2008-10#2)
system were discussed##2##3##(2008-10#1)(2008-6#1)
system were evaluated##4##3##(2008-10#4)
system were examined##3##3##(1992-3#1)(1993-12#1)(1997-3#1)
system were found to be##2##5##(2008-10#2)
system were investigated##3##3##(2008-10#3)
system were optimized and##2##4##(2008-10#2)
system were optimized##6##3##(2008-10#5)(2013-8#1)
system were studied##2##3##(2008-10#2)
system were the##2##3##(2008-10#1)(2008-7#1)
system were##47##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1997-3#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2013-8#1)
system when##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
system where##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)
system which is##6##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
system which uses##3##3##(1996-12#1)(2008-10#1)(2010-8#1)
system which##17##2##(1994-6#1)(1995-3#1)(1996-12#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-8#1)
system while##3##2##(1996-2#1)(2008-10#1)(2012-2#1)
system will allow##2##3##(2012-12#1)(2013-8#1)
system will be##6##3##(1996-3#1)(2008-10#1)(2008-11#4)
system will##12##2##(1992-12#1)(1996-3#1)(2008-10#1)(2008-11#5)(2008-8#1)(2012-12#1)(2013-7#1)(2013-8#1)
system with a carbon##2##4##(2008-10#2)
system with a##22##3##(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#2)(2009-6#1)
system with an##3##3##(2008-10#2)(2011-3#1)
system with bead injection##3##4##(2008-10#3)
system with hydride##2##3##(2008-10#2)
system with microwave irradiation##2##4##(2008-10#2)
system with microwave-assisted sample digestion##3##5##(2008-10#3)
system with on-line##2##3##(2008-10#2)
system with spectrophotometric detection##2##4##(2008-10#2)
system with spectrophotometric##3##3##(2008-10#3)
system with the##9##3##(1996-12#1)(2008-10#4)(2009-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
system with two##2##3##(2008-10#1)(2012-2#1)
system with##114##2##(1990-11#1)(1990-2#1)(1992-12#1)(1993-12#1)(1994-1#1)(1996-12#1)(2008-10#79)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#3)
system within##3##2##(2008-10#3)
system without##8##2##(2008-10#7)(2008-3#1)
system would be##2##3##(1990-3#1)(2008-10#1)
system##4137##1##(1990-10#2)(1990-11#10)(1990-12#6)(1990-2#7)(1990-3#1)(1990-5#22)(1990-6#1)(1990-8#7)(1990-9#4)(1991-1#11)(1991-10#2)(1991-11#1)(1991-12#13)(1991-2#19)(1991-3#13)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#7)(1992-1#16)(1992-10#5)(1992-11#4)(1992-12#37)(1992-2#14)(1992-3#25)(1992-5#1)(1992-6#6)(1992-8#6)(1992-9#2)(1993-1#9)(1993-11#3)(1993-12#31)(1993-2#11)(1993-3#33)(1993-5#2)(1993-6#9)(1993-8#14)(1993-9#10)(1994-1#14)(1994-11#10)(1994-12#15)(1994-2#19)(1994-3#12)(1994-5#5)(1994-6#7)(1994-8#7)(1994-9#4)(1995-1#5)(1995-11#18)(1995-12#30)(1995-2#31)(1995-3#23)(1995-5#14)(1995-6#2)(1995-8#9)(1995-9#1)(1996-1#17)(1996-11#6)(1996-12#35)(1996-2#34)(1996-3#24)(1996-5#7)(1996-6#4)(1996-8#1)(1996-9#3)(1997-1#15)(1997-2#20)(1997-3#29)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#14)(1997-8#11)(1997-9#1)(2007-11#2)(2007-12#27)(2007-8#7)(2007-9#2)(2008-1#10)(2008-10#1711)(2008-11#279)(2008-12#48)(2008-2#26)(2008-3#143)(2008-4#32)(2008-5#64)(2008-6#13)(2008-7#99)(2008-8#89)(2008-9#116)(2009-1#3)(2009-10#10)(2009-11#8)(2009-12#15)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#18)(2009-7#7)(2009-8#32)(2009-9#10)(2010-1#10)(2010-10#9)(2010-11#9)(2010-12#20)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#9)(2010-6#13)(2010-7#18)(2010-8#36)(2010-9#3)(2011-1#14)(2011-2#107)(2011-3#11)(2011-7#2)(2012-12#17)(2012-2#35)(2012-3#55)(2012-4#1)(2012-5#2)(2012-6#1)(2013-1#67)(2013-2#2)(2013-7#6)(2013-8#66)
system'##2##1##(2008-11#1)(2008-12#1)
system's##15##1##(1991-1#1)(1991-12#1)(1994-1#2)(1995-2#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#2)(2013-8#1)
system) and##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
system)##19##1##(1990-12#1)(1993-2#1)(1996-12#2)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-6#1)
system?##8##1##(1991-2#1)(1991-3#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(2012-3#1)
system]##7##1##(1990-3#1)(1993-9#1)(1997-3#1)(2008-10#1)(2011-3#1)(2012-3#2)
systematic analysis of##2##3##(1993-3#1)(2008-4#1)
systematic analysis##3##2##(1993-3#1)(2008-3#1)(2008-4#1)
systematic and random##2##3##(2008-3#1)(2011-2#1)
systematic and##6##2##(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
systematic approach to item reduction based on results of##2##9##(2012-2#2)
systematic approach to##6##3##(1995-12#1)(2006-5#1)(2008-11#1)(2012-2#2)(2013-1#1)
systematic approach##10##2##(1995-12#1)(1996-2#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#2)(2013-1#1)
systematic bias##3##2##(2008-11#1)(2009-1#1)(2013-1#1)
systematic collection##2##2##(2011-3#1)(2013-1#1)
systematic comparison of##2##3##(2008-10#1)(2008-9#1)
systematic diagnostic##2##2##(2008-3#2)
systematic differences##2##2##(1994-2#1)(2008-11#1)
systematic effect##2##2##(2008-10#1)(2010-8#1)
systematic error##6##2##(2008-10#5)(2008-3#1)
systematic errors in##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
systematic errors##8##2##(2007-12#1)(2008-10#3)(2008-3#3)(2008-6#1)
systematic evaluation of##4##3##(2008-10#1)(2011-1#1)(2013-1#2)
systematic investigation of##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
systematic literature review##4##3##(2008-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
systematic literature##5##2##(2008-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
systematic monitoring and feedback of##2##5##(2012-2#2)
systematic review and##3##3##(2010-10#1)(2013-8#2)
systematic review of the##4##4##(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
systematic review of##10##3##(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
systematic review was##5##3##(2011-2#1)(2012-12#4)
systematic review##39##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-3#1)(2010-10#1)(2011-2#8)(2011-7#1)(2012-12#10)(2012-3#1)(2013-1#8)(2013-8#4)
systematic reviews of the##2##4##(1993-12#1)(2012-2#1)
systematic reviews of##4##3##(1993-12#2)(2011-2#1)(2012-2#1)
systematic reviews##9##2##(1993-12#2)(2011-2#3)(2012-2#1)(2013-1#3)
systematic sample##2##2##(1991-8#1)(2009-10#1)
systematic search of##2##3##(2012-12#1)(2012-2#1)
systematic search##3##2##(2012-12#2)(2012-2#1)
systematic studies##2##2##(2010-10#1)(2011-2#1)
systematic study of the##4##4##(2008-10#3)(2008-2#1)
systematic study of##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2010-6#1)
systematic study##9##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-6#1)
systematic variation##2##2##(1993-1#1)(2008-10#1)
systematic way of##2##3##(1994-12#1)(2008-11#1)
systematic way##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
systematic##205##1##(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-9#1)(2006-5#1)(2007-12#1)(2008-10#25)(2008-11#13)(2008-12#3)(2008-2#1)(2008-3#16)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#3)(2009-10#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#4)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#15)(2011-3#1)(2011-7#1)(2012-12#13)(2012-2#10)(2012-3#1)(2013-1#25)(2013-8#8)
systematically and##2##2##(2008-11#2)
systematically collected in##2##3##(2008-10#2)
systematically examined##3##2##(2008-10#2)(2013-8#1)
systematically from##2##2##(2008-10#2)
systematically investigated##8##2##(2008-10#7)(2010-11#1)
systematically studied and##2##3##(1991-12#1)(2008-10#1)
systematically studied with##2##3##(2008-10#1)(2012-12#1)
systematically studied##6##2##(1991-12#1)(2008-10#4)(2012-12#1)
systematically the##2##2##(2008-11#1)(2008-3#1)
systematically##66##1##(1991-11#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#24)(2008-11#6)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#3)
systematics and##2##2##(2008-8#1)(2011-2#1)
systematics of##2##2##(2008-8#1)(2010-4#1)
systematics##6##1##(2008-10#1)(2008-8#2)(2010-1#1)(2010-4#1)(2011-2#1)
systematization##2##1##(2012-3#2)
systemic (0##2##2##(1993-6#2)
systemic acquired resistance (SAR)##5##4##(2008-10#4)(2011-10#1)
systemic acquired resistance in##2##4##(2008-10#2)
systemic acquired resistance##12##3##(2008-10#10)(2011-10#1)(2011-2#1)
systemic acquired resistance-inducing##2##3##(2008-10#2)
systemic acquired##14##2##(2008-10#12)(2011-10#1)(2011-2#1)
systemic administration of##2##3##(1992-3#1)(2011-2#1)
systemic adverse##2##2##(2008-1#1)(2013-1#1)
systemic amyloidosis##3##2##(2011-2#3)
systemic analysis of the##2##4##(2009-10#2)
systemic analysis##3##2##(2009-10#3)
systemic and oropharyngeal##2##3##(2008-8#2)
systemic and##7##2##(1992-9#1)(1994-12#1)(1996-12#1)(2008-8#2)(2009-6#1)(2013-1#1)
systemic approaches to##2##3##(2010-12#2)
systemic arterial##3##2##(1996-3#1)(2008-11#1)(2012-3#1)
systemic autoimmune disease##3##3##(2008-10#2)(2008-5#1)
systemic autoimmune##5##2##(2008-10#3)(2008-5#1)(2012-3#1)
systemic candidiasis##2##2##(1997-1#1)(2008-5#1)
systemic chemotherapy##7##2##(1992-12#1)(1992-2#1)(1994-12#2)(1997-3#1)(2008-7#1)(2011-3#1)
systemic circulation and##2##3##(1994-8#1)(2010-6#1)
systemic circulation##3##2##(1994-8#1)(2008-10#1)(2010-6#1)
systemic complications##2##2##(2011-2#1)(2013-1#1)
systemic corticosteroids##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
systemic disease control##2##3##(2008-10#2)
systemic disease##14##2##(1995-1#1)(1995-10#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-8#2)
systemic diseases##3##2##(1997-1#1)(2008-10#1)(2013-1#1)
systemic disorder##2##2##(2011-2#1)(2012-12#1)
systemic dissemination following##2##3##(2008-9#2)
systemic dissemination##3##2##(2008-5#1)(2008-9#2)
systemic drugs##2##2##(1997-1#1)(2011-2#1)
systemic effect##2##2##(1994-9#1)(2008-10#1)
systemic effects##7##2##(1997-1#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)
systemic embolization##4##2##(2009-10#1)(2012-3#3)
systemic exposure##3##2##(1992-3#1)(2010-11#2)
systemic fungal##2##2##(1997-1#1)(1997-2#1)
systemic glucose concentration##3##3##(1994-2#3)
systemic hosts##3##2##(2008-10#3)
systemic hypertension##2##2##(2011-2#2)
systemic hypotension##2##2##(2008-12#1)(2009-5#1)
systemic immunosuppressive response##2##3##(2011-2#2)
systemic infection of##3##3##(2008-10#3)
systemic infection##15##2##(1995-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2009-11#1)(2013-1#2)(2013-8#1)
systemic infections in##3##3##(2008-10#3)
systemic infections##10##2##(1995-5#1)(2008-10#7)(2008-11#1)(2008-7#1)
systemic inflammation##3##2##(2011-2#1)(2013-1#2)
systemic inflammatory response syndrome##5##4##(2008-5#1)(2008-7#2)(2010-5#2)
systemic inflammatory response##9##3##(2008-10#2)(2008-5#1)(2008-7#2)(2010-5#2)(2012-3#2)
systemic inflammatory##15##2##(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#4)
systemic level work was##2##4##(2008-12#2)
systemic level work##7##3##(2008-12#7)
systemic level##8##2##(1996-12#1)(2008-12#7)
systemic lupus erythematosus (SLE) patients##2##5##(2008-10#1)(2013-1#1)
systemic lupus erythematosus (SLE)##8##4##(1990-12#1)(2008-1#1)(2008-10#2)(2011-2#2)(2012-12#1)(2013-1#1)
systemic lupus erythematosus in remission##2##5##(1992-5#2)
systemic lupus erythematosus with##2##4##(1997-8#1)(2012-2#1)
systemic lupus erythematosus##21##3##(1990-12#1)(1990-9#1)(1992-5#2)(1995-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
systemic lupus##23##2##(1990-12#1)(1990-9#1)(1992-5#2)(1995-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)
systemic manifestations##2##2##(2011-2#1)(2012-3#1)
systemic mastocytosis and##2##3##(1991-11#1)(2010-1#1)
systemic mastocytosis##4##2##(1991-11#2)(2010-1#1)(2011-2#1)
systemic movement of##2##3##(2008-10#2)
systemic movement##4##2##(2008-10#4)
systemic or##4##2##(1990-9#1)(1994-2#1)(2008-10#1)(2008-7#1)
systemic peripheral gangrene##2##3##(2013-1#2)
systemic pneumococcal disease##3##3##(1994-9#3)
systemic protection against##2##3##(2008-10#2)
systemic protection##7##2##(2008-10#7)
systemic resistance against##3##3##(2008-10#3)
systemic resistance and##3##3##(2008-10#2)(2013-8#1)
systemic resistance in apple fruit##2##5##(2008-10#2)
systemic resistance in plants##4##4##(2008-10#4)
systemic resistance in##14##3##(2008-10#14)
systemic resistance to##5##3##(2008-10#4)(2013-8#1)
systemic resistance##44##2##(2008-10#41)(2009-8#1)(2013-8#2)
systemic responses to##2##3##(1994-2#1)(2008-10#1)
systemic responses##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
systemic sclerosis (SSc)##2##3##(2010-10#1)(2011-2#1)
systemic sclerosis##8##2##(1991-3#1)(1992-8#1)(2008-12#1)(2009-9#1)(2010-10#2)(2011-2#1)(2012-3#1)
systemic side effects##3##3##(1992-3#1)(1995-5#1)(1997-1#1)
systemic spread of##2##3##(2008-10#2)
systemic spread##4##2##(2008-10#4)
systemic steroid therapy##2##3##(2011-2#2)
systemic symptoms##4##2##(1991-4#1)(2008-10#3)
systemic therapy##10##2##(1990-6#1)(1991-8#2)(1996-11#1)(1997-8#1)(2007-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
systemic toxicity##3##2##(1997-1#1)(2008-10#1)(2013-1#1)
systemic treatment##5##2##(1993-1#1)(1997-5#1)(1997-8#1)(2008-5#1)(2013-1#1)
systemic vascular resistance##2##3##(2008-7#1)(2009-5#1)
systemic vasculitis##4##2##(1995-5#1)(1996-8#1)(2012-3#2)
systemic virus##2##2##(2008-10#2)
systemic##422##1##(1990-11#1)(1990-12#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-12#6)(1994-2#6)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#1)(1995-5#4)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#8)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#6)(2007-11#1)(2008-1#2)(2008-10#125)(2008-11#12)(2008-12#13)(2008-4#1)(2008-5#8)(2008-7#15)(2008-8#5)(2008-9#8)(2009-10#5)(2009-11#1)(2009-5#2)(2009-6#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#4)(2011-10#1)(2011-2#34)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#25)(2013-1#29)(2013-8#8)
systemically infect##2##2##(2008-10#2)
systemically infected leaves##2##3##(2008-10#2)
systemically infected wheat##2##3##(2008-10#2)
systemically infected##10##2##(1995-2#1)(2008-10#9)
systemically##32##1##(1992-9#1)(1995-2#1)(2007-11#1)(2008-10#23)(2008-5#1)(2008-8#1)(2010-12#2)(2012-2#1)(2013-8#1)
systems affected##2##2##(2011-2#1)(2013-1#1)
systems allow##4##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
systems allows##2##2##(2007-12#1)(2009-12#1)
systems and improving##2##3##(2009-7#1)(2010-8#1)
systems and in##2##3##(2008-2#1)(2008-7#1)
systems and measurement##2##3##(1992-3#1)(2008-10#1)
systems and the##8##3##(1991-3#1)(1996-3#1)(1997-3#2)(2008-10#2)(2010-2#1)(2011-2#1)
systems and will##2##3##(2008-10#2)
systems and##76##2##(1991-3#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#3)(2007-12#1)(2008-10#17)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#4)(2009-10#2)(2009-11#1)(2009-7#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#3)(2011-7#1)(2011-9#1)(2012-2#2)(2013-8#3)
systems approach to##3##3##(1992-2#1)(1994-2#1)(1995-12#1)
systems approach##7##2##(1992-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2010-5#1)
systems are also##4##3##(2008-5#1)(2010-5#1)(2010-8#1)(2012-3#1)
systems are compared##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
systems are discussed##4##3##(1991-3#1)(2008-10#2)(2008-5#1)
systems are presented##3##3##(2008-10#2)(2009-9#1)
systems are the##2##3##(2008-10#1)(2008-7#1)
systems are used##2##3##(1995-2#1)(2008-9#1)
systems are usually##2##3##(2008-10#1)(2010-7#1)
systems are##50##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-2#2)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#1)(2012-3#1)(2013-1#1)
systems as well as##4##4##(2008-10#1)(2008-12#1)(2008-9#1)(2010-4#1)
systems as##10##2##(1993-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-9#1)
systems at##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-4#1)
systems based on##9##3##(1994-12#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)
systems based##10##2##(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)
systems biology##11##2##(2008-11#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
systems but##3##2##(1997-1#2)(2008-11#1)
systems by##7##2##(1991-2#1)(2008-10#3)(2008-11#1)(2010-8#1)(2013-8#1)
systems can be##5##3##(2007-11#1)(2008-10#2)(2009-12#1)(2011-1#1)
systems can have##2##3##(1995-5#1)(2008-3#1)
systems can##11##2##(1994-3#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-1#1)
systems cannot be##2##3##(1995-5#1)(2008-10#1)
systems cannot##3##2##(1995-5#1)(2008-1#1)(2008-10#1)
systems could be##3##3##(2008-10#2)(2008-7#1)
systems could##5##2##(1996-1#1)(2008-10#2)(2008-7#1)(2008-8#1)
systems derived from##2##3##(2008-1#1)(2008-11#1)
systems developed to date have##2##5##(1995-2#1)(2008-12#1)
systems developed##3##2##(1992-3#1)(1995-2#1)(2008-12#1)
systems development##3##2##(1993-2#2)(1995-12#1)
systems did##2##2##(2008-11#1)(2008-8#1)
systems do##2##2##(1993-11#1)(1995-2#1)
systems during the##2##3##(1996-12#1)(2008-7#1)
systems during##3##2##(1992-3#1)(1996-12#1)(2008-7#1)
systems employed##2##2##(1991-3#1)(2008-6#1)
systems employing##2##2##(1995-3#1)(2008-10#1)
systems environment##2##2##(1993-2#1)(1996-3#1)
systems established##2##2##(2008-10#1)(2008-11#1)
systems exhibit##2##2##(2008-10#1)(2008-9#1)
systems exploiting##2##2##(2008-10#2)
systems for clinical##2##3##(1992-3#1)(2008-5#1)
systems for long-term##2##3##(1997-1#1)(2012-2#1)
systems for medical##2##3##(1992-5#1)(2010-6#1)
systems for nursing##2##3##(1991-2#2)
systems for public health##2##4##(1997-3#1)(2010-8#1)
systems for the##12##3##(1990-5#1)(1993-12#1)(1994-1#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)
systems for##75##2##(1990-5#2)(1991-2#2)(1991-5#1)(1992-3#3)(1992-5#1)(1993-12#3)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#3)(1997-3#3)(2008-10#18)(2008-11#8)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#1)(2013-1#1)(2013-8#2)
systems from##4##2##(1996-3#1)(2008-9#1)(2009-5#1)(2009-6#1)
systems generally##2##2##(2008-10#1)(2012-2#1)
systems give##2##2##(1994-5#1)(2008-11#1)
systems has been##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
systems has##7##2##(1991-3#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)
systems have been developed for##2##5##(2008-10#2)
systems have been developed##5##4##(1992-3#1)(2008-10#2)(2010-7#1)(2013-8#1)
systems have been implicated##2##4##(1993-3#1)(2009-7#1)
systems have been##17##3##(1990-3#1)(1992-3#1)(1993-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-7#1)(2013-8#1)
systems have evolved##2##3##(2008-8#1)(2010-9#1)
systems have##30##2##(1990-3#1)(1992-3#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-7#2)(2010-8#2)(2010-9#1)(2012-2#1)(2013-8#1)
systems in a##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
systems in an##2##3##(1996-3#1)(2010-8#1)
systems in order to##2##4##(2008-1#1)(2008-8#1)
systems in the##10##3##(1991-8#1)(1993-2#2)(1994-1#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2010-11#1)(2012-2#1)
systems in which##3##3##(1994-5#1)(2008-10#2)
systems in##57##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-8#1)(1993-2#3)(1994-1#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#4)(2013-8#3)
systems include##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
systems including the##2##3##(2008-10#1)(2010-4#1)
systems including their##2##3##(2008-10#1)(2013-8#1)
systems including##6##2##(2008-10#2)(2008-3#1)(2010-4#1)(2012-3#1)(2013-8#1)
systems into##5##2##(1991-5#1)(1996-3#1)(1997-3#3)
systems involving##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
systems is also##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
systems is discussed##2##3##(1995-12#1)(2008-4#1)
systems is of##2##3##(2008-10#1)(2008-11#1)
systems is the##2##3##(2008-11#1)(2008-9#1)
systems is##31##2##(1990-8#1)(1993-3#1)(1995-12#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-8#1)(2011-7#1)(2012-2#1)(2013-8#3)
systems like##4##2##(2008-10#3)(2008-11#1)
systems may be##2##3##(1993-1#1)(2008-11#1)
systems may##5##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-11#2)
systems mediate##2##2##(1990-8#1)(2009-7#1)
systems medicine##3##2##(2013-8#3)
systems more##3##2##(1993-2#1)(2008-11#1)(2008-3#1)
systems must be##2##3##(1997-3#1)(2007-11#1)
systems need to##2##3##(1997-1#1)(1997-3#1)
systems of care##7##3##(1992-4#2)(1994-2#1)(1997-3#1)(2010-12#3)
systems of interest##2##3##(2009-12#1)(2011-1#1)
systems of many##2##3##(2007-12#1)(2011-2#1)
systems of public health##2##4##(1996-1#1)(1997-3#1)
systems of social##2##3##(1996-1#1)(2008-11#1)
systems of the##5##3##(1993-2#1)(1993-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
systems of tumor-immune##2##3##(2013-8#2)
systems of##46##2##(1992-4#2)(1993-2#1)(1993-3#1)(1994-2#1)(1996-1#3)(1997-3#2)(2007-12#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-9#1)(2009-12#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#3)
systems often##4##2##(2007-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
systems on the##3##3##(2008-10#2)(2012-3#1)
systems on##5##2##(1993-12#1)(2008-10#2)(2012-3#1)(2013-1#1)
systems rather than##2##3##(2008-10#1)(2009-12#1)
systems rely on the##2##4##(2008-10#1)(2013-8#1)
systems rely on##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
systems require##2##2##(2008-9#1)(2009-11#1)
systems resulted in a##2##4##(2008-10#1)(2008-12#1)
systems should be##4##3##(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)
systems should##7##2##(1993-3#1)(1996-1#1)(1997-1#1)(1997-3#2)(1997-6#1)(2013-8#1)
systems shows that##2##3##(1997-8#1)(2008-7#1)
systems such as the##3##4##(2007-12#1)(2008-10#1)(2010-11#1)
systems such as##8##3##(1992-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-11#1)
systems such##9##2##(1992-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-8#1)(2010-11#1)
systems supporting##2##2##(1995-1#1)(2008-11#1)
systems than in##2##3##(2008-10#2)
systems that are##9##3##(1992-3#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-9#1)(2013-8#2)
systems that rely on##2##4##(1995-12#1)(2008-10#1)
systems that##34##2##(1992-3#1)(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-12#3)(1996-12#2)(1996-3#2)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-7#1)(2013-8#2)
systems the##4##2##(2008-10#1)(2008-3#1)(2009-9#1)(2010-10#1)
systems theory##3##2##(1993-12#2)(2009-8#1)
systems through##3##2##(1996-1#1)(2008-10#2)
systems to monitor##2##3##(1997-2#1)(2008-9#1)
systems to provide a##2##4##(1993-12#1)(2008-10#1)
systems to provide##3##3##(1993-12#1)(2008-10#2)
systems to study##2##3##(2008-10#2)
systems to the##2##3##(1992-3#1)(1996-2#1)
systems to##31##2##(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#2)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-9#1)(2012-2#2)(2013-1#1)
systems under##7##2##(1991-1#1)(1992-3#1)(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#1)
systems using the##2##3##(1996-2#1)(2008-10#1)
systems using##11##2##(1993-9#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#1)
systems was investigated##2##3##(2008-10#1)(2008-11#1)
systems was##9##2##(2008-10#6)(2008-11#1)(2008-2#1)(2013-1#1)
systems were assessed##2##3##(2008-5#1)(2008-8#1)
systems were created##2##3##(1997-3#1)(2008-11#1)
systems were established##2##3##(1994-9#1)(2008-8#1)
systems were investigated##2##3##(2008-10#1)(2008-7#1)
systems were studied##3##3##(2008-10#3)
systems were tested##3##3##(2008-10#2)(2008-9#1)
systems were useful##2##3##(2011-2#2)
systems were##39##2##(1994-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-2#6)(2012-2#1)(2013-1#1)
systems where##5##2##(1990-11#1)(2008-3#1)(2008-9#2)(2013-1#1)
systems while##3##2##(1994-8#1)(1996-2#1)(2013-1#1)
systems will be##2##3##(1993-12#1)(1995-12#1)
systems will##7##2##(1993-12#1)(1995-12#1)(1997-3#3)(2008-10#1)(2008-11#1)
systems with a##3##3##(2008-10#3)
systems with an##2##3##(1995-5#1)(2008-3#1)
systems with different##2##3##(2008-10#1)(2008-9#1)
systems with##26##2##(1992-3#1)(1995-2#1)(1995-5#1)(1997-6#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#1)
systems within##3##2##(1990-8#1)(1994-2#1)(2011-2#1)
systems without##2##2##(2008-10#1)(2008-2#1)
systems would##2##2##(2008-10#1)(2008-11#1)
systems##1479##1##(1990-11#6)(1990-12#2)(1990-3#3)(1990-5#7)(1990-6#1)(1990-8#4)(1991-1#5)(1991-12#1)(1991-2#7)(1991-3#6)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#18)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#5)(1993-11#1)(1993-12#18)(1993-2#18)(1993-3#10)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#8)(1994-12#4)(1994-2#8)(1994-3#8)(1994-5#4)(1994-8#3)(1994-9#2)(1995-1#10)(1995-11#2)(1995-12#14)(1995-2#12)(1995-3#2)(1995-5#7)(1995-8#1)(1996-1#16)(1996-12#14)(1996-2#18)(1996-3#15)(1996-5#1)(1997-1#22)(1997-2#12)(1997-3#42)(1997-6#10)(1997-7#2)(1997-8#2)(2006-5#1)(2007-11#2)(2007-12#11)(2007-8#1)(2008-1#13)(2008-10#389)(2008-11#113)(2008-12#20)(2008-2#11)(2008-3#43)(2008-4#13)(2008-5#27)(2008-6#2)(2008-7#39)(2008-8#49)(2008-9#46)(2009-10#14)(2009-11#3)(2009-12#9)(2009-3#3)(2009-5#6)(2009-6#4)(2009-7#5)(2009-8#16)(2009-9#6)(2010-1#1)(2010-10#8)(2010-11#11)(2010-12#5)(2010-2#1)(2010-4#13)(2010-5#7)(2010-6#3)(2010-7#10)(2010-8#21)(2010-9#4)(2011-1#6)(2011-2#41)(2011-3#1)(2011-7#3)(2011-9#2)(2012-12#4)(2012-2#39)(2012-3#16)(2012-5#1)(2013-1#33)(2013-7#1)(2013-8#32)
systems&quot##2##1##(1994-1#1)(2013-8#1)
systems'##4##1##(1997-1#2)(2008-11#2)
systems)##6##1##(1992-2#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
systemwide##2##1##(1993-3#1)(1995-3#1)
systolic and diastolic BP##2##4##(2010-7#2)
systolic and diastolic blood pressure##5##5##(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)
systolic and diastolic blood##6##4##(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)
systolic and diastolic##13##3##(1991-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2010-7#3)
systolic and##15##2##(1991-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2010-4#1)(2010-7#3)
systolic blood pressure (SBP)##3##4##(1992-12#1)(2010-4#1)(2013-8#1)
systolic blood pressure##13##3##(1990-11#1)(1991-6#2)(1992-12#1)(2008-10#1)(2008-7#3)(2009-5#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
systolic blood##14##2##(1990-11#1)(1991-6#2)(1992-12#1)(2008-10#1)(2008-7#3)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
systolic dysfunction##4##2##(2010-11#1)(2010-5#1)(2013-1#2)
systolic function following##3##3##(2008-11#1)(2010-6#2)
systolic function##8##2##(2008-10#1)(2008-11#1)(2008-12#2)(2010-6#2)(2012-12#1)(2013-1#1)
systolic hypertension##3##2##(1991-12#1)(1993-1#1)(2011-1#1)
systolic##53##1##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#1)(1993-1#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-7#6)(2009-5#1)(2010-10#2)(2010-11#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
sévère et##2##2##(2013-1#2)
sévère##3##1##(2013-1#3)
t -test##2##2##(2008-11#2)
t gypsum ha(-1)##3##3##(2008-12#3)
t ha(-1)##2##2##(2008-12#2)
t test##7##2##(1990-12#1)(1995-1#1)(2008-9#1)(2009-7#1)(2010-10#2)(2012-2#1)
t tests##3##2##(1992-3#1)(2009-5#1)(2012-2#1)
t##39##1##(1990-12#1)(1992-3#4)(1993-2#1)(1995-1#1)(1995-12#1)(2008-10#8)(2008-11#5)(2008-12#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-8#3)(2012-2#2)(2013-1#1)
t(0)##3##1##(2008-10#3)
t(1)##5##1##(2008-10#4)(2012-2#1)
t(1/2) values##4##2##(2008-10#4)
t(1/2)##10##1##(2008-10#7)(2012-2#3)
t(11##2##1##(2009-8#1)(2011-3#1)
t(14##6##1##(2009-8#5)(2010-11#1)
t(15##2##1##(1991-9#2)
t(2##2##1##(1993-2#2)
t(2)##2##1##(2008-10#2)
t(8##2##1##(2010-1#2)
t(ip) and##2##2##(2008-10#2)
t(ip)##3##1##(2008-10#3)
t(max)##2##1##(2008-12#1)(2010-8#1)
t)##3##1##(1991-5#1)(1995-2#2)
t-BuOH and##2##2##(2008-11#1)(2008-9#1)
t-PA expression levels##2##3##(2008-7#2)
t-PA production##2##2##(2008-11#2)
t-PA was##2##2##(2008-11#2)
t-PA##15##1##(1994-3#2)(1995-8#1)(2008-11#10)(2008-7#2)
t-PA/PAI-1 complexes are##2##3##(1995-8#2)
t-PA/PAI-1 complexes##5##2##(1995-8#5)
t-PA/PAI-1##6##1##(1995-8#6)
t-butyl##2##1##(1996-2#1)(2008-10#1)
t-test and##4##2##(1990-12#1)(1991-2#1)(2008-10#1)(2008-11#1)
t-test at the 95% confidence level##2##6##(2008-10#2)
t-test at the 95%##3##4##(2008-10#3)
t-test shows##2##2##(2008-10#2)
t-test to##2##2##(2008-10#1)(2011-2#1)
t-test##37##1##(1990-12#1)(1990-2#1)(1991-2#1)(1994-2#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-9#1)(2011-2#2)(2013-1#2)(2013-8#1)
t-test)##5##1##(1997-8#1)(2008-10#3)(2008-5#1)
t-tests##6##1##(1992-2#1)(2008-10#1)(2009-2#1)(2010-6#2)(2011-2#1)
t/ha##3##1##(2008-10#3)
tBuBHQ caused O2- production##2##4##(1996-2#2)
tBuBHQ##6##1##(1996-2#6)
tDCS##6##1##(2010-7#1)(2012-2#5)
tMCAO##3##1##(2011-2#3)
tNOX activity##2##2##(2009-9#2)
tNOX expression##2##2##(2009-9#2)
tNOX##9##1##(2009-9#9)
tPA activity##2##2##(2008-8#2)
tPA in##3##2##(2008-11#1)(2008-8#1)(2010-3#1)
tPA production##2##2##(2008-11#1)(2008-8#1)
tPA##14##1##(2008-11#5)(2008-8#6)(2008-9#1)(2010-3#2)
tPMET##2##1##(2009-9#2)
tRAUDPC##2##1##(2008-10#2)
tRNA gene##5##2##(1996-6#1)(1997-7#3)(2008-9#1)
tRNA genes and##3##3##(2008-9#3)
tRNA genes is##2##3##(2008-9#2)
tRNA genes##13##2##(1995-8#1)(1996-6#1)(1997-7#2)(2008-9#8)(2012-3#1)
tRNA species##2##2##(1995-6#1)(1995-8#1)
tRNA##28##1##(1993-8#2)(1995-6#2)(1995-8#2)(1996-6#2)(1997-6#1)(1997-7#5)(2008-8#2)(2008-9#9)(2012-2#2)(2012-3#1)
tRNA(Gly)1##4##1##(1997-7#4)
tRNA(Leu)##3##1##(2008-8#3)
tRNA(TGASer)##3##1##(1991-6#3)
tRNA(fMet)##7##1##(1995-6#7)
tRNAs##6##1##(1991-6#1)(1995-8#1)(1997-7#1)(2008-4#1)(2012-2#1)(2012-3#1)
tSAH##4##1##(2008-7#4)
tabaci and##2##2##(2008-10#2)
tabaci biotype##2##2##(2008-10#2)
tabaci population##2##2##(2008-10#2)
tabaci##34##1##(2008-10#31)(2008-12#3)
tabacina DNA##2##2##(2008-10#2)
tabacina##29##1##(2008-10#29)
tabacum cv##6##2##(2008-10#4)(2008-9#2)
tabacum##15##1##(2008-10#13)(2008-9#2)
tabes dorsalis##2##2##(1991-11#2)
tabes##3##1##(1991-11#3)
tabira population##2##2##(2010-8#2)
tabira##6##1##(2010-8#6)
table analysis of##2##3##(1991-12#1)(2008-10#1)
table analysis##5##2##(1991-12#1)(1991-3#1)(1993-2#1)(2008-10#1)(2008-9#1)
table is##3##2##(1995-9#1)(2008-10#2)
table of##6##2##(2008-10#1)(2008-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
table salt samples##5##3##(2008-10#5)
table salt##11##2##(2008-10#11)
table salts##3##2##(2008-10#3)
table to##3##2##(1993-1#1)(2009-12#1)(2011-2#1)
table##58##1##(1991-12#2)(1991-3#1)(1993-1#1)(1993-2#1)(1995-2#1)(1995-3#2)(1995-9#2)(1996-1#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#24)(2008-12#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2011-2#7)(2013-1#2)(2013-8#1)
tables and##3##2##(1995-9#1)(2008-4#1)(2012-3#1)
tables of##3##2##(1993-2#1)(2008-11#1)(2008-12#1)
tables##22##1##(1993-2#1)(1994-6#1)(1995-1#1)(1995-9#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#3)(2012-3#1)
tablet and##2##2##(2008-10#1)(2008-7#1)
tablet containing##2##2##(2008-10#2)
tablet dosage##3##2##(2008-10#3)
tablet formulation##2##2##(2008-10#1)(2012-2#1)
tablet formulations##3##2##(2008-10#3)
tablet preparations##2##2##(2008-10#2)
tablet samples##3##2##(2008-10#3)
tablet##34##1##(2008-10#27)(2008-7#3)(2011-1#1)(2012-2#2)(2012-3#1)
tablet) were##2##2##(2008-10#2)
tablet)##5##1##(2008-10#5)
tabletop##3##1##(2008-3#2)(2011-7#1)
tablets and human serum##3##4##(2008-10#3)
tablets and##19##2##(2008-10#19)
tablets by##2##2##(2008-10#2)
tablets containing##2##2##(1991-3#1)(2008-10#1)
tablets for##2##2##(2008-10#1)(2010-1#1)
tablets is##2##2##(2008-10#2)
tablets of##3##2##(1990-2#1)(2008-10#1)(2012-2#1)
tablets was##3##2##(2008-10#3)
tablets were##7##2##(2008-10#5)(2012-2#2)
tablets with##5##2##(2008-10#5)
tablets##101##1##(1990-2#1)(1991-3#1)(2008-10#86)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2011-3#2)(2012-2#5)
tablets)##2##1##(2008-10#2)
taboo search##2##2##(2008-10#2)
taboo##4##1##(1993-6#1)(1996-6#1)(2008-10#2)
tabs##3##1##(1991-5#2)(2010-8#1)
tabulated and##2##2##(1994-1#1)(2008-10#1)
tabulated##8##1##(1991-3#1)(1994-1#1)(2008-10#3)(2008-11#1)(2008-8#2)
tac promoter##2##2##(1990-5#1)(1994-8#1)
tachyarrhythmias in##2##2##(2010-4#1)(2012-2#1)
tachyarrhythmias##4##1##(2010-4#3)(2012-2#1)
tachycardia and##4##2##(1993-2#1)(1996-3#1)(2008-12#1)(2013-1#1)
tachycardia was induced##2##3##(1990-3#2)
tachycardia was##3##2##(1990-3#2)(1993-2#1)
tachycardia##33##1##(1990-3#8)(1990-5#1)(1993-2#4)(1996-3#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#3)(2009-11#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#2)
tachykinin##7##1##(1991-5#2)(1997-4#2)(2008-8#3)
tachykinins##3##1##(1991-5#2)(1997-4#1)
tackle this##3##2##(1995-5#1)(2011-2#1)(2013-8#1)
tackle##10##1##(1991-11#1)(1994-3#1)(1995-5#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
tackling##3##1##(2008-11#2)(2009-6#1)
tacrolimus##4##1##(2008-10#4)
tactic##7##1##(1991-1#2)(2008-10#1)(2008-8#3)(2010-8#1)
tactical##2##1##(1997-1#1)(2008-3#1)
tactics for the##2##3##(1991-3#1)(1993-12#1)
tactics for##3##2##(1991-3#1)(1993-12#1)(2013-8#1)
tactics including##2##2##(2008-10#2)
tactics to##3##2##(1994-12#1)(2010-1#1)(2013-1#1)
tactics##22##1##(1990-3#1)(1991-3#1)(1993-12#1)(1994-12#1)(2007-12#1)(2008-10#5)(2008-8#1)(2008-9#1)(2010-1#6)(2010-8#2)(2013-1#1)(2013-8#1)
tactile events##2##2##(2009-8#2)
tactile perception##3##2##(1995-8#1)(2008-5#2)
tactile placing##2##2##(1992-12#2)
tactile stimulation##2##2##(2008-5#2)
tactile##16##1##(1992-12#2)(1995-8#1)(1996-12#1)(2008-5#6)(2009-8#5)(2013-1#1)
tadpole##6##1##(1997-7#1)(2008-8#5)
tadpoles of##2##2##(2011-2#2)
tadpoles##5##1##(1995-12#1)(2008-8#1)(2011-2#3)
tag (EST)##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
tag at##2##2##(2008-11#2)
tag genes##2##2##(1997-8#1)(2008-10#1)
tag was##2##2##(2008-10#1)(2008-11#1)
tag##28##1##(1995-2#1)(1995-9#1)(1997-6#1)(1997-8#1)(2008-10#8)(2008-11#9)(2008-7#1)(2008-9#3)(2009-9#1)(2010-5#1)(2010-8#1)
tag)##2##1##(1996-6#1)(2008-10#1)
tagged fish##2##2##(2008-8#1)(2010-8#1)
tagged proteins##2##2##(2008-4#1)(2010-7#1)
tagged site##2##2##(2008-10#2)
tagged with##3##2##(1996-6#1)(2008-10#2)
tagged##21##1##(1995-6#1)(1996-6#1)(1997-8#3)(2008-10#6)(2008-4#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#3)
tagging of##3##2##(1995-9#1)(1997-8#1)(2013-1#1)
tagging studies##2##2##(2013-1#2)
tagging##16##1##(1995-6#1)(1995-9#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-9#1)(2010-8#4)(2013-1#3)
tagitinin C##4##2##(2008-10#4)
tags from##3##2##(2008-11#1)(2008-8#1)(2010-4#1)
tags##22##1##(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-8#1)(2009-10#2)(2010-10#1)(2010-4#2)(2010-8#2)(2011-2#1)(2013-8#1)
tai chi group##2##3##(2008-10#2)
tai chi##7##2##(2008-10#7)
taiga##3##1##(2011-2#3)
taiji quan training on##2##4##(2009-3#2)
taiji quan##5##2##(2009-3#5)
taiji##6##1##(2009-3#6)
tail DNA##3##2##(2010-5#3)
tail and##2##2##(2008-8#1)(2011-2#1)
tail at##2##2##(1993-8#1)(2008-10#1)
tail currents evoked at potentials more##2##6##(1997-2#2)
tail domain of vinculin##2##4##(2009-7#2)
tail domain of##3##3##(2009-7#2)(2011-2#1)
tail is##2##2##(2010-6#2)
tail length and##3##3##(2008-8#1)(2008-9#1)(2010-5#1)
tail length##7##2##(2008-8#3)(2008-9#1)(2010-5#3)
tail markings as##2##3##(2008-9#2)
tail markings##5##2##(2008-9#5)
tail of the##3##3##(1993-9#1)(2008-5#1)(2013-1#1)
tail of##4##2##(1993-9#1)(2008-5#1)(2008-9#1)(2013-1#1)
tail or##4##2##(1997-5#2)(2008-6#1)(2008-7#1)
tail that##2##2##(1990-5#1)(2011-2#1)
tail traits in##2##3##(2008-9#2)
tail traits##3##2##(2008-9#3)
tail##88##1##(1990-5#1)(1991-9#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1997-2#2)(1997-5#4)(1997-7#3)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#18)(2009-7#2)(2010-1#1)(2010-5#6)(2010-6#4)(2011-2#10)(2013-1#1)
tail)##4##1##(1994-11#2)(2008-8#1)(2013-8#1)
tail-flick response##5##2##(1992-3#5)
tail-flick##8##1##(1991-1#1)(1992-3#6)(1993-1#1)
tail-withdrawal##2##1##(1996-2#2)
tailflip##2##1##(2007-12#2)
tailflipping##3##1##(2007-12#3)
tailflips##2##1##(2007-12#2)
tailing##2##1##(2008-10#1)(2010-4#1)
tailor-made##5##1##(1996-6#1)(2008-11#2)(2008-4#1)(2008-5#1)
tailored for##3##2##(2008-3#1)(2012-12#2)
tailored to the individual##2##4##(2010-1#1)(2013-8#1)
tailored to##10##2##(1995-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
tailored##31##1##(1995-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#3)
tailoring the##2##2##(2008-10#2)
tailoring##13##1##(1993-12#1)(1994-3#1)(2008-10#3)(2008-4#1)(2008-6#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2013-8#1)
tails and##2##2##(2008-8#1)(2011-2#1)
tails##18##1##(1993-9#1)(1995-6#1)(1995-9#4)(2008-11#2)(2008-8#2)(2008-9#2)(2010-4#1)(2010-7#2)(2011-2#2)(2012-2#1)
tainted##2##1##(1995-6#1)(1996-8#1)
taiwanin C and##2##3##(1996-5#2)
taiwanin##3##1##(1996-5#3)
take a##10##2##(1990-6#1)(1991-3#1)(1992-3#1)(1993-2#2)(1997-7#1)(2008-11#1)(2010-8#1)(2011-2#1)(2011-3#1)
take account of the##3##4##(1990-3#1)(2008-11#1)(2008-3#1)
take account of##4##3##(1990-3#1)(2008-11#1)(2008-3#1)(2010-10#1)
take account##5##2##(1990-3#1)(2008-11#1)(2008-3#1)(2010-10#1)(2013-8#1)
take advantage of a##2##4##(2008-10#1)(2012-3#1)
take advantage of the##2##4##(1994-3#1)(2008-10#1)
take advantage of this##2##4##(1993-12#2)
take advantage of##14##3##(1990-11#1)(1991-5#1)(1993-12#2)(1994-3#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-4#1)(2012-3#1)(2013-1#1)
take advantage##15##2##(1990-11#1)(1991-5#1)(1993-12#2)(1994-3#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-3#1)(2013-1#1)
take an##2##2##(2008-8#1)(2010-10#1)
take in##3##2##(1994-1#1)(2009-10#1)(2009-9#1)
take into account the##17##4##(1993-2#1)(1993-3#1)(1995-12#1)(1995-5#2)(1997-2#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2009-12#1)
take into account##23##3##(1993-2#1)(1993-3#1)(1994-1#2)(1995-12#1)(1995-5#2)(1997-2#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#1)(2013-8#1)
take into consideration##3##3##(1995-12#1)(1996-6#1)(2008-11#1)
take into##26##2##(1993-2#1)(1993-3#1)(1994-1#2)(1995-12#2)(1995-5#2)(1996-6#1)(1997-2#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#1)(2013-8#1)
take many##3##2##(1992-1#1)(2008-10#1)(2008-5#1)
take on##4##2##(1993-12#1)(1996-2#1)(1996-3#1)(2008-11#1)
take part in##6##3##(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)
take part##9##2##(1996-11#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2013-1#1)
take place as##2##3##(1991-9#1)(2008-9#1)
take place at the##2##4##(1991-2#1)(2008-10#1)
take place at##3##3##(1991-2#1)(1996-2#1)(2008-10#1)
take place in a##4##4##(2008-10#2)(2012-2#1)(2013-8#1)
take place in the##5##4##(1995-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-3#1)
take place in##15##3##(1995-2#1)(2008-10#4)(2008-11#1)(2009-12#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
take place##37##2##(1991-2#2)(1991-9#1)(1992-2#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#9)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#2)
take several##3##2##(1992-12#1)(1996-8#1)(1997-3#1)
take that##2##2##(2008-12#1)(2013-8#1)
take the lead##3##3##(1995-12#2)(2008-8#1)
take the##10##2##(1994-3#1)(1995-12#2)(1996-3#1)(1996-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
take this into##2##3##(2011-2#1)(2012-2#1)
take this##3##2##(1996-3#1)(2011-2#1)(2012-2#1)
take to##5##2##(1991-12#1)(1995-1#1)(1997-2#1)(2008-11#1)(2011-2#1)
take up##7##2##(1991-3#1)(2006-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)
take##194##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#2)(1994-1#4)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#5)(1995-2#1)(1995-5#3)(1995-6#2)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-7#1)(2006-6#1)(2008-10#20)(2008-11#22)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#8)(2009-10#1)(2009-12#4)(2009-4#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#6)
take-all conducive soil##2##3##(2008-10#2)
take-all decline##2##2##(2008-10#2)
take-all disease##3##2##(2008-10#3)
take-all incidence##2##2##(2008-10#2)
take-all of wheat##3##3##(2008-10#3)
take-all##25##1##(2008-10#25)
take-all-suppressive##2##1##(2008-10#2)
take-up##2##1##(1993-8#1)(2008-10#1)
taken 1##2##2##(2010-12#2)
taken 2##2##2##(1995-11#1)(2013-8#1)
taken after##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
taken and the##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
taken and##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
taken any##2##2##(2013-1#2)
taken as an##4##3##(2007-11#1)(2008-10#3)
taken as evidence that##2##4##(2007-12#1)(2008-11#1)
taken as evidence##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
taken as the##4##3##(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)
taken as##19##2##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
taken at the time of##2##5##(2009-1#1)(2011-2#1)
taken at the##3##3##(1991-12#1)(2009-1#1)(2011-2#1)
taken at##12##2##(1991-12#1)(1991-9#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
taken away##2##2##(1992-5#1)(1997-1#1)
taken before##5##2##(2008-10#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
taken by a##2##3##(2008-2#1)(2010-7#1)
taken by the nurse##2##4##(2010-7#2)
taken by the##8##3##(1991-3#1)(1995-12#1)(2008-3#1)(2010-7#3)(2011-2#1)(2012-3#1)
taken by##12##2##(1991-3#1)(1995-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#4)(2011-2#1)(2012-3#1)
taken care of##2##3##(1997-5#1)(2011-3#1)
taken during the##3##3##(1990-8#1)(2011-1#1)(2011-2#1)
taken during##4##2##(1990-8#1)(1991-3#1)(2011-1#1)(2011-2#1)
taken for analysis##3##3##(2008-10#2)(2012-12#1)
taken for##14##2##(1991-3#1)(1994-12#1)(2008-10#6)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
taken four##2##2##(1997-3#1)(2010-4#1)
taken from a##2##3##(2008-10#2)
taken from an##4##3##(2008-10#4)
taken from each##2##3##(2008-10#2)
taken from the##13##3##(1991-2#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2013-1#2)
taken from##55##2##(1990-8#1)(1990-9#1)(1991-2#1)(1996-11#1)(1997-5#2)(2008-10#27)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
taken in the##3##3##(1990-8#1)(1997-3#1)(2008-10#1)
taken in##14##2##(1990-8#1)(1993-1#1)(1995-11#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
taken into account by##5##4##(2008-10#3)(2011-3#1)(2012-3#1)
taken into account in##10##4##(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-5#1)(2013-1#1)
taken into account to##2##4##(2008-10#1)(2010-4#1)
taken into account##48##3##(1990-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
taken into consideration##8##3##(1991-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
taken into##61##2##(1990-9#1)(1991-11#1)(1991-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(2007-12#2)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
taken on##7##2##(1993-1#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-6#1)
taken out of the##2##4##(1990-9#1)(1997-6#1)
taken over the##3##3##(1994-6#1)(2008-3#2)
taken over##4##2##(1994-6#1)(2008-3#2)(2011-2#1)
taken place in##4##3##(1991-2#1)(1991-3#1)(1995-3#1)(2008-2#1)
taken place##7##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1995-3#1)(2008-12#1)(2008-2#1)
taken so##3##2##(1996-12#1)(2008-11#2)
taken to avoid##2##3##(2008-10#2)
taken to be the##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
taken to be##6##3##(1992-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)
taken to indicate##2##3##(1994-8#1)(2008-10#1)
taken to prevent the##2##4##(1997-6#1)(2008-10#1)
taken to prevent##3##3##(1997-6#1)(2008-10#2)
taken to##37##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-1#2)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
taken together##5##2##(1990-12#1)(1993-9#1)(1994-12#1)(1996-12#1)(2008-11#1)
taken under##2##2##(2008-11#1)(2008-12#1)
taken up and##2##3##(1995-6#1)(2008-9#1)
taken up by the##5##4##(2008-10#2)(2008-11#2)(2008-5#1)
taken up by##12##3##(1990-2#1)(1991-12#1)(1995-6#2)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)
taken up##18##2##(1990-2#1)(1991-12#1)(1992-3#1)(1995-6#3)(2008-10#3)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)
taken with##4##2##(2008-2#2)(2008-3#1)(2012-3#1)
taken##378##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#3)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-9#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#4)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-5#3)(1997-6#2)(2007-11#1)(2007-12#5)(2008-10#93)(2008-11#33)(2008-12#10)(2008-2#7)(2008-3#14)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#6)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#2)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#18)(2013-8#8)
takers##3##1##(2009-12#3)
takes a##10##2##(1991-1#1)(1993-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
takes about##3##2##(1995-2#1)(2008-10#2)
takes account of the##2##4##(1996-3#1)(2008-10#1)
takes account of##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
takes advantage of the##5##4##(2008-10#2)(2008-3#2)(2008-8#1)
takes advantage of##6##3##(1996-2#1)(2008-10#2)(2008-3#2)(2008-8#1)
takes an average##2##3##(1994-12#1)(2008-3#1)
takes an##3##2##(1994-12#1)(2008-3#1)(2013-1#1)
takes into account the##4##4##(2008-10#1)(2008-3#2)(2008-5#1)
takes into account##11##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-3#1)(2012-2#1)
takes into##12##2##(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-3#1)(2012-2#1)
takes less than##2##3##(2008-10#1)(2008-11#1)
takes many forms##2##3##(1996-8#1)(2008-11#1)
takes place at##3##3##(2008-10#3)
takes place from##2##3##(2008-10#2)
takes place in the##5##4##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
takes place in##7##3##(1992-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-10#1)
takes place is##2##3##(2008-9#1)(2009-10#1)
takes place##31##2##(1990-11#1)(1992-6#1)(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#1)(2012-2#1)(2012-3#1)
takes the##6##2##(2008-10#3)(2008-12#1)(2008-9#1)(2012-9#1)
takes toll in##2##3##(1997-6#2)
takes toll##3##2##(1994-9#1)(1997-6#2)
takes up##2##2##(1992-3#1)(1995-2#1)
takes##115##1##(1990-11#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-6#3)(1997-8#1)(2007-12#1)(2008-10#30)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#4)(2009-11#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#3)(2012-3#7)(2012-9#1)(2013-1#1)(2013-8#2)
taking a##4##2##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)
taking account of##2##3##(1997-1#1)(2008-11#1)
taking advantage of the##6##4##(1995-3#1)(1997-3#1)(2008-10#3)(2010-7#1)
taking advantage of##12##3##(1995-3#1)(1996-1#1)(1997-3#1)(2008-10#5)(2008-11#1)(2009-10#1)(2010-5#1)(2010-7#1)
taking an##6##2##(1995-6#2)(1997-7#1)(2008-11#2)(2008-12#1)
taking and##2##2##(1995-2#1)(2011-2#1)
taking antihypertensive##2##2##(2008-8#2)
taking care of##2##3##(1991-6#1)(2008-10#1)
taking drugs##3##2##(2008-7#3)
taking from##2##2##(1994-12#1)(2009-9#1)
taking in##3##2##(1993-11#1)(1995-5#1)(2008-10#1)
taking into account all##2##4##(2008-10#1)(2008-3#1)
taking into account both##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
taking into account the##13##4##(1992-9#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-3#1)
taking into account##27##3##(1990-11#1)(1992-9#1)(1996-1#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)
taking into consideration the##2##4##(1995-9#1)(2008-10#1)
taking into consideration##3##3##(1995-9#1)(1996-2#1)(2008-10#1)
taking into##30##2##(1990-11#1)(1992-9#1)(1995-9#1)(1996-1#1)(1996-2#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)
taking medication##3##2##(2008-7#2)(2010-1#1)
taking place in the##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
taking place in##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2010-12#1)(2013-1#1)
taking place on the##2##4##(2008-10#1)(2008-8#1)
taking place##17##2##(1991-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#3)
taking stock##3##2##(1994-2#1)(1997-2#1)(2008-12#1)
taking the sample##2##3##(2008-10#2)
taking the##14##2##(1992-1#1)(1992-11#1)(1993-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)
taking their##3##2##(1995-12#1)(2010-1#2)
taking up the##2##3##(1994-9#1)(2008-11#1)
taking up##3##2##(1991-8#1)(1994-9#1)(2008-11#1)
taking##173##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-9#2)(1993-11#1)(1993-3#3)(1993-5#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#4)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(2007-12#2)(2008-10#32)(2008-11#27)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#3)(2009-10#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#8)(2013-8#1)
talar osteitis##2##2##(2009-3#2)
talar##6##1##(2009-1#1)(2009-3#2)(2010-5#2)(2011-2#1)
talbot##2##1##(2008-3#2)
talc##3##1##(2008-10#2)(2008-5#1)
tale##4##1##(1993-9#1)(1994-2#1)(2008-11#1)(2009-3#1)
talent##4##1##(1994-2#1)(2008-12#2)(2012-3#1)
talents to##2##2##(1991-12#1)(2008-10#1)
tales##2##1##(1995-1#1)(2013-8#1)
talk in##3##2##(2008-3#3)
talk will##2##2##(2008-3#1)(2008-7#1)
talk##24##1##(1993-5#1)(1994-3#1)(1997-1#1)(1997-4#1)(2008-3#10)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
talked about##2##2##(1996-11#1)(2013-1#1)
talked##3##1##(1996-11#1)(1996-8#1)(2013-1#1)
talking about the##2##3##(1996-5#1)(2008-12#1)
talking about##5##2##(1992-3#1)(1996-5#1)(2008-12#1)(2009-5#1)(2011-2#1)
talking to##2##2##(1992-3#2)
talking##7##1##(1992-3#3)(1996-5#1)(2008-12#1)(2009-5#1)(2011-2#1)
talks with##2##2##(1990-6#1)(1991-2#1)
talks##5##1##(1990-6#1)(1991-2#1)(2011-2#2)(2013-1#1)
tall fescue (Festuca arundinacea)##4##4##(2008-10#4)
tall fescue and##2##3##(2008-10#2)
tall fescue leaves##2##3##(2008-10#2)
tall fescue##18##2##(2008-10#17)(2008-8#1)
tall stature##4##2##(2008-10#2)(2013-1#2)
tall##24##1##(2008-10#20)(2008-8#1)(2013-1#3)
taller in##5##2##(2008-8#5)
taller##9##1##(2008-10#3)(2008-8#5)(2013-8#1)
tallied##2##1##(2008-10#1)(2012-2#1)
talocalcaneal coalition##3##2##(2010-5#3)
talocalcaneal##4##1##(2008-12#1)(2010-5#3)
talonavicular##4##1##(2008-12#1)(2009-10#1)(2010-3#2)
tamarillo isolates as C##2##4##(2008-10#2)
tamarillo isolates##4##2##(2008-10#4)
tamarillo##9##1##(2008-10#9)
tamarind fruit##3##2##(2008-5#3)
tamarind##5##1##(2008-5#5)
tamarind's fruit pulp##2##3##(2008-5#2)
tamoxifen (TAM)##2##2##(1993-1#2)
tamoxifen and##2##2##(2008-10#2)
tamoxifen in##2##2##(1993-11#1)(2008-10#1)
tamoxifen therapy##2##2##(2008-10#2)
tamoxifen##26##1##(1990-2#1)(1991-8#3)(1993-1#3)(1993-11#2)(1997-7#1)(2008-10#11)(2008-11#3)(2011-2#2)
tamoxifen&gt##2##1##(2008-11#2)
tamoxifene##2##1##(2013-1#2)
tan spot and leaf rust##3##5##(2008-10#3)
tan spot and##5##3##(2008-10#5)
tan spot##24##2##(2008-10#24)
tan##28##1##(2008-10#27)(2008-5#1)
tandem MS##2##2##(2012-12#2)
tandem arrays##2##2##(2008-11#1)(2008-9#1)
tandem conjugate##2##2##(1996-5#1)(2008-9#1)
tandem linked##2##2##(2008-8#2)
tandem mass spectrometric##2##3##(2008-10#2)
tandem mass spectrometry##11##3##(2008-10#10)(2008-8#1)
tandem mass##15##2##(2008-10#12)(2008-8#1)(2011-2#1)(2011-3#1)
tandem repeat##13##2##(1991-6#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-12#6)(2008-7#1)
tandem repeats of the##2##4##(1991-7#1)(2008-10#1)
tandem repeats of##3##3##(1991-7#1)(2008-10#2)
tandem repeats##9##2##(1990-8#1)(1991-12#1)(1991-7#1)(1995-12#2)(2008-10#2)(2008-12#1)(2008-8#1)
tandem with##3##2##(1995-2#1)(2008-7#1)(2010-7#1)
tandem##91##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-12#2)(1993-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-5#3)(2008-10#26)(2008-11#6)(2008-12#8)(2008-5#1)(2008-7#3)(2008-8#8)(2008-9#4)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
tandem-flow##2##1##(2008-10#2)
tandemly##3##1##(1993-12#1)(1993-2#1)(2008-9#1)
tangelo##4##1##(2008-10#4)
tangent##3##1##(2008-10#1)(2008-3#1)(2009-7#1)
tangential cells##3##2##(2008-11#3)
tangential field##2##2##(2009-2#2)
tangential flow filtration##5##3##(2008-10#2)(2008-7#3)
tangential##15##1##(2008-10#2)(2008-11#4)(2008-3#2)(2008-7#3)(2009-2#4)
tangential-flow##2##1##(2008-10#2)
tangerine pathotype of##2##3##(2008-10#2)
tangerine pathotype##3##2##(2008-10#3)
tangerine##7##1##(2008-10#7)
tangerines and##3##2##(2008-10#3)
tangible benefits##2##2##(1991-3#1)(2008-11#1)
tangible##8##1##(1991-3#1)(1992-12#1)(2008-10#1)(2008-11#2)(2009-10#1)(2013-1#2)
tangle##3##1##(1997-3#1)(2008-7#2)
tangles and##2##2##(1991-1#1)(2008-7#1)
tangles##9##1##(1991-1#5)(2008-5#1)(2008-7#3)
tangor##3##1##(2008-10#3)
tank reactor##5##2##(1997-2#1)(2008-11#2)(2008-7#2)
tank test##2##2##(2008-8#2)
tank##28##1##(1994-1#1)(1997-2#1)(2008-10#1)(2008-11#15)(2008-6#3)(2008-7#3)(2008-8#2)(2011-2#2)
tanker##2##1##(2008-10#1)(2008-11#1)
tanks and##2##2##(2009-6#1)(2011-2#1)
tanks##8##1##(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#1)
tankships have##2##2##(2008-11#2)
tankships##5##1##(2008-11#5)
tanned leather##2##2##(2008-10#2)
tanneries##4##1##(2008-10#1)(2009-12#3)
tannery effluents##2##2##(2008-10#2)
tannery wastewater##2##2##(2008-10#2)
tannery##10##1##(2008-10#10)
tannic acid##9##2##(2008-10#8)(2008-8#1)
tannin present in##2##3##(2008-10#2)
tannin##13##1##(2008-10#12)(2011-2#1)
tanning ability and##2##3##(1991-6#1)(2008-5#1)
tanning##9##1##(1991-6#1)(2008-10#5)(2008-5#1)(2008-9#2)
tannins##7##1##(1993-8#1)(2008-10#2)(2009-8#2)(2011-3#1)(2013-8#1)
tanshinones##4##1##(2008-10#4)
tansy##3##1##(2008-10#3)
tantalum##7##1##(2008-10#6)(2009-7#1)
tap and industrial wastewater)##2##4##(2008-10#2)
tap and river water samples##3##5##(2008-10#3)
tap and##15##2##(2008-10#15)
tap water and river water##2##5##(2008-10#2)
tap water and wastewater samples##2##5##(2008-10#2)
tap water and wastewater##3##4##(2008-10#3)
tap water and##19##3##(2008-10#19)
tap water sample##2##3##(2008-10#2)
tap water samples and##2##4##(2008-10#2)
tap water samples##12##3##(2008-10#12)
tap water##64##2##(2008-10#61)(2008-12#1)(2011-2#1)(2013-8#1)
tap waters##3##2##(2008-10#3)
tap##94##1##(2008-10#91)(2008-12#1)(2011-2#1)(2013-8#1)
tap*&quot##2##1##(2013-1#2)
tape recorded##3##2##(1991-12#1)(2008-10#1)(2008-12#1)
tape stripping##4##2##(2008-5#4)
tape##17##1##(1991-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#7)
taped interviews##2##2##(2008-11#2)
taper##3##1##(2008-2#2)(2013-1#1)
tapered##6##1##(1996-2#1)(2008-10#2)(2008-3#2)(2011-2#1)
tapers##2##1##(2008-10#1)(2013-1#1)
tapes##2##1##(2008-10#1)(2008-8#1)
tapeworm##3##1##(1995-12#1)(2008-7#1)(2011-2#1)
taping##5##1##(1995-12#1)(2008-10#1)(2010-9#1)(2013-1#2)
tapioca starch##3##2##(2008-5#3)
tapioca##4##1##(2008-5#4)
tapping##7##1##(1994-12#3)(1994-2#1)(2008-10#2)(2008-7#1)
taproots##4##1##(2008-10#4)
taps##3##1##(1995-8#1)(1997-1#1)(2007-12#1)
tapwater and upland soil extracts##2##5##(2008-10#2)
tapwater and##4##2##(2008-10#4)
tapwater##6##1##(2008-10#6)
tar##3##1##(2008-10#1)(2009-7#2)
tarabine PFS and##5##3##(2008-10#5)
tarabine PFS##6##2##(2008-10#6)
tardive syndromes##2##2##(2008-7#2)
tardive##4##1##(1996-2#1)(2008-7#3)
tardy diagnosis##2##2##(1995-6#1)(2008-7#1)
target DNA fragment##2##3##(1995-8#1)(2008-10#1)
target DNA in##3##3##(2008-8#2)(2013-1#1)
target DNA sequence##3##3##(2008-10#2)(2008-4#1)
target DNA##23##2##(1993-12#1)(1994-3#1)(1995-8#1)(1997-3#1)(2008-10#14)(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#1)
target DNAs##2##2##(1993-12#1)(2008-10#1)
target ODN##2##2##(2008-10#2)
target RPEs that##2##3##(2013-8#2)
target analytes##8##2##(2008-10#8)
target and the##2##3##(1995-1#1)(2010-7#1)
target and##12##2##(1990-12#1)(1995-1#1)(1995-6#1)(2008-10#3)(2008-3#2)(2010-7#1)(2011-2#1)(2012-2#2)
target antigen##5##2##(2008-10#1)(2008-11#1)(2008-9#3)
target area##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
target attainment of AUC/MIC##2##4##(2011-2#2)
target attainment##3##2##(2011-2#3)
target audience##2##2##(1996-2#1)(2010-11#1)
target can be##2##3##(1991-2#1)(2009-11#1)
target cell##9##2##(1990-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#1)(2011-3#1)
target cells by##2##3##(1993-3#1)(2008-11#1)
target cells in##2##3##(2008-7#1)(2011-2#1)
target cells of##3##3##(1993-3#1)(2008-11#2)
target cells or##2##3##(1997-8#1)(2008-4#1)
target cells##40##2##(1990-12#5)(1990-5#1)(1990-8#1)(1993-3#3)(1995-2#4)(1997-8#3)(2008-10#1)(2008-11#11)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)
target classification##2##2##(2008-11#1)(2013-1#1)
target compounds were##2##3##(2008-10#1)(2011-3#1)
target compounds##7##2##(2008-10#6)(2011-3#1)
target detection##3##2##(2008-11#1)(2008-3#2)
target different##2##2##(2009-7#1)(2012-3#1)
target during##2##2##(1992-9#1)(2009-8#1)
target elements composed of##2##4##(1995-8#2)
target factor analysis##3##3##(2008-10#3)
target factor##4##2##(2008-10#4)
target for anti-cancer therapy##2##4##(1997-1#1)(2013-1#1)
target for anti-cancer##4##3##(1997-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
target for anticancer drug##3##4##(2008-5#1)(2010-7#1)(2012-2#1)
target for cancer immunotherapy##2##4##(2008-11#2)
target for cancer therapy##4##4##(2008-11#1)(2011-2#2)(2012-2#1)
target for cancer##7##3##(2008-11#3)(2011-2#3)(2012-2#1)
target for novel##2##3##(2008-5#2)
target for the development of##2##5##(2012-2#1)(2013-1#1)
target for the treatment of##5##5##(2008-1#1)(2012-2#3)(2013-1#1)
target for the##11##3##(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#4)(2013-1#2)
target for therapy##2##3##(2008-11#1)(2011-3#1)
target for these##2##3##(2008-1#1)(2011-2#1)
target for##69##2##(1992-6#1)(1995-2#1)(1995-5#1)(1995-9#2)(1996-1#1)(1997-1#2)(1997-7#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#5)(2013-8#3)
target from a##2##3##(2008-2#1)(2008-4#1)
target gene expression##2##3##(1996-12#1)(2009-8#1)
target gene##9##2##(1996-12#1)(2008-10#3)(2008-11#1)(2008-4#3)(2009-8#1)
target genes have##2##3##(1997-7#1)(2011-2#1)
target genes of##2##3##(2008-9#1)(2013-8#1)
target genes##17##2##(1996-12#2)(1997-7#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
target groups##2##2##(1992-12#1)(2008-1#1)
target in a##2##3##(2008-10#1)(2008-3#1)
target in the##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
target in##12##2##(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2012-2#1)(2013-8#1)
target is##4##2##(1991-2#1)(2008-11#1)(2008-3#1)(2009-11#1)
target lesions of##2##3##(1990-11#2)
target mRNA##6##2##(1996-12#2)(2008-4#3)(2013-1#1)
target molecules##6##2##(2008-10#3)(2008-5#1)(2008-6#1)(2009-12#1)
target neuron##2##2##(2008-11#2)
target nucleic##2##2##(2008-10#1)(2008-9#1)
target nucleobases##2##2##(2008-10#2)
target of rapamycin (mTOR)##5##4##(2008-7#1)(2009-7#1)(2013-1#3)
target of the protein##2##4##(1995-2#1)(2011-2#1)
target of these##2##3##(1995-2#1)(2011-2#1)
target of this##2##3##(2008-10#1)(2010-12#1)
target of##30##2##(1991-9#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-2#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#3)
target oligonucleotide##2##2##(2008-10#2)
target organ damage##3##3##(2009-1#3)
target organ for##2##3##(1992-12#1)(2012-2#1)
target organ of##2##3##(1990-5#1)(2011-1#1)
target organ responses##2##3##(2008-7#2)
target organ##11##2##(1990-5#1)(1992-12#1)(2008-11#1)(2008-7#2)(2009-1#3)(2011-1#1)(2012-2#1)(2012-3#1)
target organs##3##2##(1996-2#1)(2008-5#1)(2011-2#1)
target population##5##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
target prediction##2##2##(2008-11#1)(2013-8#1)
target protein##7##2##(1994-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)
target proteins##6##2##(2008-11#3)(2008-9#1)(2009-4#1)(2012-3#1)
target selection##2##2##(2012-2#2)
target sequence in##2##3##(2008-10#1)(2008-9#1)
target sequence##8##2##(2008-10#5)(2008-4#2)(2008-9#1)
target sequences##7##2##(2008-10#3)(2008-4#1)(2008-9#3)
target site duplication##2##3##(2012-3#2)
target site##5##2##(1994-11#1)(1994-2#1)(2008-11#1)(2012-3#2)
target sites##5##2##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
target species##3##2##(1997-7#1)(2008-10#2)
target specificity##2##2##(2008-10#2)
target ssDNA##2##2##(2008-10#2)
target ssDNA(I)##2##2##(2008-10#2)
target the##14##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-7#2)(2011-2#1)(2013-1#2)(2013-8#1)
target this##2##2##(2009-7#1)(2011-2#1)
target tissue##3##2##(2008-1#1)(2009-7#1)(2011-2#1)
target tissues and##2##3##(1993-3#1)(1995-12#1)
target tissues##8##2##(1991-12#1)(1991-3#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(2012-2#1)(2012-3#1)
target to##6##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
target using##2##2##(2008-10#1)(2008-11#1)
target validation##2##2##(2008-11#1)(2013-1#1)
target value of##2##3##(2008-10#2)
target value##3##2##(2008-10#2)(2011-2#1)
target volume##5##2##(1993-9#2)(2008-2#1)(2009-11#2)
target was##4##2##(2008-10#2)(2008-11#1)(2009-4#1)
target weight##6##2##(2013-1#6)
target##671##1##(1990-11#2)(1990-12#7)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#4)(1991-9#2)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#5)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#4)(1995-12#3)(1995-2#9)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-12#6)(1996-2#3)(1997-1#5)(1997-2#4)(1997-3#2)(1997-5#1)(1997-7#3)(1997-8#3)(2008-1#9)(2008-10#149)(2008-11#71)(2008-12#6)(2008-2#3)(2008-3#26)(2008-4#17)(2008-5#8)(2008-6#3)(2008-7#10)(2008-8#15)(2008-9#24)(2009-1#3)(2009-11#7)(2009-12#4)(2009-4#5)(2009-6#5)(2009-7#8)(2009-8#12)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#4)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#7)(2010-8#4)(2011-1#4)(2011-2#46)(2011-3#5)(2012-12#6)(2012-2#23)(2012-3#13)(2013-1#31)(2013-8#14)
target(s)##2##1##(1997-3#1)(2012-2#1)
target-derived##2##1##(1990-5#1)(1996-12#1)
target-oriented##2##1##(2008-10#2)
targeted ES cell##2##3##(2008-11#1)(2008-9#1)
targeted ES cells using##2##4##(2008-8#2)
targeted ES cells##3##3##(2008-11#1)(2008-8#2)
targeted ES##5##2##(2008-11#2)(2008-8#2)(2008-9#1)
targeted against##3##2##(2008-10#3)
targeted and##5##2##(1997-1#1)(2008-11#2)(2009-3#1)(2010-10#1)
targeted at##3##2##(1995-1#1)(1996-2#1)(2008-10#1)
targeted by##9##2##(2008-10#2)(2009-4#2)(2009-8#3)(2010-9#1)(2011-2#1)
targeted clones##2##2##(2008-11#2)
targeted communities##2##2##(2010-8#1)(2013-1#1)
targeted drugs##2##2##(2010-12#1)(2010-5#1)
targeted for##6##2##(2008-1#1)(2010-12#3)(2011-1#1)(2012-2#1)
targeted in##6##2##(1994-2#1)(1997-2#1)(2008-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
targeted magnetic##2##2##(2012-2#1)(2012-3#1)
targeted quantitative##2##2##(2008-9#2)
targeted rotation##2##2##(2008-11#2)
targeted surveillance##2##2##(2011-2#1)(2012-3#1)
targeted therapies for##2##3##(2009-1#1)(2010-10#1)
targeted therapies##5##2##(2009-1#1)(2010-10#2)(2011-1#1)(2012-2#1)
targeted therapy##4##2##(2008-7#1)(2011-3#2)(2012-2#1)
targeted to##9##2##(1995-11#1)(1997-7#1)(2007-12#1)(2008-1#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#2)
targeted use of##2##3##(2008-10#1)(2008-7#1)
targeted##160##1##(1991-2#1)(1991-9#1)(1992-12#1)(1993-9#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#2)(2007-12#1)(2008-1#3)(2008-10#16)(2008-11#11)(2008-12#3)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#11)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-2#9)(2011-3#5)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#9)(2013-8#4)
targeting a##5##2##(1995-6#1)(1996-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
targeting by##2##2##(2008-4#1)(2009-4#1)
targeting construct##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
targeting fungal##2##2##(2008-10#1)(2011-2#1)
targeting gene delivery system##2##4##(2008-8#2)
targeting in##6##2##(1993-11#1)(1995-2#1)(2008-11#2)(2008-7#1)(2010-6#1)
targeting is##3##2##(2008-2#1)(2008-8#1)(2012-2#1)
targeting lesbian##2##2##(2008-12#2)
targeting methods##2##2##(2009-12#2)
targeting of its##2##3##(2008-11#1)(2012-3#1)
targeting of the##3##3##(1991-6#1)(1995-2#1)(2012-2#1)
targeting of##13##2##(1991-6#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
targeting potential##2##2##(1993-11#2)
targeting strategies##3##2##(2011-2#2)(2012-2#1)
targeting the##17##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
targeting this##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
targeting to##2##2##(2009-10#1)(2009-8#1)
targeting vector##3##2##(2008-10#1)(2008-9#2)
targeting were##2##2##(2009-10#1)(2013-1#1)
targeting##149##1##(1990-11#1)(1991-6#1)(1992-12#2)(1992-3#1)(1993-11#4)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#17)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#9)(2009-10#3)(2009-12#6)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#11)(2011-3#4)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#11)(2013-8#2)
targets and##15##2##(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-12#3)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
targets are##4##2##(1992-12#1)(2008-3#2)(2009-8#1)
targets as##4##2##(2008-11#1)(2008-7#1)(2009-12#1)(2012-3#1)
targets at##2##2##(1995-1#1)(2011-2#1)
targets by##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
targets elicited##2##2##(2008-11#2)
targets for action##2##3##(1991-2#1)(2008-11#1)
targets for chemoprevention##2##3##(2011-2#2)
targets for chemotherapy##2##3##(1991-5#1)(1997-7#1)
targets for the development of##3##5##(2008-10#1)(2011-2#2)
targets for the##6##3##(1996-1#1)(2008-10#1)(2011-2#3)(2013-7#1)
targets for therapeutic##3##3##(2008-11#1)(2011-2#2)
targets for therapy##2##3##(2011-2#2)
targets for##31##2##(1991-2#1)(1991-5#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
targets in the##6##3##(1990-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
targets in##15##2##(1990-5#1)(1992-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2009-1#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
targets is##2##2##(2009-12#1)(2012-3#1)
targets of Hox protein Ultrabithorax##2##5##(2012-2#2)
targets of a##2##3##(1992-3#1)(2008-1#1)
targets of the##2##3##(1995-2#1)(2013-8#1)
targets of this##3##3##(2008-10#1)(2008-11#2)
targets of##26##2##(1991-5#1)(1992-12#1)(1992-3#2)(1995-2#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-5#1)(2009-12#1)(2009-8#2)(2009-9#1)(2011-2#1)(2012-2#4)(2013-8#2)
targets such as##4##3##(2008-3#3)(2010-5#1)
targets than##2##2##(2008-11#1)(2013-1#1)
targets that##6##2##(1995-1#1)(2008-10#1)(2008-6#1)(2010-5#1)(2010-7#1)(2012-2#1)
targets the##4##2##(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
targets were##6##2##(2008-10#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)
targets##221##1##(1990-5#1)(1991-2#2)(1991-5#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-9#1)(1995-1#4)(1995-12#1)(1995-2#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-7#4)(2008-1#3)(2008-10#22)(2008-11#25)(2008-12#1)(2008-3#12)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#11)(2009-1#1)(2009-10#1)(2009-12#12)(2009-3#1)(2009-6#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#6)(2010-5#4)(2010-6#1)(2010-7#4)(2011-2#21)(2011-3#5)(2012-12#1)(2012-2#14)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#7)
targets'##2##1##(2008-11#1)(2010-7#1)
tarsus length##2##2##(2008-8#2)
tartarate##2##1##(2008-10#2)
tartaric acid in##2##3##(2008-10#2)
tartaric acid with##2##3##(2008-10#2)
tartaric acid##19##2##(2008-10#13)(2008-5#6)
tartaric##26##1##(2008-10#19)(2008-5#7)
tartrate and##2##2##(2008-10#2)
tartrate##16##1##(2008-10#13)(2008-6#1)(2012-2#2)
tartrazine and##3##2##(2008-10#3)
tartrazine##7##1##(2008-10#7)
task (i##2##2##(2008-11#1)(2013-8#1)
task analysis##2##2##(2010-7#1)(2012-2#1)
task and the##2##3##(2009-11#1)(2013-8#1)
task and to##2##3##(1996-2#1)(2008-11#1)
task and##9##2##(1991-2#1)(1994-3#1)(1996-2#1)(2008-11#2)(2008-9#1)(2009-11#1)(2012-2#1)(2013-8#1)
task by##2##2##(1994-8#1)(2012-2#1)
task decomposition##2##2##(2011-2#2)
task difficulty and response correctness##2##5##(2008-11#2)
task difficulty and##3##3##(2008-11#3)
task difficulty##6##2##(2008-11#5)(2013-8#1)
task faster than##2##3##(1994-8#1)(2012-2#1)
task for##6##2##(1990-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)
task force##3##2##(1994-12#1)(1994-3#1)(1997-3#1)
task has##2##2##(2008-10#1)(2008-4#1)
task in a T-maze##2##4##(1993-3#2)
task in a##4##3##(1993-3#2)(2013-8#2)
task in the##3##3##(1993-3#1)(2008-2#1)(2008-7#1)
task in which##2##3##(1994-3#2)
task in##14##2##(1993-2#1)(1993-3#3)(1994-3#2)(1995-5#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2013-8#2)
task is##6##2##(1995-5#1)(2008-10#2)(2008-11#2)(2013-8#1)
task more##2##2##(1994-8#2)
task of##12##2##(1995-11#1)(1995-2#1)(1997-6#1)(2008-10#3)(2008-12#1)(2011-2#1)(2011-4#1)(2013-1#3)
task only##2##2##(1991-2#1)(2009-10#1)
task performance##4##2##(1991-1#1)(1994-8#1)(2008-11#1)(2009-10#1)
task than any other group##2##5##(1991-2#2)
task that##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2013-8#1)
task to##5##2##(1995-11#1)(1995-5#1)(1996-1#1)(2008-11#1)(2008-9#1)
task using##3##2##(1993-3#1)(1994-3#1)(1996-2#1)
task was##6##2##(1993-3#1)(1994-3#1)(2008-11#3)(2009-10#1)
task were##3##2##(1996-2#1)(2008-8#1)(2013-8#1)
task with##2##2##(2009-10#1)(2013-8#1)
task##218##1##(1990-11#1)(1990-9#1)(1991-1#3)(1991-2#8)(1991-3#2)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#10)(1993-6#3)(1994-12#1)(1994-2#1)(1994-3#10)(1994-8#16)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1996-1#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#18)(2008-11#32)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#8)(2009-11#2)(2009-12#1)(2009-9#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2011-4#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#5)(2013-8#21)
task)##3##1##(1997-2#1)(2008-11#1)(2013-8#1)
task-irrelevant##2##1##(2008-11#2)
task-related##2##1##(1991-6#1)(1995-2#1)
task-relevant##2##1##(2008-11#2)
task-shifting##2##1##(2010-11#2)
tasks and##11##2##(1991-6#2)(1994-1#1)(1997-2#1)(2008-11#2)(2008-7#1)(2013-8#4)
tasks are##3##2##(2008-11#1)(2008-7#1)(2009-10#1)
tasks as##2##2##(2008-11#1)(2008-7#1)
tasks associated with##3##3##(2008-10#2)(2010-7#1)
tasks can##2##2##(2013-1#1)(2013-8#1)
tasks for##2##2##(1992-1#1)(2013-7#1)
tasks in the##2##3##(2008-11#1)(2013-8#1)
tasks in##6##2##(2008-11#3)(2009-11#1)(2013-8#2)
tasks including##2##2##(2009-12#1)(2009-4#1)
tasks of##4##2##(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)
tasks on the##3##3##(1997-2#2)(2008-11#1)
tasks requiring##2##2##(2008-11#2)
tasks that##3##2##(1993-12#1)(1993-3#1)(2010-9#1)
tasks to##2##2##(2008-11#1)(2009-4#1)
tasks using##2##2##(2008-11#1)(2009-7#1)
tasks was##2##2##(1991-2#1)(2013-8#1)
tasks were##5##2##(1991-6#1)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
tasks with##3##2##(2008-11#1)(2013-8#2)
tasks##134##1##(1991-2#2)(1991-6#4)(1992-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#2)(1994-2#1)(1994-3#2)(1995-2#1)(1996-1#3)(1996-11#1)(1996-2#4)(1996-3#2)(1997-2#4)(1997-3#1)(2008-10#4)(2008-11#31)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#5)(2009-11#5)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#1)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#16)
tassels##3##1##(2008-8#3)
tastant delivery##4##2##(2008-11#4)
tastant##7##1##(2008-11#7)
tastants in a single lick##2##5##(2008-11#2)
tastants##7##1##(2008-11#6)(2009-10#1)
taste analyzing system##3##3##(2008-10#3)
taste analyzing##4##2##(2008-10#4)
taste aversion##4##2##(1991-1#1)(2008-5#3)
taste panel##3##2##(2008-10#2)(2010-4#1)
taste receptor##2##2##(2008-2#2)
taste sensor##2##2##(2008-10#2)
taste stimuli in##2##3##(2008-7#2)
taste stimuli##3##2##(2008-7#3)
taste##39##1##(1991-1#1)(1991-3#3)(2008-10#16)(2008-2#4)(2008-5#4)(2008-7#6)(2008-9#1)(2009-10#2)(2010-4#1)(2010-5#1)
tastes and##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
tastes##6##1##(2008-10#4)(2008-7#1)(2012-2#1)
tasting##3##1##(2008-10#1)(2008-6#1)(2008-7#1)
tat##8##1##(1994-11#6)(2008-8#2)
tau 1 core##5##3##(1995-2#5)
tau 1##6##2##(1995-2#6)
tau and##2##2##(1991-1#1)(1993-6#1)
tau phosphatase##2##2##(1993-6#2)
tau protein##6##2##(1992-6#1)(1993-6#1)(1995-12#2)(2011-2#2)
tau##30##1##(1991-1#1)(1992-3#2)(1992-6#2)(1993-6#7)(1995-12#5)(1995-2#6)(2008-3#3)(2011-2#3)(2013-8#1)
tau(B)##2##1##(2008-7#2)
taught by##3##2##(1991-12#1)(1994-12#1)(2011-2#1)
taught in##4##2##(1991-12#1)(1994-12#1)(2008-7#1)(2012-2#1)
taught to##2##2##(2008-1#1)(2010-9#1)
taught##26##1##(1991-12#3)(1993-12#2)(1994-12#3)(1995-1#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
taurica##2##1##(2008-10#2)
taurine in##5##2##(1992-9#1)(2008-10#4)
taurine##19##1##(1992-9#1)(2008-10#14)(2008-5#3)(2013-1#1)
taurocholate##5##1##(1991-9#1)(1992-3#4)
tautomeric##3##1##(1990-9#1)(2008-10#2)
taux de##2##2##(2008-11#1)(2013-1#1)
taux##4##1##(2008-11#2)(2013-1#2)
tax exemption##7##2##(1991-3#1)(1992-8#1)(1996-2#1)(2008-11#4)
tax mRNA and protein##2##4##(2008-8#2)
tax planning##2##2##(2008-11#2)
tax##25##1##(1991-2#1)(1991-3#2)(1992-8#1)(1993-1#1)(1994-3#1)(1996-2#3)(2008-11#8)(2008-8#8)
tax-exempt bonds##2##2##(1992-8#2)
tax-exempt##6##1##(1991-2#1)(1992-8#2)(1996-2#1)(2008-11#2)
tax-exemption##6##1##(1993-1#1)(1996-2#1)(2008-11#4)
tax-financed##2##1##(1995-2#1)(2008-7#1)
taxa are##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
taxa at the##2##3##(2008-10#1)(2010-3#1)
taxa based on##2##3##(2008-10#1)(2011-2#1)
taxa by##2##2##(2011-2#2)
taxa have##3##2##(2008-10#1)(2008-11#2)
taxa in the##4##3##(2008-10#4)
taxa in##8##2##(2008-10#4)(2008-8#2)(2008-9#1)(2011-2#1)
taxa of##2##2##(2008-10#2)
taxa than##2##2##(2008-11#1)(2008-9#1)
taxa that had##2##3##(2008-8#2)
taxa with##3##2##(2008-8#2)(2008-9#1)
taxa##75##1##(2007-12#3)(2008-10#22)(2008-11#6)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#13)(2008-9#5)(2009-8#1)(2010-3#9)(2010-8#1)(2011-2#7)(2012-2#1)(2012-3#1)
taxane##3##1##(2008-9#3)
taxenes##2##1##(2008-8#2)
taxes##6##1##(1994-1#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-7#1)
taxing##3##1##(1994-2#1)(2009-9#1)(2010-8#1)
taxol##9##1##(1995-3#1)(2008-11#2)(2008-8#3)(2009-10#1)(2011-2#2)
taxometric procedures##2##2##(2007-12#2)
taxometric##3##1##(2007-12#3)
taxon groups##2##2##(2008-10#2)
taxon##13##1##(2007-12#2)(2008-10#6)(2008-5#1)(2010-6#1)(2011-2#2)(2013-8#1)
taxonomic and##2##2##(2008-12#1)(2008-8#1)
taxonomic characters##2##2##(2008-12#2)
taxonomic classification##2##2##(2008-10#1)(2011-2#1)
taxonomic group##2##2##(2008-10#1)(2008-9#1)
taxonomic groups##3##2##(2008-8#1)(2010-1#1)(2010-10#1)
taxonomic issues##2##2##(2008-10#1)(2010-10#1)
taxonomic units##2##2##(2010-10#1)(2012-2#1)
taxonomic##49##1##(1994-3#2)(1995-12#1)(2007-12#1)(2008-10#13)(2008-12#5)(2008-6#1)(2008-8#10)(2008-9#2)(2009-8#1)(2010-1#1)(2010-10#4)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#2)
taxonomically##5##1##(1996-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
taxonomy of the genus##2##4##(2008-10#1)(2008-5#1)
taxonomy of the##4##3##(2008-10#1)(2008-5#2)(2010-3#1)
taxonomy of##10##2##(2008-10#3)(2008-5#3)(2008-6#1)(2010-10#1)(2010-3#1)(2013-1#1)
taxonomy##20##1##(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#2)(2008-8#1)(2010-10#1)(2010-3#1)(2013-1#2)
taxpayers funding holistic healthcare and the first amendment requirement for separation of church and state##2##15##(2009-11#2)
tazarotene##4##1##(2007-11#3)(2010-3#1)
tbRAP1##2##1##(2011-2#2)
te##3##1##(2008-1#1)(2008-11#2)
tea and drug##3##3##(2008-10#3)
tea and##5##2##(2008-10#5)
tea components##2##2##(2008-11#2)
tea extract was##2##3##(2008-10#1)(2008-11#1)
tea extract##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
tea extracts##2##2##(2008-10#1)(2008-11#1)
tea in##2##2##(2008-11#1)(2009-8#1)
tea leaves##3##2##(2008-10#3)
tea polyphenol##2##2##(1995-9#2)
tea samples##8##2##(2008-10#8)
tea varieties##2##2##(2008-10#2)
tea was##2##2##(2008-10#1)(2009-8#1)
tea##75##1##(1995-9#2)(2008-10#49)(2008-11#11)(2008-5#1)(2009-3#1)(2009-8#8)(2010-1#1)(2011-2#1)(2012-12#1)
teach##21##1##(1993-12#2)(1994-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-2#1)
teacher expectations of##2##3##(2008-12#2)
teacher expectations##4##2##(2008-12#4)
teacher in##2##2##(2008-11#1)(2008-12#1)
teacher practices##4##2##(2008-12#4)
teacher support##2##2##(2009-7#2)
teacher##37##1##(1991-12#1)(1994-1#1)(1994-2#1)(2008-11#2)(2008-12#18)(2008-4#7)(2009-7#3)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
teacher's##5##1##(1991-12#1)(2008-11#2)(2008-12#1)(2011-2#1)
teacher-student relationships##2##2##(2008-12#1)(2011-2#1)
teacher-student##3##1##(2008-12#2)(2011-2#1)
teachers and##9##2##(2008-11#5)(2008-12#1)(2009-7#1)(2010-9#1)(2011-2#1)
teachers have##2##2##(2013-1#2)
teachers held##2##2##(2008-12#2)
teachers in##2##2##(1993-6#1)(2008-12#1)
teachers of##2##2##(1993-6#1)(2012-3#1)
teachers to##3##2##(2008-12#1)(2011-2#2)
teachers was##2##2##(2008-12#1)(2009-7#1)
teachers were not##2##3##(2008-10#1)(2008-12#1)
teachers were##3##2##(1991-12#1)(2008-10#1)(2008-12#1)
teachers who##2##2##(2008-11#1)(2011-2#1)
teachers##70##1##(1990-8#1)(1991-12#6)(1993-6#3)(1994-6#1)(1995-3#1)(2008-10#3)(2008-11#11)(2008-12#20)(2008-4#1)(2009-7#3)(2010-9#2)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
teachers'##14##1##(2008-12#3)(2009-7#3)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
teaching and assessing##3##3##(2008-11#3)
teaching and evaluation##2##3##(2008-12#2)
teaching and feeding##2##3##(1990-12#2)
teaching and learning approaches##2##4##(2008-11#1)(2008-12#1)
teaching and learning strategies##4##4##(2008-11#3)(2008-12#1)
teaching and learning strategy##4##4##(2008-11#4)
teaching and learning##26##3##(1996-1#1)(2008-11#18)(2008-12#7)
teaching and training##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
teaching and##44##2##(1990-12#2)(1992-12#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-11#26)(2008-12#10)(2011-2#1)(2013-1#1)
teaching at##3##2##(1990-3#1)(2008-12#1)(2010-1#1)
teaching clinical##4##2##(1994-12#2)(2008-11#2)
teaching hospital in##3##3##(2008-10#1)(2009-1#1)(2013-1#1)
teaching hospital##15##2##(1994-2#1)(1994-3#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-1#1)(2009-5#1)(2012-3#3)(2013-1#1)(2013-8#1)
teaching hospitals##9##2##(1991-3#1)(1992-12#1)(1994-3#1)(1996-3#1)(2008-11#4)(2008-7#1)
teaching in the##4##3##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
teaching in##11##2##(1997-2#1)(2008-11#5)(2008-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
teaching intensity##2##2##(1992-12#2)
teaching is##4##2##(1994-12#1)(2008-11#2)(2013-1#1)
teaching method##9##2##(2008-11#6)(2008-12#1)(2013-8#2)
teaching methodology##2##2##(2008-11#1)(2008-12#1)
teaching methods##3##2##(1996-2#1)(2008-11#1)(2008-12#1)
teaching nursing home##2##3##(2008-12#2)
teaching nursing##4##2##(1996-2#2)(2008-12#2)
teaching of##6##2##(1991-6#1)(2008-11#3)(2010-1#1)(2013-8#1)
teaching program##3##2##(1995-1#3)
teaching programs##3##2##(1992-12#1)(1995-1#1)(2010-9#1)
teaching sessions##2##2##(2008-11#2)
teaching strategies##5##2##(2008-11#2)(2008-12#3)
teaching strategy for##2##3##(2008-11#1)(2008-12#1)
teaching strategy is##2##3##(2008-11#2)
teaching strategy that##2##3##(2008-12#2)
teaching strategy##12##2##(2008-11#5)(2008-12#5)(2012-3#2)
teaching students about##2##3##(1995-12#1)(2009-8#1)
teaching students##3##2##(1995-12#1)(1997-2#1)(2009-8#1)
teaching the##2##2##(1994-12#1)(2008-12#1)
teaching tools##2##2##(2008-11#1)(2010-9#1)
teaching##239##1##(1990-12#6)(1990-2#2)(1990-3#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#6)(1992-2#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#7)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#4)(1995-12#2)(1995-2#1)(1996-1#7)(1996-2#4)(1996-3#1)(1997-2#4)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#87)(2008-12#34)(2008-3#1)(2008-7#2)(2009-1#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-8#1)(2010-9#2)(2011-2#8)(2012-2#2)(2012-3#7)(2013-1#9)(2013-8#7)
teaching/learning##2##1##(2008-11#2)
teachings##2##1##(1997-3#1)(2008-11#1)
team and the##2##3##(2009-6#1)(2010-1#1)
team and##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-11#1)
team approach to##3##3##(1994-12#1)(1994-2#1)(1996-3#1)
team approach##8##2##(1994-12#2)(1994-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2009-8#1)(2010-5#1)
team at the##2##3##(1995-2#1)(2010-10#1)
team can##4##2##(1993-12#1)(1993-2#1)(1994-12#1)(2008-7#1)
team for##2##2##(2008-11#1)(2009-9#1)
team has the##2##3##(2008-11#2)
team has##3##2##(1994-12#1)(2008-11#2)
team identified##2##2##(1996-1#1)(2013-1#1)
team in##2##2##(1992-2#1)(2012-3#1)
team leader##2##2##(1993-12#1)(2012-2#1)
team members##5##2##(1993-12#2)(1994-12#1)(2008-11#1)(2008-3#1)
team of health##2##3##(1994-12#1)(2008-1#1)
team of##13##2##(1990-6#1)(1994-12#1)(1995-5#1)(1996-1#2)(2008-1#1)(2008-11#3)(2008-12#1)(2009-6#1)(2010-5#1)(2011-2#1)
team performance##2##2##(1995-2#2)
team to make##2##3##(1995-9#1)(2012-2#1)
team to##9##2##(1993-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(2007-11#1)(2008-11#1)(2010-11#1)(2012-2#1)
team was##4##2##(1995-1#1)(1996-1#1)(2008-12#1)(2013-1#1)
team with##6##2##(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-8#1)
team##162##1##(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1993-1#2)(1993-12#9)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#8)(1994-2#8)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#8)(1995-5#1)(1995-9#1)(1996-1#12)(1996-2#2)(1996-3#1)(1997-2#4)(1997-4#2)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#17)(2008-12#6)(2008-3#2)(2008-7#6)(2008-9#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#2)(2011-8#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#7)
team's##7##1##(1993-12#2)(1994-1#1)(1997-2#2)(2009-6#1)(2009-9#1)
team-based structures##2##2##(1993-12#1)(1997-1#1)
team-based##8##1##(1993-12#2)(1997-1#1)(1997-2#1)(2008-12#1)(2010-8#2)(2013-1#1)
teams and##5##2##(1993-2#1)(1996-2#1)(2008-11#1)(2011-2#1)(2011-3#1)
teams are##2##2##(1993-12#2)
teams in the##2##3##(1993-11#1)(1994-1#1)
teams in##5##2##(1992-2#1)(1993-11#1)(1993-12#1)(1994-1#1)(2011-2#1)
teams of##2##2##(1993-1#1)(2012-3#1)
teams to##2##2##(1994-3#1)(2008-9#1)
teams##80##1##(1991-3#1)(1992-12#1)(1992-2#2)(1992-5#2)(1993-1#1)(1993-11#1)(1993-12#15)(1993-2#2)(1994-1#5)(1994-12#1)(1994-2#4)(1994-3#3)(1995-2#3)(1996-2#1)(1996-3#1)(1997-2#5)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
teamwork##7##1##(1993-3#1)(1996-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2013-1#1)
tear amount##4##2##(2013-8#4)
tear and##2##2##(2008-12#1)(2009-3#1)
tear##14##1##(2008-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-9#2)(2011-3#1)(2011-7#1)(2013-8#6)
tearing##2##1##(2008-5#1)(2011-2#1)
tears##9##1##(1992-6#1)(1993-11#2)(2009-10#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
teas and related components on the proliferation and invasion of##2##10##(2008-11#2)
teas and related components##3##4##(2008-11#3)
teas and##4##2##(2008-11#4)
teas were##2##2##(2008-10#2)
teas##17##1##(2008-10#10)(2008-11#6)(2009-8#1)
tease out##2##2##(1994-9#1)(2008-11#1)
teat dip##4##2##(1990-6#4)
teat##8##1##(1990-6#6)(1992-2#2)
tebuconazole effect on##3##3##(2008-10#3)
tebuconazole##11##1##(2008-10#11)
tech##4##1##(2008-12#3)(2008-7#1)
technetium##2##1##(1992-2#1)(1996-3#1)
technetium-99m##3##1##(1990-12#1)(1991-11#1)(2012-12#1)
technical advances##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
technical and medical##2##3##(1990-11#1)(1997-6#1)
technical and##9##2##(1990-11#1)(1991-1#1)(1992-9#1)(1993-1#1)(1997-6#1)(2008-11#2)(2008-5#1)(2012-3#1)
technical approaches##2##2##(2008-11#1)(2011-2#1)
technical aspects of the##2##4##(2008-11#1)(2008-9#1)
technical aspects of##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
technical aspects##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
technical assistance##2##2##(2013-1#2)
technical care##2##2##(2008-12#2)
technical change##3##2##(1992-1#3)
technical conditions##2##2##(2008-10#1)(2012-2#1)
technical details of##3##3##(1994-9#1)(2008-10#1)(2012-3#1)
technical details##4##2##(1994-9#1)(2008-10#1)(2008-9#1)(2012-3#1)
technical efficiency##3##2##(2013-8#3)
technical expertise##2##2##(1996-2#1)(2013-1#1)
technical experts and##2##3##(1996-1#1)(2010-10#1)
technical experts##3##2##(1994-12#1)(1996-1#1)(2010-10#1)
technical grade##4##2##(2008-10#3)(2012-12#1)
technical hurdles##2##2##(2008-4#1)(2011-2#1)
technical issues##3##2##(2009-10#1)(2010-4#1)(2011-2#1)
technical note##4##2##(2011-2#3)(2013-1#1)
technical oil##2##2##(2008-10#2)
technical problems##2##2##(1991-12#1)(1997-2#1)
technical report##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
technical requirements##3##2##(1996-1#1)(2008-12#1)(2010-7#1)
technical skills##5##2##(1993-12#2)(2008-11#2)(2011-2#1)
technical solutions##3##2##(1990-11#1)(1990-3#1)(2010-9#1)
technical variables##2##2##(2008-5#1)(2013-1#1)
technical waste plastics##2##3##(2008-10#2)
technical waste##3##2##(2008-10#3)
technical##155##1##(1990-11#2)(1990-3#1)(1991-1#1)(1991-12#2)(1991-3#3)(1992-1#4)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#3)(1996-2#2)(1997-2#1)(1997-3#2)(1997-6#3)(2008-1#1)(2008-10#23)(2008-11#17)(2008-12#6)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#1)(2009-3#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#18)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#6)(2013-8#3)
technically demanding##2##2##(2008-12#1)(2013-1#1)
technically feasible##5##2##(2008-12#1)(2008-7#2)(2009-8#1)(2012-3#1)
technically##20##1##(1990-5#1)(1993-11#1)(1993-3#1)(1994-9#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
technician##5##1##(2008-10#2)(2009-11#1)(2010-2#1)(2012-3#1)
technicians##4##1##(1994-12#1)(2009-11#1)(2010-8#1)(2012-2#1)
technics##2##1##(1994-3#1)(2007-8#1)
technique (DGT)##2##2##(2008-10#2)
technique after##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
technique allowed##5##2##(1997-3#1)(2008-10#3)(2008-11#1)
technique allows##9##2##(2008-10#7)(2008-7#1)(2008-9#1)
technique also provides a##2##4##(2008-10#1)(2008-3#1)
technique also##4##2##(2008-10#2)(2008-3#2)
technique and a##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
technique and by##2##3##(2008-10#2)
technique and cyclic##2##3##(2008-10#2)
technique and its##3##3##(2008-10#2)(2008-3#1)
technique and results##2##3##(1990-11#1)(1995-12#1)
technique and the##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
technique and##62##2##(1990-11#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#24)(2008-11#3)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-7#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
technique applied##2##2##(2008-10#1)(2008-5#1)
technique are discussed##2##3##(1994-9#1)(2008-10#1)
technique are##16##2##(1990-9#1)(1991-3#1)(1994-9#1)(1995-11#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2009-1#1)
technique as well##2##3##(2008-10#1)(2008-6#1)
technique as##7##2##(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2010-11#1)
technique at##6##2##(2008-10#5)(2012-3#1)
technique based on the##7##4##(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)
technique based on##13##3##(1995-5#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#1)
technique based##14##2##(1995-5#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#1)
technique because of##2##3##(1991-12#1)(2008-10#1)
technique because##4##2##(1991-12#1)(2008-10#2)(2008-3#1)
technique by##6##2##(2007-12#1)(2008-10#4)(2008-3#1)
technique called##4##2##(2008-10#1)(2008-12#1)(2008-4#2)
technique can be used to##2##5##(2008-10#2)
technique can be used##5##4##(2008-10#4)(2009-3#1)
technique can be##10##3##(1993-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-3#1)
technique can##18##2##(1993-2#1)(2008-10#10)(2008-2#1)(2008-3#3)(2009-3#1)(2012-3#1)(2013-8#1)
technique consists of##3##3##(1990-9#1)(2008-10#1)(2008-3#1)
technique could be##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
technique could##9##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
technique coupled with##2##3##(2008-10#2)
technique described in##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
technique described##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2010-4#1)
technique developed in##2##3##(2008-10#1)(2008-5#1)
technique developed##5##2##(2008-10#4)(2008-5#1)
technique during##2##2##(2008-10#1)(2011-2#1)
technique employed##4##2##(2008-10#2)(2008-7#1)(2010-4#1)
technique enables us to##2##4##(1997-8#1)(2008-10#1)
technique enables##4##2##(1997-8#1)(2008-10#3)
technique facilitates##2##2##(2008-10#1)(2008-11#1)
technique for analysis of##2##4##(2008-10#2)
technique for assessing##2##3##(2008-10#1)(2008-3#1)
technique for detection of##3##4##(2008-10#3)
technique for determining##3##3##(2008-10#1)(2008-2#1)(2010-3#1)
technique for evaluating##3##3##(1996-6#1)(2008-10#1)(2008-5#1)
technique for fascial closure##3##4##(1991-2#2)(1992-1#1)
technique for measuring the##2##4##(1991-5#1)(2008-2#1)
technique for measuring##4##3##(1991-5#1)(2007-11#1)(2008-10#1)(2008-2#1)
technique for monitoring the##2##4##(2008-10#2)
technique for monitoring##3##3##(2008-10#3)
technique for myocardial##2##3##(1991-3#1)(2013-8#1)
technique for performing##2##3##(2007-12#1)(2012-2#1)
technique for rapid##2##3##(2008-10#1)(2012-3#1)
technique for routine##4##3##(2008-10#3)(2008-9#1)
technique for single##2##3##(2009-12#2)
technique for the analysis of##4##5##(2008-10#4)
technique for the assay of##2##5##(1990-2#1)(2008-10#1)
technique for the determination of##10##5##(2008-10#8)(2008-11#1)(2009-8#1)
technique for the direct##2##4##(2008-10#2)
technique for the simultaneous determination of##2##6##(2008-10#2)
technique for the simultaneous##3##4##(2008-10#3)
technique for the##45##3##(1990-11#1)(1990-2#1)(2007-11#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
technique for treatment of##2##4##(1991-9#2)
technique for##177##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1993-3#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#84)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#7)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#2)
technique from a##2##3##(1995-12#1)(2008-11#1)
technique from##3##2##(1991-5#1)(1995-12#1)(2008-11#1)
technique gave a##2##3##(2008-10#1)(2008-7#1)
technique gave##5##2##(2008-10#4)(2008-7#1)
technique has a number of##2##5##(2008-9#2)
technique has been applied to##2##5##(2008-10#1)(2008-3#1)
technique has been developed for##3##5##(2008-10#3)
technique has been developed##7##4##(2008-10#7)
technique has been successfully applied##2##5##(2008-10#1)(2012-12#1)
technique has been used to study the##2##7##(1994-5#1)(2008-10#1)
technique has been used to##5##5##(1994-5#1)(2008-10#3)(2008-5#1)
technique has been used##7##4##(1991-11#1)(1994-5#1)(2008-10#4)(2008-5#1)
technique has been##23##3##(1991-11#1)(1991-12#1)(1994-5#1)(2007-12#1)(2008-10#16)(2008-3#1)(2008-5#1)(2012-12#1)
technique has##34##2##(1991-11#1)(1991-12#1)(1994-5#1)(2007-12#1)(2008-10#17)(2008-3#4)(2008-5#2)(2008-9#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
technique in a##2##3##(2008-10#1)(2008-3#1)
technique in both##2##3##(2008-10#2)
technique in combination with a##2##5##(2008-3#1)(2010-5#1)
technique in order to##2##4##(1992-2#1)(2008-10#1)
technique in the surgery of arteriovenous malformations of the brain##2##10##(2008-7#2)
technique in the##13##3##(1991-3#1)(1993-5#1)(2008-2#1)(2008-7#3)(2009-9#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
technique in which##4##3##(1992-9#1)(2008-10#1)(2009-7#1)(2011-2#1)
technique in##53##2##(1991-3#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-9#1)(1996-1#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#3)(2011-7#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
technique include##2##2##(2008-10#1)(2010-7#1)
technique involves##4##2##(2008-10#3)(2011-2#1)
technique is a promising##2##4##(2008-10#2)
technique is a##3##3##(2008-10#3)
technique is also##3##3##(2008-10#2)(2008-6#1)
technique is an##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
technique is applicable to##2##4##(2008-10#1)(2008-9#1)
technique is based on the##3##5##(2008-10#2)(2008-11#1)
technique is based on##10##4##(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)
technique is based##11##3##(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#2)(2010-7#1)(2010-8#1)(2011-2#1)
technique is being used##2##4##(2008-11#2)
technique is being##3##3##(2008-10#1)(2008-11#2)
technique is described for##2##4##(2008-10#2)
technique is described##6##3##(1990-9#1)(2008-10#3)(2008-11#1)(2008-2#1)
technique is discussed##2##3##(2008-10#2)
technique is employed##2##3##(2008-10#1)(2008-3#1)
technique is examined##2##3##(2008-3#2)
technique is fast and##2##4##(2008-10#1)(2010-4#1)
technique is not##3##3##(1992-6#1)(2008-10#1)(2008-2#1)
technique is now##2##3##(1994-5#1)(1997-8#1)
technique is one##2##3##(1994-12#1)(2008-3#1)
technique is presented##6##3##(2008-10#3)(2008-3#2)(2008-4#1)
technique is proposed##3##3##(2008-10#3)
technique is simple##2##3##(2008-10#1)(2010-5#1)
technique is suitable for the determination of##2##7##(2008-10#2)
technique is the##2##3##(2008-6#1)(2013-8#1)
technique is used##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
technique is useful for##3##4##(2008-3#2)(2012-3#1)
technique is##107##2##(1990-9#2)(1991-12#2)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#35)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#19)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
technique makes##2##2##(2007-8#1)(2008-11#1)
technique may be##6##3##(1992-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
technique may##10##2##(1992-2#1)(1994-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-7#1)
technique not##2##2##(2008-10#1)(2008-11#1)
technique of choice##4##3##(1992-9#1)(1995-11#1)(2012-2#2)
technique of interspecific hybridization##2##4##(2008-9#2)
technique of superficially##2##3##(2007-8#2)
technique of the##4##3##(1996-9#1)(2008-10#1)(2008-8#1)(2009-8#1)
technique of wound dressing##2##4##(2011-2#2)
technique of##62##2##(1991-11#1)(1991-3#1)(1992-9#1)(1994-2#1)(1995-11#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2007-8#2)(2008-10#17)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-8#4)(2010-11#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
technique on##5##2##(1995-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
technique or##3##2##(1996-2#1)(2008-10#2)
technique permits##3##2##(2008-10#2)(2008-2#1)
technique presented here##2##3##(2008-11#1)(2008-3#1)
technique presented##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
technique produces##2##2##(1991-3#1)(2008-10#1)
technique proposed##4##2##(2008-10#3)(2008-3#1)
technique proved##2##2##(1991-12#1)(2008-3#1)
technique provides a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
technique provides##7##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
technique ranged from##2##3##(1992-11#1)(2008-10#1)
technique represents a##2##3##(1990-2#1)(1992-6#1)
technique results##2##2##(2008-10#1)(2010-10#1)
technique seems##2##2##(1997-3#1)(2008-9#1)
technique should##3##2##(2008-10#3)
technique showed that##2##3##(2008-8#1)(2008-9#1)
technique showed##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
technique shows##2##2##(1991-3#1)(2012-2#1)
technique survival in##2##3##(2011-2#2)
technique survival overall and in anuric patients##2##7##(2011-2#2)
technique survival##7##2##(2011-2#7)
technique that allows##2##3##(2008-3#1)(2012-2#1)
technique that does not require##2##5##(1995-12#1)(2008-10#1)
technique that has##2##3##(2007-12#1)(2008-10#1)
technique that is##4##3##(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
technique that uses##4##3##(2007-12#1)(2008-3#2)(2011-2#1)
technique that##32##2##(1995-12#1)(1996-3#1)(1996-9#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#10)(2008-7#1)(2008-9#2)(2011-2#2)(2012-2#4)(2012-3#1)
technique the##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
technique to a##2##3##(2008-10#2)
technique to analyze##2##3##(2008-10#2)
technique to assess the##2##4##(2008-5#1)(2012-3#1)
technique to assess##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
technique to detect##2##3##(2008-10#1)(2012-12#1)
technique to determine##2##3##(2008-10#1)(2011-2#1)
technique to examine##2##3##(2008-3#1)(2008-9#1)
technique to investigate the##2##4##(2010-9#1)(2011-3#1)
technique to investigate##3##3##(1994-8#1)(2010-9#1)(2011-3#1)
technique to perform##2##3##(1991-2#1)(2008-10#1)
technique to study##3##3##(2008-10#2)(2008-8#1)
technique to the##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
technique to understand##2##3##(2008-11#1)(2013-8#1)
technique to##61##2##(1991-2#1)(1993-3#1)(1994-8#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2010-7#1)(2010-9#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
technique used by##2##3##(1990-9#1)(2012-2#1)
technique used for##2##3##(2008-10#1)(2012-12#1)
technique used in##2##3##(2012-2#1)(2013-1#1)
technique used to##6##3##(1994-12#1)(2008-10#3)(2008-7#1)(2008-8#1)
technique used##18##2##(1990-9#1)(1991-2#1)(1994-12#1)(1997-5#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#3)(2013-1#1)
technique using a##6##3##(1992-12#1)(1997-3#1)(2008-10#2)(2011-2#1)(2012-3#1)
technique using an##2##3##(1992-12#1)(1996-12#1)
technique using the##2##3##(1991-12#1)(2008-8#1)
technique using##21##2##(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#2)(1996-12#1)(1997-3#1)(2008-10#8)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
technique utilized##2##2##(2008-10#1)(2008-12#1)
technique was also##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
technique was applied for##2##4##(2008-10#1)(2008-2#1)
technique was applied in##2##4##(2008-10#1)(2008-3#1)
technique was applied to the##3##5##(2008-10#3)
technique was applied to##7##4##(2008-10#6)(2010-3#1)
technique was applied##12##3##(2008-10#8)(2008-2#1)(2008-3#1)(2010-3#1)(2013-1#1)
technique was confirmed##2##3##(2008-10#2)
technique was described##2##3##(2008-10#1)(2012-3#1)
technique was developed for##2##4##(2008-10#2)
technique was developed to localize##2##5##(2008-10#2)
technique was developed to produce##2##5##(2008-10#1)(2009-5#1)
technique was developed to##7##4##(2008-10#5)(2008-11#1)(2009-5#1)
technique was developed##11##3##(2008-10#9)(2008-11#1)(2009-5#1)
technique was employed##2##3##(1996-9#1)(2008-10#1)
technique was evaluated##2##3##(2008-10#2)
technique was examined##2##3##(2008-10#2)
technique was found to be##2##5##(2008-10#2)
technique was found##3##3##(2008-10#2)(2009-3#1)
technique was investigated##2##3##(2008-10#1)(2013-8#1)
technique was performed##2##3##(2008-10#1)(2011-2#1)
technique was successfully applied##2##4##(2008-10#2)
technique was used and the##2##5##(2008-10#2)
technique was used for##5##4##(1994-11#1)(2008-10#3)(2013-1#1)
technique was used to##8##4##(1990-12#1)(2008-10#5)(2010-10#1)(2011-2#1)
technique was used##22##3##(1990-12#1)(1990-5#1)(1992-2#1)(1994-11#1)(2008-10#13)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
technique was##101##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-2#1)(1994-1#1)(1994-11#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-10#58)(2008-11#3)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
technique we##2##2##(2008-11#1)(2012-3#1)
technique were compared##2##3##(2008-10#2)
technique were##12##2##(2008-10#9)(2008-11#1)(2008-5#1)(2012-3#1)
technique which can be##2##4##(1993-9#1)(1996-3#1)
technique which can##3##3##(1993-9#1)(1996-3#1)(2008-10#1)
technique which##11##2##(1991-2#1)(1993-9#1)(1994-2#1)(1996-3#1)(2008-10#4)(2008-9#1)(2010-12#1)(2013-1#1)
technique will##4##2##(2008-10#1)(2008-7#1)(2009-2#1)(2012-2#1)
technique with a##4##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
technique with an##3##3##(2008-10#2)(2008-3#1)
technique with the##2##3##(2008-10#1)(2012-12#1)
technique with##29##2##(1991-12#1)(1992-3#1)(1994-3#1)(1995-2#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-6#1)(2012-12#1)(2012-2#1)
technique without##2##2##(2008-7#1)(2013-1#1)
technique yields##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
technique##1514##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#10)(1991-1#1)(1991-11#3)(1991-12#14)(1991-2#7)(1991-3#9)(1991-5#3)(1991-6#3)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#2)(1992-2#5)(1992-3#1)(1992-5#4)(1992-6#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#4)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#8)(1996-2#5)(1996-3#6)(1996-6#2)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#9)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#6)(2006-6#2)(2007-11#5)(2007-12#9)(2007-8#4)(2008-1#3)(2008-10#632)(2008-11#57)(2008-12#16)(2008-2#21)(2008-3#127)(2008-4#11)(2008-5#22)(2008-6#6)(2008-7#34)(2008-8#34)(2008-9#44)(2009-1#3)(2009-10#2)(2009-11#2)(2009-12#5)(2009-2#4)(2009-3#4)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#3)(2010-3#5)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#10)(2010-8#2)(2010-9#3)(2011-2#64)(2011-3#4)(2011-7#5)(2012-12#10)(2012-2#43)(2012-3#21)(2012-4#1)(2012-5#1)(2013-1#45)(2013-8#13)
technique&quot##3##1##(1997-3#1)(2008-8#2)
technique)##3##1##(1991-12#1)(2008-10#2)
technique]##2##1##(1990-9#1)(1993-6#1)
techniques (e##2##2##(1997-7#1)(2011-2#1)
techniques -##2##2##(2008-10#2)
techniques a##2##2##(2008-10#2)
techniques and a##3##3##(2008-10#1)(2008-9#1)(2009-9#1)
techniques and an##2##3##(2008-10#2)
techniques and in##2##3##(2008-10#1)(2011-2#1)
techniques and it##2##3##(2008-10#1)(2011-1#1)
techniques and methodologies used##2##4##(2008-10#1)(2008-11#1)
techniques and the development of##2##5##(1994-5#1)(2008-10#1)
techniques and their##2##3##(1995-3#1)(2011-2#1)
techniques and##69##2##(1991-3#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#26)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
techniques applied##2##2##(2008-10#1)(2013-1#1)
techniques are adapted##2##3##(2008-10#1)(2008-9#1)
techniques are also##3##3##(2008-10#1)(2010-11#1)(2013-1#1)
techniques are available##3##3##(1991-9#1)(2008-11#2)
techniques are based on##2##4##(1996-9#1)(2010-8#1)
techniques are discussed##6##3##(2008-10#4)(2008-3#1)(2010-9#1)
techniques are employed to##2##4##(1994-2#1)(2008-10#1)
techniques are employed##3##3##(1994-2#1)(1994-9#1)(2008-10#1)
techniques are not##3##3##(1994-12#1)(2008-7#1)(2010-11#1)
techniques are presented##2##3##(2008-10#2)
techniques are used to enhance the##2##6##(2008-3#1)(2009-10#1)
techniques are used to##3##4##(1990-8#1)(2008-3#1)(2009-10#1)
techniques are used##5##3##(1990-8#1)(2008-3#1)(2009-10#1)(2010-12#1)(2013-1#1)
techniques are very##3##3##(2008-10#2)(2008-9#1)
techniques are##55##2##(1990-3#1)(1990-8#1)(1991-2#1)(1991-9#1)(1994-12#2)(1994-2#1)(1994-9#1)(1996-9#2)(1997-8#1)(2008-10#22)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#2)
techniques as##2##2##(2008-10#1)(2008-4#1)
techniques at##2##2##(2008-10#1)(2011-2#1)
techniques available for##4##3##(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)
techniques available##10##2##(1993-11#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
techniques based on##6##3##(1996-12#1)(2007-8#1)(2008-10#3)(2008-8#1)
techniques based##7##2##(1996-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)
techniques but##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2010-12#1)
techniques by##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
techniques can be used in the##2##6##(2011-2#2)
techniques can be used in##4##5##(2008-10#1)(2009-2#1)(2011-2#2)
techniques can be used##6##4##(2008-10#2)(2008-9#1)(2009-2#1)(2011-2#2)
techniques can be##8##3##(1997-7#1)(2008-10#3)(2008-9#1)(2009-2#1)(2011-2#2)
techniques can##13##2##(1994-3#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-6#1)(2008-9#1)(2009-2#1)(2010-1#1)(2011-2#2)
techniques cannot##2##2##(2008-3#1)(2008-9#1)
techniques described##3##2##(2008-10#2)(2008-11#1)
techniques developed in##2##3##(2008-10#1)(2008-8#1)
techniques developed to##2##3##(2008-10#1)(2008-2#1)
techniques developed##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
techniques differ##2##2##(2008-9#1)(2009-1#1)
techniques employed##3##2##(2008-10#3)
techniques for ankle arthrodesis##2##4##(2008-12#2)
techniques for detecting##2##3##(2008-10#2)
techniques for measurements##2##3##(2008-10#1)(2008-3#1)
techniques for measuring##2##3##(2008-2#1)(2008-4#1)
techniques for screening##5##3##(2008-10#4)(2011-2#1)
techniques for the analysis of##2##5##(1996-3#1)(2008-10#1)
techniques for the analysis##3##4##(1996-3#1)(2008-10#2)
techniques for the detection##2##4##(1995-12#1)(2008-2#1)
techniques for the quantification of##2##5##(1994-12#1)(2008-10#1)
techniques for the treatment of##2##5##(1991-2#1)(2011-3#1)
techniques for the##23##3##(1991-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-3#1)
techniques for##95##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-6#2)(2008-10#34)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#3)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
techniques gave##3##2##(2008-10#2)(2008-7#1)
techniques has been##2##3##(2010-4#1)(2011-2#1)
techniques has##9##2##(1994-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#2)
techniques have also##3##3##(1994-3#1)(2008-11#1)(2008-9#1)
techniques have been applied to##2##5##(2008-10#1)(2010-9#1)
techniques have been applied##3##4##(1996-3#1)(2008-10#1)(2010-9#1)
techniques have been developed##2##4##(2008-10#1)(2011-2#1)
techniques have been employed##2##4##(2008-10#1)(2008-9#1)
techniques have been modified##2##4##(2010-8#1)(2011-3#1)
techniques have been used to##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
techniques have been##22##3##(1996-3#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)
techniques have led to##2##4##(2011-1#1)(2013-8#1)
techniques have##38##2##(1990-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
techniques in recent years##2##4##(2008-12#1)(2008-4#1)
techniques in the##6##3##(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
techniques in##34##2##(1991-2#1)(1993-2#1)(1994-11#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
techniques include##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
techniques including##5##2##(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
techniques is described##4##3##(1996-2#1)(2008-10#2)(2010-11#1)
techniques is reported##2##3##(2008-10#1)(2008-2#1)
techniques is##17##2##(1996-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#2)(2010-11#1)(2012-3#1)
techniques may##4##2##(1991-12#1)(2008-10#2)(2008-12#1)
techniques of analysis##2##3##(2008-10#1)(2008-9#1)
techniques of molecular biology##2##4##(1997-7#1)(2011-2#1)
techniques of##25##2##(1994-5#1)(1997-7#1)(2008-10#10)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#2)
techniques offer##3##2##(2009-12#1)(2012-2#1)(2013-1#1)
techniques on the##2##3##(1992-2#1)(2009-1#1)
techniques on##4##2##(1992-2#1)(2008-3#1)(2009-1#1)(2013-1#1)
techniques over the last##2##4##(2008-4#1)(2009-12#1)
techniques presented##2##2##(2008-10#1)(2008-4#1)
techniques revealed##2##2##(1993-6#1)(2008-5#1)
techniques should##2##2##(1991-6#1)(1996-9#1)
techniques showed##2##2##(1994-12#1)(2008-10#1)
techniques such as##25##3##(1994-3#1)(2008-10#12)(2008-12#2)(2008-2#2)(2010-12#2)(2010-7#4)(2011-2#1)(2012-2#1)
techniques such##26##2##(1994-3#1)(2008-10#12)(2008-12#2)(2008-2#2)(2008-5#1)(2010-12#2)(2010-7#4)(2011-2#1)(2012-2#1)
techniques that are##2##3##(2008-9#1)(2011-2#1)
techniques that can be##2##4##(2008-4#1)(2008-9#1)
techniques that can##3##3##(1995-1#1)(2008-4#1)(2008-9#1)
techniques that have been developed for##2##6##(2008-11#1)(2008-4#1)
techniques that have been##6##4##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#2)
techniques that have##8##3##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-8#1)(2011-1#1)
techniques that##24##2##(1991-12#1)(1992-3#1)(1994-1#1)(1995-1#1)(1995-5#1)(2008-10#3)(2008-11#2)(2008-4#4)(2008-7#1)(2008-9#3)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
techniques to be##2##3##(2008-3#1)(2008-8#1)
techniques to determine the##2##4##(2008-10#2)
techniques to examine##2##3##(1996-12#1)(2008-8#1)
techniques to measure##2##3##(2008-7#1)(2009-7#1)
techniques to provide a##2##4##(2008-11#1)(2013-8#1)
techniques to the analysis of##2##5##(1995-5#1)(2008-10#1)
techniques to the##5##3##(1995-5#1)(2008-10#3)(2008-3#1)
techniques to water analysis Part##2##5##(2008-10#2)
techniques to water analysis##3##4##(2008-10#3)
techniques to##48##2##(1991-2#1)(1991-3#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-3#5)(2008-4#2)(2008-7#4)(2008-8#3)(2008-9#4)(2009-7#1)(2010-4#1)(2010-7#1)(2010-9#2)(2012-2#1)(2013-1#1)(2013-8#1)
techniques used for##5##3##(1992-9#1)(2008-10#2)(2008-7#1)(2011-2#1)
techniques used in##2##3##(1995-1#1)(2008-10#1)
techniques used to##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
techniques used were##2##3##(2008-10#2)
techniques used##16##2##(1992-9#1)(1995-1#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-7#2)(2009-10#1)(2010-8#1)(2011-2#2)
techniques using##7##2##(1991-5#1)(2008-1#1)(2008-10#3)(2008-9#1)(2012-2#1)
techniques was##8##2##(1991-12#1)(1995-5#1)(2008-10#4)(2008-12#1)(2008-8#1)
techniques we##2##2##(2008-10#1)(2008-5#1)
techniques were applied to##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
techniques were applied##6##3##(2008-10#2)(2008-11#1)(2011-2#2)(2013-1#1)
techniques were mainly##2##3##(1991-5#1)(2008-10#1)
techniques were used for##2##4##(2008-10#1)(2008-7#1)
techniques were used in##2##4##(1996-2#1)(2008-10#1)
techniques were used to study the##2##6##(2008-10#1)(2010-7#1)
techniques were used to##12##4##(1991-12#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-3#2)(2010-7#1)(2012-2#1)
techniques were used##18##3##(1991-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-3#2)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
techniques were##39##2##(1991-12#1)(1991-5#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#19)(2008-11#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
techniques when##2##2##(1990-9#1)(2012-3#1)
techniques which##2##2##(1992-12#1)(1995-3#1)
techniques will##2##2##(2011-2#2)
techniques with more##2##3##(1991-3#1)(2008-10#1)
techniques with##12##2##(1991-3#1)(2007-12#1)(2008-10#7)(2009-3#1)(2010-11#1)(2010-7#1)
techniques without##3##2##(2008-10#2)(2008-7#1)
techniques##1079##1##(1990-12#1)(1990-3#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#8)(1991-2#7)(1991-3#6)(1991-5#3)(1991-6#3)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#4)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#7)(1994-5#3)(1994-6#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#3)(1997-2#2)(1997-3#6)(1997-4#3)(1997-6#3)(1997-7#7)(1997-8#6)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#406)(2008-11#55)(2008-12#15)(2008-2#14)(2008-3#34)(2008-4#31)(2008-5#13)(2008-6#8)(2008-7#20)(2008-8#26)(2008-9#45)(2009-1#3)(2009-10#5)(2009-11#4)(2009-12#11)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#3)(2010-11#10)(2010-12#6)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#24)(2010-8#8)(2010-9#11)(2011-1#7)(2011-2#52)(2011-3#3)(2012-12#6)(2012-2#25)(2012-3#22)(2013-1#19)(2013-8#9)
techniques)##2##1##(2011-2#2)
techniques]##2##1##(1991-3#1)(1996-9#1)
technological advances and##2##3##(2008-11#1)(2008-12#1)
technological advances in##2##3##(2009-4#1)(2013-8#1)
technological advances##6##2##(2008-11#2)(2008-12#1)(2009-4#1)(2013-1#1)(2013-8#1)
technological and scientific##2##3##(1992-2#1)(2010-12#1)
technological and##3##2##(1992-2#1)(2010-12#2)
technological developments##2##2##(1997-8#1)(2010-7#1)
technological improvements##2##2##(1994-1#1)(2010-9#1)
technological properties##2##2##(2008-11#1)(2010-4#1)
technological systems##2##2##(2011-1#2)
technological##36##1##(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#6)(2008-12#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
technologically##5##1##(1993-12#1)(1996-3#1)(2008-3#1)(2011-1#1)(2012-2#1)
technologies and the##2##3##(2010-4#1)(2010-8#1)
technologies and##11##2##(1993-12#1)(1997-1#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-4#1)(2010-8#1)(2012-2#3)(2012-3#1)
technologies are##11##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-9#1)(2013-8#2)
technologies as##3##2##(1997-1#1)(2008-9#1)(2010-7#1)
technologies available##2##2##(2008-11#1)(2008-3#1)
technologies by##2##2##(2008-11#1)(2008-5#1)
technologies for the##2##3##(2008-3#1)(2013-1#1)
technologies for##14##2##(2008-11#4)(2008-3#1)(2008-6#1)(2009-12#3)(2009-4#1)(2009-7#1)(2010-8#1)(2011-3#1)(2013-1#1)
technologies have been developed##2##4##(2010-7#1)(2013-1#1)
technologies have been##3##3##(2010-7#1)(2011-3#1)(2013-1#1)
technologies have##4##2##(2008-11#1)(2010-7#1)(2011-3#1)(2013-1#1)
technologies in nurse education##2##4##(2008-11#2)
technologies in##9##2##(1992-2#1)(1997-1#1)(2008-11#2)(2008-6#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)
technologies such as##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
technologies that are##2##3##(2009-3#1)(2010-9#1)
technologies that##5##2##(2008-4#1)(2009-3#1)(2010-10#1)(2010-9#1)(2013-1#1)
technologies to##9##2##(1995-5#1)(2008-11#3)(2008-12#1)(2009-10#1)(2011-10#1)(2011-2#1)(2013-1#1)
technologies using##2##2##(2012-2#2)
technologies were##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-2#1)
technologies##152##1##(1992-11#1)(1992-2#3)(1992-3#2)(1993-12#2)(1995-5#1)(1997-1#4)(1997-2#1)(2008-10#17)(2008-11#25)(2008-12#3)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-12#4)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-4#1)(2010-5#2)(2010-7#8)(2010-8#7)(2010-9#3)(2011-10#1)(2011-2#5)(2011-3#2)(2012-2#14)(2012-3#2)(2013-1#6)(2013-8#4)
technologist##6##1##(1991-1#1)(1991-2#1)(1994-1#1)(1994-12#2)(2008-12#1)
technologists and##6##2##(1993-1#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(2008-12#1)
technologists##17##1##(1991-2#1)(1993-1#1)(1994-1#2)(1994-12#5)(1995-1#2)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-6#1)
technology acquisition in##2##3##(1991-1#1)(1994-12#1)
technology acquisition##3##2##(1991-1#1)(1994-12#1)(1997-1#1)
technology allows##2##2##(2008-12#1)(2008-7#1)
technology and the##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
technology and##23##2##(1993-11#1)(1994-6#1)(1995-3#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-9#2)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
technology as##3##2##(1992-6#1)(1997-2#1)(2008-11#1)
technology assessment and##2##3##(1993-3#1)(2008-2#1)
technology assessment##5##2##(1993-3#1)(1994-12#1)(2008-2#2)(2009-3#1)
technology assessments##2##2##(1994-12#1)(2009-3#1)
technology associated with the##2##4##(2008-11#1)(2008-9#1)
technology called##2##2##(2008-11#1)(2008-9#1)
technology can have a##2##4##(2008-11#2)
technology can##3##2##(2008-11#2)(2013-1#1)
technology for the##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
technology for##18##2##(1994-9#1)(1995-2#1)(1997-7#1)(2008-10#4)(2008-11#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
technology has allowed##2##3##(2008-11#1)(2008-4#1)
technology has been##3##3##(2008-11#3)
technology has##13##2##(1994-12#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#1)(2008-9#1)(2012-2#1)
technology have##3##2##(2008-9#1)(2010-6#1)(2013-1#1)
technology improves##2##2##(2010-12#1)(2012-2#1)
technology in a##2##3##(2008-10#1)(2010-4#1)
technology in clinical##3##3##(1994-12#1)(2008-8#1)(2011-7#1)
technology in health care##2##4##(2008-10#2)
technology in health##3##3##(2008-10#3)
technology in medicine##2##3##(2013-8#2)
technology in the##4##3##(1993-2#1)(2008-11#2)(2009-11#1)
technology in this##2##3##(2010-11#1)(2010-8#1)
technology in##36##2##(1993-2#1)(1994-12#1)(2008-10#8)(2008-11#7)(2008-12#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-7#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
technology into##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
technology is a##2##3##(2008-10#1)(2013-8#1)
technology is also##2##3##(2008-11#1)(2008-5#1)
technology is described##2##3##(2008-3#1)(2013-1#1)
technology is the##2##3##(2008-10#1)(2008-11#1)
technology is##22##2##(1992-1#1)(1994-12#2)(1994-2#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2009-3#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
technology may##3##2##(2008-11#1)(2008-3#1)(2009-3#1)
technology of the##3##3##(1997-5#1)(2008-10#1)(2008-5#1)
technology of##11##2##(1990-8#1)(1994-1#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#2)
technology on##2##2##(1995-12#1)(2013-1#1)
technology provides##2##2##(2008-7#1)(2013-1#1)
technology should##2##2##(2008-9#1)(2011-2#1)
technology that are##2##3##(1992-1#1)(2009-7#1)
technology that can##3##3##(2012-2#2)(2013-7#1)
technology that##13##2##(1992-1#1)(1992-11#1)(1992-9#1)(1994-3#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-7#1)(2012-2#3)(2012-3#1)(2013-7#1)
technology to facilitate##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
technology to monitor##2##3##(2008-10#1)(2013-8#1)
technology to##26##2##(1995-11#1)(1995-3#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#3)(2010-12#1)(2013-1#1)(2013-8#1)
technology using##2##2##(2008-3#1)(2008-9#1)
technology was##6##2##(2008-10#4)(2008-5#2)
technology were##3##2##(2008-10#1)(2008-12#1)(2010-7#1)
technology which##4##2##(2008-10#2)(2008-11#2)
technology will allow##2##3##(1995-12#1)(1996-1#1)
technology will##5##2##(1994-12#1)(1995-12#1)(1996-1#1)(2008-10#2)
technology with##2##2##(2008-9#1)(2013-1#1)
technology##411##1##(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1994-1#6)(1994-12#12)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1996-1#4)(1996-12#1)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#3)(2008-10#77)(2008-11#68)(2008-12#12)(2008-2#2)(2008-3#5)(2008-4#9)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#18)(2009-11#1)(2009-12#1)(2009-3#7)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#5)(2011-1#4)(2011-2#14)(2011-7#7)(2012-12#2)(2012-2#20)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#10)
technology)##4##1##(1993-2#2)(2008-10#1)(2011-2#1)
technology]##2##1##(2012-3#1)(2013-8#1)
tecnique##2##1##(2009-10#2)
tectonic plate##2##2##(2008-9#2)
tectorial membrane injury##2##3##(2012-12#2)
tedious and time consuming##3##4##(1990-2#1)(2008-10#1)(2008-9#1)
tedious and##4##2##(1990-2#1)(2008-10#2)(2008-9#1)
tedious prior separation##2##3##(2008-10#2)
tedious##10##1##(1990-2#1)(2008-10#8)(2008-9#1)
teen##4##1##(1997-2#1)(2013-1#3)
teenage##3##1##(2008-11#1)(2009-7#1)(2013-1#1)
teenagers##15##1##(1996-6#1)(2008-11#7)(2008-9#2)(2009-7#1)(2013-1#3)(2013-8#1)
teens##8##1##(2012-2#1)(2013-1#7)
teeth and##11##2##(1995-9#2)(2008-1#2)(2009-10#1)(2009-7#1)(2013-1#5)
teeth in##4##2##(1991-6#2)(2013-1#2)
teeth were##9##2##(1990-2#1)(1991-6#1)(1996-3#1)(1996-5#1)(2008-7#1)(2013-1#4)
teeth with##4##2##(1991-2#1)(1995-9#1)(2011-2#2)
teeth##79##1##(1990-2#3)(1991-2#3)(1991-3#1)(1991-6#5)(1993-2#1)(1995-9#5)(1996-3#4)(1996-5#2)(1997-2#1)(2008-1#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-10#2)(2009-3#1)(2009-7#2)(2010-8#1)(2010-9#1)(2011-2#8)(2012-3#1)(2013-1#26)
teflon membrane##6##2##(2008-10#6)
teflon##9##1##(2008-10#9)
tegmental area##9##2##(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#2)(2008-7#1)(2009-8#1)
tegmental nucleus##6##2##(1991-12#3)(1994-2#2)(2008-7#1)
tegmental##15##1##(1991-12#3)(1994-2#2)(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#2)(2008-7#2)(2009-8#1)
teicoplanin modified with acetonitrile-based##2##4##(2008-10#2)
teicoplanin modified with##3##3##(2008-10#3)
teicoplanin phase##2##2##(2008-10#2)
teicoplanin stationary phase##2##3##(2008-10#2)
teicoplanin##19##1##(2008-10#19)
teicoplanine##2##1##(2008-10#2)
telangiectasia##15##1##(1994-12#1)(1995-6#3)(2008-7#6)(2009-10#1)(2010-6#4)
telangiectasias##2##1##(2010-6#2)
telbivudine##4##1##(2009-8#3)(2013-1#1)
telecom##2##1##(2007-11#2)
telecommunication wavelength##2##2##(2008-3#2)
telecommunications system##2##2##(1995-2#1)(2007-9#1)
telecommunications##8##1##(1991-12#1)(1995-2#3)(1996-1#2)(1996-2#1)(2007-9#1)
telemedicine in##2##2##(1996-2#1)(2013-1#1)
telemedicine##14##1##(1996-2#5)(1996-3#4)(2007-9#2)(2008-11#1)(2008-12#1)(2013-1#1)
telemetry##6##1##(2008-9#4)(2010-6#1)(2010-8#1)
telencephali pars##2##2##(2008-6#2)
telencephali##3##1##(2008-6#3)
telencephalon or##2##2##(1996-5#2)
telencephalon##4##1##(1996-5#3)(2008-6#1)
teleomorph has##2##2##(2008-10#2)
teleomorph stage and##2##3##(2008-10#2)
teleomorph##10##1##(2008-10#9)(2010-3#1)
teleomorphs##3##1##(2008-10#3)
teleost fish##3##2##(1995-12#1)(2008-7#1)(2012-3#1)
teleost##9##1##(1995-12#1)(1995-2#1)(1997-9#2)(2008-5#1)(2008-7#2)(2010-4#1)(2012-3#1)
teleosts##5##1##(1995-2#2)(1997-3#1)(2010-5#1)(2010-8#1)
telephone counseling##2##2##(1996-5#1)(1997-2#1)
telephone interviews##5##2##(2008-11#3)(2010-10#1)(2013-1#1)
telephone survey of##4##3##(1993-3#1)(1997-2#1)(2008-11#1)(2013-1#1)
telephone survey##7##2##(1993-3#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
telephone systems and##2##3##(1997-2#1)(2010-2#1)
telephone systems##3##2##(1997-2#1)(2008-10#1)(2010-2#1)
telephone##46##1##(1992-8#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-5#4)(1997-2#4)(1997-5#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-2#5)(2011-2#2)(2012-12#1)(2013-1#5)(2013-8#1)
teleradiology##4##1##(1997-4#3)(2012-2#1)
telescope diameter##2##2##(2008-3#2)
telescope##12##1##(1991-2#1)(2007-11#2)(2008-3#9)
telescopes##3##1##(1990-8#1)(1995-6#1)(2008-3#1)
television and radio##3##3##(1995-2#1)(1997-1#1)(1997-6#1)
television and##4##2##(1995-2#1)(1997-1#1)(1997-6#1)(2012-12#1)
television##12##1##(1995-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-11#2)(2009-4#1)(2009-7#2)(2010-11#1)(2010-6#1)(2012-12#1)
telia##6##1##(2008-10#6)
telial hosts##2##2##(2008-10#2)
telial##3##1##(2008-10#3)
teliospore germination##8##2##(2008-10#8)
teliospores of P##2##3##(2008-10#2)
teliospores of##6##2##(2008-10#6)
teliospores on##2##2##(2008-10#2)
teliospores produced##2##2##(2008-10#2)
teliospores##20##1##(2008-10#20)
tell us about##5##3##(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)
tell us##6##2##(2008-1#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)
tell##12##1##(1991-2#1)(1996-5#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#2)(2013-8#1)
telling us about##2##3##(2011-1#1)(2011-2#1)
telling##10##1##(1990-6#1)(1995-12#1)(1996-8#1)(2008-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#3)
tells##4##1##(1994-6#2)(2008-11#1)(2008-7#1)
tellurite glass##2##2##(2008-3#2)
tellurium##8##1##(2008-10#8)
teloRZ##6##1##(2008-9#6)
teloblastic##2##1##(2007-12#2)
telogen effluvium was##2##3##(2008-5#2)
telogen effluvium##5##2##(2008-5#3)(2008-8#1)(2012-3#1)
telogen##6##1##(2008-5#4)(2008-8#1)(2012-3#1)
telomerase RNA##2##2##(2008-9#2)
telomerase activation##2##2##(2008-11#2)
telomerase activity and##5##3##(2008-11#4)(2008-9#1)
telomerase activity in##4##3##(2008-11#2)(2008-9#2)
telomerase activity##14##2##(2008-11#10)(2008-9#4)
telomerase reverse##4##2##(2008-11#4)
telomerase##46##1##(1990-5#1)(2008-11#37)(2008-9#8)
telomere length##11##2##(2008-11#3)(2012-3#6)(2013-8#2)
telomere maintenance##4##2##(2008-11#4)
telomere sequence##3##2##(2008-11#3)
telomere shortening##2##2##(2008-11#2)
telomere##38##1##(1990-5#1)(1991-7#1)(2008-11#18)(2008-8#1)(2011-2#4)(2012-3#10)(2013-1#1)(2013-8#2)
telomere-associated##2##1##(2008-8#2)
telomere-controlled senescence##3##2##(2008-11#3)
telomere-like##2##1##(1993-12#2)
telomeres and##5##2##(2008-11#3)(2011-2#1)(2012-3#1)
telomeres containing##2##2##(1991-7#2)
telomeres of##3##2##(1991-7#1)(1997-6#2)
telomeres##27##1##(1990-5#1)(1991-7#7)(1997-6#2)(2008-11#9)(2008-12#2)(2011-2#5)(2012-3#1)
telomeric DNA sequences##2##3##(2008-8#2)
telomeric DNA##8##2##(1990-5#4)(2008-11#2)(2008-8#2)
telomeric regions##3##2##(2008-12#2)(2008-8#1)
telomeric##26##1##(1990-5#4)(1993-3#1)(1994-11#1)(1995-2#2)(1997-6#1)(2008-10#1)(2008-11#5)(2008-12#4)(2008-8#4)(2009-8#1)(2010-8#1)(2011-2#1)
telotrophic##4##1##(2007-12#1)(2008-12#3)
temperament##7##1##(2008-9#1)(2009-10#5)(2012-5#1)
temperate and tropical isolates##8##4##(2008-10#8)
temperate and tropical##10##3##(2008-10#10)
temperate and##12##2##(2008-10#10)(2008-12#1)(2008-8#1)
temperate climates##2##2##(2008-10#2)
temperate forest##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
temperate isolates##5##2##(2008-10#5)
temperate regions of the##2##4##(1996-12#1)(2008-10#1)
temperate regions of##4##3##(1996-12#1)(2008-10#3)
temperate regions##5##2##(1996-12#1)(2008-10#4)
temperate##49##1##(1993-9#3)(1996-12#1)(2008-10#26)(2008-12#2)(2008-8#4)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#3)(2012-4#1)(2013-8#1)
temperature ( approximately##2##3##(2008-10#2)
temperature (20##2##2##(2010-4#1)(2011-2#1)
temperature (25##2##2##(2008-10#1)(2010-4#1)
temperature (T(m)) of##2##3##(2008-5#1)(2011-1#1)
temperature (Tc)##2##2##(1994-2#1)(2008-8#1)
temperature affected##2##2##(2008-10#1)(2008-9#1)
temperature and OH concentration profiles##2##5##(2008-3#2)
temperature and OH##3##3##(2008-3#3)
temperature and RH##3##3##(2008-10#3)
temperature and a##2##3##(2008-10#1)(2008-2#1)
temperature and density##2##3##(2008-9#2)
temperature and dew period##3##4##(2008-10#3)
temperature and humidity##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
temperature and inoculum density of##2##5##(2008-10#2)
temperature and leaf wetness duration##5##5##(2008-10#5)
temperature and leaf wetness##6##4##(2008-10#6)
temperature and modifier concentration on##2##5##(2008-10#2)
temperature and moisture##4##3##(1997-2#1)(2008-10#3)
temperature and pH for##2##4##(2008-10#2)
temperature and pH##9##3##(1993-12#1)(1994-5#1)(2008-10#6)(2008-5#1)
temperature and pressure are##2##4##(2008-3#2)
temperature and pressure##8##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2012-2#1)
temperature and rainfall##2##3##(2008-10#2)
temperature and relative humidity (RH)##2##5##(1996-12#1)(2008-10#1)
temperature and relative humidity##7##4##(1995-3#1)(1996-12#1)(2008-10#5)
temperature and relative##9##3##(1995-3#1)(1996-12#1)(2008-10#5)(2008-3#2)
temperature and that##2##3##(2008-10#1)(2013-8#1)
temperature and the##12##3##(1992-2#1)(2008-10#5)(2008-3#3)(2008-8#1)(2011-2#2)
temperature and time of##4##4##(2008-10#1)(2008-12#1)(2008-5#1)(2012-4#1)
temperature and time##6##3##(2008-10#3)(2008-12#1)(2008-5#1)(2012-4#1)
temperature and wetness duration##2##4##(2008-10#2)
temperature and wetness##4##3##(2008-10#4)
temperature and##164##2##(1991-3#1)(1992-2#2)(1993-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-2#2)(2007-12#2)(2008-10#96)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#19)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#5)(2012-2#2)(2012-4#2)(2012-6#1)(2013-1#2)(2013-8#1)
temperature are##5##2##(2008-10#4)(2008-3#1)
temperature as well as##3##4##(2008-10#1)(2008-3#2)
temperature as##6##2##(1994-2#1)(2008-10#3)(2008-3#2)
temperature at##6##2##(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
temperature below##2##2##(2008-11#1)(2009-7#1)
temperature between##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
temperature breaks##2##2##(2012-4#2)
temperature by##6##2##(1991-5#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
temperature can be##2##3##(2008-10#2)
temperature can##3##2##(2008-10#2)(2008-11#1)
temperature change##3##2##(1991-2#1)(2008-10#1)(2012-6#1)
temperature changes##3##2##(1994-9#1)(2008-10#1)(2008-8#1)
temperature coefficient##2##2##(1991-5#1)(2008-10#1)
temperature coefficients##2##2##(1994-5#1)(2008-10#1)
temperature compensation##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
temperature conditions##10##2##(1997-2#2)(2008-10#4)(2008-12#2)(2008-6#1)(2008-8#1)
temperature control##2##2##(2008-10#2)
temperature cultivation##2##2##(2008-11#2)
temperature curves##3##2##(2008-10#2)(2008-11#1)
temperature data##2##2##(2008-3#1)(2008-8#1)
temperature decreased##2##2##(2008-10#2)
temperature dependence of the##5##4##(1991-5#1)(1997-6#1)(2008-10#2)(2008-2#1)
temperature dependence of##6##3##(1991-5#1)(1997-6#1)(2008-10#3)(2008-2#1)
temperature dependence##13##2##(1991-5#1)(1992-3#1)(1992-4#1)(1996-5#1)(1997-6#1)(2008-10#5)(2008-2#2)(2008-5#1)
temperature dependent##6##2##(1994-8#3)(2008-10#2)(2008-11#1)
temperature depression##2##2##(2008-10#2)
temperature difference##3##2##(2008-10#1)(2008-3#2)
temperature distribution in##2##3##(2008-3#2)
temperature distribution##6##2##(2008-10#2)(2008-3#3)(2008-7#1)
temperature distributions and thermal deformations##2##5##(2008-3#2)
temperature distributions##3##2##(2008-3#3)
temperature drift in##2##3##(2013-8#2)
temperature drift##3##2##(2013-8#3)
temperature during the##2##3##(2008-10#2)
temperature during##9##2##(2008-10#8)(2011-2#1)
temperature effect on##2##3##(2008-10#1)(2008-11#1)
temperature effect##6##2##(2008-10#4)(2008-11#1)(2012-5#1)
temperature effects##6##2##(2008-10#3)(2008-11#1)(2008-8#2)
temperature experienced##2##2##(2008-8#1)(2011-2#1)
temperature field database##2##3##(2008-3#2)
temperature for a##2##3##(2008-10#1)(2008-11#1)
temperature for infection##2##3##(2008-10#2)
temperature for the##3##3##(2008-10#3)
temperature for##19##2##(1990-11#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-5#1)
temperature from 37 degrees C to##2##6##(2008-11#2)
temperature from##7##2##(2008-10#4)(2008-11#2)(2010-7#1)
temperature gradients##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
temperature had##2##2##(2008-10#1)(2008-11#1)
temperature have been##2##3##(2008-9#1)(2011-2#1)
temperature in a##2##3##(2008-10#1)(2008-3#1)
temperature in the range##3##4##(2008-10#3)
temperature in the##9##3##(2008-10#7)(2008-2#1)(2008-9#1)
temperature in##17##2##(1996-5#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
temperature increased##3##2##(2008-10#2)(2008-11#1)
temperature increases##2##2##(2008-10#1)(2008-9#1)
temperature is an important##2##4##(2008-10#1)(2008-9#1)
temperature is##15##2##(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)
temperature leads to##2##3##(2008-10#1)(2010-3#1)
temperature measurement##2##2##(2008-3#2)
temperature measurements of##2##3##(2008-2#1)(2008-3#1)
temperature measurements##11##2##(2007-12#1)(2008-2#2)(2008-3#8)
temperature of 1900 degrees C##2##5##(2008-10#2)
temperature of 25##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
temperature of 35 degrees C##2##5##(2008-10#1)(2008-5#1)
temperature of about##2##3##(1990-9#1)(2008-10#1)
temperature of the##17##3##(1992-2#1)(1995-6#1)(2008-10#8)(2008-3#2)(2008-7#2)(2009-3#1)(2011-2#2)
temperature of##67##2##(1990-9#1)(1992-2#1)(1995-6#2)(2008-10#43)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-7#1)(2011-2#4)(2013-1#2)
temperature on infection##2##3##(2008-10#2)
temperature on the##20##3##(1991-11#1)(1991-5#1)(1997-2#1)(2008-10#14)(2008-5#1)(2011-2#2)
temperature on##45##2##(1991-11#1)(1991-5#1)(1997-2#1)(2008-10#28)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-2#2)(2012-6#1)
temperature optimum##4##2##(1990-5#1)(1991-5#1)(2008-10#2)
temperature or##5##2##(1990-5#1)(2008-10#1)(2008-5#2)(2012-7#1)
temperature over the##2##3##(1996-2#2)
temperature phosphorescence of##3##3##(2008-10#3)
temperature phosphorescence##17##2##(2008-10#17)
temperature phosphorimetry##3##2##(2008-10#3)
temperature profile##2##2##(2008-11#1)(2008-3#1)
temperature profiles##4##2##(1996-12#1)(2008-3#1)(2011-2#2)
temperature program##4##2##(2008-10#4)
temperature range for##2##3##(2008-10#2)
temperature range of##4##3##(1993-8#1)(2008-10#3)
temperature range##20##2##(1991-5#1)(1993-8#2)(1994-5#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-7#1)
temperature ranges##4##2##(1997-2#1)(2008-10#3)
temperature ranging from##2##3##(1996-12#1)(2008-10#1)
temperature regimes##6##2##(2008-10#6)
temperature relationships##2##2##(2008-10#2)
temperature rise in the##2##4##(2008-2#1)(2008-3#1)
temperature rise##4##2##(2008-2#1)(2008-3#2)(2009-11#1)
temperature sensitive##3##2##(2008-10#2)(2011-2#1)
temperature sensitivity of##4##3##(2008-3#1)(2008-8#1)(2008-9#2)
temperature sensitivity##7##2##(1995-2#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#2)
temperature shift##5##2##(1991-2#1)(1995-6#1)(2008-11#3)
temperature stability of the##2##4##(1993-6#1)(2008-3#1)
temperature stability##3##2##(1993-6#1)(2007-12#1)(2008-3#1)
temperature stabilization##2##2##(2008-2#2)
temperature than##3##2##(1992-3#1)(2008-10#1)(2008-9#1)
temperature thresholds##2##2##(2008-10#2)
temperature to##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)
temperature treatment##2##2##(2008-10#1)(2008-9#1)
temperature under##2##2##(1997-2#1)(2007-12#1)
temperature using##2##2##(2008-10#2)
temperature variation of##2##3##(1997-2#1)(2008-3#1)
temperature variation##3##2##(1997-2#1)(2008-3#1)(2012-6#1)
temperature variations##2##2##(2008-10#2)
temperature was also##3##3##(2008-10#1)(2008-6#1)(2010-4#1)
temperature was between##3##3##(2008-10#2)(2008-6#1)
temperature was observed##3##3##(2008-10#3)
temperature was recorded##2##3##(2008-10#1)(2008-3#1)
temperature was##39##2##(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#25)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#3)(2010-4#1)(2010-7#1)
temperature we##2##2##(2007-12#1)(2008-2#1)
temperature were developed##2##3##(2008-10#2)
temperature were investigated##2##3##(2008-10#2)
temperature were optimised##2##3##(2008-10#2)
temperature were optimized##3##3##(2008-10#3)
temperature were recorded##2##3##(1991-9#1)(2008-10#1)
temperature were##23##2##(1991-9#1)(1994-8#1)(2008-10#17)(2008-2#2)(2010-4#1)(2012-2#1)
temperature with a##2##3##(2008-10#1)(2008-3#1)
temperature with##5##2##(1992-3#1)(2008-10#3)(2008-3#1)
temperature zones##2##2##(2008-10#1)(2008-9#1)
temperature##1222##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#5)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#7)(1991-9#2)(1992-10#1)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#4)(1994-8#5)(1994-9#1)(1995-2#1)(1995-3#4)(1995-6#7)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#8)(1996-2#9)(1996-5#3)(1997-2#16)(1997-6#1)(2007-11#3)(2007-12#12)(2008-10#640)(2008-11#54)(2008-12#9)(2008-2#25)(2008-3#93)(2008-4#2)(2008-5#35)(2008-6#11)(2008-7#18)(2008-8#24)(2008-9#29)(2009-11#8)(2009-3#3)(2009-5#4)(2009-7#6)(2009-8#4)(2010-12#1)(2010-3#1)(2010-4#10)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#41)(2012-2#8)(2012-3#3)(2012-4#5)(2012-5#3)(2012-6#10)(2012-7#9)(2012-9#1)(2013-1#7)(2013-8#14)
temperature) was##2##2##(2008-10#1)(2008-11#1)
temperature) were##2##2##(2008-10#1)(2011-2#1)
temperature)##13##1##(1995-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-6#1)
temperature-##2##1##(1996-3#1)(2008-10#1)
temperature-dependent sex determination##2##3##(2008-8#2)
temperature-dependent##10##1##(1990-2#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-3#3)(2008-8#2)
temperature-programmed##2##1##(2010-7#2)
temperature-sensitive for##3##2##(1991-2#2)(1994-12#1)
temperature-sensitive##19##1##(1991-2#3)(1992-3#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-9#2)(1997-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#3)
temperatures &gt##3##2##(2008-10#3)
temperatures (20##3##2##(2008-10#3)
temperatures (7 to##2##3##(2008-10#2)
temperatures above##4##2##(2008-10#3)(2010-4#1)
temperatures and exposure##2##3##(2008-10#2)
temperatures and heating##2##3##(2008-10#2)
temperatures and high##2##3##(2008-10#1)(2010-4#1)
temperatures and pH values##2##4##(2008-10#1)(2010-4#1)
temperatures and pressures##2##3##(2008-10#1)(2008-3#1)
temperatures and the##2##3##(2008-10#1)(2012-4#1)
temperatures and##28##2##(1993-5#1)(1993-8#1)(1996-12#1)(2008-10#15)(2008-12#1)(2008-3#4)(2008-9#1)(2010-4#2)(2011-2#1)(2012-4#1)
temperatures are##4##2##(2008-10#3)(2008-2#1)
temperatures at##2##2##(2008-10#2)
temperatures between 22##2##3##(2008-10#1)(2008-11#1)
temperatures between##10##2##(1991-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-7#1)(2013-8#1)
temperatures by##3##2##(2008-10#3)
temperatures during the##2##3##(2012-5#1)(2012-8#1)
temperatures during##6##2##(2008-10#3)(2012-4#1)(2012-5#1)(2012-8#1)
temperatures for pyrolysis and atomization##3##5##(2008-10#3)
temperatures for the##4##3##(2008-10#3)(2009-7#1)
temperatures for##16##2##(2008-10#14)(2008-12#1)(2009-7#1)
temperatures from 2##2##3##(2008-10#1)(2011-2#1)
temperatures from 20 to##3##4##(2008-10#3)
temperatures from 5 to##2##4##(2008-10#2)
temperatures from##15##2##(2008-10#13)(2011-2#1)(2012-2#1)
temperatures have##2##2##(2008-10#1)(2008-9#1)
temperatures in the range##2##4##(2008-10#1)(2008-3#1)
temperatures in the##3##3##(2008-10#2)(2008-3#1)
temperatures in##9##2##(2008-10#5)(2008-3#3)(2008-8#1)
temperatures may##2##2##(2008-10#2)
temperatures of &lt##2##3##(2008-10#2)
temperatures of 15##3##3##(2008-10#3)
temperatures of 20##2##3##(2008-10#2)
temperatures of##28##2##(2008-10#24)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)
temperatures on##7##2##(2008-10#3)(2008-5#1)(2010-8#1)(2012-8#2)
temperatures or##4##2##(2008-10#3)(2008-3#1)
temperatures ranging from##7##3##(2008-10#6)(2011-2#1)
temperatures tested##3##2##(2008-10#2)(2008-5#1)
temperatures that##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
temperatures the development##2##3##(2008-10#2)
temperatures the##4##2##(2008-10#3)(2008-3#1)
temperatures to##2##2##(2008-3#2)
temperatures under##2##2##(2008-10#2)
temperatures up to##5##3##(2008-10#3)(2008-6#1)(2009-7#1)
temperatures was##2##2##(2008-10#2)
temperatures were##12##2##(2008-10#10)(2008-11#1)(2008-8#1)
temperatures with##2##2##(2008-10#1)(2008-3#1)
temperatures##345##1##(1990-5#1)(1990-9#2)(1991-5#1)(1992-3#3)(1993-5#1)(1993-8#2)(1993-9#1)(1994-9#1)(1995-3#3)(1996-1#1)(1996-12#2)(1996-5#1)(1997-2#2)(2008-10#226)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#19)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#10)(2008-9#7)(2009-7#4)(2009-8#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#3)(2012-4#2)(2012-5#5)(2012-6#2)(2012-7#2)(2012-8#5)(2013-8#1)
tempered by the fact that##2##5##(2008-11#1)(2008-9#1)
tempered##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
template DNA##3##2##(2008-8#1)(2008-9#1)(2010-4#1)
template and the##2##3##(1993-12#1)(1997-3#1)
template and##7##2##(1993-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-6#1)
template for##6##2##(1995-12#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-11#2)
template molecule##5##2##(2008-10#5)
template to##2##2##(2008-8#1)(2008-9#1)
template update##2##2##(2008-6#2)
template##73##1##(1992-3#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-3#2)(1997-7#2)(2008-10#29)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#1)(2009-6#2)(2010-4#1)(2010-8#1)(2012-3#1)
templates for PCR##2##3##(1994-8#1)(1996-8#1)
templates for##6##2##(1994-8#1)(1996-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-11#1)
templates from##3##2##(2008-10#3)
templates##18##1##(1992-6#1)(1994-8#1)(1995-6#2)(1996-8#1)(2008-10#8)(2008-4#1)(2008-7#2)(2009-9#1)(2010-11#1)
tempo##2##1##(2013-8#2)
temporal Talbot##2##2##(2007-12#2)
temporal and rate##2##3##(2008-11#2)
temporal and spatial dynamics of##3##5##(2008-10#3)
temporal and spatial expression##2##4##(1996-12#1)(2012-2#1)
temporal and spatial resolution that##2##5##(2008-10#2)
temporal and spatial resolution##5##4##(2008-10#3)(2010-12#1)(2012-2#1)
temporal and spatial spread of SMV strain##2##7##(2008-10#2)
temporal and spatial##20##3##(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#14)(2010-12#1)(2012-2#2)
temporal and##33##2##(1990-8#1)(1991-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
temporal arteritis##9##2##(1994-9#3)(1997-8#6)
temporal artery##4##2##(1994-9#1)(1997-8#1)(2008-9#2)
temporal artery-superior cerebellar artery bypass##2##5##(2012-3#2)
temporal bone changes##2##3##(2008-9#2)
temporal bone computed tomography##2##4##(2008-9#1)(2011-2#1)
temporal bone erosion on##2##4##(2011-2#2)
temporal bone resection and parotidectomy##2##5##(2011-2#2)
temporal bone resection##3##3##(2011-2#3)
temporal bone##18##2##(2008-9#6)(2011-2#12)
temporal bones##2##2##(2008-9#2)
temporal changes in the##3##4##(1993-1#1)(2008-10#2)
temporal changes in##8##3##(1993-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)
temporal characteristics of##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
temporal characteristics##5##2##(2008-10#1)(2008-5#1)(2008-8#3)
temporal coding##2##2##(1996-2#2)
temporal correlation##3##2##(2008-8#1)(2009-8#1)(2013-8#1)
temporal cortex or amygdala##2##4##(1993-6#2)
temporal cortex##8##2##(1993-6#2)(1996-12#1)(1997-2#1)(2008-11#2)(2008-9#1)(2012-2#1)
temporal cortices##2##2##(1996-12#1)(2008-9#1)
temporal development of##3##3##(2008-10#3)
temporal distribution of##5##3##(2008-10#4)(2008-9#1)
temporal dynamics of the##2##4##(2008-10#1)(2009-8#1)
temporal dynamics of##7##3##(2008-10#4)(2008-8#1)(2009-8#2)
temporal dynamics##10##2##(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#2)
temporal evolution##8##2##(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#1)
temporal expression##3##2##(1996-6#1)(2008-10#1)(2012-3#1)
temporal features of##2##3##(2009-11#1)(2009-8#1)
temporal frequencies##2##2##(1996-2#2)
temporal gyrus##5##2##(1996-2#3)(2008-11#2)
temporal increase of##2##3##(2008-10#2)
temporal increase##5##2##(2008-10#5)
temporal information##3##2##(2008-3#1)(2008-9#2)
temporal lobe epilepsy##2##3##(2008-4#2)
temporal lobe epileptic##2##3##(2010-8#2)
temporal lobe##19##2##(1991-10#2)(1991-12#1)(1991-2#1)(1992-12#1)(1993-9#1)(1996-6#1)(2008-4#3)(2008-7#2)(2009-8#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-8#1)
temporal lobectomy subjects##2##3##(1992-12#2)
temporal lobectomy##4##2##(1992-12#3)(2008-11#1)
temporal macular##2##2##(2013-1#2)
temporal order##2##2##(1992-3#1)(1996-2#1)
temporal pattern of##2##3##(1995-5#1)(2010-11#1)
temporal patterns of##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)
temporal patterns##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)
temporal profile of##2##3##(2008-3#1)(2013-8#1)
temporal profile##3##2##(2008-3#2)(2013-8#1)
temporal pulse##3##2##(2007-11#1)(2008-10#2)
temporal region##4##2##(2007-12#1)(2008-9#2)(2009-1#1)
temporal relationship between##3##3##(2006-6#2)(2008-7#1)
temporal relationship##4##2##(2006-6#2)(2008-7#1)(2011-2#1)
temporal resolution of##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
temporal resolution##8##2##(1995-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2011-2#1)(2012-2#1)
temporal sequence##2##2##(2008-10#1)(2012-2#1)
temporal spread of SMV##2##4##(2008-10#2)
temporal spread##3##2##(2008-10#3)
temporal variability##6##2##(1992-9#3)(2008-10#1)(2008-8#1)(2008-9#1)
temporal variation in the opportunity for sexual selection##2##8##(2008-8#2)
temporal variation in##4##3##(2008-8#3)(2008-9#1)
temporal variation##6##2##(2008-10#1)(2008-8#3)(2008-9#2)
temporal variations of##2##3##(2008-5#1)(2013-8#1)
temporal variations##3##2##(2008-5#2)(2013-8#1)
temporal##318##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#4)(1992-3#1)(1992-9#3)(1993-1#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-3#2)(1994-8#1)(1994-9#4)(1995-2#3)(1995-5#1)(1996-12#3)(1996-2#9)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#7)(2006-6#2)(2007-11#4)(2007-12#7)(2008-10#59)(2008-11#29)(2008-12#2)(2008-2#11)(2008-3#10)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#15)(2008-9#28)(2009-1#1)(2009-10#5)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#12)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#20)(2012-12#2)(2012-2#9)(2012-3#7)(2013-1#5)(2013-8#6)
temporally and spatially##2##3##(1994-3#1)(2012-3#1)
temporally and##3##2##(1994-3#1)(2008-10#1)(2012-3#1)
temporally variable##2##2##(2008-8#1)(2008-9#1)
temporally varying##3##2##(2008-8#1)(2008-9#2)
temporally##27##1##(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
temporaria##3##1##(2011-2#3)
temporarily prior##2##2##(1990-12#1)(2008-8#1)
temporarily##18##1##(1990-12#1)(1991-2#1)(1991-6#1)(1993-11#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
temporary increase of##2##3##(2008-11#1)(2008-8#1)
temporary increase##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
temporary or##3##2##(1992-5#1)(2010-4#2)
temporary##48##1##(1992-5#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-8#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-2#3)(2012-5#1)(2013-1#6)
temporo-mandibular joint##5##2##(2011-2#5)
temporo-occipital##2##1##(2008-7#2)
temporo-parietal junction##2##2##(2008-11#2)
temporo-parietal##4##1##(2008-11#4)
temporo-suboccipital craniotomy##2##2##(2008-7#2)
temporomandibular disorder##3##2##(2013-1#3)
temporomandibular joint##5##2##(1993-1#1)(1995-10#1)(1996-2#1)(2012-3#2)
temporomandibular##8##1##(1993-1#1)(1995-10#1)(1996-2#1)(2012-3#2)(2013-1#3)
temporoparietal junction##2##2##(2008-11#2)
temporoparietal##3##1##(2008-11#2)(2008-12#1)
ten consecutive##2##2##(2008-10#2)
ten days##6##2##(1991-3#1)(1992-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-8#1)
ten determinations##5##2##(2008-10#5)
ten different##3##2##(1993-12#1)(2008-10#1)(2010-7#1)
ten gratings##3##2##(2013-8#3)
ten laminin##2##2##(2008-11#2)
ten months##2##2##(2008-9#1)(2012-2#1)
ten normal##2##2##(2008-10#1)(2012-2#1)
ten of##2##2##(2008-12#1)(2012-3#1)
ten or 100 female##2##4##(1996-12#2)
ten or 100##3##3##(1996-12#3)
ten or##4##2##(1996-12#3)(2013-8#1)
ten patients with##2##3##(1990-10#1)(1990-12#1)
ten patients##6##2##(1990-10#2)(1990-12#1)(1993-2#1)(1996-11#2)
ten percent##3##2##(1993-12#1)(2008-10#1)(2010-8#1)
ten replicate##5##2##(2008-10#5)
ten times higher##2##3##(1990-6#1)(2008-11#1)
ten times more##2##3##(1990-8#1)(2008-10#1)
ten times the##3##3##(1990-6#1)(2008-10#2)
ten times##13##2##(1990-6#3)(1990-8#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-5#1)
ten with##2##2##(2011-2#1)(2012-2#1)
ten years ago##2##3##(1990-6#1)(2008-1#1)
ten years of##2##3##(1992-1#1)(1992-12#1)
ten years##23##2##(1990-11#1)(1990-6#3)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
ten##177##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#6)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#3)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#43)(2008-11#9)(2008-12#6)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-2#5)(2011-9#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#7)
ten-fold##5##1##(1991-12#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-7#1)
ten-year##4##1##(1993-1#3)(2012-2#1)
tenant##2##1##(1996-5#1)(2013-1#1)
tenants##3##1##(1993-1#2)(1996-5#1)
tend to be more##2##4##(2008-1#1)(2012-2#1)
tend to be##20##3##(1991-12#1)(1994-3#2)(1994-9#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-8#3)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#2)
tend to develop##2##3##(2008-10#1)(2011-2#1)
tend to only##2##3##(1994-3#1)(2012-2#1)
tend to remain##2##3##(2008-10#1)(2008-9#1)
tend to##58##2##(1990-11#1)(1991-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#3)(1994-9#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#2)(2009-7#2)(2010-12#1)(2011-2#7)(2012-2#6)(2012-3#1)(2013-8#4)
tend##60##1##(1990-11#1)(1991-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#3)(1994-9#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-2#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#2)(2009-7#2)(2010-12#1)(2011-2#7)(2011-3#1)(2012-2#6)(2012-3#1)(2013-8#4)
tended to be less##2##4##(1990-12#1)(2008-9#1)
tended to be lower##2##4##(2008-5#1)(2008-7#1)
tended to be more##2##4##(2008-10#1)(2012-7#1)
tended to be similar##2##4##(2008-10#1)(2008-9#1)
tended to be younger##2##4##(1993-1#1)(2012-3#1)
tended to be##19##3##(1990-12#1)(1993-1#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-3#2)(2012-7#1)(2013-1#1)
tended to decline##2##3##(1995-12#1)(2011-2#1)
tended to decrease in##2##4##(1994-12#1)(2011-2#1)
tended to decrease##3##3##(1994-12#1)(2008-5#1)(2011-2#1)
tended to follow##2##3##(2008-12#1)(2008-9#1)
tended to give##2##3##(1991-2#1)(2008-5#1)
tended to have lower##2##4##(2008-10#1)(2008-9#1)
tended to have##6##3##(1990-5#1)(1994-3#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)
tended to improve##3##3##(2011-2#1)(2013-1#2)
tended to increase with time##2##5##(2008-10#2)
tended to increase##3##3##(2008-10#3)
tended to remain##2##3##(1991-1#1)(1993-1#1)
tended to yield##2##3##(1992-9#1)(2008-10#1)
tended to##66##2##(1990-12#1)(1990-5#2)(1991-1#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-1#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#7)(2010-1#1)(2010-10#1)(2010-8#2)(2011-2#4)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#2)
tended##69##1##(1990-12#1)(1990-5#2)(1991-1#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-1#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#7)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#2)(2011-2#4)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#2)
tendencies of##2##2##(2008-11#1)(2008-7#1)
tendencies to##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
tendencies##13##1##(1992-1#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-3#1)
tendency and##2##2##(2011-2#1)(2012-12#1)
tendency for the##2##3##(1994-3#1)(2008-5#1)
tendency for##10##2##(1991-2#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#1)
tendency in##2##2##(1995-3#1)(2008-11#1)
tendency is##2##2##(1992-5#1)(1997-8#1)
tendency of##7##2##(1990-8#1)(1991-3#1)(2008-10#1)(2008-7#1)(2008-8#3)
tendency to accumulate##2##3##(2008-10#2)
tendency to develop##2##3##(1990-12#1)(1997-8#1)
tendency to##26##2##(1990-12#1)(1991-1#1)(1994-6#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#2)
tendency toward##2##2##(2011-2#1)(2012-12#1)
tendency towards higher##2##3##(1990-2#1)(2011-2#1)
tendency towards##5##2##(1990-2#1)(1991-2#1)(1993-3#1)(1995-11#1)(2011-2#1)
tendency was##3##2##(1995-11#1)(1996-2#1)(2008-11#1)
tendency##72##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-5#3)(2008-7#4)(2008-8#6)(2008-9#2)(2010-12#1)(2010-3#1)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
tender##8##1##(1990-2#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-3#1)(2013-8#1)
tenderness##9##1##(1997-8#1)(2007-12#1)(2008-1#1)(2008-12#1)(2009-11#1)(2009-4#1)(2010-4#1)(2011-2#2)
tendinopathy##4##1##(2008-12#1)(2011-2#1)(2013-1#2)
tendinosis##10##1##(1997-6#1)(2008-8#1)(2009-10#4)(2010-3#4)
tendinous xanthomas##3##2##(1997-8#3)
tendinous##4##1##(1997-8#3)(2008-9#1)
tendon and##2##2##(2009-10#2)
tendon in##2##2##(2009-10#1)(2010-7#1)
tendon rupture following##3##3##(2009-4#1)(2010-3#2)
tendon rupture##7##2##(2009-4#4)(2010-3#3)
tendon was sectioned##2##3##(2008-9#1)(2009-4#1)
tendon was##3##2##(2008-9#1)(2009-10#1)(2009-4#1)
tendon##49##1##(1995-8#2)(1996-6#1)(1997-3#1)(1997-5#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#8)(2009-3#4)(2009-4#6)(2009-7#1)(2010-3#4)(2010-7#2)(2011-2#2)(2012-2#4)(2013-1#3)
tendonitis##2##1##(2008-12#1)(2008-9#1)
tendons and the##3##3##(1997-8#1)(2008-9#2)
tendons and##6##2##(1997-8#1)(2008-6#1)(2008-9#2)(2009-7#1)(2013-1#1)
tendons showed##2##2##(1997-8#2)
tendons##25##1##(1995-8#1)(1997-8#3)(2007-12#1)(2008-5#6)(2008-6#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
tends to be greater##2##4##(1994-3#1)(1996-12#1)
tends to be##7##3##(1994-3#1)(1996-12#1)(2008-11#2)(2008-8#1)(2009-8#1)(2013-1#1)
tends to increase with##2##4##(1991-2#1)(2008-9#1)
tends to increase##3##3##(1991-2#1)(2008-8#1)(2008-9#1)
tends to result in##2##4##(1994-9#1)(2009-10#1)
tends to##24##2##(1991-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#2)(2013-1#1)
tenellus##6##1##(2008-10#6)
tenets of##3##2##(1993-3#1)(1994-12#1)(2010-4#1)
tenets##5##1##(1993-3#1)(1994-12#1)(2008-11#1)(2010-4#1)(2011-2#1)
tenfold higher##2##2##(1993-6#1)(1997-3#1)
tenfold##5##1##(1990-11#1)(1991-1#1)(1993-6#1)(1997-3#1)(2008-10#1)
teniposide##2##1##(1992-2#1)(2008-11#1)
tennis elbow##3##2##(1997-6#1)(2008-12#1)(2011-2#1)
tennis serve##3##2##(2011-2#3)
tennis##8##1##(1997-6#1)(2008-12#1)(2009-1#1)(2011-2#5)
tenofovir resistance##4##2##(2013-1#4)
tenofovir##8##1##(2013-1#8)
tens of milligrams of##2##4##(2008-10#2)
tens of##9##2##(1991-2#1)(2008-10#6)(2008-2#1)(2008-9#1)
tens##11##1##(1991-2#1)(2008-10#8)(2008-2#1)(2008-9#1)
tense##5##1##(2008-5#3)(2009-11#1)(2011-2#1)
tense/agreement##4##1##(2009-8#4)
tensegrity principle##2##2##(2009-3#2)
tensegrity##3##1##(2008-10#1)(2009-3#2)
tensile properties##3##2##(2009-7#3)
tensile strain##3##2##(2009-7#1)(2011-2#2)
tensile strength values##2##3##(2008-5#2)
tensile strength##9##2##(2008-5#2)(2008-7#2)(2009-3#1)(2009-7#2)(2012-2#2)
tensile##25##1##(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#11)(2011-2#2)(2012-2#3)(2013-1#2)
tension and cell##2##3##(2008-7#1)(2009-5#1)
tension and pulmonary arterial##2##4##(2008-11#2)
tension and##11##2##(1995-5#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-4#2)(2009-5#2)(2010-4#1)
tension between##7##2##(1991-3#1)(1995-12#1)(2008-11#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-1#1)
tension forces##2##2##(1997-2#1)(2008-10#1)
tension of the##4##3##(1992-1#1)(1995-3#1)(1996-3#1)(2011-2#1)
tension of##8##2##(1992-1#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
tension##108##1##(1991-3#1)(1992-1#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1996-3#1)(1997-1#3)(1997-2#2)(1997-3#1)(2008-10#31)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#7)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#2)(2009-3#2)(2009-4#2)(2009-5#5)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#3)(2010-4#2)(2010-9#2)(2011-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
tension-band##2##1##(2009-3#2)
tensions between##2##2##(2008-12#1)(2013-1#1)
tensions resulting from##2##3##(1991-9#1)(1995-12#1)
tensions##14##1##(1990-12#1)(1990-5#1)(1991-9#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#2)(2010-4#1)(2012-12#1)(2013-1#1)
tensor fasciae##3##2##(2009-3#3)
tensor##9##1##(2008-2#1)(2008-3#1)(2009-10#2)(2009-3#3)(2010-8#1)(2013-1#1)
tensors of##2##2##(2013-1#2)
tensors##8##1##(2010-7#1)(2013-1#7)
tentacles##2##1##(2011-2#2)
tentative mechanism which##2##3##(1996-5#2)
tentative##11##1##(1991-2#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-9#1)(1996-2#2)(1996-5#2)(2008-10#2)
tentatively designated##2##2##(2008-10#1)(2008-7#1)
tentatively identified as##2##3##(1996-2#1)(2008-10#1)
tentatively identified##3##2##(1996-2#1)(2008-10#2)
tentatively named##2##2##(2008-10#2)
tentatively##14##1##(1996-2#1)(2008-10#9)(2008-7#2)(2008-9#1)(2009-10#1)
tenth of##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
tenth##10##1##(1996-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
tenuissima##4##1##(2008-10#4)
tenure##2##1##(2008-12#1)(2011-2#1)
terahertz (THz)##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
terahertz imaging and spectroscopy for##2##5##(2012-12#2)
terahertz imaging and spectroscopy##3##4##(2012-12#3)
terahertz imaging##6##2##(2007-11#1)(2012-12#5)
terahertz pulses##2##2##(2008-2#2)
terahertz##18##1##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)(2012-12#9)
teratocarcinosarcoma##3##1##(2008-11#3)
teratogenic##5##1##(1993-12#2)(2008-9#1)(2013-1#2)
teratogenicity##4##1##(1993-12#2)(2010-12#1)(2013-1#1)
teratoid/rhabdoid tumor of the spine##2##5##(2011-2#2)
teratoid/rhabdoid tumor of the##3##4##(2011-2#3)
teratoma and##2##2##(2008-7#1)(2013-1#1)
teratoma in an 11-month-old##2##4##(2008-12#2)
teratoma in##3##2##(2008-12#2)(2009-5#1)
teratoma is a##2##3##(2008-7#1)(2013-8#1)
teratoma of the##3##3##(2008-10#2)(2013-8#1)
teratoma of##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
teratoma##19##1##(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#3)(2008-8#1)(2009-5#2)(2013-1#2)(2013-8#5)
teratomas##5##1##(1994-12#1)(2008-10#2)(2012-12#1)(2013-1#1)
terazosin in bulk form##2##4##(2008-10#2)
terazosin in##3##2##(2008-10#3)
terazosin##6##1##(2008-10#6)
terbinafine##13##1##(2008-10#6)(2008-5#7)
terbium##8##1##(2008-10#7)(2012-2#1)
terbium(III)##9##1##(2008-10#4)(2008-4#5)
terbium-sensitised luminescence##3##2##(2008-10#3)
terbutaline in##3##2##(1997-2#1)(2008-10#2)
terbutaline##9##1##(1995-11#1)(1997-2#1)(2008-10#7)
terbuthylazine##4##1##(2008-11#3)(2008-7#1)
terbutylazine##2##1##(2008-11#2)
teres f##8##2##(2008-10#8)
teres##26##1##(2008-10#25)(2013-1#1)
teres)##2##1##(2008-10#2)
tergal##4##1##(1994-2#1)(2007-12#2)(2008-9#1)
tergites##4##1##(2007-12#4)
term &quot##11##2##(1994-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
term and preterm##3##3##(1994-3#2)(2012-3#1)
term and##7##2##(1994-3#3)(2007-11#1)(2008-11#2)(2012-3#1)
term care##11##2##(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-12#1)(2008-12#2)
term follow up##2##3##(2013-8#2)
term follow-up##2##2##(2011-2#2)
term in the##2##3##(1996-12#1)(2008-2#1)
term in##5##2##(1996-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)
term infants##6##2##(1990-11#2)(2007-11#2)(2011-2#2)
term is##2##2##(2013-8#2)
term memory##4##2##(2009-8#1)(2012-2#3)
term of the##2##3##(2008-10#2)
term of##7##2##(2008-10#6)(2008-11#1)
term outcome##2##2##(2008-10#1)(2013-1#1)
term registered##2##2##(2008-11#2)
term results##2##2##(1991-6#1)(2013-1#1)
term that##2##2##(2008-3#1)(2012-2#1)
term to##3##2##(2008-8#1)(2011-2#1)(2013-8#1)
term which##2##2##(1993-8#1)(2008-10#1)
term##235##1##(1990-11#6)(1990-2#1)(1990-3#1)(1990-5#3)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#5)(1993-6#2)(1993-8#3)(1994-1#2)(1994-12#2)(1994-3#6)(1994-6#1)(1994-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-11#4)(2008-10#35)(2008-11#21)(2008-12#4)(2008-2#3)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#5)(2009-8#1)(2010-1#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#16)(2011-3#2)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#19)(2013-8#13)
term)##2##1##(1994-3#1)(1996-11#1)
termed &quot##2##2##(2008-10#1)(2012-2#1)
termed 6##2##2##(2008-11#2)
termed as##2##2##(2008-10#1)(2010-7#1)
termed the##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
termed##66##1##(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#2)(1995-2#6)(1995-6#2)(1995-8#2)(1997-2#1)(1997-7#2)(2008-1#1)(2008-10#13)(2008-11#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-7#1)(2012-2#2)(2013-1#1)(2013-8#2)
terminal branches of the##2##4##(1997-3#1)(2012-3#1)
terminal care##3##2##(1990-3#1)(1990-6#1)(1994-12#1)
terminal deoxynucleotidyl transferase (TdT)##2##4##(1992-6#1)(1997-9#1)
terminal deoxynucleotidyl transferase##4##3##(1992-6#1)(1997-9#2)(2008-9#1)
terminal differentiation of##3##3##(1990-5#1)(1993-6#1)(2008-9#1)
terminal differentiation##13##2##(1990-5#2)(1991-5#2)(1992-12#2)(1993-6#1)(1994-11#1)(1994-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
terminal field of the##2##4##(1997-3#2)
terminal field##3##2##(1997-3#3)
terminal groups##2##2##(2008-10#2)
terminal molars##2##2##(2012-12#2)
terminal of##2##2##(1996-8#1)(2008-9#1)
terminal part of the##2##4##(1992-6#1)(1993-11#1)
terminal region of the##4##4##(1993-8#1)(2008-7#1)(2008-9#1)(2012-3#1)
terminal region of##5##3##(1993-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
terminal region##8##2##(1993-8#1)(1997-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
terminal regions of the##2##4##(1993-6#1)(2008-10#1)
terminal repeat (LTR)##3##3##(1993-8#1)(1997-8#1)(2008-11#1)
terminal repeat##13##2##(1992-12#1)(1993-8#2)(1994-12#1)(1994-5#1)(1995-6#2)(1997-6#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
terminal repeats##2##2##(2008-10#1)(2008-8#1)
terminal sequence##2##2##(1991-5#1)(1992-8#1)
terminal structure##2##2##(2008-8#2)
terminal ureter##2##2##(2008-10#1)(2013-1#1)
terminal##173##1##(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#3)(1991-7#1)(1992-12#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#7)(1995-12#3)(1995-2#2)(1995-6#3)(1996-12#4)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#9)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#2)(2007-12#4)(2008-10#23)(2008-11#7)(2008-12#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#15)(2008-9#10)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#2)
terminal-stream-limitation model##2##2##(2008-8#2)
terminalis##3##1##(1994-2#1)(2008-5#1)(2008-9#1)
terminally differentiated##3##2##(1995-2#1)(2008-5#1)(2009-10#1)
terminally ill##5##2##(1992-2#1)(1993-12#1)(1994-12#2)(2013-8#1)
terminally##11##1##(1992-2#1)(1993-12#2)(1994-12#2)(1995-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
terminally-ill##2##1##(2012-12#2)
terminals and##4##2##(1991-12#1)(1997-3#2)(2012-3#1)
terminals in the##5##3##(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-5#1)
terminals in##7##2##(1995-6#1)(1996-12#2)(1997-2#1)(1997-3#1)(2008-5#1)(2013-8#1)
terminals made##2##2##(1992-3#1)(2013-8#1)
terminals of the##3##3##(1990-5#1)(1995-12#1)(2008-10#1)
terminals of##4##2##(1990-5#1)(1995-12#1)(1997-3#1)(2008-10#1)
terminals on##2##2##(1997-2#2)
terminals##45##1##(1990-5#1)(1991-12#1)(1992-3#4)(1992-6#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#4)(1997-3#9)(1997-7#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#3)
terminate with##2##2##(1992-10#2)
terminate##9##1##(1992-10#2)(1992-6#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-6#1)(2007-12#1)(2008-11#1)
terminated in##2##2##(2007-12#2)
terminated##13##1##(1990-5#1)(1991-3#1)(1994-11#1)(1995-12#2)(1996-1#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-4#1)
terminates in##2##2##(1992-12#1)(2008-7#1)
terminates##5##1##(1992-12#1)(1997-6#1)(2008-7#1)(2009-8#1)(2012-3#1)
terminating##7##1##(1992-10#1)(1994-11#1)(1994-9#1)(1996-6#1)(2008-10#2)(2010-10#1)
termination of early pregnancy##2##4##(1995-8#2)
termination of pregnancy##5##3##(1995-8#3)(2011-1#1)(2013-8#1)
termination of##15##2##(1991-3#1)(1993-2#1)(1993-6#1)(1995-8#5)(1996-12#2)(1997-8#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-8#1)
termination##40##1##(1991-3#2)(1992-6#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-8#5)(1996-12#3)(1996-6#2)(1997-3#2)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#4)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
terminations in##2##2##(1996-12#1)(2013-8#1)
terminator of##2##2##(2008-8#2)
terminator##10##1##(1993-9#3)(2008-10#1)(2008-8#4)(2008-9#1)(2011-1#1)
termini of the##4##3##(1992-6#1)(1992-9#1)(2008-10#1)(2008-9#1)
termini of##7##2##(1990-5#1)(1992-6#1)(1992-9#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
termini##16##1##(1990-5#1)(1991-10#1)(1992-6#1)(1992-9#1)(1997-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)
terminology and##5##2##(1995-1#1)(2008-12#1)(2008-4#1)(2013-1#2)
terminology for##5##2##(1992-3#1)(1996-2#1)(2008-10#1)(2013-1#2)
terminology in##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
terminology is##4##2##(2008-10#1)(2010-9#1)(2013-1#2)
terminology of lean manufacturing and the Toyota Production System##3##9##(2012-2#3)
terminology of##8##2##(2007-12#1)(2008-10#1)(2012-2#4)(2013-1#2)
terminology##40##1##(1992-1#1)(1992-3#1)(1994-1#1)(1995-1#1)(1996-2#1)(1997-8#2)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-2#6)(2012-3#2)(2013-1#16)
terminus and the##2##3##(1993-2#1)(1996-12#1)
terminus and##5##2##(1993-2#1)(1993-3#1)(1996-12#1)(2008-10#2)
terminus is##2##2##(1992-7#1)(1995-8#1)
terminus of a##2##3##(1990-5#1)(2012-2#1)
terminus of an##2##3##(2008-10#1)(2008-4#1)
terminus of the##9##3##(1991-6#1)(1992-8#1)(1992-9#1)(1995-12#1)(1995-2#3)(1995-6#1)(2008-11#1)
terminus of##19##2##(1990-5#1)(1991-10#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1995-12#1)(1995-2#4)(1995-6#2)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-2#1)
terminus were##2##2##(1992-9#1)(2008-10#1)
terminus##57##1##(1990-5#1)(1991-10#1)(1991-6#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#5)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1995-12#1)(1995-2#6)(1995-6#7)(1995-8#1)(1996-12#6)(1997-8#1)(2008-10#8)(2008-11#7)(2008-4#1)(2008-6#1)(2012-2#1)
termite##2##1##(2007-12#1)(2010-1#1)
termites##5##1##(2011-2#1)(2013-8#4)
terms and##7##2##(1996-2#2)(2008-11#2)(2008-4#1)(2009-7#1)(2011-2#1)
terms are##4##2##(1990-11#1)(1991-6#1)(1994-12#1)(2008-11#1)
terms for##5##2##(2008-10#2)(2008-8#1)(2009-7#1)(2010-4#1)
terms of a##11##3##(1993-8#2)(1994-5#1)(1995-12#1)(2008-10#1)(2008-3#3)(2008-9#1)(2009-8#1)(2013-8#1)
terms of disease##2##3##(2011-2#1)(2012-2#1)
terms of food##2##3##(2007-12#1)(2011-2#1)
terms of length of stay##2##5##(1993-12#1)(2012-3#1)
terms of membrane##3##3##(2008-10#2)(2008-7#1)
terms of mortality##3##3##(1995-3#1)(1996-12#1)(2008-7#1)
terms of reference##2##3##(2008-12#1)(2010-12#1)
terms of specific##2##3##(1991-5#1)(2010-3#1)
terms of stability##2##3##(2008-10#2)
terms of symptom expression##2##4##(2008-10#2)
terms of the range of##2##5##(2008-8#1)(2008-9#1)
terms of the##81##3##(1990-7#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#26)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
terms of##426##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-2#3)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#3)(1992-3#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-6#2)(1993-8#2)(1994-1#1)(1994-2#2)(1994-5#2)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#3)(2008-1#2)(2008-10#138)(2008-11#27)(2008-12#12)(2008-2#4)(2008-3#13)(2008-4#4)(2008-5#13)(2008-6#1)(2008-7#7)(2008-8#11)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#3)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#18)(2011-3#1)(2012-12#3)(2012-2#14)(2012-3#6)(2012-4#2)(2013-1#13)(2013-8#7)
terms such as##2##3##(1994-9#1)(2010-4#1)
terms to##2##2##(1996-2#1)(2008-9#1)
terms used in##2##3##(2008-9#1)(2009-8#1)
terms used##3##2##(2008-9#1)(2009-8#1)(2011-2#1)
terms##506##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#5)(1991-3#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#3)(1992-3#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#6)(1996-3#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-12#3)(2008-1#2)(2008-10#146)(2008-11#33)(2008-12#12)(2008-2#5)(2008-3#14)(2008-4#6)(2008-5#13)(2008-6#2)(2008-7#9)(2008-8#14)(2008-9#14)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#8)(2009-8#4)(2009-9#2)(2010-10#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#34)(2011-3#1)(2012-12#4)(2012-2#14)(2012-3#6)(2012-4#2)(2013-1#18)(2013-8#9)
ternary and##4##2##(2008-10#4)
ternary complex formed##2##3##(1994-5#1)(2008-10#1)
ternary complex on##2##3##(2008-10#2)
ternary complex with##4##3##(2008-10#4)
ternary complex##23##2##(1993-8#1)(1994-11#1)(1994-5#6)(2008-10#15)
ternary complexes of##4##3##(2008-10#4)
ternary complexes with##2##3##(2008-10#2)
ternary complexes##14##2##(2008-10#14)
ternary inclusion complex##2##3##(2008-10#2)
ternary ion associate##2##3##(2008-10#2)
ternary ion##3##2##(2008-10#3)
ternary mixture of##4##3##(2008-10#4)
ternary mixture##6##2##(2008-10#6)
ternary mixtures of##6##3##(2008-10#6)
ternary mixtures##15##2##(2008-10#15)
ternary solvent##3##2##(2008-10#3)
ternary##85##1##(1993-8#1)(1994-11#1)(1994-5#6)(2008-10#75)(2008-11#1)(2009-8#1)
terotoma##3##1##(2012-12#3)
terpene concentration##2##2##(2011-10#2)
terpene content##2##2##(2011-10#2)
terpene emission rates##3##3##(2011-10#3)
terpene emission##4##2##(2011-10#4)
terpene trilactones##3##2##(2008-10#3)
terpene##15##1##(2008-10#3)(2008-11#1)(2011-10#11)
terpenes##6##1##(2008-10#5)(2008-11#1)
terpenoid synthesis##3##2##(2008-10#3)
terpenoid##8##1##(1990-11#1)(2008-10#7)
terpenoids in##2##2##(2008-10#1)(2013-8#1)
terpenoids##6##1##(1990-11#2)(2008-10#2)(2011-3#1)(2013-8#1)
terpolymers##2##1##(2008-5#1)(2013-1#1)
terra-cotta##2##1##(2008-10#2)
terracotta##4##1##(2008-10#4)
terrestrial and##3##2##(2008-3#1)(2009-4#1)(2012-2#1)
terrestrial mollusc##2##2##(1990-5#2)
terrestrial plants##2##2##(2008-10#1)(2008-7#1)
terrestrial slug##2##2##(2008-6#1)(2008-7#1)
terrestrial##31##1##(1990-5#2)(1991-6#2)(1995-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#2)(2009-4#1)(2011-2#1)(2012-2#2)(2012-3#2)
terreus##5##1##(2008-5#4)(2012-2#1)
terrified##2##1##(2008-11#1)(2009-10#1)
territorial animals##2##2##(2008-8#2)
territorial inheritance##2##2##(2008-8#2)
territorial##9##1##(1997-7#1)(2008-8#7)(2008-9#1)
territoriality##2##1##(2008-8#1)(2008-9#1)
territories and##6##2##(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#2)
territories##16##1##(1997-1#1)(2008-11#2)(2008-8#5)(2008-9#4)(2009-8#3)(2012-2#1)
territory of the##3##3##(1992-2#1)(1993-2#1)(1996-3#1)
territory of##5##2##(1992-2#1)(1993-2#1)(1996-3#1)(2008-11#1)(2011-2#1)
territory owners##2##2##(2008-8#1)(2008-9#1)
territory##34##1##(1992-2#1)(1993-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#8)(2008-9#6)(2009-8#1)(2010-1#1)(2011-2#2)(2012-3#3)(2013-1#2)
terror##6##1##(1990-6#1)(1990-8#1)(2009-10#4)
terrorism preparedness##2##2##(2008-9#2)
terrorism##3##1##(2008-7#1)(2008-9#2)
terrorism-preparedness training##3##2##(2008-9#3)
terrorist event##2##2##(2008-12#1)(2008-9#1)
terrorist threat##2##2##(1996-12#2)
terrorist##4##1##(1996-12#2)(2008-12#1)(2008-9#1)
tert-butyl##8##1##(1995-11#1)(1996-5#1)(2008-12#4)(2009-8#2)
tert-butylhydroquinone (TBHQ)##2##2##(2008-10#2)
tert-butylhydroquinone##3##1##(2008-10#3)
tertiary care hospital##10##3##(1997-3#1)(2008-11#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
tertiary care referral##2##3##(2012-2#2)
tertiary care##20##2##(1995-1#1)(1997-3#1)(2008-11#3)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
tertiary center##2##2##(2012-12#1)(2013-1#1)
tertiary referral##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
tertiary structure is##2##3##(1992-4#1)(2008-4#1)
tertiary structure of the##3##4##(1990-5#1)(2008-10#1)(2008-9#1)
tertiary structure of##4##3##(1990-5#1)(2008-10#2)(2008-9#1)
tertiary structure##19##2##(1990-5#1)(1992-4#1)(1993-8#1)(1995-8#1)(2008-10#2)(2008-4#10)(2008-9#3)
tertiary##67##1##(1990-5#1)(1990-6#1)(1990-8#1)(1992-4#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-8#1)(1997-3#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#12)(2008-9#4)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#2)
tertiles##4##1##(2008-3#3)(2008-7#1)
tessulatum##3##1##(1996-12#3)
test (BAT)##2##2##(2012-2#1)(2012-3#1)
test (LNT)##2##2##(2008-9#2)
test (α=0##3##2##(2013-1#3)
test a hypothesis##2##3##(2008-10#2)
test a##9##2##(1993-12#1)(1996-6#1)(2008-10#5)(2008-12#1)(2012-3#1)
test agents##2##2##(2008-10#1)(2008-5#1)
test also##3##2##(1995-1#1)(2008-5#1)(2011-2#1)
test among##2##2##(2009-5#1)(2013-1#1)
test an##3##2##(1997-3#1)(2009-3#1)(2010-4#1)
test analyte##4##2##(2008-10#4)
test and the##7##3##(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2010-1#1)
test and##33##2##(1993-3#2)(1994-2#2)(1994-3#1)(1994-8#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
test are##2##2##(2008-2#1)(2008-6#1)
test as well as##2##4##(2008-11#1)(2012-2#1)
test as##7##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-2#1)(2012-3#1)
test at##3##2##(1990-6#1)(2011-1#1)(2013-1#1)
test based on the##2##4##(2012-3#1)(2013-1#1)
test based on##6##3##(1990-12#1)(2008-10#1)(2008-11#1)(2011-3#1)(2012-3#1)(2013-1#1)
test because##2##2##(1996-5#1)(1997-1#1)
test between##4##2##(2008-11#2)(2013-1#1)(2013-8#1)
test by##2##2##(2008-10#1)(2008-5#1)
test can be##2##3##(2008-11#1)(2008-7#1)
test can##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
test case##4##2##(2008-11#1)(2008-3#2)(2009-5#1)
test compounds##2##2##(2008-11#1)(2008-5#1)
test conditions##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)
test data set##2##3##(2008-10#2)
test data##5##2##(2008-10#4)(2009-10#1)
test did not##2##3##(2010-6#1)(2013-1#1)
test for the##10##3##(1996-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
test for##48##2##(1992-5#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#3)(2009-9#1)(2010-8#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)
test gas##2##2##(2008-10#1)(2008-2#1)
test group##3##2##(1994-8#1)(2008-12#2)
test groups##4##2##(1995-8#2)(2008-12#1)(2010-7#1)
test has##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
test hypotheses about##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
test hypotheses##6##2##(2008-10#2)(2008-11#2)(2008-8#1)(2012-3#1)
test in a##3##3##(1997-2#1)(2008-9#1)(2009-5#1)
test in the##5##3##(2008-10#2)(2008-12#1)(2008-4#1)(2009-5#1)
test in##24##2##(1991-12#1)(1991-3#2)(1992-11#1)(1996-3#1)(1997-2#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#3)(2009-5#2)(2013-1#2)
test indicated##2##2##(2008-10#2)
test is a##5##3##(1997-2#1)(2008-12#1)(2008-5#2)(2008-7#1)
test is widely##2##3##(1997-2#1)(2008-9#1)
test is##26##2##(1990-2#1)(1992-11#1)(1995-9#1)(1996-3#2)(1996-5#1)(1997-2#4)(1997-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2012-3#1)
test items##3##2##(2008-11#1)(2009-12#2)
test its##4##2##(1997-1#1)(2008-12#1)(2008-8#2)
test kit##9##2##(1996-5#4)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
test laboratory sediment##2##3##(2008-10#2)
test material for##2##3##(1990-12#1)(2008-9#1)
test material##4##2##(1990-12#1)(2008-11#1)(2008-9#2)
test may be##2##3##(1994-1#1)(2008-11#1)
test method and##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
test method##10##2##(1996-12#1)(2008-10#3)(2008-11#2)(2008-5#3)(2012-3#1)
test methodologies##3##2##(1996-12#1)(2008-5#2)
test methods are##2##3##(2008-10#2)
test methods for##3##3##(2008-10#3)
test methods##14##2##(2008-10#9)(2008-5#4)(2008-9#1)
test mixtures##2##2##(2008-10#2)
test nerve##3##2##(1997-3#3)
test of the##8##3##(1992-1#1)(1994-3#1)(1996-2#1)(2008-10#3)(2008-8#1)(2013-8#1)
test of this##4##3##(1992-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
test of##38##2##(1990-2#1)(1992-1#1)(1992-11#1)(1992-7#1)(1993-3#2)(1994-2#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-8#4)(2008-9#4)(2010-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
test on##3##2##(2008-10#2)(2008-8#1)
test our##2##2##(2008-8#1)(2012-7#1)
test patterns##3##2##(2008-3#2)(2008-6#1)
test performance##5##2##(1994-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2013-1#1)
test performed##3##2##(1990-12#1)(2008-10#1)(2009-3#1)
test plants##4##2##(2008-10#4)
test portion into##2##3##(2008-10#2)
test position##3##2##(2008-12#3)
test positive##2##2##(1996-5#1)(2008-10#1)
test procedure##3##2##(1995-9#1)(2008-10#1)(2012-2#1)
test procedures##5##2##(2008-10#3)(2012-2#2)
test proteins were##2##3##(1997-2#2)
test protocols##2##2##(2008-5#2)
test provides##2##2##(2008-10#1)(2013-1#1)
test result##3##2##(1996-5#1)(1996-6#1)(2012-2#1)
test results and##2##3##(2010-12#1)(2012-3#1)
test results from##2##3##(2008-10#2)
test results##18##2##(1991-12#1)(1993-3#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-3#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
test revealed##2##2##(2010-6#1)(2012-3#1)
test sample##10##2##(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-9#1)
test samples of##2##3##(2008-10#2)
test samples##10##2##(2008-10#9)(2008-2#1)
test scores were##2##3##(2008-9#2)
test scores##5##2##(2008-12#1)(2008-9#2)(2009-7#2)
test set##9##2##(2008-10#8)(2009-3#1)
test sets##3##2##(1996-3#1)(2008-10#2)
test should be##2##3##(1991-6#1)(2012-12#1)
test should##3##2##(1991-6#1)(1996-3#1)(2012-12#1)
test showed a##2##3##(2012-3#1)(2013-1#1)
test showed that##7##3##(2008-10#3)(2008-5#1)(2008-8#2)(2010-1#1)
test showed##10##2##(2008-10#3)(2008-5#2)(2008-8#2)(2010-1#1)(2012-3#1)(2013-1#1)
test shows##2##2##(1997-2#1)(2008-11#1)
test sites##2##2##(1996-3#1)(2008-11#1)
test solution##8##2##(2008-10#7)(2012-2#1)
test solutions##10##2##(2008-10#10)
test species##6##2##(2010-11#5)(2012-3#1)
test specimens were##2##3##(2008-10#1)(2013-1#1)
test specimens##4##2##(2008-10#2)(2013-1#2)
test statistic##4##2##(1992-9#1)(1995-9#1)(2008-10#2)
test statistics and##2##3##(1995-9#1)(2008-10#1)
test statistics##6##2##(1995-9#1)(2008-10#4)(2012-3#1)
test subjects##2##2##(1997-5#1)(2008-5#1)
test substrate##2##2##(2008-11#2)
test suggested that##2##3##(2009-7#1)(2013-1#1)
test system is##3##3##(2008-11#2)(2008-5#1)
test system##8##2##(2008-10#1)(2008-11#4)(2008-5#1)(2012-3#2)
test systems##5##2##(1990-12#1)(1991-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
test that was##2##3##(1997-2#1)(2008-10#1)
test that##7##2##(1997-2#1)(2008-10#4)(2012-3#1)(2013-1#1)
test the efficacy of##2##4##(2008-9#1)(2010-8#1)
test the feasibility of##5##4##(1996-2#1)(1997-8#1)(2008-10#1)(2009-7#1)(2011-2#1)
test the feasibility##6##3##(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)
test the function of##2##4##(1995-2#1)(2008-8#1)
test the hypothesis that the##4##5##(1995-2#1)(2008-11#1)(2008-7#1)(2009-7#1)
test the hypothesis that##17##4##(1990-8#2)(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-2#2)(2012-5#1)
test the hypothesis##21##3##(1990-8#2)(1991-2#1)(1994-8#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-2#2)(2012-5#1)
test the relationship between##2##4##(2013-1#1)(2013-8#1)
test the system##2##3##(2008-10#1)(2008-11#1)
test the##91##2##(1990-8#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#25)(2008-11#7)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#3)(2008-8#8)(2008-9#4)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#4)(2012-5#2)(2013-1#1)(2013-8#2)
test theoretical##2##2##(1995-6#1)(2012-3#1)
test these hypotheses##2##3##(2008-8#2)
test these##4##2##(2008-3#1)(2008-8#3)
test this hypothesis by##2##4##(2008-8#1)(2009-7#1)
test this hypothesis##10##3##(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
test this model##2##3##(1997-1#1)(2008-9#1)
test this theory##2##3##(2008-11#1)(2008-12#1)
test this##20##2##(1991-5#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
test time##2##2##(2008-10#2)
test to the##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
test to##17##2##(1995-11#1)(1996-3#1)(2008-10#4)(2008-4#3)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
test tubes##2##2##(1991-1#1)(1997-6#1)
test under##3##2##(1996-3#2)(2008-7#1)
test used##2##2##(2011-2#1)(2013-1#1)
test using a##2##3##(2008-11#1)(2008-8#1)
test using pollen of##2##4##(2008-11#2)
test using the##2##3##(1990-2#1)(2008-12#1)
test using##12##2##(1990-2#1)(1991-3#1)(1996-12#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-8#3)
test vessel##2##2##(2008-10#2)
test was also##2##3##(1991-3#1)(2008-5#1)
test was developed##3##3##(2008-10#2)(2013-1#1)
test was performed in##2##4##(1993-3#1)(2013-1#1)
test was performed with##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
test was performed##10##3##(1993-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
test was positive##2##3##(1997-4#1)(2012-3#1)
test was used to##4##4##(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
test was used##6##3##(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
test was##44##2##(1990-6#1)(1991-3#3)(1993-3#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-5#4)(2009-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)
test were##6##2##(1992-9#1)(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)
test whether the##2##3##(2008-8#1)(2013-1#1)
test whether##18##2##(1993-2#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
test with a loaded weight of 80 kg##2##7##(2013-1#2)
test with a##5##3##(2008-5#2)(2013-1#3)
test with##11##2##(1990-5#1)(1991-12#1)(1992-9#1)(1996-3#2)(2008-5#2)(2013-1#4)
test within the##2##3##(2008-11#1)(2008-12#1)
test within##3##2##(1990-6#1)(2008-11#1)(2008-12#1)
test##1236##1##(1990-12#8)(1990-2#7)(1990-3#1)(1990-5#2)(1990-6#7)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#8)(1991-2#3)(1991-3#7)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#4)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#7)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#10)(1993-6#4)(1994-1#2)(1994-12#2)(1994-2#7)(1994-3#10)(1994-6#1)(1994-8#8)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#3)(1995-5#2)(1995-6#4)(1995-8#3)(1995-9#6)(1996-1#1)(1996-12#11)(1996-2#7)(1996-3#14)(1996-5#14)(1996-6#4)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#16)(1997-3#7)(1997-4#5)(1997-5#6)(1997-6#2)(1997-7#4)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#5)(2008-10#320)(2008-11#82)(2008-12#39)(2008-2#8)(2008-3#23)(2008-4#13)(2008-5#60)(2008-6#5)(2008-7#27)(2008-8#49)(2008-9#44)(2009-10#2)(2009-11#1)(2009-12#10)(2009-3#4)(2009-4#1)(2009-5#10)(2009-7#9)(2009-8#4)(2009-9#2)(2010-1#7)(2010-10#3)(2010-11#8)(2010-12#3)(2010-4#3)(2010-6#8)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#7)(2011-2#45)(2011-3#2)(2012-12#9)(2012-2#30)(2012-3#48)(2012-5#2)(2012-7#1)(2013-1#57)(2013-8#9)
test)##19##1##(1990-6#1)(1993-2#1)(1996-11#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
test-retest reliability##2##2##(2008-10#1)(2013-8#1)
test-retest##4##1##(2008-10#2)(2009-9#1)(2013-8#1)
test]##2##1##(1990-11#1)(1996-11#1)
testable hypotheses##2##2##(2008-11#1)(2009-6#1)
testable hypothesis##2##2##(2008-10#1)(2008-9#1)
testable##10##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-1#1)(2010-10#1)
tested (5 to##2##3##(2008-10#2)
tested a##7##2##(1994-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)
tested after##2##2##(1993-2#1)(2008-10#1)
tested against a##3##3##(2008-10#3)
tested against##23##2##(1996-12#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
tested an##2##2##(2008-5#1)(2013-1#1)
tested and applied for the##2##5##(2008-10#2)
tested and##22##2##(1991-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-5#1)(2012-3#1)(2013-8#1)
tested are##2##2##(2008-10#1)(2012-12#1)
tested as a##3##3##(1995-5#1)(1997-2#1)(2007-11#1)
tested as an##3##3##(1994-11#1)(2008-10#2)
tested as##19##2##(1994-11#1)(1994-8#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#10)(2008-11#4)
tested at the##2##3##(1992-2#1)(2008-10#1)
tested at##15##2##(1992-2#1)(1993-3#1)(2008-10#6)(2008-5#1)(2009-5#2)(2010-3#1)(2011-2#2)(2013-1#1)
tested but##3##2##(2008-10#2)(2011-2#1)
tested by ELISA##2##3##(1995-12#2)
tested by comparing##2##3##(2008-10#1)(2011-3#1)
tested by determining##3##3##(2008-10#3)
tested by the##5##3##(1994-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
tested by using##2##3##(2008-10#1)(2008-8#1)
tested by##54##2##(1990-3#1)(1991-9#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#28)(2008-11#1)(2008-5#4)(2008-6#2)(2008-8#3)(2008-9#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
tested cells##2##2##(2009-9#1)(2011-2#1)
tested compounds##4##2##(2008-10#3)(2008-5#1)
tested concentrations##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
tested different##2##2##(2008-10#1)(2008-11#1)
tested during##3##2##(1990-6#1)(1991-2#1)(2012-2#1)
tested first on synthetic##3##4##(2008-10#3)
tested first##4##2##(2008-10#4)
tested for HIV##3##3##(1995-12#1)(1996-5#1)(2009-5#1)
tested for a##3##3##(1995-2#1)(2008-10#2)
tested for differences##3##3##(2008-10#2)(2008-9#1)
tested for inhibition of##2##4##(1996-5#1)(2012-2#1)
tested for its##5##3##(2008-10#5)
tested for pathogenicity on##3##4##(2008-10#3)
tested for potential##2##3##(2008-5#1)(2008-9#1)
tested for specificity##2##3##(2008-10#2)
tested for the determination of##4##5##(2008-10#4)
tested for the##19##3##(1992-9#1)(1994-2#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
tested for their ability to inhibit##5##6##(1992-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#1)
tested for their ability to##12##5##(1992-8#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#6)(2008-4#1)
tested for their##28##3##(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-11#1)(2008-10#13)(2008-4#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
tested for virulence##4##3##(2008-10#4)
tested for##148##2##(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-5#4)(2008-1#1)(2008-10#82)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#2)(2008-9#5)(2009-5#1)(2009-7#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)
tested had an activity##2##4##(1991-6#2)
tested here##2##2##(2008-10#1)(2012-5#1)
tested in a##12##3##(1996-5#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#2)(2010-10#1)
tested in an##8##3##(1990-11#1)(1991-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#1)
tested in order to##3##4##(2008-10#3)
tested in the analysis of##3##5##(2008-10#3)
tested in the field##3##4##(1996-12#1)(2008-10#2)
tested in the greenhouse##3##4##(2008-10#3)
tested in the in vitro##2##5##(2011-1#2)
tested in the##27##3##(1990-5#1)(1990-6#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-12#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#2)(2013-1#1)(2013-8#1)
tested in this study##6##4##(1997-1#1)(2008-10#2)(2008-12#1)(2013-1#2)
tested in this##8##3##(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#2)
tested in two##2##3##(2008-10#1)(2013-8#1)
tested in vitro and in##2##5##(2008-10#1)(2008-8#1)
tested in vitro##6##3##(1994-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
tested in vivo for##2##4##(1997-3#1)(1997-7#1)
tested in##118##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-8#2)(1995-5#1)(1996-12#3)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#49)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#8)(2008-7#4)(2008-8#1)(2008-9#2)(2009-7#1)(2010-10#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-9#1)(2013-1#3)(2013-8#3)
tested isolates##5##2##(2008-10#5)
tested negative for##2##3##(2008-10#1)(2011-2#1)
tested negative##4##2##(1996-5#1)(2008-10#2)(2011-2#1)
tested on a##4##3##(1993-3#1)(2008-10#2)(2010-8#1)
tested on data##2##3##(2008-10#1)(2008-9#1)
tested on several##2##3##(2008-10#2)
tested on synthetic##2##3##(2008-10#1)(2008-3#1)
tested on the##5##3##(2008-10#4)(2012-2#1)
tested on##46##2##(1992-3#1)(1993-3#1)(1997-6#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
tested over##3##2##(2008-10#3)
tested phenols##2##2##(2008-10#1)(2011-1#1)
tested positive for circulating AFP mRNA##4##6##(2008-10#4)
tested positive##9##2##(2008-10#8)(2008-7#1)
tested postsurgically for##2##3##(1993-3#2)
tested ranged from##2##3##(1995-3#1)(2008-10#1)
tested resulted in##2##3##(2008-10#1)(2011-1#1)
tested separately##4##2##(2008-10#3)(2010-8#1)
tested showed##2##2##(2008-10#2)
tested strains##3##2##(2008-10#2)(2011-2#1)
tested that##4##2##(1993-2#1)(2008-10#3)
tested the ability of##2##4##(2008-11#1)(2008-5#1)
tested the effect of##2##4##(2008-10#1)(2013-1#1)
tested the effectiveness of##3##4##(1993-3#1)(2008-11#2)
tested the feasibility of##2##4##(2007-9#1)(2008-8#1)
tested the feasibility##3##3##(2007-9#1)(2008-8#1)(2013-1#1)
tested the hypothesis that the##5##5##(1992-8#1)(1993-6#1)(1995-8#1)(2008-10#1)(2012-3#1)
tested the hypothesis that##10##4##(1992-8#1)(1993-6#1)(1995-12#1)(1995-8#1)(2008-10#4)(2008-9#1)(2012-3#1)
tested the impact of##2##4##(1996-12#1)(1997-3#1)
tested the potential##2##3##(2009-6#1)(2010-10#1)
tested the##41##2##(1992-8#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#1)(2007-9#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2012-3#2)(2013-1#3)
tested their##2##2##(2011-2#2)
tested these##2##2##(2008-8#1)(2012-3#1)
tested this prediction by##2##4##(2008-8#2)
tested this##5##2##(1997-3#1)(2008-8#3)(2009-8#1)
tested three##3##2##(1991-3#1)(2008-8#1)(2009-11#1)
tested through##5##2##(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
tested to determine##3##3##(1990-5#1)(1992-2#1)(2009-7#1)
tested to##17##2##(1990-5#1)(1992-2#2)(2008-10#11)(2008-12#1)(2008-3#1)(2009-7#1)
tested two##2##2##(2008-8#1)(2008-9#1)
tested under##10##2##(2008-10#5)(2008-3#1)(2009-3#2)(2009-7#1)(2012-3#1)
tested using a##6##3##(1997-3#1)(2008-10#3)(2008-12#1)(2011-2#1)
tested using data##2##3##(2008-10#2)
tested using the##4##3##(2008-10#1)(2008-12#1)(2011-2#2)
tested using two##2##3##(2008-10#2)
tested using##29##2##(1990-2#1)(1992-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-9#2)(2009-12#1)(2011-2#3)
tested vaccines##2##2##(1995-5#2)
tested was observed##3##3##(2008-10#2)(2008-11#1)
tested was##8##2##(2008-10#4)(2008-11#3)(2008-12#1)
tested were highly##2##3##(2008-10#2)
tested were inhibited##2##3##(2008-10#2)
tested were sensitive##2##3##(2008-10#2)
tested were##20##2##(1992-6#1)(1994-8#1)(2008-1#1)(2008-10#14)(2008-5#1)(2009-7#1)(2011-2#1)
tested when compared to##2##4##(1990-6#1)(2008-10#1)
tested when##3##2##(1990-6#1)(2008-10#2)
tested whether##7##2##(1993-9#1)(1994-3#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
tested with a##2##3##(2008-10#1)(2008-3#1)
tested with the##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
tested with##36##2##(1990-12#1)(1993-6#1)(1996-2#2)(1996-8#1)(2008-10#19)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-1#1)(2013-1#1)
tested##1122##1##(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#4)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#6)(1991-5#1)(1991-6#5)(1991-9#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#9)(1993-5#1)(1993-6#9)(1993-8#2)(1993-9#3)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#12)(1995-11#1)(1995-12#8)(1995-2#6)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#2)(1996-12#11)(1996-2#5)(1996-3#3)(1996-5#7)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#8)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#3)(2008-10#560)(2008-11#57)(2008-12#17)(2008-2#5)(2008-3#19)(2008-4#3)(2008-5#51)(2008-6#8)(2008-7#17)(2008-8#26)(2008-9#24)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#3)(2009-5#3)(2009-6#1)(2009-7#10)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#6)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#3)(2011-1#6)(2011-2#34)(2011-3#2)(2012-12#2)(2012-2#7)(2012-3#8)(2012-5#1)(2012-9#1)(2013-1#31)(2013-8#12)
tested)##3##1##(2008-10#3)
tester isolates##5##2##(2008-10#5)
tester strains of##3##3##(2008-10#3)
tester strains##6##2##(2008-10#5)(2011-1#1)
tester##22##1##(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#3)(2009-7#1)(2011-1#1)(2012-3#1)
testers##4##1##(2008-10#3)(2008-5#1)
testes and##2##2##(2007-12#1)(2008-8#1)
testes were##3##2##(1992-12#2)(2008-9#1)
testes##29##1##(1992-12#2)(1993-12#2)(1993-9#1)(1995-2#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-8#1)(2008-9#1)(2009-10#6)(2011-2#2)(2012-2#2)(2013-7#3)
testicle##3##1##(2008-10#3)
testicles##5##1##(2008-10#3)(2008-12#1)(2013-1#1)
testicular cancer and##2##3##(1996-5#1)(2009-5#1)
testicular cancer##5##2##(1996-5#1)(2008-11#1)(2009-5#3)
testicular descent##2##2##(2008-10#2)
testicular function##2##2##(1992-12#1)(2009-10#1)
testicular hyaluronidase##4##2##(1994-5#4)
testicular shield##3##2##(2009-11#3)
testicular torsion##7##2##(2008-10#7)
testicular tumours##3##2##(2011-2#3)
testicular volumes##2##2##(1993-3#2)
testicular##62##1##(1992-12#2)(1993-12#2)(1993-3#3)(1994-11#1)(1994-5#4)(1995-6#1)(1996-5#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-12#1)(2009-10#5)(2009-11#3)(2009-5#5)(2010-5#2)(2011-2#6)(2012-2#1)(2012-3#2)
testified##4##1##(2008-10#1)(2008-8#2)(2011-3#1)
testify to the##3##3##(2008-10#3)
testify##5##1##(2008-10#4)(2008-11#1)
testifying##2##1##(2008-10#1)(2008-7#1)
testimony in the criminal proceedings##2##5##(2011-2#2)
testimony in##3##2##(1992-2#1)(2011-2#2)
testimony on##2##2##(1992-3#1)(2011-2#1)
testimony##11##1##(1992-2#1)(1992-3#1)(1994-2#1)(2008-10#1)(2008-12#1)(2011-2#6)
testing a##5##2##(1996-2#1)(1997-3#1)(2008-10#2)(2013-8#1)
testing algorithm##2##2##(1997-2#1)(2008-10#1)
testing and prevention##2##3##(2009-5#1)(2011-2#1)
testing and validation##2##3##(2008-10#2)
testing and##30##2##(1990-6#1)(1993-3#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-2#3)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-5#1)(2010-6#1)(2011-2#3)(2011-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
testing are##2##2##(2008-4#1)(2013-1#1)
testing as the##2##3##(2008-12#1)(2008-5#1)
testing as##4##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
testing at##4##2##(1991-7#1)(1995-12#1)(1997-4#1)(2008-12#1)
testing by##9##2##(1994-1#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-9#2)(2013-1#1)(2013-8#1)
testing can be##4##3##(2008-10#1)(2008-9#1)(2011-1#1)(2013-8#1)
testing can##6##2##(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#2)
testing did not##2##3##(2008-9#1)(2011-2#1)
testing for HIV##2##3##(1996-5#1)(2013-1#1)
testing for SIP##2##3##(1993-6#2)
testing for##23##2##(1993-6#2)(1994-1#1)(1996-10#1)(1996-5#1)(1996-6#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
testing has##7##2##(1996-2#1)(2008-4#1)(2008-6#2)(2011-2#1)(2012-2#1)(2013-1#1)
testing have##2##2##(2008-10#2)
testing in a##2##3##(1991-12#1)(2008-12#1)
testing in non-rodent species##2##4##(2008-10#2)
testing in the##7##3##(1994-1#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
testing in##28##2##(1991-12#1)(1994-1#2)(1994-9#1)(1995-5#1)(1996-8#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)
testing is##14##2##(1995-9#1)(1996-11#1)(1996-6#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
testing machine##3##2##(2007-11#1)(2009-7#1)(2013-1#1)
testing may##3##2##(1994-1#1)(2008-10#2)
testing method##3##2##(1990-11#1)(2008-10#1)(2011-2#1)
testing methods##4##2##(1995-1#1)(2010-7#1)(2012-3#1)(2013-8#1)
testing of a##7##3##(1995-12#1)(1996-2#1)(2008-10#3)(2008-3#1)(2010-2#1)
testing of children##3##3##(2010-7#1)(2011-2#2)
testing of sunscreens against##2##4##(2008-5#2)
testing of sunscreens##3##3##(2008-5#3)
testing of the##9##3##(1994-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-10#3)(2010-6#1)
testing of##79##2##(1990-3#1)(1991-1#1)(1992-3#2)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#3)(1996-5#1)(1996-6#2)(2008-10#18)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#3)(2010-10#3)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#1)
testing on##3##2##(1996-2#1)(2008-6#2)
testing performed##2##2##(1994-8#1)(1995-1#1)
testing procedure##4##2##(1990-11#1)(1995-9#1)(2008-4#1)(2008-5#1)
testing procedures##5##2##(1993-3#1)(2008-11#1)(2008-12#2)(2008-5#1)
testing requires##2##2##(1997-1#1)(1997-3#1)
testing revealed##2##2##(2008-10#1)(2008-8#1)
testing several##2##2##(2008-11#1)(2008-5#1)
testing should be##2##3##(2008-11#1)(2008-5#1)
testing stage##2##2##(1997-6#1)(2008-10#1)
testing the relationship between##2##4##(2008-10#1)(2008-9#1)
testing the##16##2##(1990-11#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-8#3)(2013-8#1)
testing time##2##2##(1992-3#1)(1994-3#1)
testing to##7##2##(1996-5#1)(1997-1#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
testing using##2##2##(1994-1#1)(2008-6#1)
testing was performed##4##3##(1995-3#1)(2007-11#1)(2008-7#1)(2012-3#1)
testing was##7##2##(1993-11#1)(1995-3#1)(2007-11#1)(2008-7#2)(2010-10#1)(2012-3#1)
testing were##2##2##(1993-6#1)(2011-2#1)
testing with the##3##3##(2008-5#1)(2008-9#1)(2010-10#1)
testing with##7##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-2#1)
testing##536##1##(1990-11#3)(1990-12#1)(1990-3#3)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#5)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#5)(1993-6#7)(1993-9#1)(1994-1#6)(1994-12#2)(1994-2#3)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#5)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-9#6)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#7)(1996-3#4)(1996-5#15)(1996-6#7)(1996-8#1)(1997-1#4)(1997-2#10)(1997-3#3)(1997-4#1)(1997-6#1)(2007-11#2)(2007-9#1)(2008-10#99)(2008-11#20)(2008-12#19)(2008-3#2)(2008-4#14)(2008-5#33)(2008-6#10)(2008-7#9)(2008-8#7)(2008-9#17)(2009-10#1)(2009-11#3)(2009-12#4)(2009-3#4)(2009-4#1)(2009-5#10)(2009-7#7)(2009-8#1)(2010-1#2)(2010-10#8)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#6)(2011-1#4)(2011-2#30)(2011-8#1)(2012-12#5)(2012-2#23)(2012-3#12)(2013-1#15)(2013-8#13)
testing&quot##4##1##(1995-3#1)(2008-10#1)(2011-2#2)
testings##4##1##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
testis and##7##2##(1992-12#1)(2008-10#2)(2008-8#1)(2009-7#1)(2011-2#2)
testis are##2##2##(1990-2#1)(2008-10#1)
testis by##2##2##(2008-9#1)(2010-5#1)
testis cDNA library##3##3##(1994-11#1)(1995-6#1)(2008-9#1)
testis has##2##2##(2008-7#1)(2009-10#1)
testis of##3##2##(1992-12#1)(2008-7#2)
testis showed##2##2##(1997-3#1)(2008-8#1)
testis was##4##2##(1992-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
testis were##2##2##(1992-12#1)(2008-9#1)
testis which##2##2##(1995-8#1)(2012-2#1)
testis##103##1##(1990-2#3)(1992-12#7)(1992-6#1)(1993-12#1)(1994-11#5)(1995-6#3)(1995-8#6)(1997-3#4)(1997-8#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#7)(2009-10#9)(2009-11#1)(2009-7#2)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#13)
testis-expressed##2##1##(2010-5#1)(2012-2#1)
testis-specific atypical##2##2##(2012-2#2)
testis-specific##4##1##(2008-9#1)(2009-10#1)(2012-2#2)
testosterone (T) and##2##3##(1990-11#1)(1996-2#1)
testosterone (T)##3##2##(1990-11#1)(1996-2#1)(2008-3#1)
testosterone 6 beta-hydroxylase##2##3##(1991-5#2)
testosterone and##2##2##(1990-11#1)(1993-8#1)
testosterone ester##2##2##(1995-2#2)
testosterone esters##4##2##(1995-2#4)
testosterone in the##3##3##(1995-2#1)(2008-10#1)(2012-2#1)
testosterone in##7##2##(1995-2#1)(2008-10#4)(2008-5#1)(2012-2#1)
testosterone signals##2##2##(2012-2#2)
testosterone was##2##2##(1992-12#1)(2008-10#1)
testosterone with##2##2##(1990-11#1)(2008-10#1)
testosterone##86##1##(1990-11#12)(1990-2#2)(1991-3#1)(1991-5#2)(1992-12#2)(1992-3#1)(1993-8#3)(1994-2#5)(1994-3#1)(1994-6#2)(1995-12#4)(1995-2#10)(1996-2#2)(2008-10#10)(2008-3#1)(2008-5#6)(2008-8#5)(2008-9#5)(2011-1#2)(2012-2#6)(2013-1#2)(2013-7#1)(2013-8#1)
testosterone's##2##1##(2008-8#2)
testosterone-treated males##2##2##(2008-8#2)
tests also##2##2##(2008-10#1)(2008-5#1)
tests and estimates##2##3##(1994-9#2)
tests and in##2##3##(2008-10#2)
tests and the##4##3##(2008-10#2)(2008-6#1)(2013-1#1)
tests and their##3##3##(2008-10#2)(2011-3#1)
tests and to##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
tests and##57##2##(1990-3#1)(1990-9#2)(1993-3#1)(1994-3#3)(1994-9#2)(1995-11#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(2008-10#16)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
tests are available##2##3##(1993-2#1)(1997-2#1)
tests are not##3##3##(1993-12#2)(1995-1#1)
tests are useful##2##3##(1997-1#1)(2008-11#1)
tests are##28##2##(1993-12#2)(1993-2#1)(1995-1#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#2)(2008-9#2)(2009-3#1)(2009-7#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
tests at 12 months##2##4##(2008-9#1)(2013-1#1)
tests at the##2##3##(1991-6#1)(2013-1#1)
tests at##6##2##(1991-6#1)(2008-10#2)(2008-9#1)(2013-1#2)
tests based on Vibrio fischeri##2##5##(2008-10#2)
tests based on the##6##4##(1996-3#1)(2008-10#5)
tests based on##10##3##(1996-3#1)(2008-10#7)(2012-3#1)(2013-8#1)
tests can be##2##3##(1994-9#1)(2008-12#1)
tests can##6##2##(1993-3#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
tests carried out##5##3##(1993-3#2)(2008-10#3)
tests conducted##2##2##(2008-2#1)(2008-9#1)
tests confirmed that##2##3##(2008-10#2)
tests confirmed##6##2##(2008-10#5)(2011-2#1)
tests demonstrated that the##2##4##(2008-10#1)(2008-9#1)
tests demonstrated that##3##3##(2008-10#2)(2008-9#1)
tests demonstrated the##2##3##(2008-5#1)(2008-9#1)
tests demonstrated##5##2##(2008-10#2)(2008-5#1)(2008-9#2)
tests done##2##2##(2008-10#1)(2012-2#1)
tests during##3##2##(1991-3#1)(2008-1#1)(2008-10#1)
tests for the detection of##5##5##(1991-3#2)(2008-10#2)(2008-11#1)
tests for the##11##3##(1991-3#2)(1994-9#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-9#1)(2012-3#1)
tests for##35##2##(1990-2#1)(1990-8#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-9#1)(1995-5#2)(1996-2#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
tests has been##2##3##(2008-9#1)(2012-3#1)
tests have been##4##3##(1997-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
tests have limitations either in detecting pinholes and/or they are difficult to implement for routine testing##2##16##(2012-2#2)
tests have##12##2##(1991-9#1)(1996-11#1)(1997-1#1)(2008-10#4)(2008-12#1)(2010-12#1)(2012-2#3)
tests in a##2##3##(1996-12#1)(1997-2#1)
tests in order to##2##4##(2008-10#1)(2008-5#1)
tests in the##2##3##(2008-10#1)(2008-4#1)
tests in which##2##3##(2008-10#2)
tests in##29##2##(1993-3#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2011-2#2)(2011-8#1)(2013-1#3)(2013-8#1)
tests including##2##2##(2008-12#1)(2011-2#1)
tests indicate that##2##3##(2008-10#1)(2010-4#1)
tests indicate##3##2##(2008-10#1)(2009-7#1)(2010-4#1)
tests indicated that the##2##4##(2008-10#1)(2013-1#1)
tests indicated that##3##3##(1991-12#1)(2008-10#1)(2013-1#1)
tests indicated##5##2##(1991-12#1)(1996-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
tests is##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
tests may##2##2##(2011-2#1)(2013-1#1)
tests of liver function##3##4##(1992-12#2)(1992-5#1)
tests of the##4##3##(1996-9#1)(2008-10#2)(2008-3#1)
tests of their##2##3##(1993-3#1)(2008-9#1)
tests of##35##2##(1991-3#1)(1992-12#2)(1992-5#1)(1993-3#2)(1994-2#1)(1996-9#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#6)(2010-10#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
tests on two##2##3##(1992-3#1)(2008-12#1)
tests on##14##2##(1992-3#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-3#1)(2012-12#1)
tests or##2##2##(2010-11#1)(2012-3#1)
tests over##2##2##(1996-9#1)(2010-10#1)
tests per##2##2##(1990-9#1)(2008-5#1)
tests performed##5##2##(1994-9#1)(1996-11#1)(2008-6#1)(2011-2#1)(2012-12#1)
tests provided##2##2##(2008-10#2)
tests reveal that##2##3##(1994-1#1)(2008-10#1)
tests revealed##4##2##(2008-10#2)(2010-1#1)(2012-2#1)
tests run##2##2##(2008-10#1)(2008-3#1)
tests should be performed##2##4##(2008-7#1)(2009-8#1)
tests show that##2##3##(2008-3#1)(2013-1#1)
tests show##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
tests showed that##4##3##(2008-6#1)(2008-8#1)(2009-7#1)(2013-1#1)
tests showed##7##2##(1990-6#1)(1992-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-7#1)(2013-1#1)
tests such as the##2##4##(2008-11#1)(2011-2#1)
tests that can##2##3##(2008-12#1)(2010-1#1)
tests that##9##2##(1991-2#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2013-1#1)
tests to assess##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
tests to##14##2##(1990-3#1)(1991-12#1)(1995-5#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2013-1#2)
tests used for##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
tests used to##3##3##(1996-11#1)(1997-3#1)(2010-7#1)
tests used##10##2##(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)
tests using##7##2##(2008-10#5)(2008-11#1)(2008-5#1)
tests was##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
tests were administered##2##3##(2008-12#1)(2008-7#1)
tests were carried out##2##4##(2008-5#2)
tests were conducted on##2##4##(2008-10#2)
tests were conducted##5##3##(2008-10#5)
tests were performed on##2##4##(2008-10#2)
tests were performed##5##3##(1996-2#1)(2008-10#3)(2008-5#1)
tests were used to##2##4##(2008-5#1)(2011-1#1)
tests were used##3##3##(1996-12#1)(2008-5#1)(2011-1#1)
tests were##34##2##(1994-3#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#4)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
tests with functional endpoints for the##2##6##(2008-11#2)
tests with##22##2##(1991-6#1)(1995-12#1)(1995-5#2)(2008-10#10)(2008-11#4)(2008-5#1)(2011-7#1)(2013-1#2)
tests##665##1##(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#6)(1991-12#4)(1991-2#3)(1991-3#5)(1991-4#1)(1991-6#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-5#2)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#13)(1993-6#4)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#8)(1994-6#1)(1994-8#4)(1994-9#8)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#6)(1996-1#3)(1996-11#6)(1996-12#7)(1996-2#6)(1996-3#5)(1996-6#2)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#230)(2008-11#22)(2008-12#22)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#34)(2008-6#4)(2008-7#12)(2008-8#7)(2008-9#28)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#5)(2009-8#2)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#23)(2011-3#2)(2011-7#2)(2011-8#1)(2012-12#5)(2012-2#19)(2012-3#16)(2012-4#1)(2013-1#28)(2013-8#6)
tests) in##2##2##(2008-10#1)(2008-11#1)
tests)##8##1##(1994-8#2)(2008-10#4)(2008-11#1)(2008-2#1)
tetanic stimulation##3##2##(1993-12#1)(2008-7#2)
tetanic##4##1##(1993-12#1)(2008-7#2)(2013-8#1)
tetanus toxin##5##2##(1995-2#2)(2008-10#3)
tetanus toxoid##3##2##(2011-2#3)
tetanus##23##1##(1993-12#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-6#1)(1996-8#1)(2007-11#1)(2008-10#3)(2011-2#3)(2012-3#2)(2013-1#1)
tether##3##1##(1990-2#1)(1996-5#1)(2008-9#1)
tethered cord syndrome##3##3##(2008-7#3)
tethered vagina syndrome##2##3##(2012-3#2)
tethered##12##1##(1992-4#1)(2008-11#4)(2008-7#4)(2009-12#1)(2012-3#2)
tetherin##5##1##(2013-1#5)
tethering##2##1##(2011-2#1)(2012-2#1)
tethers to##2##2##(2008-4#1)(2008-8#1)
tethers##4##1##(2008-4#1)(2008-8#2)(2008-9#1)
tetra##5##1##(2008-10#4)(2008-8#1)
tetra-##2##1##(1996-5#1)(2008-10#1)
tetra-3##3##1##(2008-10#3)
tetra-N-hexadecylpyridiniumyl porphyrin##2##2##(2008-10#2)
tetra-coordinate nickel(II) complex##2##3##(2008-10#2)
tetra-n-butylammonium##2##1##(2008-10#2)
tetra-nucleotides are##2##2##(2012-3#2)
tetra-nucleotides##4##1##(2012-3#4)
tetra-substituted amino aluminum phthalocyanine##2##4##(2008-10#2)
tetra-substituted##4##1##(2008-10#4)
tetraacetal##2##1##(1996-5#2)
tetraacetic acid##3##2##(2008-10#3)
tetraalkylammonium##3##1##(2008-10#3)
tetraaminophthalocyanine##2##1##(2008-10#2)
tetrabenzyl##2##1##(2008-10#2)
tetrabromophenolphthalein##2##1##(2008-10#2)
tetrabutylammonium (TBA)##2##2##(2008-10#2)
tetrabutylammonium bromide (TBABr)##2##3##(2008-10#2)
tetrabutylammonium bromide##8##2##(2008-10#8)
tetrabutylammonium periodate##3##2##(2008-10#3)
tetrabutylammonium##20##1##(2008-10#19)(2009-5#1)
tetracaine hydrochloride##5##2##(2008-10#5)
tetracarboxy aluminum phthalocyanine##2##3##(2008-10#2)
tetrachloride##12##1##(1992-6#1)(2008-10#7)(2009-8#1)(2010-2#1)(2010-5#1)(2013-1#1)
tetrachlorinated quinone##2##2##(2008-10#2)
tetrachloro-p-benzoquinone##2##1##(2008-10#2)
tetrachlorobenzoquinone reductase##2##2##(2009-3#2)
tetrachlorobenzoquinone##5##1##(2008-10#1)(2009-3#4)
tetrachlorodibenzo-p-dioxin (TCDD)##2##2##(2008-10#2)
tetrachloroethylene##3##1##(2008-10#3)
tetrachlorohydroquinone and##2##2##(2008-10#1)(2009-3#1)
tetrachlorohydroquinone##7##1##(2008-10#1)(2009-3#6)
tetrachloromethane##2##1##(2008-10#2)
tetrachloromethane)##2##1##(2008-10#2)
tetrachlorothallate##4##1##(2008-10#4)
tetracyanoethylene##2##1##(2008-10#2)
tetracycline (TC)##2##2##(2008-10#2)
tetracycline and##5##2##(2008-10#4)(2008-12#1)
tetracycline antibiotics in##3##3##(2008-10#3)
tetracycline antibiotics##6##2##(2008-10#6)
tetracycline in the##2##3##(2008-10#2)
tetracycline in##5##2##(2008-10#5)
tetracycline##44##1##(1997-7#2)(1997-8#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
tetracyclines in surface water samples##2##5##(2008-10#2)
tetracyclines in##3##2##(2008-10#3)
tetracyclines##7##1##(2008-10#7)
tetradentate##2##1##(2008-10#2)
tetrads##3##1##(2008-10#2)(2012-3#1)
tetraether lipid##2##2##(1990-2#2)
tetraether##3##1##(1990-2#3)
tetraethyl##2##1##(2008-10#1)(2010-11#1)
tetraethylammonium##6##1##(1994-11#1)(1994-12#1)(2008-10#4)
tetraethylenepentamine##3##1##(2008-10#3)
tetraethylorthosilicate (TEOS)##3##2##(2008-10#3)
tetraethylorthosilicate##4##1##(2008-10#4)
tetragonal zirconia##3##2##(2008-10#3)
tetragonal##5##1##(2008-10#4)(2008-9#1)
tetragonus##2##1##(2008-10#2)
tetraheme cytochrome subunit##3##3##(1993-8#3)
tetraheme cytochrome##4##2##(1993-8#3)(1994-5#1)
tetraheme##6##1##(1993-8#4)(1994-11#1)(1994-5#1)
tetrahydroborate##11##1##(2008-10#11)
tetrahydroborate(III)##4##1##(2008-10#4)
tetrahydrocortisol and tetrahydro##2##3##(1997-1#2)
tetrahydrofuran (THF)##2##2##(1996-5#1)(2008-10#1)
tetrahydrofuran and##2##2##(2008-10#2)
tetrahydrofuran##12##1##(1996-5#2)(2008-10#8)(2008-5#1)(2009-5#1)
tetrahydrofurane##3##1##(2008-10#3)
tetrahydropentalenolactone##2##1##(1994-5#2)
tetrahydropyridine##2##1##(1996-12#2)
tetraiodofluorescein##3##1##(2008-10#3)
tetrakis##5##1##(2008-10#5)
tetrakis(4-chlorophenyl)borate##6##1##(2008-10#6)
tetralogy of Fallot##3##3##(1997-3#2)(2009-10#1)
tetralogy##4##1##(1996-11#1)(1997-3#2)(2009-10#1)
tetraloops##4##1##(1992-3#4)
tetramer and##2##2##(1993-8#1)(2008-8#1)
tetramer binding##2##2##(2008-8#1)(2008-9#1)
tetramer##8##1##(1990-10#1)(1993-8#2)(2008-8#2)(2008-9#3)
tetrameric##4##1##(1993-8#1)(1995-11#1)(2008-9#2)
tetramerization##7##1##(1993-8#7)
tetramers##6##1##(2008-4#2)(2008-9#4)
tetramethylammonium hydroxide##6##2##(2008-10#6)
tetramethylammonium##9##1##(2008-10#9)
tetramethylarsonium##3##1##(2008-10#3)
tetramethylpyrazine and##2##2##(1991-6#2)
tetramethylpyrazine##6##1##(1991-6#6)
tetramethylrhodamine##2##1##(2008-10#2)
tetraoctylammonium bromide##2##2##(2008-10#2)
tetraoctylammonium##3##1##(2008-10#3)
tetrapeptide##11##1##(1990-2#1)(1991-5#2)(1993-6#1)(1993-9#1)(1994-5#3)(2008-10#3)
tetrapetalum##2##1##(2008-10#2)
tetraphenyl borate##5##2##(2008-10#5)
tetraphenylborate as##2##2##(2008-10#2)
tetraphenylborate##19##1##(2008-10#19)
tetraplegia##2##1##(2012-2#2)
tetraplegics##2##1##(1991-6#2)
tetraploid wheat##5##2##(2008-10#3)(2012-3#2)
tetraploid##12##1##(2008-10#6)(2008-11#2)(2012-3#4)
tetrapod##2##1##(1990-8#1)(2012-12#1)
tetrapods##3##1##(1990-8#1)(2009-6#2)
tetraruthenated porphyrin##2##2##(2008-10#2)
tetraspanin##3##1##(2009-8#3)
tetrasubstituted##2##1##(2008-10#1)(2010-3#1)
tetrasulfonated phthalocyanine (CoTSPc)##2##3##(2008-10#2)
tetrasulfonated phthalocyanine##3##2##(2008-10#3)
tetrasulfonated##5##1##(2008-10#5)
tetrathiafulvalene##2##1##(1996-5#1)(2008-10#1)
tetrathioethers##3##1##(2008-10#3)
tetratricopeptide repeat##2##2##(1996-2#2)
tetratricopeptide##3##1##(1996-2#2)(1997-7#1)
tetraurelia##3##1##(2008-12#3)
tetravalent##2##1##(2008-10#1)(2008-4#1)
tetrazolium##7##1##(1991-12#1)(1992-9#1)(2008-10#4)(2008-11#1)
tetrodotoxin##2##1##(1990-5#1)(1996-2#1)
tetrol I-1##9##2##(2008-10#9)
tetrol##10##1##(2008-10#10)
text alexia##2##2##(2010-7#2)
text and##2##2##(1995-1#1)(2008-11#1)
text field for##2##3##(2010-8#2)
text field##4##2##(2010-8#4)
text of##3##2##(1991-12#1)(2008-12#1)(2011-2#1)
text paging##5##2##(2010-8#5)
text reading##3##2##(2008-11#1)(2010-7#2)
text##48##1##(1991-12#1)(1994-6#1)(1995-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-12#1)(2010-7#7)(2010-8#15)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
text)##2##1##(2009-6#1)(2013-8#1)
textbook##2##1##(2009-5#1)(2009-8#1)
textbooks##9##1##(1995-12#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#2)(2013-8#2)
textile##6##1##(2008-10#4)(2009-10#1)(2012-2#1)
textiles##4##1##(1991-6#1)(2008-10#1)(2010-4#1)(2011-2#1)
texting##2##1##(2013-1#2)
texts##7##1##(2008-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2013-1#2)
textual##2##1##(2008-9#1)(2013-1#1)
textural properties##2##2##(2010-4#1)(2011-2#1)
textural##6##1##(2008-10#1)(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#1)
texture analysis##2##2##(2009-12#1)(2010-8#1)
texture and##6##2##(2008-10#4)(2008-5#1)(2011-2#1)
texture at surface##2##3##(2013-8#2)
texture at##3##2##(2013-8#3)
texture features##5##2##(2008-10#1)(2008-6#1)(2010-8#3)
texture in##2##2##(2008-10#1)(2012-2#1)
texture of##2##2##(2010-8#1)(2013-8#1)
texture pattern##2##2##(2008-6#2)
texture type conditions##2##3##(2008-6#2)
texture##52##1##(1995-3#1)(2008-10#15)(2008-5#4)(2008-6#14)(2009-12#1)(2010-4#1)(2010-8#7)(2011-2#2)(2012-2#1)(2012-6#1)(2013-8#5)
texture-based##3##1##(2008-6#3)
textures##8##1##(2008-10#2)(2008-5#4)(2008-6#2)
tga1a##3##1##(2008-9#3)
tgr-1##3##1##(2008-10#3)
th##4##1##(1990-11#1)(2008-11#2)(2012-12#1)
thalami##4##1##(2008-6#2)(2012-3#2)
thalamic afferents##2##2##(1994-3#1)(1997-2#1)
thalamic nuclei##3##2##(1991-12#1)(1997-2#1)(1997-3#1)
thalamic nucleus##3##2##(1996-5#1)(1997-2#1)(2013-8#1)
thalamic##18##1##(1991-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-2#6)(1997-3#1)(2008-7#2)(2010-1#1)(2013-8#1)
thalamocortical projection##2##2##(1994-2#2)
thalamus and##3##2##(1996-2#1)(2008-7#2)
thalamus##10##1##(1996-12#1)(1996-2#1)(1997-2#1)(2008-7#4)(2012-3#3)
thalassemia by##2##2##(1994-12#1)(2008-10#1)
thalassemia##12##1##(1994-12#1)(1995-12#2)(2008-10#7)(2013-1#2)
thaliana ecotype##2##2##(2008-10#2)
thaliana ecotypes##3##2##(2008-10#1)(2012-3#2)
thaliana roots##2##2##(2008-10#2)
thaliana##70##1##(1991-6#2)(1993-2#2)(1994-12#1)(1997-6#2)(1997-8#3)(2008-1#1)(2008-10#29)(2008-12#1)(2008-9#10)(2009-10#2)(2009-8#5)(2011-10#1)(2011-2#3)(2012-3#6)(2013-8#2)
thalidomide##2##1##(2011-2#2)
thallium (I)##2##2##(2008-10#2)
thallium (III) and##2##3##(2008-10#2)
thallium (III)##5##2##(2008-10#5)
thallium and lead##3##3##(2008-10#3)
thallium in the##2##3##(1994-5#2)
thallium in##9##2##(1991-12#1)(1994-5#3)(2008-10#5)
thallium using##2##2##(2008-10#2)
thallium was##2##2##(2008-10#2)
thallium##43##1##(1991-12#4)(1992-5#1)(1994-5#5)(2008-10#32)(2013-1#1)
thallium(I)##9##1##(2008-10#9)
than 0##155##2##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#5)(1991-12#4)(1991-2#8)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#11)(1992-12#4)(1992-2#2)(1992-3#5)(1992-9#1)(1993-1#2)(1994-1#4)(1994-3#1)(1994-5#1)(1995-1#2)(1997-2#1)(2008-10#68)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-8#2)
than 1 and##2##3##(2008-10#2)
than 1 cm##2##3##(1997-1#1)(1997-4#1)
than 1 m##3##3##(2008-10#3)
than 1 month##3##3##(2008-10#2)(2008-11#1)
than 1 year##6##3##(1991-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
than 1##81##2##(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-3#3)(1992-9#1)(1993-6#1)(1994-1#1)(1995-8#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#40)(2008-11#4)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#1)(2010-11#2)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#1)
than 1% of##5##3##(1991-12#1)(1996-11#1)(2008-10#1)(2008-5#1)(2013-7#1)
than 1%##23##2##(1991-12#1)(1992-2#1)(1996-11#1)(2008-10#16)(2008-3#1)(2008-5#1)(2008-8#1)(2013-7#1)
than 10 days##4##3##(2008-10#2)(2008-11#2)
than 10 h##2##3##(2008-10#2)
than 10 mg##2##3##(2008-10#1)(2009-8#1)
than 10 min##5##3##(2008-10#4)(2008-3#1)
than 10 mm##2##3##(2008-7#1)(2010-12#1)
than 10 mm/day)##2##3##(2008-10#2)
than 10##36##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-5#1)(1994-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-1#1)
than 10% of the##3##4##(1992-3#1)(2008-10#2)
than 10% of##9##3##(1990-5#1)(1992-3#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)
than 10%##25##2##(1990-5#1)(1992-3#1)(1995-12#1)(1996-12#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)
than 10%)##2##2##(2008-10#1)(2008-9#1)
than 10(-9) M##2##3##(1997-4#2)
than 10(-9)##3##2##(1997-4#2)(2010-1#1)
than 100 mug##2##3##(2008-10#2)
than 100##28##2##(1990-5#1)(1993-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(2008-10#13)(2008-11#1)(2008-5#2)(2009-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
than 100%##2##2##(1994-2#1)(2008-10#1)
than 1000##6##2##(1991-12#1)(1994-12#1)(1996-12#1)(2008-11#2)(2013-1#1)
than 11##5##2##(1996-12#1)(2007-12#1)(2008-10#3)
than 110##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
than 12 hours##3##3##(1990-12#1)(1993-12#1)(2010-7#1)
than 12 months##2##3##(1996-3#1)(1996-6#1)
than 12##13##2##(1990-12#1)(1992-4#1)(1993-12#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2010-7#1)(2012-2#1)
than 12%##2##2##(2008-10#1)(2008-8#1)
than 14##4##2##(1991-12#1)(1994-6#1)(2008-10#1)(2013-8#1)
than 15 years##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
than 15##16##2##(1992-8#1)(1994-3#1)(1995-12#2)(2008-10#5)(2008-7#3)(2008-9#3)(2012-2#1)
than 15%##4##2##(1997-6#1)(2008-10#1)(2011-3#1)(2013-1#1)
than 150##5##2##(1996-12#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
than 16##3##2##(2008-10#1)(2013-1#2)
than 17##2##2##(1992-3#1)(1995-11#1)
than 19##2##2##(2008-10#1)(2008-7#1)
than 2 cm##3##3##(1990-9#1)(1997-4#1)(2008-10#1)
than 2 months##5##3##(2006-5#2)(2008-10#2)(2008-11#1)
than 2 weeks##3##3##(1991-8#1)(2008-10#1)(2011-2#1)
than 2##50##2##(1990-12#1)(1990-9#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1995-2#1)(1997-4#1)(2006-5#2)(2008-10#26)(2008-11#3)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#3)(2013-1#3)
than 2% of##4##3##(1994-6#1)(2009-11#1)(2010-6#1)(2013-1#1)
than 2%##18##2##(1994-6#1)(1996-8#1)(2008-10#10)(2008-11#1)(2008-3#2)(2009-11#1)(2010-6#1)(2013-1#1)
than 20 min##3##3##(1994-3#1)(2008-10#2)
than 20 s##2##3##(2008-10#2)
than 20 years##7##3##(1993-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)
than 20##31##2##(1990-12#2)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#1)
than 20% of##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
than 20%##7##2##(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
than 200##13##2##(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
than 2000##2##2##(1995-12#1)(2008-10#1)
than 22##2##2##(2008-11#1)(2011-2#1)
than 23##2##2##(2008-10#1)(2008-8#1)
than 245##2##2##(2008-10#2)
than 25##5##2##(1990-12#1)(1993-2#1)(2008-10#2)(2008-12#1)
than 25%##7##2##(1993-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-1#1)
than 28##2##2##(2008-10#1)(2008-11#1)
than 3 kDa)##2##3##(1990-5#1)(2008-10#1)
than 3##35##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-3#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
than 3% of##2##3##(1994-6#1)(2010-5#1)
than 3%##9##2##(1993-1#1)(1994-6#1)(2008-10#5)(2010-5#1)(2013-8#1)
than 30 years##6##3##(1994-12#1)(1996-11#1)(2009-8#1)(2011-2#2)(2013-1#1)
than 30##24##2##(1990-12#1)(1990-5#1)(1993-1#1)(1994-12#1)(1996-11#1)(2008-1#1)(2008-10#10)(2008-9#1)(2009-8#1)(2011-2#2)(2011-3#1)(2013-1#3)
than 30%##4##2##(1993-2#1)(2008-11#1)(2008-5#1)(2009-7#1)
than 300 bp##2##3##(1995-12#1)(1996-3#1)
than 300 mg##2##3##(1996-11#1)(2008-11#1)
than 300##12##2##(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
than 32##2##2##(2008-1#1)(2008-10#1)
than 350##3##2##(2008-10#1)(2008-2#1)(2010-11#1)
than 37##2##2##(2007-12#1)(2008-9#1)
than 3min##2##2##(2008-10#2)
than 3 × 10(7)##2##2##(2011-2#2)
than 4##23##2##(1990-12#1)(1990-9#1)(1991-12#1)(2008-10#17)(2008-2#1)(2008-5#1)(2012-12#1)
than 4%##8##2##(1990-6#1)(2008-10#7)
than 4-h WD##2##3##(2008-10#2)
than 40 degrees C##2##4##(2007-12#1)(2008-7#1)
than 40 mm##2##3##(1992-5#1)(1996-6#1)
than 40 years of##3##4##(2008-7#1)(2012-12#1)(2012-2#1)
than 40 years##4##3##(1997-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
than 40##15##2##(1991-2#1)(1992-5#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)
than 45##3##2##(1990-12#1)(2008-7#1)(2011-2#1)
than 48##2##2##(1990-12#1)(2008-10#1)
than 5 years##4##3##(1990-6#1)(1991-6#1)(1991-8#1)(2010-11#1)
than 5##23##2##(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-11#2)(2011-2#2)(2012-3#2)
than 5% and##2##3##(2008-10#1)(2008-3#1)
than 5% blasts by the end of the second course of ADE##2##12##(2008-10#2)
than 5% error in the estimate of the 50% control mean##2##11##(2012-2#2)
than 5% of C##2##4##(2008-5#1)(2011-2#1)
than 5% of##8##3##(1991-12#1)(1995-6#1)(2008-10#1)(2008-5#2)(2009-8#1)(2011-2#2)
than 5%##37##2##(1991-12#1)(1994-9#1)(1995-6#1)(2008-10#21)(2008-3#2)(2008-5#3)(2009-8#1)(2011-2#3)(2012-2#3)(2013-1#1)
than 50 m##2##3##(2008-10#1)(2008-3#1)
than 50 microm##2##3##(2008-10#2)
than 50 ml##2##3##(1991-2#1)(1993-2#1)
than 50 years##3##3##(1993-8#1)(2008-10#1)(2011-3#1)
than 50##27##2##(1991-2#1)(1991-6#1)(1993-2#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#13)(2008-3#1)(2011-3#1)(2012-12#2)(2013-1#2)
than 50% (&quot##2##3##(2011-2#2)
than 50% of patients##2##4##(2010-12#1)(2013-1#1)
than 50% of the##6##4##(1994-11#1)(1997-6#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)
than 50% of these##2##4##(1995-2#1)(2013-1#1)
than 50% of##16##3##(1990-12#1)(1990-2#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-6#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
than 50%##34##2##(1990-12#1)(1990-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
than 500##4##2##(1993-3#1)(2008-8#1)(2012-3#1)(2013-1#1)
than 57##2##2##(2008-10#2)
than 6 h##2##3##(1993-12#1)(2008-10#1)
than 6 months##9##3##(1991-2#1)(1996-12#1)(2008-10#4)(2008-11#1)(2012-12#1)(2013-1#1)
than 6##23##2##(1990-6#1)(1991-2#1)(1992-6#1)(1993-12#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#1)
than 6%##4##2##(2008-10#3)(2010-1#1)
than 60 %##2##3##(2011-2#1)(2012-12#1)
than 60 mgCl(-1)##2##3##(2008-10#2)
than 60##16##2##(1991-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
than 60% for##2##3##(1996-12#1)(2008-10#1)
than 60%##7##2##(1990-12#1)(1996-12#1)(2008-10#2)(2008-8#1)(2010-5#1)(2012-12#1)
than 600##3##2##(2010-7#1)(2010-8#1)(2011-3#1)
than 65 years of age##4##5##(2011-2#4)
than 65 years##13##3##(2008-7#1)(2009-1#1)(2009-8#4)(2011-2#6)(2013-8#1)
than 65##14##2##(1990-3#1)(2008-7#1)(2009-1#1)(2009-8#4)(2011-2#6)(2013-8#1)
than 7##9##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1996-11#1)(2008-10#3)(2008-2#1)
than 7%##5##2##(2008-10#4)(2008-2#1)
than 70##4##2##(1991-12#1)(1993-11#1)(2011-2#1)(2013-8#1)
than 70% of the##7##4##(1992-10#1)(2008-10#5)(2008-8#1)
than 70% of##8##3##(1992-10#1)(2008-10#5)(2008-8#1)(2012-2#1)
than 70%##11##2##(1992-10#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
than 75 years##4##3##(1991-2#1)(2008-5#1)(2011-2#2)
than 75##8##2##(1991-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#2)
than 75% of the##2##4##(1995-8#1)(2011-3#1)
than 77%##2##2##(1991-6#1)(2008-10#1)
than 8##9##2##(1995-3#1)(2008-10#8)
than 8%##8##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)
than 80##5##2##(1996-3#1)(2008-10#2)(2012-3#1)(2013-1#1)
than 80% of the##2##4##(1993-6#1)(2008-8#1)
than 80% of##8##3##(1992-6#1)(1993-6#1)(1995-6#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-3#1)
than 80%##15##2##(1992-6#1)(1993-6#1)(1995-5#2)(1995-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-3#1)
than 800##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
than 84##2##2##(2008-10#1)(2008-3#1)
than 85##2##2##(2009-8#1)(2011-2#1)
than 88%##2##2##(2008-10#2)
than 9%##3##2##(2008-10#2)(2008-3#1)
than 90 ng##2##3##(2008-10#2)
than 90##6##2##(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
than 90%##26##2##(1991-12#1)(1994-9#1)(1996-11#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#2)
than 91%##2##2##(2008-10#2)
than 93%##4##2##(1995-5#1)(2008-10#2)(2012-2#1)
than 95% and##2##3##(2008-10#1)(2008-11#1)
than 95% of##2##3##(1994-8#1)(2008-10#1)
than 95%##11##2##(1994-8#1)(2008-10#8)(2008-11#2)
than 97% in##2##3##(2008-10#1)(2008-3#1)
than 97%##6##2##(2008-10#5)(2008-3#1)
than 98%##5##2##(2008-10#4)(2008-9#1)
than 99##6##2##(1992-12#1)(1997-2#1)(2008-10#3)(2008-3#1)
than 99%##10##2##(1996-12#1)(2008-10#5)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
than AAS-found metal##2##3##(2008-10#2)
than African##2##2##(2009-5#1)(2010-10#1)
than Asians##3##2##(2012-2#3)
than F##2##2##(2008-10#2)
than L##2##2##(2008-10#1)(2010-8#1)
than LLE##2##2##(2008-10#2)
than Medicare##2##2##(1991-3#2)
than Na##2##2##(2008-10#2)
than P##2##2##(2008-10#2)
than Q##3##2##(2012-5#1)(2012-9#2)
than SA##2##2##(2008-10#1)(2011-1#1)
than Shanyou63##2##2##(2008-9#2)
than T##2##2##(1991-8#1)(2008-10#1)
than T(382)##3##2##(2008-10#3)
than VCG##2##2##(2008-10#2)
than WHO TEQ values)##2##4##(2008-10#2)
than WT##2##2##(2008-9#1)(2013-1#1)
than a comparable##2##3##(2008-10#1)(2008-11#1)
than a decade##7##3##(1993-12#1)(1994-12#1)(1996-5#1)(1997-4#1)(2009-3#1)(2011-2#1)(2012-2#1)
than a simple##2##3##(1992-8#1)(2008-9#1)
than a single##5##3##(1993-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
than a traditional##2##3##(2008-10#1)(2008-9#1)
than a year##3##3##(2010-10#1)(2012-3#2)
than a##87##2##(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#1)(2008-10#13)(2008-11#8)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#3)
than about##4##2##(1990-2#1)(2008-10#1)(2008-7#1)(2010-10#1)
than absolute##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
than acidic##2##2##(2008-10#1)(2008-11#1)
than acquisition##2##2##(2008-10#2)
than actual##2##2##(1990-6#1)(1996-9#1)
than additive effects##3##3##(2008-10#3)
than additive inhibition of##2##4##(1990-2#1)(2008-10#1)
than additive##8##2##(1990-2#1)(2008-10#7)
than adult##2##2##(2008-11#1)(2011-2#1)
than adults##4##2##(1994-8#1)(2008-11#1)(2008-9#1)(2011-2#1)
than after##4##2##(1991-9#1)(1996-2#1)(2008-5#1)(2012-3#1)
than all##3##2##(2008-10#2)(2010-2#1)
than among##9##2##(1994-3#1)(1994-6#1)(1995-1#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-9#1)
than an existing##2##3##(2012-3#2)
than an##15##2##(1993-8#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)
than anticipated##2##2##(2008-11#1)(2011-2#1)
than any of the##2##4##(2008-10#2)
than any other##13##3##(1991-2#2)(1994-3#2)(1994-8#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-6#1)(2012-3#1)(2013-1#1)
than any##20##2##(1991-2#2)(1992-9#1)(1994-3#2)(1994-8#1)(1997-8#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
than are the##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
than are##7##2##(1993-2#1)(1993-6#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-8#1)
than as an##5##3##(1996-3#1)(2008-7#1)(2009-12#1)(2013-1#2)
than as##10##2##(1990-5#1)(1996-3#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#2)
than at ED##2##3##(1993-3#2)
than at any other time##2##5##(2008-5#1)(2013-1#1)
than at higher##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
than at pH##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
than at the nearby non-AP site##2##6##(2008-10#2)
than at the##7##3##(1996-6#2)(2008-10#3)(2008-11#1)(2012-2#1)
than at##36##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-3#2)(1996-6#2)(1997-2#1)(2008-10#14)(2008-11#3)(2008-5#2)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#3)(2013-8#2)
than available##2##2##(1991-1#1)(2013-1#1)
than basal##2##2##(2008-10#2)
than before##2##2##(1991-12#1)(1991-6#1)
than being##6##2##(1990-5#1)(1995-3#1)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
than between either##2##3##(2008-10#1)(2013-1#1)
than between the##2##3##(2008-10#1)(2010-10#1)
than between##8##2##(2008-10#4)(2008-11#2)(2010-10#1)(2013-1#1)
than both##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
than boys##7##2##(1990-2#2)(1994-12#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
than by the##2##3##(1996-6#1)(2008-10#1)
than by##18##2##(1992-6#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-5#1)(1996-6#1)(2008-10#6)(2008-6#1)(2008-8#2)(2009-6#1)(2012-2#1)
than can be##2##3##(2008-4#1)(2008-5#1)
than caregivers without##2##3##(2010-7#2)
than caregivers##3##2##(2010-7#3)
than cells##3##2##(2008-11#3)
than children##4##2##(1994-6#2)(1995-1#1)(2008-11#1)
than clinical##2##2##(2008-10#1)(2010-1#1)
than common##2##2##(2008-8#1)(2013-1#1)
than commonly##2##2##(2008-11#1)(2009-11#1)
than control cells##3##3##(2008-11#1)(2008-8#1)(2009-12#1)
than control##13##2##(1995-6#1)(1997-3#1)(1997-7#1)(2008-11#3)(2008-12#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#1)
than controls in##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
than controls on the##2##4##(2010-8#1)(2012-3#1)
than controls##13##2##(1991-12#1)(1993-3#2)(1994-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
than conventional##12##2##(1994-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2011-7#1)(2012-2#1)
than corresponding##2##2##(1992-3#1)(2008-9#1)
than could be##2##3##(2009-5#1)(2013-1#1)
than could##3##2##(1992-3#1)(2009-5#1)(2013-1#1)
than current##3##2##(1994-12#1)(2008-10#1)(2012-2#1)
than did D##3##3##(2008-10#3)
than did the adherent populations##2##5##(2008-10#2)
than did the untreated controls##2##5##(1997-4#2)
than did the untreated##3##4##(1997-4#2)(2008-11#1)
than did the##15##3##(1991-12#1)(1992-1#1)(1997-4#2)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2011-2#1)
than did their##2##3##(1997-3#1)(2008-10#1)
than did those##3##3##(1996-11#1)(2008-11#1)(2013-8#1)
than did##71##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-3#2)(1994-1#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2008-10#28)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
than differences##2##2##(1993-2#1)(2008-11#1)
than direct##2##2##(2008-10#1)(2009-10#1)
than directly##2##2##(2009-5#1)(2012-6#1)
than do the##3##3##(1993-12#1)(1995-1#1)(2008-3#1)
than do##10##2##(1993-12#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-4#1)
than does##4##2##(1993-8#1)(2008-5#1)(2008-8#1)(2009-8#1)
than dog##2##2##(2013-1#2)
than drug##3##2##(1991-2#1)(2010-6#1)(2011-2#1)
than during##8##2##(1994-8#1)(1995-11#1)(2008-11#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#2)
than each##2##2##(1997-2#1)(2008-10#1)
than earlier##2##2##(2008-10#2)
than either treatment alone##3##4##(2008-10#2)(2009-8#1)
than either##13##2##(1992-1#1)(1992-3#1)(1993-11#1)(1997-1#1)(2008-10#6)(2008-4#1)(2008-9#1)(2009-8#1)
than environment##2##2##(1992-1#1)(2008-8#1)
than etidronate##2##2##(2008-11#2)
than ever before##4##3##(1991-2#1)(1994-3#1)(1995-5#1)(2008-10#1)
than ever##7##2##(1991-2#1)(1991-3#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
than expected based on##2##4##(1995-1#1)(2008-10#1)
than expected from##3##3##(1993-2#1)(1995-11#1)(2008-10#1)
than expected in##3##3##(1992-2#2)(2008-7#1)
than expected levels##2##3##(1990-5#1)(2009-8#1)
than expected##21##2##(1990-5#1)(1991-6#1)(1992-1#1)(1992-2#2)(1993-2#1)(1995-1#1)(1995-11#2)(2008-10#8)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)
than female##2##2##(2013-1#1)(2013-8#1)
than females in##2##3##(2008-12#1)(2008-9#1)
than females##10##2##(1995-2#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#3)(2010-8#1)
than for a##3##3##(1997-1#1)(2008-10#2)
than for men##2##3##(2008-11#1)(2011-2#1)
than for that of##2##4##(2008-10#2)
than for the other species##2##5##(2008-10#1)(2012-5#1)
than for the other##4##4##(2008-10#2)(2011-2#1)(2012-5#1)
than for the##23##3##(1992-2#1)(1993-8#1)(1995-6#1)(1996-2#2)(2007-11#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-3#1)(2012-5#1)
than for those that##2##4##(2008-10#2)
than for those##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
than for##81##2##(1992-2#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-1#2)(1995-1#1)(1995-2#2)(1995-6#1)(1996-2#3)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#33)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#7)(2009-11#2)(2011-2#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
than found in##2##3##(1993-8#1)(2008-11#1)
than four months##2##3##(2008-10#2)
than four##12##2##(1990-12#2)(1997-4#1)(2008-10#6)(2008-4#1)(2012-12#2)
than from an##2##3##(1997-1#1)(2008-5#1)
than from##14##2##(1992-6#1)(1996-12#1)(1997-1#1)(2008-10#6)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
than general##3##2##(1991-2#1)(2013-1#2)
than generally##2##2##(1994-3#1)(1995-11#1)
than girls##2##2##(2008-12#1)(2011-2#1)
than group 1##2##3##(2009-6#2)
than group##6##2##(1993-3#1)(1994-11#1)(2009-6#2)(2011-2#1)(2012-3#1)
than growth##2##2##(1994-1#1)(2013-1#1)
than had##2##2##(2008-10#1)(2008-11#1)
than half a##2##3##(2008-10#1)(2008-11#1)
than half of the patients##3##5##(1990-9#1)(1992-6#1)(2007-12#1)
than half of the##10##4##(1990-9#1)(1991-5#1)(1992-6#1)(1995-6#1)(2007-12#1)(2008-10#2)(2010-3#1)(2011-2#1)(2013-1#1)
than half of##17##3##(1990-9#1)(1991-5#1)(1992-6#1)(1995-6#1)(2007-12#1)(2008-10#3)(2009-4#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#2)
than half the##5##3##(1990-11#1)(1994-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
than half##32##2##(1990-11#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-6#2)(1994-12#1)(1995-6#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#4)
than has been##2##3##(2008-8#2)
than has##3##2##(2008-8#2)(2012-3#1)
than have##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
than healthy##3##2##(1991-6#1)(2008-10#1)(2010-9#1)
than high##4##2##(1990-12#2)(1992-3#1)(2008-4#1)
than hospitals##2##2##(1992-12#1)(1993-3#1)
than human##3##2##(1993-2#1)(2008-6#1)(2012-2#1)
than in CSW2-amended##2##3##(2008-10#2)
than in Europe##4##3##(2008-10#2)(2008-8#2)
than in Group S##2##4##(2010-7#2)
than in MRL(+/+) mice##3##4##(2008-10#3)
than in NCH##2##3##(2012-3#2)
than in a##5##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
than in age-matched##2##3##(1995-5#1)(2008-10#1)
than in any##2##3##(1995-12#1)(2010-11#1)
than in autoclaved##2##3##(2008-10#2)
than in control mice##2##4##(1997-2#2)
than in control##6##3##(1991-5#1)(1997-2#2)(2008-10#1)(2008-11#1)(2010-1#1)
than in controls##13##3##(1992-11#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-7#2)(2011-2#5)(2012-3#1)(2012-7#1)
than in conventional##4##3##(2008-10#4)
than in conventional-till fields##3##4##(2008-10#3)
than in cv##3##3##(2008-10#3)
than in developed##2##3##(1991-3#1)(2012-2#1)
than in either of the##2##5##(1990-11#1)(2008-10#1)
than in female##2##3##(1994-2#1)(2008-10#1)
than in females##7##3##(1990-12#1)(1991-6#1)(1992-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#1)
than in group##2##3##(1996-3#1)(2010-1#1)
than in healthy##2##3##(2008-10#2)
than in leaves##2##3##(2008-10#2)
than in males##3##3##(1990-11#1)(2008-11#1)(2010-4#1)
than in nontreated##4##3##(2008-10#3)(2008-11#1)
than in normal##2##3##(1990-5#1)(1995-12#1)
than in older##3##3##(1993-12#1)(2011-2#1)(2012-3#1)
than in organic##2##3##(2008-10#2)
than in other##6##3##(2008-10#2)(2008-11#2)(2009-10#2)
than in our##2##3##(1991-11#1)(1992-9#1)
than in patients with##4##4##(1993-2#1)(2010-6#1)(2011-2#1)(2012-3#1)
than in plants##2##3##(2008-10#2)
than in soil from##2##4##(2008-10#2)
than in soil##4##3##(2008-10#4)
than in soils##2##3##(2008-10#2)
than in solution##2##3##(2008-10#1)(2008-3#1)
than in studies with mean##2##5##(2008-10#2)
than in studies##3##3##(2008-10#3)
than in summer##2##3##(2008-10#1)(2008-3#1)
than in susceptible cultivars##2##4##(2008-10#2)
than in susceptible##4##3##(2008-10#4)
than in the HB##2##4##(2011-2#2)
than in the case of##2##5##(2008-10#2)
than in the control group##2##5##(1993-2#1)(2011-2#1)
than in the control##6##4##(1991-3#1)(1993-2#1)(1995-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
than in the controls##5##4##(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#1)
than in the corresponding##2##4##(1994-11#1)(2006-6#1)
than in the environment##2##4##(1994-3#1)(2008-10#1)
than in the normal population##2##5##(1995-5#1)(1996-6#1)
than in the normal##4##4##(1995-5#1)(1996-6#1)(1997-8#1)(2008-10#1)
than in the other##5##4##(1993-12#1)(2008-10#2)(2008-7#1)(2008-8#1)
than in the past##2##4##(1993-12#1)(2008-11#1)
than in the second##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
than in the susceptible genotype##2##5##(2008-10#2)
than in the susceptible##3##4##(2008-10#3)
than in the##102##3##(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#6)(2008-12#1)(2008-4#2)(2008-7#8)(2008-8#4)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#8)(2013-1#3)(2013-8#1)
than in their nontransgenic littermates##2##5##(1992-8#2)
than in their##4##3##(1992-8#2)(2008-11#1)(2008-8#1)
than in those of##2##4##(2008-5#1)(2013-1#1)
than in those with##3##4##(1992-12#1)(2011-2#2)
than in those without##2##4##(1996-12#1)(2010-4#1)
than in those##15##3##(1991-6#1)(1992-12#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
than in treated##2##3##(2008-10#2)
than in uninfected##2##3##(2008-10#2)
than in untreated##2##3##(2008-10#2)
than in vitro##3##3##(2008-10#2)(2008-11#1)
than in winter wheat##3##4##(2008-10#3)
than in young rats##2##4##(2008-7#2)
than in young##3##3##(2008-7#3)
than in younger##2##3##(1994-12#1)(2012-3#1)
than in##426##2##(1990-11#4)(1990-12#2)(1990-5#3)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-5#3)(1991-6#3)(1992-11#1)(1992-12#5)(1992-3#5)(1992-8#3)(1992-9#1)(1993-12#4)(1993-2#2)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#3)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#4)(1997-3#1)(1997-7#2)(1997-8#4)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#154)(2008-11#29)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#21)(2008-8#9)(2008-9#11)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#4)(2010-1#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#28)(2012-12#1)(2012-2#1)(2012-3#13)(2012-7#2)(2013-1#12)(2013-8#4)
than increasing##2##2##(2008-10#2)
than individuals with other##2##4##(2008-4#2)
than induced resistance##2##3##(2008-8#2)
than induced##3##2##(1992-6#1)(2008-8#2)
than initially expected##2##3##(1994-2#1)(2010-12#1)
than initially##3##2##(1994-2#1)(2008-10#1)(2010-12#1)
than intact##2##2##(1997-2#1)(2008-10#1)
than internal##2##2##(2010-12#1)(2013-1#1)
than invasive carcinomas##2##3##(1997-8#2)
than iron##2##2##(2008-1#1)(2013-7#1)
than is currently##2##3##(2010-12#1)(2011-2#1)
than is the##5##3##(1990-11#1)(1994-3#1)(1997-8#1)(2009-8#1)(2013-8#1)
than is##13##2##(1990-11#1)(1994-1#1)(1994-3#1)(1996-9#1)(1997-8#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
than isolate##4##2##(2008-10#3)(2008-11#1)
than isolates from##2##3##(2008-10#2)
than isolates of the##2##4##(2008-10#2)
than isolates##5##2##(2008-10#5)
than it did##2##3##(2008-10#1)(2008-8#1)
than it does##2##3##(1991-2#1)(2008-8#1)
than it is##4##3##(1990-12#1)(1994-1#1)(2008-11#1)(2008-12#1)
than it was##3##3##(2008-10#2)(2008-11#1)
than it##11##2##(1990-12#1)(1991-2#1)(1994-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#2)
than its##16##2##(1991-12#1)(1992-12#1)(1994-8#2)(2008-10#2)(2008-5#1)(2008-8#4)(2008-9#2)(2009-10#1)(2010-12#1)(2013-1#1)
than just a##2##3##(1994-2#1)(2010-10#1)
than just the##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
than just##9##2##(1990-9#1)(1994-2#1)(2008-11#2)(2008-3#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
than known##2##2##(1991-6#1)(1996-12#1)
than late##3##2##(2008-10#3)
than leaf##2##2##(2008-10#2)
than less##2##2##(2008-10#1)(2008-8#1)
than light##2##2##(2008-10#1)(2008-9#1)
than male##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
than males##7##2##(1992-9#1)(1993-2#1)(1995-8#1)(2008-10#1)(2008-8#2)(2010-4#1)
than malignant##2##2##(2011-2#1)(2012-2#1)
than mean##2##2##(2008-10#2)
than members##2##2##(2008-9#1)(2009-8#1)
than men##16##2##(1992-2#1)(1996-6#1)(2008-12#3)(2008-4#2)(2008-7#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
than methanol##2##2##(2008-10#1)(2008-7#1)
than models##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
than most##5##2##(1996-8#1)(1997-2#1)(2008-4#1)(2012-2#1)(2013-8#1)
than necessary##3##2##(1991-5#1)(1995-5#1)(2011-2#1)
than negative##2##2##(1994-1#1)(2008-11#1)
than no##2##2##(2008-8#1)(2012-12#1)
than non##2##2##(2008-11#1)(2012-2#1)
than non-smokers##5##2##(1992-9#1)(2008-10#4)
than normal##14##2##(1990-11#1)(1991-12#1)(1993-3#1)(1993-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#2)
than nurses##2##2##(1992-3#1)(2013-1#1)
than nursing and##2##3##(1990-12#1)(2008-11#1)
than of the##2##3##(2008-10#1)(2008-11#1)
than of##8##2##(1990-8#1)(1991-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)
than older men##2##3##(2008-7#1)(2009-5#1)
than older##4##2##(1991-2#1)(2008-7#1)(2009-5#1)(2009-8#1)
than on Camelot##2##3##(2008-10#2)
than on isolines ECW##2##4##(2008-10#2)
than on the##6##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
than on##36##2##(1990-11#1)(1991-11#1)(1993-11#1)(1993-2#1)(2008-10#19)(2008-11#1)(2008-5#4)(2008-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2012-6#1)(2012-9#1)
than one season##2##3##(2008-8#1)(2011-2#1)
than one year##4##3##(1992-5#1)(1996-8#1)(2010-8#1)(2013-8#1)
than one##72##2##(1990-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-9#2)(1994-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#2)(2008-10#23)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#2)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
than one-half##2##2##(1994-11#1)(1994-12#1)
than or equal to 3)##2##5##(1990-12#1)(1992-4#1)
than or equal to##25##4##(1990-11#2)(1990-12#3)(1990-3#1)(1990-6#1)(1991-6#1)(1991-8#4)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(2008-10#3)(2008-5#3)(2008-9#1)(2012-2#1)(2013-8#1)
than or##26##2##(1990-11#2)(1990-12#3)(1990-3#1)(1990-6#1)(1991-6#1)(1991-8#4)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1995-12#1)(2008-10#3)(2008-5#3)(2008-9#1)(2012-2#1)(2013-8#1)
than originally##3##2##(1997-2#1)(2012-2#2)
than other groups##2##3##(2008-11#1)(2013-1#1)
than other hospital##2##3##(1990-2#1)(1990-9#1)
than other reported##3##3##(2008-10#1)(2009-10#1)(2013-8#1)
than other##50##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1997-6#1)(2007-11#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
than others by environmental##2##4##(2008-5#1)(2011-2#1)
than others##17##2##(1992-9#1)(1994-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
than parental##2##2##(1993-1#1)(2008-8#1)
than patients in group L##2##5##(1996-3#2)
than patients in group##3##4##(1996-3#3)
than patients in##4##3##(1996-3#3)(2008-7#1)
than patients who##2##3##(1993-2#1)(2013-1#1)
than patients with##2##3##(1993-2#1)(2011-2#1)
than patients##10##2##(1993-2#2)(1996-3#3)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
than physical##3##2##(1992-3#1)(2008-8#2)
than placebo##3##2##(2009-7#1)(2013-8#2)
than plants##6##2##(2008-10#1)(2008-8#1)(2012-3#1)(2012-7#2)(2013-8#1)
than plasma##2##2##(1993-2#1)(2006-6#1)
than potato##2##2##(2008-10#2)
than prairie##2##2##(2008-9#2)
than predicted by##6##3##(1990-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2013-8#1)
than predicted##9##2##(1990-5#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-8#2)(2013-8#1)
than previous##4##2##(1993-3#1)(2008-9#1)(2010-6#1)(2013-8#1)
than previously assumed##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
than previously published##2##3##(2008-10#1)(2008-11#1)
than previously recognized##2##3##(2008-10#1)(2011-2#1)
than previously reported##5##3##(1996-3#1)(2008-10#2)(2008-12#1)(2008-7#1)
than previously thought and##3##4##(1995-12#1)(2008-11#1)(2011-2#1)
than previously thought##5##3##(1990-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
than previously##28##2##(1990-5#1)(1995-12#3)(1996-12#1)(1996-3#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-7#1)(2011-2#2)(2012-2#1)
than principal##2##2##(2008-10#2)
than pure##4##2##(1990-8#1)(2009-8#1)(2009-9#1)(2010-5#1)
than quantitative##2##2##(2009-6#1)(2012-2#1)
than race##2##2##(2008-10#2)
than random##2##2##(2008-10#1)(2010-10#1)
than rates reported by##2##4##(2013-8#2)
than recommended##2##2##(1991-6#1)(1997-8#1)
than reported##3##2##(1994-11#1)(2008-10#1)(2009-7#1)
than seven##5##2##(1990-3#1)(1997-2#1)(2008-10#2)(2012-2#1)
than sexual##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
than simple##2##2##(2008-4#1)(2008-8#1)
than simply##5##2##(2008-10#1)(2008-11#1)(2009-3#1)(2012-2#2)
than single##5##2##(1997-3#1)(2008-10#2)(2009-8#1)(2013-1#1)
than sodium##2##2##(2008-2#1)(2010-4#1)
than somatostatin##2##2##(1994-11#2)
than some##3##2##(1990-6#1)(1993-3#1)(2008-5#1)
than standard##3##2##(2007-12#1)(2008-10#2)
than subjects##4##2##(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
than survivors##2##2##(1993-1#1)(1995-3#1)
than susceptible##2##2##(2008-10#2)
than that at##3##3##(2008-11#1)(2011-3#1)(2012-2#1)
than that between##4##3##(2008-10#1)(2008-8#2)(2012-9#1)
than that by##5##3##(1991-12#1)(1995-8#1)(2008-8#1)(2008-9#2)
than that for the##4##4##(1990-8#1)(1997-7#1)(2008-2#1)(2008-8#1)
than that for##16##3##(1990-8#1)(1992-3#1)(1993-8#1)(1997-2#1)(1997-7#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-8#1)
than that found in the##2##5##(2008-10#1)(2008-11#1)
than that found in##4##4##(1990-6#1)(1994-11#1)(2008-10#1)(2008-11#1)
than that found##5##3##(1990-6#1)(1994-11#1)(2008-10#2)(2008-11#1)
than that in other##2##4##(2008-9#1)(2010-5#1)
than that in the##8##4##(1994-12#2)(1995-8#1)(2008-10#2)(2008-11#3)
than that in##33##3##(1993-8#2)(1994-12#2)(1995-8#1)(1997-7#1)(2008-10#10)(2008-11#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-5#1)(2010-7#1)(2013-1#1)
than that measured##4##3##(1996-2#1)(2008-10#3)
than that observed in##2##4##(1993-6#1)(1995-8#1)
than that observed##5##3##(1990-9#1)(1993-6#1)(1993-8#1)(1995-8#1)(2008-11#1)
than that obtained by##2##4##(1995-12#1)(2008-10#1)
than that obtained in the##2##5##(2008-10#1)(2008-11#1)
than that obtained with the##3##5##(1990-12#1)(2008-10#2)
than that obtained with##4##4##(1990-12#1)(2008-10#2)(2008-11#1)
than that obtained##11##3##(1990-12#1)(1992-9#1)(1995-12#1)(2008-10#5)(2008-11#2)(2009-10#1)
than that of a##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)
than that of acetate ions##2##5##(2008-10#2)
than that of both##2##4##(2008-10#2)
than that of controls##2##4##(1997-4#1)(2008-8#1)
than that of cotyledon##2##4##(2008-9#2)
than that of its##2##4##(2008-10#1)(2008-8#1)
than that of normal control##3##5##(2011-3#3)
than that of normal##5##4##(2008-5#1)(2008-8#1)(2011-3#3)
than that of the CML hydrogel##2##6##(2009-7#2)
than that of the control##3##5##(2008-9#1)(2010-3#1)(2011-2#1)
than that of the conventional##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
than that of the wild type##3##6##(2008-10#1)(2008-8#1)(2010-10#1)
than that of the##68##4##(1990-10#1)(1991-8#1)(1992-12#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-6#2)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#14)(2008-11#6)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#9)(2009-7#5)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-8#1)
than that of wild-type##2##4##(1993-12#1)(2009-9#1)
than that of##174##3##(1990-10#1)(1990-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#4)(1994-5#1)(1994-8#2)(1995-11#1)(1995-6#3)(1995-8#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#54)(2008-11#13)(2008-3#4)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#15)(2009-2#1)(2009-7#6)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-2#4)(2011-3#5)(2012-2#1)(2013-1#1)(2013-8#1)
than that on the LB##2##5##(2008-11#2)
than that on the##3##4##(2008-11#3)
than that on##6##3##(1995-11#1)(2008-10#1)(2008-11#4)
than that previously reported##2##4##(2008-8#1)(2012-12#1)
than that previously##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
than that reported in##2##4##(1997-8#1)(2008-10#1)
than that reported##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
than that required for##2##4##(2008-10#1)(2008-7#1)
than that to##4##3##(1993-8#1)(2008-10#2)(2008-8#1)
than that with symmetrical tetraalkylammonium cations##2##6##(2008-10#2)
than that with the##3##4##(2008-10#3)
than that with##7##3##(2008-10#7)
than that##312##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#6)(1994-11#5)(1994-12#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-12#1)(1996-2#4)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#97)(2008-11#35)(2008-12#2)(2008-2#2)(2008-3#8)(2008-5#13)(2008-6#2)(2008-7#6)(2008-8#21)(2008-9#23)(2009-10#1)(2009-2#1)(2009-7#6)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#5)(2011-3#6)(2012-12#2)(2012-2#2)(2012-9#1)(2013-1#2)(2013-8#1)
than the MCS+##2##3##(2011-2#2)
than the amount##2##3##(2008-11#1)(2008-12#1)
than the average on a##2##5##(2008-10#2)
than the average##5##3##(1993-12#1)(1996-11#1)(2008-10#2)(2011-2#1)
than the basal##2##3##(1992-7#1)(2008-8#1)
than the behavioural programme##2##4##(2008-9#2)
than the binomial##2##3##(2008-10#2)
than the control group##7##4##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#4)
than the control##19##3##(1993-6#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#4)(2009-10#1)(2013-1#5)
than the controls and##2##4##(1991-1#1)(2008-10#1)
than the controls##7##3##(1991-1#1)(1997-8#1)(2008-10#2)(2008-5#2)(2008-7#1)
than the conventional univariate calibration method##2##6##(2008-10#2)
than the conventional##15##3##(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2010-8#1)
than the corresponding values##3##4##(2008-10#2)(2009-9#1)
than the corresponding wild-type##2##4##(2008-10#1)(2011-2#1)
than the corresponding##9##3##(1994-5#1)(1995-11#1)(2008-10#4)(2008-3#1)(2009-9#1)(2011-2#1)
than the cost of##2##4##(1993-1#1)(2008-8#1)
than the current##2##3##(1997-1#1)(2008-10#1)
than the direct##2##3##(1992-3#1)(2008-11#1)
than the dose of 0##2##5##(2011-1#2)
than the effect of##2##4##(1994-11#1)(2012-2#1)
than the effects of##2##4##(2008-10#1)(2008-11#1)
than the electron##2##3##(2008-10#2)
than the equivalent##2##3##(2008-11#1)(2008-3#1)
than the expected##2##3##(2008-10#1)(2008-2#1)
than the first##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
than the general population##3##4##(1996-3#1)(2009-6#1)(2013-1#1)
than the gross domestic product##2##5##(1993-3#1)(1996-2#1)
than the initial##2##3##(1996-12#1)(2008-8#1)
than the isolates##2##3##(2008-10#1)(2008-5#1)
than the limit of detection##2##5##(2008-10#2)
than the limit of##3##4##(2008-10#2)(2011-2#1)
than the maximum##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
than the mean CBF##2##4##(2008-7#2)
than the mean of the components##4##6##(2008-10#4)
than the mean of##8##4##(2008-10#7)(2011-1#1)
than the mean##15##3##(1991-12#1)(2008-10#8)(2008-11#1)(2008-7#2)(2009-11#1)(2011-1#1)(2011-2#1)
than the model group##2##4##(1990-12#2)
than the model##3##3##(1990-12#2)(1996-2#1)
than the more##2##3##(1994-5#1)(2008-10#1)
than the national average##4##4##(2008-10#3)(2008-11#1)
than the nonamended##2##3##(2008-10#2)
than the normal##4##3##(1993-1#1)(1993-3#1)(2008-10#1)(2009-10#1)
than the number of##6##4##(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)
than the one##6##3##(1995-8#1)(2008-10#3)(2008-8#1)(2008-9#1)
than the ones##2##3##(2008-10#1)(2008-8#1)
than the opposite##2##3##(2008-10#1)(2013-1#1)
than the optimal##2##3##(2008-7#1)(2008-8#1)
than the original##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
than the other four##2##4##(2008-10#2)
than the other three##3##4##(1997-6#1)(2009-11#1)(2013-8#1)
than the other two##5##4##(2008-10#4)(2013-8#1)
than the other##31##3##(1991-2#1)(1994-12#1)(1994-6#1)(1997-4#1)(1997-6#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
than the others##5##3##(1996-12#1)(1996-9#1)(2008-10#2)(2008-7#1)
than the overall##2##3##(1995-3#1)(2011-2#1)
than the parent compound##2##4##(1990-12#2)
than the parent##7##3##(1990-12#2)(1992-4#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
than the present##2##3##(1990-5#1)(2013-7#1)
than the previously##3##3##(1991-5#1)(2008-10#1)(2012-3#1)
than the protein##2##3##(2008-10#1)(2010-10#1)
than the rate##3##3##(1994-2#1)(2008-10#2)
than the referred##2##3##(2010-8#1)(2010-9#1)
than the respective##2##3##(2008-10#1)(2008-11#1)
than the response of##2##4##(2008-10#1)(2008-9#1)
than the role##2##3##(2006-6#1)(2010-10#1)
than the same##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
than the standard##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
than the stirred tank bioreactor##2##5##(2008-11#2)
than the sum of the##2##5##(1990-6#1)(2009-10#1)
than the sum of##3##4##(1990-6#1)(2008-11#1)(2009-10#1)
than the traditional##8##3##(2008-10#5)(2008-8#1)(2009-12#1)(2013-1#1)
than the two##2##3##(1994-5#1)(2013-1#1)
than the type##2##3##(2009-7#1)(2009-9#1)
than the value of##2##4##(2008-10#1)(2008-11#1)
than the wavelength##2##3##(2008-3#2)
than the wild type##4##4##(2008-10#3)(2008-11#1)
than the wild##5##3##(2008-10#4)(2008-11#1)
than the wild-type protein##2##4##(1994-5#1)(2011-1#1)
than the wild-type strain##3##4##(2008-10#3)
than the wild-type##7##3##(1993-8#1)(1994-5#1)(2008-10#4)(2011-1#1)
than the##617##2##(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#5)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#3)(1993-3#6)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#2)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(1997-9#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#207)(2008-11#38)(2008-12#5)(2008-2#6)(2008-3#20)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#22)(2008-8#26)(2008-9#16)(2009-10#4)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-7#6)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#21)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#22)(2013-7#1)(2013-8#8)
than their counterparts##2##3##(1996-3#1)(2012-3#1)
than their female counterparts##3##4##(1996-3#1)(2013-1#2)
than their male##2##3##(1991-6#1)(2009-1#1)
than their own##2##3##(2008-3#1)(2010-8#1)
than their parental##2##3##(2008-10#2)
than their##33##2##(1991-3#1)(1991-6#1)(1994-2#1)(1994-3#1)(1996-3#2)(2008-10#9)(2008-11#3)(2008-3#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)
than they were##2##3##(2008-10#1)(2009-12#1)
than they##8##2##(1993-12#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)
than this##4##2##(1992-9#1)(1997-4#1)(2008-8#1)(2012-2#1)
than those at##3##3##(2008-11#1)(2008-5#1)(2010-8#1)
than those before##2##3##(2008-8#1)(2009-10#1)
than those caused by##2##4##(2008-10#2)
than those enrolled##2##3##(1991-12#1)(2010-3#1)
than those for the##4##4##(2008-10#2)(2008-11#1)(2010-8#1)
than those for##7##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)
than those found in##2##4##(2012-2#1)(2013-1#1)
than those found##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
than those from BALB/c mice##2##5##(1996-12#2)
than those from the##2##4##(2008-11#1)(2010-5#1)
than those from##12##3##(1991-12#1)(1991-5#1)(1996-12#2)(2008-10#3)(2008-11#3)(2008-8#1)(2010-5#1)
than those generated by##2##4##(1995-8#1)(2013-1#1)
than those having##2##3##(1997-4#1)(2008-10#1)
than those in other##3##4##(1993-3#1)(2008-10#2)
than those in the control##2##5##(2011-2#2)
than those in the group##2##5##(1994-12#1)(2013-1#1)
than those in the##20##4##(1990-5#1)(1991-11#1)(1994-12#1)(1994-3#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
than those in##40##3##(1990-5#1)(1991-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#3)(1997-3#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#1)
than those induced by##2##4##(2008-8#1)(2011-2#1)
than those observed for##2##4##(2008-10#2)
than those observed##3##3##(1995-5#1)(2008-10#2)
than those obtained by the##3##5##(2008-10#2)(2008-11#1)
than those obtained by##8##4##(2008-10#7)(2008-11#1)
than those obtained from##2##4##(2008-10#1)(2008-11#1)
than those obtained in a##2##5##(2008-11#2)
than those obtained in##3##4##(2008-10#1)(2008-11#2)
than those obtained with the other##2##6##(2008-10#2)
than those obtained with##4##4##(2008-10#4)
than those obtained##22##3##(2008-10#18)(2008-11#4)
than those of a##2##4##(2008-3#1)(2012-2#1)
than those of group II##2##5##(2008-10#2)
than those of other##2##4##(2008-10#1)(2011-1#1)
than those of the control##5##5##(1994-3#1)(2008-9#4)
than those of the normal controls##2##6##(2008-10#2)
than those of the vehicle controls##2##6##(2008-9#2)
than those of the vehicle##3##5##(2008-9#3)
than those of the wild-type strain##2##6##(2008-10#2)
than those of the##27##4##(1991-11#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#8)(2011-1#2)(2011-3#1)(2013-1#1)
than those of unoriented IPMCs##2##5##(2010-4#2)
than those of##76##3##(1990-6#2)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-10#20)(2008-11#5)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#9)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#3)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
than those on##2##3##(2008-10#1)(2008-5#1)
than those produced by##2##4##(2008-10#2)
than those produced##4##3##(2008-10#4)
than those reported##2##3##(2008-10#1)(2008-11#1)
than those required##2##3##(1994-3#1)(2011-2#1)
than those seen##2##3##(1992-6#1)(2008-7#1)
than those that##6##3##(1991-5#1)(1993-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2010-8#1)
than those using##2##3##(2008-10#1)(2009-7#1)
than those who##3##3##(1993-1#1)(2013-1#1)(2013-8#1)
than those with##7##3##(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
than those without##8##3##(1994-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
than those##259##2##(1990-5#1)(1990-6#2)(1991-11#2)(1991-12#3)(1991-3#2)(1991-5#2)(1992-1#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#3)(1993-8#2)(1994-1#1)(1994-12#3)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-8#5)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#92)(2008-11#22)(2008-12#4)(2008-3#2)(2008-5#7)(2008-7#6)(2008-8#11)(2008-9#15)(2009-10#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#7)(2013-8#2)
than three months##5##3##(1990-12#2)(1996-3#1)(2008-11#1)(2012-3#1)
than three##16##2##(1990-12#2)(1996-3#1)(1997-3#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
than through##6##2##(1994-1#2)(1994-3#1)(2008-10#1)(2008-5#2)
than to changes in the##2##5##(2008-10#1)(2008-8#1)
than to changes in##3##4##(2008-10#2)(2008-8#1)
than to the##4##3##(1992-12#1)(1996-2#1)(2008-10#2)
than to those##2##3##(1997-3#1)(2008-7#1)
than to##38##2##(1990-6#1)(1992-12#1)(1992-6#1)(1993-8#2)(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#15)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#2)(2012-5#1)(2013-8#2)
than traditional##5##2##(1993-12#1)(1994-2#1)(2008-10#3)
than two weeks##3##3##(1991-9#1)(1994-6#1)(1995-11#1)
than two years##3##3##(1990-9#1)(1996-3#1)(2012-12#1)
than two##14##2##(1990-6#1)(1990-9#1)(1991-9#1)(1994-6#2)(1995-11#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-12#1)
than twofold##2##2##(2008-10#2)
than undamaged plants##2##3##(2008-8#2)
than under furrow irrigation##3##4##(2008-10#3)
than under##8##2##(1993-12#1)(1996-12#1)(2008-10#5)(2012-6#1)
than uninfected females##2##3##(2012-3#2)
than uninfected##5##2##(1993-6#1)(1994-11#1)(2008-10#1)(2012-3#2)
than urban##2##2##(1994-2#1)(1996-3#1)
than use of##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
than using##3##2##(2008-10#2)(2010-1#1)
than usual##2##2##(2007-12#1)(2012-2#1)
than usually##2##2##(1996-3#1)(2008-10#1)
than virus##2##2##(2008-10#1)(2008-11#1)
than vitamin E##2##3##(2008-5#1)(2013-1#1)
than was the##2##3##(1995-8#1)(2008-10#1)
than was##9##2##(1995-8#2)(2008-10#3)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)
than water##2##2##(2008-10#1)(2008-8#1)
than well-nourished##2##2##(2008-11#2)
than were the##3##3##(1992-2#1)(2008-10#1)(2008-3#1)
than were##15##2##(1992-2#1)(1996-12#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
than what##2##2##(2008-3#1)(2009-7#1)
than when it##2##3##(2008-8#1)(2009-5#1)
than when the##7##3##(1995-12#1)(1995-5#1)(2008-10#3)(2008-3#1)(2010-5#1)
than when they were##2##4##(2008-10#1)(2008-6#1)
than when##23##2##(1991-3#1)(1992-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(2008-10#12)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-5#1)
than white beneficiaries##2##3##(1995-2#2)
than white##4##2##(1995-12#2)(1995-2#2)
than whites##5##2##(1995-12#2)(2011-2#3)
than wild type##2##3##(1995-2#1)(2008-10#1)
than wild-type##6##2##(1995-9#1)(2008-10#4)(2012-3#1)
than with Group##2##3##(2010-7#2)
than with P##2##3##(2008-10#2)
than with a##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
than with conventional##2##3##(1990-8#1)(2008-10#1)
than with ethanol##2##3##(1997-8#1)(2008-10#1)
than with other##3##3##(1993-11#1)(2008-10#1)(2009-1#1)
than with the##4##3##(2008-10#3)(2012-3#1)
than with##42##2##(1990-8#1)(1991-6#1)(1993-11#1)(1996-3#1)(1997-8#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-1#1)(2010-6#1)(2010-7#2)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
than within the##2##3##(2008-10#1)(2008-11#1)
than within##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
than without##2##2##(2008-10#1)(2008-11#1)
than women##6##2##(1996-3#1)(2008-1#1)(2008-12#3)(2013-1#1)
than would be##3##3##(1992-3#1)(2008-10#1)(2008-8#1)
than would##4##2##(1992-3#2)(2008-10#1)(2008-8#1)
than zero##2##2##(1996-6#1)(2008-9#1)
than##5350##1##(1990-10#2)(1990-11#24)(1990-12#45)(1990-2#24)(1990-3#10)(1990-4#1)(1990-5#25)(1990-6#19)(1990-7#1)(1990-8#17)(1990-9#24)(1991-1#5)(1991-10#1)(1991-11#19)(1991-12#30)(1991-2#28)(1991-3#21)(1991-5#22)(1991-6#22)(1991-8#15)(1991-9#19)(1992-1#12)(1992-10#3)(1992-11#2)(1992-12#19)(1992-2#12)(1992-3#37)(1992-4#4)(1992-5#5)(1992-6#18)(1992-7#1)(1992-8#10)(1992-9#14)(1993-1#15)(1993-11#10)(1993-12#33)(1993-2#28)(1993-3#32)(1993-5#2)(1993-6#11)(1993-8#30)(1993-9#1)(1994-1#20)(1994-11#21)(1994-12#27)(1994-2#19)(1994-3#27)(1994-5#18)(1994-6#12)(1994-8#28)(1994-9#4)(1995-1#13)(1995-11#19)(1995-12#27)(1995-2#20)(1995-3#11)(1995-5#18)(1995-6#18)(1995-8#26)(1995-9#4)(1996-1#6)(1996-11#15)(1996-12#34)(1996-2#28)(1996-3#37)(1996-5#11)(1996-6#14)(1996-8#8)(1996-9#4)(1997-1#17)(1997-2#32)(1997-3#21)(1997-4#19)(1997-5#4)(1997-6#13)(1997-7#15)(1997-8#29)(1997-9#2)(2006-5#3)(2006-6#5)(2007-11#4)(2007-12#21)(2007-8#1)(2008-1#18)(2008-10#1734)(2008-11#326)(2008-12#70)(2008-2#32)(2008-3#108)(2008-4#31)(2008-5#117)(2008-6#17)(2008-7#133)(2008-8#175)(2008-9#165)(2009-1#3)(2009-10#17)(2009-11#14)(2009-12#11)(2009-2#2)(2009-3#13)(2009-4#11)(2009-5#12)(2009-6#10)(2009-7#33)(2009-8#49)(2009-9#7)(2010-1#16)(2010-10#18)(2010-11#18)(2010-12#24)(2010-2#3)(2010-3#11)(2010-4#20)(2010-5#9)(2010-6#16)(2010-7#30)(2010-8#24)(2010-9#6)(2011-1#18)(2011-2#207)(2011-3#20)(2011-7#1)(2012-12#23)(2012-2#94)(2012-3#79)(2012-4#1)(2012-5#4)(2012-6#3)(2012-7#4)(2012-9#6)(2013-1#159)(2013-7#4)(2013-8#76)
thank##2##1##(2008-10#1)(2013-8#1)
thanks to its##4##3##(1990-5#1)(1990-9#1)(2008-10#1)(2012-2#1)
thanks to the##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)
thanks to##13##2##(1990-5#1)(1990-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-12#1)(2010-7#1)(2011-2#2)(2012-2#1)
thanthat##2##1##(2008-11#2)
thapsigargin and##2##2##(1994-3#1)(2006-6#1)
thapsigargin##8##1##(1991-6#2)(1994-11#1)(1994-3#1)(1996-5#1)(2006-6#2)(2008-11#1)
thapsinum##3##1##(2008-10#3)
that &gt##2##2##(2008-10#1)(2008-9#1)
that &quot##15##2##(1991-3#1)(1992-6#1)(1995-1#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#3)
that (1) the##5##3##(1993-1#1)(1994-8#1)(2008-10#1)(2008-3#1)(2012-3#1)
that (1)##11##2##(1993-1#1)(1993-12#1)(1994-5#1)(1994-8#2)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
that (a)##8##2##(1990-5#1)(1993-2#1)(1994-6#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)
that (i) the##7##3##(1994-8#1)(2008-10#1)(2008-8#1)(2008-9#3)(2012-5#1)
that (i)##17##2##(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#5)(2008-8#4)(2008-9#3)(2012-5#1)
that 0##4##2##(2008-10#4)
that 1##6##2##(1995-12#2)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
that 10##3##2##(1995-8#1)(1996-2#1)(1997-3#1)
that 12##2##2##(1992-12#1)(2008-10#1)
that 14-3-3##2##2##(2008-11#2)
that 14Dea2##2##2##(2008-11#2)
that 16##2##2##(1992-12#1)(2008-8#1)
that 17##2##2##(1990-11#1)(1996-8#1)
that 2##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
that 24##2##2##(1990-11#1)(1990-5#1)
that 25%##2##2##(2008-7#1)(2011-2#1)
that 29##2##2##(1990-12#1)(1997-3#1)
that 2f detection##2##3##(2008-3#2)
that 3##3##2##(1991-5#1)(1996-2#1)(2010-1#1)
that 30%##2##2##(1997-8#1)(2008-10#1)
that 4##3##2##(2009-10#1)(2010-5#1)(2013-1#1)
that 4f##2##2##(2008-3#2)
that 5##6##2##(1991-11#1)(1997-8#1)(2008-10#2)(2009-12#1)(2012-2#1)
that 5-HT##4##2##(1992-1#1)(2008-7#2)(2011-3#1)
that 53% of##2##3##(1990-6#1)(1994-12#1)
that 7##3##2##(1994-5#2)(2008-7#1)
that 85% of##2##3##(1997-3#1)(2008-10#1)
that 9##4##2##(1992-4#1)(1994-12#1)(2011-2#1)(2012-3#1)
that 91% of##2##3##(1993-3#1)(2012-12#1)
that 95% of the##2##4##(2008-10#1)(2008-9#1)
that 99##2##2##(1996-6#1)(2008-11#1)
that A beta 1-40##2##4##(1994-11#2)
that A beta##3##3##(1994-11#2)(1996-2#1)
that A##8##2##(1994-11#2)(1996-2#1)(2008-10#3)(2009-8#1)(2011-2#1)
that AA##2##2##(1993-3#1)(2008-11#1)
that ADAMTS13 is##2##3##(2009-7#2)
that ADAMTS13##3##2##(2009-7#3)
that ADH-I##2##2##(2008-11#2)
that ANN##2##2##(2008-10#1)(2010-8#1)
that ANP##3##2##(1993-8#1)(2008-5#2)
that ASY##2##2##(2008-9#2)
that ATP##2##2##(1990-5#1)(1994-8#1)
that Affect##2##2##(2008-10#2)
that African Americans##2##3##(2010-7#1)(2013-1#1)
that African##4##2##(2010-1#1)(2010-5#1)(2010-7#1)(2013-1#1)
that Amberlite##2##2##(2008-10#2)
that AngCP##3##2##(2008-9#3)
that Argireline##2##2##(2008-5#2)
that As##2##2##(2008-10#2)
that As(2)O(3)##3##2##(2008-8#3)
that AxRF1##2##2##(2008-9#2)
that B##8##2##(2008-10#5)(2008-12#1)(2012-2#1)(2013-1#1)
that BCMoV##3##2##(2008-10#3)
that BDNF##3##2##(1997-2#1)(2012-2#1)(2013-8#1)
that BGQ60##2##2##(1995-6#2)
that BON cells##2##3##(1994-8#2)
that BR##2##2##(2008-9#2)
that Black Deaf##2##3##(2011-2#2)
that Buffon##2##2##(2008-12#2)
that C##9##2##(2008-10#6)(2008-5#1)(2008-8#1)(2011-1#1)
that C-ADR##2##2##(2012-12#2)
that CA##2##2##(1995-11#1)(2008-11#1)
that CBF is a##2##4##(1995-2#1)(2012-2#1)
that CBF##3##2##(1995-2#1)(2012-2#2)
that CC-516##4##2##(2008-5#4)
that CCSV is a##2##4##(2008-10#2)
that CD4(+) T cells were##2##5##(2008-11#2)
that CD4(+) T cells##3##4##(2008-11#3)
that CD4(+)##4##2##(2008-11#3)(2010-1#1)
that CGRP##2##2##(1992-6#2)
that CI strains##2##3##(2008-8#2)
that CI##3##2##(2008-8#3)
that CL##2##2##(2008-8#2)
that CMV##4##2##(2008-10#4)
that CNTF##2##2##(1996-2#2)
that CRF##2##2##(1997-4#2)
that CaM kinase II##2##4##(1990-5#2)
that CaM##3##2##(1990-5#2)(2008-8#1)
that Catalyser-21(TM) has##2##3##(2008-11#2)
that Catalyser-21(TM)##4##2##(2008-11#4)
that Cause##2##2##(2008-10#2)
that ChMV##2##2##(2008-10#2)
that Congress##3##2##(1991-1#1)(1995-12#1)(1995-6#1)
that CsA##4##2##(1994-3#1)(1994-8#3)
that D##4##2##(1995-2#1)(2008-10#1)(2008-8#1)(2009-8#1)
that DNA##13##2##(1990-12#1)(1990-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-11#2)(2010-5#1)(2011-2#1)
that DNA-A##2##2##(2008-10#2)
that DYS19##2##2##(2008-12#2)
that E##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)
that E2##2##2##(1995-9#1)(2008-11#1)
that EDRF1##3##2##(2008-8#1)(2008-9#2)
that EGF##4##2##(1991-7#1)(1993-3#1)(2008-6#1)(2008-8#1)
that EPEC##2##2##(2011-2#2)
that ERW supplemented with##2##4##(2008-11#2)
that ET-1##3##2##(1991-5#1)(1993-3#2)
that F##9##2##(2008-10#8)(2008-5#1)
that FALSG93A mice##2##3##(1996-5#2)
that FSH##2##2##(1993-11#1)(2012-12#1)
that Fe(II)##2##2##(1996-2#1)(2008-10#1)
that G beta##2##3##(1995-8#2)
that G##5##2##(1992-9#1)(1995-8#2)(2008-3#1)(2010-4#1)
that GABA##4##2##(1992-3#1)(1995-11#1)(2008-8#2)
that GC7##3##2##(1997-1#3)
that GD12##2##2##(2013-8#2)
that GFP##3##2##(1996-6#1)(2008-11#1)(2008-7#1)
that GSH##4##2##(1991-8#1)(1992-12#1)(2008-10#1)(2013-1#1)
that GhTub1##2##2##(2008-9#2)
that Glu-1##2##2##(2008-10#2)
that H##5##2##(2008-12#1)(2008-8#2)(2010-12#1)(2011-2#1)
that HA##3##2##(2008-10#2)(2013-8#1)
that HCWA may##2##3##(2008-10#2)
that HG##2##2##(2008-1#1)(2008-7#1)
that HIV##4##2##(1996-5#2)(1997-6#1)(2010-12#1)
that HIV-1##2##2##(2008-11#1)(2013-1#1)
that HMOs##2##2##(1993-1#1)(1994-3#1)
that HcNPV attachment to Sf21 cells##2##6##(2008-11#2)
that HcNPV##3##2##(2008-11#3)
that Hg##2##2##(2008-10#2)
that Hsp90##2##2##(1997-4#2)
that I##3##2##(1995-2#1)(2008-10#1)(2010-3#1)
that IBD slopes##2##3##(2008-9#2)
that IBD##3##2##(2008-9#3)
that IFN-gamma##3##2##(1996-12#1)(2008-8#1)(2010-12#1)
that IGF-I##2##2##(1996-2#1)(2008-8#1)
that IL-17##4##2##(2007-11#4)
that IL-6##3##2##(1990-5#1)(1996-2#1)(2008-9#1)
that IR##3##2##(2008-10#3)
that IRF-2##2##2##(1995-12#2)
that KT##2##2##(2013-1#2)
that L-PHP##5##2##(2013-7#5)
that L1##2##2##(1995-2#1)(2008-7#1)
that LAVH##2##2##(1995-1#1)(1995-3#1)
that LChV-3##2##2##(2008-10#2)
that LDH##3##2##(2008-11#1)(2011-2#2)
that LINC1##2##2##(2009-8#2)
that LIPUS##2##2##(2013-1#2)
that LPS##3##2##(1997-1#1)(2008-11#1)(2008-8#1)
that La(3+)##2##2##(2008-9#2)
that LapSVM##2##2##(2010-7#2)
that M##10##2##(1990-5#1)(2008-10#7)(2008-5#1)(2011-2#1)
that M79##2##2##(2008-8#2)
that MB##2##2##(2008-10#1)(2012-2#1)
that MC1R##3##2##(2008-9#3)
that MHC class I##2##4##(2008-1#2)
that MP##2##2##(2008-9#2)
that MPP+##2##2##(1990-5#2)
that MRI##2##2##(2008-7#1)(2010-12#1)
that MT##2##2##(1993-12#1)(2008-10#1)
that MTs##2##2##(2008-11#1)(2011-2#1)
that MaMPRV##2##2##(2008-10#2)
that Mb##2##2##(2008-10#2)
that Medicaid##3##2##(1995-2#1)(1996-1#1)(1997-1#1)
that Medicare##3##2##(1994-1#1)(1996-12#1)(1997-3#1)
that MhNPR1##2##2##(2011-10#2)
that N##2##2##(1991-8#1)(2010-8#1)
that NF-kappa B##2##3##(1995-12#1)(1995-2#1)
that NIRS##2##2##(2008-10#2)
that NMDA receptor##2##3##(1996-12#1)(1997-2#1)
that NMDA receptors##2##3##(1996-12#1)(1997-7#1)
that NMDA##5##2##(1992-8#1)(1996-12#2)(1997-2#1)(1997-7#1)
that NO is##2##3##(1995-2#1)(2008-11#1)
that NO##6##2##(1992-12#2)(1995-11#1)(1995-2#1)(2008-11#1)(2008-9#1)
that NPIK##2##2##(1997-8#2)
that O##2##2##(2008-10#1)(2008-11#1)
that OH-Tam##2##2##(1990-12#2)
that P##21##2##(2008-10#16)(2008-12#1)(2010-3#1)(2010-8#1)(2011-10#1)(2012-12#1)
that P-glycoprotein is##2##3##(2008-11#2)
that P-glycoprotein##4##2##(2008-11#3)(2008-7#1)
that P2##2##2##(2008-11#2)
that P50##2##2##(2008-10#2)
that PAI-1##2##2##(2011-2#2)
that PAP##3##2##(2008-10#3)
that PC##3##2##(1991-5#1)(2008-10#1)(2012-3#1)
that PCFV is##2##3##(2008-10#2)
that PCFV##3##2##(2008-10#3)
that PD patients##2##3##(2008-7#1)(2009-10#1)
that PD##3##2##(2008-7#2)(2009-10#1)
that PFE##2##2##(2008-9#2)
that PI 3-kinase##2##3##(1995-8#1)(2008-11#1)
that PIP2-mediated inhibition of##2##4##(1993-6#2)
that PIP3##2##2##(1993-8#2)
that PKC epsilon##2##3##(1995-2#2)
that PKC##8##2##(1990-5#1)(1991-5#1)(1993-12#2)(1993-3#1)(1995-2#2)(2008-11#1)
that PMA##2##2##(1994-6#1)(1996-2#1)
that PMM##2##2##(2007-12#2)
that PN-2/APP##2##2##(1992-12#2)
that PP DCs##2##3##(2008-11#2)
that PRms##2##2##(2008-10#2)
that PSV strain BV-15##2##4##(2008-10#2)
that PSV##3##2##(2008-10#3)
that PcpD##2##2##(2009-3#2)
that Platycopia##2##2##(2008-5#2)
that PptT is##2##3##(2013-1#2)
that PptT##4##2##(2013-1#4)
that Pythium##2##2##(2008-10#2)
that R##6##2##(2008-10#6)
that RA##3##2##(1990-6#1)(2008-11#2)
that RA538 could##2##3##(2008-8#2)
that RNA##2##2##(1994-3#1)(2008-10#1)
that ROS##4##2##(2009-8#1)(2010-12#1)(2011-2#1)(2012-6#1)
that RW##2##2##(2008-11#2)
that Rab11 is##2##3##(1997-1#2)
that RepK##2##2##(1997-6#2)
that S##8##2##(1997-7#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-3#1)
that SC##2##2##(2008-5#1)(2011-2#1)
that SFE##2##2##(2008-10#2)
that SNP##2##2##(2008-11#2)
that SR##2##2##(1995-6#2)
that SS767##2##2##(2008-10#2)
that SV-toxins##2##2##(2008-10#2)
that SYSV##2##2##(2008-10#2)
that SbPRP##2##2##(2008-8#2)
that Sec61##2##2##(1991-2#2)
that Si##3##2##(2008-10#2)(2008-9#1)
that SqVYV##2##2##(2008-10#2)
that Src##2##2##(1995-6#1)(2011-2#1)
that T##17##2##(1994-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-5#1)(2008-6#1)(2013-8#1)
that T-cells are##2##3##(2008-10#2)
that TBARS##2##2##(1993-2#1)(2008-10#1)
that TNF##2##2##(1990-5#2)
that TNF-alpha##2##2##(2013-1#2)
that TPN##2##2##(1994-6#2)
that TRH##2##2##(1994-2#1)(2013-7#1)
that TSPO##3##2##(2012-2#3)
that TSWV##4##2##(2008-10#4)
that TTM##2##2##(2010-12#2)
that TdT##2##2##(1997-9#2)
that Tf##2##2##(2013-7#2)
that Tid1##3##2##(2011-2#3)
that Trichoderma##2##2##(2008-10#2)
that U##2##2##(2008-10#2)
that UV##3##2##(2008-10#2)(2008-11#1)
that UVR##2##2##(2011-2#2)
that V##5##2##(2008-10#3)(2008-9#1)(2009-8#1)
that VEGF##3##2##(2008-9#1)(2009-8#2)
that VPA##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
that WEP##2##2##(2008-11#2)
that WIPK##2##2##(2009-8#2)
that X##5##2##(2008-10#5)
that YY1##4##2##(2008-11#4)
that Zn##4##2##(1993-12#1)(2008-10#3)
that Zn2+##2##2##(1995-6#2)
that [Ca(2+)](i)##2##2##(2008-9#2)
that a 1##3##3##(1993-12#1)(2008-7#1)(2013-8#1)
that a causal##3##3##(1997-4#1)(2008-11#1)(2013-7#1)
that a combination of##3##4##(1994-8#1)(1997-9#1)(2013-8#1)
that a conserved##2##3##(2008-3#1)(2009-8#1)
that a critical##4##3##(1994-2#1)(1995-8#1)(1996-2#1)(2010-7#1)
that a deeper understanding of##2##5##(2008-11#1)(2010-7#1)
that a factor##2##3##(1991-5#1)(2010-11#1)
that a focal adhesion-like process##2##5##(2008-7#2)
that a fragment from##2##4##(1992-6#1)(1993-3#1)
that a gene##3##3##(1997-3#2)(2008-4#1)
that a good##2##3##(1993-6#1)(1995-2#1)
that a high level of##4##5##(2008-10#1)(2008-11#2)(2008-9#1)
that a high level##5##4##(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
that a high##12##3##(1991-12#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2010-6#1)(2013-1#1)
that a higher level##2##4##(2009-10#1)(2009-5#1)
that a higher##3##3##(2008-8#1)(2009-10#1)(2009-5#1)
that a hospital##2##3##(1991-3#1)(1993-2#1)
that a large number of##2##5##(2008-10#1)(2008-11#1)
that a large##8##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-2#2)
that a larger##2##3##(1990-9#1)(2008-11#1)
that a limited##2##3##(2008-10#1)(2008-3#1)
that a low##3##3##(1993-8#1)(2008-10#1)(2008-7#1)
that a major##4##3##(1990-6#1)(1997-2#1)(2008-10#1)(2009-6#1)
that a majority of the people##2##6##(2010-12#2)
that a majority of the##4##5##(1994-2#1)(1996-3#1)(2010-12#2)
that a moderate##2##3##(2008-10#1)(2008-8#1)
that a more##2##3##(2008-5#1)(2008-8#1)
that a mutation##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
that a new##7##3##(1990-12#1)(1992-1#1)(1995-9#1)(1996-1#1)(2008-10#2)(2011-2#1)
that a nuclear##2##3##(1994-11#1)(1995-2#1)
that a number of##10##4##(1994-3#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2012-3#1)
that a parent##2##3##(2008-11#1)(2012-3#1)
that a particular##2##3##(1994-3#1)(2008-11#1)
that a patient##2##3##(1995-11#1)(2008-7#1)
that a proper##2##3##(2008-3#1)(2010-12#1)
that a protein##2##3##(1995-2#1)(2008-10#1)
that a reduction in##3##4##(1990-5#1)(1993-9#1)(2008-9#1)
that a reduction##4##3##(1990-5#1)(1993-9#1)(2008-9#1)(2011-2#1)
that a region##2##3##(1996-6#1)(1997-3#1)
that a second##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
that a shift in##2##4##(2008-5#1)(2008-9#1)
that a short##2##3##(1991-3#1)(2013-1#1)
that a significant portion of##2##5##(2008-10#1)(2012-3#1)
that a significant##4##3##(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
that a simple##6##3##(2008-10#3)(2008-11#1)(2008-8#1)(2012-2#1)
that a single dominant gene conferred##2##6##(2008-10#2)
that a single dominant gene##3##5##(2008-10#3)
that a single major gene##2##5##(2008-10#2)
that a single recessive gene##3##5##(2008-10#3)
that a single##25##3##(1990-11#1)(1992-1#1)(1993-8#1)(1994-12#2)(1996-2#1)(2006-6#1)(2008-10#14)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)
that a small##2##3##(1992-12#1)(2008-11#1)
that a specific##2##3##(1990-8#1)(2008-10#1)
that a subset of##3##4##(1990-8#1)(1994-12#1)(2009-8#1)
that a surprising number of##2##5##(2008-11#1)(2013-1#1)
that a variety of##5##4##(1990-11#1)(2008-10#2)(2008-12#1)(2008-9#1)
that a wide range of##2##5##(2008-10#1)(2008-3#1)
that a##410##2##(1990-11#5)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#3)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#8)(1995-6#4)(1995-8#3)(1995-9#3)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#4)(1996-6#2)(1996-9#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-7#2)(1997-9#2)(2006-6#2)(2007-12#2)(2008-1#2)(2008-10#75)(2008-11#28)(2008-12#8)(2008-2#1)(2008-3#12)(2008-4#5)(2008-5#11)(2008-6#1)(2008-7#17)(2008-8#19)(2008-9#11)(2009-1#1)(2009-10#6)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-6#4)(2010-7#2)(2011-2#15)(2011-4#1)(2012-12#2)(2012-2#9)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#7)
that about 20% of##2##4##(1997-2#1)(2008-7#1)
that about##7##2##(1990-2#2)(1996-2#1)(1997-2#1)(2008-7#1)(2008-8#1)(2009-8#1)
that academic##2##2##(2008-11#1)(2008-12#1)
that access##2##2##(1995-12#1)(1995-2#1)
that accompanies the##2##3##(1993-6#1)(2008-10#1)
that accompanies##3##2##(1993-6#1)(2006-6#1)(2008-10#1)
that accompany##3##2##(1990-3#1)(1994-8#1)(2008-10#1)
that account for##6##3##(1993-3#1)(1994-12#1)(1996-3#1)(2009-5#1)(2011-2#1)(2012-3#1)
that accounted for##2##3##(2008-10#1)(2008-9#1)
that accounts for the##3##4##(2008-3#1)(2008-6#1)(2013-8#1)
that accounts for##7##3##(1992-9#1)(2008-3#2)(2008-6#1)(2013-1#2)(2013-8#1)
that accumulated##2##2##(1993-12#1)(2008-10#1)
that accurate##2##2##(2008-3#1)(2008-7#1)
that achieved with##2##3##(1993-2#1)(2008-10#1)
that achieved##5##2##(1993-2#1)(2008-10#2)(2008-7#1)(2008-8#1)
that acid##3##2##(1990-9#1)(2008-10#2)
that acquire##2##2##(2008-10#1)(2008-7#1)
that act as##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
that act both##2##3##(2008-11#1)(2013-8#1)
that act##13##2##(1995-2#1)(1997-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2009-10#1)(2013-1#1)(2013-8#1)
that actin##5##2##(1990-2#2)(2008-8#1)(2008-9#1)(2009-8#1)
that activate##2##2##(2008-10#1)(2011-2#1)
that activated##4##2##(1996-12#1)(2008-1#2)(2008-7#1)
that activation of the##2##4##(1997-2#1)(2013-1#1)
that activation of##8##3##(1991-2#1)(1995-12#1)(1995-8#2)(1997-2#1)(1997-7#1)(2008-3#1)(2013-1#1)
that activation##9##2##(1991-2#1)(1995-12#1)(1995-8#2)(1997-2#1)(1997-7#1)(2008-3#1)(2008-9#1)(2013-1#1)
that active##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2012-3#1)
that acts as a##2##4##(1992-8#1)(1995-2#1)
that acts##5##2##(1992-8#1)(1995-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
that acupuncture is##2##3##(2008-10#1)(2010-6#1)
that acute##6##2##(1991-2#1)(1994-11#1)(1994-2#1)(2008-1#1)(2008-10#2)
that adaptation to##2##3##(2008-9#1)(2011-1#1)
that adaptations##2##2##(2008-10#1)(2009-8#1)
that addition of##2##3##(2009-3#1)(2010-4#1)
that additional##7##2##(1991-12#2)(2008-1#1)(2008-10#2)(2009-8#1)(2012-3#1)
that additive gene action##2##4##(2008-10#2)
that additive##4##2##(2008-10#4)
that address the##2##3##(2010-11#1)(2010-6#1)
that address this##2##3##(1993-1#1)(2012-3#1)
that address##7##2##(1993-1#1)(1997-3#1)(2008-10#1)(2009-7#1)(2010-11#1)(2010-6#1)(2012-3#1)
that addressed##2##2##(2011-2#1)(2013-1#1)
that addresses##5##2##(1991-12#1)(1992-9#1)(1995-12#1)(2013-1#2)
that adenoregulin##2##2##(1993-3#1)(1994-5#1)
that adenosine##3##2##(1993-6#1)(1994-11#1)(1994-6#1)
that adequate##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
that adhered to the leaves##2##5##(2008-10#2)
that adherence to##3##3##(2008-10#1)(2008-11#1)(2009-4#1)
that adhesive AH109A cells##2##4##(2008-11#2)
that adjusts##2##2##(2008-10#1)(2008-3#1)
that adolescents##2##2##(2008-11#2)
that adult##5##2##(1994-8#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
that adversely##2##2##(2008-10#1)(2009-5#1)
that affect the heterogeneity of##2##5##(2008-11#1)(2008-4#1)
that affect the##16##3##(1993-1#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
that affect their##2##3##(1993-2#1)(1997-1#1)
that affect this##2##3##(2008-10#1)(2008-8#1)
that affect##34##2##(1992-3#1)(1993-1#1)(1993-2#1)(1993-8#1)(1997-1#1)(2006-6#1)(2008-10#12)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
that affected##2##2##(1995-3#1)(2008-11#1)
that affects##9##2##(2008-10#4)(2008-2#1)(2008-8#1)(2009-9#1)(2011-2#2)
that after being##2##3##(1995-5#1)(2008-9#1)
that after##15##2##(1995-5#1)(1995-6#1)(2008-10#2)(2008-11#5)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
that against##2##2##(2008-11#1)(2008-7#1)
that agarobiose##2##2##(2008-10#2)
that age at first##2##4##(1990-9#1)(2009-5#1)
that age##5##2##(1990-9#1)(1991-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
that age-related##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
that aged##2##2##(1992-12#1)(1993-12#1)
that aggregate into##2##3##(2008-3#1)(2009-10#1)
that aggressive##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2012-3#1)
that aging##3##2##(2008-7#2)(2010-1#1)
that agreed##2##2##(2008-10#1)(2010-10#1)
that agreement between##2##3##(2008-8#1)(2008-9#1)
that aid##2##2##(1994-3#1)(2011-2#1)
that aim to##2##3##(1996-1#1)(2011-2#1)
that aim##3##2##(1996-1#1)(1996-3#1)(2011-2#1)
that aimed to##2##3##(2008-12#1)(2012-3#1)
that aimed##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
that albumin##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
that all individuals##2##3##(2008-11#2)
that all isolates##2##3##(2008-10#2)
that all of the##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
that all of these##3##4##(1994-8#1)(2008-10#2)
that all of##6##3##(1994-8#1)(2008-10#3)(2008-5#1)(2009-8#1)
that all patients##3##3##(1997-8#1)(2008-12#1)(2012-3#1)
that all the##15##3##(1996-5#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#2)
that all these##2##3##(1993-8#1)(2010-3#1)
that all three##9##3##(1992-3#1)(2008-10#5)(2008-8#2)(2008-9#1)
that all##79##2##(1990-12#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-8#2)(1994-8#1)(1996-12#1)(1996-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#30)(2008-11#4)(2008-12#4)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
that alleles##2##2##(2008-10#2)
that allergic##2##2##(1994-6#1)(2012-3#1)
that allow coexistence##2##3##(2008-8#2)
that allow for the##2##4##(2008-2#1)(2008-9#1)
that allow for##5##3##(1994-9#1)(2008-2#2)(2008-8#1)(2008-9#1)
that allow the##5##3##(1993-12#1)(2008-10#1)(2009-12#1)(2012-3#1)(2013-1#1)
that allow them to##2##4##(2008-10#1)(2010-9#1)
that allow us to##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
that allow##40##2##(1993-12#1)(1993-3#1)(1994-9#1)(1995-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#7)(2008-9#2)(2009-10#1)(2009-12#2)(2009-8#1)(2010-11#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
that allowed for the##2##4##(2008-12#1)(2013-1#1)
that allowed for##4##3##(2008-10#1)(2008-12#1)(2010-7#1)(2013-1#1)
that allowed the##5##3##(1995-8#1)(2008-10#3)(2009-8#1)
that allowed us to##4##4##(1993-8#1)(2008-10#2)(2009-10#1)
that allowed##17##2##(1993-8#1)(1995-8#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-7#1)(2013-1#1)
that allows for##2##3##(2007-11#1)(2008-11#1)
that allows the##13##3##(2008-11#2)(2008-2#4)(2008-3#3)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
that allows us to##4##4##(2008-2#1)(2008-8#1)(2010-5#2)
that allows##46##2##(1992-12#1)(1992-9#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-8#2)(2008-9#5)(2009-3#2)(2009-5#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
that almost##4##2##(1993-6#1)(2008-12#1)(2010-6#1)(2012-2#1)
that along with##2##3##(1996-2#1)(2008-10#1)
that alpha##3##2##(1995-11#1)(1996-12#1)(2009-12#1)
that alpha-CD##2##2##(2008-10#2)
that alpha-amylase##2##2##(2008-10#1)(2008-8#1)
that alpha-helices##2##2##(1995-2#1)(2008-10#1)
that also##16##2##(1992-12#1)(1995-6#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
that alteration of the##2##4##(2008-11#1)(2011-2#1)
that alteration of##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
that alteration##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
that alterations##2##2##(2008-9#1)(2013-8#1)
that altered##6##2##(1992-12#1)(1994-11#1)(1994-8#2)(2011-2#1)(2012-3#1)
that alternative##6##2##(1992-6#1)(1993-12#1)(1995-2#2)(2008-10#1)(2011-1#1)
that although the##4##3##(1993-12#2)(1997-8#1)(2010-3#1)
that although there##2##3##(1996-1#1)(2008-5#1)
that although##20##2##(1991-10#1)(1992-2#1)(1993-12#2)(1996-1#1)(1997-8#1)(2008-11#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-3#1)(2013-1#1)
that always##2##2##(1997-8#1)(2008-10#1)
that amantadine may be##2##4##(1997-2#2)
that amantadine##4##2##(1992-3#1)(1997-2#2)(2011-2#1)
that ambient##2##2##(2008-10#2)
that amino##2##2##(2008-10#1)(2008-9#1)
that among the##2##3##(1993-9#1)(2008-10#1)
that among##5##2##(1990-2#1)(1993-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
that amplify a##2##3##(2008-10#2)
that amplify##4##2##(2008-10#4)
that an additional##2##3##(2008-10#1)(2012-3#1)
that an early##2##3##(2008-11#1)(2009-6#1)
that an effective##2##3##(1996-9#1)(2008-3#1)
that an electrostatic##2##3##(2008-10#2)
that an experimental##2##3##(2008-11#1)(2008-3#1)
that an important##4##3##(1992-2#1)(1996-2#1)(2008-9#1)(2010-12#1)
that an increase in##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
that an increase##4##3##(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#1)
that an individual##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
that an inflammatory##2##3##(2008-12#1)(2012-3#1)
that an##106##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2008-10#19)(2008-11#13)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
that analogs##2##2##(1994-8#1)(2008-8#1)
that analysis of##3##3##(1995-12#1)(2008-11#1)(2008-9#1)
that analysis##4##2##(1995-12#1)(2008-11#1)(2008-9#1)(2010-1#1)
that anatomically##2##2##(1994-3#1)(2008-9#1)
that animal##2##2##(2008-8#1)(2009-8#1)
that animals##4##2##(1993-12#1)(1995-12#1)(2008-8#1)(2012-3#1)
that another##4##2##(1991-9#1)(2008-10#3)
that antagonism##2##2##(2008-10#2)
that anti-metatype antibodies##2##3##(1992-6#2)
that anti-metatype##3##2##(1992-6#3)
that antibacterial lotions##2##3##(2008-5#2)
that antibiosis is##2##3##(2008-10#2)
that antibodies##2##2##(1996-2#1)(2009-3#1)
that antibody production##2##3##(1990-12#1)(2008-11#1)
that antibody##5##2##(1990-12#1)(1991-12#1)(2008-10#1)(2008-11#2)
that antioxidant##2##2##(2009-8#1)(2011-1#1)
that antitrypsin Pittsburgh##2##3##(1993-2#2)
that anxiety##2##2##(2008-10#1)(2012-2#1)
that any##11##2##(1992-2#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-6#1)
that apart from##2##3##(1994-8#1)(2008-10#1)
that aphid transmission##3##3##(2008-10#3)
that apoptosis##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
that apoptotic cell death##2##4##(1996-12#1)(2012-2#1)
that apparently##2##2##(1997-3#1)(2008-10#1)
that appear morphologically##2##3##(2011-2#2)
that appear to be##3##4##(1993-3#1)(2008-4#1)(2010-5#1)
that appear to##6##3##(1993-3#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-5#1)(2013-7#1)
that appear##12##2##(1993-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#3)(2013-7#1)
that appeared in##2##3##(2008-10#1)(2012-3#1)
that appeared to be##3##4##(2008-10#1)(2009-10#1)(2009-6#1)
that appeared to##4##3##(2008-10#1)(2009-10#1)(2009-12#1)(2009-6#1)
that appeared##6##2##(2008-10#2)(2009-10#1)(2009-12#1)(2009-6#1)(2012-3#1)
that appears to be##3##4##(2008-11#2)(2008-12#1)
that appears to##7##3##(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#1)
that appears##8##2##(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)
that applicant##2##2##(1993-1#2)
that application of##5##3##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)
that application##6##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
that applied##3##2##(2008-10#2)(2013-1#1)
that apply##2##2##(2008-10#1)(2010-7#1)
that applying##2##2##(1994-3#1)(2008-10#1)
that appressoria##2##2##(2008-10#2)
that approach##3##2##(1993-1#1)(1997-2#1)(2008-10#1)
that approaches##2##2##(1997-1#1)(2007-11#1)
that appropriate##5##2##(1993-6#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
that approximately 30% of##2##4##(2008-10#1)(2013-1#1)
that approximately##7##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)
that are a##2##3##(1992-11#1)(2008-2#1)
that are able to##3##4##(2008-10#1)(2009-8#1)(2012-3#1)
that are activated##2##3##(1996-2#1)(2008-10#1)
that are also##2##3##(1995-6#1)(2013-8#1)
that are applicable##2##3##(2008-3#1)(2008-4#1)
that are appropriate##2##3##(1990-5#1)(1991-1#1)
that are as##2##3##(1997-7#1)(2008-7#1)
that are associated with the##5##5##(2008-11#1)(2008-3#1)(2008-7#2)(2012-2#1)
that are associated with##19##4##(1990-12#1)(1994-12#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
that are at##2##3##(1993-3#1)(2008-11#1)
that are available##8##3##(1992-6#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-10#1)
that are based on##3##4##(2008-3#2)(2008-4#1)
that are becoming##2##3##(2008-10#2)
that are being##2##3##(2008-10#1)(2008-4#1)
that are believed to be##2##5##(1992-10#1)(2008-11#1)
that are believed to##3##4##(1992-10#1)(2008-11#1)(2008-4#1)
that are both##2##3##(1993-3#1)(2010-11#1)
that are brought##3##3##(2008-10#1)(2009-5#1)(2012-2#1)
that are capable of##2##4##(2009-9#1)(2010-11#1)
that are capable##3##3##(2009-9#1)(2010-11#1)(2011-1#1)
that are caused by##2##4##(2008-10#1)(2013-8#1)
that are characteristic of##5##4##(1992-9#1)(2008-10#2)(2008-3#1)(2008-7#1)
that are common to##2##4##(1991-5#1)(2008-4#1)
that are commonly used##2##4##(2008-4#1)(2012-5#1)
that are commonly##5##3##(2008-10#1)(2008-4#1)(2012-3#1)(2012-5#1)(2013-3#1)
that are comparable to##2##4##(2008-10#2)
that are complex##2##3##(1996-3#1)(2008-8#1)
that are consistent with the##2##5##(2008-10#1)(2008-5#1)
that are consistent with##6##4##(2008-10#3)(2008-11#2)(2008-5#1)
that are critical for##3##4##(1994-5#1)(2008-10#1)(2009-10#1)
that are critical##5##3##(1994-5#1)(1996-2#2)(2008-10#1)(2009-10#1)
that are currently being##2##4##(1990-2#1)(2008-7#1)
that are currently##7##3##(1990-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
that are derived from##2##4##(2008-11#2)
that are designed##2##3##(2007-12#1)(2009-7#1)
that are difficult to##3##4##(2008-4#1)(2008-6#1)(2011-2#1)
that are discussed in##3##4##(1997-2#1)(2010-7#1)(2013-1#1)
that are discussed##4##3##(1993-8#1)(1997-2#1)(2010-7#1)(2013-1#1)
that are due to the##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
that are due to##10##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#6)
that are effective in##2##4##(2008-10#2)
that are effective##3##3##(2008-10#3)
that are either##4##3##(1992-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
that are embedded##2##3##(2008-11#1)(2010-8#1)
that are essential for##3##4##(1994-5#1)(2008-10#1)(2012-3#1)
that are exceptionally diverse##2##4##(2008-8#2)
that are expected to##3##4##(2008-11#1)(2008-3#1)(2012-3#1)
that are expressed##2##3##(1993-9#1)(2011-2#1)
that are found in##2##4##(2009-12#1)(2011-2#1)
that are found##3##3##(2009-12#1)(2011-2#1)(2013-8#1)
that are frequently##2##3##(2008-6#1)(2011-2#1)
that are functionally##2##3##(2010-4#1)(2013-1#1)
that are generally##3##3##(2008-10#1)(2010-1#1)(2013-8#1)
that are genetically##2##3##(1997-7#1)(2008-8#1)
that are hard to##2##4##(1990-3#1)(2008-11#1)
that are highly expressed in##2##5##(2009-10#1)(2011-2#1)
that are highly##9##3##(1990-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#2)(2011-2#1)(2012-2#1)
that are important for the##2##5##(2008-10#1)(2008-8#1)
that are important for##4##4##(2008-10#1)(2008-8#1)(2010-11#1)(2011-2#1)
that are important to##2##4##(2008-7#1)(2010-2#1)
that are important##10##3##(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
that are in agreement with##3##5##(2008-10#3)
that are in good agreement##2##5##(1994-5#1)(2010-7#1)
that are in##9##3##(1992-6#1)(1994-3#2)(1994-5#1)(2008-10#4)(2010-7#1)
that are involved in the##4##5##(1993-12#1)(2008-10#2)(2010-5#1)
that are involved in##11##4##(1993-12#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-5#1)
that are involved##12##3##(1993-12#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-5#1)(2013-8#1)
that are known to##5##4##(1993-11#1)(1995-9#1)(2008-11#2)(2008-3#1)
that are less##2##3##(2008-5#1)(2008-8#1)
that are likely to##2##4##(2008-6#1)(2010-5#1)
that are likely##3##3##(2008-6#1)(2010-5#1)(2013-8#1)
that are linked to##4##4##(2008-10#3)(2008-3#1)
that are more likely to##2##5##(1993-11#1)(2008-10#1)
that are more vulnerable##2##4##(2008-11#1)(2008-4#1)
that are more##6##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#2)
that are most frequently##2##4##(1991-12#1)(2008-10#1)
that are most##5##3##(1991-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
that are much##2##3##(2010-4#1)(2013-7#1)
that are necessary for##3##4##(1992-3#1)(2008-2#1)(2008-3#1)
that are necessary##4##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
that are not necessarily##2##4##(1995-5#1)(2013-8#1)
that are not readily##2##4##(1991-5#1)(2008-10#1)
that are not##17##3##(1991-5#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
that are now##5##3##(1997-2#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
that are of##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)(2011-3#1)
that are offered##2##3##(1993-12#1)(2008-11#1)
that are often##7##3##(2008-10#2)(2008-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
that are otherwise##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
that are possible##2##3##(2008-10#1)(2008-4#1)
that are potential##3##3##(1995-8#1)(2008-5#1)(2009-8#1)
that are predicted to##2##4##(2008-9#1)(2011-2#1)
that are present in##3##4##(2008-10#3)
that are referred##2##3##(1997-6#1)(2011-2#1)
that are related to the##2##5##(1991-12#1)(1991-3#1)
that are related to##3##4##(1991-12#1)(1991-3#1)(2010-3#1)
that are relevant to##3##4##(2008-10#1)(2009-3#1)(2013-1#1)
that are relevant##4##3##(2008-10#1)(2008-3#1)(2009-3#1)(2013-1#1)
that are required for##2##4##(1995-2#1)(2007-12#1)
that are required##4##3##(1995-2#1)(1997-1#1)(2007-12#1)(2008-11#1)
that are responsible for the##2##5##(2008-10#2)
that are responsible for##3##4##(1994-5#1)(2008-10#2)
that are restricted to##2##4##(2008-10#1)(2008-8#1)
that are selective for##2##4##(2008-11#1)(2008-5#1)
that are sensitive to##3##4##(1996-9#1)(2008-10#1)(2008-4#1)
that are significantly##3##3##(2007-12#1)(2008-8#1)(2010-4#1)
that are similar to the##2##5##(1993-12#1)(1995-2#1)
that are similar to those of##2##6##(1993-3#1)(2007-11#1)
that are similar to those##3##5##(1993-3#1)(2007-11#1)(2008-3#1)
that are similar to##10##4##(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#2)
that are smaller##2##3##(2008-10#1)(2010-6#1)
that are specific for either all##2##6##(2013-8#2)
that are specific for##6##4##(2008-10#3)(2008-4#1)(2013-8#2)
that are specific##7##3##(2008-10#3)(2008-4#1)(2012-3#1)(2013-8#2)
that are specifically##2##3##(2008-7#1)(2010-7#1)
that are still##2##3##(1995-12#1)(2013-8#1)
that are suitable for##3##4##(2008-11#1)(2008-6#1)(2011-2#1)
that are the most##2##4##(1993-12#1)(1995-6#1)
that are the##3##3##(1993-12#1)(1995-6#1)(2008-10#1)
that are thought to##2##4##(2008-6#1)(2009-10#1)
that are typical of##3##4##(1993-2#1)(2008-12#1)(2008-7#1)
that are typical##4##3##(1993-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
that are unable to##2##4##(1991-11#1)(2008-10#1)
that are unique##2##3##(2007-12#1)(2009-10#1)
that are used for##4##4##(2009-8#2)(2010-12#1)(2012-2#1)
that are used in##3##4##(1997-2#1)(2008-4#1)(2009-3#1)
that are used to monitor##2##5##(2008-10#1)(2008-9#1)
that are used to##8##4##(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#2)
that are used##18##3##(1990-12#1)(1992-9#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-12#1)(2012-2#1)
that are useful##2##3##(1994-12#1)(2008-10#1)
that are visible on##2##4##(2010-12#1)(2013-1#1)
that are widely##2##3##(2008-10#1)(2010-11#1)
that are##623##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#3)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#3)(1992-7#1)(1992-9#5)(1993-11#2)(1993-12#9)(1993-2#2)(1993-3#8)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#9)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-6#3)(1997-7#4)(2006-6#1)(2007-11#4)(2007-12#7)(2008-10#111)(2008-11#45)(2008-12#6)(2008-2#8)(2008-3#34)(2008-4#21)(2008-5#9)(2008-6#8)(2008-7#22)(2008-8#20)(2008-9#19)(2009-10#8)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#8)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#6)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#3)(2011-2#32)(2011-3#2)(2012-12#4)(2012-2#17)(2012-3#17)(2012-5#1)(2013-1#13)(2013-3#1)(2013-7#3)(2013-8#21)
that area##2##2##(2008-10#1)(2008-8#1)
that areas##3##2##(1992-1#1)(1997-8#1)(2008-11#1)
that arise during##2##3##(2008-10#1)(2012-3#1)
that arise from##4##3##(2008-11#1)(2008-3#1)(2011-2#2)
that arise in##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
that arise##13##2##(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#3)(2012-3#1)
that arises from##3##3##(1995-6#1)(2008-4#1)(2012-2#1)
that arises##4##2##(1995-6#1)(2008-11#1)(2008-4#1)(2012-2#1)
that arose from the##2##4##(1995-2#1)(2008-12#1)
that arose##4##2##(1995-2#1)(1997-1#1)(2008-12#1)(2012-3#1)
that around##2##2##(2008-11#1)(2013-8#1)
that arsenate is the main##2##5##(2008-10#2)
that arsenic##2##2##(2008-10#1)(2008-8#1)
that arterial##3##2##(1990-5#1)(2008-9#1)(2013-7#1)
that as a##2##3##(1993-6#1)(2010-9#1)
that as much as##2##4##(1993-12#1)(1995-2#1)
that as##10##2##(1993-12#1)(1993-6#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-8#1)(2010-9#1)
that asbestos-induced pleural##2##3##(1991-12#2)
that ascospores##2##2##(2008-10#2)
that asparagine##2##2##(1994-11#1)(1997-7#1)
that aspartate##2##2##(1995-6#2)
that aspirin##2##2##(2008-3#1)(2008-8#1)
that assessed##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
that assesses##2##2##(2011-2#1)(2013-1#1)
that associated with the##3##4##(1993-12#2)(2008-2#1)
that associated with##5##3##(1993-12#3)(2008-10#1)(2008-2#1)
that associated##6##2##(1993-12#3)(2008-10#2)(2008-2#1)
that association##3##2##(1991-12#1)(2008-10#1)(2010-1#1)
that assume##2##2##(2008-4#1)(2008-8#1)
that assumes##2##2##(1992-12#1)(2008-3#1)
that astaxanthin##2##2##(2010-10#1)(2013-8#1)
that at a##2##3##(2008-11#1)(2008-9#1)
that at high##2##3##(2008-3#1)(2008-7#1)
that at least part of the##2##6##(2008-10#2)
that at least part of##3##5##(1991-5#1)(2008-10#2)
that at least some##3##4##(2008-10#2)(2008-7#1)
that at least two##6##4##(1990-5#1)(1992-10#1)(1994-11#1)(2008-10#2)(2008-11#1)
that at least##24##3##(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-3#1)(1994-11#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-7#1)(2008-8#1)
that at low pH##2##4##(1990-8#1)(2008-10#1)
that at low##3##3##(1990-8#1)(2006-6#1)(2008-10#1)
that at pH##3##3##(2008-10#2)(2011-3#1)
that at physiological##2##3##(1994-5#1)(2013-8#1)
that at the##8##3##(1991-5#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
that at##62##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#2)(1992-10#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-8#2)(1996-12#1)(2006-6#1)(2008-1#1)(2008-10#21)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-3#2)(2012-2#2)(2012-3#1)(2013-8#1)
that atherosclerosis##3##2##(1997-8#2)(2008-6#1)
that atmospheric##2##2##(1996-1#1)(2008-10#1)
that attachment##2##2##(2008-10#1)(2008-11#1)
that attacks##2##2##(1990-11#1)(2008-10#1)
that attempt to##2##3##(1997-1#1)(2008-11#1)
that attention##2##2##(2008-11#1)(2008-7#1)
that attitudes##2##2##(1990-6#1)(2010-10#1)
that autologous blood donation##2##4##(1996-9#2)
that autologous blood##3##3##(1996-9#3)
that autologous##4##2##(1996-9#4)
that autophagy##3##2##(2008-7#1)(2012-3#2)
that avoids##3##2##(1997-7#1)(2008-6#1)(2008-8#1)
that bFGF##2##2##(1992-3#1)(1995-12#1)
that bacteria##3##2##(2008-10#3)
that bacterial##3##2##(2008-10#2)(2009-8#1)
that basal##2##2##(1995-11#1)(1995-12#1)
that based on##4##3##(1995-9#1)(2008-10#1)(2008-9#1)(2012-3#1)
that baseline##2##2##(1992-9#1)(2008-11#1)
that bcl-2##2##2##(2008-11#1)(2008-7#1)
that bear##2##2##(1993-8#1)(2008-9#1)
that bears##2##2##(2008-10#1)(2008-9#1)
that became##5##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
that because of##2##3##(1995-6#1)(2010-1#1)
that because##4##2##(1995-12#1)(1995-6#2)(2010-1#1)
that become##2##2##(2008-11#1)(2008-7#1)
that began##3##2##(2011-2#2)(2013-8#1)
that begins##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
that behavioral##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
that behaviors##2##2##(2008-5#1)(2009-7#1)
that belong to the##2##4##(1995-2#1)(1997-7#1)
that belong to##4##3##(1995-2#1)(1997-7#1)(2008-10#2)
that belong##5##2##(1995-2#1)(1997-7#1)(2008-10#3)
that belonged to##2##3##(2008-10#2)
that benefit the##2##3##(2008-11#1)(2011-2#1)
that benefit##3##2##(2008-11#1)(2010-10#1)(2011-2#1)
that best fits##2##3##(1996-1#2)
that best##5##2##(1996-1#2)(1997-3#1)(2008-12#1)(2013-1#1)
that beta-CGRP##2##2##(1992-6#2)
that beta-amylase##3##2##(2008-9#3)
that better##3##2##(2008-11#2)(2008-9#1)
that between##10##2##(1990-6#1)(1994-2#1)(2008-10#2)(2008-6#1)(2008-8#2)(2010-1#1)(2012-12#1)(2012-9#1)
that bind to a##2##4##(2008-1#1)(2008-4#1)
that bind to##5##3##(2008-1#1)(2008-10#2)(2008-4#2)
that bind##11##2##(1995-8#1)(2008-1#1)(2008-10#4)(2008-4#3)(2012-3#2)
that binding of##3##3##(1993-1#1)(1995-6#1)(1996-12#1)
that binding##4##2##(1993-1#1)(1995-6#1)(1996-12#1)(2008-8#1)
that binds to the##2##4##(1990-2#1)(1991-10#1)
that binds to##4##3##(1990-2#1)(1991-10#1)(1992-10#1)(1995-8#1)
that binds##9##2##(1990-2#1)(1991-10#1)(1992-10#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(2008-7#1)
that biochemical##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)
that biocontrol##2##2##(2008-10#2)
that biologically##2##2##(1994-8#1)(1996-2#1)
that black##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
that blastocyst##2##2##(2008-9#2)
that block the##2##3##(1995-6#1)(1997-6#1)
that block##4##2##(1995-6#2)(1997-6#1)(2009-9#1)
that blocks##3##2##(2008-5#1)(2009-8#1)(2010-7#1)
that blood banks##2##3##(1995-6#2)
that blood pressure##2##3##(2008-1#2)
that blood##4##2##(1995-6#2)(2008-1#2)
that boards##3##2##(1991-12#2)(1994-12#1)
that border##2##2##(2008-10#1)(2011-2#1)
that bore##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
that both antibodies##2##3##(1995-6#1)(2008-8#1)
that both body##2##3##(2008-8#1)(2010-10#1)
that both genes were##2##4##(2008-10#2)
that both genetic and##2##4##(2008-11#1)(2011-2#1)
that both groups of##2##4##(2009-11#1)(2009-9#1)
that both internal##2##3##(1996-2#1)(2008-7#1)
that both methods##3##3##(2008-10#3)
that both of them##2##4##(2008-10#1)(2008-9#1)
that both of##5##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
that both parenting and children's##2##5##(2010-1#2)
that both techniques##2##3##(1991-12#1)(2010-7#1)
that both the##22##3##(1991-10#1)(1991-6#1)(1992-9#1)(1993-2#1)(1994-3#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-9#2)(2009-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
that both##153##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#3)(1991-5#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-9#1)(2008-10#43)(2008-11#17)(2008-12#1)(2008-5#3)(2008-7#6)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
that bound the##2##3##(1995-9#1)(2008-10#1)
that bound##7##2##(1990-11#1)(1993-8#1)(1995-9#1)(2006-6#1)(2008-10#2)(2012-2#1)
that boys##2##2##(1996-6#1)(2013-8#1)
that brain##2##2##(2008-7#2)
that brain-derived##3##2##(1990-7#1)(1997-2#1)(2008-7#1)
that break##2##2##(2008-10#1)(2008-8#1)
that breast cancer##3##3##(1990-6#1)(1993-11#1)(2012-12#1)
that breastfeeding##2##2##(1991-8#1)(2008-10#1)
that breeding##3##2##(2008-10#1)(2008-9#1)(2012-4#1)
that brood amalgamation is##2##4##(2008-9#2)
that brood parasitism##2##3##(2010-8#2)
that brood##4##2##(2008-9#2)(2010-8#2)
that brought together the##2##4##(1997-3#1)(2008-12#1)
that bubbles##2##2##(2008-10#1)(2012-2#1)
that bud##2##2##(1997-3#1)(2009-8#1)
that bullying##3##2##(2009-7#3)
that burst##2##2##(1991-5#1)(1996-2#1)
that butch women##2##3##(2008-12#2)
that by choosing##2##3##(2008-12#1)(2008-9#1)
that by##35##2##(1990-9#1)(1991-12#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#3)(2009-3#1)(2010-3#1)(2010-4#1)(2010-6#1)(2013-1#1)
that c-Jun##2##2##(1995-12#1)(1995-2#1)
that cAMP##4##2##(1991-3#1)(1994-11#1)(1994-6#2)
that calcium##6##2##(1994-11#1)(1994-3#1)(1994-8#1)(2008-7#1)(2009-8#1)(2013-8#1)
that came##2##2##(2008-10#1)(2008-9#1)
that can affect##2##3##(1991-2#1)(2011-2#1)
that can be achieved##2##4##(2008-10#1)(2009-3#1)
that can be adopted##2##4##(2008-10#1)(2008-12#1)
that can be applied to##3##5##(2008-11#1)(2008-12#1)(2008-7#1)
that can be applied##7##4##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
that can be clearly##2##4##(2008-10#1)(2012-2#1)
that can be described by##2##5##(2008-10#1)(2013-1#1)
that can be detected##2##4##(2008-10#2)
that can be drawn from##2##5##(2008-12#2)
that can be drawn##3##4##(2008-10#1)(2008-12#2)
that can be easily##7##4##(1994-3#2)(2007-12#1)(2008-10#2)(2008-12#1)(2012-3#1)
that can be evaluated##2##4##(2008-3#1)(2012-3#1)
that can be found in##4##5##(2008-10#2)(2009-5#1)(2011-2#1)
that can be monitored##2##4##(2008-10#1)(2008-7#1)
that can be observed##3##4##(2008-10#1)(2008-9#1)(2010-4#1)
that can be obtained##2##4##(2008-12#1)(2011-2#1)
that can be of##5##4##(2008-11#1)(2008-4#3)(2008-9#1)
that can be related to##2##5##(2008-10#1)(2013-1#1)
that can be used as a##3##6##(1997-8#1)(2008-10#2)
that can be used as##4##5##(1997-8#1)(2008-10#2)(2012-2#1)
that can be used by##2##5##(1991-1#1)(2008-12#1)
that can be used for##9##5##(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-10#1)(2010-12#1)
that can be used freely suspended in solution to##2##9##(2008-10#2)
that can be used in##4##5##(2008-4#2)(2010-10#1)(2010-8#1)
that can be used to distinguish##2##6##(2008-10#1)(2013-8#1)
that can be used to estimate the potential risk##2##9##(2008-10#2)
that can be used to study##2##6##(2008-4#1)(2008-9#1)
that can be used to##19##5##(1996-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#3)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
that can be used##45##4##(1991-1#1)(1996-1#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#7)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
that can be useful in##2##5##(1996-12#1)(2008-10#1)
that can be useful##3##4##(1996-12#1)(2008-10#1)(2013-8#1)
that can be utilized##2##4##(1994-11#1)(2008-9#1)
that can be##166##3##(1991-1#2)(1992-1#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-8#2)(2007-12#1)(2008-10#47)(2008-11#9)(2008-12#10)(2008-2#2)(2008-3#8)(2008-4#12)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#5)(2012-3#4)(2012-9#1)(2013-1#7)(2013-8#2)
that can benefit from such##2##5##(1997-6#1)(2013-8#1)
that can bind to the##2##5##(2008-10#1)(2008-4#1)
that can bind to##3##4##(2008-10#2)(2008-4#1)
that can bind##4##3##(2008-10#2)(2008-4#1)(2009-12#1)
that can cause##4##3##(1996-11#1)(2008-11#1)(2011-2#1)(2012-2#1)
that can contribute##2##3##(2012-2#1)(2012-3#1)
that can create an##2##4##(1994-12#1)(2010-8#1)
that can distinguish##2##3##(2008-9#1)(2009-8#1)
that can facilitate the##2##4##(1997-2#1)(2008-12#1)
that can have##2##3##(2008-3#1)(2013-1#1)
that can help##6##3##(1993-2#1)(1994-1#1)(1995-1#1)(1997-2#1)(2008-12#1)(2010-7#1)
that can improve##2##3##(2008-9#1)(2013-1#1)
that can induce##2##3##(2008-10#2)
that can influence the##2##4##(2008-10#1)(2008-9#1)
that can influence##6##3##(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)
that can interfere with##2##4##(1993-3#1)(2010-11#1)
that can lead to##4##4##(2008-10#1)(2008-5#1)(2010-11#1)(2011-2#1)
that can meet##2##3##(1996-3#1)(2008-10#1)
that can mimic##2##3##(2008-10#1)(2012-2#1)
that can monitor##2##3##(2008-10#1)(2008-2#1)
that can occur in##2##4##(1991-3#1)(2010-9#1)
that can occur##4##3##(1991-3#1)(2009-6#1)(2010-9#1)(2011-2#1)
that can only be##2##4##(2008-11#1)(2010-6#1)
that can only##3##3##(2008-11#2)(2010-6#1)
that can perform##2##3##(2008-10#1)(2008-7#1)
that can produce a##2##4##(2008-2#1)(2008-3#1)
that can produce##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
that can provide##2##3##(2008-11#1)(2013-1#1)
that can result in##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
that can result##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
that can serve as##2##4##(1992-3#1)(2008-11#1)
that can support##2##3##(1996-6#1)(2008-11#1)
that can then##2##3##(2008-9#1)(2012-2#1)
that can vary##2##3##(2009-7#1)(2010-11#1)
that can##321##2##(1990-5#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-2#3)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#1)(2008-10#75)(2008-11#21)(2008-12#17)(2008-2#5)(2008-3#10)(2008-4#16)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#18)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#4)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#15)(2012-12#1)(2012-2#16)(2012-3#7)(2012-9#1)(2013-1#12)(2013-7#1)(2013-8#9)
that cancer##4##2##(2009-4#1)(2009-9#2)(2012-2#1)
that cannot be achieved##2##4##(2008-10#1)(2013-1#1)
that cannot be explained##2##4##(2008-8#1)(2013-1#1)
that cannot be##15##3##(1993-3#1)(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2013-1#2)
that cannot##17##2##(1993-3#1)(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2013-1#2)
that capsaicin##3##2##(1993-11#1)(2008-11#1)(2009-9#1)
that capture the##3##3##(2008-4#1)(2009-5#1)(2009-7#1)
that capture##4##2##(1997-1#1)(2008-4#1)(2009-5#1)(2009-7#1)
that captures the##3##3##(2008-10#1)(2009-10#1)(2012-2#1)
that captures##4##2##(2008-10#2)(2009-10#1)(2012-2#1)
that carbachol##2##2##(1996-12#2)
that carbon##2##2##(2008-10#1)(2008-8#1)
that cardiac##2##2##(2011-2#1)(2012-2#1)
that cardiovascular##2##2##(1990-5#1)(2008-7#1)
that care##8##2##(1991-3#1)(1993-3#1)(1994-2#1)(1997-2#1)(2008-11#1)(2008-9#1)(2010-10#2)
that caregivers##3##2##(1991-12#2)(1997-8#1)
that carried##4##2##(1993-3#2)(2008-10#1)(2012-12#1)
that carries##3##2##(1997-6#1)(2011-2#1)(2013-8#1)
that carry##4##2##(1993-12#1)(2007-12#1)(2011-1#1)(2011-2#1)
that case##5##2##(1995-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-7#1)
that catalyses the##2##3##(1993-8#1)(2008-10#1)
that catalyses##3##2##(1990-5#1)(1993-8#1)(2008-10#1)
that catalyzes##5##2##(1992-9#1)(1993-6#1)(1997-1#1)(1997-8#1)(2008-8#1)
that cathepsin D##2##3##(1990-5#1)(1994-5#1)
that cause a##4##3##(2008-10#2)(2009-8#1)(2012-3#1)
that cause significant##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
that cause the##3##3##(1993-6#1)(1997-1#1)(2012-2#1)
that cause##36##2##(1991-8#1)(1993-6#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#2)
that caused the##3##3##(1994-9#1)(2009-8#1)(2013-8#1)
that caused##7##2##(1994-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-8#1)
that causes a##4##3##(1991-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
that causes significant##2##3##(2008-10#2)
that causes##33##2##(1991-7#2)(1995-8#1)(1996-5#1)(1997-3#2)(2008-10#18)(2008-12#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
that caution##2##2##(2008-12#1)(2013-8#1)
that caveolae##2##2##(1995-2#1)(1995-6#1)
that caveolin##2##2##(1995-6#2)
that cell surface##2##3##(1992-6#1)(1997-9#1)
that cell##16##2##(1992-6#1)(1996-11#1)(1997-1#1)(1997-9#1)(2008-11#8)(2008-5#2)(2008-7#1)(2008-9#1)
that cells##11##2##(1992-8#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#1)
that cellular##2##2##(2008-10#1)(2009-6#1)
that central##2##2##(1996-2#1)(2008-12#1)
that cerebral##2##2##(2008-12#1)(2008-8#1)
that cerebroside##2##2##(2008-10#2)
that certain##17##2##(1993-2#1)(1994-5#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
that chance##2##2##(1994-3#1)(2008-11#1)
that change in##3##3##(2008-10#2)(2010-10#1)
that change##7##2##(2008-10#3)(2008-12#1)(2009-10#1)(2010-10#1)(2011-2#1)
that changed##3##2##(1993-9#1)(1996-12#1)(2008-11#1)
that changes in the##5##4##(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
that changes in##14##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#2)
that changes##16##2##(1994-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#2)
that changing##2##2##(2008-11#1)(2008-8#1)
that chaotic dynamics##2##3##(2008-11#2)
that characterize the##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
that characterize##6##2##(1993-1#1)(2008-10#2)(2008-3#1)(2010-5#1)(2011-2#1)
that characterizes the##3##3##(2008-3#1)(2010-5#1)(2012-3#1)
that characterizes##4##2##(2008-3#1)(2008-8#1)(2010-5#1)(2012-3#1)
that chemical##2##2##(2008-10#2)
that chest##2##2##(2008-3#1)(2009-4#1)
that childhood##2##2##(2011-2#1)(2012-2#1)
that children in##3##3##(1994-6#1)(1995-12#1)(1996-12#1)
that children with##3##3##(2008-9#1)(2010-2#1)(2012-2#1)
that children##11##2##(1990-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#2)
that children's##3##2##(1995-3#1)(2010-11#1)(2013-8#1)
that chitinase##2##2##(2008-10#2)
that chitobiase##2##2##(1992-10#2)
that chlorambucil##2##2##(2008-11#2)
that chromosome##4##2##(1996-6#1)(2008-10#3)
that chromosomes##2##2##(1996-6#1)(2008-11#1)
that chronic exposure##2##3##(2008-10#1)(2008-7#1)
that chronic treatment##2##3##(1992-3#1)(1996-12#1)
that chronic##14##2##(1992-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-12#3)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
that cigarette smoke caused##2##4##(2008-5#2)
that cigarette smoke##3##3##(2008-5#3)
that cigarette smoking##2##3##(2008-12#2)
that cigarette##6##2##(1996-1#1)(2008-12#2)(2008-5#3)
that circulating##2##2##(2008-1#1)(2008-11#1)
that citA##2##2##(1997-4#2)
that clearly##4##2##(1991-2#1)(1997-7#1)(2008-6#1)(2011-1#1)
that cleaves##3##2##(1993-3#1)(1994-11#1)(1996-12#1)
that clients##4##2##(1993-12#1)(2008-6#2)(2012-2#1)
that clinical##4##2##(2008-7#1)(2009-2#1)(2012-2#1)(2012-5#1)
that clinically##2##2##(2012-2#1)(2012-3#1)
that clinicians##6##2##(2008-1#1)(2008-11#1)(2008-12#1)(2010-4#2)(2011-2#1)
that closely resemble##2##3##(1994-3#1)(2008-11#1)
that closely##8##2##(1990-8#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-7#1)(2012-3#1)
that cloud##2##2##(2008-10#2)
that clustered with##2##3##(2008-10#2)
that clustered##3##2##(2008-10#3)
that clutch##2##2##(2008-9#2)
that co-occur in##2##3##(2008-10#1)(2010-3#1)
that co-occur##4##2##(2008-10#1)(2008-8#1)(2010-3#2)
that co-segregated with##2##3##(2008-10#2)
that co-suppression occurred##2##3##(2008-9#2)
that coalesce##2##2##(2009-10#1)(2011-2#1)
that coating##2##2##(2008-3#1)(2008-7#1)
that cochlear##2##2##(2008-9#2)
that code for##4##3##(1993-6#3)(2008-10#1)
that codes for##2##3##(1994-11#1)(1997-2#1)
that coding##4##2##(1993-12#1)(1994-6#1)(2007-12#1)(2012-12#1)
that coexistence##3##2##(2008-8#2)(2008-9#1)
that coincide with##2##3##(2008-10#1)(2008-3#1)
that coinfection##2##2##(2008-10#1)(2008-7#1)
that collectively##2##2##(2008-10#1)(2012-3#1)
that colonize##2##2##(2008-10#2)
that combination##4##2##(1995-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
that combinations of##2##3##(2008-10#1)(2009-8#1)
that combine##6##2##(1993-11#1)(1995-5#1)(2008-10#1)(2008-4#1)(2009-1#1)(2011-2#1)
that combined##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
that combines the##5##3##(1993-3#1)(2007-8#1)(2008-10#2)(2008-12#1)
that combines##23##2##(1993-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
that comes##3##2##(1995-6#1)(2008-10#2)
that commonly##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2012-2#1)
that communicate##2##2##(1996-2#1)(2008-12#1)
that communicating##2##2##(2013-1#1)(2013-8#1)
that community##2##2##(2009-12#1)(2010-9#1)
that comparative##2##2##(2008-10#1)(2011-2#1)
that compare favorably with those obtained by the##2##8##(2008-10#2)
that compare favorably with those obtained by##3##7##(2008-10#3)
that compare favorably with##4##4##(2008-10#4)
that compare favorably##5##3##(1992-2#1)(2008-10#4)
that compare##10##2##(1991-3#1)(1992-2#1)(1994-1#1)(2008-10#5)(2010-12#1)(2010-6#1)
that compared to##4##3##(1997-1#1)(2009-7#1)(2011-3#1)(2013-8#1)
that compared##6##2##(1997-1#1)(2008-10#1)(2009-7#1)(2011-2#1)(2011-3#1)(2013-8#1)
that compete##3##2##(2008-8#2)(2009-7#1)
that competition##3##2##(1997-3#1)(2008-9#2)
that complete##4##2##(2008-10#2)(2013-1#2)
that completely##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
that complex##4##2##(2008-10#2)(2010-5#1)(2013-8#1)
that complicate##2##2##(1996-11#1)(2008-8#1)
that composites of##2##3##(2009-7#1)(2010-4#1)
that compost-induced##2##2##(2008-10#2)
that compound##2##2##(2008-10#1)(2011-3#1)
that comprise the##4##3##(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
that comprise##5##2##(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
that comprises##2##2##(2007-11#1)(2008-11#1)
that concentrations of##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
that concern##2##2##(2008-10#2)
that condition##2##2##(2007-8#1)(2008-10#1)
that conditioned##2##2##(2008-10#2)
that confer resistance##2##3##(2008-10#2)
that confer##4##2##(1996-3#1)(2008-10#2)(2013-1#1)
that conferred##2##2##(2011-2#1)(2013-8#1)
that confers##7##2##(2008-10#5)(2008-8#1)(2011-2#1)
that confirm##2##2##(2008-10#1)(2008-3#1)
that confirmed##2##2##(2008-10#1)(2012-12#1)
that conidia##3##2##(2008-10#3)
that considerable##2##2##(2008-10#2)
that consideration of##2##3##(2012-2#1)(2012-3#1)
that consist of##3##3##(1994-9#1)(2008-10#1)(2008-3#1)
that consisted of a##2##4##(2008-10#2)
that consisted of##7##3##(1995-11#1)(2008-10#4)(2008-3#2)
that consistently##4##2##(1992-11#1)(2008-10#1)(2010-10#2)
that consists in##2##3##(2008-3#1)(2011-3#1)
that consists of an##4##4##(2008-10#2)(2008-11#1)(2010-6#1)
that consists of##8##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-6#1)
that consists##10##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-3#1)
that constitute the##4##3##(1991-6#1)(2008-2#1)(2008-3#1)(2012-2#1)
that constitute##6##2##(1991-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
that constitutes this##2##3##(1995-2#1)(2008-6#1)
that constitutes##4##2##(1995-2#1)(2008-6#1)(2010-10#1)(2013-8#1)
that consumers##5##2##(1993-3#1)(1997-3#2)(2010-1#2)
that consumption of##2##3##(2008-10#2)
that contain a##2##3##(2008-3#1)(2008-9#1)
that contain##24##2##(1990-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(2008-10#5)(2008-11#3)(2008-3#6)(2008-5#1)(2008-9#1)(2009-10#1)(2011-3#1)(2012-2#1)(2012-3#1)
that contained a##4##3##(1994-5#1)(2008-10#2)(2010-5#1)
that contained less than##2##4##(2008-10#2)
that contained no detectable levels of estrogen receptors##2##8##(2008-11#2)
that contained no##3##3##(2008-10#1)(2008-11#2)
that contained the##3##3##(2008-10#2)(2008-11#1)
that contained##37##2##(1990-7#1)(1991-12#1)(1993-12#2)(1994-5#1)(1996-6#2)(1997-4#1)(2008-10#13)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#2)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
that containing##2##2##(2008-10#1)(2012-12#1)
that contains a##3##3##(1992-3#1)(2008-3#1)(2008-4#1)
that contains only##2##3##(2008-3#2)
that contains the##6##3##(1992-12#1)(1993-11#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
that contains##21##2##(1990-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#1)(2008-10#3)(2008-11#2)(2008-3#8)(2008-4#1)(2011-2#1)
that contamination##2##2##(2008-10#2)
that context##2##2##(1993-3#1)(2010-10#1)
that continued##2##2##(2008-12#1)(2011-7#1)
that continuous##2##2##(2008-10#1)(2008-11#1)
that contribute to this##2##4##(2008-7#1)(2012-3#1)
that contribute to##17##3##(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#3)(2013-8#1)
that contributed to the##3##4##(1994-11#1)(2008-5#1)(2012-2#1)
that contributed to##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
that contributes to the##2##4##(2008-9#1)(2011-2#1)
that contributes to##4##3##(1997-1#1)(2007-12#1)(2008-9#1)(2011-2#1)
that contributes##5##2##(1997-1#1)(2007-12#1)(2008-9#1)(2009-7#1)(2011-2#1)
that control and##2##3##(2009-7#1)(2011-2#1)
that control of##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
that control the##6##3##(1995-9#1)(2008-11#1)(2008-7#2)(2010-4#1)(2011-2#1)
that control##26##2##(1993-6#1)(1995-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#4)(2012-3#2)(2013-1#1)
that controlled##2##2##(1994-6#1)(2008-3#1)
that controls the##2##3##(2008-10#2)
that controls##5##2##(2008-10#3)(2009-7#1)(2012-2#1)
that conventional##2##2##(1992-9#1)(2009-7#1)
that converted to##2##3##(2008-11#2)
that cooperation##3##2##(2008-8#3)
that copper##4##2##(2008-10#4)
that cord blood##2##3##(2008-11#2)
that correlate with##2##3##(1993-3#1)(2008-9#1)
that correlate##4##2##(1993-3#1)(2008-9#1)(2010-5#1)(2012-2#1)
that correlated with the##3##4##(2008-10#3)
that correlated with##6##3##(2008-10#5)(2009-8#1)
that correlated##7##2##(2008-10#6)(2009-8#1)
that correspond to a##2##4##(2008-2#1)(2008-3#1)
that correspond to the##4##4##(2007-11#1)(2008-10#2)(2008-9#1)
that correspond to##12##3##(1993-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
that correspond##13##2##(1993-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)
that corresponded to 50%##3##4##(2013-8#3)
that corresponded to##13##3##(1997-2#1)(2008-10#6)(2008-5#1)(2013-8#5)
that corresponds to the##4##4##(2008-2#1)(2008-3#1)(2009-10#1)(2013-1#1)
that corresponds to##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)(2013-1#1)
that corresponds##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)(2013-1#2)
that cosegregates##2##2##(1991-12#1)(2008-8#1)
that cost##3##2##(1994-1#1)(1994-3#1)(1994-9#1)
that could act##3##3##(1994-8#1)(2008-5#2)
that could affect##4##3##(2008-10#2)(2011-1#1)(2012-2#1)
that could be easily##2##4##(2008-10#1)(2013-1#1)
that could be used as##2##5##(1997-3#1)(2008-10#1)
that could be used for##5##5##(1992-1#1)(1995-2#1)(2008-10#1)(2009-3#1)(2012-2#1)
that could be used to discriminate between##2##7##(2008-10#1)(2008-7#1)
that could be used to##9##5##(2008-10#6)(2008-11#1)(2008-7#1)(2009-10#1)
that could be used##17##4##(1992-1#1)(1995-2#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#2)(2012-2#1)
that could be##38##3##(1991-9#1)(1992-1#1)(1993-12#1)(1993-8#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#3)(2010-10#1)(2010-3#1)(2010-4#1)(2012-2#2)(2013-1#2)
that could cause##2##3##(1995-2#1)(2011-2#1)
that could contribute to##2##4##(1997-2#1)(2008-10#1)
that could facilitate##2##3##(2008-10#1)(2008-12#1)
that could help##3##3##(1994-12#1)(2012-12#1)(2013-8#1)
that could improve##2##3##(2008-10#1)(2008-9#1)
that could influence##2##3##(2008-4#1)(2013-1#1)
that could lead to##3##4##(2008-10#1)(2008-11#1)(2009-7#1)
that could modulate##2##3##(2008-11#1)(2008-5#1)
that could not be##5##4##(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)
that could not##8##3##(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)
that could prevent##2##3##(2008-11#1)(2009-8#1)
that could provide##2##3##(2008-10#1)(2010-12#1)
that could result in##4##4##(2008-9#1)(2009-9#1)(2011-2#2)
that could support##2##3##(2008-10#1)(2013-1#1)
that could##122##2##(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#33)(2008-11#11)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#4)(2013-1#7)(2013-8#1)
that couple##2##2##(2008-3#1)(2010-12#1)
that cover the##2##3##(2008-3#1)(2008-5#1)
that cover##3##2##(2008-3#1)(2008-4#1)(2008-5#1)
that covers a##2##3##(2008-10#1)(2008-5#1)
that covers the##3##3##(2008-10#2)(2010-10#1)
that covers##6##2##(1997-7#1)(2008-10#3)(2008-5#1)(2010-10#1)
that create##4##2##(1992-1#1)(1997-3#1)(2009-10#1)(2009-12#1)
that created##2##2##(2008-8#1)(2012-3#1)
that creates the##2##3##(2008-3#1)(2008-9#1)
that creates##4##2##(2008-11#2)(2008-3#1)(2008-9#1)
that cultivar##3##2##(2008-10#3)
that cultural##2##2##(2009-10#2)
that current##9##2##(1992-12#1)(1996-2#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
that currently##4##2##(1995-12#1)(1995-2#1)(2008-10#1)(2008-3#1)
that cut##2##2##(2008-9#2)
that cutaneous##2##2##(2008-5#1)(2012-3#1)
that cyclic##3##2##(1993-6#1)(1994-11#1)(2008-10#1)
that damage to##2##3##(1994-11#1)(2009-1#1)
that damage##4##2##(1994-11#1)(2009-1#1)(2009-8#1)(2011-2#1)
that dark##2##2##(2008-3#1)(2013-8#1)
that declined##2##2##(1990-5#1)(2008-10#1)
that decrease##2##2##(2008-3#1)(2010-11#1)
that decreased##3##2##(1995-6#1)(2008-10#1)(2009-7#1)
that decreases##2##2##(1997-2#1)(2008-10#1)
that deep##2##2##(1996-2#1)(2012-2#1)
that define the##2##3##(1991-2#1)(2008-8#1)
that define##5##2##(1990-8#1)(1991-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
that defines##2##2##(1995-3#1)(2008-9#1)
that delay malaria diagnosis and treatment##2##6##(2012-12#2)
that deletions##2##2##(2008-11#2)
that delivers##2##2##(2010-6#1)(2012-3#1)
that demographic##2##2##(1996-3#1)(2008-7#1)
that demonstrate a##2##3##(2008-2#1)(2008-7#1)
that demonstrate the##4##3##(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
that demonstrate##12##2##(1996-6#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
that demonstrates the##4##3##(1993-1#1)(2008-12#1)(2009-8#1)(2012-12#1)
that demonstrates##5##2##(1993-1#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-12#1)
that dental##3##2##(1991-6#1)(2008-11#1)(2013-1#1)
that depend on the##5##4##(2008-10#2)(2008-9#1)(2010-4#1)(2010-7#1)
that depend on##7##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-4#1)(2010-7#1)
that depend##8##2##(1995-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-4#1)(2010-7#1)
that depends on the##6##4##(2008-11#1)(2008-3#3)(2011-2#1)(2013-8#1)
that depends on##8##3##(2008-10#2)(2008-11#1)(2008-3#3)(2011-2#1)(2013-8#1)
that derived from##2##3##(1994-5#1)(2008-9#1)
that describe the##8##3##(1990-8#1)(1993-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
that describe##13##2##(1990-8#1)(1993-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
that described##7##2##(1990-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2009-4#1)(2010-10#1)
that describes the##5##3##(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)
that describes##11##2##(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-8#1)
that deserve##2##2##(2009-10#1)(2012-2#1)
that despite the##4##3##(2008-11#2)(2008-7#1)(2011-1#1)
that despite##5##2##(2008-11#2)(2008-7#1)(2011-1#1)(2012-3#1)
that detailed##2##2##(1993-12#1)(2008-9#1)
that detected##4##2##(2008-10#3)(2008-3#1)
that detection##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
that determination of##2##3##(2008-10#2)
that determine the##10##3##(1994-5#1)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-5#1)(2012-2#1)(2013-8#1)
that determine##17##2##(1993-1#1)(1993-6#1)(1994-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
that determined##4##2##(1995-8#1)(2008-10#2)(2008-11#1)
that determines the##5##3##(1990-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
that determines##11##2##(1990-6#1)(1992-12#1)(1995-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
that develop##2##2##(1993-3#1)(2008-11#1)
that developed on##2##3##(2008-10#1)(2010-6#1)
that developed##13##2##(1991-6#1)(1993-6#1)(2008-10#6)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)
that development##2##2##(2008-11#1)(2008-9#1)
that developmental##2##2##(2008-10#2)
that develops##8##2##(1996-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2012-12#1)
that devolution##2##2##(1997-2#2)
that diagnostic##2##2##(1990-12#1)(2010-5#1)
that dictate##2##2##(2008-10#1)(2012-12#1)
that did not alter##2##4##(2008-10#1)(2008-5#1)
that did not##27##3##(1990-3#1)(1992-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
that died##5##2##(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
that dietary nucleotides##2##3##(2008-11#2)
that dietary##5##2##(2008-11#2)(2008-4#1)(2010-1#1)(2012-2#1)
that differ by##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2013-8#1)
that differ in levels of##2##5##(1996-12#2)
that differ in their##4##4##(1994-2#1)(1997-8#1)(2008-10#1)(2013-8#1)
that differ in##7##3##(1994-2#1)(1996-12#2)(1997-8#1)(2008-10#2)(2013-8#1)
that differ##18##2##(1994-2#1)(1996-12#2)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#2)
that differed from##2##3##(2008-10#2)
that differed in their##3##4##(2008-11#2)(2009-10#1)
that differed in##10##3##(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#2)(2009-10#1)
that differed##15##2##(1994-1#1)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#2)(2009-10#1)
that difference##4##2##(2008-11#1)(2011-2#3)
that differences between##2##3##(1993-1#1)(2008-8#1)
that differences in the##3##4##(1995-11#1)(2008-10#1)(2008-9#1)
that differences in##6##3##(1991-12#1)(1995-11#1)(2008-10#2)(2008-9#2)
that differences##11##2##(1991-12#1)(1993-1#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)
that different analytes##2##3##(2008-10#2)
that different signaling cascades##2##4##(2008-11#2)
that different##34##2##(1991-12#1)(1993-8#1)(1994-11#1)(1996-9#1)(1997-9#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
that differential##2##2##(2008-5#1)(2008-7#1)
that differentially##2##2##(1993-6#1)(2010-12#1)
that differentiate##3##2##(2008-10#1)(2008-7#1)(2010-3#1)
that differentiation of##2##3##(2008-11#1)(2008-6#1)
that differs from the previously##2##5##(2008-10#2)
that differs##4##2##(2008-10#3)(2009-7#1)
that direct##7##2##(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
that directed##3##2##(1990-5#1)(1994-11#1)(2011-1#1)
that directly address##2##3##(2013-1#2)
that directly##9##2##(2007-12#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
that directs##3##2##(1994-12#1)(1995-12#1)(2008-7#1)
that disease control##2##3##(2008-10#2)
that disease incidence was##3##4##(2008-10#3)
that disease incidence##6##3##(2008-10#6)
that disease##14##2##(1991-2#1)(2008-10#13)
that diseases##2##2##(1997-3#1)(2010-1#1)
that dispersal##2##2##(2008-8#1)(2008-9#1)
that display the##3##3##(2008-3#1)(2008-9#1)(2011-2#1)
that display##8##2##(1994-9#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
that displayed##2##2##(2008-10#1)(2008-7#1)
that displays a##2##3##(1995-12#1)(1996-5#1)
that displays##5##2##(1992-10#1)(1993-3#1)(1995-12#1)(1996-5#1)(2008-3#1)
that distance learning is##2##4##(2008-11#1)(2010-10#1)
that distance learning##3##3##(2008-11#2)(2010-10#1)
that distance##5##2##(2007-12#1)(2008-10#1)(2008-11#2)(2010-10#1)
that distinct##2##2##(1997-7#1)(2008-5#1)
that distinguish##11##2##(1991-6#1)(1996-3#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-4#1)(2012-3#1)(2013-8#1)
that distinguished##4##2##(2008-10#2)(2008-6#1)(2013-1#1)
that distinguishes##3##2##(2008-10#2)(2008-12#1)
that distribution##2##2##(1995-12#1)(2008-8#1)
that diverse##2##2##(2010-10#1)(2013-1#1)
that divorce##3##2##(2011-2#3)
that do not contain##2##4##(2008-10#1)(2008-11#1)
that do not interact##2##4##(1996-2#1)(2010-12#1)
that do not require##2##4##(1995-2#1)(2008-11#1)
that do not respond to##2##5##(2008-7#1)(2010-12#1)
that do not##24##3##(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1996-2#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#2)(2012-3#1)
that do##27##2##(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#2)(1996-2#2)(2008-10#6)(2008-11#4)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#2)(2012-3#1)
that doctors##6##2##(1994-9#1)(1995-2#2)(1995-6#1)(2011-2#2)
that does not involve##2##4##(1995-8#1)(2008-10#1)
that does not match the##2##5##(1997-7#1)(2012-2#1)
that does not need##2##4##(1996-3#1)(2008-10#1)
that does not require any##2##5##(2008-10#1)(2013-8#1)
that does not require##8##4##(1995-12#1)(1995-6#1)(2008-10#4)(2008-9#1)(2013-8#1)
that does not##26##3##(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-7#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
that dopamine##3##2##(1993-6#1)(1995-2#1)(1997-3#1)
that down-regulation of##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
that dramatically##2##2##(2008-9#2)
that draws on##2##3##(1993-12#1)(2008-8#1)
that draws##3##2##(1993-12#1)(1996-12#1)(2008-8#1)
that dreaming##2##2##(2013-8#2)
that drive##3##2##(2008-9#1)(2012-3#1)(2013-1#1)
that drives the##3##3##(2008-3#1)(2010-8#1)(2012-2#1)
that drives##6##2##(2008-10#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-1#2)
that drug##3##2##(1993-6#1)(2008-11#2)
that drugs are##2##3##(1990-2#1)(1996-3#1)
that drugs##5##2##(1990-2#1)(1994-8#1)(1996-3#1)(1997-1#1)(2012-2#1)
that dsRNA##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
that due to the##2##4##(1994-5#1)(2008-5#1)
that due to##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
that during this##2##3##(2008-11#1)(2008-8#1)
that during##15##2##(1994-11#1)(1995-9#1)(1996-2#1)(1996-9#1)(2008-10#2)(2008-11#3)(2008-8#2)(2008-9#1)(2011-2#3)
that dynamic##2##2##(2008-11#1)(2008-9#1)
that dynamics##2##2##(2008-10#1)(2008-8#1)
that each of the##2##4##(1991-7#1)(2008-10#1)
that each of these##2##4##(2008-11#1)(2008-7#1)
that each of##4##3##(1991-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
that each##26##2##(1991-5#1)(1991-7#1)(1997-2#1)(1997-8#2)(2008-10#11)(2008-11#4)(2008-7#1)(2008-8#3)(2010-7#1)(2012-3#1)
that early##12##2##(1990-5#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-1#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
that education and##2##3##(1997-8#1)(2008-11#1)
that education##3##2##(1994-8#1)(1997-8#1)(2008-11#1)
that educational##2##2##(2008-11#1)(2009-12#1)
that effect##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
that effective##4##2##(2008-11#1)(2008-8#1)(2009-5#1)(2010-7#1)
that effectively##2##2##(1995-5#1)(2008-6#1)
that effects of##2##3##(2011-2#1)(2013-1#1)
that efficacy##2##2##(2008-6#1)(2012-12#1)
that either the##2##3##(1997-7#1)(2008-10#1)
that either##12##2##(1993-12#1)(1995-6#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
that elderly##2##2##(1994-6#1)(2008-7#1)
that electron##2##2##(1990-5#1)(1994-5#1)
that electrostatic interactions##2##3##(1994-5#1)(2008-4#1)
that elevated##8##2##(1991-12#1)(1992-8#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
that elicit disgust##3##3##(2008-11#3)
that elicit##5##2##(2008-10#1)(2008-11#4)
that eliminate##2##2##(1992-9#2)
that eliminated##2##2##(2008-10#2)
that eliminates##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
that eluted##2##2##(1990-12#1)(2008-10#1)
that embryos##2##2##(2008-6#1)(2009-5#1)
that emerge from the##3##4##(2008-11#1)(2008-2#1)(2010-11#1)
that emerge##5##2##(1996-2#1)(2008-11#1)(2008-2#1)(2010-11#1)(2010-12#1)
that emerged from##3##3##(1991-12#1)(2008-11#2)
that emerged in##2##3##(2008-11#2)
that emerged##7##2##(1991-12#1)(2008-10#1)(2008-11#5)
that emerges is##2##3##(2009-6#1)(2009-7#1)
that emerges##3##2##(2008-3#1)(2009-6#1)(2009-7#1)
that emits##2##2##(2007-11#1)(2013-1#1)
that emphasize##5##2##(1994-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2012-2#1)
that emphasizes the##2##3##(2008-10#1)(2012-3#1)
that emphasizes##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
that empirical##3##2##(2008-11#1)(2008-8#1)(2009-4#1)
that employ holding beams##2##4##(2007-11#2)
that employ##7##2##(1993-12#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
that employed##2##2##(1991-5#1)(2008-11#1)
that employs##7##2##(2008-10#3)(2008-3#4)
that empower##2##2##(1993-1#1)(2008-11#1)
that emulate ocean water##2##4##(2008-3#2)
that enable##9##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-7#1)(2013-8#1)
that enabled the##3##3##(2008-10#1)(2009-6#1)(2011-1#1)
that enabled##4##2##(2008-10#2)(2009-6#1)(2011-1#1)
that enables a##2##3##(2008-10#1)(2008-11#1)
that enables the determination##2##4##(2008-10#2)
that enables the##5##3##(2008-10#3)(2008-3#1)(2008-5#1)
that enables us to##2##4##(2008-3#1)(2012-2#1)
that enables##17##2##(1995-6#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2012-2#1)
that encapsulation##2##2##(2008-11#1)(2013-1#1)
that encoded##4##2##(2008-11#1)(2008-8#2)(2008-9#1)
that encodes the##4##3##(1993-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
that encodes##11##2##(1990-5#1)(1991-7#1)(1993-2#2)(2008-10#4)(2008-4#1)(2008-9#1)(2011-2#1)
that encompass the##2##3##(2008-12#1)(2012-3#1)
that encompass##3##2##(2008-12#1)(2012-3#1)(2013-1#1)
that encompasses##2##2##(1995-6#1)(2008-8#1)
that encouraged##2##2##(1993-12#1)(2008-11#1)
that encourages##2##2##(1994-1#1)(2008-9#1)
that end##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
that endogenous##5##2##(1995-12#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-11#1)
that endos is required##2##4##(2012-3#2)
that endoscopic##2##2##(2008-10#1)(2008-12#1)
that endothelial cells##3##3##(1993-3#1)(1994-11#1)(2008-11#1)
that endothelial##4##2##(1993-3#1)(1994-11#1)(2008-11#2)
that enhance##5##2##(2008-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-1#1)
that enhanced##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
that enhances##5##2##(1993-6#1)(1994-5#1)(1995-1#1)(2008-12#1)(2008-9#1)
that ensure##5##2##(2008-11#2)(2008-12#2)(2010-11#1)
that ensured the##2##3##(2008-10#2)
that ensures##2##2##(1995-5#1)(2009-5#1)
that enters the##2##3##(2008-2#1)(2008-3#1)
that environmental##5##2##(2008-10#1)(2008-8#1)(2009-6#1)(2009-8#1)(2013-1#1)
that enzymatic##2##2##(1991-9#1)(2008-12#1)
that epidemics of##3##3##(2008-10#2)(2008-8#1)
that epidemics##5##2##(2008-10#4)(2008-8#1)
that epidermal growth factor##2##4##(1991-7#1)(1994-11#1)
that epidermal##3##2##(1991-7#1)(1994-11#1)(2008-10#1)
that epidural##3##2##(2008-7#1)(2012-3#2)
that epigenetic##4##2##(2008-12#1)(2009-10#1)(2009-4#2)
that equals##2##2##(2008-10#1)(2013-1#1)
that equilibrium##2##2##(2008-8#2)
that errors##2##2##(2008-10#1)(2012-2#1)
that establishes##2##2##(2008-11#1)(2012-2#1)
that estimated##2##2##(2008-8#1)(2011-2#1)
that estrogen##4##2##(1992-3#1)(2008-11#1)(2008-6#1)(2008-7#1)
that ethanol exposure##2##3##(2009-12#2)
that ethanol##5##2##(1992-7#1)(2008-11#1)(2009-12#2)(2009-7#1)
that ethnic##2##2##(2008-1#1)(2010-1#1)
that ethoxyresorufin##2##2##(1994-8#2)
that evaluate##2##2##(1991-2#1)(2008-10#1)
that evaluated##2##2##(2008-9#1)(2013-1#1)
that evaluation of##3##3##(1992-3#1)(2008-10#1)(2009-4#1)
that even in##2##3##(2008-9#1)(2011-2#1)
that even small##3##3##(1991-12#1)(1993-2#1)(2010-4#1)
that even though##2##3##(1993-9#1)(2011-2#1)
that even##18##2##(1991-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1996-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#2)(2011-2#4)(2012-12#1)(2013-1#1)
that eventually##3##2##(2008-1#1)(2008-12#1)(2008-8#1)
that every##4##2##(1992-3#1)(1995-2#1)(2008-9#1)(2009-4#1)
that evidence of##2##3##(1995-6#1)(2010-9#1)
that evidence##5##2##(1992-3#1)(1995-6#1)(2008-9#1)(2010-9#1)(2011-2#1)
that evolution of##2##3##(2008-8#2)
that evolution##3##2##(2008-10#1)(2008-8#2)
that evolved##2##2##(1993-12#1)(2008-10#1)
that examined##2##2##(2008-4#1)(2013-1#1)
that examines the##2##3##(2008-12#1)(2010-11#1)
that examines##3##2##(2008-11#1)(2008-12#1)(2010-11#1)
that exceed##2##2##(2008-10#1)(2013-8#1)
that exceeded##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
that excess##3##2##(1995-2#1)(2012-2#1)(2013-1#1)
that excessive##4##2##(1992-3#1)(2008-11#1)(2008-5#1)(2012-3#1)
that exclusion of##3##3##(2008-10#3)
that exhibit##13##2##(1991-5#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2012-3#2)
that exhibited##12##2##(1996-2#1)(1997-7#1)(2008-10#9)(2011-2#1)
that exhibits##5##2##(2008-11#1)(2008-3#3)(2011-1#1)
that exist in##3##3##(1993-1#1)(1996-3#1)(2008-10#1)
that exist##8##2##(1993-1#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-9#1)(2009-5#1)(2013-1#1)
that existing##2##2##(2009-4#1)(2010-10#1)
that exists among##2##3##(1997-8#1)(2008-10#1)
that exists in the##2##4##(2008-12#1)(2008-5#1)
that exists in##5##3##(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#1)
that exists##8##2##(1997-8#1)(2008-10#2)(2008-12#2)(2008-5#2)(2012-3#1)
that exogenous##4##2##(2008-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
that exogenously##2##2##(2008-11#1)(2011-10#1)
that exon##2##2##(1997-8#1)(2008-12#1)
that expansion##2##2##(1996-12#1)(2008-9#1)
that expected##3##2##(2008-10#2)(2008-7#1)
that experience##6##2##(2008-8#3)(2008-9#2)(2013-8#1)
that experiences##2##2##(2008-10#1)(2008-8#1)
that experimental##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
that explained##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
that explicitly##2##2##(2008-8#1)(2009-10#1)
that exploit the##2##3##(2008-10#1)(2008-7#1)
that exploit##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
that exploits the##2##3##(2008-3#1)(2012-2#1)
that exploits##3##2##(1995-6#1)(2008-3#1)(2012-2#1)
that explored the##2##3##(1996-3#1)(2008-12#1)
that explored##3##2##(1996-3#1)(2008-12#1)(2010-4#1)
that exposure of##2##3##(1994-11#1)(2008-7#1)
that exposure to the##3##4##(1993-6#1)(2008-10#2)
that exposure to##10##3##(1993-6#1)(1997-1#1)(2008-10#4)(2009-8#1)(2010-5#1)(2013-1#2)
that exposure##13##2##(1993-6#1)(1994-11#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#1)(2010-5#1)(2013-1#2)
that express the##5##3##(2008-10#2)(2008-9#1)(2009-6#1)(2011-1#1)
that express##16##2##(1992-10#1)(1993-12#1)(1994-2#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#1)
that expressed##7##2##(1994-5#1)(1997-7#1)(2008-10#4)(2009-6#1)
that expresses##4##2##(1995-2#1)(2008-11#1)(2012-12#1)(2013-8#1)
that expression levels of##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
that expression of these##2##4##(1997-8#1)(2009-10#1)
that expression of##11##3##(1995-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
that expression##15##2##(1995-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
that extended##5##2##(1997-3#1)(2008-10#3)(2011-2#1)
that extends##5##2##(1996-5#1)(1997-3#1)(2008-10#1)(2008-2#1)(2012-2#1)
that extensive##2##2##(2008-12#1)(2012-3#1)
that external##4##2##(2008-10#1)(2010-1#1)(2010-10#1)(2011-2#1)
that extracellular CaM##2##3##(2008-8#2)
that extracellular##5##2##(1994-11#1)(1995-2#1)(2008-8#2)(2009-6#1)
that extracts##3##2##(2008-3#1)(2010-2#2)
that fabrication##2##2##(2008-10#1)(2008-3#1)
that facilitate##9##2##(1993-9#1)(1995-3#1)(2008-11#2)(2008-12#2)(2008-9#1)(2012-2#1)(2012-3#1)
that facilitates##5##2##(1991-2#1)(2008-11#1)(2009-9#1)(2010-6#1)(2011-2#1)
that factors##4##2##(1991-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
that fail to##4##3##(1992-12#1)(2008-11#1)(2009-10#1)(2011-2#1)
that failed to develop##2##4##(2008-10#2)
that failed to##4##3##(1996-12#1)(2008-10#2)(2010-6#1)
that failure to##2##3##(2008-10#1)(2012-2#1)
that failure##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
that faithfully##2##2##(1996-2#1)(2008-11#1)
that families##2##2##(2008-8#1)(2010-9#1)
that family##4##2##(1992-7#1)(2009-12#1)(2010-1#1)(2013-1#1)
that favor##3##2##(1995-6#1)(1996-3#1)(2008-8#1)
that favors##3##2##(1995-2#1)(2008-10#1)(2013-8#1)
that favour hemi-fusion##2##3##(1991-5#2)
that favour##3##2##(1991-5#2)(1997-4#1)
that fear##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
that features##2##2##(1993-3#1)(2008-3#1)
that feeding##2##2##(2008-11#1)(2008-8#1)
that female##3##2##(2008-12#1)(2008-8#1)(2012-3#1)
that females may##2##3##(2008-8#2)
that females##11##2##(2008-4#2)(2008-5#1)(2008-8#6)(2008-9#1)(2011-2#1)
that ferritin##2##2##(1993-11#1)(2013-8#1)
that feverfew##2##2##(2008-10#2)
that field##3##2##(2008-10#3)
that fights##2##2##(2008-9#2)
that financial##3##2##(1992-1#1)(1994-2#1)(1995-12#1)
that fish##2##2##(2008-10#1)(2008-8#1)
that fit the data##2##4##(2008-3#2)
that fit##4##2##(2008-3#2)(2008-8#1)(2009-6#1)
that fitness##2##2##(2008-10#1)(2008-8#1)
that fits with##2##3##(1994-3#1)(2010-8#1)
that flow##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
that flowers were##2##3##(2008-10#2)
that fluid##2##2##(2011-2#2)
that flumorph##2##2##(2008-10#2)
that fluorescence##2##2##(2008-10#1)(2008-9#1)
that focus on the##2##4##(1994-12#1)(2008-12#1)
that focus on##7##3##(1992-12#1)(1994-12#1)(1997-2#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)
that focus##9##2##(1992-12#1)(1994-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
that focused on##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
that focuses on##2##3##(2010-8#1)(2012-2#1)
that focuses##3##2##(2010-8#1)(2012-2#1)(2013-1#1)
that foliar##2##2##(2008-10#1)(2008-8#1)
that follow##2##2##(1995-1#1)(1997-3#1)
that followed the##2##3##(1996-12#1)(2008-12#1)
that followed##6##2##(1993-12#1)(1996-12#1)(2008-11#1)(2008-12#2)(2008-6#1)
that following##2##2##(1995-11#1)(2008-7#1)
that follows the##2##3##(2008-11#2)
that follows##4##2##(1995-11#1)(2008-11#2)(2012-3#1)
that food##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
that for a##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2013-8#1)
that for certain##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
that for most##2##3##(2008-11#1)(2008-8#1)
that for some##2##3##(1994-6#1)(2008-7#1)
that for the##19##3##(1990-8#1)(1992-1#1)(1992-2#1)(1996-12#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2010-12#1)(2013-8#2)
that for##86##2##(1990-3#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-11#1)(1996-12#2)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#5)
that forage with##2##3##(2009-10#2)
that form the##4##3##(1993-12#1)(2008-12#1)(2009-8#1)(2012-2#1)
that form##12##2##(1991-12#1)(1993-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-7#1)
that formation of##4##3##(1994-3#1)(1997-3#1)(2008-5#1)(2013-1#1)
that foster##3##2##(2008-11#1)(2008-12#2)
that found in the##4##4##(2008-10#1)(2008-11#2)(2012-12#1)
that found in##12##3##(1990-6#1)(1994-11#2)(1995-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2011-2#1)(2012-12#1)
that found with##2##3##(1991-3#1)(1994-5#1)
that found##21##2##(1990-6#1)(1991-3#1)(1991-5#1)(1994-11#2)(1994-5#1)(1995-12#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-3#1)
that four##4##2##(1997-3#1)(2008-10#2)(2009-2#1)
that free##3##2##(1995-8#1)(2008-10#1)(2013-1#1)
that frequently##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2010-7#1)
that from the##7##3##(1990-5#1)(1991-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)
that from##16##2##(1990-2#1)(1990-5#1)(1991-10#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-2#1)
that fructose and glucose##2##4##(2008-9#2)
that fruit##3##2##(1994-2#1)(2008-10#2)
that fucoidan extracts##3##3##(2008-11#3)
that full##2##2##(2008-1#1)(2012-2#1)
that fully##2##2##(2008-12#1)(2008-8#1)
that function in##5##3##(2009-10#2)(2009-7#1)(2012-3#2)
that function##9##2##(2008-3#1)(2008-7#1)(2009-10#2)(2009-7#1)(2012-2#2)(2012-3#2)
that functional##4##2##(1995-2#1)(2008-11#1)(2008-5#1)(2008-7#1)
that functions as a##3##4##(1991-10#1)(2009-7#1)(2013-1#1)
that functions in##3##3##(1996-2#1)(1996-6#1)(2008-9#1)
that functions##7##2##(1991-10#1)(1995-6#1)(1996-2#1)(1996-6#1)(2008-9#1)(2009-7#1)(2013-1#1)
that fundamental##2##2##(2008-3#1)(2008-8#1)
that fungal##2##2##(2008-10#1)(2012-2#1)
that further research##2##3##(2009-5#1)(2013-1#1)
that further studies##3##3##(1990-12#1)(2008-9#1)(2009-8#1)
that further study of##2##4##(1996-8#1)(2008-7#1)
that further##15##2##(1990-12#1)(1996-8#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
that fusicoccin##2##2##(1995-2#2)
that fusion##2##2##(2008-9#1)(2011-1#1)
that future##7##2##(2008-10#2)(2008-12#3)(2008-8#2)
that gap##2##2##(2008-12#1)(2013-1#1)
that gastroenterologists##2##2##(1990-2#1)(2013-1#1)
that gave rise to##2##4##(2010-7#1)(2010-9#1)
that gave##4##2##(1991-2#1)(2010-7#1)(2010-9#1)(2012-3#1)
that gel##2##2##(2008-10#1)(2008-9#1)
that gender##3##2##(2008-12#1)(2009-4#1)(2012-2#1)
that gene flow##3##3##(2008-10#2)(2008-9#1)
that gene##8##2##(2008-10#3)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)
that general practitioners##2##3##(1993-2#1)(1997-8#1)
that general##5##2##(1993-1#1)(1993-2#1)(1997-8#1)(2008-7#1)(2009-8#1)
that generally##4##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
that generate##3##2##(2009-4#1)(2011-1#1)(2013-8#1)
that generates a##4##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
that generates##9##2##(1994-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-1#1)(2013-1#1)
that genes##7##2##(1995-12#1)(1997-6#1)(2008-10#2)(2009-8#1)(2011-3#1)(2012-3#1)
that genetic drift##2##3##(2008-10#2)
that genetic factors are##2##4##(2008-7#1)(2010-12#1)
that genetic variability##2##3##(2008-10#2)
that genetic##14##2##(1997-7#1)(2008-10#9)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
that genetically##3##2##(2008-10#1)(2009-5#1)(2010-8#1)
that genistein##2##2##(1997-7#1)(2008-11#1)
that genome##3##2##(1992-3#1)(2008-8#1)(2011-1#1)
that genomic##2##2##(1995-8#1)(2011-2#1)
that genotype##2##2##(2008-10#2)
that geographic##2##2##(2008-10#2)
that germinated##2##2##(2008-10#1)(2008-5#1)
that girls##2##2##(1990-2#1)(2012-2#1)
that give rise to##2##4##(2007-11#1)(2012-2#1)
that give##4##2##(2007-11#1)(2007-12#1)(2008-5#1)(2012-2#1)
that gives a##2##3##(2008-11#2)
that gives##7##2##(1994-9#1)(2008-10#3)(2008-11#2)(2010-4#1)
that giving##2##2##(1996-5#1)(2010-2#1)
that glial##2##2##(2008-5#1)(2008-7#1)
that glove##2##2##(1995-3#2)
that glutamatergic##2##2##(2008-7#1)(2012-2#1)
that go##2##2##(1991-6#1)(2012-3#1)
that good##6##2##(1993-12#1)(1993-6#1)(1994-12#1)(2008-10#2)(2008-3#1)
that govern##6##2##(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-1#1)
that governs##2##2##(1996-5#1)(2009-10#1)
that greater than##3##3##(1992-10#1)(1997-1#1)(2008-10#1)
that greater##5##2##(1992-10#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-5#1)
that greatly##2##2##(2007-12#1)(2008-10#1)
that grew##3##2##(2008-10#3)
that group##6##2##(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2010-4#1)
that grouper##2##2##(2010-5#2)
that grouping##2##2##(2008-9#2)
that grow##4##2##(2008-10#2)(2008-4#1)(2011-2#1)
that grows##2##2##(2008-10#1)(2008-5#1)
that guide##2##2##(2008-10#1)(2008-4#1)
that guided##3##2##(2008-11#1)(2013-1#2)
that habitat##4##2##(2008-10#1)(2008-8#3)
that had a##7##3##(2008-10#2)(2008-11#2)(2008-7#1)(2011-1#2)
that had already been##2##4##(1995-8#1)(2008-12#1)
that had an##3##3##(1991-1#1)(2008-10#2)
that had been inoculated##3##4##(2008-10#3)
that had been previously##3##4##(2008-10#3)
that had been selected for##2##5##(1997-7#1)(2008-8#1)
that had been treated##2##4##(2008-10#2)
that had been##39##3##(1992-1#1)(1993-6#2)(1994-8#1)(1996-12#3)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
that had fed on##3##4##(2008-10#3)
that had no##2##3##(1992-9#1)(1995-2#1)
that had not##4##3##(2008-10#3)(2008-11#1)
that had previously learned the task at##2##7##(1994-8#2)
that had the##2##3##(2008-10#1)(2010-4#1)
that had to##2##3##(2008-11#1)(2013-1#1)
that had##99##2##(1991-1#1)(1992-1#1)(1992-9#2)(1993-6#2)(1993-8#1)(1994-8#3)(1995-2#1)(1995-8#1)(1996-12#4)(1997-3#3)(1997-7#1)(2008-1#1)(2008-10#43)(2008-11#8)(2008-12#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2010-4#1)(2010-6#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
that hair##2##2##(2008-5#2)
that has a##9##3##(1992-12#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-3#1)
that has already been##8##4##(1994-8#1)(2008-11#6)(2012-3#1)
that has an##2##3##(1993-3#1)(2009-1#1)
that has become##2##3##(1995-1#1)(2008-10#1)
that has been developed for the##3##6##(2008-10#2)(2008-11#1)
that has been developed for##5##5##(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)
that has been developed##7##4##(2008-10#4)(2008-11#1)(2008-3#1)(2010-10#1)
that has been employed##2##4##(1996-1#1)(2008-12#1)
that has been previously##2##4##(2008-10#1)(2009-8#1)
that has been reported##2##4##(2008-10#1)(2010-7#1)
that has been shown##2##4##(1990-12#1)(2013-8#1)
that has been used in the##2##6##(1994-5#1)(2008-9#1)
that has been used to##2##5##(1996-1#1)(2012-2#1)
that has been used##4##4##(1994-5#1)(1996-1#1)(2008-9#1)(2012-2#1)
that has been##41##3##(1990-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1996-1#3)(1996-12#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#1)(2012-2#3)(2013-8#1)
that has emerged as##2##4##(2008-6#1)(2013-8#1)
that has emerged##3##3##(1994-12#1)(2008-6#1)(2013-8#1)
that has generated much##2##4##(1997-2#1)(2013-1#1)
that has its roots##2##4##(2008-9#1)(2013-8#1)
that has its##3##3##(1995-3#1)(2008-9#1)(2013-8#1)
that has not been described##2##5##(2008-10#1)(2008-11#1)
that has not been##4##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
that has not##7##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
that has only##2##3##(1990-11#1)(2011-2#1)
that has previously been##2##4##(1993-12#1)(2008-7#1)
that has received##2##3##(2008-10#1)(2008-6#1)
that has recently been##4##4##(1993-1#1)(1994-12#2)(2008-10#1)
that has recently##5##3##(1993-1#1)(1994-12#2)(2008-10#1)(2008-11#1)
that has remained##2##3##(1994-11#1)(2008-10#1)
that has the##4##3##(1997-3#1)(2008-12#1)(2011-2#1)(2011-7#1)
that has to be##4##4##(1993-11#1)(1994-3#1)(2008-10#1)(2008-11#1)
that has##137##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#3)(1996-12#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#23)(2008-11#20)(2008-12#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#3)(2009-1#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
that have a##9##3##(1993-3#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)
that have an##4##3##(1997-2#1)(2008-11#1)(2008-4#1)(2009-7#1)
that have arisen from##2##4##(1995-3#1)(2010-11#1)
that have arisen##3##3##(1995-3#1)(1997-7#1)(2010-11#1)
that have become##2##3##(2008-7#1)(2009-6#1)
that have been conducted##2##4##(2008-10#1)(2008-6#1)
that have been described##3##4##(2008-5#1)(2008-7#1)(2009-10#1)
that have been developed for##4##5##(2008-10#1)(2008-11#1)(2008-4#1)(2010-7#1)
that have been developed##7##4##(2008-10#2)(2008-11#1)(2008-4#2)(2009-7#1)(2010-7#1)
that have been encountered##2##4##(2008-8#1)(2008-9#1)
that have been made to##2##5##(1991-1#1)(2008-11#1)
that have been made##4##4##(1991-1#1)(2008-11#1)(2008-2#1)(2008-7#1)
that have been observed##2##4##(1994-6#1)(2008-10#1)
that have been proposed for##2##5##(2008-10#1)(2008-3#1)
that have been recently##2##4##(2008-4#1)(2010-11#1)
that have been reported##2##4##(2008-10#1)(2010-10#1)
that have been shown to##3##5##(1997-1#1)(2008-4#1)(2010-12#1)
that have been specifically##2##4##(1996-1#1)(2008-3#1)
that have been taken##3##4##(1996-1#1)(2008-11#1)(2012-3#1)
that have been used for##2##5##(2008-4#1)(2012-2#1)
that have been used##6##4##(2008-10#1)(2008-11#1)(2008-4#2)(2010-4#1)(2012-2#1)
that have been##88##3##(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#3)(1995-3#1)(1996-1#2)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#3)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
that have broad##2##3##(2008-2#1)(2012-3#1)
that have contributed to the##2##5##(1996-2#1)(2010-8#1)
that have emerged##2##3##(2008-11#2)
that have evaluated##2##3##(2008-6#1)(2008-7#1)
that have good##2##3##(1997-1#1)(2008-5#1)
that have had##3##3##(2008-10#1)(2011-2#1)(2011-3#1)
that have led to the##2##5##(2008-11#1)(2010-10#1)
that have led to##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
that have not been##4##4##(2008-10#1)(2008-7#1)(2009-6#1)(2010-1#1)
that have not yet been##2##5##(2008-10#1)(2008-6#1)
that have not yet##3##4##(1997-3#1)(2008-10#1)(2008-6#1)
that have not##8##3##(1997-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)
that have occurred during the##2##5##(2008-10#2)
that have occurred in the##2##5##(2008-11#1)(2010-12#1)
that have occurred in##3##4##(2008-11#2)(2010-12#1)
that have occurred##6##3##(2008-10#2)(2008-11#2)(2010-12#1)(2011-2#1)
that have previously##2##3##(2007-12#1)(2009-6#1)
that have shaped##2##3##(1994-1#1)(2013-1#1)
that have shown promise##2##4##(2008-10#1)(2010-10#1)
that have shown##4##3##(2008-10#2)(2008-12#1)(2010-10#1)
that have specific##2##3##(2009-12#1)(2009-6#1)
that have taken place in##2##5##(1991-3#1)(2008-2#1)
that have the potential to##3##5##(2008-12#1)(2012-12#1)(2012-2#1)
that have the##7##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)(2012-2#2)
that have to be##2##4##(2008-10#2)
that have##229##2##(1991-1#1)(1991-12#1)(1991-3#3)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#5)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#40)(2008-11#16)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#8)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-6#4)(2009-7#2)(2010-1#2)(2010-10#8)(2010-11#2)(2010-12#5)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#3)
that having a##2##3##(2008-11#1)(2010-2#1)
that having##3##2##(2008-11#1)(2010-2#1)(2012-12#1)
that he had##2##3##(1995-6#2)
that he would##3##3##(1995-12#1)(1995-6#2)
that he##16##2##(1990-11#1)(1991-6#1)(1993-5#1)(1995-12#2)(1995-6#4)(1996-5#3)(2008-12#1)(2008-4#1)(2008-6#1)(2010-8#1)
that health care is##2##4##(1993-3#1)(1997-5#1)
that health care organizations##2##4##(1994-1#1)(2010-7#1)
that health care##9##3##(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-5#1)(2010-7#1)(2010-8#1)
that health##13##2##(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-7#1)(2010-8#1)
that healthcare##2##2##(1994-3#1)(1996-1#1)
that help##4##2##(1992-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
that helps##3##2##(1993-3#1)(2011-2#2)
that hemi-fusion##2##2##(1991-5#2)
that hemin##2##2##(2008-10#2)
that her##5##2##(1991-12#1)(1994-12#1)(2011-2#1)(2013-1#2)
that herbivores##2##2##(2008-8#1)(2008-9#1)
that high levels of##6##4##(2008-10#2)(2008-8#1)(2009-8#1)(2010-1#1)(2013-8#1)
that high##19##2##(1992-6#1)(2008-10#6)(2008-11#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
that high-sensitivity##2##2##(2008-3#1)(2013-1#1)
that higher levels of##2##4##(2008-10#1)(2012-3#1)
that higher##16##2##(1992-3#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
that highly##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
that his##7##2##(1991-6#1)(1992-3#1)(1995-12#2)(1995-6#1)(2008-10#1)(2011-2#1)
that histamine##2##2##(1995-12#1)(2008-12#1)
that homocysteine##2##2##(1992-9#2)
that hope##2##2##(2008-11#1)(2010-10#1)
that horizontal##4##2##(2008-10#3)(2009-6#1)
that hormesis##2##2##(2008-7#2)
that hospital##3##2##(1992-1#1)(1992-12#1)(2008-11#1)
that hospitals##3##2##(1995-12#1)(1997-1#1)(2008-11#1)
that host##3##2##(2008-10#3)
that human##20##2##(1990-5#1)(1991-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#1)
that humans are##2##3##(2008-10#1)(2012-2#1)
that humans##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
that hybridization##2##2##(2008-3#1)(2008-8#1)
that hybridized##2##2##(2008-10#2)
that hydraulic and mechanical##2##4##(2009-8#2)
that hydraulic##3##2##(2009-8#2)(2010-6#1)
that hydrolyze##2##2##(1991-3#1)(1992-3#1)
that hypothesis##2##2##(1995-5#1)(2008-10#1)
that identification##2##2##(1991-3#1)(2013-1#1)
that identified##2##2##(1992-3#1)(2011-2#1)
that identifies the##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
that identify##3##2##(1994-5#1)(1995-2#1)(2008-10#1)
that if the spatial##2##4##(2008-10#1)(2008-8#1)
that if the##8##3##(1990-9#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
that if##17##2##(1990-9#1)(1994-2#2)(1994-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#2)
that ignore##3##2##(1994-1#2)(2008-8#1)
that illustrate the##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
that illustrate##4##2##(2008-11#1)(2008-9#1)(2010-11#1)(2012-2#1)
that immature CEs##2##3##(2008-5#2)
that immune##3##2##(2008-10#1)(2008-8#1)(2010-3#1)
that immunization##2##2##(1995-2#1)(1996-12#1)
that impact on##3##3##(2008-11#1)(2009-12#1)(2011-1#1)
that impact the##3##3##(2008-10#2)(2008-7#1)
that impact upon##2##3##(2008-12#2)
that impact##13##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
that impair##2##2##(2008-10#1)(2008-9#1)
that implementation##2##2##(1994-1#1)(1995-2#1)
that implicit##2##2##(2009-9#1)(2010-10#1)
that important##4##2##(1992-5#1)(1994-11#1)(2008-11#1)(2008-9#1)
that improve##3##2##(1996-3#1)(2008-8#1)(2010-1#1)
that improved##4##2##(1994-3#1)(2008-10#1)(2008-12#1)(2009-8#1)
that improves the##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
that improves##5##2##(1997-2#1)(2008-10#1)(2008-8#2)(2013-1#1)
that impulse activity##2##3##(2008-5#2)
that in a##10##3##(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-2#1)
that in addition to its##2##5##(2008-4#1)(2008-5#1)
that in addition to##6##4##(1994-5#1)(2008-10#3)(2008-4#1)(2008-5#1)
that in all##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that in an##2##3##(1996-1#1)(2008-9#1)
that in aqueous##2##3##(2008-10#2)
that in both##2##3##(1997-2#1)(2008-11#1)
that in cases##2##3##(2008-10#1)(2010-6#1)
that in contrast to##2##4##(1995-2#1)(2008-7#1)
that in control##2##3##(2008-10#2)
that in infected##3##3##(2008-10#3)
that in many cases##2##4##(2009-10#1)(2011-2#1)
that in many##3##3##(2008-8#1)(2009-10#1)(2011-2#1)
that in most##3##3##(2008-9#1)(2009-8#1)(2012-3#1)
that in normal##2##3##(1995-8#1)(2008-7#1)
that in order to##3##4##(2008-10#1)(2008-11#2)
that in order##4##3##(2008-10#1)(2008-11#2)(2010-9#1)
that in other##5##3##(1991-10#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-2#1)
that in plants##2##3##(1994-11#1)(2008-12#1)
that in some cases##2##4##(2008-10#2)
that in some##3##3##(2008-10#3)
that in spite of the##2##5##(1992-9#1)(2008-10#1)
that in such##2##3##(2007-11#1)(2008-12#1)
that in susceptible##2##3##(2008-10#2)
that in the absence of##9##5##(1990-2#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-3#1)
that in the control group(p&lt##2##5##(1994-12#2)
that in the control##3##4##(1994-12#2)(2008-9#1)
that in the developing##2##4##(1994-8#1)(2008-9#1)
that in the near future##2##5##(2008-1#1)(2009-8#1)
that in the presence of##7##5##(1993-8#1)(1997-1#1)(2008-10#3)(2008-11#1)(2013-1#1)
that in the present##3##4##(1992-5#1)(2008-10#1)(2011-2#1)
that in the process of##2##5##(1990-5#1)(2013-1#1)
that in the wild-type and the mock-transduced cells##2##8##(2008-8#2)
that in the##79##3##(1990-2#1)(1990-5#2)(1991-5#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-8#1)(1997-1#2)(1997-5#1)(2008-1#1)(2008-10#17)(2008-11#10)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#4)(2011-3#1)(2013-1#3)(2013-7#1)
that in these solvents##2##4##(2008-10#2)
that in this##5##3##(1993-6#1)(1996-3#1)(2008-11#1)(2013-1#2)
that in turn##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
that in vitro##7##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)
that in water##3##3##(2008-10#3)
that in wild type##2##4##(2008-8#1)(2008-9#1)
that in wild##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
that in young animals##2##4##(2008-7#2)
that in young##3##3##(2008-7#2)(2013-7#1)
that in##289##2##(1990-2#1)(1990-5#4)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#7)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#4)(1997-2#2)(1997-5#1)(1997-7#4)(1997-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#76)(2008-11#35)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#11)(2008-8#13)(2008-9#16)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
that inbreeding depression##2##3##(2008-8#1)(2008-9#1)
that inbreeding##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
that incidence##2##2##(1994-9#1)(2008-10#1)
that include the##2##3##(2008-10#1)(2008-7#1)
that include those##2##3##(2008-10#1)(2010-6#1)
that include##20##2##(1992-3#1)(1993-11#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2010-6#1)(2011-2#2)(2013-1#2)
that included a##4##3##(1992-6#1)(1997-1#1)(2008-10#1)(2008-12#1)
that included the##3##3##(1991-2#1)(2008-10#1)(2012-3#1)
that included##35##2##(1990-9#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1997-1#2)(2008-10#8)(2008-11#1)(2008-12#3)(2008-6#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#1)
that includes a##3##3##(1990-8#1)(1991-9#1)(2011-3#1)
that includes local##2##3##(2008-11#1)(2008-8#1)
that includes the##5##3##(1997-3#1)(1997-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
that includes##27##2##(1990-8#1)(1991-9#1)(1992-1#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-3#1)(2012-3#1)
that inclusion of##4##3##(1992-2#1)(1993-3#1)(1995-12#1)(2008-3#1)
that incorporate##7##2##(1996-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
that incorporates a##2##3##(1995-2#1)(2008-3#1)
that incorporates an##2##3##(1992-2#1)(2008-10#1)
that incorporates the##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
that incorporates##14##2##(1992-2#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2012-3#1)
that incorporating##2##2##(2008-10#1)(2012-3#1)
that increase risk##2##3##(2009-12#2)
that increase the##5##3##(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)
that increase##11##2##(1993-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-12#2)(2010-7#1)(2012-2#1)(2013-1#1)
that increased food intake may##2##5##(2009-12#2)
that increased skin##2##3##(1997-3#1)(2008-5#1)
that increased##25##2##(1991-9#1)(1992-3#1)(1994-8#2)(1995-11#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-4#1)(2009-7#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-6#1)(2013-1#1)(2013-8#1)
that increases in##3##3##(1997-1#1)(2008-10#1)(2011-2#1)
that increases the##2##3##(2008-6#1)(2008-8#1)
that increases##9##2##(1994-11#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#1)
that increasing salinity##2##3##(2008-12#1)(2009-8#1)
that increasing the##4##3##(2008-8#1)(2008-9#2)(2012-3#1)
that increasing##17##2##(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#4)(2008-9#2)(2009-5#2)(2009-8#1)(2011-2#1)(2012-3#1)
that indicate that##3##3##(1991-12#1)(2008-8#2)
that indicated that##2##3##(2008-11#1)(2008-7#1)
that indicated##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
that indirect##2##2##(2008-8#1)(2008-9#1)
that individual##14##2##(1995-8#1)(1996-3#1)(1997-6#1)(2006-6#1)(2008-11#3)(2008-12#1)(2008-8#3)(2010-12#1)(2012-12#1)(2013-8#1)
that individuals are##3##3##(1996-2#1)(2008-8#1)(2011-2#1)
that individuals with##3##3##(2010-2#1)(2012-2#1)(2012-3#1)
that individuals##15##2##(1991-12#1)(1996-2#1)(2008-1#1)(2008-8#6)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#1)
that induce a##2##3##(2008-10#2)
that induce##8##2##(1994-5#1)(1997-1#1)(2008-10#4)(2008-4#1)(2009-7#1)
that induced and constitutive##2##4##(2008-8#2)
that induced by##6##3##(1994-11#1)(1995-3#1)(1995-9#1)(1997-4#1)(2008-10#1)(2008-11#1)
that induced resistance is##3##4##(2008-10#3)
that induced resistance##4##3##(2008-10#4)
that induced##16##2##(1991-5#1)(1994-11#1)(1995-3#1)(1995-9#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-8#2)(2012-2#1)
that induces##9##2##(1993-12#1)(1995-8#1)(2008-10#3)(2009-8#1)(2013-1#2)(2013-8#1)
that induction of the##3##4##(1995-6#1)(2008-10#2)
that induction of##6##3##(1994-8#1)(1995-6#1)(2008-10#4)
that infect##9##2##(2008-10#7)(2012-2#1)(2013-1#1)
that infection of tobacco##2##4##(2008-10#1)(2012-2#1)
that infection of##4##3##(2008-10#3)(2012-2#1)
that infection with##2##3##(2008-10#1)(2011-2#1)
that infection##9##2##(1990-3#1)(2008-10#6)(2011-2#1)(2012-2#1)
that infections##2##2##(2008-10#2)
that infects##2##2##(2008-10#2)
that inflammatory##2##2##(2009-10#1)(2010-1#1)
that influence the##20##3##(1991-11#1)(1993-11#1)(1995-2#1)(1995-9#1)(2008-10#8)(2008-11#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-4#1)(2011-1#1)(2013-8#1)
that influence their##2##3##(2008-11#1)(2008-8#1)
that influence##41##2##(1991-11#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#3)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
that influenced the##4##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
that influenced##8##2##(1991-2#1)(1991-6#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-11#1)
that influenza##2##2##(2013-1#1)(2013-8#1)
that information on##2##3##(1997-3#1)(2008-10#1)
that information to##2##3##(2008-11#1)(2008-7#1)
that information##7##2##(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-11#1)
that inhibit##8##2##(1996-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
that inhibited##4##2##(1990-5#1)(1994-3#1)(2008-10#1)(2008-9#1)
that inhibition by##2##3##(1990-5#1)(1994-8#1)
that inhibition of##7##3##(1991-1#1)(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-5#1)(2011-3#1)
that inhibition##10##2##(1990-5#1)(1991-1#1)(1993-3#1)(1994-11#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-3#1)
that inhibitory##2##2##(2008-11#1)(2011-2#1)
that inhibits the##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
that inhibits##9##2##(1993-8#1)(1997-6#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-7#1)
that initial##3##2##(2008-10#2)(2008-12#1)
that initially##5##2##(1994-12#1)(2008-10#2)(2009-10#1)(2012-3#1)
that initiate##2##2##(1994-11#1)(2008-2#1)
that initiates##2##2##(2008-10#1)(2012-3#1)
that initiation##2##2##(2011-2#1)(2013-8#1)
that innovative##2##2##(2008-12#1)(2012-3#1)
that inoculated##3##2##(2008-10#2)(2008-8#1)
that inoculum##4##2##(2008-10#4)
that insulin##4##2##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
that intact##3##2##(1997-3#1)(2008-12#1)(2009-6#1)
that integrate##3##2##(2008-12#1)(2008-4#1)(2013-1#1)
that integrates##5##2##(1993-3#1)(1995-12#1)(2008-10#1)(2009-10#1)(2010-9#1)
that integration of HPV-16 DNA##2##5##(1995-2#2)
that integration of##3##3##(1995-2#2)(2008-3#1)
that integration##4##2##(1995-2#2)(2008-11#1)(2008-3#1)
that integrins##3##2##(1995-2#2)(2008-7#1)
that interact with##4##3##(2008-10#1)(2008-8#1)(2009-9#1)(2013-8#1)
that interact##5##2##(2008-10#2)(2008-8#1)(2009-9#1)(2013-8#1)
that interaction of##2##3##(1994-12#1)(2008-10#1)
that interaction##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
that interactions are##2##3##(1991-8#1)(2012-3#1)
that interactions##7##2##(1991-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2012-3#1)
that interfacial##3##2##(1991-5#1)(2009-11#1)(2009-3#1)
that interfere with##3##3##(2010-6#1)(2012-2#1)(2012-3#1)
that interfere##4##2##(2008-10#1)(2010-6#1)(2012-2#1)(2012-3#1)
that interfered with##2##3##(1993-6#1)(2008-10#1)
that interference##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
that interferes with##3##3##(1997-6#1)(2006-6#1)(2008-10#1)
that internal##4##2##(1991-10#1)(1992-12#1)(2008-10#1)(2009-4#1)
that interpartner conflict##2##3##(2009-9#2)
that interventions##2##2##(1996-12#1)(2009-6#1)
that intraarterial##2##2##(1994-11#1)(1994-3#1)
that intracellular##7##2##(1993-6#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-8#2)
that intraoperative##2##2##(2008-7#1)(2010-7#1)
that intrinsically##2##2##(1992-1#1)(2008-11#1)
that introduce##2##2##(1993-2#1)(2010-3#1)
that introduced##3##2##(2008-10#2)(2008-11#1)
that introduction of##4##3##(2008-10#2)(2008-11#1)(2009-8#1)
that investigated##2##2##(2008-10#1)(2010-3#1)
that investigates the##2##3##(2008-7#1)(2008-8#1)
that investigates##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
that investigators##4##2##(2008-10#1)(2008-9#1)(2009-4#1)(2010-8#1)
that involve the##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
that involve##17##2##(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
that involved##6##2##(2008-10#1)(2008-11#3)(2008-9#1)(2013-1#1)
that involves a##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
that involves##18##2##(1995-2#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
that ionic##2##2##(2008-10#2)
that ionizing radiation##2##3##(1995-8#1)(2008-7#1)
that ionizing##3##2##(1995-12#1)(1995-8#1)(2008-7#1)
that iron and##2##3##(2008-10#1)(2011-2#1)
that iron could##2##3##(1996-2#2)
that iron##6##2##(1996-2#2)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)
that is a##11##3##(1990-3#1)(1993-1#1)(1994-11#1)(1996-12#1)(2008-10#3)(2008-3#1)(2009-12#1)(2010-8#1)(2011-2#1)
that is able to##3##4##(1995-11#1)(2008-5#1)(2010-5#1)
that is absent in##2##4##(1993-2#1)(2008-3#1)
that is absorbed##2##3##(2008-3#1)(2012-2#1)
that is accessible##2##3##(2008-12#1)(2010-8#1)
that is also##2##3##(1997-8#1)(2008-10#1)
that is applicable##2##3##(2008-10#1)(2008-3#1)
that is as##2##3##(2008-10#1)(2008-9#1)
that is associated with##4##4##(1993-6#1)(2008-10#1)(2008-7#1)(2012-3#1)
that is associated##5##3##(1993-6#1)(2008-10#2)(2008-7#1)(2012-3#1)
that is available##4##3##(1992-9#1)(2008-2#1)(2008-9#1)(2013-8#1)
that is based on a##2##5##(2008-10#1)(2008-3#1)
that is based on the##2##5##(1992-8#1)(2008-3#1)
that is based on##8##4##(1992-8#1)(2008-10#2)(2008-3#5)
that is based##9##3##(1992-8#1)(1997-1#1)(2008-10#2)(2008-3#5)
that is being##2##3##(1996-2#1)(2008-7#1)
that is believed to##2##4##(2008-10#1)(2008-7#1)
that is both##2##3##(2012-2#1)(2012-3#1)
that is capable of##8##4##(1993-12#1)(2008-11#1)(2008-3#2)(2010-1#1)(2012-2#2)(2013-1#1)
that is characteristic of##5##4##(1996-12#1)(2008-10#2)(2008-11#1)(2009-8#1)
that is characterized by##5##4##(1994-5#1)(2008-12#1)(2008-4#1)(2010-6#1)(2011-1#1)
that is characterized##7##3##(1994-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-1#1)
that is clinically##2##3##(2008-7#1)(2008-9#1)
that is closely##2##3##(2008-10#1)(2009-5#1)
that is commonly used##2##4##(2008-8#1)(2011-2#1)
that is comparable##2##3##(2008-10#1)(2008-3#1)
that is conserved##3##3##(1993-9#1)(1995-2#1)(1995-6#1)
that is consistent with##6##4##(2008-10#3)(2008-3#1)(2008-9#2)
that is critical for##3##4##(2008-5#1)(2008-9#1)(2009-8#1)
that is currently##3##3##(1993-12#1)(2008-11#1)(2008-3#1)
that is delivered##2##3##(1997-2#1)(2009-8#1)
that is derived from##2##4##(2008-2#1)(2013-1#1)
that is different from all##2##5##(1993-12#1)(2008-10#1)
that is different from##3##4##(1993-12#1)(2008-10#2)
that is directly##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
that is distinct from##2##4##(2008-10#1)(2010-12#1)
that is due to the##4##5##(2008-2#1)(2008-3#3)
that is due to##14##4##(1993-3#1)(2007-11#1)(2008-2#3)(2008-3#9)
that is easily##2##3##(2008-10#2)
that is essential##2##3##(2008-10#1)(2012-3#1)
that is expressed##4##3##(1993-12#1)(1997-7#1)(2008-1#1)(2008-11#1)
that is extremely##2##3##(2008-10#1)(2009-5#1)
that is formed##3##3##(1994-5#1)(2008-10#2)
that is free##2##3##(1991-12#1)(2008-3#1)
that is functionally##2##3##(2008-11#1)(2009-8#1)
that is going to##2##4##(2008-7#1)(2011-2#1)
that is highly selective to##2##5##(2008-10#2)
that is highly selective##3##4##(2008-10#3)
that is highly##6##3##(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)
that is important to##2##4##(1994-2#1)(2009-11#1)
that is important##4##3##(1994-2#1)(2009-11#1)(2013-1#2)
that is in##2##3##(1994-5#1)(2012-2#1)
that is independent of##3##4##(1995-2#1)(2007-11#1)(2008-11#1)
that is indistinguishable from##2##4##(1993-12#1)(2008-7#1)
that is inherent in##3##4##(2008-3#1)(2011-2#1)(2012-3#1)
that is involved in##4##4##(1995-11#1)(1995-6#1)(2010-11#1)(2013-8#1)
that is known to be##2##5##(1996-2#1)(1997-8#1)
that is known to##4##4##(1996-2#2)(1997-8#1)(2008-3#1)
that is largely##2##3##(1994-5#1)(1997-3#1)
that is likely to##2##4##(1991-7#1)(2008-7#1)
that is located##2##3##(2009-8#1)(2011-2#1)
that is measured at##2##4##(2008-10#1)(2008-3#1)
that is more##7##3##(1996-9#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#2)
that is most##3##3##(1994-3#1)(2008-10#1)(2013-8#1)
that is necessary##2##3##(2008-11#1)(2008-3#1)
that is needed##2##3##(1993-6#1)(1994-1#1)
that is normally##2##3##(1993-1#1)(2008-10#1)
that is not predicted by##2##5##(1996-12#1)(2012-2#1)
that is not##18##3##(1991-1#2)(1994-11#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
that is often associated with##2##5##(2008-4#1)(2009-9#1)
that is often##9##3##(1996-2#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
that is open to##2##4##(1995-5#1)(2008-3#1)
that is possible##2##3##(1995-5#1)(2008-3#1)
that is predictive##2##3##(2012-3#1)(2013-8#1)
that is present in the##2##5##(1994-5#1)(2008-3#1)
that is present in##3##4##(1994-5#1)(2008-3#1)(2011-2#1)
that is produced##2##3##(1990-8#1)(2008-7#1)
that is rarely##2##3##(2008-5#1)(2011-2#1)
that is related to##2##4##(1990-8#1)(2008-4#1)
that is relevant##2##3##(2008-3#2)
that is required for the##2##5##(1995-12#1)(2008-9#1)
that is required for##12##4##(1991-12#1)(1993-12#1)(1995-12#1)(1995-2#2)(2008-3#1)(2008-9#2)(2009-10#2)(2009-8#1)(2013-7#1)
that is required##14##3##(1991-12#1)(1993-12#1)(1995-12#1)(1995-2#2)(2008-3#2)(2008-5#1)(2008-9#2)(2009-10#2)(2009-8#1)(2013-7#1)
that is responsible for##3##4##(1991-5#1)(1992-12#1)(2008-3#1)
that is seen##2##3##(2012-3#1)(2013-1#1)
that is similar to##2##4##(2008-10#1)(2012-3#1)
that is similar##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
that is smaller than##2##4##(1996-6#1)(2013-1#1)
that is specific##2##3##(2008-10#1)(2011-1#1)
that is still##3##3##(1994-1#1)(2008-10#1)(2012-3#1)
that is suitable for##2##4##(2008-10#1)(2008-3#1)
that is the question##2##4##(1994-3#1)(1996-1#1)
that is the##10##3##(1991-6#1)(1994-3#2)(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-5#1)
that is to##2##3##(2008-7#1)(2010-8#1)
that is used by##2##4##(1990-12#1)(2012-3#1)
that is used##5##3##(1990-12#1)(2008-10#1)(2008-3#2)(2012-3#1)
that is useful##2##3##(2008-2#1)(2011-2#1)
that is usually##6##3##(1991-6#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-1#1)
that is widely##2##3##(2008-10#2)
that is##537##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-8#2)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#4)(1993-12#7)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#6)(1994-6#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#7)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#6)(1997-8#2)(1997-9#1)(2007-11#5)(2007-12#6)(2008-1#1)(2008-10#92)(2008-11#19)(2008-12#5)(2008-2#14)(2008-3#62)(2008-4#7)(2008-5#10)(2008-6#2)(2008-7#18)(2008-8#10)(2008-9#22)(2009-10#5)(2009-11#3)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#9)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#15)(2012-12#1)(2012-2#16)(2012-3#18)(2013-1#14)(2013-7#3)(2013-8#10)
that ischemia##2##2##(1993-6#2)
that isocratic##2##2##(2008-10#2)
that isolated##2##2##(2008-10#1)(2012-2#1)
that isolates from##2##3##(2008-10#2)
that isolates of##5##3##(2008-10#5)
that isolates##12##2##(2008-10#10)(2011-2#1)(2012-2#1)
that it becomes a##2##4##(2008-11#1)(2008-8#1)
that it becomes##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that it can be used as##3##6##(2008-11#1)(2008-3#1)(2013-1#1)
that it can be##5##4##(1993-3#1)(1995-9#1)(2008-11#1)(2008-3#1)(2013-1#1)
that it can promote##2##4##(2010-6#1)(2013-8#1)
that it can##11##3##(1993-3#1)(1995-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2010-6#1)(2013-1#1)(2013-8#1)
that it contained##3##3##(1991-9#1)(1995-12#1)(2008-10#1)
that it could be##3##4##(1992-12#1)(2008-10#1)(2008-3#1)
that it could##8##3##(1990-5#1)(1990-6#1)(1992-12#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-3#1)
that it does not##2##4##(2008-11#1)(2009-3#1)
that it does##3##3##(2008-11#1)(2008-9#1)(2009-3#1)
that it encodes##2##3##(1990-12#1)(1994-8#1)
that it exists##2##3##(1991-12#1)(1993-3#1)
that it forms##2##3##(1992-3#1)(2008-1#1)
that it had##3##3##(2008-7#1)(2008-8#1)(2009-7#1)
that it has an important##2##5##(1990-12#1)(1993-12#1)
that it has no##2##4##(2008-7#1)(2010-6#1)
that it has##11##3##(1990-12#1)(1992-8#1)(1993-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)
that it increases##2##3##(1997-4#1)(2008-10#1)
that it is a##8##4##(1993-12#1)(1995-8#1)(1996-12#1)(2008-10#3)(2008-11#1)(2013-1#1)
that it is also##2##4##(1990-3#1)(2010-5#1)
that it is an integral##2##5##(1991-2#1)(2008-7#1)
that it is an##5##4##(1991-2#1)(2008-10#1)(2008-12#2)(2008-7#1)
that it is closely related to##2##6##(1996-12#1)(2008-10#1)
that it is closely related##3##5##(1996-12#1)(2008-10#2)
that it is essential##2##4##(2008-8#1)(2013-8#1)
that it is feasible to##2##5##(2008-10#1)(2011-1#1)
that it is important to##3##5##(2008-10#1)(2008-7#1)(2013-1#1)
that it is more##2##4##(2008-7#1)(2008-8#1)
that it is necessary to##3##5##(1996-12#1)(2008-11#1)(2012-3#1)
that it is necessary##4##4##(1996-12#1)(2008-11#2)(2012-3#1)
that it is not necessary to##2##6##(1997-6#1)(2008-11#1)
that it is not##10##4##(1992-3#1)(1995-6#2)(1997-6#1)(2008-10#2)(2008-11#2)(2010-6#1)(2010-8#1)
that it is only##2##4##(1994-12#1)(2008-10#1)
that it is possible to estimate##2##6##(2008-10#1)(2008-3#1)
that it is possible to##18##5##(1990-5#1)(1994-9#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#4)(2008-7#1)(2011-2#1)(2013-1#1)
that it is simple##2##4##(2009-10#1)(2012-2#1)
that it is the##6##4##(1991-10#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-8#1)
that it is very##2##4##(1993-2#1)(2008-11#1)
that it is##119##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-3#1)(1997-6#1)(2008-10#30)(2008-11#14)(2008-12#3)(2008-3#4)(2008-5#2)(2008-7#7)(2008-8#3)(2009-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#2)
that it may act as a##2##6##(2008-7#1)(2008-8#1)
that it may be a##4##5##(1993-2#1)(2008-10#3)
that it may be an effective##2##6##(2008-11#1)(2008-9#1)
that it may be possible to##3##6##(2008-11#1)(2008-3#1)(2009-4#1)
that it may be##13##4##(1993-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)
that it may play a##2##5##(1991-5#1)(2008-10#1)
that it may play##3##4##(1991-5#1)(2008-10#2)
that it may##27##3##(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-2#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
that it mediates##2##3##(1993-12#1)(2008-5#1)
that it might##3##3##(1990-3#1)(2012-2#2)
that it played##2##3##(2008-10#1)(2008-3#1)
that it plays a##2##4##(1993-8#1)(1997-1#1)
that it provides##2##3##(2008-10#1)(2009-8#1)
that it remains##2##3##(1991-12#1)(2008-6#1)
that it should be possible to##2##6##(2008-3#1)(2008-7#1)
that it should be##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
that it was a##2##4##(1990-5#1)(2008-10#1)
that it was not##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
that it was the##2##4##(1990-6#1)(1994-11#1)
that it was##24##3##(1990-2#2)(1990-5#1)(1990-6#1)(1993-3#1)(1993-6#2)(1994-11#1)(1995-12#2)(1995-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#2)
that it will be##7##4##(1996-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
that it will##9##3##(1993-3#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
that it would be##3##4##(1994-1#2)(2011-2#1)
that it would##5##3##(1994-1#2)(2008-10#1)(2008-11#1)(2011-2#1)
that it##294##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#4)(1992-3#4)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#5)(1993-8#1)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#3)(1995-12#5)(1995-2#3)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#5)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#68)(2008-11#27)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#11)(2013-8#4)
that its use will##2##4##(2010-12#1)(2011-7#1)
that its use##4##3##(2010-12#1)(2010-5#1)(2011-7#1)(2013-8#1)
that its##31##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-3#1)(2013-8#1)
that joint##2##2##(2008-11#1)(2008-12#1)
that juvenile##3##2##(2008-9#1)(2010-8#2)
that keeps##2##2##(2008-10#1)(2008-8#1)
that kills##2##2##(1996-9#1)(2008-9#1)
that knowledge of the##2##4##(2008-3#2)
that knowledge##4##2##(2008-11#1)(2008-3#2)(2012-12#1)
that labeled##2##2##(2008-10#2)
that lack of##2##3##(1995-2#1)(2008-10#1)
that lack##9##2##(1995-2#1)(1997-7#2)(2008-10#2)(2008-7#1)(2009-10#1)(2009-8#1)(2012-3#1)
that lacked the##2##3##(1991-8#1)(2008-10#1)
that lacked##4##2##(1991-8#1)(1992-3#1)(1993-9#1)(2008-10#1)
that lacks the##4##3##(1993-12#1)(2008-8#2)(2009-9#1)
that lactate and##2##3##(1995-8#1)(2008-7#1)
that lambda##2##2##(1992-6#2)
that language##3##2##(2011-1#1)(2013-8#2)
that laparoscopic##3##2##(1993-3#3)
that large amounts of##2##4##(2008-11#2)
that large##5##2##(1990-7#1)(2008-11#2)(2010-4#1)(2012-3#1)
that larger##3##2##(1997-1#1)(2008-9#1)(2010-8#1)
that laser##2##2##(1991-1#1)(1992-3#1)
that lasts##2##2##(2008-7#2)
that latent##3##2##(2008-10#2)(2009-12#1)
that lead latent infection to fruit rot##2##7##(2008-10#2)
that lead to the##5##4##(2008-10#2)(2008-12#1)(2010-10#1)(2012-2#1)
that lead to##19##3##(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
that lead##24##2##(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
that leads to increased##2##4##(2008-8#1)(2008-9#1)
that leads to the##3##4##(1990-5#1)(2009-6#1)(2012-2#1)
that leads to##16##3##(1990-5#1)(1993-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#2)(2011-2#1)(2011-9#1)(2012-2#2)
that leads##17##2##(1990-5#1)(1993-12#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#2)(2011-2#1)(2011-9#1)(2012-2#2)
that leaf##2##2##(2008-10#1)(2012-5#1)
that learning##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
that lecturers##2##2##(2008-11#2)
that led to the##9##4##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-12#1)(2013-8#1)
that led to##11##3##(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-8#1)
that led##13##2##(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-8#1)
that left##2##2##(1997-8#1)(2012-2#1)
that lemon##2##2##(2008-10#1)(2011-2#1)
that leptin##2##2##(2008-4#1)(2013-8#1)
that less than##2##3##(1990-12#1)(1993-12#1)
that less##3##2##(1990-12#1)(1993-12#1)(1996-12#1)
that lettuce##3##2##(2008-10#1)(2008-11#2)
that leukotrienes##2##2##(1994-8#1)(2010-1#1)
that level##2##2##(2008-10#1)(2009-8#1)
that levels##2##2##(2008-11#1)(2009-7#1)
that lies##2##2##(1993-3#1)(2013-8#1)
that life##5##2##(1990-11#1)(1997-6#1)(2008-8#1)(2009-9#1)(2011-2#1)
that ligand##4##2##(1993-8#1)(2008-10#2)(2008-4#1)
that light##2##2##(2008-10#2)
that like##2##2##(1993-8#1)(2009-10#1)
that likely##6##2##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
that limit the##3##3##(2008-2#1)(2008-4#1)(2012-2#1)
that limit##6##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-2#1)
that limits##2##2##(1994-1#1)(2008-3#1)
that linked##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
that links##4##2##(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
that lipid##3##2##(1995-8#1)(2008-4#1)(2008-9#1)
that liquid##2##2##(1995-11#1)(2008-11#1)
that little##6##2##(1991-3#1)(1992-8#1)(1994-5#1)(2008-11#1)(2008-9#1)(2009-8#1)
that live in##2##3##(2008-8#1)(2011-2#1)
that lives in##2##3##(1996-12#1)(2008-10#1)
that local administration of##2##4##(2008-12#1)(2011-2#1)
that local processes##2##3##(2008-9#2)
that local##13##2##(1990-5#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#3)(2009-10#2)(2011-2#3)
that long##4##2##(1991-2#1)(2008-12#1)(2011-2#2)
that long-term##6##2##(1992-11#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
that loss of##7##3##(1995-2#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
that lost##2##2##(2013-1#2)
that low doses of##2##4##(2008-7#2)
that low doses##5##3##(2008-7#5)
that low levels of##2##4##(2008-9#1)(2011-2#1)
that low##19##2##(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#3)(2012-2#2)
that lower##5##2##(1993-6#1)(1996-3#1)(2008-10#2)(2010-6#1)
that lung##2##2##(1994-3#1)(1997-1#1)
that luteal##2##2##(1992-9#1)(2008-9#1)
that lymphocytes##2##2##(1996-12#1)(2011-2#1)
that mRNA of##2##3##(1993-3#1)(2008-6#1)
that mRNA##3##2##(1993-3#1)(2008-6#2)
that macrophages##4##2##(1991-5#1)(1996-12#1)(2008-10#1)(2008-9#1)
that made##2##2##(1994-12#1)(2010-7#1)
that magnetic field##2##3##(2008-9#2)
that magnetic resonance imaging##2##4##(1990-12#1)(2008-7#1)
that magnetic##4##2##(1990-12#1)(2008-7#1)(2008-9#2)
that magnolol##3##2##(2011-2#3)
that maintain##5##2##(1996-12#1)(2008-4#1)(2009-12#2)(2013-7#1)
that maintaining##2##2##(2009-8#1)(2010-9#1)
that maintains##2##2##(2008-6#1)(2008-7#1)
that major##2##2##(1995-11#1)(2008-10#1)
that make it possible to##2##5##(1992-5#1)(2010-3#1)
that make it##7##3##(1992-5#1)(1993-12#1)(1997-2#1)(2008-8#2)(2008-9#1)(2010-3#1)
that make the##2##3##(1996-12#1)(2008-11#1)
that make them##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
that make up the##4##4##(2008-10#2)(2008-8#1)(2011-2#1)
that make up##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
that make##24##2##(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)
that makes##9##2##(1990-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2013-8#1)
that male##8##2##(1990-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
that males##5##2##(2008-8#3)(2009-6#1)(2013-8#1)
that manage##2##2##(1995-12#1)(2008-10#1)
that management of##2##3##(2008-10#2)
that management##5##2##(1993-12#1)(1994-12#1)(2008-10#2)(2008-11#1)
that managers##3##2##(1994-2#1)(1995-12#1)(2013-8#1)
that manifest##2##2##(2011-2#1)(2012-3#1)
that manifests##2##2##(2009-12#1)(2011-2#1)
that manual##2##2##(2008-10#2)
that manufacturers##3##2##(2008-10#2)(2008-11#1)
that many PD patients##2##4##(2008-7#1)(2009-10#1)
that many more##3##3##(1990-2#1)(1992-3#1)(2008-10#1)
that many of the##8##4##(1993-12#1)(1995-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)
that many of these##2##4##(1994-6#1)(2008-10#1)
that many of##12##3##(1990-6#1)(1993-12#1)(1994-6#1)(1995-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)
that many patients##2##3##(2010-12#1)(2011-1#1)
that many##49##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1997-1#1)(1997-5#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-3#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#2)
that mapped##2##2##(2008-10#2)
that marginal##2##2##(2008-10#1)(2011-2#1)
that maspin is##2##3##(1995-6#2)
that maspin##3##2##(1995-6#3)
that mass##2##2##(2008-5#1)(2008-9#1)
that matched##2##2##(2008-10#1)(2012-12#1)
that mate##2##2##(2008-8#2)
that material##2##2##(1990-8#1)(1995-12#1)
that maternal##3##2##(1996-11#1)(2010-8#1)(2012-3#1)
that matrix effects were##2##4##(1997-2#1)(2008-10#1)
that matrix##4##2##(1997-2#1)(2008-10#2)(2008-8#1)
that maturation of CEs was##2##5##(2008-5#2)
that maturation of##3##3##(1995-8#1)(2008-5#2)
that maximizes the##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
that maximizes##7##2##(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#2)
that maximum##2##2##(2008-10#1)(2008-8#1)
that may account for the##3##5##(2008-10#1)(2010-1#1)(2012-3#1)
that may act as a##2##5##(1990-5#1)(2008-10#1)
that may affect the##4##4##(2008-10#2)(2008-11#1)(2008-2#1)
that may affect##7##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2010-11#1)
that may alter##2##3##(2008-8#1)(2009-9#1)
that may arise##3##3##(1997-3#1)(2008-7#1)(2012-2#1)
that may be associated with##3##5##(2008-10#1)(2008-11#1)(2010-10#1)
that may be encountered##3##4##(1996-9#1)(2011-1#1)(2012-2#1)
that may be involved in the##2##6##(1991-1#1)(2008-5#1)
that may be involved in##5##5##(1991-1#1)(1992-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
that may be responsible for##2##5##(2008-7#1)(2011-2#1)
that may be used##3##4##(2008-10#1)(2008-7#1)(2009-11#1)
that may be useful##2##4##(2008-4#1)(2013-8#1)
that may be##60##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
that may cause##3##3##(1993-8#1)(2008-11#1)(2012-2#1)
that may contribute to##5##4##(1992-9#1)(1996-12#1)(2008-11#1)(2009-7#1)(2013-8#1)
that may have been##2##4##(2008-10#1)(2008-9#1)
that may have##5##3##(1992-9#1)(1993-6#1)(2008-10#2)(2008-9#1)
that may help##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
that may impact##2##3##(2007-11#1)(2008-10#1)
that may indicate##2##3##(1993-1#1)(2008-4#1)
that may lead to##6##4##(2008-11#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
that may mediate##2##3##(1991-5#1)(1995-6#1)
that may not be##2##4##(2008-10#1)(2013-1#1)
that may not##3##3##(2008-10#1)(2013-1#2)
that may occur during##2##4##(2010-8#1)(2013-1#1)
that may occur##5##3##(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
that may or may not be##2##6##(2010-1#1)(2013-1#1)
that may play a role in the##2##7##(2012-2#2)
that may play a##3##4##(2010-12#1)(2012-2#2)
that may play##5##3##(1995-11#1)(1997-1#1)(2010-12#1)(2012-2#2)
that may reduce##2##3##(2008-10#1)(2011-2#1)
that may represent##2##3##(1995-11#1)(2012-2#1)
that may result from##3##4##(1995-9#1)(2008-11#1)(2008-5#1)
that may result in##5##4##(1993-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
that may result##8##3##(1993-3#1)(1995-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
that may serve as##2##4##(2010-11#1)(2013-1#1)
that may underlie the##2##4##(1994-8#1)(2012-12#1)
that may underlie##4##3##(1990-8#1)(1994-8#1)(2010-10#1)(2012-12#1)
that may##194##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(2006-5#1)(2007-11#2)(2008-1#1)(2008-10#31)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#7)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#13)(2012-3#5)(2013-1#9)(2013-8#6)
that mean antibody values##2##4##(2011-2#2)
that mean##5##2##(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
that meaningful##2##2##(1994-2#1)(2010-12#1)
that means##2##2##(2008-10#1)(2010-1#1)
that measure##3##2##(2008-4#1)(2008-9#1)(2010-12#1)
that measured in the##2##4##(1990-5#1)(1996-2#1)
that measured in##3##3##(1990-5#1)(1996-2#1)(2012-3#1)
that measured the##2##3##(2008-10#1)(2008-5#1)
that measured##11##2##(1990-5#1)(1992-9#1)(1996-2#1)(2008-10#5)(2008-5#1)(2012-3#1)(2013-8#1)
that measurement of##6##3##(1990-2#1)(1990-8#1)(1994-12#1)(1996-6#1)(2008-12#1)(2013-1#1)
that measurement##8##2##(1990-2#1)(1990-8#1)(1994-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
that measures the##2##3##(2008-10#1)(2008-3#1)
that measures##6##2##(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#2)
that mechanical##3##2##(1990-12#1)(2007-8#1)(2012-2#1)
that mechanisms##2##2##(2008-10#1)(2008-8#1)
that mediate the##3##3##(1995-2#1)(1996-2#1)(2009-8#1)
that mediate##9##2##(1993-8#1)(1995-2#1)(1996-2#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
that mediates##8##2##(1992-9#1)(1993-12#1)(1995-2#1)(1997-7#1)(2008-11#1)(2012-2#1)(2013-1#2)
that medical##3##2##(2010-1#1)(2010-12#1)(2011-2#1)
that meet the##2##3##(1996-3#1)(1997-2#1)
that meet##3##2##(1991-1#1)(1996-3#1)(1997-2#1)
that meets the##2##3##(1997-3#1)(2008-10#1)
that meets##3##2##(1997-3#1)(2008-10#1)(2008-3#1)
that memory##3##2##(2008-7#1)(2008-8#1)(2009-10#1)
that men##4##2##(2008-11#1)(2009-5#1)(2010-10#1)(2011-2#1)
that mental##2##2##(2008-12#1)(2013-8#1)
that merit##2##2##(1991-1#1)(2012-2#1)
that met##2##2##(2012-3#1)(2013-1#1)
that metabolic##2##2##(2008-8#1)(2011-2#1)
that methods##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
that miRNAs may##2##3##(2011-2#2)
that miRNAs##3##2##(2010-7#1)(2011-2#2)
that mice##2##2##(2012-2#2)
that might be employed##2##4##(1992-12#1)(2008-11#1)
that might be##14##3##(1990-12#1)(1991-1#1)(1992-12#1)(1993-12#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
that might benefit from##2##4##(2008-10#1)(2012-7#1)
that might have##2##3##(2008-10#1)(2008-11#1)
that might help##2##3##(2009-1#1)(2009-12#1)
that might influence##3##3##(1993-1#1)(2010-2#1)(2012-3#1)
that might##40##2##(1990-12#1)(1991-1#1)(1992-12#2)(1993-1#1)(1993-12#2)(1993-8#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#1)
that migraine##2##2##(2008-9#2)
that migration##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
that mimic the##4##3##(1997-6#1)(2008-11#1)(2008-5#1)(2009-7#1)
that mimic##8##2##(1997-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#1)(2013-8#1)
that minimize the##2##3##(2008-10#1)(2008-6#1)
that minimize##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
that minimizes##4##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
that minor##3##2##(2008-10#2)(2013-8#1)
that mitochondrial##2##2##(2009-8#1)(2012-2#1)
that model##2##2##(2008-2#1)(2008-5#1)
that modeling##2##2##(1990-2#1)(2008-7#1)
that models such as##2##4##(2008-12#1)(2008-5#1)
that models##4##2##(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)
that moderate##3##2##(1990-3#1)(2008-3#1)(2011-1#1)
that modulate cellular##2##3##(2008-7#1)(2011-2#1)
that modulate##5##2##(1994-5#1)(1995-8#1)(2008-7#1)(2008-9#1)(2011-2#1)
that modulation##2##2##(1996-2#1)(2008-10#1)
that molar##2##2##(1990-5#1)(2008-10#1)
that molecular##7##2##(1990-11#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
that monitor##2##2##(2008-12#1)(2008-9#1)
that monoclonal antibodies##2##3##(1995-12#1)(2012-2#1)
that monoclonal##4##2##(1995-12#1)(2008-5#1)(2008-8#1)(2012-2#1)
that moral##2##2##(2008-11#1)(2013-8#1)
that more effective##2##3##(1990-12#1)(2012-2#1)
that more frequent##2##3##(2008-5#1)(2009-11#1)
that more than##6##3##(1997-6#2)(2008-10#3)(2012-3#1)
that more##30##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-9#1)(1994-6#1)(1995-1#1)(1997-6#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
that mortality##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
that most closely##2##3##(1994-5#1)(2008-10#1)
that most of the##15##4##(1993-3#1)(1995-12#1)(1996-2#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#3)
that most of these##5##4##(1997-2#1)(1997-3#1)(2008-5#1)(2011-3#1)(2012-3#1)
that most of##22##3##(1993-3#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#3)(2011-3#1)(2012-3#1)
that most patients##5##3##(1990-11#1)(1990-2#1)(1990-3#1)(1997-4#1)(2013-1#1)
that most##61##2##(1990-11#1)(1990-2#2)(1990-3#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
that mothers##5##2##(1991-8#1)(1994-9#1)(2009-9#1)(2011-1#1)(2012-3#1)
that motor##3##2##(2008-7#1)(2010-7#1)(2013-8#1)
that move##2##2##(1993-12#1)(1994-12#1)
that movement##2##2##(1990-11#1)(2008-7#1)
that much of the##2##4##(2012-12#1)(2013-1#1)
that much##6##2##(1993-12#1)(2008-1#1)(2008-11#1)(2010-2#1)(2012-12#1)(2013-1#1)
that multiple infections##3##3##(2008-10#2)(2008-9#1)
that multiple##22##2##(1991-6#1)(1992-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#1)
that music##3##2##(1993-2#1)(2008-11#1)(2008-9#1)
that must be addressed##2##4##(1995-2#1)(2009-12#1)
that must be considered when##2##5##(2008-4#1)(2013-1#1)
that must be considered##3##4##(1997-2#1)(2008-4#1)(2013-1#1)
that must be##14##3##(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-8#1)(2012-3#2)(2013-1#1)
that must##16##2##(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2012-3#2)(2013-1#1)
that mutant##3##2##(1991-5#1)(2008-9#1)(2011-2#1)
that mutants##2##2##(2008-10#2)
that mutation##2##2##(2008-11#1)(2008-8#1)
that mutations##2##2##(1991-12#1)(1995-8#1)
that mycoparasitism##2##2##(2008-10#2)
that natural selection in##2##4##(2008-9#2)
that natural selection##3##3##(2008-9#2)(2009-8#1)
that natural##8##2##(2008-11#1)(2008-8#3)(2008-9#2)(2009-8#1)(2011-2#1)
that naturally##3##2##(2008-10#2)(2008-11#1)
that nearly all##2##3##(2008-5#1)(2010-10#1)
that nearly##4##2##(2008-11#2)(2008-5#1)(2010-10#1)
that necrosis was##2##3##(2008-10#2)
that need further investigation##2##4##(1997-7#1)(2013-1#1)
that need to be addressed to##2##6##(2008-7#1)(2011-2#1)
that need to be addressed##5##5##(1994-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
that need to be considered##2##5##(2009-1#1)(2011-2#1)
that need to be##15##4##(1993-12#1)(1994-2#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-9#2)(2009-1#1)(2011-2#2)
that need##18##2##(1993-12#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)(2011-2#2)(2013-1#1)
that needed to##2##3##(1993-6#1)(2011-1#1)
that needed##3##2##(1990-9#1)(1993-6#1)(2011-1#1)
that negative##2##2##(2008-11#1)(2010-10#1)
that negatively regulate gene expression post-transcriptionally##2##6##(2010-7#1)(2011-2#1)
that negatively##6##2##(2008-10#2)(2008-11#1)(2010-7#2)(2011-2#1)
that neither##9##2##(1991-3#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-8#1)(2008-10#3)(2008-8#1)
that nematodes##2##2##(2008-10#2)
that neoplastic MC##2##3##(2011-2#2)
that neural##2##2##(2009-8#1)(2011-2#1)
that never##2##2##(2008-10#2)
that new##10##2##(1995-2#1)(1996-1#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-7#1)(2012-2#1)
that nicotinic acetylcholine receptor##2##4##(2008-8#2)
that nine##2##2##(1996-8#1)(2008-11#1)
that nitrate##2##2##(2008-10#2)
that nitric oxide##3##3##(1993-3#1)(2008-11#1)(2009-8#1)
that no significant changes##2##4##(2008-11#1)(2011-1#1)
that no significant##6##3##(1992-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
that no single##2##3##(2008-11#1)(2009-8#1)
that no specific##2##3##(1993-8#1)(1994-11#1)
that no##29##2##(1992-3#2)(1993-8#1)(1994-11#1)(1994-8#2)(1996-12#1)(1997-3#1)(2008-10#5)(2008-11#7)(2008-7#2)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
that none of the##2##4##(1990-12#1)(2008-12#1)
that none of##3##3##(1990-12#1)(2008-12#1)(2008-5#1)
that nonlinear##3##2##(2008-8#1)(2009-8#2)
that normal##2##2##(1991-5#1)(2006-6#1)
that normally occurs##3##3##(1994-11#1)(1995-6#1)(2009-10#1)
that normally##9##2##(1991-9#2)(1994-11#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
that not all of the##2##5##(1994-5#1)(2010-3#1)
that not all##7##3##(1994-5#1)(2008-10#3)(2008-11#1)(2010-3#1)(2012-2#1)
that not only the##5##4##(1992-2#1)(2008-10#2)(2008-11#2)
that not only##10##3##(1992-2#1)(1993-2#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#1)
that not##19##2##(1992-2#1)(1992-3#1)(1993-2#1)(1994-5#1)(1996-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2010-3#1)(2011-2#1)(2012-2#2)
that novel##2##2##(2008-8#1)(2011-2#1)
that now##2##2##(1991-3#1)(2008-10#1)
that nuclear##5##2##(1993-8#1)(2008-7#1)(2008-8#2)(2012-2#1)
that numerous##2##2##(1991-7#1)(1993-6#1)
that nurse##2##2##(2008-11#1)(2008-12#1)
that nurses are drawing##2##4##(2010-8#2)
that nurses are##3##3##(2008-11#1)(2010-8#2)
that nurses must##2##3##(2008-12#1)(2013-8#1)
that nurses##14##2##(1992-3#1)(2008-11#5)(2008-12#1)(2010-7#1)(2010-8#2)(2012-3#3)(2013-8#1)
that nursing##9##2##(1990-12#1)(2008-11#2)(2008-12#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#2)
that nutrient##2##2##(2008-10#1)(2008-11#1)
that obese##3##2##(1996-12#1)(2011-2#1)(2013-1#1)
that obesity##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
that object##2##2##(1996-2#1)(2008-11#1)
that observed at##3##3##(2008-10#2)(2008-8#1)
that observed differences##2##3##(1992-2#1)(2009-11#1)
that observed during##2##3##(1990-9#1)(2009-5#1)
that observed for##8##3##(1997-9#1)(2008-10#4)(2008-11#2)(2008-7#1)
that observed in the##6##4##(1991-2#1)(1995-12#1)(2008-10#3)(2009-12#1)
that observed in##26##3##(1991-12#1)(1991-2#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#2)(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#1)
that observed when##2##3##(1996-5#1)(2008-10#1)
that observed with##4##3##(1996-5#1)(2008-10#3)
that observed##50##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-8#2)(1996-12#3)(1996-5#3)(1997-2#1)(1997-3#1)(1997-9#1)(2008-10#17)(2008-11#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
that observers##2##2##(2008-11#2)
that obtain##2##2##(2008-11#1)(2008-8#1)
that obtained at##3##3##(2008-10#2)(2008-11#1)
that obtained by the##3##4##(2008-10#3)
that obtained by##6##3##(1995-12#1)(2007-12#1)(2008-10#4)
that obtained for##3##3##(1993-8#1)(2008-10#2)
that obtained from##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
that obtained in##7##3##(1992-12#1)(2008-10#2)(2008-11#4)
that obtained using##2##3##(2008-10#2)
that obtained with##8##3##(1990-12#1)(1990-8#1)(2008-10#5)(2008-11#1)
that obtained##38##2##(1990-12#1)(1990-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-12#1)(2007-12#1)(2008-10#20)(2008-11#7)(2008-6#1)(2009-10#1)(2012-3#1)
that occupational##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
that occur at##3##3##(1996-3#1)(2008-11#1)(2009-7#1)
that occur during the##2##4##(2008-10#1)(2008-8#1)
that occur during##7##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
that occur in affected##2##4##(1990-12#1)(2012-12#1)
that occur in dry skin##2##5##(2008-5#2)
that occur in the##2##4##(2008-10#2)
that occur in##11##3##(1990-12#1)(1997-7#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)
that occur##34##2##(1990-12#1)(1991-3#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-7#3)(2009-8#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
that occurred as##2##3##(2008-10#1)(2012-3#1)
that occurred in the##2##4##(1993-12#1)(2008-8#1)
that occurred in##5##3##(1993-12#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
that occurred on the##3##4##(1995-11#1)(2008-10#1)(2010-5#1)
that occurred##14##2##(1990-12#1)(1991-12#1)(1993-12#1)(1995-11#1)(1996-5#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#2)
that occurs after##2##3##(2008-11#1)(2008-8#1)
that occurs at the##2##4##(1990-10#1)(2008-11#1)
that occurs at##3##3##(1990-10#1)(2008-11#1)(2009-10#1)
that occurs in the##3##4##(1993-12#1)(1997-2#1)(2008-10#1)
that occurs in##12##3##(1993-12#1)(1997-2#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2013-1#2)
that occurs with##2##3##(2008-10#1)(2010-8#1)
that occurs##33##2##(1990-10#1)(1992-5#1)(1993-12#1)(1994-9#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
that of &quot##2##3##(1997-3#1)(2008-8#1)
that of 17E8##2##3##(1995-2#2)
that of 18C6##2##3##(2008-10#2)
that of C##2##3##(2008-10#2)
that of Ca2+ release##2##4##(1995-6#2)
that of CaMV 35S promoter##2##5##(2008-9#2)
that of Cu(II)##2##3##(2008-10#2)
that of HMG##2##3##(1990-3#2)
that of HRP##2##3##(2008-10#2)
that of Lowry##2##3##(2008-10#2)
that of Xmsx-1##2##3##(2008-6#2)
that of a conventional##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
that of a##36##3##(1990-6#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
that of all##3##3##(2007-12#1)(2008-5#1)(2011-3#1)
that of an##3##3##(1991-12#1)(2008-10#1)(2008-6#1)
that of both##3##3##(2008-10#2)(2008-8#1)
that of cells##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
that of chicken##3##3##(1991-3#1)(1993-2#1)(2008-5#1)
that of children##2##3##(1997-4#1)(2009-10#1)
that of classical##2##3##(2008-5#1)(2008-7#1)
that of control cells##2##4##(2008-11#2)
that of control##12##3##(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#7)(2008-9#2)
that of controls##5##3##(1990-11#1)(1997-4#1)(2008-11#1)(2008-8#1)(2013-1#1)
that of conventional##2##3##(1997-1#1)(2008-10#1)
that of cotyledon##3##3##(2008-9#3)
that of insulin##4##3##(1992-10#1)(2008-8#1)(2008-9#2)
that of its##8##3##(1990-5#1)(1993-1#1)(1997-7#2)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
that of ketoconazole##2##3##(2008-11#2)
that of mtRNA(Leu(UUR))##2##3##(2008-8#2)
that of native##6##3##(1992-8#2)(1993-8#1)(1994-8#1)(1995-2#1)(2008-8#1)
that of normal##8##3##(1990-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#3)
that of other##20##3##(1993-2#2)(1993-6#1)(1994-5#1)(1997-3#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
that of patients##2##3##(2008-7#1)(2011-2#1)
that of strain##2##3##(2008-10#2)
that of the Antarctic##2##4##(1991-5#1)(2013-8#1)
that of the cell##2##4##(2008-11#1)(2008-8#1)
that of the cells##2##4##(2008-11#1)(2009-7#1)
that of the control group##3##5##(2008-8#1)(2011-2#2)
that of the control##9##4##(1994-8#1)(2008-10#1)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#2)
that of the conventional##6##4##(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#2)
that of the culture##3##4##(2008-11#3)
that of the general population##4##5##(1991-2#1)(1993-1#1)(1997-3#1)(2008-12#1)
that of the intact##2##4##(1992-3#1)(1993-6#1)
that of the most##2##4##(1994-11#1)(2008-10#1)
that of the native##4##4##(1990-11#1)(1995-11#1)(2008-11#1)(2008-8#1)
that of the normal##2##4##(1994-12#1)(2008-9#1)
that of the original##4##4##(2008-10#2)(2008-11#1)(2009-7#1)
that of the parental##2##4##(1990-8#1)(2008-10#1)
that of the rat##4##4##(1991-7#1)(1994-11#1)(2008-8#1)(2011-2#1)
that of the wild type##7##5##(1990-5#1)(1992-6#1)(1993-3#2)(2008-10#1)(2008-8#1)(2010-10#1)
that of the wild-type enzyme##2##5##(1990-10#1)(1994-5#1)
that of the wild-type##3##4##(1990-10#1)(1994-5#1)(2008-10#1)
that of the##245##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-5#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-12#1)(1992-3#1)(1992-6#6)(1993-1#1)(1993-3#2)(1993-6#4)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-5#1)(1994-8#3)(1995-11#2)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#5)(2008-10#54)(2008-11#14)(2008-12#2)(2008-2#3)(2008-3#6)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#17)(2008-9#17)(2009-3#1)(2009-7#6)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
that of tissue from##2##4##(2008-10#2)
that of type STMV##3##4##(2008-10#3)
that of wild##2##3##(2008-11#1)(2009-8#1)
that of wild-type##5##3##(1992-9#1)(1993-12#1)(2008-10#1)(2009-9#1)(2010-10#1)
that of##747##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#7)(1990-6#1)(1990-8#4)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#5)(1992-10#2)(1992-12#3)(1992-3#3)(1992-6#7)(1992-8#3)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#3)(1993-6#5)(1993-8#7)(1993-9#2)(1994-11#6)(1994-12#4)(1994-2#4)(1994-5#3)(1994-8#8)(1995-11#2)(1995-12#1)(1995-2#9)(1995-6#6)(1995-8#2)(1996-12#6)(1996-2#7)(1996-3#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#5)(1997-3#9)(1997-4#4)(1997-6#1)(1997-7#5)(1997-8#2)(2006-6#1)(2007-12#11)(2008-1#1)(2008-10#213)(2008-11#57)(2008-12#8)(2008-2#3)(2008-3#16)(2008-5#35)(2008-6#7)(2008-7#18)(2008-8#43)(2008-9#35)(2009-10#5)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#7)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-10#2)(2011-2#25)(2011-3#7)(2012-12#3)(2012-2#7)(2012-3#6)(2013-1#7)(2013-8#4)
that offer##2##2##(1994-3#1)(2008-10#1)
that offered##3##2##(1991-2#1)(1995-11#1)(2008-12#1)
that offers##3##2##(2008-10#1)(2008-11#1)(2011-7#1)
that often##12##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
that older people##3##3##(1991-1#1)(2008-7#2)
that older##6##2##(1991-1#1)(2008-1#1)(2008-7#2)(2011-2#1)(2012-12#1)
that olfactory##2##2##(1994-8#1)(2012-2#1)
that on the cast##2##4##(2008-11#2)
that on the##4##3##(2008-11#4)
that on##15##2##(1992-6#1)(1995-11#1)(2008-10#7)(2008-11#5)(2008-3#1)
that once##5##2##(1994-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-8#1)
that one can##3##3##(2008-3#2)(2008-5#1)
that one of the##10##4##(1990-5#1)(1993-8#1)(1994-8#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
that one of these##2##4##(2008-10#1)(2009-8#1)
that one of##13##3##(1990-5#1)(1993-8#1)(1994-8#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
that one##46##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-5#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-8#1)(2010-1#1)(2013-1#1)
that one-third of the##2##4##(1995-6#1)(2008-11#1)
that only a##3##3##(1991-6#1)(2008-6#1)(2009-12#1)
that only one##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
that only the##11##3##(1994-8#1)(1995-11#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-7#1)
that only##43##2##(1990-6#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-4#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)
that oogenesis##2##2##(2007-12#1)(2008-12#1)
that oospores##3##2##(2008-10#3)
that operate in##2##3##(2008-10#1)(2012-2#1)
that operate##8##2##(1990-9#1)(2008-10#1)(2008-11#5)(2012-2#1)
that operates at##2##3##(1997-2#1)(2008-3#1)
that operates in##4##3##(1993-12#1)(1995-6#2)(2008-10#1)
that operates##7##2##(1993-12#1)(1995-6#2)(1997-2#1)(2008-10#1)(2008-3#2)
that optical##2##2##(1992-4#1)(2008-11#1)
that optimal##2##2##(2008-11#1)(2008-8#1)
that optimally##2##2##(1994-2#1)(2008-6#1)
that optimize##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
that oral administration of##3##4##(2008-11#2)(2009-8#1)
that oral##7##2##(1991-3#1)(2008-11#3)(2008-5#1)(2009-8#1)(2011-2#1)
that orally administered##2##3##(1990-2#1)(2008-11#1)
that orally fed##2##3##(2008-11#2)
that orally##4##2##(1990-2#1)(2008-11#3)
that orchestrate##2##2##(2009-5#1)(2012-3#1)
that organic matter##2##3##(2008-10#1)(2008-11#1)
that organic##3##2##(2008-10#2)(2008-11#1)
that organisms##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
that originated from##3##3##(2008-10#2)(2010-6#1)
that originated in##2##3##(2008-10#1)(2011-2#1)
that originated##8##2##(2008-10#5)(2009-12#1)(2010-6#1)(2011-2#1)
that osteoporosis##2##2##(1996-6#1)(2010-3#1)
that other factors are##2##4##(2008-1#1)(2013-1#1)
that other factors##4##3##(2008-1#1)(2008-10#1)(2013-1#2)
that other mechanisms##3##3##(2008-10#2)(2010-12#1)
that other##27##2##(1990-2#2)(1992-7#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
that otherwise##4##2##(1997-2#1)(2008-10#2)(2009-3#1)
that our approach##2##3##(2008-10#1)(2008-6#1)
that our model##2##3##(2008-10#2)
that our##30##2##(1991-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#4)
that over##3##2##(1994-12#1)(2008-10#1)(2008-8#1)
that over-expression of##3##3##(1996-12#1)(2008-11#2)
that overexpression of##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
that overwintered in##2##3##(2008-10#2)
that oxidation##2##2##(2008-5#1)(2013-7#1)
that oxidative metabolism##2##3##(1994-2#2)
that oxidative stress##2##3##(1992-12#1)(1995-6#1)
that oxidative##5##2##(1992-12#1)(1994-2#2)(1995-6#1)(2010-12#1)
that p16(INK4A)##3##2##(2013-1#3)
that p21##3##2##(1995-6#3)
that p53##4##2##(1994-9#1)(2008-9#2)(2011-2#1)
that p72syk is##2##3##(1992-6#2)
that p73##2##2##(2010-3#2)
that pH##3##2##(2008-10#2)(2008-11#1)
that pain##3##2##(1997-5#1)(2010-4#1)(2012-2#1)
that parasites##2##2##(2008-8#2)
that parents##5##2##(1992-2#1)(1995-5#1)(2010-10#1)(2010-8#1)(2011-1#1)
that part of the##2##4##(2008-10#1)(2010-4#1)
that part of##4##3##(1990-12#1)(1993-9#1)(2008-10#1)(2010-4#1)
that partial##3##2##(1991-12#1)(2008-10#2)
that participants had##2##3##(2009-10#1)(2010-9#1)
that participants##7##2##(1995-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-9#1)(2013-1#1)(2013-8#1)
that participate in the##2##4##(2010-12#1)(2013-1#1)
that participate in##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
that participated in##3##3##(1994-12#1)(2010-8#1)(2011-2#1)
that participated##4##2##(1994-12#1)(2008-12#1)(2010-8#1)(2011-2#1)
that particles##3##2##(1997-2#1)(2008-10#2)
that particular##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
that pass##2##2##(1995-3#1)(2013-1#1)
that passes through the##2##4##(2008-3#2)
that passes##3##2##(2008-3#2)(2010-8#1)
that passive##2##2##(1996-3#1)(2009-7#1)
that pathogen##3##2##(2008-10#3)
that pathogens##2##2##(2008-10#2)
that patients who##2##3##(2008-10#1)(2010-4#1)
that patients with##9##3##(1991-5#1)(1993-11#2)(2008-1#1)(2008-6#1)(2009-10#1)(2011-2#2)(2012-3#1)
that patients##24##2##(1991-3#1)(1991-5#1)(1993-11#2)(1993-12#1)(1994-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-6#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
that patterns of##2##3##(1996-1#1)(2008-12#1)
that patterns##4##2##(1996-1#1)(2008-12#1)(2009-8#1)(2013-1#1)
that payment##2##2##(1993-12#1)(1994-12#1)
that peak##2##2##(1997-3#1)(2010-3#1)
that penetrated the##2##3##(2008-10#2)
that penetrated##4##2##(2008-10#3)(2013-1#1)
that penetration##3##2##(2008-10#2)(2012-2#1)
that people with dementia##2##4##(2013-8#2)
that people with disabilities##2##4##(1995-6#1)(1996-1#1)
that people with##8##3##(1995-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#1)(2013-8#2)
that people##14##2##(1993-12#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#2)
that perceived##3##2##(2008-4#1)(2009-7#1)(2010-1#1)
that perceivers##3##2##(2008-11#2)(2013-8#1)
that perform##2##2##(2008-3#1)(2012-12#1)
that performance##3##2##(1992-12#1)(2009-4#1)(2012-2#1)
that performed##2##2##(1994-3#1)(1995-12#1)
that performs the##2##3##(2008-10#1)(2008-3#1)
that performs##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
that period##4##2##(1991-6#1)(2008-12#2)(2010-1#1)
that peripheral##4##2##(1997-2#1)(2008-7#1)(2013-8#2)
that permit##10##2##(1991-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
that permits the##2##3##(2008-10#1)(2008-3#1)
that permits##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-10#1)
that permitted##2##2##(2007-11#1)(2008-2#1)
that persisted##5##2##(1990-5#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
that persistent##3##2##(2008-8#2)(2009-8#1)
that persists##2##2##(2008-5#1)(2009-8#1)
that personal##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
that personality##2##2##(2008-11#2)
that persons with##2##3##(1997-2#1)(2008-7#1)
that persons##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
that phenanthrene##2##2##(1994-5#1)(2008-10#1)
that phenolics##2##2##(2008-10#2)
that phenytoin##2##2##(2008-11#2)
that phosphate##2##2##(1992-6#2)
that phosphorylation##2##2##(1994-11#1)(2010-12#1)
that photoactivated##2##2##(1993-8#1)(2009-6#1)
that physical activity##2##3##(2013-1#2)
that physical##3##2##(1994-3#1)(2013-1#2)
that physician##2##2##(1995-12#1)(2008-12#1)
that physicians must##2##3##(2008-8#2)
that physicians##9##2##(1990-2#1)(1991-2#1)(1991-3#1)(1994-1#2)(1995-6#1)(2008-8#2)(2010-1#1)
that physiological##2##2##(2008-10#1)(2009-8#1)
that phytoplasma##2##2##(2008-10#2)
that pigs##2##2##(1995-8#1)(2013-8#1)
that planning##2##2##(1994-2#1)(2010-11#1)
that plant resistance##2##3##(2008-8#1)(2008-9#1)
that plant##7##2##(2008-10#2)(2008-8#3)(2008-9#2)
that plants##7##2##(2008-10#3)(2008-11#1)(2009-8#1)(2012-7#1)(2013-8#1)
that plasma##5##2##(1992-12#1)(1992-9#1)(2008-7#1)(2012-3#1)(2013-1#1)
that platelets##4##2##(2006-6#4)
that play a role in##2##5##(2008-10#1)(2011-2#1)
that play a##3##3##(2008-10#2)(2011-2#1)
that play important roles in##3##5##(2008-10#1)(2008-9#1)(2013-1#1)
that play important##4##3##(1995-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
that play##11##2##(1995-8#1)(2008-1#1)(2008-10#3)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#2)
that plays a critical role in##2##6##(2008-10#1)(2012-2#1)
that plays a##5##3##(1995-6#1)(2008-10#2)(2011-2#1)(2012-2#1)
that plays an##2##3##(1993-11#1)(2008-6#1)
that plays##7##2##(1993-11#1)(1995-6#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#1)
that podoplanin##2##2##(2013-1#2)
that polyphenols##3##2##(2009-3#1)(2009-8#1)(2012-12#1)
that poor##4##2##(2008-10#1)(2008-11#1)(2009-5#1)(2013-1#1)
that population##5##2##(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#2)
that populations of##3##3##(2008-10#3)
that populations##6##2##(2008-10#5)(2008-8#1)
that position##4##2##(1993-12#1)(1996-3#1)(2008-9#1)(2010-6#1)
that positive##4##2##(1994-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
that possess##5##2##(2008-8#1)(2008-9#2)(2009-6#1)(2011-1#1)
that possesses##2##2##(2008-8#1)(2009-5#1)
that possible##4##2##(1990-9#1)(1992-11#1)(2008-10#1)(2011-2#1)
that post-translational##3##2##(1991-7#1)(1995-8#1)(2011-2#1)
that postoperative##2##2##(2008-9#1)(2009-3#1)
that potential##2##2##(2008-1#1)(2010-8#1)
that potentially##4##2##(1991-9#1)(2008-10#1)(2008-12#1)(2013-1#1)
that power is##2##3##(1997-3#1)(2012-3#1)
that practice##2##2##(2008-11#2)
that pre-registration##2##2##(2008-11#2)
that preceded the##2##3##(1991-2#1)(2008-1#1)
that precedes##2##2##(1995-11#1)(2011-2#1)
that precisely##2##2##(2008-10#2)
that predict##7##2##(1992-9#1)(1995-3#1)(1995-9#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
that predicted by the##2##4##(2008-3#1)(2008-8#1)
that predicted by##4##3##(2008-3#2)(2008-8#2)
that predicted##5##2##(1996-2#1)(2008-3#2)(2008-8#2)
that predicts##7##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)
that predominantly##2##2##(2008-10#1)(2008-9#1)
that premating barriers##2##3##(2008-8#1)(2012-3#1)
that premating##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
that prenatal##2##2##(1995-12#1)(2008-11#1)
that presence of##2##3##(2008-10#2)
that present##3##2##(2008-11#1)(2011-2#1)(2012-9#1)
that presented as##2##3##(2008-10#1)(2010-6#1)
that presented with##3##3##(2008-1#1)(2010-3#1)(2013-1#1)
that presented##7##2##(2008-1#1)(2008-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
that presents##3##2##(1991-3#1)(2008-10#2)
that preservation##2##2##(1996-12#1)(2008-10#1)
that preserves##5##2##(1994-5#1)(2008-10#2)(2009-8#1)(2009-9#1)
that prevent##8##2##(1993-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-7#1)(2011-1#1)(2013-8#1)
that prevented##3##2##(1996-9#1)(2008-10#1)(2008-7#1)
that prevents##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
that previous exposure##2##3##(1996-12#1)(1997-3#1)
that previous studies##2##3##(2008-10#1)(2010-5#1)
that previous##10##2##(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-5#1)(2013-8#1)
that previously reported##3##3##(1993-1#1)(2008-8#1)(2012-12#1)
that previously##8##2##(1990-2#1)(1990-8#1)(1993-1#1)(2008-10#2)(2008-8#1)(2010-8#1)(2012-12#1)
that primarily##3##2##(2008-1#1)(2008-7#1)(2011-1#1)
that primary##2##2##(1995-11#1)(2008-8#1)
that probably##5##2##(1993-3#1)(2008-10#1)(2008-6#1)(2009-10#1)(2011-2#1)
that probiotics##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
that process##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
that processes##2##2##(2008-9#1)(2010-9#1)
that processing of##4##3##(1993-6#1)(2008-11#1)(2010-7#1)(2011-1#1)
that processing##6##2##(1993-6#1)(1997-1#1)(2008-11#1)(2010-10#1)(2010-7#1)(2011-1#1)
that produce the antibiotic 2##2##5##(2008-10#2)
that produce##16##2##(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
that produced SLS##2##3##(2008-10#2)
that produced a##2##3##(2008-12#1)(2008-5#1)
that produced by##2##3##(1992-10#1)(2008-11#1)
that produced high amounts of IAA##2##6##(2008-10#2)
that produced the##2##3##(2008-12#1)(2009-8#1)
that produced##18##2##(1991-12#1)(1992-10#1)(1995-2#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-5#1)(2009-8#1)
that produces an##2##3##(2012-3#1)(2013-1#1)
that produces##11##2##(1993-12#1)(1995-8#1)(1996-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-10#2)(2012-3#1)(2013-1#1)
that professional##2##2##(1994-12#1)(2013-8#1)
that profoundly##2##2##(1995-2#1)(2008-11#1)
that progress##2##2##(1997-3#1)(2010-9#1)
that project##2##2##(2007-12#1)(2013-8#1)
that proliferation of##2##3##(2008-10#1)(2010-11#1)
that prolong##3##2##(2008-10#1)(2008-8#1)(2010-7#1)
that promote a##2##3##(1992-12#1)(2008-7#1)
that promote the##3##3##(2008-11#1)(2010-11#1)(2010-8#1)
that promote tumor##2##3##(2009-3#1)(2011-2#1)
that promote##16##2##(1992-12#1)(2008-10#1)(2008-11#4)(2008-7#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)
that promotes##5##2##(1992-11#1)(1994-12#1)(1997-2#1)(2008-12#1)(2010-6#1)
that prompt##2##2##(1993-8#1)(2013-1#1)
that propagules##2##2##(2008-10#1)(2008-8#1)
that proper##2##2##(2008-8#1)(2013-1#1)
that proposed##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
that prostaglandin##3##2##(1991-3#1)(1994-5#1)(1996-12#1)
that prostate cancer is##2##4##(2010-10#1)(2011-2#1)
that protect against##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
that protect##5##2##(2008-11#1)(2008-5#1)(2008-7#2)(2010-11#1)
that protection##2##2##(1991-5#1)(2012-7#1)
that protein G-liposomal nanovesicles##2##4##(2008-10#2)
that protein kinase A##2##4##(1993-8#1)(2008-11#1)
that protein kinase C##2##4##(1995-6#1)(2008-11#1)
that protein kinase##4##3##(1993-8#1)(1995-6#1)(2008-11#2)
that protein##16##2##(1991-5#1)(1993-8#2)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-9#2)(2009-6#1)(2009-8#2)(2011-3#1)
that proteins from##2##3##(2008-10#1)(2010-4#1)
that proteins##5##2##(1991-5#1)(2008-10#2)(2010-4#2)
that proved to be##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
that proved to##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
that proved##5##2##(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
that provide a##2##3##(2008-10#1)(2008-3#1)
that provide the##3##3##(2008-12#1)(2008-4#1)(2008-5#1)
that provide##23##2##(1991-1#1)(1993-12#1)(1994-1#2)(1995-1#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#2)
that provided by##3##3##(2008-10#2)(2008-9#1)
that provided##8##2##(1996-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)
that provider##3##2##(1994-1#2)(2009-3#1)
that provides a##2##3##(2008-11#1)(2008-6#1)
that provides structural##2##3##(2009-8#1)(2012-2#1)
that provides the##3##3##(1997-7#1)(2008-10#1)(2009-12#1)
that provides##20##2##(1991-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#2)
that proximal##2##2##(2012-3#1)(2013-1#1)
that psilocybin##2##2##(2013-8#2)
that psychological##2##2##(2008-12#1)(2008-6#1)
that public health##4##3##(1995-12#1)(1996-2#1)(2008-10#1)(2010-9#1)
that public##6##2##(1991-3#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-9#1)
that pulmonary##2##2##(1997-1#1)(2008-1#1)
that purified##5##2##(1990-11#1)(1990-12#1)(1991-7#1)(1995-2#1)(2012-2#1)
that purpose##5##2##(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#2)
that qualitatively##2##2##(2008-11#1)(2008-8#1)
that quantify the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that quantitative##5##2##(2008-10#4)(2008-9#1)
that question##2##2##(2010-10#1)(2011-2#1)
that rabbit##2##2##(1990-8#1)(1992-6#1)
that race##3##2##(2008-10#3)
that radiation-induced##2##2##(2008-7#2)
that raised##2##2##(2010-5#1)(2011-2#1)
that range from##2##3##(1993-8#1)(2011-2#1)
that range##3##2##(1993-8#1)(2008-5#1)(2011-2#1)
that ranged from mild##2##4##(1995-8#1)(2008-10#1)
that ranged from##6##3##(1995-8#1)(2008-10#2)(2008-12#2)(2008-2#1)
that rapid##3##2##(1992-6#1)(2008-12#1)(2008-8#1)
that rapidly##4##2##(1991-12#1)(2008-10#2)(2013-1#1)
that rat##4##2##(1990-2#1)(1993-3#1)(1993-8#1)(1995-12#1)
that rate of aging##2##4##(2008-9#2)
that rate of##3##3##(2008-9#3)
that rate##4##2##(2008-3#1)(2008-9#3)
that rates of##3##3##(2008-1#1)(2008-10#1)(2010-7#1)
that react with the##2##4##(1995-2#1)(2006-6#1)
that react with##3##3##(1995-2#1)(2006-6#1)(2008-7#1)
that react##4##2##(1995-2#1)(2006-6#1)(2008-10#1)(2008-7#1)
that reacted with##3##3##(1993-6#1)(2008-10#2)
that reaction##2##2##(2008-10#1)(2008-9#1)
that reactive##4##2##(1994-6#1)(2008-10#1)(2008-8#1)(2013-7#1)
that reacts##2##2##(1995-12#1)(2008-10#1)
that real##3##2##(1994-1#1)(2008-10#1)(2008-11#1)
that rearrangement of##2##3##(1995-6#1)(1996-6#1)
that receive##3##2##(1997-2#1)(2008-8#1)(2012-2#1)
that received more than##2##4##(2008-10#1)(2011-2#1)
that received##12##2##(1993-1#1)(1995-2#1)(2008-10#5)(2008-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
that receivers##2##2##(1995-5#2)
that recently##4##2##(1993-3#1)(1994-3#2)(2013-8#1)
that recognition of the##2##4##(2008-10#2)
that recognition of##3##3##(1993-3#1)(2008-10#2)
that recognize intact proteins##2##4##(2008-4#2)
that recognize the##3##3##(1996-2#1)(2008-4#1)(2008-9#1)
that recognize##12##2##(1996-12#3)(1996-2#1)(2008-1#1)(2008-4#6)(2008-9#1)
that recognizes the##2##3##(1992-10#1)(1992-9#1)
that recognizes##4##2##(1992-10#1)(1992-9#1)(1995-2#1)(1997-7#1)
that recombinant##4##2##(1995-2#1)(2008-11#3)
that recombination##4##2##(2008-10#3)(2013-8#1)
that recommended##2##2##(2010-11#2)
that recorded in##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
that recorded##4##2##(2008-10#2)(2008-3#1)(2012-3#1)
that recovered##3##2##(1991-2#1)(2008-10#2)
that reduce the##3##3##(2008-7#1)(2009-6#1)(2012-3#1)
that reduce##10##2##(2008-10#4)(2008-12#2)(2008-7#1)(2008-8#1)(2009-6#1)(2012-3#1)
that reduced##6##2##(1992-12#1)(1994-5#1)(2008-10#2)(2008-6#1)(2012-2#1)
that reduces the##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
that reduces##11##2##(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2013-8#1)
that reducing##2##2##(2008-9#1)(2009-10#1)
that reduction##2##2##(1992-1#1)(2013-8#1)
that reflect the##5##3##(1991-3#1)(1995-12#1)(1997-8#1)(2008-9#1)(2009-12#1)
that reflect##9##2##(1991-3#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2011-1#1)
that reflection##3##2##(2008-11#3)
that reflects##3##2##(1994-5#1)(2008-11#1)(2008-6#1)
that regenerated host axons##2##4##(2011-2#2)
that regenerated##3##2##(2011-2#3)
that region##4##2##(1990-5#1)(2008-11#1)(2008-5#2)
that regions##4##2##(1990-5#1)(1993-3#1)(2008-12#2)
that regulate the##6##3##(1995-8#1)(1996-12#1)(2008-12#1)(2008-9#1)(2009-12#1)(2012-2#1)
that regulate##23##2##(1995-8#2)(1996-12#2)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#4)(2013-1#1)
that regulates biofilm decay in P##2##6##(2009-6#2)
that regulates cell##2##3##(2008-1#1)(2008-11#1)
that regulates the##2##3##(2008-7#1)(2010-7#1)
that regulates##14##2##(1995-8#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-11#1)(2010-7#1)(2012-2#2)
that regulation of##5##3##(1995-11#1)(1995-12#1)(1997-1#1)(2008-7#2)
that regulation##6##2##(1995-11#1)(1995-12#1)(1997-1#1)(2008-7#2)(2009-10#1)
that reinforces the##2##3##(2008-12#1)(2013-8#1)
that reinforces##3##2##(2008-12#1)(2009-10#1)(2013-8#1)
that relate##2##2##(1995-3#1)(2008-10#1)
that relates##4##2##(1990-8#1)(2008-12#1)(2008-3#2)
that relationship##2##2##(1992-3#1)(2008-10#1)
that relative##4##2##(2008-10#1)(2008-3#1)(2011-1#1)(2013-8#1)
that relatively##3##2##(1997-1#1)(2008-11#1)(2008-3#1)
that release##7##2##(1990-2#1)(1994-11#1)(1997-1#3)(2008-8#1)(2013-7#1)
that reliable results can be obtained##2##6##(2008-10#2)
that reliable##3##2##(2008-10#3)
that relies on##2##3##(2007-12#1)(2010-1#1)
that relies##3##2##(1996-1#1)(2007-12#1)(2010-1#1)
that religious##3##2##(1993-12#1)(2008-12#1)(2009-11#1)
that rely on##5##3##(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#2)
that remain to be##3##4##(1994-5#1)(2009-6#1)(2012-12#1)
that remain##6##2##(1994-5#1)(1997-1#1)(2007-12#1)(2009-6#1)(2012-12#1)(2013-8#1)
that remained##2##2##(2008-10#2)
that remains to be##2##4##(2008-10#1)(2008-11#1)
that remains##7##2##(1994-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
that remote##2##2##(2008-10#1)(2008-11#1)
that removal of the##3##4##(2008-11#1)(2008-4#1)(2012-12#1)
that removal of##6##3##(1993-9#1)(1994-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
that remove##2##2##(2007-12#1)(2008-10#1)
that render##2##2##(1997-3#1)(2010-7#1)
that repeated##4##2##(2008-10#2)(2008-7#1)(2010-12#1)
that repeatedly##3##2##(2008-10#2)(2008-8#1)
that report##2##2##(2008-12#1)(2009-1#1)
that reported in##4##3##(1991-2#1)(1991-3#1)(1997-8#1)(2008-10#1)
that reported##17##2##(1990-2#1)(1991-2#1)(1991-3#1)(1993-3#2)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2012-12#4)
that represent the##5##3##(1995-9#2)(1996-2#1)(2008-10#1)(2010-8#1)
that represent##11##2##(1995-9#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-8#1)(2011-1#1)
that represents the##3##3##(2008-10#2)(2010-5#1)
that represents##6##2##(1994-3#1)(1995-2#1)(2008-10#2)(2009-1#1)(2010-5#1)
that represses##2##2##(2008-11#1)(2009-8#1)
that reproduce sexually##2##3##(2008-8#2)
that reproduce##4##2##(2008-3#1)(2008-8#3)
that reproductive success##2##3##(2008-8#1)(2008-9#1)
that reproductive##4##2##(1994-3#1)(2008-8#2)(2008-9#1)
that require the##2##3##(2008-12#1)(2008-9#1)
that require##21##2##(1991-2#1)(1994-3#1)(1996-3#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-9#4)(2009-12#1)(2010-1#1)(2011-2#1)(2013-1#2)
that required##14##2##(1990-8#1)(1996-12#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)(2013-8#2)
that requires a##3##3##(2008-10#1)(2011-2#2)
that requires##11##2##(1993-2#1)(1994-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#4)
that research##2##2##(1993-2#1)(2008-11#1)
that researchers##4##2##(1992-3#1)(1997-5#1)(2008-4#2)
that resemble##4##2##(1991-9#1)(2008-4#1)(2008-8#1)(2012-3#1)
that residents##2##2##(1995-3#2)
that residual##4##2##(2008-10#2)(2008-9#1)(2009-9#1)
that residues##2##2##(2008-8#1)(2008-9#1)
that resistance in##2##3##(2008-10#2)
that resistance to these##2##4##(2008-10#2)
that resistance to##6##3##(2008-10#6)
that resistance##15##2##(2008-10#15)
that resisted##2##2##(2008-10#1)(2010-7#1)
that resolved##2##2##(1996-9#1)(2012-12#1)
that respects##2##2##(1997-5#1)(2008-12#1)
that respond to##4##3##(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
that responded to##6##3##(1992-6#2)(1992-9#1)(1995-1#1)(2008-10#1)(2008-9#1)
that responded##7##2##(1992-6#2)(1992-9#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-9#1)
that respondents##2##2##(2007-12#1)(2009-7#1)
that responds to the##2##4##(2008-11#1)(2008-12#1)
that responds##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
that response##2##2##(1995-8#1)(2013-8#1)
that responses##2##2##(2008-11#1)(2008-8#1)
that restriction of##2##3##(2008-10#2)
that result from##9##3##(1990-8#1)(1994-3#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-3#1)(2012-2#1)
that result in##8##3##(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-2#1)
that result##19##2##(1990-8#1)(1994-3#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#2)
that resulted from##3##3##(2008-10#3)
that resulted in a##2##4##(2008-3#1)(2008-8#1)
that resulted in##9##3##(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-9#1)(2013-1#1)
that resulted##12##2##(1997-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-9#1)(2013-1#1)
that resulting from##2##3##(1991-3#1)(1995-12#1)
that results from the use of a##2##7##(2008-10#2)
that results from the##3##4##(2008-10#3)
that results from##6##3##(1990-5#1)(2008-10#3)(2008-12#1)(2008-3#1)
that results in a##3##4##(1994-5#1)(2008-7#1)(2008-8#1)
that results in an##2##4##(1991-7#1)(1997-7#1)
that results in the##2##4##(1994-12#1)(2012-3#1)
that results in##11##3##(1991-7#1)(1994-12#2)(1994-5#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
that results##19##2##(1990-5#1)(1991-7#1)(1994-12#2)(1994-5#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
that resveratrol##2##2##(2008-5#2)
that retain##3##2##(2008-8#1)(2009-10#1)(2011-1#1)
that retained##2##2##(2008-10#1)(2012-2#1)
that retinol-binding protein##2##3##(1995-6#2)
that reveal##2##2##(2007-12#1)(2008-3#1)
that revealed##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
that reveals##2##2##(2008-11#1)(2008-9#1)
that rhabdomyolysis##2##2##(2011-2#1)(2013-8#1)
that rhizosphere priming may##2##4##(2013-8#2)
that rice##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
that risk##4##2##(1993-1#1)(2009-10#1)(2011-2#1)(2013-1#1)
that role models##2##3##(2009-7#2)
that role##5##2##(1997-1#1)(1997-3#1)(2009-4#1)(2009-7#2)
that root colonization##2##3##(2008-10#2)
that root##4##2##(2008-10#4)
that roots##2##2##(2009-8#2)
that routine##3##2##(1990-8#1)(1997-8#1)(2008-10#1)
that rpGH##2##2##(2008-9#2)
that rps14 is##2##3##(1996-6#2)
that runs##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
that rupintrivir##2##2##(2008-10#2)
that sample##4##2##(2008-10#4)
that samples##2##2##(2008-10#1)(2008-6#1)
that sanguinarine##2##2##(2011-2#2)
that satisfies##3##2##(2008-3#1)(2008-7#1)(2009-12#1)
that satisfy the##2##3##(1994-12#1)(2008-3#1)
that satisfy##4##2##(1994-12#1)(2008-3#2)(2008-6#1)
that scaling relations##2##3##(2008-8#2)
that scattering##2##2##(2008-2#1)(2008-3#1)
that school##2##2##(2008-12#1)(2012-2#1)
that schools of##3##3##(1996-1#1)(2008-11#1)(2010-8#1)
that scientific##2##2##(2012-2#2)
that screening##4##2##(1991-6#1)(1992-2#1)(1992-5#1)(1994-6#1)
that secondary spread##2##3##(2008-10#2)
that secrete##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
that seeds##2##2##(2008-10#1)(2012-9#1)
that seem to be##2##4##(2008-10#1)(2008-11#1)
that seem to##3##3##(2008-10#2)(2008-11#1)
that seem##4##2##(2008-10#3)(2008-11#1)
that seemed to##2##3##(2008-9#1)(2010-8#1)
that seen in the##2##4##(1992-8#1)(2008-11#1)
that seen in##7##3##(1992-8#1)(1994-5#2)(2008-10#1)(2008-11#2)(2012-3#1)
that seen##12##2##(1992-8#1)(1994-5#2)(1995-12#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2012-3#1)(2013-1#1)
that segregated for##2##3##(2008-10#1)(2012-3#1)
that segregated##4##2##(2008-10#3)(2012-3#1)
that selected##2##2##(1991-12#1)(1992-2#1)
that selecting an##2##3##(2008-10#1)(2008-9#1)
that selecting##3##2##(1997-2#1)(2008-10#1)(2008-9#1)
that selection for##3##3##(2008-10#2)(2008-9#1)
that selection##7##2##(2008-10#5)(2008-8#1)(2008-9#1)
that selective##2##2##(2008-10#1)(2010-1#1)
that selectively##3##2##(2009-12#1)(2010-7#1)(2011-2#1)
that selenium##3##2##(2008-6#3)
that sensory neurons##2##3##(2007-12#2)
that sensory##6##2##(1992-6#1)(2007-12#2)(2008-11#1)(2013-8#2)
that separated the##2##3##(2008-9#1)(2011-2#1)
that separated##4##2##(2008-10#1)(2008-9#2)(2011-2#1)
that separation##2##2##(2008-10#2)
that sequence##2##2##(1995-2#1)(1996-6#1)
that sequences##3##2##(1995-12#1)(1995-2#1)(2008-10#1)
that sequesters##2##2##(1991-9#1)(2008-11#1)
that serotonin plays##2##3##(1993-3#1)(2008-5#1)
that serotonin##3##2##(1993-3#1)(1995-12#1)(2008-5#1)
that serum starvation of##2##4##(2008-9#2)
that serum##8##2##(1997-1#1)(2008-10#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-5#1)
that serve as##2##3##(1997-6#1)(2012-2#1)
that served as##3##3##(2008-10#2)(2008-11#1)
that serves as##2##3##(1991-5#1)(2012-2#1)
that serves the##2##3##(1991-3#1)(2010-5#1)
that serves##4##2##(1991-3#1)(1991-5#1)(2010-5#1)(2012-2#1)
that service industries are##2##4##(1995-1#1)(2009-8#1)
that settlers win space by winning fights##2##7##(2008-9#2)
that several of##2##3##(1991-9#1)(2008-10#1)
that several##25##2##(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1996-2#1)(1996-8#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#5)
that severe##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
that severity##2##2##(1993-3#1)(2008-10#1)
that sex ratio##2##3##(2008-8#2)
that sex##5##2##(1997-7#1)(2008-11#1)(2008-8#2)(2008-9#1)
that sexual recombination is##2##4##(2008-10#2)
that sexual recombination may##2##4##(2008-10#2)
that sexual recombination##6##3##(2008-10#6)
that sexual reproduction##3##3##(2008-10#3)
that sexual selection##2##3##(1995-2#1)(2008-8#1)
that sexual##14##2##(1993-9#1)(1995-2#1)(2008-10#9)(2008-8#2)(2012-3#1)
that sexually##2##2##(1990-3#1)(2012-2#1)
that sgcD##2##2##(2008-9#2)
that shape the##2##3##(2008-8#1)(2013-8#1)
that shape##6##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
that share common##2##3##(2011-2#1)(2012-3#1)
that share##8##2##(1995-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
that shares##3##2##(1993-12#1)(2008-10#2)
that she was##2##3##(1995-12#1)(1996-5#1)
that she##8##2##(1992-9#1)(1995-12#2)(1995-6#1)(1996-5#1)(2011-2#1)(2013-1#2)
that shed light on the##2##5##(2008-4#1)(2010-12#1)
that short DNA##2##3##(2008-11#2)
that short-term##4##2##(1995-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
that should be addressed##2##4##(2012-2#2)
that should be considered when##2##5##(1995-1#1)(2008-10#1)
that should be considered##5##4##(1994-1#1)(1995-1#1)(2008-10#2)(2011-2#1)
that should be followed##2##4##(1997-6#1)(2008-9#1)
that should be useful##2##4##(2008-10#1)(2008-8#1)
that should be##22##3##(1992-12#1)(1994-1#1)(1995-1#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#2)
that should##29##2##(1992-12#1)(1994-1#1)(1995-1#1)(1997-6#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
that show a##5##3##(1994-12#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
that show##18##2##(1991-10#1)(1991-9#1)(1994-12#1)(1994-5#1)(2008-10#4)(2008-7#2)(2008-8#1)(2011-2#3)(2012-3#2)(2013-1#2)
that showed the##5##3##(2007-12#1)(2008-10#2)(2012-12#1)(2012-2#1)
that showed##14##2##(1994-11#1)(2007-12#1)(2008-10#8)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
that shows a##2##3##(1992-6#1)(2010-6#1)
that shows##5##2##(1992-6#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-6#1)
that sigma##2##2##(1993-12#1)(1996-3#1)
that signal##4##2##(1997-8#1)(2008-10#2)(2008-3#1)
that significant##8##2##(1990-3#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-8#1)
that significantly##6##2##(1992-2#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
that similar##4##2##(1994-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
that simple##4##2##(1993-9#1)(1995-5#1)(2008-10#1)(2008-9#1)
that simulates a##2##3##(2008-10#1)(2011-2#1)
that simulates the##3##3##(2008-10#2)(2009-10#1)
that simulates##5##2##(2008-10#3)(2009-10#1)(2011-2#1)
that simultaneous determination##2##3##(2008-10#2)
that simultaneous##4##2##(2008-10#3)(2008-3#1)
that simultaneously##3##2##(2010-8#1)(2012-2#1)(2012-3#1)
that since##2##2##(2008-10#2)
that single##4##2##(1993-1#1)(1996-12#1)(2008-10#2)
that sites##2##2##(2008-10#1)(2012-3#1)
that six##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
that size##2##2##(2008-10#1)(2008-11#1)
that skin##3##2##(2008-5#3)
that small##8##2##(1990-8#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-9#3)(2009-7#1)
that snow##2##2##(2008-10#2)
that social##7##2##(1994-12#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-11#1)(2010-7#1)(2012-3#1)
that sodium##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
that soft##2##2##(2010-8#1)(2013-1#1)
that soil##2##2##(2008-10#2)
that soils are a substantial source of##2##7##(2008-11#2)
that soils##3##2##(2008-11#3)
that soluble##3##2##(1990-2#1)(2008-10#2)
that somatostatin##2##2##(1997-4#2)
that some components##2##3##(2008-10#2)
that some individuals##2##3##(2008-10#1)(2008-9#1)
that some of the##10##4##(1991-9#1)(1996-6#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)
that some of these##2##4##(1996-3#1)(2012-2#1)
that some of##12##3##(1991-9#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
that some##76##2##(1990-12#1)(1991-3#1)(1991-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-2#3)(1995-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-9#1)(2007-11#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#4)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#7)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
that sought to##3##3##(2008-8#1)(2010-10#1)(2011-2#1)
that span the##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
that span##6##2##(1994-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
that spatial redistribution##2##3##(2008-8#2)
that spatial variation in##2##4##(2008-8#2)
that spatial##9##2##(2008-10#1)(2008-8#8)
that specially##2##2##(1993-2#1)(1995-3#1)
that species were##2##3##(2008-12#2)
that species##14##2##(1990-6#1)(2008-10#2)(2008-12#3)(2008-8#4)(2009-8#1)(2012-3#2)(2012-6#1)
that specific##16##2##(1991-12#1)(1992-3#1)(1994-11#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-8#2)(2008-9#2)(2012-12#1)(2012-2#1)
that specifically binds##2##3##(1995-6#1)(2008-11#1)
that specifically##16##2##(1993-12#1)(1993-9#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#2)
that spectral##3##2##(2008-10#2)(2008-2#1)
that sperm##3##2##(2008-12#1)(2008-7#1)(2008-8#1)
that splenectomized patients run increased risk of##2##7##(1990-9#1)(1994-9#1)
that splenic##2##2##(2008-11#2)
that spontaneous##4##2##(1996-11#1)(1997-2#1)(2008-11#2)
that spore##2##2##(2008-10#2)
that spores of##2##3##(2008-10#1)(2008-8#1)
that spores##3##2##(2008-10#2)(2008-8#1)
that stable##3##2##(2008-10#2)(2011-2#1)
that staff##2##2##(2010-10#1)(2011-2#1)
that stained##2##2##(2008-10#2)
that standard##3##2##(2008-10#2)(2011-2#1)
that state##5##2##(1992-2#1)(1995-3#1)(1995-6#1)(2008-11#2)
that stem cells##2##3##(2008-10#1)(2011-2#1)
that stereotypies##2##2##(2008-11#2)
that still##3##2##(1995-8#1)(1997-1#1)(2008-11#1)
that stimulate the##2##3##(2008-7#1)(2011-2#1)
that stimulate##5##2##(1994-3#1)(2008-10#2)(2008-7#1)(2011-2#1)
that stimulated##2##2##(1991-3#1)(2008-11#1)
that stimulation of the##2##4##(1996-2#1)(1997-7#1)
that stimulation of##7##3##(1994-2#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2013-1#1)
that strain##3##2##(2008-10#3)
that strains of X##2##4##(2008-10#2)
that stress##6##2##(1994-2#1)(1996-6#1)(2008-11#2)(2008-7#1)(2011-2#1)
that strong##4##2##(2008-10#2)(2008-8#1)(2012-2#1)
that strongly##4##2##(1995-11#1)(2008-10#2)(2008-9#1)
that structural##2##2##(2008-1#1)(2008-10#1)
that structurally different##2##3##(2009-12#2)
that structurally##3##2##(2009-12#3)
that student nurses##2##3##(2008-11#2)
that students are##3##3##(2008-11#2)(2008-12#1)
that students##15##2##(1996-1#1)(2008-11#6)(2008-12#4)(2009-7#1)(2012-12#1)(2013-8#2)
that students'##3##2##(2008-11#1)(2008-12#2)
that studies of##2##3##(2008-11#2)
that studies##4##2##(2008-10#1)(2008-11#2)(2011-1#1)
that study##2##2##(2008-11#1)(2013-1#1)
that subcultured isolates##2##3##(2008-10#2)
that subjects##3##2##(1991-2#1)(2008-10#2)
that subpopulations##2##2##(1997-3#1)(2008-10#1)
that subsequent##2##2##(1990-5#1)(2008-11#1)
that subsequently##2##2##(2008-11#1)(2008-12#1)
that substantial##3##2##(1994-12#1)(1996-9#1)(2008-2#1)
that substitutes##2##2##(1994-12#1)(2012-2#1)
that subtelomeres##2##2##(2009-10#2)
that successful##4##2##(1993-1#1)(2006-6#1)(2008-10#2)
that such a correlation##2##4##(2008-12#1)(2012-2#1)
that such a##12##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
that such an##2##3##(1995-2#1)(2009-10#1)
that such##41##2##(1992-12#1)(1992-3#1)(1993-3#3)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#3)(2009-7#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that sufficient##3##2##(1994-2#1)(1996-2#1)(2008-9#1)
that suggest that##4##3##(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
that suggest##6##2##(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)
that suggests##2##2##(1993-12#1)(1995-6#1)
that summarizes##2##2##(1996-3#1)(2008-10#1)
that supply##2##2##(2007-12#1)(2008-9#1)
that support##10##2##(1994-9#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-7#1)(2010-11#1)
that supports the##2##3##(2008-10#1)(2008-11#1)
that supports##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
that suppress fire blight##2##4##(2008-10#2)
that suppress##4##2##(2008-10#3)(2013-8#1)
that suppresses##3##2##(1997-8#1)(2008-10#2)
that suppression of##5##3##(2008-10#3)(2008-11#2)
that suppression##7##2##(2008-10#5)(2008-11#2)
that suprathreshold##2##2##(2008-9#1)(2011-2#1)
that surface##2##2##(2007-12#1)(2008-10#1)
that surfactant##4##2##(1994-5#1)(1997-2#1)(2008-10#2)
that surgery can##2##3##(1992-5#1)(2011-2#1)
that surgery##4##2##(1992-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
that surgical treatment##2##3##(1992-9#1)(2010-12#1)
that surrounds##2##2##(2007-12#2)
that survival##2##2##(1990-9#1)(1995-9#1)
that survived##2##2##(1995-2#1)(2008-10#1)
that sustained##2##2##(1995-11#1)(2008-11#1)
that sustains##2##2##(2008-11#1)(2008-12#1)
that symptomless##2##2##(2008-10#2)
that symptoms##3##2##(2008-10#2)(2010-11#1)
that synaptic##2##2##(1993-12#1)(2008-11#1)
that synthesis of##2##3##(1991-2#1)(1993-12#1)
that synthesized##2##2##(2008-10#1)(2008-6#1)
that system##2##2##(1992-3#1)(2008-10#1)
that systematically##2##2##(1996-3#1)(2008-10#1)
that systemic##4##2##(1997-2#1)(2008-10#2)(2012-2#1)
that systolic##2##2##(2008-7#1)(2010-7#1)
that take place##2##3##(2008-10#1)(2009-12#1)
that take##3##2##(2008-10#1)(2008-8#1)(2009-12#1)
that takes into account##2##4##(2008-8#1)(2010-3#1)
that takes##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-8#1)
that target##7##2##(2008-10#1)(2008-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-8#1)(2013-8#1)
that targeted##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2010-10#1)
that targeting##2##2##(2012-2#1)(2013-1#1)
that targets of##2##3##(2008-11#2)
that targets the##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
that targets##6##2##(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
that tat##2##2##(1994-11#2)
that teachers##2##2##(2008-12#1)(2013-1#1)
that teliospores##2##2##(2008-10#2)
that telomeres##2##2##(2008-11#1)(2011-2#1)
that temperature##3##2##(2008-10#3)
that temporal##2##2##(2008-8#1)(2011-2#1)
that temporally##2##2##(1995-2#1)(2008-3#1)
that territorial##2##2##(2008-8#2)
that tested##3##2##(1997-3#1)(2008-10#1)(2008-9#1)
that testosterone##2##2##(1995-12#1)(2008-9#1)
that that##4##2##(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
that the &quot##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that the 175R##2##3##(1993-2#2)
that the 5##2##3##(2008-10#1)(2008-8#1)
that the ASC-DHA pair##2##4##(2008-11#2)
that the B##2##3##(1997-2#1)(2008-10#1)
that the C##4##3##(2008-10#2)(2008-11#1)(2010-11#1)
that the C-terminal##3##3##(1991-5#1)(1993-11#1)(2008-9#1)
that the DNA##3##3##(1993-8#1)(2008-10#2)
that the DPH2 gene##2##4##(1993-9#2)
that the ELISA##2##3##(2008-10#2)
that the G##2##3##(1993-9#1)(2008-10#1)
that the Glu-50--&gt##2##3##(1995-6#2)
that the H(2)O(2) system containing Cu(2+)##2##6##(2008-10#2)
that the H-Wave(R) device##3##4##(2010-1#3)
that the HC-Pro##2##3##(2008-10#2)
that the ILS##2##3##(2008-10#2)
that the Internet##2##3##(1996-5#1)(2009-5#1)
that the Kd values##2##4##(1994-8#1)(2008-8#1)
that the LDH##2##3##(2008-11#1)(2010-4#1)
that the MNS is##2##4##(2008-11#2)
that the N##2##3##(1993-2#1)(2008-10#1)
that the N-terminal##5##3##(1991-5#1)(1992-6#1)(1994-5#1)(2008-10#1)(2008-9#1)
that the NADH##2##3##(2008-10#1)(2008-11#1)
that the NFL theorems##3##4##(2010-3#3)
that the P##3##3##(2008-10#2)(2008-5#1)
that the PANI##2##3##(2008-10#2)
that the P[1##2##3##(1991-3#2)
that the QTL##2##3##(2008-10#2)
that the R##4##3##(1993-6#1)(2008-10#3)
that the RGD##2##3##(1995-6#1)(2008-7#1)
that the RNA##3##3##(1997-7#2)(2009-12#1)
that the RR##2##3##(2008-10#2)
that the RT-PCR##2##3##(2008-10#1)(2008-5#1)
that the RpoN sigma factor##2##5##(1993-12#2)
that the S##2##3##(2008-10#2)
that the S-dsRNA was##2##4##(2008-10#2)
that the Span80-CPL##2##3##(2008-11#2)
that the U##2##3##(2008-10#2)
that the ability of the##2##5##(2008-10#1)(2008-9#1)
that the ability of##8##4##(1992-12#1)(2008-10#5)(2008-9#1)(2012-3#1)
that the ability to##5##4##(1990-11#1)(1991-2#1)(1992-10#1)(2008-10#1)(2009-7#1)
that the ability##13##3##(1990-11#1)(1991-2#1)(1992-10#1)(1992-12#1)(2008-10#6)(2008-9#1)(2009-7#1)(2012-3#1)
that the abnormal##2##3##(2008-11#1)(2008-8#1)
that the abomasum##2##3##(2011-2#2)
that the above##4##3##(1991-1#1)(1991-6#1)(2008-10#1)(2009-11#1)
that the absence of##5##4##(2009-6#1)(2012-2#1)(2013-1#2)(2013-7#1)
that the absorption and scattering##2##5##(2008-3#1)(2009-12#1)
that the absorption##4##3##(2008-3#1)(2008-8#1)(2009-12#1)(2011-3#1)
that the abundance of##2##4##(1994-11#1)(2010-8#1)
that the accumulation##2##3##(2008-10#1)(2008-7#1)
that the accuracy of the##2##5##(2008-3#1)(2010-5#1)
that the accuracy of##3##4##(2008-10#1)(2008-3#1)(2010-5#1)
that the actin cytoskeleton##2##4##(2008-11#1)(2008-9#1)
that the actin##3##3##(1992-3#1)(2008-11#1)(2008-9#1)
that the activation of the##3##5##(1995-2#1)(1997-2#2)
that the activation of##6##4##(1993-6#1)(1995-2#1)(1997-2#2)(2006-6#1)(2012-2#1)
that the activation##7##3##(1993-6#1)(1995-2#1)(1997-2#2)(2006-6#1)(2008-10#1)(2012-2#1)
that the active##5##3##(1990-5#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)
that the activity of##5##4##(1992-2#1)(1997-2#2)(2008-9#2)
that the activity##8##3##(1992-2#1)(1993-2#1)(1997-2#2)(2008-11#1)(2008-9#2)(2013-1#1)
that the actual##2##3##(2008-11#1)(2008-8#1)
that the addition of##10##4##(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
that the addition##11##3##(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
that the additional##2##3##(1994-5#1)(2007-11#1)
that the administration of##4##4##(1994-8#1)(2008-11#1)(2008-12#1)(2012-2#1)
that the adsorption##3##3##(2008-10#3)
that the age##2##3##(1996-3#1)(2008-10#1)
that the age-related##2##3##(2008-7#1)(2011-2#1)
that the algorithm##2##3##(2008-10#2)
that the alkyl##2##3##(2008-11#1)(2008-5#1)
that the alpha##2##3##(1990-8#1)(1996-12#1)
that the alteration##2##3##(2008-8#1)(2008-9#1)
that the alternative##2##3##(2009-8#1)(2013-1#1)
that the amount of##10##4##(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#1)(2009-7#1)(2012-2#1)
that the amount##12##3##(1990-5#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#2)(2009-7#1)(2012-2#1)
that the amounts of##4##4##(1994-11#1)(2008-10#1)(2008-12#2)
that the amygdala##3##3##(1993-6#2)(2013-8#1)
that the analysis of##3##4##(2008-10#3)
that the analysis##5##3##(2008-10#5)
that the annual##2##3##(1995-3#1)(1996-11#1)
that the antagonist##2##3##(2008-10#2)
that the antagonistic##2##3##(2008-10#2)
that the antibody##6##3##(1995-2#1)(2008-10#1)(2008-8#1)(2013-1#3)
that the antifungal##2##3##(2008-10#2)
that the antinociceptive##2##3##(1996-2#1)(2008-11#1)
that the antioxidant##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
that the antioxidative property of##2##5##(2008-11#2)
that the apparent##3##3##(1995-6#1)(2008-10#1)(2009-8#1)
that the applicability of##2##4##(2008-10#2)
that the application of the##2##5##(2008-10#1)(2008-3#1)
that the application of##8##4##(2008-10#5)(2008-11#1)(2008-3#2)
that the applied##3##3##(2008-10#2)(2008-5#1)
that the approach##4##3##(1992-2#1)(2008-11#1)(2008-7#1)(2009-10#1)
that the assay##3##3##(1990-12#1)(2008-10#1)(2011-3#1)
that the association between##3##4##(2009-7#1)(2009-8#1)(2013-1#1)
that the association of##4##4##(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
that the association##8##3##(1995-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-7#1)(2009-8#1)(2013-1#1)
that the assumption of a linear increase in risk with increasing dose in##2##13##(2008-7#2)
that the asymptotic##2##3##(2008-3#1)(2010-1#1)
that the attenuation##2##3##(2008-3#2)
that the authors##2##3##(1996-12#1)(2008-7#1)
that the availability of##2##4##(2008-10#1)(2008-3#1)
that the average##7##3##(1995-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
that the aziridine##2##3##(1991-5#2)
that the background##2##3##(1991-12#1)(2008-3#1)
that the backscattering##2##3##(2008-3#2)
that the barrier function##2##4##(2008-5#1)(2008-7#1)
that the barrier##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
that the basal ganglia##2##4##(1997-3#1)(2009-10#1)
that the basal##5##3##(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)
that the basic##3##3##(1995-6#1)(2008-11#1)(2008-5#1)
that the behavior##2##3##(2008-10#1)(2009-11#1)
that the behaviour of##2##4##(2008-10#1)(2011-2#1)
that the best##8##3##(1991-3#1)(1996-3#1)(2008-10#2)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
that the binding of##7##4##(1991-9#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
that the binding site##2##4##(2008-11#1)(2008-8#1)
that the binding##12##3##(1991-9#1)(1993-9#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#4)
that the biocontrol##2##3##(2008-10#2)
that the biological##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
that the botanical##2##3##(2008-10#2)
that the brain is##2##4##(1994-5#1)(2008-11#1)
that the brain##3##3##(1994-5#1)(2008-11#2)
that the cDNA##4##3##(1993-6#1)(1995-8#1)(1997-7#1)(2008-8#1)
that the capacity of the##2##5##(1995-2#1)(2008-3#1)
that the capacity##3##3##(1995-1#1)(1995-2#1)(2008-3#1)
that the carboxyl groups##2##4##(2008-10#2)
that the carboxyl##3##3##(1992-7#1)(2008-10#2)
that the cardiac##2##3##(1993-3#1)(1995-2#1)
that the catalytic##2##3##(1997-3#1)(2008-10#1)
that the cause of the##2##5##(2008-10#1)(2011-2#1)
that the cause of##5##4##(2008-10#2)(2011-2#2)(2013-1#1)
that the cell##8##3##(1990-2#1)(1997-1#1)(1997-3#1)(2008-11#4)(2008-9#1)
that the cells##3##3##(1996-2#1)(2008-11#1)(2008-9#1)
that the change##3##3##(1990-8#1)(1991-5#1)(2012-12#1)
that the changes in##3##4##(1992-1#1)(2008-7#1)(2008-9#1)
that the charge##3##3##(2008-10#2)(2008-8#1)
that the child##2##3##(1990-12#1)(2010-8#1)
that the chromosome##2##3##(2008-8#1)(2012-3#1)
that the clinical##3##3##(1992-3#1)(2013-1#2)
that the clone##2##3##(2008-8#2)
that the cloned##2##3##(1992-3#1)(1993-8#1)
that the close##2##3##(2008-10#2)
that the coding##2##3##(1993-2#1)(2008-12#1)
that the cold##2##3##(1994-12#1)(2009-8#1)
that the colonization##2##3##(2008-10#1)(2008-8#1)
that the combination of##6##4##(1990-8#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
that the combination##7##3##(1990-8#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
that the combined##3##3##(1991-7#1)(1993-9#1)(2009-12#1)
that the common##2##3##(1990-11#1)(2008-1#1)
that the commonly used##2##4##(2008-3#1)(2013-1#1)
that the community can##2##4##(2008-11#1)(2011-2#1)
that the community##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
that the complete##2##3##(1990-5#1)(2008-10#1)
that the complex##5##3##(1993-8#1)(1994-5#1)(2008-10#3)
that the complexation##3##3##(2008-10#3)
that the complexes##2##3##(1991-9#1)(2009-8#1)
that the components of##2##4##(2007-12#1)(2008-12#1)
that the composition of the##2##5##(2008-10#1)(2008-8#1)
that the compounds##3##3##(1992-12#1)(2008-10#1)(2012-3#1)
that the concentration of##4##4##(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
that the concentration##6##3##(1997-2#1)(2008-10#2)(2010-3#1)(2011-2#1)(2012-2#1)
that the concentrations of##2##4##(2008-10#2)
that the concept of##3##4##(1992-12#1)(2011-2#1)(2012-2#1)
that the conditions for##2##4##(2008-11#1)(2008-8#1)
that the conditions##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that the conformation of##4##4##(2008-10#3)(2008-8#1)
that the consumption##2##3##(2008-1#1)(2008-10#1)
that the content of##2##4##(2008-10#2)
that the continuous##2##3##(2008-10#1)(2009-8#1)
that the contribution of##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
that the control of##3##4##(2008-8#1)(2009-8#1)(2012-2#1)
that the control##5##3##(2008-8#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-2#1)
that the correct##2##3##(1997-5#1)(2010-8#1)
that the correlation##3##3##(2007-12#1)(2008-5#1)(2010-11#1)
that the course##2##3##(1990-11#1)(2010-7#1)
that the court##2##3##(1990-11#2)
that the criteria##2##3##(2010-2#2)
that the current##8##3##(1993-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
that the cytoplasmic##2##3##(1997-7#1)(2008-9#1)
that the data are##2##4##(1990-8#1)(1994-2#1)
that the data##10##3##(1990-8#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
that the decrease##2##3##(1997-2#1)(2008-8#1)
that the degeneracy##2##3##(1995-5#1)(2008-8#1)
that the degradation##2##3##(1991-5#1)(2009-11#1)
that the degree of##2##4##(1992-9#1)(1993-3#1)
that the degree##3##3##(1992-9#1)(1993-3#1)(2008-11#1)
that the delay##3##3##(1996-2#1)(1997-2#2)
that the delivered dose##2##4##(1996-2#2)
that the delivered##3##3##(1996-2#2)(2008-11#1)
that the demographic##2##3##(1995-2#1)(2008-7#1)
that the density effect on spore production##2##7##(2008-10#2)
that the density##3##3##(1994-5#1)(2008-10#2)
that the detected##2##3##(2008-2#2)
that the detection limit##2##4##(2008-10#1)(2008-11#1)
that the detection##4##3##(2008-10#3)(2008-11#1)
that the developed method##2##4##(2008-10#1)(2012-12#1)
that the developed##5##3##(2008-10#3)(2012-12#1)(2013-1#1)
that the difference in##2##4##(1993-12#1)(2008-2#1)
that the difference of##2##4##(2008-11#1)(2010-7#1)
that the difference##5##3##(1993-12#1)(2008-11#2)(2008-2#1)(2010-7#1)
that the differences between the##2##5##(2008-10#1)(2013-8#1)
that the differences in##4##4##(1995-8#1)(2008-11#1)(2009-8#1)(2012-3#1)
that the differences##7##3##(1995-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-8#1)(2012-3#1)(2013-8#1)
that the different##11##3##(1993-8#1)(1994-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-2#1)
that the differential##4##3##(1993-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
that the digestion##2##3##(2008-10#2)
that the direct##2##3##(2008-10#2)
that the disease is##2##4##(2008-10#1)(2008-4#1)
that the disease was##2##4##(2008-10#1)(2012-3#1)
that the disease##5##3##(2008-10#3)(2008-4#1)(2012-3#1)
that the distal##2##3##(1991-6#1)(2007-12#1)
that the distribution of##9##4##(2008-10#2)(2008-11#1)(2008-8#4)(2008-9#1)(2013-8#1)
that the dominant##4##3##(1994-6#1)(1997-2#1)(2008-10#1)(2009-8#1)
that the downstream##2##3##(1994-11#1)(2008-9#1)
that the drug##2##3##(2008-10#1)(2008-11#1)
that the duration of the##3##5##(1991-11#1)(2008-11#1)(2008-12#1)
that the duration of##4##4##(1991-11#1)(2008-11#1)(2008-12#1)(2008-7#1)
that the dynamic##2##3##(2008-10#2)
that the dynamics of##3##4##(1997-1#1)(2008-8#1)(2008-9#1)
that the early##5##3##(1990-11#1)(1996-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
that the efe gene##3##4##(2008-10#3)
that the effect of aging on the##2##7##(2008-7#2)
that the effect of the##2##5##(2008-10#2)
that the effect of##15##4##(1994-11#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#3)(2010-8#1)
that the effect##16##3##(1994-11#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#3)(2010-8#1)
that the effective##3##3##(2008-10#2)(2008-3#1)
that the effectiveness of##3##4##(1992-5#1)(1992-9#1)(2013-8#1)
that the effects of##14##4##(1992-2#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-3#1)
that the effects were not##2##5##(1991-1#1)(1994-2#1)
that the effects##20##3##(1991-1#1)(1991-5#1)(1992-2#1)(1994-2#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-3#1)
that the efficacy of##2##4##(2008-6#1)(2010-5#1)
that the electrode potential##2##4##(2008-10#2)
that the electrode##7##3##(2008-10#7)
that the elevated##2##3##(1990-8#1)(2008-5#1)
that the endogenous##2##3##(1990-5#1)(2008-7#1)
that the endometrium##2##3##(1991-3#1)(2012-3#1)
that the energy##2##3##(2008-8#1)(2009-5#1)
that the enhanced##4##3##(1990-5#1)(2008-10#3)
that the enhancement of##2##4##(1992-8#1)(2008-10#1)
that the enhancement##3##3##(1992-8#1)(2008-10#1)(2008-7#1)
that the entire##4##3##(2008-10#2)(2008-11#1)(2009-9#1)
that the environmental##4##3##(2008-10#1)(2008-3#1)(2011-3#1)(2012-2#1)
that the enzymatic##2##3##(1996-2#1)(2008-10#1)
that the enzyme##7##3##(1991-5#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)
that the equilibrium##3##3##(1993-6#1)(2008-10#1)(2008-8#1)
that the event will##2##4##(2008-10#2)
that the evolution of##3##4##(2008-8#2)(2012-3#1)
that the evolution##4##3##(2008-8#2)(2008-9#1)(2012-3#1)
that the evolutionarily stable##2##4##(2008-8#1)(2008-9#1)
that the evolutionary##3##3##(2008-10#2)(2010-4#1)
that the excellent##2##3##(2008-10#2)
that the existence of##2##4##(1997-2#1)(2008-8#1)
that the existing##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
that the experimental##3##3##(1996-2#1)(2008-7#1)(2008-8#1)
that the exposure of##2##4##(2008-11#1)(2012-2#1)
that the exposure##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
that the expressed##2##3##(2008-8#1)(2010-6#1)
that the expression level##2##4##(2008-10#1)(2008-8#1)
that the expression levels##2##4##(2008-10#1)(2008-9#1)
that the expression of the##3##5##(1997-7#1)(2008-9#1)(2013-1#1)
that the expression of these##2##5##(1991-9#1)(1997-3#1)
that the expression of##17##4##(1990-5#1)(1991-9#1)(1993-3#1)(1993-8#1)(1996-12#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-8#3)(2008-9#3)(2013-1#2)
that the expression##24##3##(1990-5#1)(1991-9#1)(1993-3#1)(1993-8#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-11#1)(2008-10#3)(2008-6#1)(2008-8#4)(2008-9#5)(2013-1#2)
that the extractability##2##3##(1994-8#1)(2008-10#1)
that the extraction of##2##4##(2008-10#2)
that the extraction##3##3##(2008-10#3)
that the factors##3##3##(2008-10#3)
that the features of##2##4##(1992-4#1)(2007-12#1)
that the features##3##3##(1992-4#1)(2007-12#1)(2008-3#1)
that the federal government##2##4##(1997-2#1)(1997-3#1)
that the federal##3##3##(1995-2#1)(1997-2#1)(1997-3#1)
that the feedback##2##3##(2008-8#1)(2009-8#1)
that the film##2##3##(2008-10#2)
that the final##4##3##(1992-12#1)(2008-3#1)(2008-5#1)(2010-3#1)
that the findings##2##3##(2008-11#1)(2008-7#1)
that the first##10##3##(1993-8#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
that the five##2##3##(1996-8#1)(2008-10#1)
that the flexural##2##3##(2009-5#1)(2009-7#1)
that the fluorescence##5##3##(2008-10#4)(2010-12#1)
that the form of the##2##5##(2008-10#1)(2008-8#1)
that the form of##4##4##(2008-10#2)(2008-8#2)
that the form##5##3##(1990-2#1)(2008-10#2)(2008-8#2)
that the formation of##5##4##(1994-8#2)(2008-11#1)(2008-5#1)(2009-7#1)
that the former##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
that the formulations##2##3##(2008-5#2)
that the four##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#1)
that the fraction of##2##4##(2008-10#1)(2008-7#1)
that the fractions##2##3##(2008-10#2)
that the fragmentation of Cu##2##5##(1997-8#2)
that the frequency of the##2##5##(2008-3#1)(2013-1#1)
that the frequency of##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
that the frequency##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
that the full##2##3##(2008-1#1)(2008-8#1)
that the function of##3##4##(2008-11#1)(2008-6#1)(2008-9#1)
that the functional##4##3##(1995-9#1)(2007-12#1)(2008-10#1)(2012-2#1)
that the fungal##2##3##(2008-10#1)(2008-12#1)
that the fungus##6##3##(2008-10#6)
that the fusion of##2##4##(1991-5#1)(2008-8#1)
that the fusion##4##3##(1991-5#1)(1994-11#1)(1997-3#1)(2008-8#1)
that the gamma##2##3##(2008-10#1)(2008-8#1)
that the gene encoding##2##4##(1995-6#1)(2008-9#1)
that the gene##11##3##(1990-5#1)(1990-7#1)(1992-3#1)(1993-2#1)(1995-6#2)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
that the general##2##3##(2008-12#1)(2011-2#1)
that the genes##4##3##(1993-3#1)(1995-12#1)(2012-3#2)
that the genetic##7##3##(1991-2#1)(1994-11#1)(2008-10#2)(2008-9#2)(2009-8#1)
that the genome##2##3##(2011-2#2)
that the genus##3##3##(2008-6#1)(2010-3#2)
that the global##2##3##(1996-5#1)(2008-8#1)
that the glucose##3##3##(1994-2#1)(2008-10#2)
that the glutamatergic system##2##4##(2008-7#2)
that the gold##2##3##(2008-10#2)
that the granule##2##3##(1994-8#1)(1995-8#1)
that the greater##2##3##(1997-1#1)(2009-8#1)
that the group##3##3##(1993-3#2)(2008-10#1)
that the growth of##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
that the growth##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)
that the guards were concerned about##2##6##(1995-6#2)
that the heavy##2##3##(1997-9#1)(2008-10#1)
that the high##5##3##(1995-12#1)(2008-10#1)(2009-7#1)(2010-4#1)(2010-6#1)
that the higher##7##3##(1990-9#1)(1996-12#1)(2008-10#4)(2008-3#1)
that the highest##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
that the hippocampus##2##3##(1993-6#1)(2013-8#1)
that the hormone##2##3##(1995-12#1)(2008-10#1)
that the host##6##3##(2008-10#4)(2008-8#2)
that the human##10##3##(1992-5#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)
that the hybrid##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
that the hydrophobic##2##3##(1994-8#1)(2008-10#1)
that the hydrophobicity##2##3##(2008-10#2)
that the idea of##2##4##(2010-10#1)(2011-2#1)
that the identity##2##3##(1991-2#1)(2010-3#1)
that the image##2##3##(1997-8#1)(2008-10#1)
that the immobilized##3##3##(2008-10#2)(2008-7#1)
that the immune system##2##4##(2013-1#1)(2013-7#1)
that the immunosuppressive##2##3##(1990-5#2)
that the impact of##4##4##(1992-8#1)(2008-10#2)(2008-8#1)
that the importance of##2##4##(2008-1#1)(2008-5#1)
that the improved##4##3##(1996-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
that the improvements##2##3##(2010-7#1)(2013-8#1)
that the in-flight##2##3##(1990-11#1)(2008-3#1)
that the incidence of##4##4##(1994-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
that the incidence##5##3##(1994-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
that the inclusion##2##3##(2008-10#1)(2011-2#1)
that the increase in the##2##5##(1992-12#1)(2008-11#1)
that the increase in##10##4##(1991-11#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-6#2)(1997-1#1)(2008-10#1)(2008-11#2)
that the increase of##2##4##(2008-10#1)(2008-12#1)
that the increase##12##3##(1991-11#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-6#2)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)
that the increased susceptibility##2##4##(2008-10#2)
that the increased##12##3##(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#2)(2010-10#1)(2013-1#1)
that the individual##4##3##(1990-12#1)(1995-9#1)(2008-10#1)(2008-3#1)
that the induced##2##3##(2008-11#1)(2008-2#1)
that the induction of metallothionein by##2##6##(1991-5#2)
that the induction of##6##4##(1991-5#2)(1997-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
that the infection##2##3##(1997-1#1)(2011-2#1)
that the influence of##2##4##(1996-12#1)(2011-2#1)
that the influence##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
that the information##3##3##(1993-2#1)(2008-9#2)
that the inheritance of##2##4##(2008-10#1)(2008-4#1)
that the inhibition of##8##4##(1993-12#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-9#1)
that the inhibitor was##2##4##(1990-5#1)(1991-3#1)
that the inhibitor##3##3##(1990-5#1)(1991-3#1)(1994-11#1)
that the inhibitory effect of##2##5##(1991-6#1)(1994-8#1)
that the inhibitory effects of##2##5##(1995-11#1)(2008-11#1)
that the inhibitory effects##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
that the inhibitory##6##3##(1990-5#1)(1991-6#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
that the initial##8##3##(1990-10#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)
that the initiation of##2##4##(2008-10#1)(2008-6#1)
that the injection of##2##4##(2008-8#1)(2012-3#1)
that the inner##2##3##(1995-3#1)(2008-8#1)
that the insertion##2##3##(2008-8#1)(2009-7#1)
that the instrument##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
that the integrated##2##3##(1997-8#1)(2008-10#1)
that the integrity of the##2##5##(2008-10#1)(2008-7#1)
that the intensity of##2##4##(1997-2#1)(2008-10#1)
that the intensity##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
that the interaction between##2##4##(2008-8#2)
that the interaction of##5##4##(1994-6#1)(2008-10#3)(2008-9#1)
that the interaction##10##3##(1994-6#1)(1995-2#1)(2008-10#5)(2008-8#2)(2008-9#1)
that the interference from##2##4##(2008-10#1)(2008-3#1)
that the interference##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
that the interferences##2##3##(2008-10#2)
that the intermediary##2##3##(2008-10#2)
that the intervention##2##3##(2008-12#1)(2008-9#1)
that the introduction of##3##4##(1990-5#1)(2008-11#1)(2013-1#1)
that the iron chalcogenide membrane comprises##2##6##(2008-10#2)
that the iron##3##3##(2008-10#3)
that the isolated##2##3##(2008-10#1)(2008-8#1)
that the isolates were##2##4##(1996-12#1)(2008-10#1)
that the isolates##4##3##(1996-12#1)(2008-10#3)
that the key to##2##4##(2011-2#2)
that the key##3##3##(1992-8#1)(2011-2#2)
that the lack of##6##4##(1991-2#1)(2006-6#1)(2008-10#2)(2009-10#1)(2013-8#1)
that the lateral##2##3##(1993-6#1)(2009-10#1)
that the latter method##2##4##(2008-10#1)(2011-2#1)
that the latter##7##3##(1995-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)
that the law##2##3##(1991-9#1)(1997-8#1)
that the length##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
that the lesion##3##3##(1992-2#1)(2010-6#1)(2013-1#1)
that the lesions##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
that the level of##12##4##(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-8#2)(2013-8#1)
that the light##2##3##(2008-10#1)(2013-8#1)
that the longer##3##3##(1990-2#1)(1995-8#1)(2008-5#1)
that the loss of##3##4##(1995-6#1)(1997-7#1)(2013-1#1)
that the loss##4##3##(1995-6#1)(1997-7#1)(2008-3#1)(2013-1#1)
that the low##5##3##(1991-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
that the lower##2##3##(2008-11#1)(2013-1#1)
that the lung##2##3##(2010-5#1)(2011-3#1)
that the mRNA##2##3##(1995-8#1)(1996-12#1)
that the magnetic field increased##2##5##(2008-8#2)
that the magnetic field##4##4##(2008-8#4)
that the magnitude of the##3##5##(2008-10#2)(2008-9#1)
that the magnitude of##5##4##(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)
that the main##12##3##(1990-6#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)
that the maintenance of##3##4##(1991-2#1)(2008-10#1)(2013-1#1)
that the major##12##3##(1990-5#1)(1994-11#1)(1997-8#1)(1997-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-3#1)
that the majority of the##3##5##(1996-6#1)(1997-3#2)
that the majority of##13##4##(1990-8#1)(1993-2#1)(1996-6#1)(1997-3#2)(1997-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-2#1)
that the majority were##2##4##(2008-12#1)(2011-2#1)
that the majority##16##3##(1990-8#1)(1993-2#1)(1996-6#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)
that the male##4##3##(2008-8#2)(2010-5#1)(2011-1#1)
that the management##2##3##(1991-3#1)(1996-3#1)
that the mass was a##2##5##(2008-7#1)(2013-8#1)
that the mass##3##3##(2008-7#1)(2008-9#1)(2013-8#1)
that the maximum##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
that the mean##7##3##(1994-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-7#1)(2012-3#1)
that the measure##3##3##(1995-6#2)(2008-10#1)
that the measurement##3##3##(2006-6#1)(2008-12#1)(2008-3#1)
that the mechanical##2##3##(1995-2#1)(2009-7#1)
that the mechanism of##5##4##(1990-2#1)(1991-5#1)(1997-2#1)(2008-10#1)(2013-8#1)
that the mechanisms of##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
that the mechanisms##4##3##(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
that the medial##3##3##(1992-12#1)(2008-11#1)(2008-7#1)
that the medical##3##3##(1992-3#1)(2008-11#1)(2010-8#1)
that the medium##2##3##(2008-11#1)(2008-7#1)
that the members of a##2##5##(2008-9#1)(2011-2#1)
that the mentor##2##3##(2008-12#1)(2008-7#1)
that the metapopulation##2##3##(2008-10#1)(2008-8#1)
that the method is suitable for the##2##7##(2008-10#2)
that the method is##8##4##(2008-10#7)(2009-5#1)
that the method was##4##4##(2008-10#3)(2008-8#1)
that the method##24##3##(2008-10#18)(2008-3#1)(2008-8#1)(2009-5#1)(2010-6#2)(2013-8#1)
that the methodology##2##3##(2008-10#2)
that the methods##2##3##(1995-9#1)(2008-5#1)
that the microenvironment of##2##4##(2008-10#2)
that the minimal##2##3##(1993-12#1)(2012-2#1)
that the mixture##2##3##(1990-12#1)(2012-3#1)
that the model has##2##4##(2008-10#1)(2013-8#1)
that the model is##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
that the model##10##3##(1991-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)(2013-8#1)
that the modification of##2##4##(2008-10#1)(2008-7#1)
that the modified electrode##2##4##(2008-10#2)
that the modified##5##3##(1992-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
that the molecular##2##3##(2008-2#1)(2009-6#1)
that the more##4##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
that the morphology of##2##4##(1991-12#1)(2008-7#1)
that the most common##2##4##(2008-9#1)(2011-2#1)
that the most important##4##4##(1995-12#1)(2008-10#2)(2008-9#1)
that the most##17##3##(1994-3#1)(1994-8#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
that the mutant##5##3##(1991-2#1)(1995-2#1)(2008-10#2)(2008-8#1)
that the mutation##2##3##(2008-12#1)(2008-9#1)
that the mutations##4##3##(1995-6#1)(2008-10#2)(2008-8#1)
that the native##3##3##(1990-5#1)(1993-8#1)(2008-10#1)
that the natural##3##3##(1997-1#1)(2010-1#1)(2010-10#1)
that the nature of##4##4##(1994-5#1)(2008-10#2)(2008-11#1)
that the negative##4##3##(1995-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
that the network##2##3##(1994-3#1)(2008-10#1)
that the neural##7##3##(1991-2#1)(1996-2#1)(2008-10#1)(2008-11#3)(2013-8#1)
that the new##5##3##(1992-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2009-6#1)
that the normal##3##3##(2008-12#1)(2008-5#1)(2008-9#1)
that the novel##2##3##(2008-10#1)(2010-10#1)
that the nucleus accumbens##2##4##(1994-2#1)(2008-7#1)
that the number of##22##4##(1991-2#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
that the number##23##3##(1991-2#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
that the observed##9##3##(1992-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2013-7#1)
that the oil##2##3##(2008-11#1)(2008-5#1)
that the only##2##3##(1991-7#1)(2010-12#1)
that the open##2##3##(2008-10#2)
that the opening##2##3##(2008-9#2)
that the optical##2##3##(1990-8#1)(2013-8#1)
that the optimal##8##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#4)
that the optimum##4##3##(2008-10#3)(2008-3#1)
that the original##2##3##(1995-9#1)(2008-11#1)
that the oscillation##2##3##(2008-10#1)(2010-10#1)
that the other##2##3##(1997-3#1)(2008-8#1)
that the outer##2##3##(1997-8#1)(2008-7#1)
that the outpatient##2##3##(1994-2#1)(2008-11#1)
that the overall##8##3##(1993-2#1)(2008-11#1)(2008-5#1)(2010-6#1)(2010-7#1)(2012-2#2)(2013-8#1)
that the oxidative burst##2##4##(1995-6#1)(2008-10#1)
that the oxidative##3##3##(1991-5#1)(1995-6#1)(2008-10#1)
that the paradigm##2##3##(1994-12#1)(2013-8#1)
that the partial##3##3##(1997-2#1)(2008-11#2)
that the particles##2##3##(1996-12#1)(1997-1#1)
that the pathogen##7##3##(2008-10#6)(2008-8#1)
that the pathway##2##3##(2008-10#1)(2011-3#1)
that the patient had##2##4##(1996-6#1)(2011-2#1)
that the patient is##2##4##(1990-11#1)(2013-1#1)
that the patient##6##3##(1990-11#1)(1996-5#1)(1996-6#1)(2008-11#1)(2011-2#1)(2013-1#1)
that the patients with##2##4##(1994-12#1)(2011-2#1)
that the pattern of##2##4##(1994-5#1)(2008-10#1)
that the peak##5##3##(2008-10#5)
that the peptide##6##3##(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#2)(2008-10#1)
that the peptides##2##3##(1997-2#1)(2008-9#1)
that the percentage of##2##4##(2008-10#1)(2008-8#1)
that the performance of##3##4##(2008-10#2)(2008-12#1)
that the performance##4##3##(1992-2#1)(2008-10#2)(2008-12#1)
that the period of##2##4##(2008-10#2)
that the permeability##2##3##(2008-11#1)(2008-7#1)
that the phenomenon of##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
that the phenomenon##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
that the phosphorylation##2##3##(1993-8#1)(1997-2#1)
that the physiological##2##3##(2008-8#1)(2013-1#1)
that the phytoplasmas##2##3##(2008-10#2)
that the plant##2##3##(1992-3#1)(1994-11#1)
that the policy##2##3##(1992-12#1)(1996-5#1)
that the polymer##5##3##(2008-10#1)(2008-11#2)(2008-5#1)(2011-3#1)
that the poor##3##3##(1991-2#1)(1992-2#1)(2011-3#1)
that the population of##2##4##(2008-10#2)
that the population##7##3##(1992-9#1)(2008-10#4)(2008-12#1)(2008-8#1)
that the populations are##2##4##(2008-10#1)(2008-6#1)
that the porcine##2##3##(2008-11#1)(2012-2#1)
that the positive##3##3##(1994-2#1)(2008-6#1)(2008-8#1)
that the potency##2##3##(1992-3#1)(1994-8#1)
that the potential##2##3##(1991-3#1)(2008-4#1)
that the precision##2##3##(2008-2#1)(2008-3#1)
that the predicted##2##3##(1993-12#1)(2008-8#1)
that the predominant##2##3##(1992-12#1)(2008-12#1)
that the preference##2##3##(2008-5#1)(2008-9#1)
that the prepared##2##3##(2008-10#2)
that the presence of a##2##5##(2008-10#2)
that the presence of the##3##5##(2008-10#2)(2011-2#1)
that the presence of##31##4##(1990-5#1)(1992-9#2)(1995-11#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
that the present##6##3##(1996-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-6#1)
that the presented##2##3##(2008-10#1)(2008-11#1)
that the presently##2##3##(1991-2#1)(1995-12#1)
that the prevalence of##6##4##(1990-6#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-8#1)(2012-12#1)
that the previously##3##3##(1990-5#1)(1992-4#1)(1995-9#1)
that the primary##6##3##(1991-5#1)(1994-12#1)(1997-7#1)(2008-10#1)(2009-8#1)(2010-4#1)
that the principal##2##3##(2008-10#1)(2008-11#1)
that the probability of##4##4##(1990-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
that the procedure is##2##4##(2008-10#1)(2011-2#1)
that the procedure##6##3##(1995-12#1)(1996-9#1)(2008-10#3)(2011-2#1)
that the process of##2##4##(2008-11#1)(2012-3#1)
that the process##6##3##(1990-11#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
that the processes##2##3##(2008-3#1)(2008-7#1)
that the product##7##3##(1995-2#1)(2008-10#1)(2008-11#3)(2011-2#1)(2012-2#1)
that the production of##4##4##(1994-8#1)(1997-8#1)(2008-11#1)(2008-7#1)
that the program has##3##4##(1991-1#1)(1992-2#1)(1995-12#1)
that the program##4##3##(1991-1#1)(1992-12#1)(1992-2#1)(1995-12#1)
that the promoter##3##3##(1993-3#1)(1996-12#1)(2011-1#1)
that the properties of the##2##5##(1991-4#1)(1993-8#1)
that the proportion of##3##4##(1991-3#1)(1992-12#1)(2008-10#1)
that the proposed method is##3##5##(2008-10#2)(2012-3#1)
that the proposed method##5##4##(2008-10#4)(2012-3#1)
that the proposed model##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
that the proposed procedure##5##4##(2008-10#5)
that the proposed##25##3##(1995-9#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
that the protective##2##3##(1993-6#1)(2010-7#1)
that the protein is##2##4##(1996-12#1)(2008-5#1)
that the protein##9##3##(1990-5#1)(1993-12#1)(1995-2#1)(1996-12#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-1#1)
that the proteins were##2##4##(1995-8#1)(1996-2#1)
that the proteins##3##3##(1995-2#1)(1995-8#1)(1996-2#1)
that the public##3##3##(1996-11#1)(1996-3#1)(1997-8#1)
that the purified##3##3##(1990-10#1)(1995-8#1)(2008-9#1)
that the purity of##2##4##(2008-11#1)(2008-8#1)
that the purpose of##2##4##(2008-11#1)(2012-2#1)
that the putative##2##3##(2008-10#1)(2009-3#1)
that the quality of the##2##5##(1991-6#1)(2008-11#1)
that the quality of##5##4##(1991-6#1)(1994-5#1)(1997-1#1)(2008-11#1)(2011-2#1)
that the quality##6##3##(1991-6#1)(1994-5#1)(1997-1#1)(2008-1#1)(2008-11#1)(2011-2#1)
that the radar##2##3##(2008-3#2)
that the rat##2##3##(1991-6#1)(1993-8#1)
that the rate of##7##4##(1991-2#1)(1992-1#2)(1993-3#1)(2008-10#1)(2008-11#1)(2009-4#1)
that the rate##11##3##(1991-2#1)(1992-1#2)(1993-3#1)(2008-10#4)(2008-11#1)(2009-4#1)(2013-1#1)
that the ratio of##5##4##(1991-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
that the ratio##6##3##(1991-12#1)(2008-10#2)(2008-11#2)(2008-4#1)
that the reaction of##3##4##(1996-5#1)(2008-10#2)
that the reaction rate##3##4##(2008-10#2)(2011-2#1)
that the reaction##8##3##(1996-5#1)(2008-10#6)(2011-2#1)
that the reactions##2##3##(2008-10#2)
that the reader will##2##4##(2008-4#1)(2012-3#1)
that the real##2##3##(1994-1#1)(2010-12#1)
that the recently##2##3##(2008-10#1)(2011-2#1)
that the receptor##4##3##(1990-11#1)(1991-5#1)(2008-4#1)(2008-7#1)
that the recombinant##5##3##(1990-11#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#1)
that the reconstituted##2##3##(1993-8#1)(2008-11#1)
that the recovery of##2##4##(2008-10#2)
that the recovery##4##3##(2008-10#3)(2013-8#1)
that the reduced##7##3##(1995-12#1)(1997-3#1)(2008-10#3)(2008-5#1)(2008-9#1)
that the reduction in##2##4##(2008-8#1)(2010-7#1)
that the reduction##3##3##(1990-8#1)(2008-8#1)(2010-7#1)
that the region##4##3##(1990-10#1)(1997-8#1)(2008-8#2)
that the regulatory##2##3##(1995-12#1)(2011-10#1)
that the related##2##3##(2009-8#1)(2012-12#1)
that the relationship between##5##4##(2008-10#1)(2008-11#2)(2008-8#2)
that the relationship##6##3##(2008-10#2)(2008-11#2)(2008-8#2)
that the relationships between##2##4##(2009-7#2)
that the relative standard##2##4##(2008-10#2)
that the relative##8##3##(1994-8#1)(1996-5#1)(2008-10#3)(2008-5#1)(2011-1#1)(2012-3#1)
that the relaxation##2##3##(2008-12#1)(2008-3#1)
that the release of##4##4##(1992-6#1)(2008-10#2)(2008-11#1)
that the research##2##3##(1995-1#1)(2008-11#1)
that the resistance is##3##4##(2008-10#3)
that the resistance of the##2##5##(1991-5#1)(2008-10#1)
that the resistance of##4##4##(1991-5#1)(2008-10#3)
that the resistance was##2##4##(2008-10#2)
that the resistance##12##3##(1991-5#1)(2008-10#11)
that the respective##2##3##(1995-11#1)(2008-1#1)
that the response is##2##4##(2008-10#1)(2008-3#1)
that the response of##5##4##(1997-3#1)(2008-10#3)(2008-11#1)
that the response##13##3##(1997-3#1)(2008-10#6)(2008-11#4)(2008-3#1)(2009-8#1)
that the responses##2##3##(2008-9#1)(2009-8#1)
that the resulting##3##3##(1991-6#1)(2008-9#1)(2010-3#1)
that the results of##2##4##(2008-8#2)
that the results##7##3##(1991-6#1)(1997-1#1)(2008-10#1)(2008-8#2)(2010-8#1)(2012-5#1)
that the retention##4##3##(1992-6#1)(2008-10#3)
that the risk of##4##4##(1992-9#1)(2008-11#1)(2008-4#1)(2013-1#1)
that the risk##7##3##(1992-2#1)(1992-9#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
that the role##4##3##(1991-5#1)(1996-12#1)(2008-11#1)(2010-1#1)
that the rust##2##3##(2008-10#2)
that the same gene##2##4##(2008-10#2)
that the same##13##3##(1994-12#1)(1995-3#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#2)(2009-8#1)
that the sample##3##3##(1995-9#1)(2008-10#2)
that the samples##2##3##(2008-10#2)
that the sampling##2##3##(2008-10#2)
that the scientific##2##3##(2012-3#1)(2013-1#1)
that the second##6##3##(1995-6#1)(1997-2#1)(2007-11#1)(2008-3#1)(2009-6#1)(2009-8#1)
that the secondary structure of##4##5##(1992-8#1)(1993-8#1)(2008-10#2)
that the secondary##5##3##(1992-8#1)(1993-8#1)(2007-12#1)(2008-10#2)
that the selectivity##3##3##(2008-10#3)
that the sensitivity of the##5##5##(1997-2#1)(2008-10#3)(2008-8#1)
that the sensitivity of##8##4##(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#2)
that the sensor can##2##4##(2008-10#2)
that the sensor##4##3##(2008-10#4)
that the sequence##2##3##(1996-2#1)(2008-8#1)
that the sequences##4##3##(1995-8#1)(1996-2#1)(2011-2#1)(2011-3#1)
that the serotonin##2##3##(2008-5#2)
that the severity of the##2##5##(2008-5#1)(2009-7#1)
that the severity of##3##4##(1991-9#1)(2008-5#1)(2009-7#1)
that the sex difference in##2##5##(1994-2#1)(2008-4#1)
that the sex##4##3##(1994-2#1)(2008-4#1)(2012-3#1)(2013-8#1)
that the signal##4##3##(1993-8#1)(1996-3#1)(2007-11#1)(2008-10#1)
that the signaling##2##3##(2008-8#1)(2010-4#1)
that the single##3##3##(1993-12#1)(2008-10#1)(2012-2#1)
that the sites##3##3##(1993-8#1)(1994-5#2)
that the size of the##2##5##(1997-2#1)(2008-8#1)
that the size of##4##4##(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
that the size##5##3##(1992-8#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
that the skill set##2##4##(2007-12#2)
that the skills##2##3##(2008-11#1)(2012-2#1)
that the skin##4##3##(1995-11#1)(2008-5#3)
that the small##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
that the soil##2##3##(2008-10#2)
that the solubility of##2##4##(2008-10#2)
that the soluble##2##3##(1992-6#2)
that the spatial##3##3##(2008-10#2)(2008-11#1)
that the species##9##3##(2008-10#3)(2008-8#3)(2008-9#1)(2012-2#1)(2012-3#1)
that the specific##5##3##(1996-8#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
that the specificity##2##3##(1992-3#1)(1994-3#1)
that the spectral properties##2##4##(1992-1#1)(1994-11#1)
that the speech##2##3##(2008-2#1)(2008-9#1)
that the speed of##2##4##(2008-10#1)(2008-6#1)
that the spinach curtovirus##2##4##(2008-10#2)
that the stability##2##3##(2008-10#2)
that the standard##3##3##(1995-9#1)(2008-10#1)(2008-12#1)
that the state##3##3##(1995-2#2)(2008-11#1)
that the stereochemistry of##2##4##(1996-5#1)(2011-2#1)
that the stimulation of##3##4##(1994-8#1)(2008-11#2)
that the stimulatory##2##3##(1997-8#1)(2013-1#1)
that the stoichiometry of##2##4##(1991-5#1)(2008-10#1)
that the stoichiometry##3##3##(1991-5#1)(1996-2#1)(2008-10#1)
that the strains##4##3##(1996-12#1)(2008-10#3)
that the stratum corneum##2##4##(2008-5#2)
that the strength of##2##4##(2008-11#1)(2008-8#1)
that the strength##3##3##(2008-11#1)(2008-8#1)(2009-9#1)
that the structural##4##3##(1991-3#1)(2008-11#1)(2008-8#2)
that the structure##3##3##(1992-4#1)(1993-6#1)(1994-3#1)
that the structures##3##3##(1992-4#1)(2008-7#1)(2008-8#1)
that the student##2##3##(2008-11#2)
that the students##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
that the study of ethics offers no right or wrong responses##2##11##(1994-1#2)
that the study##5##3##(1993-3#1)(1994-1#2)(2008-11#1)(2011-2#1)
that the subject##2##3##(1990-2#1)(2008-11#1)
that the superior##2##3##(2008-7#1)(2008-8#1)
that the suppression of the##2##5##(1993-12#1)(2008-5#1)
that the suppression of##3##4##(1993-12#1)(2008-11#1)(2008-5#1)
that the suppressive##2##3##(2008-10#1)(2009-8#1)
that the surface##7##3##(2008-10#4)(2009-7#1)(2013-1#1)(2013-8#1)
that the survival of##2##4##(1991-3#1)(1993-8#1)
that the swarming##2##3##(2009-6#2)
that the synthesis of##3##4##(1990-11#1)(1996-11#1)(1997-1#1)
that the synthesis##4##3##(1990-11#1)(1995-11#1)(1996-11#1)(1997-1#1)
that the system can##2##4##(2008-10#1)(2008-3#1)
that the system##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
that the technique could##2##4##(2008-10#1)(2008-7#1)
that the technique may be##2##5##(1992-2#1)(2006-6#1)
that the technique##7##3##(1992-2#1)(1996-3#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-7#1)
that the temperature##2##3##(2008-10#1)(2008-3#1)
that the tensile##2##3##(2008-7#1)(2009-7#1)
that the term##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that the terminal##2##3##(2008-12#1)(2008-8#1)
that the testing of##2##4##(1993-3#1)(2012-2#1)
that the theoretical##2##3##(2008-11#1)(2012-3#1)
that the thermal##2##3##(2008-10#2)
that the three groups##2##4##(2008-10#1)(2009-9#1)
that the three##17##3##(1995-6#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)
that the thymic##2##3##(1993-12#1)(2013-7#1)
that the time##2##3##(2011-2#1)(2013-1#1)
that the total amount of##2##5##(1991-6#1)(2008-10#1)
that the total##7##3##(1991-6#1)(1994-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)
that the traditional##3##3##(1996-1#1)(2008-10#1)(2012-3#1)
that the transcription##2##3##(1993-12#1)(2010-11#1)
that the transfer of##2##4##(2008-11#1)(2008-3#1)
that the transmission##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
that the transport##2##3##(1994-6#1)(2008-10#1)
that the tumor cells##2##4##(1997-1#2)
that the tumor was##2##4##(2008-12#1)(2013-1#1)
that the tumor##6##3##(1991-5#1)(1997-1#2)(2008-12#1)(2011-2#1)(2013-1#1)
that the tumour was##2##4##(2008-7#1)(2012-2#1)
that the two genes##2##4##(1990-11#1)(2008-10#1)
that the two species##3##4##(2008-10#2)(2008-9#1)
that the two##40##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#1)(1993-1#1)(1993-11#1)(1995-6#3)(1996-2#3)(1996-5#1)(2008-10#10)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
that the type and##2##4##(1995-12#1)(2008-11#1)
that the type of##2##4##(1995-11#1)(2008-10#1)
that the type##6##3##(1995-11#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#1)
that the university##3##3##(2008-10#2)(2008-12#1)
that the use of a##2##5##(1992-2#1)(2008-10#1)
that the use of the##2##5##(2008-10#1)(2011-2#1)
that the use of this##2##5##(2008-11#1)(2013-1#1)
that the use of##31##4##(1992-2#1)(1993-2#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#4)(2013-8#1)
that the values of##2##4##(2008-10#1)(2010-6#1)
that the values##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2010-6#1)
that the variability in the##2##5##(1991-12#1)(2008-10#1)
that the various##5##3##(1994-8#1)(1995-5#1)(1995-6#1)(2008-12#1)(2011-2#1)
that the vascular##2##3##(2008-10#1)(2008-5#1)
that the vast majority of##2##5##(2008-11#2)
that the vast##3##3##(2008-10#1)(2008-11#2)
that the vehicle in which a chemical is##2##8##(2008-5#2)
that the vehicle##4##3##(2008-5#4)
that the vesicular ER##2##4##(2009-8#2)
that the virulence##2##3##(2008-10#2)
that the virus##7##3##(2008-10#6)(2008-11#1)
that the viscosity of the##2##5##(2008-10#2)
that the viscosity##3##3##(2008-10#3)
that the visual input is both necessary and sufficient for the##2##11##(1991-2#2)
that the visual##4##3##(1991-2#2)(1995-5#1)(2008-8#1)
that the waiver program is##2##5##(1991-1#1)(1993-1#1)
that the waiver##3##3##(1991-1#1)(1992-2#1)(1993-1#1)
that the water-soluble fraction of Kefram-Kefir##2##6##(2008-11#2)
that the water-soluble fraction of##3##5##(2008-11#3)
that the weak CL of##2##5##(2008-10#2)
that the weak##3##3##(2008-10#3)
that the whole##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
that the width##2##3##(2008-3#2)
that the wireless ECG##2##4##(2010-8#2)
that the##3867##2##(1990-10#3)(1990-11#22)(1990-12#11)(1990-2#16)(1990-3#2)(1990-5#31)(1990-6#5)(1990-7#2)(1990-8#14)(1990-9#1)(1991-1#6)(1991-11#4)(1991-12#14)(1991-2#21)(1991-3#13)(1991-4#1)(1991-5#26)(1991-6#17)(1991-7#3)(1991-8#1)(1991-9#9)(1992-1#9)(1992-10#3)(1992-12#19)(1992-2#13)(1992-3#13)(1992-4#5)(1992-5#6)(1992-6#8)(1992-7#1)(1992-8#8)(1992-9#14)(1993-1#8)(1993-11#5)(1993-12#26)(1993-2#13)(1993-3#19)(1993-6#29)(1993-8#30)(1993-9#7)(1994-1#7)(1994-11#27)(1994-12#10)(1994-2#20)(1994-3#15)(1994-5#21)(1994-6#5)(1994-8#28)(1995-1#3)(1995-11#14)(1995-12#31)(1995-2#37)(1995-3#5)(1995-5#5)(1995-6#57)(1995-8#22)(1995-9#15)(1996-1#3)(1996-11#5)(1996-12#26)(1996-2#28)(1996-3#11)(1996-5#26)(1996-6#6)(1996-8#3)(1996-9#3)(1997-1#23)(1997-2#40)(1997-3#18)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#17)(1997-8#24)(1997-9#3)(2006-6#6)(2007-11#7)(2007-12#27)(2007-9#1)(2008-1#15)(2008-10#1014)(2008-11#304)(2008-12#62)(2008-2#17)(2008-3#125)(2008-4#18)(2008-5#113)(2008-6#35)(2008-7#87)(2008-8#207)(2008-9#131)(2009-1#4)(2009-10#13)(2009-11#6)(2009-12#7)(2009-3#6)(2009-4#2)(2009-5#7)(2009-6#17)(2009-7#23)(2009-8#36)(2009-9#9)(2010-1#14)(2010-10#12)(2010-11#7)(2010-12#10)(2010-2#3)(2010-3#13)(2010-4#12)(2010-5#12)(2010-6#14)(2010-7#14)(2010-8#15)(2010-9#2)(2011-1#10)(2011-10#2)(2011-2#113)(2011-3#20)(2012-12#10)(2012-2#45)(2012-3#57)(2012-5#1)(2012-8#1)(2013-1#93)(2013-7#7)(2013-8#55)
that their epitopes##2##3##(2008-8#2)
that their expression##3##3##(2008-12#1)(2008-6#1)(2010-4#1)
that their##45##2##(1990-8#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-8#1)
that then##3##2##(2008-3#1)(2010-7#1)(2013-1#1)
that there are a##2##4##(2008-4#1)(2008-8#1)
that there are at least##2##5##(2008-10#1)(2008-11#1)
that there are many##3##4##(2007-12#1)(2008-11#1)(2009-1#1)
that there are no significant differences between##2##7##(2008-10#2)
that there are no significant##3##5##(2008-10#2)(2008-11#1)
that there are no##5##4##(1996-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
that there are significant##3##4##(2008-1#1)(2008-12#1)(2010-12#1)
that there are six##2##4##(1994-2#1)(2010-1#1)
that there are some##3##4##(1992-3#1)(2008-11#1)(2012-3#1)
that there are two##10##4##(1992-3#1)(1994-5#1)(2008-10#1)(2008-3#2)(2008-8#2)(2008-9#2)(2011-3#1)
that there are##68##3##(1991-1#1)(1991-2#1)(1991-6#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-10#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
that there can be##3##4##(2008-12#1)(2008-8#2)
that there exist##4##3##(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
that there exists##2##3##(1997-2#1)(2008-9#1)
that there is a complex##2##5##(2010-8#1)(2011-2#1)
that there is a good##3##5##(1993-1#1)(2008-10#1)(2008-6#1)
that there is a high##2##5##(2008-10#1)(2008-9#1)
that there is a need for##5##6##(2008-11#1)(2009-12#1)(2013-1#3)
that there is a need##6##5##(2008-11#1)(2009-12#1)(2010-5#1)(2013-1#3)
that there is a significant##2##5##(2008-10#1)(2008-9#1)
that there is a##40##4##(1990-2#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#4)(2009-12#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
that there is an##7##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
that there is no direct relationship between##2##7##(1996-2#1)(2008-5#1)
that there is no relationship between##2##6##(2008-11#1)(2008-12#1)
that there is no##17##4##(1991-2#1)(1992-12#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-3#1)
that there is widespread##2##4##(1992-3#1)(2008-7#1)
that there is##91##3##(1990-2#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#3)(1996-3#2)(1997-1#2)(1997-9#1)(2007-11#1)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#5)(2009-1#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)
that there may be a##5##5##(1991-2#1)(1996-12#1)(2008-9#1)(2013-7#1)(2013-8#1)
that there may be##10##4##(1991-2#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
that there may##13##3##(1991-2#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
that there might be##3##4##(2009-10#1)(2010-10#1)(2012-2#1)
that there was a good##2##5##(2008-10#1)(2008-5#1)
that there was a significant##2##5##(2008-10#1)(2013-8#1)
that there was a strong##2##5##(1994-8#1)(2008-10#1)
that there was a wide variation in##2##7##(1997-3#1)(2012-3#1)
that there was a##18##4##(1991-12#1)(1991-3#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
that there was an##4##4##(1997-8#1)(2008-10#1)(2009-3#1)(2013-8#1)
that there was no evidence of##2##6##(2008-10#1)(2013-1#1)
that there was no significant difference between##2##7##(1997-8#1)(2008-10#1)
that there was no##15##4##(1991-2#1)(1992-12#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#2)
that there was##44##3##(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-8#2)(2008-10#13)(2008-11#5)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2012-3#2)(2013-1#2)(2013-8#2)
that there were many##3##4##(2008-10#2)(2008-8#1)
that there were no##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
that there were significant differences##3##5##(1993-2#1)(2008-10#1)(2008-12#1)
that there were##17##3##(1990-5#1)(1993-2#1)(1996-12#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#3)(2012-12#1)
that there##253##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#3)(1992-3#3)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-12#4)(1996-2#4)(1996-3#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#42)(2008-11#20)(2008-12#9)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#24)(2008-9#17)(2009-1#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#4)
that therefore##2##2##(1991-12#1)(2011-2#1)
that thermal lens spectrometry##2##4##(2008-10#2)
that thermal##4##2##(2008-10#3)(2008-9#1)
that these X##2##3##(1993-6#1)(2008-10#1)
that these actions##2##3##(1997-2#1)(2008-11#1)
that these agents##2##3##(2010-11#1)(2010-5#1)
that these antibodies are##2##4##(1991-2#1)(1995-12#1)
that these antibodies##3##3##(1991-2#1)(1995-12#1)(2008-11#1)
that these cells##3##3##(1990-8#1)(1996-12#1)(2008-11#1)
that these changes##2##3##(1992-6#1)(2011-2#1)
that these compounds are##3##4##(2006-6#1)(2008-10#1)(2008-8#1)
that these compounds##7##3##(1991-5#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-8#1)
that these differences##3##3##(1992-3#1)(1994-1#1)(1997-7#1)
that these disorders##2##3##(2011-2#1)(2012-3#1)
that these drugs may##3##4##(1993-2#1)(1993-8#1)(1995-2#1)
that these effects##2##3##(2009-6#1)(2012-3#1)
that these elements are##2##4##(1995-8#1)(2008-10#1)
that these factors##5##3##(1993-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
that these findings##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
that these genes were##2##4##(1996-8#1)(2010-4#1)
that these genes##6##3##(1995-12#1)(1996-8#1)(1997-8#1)(2008-10#1)(2009-8#1)(2010-4#1)
that these induced##2##3##(2008-7#1)(2009-10#1)
that these metal ions##3##4##(2008-10#3)
that these mutations##3##3##(1993-11#1)(1994-9#1)(1995-2#1)
that these neurons##2##3##(2009-10#1)(2013-8#1)
that these novel##2##3##(1995-6#1)(2012-3#1)
that these nurses##3##3##(2008-1#1)(2008-7#1)(2010-8#1)
that these parameters##2##3##(1992-3#1)(2008-7#1)
that these patterns##2##3##(2008-11#1)(2008-8#1)
that these populations are##2##4##(2008-10#2)
that these populations##3##3##(2008-10#3)
that these proteins are##4##4##(1994-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
that these proteins##6##3##(1993-8#1)(1994-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
that these relationships##2##3##(2009-4#1)(2009-5#1)
that these species are##2##4##(2008-10#1)(2008-11#1)
that these strains##3##3##(2008-10#1)(2013-8#2)
that these students had##2##4##(2008-11#2)
that these students##3##3##(2008-11#3)
that these tissues##2##3##(2008-1#1)(2012-2#1)
that these treatments##2##3##(2008-10#1)(2009-7#1)
that these two proteins##2##4##(1990-8#1)(1997-7#1)
that these two##19##3##(1990-8#1)(1992-12#1)(1993-12#2)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)
that these will##2##3##(2008-11#1)(2009-5#1)
that these##235##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-5#1)(1996-8#1)(1997-2#4)(1997-7#3)(1997-8#2)(2006-6#2)(2007-12#5)(2008-1#4)(2008-10#43)(2008-11#24)(2008-12#2)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#5)(2009-10#6)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#5)(2012-3#7)(2013-1#2)(2013-8#5)
that they are effective##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
that they are in##2##4##(2008-10#1)(2008-7#1)
that they are##38##3##(1990-11#1)(1990-2#1)(1991-5#1)(1992-3#1)(1993-12#2)(1993-3#1)(1995-1#1)(1995-3#1)(1996-6#1)(1997-2#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#4)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-3#1)
that they belong to##2##4##(2008-11#1)(2008-8#1)
that they can be##6##4##(1994-3#1)(2008-10#1)(2008-9#2)(2011-2#1)(2013-8#1)
that they can##12##3##(1994-3#1)(1997-5#1)(2008-10#3)(2008-9#3)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
that they could be##2##4##(1996-9#1)(2008-10#1)
that they could##9##3##(1994-3#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#2)(2013-8#1)
that they did not##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
that they do not##2##4##(1992-12#1)(1993-8#1)
that they do##3##3##(1991-2#1)(1992-12#1)(1993-8#1)
that they felt##2##3##(1994-3#1)(2008-11#1)
that they function##2##3##(1993-12#1)(2008-6#1)
that they had##9##3##(1992-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#2)
that they have a##2##4##(1991-12#1)(2008-1#1)
that they have##16##3##(1991-12#1)(1992-1#1)(1992-2#1)(1995-1#1)(1995-11#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#2)(2013-1#1)
that they include##2##3##(1997-3#1)(2008-11#1)
that they may be##3##4##(1993-8#1)(2008-11#1)(2008-8#1)
that they may have##2##4##(1992-2#1)(2008-5#1)
that they may##12##3##(1992-2#1)(1993-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
that they never##2##3##(1993-1#1)(2008-8#1)
that they represent##3##3##(2008-10#2)(2011-2#1)
that they share##4##3##(1995-2#1)(2007-12#1)(2008-10#2)
that they support the##2##4##(2010-5#1)(2012-2#1)
that they were derived from##3##5##(2008-10#3)
that they were##31##3##(1990-2#1)(1991-5#1)(1993-8#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2013-8#2)
that they will be##3##4##(1992-2#1)(1997-3#1)(1997-7#1)
that they will##6##3##(1992-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
that they would##7##3##(1990-6#2)(2010-4#4)(2011-2#1)
that they##233##2##(1990-11#1)(1990-2#3)(1990-6#3)(1991-12#2)(1991-2#2)(1991-5#2)(1992-1#1)(1992-12#1)(1992-2#6)(1992-3#3)(1992-9#1)(1993-1#2)(1993-12#3)(1993-3#1)(1993-8#3)(1994-3#3)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#5)(1997-5#2)(1997-7#1)(1997-8#2)(2007-12#2)(2008-1#4)(2008-10#39)(2008-11#20)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#10)(2008-9#10)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#6)(2010-5#2)(2010-8#5)(2011-1#1)(2011-2#15)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#5)
that this &quot##3##3##(1993-1#1)(1995-5#1)(2009-3#1)
that this DNA fragment##2##4##(2008-8#2)
that this activation##2##3##(1994-2#1)(2012-12#1)
that this agent##2##3##(1995-8#1)(2008-10#1)
that this antibody##2##3##(2013-1#2)
that this approach can##2##4##(1995-6#1)(2008-11#1)
that this approach##5##3##(1992-9#1)(1995-6#1)(2008-11#1)(2008-7#1)(2010-7#1)
that this approximation##2##3##(2008-3#1)(2013-1#1)
that this area may##2##4##(2007-12#1)(2008-10#1)
that this area##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
that this change##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
that this clone##2##3##(1993-6#1)(2008-8#1)
that this component##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
that this compound##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
that this cycle##2##3##(2008-9#2)
that this device##2##3##(2008-11#1)(2008-5#1)
that this disease##2##3##(1994-9#1)(1997-8#1)
that this effect is##2##4##(1993-3#1)(2009-4#1)
that this effect##5##3##(1993-3#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)
that this event##2##3##(2008-10#1)(2009-10#1)
that this factor##2##3##(1992-6#1)(1994-12#1)
that this form##2##3##(1990-5#1)(1993-6#1)
that this gene is##3##4##(1990-12#1)(1993-9#1)(1994-12#1)
that this gene##8##3##(1990-12#1)(1992-3#1)(1993-9#1)(1994-12#1)(2008-2#1)(2008-8#2)(2008-9#1)
that this group of##2##4##(2008-11#1)(2012-2#1)
that this group##3##3##(1994-9#1)(2008-11#1)(2012-2#1)
that this has##2##3##(2008-10#1)(2008-11#1)
that this in vitro##4##4##(2008-11#2)(2008-5#2)
that this in##5##3##(2008-11#2)(2008-5#2)(2010-4#1)
that this increase##2##3##(2007-12#1)(2008-11#1)
that this information will be useful##2##6##(2008-12#1)(2012-2#1)
that this interaction##2##3##(2008-10#1)(2013-8#1)
that this is a##8##4##(1991-3#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2009-8#1)(2011-2#1)
that this is an important##2##5##(1993-1#1)(2008-10#1)
that this is an##3##4##(1993-1#1)(2008-1#1)(2008-10#1)
that this is due##2##4##(2012-3#2)
that this is the##2##4##(2008-11#1)(2010-3#1)
that this is##19##3##(1991-3#1)(1993-1#1)(1993-2#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-8#1)(2009-1#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#2)
that this may##3##3##(1990-5#1)(1991-5#1)(2008-7#1)
that this method can be##2##5##(1992-5#1)(2008-11#1)
that this method##8##3##(1992-5#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2011-2#1)
that this model##3##3##(2008-10#2)(2013-8#1)
that this molecule##2##3##(2008-10#2)
that this new##11##3##(1991-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2011-7#1)(2012-2#2)
that this organism##2##3##(1997-1#1)(1997-7#1)
that this particular##3##3##(1995-5#1)(2008-10#1)(2009-1#1)
that this phenomenon##2##3##(1992-8#1)(2008-9#1)
that this population##3##3##(2008-10#2)(2013-1#1)
that this procedure##4##3##(2008-10#2)(2009-8#1)(2012-2#1)
that this process##3##3##(2008-3#1)(2010-12#1)(2010-4#1)
that this property##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
that this protein##6##3##(1990-5#1)(1994-11#1)(1994-5#1)(1996-12#1)(2008-10#1)(2009-4#1)
that this receptor is##2##4##(1995-11#1)(2008-5#1)
that this receptor##4##3##(1993-3#1)(1994-8#1)(1995-11#1)(2008-5#1)
that this region##6##3##(1995-8#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-5#2)
that this relationship##2##3##(2008-10#1)(2008-4#1)
that this resistance##2##3##(2008-10#1)(2009-9#1)
that this role##2##3##(2008-10#1)(2012-2#1)
that this sensor can##2##4##(2008-10#1)(2008-2#1)
that this species is##2##4##(2008-10#1)(2012-6#1)
that this strain##2##3##(2008-10#1)(2012-2#1)
that this strategy##2##3##(1997-2#1)(2010-11#1)
that this system##2##3##(1997-8#1)(2008-11#1)
that this technique can##4##4##(2008-10#2)(2008-3#1)(2013-8#1)
that this technique##7##3##(2008-10#3)(2008-3#2)(2012-12#1)(2013-8#1)
that this technology##2##3##(2008-10#1)(2011-2#1)
that this type of##3##4##(1991-11#1)(1997-5#1)(2008-5#1)
that this virus##5##3##(2008-10#4)(2008-12#1)
that this was##2##3##(2008-10#1)(2011-2#1)
that this will be##2##4##(2008-11#1)(2008-5#1)
that this will##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
that this would be##2##4##(1994-5#1)(2008-10#1)
that this would##3##3##(1994-5#1)(1997-1#1)(2008-10#1)
that this##397##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#4)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-5#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#4)(1995-2#1)(1995-5#5)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#2)(1996-6#1)(1996-8#2)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2006-6#2)(2007-12#5)(2007-9#1)(2008-1#2)(2008-10#83)(2008-11#37)(2008-12#8)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#19)(2008-6#2)(2008-7#10)(2008-8#18)(2008-9#7)(2009-1#4)(2009-10#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#11)(2011-7#1)(2012-12#2)(2012-2#9)(2012-3#6)(2012-6#1)(2013-1#9)(2013-8#7)
that those who##2##3##(2009-7#1)(2010-2#1)
that those##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)(2010-2#1)(2013-1#1)
that threaten##2##2##(1994-12#1)(2008-12#1)
that three different##2##3##(2008-10#1)(2008-12#1)
that three of##2##3##(1992-9#1)(2008-10#1)
that three##16##2##(1992-12#1)(1992-9#1)(1995-12#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2012-3#1)
that thrips##2##2##(2008-10#2)
that thrombin##2##2##(1997-7#2)
that through the##2##3##(2008-12#1)(2013-8#1)
that thymocytes##2##2##(2008-10#1)(2008-8#1)
that time##12##2##(1993-3#1)(1995-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-1#1)(2010-3#1)(2011-2#1)(2013-8#1)
that to achieve##2##3##(1995-1#1)(2008-7#1)
that to##14##2##(1992-1#1)(1993-8#1)(1995-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-3#1)(2013-1#2)
that together##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
that too##2##2##(2008-11#1)(2010-12#1)
that took into account##2##4##(1992-9#1)(2008-10#1)
that took place in##2##4##(2012-2#1)(2013-1#1)
that took place##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
that took##5##2##(1992-9#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
that total##3##2##(1994-3#1)(2008-12#1)(2012-2#1)
that trace##4##2##(2008-10#4)
that traditional##8##2##(1996-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#2)
that trait##4##2##(2008-11#2)(2008-8#1)(2012-3#1)
that traits that##2##3##(2008-8#1)(2012-3#1)
that transcriptional control##2##3##(1993-8#1)(1994-12#1)
that transcriptional##6##2##(1993-8#1)(1994-11#1)(1994-12#1)(2008-8#1)(2012-3#2)
that transgenic##4##2##(2008-10#3)(2008-8#1)
that transient##3##2##(1991-3#1)(1997-7#1)(2008-11#1)
that translocation of##2##3##(1991-12#1)(2008-9#1)
that transmission of##2##3##(2008-10#2)
that transmission##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
that transmit##3##2##(2008-10#2)(2012-2#1)
that transmits##2##2##(2008-10#1)(2008-3#1)
that transplantation of##2##3##(2010-12#1)(2011-2#1)
that treat##2##2##(2008-3#1)(2009-5#1)
that treated##3##2##(1995-2#1)(2008-10#1)(2008-12#1)
that treatment aimed at the##2##5##(2010-1#1)(2010-9#1)
that treatment of##5##3##(1990-5#1)(1997-5#1)(2008-10#2)(2011-2#1)
that treatment with VPA##2##4##(2011-2#2)
that treatment with##12##3##(1990-12#1)(1991-11#1)(1993-2#1)(1994-11#2)(1996-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#2)(2012-12#1)
that treatment##21##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-9#1)(1993-2#1)(1994-11#2)(1995-2#1)(1996-12#1)(1997-5#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#3)(2012-12#1)
that treatments##2##2##(2011-10#1)(2012-12#1)
that trigger##2##2##(2011-2#1)(2012-3#1)
that triggers##2##2##(2010-3#1)(2013-8#1)
that true##2##2##(2008-11#1)(2008-9#1)
that try to##2##3##(2009-8#1)(2011-2#1)
that try##3##2##(1995-1#1)(2009-8#1)(2011-2#1)
that tumor##7##2##(1994-11#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
that two different##2##3##(1994-5#1)(2008-8#1)
that two of the##4##4##(1992-3#1)(1994-11#1)(1996-12#1)(2008-10#1)
that two of them##2##4##(2008-9#1)(2012-3#1)
that two of##6##3##(1992-3#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
that two##37##2##(1990-9#1)(1991-12#1)(1992-3#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#2)(1995-8#1)(1996-12#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
that type IV##2##3##(2008-8#2)
that typically##5##2##(2008-10#4)(2008-8#1)
that ultimately leads to##2##4##(2008-10#1)(2008-11#1)
that ultimately##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
that ultrasound##3##2##(1991-6#1)(1997-8#1)(2011-2#1)
that under the##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
that under##13##2##(1990-6#1)(1992-3#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#2)
that undergo##3##2##(2009-5#1)(2010-4#2)
that underlie the##3##3##(2008-10#1)(2008-9#1)(2010-4#1)
that underlie##11##2##(1995-11#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2010-4#3)
that underlies##2##2##(2008-10#1)(2010-11#1)
that underwent##7##2##(1996-5#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
that unique##2##2##(2008-10#1)(2008-4#1)
that until##2##2##(1992-11#1)(2008-8#1)
that urinary##4##2##(1991-12#1)(1992-3#1)(2008-10#2)
that urine##2##2##(1990-2#1)(2011-2#1)
that use a##3##3##(2008-3#3)
that use of this##2##4##(2008-10#1)(2010-7#1)
that use of##9##3##(2008-10#5)(2008-12#1)(2010-10#1)(2010-7#1)(2010-9#1)
that use##27##2##(1993-3#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#7)(2008-7#1)(2010-10#1)(2010-7#1)(2010-9#1)(2012-2#4)
that used##14##2##(2008-10#7)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#4)
that uses a##9##3##(2007-11#1)(2008-2#1)(2008-3#4)(2008-7#2)(2012-3#1)
that uses an inclined##2##4##(2008-3#2)
that uses an##4##3##(2008-2#1)(2008-3#2)(2012-3#1)
that uses the##3##3##(2008-3#2)(2008-6#1)
that uses##40##2##(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#16)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#3)(2013-1#1)
that using a##3##3##(2008-10#1)(2008-11#2)
that using##10##2##(1993-2#1)(2008-10#5)(2008-11#2)(2010-5#1)(2012-3#1)
that usually occurs in##2##4##(2008-11#1)(2013-1#1)
that usually##6##2##(1997-3#1)(2008-11#2)(2008-9#1)(2009-1#1)(2013-1#1)
that utilize##7##2##(1997-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)
that utilized##3##2##(2008-10#2)(2012-2#1)
that utilizes the##3##3##(1994-5#1)(2008-3#1)(2012-2#1)
that utilizes##6##2##(1994-5#1)(1996-3#1)(2008-1#1)(2008-3#1)(2010-8#1)(2012-2#1)
that vaccination##3##2##(1996-3#1)(2008-5#1)(2012-12#1)
that variability in##3##3##(1995-11#1)(2008-10#1)(2008-7#1)
that variation in##2##3##(2008-8#1)(2008-9#1)
that variations in##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
that varied##5##2##(1994-2#1)(1995-3#1)(2008-10#2)(2013-1#1)
that varies##2##2##(2008-10#1)(2011-2#1)
that various##6##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2012-2#1)
that vary according to##2##4##(1995-1#1)(2010-6#1)
that vary in their##2##4##(1993-9#1)(2008-8#1)
that vary in##4##3##(1993-9#1)(2008-12#1)(2008-5#1)(2008-8#1)
that vary##9##2##(1993-9#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-3#1)
that varying##2##2##(2008-10#2)
that vertebral##2##2##(2011-2#2)
that vertebrate##2##2##(2011-2#1)(2012-3#1)
that vertical##2##2##(2011-3#2)
that very little##2##3##(1992-12#1)(2010-8#1)
that very low##2##3##(1991-12#1)(2008-10#1)
that very##7##2##(1991-12#1)(1992-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2010-8#1)
that viability##2##2##(2008-11#1)(2009-7#1)
that victims' reciprocal##2##3##(2009-7#2)
that virions##2##2##(2008-10#2)
that virtually all##2##3##(1997-2#1)(2008-10#1)
that virulence##3##2##(2008-10#3)
that virus replication##3##3##(1997-3#1)(2008-10#2)
that virus##8##2##(1997-3#2)(2008-10#5)(2011-2#1)
that vitamin B12 deficiency##2##4##(1993-12#1)(1995-11#1)
that vitamin B12##4##3##(1993-12#1)(1995-11#2)(2008-8#1)
that vitamin##9##2##(1993-12#1)(1994-3#1)(1995-11#2)(2008-11#2)(2008-8#2)(2012-3#1)
that volatile##2##2##(2008-11#2)
that volunteers##2##2##(1994-3#2)
that warrant##2##2##(1996-2#1)(2008-11#1)
that was consistently##2##3##(2008-10#1)(2008-9#1)
that was developed and##2##4##(2008-10#2)
that was developed for##2##4##(2008-10#1)(2009-3#1)
that was developed##7##3##(1992-2#1)(1994-3#1)(1995-2#1)(2008-10#3)(2009-3#1)
that was diagnosed##2##3##(2007-8#1)(2011-3#1)
that was either##2##3##(2008-10#1)(2008-11#1)
that was first##2##3##(2008-10#1)(2011-2#1)
that was followed by##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
that was found in##2##4##(2008-5#1)(2013-1#1)
that was independent of##2##4##(1993-3#1)(1995-6#1)
that was located near##2##4##(2012-3#2)
that was more##2##3##(2008-11#1)(2008-12#1)
that was no longer##2##4##(1995-2#1)(2008-11#1)
that was not observed in##2##5##(2008-10#1)(2008-11#1)
that was not##9##3##(2008-10#4)(2008-11#2)(2008-7#1)(2013-1#2)
that was observed##3##3##(1993-8#1)(2008-10#1)(2012-2#1)
that was originally##2##3##(2008-10#1)(2008-4#1)
that was recently##2##3##(2012-12#1)(2013-1#1)
that was reduced in##2##4##(1990-5#1)(2010-5#1)
that was segregating##2##3##(2008-10#2)
that was used to##2##4##(1997-2#1)(2008-10#1)
that was used##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
that was##168##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1992-1#1)(1992-10#2)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-3#2)(1994-5#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-3#4)(1997-8#1)(2007-8#1)(2008-10#54)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#1)
that water##5##2##(1994-8#1)(2008-10#1)(2008-5#2)(2011-2#1)
that way##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
that we are##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
that we believe##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
that we can##8##3##(1993-1#1)(1995-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#2)(2013-7#1)
that we have previously##2##4##(2008-10#1)(2012-2#1)
that we have produced##2##4##(1995-12#1)(2010-11#1)
that we have##7##3##(1993-12#1)(1995-12#1)(2008-10#2)(2008-9#1)(2010-11#1)(2012-2#1)
that we hypothesize##2##3##(2008-10#1)(2010-1#1)
that we named##3##3##(2008-11#1)(2008-5#1)(2010-10#1)
that we previously##2##3##(1995-5#1)(2008-9#1)
that we recently##2##3##(2008-5#1)(2011-2#1)
that we screened##2##3##(2008-10#1)(2009-8#1)
that we see##2##3##(2008-11#1)(2008-12#1)
that we used##2##3##(2008-3#1)(2008-8#1)
that we will##2##3##(2009-11#1)(2009-3#1)
that we##73##2##(1991-1#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-5#2)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
that weight##2##2##(2010-12#1)(2010-8#1)
that were also##2##3##(2008-10#2)
that were associated##2##3##(2008-10#2)
that were characteristic of##2##4##(1992-8#1)(2008-10#1)
that were characterized by##2##4##(1993-12#1)(2011-3#1)
that were collected in the##3##5##(2008-10#3)
that were collected##5##3##(1992-1#1)(2008-10#3)(2012-3#1)
that were comparable##2##3##(1995-6#1)(2013-1#1)
that were compared##2##3##(2008-10#1)(2010-9#1)
that were composed of##2##4##(2008-10#1)(2013-8#1)
that were considered##2##3##(2008-5#1)(2010-7#1)
that were consistent with the##2##5##(2008-11#2)
that were consistent with##3##4##(2008-10#1)(2008-11#2)
that were consistent##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
that were designed to##5##4##(1994-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#1)
that were detected##3##3##(2008-10#3)
that were developed##4##3##(2008-10#2)(2008-3#1)(2010-1#1)
that were either##2##3##(2008-10#1)(2009-8#1)
that were evaluated##2##3##(2008-10#2)
that were found to be significantly##2##6##(2007-12#1)(2008-12#1)
that were found to be##3##5##(2007-12#1)(2008-11#1)(2008-12#1)
that were found##6##3##(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)
that were greater than##2##4##(2008-10#2)
that were grouped##2##3##(2008-10#1)(2008-11#1)
that were highly##2##3##(2008-10#2)
that were identified as##5##4##(1996-12#1)(2008-10#2)(2012-3#1)(2013-8#1)
that were identified by##2##4##(1995-6#1)(1997-6#1)
that were identified##8##3##(1995-6#1)(1996-12#1)(1997-6#1)(2008-10#3)(2012-3#1)(2013-8#1)
that were in the##3##4##(2008-10#3)
that were in##5##3##(2008-10#4)(2013-1#1)
that were infected with R##2##5##(2008-10#2)
that were infected with##3##4##(2008-10#3)
that were inoculated with##2##4##(2008-10#2)
that were inoculated##5##3##(2008-10#5)
that were less##2##3##(2008-10#1)(2008-5#1)
that were more##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
that were not##20##3##(1993-6#1)(1997-3#1)(2008-10#10)(2008-11#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-4#1)(2013-1#2)
that were observed##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
that were open##2##3##(1992-9#1)(2008-10#1)
that were originally##3##3##(2008-10#2)(2008-11#1)
that were prepared##2##3##(2008-10#1)(2008-5#1)
that were present in##2##4##(2008-4#1)(2010-4#1)
that were present##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
that were previously##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-6#1)
that were recovered from##2##4##(2008-10#2)
that were resistant to##2##4##(2008-10#2)
that were seen##2##3##(1997-3#1)(2013-8#1)
that were sensitive##2##3##(2008-10#2)
that were significantly lower##2##4##(2008-10#1)(2013-8#1)
that were specific for each##2##5##(2008-10#2)
that were specific for##3##4##(2008-10#3)
that were specific##4##3##(2008-10#4)
that were studied##2##3##(2008-10#1)(2012-2#1)
that were successfully enriched##2##4##(2008-10#2)
that were synthesized##2##3##(2008-10#2)
that were taken##2##3##(1990-11#1)(2007-12#1)
that were tested##4##3##(2008-10#3)(2008-7#1)
that were treated with np-BNR##2##5##(2008-10#2)
that were treated with##4##4##(2008-10#3)(2011-2#1)
that were treated##5##3##(2008-10#3)(2009-1#1)(2011-2#1)
that were unaffected by##2##4##(1994-8#1)(1996-12#1)
that were used to##2##4##(2009-8#1)(2012-2#1)
that were used##3##3##(2008-6#1)(2009-8#1)(2012-2#1)
that were utilized##2##3##(1995-3#1)(2008-10#1)
that were virulent on##2##4##(2008-10#2)
that were well##2##3##(2008-5#1)(2008-8#1)
that were##317##2##(1990-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-8#2)(1994-9#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#155)(2008-11#20)(2008-12#10)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#8)(2008-9#3)(2009-1#2)(2009-10#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2011-3#2)(2011-9#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#10)(2013-8#6)
that when a##3##3##(1993-12#1)(2008-5#1)(2009-10#1)
that when the##4##3##(1997-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
that when##32##2##(1990-6#1)(1991-3#1)(1992-10#1)(1993-12#1)(1997-2#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2010-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
that which##7##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)
that while activation of##2##4##(1992-8#1)(2013-1#1)
that while the##3##3##(1990-5#1)(1996-3#1)(2008-11#1)
that while##23##2##(1990-5#1)(1991-5#1)(1992-8#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
that whilst##2##2##(2008-1#1)(2010-11#1)
that wild##2##2##(2008-10#1)(2008-8#1)
that will allow##3##3##(1991-2#1)(1997-3#1)(2008-10#1)
that will be used to##2##5##(1992-2#1)(1995-2#1)
that will be used##3##4##(1992-2#1)(1995-2#1)(2008-10#1)
that will be##15##3##(1992-2#1)(1995-1#1)(1995-2#2)(1996-3#1)(2008-10#5)(2008-11#1)(2008-3#2)(2009-12#1)(2012-2#1)
that will help##2##3##(2008-6#1)(2011-2#1)
that will lead to##2##4##(2008-11#1)(2012-3#1)
that will meet the##2##4##(1994-12#1)(2008-3#1)
that will result in a##2##5##(1991-2#1)(1994-12#1)
that will##65##2##(1990-11#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-3#2)(1997-1#4)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-3#3)(2008-6#2)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#1)
that winter##2##2##(2010-8#2)
that with a##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
that with the use of##2##5##(2008-10#1)(2008-11#1)
that with the##15##3##(1990-9#1)(1994-9#1)(1995-12#1)(2008-10#7)(2008-11#2)(2008-7#1)(2013-1#2)
that with##39##2##(1990-9#1)(1991-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(2007-11#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2011-2#2)(2013-1#3)
that within##5##2##(1992-4#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-3#1)
that without##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
that women are##2##3##(1995-12#1)(2008-1#1)
that women with##2##3##(2008-12#1)(2008-4#1)
that women##9##2##(1990-2#2)(1995-12#1)(2008-1#1)(2008-12#2)(2008-4#2)(2008-7#1)
that work##4##2##(1991-2#1)(1996-2#1)(2010-10#1)(2013-1#1)
that works on##2##3##(2008-10#1)(2010-4#1)
that works##5##2##(1992-12#1)(2008-10#2)(2008-12#1)(2010-4#1)
that would allow##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
that would be##5##3##(1990-8#1)(1996-9#1)(2008-10#1)(2008-3#1)(2010-11#1)
that would enable##2##3##(2008-10#1)(2012-2#1)
that would favor##2##3##(2008-9#1)(2009-10#1)
that would have been##3##4##(2008-10#1)(2008-7#2)
that would have##8##3##(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-7#2)(2008-9#1)
that would otherwise##5##3##(1996-3#1)(2008-10#3)(2011-2#1)
that would remain##2##3##(1996-12#1)(2013-1#1)
that would require##2##3##(1993-3#1)(2009-7#1)
that would##59##2##(1990-2#1)(1990-8#1)(1991-1#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#4)
that wrap around##2##3##(1994-5#1)(2008-9#1)
that year##4##2##(1991-1#1)(1993-12#1)(1997-3#1)(2008-10#1)
that yeast##7##2##(1993-6#1)(1996-3#1)(1997-3#2)(2008-10#2)(2011-2#1)
that yield##7##2##(1996-12#1)(1996-3#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
that yielded##4##2##(2008-10#4)
that yields##2##2##(1996-12#1)(2008-10#1)
that you##5##2##(1991-3#2)(1994-2#1)(1996-3#1)(2012-2#1)
that young##6##2##(1994-12#1)(1995-5#1)(2009-12#2)(2010-4#1)(2010-8#1)
that zinc##3##2##(2008-10#2)(2013-7#1)
that##23276##1##(1990-10#5)(1990-11#66)(1990-12#67)(1990-2#80)(1990-3#25)(1990-4#2)(1990-5#129)(1990-6#34)(1990-7#6)(1990-8#60)(1990-9#27)(1991-1#33)(1991-10#11)(1991-11#18)(1991-12#109)(1991-2#84)(1991-3#76)(1991-4#1)(1991-5#97)(1991-6#54)(1991-7#20)(1991-8#15)(1991-9#46)(1992-1#35)(1992-10#24)(1992-11#8)(1992-12#98)(1992-2#54)(1992-3#107)(1992-4#18)(1992-5#15)(1992-6#70)(1992-7#7)(1992-8#33)(1992-9#75)(1993-1#71)(1993-11#35)(1993-12#171)(1993-2#83)(1993-3#138)(1993-5#1)(1993-6#124)(1993-8#139)(1993-9#45)(1994-1#49)(1994-11#133)(1994-12#112)(1994-2#106)(1994-3#103)(1994-5#117)(1994-6#35)(1994-8#130)(1994-9#36)(1995-1#41)(1995-10#1)(1995-11#86)(1995-12#191)(1995-2#246)(1995-3#47)(1995-5#49)(1995-6#203)(1995-8#107)(1995-9#43)(1996-1#49)(1996-11#16)(1996-12#185)(1996-2#167)(1996-3#97)(1996-5#70)(1996-6#35)(1996-8#16)(1996-9#29)(1997-1#135)(1997-2#149)(1997-3#162)(1997-4#33)(1997-5#15)(1997-6#49)(1997-7#108)(1997-8#103)(1997-9#16)(2006-5#1)(2006-6#33)(2007-11#52)(2007-12#156)(2007-8#11)(2007-9#2)(2008-1#110)(2008-10#5269)(2008-11#1818)(2008-12#478)(2008-2#139)(2008-3#651)(2008-4#204)(2008-5#535)(2008-6#169)(2008-7#606)(2008-8#1117)(2008-9#889)(2009-1#32)(2009-10#179)(2009-11#32)(2009-12#99)(2009-2#3)(2009-3#57)(2009-4#52)(2009-5#62)(2009-6#82)(2009-7#138)(2009-8#284)(2009-9#62)(2010-1#105)(2010-10#120)(2010-11#101)(2010-12#119)(2010-2#26)(2010-3#61)(2010-4#97)(2010-5#85)(2010-6#78)(2010-7#108)(2010-8#119)(2010-9#40)(2011-1#103)(2011-10#14)(2011-2#885)(2011-3#66)(2011-4#1)(2011-7#8)(2011-9#2)(2012-12#128)(2012-2#491)(2012-3#453)(2012-4#2)(2012-5#8)(2012-6#4)(2012-7#4)(2012-8#1)(2012-9#4)(2013-1#609)(2013-3#1)(2013-7#43)(2013-8#383)
that's##2##1##(2008-11#1)(2010-6#1)
thatthe##6##1##(2008-11#6)
thaumatin-like protein##3##2##(2008-10#3)
thaw##3##1##(1996-8#1)(2008-11#1)(2008-9#1)
thawed##3##1##(2008-11#1)(2008-9#1)(2011-2#1)
thawing##15##1##(1994-11#1)(1994-8#1)(1996-3#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-9#3)
thaxtomin A in##2##3##(2008-10#2)
thaxtomin A##5##2##(2008-10#5)
thaxtomin##8##1##(2008-10#8)
thdF##2##1##(1996-12#2)
the %##2##2##(1991-5#1)(1992-11#1)
the &gt##2##2##(1996-2#1)(2008-10#1)
the &quot##180##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-6#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#5)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2008-1#2)(2008-10#22)(2008-11#10)(2008-12#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#6)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-12#3)(2010-4#2)(2010-7#3)(2010-8#1)(2011-2#7)(2011-3#1)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#2)
the '90s##4##2##(1992-1#1)(1992-3#1)(1994-3#2)
the 'B'##2##2##(1997-6#2)
the 'Oketsu'##3##2##(2008-10#3)
the 'all on##2##3##(2010-5#2)
the 'epidemic##2##2##(2008-10#2)
the 'stop' cue##3##3##(2008-11#3)
the 'urgent' cases##2##3##(1994-3#2)
the (0##2##2##(2008-3#2)
the (1)H##3##2##(2008-10#2)(2009-7#1)
the (13)C NMR##2##3##(1996-5#1)(2008-10#1)
the (27)Al NMR##2##3##(2008-10#2)
the (44)Ca/(42)Ca isotope##2##3##(2008-10#2)
the (45)Ca(2+) uptake##2##3##(2008-11#2)
the (n##2##2##(2008-10#1)(2008-3#1)
the +49(∗)G allele##2##3##(2010-12#2)
the -1##2##2##(2008-8#1)(2013-1#1)
the -c face of##2##4##(2008-2#2)
the 0##41##2##(1990-5#1)(1991-3#1)(1994-11#1)(1994-5#3)(1996-8#1)(2008-10#26)(2008-11#2)(2008-3#4)(2012-2#1)(2013-1#1)
the 0%##2##2##(2012-2#2)
the 0-50##2##2##(2008-10#2)
the 1 to##2##3##(2007-12#1)(2008-10#1)
the 1##76##2##(1992-3#1)(1993-1#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-12#2)(1995-8#1)(1996-2#2)(1996-5#5)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#37)(2008-11#2)(2008-2#1)(2008-3#5)(2008-8#3)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#1)
the 1-Mb##2##2##(1996-8#2)
the 1-month##2##2##(2008-10#2)
the 1-year follow-up##2##3##(2008-10#1)(2012-3#1)
the 1-year survival rate was##2##5##(1991-2#2)
the 1-year##6##2##(1991-2#2)(1991-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
the 10 Commandments##2##3##(2008-12#2)
the 10 inoculated isolates##2##4##(2008-10#2)
the 10 mg##2##3##(2008-10#2)
the 10 years##2##3##(1991-7#1)(2010-11#1)
the 10##30##2##(1990-2#1)(1991-7#1)(1995-1#1)(1995-6#1)(2008-10#12)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#3)(2008-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
the 10-year##4##2##(1993-2#1)(1997-2#1)(2009-10#1)(2013-1#1)
the 100##7##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-9#1)(2013-1#2)(2013-8#1)
the 100%##2##2##(2008-10#1)(2009-11#1)
the 1000##2##2##(1990-3#1)(2012-3#1)
the 101-point scale##2##3##(2012-2#2)
the 105##2##2##(2008-10#1)(2010-12#1)
the 106##2##2##(2008-10#1)(2011-2#1)
the 10th##2##2##(2008-12#1)(2008-5#1)
the 11##22##2##(1993-11#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#3)(2010-4#1)(2012-12#1)
the 110##2##2##(1990-11#1)(1994-9#1)
the 12 genes##2##3##(2009-10#2)
the 12 patients##3##3##(1991-11#1)(1997-7#1)(1997-8#1)
the 12##23##2##(1991-11#1)(1996-6#2)(1997-7#1)(1997-8#2)(2008-10#7)(2008-5#1)(2008-9#1)(2009-10#3)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
the 120##2##2##(2008-10#2)
the 125##2##2##(2008-1#1)(2008-9#1)
the 12th##6##2##(1992-8#2)(1994-6#1)(1996-6#1)(2008-10#1)(2009-5#1)
the 13##12##2##(1991-12#1)(1994-5#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-5#1)
the 130K replication protein##2##4##(2008-10#2)
the 133 RILs##2##3##(2008-10#2)
the 133##3##2##(2008-1#1)(2008-10#2)
the 13th##2##2##(1996-5#1)(2008-8#1)
the 14##10##2##(1991-2#1)(1991-6#1)(1993-8#1)(1996-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-1#2)
the 14-kDa##3##2##(1995-6#2)(2008-10#1)
the 15 min##2##3##(1994-6#1)(2008-5#1)
the 15##16##2##(1992-1#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-9#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
the 15- and##2##3##(1994-3#2)
the 15-##3##2##(1994-3#3)
the 15-ketosterol##3##2##(1993-6#3)
the 150##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
the 15th##4##2##(1995-8#1)(2008-10#1)(2008-7#1)(2009-10#1)
the 16##15##2##(1991-7#1)(1992-2#1)(1994-12#1)(1994-3#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#3)(2012-2#1)(2013-1#1)
the 1629-bp##2##2##(1993-12#2)
the 16S rDNA##3##3##(2008-10#1)(2008-12#2)
the 16S rRNA gene##3##4##(2008-10#1)(2009-6#1)(2013-8#1)
the 16S rRNA##6##3##(2008-10#4)(2009-6#1)(2013-8#1)
the 16S ribosomal RNA gene##2##5##(2011-2#1)(2013-1#1)
the 16S##12##2##(2008-10#6)(2008-12#2)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
the 16S-23S rDNA spacer region##2##5##(2008-10#2)
the 16S-23S rDNA##3##3##(2008-10#3)
the 16S-23S##4##2##(2008-10#4)
the 16SrI-B subgroup##2##3##(2008-10#2)
the 16s rRNA gene##2##4##(2008-10#1)(2008-12#1)
the 16th##4##2##(1997-4#1)(2008-11#2)(2008-7#1)
the 17##13##2##(1990-2#1)(1991-11#1)(1992-11#1)(2008-1#1)(2008-10#7)(2008-11#2)
the 17-kDa protein were##2##4##(2008-10#2)
the 17-kDa protein##4##3##(2008-10#4)
the 175R protein##3##3##(1993-2#3)
the 175R##4##2##(1993-2#4)
the 178##2##2##(1995-8#1)(2008-12#1)
the 17th##3##2##(1997-8#1)(2008-11#1)(2009-8#1)
the 18 patients##2##3##(1996-11#1)(2013-1#1)
the 18##11##2##(1996-11#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#3)(2009-8#1)(2012-2#1)(2013-1#1)
the 18-month##2##2##(2008-4#1)(2008-5#1)
the 181-bp PRE##2##3##(2012-3#2)
the 18S##6##2##(2008-10#5)(2008-9#1)
the 18q- syndrome##3##3##(1997-3#3)
the 18th and##2##3##(1993-11#1)(2008-6#1)
the 18th century##4##3##(1993-11#2)(2008-12#1)(2010-1#1)
the 18th##8##2##(1993-11#3)(2008-1#1)(2008-12#1)(2008-6#1)(2010-1#1)(2011-2#1)
the 19##10##2##(1990-2#1)(1991-1#2)(1997-7#1)(2008-10#3)(2008-12#1)(2010-11#1)(2013-8#1)
the 19(th) century##3##3##(2008-12#2)(2009-8#1)
the 1906##2##2##(1990-11#2)
the 1920s##2##2##(2008-10#1)(2010-1#1)
the 1930s##4##2##(1991-12#1)(2008-8#1)(2010-1#1)(2013-8#1)
the 1940s##5##2##(1993-6#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
the 1950s##2##2##(2008-5#1)(2010-10#1)
the 1960s##11##2##(1992-1#1)(1996-3#1)(1997-2#1)(2008-10#5)(2010-10#1)(2010-5#1)(2013-1#1)
the 1970s##18##2##(1991-2#2)(1991-3#3)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-10#4)(2009-7#1)
the 1980's and early 1990's##2##5##(2008-10#1)(2008-11#1)
the 1980's##3##2##(2008-10#1)(2008-11#2)
the 1980s by the##2##4##(1994-9#1)(2008-7#1)
the 1980s by##3##3##(1994-9#1)(2008-4#1)(2008-7#1)
the 1980s##16##2##(1991-11#1)(1991-3#2)(1992-2#1)(1993-3#2)(1994-2#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
the 1982##2##2##(1991-1#1)(1995-2#1)
the 1985##6##2##(1991-1#1)(1991-12#1)(1992-3#2)(1996-2#1)(2011-2#1)
the 1988 1990 data##2##4##(1995-9#2)
the 1988##5##2##(1992-1#1)(1992-2#1)(1994-3#1)(1995-9#2)
the 1989 Loma Prieta earthquake##2##5##(1990-11#2)
the 1989##8##2##(1990-11#2)(1991-1#1)(1992-1#1)(1992-2#1)(1993-3#1)(1995-12#1)(1995-2#1)
the 1989-90 influenza##2##3##(1992-6#2)
the 1990##4##2##(1990-3#1)(1991-5#1)(1992-12#1)(2010-7#1)
the 1990-91 influenza##2##3##(1992-6#2)
the 1990s##35##2##(1990-11#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#2)
the 1992 Medicare Current Beneficiary Survey (MCBS)##2##7##(1995-3#1)(1996-3#1)
the 1992##5##2##(1993-3#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#1)
the 1993##6##2##(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-3#1)(2008-10#1)
the 1995##7##2##(1996-6#2)(1997-2#1)(1997-3#1)(2008-10#3)
the 1996 to 1997##2##4##(2008-10#2)
the 1996##5##2##(1997-6#1)(2008-10#3)(2008-11#1)
the 1997 and##2##3##(2008-10#2)
the 1997##6##2##(1997-4#1)(2008-10#3)(2008-12#1)(2008-3#1)
the 1998##5##2##(2008-10#3)(2008-11#2)
the 1999##12##2##(2008-10#5)(2008-11#7)
the 19th century##6##3##(1991-6#1)(1994-5#1)(1996-1#1)(2008-10#1)(2008-12#1)(2012-2#1)
the 19th##9##2##(1991-6#1)(1993-11#1)(1994-5#1)(1995-11#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)
the 1BL##2##2##(2008-10#2)
the 1H##3##2##(1994-2#1)(1994-5#1)(2009-7#1)
the 1PS paper##3##3##(2008-10#3)
the 1st antibody##3##3##(2008-10#3)
the 1st##9##2##(1993-11#1)(1995-8#2)(2008-10#4)(2009-12#1)(2010-12#1)
the 2 groups##7##3##(1991-11#4)(1997-3#1)(2012-3#1)(2013-1#1)
the 2 microns plasmid##2##4##(1993-9#2)
the 2 years##3##3##(2008-10#3)
the 2##65##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#4)(1992-3#1)(1993-9#2)(1994-5#1)(1996-2#1)(1996-5#1)(1997-3#2)(2008-10#31)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the 2-D##2##2##(2010-12#1)(2010-8#1)
the 2-DE maps##2##3##(2011-3#2)
the 2-DE##3##2##(2008-12#1)(2011-3#2)
the 2-methyl-2-phenylpropyl radical##2##3##(1996-5#2)
the 2-position##3##2##(1994-5#1)(1997-1#1)(2008-12#1)
the 2-year##4##2##(1996-5#1)(2011-2#1)(2013-1#2)
the 20 reported##2##3##(2008-10#2)
the 20##21##2##(1990-2#1)(1993-1#1)(1995-12#1)(1997-5#1)(2008-10#13)(2008-12#1)(2008-8#1)(2011-2#2)
the 2000##12##2##(2008-10#2)(2008-11#8)(2011-2#2)
the 2001##12##2##(2008-10#2)(2008-11#9)(2012-12#1)
the 2002##13##2##(2008-10#5)(2008-11#6)(2008-3#1)(2011-2#1)
the 2003##11##2##(2008-10#1)(2008-11#8)(2008-6#1)(2010-5#1)
the 2004##10##2##(2008-10#1)(2008-11#7)(2011-2#1)(2012-2#1)
the 2005##13##2##(2008-11#8)(2008-12#1)(2008-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
the 2006##12##2##(2008-10#1)(2008-11#9)(2008-12#1)(2011-2#1)
the 2007##8##2##(2008-11#4)(2008-12#1)(2011-1#1)(2011-2#1)(2012-5#1)
the 2010##4##2##(2011-2#2)(2013-1#2)
the 20th century##11##3##(1994-12#1)(2008-10#4)(2008-4#2)(2008-8#1)(2010-1#1)(2010-10#1)(2011-7#1)
the 20th##16##2##(1994-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-8#2)(2010-1#1)(2010-10#1)(2010-6#1)(2011-7#1)
the 21 day##2##3##(1996-12#1)(2012-2#1)
the 21##8##2##(1991-12#1)(1991-2#1)(1993-9#1)(1996-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
the 21q22##2##2##(1997-2#1)(1997-8#1)
the 21st Century##2##3##(1995-12#1)(2011-2#1)
the 21st amino##2##3##(2012-2#2)
the 21st century and##2##4##(2008-11#1)(2012-12#1)
the 21st century##29##3##(1990-12#1)(1991-12#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-12#1)
the 21st##35##2##(1990-12#1)(1991-12#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
the 22##7##2##(1994-11#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
the 22-month-old##2##2##(1994-3#2)
the 22nd##2##2##(1990-12#1)(2011-2#1)
the 22q11##4##2##(1997-3#3)(2012-12#1)
the 23##8##2##(1991-2#1)(1994-12#1)(1996-3#1)(2008-10#2)(2008-8#1)(2010-10#1)(2013-8#1)
the 24 h##5##3##(1996-12#2)(1996-2#1)(2008-10#2)
the 24##14##2##(1993-2#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#4)(2011-1#1)(2012-12#1)(2012-3#1)
the 24-h mean##2##3##(1990-3#2)
the 24-h##6##2##(1990-3#2)(1994-8#1)(1995-11#1)(2008-10#1)(2008-9#1)
the 24th##3##2##(1995-8#2)(1996-11#1)
the 25 degrees##4##3##(2008-5#4)
the 25##14##2##(1992-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)
the 25-hydroxysterol and the 15-ketosterol##2##5##(1993-6#2)
the 257 patients##2##3##(1996-11#1)(2011-2#1)
the 26 cases##2##3##(1996-11#1)(2012-3#1)
the 26##5##2##(1995-2#1)(1996-11#1)(2009-9#1)(2011-2#1)(2012-3#1)
the 260##2##2##(2010-8#1)(2011-1#1)
the 265##2##2##(2008-10#1)(2013-1#1)
the 26S proteasome##2##3##(2008-4#2)
the 28##8##2##(1991-3#1)(1993-8#1)(1996-12#3)(1997-2#1)(2008-10#1)(2008-7#1)
the 28S##3##2##(2008-10#2)(2010-4#1)
the 28th##2##2##(1996-12#1)(2008-10#1)
the 29##4##2##(1991-12#1)(1996-8#1)(2008-10#2)
the 29-kb plasmid##2##3##(2008-10#2)
the 2a##2##2##(2008-10#2)
the 2b protein##2##3##(2012-2#2)
the 2nd antibody##3##3##(2008-10#3)
the 2nd##6##2##(1991-3#1)(2008-10#3)(2010-12#2)
the 3 x 1 S##2##5##(1997-8#2)
the 3 year period##2##4##(2008-7#2)
the 3 years##6##3##(1995-12#1)(2008-10#5)
the 3##31##2##(1990-11#2)(1992-3#1)(1995-12#1)(1996-2#1)(1997-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the 3%##3##2##(2008-10#1)(2008-3#2)
the 3' UTR of the##2##5##(1996-12#1)(2011-2#1)
the 3' UTR##3##3##(1996-12#2)(2011-2#1)
the 3' end of the genome##2##6##(2008-10#1)(2008-11#1)
the 3' end of the open reading frame##2##8##(1992-6#1)(1992-8#1)
the 3' end of the##13##5##(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2013-1#1)
the 3' end of##18##4##(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
the 3' end##22##3##(1990-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
the 3' non-coding##2##3##(1993-12#1)(1997-7#1)
the 3' nontranslated##2##3##(1993-3#1)(2008-10#1)
the 3' part##2##3##(2008-10#2)
the 3' region##2##3##(1997-3#1)(2008-10#1)
the 3' terminal##5##3##(1991-7#1)(1997-3#2)(2008-10#2)
the 3' termini of##2##4##(2008-10#1)(2008-8#1)
the 3' termini##3##3##(2008-10#2)(2008-8#1)
the 3' untranslated region##3##4##(1991-9#1)(1995-2#1)(2008-10#1)
the 3' untranslated##4##3##(1991-9#1)(1995-2#1)(1997-8#1)(2008-10#1)
the 3'##62##2##(1990-2#1)(1991-7#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#3)(1997-7#2)(1997-8#1)(2008-10#21)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#3)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
the 3'-##2##2##(1990-5#1)(1997-6#1)
the 3'-UTR##2##2##(1995-12#1)(2013-1#1)
the 3'-end of##5##3##(1993-8#1)(1993-9#1)(1994-8#1)(2013-1#2)
the 3'-tRNA-like structure of##2##4##(1997-3#2)
the 3'-terminal##3##2##(1993-8#1)(2008-10#2)
the 3'-untranslated region##4##3##(1993-2#1)(1995-12#1)(2008-10#1)(2011-2#1)
the 3'-untranslated##5##2##(1993-2#2)(1995-12#1)(2008-10#1)(2011-2#1)
the 3'UTR of##3##3##(1994-12#1)(2008-9#1)(2011-2#1)
the 3'UTR##4##2##(1994-12#2)(2008-9#1)(2011-2#1)
the 3-(N-tert-butylcarboxamido)-1-propyl##2##2##(2008-4#2)
the 3-D culture##2##3##(2008-11#1)(2009-3#1)
the 3-D model of hIL-6R##2##5##(2008-8#2)
the 3-D model##3##3##(2008-3#1)(2008-8#2)
the 3-D##10##2##(2008-11#2)(2008-3#3)(2008-8#2)(2009-3#1)(2011-2#2)
the 3-h##2##2##(2008-10#2)
the 3-month##6##2##(1994-3#2)(2011-2#3)(2012-3#1)
the 3-week##2##2##(1996-1#1)(2008-12#1)
the 30 patients##2##3##(1991-2#1)(2009-8#1)
the 30##14##2##(1991-2#1)(1995-6#1)(2007-11#1)(2008-10#5)(2008-12#1)(2009-8#1)(2012-2#4)
the 30-day##2##2##(2008-10#1)(2010-6#1)
the 30-kDa enzyme##2##3##(1994-11#2)
the 30-kDa##3##2##(1994-11#2)(1995-2#1)
the 305/311##2##2##(2008-3#2)
the 30th day##2##3##(2008-7#1)(2012-3#1)
the 30th##6##2##(1995-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-3#1)
the 31##2##2##(2008-10#1)(2008-9#1)
the 32##6##2##(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the 32-kDa##2##2##(1994-11#1)(2008-10#1)
the 32nd##2##2##(1996-11#1)(2008-8#1)
the 34##8##2##(1993-3#1)(1996-3#2)(2008-7#1)(2009-7#4)
the 35##6##2##(1991-3#1)(1994-3#1)(1996-8#1)(2008-10#1)(2008-9#2)
the 36##6##2##(1990-2#1)(1993-1#1)(1997-5#1)(2008-10#2)(2008-5#1)
the 37##5##2##(1993-3#1)(2008-10#1)(2008-5#2)(2010-8#1)
the 39##3##2##(1990-6#1)(1997-7#1)(2008-10#1)
the 3CaO##2##2##(2008-10#2)
the 3D reconstruction of the sellar region##2##7##(2012-3#2)
the 3D##16##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#3)
the 3rd year of life##2##5##(1991-8#2)
the 3rd year of##3##4##(1991-8#2)(2011-1#1)
the 3rd##12##2##(1991-8#2)(1992-9#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-1#1)
the 3sigma##3##2##(2008-10#3)
the 4 beta-methyl group of##2##5##(1992-3#2)
the 4 patients in##2##4##(1996-6#1)(2008-7#1)
the 4 patients##3##3##(1991-2#1)(1996-6#1)(2008-7#1)
the 4 study years##2##4##(1993-3#2)
the 4##23##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#2)(1993-3#2)(1996-6#1)(1997-2#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-1#2)
the 4-position##2##2##(1991-3#1)(2008-10#1)
the 4-year period##3##3##(2008-10#3)
the 4-year##7##2##(2008-10#6)(2013-1#1)
the 40##6##2##(1990-5#1)(1995-8#1)(1996-12#3)(2008-9#1)
the 40-kDa complex##3##3##(1997-1#3)
the 41-week study##3##3##(2008-9#3)
the 42##5##2##(1990-2#1)(1990-6#2)(1992-5#1)(2013-1#1)
the 43##4##2##(1991-2#1)(1996-3#1)(2008-11#1)(2009-7#1)
the 45##10##2##(1993-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-4#1)
the 45-kDa##2##2##(1993-1#1)(1994-11#1)
the 45th##2##2##(2008-10#1)(2008-7#1)
the 47th##2##2##(1990-2#2)
the 48##2##2##(2008-5#1)(2013-8#1)
the 4th##11##2##(1990-12#1)(1992-9#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-8#1)(2010-12#1)(2011-1#1)
the 5 patients##2##3##(2011-2#1)(2013-1#1)
the 5##43##2##(1991-8#1)(1992-2#1)(1993-8#1)(1995-11#2)(1995-12#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#16)(2008-12#2)(2008-4#2)(2008-5#3)(2008-8#4)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#2)
the 5' UTR##2##3##(2008-10#2)
the 5' and 3'##7##4##(1993-2#1)(1997-8#1)(2008-10#4)(2008-8#1)
the 5' and the##2##4##(2008-10#2)
the 5' and##10##3##(1993-2#1)(1993-3#1)(1997-8#1)(2008-10#6)(2008-8#1)
the 5' end of the##5##5##(1991-5#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
the 5' end of##7##4##(1991-5#1)(1997-7#2)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
the 5' end##10##3##(1991-5#1)(1992-6#1)(1997-7#2)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2013-8#1)
the 5' exonuclease##3##3##(1997-8#3)
the 5' flanking region##3##4##(1992-3#1)(1993-12#1)(1993-2#1)
the 5' flanking##6##3##(1991-6#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)
the 5' noncoding##2##3##(1995-5#1)(2008-10#1)
the 5' promoter region##2##4##(1991-6#1)(1996-8#1)
the 5' region of the human##2##6##(1991-6#1)(1991-7#1)
the 5' region of the##6##5##(1991-6#3)(1991-7#1)(1995-2#1)(2008-8#1)
the 5' side##3##3##(1993-12#1)(1993-6#1)(1995-6#1)
the 5' splice site##2##4##(1991-5#2)
the 5' untranslated region##2##4##(1997-8#1)(2008-10#1)
the 5'##63##2##(1991-5#4)(1991-6#5)(1991-7#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#3)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#5)(2008-10#19)(2008-4#1)(2008-8#5)(2008-9#1)(2013-8#1)
the 5'- and##2##3##(1993-12#1)(2008-10#1)
the 5'-end of the##2##4##(1993-8#1)(2008-10#1)
the 5'-end of##3##3##(1993-8#1)(1995-8#1)(2008-10#1)
the 5'-end##4##2##(1993-8#1)(1995-8#1)(2008-10#2)
the 5'-flanking region and##2##4##(1991-7#1)(2010-5#1)
the 5'-flanking region of##2##4##(1993-8#1)(1997-8#1)
the 5'-flanking region##7##3##(1991-6#1)(1991-7#1)(1993-8#1)(1994-11#1)(1997-8#1)(2010-5#2)
the 5'-flanking sequence##3##3##(1995-6#1)(1997-7#1)(2008-8#1)
the 5'-flanking##12##2##(1991-6#1)(1991-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-6#2)(1997-7#1)(1997-8#1)(2008-8#1)(2010-5#2)
the 5'-terminal##2##2##(1993-3#1)(2008-10#1)
the 5'-untranslated region##2##3##(1991-7#1)(2008-10#1)
the 5'-untranslated##3##2##(1991-7#1)(1993-2#1)(2008-10#1)
the 5'-upstream region of##3##4##(1993-12#1)(1996-3#2)
the 5'-upstream##4##2##(1993-12#1)(1996-3#2)(2008-11#1)
the 5-2-1-AN message##2##3##(2010-8#2)
the 5-HT1A receptor##5##3##(1993-3#2)(1994-2#3)
the 5-HT2C receptor mRNA##2##4##(1996-12#2)
the 5-HT2C receptor##5##3##(1996-12#5)
the 5-HT7 receptor##2##3##(2008-5#2)
the 5-choice serial reaction time task##2##6##(2008-4#2)
the 5-year disease-free##3##3##(1997-7#3)
the 5-year non-recurrence rate##3##4##(1997-7#3)
the 5-year survival rate##2##4##(1990-9#1)(1997-7#1)
the 5-year##10##2##(1990-9#1)(1997-7#7)(2008-7#1)(2011-1#1)
the 50 mg/kg/dose regimen##2##4##(2008-10#2)
the 50##7##2##(2008-10#5)(2008-11#1)(2010-5#1)
the 50% control##3##3##(2012-2#3)
the 50% of##2##3##(2013-1#2)
the 50% survival age##2##4##(1996-2#2)
the 50%##10##2##(1996-2#2)(2008-10#1)(2009-8#1)(2012-2#3)(2013-1#3)
the 50-kDa##2##2##(2008-10#2)
the 500 mg/kg##3##3##(2008-9#3)
the 500##4##2##(2008-9#3)(2011-2#1)
the 51##2##2##(2008-12#1)(2008-7#1)
the 53##2##2##(1994-1#1)(2011-2#1)
the 54##6##2##(1990-2#1)(1991-2#1)(2008-10#4)
the 54-kDa##2##2##(1994-11#1)(1995-8#1)
the 55##3##2##(1993-6#1)(1996-12#1)(2008-8#1)
the 56##3##2##(1990-3#1)(2010-9#1)(2013-8#1)
the 57 amino acids##2##4##(1995-12#2)
the 57##5##2##(1990-8#1)(1995-12#2)(2008-10#1)(2012-12#1)
the 57-kDa form was##2##4##(1995-8#2)
the 58K-like protein##2##3##(2008-8#2)
the 59-kDa protein##3##3##(1990-5#3)
the 5HT1D pseudogene##2##3##(1993-12#2)
the 5HT1D##3##2##(1993-12#3)
the 5P(3/2)##2##2##(2008-3#2)
the 5S##3##2##(2008-10#3)
the 5th##7##2##(1991-2#1)(1991-9#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
the 6 months before##2##4##(2008-1#1)(2013-1#1)
the 6 months##3##3##(2008-1#2)(2013-1#1)
the 6##13##2##(1995-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the 6-methylquinolinium##2##2##(2008-10#2)
the 6-month##2##2##(1991-1#1)(2008-8#1)
the 6-week##2##2##(2008-4#1)(2010-2#1)
the 60 kDa IGBP##2##4##(1996-12#2)
the 60##3##2##(1996-12#2)(2009-10#1)
the 61 patients##2##3##(2011-2#2)
the 64##3##2##(1996-12#1)(2008-8#1)(2008-9#1)
the 65##4##2##(2008-10#2)(2008-12#1)(2008-7#1)
the 650-bp##2##2##(2008-10#2)
the 66 and##2##3##(1990-12#1)(2008-8#1)
the 67 K protein##6##4##(1995-12#6)
the 67 K##7##3##(1995-12#7)
the 67##8##2##(1995-12#7)(1996-12#1)
the 68 isolates##2##3##(2008-10#1)(2013-8#1)
the 68##4##2##(1997-2#1)(2008-10#2)(2013-8#1)
the 6th##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-4#1)
the 7 patients##2##3##(1990-3#1)(1995-12#1)
the 7##17##2##(1990-3#1)(1991-3#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
the 7-ku##3##2##(2008-9#3)
the 70##2##2##(1997-7#1)(2008-10#1)
the 75 kDa protein##2##4##(2008-7#2)
the 75 kDa##3##3##(2008-7#3)
the 75##5##2##(1992-12#1)(2008-7#4)
the 79 degrees-81 degrees region of the Bacillus subtilis genome##2##10##(1996-8#2)
the 793/B##5##2##(2008-5#5)
the 7DL suppressor##4##3##(2008-10#4)
the 7q31-q32 region##2##3##(1996-6#2)
the 7th##4##2##(1992-12#1)(1992-5#1)(2013-1#1)(2013-8#1)
the 8##7##2##(1990-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)
the 8-bp sequence##4##3##(1995-6#4)
the 8-week##2##2##(1994-12#1)(2012-2#1)
the 80 kDa##2##3##(1992-6#1)(1996-2#1)
the 80##3##2##(1992-6#1)(1996-2#1)(2008-7#1)
the 8th##7##2##(1992-3#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-2#1)(2011-4#1)
the 9##5##2##(1991-5#1)(2008-7#1)(2010-5#1)(2011-2#2)
the 90 kDa protein##2##4##(2008-7#2)
the 90##7##2##(1990-6#1)(1993-8#1)(2008-10#2)(2008-7#2)(2011-2#1)
the 90%##2##2##(1993-9#1)(2008-7#1)
the 95% confidence interval of##2##5##(2008-10#1)(2010-3#1)
the 95% confidence interval##3##4##(2008-10#2)(2010-3#1)
the 95% confidence##24##3##(2008-10#23)(2010-3#1)
the 95%##29##2##(2008-10#27)(2010-3#1)(2012-2#1)
the 98- to 120-aa##2##4##(2008-10#2)
the 99##2##2##(1991-9#1)(1997-2#1)
the 9alpha-hydroxylase system##2##3##(2008-11#2)
the 9th day##2##3##(2008-10#1)(2008-11#1)
the 9th grade##3##3##(1991-9#3)
the 9th##8##2##(1991-9#3)(2008-10#1)(2008-11#2)(2008-8#1)(2013-1#1)
the ?(3/2) (v?##2##3##(2008-3#2)
the A and B##3##4##(1995-2#1)(1997-7#1)(2008-10#1)
the A and##4##3##(1995-2#1)(1997-7#1)(2008-10#2)
the A beta##2##3##(1994-11#1)(1995-12#1)
the A chain##2##3##(1993-11#2)
the A genotype##4##3##(2008-10#4)
the A or##3##3##(1994-5#1)(2008-10#2)
the A##34##2##(1993-11#2)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#2)(1997-7#1)(1997-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)
the A(section)E((R)) discrimination test##2##4##(2008-9#2)
the A(section)E((R))##3##2##(2008-9#3)
the A1 adenosine receptor##3##4##(1993-3#1)(1993-6#1)(1994-5#1)
the A1 cell group##2##4##(1990-5#2)
the A1##11##2##(1990-5#3)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(2008-10#3)
the A2 mating type##4##4##(2008-10#4)
the A2##10##2##(1993-6#1)(1996-3#3)(2008-10#5)(2008-12#1)
the A2-receptor-induced##2##2##(1994-6#2)
the A4##2##2##(1991-1#1)(1994-5#1)
the A7 monoclonal antibody##2##4##(2008-11#2)
the AA##4##2##(2008-8#1)(2011-2#3)
the AABB##5##2##(1995-6#5)
the AAC##3##2##(2008-10#3)
the AAPCC##5##2##(1993-3#5)
the AAS##5##2##(2008-10#5)
the AB##2##2##(2009-4#2)
the ABBP##3##2##(2008-8#3)
the ABC##3##2##(1994-3#2)(2011-2#1)
the ABCD##2##2##(2008-2#1)(2008-3#1)
the ABL##4##2##(2008-2#4)
the ABQ##2##2##(2010-11#2)
the AC##2##2##(1994-12#1)(2008-10#1)
the ACDF group##2##3##(2012-12#2)
the ACE##6##2##(2008-6#1)(2008-7#1)(2008-9#4)
the ACL##5##2##(1997-8#2)(2013-1#3)
the ACP##2##2##(1995-6#1)(2013-1#1)
the ACTH##2##2##(1992-8#1)(2011-1#1)
the AD cases##4##3##(1991-1#4)
the AD duration##3##3##(1992-12#1)(1994-2#2)
the AD group##2##3##(2008-7#2)
the AD##10##2##(1991-1#4)(1992-12#1)(1994-2#2)(2008-7#2)(2011-2#1)
the AD3 subtype##2##3##(1995-8#2)
the ADA##12##2##(1994-1#2)(1995-12#3)(1995-6#2)(1996-1#2)(1996-5#2)(2008-3#1)
the ADP-ribosylation of HMG##2##4##(1990-3#2)
the ADP-ribosylation of##8##3##(1990-3#3)(1993-3#5)
the ADR of##2##3##(2008-10#2)
the ADR##3##2##(2008-10#2)(2011-2#1)
the ADR/AE##3##2##(2011-2#3)
the ADS##2##2##(2008-10#1)(2009-10#1)
the AF4Q initiative has##3##4##(2013-1#3)
the AF4Q initiative##8##3##(2013-1#8)
the AF4Q##11##2##(2013-1#11)
the AFC assay##5##3##(2008-10#5)
the AFC##11##2##(2008-10#5)(2011-2#6)
the AFLP data##2##3##(2008-10#2)
the AFLP groups##2##3##(2008-10#2)
the AFLP##12##2##(2008-10#12)
the AFM tip##2##3##(2008-10#1)(2008-7#1)
the AFM##3##2##(2008-10#2)(2008-7#1)
the AG##2##2##(2008-10#2)
the AGL2##2##2##(1997-8#2)
the AGT##2##2##(1993-11#1)(2008-5#1)
the AH109A invasion##2##3##(2008-11#2)
the AH109A##3##2##(2008-11#3)
the AHA##3##2##(1991-12#2)(1997-3#1)
the AHP##2##2##(1995-1#1)(2008-10#1)
the AHRA Statistical Resource Committee##2##5##(1991-3#1)(1993-1#1)
the AHRA##3##2##(1991-3#1)(1993-1#1)(1996-1#1)
the AI##2##2##(2008-10#1)(2013-1#1)
the AIDS epidemic##9##3##(1990-12#2)(1990-3#3)(1994-9#1)(1995-1#1)(1996-5#1)(2008-5#1)
the AIDS virus##2##3##(1990-6#1)(1992-12#1)
the AIDS##15##2##(1990-12#2)(1990-3#4)(1990-6#1)(1992-12#1)(1992-9#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#1)(2008-5#1)
the AII-induced##2##2##(1991-5#2)
the AIS##3##2##(2008-10#2)(2010-7#1)
the ALD##2##2##(1993-3#1)(1995-2#1)
the AM##3##2##(1994-2#2)(2008-11#1)
the AMARTIS model##2##3##(2008-3#2)
the AMARTIS##3##2##(2008-3#3)
the AML##3##2##(2008-10#3)
the AN##2##2##(1991-11#2)
the ANN method proved to be##2##6##(2008-10#2)
the ANN##8##2##(2008-10#7)(2010-8#1)
the ANN/FTNIR##2##2##(2008-10#2)
the AP site##2##3##(2008-10#2)
the AP##3##2##(2008-10#2)(2009-11#1)
the APS##2##2##(2008-10#1)(2008-11#1)
the AR cDNA##2##3##(1995-12#2)
the AR in##2##3##(1990-11#1)(2010-1#1)
the AR of##2##3##(1990-11#1)(2008-8#1)
the AR##8##2##(1990-11#2)(1995-12#2)(2008-8#3)(2010-1#1)
the ARE##2##2##(2008-9#1)(2009-8#1)
the ARF18-C##2##2##(2008-10#2)
the ARIA##3##2##(2012-12#3)
the ARS##2##2##(2008-10#1)(2008-3#1)
the ASA##6##2##(1997-6#5)(2009-5#1)
the ASAD##2##2##(2012-2#2)
the ASE cartridge##2##3##(2008-10#2)
the ASE##3##2##(2008-10#3)
the ASR##2##2##(1992-2#1)(1996-5#1)
the ASRC given##2##3##(1996-12#2)
the ASRC##4##2##(1996-12#4)
the ASTM##2##2##(2008-10#2)
the ASV peaks##2##3##(2008-10#2)
the ASV##4##2##(2008-10#4)
the AT region##3##3##(1995-6#3)
the AT2 receptor##2##3##(1994-8#2)
the ATG12##2##2##(2013-1#2)
the ATP binding##2##3##(1993-6#1)(2011-2#1)
the ATP##12##2##(1990-5#1)(1993-6#3)(1993-8#3)(1994-11#1)(2008-11#2)(2008-5#1)(2011-2#1)
the ATPase##3##2##(1993-9#1)(1995-6#1)(2006-6#1)
the AUD severity factor##2##4##(2013-8#2)
the AUDPC##3##2##(2008-10#3)
the AV##2##2##(2011-3#2)
the AVM without##2##3##(2008-7#2)
the AVM##11##2##(1997-6#1)(2008-7#10)
the Ab production efficiency##3##4##(2008-11#3)
the Ac elements are##2##4##(2012-3#2)
the Ac elements##3##3##(2012-3#3)
the Ac##5##2##(2012-3#5)
the Achilles tendon##2##3##(2009-10#2)
the Achilles##5##2##(1997-8#1)(2008-5#1)(2009-10#2)(2011-2#1)
the Act##2##2##(1991-1#1)(1997-8#1)
the Activity of##2##3##(2008-10#2)
the Ad9 E4 region##3##4##(1992-9#3)
the Advanced##3##2##(2008-10#2)(2008-11#1)
the Afmadow to Garissa routes##2##5##(2011-2#2)
the African##4##2##(2008-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
the Afro-Andean##3##2##(2008-10#3)
the Age of##4##3##(1996-5#1)(2008-12#3)
the Age##5##2##(1996-5#1)(2008-12#3)(2009-7#1)
the Agency for Health Care Policy and Research##2##8##(1992-8#1)(1993-12#1)
the Agency##3##2##(1992-8#1)(1993-12#1)(1997-3#1)
the Ah receptor##3##3##(1992-12#1)(1993-12#1)(1995-11#1)
the Ah##4##2##(1992-12#1)(1993-12#2)(1995-11#1)
the AhR##2##2##(2008-10#2)
the Al concentration##2##3##(2008-10#2)
the Al powder industry##2##4##(2013-8#2)
the Al##9##2##(2008-10#7)(2013-8#2)
the Albanian##2##2##(2008-10#1)(2011-2#1)
the Alberta##4##2##(1993-12#3)(2012-12#1)
the Aligning Forces for Quality (AF4Q)##2##6##(2013-1#2)
the Aligning Forces for Quality##4##5##(2013-1#4)
the Allee effect##6##3##(2008-10#1)(2008-8#5)
the AlloMap test##2##3##(2008-10#2)
the AlloMap##3##2##(2008-10#3)
the Alps##3##2##(2008-11#3)
the Alu consensus sequence##2##4##(1991-5#1)(1993-12#1)
the Alu##4##2##(1991-5#2)(1993-12#1)(1997-2#1)
the Alzheimer's##3##2##(1995-8#1)(2008-6#1)(2011-2#1)
the Amazon rainforest##2##3##(2010-7#2)
the Amazon##3##2##(2010-7#3)
the Amendment's##2##2##(1993-12#2)
the American Academy of Pediatrics##4##5##(1996-6#1)(2008-11#1)(2010-8#1)(2013-1#1)
the American Association for Partial Hospitalization##2##6##(1991-1#2)
the American Association for##3##4##(1991-1#2)(2008-9#1)
the American Association of##3##4##(1995-6#1)(2008-1#1)(2012-3#1)
the American Association##6##3##(1991-1#2)(1995-6#1)(2008-1#1)(2008-9#1)(2012-3#1)
the American College of##6##4##(1993-12#2)(1993-3#1)(1994-12#1)(2009-6#1)(2010-12#1)
the American Heart Association and##3##5##(1996-6#2)(2010-9#1)
the American Heart Association##7##4##(1996-6#2)(2008-3#1)(2009-5#1)(2010-1#1)(2010-9#1)(2012-12#1)
the American Hospital Association Annual Survey##2##6##(1992-2#1)(2008-11#1)
the American Hospital Association##3##4##(1992-2#2)(2008-11#1)
the American Psychological Association##3##4##(1994-12#3)
the American Society of Clinical Oncology##3##6##(2008-7#2)(2010-11#1)
the American Society of Naturalists##2##5##(2008-8#1)(2013-1#1)
the American Society of##6##4##(2008-7#3)(2008-8#1)(2010-11#1)(2013-1#1)
the American Society##8##3##(1997-7#1)(2008-7#3)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
the American##68##2##(1991-1#2)(1991-12#1)(1991-8#2)(1992-2#2)(1993-12#2)(1993-3#1)(1994-12#4)(1994-2#1)(1995-6#4)(1996-2#1)(1996-5#1)(1996-6#3)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
the Americans With Disabilities Act (ADA)##2##6##(1994-1#2)
the Americans With Disabilities Act##4##5##(1991-12#1)(1994-1#2)(1995-1#1)
the Americans with Disabilities Act (ADA) by##2##7##(1995-6#1)(1996-5#1)
the Americans with Disabilities Act (ADA)##8##6##(1995-12#4)(1995-6#2)(1996-1#1)(1996-5#1)
the Americans with Disabilities Act##14##5##(1992-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)
the Americans with Disabilities##15##4##(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)
the Americans##20##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)
the Americas and was##2##4##(1994-9#1)(2008-10#1)
the Americas##7##2##(1994-9#2)(2008-10#5)
the Ames##2##2##(2008-2#1)(2011-1#1)
the An1##2##2##(1993-6#2)
the Analysis of##2##3##(2008-3#1)(2009-8#1)
the Anarrhichomenum complex##6##3##(2008-10#6)
the Andalusian##2##2##(2008-11#1)(2009-10#1)
the Andean highlands##2##3##(2008-10#2)
the Andean##6##2##(2008-10#5)(2008-11#1)
the Annual##8##2##(2008-11#1)(2011-2#7)
the Antagonist##2##2##(2008-10#2)
the Antagonistic##2##2##(2008-10#2)
the Antarctic##4##2##(1991-5#1)(1996-1#1)(2013-8#2)
the Anterior##4##2##(1997-6#1)(2008-12#1)(2013-1#2)
the Aphid Schizaphis graminum##2##4##(2008-10#2)
the Apple##4##2##(1991-12#1)(2008-10#3)
the Approved Lists of Bacterial Names##2##6##(2008-10#2)
the Arab##2##2##(2008-10#1)(2012-2#1)
the Arabidopsis CAB2##2##3##(1995-2#2)
the Arabidopsis genome##2##3##(2007-12#1)(2009-10#1)
the Arabidopsis thaliana##4##3##(1994-12#1)(1997-6#1)(1997-8#1)(2008-10#1)
the Arabidopsis##13##2##(1994-12#2)(1995-2#3)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-10#1)(2012-3#1)
the Arctic polar##2##3##(1991-5#2)
the Arctic##3##2##(1991-5#2)(2008-11#1)
the Area Resource File##2##4##(2008-11#2)
the Arg and##2##3##(1992-4#1)(1995-6#1)
the Arg##3##2##(1992-4#1)(1994-12#1)(1995-6#1)
the Arina##2##2##(2008-10#2)
the Arizona##2##2##(1995-12#1)(2008-5#1)
the ArsA protein##3##3##(1994-5#3)
the As matrix##2##3##(2008-10#2)
the As##3##2##(2008-10#3)
the As(3+)-DDTP##2##2##(2008-10#2)
the As(III)##2##2##(2008-10#2)
the Asian##3##2##(2008-10#1)(2010-6#1)(2013-1#1)
the Aspergillus nidulans trpC##2##4##(2008-10#1)(2011-1#1)
the Aspergillus##3##2##(2008-10#2)(2011-1#1)
the Association for Volunteer Administration##2##5##(1994-3#1)(1995-12#1)
the Association for##4##3##(1992-3#1)(1994-3#2)(1995-12#1)
the Association of Official##2##4##(2008-10#2)
the Association of##6##3##(1995-12#1)(2008-10#2)(2009-11#1)(2010-3#1)(2012-12#1)
the Association##14##2##(1990-6#1)(1992-3#1)(1994-3#2)(1995-12#2)(2008-10#3)(2009-11#1)(2010-3#1)(2011-4#1)(2012-12#1)(2012-3#1)
the Ataxia##2##2##(1995-6#1)(2008-7#1)
the Atkins diet##2##3##(2008-3#2)
the Atkins##4##2##(2008-3#4)
the Atlantic##3##2##(1995-11#1)(2008-10#1)(2012-3#1)
the Atmospheric##2##2##(2008-3#2)
the Atp7a gene##4##3##(2008-12#4)
the AuAE##2##2##(2008-10#2)
the Aurora##3##2##(2013-1#3)
the Australian##9##2##(1991-2#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-12#1)
the Authors describe a##2##4##(1990-3#1)(1992-9#1)
the Authors describe##3##3##(1990-3#1)(1990-9#1)(1992-9#1)
the Authors##15##2##(1990-2#1)(1990-3#4)(1990-5#1)(1990-9#3)(1991-3#2)(1992-9#4)
the Autographa californica##3##3##(1993-12#1)(1997-3#1)(2008-7#1)
the B site##2##3##(1994-5#2)
the B##43##2##(1990-11#1)(1990-2#1)(1991-3#1)(1994-1#1)(1994-11#1)(1994-5#4)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-4#2)(2011-2#3)
the B- and##2##3##(1995-2#2)
the B1##2##2##(1994-5#1)(2008-10#1)
the B73 genome##3##3##(2012-3#3)
the B73 x Tex6 cross##2##5##(2008-10#2)
the B73##5##2##(2008-10#2)(2012-3#3)
the BAA showed##2##3##(2011-2#2)
the BAC##4##2##(2008-10#1)(2008-4#2)(2008-8#1)
the BAC2##2##2##(2008-8#2)
the BAL##2##2##(2010-12#2)
the BBA##6##2##(2008-11#6)
the BC##2##2##(1993-3#1)(2008-9#1)
the BCA##2##2##(2008-10#2)
the BCR##3##2##(2008-10#3)
the BET##2##2##(2009-11#1)(2012-12#1)
the BHLF1 promoter##2##3##(1997-3#2)
the BHLF1##3##2##(1997-3#3)
the BHS##2##2##(2010-7#2)
the BHT-task##2##2##(2013-8#2)
the BHU##2##2##(2011-2#2)
the BLAST##2##2##(2008-4#1)(2008-9#1)
the BMI##2##2##(2008-1#1)(2008-3#1)
the BNR##2##2##(2008-10#2)
the BOD##4##2##(2008-10#4)
the BP titer##3##3##(2008-11#3)
the BP##5##2##(2008-10#1)(2008-11#4)
the BPMV-pCP##2##2##(2008-10#2)
the BRA-3 mRNA##2##3##(1993-6#2)
the BRDF##3##2##(2008-3#3)
the BTB must##2##3##(2009-10#2)
the BTB##22##2##(2009-10#10)(2012-2#12)
the BYDV##2##2##(2008-10#1)(2008-8#1)
the BYSV CP##3##3##(2008-10#3)
the BZ oscillating chemical system##3##5##(2008-10#3)
the Bacillus cereus group collected in##2##6##(2011-2#2)
the Bacillus cereus group##3##4##(2011-2#3)
the Bacillus subtilis##6##3##(1993-12#1)(1995-12#1)(1996-8#2)(1997-7#2)
the Bacillus##13##2##(1993-12#1)(1995-12#1)(1996-8#2)(1997-7#2)(2008-10#3)(2011-2#4)
the Bacterial##2##2##(2008-10#1)(2008-7#1)
the Balance##2##2##(2008-11#1)(2010-12#1)
the Balanced Budget Act##2##4##(2008-11#2)
the Balanced Budget##3##3##(2008-11#3)
the Baldrige##2##2##(1995-2#1)(1995-3#1)
the Baltic Sea##6##3##(2007-12#2)(2008-11#2)(2010-8#2)
the Baltic##8##2##(1995-2#1)(2007-12#2)(2008-10#1)(2008-11#2)(2010-8#2)
the Barley Scald##2##3##(2008-10#2)
the Barley##4##2##(2008-10#4)
the Baroque and Rococo lacquer films##2##6##(2008-10#2)
the Basic##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
the Bayer DCA 2000 in##2##5##(2008-6#2)
the Bayesian##3##2##(1994-9#3)
the Bcl-2 expression was##2##4##(2008-9#2)
the Bcl-2 family##7##3##(2008-11#2)(2009-12#2)(2011-2#3)
the Bcl-2##10##2##(2008-11#3)(2008-9#2)(2009-12#2)(2011-2#3)
the Bean##3##2##(2008-10#3)
the Beck Depression Inventory##2##4##(1991-2#1)(2013-8#1)
the Beck##3##2##(1991-2#1)(2012-2#1)(2013-8#1)
the Becton Dickinson FACS Calibur##2##5##(2008-4#2)
the Beet##2##2##(2008-10#2)
the Behavioral##2##2##(2011-2#1)(2012-3#1)
the Belgian##4##2##(2008-10#3)(2011-2#1)
the Belousov-Zhabotinsky##2##2##(2008-10#2)
the Better Beginnings##5##3##(1995-3#5)
the BiP##2##2##(2008-11#1)(2008-7#1)
the Biceps femoris##4##3##(2010-4#4)
the Bielschowsky##2##2##(1991-1#1)(2013-1#1)
the Biocontrol Agent##4##3##(2008-10#4)
the Biocontrol Fungus##2##3##(2008-10#2)
the Biocontrol##9##2##(2008-10#9)
the Biological Control of##2##4##(2008-10#2)
the Biological##4##2##(1992-12#1)(2008-10#2)(2010-4#1)
the Bligh-Dyer##2##2##(2008-10#1)(2008-11#1)
the Blue##3##2##(1990-12#1)(1994-12#1)(1997-6#1)
the BmNPV##3##2##(1997-3#3)
the Bmax values##2##3##(1994-8#1)(1997-2#1)
the Bmax##4##2##(1994-8#1)(1996-2#1)(1997-2#2)
the Board of##3##3##(1991-12#1)(1994-12#1)(2008-10#1)
the Bombyx mori##2##3##(1995-6#1)(2008-11#1)
the Bournemouth Collaborative Model##2##4##(2008-11#2)
the Bowman##2##2##(1992-1#1)(2008-10#1)
the BqsS-BqsR two-component system##2##4##(2009-6#2)
the BrAAP component##2##3##(1994-5#2)
the Bragg##2##2##(2008-3#1)(2008-7#1)
the Brain##3##2##(2007-9#1)(2008-2#1)(2008-6#1)
the Branch &amp##2##3##(2008-6#2)
the Brassica##3##2##(2008-10#1)(2011-10#1)(2012-3#1)
the Bratton-Marshall##3##2##(2008-10#3)
the Brazilian##8##2##(2008-10#4)(2008-11#1)(2011-2#2)(2012-3#1)
the Breast##4##2##(1994-12#1)(1995-9#1)(1997-1#1)(1997-7#1)
the Brief##2##2##(2008-7#1)(2010-2#1)
the British Pharmacopoeia##3##3##(2008-10#3)
the British##14##2##(1991-1#1)(1992-1#1)(1992-2#1)(1995-8#1)(2008-10#7)(2008-11#1)(2010-2#1)(2012-12#1)
the Brn-3##3##2##(1996-12#3)
the Brown Norway rat##3##4##(2008-10#3)
the Brown##4##2##(2008-10#4)
the Bruhat##2##2##(1991-12#2)
the Bureau of##2##3##(1993-1#1)(2008-10#1)
the Button Sampler##5##3##(2008-5#5)
the Button##6##2##(2008-5#6)
the C balance##2##3##(2008-11#2)
the C derived from##2##4##(2010-3#2)
the C terminal##3##3##(2008-8#1)(2008-9#2)
the C terminus of the##3##5##(1991-6#1)(1995-2#1)(1995-6#1)
the C terminus of##4##4##(1991-6#1)(1995-2#2)(1995-6#1)
the C terminus##6##3##(1991-6#1)(1993-6#1)(1995-2#3)(1995-6#1)
the C##44##2##(1990-6#1)(1991-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-2#3)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(2008-10#14)(2008-11#4)(2008-5#2)(2008-8#2)(2008-9#2)(2010-11#1)(2010-3#2)(2010-6#2)(2012-3#2)(2013-1#1)
the C(18) phase##2##3##(2008-10#2)
the C(18)##6##2##(2008-10#6)
the C-##2##2##(1991-5#1)(2008-7#1)
the C-Leg##3##2##(2013-1#3)
the C-domain of IGF-1##2##4##(2008-9#2)
the C-domain of##3##3##(2008-9#3)
the C-terminal actin-binding domain##2##4##(2009-7#2)
the C-terminal domain of##2##4##(2008-9#1)(2009-7#1)
the C-terminal domain##3##3##(2008-9#1)(2009-7#1)(2012-2#1)
the C-terminal domains##3##3##(1993-8#1)(2008-10#2)
the C-terminal half of the##2##5##(1994-5#1)(2008-10#1)
the C-terminal half of##3##4##(1994-5#1)(2008-10#1)(2010-5#1)
the C-terminal part##2##3##(1996-12#1)(2008-10#1)
the C-terminal region of##3##4##(1993-8#1)(1994-5#1)(1997-7#1)
the C-terminal region##7##3##(1993-8#1)(1994-12#1)(1994-5#2)(1995-2#1)(1997-7#1)(2008-10#1)
the C-terminal sequence of##2##4##(1994-11#1)(2008-4#1)
the C-terminal##46##2##(1990-2#1)(1991-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-5#3)(1995-2#2)(1995-6#3)(1996-12#2)(1997-4#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#3)(2009-7#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
the C-terminus of##6##3##(1992-6#2)(1994-12#1)(2008-10#1)(2009-10#1)(2012-3#1)
the C-terminus##15##2##(1992-6#2)(1994-11#2)(1994-12#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
the C1 and##2##3##(1994-5#1)(2013-1#1)
the C1##6##2##(1994-5#1)(2008-10#1)(2012-12#3)(2013-1#1)
the C1-C2##2##2##(1993-8#1)(2011-2#1)
the C2##2##2##(2009-10#1)(2012-3#1)
the C26-CBS/diC14-PC mixture##2##3##(1993-8#2)
the C3##2##2##(1990-8#1)(2008-10#1)
the C40/C40+##2##2##(2008-9#2)
the C7##2##2##(1994-5#1)(2009-3#1)
the C8##2##2##(2008-4#2)
the CA and OR##2##4##(2008-10#2)
the CA and##3##3##(1995-11#1)(2008-10#2)
the CA##6##2##(1994-2#1)(1995-11#2)(1995-3#1)(2008-10#2)
the CA-clonal##3##2##(2008-10#3)
the CA1 region##2##3##(1995-12#1)(1996-12#1)
the CA1##6##2##(1990-5#3)(1995-12#1)(1996-12#2)
the CA3##5##2##(1990-5#1)(1996-12#1)(2008-11#2)(2009-8#1)
the CAA##2##2##(2008-10#2)
the CAF+FT group##5##3##(1997-7#5)
the CAF+FT##6##2##(1997-7#6)
the CAF+FT+ADR group##2##3##(1997-7#2)
the CAF+FT+TAM group##4##3##(1997-7#4)
the CAK activity##2##3##(1997-1#2)
the CALUX bioassay for##3##4##(2008-10#3)
the CALUX bioassay##8##3##(2008-10#8)
the CALUX response##3##3##(2008-10#3)
the CALUX technique##2##3##(2008-10#2)
the CALUX##17##2##(2008-10#17)
the CART models##2##3##(2008-10#2)
the CART##3##2##(2008-10#3)
the CASA assay##2##3##(1993-2#2)
the CAT##3##2##(1993-8#1)(1997-8#1)(2008-4#1)
the CATT/T##2##2##(2011-2#2)
the CAdSV##4##2##(2008-10#4)
the CArG##4##2##(1993-8#3)(2009-8#1)
the CB##4##2##(2008-11#3)(2009-12#1)
the CB(2)##2##2##(2009-8#2)
the CB3##2##2##(1994-5#2)
the CBA##2##2##(1995-12#1)(2008-12#1)
the CBS##5##2##(1993-8#4)(2008-10#1)
the CC##3##2##(2008-10#2)(2013-1#1)
the CCD##2##2##(2008-3#1)(2011-2#1)
the CCKA receptor##2##3##(1993-6#1)(1996-2#1)
the CD Plus##2##3##(1991-12#2)
the CD _ 2 bending and CH _ 2 rocking modes##2##11##(2008-5#2)
the CD _ 2##3##4##(2008-5#3)
the CD##11##2##(1991-12#2)(1994-5#2)(2008-10#3)(2008-12#1)(2008-5#3)
the CD-ROM##2##2##(1991-3#1)(2008-11#1)
the CD4##3##2##(1992-6#1)(2009-8#1)(2010-12#1)
the CD4(+)##2##2##(2008-11#1)(2008-9#1)
the CD4/CD8 ratio##2##3##(1991-6#2)
the CDC##6##2##(1992-6#1)(1996-1#1)(1996-5#2)(2011-2#1)(2012-12#1)
the CDER##2##2##(2010-11#2)
the CDOM##2##2##(2008-2#2)
the CE method##3##3##(1997-2#1)(2008-10#2)
the CE procedure developed##2##4##(2008-10#2)
the CE##11##2##(1997-2#1)(2008-10#7)(2008-5#3)
the CEA##3##2##(1990-5#2)(1994-5#1)
the CEF##3##2##(2007-12#1)(2008-10#2)
the CER3 and##4##3##(2008-10#4)
the CER3##6##2##(2008-10#6)
the CER3/PA-d(31) dispersion at pH 5##2##6##(2008-10#2)
the CEs##2##2##(2008-10#1)(2008-5#1)
the CFH and Worland##3##4##(2008-10#3)
the CFH##6##2##(2008-10#6)
the CFTR gene##2##3##(1997-1#2)
the CGRP##2##2##(1992-6#1)(1997-3#1)
the CH _ 2##2##4##(2008-5#2)
the CH cartridge##2##3##(2008-10#2)
the CH##8##2##(2008-10#6)(2008-5#2)
the CH(2) antisymmetric##2##3##(2008-10#2)
the CH(2)##8##2##(1997-2#1)(2008-10#6)(2008-5#1)
the CH(3) scissoring##2##3##(2008-10#2)
the CH(3) symmetric and asymmetric stretching##2##6##(2008-10#2)
the CH(3)##5##2##(2008-10#5)
the CH1##2##2##(1993-6#1)(1997-2#1)
the CHAP domain##2##3##(2009-6#2)
the CHAP-SH3b fusion##2##3##(2009-6#2)
the CHIN (community health information network)##3##6##(1996-1#3)
the CHIN##4##2##(1996-1#4)
the CHO##6##2##(1993-8#1)(2008-11#5)
the CHO-K1 cell##2##3##(1997-1#1)(2008-11#1)
the CIP##3##2##(2008-10#3)
the CIPIC-conjugated CCL##2##3##(2008-10#2)
the CIS strategy##2##3##(2008-9#2)
the CL detection##5##3##(2008-10#5)
the CL emission##3##3##(2008-10#3)
the CL intensity of##2##4##(2008-10#2)
the CL intensity was linear to the##2##7##(2008-10#2)
the CL intensity was linear##3##5##(2008-10#3)
the CL intensity##11##3##(2008-10#11)
the CL reaction between##3##4##(2008-10#3)
the CL reaction of##8##4##(2008-10#8)
the CL reaction was##2##4##(2008-10#2)
the CL reaction##14##3##(2008-10#14)
the CL##48##2##(2008-10#43)(2008-8#2)(2008-9#3)
the CL-1000##5##2##(2008-11#5)
the CLP##4##2##(2012-3#4)
the CM##3##2##(2008-10#1)(2011-2#2)
the CMC##3##2##(2008-10#3)
the CME##3##2##(2008-10#3)
the CMM group##3##3##(2008-7#3)
the CMV promoter##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
the CMV##6##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#2)
the CMV-based##2##2##(2008-8#2)
the CNC##5##2##(2013-8#5)
the CNS##40##2##(1990-3#1)(1991-12#3)(1991-2#1)(1992-10#3)(1992-8#1)(1994-2#1)(1995-12#3)(1996-12#4)(1997-5#1)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#8)(2010-12#2)(2011-2#1)(2012-3#2)(2013-1#2)
the CNT##2##2##(2008-10#1)(2008-7#1)
the CNVM##2##2##(2010-10#2)
the CO 2 laser via laparoscopy##2##6##(1991-3#2)
the CO 2 laser##8##4##(1991-3#2)(1992-1#3)(1992-3#3)
the CO 2##9##3##(1991-3#2)(1992-1#3)(1992-3#4)
the CO isolate##2##3##(2008-10#2)
the CO##15##2##(1991-3#2)(1992-1#3)(1992-3#4)(1992-6#1)(2008-10#4)(2008-3#1)
the CO(2) concentration##2##3##(2008-10#1)(2008-11#1)
the CO(2)##8##2##(2008-10#5)(2008-11#1)(2009-6#1)(2012-3#1)
the CO-sensing##2##2##(2008-10#2)
the CO2 activation##2##3##(1993-6#2)
the CO2##4##2##(1993-6#2)(1994-12#2)
the COLIPA##2##2##(2008-5#2)
the COMFORT Behavior##2##3##(2012-2#2)
the COMFORT-B##2##2##(2012-2#2)
the COOH-terminal domain of the##2##5##(1995-6#2)
the COOH-terminal domain of##3##4##(1995-6#3)
the COOH-terminal region of##2##4##(1995-6#2)
the COOH-terminal##7##2##(1990-8#1)(1992-9#1)(1995-6#5)
the CP and the##2##4##(2008-10#2)
the CP and##3##3##(1995-6#1)(2008-10#2)
the CP gene of##2##4##(2008-10#2)
the CP gene##10##3##(2008-10#10)
the CP sequences of##2##4##(2008-10#2)
the CP transgene##2##3##(2008-8#2)
the CP##31##2##(1995-6#1)(2008-10#27)(2008-8#2)(2008-9#1)
the CP7 mutant##2##3##(2008-10#2)
the CPM##2##2##(2008-11#2)
the CPMG sequence##2##3##(2011-2#2)
the CPP##3##2##(1993-6#3)
the CPPSU##2##2##(2008-11#2)
the CPTQ##4##2##(2008-12#4)
the CPy(+) cation##2##3##(2008-10#2)
the CR lever##3##3##(1993-6#3)
the CR##5##2##(1993-6#4)(2008-10#1)
the CR011-vcMMAE antibody-drug conjugate##2##4##(2009-4#2)
the CRB##2##2##(2008-10#2)
the CRE##3##2##(1997-2#1)(2013-1#2)
the CRF receptor##2##3##(1997-4#1)(2008-4#1)
the CRF##3##2##(1997-4#1)(2008-4#2)
the CRMs##2##2##(2008-10#2)
the CS##6##2##(2008-10#1)(2008-5#2)(2008-7#1)(2012-3#2)
the CSF##3##2##(1996-12#1)(2008-12#1)(2011-2#1)
the CSF-1##5##2##(1991-6#2)(1997-7#3)
the CT activity of##2##4##(2008-7#2)
the CT##10##2##(1990-6#1)(1996-3#1)(2008-7#3)(2009-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
the CT60(∗)G allele##2##3##(2010-12#2)
the CTN##2##2##(1997-2#2)
the CTV status of##2##4##(2008-10#2)
the CTV##7##2##(2008-10#7)
the CUDS##2##2##(2008-10#2)
the CV##3##2##(2008-10#2)(2008-8#1)
the CVB1##3##2##(2013-8#3)
the CYP1A##2##2##(1994-8#2)
the CYP3A subfamily##2##3##(1994-5#1)(1994-8#1)
the CYP3A##3##2##(1994-5#2)(1994-8#1)
the CYVD strains##2##3##(2008-10#2)
the Ca##2##2##(2008-10#1)(2008-3#1)
the Ca(2+)-triggered##2##2##(1992-6#1)(2012-2#1)
the Ca2+##9##2##(1990-2#1)(1991-6#1)(1993-8#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-1#1)
the Ca2+/CaM/CaN signal pathway in 5-HT-induced proliferation of rat##2##9##(2011-3#2)
the CaM-BP68##3##2##(1994-5#3)
the CaMV 35S promoter##2##4##(1997-8#1)(2011-10#1)
the CaSR mRNA##2##3##(2008-11#2)
the Caco-2 cell##3##3##(2008-11#3)
the Caco-2##4##2##(2008-11#4)
the Caenorhabditis elegans homologue##2##4##(1995-6#2)
the Caenorhabditis elegans##5##3##(1993-12#1)(1995-6#2)(2012-3#2)
the California Critical Thinking##2##4##(2008-11#2)
the California isolates##2##3##(2008-10#2)
the California##15##2##(1995-12#2)(1995-8#1)(2008-10#8)(2008-11#2)(2010-8#2)
the Canadian Criminal Code##2##4##(1993-9#1)(1996-1#1)
the Canadian guideline values for##2##5##(2008-10#2)
the Canadian healthcare system##2##4##(1997-3#2)
the Canadian##26##2##(1993-9#2)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#7)(2008-11#4)(2009-3#1)(2012-12#1)(2013-1#2)
the Canary Island##2##3##(2008-10#2)
the Canary##3##2##(2008-10#3)
the Cancer Atlas Viewer##2##4##(2008-5#2)
the Cancer##5##2##(1991-3#1)(1995-2#1)(2008-5#2)(2008-7#1)
the Candida##3##2##(1991-9#1)(2011-2#1)(2013-1#1)
the Canton of##4##3##(1990-6#1)(1996-11#3)
the Capacity##2##2##(1997-1#1)(2011-2#1)
the Care of##4##3##(1992-3#1)(1994-3#1)(2010-7#1)(2012-12#1)
the Caribbean Basin##5##3##(2008-10#5)
the Caribbean and##2##3##(2008-10#1)(2008-5#1)
the Caribbean region and##2##4##(2008-10#2)
the Caribbean region##4##3##(2008-10#3)(2008-11#1)
the Caribbean##19##2##(1991-3#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
the Carolinas##5##2##(2008-8#5)
the Catholic University of##3##4##(1990-8#1)(2013-1#2)
the Catholic##4##2##(1990-6#1)(1990-8#1)(2013-1#2)
the Caucasian##2##2##(2008-1#1)(2010-5#1)
the Caucasus##8##2##(2008-10#7)(2008-11#1)
the Causal Agent of Bacterial##2##5##(2008-10#2)
the Causal Agent of Green Mold##2##6##(2008-10#2)
the Causal Agent of##13##4##(2008-10#13)
the Cause of Citrus Greasy Spot##2##6##(2008-10#2)
the Cause of##5##3##(2008-10#5)
the Cd##4##2##(2008-10#4)
the Ce-PbO(2) modified electrode was##2##5##(2008-10#2)
the Cell SELEX##2##3##(2010-5#2)
the Cellscreen system##2##3##(2008-11#2)
the Center for Devices and Radiological Health##2##7##(1993-3#1)(2010-6#1)
the Center for##7##3##(1990-11#2)(1993-3#1)(2008-11#2)(2010-5#1)(2010-6#1)
the Center of Origin##2##4##(2008-10#2)
the Center##12##2##(1990-11#2)(1992-2#3)(1993-3#1)(2008-10#2)(2008-11#2)(2010-5#1)(2010-6#1)
the Centers for Disease Control and Prevention (CDC)##7##8##(1995-12#2)(1995-6#3)(1996-5#1)(1997-1#1)
the Centers for Disease Control and Prevention##9##7##(1995-12#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)
the Centers for Disease Control and##11##6##(1995-12#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#2)(2008-11#1)
the Centers for Disease Control##12##5##(1992-2#1)(1995-12#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#2)(2008-11#1)
the Centers for##13##3##(1992-2#1)(1995-12#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#2)(2008-11#1)(2012-12#1)
the Central##10##2##(1991-9#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#3)
the Centre##2##2##(1993-12#1)(2008-11#1)
the Centro##2##2##(1993-3#1)(2008-10#1)
the ChL##3##2##(2008-10#3)
the Changbai Mountain##2##3##(2008-9#2)
the Chernobyl##3##2##(2008-10#2)(2008-7#1)
the Child and Adolescent Social Support Scale##2##7##(2010-1#2)
the Child and Adolescent##3##4##(2008-11#1)(2010-1#2)
the Child##7##2##(1992-12#1)(1993-1#1)(1996-12#1)(2008-11#1)(2008-9#1)(2010-1#2)
the Children's##3##2##(1994-3#1)(2008-11#1)(2010-5#1)
the Chinese hamster ovary##2##4##(1995-11#1)(2008-11#1)
the Chinese hamster##3##3##(1995-11#1)(1997-7#1)(2008-11#1)
the Chinese herbal##3##3##(2008-10#3)
the Chinese##17##2##(1995-11#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#2)(2011-2#3)(2011-3#1)(2013-1#1)
the Chlamydia##2##2##(1993-9#1)(2008-5#1)
the Cibacron Blue##2##3##(1990-12#1)(1997-2#1)
the Cincinnati##4##2##(1994-12#1)(1995-3#1)(2008-5#1)(2011-2#1)
the City##2##2##(1991-12#2)
the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)##2##11##(1994-12#1)(1996-12#1)
the Classification##2##2##(1991-12#2)
the Clauss##2##2##(2008-10#2)
the Cleveland##2##2##(1996-1#1)(2008-7#1)
the Clinic##5##2##(1993-12#1)(1995-9#1)(1996-11#1)(2011-2#1)(2012-3#1)
the Clinical##9##2##(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
the Clinton##4##2##(1995-1#1)(1995-2#2)(1995-6#1)
the Co-4##3##2##(2008-10#3)
the Coat Protein Gene##2##4##(2008-10#2)
the Coat Protein##3##3##(2008-10#3)
the Cochrane Database of Systematic Reviews##2##6##(1993-12#1)(2011-2#1)
the Cochrane##3##2##(1993-12#1)(2011-2#1)(2013-1#1)
the Cohesion to Therapist Scale##2##5##(2013-1#2)
the College of##2##3##(1993-12#1)(2008-12#1)
the Collins##4##2##(1994-8#4)
the Colombian##4##2##(2008-10#1)(2008-5#1)(2012-12#2)
the Colorado potato beetle##3##4##(2008-10#3)
the Colorado##4##2##(2008-10#4)
the Columbia Basin of Washington and Oregon##2##7##(2008-10#2)
the Columbia Basin of Washington##3##5##(2008-10#3)
the Columbia Basin##7##3##(2008-10#7)
the Columbia##8##2##(2008-10#7)(2010-8#1)
the Commission on##2##3##(2012-12#1)(2012-2#1)
the Commission##4##2##(2008-10#2)(2012-12#1)(2012-2#1)
the Committee on##3##3##(1991-1#1)(2008-7#1)(2013-1#1)
the Committee##6##2##(1991-1#1)(1993-1#2)(2008-11#1)(2008-7#1)(2013-1#1)
the Common Bean##2##3##(2008-10#2)
the Common##5##2##(1996-5#1)(2008-10#2)(2008-12#1)(2008-5#1)
the Community##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
the Complex##2##2##(2008-11#1)(2008-12#1)
the Consejo Superior de Investigaciones##2##5##(2008-10#2)
the Constitution##2##2##(2011-2#2)
the Consumer Price Index for prescription drugs##2##7##(1993-1#2)
the Consumer Price Index##3##4##(1993-1#2)(1993-3#1)
the Control condition##2##3##(2008-4#2)
the Control##5##2##(2008-4#3)(2011-2#2)
the Convention##3##2##(1992-12#3)
the Coomassie brilliant blue##2##4##(2008-10#2)
the Coping##2##2##(2008-11#1)(2008-12#1)
the Core##2##2##(1995-12#1)(2008-10#1)
the Corneometer##2##2##(2008-5#2)
the Coroner's##2##2##(1996-1#2)
the Council on##2##3##(1991-8#1)(1997-3#1)
the Council##7##2##(1991-8#1)(1995-6#5)(1997-3#1)
the Course of##2##3##(2010-1#1)(2012-3#1)
the CpG##2##2##(1994-5#1)(1996-6#1)
the Cr##3##2##(2008-10#2)(2008-2#1)
the Cr(III)##2##2##(2008-10#1)(2011-2#1)
the Cr(VI) concentrations##2##3##(2008-10#2)
the Cr(VI)##8##2##(2008-10#8)
the Cr2 gene##3##3##(2008-10#3)
the Cr2 phenotype##2##3##(2008-10#2)
the Cr2##6##2##(2008-10#6)
the CrCL##2##2##(2012-3#2)
the Cricket##3##2##(2008-5#2)(2008-6#1)
the Crisis Center for##2##4##(1995-5#2)
the Critical Indicator Project in##2##5##(1992-2#2)
the Critical##3##2##(1992-2#2)(2013-1#1)
the Croatian##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
the Cross##2##2##(2008-10#1)(2013-1#1)
the Cryptosporidium DNA##2##3##(2008-10#2)
the Cu##5##2##(1997-8#1)(2008-10#3)(2008-12#1)
the Cu(II)##3##2##(2008-10#3)
the Cu(II)-DDTC complex##3##3##(2008-10#3)
the CuO2##2##2##(1992-8#1)(1996-9#1)
the CyA##2##2##(2008-10#2)
the Czech Republic##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
the D genotype##2##3##(2008-10#2)
the D##16##2##(1993-8#1)(1995-2#2)(2007-12#1)(2008-10#11)(2008-9#1)
the D-alanyl##2##2##(1995-6#2)
the D-lactate##2##2##(1991-12#1)(2008-7#1)
the D-loop##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
the D-wave##2##2##(2008-7#2)
the D2##3##2##(1993-9#1)(1995-2#1)(2008-7#1)
the D3 receptor##4##3##(1995-2#4)
the DA##4##2##(1993-6#1)(1996-12#1)(1997-2#1)(2008-10#1)
the DAV##2##2##(2008-8#2)
the DAX-8 and XAD-8 resins##2##5##(2008-10#2)
the DAX-8##3##2##(2008-10#3)
the DD##3##2##(2008-10#3)
the DDR##5##2##(2011-2#3)(2013-1#2)
the DEB test to##2##4##(2008-4#2)
the DEB test##3##3##(2008-4#3)
the DEJ##3##2##(2008-5#1)(2010-10#2)
the DGN##6##2##(2012-2#6)
the DH##2##2##(2008-10#2)
the DI##3##2##(1995-11#1)(2008-10#1)(2008-3#1)
the DII progress##2##3##(2008-10#2)
the DII##3##2##(2008-10#3)
the DIPD##2##2##(2008-10#2)
the DM group##2##3##(2011-2#2)
the DM-Allo group##2##3##(2011-2#2)
the DMI##2##2##(2008-10#2)
the DMN##2##2##(2013-8#2)
the DNA IQ System##2##4##(2008-12#2)
the DNA backbone##3##3##(1994-5#1)(2008-10#2)
the DNA binding properties of##2##5##(1991-3#1)(1996-3#1)
the DNA binding##3##3##(1991-3#1)(1995-6#1)(1996-3#1)
the DNA concentration##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
the DNA content##2##3##(1991-6#1)(2008-11#1)
the DNA damage checkpoint##2##4##(2008-11#1)(2013-1#1)
the DNA damage response (DDR)##2##5##(2011-2#1)(2013-1#1)
the DNA damage response##3##4##(2011-2#1)(2013-1#2)
the DNA damage##7##3##(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#3)
the DNA data##2##3##(1997-6#2)
the DNA double helix##2##4##(2008-10#1)(2008-11#1)
the DNA double##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
the DNA fingerprint probe pSTL70##2##5##(2008-10#2)
the DNA fragments##3##3##(2008-10#2)(2008-11#1)
the DNA hybridization##3##3##(2008-10#3)
the DNA molecule##2##3##(2008-11#2)
the DNA of##4##3##(1993-8#1)(2008-10#1)(2013-1#2)
the DNA polymerase##2##3##(1992-3#1)(1995-6#1)
the DNA sequence of the##2##5##(1993-8#1)(2008-10#1)
the DNA sequence##3##3##(1993-8#1)(2008-10#1)(2008-8#1)
the DNA sequences of the##2##5##(2008-10#1)(2008-8#1)
the DNA sequences of##3##4##(1997-7#1)(2008-10#1)(2008-8#1)
the DNA sequences##5##3##(1997-7#1)(2008-10#3)(2008-8#1)
the DNA substrate##2##3##(1991-9#1)(1997-3#1)
the DNA target##2##3##(1994-3#1)(2008-10#1)
the DNA template##3##3##(1995-2#1)(2008-4#1)(2008-7#1)
the DNA was##3##3##(1993-8#2)(2008-10#1)
the DNA##100##2##(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-3#1)(1992-6#1)(1993-2#1)(1993-8#8)(1994-3#2)(1994-5#2)(1995-2#2)(1995-6#2)(1995-8#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(2008-10#30)(2008-11#11)(2008-12#4)(2008-4#5)(2008-7#1)(2008-8#3)(2008-9#2)(2011-2#1)(2013-1#5)
the DNA-A##2##2##(2008-10#2)
the DNA-binding activity of##2##4##(1991-7#1)(2008-9#1)
the DNA-binding##3##2##(1991-7#1)(1993-12#1)(2008-9#1)
the DNAbeta molecules##2##3##(2008-10#2)
the DNAzyme##2##2##(2008-10#2)
the DNB and NBM##2##4##(1993-3#2)
the DNB and##3##3##(1993-3#3)
the DNB##4##2##(1993-3#4)
the DNS##3##2##(2013-8#3)
the DP method##2##3##(2008-2#2)
the DP##3##2##(2008-2#2)(2010-1#1)
the DPH2 gene##3##3##(1993-9#3)
the DPH2##6##2##(1993-9#6)
the DPP##2##2##(2008-10#2)
the DPPH##5##2##(2008-10#1)(2008-11#2)(2008-5#2)
the DQB1(*)0602##2##2##(1997-9#2)
the DR-CALUX((R)) measured##2##3##(2008-10#2)
the DR-CALUX((R))##3##2##(2008-10#3)
the DRA##2##2##(2007-12#2)
the DRG##8##2##(1992-2#1)(1993-1#1)(1994-12#2)(1997-2#2)(2008-9#2)
the DRR206 promoter##3##3##(2008-10#3)
the DRUJ##3##2##(2008-9#3)
the DS##5##2##(1996-2#3)(2008-10#1)(2011-2#1)
the DSES##3##2##(2009-11#3)
the DSM##3##2##(1996-9#1)(2009-10#2)
the DSM-IV##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
the DSRU##2##2##(2008-11#2)
the DSTD##3##2##(2008-10#3)
the DT##2##2##(2011-1#2)
the DUF683 family##2##3##(2009-7#2)
the Dana-Farber Cancer Institute##2##4##(2008-5#1)(2013-1#1)
the Dane County Drug Treatment Court##2##6##(2010-6#2)
the Danish##5##2##(1990-12#3)(1997-3#1)(2012-2#1)
the Data##3##2##(1996-6#1)(1997-5#1)(2013-8#1)
the DeFord and Hume formalism##2##5##(2008-10#2)
the Deaf##3##2##(2011-2#3)
the Debye length##2##3##(1997-6#2)
the Debye-Hückel equation##2##3##(2008-10#2)
the December##2##2##(1995-12#1)(2009-8#1)
the Department of Defense (DOD)##2##5##(1995-6#1)(1996-5#1)
the Department of Defense##3##4##(1995-6#1)(1996-12#1)(1996-5#1)
the Department of Energy (DOE)##2##5##(2008-10#1)(2008-5#1)
the Department of Energy##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
the Department of Health and Human##2##6##(1996-5#1)(1997-3#1)
the Department of Health##6##4##(1991-2#1)(1992-1#1)(1996-5#1)(1997-3#1)(2008-9#1)(2013-8#1)
the Department of Infection Control and Prevention##2##7##(2010-6#2)
the Department of Orthopaedics and Traumatology##2##6##(2013-1#2)
the Department of Pathology##2##4##(1991-9#1)(2008-5#1)
the Department of the##2##4##(1992-12#1)(2007-8#1)
the Department of##53##3##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-6#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the Department##57##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-8#2)(2008-10#8)(2008-11#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-6#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the Depression##2##2##(1991-2#1)(2007-12#1)
the Development of##4##3##(1997-6#1)(2008-10#3)
the Diagnostic and Statistical Manual of Mental Disorders##4##8##(2010-11#1)(2011-2#3)
the Diagnostic##5##2##(2008-11#1)(2010-11#1)(2011-2#3)
the Diels-Alder##5##2##(1996-5#5)
the Dimension##2##2##(2008-10#2)
the Diskus##5##2##(1996-2#5)
the District of##3##3##(1992-2#1)(1997-1#1)(2010-5#1)
the Division of##4##3##(1991-12#1)(1995-6#1)(2008-8#2)
the DnaB helicase##2##3##(1991-12#2)
the Dobson##2##2##(2008-3#2)
the Dominican Republic in the##2##5##(2008-10#2)
the Dominican Republic##10##3##(2008-10#9)(2008-11#1)
the Donnan effect##4##3##(2011-2#4)
the Doppler shift in the frequency##2##6##(2008-3#2)
the Doppler shift in the##3##5##(2008-2#1)(2008-3#2)
the Doppler shift##4##3##(2008-2#1)(2008-3#3)
the Doppler##6##2##(2008-2#1)(2008-3#5)
the Doto area##2##3##(2010-8#2)
the Doto##3##2##(2010-8#3)
the Down syndrome##4##3##(1996-2#2)(1997-2#1)(2008-11#1)
the Drosophila segment polarity gene hedgehog##2##6##(1993-12#1)(1994-12#1)
the Drosophila segment polarity gene##3##5##(1993-12#2)(1994-12#1)
the Drosophila##17##2##(1993-12#2)(1993-6#1)(1994-12#2)(1995-6#3)(1997-3#1)(1997-8#1)(2008-9#6)(2012-3#1)
the Drug##2##2##(1991-3#1)(2008-11#1)
the Ds##2##2##(2008-10#1)(2012-3#1)
the Dutch TAD soils##2##4##(2008-10#2)
the Dutch##11##2##(1994-12#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)(2013-8#1)
the Dynabeads##2##2##(1990-12#2)
the E##18##2##(1990-11#2)(1992-9#2)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1997-7#1)(1997-8#1)(2008-4#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
the E(pa)##2##2##(2008-10#2)
the E1A##2##2##(1993-2#1)(2008-11#1)
the E1A/E1B sequence##2##3##(2008-11#2)
the E2##4##2##(2008-10#4)
the E2F##2##2##(2012-2#2)
the E5-1 gene##2##3##(1995-8#2)
the E5-1##3##2##(1995-8#3)
the EA##2##2##(1995-2#1)(2008-10#1)
the EAP##2##2##(1995-6#2)
the EASE##4##2##(2008-11#4)
the EB##2##2##(2008-10#1)(2008-3#1)
the EBV##4##2##(1997-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
the EBs##2##2##(2008-11#2)
the EC Standards##2##3##(2008-10#2)
the EC##4##2##(2008-10#2)(2008-7#1)(2009-10#1)
the EC(50) values##2##3##(2008-10#1)(2008-11#1)
the EC3##3##2##(2008-10#3)
the EC50##2##2##(1995-11#1)(1995-2#1)
the ECD##2##2##(1995-12#1)(2008-10#1)
the ECG##5##2##(1991-3#1)(1992-6#1)(1996-3#1)(2008-10#1)(2010-8#1)
the ECL intensity of##2##4##(2008-10#2)
the ECL intensity##3##3##(2008-10#3)
the ECL of##5##3##(2008-10#5)
the ECL##10##2##(2008-10#10)
the ECM##2##2##(1993-3#1)(2009-12#1)
the ED and##2##3##(2009-6#1)(2010-8#1)
the ED or##2##3##(1997-2#1)(2008-11#1)
the ED##20##2##(1997-2#3)(1997-8#1)(2008-11#5)(2009-6#3)(2010-8#2)(2012-2#2)(2013-1#4)
the ED(50)##4##2##(2008-10#2)(2008-11#2)
the EDTA##5##2##(2008-10#4)(2008-11#1)
the EEG##4##2##(1991-9#1)(2009-8#2)(2010-8#1)
the EF##2##2##(2008-10#2)
the EFS-evoked##2##2##(1997-4#2)
the EGF +61##2##3##(2011-2#2)
the EGF receptor##4##3##(1993-8#3)(1994-11#1)
the EGF##6##2##(1993-8#3)(1994-11#1)(2011-2#2)
the EGFP expression##2##3##(2008-11#2)
the EGFP##5##2##(2008-11#5)
the EGFR##2##2##(1993-8#1)(2010-5#1)
the EIA##2##2##(2008-10#1)(2008-5#1)
the ELISA method##4##3##(2008-10#4)
the ELISA##20##2##(1990-2#1)(1991-12#1)(1992-12#1)(1995-2#2)(1995-6#1)(2008-10#10)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
the ELISA-based assays are##2##4##(2008-10#2)
the ELISE##3##2##(2008-3#3)
the EMC test system of##2##5##(2012-3#2)
the EMC##3##2##(2012-3#3)
the EMEP##2##2##(2008-10#2)
the EN 12341 standard##3##4##(2008-10#3)
the EN##5##2##(2008-10#3)(2008-11#2)
the EPCS substrate##2##3##(2011-2#2)
the EPR##2##2##(1997-7#1)(2008-10#1)
the EQ-5D##2##2##(2011-2#1)(2012-12#1)
the ER gene##2##3##(1997-7#2)
the ER in##2##3##(1994-12#1)(2008-11#1)
the ER##26##2##(1991-2#2)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#2)(1995-2#2)(1997-7#2)(2008-11#7)(2009-8#3)(2011-2#2)(2013-1#1)
the ES##3##2##(2008-8#2)(2012-2#1)
the ESI##2##2##(1997-8#1)(2011-2#1)
the ESR##4##2##(2008-10#3)(2012-2#1)
the ESRD population is##2##4##(1991-3#2)
the ESRD##4##2##(1991-3#2)(1996-2#2)
the ESS level of selfishness is##2##6##(2008-9#2)
the ESS##7##2##(2008-8#3)(2008-9#3)(2012-3#1)
the ET##2##2##(2008-10#1)(2013-1#1)
the ETAAS##6##2##(2008-10#6)
the ETV##2##2##(2008-10#2)
the EU race##2##3##(2008-10#2)
the EU##13##2##(2008-10#10)(2008-11#1)(2009-8#1)(2013-8#1)
the EURACHEM Guide##2##3##(2008-10#2)
the EURACHEM##3##2##(2008-10#3)
the EV71 strains##2##3##(2008-12#2)
the EV71##3##2##(2008-12#2)(2008-8#1)
the Early##6##2##(1993-12#1)(2008-10#3)(2011-2#1)(2012-12#1)
the Earth##6##2##(2008-10#1)(2008-12#1)(2008-3#3)(2011-2#1)
the Earth's atmosphere##3##3##(2008-11#1)(2008-3#2)
the Earth's##4##2##(2008-11#1)(2008-3#3)
the East##8##2##(2008-10#3)(2008-11#1)(2010-1#1)(2010-8#1)(2011-2#2)
the Eating##2##2##(2012-5#2)
the Ebro river basin##3##4##(2008-10#3)
the Economic Stabilization Program##2##4##(1994-12#2)
the Editor##5##2##(2008-10#2)(2009-10#1)(2011-2#1)(2012-2#1)
the Editors-in-Chief##3##2##(2008-10#3)
the Effect of##2##3##(2008-10#2)
the Effects of##5##3##(2008-10#4)(2008-11#1)
the Egyptian##3##2##(2008-1#1)(2008-10#2)
the Ehrlich ascites tumour##2##4##(1990-5#2)
the Ehrlich##3##2##(1990-5#2)(2012-3#1)
the El##4##2##(1992-5#1)(2008-12#1)(2008-9#1)(2010-8#1)
the Elderly (PACE)##4##3##(1992-1#1)(1994-2#1)(1995-1#1)(2008-7#1)
the Elderly##9##2##(1992-1#1)(1994-2#1)(1995-1#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
the Emergency Department##5##3##(1991-12#1)(1997-2#1)(2008-11#1)(2008-3#1)(2012-12#1)
the Endophytic##2##2##(2008-10#2)
the English National Board##2##4##(2008-11#2)
the English literature##5##3##(2008-12#1)(2009-3#1)(2010-6#1)(2011-2#2)
the English##10##2##(1995-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-3#1)(2010-6#1)(2011-2#2)(2013-1#1)
the Environment##4##2##(1995-6#1)(2008-10#1)(2008-11#2)
the Environmental Satellite##2##3##(2008-3#2)
the Environmental##5##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-3#2)
the Epstein-Barr virus##3##3##(1993-8#1)(1995-2#1)(2011-2#1)
the Er##2##2##(2008-7#2)
the Eremothecium##2##2##(2012-3#2)
the Escherichia coli DNA##2##4##(1992-3#2)
the Escherichia coli##22##3##(1990-7#1)(1991-10#1)(1991-7#1)(1992-3#2)(1992-9#1)(1993-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#4)(1996-3#1)(1996-6#3)(1997-2#1)(1997-8#1)(2013-1#1)
the Ethical##2##2##(1991-3#2)
the Eu(3+)##3##2##(2008-10#1)(2008-3#2)
the Euclidean perimeter of the##2##5##(2008-6#2)
the Euclidean##4##2##(2008-6#2)(2010-7#1)(2011-2#1)
the Eurasian badger##2##3##(2008-12#2)
the Eurasian##3##2##(2008-12#2)(2008-9#1)
the European (EU) race of Gremmeniella abietina##2##7##(2008-10#2)
the European Commission##7##3##(1996-1#1)(2008-10#6)
the European Community##4##3##(1993-2#1)(1994-5#1)(2008-10#2)
the European Pharmacopoeia##2##3##(2008-10#2)
the European Race of Gremmeniella abietina##2##6##(2008-10#2)
the European Society for##2##4##(2008-10#1)(2013-1#1)
the European Society of Radiology (ESR)##2##6##(2012-2#2)
the European Society of Radiology##6##5##(2012-2#6)
the European Society of##8##4##(2008-7#1)(2012-2#6)(2013-1#1)
the European Society##10##3##(2008-10#1)(2008-7#1)(2012-2#6)(2013-1#2)
the European Union and##3##4##(2008-10#3)
the European Union##12##3##(1996-3#1)(2008-10#9)(2008-5#1)(2013-8#1)
the European market##2##3##(2008-11#1)(2008-5#1)
the European##71##2##(1990-11#1)(1990-2#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#36)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-2#6)(2013-1#5)(2013-8#1)
the Evaluation of##2##3##(2008-11#1)(2012-3#1)
the Evaluation##3##2##(2008-11#1)(2010-9#1)(2012-3#1)
the Evolutionary##2##2##(2009-8#1)(2011-2#1)
the Excimer-laser##2##2##(1991-9#2)
the Executive Office Building##2##4##(1995-6#2)
the Executive##4##2##(1992-2#1)(1995-6#2)(1996-9#1)
the Experimental##2##2##(2008-12#1)(2008-3#1)
the F sex factor TraD protein##2##6##(1992-7#2)
the F##21##2##(1992-7#2)(2008-10#15)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
the F(1) generation##3##3##(2008-10#3)
the F(1) hybrid of##2##4##(2008-10#2)
the F(1) hybrid##3##3##(2008-10#2)(2008-9#1)
the F(1) hybrids##2##3##(2008-10#2)
the F(1)##14##2##(2008-10#13)(2008-9#1)
the F(2) generation and##2##4##(2008-10#2)
the F(2) generation##3##3##(2008-10#3)
the F(2) population##3##3##(2008-10#2)(2008-8#1)
the F(2)##9##2##(2008-10#8)(2008-8#1)
the F(3) and##3##3##(2008-10#3)
the F(3)##7##2##(2008-10#7)
the F-actin content##2##3##(1994-6#2)
the F-actin##4##2##(1993-8#1)(1994-6#2)(2008-10#1)
the F-test##2##2##(2008-10#2)
the F1 and F2 populations##2##5##(2008-10#2)
the F1##4##2##(2008-10#3)(2008-12#1)
the F1021##2##2##(1997-7#2)
the F1Fo-ATPsynthase in##2##3##(2012-2#2)
the F3 generation##2##3##(2008-12#2)
the F3##3##2##(2008-12#3)
the FAAS##2##2##(2008-10#2)
the FAME##2##2##(2008-10#1)(2009-8#1)
the FAS and CTLA-4 genes##2##5##(2009-8#2)
the FAS##3##2##(2009-8#2)(2009-9#1)
the FCO##3##2##(2008-7#3)
the FDA issued##2##3##(2008-9#1)(2013-8#1)
the FDA##7##2##(2008-8#1)(2008-9#2)(2010-12#1)(2010-9#1)(2013-1#1)(2013-8#1)
the FDA's warning##2##3##(2013-8#2)
the FDA's##3##2##(2008-5#1)(2013-8#2)
the FDTD##3##2##(2008-3#3)
the FED##2##2##(1996-12#2)
the FFA##2##2##(2008-12#1)(2013-8#1)
the FHB##2##2##(2008-10#2)
the FI system##5##3##(2008-10#5)
the FI##10##2##(2008-10#10)
the FIA method##2##3##(2008-10#2)
the FIA system and##3##4##(2008-10#3)
the FIA system##6##3##(2008-10#6)
the FIA##16##2##(1995-3#1)(2008-10#15)
the FISH##3##2##(1996-8#1)(2008-11#1)(2008-9#1)
the FLACC##3##2##(2012-2#3)
the FMS##2##2##(2011-2#2)
the FOAD-hypothesis##3##2##(2013-1#3)
the FRET##2##2##(2008-4#1)(2008-9#1)
the FS##5##2##(1991-12#2)(2011-2#3)
the FSH receptor##2##3##(1995-11#1)(2010-8#1)
the FSMD##3##2##(2008-10#3)
the FT##2##2##(1991-11#2)
the FT-IR spectra##2##3##(2008-10#1)(2008-5#1)
the FT-IR##5##2##(2008-10#4)(2008-5#1)
the FTIR spectra##3##3##(2008-10#3)
the FTIR##8##2##(2008-10#7)(2008-3#1)
the FY##2##2##(1992-12#1)(1994-1#1)
the Face##2##2##(2010-1#2)
the Faculty of##3##3##(1996-12#1)(2008-10#1)(2010-1#1)
the Family##7##2##(1997-6#1)(2008-10#4)(2009-12#1)(2013-8#1)
the Fano factor can##2##4##(2010-10#2)
the Fano factor##3##3##(2010-10#3)
the Fc##5##2##(1990-12#3)(2008-11#2)
the FcepsilonRI##2##2##(2008-11#2)
the Fd##3##2##(1992-12#1)(1993-6#2)
the Fe(II)##2##2##(2008-10#2)
the Fe(III)##2##2##(2008-10#2)
the Federal Government##5##3##(1995-3#1)(1997-2#1)(2008-11#1)(2008-6#2)
the Federal Republic of Germany##5##5##(1991-12#1)(1991-2#1)(1992-1#2)(1995-1#1)
the Federal##18##2##(1991-12#1)(1991-2#1)(1992-1#3)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#1)(2012-3#1)(2013-1#1)
the Feldenkrais method##2##3##(2010-6#2)
the Fenton reaction##2##3##(2008-10#1)(2008-5#1)
the Fermi##2##2##(2008-10#2)
the Fertile Crescent##3##3##(2008-10#3)
the Field##4##2##(2008-10#2)(2009-11#1)(2011-2#1)
the Fiji Islands##2##3##(2008-1#2)
the Fiji##5##2##(2008-1#5)
the Final Rule##2##3##(2009-4#2)
the Fire##2##2##(1993-12#1)(2008-10#1)
the First Dental Home##2##4##(2011-2#2)
the First World War##3##4##(2008-10#2)(2011-4#1)
the First##7##2##(2007-12#1)(2008-10#2)(2011-2#2)(2011-4#1)(2013-1#1)
the Firth of Vistula##2##4##(2008-11#2)
the Florida##5##2##(1996-2#1)(2008-10#3)(2008-12#1)
the Flu-6plx PCR##2##3##(2011-2#2)
the Flu-6plx##3##2##(2011-2#3)
the Fny-CMV##2##2##(2008-10#2)
the Food and Drug Administration (FDA)##3##6##(1996-5#2)(2008-5#1)
the Food and Drug Administration##7##5##(1996-5#2)(2008-5#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
the Food##12##2##(1991-2#1)(1996-5#2)(2008-10#2)(2008-5#1)(2008-8#1)(2010-6#1)(2010-9#1)(2012-2#2)(2013-1#1)
the Foster/CIho 4780##3##3##(2008-10#3)
the Foster/CIho##4##2##(2008-10#4)
the Foundation##3##2##(1994-3#1)(2008-10#1)(2009-3#1)
the Fourier##5##2##(2008-3#5)
the Fourth##4##2##(1995-6#2)(1997-6#1)(2008-11#1)
the Framingham##4##2##(1993-3#1)(2008-1#2)(2009-12#1)
the Freedom##2##2##(1995-6#1)(2009-11#1)
the French##16##2##(1990-8#3)(1994-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2010-9#1)(2011-3#1)(2012-3#1)(2013-1#1)
the Fresnel##2##2##(2007-12#1)(2008-3#1)
the Freundlich##3##2##(2008-10#2)(2013-1#1)
the FsphDNase##2##2##(2008-10#2)
the Functional##5##2##(1993-1#1)(2008-7#2)(2011-2#2)
the Fungus##2##2##(2008-10#2)
the Fusarium oxysporum##3##3##(2008-10#3)
the Fusarium redolens-F##2##3##(2008-10#2)
the Fusarium##9##2##(2008-10#9)
the Future##6##2##(1994-12#2)(2008-10#2)(2010-7#1)(2013-1#1)
the G bead##2##3##(2008-6#2)
the G beta gamma dimer##2##5##(1993-9#2)
the G beta##3##3##(1993-9#2)(1995-8#1)
the G protein-coupled##2##3##(1994-12#1)(2009-7#1)
the G##18##2##(1990-6#1)(1993-1#1)(1993-8#1)(1993-9#4)(1994-12#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-6#2)(2009-7#1)
the G(1)##2##2##(2008-11#2)
the G-protein##2##2##(1991-5#1)(1993-6#1)
the G1 phase of##2##4##(1993-3#1)(1994-3#1)
the G1 phase##7##3##(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(2008-11#2)(2009-8#1)
the G1##11##2##(1992-10#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(2008-11#5)(2009-8#1)
the G1-to-S transition##2##3##(1994-3#2)
the G1-to-S##3##2##(1991-5#1)(1994-3#2)
the G1/S boundary##2##3##(1997-1#2)
the GA##3##2##(2008-10#2)(2009-8#1)
the GAB mutant##2##3##(2008-10#2)
the GAB##5##2##(2008-10#3)(2010-4#2)
the GABAA##3##2##(1990-5#1)(1995-11#2)
the GAC mutant##2##3##(2008-10#2)
the GATA-a motif##2##3##(2012-2#2)
the GB##3##2##(2008-10#3)
the GC electrode##2##3##(2008-10#2)
the GC rich region##2##4##(1993-3#2)
the GC##10##2##(1993-3#2)(1997-2#1)(2008-10#7)
the GC-HRMS##6##2##(2008-10#6)
the GC-MS##2##2##(2008-10#2)
the GC/MS##3##2##(2008-10#3)
the GCS##2##2##(2011-2#1)(2013-1#1)
the GDC##2##2##(1997-6#2)
the GDI##2##2##(2013-1#2)
the GEPR##2##2##(1996-12#2)
the GEPR-3##2##2##(1996-12#2)
the GFAP gene and##2##4##(2011-2#2)
the GFAP##3##2##(1997-2#1)(2011-2#2)
the GFD##2##2##(2011-2#2)
the GGP1##2##2##(1996-3#2)
the GH receptor##2##3##(1995-8#1)(1996-2#1)
the GH##6##2##(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#1)(2010-5#1)(2011-1#1)
the GHR1##4##2##(1995-8#4)
the GI##4##2##(2008-1#2)(2008-10#1)(2009-8#1)
the GIT is##2##3##(2012-2#1)(2013-1#1)
the GLU and PWB##2##4##(2010-8#2)
the GM##3##2##(2008-8#1)(2009-7#2)
the GNRs##2##2##(2012-12#2)
the GO##3##2##(2008-9#2)(2010-1#1)
the GP##3##2##(1990-6#1)(1997-4#1)(2008-11#1)
the GPIIIa##4##2##(2006-6#4)
the GPRD##2##2##(2008-11#2)
the GRAV CP sequence##2##4##(2008-10#2)
the GRAV CP##3##3##(2008-10#3)
the GRAV##4##2##(2008-10#4)
the GRNN##2##2##(2008-10#2)
the GROC and had a##2##5##(2008-12#2)
the GROC and##3##3##(2008-12#3)
the GS gene amplification system##2##5##(2008-11#2)
the GS##3##2##(1993-12#1)(2008-11#2)
the GSC and its##2##4##(2011-2#2)
the GSC##3##2##(2011-2#3)
the GSEM##2##2##(2008-10#2)
the GSH##2##2##(1990-2#2)
the GST##3##2##(1990-2#1)(1994-2#1)(1995-6#1)
the GUM##2##2##(2008-10#2)
the GaAs##2##2##(2008-2#1)(2008-3#1)
the Gait Deviation Index##2##4##(2013-1#2)
the Galician##2##2##(2008-10#2)
the Gamma Knife##2##3##(1997-4#2)
the Gamma##3##2##(1996-3#1)(1997-4#2)
the Gaussian beam##2##3##(2008-2#1)(2008-3#1)
the Gaussian##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
the GenMark##2##2##(1995-12#2)
the Gene Ontology##4##3##(2008-9#2)(2011-2#1)(2013-1#1)
the Gene##5##2##(2008-9#3)(2011-2#1)(2013-1#1)
the GeneMark##2##2##(1996-6#1)(2008-4#1)
the General Health Questionnaire##3##4##(2008-1#2)(2008-11#1)
the General Health##4##3##(1994-3#1)(2008-1#2)(2008-11#1)
the General##7##2##(1994-3#1)(2008-1#2)(2008-10#1)(2008-11#3)
the Generation##2##2##(2008-10#1)(2010-10#1)
the Genetic Diversity of##2##4##(2008-10#2)
the Genetic##3##2##(2008-10#3)
the Genomic Standards Consortium##2##4##(2011-2#2)
the Genomic##32##2##(2008-10#1)(2011-2#31)
the Georgia system##3##3##(1996-12#3)
the Geriatric##2##2##(2008-7#2)
the German Health##3##3##(1994-6#1)(2009-7#1)(2012-2#1)
the German##15##2##(1990-11#1)(1994-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#3)(2011-2#1)(2012-2#4)(2013-1#1)
the Gibbs##3##2##(1994-9#1)(2008-10#1)(2011-2#1)
the Gibbs-Donnan model##2##3##(2008-10#2)
the Global Ozone Monitoring by Occultation of Stars (GOMOS)##2##9##(2008-3#2)
the Global Ozone Monitoring##3##4##(2008-3#3)
the Global##8##2##(1991-2#1)(2008-11#1)(2008-12#1)(2008-3#3)(2011-1#1)(2011-2#1)
the Glu-50--&gt##7##2##(1995-6#7)
the Golgi apparatus##7##3##(1990-5#1)(1992-12#1)(1995-5#1)(2008-11#3)(2012-2#1)
the Golgi##22##2##(1990-5#1)(1992-12#1)(1994-12#1)(1995-2#3)(1995-5#1)(1995-8#1)(2008-11#6)(2008-7#4)(2009-8#2)(2012-2#2)
the Gompertz model##5##3##(2008-10#4)(2008-9#1)
the Gompertz##8##2##(1993-12#1)(2008-1#1)(2008-10#5)(2008-9#1)
the Government##4##2##(1995-3#2)(2008-10#1)(2008-11#1)
the Graham##2##2##(1997-3#1)(2008-9#1)
the Great Plains##5##3##(2008-10#5)
the Great##8##2##(2008-10#6)(2008-5#1)(2013-8#1)
the Greater##3##2##(1995-2#2)(2008-11#1)
the Greek##3##2##(2009-1#1)(2010-2#1)(2011-2#1)
the Green##2##2##(2008-10#1)(2009-8#1)
the Green's function##4##3##(2008-3#4)
the Group##5##2##(2008-10#1)(2008-11#2)(2013-1#2)
the Guglielmi##2##2##(1996-9#1)(2008-7#1)
the Guidelines##2##2##(2008-7#1)(2011-2#1)
the Gulf of Gdańsk##2##4##(2008-11#2)
the Gus##3##2##(1993-8#3)
the Guttmacher Institute##2##3##(2013-1#2)
the Guyon's canal##3##3##(2008-9#3)
the H and##2##3##(2008-11#1)(2011-2#1)
the H group##4##3##(2011-2#4)
the H##15##2##(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#7)
the H(+)##2##2##(2008-10#1)(2008-8#1)
the H(+)-ATPase from##2##3##(1995-2#2)
the H(2)O(2) generated##2##3##(2008-10#2)
the H(2)O(2)##7##2##(2008-10#7)
the H+##3##2##(1994-6#2)(1997-8#1)
the H-Wave(R) device is##2##4##(2010-1#2)
the H-Wave(R) device##7##3##(2010-1#7)
the H-bond##2##2##(1992-10#1)(2008-10#1)
the H-point and generalised H-point standard##2##6##(2008-10#2)
the H-point standard addition method##6##5##(2008-10#6)
the H-point standard##7##3##(2008-10#7)
the H-point##9##2##(2008-10#9)
the H1##2##2##(1993-6#2)
the HA##10##2##(1993-12#2)(2008-10#3)(2010-8#1)(2011-2#4)
the HB group##2##3##(2011-2#2)
the HB##3##2##(2011-2#3)
the HBV##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
the HC##4##2##(2008-10#4)
the HC-Pro##4##2##(2008-10#3)(2008-9#1)
the HCl##3##2##(2008-10#3)
the HD region##2##3##(1996-8#2)
the HD##3##2##(1996-8#2)(2008-1#1)
the HDL-C##2##2##(2013-1#2)
the HEV71 strains##3##3##(2013-8#3)
the HF + HClO(4) digestion##2##5##(2008-10#2)
the HFD test##3##3##(2008-7#3)
the HG##2##2##(2008-10#2)
the HGDP-CEPH##2##2##(2012-3#2)
the HIC1##2##2##(2009-8#2)
the HIV epidemic##8##3##(1990-12#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(2010-5#1)
the HIV##18##2##(1990-12#1)(1991-1#1)(1992-9#1)(1993-12#2)(1994-9#1)(1995-1#1)(1995-12#2)(1996-11#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-6#1)(2008-4#2)(2010-5#1)
the HIV-1##12##2##(1992-12#1)(1997-3#1)(2008-11#2)(2008-4#1)(2011-2#1)(2011-3#3)(2013-1#3)
the HIV-positive##2##2##(1992-12#1)(1996-5#1)
the HLA##3##2##(1991-11#1)(1997-5#1)(2008-10#1)
the HLA-DR##2##2##(1991-2#1)(1997-9#1)
the HMG##4##2##(1993-2#1)(1995-8#1)(2008-8#2)
the HMG-CoA reductase inhibitor Pravastatin##2##5##(1991-12#2)
the HMO industry##2##3##(1991-3#2)
the HMO##6##2##(1991-3#3)(1993-3#2)(1996-2#1)
the HMPS pathway##2##3##(1993-3#2)
the HN##2##2##(2008-11#1)(2008-9#1)
the HOS##2##2##(2008-3#2)
the HPLC determination of##3##4##(2008-10#3)
the HPLC method with##2##4##(2008-10#2)
the HPLC method##10##3##(2008-10#7)(2008-5#1)(2009-8#2)
the HPLC##23##2##(2008-10#19)(2008-5#1)(2008-8#1)(2009-8#2)
the HPSAM and GHPSAM##2##4##(2008-10#2)
the HPSAM##3##2##(2008-10#3)
the HR deceleration##2##3##(2013-8#2)
the HR in##2##3##(2008-10#2)
the HR##12##2##(1996-3#1)(2008-10#5)(2008-11#1)(2013-1#1)(2013-8#4)
the HRCT##2##2##(2011-2#1)(2012-2#1)
the HS concentration##2##3##(2008-10#2)
the HS##5##2##(2008-10#5)
the HS2core DNA sequence which##2##5##(2008-8#2)
the HS2core DNA sequence##3##4##(2008-8#3)
the HSA-hormone binding and##2##4##(2008-10#2)
the HSGC##2##2##(2008-10#2)
the HSP70 gene##2##3##(1994-8#2)
the HSP70##4##2##(1994-8#2)(2008-10#2)
the HT plan##2##3##(2008-11#2)
the HTS group##2##3##(2008-10#2)
the HUT11##2##2##(1995-6#2)
the HaCaT##2##2##(1997-1#1)(2008-11#1)
the Hach##2##2##(2008-10#2)
the Hacinas monster##2##3##(2009-10#2)
the Hacinas##4##2##(2009-10#4)
the Haemophilus influenzae##3##3##(1995-5#1)(2008-11#1)(2008-7#1)
the Hall##5##2##(2008-10#2)(2013-1#3)
the Hamilton-Zuk hypothesis or the immunocompetence##2##6##(2008-8#2)
the Hardy-Weinberg##2##2##(2008-10#1)(2013-8#1)
the Harvard##4##2##(1990-11#1)(1993-3#1)(2008-1#1)(2010-5#1)
the HbO-HA ELISA##2##3##(1990-12#2)
the HeLa##2##2##(2008-11#2)
the Health Care Financing Administration (HCFA) to##3##7##(1994-1#1)(1995-12#1)(1997-3#1)
the Health Care Financing Administration (HCFA)##10##6##(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#3)(1997-3#1)
the Health Care Financing Administration##16##5##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#3)(1997-3#2)
the Health Care Financing##20##4##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1994-1#2)(1994-12#2)(1994-3#1)(1995-12#1)(1996-2#3)(1997-2#3)(1997-3#3)
the Health Care Quality Improvement Act##3##6##(1991-1#2)(1994-1#1)
the Health Care Quality Improvement##4##5##(1991-1#2)(1994-1#1)(1996-2#1)
the Health Care##25##3##(1991-1#3)(1991-2#2)(1991-3#1)(1992-1#1)(1994-1#3)(1994-12#2)(1994-3#1)(1995-12#1)(1996-2#4)(1997-2#3)(1997-3#3)(2008-11#1)
the Health Council##2##3##(1996-8#2)
the Health and##3##3##(1993-11#1)(1994-1#1)(2008-10#1)
the Health##42##2##(1990-2#1)(1991-1#3)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#1)(1993-11#1)(1993-12#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#5)(1996-8#2)(1997-2#5)(1997-3#3)(2008-10#2)(2008-11#1)(2009-7#1)(2012-3#1)
the Healthcare##2##2##(2008-11#1)(2008-12#1)
the Heaney method##2##3##(1995-12#2)
the Heaney##3##2##(1995-12#3)
the Hepatitis B##2##3##(2008-10#1)(2008-11#1)
the Hg electrode##4##3##(2008-10#4)
the Hg##7##2##(2008-10#7)
the Hg(2+)##2##2##(2008-10#2)
the Hg(II)##4##2##(2008-10#4)
the Hg(II)/HS ratio##2##3##(2008-10#2)
the HiRIS##4##2##(2008-10#4)
the High Court##2##3##(1995-6#2)
the High##5##2##(1995-6#2)(2008-11#1)(2008-3#1)(2012-7#1)
the Higher##2##2##(1995-3#1)(2008-11#1)
the Hill coefficient##2##3##(1991-5#1)(1993-8#1)
the Hill##3##2##(1991-5#1)(1993-5#1)(1993-8#1)
the Himalayan##3##2##(2008-8#1)(2011-2#2)
the History of##2##3##(1995-12#1)(2013-1#1)
the Home Health##2##3##(1994-2#1)(1995-3#1)
the Home##3##2##(1991-2#1)(1994-2#1)(1995-3#1)
the Hong Kong##2##3##(2008-8#1)(2010-2#1)
the Hospital for##2##3##(2008-8#1)(2009-3#1)
the Hospital##6##2##(1993-12#1)(2008-10#2)(2008-8#1)(2009-3#1)(2013-8#1)
the Host##3##2##(2008-10#3)
the House version##3##3##(1995-6#3)
the House##9##2##(1995-12#1)(1995-6#5)(1996-5#1)(1997-2#1)(2008-11#1)
the Howard##2##2##(2008-9#1)(2013-1#1)
the Hsp70##2##2##(1991-9#2)
the Hubble Space Telescope##2##4##(1990-11#1)(2008-2#1)
the Human Genome##3##3##(1994-9#2)(2008-4#1)
the Human##9##2##(1994-9#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-2#1)(2012-3#1)
the Hunger##2##2##(2012-12#2)
the Huntington's disease##4##3##(1996-8#2)(2011-2#1)(2012-2#1)
the Huntington's##5##2##(1995-9#1)(1996-8#2)(2011-2#1)(2012-2#1)
the Hückel##2##2##(2008-10#2)
the I allele##2##3##(2008-10#2)
the I##5##2##(2008-10#5)
the IA##2##2##(1992-8#1)(2010-3#1)
the IAHSS##3##2##(1992-12#2)(1993-2#1)
the IAI##3##2##(2008-12#3)
the IBM##3##2##(2008-8#1)(2012-3#2)
the IBZM##2##2##(1996-12#2)
the IC columns##2##3##(2008-10#2)
the IC##7##2##(2008-10#6)(2008-5#1)
the IC50##2##2##(1995-8#1)(1996-2#1)
the ICA##5##2##(1997-3#2)(2012-3#1)(2013-1#2)
the ICEUs##3##2##(2008-7#3)
the ICF##4##2##(2011-2#3)(2012-12#1)
the ICH##3##2##(2008-10#2)(2010-11#1)
the ICP level##2##3##(2008-7#2)
the ICP##3##2##(2008-10#1)(2008-7#2)
the ICP-AES method##3##3##(2008-10#3)
the ICP-AES##4##2##(2008-10#4)
the ICP-MS determination##2##3##(2008-10#2)
the ICP-MS##8##2##(2008-10#8)
the ICPD##5##2##(1994-9#5)
the ICU##11##2##(1991-2#3)(1992-2#5)(2010-12#1)(2010-5#1)(2012-3#1)
the ICs##4##2##(2008-8#4)
the IDH##4##2##(2008-9#4)
the IE1##2##2##(1993-8#2)
the IFN-gamma inducible IDO##2##4##(2008-11#2)
the IFN-gamma##6##2##(1996-12#1)(1996-2#1)(2008-11#4)
the IFSP process##2##3##(1991-12#2)
the IGF-1##2##2##(1994-11#2)
the IGF-I receptor##2##3##(1996-2#1)(2008-5#1)
the IGF-I##4##2##(1996-2#2)(2008-11#1)(2008-5#1)
the IGKC##2##2##(1997-8#2)
the IGS##2##2##(2008-10#2)
the IIB promoter##2##3##(1995-6#2)
the IL-1 beta##4##3##(1995-2#2)(1996-12#2)
the IL-1##5##2##(1995-2#3)(1996-12#2)
the IL-12##2##2##(2008-8#2)
the IL-2##3##2##(1994-11#2)(2008-8#1)
the IL-6##4##2##(1990-5#1)(1996-2#2)(2012-3#1)
the ILL algorithm##2##3##(2008-3#2)
the ILS in##3##3##(2008-10#2)(2008-3#1)
the ILS##6##2##(2008-10#4)(2008-3#2)
the IMC technique##2##3##(2008-3#2)
the IMC##3##2##(2008-3#3)
the IMS##6##2##(2008-10#6)
the IN isolate##2##3##(2008-10#2)
the IN##3##2##(2008-10#3)
the IOP##2##2##(2011-2#2)
the IP(L) condition##2##3##(2008-10#2)
the IPD##2##2##(2008-10#1)(2008-7#1)
the IPSF##2##2##(2008-11#2)
the IR##8##2##(1994-11#1)(2008-10#2)(2008-3#3)(2008-7#2)
the IRB-RAT##3##2##(2009-4#3)
the IRMA##4##2##(1993-2#4)
the IS##3##2##(1993-3#1)(2008-10#2)
the IS1112 probe##2##3##(2008-10#2)
the ISE##3##2##(2008-10#3)
the ISO##3##2##(2008-10#2)(2008-12#1)
the ITS 1##2##3##(2008-10#2)
the ITS region##9##3##(2008-10#8)(2010-3#1)
the ITS##20##2##(2008-10#18)(2010-3#2)
the ITS-1##2##2##(2008-10#1)(2008-9#1)
the ITS1 region of##2##4##(2008-10#2)
the IV##2##2##(1994-11#1)(1995-5#1)
the IVB and IVB/IVT groups##2##5##(2011-2#2)
the IVB and##4##3##(2011-2#4)
the IVB##5##2##(2011-2#5)
the IVB/IVT##4##2##(2011-2#4)
the IVC##9##2##(2011-2#7)(2013-1#2)
the IVD##2##2##(2012-2#2)
the IVIG solution##2##3##(1996-3#2)
the Ia##2##2##(2008-10#2)
the Iberian Peninsula##3##3##(2008-10#2)(2013-8#1)
the Iberian##4##2##(2008-10#3)(2013-8#1)
the Ig-fold##2##2##(2011-2#2)
the IgA##2##2##(1991-12#1)(2008-10#1)
the IgG##10##2##(1990-12#2)(1991-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)
the Ilizarov technique##2##3##(2009-3#2)
the Ilizarov##5##2##(2009-3#2)(2009-4#1)(2013-1#2)
the Illinois##3##2##(1992-9#1)(1996-12#1)(2008-9#1)
the Impact of Events##2##4##(2008-1#1)(2010-2#1)
the Impact of##4##3##(2008-1#2)(2008-10#1)(2010-2#1)
the Imperial##2##2##(2008-10#1)(2008-5#1)
the Implementation Teams##2##3##(1996-1#2)
the Implementation##4##2##(1996-1#2)(2008-10#1)(2008-12#1)
the Indian population##2##3##(1997-8#1)(2010-5#1)
the Indian subcontinent##3##3##(2008-10#2)(2011-2#1)
the Indian##14##2##(1994-8#1)(1997-8#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)
the Indiana and##2##3##(2008-10#2)
the Indiana##4##2##(2008-10#4)
the Infection of##2##3##(2008-10#2)
the Information##4##2##(1991-3#1)(1995-12#1)(2009-8#1)(2011-2#1)
the InsP(3) binding activity##2##4##(2008-8#2)
the Institut Pasteur##3##3##(2010-1#3)
the Institut für##3##3##(2008-10#2)(2008-11#1)
the Institut##8##2##(1992-9#1)(2008-10#3)(2008-11#1)(2010-1#3)
the Institute of Forensic Medicine##2##5##(1997-8#2)
the Institute of Medicine##4##4##(1996-1#1)(1996-5#1)(1997-2#1)(2012-2#1)
the Institute of##10##3##(1990-2#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#2)(2010-10#1)(2012-2#1)
the Institute##13##2##(1990-2#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#2)(2010-1#2)(2010-10#1)(2011-2#1)(2012-2#1)
the Institutes for##2##3##(1994-12#1)(2012-2#1)
the Institution##2##2##(2008-11#2)
the Insulin##2##2##(2008-6#1)(2008-9#1)
the Intensive Care Unit##3##4##(2008-5#1)(2012-3#1)(2013-1#1)
the Interaction Between##3##3##(2008-10#3)
the Interaction##4##2##(2008-10#4)
the Internal Medicine##2##3##(1996-11#1)(2008-11#1)
the Internal##5##2##(1995-6#1)(1996-11#1)(2008-10#2)(2008-11#1)
the International AIDS##3##3##(1990-11#2)(2013-1#1)
the International Blackleg of Crucifers Network##2##6##(2008-10#2)
the International Classification of##2##4##(1991-9#1)(1994-6#1)
the International Code of##2##4##(2008-10#2)
the International Conference on##2##4##(2008-10#1)(2008-11#1)
the International Labour Office (ILO)##2##5##(1991-12#2)
the International Liaison Committee on Resuscitation##2##6##(2008-11#2)
the International Maritime Organization##2##4##(2008-11#2)
the International Society for##3##4##(2008-11#1)(2008-12#1)(2011-9#1)
the International##39##2##(1990-11#2)(1991-12#2)(1991-9#1)(1994-6#1)(1995-12#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-4#2)(2008-7#1)(2009-4#1)(2010-11#1)(2011-2#2)(2011-3#1)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the Internet and information technology to##2##6##(2008-11#2)
the Internet and##6##3##(1994-3#1)(2008-11#2)(2008-4#1)(2010-12#1)(2010-8#1)
the Internet has##2##3##(2009-5#1)(2011-1#1)
the Internet to##2##3##(2008-10#1)(2008-11#1)
the Internet##36##2##(1994-3#2)(1995-12#1)(1996-2#5)(1996-5#1)(1996-8#1)(2008-10#4)(2008-11#8)(2008-4#2)(2009-5#6)(2010-12#1)(2010-8#2)(2011-1#2)(2013-1#1)
the Intervention condition##2##3##(2008-4#2)
the Intervention##4##2##(2008-4#4)
the Iowa##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
the Irish##2##2##(2008-11#1)(2013-8#1)
the Island of Rab##2##4##(2011-2#2)
the Israeli##7##2##(2008-10#6)(2013-1#1)
the Italian National##2##3##(1990-6#1)(2010-11#1)
the Italian Society for##2##4##(2011-2#2)
the Italian Society##3##3##(2011-2#3)
the Italian version of the##2##5##(2008-10#1)(2011-2#1)
the Italian##29##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(2008-10#4)(2008-11#2)(2008-7#2)(2008-8#2)(2010-1#1)(2010-11#2)(2011-2#5)(2011-3#1)
the IxxLxQ motif##2##3##(1997-8#2)
the J##4##2##(1992-10#1)(2008-10#2)(2008-7#1)
the JAK##2##2##(1996-2#1)(2008-1#1)
the JCAHO##3##2##(1995-1#3)
the JDBM##2##2##(2012-2#2)
the JFP##2##2##(1995-6#2)
the JNDs measured##2##3##(1990-11#2)
the JUPITER##2##2##(2010-12#2)
the Jaccard index##2##3##(2008-10#2)
the Jackson##4##2##(1994-1#2)(2011-2#1)(2013-8#1)
the Jamaican##2##2##(2010-1#1)(2011-2#1)
the Janus##2##2##(1996-2#1)(2008-4#1)
the Japan##2##2##(2008-11#1)(2008-8#1)
the Japanese Erwinia##2##3##(2008-10#2)
the Japanese Society of Clinical Chemistry##2##6##(1994-12#2)
the Japanese Society of Clinical##3##5##(1994-12#3)
the Japanese Society of##4##4##(1994-12#3)(2010-1#1)
the Japanese pear##2##3##(2008-10#2)
the Japanese##26##2##(1991-5#1)(1993-3#2)(1994-12#3)(1995-2#1)(1997-8#3)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#3)(2008-7#1)(2010-1#1)(2011-3#1)(2012-12#1)(2013-1#1)
the Jennings Disaster Nursing Management Model##2##6##(2008-11#2)
the Jet Propulsion##2##3##(2008-2#1)(2008-3#1)
the Job##2##2##(2008-10#2)
the Johns Hopkins Ambulatory Care Group##2##6##(1995-2#2)
the Johns Hopkins##5##3##(1992-3#1)(1995-2#2)(1996-9#1)(2011-2#1)
the Joint Council of Governmental Public Health Agencies##3##8##(1996-3#3)
the Joint##8##2##(1995-2#1)(1995-3#1)(1996-3#3)(2008-8#1)(2009-9#1)(2011-2#1)
the Journal of the##2##4##(1990-6#1)(2008-3#1)
the Journal of##9##3##(1990-6#1)(2008-10#3)(2008-3#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-7#1)
the Journal##13##2##(1990-6#1)(1997-1#1)(2008-10#5)(2008-3#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-4#1)
the Justice Department##2##3##(1995-12#1)(1995-6#1)
the K##4##2##(1990-2#1)(1997-7#3)
the K&amp##2##2##(2008-10#2)
the K(ex##3##2##(2008-10#3)
the K(m) for the##3##4##(2008-7#3)
the K+##2##2##(1991-11#1)(1996-2#1)
the K22DAP complexes of##2##4##(2008-10#2)
the KD##2##2##(2011-2#2)
the KDN-containing##2##2##(1994-5#2)
the KF##2##2##(1996-5#1)(2008-10#1)
the KP##2##2##(2009-6#1)(2010-8#1)
the KPI##2##2##(1992-12#1)(1996-12#1)
the KR##3##2##(2008-10#3)
the KTP##2##2##(2008-3#2)
the Kappa value##2##3##(2008-5#2)
the Kd##4##2##(1994-8#1)(1996-2#1)(1997-2#1)(2008-8#1)
the Kefir extract##5##3##(2008-11#5)
the Kentucky##2##2##(1994-3#1)(2008-10#1)
the Keystone action plan criteria##3##5##(2011-1#3)
the Kidd##2##2##(1995-6#2)
the Kingdom of##2##3##(2008-10#1)(2013-1#1)
the Kingdom##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
the Kirchhoff approximation##2##3##(2008-2#2)
the Kjeldahl##4##2##(2008-10#4)
the Km for##3##3##(1990-11#2)(1994-8#1)
the Km values for##3##4##(1995-6#3)
the Km values##4##3##(1990-5#1)(1995-6#3)
the Km##11##2##(1990-11#2)(1990-5#1)(1994-5#2)(1994-8#1)(1995-6#3)(1995-8#1)(2008-5#1)
the Korean##2##2##(1992-12#1)(2008-10#1)
the KpnI##2##2##(1993-3#1)(2008-10#1)
the Kruskal-Wallis test##2##3##(2013-1#2)
the Kubelka-Munk##3##2##(2008-10#3)
the Kuna##2##2##(2010-4#2)
the Kunitz-type##3##2##(1994-11#1)(1996-12#2)
the Kuruma Prawn##2##3##(2008-5#1)(2008-6#1)
the Kyoto Encyclopedia of Genes and Genomes (KEGG)##2##8##(2008-4#1)(2009-11#1)
the L##11##2##(1992-8#2)(1993-2#1)(1994-5#1)(2008-10#4)(2010-4#1)(2011-2#2)
the L(4) resistance gene##2##4##(2008-10#2)
the L(4)##4##2##(2008-10#4)
the L-dsRNA##3##2##(2008-10#3)
the L1##3##2##(1991-11#1)(1997-2#1)(2013-8#1)
the L3##3##2##(1991-11#1)(1992-8#1)(2008-8#1)
the L4-5##2##2##(2012-3#2)
the LA##5##2##(2008-10#1)(2011-2#4)
the LAD group and##2##4##(2013-1#2)
the LAD group##4##3##(2013-1#4)
the LAMP##2##2##(2009-6#2)
the LAN##2##2##(2007-12#2)
the LAS##2##2##(2008-10#2)
the LB##8##2##(2008-10#1)(2008-11#7)
the LBL##2##2##(2008-10#2)
the LC group##2##3##(2008-4#2)
the LC##6##2##(2008-10#3)(2008-4#2)(2011-2#1)
the LC/MS##2##2##(2008-10#1)(2009-8#1)
the LDH##3##2##(2008-11#1)(2010-4#2)
the LDL receptor##3##3##(1995-6#1)(2008-6#2)
the LDL##7##2##(1991-12#2)(1992-5#1)(1995-6#1)(2008-6#2)(2011-1#1)
the LDLR##2##2##(1995-2#2)
the LE model##5##3##(2008-10#5)
the LEF-1##2##2##(1995-8#2)
the LEOPARD syndrome##3##3##(2013-8#3)
the LFD##2##2##(2008-10#2)
the LG##3##2##(2008-10#3)
the LGC/VAM protocol##2##3##(2008-10#2)
the LH##4##2##(2009-10#4)
the LH/hCG receptor##2##3##(1995-8#2)
the LILACS##2##2##(2012-3#2)
the LIP##2##2##(1990-12#2)
the LLNA##2##2##(2008-5#2)
the LLPS##2##2##(2008-10#2)
the LMP2##2##2##(1997-9#1)(2012-2#1)
the LNT model##2##3##(2008-7#1)(2013-1#1)
the LNT theory##2##3##(2008-7#2)
the LNT##4##2##(2008-7#3)(2013-1#1)
the LOD was##2##3##(2008-10#2)
the LOD##6##2##(2008-10#6)
the LODs##3##2##(2008-10#3)
the LOV##2##2##(2008-10#2)
the LPP##3##2##(1994-8#2)(2008-5#1)
the LPS-induced IL-12##2##3##(2008-8#2)
the LPS-induced##7##2##(1997-1#1)(2008-10#1)(2008-8#4)(2011-2#1)
the LR parsing##3##3##(2011-3#3)
the LS method##2##3##(2008-10#2)
the LSPV##2##2##(2011-2#2)
the LTR##2##2##(1991-2#1)(1994-12#1)
the LV##5##2##(1991-3#2)(2008-10#2)(2012-2#1)
the Laboratory##7##2##(1990-11#1)(1995-9#1)(2008-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
the Labour Inspection##2##3##(1992-5#1)(1995-2#1)
the Lake Maggiore##2##3##(2008-10#2)
the Lake##3##2##(2008-10#3)
the Landolt paradigm##3##3##(2013-8#3)
the Landolt##4##2##(2013-8#4)
the Langmuir isotherm approach##2##4##(2008-10#2)
the Langmuir isotherm##3##3##(2008-10#3)
the Langmuir##8##2##(1994-5#1)(2008-10#7)
the Latin American clade##2##4##(2008-10#2)
the Latin American##5##3##(1992-5#1)(2008-10#3)(2010-10#1)
the Latium##2##2##(1992-9#2)
the Leptosphaeria##3##2##(2008-10#3)
the Let-7##2##2##(2010-7#2)
the Leuven Intensive Insulin Therapy Trial##2##6##(2010-12#2)
the Levenberg-Marquardt algorithm##2##3##(2008-10#1)(2010-8#1)
the Lithuanian health system##2##4##(2013-8#2)
the Log TG/HDL-C ratio##3##4##(2008-3#3)
the Logan Rep protein##2##4##(2008-10#2)
the Loma##2##2##(1992-12#1)(1993-2#1)
the London Health Sciences Centre##2##5##(2008-11#2)
the London##4##2##(1997-1#1)(2008-11#2)(2012-2#1)
the Long Ashton splashmeter##2##4##(2008-10#2)
the Long##3##2##(2008-10#2)(2011-2#1)
the Lorentz-Lorenz formula##2##3##(2008-2#2)
the Lorentzian##2##2##(2008-10#1)(2008-3#1)
the Lotka-Volterra##2##2##(2008-8#2)
the Low##3##2##(1997-3#1)(2008-3#1)(2012-7#1)
the Lower##2##2##(2008-10#1)(2013-8#1)
the Lp(a)##4##2##(1991-12#1)(1993-2#3)
the Lr26##2##2##(2008-10#2)
the Ly-49+##2##2##(1995-2#2)
the Lys##2##2##(1990-8#1)(1995-6#1)
the Lysholm##2##2##(2011-2#1)(2013-1#1)
the M genotypes##2##3##(2008-10#2)
the M##17##2##(1993-12#1)(1997-3#5)(2008-10#6)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-10#1)
the M-cell monolayer##2##3##(2008-11#2)
the M2(D)##3##2##(2008-8#3)
the MA Advanced##2##3##(2008-11#2)
the MA##4##2##(2008-10#2)(2008-11#2)
the MAC genome##2##3##(2012-3#2)
the MAP kinase##2##3##(1995-8#1)(1996-2#1)
the MAPK module is localized to##2##6##(2009-8#2)
the MAPK module is##3##4##(2009-8#3)
the MAPK module##4##3##(2009-8#4)
the MAPK signal##2##3##(2008-11#2)
the MAPK##9##2##(1995-2#1)(2008-11#2)(2009-8#6)
the MAT-1 pheromone##2##3##(2008-10#2)
the MAX##2##2##(1995-6#2)
the MAb##2##2##(2008-10#1)(2008-11#1)
the MAbs##2##2##(2008-10#2)
the MB signal##2##3##(2008-10#2)
the MB##4##2##(2008-10#4)
the MC##3##2##(2008-10#2)(2008-11#1)
the MCA##4##2##(2008-12#4)
the MCBS##2##2##(1995-2#1)(1996-2#1)
the MCF-7##3##2##(1994-12#1)(2008-11#1)(2012-3#1)
the MCMC##2##2##(2009-12#1)(2009-4#1)
the MCS+##4##2##(2011-2#4)
the MDCK##4##2##(1995-11#3)(2008-11#1)
the MDI##11##2##(1992-3#5)(1996-1#3)(1996-2#2)(1997-2#1)
the MDR phenotype##2##3##(2008-11#2)
the MDR##3##2##(1993-3#1)(2008-11#2)
the MED-EL COMBI 40+##2##4##(2008-9#2)
the MED-EL##4##2##(2008-9#4)
the MEP##2##2##(2008-11#1)(2008-7#1)
the MF##2##2##(1993-9#1)(2008-10#1)
the MFN was##2##3##(2008-11#2)
the MFN##3##2##(2008-11#3)
the MFS##7##2##(1994-1#6)(2011-1#1)
the MHC molecules##2##3##(1995-5#2)
the MHC##8##2##(1990-5#1)(1995-5#2)(1997-9#1)(2008-4#2)(2008-9#1)(2010-5#1)
the MHO phenotype##3##3##(2013-1#3)
the MIC##2##2##(2008-5#2)
the MICs of##2##3##(2008-5#1)(2010-6#1)
the MIH##4##2##(2008-6#1)(2013-1#3)
the MIMS response of##3##4##(2008-10#3)
the MIMS response##4##3##(2008-10#4)
the MINT##2##2##(2008-4#2)
the MIP##2##2##(2008-10#2)
the MLPNN##2##2##(2010-8#2)
the MM3##2##2##(1996-5#2)
the MMP-1 and MMP-9 expressions##2##5##(2012-3#2)
the MMP-1 and MMP-9 mRNA##2##5##(2012-3#2)
the MMP-1 and MMP-9##4##4##(2012-3#4)
the MMP-1##5##2##(2008-5#1)(2012-3#4)
the MNS##6##2##(2008-11#6)
the MOF is##2##3##(2008-10#2)
the MOSFET##3##2##(2009-5#3)
the MP##5##2##(1997-3#1)(2008-10#1)(2008-9#3)
the MPC##3##2##(1994-5#1)(1996-2#1)(2008-11#1)
the MPOA##2##2##(1994-2#2)
the MPQ as##2##3##(2012-2#2)
the MPQ in##2##3##(2012-2#2)
the MPQ##7##2##(2012-2#7)
the MR##6##2##(1996-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
the MRI##3##2##(1992-3#1)(2008-5#1)(2011-2#1)
the MS##9##2##(1995-12#1)(1996-12#2)(2008-10#4)(2008-3#1)(2012-3#1)
the MSH27Ep##2##2##(2008-8#2)
the MSKCC grading##2##3##(2011-2#2)
the MSP procedure##2##3##(2008-10#2)
the MSV resistance of##2##4##(2008-10#2)
the MT##7##2##(2008-10#6)(2013-1#1)
the MT-1 peak##2##3##(2008-10#2)
the MT-1##3##2##(2008-10#3)
the MT-2 isoform was##2##4##(2008-10#2)
the MT-like##2##2##(1990-5#2)
the MT1 receptor##3##3##(2013-7#3)
the MT1##4##2##(2013-7#4)
the MTT assay##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
the MTT##4##2##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
the MTX concentration##2##3##(2008-11#2)
the MTX##3##2##(1994-2#1)(2008-11#2)
the MWNT-film##2##2##(2008-10#2)
the MWNTs##2##2##(2008-10#2)
the MX line##7##3##(2008-10#7)
the Mabs##2##2##(2008-5#2)
the Magic 1##2##3##(1997-3#2)
the Major##2##2##(2008-10#1)(2008-11#1)
the Majority##2##2##(2010-9#2)
the Management of##4##3##(2008-1#1)(2008-3#1)(2011-2#2)
the Mancozeb##2##2##(2008-10#2)
the Manus Basin##4##3##(2008-6#4)
the Marfan##2##2##(2008-8#1)(2013-1#1)
the Mashona heifers##2##3##(1996-12#2)
the Mashona##3##2##(1996-12#3)
the Maslach Burnout Inventory##5##4##(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-7#1)
the Massachusetts General Hospital##6##4##(1991-12#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-7#1)
the Massachusetts##8##2##(1991-12#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-5#1)
the Maximizer##4##2##(2008-11#4)
the McGill Pain Questionnaire##3##4##(2009-12#1)(2010-6#1)(2012-2#1)
the MeOH##2##2##(2008-11#2)
the Mean##2##2##(2008-10#1)(2008-12#1)
the Mechanisms##2##2##(2008-10#2)
the Medicaid and Medicare##2##4##(1995-12#1)(1995-3#1)
the Medicaid program##2##3##(1996-1#1)(1997-2#1)
the Medicaid##12##2##(1991-2#1)(1991-3#1)(1993-1#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-1#1)(1997-2#3)(2008-11#1)
the Medicaid-eligible elderly##2##3##(1993-3#1)(1997-2#1)
the Medical Faculty##2##3##(1993-6#1)(2007-8#1)
the Medical##14##2##(1991-8#2)(1992-12#2)(1993-2#1)(1993-6#2)(1996-11#1)(1997-2#1)(1997-5#1)(2007-8#2)(2010-2#1)(2013-1#1)
the Medicare Current Beneficiary Survey (MCBS)##6##6##(1994-1#1)(1995-12#3)(1995-2#1)(1997-2#1)
the Medicare Current Beneficiary Survey##7##5##(1994-1#1)(1995-12#3)(1995-2#2)(1997-2#1)
the Medicare Part A##2##4##(1991-1#1)(1993-3#1)
the Medicare and Medicaid programs##2##5##(1991-2#1)(1996-3#1)
the Medicare and Medicaid##3##4##(1991-12#1)(1991-2#1)(1996-3#1)
the Medicare diagnosis-related groups##2##4##(1994-12#2)
the Medicare fee schedule (MFS)##3##5##(1994-1#2)(1994-12#1)
the Medicare fee schedule##8##4##(1991-12#1)(1993-3#1)(1994-1#4)(1994-12#1)(1996-3#1)
the Medicare population##5##3##(1993-12#2)(1995-12#1)(1995-2#1)(1996-3#1)
the Medicare program##10##3##(1991-1#2)(1991-3#1)(1992-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1997-3#2)
the Medicare prospective payment system (PPS)##3##6##(1992-12#1)(1993-12#1)(1993-3#1)
the Medicare prospective payment system##6##5##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)
the Medicare prospective payment##7##4##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-3#1)
the Medicare##65##2##(1991-1#3)(1991-12#2)(1991-2#3)(1991-3#3)(1992-1#1)(1992-12#3)(1992-2#4)(1993-1#1)(1993-12#4)(1993-3#5)(1994-1#6)(1994-12#6)(1994-3#2)(1995-1#1)(1995-12#6)(1995-2#5)(1995-3#2)(1996-3#3)(1997-2#2)(1997-3#2)(2008-11#1)
the Medicinal##2##2##(2008-10#1)(2008-5#1)
the Mediterranean Basin##5##3##(2008-10#3)(2011-2#2)
the Mediterranean##14##2##(1990-8#1)(2008-10#7)(2010-1#1)(2011-2#5)
the Melbourne perspective##2##3##(2008-10#2)
the Melbourne##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
the Metrohm##2##2##(2008-10#2)
the Metropolitan Region##2##3##(2013-1#2)
the Metropolitan##4##2##(1994-1#1)(2008-5#1)(2013-1#2)
the Mexican##7##2##(1993-6#1)(2008-10#2)(2008-12#1)(2011-2#2)(2012-12#1)
the Mg(2+)##2##2##(2008-10#2)
the Michaelis constant##2##3##(1990-5#1)(1993-3#1)
the Michelson Interferometer for Passive Atmospheric Sounding##3##7##(2008-3#3)
the Michigan##2##2##(1995-12#1)(2012-2#1)
the Microbial##3##2##(2008-10#3)
the Mid##3##2##(2008-10#1)(2013-8#2)
the Middle Ages##3##3##(2009-10#1)(2013-8#2)
the Middle East and##3##4##(1997-8#1)(2008-10#1)(2011-2#1)
the Middle East##10##3##(1995-3#1)(1997-8#1)(2008-10#5)(2011-2#3)
the Middle Eastern##2##3##(2008-10#2)
the Middle##15##2##(1995-3#1)(1997-8#1)(2008-10#7)(2009-10#1)(2011-2#3)(2013-8#2)
the Mini-Mental State Examination##2##4##(2008-7#2)
the Ministry of Health and Social Affairs##2##7##(1993-6#2)
the Ministry of Health and the##2##6##(1993-1#1)(2013-1#1)
the Ministry of Health and##5##5##(1993-1#1)(1993-6#2)(2008-5#1)(2013-1#1)
the Ministry of Health##10##4##(1991-2#1)(1993-1#1)(1993-6#2)(1994-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2013-1#1)
the Ministry of##14##3##(1991-2#1)(1991-3#1)(1993-1#1)(1993-6#2)(1994-12#1)(1996-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-10#1)(2013-1#1)
the Ministry##15##2##(1991-2#2)(1991-3#1)(1993-1#1)(1993-6#2)(1994-12#1)(1996-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-10#1)(2013-1#1)
the Minnesota Department of Health's##2##5##(2012-12#2)
the Minnesota##8##2##(1990-2#2)(1991-2#1)(2008-10#1)(2010-1#1)(2012-12#2)(2012-2#1)
the Miocene##2##2##(2008-10#1)(2008-6#1)
the Mississippi##2##2##(2008-10#2)
the Missouri##2##2##(1995-12#1)(1996-2#1)
the Mmd1 gene##2##3##(2008-10#2)
the Mmd1##3##2##(2008-10#3)
the Modified Bromley's Methodology (MBM)##2##5##(2008-10#2)
the Molecular##2##2##(2008-10#1)(2013-1#1)
the Monte Carlo method##2##4##(2008-10#1)(2008-3#1)
the Monte Carlo##3##3##(2008-10#1)(2008-3#2)
the Montreal Protocol##2##3##(1996-1#1)(1996-2#1)
the More Individuals Hypothesis##3##4##(2008-9#3)
the Morris water maze##3##4##(1993-3#1)(2008-12#1)(2011-2#1)
the Morris water-maze##2##3##(1993-3#1)(1994-8#1)
the Morris##5##2##(1993-3#2)(1994-8#1)(2008-12#1)(2011-2#1)
the Mount Sinai##3##3##(1991-12#1)(1995-8#1)(1996-3#1)
the Mount##4##2##(1991-12#1)(1995-8#1)(1996-3#1)(2010-6#1)
the Mueller matrix##2##3##(2008-3#2)
the Mueller##4##2##(2008-3#4)
the Museum##3##2##(2010-1#2)(2011-2#1)
the MycER##2##2##(2008-11#2)
the Mycoparasite Pythium oligandrum##2##4##(2008-10#2)
the Mycoparasite##3##2##(2008-10#3)
the N and##3##3##(1997-8#1)(2008-5#1)(2012-5#1)
the N epsilon##2##3##(1991-3#1)(1994-5#1)
the N gene of##2##4##(2008-10#2)
the N gene##4##3##(2008-10#4)
the N protein##3##3##(2008-10#3)
the N terminus and##2##4##(1993-2#1)(2008-10#1)
the N terminus##4##3##(1993-2#1)(2008-10#2)(2008-6#1)
the N##24##2##(1991-3#1)(1993-2#1)(1994-5#1)(1997-8#1)(2008-10#14)(2008-12#1)(2008-5#2)(2008-6#1)(2012-3#1)(2012-5#1)
the N- and##2##3##(1991-5#1)(1992-6#1)
the N-##3##2##(1991-5#1)(1992-6#1)(1996-12#1)
the N-N##2##2##(1996-5#1)(2008-10#1)
the N-S##2##2##(1992-10#1)(2008-10#1)
the N-linked##5##2##(1990-5#1)(1993-8#1)(2008-11#1)(2008-7#2)
the N-methyl-D-aspartate (NMDA)##2##3##(1997-2#2)
the N-methyl-D-aspartate##4##2##(1990-7#1)(1995-12#1)(1997-2#2)
the N-ras##2##2##(1995-2#2)
the N-terminal amino acid##3##4##(1993-9#1)(1994-8#1)(2008-6#1)
the N-terminal amphiphilic leader##2##4##(1991-10#2)
the N-terminal domain of the GPIIIa subunit##2##7##(2006-6#2)
the N-terminal domain of the##3##5##(2006-6#2)(2012-2#1)
the N-terminal domain of##11##4##(2006-6#3)(2008-9#2)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
the N-terminal domain##12##3##(2006-6#3)(2008-4#1)(2008-9#2)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
the N-terminal half of the RTD##2##6##(2008-10#2)
the N-terminal half of the##4##5##(2008-10#3)(2011-1#1)
the N-terminal of the##3##4##(1990-2#1)(2006-6#1)(2008-11#1)
the N-terminal part of##2##4##(1991-5#1)(1992-6#1)
the N-terminal region of human La##2##6##(2009-7#2)
the N-terminal region of##4##4##(1991-5#1)(1996-3#1)(2009-7#2)
the N-terminal region##6##3##(1991-5#1)(1994-5#1)(1996-3#2)(2009-7#2)
the N-terminal sequence of##2##4##(1990-12#1)(1994-11#1)
the N-terminal sequence##4##3##(1990-12#1)(1993-8#1)(1994-11#1)(1994-5#1)
the N-terminal##59##2##(1990-12#1)(1990-2#1)(1991-10#4)(1991-5#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#4)(1994-8#2)(1995-11#1)(1995-8#1)(1996-3#2)(2006-6#4)(2008-10#9)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#4)(2009-7#7)(2009-8#1)(2011-1#2)(2011-2#2)(2012-2#1)
the N-terminus of the##3##4##(1992-6#1)(1997-3#1)(2008-10#1)
the N-terminus of##5##3##(1992-6#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-8#1)
the N-terminus##12##2##(1990-5#1)(1990-8#1)(1992-6#1)(1995-8#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-8#1)(2008-9#3)(2010-11#1)
the N1##3##2##(2008-4#1)(2008-8#2)
the N2##2##2##(2008-11#2)
the NA and##2##3##(1994-3#2)
the NAD(+)##3##2##(2008-10#3)
the NAD(P)H##2##2##(1996-2#1)(2008-10#1)
the NADH concentration##2##3##(2008-10#2)
the NADH reductase component of the steroid 9alpha-hydroxylase##2##8##(2008-11#2)
the NADH##6##2##(1993-6#1)(1997-8#1)(2008-10#2)(2008-11#2)
the NADPH oxidase##2##3##(1990-5#1)(1994-6#1)
the NAc##7##2##(2008-7#7)
the NB##2##2##(1991-9#1)(2008-10#1)
the NB1-RGB cells##2##3##(2008-11#2)
the NBICU##2##2##(1991-12#2)
the NBM and COMB groups##2##5##(1993-3#2)
the NBM##3##2##(1993-3#3)
the NBMPR-sensitive transporter##2##3##(1995-8#2)
the NBS domain were##2##4##(2008-10#2)
the NBS##3##2##(2008-10#3)
the NC##4##2##(2008-10#4)
the NCBI##2##2##(2008-4#1)(2012-3#1)
the ND##3##2##(1995-2#3)
the NDELA content of##2##4##(2008-5#2)
the NDNAD##2##2##(2008-12#2)
the NF-kappa##2##2##(1995-12#1)(1995-2#1)
the NF-κB##2##2##(2011-2#2)
the NFL theorems are not##2##5##(2010-3#2)
the NFL theorems##5##3##(2010-3#5)
the NFL##6##2##(1991-10#1)(2010-3#5)
the NFP hospital tax exemption##2##5##(2008-11#2)
the NH2 terminus##4##3##(1992-9#1)(1993-3#1)(1995-6#2)
the NH2##5##2##(1992-9#2)(1993-3#1)(1995-6#2)
the NH2-terminal##7##2##(1992-9#2)(1995-12#1)(1995-6#2)(1997-1#2)
the NH2-terminus##2##2##(1992-4#1)(1997-1#1)
the NHS##18##2##(1991-8#1)(1997-5#5)(2008-11#5)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#4)
the NICE guidance##2##3##(2010-2#2)
the NICE##4##2##(2010-2#3)(2013-8#1)
the NICU##4##2##(1991-1#2)(1991-12#1)(2010-10#1)
the NIH##3##2##(1997-3#1)(2008-11#2)
the NIL sets##2##3##(2008-10#2)
the NIL##3##2##(2008-10#3)
the NILs##11##2##(2008-10#11)
the NIR spectra of##2##4##(2008-10#2)
the NIR spectra##3##3##(2008-10#3)
the NIR##6##2##(2008-10#6)
the NIRS technique##3##3##(2008-10#3)
the NIS##2##2##(1995-3#1)(1997-1#1)
the NIST##4##2##(2008-10#4)
the NJ##2##2##(2008-9#1)(2010-7#1)
the NMDA receptor##7##3##(1996-2#4)(2008-11#1)(2008-7#1)(2010-4#1)
the NMDA##10##2##(1992-3#1)(1996-2#5)(1997-2#1)(2008-11#1)(2008-7#1)(2010-4#1)
the NMDA-receptor##2##2##(1995-12#1)(1997-7#1)
the NMR##9##2##(1990-5#1)(1994-5#2)(2008-10#2)(2009-7#4)
the NO message##2##3##(2011-2#2)
the NO##3##2##(1996-2#1)(2011-2#2)
the NO(2)(-)##2##2##(2008-10#2)
the NOD##2##2##(1995-12#1)(2010-11#1)
the NOM##2##2##(1992-5#2)
the NPC##10##2##(2011-2#10)
the NPD##2##2##(2008-9#2)
the NR##2##2##(1993-6#1)(2008-10#1)
the NSAIDs##2##2##(1990-11#1)(1993-2#1)
the NSCs cultured in##2##4##(2008-11#2)
the NSE concentrations##2##3##(1992-11#2)
the NSE##3##2##(1992-11#2)(2011-2#1)
the NSI##2##2##(2013-1#2)
the NSm##3##2##(2008-10#3)
the NSs##3##2##(2008-10#3)
the NT(+)##2##2##(2008-11#2)
the NTP-binding##2##2##(2008-10#2)
the NXSM##2##2##(1994-8#2)
the NYAPs##3##2##(2008-10#3)
the NZ##3##2##(2008-11#2)(2008-8#1)
the Na(2)CO(3) fusion##2##3##(2008-10#2)
the Na+##5##2##(1991-9#1)(1992-12#1)(1992-3#1)(1995-11#1)(1997-8#1)
the Na+-ATPase##2##2##(2008-11#2)
the Na+/H+ exchanger and##2##4##(1993-3#2)
the Na+/H+##3##2##(1993-3#2)(1994-3#1)
the NaCl##3##2##(2008-10#2)(2013-1#1)
the Nafion##2##2##(2008-10#2)
the Nafion/MV modified GDME##2##4##(2008-10#2)
the Nafion/MV modified##4##3##(2008-10#4)
the Nafion/MV##5##2##(2008-10#5)
the Nation##2##2##(1993-3#1)(2008-11#1)
the Nation's##6##2##(1992-12#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-6#1)
the National Association of##3##4##(1992-3#1)(1994-12#1)(1996-5#1)
the National Cancer Institute (NCI)##2##5##(1997-1#1)(1997-3#1)
the National Cancer Institute##9##4##(1991-3#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
the National Cancer##12##3##(1991-3#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-4#1)(2012-3#1)(2013-8#1)
the National Center for Prevention Services##2##6##(1997-3#2)
the National Health Interview Survey##3##5##(1995-12#1)(1996-5#1)(1997-3#1)
the National Health Service (NHS)##2##5##(2008-11#1)(2011-2#1)
the National Health Service##5##4##(2008-11#3)(2008-12#1)(2011-2#1)
the National Health and Nutrition Examination Survey##2##7##(2008-1#1)(2010-12#1)
the National Health##15##3##(1991-2#1)(1991-6#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
the National Ignition Facility##3##4##(2008-3#3)
the National Institute of Environmental Health Sciences##2##7##(2008-9#2)
the National Institute of Standards and Technology##3##7##(2008-10#1)(2008-3#2)
the National Institute of##12##4##(1991-3#3)(1992-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#2)(2011-2#1)
the National Institute on##2##4##(1992-3#1)(2010-5#1)
the National Institute##15##3##(1991-3#3)(1992-12#1)(1992-3#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)
the National Institutes of Health (NIH)##2##6##(1997-8#1)(2008-5#1)
the National Institutes of Health##7##5##(1996-5#1)(1996-9#1)(1997-8#1)(2008-5#2)(2008-7#1)(2012-3#1)
the National Institutes of##8##4##(1994-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2008-5#2)(2008-7#1)(2012-3#1)
the National Library of Medicine (NLM)##3##6##(1991-2#1)(1992-1#1)(1994-12#1)
the National Library of Medicine##8##5##(1991-2#2)(1992-1#2)(1994-12#1)(2010-4#1)(2010-5#1)(2012-3#1)
the National Library of##9##4##(1991-2#2)(1992-1#2)(1994-12#1)(1995-11#1)(2010-4#1)(2010-5#1)(2012-3#1)
the National Longitudinal Study of Adolescent Health##3##7##(2009-7#1)(2010-7#1)(2013-8#1)
the National Science Foundation##2##4##(2008-10#1)(2013-8#1)
the National Science Foundation's##2##4##(1997-6#1)(2010-12#1)
the National Science##4##3##(1997-6#1)(2008-10#1)(2010-12#1)(2013-8#1)
the National University##2##3##(2011-2#1)(2012-12#1)
the National##111##2##(1990-6#1)(1991-12#1)(1991-2#4)(1991-3#4)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#2)(1993-2#1)(1993-6#1)(1994-12#3)(1994-2#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-11#1)(1996-5#4)(1996-9#1)(1997-1#2)(1997-3#5)(1997-6#2)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#5)(2008-5#4)(2008-7#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-3#3)(2013-1#2)(2013-8#5)
the Navon task##2##3##(2008-11#2)
the Nd##8##2##(1991-3#2)(1994-2#1)(2008-10#3)(2008-3#2)
the Neck Disability Index##2##4##(2008-12#2)
the Nederlands Tijdschrift voor##2##4##(1995-12#2)
the Nepalese##3##2##(2008-8#2)(2012-3#1)
the Nestin gene##2##3##(2011-2#2)
the Netherlands were##2##3##(2008-10#2)
the Netherlands##45##2##(1991-8#2)(1992-12#1)(1994-12#3)(1995-12#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-5#2)(1997-8#1)(2008-10#16)(2008-11#1)(2008-12#5)(2008-7#1)(2009-12#1)(2009-9#1)(2010-1#1)(2012-3#1)(2013-8#2)
the Network##2##2##(1991-3#2)
the Neurobehavioral Symptom Inventory##2##4##(2013-1#2)
the New World##2##3##(2008-10#2)
the New York City Board of Education##2##7##(1991-12#2)
the New York City##3##4##(1991-12#2)(1996-3#1)
the New York State Department of Health##3##7##(1994-12#1)(1996-3#1)(1997-1#1)
the New York State##5##4##(1992-8#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-1#1)
the New York##12##3##(1991-12#2)(1992-8#1)(1994-12#3)(1996-3#2)(1996-5#1)(1997-1#2)(2008-8#1)
the New Zealand##4##3##(2008-10#1)(2008-11#2)(2011-1#1)
the New##23##2##(1991-12#2)(1992-8#1)(1994-1#1)(1994-12#3)(1996-3#2)(1996-5#1)(1997-1#2)(1997-3#2)(2008-10#4)(2008-11#2)(2008-8#1)(2011-1#1)(2012-12#1)
the Newtonian##2##2##(2013-8#2)
the NgoII##2##2##(1993-9#2)
the Ni##2##2##(2008-10#2)
the Ni-Ti alloy electrode##2##4##(2008-10#2)
the Ni-Ti##3##2##(2008-10#3)
the NifA##2##2##(1993-12#1)(2008-9#1)
the Nikolskii-Eisenman equation##2##3##(2008-10#2)
the Nikolskii-Eisenman##3##2##(2008-10#3)
the Nile River Delta and##2##5##(2008-10#2)
the Nile River Delta##3##4##(2008-10#3)
the Nile##4##2##(2008-10#4)
the Nipah virus##2##3##(2008-12#2)
the Nobel##2##2##(2010-1#1)(2010-7#1)
the Nordic Psychiatric##2##3##(2011-4#2)
the Nordic countries##6##3##(1990-11#2)(2008-10#3)(2011-4#1)
the Nordic##12##2##(1990-11#2)(1991-2#2)(2008-10#3)(2011-4#5)
the North American Great Lakes##4##5##(2008-11#4)
the North American##10##3##(2008-10#4)(2008-11#4)(2008-7#1)(2010-10#1)
the North Carolina sample##3##4##(2008-10#3)
the North Fiji Basin##5##4##(2008-6#5)
the North Sea##4##3##(2008-10#1)(2009-10#3)
the North and##2##3##(1992-2#1)(2011-2#1)
the North##33##2##(1991-1#1)(1992-2#4)(1992-5#1)(2008-10#9)(2008-11#4)(2008-6#5)(2008-7#1)(2008-9#1)(2009-10#3)(2010-10#1)(2011-1#1)(2011-2#2)
the Northern##9##2##(1992-2#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-12#2)(2008-8#1)(2013-8#1)
the Northwest##2##2##(2008-11#1)(2008-8#1)
the Norwegian Board of Health##2##5##(1996-6#1)(1997-8#1)
the Norwegian Institute of Public Health##2##6##(2008-10#1)(2010-6#1)
the Norwegian Institute of##3##4##(1996-6#1)(2008-10#1)(2010-6#1)
the Norwegian Medical Association##2##4##(1990-6#2)
the Norwegian Medical##3##3##(1990-6#2)(1991-11#1)
the Norwegian Mother and Child Cohort Study##2##7##(2010-6#2)
the Norwegian##23##2##(1990-6#3)(1991-11#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-6#1)(1994-6#1)(1994-9#2)(1996-6#3)(1997-8#2)(2008-10#1)(2010-6#3)(2011-2#2)(2012-3#1)
the Nuclear##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
the Nucleus 24 cochlear implant system##4##6##(2008-9#4)
the Nucleus 24 cochlear implant##5##5##(2008-9#5)
the Nucleus##9##2##(2008-9#9)
the Number##2##2##(1996-9#1)(2008-10#1)
the Nursing Care Comfort Scale##2##5##(2008-11#2)
the Nursing Outcomes Classification##2##4##(2013-1#2)
the Nursing##11##2##(2008-11#6)(2008-12#1)(2013-1#4)
the Nyquist plot##2##3##(2008-10#2)
the O antigen of##2##4##(1996-12#2)
the O##7##2##(1996-12#2)(1997-4#1)(2008-10#3)(2008-11#1)
the O(2) A-band absorption##2##4##(2008-2#2)
the O(2)##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
the O(3)##4##2##(2008-3#4)
the O-buffer##2##2##(2008-6#2)
the O111 and O145##2##4##(2012-2#2)
the OAP system##3##3##(2008-11#3)
the OCLC Online Union Catalog##2##5##(1991-12#2)
the OCT##2##2##(2011-7#2)
the OECD##4##2##(1994-1#1)(2008-5#1)(2011-1#2)
the OEIS complex##2##3##(2008-10#2)
the OH group##2##3##(2008-10#1)(2008-8#1)
the OH##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
the OH(-) group in##2##4##(2008-10#2)
the OIE##2##2##(2011-2#2)
the OLUC##2##2##(1991-12#2)
the OMIM database##3##3##(2008-4#2)(2008-9#1)
the ONL##2##2##(2010-1#2)
the OPA##2##2##(2008-2#2)
the OPC instrument##3##3##(2010-10#3)
the OPO##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the OR##2##2##(1994-3#1)(1997-1#1)
the ORA##2##2##(2008-3#2)
the ORF I##2##3##(2008-10#2)
the ORF##4##2##(2008-10#2)(2008-8#2)
the ORFs##2##2##(1996-3#1)(1997-3#1)
the ORL-1 receptor##4##3##(2008-11#4)
the OS##2##2##(1991-8#1)(2008-10#1)
the OSCE##3##2##(2008-11#3)
the OUR##2##2##(2008-11#2)
the OVA/IL12##3##2##(2008-11#3)
the OY phytoplasmas##2##3##(2008-10#2)
the Obligate Biotroph##2##3##(2008-10#2)
the Occupational##2##2##(1993-3#2)
the Odin##2##2##(2008-3#2)
the Office of##2##3##(1991-1#1)(1993-12#1)
the Okavango Delta##3##3##(2008-10#3)
the Oklahoma##3##2##(1994-3#1)(1995-12#1)(2008-10#1)
the Old##2##2##(2008-10#1)(2008-7#1)
the Omnibus Budget Reconciliation Act (OBRA) of 1990##2##8##(1991-12#1)(1997-3#1)
the Omnibus Budget Reconciliation Act (OBRA) of##3##7##(1991-12#1)(1994-3#1)(1997-3#1)
the Omnibus Budget Reconciliation Act##4##5##(1991-12#1)(1994-1#1)(1994-3#1)(1997-3#1)
the Omnibus Budget Reconciliation##5##4##(1991-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1997-3#1)
the Omnibus##6##2##(1991-1#1)(1991-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1997-3#1)
the Ontario Ministry of Health##3##5##(1991-2#2)(1994-1#1)
the Ontario Ministry of##4##4##(1991-2#2)(1994-1#1)(1995-3#1)
the Ontario##9##2##(1991-2#6)(1993-3#1)(1994-1#1)(1995-3#1)
the Optical Society of America##2##5##(2008-3#2)
the Oral##2##2##(2011-2#1)(2013-1#1)
the Oregon Coast Range##3##4##(2008-10#3)
the Oregon coast##2##3##(2008-10#2)
the Oregon##10##2##(1992-2#1)(1993-1#1)(1995-1#1)(1996-1#1)(2008-10#5)(2008-12#1)
the Organization for Economic Cooperation and Development (OECD)##2##8##(1993-2#1)(1993-3#1)
the Organization for Economic Cooperation and Development countries##2##8##(1993-3#1)(1994-1#1)
the Organization for Economic Cooperation and Development##4##7##(1993-2#1)(1993-3#2)(1994-1#1)
the Origin of##3##3##(1996-5#1)(2008-10#1)(2010-5#1)
the Ortigas river##2##3##(2008-10#2)
the Oryza##2##2##(2008-10#2)
the OsMADS genes##2##3##(1997-8#2)
the Oxford Colposcopy Clinic##2##4##(1994-2#2)
the Oxford##3##2##(1994-2#2)(2008-2#1)
the P##34##2##(1990-5#1)(1993-9#2)(1995-2#1)(2008-10#24)(2008-12#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)
the P-glycoprotein##5##2##(1992-12#1)(2008-11#4)
the P1 helix##2##3##(1995-6#2)
the P1##11##2##(1993-12#2)(1994-5#2)(1995-6#2)(1996-2#1)(2008-10#2)(2008-8#1)(2008-9#1)
the P2 Tin protein##2##4##(1997-3#2)
the P2##5##2##(1990-11#1)(1995-12#1)(1995-8#1)(1997-3#2)
the P3##4##2##(1994-5#2)(2008-10#2)
the P450##3##2##(1993-8#1)(2009-9#2)
the PA method##3##3##(2012-2#3)
the PA##5##2##(2009-11#1)(2012-2#4)
the PAA##2##2##(2008-10#2)
the PACE##4##2##(1992-1#1)(2008-7#3)
the PAD and##2##3##(2008-10#2)
the PAD##3##2##(2008-10#3)
the PAH##3##2##(2008-10#2)(2010-10#1)
the PAHs##3##2##(2008-10#3)
the PAI##3##2##(1995-2#1)(2008-10#2)
the PANI film##3##3##(2008-10#3)
the PANI##4##2##(2008-10#4)
the PAP system##3##3##(2008-11#3)
the PAP##6##2##(2008-11#6)
the PAR1 region##2##3##(2008-7#2)
the PARI IS-2##2##3##(1995-3#2)
the PARP##2##2##(1993-12#1)(2010-6#1)
the PAV##2##2##(2008-10#2)
the PB film##2##3##(2008-10#2)
the PB layer##4##3##(2008-10#4)
the PB modified##2##3##(2008-10#2)
the PB##10##2##(2008-10#10)
the PB/HC-OES method and##2##4##(2010-11#2)
the PBL##5##2##(2008-10#1)(2008-12#1)(2013-8#3)
the PBMC##2##2##(2008-7#1)(2010-12#1)
the PBN##2##2##(2009-10#2)
the PBS##2##2##(2008-11#1)(2010-1#1)
the PC##3##2##(1993-8#2)(2008-10#1)
the PC/TD system##3##3##(2008-10#3)
the PCA-BP neural network##2##4##(2013-8#2)
the PCB##2##2##(2008-10#2)
the PCDD/Fs##2##2##(2008-10#2)
the PCNA gene##2##3##(1995-6#2)
the PCR and##2##3##(2008-10#1)(2008-4#1)
the PCR product##2##3##(2008-10#1)(2008-9#1)
the PCR products##4##3##(1992-8#1)(2008-10#3)
the PCR##14##2##(1992-8#1)(1994-11#1)(1995-6#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#1)
the PCR-amplified##2##2##(2008-10#2)
the PCR-based##2##2##(2008-10#2)
the PD patients##4##3##(2008-7#4)
the PD##12##2##(2008-10#1)(2008-7#6)(2011-2#3)(2013-1#2)
the PD-score##2##2##(2010-8#2)
the PDA##7##2##(2008-10#3)(2008-12#2)(2012-12#1)(2012-2#1)
the PDGF##2##2##(1994-6#2)
the PDL##4##2##(2008-11#3)(2008-3#1)
the PDSI##2##2##(2008-7#2)
the PDZ-binding domain##2##3##(2011-2#2)
the PEG hydrogel group##3##4##(2012-3#3)
the PEG hydrogel##4##3##(2012-3#4)
the PEI##2##2##(1992-11#1)(2008-11#1)
the PEMS##2##2##(2009-5#2)
the PEP##4##2##(1997-3#1)(2009-12#3)
the PET##2##2##(2011-2#1)(2012-12#1)
the PFC of##3##3##(1997-2#3)
the PFC##15##2##(1996-5#2)(1997-2#7)(2008-4#1)(2013-8#5)
the PG##6##2##(1990-2#3)(2008-10#1)(2008-8#1)(2011-2#1)
the PGHS##3##2##(1997-1#3)
the PI##4##2##(1994-11#1)(1996-2#1)(2009-3#2)
the PIG1 locus##2##3##(2008-10#2)
the PILP approach##2##3##(2009-11#2)
the PILP models learned from##2##5##(2009-11#2)
the PILP##4##2##(2009-11#4)
the PK##4##2##(2011-2#1)(2013-1#3)
the PKC##4##2##(1993-3#1)(1995-2#2)(1995-8#1)
the PLL is##2##3##(2008-10#2)
the PLLA##2##2##(2009-7#2)
the PLNA##3##2##(2008-10#3)
the PLS model##2##3##(2008-10#2)
the PLS models##2##3##(2008-10#2)
the PLS##7##2##(2008-10#6)(2008-5#1)
the PM##9##2##(2008-10#2)(2008-7#7)
the PM(2##3##2##(2008-5#3)
the PMP22##2##2##(1997-3#2)
the PMT##2##2##(2008-10#1)(2008-5#1)
the PNDC##3##2##(2008-11#3)
the PNS##2##2##(2008-7#2)
the PNW were##2##3##(2008-10#2)
the PNW##3##2##(2008-10#3)
the POA neurons in##2##4##(2008-8#2)
the POA neurons##3##3##(2008-8#3)
the PPA/HP-beta-CD##2##2##(2008-10#2)
the PPP##2##2##(2008-7#2)
the PPT##2##2##(2009-5#2)
the PPTg##3##2##(1994-2#3)
the PPy##2##2##(2008-10#2)
the PR##3##2##(2008-10#2)(2010-1#1)
the PROT protein##2##3##(1995-6#2)
the PS##3##2##(2008-10#3)
the PSD##5##2##(1996-12#4)(2008-3#1)
the PTFE##4##2##(2008-10#3)(2008-3#1)
the PVA##3##2##(2008-10#2)(2008-12#1)
the PVN##2##2##(1994-8#2)
the PVV isolates##2##3##(2008-10#2)
the Pacific Island##2##3##(2008-1#2)
the Pacific Northwest##9##3##(2008-10#9)
the Pacific Ocean##2##3##(2008-2#1)(2008-9#1)
the Pacific coast of##2##4##(2008-10#1)(2012-12#1)
the Pacific##26##2##(1995-11#2)(2008-1#9)(2008-10#10)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)
the Pacificans'##2##2##(2008-1#2)
the Page serovar C##2##4##(2008-5#2)
the Painlevé##2##2##(1991-9#2)
the Pan American Health Organization##3##5##(1992-5#1)(1994-9#1)(2013-1#1)
the Panhandle##2##2##(2008-10#2)
the Pap smear##3##3##(1992-3#3)
the Pap test##2##3##(1991-6#1)(2008-11#1)
the Pap##5##2##(1991-6#1)(1992-3#3)(2008-11#1)
the Parasitic##2##2##(2008-10#2)
the Parent##3##2##(1992-2#1)(1994-3#1)(2011-2#1)
the Paridae##2##2##(2008-9#2)
the Paris##3##2##(2008-2#1)(2010-1#1)(2012-3#1)
the Parkinson's##2##2##(2008-7#2)
the Parry##2##2##(2008-3#2)
the Part##2##2##(1993-12#1)(1995-12#1)
the Parties##2##2##(1996-1#2)
the Pathogen##3##2##(2008-10#3)
the Patient##2##2##(1994-1#1)(1996-1#1)
the Ped gene (Qa-2(a))##2##4##(2008-5#2)
the Ped gene##3##3##(2008-5#3)
the Pediatric##4##2##(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
the Peltier##2##2##(2008-10#1)(2008-9#1)
the Pennsylvania##2##2##(1995-1#1)(2010-1#1)
the Pentagon##2##2##(1996-5#2)
the Peruvian##4##2##(2013-8#4)
the Philippine##2##2##(2008-10#2)
the Physical##3##2##(1994-3#1)(1997-3#1)(2008-4#1)
the Phytophthora genus-specific amplicon##2##4##(2008-10#2)
the Phytophthora genus-specific primer pair##2##5##(2008-10#2)
the Phytophthora genus-specific##5##3##(2008-10#5)
the Phytophthora sp-h isolates##4##4##(2008-10#4)
the Phytophthora##12##2##(2008-10#12)
the Pi-ta##4##2##(2008-10#4)
the Picture Description Task##2##4##(2008-7#2)
the Plant##3##2##(2008-10#3)
the Plaque Assay and##2##4##(2008-10#2)
the Plaque Assay##5##3##(2008-10#5)
the Pm-AMP1##4##2##(2008-10#4)
the Pm3##2##2##(2008-10#2)
the Poisson distribution##2##3##(1995-6#1)(2008-10#1)
the Poisson##4##2##(1995-6#1)(2008-10#3)
the Polish intelligentsia##2##3##(2008-12#2)
the Polish##7##2##(2008-11#2)(2008-12#2)(2012-2#1)(2013-1#2)
the Postharvest##3##2##(2008-10#3)
the Potato##2##2##(2008-10#2)
the Power##2##2##(2009-11#1)(2013-1#1)
the Presence of##5##3##(1996-5#1)(2008-10#4)
the President signed into law House Resolution##3##7##(1991-12#1)(1991-3#1)(1993-1#1)
the President signed into law##4##5##(1991-12#1)(1991-3#1)(1993-1#1)(1994-3#1)
the President##7##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-12#1)
the President's##2##2##(1993-5#1)(2010-1#1)
the Prestige's##2##2##(2008-10#2)
the Prevention of##2##3##(2010-12#1)(2013-8#1)
the Primary Care##2##3##(1996-1#1)(1996-2#1)
the Primary Health Care##2##4##(1990-6#1)(2009-10#1)
the Primary##6##2##(1990-6#1)(1996-1#1)(1996-2#1)(2008-10#2)(2009-10#1)
the Production of##3##3##(2008-10#1)(2008-11#2)
the Profile##2##2##(2008-4#1)(2009-10#1)
the Program of##2##3##(1991-2#1)(1994-2#1)
the Program##3##2##(1991-2#1)(1994-2#1)(2013-1#1)
the Programme of Action##3##4##(2008-11#3)
the Project 2000 curriculum##2##4##(2008-11#2)
the Project 2000##3##3##(2008-11#3)
the Province of##3##3##(1991-2#1)(1991-6#1)(1992-12#1)
the Prussian blue##2##3##(2008-10#2)
the Prussian##5##2##(2008-10#5)
the Pseudomonas##5##2##(1995-2#1)(2008-10#3)(2009-6#1)
the Public Health Service##2##4##(1991-1#1)(2012-2#1)
the Public Health##6##3##(1991-1#1)(1996-2#1)(1997-2#1)(2012-12#2)(2012-2#1)
the Public##7##2##(1991-1#1)(1996-2#1)(1997-2#1)(2008-10#1)(2012-12#2)(2012-2#1)
the PurR function##2##3##(2008-8#2)
the PurR##3##2##(2008-8#3)
the Purkinje cell##2##3##(1992-9#1)(2013-8#1)
the Purkinje##3##2##(1992-9#1)(1994-2#1)(2013-8#1)
the Pythium##3##2##(2008-10#3)
the Q factor of##2##4##(2008-3#2)
the Q-switched pulse##3##3##(2008-3#3)
the Q-switched##4##2##(2008-3#4)
the QCM##5##2##(2008-10#5)
the QDA##2##2##(2008-10#2)
the QOL score##2##3##(1994-12#2)
the QOL##3##2##(1994-12#3)
the QRS complex##2##3##(2010-8#2)
the QRS##4##2##(2008-10#1)(2010-1#1)(2010-8#2)
the QTL for##3##3##(2008-10#3)
the QTL on##3##3##(2008-10#3)
the QTL##13##2##(2008-10#12)(2009-10#1)
the QTLs##2##2##(2008-10#1)(2008-8#1)
the Qinghai-Tibet Plateau##3##3##(2008-9#2)(2009-5#1)
the Quality##3##2##(1993-12#1)(1997-2#1)(2008-11#1)
the Quebec experience##2##3##(2012-2#2)
the Quebec##6##2##(1991-12#1)(1993-12#1)(2008-11#1)(2008-3#1)(2012-2#2)
the Quercus species##2##3##(2012-6#1)(2012-9#1)
the QuickVue##3##2##(2011-2#3)
the R##37##2##(1990-8#2)(1993-6#6)(2008-10#27)(2009-7#1)(2010-10#1)
the R&amp##3##2##(2008-5#1)(2008-8#2)
the R(50) transition##2##3##(2008-3#2)
the R-D-LSI##3##2##(2012-2#3)
the RAD3##2##2##(1993-12#1)(1995-9#1)
the RAM##2##2##(2008-10#1)(2012-2#1)
the RAND##3##2##(2008-10#2)(2010-12#1)
the RAPD##3##2##(2008-10#3)
the RB##3##2##(1996-2#1)(2008-10#1)(2013-1#1)
the RBC##3##2##(1995-2#1)(2013-1#2)
the RE##2##2##(2008-10#2)
the REE concentrations##2##3##(2008-10#2)
the REE##4##2##(2008-10#4)
the RESEARCH and T-SEARCH##2##4##(2008-11#2)
the RF##2##2##(2008-10#1)(2008-8#1)
the RFLP markers##2##3##(2008-10#1)(2008-9#1)
the RFLP##3##2##(2008-10#2)(2008-9#1)
the RGD sequence##6##3##(1994-11#2)(1995-6#4)
the RGD##8##2##(1994-11#2)(1995-6#4)(2008-7#2)
the RIG##2##2##(2008-10#2)
the RIL population##4##3##(2008-10#4)
the RIPs##2##2##(1990-12#2)
the RK motif##3##3##(1995-6#3)
the RK##5##2##(1995-6#5)
the RLS signals of##2##4##(2008-10#2)
the RLS signals##4##3##(2008-10#4)
the RLS##7##2##(2008-10#7)
the RLV-2100 &quot##2##3##(1991-3#2)
the RM##3##2##(1996-2#1)(2008-10#2)
the RN buddy role##2##4##(2008-12#2)
the RN##6##2##(2008-12#4)(2010-2#1)(2010-4#1)
the RN's##2##2##(2010-11#2)
the RNA component of##2##4##(2008-11#1)(2008-9#1)
the RNA from##2##3##(1993-8#1)(2008-10#1)
the RNA polymerase II##2##4##(1997-7#1)(2008-10#1)
the RNA polymerase##5##3##(1995-6#2)(1997-2#1)(1997-7#1)(2008-10#1)
the RNA secondary structure##3##4##(1991-9#2)(2011-3#1)
the RNA secondary##4##3##(1991-9#2)(2008-4#1)(2011-3#1)
the RNA structure##2##3##(1994-11#1)(2008-10#1)
the RNA##33##2##(1991-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-6#3)(1997-2#1)(1997-7#3)(2008-10#10)(2008-11#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-3#1)
the RNA-dependent RNA polymerase##3##4##(2008-10#3)
the RO children at##2##4##(2008-11#2)
the RO children were##2##4##(2008-11#2)
the RO children##5##3##(2008-11#5)
the RO##6##2##(2008-11#6)
the RP##4##2##(2010-1#1)(2010-10#1)(2012-2#2)
the RP-HPLC official method##2##4##(2008-10#2)
the RR values##2##3##(2008-10#2)
the RR##3##2##(2008-10#3)
the RRE with##3##3##(1993-8#3)
the RRE##8##2##(1993-8#8)
the RRS intensity##2##3##(2008-10#2)
the RRS technology##2##3##(2008-10#2)
the RRS##6##2##(2008-10#6)
the RSD of the##4##4##(2008-10#4)
the RSD was##3##3##(2008-10#3)
the RSD##9##2##(2008-10#9)
the RT##5##2##(1995-5#1)(1997-3#3)(2011-2#1)
the RT-PCR##9##2##(2008-10#3)(2008-5#3)(2008-8#1)(2010-5#1)(2012-2#1)
the RTD##4##2##(2008-10#4)
the RTP quenching##2##3##(2008-10#2)
the RTP##10##2##(2008-10#10)
the RTS endpoints##2##3##(2008-10#2)
the RTS##3##2##(2008-10#3)
the RV##2##2##(2008-10#2)
the RVC##4##2##(2008-10#4)
the RWJF##2##2##(2013-1#2)
the RYSV##2##2##(2008-8#2)
the Rainbow Trout##2##3##(2008-5#1)(2008-6#1)
the Ram1##2##2##(1993-9#2)
the Raman gain##2##3##(2008-3#2)
the Raman spectra##2##3##(2008-10#1)(2013-8#1)
the Raman##14##2##(1991-5#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-9#1)(2013-8#1)
the Rasch model##3##3##(2008-11#1)(2012-2#2)
the Rasch##5##2##(2008-11#1)(2011-2#1)(2012-2#3)
the Rayleigh scattering##2##3##(2008-3#2)
the Rayleigh##3##2##(2008-10#1)(2008-3#2)
the Rayleigh-Sommerfeld##2##2##(2008-3#2)
the ReView##2##2##(2008-11#2)
the Reagan administration##5##3##(1991-1#5)
the Reduced##2##2##(1990-11#1)(2008-10#1)
the Regional##3##2##(2008-10#3)
the Rehabilitation Act##2##3##(1995-12#2)
the Rehabilitation##4##2##(1995-12#2)(2007-11#1)(2008-10#1)
the Relationship between##2##3##(1996-9#1)(2013-1#1)
the Release of##2##3##(2008-10#2)
the Release##3##2##(2008-10#3)
the Religious Society of Friends##2##5##(2012-2#2)
the Renaissance##2##2##(2008-11#1)(2011-2#1)
the Rep##5##2##(2008-10#5)
the Republic of Belarus##2##4##(2008-10#1)(2011-2#1)
the Republic of Croatia##2##4##(2011-2#2)
the Republic of##8##3##(2008-1#1)(2008-10#2)(2010-11#1)(2011-2#4)
the Republic##9##2##(2008-1#1)(2008-10#2)(2010-11#1)(2011-2#4)(2012-3#1)
the Republicans##2##2##(1995-6#1)(1997-2#1)
the Research##3##2##(1997-8#1)(2011-2#1)(2012-3#1)
the Response##3##2##(2008-10#2)(2009-4#1)
the Restin##2##2##(2008-9#2)
the Rev-mediated RNA nuclear export##2##5##(2011-3#2)
the Rhizobium-legume symbiosis##2##3##(2008-11#2)
the Rhône##2##2##(2008-10#1)(2010-8#1)
the Rice##4##2##(2008-10#2)(2009-10#1)(2013-8#1)
the Richards function##2##3##(2008-10#2)
the Richards model##2##3##(2008-10#2)
the Richards##5##2##(2008-10#5)
the Rio Grande Valley##2##4##(2008-10#2)
the Rio##3##2##(2008-10#3)
the Risk of##3##3##(2008-10#2)(2009-6#1)
the Ritz-Carlton's approach to strategic planning##2##6##(1994-2#1)(1994-3#1)
the Robert Wood Johnson Foundation's##2##5##(1996-12#1)(2013-1#1)
the Robert Wood Johnson##3##4##(1993-2#1)(1996-12#1)(2013-1#1)
the Robert##4##2##(1993-2#1)(1996-1#1)(1996-12#1)(2013-1#1)
the Robo1##2##2##(2011-2#2)
the Rochester##2##2##(1992-12#1)(1996-2#1)
the Role of##7##3##(2008-10#3)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)
the Role##8##2##(2008-10#3)(2008-6#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-2#1)
the Roman##4##2##(2008-10#2)(2010-1#2)
the Romanian##2##2##(1990-5#1)(2008-1#1)
the Root##2##2##(2008-10#2)
the Root-Knot Nematode##2##3##(2008-10#2)
the Rosascos##3##2##(1996-5#3)
the Royal College of Physicians##3##5##(1994-12#1)(1996-8#2)
the Royal College of##6##4##(1990-3#1)(1994-12#2)(1996-8#2)(2012-12#1)
the Royal##7##2##(1990-3#1)(1992-1#1)(1994-12#2)(1996-8#2)(2012-12#1)
the RpII LS##3##3##(1997-7#3)
the Rpc1 locus##2##3##(2008-10#2)
the Rph3##2##2##(2008-10#2)
the Russian##4##2##(1995-3#1)(1997-1#1)(2008-9#1)(2010-12#1)
the Rust##2##2##(2008-10#2)
the Rx1##2##2##(2008-10#2)
the RyR1s##5##2##(2008-9#5)
the Ryan White CARE Act and##2##6##(1995-12#1)(1996-5#1)
the Ryan White##3##3##(1995-12#1)(1995-6#1)(1996-5#1)
the S RNA##3##3##(2008-10#3)
the S and##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
the S phase##5##3##(1993-8#2)(2008-11#2)(2008-9#1)
the S strain##3##3##(2008-10#3)
the S##39##2##(1991-5#1)(1993-1#1)(1993-2#3)(1993-8#2)(1994-3#1)(1995-5#1)(1996-6#3)(1997-7#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
the S-dsRNA##5##2##(2008-10#5)
the S-phase fraction##3##3##(1993-1#1)(1993-11#1)(1994-12#1)
the S-phase##5##2##(1993-1#1)(1993-11#1)(1994-12#1)(1997-1#2)
the S1##4##2##(2008-4#1)(2008-5#3)
the S182 gene on chromosome 14q24##2##6##(1995-8#2)
the S182 gene##3##3##(1995-8#3)
the S182##4##2##(1995-8#4)
the SA concentration range##2##4##(2008-10#2)
the SA##6##2##(1995-11#1)(2008-10#3)(2009-8#1)(2011-10#1)
the SAB1##2##2##(1997-8#2)
the SAM##8##2##(2008-10#8)
the SAMs##3##2##(2008-10#3)
the SAR##3##2##(1992-3#1)(2008-8#2)
the SAR-inducing##3##2##(2008-10#3)
the SAS##2##2##(2008-7#1)(2009-8#1)
the SC and HDC##2##4##(2008-10#2)
the SC##23##2##(2008-10#4)(2008-5#19)
the SCA 4 l/min group##2##5##(2011-2#2)
the SCAR locus##2##3##(2008-10#2)
the SCAR##4##2##(2008-10#4)
the SCAVM##2##2##(1995-11#1)(1997-6#1)
the SCMV##3##2##(2008-10#3)
the SCN##3##2##(1994-2#3)
the SCR##2##2##(2008-10#1)(2011-2#1)
the SD of HbA1c levels (r = 0##2##6##(2012-5#2)
the SD of HbA1c levels##3##5##(2012-5#3)
the SD##4##2##(2008-6#1)(2012-5#3)
the SDS gel##2##3##(2008-10#2)
the SDS##5##2##(2008-10#4)(2008-5#1)
the SE United States##2##4##(2008-10#2)
the SE##6##2##(2008-10#5)(2008-11#1)
the SEA##3##2##(1993-6#3)
the SEC##2##2##(1991-2#1)(1997-2#1)
the SERS spectrum##2##3##(2008-10#2)
the SERS-active##2##2##(2008-10#2)
the SERVQUAL scale##2##3##(1993-12#2)
the SF-CO(2) extraction##2##3##(2008-10#2)
the SF-CO(2)##3##2##(2008-10#3)
the SFE and##2##3##(2008-10#2)
the SFE##5##2##(2008-10#5)
the SFLLR##2##2##(1992-4#2)
the SFO##2##2##(1994-2#2)
the SFV expression##2##3##(2008-11#2)
the SGD##3##2##(2013-8#3)
the SH##2##2##(2006-6#1)(2007-12#1)
the SH2 domain of##2##4##(1995-6#1)(1997-7#1)
the SH2 domains of Src##2##5##(1995-6#2)
the SH2 domains of##3##4##(1995-6#3)
the SH2##5##2##(1995-6#4)(1997-7#1)
the SHIP2-SH2 domain##2##3##(2012-2#2)
the SHIP2-SH2##3##2##(2012-2#3)
the SHM##3##2##(2008-8#2)(2011-2#1)
the SHR##2##2##(1994-2#1)(1994-8#1)
the SI system##2##3##(2008-10#2)
the SI##8##2##(1996-2#1)(2007-12#1)(2008-10#3)(2012-2#3)
the SIA system##5##3##(2008-10#5)
the SIA##6##2##(2008-10#6)
the SMI##2##2##(2009-6#2)
the SNAP-25 gene##2##3##(1996-12#1)(1997-7#1)
the SNAP-25 promoter##3##3##(1996-12#3)
the SNAP-25##5##2##(1996-12#4)(1997-7#1)
the SNF##2##2##(1994-12#1)(1994-2#1)
the SNP##3##2##(2008-10#2)(2012-5#1)
the SNR##2##2##(2008-3#2)
the SO(2)##2##2##(2008-10#1)(2008-11#1)
the SOC(4) -conjugates##2##3##(2011-2#2)
the SOM##2##2##(1992-1#2)
the SOWG##4##2##(2008-10#4)
the SOX3-positive primordial germ cells develop toward##2##7##(2010-5#2)
the SP##4##2##(2008-10#1)(2008-12#1)(2010-4#1)(2010-6#1)
the SPD##2##2##(2008-5#2)
the SPE cartridge##3##3##(1997-2#2)(2008-10#1)
the SPE column##2##3##(2008-10#2)
the SPE step##2##3##(2008-10#2)
the SPE##16##2##(1997-2#3)(2008-10#12)(2011-2#1)
the SPF##6##2##(1993-1#1)(2008-5#5)
the SPME fiber##3##3##(2008-10#3)
the SPME fibre##3##3##(2008-10#3)
the SPME##8##2##(2008-10#8)
the SPR biosensor##2##3##(2008-10#2)
the SPR intensity##3##3##(2008-10#3)
the SPR sensor system##2##4##(2008-10#2)
the SPR sensor##6##3##(2008-10#5)(2008-4#1)
the SPR##17##2##(2008-10#16)(2008-4#1)
the SQUID##2##2##(2008-7#2)
the SR##4##2##(1994-8#1)(1995-6#1)(2008-10#2)
the SS inlet##2##3##(2008-10#2)
the SS##5##2##(1993-8#1)(2008-10#2)(2009-11#1)(2011-2#1)
the SSCP analysis##2##3##(2008-10#2)
the SSCT##5##2##(2008-9#5)
the SSE##2##2##(2013-1#1)(2013-8#1)
the SSG##4##2##(1995-11#4)
the SSLB resistance##2##3##(2008-10#2)
the ST##2##2##(1996-6#1)(2008-7#1)
the STARD and QUADAS##2##4##(2008-12#2)
the STARD##3##2##(2008-12#3)
the STR##4##2##(2008-12#3)(2008-7#1)
the SV40 early promoter##2##4##(1995-6#1)(2008-11#1)
the SV40##3##2##(1995-6#1)(2008-11#2)
the SVP##2##2##(1993-6#2)
the SZ##4##2##(2009-7#4)
the Sac locus##2##3##(2008-2#2)
the Saccharomyces cerevisiae##9##3##(1990-7#1)(1993-9#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-10#1)(2010-4#1)(2012-3#1)
the Saccharomyces complex##2##3##(2012-3#2)
the Saccharomyces##11##2##(1990-7#1)(1993-9#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-10#1)(2010-4#1)(2012-3#3)
the Safety of##3##3##(2008-10#2)(2012-3#1)
the Safety##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
the Salinas valley##2##3##(2008-10#2)
the Salinas##6##2##(2008-10#6)
the Salmonella##4##2##(1991-12#1)(1995-11#1)(1996-6#1)(2011-1#1)
the San Joaquin Valley##3##4##(2008-10#3)
the San##6##2##(1990-11#1)(1991-2#1)(2008-1#1)(2008-10#3)
the Sarason##2##2##(1992-1#2)
the Saskatchewan##2##2##(1995-12#1)(2008-8#1)
the Sauerbrey shift##2##3##(2009-5#2)
the Scandinavian##3##2##(2011-4#3)
the Scatchard##2##2##(2008-10#2)
the Schaffer collateral-CA1 region##2##4##(2008-7#2)
the Schaffer##4##2##(1995-12#1)(2008-7#3)
the Schiff base##6##3##(1994-5#2)(2008-10#4)
the Schiff##7##2##(1994-5#2)(2008-10#5)
the Schlieren effect##3##3##(2008-10#3)
the School of Medical Sciences##2##5##(2008-10#2)
the School of Nursing and Midwifery##2##6##(2008-11#2)
the School of Nursing##3##4##(2008-11#2)(2008-12#1)
the School of##9##3##(1992-1#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-12#2)
the School##11##2##(1992-1#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2010-9#1)
the Scientific##2##2##(1991-3#1)(2008-10#1)
the Scottish##6##2##(2008-11#4)(2008-12#1)(2008-9#1)
the SeaWiFS 765-nm band##2##4##(2008-2#2)
the SeaWiFS 765-nm##3##3##(2008-2#3)
the SeaWiFS##10##2##(2008-2#6)(2008-3#4)
the SecA##2##2##(2008-10#2)
the Second World War##3##4##(2008-11#1)(2008-7#1)(2011-4#1)
the Second##6##2##(1996-5#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-4#1)
the Secret##2##2##(1995-6#2)
the Self##2##2##(2008-11#2)
the Self-Help Clearinghouse of Metropolitan Toronto##2##6##(1994-1#1)(1996-3#1)
the Self-Help Clearinghouse##3##3##(1994-1#2)(1996-3#1)
the Semliki Forest##3##3##(2008-11#3)
the Senate##8##2##(1995-6#6)(1997-2#1)(2008-8#1)
the Septoria tritici##2##3##(2008-10#2)
the Septoria##3##2##(2008-10#3)
the Sertoli cell##2##3##(2012-2#2)
the Sertoli##5##2##(2009-10#1)(2012-2#4)
the Sexual Stage of##2##4##(2008-10#2)
the Shannon##2##2##(2008-10#1)(2008-8#1)
the Shc##3##2##(1997-7#3)
the Shine-Dalgarno sequence##2##3##(1996-8#1)(1997-2#1)
the Short Form##2##3##(2008-10#2)
the Short##5##2##(2008-10#3)(2009-10#1)(2010-8#1)
the Siberian##2##2##(1994-2#1)(2008-6#1)
the Singapore Chinese Health Study##3##5##(2010-6#3)
the Sixth##2##2##(1996-1#1)(2012-3#1)
the Slump Test in##2##4##(2008-12#2)
the Slump Test##5##3##(2008-12#5)
the Sm##2##2##(1997-9#1)(2008-10#1)
the Smad2 conditional##2##3##(2008-9#2)
the Social Action##2##3##(2008-11#2)
the Social Security##3##3##(1992-2#1)(1993-1#1)(2012-12#1)
the Social##5##2##(1992-2#1)(1993-1#1)(2008-11#2)(2012-12#1)
the Society for##3##3##(1996-8#1)(2013-1#1)(2013-8#1)
the Society of##3##3##(1994-6#1)(2008-10#1)(2013-1#1)
the Society##7##2##(1994-12#1)(1994-6#1)(1996-8#1)(2008-10#1)(2013-1#2)(2013-8#1)
the Somogyi-Nelson batch procedure##2##4##(2008-10#2)
the Sonoran Desert##4##3##(2008-10#3)(2009-8#1)
the Soret band##3##3##(1990-8#3)
the Soret##4##2##(1990-8#3)(2008-10#1)
the South African##3##3##(2008-8#1)(2010-1#1)(2010-3#1)
the South American##3##3##(2008-10#2)(2011-2#1)
the South Carolina##2##3##(2008-10#1)(2011-2#1)
the South Pacific##3##3##(2008-1#3)
the South West##2##3##(2008-11#2)
the South##26##2##(1992-2#3)(1997-2#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#5)(2013-1#1)(2013-8#1)
the Southern##5##2##(1990-8#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-2#1)
the Soviet Union##3##3##(1990-3#1)(2008-12#2)
the Soviet##4##2##(1990-3#2)(2008-12#2)
the Soybean##4##2##(2008-10#4)
the Span80-CPL##3##2##(2008-11#3)
the Spanish isolates##2##3##(2008-10#2)
the Spanish##14##2##(1993-5#2)(2008-10#9)(2009-10#3)
the Spatial##2##2##(2008-10#2)
the Spatiotemporal##2##2##(2008-10#1)(2008-11#1)
the Special Supplemental##2##3##(1996-12#2)
the Spectra Optia##5##3##(2011-2#5)
the Spectromètre à Diodes Laser Accordables##2##6##(2008-3#2)
the Spo0A##2##2##(1995-6#1)(2011-2#1)
the Spodoptera frugiperda##3##3##(2008-11#2)(2008-7#1)
the Spr3 locus##3##3##(2009-10#3)
the Spread of##2##3##(2008-10#2)
the Spread##3##2##(2008-10#3)
the Sri Lankan strains##3##4##(2008-10#3)
the St##2##2##(1993-12#1)(1996-3#1)
the Standard##2##2##(2008-10#1)(2008-9#1)
the Stanford##2##2##(1995-9#1)(2013-1#1)
the Star-PAP##2##2##(2013-1#2)
the State Food and Drug Administration##2##6##(2011-2#1)(2012-3#1)
the State of##9##3##(1990-11#1)(1991-8#2)(1997-3#1)(2008-10#2)(2010-10#2)(2011-2#1)
the State##16##2##(1990-11#1)(1991-8#2)(1995-12#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2010-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
the Statement##2##2##(1993-11#2)
the States##6##2##(1992-3#1)(1994-1#1)(1994-3#2)(1995-1#1)(1997-2#1)
the Stb4 locus in##2##4##(2008-10#2)
the Stb4 locus##3##3##(2008-10#3)
the Stb4##4##2##(2008-10#4)
the Stem##2##2##(2008-10#2)
the Stern-Volmer plot##2##3##(2008-10#2)
the Stern-Volmer##4##2##(2008-10#4)
the Stokes##6##2##(1993-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
the Strehl##2##2##(2008-3#2)
the Streptococcus##5##2##(1992-5#1)(2009-6#2)(2011-1#1)(2011-2#1)
the Strong##3##2##(1996-9#1)(2012-3#1)(2013-1#1)
the Student##2##2##(2008-11#1)(2011-2#1)
the Student's##2##2##(2008-10#2)
the Study of##7##3##(1992-2#1)(1995-11#2)(2008-10#2)(2008-5#1)(2013-1#1)
the Study##8##2##(1992-2#1)(1995-11#2)(1997-7#1)(2008-10#2)(2008-5#1)(2013-1#1)
the Sun##2##2##(1991-9#1)(2008-3#1)
the Sunnybrook##2##2##(1995-12#1)(2007-9#1)
the Supplemental Security Income Program##2##5##(1995-12#2)
the Surgical Department of##3##4##(1990-9#1)(1993-3#1)(2008-10#1)
the Surgical##5##2##(1990-9#1)(1993-3#1)(1994-12#1)(1997-8#1)(2008-10#1)
the Survival of##3##3##(2008-10#2)(2010-7#1)
the Swedish##2##2##(2008-2#1)(2013-1#1)
the Swiss##5##2##(1991-2#1)(1991-6#1)(1996-8#1)(2008-10#1)(2008-3#1)
the SyF##2##2##(2008-10#2)
the Synechocystis##2##2##(1995-12#1)(1996-6#1)
the Syrian##3##2##(1990-6#1)(1990-7#1)(1996-8#1)
the Szeged and PI indices of##2##6##(2009-3#2)
the Szeged and##3##3##(2009-3#3)
the T cell receptor##2##4##(1995-8#1)(2007-12#1)
the T cell##6##3##(1995-8#1)(2007-12#1)(2008-11#3)(2008-4#1)
the T current##2##3##(1992-8#2)
the T growth##2##3##(2013-8#2)
the T matrix##2##3##(2008-3#2)
the T state##2##3##(1990-8#2)
the T##36##2##(1990-8#4)(1991-3#1)(1992-8#3)(1993-1#1)(1993-8#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-3#2)(2008-4#1)(2008-8#1)(2011-2#3)(2013-8#2)
the T(2) progeny of line##2##5##(2008-10#2)
the T(2) progeny of##3##4##(2008-10#3)
the T-DNA in a##2##4##(2008-10#2)
the T-DNA##6##2##(2008-10#6)
the T-cell##3##2##(1990-5#1)(1995-2#1)(2008-10#1)
the T-cell-dependent antigen##2##3##(1993-12#1)(2008-10#1)
the T-cell-dependent##3##2##(1993-12#1)(2008-10#2)
the T-matrix method to##2##4##(2008-3#2)
the T3##4##2##(1995-8#1)(2008-10#3)
the T3-resistant##2##2##(2008-10#2)
the T36##3##2##(2008-10#3)
the T4##5##2##(1990-5#1)(1995-6#1)(1997-3#2)(2008-6#1)
the T7##3##2##(1990-11#1)(2008-11#1)(2008-8#1)
the TA2 domain was##2##4##(1995-6#2)
the TAD soils##2##3##(2008-10#2)
the TAD##3##2##(2008-10#3)
the TATA-binding protein##2##3##(1993-8#1)(1993-9#1)
the TB##2##2##(2008-10#1)(2013-8#1)
the TB/C3-bcl2##2##2##(2008-11#2)
the TB/C3-pEF##2##2##(2008-11#2)
the TBP extraction method##2##4##(2008-10#2)
the TCA##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
the TCR##4##2##(1994-3#1)(2008-11#3)
the TCRAC gene##3##3##(1997-9#3)
the TCRAC##4##2##(1997-9#4)
the TDT##2##2##(2008-9#2)
the TE##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
the TEMPO+##8##2##(2008-9#8)
the TEWL##2##2##(2008-5#2)
the TGF beta##2##3##(1992-8#1)(2013-8#1)
the TGF##3##2##(1992-8#1)(1997-1#1)(2013-8#1)
the TGF-beta##3##2##(1995-2#3)
the TIR##2##2##(2008-8#2)
the TIRF-based biosensor##2##3##(2008-10#2)
the TLC-LSD method##2##3##(2008-10#2)
the TM##7##2##(2008-3#1)(2009-7#6)
the TMG##2##2##(2008-10#2)
the TMS coil##2##3##(2010-7#2)
the TNF alpha-308 polymorphism##2##4##(1995-12#2)
the TNF##5##2##(1995-12#2)(1997-2#1)(2008-8#1)(2009-3#1)
the TNF-alpha##4##2##(1991-6#1)(1995-12#2)(2013-1#1)
the TNM##2##2##(1993-11#1)(2012-3#1)
the TP53 locus##2##3##(2009-8#2)
the TP53##3##2##(2009-8#3)
the TP82-induced intracellular Ca2+##2##4##(1990-8#2)
the TPA-induced MMP-1 and MMP-9##2##5##(2012-3#2)
the TPDE##2##2##(2008-10#2)
the TPF##5##2##(2008-10#2)(2008-3#3)
the TRA##4##2##(2011-2#4)
the TRF spectra##2##3##(2008-10#2)
the TS##3##2##(2008-11#3)
the TSC##2##2##(1992-1#2)
the TSH##2##2##(1993-8#1)(1994-11#1)
the TSHr##2##2##(2008-4#2)
the TSI##5##2##(2012-3#5)
the TSK##3##2##(1997-8#2)(2008-10#1)
the TSPO##9##2##(2012-2#9)
the TSPO-labeled##2##2##(2012-2#2)
the TSWV N##2##3##(2008-10#2)
the TSWV##5##2##(2008-10#5)
the TTM##3##2##(2010-12#1)(2010-2#2)
the TUNEL##3##2##(2008-11#1)(2008-7#1)(2010-1#1)
the Taiwan##2##2##(2008-8#1)(2010-8#1)
the TaqMan##3##2##(2008-10#2)(2010-4#1)
the Tarasca is##2##3##(2009-10#2)
the Tarasca##8##2##(2009-10#8)
the Tarasca's##2##2##(2009-10#2)
the Tasmanian##2##2##(2008-9#2)
the Taylor's##2##2##(2008-10#1)(2008-2#1)
the Tb-Gd-Trp-SDBS system##2##3##(2008-10#2)
the Teakettle##2##2##(2008-10#2)
the Teflon##3##2##(2008-10#3)
the Texas##6##2##(1996-2#1)(2008-10#5)
the Third International##2##3##(2008-11#1)(2011-2#1)
the Third##5##2##(2008-11#1)(2008-7#1)(2011-2#3)
the Thirteenth Amendment##5##3##(2011-2#5)
the Thr147##2##2##(2012-2#2)
the TiNi foam samples##2##4##(2009-7#2)
the TiNi##3##2##(2009-7#3)
the Time##2##2##(1991-8#1)(2010-11#1)
the Tn3##2##2##(1996-12#2)
the Toluca Valley of##2##4##(2008-10#2)
the Toluca Valley##5##3##(2008-10#5)
the Toluca valley##2##3##(2008-10#2)
the Toluca##7##2##(2008-10#7)
the Toronto Clearinghouse##3##3##(1996-3#3)
the Toronto##4##2##(1992-3#1)(1996-3#3)
the Torpedo nicotinic acetylcholine receptor##2##5##(1994-5#2)
the Toyota Production System##4##4##(2012-2#4)
the Toyota##5##2##(2012-2#4)(2013-8#1)
the Traditional##2##2##(1995-12#1)(2009-5#1)
the Translocator Protein (TSPO)##3##4##(2012-2#3)
the Translocator Protein##4##3##(2012-2#4)
the Transtheoretical Model##2##3##(2008-4#1)(2013-1#1)
the Transverse Ranges##2##3##(1995-6#2)
the Transverse##3##2##(1995-6#2)(2011-2#1)
the Treatment of##9##3##(1997-3#1)(2008-10#1)(2008-12#1)(2009-6#1)(2009-9#1)(2012-2#1)(2012-3#3)
the Trichoderma##4##2##(2008-10#4)
the Ts65Dn mouse model of##2##5##(2012-2#2)
the Tsukuba and Chiba populations##2##5##(2008-10#2)
the Turkish##3##2##(1997-5#1)(2010-11#1)(2011-1#1)
the Tutotest in a hybrid##2##5##(2008-10#2)
the Tutotest##4##2##(2008-10#4)
the Type I error rate##3##5##(2012-2#3)
the U##79##2##(1990-11#2)(1990-6#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-3#3)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1994-1#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#4)(1997-6#1)(2008-10#20)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the U-G units##3##3##(1997-3#3)
the U2##2##2##(1993-6#1)(1993-8#1)
the U6 chimeric ribozyme##2##4##(2008-9#2)
the UG reflex##4##3##(1994-2#4)
the UGT2B17 deletion##2##3##(2013-8#2)
the UGT2B17 genotype##3##3##(2013-8#3)
the UGT2B17##6##2##(2013-8#6)
the UICC##2##2##(1991-8#1)(1994-12#1)
the UK and Ireland##3##4##(2008-10#2)(2008-12#1)
the UK and##9##3##(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)
the UK is##2##3##(2009-4#1)(2012-12#1)
the UK##58##2##(1996-1#1)(2008-10#7)(2008-11#21)(2008-12#8)(2008-5#4)(2008-9#2)(2009-4#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#2)
the UL9 gene of##2##4##(1994-11#2)
the UL9 promoter##3##3##(1994-11#3)
the UL9##5##2##(1994-11#5)
the UNICEF##3##2##(2008-11#2)(2010-3#1)
the UPDRS##2##2##(2008-7#2)
the UR cell line##2##4##(2008-11#2)
the URA3##2##2##(2008-10#2)
the US Congress passed##2##4##(1994-8#1)(2008-8#1)
the US Congress##3##3##(1994-8#1)(2008-5#1)(2008-8#1)
the US Court of Appeals for the##2##7##(1995-6#2)
the US FDA##4##3##(2008-5#2)(2010-5#1)(2011-2#1)
the US Food and Drug Administration (FDA)##3##7##(2008-9#2)(2013-1#1)
the US Food and Drug Administration##4##6##(1995-8#1)(2008-9#2)(2013-1#1)
the US Food and Drug##5##5##(1995-8#1)(2008-11#1)(2008-9#2)(2013-1#1)
the US National##2##3##(2010-10#1)(2010-12#1)
the US ONCHIT##2##3##(2010-8#2)
the US Pharmacopoeia##2##3##(2008-10#2)
the US and Japan##2##4##(2008-5#1)(2010-12#1)
the US and##6##3##(2008-11#1)(2008-5#1)(2010-12#2)(2011-2#1)(2012-12#1)
the US government##2##3##(2008-11#1)(2009-3#1)
the US image##2##3##(1990-9#2)
the US population##3##3##(2008-9#1)(2010-5#1)(2010-8#1)
the US##81##2##(1990-2#1)(1990-9#2)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#5)(1995-8#1)(1996-9#4)(1997-2#3)(2008-10#9)(2008-11#5)(2008-5#10)(2008-8#2)(2008-9#3)(2009-3#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#3)(2010-8#5)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#3)
the US-1 genotype##3##3##(2008-10#3)
the US-1##8##2##(2008-10#8)
the US-8 genotype##4##3##(2008-10#4)
the US-8##9##2##(2008-10#9)
the USA and##4##3##(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)
the USA##12##2##(1997-8#1)(2008-5#1)(2008-8#1)(2009-4#5)(2010-11#2)(2010-12#1)(2013-8#1)
the USDA's Food Guide Pyramid diet##2##6##(2008-3#2)
the USEPA##2##2##(2008-10#2)
the USP and##2##3##(2008-5#1)(2012-2#1)
the USP##6##2##(2008-10#3)(2008-5#1)(2012-2#2)
the USSR##3##2##(1990-2#1)(1990-3#2)
the UV and##2##3##(2008-10#1)(2009-12#1)
the UV detection##2##3##(2008-10#2)
the UV radiation##2##3##(2011-2#2)
the UV spectra##2##3##(1996-5#1)(2008-10#1)
the UV##24##2##(1996-5#1)(2008-10#16)(2008-3#1)(2008-5#3)(2009-12#1)(2011-2#2)
the UV-VIS##2##2##(2008-10#1)(2010-11#1)
the UV-blocking capacity##2##3##(2008-5#2)
the UV-spectrophotometric##2##2##(2008-10#2)
the UV-vis spectra of##2##4##(2008-10#2)
the UV-vis##3##2##(2008-10#3)
the UVA protection##2##3##(2008-5#2)
the UVA##6##2##(2008-5#6)
the UVA/UVB ratio##3##3##(2008-5#3)
the UVA/UVB##4##2##(2008-5#4)
the UVS112 gene##2##3##(1995-9#2)
the Unified Parkinson's##2##3##(2008-7#2)
the Unified##4##2##(2008-7#2)(2012-3#1)(2013-8#1)
the UniformMu##3##2##(2012-3#3)
the United Kingdom##35##3##(1991-2#1)(1991-3#1)(1991-8#2)(1992-1#1)(1994-12#2)(1995-1#2)(1995-2#1)(2008-10#9)(2008-11#7)(2008-12#3)(2008-9#2)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
the United Kingdom's##2##3##(2008-11#1)(2012-3#1)
the United Nations##2##3##(1996-1#1)(2008-11#1)
the United States Department of##5##5##(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)
the United States Pharmacopeia##3##4##(2008-10#3)
the United States and Brazil##2##5##(2008-10#2)
the United States and Canada##14##5##(1991-12#1)(2007-12#1)(2008-10#10)(2012-2#2)
the United States and the##2##5##(1991-12#1)(2008-10#1)
the United States and##38##4##(1991-12#2)(1992-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#23)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
the United States are##3##4##(1991-2#1)(1993-1#1)(2011-2#1)
the United States as##3##4##(2008-10#1)(2009-5#1)(2011-1#1)
the United States has##2##4##(1997-2#1)(2008-10#1)
the United States have##4##4##(1993-3#2)(2008-10#1)(2013-1#1)
the United States in##9##4##(1993-2#1)(1994-1#1)(1994-2#1)(1995-8#1)(2008-10#5)
the United States to##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
the United States was##2##4##(2008-10#2)
the United States were tested##2##5##(2008-10#1)(2008-5#1)
the United States were##10##4##(2008-10#9)(2008-5#1)
the United States will##4##4##(1993-3#1)(1995-12#1)(1995-2#1)(2012-12#1)
the United States##303##3##(1991-1#1)(1991-12#6)(1991-2#1)(1991-3#3)(1991-8#3)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#2)(1993-2#6)(1993-3#7)(1994-1#1)(1994-12#3)(1994-2#3)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-1#3)(1997-2#4)(1997-3#6)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#128)(2008-11#10)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#5)(2009-7#1)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#17)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#10)(2013-8#6)
the United##351##2##(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#4)(1991-8#5)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#2)(1993-2#7)(1993-3#7)(1994-1#1)(1994-12#5)(1994-2#3)(1995-1#4)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1997-1#3)(1997-2#4)(1997-3#6)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#140)(2008-11#19)(2008-12#7)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#5)(2009-7#1)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#18)(2012-12#5)(2012-2#7)(2012-3#7)(2013-1#11)(2013-8#8)
the Universitary##2##2##(2008-5#1)(2012-3#1)
the University Hospital of the West Indies##2##7##(2011-2#2)
the University Hospital of##4##4##(1996-11#1)(2008-10#1)(2011-2#2)
the University Hospital##6##3##(1996-11#1)(2008-10#1)(2011-2#4)
the University of Alberta Hospitals##2##5##(1992-12#1)(1996-3#1)
the University of California##2##4##(2008-10#2)
the University of Dundee##3##4##(2008-11#2)(2008-12#1)
the University of Michigan##5##4##(1991-3#1)(1994-1#1)(1995-3#1)(1996-1#1)(2008-11#1)
the University of Toronto##3##4##(1991-1#1)(1991-2#1)(2008-11#1)
the University of Tromsø##2##4##(1993-6#2)
the University of the##2##4##(2011-2#2)
the University of##57##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1993-1#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-3#2)(1997-6#1)(2008-10#3)(2008-11#8)(2008-12#7)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#3)
the University##69##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1993-1#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-3#2)(1997-6#1)(2008-10#6)(2008-11#11)(2008-12#7)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#8)(2012-2#1)(2013-1#1)(2013-8#3)
the Upper##2##2##(2007-12#1)(2008-10#1)
the Use of##3##3##(2009-3#1)(2012-3#1)(2013-1#1)
the Use##4##2##(2009-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
the Ushuaia##2##2##(2008-3#2)
the V##3##2##(2008-10#3)
the V-PPase##2##2##(2008-11#2)
the VDR gene##2##3##(1997-7#1)(2013-1#1)
the VH##2##2##(1997-2#1)(1997-9#1)
the VHA has been##2##4##(2008-7#2)
the VIP-receptor##2##2##(1994-3#1)(1995-11#1)
the VLDL receptor##4##3##(1995-6#4)
the VP1 coding regions of##2##5##(2013-8#2)
the VP1##3##2##(2008-12#1)(2013-8#2)
the VP6##2##2##(2008-5#2)
the VSF##3##2##(2008-3#3)
the VT group##2##3##(2008-10#2)
the VT##3##2##(2008-10#3)
the VWA STR##2##3##(2008-12#2)
the VWA##3##2##(2008-12#3)
the Vatican##2##2##(1990-6#1)(1994-9#1)
the Vector##3##2##(2008-10#3)
the Venus flytrap##2##3##(2009-8#2)
the Venus##3##2##(1991-5#1)(2009-8#2)
the Vermont Academic Medical Center##2##5##(1994-2#2)
the Veterans Administration##2##3##(2009-11#1)(2012-12#1)
the Veterans Health Administration##2##4##(2008-7#2)
the Veterans##6##2##(1990-11#1)(2008-7#2)(2009-11#1)(2012-12#1)(2013-1#1)
the Veterinary##2##2##(1992-2#1)(1996-12#1)
the Vf gene##5##3##(2008-10#5)
the Vf##8##2##(2008-10#8)
the Vg##2##2##(2008-10#2)
the Vistula River##2##3##(2008-11#2)
the Vitamin##2##2##(2008-10#2)
the Vmax of##4##3##(1991-5#1)(1993-6#1)(1994-5#2)
the Vmax##7##2##(1990-2#1)(1991-5#1)(1993-6#2)(1994-5#2)(1994-8#1)
the W (VI)##2##3##(2008-10#2)
the W##3##2##(2008-10#3)
the WAN##4##2##(2010-3#4)
the WB##3##2##(2008-10#2)(2008-5#1)
the WGA diet##2##3##(2008-7#2)
the WGA-fed larvae##2##3##(2008-7#2)
the WHO##15##2##(1990-12#1)(1991-2#1)(1994-9#1)(1997-5#1)(2008-1#2)(2008-10#2)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
the WHOQOL-OLD##2##2##(2011-2#2)
the WRAP##3##2##(2008-11#3)
the WT##5##2##(1995-6#1)(2008-10#2)(2008-8#1)(2012-12#1)
the WT-voltammetric analyzer##2##3##(2008-10#2)
the WT1##2##2##(1991-10#2)
the WWTP##3##2##(2008-10#3)
the Washington##2##2##(1997-2#1)(2013-1#1)
the Wave Bioreactor##3##3##(2008-11#3)
the Wave##4##2##(2008-11#4)
the Web or##2##3##(2008-4#1)(2008-9#1)
the Web##6##2##(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)(2011-2#1)
the Weibull function##2##3##(2008-10#2)
the Weibull model##3##3##(2008-9#1)(2010-4#2)
the Weibull##8##2##(2008-10#4)(2008-9#2)(2010-4#2)
the Wellcome##2##2##(2008-7#2)
the West##10##2##(1995-1#1)(2008-10#4)(2010-8#1)(2011-2#4)
the Western Hemisphere##3##3##(2008-10#3)
the Western United States##2##4##(2008-10#2)
the Western##18##2##(1995-6#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
the WhiA##2##2##(2012-2#2)
the White House##2##3##(1994-12#1)(1995-6#1)
the Wilcoxon test##2##3##(1996-3#1)(2013-1#1)
the Wilcoxon##6##2##(1996-3#3)(1997-8#1)(2010-6#1)(2013-1#1)
the Wisconsin Card Sorting##2##4##(1995-5#1)(2008-7#1)
the Wisconsin biotype##3##3##(2008-10#3)
the Wisconsin##6##2##(1995-5#1)(1995-9#1)(2008-10#3)(2008-7#1)
the Wld(S) mutation##4##3##(1997-3#4)
the Wld(S)##5##2##(1997-3#5)
the Wnt##2##2##(2008-10#1)(2013-1#1)
the Working Group##2##3##(1996-6#1)(2007-9#1)
the Working##3##2##(1996-6#1)(2007-9#1)(2008-4#1)
the Worland##2##2##(2008-10#2)
the World AIDS Day##2##4##(1990-11#2)
the World Bank##2##3##(1997-8#2)
the World Health Organisation##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
the World Health Organization (WHO)##8##5##(1994-9#1)(1997-6#1)(2008-1#1)(2008-12#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
the World Health Organization##25##4##(1990-11#1)(1991-9#1)(1992-1#1)(1993-11#1)(1994-9#2)(1996-9#1)(1997-6#2)(2008-1#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#4)(2011-7#1)(2012-12#2)(2013-1#3)
the World Health##28##3##(1990-11#1)(1991-9#1)(1992-1#1)(1993-11#1)(1994-9#2)(1996-9#1)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#1)(2013-1#3)
the World Organisation for Animal Health##3##6##(2011-2#3)
the World Wide Web##5##4##(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#1)
the X and Y##3##4##(2008-7#1)(2008-8#1)(2010-5#1)
the X and##4##3##(2008-7#1)(2008-8#1)(2010-5#2)
the X chromosome##5##3##(1996-12#2)(2008-11#2)(2008-8#1)
the X##22##2##(1993-6#1)(1996-12#2)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-5#2)
the X-chromosome##4##2##(1990-8#1)(1994-11#1)(2008-12#2)
the X-ray structure##2##3##(1993-8#2)
the X-ray##9##2##(1992-12#1)(1993-8#2)(1996-5#1)(1997-8#1)(2008-10#1)(2013-8#3)
the XAD-8 resin##2##3##(2008-10#2)
the Xa22(t) locus##2##3##(2008-10#2)
the Xenopus##10##2##(1992-6#2)(1993-12#1)(1993-6#3)(1995-2#1)(1997-7#2)(2012-3#1)
the Xist gene##2##3##(1994-11#2)
the Y chromosome##2##3##(2008-8#1)(2012-3#1)
the Y##4##2##(2008-8#2)(2012-3#1)(2013-8#1)
the YAC##2##2##(1995-6#1)(1996-12#1)
the YG bead caused##2##4##(2008-6#2)
the Young's modulus##2##3##(2009-7#1)(2010-8#1)
the Young's##3##2##(2009-7#2)(2010-8#1)
the Z##5##2##(2007-12#1)(2008-6#3)(2010-5#1)
the ZP3##2##2##(2008-4#2)
the ZPA##3##2##(1993-12#3)
the Zea genus##2##3##(1995-12#2)
the Zea##3##2##(1995-12#2)(2009-8#1)
the Zeeman shift##2##3##(2008-2#2)
the Zeeman##5##2##(2008-2#2)(2008-3#3)
the Zn (-) treatment##2##4##(2013-8#2)
the Zn##7##2##(1993-12#1)(2008-10#3)(2010-11#1)(2013-8#2)
the Zn(2+)##2##2##(2008-10#2)
the Zone Diet##2##3##(2008-3#2)
the [K5HPg]##2##2##(1993-8#2)
the a##3##2##(2008-10#2)(2008-11#1)
the a3##2##2##(2008-10#1)(2008-8#1)
the aa sequence##4##3##(1990-5#1)(1991-6#1)(1993-2#1)(1993-6#1)
the aa##6##2##(1990-5#1)(1991-6#1)(1993-12#2)(1993-2#1)(1993-6#1)
the ab initio##2##3##(1996-5#2)
the abdomen and pelvis and##2##5##(2012-2#2)
the abdomen and##3##3##(1997-5#1)(2012-2#2)
the abdomen was##2##3##(1993-6#1)(2011-2#1)
the abdomen##21##2##(1990-9#1)(1991-9#1)(1992-5#1)(1993-6#1)(1995-3#2)(1997-3#1)(1997-5#2)(2007-12#1)(2008-11#1)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#2)
the abdominal aorta##4##3##(1997-8#3)(2010-11#1)
the abdominal cavity##4##3##(1991-2#1)(1993-6#1)(2011-2#1)(2013-1#1)
the abdominal wall##7##3##(1991-12#1)(1995-3#2)(1996-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
the abdominal##22##2##(1991-12#1)(1991-2#1)(1993-6#2)(1995-3#2)(1996-3#1)(1997-8#3)(2010-11#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
the aberrant##4##2##(1991-12#1)(2012-2#2)(2012-3#1)
the abilities of##2##3##(1992-8#1)(1995-8#1)
the abilities##6##2##(1992-8#1)(1995-8#1)(2008-11#1)(2008-9#1)(2010-2#2)
the ability and##3##3##(1994-9#1)(1995-12#1)(2008-11#1)
the ability of C##4##4##(2008-10#3)(2011-1#1)
the ability of Trichoderma spp##2##5##(2008-10#2)
the ability of a##9##4##(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
the ability of cells##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
the ability of in vitro##2##5##(2008-8#1)(2008-9#1)
the ability of some##2##4##(2008-10#2)
the ability of specific##2##4##(1996-3#1)(2008-11#1)
the ability of the##31##4##(1993-6#1)(1995-11#1)(1995-8#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-5#3)(2008-9#2)(2009-9#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)
the ability of these##8##4##(1992-12#1)(1992-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#2)
the ability of this##4##4##(1990-2#1)(1995-5#1)(2008-10#1)(2008-5#1)
the ability of##154##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-5#3)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#46)(2008-11#15)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#10)(2008-7#4)(2008-8#6)(2008-9#9)(2009-1#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
the ability to be##6##4##(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
the ability to bind##2##4##(1990-5#1)(1994-12#1)
the ability to cause##2##4##(2008-10#2)
the ability to communicate##3##4##(2008-11#1)(2013-1#2)
the ability to detect##2##4##(2008-11#1)(2010-4#1)
the ability to diagnose it during life##2##7##(2008-7#2)
the ability to diagnose##3##4##(1995-3#1)(2008-7#2)
the ability to differentiate##5##4##(1990-5#1)(1991-12#1)(2008-11#1)(2008-9#2)
the ability to discriminate##2##4##(1993-8#1)(2008-10#1)
the ability to form H-bonds##2##5##(1992-10#2)
the ability to form##3##4##(1992-10#2)(2008-10#1)
the ability to generate##2##4##(2008-7#1)(2008-9#1)
the ability to grow on##2##5##(2008-10#1)(2008-8#1)
the ability to handle##3##4##(2008-10#1)(2008-4#2)
the ability to induce the##2##5##(2008-10#2)
the ability to induce##9##4##(2006-6#1)(2008-10#6)(2008-8#1)(2011-2#1)
the ability to infect##2##4##(2008-10#2)
the ability to maintain##2##4##(2008-8#1)(2012-3#1)
the ability to make##4##4##(2011-2#3)(2012-2#1)
the ability to multiply##2##4##(1995-2#1)(2008-10#1)
the ability to organize##2##4##(1994-3#1)(1997-6#1)
the ability to penetrate##2##4##(2008-10#1)(2008-8#1)
the ability to produce##8##4##(2008-10#7)(2012-2#1)
the ability to proliferate##2##4##(2008-11#2)
the ability to recognize##2##4##(1991-2#1)(2008-5#1)
the ability to resolve##2##4##(2008-3#1)(2008-9#1)
the ability to understand##2##4##(1993-1#1)(2010-11#1)
the ability to##143##3##(1990-11#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-10#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-2#4)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-11#1)(2008-10#43)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#10)(2009-7#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#5)
the ability##302##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-10#3)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-12#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#3)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#90)(2008-11#26)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#12)(2008-9#19)(2009-1#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#13)(2012-12#1)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#7)(2013-8#3)
the abiotic##2##2##(2008-10#2)
the ablation of##2##3##(1995-2#1)(2009-10#1)
the ablation##6##2##(1995-2#1)(2008-11#2)(2008-3#1)(2009-10#1)(2011-2#1)
the abnormal EF group##2##4##(2011-2#2)
the abnormal##10##2##(1990-5#1)(1991-6#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#2)(2012-2#1)
the abolition##2##2##(1994-11#1)(2008-10#1)
the abomasum##5##2##(1991-8#1)(2011-2#4)
the abortion##2##2##(1996-5#1)(2008-8#1)
the above conditions##2##3##(2008-10#1)(2011-3#1)
the above findings##4##3##(1997-8#1)(2008-10#3)
the above mentioned##18##3##(1990-9#1)(1996-2#1)(2008-10#12)(2010-6#1)(2011-2#1)(2012-3#2)
the above parameters##4##3##(1994-5#1)(1995-9#1)(2008-8#1)(2013-1#1)
the above procedure has been successfully employed for##2##8##(2008-10#2)
the above questions##2##3##(1991-1#1)(1992-2#1)
the above results##4##3##(1994-8#1)(2008-10#2)(2012-2#1)
the above two##3##3##(1991-5#1)(1995-11#1)(2008-4#1)
the above##93##2##(1990-9#4)(1991-1#2)(1991-5#1)(1991-6#1)(1992-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#39)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
the above-mentioned##10##2##(1997-8#2)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)
the abovementioned##3##2##(2008-10#2)(2011-2#1)
the abrasives##2##2##(2008-5#2)
the abrupt##2##2##(1995-6#1)(2008-11#1)
the abscissa##2##2##(2008-10#2)
the absence and presence of##11##5##(1994-11#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-5#1)
the absence and##12##3##(1994-11#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-5#1)
the absence of ATP##2##4##(1993-6#1)(1993-8#1)
the absence of a##20##4##(1990-5#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#2)
the absence of aminoacylation##3##4##(1997-3#3)
the absence of an##3##4##(2008-7#1)(2008-9#1)(2009-10#1)
the absence of any##11##4##(1991-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#1)(2012-12#1)
the absence of competitive##2##4##(1992-2#1)(2008-8#1)
the absence of data##2##4##(2008-10#1)(2008-9#1)
the absence of direct##2##4##(1992-6#1)(2008-7#1)
the absence of estrogen##2##4##(1997-7#1)(2008-6#1)
the absence of exogenous##2##4##(2008-11#1)(2012-3#1)
the absence of glucose##2##4##(1995-8#2)
the absence of glutamine##2##4##(2008-11#2)
the absence of light##3##4##(1993-8#1)(1994-8#1)(2009-8#1)
the absence of serum##4##4##(2008-11#4)
the absence of such##5##4##(1991-12#1)(1991-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
the absence of the##23##4##(1991-9#1)(1992-3#1)(1993-9#1)(1994-6#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the absence of these##3##4##(1993-8#1)(2008-11#1)(2009-10#1)
the absence of##321##3##(1990-11#5)(1990-2#2)(1990-5#3)(1990-6#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-6#5)(1993-8#7)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#4)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#2)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#3)(2007-12#4)(2007-8#1)(2008-10#62)(2008-11#34)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#19)(2008-9#14)(2009-1#1)(2009-10#5)(2009-11#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#12)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#3)
the absence or##7##3##(1990-2#1)(1994-8#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
the absence##343##2##(1990-11#5)(1990-2#3)(1990-5#3)(1990-6#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-6#5)(1993-8#7)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#4)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#4)(1995-8#6)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#2)(1997-3#3)(1997-6#1)(1997-7#3)(1997-8#3)(2007-12#4)(2007-8#1)(2008-10#67)(2008-11#37)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#19)(2008-9#15)(2009-1#1)(2009-10#5)(2009-11#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#14)(2012-12#3)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#3)
the absolute EC50/IC50##2##3##(2012-2#2)
the absolute and##2##3##(2008-10#1)(2012-3#1)
the absolute concentration of##2##4##(2008-10#2)
the absolute number of##4##4##(1991-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
the absolute number##5##3##(1991-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)
the absolute##31##2##(1991-3#1)(1992-2#1)(1992-6#2)(1993-8#1)(1995-5#1)(1995-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2011-3#2)(2012-2#2)(2012-3#1)
the absorbance and fluorescence spectra were##2##6##(2008-10#2)
the absorbance and fluorescence##3##4##(2008-10#3)
the absorbance and##4##3##(2008-10#4)
the absorbance at##5##3##(2008-10#5)
the absorbance of MB##2##4##(2008-10#2)
the absorbance of the dye##2##5##(2008-10#2)
the absorbance of the formed##2##5##(2008-10#2)
the absorbance of the##19##4##(2008-10#19)
the absorbance of##29##3##(2008-10#29)
the absorbance values and##2##4##(2008-10#2)
the absorbance values##3##3##(2008-10#3)
the absorbance versus the##2##4##(2008-10#2)
the absorbance versus##4##3##(2008-10#4)
the absorbance##65##2##(2008-10#63)(2008-8#1)(2013-1#1)
the absorbances##2##2##(2008-10#2)
the absorbed##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
the absorbing solution##3##3##(2008-10#3)
the absorbing##4##2##(2008-10#4)
the absorption and##5##3##(2008-10#1)(2008-3#2)(2008-5#1)(2009-12#1)
the absorption band##2##3##(2008-10#2)
the absorption coefficient##5##3##(2008-3#5)
the absorption cross section##2##4##(2008-3#2)
the absorption efficiency and single-scattering albedo of##3##7##(2008-3#3)
the absorption maximum of##3##4##(2008-10#1)(2008-8#2)
the absorption maximum##6##3##(1994-5#2)(2008-10#2)(2008-8#2)
the absorption of Hct##2##4##(2011-3#2)
the absorption of##13##3##(1997-1#1)(2007-12#1)(2008-10#4)(2008-3#2)(2011-3#5)
the absorption signal##3##3##(2008-10#2)(2008-3#1)
the absorption spectra of the##4##5##(2008-10#4)
the absorption spectra of##9##4##(2008-10#8)(2008-9#1)
the absorption spectra##12##3##(2008-10#9)(2008-3#2)(2008-9#1)
the absorption spectrum##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
the absorption##74##2##(1994-5#2)(1997-1#1)(2007-12#1)(2008-10#29)(2008-11#2)(2008-2#1)(2008-3#22)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2011-3#6)
the abstract##4##2##(2008-11#1)(2009-4#3)
the abundance of the##2##4##(1994-6#1)(2008-9#1)
the abundance of##17##3##(1994-11#1)(1994-2#3)(1994-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#4)(2009-6#1)(2009-8#1)(2010-8#1)
the abundance of C##2##3##(2012-3#2)
the abundance##22##2##(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#4)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#2)
the abundances of##2##3##(1994-2#1)(2008-9#1)
the abundances##3##2##(1994-2#1)(2008-8#1)(2008-9#1)
the abundant##8##2##(1990-5#1)(1992-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-8#1)(2012-2#1)
the abuse##2##2##(2010-7#1)(2012-3#1)
the academic community##3##3##(1990-2#1)(1996-1#1)(2008-10#1)
the academic engagement##2##3##(2008-12#2)
the academic performance and##2##4##(2013-8#2)
the academic performance##8##3##(2013-8#8)
the academic##23##2##(1990-2#2)(1991-8#1)(1993-6#1)(1996-1#1)(2008-10#1)(2008-11#4)(2008-12#4)(2010-1#1)(2013-8#8)
the accelerated failure time model##2##5##(2008-10#2)
the accelerated##4##2##(2008-1#1)(2008-10#2)(2012-2#1)
the accelerating effect of##3##4##(2008-10#2)(2008-11#1)
the accelerating##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
the acceleration##3##2##(1996-2#1)(2008-2#1)(2013-8#1)
the acceptability and##2##3##(2009-11#1)(2010-10#1)
the acceptability of##3##3##(2009-11#1)(2011-2#1)(2013-1#1)
the acceptability##6##2##(2008-7#1)(2009-11#2)(2010-10#1)(2011-2#1)(2013-1#1)
the acceptable##4##2##(2008-10#3)(2008-11#1)
the acceptance##3##2##(1995-2#1)(2008-10#2)
the accepted##4##2##(1991-3#1)(1993-3#1)(1997-8#1)(2008-10#1)
the acceptor stream##4##3##(2008-10#4)
the acceptor##14##2##(1995-6#1)(1996-5#1)(2008-10#12)
the access of the##2##4##(2008-10#1)(2009-8#1)
the access of##5##3##(1993-8#1)(2008-10#2)(2009-8#1)(2011-2#1)
the access##6##2##(1993-8#1)(1994-2#1)(2008-10#2)(2009-8#1)(2011-2#1)
the accessible##4##2##(1995-2#1)(1997-6#1)(2008-11#2)
the accessory nerve##2##3##(2008-7#2)
the accessory nuclei##2##3##(2007-12#1)(2008-7#1)
the accessory##9##2##(2007-12#1)(2008-10#1)(2008-7#5)(2012-2#1)(2013-1#1)
the accident##5##2##(1990-9#2)(1995-11#1)(2009-10#2)
the acclimation phase##2##3##(2008-7#2)
the acclimation##3##2##(2008-7#3)
the accompanying##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
the accumulated##6##2##(1990-8#1)(1994-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
the accumulation and##2##3##(2008-10#2)
the accumulation of a##2##4##(1995-12#1)(2011-2#1)
the accumulation of malonyl-CoA##2##4##(1995-6#2)
the accumulation of sequence##2##4##(1995-8#1)(1997-2#1)
the accumulation of the##6##4##(2008-10#5)(2008-7#1)
the accumulation of these##2##4##(2008-10#1)(2011-1#1)
the accumulation of##59##3##(1990-5#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-6#5)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#26)(2008-11#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
the accumulation time##4##3##(2008-10#4)
the accumulation##72##2##(1990-5#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#5)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#36)(2008-11#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
the accuracy and precision of##4##5##(2008-10#4)
the accuracy and precision##6##4##(2008-10#6)
the accuracy and reproducibility of##3##5##(2008-10#2)(2008-9#1)
the accuracy and the##4##4##(2008-10#3)(2010-8#1)
the accuracy and##20##3##(2008-10#14)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-8#1)
the accuracy for the##2##4##(2008-10#2)
the accuracy for##3##3##(1994-12#1)(2008-10#2)
the accuracy in##3##3##(2008-10#3)
the accuracy of the analysis##2##5##(2008-10#1)(2012-2#1)
the accuracy of the developed method##4##6##(2008-10#4)
the accuracy of the method##3##5##(2008-10#3)
the accuracy of the procedure##2##5##(2008-10#1)(2010-5#1)
the accuracy of the proposed method##3##6##(2008-10#3)
the accuracy of the proposed##6##5##(2008-10#6)
the accuracy of the results##2##5##(2008-10#1)(2008-3#1)
the accuracy of the technique##2##5##(2008-10#1)(2008-3#1)
the accuracy of the##36##4##(1992-2#1)(1993-1#1)(2008-10#22)(2008-2#1)(2008-3#5)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#2)
the accuracy of##63##3##(1990-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-3#2)(2007-12#1)(2008-10#26)(2008-11#1)(2008-2#1)(2008-3#8)(2008-6#1)(2009-12#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
the accuracy was##2##3##(2008-10#2)
the accuracy##102##2##(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-3#2)(2007-12#1)(2008-10#55)(2008-11#2)(2008-2#1)(2008-3#9)(2008-6#2)(2008-9#1)(2009-11#1)(2009-12#2)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
the accurate analysis of##2##4##(2008-10#1)(2008-2#1)
the accurate determination of##3##4##(2008-10#3)
the accurate##15##2##(1994-3#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)
the acetate##7##2##(1997-2#2)(2008-10#2)(2008-7#2)(2011-1#1)
the acetoxy##2##2##(1996-5#2)
the acetylcholinesterase##5##2##(2008-10#1)(2008-11#3)(2012-2#1)
the achievable##2##2##(2008-10#1)(2008-3#1)
the achievement of a##2##4##(1994-3#1)(1996-2#1)
the achievement of##8##3##(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-2#1)
the achievement##9##2##(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2012-2#1)
the achievements of the##2##4##(2008-12#2)
the achievements of##3##3##(1995-1#1)(2008-12#2)
the achievements##4##2##(1995-1#1)(2008-12#2)(2009-5#1)
the acid and the##2##4##(2008-10#1)(2008-9#1)
the acid and##3##3##(2008-10#2)(2008-9#1)
the acid##25##2##(2008-10#22)(2008-7#2)(2008-9#1)
the acid-base behaviour of##2##4##(2008-10#2)
the acid-base properties of##2##4##(2008-10#2)
the acid-base properties##3##3##(2008-10#3)
the acid-base##9##2##(2008-10#9)
the acid-extractable##2##2##(2008-10#2)
the acid-washed PM 1648 instilled##2##5##(2008-10#2)
the acid-washed PM 1648##3##4##(2008-10#3)
the acidic and##3##3##(2008-10#3)
the acidic hydrolysis of lorazepam##2##5##(2008-10#2)
the acidic##20##2##(1994-5#1)(2006-6#1)(2008-10#16)(2008-7#1)(2010-12#1)
the acidification##2##2##(2008-10#1)(2012-3#1)
the acidity and##2##3##(2008-10#2)
the acidity of the##4##4##(2008-10#4)
the acidity of##6##3##(2008-10#6)
the acidity##13##2##(2008-10#13)
the acids##4##2##(2008-10#3)(2008-5#1)
the acinar##2##2##(1992-8#1)(2008-7#1)
the acorn barnacle##5##3##(1990-5#4)(1993-6#1)
the acoustic measures##2##3##(2011-1#2)
the acoustic##6##2##(1996-2#1)(2008-3#1)(2009-3#1)(2009-5#1)(2011-1#2)
the acquired immunodeficiency syndrome (AIDS)##2##5##(1990-6#1)(1993-12#1)
the acquired immunodeficiency syndrome##3##4##(1990-6#1)(1991-12#1)(1993-12#1)
the acquired##14##2##(1990-6#1)(1991-12#1)(1993-12#1)(2008-10#2)(2008-5#1)(2009-3#3)(2009-8#1)(2010-3#1)(2012-3#1)(2013-1#2)
the acquisition and##2##3##(2008-10#1)(2008-11#1)
the acquisition of a##2##4##(1993-6#2)
the acquisition of data##2##4##(2008-10#1)(2008-7#1)
the acquisition of the##2##4##(1991-2#1)(2009-3#1)
the acquisition of##24##3##(1991-2#1)(1992-2#1)(1993-3#1)(1993-6#2)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#2)(2013-1#1)
the acquisition##31##2##(1991-2#1)(1992-2#1)(1993-3#1)(1993-6#2)(1994-8#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#2)(2013-1#1)
the acronym of##2##3##(2008-3#1)(2011-2#1)
the acronym##3##2##(1996-12#1)(2008-3#1)(2011-2#1)
the acrosomal membrane##2##3##(1994-8#2)
the acrosomal##4##2##(1994-8#3)(2007-12#1)
the acrosome reaction##7##3##(2008-8#7)
the acrosome##11##2##(2008-7#4)(2008-8#7)
the act of##2##3##(2009-10#1)(2013-1#1)
the act##3##2##(1994-1#1)(2009-10#1)(2013-1#1)
the actin cytoskeleton in##2##4##(2008-11#2)
the actin cytoskeleton##13##3##(1996-12#2)(1996-2#1)(2008-11#5)(2008-9#2)(2009-7#2)(2011-2#1)
the actin gene##2##3##(2008-10#2)
the actin##23##2##(1992-3#3)(1996-12#2)(1996-2#1)(2008-10#2)(2008-11#8)(2008-9#3)(2009-7#3)(2011-2#1)
the actin-binding site##2##3##(1993-8#2)
the actin-binding##3##2##(1993-8#3)
the actin-related protein centractin (Arp-1)##2##5##(1995-2#2)
the actinobacterial family Cellulomonadaceae##2##4##(2011-2#2)
the actinobacterial family##3##3##(2011-2#3)
the actinobacterial##4##2##(2011-2#4)
the action of a##5##4##(2008-10#3)(2008-3#1)(2010-3#1)
the action of insulin##2##4##(1996-2#1)(2008-11#1)
the action of the##5##4##(1992-3#2)(2008-11#1)(2011-2#1)(2012-3#1)
the action of this##2##4##(1994-3#1)(1997-2#1)
the action of##54##3##(1990-2#1)(1991-5#1)(1992-3#2)(1992-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-12#3)(1995-8#1)(1996-2#1)(1997-2#3)(2008-10#7)(2008-11#7)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
the action potential##2##3##(1996-2#1)(2008-11#1)
the action##67##2##(1990-2#1)(1990-9#2)(1991-3#1)(1991-5#1)(1992-3#2)(1992-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#3)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#3)(2008-10#7)(2008-11#10)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)
the action-perception cycle##2##3##(2008-11#2)
the actions of##12##3##(1990-8#1)(1991-12#1)(1991-9#1)(1993-2#1)(1997-1#1)(2008-10#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-9#1)
the activated macrophages##3##3##(2008-11#2)(2009-12#1)
the activated partial##2##3##(1996-6#1)(2008-9#1)
the activated polycarbonate##3##3##(2008-10#3)
the activated##26##2##(1991-9#1)(1993-6#1)(1994-2#1)(1996-2#1)(1996-6#1)(1997-7#2)(2008-10#13)(2008-11#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)
the activating effect of ET-1##2##5##(1994-8#2)
the activating##3##2##(1994-11#1)(1994-8#2)
the activation energy for the##2##5##(2008-10#2)
the activation energy for##5##4##(2008-10#4)(2012-2#1)
the activation energy##7##3##(1990-2#1)(2008-10#5)(2012-2#1)
the activation of NADPH oxidase##2##5##(1993-6#1)(1994-6#1)
the activation of a##6##4##(1992-8#1)(1994-2#1)(1995-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
the activation of complement##2##4##(1993-3#2)
the activation of either##2##4##(1996-2#2)
the activation of protein kinase C##2##6##(1990-8#1)(1993-6#1)
the activation of protein##4##4##(1990-8#1)(1993-6#1)(1995-11#1)(2008-7#1)
the activation of quiescent##2##4##(2008-10#2)
the activation of the##10##4##(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#2)(1997-2#2)(2008-5#1)(2011-3#1)(2012-2#1)
the activation of various##2##4##(2008-11#1)(2010-7#1)
the activation of##70##3##(1990-8#1)(1991-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#3)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#2)(1995-2#3)(1995-6#3)(1996-2#4)(1997-2#2)(1997-3#1)(1997-4#1)(2006-6#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#4)(2008-8#3)(2009-12#2)(2009-6#1)(2010-7#2)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-8#1)
the activation parameters for the interconversion between the alpha- and beta-conformations of fac-Re(CO)(3)(dpknph)Cl##2##13##(2008-10#2)
the activation state of##2##4##(1995-6#1)(2008-9#1)
the activation##96##2##(1990-2#2)(1990-8#1)(1991-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#3)(1993-6#4)(1993-8#3)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-11#2)(1995-2#3)(1995-6#5)(1996-2#4)(1997-2#2)(1997-3#3)(1997-4#1)(2006-6#1)(2008-10#13)(2008-11#3)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#3)(2009-12#2)(2009-6#1)(2010-7#2)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-8#1)
the activator##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
the active channel##2##3##(1997-8#2)
the active components of##2##4##(2008-10#2)
the active components##3##3##(2008-10#3)
the active compound##2##3##(2008-10#2)
the active compounds##3##3##(2008-10#2)(2010-7#1)
the active immunoglobulin heavy chain gene##2##6##(2008-11#2)
the active ingredient##6##3##(2008-10#1)(2008-5#5)
the active ingredients##3##3##(2008-5#2)(2010-9#1)
the active material##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
the active oxygen##2##3##(1994-5#1)(2008-8#1)
the active participation of##2##4##(1993-3#1)(2008-10#1)
the active principle##3##3##(2008-10#3)
the active region##2##3##(2008-8#2)
the active ret##2##3##(1993-8#2)
the active site nucleophile##2##4##(1995-6#2)
the active site of the enzyme##2##6##(1990-9#1)(1994-5#1)
the active site of##15##4##(1990-2#1)(1990-9#1)(1991-5#2)(1992-6#1)(1994-5#7)(1994-8#1)(1995-6#1)(2008-8#1)
the active site##35##3##(1990-2#1)(1990-5#2)(1990-9#1)(1991-3#2)(1991-5#3)(1992-4#2)(1992-6#2)(1993-8#1)(1994-5#10)(1994-8#1)(1995-6#4)(1995-8#1)(1996-8#1)(1997-6#1)(2008-8#2)(2010-11#1)
the active sites##2##3##(2008-10#1)(2012-12#1)
the active species##2##3##(1990-5#1)(1993-6#1)
the active substance##4##3##(1990-5#1)(2008-10#3)
the active transport of##2##4##(1990-9#1)(2011-2#1)
the active##136##2##(1990-2#2)(1990-5#4)(1990-9#2)(1991-3#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-12#1)(1992-4#2)(1992-6#5)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#4)(1993-9#1)(1994-3#1)(1994-5#11)(1994-8#2)(1995-11#1)(1995-6#5)(1995-8#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#34)(2008-11#6)(2008-2#1)(2008-3#2)(2008-5#10)(2008-7#1)(2008-8#9)(2009-11#1)(2009-8#1)(2010-11#3)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
the active-site##3##2##(1994-5#2)(1995-6#1)
the activities of the##7##4##(1991-12#1)(1992-2#1)(1994-8#1)(1995-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
the activities of these##2##4##(1994-8#1)(2008-9#1)
the activities of##25##3##(1990-3#2)(1991-12#1)(1992-2#1)(1992-6#1)(1994-8#2)(1995-5#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the activities##31##2##(1990-3#2)(1991-12#1)(1992-2#1)(1992-6#1)(1994-5#1)(1994-8#2)(1995-5#1)(1997-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the activity and##5##3##(1994-8#1)(2008-10#1)(2008-11#2)(2009-10#1)
the activity in##2##3##(1993-3#1)(2008-11#1)
the activity of NK cells##2##5##(2008-10#2)
the activity of a##5##4##(1995-2#2)(2009-8#1)(2011-3#1)(2012-3#1)
the activity of both##2##4##(2008-10#1)(2008-11#1)
the activity of cytosolic##2##4##(1990-5#1)(1991-5#1)
the activity of phospholipase A2##2##5##(1994-5#2)
the activity of phospholipase##3##4##(1994-5#2)(2011-2#1)
the activity of recombinant##2##4##(2008-10#1)(2011-2#1)
the activity of the enzyme##3##5##(1996-2#1)(2008-9#1)(2009-6#1)
the activity of the##32##4##(1991-12#1)(1991-5#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
the activity of this##3##4##(1990-5#1)(1994-8#1)(1997-2#1)
the activity of various##2##4##(1994-12#1)(1994-8#1)
the activity of##147##3##(1990-11#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#3)(1994-6#3)(1994-8#6)(1994-9#1)(1995-11#2)(1995-2#5)(1995-5#2)(1995-6#1)(1996-2#5)(1997-1#2)(1997-2#5)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#3)(2008-10#20)(2008-11#9)(2008-12#2)(2008-5#5)(2008-7#2)(2008-8#7)(2008-9#9)(2009-3#2)(2009-6#1)(2009-8#4)(2010-12#2)(2010-9#1)(2011-2#4)(2011-3#3)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
the activity profile during the host infection process and the effect of lipase activity inhibitor ebelactone B on infection##2##19##(2010-10#2)
the activity therapies##2##3##(1993-2#2)
the activity was##4##3##(1990-2#1)(1994-11#1)(2008-10#1)(2013-1#1)
the activity##183##2##(1990-11#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1993-2#2)(1993-3#3)(1993-8#2)(1994-11#3)(1994-12#3)(1994-5#3)(1994-6#3)(1994-8#8)(1994-9#1)(1995-11#2)(1995-2#5)(1995-5#2)(1995-6#2)(1996-2#5)(1996-3#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#3)(2008-10#27)(2008-11#14)(2008-12#2)(2008-5#5)(2008-7#2)(2008-8#9)(2008-9#9)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#4)(2011-3#3)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#3)
the actor effect##2##3##(2013-8#2)
the actor##5##2##(2008-11#2)(2013-8#3)
the actual capacity (equipment##2##4##(2008-10#2)
the actual concentrations##2##3##(2008-10#2)
the actual mechanism##2##3##(1993-6#1)(2008-11#1)
the actual use of medicines##2##5##(2008-11#2)
the actual##58##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-11#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#2)(2010-7#1)(2011-2#3)(2012-3#1)
the actuarial##2##2##(1990-6#1)(2011-2#1)
the actuation##2##2##(2010-4#2)
the acupoints of left HM##3##5##(2008-9#3)
the acupoints of##4##3##(2008-9#4)
the acute and chronic##4##4##(1991-9#1)(1997-1#1)(2008-5#1)(2013-1#1)
the acute and##5##3##(1991-9#1)(1997-1#1)(2008-5#1)(2008-9#1)(2013-1#1)
the acute care##4##3##(1996-2#1)(2010-4#1)(2013-1#2)
the acute coronary##2##3##(2008-3#1)(2010-12#1)
the acute effects of##2##4##(1993-8#1)(1997-2#1)
the acute phase of##10##4##(1997-5#6)(2008-12#1)(2008-7#1)(2013-1#2)
the acute phase response##3##4##(1992-9#1)(1993-12#1)(1994-6#1)
the acute phase##14##3##(1992-9#1)(1993-12#1)(1994-6#1)(1997-5#6)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#2)
the acute##49##2##(1990-12#1)(1990-9#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-5#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#2)(2013-1#6)
the acyclic##4##2##(1990-9#2)(1996-5#1)(2008-10#1)
the acyl chain##2##3##(1993-8#1)(1994-5#1)
the acyl##6##2##(1991-3#1)(1993-8#1)(1994-5#1)(1996-5#1)(2008-10#2)
the acylation##3##2##(1990-5#2)(1997-4#1)
the adaptation of##5##3##(1990-12#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-11#1)
the adaptation##9##2##(1990-12#1)(1992-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2010-1#1)(2011-1#1)
the adapted##2##2##(2008-7#1)(2013-8#1)
the adaptive immune response##2##4##(2008-10#1)(2009-10#1)
the adaptive immune##4##3##(2008-1#1)(2008-10#1)(2009-10#1)(2013-8#1)
the adaptive response##2##3##(2008-7#1)(2013-1#1)
the adaptive value of##2##4##(2008-8#1)(2009-8#1)
the adaptive##20##2##(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#2)
the adaptor protein##2##3##(2013-1#2)
the added##12##2##(1993-12#1)(1994-5#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-8#2)(2011-2#2)(2013-1#1)
the addition of 0##2##4##(2008-10#2)
the addition of Cu##2##4##(2008-11#2)
the addition of a known##2##5##(2008-10#1)(2008-9#1)
the addition of a##10##4##(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#1)(2013-1#1)
the addition of an##4##4##(1992-9#1)(2008-10#2)(2011-2#1)
the addition of exogenous genes##2##5##(2012-3#2)
the addition of exogenous##3##4##(2008-11#1)(2012-3#2)
the addition of muramyl##2##4##(2008-11#2)
the addition of salt##3##4##(2008-10#3)
the addition of small##3##4##(2008-10#3)
the addition of sodium##3##4##(2008-10#3)
the addition of the##13##4##(1990-8#2)(1992-12#1)(1995-1#2)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-8#1)
the addition of water##2##4##(2008-10#1)(2009-8#1)
the addition of##165##3##(1990-8#3)(1991-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1996-1#1)(1996-12#1)(1997-1#3)(1997-8#1)(2007-11#1)(2008-10#74)(2008-11#29)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#4)
the addition or##2##3##(2009-8#2)
the addition##170##2##(1990-8#3)(1991-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1996-1#1)(1996-12#1)(1997-1#3)(1997-8#1)(2007-11#1)(2008-10#75)(2008-11#30)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#4)
the additional advantage##2##3##(2008-10#2)
the additional##20##2##(1991-3#1)(1992-12#1)(1992-5#1)(1994-5#2)(1995-11#1)(1996-3#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)
the additive##8##2##(1996-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)
the additivity##2##2##(1992-3#1)(2008-10#1)
the adduct formation##2##3##(2008-10#2)
the adduct##4##2##(1991-5#1)(2008-10#3)
the adducts##2##2##(2008-10#2)
the adenine##3##2##(1993-1#1)(1994-5#1)(2008-10#1)
the adenosine receptor##4##3##(1993-3#1)(1994-5#1)(1995-8#2)
the adenosine##6##2##(1993-3#1)(1993-6#1)(1994-5#1)(1995-8#2)(2008-4#1)
the adenovirus##4##2##(1992-9#1)(1993-2#1)(2008-11#2)
the adenylate##2##2##(1996-2#1)(1996-6#1)
the adequacy of a##2##4##(1990-11#1)(2008-11#1)
the adequacy of##12##3##(1990-11#1)(1991-1#1)(1992-12#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-3#2)(2008-11#2)(2008-5#1)(2012-3#1)
the adequate##6##2##(1993-6#1)(2008-10#1)(2010-6#1)(2011-2#2)(2012-12#1)
the adherence##3##2##(2008-10#2)(2011-2#1)
the adherent##7##2##(1990-8#1)(2008-10#3)(2008-11#3)
the adhesion of the##2##4##(2008-10#1)(2012-2#1)
the adhesion of##4##3##(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
the adhesion to the##2##4##(2008-11#1)(2012-3#1)
the adhesion##14##2##(1992-1#1)(2008-10#3)(2008-11#5)(2008-5#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
the adhesive##4##2##(1994-9#1)(2008-5#2)(2008-9#1)
the adipocyte##2##2##(1994-12#1)(2008-11#1)
the adipogenic program##2##3##(2012-2#2)
the adipogenic##3##2##(2012-2#3)
the adipose##2##2##(1994-12#1)(2008-10#1)
the adjacent##20##2##(1990-11#1)(1990-5#1)(1991-12#1)(1994-11#1)(1995-6#1)(1996-5#2)(1997-3#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2013-1#2)
the adjustment of the##2##4##(2008-2#1)(2008-7#1)
the adjustment##7##2##(1991-1#1)(1992-12#2)(2008-2#1)(2008-7#1)(2009-12#1)(2013-8#1)
the adjustments##2##2##(1991-1#1)(1992-12#1)
the administration of RS extract##2##5##(2008-11#2)
the administration of a##2##4##(1994-3#1)(2012-2#1)
the administration of the##5##4##(1993-1#1)(1996-6#1)(2007-11#1)(2008-12#1)(2013-1#1)
the administration of##30##3##(1990-11#1)(1991-12#1)(1993-1#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-11#4)(2008-12#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
the administration##32##2##(1990-11#1)(1991-12#2)(1993-1#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-11#4)(2008-12#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#2)
the administrative##6##2##(1993-2#1)(1995-12#1)(1997-2#1)(2012-3#3)
the administrator##2##2##(1992-2#1)(1994-2#1)
the admission##5##2##(1990-9#1)(1991-2#2)(1997-2#1)(2008-3#1)
the adolescent##11##2##(1990-12#3)(1990-6#1)(1993-3#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-7#2)(2013-1#1)
the adolescents reported##2##3##(1993-3#1)(2010-11#1)
the adolescents##3##2##(1990-2#1)(1993-3#1)(2010-11#1)
the adoption of a##3##4##(1995-1#1)(1995-9#1)(2008-10#1)
the adoption of the##6##4##(1993-3#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-8#1)(2012-3#1)
the adoption of##21##3##(1991-12#2)(1993-3#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
the adoption##22##2##(1991-12#2)(1993-3#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
the adoptive##2##2##(2009-11#1)(2011-2#1)
the adrenal cortex##6##3##(1990-11#1)(1990-5#2)(2008-4#1)(2011-1#1)(2011-2#1)
the adrenal gland##7##3##(1990-5#1)(1991-6#1)(2008-12#1)(2011-2#3)(2013-1#1)
the adrenal medulla##3##3##(1990-5#2)(1996-12#1)
the adrenal##21##2##(1990-11#1)(1990-5#5)(1991-5#3)(1991-6#1)(1996-12#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#1)
the adrenals##2##2##(2008-4#1)(2012-2#1)
the adsorbate##2##2##(2008-10#2)
the adsorbed elements##2##3##(2008-10#2)
the adsorbed##15##2##(1990-12#1)(2008-10#13)(2011-2#1)
the adsorbent surface##2##3##(2008-10#2)
the adsorbent##10##2##(2008-10#10)
the adsorbents##4##2##(1997-2#1)(2008-10#3)
the adsorption and##2##3##(2008-10#1)(2008-7#1)
the adsorption capacities##2##3##(2008-10#2)
the adsorption constant##2##3##(2008-10#2)
the adsorption equilibrium##2##3##(2008-10#2)
the adsorption of atrazine onto a##2##6##(2008-10#2)
the adsorption of the##3##4##(2008-10#3)
the adsorption of##20##3##(2008-10#20)
the adsorption process##2##3##(2008-10#2)
the adsorption##45##2##(1997-2#2)(2008-10#41)(2008-7#1)(2011-2#1)
the adsorptive##5##2##(2008-10#4)(2008-11#1)
the adult and##3##3##(1991-12#1)(2007-12#1)(2013-7#1)
the adult brain##2##3##(1996-12#1)(2008-7#1)
the adult mice##2##3##(2008-9#1)(2012-3#1)
the adult mouse##3##3##(1995-2#1)(2008-11#2)
the adult population##8##3##(1996-6#1)(1997-2#1)(2008-11#1)(2008-8#3)(2010-7#1)(2013-1#1)
the adult rat testis##2##4##(2009-10#1)(2012-2#1)
the adult rat##9##3##(1991-12#1)(1996-12#3)(1997-3#2)(2008-11#1)(2009-10#1)(2012-2#1)
the adult stage##6##3##(1990-3#2)(2008-10#4)
the adult##83##2##(1990-11#1)(1990-3#2)(1990-5#2)(1991-12#3)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#2)(1994-8#1)(1995-2#2)(1996-12#8)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#8)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)
the adults##6##2##(2008-12#1)(2008-9#3)(2010-8#1)(2012-12#1)
the advanced stages of##2##4##(2007-12#1)(2008-10#1)
the advanced##7##2##(1992-12#1)(1994-12#1)(2007-12#1)(2008-10#2)(2010-12#2)
the advancement of##5##3##(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)
the advances in##6##3##(1996-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2012-2#1)(2013-1#1)
the advances##9##2##(1996-2#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#1)
the advantage of a##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
the advantage of being##4##4##(2008-10#2)(2008-11#1)(2008-4#1)
the advantage of reduced##3##4##(2011-2#2)(2012-3#1)
the advantage of specificity##2##4##(2008-10#2)
the advantage of using##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
the advantage of##45##3##(1990-11#1)(1991-1#1)(1991-3#1)(1994-3#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-10#18)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#4)(2010-12#1)(2011-2#4)(2012-3#1)(2012-5#1)(2013-1#2)
the advantage that##6##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-5#1)
the advantage##54##2##(1990-11#1)(1991-1#1)(1991-3#1)(1992-3#1)(1994-3#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-10#20)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#5)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#2)(2012-5#1)(2013-1#2)
the advantages and disadvantages of each##2##6##(2011-2#1)(2013-8#1)
the advantages and disadvantages of the##2##6##(2008-10#1)(2009-5#1)
the advantages and disadvantages of##7##5##(1991-1#1)(2008-10#2)(2009-5#2)(2011-2#1)(2013-8#1)
the advantages and disadvantages##8##4##(1991-1#1)(2008-10#3)(2009-5#2)(2011-2#1)(2013-8#1)
the advantages and limitations of the##2##6##(2008-10#1)(2008-9#1)
the advantages and limitations of##4##5##(2008-10#2)(2008-9#1)(2012-3#1)
the advantages and limitations##5##4##(1994-1#1)(2008-10#2)(2008-9#1)(2012-3#1)
the advantages and##19##3##(1991-1#1)(1994-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the advantages of a##2##4##(1994-3#1)(1997-1#1)
the advantages of low resistance##2##5##(2008-10#2)
the advantages of simplicity##2##4##(2008-10#2)
the advantages of the##3##4##(1994-9#1)(1996-3#1)(2008-12#1)
the advantages of this##3##4##(1993-1#1)(2008-10#1)(2008-11#1)
the advantages of##42##3##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-6#1)(2010-7#2)(2012-3#1)(2013-1#1)
the advantages##72##2##(1990-12#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#2)(2010-12#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the advent of##13##3##(1996-11#1)(1996-2#1)(1996-6#1)(2008-11#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the adventitia##5##2##(1991-8#1)(1997-3#1)(1997-8#3)
the adventitial##3##2##(1992-12#1)(1997-1#1)(2010-4#1)
the adverse consequences of##2##4##(1993-3#1)(2008-11#1)
the adverse consequences##3##3##(1992-2#1)(1993-3#1)(2008-11#1)
the adverse effect of##4##4##(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#1)
the adverse effects of##4##4##(1996-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
the adverse effects##5##3##(1992-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
the adverse outcomes##2##3##(2008-11#1)(2009-9#1)
the adverse##21##2##(1992-2#1)(1992-3#1)(1993-3#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
the advisability of##2##3##(1992-2#1)(1995-1#1)
the aeciospores##2##2##(2008-10#2)
the aerial parts##2##3##(2008-11#2)
the aerial##3##2##(2008-11#3)
the aero-optic linking equation##2##4##(2008-3#2)
the aerobic##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
the aerodynamic size##2##3##(1992-3#2)
the aerodynamic##4##2##(1992-3#2)(2008-11#1)(2008-3#1)
the aerosol and##2##3##(1991-1#1)(1992-3#1)
the aerosol backscattering##2##3##(2008-3#2)
the aerosol bolus##2##3##(1997-1#2)
the aerosol size distribution##2##4##(2008-3#2)
the aerosol was##2##3##(1992-2#1)(1994-12#1)
the aerosol##31##2##(1991-1#2)(1992-2#1)(1992-3#4)(1994-12#3)(1995-3#2)(1996-2#2)(1996-3#1)(1997-1#2)(2008-10#3)(2008-2#1)(2008-3#10)
the aerosols##5##2##(1992-2#1)(2008-10#2)(2008-3#2)
the aesthetic##4##2##(1990-9#1)(2008-5#1)(2008-9#1)(2013-1#1)
the aetiological##3##2##(2008-5#1)(2008-7#1)(2010-1#1)
the aetiologies##2##2##(1995-10#1)(2008-12#1)
the aetiology and##3##3##(1997-1#1)(2008-12#1)(2008-7#1)
the aetiology of##13##3##(1992-5#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-2#1)
the aetiology##17##2##(1992-5#1)(1997-1#2)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-2#1)
the affect##3##2##(1993-6#1)(1994-2#1)(2008-11#1)
the affected knee##2##3##(2008-12#1)(2013-1#1)
the affected##25##2##(1990-3#1)(1991-3#1)(1991-8#1)(1993-3#1)(1994-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#6)(2012-2#2)(2013-1#3)
the afferent##4##2##(1997-3#1)(2008-10#1)(2008-7#2)
the affinities of##3##3##(1991-9#1)(1993-8#1)(2008-10#1)
the affinity between##2##3##(2008-10#2)
the affinity constant of the##2##5##(2008-10#2)
the affinity constant##6##3##(1991-5#1)(2008-10#5)
the affinity of P1 for DNA##2##6##(1992-6#2)
the affinity of protein kinase C for##2##7##(1994-5#2)
the affinity of sIL-1R for##2##5##(1995-2#2)
the affinity of the##6##4##(1993-6#1)(1993-8#1)(1994-5#1)(1997-4#1)(2008-8#2)
the affinity of##18##3##(1990-2#1)(1990-8#1)(1992-6#2)(1993-6#2)(1993-8#1)(1994-5#3)(1995-2#2)(1995-8#1)(1996-2#1)(1997-4#1)(2008-11#1)(2008-8#2)
the affinity##34##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-6#2)(1993-1#1)(1993-6#2)(1993-8#1)(1994-5#4)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)
the aforementioned##10##2##(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the after##2##2##(1991-12#1)(2012-2#1)
the afternoon##4##2##(1993-12#1)(2008-3#1)(2008-5#1)(2010-5#1)
the agar surface##4##3##(2008-10#4)
the agar##8##2##(2008-10#6)(2008-12#1)(2012-2#1)
the agarose gel##2##3##(2008-10#2)
the agarose##3##2##(2008-10#2)(2008-8#1)
the agate industry##2##3##(2009-12#2)
the age and##5##3##(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#2)
the age at which##3##4##(2008-10#1)(2008-8#1)(2009-5#1)
the age at##5##3##(2008-10#1)(2008-8#1)(2009-5#1)(2010-3#1)(2012-2#1)
the age distribution of##2##4##(1997-8#1)(2009-7#1)
the age group of##2##4##(2008-11#1)(2008-7#1)
the age group##9##3##(1990-12#1)(1990-2#1)(1990-6#1)(1993-11#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-3#2)
the age groups##2##3##(1991-6#1)(2008-7#1)
the age of 10##2##4##(2008-5#1)(2008-9#1)
the age of 18##2##4##(1991-11#1)(2011-2#1)
the age of 3##4##4##(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
the age of 30##3##4##(1991-8#1)(2008-11#1)(2009-10#1)
the age of 4##2##4##(1995-12#1)(1996-11#1)
the age of 40 years##2##5##(2008-5#2)
the age of 40##6##4##(2008-5#2)(2008-7#1)(2012-3#3)
the age of 5##2##4##(1997-3#1)(2010-6#1)
the age of 50##5##4##(1994-12#2)(2008-5#2)(2011-2#1)
the age of 6##3##4##(1997-3#1)(2008-7#1)(2013-1#1)
the age of 75##3##4##(1997-8#1)(2011-2#1)(2013-7#1)
the age of a##5##4##(1996-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
the age of one year##2##5##(1990-12#1)(1994-6#1)
the age of the##11##4##(1990-6#1)(1990-9#1)(1994-11#1)(1997-6#2)(2008-10#3)(2008-6#1)(2008-9#1)(2011-2#1)
the age of##81##3##(1990-12#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-11#1)(1996-3#3)(1997-3#4)(1997-6#2)(1997-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#7)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
the age range##5##3##(2008-7#4)(2013-1#1)
the age related changes##2##4##(2008-12#1)(2011-2#1)
the age##116##2##(1990-12#2)(1990-2#1)(1990-6#3)(1990-9#1)(1991-11#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-5#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-11#1)(1996-3#4)(1997-3#4)(1997-6#2)(1997-8#3)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#4)(2009-10#1)(2009-5#3)(2009-7#2)(2010-10#2)(2010-3#1)(2010-6#1)(2011-2#9)(2012-2#1)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#1)
the age-adjusted death##2##3##(1997-7#1)(2008-10#1)
the age-adjusted##4##2##(1997-7#1)(2008-10#1)(2012-3#2)
the age-related changes##2##3##(1990-3#1)(2008-7#1)
the age-related##7##2##(1990-3#1)(1995-6#1)(1996-2#1)(2008-7#2)(2011-2#2)
the age-specific##2##2##(1992-5#1)(2008-7#1)
the aged rat##2##3##(1992-12#1)(1994-2#1)
the aged##13##2##(1990-11#1)(1991-1#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-8#2)(1996-2#3)(2011-2#1)
the aged-care##2##2##(2010-10#2)
the aged]##2##2##(1991-11#1)(1996-2#1)
the ageing process##3##3##(1992-11#1)(2008-5#1)(2008-7#1)
the ageing##6##2##(1992-11#1)(1995-8#1)(2008-10#1)(2008-5#2)(2008-7#1)
the agency's##2##2##(1992-8#1)(1995-6#1)
the agent##7##2##(1991-3#2)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#1)
the agents##11##2##(1990-6#1)(1994-6#1)(1997-2#1)(2008-10#3)(2008-8#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
the ages of##5##3##(1990-2#1)(1995-12#1)(1995-8#1)(2008-9#1)(2012-2#1)
the ages##6##2##(1990-2#1)(1993-2#1)(1995-12#1)(1995-8#1)(2008-9#1)(2012-2#1)
the aggrecan mRNA##2##3##(1992-1#1)(2008-11#1)
the aggrecan##6##2##(1992-1#5)(2008-11#1)
the aggregate##9##2##(1994-5#1)(1996-3#1)(2008-10#2)(2009-3#1)(2010-3#1)(2012-2#2)(2013-1#1)
the aggregated##5##2##(2008-10#2)(2008-8#1)(2009-10#2)
the aggregates##2##2##(2008-10#2)
the aggregation of##7##3##(2008-10#4)(2009-8#1)(2010-6#1)(2013-1#1)
the aggregation##10##2##(2008-10#5)(2008-5#1)(2009-8#1)(2010-6#1)(2013-1#2)
the aggressive##8##2##(2008-10#6)(2009-3#1)(2011-2#1)
the aggressiveness of##3##3##(2008-10#2)(2012-3#1)
the aging of the population##2##5##(1992-1#1)(1996-3#1)
the aging of##4##3##(1992-1#2)(1996-3#1)(2008-10#1)
the aging population##2##3##(1996-8#1)(2008-12#1)
the aging process##10##3##(1994-2#1)(1995-6#1)(1997-2#4)(2008-10#3)(2008-11#1)
the aging##20##2##(1992-1#2)(1994-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)
the agitation##2##2##(2008-10#1)(2013-1#1)
the agonist concentration##3##3##(1994-6#3)
the agonist##5##2##(1994-6#3)(2012-2#2)
the agonists##3##2##(1995-11#1)(1995-12#1)(2008-9#1)
the agranular##3##2##(1994-2#1)(2008-5#2)
the agreement between##4##3##(2008-10#3)(2008-3#1)
the agreement##7##2##(1995-6#1)(2008-10#4)(2008-3#2)
the agricultural##5##2##(1991-6#1)(1996-3#1)(2008-10#2)(2008-11#1)
the agrochemical##2##2##(1997-7#1)(2008-10#1)
the agroecological##2##2##(2008-10#1)(2013-8#1)
the aid of the##5##4##(1991-6#1)(1991-8#1)(1992-9#1)(2008-10#2)
the aid of##31##3##(1990-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1994-11#1)(1997-6#1)(2008-10#20)(2008-11#2)(2008-3#1)(2008-5#1)(2013-1#1)
the aim is to##3##4##(1991-12#1)(2008-10#1)(2011-3#1)
the aim of the present study was to##3##8##(2008-12#1)(2011-2#1)(2012-12#1)
the aim of the present study##4##6##(2008-12#1)(2009-10#1)(2011-2#1)(2012-12#1)
the aim of the present##5##5##(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
the aim of the##6##4##(2008-10#1)(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
the aim of this study to##2##6##(1990-11#1)(2008-11#1)
the aim of this study was to##2##7##(2008-7#1)(2012-3#1)
the aim of this study##4##5##(1990-11#1)(2008-11#1)(2008-7#1)(2012-3#1)
the aim of this##6##4##(1990-11#1)(1994-5#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-3#1)
the aim of##42##3##(1990-11#1)(1992-2#1)(1993-11#1)(1994-5#2)(1995-8#1)(1996-11#1)(1997-3#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
the aim to##11##3##(1990-9#1)(1992-6#1)(2008-10#3)(2008-11#2)(2009-12#1)(2010-11#1)(2012-2#1)(2013-1#1)
the aim##58##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-5#2)(1995-8#1)(1996-11#1)(1997-3#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the aims of##3##3##(1997-7#1)(2011-3#1)(2012-2#1)
the air sample##3##3##(2008-10#3)
the air samples##5##3##(2008-10#5)
the air temperature was##2##4##(2008-6#2)
the air temperature##4##3##(2008-10#1)(2008-6#3)
the air##47##2##(1990-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#3)(2009-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
the air-acetylene flame##2##3##(2008-10#2)
the air-acetylene##3##2##(2008-10#3)
the airborne##3##2##(2008-10#2)(2008-3#1)
the aircraft##4##2##(1996-12#1)(2008-3#3)
the airway and##2##3##(1992-2#1)(1997-1#1)
the airway circulation##4##3##(1996-1#1)(1997-1#3)
the airway epithelium##2##3##(1997-2#2)
the airway is##2##3##(1996-1#1)(2010-7#1)
the airway sealing pressure##3##4##(2010-7#3)
the airway##29##2##(1992-2#4)(1994-2#1)(1994-6#1)(1995-12#1)(1996-1#3)(1996-12#1)(1997-1#6)(1997-2#2)(2008-10#1)(2008-12#3)(2010-12#1)(2010-5#1)(2010-7#4)
the airways and the##2##4##(1996-12#1)(2009-1#1)
the airways of the##2##4##(1997-1#2)
the airways of##5##3##(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#2)
the airways##21##2##(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-2#1)(1996-12#1)(1997-1#10)(1997-2#2)(2009-1#1)(2010-7#1)(2012-2#1)
the alane decomposition and##2##4##(2010-4#2)
the alanine##2##2##(2008-11#2)
the alarming##2##2##(1996-1#1)(2013-1#1)
the albumin concentration##2##3##(1993-8#1)(2008-10#1)
the albumin secretion##3##3##(2008-11#3)
the albumin##7##2##(1990-8#1)(1993-8#1)(2008-10#1)(2008-11#4)
the alcohol in the##2##4##(2008-10#1)(2008-7#1)
the alcohol##18##2##(1992-7#1)(1994-11#1)(1994-6#1)(1997-8#1)(2008-10#7)(2008-7#2)(2009-8#1)(2010-7#2)(2011-1#1)(2013-8#1)
the alcoholic##4##2##(1991-1#1)(1995-2#1)(2008-10#2)
the aldehyde##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
the alfalfa##4##2##(2008-10#4)
the algae##4##2##(2008-10#4)
the alginate##3##2##(2008-11#2)(2008-7#1)
the algorithm is##2##3##(2008-10#1)(2008-6#1)
the algorithm##13##2##(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#4)(2009-12#1)(2013-1#2)
the algorithms##3##2##(2008-3#2)(2013-1#1)
the aligning forces for quality initiative##3##6##(2013-1#3)
the alignment##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
the alkali metal##5##3##(2008-10#5)
the alkali##7##2##(2008-10#7)
the alkaline hydrothermal conversion of##2##5##(2008-10#2)
the alkaline##12##2##(1990-12#1)(1992-3#1)(1993-12#2)(2008-10#6)(2008-11#1)(2008-9#1)
the alkene##2##2##(1996-5#2)
the alkyl chain##3##3##(1995-11#1)(2008-10#1)(2008-5#1)
the alkyl##7##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#3)
the alkylphenols##4##2##(2008-10#2)(2008-11#2)
the all##2##2##(1990-12#1)(2007-8#1)
the all-trans##2##2##(1991-5#1)(1992-9#1)
the alleged##3##2##(1996-5#1)(2008-10#2)
the allele##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
the alleles##2##2##(1997-8#1)(2008-8#1)
the allelic##5##2##(1995-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
the allergen##2##2##(2008-10#2)
the alliances'##2##2##(2013-1#2)
the alligator gar##3##3##(2008-7#3)
the allocation of##8##3##(1991-6#1)(1995-12#1)(2008-11#2)(2008-8#4)
the allograft group##2##3##(2009-3#1)(2012-3#1)
the allograft##4##2##(2008-10#1)(2009-3#1)(2012-3#2)
the allometric##2##2##(2008-8#1)(2010-8#1)
the allosteric interaction##4##3##(1995-11#4)
the allosteric##5##2##(1995-11#4)(2008-4#1)
the alloy##3##2##(2008-10#1)(2009-7#2)
the alloys##2##2##(2009-7#1)(2013-1#1)
the allozyme##2##2##(2008-10#1)(2008-9#1)
the almond##3##2##(2008-10#2)(2008-11#1)
the almost##4##2##(1992-12#1)(1995-2#1)(2009-8#1)(2013-1#1)
the alpha 1 (I) promoter##2##5##(1991-5#2)
the alpha 1 (I)##3##4##(1991-5#3)
the alpha 1 beta 1 dimer##3##6##(1993-8#3)
the alpha 1##7##3##(1991-5#3)(1993-8#3)(1996-2#1)
the alpha 2##2##3##(1992-8#1)(1993-8#1)
the alpha 2(I) promoter##2##4##(1991-5#2)
the alpha 2(I)##3##3##(1991-5#3)
the alpha 5##2##3##(1992-2#1)(1995-11#1)
the alpha 7##4##3##(1996-12#3)(2010-8#1)
the alpha and beta subunits of##5##6##(1991-10#1)(1993-2#2)(1993-6#1)(1995-11#1)
the alpha and beta subunits##7##5##(1990-8#1)(1991-10#1)(1992-6#1)(1993-2#2)(1993-6#1)(1995-11#1)
the alpha and beta##8##4##(1990-8#1)(1991-10#1)(1992-6#1)(1993-2#2)(1993-6#1)(1995-11#1)(2008-10#1)
the alpha subunit of calcium/calmodulin-dependent protein kinase II##2##8##(1995-2#2)
the alpha subunit of calcium/calmodulin-dependent##3##5##(1995-2#2)(1996-12#1)
the alpha subunit of##7##4##(1994-12#1)(1994-2#1)(1995-2#2)(1996-12#1)(2008-7#1)(2012-2#1)
the alpha subunit##10##3##(1992-6#1)(1994-12#1)(1994-2#1)(1995-2#2)(1995-8#1)(1996-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
the alpha##60##2##(1990-8#2)(1991-10#1)(1991-5#7)(1992-2#2)(1992-6#2)(1992-8#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#5)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#3)(1995-11#6)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
the alpha- and##6##3##(1992-3#1)(1995-3#1)(2008-10#4)
the alpha-##7##2##(1992-3#1)(1994-5#1)(1995-3#1)(2008-10#4)
the alpha-[PMo(12)O(40)](3-) complex##2##3##(2008-10#2)
the alpha-[PMo(12)O(40)](3-)##3##2##(2008-10#3)
the alpha-cycloadduct##2##2##(1996-5#2)
the alpha-meso##2##2##(1994-5#2)
the alpha-phosphate##2##2##(1993-8#2)
the alpha-subunit of##2##3##(1991-3#2)
the alpha-subunit##5##2##(1991-3#4)(1995-6#1)
the alpha-toxin gene##2##3##(2010-6#2)
the alpha-toxin##4##2##(2010-6#4)
the alpha/alpha'##2##2##(1992-6#2)
the alpha2##3##2##(2008-11#3)
the already known##2##3##(2008-12#1)(2011-2#1)
the already##6##2##(2007-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
the alteration of the##2##4##(1993-8#1)(2008-10#1)
the alteration of##6##3##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
the alteration##8##2##(1993-8#1)(2008-10#1)(2008-8#3)(2008-9#1)(2011-2#2)
the alterations and##2##3##(1992-12#1)(2013-1#1)
the alterations in##2##3##(2008-7#2)
the alterations of##2##3##(1991-3#1)(2013-8#1)
the alterations##7##2##(1991-3#1)(1992-12#1)(1992-5#1)(2008-7#2)(2013-1#1)(2013-8#1)
the altered mineral metabolism of CKD##2##6##(2009-1#2)
the altered mineral metabolism of##3##5##(2009-1#3)
the altered mineral metabolism##4##4##(2009-1#4)
the altered##23##2##(1990-5#1)(1992-1#2)(1993-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-1#4)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the alternata##2##2##(2008-10#2)
the alternate##7##2##(1993-12#1)(2008-10#4)(2008-2#2)
the alternating##3##2##(2008-10#2)(2009-6#1)
the alternative oxidase (AOX)##2##4##(2008-9#1)(2009-8#1)
the alternative oxidase##3##3##(1991-5#1)(2008-9#1)(2009-8#1)
the alternative procedure##3##3##(2008-10#1)(2008-11#2)
the alternative splicing##2##3##(1993-8#1)(1995-12#1)
the alternative##21##2##(1990-9#1)(1991-5#1)(1993-3#1)(1993-8#1)(1995-12#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#3)(2012-3#1)(2013-1#1)(2013-8#1)
the alternatives##4##2##(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#1)
the altitude##2##2##(2008-2#1)(2008-3#1)
the aluminium matrix##2##3##(2008-10#2)
the aluminium##6##2##(2008-10#6)
the aluminum##2##2##(1995-5#1)(2010-4#1)
the alveolar##9##2##(1992-12#2)(1994-12#1)(1995-12#1)(1995-8#2)(1997-1#1)(2010-12#1)(2013-1#1)
the amaranth method for##2##4##(2008-10#2)
the amaranth method##3##3##(2008-10#3)
the amaranth##4##2##(2008-10#3)(2008-11#1)
the ambient air##2##3##(1995-3#1)(2008-10#1)
the ambient atmosphere##2##3##(2008-11#2)
the ambient temperature##2##3##(2008-10#2)
the ambient thermal conditions##2##4##(2008-6#2)
the ambient##14##2##(1995-3#1)(2008-10#7)(2008-11#3)(2008-6#2)(2010-7#1)
the ambiguity##3##2##(1992-4#1)(2008-12#1)(2010-11#1)
the ambiguous##2##2##(2008-11#1)(2008-5#1)
the amendment##2##2##(1995-6#1)(1996-5#1)
the amide##7##2##(1991-3#1)(1996-5#1)(2008-10#3)(2008-12#1)(2011-2#1)
the amine and##2##3##(2008-10#2)
the amine group##3##3##(2008-10#3)
the amine##10##2##(1996-5#1)(2008-10#8)(2010-4#1)
the amino acid at position##2##5##(2008-10#2)
the amino acid composition of the##3##6##(1990-8#1)(1993-8#1)(2008-9#1)
the amino acid composition##4##4##(1990-8#1)(1993-8#1)(2008-10#1)(2008-9#1)
the amino acid content##2##4##(1994-8#1)(2008-11#1)
the amino acid level##2##4##(1991-9#1)(2008-8#1)
the amino acid residues##2##4##(2008-10#1)(2009-8#1)
the amino acid sequence of the##5##6##(1990-5#1)(1991-12#1)(1993-8#1)(1996-12#1)(2008-10#1)
the amino acid sequence of##11##5##(1990-5#1)(1991-12#1)(1992-10#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-12#2)(1997-8#1)(2008-10#1)(2008-9#1)
the amino acid sequence##18##4##(1990-5#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-12#2)(1997-8#1)(2008-10#2)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
the amino acid sequences of##2##5##(2008-10#2)
the amino acid sequences##3##4##(2008-10#2)(2010-5#1)
the amino acid substitutions##2##4##(1997-9#1)(2008-10#1)
the amino acid##58##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-9#2)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-8#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#2)(1997-1#1)(1997-3#1)(1997-8#1)(1997-9#1)(2008-10#17)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#2)
the amino acids##9##3##(1994-12#1)(1995-12#1)(2008-10#3)(2008-11#3)(2011-1#1)
the amino group of the##2##5##(1992-3#1)(2008-10#1)
the amino group of##4##4##(1992-3#2)(2008-10#2)
the amino group##6##3##(1991-3#1)(1992-3#2)(2008-10#3)
the amino terminus##8##3##(1991-10#1)(1995-2#1)(1996-12#2)(1997-8#1)(2008-10#1)(2008-11#2)
the amino##87##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#2)(1995-12#2)(1995-2#3)(1995-8#1)(1996-12#4)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#2)(1997-9#1)(2008-10#26)(2008-11#9)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
the amino-terminal##4##2##(1995-6#2)(1996-8#1)(1997-6#1)
the aminoacid##2##2##(1992-9#2)
the ammine-complexes##2##2##(2008-10#2)
the ammonia##4##2##(2008-10#2)(2008-11#2)
the ammonium##3##2##(2008-10#2)(2008-12#1)
the amniotic fluid##2##3##(1990-9#1)(2008-9#1)
the amniotic##4##2##(1990-9#1)(2008-10#1)(2008-9#2)
the amorphous content of a##2##5##(2008-10#2)
the amorphous content of##4##4##(2008-10#4)
the amorphous content##5##3##(2008-10#5)
the amorphous##8##2##(2008-10#7)(2010-8#1)
the amount and##4##3##(1990-5#1)(1995-11#1)(2008-10#1)(2008-5#1)
the amount of B-GOx##2##4##(2008-10#2)
the amount of active ingredient delivered to the scalp##2##9##(2008-5#2)
the amount of anesthetic medicine to be applied##2##8##(2010-8#2)
the amount of aromatase##2##4##(1993-8#2)
the amount of arsenic##2##4##(2008-10#2)
the amount of black carbon##2##5##(2008-3#2)
the amount of blood##2##4##(1994-3#2)
the amount of chemical##2##4##(2008-10#2)
the amount of disease##2##4##(2008-10#2)
the amount of dust##2##4##(1992-12#1)(2008-11#1)
the amount of energy delivered##3##5##(2008-9#1)(2013-1#2)
the amount of energy##4##4##(2008-9#2)(2013-1#2)
the amount of information##2##4##(1997-3#1)(2008-7#1)
the amount of intracellular##2##4##(2008-11#2)
the amount of pathogen DNA present in the##2##8##(2008-10#2)
the amount of pathogen DNA##3##5##(2008-10#3)
the amount of pathogen##4##4##(2008-10#4)
the amount of reagent##2##4##(2008-10#2)
the amount of released##2##4##(2009-8#2)
the amount of residual##2##4##(2008-10#1)(2009-7#1)
the amount of resources##2##4##(2008-10#1)(2008-8#1)
the amount of sample##3##4##(2008-10#3)
the amount of spread##2##4##(2008-10#2)
the amount of the##11##4##(1992-6#3)(2008-10#6)(2008-8#1)(2009-8#1)
the amount of time elapsed between##2##6##(1996-3#1)(2008-11#1)
the amount of time##5##4##(1996-3#1)(2008-11#2)(2008-12#1)(2011-2#1)
the amount of##215##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#5)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#98)(2008-11#19)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#10)(2009-10#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#4)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
the amount##232##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#5)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#101)(2008-11#19)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#10)(2009-10#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#4)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
the amounts of iron transferred to the palm##2##8##(2008-10#2)
the amounts of the##2##4##(2008-10#1)(2008-6#1)
the amounts of##24##3##(1991-11#1)(1994-11#2)(1995-2#1)(1997-2#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2013-1#1)
the amounts##30##2##(1991-11#1)(1994-11#2)(1995-1#1)(1995-2#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-12#3)(2008-5#2)(2008-6#2)(2011-2#1)(2013-1#1)
the amperometric detection of##7##4##(2008-10#7)
the amperometric response of##2##4##(2008-10#2)
the amperometric response##4##3##(2008-10#4)
the amperometric##24##2##(2008-10#24)
the amphibian##4##2##(1996-2#1)(1997-3#1)(2008-12#1)(2008-9#1)
the amphiphilic##4##2##(1991-10#1)(1994-11#1)(1994-5#2)
the ampicillin##2##2##(2008-10#1)(2011-1#1)
the amplification of a##2##4##(2008-10#2)
the amplification of##13##3##(1991-6#1)(1993-2#1)(1994-3#1)(1997-7#1)(2008-10#7)(2008-11#2)
the amplification##18##2##(1991-6#2)(1993-2#1)(1994-3#1)(1997-7#2)(2008-10#9)(2008-11#2)(2009-5#1)
the amplified DNA##2##3##(1993-12#1)(2011-2#1)
the amplified fragment length polymorphism##3##5##(2008-10#3)
the amplified fragment##4##3##(1996-8#1)(2008-10#3)
the amplified products##3##3##(2008-10#2)(2012-2#1)
the amplified##17##2##(1993-12#1)(1996-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#2)
the amplifier##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
the amplitude and##4##3##(1990-12#1)(1996-2#1)(2008-3#1)(2011-2#1)
the amplitude matrix for a nonspherical particle in##2##8##(2008-3#2)
the amplitude of the NANC##2##5##(1997-4#2)
the amplitude of the##6##4##(1993-3#1)(1994-2#1)(1997-4#2)(2008-10#1)(2008-7#1)
the amplitude of##8##3##(1993-3#1)(1994-2#1)(1997-4#3)(2007-12#1)(2008-10#1)(2008-7#1)
the amplitude##15##2##(1990-12#1)(1993-3#1)(1994-2#1)(1996-2#1)(1997-4#3)(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#2)(2011-2#1)
the amygdala and##4##3##(1993-6#2)(1994-2#1)(2008-11#1)
the amygdala does##2##3##(1993-6#1)(2008-11#1)
the amygdala in##3##3##(1991-1#1)(1992-6#1)(2008-11#1)
the amygdala is##3##3##(1992-6#1)(2008-11#2)
the amygdala##34##2##(1991-1#2)(1991-10#2)(1992-6#3)(1993-6#8)(1994-2#3)(1996-12#2)(1996-5#2)(2008-11#9)(2009-10#1)(2013-8#2)
the amylase from##2##3##(2008-10#2)
the amyloid##5##2##(1992-12#2)(2008-5#2)(2011-2#1)
the anabolic##2##2##(1992-6#1)(2008-11#1)
the anaerobic##6##2##(1990-12#1)(1991-12#1)(2010-12#1)(2011-2#2)(2013-1#1)
the anaesthetic management of##2##4##(2010-7#1)(2011-2#1)
the anaesthetic##4##2##(1991-6#1)(2010-7#2)(2011-2#1)
the anagen hair percentage##2##4##(2008-5#2)
the anal canal##2##3##(2013-1#2)
the anal##5##2##(1997-8#1)(2013-1#4)
the analgesic effect of morphine##2##5##(1996-2#2)
the analgesic effect##3##3##(1991-2#1)(1996-2#2)
the analgesic##8##2##(1991-2#1)(1993-1#1)(1996-2#2)(1997-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
the analog##2##2##(1997-6#2)
the analogous##6##2##(1994-5#1)(1996-5#1)(2008-10#2)(2010-7#2)
the analogue##3##2##(1994-11#1)(1994-8#2)
the analogues of##2##3##(2008-10#1)(2011-2#1)
the analogues##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
the analysed samples in the##2##5##(2008-10#2)
the analysed samples##4##3##(2008-10#4)
the analysed##7##2##(2008-10#7)
the analyses of##13##3##(1995-5#1)(2008-10#12)
the analyses##26##2##(1994-12#1)(1995-5#1)(1997-7#1)(2008-10#20)(2008-11#1)(2011-2#1)(2013-8#1)
the analysis and##8##3##(1992-3#1)(1993-2#1)(2008-10#3)(2008-4#2)(2013-1#1)
the analysis by##3##3##(2008-10#2)(2008-9#1)
the analysis for##2##3##(2008-10#2)
the analysis is##5##3##(1992-9#1)(2008-10#3)(2008-9#1)
the analysis of a##5##4##(2008-10#5)
the analysis of aroma##2##4##(2008-10#2)
the analysis of biological##2##4##(2008-10#2)
the analysis of both##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
the analysis of cancer##2##4##(1994-2#1)(2009-12#1)
the analysis of certified reference material##2##6##(2008-10#2)
the analysis of certified reference materials and##3##7##(2008-10#3)
the analysis of certified reference materials##8##6##(2008-10#8)
the analysis of certified reference##11##5##(2008-10#11)
the analysis of certified##12##4##(2008-10#12)
the analysis of complex##2##4##(1997-2#1)(2008-10#1)
the analysis of data##3##4##(1997-2#1)(2008-10#1)(2011-8#1)
the analysis of different##3##4##(2007-8#1)(2008-10#2)
the analysis of environmental##2##4##(2008-10#2)
the analysis of four certified reference##2##6##(2008-10#2)
the analysis of major##2##4##(2008-10#2)
the analysis of organic##3##4##(2008-10#2)(2008-11#1)
the analysis of patients##2##4##(2011-2#1)(2013-1#1)
the analysis of pharmaceutical##4##4##(2008-10#4)
the analysis of potable##2##4##(2008-10#2)
the analysis of proteins and##2##5##(2008-10#1)(2008-9#1)
the analysis of real samples##3##5##(2008-10#3)
the analysis of real##7##4##(2008-10#6)(2008-2#1)
the analysis of serum##2##4##(2008-10#2)
the analysis of several##3##4##(2008-10#2)(2009-10#1)
the analysis of small##2##4##(2008-10#2)
the analysis of some##9##4##(2008-10#9)
the analysis of spiked##3##4##(2008-10#3)
the analysis of standard reference materials##2##6##(2008-10#2)
the analysis of such##3##4##(1996-3#1)(2008-10#1)(2012-2#1)
the analysis of synthetic##7##4##(2008-10#6)(2008-4#1)
the analysis of the data##2##5##(1995-8#1)(2010-10#1)
the analysis of the##50##4##(1990-5#2)(1992-9#2)(1993-12#1)(1995-8#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
the analysis of these compounds##2##5##(2008-10#2)
the analysis of these herbicides in spiked##2##7##(2008-10#2)
the analysis of these herbicides in##3##6##(2008-10#3)
the analysis of these##7##4##(2008-10#7)
the analysis of this##6##4##(2008-10#6)
the analysis of three##2##4##(2008-10#2)
the analysis of total##2##4##(2008-10#2)
the analysis of toxic metal##2##5##(2008-10#2)
the analysis of trace##5##4##(2008-10#5)
the analysis of two##4##4##(2008-10#4)
the analysis of urine samples##2##5##(2008-10#2)
the analysis of urine##3##4##(2008-10#3)
the analysis of variance (ANOVA)##2##5##(2008-10#1)(2013-1#1)
the analysis of water samples##2##5##(2008-10#2)
the analysis of##410##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1992-9#2)(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-3#3)(1997-2#2)(2007-8#1)(2008-10#320)(2008-11#12)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#9)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#7)(2009-10#2)(2009-12#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#6)(2011-8#1)(2012-2#1)(2012-3#2)(2013-1#4)
the analysis time and##2##4##(2008-10#2)
the analysis time is##2##4##(2008-10#2)
the analysis time##5##3##(2008-10#5)
the analysis to##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
the analysis was##10##3##(1993-12#1)(2008-10#6)(2008-8#1)(2010-10#1)(2013-8#1)
the analysis##497##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1992-12#1)(1992-3#2)(1992-9#3)(1993-12#3)(1993-2#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#3)(1997-2#3)(2007-8#1)(2008-10#363)(2008-11#14)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#12)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#12)(2009-10#2)(2009-12#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#7)(2011-8#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#3)
the analyte and the##4##4##(2008-10#3)(2010-7#1)
the analyte and##9##3##(2008-10#8)(2010-7#1)
the analyte at##2##3##(2008-10#2)
the analyte by##4##3##(2008-10#3)(2009-8#1)
the analyte concentration##6##3##(2008-10#5)(2008-7#1)
the analyte concentrations##2##3##(2008-10#1)(2008-7#1)
the analyte elements were##4##4##(2008-10#4)
the analyte elements##6##3##(2008-10#6)
the analyte from the##3##4##(2008-10#3)
the analyte in the##8##4##(2008-10#7)(2009-8#1)
the analyte in##12##3##(2008-10#11)(2009-8#1)
the analyte is##5##3##(2008-10#5)
the analyte pulse perturbation##3##4##(2008-10#3)
the analyte pulse##4##3##(2008-10#4)
the analyte signal from the##2##5##(2008-10#2)
the analyte solution##8##3##(2008-10#8)
the analyte to##5##3##(2008-10#5)
the analyte was retained##2##4##(2008-10#2)
the analyte was##8##3##(2008-10#8)
the analyte##130##2##(2008-10#124)(2008-7#2)(2009-8#2)(2010-7#1)(2012-12#1)
the analyte's##2##2##(2008-10#2)
the analytes and##4##3##(2008-10#4)
the analytes are##6##3##(2008-10#6)
the analytes from##3##3##(1997-2#1)(2008-10#2)
the analytes in##6##3##(2008-10#6)
the analytes of interest##2##4##(2008-10#2)
the analytes was##3##3##(2008-10#3)
the analytes were##13##3##(2008-10#13)
the analytes with##3##3##(2008-10#3)
the analytes##86##2##(1997-2#3)(2008-10#82)(2010-5#1)
the analytic hierarchy process##3##4##(2008-10#1)(2011-2#2)
the analytic##6##2##(1995-2#2)(2008-10#2)(2011-2#2)
the analytical capabilities of##2##4##(2008-10#1)(2010-11#1)
the analytical characteristics of the procedure##2##6##(2008-10#2)
the analytical characteristics of the##3##5##(2008-10#3)
the analytical characteristics##8##3##(2008-10#8)
the analytical chemical##2##3##(2008-10#2)
the analytical chemistry##2##3##(2008-10#2)
the analytical column##3##3##(2008-10#3)
the analytical community##2##3##(2008-10#2)
the analytical conditions##2##3##(2008-10#2)
the analytical curve was##2##4##(2008-10#2)
the analytical curve##4##3##(2008-10#4)
the analytical curves##3##3##(2008-10#3)
the analytical data##4##3##(1995-5#1)(2008-10#3)
the analytical determination of##2##4##(2008-10#2)
the analytical determination##3##3##(2008-10#3)
the analytical figures of merit##3##5##(2008-10#3)
the analytical method##5##3##(2008-10#3)(2010-11#1)(2012-2#1)
the analytical methods##2##3##(1996-12#1)(2010-7#1)
the analytical minimalism concept##2##4##(2008-10#2)
the analytical performance of the method##2##6##(2008-10#2)
the analytical performance of the##6##5##(2008-10#6)
the analytical performance of##7##4##(2008-10#7)
the analytical performance##9##3##(2008-10#9)
the analytical performances of the##2##5##(2008-10#2)
the analytical performances of##3##4##(2008-10#3)
the analytical performances##4##3##(2008-10#4)
the analytical procedure##7##3##(2008-10#7)
the analytical response##2##3##(2008-10#2)
the analytical results were in good agreement with##2##8##(2008-10#2)
the analytical results were##5##4##(2008-10#5)
the analytical results##7##3##(2008-10#7)
the analytical sensitivity and##2##4##(2008-10#2)
the analytical sensitivity##5##3##(2008-10#4)(2011-2#1)
the analytical signal from##2##4##(2008-10#2)
the analytical signal is##2##4##(2008-10#2)
the analytical signal of##2##4##(2008-10#2)
the analytical signal showed a very good linearity in the range##2##11##(2008-10#2)
the analytical signal to##2##4##(2008-10#2)
the analytical signal versus concentration dependence was linear##2##8##(2008-10#2)
the analytical signal##24##3##(2008-10#24)
the analytical signals##6##3##(2008-10#5)(2008-3#1)
the analytical solution##3##3##(2008-10#1)(2008-3#2)
the analytical system##3##3##(2008-10#3)
the analytical time was##2##4##(2008-10#2)
the analytical##169##2##(1992-2#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#149)(2008-3#4)(2008-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
the analyzed##10##2##(2008-10#7)(2008-12#1)(2009-10#1)(2012-2#1)
the anastomosis##2##2##(1991-3#1)(1993-6#1)
the anatomic##8##2##(1990-9#1)(1994-3#1)(1994-6#1)(2008-9#1)(2012-3#3)(2013-1#1)
the anatomical features##2##3##(1996-9#1)(2013-1#1)
the anatomical##19##2##(1992-12#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the anatomy and##3##3##(1993-6#1)(2010-6#1)(2010-9#1)
the anatomy of the##2##4##(1990-11#1)(2008-10#1)
the anatomy of this region##2##5##(1994-3#1)(1996-9#1)
the anatomy of##4##3##(1990-11#1)(1994-3#1)(1996-9#1)(2008-10#1)
the anatomy##11##2##(1990-11#1)(1990-8#1)(1993-6#1)(1994-3#1)(1996-9#1)(2008-10#1)(2010-6#1)(2010-9#1)(2013-1#3)
the ancestor of##3##3##(2008-9#2)(2009-10#1)
the ancestral##6##2##(2008-12#1)(2008-8#2)(2011-2#1)(2013-1#2)
the anchor##5##2##(1994-12#1)(1997-6#1)(1997-7#1)(2008-10#1)(2010-10#1)
the ancient##5##2##(1991-2#1)(2008-10#3)(2009-10#1)
the ancillary##3##2##(1994-6#1)(2008-4#1)(2011-7#1)
the androgen receptor (AR)##2##4##(1990-11#2)
the androgen receptor##4##3##(1990-11#2)(2008-4#1)(2012-2#1)
the androgen##7##2##(1990-11#2)(2008-4#1)(2008-9#2)(2009-10#1)(2012-2#1)
the androgenic steroid##3##3##(1990-11#2)(1993-1#1)
the androgenic##4##2##(1990-11#2)(1993-1#1)(2010-1#1)
the anesthesia##3##2##(2010-8#3)
the anesthetic##3##2##(1991-6#1)(2009-8#1)(2010-8#1)
the aneurysm##15##2##(1997-3#1)(1997-6#2)(2008-12#2)(2008-7#2)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#3)
the aneurysmal##6##2##(1997-3#3)(1997-6#1)(2008-12#1)(2008-7#1)
the aneurysms were##2##3##(1995-11#1)(1997-3#1)
the aneurysms##4##2##(1995-11#1)(1997-3#1)(2009-8#1)(2013-8#1)
the angiogenic##4##2##(2009-8#1)(2011-2#1)(2013-1#2)
the angiographic findings##3##3##(1997-8#3)
the angiographic##6##2##(1992-9#1)(1996-6#1)(1997-8#3)(2008-7#1)
the angiotensin II receptor##2##4##(1994-8#1)(1995-11#1)
the angiotensin II##3##3##(1994-8#1)(1995-11#1)(2008-1#1)
the angiotensin##6##2##(1994-2#2)(1994-8#1)(1995-11#2)(2008-1#1)
the angle of##2##3##(2008-10#1)(2008-3#1)
the angle##9##2##(2008-10#1)(2008-3#5)(2012-2#1)(2013-1#1)(2013-8#1)
the angular distribution of##2##4##(2008-2#2)
the angular##12##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#7)
the anhydride##2##2##(1995-11#1)(2008-10#1)
the anhydrous##2##2##(2008-10#2)
the aniline##2##2##(2008-10#2)
the animal hemisphere of##2##4##(1993-6#2)
the animal kingdom##2##3##(1996-12#1)(2009-8#1)
the animal model##2##3##(2008-9#2)
the animal species##2##3##(2010-11#1)(2012-2#1)
the animal test species##2##4##(2010-11#2)
the animal##32##2##(1990-2#1)(1992-12#1)(1992-6#1)(1993-6#2)(1995-12#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#2)(2010-1#1)(2010-11#3)(2010-6#1)(2012-2#1)(2013-1#2)
the animal's behavior##2##3##(2008-11#2)
the animal's##3##2##(1993-12#1)(2008-11#2)
the animal-sourced proteins##2##3##(2008-11#2)
the animals had been##2##4##(1990-11#1)(2008-12#1)
the animals had##3##3##(1990-11#1)(1990-5#1)(2008-12#1)
the animals kept##2##3##(2008-7#2)
the animals that##3##3##(2008-11#1)(2008-7#1)(2010-7#1)
the animals were allowed##2##4##(2009-3#2)
the animals were anesthetized##2##4##(2011-2#2)
the animals were##15##3##(1992-12#1)(1992-3#1)(1994-3#1)(1996-12#1)(2008-12#1)(2008-7#4)(2009-3#2)(2010-8#1)(2011-2#2)(2013-1#1)
the animals##49##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-2#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-12#2)(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#8)(2008-8#1)(2009-3#2)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#5)(2013-1#3)(2013-8#1)
the anion of##2##3##(1996-5#1)(2008-10#1)
the anion##11##2##(1994-5#1)(1994-6#1)(1996-5#1)(2008-10#7)(2008-11#1)
the anion-exchange##3##2##(2008-10#3)
the anionic additive##3##3##(2008-10#3)
the anionic exchanger##2##3##(2008-10#2)
the anionic form of the##2##5##(2008-10#2)
the anionic surfactant sodium##3##4##(2008-10#3)
the anionic surfactant##5##3##(2008-10#5)
the anionic##21##2##(1990-5#1)(2008-10#18)(2008-11#1)(2008-5#1)
the anions##5##2##(2008-10#4)(2010-4#1)
the anisotropic##3##2##(2008-3#2)(2010-4#1)
the anisotropy##4##2##(1991-5#1)(2008-10#1)(2008-3#2)
the ankle and##4##3##(2009-11#1)(2011-2#3)
the ankle joint##7##3##(2009-7#2)(2010-5#1)(2011-2#2)(2012-2#2)
the ankle##19##2##(2008-12#1)(2009-11#1)(2009-7#2)(2010-5#1)(2011-2#6)(2012-2#6)(2012-3#1)(2013-1#1)
the annotation of##3##3##(2008-9#2)(2010-11#1)
the annual frequency##2##3##(1996-3#1)(1997-8#1)
the annual incidence##2##3##(1996-11#2)
the annual mortality rate##2##4##(1995-3#2)
the annual##22##2##(1991-6#1)(1992-2#3)(1993-12#1)(1995-3#2)(1996-11#2)(1996-3#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)
the annulus##5##2##(1996-6#3)(2008-9#1)(2011-2#1)
the anode##2##2##(2008-10#2)
the anodic oxidation##2##3##(2008-10#2)
the anodic peak##4##3##(2008-10#4)
the anodic stripping voltammetric##2##4##(2008-10#2)
the anodic stripping##4##3##(2008-10#4)
the anodic##15##2##(2008-10#15)
the anodized##2##2##(2009-7#2)
the anomalous##2##2##(2008-3#1)(2012-3#1)
the answer##7##2##(1992-11#1)(1994-12#2)(2008-10#1)(2008-8#1)(2012-2#2)
the answers##3##2##(1996-2#1)(1996-3#1)(2012-2#1)
the ant sex ratio##2##4##(2008-8#2)
the ant##5##2##(2007-12#1)(2008-5#1)(2008-8#3)
the ant's##2##2##(2007-12#1)(2012-3#1)
the antagonist and the pathogen##2##5##(2008-10#2)
the antagonist and##4##3##(2008-10#4)
the antagonist effects of naloxonazine were##2##6##(1996-2#2)
the antagonist effects of naloxonazine##3##5##(1996-2#3)
the antagonist on##2##3##(2008-10#2)
the antagonist##31##2##(1992-6#1)(1995-11#1)(1996-2#3)(2008-10#26)
the antagonist's##2##2##(1995-11#1)(2008-10#1)
the antagonistic activity of##2##4##(2008-10#1)(2008-12#1)
the antagonistic process##2##3##(2008-10#2)
the antagonistic##13##2##(2008-10#10)(2008-12#2)(2008-8#1)
the antagonists##4##2##(1995-11#1)(2008-10#1)(2008-8#2)
the antenatal##2##2##(2008-11#1)(2013-1#1)
the antenna##2##2##(2008-10#1)(2008-5#1)
the antennal##3##2##(2007-12#2)(2008-7#1)
the antennular##2##2##(2007-12#2)
the anterior and posterior##4##4##(1995-2#1)(1997-3#1)(2011-2#1)(2013-1#1)
the anterior border of the Fl1-Fl6 flagellomeres##2##7##(2007-12#2)
the anterior chamber##3##3##(2011-2#3)
the anterior cingulate##3##3##(1994-3#3)
the anterior communicating artery##2##4##(2008-7#2)
the anterior cranial base##2##4##(2011-2#2)
the anterior cruciate ligament##3##4##(2009-1#1)(2013-1#2)
the anterior hypothalamic-preoptic area##2##4##(1994-8#2)
the anterior lobe##3##3##(1992-9#3)
the anterior mesenteron##2##3##(2008-7#2)
the anterior of##2##3##(1993-12#1)(2007-12#1)
the anterior part of the##5##5##(1996-2#1)(1996-6#2)(2010-5#1)(2012-2#1)
the anterior pituitary##2##3##(1992-10#1)(1997-2#1)
the anterior pole of the##2##5##(1994-12#1)(2008-12#1)
the anterior pole##3##3##(1994-12#1)(2007-12#1)(2008-12#1)
the anterior portion of the##2##5##(1991-8#1)(2009-1#1)
the anterior region of the##4##5##(2008-7#1)(2009-1#2)(2013-1#1)
the anterior region of##5##4##(2007-12#1)(2008-7#1)(2009-1#2)(2013-1#1)
the anterior segment of the eye##3##6##(2010-1#1)(2011-7#2)
the anterior segment of the##4##5##(2010-1#1)(2011-7#3)
the anterior segment##5##3##(2010-1#1)(2010-9#1)(2011-7#3)
the anterior side##2##3##(1997-8#1)(2013-2#1)
the anterior wall of the##3##5##(2011-2#1)(2011-7#1)(2012-12#1)
the anterior##91##2##(1990-9#2)(1991-1#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-9#3)(1993-12#2)(1994-12#2)(1994-3#3)(1994-8#2)(1995-2#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-12#6)(2008-10#4)(2008-12#5)(2008-4#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-1#4)(2010-1#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#10)(2011-7#4)(2012-12#2)(2012-2#3)(2013-1#6)(2013-2#1)(2013-7#1)
the anterior-posterior##2##2##(1993-2#1)(2008-5#1)
the anterolateral approach##4##3##(2011-2#2)(2012-3#2)
the anther##2##2##(2008-8#2)
the anthropogenic##3##2##(2008-10#1)(2008-11#2)
the anti-IL-6##2##2##(2008-10#2)
the anti-TNP antibody##3##3##(2008-10#3)
the anti-aging##2##2##(1990-3#1)(2008-5#1)
the anti-apoptotic gene##2##3##(2008-11#1)(2010-1#1)
the anti-apoptotic##6##2##(2008-11#4)(2010-1#1)(2013-1#1)
the anti-gluconeogenic##2##2##(1994-8#2)
the anti-hypertensive##2##2##(2008-10#1)(2008-7#1)
the anti-inflammatory drug##3##3##(2008-10#3)
the anti-inflammatory##7##2##(2008-10#5)(2009-1#1)(2012-2#1)
the anti-proliferative##2##2##(2009-9#1)(2013-1#1)
the anti-tumor##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
the antiadipogenic effect of retinol##2##5##(2008-5#2)
the antiaggregating drug picotamide##2##4##(2008-7#2)
the antibacterial##4##2##(1990-6#1)(2008-5#3)
the antibiogram##3##2##(2013-1#3)
the antibiotic 2##6##3##(2008-10#6)
the antibiotic chloramphenicol##2##3##(2008-10#2)
the antibiotic treatment##2##3##(1990-2#1)(2008-10#1)
the antibiotic##22##2##(1990-2#2)(1992-12#2)(1993-2#1)(1994-5#1)(1995-6#1)(1997-2#1)(2008-10#12)(2008-11#1)(2012-2#1)
the antibiotics produced by the##2##5##(2008-10#2)
the antibiotics##7##2##(1991-1#1)(2008-10#5)(2012-3#1)
the antibodies##14##2##(1990-12#1)(1993-8#1)(2008-10#7)(2008-8#3)(2008-9#1)(2011-2#1)
the antibody concentration##2##3##(2008-10#1)(2008-11#1)
the antibody for##2##3##(1995-8#1)(2008-10#1)
the antibody is##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
the antibody were##2##3##(2008-10#1)(2008-8#1)
the antibody##40##2##(1991-5#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(2008-10#12)(2008-11#6)(2008-4#1)(2008-7#4)(2008-8#4)(2009-3#1)(2013-1#4)(2013-8#1)
the anticancer PG##2##3##(2008-11#2)
the anticancer activity##2##3##(2009-12#1)(2009-4#1)
the anticancer benefits##2##3##(2009-12#2)
the anticancer drug##2##3##(2008-10#1)(2008-7#1)
the anticancer##9##2##(2008-10#1)(2008-11#2)(2008-7#1)(2009-12#3)(2009-4#1)(2009-9#1)
the anticipated##5##2##(1993-12#1)(1996-1#1)(2008-10#2)(2008-3#1)
the anticoagulant##3##2##(1997-3#1)(2008-10#2)
the anticonvulsant effects##2##3##(1990-5#1)(1994-2#1)
the anticonvulsant##8##2##(1990-5#1)(1992-3#2)(1994-2#2)(1994-8#3)
the antidepressant drug##2##3##(2008-10#2)
the antidepressant##4##2##(2008-10#3)(2008-6#1)
the antidepressants##2##2##(2008-11#1)(2008-9#1)
the antiestrogen##3##2##(1993-1#1)(2008-11#2)
the antifouling agent##2##3##(2008-10#2)
the antifouling##4##2##(2008-10#2)(2008-11#2)
the antifungal activity##2##3##(2008-10#2)
the antifungal compounds##2##3##(2008-10#2)
the antifungal properties of##2##4##(2008-10#1)(2012-2#1)
the antifungal properties##3##3##(2008-10#2)(2012-2#1)
the antifungal##14##2##(2008-10#11)(2008-5#2)(2012-2#1)
the antigen by##3##3##(1990-12#2)(2008-4#1)
the antigen receptor##3##3##(1995-6#2)(2008-4#1)
the antigen##23##2##(1990-12#4)(1995-2#1)(1995-6#2)(1996-2#1)(2008-10#7)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#2)
the antigen-antibody reaction##2##3##(2008-10#2)
the antigen-antibody##4##2##(2008-10#4)
the antigenic##9##2##(1993-1#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(2008-4#1)(2013-8#2)
the antigenicity##2##2##(2008-10#1)(2013-8#1)
the antigens of##2##3##(1997-1#1)(2008-5#1)
the antigens##8##2##(1990-12#2)(1995-5#2)(1997-1#2)(2008-5#2)
the antihypertensive##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
the antiinflammatory##2##2##(1993-11#1)(2008-11#1)
the antimalarial##3##2##(1994-8#1)(2008-10#1)(2010-1#1)
the antimetamorphic action of JH##2##5##(2012-2#2)
the antimicrobial activity of##2##4##(2008-11#1)(2008-5#1)
the antimicrobial activity##3##3##(2008-11#1)(2008-5#1)(2012-3#1)
the antimicrobial##8##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
the antinociception##2##2##(1996-2#2)
the antinociceptive and ventilatory effects of##2##6##(1996-2#2)
the antinociceptive and##3##3##(1996-2#2)(2008-11#1)
the antinociceptive effect of buprenorphine##2##5##(2008-11#2)
the antinociceptive effect of morphine##2##5##(1996-2#2)
the antinociceptive effect of##4##4##(1996-2#2)(2008-11#2)
the antinociceptive##7##2##(1996-2#4)(2008-11#3)
the antioxidant activity of##7##4##(1992-9#1)(2008-10#5)(2013-1#1)
the antioxidant activity##9##3##(1992-9#1)(2008-10#6)(2013-1#1)(2013-8#1)
the antioxidant properties of##2##4##(2008-10#2)
the antioxidant system##3##3##(2008-7#1)(2010-5#1)(2012-6#1)
the antioxidant##32##2##(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#1)(2008-10#17)(2008-11#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
the antioxidants##8##2##(1992-9#1)(1993-2#1)(2008-10#4)(2008-5#2)
the antioxidative##4##2##(2008-11#4)
the antiproliferative effect of GC7##2##5##(1997-1#2)
the antiproliferative effect of##4##4##(1990-12#1)(1995-2#1)(1997-1#2)
the antiproliferative##6##2##(1990-12#2)(1990-2#1)(1995-2#1)(1997-1#2)
the antisense##4##2##(1994-11#1)(1995-2#1)(2008-11#1)(2008-8#1)
the antisera only##2##3##(2008-10#1)(2008-5#1)
the antisera##3##2##(2008-10#1)(2008-5#1)(2010-6#1)
the antithetic##2##2##(2009-6#1)(2011-2#1)
the antithrombotic activity##2##3##(2006-6#2)
the antitumor drug##2##3##(1991-6#1)(1993-8#1)
the antitumor##4##2##(1991-6#1)(1993-8#1)(1994-5#1)(2013-1#1)
the antiviral drug##2##3##(1994-6#1)(1995-6#1)
the antiviral##6##2##(1990-10#1)(1994-6#1)(1995-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
the anurans##2##2##(1997-3#2)
the anxiety##6##2##(1991-2#1)(2008-11#2)(2009-7#1)(2010-5#1)(2013-1#1)
the anxiolytic##4##2##(1994-2#1)(2008-10#1)(2008-11#2)
the aorta and its branches##2##5##(1997-8#2)
the aorta and its##3##4##(1997-8#3)
the aorta##12##2##(1996-11#1)(1997-1#1)(1997-8#4)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-3#1)
the aortic arch##2##3##(1997-8#1)(2010-7#1)
the aortic pre-ejection time##2##4##(2008-10#2)
the aortic wall##2##3##(1997-8#1)(2009-7#1)
the aortic##11##2##(1991-5#1)(1991-9#1)(1997-5#1)(1997-8#2)(2008-10#2)(2009-7#1)(2010-12#1)(2010-7#1)(2012-2#1)
the aortomitral angle##2##3##(2008-10#2)
the ape chromosomes##2##3##(1997-6#2)
the aperture field##2##3##(2011-2#2)
the aperture##4##2##(2008-2#1)(2008-3#1)(2011-2#2)
the apex of the##2##4##(2008-7#1)(2012-2#1)
the apex of##4##3##(2007-8#2)(2008-7#1)(2012-2#1)
the apex##12##2##(2007-8#2)(2008-10#3)(2008-7#1)(2009-2#3)(2012-2#1)(2013-1#2)
the aphid Acyrthosiphon pisum##2##4##(1996-12#1)(2007-12#1)
the aphid Rhopalosiphum##2##3##(2008-10#2)
the aphid that inoculated the##2##5##(2008-10#2)
the aphid vector##2##3##(2008-10#2)
the aphid##16##2##(1996-12#4)(2007-12#2)(2008-10#10)
the aphid-transmitted isolates##2##3##(2008-10#2)
the apical ES##7##3##(2012-2#7)
the apical and##3##3##(2008-9#1)(2012-2#2)
the apical cell membrane##2##4##(2007-12#2)
the apical cell##3##3##(2007-12#2)(2009-8#1)
the apical ectoplasmic specialization##2##4##(2012-2#2)
the apical portion of the##2##5##(2007-12#1)(2013-1#1)
the apical surface##2##3##(1995-8#1)(2007-12#1)
the apical##35##2##(1995-8#1)(1997-1#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2012-2#13)(2013-1#5)
the apo and##2##3##(1991-12#1)(2009-7#1)
the apo##6##2##(1991-12#2)(1993-8#1)(1997-8#2)(2009-7#1)
the apo(a)-EIA##2##2##(1993-2#2)
the apo-E gene##2##3##(2008-10#2)
the apo-E##3##2##(2008-10#3)
the apoprotein##3##2##(1991-12#1)(1992-10#1)(1993-8#1)
the apoptosis of##3##3##(2008-11#2)(2009-4#1)
the apoptosis##11##2##(1995-6#1)(2008-10#1)(2008-11#5)(2008-9#1)(2009-4#1)(2011-2#2)
the apoptotic cell##2##3##(2010-10#1)(2011-2#1)
the apoptotic effects of##2##4##(1995-2#1)(2008-11#1)
the apoptotic process##2##3##(2008-9#1)(2009-3#1)
the apoptotic##15##2##(1995-12#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#2)(2011-2#1)(2013-1#1)
the apparatus##4##2##(1995-12#1)(1997-6#1)(2008-3#2)
the apparent K(m) for exogenous ADP##2##6##(2008-7#2)
the apparent K(m) for##3##4##(2008-7#3)
the apparent K(m)##5##3##(2008-7#5)
the apparent binding##4##3##(1991-5#1)(1997-2#1)(2008-10#2)
the apparent diffusion coefficient##3##4##(2008-10#2)(2010-12#1)
the apparent molar##5##3##(2008-10#5)
the apparent molecular mass of the##2##6##(1995-6#2)
the apparent molecular mass of##4##5##(1990-5#1)(1992-10#1)(1995-6#2)
the apparent viscosity and##2##4##(2008-5#1)(2011-2#1)
the apparent viscosity##4##3##(2008-5#3)(2011-2#1)
the apparent##73##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-6#2)(1996-12#1)(1997-2#3)(1997-3#1)(2008-10#33)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#2)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)
the apparently##3##2##(2008-10#1)(2009-8#2)
the appeals court##2##3##(1996-5#2)
the appeals##3##2##(1995-6#1)(1996-5#2)
the appearance of a##6##4##(1992-10#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-8#1)
the appearance of the first##2##5##(2008-10#2)
the appearance of the##10##4##(1991-6#1)(1994-11#2)(1996-6#1)(2008-10#3)(2008-6#1)(2009-12#1)(2012-2#1)
the appearance of##61##3##(1990-10#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
the appearance ofa##2##3##(2008-11#1)(2013-8#1)
the appearance##66##2##(1990-10#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the appendiceal wall##2##3##(2009-7#1)(2011-2#1)
the appendicular##4##2##(1991-11#1)(2007-12#1)(2011-2#2)
the appendix##14##2##(1992-2#1)(1993-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2009-7#4)(2011-2#4)
the apple pectin##2##3##(2008-10#2)
the apple proliferation##3##3##(2008-10#3)
the apple sooty blotch##2##4##(2008-10#2)
the apple##13##2##(1996-2#1)(2008-10#10)(2008-11#2)
the applicability of the method to##2##6##(2008-10#2)
the applicability of the method##4##5##(2008-10#3)(2008-3#1)
the applicability of the proposed method##3##6##(2008-10#3)
the applicability of the##12##4##(2008-10#9)(2008-3#1)(2008-8#1)(2009-12#1)
the applicability of this##3##4##(1995-9#1)(2008-10#1)(2008-2#1)
the applicability of##28##3##(1994-2#1)(1995-1#1)(1995-11#1)(1995-9#1)(2007-11#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
the applicability##29##2##(1994-2#1)(1995-1#1)(1995-11#1)(1995-9#1)(2007-11#1)(2008-10#14)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
the applicable##4##2##(1991-2#1)(1992-12#1)(2008-11#1)(2008-2#1)
the application of SPA technology to##2##6##(2008-4#2)
the application of a##16##4##(1992-2#1)(1993-2#1)(1995-5#1)(1995-9#1)(2008-10#7)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
the application of an##6##4##(1993-3#1)(2008-10#3)(2008-11#1)(2008-5#1)
the application of both##2##4##(1996-12#1)(2008-10#1)
the application of cancer control science##2##6##(1997-1#2)
the application of data##2##4##(2008-10#1)(2008-9#1)
the application of different##2##4##(2008-10#2)
the application of molecular##2##4##(2008-10#1)(2011-1#1)
the application of new##2##4##(2009-8#1)(2010-11#1)
the application of the hybrid method##2##6##(2008-3#2)
the application of the new##2##5##(1992-9#1)(2008-7#1)
the application of the proposed##2##5##(2008-10#2)
the application of the##31##4##(1990-9#1)(1992-9#1)(1997-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#1)(2010-2#1)(2012-3#3)(2013-1#3)
the application of these techniques to##2##6##(2008-8#1)(2010-9#1)
the application of these##8##4##(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#3)(2010-9#1)(2012-2#1)
the application of this##6##4##(1994-5#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
the application of##189##3##(1990-9#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-5#2)(1994-9#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-9#1)(1997-1#3)(1997-6#1)(1997-7#1)(2008-10#68)(2008-11#21)(2008-12#5)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#6)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#9)(2012-2#1)(2012-3#4)(2013-1#8)(2013-8#1)
the application to##3##3##(2008-10#3)
the application##210##2##(1990-9#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-5#2)(1994-9#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-9#1)(1997-1#3)(1997-6#1)(1997-7#1)(2008-10#79)(2008-11#21)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#7)(2008-7#5)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#9)(2012-2#1)(2012-3#4)(2013-1#10)(2013-8#1)
the applications of##5##3##(2008-10#2)(2010-7#1)(2011-2#1)(2011-7#1)
the applications##10##2##(1994-1#1)(2008-10#5)(2008-5#1)(2010-7#1)(2011-2#1)(2011-7#1)
the applied potential##6##3##(2008-10#6)
the applied##37##2##(1995-3#2)(1996-2#1)(2007-12#1)(2008-10#24)(2008-11#2)(2008-5#3)(2008-7#2)(2009-5#1)(2010-4#1)
the appointment##2##2##(1993-6#1)(1997-8#1)
the apprentice's##2##2##(2008-7#2)
the approach allows##2##3##(2008-9#1)(2009-10#1)
the approach is##6##3##(1996-5#1)(2008-10#3)(2008-12#1)(2008-3#1)
the approach of##2##3##(2008-10#1)(2012-2#1)
the approach taken##2##3##(1991-12#1)(2008-11#1)
the approach to a##2##4##(1993-6#1)(2008-11#1)
the approach to the##2##4##(2008-11#1)(2008-7#1)
the approach to##11##3##(1991-2#1)(1993-6#1)(1995-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)
the approach used in##2##4##(1996-8#1)(2008-3#1)
the approach##38##2##(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-1#1)(1996-5#1)(1996-8#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)
the approaches that##2##3##(1994-1#1)(2008-11#1)
the approaches used##2##3##(2008-12#1)(2013-1#1)
the approaches##7##2##(1994-1#1)(1997-2#2)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
the appropriate administrative##2##3##(1994-3#1)(1997-3#1)
the appropriate number of##2##4##(1992-9#1)(2013-8#1)
the appropriate sample##2##3##(2008-10#2)
the appropriate##66##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-9#2)(1994-12#3)(1994-3#1)(1995-12#2)(1996-1#1)(1996-5#2)(1996-8#1)(1997-3#2)(2007-12#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
the appropriateness of a##2##4##(2008-12#1)(2010-11#1)
the appropriateness of##7##3##(1992-1#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)
the appropriation##2##2##(1995-6#2)
the approval##3##2##(1991-3#1)(1993-12#1)(2008-10#1)
the approximate##4##2##(1992-4#1)(1992-6#1)(2008-3#1)(2008-4#1)
the approximately##6##2##(1990-5#1)(1995-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-5#1)
the approximation##6##2##(1990-8#1)(1996-3#1)(2008-10#2)(2008-3#1)(2013-1#1)
the aprX mutant##2##3##(2008-10#2)
the aprX##3##2##(2008-10#3)
the apricot##2##2##(2008-10#1)(2012-8#1)
the aqua regia extraction##3##4##(2008-10#3)
the aqua regia##4##3##(2008-10#4)
the aquatic environment##3##3##(2008-10#2)(2008-11#1)
the aquatic habitat##3##3##(2008-9#2)(2011-2#1)
the aquatic macrophyte Stratiotes aloides##2##5##(2010-6#2)
the aquatic##17##2##(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#4)(2010-6#2)(2011-2#1)
the aquation process##2##3##(2008-10#2)
the aquation##3##2##(2008-10#3)
the aqueous and##4##3##(1994-5#1)(2008-10#1)(2010-4#2)
the aqueous ion-pair formation (K(MLA))##2##5##(2008-10#2)
the aqueous phase and##5##4##(2008-10#4)(2010-4#1)
the aqueous phase as a##2##5##(2008-10#1)(2008-7#1)
the aqueous phase##27##3##(1990-5#1)(1991-5#1)(2008-10#20)(2008-5#2)(2008-7#2)(2010-4#1)
the aqueous sample##2##3##(2008-10#2)
the aqueous samples##2##3##(2008-10#2)
the aqueous solution was##2##4##(2008-10#2)
the aqueous solution##7##3##(1997-2#1)(2008-10#6)
the aqueous solutions##3##3##(2008-10#3)
the aqueous to##2##3##(2008-10#2)
the aqueous##77##2##(1990-5#1)(1991-5#3)(1994-5#1)(1997-2#1)(2008-10#61)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2010-4#3)
the arbuscular##2##2##(2008-10#1)(2010-10#1)
the archaeological##2##2##(2008-10#2)
the archetypal##2##2##(1990-8#1)(1993-2#1)
the architecture##3##2##(1991-11#1)(2008-12#1)(2010-11#1)
the archival##2##2##(1992-1#1)(1996-3#1)
the arcjet's##2##2##(2008-3#2)
the arcuate nucleus##2##3##(1994-2#1)(1996-12#1)
the arcuate##4##2##(1994-2#1)(1996-12#1)(2008-4#1)(2008-7#1)
the area around the##2##4##(1992-1#1)(2008-5#1)
the area around##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
the area irradiated##2##3##(1997-3#1)(2008-10#1)
the area is##2##3##(2008-10#1)(2008-11#1)
the area of the##11##4##(1991-2#1)(1993-3#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#2)(2013-1#1)
the area of##48##3##(1991-2#1)(1992-1#1)(1992-2#1)(1993-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-10#11)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
the area the##2##3##(2008-10#2)
the area to##2##3##(1995-3#1)(2008-10#1)
the area under the curve (AUC)##2##6##(2008-11#1)(2012-3#1)
the area under the curve##5##5##(1992-9#1)(2008-10#2)(2008-11#1)(2012-3#1)
the area under the disease progress curve (AUDPC)##2##8##(2008-10#2)
the area under the disease progress curve##4##7##(2008-10#4)
the area under the##12##4##(1992-9#1)(2008-10#8)(2008-11#1)(2009-12#1)(2012-3#1)
the area under##13##3##(1992-9#1)(2008-10#9)(2008-11#1)(2009-12#1)(2012-3#1)
the area where##3##3##(1995-1#1)(2008-10#2)
the area##95##2##(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-9#1)(1993-3#1)(1994-12#2)(1995-1#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-3#3)(1997-6#1)(1997-8#1)(2008-10#32)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#3)
the areas of##16##3##(1991-1#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(2008-11#2)(2008-12#3)(2010-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
the areas##22##2##(1991-1#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#4)(2010-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
the arena##3##2##(2008-11#1)(2009-3#1)(2012-3#1)
the argon beam coagulator##3##4##(1993-12#2)(1994-3#1)
the argon##4##2##(1993-12#2)(1994-3#1)(2008-10#1)
the argument for##2##3##(1996-1#2)
the argument that##3##3##(1995-6#1)(2008-8#2)
the argument##6##2##(1995-6#1)(1996-1#2)(2008-8#3)
the arguments##3##2##(1996-2#1)(2008-9#1)(2011-2#1)
the arm##10##2##(1993-6#2)(1994-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)
the arms##2##2##(2010-6#1)(2012-2#1)
the aroma##3##2##(2008-10#3)
the aromatase##3##2##(1993-8#3)
the aromatic ring##2##3##(1993-12#1)(2010-4#1)
the aromatic##10##2##(1992-6#1)(1993-12#1)(1993-8#1)(2008-10#6)(2010-4#1)
the arrangement of##4##3##(1994-5#1)(2008-7#2)(2009-8#1)
the arrangement##6##2##(1993-12#1)(1994-5#1)(2008-7#2)(2008-8#1)(2009-8#1)
the array and##3##3##(2008-10#2)(2012-3#1)
the array of##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
the array was##2##3##(2008-10#1)(2011-2#1)
the array##16##2##(1991-3#1)(2008-10#6)(2008-3#2)(2008-4#1)(2009-10#1)(2011-2#2)(2012-3#3)
the arrays##2##2##(2008-10#1)(2008-7#1)
the arrested##3##2##(1991-2#1)(2007-12#1)(2008-11#1)
the arsenic and selenium##2##4##(2008-10#2)
the arsenic and##3##3##(2008-10#3)
the arsenic species##6##3##(2008-10#6)
the arsenic##18##2##(2008-10#17)(2009-7#1)
the arsine##2##2##(2008-10#2)
the art of##5##3##(2008-4#1)(2008-5#1)(2009-12#1)(2011-1#1)(2012-2#1)
the art##19##2##(1993-3#2)(1994-8#1)(1995-2#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
the arterial wall and##2##4##(2008-6#1)(2008-9#1)
the arterial wall##6##3##(2008-6#1)(2008-9#2)(2009-1#1)(2011-2#1)(2013-1#1)
the arterial##19##2##(1991-6#1)(1993-1#1)(1995-8#1)(1997-4#1)(1997-8#2)(2006-6#2)(2008-6#1)(2008-9#4)(2009-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
the arteriovenous malformation##2##3##(2008-7#2)
the arteriovenous##4##2##(1993-6#1)(2008-7#2)(2011-3#1)
the artery##6##2##(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
the article describes##2##3##(1993-3#1)(1994-1#1)
the article discusses the##2##4##(1994-1#2)
the article includes##2##3##(1994-1#1)(2008-12#1)
the article##39##2##(1991-2#1)(1993-3#2)(1993-6#1)(1994-1#4)(1996-3#1)(1996-6#1)(1997-2#1)(2008-11#5)(2008-12#2)(2008-7#5)(2009-4#2)(2009-5#2)(2009-6#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#2)
the articles published in this issue of the Review##2##9##(1997-2#1)(1997-3#1)
the articles##6##2##(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2012-2#1)
the articular##2##2##(1997-6#1)(2012-3#1)
the artificial##16##2##(1990-11#1)(1990-2#1)(1992-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2011-2#1)
the aryl hydrocarbon receptor##2##4##(2008-10#1)(2013-1#1)
the aryl hydrocarbon##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
the asbestos##2##2##(1991-12#2)
the ascending aorta##9##3##(1997-5#4)(1997-8#2)(2008-11#1)(2010-6#1)(2011-2#1)
the ascending##14##2##(1996-9#1)(1997-5#4)(1997-8#2)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)(2013-3#2)
the ascomycete##4##2##(2008-10#4)
the ascorbate##3##2##(1990-2#1)(1990-9#2)
the ascorbic acid##3##3##(2008-10#3)
the asexual##4##2##(2008-10#4)
the ash content##2##3##(2008-10#2)
the ash##4##2##(2008-10#4)
the ashing##2##2##(2008-10#2)
the asialoglycoprotein receptor##2##3##(1995-2#1)(2008-8#1)
the aspartate##2##2##(1991-12#1)(1992-9#1)
the aspect of##5##3##(1993-11#1)(1995-5#1)(2008-10#2)(2008-8#1)
the aspects of##7##3##(1993-1#1)(1994-3#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
the aspects##8##2##(1993-1#1)(1994-3#1)(1994-8#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
the aspiration##3##2##(2008-10#3)
the assay conditions##4##3##(1990-2#1)(1993-8#1)(2008-4#1)(2008-9#1)
the assay in the##2##4##(2008-10#1)(2011-1#1)
the assay in this##2##4##(2008-11#1)(2013-8#1)
the assay in##5##3##(2008-10#2)(2008-11#1)(2011-1#1)(2013-8#1)
the assay is carried out##2##5##(2008-10#2)
the assay is##4##3##(2008-10#2)(2008-9#1)(2011-3#1)
the assay of S-perindopril##2##4##(2008-10#2)
the assay of this##2##4##(1990-2#1)(2008-11#1)
the assay of##61##3##(1990-2#1)(1991-11#1)(2008-10#56)(2008-11#1)(2008-4#2)
the assay results##3##3##(2008-10#3)
the assay was##7##3##(1990-12#1)(1991-12#1)(1992-6#1)(2008-10#3)(2008-11#1)
the assay##114##2##(1990-12#3)(1990-2#2)(1991-11#1)(1991-12#2)(1991-5#1)(1992-6#2)(1993-8#1)(1997-2#1)(2008-10#79)(2008-11#6)(2008-4#5)(2008-9#5)(2010-4#1)(2011-1#1)(2011-3#1)(2013-8#3)
the assayed##2##2##(2008-10#1)(2008-9#1)
the assays were##2##3##(2008-10#1)(2011-2#1)
the assays##14##2##(1993-2#1)(2008-10#9)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
the assemblage##3##2##(2008-8#1)(2008-9#1)(2010-8#1)
the assembled sequence##2##3##(1996-6#2)
the assembled##5##2##(1996-6#2)(2008-10#2)(2008-8#1)
the assembly of the##4##4##(1993-12#1)(2008-9#2)(2013-1#1)
the assembly of##14##3##(1993-12#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#2)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
the assembly##21##2##(1990-5#1)(1993-12#1)(1994-11#1)(1995-8#2)(2008-10#4)(2008-11#2)(2008-8#3)(2008-9#2)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
the assessment and management of##3##5##(2010-10#2)(2010-12#1)
the assessment and treatment of##2##5##(2008-10#1)(2010-9#1)
the assessment and treatment##3##4##(2008-10#1)(2008-11#1)(2010-9#1)
the assessment and##8##3##(1992-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-9#1)
the assessment of cardiac##2##4##(2009-1#1)(2012-2#1)
the assessment of learning##2##4##(2008-11#2)
the assessment of left ventricular##2##5##(2008-12#1)(2009-1#1)
the assessment of the##12##4##(1996-12#1)(2008-10#4)(2008-11#2)(2008-5#3)(2011-2#1)(2013-8#1)
the assessment of treatment##2##4##(1996-6#1)(2010-12#1)
the assessment of##81##3##(1990-12#1)(1990-2#1)(1991-1#2)(1991-5#1)(1991-6#1)(1994-6#1)(1996-12#2)(1996-6#1)(1997-8#2)(2007-11#1)(2008-10#17)(2008-11#13)(2008-12#2)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the assessment##100##2##(1990-12#1)(1990-2#1)(1991-1#2)(1991-5#1)(1991-6#1)(1992-12#1)(1994-6#1)(1996-12#2)(1996-6#1)(1997-8#2)(2007-11#1)(2008-10#18)(2008-11#19)(2008-12#2)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#2)(2009-7#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
the assigned##5##2##(2008-10#2)(2010-5#1)(2013-1#1)(2013-8#1)
the assignment of a##2##4##(2008-10#1)(2009-7#1)
the assignment of the##2##4##(1995-9#1)(2008-10#1)
the assignment of##8##3##(1995-9#1)(2008-10#3)(2008-12#1)(2009-7#2)(2010-11#1)
the assignment##13##2##(1992-2#1)(1995-12#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-12#3)(2009-7#2)(2010-11#1)
the assignments##2##2##(2008-11#2)
the assistance of##3##3##(1993-1#1)(2008-12#1)(2011-1#1)
the assistance##4##2##(1991-1#1)(1993-1#1)(2008-12#1)(2011-1#1)
the assistant's##2##2##(1992-1#1)(2009-4#1)
the associated##38##2##(1990-11#1)(1991-12#1)(1997-1#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
the association between interparental conflict and##2##6##(2010-1#2)
the association between the##5##4##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
the association between##44##3##(1991-12#1)(1991-8#1)(1992-8#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
the association complex##2##3##(2008-10#2)
the association constant##3##3##(2008-10#3)
the association constants were##2##4##(2008-10#2)
the association constants##4##3##(2008-10#4)
the association of adiposity with cardiovascular reactivity in##2##8##(2012-2#2)
the association of adiposity with cardiovascular reactivity##4##7##(2012-2#4)
the association of adiposity with##5##5##(2012-2#5)
the association of chronic##2##4##(2011-2#1)(2013-1#1)
the association of the##2##4##(2008-5#1)(2010-12#1)
the association of this##3##4##(2008-10#1)(2009-8#1)(2012-12#1)
the association of two##2##4##(2008-10#2)
the association of##41##3##(1990-5#1)(1990-8#1)(1995-2#2)(1996-8#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#4)
the association rate##3##3##(1993-8#2)(2008-10#1)
the association with cigarette smoking##2##5##(2008-10#2)
the association with the##2##4##(2008-10#1)(2011-2#1)
the association with##5##3##(2008-10#3)(2009-4#1)(2011-2#1)
the association##107##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-8#2)(1995-2#3)(1996-2#1)(1996-3#1)(1996-8#1)(2008-10#29)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#8)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#12)(2013-8#1)
the associations between sexual##2##4##(2009-5#2)
the associations between##6##3##(2008-11#1)(2009-5#2)(2011-2#1)(2013-8#2)
the associations##10##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#2)(2010-10#1)(2011-2#1)(2013-8#2)
the assumed##6##2##(1993-8#1)(2008-10#4)(2009-11#1)
the assumption of a##3##4##(2008-7#2)(2011-2#1)
the assumption of horizontal homogeneity##2##5##(2008-3#2)
the assumption of##14##3##(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#2)(2011-2#1)(2013-8#2)
the assumption that a##2##4##(1995-9#1)(2008-10#1)
the assumption that the##4##4##(1995-3#1)(2008-3#1)(2008-5#1)(2013-1#1)
the assumption that##15##3##(1995-3#1)(1995-9#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
the assumption##30##2##(1993-3#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
the assumptions and##2##3##(1992-2#1)(1993-3#1)
the assumptions of the##4##4##(1995-8#1)(2008-10#1)(2008-9#1)(2010-3#1)
the assumptions of##9##3##(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#2)(2010-3#1)
the assumptions##17##2##(1991-2#1)(1992-2#1)(1993-3#1)(1994-9#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#4)(2010-3#1)(2012-2#1)
the aster yellows##5##3##(2008-10#5)
the astrocyte##4##2##(1990-7#3)(2008-11#1)
the asylums##2##2##(1990-6#1)(2010-6#1)
the asymmetric synthesis of##2##4##(2008-11#2)
the asymmetric unit##10##3##(1992-4#3)(1992-9#1)(1993-8#1)(2008-8#3)(2008-9#2)
the asymmetric##16##2##(1992-3#1)(1992-4#3)(1992-9#1)(1993-8#1)(1994-2#1)(1994-9#1)(2008-11#2)(2008-8#3)(2008-9#2)(2009-7#1)
the asymmetry parameter##3##3##(2008-2#2)(2008-3#1)
the asymmetry##9##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-8#1)
the asymptomatic##6##2##(1990-8#2)(1996-9#1)(2008-10#2)(2013-1#1)
the asymptotic##9##2##(1996-3#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#2)(2010-1#1)(2013-8#1)
the atherogenic##2##2##(2008-12#1)(2008-3#1)
the atherosclerotic process##2##3##(2008-6#1)(2008-7#1)
the atherosclerotic##4##2##(2008-6#1)(2008-7#1)(2010-9#1)(2011-2#1)
the atlas##2##2##(1997-4#1)(2012-3#1)
the atmosphere and##4##3##(1997-1#1)(2008-10#1)(2008-3#2)
the atmosphere are##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
the atmosphere is##2##3##(2008-10#1)(2008-3#1)
the atmosphere of##4##3##(2008-10#1)(2008-3#1)(2008-5#2)
the atmosphere with a##2##4##(2008-3#2)
the atmosphere##46##2##(1991-3#1)(1991-6#1)(1995-3#2)(1996-1#1)(1997-1#1)(2008-10#10)(2008-11#7)(2008-2#2)(2008-3#19)(2008-5#2)
the atmospheric aerosol##2##3##(2008-10#1)(2008-2#1)
the atmospheric physical parameters##2##4##(2013-8#2)
the atmospheric profile##2##3##(2008-2#2)
the atmospheric##20##2##(1996-1#1)(2008-10#3)(2008-2#7)(2008-3#7)(2013-8#2)
the atomic absorption spectrometric determination of##2##6##(2008-10#2)
the atomic absorption spectrometric##3##4##(2008-10#3)
the atomic absorption##9##3##(2008-10#9)
the atomic and##2##3##(2008-10#1)(2010-7#1)
the atomic bomb survivor##2##4##(2013-1#2)
the atomic number##3##3##(2008-10#2)(2008-3#1)
the atomic##21##2##(2008-10#13)(2008-11#1)(2008-3#2)(2008-7#1)(2010-7#2)(2013-1#2)
the atomization##3##2##(2008-10#3)
the atrial septal defect##2##4##(2008-11#2)
the atrial septal defects##2##4##(2008-11#1)(2012-3#1)
the atrial septal##4##3##(2008-11#3)(2012-3#1)
the atrial##5##2##(1990-9#1)(2008-11#3)(2012-3#1)
the atrophic##2##2##(2010-5#1)(2011-7#1)
the atrophy of##2##3##(2008-7#1)(2011-2#1)
the atrophy##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
the atropine-resistant##2##2##(1990-5#1)(1997-4#1)
the atropine-sensitive##2##2##(1997-4#2)
the attached##3##2##(1995-2#1)(2008-11#1)(2011-2#1)
the attachment of the##3##4##(1994-12#1)(2008-10#1)(2009-4#1)
the attachment of##5##3##(1994-12#1)(2008-10#2)(2008-4#1)(2009-4#1)
the attachment##9##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-2#1)
the attack##3##2##(2008-9#1)(2009-10#1)(2013-1#1)
the attacked##2##2##(2010-3#1)(2012-3#1)
the attainable precision##2##3##(2008-10#2)
the attainable##3##2##(2008-10#3)
the attainment of##2##3##(2012-5#1)(2013-8#1)
the attempt to##2##3##(1997-6#2)
the attempt##3##2##(1997-6#2)(2010-4#1)
the attempts to##2##3##(2008-11#1)(2011-1#1)
the attempts##4##2##(1991-1#1)(2008-11#2)(2011-1#1)
the attention of the##3##4##(1991-6#1)(2008-10#2)
the attention of##7##3##(1991-6#1)(1994-2#1)(2008-10#2)(2008-6#1)(2009-8#1)(2013-1#1)
the attention##13##2##(1991-6#1)(1992-1#1)(1994-2#2)(2008-10#3)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the attentional blink##3##3##(2008-11#1)(2009-4#2)
the attentional##4##2##(2008-11#1)(2009-4#2)(2013-8#1)
the attenuated##5##2##(2008-7#2)(2008-9#2)(2012-2#1)
the attenuation##5##2##(2008-3#4)(2012-3#1)
the attine##3##2##(2008-8#3)
the attitude of##3##3##(1990-6#1)(2008-1#1)(2009-10#1)
the attitude##5##2##(1990-6#1)(2008-1#2)(2009-10#1)(2010-12#1)
the attitudes and##2##3##(1990-11#1)(2011-1#1)
the attitudes of##3##3##(1994-3#1)(2008-10#1)(2010-10#1)
the attitudes##5##2##(1990-11#1)(1994-3#1)(2008-10#1)(2010-10#1)(2011-1#1)
the attractiveness of##4##3##(2008-10#2)(2008-5#1)(2009-8#1)
the attractiveness##5##2##(2008-10#2)(2008-5#2)(2009-8#1)
the attributes##3##2##(1995-2#1)(2008-10#1)(2008-6#1)
the atypical clinical##2##3##(1990-5#1)(2008-7#1)
the atypical presentation##2##3##(2009-8#1)(2012-12#1)
the atypical##7##2##(1990-5#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
the audit##5##2##(1993-1#2)(2008-11#3)
the auditory nerve##3##3##(2008-8#1)(2008-9#2)
the auditory system##2##3##(1996-6#1)(2008-9#1)
the auditory##16##2##(1991-1#1)(1996-6#1)(2008-8#1)(2008-9#8)(2010-5#1)(2010-7#3)(2013-8#1)
the augmentation of glucose uptake##2##5##(2008-10#1)(2008-11#1)
the augmentation of##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
the augmentation##4##2##(1991-8#1)(1992-8#1)(2008-10#1)(2008-11#1)
the authentic##4##2##(1994-11#1)(2008-10#2)(2008-11#1)
the authenticity of##6##3##(1991-5#1)(2008-10#3)(2008-11#1)(2010-11#1)
the author and##2##3##(1991-11#1)(1996-12#1)
the author describes##4##3##(1991-1#1)(1991-2#1)(1992-2#1)(2008-11#1)
the author discusses the##4##4##(1991-2#1)(1992-2#1)(1993-2#1)(1994-6#1)
the author examines##2##3##(1993-1#1)(1994-1#1)
the author has##2##3##(2009-9#1)(2011-3#1)
the author in##2##3##(1997-6#1)(2008-12#1)
the author of this case study##2##6##(1991-1#1)(1992-3#1)
the author of##4##3##(1991-1#1)(1992-3#1)(2008-12#1)(2010-10#1)
the author points##2##3##(1996-6#1)(2008-12#1)
the author presents the##2##4##(1991-2#1)(2008-12#1)
the author presents##4##3##(1991-2#1)(1992-12#1)(2008-12#2)
the author##67##2##(1991-1#3)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#5)(1992-1#1)(1992-12#2)(1992-2#5)(1992-3#3)(1993-1#1)(1993-12#1)(1993-2#3)(1994-1#2)(1994-12#2)(1994-2#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2008-11#3)(2008-12#5)(2008-9#1)(2009-12#1)(2009-9#3)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)
the author's own##2##3##(2008-10#1)(2008-12#1)
the author's##15##2##(1991-1#1)(1991-3#1)(1992-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
the authority to##2##3##(1991-12#1)(1994-12#1)
the authors are aware of##2##5##(2008-7#1)(2010-1#1)
the authors are aware##3##4##(2008-7#1)(2010-1#1)(2011-2#1)
the authors argue that##2##4##(1993-3#1)(2008-12#1)
the authors believe that##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
the authors believe##4##3##(1994-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
the authors conclude that##2##4##(1994-2#1)(2008-11#1)
the authors describe a##2##4##(2008-11#1)(2009-9#1)
the authors describe##6##3##(1993-2#2)(1995-12#1)(2008-11#1)(2008-9#1)(2009-9#1)
the authors developed##2##3##(1993-12#1)(1996-3#1)
the authors discuss##2##3##(1993-3#1)(2007-12#1)
the authors examine the##2##4##(1991-12#2)
the authors examine##4##3##(1991-12#2)(1993-12#1)(1994-3#1)
the authors explore##3##3##(1991-12#1)(1994-3#1)(2010-10#1)
the authors have##4##3##(1993-2#1)(2008-10#1)(2008-4#1)(2008-9#1)
the authors measured##2##3##(1996-6#1)(2012-3#1)
the authors of##2##3##(1996-12#1)(2008-3#1)
the authors present##5##3##(1990-5#1)(1992-12#1)(1993-2#1)(2008-11#1)(2008-9#1)
the authors recommend##2##3##(2008-9#1)(2011-2#1)
the authors report the##2##4##(1990-9#1)(2008-7#1)
the authors report##4##3##(1990-9#1)(1996-2#1)(2008-11#1)(2008-7#1)
the authors show that##2##4##(1993-1#1)(1993-2#1)
the authors show##3##3##(1993-1#1)(1993-2#1)(2010-10#1)
the authors suggest##3##3##(1990-9#1)(1993-12#1)(1996-1#1)
the authors to##5##3##(1991-2#1)(1994-2#1)(2008-5#1)(2009-4#1)(2009-5#1)
the authors use##2##3##(2008-11#1)(2010-10#1)
the authors will##2##3##(1993-2#1)(2008-7#1)
the authors##119##2##(1990-5#1)(1990-9#3)(1991-1#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-5#1)(1993-1#1)(1993-12#3)(1993-2#7)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#7)(2010-12#1)(2010-6#1)(2011-2#7)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
the authors' experience of##2##4##(2008-12#1)(2009-11#1)
the authors' experience##4##3##(2008-12#1)(2009-11#1)(2010-11#1)(2011-3#1)
the authors' knowledge##5##3##(2007-11#1)(2008-10#1)(2008-7#1)(2010-9#1)(2012-3#1)
the authors' laboratory##2##3##(2008-10#1)(2008-4#1)
the authors' personal##2##3##(1993-3#1)(2012-3#1)
the authors'##22##2##(1990-11#1)(1990-9#1)(1992-1#1)(1993-3#2)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-3#1)(2012-3#2)
the autistic##2##2##(2008-11#2)
the autoclaved rockwool##2##3##(2008-10#2)
the autoclaved##3##2##(2008-10#3)
the autocorrelation##5##2##(2008-3#1)(2008-8#2)(2013-1#2)
the autocrine##3##2##(1993-3#1)(2008-11#1)(2013-1#1)
the autograft##2##2##(2009-3#1)(2012-3#1)
the autoimmune##2##2##(1997-2#1)(2008-10#1)
the autologous##3##2##(1995-12#1)(2008-11#1)(2012-12#1)
the automated marine pH sensor (AMpS)##2##6##(2008-10#2)
the automated method##2##3##(2008-10#2)
the automated##19##2##(2008-10#17)(2008-11#1)(2010-7#1)
the automatic##7##2##(2008-10#6)(2008-11#1)
the automation of the##2##4##(2008-10#2)
the automation of##5##3##(2008-10#5)
the automation##7##2##(2008-10#7)
the autonomic nervous system##7##4##(2008-10#1)(2008-2#1)(2009-11#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
the autonomic nervous##8##3##(2008-10#1)(2008-2#1)(2009-11#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
the autonomic##10##2##(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
the autophagy interactome##2##3##(2013-1#2)
the autophagy pathway##2##3##(2013-1#2)
the autophagy##5##2##(2013-1#5)
the autophosphorylation##3##2##(1993-6#1)(1993-8#1)(1995-2#1)
the autopsy##2##2##(1991-9#1)(1992-2#1)
the autoregressive##2##2##(2008-8#1)(2009-4#1)
the autosampler cup##3##3##(2008-10#3)
the autosampler##9##2##(2008-10#9)
the autosomal recessive##2##3##(2008-6#1)(2008-7#1)
the autosomes##2##2##(2008-12#2)
the autumn##6##2##(1994-12#1)(2008-10#2)(2008-11#1)(2010-8#2)
the autumnal##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
the auxiliary telescope##2##3##(2008-3#2)
the auxiliary##4##2##(1991-2#1)(2008-3#2)(2008-7#1)
the auxins##2##2##(2008-10#1)(2008-12#1)
the availability and##2##3##(1991-12#1)(1993-8#1)
the availability of a##5##4##(1994-8#1)(2008-10#1)(2008-8#2)(2011-2#1)
the availability of free##2##4##(2008-10#1)(2008-5#1)
the availability of partial##2##4##(1991-1#1)(2013-1#1)
the availability of simple##2##4##(1997-7#1)(2008-10#1)
the availability of the##4##4##(1994-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
the availability of##57##3##(1990-11#1)(1990-12#1)(1991-1#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#2)(1997-2#1)(1997-7#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#3)(2013-1#3)
the availability##62##2##(1990-11#1)(1990-12#1)(1991-1#2)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#2)(1997-2#1)(1997-7#1)(2008-10#16)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#3)(2013-1#3)
the available data##9##3##(1991-12#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-1#2)
the available evidence##5##3##(1992-2#1)(1993-12#1)(2008-12#2)(2012-3#1)
the available information on the##2##5##(1993-1#1)(2011-2#1)
the available information##6##3##(1993-1#1)(2008-10#1)(2010-10#1)(2011-2#2)(2012-2#1)
the available literature on the##2##5##(2008-11#1)(2008-4#1)
the available literature on##3##4##(2008-11#2)(2008-4#1)
the available literature##8##3##(1996-12#1)(2008-11#3)(2008-4#1)(2009-4#1)(2010-3#1)(2012-3#1)
the available resources##2##3##(1994-3#1)(2008-11#1)
the available##61##2##(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#2)(1994-3#1)(1994-5#2)(1996-1#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
the avascular##4##2##(2011-2#3)(2013-1#1)
the avenue##2##2##(2008-10#2)
the average and median ratios##2##5##(1996-12#2)
the average and##3##3##(1990-9#1)(1996-12#2)
the average annual##2##3##(1993-3#1)(2010-12#1)
the average cost of##2##4##(1993-1#1)(1995-12#1)
the average daily##2##3##(1992-12#1)(2008-9#1)
the average degree of substitution of methyl-β-cyclodextrin##2##7##(2011-2#2)
the average degree of##3##4##(1990-5#1)(2011-2#2)
the average detection##2##3##(2008-10#2)
the average duration of##3##4##(2008-1#1)(2011-2#2)
the average flow velocity of##2##5##(2011-2#2)
the average flow##3##3##(2008-3#1)(2011-2#2)
the average genetic distance##2##4##(2008-10#1)(2011-2#1)
the average genetic##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
the average improvement in##2##4##(2008-9#2)
the average mortality rate##2##4##(1995-12#1)(2008-7#1)
the average number of##9##4##(1991-7#1)(1992-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-12#1)(2012-3#2)
the average number##11##3##(1991-7#1)(1992-2#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-12#1)(2012-3#2)
the average of##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
the average prediction##2##3##(2008-10#2)
the average recoveries varied from##2##5##(2008-10#2)
the average recoveries##3##3##(2008-10#3)
the average recovery##3##3##(2008-10#3)
the average relative standard##2##4##(2008-10#2)
the average size of##5##4##(1995-8#1)(1996-1#1)(1997-2#1)(2008-5#1)(2011-1#1)
the average temperature##3##3##(2008-10#1)(2008-8#2)
the average time between##2##4##(2008-3#1)(2012-12#1)
the average time required was##3##5##(2010-6#3)
the average time##5##3##(2008-3#1)(2010-6#3)(2012-12#1)
the average value##4##3##(1993-3#1)(2008-10#2)(2011-2#1)
the average##159##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-12#3)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-5#1)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-8#4)(2008-1#1)(2008-10#46)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#7)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#3)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#4)
the averaging##3##2##(2008-3#1)(2008-6#1)(2008-9#1)
the avian##5##2##(1993-6#1)(1995-12#1)(1995-2#2)(2008-5#1)
the avirulence gene##4##3##(2008-10#4)
the avirulence##5##2##(2008-10#5)
the avocado##2##2##(2008-10#2)
the avoidance of##2##3##(1993-3#1)(2008-10#1)
the avrBs1##3##2##(2008-10#3)
the awareness and##2##3##(2010-12#1)(2013-1#1)
the awareness in##2##3##(2008-11#1)(2012-3#1)
the awareness of##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
the awareness##10##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
the axial skeleton##2##3##(2011-2#2)
the axial##8##2##(1995-8#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-2#3)
the axilla in##2##3##(1994-12#1)(2008-5#1)
the axilla##15##2##(1994-12#1)(2008-5#13)(2008-8#1)
the axillary lymph nodes##2##4##(1994-12#1)(2010-6#1)
the axillary microflora was##2##4##(2008-5#2)
the axillary microflora##4##3##(2008-5#4)
the axillary nerve##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
the axillary##13##2##(1994-12#1)(2008-5#7)(2008-8#1)(2008-9#1)(2010-6#2)(2013-1#1)
the axis of##5##3##(2008-2#1)(2008-3#2)(2008-8#1)(2013-8#1)
the axis##11##2##(2008-11#1)(2008-2#1)(2008-3#7)(2008-8#1)(2013-8#1)
the axon##3##2##(1995-2#1)(2012-2#2)
the axonal##4##2##(1995-2#1)(2008-7#2)(2012-2#1)
the axons##2##2##(1990-5#1)(2008-5#1)
the azo dye##2##3##(2008-10#1)(2011-1#1)
the azo##4##2##(2008-10#3)(2011-1#1)
the azobenzene##4##2##(2008-10#4)
the azygos vein##3##3##(2008-11#1)(2011-2#2)
the b##2##2##(2008-10#2)
the bZIP##2##2##(2008-9#1)(2013-8#1)
the baboon and rabbit##2##4##(2008-9#2)
the baboon and##3##3##(1993-6#1)(2008-9#2)
the baby##7##2##(1993-12#1)(1994-3#1)(1995-1#1)(2008-1#1)(2008-11#1)(2009-5#1)(2012-3#1)
the back and##2##3##(1997-3#1)(2008-5#1)
the back of the##2##4##(1991-6#1)(2008-9#1)
the back of##5##3##(1991-6#1)(2008-11#2)(2008-5#1)(2008-9#1)
the back or##2##3##(1997-4#1)(2008-12#1)
the back skin and##2##4##(1997-7#2)
the back##21##2##(1991-6#1)(1997-3#1)(1997-4#1)(1997-7#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-8#1)(2008-9#1)(2011-2#3)(2013-1#2)
the back-up device##2##3##(2008-9#2)
the back-up##3##2##(2008-11#1)(2008-9#2)
the backbone and##2##3##(2009-7#2)
the backbone of##4##3##(1993-12#1)(1995-8#1)(2008-9#1)(2013-1#1)
the backbone##10##2##(1993-12#1)(1994-5#1)(1995-8#1)(2008-9#1)(2009-7#5)(2013-1#1)
the background current##2##3##(2008-10#2)
the background electrolyte##2##3##(2008-10#2)
the background noise##2##3##(2008-10#2)
the background of the##2##4##(1995-2#1)(2008-12#1)
the background of##5##3##(1995-2#1)(2008-12#1)(2008-9#2)(2013-8#1)
the background signal##2##3##(2008-10#2)
the background signals##6##3##(2008-10#1)(2008-3#5)
the background##37##2##(1991-12#1)(1995-2#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#5)(2008-7#1)(2008-9#4)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
the backing##3##2##(2008-10#1)(2009-5#1)(2009-7#1)
the backpropagation algorithm##2##3##(2008-10#1)(2010-8#1)
the backscatter##3##2##(2008-3#3)
the backscattered light##2##3##(2008-2#2)
the backscattered##3##2##(2008-10#1)(2008-2#2)
the backscattering coefficient##5##3##(2008-3#5)
the backscattering cross section for##2##5##(2008-3#2)
the backscattering##10##2##(2008-3#10)
the backup##2##2##(1997-2#1)(2008-9#1)
the backward##4##2##(2008-3#2)(2009-3#1)(2010-10#1)
the bacteria on##2##3##(2008-10#2)
the bacteria were##3##3##(1996-12#1)(2008-10#2)
the bacteria##31##2##(1995-2#1)(1996-12#4)(1997-8#1)(2006-6#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
the bacterial cell##3##3##(2008-10#3)
the bacterial number##3##3##(2008-7#3)
the bacterial pathogen##2##3##(2008-10#2)
the bacterial populations##3##3##(2008-10#3)
the bacterial spot pathogen##3##4##(2008-10#3)
the bacterial strain##2##3##(2008-10#1)(2008-5#1)
the bacterial##52##2##(1991-12#2)(1991-3#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(2008-10#24)(2008-11#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-6#2)(2011-2#3)(2012-2#1)(2013-8#1)
the bacterially expressed##3##3##(1994-11#2)(1994-5#1)
the bacteriophage T4##2##3##(1990-5#1)(1995-6#1)
the bacteriophage##6##2##(1990-5#1)(1991-5#1)(1995-6#1)(1996-2#1)(2008-2#1)(2008-8#1)
the bacterium Erwinia##3##3##(2008-10#3)
the bacterium Pseudomonas##2##3##(2008-10#1)(2008-8#1)
the bacterium to##3##3##(2008-10#2)(2011-1#1)
the bacterium##24##2##(1992-11#1)(1996-11#1)(1996-12#1)(2008-10#16)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)
the baculovirus##7##2##(1995-6#1)(1997-3#3)(2008-11#1)(2008-7#2)
the baculovirus-insect cell system##3##4##(2008-11#2)(2008-7#1)
the bad##3##2##(1993-11#1)(2008-10#1)(2013-8#1)
the baffle system##3##3##(1995-3#3)
the bait-lamina test##2##3##(2008-11#2)
the baking industry##2##3##(2010-7#2)
the baking##3##2##(1990-3#1)(2010-7#2)
the balance between##9##3##(1993-1#1)(2008-1#1)(2008-10#1)(2008-11#3)(2009-12#1)(2010-7#2)
the balance of the##2##4##(2008-5#1)(2008-9#1)
the balance of##10##3##(1994-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
the balance##20##2##(1993-1#1)(1994-11#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#2)(2011-2#1)(2013-8#1)
the balanced##2##2##(2008-10#1)(2008-3#1)
the ball##5##2##(2008-11#1)(2008-6#3)(2011-2#1)
the balloon##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
the ban on##2##3##(1996-5#1)(2011-3#1)
the ban##6##2##(1995-6#3)(1996-1#1)(1996-5#1)(2011-3#1)
the band positions##2##3##(2008-10#1)(2008-9#1)
the band##6##2##(2008-10#3)(2008-2#1)(2008-9#1)(2012-12#1)
the bandgap##2##2##(2007-12#1)(2008-3#1)
the bands in##3##3##(2008-10#2)(2008-9#1)
the bands##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
the bandwidth of##2##3##(2008-10#1)(2008-3#1)
the bandwidth##5##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
the bare electrode##4##3##(2008-10#4)
the bare##9##2##(2008-10#8)(2008-3#1)
the barium hydroxide##2##3##(2008-10#2)
the barium##3##2##(2008-10#3)
the barley##9##2##(1997-3#1)(2008-10#7)(2008-9#1)
the barn owl##2##3##(1990-5#2)
the barn##3##2##(1990-5#2)(2008-9#1)
the barrier function of the##2##5##(2008-5#2)
the barrier function of##3##4##(2008-5#3)
the barrier function##7##3##(2008-5#6)(2008-7#1)
the barrier##14##2##(2008-10#3)(2008-11#1)(2008-5#8)(2008-7#1)(2013-1#1)
the barriers that##3##3##(2009-5#1)(2011-1#1)(2012-2#1)
the barriers to##5##3##(1993-12#1)(1996-5#1)(1997-2#1)(2008-11#1)(2013-1#1)
the barriers##13##2##(1993-12#1)(1994-1#2)(1996-5#1)(1997-2#1)(2008-11#3)(2009-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
the basal ES at the##2##5##(2012-2#2)
the basal ES##5##3##(2012-2#5)
the basal activity##2##3##(1992-7#1)(1995-6#1)
the basal and##3##3##(1996-2#2)(2009-10#1)
the basal body of the flagellum##2##6##(2008-7#2)
the basal expression##2##3##(1993-12#1)(2008-6#1)
the basal forebrain cholinergic neurons##2##5##(1991-12#2)
the basal ganglia of amphibians##2##5##(1997-3#2)
the basal ganglia##14##3##(1996-12#2)(1997-3#2)(2008-7#5)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#2)
the basal lamina##5##3##(2007-12#1)(2008-12#2)(2008-5#1)(2009-10#1)
the basal medium##4##3##(2008-10#1)(2008-11#3)
the basal or##2##3##(1995-2#1)(2008-6#1)
the basal part of the##2##5##(1991-9#2)
the basal##81##2##(1991-12#2)(1991-9#2)(1992-7#1)(1993-12#1)(1994-11#1)(1995-2#3)(1995-6#3)(1996-12#4)(1996-2#4)(1996-5#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#6)(2008-12#3)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#2)(2009-10#4)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#7)(2012-3#3)(2013-1#1)(2013-8#2)
the base and##2##3##(2008-10#2)
the base of the##12##4##(1991-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
the base of tongue##5##4##(2013-1#5)
the base of##23##3##(1991-2#1)(1992-9#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#6)
the base##42##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#2)(1992-9#1)(1995-6#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#6)
the baseline and##4##3##(1992-9#1)(2008-10#2)(2012-4#1)
the baseline drift##2##3##(2008-10#2)
the baseline separation of##2##4##(2008-10#2)
the baseline startle##2##3##(2008-11#2)
the baseline##37##2##(1992-9#1)(1993-3#1)(2008-10#13)(2008-11#4)(2008-7#4)(2009-12#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-4#1)(2013-1#4)
the basement membrane##9##3##(1995-12#1)(2009-10#5)(2012-2#2)(2013-8#1)
the bases of##7##3##(1991-5#1)(1994-3#1)(1995-2#1)(2008-10#4)
the bases##8##2##(1991-5#1)(1994-3#1)(1995-2#1)(2008-10#5)
the basic concepts of##3##4##(1993-3#1)(1994-3#1)(2011-2#1)
the basic concepts##5##3##(1993-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
the basic features of##4##4##(2008-10#1)(2008-3#1)(2011-2#2)
the basic mechanisms##3##3##(2010-10#1)(2010-9#1)(2013-1#1)
the basic methodology for##2##4##(2008-10#1)(2008-4#1)
the basic principles of the##2##5##(2008-9#1)(2011-7#1)
the basic principles of##5##4##(1997-3#1)(2008-2#1)(2008-9#1)(2010-7#1)(2011-7#1)
the basic principles##6##3##(1997-3#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-7#1)(2011-7#1)
the basic procedures##2##3##(2008-4#1)(2008-7#1)
the basic question##2##3##(2010-8#1)(2013-1#1)
the basic reproductive number##4##4##(2008-10#4)
the basic requirements##2##3##(2008-10#1)(2008-5#1)
the basic side chain##2##4##(1995-11#2)
the basic##83##2##(1990-12#1)(1991-12#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2011-7#1)(2012-3#1)(2013-1#2)
the basicity##2##2##(2008-10#2)
the basics of##3##3##(2008-4#2)(2013-1#1)
the basil##2##2##(2008-10#2)
the basilar artery##6##3##(1996-6#1)(1997-6#2)(2011-2#1)(2013-8#2)
the basilar##8##2##(1996-6#1)(1997-6#3)(2008-7#1)(2011-2#1)(2013-8#2)
the basin##2##2##(2008-11#2)
the basis and##2##3##(2008-12#1)(2011-2#1)
the basis for a##5##4##(2008-10#3)(2008-7#1)(2008-9#1)
the basis for the##16##4##(1990-5#1)(1991-9#1)(1995-1#1)(1995-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-7#1)(2010-12#1)(2012-2#1)(2012-3#2)
the basis for this effect is not##2##7##(2008-10#1)(2012-3#1)
the basis for this##3##4##(2008-10#1)(2010-3#1)(2012-3#1)
the basis for##49##3##(1990-5#1)(1991-9#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-8#1)
the basis of a##24##4##(1990-2#1)(1990-9#1)(1991-3#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2013-1#2)
the basis of an##4##4##(1994-6#1)(2008-10#2)(2010-11#1)
the basis of clinical##2##4##(2008-10#1)(2012-12#1)
the basis of data##2##4##(1990-9#1)(1994-5#1)
the basis of differences in##2##5##(2008-10#2)
the basis of its##5##4##(1992-12#1)(2008-10#3)(2008-3#1)
the basis of molecular##2##4##(2008-10#1)(2008-8#1)
the basis of personal experience##2##5##(1990-3#2)
the basis of previous##2##4##(1990-12#1)(1996-12#1)
the basis of the available##2##5##(1991-12#1)(2009-4#1)
the basis of the data obtained##3##6##(1991-2#1)(1993-6#1)(2008-10#1)
the basis of the data##4##5##(1991-2#1)(1993-6#1)(2008-10#2)
the basis of the mechanism##2##5##(2008-10#2)
the basis of the results of##4##6##(1991-9#1)(1995-12#1)(2008-10#2)
the basis of the results##6##5##(1991-3#1)(1991-9#1)(1995-12#1)(1997-6#1)(2008-10#2)
the basis of the##67##4##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#25)(2008-11#5)(2008-3#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-5#1)(2012-3#1)(2013-1#4)
the basis of their##18##4##(1990-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#1)
the basis of these results##7##5##(1993-1#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
the basis of these studies##2##5##(1994-5#1)(2008-10#1)
the basis of these##20##4##(1991-3#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-3#2)(2008-5#1)(2008-6#1)(2009-11#1)(2013-1#1)
the basis of this##8##4##(1991-2#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2011-2#1)(2012-3#1)
the basis of##290##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#3)(1990-9#5)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#6)(1991-6#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#6)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1995-12#4)(1995-2#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#88)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#4)(2009-11#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#3)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#12)(2013-8#1)
the basis##345##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#4)(1990-9#5)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#6)(1991-6#1)(1991-9#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#7)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#99)(2008-11#20)(2008-12#5)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#7)(2009-11#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#8)(2013-1#12)(2013-8#2)
the basitarsus##2##2##(2007-12#2)
the basolateral amygdala##5##3##(1990-5#1)(1993-6#3)(1997-7#1)
the basolateral membrane##3##3##(1993-3#1)(1994-3#1)(2008-11#1)
the basolateral##13##2##(1990-5#3)(1993-3#1)(1993-6#3)(1994-3#1)(1997-7#1)(2008-11#4)
the basophilic cells##2##3##(2008-7#2)
the batch components##2##3##(2011-2#2)
the batch culture##3##3##(1994-8#1)(2008-11#1)(2012-2#1)
the batch injection analysis##3##4##(2008-10#3)
the batch method##2##3##(2008-10#2)
the batch mode##2##3##(2008-10#2)
the batch##23##2##(1994-8#1)(2008-10#13)(2008-11#3)(2008-7#2)(2010-8#1)(2011-2#2)(2012-2#1)
the batchculture with medium exchange##2##5##(2008-11#2)
the batchwise method##2##3##(2008-10#2)
the batchwise##3##2##(2008-10#3)
the battery##4##2##(1996-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
the battle##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
the bc-1(2)##2##2##(2008-10#2)
the bcl-2 and bag-1##2##4##(2008-11#2)
the bcl-2 gene##2##3##(1993-3#1)(1994-3#1)
the bcl-2 transfected cells##2##4##(2008-11#2)
the bcl-2 transfected##4##3##(2008-11#4)
the bcl-2##12##2##(1993-3#3)(1994-3#1)(2008-11#8)
the bead injection##2##3##(2008-10#2)
the bead##6##2##(2008-10#3)(2008-11#1)(2008-4#2)
the beads##12##2##(1995-6#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)
the beam fanning##2##3##(2008-3#2)
the beam is##3##3##(2008-2#1)(2008-3#2)
the beam quality produced by the##2##6##(2008-3#2)
the beam quality##3##3##(2008-3#3)
the beam##28##2##(1997-8#2)(2008-10#2)(2008-2#2)(2008-3#19)(2009-11#1)(2009-7#1)(2012-3#1)
the beam's##2##2##(2008-3#2)
the beam-quality parameter##2##3##(2008-3#2)
the bean crop##2##3##(2008-10#2)
the bean population##2##3##(2008-8#2)
the bean##8##2##(2008-10#3)(2008-8#2)(2010-11#2)(2011-10#1)
the beans##4##2##(2008-10#1)(2008-3#3)
the beating##3##2##(2008-11#2)(2009-12#1)
the bed##8##2##(1994-2#1)(2008-10#1)(2008-11#3)(2008-7#3)
the beet cyst nematode##3##4##(2008-10#1)(2008-12#2)
the beet##6##2##(2008-10#4)(2008-12#2)
the beginning of a##5##4##(1991-12#1)(1997-2#1)(2008-10#2)(2012-2#1)
the beginning of each##5##4##(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)
the beginning of the##27##4##(1990-12#1)(1990-2#1)(1992-2#1)(1994-5#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2012-2#1)
the beginning of##61##3##(1990-12#1)(1990-2#2)(1991-12#2)(1992-2#1)(1993-12#2)(1994-3#1)(1994-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#17)(2008-11#6)(2008-12#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#2)(2013-1#3)
the beginning##72##2##(1990-12#1)(1990-2#2)(1991-12#2)(1992-2#1)(1993-12#2)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#17)(2008-11#9)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#2)(2012-7#1)(2013-1#3)
the beginnings of##2##3##(2008-10#2)
the behavior and##4##3##(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)
the behavior observed##4##3##(2008-10#2)(2008-7#1)(2009-11#1)
the behavior of a##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
the behavior of cells##2##4##(2008-11#1)(2009-12#1)
the behavior of its##2##4##(2008-8#1)(2009-5#1)
the behavior of the wild-type##2##5##(1995-6#1)(2008-10#1)
the behavior of the##12##4##(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2010-7#1)(2013-1#1)
the behavior of these pumps##2##5##(2011-2#2)
the behavior of these##3##4##(1996-5#1)(2011-2#2)
the behavior of##46##3##(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#2)(2008-10#7)(2008-11#5)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#1)(2009-12#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
the behavior##57##2##(1993-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#2)(2008-10#10)(2008-11#7)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#9)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
the behavioral and neurochemical##2##4##(2008-4#1)(2011-2#1)
the behavioral and##5##3##(1991-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
the behavioral tasks##2##3##(1997-2#2)
the behavioral##17##2##(1991-1#2)(1993-3#1)(1994-2#1)(1996-2#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
the behaviors##2##2##(2008-11#1)(2008-8#1)
the behaviour of a##2##4##(2008-10#1)(2008-12#1)
the behaviour of the##4##4##(2008-10#2)(2008-5#2)
the behaviour of##24##3##(1991-5#1)(1993-11#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#2)(2011-2#3)(2012-7#1)
the behaviour##26##2##(1991-5#1)(1993-11#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#3)(2011-2#3)(2012-7#1)
the behavioural##6##2##(1994-3#1)(1994-8#1)(1996-2#1)(2008-9#3)
the belief that##7##3##(1990-5#1)(1991-6#1)(1994-2#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
the beliefs##2##2##(1994-12#1)(2008-11#1)
the belly and groin##2##4##(1996-12#2)
the benchmark##3##2##(1991-2#1)(2008-5#1)(2013-1#1)
the beneficial effect of##5##4##(1996-1#1)(1997-5#1)(2008-10#2)(2013-7#1)
the beneficial effects of##4##4##(1996-2#1)(2008-10#1)(2008-7#1)(2012-12#1)
the beneficial effects##5##3##(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)
the beneficial role##2##3##(2008-1#1)(2010-1#1)
the beneficial##17##2##(1996-1#1)(1996-2#1)(1996-9#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-11#1)(2010-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
the benefit of the##6##4##(1992-2#1)(1997-2#1)(1997-8#1)(2008-11#1)(2013-1#2)
the benefit of##25##3##(1992-2#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
the benefit##30##2##(1992-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
the benefits and costs of##2##5##(1993-1#1)(2009-4#1)
the benefits and costs##3##4##(1993-1#1)(1995-3#1)(2009-4#1)
the benefits and drawbacks of##2##5##(2013-1#2)
the benefits and limitations of##2##5##(1997-3#1)(2008-10#1)
the benefits and risks of##4##5##(1993-1#1)(2009-12#1)(2010-4#1)(2012-2#1)
the benefits and##13##3##(1990-2#1)(1993-1#2)(1995-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2009-12#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#2)
the benefits of a##3##4##(1991-2#1)(1994-2#1)(1996-3#1)
the benefits of philopatry##2##4##(2008-8#2)
the benefits of the##7##4##(1996-3#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
the benefits of##44##3##(1990-11#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-3#3)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#2)(2010-10#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#3)
the benefits##68##2##(1990-11#1)(1990-2#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#2)(1994-2#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#3)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-12#1)(2009-4#1)(2010-10#2)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#5)
the benign##3##2##(2010-12#1)(2011-2#1)(2013-8#1)
the benomyl-resistant##2##2##(2008-10#2)
the benzene ring##2##3##(2008-10#2)
the benzene sulfonic acid monolayer film##2##6##(2008-10#2)
the benzene##6##2##(2008-10#6)
the benzodiazepine receptor##2##3##(1994-2#1)(1995-11#1)
the benzodiazepine##6##2##(1994-2#1)(1995-11#5)
the benzodiazepine-Gaba receptor complex##2##4##(1991-1#2)
the benzoyl##3##2##(1990-9#1)(1991-3#1)(2008-10#1)
the bereaved##2##2##(1991-2#1)(2008-12#1)
the berry surface##2##3##(2008-10#2)
the best accuracy##2##3##(2008-10#1)(2011-2#1)
the best alternative##2##3##(2008-10#2)
the best analytical performance##2##4##(2008-10#2)
the best analytical##4##3##(2008-10#4)
the best approach for##2##4##(1996-1#1)(2008-10#1)
the best approach##3##3##(1996-1#1)(2008-10#1)(2009-12#1)
the best available##2##3##(2008-3#1)(2008-9#1)
the best basis##2##3##(2008-10#1)(2010-8#1)
the best candidate##2##3##(2006-6#1)(2008-10#1)
the best care##2##3##(1992-11#1)(2010-11#1)
the best chance of##3##4##(1994-6#1)(1997-3#1)(2013-1#1)
the best choice for##5##4##(2008-10#4)(2012-3#1)
the best choice##6##3##(2008-10#5)(2012-3#1)
the best combination of##3##4##(1993-1#1)(2008-12#1)(2008-7#1)
the best combination##4##3##(1993-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
the best compromise##2##3##(2008-10#1)(2009-7#1)
the best conditions for the##2##5##(2008-10#1)(2011-2#1)
the best conditions for##5##4##(2008-10#4)(2011-2#1)
the best conditions##9##3##(2008-10#6)(2008-11#1)(2011-2#1)(2013-1#1)
the best diagnostic##3##3##(1990-9#1)(1991-2#1)(2013-8#1)
the best extraction efficiency##2##4##(2008-10#2)
the best fit##3##3##(1996-12#1)(2008-10#2)
the best for##5##3##(1994-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
the best interests of##3##4##(1995-2#1)(2010-9#2)
the best jump height##2##4##(2009-1#2)
the best known##5##3##(1995-5#1)(1996-3#1)(2008-10#1)(2008-12#2)
the best long-term##2##3##(2008-10#1)(2009-8#1)
the best method of##2##4##(2008-3#1)(2013-1#1)
the best method##4##3##(1990-12#1)(1994-5#1)(2008-3#1)(2013-1#1)
the best model##3##3##(2008-10#2)(2011-2#1)
the best modifier##2##3##(2008-10#2)
the best of our knowledge##15##5##(1994-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
the best of our##16##4##(1994-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
the best of##21##3##(1994-1#1)(1994-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
the best one##2##3##(1991-3#1)(2011-2#1)
the best option##2##3##(1996-3#1)(2008-9#1)
the best peak##2##3##(2008-10#2)
the best performance in##2##4##(2008-10#2)
the best performance of##3##4##(2008-10#2)(2008-11#1)
the best performance was##2##4##(2008-10#2)
the best performance##9##3##(1995-3#1)(2008-10#7)(2008-11#1)
the best possible##8##3##(1993-12#1)(1994-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
the best prediction results##2##4##(2008-10#2)
the best prediction##3##3##(1992-12#1)(2008-10#2)
the best predictor of##2##4##(2009-8#1)(2011-2#1)
the best predictors of##2##4##(2008-10#1)(2008-12#1)
the best predictors##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
the best recoveries##2##3##(2008-10#2)
the best recovery##2##3##(2008-10#2)
the best result##5##3##(2008-10#5)
the best results were obtained##4##5##(2008-10#3)(2008-5#1)
the best results##15##3##(1990-11#1)(2008-10#9)(2008-11#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)
the best selectivity for the##2##5##(2008-10#2)
the best selectivity in##2##4##(2008-10#2)
the best selectivity##6##3##(2008-10#6)
the best separation##3##3##(2008-10#3)
the best single##2##3##(1991-12#1)(2008-3#1)
the best solution##2##3##(1990-3#1)(2011-2#1)
the best strategy##2##3##(2011-2#1)(2011-3#1)
the best system##2##3##(1991-2#1)(2012-2#1)
the best temperatures for pyrolysis and atomization were##2##8##(2008-10#2)
the best temperatures for##3##4##(2008-10#3)
the best therapy##2##3##(1993-12#1)(2013-1#1)
the best treatment##4##3##(1997-8#1)(2008-7#2)(2012-3#1)
the best value##2##3##(2008-10#1)(2008-3#1)
the best way to integrate##2##5##(1997-2#1)(2008-9#1)
the best way to##4##4##(1994-3#1)(1997-2#1)(2008-9#2)
the best way##5##3##(1994-3#1)(1997-2#1)(2008-9#2)(2010-12#1)
the best ways##2##3##(2008-10#1)(2008-11#1)
the best##324##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#132)(2008-11#14)(2008-12#9)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#10)(2009-1#2)(2009-11#1)(2009-12#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#5)
the best-focus frame##2##3##(2008-3#2)
the best-known##2##2##(2008-8#1)(2008-9#1)
the beta 1##4##3##(1992-2#2)(1992-3#1)(1995-6#1)
the beta 2 strand of WW##2##6##(2008-11#2)
the beta 2 strand of##3##5##(2008-11#3)
the beta 2 strand##4##4##(2008-11#4)
the beta 2##6##3##(1993-6#1)(2008-11#4)(2010-6#1)
the beta 3-adrenoceptor##3##3##(1995-11#3)
the beta gamma##2##3##(1992-9#1)(1993-6#1)
the beta subunit of##3##4##(1993-12#1)(1994-11#1)(1995-2#1)
the beta subunit##12##3##(1992-3#1)(1992-9#3)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#2)
the beta##42##2##(1991-5#2)(1991-6#1)(1992-2#2)(1992-3#3)(1992-9#4)(1993-12#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#3)(1995-2#1)(1995-6#2)(1995-8#2)(1996-11#1)(1997-1#1)(2008-10#4)(2008-11#5)(2009-7#1)(2010-5#1)(2010-6#1)
the beta- and##2##3##(1993-8#1)(2008-10#1)
the beta-1##3##2##(2008-10#3)
the beta-CD cavity##2##3##(2008-10#2)
the beta-CD##4##2##(2008-10#3)(2008-11#1)
the beta-CGRP gene##2##3##(1992-6#2)
the beta-MyHC gene##2##3##(1995-2#2)
the beta-actin##2##2##(1996-2#1)(2008-11#1)
the beta-binomial distribution and##2##4##(2008-10#2)
the beta-binomial distribution to##2##4##(2008-10#2)
the beta-binomial distribution##11##3##(2008-10#11)
the beta-binomial##19##2##(2008-10#19)
the beta-binomial-based function##2##3##(2008-10#2)
the beta-carboline##2##2##(2008-10#2)
the beta-chain of##3##3##(1995-3#2)(1995-6#1)
the beta-chain##4##2##(1993-8#1)(1995-3#2)(1995-6#1)
the beta-cyclodextrin##2##2##(2008-10#2)
the beta-gal##2##2##(1997-8#1)(2008-7#1)
the beta-galactosidase##4##2##(1994-11#1)(1997-8#2)(2008-11#1)
the beta-glucuronidase##3##2##(2008-10#2)(2008-9#1)
the beta-peptide##3##2##(2008-5#3)
the beta-secretase##2##2##(2008-11#2)
the beta-tubulin gene##5##3##(2008-10#5)
the beta-tubulin##7##2##(2008-10#6)(2010-3#1)
the beta-type complex of Y-CPApK##2##5##(2008-10#2)
the better##14##2##(1994-3#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-5#1)(2010-8#1)(2012-2#1)
the bias and##2##3##(1995-12#1)(1996-3#1)
the bias error##2##3##(2008-10#2)
the bias##7##2##(1995-12#1)(1996-3#1)(2008-10#4)(2013-8#1)
the biceps##3##2##(1990-8#1)(2008-10#1)(2008-12#1)
the bidirectional##3##2##(2008-3#2)(2008-6#1)
the bifunctional fusion protein RM4/TNF##2##5##(1997-2#2)
the bifurcation##3##2##(2008-11#1)(2008-3#1)(2009-8#1)
the big##2##2##(1995-6#1)(2009-8#1)
the biggest impact##2##3##(2010-7#1)(2012-12#1)
the biggest##10##2##(1991-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)
the bilateral##10##2##(1990-9#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-7#3)(2008-9#1)(2011-3#1)(2013-1#1)
the bilayer##8##2##(1992-9#1)(1993-8#1)(2008-10#5)(2008-8#1)
the bilayers##2##2##(2008-10#2)
the bile duct##2##3##(1991-8#1)(2013-1#1)
the bile##8##2##(1991-3#2)(1991-8#1)(2008-10#1)(2008-11#2)(2012-2#1)(2013-1#1)
the biliary tree##2##3##(2008-11#1)(2012-12#1)
the biliary##15##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-9#5)(2008-11#1)(2010-12#3)(2012-12#1)(2012-2#1)
the bill##4##2##(1995-6#3)(1996-5#1)
the bimodal response##2##3##(2008-10#2)
the bimodal##5##2##(1991-2#1)(2008-10#2)(2008-12#1)(2009-7#1)
the binary complexes of##2##4##(2008-10#2)
the binary form of Taylor's power law##2##7##(2008-10#2)
the binary form of the##2##5##(2008-10#2)
the binary form of##4##4##(2008-10#4)
the binary mixture of##2##4##(2008-10#2)
the binary power law##4##4##(2008-10#4)
the binary power##5##3##(2008-10#5)
the binary##20##2##(2008-10#20)
the binder##2##2##(2008-10#2)
the binding ability of##2##4##(2008-10#2)
the binding affinity##5##3##(1991-12#1)(1995-11#2)(1997-3#1)(2008-10#1)
the binding and##4##3##(1991-9#1)(1994-5#1)(1995-2#1)(2008-10#1)
the binding between##2##3##(2009-10#1)(2011-2#1)
the binding capacity of##2##4##(1991-5#1)(2008-8#1)
the binding cavity##2##3##(2010-12#1)(2013-8#1)
the binding characteristics of##7##4##(1991-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)
the binding constant of the##2##5##(2008-10#2)
the binding constant##6##3##(1994-5#1)(2008-10#5)
the binding constants##2##3##(1992-4#1)(2008-10#1)
the binding domain##2##3##(2008-8#2)
the binding energies##2##3##(2010-7#2)
the binding kinetics##2##3##(2008-10#1)(2009-10#1)
the binding number##3##3##(2008-10#3)
the binding of ATP##2##4##(1991-9#1)(1993-6#1)
the binding of FSH##2##4##(1995-11#2)
the binding of [3H]MK-801 was increased in pons and medulla and##2##11##(1997-2#2)
the binding of [3H]MK-801##3##4##(1997-2#3)
the binding of [3H]flunitrazepam to##2##5##(1996-2#2)
the binding of [3H]prazosin to##2##5##(1991-6#2)
the binding of a##4##4##(1995-2#1)(2008-10#1)(2008-3#1)(2010-4#1)
the binding of casein kinase I##2##6##(1994-11#2)
the binding of plasmid DNA to##2##6##(2008-8#2)
the binding of the##8##4##(1993-6#1)(1994-5#1)(1994-6#1)(2008-10#2)(2008-7#1)(2013-1#2)
the binding of these##2##4##(1994-5#1)(1995-2#1)
the binding of##88##3##(1990-11#2)(1990-5#2)(1990-6#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-6#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#8)(1995-12#1)(1995-2#6)(1995-6#3)(1996-12#1)(1996-2#3)(1997-2#3)(1997-9#1)(2006-6#1)(2007-11#1)(2008-10#12)(2008-11#3)(2008-3#2)(2008-7#3)(2008-8#5)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
the binding process##4##3##(1991-12#1)(1997-2#1)(2008-10#2)
the binding site in##2##4##(1990-8#1)(2008-10#1)
the binding site of##4##4##(1992-9#1)(1993-2#1)(2008-10#1)(2008-8#1)
the binding site##9##3##(1990-8#1)(1992-9#1)(1993-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
the binding sites##8##3##(1994-5#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-3#2)
the binding to DREF##2##4##(1995-6#2)
the binding to##3##3##(1995-6#2)(2009-8#1)
the binding was##3##3##(1993-6#1)(1994-2#1)(2010-5#1)
the binding##190##2##(1990-11#2)(1990-5#2)(1990-6#2)(1990-8#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#4)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#3)(1994-5#9)(1994-6#1)(1994-8#2)(1995-11#11)(1995-12#3)(1995-2#8)(1995-6#5)(1995-8#1)(1996-12#1)(1996-2#5)(1996-5#1)(1997-2#4)(1997-3#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-11#1)(2008-10#45)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#11)(2008-9#5)(2009-10#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#3)(2011-2#2)(2011-3#2)(2012-2#4)(2013-1#2)(2013-8#1)
the binomial distribution##6##3##(2008-10#6)
the binomial##8##2##(2008-10#8)
the binuclear centre##2##3##(1997-7#2)
the binuclear##3##2##(1995-2#1)(1997-7#2)
the bioaccumulation of##2##3##(2008-12#2)
the bioaccumulation##3##2##(2008-11#1)(2008-12#2)
the bioactive##7##2##(1994-8#1)(2008-12#1)(2009-7#2)(2011-1#1)(2012-2#1)(2013-1#1)
the bioanalytical##3##2##(2008-10#3)
the bioassay and##2##3##(2008-10#2)
the bioassay##5##2##(2008-10#3)(2008-12#1)(2008-4#1)
the bioavailability of##6##3##(2008-10#3)(2009-12#1)(2010-7#1)(2011-2#1)
the bioavailability##8##2##(2008-10#3)(2008-11#1)(2009-12#1)(2010-7#1)(2011-2#1)(2011-3#1)
the biocatalytic##3##2##(2008-10#3)
the biochemical and##3##3##(1993-8#1)(1994-8#1)(2012-2#1)
the biochemical basis##2##3##(1990-8#1)(2009-8#1)
the biochemical effects of##2##4##(1993-8#1)(2010-1#1)
the biochemical mechanism##2##3##(2010-7#2)
the biochemical pathways and##2##4##(2011-1#2)
the biochemical properties and##2##4##(1995-6#1)(1997-7#1)
the biochemical properties##3##3##(1995-6#1)(1997-7#1)(2009-3#1)
the biochemical##28##2##(1990-8#1)(1991-9#1)(1992-9#1)(1993-8#3)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-7#2)(2011-1#2)(2012-2#1)(2012-3#1)
the biochemistry##2##2##(1997-8#1)(2008-11#1)
the biocontrol activity of CHA0##2##5##(2008-10#2)
the biocontrol activity of##5##4##(2008-10#5)
the biocontrol agent Trichoderma##2##4##(2008-10#2)
the biocontrol agent was##2##4##(2008-10#2)
the biocontrol agent##8##3##(2008-10#8)
the biocontrol agents##6##3##(2008-10#6)
the biocontrol fungus Trichoderma##3##4##(2008-10#3)
the biocontrol isolates were##3##4##(2008-10#3)
the biocontrol isolates##5##3##(2008-10#5)
the biocontrol strain##2##3##(2008-10#2)
the biocontrol##35##2##(2008-10#35)
the biodegradation of##3##3##(2008-10#1)(2009-3#2)
the biodiversity##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
the biofilm formation##2##3##(2009-6#1)(2013-8#1)
the biofilm were##2##3##(2008-7#2)
the biofilm##9##2##(2008-7#4)(2009-4#1)(2009-6#1)(2013-1#2)(2013-8#1)
the biogenesis of##3##3##(2008-11#1)(2010-5#1)(2011-2#1)
the biogeochemical##2##2##(2008-10#2)
the biologic activity of##2##4##(1995-3#1)(1995-5#1)
the biologic##8##2##(1992-10#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-3#1)(2008-9#1)(2013-1#2)
the biological action of##5##4##(1992-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2013-7#1)
the biological activities of the##3##5##(2010-5#1)(2013-8#2)
the biological activities##4##3##(2010-5#1)(2011-3#1)(2013-8#2)
the biological activity of the##3##5##(1997-7#1)(2008-8#1)(2009-3#1)
the biological activity of##11##4##(1992-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#2)(2009-3#1)(2012-2#1)
the biological activity##16##3##(1992-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-3#2)(2010-12#1)(2010-6#1)(2012-2#1)
the biological and genetic##2##4##(2008-7#1)(2008-9#1)
the biological and##5##3##(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)
the biological aspects##2##3##(2012-12#1)(2012-3#1)
the biological basis of##2##4##(1993-9#1)(2013-1#1)
the biological behaviour of##2##4##(1993-6#1)(2008-7#1)
the biological characteristics##2##3##(2008-4#1)(2013-8#1)
the biological consequences of##2##4##(1997-7#1)(2008-7#1)
the biological control activity##2##4##(2008-10#2)
the biological control agent##2##4##(2008-10#1)(2008-5#1)
the biological control of##9##4##(2008-10#8)(2008-8#1)
the biological control##16##3##(2008-10#13)(2008-5#1)(2008-8#2)
the biological effect of##4##4##(1991-12#1)(1996-12#1)(2008-10#1)(2008-8#1)
the biological effects of##5##4##(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
the biological effects##6##3##(1995-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
the biological importance of##3##4##(2008-10#2)(2012-3#1)
the biological markers##2##3##(1991-11#1)(1993-2#1)
the biological relevance of##2##4##(1997-1#1)(2009-8#1)
the biological sample##2##3##(2008-10#2)
the biological significance of the##2##5##(1996-3#1)(2010-12#1)
the biological significance of##6##4##(1990-9#1)(1996-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
the biological##127##2##(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-10#40)(2008-11#7)(2008-4#3)(2008-5#6)(2008-7#4)(2008-8#6)(2008-9#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
the biologically active##5##3##(1992-5#1)(1993-3#1)(1994-5#1)(2008-8#1)(2010-5#1)
the biologically##8##2##(1992-5#1)(1993-3#1)(1994-5#1)(1995-2#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-5#1)
the biology and##5##3##(1993-11#1)(2008-10#2)(2008-12#1)(2008-6#1)
the biology of the##6##4##(2008-10#4)(2008-12#1)(2008-5#1)
the biology of##17##3##(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-3#2)
the biology##23##2##(1993-11#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)
the bioluminescence inhibition of##3##4##(2008-10#3)
the bioluminescence inhibition##4##3##(2008-10#4)
the biomarker##2##2##(2008-11#1)(2010-9#1)
the biomass of##3##3##(2008-10#2)(2008-8#1)
the biomass##16##2##(2008-10#7)(2008-12#2)(2008-7#4)(2008-8#2)(2008-9#1)
the biomaterial##2##2##(2008-10#1)(2009-12#1)
the biomechanical properties of##2##4##(2009-3#1)(2009-8#1)
the biomechanical properties##3##3##(2008-5#1)(2009-3#1)(2009-8#1)
the biomechanical##7##2##(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-9#1)(2013-1#2)
the biomechanics of##3##3##(2013-1#3)
the biomedical##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
the biomolecules##2##2##(2008-9#1)(2011-2#1)
the biophysical##4##2##(1996-12#1)(1997-1#1)(2008-11#1)(2009-9#1)
the biopolymer##2##2##(2008-10#1)(2008-11#1)
the biopreparation treatments and the older control treatment##2##8##(2008-10#2)
the biopsies##4##2##(1990-11#1)(1991-11#1)(1994-1#1)(2008-11#1)
the biopsy##2##2##(2009-3#1)(2011-2#1)
the bioreactor##20##2##(2008-11#16)(2008-7#2)(2010-5#1)(2012-2#1)
the biosafety##2##2##(2008-11#1)(2008-8#1)
the biosensor for##3##3##(2008-10#3)
the biosensor performance##2##3##(1994-8#1)(2008-10#1)
the biosensor was##4##3##(2008-10#4)
the biosensor##44##2##(1994-8#1)(2008-10#43)
the biosensors were##2##3##(2008-10#2)
the biosensors##8##2##(2008-10#8)
the biosorption##2##2##(2011-2#2)
the biosynthesis of active##2##4##(1994-5#1)(2012-3#1)
the biosynthesis of the##6##4##(1993-2#1)(1993-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
the biosynthesis of##23##3##(1990-5#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
the biosynthesis##26##2##(1990-5#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
the biosynthetic##2##2##(1990-12#1)(2012-2#1)
the biotech industry##2##3##(2008-11#2)
the biotechnology industry##4##3##(2008-10#2)(2008-7#2)
the biotic##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
the biotin##3##2##(2008-10#3)
the biotin/avidin interaction##2##3##(2008-10#2)
the biotinylated polypyrrole/avidin assembly##2##4##(2008-10#2)
the biotinylated##6##2##(1992-6#1)(1995-6#1)(1995-8#1)(2008-10#3)
the biotinylation of the cap structure##2##6##(1997-2#2)
the biotinylation of##3##3##(1997-2#2)(2008-4#1)
the biotransformation of xenobiotics##2##4##(1990-6#1)(2008-11#1)
the biotransformation of##5##3##(1990-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
the biotransformation##7##2##(1990-6#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
the biotrophic fungus##2##3##(2008-10#2)
the biovolume##3##2##(2008-11#3)
the bipartite##3##2##(2008-10#3)
the biphosphonate##2##2##(1991-11#1)(2013-1#1)
the bird##3##2##(2008-8#2)(2012-2#1)
the birds with##2##3##(2008-8#2)
the birds##7##2##(1991-11#2)(1992-2#1)(2008-5#1)(2008-8#2)(2008-9#1)
the birefringence##3##2##(2007-11#1)(2008-3#1)(2010-4#1)
the birth of##4##3##(1991-6#1)(1996-8#1)(1996-9#1)(2008-12#1)
the birth##6##2##(1991-6#1)(1996-8#1)(1996-9#1)(2008-11#1)(2008-12#1)(2009-11#1)
the bis(phenylsulfonyl)diene##2##2##(1996-5#2)
the bis-phosphorylated##2##2##(2010-12#2)
the bis[[(dimethylamino)methyl]furans] in##2##3##(1992-8#2)
the bismuth film electrode##2##4##(2008-10#2)
the bismuth##4##2##(2008-10#3)(2010-11#1)
the bismuth(III)##2##2##(2008-10#2)
the bisphenol##2##2##(2008-10#1)(2013-1#1)
the bisphosphonate##2##2##(2008-11#1)(2010-3#1)
the bitch##2##2##(1996-11#2)
the bite of##2##3##(2010-1#2)
the bite##3##2##(2010-1#2)(2010-9#1)
the bits##2##2##(2007-11#1)(2008-4#1)
the biuret method##3##3##(2008-10#2)(2009-8#1)
the biuret##5##2##(2008-10#4)(2009-8#1)
the bivariate##3##2##(1994-2#1)(2008-8#1)(2012-3#1)
the black##6##2##(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
the bladder and##3##3##(2008-10#1)(2011-2#2)
the bladder cases##2##3##(2008-10#2)
the bladder is a rare##3##5##(1992-12#1)(2010-12#1)(2013-1#1)
the bladder is a##4##4##(1992-12#1)(2008-10#1)(2010-12#1)(2013-1#1)
the bladder wall##4##3##(1992-12#3)(1993-11#1)
the bladder##41##2##(1991-9#1)(1992-12#5)(1992-3#1)(1993-11#1)(1993-2#1)(1994-3#2)(1994-8#1)(2008-10#17)(2008-12#1)(2010-12#2)(2011-2#3)(2012-12#2)(2013-1#4)
the blank values##2##3##(2008-10#2)
the blank##18##2##(2008-10#18)
the blastocyst##4##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
the bleaching##2##2##(2008-10#1)(2012-2#1)
the bleeding##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
the blend##2##2##(2009-8#2)
the blended##2##2##(2008-5#2)
the blind##4##2##(2008-7#3)(2008-9#1)
the blister rust##2##3##(2008-10#2)
the block##3##2##(1997-1#1)(2008-8#1)(2010-7#1)
the blockade of##3##3##(1990-5#1)(2008-11#2)
the blocks##2##2##(2008-11#1)(2008-9#1)
the blood and##3##3##(1996-5#1)(2008-10#1)(2009-9#1)
the blood flow of##3##4##(2008-10#3)
the blood flow##6##3##(2008-10#4)(2008-12#1)(2012-3#1)
the blood glucose level##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
the blood glucose##6##3##(1993-1#1)(2008-1#1)(2008-10#2)(2011-3#1)(2012-2#1)
the blood is##3##3##(1991-11#1)(1992-5#1)(2008-10#1)
the blood pressure and##2##4##(1990-5#1)(2008-7#1)
the blood pressure is##2##4##(1997-5#1)(2008-5#1)
the blood pressure##8##3##(1990-5#1)(1992-2#1)(1997-5#1)(2008-5#2)(2008-7#2)(2012-3#1)
the blood samples##3##3##(1990-12#1)(2008-5#1)(2011-1#1)
the blood sugar##2##3##(1994-8#1)(1996-11#1)
the blood supply##4##3##(1995-6#1)(1996-9#3)
the blood vessels of recipient##2##5##(2008-11#2)
the blood vessels of##3##4##(2008-11#3)
the blood vessels##4##3##(1996-3#1)(2008-11#3)
the blood##84##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#4)(1997-1#2)(1997-5#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#5)(2009-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)
the blood-brain barrier and##2##4##(2010-12#1)(2012-2#1)
the blood-brain barrier##11##3##(1990-5#2)(1990-7#1)(1992-3#2)(1994-5#1)(1995-2#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
the blood-labyrinth barrier##5##3##(2009-8#4)(2012-2#1)
the blood-testis barrier (BTB)##2##4##(2009-10#1)(2012-2#1)
the blood-testis barrier##3##3##(2009-10#2)(2012-2#1)
the bloodstream##2##2##(2008-7#1)(2010-12#1)
the bloom##3##2##(2008-8#3)
the blubber##4##2##(2008-10#4)
the blue crab Callinectes sapidus##2##5##(1994-11#2)
the blue spectral region##2##4##(2007-11#1)(2008-3#1)
the blue##19##2##(1990-9#1)(1992-11#1)(1994-11#2)(1994-5#1)(2007-11#1)(2008-10#8)(2008-3#4)(2008-5#1)
the blue-green##2##2##(2008-10#1)(2013-1#1)
the board##6##2##(1991-1#1)(1995-12#3)(1995-6#1)(2010-3#1)
the board's role in##2##4##(1991-12#1)(2008-11#1)
the board's role##3##3##(1991-12#1)(1995-12#1)(2008-11#1)
the body and is##2##4##(2008-10#1)(2011-2#1)
the body and##8##3##(1992-3#1)(2008-10#3)(2008-5#2)(2008-6#1)(2011-2#1)
the body are##2##3##(2008-10#1)(2009-7#1)
the body cavity##3##3##(1996-12#1)(1997-3#1)(2008-9#1)
the body of##7##3##(1995-12#1)(2008-10#3)(2008-5#1)(2010-5#1)(2011-2#1)
the body temperature##2##3##(2008-6#1)(2008-8#1)
the body weight of##2##4##(2010-5#1)(2013-1#1)
the body##81##2##(1991-11#1)(1992-3#3)(1993-3#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-12#2)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-5#9)(2008-6#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#8)(2013-1#4)(2013-7#3)(2013-8#1)
the body's##2##2##(2008-4#1)(2008-5#1)
the bolus##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
the bond strength of##2##4##(2013-1#2)
the bond##5##2##(1991-9#1)(2008-9#2)(2013-1#2)
the bonded##3##2##(1992-6#1)(1997-2#1)(2008-10#1)
the bonding force between the##2##5##(2008-10#2)
the bone and soft##2##4##(2010-6#1)(2011-2#1)
the bone and##5##3##(2008-10#1)(2010-6#2)(2011-2#1)(2013-1#1)
the bone defect in the mastoid area##2##7##(2008-7#2)
the bone in the##2##4##(2007-8#1)(2009-7#1)
the bone in##3##3##(2007-8#1)(2009-7#1)(2010-6#1)
the bone marrow aspirate##2##4##(2008-11#2)
the bone marrow##16##3##(1990-6#1)(1993-8#2)(1996-3#1)(2008-10#1)(2008-11#4)(2008-7#1)(2010-6#3)(2010-8#1)(2011-2#2)
the bone union##4##3##(2007-8#4)
the bone##51##2##(1990-6#1)(1991-11#4)(1991-8#1)(1993-8#2)(1996-3#1)(2007-8#5)(2008-10#3)(2008-11#5)(2008-12#1)(2008-7#4)(2008-9#1)(2009-7#2)(2010-3#1)(2010-6#6)(2010-8#1)(2011-2#9)(2012-12#2)(2013-1#1)(2013-8#1)
the bone-resorbing activity of mature osteoclasts through##2##7##(2008-11#2)
the bone-resorbing activity of##3##4##(2008-11#3)
the bone-resorbing##4##2##(2008-11#4)
the bony##3##2##(2008-7#1)(2009-11#1)(2009-4#1)
the bootstrap analysis##2##3##(2008-10#2)
the bootstrap##3##2##(2008-10#3)
the border of##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
the border##6##2##(1997-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
the border-crossing adjustment##2##3##(1995-12#2)
the borderline##4##2##(1990-2#2)(1990-9#1)(1992-1#1)
the borders of the##2##4##(1990-7#1)(2008-10#1)
the borders of##3##3##(1990-7#1)(2008-10#2)
the botanical origin of the##2##5##(2008-10#2)
the botanical##3##2##(2008-10#3)
the both##4##2##(2008-10#1)(2008-9#1)(2013-1#2)
the bottleneck##2##2##(2008-10#1)(2010-7#1)
the bottom of the##6##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-4#1)
the bottom of##8##3##(1992-4#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-4#1)
the bottom phase##2##3##(2008-10#2)
the bottom##20##2##(1992-4#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-11#1)(2012-4#1)
the bound CaD*##2##3##(1994-5#2)
the bound thymocytes on##2##4##(2008-8#2)
the bound##15##2##(1990-10#1)(1990-12#2)(1994-5#2)(1995-11#1)(2008-10#3)(2008-7#1)(2008-8#2)(2012-12#1)(2012-2#2)
the boundaries##4##2##(1997-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
the boundary between##3##3##(1994-12#1)(1995-6#1)(2013-1#1)
the boundary layer##3##3##(2008-11#2)(2008-3#1)
the boundary of the##2##4##(1996-12#1)(2008-10#1)
the boundary of##3##3##(1996-12#1)(2008-10#1)(2009-8#1)
the boundary##14##2##(1994-12#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2009-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
the bovine NPR-B##2##3##(1994-8#2)
the bovine brain##2##3##(1991-5#1)(1997-2#1)
the bovine natriuretic peptide receptor-B##2##5##(1994-8#2)
the bovine##14##2##(1991-5#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-2#2)(1994-8#4)(1996-3#1)(1997-2#1)(2008-10#1)(2008-8#1)
the bowel and##2##3##(1996-3#1)(1996-6#1)
the bowel wall##4##3##(2009-12#2)(2012-2#2)
the bowel##7##2##(1991-3#1)(1996-3#1)(1996-6#1)(2009-12#2)(2012-2#2)
the bowels##2##2##(1996-6#2)
the box##2##2##(1993-9#1)(2010-11#1)
the boy and##2##3##(1996-5#1)(2012-2#1)
the boy##7##2##(1995-5#2)(1996-5#3)(2008-10#1)(2012-2#1)
the boys##4##2##(1991-9#3)(1996-6#1)
the boys'##2##2##(2009-10#1)(2011-1#1)
the bradycardic##2##2##(1997-2#2)
the brain and lungs##2##4##(2008-7#1)(2009-9#1)
the brain and reproductive##2##4##(1990-11#1)(2010-1#1)
the brain and spinal cord##4##5##(1996-12#1)(1997-3#1)(2008-7#1)(2010-12#1)
the brain and##19##3##(1990-11#1)(1991-2#1)(1995-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#1)
the brain are##6##3##(1995-5#1)(1997-6#1)(2008-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
the brain areas##2##3##(2008-7#1)(2008-9#1)
the brain as##3##3##(1994-5#1)(2009-12#1)(2009-6#1)
the brain damage##2##3##(1994-2#1)(2011-2#1)
the brain has a unique##2##5##(2008-11#2)
the brain has been##4##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
the brain has##6##3##(2007-12#1)(2008-1#1)(2008-11#3)(2008-4#1)
the brain in##4##3##(1997-2#1)(1997-4#1)(2009-8#1)(2013-1#1)
the brain is##6##3##(1994-5#2)(1995-12#1)(2008-11#2)(2009-5#1)
the brain must##2##3##(1990-5#1)(2009-8#1)
the brain networks##2##3##(2009-8#1)(2013-8#1)
the brain of the leech Theromyzon tessulatum##2##7##(1996-12#2)
the brain of the##6##4##(1994-2#1)(1996-12#2)(1997-3#1)(2008-6#2)
the brain of##13##3##(1993-3#1)(1994-2#2)(1994-8#1)(1996-12#2)(1996-5#1)(1997-3#1)(2008-6#3)(2008-7#2)
the brain parenchyma##3##3##(1992-12#1)(2008-8#1)(2009-8#1)
the brain reward##2##3##(2008-7#1)(2013-8#1)
the brain stem and spinal cord##2##6##(2008-7#2)
the brain stem##9##3##(1990-5#1)(1993-3#1)(1994-2#1)(2008-7#5)(2012-3#1)
the brain structures##2##3##(1996-12#2)
the brain to##3##3##(1991-1#1)(2008-10#1)(2008-9#1)
the brain##206##2##(1990-11#1)(1990-5#4)(1990-8#1)(1991-1#1)(1991-2#2)(1991-6#1)(1992-12#3)(1992-6#3)(1993-1#1)(1993-3#4)(1993-8#2)(1994-12#1)(1994-2#7)(1994-5#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#2)(1995-5#1)(1996-12#13)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#19)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#4)(2008-6#7)(2008-7#25)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#3)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#2)(2010-1#4)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#3)
the brain's##4##2##(1994-2#1)(2008-11#1)(2009-8#1)(2012-12#1)
the brains of##8##3##(1995-12#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-11#2)(2011-2#1)
the brains##10##2##(1995-12#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-11#2)(2008-6#2)(2011-2#1)
the brainstem##5##2##(1992-3#1)(1994-2#1)(2008-7#1)(2008-9#1)(2012-3#1)
the branch cuts##3##3##(2008-3#3)
the branch##4##2##(2008-3#3)(2008-9#1)
the branches of the external carotid artery##2##7##(1997-3#2)
the branches of the##4##4##(1997-3#2)(2008-11#1)(2012-3#1)
the branchial heart##5##3##(2008-7#5)
the branchial##6##2##(2008-7#6)
the branching##3##2##(1997-3#1)(2008-7#1)(2008-8#1)
the breadth of the##2##4##(2008-1#1)(2008-10#1)
the breadth of##4##3##(2008-1#1)(2008-10#3)
the breadth##5##2##(1995-2#1)(2008-1#1)(2008-10#3)
the break##2##2##(2008-10#1)(2012-2#1)
the breakdown of##5##3##(2008-10#2)(2008-12#1)(2010-3#1)(2011-2#1)
the breakdown products of the chemical warfare agent##2##8##(2008-11#2)
the breakdown pulses##2##3##(1991-5#2)
the breakdown##11##2##(1991-5#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2010-3#1)(2011-2#1)
the breakpoint junction of the##2##5##(1996-12#2)
the breakthrough##2##2##(1997-6#1)(2008-10#1)
the breakup of##2##3##(2008-7#1)(2009-8#1)
the breast cancer##3##3##(1993-11#1)(1994-12#1)(2012-3#1)
the breast epithelial mucin##4##4##(1993-1#4)
the breast##38##2##(1990-11#1)(1990-6#1)(1991-8#1)(1992-2#3)(1992-5#1)(1993-1#4)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-6#2)(1997-7#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-1#1)(2009-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#4)
the breath holding task##2##4##(2013-8#2)
the breath##3##2##(2008-10#1)(2013-8#2)
the breathing##2##2##(1996-2#1)(2011-2#1)
the breeding season##7##3##(2008-8#4)(2008-9#1)(2010-8#2)
the breeding##13##2##(1995-6#1)(2008-10#2)(2008-8#5)(2008-9#2)(2009-10#1)(2010-8#2)
the breeds##2##2##(1996-12#1)(2011-2#1)
the bridge##3##2##(2013-1#3)
the bridging##2##2##(2008-10#1)(2012-2#1)
the brief##3##2##(1996-3#1)(2008-11#1)(2009-4#1)
the bright##3##2##(2008-3#2)(2013-1#1)
the brine shrimp Artemia##3##4##(2007-12#2)(2008-9#1)
the broad host##2##3##(2012-2#2)
the broad spectrum of##2##4##(2008-10#1)(2008-12#1)
the broad##16##2##(1994-12#1)(1995-12#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-5#1)(2012-2#2)(2013-1#1)
the broadening##2##2##(2008-2#1)(2008-3#1)
the broader##9##2##(1994-12#2)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)
the broadest##2##2##(2008-10#1)(2008-8#1)
the bromate oxidation of N##2##5##(2008-10#2)
the bromide ion##2##3##(2008-10#2)
the bromide##3##2##(2008-10#3)
the bromine##2##2##(1991-3#1)(1996-5#1)
the bronchial circulation##2##3##(1997-1#2)
the bronchial tree##4##3##(1994-9#1)(1995-12#2)(1996-1#1)
the bronchial vasculature##3##3##(1997-1#3)
the bronchial##13##2##(1991-12#1)(1994-9#1)(1995-12#3)(1996-1#1)(1997-1#6)(2008-1#1)
the bronchiolitis obliterans syndrome##3##4##(2011-3#3)
the brood##3##2##(2008-8#1)(2008-9#1)(2010-8#1)
the broth##2##2##(2008-12#1)(2008-7#1)
the brown citrus aphid##2##4##(2008-10#2)
the brown##4##2##(2008-10#3)(2013-1#1)
the brown-headed cowbird##2##3##(2008-9#2)
the brush border##3##3##(1990-12#1)(2008-7#2)
the brush phase##2##3##(2008-10#2)
the brush##7##2##(1990-12#1)(2008-10#2)(2008-7#2)(2009-5#2)
the buccal mucosa##2##3##(1991-2#1)(1992-9#1)
the buccal##4##2##(1991-2#1)(1992-9#1)(2011-2#1)(2012-3#1)
the bud##5##2##(2008-10#2)(2009-8#1)(2011-2#2)
the budding yeast Saccharomyces cerevisiae##4##5##(1993-8#2)(1996-3#1)(1997-7#1)
the budding yeast##8##3##(1993-8#3)(1996-3#1)(1996-6#1)(1997-7#1)(2008-9#2)
the budding##12##2##(1993-8#3)(1996-3#1)(1996-6#3)(1997-7#1)(2008-10#1)(2008-9#2)(2011-2#1)
the budget of##2##3##(2008-11#2)
the budget##4##2##(1991-3#1)(1993-1#1)(2008-11#2)
the buffer capacity##2##3##(2008-10#2)
the buffer in##2##3##(2008-10#1)(2008-4#1)
the buffer solution at##2##4##(1994-3#1)(2008-10#1)
the buffer solution##7##3##(1990-5#1)(1994-3#1)(2008-10#4)(2008-8#1)
the buffer to##2##3##(1992-10#1)(1994-3#1)
the buffer##39##2##(1990-5#1)(1991-5#2)(1992-10#1)(1994-3#2)(1996-9#1)(2008-10#29)(2008-3#1)(2008-4#1)(2008-8#1)
the buffered##2##2##(1991-5#1)(2008-10#1)
the buffering##3##2##(2008-10#2)(2011-2#1)
the building block of##2##4##(1992-6#1)(2010-7#1)
the building blocks##3##3##(1992-11#1)(2008-11#2)
the building##6##2##(1992-11#1)(1992-2#1)(1992-6#1)(2008-11#2)(2010-7#1)
the bulk mating experiment##2##4##(2008-10#2)
the bulk of the##6##4##(2008-10#4)(2008-3#1)(2012-2#1)
the bulk of variance in academic buoyancy##2##7##(2008-12#2)
the bulk of##11##3##(2008-10#5)(2008-12#2)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
the bulk phase##2##3##(2008-10#1)(2008-7#1)
the bulk solution##5##3##(2008-10#5)
the bulk##44##2##(1992-11#1)(2008-10#29)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-4#2)(2010-7#1)(2012-2#2)
the buoyant##2##2##(1990-5#1)(1996-12#1)
the burden of disease##4##4##(2011-2#1)(2012-12#2)(2013-8#1)
the burden of stroke##2##4##(2008-8#2)
the burden of##18##3##(1996-1#1)(2007-12#1)(2008-11#3)(2008-8#2)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#2)
the burden##19##2##(1996-1#1)(2007-12#1)(2008-11#3)(2008-8#2)(2009-5#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#2)
the burden-of-illness##2##2##(1994-9#2)
the bureaucracy##2##2##(1994-5#1)(1995-3#1)
the bureaucratic##2##2##(2008-11#1)(2008-6#1)
the burgeoning##2##2##(1994-1#1)(2008-5#1)
the buried residues##2##3##(2008-10#2)
the burning##2##2##(2008-10#1)(2008-11#1)
the bus##2##2##(2008-3#1)(2012-12#1)
the business of##2##3##(1992-3#1)(1995-2#1)
the business##9##2##(1992-3#1)(1994-1#3)(1995-2#2)(1996-3#2)(2013-8#1)
the button##2##2##(1991-2#1)(2013-8#1)
the butyltin chloride##2##3##(2008-10#2)
the butyrate##2##2##(1990-6#1)(1993-6#1)
the c##2##2##(2008-10#1)(2010-8#1)
the c-Jun##2##2##(1995-2#2)
the c-erbB-2 gene product##3##4##(1994-11#3)
the c-met##2##2##(1995-8#2)
the c-myc allele on the translocated chromosome##2##7##(1993-2#2)
the c-myc gene##5##3##(1993-2#2)(1993-3#2)(2008-11#1)
the c-myc##9##2##(1993-2#4)(1993-3#2)(1995-9#1)(2008-11#2)
the c1/c1 genotype##3##3##(2008-8#3)
the cAMP level of brain##2##5##(2008-8#2)
the cAMP##7##2##(1994-8#1)(1995-8#1)(1997-2#1)(2008-11#2)(2008-8#2)
the cDNA and##3##3##(1993-6#1)(2008-11#1)(2008-4#1)
the cDNA as##2##3##(1995-6#1)(2008-9#1)
the cDNA clone##3##3##(1991-5#1)(1994-11#1)(1995-8#1)
the cDNA clones##3##3##(1993-6#1)(1996-2#1)(1997-8#1)
the cDNA cloning of##2##4##(1993-3#1)(1994-11#1)
the cDNA encoding##4##3##(1993-2#1)(1993-6#1)(1995-8#1)(2008-11#1)
the cDNA for##5##3##(1990-5#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-7#1)
the cDNA library##2##3##(1995-6#1)(2008-2#1)
the cDNA of##4##3##(2008-10#1)(2008-12#2)(2008-8#1)
the cDNA sequence##5##3##(1990-8#1)(1992-10#1)(1993-6#1)(1994-12#1)(2008-4#1)
the cDNA was##2##3##(1994-11#1)(2008-10#1)
the cDNA##53##2##(1990-5#1)(1990-8#1)(1991-5#2)(1992-10#2)(1992-6#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#2)(1994-11#4)(1994-12#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-7#2)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-8#3)(2008-9#3)(2010-5#1)
the cDNAs##5##2##(1994-11#1)(1995-8#2)(2008-8#1)(2010-5#1)
the cabbage looper##3##3##(1990-8#2)(2008-7#1)
the cabbage##4##2##(1990-8#2)(2008-7#1)(2008-8#1)
the cabin##3##2##(1996-12#3)
the cable##4##2##(2008-10#1)(2008-9#3)
the cadmium speciation##2##3##(2008-10#2)
the cadmium##5##2##(2008-10#5)
the cages were recovered##2##4##(2008-10#2)
the cages were##3##3##(2008-10#3)
the calcaneus##2##2##(2009-10#1)(2010-11#1)
the calcitonin##2##2##(1990-2#1)(2013-8#1)
the calcitonin/alpha-CGRP and beta-CGRP genes##2##5##(1992-6#2)
the calcitonin/alpha-CGRP gene##3##3##(1992-6#3)
the calcitonin/alpha-CGRP##5##2##(1992-6#5)
the calcium and##2##3##(2008-10#1)(2013-8#1)
the calcium channel##2##3##(1996-5#1)(2012-12#1)
the calcium##15##2##(1991-11#1)(1991-5#1)(1991-8#1)(1994-5#1)(1995-11#1)(1996-5#1)(2008-10#5)(2008-11#1)(2010-8#1)(2012-12#1)(2013-8#1)
the calculated detection##2##3##(2008-10#2)
the calculated times##2##3##(2012-12#2)
the calculated values##2##3##(2008-10#1)(2008-3#1)
the calculated##28##2##(1991-3#1)(1994-5#1)(1995-12#1)(1996-5#1)(2008-10#14)(2008-3#6)(2009-1#1)(2009-7#1)(2012-12#2)
the calculation of a##2##4##(1992-12#1)(2008-10#1)
the calculation of the effective##2##5##(2008-3#1)(2008-8#1)
the calculation of the##9##4##(1993-3#1)(2008-10#5)(2008-3#1)(2008-8#1)(2010-12#1)
the calculation of##21##3##(1992-12#1)(1993-3#1)(1994-9#1)(1997-3#1)(2008-10#12)(2008-3#2)(2008-8#1)(2010-12#2)
the calculation##25##2##(1992-12#1)(1993-3#1)(1994-9#1)(1997-3#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#2)(2013-1#1)
the calculations of##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
the calculations##10##2##(1990-12#1)(2008-10#6)(2008-3#3)
the calf##7##2##(1990-11#2)(1991-6#1)(2008-10#1)(2008-5#2)(2011-2#1)
the calibration and the##2##4##(2008-10#1)(2008-11#1)
the calibration by##3##3##(2008-10#3)
the calibration curve is linear##6##5##(2008-10#6)
the calibration curve is##7##4##(2008-10#7)
the calibration curve was##5##4##(2008-10#5)
the calibration curve##19##3##(2008-10#19)
the calibration curves are linear##2##5##(2008-10#2)
the calibration curves##11##3##(2008-10#10)(2009-8#1)
the calibration for the##3##4##(2008-10#1)(2008-2#2)
the calibration function##2##3##(2008-10#2)
the calibration graph is linear##3##5##(2008-10#3)
the calibration graph is##8##4##(2008-10#8)
the calibration graph was linear from 0##3##7##(2008-10#3)
the calibration graph was linear in the##2##7##(2008-10#2)
the calibration graph was linear##7##5##(2008-10#7)
the calibration graph was##8##4##(2008-10#8)
the calibration graph##19##3##(2008-10#19)
the calibration graphs were linear##2##5##(2008-10#2)
the calibration graphs were##3##4##(2008-10#3)
the calibration graphs##7##3##(2008-10#7)
the calibration line##2##3##(2008-10#2)
the calibration matrix was##2##4##(2008-10#2)
the calibration matrix##7##3##(2008-10#7)
the calibration model is based on absorption spectra in the##2##10##(2008-10#2)
the calibration model is##3##4##(2008-10#3)
the calibration model##6##3##(2008-10#6)
the calibration models##4##3##(2008-10#4)
the calibration of##5##3##(2008-10#5)
the calibration parameters##3##3##(1995-9#3)
the calibration plot##2##3##(2008-10#2)
the calibration plots##3##3##(2008-10#3)
the calibration range##8##3##(2008-10#8)
the calibration recovery##2##3##(2008-10#2)
the calibration set##4##3##(2008-10#4)
the calibration standards##2##3##(2008-10#2)
the calibration was##2##3##(2008-10#2)
the calibration##140##2##(1995-9#3)(2008-10#131)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)
the calibrator##5##2##(2008-10#5)
the call##3##2##(2008-8#2)(2009-11#1)
the callus##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
the calorimeter##2##2##(2008-10#2)
the calvaria##2##2##(2008-10#1)(2008-11#1)
the calves##4##2##(1996-3#1)(1997-5#2)(2012-2#1)
the calyptra##3##2##(2008-10#3)
the calyx##2##2##(2008-10#2)
the cambium##4##2##(2008-10#4)
the cameras'##2##2##(2008-6#2)
the campaign##5##2##(1992-2#2)(1997-6#1)(2008-11#1)(2008-3#1)
the campaigns##2##2##(1997-6#1)(2011-3#1)
the canalicular##3##2##(1995-2#1)(2008-11#2)
the cancer cells##5##3##(1990-5#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
the cancer risk##2##3##(2013-1#2)
the cancer##16##2##(1990-5#1)(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#3)
the cancerous##2##2##(2009-10#2)
the candidate genes for##2##4##(2008-8#1)(2009-10#1)
the candidate genes##4##3##(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
the candidate##11##2##(1994-1#2)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
the canine##7##2##(1993-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2013-1#1)
the canker##2##2##(2008-10#2)
the cannabinoid receptors in the##2##5##(1991-4#2)
the cannabinoid##5##2##(1991-1#2)(1991-4#2)(1996-2#1)
the canonical##2##2##(1997-9#1)(2009-8#1)
the canopy and##2##3##(2008-10#2)
the canopy##11##2##(2008-10#10)(2008-9#1)
the cantaloupe##2##2##(2008-10#2)
the cantilever##2##2##(2008-10#1)(2012-2#1)
the cantilevers##2##2##(2008-3#2)
the cap structure is##2##4##(1997-2#1)(2008-10#1)
the cap structure##6##3##(1997-2#2)(2008-10#4)
the cap##8##2##(1995-6#1)(1997-2#2)(2008-10#4)(2008-7#1)
the capabilities of the##2##4##(2008-10#1)(2011-7#1)
the capabilities of this##3##4##(2008-3#2)(2008-6#1)
the capabilities of##9##3##(1996-1#1)(2008-10#3)(2008-3#2)(2008-6#1)(2011-1#1)(2011-7#1)
the capability of the proposed##2##5##(2008-3#1)(2013-1#1)
the capability of the##9##4##(2008-10#4)(2008-3#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
the capability of##20##3##(1993-2#1)(1993-8#1)(2008-10#8)(2008-11#1)(2008-3#2)(2009-5#1)(2009-7#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the capability to##3##3##(1993-3#1)(2008-11#1)(2008-5#1)
the capability##24##2##(1993-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the capacitance##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
the capacities##2##2##(1997-2#1)(2012-7#1)
the capacity for##6##3##(1995-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-6#1)
the capacity of a##2##4##(2008-7#1)(2010-10#1)
the capacity of some##2##4##(2010-7#1)(2013-1#1)
the capacity of the##10##4##(1992-6#1)(1995-2#1)(1996-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-8#1)(2013-7#1)
the capacity of##30##3##(1992-6#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
the capacity to##18##3##(1990-5#1)(1991-11#1)(1994-1#1)(1995-2#1)(1996-2#1)(1997-3#3)(1997-8#1)(2008-10#3)(2008-11#3)(2008-5#1)(2011-2#1)(2013-1#1)
the capacity##59##2##(1990-5#1)(1991-11#1)(1992-6#1)(1993-12#1)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-8#1)(2008-10#15)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
the capillary electrophoresis method##2##4##(2008-10#2)
the capillary of a##2##4##(2008-10#2)
the capillary##22##2##(2008-10#18)(2008-3#3)(2011-2#1)
the capital city##2##3##(1994-9#1)(2013-1#1)
the capital##5##2##(1991-1#1)(1992-12#1)(1994-9#1)(2008-1#1)(2013-1#1)
the capping##2##2##(1991-6#1)(2009-5#1)
the capsaicin##2##2##(2008-10#1)(2008-11#1)
the capsid polyprotein##2##3##(2008-10#2)
the capsid protein##2##3##(2008-10#2)
the capsid##9##2##(1991-5#2)(2008-10#6)(2008-8#1)
the capstone course##2##3##(1993-1#2)
the capsule##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
the capsules##2##2##(2008-10#2)
the capture of##3##3##(1990-12#2)(2008-10#1)
the capture##4##2##(1990-12#2)(2008-10#2)
the carbamates##2##2##(2008-10#2)
the carbohydrate moiety of##2##4##(1994-8#1)(2008-11#1)
the carbohydrate##11##2##(1990-5#2)(1990-8#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
the carbon and##3##3##(1996-3#1)(2008-10#1)(2010-11#1)
the carbon dioxide laser##3##4##(1991-12#2)(1993-8#1)
the carbon paste electrode##5##4##(2008-10#5)
the carbon paste##8##3##(2008-10#8)
the carbon source##3##3##(1995-9#1)(2008-10#2)
the carbon##35##2##(1991-12#2)(1991-3#1)(1993-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#20)(2008-11#2)(2010-11#1)(2011-2#1)(2012-5#1)(2013-1#2)
the carbonate##4##2##(2008-10#4)
the carbonyl oxygen of##2##4##(1991-3#1)(1996-5#1)
the carbonyl oxygen##3##3##(1991-3#1)(1996-5#2)
the carbonyl##7##2##(1991-3#1)(1995-6#1)(1996-5#2)(2008-10#2)(2008-8#1)
the carboxy-terminus##2##2##(1992-6#1)(1995-6#1)
the carboxyl group##3##3##(1993-3#2)(2008-10#1)
the carboxyl groups##3##3##(2008-10#3)
the carboxyl terminus of##2##4##(1992-8#1)(2012-2#1)
the carboxyl terminus##6##3##(1992-7#1)(1992-8#1)(1992-9#3)(2012-2#1)
the carboxyl##16##2##(1992-7#1)(1992-8#1)(1992-9#3)(1993-3#2)(1993-8#1)(1994-5#2)(2008-10#5)(2012-2#1)
the carboxylate groups##2##3##(2008-10#2)
the carboxylic acid##2##3##(1991-9#1)(2008-10#1)
the carboxylic group is##2##4##(2008-10#2)
the carboxylic##7##2##(1991-9#2)(2008-10#5)
the carboxyltransferase component##2##3##(1992-9#2)
the carboxymethyl##2##2##(2008-10#2)
the carcases##3##2##(1997-5#3)
the carcass and##2##3##(2013-1#2)
the carcass##3##2##(2013-1#3)
the carcinogen##2##2##(1993-8#1)(1994-5#1)
the carcinogenic##5##2##(1990-5#2)(2007-11#1)(2008-10#1)(2011-1#1)
the carcinogenicity of##6##3##(1991-12#4)(1992-9#1)(1993-8#1)
the cardiac and##2##3##(1995-2#1)(2007-12#1)
the cardiac myocytes##2##3##(1993-3#1)(1994-11#1)
the cardiac output##2##3##(2008-12#1)(2012-3#1)
the cardiac tissue##2##3##(2008-10#1)(2008-8#1)
the cardiac##27##2##(1990-12#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#3)(1995-2#1)(1996-6#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
the cardinal##2##2##(2010-6#1)(2011-2#1)
the cardiomyocytes##2##2##(1992-9#1)(1994-8#1)
the cardiomyopathy locus##2##3##(1996-8#2)
the cardiomyopathy##4##2##(1990-9#1)(1996-8#2)(2008-10#1)
the cardiovascular and##3##3##(1991-1#1)(2008-1#1)(2010-6#1)
the cardiovascular system##9##3##(2008-10#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
the cardiovascular##20##2##(1991-1#1)(1994-3#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-7#2)(2009-10#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
the care of elderly##3##4##(1992-3#1)(2008-11#1)(2012-3#1)
the care of older people##5##5##(2010-10#5)
the care of patients with##2##5##(1997-4#1)(2008-1#1)
the care of the##4##4##(1992-1#1)(1993-12#1)(2008-11#1)(2008-7#1)
the care of##31##3##(1992-1#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-2#1)(1997-4#2)(2008-1#2)(2008-10#1)(2008-11#7)(2008-3#1)(2008-7#1)(2010-10#5)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
the care plan##5##3##(1993-3#1)(2013-1#4)
the care provided to##2##4##(1991-3#1)(2010-8#1)
the care provided##3##3##(1991-3#1)(1993-3#1)(2010-8#1)
the care reform##2##3##(1997-8#2)
the care requirements of##2##4##(1994-12#1)(1996-1#1)
the care##63##2##(1991-3#1)(1992-1#2)(1992-2#2)(1992-3#1)(1993-12#1)(1993-3#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#2)(1997-8#3)(2008-1#2)(2008-10#1)(2008-11#9)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#5)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)
the careers##2##2##(1993-6#1)(2010-1#1)
the careful##3##2##(1992-9#1)(2008-10#1)(2013-1#1)
the caregiver##2##2##(1992-2#1)(2009-5#1)
the caregivers##4##2##(1992-3#3)(2008-10#1)
the caregiving##3##2##(1992-3#2)(2008-7#1)
the carina##3##2##(2010-7#2)(2012-3#1)
the caring##4##2##(1992-1#1)(1992-3#1)(2008-11#1)(2011-1#1)
the carotenoid##2##2##(2008-8#1)(2009-10#1)
the carotenoids##2##2##(1992-9#2)
the carotid artery is##2##4##(1993-3#2)
the carotid artery##6##3##(1993-3#2)(2006-6#1)(2008-7#2)(2011-2#1)
the carotid canal and jugular foramen##2##6##(2012-3#2)
the carotid##12##2##(1993-3#2)(1996-6#1)(2006-6#1)(2008-7#3)(2010-6#1)(2011-2#2)(2012-3#2)
the carp##4##2##(2008-5#3)(2008-9#1)
the carpal##4##2##(2008-12#1)(2008-9#2)(2013-1#1)
the carpenter bee##2##3##(2008-7#2)
the carriage of##2##3##(2008-11#1)(2008-5#1)
the carrier buffer##3##3##(2008-10#3)
the carrier concentration##2##3##(2008-10#2)
the carrier gas flow rate##2##5##(2008-10#2)
the carrier gas##5##3##(2008-10#5)
the carrier solution was##2##4##(2008-10#2)
the carrier solution##12##3##(2008-10#12)
the carrier stream##9##3##(2008-10#9)
the carrier##47##2##(1991-5#2)(1995-3#1)(1997-2#1)(2007-11#1)(2008-10#39)(2008-7#3)
the carriers and##2##3##(2008-10#1)(2008-11#1)
the carriers##5##2##(2008-10#1)(2008-11#4)
the carrot##3##2##(2008-10#2)(2008-9#1)
the cartilage and bone##2##4##(2007-11#1)(2008-7#1)
the cartilage##8##2##(1990-3#1)(1993-2#1)(2007-11#1)(2008-7#3)(2009-1#1)(2012-3#1)
the cartilaginous region##2##3##(2008-9#2)
the cartridge is##2##3##(2008-10#2)
the cartridge##6##2##(2008-10#6)
the cascade of##3##3##(1994-6#1)(2012-2#1)(2012-3#1)
the cascade##4##2##(1992-2#1)(1994-6#1)(2012-2#1)(2012-3#1)
the case and review##2##4##(2010-5#1)(2013-1#1)
the case described##2##3##(1990-3#1)(2008-11#1)
the case for a##3##4##(1992-1#1)(1995-2#1)(2010-5#1)
the case for the##3##4##(1991-6#1)(2008-11#2)
the case for##21##3##(1991-6#1)(1991-7#1)(1992-1#1)(1994-5#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
the case in the##3##4##(1995-6#1)(2008-10#2)
the case in##12##3##(1995-6#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2011-2#2)(2013-1#1)
the case mix##2##3##(1995-2#2)
the case of B##2##4##(2008-10#2)
the case of a 35-year-old woman##2##6##(2011-2#1)(2013-1#1)
the case of a 51-year-old##2##5##(2011-2#1)(2013-1#1)
the case of a 63 years old##2##7##(1991-11#1)(2013-7#1)
the case of a 70-year-old##2##5##(2012-3#1)(2013-1#1)
the case of a female patient with##2##7##(1992-12#1)(2008-1#1)
the case of a man##3##5##(2008-11#1)(2008-8#1)(2011-2#1)
the case of a patient affected##2##6##(1993-6#2)
the case of a patient who##2##6##(2008-10#1)(2011-2#1)
the case of a patient with##2##6##(2011-2#1)(2013-1#1)
the case of a patient##7##5##(1993-6#2)(2008-10#1)(2011-2#2)(2013-1#2)
the case of a##83##4##(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1992-12#1)(1993-6#3)(1994-1#1)(1995-5#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-1#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#3)(2011-2#11)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#2)
the case of an##7##4##(1990-6#1)(1991-2#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
the case of cell##2##4##(1994-6#1)(2008-11#1)
the case of diffuse##2##4##(2008-10#1)(2008-3#1)
the case of the biosensor##2##5##(2008-10#2)
the case of the##31##4##(1990-11#1)(1991-11#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)
the case of very##3##4##(2008-10#3)
the case of##305##3##(1990-11#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#3)(1995-12#4)(1995-5#1)(1996-11#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#101)(2008-11#18)(2008-12#3)(2008-2#3)(2008-3#15)(2008-5#6)(2008-7#14)(2008-8#4)(2008-9#7)(2009-1#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#2)(2011-2#19)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#18)(2013-7#2)(2013-8#3)
the case report of a##2##5##(2008-11#1)(2013-1#1)
the case study method##2##4##(1993-3#1)(1994-2#1)
the case study##3##3##(1993-3#1)(1994-2#1)(2008-11#1)
the case that##3##3##(1993-2#1)(2008-12#1)(2008-4#1)
the case when the##2##4##(2008-10#1)(2008-3#1)
the case when##4##3##(1991-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
the case where##3##3##(1995-9#1)(2008-11#1)(2008-8#1)
the case with##8##3##(2008-10#1)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#3)(2013-7#1)
the case without##2##3##(2012-3#1)(2013-8#1)
the case##405##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-2#3)(1993-3#3)(1993-6#5)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#3)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-9#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#114)(2008-11#28)(2008-12#5)(2008-2#3)(2008-3#16)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#9)(2008-9#10)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#2)(2011-2#27)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#26)(2013-7#3)(2013-8#5)
the cases and##4##3##(1990-6#1)(1993-2#1)(2008-11#1)(2008-5#1)
the cases of##7##3##(1993-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
the cases that##3##3##(1997-3#1)(1997-6#1)(2008-6#1)
the cases with##2##3##(1991-8#1)(1993-8#1)
the cases##90##2##(1990-12#3)(1990-6#1)(1990-9#2)(1991-2#1)(1991-6#1)(1991-8#4)(1991-9#3)(1992-12#1)(1992-5#2)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-1#1)(1995-11#1)(1995-12#2)(1996-3#2)(1996-6#1)(1997-3#1)(1997-6#2)(1997-8#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#4)(2013-1#4)(2013-8#3)
the casino##2##2##(2012-2#2)
the caspase##2##2##(2008-11#1)(2012-2#1)
the caspases##2##2##(2008-4#1)(2008-7#1)
the casual##2##2##(2008-10#2)
the cat##4##2##(1991-2#1)(2008-8#3)
the cat-86##2##2##(1991-9#2)
the catabolism of##6##3##(1990-2#1)(1991-9#1)(1994-8#1)(2008-11#1)(2008-6#1)(2011-1#1)
the catalog of##2##3##(2008-9#2)
the catalysis of##5##3##(1993-8#1)(2008-10#4)
the catalysis##8##2##(1991-5#2)(1993-8#1)(2008-10#4)(2008-11#1)
the catalyst and##4##3##(2008-10#3)(2008-12#1)
the catalyst for##2##3##(2008-10#2)
the catalyst is##2##3##(2008-10#2)
the catalyst##14##2##(1995-2#1)(1997-2#1)(2008-10#10)(2008-12#1)(2008-5#1)
the catalytic Zn(II)##2##3##(1992-3#2)
the catalytic activity of the##2##5##(2008-10#2)
the catalytic activity of##8##4##(2008-10#7)(2012-2#1)
the catalytic chains of Escherichia coli aspartate transcarbamoylase##2##8##(1995-6#2)
the catalytic core##3##3##(2008-4#2)(2011-1#1)
the catalytic domain of##3##4##(1991-10#1)(1992-11#2)
the catalytic domain##6##3##(1991-10#1)(1992-11#2)(1993-12#1)(1995-8#1)(1997-3#1)
the catalytic domains of##2##4##(1993-2#1)(1997-8#1)
the catalytic function##3##3##(1992-6#2)(2008-9#1)
the catalytic hydrogen##4##3##(2008-10#4)
the catalytic mechanism of##2##4##(1995-2#1)(1995-6#1)
the catalytic reaction##4##3##(2008-10#4)
the catalytic site##5##3##(1994-5#2)(2009-7#3)
the catalytic subunit of the##2##5##(1994-5#1)(1995-11#1)
the catalytic subunit of##6##4##(1994-5#1)(1995-11#2)(1995-8#1)(1996-2#1)(2008-11#1)
the catalytic subunit##9##3##(1994-5#1)(1995-11#2)(1995-2#3)(1995-8#1)(1996-2#1)(2008-11#1)
the catalytic triad##2##3##(1992-3#2)
the catalytic##98##2##(1991-10#1)(1992-11#2)(1992-3#5)(1992-4#1)(1992-6#4)(1993-12#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-5#4)(1995-11#2)(1995-2#4)(1995-6#5)(1995-8#2)(1996-2#3)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#41)(2008-11#3)(2008-12#1)(2008-4#2)(2008-9#1)(2009-7#3)(2010-4#1)(2011-1#1)(2012-2#2)
the catalyzed reaction##2##3##(2008-10#2)
the catalyzed##3##2##(2008-10#3)
the catch-up##2##2##(2013-1#2)
the catechol##3##2##(2008-10#3)
the categorical##2##2##(2008-10#1)(2013-8#1)
the categories of##2##3##(2008-9#1)(2010-10#1)
the categorization of##3##3##(2008-11#2)(2010-11#1)
the category membership for##2##4##(2008-9#2)
the category of##4##3##(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
the category##9##2##(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#2)(2011-2#1)
the catheter material##2##3##(2011-2#2)
the catheter was##2##3##(2008-7#1)(2011-2#1)
the catheter##12##2##(1996-3#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#7)
the catheters##2##2##(1997-3#1)(2011-2#1)
the cathode##4##2##(2008-10#4)
the cathodic adsorptive stripping##3##4##(2008-10#3)
the cathodic stripping##2##3##(2008-10#2)
the cathodic##12##2##(2008-10#11)(2010-6#1)
the cation exchange##2##3##(2008-10#2)
the cation of the##2##4##(2008-10#2)
the cation of##3##3##(2008-10#3)
the cation##10##2##(2008-10#10)
the cation-exchange##2##2##(2008-10#2)
the cationic polymer##2##3##(2008-11#1)(2008-5#1)
the cationic surfactant##4##3##(2008-10#2)(2008-5#1)(2008-8#1)
the cationic##16##2##(1991-7#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-8#1)(2011-1#1)
the cations and anions##2##4##(2008-10#2)
the cations##10##2##(2008-10#10)
the cattle population##2##3##(1990-3#1)(2011-2#1)
the cattle tick##2##3##(1997-7#1)(2010-10#1)
the cattle##6##2##(1990-3#1)(1997-7#1)(2010-10#1)(2010-4#2)(2011-2#1)
the caudal KF##2##3##(1996-5#2)
the caudal##12##2##(1990-3#1)(1990-5#1)(1990-9#1)(1993-3#1)(1996-5#2)(1997-3#1)(1997-8#1)(2008-10#1)(2012-3#2)(2013-8#1)
the caudate##8##2##(1991-4#1)(1995-6#1)(1996-12#2)(2008-10#1)(2008-6#1)(2008-7#2)
the caudate-putamen##4##2##(1993-6#3)(2008-7#1)
the cauliflower##3##2##(2008-10#3)
the causal agent has not been##2##6##(2008-10#2)
the causal agent has##3##4##(2008-10#3)
the causal agent of Alternaria##2##5##(2008-10#2)
the causal agent of Dutch elm disease##2##7##(2008-10#2)
the causal agent of Fusarium##2##5##(2008-10#2)
the causal agent of bacterial##2##5##(2008-10#2)
the causal agent of dollar spot of##2##7##(2008-10#2)
the causal agent of gray mold##2##6##(1997-4#1)(2008-10#1)
the causal agent of late##2##5##(2008-10#2)
the causal agent of maize##2##5##(2008-10#2)
the causal agent of potato and tomato late blight##2##9##(2008-10#2)
the causal agent of potato##5##5##(2008-10#5)
the causal agent of stem canker of oilseed rape##2##9##(2008-10#2)
the causal agent of this##2##5##(2008-10#2)
the causal agent of##68##4##(1997-4#1)(2008-10#65)(2008-12#1)(2011-10#1)
the causal agent##76##3##(1997-4#1)(2008-10#73)(2008-12#1)(2011-10#1)
the causal agents of##3##4##(2008-10#3)
the causal mechanisms##2##3##(2009-8#2)
the causal organism of##2##4##(2008-10#2)
the causal organism##4##3##(2008-10#4)
the causal##94##2##(1997-4#1)(2008-10#86)(2008-12#1)(2009-8#2)(2010-5#1)(2011-10#1)(2011-2#1)(2012-3#1)
the causative agent of##10##4##(1992-8#1)(2008-10#2)(2011-2#4)(2012-2#1)(2013-1#2)
the causative agent##13##3##(1992-8#1)(2008-10#3)(2008-5#1)(2011-2#5)(2012-2#1)(2013-1#2)
the causative##18##2##(1991-8#1)(1992-5#1)(1992-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)
the cause for##5##3##(2008-10#1)(2010-1#2)(2011-2#1)(2013-1#1)
the cause of a##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
the cause of citrus##2##4##(2008-10#2)
the cause of death##4##4##(1990-11#1)(1995-11#1)(2011-2#1)(2013-1#1)
the cause of the disease##2##5##(2008-10#1)(2011-2#1)
the cause of the##7##4##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)
the cause of this##4##4##(1990-11#1)(1992-12#1)(2008-11#1)(2010-3#1)
the cause of##57##3##(1990-11#2)(1990-9#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#7)(2012-2#2)(2013-1#3)
the cause##73##2##(1990-11#2)(1990-9#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#11)(2012-2#2)(2013-1#4)(2013-7#1)
the causes and##4##3##(1990-9#1)(1995-1#1)(2008-10#1)(2008-8#1)
the causes for##3##3##(1996-11#1)(2009-3#1)(2012-3#1)
the causes of the##2##4##(1996-8#1)(2012-12#1)
the causes of##13##3##(1995-5#1)(1996-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-3#1)(2012-12#2)(2013-1#1)
the causes##24##2##(1990-9#1)(1991-6#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-3#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
the cavernous sinus and##2##4##(1990-12#1)(2011-2#1)
the cavernous sinus##10##3##(1990-12#3)(1993-9#1)(2008-7#2)(2011-2#3)(2012-3#1)
the cavernous##13##2##(1990-12#3)(1993-9#1)(1996-9#1)(2008-7#2)(2009-10#1)(2011-2#3)(2012-3#2)
the cavities##2##2##(2008-10#1)(2012-2#1)
the cavity and the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the cavity and##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
the cavity of##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
the cavity##25##2##(1996-5#2)(1997-8#1)(2007-12#2)(2008-10#4)(2008-2#4)(2008-3#11)(2008-7#1)
the cecum##4##2##(2008-12#4)
the ceiling##2##2##(1996-12#1)(2008-11#1)
the cell adhesion and##2##4##(1994-11#1)(2008-9#1)
the cell adhesion##3##3##(1994-11#1)(2008-9#1)(2009-9#1)
the cell alone##2##3##(2008-11#2)
the cell and##6##3##(1994-6#1)(2008-10#1)(2008-6#1)(2008-9#2)(2009-5#1)
the cell attachment##2##3##(1992-3#1)(2010-2#1)
the cell body##5##3##(2008-11#1)(2008-7#3)(2013-1#1)
the cell concentration##2##3##(2008-11#1)(2008-7#1)
the cell culture medium##2##4##(2008-11#1)(2013-1#1)
the cell culture method##2##4##(2012-2#2)
the cell culture##12##3##(1996-2#1)(2008-10#1)(2008-11#6)(2008-5#1)(2012-2#2)(2013-1#1)
the cell cycle and##2##4##(2008-11#2)
the cell cycle arrest##2##4##(1997-3#1)(2008-11#1)
the cell cycle during##2##4##(2009-8#1)(2012-3#1)
the cell cycle in##3##4##(1996-3#1)(2008-11#1)(2008-4#1)
the cell cycle progression##2##4##(2008-11#1)(2011-2#1)
the cell cycle##48##3##(1992-10#1)(1993-8#1)(1994-3#3)(1995-2#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#19)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
the cell cytoplasm##3##3##(2007-12#1)(2008-10#2)
the cell death machinery##2##4##(2008-11#2)
the cell death##7##3##(1993-8#1)(2008-11#4)(2008-8#1)(2012-3#1)
the cell density on the##2##5##(2008-11#2)
the cell density##8##3##(2008-11#8)
the cell division##2##3##(1997-6#1)(2009-10#1)
the cell entered##2##3##(2008-8#2)
the cell fraction##2##3##(2008-11#1)(2009-3#1)
the cell growth and##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
the cell growth in##2##4##(2008-11#2)
the cell growth##13##3##(2008-11#9)(2008-7#2)(2008-8#1)(2009-8#1)
the cell into##2##3##(2007-12#1)(2008-11#1)
the cell is##3##3##(1993-8#1)(2008-10#2)
the cell killing##2##3##(1993-8#1)(2008-8#1)
the cell line##16##3##(1990-5#1)(1992-10#1)(1994-5#1)(1997-1#1)(2008-11#11)(2010-11#1)
the cell lineage of##2##4##(2007-12#1)(2012-3#1)
the cell lineage##3##3##(2007-12#1)(2008-9#1)(2012-3#1)
the cell lines to##2##4##(2008-11#2)
the cell lines used##2##4##(2008-11#1)(2013-1#1)
the cell lines##12##3##(1992-8#1)(1995-12#1)(2008-11#7)(2008-8#1)(2009-8#1)(2013-1#1)
the cell lysate##2##3##(2008-10#1)(2010-11#1)
the cell lysates##2##3##(2008-7#2)
the cell membrane##20##3##(1990-12#2)(1990-2#2)(1990-5#1)(1991-5#1)(1993-11#1)(1993-12#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-2#1)(2013-8#1)
the cell nucleus##2##3##(1991-2#1)(2008-4#1)
the cell number##4##3##(1992-3#1)(2008-10#1)(2008-11#2)
the cell of##2##3##(2008-10#1)(2013-1#1)
the cell periphery##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#2)
the cell population##7##3##(2008-11#3)(2008-7#3)(2013-1#1)
the cell proliferation##4##3##(1990-12#2)(2008-9#2)
the cell protein content##2##4##(1995-9#2)
the cell size##6##3##(1995-9#3)(2008-10#1)(2008-7#2)
the cell surface FcepsilonRI expression##2##5##(2008-11#2)
the cell surface is##2##4##(2008-11#1)(2008-4#1)
the cell surface of##5##4##(2008-10#1)(2008-11#3)(2008-5#1)
the cell surface with##2##4##(1995-2#1)(2008-4#1)
the cell surface##36##3##(1990-5#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#3)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-9#4)(2011-2#1)
the cell suspension##4##3##(2008-11#4)
the cell to potentials more##2##5##(1993-3#2)
the cell to##4##3##(1992-9#1)(1993-3#2)(2008-11#1)
the cell type##2##3##(1993-8#1)(1997-3#1)
the cell viability##2##3##(2008-11#2)
the cell volume##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
the cell wall##16##3##(1990-5#1)(2008-10#10)(2008-11#2)(2008-9#2)(2011-2#1)
the cell walls of##3##4##(2008-10#2)(2008-11#1)
the cell walls##4##3##(2008-10#3)(2008-11#1)
the cell were##2##3##(1996-8#1)(2008-11#1)
the cell##392##2##(1990-12#5)(1990-2#2)(1990-5#5)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#1)(1992-10#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#7)(1994-11#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#5)(1995-8#2)(1995-9#8)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#5)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#6)(2008-1#1)(2008-10#47)(2008-11#124)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#22)(2008-8#14)(2008-9#22)(2009-10#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#7)(2009-9#7)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#2)(2011-2#10)(2011-3#1)(2012-2#6)(2012-3#5)(2013-1#8)(2013-8#1)
the cell)##2##2##(1990-5#1)(2008-10#1)
the cell-cell##2##2##(2008-9#1)(2009-8#1)
the cell-free##4##2##(2008-8#1)(2011-2#3)
the cell-to-cell movement of##2##4##(2008-10#2)
the cell-to-cell##3##2##(2008-10#3)
the cells and the##2##4##(1995-2#1)(2008-7#1)
the cells and##17##3##(1990-8#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#6)(2008-7#1)(2008-9#1)
the cells are##5##3##(1991-5#1)(1992-6#1)(2008-4#1)(2009-8#1)(2012-2#1)
the cells at##6##3##(1993-8#1)(2008-11#4)(2008-9#1)
the cells could##2##3##(2008-11#2)
the cells for##2##3##(1991-5#1)(2008-8#1)
the cells from the##2##4##(1992-6#1)(1994-11#1)
the cells from##6##3##(1990-8#1)(1992-6#1)(1994-11#1)(2008-11#2)(2008-8#1)
the cells grown##3##3##(2008-11#2)(2008-5#1)
the cells had##2##3##(1994-8#1)(2008-9#1)
the cells in the##5##4##(1993-11#1)(1994-11#1)(2008-11#2)(2010-2#1)
the cells in##12##3##(1993-11#1)(1994-11#1)(1995-9#1)(2008-11#8)(2010-2#1)
the cells incubated##2##3##(1994-3#1)(2008-11#1)
the cells into##2##3##(2008-10#1)(2008-7#1)
the cells of the female germ unit and##2##8##(2008-11#2)
the cells of the##8##4##(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)
the cells of##15##3##(1996-9#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
the cells on##2##3##(1992-6#1)(2008-11#1)
the cells rather than##2##4##(1994-8#1)(2008-10#1)
the cells that##5##3##(1992-6#1)(2007-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
the cells to##7##3##(1990-5#1)(1992-8#1)(2008-11#5)
the cells treated##2##3##(2008-11#2)
the cells was##6##3##(2008-10#1)(2008-11#4)(2013-1#1)
the cells were resuspended##2##4##(2008-11#2)
the cells were subjected to##2##5##(2008-11#2)
the cells were##24##3##(1991-12#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-8#2)(1997-1#1)(1997-8#1)(2008-11#13)(2011-2#1)
the cells with a##2##4##(2008-11#1)(2008-7#1)
the cells with##16##3##(1992-6#1)(1995-12#1)(1997-1#4)(2008-11#5)(2008-2#1)(2008-7#2)(2012-3#1)(2013-1#1)
the cells##242##2##(1990-12#2)(1990-5#2)(1990-8#3)(1991-12#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-2#3)(1992-6#6)(1992-8#2)(1993-11#1)(1993-12#1)(1993-8#4)(1994-11#2)(1994-3#5)(1994-8#5)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#3)(1995-9#1)(1996-2#2)(1996-9#1)(1997-1#6)(1997-7#3)(1997-8#1)(2007-12#3)(2008-10#16)(2008-11#98)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#7)(2009-12#1)(2009-7#2)(2009-8#4)(2010-2#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
the cells'##5##2##(2008-7#2)(2008-8#1)(2012-2#1)(2013-8#1)
the cells)##2##2##(1990-12#1)(1993-3#1)
the cellular accumulation of##2##4##(1993-8#1)(2013-1#1)
the cellular and molecular##3##4##(2008-7#1)(2008-8#1)(2010-1#1)
the cellular and##5##3##(2008-7#2)(2008-8#1)(2010-1#1)(2013-1#1)
the cellular changes##2##3##(2008-10#1)(2009-12#1)
the cellular components##2##3##(1990-2#1)(2008-10#1)
the cellular distribution of##2##4##(2008-11#1)(2012-2#1)
the cellular environment##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
the cellular expression##2##3##(1996-12#1)(2010-1#1)
the cellular growth##3##3##(1993-11#1)(2008-7#1)(2011-2#1)
the cellular level##10##3##(1993-11#1)(1994-2#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
the cellular membrane##2##3##(2008-9#2)
the cellular metabolism##2##3##(2008-11#2)
the cellular morphology##2##3##(2008-11#2)
the cellular proliferation##2##3##(2008-11#2)
the cellular response to##2##4##(2008-4#1)(2011-2#1)
the cellular response##4##3##(2008-4#1)(2011-2#3)
the cellular transport##2##3##(2008-11#2)
the cellular uptake of##2##4##(2008-11#2)
the cellular##91##2##(1990-2#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#20)(2008-4#5)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-12#3)(2009-8#2)(2010-1#2)(2010-11#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#3)
the cellulose##5##2##(2008-10#2)(2008-7#2)(2013-1#1)
the cement##2##2##(2009-7#1)(2013-1#1)
the centenarians##3##2##(2008-7#3)
the center of origin of##2##5##(2008-10#2)
the center of origin##3##4##(2008-10#3)
the center of pressure##2##4##(2010-9#1)(2012-2#1)
the center of the city##2##5##(2008-10#1)(2008-5#1)
the center of the##14##4##(1993-8#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
the center of##28##3##(1991-2#1)(1991-3#1)(1993-8#1)(1995-2#1)(1996-3#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the center##36##2##(1991-2#1)(1991-3#1)(1991-8#1)(1993-8#1)(1995-2#1)(1996-3#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the centerpiece of##2##3##(1996-3#1)(2011-2#1)
the centers of##3##3##(1991-10#1)(2008-10#1)(2008-11#1)
the centers##4##2##(1991-10#1)(2008-10#1)(2008-11#1)(2010-8#1)
the central United States##2##4##(2008-10#1)(2008-11#1)
the central and peripheral##4##4##(1996-12#2)(2008-7#1)(2013-8#1)
the central and##6##3##(1996-12#2)(2007-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
the central axis of the##2##5##(2009-2#1)(2013-1#1)
the central axis of##3##4##(2008-10#1)(2009-2#1)(2013-1#1)
the central axis##4##3##(2008-10#2)(2009-2#1)(2013-1#1)
the central cell and primary endosperm##2##6##(2008-9#2)
the central cell and##3##4##(2008-9#3)
the central cell##9##3##(2007-12#1)(2008-11#2)(2008-9#6)
the central cells of the##2##5##(2008-5#2)
the central complex##3##3##(2007-12#3)
the central core##2##3##(1997-3#1)(2012-3#1)
the central lumen##3##3##(2008-6#2)(2008-7#1)
the central metabolism of##2##4##(2008-7#2)
the central metabolism##4##3##(2008-7#4)
the central nervous depressive##2##4##(1995-12#2)
the central nervous system (CNS) is##2##6##(2008-7#1)(2013-8#1)
the central nervous system (CNS)##18##5##(1991-12#1)(1991-2#1)(1994-2#1)(1996-12#3)(1997-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the central nervous system and##6##5##(1996-12#2)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
the central nervous system of##4##5##(1992-6#1)(1995-2#1)(1996-12#1)(1997-3#1)
the central nervous system##74##4##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-2#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-12#8)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#10)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
the central nervous##76##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-2#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-8#1)(1996-12#8)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#10)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
the central nucleus##2##3##(1992-6#1)(2012-3#1)
the central part of the##3##5##(2008-10#1)(2008-5#1)(2013-8#1)
the central part##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
the central posterior/prepacemaker nucleus##2##4##(1995-12#2)
the central region of the perikaryon##2##6##(2008-7#2)
the central region of the##3##5##(2008-7#2)(2008-9#1)
the central region##4##3##(1997-8#1)(2008-7#2)(2008-9#1)
the central role of##6##4##(2008-1#1)(2008-11#2)(2009-8#2)(2011-2#1)
the central##197##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-7#1)(1992-3#2)(1992-6#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#2)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#12)(1996-2#4)(1997-2#4)(1997-3#3)(1997-4#2)(1997-8#2)(2007-12#7)(2008-1#1)(2008-10#28)(2008-11#8)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#20)(2008-8#4)(2008-9#13)(2009-2#1)(2009-6#1)(2009-8#3)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#7)(2012-2#2)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#7)
the centre of##6##3##(1997-4#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-7#1)
the centre##11##2##(1992-12#1)(1995-5#2)(1996-6#2)(1997-4#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-7#1)
the centrioles##2##2##(2008-7#2)
the centromere on the##2##4##(1996-3#1)(2008-10#1)
the centromere on##3##3##(1996-3#1)(2008-10#2)
the centromere##5##2##(1996-3#1)(2008-10#2)(2008-8#1)(2012-3#1)
the centromeric region##3##3##(1996-8#1)(2008-10#1)(2010-8#1)
the centromeric##4##2##(1996-8#1)(1997-6#1)(2008-10#1)(2010-8#1)
the centrosome##3##2##(2008-9#2)(2009-7#1)
the century##7##2##(1992-2#1)(1994-9#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
the cephalosporin##2##2##(2011-1#2)
the ceramide dispersions##2##3##(1994-5#2)
the ceramide##5##2##(1994-5#2)(2008-5#3)
the cerebellar##8##2##(1992-6#1)(1995-8#1)(1997-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the cerebellopontine angle##2##3##(2011-2#1)(2012-3#1)
the cerebellum in the##2##4##(1992-6#1)(2013-1#1)
the cerebellum##25##2##(1991-1#3)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#5)(1997-8#1)(2008-11#1)(2008-7#1)(2009-5#1)(2013-1#4)(2013-8#1)
the cerebral cortex##18##3##(1994-2#1)(1995-11#1)(1996-12#1)(1997-2#2)(2008-11#6)(2008-7#5)(2011-2#2)
the cerebral hemisphere##3##3##(2008-7#2)(2013-8#1)
the cerebral neocortex##2##3##(2008-11#2)
the cerebral white matter##3##4##(2008-7#1)(2010-12#2)
the cerebral##44##2##(1990-5#1)(1992-12#1)(1994-2#4)(1995-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-9#1)(2008-11#8)(2008-5#2)(2008-7#15)(2009-5#1)(2010-12#2)(2011-2#2)(2013-8#1)
the cerebrospinal fluid (CSF) of##2##5##(2011-2#2)
the cerebrospinal fluid (CSF)##3##4##(1996-12#1)(2011-2#2)
the cerebrospinal fluid##11##3##(1996-12#1)(1997-3#1)(1997-5#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#3)
the cerebrovascular##2##2##(1991-6#1)(2012-3#1)
the certified and##2##3##(2008-10#2)
the certified range##2##3##(2008-10#2)
the certified reference material##4##4##(2008-10#4)
the certified reference materials##3##4##(2008-10#3)
the certified reference##8##3##(2008-10#8)
the certified value and##2##4##(2008-10#2)
the certified value##16##3##(2008-10#16)
the certified values and##6##4##(2008-10#6)
the certified values##23##3##(2008-10#23)
the certified##62##2##(2008-10#62)
the cervical and thoracic##2##4##(2008-12#2)
the cervical and##3##3##(2008-12#2)(2013-8#1)
the cervical spine in a##2##5##(2008-12#1)(2011-2#1)
the cervical spine##22##3##(1995-11#1)(1997-4#1)(2008-12#3)(2009-3#3)(2010-12#3)(2011-2#4)(2012-12#5)(2013-1#2)
the cervical##44##2##(1990-6#1)(1991-2#1)(1992-9#1)(1993-12#1)(1995-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(2008-12#7)(2008-7#2)(2009-3#3)(2010-12#4)(2010-5#2)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#5)(2012-3#1)(2013-1#3)(2013-8#1)
the cervix##10##2##(1990-8#3)(1991-3#1)(1992-2#1)(1994-1#1)(1994-2#1)(1996-6#1)(2008-11#1)(2012-3#1)
the cesium D(2) line##2##4##(2008-3#2)
the cesium##4##2##(2008-10#1)(2008-3#3)
the cessation of##2##3##(1995-6#1)(2008-11#1)
the cessation##3##2##(1995-6#1)(2008-11#1)(2010-2#1)
the chain length##2##3##(2008-12#1)(2009-3#1)
the chain of##4##3##(1994-2#1)(2008-10#1)(2008-12#1)(2010-8#1)
the chain##11##2##(1994-2#1)(2008-10#1)(2008-12#6)(2008-8#1)(2009-3#1)(2010-8#1)
the chalcogenide##3##2##(2008-10#3)
the challenge for##2##3##(1996-3#1)(2008-11#1)
the challenge of##12##3##(1992-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
the challenge##21##2##(1992-3#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
the challenges and##5##3##(1996-2#1)(1997-2#1)(2010-5#1)(2010-6#1)(2013-1#1)
the challenges faced##2##3##(1994-3#1)(2009-11#1)
the challenges facing##3##3##(1996-1#1)(1996-2#1)(1997-3#1)
the challenges in##2##3##(2008-10#1)(2008-8#1)
the challenges of the##2##4##(1992-12#1)(1994-2#1)
the challenges of##12##3##(1992-1#1)(1992-12#1)(1994-2#1)(1996-1#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-9#1)(2011-1#1)
the challenges##38##2##(1992-1#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#2)(1996-2#3)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the challenging##3##2##(1997-2#1)(2009-9#1)(2010-12#1)
the chamber and##2##3##(2008-10#1)(2008-11#1)
the chamber##6##2##(2008-1#1)(2008-10#4)(2008-11#1)
the chambers##2##2##(2008-10#1)(2012-12#1)
the chance of##8##3##(1995-12#1)(1995-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#2)
the chance to##4##3##(1997-7#1)(2010-6#1)(2013-1#2)
the chance##15##2##(1995-1#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#2)
the chances of##2##3##(1993-8#1)(2008-11#1)
the chances##3##2##(1993-8#1)(1996-9#1)(2008-11#1)
the change from the##2##4##(1990-8#1)(2009-8#1)
the change from##4##3##(1990-8#1)(1995-11#1)(2008-5#1)(2009-8#1)
the change in absorbance##5##4##(2008-10#5)
the change in average##2##4##(2008-11#2)
the change in fluorescence intensity##2##5##(1995-11#1)(2008-10#1)
the change in the##8##4##(1990-5#1)(1994-3#1)(1997-2#1)(2008-10#4)(2008-3#1)
the change in##34##3##(1990-5#1)(1991-5#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#15)(2008-11#4)(2008-3#2)(2009-12#2)(2013-8#1)
the change is##2##3##(1994-1#1)(2008-11#1)
the change of##15##3##(1996-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
the change to##4##3##(1992-1#1)(1996-1#1)(2008-11#1)(2008-7#1)
the change would##2##3##(2008-12#1)(2012-12#1)
the change##72##2##(1990-5#1)(1990-8#2)(1991-5#2)(1992-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-5#1)(1997-2#2)(2008-10#22)(2008-11#9)(2008-12#3)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#2)
the changed##3##2##(1996-2#1)(1997-4#1)(2010-6#1)
the changes in sialylation pattern of##2##6##(2008-11#2)
the changes in the fluorescence##2##5##(2008-10#2)
the changes in the##17##4##(1990-8#1)(1995-12#1)(1996-6#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)
the changes in##46##3##(1990-8#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-6#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#3)(2013-1#1)(2013-8#3)
the changes induced in the##2##5##(1994-3#1)(2008-2#1)
the changes observed##2##3##(2008-11#1)(2008-7#1)
the changes of the##4##4##(1997-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
the changes of##13##3##(1996-6#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-8#3)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
the changes that are##2##4##(1996-2#1)(2008-7#1)
the changes that##5##3##(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)
the changes were##3##3##(1992-6#1)(1994-3#1)(1997-2#1)
the changes##90##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-1#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-5#1)(1996-12#3)(1996-2#1)(1996-6#2)(1997-2#2)(1997-9#1)(2008-10#13)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#2)(2009-8#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2013-1#3)(2013-8#5)
the changing##10##2##(1993-3#1)(1994-2#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2013-8#2)
the channel molecule by the agonist##2##6##(2012-2#2)
the channel##12##2##(1992-3#1)(2007-12#1)(2008-10#4)(2008-12#3)(2008-2#1)(2012-2#2)
the channels##5##2##(1994-11#1)(1995-2#1)(1995-3#1)(2008-10#1)(2010-4#1)
the chaotic##2##2##(2008-8#1)(2010-1#1)
the chaperone##2##2##(2008-7#2)
the character of##2##3##(2008-3#1)(2008-8#1)
the character##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
the characterisation and##2##3##(2008-10#2)
the characterisation of##11##3##(1995-3#1)(2008-10#8)(2008-11#1)(2012-2#1)
the characterisation##13##2##(1995-3#1)(2008-10#10)(2008-11#1)(2012-2#1)
the characteristic clinical##2##3##(2011-2#2)
the characteristic features of the##2##5##(2008-2#1)(2008-3#1)
the characteristic features of##6##4##(1990-11#1)(1996-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)
the characteristic features##8##3##(1990-11#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-7#1)
the characteristic mass (m(o)) was of##2##6##(2008-10#2)
the characteristic mass of##2##4##(2008-10#2)
the characteristic mass##5##3##(2008-10#5)
the characteristic of negative phototropism when##2##6##(2008-9#2)
the characteristic of##5##3##(2008-9#3)(2011-2#1)(2013-8#1)
the characteristic##57##2##(1990-11#2)(1991-3#1)(1992-12#1)(1992-6#1)(1994-11#1)(1996-12#1)(2008-10#15)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#4)(2009-11#1)(2010-10#2)(2010-7#2)(2011-2#6)(2012-2#2)(2013-1#2)(2013-8#2)
the characteristics of a##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
the characteristics of male##2##4##(1997-7#1)(2009-5#1)
the characteristics of the##25##4##(1993-12#1)(1996-9#2)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#1)
the characteristics of##59##3##(1991-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-9#2)(1997-3#1)(1997-7#2)(2008-1#1)(2008-10#10)(2008-11#8)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#4)(2008-9#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#3)
the characteristics that##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
the characteristics##65##2##(1991-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-7#2)(2008-1#1)(2008-10#12)(2008-11#8)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#4)(2008-9#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#3)
the characterization and the##2##4##(2008-3#2)
the characterization and##5##3##(2008-10#2)(2008-3#2)(2010-12#1)
the characterization of a##3##4##(2008-10#1)(2009-7#1)(2012-3#1)
the characterization of materials##2##4##(2008-10#2)
the characterization of the##8##4##(1991-5#1)(1992-2#1)(1994-5#1)(1996-2#1)(2008-11#2)(2008-5#1)(2011-1#1)
the characterization of##35##3##(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#13)(2008-11#3)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-3#1)
the characterization##43##2##(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#3)(2010-5#1)(2011-1#1)(2012-3#1)
the characters##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
the charge density##3##3##(1991-5#1)(2008-10#2)
the charge of##2##3##(2008-10#1)(2013-1#1)
the charge separation##2##3##(2008-8#2)
the charge transfer##3##3##(2008-10#3)
the charge##21##2##(1991-5#1)(1997-6#1)(2007-11#2)(2008-10#13)(2008-6#1)(2008-8#2)(2013-1#1)
the charge-transfer##2##2##(2008-10#2)
the charged##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
the cheapest##2##2##(1993-11#1)(2008-10#1)
the cheek##9##2##(1995-9#1)(2008-5#8)
the chelate-modified Fenton reaction##2##4##(2010-4#2)
the chelating agent-metal##2##3##(2008-10#2)
the chelating fiber##3##3##(2008-10#3)
the chelating##16##2##(1994-5#1)(2008-10#15)
the chelation of##2##3##(2008-10#2)
the chelator##2##2##(2008-10#2)
the chemical analysis##3##3##(2008-10#3)
the chemical and physical##3##4##(2008-10#1)(2008-2#1)(2010-7#1)
the chemical and##10##3##(1994-12#1)(2008-10#6)(2008-2#1)(2009-10#1)(2010-7#1)
the chemical availability##2##3##(2008-10#2)
the chemical characteristics of##2##4##(2008-10#2)
the chemical composition of the##2##5##(1991-5#1)(2008-11#1)
the chemical composition of##5##4##(1991-5#1)(2008-11#1)(2009-7#1)(2010-7#1)(2013-1#1)
the chemical composition##6##3##(1991-5#1)(2008-11#1)(2009-7#1)(2010-4#1)(2010-7#1)(2013-1#1)
the chemical constituents of##2##4##(2008-11#1)(2012-2#1)
the chemical constituents##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
the chemical context (pH)##2##4##(2008-10#2)
the chemical environment and##2##4##(2010-11#1)(2012-2#1)
the chemical environment##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
the chemical modifier##4##3##(2008-10#4)
the chemical nature of the lesions##2##6##(2008-11#2)
the chemical properties of##3##4##(1997-2#1)(2008-10#2)
the chemical reaction##4##3##(2008-10#4)
the chemical shift of##2##4##(2008-10#2)
the chemical shift##4##3##(1994-5#1)(2008-10#3)
the chemical species##4##3##(2008-10#3)(2008-3#1)
the chemical stability##2##3##(2008-10#2)
the chemical structure of the##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
the chemical structure of##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
the chemical structure##6##3##(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)
the chemical variables##3##3##(2008-10#3)
the chemical##124##2##(1991-5#2)(1993-12#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-6#1)(1996-12#2)(1997-2#1)(2008-10#75)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-7#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#4)
the chemically##3##2##(1994-5#1)(2008-10#2)
the chemicals##3##2##(1996-12#1)(2008-10#1)(2011-1#1)
the chemiluminescence (CL) intensity##2##4##(2008-10#2)
the chemiluminescence (CL)##7##3##(2008-10#7)
the chemiluminescence determination of##2##4##(2008-10#2)
the chemiluminescence emission##3##3##(2008-10#3)
the chemiluminescence intensity##3##3##(2008-10#3)
the chemiluminescence reaction##5##3##(2008-10#5)
the chemiluminescence##33##2##(2008-10#33)
the chemiluminescent behaviour of phenols and polyphenols##2##7##(2008-10#2)
the chemiluminescent behaviour of##3##4##(2008-10#3)
the chemiluminescent##9##2##(2008-10#9)
the chemiluminometric##3##2##(2008-10#3)
the chemistry of##3##3##(2008-10#1)(2013-1#2)
the chemistry##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
the chemokine##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
the chemometric approach##3##3##(2008-10#3)
the chemometric##7##2##(2008-10#7)
the chemostat##3##2##(2008-7#3)
the chemotherapy##6##2##(1991-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)
the chest pain##3##3##(1996-3#1)(2008-3#2)
the chest wall##5##3##(1991-12#1)(2009-1#1)(2010-6#1)(2012-2#1)(2013-1#1)
the chest##18##2##(1990-5#1)(1990-6#1)(1991-12#2)(1991-9#1)(1994-2#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
the chestnut blight fungus##3##4##(2008-10#2)(2008-9#1)
the chestnut blight##4##3##(2008-10#3)(2008-9#1)
the chicken H3 histone-encoding gene family##2##6##(1991-6#2)
the chicken T-cell receptor alpha chain constant region##2##8##(1997-9#2)
the chicken anaemia##2##3##(1991-3#1)(2008-5#1)
the chicken embryo model##2##4##(2008-12#2)
the chicken transferrin receptor##2##4##(1991-6#2)
the chicken##37##2##(1990-8#1)(1991-3#1)(1991-5#3)(1991-6#4)(1993-12#1)(1993-2#1)(1995-2#1)(1997-1#1)(1997-3#3)(1997-7#1)(1997-9#6)(2008-11#2)(2008-12#2)(2008-5#9)(2010-12#1)
the chickpea##5##2##(2008-10#5)
the chicks##2##2##(2008-5#1)(2008-6#1)
the chief##9##2##(1991-3#1)(1993-11#1)(1995-6#1)(1997-8#1)(2008-10#1)(2013-1#4)
the child and family##2##4##(2008-11#2)
the child and##7##3##(1995-5#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
the child from##4##3##(1991-6#1)(1995-5#2)(2010-7#1)
the child in##2##3##(1995-5#1)(2010-6#1)
the child is##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
the child poverty rate##2##4##(2008-11#2)
the child to##2##3##(1995-5#1)(2011-2#1)
the child was##2##3##(2008-9#1)(2010-6#1)
the child with##3##3##(2008-10#1)(2008-11#1)(2010-9#1)
the child##67##2##(1990-12#3)(1991-6#3)(1992-12#1)(1993-3#1)(1994-6#1)(1995-5#10)(1996-2#1)(1997-2#1)(1997-8#1)(2006-5#5)(2008-10#2)(2008-11#9)(2008-12#1)(2008-9#1)(2009-10#1)(2009-11#2)(2010-12#1)(2010-3#1)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the child's testimony##4##3##(2011-2#4)
the child's##19##2##(1992-1#2)(1992-2#2)(1993-2#4)(1995-1#1)(1995-12#1)(2008-10#1)(2008-12#1)(2010-6#1)(2010-9#2)(2011-2#4)
the childhood obesity epidemic##2##4##(2012-2#2)
the childhood##5##2##(1993-11#1)(1995-5#1)(2008-7#1)(2012-2#2)
the children had##2##3##(2008-9#1)(2012-12#1)
the children in##2##3##(1992-2#1)(2008-3#1)
the children included in the study##2##6##(2012-12#1)(2013-1#1)
the children were##4##3##(1990-12#1)(1996-1#1)(2008-9#1)(2012-12#1)
the children who received##2##4##(2010-4#1)(2011-1#1)
the children who##3##3##(1994-6#1)(2010-4#1)(2011-1#1)
the children with##6##3##(1996-1#1)(2008-1#1)(2008-11#2)(2008-2#1)(2012-2#1)
the children##51##2##(1990-11#1)(1990-12#4)(1990-6#1)(1991-2#1)(1991-6#2)(1991-8#2)(1992-2#1)(1994-1#1)(1994-12#2)(1994-6#2)(1995-5#1)(1996-1#2)(1996-9#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#9)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
the children's speech##2##3##(2008-9#1)(2011-1#1)
the children's usual prehospital##2##4##(1991-2#2)
the children's##11##2##(1990-2#1)(1991-2#3)(1991-6#1)(1994-6#1)(1995-12#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
the chimeric##6##2##(1997-2#3)(1997-3#1)(2008-8#1)(2011-2#1)
the chin##2##2##(2011-2#1)(2012-2#1)
the chip##4##2##(2008-10#3)(2012-3#1)
the chiral recognition##3##3##(2008-10#3)
the chiral selector##2##3##(2008-10#2)
the chiral##15##2##(1995-6#1)(1997-2#1)(2008-10#13)
the chirp amplitude##2##3##(2008-2#2)
the chit33 gene##2##3##(2008-10#2)
the chitin##2##2##(2008-10#2)
the chitinase##2##2##(2008-10#2)
the chitobiase gene##2##3##(1992-10#2)
the chitosan##3##2##(2008-10#3)
the chloramphenicol acetyltransferase (CAT)##3##4##(1992-6#1)(1997-8#1)(2008-4#1)
the chloramphenicol acetyltransferase##4##3##(1992-6#1)(1995-2#1)(1997-8#1)(2008-4#1)
the chloramphenicol##5##2##(1992-6#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-4#1)
the chloride##10##2##(1990-5#1)(1994-5#1)(2008-10#7)(2011-3#1)
the chlorinated##2##2##(2008-10#2)
the chlorine##3##2##(2008-10#3)
the chloroform extraction##2##3##(2008-10#2)
the chloroform##4##2##(2008-10#3)(2012-2#1)
the chloroplast##12##2##(1990-5#1)(1994-11#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#2)(2010-10#1)(2012-3#3)
the choice between##3##3##(1990-3#1)(1995-12#1)(1995-5#1)
the choice of a##2##4##(2008-9#1)(2010-3#1)
the choice of appropriate##2##4##(2008-10#1)(2008-6#1)
the choice of the##10##4##(1990-2#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#2)(2011-2#2)(2012-12#1)(2013-1#1)
the choice of treatment##3##4##(1991-3#1)(2010-12#1)(2011-2#1)
the choice of##50##3##(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-1#1)(1995-12#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#11)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#3)
the choice##62##2##(1990-2#1)(1990-3#2)(1991-2#1)(1991-3#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-12#2)(1995-5#2)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#14)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#4)
the choices of##2##3##(2008-8#1)(2009-8#1)
the choices##5##2##(1991-2#1)(1994-3#1)(2008-8#1)(2009-8#1)(2010-11#1)
the cholesterol##8##2##(1993-3#1)(1994-8#1)(2008-10#4)(2008-4#1)(2008-6#1)
the cholinergic##4##2##(1992-8#1)(1994-8#2)(2008-8#1)
the chondrogenic##3##2##(1994-11#1)(2008-11#2)
the chopstick##2##2##(2011-2#2)
the chorion##5##2##(1993-1#1)(2008-12#4)
the choroid plexus##4##3##(1996-12#4)
the choroid with##2##3##(2011-7#2)
the choroid##10##2##(1996-12#4)(2011-7#3)(2013-1#3)
the chosen level of confidence##2##5##(2008-10#2)
the chosen##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
the chromate anion##2##3##(2008-10#2)
the chromatin##7##2##(2007-12#2)(2008-8#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
the chromatographic behavior of##4##4##(2008-10#4)
the chromatographic column##3##3##(2008-10#3)
the chromatographic conditions##2##3##(2008-10#2)
the chromatographic determination##3##3##(2008-10#3)
the chromatographic methods##2##3##(2008-10#2)
the chromatographic response##2##3##(2008-10#2)
the chromatographic separation##2##3##(2008-10#2)
the chromatographic##38##2##(1994-11#1)(2008-10#35)(2009-8#1)(2010-11#1)
the chromatography##3##2##(2008-10#2)(2010-7#1)
the chromatomembrane cell##3##3##(2008-10#3)
the chromatomembrane##5##2##(2008-10#5)
the chromium isotope ratios was##2##5##(2008-10#2)
the chromium##6##2##(2008-10#6)
the chromium(VI) concentration##2##3##(2008-10#2)
the chromium(VI)##3##2##(2008-10#3)
the chromogenic reaction of##2##4##(2008-10#2)
the chromogenic reaction##4##3##(2008-10#4)
the chromogenic reagent##4##3##(2008-10#4)
the chromogenic##9##2##(1990-2#1)(2008-10#8)
the chromophore and##2##3##(1991-3#1)(2008-10#1)
the chromophore##11##2##(1991-3#1)(1994-5#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-9#1)
the chromosomal DNA##2##3##(2009-6#1)(2011-2#1)
the chromosomal gene##2##3##(2008-10#2)
the chromosomal location of the##2##5##(1997-2#1)(2008-11#1)
the chromosomal location of##3##4##(1997-2#1)(2008-10#1)(2008-11#1)
the chromosomal##18##2##(1993-12#1)(1993-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
the chromosome of##3##3##(1993-9#1)(2008-10#2)
the chromosome##24##2##(1990-8#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-9#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-8#1)
the chromosomes of the##2##4##(1997-6#1)(1997-8#1)
the chromosomes of##4##3##(1997-6#1)(1997-8#1)(2007-12#1)(2010-8#1)
the chromosomes##11##2##(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
the chronic inflammation##2##3##(1991-3#1)(2009-1#1)
the chronic stage##2##3##(2009-11#1)(2012-3#1)
the chronic##20##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
the chronically##2##2##(1992-1#1)(1995-2#1)
the chronoamperometric##2##2##(2008-10#2)
the chronological##2##2##(2008-7#1)(2012-3#1)
the chronology of##3##3##(1993-12#1)(1996-11#1)(2008-10#1)
the cichlid Pelvicachromis taeniatus##2##4##(2010-8#2)
the cigarette##2##2##(2008-1#1)(2008-5#1)
the cilium##4##2##(2008-7#1)(2013-1#3)
the cine loop##2##3##(2013-1#2)
the circadian amplitude##2##3##(2008-11#2)
the circadian clock and##3##4##(1995-2#1)(2009-8#2)
the circadian clock##5##3##(1995-2#2)(2009-8#3)
the circadian##14##2##(1993-6#1)(1994-2#1)(1995-2#3)(2008-11#5)(2008-5#1)(2009-8#3)
the circle of Willis##2##4##(1995-11#1)(2008-7#1)
the circle##4##2##(1993-1#1)(1995-11#1)(2008-7#1)(2008-8#1)
the circuit##4##2##(2008-11#3)(2010-9#1)
the circuits##3##2##(1992-1#1)(1995-3#1)(2013-8#1)
the circular muscle##4##3##(1997-3#1)(1997-4#3)
the circular##6##2##(1996-6#1)(1997-3#1)(1997-4#3)(2008-2#1)
the circulating reagent solution##3##4##(2008-10#3)
the circulating##7##2##(1993-11#1)(1994-8#1)(2006-6#1)(2008-10#3)(2008-7#1)
the circulation of the##2##4##(2008-10#1)(2009-10#1)
the circulation of##4##3##(1992-3#1)(2008-1#1)(2008-10#1)(2009-10#1)
the circulation##11##2##(1992-3#1)(1993-6#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-10#3)(2013-8#1)
the circumstances##6##2##(1992-9#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)
the cis##3##2##(1990-9#1)(1996-5#1)(2008-9#1)
the cis-isomer##2##2##(1994-8#1)(2008-10#1)
the cisplatin##2##2##(1990-12#1)(1991-2#1)
the cited##3##2##(2008-10#3)
the cities##5##2##(2008-11#2)(2012-12#2)(2013-8#1)
the citizens of##2##3##(2008-12#1)(2009-3#1)
the citizens##3##2##(2008-12#1)(2009-3#1)(2012-3#1)
the citrate##4##2##(1992-9#2)(2008-7#1)(2012-5#1)
the citrus industry##2##3##(2008-10#1)(2013-8#1)
the citrus strains from all##2##5##(2008-10#2)
the citrus##6##2##(2008-10#5)(2013-8#1)
the city center##2##3##(2008-10#1)(2008-5#1)
the city of##17##3##(1991-6#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-5#3)(2009-10#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
the city##31##2##(1990-11#1)(1991-6#1)(1994-2#1)(1995-12#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#6)(2009-10#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
the city's##4##2##(1995-12#2)(1996-5#1)(2008-11#1)
the civil war##2##3##(1994-9#1)(1997-6#1)
the civil##4##2##(1994-9#1)(1996-12#1)(1996-5#1)(1997-6#1)
the cladding##5##2##(2008-10#1)(2008-3#4)
the claim that##4##3##(1992-2#1)(2008-7#1)(2008-8#1)(2010-4#1)
the claim##5##2##(1992-2#1)(1995-6#1)(2008-7#1)(2008-8#1)(2010-4#1)
the claimed##4##2##(1997-4#1)(2008-10#3)
the clamp##4##2##(1994-12#3)(2011-2#1)
the clarification of the##2##4##(2008-10#1)(2010-5#1)
the clarified##3##2##(2008-10#2)(2008-7#1)
the clarity and##2##3##(1996-1#1)(2013-8#1)
the clarity##3##2##(1990-12#1)(1996-1#1)(2013-8#1)
the class Actinomycetes##2##3##(2008-10#2)
the class I##3##3##(1991-2#1)(1995-12#1)(2010-7#1)
the class identity of##2##4##(2008-10#2)
the class of##9##3##(1994-5#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#2)(2011-2#1)
the class##26##2##(1991-2#1)(1991-3#1)(1994-5#1)(1995-12#2)(2008-10#9)(2008-11#4)(2008-9#1)(2009-12#2)(2010-7#1)(2011-2#4)
the classes of##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
the classic##19##2##(1992-9#1)(1994-3#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#2)(2009-1#1)(2009-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#2)
the classical gene-for-gene##2##3##(2008-10#1)(2008-8#1)
the classical mixed effects##2##4##(2012-3#2)
the classical##53##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-8#1)(1995-11#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
the classification and##4##3##(1990-2#1)(2008-10#2)(2008-8#1)
the classification of the##5##4##(2008-10#3)(2008-12#1)(2011-2#1)
the classification of##22##3##(1990-2#1)(1990-3#1)(1996-3#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-4#1)(2009-6#1)(2010-12#2)(2011-2#1)(2013-8#1)
the classification##42##2##(1990-2#2)(1990-3#1)(1991-12#2)(1991-9#1)(1996-3#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-8#1)
the classifications##2##2##(2011-2#2)
the classroom and##3##3##(2008-11#1)(2008-12#2)
the classroom environment##3##3##(2008-12#3)
the classroom setting##2##3##(2008-11#2)
the classroom##16##2##(2008-11#5)(2008-12#11)
the classwide##2##2##(2013-1#2)
the claw##3##2##(2011-2#3)
the claws##2##2##(2011-2#2)
the clean-up##3##2##(2008-10#2)(2008-11#1)
the cleaning##2##2##(2008-10#2)
the clear##9##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-10#1)(2011-2#2)
the clearance of##3##3##(1995-2#1)(1996-1#1)(2008-6#1)
the cleavage of the##4##4##(2008-10#3)(2008-8#1)
the cleavage of##9##3##(1994-9#1)(1995-6#1)(2008-10#5)(2008-8#1)(2008-9#1)
the cleavage site##2##3##(1991-10#1)(2008-5#1)
the cleavage##19##2##(1991-10#1)(1994-9#1)(1995-6#3)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#3)(2013-1#1)
the client with##3##3##(2008-11#1)(2012-3#2)
the client##7##2##(1994-2#1)(2008-11#2)(2009-6#1)(2012-3#2)(2013-8#1)
the climate of##2##3##(2012-3#1)(2012-5#1)
the climate##4##2##(2012-3#1)(2012-5#2)(2012-9#1)
the climbing##3##2##(1992-6#1)(1994-2#1)(2010-8#1)
the clinic##19##2##(1990-3#1)(1992-3#1)(1995-2#1)(1996-1#1)(1996-6#1)(2008-10#2)(2008-11#6)(2010-12#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
the clinical and histopathological##2##4##(2008-1#1)(2010-6#1)
the clinical and morphological##2##4##(1997-6#1)(2009-8#1)
the clinical and pathological features of##2##6##(1991-12#1)(1991-6#1)
the clinical and pathological##4##4##(1991-12#1)(1991-6#1)(1991-8#1)(2011-2#1)
the clinical and radiological##2##4##(1991-11#1)(1997-3#1)
the clinical and##28##3##(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-8#2)(1992-5#1)(1993-12#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
the clinical application of##3##4##(1990-2#1)(2008-10#1)(2008-4#1)
the clinical application##4##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
the clinical area##6##3##(2008-11#5)(2008-12#1)
the clinical assessment of##2##4##(2008-5#1)(2010-6#1)
the clinical benefit##3##3##(1997-7#2)(2008-10#1)
the clinical benefits of##2##4##(2009-6#1)(2011-2#1)
the clinical benefits##3##3##(2009-6#1)(2010-6#1)(2011-2#1)
the clinical case of a##2##5##(2013-1#2)
the clinical characteristics of##3##4##(1992-2#1)(1994-12#1)(2011-2#1)
the clinical condition of the##2##5##(1991-3#1)(2008-11#1)
the clinical course of##5##4##(1996-11#1)(1997-5#1)(2010-1#1)(2010-11#1)(2011-2#1)
the clinical course##8##3##(1996-11#1)(1997-3#1)(1997-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#1)
the clinical data##4##3##(1991-3#1)(2007-12#3)
the clinical development of##2##4##(2008-10#1)(2008-8#1)
the clinical diagnosis of##2##4##(1992-12#1)(1996-11#1)
the clinical diagnosis##3##3##(1992-12#1)(1996-11#1)(2011-1#1)
the clinical diagnostic##2##3##(2008-5#1)(2010-12#1)
the clinical effect of##2##4##(1997-5#1)(2013-8#1)
the clinical efficacy of##2##4##(2008-11#1)(2012-2#1)
the clinical efficacy##3##3##(1990-3#1)(2008-11#1)(2012-2#1)
the clinical environment##4##3##(2008-11#2)(2008-12#2)
the clinical evaluation##2##3##(1997-2#1)(2012-2#1)
the clinical evidence for##2##4##(2008-10#1)(2011-2#1)
the clinical evidence##5##3##(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
the clinical features of##2##4##(2008-5#1)(2012-2#1)
the clinical features##6##3##(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-2#1)
the clinical findings##2##3##(1997-4#1)(2013-1#1)
the clinical forms of##2##4##(2008-5#1)(2008-6#1)
the clinical hematology##2##3##(2008-9#2)
the clinical history##2##3##(1995-11#1)(1996-9#1)
the clinical interview]##2##3##(1993-11#1)(1993-3#1)
the clinical isolates##2##3##(2008-5#1)(2012-2#1)
the clinical learning environment and##2##5##(2008-11#1)(2008-12#1)
the clinical learning environment##5##4##(2008-11#1)(2008-12#4)
the clinical learning##7##3##(2008-11#2)(2008-12#5)
the clinical literature##3##3##(1992-12#1)(1993-12#2)
the clinical management of##2##4##(2008-11#1)(2009-12#1)
the clinical management##4##3##(2008-11#2)(2009-12#1)(2011-2#1)
the clinical manifestations##2##3##(1991-3#1)(1994-6#1)
the clinical outcome##5##3##(1991-2#1)(1997-3#1)(2011-2#1)(2013-1#2)
the clinical outcomes##4##3##(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
the clinical phenotype and##2##4##(2011-2#1)(2012-3#1)
the clinical phenotype##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
the clinical phenotypes##2##3##(2008-11#1)(2010-1#1)
the clinical picture##6##3##(1997-4#1)(1997-6#2)(2008-7#1)(2012-12#1)(2013-1#1)
the clinical placement##2##3##(2008-11#1)(2008-12#1)
the clinical practice of##3##4##(1993-11#1)(2008-12#1)(2010-8#1)
the clinical practice##5##3##(1993-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
the clinical presentation and##2##4##(2009-8#1)(2012-12#1)
the clinical presentation##5##3##(1996-3#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
the clinical profile##2##3##(2009-11#1)(2012-3#1)
the clinical response of##3##4##(1991-3#1)(2008-5#1)(2013-1#1)
the clinical response##4##3##(1991-3#1)(1991-6#1)(2008-5#1)(2013-1#1)
the clinical setting##19##3##(1991-11#1)(1992-3#1)(1993-3#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-9#3)(2009-9#1)(2011-2#1)(2012-12#1)
the clinical significance of##2##4##(2008-2#1)(2012-3#1)
the clinical significance##3##3##(2008-2#1)(2012-3#1)(2013-2#1)
the clinical signs and symptoms##2##5##(1992-1#1)(2013-1#1)
the clinical signs##3##3##(1992-1#1)(2013-1#2)
the clinical situation##3##3##(1990-2#1)(2008-11#1)(2013-1#1)
the clinical stage IV##2##4##(2008-1#2)
the clinical stage##3##3##(1990-9#1)(2008-1#2)
the clinical status of the##2##5##(1995-11#1)(2008-7#1)
the clinical status of##3##4##(1995-11#1)(2008-7#1)(2009-5#1)
the clinical status##4##3##(1995-11#1)(2008-7#1)(2009-5#1)(2013-1#1)
the clinical studies##3##3##(2008-11#2)(2010-5#1)
the clinical symptoms##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
the clinical trial##3##3##(1992-9#1)(2008-7#1)(2010-6#1)
the clinical trials##2##3##(2008-11#1)(2013-1#1)
the clinical use of##5##4##(1991-12#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
the clinical##310##2##(1990-2#3)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#5)(1991-6#3)(1991-8#2)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-11#3)(1993-12#4)(1993-3#2)(1993-5#1)(1994-1#2)(1994-12#5)(1994-6#3)(1995-11#3)(1995-12#2)(1995-5#1)(1996-11#3)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#6)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#2)(1997-8#3)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#29)(2008-12#18)(2008-2#1)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#2)(2010-5#2)(2010-6#4)(2010-8#1)(2011-1#1)(2011-2#19)(2011-7#1)(2012-12#7)(2012-2#9)(2012-3#8)(2013-1#29)(2013-2#1)(2013-7#2)(2013-8#3)
the clinically important##4##3##(1993-12#1)(2008-5#1)(2009-10#1)(2012-3#1)
the clinically##6##2##(1993-12#1)(1997-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-3#1)
the clinician in##2##3##(2008-12#1)(2011-2#1)
the clinician to##6##3##(1991-2#1)(1994-12#1)(2007-9#1)(2008-12#2)(2013-1#1)
the clinician##22##2##(1990-9#1)(1991-2#1)(1993-1#1)(1994-12#1)(1997-3#1)(2007-9#1)(2008-12#3)(2008-6#1)(2009-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)
the clinician's##4##2##(2008-12#1)(2008-3#1)(2009-6#1)(2010-1#1)
the clinicians##4##2##(1994-12#1)(1995-1#1)(2007-9#1)(2008-9#1)
the clinicopathologic features##2##3##(2008-11#1)(2010-1#1)
the clinics##4##2##(1991-1#1)(1994-1#2)(1996-1#1)
the clock##3##2##(1991-12#1)(1997-1#1)(2008-9#1)
the clonal lineage##2##3##(2008-10#2)
the clonal##11##2##(1994-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
the clone was inserted into the pSVL vector (pUDPGTh2) and expressed in COS 1 cells##2##15##(2008-11#2)
the clone was##3##3##(2008-10#1)(2008-11#2)
the clone##10##2##(1990-5#1)(1993-3#1)(2008-10#2)(2008-11#4)(2008-8#2)
the cloned DNA##2##3##(1991-9#1)(2008-10#1)
the cloned embryos##2##3##(2008-9#2)
the cloned fragment##3##3##(1991-6#2)(1996-12#1)
the cloned fragments##3##3##(2008-10#3)
the cloned human##2##3##(1993-8#1)(1995-11#1)
the cloned receptor##2##3##(1992-3#2)
the cloned##26##2##(1990-11#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-11#2)(1995-11#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-8#1)(2008-9#2)
the clones##7##2##(1993-3#1)(1997-2#3)(1997-8#1)(2008-11#2)
the cloning and##3##3##(1993-12#1)(1993-6#1)(2008-4#1)
the cloning of the##5##4##(1993-8#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-8#1)
the cloning of##9##3##(1993-2#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-8#1)(2009-12#1)
the cloning##15##2##(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)
the close collaboration##2##3##(2008-10#1)(2012-2#1)
the close phylogenetic relationship of##2##5##(1994-11#1)(1996-12#1)
the close##18##2##(1990-11#1)(1991-6#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
the closed##3##2##(1992-3#1)(2008-8#1)(2011-2#1)
the closely related##8##3##(1991-5#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-5#1)
the closely##10##2##(1991-5#1)(1995-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)(2012-5#1)
the closer##3##2##(2011-2#3)
the closest relative for the##2##5##(2008-10#2)
the closest relative##3##3##(2008-10#3)
the closest to the##2##4##(2006-6#1)(2008-6#1)
the closest##11##2##(2006-6#1)(2008-10#7)(2008-6#1)(2008-9#1)(2012-12#1)
the closure of##2##3##(1996-3#1)(1997-3#1)
the closure##3##2##(1996-3#1)(1997-3#1)(2008-10#1)
the clotting##2##2##(2008-9#1)(2011-2#1)
the cloud point extraction##2##4##(2008-10#2)
the cloud point##4##3##(2008-10#4)
the cloud##9##2##(1991-5#1)(2008-10#4)(2008-2#1)(2008-3#3)
the cluster analysis##2##3##(2008-10#2)
the cluster##11##2##(1996-6#3)(2008-10#5)(2008-6#1)(2010-10#1)(2013-1#1)
the clustering##6##2##(2008-10#3)(2008-5#1)(2008-6#1)(2011-2#1)
the clusters of##2##3##(1995-6#1)(2008-10#1)
the clusters##4##2##(1995-6#1)(2008-10#2)(2008-6#1)
the clutch##2##2##(2008-8#1)(2008-9#1)
the co- polymer trimethylamine microcarriers##2##5##(2008-11#2)
the co-evolution of##3##3##(2011-10#2)(2013-8#1)
the co-existence of##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
the co-existence##4##2##(1995-12#1)(2008-10#1)(2012-3#2)
the co-localization of##2##3##(2008-10#1)(2010-12#1)
the co-migration##2##2##(2008-10#2)
the co-polymer trimethylamine microcarriers##2##4##(2008-11#2)
the co-researchers##2##2##(2008-11#2)
the coaggregation of##2##3##(2008-5#2)
the coagulation##2##2##(2008-10#1)(2012-12#1)
the coastal##5##2##(2008-10#3)(2010-8#1)(2013-8#1)
the coat protein (CP) and##3##5##(2008-10#3)
the coat protein (CP) gene of##4##6##(2008-10#4)
the coat protein (CP) gene##7##5##(2008-10#6)(2008-8#1)
the coat protein (CP)##13##4##(2008-10#12)(2008-8#1)
the coat protein gene of##2##5##(2008-10#2)
the coat protein gene##4##4##(2008-10#4)
the coat protein##24##3##(2008-10#23)(2008-8#1)
the coat##30##2##(2008-10#29)(2008-8#1)
the coated##8##2##(2008-10#6)(2008-2#1)(2008-4#1)
the coating of the##2##4##(1993-3#1)(2008-2#1)
the coating or film##2##4##(2008-10#2)
the coating thickness##3##3##(2008-3#3)
the coating##16##2##(1993-3#1)(2008-10#8)(2008-2#1)(2008-3#5)(2009-7#1)
the coatings##3##2##(2008-3#1)(2010-4#2)
the cochlea##7##2##(2008-9#3)(2009-9#1)(2012-2#3)
the cochlear implant##7##3##(2008-9#5)(2012-2#2)
the cochlear##10##2##(2008-9#6)(2009-8#1)(2012-2#3)
the cochleostomy site##2##3##(2008-9#2)
the cockroach##4##2##(1995-11#1)(2007-12#2)(2008-8#1)
the coculture##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
the code##2##2##(2008-10#1)(2008-3#1)
the coded##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
the coding region and##3##4##(1990-6#1)(1993-6#1)(2008-12#1)
the coding region of lambdaN gene##3##6##(2008-8#3)
the coding region of the##2##5##(1997-7#1)(2008-4#1)
the coding region of##10##4##(1990-8#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-8#3)
the coding region##25##3##(1990-6#1)(1990-7#2)(1990-8#1)(1993-2#3)(1993-6#2)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#4)(2010-5#1)(2013-8#1)
the coding sequence of##3##4##(1992-10#1)(1993-2#1)(1997-8#1)
the coding sequence was##2##4##(1997-4#1)(2008-8#1)
the coding sequence##7##3##(1992-10#1)(1993-12#1)(1993-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-8#1)
the coding sequences of##5##4##(1995-8#2)(1996-2#3)
the coding##49##2##(1990-6#1)(1990-7#2)(1990-8#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-2#5)(1993-6#2)(1994-5#2)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#3)(1996-2#4)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#5)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
the codon for##3##3##(1993-8#1)(2008-10#2)
the codon##5##2##(1993-8#1)(1997-6#1)(1997-8#1)(2008-10#2)
the coefficient of determination##2##4##(2008-10#1)(2011-2#1)
the coefficient of variation (CV) of##2##6##(2008-10#1)(2008-8#1)
the coefficient of variation for##2##5##(1990-2#1)(2008-10#1)
the coefficient of variation##11##4##(1990-2#1)(1992-3#1)(2008-10#8)(2008-8#1)
the coefficient of##16##3##(1990-2#1)(1992-3#1)(2008-10#11)(2008-8#1)(2008-9#1)(2011-2#1)
the coefficients of variation##4##4##(1996-3#2)(2008-10#2)
the coefficients of##6##3##(1996-3#2)(2008-10#4)
the coefficients##7##2##(1996-3#2)(2008-10#4)(2008-8#1)
the coelomic##3##2##(1990-5#1)(2008-5#1)(2011-2#1)
the coenzyme##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
the coevolution between##2##3##(2008-8#2)
the coevolution##4##2##(2008-10#1)(2008-8#3)
the coevolutionary##2##2##(1995-5#1)(2008-10#1)
the coexistence of both##2##4##(2008-9#1)(2013-8#1)
the coexistence of competitors##2##4##(2008-8#1)(2008-9#1)
the coexistence of##13##3##(1992-6#1)(2008-10#3)(2008-8#4)(2008-9#3)(2010-6#1)(2013-8#1)
the coexisting##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
the cofactor##9##2##(1990-5#1)(1993-12#1)(1994-11#1)(1994-5#4)(2008-11#1)(2009-3#1)
the cognate mRNA##2##3##(2008-9#2)
the cognate##7##2##(2008-10#3)(2008-4#1)(2008-9#3)
the cognitive and##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
the cognitive decline##2##3##(2008-7#1)(2013-8#1)
the cognitive##14##2##(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-10#1)(2013-8#1)
the cohered structures##2##3##(1991-7#2)
the cohered##4##2##(1991-7#4)
the coherence of##2##3##(2008-3#2)
the coherence##4##2##(2008-3#4)
the cohort was##2##3##(2007-12#1)(2008-8#1)
the cohort##6##2##(1994-12#1)(2007-12#1)(2008-6#1)(2008-8#1)(2012-12#2)
the coil and##2##3##(2008-10#2)
the coil##7##2##(1996-9#1)(2008-10#3)(2010-7#3)
the coiled-coil pitch##2##3##(1992-9#2)
the coiled-coil##3##2##(1992-9#3)
the coils##2##2##(1995-11#1)(1996-9#1)
the coincidence of##3##3##(1996-6#1)(2008-8#1)(2009-2#1)
the coincidence##4##2##(1996-6#1)(2007-12#1)(2008-8#1)(2009-2#1)
the col-36##2##2##(1993-12#2)
the col-6##2##2##(1993-12#2)
the cold vapor mercury##2##4##(2008-10#2)
the cold##11##2##(1994-12#1)(1994-9#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
the cold-hardiness strategies##2##3##(2008-8#2)
the cold-shock response in mammalian##2##5##(2008-11#2)
the collaborative efforts of##4##4##(1994-9#1)(1996-1#1)(2010-10#1)(2013-1#1)
the collaborative##11##2##(1994-9#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
the collagen network##2##3##(2008-5#1)(2008-7#1)
the collagen##17##2##(1992-6#6)(1993-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2012-12#1)(2013-1#3)
the collagenous##2##2##(2008-11#1)(2008-7#1)
the collapse of the##2##4##(2008-10#1)(2008-12#1)
the collapse of##5##3##(1991-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)
the collateral##6##2##(1991-2#1)(1994-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2012-2#1)
the collected data##7##3##(1992-1#1)(1994-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#1)
the collected##13##2##(1992-1#1)(1994-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)
the collecting lens aperture##3##4##(2008-2#3)
the collecting##4##2##(2008-2#3)(2011-2#1)
the collection and##3##3##(2008-10#2)(2010-1#1)
the collection of data##3##4##(1995-12#1)(1997-3#2)
the collection of##18##3##(1995-12#1)(1996-3#1)(1997-3#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)
the collection##32##2##(1995-12#1)(1996-3#1)(1997-3#3)(2008-10#16)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#3)
the collective knowledge##2##3##(2008-10#1)(2010-10#1)
the collective##7##2##(1991-11#1)(1994-1#1)(1995-3#1)(2008-10#1)(2009-8#2)(2010-10#1)
the collector##4##2##(2008-10#4)
the college##3##2##(1992-1#1)(1996-1#1)(2013-8#1)
the collembola-biotest##2##2##(2008-11#2)
the colloidal##5##2##(2008-10#4)(2008-5#1)
the colon of##5##3##(2008-12#4)(2011-3#1)
the colon##29##2##(1990-11#1)(1990-3#2)(1990-9#1)(1991-6#2)(1992-6#1)(1994-2#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#8)(2009-1#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
the colonic##2##2##(2009-1#1)(2011-3#1)
the colonies##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-1#1)
the colonization effect##2##3##(2008-8#2)
the colonization of##5##3##(2008-10#5)
the colonization##11##2##(2008-10#7)(2008-8#4)
the colony counting method##2##4##(2008-10#2)
the colony##17##2##(2008-10#7)(2008-11#2)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#4)
the color of the##3##4##(2008-10#2)(2011-2#1)
the color of##5##3##(2008-10#3)(2009-8#1)(2011-2#1)
the color reaction##3##3##(2008-10#3)
the color##20##2##(1993-3#2)(2008-10#13)(2008-3#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
the colorants##4##2##(2008-10#4)
the colored##4##2##(2008-10#4)
the colorimetric method##5##3##(1994-3#2)(2008-10#3)
the colorimetric reaction between##2##4##(2008-10#2)
the colorimetric##13##2##(1994-3#2)(2008-10#10)(2008-5#1)
the colour induced##2##3##(2008-5#2)
the colour of the##2##4##(2008-10#2)
the colour of##3##3##(2008-10#3)
the colour##10##2##(1990-12#1)(2008-10#6)(2008-5#3)
the coloured##7##2##(2008-10#6)(2008-5#1)
the colposcopy directed biopsy##3##4##(2008-11#3)
the colposcopy directed cytology##2##4##(2008-11#2)
the colposcopy directed##6##3##(2008-11#6)
the column and##3##3##(2008-10#2)(2008-9#1)
the column could tolerate##2##4##(2008-10#2)
the column could##3##3##(2008-10#3)
the column eluate##2##3##(2008-10#2)
the column temperature##3##3##(2008-10#3)
the column was##5##3##(1992-6#1)(2008-10#4)
the column with##4##3##(1990-12#1)(2008-10#3)
the column##57##2##(1990-12#1)(1992-11#1)(1992-6#1)(1993-6#1)(2008-10#51)(2008-9#2)
the columnar##3##2##(2008-2#1)(2008-3#1)(2009-10#1)
the columns##6##2##(2008-10#6)
the combination of DTPA and BHT##2##6##(2008-5#2)
the combination of Nep1 and P##2##6##(2008-10#2)
the combination of different##2##4##(2008-10#2)
the combination of high##2##4##(2008-10#1)(2012-3#1)
the combination of the##5##4##(1997-8#1)(2008-10#2)(2008-7#1)(2012-5#1)
the combination of these##3##4##(2008-7#1)(2008-9#1)(2009-1#1)
the combination of##73##3##(1990-2#1)(1990-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(1997-8#2)(2008-10#23)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#4)(2008-9#4)(2009-1#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-5#1)(2013-8#1)
the combination with##2##3##(2011-2#1)(2013-8#1)
the combination##90##2##(1990-2#1)(1990-8#1)(1991-6#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#6)(1996-12#1)(1997-7#1)(1997-8#2)(2008-10#27)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-8#2)
the combinations of##6##3##(2008-10#3)(2008-9#2)(2013-1#1)
the combinations##8##2##(2008-10#3)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
the combinatorial##3##2##(1996-3#1)(1997-9#1)(2010-4#1)
the combined action of##2##4##(2008-10#1)(2008-11#1)
the combined data set##4##4##(2008-10#3)(2008-11#1)
the combined data##6##3##(2008-10#4)(2008-11#1)(2010-4#1)
the combined density of##2##4##(1993-9#1)(2008-9#1)
the combined effect of##5##4##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-4#1)
the combined effects of temperature##2##5##(2008-10#2)
the combined effects of##5##4##(2008-10#5)
the combined power of##2##4##(2012-2#1)(2012-3#1)
the combined therapy##4##3##(2008-1#1)(2012-3#1)(2013-1#2)
the combined use of##6##4##(1997-7#1)(2006-6#1)(2008-10#2)(2008-7#1)(2013-1#1)
the combined use##7##3##(1997-7#1)(2006-6#1)(2008-10#3)(2008-7#1)(2013-1#1)
the combined##68##2##(1991-7#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#2)(2012-6#3)(2013-1#6)(2013-8#2)
the combustion of##2##3##(2008-10#1)(2008-11#1)
the combustion##7##2##(1996-12#1)(2008-10#2)(2008-11#2)(2008-3#2)
the comet assay##5##3##(2008-10#2)(2010-5#2)(2013-1#1)
the comet##6##2##(2008-10#3)(2010-5#2)(2013-1#1)
the comfort##2##2##(2008-11#1)(2011-2#1)
the coming##2##2##(1996-1#1)(2010-1#1)
the commercial##23##2##(1994-8#1)(1997-2#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-12#1)
the commercially available##5##3##(1991-12#1)(2008-10#3)(2008-5#1)
the commercially##6##2##(1991-12#1)(2008-10#3)(2008-5#1)(2011-1#1)
the commitment##2##2##(1996-5#1)(2008-11#1)
the committee##2##2##(1994-2#1)(2012-2#1)
the common ancestor of##2##4##(1997-6#1)(2010-4#1)
the common and comet##2##4##(2010-8#2)
the common and##3##3##(2010-8#2)(2012-2#1)
the common bean##5##3##(2008-10#5)
the common bile duct##7##4##(1990-5#2)(1990-9#2)(1991-3#1)(1996-11#1)(2009-9#1)
the common characteristics##2##3##(2008-10#1)(2009-12#1)
the common cold##6##3##(1992-3#1)(2008-10#4)(2012-3#1)
the common diagnostic##2##3##(1991-8#1)(2010-5#1)
the common practice of##2##4##(2008-10#1)(2012-2#1)
the common region##3##3##(1990-11#1)(2008-10#2)
the common sense##2##3##(2008-1#1)(2010-4#1)
the common##112##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#3)(2008-10#36)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
the commonest species##3##3##(2008-5#3)
the commonest##17##2##(1990-6#1)(1997-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#3)(2010-11#1)(2012-3#2)(2013-1#1)
the commonly used##6##3##(1995-11#1)(2008-10#2)(2008-3#1)(2010-11#1)(2013-1#1)
the commonly##10##2##(1992-11#1)(1992-2#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)(2010-11#1)(2013-1#1)
the communication and##2##3##(2008-11#1)(2008-12#1)
the communication between##2##3##(2008-10#1)(2009-8#1)
the communication of##2##3##(1990-12#1)(2010-4#1)
the communication##11##2##(1990-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)
the communities in which they##2##5##(1995-3#1)(1996-3#1)
the communities in which##3##4##(1995-3#1)(1996-3#2)
the communities##5##2##(1995-3#1)(1996-3#2)(2008-11#1)(2012-12#1)
the community and the##2##4##(1994-1#1)(1995-3#1)
the community and##6##3##(1991-2#1)(1994-1#1)(1995-3#1)(2013-1#2)(2013-8#1)
the community approach##2##3##(1992-1#2)
the community burden of##2##4##(2008-10#1)(2008-11#1)
the community care##2##3##(1997-8#1)(2010-10#1)
the community health##4##3##(1991-3#1)(1997-2#2)(2008-1#1)
the community in##4##3##(1997-1#1)(2009-6#1)(2013-1#2)
the community to##2##3##(1992-1#1)(2009-10#1)
the community##96##2##(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1992-1#4)(1993-1#1)(1993-11#1)(1993-2#1)(1994-1#4)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-8#2)(2008-1#2)(2008-10#2)(2008-11#13)(2008-12#4)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#10)(2013-8#1)
the compact##2##2##(1995-2#1)(2008-10#1)
the company##6##2##(2008-10#1)(2008-11#4)(2010-4#1)
the company's##5##2##(1990-2#1)(1993-12#1)(1995-6#1)(2008-10#1)(2011-2#1)
the comparability of##4##3##(1990-6#1)(2008-10#2)(2012-2#1)
the comparative##14##2##(1990-6#1)(1994-5#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
the comparator##2##2##(2008-11#1)(2013-1#1)
the comparison among##2##3##(2008-10#1)(2011-2#1)
the comparison between##4##3##(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)
the comparison group##3##3##(1995-1#1)(1995-3#1)(2008-11#1)
the comparison is##3##3##(1994-9#1)(1996-3#1)(2013-1#1)
the comparison of the##5##4##(1990-8#1)(2008-10#4)
the comparison of two##2##4##(1994-9#1)(2008-10#1)
the comparison of##14##3##(1990-8#1)(1994-9#2)(2008-10#10)(2013-1#1)
the comparison##30##2##(1990-8#1)(1994-2#1)(1994-9#3)(1995-1#1)(1995-3#1)(1996-3#2)(2008-10#13)(2008-11#2)(2008-2#2)(2009-12#1)(2011-2#1)(2013-1#2)
the compartmentalization of##2##3##(2010-5#1)(2012-2#1)
the compartmentalization##3##2##(1994-11#1)(2010-5#1)(2012-2#1)
the compatibility of SHLI with##2##5##(2011-2#2)
the compatibility of##7##3##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#3)
the compatibility##9##2##(1995-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#3)
the compensated##2##2##(1991-2#1)(2009-7#1)
the compensation of##2##3##(1991-2#2)
the compensation##5##2##(1991-2#2)(2008-10#2)(2008-3#1)
the compensatory##2##2##(2008-8#1)(2011-2#1)
the competence of nurses##2##4##(2008-12#2)
the competence of##3##3##(1996-2#1)(2008-12#2)
the competence##4##2##(1996-2#1)(2008-12#2)(2009-6#1)
the competing##5##2##(1995-9#1)(2008-11#1)(2008-8#2)(2009-12#1)
the competition between##2##3##(2008-10#1)(2008-7#1)
the competition with##2##3##(2008-10#1)(2008-11#1)
the competition##10##2##(1992-2#1)(2008-10#4)(2008-11#1)(2008-7#2)(2011-2#1)(2013-8#1)
the competitive adsorption of##2##4##(2008-10#2)
the competitive reaction##3##3##(2008-10#3)
the competitive##32##2##(1992-8#1)(1995-11#1)(1997-2#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-8#3)(2008-9#1)(2009-7#1)
the complaint##2##2##(2008-5#1)(2012-12#1)
the complaints##3##2##(1990-11#1)(1996-3#1)(2011-2#1)
the complement of##2##3##(2008-5#1)(2010-12#1)
the complement##9##2##(1991-2#1)(1991-3#2)(1993-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-12#1)
the complementarity-determining region##2##3##(1995-2#2)
the complementary and alternative##2##4##(1991-3#1)(2008-10#1)
the complementary target##3##3##(2008-10#3)
the complementary##13##2##(1991-3#1)(1993-8#1)(2008-10#9)(2008-4#1)(2008-9#1)
the complete ITS##3##3##(2008-10#3)
the complete coding##2##3##(1993-2#1)(1997-7#1)
the complete genome of##2##4##(2008-10#1)(2012-3#1)
the complete genome sequence of##2##5##(2008-9#1)(2013-8#1)
the complete genome sequence##21##4##(2008-9#1)(2011-2#19)(2013-8#1)
the complete genome sequences##2##4##(2008-10#2)
the complete genome##26##3##(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#19)(2012-3#1)(2013-8#1)
the complete genomic##2##3##(2008-10#1)(2008-8#1)
the complete nucleotide sequence of a##4##6##(1993-3#1)(1995-9#1)(1997-4#1)(2008-10#1)
the complete nucleotide sequence of##5##5##(1993-3#1)(1995-9#1)(1997-4#1)(1997-7#1)(2008-10#1)
the complete nucleotide sequence##7##4##(1993-3#1)(1995-8#1)(1995-9#1)(1997-4#1)(1997-7#1)(2008-10#2)
the complete nucleotide sequences of##2##5##(2008-10#1)(2013-8#1)
the complete nucleotide##10##3##(1993-12#1)(1993-3#1)(1995-8#1)(1995-9#1)(1997-4#1)(1997-7#1)(2008-10#3)(2013-8#1)
the complete removal of##2##4##(1994-11#1)(2011-1#1)
the complete separation of the##2##5##(1990-12#2)
the complete separation of##3##4##(1990-12#2)(2008-10#1)
the complete sequence of##3##4##(1993-2#1)(2007-12#1)(2010-5#1)
the complete sequence##4##3##(1993-2#1)(2007-12#1)(2010-5#1)(2011-2#1)
the complete set of##3##4##(1997-7#1)(2008-6#1)(2012-3#1)
the complete system##2##3##(2008-10#1)(2008-3#1)
the complete##104##2##(1990-12#2)(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#6)(2007-12#2)(2008-10#30)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#20)(2012-3#3)(2013-8#3)
the completed##4##2##(1992-3#2)(2010-6#1)(2012-12#1)
the completely##2##2##(2008-12#1)(2008-7#1)
the completeness##2##2##(2008-12#1)(2013-7#1)
the completion of the##8##4##(1993-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#1)
the completion of##15##3##(1990-12#1)(1991-8#1)(1993-9#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
the completion##16##2##(1990-12#1)(1991-8#1)(1993-9#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#2)
the complex ML(2)##2##3##(2008-10#2)
the complex and##4##3##(2008-10#1)(2010-5#1)(2010-6#1)(2011-2#1)
the complex at##2##3##(2008-10#2)
the complex biological##2##3##(2008-4#1)(2008-5#1)
the complex formation between##3##4##(2008-10#2)(2008-7#1)
the complex formation##12##3##(2008-10#11)(2008-7#1)
the complex formed between##2##4##(1994-5#1)(2008-10#1)
the complex formed##3##3##(1994-5#1)(2008-10#2)
the complex genetic##2##3##(2009-10#1)(2009-3#1)
the complex impedance##2##3##(2008-10#2)
the complex in##3##3##(2008-10#3)
the complex interactions between##2##4##(2008-5#1)(2008-7#1)
the complex interactions##4##3##(1993-8#1)(2008-5#1)(2008-7#1)(2009-3#1)
the complex is##11##3##(1995-12#1)(1995-2#1)(2008-10#9)
the complex mechanisms##2##3##(2008-10#1)(2008-11#1)
the complex nature of##3##4##(2008-10#2)(2008-11#1)
the complex of the##2##4##(2008-10#2)
the complex of##10##3##(1992-4#1)(1993-8#4)(2008-10#3)(2008-11#1)(2008-8#1)
the complex process##2##3##(2009-6#1)(2011-2#1)
the complex refractive index##2##4##(2008-10#1)(2008-3#1)
the complex relationship between##3##4##(2008-11#1)(2011-2#2)
the complex relationship##4##3##(2008-11#1)(2011-2#3)
the complex structure##3##3##(1995-9#1)(2008-10#2)
the complex was##7##3##(1990-5#1)(2008-10#6)
the complex with##3##3##(2008-10#3)
the complex##187##2##(1990-5#2)(1990-6#1)(1991-3#1)(1992-10#1)(1992-4#1)(1993-3#1)(1993-8#7)(1993-9#2)(1994-11#2)(1994-3#1)(1994-5#4)(1995-12#1)(1995-2#2)(1995-9#1)(1997-1#1)(1997-3#1)(2008-10#104)(2008-11#8)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2009-10#2)(2009-3#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#8)(2012-2#3)(2012-3#3)(2013-8#5)
the complex-formation##2##2##(2008-10#2)
the complexation between##2##3##(2008-10#2)
the complexation constants of##2##4##(2008-10#2)
the complexation in water##2##4##(2008-10#2)
the complexation in##3##3##(2008-10#3)
the complexation of##6##3##(2008-10#6)
the complexation reaction is##2##4##(2008-10#2)
the complexation reaction of##2##4##(2008-10#2)
the complexation reaction##8##3##(2008-10#8)
the complexation with##3##3##(2008-10#3)
the complexation##33##2##(2008-10#33)
the complexed##3##2##(2008-10#3)
the complexes are##2##3##(2008-10#1)(2009-8#1)
the complexes formed##3##3##(2008-10#3)
the complexes of##6##3##(1997-3#1)(2008-10#5)
the complexes were##3##3##(1994-5#1)(2008-10#2)
the complexes##32##2##(1990-2#1)(1991-9#1)(1994-5#1)(1997-3#1)(2008-10#25)(2009-8#1)(2010-7#2)
the complexing agent##8##3##(2008-10#8)
the complexing properties of##2##4##(2008-10#2)
the complexing##14##2##(2008-10#14)
the complexities of##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
the complexities##7##2##(1994-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-5#1)(2013-8#1)
the complexity of the apparatus##2##5##(2008-3#2)
the complexity of the feeding apparatus##2##6##(2010-8#2)
the complexity of the##28##4##(1993-2#1)(1993-3#1)(1993-9#1)(1995-5#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-12#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
the complexity of##45##3##(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-5#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#4)(2013-1#1)(2013-8#1)
the complexity##49##2##(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-5#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#5)(2013-1#2)(2013-8#1)
the complexometric##2##2##(2008-10#2)
the compliance of##2##3##(1996-3#1)(2008-10#1)
the compliance with##2##3##(1996-2#1)(2008-10#1)
the compliance##5##2##(1996-2#1)(1996-3#1)(2008-10#2)(2012-2#1)
the complicated##3##2##(2008-11#1)(2009-6#1)(2013-8#1)
the complication rate##2##3##(2007-8#1)(2013-1#1)
the complication##11##2##(1992-5#1)(1993-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#1)
the complications of##2##3##(2008-1#1)(2012-3#1)
the complications that##2##3##(1994-6#1)(2012-2#1)
the complications##10##2##(1994-6#1)(1996-12#1)(1996-3#1)(2008-1#1)(2009-3#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the component of##2##3##(1990-4#1)(2008-11#1)
the component##12##2##(1990-4#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(2008-10#5)(2008-11#1)(2013-8#1)
the components are##2##3##(2008-10#1)(2008-3#1)
the components of a##5##4##(1993-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
the components of the##14##4##(1991-12#1)(1993-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2009-10#1)(2010-1#1)
the components of##31##3##(1991-12#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2011-2#1)(2013-1#1)
the components##49##2##(1991-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#1)
the composite OWG##2##3##(2008-10#2)
the composite interval mapping##2##4##(2008-10#2)
the composite##12##2##(2008-10#10)(2009-7#2)
the composites##2##2##(2010-4#2)
the composition and##6##3##(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)
the composition change of##2##4##(2008-10#2)
the composition in##2##3##(1990-5#1)(2008-3#1)
the composition of a##3##4##(1990-9#1)(2008-10#2)
the composition of evacuees who##2##5##(2011-2#2)
the composition of the natural enemy community##2##7##(2008-8#2)
the composition of the##23##4##(1992-1#1)(2008-10#18)(2008-8#2)(2011-2#2)
the composition of##54##3##(1990-9#1)(1992-1#1)(1994-2#2)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#34)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
the composition##70##2##(1990-12#1)(1990-5#1)(1990-9#1)(1992-1#1)(1994-2#2)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#42)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#2)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the compositions of##2##3##(2008-10#1)(2008-8#1)
the compositions##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
the compost mix##7##3##(2008-10#7)
the compost##13##2##(2008-10#12)(2008-12#1)
the compound fertilizer##2##3##(2008-10#2)
the compound that##3##3##(1990-5#1)(2008-8#2)
the compound to##3##3##(2008-10#2)(2008-5#1)
the compound was##2##3##(2008-10#1)(2009-6#1)
the compound##27##2##(1990-5#1)(1992-9#1)(1993-1#1)(2007-12#1)(2008-10#15)(2008-5#1)(2008-8#2)(2009-6#1)(2011-3#2)(2013-1#2)
the compounds are##2##3##(2008-10#1)(2009-8#1)
the compounds at##3##3##(2008-10#2)(2011-3#1)
the compounds except##2##3##(1994-8#1)(2008-10#1)
the compounds having##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
the compounds studied##3##3##(1994-8#1)(2008-10#2)
the compounds tested##4##3##(1990-12#1)(1994-11#1)(1994-8#1)(2009-8#1)
the compounds were##6##3##(1993-1#1)(2008-10#4)(2008-5#1)
the compounds##64##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-8#3)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#37)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#2)(2011-3#1)(2012-12#1)(2012-3#1)
the comprehension of##4##3##(1997-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
the comprehension##5##2##(1997-3#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
the comprehensive##5##2##(1995-12#1)(2008-10#1)(2008-5#1)(2010-1#1)(2012-3#1)
the compression effect##2##3##(2013-8#2)
the compression##6##2##(1993-3#1)(2008-10#1)(2008-9#1)(2013-8#3)
the compressive##4##2##(2009-7#4)
the compromise##2##2##(2008-10#1)(2008-3#1)
the compulsory##3##2##(1991-6#1)(1994-1#1)(2008-11#1)
the computation of##6##3##(2008-10#3)(2008-3#2)(2008-4#1)
the computation##8##2##(2008-10#3)(2008-3#3)(2008-4#1)(2013-8#1)
the computational effort##2##3##(2008-8#1)(2011-2#1)
the computational methodology for##2##4##(2008-10#1)(2008-3#1)
the computational##9##2##(1990-11#1)(1992-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the computationally##2##2##(2008-11#1)(2008-8#1)
the computed##3##2##(1991-12#1)(1996-12#1)(2009-8#1)
the computer and##2##3##(1995-12#1)(2012-12#1)
the computer program##6##3##(1995-12#3)(1997-2#1)(2008-10#1)(2008-11#1)
the computer##19##2##(1991-9#1)(1992-12#1)(1995-12#4)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2010-5#1)(2012-12#1)
the computer-based##2##2##(1994-2#1)(1994-6#1)
the concave side of the##2##5##(1996-5#1)(2012-2#1)
the concave side of##3##4##(1996-5#1)(2012-2#2)
the concentrated##7##2##(2008-10#6)(2012-2#1)
the concentration and##11##3##(1990-2#1)(1991-5#1)(2008-10#8)(2011-2#1)
the concentration corresponding to##2##4##(2008-10#1)(2012-2#1)
the concentration in##2##3##(2008-10#2)
the concentration level of##3##4##(2008-10#3)
the concentration level##5##3##(2008-10#5)
the concentration levels of##3##4##(2008-10#2)(2008-11#1)
the concentration levels##6##3##(2008-10#5)(2008-11#1)
the concentration of 0##2##4##(2008-10#2)
the concentration of AA in the range##2##7##(2008-10#2)
the concentration of CV and##2##5##(2008-10#2)
the concentration of Cr(VI)##2##4##(2008-10#2)
the concentration of FP-IX##2##4##(1994-8#2)
the concentration of NO##2##4##(1993-8#1)(2008-10#1)
the concentration of STA ion##2##5##(2008-10#2)
the concentration of TCE in the##2##6##(2008-10#1)(2010-4#1)
the concentration of Zn(2+)##2##4##(2008-10#2)
the concentration of a##2##4##(2008-10#1)(2008-9#1)
the concentration of ascorbic acid##3##5##(2008-10#3)
the concentration of each##4##4##(2008-10#4)
the concentration of free##3##4##(2008-10#2)(2011-2#1)
the concentration of glucose##2##4##(2008-10#1)(2008-11#1)
the concentration of hormones##2##4##(1997-4#1)(2008-8#1)
the concentration of hydrogen##2##4##(2008-10#2)
the concentration of iron##2##4##(2008-10#2)
the concentration of metal##2##4##(2008-10#2)
the concentration of nitrite##2##4##(2008-10#2)
the concentration of nucleic acids##4##5##(2008-10#4)
the concentration of orthophosphate##2##4##(2008-10#2)
the concentration of oxygen##2##4##(2008-10#2)
the concentration of the free##2##5##(2008-10#2)
the concentration of the sulfate ion##2##6##(2008-10#2)
the concentration of the##36##4##(1991-5#1)(1993-6#1)(1994-5#1)(1995-3#1)(2008-10#26)(2008-12#2)(2008-5#2)(2008-6#1)(2010-3#1)
the concentration of vanadium##4##4##(1990-5#1)(2008-10#3)
the concentration of which##2##4##(2008-10#2)
the concentration of##269##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#195)(2008-11#8)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-6#1)(2010-3#2)(2010-4#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-8#1)
the concentration range 0##23##4##(2008-10#23)
the concentration range 1##6##4##(2008-10#6)
the concentration range 10(-6)-10(-3)##2##4##(2008-10#2)
the concentration range 2##3##4##(2008-10#3)
the concentration range between##4##4##(2008-10#4)
the concentration range from 0##2##5##(2008-10#2)
the concentration range from 5##6##5##(2008-10#6)
the concentration range from 50 to##2##6##(2008-10#2)
the concentration range from##22##4##(2008-10#22)
the concentration range of 0##22##5##(2008-10#21)(2011-3#1)
the concentration range of 1##6##5##(1995-11#1)(2008-10#5)
the concentration range of 1x10(-6) to 1x10(-5)M##2##7##(2008-10#2)
the concentration range of 5##3##5##(2008-10#3)
the concentration range of##63##4##(1995-11#1)(2008-10#61)(2011-3#1)
the concentration range studied##3##4##(1991-5#1)(2008-10#2)
the concentration range##171##3##(1991-5#1)(1995-11#1)(2008-10#168)(2011-3#1)
the concentration ranges of##7##4##(2008-10#7)
the concentration ranges##12##3##(2008-10#12)
the concentration ratio of##2##4##(2008-10#2)
the concentration ratio##3##3##(2008-10#3)
the concentration sensitivity##2##3##(2008-10#1)(2010-7#1)
the concentration was##3##3##(2008-10#2)(2011-2#1)
the concentration##520##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#3)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-5#1)(2008-10#428)(2008-11#9)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-6#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-2#4)(2012-3#1)(2013-8#1)
the concentration-response##2##2##(1992-8#1)(2008-10#1)
the concentrations found##2##3##(2008-10#2)
the concentrations in##2##3##(1992-11#1)(2008-10#1)
the concentrations of extracellular##2##4##(2008-11#1)(2013-8#1)
the concentrations of the analytes##2##5##(2008-10#2)
the concentrations of the##11##4##(1990-6#1)(1990-8#1)(2008-10#9)
the concentrations of these##2##4##(2008-10#2)
the concentrations of##52##3##(1990-5#1)(1990-6#1)(1990-8#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-5#1)(2008-10#38)(2008-11#3)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
the concentrations ranged##2##3##(2008-10#2)
the concentrations tested##2##3##(2008-10#1)(2008-11#1)
the concentrations used##2##3##(2008-10#1)(2008-11#1)
the concentrations##75##2##(1990-5#1)(1990-6#1)(1990-8#1)(1992-11#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-5#1)(2008-10#55)(2008-11#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-8#1)
the concept and##2##3##(2009-12#1)(2009-5#1)
the concept of HC-transcomplementation##2##4##(2008-10#2)
the concept of a##7##4##(1990-3#1)(1991-1#1)(1992-2#1)(1995-12#1)(1996-1#1)(2008-12#1)(2008-9#1)
the concept of an##2##4##(1994-11#1)(1997-8#1)
the concept of stewardship in health##2##6##(2012-2#2)
the concept of the##4##4##(1992-12#1)(1997-6#1)(2008-12#1)(2009-5#1)
the concept of##66##3##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#4)(2008-12#5)(2008-3#3)(2008-7#2)(2008-9#4)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)
the concept that the##2##4##(2008-3#1)(2008-7#1)
the concept that##8##3##(1995-2#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2011-2#1)(2013-8#1)
the concept##88##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-8#1)(2008-10#9)(2008-11#4)(2008-12#6)(2008-3#5)(2008-7#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#1)
the conception rate##2##3##(2013-1#2)
the concepts of##5##3##(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2013-8#1)
the concepts##11##2##(1992-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)(2013-8#1)
the conceptual framework##3##3##(1994-12#1)(1997-2#1)(1997-3#1)
the conceptual##9##2##(1993-3#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-8#2)
the concern##3##2##(2008-11#1)(2008-5#1)(2009-3#1)
the concerns##5##2##(1994-1#1)(1996-3#1)(1996-5#1)(2008-11#2)
the concerted##3##2##(1991-9#1)(1995-6#1)(2013-8#1)
the conclusion of a##2##4##(1992-3#1)(1994-1#1)
the conclusion of the study##2##5##(2008-11#1)(2013-8#1)
the conclusion of the##3##4##(2008-11#2)(2013-8#1)
the conclusion of##7##3##(1992-3#2)(1994-1#1)(2008-10#1)(2008-11#2)(2013-8#1)
the conclusion that the##8##4##(1992-9#1)(2008-10#4)(2008-3#1)(2008-7#1)(2013-1#1)
the conclusion that##24##3##(1990-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-3#1)(1995-12#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the conclusion##33##2##(1990-6#1)(1992-3#4)(1992-5#1)(1992-9#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-5#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the conclusions drawn from##2##4##(2010-7#1)(2011-2#1)
the conclusions##7##2##(1993-12#1)(2008-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
the conclusive identification of##2##4##(1993-2#1)(2010-6#1)
the concomitant use of##2##4##(2008-10#1)(2011-2#1)
the concomitant##16##2##(1992-3#1)(1994-6#1)(1995-6#1)(1996-2#2)(1997-2#1)(2008-10#6)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
the concordance between##2##3##(1991-2#1)(2008-8#1)
the concordance##3##2##(1991-2#1)(2008-10#1)(2008-8#1)
the concurrent##5##2##(1994-11#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-8#1)
the condensation of the amino##2##5##(1992-3#1)(2011-1#1)
the condensation of##4##3##(1992-3#1)(2008-10#2)(2011-1#1)
the condensation product##2##3##(2008-10#2)
the condensation reaction between##2##4##(2008-10#1)(2008-8#1)
the condensation reaction##3##3##(2008-10#2)(2008-8#1)
the condensation##9##2##(1992-3#1)(2008-10#6)(2008-8#1)(2011-1#1)
the condensed##4##2##(2008-10#4)
the condition and##3##3##(1992-5#1)(1996-6#1)(2013-1#1)
the condition of the##4##4##(1990-6#1)(1991-3#1)(2008-6#1)(2010-8#1)
the condition of##10##3##(1990-6#1)(1991-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-8#1)(2013-8#1)
the condition##35##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1992-5#1)(1995-2#1)(1996-11#2)(1996-6#2)(1997-8#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#2)(2013-1#4)(2013-8#1)
the conditional##8##2##(1993-8#1)(1995-9#1)(2008-10#4)(2008-5#1)(2010-7#1)
the conditioned medium##3##3##(1997-1#1)(2008-11#2)
the conditioned##7##2##(1997-1#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-5#1)
the conditioning effects of##3##4##(2008-5#3)
the conditioning##6##2##(2008-10#1)(2008-11#1)(2008-5#4)
the conditions employed##4##3##(2008-10#4)
the conditions for the##7##4##(2008-10#6)(2008-9#1)
the conditions for##28##3##(1995-6#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-8#5)(2008-9#4)(2012-2#1)
the conditions in##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
the conditions of the##2##4##(2008-10#1)(2008-5#1)
the conditions of this##4##4##(1990-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
the conditions of##22##3##(1990-6#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#5)(2010-7#2)(2012-3#1)(2013-1#1)
the conditions that##2##3##(1991-5#1)(1996-8#1)
the conditions under which##5##4##(2008-11#2)(2008-8#2)(2012-2#1)
the conditions used##3##3##(1996-2#1)(1997-1#1)(2008-10#1)
the conditions##77##2##(1990-6#1)(1991-5#1)(1993-6#1)(1995-6#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#29)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#8)(2008-9#9)(2009-12#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
the condom##2##2##(2008-10#2)
the conduciveness of the environment##2##5##(2008-10#2)
the conduciveness of##3##3##(2008-10#3)
the conduct and##2##3##(2008-10#1)(2010-5#1)
the conduct of human##2##4##(2008-9#1)(2009-4#1)
the conduct of##5##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)
the conduct##7##2##(1992-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2010-5#1)
the conducting airways##4##3##(1991-12#2)(2013-1#2)
the conducting##8##2##(1991-12#2)(2008-10#2)(2008-11#1)(2013-1#3)
the conductivity of the##2##4##(2008-10#1)(2013-1#1)
the conductivity##6##2##(2008-10#4)(2009-8#1)(2013-1#1)
the conductor##2##2##(2008-10#2)
the conduits of##3##3##(2008-10#3)
the cone##2##2##(1991-1#1)(2013-1#1)
the conference##7##2##(1993-12#1)(1996-6#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)
the confidence interval##3##3##(2008-10#3)
the confidence##6##2##(2008-10#5)(2008-11#1)
the configuration of##3##3##(2008-11#1)(2009-6#1)(2012-2#1)
the configuration##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2012-2#1)
the confined water##2##3##(2008-10#2)
the confirmation##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
the conflict##5##2##(2008-11#2)(2008-8#1)(2009-9#1)(2010-7#1)
the conflicting##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
the confluence##2##2##(2008-10#1)(2008-11#1)
the conformation and##3##3##(2008-8#1)(2009-3#2)
the conformation of the##9##4##(1992-4#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-8#2)(2008-9#2)(2012-2#1)
the conformation of##17##3##(1992-4#1)(1993-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-8#3)(2008-9#3)(2012-2#2)
the conformation##21##2##(1992-4#1)(1993-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-8#4)(2008-9#3)(2009-3#2)(2012-2#2)
the conformational change of##3##4##(2008-11#1)(2009-3#2)
the conformational change##7##3##(1995-6#2)(2008-11#1)(2008-8#1)(2009-3#2)(2009-5#1)
the conformational changes of immobilized##2##5##(2008-10#2)
the conformational changes of the##2##5##(2008-9#1)(2009-3#1)
the conformational changes of##5##4##(1993-8#1)(2008-10#2)(2008-9#1)(2009-3#1)
the conformational##19##2##(1991-5#1)(1992-6#1)(1993-8#2)(1995-6#2)(1996-2#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#3)(2009-5#1)
the confounding factors that##2##4##(2008-7#1)(2013-1#1)
the confounding##5##2##(1995-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
the conically sculpted##3##3##(1995-2#3)
the conidia germinated##2##3##(2008-10#2)
the conidia germination##2##3##(2008-10#2)
the conidia were##2##3##(2008-10#2)
the conidia##8##2##(2008-10#8)
the conidial##4##2##(2008-10#4)
the conjugate was##2##3##(2008-10#1)(2008-11#1)
the conjugate##7##2##(1994-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
the conjugated##3##2##(1991-5#2)(1992-3#1)
the conjunctival##3##2##(2008-11#2)(2012-3#1)
the connecting peptide##4##3##(2008-9#4)
the connection between##4##3##(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
the connection of##3##3##(2008-11#1)(2008-3#2)
the connection##7##2##(2008-11#1)(2008-3#3)(2008-4#1)(2012-2#1)(2013-1#1)
the connections between##2##3##(2008-11#1)(2012-5#1)
the connections##4##2##(1991-6#1)(2008-11#2)(2012-5#1)
the connective tissue##3##3##(1990-2#1)(2008-5#1)(2012-2#1)
the connective tissues##2##3##(1990-2#2)
the connective##5##2##(1990-2#3)(2008-5#1)(2012-2#1)
the consecutive##3##2##(2008-10#2)(2009-5#1)
the consensus sequence##5##3##(1993-6#1)(1996-6#1)(2008-1#1)(2008-10#1)(2009-6#1)
the consensus statements##2##3##(2011-2#2)
the consensus##19##2##(1991-5#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1996-6#1)(2008-1#1)(2008-10#7)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#2)
the consent##4##2##(1991-3#1)(2009-4#2)(2010-11#1)
the consequence of the##2##4##(2008-8#1)(2011-2#1)
the consequence of##13##3##(1990-12#1)(1991-12#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the consequence##16##2##(1990-12#1)(1991-12#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
the consequences for##4##3##(2008-6#1)(2008-8#2)(2012-2#1)
the consequences of the##2##4##(1993-3#1)(2010-10#1)
the consequences of this##2##4##(2008-8#1)(2013-8#1)
the consequences of##36##3##(1990-2#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
the consequences##47##2##(1990-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-4#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
the consequent##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
the conservation of the##2##4##(1991-6#1)(2008-8#1)
the conservation of##6##3##(1991-6#1)(1993-8#1)(1996-12#1)(2008-12#1)(2008-8#1)(2013-1#1)
the conservation state of##3##4##(2008-10#3)
the conservation##11##2##(1991-6#1)(1993-8#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#2)
the conservative##8##2##(1993-9#1)(2008-5#1)(2008-8#1)(2008-9#3)(2013-1#2)
the conserved C-terminal##2##3##(1993-8#2)
the conserved motifs##2##3##(2008-10#2)
the conserved region##3##3##(1992-6#1)(1996-12#1)(2008-8#1)
the conserved sequence##3##3##(1993-3#1)(1995-6#1)(2008-10#1)
the conserved sequences of##2##4##(1997-4#1)(2013-8#1)
the conserved sequences##3##3##(1995-8#1)(1997-4#1)(2013-8#1)
the conserved##30##2##(1992-6#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-9#1)(2008-10#8)(2008-6#1)(2008-8#2)(2009-8#1)(2013-8#1)
the considerable difference##2##3##(2008-10#2)
the considerable##4##2##(1990-11#1)(1995-12#1)(2008-10#2)
the consideration of##5##3##(1993-2#1)(1995-6#1)(2008-7#1)(2009-9#1)(2011-2#1)
the consideration##7##2##(1993-2#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
the considered##8##2##(1992-2#2)(2008-10#5)(2013-8#1)
the consistency and##2##3##(2008-10#2)
the consistency of##2##3##(2008-11#2)
the consistency##6##2##(2008-10#2)(2008-11#3)(2011-2#1)
the consortium##2##2##(2010-5#2)
the constant comparative method##2##4##(2008-11#1)(2008-12#1)
the constant current##2##3##(2008-10#2)
the constant ratio method##3##4##(2008-10#3)
the constant##17##2##(1990-11#1)(1990-5#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#2)
the constants for##2##3##(2008-10#2)
the constants##6##2##(2008-10#5)(2011-2#1)
the constituent equilibrium constants##3##4##(2008-10#3)
the constituent##7##2##(2008-10#4)(2008-8#1)(2009-7#1)(2012-2#1)
the constituents of the##3##4##(2008-10#1)(2009-8#1)(2012-2#1)
the constituents##6##2##(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)(2011-3#1)(2012-2#1)
the constitutional##5##2##(1995-10#1)(1995-3#1)(1996-9#1)(1997-6#1)(2011-2#1)
the constitutive expression and##2##4##(1994-6#1)(2009-3#1)
the constitutive expression##3##3##(1994-6#1)(1997-8#1)(2009-3#1)
the constitutive form of##2##4##(1992-12#1)(2008-4#1)
the constitutive##11##2##(1991-9#1)(1992-12#1)(1994-6#1)(1995-11#1)(1997-8#1)(2008-11#1)(2008-4#1)(2009-3#1)(2013-1#3)
the constrained##2##2##(2008-10#1)(2009-8#1)
the constraint of##2##3##(1994-9#1)(2008-8#1)
the constraint##3##2##(1994-9#1)(2008-8#1)(2012-3#1)
the constraints of##3##3##(2008-10#2)(2012-2#1)
the constraints##6##2##(2008-10#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)
the construct##5##2##(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
the constructed##2##2##(2008-10#1)(2010-1#1)
the construction and testing of##2##5##(2011-1#1)(2011-2#1)
the construction and##10##3##(1990-8#1)(1993-9#1)(1997-1#1)(2008-10#3)(2008-4#1)(2009-8#1)(2011-1#1)(2011-2#1)
the construction of a##16##4##(1990-8#1)(1991-5#1)(1997-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-3#1)
the construction of calibration##2##4##(2008-10#2)
the construction of expression##2##4##(1993-2#1)(2008-8#1)
the construction of the##5##4##(1996-8#1)(2008-10#3)(2010-8#1)
the construction of##44##3##(1990-8#1)(1991-5#1)(1993-2#1)(1996-8#1)(1997-8#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
the construction##55##2##(1990-8#2)(1991-12#1)(1991-5#1)(1993-2#1)(1993-9#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the constructs##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
the consultant##3##2##(1990-2#1)(1996-2#1)(2012-3#1)
the consultation##2##2##(2008-10#1)(2013-8#1)
the consumed##2##2##(2008-10#2)
the consumer or##2##3##(2008-5#1)(2011-2#1)
the consumer##15##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-5#5)(2008-8#4)(2008-9#2)(2011-2#1)
the consumer's##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
the consumers##3##2##(2008-8#1)(2010-4#1)(2010-8#1)
the consumption of##18##3##(1990-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2010-8#3)(2011-2#1)(2012-12#1)(2013-1#1)
the consumption##21##2##(1990-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1996-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2010-8#3)(2011-2#1)(2012-12#1)(2013-1#2)
the contact area##2##3##(2013-1#2)
the contact of##3##3##(1991-5#1)(2008-10#2)
the contact time##2##3##(2008-10#2)
the contact with##2##3##(1991-2#1)(2007-8#1)
the contact##23##2##(1991-2#1)(1991-5#1)(1993-1#1)(1993-9#1)(1995-2#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-4#1)(2013-1#2)
the contaminant##2##2##(2008-3#2)
the contaminants##2##2##(2008-10#1)(2008-11#1)
the contaminated##2##2##(2008-10#2)
the contamination of##8##3##(1991-11#1)(1994-3#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
the contamination risk##2##3##(2008-10#1)(2012-2#1)
the contamination source##2##3##(2008-10#2)
the contamination##14##2##(1991-11#1)(1994-3#1)(1997-5#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2012-2#1)
the contemporary##4##2##(1996-1#1)(2011-2#2)(2013-8#1)
the content and##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#2)
the content of phosphorus##2##4##(2008-10#2)
the content of the##6##4##(1994-12#1)(1995-2#1)(2008-10#3)(2011-3#1)
the content of##40##3##(1993-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(2008-10#23)(2008-11#4)(2008-12#1)(2008-8#1)(2009-8#2)(2010-10#1)(2011-3#1)(2012-3#1)(2013-7#1)(2013-8#1)
the content##50##2##(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-9#1)(2011-3#1)(2012-3#1)(2013-7#2)(2013-8#2)
the contention that##5##3##(1996-12#1)(1996-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
the contents of##7##3##(1990-2#1)(1995-5#1)(2008-10#5)
the contents##11##2##(1990-2#1)(1995-5#1)(2008-10#6)(2008-12#1)(2008-8#1)(2011-3#1)
the contest##3##2##(2009-10#1)(2012-3#2)
the context of a##11##4##(1996-2#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-2#1)(2012-2#1)
the context of an##4##4##(1992-1#1)(2008-1#1)(2008-6#1)(2008-9#1)
the context of current##3##4##(2008-11#1)(2008-7#1)(2011-1#1)
the context of health##2##4##(2008-7#1)(2009-6#1)
the context of the current##2##5##(1994-1#1)(2008-3#1)
the context of the##25##4##(1991-3#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)
the context of their##2##4##(2010-10#1)(2012-2#1)
the context of##129##3##(1991-11#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#1)(1996-2#2)(1996-3#2)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#16)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#4)(2012-8#1)(2013-1#1)(2013-8#4)
the context##133##2##(1991-11#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#1)(1996-2#2)(1996-3#2)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#17)(2008-12#5)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#4)(2012-8#1)(2013-1#1)(2013-8#4)
the contexts##2##2##(2011-2#1)(2013-1#1)
the contextual##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
the continent##4##2##(2008-10#3)(2008-12#1)
the continental##5##2##(1995-6#1)(2008-10#2)(2010-8#2)
the continual reassessment method##2##4##(1994-9#2)
the continual##3##2##(1994-9#2)(2010-11#1)
the continuation of##3##3##(1997-7#1)(2011-1#1)(2011-2#1)
the continuation##5##2##(1997-7#1)(2010-8#2)(2011-1#1)(2011-2#1)
the continued##9##2##(1991-12#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2010-11#1)(2012-3#1)
the continuing education of##2##4##(1994-12#1)(1997-8#1)
the continuing education##3##3##(1992-3#1)(1994-12#1)(1997-8#1)
the continuing##8##2##(1992-3#1)(1993-3#1)(1994-12#2)(1994-2#1)(1997-8#1)(2008-10#1)(2008-9#1)
the continuity of##5##3##(1993-1#1)(1993-8#1)(1995-3#1)(2012-12#1)(2012-2#1)
the continuity##6##2##(1993-1#1)(1993-8#1)(1995-3#1)(2008-11#1)(2012-12#1)(2012-2#1)
the continuous ER morphology##2##4##(2009-8#2)
the continuous culture of##2##4##(2008-11#1)(2008-7#1)
the continuous culture##3##3##(2008-11#2)(2008-7#1)
the continuous extraction##3##3##(2008-10#3)
the continuous##48##2##(1991-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1997-2#1)(1997-7#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#3)(2009-8#2)(2010-12#1)(2013-8#1)
the continuum of care##3##4##(1991-1#1)(1994-12#2)
the continuum of##4##3##(1991-1#1)(1994-12#2)(2008-11#1)
the continuum##6##2##(1991-1#1)(1994-12#2)(1997-1#1)(2008-10#1)(2008-11#1)
the contour group##2##3##(1991-2#2)
the contour##4##2##(1991-2#3)(2008-10#1)
the contraceptive##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
the contract##5##2##(1992-2#1)(1993-12#2)(1996-12#1)(2008-11#1)
the contractile##8##2##(1990-5#2)(1991-5#1)(1991-6#1)(1997-4#2)(2008-7#1)(2010-6#1)
the contraction of##2##3##(1994-11#1)(2008-12#1)
the contraction##5##2##(1990-8#1)(1994-11#1)(2008-12#1)(2009-7#1)(2013-8#1)
the contradictory##2##2##(1996-6#1)(2008-9#1)
the contralateral side##3##3##(1991-2#1)(2008-9#2)
the contralateral stimulation was##2##4##(1993-3#2)
the contralateral stimulation##3##3##(1993-3#3)
the contralateral##23##2##(1990-9#1)(1991-2#1)(1992-3#1)(1993-3#3)(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#3)(2009-11#1)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
the contrary##39##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-2#2)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
the contrast between##2##3##(2008-6#1)(2008-8#1)
the contrast##6##2##(1991-1#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)
the contribution of DNA repair to##2##6##(2008-11#2)
the contribution of DNA##3##4##(1994-3#1)(2008-11#2)
the contribution of a##2##4##(2008-10#1)(2008-11#1)
the contribution of different##2##4##(2008-10#1)(2008-5#1)
the contribution of each##4##4##(1992-1#1)(2008-10#1)(2008-5#1)(2010-11#1)
the contribution of teacher##2##4##(2008-12#2)
the contribution of the Responsive Classroom##2##6##(2008-12#2)
the contribution of the##7##4##(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2010-4#1)
the contribution of these##2##4##(2008-6#1)(2013-1#1)
the contribution of##58##3##(1992-1#1)(1992-12#1)(1993-1#2)(1994-1#1)(1994-3#1)(1995-5#1)(1995-8#1)(2008-10#12)(2008-11#8)(2008-12#7)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
the contribution##64##2##(1991-12#1)(1992-1#1)(1992-12#1)(1993-1#2)(1994-1#1)(1994-3#2)(1995-5#1)(1995-8#1)(2008-10#12)(2008-11#9)(2008-12#7)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
the contributions of##8##3##(1992-12#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
the contributions##9##2##(1992-12#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
the control and the##2##4##(2011-3#1)(2013-8#1)
the control and##14##3##(1991-8#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-3#1)(2013-8#1)
the control cell##3##3##(1990-8#1)(2008-11#2)
the control cells##3##3##(2008-11#2)(2008-9#1)
the control condition##4##3##(1992-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
the control culture##2##3##(2008-11#2)
the control flies##2##3##(1995-6#2)
the control group (n =##2##5##(2010-4#1)(2012-3#1)
the control group (p&lt##2##4##(1994-12#1)(2010-12#1)
the control group in##2##4##(2008-8#1)(2010-6#1)
the control group received##3##4##(2008-11#1)(2008-12#1)(2009-12#1)
the control group was##2##4##(2008-12#1)(2008-8#1)
the control group##85##3##(1990-11#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#4)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#8)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#5)(2010-12#2)(2010-4#4)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#11)(2012-2#1)(2012-3#3)(2013-1#10)
the control groups throughout##2##4##(2008-9#2)
the control groups##12##3##(1993-3#1)(2008-11#1)(2008-12#1)(2008-9#7)(2011-2#2)
the control level##5##3##(1994-12#2)(2008-11#1)(2008-6#2)
the control method was##2##4##(2013-8#2)
the control of a##5##4##(1992-10#1)(1995-6#1)(2008-10#2)(2013-8#1)
the control of several##2##4##(2008-7#1)(2010-10#1)
the control of soilborne##2##4##(2008-10#2)
the control of spermatogenesis##2##4##(2009-10#1)(2012-2#1)
the control of the##26##4##(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#3)(2013-7#1)
the control of##110##3##(1990-11#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#4)(1996-12#2)(1996-3#1)(1997-1#1)(1997-7#2)(2008-1#3)(2008-10#28)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#4)
the control one##2##3##(2008-10#1)(2009-6#1)
the control over behaviour by##3##5##(1993-6#3)
the control rats##3##3##(1991-5#1)(1994-5#1)(2008-8#1)
the control treatment##4##3##(2008-10#3)(2010-9#1)
the control value##2##3##(1992-6#1)(1993-1#1)
the control##348##2##(1990-11#3)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#7)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#7)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#6)(1995-12#1)(1995-2#2)(1995-6#6)(1996-12#4)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(2008-1#4)(2008-10#62)(2008-11#33)(2008-12#13)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#15)(2008-9#17)(2009-1#1)(2009-10#2)(2009-12#5)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#3)(2010-4#8)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#20)(2011-3#1)(2012-2#9)(2012-3#3)(2012-6#2)(2013-1#12)(2013-7#1)(2013-8#12)
the controlled##13##2##(1990-11#1)(1995-3#1)(2008-10#4)(2008-11#3)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)
the controller output##3##3##(2008-10#3)
the controller voltage##2##3##(2008-10#2)
the controller##6##2##(2008-10#6)
the controlling##4##2##(2008-10#3)(2009-5#1)
the controls and##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
the controls##41##2##(1991-1#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-5#1)(1996-11#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-3#2)
the controversial##2##2##(2008-4#1)(2011-2#1)
the controversies over##2##3##(2008-11#1)(2008-9#1)
the controversies surrounding##2##3##(2008-11#2)
the controversies##5##2##(2008-11#4)(2008-9#1)
the controversy##2##2##(1995-11#1)(2010-8#1)
the controversy's##2##2##(2008-11#2)
the conus medullaris##3##3##(2008-7#3)
the convective##4##2##(2008-10#1)(2008-3#3)
the convenience##2##2##(2008-12#1)(2008-3#1)
the convenient##3##2##(2008-10#2)(2008-9#1)
the conventional culture dish##3##4##(2008-11#3)
the conventional method##10##3##(2008-10#4)(2008-11#2)(2008-12#2)(2008-8#1)(2010-6#1)
the conventional methods##2##3##(2008-10#2)
the conventional pellet culture##2##4##(2008-11#2)
the conventional procedure##3##3##(2008-10#1)(2011-2#1)(2011-3#1)
the conventional technique##3##3##(2008-3#1)(2011-2#1)(2011-7#1)
the conventional##121##2##(1992-3#1)(1993-12#1)(1994-1#1)(1995-6#1)(1995-9#1)(1996-2#2)(1997-8#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#60)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-6#2)(2010-8#4)(2011-2#3)(2011-3#1)(2011-7#1)(2013-1#6)(2013-8#2)
the convergence rate##2##3##(2007-12#2)
the convergence##3##2##(2007-12#2)(2009-3#1)
the conversion from##2##3##(1994-3#1)(2011-2#1)
the conversion of 5-monosubstituted hydantoins to enantiomerically pure L-amino acids##2##10##(1995-3#2)
the conversion of glucose to glycogen in##2##7##(1995-8#2)
the conversion of glucose to glycogen##3##6##(1995-8#3)
the conversion of the##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
the conversion of##31##3##(1991-5#2)(1993-3#1)(1993-9#1)(1995-11#1)(1995-3#3)(1995-6#1)(1995-8#4)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-5#1)
the conversion##41##2##(1991-5#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#3)(1995-6#1)(1995-8#4)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#1)
the converter##3##2##(2008-10#3)
the convex side of##2##4##(1996-5#1)(2012-2#1)
the convex##5##2##(1996-5#2)(2008-10#1)(2008-6#1)(2012-2#1)
the convolution##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
the cooperation##2##2##(1991-3#1)(2011-1#1)
the cooperative##4##2##(1995-6#1)(1997-6#1)(2008-10#1)(2008-8#1)
the coordinate##5##2##(1991-5#2)(1994-12#1)(2008-10#1)(2010-7#1)
the coordinated##2##2##(1993-6#1)(1994-5#1)
the coordinates of##2##3##(1991-6#1)(1992-4#1)
the coordinates##3##2##(1991-6#1)(1992-4#2)
the coordination of##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
the coordination##8##2##(2008-10#5)(2008-8#1)(2008-9#1)(2011-2#1)
the copolymer##4##2##(2008-10#2)(2008-11#1)(2009-7#1)
the copper oxide##3##3##(1993-5#1)(2008-10#2)
the copper##16##2##(1993-2#1)(1993-5#1)(2008-10#12)(2008-5#1)(2012-2#1)
the copper-modified gold electrode##2##4##(2008-10#2)
the copper-protein complexes##2##3##(2008-10#2)
the copper-protein##3##2##(2008-10#3)
the coprecipitation##3##2##(2008-10#3)
the copy number of##3##4##(2008-10#1)(2008-11#1)(2010-5#1)
the coracoid##3##2##(2013-1#3)
the cord##4##2##(2008-10#1)(2008-7#2)(2011-1#1)
the core functions of public health##2##6##(1995-12#2)
the core functions##3##3##(1995-12#2)(1996-2#1)
the core of a##2##4##(1991-2#1)(2012-2#1)
the core of the##8##4##(2008-10#5)(2008-5#1)(2009-12#1)(2011-2#1)
the core of##16##3##(1991-2#2)(1993-3#1)(2008-10#6)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the core public health functions and##2##6##(1996-2#2)
the core public health##3##4##(1996-2#2)(1997-1#1)
the core region##2##3##(2008-5#1)(2008-7#1)
the core sequences##2##3##(1996-2#1)(1996-8#1)
the core##53##2##(1991-2#2)(1991-9#1)(1993-3#1)(1994-5#1)(1995-12#2)(1995-5#1)(1996-2#4)(1996-8#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#4)(2009-12#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
the cores##2##2##(2007-11#1)(2008-10#1)
the corn##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
the cornea and##2##3##(2008-11#1)(2011-2#1)
the cornea retention time##2##4##(2011-3#2)
the cornea##9##2##(2008-11#3)(2010-1#1)(2011-2#1)(2011-3#2)(2011-7#1)(2013-1#1)
the corneal surface##2##3##(2010-10#1)(2011-7#1)
the corneal##9##2##(2008-11#2)(2010-10#1)(2011-2#5)(2011-7#1)
the cornerstone of##6##3##(1994-3#1)(1995-3#1)(1997-1#1)(2008-12#1)(2008-6#1)(2012-2#1)
the coronal##2##2##(2008-9#1)(2013-1#1)
the coronary arteries##5##3##(2008-10#1)(2012-3#4)
the coronary artery##5##3##(2008-10#1)(2008-12#1)(2009-10#1)(2012-2#1)(2013-2#1)
the coronary care unit##2##4##(2008-3#1)(2012-2#1)
the coronary##23##2##(1990-8#1)(1992-9#1)(1993-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#2)(2012-3#6)(2013-2#3)(2013-8#1)
the coronoid process##4##3##(1991-2#1)(2008-7#2)(2012-3#1)
the corpora##4##2##(1995-11#1)(2008-10#2)(2008-9#1)
the corpus callosum##3##3##(1996-2#1)(2008-7#1)(2011-2#1)
the corpus##7##2##(1994-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
the correct diagnosis of the##2##5##(1991-2#1)(2013-1#1)
the correct diagnosis of##3##4##(1991-2#1)(2011-2#1)(2013-1#1)
the correct diagnosis##10##3##(1990-5#1)(1991-2#1)(1991-3#1)(1997-5#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the correct use of##3##4##(1993-8#1)(2008-11#1)(2008-9#1)
the correct value##3##3##(2008-10#1)(2008-2#2)
the correct##52##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-3#2)(1996-6#1)(1997-5#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#6)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
the corrected##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
the correction of##6##3##(1997-8#1)(2008-10#2)(2008-3#1)(2009-10#1)(2013-1#1)
the correction##9##2##(1997-8#1)(2008-10#4)(2008-3#1)(2009-10#1)(2013-1#1)(2013-8#1)
the corrective##2##2##(1993-1#1)(1994-8#1)
the correlated##2##2##(1993-6#1)(2008-8#1)
the correlates of##2##3##(1992-11#1)(1995-3#1)
the correlation between laminin 332##3##5##(2013-8#3)
the correlation between the##7##4##(1992-9#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
the correlation between##32##3##(1991-9#1)(1992-9#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#2)(2009-8#1)(2010-8#2)(2012-3#1)(2013-8#3)
the correlation coefficient of 0##2##5##(2008-10#2)
the correlation coefficient of##4##4##(2008-10#4)
the correlation coefficient was##2##4##(1990-12#1)(2008-10#1)
the correlation coefficient##8##3##(1990-12#1)(2008-10#6)(2011-3#1)
the correlation coefficients##7##3##(1992-3#1)(2008-10#6)
the correlation of disease status of plants##2##7##(2008-10#2)
the correlation of##12##3##(1990-2#1)(1992-3#1)(1996-6#1)(2008-10#3)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
the correlation##69##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-3#2)(1992-9#1)(1994-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
the correlations between NaCl and other##2##6##(2009-10#2)
the correlations between##7##3##(1995-2#1)(2008-10#1)(2009-10#2)(2012-3#1)(2012-4#1)(2013-8#1)
the correlations##8##2##(1995-2#1)(2008-10#1)(2009-10#2)(2009-11#1)(2012-3#1)(2012-4#1)(2013-8#1)
the correlative##3##2##(2008-10#1)(2008-9#1)(2011-3#1)
the corresponded##4##2##(2008-11#4)
the corresponding 1##2##3##(2008-10#1)(2008-5#1)
the corresponding FTIR spectrum##2##4##(2008-10#2)
the corresponding FTIR##3##3##(2008-10#3)
the corresponding RNAs##2##3##(1995-6#1)(2008-10#1)
the corresponding avirulence gene##2##4##(2008-10#2)
the corresponding cDNA##2##3##(1993-2#1)(1995-6#1)
the corresponding cell##2##3##(1990-5#1)(2008-10#1)
the corresponding controls##2##3##(1995-8#1)(2006-6#1)
the corresponding gene##7##3##(1993-2#1)(1995-8#1)(1997-6#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#1)
the corresponding genes##6##3##(1995-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
the corresponding hydrides##2##3##(2008-10#2)
the corresponding mean##2##3##(2007-12#1)(2010-7#1)
the corresponding proteins##4##3##(1996-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
the corresponding quenching##2##3##(2008-10#2)
the corresponding solution##2##3##(2008-10#1)(2008-9#1)
the corresponding values for##2##4##(2008-10#1)(2010-4#1)
the corresponding values in the bulk sediments##2##7##(2008-10#2)
the corresponding values in the##3##5##(2008-10#2)(2008-5#1)
the corresponding values##6##3##(2008-10#3)(2008-5#1)(2009-9#1)(2010-4#1)
the corresponding##194##2##(1990-11#3)(1990-12#1)(1990-5#4)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-12#1)(1993-2#2)(1993-3#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-2#3)(1996-3#1)(1996-5#12)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#76)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#5)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#9)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
the corrosion##2##2##(2008-10#2)
the cortex of sour orange##2##5##(2008-10#2)
the cortex of the##4##4##(1992-9#1)(2008-11#1)(2008-9#1)(2011-2#1)
the cortex of trifoliate orange##2##5##(2008-10#2)
the cortex of##9##3##(1992-9#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
the cortex##32##2##(1990-12#1)(1990-9#1)(1992-9#1)(1994-2#2)(1995-6#1)(1996-12#3)(2008-10#7)(2008-11#7)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#3)(2011-2#1)
the cortical and basal##2##4##(1991-10#2)
the cortical cells of##3##4##(2008-10#3)
the cortical region##2##3##(2008-11#1)(2010-7#1)
the cortical tissue##2##3##(1996-12#1)(2008-10#1)
the cortical##19##2##(1990-9#2)(1991-10#2)(1994-11#1)(1994-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-7#3)
the corticoid##2##2##(1997-2#1)(2010-12#1)
the cortisol awakening##2##3##(2008-11#1)(2013-1#1)
the cortisol##4##2##(2008-11#1)(2011-2#1)(2013-1#2)
the cos site##2##3##(1996-2#2)
the cos##3##2##(1990-11#1)(1996-2#2)
the cosine of the##2##4##(2008-10#1)(2008-3#1)
the cosmetic industry##3##3##(2008-5#3)
the cosmetic##10##2##(1991-2#1)(1993-9#1)(1994-12#1)(2008-5#7)
the cosmetics##2##2##(2008-5#2)
the cosmid##2##2##(1995-9#1)(1997-2#1)
the cosmogonic hypothesis##2##3##(2008-12#2)
the cosmopolitan##2##2##(2008-10#1)(2008-12#1)
the cost and##3##3##(1992-5#1)(2008-3#1)(2008-9#1)
the cost effectiveness of##2##4##(1992-2#1)(2012-12#1)
the cost of a drug##2##5##(1995-1#1)(1996-2#1)
the cost of a##7##4##(1995-1#2)(1996-2#1)(2008-8#2)(2012-12#1)(2012-2#1)
the cost of an additional##2##5##(2008-10#2)
the cost of outpatient##2##4##(1995-12#1)(1995-2#1)
the cost of parasitism##2##4##(2008-8#2)
the cost of prescription drugs##2##5##(2008-11#2)
the cost of providing##2##4##(1993-1#1)(2008-2#1)
the cost of the##5##4##(1993-1#1)(1996-5#1)(2008-10#1)(2008-11#1)(2012-12#1)
the cost of##54##3##(1990-11#1)(1992-12#1)(1993-1#3)(1993-2#1)(1994-2#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-2#1)(2008-4#1)(2008-8#9)(2008-9#3)(2009-9#1)(2012-12#3)(2012-2#1)(2013-8#1)
the cost per##3##3##(1992-2#1)(1992-5#1)(1997-2#1)
the cost##69##2##(1990-11#1)(1991-3#1)(1992-12#2)(1992-2#2)(1992-5#2)(1993-1#3)(1993-2#1)(1994-2#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#10)(2008-9#5)(2009-9#1)(2011-7#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
the cost-effectiveness of advanced cancer imaging##2##6##(2008-2#2)
the cost-effectiveness of##6##3##(1996-6#1)(2008-10#1)(2008-2#2)(2008-9#1)(2012-12#1)
the cost/benefit##2##2##(1991-3#2)
the costly##2##2##(1991-6#1)(2008-11#1)
the costs and benefits##2##4##(1994-12#1)(2008-6#1)
the costs and rewards of diabetes and its##2##8##(2010-9#2)
the costs and##7##3##(1993-12#1)(1994-12#1)(1994-2#1)(2008-6#1)(2008-9#1)(2010-9#2)
the costs associated with##4##4##(1994-2#1)(2008-10#1)(2008-11#1)(2010-5#1)
the costs of control##2##4##(2008-10#2)
the costs of the##2##4##(1990-8#1)(2008-10#1)
the costs of##25##3##(1990-8#1)(1990-9#1)(1992-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#5)(2008-9#4)
the costs##40##2##(1990-8#1)(1990-9#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-4#1)(2008-10#5)(2008-11#5)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#5)(2010-5#1)(2010-9#2)
the cotransfection##2##2##(1993-8#1)(2008-11#1)
the cotton##4##2##(2008-10#3)(2013-8#1)
the cotyledon##2##2##(2008-10#2)
the cotyledonary##2##2##(2008-10#1)(2013-8#1)
the cotyledons##3##2##(2008-10#2)(2013-8#1)
the coulombic interactions##2##3##(2008-10#2)
the counter electrode##2##3##(2008-10#2)
the counter##5##2##(1996-5#1)(2008-10#4)
the counterparts##2##2##(2008-10#1)(2008-8#1)
the counting##2##2##(2008-10#1)(2013-8#1)
the countries##4##2##(1990-12#1)(1996-9#1)(2010-3#1)(2011-2#1)
the country and##2##3##(1996-1#1)(2013-1#1)
the country are##2##3##(1995-2#1)(2009-12#1)
the country in##2##3##(1997-6#1)(2009-10#1)
the country##39##2##(1991-6#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-3#1)(1997-2#1)(1997-6#4)(1997-8#1)(2008-10#6)(2008-11#2)(2009-10#2)(2009-12#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#2)
the country's##3##2##(1995-12#1)(1997-6#1)(2008-11#1)
the counts of##2##3##(1996-3#1)(2008-10#1)
the county##3##2##(1991-1#1)(1991-3#1)(1992-2#1)
the coupled system##2##3##(2008-10#2)
the coupled##6##2##(2008-10#6)
the couples##3##2##(1996-9#2)(2012-2#1)
the coupling of an##3##4##(2008-10#2)(2008-3#1)
the coupling of##11##3##(2008-10#9)(2008-3#1)(2008-4#1)
the coupling##25##2##(1995-11#1)(2008-10#15)(2008-2#1)(2008-3#3)(2008-4#4)(2009-5#1)
the course and##6##3##(2008-11#5)(2008-4#1)
the course of a##10##4##(1990-6#1)(1991-3#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)
the course of pregnancy##5##4##(1995-12#1)(2012-3#4)
the course of rheumatoid arthritis##2##5##(2013-1#2)
the course of the disease##10##5##(1990-6#1)(1991-6#1)(1993-12#1)(1997-8#1)(2007-8#2)(2008-2#1)(2008-7#2)(2011-1#1)
the course of the epidemic##2##5##(1996-5#1)(2008-10#1)
the course of the experiment##2##5##(2008-10#1)(2008-7#1)
the course of the outbreak and##2##6##(2011-3#1)(2013-1#1)
the course of the titration##2##5##(2008-10#2)
the course of the##40##4##(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-8#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
the course of their##5##4##(1991-12#1)(2008-12#2)(2008-9#1)(2013-1#1)
the course of therapy##2##4##(2012-2#2)
the course of these##2##4##(2008-10#1)(2008-6#1)
the course of this study##2##5##(2008-10#2)
the course of this##3##4##(2008-10#2)(2011-2#1)
the course of treatment and##2##5##(1996-9#1)(2008-12#1)
the course of treatment##6##4##(1991-12#1)(1991-6#1)(1996-9#1)(2008-12#1)(2012-2#1)(2013-8#1)
the course of##149##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1991-11#2)(1991-12#2)(1991-3#2)(1991-6#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(1997-9#1)(2007-8#2)(2008-10#24)(2008-11#12)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#1)(2010-10#2)(2010-12#3)(2011-1#1)(2011-2#11)(2011-3#1)(2012-2#6)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#3)
the course was##2##3##(1995-5#1)(2008-11#1)
the course##188##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1991-11#2)(1991-12#2)(1991-3#2)(1991-6#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(1997-9#1)(2007-8#2)(2008-10#24)(2008-11#34)(2008-12#7)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#1)(2010-10#2)(2010-12#3)(2010-7#1)(2011-1#2)(2011-2#14)(2011-3#1)(2012-2#7)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#6)
the court##9##2##(1990-11#2)(1990-2#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-5#1)(2008-11#1)
the courts##2##2##(1996-1#1)(1996-2#1)
the covalent attachment of##2##4##(2008-5#1)(2013-1#1)
the covalent binding of##2##4##(1994-5#1)(2008-10#1)
the covalent linkage of##2##4##(1992-6#1)(2008-11#1)
the covalent##9##2##(1992-6#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
the covariance matrix##2##3##(2009-4#2)
the covariance##4##2##(1992-9#1)(2008-3#1)(2009-4#2)
the coverage of the##2##4##(1993-9#1)(2011-2#1)
the coverage probability of##2##4##(2008-10#2)
the coverage probability##4##3##(1995-9#1)(2008-10#3)
the coverage reduction##2##3##(2008-10#2)
the coverage##11##2##(1993-9#1)(1995-9#1)(1996-5#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-12#1)
the covered##2##2##(1991-1#1)(1996-12#1)
the cows##3##2##(1990-6#2)(1991-8#1)
the coxa and##2##3##(2007-12#1)(2008-5#1)
the crack phenomena at a##2##5##(2009-7#2)
the crack##5##2##(2009-7#5)
the cranial nerves##4##3##(2008-1#3)(2012-3#1)
the cranial##8##2##(1996-6#1)(1997-4#1)(2008-1#3)(2008-7#1)(2012-3#1)(2013-8#1)
the craniocervical##5##2##(2011-2#4)(2012-12#1)
the craniofacial region##3##3##(2008-9#3)
the craniofacial##7##2##(2008-9#3)(2010-6#4)
the cranium##7##2##(1996-9#2)(2008-7#2)(2010-6#1)(2011-2#1)(2013-8#1)
the cream##2##2##(2008-5#2)
the creatinine##2##2##(1995-3#1)(2008-10#1)
the creation of a new##2##5##(2008-10#1)(2010-1#1)
the creation of a##9##4##(1991-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
the creation of new##3##4##(1997-6#1)(2008-10#1)(2008-11#1)
the creation of the##2##4##(2008-3#1)(2010-1#1)
the creation of##34##3##(1991-3#1)(1992-1#1)(1993-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the creation##35##2##(1991-3#1)(1992-1#1)(1993-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the creative##3##2##(1994-12#1)(1996-1#1)(1997-1#1)
the cribriform plate##2##3##(2008-11#1)(2011-2#1)
the crime##2##2##(1996-11#1)(2008-10#1)
the criminal justice system##5##4##(1996-1#2)(2008-11#3)
the criminal justice##6##3##(1996-1#3)(2008-11#3)
the criminal##8##2##(1996-1#3)(2008-11#3)(2011-2#2)
the crisis##5##2##(1995-5#1)(1996-8#1)(1997-5#1)(2013-8#2)
the criteria for##8##3##(1993-6#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#2)
the criteria of##6##3##(1991-3#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-2#1)(2013-1#1)
the criteria used to##2##4##(1993-12#1)(1996-3#1)
the criteria##26##2##(1991-11#1)(1991-3#2)(1992-3#1)(1993-12#1)(1993-6#1)(1995-5#1)(1996-3#1)(1997-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-2#2)(2011-2#2)(2012-2#3)(2013-1#1)
the criterion for##2##3##(2008-10#1)(2012-9#1)
the criterion of##4##3##(1991-2#1)(1993-1#1)(2010-2#2)
the criterion##8##2##(1991-2#1)(1993-1#1)(2008-10#2)(2010-2#2)(2012-9#1)(2013-1#1)
the critical concentration##4##3##(1992-3#1)(1993-8#1)(2008-10#1)(2008-6#1)
the critical depth of##3##4##(2008-10#3)
the critical depth##4##3##(2008-10#4)
the critical dilution rate##2##4##(1997-2#1)(2008-7#1)
the critical evaluation of##2##4##(2008-10#1)(2009-8#1)
the critical examination of the##2##5##(2008-10#1)(2008-11#1)
the critical importance of##2##4##(2008-11#1)(2012-2#1)
the critical level##2##3##(2008-11#1)(2008-7#1)
the critical micelle concentration for##2##5##(2008-10#2)
the critical micelle concentration##5##4##(2008-10#5)
the critical need for##2##4##(2009-8#1)(2012-2#1)
the critical need##3##3##(1995-3#1)(2009-8#1)(2012-2#1)
the critical parameters##2##3##(2008-10#1)(2008-4#1)
the critical period##3##3##(2012-2#3)
the critical role of##6##4##(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-1#1)
the critical stages of##2##4##(2008-7#1)(2010-4#1)
the critical thinking and##2##4##(2008-12#1)(2012-2#1)
the critical thinking##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
the critical threshold##2##3##(2010-10#2)
the critical value##2##3##(2008-7#1)(2012-2#1)
the critical wavelength##3##3##(2008-5#3)
the critical##87##2##(1990-5#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-10#19)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-7#1)(2009-8#2)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#8)(2013-1#2)
the critically endangered Arakan forest turtle (Heosemys depressa)##2##8##(2013-1#2)
the critically##3##2##(2008-11#1)(2013-1#2)
the cromoglycate##2##2##(2008-10#2)
the crop is##2##3##(2008-10#2)
the crop production system##2##4##(2008-10#2)
the crop##12##2##(1991-11#1)(2008-10#9)(2008-11#1)(2008-8#1)
the cropping season##2##3##(2008-10#2)
the cropping##5##2##(2008-10#5)
the cross between##7##3##(2008-10#6)(2012-3#1)
the cross of##7##3##(2008-10#7)
the cross talk##4##3##(2008-3#1)(2009-12#1)(2013-1#2)
the cross##40##2##(2008-10#30)(2008-3#2)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
the cross-bridge##2##2##(1992-3#1)(2009-6#1)
the cross-linked##3##2##(1990-8#1)(1995-6#2)
the cross-linker##2##2##(2008-10#1)(2010-4#1)
the cross-linking##4##2##(1993-8#1)(1995-6#1)(2008-10#1)(2013-1#1)
the cross-reactivity##3##2##(2008-10#2)(2008-11#1)
the cross-sectional design##2##3##(2010-2#1)(2012-5#1)
the cross-sectional##4##2##(2010-2#1)(2011-2#1)(2012-5#1)(2013-3#1)
the cross-validation##2##2##(2008-10#1)(2011-3#1)
the crosses were##2##3##(2008-10#2)
the crosses##4##2##(2008-10#4)
the crosstalk##2##2##(2008-11#1)(2013-7#1)
the crown ether##5##3##(2008-10#5)
the crown of##2##3##(2013-1#2)
the crown rust resistance gene##2##5##(2008-10#2)
the crown##12##2##(2008-10#10)(2013-1#2)
the crowns##3##2##(1995-9#1)(2008-10#1)(2013-1#1)
the crucial role of##4##4##(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
the crucial##10##2##(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
the crude drug was##2##4##(2008-11#2)
the crude extract and##2##4##(2008-11#2)
the crude extract of##2##4##(2008-11#1)(2008-12#1)
the crude extract##6##3##(2008-10#1)(2008-11#4)(2008-12#1)
the crude extracts of##2##4##(2008-10#1)(2008-11#1)
the crude extracts##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
the crude##28##2##(1990-2#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-7#1)(2008-10#9)(2008-11#8)(2008-12#3)(2008-8#1)(2008-9#1)(2013-1#1)
the crustacean##3##2##(1990-2#2)(2008-10#1)
the cry1Ab gene##2##3##(2008-9#2)
the crypts##2##2##(2009-12#1)(2013-1#1)
the crystal and##2##3##(2008-2#1)(2012-2#1)
the crystal structure of allophycocyanin from##2##6##(2008-8#2)
the crystal structure of the##2##5##(1994-3#1)(2008-8#1)
the crystal structure of##9##4##(1993-9#1)(1994-3#1)(1994-5#1)(2008-8#3)(2008-9#1)(2012-2#2)
the crystal structure##14##3##(1991-3#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-5#1)(2008-8#3)(2008-9#1)(2011-1#1)(2012-2#2)(2013-8#1)
the crystal structures of##3##4##(1994-5#2)(2009-8#1)
the crystal temperature##2##3##(2007-12#1)(2008-3#1)
the crystal violet##2##3##(2008-10#1)(2008-9#1)
the crystal##48##2##(1991-3#1)(1992-12#1)(1992-4#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#3)(1996-5#2)(1997-7#4)(2007-12#1)(2008-10#2)(2008-2#7)(2008-3#7)(2008-8#3)(2008-9#2)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#3)(2013-8#2)
the crystalline##8##2##(1990-9#1)(1993-8#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
the crystallographic##2##2##(1992-9#1)(2008-3#1)
the cubic##2##2##(2008-3#1)(2010-3#1)
the cue-based retrieval##2##3##(2007-12#2)
the cued side##2##3##(2010-5#2)
the cues##3##2##(2008-11#1)(2013-8#2)
the cuff##4##2##(1991-12#3)(2013-8#1)
the cultivar##9##2##(2008-10#9)
the cultivars were##2##3##(2008-10#2)
the cultivars##9##2##(2008-10#8)(2008-8#1)
the cultivated##7##2##(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#2)
the cultivation of##10##3##(2008-11#9)(2008-9#1)
the cultivation##15##2##(2008-10#1)(2008-11#13)(2008-9#1)
the culturable##3##2##(2008-10#3)
the cultural and##2##3##(1997-1#1)(2008-11#1)
the cultural##17##2##(1994-1#1)(1996-1#1)(1997-1#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#2)(2009-10#2)(2010-1#1)(2012-3#1)
the culture and##4##3##(2008-11#3)(2008-7#1)
the culture broth##2##3##(2008-11#1)(2008-6#1)
the culture conditions##4##3##(2008-11#4)
the culture filtrate of##2##4##(2008-10#2)
the culture filtrate##4##3##(2008-10#3)(2008-8#1)
the culture incubated##2##3##(2008-11#2)
the culture media##5##3##(1992-5#1)(1992-8#1)(2008-11#3)
the culture medium and##3##4##(1995-3#1)(2008-11#1)(2008-7#1)
the culture medium by##2##4##(1993-3#1)(1993-6#1)
the culture medium of##3##4##(1997-1#1)(2009-3#2)
the culture medium resulted in##3##5##(1993-12#1)(1994-6#1)(2008-11#1)
the culture medium##43##3##(1990-8#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#19)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#2)(2010-10#1)(2011-2#2)
the culture of the##2##4##(1994-2#1)(2008-8#1)
the culture of##11##3##(1994-1#1)(1994-2#1)(2008-11#7)(2008-8#1)(2008-9#1)
the culture period##4##3##(2008-11#4)
the culture plate method##2##4##(2008-10#2)
the culture process##2##3##(2008-11#2)
the culture solution was##2##4##(2010-3#2)
the culture supernatant##3##3##(1990-8#1)(2008-11#2)
the culture supernatants##2##3##(1990-2#1)(2011-3#1)
the culture system##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
the culture temperature##3##3##(2008-11#2)(2008-7#1)
the culture was##2##3##(2008-11#1)(2008-7#1)
the culture with##2##3##(2008-11#2)
the culture##140##2##(1990-2#1)(1990-8#2)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#2)(2008-10#6)(2008-11#83)(2008-5#1)(2008-6#2)(2008-7#13)(2008-8#4)(2008-9#2)(2009-3#2)(2009-6#1)(2010-10#1)(2010-3#2)(2010-6#1)(2011-2#2)(2011-3#1)
the cultured cardiac myocytes##2##4##(1993-3#2)
the cultured cells##7##3##(2008-11#3)(2008-4#1)(2008-6#1)(2009-12#1)(2012-2#1)
the cultured##16##2##(1993-3#3)(1995-11#1)(1995-6#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2012-2#1)
the cultures by##2##3##(2008-10#1)(2008-11#1)
the cultures had##2##3##(1992-3#1)(2008-11#1)
the cultures was##2##3##(2008-10#2)
the cultures with##2##3##(2008-11#2)
the cultures##26##2##(1992-3#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#14)(2008-4#1)(2008-5#1)(2010-8#1)
the culturing##2##2##(2008-11#1)(2008-9#1)
the cumbersome##2##2##(1995-2#1)(2008-9#1)
the cumulative amount of##3##4##(2008-5#1)(2008-7#1)(2011-3#1)
the cumulative effect of##2##4##(2008-10#1)(2012-12#1)
the cumulative effects##2##3##(2008-10#1)(2008-6#1)
the cumulative number of##2##4##(2008-10#2)
the cumulative probability of##3##4##(2011-3#2)(2013-8#1)
the cumulative##28##2##(1991-6#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the cups##3##2##(1996-3#1)(2008-10#2)
the curative##2##2##(2012-2#1)(2012-3#1)
the cure##3##2##(1992-12#1)(2008-1#1)(2012-3#1)
the current and##3##3##(2008-10#1)(2008-11#2)
the current case##2##3##(2010-10#1)(2013-1#1)
the current classification##4##3##(2008-10#2)(2008-4#1)(2013-1#1)
the current data##2##3##(2008-8#1)(2010-6#1)
the current evidence##2##3##(2008-11#1)(2013-1#1)
the current experimental##2##3##(2011-2#1)(2012-2#1)
the current findings##2##3##(2008-10#1)(2013-8#1)
the current health##3##3##(1993-3#1)(1997-1#1)(1997-3#1)
the current knowledge of##5##4##(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
the current knowledge on##5##4##(2008-10#1)(2008-11#1)(2009-4#1)(2010-12#1)(2011-7#1)
the current knowledge##12##3##(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)
the current level of##4##4##(1996-12#1)(2007-12#1)(2008-11#1)(2008-4#1)
the current literature on##2##4##(1995-12#1)(2011-2#1)
the current literature##11##3##(1995-12#1)(1997-8#1)(2008-11#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
the current methods used for##2##5##(2008-11#1)(2013-1#1)
the current methods##3##3##(1997-7#1)(2008-11#1)(2013-1#1)
the current paper##3##3##(1997-3#1)(2010-10#1)(2010-3#1)
the current policy##3##3##(1995-6#1)(1996-2#1)(2008-11#1)
the current practice of##3##4##(1991-6#1)(2008-10#1)(2013-1#1)
the current practice##4##3##(1991-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
the current problem##2##3##(2008-3#1)(2010-5#1)
the current problems##2##3##(1991-2#1)(1997-8#1)
the current response##3##3##(2008-10#3)
the current results##2##3##(2007-12#1)(2010-12#1)
the current shortage of##2##4##(2008-11#1)(2008-12#1)
the current situation##2##3##(1991-3#1)(2012-12#1)
the current standard##2##3##(2008-11#1)(2011-2#1)
the current state of knowledge##4##5##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
the current state of the##5##5##(1994-9#1)(1997-4#1)(2008-10#1)(2009-5#1)(2009-7#1)
the current state of##18##4##(1994-9#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#2)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
the current state##20##3##(1994-9#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-11#2)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)
the current status of knowledge##2##5##(2008-11#1)(2013-1#1)
the current status of research##2##5##(2008-11#1)(2010-11#1)
the current status of##16##4##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
the current status##17##3##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
the current study##24##3##(1995-2#1)(2008-10#9)(2008-11#5)(2008-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
the current understanding of the##3##5##(2008-7#2)(2009-12#1)
the current understanding of##4##4##(2008-10#1)(2008-7#2)(2009-12#1)
the current##289##2##(1991-1#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#3)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-1#4)(2008-10#47)(2008-11#38)(2008-12#7)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2010-10#4)(2010-11#3)(2010-12#10)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#14)(2011-7#3)(2012-12#3)(2012-2#15)(2012-3#11)(2013-1#13)(2013-8#7)
the currently available##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
the currently##13##2##(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-7#1)
the curricula##2##2##(1996-1#1)(2008-12#1)
the curricular##2##2##(1996-2#1)(2008-11#1)
the curriculum of##2##3##(1996-8#1)(2011-2#1)
the curriculum##14##2##(1993-2#1)(1994-1#2)(1994-12#1)(1995-2#1)(1996-8#1)(2008-11#5)(2008-12#2)(2011-2#1)
the curvature##7##2##(2008-3#2)(2008-9#2)(2009-2#3)
the curve of the##2##4##(2007-8#1)(2008-10#1)
the curve of##5##3##(2007-8#1)(2008-10#2)(2012-3#1)(2013-1#1)
the curve##17##2##(1992-9#1)(1994-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2010-8#1)(2012-3#2)(2013-1#1)
the curves##10##2##(2008-1#2)(2008-10#2)(2008-5#2)(2008-7#3)(2008-8#1)
the custom##2##2##(2008-10#2)
the customer##2##2##(1994-12#1)(1996-1#1)
the customer's##2##2##(1994-12#2)
the customers##2##2##(1994-12#1)(1996-1#1)
the cut##2##2##(2008-10#1)(2008-7#1)
the cut-off values##2##3##(1994-12#1)(2011-1#1)
the cut-off##4##2##(1993-1#1)(1994-12#1)(2008-10#1)(2011-1#1)
the cutaneous lesions##3##3##(2008-5#2)(2013-8#1)
the cutaneous##10##2##(1990-9#1)(2008-5#4)(2009-1#1)(2010-6#2)(2013-8#2)
the cuticle and##4##3##(2008-10#4)
the cuticle##16##2##(1993-12#2)(2007-12#2)(2008-10#10)(2008-5#1)(2008-7#1)
the cuticular##6##2##(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#2)
the cutting edge##2##3##(1994-1#1)(2008-6#1)
the cw laser##2##3##(2008-2#1)(2008-3#1)
the cw##5##2##(2008-2#2)(2008-3#3)
the cyanide complex of##2##4##(1993-8#2)
the cyanide##5##2##(1990-12#1)(1993-8#2)(2008-10#2)
the cyano propyl stationary phase##2##5##(2008-10#2)
the cyano propyl stationary##3##4##(2008-10#3)
the cyanobacterial##2##2##(1990-11#1)(2012-2#1)
the cyanobacterium##4##2##(1995-12#1)(1996-12#2)(1996-6#1)
the cycad Lepidozamia peroffskyana##2##4##(1994-11#2)
the cycle of the seminiferous epithelium##2##6##(2009-10#2)
the cycle of##4##3##(2008-10#1)(2009-10#2)(2010-1#1)
the cycle##6##2##(1990-12#1)(2008-10#1)(2009-10#3)(2010-1#1)
the cyclic##13##2##(1990-11#1)(1993-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#2)(2008-10#1)(2009-10#1)(2009-8#3)(2013-7#1)
the cyclo-oxygenase inhibitor##2##3##(1995-11#1)(2006-6#1)
the cyclo-oxygenase##3##2##(1995-11#1)(1995-6#1)(2006-6#1)
the cycloadditions##2##2##(1996-5#2)
the cyclodextrin (CD)##2##3##(2008-10#2)
the cyclodextrin##5##2##(2008-10#5)
the cyclooxygenase##3##2##(1992-3#1)(1994-5#2)
the cylinder diameters##2##3##(2009-2#2)
the cylinder##10##2##(2008-10#1)(2008-2#1)(2008-3#3)(2009-2#5)
the cylindrical inclusion##2##3##(2008-10#2)
the cylindrical##4##2##(2008-10#3)(2008-3#1)
the cyst and##4##3##(1991-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
the cyst##21##2##(1990-6#1)(1991-8#3)(1995-12#1)(1997-8#2)(2008-10#1)(2008-12#2)(2008-7#4)(2009-9#1)(2012-2#4)(2013-1#2)
the cysteine residues##2##3##(1993-8#1)(1993-9#1)
the cysteine##3##2##(1990-5#1)(1993-8#1)(1993-9#1)
the cysteine-rich##3##2##(1995-2#1)(1995-6#1)(2008-10#1)
the cysteines##2##2##(1994-11#2)
the cysteinyl##2##2##(1991-5#2)
the cystic duct##8##3##(1992-9#3)(2008-12#3)(2010-12#2)
the cystic lumen##2##3##(2009-3#2)
the cystic##12##2##(1992-9#3)(2008-10#1)(2008-12#3)(2008-5#1)(2009-3#2)(2010-12#2)
the cysts are##2##3##(1993-1#1)(2008-7#1)
the cysts were##2##3##(2008-7#1)(2012-3#1)
the cysts##12##2##(1993-1#3)(1995-12#1)(2008-10#2)(2008-7#4)(2012-2#1)(2012-3#1)
the cytobrush##3##2##(1992-1#3)
the cytochrome P450##3##3##(1994-5#1)(1994-8#1)(2008-4#1)
the cytochrome b gene##2##4##(2008-10#2)
the cytochrome b##3##3##(2008-10#2)(2009-9#1)
the cytochrome##19##2##(1992-3#1)(1992-8#1)(1994-5#4)(1994-8#1)(1995-6#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#2)
the cytogenetic##3##2##(1990-8#1)(2012-3#2)
the cytokine secretion##3##3##(2008-10#1)(2008-11#2)
the cytokine##11##2##(1991-2#1)(1996-12#1)(1996-2#3)(2008-10#2)(2008-11#2)(2013-8#2)
the cytokines##4##2##(1992-3#1)(1994-6#1)(1995-12#1)(2008-11#1)
the cytological##6##2##(1991-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
the cytomegalovirus (CMV) promoter##2##4##(1995-12#1)(2008-11#1)
the cytomegalovirus##4##2##(1995-12#1)(2008-11#3)
the cytoplasm and##5##3##(2008-11#1)(2009-8#1)(2011-2#3)
the cytoplasm of oocytes##2##4##(1995-12#1)(2013-1#1)
the cytoplasm of the##7##4##(1991-2#1)(1992-2#1)(1995-5#1)(2008-11#2)(2008-9#1)(2012-2#1)
the cytoplasm of##28##3##(1991-11#2)(1991-2#1)(1992-2#1)(1993-8#1)(1994-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1997-2#1)(1997-4#1)(2006-6#1)(2008-10#4)(2008-11#4)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)
the cytoplasm was##3##3##(1994-6#1)(2008-8#1)(2008-9#1)
the cytoplasm##72##2##(1991-11#4)(1991-2#2)(1992-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-6#2)(2007-12#1)(2008-10#9)(2008-11#10)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#1)(2009-8#1)(2011-2#6)(2012-2#1)(2012-7#2)(2013-1#2)(2013-8#1)
the cytoplasmic domain##2##3##(1995-2#1)(2013-1#1)
the cytoplasmic face of##2##4##(2009-7#1)(2013-1#1)
the cytoplasmic membrane and##3##4##(1991-10#2)(2011-2#1)
the cytoplasmic membrane##5##3##(1991-10#2)(1991-5#1)(2008-5#1)(2011-2#1)
the cytoplasmic receptor domain##2##4##(1997-7#2)
the cytoplasmic tail##2##3##(2008-9#2)
the cytoplasmic##23##2##(1991-10#2)(1991-5#2)(1992-10#1)(1993-3#1)(1995-2#1)(1995-6#1)(1997-7#3)(2008-10#1)(2008-5#1)(2008-9#5)(2009-7#1)(2009-9#1)(2011-2#1)(2013-1#2)
the cytoskeletal fraction##3##3##(1997-2#3)
the cytoskeletal##4##2##(1997-2#3)(2008-11#1)
the cytoskeleton##4##2##(2008-11#3)(2009-10#1)
the cytosol and##4##3##(1990-2#1)(1990-5#2)(2008-11#1)
the cytosol fraction##4##3##(1990-11#2)(1992-6#1)(2008-10#1)
the cytosol from##2##3##(1990-5#1)(1994-5#1)
the cytosol of##3##3##(1990-5#1)(1997-4#1)(2013-1#1)
the cytosol##26##2##(1990-11#2)(1990-2#1)(1990-5#4)(1992-10#1)(1992-12#1)(1992-6#2)(1993-8#1)(1994-5#1)(1995-9#1)(1997-1#1)(1997-4#1)(1997-7#2)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#3)(2013-1#1)
the cytosolic free##2##3##(1990-2#1)(1992-6#1)
the cytosolic space##2##3##(2007-12#2)
the cytosolic transport##2##3##(1994-6#2)
the cytosolic##17##2##(1990-2#1)(1990-5#1)(1992-6#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#2)(2007-12#2)
the cytotoxic activity of human natural killer cells##3##8##(1990-12#3)
the cytotoxic activity##4##3##(1990-12#3)(2011-2#1)
the cytotoxic and##2##3##(1993-8#1)(2011-2#1)
the cytotoxic effect##2##3##(1995-8#1)(2010-12#1)
the cytotoxic effects of##3##4##(2008-11#1)(2012-3#1)(2013-1#1)
the cytotoxic response##2##3##(1992-10#1)(1995-8#1)
the cytotoxic##19##2##(1990-12#4)(1992-10#1)(1992-7#1)(1993-1#2)(1993-8#1)(1995-8#2)(2008-11#2)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#1)
the cytotoxicity of the##5##4##(2008-11#1)(2008-5#1)(2008-8#3)
the cytotoxicity of##12##3##(1991-5#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#5)(2013-1#1)
the cytotoxicity##17##2##(1990-2#1)(1991-5#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-8#6)(2011-1#1)(2011-3#1)(2013-1#1)
the d##2##2##(2008-10#1)(2008-11#1)
the dRTA was##2##3##(2008-1#2)
the dRTA##3##2##(2008-1#3)
the daily life of##2##4##(2008-11#1)(2010-10#1)
the daily routine##2##3##(1993-12#1)(2008-11#1)
the daily##18##2##(1991-12#2)(1993-12#1)(1993-3#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
the damage threshold##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
the damage to##4##3##(1996-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
the damage##19##2##(1996-12#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#2)
the damaged##5##2##(1990-11#1)(1991-2#1)(2009-6#1)(2010-1#1)(2010-8#1)
the damages##3##2##(1990-11#1)(1995-6#1)(2009-8#1)
the damselfish##2##2##(2008-5#2)
the dance##2##2##(2009-3#2)
the danger of##4##3##(1990-11#1)(1997-4#1)(2008-10#2)
the danger##6##2##(1990-11#1)(1997-4#1)(2008-10#4)
the dangers of AIDS##2##4##(1992-2#1)(1997-6#1)
the dangers of##4##3##(1992-2#1)(1997-6#1)(2008-10#1)(2010-5#1)
the dangers##6##2##(1992-2#1)(1992-3#1)(1996-3#1)(1997-6#1)(2008-10#1)(2010-5#1)
the dansyl group##2##3##(1994-5#2)
the dansyl##8##2##(1994-5#5)(2008-10#3)
the dansylation##2##2##(2008-10#2)
the dark period##4##3##(1995-11#1)(1997-2#2)(2008-11#1)
the dark phase##2##3##(1994-2#1)(2008-5#1)
the dark##30##2##(1991-5#1)(1993-6#1)(1994-2#1)(1995-11#1)(1996-1#1)(1997-2#2)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#2)(2008-8#1)(2009-10#1)
the data acquired##2##3##(2008-10#1)(2008-3#1)
the data analysis##3##3##(2008-10#2)(2010-12#1)
the data and##6##3##(1992-3#1)(1995-11#1)(2008-8#1)(2009-5#1)(2011-3#1)(2012-3#1)
the data are##11##3##(1990-8#1)(1994-2#2)(1994-9#1)(1995-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
the data as well as##2##5##(2008-3#1)(2013-8#1)
the data as##3##3##(1994-9#1)(2008-3#1)(2013-8#1)
the data available##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
the data base##2##3##(1991-2#1)(1993-12#1)
the data better than the##2##5##(1997-7#1)(2008-10#1)
the data by##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
the data can be##2##4##(2010-11#1)(2010-12#1)
the data collected##2##3##(1992-2#1)(1997-4#1)
the data concerning##2##3##(2008-12#1)(2013-1#1)
the data elements##2##3##(1997-3#1)(2008-6#1)
the data for##4##3##(1992-9#1)(1996-1#1)(2008-11#1)(2008-2#1)
the data from the##4##4##(2008-10#2)(2008-11#1)(2010-6#1)
the data from##7##3##(2008-1#1)(2008-10#4)(2008-11#1)(2010-6#1)
the data generated##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
the data have been##3##4##(1994-6#1)(2008-10#2)
the data in##3##3##(2008-10#2)(2008-11#1)
the data indicate that the##2##5##(1990-8#1)(2008-10#1)
the data indicate that##4##4##(1990-8#1)(2008-10#2)(2009-8#1)
the data indicate##5##3##(1990-8#1)(2008-10#2)(2008-11#1)(2009-8#1)
the data indicated that##2##4##(2008-10#2)
the data indicated##3##3##(2008-10#3)
the data is##3##3##(2008-11#1)(2008-3#1)(2008-6#1)
the data may##2##3##(2013-8#2)
the data obtained at the##2##5##(2011-1#1)(2013-1#1)
the data obtained by##3##4##(2008-10#3)
the data obtained using the##2##5##(2008-10#2)
the data obtained##16##3##(1991-2#1)(1992-3#1)(1993-6#1)(1993-8#1)(2008-10#8)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
the data of the##6##4##(1997-8#1)(2008-10#4)(2013-1#1)
the data of##11##3##(1997-8#1)(2008-10#7)(2008-8#1)(2012-3#1)(2013-1#1)
the data on##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
the data points##2##3##(2008-10#1)(2008-2#1)
the data provide##2##3##(2008-11#1)(2009-8#1)
the data recorded in##2##4##(2008-10#1)(2012-3#1)
the data set##10##3##(1997-6#1)(2008-10#6)(2008-11#2)(2008-3#1)
the data sets##9##3##(2008-10#8)(2008-8#1)
the data sources##2##3##(1991-2#1)(2009-11#1)
the data structure##2##3##(2008-10#2)
the data suggest a##2##4##(1995-6#1)(2008-5#1)
the data suggest that##6##4##(1990-2#1)(1994-5#1)(1995-12#1)(1997-8#1)(2008-8#1)(2012-2#1)
the data suggest##9##3##(1990-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-5#1)(2008-8#2)(2012-2#1)
the data suggested##2##3##(1990-6#1)(1997-2#1)
the data to inform##2##4##(2008-11#1)(2008-12#1)
the data to the##2##4##(2008-10#1)(2010-4#1)
the data to##8##3##(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2010-4#1)
the data used##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
the data was##7##3##(1995-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
the data were used to##2##5##(2008-10#1)(2008-8#1)
the data were##6##3##(1994-1#1)(2008-10#4)(2008-8#1)
the data with a##2##4##(2008-7#1)(2009-6#1)
the data with##4##3##(1994-3#1)(2008-10#1)(2008-7#1)(2009-6#1)
the data##275##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-2#3)(1991-5#2)(1992-2#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#90)(2008-11#29)(2008-12#3)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#7)(2008-8#11)(2008-9#6)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#6)
the database in##2##3##(2008-11#1)(2010-5#1)
the database is##2##3##(1991-3#1)(1993-1#1)
the database of##5##3##(1993-8#1)(1997-8#1)(2008-7#2)(2012-2#1)
the database##24##2##(1991-12#1)(1991-3#2)(1992-12#1)(1993-1#2)(1993-8#1)(1994-12#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-7#3)(2009-10#1)(2010-5#4)(2011-2#1)(2012-2#1)
the databases##7##2##(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-4#1)(2013-8#1)
the dataset##5##2##(2008-10#1)(2008-4#1)(2010-7#1)(2010-8#1)(2012-3#1)
the date of##12##3##(1990-8#1)(1991-12#1)(1997-5#1)(2008-10#6)(2008-7#1)(2009-11#1)(2013-1#1)
the date##17##2##(1990-8#1)(1991-11#1)(1991-12#1)(1997-5#1)(2008-10#8)(2008-7#2)(2008-8#1)(2009-11#1)(2013-1#1)
the daughter##4##2##(1995-9#2)(2009-10#1)(2009-3#1)
the dawn of##2##3##(2011-2#1)(2013-7#1)
the day after##2##3##(2007-12#1)(2011-2#1)
the day following##2##3##(1995-3#1)(2010-6#1)
the day hospital##2##3##(2008-7#2)
the day of surgery##2##4##(1997-7#1)(2012-2#1)
the day of the##2##4##(1996-1#1)(1996-3#1)
the day of##11##3##(1996-1#2)(1996-3#1)(1997-7#1)(2008-10#4)(2008-5#1)(2010-6#1)(2012-2#1)
the day##29##2##(1991-9#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#2)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-5#2)(2008-7#2)(2010-6#3)(2010-7#1)(2011-2#3)(2012-2#1)
the days##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
the db/db##2##2##(2012-3#2)
the de novo##4##3##(1994-6#1)(1995-12#1)(1997-3#1)(2008-4#1)
the de##7##2##(1994-6#1)(1995-12#1)(1997-3#1)(2008-10#3)(2008-4#1)
the dead##10##2##(1991-11#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-5#1)(2011-2#1)
the deadly##2##2##(2008-10#1)(2010-1#1)
the deafferented##2##2##(1991-2#1)(1997-3#1)
the death certificate##2##3##(1991-12#1)(1991-2#1)
the death of a grandchild##2##5##(2010-9#2)
the death of a##5##4##(2008-11#1)(2009-5#2)(2010-9#2)
the death of##9##3##(1995-11#1)(2008-11#1)(2009-5#2)(2009-8#1)(2010-9#2)(2011-2#1)(2013-1#1)
the death programme##2##3##(2008-11#2)
the death rate##3##3##(2008-11#1)(2008-7#1)(2012-3#1)
the death##20##2##(1991-12#1)(1991-2#1)(1995-11#1)(1997-7#1)(2008-11#4)(2008-7#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-9#2)(2011-2#3)(2012-3#1)(2013-1#1)
the debate on##5##3##(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
the debate over##3##3##(1996-5#1)(2008-8#2)
the debate surrounding##2##3##(1990-6#1)(2008-12#1)
the debate##18##2##(1990-6#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#2)(2010-7#1)(2012-3#1)
the debriefing##2##2##(2008-11#2)
the decade##6##2##(1992-6#1)(1994-2#2)(1994-9#1)(2008-11#1)(2013-1#1)
the decarboxylation##2##2##(1993-8#2)
the decay constant##2##3##(2008-10#1)(2008-8#1)
the decay of the##2##4##(1992-12#1)(2006-6#1)
the decay of##3##3##(1992-12#1)(1995-2#1)(2006-6#1)
the decay##9##2##(1992-12#1)(1995-2#1)(2006-6#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-8#1)
the decaying##3##2##(2008-10#3)
the decidua##2##2##(2008-10#1)(2012-3#1)
the decision making process##3##4##(1992-3#1)(1996-6#2)
the decision of nurses to receive influenza vaccinations##2##8##(2012-3#2)
the decision of##7##3##(1997-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)
the decision to##11##3##(1991-3#1)(1995-12#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#2)
the decision tree##2##3##(2008-10#1)(2012-3#1)
the decision##40##2##(1991-3#1)(1992-3#1)(1992-9#1)(1993-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-6#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#3)(2012-3#6)(2013-1#1)
the decision-making process for##2##4##(2008-12#2)
the decision-making process of##2##4##(1993-1#1)(2009-1#1)
the decision-making process##7##3##(1993-1#1)(2008-12#3)(2009-1#1)(2009-10#1)(2011-2#1)
the decision-making##8##2##(1993-1#1)(1993-2#1)(2008-12#3)(2009-1#1)(2009-10#1)(2011-2#1)
the decisions##2##2##(2009-6#1)(2010-9#1)
the decisive##2##2##(2008-5#1)(2008-9#1)
the decline in the##2##4##(1990-6#1)(1991-3#1)
the decline in##5##3##(1990-3#1)(1990-6#1)(1991-3#1)(2008-10#1)(2008-8#1)
the decline of##4##3##(1995-3#1)(2008-10#1)(2012-7#2)
the decline was##2##3##(2008-11#1)(2013-1#1)
the decline##16##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2010-3#1)(2012-7#2)(2013-1#1)
the declining##2##2##(1993-3#1)(2012-2#1)
the decoloration of##2##3##(2008-10#1)(2008-11#1)
the decomposition of the##3##4##(1992-12#1)(1994-8#1)(2008-10#1)
the decomposition of##8##3##(1992-12#1)(1994-8#1)(2008-10#5)(2009-11#1)
the decomposition plateau##2##3##(2008-10#2)
the decomposition##12##2##(1992-12#1)(1994-8#1)(2008-10#9)(2009-11#1)
the deconvolved##2##2##(2008-10#1)(2008-3#1)
the decoration##3##2##(1995-2#1)(2008-10#2)
the decrease in absorbance of##6##5##(2008-10#6)
the decrease in absorbance##8##4##(2008-10#8)
the decrease in the absorbance of the##2##7##(2008-10#2)
the decrease in the absorbance of##4##6##(2008-10#4)
the decrease in the##10##4##(1992-6#1)(2008-10#7)(2008-11#2)
the decrease in##37##3##(1990-11#1)(1990-5#1)(1991-3#1)(1992-6#1)(1994-5#1)(1995-11#2)(1996-12#1)(1997-2#1)(2006-6#1)(2008-10#22)(2008-11#2)(2008-8#1)(2009-7#1)(2013-7#1)
the decrease of the##5##4##(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)
the decrease of##19##3##(2008-10#11)(2008-12#1)(2008-3#1)(2008-8#4)(2009-10#1)(2011-2#1)
the decrease##60##2##(1990-11#1)(1990-5#1)(1991-3#1)(1992-6#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-12#1)(1997-2#1)(2006-6#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#6)(2009-10#1)(2009-7#1)(2011-2#1)(2013-7#1)
the decreased CL intensity##2##4##(2008-10#2)
the decreased risk of##2##4##(1992-9#1)(2013-1#1)
the decreased##12##2##(1992-6#1)(1992-9#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-1#1)(2011-1#1)(2013-1#2)
the decreasing of##2##3##(2008-10#1)(2008-9#1)
the decreasing##5##2##(2008-10#3)(2008-9#1)(2012-3#1)
the decrement of CL intensity##2##5##(2008-10#2)
the decrement of##3##3##(2008-10#3)
the dedifferentiation##2##2##(2008-11#2)
the deduced aa##2##3##(1993-12#1)(1993-6#1)
the deduced amino acid sequence##6##5##(1993-9#1)(1997-2#1)(2008-10#2)(2008-8#1)(2008-9#1)
the deduced amino acid##10##4##(1993-6#1)(1993-9#1)(1997-2#1)(2008-10#4)(2008-8#1)(2008-9#2)
the deduced amino##11##3##(1993-6#1)(1993-9#1)(1997-2#1)(2008-10#4)(2008-8#1)(2008-9#3)
the deduced sequence##3##3##(1992-8#1)(1992-9#1)(1995-6#1)
the deduced##24##2##(1991-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#3)(1993-9#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-8#3)(2008-9#3)
the deep breathing##2##3##(1994-3#1)(2012-2#1)
the deep squat##2##3##(2011-2#2)
the deep##16##2##(1994-3#1)(1995-3#1)(2008-10#2)(2008-9#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
the deep-sea fish##2##3##(2008-11#2)
the deeper furrows##2##3##(2008-5#2)
the deeper layers##2##3##(1990-5#1)(2008-5#1)
the deeper##5##2##(1990-5#1)(2008-5#4)
the deepest##3##2##(1996-2#1)(2008-5#1)(2011-2#1)
the default##2##2##(2008-9#1)(2013-8#1)
the defect is##2##3##(2008-7#1)(2013-8#1)
the defect of##3##3##(1993-9#1)(1997-3#1)(2009-8#1)
the defect was##3##3##(1996-6#1)(2008-12#1)(2011-2#1)
the defect##17##2##(1991-2#1)(1993-9#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
the defective retrovirus##2##3##(2008-11#2)
the defective##4##2##(1995-9#1)(2008-10#1)(2008-11#2)
the defects##2##2##(2008-3#1)(2008-4#1)
the defendants'##2##2##(1995-6#2)
the defense bill##2##3##(1995-6#1)(1996-5#1)
the defense gene##2##3##(2008-10#2)
the defense in##2##3##(1993-2#1)(1996-12#1)
the defense mechanisms of##2##4##(2008-10#2)
the defense mechanisms##3##3##(2008-10#3)
the defense response##5##3##(2008-10#4)(2008-9#1)
the defense system of the human lungs##2##7##(1992-12#2)
the defense system of##3##4##(1992-12#2)(2008-10#1)
the defense##25##2##(1992-12#2)(1993-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#11)(2008-9#5)(2010-7#1)
the defensive behavior##2##3##(2007-12#2)
the defensive##3##2##(2007-12#3)
the deficiency of##5##3##(1993-2#1)(2006-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
the deficiency##8##2##(1993-2#1)(2006-6#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-3#1)
the deficit irrigation regime##2##4##(2008-10#2)
the deficit was##2##3##(1997-2#2)
the deficit##5##2##(1997-2#2)(2008-10#2)(2008-8#1)
the defined##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
the defining##3##2##(1996-1#1)(2009-5#1)(2013-1#1)
the definition and##2##3##(2008-10#1)(2008-12#1)
the definition of the##6##4##(1993-1#1)(2008-11#1)(2008-3#1)(2010-7#1)(2012-2#2)
the definition of##16##3##(1991-12#1)(1993-1#1)(1993-2#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)
the definition##18##2##(1991-12#1)(1993-1#1)(1993-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)
the definitions of the##2##4##(2008-1#1)(2011-2#1)
the definitions##5##2##(1991-2#1)(1993-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
the definitive##5##2##(1995-8#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
the deformation##4##2##(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
the deformity##3##2##(2008-8#2)(2012-2#1)
the degeneration of the##3##4##(1990-5#1)(2010-5#1)(2011-2#1)
the degeneration of##7##3##(1990-5#3)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
the degeneration##8##2##(1990-5#3)(1994-8#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
the degenerative##3##2##(2008-7#1)(2011-2#2)
the degradation of IkappaBalpha##2##4##(2008-8#2)
the degradation of the old##2##5##(2008-7#2)
the degradation of the##7##4##(1991-5#1)(1992-12#1)(1994-2#1)(2008-11#1)(2008-7#2)(2008-9#1)
the degradation of##30##3##(1991-5#1)(1992-10#1)(1992-12#1)(1994-2#1)(1994-8#2)(1995-6#1)(1995-8#3)(1996-8#1)(1997-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)
the degradation pathway##2##3##(2008-10#1)(2010-4#1)
the degradation product##2##3##(1991-5#1)(2008-10#1)
the degradation products##7##3##(2008-10#7)
the degradation rate##3##3##(2008-10#1)(2008-11#2)
the degradation##56##2##(1991-5#2)(1992-10#1)(1992-12#1)(1994-2#1)(1994-8#2)(1995-6#1)(1995-8#3)(1996-8#1)(1997-1#1)(2008-10#22)(2008-11#6)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2010-4#1)(2013-8#1)
the degree and##2##3##(2008-11#1)(2008-7#1)
the degree of aggregation##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
the degree of carotid artery##2##5##(2011-2#2)
the degree of correlation##2##4##(1996-3#1)(2008-3#1)
the degree of coupling##2##4##(2008-9#1)(2011-1#1)
the degree of disease control##2##5##(2008-10#2)
the degree of fasting hyperglycemia##2##5##(1991-7#2)
the degree of fluorescence##2##4##(1991-3#1)(1995-8#1)
the degree of fungal##2##4##(2008-10#2)
the degree of heterogeneity##3##4##(2008-10#3)
the degree of impairment##2##4##(1991-1#1)(1991-2#1)
the degree of increase##2##4##(1993-6#1)(2008-11#1)
the degree of inhibition##3##4##(1995-11#1)(2008-10#1)(2008-7#1)
the degree of liver fibrosis##2##5##(2013-1#2)
the degree of omnivory##2##4##(2008-9#2)
the degree of order of the##2##6##(2008-5#2)
the degree of order of##3##5##(2008-5#3)
the degree of resistance##2##4##(2008-10#2)
the degree of role conflict##2##5##(1990-2#2)
the degree of size##2##4##(2008-8#2)
the degree of specialization of##2##5##(2008-8#2)
the degree of stress##2##4##(2008-12#1)(2008-5#1)
the degree of the##7##4##(1997-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2013-8#1)
the degree of tolerance##2##4##(2008-10#2)
the degree of variability##2##4##(2008-10#1)(2009-11#1)
the degree of##184##3##(1990-2#2)(1990-3#2)(1990-6#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-3#1)(1997-3#5)(1997-6#2)(2008-1#2)(2008-10#51)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#13)(2008-9#10)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-5#1)(2013-1#4)(2013-8#3)
the degree to which the##3##5##(1996-3#1)(2010-6#1)(2011-2#1)
the degree to which##12##4##(1992-2#1)(1993-3#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-6#1)(2011-2#1)
the degree##199##2##(1990-2#2)(1990-3#2)(1990-6#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-3#5)(1997-6#2)(2008-1#2)(2008-10#51)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#11)(2008-8#14)(2008-9#11)(2009-11#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-5#1)(2013-1#4)(2013-8#3)
the dehydrated##2##2##(2008-10#2)
the dehydration##3##2##(2008-10#2)(2012-2#1)
the dehydrogenase##2##2##(1990-11#1)(2008-11#1)
the delay and diffusion##2##4##(2013-8#2)
the delay in##5##3##(1991-2#1)(1992-3#1)(2008-10#2)(2008-12#1)
the delay of ascospore##2##4##(2008-10#2)
the delay of##4##3##(2008-10#2)(2012-12#2)
the delay##21##2##(1991-2#2)(1992-3#1)(1996-2#1)(1997-2#2)(2008-10#4)(2008-12#2)(2008-5#1)(2010-9#1)(2012-12#2)(2013-8#5)
the delayed##5##2##(1992-6#1)(2010-10#1)(2013-1#2)(2013-8#1)
the deleted receptor##2##3##(1997-7#2)
the deleted##5##2##(1993-6#1)(1997-3#1)(1997-7#2)(2008-10#1)
the deleterious effects of##3##4##(1991-6#1)(2008-1#1)(2008-4#1)
the deleterious effects##4##3##(1991-6#1)(2008-1#1)(2008-4#1)(2008-9#1)
the deleterious##6##2##(1991-6#1)(1992-3#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-6#1)
the deletion mutant##2##3##(1997-3#1)(2012-3#1)
the deletion of##4##3##(1993-6#1)(1995-12#1)(2008-10#1)(2008-8#1)
the deletion##14##2##(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#3)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
the delineation of##3##3##(2009-11#2)(2010-5#1)
the delinquent adolescent##3##3##(1990-12#3)
the delinquent group##2##3##(1990-12#2)
the delinquent##5##2##(1990-12#5)
the delirium protocol##2##3##(2010-10#2)
the delivered protein##2##3##(2008-11#2)
the delivered##7##2##(1991-12#1)(1996-2#2)(1997-8#1)(2008-11#2)(2008-3#1)
the delivery and##2##3##(1992-3#1)(1996-3#1)
the delivery of a##2##4##(2008-11#1)(2012-3#1)
the delivery of aerosolized##2##4##(1995-3#2)
the delivery of an##3##4##(2008-5#2)(2010-8#1)
the delivery of care##2##4##(1992-2#1)(2008-11#1)
the delivery of health care##2##5##(1992-1#1)(1994-12#1)
the delivery of health##4##4##(1992-1#1)(1993-2#1)(1994-12#1)(2009-3#1)
the delivery of mental health services##2##6##(1994-1#2)
the delivery of##40##3##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#3)(1996-2#2)(1997-2#3)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-3#1)(2010-8#1)(2011-2#2)(2012-3#1)
the delivery system of choice##2##5##(1996-1#1)(1996-2#1)
the delivery system##4##3##(1993-3#1)(1996-1#1)(1996-2#1)(1997-2#1)
the delivery##51##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#3)(1996-1#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-2#4)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-3#1)(2010-8#1)(2011-2#2)(2012-3#2)
the delta G degrees value of##2##6##(1993-8#2)
the delta G degrees##3##4##(1993-8#3)
the delta##11##2##(1992-3#1)(1993-8#3)(1994-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#2)(2013-8#1)
the delta-9##2##2##(1996-6#2)
the deltoid##2##2##(2010-4#2)
the demand for##11##3##(1990-6#2)(1994-12#1)(1996-2#1)(1997-8#2)(2006-6#1)(2008-10#1)(2008-11#2)(2008-9#1)
the demand of grain filling##2##5##(2008-9#2)
the demand##15##2##(1990-6#2)(1994-1#1)(1994-12#1)(1996-2#1)(1997-8#2)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#3)
the demands for##2##3##(2008-4#1)(2008-9#1)
the demands of the##2##4##(1993-12#1)(1994-2#1)
the demands of##4##3##(1993-12#1)(1994-2#1)(1995-2#1)(2012-3#1)
the demands##9##2##(1992-3#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2012-3#1)
the demetalization##2##2##(2008-10#2)
the demethylated##2##2##(1991-5#2)
the demise of##3##3##(2008-11#1)(2008-12#1)(2013-7#1)
the demographic basis of##3##4##(2008-8#3)
the demographic##16##2##(1992-1#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2012-3#1)(2013-1#1)
the demography##2##2##(2008-8#2)
the demonstrated##3##2##(1995-2#1)(2007-11#1)(2013-1#1)
the demonstration of the##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
the demonstration of##9##3##(1995-11#1)(1995-12#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
the demonstration##11##2##(1995-11#1)(1995-12#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
the denaturation##2##2##(2008-10#2)
the denatured##5##2##(1990-5#2)(2008-10#2)(2009-9#1)
the dendritic arbors of##2##4##(1994-2#2)
the dendritic##8##2##(1990-5#1)(1994-2#4)(2007-12#1)(2008-7#1)(2013-1#1)
the denominator##5##2##(1992-12#1)(1995-3#1)(1996-2#2)(2013-1#1)
the dense##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
the densities and##2##3##(1995-11#1)(2008-10#1)
the densities of##3##3##(1994-2#1)(2008-10#2)
the densities##5##2##(1994-2#1)(1995-11#1)(2008-10#3)
the density and##3##3##(2008-10#2)(2008-11#1)
the density of its partner##2##5##(2008-8#2)
the density of opioid receptors##2##5##(2008-11#2)
the density of the##7##4##(1994-2#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-3#1)(2013-8#1)
the density of type II pneumocytes is reduced in##2##9##(1994-5#2)
the density of##29##3##(1990-11#1)(1993-9#2)(1994-2#2)(1994-5#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2013-1#1)(2013-8#1)
the density##42##2##(1990-11#1)(1993-9#2)(1994-2#2)(1994-5#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#1)(2008-10#11)(2008-11#3)(2008-3#5)(2008-5#3)(2008-8#3)(2008-9#2)(2013-1#1)(2013-8#2)
the dental biofilms of patients with##2##6##(2013-1#2)
the dental##16##2##(1990-2#1)(1990-9#1)(1991-3#1)(1993-1#1)(2008-1#1)(2008-10#2)(2008-7#2)(2012-2#1)(2012-3#1)(2013-1#5)
the dentate gyrus and##4##4##(1994-8#1)(1996-12#2)(2008-11#1)
the dentate gyrus##12##3##(1990-5#1)(1994-8#3)(1995-12#2)(1996-12#4)(2008-11#1)(2013-8#1)
the dentate##15##2##(1990-5#1)(1991-7#1)(1994-8#4)(1995-12#2)(1996-12#4)(2008-1#1)(2008-11#1)(2013-8#1)
the denuder-based##2##2##(2008-10#2)
the department in##2##3##(1997-4#1)(2008-12#1)
the department of##5##3##(1991-3#1)(1993-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
the department##14##2##(1990-12#1)(1991-11#1)(1991-3#1)(1993-3#1)(1996-1#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#3)(2013-1#1)(2013-8#1)
the departments##6##2##(1990-9#1)(1997-3#1)(2012-12#3)(2013-1#1)
the dependence between##2##3##(2008-10#2)
the dependence of the peak##2##5##(2008-10#1)(2008-3#1)
the dependence of the##18##4##(1990-5#1)(1995-11#1)(2008-10#7)(2008-2#1)(2008-3#6)(2009-7#1)(2009-8#1)
the dependence of##26##3##(1990-5#1)(1991-5#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#7)(2008-7#1)(2009-7#1)(2009-8#1)
the dependence##28##2##(1990-5#1)(1991-5#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#12)(2008-2#1)(2008-3#7)(2008-7#1)(2009-7#1)(2009-8#1)
the dependency of##3##3##(1997-2#1)(2008-11#1)(2011-2#1)
the dependent variable##2##3##(1992-1#1)(2008-10#1)
the dependent virus##2##3##(2008-10#2)
the dependent##6##2##(1992-1#1)(2008-10#3)(2008-11#1)(2008-12#1)
the dephosphorylation of##4##3##(1993-6#1)(1994-11#1)(2008-7#1)(2013-8#1)
the dephosphorylation##5##2##(1993-6#2)(1994-11#1)(2008-7#1)(2013-8#1)
the depigmenting##2##2##(2008-5#2)
the depletion of the##3##4##(1993-2#1)(2008-7#1)(2009-8#1)
the depletion of##6##3##(1993-2#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)
the deployment of resistant##2##4##(2008-10#2)
the deployment of##5##3##(2008-10#3)(2008-11#1)(2008-9#1)
the depolarization##2##2##(1990-8#1)(2008-3#1)
the deposit##4##2##(1995-12#1)(2008-10#2)(2008-5#1)
the deposited layers##2##3##(2008-10#1)(2008-3#1)
the deposited##5##2##(2008-10#3)(2008-3#2)
the deposition of the##2##4##(2008-10#1)(2008-7#1)
the deposition of##16##3##(1991-12#1)(1994-12#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-7#1)(2013-8#1)
the deposition on the##2##4##(2008-10#2)
the deposition step##3##3##(2008-10#3)
the deposition##28##2##(1991-12#1)(1993-8#1)(1994-12#2)(1994-2#1)(1997-8#1)(2008-10#18)(2008-11#1)(2008-7#2)(2013-8#1)
the depression##2##2##(2008-9#1)(2010-5#1)
the depressive##2##2##(1991-11#1)(2011-2#1)
the depside##2##2##(2008-5#2)
the depth of the avascular plane and##2##7##(2011-2#2)
the depth of the avascular plane##3##6##(2011-2#3)
the depth of the##4##4##(2007-12#1)(2011-2#3)
the depth of##12##3##(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-8#2)(2011-2#4)(2013-8#1)
the depth profile##2##3##(2008-3#2)
the depth##19##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#4)(2013-8#1)
the deregulation of##2##3##(2011-2#2)
the derivation of the##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
the derivation of##7##3##(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-4#1)
the derivation##9##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-2#1)(2012-4#1)
the derivatisation reaction##2##3##(2008-10#2)
the derivative method##2##3##(2008-10#2)
the derivative##10##2##(2008-10#8)(2008-3#1)(2008-9#1)
the derivatives in##2##3##(2008-10#2)
the derivatives##11##2##(2008-10#4)(2008-11#3)(2008-6#2)(2008-7#1)(2011-2#1)
the derivatization of##2##3##(2008-10#2)
the derivatization reaction##4##3##(2008-10#4)
the derivatization##12##2##(2008-10#12)
the derivatized##4##2##(2008-10#3)(2008-7#1)
the derived##10##2##(2007-12#1)(2008-10#3)(2008-3#4)(2010-1#1)(2010-8#1)
the dermal and##2##3##(2008-5#1)(2008-9#1)
the dermal layer##2##3##(2008-9#1)(2012-3#1)
the dermal##9##2##(1992-12#1)(2008-5#3)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
the dermal-epidermal junction##2##3##(1992-6#1)(2008-5#1)
the dermis##14##2##(1996-12#6)(2008-5#4)(2010-6#3)(2012-3#1)
the descending thoracic##2##3##(2008-10#1)(2013-3#1)
the descending##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2013-3#1)
the described method##2##3##(1990-9#1)(2008-10#1)
the described technique##2##3##(2008-10#1)(2008-11#1)
the described##13##2##(1990-9#2)(1994-11#1)(1995-6#1)(1996-1#1)(2008-10#7)(2008-11#1)
the description of the##2##4##(2008-11#1)(2009-6#1)
the description of##9##3##(1996-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-6#1)(2010-7#1)(2011-7#1)
the description##12##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-1#1)(2010-7#2)(2011-7#1)
the descriptive data##2##3##(2008-11#1)(2008-7#1)
the descriptive##4##2##(1991-6#2)(2008-11#1)(2008-7#1)
the descriptors##3##2##(1997-2#1)(2008-10#2)
the desert##4##2##(1996-12#1)(2007-12#1)(2008-10#1)(2013-1#1)
the design and fabrication of##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
the design and implementation of##6##5##(1991-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2010-11#2)
the design and the##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
the design and##24##3##(1991-1#1)(1992-2#1)(1996-2#1)(1996-6#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2010-11#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
the design of a new##2##5##(1996-6#1)(2008-3#1)
the design of a##6##4##(1996-6#1)(2008-10#2)(2008-3#2)(2008-7#1)
the design of an##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
the design of clinical trials##2##5##(2008-8#1)(2010-11#1)
the design of efficient##2##4##(2008-10#1)(2009-4#1)
the design of new##4##4##(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
the design of such##2##4##(2008-3#1)(2008-9#1)
the design of the system##2##5##(2008-2#1)(2012-3#1)
the design of the##7##4##(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2011-1#1)(2012-3#1)
the design of##59##3##(1992-9#2)(1995-5#1)(1996-6#1)(1997-6#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#2)
the design##114##2##(1990-11#1)(1991-1#1)(1992-2#1)(1992-9#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-6#4)(1997-6#1)(2008-10#22)(2008-11#6)(2008-12#8)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#4)
the designed##4##2##(2008-10#3)(2011-2#1)
the desirability function##2##3##(2008-10#2)
the desirability of health technology##2##5##(2009-3#2)
the desirability of##3##3##(2008-3#1)(2009-3#2)
the desirability##6##2##(1994-1#1)(2008-10#2)(2008-3#1)(2009-3#2)
the desirable##3##2##(1992-1#1)(2008-10#1)(2008-11#1)
the desire for##2##3##(1993-1#1)(2008-7#1)
the desire to##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
the desire##5##2##(1993-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
the desired characteristics##2##3##(1990-8#1)(1993-2#1)
the desired product##3##3##(2008-10#2)(2010-4#1)
the desired##37##2##(1990-8#1)(1992-1#1)(1992-6#1)(1993-12#2)(1993-2#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
the desmosome and gap junction##2##5##(2012-2#2)
the desorption of##2##3##(2008-10#1)(2009-12#1)
the desorption##3##2##(2008-10#2)(2009-12#1)
the desquamation##3##2##(2008-5#2)(2012-3#1)
the destruction of##5##3##(2007-11#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
the destruction##7##2##(1993-9#1)(2007-11#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
the destructive##5##2##(1990-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-11#1)
the detached##2##2##(2008-10#2)
the detachment##2##2##(1991-3#1)(2008-11#1)
the detailed description of the##2##5##(2008-9#1)(2010-12#1)
the detailed molecular##2##3##(2010-12#2)
the detailed study of##2##4##(2008-10#1)(2008-11#1)
the detailed##17##2##(1993-8#1)(1995-5#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#3)(2011-3#1)
the details of the##2##4##(1992-2#1)(1996-12#1)
the details of##14##3##(1992-2#1)(1992-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-11#1)(2008-4#1)(2009-12#1)(2011-2#1)(2013-8#2)
the details##15##2##(1992-2#1)(1992-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-11#2)(2008-4#1)(2009-12#1)(2011-2#1)(2013-8#2)
the detectability of##2##3##(2008-10#2)
the detectability##3##2##(2008-10#2)(2008-3#1)
the detected fluorescence##3##3##(2008-10#2)(2008-3#1)
the detected##14##2##(1994-1#1)(1997-7#1)(2008-10#7)(2008-2#2)(2008-3#2)(2012-3#1)
the detecting##3##2##(2008-10#2)(2009-8#1)
the detection and characterization of##2##5##(2008-10#1)(2011-2#1)
the detection and quantification limits##3##5##(2008-10#3)
the detection and##27##3##(1990-12#1)(1990-6#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#2)(2011-2#1)
the detection area##2##3##(2008-10#2)
the detection cell##3##3##(2008-10#3)
the detection electrode##2##3##(2008-10#2)
the detection frequency##2##3##(2008-10#2)
the detection limit (3sigma) of##2##5##(2008-10#2)
the detection limit (3sigma)##5##4##(2008-10#5)
the detection limit (S/N=3)##2##4##(2008-10#2)
the detection limit and the##2##5##(2008-10#2)
the detection limit and##3##4##(2008-10#3)
the detection limit for##6##4##(2008-10#6)
the detection limit in##2##4##(2008-10#1)(2008-3#1)
the detection limit is 0##6##5##(2008-10#6)
the detection limit is 1##4##5##(2008-10#4)
the detection limit is 2##2##5##(2008-10#2)
the detection limit is##18##4##(2008-10#18)
the detection limit obtained##2##4##(2008-10#1)(2008-3#1)
the detection limit of 0##6##5##(2008-10#6)
the detection limit of 1##6##5##(2008-10#5)(2008-11#1)
the detection limit of 2##2##5##(2008-10#2)
the detection limit of the##3##5##(2008-10#3)
the detection limit of##31##4##(2008-10#29)(2008-11#2)
the detection limit was 0##12##5##(2008-10#12)
the detection limit was 1##4##5##(2008-10#4)
the detection limit was 3##2##5##(2008-10#2)
the detection limit was estimated as 0##2##7##(2008-10#2)
the detection limit was lower than##2##6##(2008-10#2)
the detection limit was##47##4##(2008-10#47)
the detection limit##141##3##(2008-10#137)(2008-11#2)(2008-3#2)
the detection limits (DL)##2##4##(2008-10#2)
the detection limits and##2##4##(2008-10#2)
the detection limits are##2##4##(2008-10#2)
the detection limits for##5##4##(2008-10#5)
the detection limits of the##3##5##(2008-10#3)
the detection limits of##17##4##(2008-10#17)
the detection limits were##8##4##(2008-10#8)
the detection limits##56##3##(2008-10#56)
the detection of 0##2##4##(2008-10#2)
the detection of DNA##6##4##(1995-12#1)(2008-10#5)
the detection of Escherichia##3##4##(2008-10#3)
the detection of F(-)##2##4##(2008-10#2)
the detection of FZ##2##4##(2008-10#2)
the detection of NO##5##4##(2008-10#2)(2008-3#2)(2010-7#1)
the detection of P##3##4##(2008-10#3)
the detection of TNT##2##4##(2008-10#1)(2009-3#1)
the detection of a variety of##2##6##(2008-10#1)(2010-11#1)
the detection of a##5##4##(2008-10#2)(2008-3#1)(2009-3#1)(2010-11#1)
the detection of an##2##4##(2008-10#2)
the detection of cholera antitoxin##2##5##(2008-10#2)
the detection of human##2##4##(1992-6#1)(2008-10#1)
the detection of lipids##2##4##(2008-10#1)(2012-12#1)
the detection of low##3##4##(2008-10#2)(2008-5#1)
the detection of membrane##2##4##(1992-11#2)
the detection of nitric oxide (NO)##2##6##(2008-10#2)
the detection of nitric oxide##3##5##(2008-10#3)
the detection of nitrite##2##4##(2008-10#2)
the detection of outlier data in chemical analysis##2##8##(2008-10#2)
the detection of phenolic##2##4##(2008-10#2)
the detection of short##3##4##(1996-12#2)(2008-10#1)
the detection of sulfur##2##4##(2008-10#2)
the detection of the mecA gene##2##6##(2008-10#2)
the detection of the##14##4##(1990-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-9#1)
the detection of trace##7##4##(2008-10#7)
the detection of##260##3##(1990-12#10)(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#3)(1992-11#2)(1992-3#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#4)(1996-3#1)(1997-3#2)(1997-6#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#156)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#4)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#3)
the detection point##3##3##(2008-10#3)
the detection system##3##3##(2008-10#2)(2008-9#1)
the detection technique##2##3##(2008-10#2)
the detection zone##2##3##(2008-10#2)
the detection##531##2##(1990-12#11)(1990-2#1)(1990-6#2)(1990-8#2)(1991-12#1)(1991-3#3)(1992-11#2)(1992-3#1)(1992-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-12#4)(1996-3#1)(1997-3#2)(1997-6#3)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#401)(2008-11#15)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#2)(2008-5#6)(2008-6#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-3#4)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#3)
the detector as##2##3##(2008-10#1)(2008-3#1)
the detector at a##2##4##(2008-10#2)
the detector response is linear##2##5##(2008-10#2)
the detector response##4##3##(2008-10#4)
the detector##41##2##(2008-10#35)(2008-11#1)(2008-3#5)
the detectors##2##2##(2008-3#2)
the detectors' field of view##2##5##(2008-3#2)
the detergent##2##2##(1990-5#1)(1994-8#1)
the determinants of##8##3##(1991-3#1)(1992-2#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(2012-2#1)
the determinants##10##2##(1991-3#1)(1992-2#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-1#1)(2008-10#1)(2012-2#1)
the determination and##7##3##(2008-10#6)(2010-11#1)
the determination is based on##2##5##(2008-10#1)(2010-6#1)
the determination is##8##3##(2008-10#6)(2008-5#1)(2010-6#1)
the determination limit##2##3##(2008-10#2)
the determination method for##2##4##(2008-10#2)
the determination method##3##3##(2008-10#3)
the determination of 0##8##4##(2008-10#8)
the determination of 1##3##4##(2008-10#3)
the determination of Ag##4##4##(2008-10#4)
the determination of Al##3##4##(2008-10#3)
the determination of As and##3##5##(2008-10#3)
the determination of As##6##4##(2008-10#6)
the determination of As(III) and As(V)##2##6##(2008-10#2)
the determination of As(III) in water samples##2##7##(2008-10#2)
the determination of As(III) in##3##5##(2008-10#3)
the determination of As(III)##7##4##(2008-10#7)
the determination of Au##2##4##(2008-10#2)
the determination of BPA in##2##5##(2008-10#1)(2009-8#1)
the determination of Bi in##2##5##(2008-10#2)
the determination of Bi##4##4##(2008-10#4)
the determination of Ca##3##4##(2008-10#3)
the determination of Captopril by differential pulse polarography##2##8##(2008-10#2)
the determination of Captopril##4##4##(2008-10#4)
the determination of Cd and Pb##3##6##(2008-10#3)
the determination of Cd##9##4##(2008-10#9)
the determination of Co(II)##2##4##(2008-10#2)
the determination of Cr(III)##4##4##(2008-10#4)
the determination of Cr(VI)##3##4##(2008-10#3)
the determination of DMA in##3##5##(2008-10#3)
the determination of DMA##4##4##(2008-10#4)
the determination of DNA##2##4##(2008-10#1)(2008-9#1)
the determination of Fe##4##4##(2008-10#3)(2013-8#1)
the determination of H(2)O(2)##4##4##(2008-10#4)
the determination of Hg in##2##5##(2008-10#2)
the determination of Hg(II) in##2##5##(2008-10#2)
the determination of Hg(II) is##2##5##(2008-10#2)
the determination of Hg(II)##5##4##(2008-10#5)
the determination of Mg in##2##5##(2008-10#2)
the determination of Mo##3##4##(2008-10#3)
the determination of NAA##2##4##(2008-10#2)
the determination of NAL in##2##5##(2008-10#2)
the determination of Ni##4##4##(2008-10#4)
the determination of PA##3##4##(2008-10#3)
the determination of PBDEs##3##4##(2008-10#3)
the determination of Pb(2+)##3##4##(2008-10#3)
the determination of Pu##3##4##(2008-10#3)
the determination of Sb(III) in##2##5##(2008-10#2)
the determination of Se in##3##5##(2008-10#3)
the determination of Se##8##4##(2008-10#8)
the determination of Se(IV)##3##4##(2008-10#3)
the determination of Si-tot##2##4##(2008-10#2)
the determination of V(V)##2##4##(2008-10#2)
the determination of W(VI)##2##4##(2008-10#2)
the determination of a##5##4##(2008-10#5)
the determination of acetaminophen in##2##5##(2008-10#2)
the determination of acetylcholine##4##4##(2008-10#4)
the determination of acid volatile##3##5##(2008-10#3)
the determination of acid##4##4##(2008-10#4)
the determination of aliphatic amines in##2##6##(2008-10#2)
the determination of aliphatic##3##4##(2008-10#3)
the determination of ammonia in##3##5##(2008-10#3)
the determination of ammonium ion##2##5##(2008-10#2)
the determination of ammonium##4##4##(2008-10#4)
the determination of an##3##4##(2008-10#3)
the determination of analytes in##2##5##(2008-10#2)
the determination of anionic surfactants in river water##2##8##(2008-10#2)
the determination of anionic surfactants in##3##6##(2008-10#3)
the determination of anionic##5##4##(2008-10#5)
the determination of antimony by hydride generation##2##7##(2008-10#2)
the determination of antimony by##4##5##(2008-10#4)
the determination of antimony in##3##5##(2008-10#3)
the determination of antimony##8##4##(2008-10#8)
the determination of arsenic in##7##5##(2008-10#7)
the determination of arsenic##11##4##(2008-10#11)
the determination of ascorbic acid in##3##6##(2008-10#3)
the determination of ascorbic acid##9##5##(2008-10#9)
the determination of benzo[a]pyrene##4##4##(2008-10#4)
the determination of bismuth in##2##5##(2008-10#2)
the determination of bismuth##4##4##(2008-10#4)
the determination of boron in##3##5##(2008-10#3)
the determination of boron##5##4##(2008-10#5)
the determination of both##5##4##(2008-10#5)
the determination of bromide in seawater##3##6##(2008-10#3)
the determination of bromide in##4##5##(2008-10#4)
the determination of bromide##7##4##(2008-10#7)
the determination of cadmium and##3##5##(2008-10#3)
the determination of cadmium in##8##5##(2008-10#8)
the determination of cadmium##16##4##(2008-10#16)
the determination of calcium and magnesium##2##6##(2008-10#2)
the determination of calcium##4##4##(2008-10#4)
the determination of cationic polyelectrolytes such as poly (diallyldimethylammonium chloride) (Cat-floc) by##2##12##(2008-10#2)
the determination of cationic##3##4##(2008-10#3)
the determination of cefadroxil##3##4##(2008-10#3)
the determination of cefixime##2##4##(2008-10#2)
the determination of chlorate##2##4##(2008-10#2)
the determination of chloride in##4##5##(2008-10#4)
the determination of chloride##7##4##(2008-10#7)
the determination of chromium in##5##5##(2008-10#5)
the determination of chromium##12##4##(2008-10#12)
the determination of chromium(VI) in##3##5##(2008-10#3)
the determination of chromium(VI)##4##4##(2008-10#4)
the determination of ciprofloxacin in##3##5##(2008-10#3)
the determination of ciprofloxacin##4##4##(2008-10#4)
the determination of cobalt and##2##5##(2008-10#2)
the determination of cobalt in##5##5##(2008-10#5)
the determination of cobalt##12##4##(2008-10#12)
the determination of copper in the##2##6##(2008-10#2)
the determination of copper in##8##5##(2008-10#8)
the determination of copper##18##4##(2008-10#18)
the determination of creatinine##2##4##(2008-10#2)
the determination of cyanide in##2##5##(2008-10#2)
the determination of cyanide##4##4##(2008-10#4)
the determination of dimethyltin chloride##2##5##(2008-10#2)
the determination of dissolved silver##3##5##(2008-10#3)
the determination of dissolved##8##4##(2008-10#8)
the determination of dopamine in injection##2##6##(2008-10#2)
the determination of dopamine in##3##5##(2008-10#3)
the determination of dopamine##7##4##(2008-10#7)
the determination of doxycycline hydrochloride##3##5##(2008-10#3)
the determination of electroosmotic mobility##2##5##(2008-10#2)
the determination of fluoride in##3##5##(2008-10#3)
the determination of fluoride##6##4##(2008-10#6)
the determination of fluoxetine##2##4##(2008-10#2)
the determination of formaldehyde in##2##5##(2008-10#2)
the determination of formaldehyde##3##4##(2008-10#3)
the determination of free ammonium and##2##6##(2008-10#2)
the determination of free##3##4##(2008-10#3)
the determination of gallium##3##4##(2008-10#3)
the determination of gentamycin##2##4##(2008-10#2)
the determination of glucose in the##2##6##(2008-10#2)
the determination of glucose in##8##5##(2008-10#8)
the determination of glucose##10##4##(2008-10#10)
the determination of hydrazine##6##4##(2008-10#6)
the determination of hydrochlorothiazide##2##4##(2008-10#2)
the determination of hydrogen peroxide in rainwater##3##7##(2008-10#3)
the determination of hydrogen peroxide in##5##6##(2008-10#5)
the determination of hydrogen peroxide##11##5##(2008-10#11)
the determination of hydrogen##12##4##(2008-10#12)
the determination of hydroquinone in photographic developers##2##7##(2008-10#2)
the determination of hydroquinone in##3##5##(2008-10#3)
the determination of indium##2##4##(2008-10#2)
the determination of iodate and iodide##2##6##(2008-10#2)
the determination of iodide in##2##5##(2008-10#2)
the determination of iodide##3##4##(2008-10#3)
the determination of iridium in##2##5##(2008-10#2)
the determination of iron and##2##5##(2008-10#2)
the determination of iron in##9##5##(2008-10#9)
the determination of iron##16##4##(2008-10#16)
the determination of lactic acid in##2##6##(2008-10#2)
the determination of lead in##15##5##(2008-10#15)
the determination of lead isotope ratios in wine##2##8##(2008-10#2)
the determination of lead##23##4##(2008-10#23)
the determination of lead(II)##5##4##(2008-10#5)
the determination of lithium##2##4##(2008-10#2)
the determination of low levels##2##5##(2008-10#2)
the determination of low##5##4##(2008-10#5)
the determination of magnesium##2##4##(2008-10#2)
the determination of manganese in##4##5##(2008-10#4)
the determination of manganese##6##4##(2008-10#6)
the determination of manganese(II)##5##4##(2008-10#5)
the determination of mercury in##3##5##(2008-10#3)
the determination of mercury##8##4##(2008-10#8)
the determination of mercury(II)##2##4##(2008-10#2)
the determination of methionine##2##4##(2008-10#2)
the determination of metoclopramide##2##4##(2008-10#2)
the determination of metrifonate##2##4##(2008-10#2)
the determination of minoxidil##2##4##(2008-10#2)
the determination of molybdenum in##4##5##(2008-10#4)
the determination of molybdenum##10##4##(2008-10#10)
the determination of naproxen##3##4##(2008-10#3)
the determination of nickel in##6##5##(2008-10#6)
the determination of nickel##9##4##(2008-10#9)
the determination of nitrate and##2##5##(2008-10#2)
the determination of nitrate in##3##5##(2008-10#3)
the determination of nitrate##6##4##(2008-10#6)
the determination of nitrite in the##2##6##(2008-10#2)
the determination of nitrite in##8##5##(2008-10#8)
the determination of nitrite##17##4##(2008-10#16)(2008-11#1)
the determination of nitrogen oxides##2##5##(2008-10#2)
the determination of nitrogen##3##4##(2008-10#3)
the determination of nucleic acids##4##5##(2008-10#4)
the determination of ofloxacin in##2##5##(2008-10#2)
the determination of orthophosphate in##2##5##(2008-10#2)
the determination of orthophosphate##3##4##(2008-10#3)
the determination of oxalate##2##4##(2008-10#2)
the determination of oxidizable##2##4##(2008-10#2)
the determination of paracetamol in pharmaceuticals##2##6##(2008-10#2)
the determination of paracetamol in##4##5##(2008-10#4)
the determination of paraquat in##2##5##(2008-10#2)
the determination of paraquat##5##4##(2008-10#5)
the determination of partition coefficients of drugs##2##7##(2008-10#2)
the determination of partition coefficients##3##5##(2008-10#3)
the determination of perchlorate in##3##5##(2008-10#3)
the determination of periodate and iodate##2##6##(2008-10#2)
the determination of perphenazine in##2##5##(2008-10#2)
the determination of perphenazine##3##4##(2008-10#3)
the determination of phenols##2##4##(2008-10#2)
the determination of phosphate##2##4##(2008-10#2)
the determination of phosphatidylcholine in sediment##2##6##(2008-10#2)
the determination of phosphatidylcholine##3##4##(2008-10#3)
the determination of phosphorus by##2##5##(2008-10#2)
the determination of phosphorus species##3##5##(2008-10#3)
the determination of phosphorus##8##4##(2008-10#8)
the determination of piroxicam##3##4##(2008-10#3)
the determination of plasma##2##4##(1991-3#1)(1994-8#1)
the determination of platinum##4##4##(2008-10#4)
the determination of polychlorinated##2##4##(2008-10#2)
the determination of potassium##2##4##(2008-10#2)
the determination of procaine hydrochloride##2##5##(2008-10#2)
the determination of protein in##2##5##(2008-10#2)
the determination of protein##5##4##(1990-12#1)(2008-10#3)(2008-4#1)
the determination of proteins in##2##5##(2008-10#2)
the determination of proteins with##3##5##(2008-10#3)
the determination of proteins##7##4##(2008-10#7)
the determination of psilocin and psilocybin##2##6##(2008-10#2)
the determination of pyridoxine hydrochloride##2##5##(2008-10#2)
the determination of rhodium in##2##5##(2008-10#2)
the determination of rhodium##5##4##(2008-10#5)
the determination of rubidate in##2##5##(2008-10#2)
the determination of rutin in##2##5##(2008-10#2)
the determination of rutin##3##4##(2008-10#3)
the determination of salbutamol##2##4##(2008-10#2)
the determination of salsalate in##2##5##(2008-10#2)
the determination of salsalate##3##4##(2008-10#3)
the determination of scandium##2##4##(2008-10#2)
the determination of selenium in##2##5##(2008-10#2)
the determination of selenium##5##4##(2008-10#5)
the determination of several##3##4##(2008-10#3)
the determination of silicate##2##4##(2008-10#2)
the determination of silicon##2##4##(2008-10#2)
the determination of silver in##4##5##(2008-10#4)
the determination of silver##5##4##(2008-10#5)
the determination of silver(I)##3##4##(2008-10#3)
the determination of sodium##5##4##(2008-10#5)
the determination of soluble##2##4##(2008-10#2)
the determination of studied##2##4##(2008-10#2)
the determination of sucrose##2##4##(2008-10#2)
the determination of sulfide in##4##5##(2008-10#4)
the determination of sulfide##5##4##(2008-10#5)
the determination of sulfite in##3##5##(2008-10#3)
the determination of sulfite##5##4##(2008-10#5)
the determination of terbium##3##4##(2008-10#3)
the determination of thallium##6##4##(1991-12#2)(2008-10#4)
the determination of the above mentioned##2##6##(2008-10#2)
the determination of the above##4##5##(2008-10#4)
the determination of the analyte in a##2##7##(2008-10#2)
the determination of the analyte##4##5##(2008-10#4)
the determination of the drug in capsules and##2##8##(2008-10#2)
the determination of the drug in##6##6##(2008-10#6)
the determination of the drug##7##5##(2008-10#7)
the determination of the drugs in##4##6##(2008-10#4)
the determination of the four##3##5##(2008-10#3)
the determination of the inclusion constant##2##6##(2008-10#2)
the determination of the investigated##3##5##(2008-10#3)
the determination of the levels of##2##6##(2008-10#1)(2011-2#1)
the determination of the metal##2##5##(2008-10#2)
the determination of the studied##3##5##(2008-10#3)
the determination of the surfactant##2##5##(2008-10#2)
the determination of the trace##2##5##(2008-10#2)
the determination of the##120##4##(1990-12#2)(1991-7#1)(1993-1#1)(1995-11#1)(1996-11#1)(1997-1#1)(2008-10#104)(2008-11#2)(2008-12#2)(2009-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
the determination of their##2##4##(1995-6#1)(2008-10#1)
the determination of these antioxidants##2##5##(2008-10#2)
the determination of these catecholamines##2##5##(2008-10#2)
the determination of these compounds##6##5##(2008-10#6)
the determination of these ions##3##5##(2008-10#3)
the determination of these parameters##2##5##(2008-10#2)
the determination of these##28##4##(2008-10#28)
the determination of thiamine in pharmaceutical##2##6##(2008-10#2)
the determination of thiamine##4##4##(2008-10#4)
the determination of this##5##4##(2008-10#5)
the determination of thorium##2##4##(2008-10#2)
the determination of three##5##4##(2008-10#5)
the determination of tin##3##4##(2008-10#3)
the determination of total arsenic##3##5##(2008-10#3)
the determination of total iron##2##5##(2008-10#2)
the determination of total sulfur##3##5##(2008-10#3)
the determination of total##32##4##(2008-10#32)
the determination of trace Cd and Pb##2##7##(2008-10#2)
the determination of trace amount of##12##6##(2008-10#12)
the determination of trace amounts of lead##2##7##(2008-10#2)
the determination of trace amounts of##32##6##(2008-10#32)
the determination of trace cobalt##3##5##(2008-10#3)
the determination of trace levels of##7##6##(2008-10#7)
the determination of trace manganese##3##5##(2008-10#3)
the determination of trace mercury##3##5##(2008-10#3)
the determination of trace metals in##3##6##(2008-10#3)
the determination of trace metals##6##5##(2008-10#6)
the determination of trace nitrite in##2##6##(2008-10#2)
the determination of trace##103##4##(2008-10#102)(2011-2#1)
the determination of trihalomethanes##2##4##(2008-10#2)
the determination of trimethylamine##2##4##(2008-10#2)
the determination of tungsten in##3##5##(2008-10#3)
the determination of tungsten##4##4##(2008-10#4)
the determination of uptake rates##2##5##(2008-10#2)
the determination of uranium in##4##5##(2008-10#4)
the determination of uranium##6##4##(2008-10#6)
the determination of urea##2##4##(2008-10#2)
the determination of uric acid##4##5##(2008-10#4)
the determination of vanadium in##10##5##(2008-10#10)
the determination of vanadium##16##4##(2008-10#16)
the determination of vitamin##3##4##(2008-10#3)
the determination of yperites##2##4##(2008-10#2)
the determination of zinc and nickel##2##6##(2008-10#2)
the determination of zinc in##2##5##(2008-10#2)
the determination of zinc##7##4##(2008-10#7)
the determination of##1678##3##(1990-12#6)(1990-2#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#1614)(2008-11#10)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
the determination range##2##3##(2008-10#2)
the determination was performed##2##4##(2008-10#2)
the determination was##12##3##(2008-10#12)
the determination were investigated##2##4##(2008-10#2)
the determination were##3##3##(2008-10#3)
the determination##1747##2##(1990-12#6)(1990-2#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#1679)(2008-11#10)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
the determinations of##7##3##(2008-10#7)
the determinations##15##2##(2008-10#15)
the determined and foreign ions##2##5##(2008-10#2)
the determined values##5##3##(2008-10#5)
the determined##20##2##(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#15)(2008-8#1)(2010-12#1)
the deterministic##2##2##(2008-8#1)(2008-9#1)
the detoxification of##2##3##(2008-10#1)(2008-11#1)
the detoxification##3##2##(2008-10#2)(2008-11#1)
the detrimental effect of##2##4##(2008-10#1)(2008-11#1)
the detrimental##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
the deuterium##2##2##(1996-5#1)(2008-10#1)
the developed method are##3##4##(2008-10#3)
the developed method is##3##4##(2008-10#3)
the developed method was##7##4##(2008-10#7)
the developed method##38##3##(2008-10#37)(2012-12#1)
the developed methodology was##2##4##(2008-10#2)
the developed methodology##3##3##(2008-10#2)(2011-2#1)
the developed methods##2##3##(2008-10#2)
the developed model##2##3##(2008-10#1)(2009-3#1)
the developed procedure##6##3##(2008-10#6)
the developed system##4##3##(2008-10#2)(2010-10#1)(2010-8#1)
the developed world##3##3##(1994-9#1)(2008-10#1)(2010-12#1)
the developed##92##2##(1994-9#1)(1997-7#2)(2008-10#76)(2008-3#1)(2008-5#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
the developers##2##2##(1994-1#1)(1995-2#1)
the developing fruit##3##3##(2008-10#3)
the developing human##2##3##(1991-7#1)(2008-7#1)
the developing limb##4##3##(2008-11#3)(2009-3#1)
the developing lung##2##3##(1991-12#1)(2009-9#1)
the developing rodent brain##2##4##(1994-2#1)(2008-7#1)
the developing world##8##3##(1997-7#3)(2008-12#1)(2010-12#1)(2011-2#1)(2013-8#2)
the developing##63##2##(1991-12#1)(1991-7#1)(1993-12#1)(1994-2#3)(1994-8#1)(1995-12#4)(1996-12#3)(1997-3#1)(1997-7#3)(1997-9#2)(2007-12#4)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
the development and assessment of##2##5##(2008-11#1)(2011-8#1)
the development and characterization of a##2##6##(2008-3#1)(2013-1#1)
the development and evaluation of a##3##6##(2008-11#1)(2008-12#2)
the development and implementation of##6##5##(1993-3#1)(1994-2#2)(2008-11#3)
the development and maintenance of##3##5##(2008-12#1)(2008-4#1)(2011-2#1)
the development and maintenance##4##4##(2008-12#1)(2008-4#1)(2011-2#2)
the development and perpetuation of##3##5##(2008-12#3)
the development and progression of##4##5##(2008-10#1)(2011-2#1)(2013-1#2)
the development and use of##5##5##(1992-1#1)(1993-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
the development and validation of a##2##6##(2008-10#1)(2008-5#1)
the development and##53##3##(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-2#2)(1995-9#1)(1996-2#2)(2008-10#10)(2008-11#7)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2011-2#5)(2011-8#1)(2012-12#1)(2013-1#5)(2013-8#1)
the development in##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
the development is##2##3##(2008-10#2)
the development of DME and retinal NV##2##7##(2008-1#2)
the development of FHB##2##4##(2011-10#2)
the development of a capillary electrophoresis method for the##2##9##(2008-10#2)
the development of a capillary##3##5##(2008-10#3)
the development of a highly##2##5##(2008-10#1)(2008-3#1)
the development of a marketing plan will provide a strategy that will keep the medical group competitive among older consumers##2##20##(1994-3#2)
the development of a more##4##5##(1994-11#1)(1997-2#1)(2008-11#1)(2010-8#1)
the development of a new##8##5##(1996-3#1)(1997-4#1)(2008-10#5)(2008-5#1)
the development of a shared##2##5##(1993-12#1)(2008-11#1)
the development of a successful##2##5##(2008-10#1)(2010-10#1)
the development of a vaccine##2##5##(1997-7#1)(2011-2#1)
the development of a##93##4##(1992-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#4)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#33)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#2)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the development of alternative##3##4##(1997-1#1)(1997-7#1)(2008-10#1)
the development of an in##2##5##(1990-12#1)(2008-3#1)
the development of an integrated##2##5##(2008-10#2)
the development of an##23##4##(1990-12#1)(1991-1#1)(1993-12#1)(1993-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(2008-10#8)(2008-11#2)(2008-3#3)(2012-2#1)(2013-1#2)
the development of analytical methods for the determination of rhodium has increased##2##12##(2008-10#2)
the development of analytical##4##4##(2008-10#3)(2011-2#1)
the development of animal##3##4##(1992-9#1)(2008-11#1)(2011-2#1)
the development of arterial hypertension in##2##6##(2011-2#2)
the development of atrial##2##4##(2012-12#2)
the development of autism##2##4##(2012-3#2)
the development of autoimmune##2##4##(2008-10#2)
the development of autoimmunity##3##4##(2008-10#2)(2010-5#1)
the development of both##2##4##(1991-8#1)(1992-12#1)
the development of case##2##4##(1995-2#1)(2008-11#1)
the development of chronic##3##4##(2008-10#1)(2010-10#1)(2011-2#1)
the development of clinical##7##4##(1993-12#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
the development of competencies##2##4##(2008-12#1)(2012-3#1)
the development of competent practitioners##2##5##(2008-11#1)(2008-12#1)
the development of early##3##4##(1992-12#1)(1994-2#1)(2008-10#1)
the development of educational##2##4##(2008-1#1)(2008-12#1)
the development of effective##2##4##(2008-10#1)(2008-4#1)
the development of further##2##4##(2008-11#1)(2008-5#1)
the development of future##2##4##(2008-7#1)(2011-2#1)
the development of gastric##2##4##(1995-2#1)(2008-12#1)
the development of highly sensitive##2##5##(2008-10#1)(2010-7#1)
the development of improved##2##4##(2008-11#1)(2011-2#1)
the development of latent##2##4##(2008-5#1)(2012-2#1)
the development of lesions##3##4##(2008-10#2)(2010-12#1)
the development of long-term potentiation##2##5##(1990-5#2)
the development of medical##3##4##(1993-2#1)(2010-1#1)(2012-3#1)
the development of molecular##2##4##(2008-10#2)
the development of more accurate##2##5##(2008-3#1)(2008-5#1)
the development of more##10##4##(1994-5#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-2#1)
the development of motor complications##2##5##(2010-12#2)
the development of multiple##2##4##(2008-10#1)(2013-1#1)
the development of nanosensors##2##4##(2008-10#2)
the development of new methods##2##5##(1997-1#1)(2008-10#1)
the development of new programs##2##5##(1992-1#1)(1994-1#1)
the development of new strategies and##2##6##(2008-11#1)(2011-10#1)
the development of new strategies##5##5##(1997-8#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-10#1)
the development of new##32##4##(1991-12#1)(1992-1#1)(1993-3#1)(1994-1#1)(1994-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-10#1)(2011-2#1)
the development of novel cancer##2##5##(2010-5#1)(2011-2#1)
the development of novel##13##4##(2008-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
the development of nursing##2##4##(2008-12#2)
the development of one of##2##5##(2008-10#2)
the development of our##2##4##(1997-8#1)(2012-2#1)
the development of patient-based measurement systems##2##6##(1994-3#2)
the development of periodic##2##4##(2008-10#2)
the development of policies##2##4##(1996-1#1)(2010-7#1)
the development of preeclampsia##2##4##(2008-11#2)
the development of programs##2##4##(1995-3#1)(2008-1#1)
the development of pulmonary##2##4##(1994-8#1)(2009-5#1)
the development of rapid##2##4##(2008-10#2)
the development of reflective##2##4##(2008-12#2)
the development of resistance##4##4##(1994-8#1)(2008-5#1)(2011-3#1)(2012-3#1)
the development of robust##3##4##(2008-10#2)(2008-7#1)
the development of several##2##4##(2008-12#1)(2010-7#1)
the development of sexual##2##4##(2008-7#1)(2012-3#1)
the development of significant##2##4##(2008-10#1)(2008-7#1)
the development of skills##2##4##(1990-12#1)(2011-2#1)
the development of specific##4##4##(1994-1#1)(2008-10#2)(2010-11#1)
the development of stable##2##4##(2008-11#1)(2008-5#1)
the development of strategies##2##4##(1994-3#1)(2010-11#1)
the development of such##2##4##(1995-3#1)(1996-11#1)
the development of the Georgia system##2##6##(1996-12#2)
the development of the immune##2##5##(1993-12#1)(1995-12#1)
the development of the reaction between##3##6##(2008-10#3)
the development of the##52##4##(1992-6#1)(1993-12#1)(1995-12#2)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-6#1)(2008-10#14)(2008-11#5)(2008-12#5)(2008-3#3)(2008-4#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)
the development of their##3##4##(1990-12#1)(2008-11#1)(2008-12#1)
the development of therapeutic##2##4##(1990-6#1)(2009-6#1)
the development of these##6##4##(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2011-7#1)
the development of this##8##4##(1994-6#1)(1995-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
the development of type 2 diabetes##2##6##(2008-1#1)(2008-11#1)
the development of various##2##4##(2012-2#1)(2013-8#1)
the development of vascular##3##4##(1996-12#1)(2008-9#1)(2009-1#1)
the development of##717##3##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#3)(1990-6#2)(1991-1#1)(1991-12#3)(1991-2#3)(1991-6#1)(1991-8#2)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#8)(1993-2#1)(1993-3#3)(1994-1#3)(1994-11#2)(1994-12#8)(1994-2#4)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#7)(1996-6#2)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#7)(2006-6#2)(2008-1#9)(2008-10#158)(2008-11#77)(2008-12#29)(2008-2#1)(2008-3#9)(2008-4#11)(2008-5#15)(2008-6#1)(2008-7#13)(2008-8#6)(2008-9#15)(2009-1#3)(2009-10#3)(2009-12#4)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#9)(2009-8#2)(2009-9#1)(2010-1#7)(2010-10#2)(2010-11#8)(2010-12#12)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#6)(2010-8#4)(2010-9#3)(2011-1#2)(2011-10#3)(2011-2#44)(2011-3#6)(2011-7#3)(2012-12#9)(2012-2#19)(2012-3#16)(2012-4#1)(2012-5#2)(2013-1#20)(2013-7#2)(2013-8#13)
the development##794##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#3)(1990-6#2)(1991-1#1)(1991-12#3)(1991-2#3)(1991-6#1)(1991-8#2)(1992-1#4)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#9)(1993-2#1)(1993-3#4)(1994-1#3)(1994-11#2)(1994-12#8)(1994-2#6)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#4)(1996-12#4)(1996-2#6)(1996-3#7)(1996-6#2)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#7)(2006-6#2)(2008-1#9)(2008-10#178)(2008-11#87)(2008-12#37)(2008-2#1)(2008-3#10)(2008-4#13)(2008-5#18)(2008-6#2)(2008-7#14)(2008-8#7)(2008-9#16)(2009-1#3)(2009-10#3)(2009-12#4)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#10)(2009-8#2)(2009-9#1)(2010-1#7)(2010-10#2)(2010-11#8)(2010-12#12)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#6)(2010-8#5)(2010-9#3)(2011-1#2)(2011-10#3)(2011-2#49)(2011-3#6)(2011-7#3)(2011-8#1)(2012-12#10)(2012-2#19)(2012-3#17)(2012-4#1)(2012-5#2)(2013-1#25)(2013-7#2)(2013-8#16)
the developmental periods##2##3##(2009-11#1)(2011-2#1)
the developmental stages##3##3##(1994-9#1)(2008-10#1)(2008-8#1)
the developmental toxicity##2##3##(1993-12#1)(2010-1#1)
the developmental##30##2##(1991-6#1)(1991-8#1)(1992-12#1)(1993-12#2)(1994-9#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#1)
the developmentally disabled##2##3##(1997-6#1)(2008-12#1)
the developmentally regulated##2##3##(1995-8#1)(2008-10#1)
the developmentally##5##2##(1992-12#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-12#1)
the developments in##7##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
the deviance##3##2##(1994-9#2)(1996-3#1)
the deviation##5##2##(2008-10#3)(2008-3#2)
the deviations##4##2##(2008-10#3)(2008-3#1)
the device and##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
the device is##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
the device sensitivity##2##3##(2009-5#2)
the device to##2##3##(2007-11#1)(2008-11#1)
the device was##3##3##(1994-9#1)(2008-10#1)(2008-9#1)
the device##48##2##(1991-12#1)(1994-9#2)(1996-2#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-2#1)(2008-3#4)(2008-9#5)(2009-10#1)(2009-5#2)(2010-6#4)(2010-7#2)(2012-3#1)(2013-1#1)
the device's##2##2##(2007-11#1)(2011-7#1)
the devices were##2##3##(1993-12#1)(2008-9#1)
the devices##7##2##(1993-12#2)(1996-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
the dextran##2##2##(2008-10#2)
the diabetes##6##2##(1993-11#1)(1996-11#3)(2008-1#1)(2008-10#1)
the diabetic patient##2##3##(2008-7#1)(2012-2#1)
the diabetic patients##3##3##(1991-12#1)(1993-11#1)(2013-1#1)
the diabetic rats##2##3##(1994-11#1)(1994-8#1)
the diabetic retinal microvascular environment##2##5##(2012-4#2)
the diabetic##18##2##(1990-3#1)(1991-12#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(2008-1#2)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#3)(2012-4#2)(2013-1#1)
the diafiltration buffer pH for##2##5##(2011-2#2)
the diafiltration buffer##3##3##(2011-2#3)
the diafiltration##4##2##(2011-2#4)
the diagnoses##5##2##(1990-12#1)(1994-6#1)(1995-11#1)(2008-11#1)(2012-12#1)
the diagnosis and follow-up of patients with##2##7##(2012-2#2)
the diagnosis and follow-up of##5##5##(2011-1#1)(2011-2#1)(2012-2#3)
the diagnosis and management of a##2##6##(2008-12#2)
the diagnosis and management of neovascular age-related macular degeneration##2##9##(2011-7#2)
the diagnosis and management of##17##5##(1992-5#1)(2008-12#3)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#2)(2011-2#3)(2011-7#5)
the diagnosis and monitoring of##2##5##(2008-5#1)(2013-1#1)
the diagnosis and prognosis of##3##5##(1995-9#1)(2008-11#1)(2008-4#1)
the diagnosis and the##5##4##(1991-3#1)(1993-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
the diagnosis and treatment of this##4##6##(1992-5#1)(2010-12#1)(2011-7#1)(2013-1#1)
the diagnosis and treatment of##13##5##(1992-2#1)(1992-3#1)(1992-5#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#2)(2011-7#2)(2013-1#2)
the diagnosis and treatment##14##4##(1992-2#1)(1992-3#1)(1992-5#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-7#2)(2013-1#2)
the diagnosis and##56##3##(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-6#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#3)(2009-10#1)(2009-4#1)(2010-12#6)(2010-5#1)(2011-1#1)(2011-2#5)(2011-7#7)(2012-12#2)(2012-2#4)(2013-1#4)
the diagnosis are##3##3##(1997-8#1)(2013-1#2)
the diagnosis can##2##3##(2010-8#1)(2012-12#1)
the diagnosis in##2##3##(2008-5#1)(2011-2#1)
the diagnosis is##7##3##(1990-12#1)(1991-2#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#2)
the diagnosis of M##2##4##(2008-5#1)(2011-2#1)
the diagnosis of a##4##4##(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
the diagnosis of acute##4##4##(1994-9#1)(2008-3#1)(2008-9#1)(2013-1#1)
the diagnosis of an##2##4##(2012-3#2)
the diagnosis of coronary artery##2##5##(2008-11#1)(2012-2#1)
the diagnosis of early##2##4##(1991-12#1)(2008-5#1)
the diagnosis of invasive##2##4##(2011-2#1)(2013-1#1)
the diagnosis of primary##2##4##(2013-1#2)
the diagnosis of pulmonary##2##4##(1991-11#1)(2008-10#1)
the diagnosis of renal##2##4##(1990-9#1)(2011-2#1)
the diagnosis of the##3##4##(1990-3#1)(2008-12#1)(2011-2#1)
the diagnosis of these##2##4##(1990-5#1)(2012-2#1)
the diagnosis of this##2##4##(1997-8#1)(2008-8#1)
the diagnosis of tuberculosis##2##4##(2008-12#1)(2013-1#1)
the diagnosis of##116##3##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-3#4)(1992-9#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-11#3)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#4)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-3#3)(2010-6#3)(2010-7#1)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#17)(2013-8#2)
the diagnosis was confirmed##3##4##(2008-7#1)(2010-12#1)(2010-5#1)
the diagnosis was##11##3##(1990-3#2)(2008-7#2)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
the diagnosis##240##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#5)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-9#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-9#1)(1996-11#4)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#7)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-8#2)(2010-1#2)(2010-12#10)(2010-3#3)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#27)(2011-3#1)(2011-7#7)(2012-12#8)(2012-2#14)(2012-3#7)(2013-1#29)(2013-8#4)
the diagnostic accuracy of##4##4##(2008-12#1)(2009-11#1)(2012-2#1)(2013-1#1)
the diagnostic and therapeutic##2##4##(2008-10#1)(2008-12#1)
the diagnostic and##3##3##(2008-10#1)(2008-12#1)(2011-3#1)
the diagnostic approach##2##3##(1992-9#1)(2008-1#1)
the diagnostic armamentarium##2##3##(1996-1#1)(2011-2#1)
the diagnostic criteria for##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
the diagnostic criteria##6##3##(1994-12#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
the diagnostic evaluation##2##3##(1992-12#1)(2013-1#1)
the diagnostic procedures##3##3##(1997-4#1)(2008-5#1)(2008-7#1)
the diagnostic process##3##3##(1990-9#1)(2008-10#1)(2013-1#1)
the diagnostic utility of##2##4##(2008-12#2)
the diagnostic value of##2##4##(1991-6#1)(1996-3#1)
the diagnostic workup##2##3##(1992-1#1)(2012-2#1)
the diagnostic yield of##3##4##(2010-12#1)(2011-2#2)
the diagnostic yield##5##3##(1997-8#1)(2010-12#1)(2011-2#3)
the diagnostic##64##2##(1990-2#1)(1990-9#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#3)(1997-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#1)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#5)(2013-1#7)
the diagnostics of##2##3##(1990-5#1)(2007-11#1)
the diagrams##2##2##(1993-2#1)(2008-10#1)
the dialysate from the##2##4##(2008-10#2)
the dialysate##6##2##(2008-10#5)(2011-2#1)
the dialysis##8##2##(1996-12#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)
the diamagnetic##2##2##(1994-5#1)(2008-9#1)
the diameter of the##2##4##(2008-2#1)(2013-1#1)
the diameter of##4##3##(2008-10#1)(2008-2#1)(2012-2#1)(2013-1#1)
the diameter##9##2##(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the diameters##2##2##(1990-6#1)(2008-10#1)
the diamond##4##2##(2008-10#3)(2008-3#1)
the diaphragm and##3##3##(1990-2#1)(2010-9#1)(2012-2#1)
the diaphragm##13##2##(1990-2#2)(1990-5#1)(1991-3#1)(1991-8#1)(1993-6#1)(2008-11#1)(2009-6#1)(2010-5#2)(2010-9#1)(2012-2#1)(2013-1#1)
the diastolic##4##2##(1996-6#2)(2008-10#1)(2008-8#1)
the diauxic growth pattern##2##4##(2008-7#2)
the diazepam-insensitive site##2##3##(1995-11#2)
the dichloromethane fraction##3##3##(2008-11#3)
the dichotomous##2##2##(1996-2#1)(2009-12#1)
the dichotomy##2##2##(2008-4#1)(2008-6#1)
the dielectric##6##2##(1993-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2013-1#1)
the diet is##2##3##(2008-10#1)(2008-9#1)
the diet of##4##3##(1994-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
the diet##15##2##(1990-8#1)(1991-2#2)(1991-6#1)(1993-12#1)(1994-8#1)(2008-10#2)(2008-9#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
the dietary fiber##2##3##(1993-11#1)(2010-8#1)
the dietary##10##2##(1990-6#1)(1990-8#1)(1993-11#1)(1994-12#1)(2008-10#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
the diethyl##2##2##(2008-10#1)(2010-5#1)
the dietitian##3##2##(1993-12#3)
the diets##3##2##(1993-11#1)(2010-8#1)(2011-2#1)
the difference and##2##3##(2008-10#1)(2008-9#1)
the difference between the groups##2##5##(1991-2#1)(2008-7#1)
the difference between the two##3##5##(1996-6#1)(2008-10#1)(2008-9#1)
the difference between the##21##4##(1990-5#1)(1991-2#1)(1991-6#1)(1993-2#1)(1994-9#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2013-8#1)
the difference between total inorganic##2##5##(2008-10#2)
the difference between total##3##4##(2008-10#3)
the difference between##36##3##(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-6#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#1)(2013-8#2)
the difference in log K(ex)##2##5##(2008-10#2)
the difference in the##11##4##(1997-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
the difference in##39##3##(1990-11#1)(1992-12#1)(1992-9#1)(1993-12#2)(1997-2#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
the difference of the##2##4##(2008-10#1)(2008-3#1)
the difference of##11##3##(1990-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#3)(2010-7#1)(2011-2#1)(2013-8#1)
the difference was not significant##2##5##(2008-10#1)(2013-1#1)
the difference was##4##3##(2008-10#3)(2013-1#1)
the difference##104##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#2)(1994-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#39)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the differences among##2##3##(2008-10#1)(2009-1#1)
the differences between the two##2##5##(2008-8#1)(2013-8#1)
the differences between the##4##4##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
the differences between these##2##4##(2008-10#1)(2013-8#1)
the differences between##23##3##(1990-2#1)(1991-11#1)(1994-8#1)(1996-1#1)(1997-6#1)(2008-10#6)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
the differences in the##11##4##(1991-9#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-9#1)
the differences in their##2##4##(2008-10#1)(2013-8#1)
the differences in##37##3##(1991-9#1)(1992-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#2)
the differences observed in##2##4##(1997-9#1)(2013-8#1)
the differences observed##3##3##(1997-9#1)(2008-5#1)(2013-8#1)
the differences of##4##3##(2008-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
the differences##81##2##(1990-2#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-9#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#6)
the different areas of##2##4##(2008-10#1)(2009-10#1)
the different aspects of##3##4##(2008-11#1)(2013-1#2)
the different cell cycle##2##4##(1995-9#1)(2008-11#1)
the different cell##3##3##(1995-9#1)(2008-11#2)
the different classes of##3##4##(1997-6#1)(2008-10#1)(2012-12#1)
the different classes##4##3##(1997-6#1)(2008-10#2)(2012-12#1)
the different components of##2##4##(2008-10#1)(2008-8#1)
the different concentration##2##3##(2008-10#2)
the different countries##2##3##(1990-11#1)(2008-10#1)
the different detection##2##3##(2008-10#2)
the different factors##4##3##(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)
the different forms##3##3##(1990-12#2)(1990-5#1)
the different groups##4##3##(1993-8#1)(1996-12#1)(2008-10#1)(2013-1#1)
the different methods##4##3##(1991-3#1)(2008-10#3)
the different mobility species##2##4##(1991-7#2)
the different parameters##2##3##(1990-9#1)(2008-10#1)
the different phases##2##3##(2008-10#1)(2013-1#1)
the different plant##2##3##(2008-10#2)
the different species##8##3##(2008-10#7)(2008-8#1)
the different stages of##2##4##(2008-11#1)(2011-2#1)
the different techniques available##3##4##(2008-10#2)(2009-12#1)
the different treatments##2##3##(2008-10#2)
the different types of##8##4##(1993-8#1)(1996-9#1)(2008-10#2)(2008-5#1)(2012-2#1)(2012-8#1)(2013-1#1)
the different types##9##3##(1993-8#1)(1996-9#1)(2008-10#3)(2008-5#1)(2012-2#1)(2012-8#1)(2013-1#1)
the different##265##2##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#3)(1990-9#4)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-6#1)(1995-12#2)(1995-9#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#121)(2008-11#17)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#7)(2008-7#5)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2012-8#1)(2012-9#1)(2013-1#8)(2013-8#4)
the differential absorption##2##3##(2008-3#2)
the differential cultivars##2##3##(2008-10#2)
the differential determination of##2##4##(2008-10#2)
the differential diagnosis of##33##4##(1990-2#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-6#1)(1992-2#1)(1996-11#2)(1996-3#1)(1997-3#1)(1997-7#1)(2008-12#2)(2008-5#3)(2009-1#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the differential diagnosis##47##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-2#2)(1993-8#1)(1996-11#2)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#3)(2009-1#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
the differential effect of##4##4##(2008-10#2)(2010-1#1)(2013-1#1)
the differential expression of the##2##5##(1993-12#1)(1997-7#1)
the differential expression of##3##4##(1992-10#1)(1993-12#1)(1997-7#1)
the differential hosts##3##3##(2008-10#3)
the differential pressure##3##3##(2008-10#3)
the differential pulse voltammetry (DPV)##3##5##(2008-10#3)
the differential pulse##10##3##(2008-10#10)
the differential##111##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-8#1)(1995-8#1)(1996-11#2)(1996-3#2)(1997-3#1)(1997-7#2)(2007-11#1)(2007-12#4)(2008-10#34)(2008-11#3)(2008-12#2)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
the differentially expressed##4##3##(2008-8#1)(2011-3#3)
the differentiated phenotype##2##3##(1994-11#1)(1994-6#1)
the differentiated status##2##3##(2008-11#2)
the differentiated##9##2##(1994-11#1)(1994-6#1)(1995-3#1)(2008-11#4)(2008-9#2)
the differentiating##3##2##(1990-5#2)(2013-1#1)
the differentiation and activation##2##4##(1990-9#1)(1995-6#1)
the differentiation and##4##3##(1990-9#1)(1995-6#1)(2008-10#1)(2009-10#1)
the differentiation between##4##3##(1991-3#1)(1996-3#1)(2008-10#2)
the differentiation capacity of##2##4##(2008-11#1)(2010-6#1)
the differentiation of human##2##4##(2008-11#2)
the differentiation of the##6##4##(1994-12#1)(2008-10#5)
the differentiation of##24##3##(1993-3#1)(1993-6#1)(1994-12#2)(2008-10#7)(2008-11#6)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#1)(2013-1#1)
the differentiation ofHL-60##2##3##(2008-11#2)
the differentiation process##2##3##(2008-5#1)(2010-8#1)
the differentiation##51##2##(1990-9#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-12#2)(1995-6#2)(1996-2#1)(1996-3#2)(2008-10#12)(2008-11#13)(2008-5#3)(2008-7#1)(2008-9#3)(2009-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
the differing##5##2##(1991-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
the difficult##6##2##(1992-5#1)(1995-3#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
the difficulties encountered in##2##4##(1997-3#1)(2008-11#1)
the difficulties encountered##4##3##(1996-12#1)(1997-3#1)(2008-11#1)(2008-7#1)
the difficulties faced by##2##4##(1992-3#1)(2011-2#1)
the difficulties in##4##3##(2008-11#1)(2008-5#1)(2009-12#1)(2013-1#1)
the difficulties of##2##3##(1991-6#1)(2011-2#1)
the difficulties##21##2##(1991-6#1)(1992-3#1)(1992-5#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
the difficulty in##10##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
the difficulty of the##3##4##(1997-2#1)(2011-3#1)(2012-2#1)
the difficulty of##15##3##(1992-12#1)(1995-2#1)(1997-2#1)(2008-10#4)(2008-11#3)(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
the difficulty to##3##3##(1993-6#1)(2008-5#1)(2011-2#1)
the difficulty##28##2##(1992-12#1)(1993-6#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
the diffraction efficiency##4##3##(2008-2#1)(2008-3#3)
the diffraction of##2##3##(2008-3#1)(2009-5#1)
the diffraction##12##2##(1992-4#1)(1992-9#1)(2008-2#2)(2008-3#6)(2009-5#1)(2012-2#1)
the diffraction-order##2##2##(2008-3#2)
the diffractive EPE##2##3##(2008-3#2)
the diffuse attenuation coefficient##2##4##(2008-2#1)(2008-3#1)
the diffuse reflectance spectrum of##2##5##(2008-10#1)(2008-3#1)
the diffuse reflection coefficient of##2##5##(2008-2#2)
the diffuse##12##2##(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#3)(2013-1#1)
the diffuser##2##2##(2008-3#2)
the diffusion coefficient##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
the diffusion coefficients##3##3##(1991-5#1)(2008-10#1)(2008-7#1)
the diffusion layer##3##3##(1990-12#1)(2008-10#2)
the diffusion of the complex##2##5##(2008-10#2)
the diffusion of the##3##4##(2008-10#3)
the diffusion of##12##3##(1993-8#1)(1994-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-10#1)(2012-2#1)
the diffusion##38##2##(1990-12#1)(1991-5#1)(1993-8#1)(1994-12#1)(1997-6#2)(2008-10#19)(2008-11#4)(2008-5#3)(2008-7#2)(2010-10#1)(2012-2#3)
the diffusive##3##2##(1992-9#1)(2008-10#2)
the digest##2##2##(1997-2#1)(2008-10#1)
the digested sample##2##3##(2008-10#2)
the digested##6##2##(2008-10#6)
the digestion method##2##3##(2008-10#2)
the digestion of##6##3##(2008-10#5)(2010-8#1)
the digestion##15##2##(1993-8#1)(2008-10#13)(2010-8#1)
the digestive cells##2##3##(2007-12#2)
the digestive system##2##3##(2008-10#1)(2009-6#1)
the digestive tract##10##3##(1990-8#2)(2008-10#2)(2008-11#1)(2009-5#1)(2011-2#3)(2012-2#1)
the digestive##20##2##(1990-8#2)(2007-12#2)(2008-10#6)(2008-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
the digital##4##2##(2008-1#1)(2008-10#1)(2008-4#1)(2009-11#1)
the dihedral angle of C4-C1-C2-S3##2##5##(1993-8#2)
the dihedral angle##3##3##(1993-8#3)
the dihydrofolate reductase##2##3##(2008-11#2)
the dihydropyridine##2##2##(1996-5#1)(2012-12#1)
the dilated ureter##2##3##(2008-10#2)
the dilemma of##6##3##(1991-8#1)(1992-1#1)(1992-3#1)(1996-2#1)(2008-11#1)(2013-1#1)
the diluent##3##2##(2008-10#3)
the diluents##2##2##(2008-10#2)
the dilute##3##2##(2008-10#3)
the diluted##4##2##(1994-9#1)(2008-10#3)
the dilution of##2##3##(1995-3#1)(2008-10#1)
the dilution##5##2##(1995-3#1)(2008-10#4)
the dimension of##3##3##(1996-2#1)(2008-10#1)(2009-1#1)
the dimension##5##2##(1996-2#1)(2008-10#2)(2009-1#1)(2011-2#1)
the dimensionality of the TSI##2##5##(2012-3#2)
the dimensionality of the##3##4##(2008-11#1)(2012-3#2)
the dimensionality of##5##3##(1994-9#1)(2008-11#1)(2012-2#1)(2012-3#2)
the dimensions of##6##3##(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-12#1)
the dimensions##8##2##(1991-12#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-3#1)
the dimer##9##2##(1991-7#1)(1994-11#1)(1994-8#1)(2008-10#3)(2008-8#3)
the dimeric##8##2##(1990-5#1)(1994-12#1)(2008-10#3)(2008-8#2)(2008-9#1)
the dimerization##5##2##(2008-10#4)(2008-9#1)
the dimethyl##3##2##(1994-8#2)(2010-5#1)
the dimorphic##2##2##(1996-6#1)(2008-5#1)
the dinucleotide##3##2##(1991-5#1)(1997-6#2)
the diode laser##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
the diode##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2013-1#1)
the diode-laser##2##2##(2008-3#2)
the diol##2##2##(1991-5#1)(2008-11#1)
the dioxin##10##2##(2008-10#10)
the dioxygen concentration in##2##4##(2008-10#2)
the dioxygen##3##2##(2008-10#3)
the dipole##6##2##(1992-12#2)(1997-6#2)(2008-10#1)(2010-8#1)
the dipping##2##2##(2008-10#1)(2008-12#1)
the direct analysis of the##2##5##(2008-10#2)
the direct analysis of trace metals in estuarine waters by square-wave anodic stripping voltammetry##2##14##(2008-10#2)
the direct analysis of##7##4##(2008-10#7)
the direct analysis##8##3##(2008-10#8)
the direct and indirect##3##4##(1997-1#1)(2008-10#1)(2008-11#1)
the direct and##7##3##(1990-9#1)(1997-1#1)(2008-10#4)(2008-11#1)
the direct assay##2##3##(2008-10#2)
the direct detection and##2##4##(2008-10#2)
the direct detection of##3##4##(2008-10#2)(2008-4#1)
the direct detection##5##3##(2008-10#4)(2008-4#1)
the direct determination of antimony##2##5##(2008-10#2)
the direct determination of the##4##5##(2008-10#4)
the direct determination of this compound in##2##7##(2008-10#2)
the direct determination of trace##2##5##(2008-10#2)
the direct determination of##44##4##(1991-12#1)(2008-10#43)
the direct determination##46##3##(1991-12#1)(2008-10#45)
the direct effect of##3##4##(2008-8#1)(2009-9#1)(2012-2#1)
the direct effects of##5##4##(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)
the direct electrochemistry of##2##4##(2008-10#2)
the direct identification of##2##4##(2008-10#1)(2011-2#1)
the direct injection##2##3##(2008-10#2)
the direct irradiance##2##3##(2008-2#2)
the direct##155##2##(1990-12#1)(1990-9#1)(1991-12#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-2#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-1#1)(2008-10#104)(2008-11#7)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-9#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
the direction and##2##3##(1992-2#1)(2012-3#1)
the direction of the##6##4##(1995-11#1)(2008-10#2)(2008-3#1)(2009-7#1)(2013-8#1)
the direction of##23##3##(1990-9#1)(1991-3#1)(1995-11#1)(1997-1#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
the direction selectivity##2##3##(2008-8#2)
the direction##35##2##(1990-9#1)(1991-3#1)(1992-2#1)(1993-12#1)(1995-11#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-5#1)(2008-8#4)(2008-9#2)(2009-7#1)(2010-4#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#1)
the directional##2##2##(2008-3#1)(2008-8#1)
the directly##2##2##(2008-10#2)
the director of##2##3##(1990-11#1)(1993-12#1)
the director's##2##2##(1994-3#2)
the directors##2##2##(1994-1#1)(2008-4#1)
the disability##4##2##(1991-1#1)(1995-12#1)(1995-3#1)(1997-1#1)
the disabled##10##2##(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-12#2)(1995-2#1)(1997-2#1)(2009-6#2)
the disaccharide##3##2##(1990-2#1)(1992-12#1)(1992-6#1)
the disadvantage of being##2##4##(2008-11#1)(2009-8#1)
the disadvantage that##2##3##(1990-2#1)(2013-1#1)
the disadvantage##4##2##(1990-2#1)(2008-11#1)(2009-8#1)(2013-1#1)
the disadvantages of##3##3##(1990-11#1)(2012-3#1)(2013-1#1)
the disadvantages##4##2##(1990-11#1)(1994-3#1)(2012-3#1)(2013-1#1)
the disappearance of the##5##4##(1993-8#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-9#1)
the disappearance of##10##3##(1990-5#1)(1993-8#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#2)
the disaster##2##2##(1991-2#1)(2008-12#1)
the disc harrow##2##3##(2008-10#2)
the disc##10##2##(1994-11#1)(1995-12#1)(1996-6#2)(2008-10#2)(2008-12#1)(2011-2#2)(2012-2#1)
the discharge##5##2##(1993-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
the discipline##3##2##(2008-12#3)
the disciplines##2##2##(1991-2#1)(1996-3#1)
the discomfort##2##2##(1995-6#1)(2008-4#1)
the discontinued##2##2##(2008-11#2)
the discoveries of##2##3##(2010-1#1)(2011-2#1)
the discovery and characterization of##2##5##(1997-1#1)(2008-10#1)
the discovery and##4##3##(1997-1#1)(2008-10#1)(2010-8#1)(2011-3#1)
the discovery of a##2##4##(1992-6#1)(2010-7#1)
the discovery of new##3##4##(2008-10#1)(2009-12#1)(2011-3#1)
the discovery of novel##3##4##(2008-9#1)(2011-1#1)(2011-2#1)
the discovery of potential therapeutic##2##5##(2009-12#1)(2010-12#1)
the discovery of potential##4##4##(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)
the discovery of the##9##4##(1991-8#1)(2008-10#1)(2008-11#2)(2009-5#2)(2010-7#1)(2011-3#1)(2013-8#1)
the discovery of##41##3##(1991-8#1)(1992-6#1)(1994-11#1)(1995-8#1)(1996-11#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#3)(2011-3#3)(2012-3#1)(2013-8#1)
the discovery phase##2##3##(2008-9#1)(2010-5#1)
the discovery that##2##3##(1997-2#1)(1997-3#1)
the discovery##50##2##(1991-8#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#3)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-3#1)(2013-8#1)
the discrepancy between##2##3##(2008-11#1)(2008-8#1)
the discrepancy in##2##3##(1993-9#1)(2008-1#1)
the discrepancy##6##2##(1993-9#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)
the discrete ordinates method##2##4##(2008-2#1)(2008-3#1)
the discrete##6##2##(1995-3#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
the discrete-time##2##2##(2008-6#1)(2008-8#1)
the discretion of##2##3##(1996-9#1)(2011-2#1)
the discretion##3##2##(1996-9#1)(1997-6#1)(2011-2#1)
the discriminant##2##2##(2008-10#2)
the discrimination between different##2##4##(2008-10#2)
the discrimination between##5##3##(1991-5#1)(2008-10#4)
the discrimination of##6##3##(2008-10#4)(2008-12#1)(2008-3#1)
the discrimination power of##2##4##(1995-11#1)(2011-2#1)
the discrimination##15##2##(1991-5#1)(1995-11#1)(2008-10#10)(2008-12#1)(2008-3#1)(2011-2#1)
the discussion and##2##3##(2008-12#1)(2011-2#1)
the discussion of##5##3##(1996-3#1)(2007-12#1)(2008-10#1)(2009-8#1)(2011-2#1)
the discussion on##2##3##(2008-10#1)(2008-11#1)
the discussion will##2##3##(2008-10#1)(2008-11#1)
the discussion##15##2##(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2009-8#1)(2010-11#1)(2011-2#2)
the discussions##3##2##(1994-12#1)(2008-12#1)(2011-2#1)
the disease among##2##3##(1993-2#1)(1996-8#1)
the disease and the##4##4##(1992-3#1)(2007-8#1)(2008-10#2)
the disease and##21##3##(1990-3#1)(1990-9#1)(1991-2#1)(1992-3#1)(1995-9#1)(1997-8#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)
the disease as##5##3##(1993-11#1)(2008-10#1)(2008-11#3)
the disease by the##2##4##(1993-11#1)(1994-9#1)
the disease caused##2##3##(2008-10#1)(2011-2#1)
the disease cycle of##2##4##(2008-10#2)
the disease cycle##4##3##(2008-10#4)
the disease development##3##3##(2008-10#3)
the disease during##2##3##(1992-9#1)(2011-2#1)
the disease gene##3##3##(1992-3#1)(1993-1#1)(1997-8#1)
the disease has been##3##4##(1997-8#1)(2008-10#1)(2013-1#1)
the disease has##6##3##(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#2)(2013-1#1)
the disease in the field##2##5##(2008-10#2)
the disease in the##8##4##(1990-9#1)(1992-9#2)(1994-9#1)(2008-10#3)(2009-12#1)
the disease in##22##3##(1990-9#1)(1991-12#1)(1991-8#1)(1992-9#3)(1994-9#2)(1995-2#1)(2008-10#10)(2009-12#1)(2011-2#1)(2012-3#1)
the disease incidence##4##3##(1990-3#1)(2008-10#3)
the disease intensity##2##3##(2008-10#2)
the disease is of##2##4##(2008-10#2)
the disease is##22##3##(1991-11#1)(1991-2#1)(1991-8#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-5#1)(2008-10#7)(2008-4#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the disease level##2##3##(2008-10#2)
the disease of##2##3##(1997-8#1)(2008-10#1)
the disease on##3##3##(2008-10#2)(2008-8#1)
the disease process and##2##4##(2013-1#1)(2013-8#1)
the disease process##3##3##(2010-3#1)(2013-1#1)(2013-8#1)
the disease progress curve was##2##5##(2008-10#2)
the disease progress curve##20##4##(2008-10#20)
the disease progress##23##3##(2008-10#23)
the disease progresses##2##3##(2008-2#1)(2008-8#1)
the disease progression##2##3##(2008-10#1)(2010-5#1)
the disease ratings of the##2##5##(2008-10#2)
the disease resistance##2##3##(2008-10#1)(2008-9#1)
the disease severity##4##3##(2008-10#4)
the disease should be##2##4##(2008-10#2)
the disease should##3##3##(2008-10#2)(2013-1#1)
the disease spread##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
the disease status of patients##2##5##(1992-3#2)
the disease status of##5##4##(1992-3#2)(2008-10#2)(2008-9#1)
the disease to##4##3##(1990-9#1)(2008-10#1)(2010-1#1)(2011-2#1)
the disease under##2##3##(2008-10#2)
the disease was observed##2##4##(2008-10#2)
the disease was##15##3##(1991-8#1)(1993-1#1)(1994-9#1)(1997-5#1)(2008-10#9)(2011-2#1)(2012-3#1)
the disease will##2##3##(2008-7#1)(2013-8#1)
the disease##392##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#3)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#4)(1992-3#5)(1992-6#2)(1992-9#4)(1993-1#2)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#11)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-6#4)(1996-8#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#9)(2006-6#1)(2007-8#3)(2008-1#1)(2008-10#155)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#2)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#9)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#28)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#15)(2013-7#1)(2013-8#5)
the disease-free survival rate##3##4##(1997-7#2)(2011-2#1)
the diseased seedlings##2##3##(2008-10#2)
the diseased##13##2##(1992-3#2)(1992-6#1)(1994-11#1)(2008-10#5)(2011-2#1)(2012-2#2)(2012-3#1)
the diseases caused by these##2##5##(2008-10#1)(2008-9#1)
the diseases of##2##3##(1997-1#1)(2008-1#1)
the diseases##12##2##(1991-6#1)(1993-11#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-5#1)
the disgust induction##2##3##(2012-2#2)
the dish##5##2##(2008-11#5)
the disinfection rates##2##3##(2013-1#2)
the disintegration of##2##3##(2008-10#1)(2011-2#1)
the disk##10##2##(2008-10#8)(2008-11#1)(2009-3#1)
the disks##2##2##(2008-10#2)
the disorder##26##2##(1991-12#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#4)(2008-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2012-2#4)(2012-3#1)(2013-8#2)
the disorders of##2##3##(1991-12#1)(2012-3#1)
the disorders##6##2##(1991-12#1)(1996-3#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-7#1)
the disparity##2##2##(1990-8#1)(1997-1#1)
the dispersal of##8##3##(2008-10#6)(2010-3#1)(2012-3#1)
the dispersal rate of the##2##5##(2008-8#2)
the dispersal##15##2##(2008-10#9)(2008-8#4)(2010-3#1)(2012-3#1)
the dispersed##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
the disperser##2##2##(2008-5#2)
the dispersion in##2##3##(2008-10#2)
the dispersion of the##2##4##(2008-10#1)(2010-4#1)
the dispersion of##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
the dispersion##7##2##(2008-10#4)(2008-11#1)(2008-3#1)(2010-4#1)
the displaced##3##2##(1991-9#1)(2012-12#1)(2013-1#1)
the displacement of the##2##4##(2009-10#1)(2010-7#1)
the displacement of##7##3##(1997-1#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-7#1)(2012-2#1)
the displacement##11##2##(1997-1#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-10#1)(2010-7#1)(2012-2#1)
the displacer##2##2##(2008-7#2)
the display exit pupil##2##4##(2008-3#2)
the display##11##2##(2008-3#7)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
the disposable screen-printed electrode##2##4##(2008-10#2)
the disposable##3##2##(2008-10#2)(2011-1#1)
the disposition##2##2##(2008-10#1)(2013-1#1)
the disrupted##3##2##(1995-2#1)(2008-10#2)
the disruption of the##2##4##(1994-11#1)(2008-10#1)
the disruption of##8##3##(1994-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2010-7#1)
the disruption##10##2##(1994-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2010-7#1)
the dissection of the##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
the dissection of##4##3##(2008-11#2)(2011-2#1)(2013-1#1)
the dissection##7##2##(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)(2013-1#2)
the disseminating structures are##2##4##(2007-12#2)
the dissemination of##2##3##(2008-10#1)(2010-2#1)
the dissemination##4##2##(1993-12#1)(2008-10#1)(2010-2#1)(2013-1#1)
the dissociated##2##2##(2008-10#1)(2008-8#1)
the dissociation constant of##2##4##(1993-8#1)(2008-10#1)
the dissociation constant##6##3##(1993-8#3)(2008-10#3)
the dissociation constants of the##2##5##(1993-8#1)(2008-10#1)
the dissociation constants of##4##4##(1993-8#1)(1995-11#1)(2008-10#2)
the dissociation constants##8##3##(1992-3#1)(1993-8#2)(1995-11#1)(2008-10#4)
the dissociation of##3##3##(1994-2#1)(1994-8#1)(2008-10#1)
the dissociation##24##2##(1992-3#1)(1993-8#5)(1994-2#1)(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#13)(2010-8#1)
the dissociative disorders and##2##4##(2009-10#2)
the dissolution of the##4##4##(2008-10#2)(2008-12#1)(2009-7#1)
the dissolution of##11##3##(2008-10#9)(2008-12#1)(2009-7#1)
the dissolution rate of mefenamic acid##3##6##(2012-2#3)
the dissolution rate##4##3##(2008-10#1)(2012-2#3)
the dissolution##25##2##(2008-10#19)(2008-12#1)(2009-7#2)(2012-2#3)
the dissolved organic##3##3##(2008-10#2)(2008-3#1)
the dissolved oxygen##3##3##(2008-10#2)(2008-11#1)
the dissolved##16##2##(2008-10#12)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
the distal end of a##2##5##(1992-12#1)(2008-8#1)
the distal end of the external carotid artery##2##8##(1997-6#2)
the distal end of the##4##5##(1997-6#2)(2008-10#1)(2008-9#1)
the distal end of##7##4##(1992-12#1)(1997-6#2)(2008-10#1)(2008-8#2)(2008-9#1)
the distal part of the femur##2##6##(2008-7#1)(2013-1#1)
the distal part of the##6##5##(1997-8#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-1#2)
the distal portion of the##2##5##(1991-5#1)(2007-12#1)
the distal portion of##3##4##(1991-5#1)(1996-8#1)(2007-12#1)
the distal portion##5##3##(1991-5#1)(1996-8#1)(2007-12#1)(2011-2#2)
the distal urethra##2##3##(2008-10#2)
the distal##67##2##(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#2)(1995-2#1)(1996-3#1)(1996-8#1)(1997-3#2)(1997-6#2)(1997-8#3)(2007-12#7)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#8)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#7)(2013-8#1)
the distance between the##9##4##(1993-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#3)
the distance between##16##3##(1993-12#1)(1993-8#2)(1997-7#1)(2008-10#7)(2008-11#2)(2008-3#3)
the distance from##2##3##(2008-10#2)
the distance of##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
the distance that##2##3##(2008-10#2)
the distance##28##2##(1993-12#1)(1993-8#2)(1996-6#1)(1997-7#1)(2008-10#15)(2008-11#2)(2008-3#3)(2008-8#1)(2010-5#1)(2011-2#1)
the distances between##2##3##(2008-10#1)(2008-9#1)
the distances##5##2##(2008-10#1)(2008-9#1)(2010-10#1)(2010-7#2)
the distant##2##2##(1993-1#1)(2013-1#1)
the distinct##10##2##(1994-2#1)(1995-5#1)(1997-1#1)(2008-1#1)(2008-10#4)(2010-10#1)(2011-1#1)
the distinction between the##2##4##(2008-10#2)
the distinction between##8##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)
the distinction of##2##3##(1997-5#1)(2008-10#1)
the distinction##10##2##(1995-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)
the distinctive##6##2##(1991-7#1)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#1)(2011-2#1)
the distinguishing##2##2##(1996-1#1)(2013-1#1)
the distortion amplitude##2##3##(2008-2#2)
the distribution and##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
the distribution between##2##3##(1992-9#1)(2008-5#1)
the distribution coefficient##2##3##(2008-10#2)
the distribution coefficients##2##3##(2008-10#2)
the distribution constants of 16C5##2##5##(2008-10#2)
the distribution constants of##3##4##(2008-10#3)
the distribution constants##4##3##(2008-10#4)
the distribution function##2##3##(2008-3#2)
the distribution is##2##3##(1994-5#1)(2008-10#1)
the distribution of iron##2##4##(2008-10#1)(2013-8#1)
the distribution of paternity##2##4##(2008-8#2)
the distribution of the##19##4##(1990-5#1)(1991-1#1)(1992-2#2)(1997-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
the distribution of##105##3##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#5)(1992-9#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-2#1)(1997-1#3)(1997-3#1)(1997-8#2)(2008-10#27)(2008-11#5)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#15)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
the distribution pattern of the##2##5##(2008-5#1)(2012-3#1)
the distribution pattern of##4##4##(2008-10#2)(2008-5#1)(2012-3#1)
the distribution pattern##5##3##(2008-10#2)(2008-5#1)(2012-3#2)
the distribution##143##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#3)(1991-6#1)(1992-12#1)(1992-2#5)(1992-9#2)(1994-5#4)(1994-6#1)(1995-9#1)(1996-2#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#46)(2008-11#7)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#16)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
the distributions of##4##3##(2008-10#1)(2008-11#2)(2013-8#1)
the distributions##8##2##(1992-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-2#1)(2013-8#1)
the district##4##2##(1993-3#1)(1997-6#2)(2011-2#1)
the disturbance of##2##3##(2008-10#1)(2009-12#1)
the disturbance##5##2##(1995-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)
the disulfide##3##2##(1990-5#1)(1992-1#1)(1993-8#1)
the diuretic##2##2##(2008-10#1)(2012-2#1)
the diuretics##2##2##(1994-8#1)(2008-10#1)
the diurnal pattern of##2##4##(1997-8#1)(2013-1#1)
the diurnal schedule of male female-search##2##6##(2008-6#2)
the diurnal schedule of##3##4##(2008-6#3)
the diurnal##7##2##(1990-3#1)(1997-8#1)(2008-6#3)(2013-1#2)
the divalent##3##2##(2008-10#3)
the divergence of the##2##4##(1993-6#1)(2008-2#1)
the divergence of##3##3##(1993-6#1)(1994-11#1)(2008-2#1)
the divergence##5##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
the diverse range of##2##4##(2009-12#1)(2011-3#1)
the diverse##16##2##(1991-3#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-7#1)(2009-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#2)
the diversity among##2##3##(2008-10#1)(2008-6#1)
the diversity and##2##3##(2011-1#1)(2012-3#1)
the diversity in##4##3##(1992-8#1)(1997-8#1)(2008-10#1)(2012-3#1)
the diversity of the##5##4##(1997-5#1)(2008-10#2)(2008-5#1)(2008-8#1)
the diversity of##26##3##(1990-12#1)(1992-3#1)(1997-5#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#2)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
the diversity##41##2##(1990-12#1)(1992-3#1)(1992-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#2)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
the diverticulum##2##2##(1992-1#1)(2008-10#1)
the dividing##2##2##(2008-10#1)(2008-9#1)
the division of##6##3##(1991-2#1)(2008-5#1)(2008-8#1)(2009-10#2)(2012-2#1)
the division##11##2##(1991-2#1)(1994-3#1)(2008-5#1)(2008-8#2)(2009-10#2)(2009-12#2)(2009-6#1)(2012-2#1)
the dlt operon##2##3##(1995-6#2)
the dnaA##3##2##(1996-12#3)
the docked##2##2##(1992-9#1)(1997-7#1)
the doctor##3##2##(1991-6#1)(1996-6#1)(1997-4#1)
the doctors##8##2##(1990-9#2)(1991-6#1)(1993-11#1)(1994-6#1)(1995-6#1)(1996-8#1)(1997-4#1)
the doctors'##4##2##(1993-11#1)(1994-6#1)(2011-2#2)
the doctrine of double effect##2##5##(2012-2#2)
the doctrine of##3##3##(1994-3#1)(2012-2#2)
the doctrine##4##2##(1994-3#2)(2012-2#2)
the documentation of##2##3##(2010-5#1)(2011-1#1)
the documentation##3##2##(2008-11#1)(2010-5#1)(2011-1#1)
the documented##2##2##(2008-11#1)(2011-3#1)
the dog is##2##3##(1995-2#1)(1996-11#1)
the dog liver##2##3##(1995-11#2)
the dog##11##2##(1991-3#1)(1995-11#4)(1995-2#1)(1996-11#1)(2008-5#2)(2012-2#1)(2013-1#1)
the dogma##2##2##(2008-11#1)(2008-12#1)
the dogs##8##2##(1992-5#3)(1996-12#1)(1996-6#1)(2008-6#1)(2012-3#2)
the dollar##2##2##(1991-1#1)(1993-3#1)
the domain of the##2##4##(1991-3#1)(1997-4#1)
the domain of##4##3##(1991-3#1)(1997-4#1)(2008-10#2)
the domain##12##2##(1991-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-9#1)
the domains##4##2##(1994-5#1)(2008-11#1)(2008-8#1)(2010-11#1)
the dome of the bladder##2##5##(2008-10#2)
the dome of##3##3##(2008-10#2)(2010-5#1)
the dome##5##2##(1991-6#1)(2008-10#2)(2009-7#1)(2010-5#1)
the domestic hen (Gallus domesticus)##2##5##(2008-12#2)
the domestic hen##3##3##(2008-12#3)
the domestic##6##2##(2007-12#1)(2008-12#3)(2008-6#1)(2011-2#1)
the dominance of##3##3##(2008-10#2)(2008-3#1)
the dominance##6##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
the dominant and##2##3##(2010-8#1)(2012-3#1)
the dominant factor determining##2##4##(2008-10#2)
the dominant factor##3##3##(1993-1#1)(2008-10#2)
the dominant haplotype##2##3##(2008-10#2)
the dominant or##2##3##(1996-6#1)(2008-10#1)
the dominant role in##2##4##(2010-11#1)(2011-3#1)
the dominant species##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
the dominant##51##2##(1990-11#1)(1993-1#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#4)(2013-1#1)(2013-8#1)
the dominating##2##2##(1996-6#1)(2008-8#1)
the donor phase##2##3##(2008-10#2)
the donor site##3##3##(2011-2#3)
the donor strains##2##3##(1993-12#2)
the donor##22##2##(1991-1#1)(1993-12#2)(1994-5#1)(1994-6#1)(2008-10#7)(2008-11#1)(2008-9#3)(2010-10#1)(2011-2#4)(2011-3#1)
the dopamine D3 receptor##2##4##(1995-2#2)
the dopamine uptake system##3##4##(1995-11#3)
the dopamine##15##2##(1993-1#1)(1995-11#4)(1995-2#3)(1996-12#1)(1996-2#3)(2008-10#2)(2008-7#1)
the dopaminergic function in##2##4##(2008-7#2)
the dopaminergic neurons of the##2##5##(1996-12#1)(2008-7#1)
the dopaminergic neurons##3##3##(1990-7#1)(1996-12#1)(2008-7#1)
the dopaminergic neurotoxicant##2##3##(1990-7#2)
the dopaminergic##7##2##(1990-7#3)(1996-12#1)(2008-7#3)
the dopant##2##2##(2008-3#1)(2010-11#1)
the doping##4##2##(2008-10#3)(2009-11#1)
the dorsal and medial raphe##2##5##(1991-12#1)(2008-7#1)
the dorsal and ventral##3##4##(1996-12#2)(2011-2#1)
the dorsal and##6##3##(1991-12#1)(1996-12#3)(2008-7#1)(2011-2#1)
the dorsal caudate-putamen##2##3##(1993-6#2)
the dorsal hippocampus##3##3##(1991-2#1)(2008-11#1)(2013-8#1)
the dorsal horn of the rat##2##6##(1994-2#1)(1995-12#1)
the dorsal horn##9##3##(1994-2#1)(1995-12#3)(1996-12#1)(1997-3#4)
the dorsal nucleus of the lateral lemniscus##5##7##(1997-3#5)
the dorsal nucleus of##6##4##(1991-7#1)(1997-3#5)
the dorsal olfactory mucosae##2##4##(1993-3#2)
the dorsal papillae##2##3##(2008-5#2)
the dorsal raphe##3##3##(1994-2#2)(1996-12#1)
the dorsal root ganglia##2##4##(1997-3#1)(2008-9#1)
the dorsal root ganglion##5##4##(1995-12#1)(1997-2#2)(2008-8#1)(2011-2#1)
the dorsal root##7##3##(1995-12#1)(1997-2#2)(1997-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
the dorsal side##5##3##(2008-5#3)(2008-7#1)(2011-2#1)
the dorsal striatum##3##3##(1993-6#1)(1996-2#1)(2013-8#1)
the dorsal surface of the foot##2##6##(2012-3#2)
the dorsal surface of the##3##5##(2011-2#1)(2012-3#2)
the dorsal##66##2##(1991-12#1)(1991-2#1)(1991-7#1)(1993-3#3)(1993-6#3)(1994-2#3)(1994-8#2)(1995-12#4)(1996-12#5)(1996-2#2)(1997-2#2)(1997-3#10)(2007-12#5)(2008-11#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#4)(2012-3#2)(2013-8#4)
the dorsolateral##6##2##(1994-8#1)(2007-12#2)(2008-12#1)(2008-7#1)(2010-7#1)
the dorsomedial posterior tubercle##2##4##(1997-3#2)
the dorsomedial##3##2##(1994-8#1)(1997-3#2)
the dorsoventral plane##3##3##(1990-3#1)(1997-3#2)
the dorsoventral##4##2##(1990-3#1)(1997-3#2)(2010-4#1)
the dorsum of the##2##4##(1997-4#1)(2012-3#1)
the dorsum of##3##3##(1997-4#1)(2010-3#1)(2012-3#1)
the dosage and##2##3##(2007-11#1)(2013-1#1)
the dosage of##4##3##(1991-2#1)(2007-8#1)(2008-11#1)(2010-5#1)
the dosage##12##2##(1990-9#1)(1991-2#2)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-5#1)(2013-1#1)
the dose and##2##3##(1995-12#1)(2008-2#1)
the dose delivered from the##2##5##(1995-3#1)(1997-2#1)
the dose of 0##3##4##(1990-9#1)(2011-1#2)
the dose of##19##3##(1990-9#2)(1992-12#2)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#2)(2007-11#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
the dose range of##2##4##(1994-8#2)
the dose range##3##3##(1993-6#1)(1994-8#2)
the dose##49##2##(1990-9#2)(1991-11#1)(1991-2#1)(1992-12#2)(1993-6#2)(1993-9#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
the dose-effect##2##2##(1993-6#1)(2008-7#1)
the dose-related##2##2##(1994-8#1)(2011-2#1)
the dose-response curve##4##3##(1994-11#2)(1996-2#1)(1997-1#1)
the dose-response relationship##2##3##(1992-9#1)(2008-10#1)
the dose-response##10##2##(1992-9#1)(1994-11#2)(1996-2#1)(1997-1#1)(2008-10#3)(2008-7#1)(2012-2#1)
the doses of##3##3##(2008-7#3)
the doses tested##2##3##(1994-11#1)(2010-1#1)
the doses##8##2##(1994-11#1)(1995-12#1)(2008-6#1)(2008-7#3)(2010-1#1)(2013-1#1)
the dosing##2##2##(1996-3#1)(1997-2#1)
the dot##2##2##(1994-1#1)(2009-11#1)
the double mutant receptor##2##4##(1995-6#2)
the double mutant##4##3##(1995-6#3)(1997-1#1)
the double##24##2##(1991-5#1)(1995-6#4)(1995-8#1)(1997-1#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-9#2)(2009-8#1)(2010-5#1)
the double-edge##3##2##(2008-3#3)
the double-stranded DNA##2##3##(1992-3#1)(2008-10#1)
the double-stranded##4##2##(1992-3#1)(2008-10#3)
the doubled haploid##2##3##(2008-10#2)
the doubling crystal##2##3##(2008-3#2)
the doubly##3##2##(1991-3#1)(1992-3#1)(2008-3#1)
the down-regulation of##7##3##(1993-8#1)(1995-6#1)(1996-2#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)
the downgrading##2##2##(1990-9#2)
the downsizing##3##2##(1997-2#1)(2008-10#1)(2012-3#1)
the downstream component of oriLyt##2##5##(1997-3#2)
the downstream component##4##3##(1997-3#4)
the downstream##23##2##(1994-11#2)(1994-2#1)(1995-2#1)(1997-1#1)(1997-3#4)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-5#2)(2012-2#2)(2013-1#1)
the downward##3##2##(2008-11#1)(2008-3#2)
the downy mildew##3##3##(2008-10#2)(2012-3#1)
the drain of precursors##2##4##(2008-7#2)
the draining veins##4##3##(1997-3#1)(2008-7#2)(2012-3#1)
the draining##6##2##(1997-3#1)(2008-10#1)(2008-7#3)(2012-3#1)
the dramatic##2##2##(1997-3#1)(2012-12#1)
the drawbacks of the##2##4##(2008-10#2)
the drawbacks of##3##3##(1995-3#1)(2008-10#2)
the drawbacks##4##2##(1990-2#1)(1995-3#1)(2008-10#2)
the dreaded##2##2##(1990-11#1)(1993-2#1)
the dried##2##2##(2008-10#1)(2008-12#1)
the drift of the##2##4##(2008-10#1)(2008-3#1)
the drift of##4##3##(2008-10#1)(2008-3#2)(2010-4#1)
the drift##7##2##(2008-10#4)(2008-3#2)(2010-4#1)
the drinking water for##3##4##(2008-10#1)(2008-9#2)
the drinking water##11##3##(1990-6#1)(2008-10#3)(2008-9#6)(2013-7#1)
the drinking##12##2##(1990-6#1)(2008-10#3)(2008-11#1)(2008-9#6)(2013-7#1)
the drip##2##2##(2008-10#1)(2011-2#1)
the drive##2##2##(2008-11#1)(2010-12#1)
the drivers##3##2##(2008-12#1)(2008-5#1)(2010-8#1)
the driving##5##2##(1991-12#1)(1993-1#1)(1994-8#1)(2008-11#1)(2008-3#1)
the drop volume##2##3##(2008-10#2)
the drop##11##2##(1991-5#3)(2008-10#8)
the droplet and##2##3##(1995-3#1)(2008-10#1)
the droplet##6##2##(1995-3#1)(2008-10#2)(2008-3#2)(2012-2#1)
the droplets##5##2##(1995-3#2)(1996-3#1)(2008-10#2)
the dropping mercury electrode##5##4##(2008-10#5)
the dropping##6##2##(1991-12#1)(2008-10#5)
the drug and the##2##4##(1994-5#1)(2008-10#1)
the drug and##6##3##(1993-6#1)(1994-5#1)(2008-10#2)(2010-9#1)(2011-2#1)
the drug by##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
the drug concentration##2##3##(1990-2#1)(1996-3#1)
the drug delivery##2##3##(2012-2#2)
the drug discovery##2##3##(2008-11#1)(2011-3#1)
the drug disorder diagnosed population##2##5##(1993-12#2)
the drug for##3##3##(2008-11#1)(2008-8#1)(2012-3#1)
the drug from##3##3##(2008-10#3)
the drug in the##4##4##(1990-11#1)(2008-10#3)
the drug in urine and##2##5##(2008-10#2)
the drug in##17##3##(1990-11#1)(2008-10#16)
the drug is##3##3##(1992-3#1)(1996-1#1)(2008-10#1)
the drug of choice##2##4##(1991-10#1)(2011-2#1)
the drug release##3##3##(2012-2#3)
the drug solution##2##3##(2008-10#2)
the drug substance##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
the drug to##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
the drug treatment##2##3##(2008-10#1)(2011-2#1)
the drug was##5##3##(1994-5#1)(2008-1#1)(2008-10#2)(2008-7#1)
the drug were##5##3##(1990-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
the drug##150##2##(1990-11#3)(1990-2#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-3#4)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-12#2)(1993-6#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-3#2)(1996-5#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(2008-1#2)(2008-10#57)(2008-11#11)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#9)(2011-3#1)(2012-2#6)(2012-3#1)(2013-1#2)
the drug's##3##2##(1994-8#1)(2011-2#1)(2013-8#1)
the drugs and##3##3##(2008-10#1)(2009-10#1)(2013-8#1)
the drugs used to##2##4##(1996-3#1)(2011-1#1)
the drugs used##3##3##(1996-1#1)(1996-3#1)(2011-1#1)
the drugs##49##2##(1990-2#2)(1991-8#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#25)(2008-11#2)(2008-7#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the dry##6##2##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)
the drying process##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
the drying##11##2##(2008-10#6)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
the dsDNA##4##2##(1995-2#2)(2008-10#2)
the dsRNA##7##2##(2008-10#6)(2008-9#1)
the dual blood supply to the hand##2##7##(2011-2#2)
the dual grid##4##3##(2013-1#4)
the dual##17##2##(1990-2#1)(1991-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#4)
the dually##2##2##(2008-10#1)(2008-5#1)
the duct cells##2##3##(2007-12#2)
the duct##4##2##(1991-9#1)(2007-12#3)
the ductus##2##2##(1994-9#1)(1996-3#1)
the duodenum##6##2##(1995-11#1)(1996-8#1)(2008-12#2)(2013-1#2)
the duplex##6##2##(2008-10#2)(2008-11#2)(2008-12#1)(2013-8#1)
the duplication event##2##3##(1997-8#1)(2009-8#1)
the duplication##4##2##(1997-8#1)(2009-8#1)(2012-3#2)
the dura and##2##3##(2008-7#1)(2009-8#1)
the dura mater##2##3##(2009-8#1)(2013-1#1)
the dura propria of the temporal lobe##2##7##(2011-2#2)
the dura##9##2##(1996-9#1)(2008-7#2)(2009-8#3)(2011-2#2)(2013-1#1)
the durability of resistance to##2##5##(2008-10#2)
the durability of resistance##5##4##(2008-10#5)
the durability of##10##3##(2008-10#9)(2012-12#1)
the durability##11##2##(2008-10#9)(2012-12#1)(2012-2#1)
the dural defect##2##3##(2011-2#1)(2013-8#1)
the dural sinuses##2##3##(2008-7#2)
the dural##8##2##(2008-7#5)(2011-2#1)(2012-3#1)(2013-8#1)
the duration (h)##2##3##(2008-10#2)
the duration and##2##3##(1993-1#1)(2012-3#1)
the duration of exposure##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
the duration of leaf wetness##2##5##(2008-10#2)
the duration of symptoms##2##4##(2008-5#1)(2013-1#1)
the duration of the disease##2##5##(1994-12#1)(2013-1#1)
the duration of the following##2##5##(1997-2#1)(2008-7#1)
the duration of the inhibition##2##5##(1991-12#1)(1996-2#1)
the duration of the study##2##5##(2008-10#1)(2008-7#1)
the duration of the##33##4##(1991-11#1)(1991-12#1)(1992-12#1)(1994-12#1)(1996-2#2)(1997-2#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
the duration of##61##3##(1991-11#2)(1991-12#1)(1991-9#1)(1992-12#1)(1994-12#1)(1995-12#1)(1996-2#2)(1997-2#3)(2007-11#1)(2008-10#13)(2008-11#8)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#8)(2008-8#2)(2008-9#2)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
the duration##69##2##(1991-11#2)(1991-12#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-12#1)(1995-12#1)(1996-2#2)(1997-2#3)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#8)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#9)(2008-8#2)(2008-9#2)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the durum##3##2##(2008-10#2)(2012-3#1)
the duty cycle ratio##2##4##(2008-3#2)
the duty##3##2##(2008-3#2)(2013-8#1)
the dwell time##2##3##(2008-10#1)(2009-7#1)
the dye is##2##3##(1991-5#1)(2008-10#1)
the dye methylene blue##2##4##(2008-10#1)(2012-2#1)
the dye##34##2##(1990-12#1)(1991-5#4)(2008-10#19)(2008-3#1)(2008-4#1)(2008-9#2)(2010-4#5)(2012-2#1)
the dyeing##2##2##(2008-5#1)(2011-1#1)
the dyes and nitrite##3##4##(1990-6#3)
the dyes##9##2##(1990-6#3)(2008-10#5)(2008-5#1)
the dying##7##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-6#1)(1997-6#1)(2010-10#1)(2010-8#1)
the dynamic and##2##3##(2008-3#1)(2011-2#1)
the dynamic changes##2##3##(2008-12#1)(2008-8#1)
the dynamic coating##2##3##(2008-10#2)
the dynamic nature of##3##4##(2008-10#1)(2008-9#1)(2010-8#1)
the dynamic performance##2##3##(2008-7#1)(2012-2#1)
the dynamic progression##2##3##(2010-6#1)(2013-8#1)
the dynamic properties##2##3##(1993-8#1)(1995-6#1)
the dynamic range and##2##4##(2008-10#1)(2008-3#1)
the dynamic range of Cu(II)##2##5##(2008-10#2)
the dynamic range of##7##4##(2007-11#1)(2008-10#5)(2013-8#1)
the dynamic range##12##3##(2007-11#1)(2008-10#9)(2008-3#1)(2013-8#1)
the dynamic surface tension detector (DSTD)##2##6##(2008-10#2)
the dynamic surface tension##4##4##(2008-10#4)
the dynamic##50##2##(1993-8#1)(1995-6#1)(2007-11#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
the dynamical##2##2##(1990-5#1)(2010-10#1)
the dynamics and##9##3##(1997-4#1)(2008-10#1)(2008-8#2)(2010-10#1)(2011-2#1)(2012-3#2)(2013-8#1)
the dynamics of a##5##4##(1993-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)
the dynamics of actin##2##4##(2008-9#1)(2012-2#1)
the dynamics of ecological##2##4##(2008-8#1)(2008-9#1)
the dynamics of host-pathogen interactions##2##5##(2008-9#2)
the dynamics of the##13##4##(1993-2#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-8#1)(2010-10#1)(2012-3#1)
the dynamics of##64##3##(1990-8#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-6#1)(1997-1#2)(2008-1#1)(2008-10#15)(2008-11#6)(2008-3#2)(2008-8#11)(2008-9#7)(2009-6#1)(2010-10#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
the dynamics##78##2##(1990-8#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-6#1)(1997-1#2)(1997-4#1)(2008-1#1)(2008-10#16)(2008-11#6)(2008-3#2)(2008-8#13)(2008-9#9)(2009-6#1)(2010-10#2)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#7)
the dysfunction of##3##3##(2008-11#1)(2008-4#1)(2009-8#1)
the dyslipidaemia##2##2##(2008-6#2)
the dyslipidemia of the metabolic syndrome##2##6##(2008-3#2)
the dysthymic group and major depression group##3##7##(2011-2#3)
the e##2##2##(1995-2#1)(1997-4#1)
the eSRT programme##3##3##(2008-9#3)
the ear leaf##2##3##(2008-10#2)
the ear##9##2##(2008-1#1)(2008-10#3)(2008-7#3)(2008-9#1)(2011-2#1)
the earlier##14##2##(1990-3#1)(1991-12#2)(1991-6#1)(1993-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2011-2#2)
the earliest events##2##3##(1995-2#1)(1997-8#1)
the earliest stages of##4##4##(2008-10#2)(2008-9#1)(2012-7#1)
the earliest times##2##3##(1990-2#1)(1995-12#1)
the earliest##21##2##(1990-2#1)(1992-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-9#2)(2011-2#1)(2012-3#1)(2012-7#1)
the early 1900s##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
the early 1950s##3##3##(2008-12#1)(2008-9#1)(2010-1#1)
the early 1960s##4##3##(1996-12#1)(2009-7#2)(2010-7#1)
the early 1970s##6##3##(1994-12#1)(1994-3#2)(1996-3#1)(2008-11#1)(2008-12#1)
the early 1980s##5##3##(1994-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(2008-5#1)
the early 1990s##10##3##(1993-3#1)(2008-10#6)(2008-12#1)(2008-6#1)(2010-12#1)
the early and##3##3##(2008-10#1)(2009-8#1)(2010-8#1)
the early appearance##2##3##(2008-4#1)(2009-4#1)
the early beta ERD##2##4##(2013-8#2)
the early control##3##3##(2013-1#3)
the early days of##2##4##(2008-11#1)(2009-10#1)
the early detection of##6##4##(1994-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
the early development of##2##4##(2008-4#1)(2010-12#1)
the early development##3##3##(2008-11#1)(2008-4#1)(2010-12#1)
the early diagnosis and##2##4##(2013-1#2)
the early diagnosis of##3##4##(1990-9#1)(1991-2#1)(1993-3#1)
the early diagnosis##6##3##(1990-9#1)(1991-2#1)(1993-3#1)(1994-3#1)(2013-1#2)
the early embryo##5##3##(2007-12#2)(2008-10#1)(2009-8#1)(2012-3#1)
the early embryonic brain of the grasshopper Schistocerca gregaria##2##9##(2007-12#2)
the early embryonic##3##3##(2007-12#2)(2008-11#1)
the early event of cytotoxicity of##2##6##(2009-12#2)
the early events##3##3##(2008-10#1)(2012-2#2)
the early identification##2##3##(2010-12#1)(2011-1#1)
the early induction##2##3##(1996-12#1)(2008-10#1)
the early life##2##3##(2010-7#1)(2010-8#1)
the early morning hours##2##4##(2008-10#1)(2013-1#1)
the early morning##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
the early part of the##2##5##(1991-8#1)(2008-9#1)
the early period after##2##4##(2010-11#1)(2012-3#1)
the early period##3##3##(2008-11#1)(2010-11#1)(2012-3#1)
the early phase of##5##4##(1993-9#1)(1994-11#1)(1996-2#1)(2008-9#1)(2010-1#1)
the early phase##6##3##(1993-9#1)(1994-11#1)(1996-2#1)(2008-9#1)(2010-1#1)(2011-2#1)
the early phases of##3##4##(1995-3#1)(2008-11#1)(2012-12#1)
the early phases##4##3##(1991-8#1)(1995-3#1)(2008-11#1)(2012-12#1)
the early postnatal##3##3##(1990-5#1)(2008-11#1)(2010-1#1)
the early postoperative period##4##4##(1991-2#1)(1994-3#1)(2011-2#1)(2012-3#1)
the early postoperative##5##3##(1991-2#1)(1994-3#1)(2011-2#2)(2012-3#1)
the early stage of the##3##5##(1991-12#1)(2008-10#1)(2008-9#1)
the early stage of##14##4##(1991-12#1)(1992-12#1)(1993-12#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-9#3)(2009-12#1)(2013-1#1)
the early stages of development##2##5##(2008-6#1)(2011-2#1)
the early stages of disasters##2##5##(2010-8#2)
the early stages of peritonitis##2##5##(2008-12#2)
the early stages of##27##4##(1993-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#3)(2011-10#1)(2011-2#2)(2013-1#3)(2013-8#1)
the early stages##31##3##(1993-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#3)(2011-10#1)(2011-2#3)(2013-1#3)(2013-8#1)
the early subjective##2##3##(2008-5#2)
the early to##4##3##(1997-8#1)(2008-10#2)(2008-11#1)
the early twentieth century##3##4##(2008-12#1)(2010-1#1)(2012-12#1)
the early years of##2##4##(1992-2#1)(1993-12#1)
the early years##3##3##(1992-2#1)(1993-12#1)(2008-11#1)
the early##231##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#5)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-8#3)(2007-12#6)(2007-8#1)(2008-10#31)(2008-11#21)(2008-12#10)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#3)(2009-4#1)(2009-7#2)(2009-8#4)(2010-1#5)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#2)(2011-10#1)(2011-2#11)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#4)
the earth surface##2##3##(2008-10#2)
the earthquake##6##2##(2013-1#4)(2013-8#2)
the earthworm##5##2##(2008-5#3)(2008-9#1)(2011-1#1)
the ease of scientific##2##4##(2012-2#2)
the ease of use of##2##5##(2012-3#1)(2013-1#1)
the ease of##10##3##(2008-10#3)(2008-11#1)(2008-9#1)(2012-2#3)(2012-3#1)(2013-1#1)
the easiest##2##2##(1990-3#1)(2011-2#1)
the east and west coasts of##2##6##(2008-10#2)
the east and##3##3##(2008-10#3)
the east##6##2##(2008-10#5)(2008-5#1)
the eastern United States##5##4##(2008-10#5)
the eastern##18##2##(2008-10#12)(2008-5#1)(2008-9#1)(2009-8#1)(2010-8#2)(2012-3#1)
the easy##8##2##(1990-5#1)(1990-9#1)(1995-2#1)(1996-12#1)(2008-4#1)(2008-9#1)(2013-8#2)
the eating##2##2##(2008-11#1)(2012-3#1)
the ecdysial##2##2##(2008-7#2)
the echinocandin##2##2##(2011-2#2)
the echo##2##2##(2011-2#1)(2012-3#1)
the ecological significance of##2##4##(2009-8#2)
the ecological significance##3##3##(2008-10#1)(2009-8#2)
the ecological##22##2##(1994-3#1)(2008-10#2)(2008-11#3)(2008-8#4)(2008-9#1)(2009-8#3)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#4)(2012-5#1)
the ecologically##2##2##(2008-10#1)(2008-9#1)
the ecology and evolution of##3##5##(2008-8#1)(2009-8#1)(2012-3#1)
the ecology and##4##3##(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#1)
the ecology of##9##3##(2008-10#6)(2008-8#1)(2008-9#1)(2013-1#1)
the ecology##13##2##(2008-10#6)(2008-8#2)(2008-9#2)(2009-8#1)(2012-3#1)(2013-1#1)
the economic aspects of##2##4##(1993-12#2)
the economic burden of##3##4##(1995-11#1)(2008-6#1)(2010-3#1)
the economic cost##2##3##(2008-11#1)(2013-8#1)
the economic##25##2##(1993-12#2)(1994-3#1)(1995-11#1)(1995-5#2)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#2)
the economically inactive##2##3##(2013-8#2)
the economically##3##2##(2010-3#1)(2013-8#2)
the economy of##2##3##(2008-10#1)(2013-8#1)
the economy##8##2##(1991-1#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-8#1)
the ecosystem##5##2##(1997-7#1)(2008-12#2)(2008-8#1)(2008-9#1)
the ecotoxicological effect of##2##4##(2008-10#1)(2008-11#1)
the ectomycorrhizal##2##2##(2012-6#2)
the ectopic##3##2##(1990-9#1)(2008-11#1)(2009-8#1)
the edge of a##2##4##(2008-3#1)(2008-9#1)
the edge of the orchard##2##5##(2008-10#2)
the edge of the##7##4##(1994-5#1)(1995-6#1)(2008-10#3)(2011-2#1)(2012-3#1)
the edge of##12##3##(1994-5#1)(1995-6#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
the edge##15##2##(1994-5#1)(1995-6#1)(2008-10#5)(2008-3#2)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-3#1)
the edges of the##2##4##(2010-7#1)(2011-2#1)
the edges of##3##3##(1997-3#1)(2010-7#1)(2011-2#1)
the edges##4##2##(1997-3#1)(2008-3#1)(2010-7#1)(2011-2#1)
the edible##4##2##(2008-10#3)(2008-11#1)
the editing##2##2##(1997-2#1)(2011-1#1)
the editor##21##2##(1996-9#1)(1997-3#1)(2008-11#4)(2008-12#8)(2008-9#2)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#2)
the editorial##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
the education and training##4##4##(1991-1#1)(2008-11#1)(2008-12#2)
the education of health care##2##5##(1992-2#1)(2008-12#1)
the education of health##5##4##(1992-2#1)(1993-2#1)(2008-11#2)(2008-12#1)
the education of##10##3##(1992-2#1)(1993-2#1)(1994-12#1)(2008-11#5)(2008-12#2)
the education##21##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-11#7)(2008-12#5)(2008-9#1)(2011-2#2)
the educational and##2##3##(1996-2#1)(2008-12#1)
the educational needs of##3##4##(1992-12#2)(2008-11#1)
the educational process##2##3##(1993-3#1)(2008-12#1)
the educational value##2##3##(2008-11#1)(2008-12#1)
the educational##27##2##(1990-3#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-3#1)(1996-2#1)(2008-11#8)(2008-12#7)(2010-9#2)(2011-1#1)(2011-2#1)
the educator##2##2##(1996-3#1)(2008-12#1)
the efe gene##6##3##(2008-10#6)
the efe##9##2##(2008-10#9)
the effect and##2##3##(1996-12#1)(2008-11#1)
the effect of Cisplatin-liposome on Hela cells##2##7##(2008-10#2)
the effect of a##23##4##(1991-2#2)(1991-6#2)(1992-6#1)(1995-1#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the effect of acute##4##4##(1991-10#1)(1994-11#1)(1996-2#1)(2008-10#1)
the effect of adding##2##4##(2008-10#1)(2010-4#1)
the effect of age##3##4##(2008-7#2)(2009-5#1)
the effect of aging on##4##5##(2008-7#4)
the effect of aging##5##4##(2008-7#5)
the effect of an##4##4##(2008-3#1)(2008-5#1)(2009-12#1)(2013-1#1)
the effect of both##2##4##(1997-1#1)(2008-10#1)
the effect of carbachol##2##4##(1996-12#2)
the effect of cell##4##4##(2008-11#3)(2008-7#1)
the effect of changes##2##4##(1997-2#1)(2012-2#1)
the effect of chronic##3##4##(1994-2#1)(2008-10#1)(2013-1#1)
the effect of cigarette smoking on##3##6##(1996-3#1)(2008-10#1)(2008-12#1)
the effect of cocaine##3##4##(2013-8#3)
the effect of continuous##2##4##(2008-11#1)(2008-12#1)
the effect of copper##2##4##(1990-8#1)(2008-10#1)
the effect of dementia##2##4##(2008-7#2)
the effect of diabetes on##2##5##(2008-10#2)
the effect of different##11##4##(1995-12#1)(2008-10#3)(2008-12#3)(2012-3#1)(2012-8#1)(2013-1#2)
the effect of duration of##2##5##(2008-10#1)(2010-8#1)
the effect of exercise##2##4##(2008-8#1)(2013-1#1)
the effect of exogenous##2##4##(2008-11#1)(2008-12#1)
the effect of family##3##4##(2010-9#1)(2011-2#1)(2013-1#1)
the effect of flow rate##2##5##(2008-10#2)
the effect of foreign ions##3##5##(2008-10#3)
the effect of gene##2##4##(2008-8#2)
the effect of increasing##2##4##(1991-2#1)(2008-10#1)
the effect of interferences##2##4##(2008-10#2)
the effect of light initiation##2##5##(2008-10#2)
the effect of lithium##2##4##(1996-12#1)(2009-8#1)
the effect of low##4##4##(1993-1#1)(1996-12#1)(2008-7#1)(2010-9#1)
the effect of massage##2##4##(2008-12#2)
the effect of morphine##5##4##(1991-1#1)(1996-2#4)
the effect of nicotine on naloxone-induced jumping##2##7##(1996-2#2)
the effect of nicotine##3##4##(1996-2#3)
the effect of nutrient availability##2##5##(2008-10#2)
the effect of pH and##2##5##(2008-10#1)(2008-7#1)
the effect of pH on the peak##2##7##(2008-10#2)
the effect of pH on##3##5##(2008-10#3)
the effect of pH##13##4##(2008-10#11)(2008-5#1)(2008-7#1)
the effect of quadrat##2##4##(2008-10#2)
the effect of radiation##2##4##(2008-5#1)(2013-1#1)
the effect of recombinant hFGF-10 adenovirus on##2##7##(2011-3#2)
the effect of recombinant##3##4##(1994-8#1)(2011-3#2)
the effect of relevant##2##4##(2008-10#1)(2008-7#1)
the effect of retention##3##4##(2008-10#2)(2008-12#1)
the effect of sex##2##4##(1991-3#1)(1997-7#1)
the effect of soil##3##4##(2008-10#3)
the effect of some##4##4##(1996-12#1)(2008-10#2)(2008-8#1)
the effect of such##4##4##(1993-1#1)(2008-11#1)(2009-6#1)(2013-8#1)
the effect of surgical##2##4##(2008-10#1)(2008-7#1)
the effect of temperature on##3##5##(2008-10#2)(2009-8#1)
the effect of temperature##6##4##(2008-10#4)(2008-11#1)(2009-8#1)
the effect of the time##2##5##(2008-10#1)(2013-1#1)
the effect of the##57##4##(1991-2#1)(1993-6#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-1#1)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#4)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#4)(2013-1#1)(2013-8#1)
the effect of thermal injury on##2##6##(2008-9#2)
the effect of these##5##4##(1991-12#1)(1996-2#1)(1997-2#1)(2008-11#1)(2013-8#1)
the effect of various##2##4##(2008-11#1)(2013-1#1)
the effect of water##3##4##(2008-10#3)
the effect of##612##3##(1990-10#1)(1990-12#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#8)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-2#1)(1992-3#4)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#5)(1994-11#7)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#4)(1995-12#6)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#5)(1995-9#1)(1996-12#6)(1996-2#13)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#7)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#165)(2008-11#41)(2008-12#24)(2008-2#2)(2008-3#21)(2008-4#1)(2008-5#15)(2008-6#4)(2008-7#28)(2008-8#21)(2008-9#15)(2009-10#1)(2009-12#5)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#24)(2011-3#5)(2012-12#2)(2012-2#14)(2012-3#10)(2012-8#1)(2013-1#21)(2013-8#14)
the effect on temperature##2##4##(1996-2#2)
the effect on the##3##4##(1993-3#1)(1994-2#1)(2008-10#1)
the effect on##15##3##(1993-3#1)(1994-2#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
the effect that##5##3##(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)
the effect was##11##3##(1993-6#1)(1994-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-9#1)(2009-7#1)(2010-8#1)
the effect##667##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#8)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-2#1)(1992-3#4)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#5)(1994-11#7)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#4)(1995-1#1)(1995-11#4)(1995-12#6)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#5)(1995-9#1)(1996-12#8)(1996-2#16)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#7)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#2)(2007-12#1)(2008-1#4)(2008-10#175)(2008-11#50)(2008-12#25)(2008-2#2)(2008-3#23)(2008-4#1)(2008-5#17)(2008-6#4)(2008-7#30)(2008-8#23)(2008-9#21)(2009-10#1)(2009-12#5)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#5)(2011-2#26)(2011-3#5)(2012-12#2)(2012-2#16)(2012-3#10)(2012-8#1)(2013-1#22)(2013-8#14)
the effective concentration##3##3##(2008-10#3)
the effective dose##4##3##(1995-12#1)(1997-8#2)(2008-12#1)
the effective immobilization of##2##4##(2008-10#2)
the effective migration rate##2##4##(2008-10#1)(2008-8#1)
the effective size of##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
the effective sizes of##2##4##(2008-10#2)
the effective use##2##3##(1992-2#1)(1992-9#1)
the effective utilization of##2##4##(2008-10#1)(2010-10#1)
the effective##55##2##(1992-2#1)(1992-9#1)(1995-12#1)(1996-6#1)(1997-8#2)(2006-6#1)(2007-12#2)(2008-10#23)(2008-11#3)(2008-12#1)(2008-3#7)(2008-8#4)(2009-4#1)(2010-10#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
the effectiveness of ASPs##2##4##(2013-1#2)
the effectiveness of a##7##4##(1990-6#1)(1995-3#1)(1996-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
the effectiveness of an##4##4##(1997-1#1)(2008-8#1)(2010-10#1)(2012-2#1)
the effectiveness of different##4##4##(1994-12#1)(2013-1#2)(2013-8#1)
the effectiveness of exercise for##2##5##(2013-1#2)
the effectiveness of five##2##4##(2008-11#1)(2008-4#1)
the effectiveness of our##2##4##(2008-7#1)(2010-9#1)
the effectiveness of the##25##4##(1992-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-3#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)
the effectiveness of their##4##4##(1997-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
the effectiveness of these##2##4##(1996-1#1)(2012-2#1)
the effectiveness of this method##4##5##(1996-1#1)(2008-11#1)(2008-12#1)(2008-3#1)
the effectiveness of this technique##2##5##(2008-10#1)(2008-11#1)
the effectiveness of this type of##2##6##(2012-2#2)
the effectiveness of this##11##4##(1990-8#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2012-12#1)(2012-2#2)
the effectiveness of##136##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-12#4)(2012-2#12)(2013-1#19)(2013-8#1)
the effectiveness##139##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#8)(2008-12#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#4)(2012-2#12)(2013-1#20)(2013-8#1)
the effector cells##2##3##(1990-12#1)(1995-2#1)
the effector phase##3##3##(2008-10#3)
the effector##7##2##(1990-12#1)(1995-2#1)(1995-6#1)(2008-10#3)(2011-2#1)
the effectors of##2##3##(1996-2#1)(2008-9#1)
the effects and##6##3##(1995-2#1)(1996-3#1)(2008-12#1)(2008-3#1)(2011-3#1)(2012-3#1)
the effects are##4##3##(2008-3#1)(2008-7#1)(2009-11#1)(2013-1#1)
the effects in##2##3##(1995-2#1)(2011-2#1)
the effects of ET##2##4##(2012-3#2)
the effects of a##16##4##(1993-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-3#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
the effects of age and##2##5##(1994-9#1)(2008-8#1)
the effects of agents##2##4##(1996-2#1)(2008-5#1)
the effects of agricultural practices##2##5##(2008-10#2)
the effects of agricultural##3##4##(2008-10#2)(2008-11#1)
the effects of an##2##4##(2011-1#1)(2011-2#1)
the effects of bortezomib##2##4##(2011-2#2)
the effects of cetyltriethylammonium bromide (CTAB) on the##2##8##(2008-11#2)
the effects of chronic##2##4##(1996-12#1)(2010-6#1)
the effects of cisapride and BRL 24924##2##7##(1990-5#2)
the effects of continuous##2##4##(1995-12#1)(2010-6#1)
the effects of dexamethasone##2##4##(1994-3#1)(2010-12#1)
the effects of different types of##2##6##(2008-8#1)(2011-1#1)
the effects of different##6##4##(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2013-1#2)
the effects of each##2##4##(2008-12#1)(2008-8#1)
the effects of either##2##4##(2008-10#1)(2009-12#1)
the effects of estrogen on##3##5##(2008-11#2)(2008-7#1)
the effects of estrogen##4##4##(2008-11#2)(2008-7#2)
the effects of frequent##2##4##(2009-7#1)(2009-8#1)
the effects of gamma-aminobutyric acid (GABA)##2##6##(2008-8#1)(2008-9#1)
the effects of genes##3##4##(1997-7#2)(2012-3#1)
the effects of health care##2##5##(1993-12#2)
the effects of inoculum density##3##5##(2008-10#3)
the effects of inoculum##4##4##(2008-10#4)
the effects of long-term##2##4##(2008-5#1)(2012-2#1)
the effects of low doses of##2##6##(2008-7#1)(2013-1#1)
the effects of low##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
the effects of maternal##2##4##(1992-12#1)(2009-7#1)
the effects of mutations in##2##5##(2007-12#1)(2010-4#1)
the effects of natural perturbations##2##5##(2008-10#2)
the effects of noncompliance##2##4##(2007-11#2)
the effects of other##2##4##(2008-10#1)(2011-2#1)
the effects of pH##4##4##(1991-5#1)(2008-10#3)
the effects of physical##2##4##(2008-9#1)(2012-12#1)
the effects of sample##2##4##(2008-10#1)(2009-10#1)
the effects of selective##2##4##(2008-10#1)(2010-1#1)
the effects of several##2##4##(2008-10#1)(2012-5#1)
the effects of solvent and##2##5##(2008-10#2)
the effects of spatial##2##4##(2008-10#1)(2008-8#1)
the effects of temperature on the##2##6##(1991-11#1)(1991-5#1)
the effects of temperature on##3##5##(1991-11#1)(1991-5#1)(2008-10#1)
the effects of temperature##6##4##(1991-11#1)(1991-5#1)(2008-10#2)(2008-9#1)(2010-4#1)
the effects of the absence of##2##6##(1992-1#1)(2008-11#1)
the effects of the##43##4##(1991-10#1)(1991-5#1)(1992-1#1)(1992-2#2)(1993-8#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#2)(2009-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the effects of therapy##2##4##(1996-2#1)(2012-2#1)
the effects of these mutations##2##5##(1993-3#1)(2008-11#1)
the effects of these variables##2##5##(2008-4#2)
the effects of these##15##4##(1993-3#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2012-2#1)
the effects of this##3##4##(1991-2#1)(2008-3#1)(2008-8#1)
the effects of tillage practices on##2##6##(2008-10#2)
the effects of two factors##2##5##(2008-10#2)
the effects of two##7##4##(1993-1#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-8#1)
the effects of various cationic##2##5##(2008-10#2)
the effects of various##5##4##(1992-1#1)(1994-2#1)(2008-10#2)(2013-8#1)
the effects of varying##3##4##(2008-10#2)(2008-5#1)
the effects of##528##3##(1990-11#1)(1990-2#2)(1990-5#6)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#1)(1991-9#1)(1992-1#5)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#4)(1993-3#7)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#1)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#4)(1995-2#6)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-12#7)(1996-2#8)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#102)(2008-11#47)(2008-12#8)(2008-2#4)(2008-3#11)(2008-4#5)(2008-5#18)(2008-6#5)(2008-7#11)(2008-8#20)(2008-9#16)(2009-10#5)(2009-11#3)(2009-12#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#3)(2010-1#3)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#7)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#3)(2011-10#2)(2011-2#12)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#12)(2012-3#16)(2012-5#2)(2013-1#16)(2013-7#1)(2013-8#9)
the effects on the##4##4##(1992-6#1)(2008-5#1)(2011-3#2)
the effects on##20##3##(1992-6#1)(1993-12#1)(1994-1#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2011-3#2)(2012-4#1)(2013-1#1)
the effects that##3##3##(1991-2#1)(2008-10#2)
the effects were##3##3##(1991-1#1)(1993-6#1)(1994-2#1)
the effects##583##2##(1990-11#1)(1990-2#3)(1990-5#6)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-5#5)(1991-6#1)(1991-9#1)(1992-1#5)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#5)(1993-3#7)(1993-6#3)(1993-8#3)(1994-1#2)(1994-11#1)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#4)(1995-2#9)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-12#7)(1996-2#9)(1996-3#4)(1996-6#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#113)(2008-11#49)(2008-12#10)(2008-2#4)(2008-3#15)(2008-4#5)(2008-5#19)(2008-6#6)(2008-7#13)(2008-8#20)(2008-9#17)(2009-10#6)(2009-11#4)(2009-12#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#3)(2010-1#4)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#7)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#3)(2011-10#2)(2011-2#14)(2011-3#4)(2011-7#1)(2012-12#2)(2012-2#12)(2012-3#17)(2012-4#1)(2012-5#2)(2013-1#18)(2013-7#1)(2013-8#9)
the efferent vessel##2##3##(2008-7#2)
the efferent##5##2##(1992-3#1)(1994-2#1)(1997-3#1)(2008-7#2)
the efficacy and safety of##5##5##(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
the efficacy and tolerance of##2##5##(2008-10#1)(2008-5#1)
the efficacy and##12##3##(1993-1#1)(1993-12#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#2)
the efficacy of ASRC##2##4##(1996-12#2)
the efficacy of a new##2##5##(2008-10#1)(2012-3#1)
the efficacy of a##10##4##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-3#3)(2013-1#1)
the efficacy of an alternative##2##5##(1993-5#1)(2012-12#1)
the efficacy of drug##2##4##(2009-12#1)(2012-2#1)
the efficacy of resistance elicitors##2##5##(2008-10#2)
the efficacy of self-tanning##2##4##(2008-5#2)
the efficacy of the##12##4##(1993-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-8#2)(2012-3#1)
the efficacy of these##2##4##(2008-11#1)(2010-5#1)
the efficacy of treatment##3##4##(1994-5#1)(2012-2#1)(2013-1#1)
the efficacy of##113##3##(1992-1#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#9)(2013-8#1)
the efficacy profile of sunscreens##2##5##(2008-5#2)
the efficacy##136##2##(1990-2#1)(1992-1#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#13)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-12#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#11)(2013-8#1)
the efficiency and##8##3##(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
the efficiency of different##2##4##(2008-10#1)(2008-3#1)
the efficiency of extraction##2##4##(2008-10#2)
the efficiency of the##13##4##(1992-2#1)(1992-9#1)(1997-8#1)(2008-10#7)(2008-6#1)(2010-8#2)
the efficiency of this##2##4##(2008-10#1)(2009-10#1)
the efficiency of transmission##2##4##(2008-10#2)
the efficiency of##66##3##(1991-2#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-5#1)(1995-9#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#29)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#3)(2013-7#1)
the efficiency##83##2##(1991-2#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-5#1)(1995-1#1)(1995-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#34)(2008-11#4)(2008-12#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
the efficient and##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
the efficient use of##3##4##(1992-2#1)(2008-10#1)(2008-2#1)
the efficient##17##2##(1992-2#1)(2008-10#7)(2008-11#3)(2008-2#3)(2011-1#1)(2011-2#1)(2013-1#1)
the effluent of##2##3##(2008-10#2)
the effluent##13##2##(2008-10#10)(2008-11#2)(2008-7#1)
the efflux##2##2##(1992-12#1)(1994-8#1)
the effort to##4##3##(1993-12#1)(1994-9#1)(2008-11#1)(2012-3#1)
the effort##9##2##(1991-3#1)(1992-3#1)(1993-12#1)(1994-9#3)(2008-10#1)(2008-11#1)(2012-3#1)
the efforts by the##2##4##(1991-6#1)(1993-12#1)
the efforts of the##3##4##(1992-1#1)(1994-9#1)(1996-1#1)
the efforts of##6##3##(1992-1#2)(1994-9#1)(1995-3#1)(1996-1#1)(2012-2#1)
the efforts to##4##3##(1993-3#1)(1996-11#1)(1997-7#1)(2008-12#1)
the efforts##13##2##(1991-6#1)(1992-1#2)(1993-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-7#1)(2007-8#1)(2008-12#1)(2012-2#1)
the egg capsule##2##3##(2008-12#2)
the egg cell and##2##4##(2008-11#1)(2008-9#1)
the egg cell##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
the egg shell/lipid layer##2##4##(2008-10#2)
the egg stage##2##3##(1990-3#1)(2008-8#1)
the egg##27##2##(1990-3#1)(1994-11#1)(1997-6#2)(2007-12#2)(2008-10#3)(2008-11#4)(2008-12#5)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2011-2#1)
the egl1 gene##3##3##(2008-10#3)
the eight Ac##2##3##(2012-3#2)
the eight races##3##3##(2008-10#3)
the eight##26##2##(1991-12#1)(1993-6#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-3#2)(2008-10#12)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
the eight-channel condition##2##3##(2008-9#2)
the eighteen##2##2##(2012-3#2)
the eighteenth century##2##3##(2008-10#1)(2010-5#1)
the eighteenth##3##2##(2008-10#1)(2010-1#1)(2010-5#1)
the eighth day##2##3##(2008-5#1)(2011-2#1)
the eighth##7##2##(2008-5#2)(2008-8#1)(2011-2#3)(2013-1#1)
the ejaculatory duct lumen##2##4##(2008-7#2)
the ejaculatory duct##5##3##(2008-7#5)
the ejaculatory##8##2##(1997-8#3)(2008-7#5)
the ejection fraction and the cardiac index##2##7##(1993-2#2)
the ejection fraction and##3##4##(1993-2#2)(2009-5#1)
the ejection fraction##4##3##(1990-9#1)(1993-2#2)(2009-5#1)
the ejection##5##2##(1990-9#2)(1993-2#2)(2009-5#1)
the elaboration of##6##3##(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)
the elaboration##8##2##(2008-10#3)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)
the elastic modulus##3##3##(2009-7#1)(2010-4#1)(2010-8#1)
the elastic properties of##3##4##(2008-10#1)(2009-7#1)(2010-4#1)
the elastic properties##4##3##(2008-10#1)(2009-7#2)(2010-4#1)
the elastic##8##2##(2008-10#1)(2008-5#1)(2009-7#3)(2010-4#2)(2010-8#1)
the elbow##6##2##(2008-12#1)(2008-9#3)(2010-11#1)(2013-1#1)
the elderly and##8##3##(1991-3#1)(1992-3#1)(1997-8#1)(2008-11#1)(2008-7#2)(2012-3#1)(2013-1#1)
the elderly are##4##3##(1990-11#1)(1994-1#1)(1995-2#1)(2008-10#1)
the elderly in##5##3##(1991-2#1)(1995-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
the elderly living##2##3##(2008-7#2)
the elderly patient##4##3##(1990-11#1)(1992-3#1)(1993-11#1)(1996-3#1)
the elderly population##11##3##(1991-3#1)(1993-3#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2011-7#1)(2012-3#1)
the elderly were##2##3##(1994-1#1)(1995-8#1)
the elderly with##2##3##(1991-2#1)(1991-6#1)
the elderly##131##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#6)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#4)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-9#1)(1994-1#7)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-8#2)(2008-10#4)(2008-11#8)(2008-12#2)(2008-5#5)(2008-7#20)(2008-8#7)(2008-9#1)(2009-1#3)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#6)(2011-7#1)(2012-2#1)(2012-3#4)(2013-1#4)
the elderly]##5##2##(1990-3#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-6#1)
the elective##2##2##(1991-6#1)(1997-2#1)
the electric field of the##2##5##(2008-10#1)(2008-3#1)
the electric field##8##3##(2008-10#5)(2008-3#3)
the electric##12##2##(2008-10#6)(2008-3#3)(2008-7#1)(2009-12#1)(2010-6#1)
the electrical activity of##3##4##(1994-2#1)(1996-2#1)(2010-8#1)
the electrical stimulus##2##3##(2009-8#1)(2012-12#1)
the electrical##18##2##(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-9#1)(2009-8#3)(2010-8#3)(2012-12#1)(2012-3#1)(2013-1#1)
the electrically##3##2##(1990-5#2)(2008-10#1)
the electro##2##2##(2008-10#1)(2012-2#1)
the electro-optic crystal##2##3##(2008-3#2)
the electro-reduction of the product of the enzyme-catalyzed reaction have been##2##11##(2008-10#2)
the electro-reduction##3##2##(2008-10#3)
the electroactive##6##2##(2008-10#6)
the electroanalytical##4##2##(2008-10#4)
the electrocardiogram##2##2##(2008-11#1)(2013-1#1)
the electrocatalytic oxidation of##2##4##(2008-10#2)
the electrocatalytic process##2##3##(2008-10#2)
the electrocatalytic reduction of##2##4##(2008-10#2)
the electrocatalytic##8##2##(2008-10#8)
the electrocautery##2##2##(1994-12#2)
the electrochemical behavior of the##2##5##(2008-10#2)
the electrochemical behavior of##5##4##(2008-10#4)(2010-6#1)
the electrochemical detection of##3##4##(2008-10#1)(2008-12#2)
the electrochemical detection##6##3##(1993-1#1)(2008-10#3)(2008-12#2)
the electrochemical determination of##5##4##(2008-10#5)
the electrochemical hydride generation##4##4##(2008-10#4)
the electrochemical oxidation of##4##4##(2008-10#4)
the electrochemical reaction##2##3##(1990-12#1)(2008-10#1)
the electrochemical reduction of##2##4##(2008-10#2)
the electrochemical response of##2##4##(2008-10#2)
the electrochemical response##5##3##(2008-10#5)
the electrochemical##52##2##(1990-12#1)(1993-1#1)(2008-10#45)(2008-12#2)(2008-8#2)(2010-6#1)
the electrochemically##5##2##(2008-10#4)(2009-12#1)
the electrochemistry of##2##3##(2008-10#2)
the electrode and##9##3##(1990-5#1)(2008-10#6)(2008-12#1)(2008-9#1)
the electrode based on##3##4##(2008-10#3)
the electrode by##5##3##(1995-6#1)(2008-10#4)
the electrode can be used##2##5##(2008-10#2)
the electrode can be##4##4##(2008-10#4)
the electrode can##5##3##(2008-10#5)
the electrode exhibited good selectivity##2##5##(2008-10#2)
the electrode exhibited##4##3##(2008-10#4)
the electrode has##2##3##(2008-10#2)
the electrode in a##2##4##(2008-10#2)
the electrode in the##2##4##(2008-10#2)
the electrode in##7##3##(2008-10#7)
the electrode is##6##3##(2008-10#6)
the electrode materials##2##3##(2008-10#2)
the electrode membrane##3##3##(2008-10#3)
the electrode performance##2##3##(2008-10#2)
the electrode potential and##2##4##(2008-10#2)
the electrode potential is##2##4##(2008-10#2)
the electrode potential##7##3##(2008-10#7)
the electrode prepared##3##3##(2008-10#3)
the electrode process was##2##4##(2008-10#2)
the electrode process##3##3##(2008-10#3)
the electrode reaction was##2##4##(2008-10#2)
the electrode response##8##3##(2008-10#8)
the electrode responses##2##3##(2008-10#2)
the electrode selectivity##2##3##(2008-10#2)
the electrode shows##2##3##(2008-10#2)
the electrode surface and##4##4##(2008-10#4)
the electrode surface by##3##4##(2008-10#3)
the electrode surface such that##2##5##(2008-10#2)
the electrode surface was##2##4##(2008-10#2)
the electrode surface##49##3##(2008-10#48)(2009-12#1)
the electrode was##17##3##(2008-10#17)
the electrode were##2##3##(2008-10#2)
the electrode with##3##3##(2008-10#3)
the electrode##216##2##(1990-5#1)(1995-6#1)(2008-10#204)(2008-12#1)(2008-9#8)(2009-12#1)
the electrodeposited##3##2##(2008-10#3)
the electrodeposition##3##2##(2008-10#3)
the electrodes are##6##3##(2008-10#6)
the electrodes based on##2##4##(2008-10#2)
the electrodes were##4##3##(2008-10#3)(2008-9#1)
the electrodes##35##2##(1996-2#1)(2008-10#30)(2008-9#2)(2009-8#1)(2010-7#1)
the electroencephalogram##2##2##(2009-8#1)(2011-2#1)
the electrogenerated##2##2##(2008-10#2)
the electrolyte##5##2##(2008-10#4)(2010-7#1)
the electrolytic chamber##2##3##(2008-10#2)
the electrolytic##5##2##(2008-10#5)
the electromagnetic##7##2##(2007-12#1)(2008-2#3)(2008-3#2)(2012-12#1)
the electromyographic activity of the##3##5##(2010-6#1)(2010-9#2)
the electromyographic signal##2##3##(2010-6#1)(2010-9#1)
the electromyographic##5##2##(2010-6#2)(2010-9#3)
the electron impact##2##3##(2008-10#2)
the electron microscope##5##3##(1997-3#1)(2008-10#3)(2008-7#1)
the electron microscopic level##2##4##(1995-3#1)(2008-7#1)
the electron phase space beam model##2##6##(2009-11#2)
the electron spin resonance technique##2##5##(2008-10#1)(2008-8#1)
the electron transfer between##2##4##(2008-10#2)
the electron transfer was##2##4##(2008-10#2)
the electron transfer##10##3##(2008-10#8)(2008-8#1)(2009-9#1)
the electron##36##2##(1995-3#1)(1997-3#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#2)(2009-7#1)(2009-9#1)
the electron-transfer##4##2##(1990-5#1)(2008-10#3)
the electronic absorption##2##3##(2008-10#2)
the electronic patient record##2##4##(1997-1#2)
the electronic tongue##2##3##(2008-10#2)
the electronic##21##2##(1997-1#2)(1997-5#1)(2008-10#8)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#4)
the electronics##2##2##(2008-10#2)
the electroosmotic flow (EOF)##3##4##(1997-2#1)(2008-10#2)
the electrophoresis##2##2##(2008-10#1)(2009-8#1)
the electrophoretic mobility of the##2##5##(1994-11#1)(2008-10#1)
the electrophoretic##6##2##(1994-11#1)(1997-2#1)(2008-10#3)(2008-2#1)
the electrophysiological and##2##3##(2008-11#1)(2008-9#1)
the electrophysiological##4##2##(1990-9#1)(1993-8#1)(2008-11#1)(2008-9#1)
the electropolymerization of pyrrole##2##4##(2008-10#2)
the electropolymerization of##4##3##(2008-10#4)
the electropolymerization##8##2##(2008-10#8)
the electrospray##2##2##(1997-2#1)(2008-10#1)
the electrostatic contribution##2##3##(2008-4#1)(2008-7#1)
the electrostatic force##2##3##(2008-10#2)
the electrostatic##15##2##(1994-5#2)(2008-10#7)(2008-4#4)(2008-7#1)(2013-1#1)
the electrothermal atomic absorption spectrometric##2##5##(2008-10#2)
the electrothermal atomic absorption##3##4##(2008-10#3)
the electrothermal atomizer##2##3##(2008-10#2)
the electrothermal##5##2##(2008-10#5)
the element##8##2##(1990-3#1)(2008-10#5)(2008-3#1)(2009-6#1)
the elemental analysis of##2##4##(2008-10#2)
the elemental analysis##3##3##(2008-10#3)
the elemental composition of##3##4##(2008-10#3)
the elemental##13##2##(2008-10#13)
the elementary events underlying force generation##2##6##(2012-2#2)
the elements and##4##3##(1997-1#1)(2008-10#2)(2013-1#1)
the elements in##4##3##(2008-10#4)
the elements investigated##2##3##(2008-10#2)
the elements of the##3##4##(2008-9#1)(2013-1#2)
the elements of##8##3##(1994-12#1)(1994-3#2)(2008-10#2)(2008-9#1)(2013-1#2)
the elements studied##2##3##(2008-10#2)
the elements##45##2##(1993-12#1)(1994-12#1)(1994-3#2)(1997-1#1)(2008-10#35)(2008-11#1)(2008-9#1)(2013-1#3)
the elevated blood pressure##2##4##(1997-5#2)
the elevated blood##3##3##(1992-5#1)(1997-5#2)
the elevated levels of##2##4##(1990-8#1)(2011-2#1)
the elevated plus-maze and the shock-probe burying tests##2##8##(1993-3#2)
the elevated plus-maze test##3##4##(1993-3#2)(2008-11#1)
the elevated plus-maze##7##3##(1993-3#4)(2008-11#3)
the elevated##19##2##(1990-8#1)(1992-5#1)(1993-3#4)(1997-5#2)(2008-11#3)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
the elevation angle##2##3##(2008-3#2)
the elevation of blood##2##4##(2009-7#1)(2010-11#1)
the elevation of the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
the elevation of##9##3##(1995-6#1)(2008-10#2)(2008-11#1)(2009-1#1)(2009-7#1)(2010-11#1)(2011-2#1)(2011-3#1)
the elevation##12##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-1#1)(2009-7#1)(2010-11#1)(2011-2#1)(2011-3#1)
the elicitation##3##2##(2008-10#2)(2008-4#1)
the elicitin family##2##3##(2008-10#2)
the eligibility##2##2##(1997-2#1)(2013-1#1)
the elimination of the##3##4##(1991-3#1)(2008-10#1)(2012-12#1)
the elimination of##18##3##(1990-11#1)(1991-3#1)(1994-2#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#4)
the elimination##20##2##(1990-11#2)(1991-3#1)(1994-2#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#5)
the elongated##3##2##(1994-5#1)(2009-8#1)(2011-2#1)
the elongating##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
the elongation##2##2##(2008-7#1)(2011-2#1)
the eluant##3##2##(2008-10#3)
the eluate was evaporated##2##4##(2008-10#2)
the eluate was##3##3##(2008-10#3)
the eluate##6##2##(2008-10#6)
the elucidation of the##2##4##(2009-12#1)(2010-1#1)
the elucidation of##4##3##(1997-8#1)(2008-5#1)(2009-12#1)(2010-1#1)
the eluent##12##2##(2008-10#12)
the elusive##2##2##(1997-2#1)(2008-10#1)
the eluted##3##2##(2008-10#3)
the eluting##3##2##(2008-10#3)
the elution of##5##3##(2008-10#5)
the elution order of##2##4##(2008-10#2)
the elution##17##2##(1990-12#1)(1990-5#1)(1992-6#1)(2008-10#14)
the embedded##4##2##(2008-10#2)(2008-11#1)(2009-8#1)
the embolization##4##2##(1991-2#1)(2008-7#3)
the embryo implantation##2##3##(2008-9#1)(2013-1#1)
the embryo sac##5##3##(2008-11#2)(2009-8#3)
the embryo to##2##3##(2007-12#1)(2008-11#1)
the embryo##26##2##(1993-12#1)(1994-12#1)(1994-9#1)(2007-12#4)(2008-10#6)(2008-11#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#4)(2013-1#1)
the embryology##2##2##(2008-11#1)(2008-12#1)
the embryonal##3##2##(1994-11#1)(2008-11#1)(2009-8#1)
the embryonic brain of the grasshopper Schistocerca gregaria##2##8##(2007-12#2)
the embryonic development of##2##4##(2008-6#1)(2010-5#1)
the embryonic##10##2##(1990-5#1)(1993-6#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-9#2)(2010-5#1)(2012-12#1)
the embryos##3##2##(2008-10#2)(2008-11#1)
the emergence and##2##3##(2008-10#1)(2013-1#1)
the emergence of a new##3##5##(1994-1#1)(1994-12#1)(2008-10#1)
the emergence of a##5##4##(1994-1#1)(1994-12#1)(2008-10#1)(2008-11#2)
the emergence of novel##2##4##(2009-6#1)(2011-9#1)
the emergence of women's health centers has been a nationally growing trend##2##12##(1994-3#2)
the emergence of##37##3##(1991-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(2008-10#4)(2008-11#8)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#2)(2011-2#2)(2011-3#1)(2011-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
the emergence##40##2##(1991-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(2008-10#6)(2008-11#8)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#2)(2011-2#2)(2011-3#1)(2011-9#1)(2012-2#1)(2013-1#4)(2013-8#1)
the emergency department (ED)##4##4##(2009-6#2)(2010-8#1)(2012-2#1)
the emergency department of##2##4##(2008-10#1)(2013-1#1)
the emergency department with cardiac magnetic resonance imaging##2##8##(2008-3#2)
the emergency department with cardiac magnetic resonance##3##7##(2008-3#3)
the emergency department with##6##4##(2008-3#3)(2009-9#1)(2011-2#1)(2013-1#1)
the emergency department##34##3##(1991-12#1)(2006-5#2)(2008-10#2)(2008-11#3)(2008-3#7)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-9#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
the emergency room for##3##4##(1995-11#1)(2011-2#1)(2013-1#1)
the emergency room##7##3##(1995-11#1)(2007-12#3)(2010-12#1)(2011-2#1)(2013-1#1)
the emergency##53##2##(1991-12#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(2006-5#4)(2007-12#3)(2007-9#1)(2008-10#3)(2008-11#4)(2008-3#7)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#5)
the emergent##6##2##(2008-10#1)(2010-1#2)(2011-2#1)(2012-12#2)
the emerging field of##2##4##(2009-7#1)(2013-8#1)
the emerging##20##2##(1991-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
the emission intensity##2##3##(2008-10#2)
the emission of the##2##4##(2008-10#2)
the emission of##14##3##(1996-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2012-2#1)
the emission spectra of##2##4##(1990-5#1)(2008-10#1)
the emission spectra##4##3##(1990-5#1)(2008-10#3)
the emission wavelength##5##3##(2008-10#5)
the emission##43##2##(1990-5#1)(1991-5#1)(1996-2#1)(2007-12#1)(2008-10#33)(2008-11#2)(2008-3#2)(2010-7#1)(2012-2#1)
the emitted##4##2##(2008-10#4)
the emollient##2##2##(2008-5#2)
the emotional distress##2##3##(1991-12#1)(1995-9#1)
the emotional##10##2##(1990-11#1)(1991-12#1)(1992-3#1)(1993-11#1)(1995-9#1)(1997-4#1)(2008-11#2)(2011-1#1)(2013-1#1)
the emotionality of##2##3##(1993-3#1)(2010-10#1)
the emotionality##3##2##(1993-3#1)(2010-10#2)
the emotions##4##2##(2008-11#1)(2010-1#1)(2013-8#2)
the emphasis##4##2##(1996-6#1)(2008-12#1)(2008-5#1)(2012-2#1)
the empirical results##2##3##(2008-8#1)(2013-1#1)
the empirical##13##2##(1993-2#1)(1995-11#1)(1996-2#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-4#2)(2013-1#1)
the empirically##2##2##(1994-8#1)(2013-1#1)
the employee##4##2##(1991-2#1)(1994-2#1)(1995-6#1)(1996-5#1)
the employer##2##2##(1995-6#1)(1997-2#1)
the employer's##3##2##(1994-2#1)(1995-12#1)(2008-6#1)
the employment of##4##3##(2008-10#3)(2008-12#1)
the employment##5##2##(1994-1#1)(2008-10#3)(2008-12#1)
the emptying##2##2##(1997-4#2)
the emulsion##7##2##(2008-10#4)(2008-11#1)(2008-5#2)
the emulsions##4##2##(2008-10#1)(2008-5#3)
the enamel##2##2##(2008-7#1)(2013-1#1)
the enantiomeric composition of##3##4##(2008-10#3)
the enantiomeric composition##4##3##(2008-10#4)
the enantiomeric separation##2##3##(2008-10#2)
the enantiomeric##7##2##(2008-10#7)
the enantiomers of##5##3##(2008-10#4)(2008-11#1)
the enantiomers##11##2##(1997-2#1)(2008-10#9)(2008-11#1)
the enantiopurity of##4##3##(2008-10#4)
the enantioselective##4##2##(2008-10#4)
the enantioseparation##3##2##(2008-10#3)
the encapsulation of##3##3##(2008-10#2)(2010-6#1)
the encapsulation##4##2##(2008-10#3)(2010-6#1)
the enchytraeid-biotest##2##2##(2008-11#2)
the encoding of##2##3##(2008-11#1)(2013-8#1)
the encoding##8##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-3#1)(2012-3#1)(2013-8#1)
the end of 1994##3##4##(1996-3#1)(1997-6#2)
the end of 2006##2##4##(2008-10#1)(2011-2#1)
the end of World War II##2##6##(2008-12#1)(2011-2#1)
the end of a##11##4##(1994-2#1)(1997-1#1)(2008-10#7)(2008-8#1)(2013-1#1)
the end of each##5##4##(1994-3#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-1#1)
the end of follow up##2##5##(2013-1#2)
the end of the common##2##5##(2007-12#1)(2008-11#1)
the end of the course##4##5##(2008-11#3)(2013-8#1)
the end of the decade##2##5##(1994-2#1)(1994-9#1)
the end of the follow-up period##2##6##(2008-7#2)
the end of the fourth year##2##6##(1992-12#2)
the end of the fourth##4##5##(1992-12#2)(1995-6#1)(2012-9#1)
the end of the growing season##2##6##(2008-10#2)
the end of the growth##3##5##(2008-11#3)
the end of the season##3##5##(2008-10#1)(2008-8#2)
the end of the second year##2##6##(1996-11#1)(1996-12#1)
the end of the second##6##5##(1996-11#1)(1996-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
the end of the study##6##5##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)
the end of the third year##2##6##(1992-12#2)
the end of the treatment##5##5##(1990-11#1)(1990-9#1)(1991-8#1)(1997-3#1)(2013-1#1)
the end of the trial##3##5##(1991-3#1)(1994-9#1)(2008-8#1)
the end of the##104##4##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#5)(1992-8#1)(1993-9#1)(1994-2#3)(1994-9#3)(1995-6#1)(1996-11#1)(1996-12#3)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#22)(2008-11#12)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#5)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-7#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
the end of their lives##2##5##(2012-12#1)(2013-1#1)
the end of their##6##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
the end of therapy##4##4##(2008-9#1)(2012-2#2)(2013-1#1)
the end of this##5##4##(1996-1#1)(2008-10#2)(2010-5#1)(2011-3#1)
the end of##190##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#5)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#4)(1994-3#1)(1994-9#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#3)(2007-12#2)(2008-10#42)(2008-11#13)(2008-12#9)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#8)(2009-12#2)(2010-1#2)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#4)(2012-7#1)(2012-9#1)(2013-1#13)(2013-7#1)(2013-8#2)
the end point##5##3##(2008-10#4)(2012-12#1)
the end product##2##3##(2008-10#2)
the end result##3##3##(1997-3#1)(2009-3#1)(2013-1#1)
the end stage##2##3##(1996-2#1)(2009-10#1)
the end##213##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#6)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#4)(1994-3#1)(1994-9#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#4)(2007-12#2)(2008-10#48)(2008-11#14)(2008-12#10)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2010-1#4)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#1)(2012-7#1)(2012-9#1)(2013-1#14)(2013-7#1)(2013-8#2)
the end-point of##2##3##(2008-10#1)(2011-2#1)
the end-point##9##2##(2008-10#8)(2011-2#1)
the endemic##7##2##(1996-11#1)(2008-12#1)(2008-5#1)(2011-2#3)(2012-12#1)
the endo##4##2##(1996-5#4)
the endobronchial route##2##3##(1994-9#2)
the endobronchial##4##2##(1994-9#4)
the endocervical##2##2##(1991-2#2)
the endocervix##2##2##(1992-3#1)(1994-12#1)
the endocrine effects of subcutaneous##2##5##(1991-6#2)
the endocrine pancreas##2##3##(1991-7#1)(1994-8#1)
the endocrine system##2##3##(2008-11#2)
the endocrine systems##2##3##(2008-5#1)(2010-5#1)
the endocrine##13##2##(1990-11#1)(1991-3#1)(1991-6#2)(1991-7#1)(1994-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)
the endocrinology##2##2##(2011-2#2)
the endoderm##4##2##(2008-11#1)(2008-6#2)(2008-7#1)
the endodontic##2##2##(2012-3#2)
the endogenous##38##2##(1990-5#2)(1992-8#1)(1992-9#2)(1993-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-10#3)(2008-11#7)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#3)(2010-11#2)(2011-2#1)(2012-3#1)(2013-7#1)
the endometrial##5##2##(1995-3#1)(2008-10#1)(2008-9#2)(2009-8#1)
the endometrium and##2##3##(1991-3#1)(2012-3#1)
the endometrium is##3##3##(2011-2#1)(2012-3#2)
the endometrium##18##2##(1991-3#1)(1993-9#1)(1995-3#1)(2008-9#2)(2011-2#9)(2012-3#4)
the endonuclease##2##2##(1992-12#1)(1995-12#1)
the endophyte##3##2##(2008-10#3)
the endoplasmic reticulum (ER)##7##4##(1991-2#1)(1994-12#1)(1995-2#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
the endoplasmic reticulum and##4##4##(1995-5#1)(2008-11#1)(2009-7#1)(2009-8#1)
the endoplasmic reticulum membrane##4##4##(1991-10#1)(1995-6#3)
the endoplasmic reticulum##35##3##(1991-10#1)(1991-2#2)(1993-8#2)(1994-12#2)(1995-2#3)(1995-5#1)(1995-6#3)(1996-3#3)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#6)(2008-7#2)(2009-7#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
the endoplasmic##39##2##(1991-10#1)(1991-2#2)(1993-8#3)(1994-11#1)(1994-12#2)(1995-2#3)(1995-5#1)(1995-6#3)(1996-3#3)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#6)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
the endoscope##3##2##(2008-7#1)(2009-8#1)(2013-1#1)
the endoscopic##7##2##(1990-3#1)(1991-3#1)(1993-12#1)(1994-3#1)(2010-12#1)(2011-2#2)
the endoscopy##2##2##(1992-11#1)(1992-5#1)
the endosome##2##2##(1994-5#1)(2008-11#1)
the endosperm##4##2##(2008-10#3)(2009-12#1)
the endosymbiont##4##2##(1996-12#3)(2012-3#1)
the endothelial cell loss and clinical outcome##2##7##(2011-2#2)
the endothelial cell##5##3##(1993-8#1)(1995-2#2)(2011-2#2)
the endothelial dysfunction##3##3##(2008-1#1)(2008-11#1)(2010-10#1)
the endothelial##11##2##(1993-8#1)(1995-11#1)(1995-2#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#2)(2011-2#2)
the endothelin-B receptor gene##2##4##(1994-12#2)
the endothelin-B receptor##4##3##(1994-12#4)
the endothelium and perivascular infiltrating inflammatory cells##2##7##(2012-3#2)
the endothelium and##4##3##(1995-2#1)(2008-10#1)(2012-3#2)
the endothelium##10##2##(1992-11#1)(1994-9#1)(1995-2#2)(2008-10#1)(2008-5#1)(2012-3#4)
the endotoxin##2##2##(1990-12#1)(2012-12#1)
the endotracheal tube##2##3##(1996-3#1)(2010-7#1)
the endovascular procedure##3##3##(1996-6#1)(2008-7#1)(2013-8#1)
the endovascular##5##2##(1995-11#1)(1996-6#1)(1996-9#1)(2008-7#1)(2013-8#1)
the endpoint##2##2##(1992-9#1)(2008-7#1)
the ends of##7##3##(1997-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)
the ends##11##2##(1993-6#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-9#1)
the energetic equivalence rule##2##4##(2008-9#2)
the energetic invariant##2##3##(2008-3#2)
the energetic##10##2##(1994-3#1)(2008-10#1)(2008-3#3)(2008-8#2)(2008-9#3)
the energy gap##2##3##(1993-5#1)(2012-12#1)
the energy of##2##3##(2008-10#1)(2008-4#1)
the energy supply##2##3##(1994-2#1)(2009-8#1)
the energy transfer##7##3##(2008-10#4)(2008-8#3)
the energy##45##2##(1993-5#1)(1994-2#2)(1995-11#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#6)(2008-3#7)(2008-4#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2009-8#3)(2010-4#1)(2012-12#1)(2013-1#3)(2013-8#1)
the energy-density distribution##2##3##(2008-2#2)
the engineering of##2##3##(1995-3#1)(2008-11#1)
the engineering##5##2##(1995-3#1)(2008-11#2)(2009-12#1)(2012-3#1)
the engineerized enzyme##2##3##(2008-10#2)
the engrailed protein##2##3##(2007-12#2)
the enhanced ECL##4##3##(2008-10#4)
the enhanced RLS intensity##4##4##(2008-10#4)
the enhanced growth##2##3##(1992-8#1)(2008-11#1)
the enhanced intensity of fluorescence is in proportion to the concentration of##2##12##(2008-10#2)
the enhanced resonance light scattering (RLS)##2##6##(2008-10#2)
the enhanced##37##2##(1990-5#1)(1990-8#1)(1992-8#1)(1992-9#1)(1996-12#1)(1997-8#1)(2008-10#22)(2008-11#4)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-8#1)
the enhancement effect##2##3##(2008-10#2)
the enhancement factor was##4##4##(2008-10#4)
the enhancement in##2##3##(1997-8#1)(2008-7#1)
the enhancement of the##7##4##(1993-3#1)(2008-10#4)(2008-11#1)(2008-8#1)
the enhancement of##32##3##(1990-6#1)(1992-8#1)(1993-3#1)(1995-11#1)(1995-6#1)(1996-2#2)(1997-8#1)(2008-10#15)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
the enhancement##46##2##(1990-6#2)(1992-8#1)(1993-3#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-2#2)(1997-8#3)(2008-10#21)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#2)
the enhancer##6##2##(1991-5#1)(1992-10#1)(1994-11#1)(1995-8#1)(2008-9#1)(2012-3#1)
the enhancing effect of##3##4##(2008-10#2)(2008-11#1)
the enhancing effect##6##3##(2008-10#3)(2008-11#2)(2009-8#1)
the enhancing##7##2##(2008-10#3)(2008-11#2)(2008-5#1)(2009-8#1)
the enlarged##5##2##(1997-7#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
the enormous##7##2##(1995-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
the enriched##5##2##(1991-2#1)(2008-10#2)(2008-11#1)(2010-2#1)
the enrichment column##2##3##(2008-10#2)
the enrichment factor##4##3##(2008-10#4)
the enrichment factors##2##3##(2008-10#2)
the enrichment of##8##3##(2008-10#6)(2008-11#1)(2011-2#1)
the enrichment##23##2##(1991-12#1)(2008-10#18)(2008-11#1)(2011-2#3)
the enrollment##2##2##(1991-1#1)(1991-2#1)
the ensuing##8##2##(1996-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-3#2)
the entA mutant##3##3##(2008-10#3)
the enteric nervous system##2##4##(1992-6#2)
the enteric##3##2##(1992-6#2)(2013-1#1)
the enterprise##2##2##(1994-12#1)(1997-3#1)
the enthalpy and##2##3##(1990-8#1)(2008-10#1)
the enthalpy change##3##3##(1993-8#1)(2008-10#2)
the enthalpy##9##2##(1990-8#1)(1992-10#1)(1993-8#1)(1994-5#1)(1997-2#2)(2008-10#3)
the entire ITS##3##3##(2008-10#3)
the entire body##2##3##(2007-12#1)(2012-2#1)
the entire coding region of##2##5##(1990-8#1)(1993-6#1)
the entire coding region##3##4##(1990-8#1)(1993-6#1)(1996-2#1)
the entire control##2##3##(2008-12#2)
the entire experiment##3##3##(2008-10#2)(2012-9#1)
the entire genome of##2##4##(1996-6#1)(2008-8#1)
the entire genome##10##3##(1996-12#1)(1996-6#4)(1996-8#1)(1997-2#1)(2008-8#2)(2011-2#1)
the entire length##3##3##(1996-6#1)(1997-4#1)(2009-7#1)
the entire pH range##2##4##(2008-10#2)
the entire population##4##3##(1997-6#1)(2008-10#1)(2011-2#2)
the entire procedure##5##3##(1993-1#1)(1994-8#1)(2008-10#3)
the entire range of##2##4##(2008-10#1)(2012-2#1)
the entire region of##2##4##(1995-6#1)(2009-7#1)
the entire section##2##3##(2011-2#2)
the entire sequence of##3##4##(1991-3#1)(2008-5#1)(2013-8#1)
the entire sequence##7##3##(1991-3#1)(1992-3#1)(1993-8#1)(1995-9#1)(1997-6#1)(2008-5#1)(2013-8#1)
the entire set of##2##4##(2008-10#2)
the entire time##2##3##(1990-8#1)(2009-7#1)
the entire##152##2##(1990-2#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#2)(1995-9#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#5)(1996-8#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#34)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#5)(2009-12#1)(2009-2#1)(2009-7#3)(2009-8#1)(2009-9#3)(2010-11#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#9)(2012-2#6)(2012-3#2)(2012-9#1)(2013-1#1)(2013-3#1)(2013-8#1)
the entity##4##2##(1993-12#1)(1993-8#1)(2008-10#1)(2008-12#1)
the entorhinal-hippocampal loop circuits##2##4##(2008-11#2)
the entrainment##2##2##(1994-2#1)(2008-5#1)
the entrance to the##2##4##(2008-11#1)(2011-2#1)
the entrance##5##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
the entrapment##3##2##(2008-10#2)(2008-8#1)
the entrapped##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
the entry into##2##3##(1994-5#1)(2010-5#1)
the entry of##2##3##(1997-2#1)(2011-3#1)
the entry point##2##3##(2008-11#1)(2013-8#1)
the entry##8##2##(1994-5#1)(1997-2#1)(2008-11#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-8#1)
the enucleated##2##2##(2008-9#2)
the envelope##2##2##(1993-12#1)(2011-2#1)
the environment and##13##3##(1990-9#1)(1993-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
the environment has##2##3##(2008-10#2)
the environment in##2##3##(1990-3#1)(2008-8#1)
the environment is##5##3##(2008-10#4)(2008-8#1)
the environment of the##4##4##(1991-6#1)(1994-5#1)(2008-10#1)(2013-1#1)
the environment##117##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#2)(1993-12#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#47)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#9)(2008-9#3)(2009-6#2)(2009-8#1)(2010-12#1)(2010-5#3)(2010-7#1)(2011-1#5)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
the environmental and biological##2##4##(2008-10#2)
the environmental and##6##3##(2008-10#4)(2008-3#1)(2008-7#1)
the environmental conditions##3##3##(2008-10#1)(2008-8#2)
the environmental factors##3##3##(2008-10#2)(2011-3#1)
the environmental impact of##2##4##(2008-10#1)(2008-11#1)
the environmental impacts of##2##4##(2008-11#2)
the environmental index##2##3##(2008-10#2)
the environmental monitoring of##2##4##(2008-10#2)
the environmental risk##2##3##(2008-10#1)(2008-11#1)
the environmental variance##2##3##(2008-8#1)(2008-9#1)
the environmental##59##2##(1991-12#1)(1996-1#1)(2008-1#1)(2008-10#31)(2008-11#7)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-2#2)
the environmentally##2##2##(2008-8#1)(2012-2#1)
the environments##3##2##(2008-10#2)(2008-9#1)
the enzymatic activities of##2##4##(1993-12#1)(2008-10#1)
the enzymatic activity of the##3##5##(2008-10#2)(2008-6#1)
the enzymatic activity of##8##4##(1995-2#1)(2008-10#5)(2008-11#1)(2008-6#1)
the enzymatic activity was##3##4##(1992-6#1)(2008-10#2)
the enzymatic activity##14##3##(1992-6#1)(1995-2#1)(2008-10#8)(2008-11#2)(2008-6#1)(2008-7#1)
the enzymatic degradation##3##3##(2008-10#2)(2011-1#1)
the enzymatic hydrolysis of##4##4##(2008-10#4)
the enzymatic hydrolysis process##2##4##(2008-10#2)
the enzymatic hydrolysis##8##3##(2008-10#8)
the enzymatic probe sonication##2##4##(2008-10#2)
the enzymatic reaction and##2##4##(2008-10#1)(2011-2#1)
the enzymatic reaction is##2##4##(2008-10#2)
the enzymatic reaction of##4##4##(1991-5#1)(2008-10#3)
the enzymatic reaction##16##3##(1991-5#1)(2008-10#14)(2011-2#1)
the enzymatic reactor##2##3##(2008-10#2)
the enzymatic##65##2##(1990-11#1)(1990-12#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-2#1)(1996-2#1)(2008-10#46)(2008-11#2)(2008-12#1)(2008-6#3)(2008-7#3)(2009-5#1)(2011-1#1)(2011-2#1)
the enzyme active site##3##4##(1995-6#3)
the enzyme activities##2##3##(1994-11#1)(2008-10#1)
the enzyme activity by 22##2##5##(1994-8#2)
the enzyme activity by##3##4##(1990-5#1)(1994-8#2)
the enzyme activity in##2##4##(1994-8#1)(2008-7#1)
the enzyme activity inNocardia andRhodococcus##2##5##(2008-11#2)
the enzyme activity##24##3##(1990-5#2)(1992-6#1)(1993-3#2)(1994-8#3)(1995-11#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
the enzyme and the##3##4##(2008-10#3)
the enzyme and##8##3##(1990-9#1)(1992-6#1)(2008-10#6)
the enzyme at##5##3##(1992-3#1)(1993-8#1)(2008-10#2)(2008-9#1)
the enzyme by##7##3##(1993-9#1)(1994-11#2)(1995-6#1)(1997-8#1)(2008-7#1)(2009-7#1)
the enzyme complex##2##3##(2012-2#1)(2012-3#1)
the enzyme conjugate##2##3##(2008-7#2)
the enzyme dilution##2##3##(2008-10#2)
the enzyme exhibited##2##3##(1994-11#1)(2012-2#1)
the enzyme from the##2##4##(2008-10#1)(2008-11#1)
the enzyme from##10##3##(1992-3#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-2#3)(1997-2#1)(2008-10#1)(2008-11#1)
the enzyme has been##2##4##(1990-5#1)(2008-10#1)
the enzyme has##3##3##(1990-5#1)(2008-10#1)(2011-1#1)
the enzyme in an##2##4##(2008-10#1)(2008-5#1)
the enzyme in the##5##4##(1990-5#1)(2008-10#3)(2008-4#1)
the enzyme in##13##3##(1990-11#1)(1990-5#1)(1996-2#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)
the enzyme is##4##3##(1992-4#1)(1993-8#1)(1996-2#1)(2008-9#1)
the enzyme layer##2##3##(2008-10#2)
the enzyme loading and time of##2##6##(2008-10#2)
the enzyme loading and##3##4##(2008-10#3)
the enzyme molecules##2##3##(2008-10#2)
the enzyme purified from##2##4##(1993-8#2)
the enzyme reaction##5##3##(2008-10#5)
the enzyme responsible for the##2##5##(1990-8#1)(2008-11#1)
the enzyme solution##3##3##(2008-10#3)
the enzyme that is##2##4##(2008-7#1)(2009-8#1)
the enzyme that##5##3##(1990-5#1)(1997-1#1)(2008-7#1)(2009-8#1)(2013-1#1)
the enzyme to##4##3##(1992-12#1)(1995-8#1)(2008-10#1)(2009-8#1)
the enzyme toward##2##3##(1993-6#1)(1995-6#1)
the enzyme was purified##2##4##(1994-6#1)(1994-8#1)
the enzyme was shown##2##4##(1990-10#1)(2008-9#1)
the enzyme was##10##3##(1990-10#1)(1991-5#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-9#1)
the enzyme which##3##3##(1993-8#1)(2008-11#1)(2008-5#1)
the enzyme with a##2##4##(1993-6#1)(1994-5#1)
the enzyme with##4##3##(1993-6#1)(1994-5#1)(1995-6#1)(2008-10#1)
the enzyme##256##2##(1990-10#1)(1990-11#2)(1990-5#10)(1990-8#2)(1990-9#2)(1991-12#3)(1991-3#1)(1991-5#4)(1991-9#1)(1992-12#1)(1992-3#5)(1992-4#1)(1992-6#3)(1993-2#1)(1993-3#4)(1993-6#5)(1993-8#9)(1993-9#1)(1994-11#8)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#7)(1995-11#3)(1995-12#1)(1995-2#2)(1995-6#10)(1995-8#5)(1996-2#6)(1997-1#3)(1997-2#2)(1997-6#2)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#82)(2008-11#11)(2008-4#1)(2008-5#4)(2008-7#12)(2008-8#2)(2008-9#7)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
the enzyme's##5##2##(1993-8#1)(1994-5#1)(1995-6#1)(2008-10#1)(2011-1#1)
the enzyme-bound##2##2##(1991-9#1)(1992-3#1)
the enzyme-catalyzed##7##2##(1993-8#1)(2008-10#4)(2008-7#1)(2008-9#1)
the enzyme-linked immunosorbent assay (ELISA)##3##5##(1996-9#1)(2008-10#2)
the enzyme-linked immunosorbent assay##4##4##(1996-9#1)(2008-10#3)
the enzyme-linked immunosorbent##5##3##(1996-9#1)(2008-10#4)
the enzyme-substrate complex##2##3##(1994-5#1)(2008-5#1)
the enzyme-substrate##6##2##(1990-9#1)(1994-5#2)(2008-10#2)(2008-5#1)
the enzymes and##2##3##(1993-9#1)(1997-6#1)
the enzymes involved in##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
the enzymes of##2##3##(1997-1#1)(2010-7#1)
the enzymes##23##2##(1990-5#1)(1991-5#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-3#1)(1997-6#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-7#1)(2011-1#1)(2012-2#1)
the eosinophil##2##2##(1992-3#1)(1992-6#1)
the eosinophilic##2##2##(2008-11#1)(2008-5#1)
the epidemic in##5##3##(1990-12#1)(1992-5#1)(1995-6#1)(1996-11#1)(2011-2#1)
the epidemic onset##2##3##(2008-10#2)
the epidemic was##2##3##(2008-10#2)
the epidemic##40##2##(1990-12#3)(1992-5#1)(1995-12#1)(1995-6#1)(1996-11#3)(1996-3#1)(1996-5#1)(2008-10#25)(2011-2#2)(2013-8#2)
the epidemic's##2##2##(1997-6#1)(2008-8#1)
the epidemics##8##2##(2008-10#6)(2012-3#2)
the epidemiologic##3##2##(1990-9#1)(2008-7#1)(2013-8#1)
the epidemiological evidence##2##3##(2010-6#1)(2013-1#1)
the epidemiological situation in Norway##2##5##(1994-6#1)(1996-6#1)
the epidemiological##8##2##(1994-6#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
the epidemiology and management of soilborne##2##6##(2008-10#2)
the epidemiology and management of##4##5##(2008-10#4)
the epidemiology and##7##3##(2008-10#5)(2008-4#1)(2008-9#1)
the epidemiology of the##4##4##(2008-10#3)(2008-9#1)
the epidemiology of##21##3##(1995-9#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-9#2)(2009-4#1)(2011-2#3)(2011-3#1)
the epidemiology##35##2##(1995-9#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#3)(2009-4#2)(2010-12#1)(2011-2#5)(2011-3#1)
the epidermal cell##2##3##(2008-10#1)(2008-7#1)
the epidermal growth factor receptor##3##5##(1993-8#1)(1995-6#2)
the epidermal growth factor##4##4##(1993-8#1)(1995-6#2)(2011-2#1)
the epidermal##14##2##(1993-8#1)(1994-5#1)(1995-6#2)(2007-12#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-9#2)(2011-2#1)
the epidermis and dermis##2##4##(1996-12#1)(2008-5#1)
the epidermis and outer cortex tissues##4##6##(2008-10#4)
the epidermis and the##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
the epidermis and##13##3##(1996-12#1)(2008-10#7)(2008-11#1)(2008-5#3)(2008-7#1)
the epidermis of##4##3##(1996-12#1)(2008-10#2)(2008-5#1)
the epidermis##41##2##(1994-5#1)(1995-11#1)(1996-12#4)(1996-2#1)(1996-6#1)(2008-10#13)(2008-11#1)(2008-5#11)(2008-7#2)(2010-6#4)(2010-7#1)(2011-3#1)
the epidural space##2##3##(2009-3#1)(2010-7#1)
the epidural##3##2##(2009-3#1)(2010-7#1)(2012-3#1)
the epigenetic influence of##2##4##(2009-3#2)
the epigenetic influence##3##3##(2009-3#3)
the epigenetic##5##2##(2009-3#3)(2011-2#1)(2013-8#1)
the epilepsy service##2##3##(1997-8#2)
the epilepsy##3##2##(1997-8#2)(2010-8#1)
the epileptic##3##2##(2008-11#1)(2008-7#1)(2009-8#1)
the epiphyseal##3##2##(1996-11#1)(2007-11#1)(2011-2#1)
the epiphysis##2##2##(2008-8#2)
the epithelial cells##4##3##(1997-1#1)(1997-2#1)(2008-12#1)(2013-1#1)
the epithelial cycle##6##3##(2009-10#3)(2012-2#3)
the epithelial lining##2##3##(2007-12#1)(2010-5#1)
the epithelial##16##2##(1991-12#1)(1991-5#1)(1997-1#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2009-10#3)(2010-5#1)(2012-2#3)(2013-1#1)
the epithelium and##3##3##(2007-12#1)(2013-1#2)
the epithelium of the##4##4##(2007-12#1)(2008-12#1)(2008-7#1)(2010-11#1)
the epithelium##23##2##(1991-5#1)(1995-8#1)(1997-1#2)(2007-12#2)(2008-12#1)(2008-5#1)(2008-7#3)(2009-10#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#3)
the epitope regions##2##3##(2008-11#2)
the epitope##6##2##(1993-12#1)(2008-11#3)(2008-8#2)
the epitopes##4##2##(2006-6#1)(2008-10#2)(2008-8#1)
the epoxy##3##2##(1996-5#1)(2008-10#2)
the epsilon##2##2##(1995-12#2)
the equal##2##2##(2008-10#1)(2011-2#1)
the equation##9##2##(2008-10#5)(2008-11#1)(2008-3#1)(2011-3#1)(2013-8#1)
the equations for the##2##4##(1996-12#1)(2008-10#1)
the equations for##4##3##(1996-12#1)(2008-10#2)(2012-3#1)
the equations##9##2##(1996-12#1)(2008-10#4)(2008-11#2)(2011-2#1)(2012-3#1)
the equatorial##2##2##(1996-5#1)(2008-3#1)
the equilibration time##2##3##(2008-10#2)
the equilibration##3##2##(2008-10#3)
the equilibria##2##2##(2008-10#2)
the equilibrium between the##2##4##(2008-10#2)
the equilibrium concentration of##2##4##(2008-10#2)
the equilibrium constant##5##3##(1995-6#1)(1997-2#1)(2008-10#3)
the equilibrium constants##4##3##(2008-10#4)
the equilibrium frequency of##2##4##(2008-9#2)
the equilibrium of##2##3##(2008-10#2)
the equilibrium population size##3##4##(2008-8#2)(2008-9#1)
the equilibrium population##4##3##(2008-8#2)(2008-9#2)
the equilibrium##44##2##(1993-3#1)(1993-6#1)(1995-6#1)(1997-2#1)(2008-10#29)(2008-12#1)(2008-8#4)(2008-9#4)(2009-5#2)
the equimolar##2##2##(1990-2#1)(2008-10#1)
the equipment##7##2##(1992-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-3#1)
the equivalence point (EP)##2##4##(2008-10#2)
the equivalence point##8##3##(2008-10#8)
the equivalence##10##2##(1995-9#1)(2008-10#9)
the equivalent##13##2##(1992-12#1)(1995-12#1)(1997-6#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2009-12#1)(2012-3#1)
the era of##8##3##(1993-1#3)(1996-1#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-12#1)
the eradication of##6##3##(1995-5#1)(2007-12#1)(2008-11#2)(2010-1#1)(2011-2#1)
the eradication##9##2##(1995-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2010-1#1)(2011-2#1)(2012-12#1)
the eriophyid mite-transmitted##2##3##(2008-10#2)
the eriophyid##3##2##(2008-10#3)
the erosion of##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
the error in##2##3##(2008-10#1)(2008-3#1)
the error is##2##3##(1995-3#1)(2008-3#1)
the error of the##2##4##(2008-3#2)
the error propagation theory##2##4##(2008-10#2)
the error rate##2##3##(2012-2#1)(2013-1#1)
the error that##2##3##(2008-3#2)
the error##24##2##(1995-3#1)(2008-10#7)(2008-2#1)(2008-3#10)(2008-6#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the errors in##2##3##(2008-3#2)
the errors##8##2##(1992-9#1)(2008-10#3)(2008-3#4)
the erythrocyte membrane##2##3##(1995-8#1)(2008-11#1)
the erythrocyte membranes##2##3##(1991-5#1)(1994-8#1)
the erythrocyte##6##2##(1990-12#1)(1991-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-11#1)
the erythrocytes##2##2##(1994-9#1)(1997-6#1)
the erythroid##3##2##(1990-5#1)(1991-5#1)(1992-12#1)
the escalation##2##2##(2009-10#2)
the escape of MeBr##2##4##(1995-3#2)
the escape of##3##3##(1995-3#2)(1996-12#1)
the escape##4##2##(1995-3#2)(1996-12#1)(2008-9#1)
the esophagus and stomach##2##4##(2011-2#1)(2012-3#1)
the esophagus and##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
the esophagus##13##2##(1992-6#1)(1992-9#1)(1993-8#2)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#5)(2012-3#1)
the essay##2##2##(2008-12#2)
the essence of the##2##4##(2008-8#1)(2009-7#1)
the essence of##5##3##(1997-2#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-7#1)
the essence##6##2##(1997-2#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)
the essential downstream component of##2##5##(1997-3#2)
the essential oil of the fruits##5##6##(2008-11#4)(2008-12#1)
the essential oil of the##6##5##(2008-11#5)(2008-12#1)
the essential oil of##8##4##(2008-11#7)(2008-12#1)
the essential oil##9##3##(2008-11#7)(2008-12#2)
the essential oils and their##2##5##(2008-10#2)
the essential oils of##2##4##(2008-10#1)(2008-11#1)
the essential oils##6##3##(2008-10#3)(2008-11#2)(2008-12#1)
the essential role of the##2##5##(1995-12#1)(2010-5#1)
the essential role of##6##4##(1995-12#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
the essential role##7##3##(1995-12#1)(2008-1#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
the essential##42##2##(1990-5#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-3#4)(2008-1#1)(2008-10#4)(2008-11#9)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#3)
the established experimental conditions##2##4##(2008-10#2)
the established##16##2##(1992-3#1)(1996-9#1)(2008-10#10)(2008-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
the establishment and##2##3##(2008-10#1)(2013-1#1)
the establishment of a##7##4##(1991-12#1)(2006-6#1)(2008-10#3)(2011-2#1)(2013-1#1)
the establishment of the##11##4##(1991-6#1)(1992-6#1)(1993-6#1)(1994-5#1)(1996-1#1)(1996-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)
the establishment of this##2##4##(2008-10#1)(2008-11#1)
the establishment of##45##3##(1991-12#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
the establishment or##2##3##(2011-2#2)
the establishment##49##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)(2011-10#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
the ester##2##2##(2008-10#1)(2008-7#1)
the ester-type##2##2##(2008-10#2)
the esterification of##2##3##(1992-6#1)(2008-7#1)
the esterification reaction##2##3##(2008-10#1)(2008-7#1)
the esterification##4##2##(1992-6#1)(2008-10#1)(2008-7#2)
the esterified##2##2##(1994-11#2)
the estimate of the##4##4##(2008-10#1)(2010-7#1)(2012-2#2)
the estimate##5##2##(2008-10#1)(2008-6#1)(2010-7#1)(2012-2#2)
the estimated average##2##3##(1997-2#1)(2008-10#1)
the estimated convexity is##2##4##(2008-6#2)
the estimated mean##2##3##(1991-6#1)(2008-10#1)
the estimated##36##2##(1991-6#1)(1992-3#1)(1993-3#1)(1995-12#1)(1997-2#1)(1997-4#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the estimates of the##2##4##(2008-10#1)(2012-2#1)
the estimates##6##2##(1991-3#1)(2008-10#1)(2008-3#1)(2008-8#2)(2012-2#1)
the estimation of the activity coefficients##2##6##(2008-10#2)
the estimation of the##10##4##(2008-10#7)(2008-8#1)(2009-10#2)
the estimation of##34##3##(1992-9#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#2)(2011-2#1)
the estimation##42##2##(1992-9#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2011-2#1)(2012-2#1)(2013-8#4)
the estrogen receptor##13##3##(1990-5#1)(2008-11#10)(2010-5#1)(2011-1#1)
the estrogen response element##2##4##(1992-6#2)
the estrogen##19##2##(1990-5#1)(1992-6#2)(2008-10#2)(2008-11#12)(2010-5#1)(2011-1#1)
the estrogenic##2##2##(2010-5#2)
the estrogens##2##2##(2008-11#1)(2012-2#1)
the etched##3##2##(1997-2#1)(2008-10#2)
the etching process##2##3##(1997-2#1)(2008-10#1)
the etching solution##3##3##(2008-10#3)
the etching##9##2##(1997-2#1)(2008-10#5)(2008-3#3)
the ethanol extract of##2##4##(2008-11#1)(2011-3#1)
the ethanol##10##2##(1997-2#1)(2008-10#6)(2008-11#1)(2011-3#1)(2013-1#1)
the ethanol-induced##2##2##(1994-5#1)(2009-7#1)
the ethanolic extract##2##3##(2008-10#2)
the ethical##14##2##(1991-2#2)(1995-6#1)(1996-2#1)(2008-11#2)(2008-12#2)(2009-11#1)(2009-4#1)(2010-11#2)(2012-3#1)(2013-1#1)
the ethics##2##2##(1991-3#1)(2008-11#1)
the ethnic composition of school##2##5##(2010-1#2)
the ethnic composition of##3##4##(2010-1#3)
the ethnic specific##2##3##(2008-1#2)
the ethnic##11##2##(1991-11#1)(1994-12#1)(2008-1#2)(2008-5#1)(2008-9#1)(2010-1#5)
the ethyl acetate##2##3##(2008-10#2)
the ethyl ester##2##3##(2008-5#1)(2008-7#1)
the ethyl##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
the ethylene##3##2##(1993-12#1)(1995-2#1)(2008-10#1)
the etiologic agent of##2##4##(1997-5#1)(2008-4#1)
the etiologic agent##3##3##(1997-5#1)(2008-4#1)(2012-3#1)
the etiological agent of##2##4##(1992-3#1)(2008-9#1)
the etiological##3##2##(1992-3#1)(2008-9#1)(2011-2#1)
the etiology and##8##3##(1990-11#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-9#1)(2013-8#1)
the etiology of obesity in Mäori children##2##7##(2008-1#2)
the etiology of the##7##4##(1996-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#1)
the etiology of##42##3##(1990-8#1)(1991-2#1)(1995-2#2)(1996-11#1)(1997-2#1)(2007-11#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#5)(2009-10#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the etiology##56##2##(1990-11#1)(1990-8#1)(1991-2#1)(1995-2#2)(1996-11#1)(1997-2#1)(2007-11#1)(2008-1#4)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#6)(2008-8#1)(2009-10#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the etiopathogenesis of##4##3##(1990-2#1)(1991-2#1)(2010-1#1)(2013-7#1)
the etiopathogenetic##2##2##(1990-9#1)(1991-6#1)
the etiopathogenic##2##2##(2012-12#2)
the eukaryotic##9##2##(1993-9#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)
the evacuation of##2##3##(2012-3#1)(2013-1#1)
the evacuation##3##2##(1991-2#1)(2012-3#1)(2013-1#1)
the evaluated##4##2##(1990-12#1)(2013-1#3)
the evaluation and monitoring of##2##5##(1995-5#1)(2011-3#1)
the evaluation and treatment of##2##5##(2009-1#1)(2009-3#1)
the evaluation and treatment##3##4##(2008-9#1)(2009-1#1)(2009-3#1)
the evaluation and##12##3##(1995-5#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#2)(2009-1#1)(2009-3#1)(2011-2#1)(2011-3#1)
the evaluation of antimicrobial agents##2##5##(2008-7#2)
the evaluation of new##2##4##(2008-11#1)(2008-9#1)
the evaluation of patients##4##4##(2008-9#2)(2009-8#1)(2012-2#1)
the evaluation of possible##2##4##(2009-6#1)(2011-2#1)
the evaluation of potential##2##4##(2008-10#2)
the evaluation of some##2##4##(2008-10#2)
the evaluation of the##29##4##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-6#1)(1996-12#1)(2008-10#11)(2008-5#2)(2008-7#3)(2008-9#1)(2012-2#1)(2013-1#4)
the evaluation of this##2##4##(2008-5#1)(2013-1#1)
the evaluation of various##2##4##(2008-11#1)(2012-2#1)
the evaluation of##105##3##(1990-11#4)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-2#1)(1995-5#1)(1996-12#3)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#30)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#10)(2008-7#6)(2008-9#5)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-5#1)(2011-2#5)(2012-2#6)(2012-3#1)(2013-1#6)(2013-8#1)
the evaluation process##2##3##(2008-10#1)(2008-12#1)
the evaluation##129##2##(1990-11#4)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-2#1)(1995-3#1)(1995-5#2)(1996-12#3)(1996-2#1)(1997-2#2)(1997-3#1)(2006-5#1)(2008-1#1)(2008-10#32)(2008-11#8)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#11)(2008-7#6)(2008-9#7)(2009-1#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-5#1)(2011-2#6)(2011-3#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#1)
the evaluations of##2##3##(2009-6#1)(2011-2#1)
the evaluations##3##2##(2008-11#1)(2009-6#1)(2011-2#1)
the evaporation of##2##3##(2008-10#1)(2008-5#1)
the evaporation##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
the even##3##2##(1991-1#1)(1994-5#1)(1994-9#1)
the evening##4##2##(2008-5#1)(2011-2#1)(2012-5#2)
the event and##2##3##(2008-11#1)(2013-8#1)
the event of an emergency##2##5##(1997-2#1)(2010-1#1)
the event of##10##3##(1990-3#1)(1990-9#1)(1991-6#1)(1997-2#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#3)
the event##24##2##(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#3)(2013-8#3)
the event-related##3##2##(2008-11#2)(2013-8#1)
the events and##2##3##(1996-2#1)(2009-10#1)
the events leading to##2##4##(1995-2#1)(2008-11#1)
the events that##3##3##(2008-11#2)(2008-4#1)
the events##11##2##(1991-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(2008-11#3)(2008-4#1)(2008-8#1)(2009-10#1)
the eventual##8##2##(1994-12#1)(1995-2#1)(2008-10#4)(2008-12#1)(2011-2#1)
the everyday##5##2##(1995-1#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-9#1)
the evidence and##2##3##(1993-12#1)(2008-8#1)
the evidence base for##2##4##(2008-2#1)(2013-1#1)
the evidence base##7##3##(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)(2010-5#2)(2013-1#1)
the evidence for##9##3##(1991-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
the evidence from##2##3##(1993-12#1)(2009-7#1)
the evidence in##3##3##(1995-5#1)(2010-1#1)(2013-1#1)
the evidence is##9##3##(1992-5#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
the evidence of##2##3##(2008-10#1)(2009-8#1)
the evidence on the##2##4##(1995-5#1)(2013-1#1)
the evidence on##5##3##(1995-5#1)(1996-6#1)(2008-12#1)(2013-1#2)
the evidence suggests that##3##4##(2008-1#1)(2008-11#1)(2008-9#1)
the evidence supporting the##2##4##(2009-10#1)(2011-2#1)
the evidence supporting##5##3##(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#2)
the evidence that##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
the evidence to##3##3##(2008-11#1)(2008-8#1)(2010-1#1)
the evidence##65##2##(1991-12#1)(1992-5#1)(1993-12#6)(1995-5#2)(1996-12#2)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-5#2)(2011-2#7)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#2)
the evidence-based##4##2##(2008-12#1)(2008-8#2)(2013-1#1)
the evolution and##4##3##(1996-2#1)(1996-3#1)(2008-8#1)(2009-7#1)
the evolution in##2##3##(2008-10#1)(2011-2#1)
the evolution of a##2##4##(2008-10#1)(2013-1#1)
the evolution of altruism##2##4##(2008-8#1)(2008-9#1)
the evolution of clutch size##2##5##(2008-9#2)
the evolution of cooperation through reciprocal altruism##2##7##(2008-8#2)
the evolution of cooperation##3##4##(2008-8#2)(2010-4#1)
the evolution of dispersal##3##4##(2008-8#2)(2008-9#1)
the evolution of emotional communication##2##5##(2008-11#2)
the evolution of guppy##2##4##(2008-8#2)
the evolution of host##2##4##(2008-8#1)(2008-9#1)
the evolution of mating##2##4##(2008-8#1)(2008-9#1)
the evolution of natural##2##4##(2008-10#1)(2008-8#1)
the evolution of new traits##3##5##(2010-4#3)
the evolution of new##4##4##(2008-10#1)(2010-4#3)
the evolution of optimal phenotypes##2##5##(2008-8#2)
the evolution of parasite virulence##3##5##(2008-8#3)
the evolution of parasite##4##4##(2008-8#4)
the evolution of plant##2##4##(2008-10#1)(2008-8#1)
the evolution of resistance##2##4##(1995-6#1)(2008-9#1)
the evolution of sexual dimorphism##3##5##(2008-8#3)
the evolution of sibling pathogens in##3##6##(2008-10#3)
the evolution of the##23##4##(1992-11#1)(1993-2#1)(1996-1#1)(1997-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-8#3)(2010-7#3)(2011-2#1)(2012-3#2)(2013-8#1)
the evolution of their##2##4##(2008-10#1)(2013-1#1)
the evolution of virulence##3##4##(2008-10#1)(2008-8#2)
the evolution of viviparity##2##4##(2008-8#2)
the evolution of worker policing##2##5##(2008-8#2)
the evolution of##188##3##(1990-7#1)(1991-1#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-2#3)(1993-3#1)(1995-5#2)(1995-6#3)(1996-1#2)(1997-6#2)(1997-9#1)(2007-12#2)(2008-10#21)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#64)(2008-9#23)(2009-10#2)(2009-6#3)(2009-8#4)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#6)(2011-2#1)(2012-2#2)(2012-3#11)(2013-1#4)(2013-8#4)
the evolution##197##2##(1990-7#1)(1991-1#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-2#3)(1993-3#1)(1995-5#2)(1995-6#3)(1996-1#2)(1996-2#1)(1996-3#1)(1997-6#2)(1997-9#1)(2007-12#2)(2008-10#22)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#65)(2008-9#24)(2009-10#2)(2009-6#3)(2009-7#1)(2009-8#4)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#6)(2011-2#2)(2012-2#2)(2012-3#12)(2013-1#4)(2013-8#4)
the evolutionarily stable (ES)##2##4##(2008-8#2)
the evolutionarily stable strategy (ESS)##3##5##(2008-8#1)(2008-9#2)
the evolutionarily stable##9##3##(2008-8#5)(2008-9#4)
the evolutionarily##11##2##(2008-8#5)(2008-9#4)(2011-2#2)
the evolutionary consequences of##2##4##(2008-8#2)
the evolutionary dynamics of##2##4##(2008-8#2)
the evolutionary dynamics##3##3##(2008-8#3)
the evolutionary forces##3##3##(2008-9#1)(2009-6#1)(2012-3#1)
the evolutionary history of the##2##5##(2008-10#1)(2008-8#1)
the evolutionary interests##2##3##(2008-8#2)
the evolutionary origin##2##3##(2008-8#1)(2010-1#1)
the evolutionary outcome##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
the evolutionary process##3##3##(2010-4#1)(2010-5#1)(2012-3#1)
the evolutionary processes##2##3##(2008-10#1)(2012-12#1)
the evolutionary significance of##2##4##(2012-2#1)(2012-3#1)
the evolutionary stability of##2##4##(2008-8#1)(2012-3#1)
the evolutionary trajectories##2##3##(2008-8#1)(2012-3#1)
the evolutionary transition##2##3##(2008-9#1)(2009-6#1)
the evolutionary##51##2##(1994-11#1)(1997-7#1)(1997-9#2)(2008-10#5)(2008-11#2)(2008-8#17)(2008-9#4)(2009-6#3)(2010-1#1)(2010-4#3)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-8#2)
the evolved##4##2##(2008-8#1)(2011-1#3)
the evolving role of##3##4##(1993-12#1)(1994-2#1)(1996-9#1)
the evolving##5##2##(1993-12#1)(1994-2#1)(1995-1#1)(1996-9#1)(2010-7#1)
the ex vivo##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
the ex##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
the ex-type strain##2##3##(2008-10#2)
the exact conditional test under inverse sampling##2##7##(1996-3#2)
the exact conditional##3##3##(1995-9#1)(1996-3#2)
the exact location of the##2##5##(1995-2#1)(2012-12#1)
the exact location##3##3##(1995-2#1)(1996-6#1)(2012-12#1)
the exact mechanism##2##3##(2008-7#2)
the exact nature of the##2##5##(2008-7#1)(2008-9#1)
the exact nature of##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
the exact same##2##3##(2008-11#2)
the exact size of##2##4##(2008-7#1)(2013-1#1)
the exact##39##2##(1990-12#1)(1990-8#1)(1991-3#1)(1993-1#1)(1995-2#1)(1995-9#1)(1996-3#3)(1996-6#1)(2007-11#1)(2008-10#9)(2008-11#4)(2008-3#3)(2008-7#4)(2008-9#3)(2009-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
the examination and##3##3##(1990-3#1)(1995-11#1)(1996-11#1)
the examination of##5##3##(1995-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
the examination was##2##3##(1991-6#1)(2007-12#1)
the examination##16##2##(1990-3#2)(1991-6#2)(1995-11#2)(1996-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
the examinations##2##2##(1992-5#1)(1995-5#1)
the examined##8##2##(2008-10#8)
the example of oxidation of##2##5##(1990-5#1)(2008-10#1)
the example of##8##3##(1990-5#1)(1995-1#1)(2008-10#2)(2008-11#2)(2010-6#1)(2011-2#1)
the example##10##2##(1990-5#1)(1995-1#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-6#1)(2011-2#1)
the examples of##3##3##(2008-10#1)(2009-12#1)(2009-5#1)
the examples##6##2##(1991-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-5#1)(2010-7#1)
the excellent##11##2##(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)
the exception of a single##2##5##(2008-10#1)(2008-9#1)
the exception of a##4##4##(1991-9#1)(2008-10#1)(2008-12#1)(2008-9#1)
the exception of the##11##4##(1993-12#1)(1993-8#1)(1996-11#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2011-2#2)
the exception of two##2##4##(2008-10#1)(2008-12#1)
the exception of##64##3##(1990-5#1)(1991-12#2)(1991-9#1)(1992-3#1)(1993-12#2)(1993-8#2)(1994-3#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#24)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
the exception##72##2##(1990-5#1)(1991-12#2)(1991-9#1)(1992-3#1)(1993-12#2)(1993-8#2)(1994-3#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#29)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
the exceptional##2##2##(1995-2#1)(2008-10#1)
the exceptions##7##2##(1997-2#1)(2007-11#1)(2008-10#3)(2008-8#1)(2010-5#1)
the excess demand argument##2##4##(1995-2#2)
the excess of##4##3##(2008-10#4)
the excess##14##2##(1991-12#2)(1995-2#2)(1995-8#1)(2008-10#8)(2013-1#1)
the excessive##7##2##(1992-11#1)(2008-10#3)(2008-11#1)(2008-5#2)
the exchange and##2##3##(2008-11#1)(2010-8#1)
the exchange of##10##3##(1995-8#1)(2008-10#2)(2008-11#2)(2010-5#1)(2011-2#3)(2012-2#1)
the exchange##19##2##(1992-4#1)(1995-8#1)(2008-10#6)(2008-11#4)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)
the exchanger##3##2##(2008-10#3)
the excipients##5##2##(2008-10#5)
the excised##6##2##(1991-5#1)(2008-10#3)(2008-5#1)(2012-2#1)
the excision of##2##3##(2008-10#1)(2009-1#1)
the excision##4##2##(1995-9#1)(2008-10#1)(2009-1#1)(2009-3#1)
the excitation and emission##2##4##(2008-10#2)
the excitation and##4##3##(2008-10#4)
the excitation beam##3##3##(2008-10#1)(2008-3#2)
the excitation light##2##3##(2008-3#1)(2008-7#1)
the excitation of##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
the excitation wavelength##2##3##(1994-5#1)(2008-3#1)
the excitation##25##2##(1994-5#1)(1996-2#1)(2008-10#11)(2008-11#1)(2008-3#9)(2008-7#2)
the excitatory##4##2##(1994-2#1)(1996-2#1)(1996-5#1)(2008-7#1)
the excited state of##2##4##(2008-10#2)
the excited state##4##3##(1995-11#1)(2008-10#3)
the excited states of##2##4##(2008-10#1)(2010-7#1)
the excited##11##2##(1995-11#1)(1995-6#1)(2008-10#4)(2008-3#3)(2010-7#1)(2012-12#1)
the excited-state absorption##3##3##(2008-10#2)(2008-3#1)
the excitement##2##2##(1995-12#1)(2008-7#1)
the excitotoxic process##2##3##(2008-7#1)(2011-2#1)
the exclusion of an##2##4##(1991-6#1)(2010-12#1)
the exclusion of##9##3##(1991-6#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-9#2)(2010-12#1)(2012-3#1)
the exclusion##10##2##(1991-6#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-9#2)(2010-12#1)(2012-2#1)(2012-3#1)
the exclusive##5##2##(1991-1#1)(1996-5#1)(2008-10#1)(2008-8#1)(2010-12#1)
the excretion action##2##3##(2011-3#2)
the excretion of##5##3##(1991-12#1)(1993-12#1)(1997-8#1)(2008-10#1)(2012-2#1)
the excretion##9##2##(1990-5#1)(1991-12#1)(1993-12#1)(1994-5#1)(1997-8#1)(2008-10#1)(2011-3#2)(2012-2#1)
the excretory duct##2##3##(2007-12#2)
the execution of##4##3##(2009-8#1)(2013-1#1)(2013-8#2)
the executive##5##2##(1993-2#1)(1995-3#1)(2008-11#1)(2008-8#1)(2013-8#1)
the exemption##2##2##(1996-2#2)
the exercise of power##2##4##(2008-11#2)
the exercise of##3##3##(2008-11#2)(2012-3#1)
the exercise was##3##3##(2008-10#2)(2008-12#1)
the exercise##18##2##(1991-12#1)(1991-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2010-3#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
the exhaust##7##2##(2008-10#1)(2008-11#1)(2008-3#5)
the exine##2##2##(2011-2#2)
the existence and stability of##2##5##(2007-12#1)(2009-8#1)
the existence and##8##3##(1990-5#1)(1991-12#1)(2007-12#1)(2008-8#2)(2009-10#1)(2009-8#1)(2013-8#1)
the existence of God##4##4##(2013-1#4)
the existence of a new type of##2##7##(1992-6#1)(2008-8#1)
the existence of a new##3##5##(1992-6#1)(2008-7#1)(2008-8#1)
the existence of a##26##4##(1990-5#1)(1990-8#2)(1992-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#3)(1995-8#1)(1997-9#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2013-1#1)
the existence of an##7##4##(1990-5#1)(1992-12#1)(1993-12#1)(1997-6#1)(2008-10#2)(2008-12#1)
the existence of at least##2##5##(2008-10#1)(2013-1#1)
the existence of both##2##4##(2008-10#1)(2008-8#1)
the existence of distinct##2##4##(1995-8#1)(2008-10#1)
the existence of four major##2##5##(1997-7#1)(2008-5#1)
the existence of many##2##4##(2008-5#1)(2010-8#1)
the existence of multiple##2##4##(1991-5#1)(2008-7#1)
the existence of the##8##4##(1991-3#1)(1994-11#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-5#1)
the existence of two##3##4##(2008-10#1)(2008-11#2)
the existence of##133##3##(1990-12#1)(1990-5#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#4)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#3)(1997-9#1)(2007-12#2)(2008-10#31)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#8)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#3)
the existence##143##2##(1990-12#1)(1990-5#3)(1990-8#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#4)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#3)(1997-9#1)(2007-12#3)(2008-10#31)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#8)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#5)
the existing channels##2##3##(2008-2#2)
the existing conventional procedure##2##4##(2008-10#2)
the existing evidence##2##3##(2013-1#2)
the existing literature on##2##4##(1993-12#1)(1996-11#1)
the existing literature##4##3##(1993-12#1)(1996-11#1)(2008-7#1)(2013-1#1)
the existing methods##3##3##(2008-10#1)(2008-5#1)(2010-6#1)
the existing problems##2##3##(2010-12#1)(2012-3#1)
the existing process##2##3##(1993-12#1)(2012-3#1)
the existing system##3##3##(1997-4#2)(2008-11#1)
the existing##55##2##(1992-1#1)(1992-3#1)(1993-12#2)(1994-1#1)(1995-6#1)(1996-1#2)(1996-11#1)(1997-4#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
the exit pupil##2##3##(2008-3#2)
the exit site##3##3##(2011-2#3)
the exit##7##2##(1994-3#1)(2008-2#1)(2008-3#2)(2011-2#3)
the exogenous application of##2##4##(1990-5#1)(2008-10#1)
the exogenous##11##2##(1990-10#1)(1990-5#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#2)(2010-10#1)
the exon 7 and 8##2##5##(1993-8#2)
the exon##13##2##(1991-5#1)(1992-8#1)(1993-12#1)(1993-8#6)(1995-6#1)(1997-8#1)(2008-9#1)(2012-3#1)
the exons##3##2##(1993-8#1)(1997-2#1)(2008-8#1)
the expanded uncertainty##2##3##(2008-10#2)
the expanded##4##2##(2008-10#4)
the expanding##2##2##(1997-8#1)(2008-10#1)
the expansion of activated##2##4##(2008-10#2)
the expansion of the##5##4##(1997-1#1)(2008-10#2)(2008-4#1)(2013-1#1)
the expansion of##13##3##(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2012-3#1)(2013-1#1)
the expectation##3##2##(1997-6#1)(2008-12#1)(2008-8#1)
the expectations of mothers##2##4##(2008-9#2)
the expectations of##3##3##(2008-9#3)
the expected and observed##2##4##(2008-9#2)
the expected and##3##3##(2008-10#1)(2008-9#2)
the expected final##2##3##(2008-10#1)(2008-2#1)
the expected population##2##3##(2008-10#1)(2008-8#1)
the expected response of##2##4##(2008-10#1)(2008-9#1)
the expected sizes##2##3##(1991-5#1)(1995-12#1)
the expected time to extinction##2##5##(2008-9#2)
the expected time to##3##4##(2008-5#1)(2008-9#2)
the expected time##4##3##(2008-10#1)(2008-5#1)(2008-9#2)
the expected##76##2##(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-8#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#2)(2008-10#22)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-8#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the expense##11##2##(1990-9#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-1#1)(2012-3#1)(2012-9#1)
the expenses##2##2##(1990-12#1)(2013-8#1)
the expensive##3##2##(1997-6#1)(2008-10#2)
the experience of being a lecturer practitioner##2##7##(2008-12#2)
the experience of one##2##4##(2008-12#1)(2009-2#1)
the experience of the##6##4##(1992-3#1)(1994-1#1)(1994-12#1)(1997-3#1)(2008-11#1)(2012-3#1)
the experience of##25##3##(1992-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-11#3)(2008-12#7)(2008-7#2)(2009-2#1)(2009-7#1)(2010-6#1)(2012-12#1)(2012-3#1)
the experience with##5##3##(1995-5#1)(2008-1#1)(2010-6#1)(2012-3#1)(2013-8#1)
the experience##43##2##(1992-12#1)(1992-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#4)(2008-12#12)(2008-7#2)(2009-2#1)(2009-7#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-8#1)
the experiences and perceptions##2##4##(2008-11#1)(2010-10#1)
the experiences of two clinical##2##5##(2008-11#2)
the experiences of##21##3##(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1995-1#1)(1995-3#1)(2008-11#4)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2013-1#1)
the experiences##27##2##(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#5)(2008-12#7)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2012-12#1)(2013-1#1)
the experiential##3##2##(2008-11#2)(2010-10#1)
the experiment and##2##3##(1997-3#1)(2008-10#1)
the experiment was##2##3##(2008-12#1)(2009-8#1)
the experiment were##2##3##(2008-5#1)(2008-7#1)
the experiment##28##2##(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-1#1)
the experimental and theoretical##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
the experimental and##6##3##(1991-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
the experimental area##2##3##(2008-10#2)
the experimental conditions employed##2##4##(2008-10#2)
the experimental conditions of##2##4##(1992-4#1)(2008-10#1)
the experimental conditions was##2##4##(2008-10#2)
the experimental conditions##29##3##(1992-4#1)(1996-6#1)(2008-10#25)(2008-11#2)
the experimental data##21##3##(1996-5#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2012-2#1)
the experimental design##5##3##(2008-10#3)(2008-7#1)(2011-1#1)
the experimental findings##2##3##(2008-11#2)
the experimental group and##2##4##(2008-12#2)
the experimental group##14##3##(1991-12#1)(1992-9#1)(1993-6#1)(1995-1#1)(2008-11#3)(2008-12#5)(2010-4#1)(2012-3#1)
the experimental model##3##3##(1997-6#1)(2008-12#1)(2008-7#1)
the experimental parameters##6##3##(2008-10#6)
the experimental periods##3##3##(2008-10#2)(2013-1#1)
the experimental results and##2##4##(2008-8#1)(2013-8#1)
the experimental results##15##3##(1990-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
the experimental sorption isotherms##2##4##(2010-4#2)
the experimental spectra##2##3##(2008-3#2)
the experimental studies##2##3##(2008-10#1)(2008-3#1)
the experimental teat dip##2##4##(1990-6#2)
the experimental values##3##3##(1995-6#1)(2008-10#2)
the experimental variables affecting the##2##5##(2008-10#2)
the experimental variables##4##3##(2008-10#4)
the experimental##200##2##(1990-12#1)(1990-6#3)(1990-8#1)(1991-12#2)(1991-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-1#2)(1995-3#1)(1995-6#5)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#96)(2008-11#10)(2008-12#6)(2008-2#5)(2008-3#16)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#3)(2013-8#2)
the experimentally determined##2##3##(2008-10#1)(2008-3#1)
the experimentally measured##2##3##(2008-10#1)(2009-5#1)
the experimentally##8##2##(1997-6#2)(2008-10#2)(2008-3#1)(2009-5#2)(2012-2#1)
the experiments##27##2##(1991-12#1)(2008-10#11)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)
the expert##8##2##(1992-1#1)(1994-1#1)(1997-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-8#1)
the expertise of the##2##4##(1997-8#1)(2011-1#1)
the expertise of##3##3##(1996-1#1)(1997-8#1)(2011-1#1)
the expertise##4##2##(1996-1#1)(1996-2#1)(1997-8#1)(2011-1#1)
the experts##4##2##(1996-2#1)(2010-12#1)(2011-10#1)(2011-2#1)
the explained variance##2##3##(1993-3#1)(2008-10#1)
the explained##3##2##(1993-3#1)(2008-10#2)
the explanation for##2##3##(2008-5#1)(2011-2#1)
the explanatory power of##2##4##(1993-3#1)(2008-10#1)
the explant##2##2##(2008-11#1)(2011-3#1)
the explanted##2##2##(2008-9#1)(2010-1#1)
the explicit goal##2##3##(2008-11#2)
the explicit##3##2##(2008-11#2)(2008-8#1)
the exploitation of##2##3##(2008-3#1)(2008-8#1)
the exploration of##5##3##(2008-5#1)(2009-12#1)(2011-2#1)(2012-5#1)(2013-8#1)
the exploration##7##2##(2008-5#2)(2008-8#1)(2009-12#1)(2011-2#1)(2012-5#1)(2013-8#1)
the exponential growth phase##5##4##(2008-11#2)(2008-7#2)(2011-2#1)
the exponential growth##6##3##(2008-11#2)(2008-7#3)(2011-2#1)
the exponential phase of##6##4##(1994-8#1)(2008-11#5)
the exponential phase##11##3##(1994-8#1)(2008-11#9)(2011-2#1)
the exponential##29##2##(1994-8#1)(1995-3#1)(1995-9#1)(1996-1#1)(2008-10#4)(2008-11#12)(2008-3#2)(2008-6#1)(2008-7#3)(2011-2#3)
the exposed workers##4##3##(2008-10#1)(2009-12#3)
the exposed##16##2##(1993-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#4)(2011-2#2)(2013-1#1)
the exposure of fibrinogen receptor in thrombin-stimulated platelets##2##8##(1993-8#2)
the exposure of fibrinogen receptor in##3##6##(1993-8#3)
the exposure of the##4##4##(2008-10#3)(2008-8#1)
the exposure of##14##3##(1993-8#4)(1995-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#2)(2012-2#1)(2013-1#1)
the exposure time is##2##4##(2008-10#1)(2008-3#1)
the exposure time##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
the exposure to##9##3##(1991-12#1)(1993-2#1)(1996-2#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#2)
the exposure##35##2##(1990-5#1)(1991-12#2)(1993-2#1)(1993-8#4)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-8#3)(2009-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
the expressed protein##6##3##(1993-6#1)(1995-11#1)(2008-11#1)(2008-4#1)(2010-6#1)(2013-1#1)
the expressed##15##2##(1991-5#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-6#1)(2013-1#1)
the expression and function of the##2##6##(1994-8#1)(2007-12#1)
the expression and function of##3##5##(1994-8#1)(2007-12#1)(2008-6#1)
the expression and purification of##2##5##(2008-4#1)(2009-9#1)
the expression and secretion of##2##5##(1996-2#1)(2008-5#1)
the expression and##13##3##(1990-2#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#1)(2012-3#1)(2013-8#1)
the expression cassette##2##3##(2008-11#1)(2008-8#1)
the expression in the##2##4##(1996-12#1)(2009-6#1)
the expression in##5##3##(1994-2#1)(1996-12#1)(2008-6#1)(2008-8#1)(2009-6#1)
the expression level and##2##4##(2008-9#1)(2010-5#1)
the expression level of the##3##5##(1997-8#1)(2008-10#1)(2008-9#1)
the expression level of##10##4##(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2013-8#1)
the expression level##13##3##(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2010-5#1)(2013-8#1)
the expression levels of##5##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
the expression levels were##3##4##(2008-8#1)(2008-9#2)
the expression levels##8##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#3)(2010-5#1)
the expression of 'anxious'##2##4##(1993-3#2)
the expression of ICAM-1 mRNA##2##5##(2010-1#2)
the expression of IGF-I receptor##2##5##(1996-2#1)(2008-11#1)
the expression of IGF-I##3##4##(1996-2#1)(2008-11#2)
the expression of IL-10##2##4##(2011-3#2)
the expression of IL-12 p40 and p35 mRNA##2##8##(2008-8#2)
the expression of IL-12##3##4##(2008-8#3)
the expression of MEDDF##2##4##(2008-8#2)
the expression of MMP-2##2##4##(2008-9#2)
the expression of SSTR2 in the carcinoid cells##2##8##(2011-2#2)
the expression of a##8##4##(1992-6#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-10#1)
the expression of an##5##4##(1990-3#1)(1990-5#1)(1992-3#1)(1994-11#1)(2008-5#1)
the expression of both##3##4##(1993-12#1)(2008-10#1)(2009-12#1)
the expression of c-Met receptor##2##5##(2011-2#2)
the expression of c-myc##2##4##(2008-11#1)(2008-8#1)
the expression of cellular##2##4##(2008-11#1)(2010-1#1)
the expression of certain##2##4##(1997-8#1)(2008-9#1)
the expression of exogenous gene##2##5##(2008-9#2)
the expression of foreign##2##4##(1995-5#1)(1997-8#1)
the expression of genes in##2##5##(2008-10#2)
the expression of genes##6##4##(2008-10#3)(2008-6#1)(2008-7#1)(2012-2#1)
the expression of human##3##4##(1993-9#1)(2008-10#1)(2008-11#1)
the expression of inducible##2##4##(1996-12#2)
the expression of lambdaN gene##2##5##(2008-8#2)
the expression of mRNAs##2##4##(1996-12#2)
the expression of more than 100##2##6##(2010-7#1)(2011-2#1)
the expression of other##2##4##(2008-10#1)(2008-8#1)
the expression of p-p53##2##4##(2011-2#2)
the expression of pathogenesis-related##2##4##(2008-10#1)(2011-10#1)
the expression of pro- and anti-apoptotic##2##6##(2009-12#2)
the expression of recombinant##3##4##(2008-11#3)
the expression of regulatory##2##4##(1994-11#1)(2009-3#1)
the expression of select##2##4##(2008-11#1)(2013-1#1)
the expression of some##4##4##(1990-6#1)(1995-8#1)(2008-11#1)(2008-9#1)
the expression of specific genes##2##5##(1994-3#1)(2008-4#1)
the expression of the gene##2##5##(1993-1#1)(2009-10#1)
the expression of the genes##2##5##(1996-2#1)(1997-8#1)
the expression of the major##3##5##(2008-11#1)(2008-5#2)
the expression of the##47##4##(1990-12#1)(1990-5#1)(1991-5#1)(1992-1#2)(1993-1#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-7#3)(1997-8#3)(2008-10#3)(2008-11#8)(2008-5#2)(2008-8#2)(2008-9#6)(2009-10#1)(2013-1#3)(2013-8#1)
the expression of these genes in##2##6##(1996-12#1)(2008-11#1)
the expression of these genes##3##5##(1995-12#1)(1996-12#1)(2008-11#1)
the expression of these##6##4##(1991-9#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-11#1)(2009-9#1)
the expression of this##4##4##(1991-5#1)(1994-8#1)(1996-2#1)(2008-10#1)
the expression of topoisomerase##2##4##(1993-8#2)
the expression of##311##3##(1990-12#3)(1990-3#2)(1990-5#3)(1990-6#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#5)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#4)(1995-11#1)(1995-12#6)(1995-2#3)(1995-5#1)(1995-8#3)(1995-9#2)(1996-12#18)(1996-2#3)(1996-3#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#5)(1997-8#8)(2006-6#2)(2008-10#28)(2008-11#34)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#27)(2008-9#21)(2009-10#2)(2009-12#3)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-10#1)(2011-2#16)(2011-3#4)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#5)
the expression pattern of Xmsx-2B##2##5##(2008-6#2)
the expression pattern of##8##4##(1995-2#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#1)(2011-2#1)
the expression pattern##10##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
the expression patterns of##2##4##(1991-5#1)(2008-10#1)
the expression patterns##3##3##(1991-5#1)(1994-12#1)(2008-10#1)
the expression plasmids##3##3##(2008-8#1)(2008-9#2)
the expression vector##9##3##(1990-5#1)(1994-5#2)(1997-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
the expression was##2##3##(2008-8#1)(2008-9#1)
the expression##403##2##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#1)(1991-5#4)(1991-9#1)(1992-1#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#4)(1993-3#5)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#5)(1995-11#1)(1995-12#6)(1995-2#4)(1995-5#1)(1995-8#3)(1995-9#2)(1996-12#20)(1996-2#4)(1996-3#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#5)(1997-8#12)(2006-6#2)(2007-11#2)(2007-12#1)(2008-10#35)(2008-11#48)(2008-3#1)(2008-4#7)(2008-5#8)(2008-6#6)(2008-7#6)(2008-8#40)(2008-9#33)(2009-10#3)(2009-12#4)(2009-3#3)(2009-4#2)(2009-6#3)(2009-8#3)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#1)(2011-10#1)(2011-2#17)(2011-3#4)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#7)
the expressions of##6##3##(1990-2#1)(2008-11#1)(2011-2#2)(2011-3#1)(2013-8#1)
the expressions##8##2##(1990-2#1)(2008-11#2)(2011-2#2)(2011-3#1)(2013-8#2)
the expressive##2##2##(2008-6#1)(2008-9#1)
the extant##2##2##(2008-6#1)(2010-11#1)
the extended boundary condition method (EBCM)##2##6##(2008-3#2)
the extended boundary condition method##4##5##(2008-3#4)
the extended##12##2##(1990-8#1)(1992-5#1)(1993-12#1)(1993-6#1)(2007-11#1)(2008-3#4)(2008-5#1)(2009-4#1)(2010-4#1)
the extension of the##6##4##(1995-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)
the extension of##10##3##(1991-12#1)(1991-5#1)(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)
the extension phase##3##3##(1997-2#3)
the extension##13##2##(1991-12#1)(1991-5#1)(1995-9#1)(1997-2#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)
the extensive##14##2##(1991-2#1)(1992-1#1)(1992-12#1)(1994-11#1)(2008-10#4)(2008-11#1)(2009-6#1)(2012-2#1)(2012-3#2)(2013-8#1)
the extensor carpi radialis##2##4##(1996-6#1)(2008-12#1)
the extensor##4##2##(1996-6#1)(1997-2#1)(2008-12#1)(2010-6#1)
the extent and##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
the extent of infection##2##4##(2008-10#2)
the extent of its##2##4##(2008-10#2)
the extent of surgical resection##2##5##(2008-7#2)
the extent of the disease##2##5##(1994-9#1)(2010-8#1)
the extent of the problem##3##5##(1991-6#1)(1995-12#1)(2008-10#1)
the extent of the##10##4##(1991-6#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(2008-10#3)(2010-6#1)(2010-8#1)
the extent of their##2##4##(2008-10#1)(2008-11#1)
the extent of tumors##2##4##(1990-6#1)(2013-1#1)
the extent of##79##3##(1990-6#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1996-2#1)(1997-6#2)(1997-8#2)(2008-10#29)(2008-11#8)(2008-12#3)(2008-7#5)(2008-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#2)
the extent to which race##2##5##(2008-11#2)
the extent to which the##5##5##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)
the extent to which they##4##5##(1996-2#2)(2010-7#1)(2012-2#1)
the extent to which##40##4##(1991-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#9)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#3)(2012-3#1)
the extent##128##2##(1990-6#1)(1991-12#2)(1991-6#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#2)(2007-12#1)(2008-10#34)(2008-11#18)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#5)(2008-9#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#2)
the external boundary##2##3##(2008-7#2)
the external carotid##10##3##(1996-9#3)(1997-3#2)(1997-6#4)(2013-1#1)
the external phloem##2##3##(2008-10#2)
the external surface of##2##4##(1994-11#1)(2008-10#1)
the external surface##4##3##(1994-11#1)(2008-10#3)
the external vertebral venous plexus##2##5##(2011-2#2)
the external##52##2##(1990-3#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#1)(1996-9#3)(1997-3#2)(1997-4#1)(1997-6#4)(2008-10#12)(2008-11#6)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#4)(2013-1#2)(2013-8#1)
the extinction cross sections##2##4##(2008-2#2)
the extinction of##2##3##(2008-8#2)
the extinction##14##2##(2008-10#2)(2008-2#3)(2008-3#2)(2008-8#5)(2009-12#1)(2010-4#1)
the extra survival time##2##4##(1995-12#2)
the extra##4##2##(1995-12#2)(2008-10#1)(2008-9#1)
the extracellular domain and##2##4##(1993-6#1)(1993-8#1)
the extracellular domain of##5##4##(1991-5#1)(1991-6#1)(1992-12#1)(1994-11#1)(1995-11#1)
the extracellular domain##10##3##(1991-5#1)(1991-6#1)(1992-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-11#1)(2008-11#1)(2009-8#1)
the extracellular domains of##2##4##(1991-6#2)
the extracellular domains##3##3##(1991-6#2)(1995-11#1)
the extracellular levels of##2##4##(1994-8#1)(1997-2#1)
the extracellular matrix and##2##4##(1995-8#1)(2006-6#1)
the extracellular matrix in##2##4##(2008-1#1)(2008-5#1)
the extracellular matrix of##2##4##(2008-5#1)(2009-8#1)
the extracellular matrix on the##2##5##(1994-8#1)(2008-11#1)
the extracellular matrix##19##3##(1990-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-5#3)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-8#1)
the extracellular medium##2##3##(1991-2#1)(1994-11#1)
the extracellular part of##2##4##(1993-2#1)(1997-9#1)
the extracellular space##4##3##(1992-11#1)(1994-8#1)(2009-9#1)(2012-3#1)
the extracellular##66##2##(1990-2#2)(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-11#1)(1992-12#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#2)(1994-11#2)(1994-3#1)(1994-8#5)(1995-11#3)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-9#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-5#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the extracorporeal##3##2##(1991-11#1)(1992-1#2)
the extract in##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
the extract were investigated##2##4##(2008-5#2)
the extract were##3##3##(2008-10#1)(2008-5#2)
the extract##27##2##(1992-3#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-5#6)(2008-8#1)
the extractability of##6##3##(1994-8#1)(2008-10#4)(2008-7#1)
the extractability##8##2##(1994-8#1)(2008-10#6)(2008-7#1)
the extractable##7##2##(2008-10#7)
the extractant solution##2##3##(2008-10#2)
the extractant##5##2##(2008-10#5)
the extractants##5##2##(2008-10#5)
the extracted complex##3##3##(2008-10#3)
the extracted species##7##3##(2008-10#7)
the extracted##25##2##(1993-6#1)(2008-10#20)(2008-8#2)(2012-2#1)(2013-8#1)
the extracting solvent##3##3##(2008-10#3)
the extracting##6##2##(2008-10#6)
the extraction ability##2##3##(2008-10#2)
the extraction and desorption##2##4##(2008-10#2)
the extraction and determination of molybdenum(VI)##2##6##(2008-10#2)
the extraction and determination of##7##5##(2008-10#7)
the extraction and##16##3##(2008-10#16)
the extraction behavior of##2##4##(2008-10#2)
the extraction behavior##3##3##(2008-10#3)
the extraction chromatography method were##2##5##(2008-10#2)
the extraction chromatography method##3##4##(2008-10#3)
the extraction coil##2##3##(2008-10#2)
the extraction constant##2##3##(2008-10#2)
the extraction constants##2##3##(2008-10#2)
the extraction efficiency and selectivity##2##5##(2008-10#2)
the extraction efficiency and##3##4##(2008-10#3)
the extraction efficiency of the##4##5##(2008-10#4)
the extraction efficiency of these##2##5##(2008-10#2)
the extraction efficiency of##8##4##(2008-10#8)
the extraction efficiency##17##3##(2008-10#17)
the extraction is##3##3##(2008-10#3)
the extraction mechanism##2##3##(2008-10#2)
the extraction medium##2##3##(2008-10#2)
the extraction membrane##3##3##(2008-10#3)
the extraction of a##5##4##(2008-10#5)
the extraction of b(5)##2##4##(2008-7#2)
the extraction of both##2##4##(2008-10#2)
the extraction of mercury##2##4##(2008-10#2)
the extraction of metal ions##2##5##(2008-10#2)
the extraction of metals##2##4##(2008-10#2)
the extraction of the##8##4##(2008-10#6)(2010-12#1)(2013-8#1)
the extraction of##65##3##(2008-10#58)(2008-11#1)(2008-12#1)(2008-7#2)(2009-11#1)(2010-12#1)(2013-8#1)
the extraction procedure##4##3##(1990-5#1)(2008-10#3)
the extraction procedures##3##3##(2008-10#3)
the extraction process and the##2##5##(2008-10#2)
the extraction process and##3##4##(2008-10#3)
the extraction process was performed##2##5##(2008-10#2)
the extraction process were##2##4##(2008-10#2)
the extraction process##16##3##(2008-10#16)
the extraction rate##3##3##(2008-10#3)
the extraction selectivity for##2##4##(2008-10#2)
the extraction selectivity##3##3##(2008-10#3)
the extraction solution##4##3##(2008-10#4)
the extraction solvent##3##3##(2008-10#3)
the extraction step##3##3##(2008-10#2)(2008-7#1)
the extraction technique##2##3##(1991-12#1)(2008-10#1)
the extraction temperature##2##3##(2008-10#2)
the extraction time##6##3##(2008-10#6)
the extraction vessel##5##3##(2008-10#5)
the extraction was##4##3##(2008-10#4)
the extraction with##2##3##(2008-10#2)
the extraction yield##3##3##(2008-10#3)
the extraction##221##2##(1990-5#1)(1991-12#1)(2008-10#211)(2008-11#1)(2008-12#1)(2008-7#3)(2009-11#1)(2010-12#1)(2013-8#1)
the extractive fermentation##2##3##(2011-2#2)
the extractive##6##2##(2008-10#4)(2011-2#2)
the extracts and##2##3##(2008-10#2)
the extracts from##2##3##(2008-10#1)(2008-11#1)
the extracts of##4##3##(2008-10#3)(2008-5#1)
the extracts were##8##3##(2008-10#8)
the extracts##31##2##(2008-10#24)(2008-11#2)(2008-5#1)(2013-1#3)(2013-8#1)
the extraocular##2##2##(1997-3#2)
the extrapolation##2##2##(2008-10#1)(2013-1#1)
the extreme cloacal malformation##2##4##(2008-10#2)
the extreme##18##2##(1990-8#1)(1991-6#1)(1992-10#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#2)
the extremely high##2##3##(2008-11#1)(2009-3#1)
the extremely low##2##3##(1993-8#1)(2011-2#1)
the extremely##14##2##(1993-2#1)(1993-8#1)(1995-6#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#2)(2011-3#1)
the extremes##2##2##(2008-10#1)(2008-8#1)
the extremities and##2##3##(2007-12#1)(2010-6#1)
the extremities##3##2##(2007-12#1)(2010-6#1)(2013-1#1)
the extremity##4##2##(1993-9#1)(2008-3#1)(2013-1#2)
the extrinsic risk factors for inpatient falls from##2##8##(2010-10#2)
the extrinsic##3##2##(2009-9#1)(2010-10#2)
the extruded##2##2##(2012-2#2)
the eye##19##2##(1994-2#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-1#3)(2011-2#4)(2011-7#3)(2013-8#1)
the eyes of##7##3##(1994-3#1)(2007-12#2)(2008-1#1)(2008-6#1)(2010-8#1)(2013-1#1)
the eyes##13##2##(1994-3#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the eyestalk##2##2##(1994-11#1)(2008-5#1)
the fMRI##2##2##(2009-9#2)
the fabrication and##4##3##(2008-12#1)(2008-4#1)(2009-12#1)(2012-2#1)
the fabrication of##13##3##(2007-11#1)(2008-10#5)(2008-12#2)(2008-3#3)(2009-3#1)(2009-7#1)
the fabrication##22##2##(2007-11#1)(2008-10#7)(2008-12#3)(2008-3#6)(2008-4#1)(2009-12#1)(2009-3#1)(2009-7#1)(2012-2#1)
the facades of##2##3##(2008-2#1)(2008-3#1)
the face and##8##3##(1996-11#1)(1996-3#1)(2008-5#2)(2010-1#1)(2010-6#2)(2011-2#1)
the face of##11##3##(1993-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#2)
the face##45##2##(1993-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-11#2)(2008-5#8)(2008-7#2)(2009-8#2)(2010-1#6)(2010-6#2)(2010-7#1)(2011-2#6)(2012-2#1)(2012-3#4)(2013-1#4)
the faces##2##2##(2010-10#2)
the facet joints##3##3##(1996-9#2)(2013-8#1)
the facet##6##2##(1996-9#3)(2011-2#2)(2013-8#1)
the facial canal##2##3##(2008-9#1)(2011-2#1)
the facial nerve and##2##4##(2008-9#1)(2011-2#1)
the facial nerve##9##3##(2008-12#1)(2008-7#1)(2008-9#3)(2011-2#3)(2012-3#1)
the facial skeleton##2##3##(1992-4#1)(2012-3#1)
the facial skin##4##3##(2008-5#4)
the facial##24##2##(1992-4#1)(2008-12#2)(2008-5#4)(2008-7#2)(2008-9#4)(2009-1#1)(2011-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
the facilitation of##5##3##(2008-11#2)(2008-7#1)(2010-10#1)(2012-3#1)
the facilitator##4##2##(1993-12#1)(2008-11#1)(2008-12#2)
the facilitatory effect of##2##4##(1991-2#2)
the facility management staff##2##4##(1992-2#2)
the facility##14##2##(1991-12#3)(1992-2#4)(1994-12#2)(1994-3#1)(2008-9#1)(2009-11#1)(2013-1#2)
the fact that a number of papers appear to have been plagiarized from other previously published papers##2##17##(2008-10#2)
the fact that a##7##4##(1990-11#1)(1991-2#1)(1996-5#1)(2008-10#3)(2008-3#1)
the fact that both##2##4##(2008-10#1)(2009-10#1)
the fact that for##2##4##(1994-6#1)(2011-2#1)
the fact that in##2##4##(2007-11#1)(2008-10#1)
the fact that it is##3##5##(1994-9#1)(2008-10#1)(2012-12#1)
the fact that many##2##4##(1995-11#1)(2009-4#1)
the fact that no##2##4##(1994-8#1)(2008-10#1)
the fact that some##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
the fact that the##37##4##(1990-2#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-8#1)(2008-10#9)(2008-11#9)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
the fact that there##2##4##(2008-10#1)(2008-11#1)
the fact that they##6##4##(2008-10#3)(2008-11#1)(2012-2#1)(2012-3#1)
the fact that##123##3##(1990-11#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#35)(2008-11#17)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#2)(2009-12#1)(2009-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
the fact##125##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#36)(2008-11#17)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#2)(2009-12#1)(2009-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
the factor of##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
the factor##12##2##(1990-5#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2010-10#1)
the factors affecting the##6##4##(2008-10#4)(2008-7#2)
the factors affecting##10##3##(1990-12#1)(1990-6#1)(2008-10#6)(2008-7#2)
the factors and##2##3##(2008-10#2)
the factors associated with the##2##5##(1994-12#1)(2013-1#1)
the factors associated with##6##4##(1994-12#1)(1995-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
the factors contributing to##3##4##(1994-12#1)(2008-10#1)(2012-3#1)
the factors in##3##3##(1997-8#1)(2009-5#1)(2009-6#1)
the factors influencing##4##3##(1996-2#1)(2008-4#1)(2008-7#1)(2010-12#1)
the factors involved in##2##4##(2008-1#1)(2009-6#1)
the factors involved##3##3##(2008-1#1)(2009-6#2)
the factors of##3##3##(1996-3#1)(2008-10#2)
the factors that are##2##4##(2008-8#1)(2013-1#1)
the factors that influence the##6##5##(1991-11#1)(1995-2#1)(2008-10#2)(2010-10#1)(2011-1#1)
the factors that influence##8##4##(1991-11#1)(1995-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)
the factors that##28##3##(1991-11#1)(1991-2#1)(1993-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#4)(2008-9#3)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the factors which were##2##4##(1992-1#1)(2011-2#1)
the factors which##8##3##(1992-1#1)(1996-3#1)(2008-10#1)(2008-7#2)(2010-9#2)(2011-2#1)
the factors##88##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#2)(1993-12#1)(1994-12#2)(1995-12#3)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-8#1)(2008-1#1)(2008-10#20)(2008-12#2)(2008-4#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-5#1)(2009-6#3)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-9#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the facts##4##2##(1994-1#1)(1995-1#1)(2008-10#1)(2010-7#1)
the faculty##4##2##(1992-1#1)(1993-2#1)(1996-1#1)(2009-10#1)
the faeces of##3##3##(1996-12#1)(2008-11#1)(2008-5#1)
the failure of##10##3##(1991-2#1)(1995-12#1)(1995-3#1)(1997-3#2)(2008-11#3)(2008-8#1)(2011-3#1)
the failure to##3##3##(2008-11#2)(2012-2#1)
the failure##18##2##(1991-2#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#2)(2008-10#1)(2008-11#6)(2008-8#1)(2009-7#1)(2011-3#1)(2012-2#1)(2013-8#1)
the fall of 1995 and 1996##2##6##(2008-10#2)
the fall of##10##3##(1991-2#1)(1996-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2011-9#1)
the fall##20##2##(1991-2#2)(1995-2#2)(1996-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-9#1)(2013-1#1)
the fallacy##2##2##(1995-1#1)(2011-2#1)
the fallopian tube##5##3##(1991-3#1)(1992-1#2)(1992-12#1)(1993-2#1)
the fallopian##7##2##(1991-12#1)(1991-3#1)(1992-1#2)(1992-12#1)(1993-2#1)(2008-7#1)
the false lumen##2##3##(2008-11#2)
the false##3##2##(2008-11#2)(2008-6#1)
the familial##4##2##(1990-9#1)(2008-7#1)(2012-3#1)(2013-1#1)
the familiar##4##2##(1990-11#1)(1994-1#1)(2012-3#2)
the families of##4##3##(2008-1#1)(2008-4#1)(2010-1#1)(2010-10#1)
the families##15##2##(1992-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-3#2)(2013-8#2)
the family Actinomycetaceae##2##3##(2011-2#2)
the family Aquificaceae##2##3##(2011-2#2)
the family Araceae##5##3##(2008-10#5)
the family Comoviridae##2##3##(2008-10#2)
the family Cucurbitaceae##5##3##(2008-10#5)
the family Enterobacteriaceae##4##3##(2008-10#2)(2010-6#2)
the family Pasteurellaceae Pohl 1981##2##5##(2008-5#2)
the family Potyviridae##6##3##(2008-10#6)
the family Reoviridae##2##3##(2008-10#2)
the family Synergistaceae##3##3##(2011-2#3)
the family and##5##3##(1995-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-12#1)
the family are##2##3##(1997-4#1)(2008-12#1)
the family of##6##3##(1993-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#1)(2009-7#1)
the family physician##4##3##(1993-3#1)(1995-11#1)(1997-4#2)
the family##139##2##(1990-11#1)(1990-12#3)(1990-3#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-1#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-8#2)(2007-12#1)(2008-10#39)(2008-11#3)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-6#3)(2010-9#1)(2011-2#32)(2012-12#1)(2012-2#2)(2012-3#6)
the family's##3##2##(1994-5#1)(1995-1#2)
the fan-beam DT##2##3##(2008-3#2)
the fan-beam##3##2##(2008-3#3)
the fantail and eggfish##3##4##(2010-8#3)
the fantail##4##2##(2010-8#4)
the far##3##2##(2008-2#1)(2008-3#2)
the far-field diffraction##2##3##(2008-3#2)
the far-field##9##2##(2008-2#1)(2008-3#8)
the farm##7##2##(1990-9#1)(1994-3#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)
the farmer##2##2##(1997-7#1)(2008-12#1)
the farms##2##2##(1996-12#2)
the fascia##5##2##(2009-1#3)(2009-9#1)(2010-7#1)
the fast rate varied from##2##5##(2008-9#2)
the fast rate##3##3##(2008-9#3)
the fast##18##2##(1991-12#1)(1995-3#1)(2007-12#1)(2008-10#8)(2008-7#1)(2008-9#3)(2011-1#1)(2011-2#1)(2013-8#1)
the faster##3##2##(1996-2#1)(2008-10#2)
the fastest growing##3##3##(1994-3#1)(2008-11#1)(2013-8#1)
the fastest rate##2##3##(2008-10#2)
the fastest##9##2##(1994-3#1)(2008-10#6)(2008-11#1)(2013-8#1)
the fastest-growing##2##2##(1997-5#1)(2011-2#1)
the fasting##3##2##(1991-7#1)(2008-1#1)(2008-6#1)
the fat##13##2##(1995-2#3)(1997-3#1)(2008-10#3)(2008-11#3)(2010-12#1)(2011-2#1)(2012-2#1)
the fate of the##3##4##(2008-10#3)
the fate of##12##3##(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-11#2)(2009-8#1)(2010-11#1)
the father##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
the fatigue protocol##2##3##(2013-8#2)
the fatigue##3##2##(2013-8#3)
the fatty acid composition of##2##5##(1991-12#1)(1992-12#1)
the fatty acid##8##3##(1991-12#2)(1992-12#1)(1992-3#1)(1996-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
the fatty acids##4##3##(1991-6#1)(2008-10#2)(2011-1#1)
the fatty##13##2##(1991-12#2)(1991-6#1)(1992-12#1)(1992-3#1)(1996-3#1)(2008-10#3)(2008-5#1)(2011-1#2)(2011-2#1)
the favorable##5##2##(1990-6#1)(1990-8#1)(2008-10#2)(2011-2#1)
the favourable##2##2##(2008-10#1)(2013-1#1)
the fear of##2##3##(1991-6#1)(1997-3#1)
the fear##3##2##(1991-6#1)(1997-3#1)(2010-9#1)
the fears and##2##3##(1995-2#1)(2011-2#1)
the fears expressed by##2##4##(2008-12#1)(2011-2#1)
the fears##4##2##(1995-2#1)(2008-12#1)(2011-2#2)
the feasibility and desirability of##2##5##(1992-2#2)
the feasibility and safety of##4##5##(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
the feasibility and##10##3##(1992-2#2)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
the feasibility for##2##3##(2008-10#1)(2011-2#1)
the feasibility of NeutrAvidin-tagged##2##4##(2008-10#2)
the feasibility of a##5##4##(1990-5#1)(1996-2#1)(2008-10#1)(2008-2#1)(2010-10#1)
the feasibility of developing an in vitro##2##7##(2009-7#2)
the feasibility of developing##3##4##(1994-3#1)(2009-7#2)
the feasibility of the method##2##5##(2008-11#1)(2008-3#1)
the feasibility of the##14##4##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#2)(2010-11#1)(2011-2#1)(2013-1#1)
the feasibility of this##2##4##(2008-10#2)
the feasibility of using the##2##5##(2008-10#2)
the feasibility of using##8##4##(1994-11#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-8#1)
the feasibility of##65##3##(1990-11#1)(1990-5#1)(1992-12#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-2#2)(1996-3#2)(1997-8#1)(2007-9#1)(2008-10#21)(2008-11#5)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#4)(2008-9#1)(2009-7#2)(2010-10#2)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
the feasibility##81##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-2#2)(1994-11#1)(1994-3#1)(1995-11#1)(1996-2#2)(1996-3#2)(1997-3#1)(1997-8#1)(2007-9#1)(2008-10#24)(2008-11#6)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#5)(2008-9#1)(2009-7#2)(2010-10#2)(2010-11#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
the feature##6##2##(2008-10#1)(2008-12#1)(2008-3#3)(2008-7#1)
the features and##5##3##(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#1)(2012-2#1)
the features described##2##3##(2008-7#2)
the features of the##7##4##(1991-8#1)(1993-12#1)(2007-12#1)(2009-10#1)(2011-2#3)
the features of this##15##4##(2008-12#1)(2011-2#14)
the features of##30##3##(1991-8#1)(1992-4#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#19)(2012-2#2)
the features##45##2##(1991-8#1)(1992-4#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-8#4)(2011-2#19)(2012-2#3)(2013-8#1)
the feces##2##2##(1990-6#1)(2007-12#1)
the fecundity##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
the fed##2##2##(1991-3#1)(2012-2#1)
the fed-batch##6##2##(2008-11#3)(2008-7#2)(2013-1#1)
the federal government to##3##4##(1991-1#1)(2008-10#1)(2008-11#1)
the federal government##7##3##(1991-1#1)(1992-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)
the federal government's##2##3##(1992-3#1)(2012-3#1)
the federal##18##2##(1991-1#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2010-5#1)(2012-3#1)
the federally##2##2##(1995-2#2)
the fee##4##2##(1993-3#1)(1994-1#1)(1994-12#1)(2013-8#1)
the fee-for-service##3##2##(1993-1#1)(1993-3#1)(1997-2#1)
the feed solution##4##3##(2008-10#4)
the feed##10##2##(1995-11#1)(2008-10#6)(2008-12#1)(2008-7#1)(2011-2#1)
the feedback from##2##3##(2008-8#1)(2009-10#1)
the feedback##5##2##(1994-12#1)(2008-8#1)(2009-10#2)(2009-8#1)
the feedback-based operation##2##3##(2008-10#2)
the feeder##5##2##(1993-3#1)(1997-3#3)(2008-10#1)
the feeding##17##2##(1994-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-8#4)
the feeling of##2##3##(1994-1#1)(2008-11#1)
the feelings and##2##3##(2008-9#1)(2012-3#1)
the feelings##3##2##(2008-9#1)(2010-7#1)(2012-3#1)
the feet##11##2##(1994-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-9#2)(2012-3#1)(2013-1#4)
the female genital##4##3##(2007-12#1)(2009-2#1)(2011-2#1)(2012-3#1)
the female parent##2##3##(2008-10#2)
the female reproductive##2##3##(2007-12#1)(2010-3#1)
the female sex pheromone##2##4##(1990-8#1)(2008-10#1)
the female##47##2##(1990-11#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-3#6)(1993-12#1)(1993-2#2)(1994-2#1)(1995-8#1)(1995-9#1)(1997-7#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
the females##9##2##(1993-11#1)(1994-2#2)(2007-12#1)(2008-12#1)(2008-7#2)(2008-9#2)
the femoral artery##2##3##(2008-10#1)(2008-3#1)
the femoral neck##7##3##(2009-3#4)(2010-3#1)(2011-2#1)(2013-1#1)
the femoral##21##2##(1992-3#1)(1992-6#1)(2008-10#1)(2008-3#1)(2009-3#4)(2010-3#1)(2011-2#5)(2012-3#1)(2013-1#6)
the femur##7##2##(1991-11#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#3)
the fenestrated A1##2##3##(2013-8#2)
the fenestrated##4##2##(2010-12#1)(2013-8#3)
the fermentation broth##2##3##(2008-7#1)(2012-2#1)
the fermentation##11##2##(2008-10#2)(2008-7#2)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)
the fermenting##2##2##(2008-10#2)
the ferret group##2##3##(2008-6#2)
the ferret##4##2##(2008-6#4)
the ferric siderophore##2##3##(2011-2#2)
the ferric##6##2##(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#3)
the ferricyanide##2##2##(2008-10#2)
the ferritin##4##2##(1990-5#1)(2008-1#1)(2013-8#2)
the ferrozine method##2##3##(2008-10#2)
the fertilization##2##2##(1994-11#1)(2010-8#1)
the festival##2##2##(2009-10#2)
the fetal##9##2##(1993-12#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
the fetus is##2##3##(1990-9#1)(2010-11#1)
the fetus##10##2##(1990-9#1)(1996-11#1)(1997-8#1)(2010-11#4)(2012-2#1)(2013-1#2)
the fetuses##4##2##(1995-11#1)(1996-3#1)(2008-11#1)(2012-3#1)
the fever##2##2##(1994-2#1)(2009-6#1)
the few cells that##2##4##(2007-12#1)(2008-10#1)
the few studies that##2##4##(2008-11#1)(2011-2#1)
the few##12##2##(1994-12#1)(1994-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2011-2#1)(2012-3#1)
the fewest##3##2##(1990-3#1)(2008-10#1)(2008-8#1)
the fiber cells##3##3##(2008-10#3)
the fiber core##2##3##(2008-3#2)
the fiber end##2##3##(2008-3#2)
the fiber laser##2##3##(2008-2#1)(2008-3#1)
the fiber optic##3##3##(2008-10#3)
the fiber tip in##2##4##(1992-1#1)(2008-3#1)
the fiber tip##3##3##(1992-1#1)(1995-2#1)(2008-3#1)
the fiber was##6##3##(1992-1#1)(2008-10#5)
the fiber##48##2##(1992-1#3)(1995-2#1)(2007-11#1)(2007-12#3)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#16)(2008-8#2)(2010-4#1)
the fiber's##4##2##(2007-11#1)(2008-3#3)
the fiber-optic DNA##2##3##(2008-9#2)
the fiber-optic##4##2##(2008-10#2)(2008-9#2)
the fibers are##2##3##(2007-11#1)(2008-10#1)
the fibers##11##2##(1991-12#2)(1996-12#1)(2007-11#1)(2008-10#5)(2009-7#1)(2012-3#1)
the fibre type composition of the##2##6##(2011-2#2)
the fibre type composition##4##4##(2011-2#4)
the fibre##14##2##(2008-10#8)(2009-7#1)(2011-2#4)(2013-1#1)
the fibrillar##2##2##(2010-4#2)
the fibrils##2##2##(2008-5#2)
the fibrinogen binding##2##3##(1995-2#1)(2006-6#1)
the fibrinogen##5##2##(1993-8#1)(1995-2#2)(2006-6#1)(2008-10#1)
the fibrinolytic system in##3##4##(1997-1#3)
the fibrinolytic system##4##3##(1994-3#1)(1997-1#3)
the fibrinolytic##6##2##(1993-2#1)(1994-3#1)(1994-5#1)(1997-1#3)
the fibroblast##2##2##(2008-11#2)
the fibrous matrix##5##3##(2008-11#5)
the fibrous##8##2##(2008-10#1)(2008-11#6)(2011-2#1)
the fideistic probability that God##2##5##(2013-1#2)
the field and the##2##4##(2008-5#1)(2013-1#1)
the field and##13##3##(2008-10#9)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
the field as a##2##4##(1996-2#1)(2008-10#1)
the field as##3##3##(1996-2#1)(2008-10#2)
the field by##2##3##(1995-12#1)(2008-10#1)
the field experiment##5##3##(2008-10#5)
the field experiments##3##3##(2008-10#2)(2008-9#1)
the field for##4##3##(2008-10#2)(2008-8#1)(2010-7#1)
the field from##2##3##(2008-10#2)
the field in##7##3##(2008-10#6)(2008-3#1)
the field is##3##3##(2008-10#2)(2008-9#1)
the field of health insurance##2##5##(1992-3#2)
the field of health##4##4##(1992-3#2)(2010-12#1)(2011-2#1)
the field of mechanotherapy##2##4##(2008-12#2)
the field of radiology##2##4##(1991-1#1)(1992-1#1)
the field of routine##2##4##(2008-10#1)(2011-2#1)
the field of science##2##4##(2008-11#1)(2011-2#1)
the field of##101##3##(1990-3#1)(1991-1#2)(1991-8#1)(1992-1#2)(1992-3#2)(1993-1#1)(1993-2#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-9#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-10#16)(2008-11#6)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#3)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#5)
the field results##2##3##(2008-10#2)
the field soil##2##3##(2008-10#2)
the field to##4##3##(1995-6#1)(2008-10#2)(2008-9#1)
the field was##4##3##(2008-10#4)
the field with##5##3##(1996-6#1)(2008-10#3)(2008-11#1)
the field##335##2##(1990-3#1)(1991-1#2)(1991-2#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-3#3)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#2)(1995-1#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#4)(1996-6#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#180)(2008-11#10)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#12)(2009-10#3)(2009-4#3)(2009-6#3)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#9)(2012-8#1)(2013-1#5)(2013-8#5)
the fields of##7##3##(1996-3#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#1)(2013-8#1)
the fields##15##2##(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#1)(2012-2#1)(2013-8#1)
the fifth and##2##3##(2008-10#1)(2013-7#1)
the fifth patient##2##3##(1995-5#1)(1997-3#1)
the fifth year of the##2##5##(1992-12#1)(2008-10#1)
the fifth year##3##3##(1992-12#1)(2008-10#2)
the fifth##30##2##(1991-9#1)(1992-12#1)(1992-5#1)(1994-12#1)(1995-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
the fight against domestic##2##4##(1993-12#2)
the fight against##5##3##(1993-12#2)(1995-1#1)(2011-2#1)(2012-3#1)
the fight##8##2##(1993-12#2)(1995-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
the figure##2##2##(1990-6#1)(2008-10#1)
the figure-of-8 construct##3##3##(2009-3#3)
the figure-of-8##4##2##(2009-3#4)
the figures of merit of the##3##6##(2008-10#3)
the figures of merit##5##4##(2008-10#5)
the figures##7##2##(1996-1#1)(1997-4#1)(2008-10#5)
the filamentous##5##2##(1995-6#1)(2008-10#2)(2008-8#1)(2012-2#1)
the filaments##3##2##(1993-12#1)(2008-7#1)(2008-8#1)
the filarial##2##2##(1991-5#2)
the files##3##2##(1990-2#1)(1995-12#1)(2008-10#1)
the filling in##2##3##(2008-3#2)
the film and the##3##4##(2007-12#1)(2008-10#2)
the film and##5##3##(2007-12#1)(2008-10#4)
the film forming process##2##4##(2008-5#2)
the film may##2##3##(2008-10#2)
the film thickness##4##3##(2008-10#4)
the film was##3##3##(2008-10#2)(2010-4#1)
the film with##2##3##(2008-10#1)(2008-11#1)
the film##48##2##(1996-1#1)(1997-2#2)(2007-12#1)(2008-10#31)(2008-11#2)(2008-2#1)(2008-5#7)(2008-7#1)(2010-4#1)(2013-1#1)
the films in the medium##2##5##(2008-10#1)(2008-11#1)
the films in the##3##4##(2008-10#2)(2008-11#1)
the films were##3##3##(2008-10#3)
the films##21##2##(2008-10#14)(2008-11#4)(2008-12#2)(2009-11#1)
the filter was##2##3##(1992-6#2)
the filter##14##2##(1992-6#2)(2008-10#9)(2008-2#1)(2008-3#2)
the filters##3##2##(1992-5#1)(2008-10#2)
the filtrate##11##2##(2008-10#9)(2008-7#2)
the filtrates##2##2##(2008-10#2)
the fimA and fimF genes##2##5##(2008-10#2)
the fimA and fimF##3##4##(2008-10#3)
the fimA##4##2##(2008-10#4)
the fimbrial##2##2##(2008-10#2)
the final analysis##3##3##(1992-3#1)(1996-3#1)(2012-2#1)
the final decision##3##3##(1992-5#1)(1994-3#1)(1995-11#1)
the final diagnosis of##3##4##(2008-5#1)(2010-6#1)(2012-3#1)
the final diagnosis##5##3##(2008-10#1)(2008-5#1)(2010-6#1)(2012-3#2)
the final disease intensity##2##4##(2008-10#2)
the final disease##3##3##(2008-10#3)
the final germination percentage of##2##5##(2008-10#2)
the final model##4##3##(1992-4#1)(2008-10#2)(2009-7#1)
the final outcome of##2##4##(2007-11#1)(2008-7#1)
the final outcome##3##3##(2007-11#1)(2008-7#2)
the final part of##2##4##(1993-12#1)(2009-8#1)
the final product##9##3##(2008-10#4)(2008-5#2)(2010-10#1)(2012-2#2)
the final products##4##3##(1996-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
the final results##2##3##(2008-10#2)
the final stages of##4##4##(1990-5#1)(1997-8#1)(2007-12#1)(2008-5#1)
the final step of##2##4##(1993-8#1)(1994-11#1)
the final steps of##2##4##(1992-12#1)(1997-7#1)
the final year of##2##4##(2008-11#1)(2008-12#1)
the final##136##2##(1990-5#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#4)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#39)(2008-11#13)(2008-12#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-7#3)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)
the financial and##2##3##(1992-2#1)(2008-11#1)
the financial performance of##3##4##(1991-3#1)(1994-12#1)(1994-2#1)
the financial world##2##3##(2010-5#2)
the financial##14##2##(1991-3#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-12#2)(1994-2#1)(1997-1#1)(2008-11#2)(2010-10#1)(2010-5#2)
the financing of##2##3##(1993-2#1)(2008-10#1)
the financing##3##2##(1993-2#1)(1993-3#1)(2008-10#1)
the finding of a##2##4##(1996-12#1)(2013-1#1)
the finding of##9##3##(1991-11#1)(1991-12#1)(1994-11#1)(1996-11#1)(1996-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
the finding that the##5##4##(1994-8#1)(1995-11#1)(1995-6#1)(2008-10#2)
the finding that##14##3##(1992-6#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-6#1)(2008-10#4)(2009-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
the finding##26##2##(1991-11#1)(1991-12#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-6#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the findings and##2##3##(2009-10#1)(2012-3#1)
the findings are discussed##2##4##(1995-1#1)(2012-2#1)
the findings are##7##3##(1991-12#1)(1992-12#1)(1995-1#1)(2008-10#2)(2012-2#1)(2013-8#1)
the findings from##3##3##(1992-11#1)(2008-11#1)(2012-3#1)
the findings in##4##3##(1995-1#1)(2008-7#2)(2010-10#1)
the findings may##2##3##(2008-11#1)(2013-1#1)
the findings obtained##2##3##(1991-2#1)(2008-5#1)
the findings of a survey##2##5##(2008-1#1)(2008-11#1)
the findings of a##6##4##(1995-1#1)(1996-3#1)(2008-1#1)(2008-11#3)
the findings of the##4##4##(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)
the findings of this##3##4##(2008-7#1)(2010-4#1)(2013-1#1)
the findings of##28##3##(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-10#1)(2012-2#1)(2013-1#2)
the findings on##5##3##(1997-3#1)(1997-8#2)(2008-11#1)(2008-12#1)
the findings provide##2##3##(1997-3#1)(2008-11#1)
the findings to##2##3##(1995-1#1)(2008-12#1)
the findings with##2##3##(1991-2#1)(1994-3#1)
the findings##85##2##(1990-11#1)(1990-2#1)(1991-12#2)(1991-2#3)(1991-6#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#4)(1996-3#1)(1997-1#1)(1997-3#2)(1997-8#2)(2008-1#1)(2008-10#4)(2008-11#15)(2008-12#7)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#3)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
the fine particle mass##2##4##(1996-2#2)
the fine structure of##2##4##(1992-1#1)(2007-12#1)
the fine structure##3##3##(1992-1#1)(2007-12#2)
the fine##11##2##(1992-1#1)(1992-6#1)(1996-2#2)(1997-5#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)
the fine-tuning of##2##3##(1995-9#1)(2013-8#1)
the fingers##2##2##(2008-1#1)(2008-5#1)
the finite sample##2##3##(2009-10#1)(2010-11#1)
the finite##5##2##(1990-5#1)(2008-3#1)(2009-10#1)(2010-11#1)(2013-1#1)
the finite-difference time-domain method and##2##5##(2008-2#1)(2008-3#1)
the fire##5##2##(1996-12#3)(2007-12#2)
the firing pattern of##2##4##(2008-11#1)(2008-7#1)
the firing process##2##3##(2008-10#2)
the firing rate##4##3##(1996-2#1)(2008-11#3)
the firing##11##2##(1996-2#1)(2008-10#2)(2008-11#7)(2008-7#1)
the firm##3##2##(1993-3#2)(1997-1#1)
the first 10 h##2##4##(2008-10#1)(2008-7#1)
the first 10##4##3##(1991-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
the first 100##2##3##(1994-12#1)(2008-10#1)
the first 12 months##2##4##(1990-2#1)(2009-10#1)
the first 15##2##3##(2008-10#2)
the first 2 weeks of##3##5##(2008-10#1)(2008-6#2)
the first 2 weeks##5##4##(2008-10#2)(2008-6#2)(2008-7#1)
the first 2 years of##2##5##(1995-1#1)(2008-10#1)
the first 2 years##3##4##(1995-1#1)(2008-10#1)(2008-7#1)
the first 2##12##3##(1995-1#1)(2008-10#4)(2008-6#2)(2008-7#3)(2008-9#1)(2013-1#1)
the first 24 h##2##4##(2008-11#1)(2012-3#1)
the first 24 residues##2##4##(1991-10#2)
the first 24##5##3##(1991-10#2)(1996-6#1)(2008-11#1)(2012-3#1)
the first 3 days after##2##5##(2011-2#2)
the first 3 days##4##4##(1995-3#1)(2008-11#1)(2011-2#2)
the first 3 months after##2##5##(2011-2#1)(2013-1#1)
the first 3 months of life##2##6##(2008-10#1)(2010-6#1)
the first 3 months##4##4##(2008-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
the first 3 years##2##4##(1991-3#1)(1992-12#1)
the first 3##13##3##(1991-3#1)(1992-12#1)(1993-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-6#1)(2011-2#3)(2013-1#1)
the first 30##2##3##(1996-8#1)(2008-7#1)
the first 4##4##3##(1994-8#1)(1995-11#1)(2008-10#1)(2008-8#1)
the first 48##2##3##(1992-12#1)(2012-2#1)
the first 5 years##4##4##(1992-1#1)(1994-12#1)(2008-9#1)(2011-2#1)
the first 5##8##3##(1992-1#1)(1993-12#1)(1994-12#1)(1995-6#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
the first 6##5##3##(1992-4#1)(2008-10#2)(2008-11#1)(2011-2#1)
the first 8##2##3##(1992-1#1)(1992-12#1)
the first analytical##2##3##(2008-10#2)
the first and last##2##4##(1997-3#1)(2008-10#1)
the first and second period##2##5##(1996-3#2)
the first and second##21##4##(1990-8#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#7)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#2)(2013-8#1)
the first and the second##5##5##(2008-10#4)(2008-11#1)
the first and##30##3##(1990-8#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#14)(2008-11#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#2)(2013-8#1)
the first application##3##3##(2008-10#1)(2008-3#2)
the first assay##2##3##(2008-10#1)(2008-5#1)
the first attempt to##2##4##(2008-10#1)(2008-11#1)
the first attempt##4##3##(1997-6#1)(2008-10#1)(2008-11#1)(2010-2#1)
the first attempts to##2##4##(2008-10#1)(2011-1#1)
the first basic##2##3##(1992-2#1)(2008-4#1)
the first being##2##3##(1994-6#1)(2008-9#1)
the first case in##2##4##(2010-11#1)(2013-1#1)
the first case of a##4##5##(1997-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
the first case of##15##4##(1996-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
the first case report##2##4##(2008-12#1)(2012-3#1)
the first case##31##3##(1991-2#1)(1993-2#1)(1995-6#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-12#3)(2008-5#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#2)
the first cause of##2##4##(2008-1#1)(2011-3#1)
the first cell##2##3##(2008-10#1)(2008-11#1)
the first characterized##2##3##(1995-6#1)(2008-9#1)
the first choice##3##3##(1992-9#1)(2011-2#1)(2013-1#1)
the first class##2##3##(1994-11#2)
the first clear case##2##4##(2008-10#1)(2008-9#1)
the first clinical##2##3##(1990-12#1)(2008-5#1)
the first coding exon##3##4##(1990-8#3)
the first complete genome sequence of##8##6##(2008-10#1)(2011-2#7)
the first completed genome sequence##10##5##(2011-2#10)
the first completed##12##3##(2011-2#12)
the first constant domain##2##4##(1993-6#2)
the first constant##3##3##(1993-6#2)(2008-10#1)
the first cycle##2##3##(1990-12#1)(2008-7#1)
the first data##2##3##(2008-10#1)(2008-11#1)
the first day of life##2##5##(1993-12#2)
the first day of##4##4##(1990-12#1)(1992-5#1)(1993-12#2)
the first day##9##3##(1990-12#3)(1991-6#1)(1992-5#1)(1993-12#2)(2008-5#1)(2011-2#1)
the first days of the##2##5##(2007-8#1)(2008-11#1)
the first days##4##3##(1992-9#1)(2007-8#1)(2008-11#1)(2012-3#1)
the first demonstration of a##2##5##(1993-9#1)(2007-12#1)
the first demonstration of##7##4##(1993-9#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-8#1)
the first demonstration that##3##4##(1997-2#1)(2008-10#2)
the first demonstration##11##3##(1993-9#1)(1994-5#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-8#1)
the first derivative of the ratio spectra##2##7##(2008-10#2)
the first derivative of the ratio##3##6##(2008-10#3)
the first derivative of##5##4##(2008-10#5)
the first derivative spectra##2##4##(2008-10#2)
the first derivative##9##3##(2008-10#9)
the first described##3##3##(1994-3#1)(1995-8#1)(2008-10#1)
the first description of the##4##5##(1993-12#1)(1997-8#1)(2008-10#1)(2009-7#1)
the first description of##7##4##(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-7#1)
the first detailed##2##3##(2008-10#1)(2008-11#1)
the first dimension##2##3##(2008-10#2)
the first direct evidence that##3##5##(1996-12#1)(2008-10#2)
the first direct##5##3##(1993-3#1)(1996-12#1)(2008-10#2)(2011-1#1)
the first documented##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
the first dorsal web space##2##5##(2008-9#2)
the first dose of medication##2##5##(2008-7#1)(2012-12#1)
the first dose of##3##4##(1995-3#1)(2008-7#1)(2012-12#1)
the first dose##8##3##(1995-3#1)(2007-11#1)(2008-7#2)(2012-12#4)
the first eight##3##3##(1990-11#1)(1997-1#1)(2008-10#1)
the first evidence for##2##4##(2008-10#1)(2013-8#1)
the first evidence of##4##4##(1992-2#1)(2008-8#1)(2008-9#1)(2010-2#1)
the first evidence that##2##4##(1994-5#1)(2010-6#1)
the first evidence##9##3##(1992-2#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2013-8#1)
the first examination##3##3##(1996-6#1)(2008-5#1)(2008-7#1)
the first example of a##5##5##(1991-2#1)(1995-2#1)(1996-3#1)(2008-6#1)(2012-3#1)
the first example of##7##4##(1991-2#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
the first exon and##3##4##(1991-5#1)(1993-2#1)(1993-6#1)
the first exon##4##3##(1991-5#1)(1993-2#1)(1993-6#1)(1993-8#1)
the first experiment##7##3##(1996-12#1)(2008-10#6)
the first experimental##3##3##(2007-8#1)(2008-11#1)(2012-3#1)
the first few minutes##2##4##(1996-1#1)(2008-7#1)
the first few years of##2##5##(1996-9#1)(2008-9#1)
the first few##13##3##(1991-5#1)(1996-1#1)(1996-9#2)(1997-5#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)
the first five years of##2##5##(1992-2#1)(2011-2#1)
the first five##4##3##(1990-3#1)(1992-2#1)(2008-10#1)(2011-2#1)
the first four##4##3##(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#1)
the first fusion##2##3##(1991-10#1)(2011-3#1)
the first gene##3##3##(1991-5#1)(1996-12#1)(2008-8#1)
the first genome##3##3##(2010-8#1)(2011-2#2)
the first glutamatergic##2##3##(2012-2#2)
the first grade##2##3##(2008-10#1)(2008-11#1)
the first group##13##3##(1990-2#2)(1991-5#1)(1994-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#2)(2013-1#3)
the first half of the##5##5##(2008-11#1)(2008-12#1)(2009-8#1)(2010-1#2)
the first half of##6##4##(1993-3#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-1#2)
the first imaging##3##3##(1993-6#1)(2010-6#1)(2012-2#1)
the first in a##2##4##(2008-10#1)(2008-4#1)
the first in##4##3##(2008-10#2)(2008-4#1)(2010-5#1)
the first infestation##2##3##(1996-12#2)
the first injection of##2##4##(1993-11#1)(2013-8#1)
the first injection##3##3##(1993-11#1)(2011-2#1)(2013-8#1)
the first instance##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
the first intron of##2##4##(1992-6#1)(2012-3#1)
the first intron##8##3##(1991-6#1)(1992-6#1)(1993-2#2)(1993-6#1)(2010-5#1)(2012-3#2)
the first investigation##4##3##(1996-3#1)(2008-6#1)(2009-10#1)(2013-8#1)
the first known##2##3##(1992-5#1)(2013-1#1)
the first line of defense against##2##6##(1993-12#1)(2008-11#1)
the first line of defense##3##5##(1993-12#1)(2008-10#1)(2008-11#1)
the first line of##6##4##(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
the first line##7##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
the first major##2##3##(2008-10#1)(2013-1#1)
the first manifestation of##2##4##(1991-3#1)(1996-11#1)
the first manifestation##3##3##(1991-3#1)(1996-11#1)(2011-2#1)
the first member of##2##4##(1990-5#1)(2008-10#1)
the first metatarsal##4##3##(2008-12#4)
the first metatarsophalangeal joint##2##4##(2010-5#2)
the first method##3##3##(2008-10#2)(2008-3#1)
the first month of##3##4##(1993-2#1)(1996-8#1)(1997-8#1)
the first month##5##3##(1993-2#2)(1996-8#2)(1997-8#1)
the first national##2##3##(1997-8#1)(2011-2#1)
the first observation##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
the first of its kind##2##5##(2008-12#1)(2012-2#1)
the first of##8##3##(1993-2#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
the first one##3##3##(2008-10#1)(2009-10#1)(2013-1#1)
the first operation##2##3##(1991-3#1)(2008-7#1)
the first or##4##3##(1990-8#1)(2008-3#1)(2008-6#1)(2008-7#1)
the first order##3##3##(2008-10#1)(2008-11#2)
the first part of a##2##5##(2008-11#1)(2013-8#1)
the first part of this##4##5##(2008-10#2)(2010-12#1)(2012-2#1)
the first part of##7##4##(1997-4#1)(2008-10#2)(2008-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
the first part##9##3##(1997-4#1)(2008-10#2)(2008-11#2)(2010-12#1)(2012-2#1)(2013-8#2)
the first patient##2##3##(1995-11#1)(2009-1#1)
the first peak of##2##4##(1996-12#2)
the first period##4##3##(1996-11#1)(2008-10#1)(2011-2#2)
the first phase of##3##4##(2008-1#1)(2008-11#1)(2008-12#1)
the first phase##5##3##(2008-1#1)(2008-11#1)(2008-12#2)(2011-3#1)
the first place##3##3##(2008-1#1)(2008-9#1)(2011-2#1)
the first polar body##2##4##(2008-9#1)(2013-1#1)
the first presentation of##2##4##(2008-4#1)(2011-2#1)
the first priority##2##3##(1992-12#1)(2010-8#1)
the first procedure##2##3##(1997-8#1)(2008-10#1)
the first published##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
the first quantitative##3##3##(1994-3#1)(2008-10#1)(2012-2#1)
the first reaction##3##3##(2008-10#3)
the first record##2##3##(2008-10#2)
the first report of this##2##5##(1990-6#1)(1992-3#1)
the first report of##45##4##(1990-6#1)(1991-4#1)(1992-10#1)(1992-3#1)(1997-2#1)(1997-7#1)(2008-10#23)(2008-11#4)(2008-7#1)(2008-9#2)(2009-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
the first report##87##3##(1990-5#1)(1990-6#1)(1991-4#1)(1992-10#1)(1992-3#2)(1994-12#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#39)(2008-11#9)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#4)(2009-1#1)(2009-12#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
the first reported case of such a##2##7##(2010-7#1)(2012-2#1)
the first reported case of such##3##6##(2008-11#1)(2010-7#1)(2012-2#1)
the first reported case of##12##5##(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the first reported##17##3##(1992-8#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the first round##3##3##(1991-6#2)(1995-12#1)
the first sample##2##3##(2008-10#2)
the first sampling##2##3##(2008-10#1)(2008-8#1)
the first season##2##3##(2008-10#2)
the first sequence##2##3##(2008-10#1)(2008-4#1)
the first sign of##2##4##(1993-2#1)(2011-2#1)
the first signs of##2##4##(2007-9#1)(2011-2#1)
the first six months##2##4##(1991-6#1)(1996-11#1)
the first six##4##3##(1991-6#1)(1993-2#1)(1996-11#1)(2011-1#1)
the first sonication##2##3##(2008-10#2)
the first stage of##3##4##(2008-10#2)(2011-2#1)
the first stage##9##3##(1990-12#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the first stages of the titration##2##6##(2008-10#2)
the first step for##4##4##(1993-8#1)(1996-3#1)(2008-10#1)(2013-1#1)
the first step in a##2##5##(1995-12#1)(2008-10#1)
the first step in the##3##5##(1995-2#1)(1997-1#1)(2008-10#1)
the first step in##11##4##(1990-7#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-10#3)(2010-11#1)(2010-9#1)(2011-2#1)
the first step of the##2##5##(1992-8#1)(2013-8#1)
the first step of##9##4##(1992-8#1)(1994-8#1)(2008-10#4)(2008-9#1)(2013-8#2)
the first step toward##2##4##(2008-6#1)(2009-1#1)
the first step##36##3##(1990-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-10#11)(2008-6#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
the first stereoselective step of chiral##2##6##(1994-8#2)
the first structural##2##3##(1991-3#1)(2013-8#1)
the first study##9##3##(1994-3#1)(2008-10#5)(2008-5#1)(2008-8#1)(2011-2#1)
the first ten##2##3##(2008-10#1)(2008-9#1)
the first third of the##2##5##(2008-10#1)(2008-8#1)
the first three##7##3##(1992-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)
the first time a##5##4##(2008-10#3)(2009-8#1)(2012-2#1)
the first time in##13##4##(1991-11#1)(1993-2#1)(1994-12#1)(2007-12#2)(2008-10#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)
the first time it was given##2##6##(1993-6#2)
the first time it##3##4##(1990-3#1)(1993-6#2)
the first time that##20##4##(1991-3#1)(1992-12#1)(1992-8#1)(2008-10#6)(2008-11#1)(2008-9#3)(2011-2#3)(2012-2#3)(2013-8#1)
the first time the##11##4##(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
the first time to##19##4##(1992-9#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#4)(2008-9#2)(2009-7#1)
the first time##216##3##(1990-2#2)(1990-3#1)(1990-5#2)(1991-11#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#3)(2007-12#4)(2008-10#94)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#8)(2009-1#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#3)(2012-2#9)(2012-3#2)(2012-8#1)(2013-1#9)(2013-8#2)
the first to investigate the##2##5##(2010-11#1)(2012-3#1)
the first to show##3##4##(2008-11#1)(2011-2#1)(2013-3#1)
the first to##17##3##(1990-2#1)(1991-6#1)(1993-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-3#1)
the first treatment##2##3##(1993-8#1)(1996-9#1)
the first trimester##8##3##(1990-6#1)(1990-9#1)(1993-3#2)(2011-1#1)(2013-1#3)
the first two rounds##2##4##(2008-10#2)
the first two years##4##4##(2008-11#1)(2011-2#2)(2012-2#1)
the first two##22##3##(1990-8#1)(1991-2#1)(1993-8#2)(1994-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
the first type##5##3##(2008-10#3)(2008-3#1)(2011-2#1)
the first upper true leaves at 14 dpi##3##8##(2008-10#3)
the first upper true leaves at 14##4##7##(2008-10#4)
the first upper##5##3##(2008-10#4)(2008-8#1)
the first vaccination##2##3##(1994-9#1)(1995-3#1)
the first week##4##3##(1991-2#1)(1996-3#1)(2008-10#1)(2012-3#1)
the first with the chief nurse##2##6##(2013-1#2)
the first with##3##3##(2011-2#1)(2013-1#2)
the first year after##2##4##(2007-9#1)(2011-2#1)
the first year of Medicare coverage##2##6##(1995-1#2)
the first year of a##2##5##(1995-3#1)(2008-12#1)
the first year of life##5##5##(1995-8#1)(1996-11#1)(2008-12#1)(2008-7#2)
the first year of the##4##5##(1991-2#1)(1991-3#1)(1993-3#1)(2008-10#1)
the first year of this##2##5##(1990-11#1)(1997-1#1)
the first year of##21##4##(1990-11#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-11#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2013-1#2)
the first year##33##3##(1990-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#3)(1997-1#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
the first##1296##2##(1990-11#4)(1990-12#7)(1990-2#7)(1990-3#2)(1990-5#7)(1990-6#4)(1990-7#1)(1990-8#7)(1990-9#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#8)(1991-3#6)(1991-4#1)(1991-5#6)(1991-6#11)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#7)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#4)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#8)(1993-2#12)(1993-3#8)(1993-6#9)(1993-8#8)(1993-9#1)(1994-1#2)(1994-11#5)(1994-12#9)(1994-2#1)(1994-3#8)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#4)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#9)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#13)(1996-3#8)(1996-5#4)(1996-6#4)(1996-8#4)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#8)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#7)(2007-11#5)(2007-12#8)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#357)(2008-11#70)(2008-12#26)(2008-2#9)(2008-3#24)(2008-4#10)(2008-5#25)(2008-6#11)(2008-7#28)(2008-8#21)(2008-9#40)(2009-1#4)(2009-10#6)(2009-11#4)(2009-12#4)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#8)(2009-8#5)(2009-9#4)(2010-1#6)(2010-10#3)(2010-11#5)(2010-12#6)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#2)(2010-8#8)(2010-9#3)(2011-1#10)(2011-2#82)(2011-3#7)(2011-8#1)(2012-12#7)(2012-2#29)(2012-3#25)(2012-8#1)(2013-1#53)(2013-3#1)(2013-8#25)
the first-derivative##3##2##(2008-10#3)
the first-dimension gel##2##3##(2008-4#2)
the first-line therapy##2##3##(2010-12#2)
the first-line treatment of##2##4##(2011-2#1)(2013-8#1)
the first-line treatment##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
the first-line##10##2##(1997-2#1)(2009-8#1)(2010-12#5)(2011-2#1)(2012-3#1)(2013-8#1)
the first-order##5##2##(2008-10#2)(2008-3#3)
the first-round##2##2##(2008-10#2)
the first-strand cDNA synthesis##2##4##(1997-2#2)
the fiscal##5##2##(1991-1#1)(1992-2#1)(1994-2#1)(1995-6#1)(1997-2#1)
the fish were##2##3##(2008-12#1)(2010-8#1)
the fish##11##2##(1993-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
the fission of peroxisomes and mitochondria##2##6##(2009-10#2)
the fission yeast Schizosaccharomyces pombe##3##5##(1995-9#1)(1997-3#1)(2008-9#1)
the fission##6##2##(1995-9#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-10#2)
the fistula was##4##3##(1996-9#3)(1997-3#1)
the fistula##15##2##(1996-9#5)(1997-3#3)(2008-7#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#2)
the fit of the##3##4##(2008-10#3)
the fit of##4##3##(2008-10#3)(2008-12#1)
the fit##6##2##(2008-10#4)(2008-12#1)(2009-7#1)
the fitness consequences of##2##4##(2008-8#2)
the fitness of the##2##4##(2008-10#1)(2008-8#1)
the fitness of##9##3##(2008-10#4)(2008-8#3)(2008-9#2)
the fitness##19##2##(2008-10#6)(2008-11#1)(2008-8#7)(2008-9#5)
the fitted model##2##3##(2008-10#1)(2008-8#1)
the fitted##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
the fitting##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
the five candidate genes##2##4##(1996-8#2)
the five most##2##3##(2008-10#1)(2008-11#1)
the five species##2##3##(2008-10#1)(2008-11#1)
the five teacher actions##2##4##(2008-4#2)
the five##61##2##(1991-2#1)(1991-6#1)(1992-9#1)(1993-1#2)(1993-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-8#2)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#34)(2008-11#4)(2008-4#2)(2008-8#2)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
the fixation##5##2##(2008-10#3)(2008-11#1)(2012-3#1)
the fixed interference##2##3##(2008-10#2)
the fixed time and##2##4##(2008-10#2)
the fixed##6##2##(1997-2#1)(2008-10#4)(2008-7#1)
the fixed-time##2##2##(2008-10#2)
the flag leaf sheath##2##4##(2008-10#2)
the flag leaf##4##3##(2008-10#4)
the flag##5##2##(2008-10#5)
the flagellum##6##2##(2008-10#1)(2008-7#5)
the flame atomic absorption spectrometer nebulizer##2##6##(2008-10#2)
the flame atomic absorption spectrometer##4##5##(2008-10#4)
the flame atomic absorption##7##4##(2008-10#7)
the flame atomizer##3##3##(2008-10#3)
the flame composition##2##3##(2008-10#2)
the flame structure##3##3##(2008-3#3)
the flame##28##2##(2008-10#22)(2008-3#6)
the flanking##7##2##(1993-6#1)(1994-11#1)(2008-10#2)(2008-8#2)(2008-9#1)
the flap##3##2##(2008-9#2)(2012-2#1)
the flat group##3##3##(1991-2#3)
the flat##6##2##(1991-2#3)(1995-2#1)(2008-10#2)
the flavonoid##4##2##(2008-10#3)(2010-6#1)
the flavonoids##4##2##(1992-5#1)(2008-11#3)
the flavor##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
the fleece##3##2##(1997-5#3)
the flesh##2##2##(2008-12#1)(2008-9#1)
the flexibility of the##2##4##(2008-10#1)(2008-8#1)
the flexibility of##7##3##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-9#1)
the flexibility##9##2##(1997-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-9#1)
the flexible##2##2##(2008-5#1)(2008-7#1)
the flexor digitorum##2##3##(2008-12#1)(2010-5#1)
the flexor hallucis longus tendon##2##5##(2010-7#2)
the flexor hallucis longus##3##4##(2009-10#1)(2010-7#2)
the flexor##9##2##(2008-12#1)(2008-9#3)(2009-1#1)(2009-10#1)(2010-5#1)(2010-7#2)
the flexural resonance frequency shift of##2##6##(2009-5#2)
the flexural strength of##2##4##(2009-7#2)
the flexural##5##2##(2008-5#1)(2009-5#2)(2009-7#2)
the flight ability##2##3##(2008-6#2)
the flight##5##2##(2008-10#1)(2008-6#2)(2008-8#1)(2012-3#1)
the floater##2##2##(2008-9#2)
the flood##4##2##(1991-2#1)(2007-11#1)(2008-10#2)
the floods##2##2##(1996-6#2)
the floor of the middle##2##5##(2008-7#1)(2011-2#1)
the floor of the##4##4##(1996-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
the floor##9##2##(1995-6#1)(1996-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#2)(2011-2#1)(2013-1#1)
the floral cavity##2##3##(2008-10#2)
the floral organs of Hyacinthus orientalis L##2##7##(2008-8#2)
the floral##8##2##(2008-10#4)(2008-8#4)
the floras of##2##3##(2008-8#2)
the floret##3##2##(2008-10#3)
the floristic##2##2##(2008-8#2)
the flotation##3##2##(2008-10#3)
the flow analysis##2##3##(2008-10#2)
the flow cell and##3##4##(2008-10#3)
the flow cell to##2##4##(2008-10#2)
the flow cell##25##3##(2008-10#25)
the flow cytometric##5##3##(1990-12#1)(2008-11#2)(2008-9#2)
the flow field##2##3##(2008-11#1)(2008-3#1)
the flow initially##2##3##(2008-10#2)
the flow injection analysis (FIA)##3##5##(2008-10#3)
the flow injection analysis##5##4##(2008-10#5)
the flow injection manifold##2##4##(2008-10#2)
the flow injection system##5##4##(2008-10#5)
the flow injection technique##2##4##(2008-10#2)
the flow injection##20##3##(2008-10#20)
the flow line##4##3##(2008-10#4)
the flow of air towards the heart##2##7##(1991-3#2)
the flow of information##2##4##(1994-2#1)(2008-11#1)
the flow of the carrier solution##2##6##(2008-10#2)
the flow of the##4##4##(2008-10#4)
the flow of##18##3##(1991-12#1)(1991-3#2)(1994-2#1)(1996-6#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)
the flow rate and##3##4##(2008-10#2)(2008-7#1)
the flow rate of the##5##5##(2008-10#5)
the flow rate of##9##4##(2008-10#9)
the flow rate##26##3##(1994-2#1)(2008-10#23)(2008-7#1)(2008-8#1)
the flow set-up##2##3##(2008-10#2)
the flow system in##2##4##(2008-10#2)
the flow system##20##3##(2008-10#20)
the flow velocity##2##3##(2008-11#1)(2011-2#1)
the flow##167##2##(1990-12#1)(1991-12#1)(1991-3#3)(1994-2#2)(1995-3#1)(1996-6#1)(1996-9#1)(2008-10#128)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
the flow-injection determination of##4##4##(2008-10#4)
the flow-injection##9##2##(2008-10#9)
the flow-rate##4##2##(1997-2#1)(2008-10#3)
the flow-through cell##2##3##(2008-10#2)
the flow-through sensor##2##3##(2008-10#2)
the flow-through##6##2##(2008-10#6)
the flower##3##2##(2008-10#2)(2011-10#1)
the flowering##3##2##(2008-10#1)(2008-8#2)
the flowers##2##2##(2008-10#1)(2008-12#1)
the flowing##7##2##(2008-10#6)(2011-2#1)
the fluctuation of##2##3##(1996-12#1)(2008-10#1)
the fluctuations in the##2##4##(2008-5#1)(2008-8#1)
the fluctuations in##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
the fluctuations##4##2##(2008-5#1)(2008-8#1)(2008-9#2)
the flue gas##2##3##(2008-10#2)
the fluid##10##2##(1990-6#1)(1990-8#1)(2008-10#3)(2008-6#1)(2008-7#4)
the fluidic##2##2##(2009-5#2)
the fluidity of##3##3##(1995-8#1)(2008-7#1)(2008-9#1)
the fluidized##2##2##(2008-11#2)
the fluids##4##2##(2008-10#2)(2008-7#2)
the fluorescein##3##2##(1990-5#1)(2008-10#2)
the fluorescence and##2##3##(2008-3#2)
the fluorescence changes##2##3##(1994-5#1)(2008-10#1)
the fluorescence emission maximum at##2##5##(2008-8#2)
the fluorescence emission##10##3##(2008-10#6)(2008-8#3)(2008-9#1)
the fluorescence enhancement of##4##4##(2008-10#4)
the fluorescence enhancement##5##3##(2008-10#5)
the fluorescence excitation##2##3##(2008-10#2)
the fluorescence intensities##3##3##(2008-10#3)
the fluorescence intensity and the##2##5##(2008-10#2)
the fluorescence intensity and##3##4##(2008-10#3)
the fluorescence intensity of the##7##5##(1990-12#1)(1995-6#1)(2008-10#5)
the fluorescence intensity of##12##4##(1990-12#1)(1995-6#1)(2008-10#10)
the fluorescence intensity##26##3##(1990-12#1)(1995-6#1)(2008-10#22)(2008-3#2)
the fluorescence is##2##3##(2008-10#1)(2008-11#1)
the fluorescence of the##4##4##(2008-10#3)(2008-9#1)
the fluorescence of##22##3##(1990-5#1)(1995-6#1)(2008-1#1)(2008-10#13)(2008-4#2)(2008-9#3)(2009-5#1)
the fluorescence quenching##10##3##(2008-10#9)(2008-8#1)
the fluorescence reaction between##2##4##(2008-10#2)
the fluorescence resonance energy transfer (FRET)##2##6##(2008-10#2)
the fluorescence resonance energy##3##4##(2008-10#2)(2008-9#1)
the fluorescence signal##4##3##(2008-10#3)(2008-11#1)
the fluorescence spectra##2##3##(2008-10#2)
the fluorescence spectrum##2##3##(2008-10#2)
the fluorescence##132##2##(1990-12#1)(1990-5#1)(1994-5#2)(1995-6#3)(1996-2#2)(2008-1#2)(2008-10#90)(2008-11#3)(2008-2#1)(2008-3#9)(2008-4#3)(2008-7#2)(2008-8#5)(2008-9#6)(2009-5#1)(2010-12#1)
the fluorescent dye##3##3##(1991-11#1)(1997-7#1)(2008-10#1)
the fluorescent probe##2##3##(2008-10#1)(2008-8#1)
the fluorescent signal of##2##4##(2008-10#1)(2008-11#1)
the fluorescent##25##2##(1990-8#1)(1991-11#1)(1994-5#2)(1995-6#1)(1997-7#1)(2008-10#14)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
the fluoride concentration in##2##4##(2008-10#2)
the fluoride##9##2##(2008-10#7)(2008-11#1)(2008-5#1)
the fluorimetric method##2##3##(2008-10#2)
the fluorimetric##11##2##(2008-10#11)
the fluorine ion##2##3##(2008-10#2)
the fluorine##3##2##(2008-10#3)
the fluorochrome##2##2##(2008-10#1)(2008-12#1)
the fluorogenic##4##2##(2008-10#4)
the fluorometric##7##2##(1993-3#1)(2008-10#6)
the fluorophore##4##2##(2008-10#3)(2008-3#1)
the fluorophores##2##2##(2008-10#2)
the fluoroquinolones##3##2##(2008-10#2)(2012-2#1)
the flushing reaction##2##3##(1994-5#2)
the flux of##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2012-2#1)
the flux through the##2##4##(1994-8#1)(2008-3#1)
the flux##13##2##(1994-8#1)(1995-3#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2012-2#1)
the fluxes##3##2##(2008-10#1)(2008-7#2)
the fly ash precipitates##3##4##(2008-10#3)
the fly ash##4##3##(2008-10#4)
the fly##9##2##(2007-12#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-9#1)
the fmol##2##2##(2008-10#2)
the foam##3##2##(2008-10#1)(2012-2#2)
the focal length of##2##4##(2008-2#1)(2008-3#1)
the focal plane##2##3##(2008-2#1)(2011-2#1)
the focal point of the##2##5##(1997-6#1)(2008-10#1)
the focal point of##3##4##(1992-3#1)(1997-6#1)(2008-10#1)
the focal##13##2##(1992-3#1)(1997-6#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#2)(2010-12#1)(2011-2#1)(2013-1#1)
the focus group##2##3##(1992-2#1)(2008-11#1)
the focus groups##4##3##(1997-3#1)(2012-3#3)
the focus of intense##2##4##(2008-9#1)(2010-7#1)
the focus of much research##2##5##(2008-10#1)(2008-11#1)
the focus of the##2##4##(1994-3#1)(2008-4#1)
the focus of this review##3##5##(2008-10#1)(2010-6#1)(2011-2#1)
the focus of this##5##4##(2008-10#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
the focus of##18##3##(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-2#1)
the focus on##4##3##(2008-10#2)(2009-6#1)(2010-8#1)
the focus should##2##3##(1997-2#2)
the focus##41##2##(1992-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#6)(2008-11#6)(2008-12#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#1)
the foetal##5##2##(1990-5#3)(1996-11#1)(2012-2#1)
the foetus##7##2##(1991-9#2)(1992-5#1)(1996-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
the folate receptor##2##3##(1994-6#2)
the folate##3##2##(1994-6#3)
the fold##3##2##(2009-6#1)(2009-9#2)
the folded##4##2##(1991-6#1)(1992-6#1)(2009-7#1)(2009-9#1)
the folding and##6##3##(1991-6#1)(1994-12#1)(2008-4#2)(2009-6#2)
the folding##14##2##(1991-6#4)(1992-6#2)(1994-12#1)(2008-4#2)(2008-9#2)(2009-6#2)(2010-4#1)
the foliage of##3##3##(2008-10#3)
the foliage##8##2##(2008-10#8)
the follicle cells##5##3##(2008-6#4)(2008-7#1)
the follicle##12##2##(1990-8#1)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2011-2#3)
the follicles##4##2##(2008-12#1)(2012-3#2)(2013-7#1)
the follicular epithelium##2##3##(2008-5#1)(2008-7#1)
the follicular unit-like wigs##2##4##(2012-3#2)
the follicular wall##2##3##(2008-12#1)(2008-7#1)
the follicular##8##2##(2008-12#2)(2008-5#2)(2008-7#2)(2012-3#2)
the follow up##5##3##(1996-3#1)(2008-10#1)(2010-3#1)(2013-1#2)
the follow-up of coronary##2##4##(2011-2#2)
the follow-up of##6##3##(1990-6#1)(1997-4#1)(1997-8#2)(2011-2#2)
the follow-up period##8##3##(1996-3#1)(1997-8#1)(2008-7#4)(2011-1#1)(2011-2#1)
the follow-up##31##2##(1990-6#1)(1990-9#1)(1994-2#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-8#5)(2008-11#2)(2008-12#1)(2008-7#4)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2013-1#2)(2013-8#1)
the following 10##2##3##(2008-10#2)
the following advantages##2##3##(2008-10#1)(2008-8#1)
the following aspects##2##3##(1994-12#1)(2008-4#1)
the following categories##2##3##(2011-3#1)(2012-3#1)
the following characteristics##3##3##(2007-12#1)(2008-10#2)
the following clinical##3##3##(1997-3#1)(2010-2#1)(2010-6#1)
the following concentrations##2##3##(2008-10#1)(2013-1#1)
the following conclusions##3##3##(1994-5#1)(2008-10#1)(2008-9#1)
the following conditions##2##3##(2008-10#2)
the following criteria##2##3##(1992-5#1)(2013-1#1)
the following days##2##3##(1991-6#1)(2008-10#1)
the following equation##2##3##(2008-10#2)
the following experimental##2##3##(2008-10#2)
the following four##4##3##(1991-2#1)(1992-2#1)(2008-10#1)(2010-6#1)
the following groups##2##3##(2008-7#1)(2013-1#1)
the following linear##4##3##(2008-10#4)
the following main##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the following means##2##3##(1994-8#1)(2008-11#1)
the following mechanism##2##3##(2008-5#1)(2008-7#1)
the following order of##2##4##(1995-12#2)
the following order##10##3##(1995-12#2)(2008-10#7)(2008-11#1)
the following paper##2##3##(2012-3#1)(2013-1#1)
the following parameters were##2##4##(2008-10#2)
the following parameters##5##3##(2008-10#3)(2008-7#1)(2008-8#1)
the following proposed##2##3##(2008-4#1)(2008-7#1)
the following questions##5##3##(1994-8#1)(1997-3#1)(2008-12#1)(2008-9#1)(2009-10#1)
the following results##3##3##(2008-10#2)(2011-2#1)
the following risk factors for##2##5##(2008-5#1)(2013-1#1)
the following skin parameters##2##4##(2008-5#2)
the following spring##3##3##(2008-10#2)(2008-8#1)
the following steps##2##3##(1991-12#1)(2008-2#1)
the following three##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
the following two##2##3##(2008-11#1)(2008-8#1)
the following units##2##3##(2008-10#1)(2008-4#1)
the following values##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
the following were##3##3##(1997-8#1)(2008-11#1)(2010-11#1)
the following year##2##3##(2008-10#1)(2008-9#1)
the following##241##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#3)(1991-6#2)(1992-12#1)(1992-2#2)(1992-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#4)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#2)(2007-12#3)(2008-10#73)(2008-11#13)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#8)(2008-9#11)(2009-10#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-6#3)(2010-7#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#17)(2013-8#2)
the food bolus##2##3##(2007-12#2)
the food chain##9##3##(1994-3#1)(2008-10#4)(2008-9#2)(2011-2#1)(2013-8#1)
the food industry##4##3##(2008-10#1)(2010-7#1)(2011-2#2)
the food intake##2##3##(2010-6#2)
the food manufacturer has to##2##5##(1994-3#2)
the food web##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
the food##41##2##(1994-3#6)(1995-5#1)(2007-12#4)(2008-10#12)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-8#1)(2010-6#2)(2010-7#2)(2011-2#4)(2012-2#1)(2013-8#1)
the foodborne##2##2##(2011-2#2)
the foot and ankle are##2##5##(2011-2#2)
the foot and ankle##12##4##(2008-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#4)(2012-3#1)
the foot and##13##3##(2008-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#5)(2012-3#1)
the foot##31##2##(2008-12#4)(2008-7#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#2)
the foraging##2##2##(2008-8#1)(2008-9#1)
the foramen magnum##4##3##(1996-9#2)(2008-7#1)(2011-2#1)
the foramen##8##2##(1996-3#1)(1996-9#2)(2008-7#1)(2011-2#1)(2012-12#3)
the force##7##2##(1994-9#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-12#1)
the forced expression of##2##4##(2008-11#1)(2011-2#1)
the forced##4##2##(1990-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
the forces that##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
the forces##7##2##(1993-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-3#1)
the forearm##9##2##(1994-6#1)(2008-10#1)(2008-5#3)(2008-9#2)(2011-2#2)
the forearms of##2##3##(2008-10#1)(2008-5#1)
the forearms##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
the forebrain##2##2##(1993-8#1)(1994-8#1)
the forecast##2##2##(2008-10#1)(2013-8#1)
the forefront of##2##3##(1994-1#1)(2010-4#1)
the forefront##3##2##(1994-1#1)(1997-8#1)(2010-4#1)
the foregut##3##2##(2008-10#1)(2011-2#2)
the forehead than##2##3##(2008-5#2)
the forehead##8##2##(1992-2#1)(2008-5#6)(2010-6#1)
the foreign gene expression##2##4##(2008-11#2)
the foreign gene##3##3##(2008-11#3)
the foreign substances##2##3##(2008-10#2)
the foreign##16##2##(1990-3#1)(1996-12#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-8#1)(2011-2#1)
the forelimbs##6##2##(1992-12#1)(1993-3#1)(1996-6#1)(2011-2#2)(2012-3#1)
the forensic analysis of##3##4##(2008-10#3)
the forensic##5##2##(2008-10#5)
the foreseeable future##3##3##(1996-1#1)(2007-12#1)(2008-8#1)
the forest ecosystem services of##2##5##(2008-9#2)
the forest##7##2##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2009-8#1)
the forgotten##3##2##(1992-2#1)(2008-8#1)(2012-2#1)
the form of a##17##4##(1991-12#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
the form of the##8##4##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
the form of##98##3##(1991-12#1)(1992-11#1)(1993-12#1)(1994-5#2)(1994-9#1)(1995-3#2)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#40)(2008-11#7)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
the form##104##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-5#2)(1994-9#1)(1995-3#2)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#42)(2008-11#7)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
the formal potential of##2##4##(2008-10#2)
the formal potential##6##3##(2008-10#6)
the formal##14##2##(1995-2#1)(1997-3#2)(2008-10#10)(2010-7#1)
the formaldehyde in##2##3##(2008-10#2)
the formaldehyde##4##2##(2008-10#4)
the formalism##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
the format of##2##3##(1990-2#1)(2012-2#1)
the formation and stabilization of##2##5##(1994-5#1)(2008-10#1)
the formation and##16##3##(1994-5#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-3#1)(2012-12#1)(2012-2#2)
the formation constant of##2##4##(2008-10#2)
the formation constant##4##3##(2008-10#4)
the formation constants of##3##4##(2008-10#3)
the formation constants##5##3##(2008-10#5)
the formation of 1##2##4##(2008-10#2)
the formation of As(III)##2##4##(2008-10#2)
the formation of GS and SAG##2##6##(2008-10#2)
the formation of N-acetylglucosamine##2##4##(1997-1#2)
the formation of NO in##2##5##(1992-5#2)
the formation of R-ibuprofenyl-adenylate##2##4##(1994-8#2)
the formation of a 1##3##5##(2008-10#3)
the formation of a complex with##2##6##(2008-10#2)
the formation of a complex##3##5##(2008-10#2)(2008-4#1)
the formation of a new##2##5##(2008-10#2)
the formation of a##42##4##(1991-3#1)(1991-5#1)(1991-9#1)(1993-6#1)(1994-12#1)(2007-12#1)(2008-10#27)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
the formation of actin##2##4##(2008-9#1)(2012-2#1)
the formation of an##8##4##(1992-9#1)(1994-5#1)(2007-12#1)(2008-10#5)
the formation of apoptotic bodies##4##5##(2008-11#2)(2008-7#1)(2012-3#1)
the formation of both##3##4##(2006-6#1)(2008-12#1)(2013-1#1)
the formation of different##2##4##(2008-10#2)
the formation of new##3##4##(1990-11#1)(2008-9#1)(2013-8#1)
the formation of normal##2##4##(2010-5#1)(2010-6#1)
the formation of papillae##2##4##(2008-10#2)
the formation of physical##2##4##(2008-10#2)
the formation of reactive species##2##5##(2008-11#2)
the formation of reactive##4##4##(1992-12#1)(2008-11#3)
the formation of secondary##2##4##(2008-11#1)(2011-2#1)
the formation of such##2##4##(1994-2#1)(2008-10#1)
the formation of the complex##4##5##(2008-10#4)
the formation of the ion##2##5##(2008-10#2)
the formation of the##48##4##(1990-5#1)(1991-3#2)(1992-10#1)(1992-12#1)(1993-2#1)(1994-8#1)(1995-6#1)(1996-5#2)(1997-7#1)(1997-8#1)(2008-10#27)(2008-5#3)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-5#1)
the formation of these##2##4##(1991-5#2)
the formation of two##3##4##(1994-8#1)(2008-10#2)
the formation of##318##3##(1990-11#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#7)(1995-12#1)(1995-2#3)(1995-6#3)(1996-3#1)(1996-5#9)(1997-1#3)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#3)(2008-10#146)(2008-11#18)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#12)(2011-3#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
the formation##351##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#7)(1995-12#1)(1995-2#3)(1995-6#3)(1996-3#1)(1996-5#9)(1997-1#3)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#3)(2008-10#167)(2008-11#20)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#12)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
the formed complexes##3##3##(2008-10#3)
the formed##17##2##(2008-10#16)(2011-2#1)
the former Soviet Union##2##4##(1995-3#1)(1997-1#1)
the former Soviet##3##3##(1995-3#1)(1997-1#1)(1997-6#1)
the former ammunition plant &quot##2##5##(2008-11#2)
the former and##4##3##(1995-6#1)(2007-8#1)(2008-10#2)
the former is a##2##4##(2008-10#1)(2008-8#1)
the former is##3##3##(1990-12#1)(2008-10#1)(2008-8#1)
the former storage##2##3##(2008-10#2)
the former##71##2##(1990-12#1)(1990-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(2007-8#1)(2008-10#15)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
the formerly##2##2##(1995-12#1)(2008-10#1)
the forming of##3##3##(1991-6#1)(2008-8#1)(2011-2#1)
the forming##4##2##(1991-6#1)(1997-8#1)(2008-8#1)(2011-2#1)
the forms of##4##3##(1991-3#1)(1996-1#1)(2008-10#1)(2012-3#1)
the forms##7##2##(1991-3#1)(1991-6#1)(1996-1#1)(2008-10#2)(2009-4#1)(2012-3#1)
the formula presented##2##3##(2008-8#2)
the formula##12##2##(1993-3#1)(1994-12#1)(2008-10#2)(2008-5#4)(2008-8#3)(2012-3#1)
the formulated##3##2##(2008-10#2)(2008-5#1)
the formulation of a##2##4##(2008-11#1)(2011-2#1)
the formulation of the##3##4##(2008-10#2)(2010-1#1)
the formulation of##13##3##(1993-2#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-7#1)(2010-1#1)(2011-2#1)(2011-3#1)
the formulation##27##2##(1993-2#1)(1995-12#2)(2008-10#6)(2008-11#2)(2008-5#10)(2008-7#1)(2010-1#1)(2011-2#1)(2011-3#3)
the formulations of##2##3##(2008-5#2)
the formulations was##2##3##(2008-10#1)(2008-5#1)
the formulations##10##2##(2008-10#3)(2008-5#7)
the formulator##3##2##(2008-10#1)(2008-5#2)
the fornix##2##2##(1991-8#1)(1993-3#1)
the fortification##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
the forward and##2##3##(1992-6#1)(2008-2#1)
the forward##11##2##(1991-9#1)(1992-6#1)(1996-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2010-9#1)
the fossil##2##2##(1994-3#1)(2008-6#1)
the found##4##2##(2008-10#4)
the foundation for a##3##4##(2008-10#1)(2009-10#1)(2012-12#1)
the foundation for the##2##4##(2008-10#1)(2013-8#1)
the foundation for##10##3##(2008-10#3)(2008-11#1)(2008-4#2)(2009-10#1)(2012-12#1)(2013-8#2)
the foundation of##5##3##(1994-12#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-9#1)
the foundation##17##2##(1994-12#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2012-12#1)(2013-8#2)
the four Botrytis spp##2##4##(2008-10#2)
the four S compounds##2##4##(2008-10#2)
the four Stokes vectors##2##4##(2007-11#2)
the four arsenic species##2##4##(2008-10#2)
the four compounds##2##3##(2008-10#2)
the four cultivars##2##3##(2008-10#2)
the four different##2##3##(2008-10#2)
the four dimensions of##2##4##(2011-2#2)
the four drug##2##3##(1994-2#1)(2008-10#1)
the four groups##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the four methods##2##3##(2008-10#2)
the four most##2##3##(2008-10#2)
the four patients##2##3##(1993-2#1)(2009-4#1)
the four populations##2##3##(2008-10#2)
the four religious coping##2##4##(2009-11#2)
the four strains##3##3##(2008-10#3)
the four##139##2##(1990-11#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-3#3)(1992-4#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-6#2)(1996-2#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#2)(2008-10#78)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#2)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-3#1)(2013-8#2)
the four-channel##2##2##(1996-1#2)
the four-step##2##2##(1990-8#1)(2011-2#1)
the four-stranded beta-pleated sheet##2##4##(1997-9#2)
the four-stranded##3##2##(1997-9#3)
the fourth and fifth##5##4##(1997-3#2)(2008-10#3)
the fourth and##7##3##(1997-3#2)(2008-10#3)(2012-3#1)(2012-9#1)
the fourth day##3##3##(2008-5#1)(2008-7#1)(2009-12#1)
the fourth harmonic##2##3##(2008-3#2)
the fourth ventricle##4##3##(2008-7#1)(2013-1#3)
the fourth##43##2##(1990-2#2)(1992-12#2)(1992-4#1)(1993-12#1)(1993-8#1)(1995-6#1)(1995-8#1)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#5)
the fraction bound to##2##4##(2008-10#2)
the fraction of cells in the S phase##2##8##(2008-11#1)(2008-9#1)
the fraction of plasmid-carrying cells##2##5##(2008-7#2)
the fraction of the##4##4##(1995-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
the fraction of##30##3##(1990-8#1)(1991-11#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#9)(2008-11#3)(2008-7#5)(2008-8#3)(2008-9#1)(2011-2#1)(2011-3#1)
the fraction##39##2##(1990-8#1)(1991-11#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#13)(2008-11#6)(2008-7#5)(2008-8#4)(2008-9#1)(2011-2#1)(2011-3#1)
the fractional##8##2##(1993-5#1)(1994-5#1)(2008-3#3)(2008-7#3)
the fractionation of arsenic##2##4##(2008-10#2)
the fractionation of##5##3##(2008-10#5)
the fractionation##6##2##(2008-10#5)(2008-7#1)
the fractions of##7##3##(1992-6#1)(2008-10#4)(2008-7#1)(2008-9#1)
the fractions##14##2##(1992-6#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-9#1)
the fracture site##2##3##(2008-9#1)(2011-2#1)
the fracture##15##2##(1991-11#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-9#2)(2009-7#2)(2011-2#4)(2012-2#1)(2013-1#1)
the fractured##2##2##(2011-2#1)(2013-1#1)
the fragile##3##2##(1991-2#1)(2008-10#1)(2008-5#1)
the fragility of##2##3##(1992-6#1)(1995-3#1)
the fragility##3##2##(1992-6#1)(1995-3#2)
the fragment##8##2##(1997-2#1)(1997-6#2)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)
the fragmentation of Cu##3##4##(1997-8#3)
the fragmentation of the##2##4##(1996-5#1)(2008-10#1)
the fragmentation of##9##3##(1992-2#1)(1996-5#1)(1997-8#5)(2008-10#1)(2011-2#1)
the fragmentation##11##2##(1992-2#1)(1996-5#1)(1997-8#7)(2008-10#1)(2011-2#1)
the fragments were##3##3##(1993-6#1)(2008-7#1)(2008-9#1)
the fragments##11##2##(1992-3#1)(1992-6#1)(1993-6#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)
the fragrance##7##2##(2008-5#7)
the frail elderly##6##3##(1993-1#3)(1993-3#1)(1994-2#1)(1995-2#1)
the frame was##2##3##(2013-1#2)
the frame##7##2##(2008-10#1)(2008-3#2)(2012-2#2)(2013-1#2)
the frames##2##2##(2008-3#2)
the framework for##3##3##(2008-11#1)(2008-5#1)(2010-10#1)
the framework of a##4##4##(1990-12#1)(1995-5#1)(2008-2#1)(2008-3#1)
the framework of an##2##4##(1995-12#1)(2008-10#1)
the framework of the##9##4##(1990-6#1)(1994-6#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
the framework of##23##3##(1990-12#1)(1990-6#1)(1991-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2013-1#1)
the framework##36##2##(1990-12#1)(1990-6#1)(1991-3#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-1#1)(2010-10#1)(2012-2#2)(2013-1#2)
the framing of##2##3##(2008-4#2)
the framing##3##2##(2008-4#3)
the free amino##2##3##(1990-12#1)(1990-5#1)
the free and##3##3##(1994-3#1)(2008-10#2)
the free concentration of taurine##2##5##(2008-10#2)
the free concentration of##4##4##(2008-10#4)
the free energy##8##3##(1996-6#1)(2010-7#2)(2012-2#1)(2013-1#4)
the free enzyme##2##3##(2008-7#1)(2011-2#1)
the free metal##2##3##(2008-10#2)
the free radical##2##3##(1995-8#1)(2008-11#1)
the free##50##2##(1990-12#1)(1990-5#2)(1994-3#2)(1994-5#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-7#2)(2010-10#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
the free-running##2##2##(2008-2#1)(2008-3#1)
the free-space##3##2##(2008-3#1)(2009-5#1)(2013-8#1)
the freerunning period##2##3##(2008-5#2)
the freerunning##3##2##(2008-5#3)
the frequencies of the##2##4##(2011-2#2)
the frequencies of##9##3##(1993-8#1)(1997-8#1)(2008-10#3)(2011-1#1)(2011-2#2)(2013-1#1)
the frequencies##11##2##(1990-3#1)(1993-8#1)(1997-8#1)(2008-10#4)(2011-1#1)(2011-2#2)(2013-1#1)
the frequency and the##4##4##(1997-3#1)(2008-3#2)(2008-7#1)
the frequency and##12##3##(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-11#1)(2013-1#2)
the frequency autocorrelation of the differential group delay##2##8##(2007-12#2)
the frequency changes##2##3##(2007-12#1)(2008-10#1)
the frequency chirp##2##3##(2008-3#2)
the frequency composition of##2##4##(2008-9#2)
the frequency of 1##2##4##(2008-9#1)(2012-3#1)
the frequency of resistant##2##4##(2008-10#1)(2008-8#1)
the frequency of the virulence##2##5##(2008-10#2)
the frequency of the##12##4##(1993-11#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2011-2#2)(2013-1#1)
the frequency of##97##3##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-7#2)(2011-2#8)(2012-3#4)(2013-1#4)(2013-8#2)
the frequency response##2##3##(2008-10#1)(2009-5#1)
the frequency shift##4##3##(2007-12#1)(2008-10#3)
the frequency with which##3##4##(1995-3#1)(2008-11#1)(2008-7#1)
the frequency##149##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-1#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#33)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#11)(2008-5#1)(2008-7#8)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2011-2#8)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#2)
the frequent occurrence of##2##4##(2008-10#1)(2012-3#1)
the frequent use of##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
the frequent##12##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the frequently##2##2##(1996-2#1)(2008-4#1)
the fresh material##2##3##(2008-10#2)
the fresh##5##2##(2008-10#3)(2008-11#2)
the freshly##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
the freshness##2##2##(2008-10#2)
the freshwater##8##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#4)
the friction coefficient of##2##4##(2008-5#1)(2010-4#1)
the friction##5##2##(1994-9#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-4#1)
the frictional##3##2##(2008-5#1)(2010-10#2)
the fringe##4##2##(2008-3#4)
the frog##3##2##(1993-3#1)(2008-4#1)(2008-7#1)
the front and##2##3##(2008-10#2)
the front facet modal reflectivity of##2##6##(2008-3#2)
the front lines##2##3##(1994-1#1)(1995-6#1)
the front of the##2##4##(2008-10#2)
the front##13##2##(1994-1#1)(1995-6#1)(1996-8#1)(1997-4#1)(2008-10#5)(2008-3#3)(2012-12#1)
the frontal and##2##3##(1996-12#1)(2008-5#1)
the frontal lobe##2##3##(2008-7#1)(2011-2#1)
the frontal lobes##2##3##(2008-7#2)
the frontal plane##2##3##(2010-8#2)
the frontal##14##2##(1996-12#2)(1997-8#1)(2008-5#1)(2008-7#3)(2010-5#1)(2010-8#2)(2011-2#3)(2012-3#1)
the frontier##2##2##(1996-5#1)(2008-10#1)
the frontline##2##2##(2010-11#1)(2012-3#1)
the fruit development##5##3##(2008-9#5)
the fruit fly Drosophila melanogaster##2##5##(1997-7#1)(2008-10#1)
the fruit fly##6##3##(1997-7#1)(2008-10#1)(2008-9#2)(2010-5#1)(2013-8#1)
the fruit is##2##3##(2008-10#2)
the fruit of##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
the fruit##36##2##(1993-3#1)(1997-7#1)(2008-10#19)(2008-11#1)(2008-9#9)(2010-5#1)(2011-2#2)(2013-8#2)
the fruits of##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
the fruits##12##2##(2008-11#8)(2008-12#1)(2012-2#2)(2012-3#1)
the frying##2##2##(2008-10#1)(2008-6#1)
the ftz##2##2##(1993-9#2)
the fucoidan extracts##3##3##(2008-11#3)
the fuel##2##2##(2008-3#2)
the full exploitation of##2##4##(2007-11#1)(2011-1#1)
the full length##3##3##(1995-12#1)(1997-7#1)(2008-8#1)
the full range of##4##4##(2008-10#2)(2008-7#2)
the full spectral##3##3##(2011-2#3)
the full spectrum of##3##4##(2008-10#1)(2009-7#1)(2012-3#1)
the full spectrum##4##3##(2008-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
the full width at half-maximum of##2##6##(2008-2#2)
the full##59##2##(1991-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#4)(2009-11#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#2)
the full-length cDNA of##3##4##(1997-7#1)(2008-8#2)
the full-length cDNA##6##3##(1993-8#1)(1996-2#1)(1997-7#2)(2008-8#2)
the full-length##22##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-11#1)(1996-12#1)(1996-2#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)
the fully##10##2##(1990-8#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-2#2)(2012-2#2)
the fume is##3##3##(2008-10#3)
the fume##5##2##(2008-10#5)
the fumonisin##2##2##(2008-10#1)(2013-1#1)
the function and the##2##4##(1994-5#1)(1997-8#1)
the function and##6##3##(1994-5#1)(1997-8#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
the function of EDRF1##3##4##(2008-8#2)(2008-9#1)
the function of Smad5##2##4##(2008-8#2)
the function of basonuclin##2##4##(2008-9#2)
the function of human##2##4##(2006-6#1)(2008-11#1)
the function of the hypopharyngeal gland##2##6##(2008-6#2)
the function of the##23##4##(1995-6#1)(1996-12#1)(1997-1#1)(1997-7#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#3)(2011-2#2)(2012-3#1)
the function of these##4##4##(1995-2#1)(2008-11#1)(2008-9#1)(2013-1#1)
the function of##85##3##(1993-12#1)(1994-5#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-6#2)(2007-12#2)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#19)(2009-10#1)(2009-6#1)(2009-8#4)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
the function##95##2##(1993-12#1)(1993-6#1)(1994-2#1)(1994-5#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#2)(2006-6#2)(2007-12#2)(2008-10#6)(2008-11#6)(2008-3#1)(2008-4#4)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#19)(2009-10#1)(2009-6#1)(2009-8#4)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
the functional 5HT1D alpha gene##2##5##(1993-12#2)
the functional activity of##2##4##(2008-10#1)(2008-7#1)
the functional activity##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
the functional analysis of##3##4##(2008-10#1)(2008-11#2)
the functional characterization of##2##4##(1995-2#1)(2008-11#1)
the functional consequences of##2##4##(2008-9#1)(2013-1#1)
the functional diversity of##2##4##(2008-10#1)(2008-2#1)
the functional expression of the##2##5##(1993-8#1)(2008-6#1)
the functional expression of##4##4##(1993-8#1)(1994-12#1)(2008-6#1)(2011-2#1)
the functional form of the##2##5##(2008-7#1)(2012-2#1)
the functional form##3##3##(2008-7#1)(2012-2#2)
the functional group##2##3##(2008-10#2)
the functional groups of##2##4##(2008-10#2)
the functional groups##4##3##(2008-10#4)
the functional importance of##4##4##(1994-5#1)(2009-5#1)(2012-6#1)(2013-1#1)
the functional maturation of the visual##2##6##(2011-2#2)
the functional monomer##3##3##(2008-10#3)
the functional organization of##2##4##(2008-8#2)
the functional properties of##3##4##(1994-8#1)(1995-8#1)(2008-4#1)
the functional reconstitution##2##3##(1991-5#1)(1995-2#1)
the functional response of##2##4##(2008-10#1)(2008-8#1)
the functional response##3##3##(2008-10#1)(2008-8#2)
the functional role of PTHrP on their own##2##8##(1993-3#2)
the functional role of##14##4##(1993-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
the functional roles of##3##4##(1993-3#1)(1994-5#1)(2009-10#1)
the functional significance of this##2##5##(1995-2#1)(2012-2#1)
the functional significance of##8##4##(1995-2#2)(1995-6#1)(2008-7#1)(2009-1#1)(2012-2#2)(2012-3#1)
the functional status of the neurohypophyseal system in##2##8##(1997-8#2)
the functional status of the##3##5##(1997-8#2)(2008-9#1)
the functional status of##4##4##(1995-2#1)(1997-8#2)(2008-9#1)
the functional##129##2##(1990-3#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-11#3)(1995-2#6)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-7#1)(2010-8#2)(2011-2#6)(2011-3#1)(2012-2#7)(2012-3#4)(2012-6#1)(2013-1#6)
the functionality of the##3##4##(2008-10#1)(2012-3#1)(2012-6#1)
the functionality of##4##3##(1990-5#1)(2008-10#1)(2012-3#1)(2012-6#1)
the functionality##6##2##(1990-5#1)(2008-10#2)(2012-3#1)(2012-6#1)(2013-1#1)
the functionally##3##2##(1990-7#1)(1994-5#1)(2009-10#1)
the functioning of the##6##4##(1992-1#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
the functioning of##7##3##(1992-1#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
the functions of genes##2##4##(1993-9#1)(2012-3#1)
the functions of the genes##2##5##(1997-8#1)(2008-9#1)
the functions of the##4##4##(1994-2#1)(1997-8#1)(2007-12#1)(2008-9#1)
the functions of##22##3##(1993-8#1)(1993-9#1)(1994-2#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
the functions##25##2##(1993-8#1)(1993-9#1)(1994-2#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-3#2)(2013-1#1)
the fundamental and##3##3##(2008-3#2)(2013-8#1)
the fundamental mode##2##3##(2008-3#2)
the fundamental##44##2##(1991-3#2)(1992-3#1)(1992-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#10)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the fundamentals of##4##3##(1994-12#3)(2008-10#1)
the funding##5##2##(1991-12#1)(1992-1#1)(1995-6#1)(1997-7#1)(2010-5#1)
the fundus##3##2##(1991-12#1)(2010-6#1)(2011-2#1)
the fungal cell wall##3##4##(2008-10#3)
the fungal genome##4##3##(2008-10#3)(2011-1#1)
the fungal isolates##2##3##(2008-10#2)
the fungal pathogen Leptosphaeria maculans##3##5##(2008-10#2)(2011-10#1)
the fungal pathogen##9##3##(2008-10#8)(2011-10#1)
the fungal population was##2##4##(2008-10#1)(2008-12#1)
the fungal population##3##3##(2008-10#2)(2008-12#1)
the fungal##55##2##(1992-2#1)(2008-10#42)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-8#2)(2011-1#1)(2011-10#2)(2012-2#1)
the fungi are##2##3##(2008-10#1)(2008-8#1)
the fungi associated with##2##4##(2008-10#2)
the fungi were##2##3##(2008-10#2)
the fungi##18##2##(2008-10#12)(2008-5#1)(2008-8#2)(2009-6#1)(2010-7#1)(2012-2#1)
the fungicide metalaxyl##5##3##(2008-10#5)
the fungicide was applied##2##4##(2008-10#2)
the fungicide##26##2##(2008-10#24)(2008-11#2)
the fungicides##13##2##(2008-10#12)(2008-5#1)
the fungus Aspergillus##2##3##(2008-10#1)(2008-9#1)
the fungus Pyrenophora tritici-repentis##2##4##(2008-10#2)
the fungus from##2##3##(2008-10#2)
the fungus grew##2##3##(2008-10#2)
the fungus had##2##3##(2008-10#2)
the fungus has been##2##4##(2008-10#1)(2008-5#1)
the fungus is##3##3##(2008-10#3)
the fungus rapidly colonized the##2##5##(2008-10#2)
the fungus that causes##2##4##(2008-10#2)
the fungus that##3##3##(2008-10#3)
the fungus to##4##3##(2008-10#4)
the fungus was##11##3##(2008-10#10)(2011-2#1)
the fungus##109##2##(2008-10#97)(2008-11#3)(2008-12#1)(2008-5#4)(2008-9#1)(2010-3#1)(2011-10#1)(2011-2#1)
the fur##2##2##(2009-6#2)
the furnace##3##2##(2008-10#3)
the further development of##4##4##(1991-3#1)(1997-8#1)(2010-11#1)(2013-8#1)
the further understanding of the##2##5##(2008-10#1)(2008-9#1)
the further##22##2##(1990-10#1)(1991-3#2)(1995-11#1)(1996-2#1)(1997-8#1)(2008-10#6)(2008-8#1)(2008-9#2)(2010-10#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
the fused##5##2##(1997-2#1)(1997-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
the fusiform##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
the fusion gene##2##3##(2008-9#1)(2013-1#1)
the fusion genes##2##3##(2008-8#2)
the fusion of the##3##4##(2008-5#2)(2009-12#1)
the fusion of##10##3##(1991-5#1)(2008-11#3)(2008-5#2)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)
the fusion protein##4##3##(1994-8#1)(1996-12#1)(2008-11#1)(2008-9#1)
the fusion proteins##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
the fusion##33##2##(1991-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#5)(2008-4#1)(2008-5#2)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)
the fusionof pOCs into##2##4##(2008-11#2)
the future a##2##3##(2008-11#1)(2009-7#1)
the future development of##4##4##(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
the future direction##2##3##(2011-7#1)(2013-1#1)
the future directions##2##3##(1994-2#1)(2013-1#1)
the future for##3##3##(1990-2#1)(2008-10#1)(2008-11#1)
the future impact of##2##4##(2008-10#1)(2013-8#1)
the future is##3##3##(1992-11#1)(1993-2#1)(2008-7#1)
the future of peer review##2##5##(1991-1#2)
the future of public health##2##5##(1994-1#1)(1995-12#1)
the future of the##3##4##(1991-1#1)(1996-1#1)(2008-11#1)
the future of##25##3##(1991-1#3)(1992-3#2)(1993-1#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-11#5)(2008-4#1)(2009-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
the future should##3##3##(2007-12#1)(2008-11#1)(2010-4#1)
the future##173##2##(1990-2#1)(1990-3#1)(1990-9#2)(1991-1#6)(1991-12#3)(1991-2#1)(1991-3#2)(1992-11#1)(1992-2#1)(1992-3#6)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#6)(1993-3#4)(1994-1#2)(1994-12#3)(1994-2#3)(1994-3#1)(1994-6#2)(1995-1#2)(1995-12#2)(1995-2#1)(1996-1#4)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#7)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#3)(2008-10#17)(2008-11#18)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#8)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#1)
the future?##3##2##(1997-2#1)(2011-2#1)(2013-7#1)
the fuzzy##2##2##(2008-10#2)
the gabapentin##2##2##(2011-3#2)
the gadd genes##2##3##(1992-12#2)
the gadd##3##2##(1992-12#3)
the gadd153promoter##2##2##(2008-11#2)
the gain and##2##3##(2008-3#2)
the gain margin##2##3##(2008-3#2)
the gain##12##2##(2007-11#2)(2008-3#9)(2012-3#1)
the gains##2##2##(1996-5#1)(2008-10#1)
the gait##4##2##(2012-12#1)(2013-1#3)
the galanin##2##2##(1994-8#2)
the gallbladder##15##2##(1990-9#1)(1991-12#3)(1991-6#2)(1991-8#1)(1992-9#1)(1996-6#1)(1997-8#3)(2011-2#2)(2012-3#1)
the gallstone##2##2##(2008-12#2)
the game##2##2##(2008-9#1)(2010-4#1)
the gamma camera##2##3##(1996-2#2)
the gamma##15##2##(1992-3#1)(1993-12#2)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#2)(2008-10#2)(2008-2#2)(2008-7#1)(2008-8#1)
the ganglia of the##2##4##(1990-2#1)(2009-8#1)
the ganglia of##3##3##(1990-2#1)(1991-5#1)(2009-8#1)
the ganglia##4##2##(1990-2#1)(1991-5#1)(2008-7#1)(2009-8#1)
the ganglion##2##2##(2008-5#1)(2011-2#1)
the ganglioside##2##2##(1991-5#2)
the gap between##12##3##(1993-12#1)(1994-12#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2013-1#1)
the gaps in##3##3##(1995-12#1)(2010-12#1)(2012-12#1)
the gaps##4##2##(1995-12#1)(1997-1#1)(2010-12#1)(2012-12#1)
the garden lizard##2##3##(2008-7#2)
the gas chromatographic##4##3##(2008-10#4)
the gas phase##11##3##(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-7#1)
the gas pressure##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
the gas##40##2##(1992-12#1)(1995-11#1)(1996-12#1)(1997-1#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#8)(2008-6#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-2#1)
the gaseous species##2##3##(2008-10#2)
the gaseous##7##2##(2008-10#7)
the gases##2##2##(1996-12#1)(2008-10#1)
the gastric emptying rate of##2##5##(1997-4#2)
the gastric emptying##3##3##(1997-4#3)
the gastric inhibitory##2##3##(1997-4#1)(2008-11#1)
the gastric mucosa##4##3##(1990-3#1)(1996-3#1)(1997-1#1)(1997-7#1)
the gastric wall##2##3##(2009-8#1)(2010-12#1)
the gastric##29##2##(1990-2#1)(1990-3#1)(1990-9#3)(1991-6#1)(1992-12#1)(1992-6#1)(1996-3#1)(1997-1#4)(1997-4#5)(1997-7#1)(2008-10#1)(2008-11#1)(2009-8#2)(2010-12#1)(2011-2#4)(2012-2#1)
the gastrointestinal and##2##3##(1992-6#1)(2008-5#1)
the gastrointestinal system##2##3##(2008-11#1)(2012-2#1)
the gastrointestinal tract (GIT)##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
the gastrointestinal tract of##5##4##(2011-2#2)(2013-1#3)
the gastrointestinal tract##30##3##(1990-11#1)(1990-8#1)(1994-12#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-1#1)(2009-12#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
the gastrointestinal##38##2##(1990-11#1)(1990-8#1)(1992-6#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-12#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
the gate helix##2##3##(2012-2#2)
the gate##4##2##(1995-1#1)(2009-5#1)(2012-2#2)
the gathering of##2##3##(2008-10#1)(2013-1#1)
the gauche conformation##2##3##(2008-8#2)
the gaze##5##2##(2008-11#5)
the gear##2##2##(2008-3#2)
the gel beads##3##3##(2008-10#2)(2008-7#1)
the gel entrapment carrier##2##4##(2008-7#2)
the gel entrapment##3##3##(2008-7#3)
the gel phase##2##3##(1993-8#1)(2008-10#1)
the gel##34##2##(1990-11#1)(1991-5#1)(1993-8#4)(1996-9#1)(2008-10#16)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)
the gelatin method##3##3##(2008-11#3)
the gelation##2##2##(2008-10#2)
the gels##2##2##(1995-12#1)(2008-10#1)
the gender of the##2##4##(1992-3#1)(2012-3#1)
the gender of##3##3##(1992-3#1)(2012-3#2)
the gender##7##2##(1992-3#1)(1994-2#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#2)
the gene coding for the##3##5##(1992-3#1)(1993-8#1)(2008-6#1)
the gene coding for##6##4##(1992-3#1)(1993-8#1)(1996-8#1)(1997-2#1)(2008-6#1)(2010-8#1)
the gene encoding the##14##4##(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-2#2)(1996-12#2)(1996-8#1)(2008-5#1)(2008-9#2)(2013-1#1)
the gene encoding this##2##4##(1995-6#1)(2008-10#1)
the gene encoding##30##3##(1990-5#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2013-1#1)
the gene expression and##2##4##(1997-8#1)(2010-5#1)
the gene expression in##2##4##(1993-9#1)(2008-11#1)
the gene expression of##6##4##(1991-5#1)(1992-6#1)(1994-12#1)(1995-2#1)(1997-2#1)(2013-7#1)
the gene expression profile##2##4##(1997-6#1)(2010-11#1)
the gene expression profiles##3##4##(2008-10#3)
the gene expression##19##3##(1991-5#2)(1992-6#1)(1993-9#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-7#1)
the gene family##3##3##(2008-10#2)(2008-8#1)
the gene for##6##3##(1990-5#1)(1994-11#2)(2008-10#1)(2008-11#1)(2010-4#1)
the gene in##3##3##(1997-1#1)(2008-10#2)
the gene is##5##3##(1993-2#2)(1993-8#1)(2008-8#1)(2011-2#1)
the gene of interest##3##4##(2008-11#2)(2008-4#1)
the gene of##7##3##(1995-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-1#1)
the gene on##3##3##(2008-10#2)(2011-1#1)
the gene or genes##2##4##(1995-6#1)(2008-10#1)
the gene organization##2##3##(1995-11#1)(1996-6#1)
the gene to a##2##4##(1993-2#1)(2008-10#1)
the gene transfer##6##3##(1997-8#1)(2008-9#5)
the gene was##8##3##(1996-2#1)(1997-8#1)(2008-10#2)(2008-8#3)(2008-9#1)
the gene##183##2##(1990-5#4)(1990-7#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#3)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#3)(1993-2#10)(1993-3#2)(1993-6#3)(1993-8#5)(1993-9#2)(1994-11#4)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#3)(1995-2#3)(1995-6#7)(1996-12#2)(1996-2#3)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#3)(1997-8#3)(2008-10#31)(2008-11#6)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#16)(2009-10#1)(2009-6#2)(2010-10#2)(2010-11#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
the gene-for-gene model##2##3##(2008-10#2)
the gene-for-gene##6##2##(2008-10#5)(2011-10#1)
the genera##15##2##(2008-10#6)(2008-5#2)(2008-6#2)(2011-2#1)(2013-8#4)
the general applicability##2##3##(2008-10#1)(2008-9#1)
the general class of##2##4##(2008-5#1)(2008-6#1)
the general health status and##2##5##(2008-10#1)(2008-7#1)
the general health##5##3##(1993-3#1)(2008-10#1)(2008-7#2)(2013-1#1)
the general population and##3##4##(1992-2#1)(2010-12#1)(2013-1#1)
the general population is##2##4##(1992-11#1)(2013-8#1)
the general population of the##2##5##(1991-2#1)(2008-7#1)
the general population of##5##4##(1991-2#1)(2007-12#1)(2008-1#1)(2008-7#2)
the general population##45##3##(1990-11#1)(1991-12#1)(1991-2#3)(1992-11#1)(1992-2#3)(1992-9#1)(1993-1#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#4)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#2)
the general practitioner##9##3##(1990-3#2)(1992-5#1)(1993-11#1)(1994-6#1)(1995-11#2)(1997-4#1)(2012-12#1)
the general practitioners##6##3##(1993-2#1)(1997-4#3)(2008-10#1)(2011-2#1)
the general principle##2##3##(1993-9#1)(2008-8#1)
the general public regarding the##2##5##(2010-12#1)(2012-3#1)
the general public##7##3##(1993-2#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the general##149##2##(1990-11#2)(1990-3#2)(1990-6#1)(1991-12#2)(1991-2#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#2)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#14)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#6)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-3#6)(2013-1#9)(2013-8#3)
the generalist##3##2##(1993-2#2)(2009-8#1)
the generality of the##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
the generality of##5##3##(2008-10#1)(2008-5#1)(2008-8#3)
the generalization of treatment effects##2##5##(2009-9#2)
the generalization of##4##3##(2008-6#1)(2009-9#2)(2010-8#1)
the generalization##5##2##(2008-6#1)(2008-9#1)(2009-9#2)(2010-8#1)
the generalized Lorenz-Mie theory##2##4##(2008-2#1)(2008-3#1)
the generalized estimating equation##2##4##(1995-9#1)(2012-12#1)
the generalized##13##2##(1991-9#1)(1992-2#1)(1994-2#1)(1995-9#1)(1996-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2012-12#1)
the generally accepted##2##3##(2008-10#1)(2008-11#1)
the generally##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
the generated##11##2##(1995-3#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-9#1)(2011-2#1)
the generation and characterization of##2##5##(2011-2#1)(2012-2#1)
the generation and##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
the generation of a##5##4##(1993-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
the generation of an##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
the generation of data##2##4##(2008-10#1)(2008-5#1)
the generation of human##3##4##(1995-12#1)(2008-11#1)(2008-4#1)
the generation of new##2##4##(2008-7#1)(2012-4#1)
the generation of reactive oxygen species##2##6##(2008-1#1)(2009-3#1)
the generation of the##5##4##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
the generation of transgenic mice##2##5##(2008-4#2)
the generation of transgenic##3##4##(2008-11#1)(2008-4#2)
the generation of##75##3##(1990-5#1)(1991-5#2)(1992-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#2)(1995-9#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#9)(2008-11#18)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#3)(2011-9#1)(2012-12#2)(2012-3#1)(2012-4#1)(2013-8#1)
the generation time##2##3##(2008-8#2)
the generation##85##2##(1990-5#1)(1991-5#2)(1992-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#2)(1995-9#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#11)(2008-11#19)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#4)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-8#1)
the generations##2##2##(1992-2#1)(2009-10#1)
the generative##3##2##(2008-10#2)(2009-12#1)
the generator##3##2##(2007-12#1)(2008-10#2)
the generic##4##2##(1996-3#1)(2008-10#1)(2008-6#1)(2009-5#1)
the generosity of##2##3##(1996-2#1)(2008-10#1)
the genes and##2##3##(2008-8#1)(2008-9#1)
the genes coding for##2##4##(1995-12#1)(2008-9#1)
the genes encoding##9##3##(1991-6#1)(1992-9#1)(1993-12#1)(1996-2#1)(1997-7#1)(2008-7#1)(2010-10#2)(2010-7#1)
the genes for the##2##4##(2010-11#1)(2011-2#1)
the genes for##5##3##(1997-2#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
the genes in##4##3##(1996-2#1)(2008-10#2)(2008-4#1)
the genes involved in##5##4##(1996-6#1)(2008-10#1)(2008-11#2)(2008-9#1)
the genes involved##7##3##(1996-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#1)(2013-8#1)
the genes may be##2##4##(1993-3#1)(2008-9#1)
the genes of##4##3##(1995-12#1)(2008-8#3)
the genes on chromosome VI of##2##6##(1997-6#2)
the genes participating in##2##4##(1996-6#1)(2012-3#1)
the genes responsible for##2##4##(1994-9#1)(2009-6#1)
the genes that encode##2##4##(1993-9#1)(2008-11#1)
the genes that##4##3##(1993-6#1)(1993-9#1)(2007-12#1)(2008-11#1)
the genes underlying##3##3##(2009-10#2)(2012-3#1)
the genes were##3##3##(2008-10#2)(2009-10#1)
the genes##88##2##(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#2)(1994-9#1)(1995-12#2)(1996-2#2)(1996-6#2)(1997-2#1)(1997-6#4)(1997-7#3)(1997-8#3)(2007-12#1)(2008-10#13)(2008-11#6)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#7)(2009-10#4)(2009-6#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#2)
the genesis of##6##3##(1991-12#1)(1995-8#1)(2008-10#2)(2008-7#1)(2012-2#1)
the genesis##7##2##(1991-12#1)(1995-8#1)(2008-10#3)(2008-7#1)(2012-2#1)
the genetic analysis##3##3##(2008-10#1)(2010-1#2)
the genetic and##8##3##(2008-10#5)(2008-7#2)(2011-10#1)
the genetic architecture of##2##4##(2010-12#1)(2012-3#1)
the genetic background of the##2##5##(2008-2#1)(2012-3#1)
the genetic background of##6##4##(2008-10#2)(2008-2#1)(2009-10#1)(2012-3#2)
the genetic background##7##3##(1995-12#1)(2008-10#2)(2008-2#1)(2009-10#1)(2012-3#2)
the genetic basis of heterosis##2##5##(2008-8#1)(2009-10#1)
the genetic basis of##10##4##(1995-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-10#2)(2010-5#1)(2012-3#2)
the genetic basis##13##3##(1995-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#2)(2010-4#1)(2010-5#1)(2012-3#3)
the genetic characteristics of viral quasispecies##2##6##(2013-8#2)
the genetic characteristics of##3##4##(2011-2#1)(2013-8#2)
the genetic code##5##3##(1994-5#1)(1997-6#1)(2008-4#1)(2012-2#2)
the genetic composition of##4##4##(2008-10#3)(2009-8#1)
the genetic constitution of##2##4##(2008-10#2)
the genetic control of##3##4##(2008-10#1)(2008-8#2)
the genetic defect##2##3##(1990-5#1)(1996-12#1)
the genetic distance##2##3##(2008-10#2)
the genetic distances##2##3##(2008-10#1)(2008-6#1)
the genetic diversity among##4##4##(2008-10#4)
the genetic diversity and##3##4##(2008-10#2)(2013-8#1)
the genetic diversity between##2##4##(1995-2#1)(2008-7#1)
the genetic diversity of the##3##5##(2008-10#2)(2008-6#1)
the genetic diversity of##7##4##(2008-10#5)(2008-6#1)(2010-7#1)
the genetic diversity within##2##4##(2008-10#2)
the genetic diversity##22##3##(1995-2#1)(2008-10#15)(2008-12#1)(2008-6#1)(2008-7#1)(2010-7#1)(2012-3#1)(2013-8#1)
the genetic map##10##3##(1992-4#1)(1996-12#2)(1996-6#1)(2008-10#5)(2012-3#1)
the genetic mechanism##2##3##(2008-10#2)
the genetic modification##2##3##(2008-10#1)(2008-11#1)
the genetic relationship between##2##4##(2008-10#1)(2008-9#1)
the genetic relationship##3##3##(2008-10#2)(2008-9#1)
the genetic relationships among##2##4##(2008-10#2)
the genetic relationships##4##3##(2008-10#3)(2011-2#1)
the genetic structure of M##2##5##(2008-10#2)
the genetic structure of parasite##2##5##(2008-8#1)(2011-2#1)
the genetic structure of these##2##5##(2008-10#1)(2012-3#1)
the genetic structure of##20##4##(2008-10#14)(2008-8#2)(2011-2#1)(2012-3#2)(2013-8#1)
the genetic structure##21##3##(2008-10#15)(2008-8#2)(2011-2#1)(2012-3#2)(2013-8#1)
the genetic variability##4##3##(2008-10#4)
the genetic variance##2##3##(2008-10#1)(2008-8#1)
the genetic variation##9##3##(2008-10#5)(2008-8#1)(2010-1#1)(2010-4#1)(2013-8#1)
the genetic##192##2##(1990-5#1)(1991-2#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-12#5)(1995-2#1)(1996-12#4)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#79)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#13)(2008-9#12)(2009-10#3)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-10#1)(2011-2#5)(2012-2#3)(2012-3#13)(2013-8#8)
the genetically##6##2##(2008-10#3)(2008-8#1)(2012-3#1)(2013-7#1)
the genetics and physiology of##2##5##(2008-10#2)
the genetics and##4##3##(2008-10#3)(2008-8#1)
the genetics of reproductive isolation##2##5##(2008-8#2)
the genetics of resistance in##3##5##(2008-10#2)(2011-10#1)
the genetics of resistance##4##4##(2008-10#3)(2011-10#1)
the genetics of##13##3##(2008-10#8)(2008-8#2)(2011-10#1)(2012-3#2)
the genetics##18##2##(2008-10#11)(2008-8#3)(2009-3#1)(2011-10#1)(2012-3#2)
the geniculate ganglion##2##3##(2011-2#2)
the geniculate##4##2##(2008-11#1)(2011-2#3)
the genital##4##2##(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
the genitalia##5##2##(1997-3#1)(2008-10#3)(2010-4#1)
the genome contains##2##3##(2008-10#1)(2011-2#1)
the genome of S##2##4##(1992-6#1)(2008-9#1)
the genome of Synechocystis sp##5##5##(1995-8#1)(1996-8#1)(1997-2#1)(1997-6#2)
the genome of the cyanobacterium##2##5##(1995-12#1)(1996-12#1)
the genome of the unicellular cyanobacterium Synechocystis sp##4##8##(1995-6#1)(1995-8#1)(1996-6#2)
the genome of the##10##4##(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)(1997-3#1)(2008-10#1)(2010-8#1)(2011-2#1)
the genome of##26##3##(1992-6#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-10#4)(2008-8#2)(2008-9#2)(2009-3#1)(2010-8#2)(2011-2#1)(2012-3#1)
the genome organization##2##3##(2008-10#1)(2008-9#1)
the genome sequence of##3##4##(1996-8#1)(2008-7#2)
the genome sequence##4##3##(1996-8#1)(2008-7#2)(2011-2#1)
the genome that##2##3##(2008-2#1)(2008-9#1)
the genome were##2##3##(2008-10#2)
the genome##98##2##(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-12#2)(1996-2#1)(1996-6#10)(1996-8#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-3#1)(2009-6#1)(2009-8#1)(2010-8#2)(2011-2#9)(2012-2#1)(2012-3#4)(2013-1#1)
the genome-wide##2##2##(2011-2#2)
the genomes of##9##3##(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#3)
the genomic DNA of##2##4##(1992-6#1)(2008-10#1)
the genomic DNA##6##3##(1992-6#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-8#1)(2010-7#1)
the genomic RNA of##2##4##(1997-3#1)(2008-10#1)
the genomic RNA##3##3##(1997-3#2)(2008-10#1)
the genomic location of##2##4##(2008-10#1)(2008-4#1)
the genomic location##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
the genomic locus##2##3##(1991-6#1)(1996-6#1)
the genomic sequence##4##3##(1995-12#1)(2008-10#2)(2008-8#1)
the genomic structure##3##3##(1993-12#2)(2008-7#1)
the genomic##45##2##(1990-8#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-12#2)(1993-6#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-6#2)(1997-2#2)(1997-3#2)(1997-7#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
the genomics##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
the genotoxic effects of##2##4##(2008-8#1)(2010-5#1)
the genotype##6##2##(2006-6#1)(2008-10#2)(2008-8#1)(2012-3#1)(2013-8#1)
the genotypes##7##2##(1995-6#1)(2008-10#6)
the genotypic composition of##2##4##(2008-10#2)
the genotypic##6##2##(2008-10#5)(2008-8#1)
the genuine##2##2##(2008-8#1)(2010-11#1)
the genus Astyanax##3##3##(2010-8#3)
the genus Bacillus##2##3##(2008-10#1)(2011-2#1)
the genus Begomovirus##4##3##(2008-10#4)
the genus Borrelia##2##3##(2013-8#2)
the genus Closterovirus##3##3##(2008-10#3)
the genus Potyvirus##6##3##(2008-10#6)
the genus Sigmodon##2##3##(2010-4#2)
the genus Thermocrinis##2##3##(2011-2#2)
the genus Tobamovirus##3##3##(2008-10#3)
the genus Tospovirus##7##3##(2008-10#7)
the genus Trichoderma##3##3##(2008-10#3)
the genus##154##2##(1997-2#1)(2008-10#68)(2008-11#1)(2008-5#5)(2008-6#7)(2008-8#3)(2008-9#3)(2010-1#1)(2010-10#1)(2010-2#3)(2010-3#3)(2010-4#2)(2010-8#4)(2011-2#47)(2013-1#2)(2013-8#3)
the geochemical##2##2##(2008-10#2)
the geographic adjustment##2##3##(1991-3#1)(1992-2#1)
the geographic location##2##3##(2008-10#2)
the geographic origin of##2##4##(2008-10#2)
the geographic regions##2##3##(2008-10#1)(2008-8#1)
the geographic##19##2##(1991-12#1)(1991-3#5)(1992-2#1)(1994-1#1)(1994-2#1)(2008-10#7)(2008-11#1)(2008-8#1)(2009-8#1)
the geographical distribution of##2##4##(2008-10#2)
the geographical##6##2##(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)
the geological##2##2##(2008-10#2)
the geometric properties of##3##4##(2008-3#2)(2008-6#1)
the geometric##9##2##(2008-10#3)(2008-3#4)(2008-6#1)(2008-8#1)
the geometrical##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2013-8#1)
the geometry of the##5##4##(1990-5#1)(2008-10#2)(2008-3#2)
the geometry of##9##3##(1990-5#1)(1991-9#1)(1992-9#1)(1993-5#1)(2008-10#3)(2008-3#2)
the geometry##10##2##(1990-5#1)(1991-9#1)(1992-9#1)(1993-5#1)(2008-10#3)(2008-3#2)(2008-9#1)
the geriatric patient##2##3##(1990-9#1)(1991-2#1)
the geriatric##9##2##(1990-9#1)(1991-2#1)(1992-1#1)(1993-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#2)
the germ cells in the testis of matrinxã##2##8##(2008-7#2)
the germ cells in the##3##5##(2008-7#3)
the germ plasm##3##3##(2008-10#3)
the germ##14##2##(1995-2#2)(2008-10#4)(2008-7#5)(2009-10#1)(2010-3#1)(2012-12#1)
the germinal vesicle##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
the germinating##2##2##(2008-10#2)
the germination of##3##3##(2008-10#3)
the germination##10##2##(2008-10#7)(2011-2#3)
the germline##4##2##(1992-10#1)(2010-5#2)(2012-3#1)
the gerontological profile##2##3##(2012-12#2)
the gfp gene##3##3##(1996-6#2)(2008-10#1)
the giant grouper (Epinephelus lanceolatus)##2##5##(2010-5#2)
the giant grouper##3##3##(2010-5#3)
the giant panda were##2##4##(2008-8#2)
the giant##9##2##(1991-5#1)(2008-10#1)(2008-7#2)(2008-8#2)(2010-5#3)
the gibbon HBV##3##3##(1993-8#3)
the gill##3##2##(2008-10#1)(2008-7#2)
the gills##5##2##(2008-10#1)(2008-12#1)(2008-7#2)(2010-8#1)
the given##10##2##(1997-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-8#1)
the gland opening##4##3##(2007-12#4)
the gland##14##2##(1991-9#1)(2007-12#9)(2008-7#3)(2011-2#1)
the glands##4##2##(2007-12#3)(2008-5#1)
the glandular region##2##3##(2007-12#2)
the glandular##7##2##(1995-6#1)(1997-1#1)(2007-12#4)(2008-7#1)
the glass capillary of a##2##5##(2008-10#2)
the glass electrode##4##3##(2008-10#4)
the glass transition in##2##4##(1995-3#2)
the glass transition temperature##2##4##(1995-3#1)(2008-3#1)
the glass transition##6##3##(1995-3#3)(2008-3#1)(2012-2#2)
the glass##30##2##(1995-3#3)(2008-10#19)(2008-3#3)(2009-7#1)(2010-4#1)(2012-2#3)
the glassy carbon electrode (GCE)##3##5##(2008-10#3)
the glassy carbon electrode##11##4##(2008-10#11)
the glassy carbon##12##3##(2008-10#12)
the glassy##13##2##(1995-3#1)(2008-10#12)
the glassy-winged sharpshooter##2##3##(2007-12#2)
the gleaner-opportunist trade-off##2##3##(2008-8#2)
the glial##3##2##(1997-2#1)(2008-11#1)(2009-8#1)
the global and##2##3##(2008-10#1)(2008-11#1)
the global budgets##2##3##(1991-12#1)(2008-11#1)
the global gene expression profile of##2##6##(2011-2#2)
the global gene expression##3##4##(2009-12#1)(2011-2#2)
the global genomic##2##3##(2008-11#2)
the global optimum can##2##4##(2008-10#2)
the global optimum##3##3##(2008-10#3)
the global population##3##3##(2007-12#1)(2008-8#2)
the global regulation of##2##4##(2009-6#2)
the global sun radiation##2##4##(2011-2#2)
the global##56##2##(1990-11#1)(1990-12#1)(1990-9#2)(1991-12#1)(1991-6#1)(1996-5#1)(2007-12#2)(2008-10#12)(2008-11#7)(2008-12#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the globe to##2##3##(1990-11#1)(2008-10#1)
the globe##6##2##(1990-11#1)(2008-10#2)(2009-6#1)(2012-2#1)(2013-1#1)
the globin##3##2##(1990-8#1)(2008-10#1)(2008-9#1)
the globular##3##2##(1995-12#1)(2009-12#1)(2011-2#1)
the glomerular filtration rate##2##4##(1996-6#1)(2013-8#1)
the glomerular##5##2##(1996-6#2)(2007-12#1)(2012-3#1)(2013-8#1)
the gloves##5##2##(1995-6#3)(2012-2#2)
the glucagon##4##2##(1995-11#2)(2011-2#1)(2012-3#1)
the glucagon-evoked##2##2##(1996-2#2)
the glucagon-induced increase of NAD(P)H##2##5##(1996-2#2)
the glucocorticoid receptor##6##3##(1990-11#1)(1991-12#1)(1996-12#3)(2008-11#1)
the glucose biosensor##3##3##(2008-10#3)
the glucose concentration##6##3##(2008-10#6)
the glucose consumption rate##2##4##(2008-11#2)
the glucose consumption##3##3##(2008-11#3)
the glucose oxidase##4##3##(2008-10#4)
the glucose sensors##2##3##(2008-10#2)
the glucose tolerance test##2##4##(2008-10#1)(2012-12#1)
the glucose uptake##3##3##(2008-11#2)(2008-8#1)
the glucose##39##2##(1994-12#1)(1994-2#2)(2008-10#25)(2008-11#7)(2008-8#1)(2011-1#1)(2012-12#1)(2012-4#1)
the glutamate transporter##2##3##(1995-11#1)(1996-2#1)
the glutamate##11##2##(1994-2#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-7#5)(2008-8#2)
the glutamatergic system is##2##4##(2008-7#2)
the glutamatergic system##5##3##(2008-7#5)
the glutamine##6##2##(1993-8#1)(1997-1#1)(2008-11#4)
the glutaminolysis##2##2##(2008-11#2)
the glutathione##2##2##(2008-10#1)(2008-11#1)
the gluteal region with##2##4##(1992-2#1)(2011-2#1)
the gluteal region##3##3##(1992-2#1)(2009-9#1)(2011-2#1)
the glutinous cultivars##2##3##(2008-10#2)
the glutinous##3##2##(2008-10#3)
the glycan##3##2##(1991-12#1)(1992-9#1)(2008-4#1)
the glycemic index and the glycemic load##2##7##(2008-1#2)
the glycemic##4##2##(2008-1#4)
the glycine cleavage complex##2##4##(1997-1#2)
the glycine cleavage##3##3##(1992-10#1)(1997-1#2)
the glycine##4##2##(1992-10#1)(1996-2#1)(1997-1#2)
the glycolysis##2##2##(2008-11#1)(2010-7#1)
the glycolytic pathway##4##3##(1996-6#1)(2008-11#1)(2008-7#2)
the glycolytic##8##2##(1994-8#2)(1996-6#2)(2008-11#1)(2008-7#3)
the glycopeptide##2##2##(1990-5#1)(1990-8#1)
the glycoprotein IIb-IIIa##2##3##(1990-5#1)(2006-6#1)
the glycoprotein processing##2##3##(1993-8#2)
the glycoprotein##9##2##(1990-5#1)(1991-11#1)(1993-6#1)(1993-8#3)(1994-8#1)(2006-6#1)(2008-7#1)
the glycosylation site##3##3##(1990-5#2)(1992-10#1)
the glycosylation##7##2##(1990-5#2)(1992-10#1)(2008-11#3)(2008-7#1)
the glyoxalase##2##2##(2008-10#1)(2008-11#1)
the glyoxylate##2##2##(2008-10#1)(2008-7#1)
the go##2##2##(1991-6#1)(2013-8#1)
the goal of developing##2##4##(2008-11#1)(2011-8#1)
the goal of preventing##2##4##(1993-2#1)(2008-10#1)
the goal of this##2##4##(2008-10#1)(2008-11#1)
the goal of##20##3##(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-8#1)(2012-2#1)(2013-1#1)
the goal to##2##3##(1994-3#1)(2010-9#1)
the goal##26##2##(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the goals of##8##3##(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
the goals##12##2##(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
the gold electrode modified with a self-assembled monolayer of l-cysteine##2##10##(2008-10#2)
the gold electrode surface##3##4##(2008-10#3)
the gold electrode##7##3##(2008-10#7)
the gold standard for##4##4##(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
the gold standard in##2##4##(2011-2#1)(2011-3#1)
the gold standard of##2##4##(2008-10#1)(2011-2#1)
the gold standard##16##3##(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#4)(2011-3#2)(2012-12#2)(2012-3#2)(2013-8#1)
the gold surface of a##2##5##(2008-10#2)
the gold surface##5##3##(2008-10#5)
the gold##39##2##(1994-5#2)(1996-6#1)(2008-10#20)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#4)(2011-3#2)(2012-12#2)(2012-3#2)(2013-8#1)
the gold/poly(o-PD) electrode##2##3##(2008-10#2)
the golden standard##2##3##(2008-11#2)
the golden##3##2##(1993-2#1)(2008-11#2)
the goldfish##8##2##(1991-2#5)(2008-6#1)(2011-2#2)
the gonadal##4##2##(2008-11#4)
the gonads is##2##3##(2009-11#1)(2009-7#1)
the gonads##4##2##(2009-11#3)(2009-7#1)
the good performance of##2##4##(2008-10#2)
the good##21##2##(1990-2#1)(1990-9#2)(1992-5#1)(1993-12#1)(1994-3#1)(2008-10#11)(2008-5#1)(2009-10#1)(2013-8#2)
the goodness of the##3##4##(1990-5#1)(2008-10#2)
the goodness of##4##3##(1990-5#1)(2008-10#3)
the government and##4##3##(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)
the government of Delhi##2##4##(1994-9#2)
the government##18##2##(1994-12#2)(1994-9#2)(1995-12#1)(1995-3#4)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2011-2#1)
the government's##8##2##(1996-3#1)(1996-5#2)(2008-11#4)(2010-11#1)
the governmental##2##2##(1997-2#1)(2010-11#1)
the gradient##9##2##(2008-10#6)(2008-3#1)(2008-8#1)(2010-8#1)
the gradients##2##2##(1995-6#1)(2008-8#1)
the gradual##7##2##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)
the graduate##2##2##(2008-11#2)
the graft##12##2##(1996-2#1)(1996-3#1)(2006-6#1)(2007-11#1)(2008-10#2)(2009-10#1)(2010-3#1)(2011-3#2)(2013-1#2)
the grafted polymer##2##3##(2008-10#2)
the grafted##4##2##(1997-5#1)(2008-10#3)
the grafts##4##2##(1997-8#1)(2006-6#1)(2008-10#1)(2008-11#1)
the grain##8##2##(2008-10#5)(2008-5#2)(2009-7#1)
the grammatical##2##2##(1991-2#2)
the grants##2##2##(1996-3#2)
the granular##3##2##(1992-11#1)(1995-3#1)(2013-8#1)
the granule cell##3##3##(1994-8#2)(2013-8#1)
the granule##8##2##(1992-6#1)(1994-8#2)(1995-8#3)(2008-6#1)(2013-8#1)
the granules##5##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
the granulosa##5##2##(2008-12#3)(2008-8#1)(2008-9#1)
the grape##2##2##(2008-10#2)
the grapevine##2##2##(2008-10#2)
the graphical##2##2##(2008-10#1)(2011-2#1)
the graphite furnace##5##3##(2008-10#5)
the graphite tube and the##2##5##(2008-10#2)
the graphite tube and##3##4##(2008-10#3)
the graphite tube##16##3##(2008-10#16)
the graphite##29##2##(2008-10#29)
the grass##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
the grating diffraction##2##3##(2008-2#2)
the grating is##2##3##(2008-2#1)(2008-3#1)
the grating##22##2##(2007-12#2)(2008-2#5)(2008-3#15)
the gravity vector##2##3##(2008-11#1)(2009-8#1)
the gravity##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
the gray##5##2##(1995-6#1)(1997-8#1)(2008-10#2)(2008-6#1)
the gray-scale fabrication of diffractive optical elements##2##7##(2008-3#2)
the grazing season##3##3##(1991-8#1)(1996-12#2)
the grazing##6##2##(1991-8#1)(1996-12#4)(2008-3#1)
the great majority of##2##4##(2008-10#1)(2008-11#1)
the great majority##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
the great number of##2##4##(1994-6#1)(2008-10#1)
the great potential of this##2##5##(2008-10#1)(2008-5#1)
the great potential of##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
the great tit##2##3##(2008-9#2)
the great##33##2##(1990-11#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-2#1)(2013-8#1)
the greater than additive##2##4##(2008-10#2)
the greater the##4##3##(1993-11#1)(2008-3#1)(2010-10#2)
the greater##26##2##(1990-12#1)(1990-8#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#2)
the greatest barrier to##2##4##(2008-11#1)(2011-2#1)
the greatest challenge##2##3##(1994-2#1)(2008-10#1)
the greatest contribution to##2##4##(1994-2#1)(2008-10#1)
the greatest effect##3##3##(2008-10#3)
the greatest genetic##2##3##(2008-10#2)
the greatest impact on##2##4##(2008-10#1)(2008-8#1)
the greatest impact##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
the greatest increase in##2##4##(2008-10#2)
the greatest number of##3##4##(1992-9#1)(2008-10#2)
the greatest opportunity for##2##4##(1994-2#1)(2008-4#1)
the greatest sensitivity##2##3##(2008-10#2)
the greatest##79##2##(1991-2#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-2#3)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#36)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
the green fluorescence was##2##4##(2008-9#2)
the green fluorescent protein (GFP) gene##2##6##(2008-8#1)(2008-9#1)
the green fluorescent protein (GFP)##4##5##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
the green fluorescent protein##7##4##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)
the green fluorescent##8##3##(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)
the green##21##2##(1996-2#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2009-9#1)(2012-3#1)
the greenhouse effect##4##3##(1991-6#4)
the greenhouse##58##2##(1991-6#4)(2008-10#54)
the grey phenotype##2##3##(2008-8#2)
the grinding##2##2##(2008-10#2)
the gripping##2##2##(2008-10#2)
the grooves##2##2##(1995-8#1)(2008-10#1)
the gross##10##2##(1993-1#1)(1993-3#1)(1995-5#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-4#1)
the ground and##3##3##(2008-10#3)
the ground squirrel jejunum##2##4##(1990-5#2)
the ground squirrel##7##3##(1990-5#2)(2008-8#5)
the ground state##2##3##(1991-5#1)(2008-10#1)
the ground##30##2##(1990-5#2)(1990-8#1)(1991-5#1)(2007-12#1)(2008-10#11)(2008-3#4)(2008-5#1)(2008-8#6)(2008-9#1)(2009-6#1)(2012-12#1)
the grounded theory##2##3##(2008-11#1)(2008-12#1)
the grounds##5##2##(1991-12#1)(1992-3#1)(1995-12#1)(1997-4#1)(2011-2#1)
the group of patients who##3##5##(2011-2#2)(2012-3#1)
the group of patients with##2##5##(1992-12#1)(2013-1#1)
the group of patients##7##4##(1992-12#1)(2011-2#3)(2012-3#1)(2013-1#2)
the group of##28##3##(1991-9#1)(1992-12#1)(1992-3#1)(1994-5#1)(2008-10#5)(2008-12#3)(2008-7#2)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#5)(2012-3#3)(2013-1#3)
the group practice##3##3##(1994-3#2)(1995-1#1)
the group receiving##2##3##(2008-10#2)
the group refractive index##2##4##(2008-2#2)
the group size##3##3##(2008-8#2)(2008-9#1)
the group that##2##3##(1993-1#1)(2013-1#1)
the group treated with##4##4##(1991-2#1)(1993-2#1)(1995-12#1)(2013-1#1)
the group treated##5##3##(1991-2#1)(1993-2#1)(1995-12#1)(2011-2#1)(2013-1#1)
the group tried to turn several local health clubs into sports medicine clinics##2##13##(1994-3#2)
the group velocity##2##3##(2008-2#2)
the group which started with##2##5##(1991-2#2)
the group with the##2##4##(1995-2#1)(2012-12#1)
the group with##11##3##(1990-8#1)(1992-1#1)(1992-2#1)(1994-12#1)(1995-2#2)(1997-8#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
the group without##3##3##(1993-8#1)(1994-12#2)
the group##113##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#3)(1994-3#4)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#6)(2008-12#4)(2008-2#5)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#10)(2009-10#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#1)
the group's##3##2##(1993-1#1)(1993-3#1)(1997-3#1)
the grouper##3##2##(2010-5#3)
the groups of##5##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-9#2)
the groups were##2##3##(2008-11#1)(2010-1#1)
the groups with##2##3##(2008-6#1)(2009-12#1)
the groups##40##2##(1991-2#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-7#2)(1997-8#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)
the grove##5##2##(2008-10#5)
the grower##2##2##(2008-10#2)
the growing interest in##3##4##(2008-10#1)(2009-7#1)(2010-1#1)
the growing interest##4##3##(2008-10#1)(2009-7#1)(2010-1#1)(2013-8#1)
the growing need for##2##4##(1991-10#1)(2013-8#1)
the growing number of##4##4##(1991-1#1)(2008-10#1)(2009-10#1)(2011-3#1)
the growing pressure on##2##4##(1997-1#1)(2008-12#1)
the growing season in the##2##5##(2008-10#2)
the growing season may##2##4##(2008-10#2)
the growing season##25##3##(2008-10#23)(2010-8#1)(2012-5#1)
the growing##57##2##(1991-1#1)(1991-10#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-10#29)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#2)(2010-5#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-5#2)(2013-1#2)(2013-8#2)
the growth and development of##6##5##(1994-1#1)(1996-3#1)(2008-12#3)(2008-8#1)
the growth and##23##3##(1991-6#1)(1994-1#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-11#9)(2008-12#3)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#2)
the growth behaviour of##2##4##(2008-11#2)
the growth characteristics of##2##4##(2008-11#2)
the growth characteristics##3##3##(2008-11#3)
the growth conditions##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
the growth factor##9##3##(1990-8#1)(1992-10#1)(1993-3#1)(1997-1#1)(1997-7#2)(2008-11#1)(2008-8#1)(2009-8#1)
the growth in hospital##2##4##(1992-1#1)(1992-2#1)
the growth in##8##3##(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1995-6#1)(2008-10#1)(2010-4#1)
the growth inhibition##3##3##(1995-2#1)(2008-11#1)(2008-5#1)
the growth inhibitory effect of##2##5##(1995-2#1)(2008-11#1)
the growth inhibitory effects of##2##5##(1997-3#1)(2008-11#1)
the growth inhibitory##5##3##(1995-2#1)(1996-2#1)(1997-3#1)(2008-11#2)
the growth kinetics##3##3##(2008-11#2)(2008-7#1)
the growth medium##12##3##(1990-6#1)(1991-10#1)(1991-11#2)(1996-6#1)(2008-10#4)(2008-11#3)
the growth of A##2##4##(2008-10#2)
the growth of B##2##4##(2011-2#2)
the growth of HeLa cells and##2##6##(1997-1#1)(2008-8#1)
the growth of M##2##4##(2008-10#1)(2013-1#1)
the growth of R##3##4##(2008-10#3)
the growth of SC115##2##4##(1990-11#2)
the growth of a##3##4##(2008-10#1)(2008-11#2)
the growth of both##5##4##(1997-1#1)(2008-10#3)(2008-5#1)
the growth of cultured cells##2##5##(1994-3#1)(2008-11#1)
the growth of health care expenditures##2##6##(1992-1#1)(1995-3#1)
the growth of health care##3##5##(1992-1#1)(1995-1#1)(1995-3#1)
the growth of health##4##4##(1991-2#1)(1992-1#1)(1995-1#1)(1995-3#1)
the growth of human hepatoma##3##5##(2008-11#1)(2008-8#2)
the growth of human##7##4##(1994-8#1)(2008-11#3)(2008-8#2)(2010-6#1)
the growth of lactic acid bacteria##4##6##(2008-11#4)
the growth of managed care##3##5##(1995-12#1)(1996-2#1)(1997-3#1)
the growth of managed##4##4##(1991-3#1)(1995-12#1)(1996-2#1)(1997-3#1)
the growth of public expenditures##3##5##(1994-2#3)
the growth of the cell##2##5##(1990-5#1)(2008-8#1)
the growth of the##15##4##(1990-5#1)(1992-8#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#2)
the growth of these##2##4##(1996-3#1)(2008-10#1)
the growth of tumors##2##4##(2012-2#1)(2013-8#1)
the growth of vascular##2##4##(1993-3#1)(1994-11#1)
the growth of##135##3##(1990-11#3)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#2)(1994-11#3)(1994-2#4)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#3)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#40)(2008-11#20)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-10#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
the growth patterns##2##3##(1992-8#1)(2010-12#1)
the growth period##2##3##(2008-11#1)(2010-11#1)
the growth phase of##2##4##(2008-11#2)
the growth phase##6##3##(2008-11#5)(2009-6#1)
the growth rate and##3##4##(1996-3#1)(2008-11#2)
the growth rate of the##4##5##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
the growth rate of##11##4##(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#2)(2009-9#1)(2012-2#1)
the growth rate##19##3##(1992-2#1)(1996-3#1)(2008-10#2)(2008-11#6)(2008-12#3)(2008-7#2)(2008-9#2)(2009-9#1)(2012-2#1)
the growth rates of##3##4##(2008-11#2)(2011-1#1)
the growth surface##2##3##(2008-11#1)(2009-11#1)
the growth##278##2##(1990-11#4)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-4#1)(1992-8#2)(1993-12#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-2#4)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-6#2)(1997-1#4)(1997-3#2)(1997-7#3)(2007-11#1)(2008-10#54)(2008-11#65)(2008-12#10)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#11)(2008-9#10)(2009-10#1)(2009-11#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#6)
the growth-phase-dependent##2##2##(2009-6#2)
the growth-stimulating effect##2##3##(1995-8#2)
the growth-stimulating##3##2##(1995-8#3)
the gsa-1 gene encoding a G protein##2##7##(1997-7#2)
the gsa-1 gene##3##3##(1997-7#3)
the guanine##5##2##(1991-5#1)(1994-5#1)(2008-10#3)
the guard##3##2##(1991-3#1)(2008-10#1)(2008-8#1)
the guardian##2##2##(1990-11#1)(2011-2#1)
the guards##4##2##(1995-6#4)
the guest molecules##2##3##(2008-10#2)
the guest##7##2##(2008-10#5)(2013-1#1)(2013-8#1)
the guidance of the##3##4##(2008-1#1)(2009-3#1)(2009-8#1)
the guidance of##7##3##(1993-12#1)(2008-1#1)(2008-11#1)(2009-3#1)(2009-8#1)(2011-2#2)
the guide##5##2##(1996-2#3)(2008-11#1)(2008-3#1)
the guided light##3##3##(2008-10#3)
the guided##5##2##(1990-9#1)(2008-10#4)
the guideline##6##2##(2008-10#4)(2012-2#1)(2013-1#1)
the guidelines for the##2##4##(2008-10#1)(2012-12#1)
the guidelines for##5##3##(1997-8#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
the guidelines of##2##3##(1991-3#1)(1997-2#1)
the guidelines##16##2##(1990-6#4)(1991-3#1)(1992-8#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
the guinea pig##9##3##(1990-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1997-3#3)(2008-10#2)
the guinea##10##2##(1990-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1997-3#3)(2008-10#2)(2008-5#1)
the guinea-pig##4##2##(1990-5#2)(1997-4#2)
the gum##2##2##(2008-10#1)(2008-5#1)
the guppy##2##2##(2008-8#2)
the gut lumen##2##3##(2007-12#1)(2008-10#1)
the gut##25##2##(1990-5#1)(1992-6#2)(2007-12#1)(2008-10#9)(2008-5#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#8)
the gynecologic##2##2##(1991-3#1)(1993-12#1)
the hAT2R mRNA was##2##4##(1994-11#2)
the hAT2R##3##2##(1994-11#3)
the hESC microenvironment##2##3##(2009-3#2)
the hEp##3##2##(1993-12#1)(1993-6#2)
the hIL-6 productivity rate##2##4##(2008-11#2)
the hIL-6##3##2##(2008-11#3)
the hTERT gene##2##3##(2008-11#2)
the hTERT promoter##2##3##(2008-11#2)
the hTERT##7##2##(2008-11#7)
the habitat in##2##3##(2008-10#1)(2008-8#1)
the habitat patches##2##3##(2008-8#2)
the habitat##8##2##(2008-10#2)(2008-8#4)(2010-8#1)(2013-1#1)
the haemagglutinins##2##2##(2008-5#2)
the haemodynamic##2##2##(2011-2#1)(2012-2#1)
the hair and##4##3##(2007-12#1)(2008-5#3)
the hair follicle##3##3##(2008-5#2)(2008-8#1)
the hair samples##2##3##(2008-10#1)(2008-5#1)
the hair structure##2##3##(2008-5#2)
the hair##26##2##(2007-12#1)(2008-10#1)(2008-5#21)(2008-8#2)(2010-6#1)
the hairy##3##2##(1990-9#1)(2008-10#1)(2008-7#1)
the half neutralization potential by about##2##6##(2008-10#2)
the half##10##2##(1996-1#1)(2008-10#6)(2008-11#2)(2008-8#1)
the half-life of the viable cell##2##6##(2008-11#2)
the half-life of##3##3##(2008-10#1)(2008-11#2)
the half-life##4##2##(1995-6#1)(2008-10#1)(2008-11#2)
the half-visor group##2##3##(2010-1#2)
the half-visor##4##2##(2010-1#4)
the halftone##2##2##(2008-3#2)
the hallmark of the##2##4##(2008-11#1)(2011-2#1)
the hallmark##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
the hamster model##2##3##(2008-9#2)
the hamster##6##2##(1995-6#1)(1996-8#2)(2008-9#3)
the hand and wrist##2##4##(2012-2#2)
the hand and##4##3##(2010-9#1)(2012-2#2)(2013-1#1)
the hand##13##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#4)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)
the handling of##4##3##(2008-10#3)(2010-8#1)
the hands of the##2##4##(1997-5#1)(2008-10#1)
the hands of##6##3##(1997-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
the hands##13##2##(1995-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
the hanging mercury drop electrode (HMDE)##5##6##(2008-10#5)
the hanging mercury drop electrode was##3##6##(2008-10#3)
the hanging mercury drop electrode##14##5##(2008-10#14)
the hanging##16##2##(2008-10#15)(2008-11#1)
the hard##9##2##(1991-11#3)(2007-12#1)(2008-10#1)(2008-9#2)(2011-2#1)(2013-1#1)
the hardening##3##2##(2008-10#3)
the hardness##2##2##(2008-10#1)(2008-5#1)
the harmful effects##2##3##(1991-6#2)
the harmful##4##2##(1991-6#2)(2008-5#1)(2011-2#1)
the harmonization##2##2##(2008-10#1)(2010-8#1)
the harvested##2##2##(2008-10#1)(2008-11#1)
the harvesting time##2##3##(2012-2#2)
the harvesting##5##2##(2008-4#1)(2008-8#2)(2012-2#2)
the hatched##2##2##(1992-6#1)(2008-5#1)
the hazard##6##2##(1996-12#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
the hazards of##4##3##(1990-11#1)(1992-3#1)(2008-11#2)
the hazards##7##2##(1990-11#1)(1992-3#1)(1995-9#1)(1996-12#1)(2008-11#3)
the head and neck region##4##5##(1992-5#1)(1997-6#1)(2011-2#1)(2013-1#1)
the head and neck##13##4##(1990-6#2)(1992-5#1)(1994-6#1)(1997-6#1)(2007-11#1)(2008-12#1)(2011-2#3)(2013-1#2)(2013-8#1)
the head and##19##3##(1990-6#2)(1992-5#1)(1994-6#1)(1995-11#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
the head of the Department of##3##6##(2008-10#3)
the head of the pancreas##3##5##(1990-9#1)(1991-3#1)(2013-1#1)
the head of the##8##4##(1990-9#1)(1991-3#1)(1995-11#1)(2008-10#3)(2008-6#1)(2013-1#1)
the head of##12##3##(1990-9#1)(1991-3#1)(1995-11#1)(2007-12#1)(2008-10#5)(2008-6#1)(2012-3#1)(2013-1#1)
the head were significantly##2##4##(1991-11#1)(1995-11#1)
the head##53##2##(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-6#2)(1995-11#5)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
the headspace above the##2##4##(2008-10#2)
the headspace and##2##3##(2008-10#2)
the headspace of##3##3##(2008-10#2)(2008-11#1)
the headspace solvent microextraction##2##4##(2008-10#2)
the headspace##16##2##(2008-10#14)(2008-11#1)(2011-2#1)
the healing of##3##3##(2009-3#1)(2010-1#1)(2011-2#1)
the healing process##2##3##(1996-12#1)(2009-5#1)
the healing##7##2##(1996-12#1)(2008-10#1)(2009-3#1)(2009-5#1)(2010-1#1)(2011-2#2)
the health and well-being of##2##5##(2010-7#1)(2010-9#1)
the health and##11##3##(1991-3#1)(1992-3#1)(1996-3#2)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-9#2)
the health authorities of the##2##5##(1990-6#1)(2012-12#1)
the health authorities##4##3##(1990-6#1)(1994-3#1)(1994-6#1)(2012-12#1)
the health care community##2##4##(1992-12#1)(1995-12#1)
the health care context##3##4##(1997-3#2)(2008-11#1)
the health care delivery system##3##5##(1991-1#1)(1993-12#1)(1995-2#1)
the health care enterprise##2##4##(1994-12#1)(1996-3#1)
the health care environment##3##4##(1991-3#1)(1993-3#2)
the health care industry##16##4##(1991-1#1)(1991-12#1)(1992-3#1)(1993-12#3)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-3#2)(2008-11#3)
the health care needs##2##4##(1994-2#1)(1995-12#1)
the health care organization##2##4##(1994-12#1)(1994-3#1)
the health care provider##3##4##(1992-2#1)(2010-1#1)(2013-1#1)
the health care sector##5##4##(1992-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2010-7#1)
the health care system and##5##5##(1993-11#1)(1996-2#1)(1997-6#1)(2010-4#1)(2011-1#1)
the health care system##25##4##(1991-2#1)(1992-12#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#2)(1997-2#1)(1997-6#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)
the health care team##7##4##(1995-2#2)(2008-11#2)(2008-7#2)(2010-4#1)
the health care use##3##4##(1997-3#1)(2013-1#2)
the health care##95##3##(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#2)(1992-12#4)(1992-2#3)(1992-3#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#5)(1995-3#2)(1996-2#6)(1996-3#1)(1997-2#3)(1997-3#6)(1997-6#2)(1997-8#3)(2008-11#10)(2008-12#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#3)
the health consequences of##2##4##(1994-6#1)(2008-10#1)
the health effects of##2##4##(2008-11#1)(2013-8#1)
the health information##2##3##(1996-1#1)(2007-12#1)
the health insurance industry##2##4##(1992-3#1)(1993-1#1)
the health insurance##4##3##(1992-3#1)(1993-1#1)(1995-12#1)(1997-8#1)
the health of children##3##4##(1995-1#1)(2008-11#2)
the health of individuals and##2##5##(1993-3#1)(2008-1#1)
the health of the public##2##5##(1996-2#1)(2010-6#1)
the health of the##6##4##(1991-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-6#1)(2013-1#1)
the health of##23##3##(1991-1#1)(1991-6#1)(1993-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
the health policy##2##3##(2008-7#1)(2012-2#1)
the health professions##2##3##(1992-3#1)(2008-11#1)
the health promotion##2##3##(2008-1#1)(2008-12#1)
the health risks of##2##4##(2008-7#1)(2010-2#1)
the health risks##3##3##(2008-7#2)(2010-2#1)
the health sciences##3##3##(1994-3#1)(2008-11#1)(2008-12#1)
the health sector##5##3##(1992-1#1)(1994-2#1)(1997-2#1)(2012-3#1)(2013-8#1)
the health services##9##3##(1990-11#1)(1991-6#2)(1991-9#1)(1992-12#1)(1993-12#1)(1996-11#2)(2008-1#1)
the health status of##6##4##(1994-9#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2010-10#1)
the health status##7##3##(1993-6#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2010-10#1)
the health system##7##3##(1993-12#1)(1996-3#1)(1997-3#1)(2008-1#3)(2013-8#1)
the health##213##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-1#3)(1991-12#1)(1991-2#3)(1991-3#5)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#5)(1992-2#3)(1992-3#6)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#4)(1993-6#1)(1994-12#4)(1994-2#3)(1994-3#5)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#5)(1995-2#5)(1995-3#2)(1996-1#1)(1996-11#2)(1996-2#9)(1996-3#6)(1997-2#7)(1997-3#7)(1997-4#1)(1997-6#2)(1997-8#5)(2007-12#1)(2008-1#9)(2008-10#5)(2008-11#18)(2008-12#7)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2010-1#1)(2010-10#2)(2010-2#3)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#4)
the health-related##3##2##(1996-1#1)(2008-11#1)(2008-12#1)
the healthcare industry##5##3##(1991-2#1)(1993-3#1)(1994-2#1)(2009-8#1)(2013-8#1)
the healthcare system##6##3##(1991-3#2)(2009-8#1)(2011-7#1)(2013-1#2)
the healthcare##27##2##(1991-2#1)(1991-3#2)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#3)(2009-8#2)(2011-1#1)(2011-2#2)(2011-7#1)(2013-1#2)(2013-8#1)
the healthy control group##2##4##(2008-7#2)
the healthy controls##2##3##(1997-8#1)(2010-12#1)
the healthy human##2##3##(2012-2#1)(2012-3#1)
the healthy skin microflora##2##4##(2012-3#2)
the healthy##27##2##(1993-5#1)(1994-3#1)(1995-12#1)(1997-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#3)
the hearing##4##2##(2008-9#4)
the heart and##3##3##(1991-5#1)(1994-2#1)(1996-2#1)
the heart in##2##3##(1993-12#1)(2013-1#1)
the heart meridian##2##3##(2008-9#2)
the heart of the##4##4##(1994-3#1)(2008-11#1)(2008-3#1)(2013-1#1)
the heart of##11##3##(1994-3#1)(1996-12#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2010-11#1)(2013-1#2)
the heart rate##6##3##(1990-5#1)(1990-9#1)(1991-6#2)(2012-2#2)
the heart valves##2##3##(2006-6#1)(2008-8#1)
the heart was##3##3##(1993-12#1)(2013-1#2)
the heart with##3##3##(1991-3#1)(2008-7#1)(2009-1#1)
the heart##64##2##(1990-5#1)(1990-9#1)(1991-3#3)(1991-5#1)(1991-6#3)(1992-6#1)(1993-1#1)(1993-12#4)(1993-6#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#2)(1996-2#1)(2006-6#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-1#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#7)
the heat capacities of##2##4##(1997-2#2)
the heat of solvation##2##4##(2008-10#2)
the heat of##3##3##(2008-10#3)
the heat shock protein 70 homolog##3##6##(2008-10#3)
the heat shock protein 70##4##5##(1995-11#1)(2008-10#3)
the heat shock protein##6##4##(1995-11#1)(1996-12#1)(2008-10#3)(2008-7#1)
the heat shock response##2##4##(2008-7#2)
the heat shock##12##3##(1992-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-7#3)
the heat transfer##2##3##(2008-10#1)(2011-2#1)
the heat treatment##2##3##(2008-10#1)(2008-11#1)
the heat##37##2##(1991-5#1)(1992-12#1)(1992-2#1)(1993-8#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#3)(2008-10#10)(2008-11#2)(2008-3#2)(2008-7#3)(2010-3#1)(2010-4#3)(2011-2#1)(2013-8#2)
the heat-treated##2##2##(2008-10#2)
the heated##3##2##(2008-10#2)(2010-9#1)
the heating##3##2##(2008-10#3)
the heavy and light chains##2##5##(1994-11#1)(1994-5#1)
the heavy chain of##4##4##(1990-5#1)(1994-5#2)(1995-2#1)
the heavy chain##8##3##(1990-5#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-2#1)(1997-9#2)
the heavy metals##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
the heavy##18##2##(1990-5#1)(1992-12#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#3)(1995-12#1)(1995-2#1)(1997-9#2)(2008-10#4)(2008-12#1)
the height of the##2##4##(2008-10#2)
the height of##3##3##(2008-10#2)(2009-5#1)
the height##7##2##(2008-10#3)(2008-3#2)(2008-9#1)(2009-5#1)
the heightened##2##2##(1991-3#1)(2008-7#1)
the helical##6##2##(1995-6#2)(1997-3#1)(1997-7#1)(2008-10#2)
the helicase##2##2##(1995-6#1)(2008-11#1)
the helix##6##2##(1994-5#4)(2008-2#1)(2010-7#1)
the help of a##4##4##(2008-10#3)(2012-3#1)
the help of the##2##4##(1993-1#1)(2008-1#1)
the help of##16##3##(1993-1#1)(1993-8#1)(1994-3#1)(1996-3#1)(1997-6#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-8#2)(2012-3#2)
the help##17##2##(1993-1#1)(1993-8#1)(1994-3#1)(1995-1#1)(1996-3#1)(1997-6#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-8#2)(2012-3#2)
the helper strategy##2##3##(2008-10#2)
the helper virus##4##3##(2008-10#4)
the helper##10##2##(2008-10#9)(2008-4#1)
the hematopoietic growth##2##3##(2008-11#1)(2008-7#1)
the hematopoietic##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
the heme group and##2##4##(1994-5#1)(2010-4#1)
the heme group##3##3##(1994-5#2)(2010-4#1)
the heme##12##2##(1990-8#1)(1991-9#1)(1993-8#2)(1994-5#6)(2010-4#1)(2011-1#1)
the hemin##2##2##(1994-5#2)
the hemodialysis##2##2##(2008-1#1)(2008-10#1)
the hemodynamic##3##2##(2008-7#1)(2009-1#1)(2010-12#1)
the hemodynamics of##2##3##(2008-12#1)(2013-1#1)
the hemodynamics##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
the hemoglobin##3##2##(1990-8#1)(1993-8#1)(2012-12#1)
the hemolymph of##3##3##(1990-5#1)(2008-10#2)
the hemolymph##18##2##(1990-5#1)(2008-10#8)(2008-6#5)(2008-7#3)(2012-2#1)
the hemorrhage##2##2##(2008-12#1)(2012-3#1)
the hemorrhagic##3##2##(2008-7#1)(2010-6#1)(2012-3#1)
the heparin##2##2##(1992-3#1)(2010-3#1)
the hepatic arterial##2##3##(2013-1#2)
the hepatic endoderm##3##3##(2008-6#3)
the hepatic##18##2##(1992-3#1)(1993-2#1)(1994-8#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-6#5)(2008-8#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#3)
the hepatitis C virus##3##4##(1997-7#1)(2008-10#1)(2009-7#1)
the hepatitis C##4##3##(1994-11#1)(1997-7#1)(2008-10#1)(2009-7#1)
the hepatitis##7##2##(1994-11#2)(1996-12#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-7#1)
the hepatocellular##3##2##(1990-2#1)(1992-3#2)
the hepatocyte##12##2##(1995-11#1)(1996-11#1)(2008-11#6)(2008-7#1)(2008-9#3)
the hepatocytes with##2##3##(1993-3#1)(1996-2#1)
the hepatocytes##5##2##(1993-3#1)(1993-8#1)(1995-2#1)(1996-2#1)(2008-11#1)
the hepatoma cells##2##3##(2008-11#2)
the hepatoma##5##2##(1992-8#1)(2008-11#4)
the hepatopancreas##4##2##(2008-6#2)(2008-7#2)
the hepatoprotective##2##2##(2008-11#1)(2013-1#1)
the heptapeptide##2##2##(1994-2#2)
the herbicide 2##3##3##(2008-10#3)
the herbicide##18##2##(2008-10#17)(2010-1#1)
the herbicides##6##2##(2008-10#3)(2008-11#2)(2008-7#1)
the herd and##2##3##(1996-12#2)
the heritability of##3##3##(2008-2#1)(2008-8#2)
the heritability##4##2##(2008-10#1)(2008-2#1)(2008-8#2)
the hermaphroditic##3##2##(2008-9#1)(2010-5#1)(2011-2#1)
the hernia##2##2##(2009-8#1)(2012-12#1)
the heterochromatic##2##2##(2009-10#2)
the heterocyclic##3##2##(1992-6#1)(2008-10#1)(2012-2#1)
the heterodimer##3##2##(1993-9#1)(1995-8#1)(2008-9#1)
the heterodimeric##5##2##(1993-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
the heteroduplexes obtained##2##3##(2008-10#2)
the heterogeneity of the test samples##2##6##(2008-10#2)
the heterogeneity of the test##3##5##(2008-10#3)
the heterogeneity of the##5##4##(2008-10#3)(2011-2#1)(2012-2#1)
the heterogeneity of##11##3##(1997-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
the heterogeneity##18##2##(1994-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-3#1)
the heterogeneous electron transfer##3##4##(2008-10#3)
the heterogeneous populations##2##3##(2008-10#1)(2010-10#1)
the heterogeneous##15##2##(1993-3#1)(1996-6#1)(2006-6#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-3#1)
the heterogenous##2##2##(2008-10#1)(2008-11#1)
the heterologous CP coding region##2##5##(2008-10#2)
the heterologous expression of##2##4##(2008-10#1)(2009-9#1)
the heterologous##16##2##(1990-8#1)(1993-8#1)(2008-10#10)(2008-11#3)(2009-9#1)
the heterologously expressed reductase##2##4##(1996-3#2)
the heterozygote##2##2##(1997-8#1)(2008-10#1)
the hexagonal column##7##3##(2008-3#7)
the hexagonal##8##2##(2008-3#8)
the hexapeptide##3##2##(2008-4#1)(2008-5#2)
the hidden Markov model (HMM)##2##5##(1996-12#1)(1997-2#1)
the hidden Markov model##4##4##(1996-12#2)(1997-2#2)
the hidden and##5##3##(2008-10#5)
the hidden image##2##3##(2008-3#2)
the hidden layer and the output layer##3##7##(2010-8#3)
the hidden layer and the##4##5##(2008-10#1)(2010-8#3)
the hidden layer and##5##4##(2008-10#1)(2010-8#4)
the hidden layer##7##3##(2008-10#3)(2010-8#4)
the hidden##20##2##(1993-2#1)(1996-12#2)(1997-2#2)(2008-10#9)(2008-3#2)(2010-8#4)
the hierarchical##4##2##(1992-5#2)(2008-10#1)(2008-11#1)
the hierarchy of selenoprotein expression##2##5##(2012-2#2)
the hierarchy of##3##3##(2008-11#1)(2012-2#2)
the hierarchy##4##2##(2008-11#1)(2008-12#1)(2012-2#2)
the high accuracy of the##2##5##(2008-10#2)
the high affinity of##2##4##(2008-9#1)(2010-1#1)
the high affinity##9##3##(1990-12#1)(1994-11#1)(1995-11#1)(1997-4#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)
the high and low energy electronic states of DSKNPH##2##9##(2008-10#2)
the high and low##4##4##(1995-11#1)(2008-10#2)(2010-1#1)
the high concentration groups##2##4##(2008-9#2)
the high concentration of##3##4##(2008-10#2)(2008-3#1)
the high concentration##5##3##(2008-10#2)(2008-3#1)(2008-9#2)
the high content of##2##4##(2008-10#2)
the high cost##2##3##(2008-10#1)(2008-11#1)
the high dissociation##2##3##(2008-10#2)
the high dose of##2##4##(2008-10#1)(2008-7#1)
the high dose##4##3##(1995-11#1)(2008-10#1)(2008-7#1)(2010-1#1)
the high elevations##3##3##(2008-10#3)
the high energy##2##3##(2008-10#1)(2013-8#1)
the high expression of##2##4##(1996-12#1)(2009-9#1)
the high frequency of##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
the high frequency##4##3##(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
the high genetic##2##3##(2008-10#1)(2013-8#1)
the high incidence of##2##4##(1992-2#1)(1993-3#1)
the high level expression##2##4##(2008-8#2)
the high level of##4##4##(1997-7#1)(2008-10#2)(2008-8#1)
the high level##7##3##(1997-7#1)(2008-10#2)(2008-8#3)(2012-2#1)
the high levels of##5##4##(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
the high molecular weight##2##4##(1992-10#1)(2008-10#1)
the high mortality rate##2##4##(1993-6#1)(2011-2#1)
the high number of##3##4##(1993-6#1)(2008-10#1)(2008-7#1)
the high pH##2##3##(2008-10#2)
the high pressure##2##3##(1996-5#1)(2008-7#1)
the high quality##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
the high rate of##3##4##(2008-10#1)(2009-3#1)(2009-5#1)
the high resolution##2##3##(1997-7#1)(2008-7#1)
the high risk##4##3##(1991-6#1)(2009-8#1)(2011-1#1)(2012-3#1)
the high salt##2##3##(2008-10#2)
the high school##2##3##(1990-3#1)(2008-12#1)
the high selectivity of the##3##5##(2008-10#3)
the high selectivity of##6##4##(2008-10#5)(2010-7#1)
the high sensitivity of the##2##5##(2008-10#1)(2008-2#1)
the high sensitivity of##6##4##(2008-10#3)(2008-2#1)(2010-5#1)(2013-8#1)
the high sensitivity##9##3##(2008-10#5)(2008-2#1)(2009-5#1)(2010-5#1)(2013-8#1)
the high speed##2##3##(1997-6#1)(2008-10#1)
the high##191##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-8#1)(1995-11#3)(1995-12#2)(1996-12#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#2)(2008-10#68)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#6)(2008-7#7)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#3)(2010-11#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#4)(2012-4#1)(2012-9#1)(2013-1#5)(2013-8#4)
the high-CHO diet##2##3##(2013-8#2)
the high-affinity##9##2##(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#1)(1996-12#1)(2009-6#2)(2009-7#1)
the high-dispersal##2##2##(2013-1#2)
the high-frequency##3##2##(1992-9#1)(2008-11#1)(2008-2#1)
the high-level expression of##2##4##(2008-9#2)
the high-level##6##2##(2008-10#1)(2008-8#1)(2008-9#2)(2010-7#1)(2013-8#1)
the high-performance liquid##3##3##(1997-2#1)(2008-10#2)
the high-profile##2##2##(2009-6#1)(2011-2#1)
the high-resolution##2##2##(1994-3#1)(2008-3#1)
the high-risk##2##2##(1991-6#1)(2011-2#1)
the high-temperature##3##2##(2008-10#2)(2008-4#1)
the higher concentration##2##3##(1993-8#1)(2008-10#1)
the higher dose##2##3##(1994-2#1)(1997-4#1)
the higher education sector##2##4##(2008-11#1)(2008-12#1)
the higher levels##2##3##(1996-12#1)(2008-10#1)
the higher number of##2##4##(2008-10#1)(2012-3#1)
the higher rate of##2##4##(2008-10#2)
the higher risk of##2##4##(1993-3#1)(2011-2#1)
the higher sensitivity of##2##4##(2008-10#2)
the higher sensitivity##3##3##(2008-10#2)(2008-11#1)
the higher sun radiation##2##4##(2011-2#2)
the higher the resistance##2##4##(2008-10#2)
the higher the##7##3##(1993-11#1)(1993-8#1)(1996-1#1)(2008-10#3)(2008-5#1)
the higher##81##2##(1990-12#1)(1990-5#2)(1990-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#2)(1996-1#1)(1996-12#1)(1997-4#1)(2008-10#37)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#2)
the higher-order##2##2##(2008-11#1)(2008-3#1)
the highest EFs for##2##4##(2008-10#2)
the highest GUS activity of##2##5##(2008-9#2)
the highest YAP+##2##3##(2008-9#2)
the highest activity##2##3##(2009-6#1)(2013-1#1)
the highest affinity for##2##4##(2008-10#1)(2008-5#1)
the highest affinity##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
the highest amount of##2##4##(2008-5#1)(2013-1#1)
the highest and lowest##4##4##(2008-10#2)(2008-7#1)(2012-3#1)
the highest and##5##3##(2008-10#3)(2008-7#1)(2012-3#1)
the highest antioxidant##2##3##(2008-5#1)(2013-8#1)
the highest concentration of##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
the highest concentration##7##3##(2008-10#3)(2008-5#2)(2008-9#1)(2013-1#1)
the highest concentrations##2##3##(1997-1#1)(2008-12#1)
the highest correlation##3##3##(2008-10#3)
the highest current signals##2##4##(2008-10#2)
the highest degree of##3##4##(2008-10#2)(2008-8#1)
the highest disease severity##2##4##(2008-10#2)
the highest disease##5##3##(2008-10#5)
the highest dose to##2##4##(2009-2#2)
the highest dose##6##3##(1993-6#1)(2008-10#1)(2008-5#1)(2009-2#2)(2013-8#1)
the highest expression##3##3##(2008-9#2)(2012-2#1)
the highest homology##2##3##(2008-10#1)(2008-8#1)
the highest in the world##2##5##(2008-12#1)(2010-10#1)
the highest in the##4##4##(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)
the highest in##11##3##(2008-10#3)(2008-11#2)(2008-12#2)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
the highest incidence in##2##4##(1991-11#1)(1994-9#1)
the highest incidence of##3##4##(1990-3#1)(1994-9#1)(2008-10#1)
the highest incidence##5##3##(1990-3#1)(1991-11#1)(1994-9#2)(2008-10#1)
the highest level of virulence##2##5##(2008-10#2)
the highest level of##8##4##(2008-10#4)(2008-12#1)(2008-8#2)(2010-3#1)
the highest level##11##3##(1993-3#1)(2008-10#6)(2008-12#1)(2008-8#2)(2010-3#1)
the highest levels of disease##2##5##(2008-10#2)
the highest levels of##10##4##(1993-6#1)(1993-8#1)(1995-12#1)(2008-10#7)
the highest levels##14##3##(1993-6#1)(1993-8#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
the highest lipase##2##3##(2008-10#1)(2012-2#1)
the highest number##2##3##(2008-10#1)(2011-1#1)
the highest percentage of##2##4##(1996-12#1)(2008-10#1)
the highest percentage##5##3##(1996-12#1)(2008-10#2)(2012-7#1)(2013-1#1)
the highest percentages##2##3##(2008-10#1)(2010-6#1)
the highest power##2##3##(2008-10#1)(2008-12#1)
the highest proportion##2##3##(2013-8#2)
the highest quality##2##3##(1991-12#1)(2011-1#1)
the highest rate of##4##4##(1997-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
the highest rate##6##3##(1997-8#1)(2006-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
the highest rates##2##3##(1990-8#1)(2008-11#1)
the highest ratio##2##3##(1993-6#1)(2008-10#1)
the highest ration##2##3##(2010-8#2)
the highest released amount##2##4##(2008-5#2)
the highest reported##2##3##(2008-11#2)
the highest risk of##2##4##(1996-6#1)(2013-1#1)
the highest risk##6##3##(1991-6#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
the highest selectivity##2##3##(2008-10#2)
the highest sensitivity##5##3##(2008-10#3)(2008-11#1)(2012-2#1)
the highest specific##3##3##(1992-6#1)(1995-6#1)(2008-10#1)
the highest stability##2##3##(2008-10#1)(2012-2#1)
the highest total##2##3##(2008-9#1)(2011-2#1)
the highest value##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
the highest values of##2##4##(2008-10#2)
the highest values##3##3##(2008-10#2)(2011-2#1)
the highest##294##2##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#3)(2006-6#1)(2008-1#2)(2008-10#110)(2008-11#14)(2008-12#14)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#14)(2008-7#3)(2008-8#8)(2008-9#13)(2009-2#2)(2009-6#3)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#4)(2011-2#9)(2012-12#3)(2012-2#6)(2012-3#5)(2012-7#1)(2013-1#16)(2013-8#9)
the highly aggressive##2##3##(2008-10#1)(2013-1#1)
the highly chlorinated##2##3##(1993-12#2)
the highly conserved##5##3##(1991-9#1)(1994-12#1)(1994-5#1)(1997-3#1)(2008-8#1)
the highly controversial issue##2##4##(1994-1#2)
the highly reactive##2##3##(2008-11#2)
the highly selective##4##3##(1996-2#1)(1996-5#1)(2008-10#2)
the highly sensitive##4##3##(1995-8#1)(2008-10#2)(2010-12#1)
the highly susceptible cv##2##4##(2008-10#2)
the highly susceptible##6##3##(1995-2#1)(2008-10#5)
the highly variable##2##3##(2011-2#2)
the highly virulent##3##3##(2008-10#2)(2009-6#1)
the highly##58##2##(1991-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#20)(2008-11#6)(2008-4#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-12#2)(2011-2#2)(2012-2#2)(2013-1#3)
the hind leg muscle of##2##5##(1995-2#1)(2008-9#1)
the hindgut##2##2##(2007-12#1)(2008-10#1)
the hindlimbs##2##2##(1992-12#1)(1996-6#1)
the hinge region##2##3##(1995-6#1)(1997-2#1)
the hip##15##2##(1991-11#1)(1995-5#1)(1997-6#2)(2008-11#1)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#3)(2013-1#2)(2013-7#2)
the hippocampal CA1##4##3##(1991-10#1)(2008-11#3)
the hippocampal CA3##2##3##(1995-8#1)(2008-11#1)
the hippocampal##14##2##(1990-11#2)(1991-10#1)(1994-2#1)(1995-3#1)(1995-8#1)(2008-11#4)(2008-4#1)(2008-7#1)(2010-12#1)(2013-8#1)
the hippocampus and##7##3##(1993-6#2)(1996-11#1)(1996-12#1)(1997-2#1)(2008-11#1)(2012-3#1)
the hippocampus in##3##3##(1996-12#1)(2008-7#1)(2013-8#1)
the hippocampus or parahippocampus##2##4##(1990-11#2)
the hippocampus to##2##3##(2008-11#1)(2008-12#1)
the hippocampus##56##2##(1990-11#2)(1991-10#2)(1991-12#1)(1992-10#1)(1993-12#1)(1993-6#6)(1994-2#1)(1996-11#1)(1996-12#9)(1997-2#3)(1997-3#2)(2008-11#13)(2008-12#1)(2008-7#5)(2012-3#1)(2013-8#7)
the histamine##3##2##(1995-12#1)(1997-1#1)(2008-10#1)
the histidine##3##2##(1994-5#1)(1996-8#1)(2008-10#1)
the histograms##2##2##(2008-10#1)(2008-6#1)
the histologic##7##2##(1990-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(2008-7#1)(2010-6#1)(2011-2#1)
the histological and##2##3##(2009-7#1)(2010-9#1)
the histological diagnosis##4##3##(2008-10#1)(2011-1#1)(2011-7#1)(2013-1#1)
the histological examination of the##2##5##(2010-12#1)(2010-6#1)
the histological examination##3##3##(1992-5#1)(2010-12#1)(2010-6#1)
the histological findings##2##3##(1995-11#1)(2009-7#1)
the histological##20##2##(1992-5#1)(1993-11#1)(1995-11#2)(2008-10#5)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-3#1)(2011-7#1)(2013-1#1)
the histology of the##2##4##(1994-1#1)(2009-1#1)
the histology of##3##3##(1994-1#1)(2008-10#1)(2009-1#1)
the histology##5##2##(1994-1#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-12#1)
the histopathologic##2##2##(2013-1#1)(2013-8#1)
the histopathological examination##2##3##(2011-2#1)(2012-12#1)
the histopathological##8##2##(1997-8#2)(2008-5#1)(2011-2#4)(2012-12#1)
the historic##5##2##(1991-12#1)(1995-12#1)(2008-10#1)(2011-2#2)
the historical background##2##3##(1994-6#1)(2008-9#1)
the historical development of##2##4##(1996-3#1)(2013-1#1)
the historical evolution of##2##4##(2008-10#2)
the historical##17##2##(1992-12#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#2)
the history and##3##3##(1997-3#1)(2008-5#1)(2010-1#1)
the history of American##2##4##(1994-12#1)(2012-3#1)
the history of medical##2##4##(2010-1#2)
the history of medicine##3##4##(1993-11#1)(1993-6#1)(2008-9#1)
the history of the##11##4##(1990-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-1#1)(2012-2#1)(2012-5#1)
the history of##35##3##(1990-11#1)(1991-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#4)(2008-8#2)(2008-9#1)(2010-1#3)(2010-6#1)(2010-7#1)(2010-8#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)
the history##45##2##(1990-11#1)(1991-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#5)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-1#4)(2010-6#1)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#2)
the histotype of metastatic cells##2##5##(1990-2#2)
the histotype of##3##3##(1990-2#3)
the hitherto##3##2##(2008-10#1)(2009-9#1)(2010-10#1)
the holding coil to##2##4##(2008-10#2)
the holding coil##5##3##(2008-10#5)
the holding##7##2##(2007-11#1)(2008-10#6)
the hollow##2##2##(2008-11#2)
the holoenzyme##3##2##(1992-6#1)(1994-3#1)(2008-11#1)
the holoprotein##2##2##(1993-8#2)
the home and##6##3##(1991-1#1)(1993-1#1)(2007-12#1)(2009-5#2)(2013-8#1)
the home health##2##3##(1995-3#2)
the home is##3##3##(1991-1#1)(2007-12#2)
the home modalities##3##3##(1995-12#3)
the home##36##2##(1990-11#1)(1990-8#1)(1991-1#4)(1991-8#2)(1992-2#2)(1993-1#1)(1994-12#1)(1995-12#3)(1995-2#1)(1995-3#3)(2007-12#8)(2008-11#1)(2009-10#1)(2009-11#1)(2009-5#2)(2011-2#3)(2013-8#1)
the home-made##2##2##(2008-10#2)
the homebound##3##2##(1995-2#1)(1996-3#1)(1997-2#1)
the homeless##2##2##(2013-8#2)
the homeostasis of##4##3##(1992-5#1)(2009-10#1)(2012-2#1)(2013-8#1)
the homeostasis##5##2##(1992-5#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
the homo- and heteromeric##2##4##(1995-11#2)
the homogeneity of the##2##4##(2008-10#2)
the homogeneity of##5##3##(2008-10#5)
the homogeneous##2##2##(2008-10#2)
the homogenous##2##2##(1994-8#1)(2008-10#1)
the homologous antigen##2##3##(2008-10#1)(2008-5#1)
the homologous##14##2##(1990-4#1)(1992-1#1)(1992-4#1)(1995-9#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-2#1)
the homology of the##2##4##(2008-9#2)
the homology##4##2##(2008-9#3)(2009-10#1)
the homozygous deletion##2##3##(1996-12#2)
the homozygous##4##2##(1996-12#2)(2008-10#1)(2008-6#1)
the honey##5##2##(2008-10#3)(2008-6#1)(2013-1#1)
the honeybee##6##2##(1994-8#2)(2008-7#2)(2008-8#2)
the hope of##3##3##(1996-3#1)(2010-12#1)(2013-8#1)
the hope##4##2##(1996-3#1)(2008-11#1)(2010-12#1)(2013-8#1)
the hopes of##2##3##(1992-2#1)(2011-2#1)
the horizon of##3##3##(2008-12#1)(2010-8#1)(2012-2#1)
the horizon##4##2##(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
the horizontal distance between##2##4##(2008-3#1)(2008-5#1)
the horizontal##18##2##(1993-1#2)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#6)(2008-5#2)(2008-9#2)(2009-6#1)
the hormetic##3##2##(2008-7#3)
the hormonal effects##2##3##(1991-3#1)(2008-11#1)
the hormonal##9##2##(1990-2#1)(1991-3#1)(1993-3#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-7#1)(2012-12#1)
the hormone in##3##3##(1990-2#1)(1993-6#1)(2010-5#1)
the hormone##15##2##(1990-2#1)(1991-3#1)(1993-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#1)(2013-8#1)
the hormone-dependent##2##2##(1993-1#1)(1993-8#1)
the hormones##3##2##(1995-11#1)(2008-10#1)(2009-8#1)
the horse##3##2##(1997-4#1)(2008-10#1)(2010-4#1)
the hospital and the##3##4##(1991-1#1)(2008-10#1)(2011-2#1)
the hospital and##8##3##(1991-1#1)(1992-2#1)(1995-6#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#2)
the hospital as##2##3##(1994-3#1)(1996-3#1)
the hospital environment##4##3##(1992-3#1)(1996-1#1)(2010-11#1)(2013-8#1)
the hospital in good##2##4##(1993-6#1)(2010-12#1)
the hospital in##4##3##(1991-12#1)(1993-6#1)(2008-12#1)(2010-12#1)
the hospital industry##4##3##(1994-12#1)(1995-12#1)(2008-11#2)
the hospital is##2##3##(1993-12#1)(2008-11#1)
the hospital laboratory##2##3##(1997-1#1)(2008-10#1)
the hospital setting##4##3##(1991-1#1)(1991-12#1)(2008-11#1)(2010-9#1)
the hospital to##4##3##(1995-1#1)(1995-12#1)(1996-5#1)(2009-4#1)
the hospital with##4##3##(1996-5#1)(2008-12#1)(2012-12#1)(2013-1#1)
the hospital##134##2##(1990-3#1)(1990-9#2)(1991-1#4)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#5)(1992-3#4)(1992-5#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#3)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#4)(1995-6#1)(1996-1#1)(1996-3#3)(1996-5#4)(1997-1#1)(1997-2#2)(1997-4#2)(1997-8#1)(2007-9#1)(2008-10#3)(2008-11#9)(2008-12#2)(2008-3#2)(2008-7#3)(2009-10#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
the hospital's##8##2##(1991-1#1)(1991-12#1)(1991-2#1)(1993-12#2)(1994-2#1)(1996-3#1)(2011-2#1)
the hospitalization##5##2##(1993-3#1)(1995-1#1)(1995-3#1)(2008-10#1)(2011-2#1)
the hospitalizations##2##2##(1995-12#1)(1996-3#1)
the hospitalized##2##2##(1994-12#1)(2012-2#1)
the hospitals##8##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-3#1)(1995-1#1)(1997-8#1)
the host and the##2##4##(2008-10#1)(2008-8#1)
the host and##6##3##(2008-10#4)(2008-8#1)(2011-2#1)
the host animal##2##3##(2008-11#1)(2008-4#1)
the host at##2##3##(2008-10#1)(2013-1#1)
the host by##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
the host cell wall##6##4##(2008-10#5)(2010-3#1)
the host cell##19##3##(2008-10#6)(2008-11#6)(2008-9#2)(2009-6#2)(2010-1#1)(2010-3#1)(2011-2#1)
the host cells##2##3##(1994-6#1)(2008-10#1)
the host crop##3##3##(2008-10#3)
the host cytoplasm##3##3##(1996-12#2)(2008-10#1)
the host defense##3##3##(1992-10#1)(2008-9#1)(2013-1#1)
the host from##3##3##(2008-10#2)(2008-8#1)
the host genome##2##3##(1993-6#2)
the host in##3##3##(2008-10#2)(2011-2#1)
the host infection process##4##4##(2010-10#4)
the host is##4##3##(1996-3#1)(2008-10#2)(2008-9#1)
the host of origin##4##4##(2008-10#3)(2008-9#1)
the host of##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
the host or##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
the host phytoalexin response##2##4##(2008-10#2)
the host plant##14##3##(2007-12#1)(2008-10#11)(2008-8#1)(2011-2#1)
the host population##11##3##(1994-2#1)(2008-10#4)(2008-8#2)(2008-9#2)(2011-2#2)
the host range expanded##2##4##(2008-11#2)
the host range##6##3##(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)
the host response to##2##4##(1990-2#1)(2008-10#1)
the host response##3##3##(1990-2#1)(2008-10#1)(2011-2#1)
the host shift##3##3##(2008-8#3)
the host species##6##3##(2008-10#2)(2008-8#4)
the host surface##2##3##(2008-10#2)
the host tissues##4##3##(2008-10#4)
the host to##2##3##(2008-10#2)
the host wall##2##3##(2008-10#2)
the host was##2##3##(2008-10#2)
the host##226##2##(1990-2#1)(1992-10#1)(1993-11#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-6#3)(1995-2#1)(1996-12#2)(1996-3#2)(2007-12#1)(2008-10#111)(2008-11#11)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#24)(2008-9#12)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#4)(2010-1#2)(2010-10#6)(2010-3#1)(2011-2#17)(2012-2#1)(2013-1#7)(2013-8#2)
the host's immune##2##3##(2008-5#1)(2013-7#1)
the host's##5##2##(2006-6#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-7#1)
the host)##2##2##(2008-8#1)(2011-2#1)
the host-free period##3##3##(2008-10#3)
the host-guest##2##2##(2008-10#1)(2010-4#1)
the host-parasite relationship##2##3##(1997-7#1)(2008-10#1)
the host-parasite##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
the host-pathogen##2##2##(2008-10#1)(2010-8#1)
the host-selective##2##2##(2008-10#2)
the hostage group##2##3##(2008-1#2)
the hosts and##2##3##(2008-10#1)(2012-3#1)
the hosts##5##2##(2008-10#3)(2011-2#1)(2012-3#1)
the hosts'##3##2##(1996-12#1)(2008-10#2)
the hot plate test##3##4##(1992-3#1)(1996-2#2)
the hot##9##2##(1992-3#1)(1996-2#2)(2008-10#3)(2008-8#1)(2009-5#1)(2011-2#1)
the hour##2##2##(1993-6#1)(2008-10#1)
the hourly##2##2##(2008-10#2)
the hours##2##2##(2010-6#1)(2013-8#1)
the household##4##2##(1991-12#1)(1994-6#1)(2010-5#1)(2011-2#1)
the hph##2##2##(2008-10#2)
the hprt locus##2##3##(1997-3#2)
the hprt##3##2##(1997-3#3)
the huge##3##2##(2008-10#1)(2010-3#1)(2011-2#1)
the human LDL##2##3##(1992-5#1)(2008-10#1)
the human LPL##2##3##(1995-6#1)(2008-11#1)
the human MNS##2##3##(2008-11#2)
the human THP-1 cell##2##4##(1993-6#2)
the human X##2##3##(2008-7#1)(2010-5#1)
the human alpha##2##3##(1995-11#2)
the human and##4##3##(1997-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
the human body and##2##4##(2008-10#1)(2012-3#1)
the human body##9##3##(2008-10#3)(2008-11#1)(2008-5#1)(2009-12#1)(2012-3#1)(2013-1#2)
the human brain##9##3##(1992-3#1)(1992-6#2)(1994-2#1)(1995-12#1)(1997-2#1)(2008-11#1)(2009-5#1)(2010-7#1)
the human chromosome##3##3##(1996-8#1)(1997-8#1)(2009-9#1)
the human embryonic##3##3##(2008-11#3)
the human enzyme and##2##4##(1994-8#2)
the human enzyme##3##3##(1994-8#3)
the human erythrocyte membrane##3##4##(1990-12#1)(2008-11#2)
the human eye##2##3##(2011-7#1)(2013-8#1)
the human ferredoxin gene##2##4##(1991-5#2)
the human gastrointestinal tract##2##4##(2010-10#1)(2012-2#1)
the human gene##5##3##(1991-6#1)(1991-7#1)(1993-3#1)(1997-7#1)(2008-6#1)
the human genome project##2##4##(1995-8#1)(2008-11#1)
the human genome##14##3##(1991-6#1)(1992-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-11#2)(2008-4#4)(2008-5#2)(2011-2#1)
the human glucocorticoid receptor##3##4##(1990-11#1)(1995-2#2)
the human health##3##3##(2008-10#2)(2013-1#1)
the human homologue of##2##4##(1997-3#1)(1997-7#1)
the human host##2##3##(2011-2#1)(2013-1#1)
the human hsp27##3##3##(1993-6#3)
the human immune system##3##4##(2008-10#2)(2011-2#1)
the human immunodeficiency virus (HIV)##5##5##(1991-2#1)(1993-12#1)(1993-8#1)(1996-11#1)(2008-5#1)
the human immunodeficiency virus##7##4##(1991-2#1)(1993-12#1)(1993-8#2)(1996-11#1)(1997-7#1)(2008-5#1)
the human immunodeficiency##8##3##(1991-2#1)(1993-12#1)(1993-8#2)(1996-11#1)(1996-6#1)(1997-7#1)(2008-5#1)
the human interleukin-1##2##3##(1993-8#1)(2008-5#1)
the human lifespan##2##3##(2012-2#2)
the human likeness of##2##4##(2008-11#2)
the human lysosomal##2##3##(1993-8#1)(1994-11#1)
the human pathogen##2##3##(1992-8#1)(2011-2#1)
the human platelet and##2##4##(1992-8#1)(2008-11#1)
the human platelet##4##3##(1992-8#1)(2006-6#2)(2008-11#1)
the human respiratory tract##5##4##(1995-12#1)(1997-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
the human serum##4##3##(1993-3#1)(2008-10#2)(2008-5#1)
the human services##3##3##(1992-1#1)(2008-11#2)
the human skin##5##3##(2008-5#4)(2011-2#1)
the human spermidine/spermine N1-acetyltransferase##2##4##(1991-9#1)(1992-10#1)
the human thyrotropin receptor##2##4##(1991-5#1)(1995-12#1)
the human thyrotropin##3##3##(1991-5#2)(1995-12#1)
the human##332##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#6)(1991-7#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#7)(1993-6#8)(1993-8#6)(1994-11#4)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#6)(1995-11#5)(1995-12#7)(1995-2#7)(1995-6#5)(1995-8#4)(1996-11#1)(1996-12#8)(1996-2#3)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#9)(1997-8#2)(1997-9#5)(2006-6#3)(2008-10#16)(2008-11#43)(2008-12#2)(2008-4#7)(2008-5#15)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#3)(2009-12#2)(2009-5#1)(2009-7#6)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#15)(2011-3#3)(2011-7#1)(2012-2#5)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#1)
the humanities in the education of health professionals##2##8##(2008-11#2)
the humanities##4##2##(2008-11#4)
the humic##4##2##(2008-10#4)
the humid##2##2##(2008-10#1)(2010-7#1)
the humidity##3##2##(2008-10#3)
the humoral immune response##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
the humoral immune##5##3##(1996-9#1)(2008-10#1)(2008-11#2)(2011-2#1)
the humoral##7##2##(1991-12#1)(1996-9#1)(2008-10#2)(2008-11#2)(2011-2#1)
the hurdles that##2##3##(1994-2#1)(2008-4#1)
the hybrid##24##2##(1993-9#1)(2008-10#9)(2008-11#1)(2008-3#5)(2008-8#4)(2008-9#2)(2012-3#2)
the hybridization event##3##3##(2008-10#3)
the hybridization of the##2##4##(2008-10#1)(2008-7#1)
the hybridization of##4##3##(2008-10#3)(2008-7#1)
the hybridization##15##2##(2008-10#12)(2008-4#1)(2008-6#1)(2008-7#1)
the hybridoma cell##3##3##(2008-10#1)(2008-11#2)
the hybridoma##8##2##(2008-10#1)(2008-11#7)
the hybridomas##2##2##(2008-11#2)
the hybrids and##2##3##(2008-10#1)(2008-11#1)
the hybrids##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2009-10#1)(2010-4#1)
the hydration level##2##3##(2008-5#2)
the hydration process##5##3##(2008-10#5)
the hydration##10##2##(2008-10#7)(2008-5#2)(2008-7#1)
the hydraulic##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
the hydride generation##4##3##(2008-10#4)
the hydride##8##2##(2008-10#8)
the hydrocarbon##5##2##(1992-9#1)(2008-10#2)(2013-1#2)
the hydrogel##4##2##(2008-5#2)(2009-12#1)(2009-7#1)
the hydrogen bond donating ability of##2##6##(2008-10#2)
the hydrogen bond##4##3##(2008-10#2)(2010-7#2)
the hydrogen ion concentration##2##4##(2008-10#2)
the hydrogen peroxide generated##2##4##(2008-10#2)
the hydrogen peroxide##3##3##(2008-10#2)(2011-2#1)
the hydrogen##18##2##(1992-12#1)(2008-10#12)(2010-12#1)(2010-7#3)(2011-2#1)
the hydrogen-bonding##2##2##(1991-3#1)(2012-2#1)
the hydrolysis and##3##3##(1997-1#1)(2008-10#2)
the hydrolysis of Reactive Red##2##5##(2008-10#2)
the hydrolysis of the##3##4##(1994-5#2)(2008-10#1)
the hydrolysis of##25##3##(1991-5#1)(1992-3#1)(1993-8#3)(1994-5#7)(2008-10#6)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#2)(2013-1#1)
the hydrolysis process##3##3##(2008-10#2)(2008-11#1)
the hydrolysis rate##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
the hydrolysis##38##2##(1991-5#1)(1992-3#1)(1993-8#3)(1994-5#7)(1997-1#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#1)(2011-2#2)(2013-1#1)
the hydrolytic##3##2##(1995-2#1)(2008-10#1)(2008-12#1)
the hydrophilic##4##2##(1992-3#1)(2008-10#2)(2008-5#1)
the hydrophobic cavity of##2##4##(2008-10#2)
the hydrophobic core##3##3##(1991-5#1)(1991-6#1)(1994-5#1)
the hydrophobic interaction##2##3##(2008-10#2)
the hydrophobic##19##2##(1991-10#1)(1991-5#1)(1991-6#1)(1994-5#1)(1994-8#1)(2008-10#13)(2008-11#1)
the hydrophobicity of the##4##4##(2008-10#2)(2008-6#1)(2008-7#1)
the hydrophobicity##6##2##(2008-10#4)(2008-6#1)(2008-7#1)
the hydroquinone##3##2##(2008-10#2)(2008-6#1)
the hydrothermal##2##2##(2008-10#1)(2009-11#1)
the hydrous##2##2##(2008-10#2)
the hydroxide##4##2##(2008-10#4)
the hydroxyapatite##2##2##(2008-7#1)(2011-2#1)
the hydroxyl radical##3##3##(2008-10#2)(2008-4#1)
the hydroxyl##8##2##(1996-5#1)(2008-10#5)(2008-4#1)(2008-8#1)
the hygromycin##3##2##(2008-10#2)(2008-11#1)
the hygroscopic effects##2##3##(2013-1#2)
the hyperbenthic##2##2##(2008-5#2)
the hyperglycemia##2##2##(1991-7#1)(2010-11#1)
the hyperglycemic##2##2##(1990-5#1)(1994-2#1)
the hyperparasite##5##2##(2008-10#1)(2008-9#4)
the hyperplastic##2##2##(2008-10#1)(2009-12#1)
the hypersensitive reaction and##2##4##(2008-10#2)
the hypersensitive reaction##7##3##(2008-10#7)
the hypersensitive response (HR)##5##4##(2008-10#5)
the hypersensitive response##7##3##(2008-10#7)
the hypersensitive##15##2##(2008-10#14)(2008-11#1)
the hypertension##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
the hyperthermophilic archaeon##2##3##(1993-9#2)
the hyperthermophilic##3##2##(1993-9#2)(2008-9#1)
the hypervariable##2##2##(2008-10#2)
the hyphae of##3##3##(2008-10#3)
the hyphae##7##2##(2008-10#6)(2008-7#1)
the hyphal##5##2##(1996-6#1)(2008-11#1)(2008-7#3)
the hypocotyl##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
the hypoglossal canal##2##3##(2011-2#2)
the hypopharyngeal gland##3##3##(2008-6#3)
the hypotensive##3##2##(1990-9#1)(1991-5#1)(1994-11#1)
the hypothalamic paraventricular nucleus##4##4##(1994-8#2)(1996-12#2)
the hypothalamic##9##2##(1994-8#4)(1995-5#1)(1996-12#2)(2009-6#1)(2012-3#1)
the hypothalamic-pituitary-adrenal (HPA) axis##2##4##(1996-12#1)(2013-1#1)
the hypothalamic-pituitary-adrenal##5##2##(1996-12#1)(1997-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
the hypothalamus and##2##3##(1996-12#1)(1997-3#1)
the hypothalamus##13##2##(1994-2#5)(1995-12#1)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#1)(2010-6#1)
the hypothermic##3##2##(1994-2#1)(1996-12#2)
the hypotheses that##6##3##(2008-10#3)(2008-7#1)(2010-6#1)(2012-3#1)
the hypotheses##9##2##(2008-10#3)(2008-7#1)(2008-9#2)(2009-11#1)(2010-6#1)(2012-3#1)
the hypothesis has##2##3##(2013-1#2)
the hypothesis of a single##2##5##(2008-10#2)
the hypothesis of a##8##4##(1991-12#1)(1991-2#1)(1991-5#1)(2008-10#4)(2013-1#1)
the hypothesis of an##2##4##(2008-10#1)(2011-2#1)
the hypothesis of random mating##2##5##(2008-10#2)
the hypothesis of##18##3##(1991-12#1)(1991-2#1)(1991-5#1)(2008-10#10)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the hypothesis that a##5##4##(1990-5#1)(1992-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
the hypothesis that an##2##4##(2008-10#1)(2008-11#1)
the hypothesis that it##2##4##(1990-3#1)(2008-10#1)
the hypothesis that occupational##2##4##(1991-12#1)(2008-10#1)
the hypothesis that the disease##2##5##(2008-10#2)
the hypothesis that the##37##4##(1990-6#1)(1991-2#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-2#2)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
the hypothesis that there is a##2##6##(1996-3#1)(2011-2#1)
the hypothesis that there is##3##5##(1996-3#1)(2008-12#1)(2011-2#1)
the hypothesis that there##4##4##(1996-3#1)(2008-12#1)(2008-5#1)(2011-2#1)
the hypothesis that##132##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-8#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#33)(2008-11#5)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#2)
the hypothesis##168##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-2#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-5#2)(1995-8#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#45)(2008-11#6)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#9)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#9)(2013-8#3)
the hypothesized##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
the hypothetical##5##2##(1994-5#1)(1996-6#1)(1997-3#1)(2008-12#1)(2008-9#1)
the hypovirulent phenotype##2##3##(2008-10#2)
the hypovirulent##6##2##(2008-10#6)
the i##4##2##(1993-11#1)(1995-11#1)(1996-2#2)
the iCFA##2##2##(1994-8#2)
the iView-GT##2##2##(2009-11#2)
the icEEG data##2##3##(2013-8#2)
the ice##4##2##(2008-10#3)(2008-3#1)
the ice-like water##2##3##(2008-5#2)
the idea of a##3##4##(2010-10#1)(2012-2#1)(2013-8#1)
the idea of##12##3##(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)(2011-2#2)(2012-2#3)(2013-8#2)
the idea that the##7##4##(1990-10#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-5#1)
the idea that##30##3##(1990-10#1)(1990-11#1)(1992-3#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#2)
the idea##47##2##(1990-10#1)(1990-11#1)(1992-3#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-8#2)
the ideal of##2##3##(2008-10#1)(2008-5#1)
the ideal##19##2##(1992-3#1)(1994-12#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2013-1#1)
the identical##5##2##(1995-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
the identification and differentiation of##2##5##(2008-10#2)
the identification and##19##3##(1991-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#2)(2013-8#1)
the identification in##2##3##(2008-10#1)(2009-8#1)
the identification of a##9##4##(1993-12#2)(2008-10#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
the identification of all##2##4##(2008-9#1)(2011-3#1)
the identification of genes##2##4##(2008-10#1)(2011-2#1)
the identification of new##2##4##(2009-6#1)(2011-2#1)
the identification of potential##2##4##(2008-10#1)(2010-12#1)
the identification of proteins##3##4##(1997-2#1)(2008-1#1)(2008-10#1)
the identification of the##19##4##(1990-2#1)(1995-11#1)(1995-9#1)(2008-10#10)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
the identification of this##2##4##(1996-12#1)(2009-10#1)
the identification of two new##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
the identification of two##8##4##(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
the identification of##127##3##(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-9#2)(1993-12#3)(1993-6#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-12#1)(1997-1#2)(1997-2#3)(2007-11#1)(2008-1#1)(2008-10#43)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#3)(2009-4#1)(2009-6#3)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#3)
the identification##151##2##(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#2)(1991-9#1)(1992-12#1)(1992-9#2)(1993-12#3)(1993-3#1)(1993-6#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-12#1)(1997-1#2)(1997-2#3)(2007-11#1)(2008-1#2)(2008-10#55)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#3)(2009-4#1)(2009-6#3)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#4)
the identified##12##2##(1991-8#1)(1993-6#1)(2008-10#3)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)
the identities##2##2##(2008-8#1)(2011-2#1)
the identity and diversity of##2##5##(2008-10#1)(2012-2#1)
the identity and##6##3##(1991-2#1)(2008-10#3)(2012-2#2)
the identity of the upcoming tastant##2##6##(2008-11#2)
the identity of the##9##4##(1992-9#1)(2008-10#3)(2008-11#2)(2008-8#1)(2010-3#1)(2013-8#1)
the identity of##14##3##(1992-4#1)(1992-9#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-8#1)
the identity##24##2##(1991-2#1)(1992-4#1)(1992-9#1)(1993-6#1)(1996-5#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#3)(2013-8#3)
the idler##4##2##(2008-2#1)(2008-3#3)
the ileocecal##3##2##(1990-8#1)(1994-5#1)(2010-12#1)
the ileum##2##2##(1993-6#1)(2013-1#1)
the iliac artery##2##3##(2008-3#2)
the iliac crest##3##3##(2009-9#2)(2010-8#1)
the iliac##8##2##(1991-11#1)(2008-12#1)(2008-3#2)(2009-9#2)(2010-3#1)(2010-8#1)
the iliotibial##2##2##(2012-2#2)
the illness##11##2##(1996-11#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#2)
the illumination angle##2##3##(2008-3#2)
the illumination##6##2##(2008-3#6)
the ilv3##2##2##(1993-12#2)
the image data and##2##4##(2008-6#1)(2012-3#1)
the image of the##5##4##(2008-12#1)(2008-3#2)(2009-10#1)(2010-8#1)
the image of##7##3##(1996-12#1)(2008-12#2)(2008-3#2)(2009-10#1)(2010-8#1)
the image space##2##3##(2008-6#1)(2011-2#1)
the image##27##2##(1993-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-12#4)(2008-3#4)(2008-6#4)(2009-10#2)(2010-8#1)(2011-2#1)(2012-3#1)
the image-guided##2##2##(2009-12#1)(2013-1#1)
the imager##2##2##(2008-3#2)
the images##9##2##(1995-11#1)(2007-12#1)(2008-3#2)(2008-5#1)(2010-1#1)(2011-7#1)(2012-2#1)(2012-3#1)
the imaginary part##3##3##(2008-3#3)
the imaginary##5##2##(2008-3#5)
the imagination##2##2##(2009-10#1)(2010-7#1)
the imaging characteristics of##2##4##(1997-8#1)(2012-2#1)
the imaging features of##2##4##(2008-1#1)(2012-2#1)
the imaging features##3##3##(2008-1#1)(2008-7#1)(2012-2#1)
the imaging findings##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
the imaging of##3##3##(2008-2#1)(2012-2#2)
the imaging##29##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2010-3#1)(2011-2#2)(2012-12#3)(2012-2#8)(2013-1#1)(2013-8#2)
the imidazole derivative##2##3##(2008-10#2)
the imidazole##5##2##(2008-10#3)(2008-8#2)
the immature##7##2##(1994-3#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
the immediate effects of##2##4##(2008-12#1)(2010-12#1)
the immediate postflame zone##2##4##(2008-3#2)
the immediate postoperative##2##3##(2008-7#1)(2008-8#1)
the immediate##25##2##(1990-3#1)(1991-9#1)(1993-8#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#3)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#1)(2013-1#3)(2013-8#1)
the immediately postoperative##2##3##(1991-2#2)
the immersion##2##2##(2008-10#1)(2013-1#1)
the immigration##2##2##(2008-10#1)(2012-2#1)
the imminent##2##2##(1993-6#1)(2013-8#1)
the immobilisation##3##2##(2008-10#3)
the immobilised##3##2##(1997-2#1)(2008-10#2)
the immobilization of a##2##4##(2008-10#1)(2009-3#1)
the immobilization of polyphenol oxidase##2##5##(2008-10#2)
the immobilization of the##4##4##(2008-10#4)
the immobilization of##21##3##(2008-10#18)(2008-11#2)(2009-3#1)
the immobilization##26##2##(2008-10#23)(2008-11#2)(2009-3#1)
the immobilized Chiralpak IA##2##4##(2008-10#2)
the immobilized HRP##2##3##(2008-10#2)
the immobilized cells##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
the immobilized enzyme was##2##4##(2008-10#1)(2008-7#1)
the immobilized enzyme##5##3##(2008-10#3)(2008-7#1)(2009-10#1)
the immobilized oligonucleotide##2##3##(2008-10#2)
the immobilized##40##2##(1990-12#2)(1990-5#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-7#6)(2009-10#1)
the immortalization of##2##3##(1993-11#1)(2008-11#1)
the immune and##2##3##(2009-6#1)(2012-3#1)
the immune cells##2##3##(1994-5#1)(2013-1#1)
the immune inflammatory response##2##4##(2013-1#2)
the immune response and##2##4##(2008-10#1)(2008-5#1)
the immune response in##2##4##(1995-5#1)(2008-11#1)
the immune response to##3##4##(1993-8#1)(1995-5#1)(2009-12#1)
the immune response##20##3##(1991-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-5#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#4)
the immune responses##5##3##(1992-5#1)(1995-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
the immune stimulatory potential of##2##5##(2008-10#2)
the immune system and##7##4##(1990-11#1)(1990-9#1)(1995-12#1)(1996-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
the immune system are##4##4##(2008-10#1)(2008-2#1)(2008-5#2)
the immune system in##4##4##(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
the immune system of##4##4##(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
the immune system through the##2##5##(1997-7#1)(2008-9#1)
the immune system to##2##4##(2011-2#1)(2013-7#1)
the immune system##56##3##(1990-11#1)(1990-9#1)(1993-12#3)(1993-3#2)(1995-12#2)(1996-11#1)(1997-7#1)(1997-9#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#2)(2008-7#4)(2008-9#1)(2011-2#6)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#2)
the immune##104##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#5)(1993-3#2)(1993-8#1)(1994-5#1)(1995-12#3)(1995-5#4)(1996-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#3)(2008-2#2)(2008-4#4)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2011-2#8)(2012-2#3)(2012-3#5)(2013-1#13)(2013-7#3)
the immunization##9##2##(1990-12#1)(1993-2#1)(1994-9#1)(1995-5#1)(1996-1#1)(1997-8#1)(2008-9#1)(2013-1#2)
the immunized##4##2##(2008-11#2)(2008-9#2)
the immunoaffinity column##2##3##(2008-10#1)(2008-11#1)
the immunoaffinity##3##2##(2008-10#2)(2008-11#1)
the immunoassay##7##2##(2008-10#7)
the immunochemical##2##2##(2008-10#2)
the immunocompromised##3##2##(2008-12#1)(2012-3#1)(2013-1#1)
the immunocytochemical##2##2##(2008-9#1)(2011-2#1)
the immunofluorescence##2##2##(1990-12#1)(1991-3#1)
the immunogenicity of##8##3##(1995-5#2)(2008-10#3)(2008-8#3)
the immunogenicity##9##2##(1995-5#2)(2008-10#4)(2008-8#3)
the immunoglobulin##11##2##(1993-2#1)(1996-12#1)(1996-3#1)(1997-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)
the immunologic##4##2##(1995-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
the immunological barrier##2##3##(2009-10#1)(2012-2#1)
the immunological##11##2##(1990-12#1)(2007-11#1)(2008-10#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2012-2#1)
the immunomodulating properties##2##3##(1991-6#1)(1994-3#1)
the immunomodulatory##2##2##(2008-10#1)(2012-2#1)
the immunopathogenesis of##3##3##(2008-10#1)(2008-4#1)(2009-12#1)
the immunoreaction between##2##3##(2008-10#2)
the immunoreaction##4##2##(1994-2#1)(2008-10#3)
the immunoreactive##2##2##(1993-8#1)(1996-2#1)
the immunoreactivity##3##2##(1992-3#1)(1995-12#1)(2008-7#1)
the immunosensor##9##2##(2008-10#8)(2008-7#1)
the immunosuppressant##3##2##(1993-8#1)(2010-12#1)(2010-3#1)
the immunosuppressive activity of##2##4##(1990-5#2)
the immunosuppressive##5##2##(1990-5#3)(2008-10#1)(2011-2#1)
the immunotoxicological potential of##2##4##(2008-10#2)
the impact and##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
the impact of a##10##4##(1992-1#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-2#1)(2012-3#1)
the impact of changes##2##4##(1995-12#1)(1996-2#1)
the impact of education##2##4##(2008-11#1)(2008-9#1)
the impact of environmental##2##4##(2008-8#1)(2011-1#1)
the impact of false-negatives##3##4##(2012-12#3)
the impact of foodborne disease##2##5##(2007-12#2)
the impact of imaging on##2##5##(2008-2#2)
the impact of imaging##3##4##(2008-2#2)(2009-11#1)
the impact of n-3 PUFAs on##2##6##(2013-1#2)
the impact of obesity on the##2##6##(2011-2#2)
the impact of temperature##2##4##(2011-2#1)(2013-8#1)
the impact of the##30##4##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the impact of these##6##4##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#2)
the impact of this##6##4##(2008-10#2)(2008-11#3)(2011-2#1)
the impact of treatment##2##4##(1992-9#1)(2008-2#1)
the impact of using##2##4##(2008-11#1)(2008-12#1)
the impact of##184##3##(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-6#1)(1994-1#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#5)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-5#1)(2007-12#3)(2008-10#22)(2008-11#26)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#12)(2012-12#4)(2012-2#2)(2012-3#8)(2012-9#1)(2013-1#14)(2013-8#8)
the impact on patient##2##4##(1994-3#1)(2010-2#1)
the impact on##14##3##(1991-2#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-5#1)(2008-10#2)(2008-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
the impact that the##2##4##(1992-1#1)(2008-12#1)
the impact that##4##3##(1992-1#1)(2008-10#1)(2008-12#1)(2010-7#1)
the impact##212##2##(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-6#2)(1994-1#6)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#2)(1995-12#6)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-5#1)(2007-12#3)(2008-10#26)(2008-11#28)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#15)(2011-4#1)(2012-12#4)(2012-2#3)(2012-3#9)(2012-9#1)(2013-1#15)(2013-8#8)
the impacted##2##2##(2010-12#1)(2013-1#1)
the impacts of##5##3##(1992-3#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
the impaired##2##2##(2008-9#1)(2010-4#1)
the impairment of the##2##4##(1995-11#1)(2010-10#1)
the impairment of##10##3##(1991-6#1)(1994-11#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#1)
the impairment##12##2##(1991-6#1)(1992-12#1)(1994-11#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#1)
the impeller centrifugal pump##2##4##(1992-1#2)
the impeller##3##2##(1992-1#2)(2008-8#1)
the impending##3##2##(1992-3#1)(2013-1#1)(2013-8#1)
the imperative of##2##3##(1996-2#1)(1997-1#1)
the imperative to##2##3##(1997-2#1)(2008-11#1)
the imperative##4##2##(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)
the impetus for##2##3##(1997-7#1)(2008-12#1)
the implant site##2##3##(2008-9#1)(2012-3#1)
the implant was##2##3##(2008-9#1)(2013-1#1)
the implant##20##2##(2008-9#13)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
the implantation of##4##3##(2010-6#1)(2011-2#2)(2012-3#1)
the implantation##5##2##(2010-6#1)(2011-2#2)(2012-3#2)
the implanted twin##2##3##(2008-9#2)
the implanted##8##2##(1994-9#1)(1995-11#1)(2008-9#4)(2009-3#1)(2012-2#1)
the implants##3##2##(2013-1#3)
the implementation of a##10##4##(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#2)(2012-2#1)(2013-1#2)
the implementation of an##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
the implementation of new##2##4##(2008-10#1)(2011-2#1)
the implementation of programs##2##4##(1994-1#1)(1994-2#1)
the implementation of the##13##4##(1991-1#1)(1991-3#1)(1992-1#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-2#1)
the implementation of these##3##4##(1994-1#2)(1997-7#1)
the implementation of this##3##4##(2008-11#1)(2010-10#1)(2010-8#1)
the implementation of##61##3##(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-3#1)(1997-2#2)(1997-3#2)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-10#3)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the implementation process##2##3##(1996-1#1)(2008-11#1)
the implementation strategies##4##3##(2013-1#4)
the implementation##74##2##(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-1#5)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#4)(1997-3#2)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-10#3)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
the implication is that##2##4##(1996-1#1)(2007-12#1)
the implication of##4##3##(1992-6#1)(2008-11#1)(2008-5#1)(2011-2#1)
the implication##7##2##(1992-6#1)(1996-1#1)(2007-12#2)(2008-11#1)(2008-5#1)(2011-2#1)
the implications for##7##3##(1993-1#1)(1993-11#1)(1995-2#1)(1996-1#1)(2008-11#1)(2010-5#1)(2010-7#1)
the implications of a##4##4##(1994-12#1)(1994-2#1)(1995-2#1)(2012-12#1)
the implications of such##2##4##(2009-8#1)(2010-1#1)
the implications of the##2##4##(1995-1#1)(2008-8#1)
the implications of these##3##4##(1991-2#1)(1994-1#1)(2008-10#1)
the implications of this##4##4##(1991-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
the implications of##23##3##(1991-12#1)(1991-2#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
the implications##34##2##(1991-1#1)(1991-12#1)(1991-2#2)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1996-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
the importance and##4##3##(1995-1#1)(2008-11#1)(2009-8#1)(2011-2#1)
the importance of a##12##4##(1991-6#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#2)
the importance of an##2##4##(1995-11#1)(2008-4#1)
the importance of clinical##2##4##(2011-1#1)(2012-2#1)
the importance of considering spatial##2##5##(2008-8#2)
the importance of considering##6##4##(1997-3#1)(1997-8#1)(2007-12#1)(2008-8#2)(2012-12#1)
the importance of early##5##4##(1990-9#1)(2008-11#2)(2008-9#1)(2013-1#1)
the importance of emergency services]##2##5##(1997-5#2)
the importance of examining ethnic##2##5##(2009-7#1)(2010-10#1)
the importance of examining##3##4##(2009-7#1)(2010-1#1)(2010-10#1)
the importance of integrating##2##4##(2010-7#1)(2012-3#1)
the importance of lipase activity in M##2##7##(2010-10#2)
the importance of local##2##4##(2008-10#1)(2012-2#1)
the importance of public health##2##5##(1996-3#1)(2011-2#1)
the importance of regular##2##4##(2011-2#1)(2013-8#1)
the importance of social##3##4##(2008-11#1)(2009-7#1)(2010-6#1)
the importance of spatial##2##4##(2008-10#1)(2008-7#1)
the importance of taking##3##4##(1995-9#1)(2008-12#1)(2013-8#1)
the importance of the##30##4##(1991-12#1)(1991-3#2)(1993-2#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-3#1)(2013-1#3)
the importance of these##4##4##(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#1)
the importance of this##9##4##(1990-5#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-9#1)(2013-1#1)
the importance of using##2##4##(1991-6#1)(2008-10#1)
the importance of##270##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-8#1)(1997-9#1)(2007-12#2)(2008-1#2)(2008-10#37)(2008-11#38)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#9)(2008-8#8)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#5)(2010-1#2)(2010-10#7)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#15)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#9)(2013-8#4)
the importance to##2##3##(2008-5#1)(2012-3#1)
the importance##279##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#4)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-8#1)(1997-9#1)(2007-12#2)(2008-1#2)(2008-10#37)(2008-11#39)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#8)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#6)(2010-1#2)(2010-10#7)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#8)(2013-1#9)(2013-8#4)
the important factors##3##3##(2008-8#1)(2008-9#2)
the important role of##11##4##(1991-7#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
the important role##12##3##(1991-7#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
the important roles played by##2##5##(1994-12#1)(2008-5#1)
the important roles##3##3##(1994-12#1)(2008-5#1)(2012-3#1)
the important##59##2##(1991-7#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-7#1)(2009-8#2)(2010-11#1)(2010-7#1)(2011-2#2)(2011-3#1)(2011-4#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the importation of##2##3##(2007-12#1)(2008-10#1)
the imposition of##2##3##(2008-11#1)(2009-8#1)
the impossibility of##2##3##(1996-12#1)(2012-2#1)
the impossibility##3##2##(1990-3#1)(1996-12#1)(2012-2#1)
the impression##2##2##(1990-6#1)(2012-2#1)
the imprinted polymer for##2##4##(2008-10#2)
the imprinted polymer##6##3##(2008-10#6)
the imprinted##10##2##(2008-10#10)
the imprinting##3##2##(2008-10#3)
the improved##21##2##(1993-8#1)(1996-11#1)(1997-3#1)(2008-10#9)(2008-11#3)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
the improvement in##5##3##(2008-10#2)(2008-5#1)(2010-11#1)(2013-8#1)
the improvement is##2##3##(1993-11#1)(2008-10#1)
the improvement of the##2##4##(2006-6#1)(2008-10#1)
the improvement of##15##3##(1994-3#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-6#1)(2011-7#1)(2013-1#1)(2013-8#1)
the improvement##29##2##(1991-6#1)(1993-11#1)(1994-3#1)(2006-6#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-7#1)(2012-2#1)(2013-1#2)(2013-8#2)
the improvements are##2##3##(2013-1#1)(2013-8#1)
the improvements in##2##3##(2010-7#2)
the improvements##5##2##(1991-12#1)(2010-7#2)(2013-1#1)(2013-8#1)
the impurities##4##2##(2008-10#1)(2010-2#2)(2012-2#1)
the in situ##22##3##(1996-12#1)(2008-10#12)(2008-11#1)(2008-3#5)(2008-5#1)(2009-12#1)(2011-2#1)
the in vitro adherence of Candida albicans##2##7##(2008-5#2)
the in vitro and in vivo##3##6##(1990-2#1)(2008-5#1)(2009-12#1)
the in vitro and in##4##5##(1990-2#1)(2008-5#1)(2009-12#2)
the in vitro antifungal##2##4##(2008-5#2)
the in vitro assembled U2 snRNPs##2##6##(1993-8#2)
the in vitro biological activity of##2##6##(2008-8#2)
the in vitro experiments##2##4##(1994-5#1)(2008-5#1)
the in vitro phosphorylation of##2##5##(1997-2#2)
the in vitro release##2##4##(1992-3#1)(2008-10#1)
the in vitro selection##2##4##(1990-8#1)(2010-5#1)
the in vitro sensitivity of##2##5##(1991-2#1)(1993-1#1)
the in vitro study of##2##5##(2008-11#1)(2013-8#1)
the in vitro##70##3##(1990-11#1)(1990-2#1)(1990-8#2)(1991-2#1)(1991-3#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-1#1)(2008-10#8)(2008-11#11)(2008-5#12)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#2)(2009-6#2)(2009-8#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
the in vivo activity of antimicrobial agents##2##7##(2008-7#2)
the in vivo and in vitro##2##6##(1994-5#1)(2008-5#1)
the in vivo effects of##2##5##(1995-12#1)(2008-10#1)
the in vivo function of##3##5##(2008-11#1)(2008-9#1)(2012-2#1)
the in vivo##39##3##(1990-8#1)(1991-1#1)(1992-9#1)(1993-12#2)(1994-5#2)(1994-8#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#8)(2008-7#3)(2008-9#3)(2009-12#1)(2009-7#1)(2012-12#1)(2012-2#1)
the in##136##2##(1990-11#1)(1990-2#1)(1990-8#3)(1991-1#1)(1991-2#1)(1991-3#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-5#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#2)(2008-1#1)(2008-10#27)(2008-11#15)(2008-3#5)(2008-4#2)(2008-5#21)(2008-7#4)(2008-8#3)(2008-9#5)(2009-12#4)(2009-6#2)(2009-7#1)(2009-8#3)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
the in-line##3##2##(2008-10#3)
the inability of##7##3##(1995-11#1)(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)
the inability to##6##3##(2008-1#1)(2008-10#2)(2008-6#1)(2009-7#1)(2012-3#1)
the inability##13##2##(1995-11#1)(2008-1#1)(2008-10#5)(2008-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#2)
the inactivation of##12##3##(1993-6#1)(1993-8#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#3)
the inactivation##13##2##(1993-6#1)(1993-8#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#3)
the inactive X and Y##2##5##(1990-3#2)
the inactive X chromosome##2##4##(1991-6#1)(1994-11#1)
the inactive X##4##3##(1990-3#2)(1991-6#1)(1994-11#1)
the inactive product##2##3##(1992-6#2)
the inactive##15##2##(1990-3#2)(1991-6#1)(1992-6#2)(1993-6#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-6#1)(1997-1#1)(2013-1#1)(2013-8#1)
the inadequacy of the##2##4##(2009-5#1)(2012-3#1)
the inadequacy of##3##3##(1995-11#1)(2009-5#1)(2012-3#1)
the inadequate##4##2##(1992-12#1)(1997-8#1)(2008-10#1)(2008-11#1)
the inalienable right to life and##4##6##(2011-2#4)
the inappropriate##2##2##(1993-12#1)(1994-5#1)
the inbred##5##2##(2008-10#3)(2008-11#1)(2012-3#1)
the incentive##2##2##(1992-3#1)(1995-1#1)
the incentives##2##2##(1992-2#1)(1993-12#1)
the incidence and prevalence of##3##5##(1996-11#1)(2008-10#1)(2008-12#1)
the incidence and severity of##5##5##(2008-10#4)(2012-3#1)
the incidence and##15##3##(1991-11#1)(1996-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
the incidence angle shift##2##4##(2008-10#2)
the incidence function model##2##4##(2008-9#2)
the incidence in##2##3##(2008-7#1)(2012-3#1)
the incidence is approximately##2##4##(2008-10#1)(2008-7#1)
the incidence is##5##3##(2008-10#1)(2008-7#3)(2013-1#1)
the incidence of A##2##4##(2008-10#2)
the incidence of BYDV##3##4##(2008-10#3)
the incidence of TYLCV##2##4##(2008-10#2)
the incidence of acute##2##4##(1996-6#1)(2013-8#1)
the incidence of adverse##3##4##(1997-7#1)(2008-11#1)(2011-2#1)
the incidence of both##2##4##(2008-10#1)(2008-12#1)
the incidence of breast cancer##3##5##(2008-7#1)(2013-7#2)
the incidence of cancer##3##4##(1994-5#1)(2008-4#1)(2008-7#1)
the incidence of congenital##2##4##(1990-9#1)(2008-7#1)
the incidence of death from##2##5##(1995-12#1)(2011-2#1)
the incidence of discolored achenes##2##5##(2008-10#2)
the incidence of fire blight in##2##6##(2008-10#2)
the incidence of fire blight##3##5##(2008-10#3)
the incidence of fruit##2##4##(2008-10#2)
the incidence of hypo-##2##4##(1991-8#2)
the incidence of infection##2##4##(2008-10#2)
the incidence of melanoma increased by##2##6##(2011-2#2)
the incidence of neurosurgical complications was##2##6##(2012-3#2)
the incidence of renal##2##4##(1994-5#1)(2011-2#1)
the incidence of southern blight##2##5##(2008-10#2)
the incidence of strawberry##2##4##(2008-10#2)
the incidence of such##2##4##(1993-3#1)(2012-2#1)
the incidence of sudden infant death syndrome##2##7##(1991-11#1)(1991-9#1)
the incidence of surgical site##2##5##(2012-3#2)
the incidence of the##5##4##(1992-9#1)(1993-8#1)(2008-10#1)(2010-12#1)(2013-8#1)
the incidence of this##2##4##(2008-11#1)(2010-5#1)
the incidence of varicocele##2##4##(1990-3#2)
the incidence of##176##3##(1990-2#1)(1990-3#3)(1990-6#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#3)(1991-9#1)(1992-12#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#2)(1994-5#2)(1995-12#1)(1995-5#1)(1996-11#1)(1996-6#2)(1997-5#2)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#3)(2008-10#47)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#5)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#14)(2012-12#1)(2012-2#2)(2012-3#10)(2013-1#15)(2013-7#2)(2013-8#3)
the incidence rate##3##3##(1996-3#1)(2008-11#1)(2011-2#1)
the incidence##214##2##(1990-11#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#3)(1991-9#1)(1992-12#3)(1992-2#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#2)(1994-5#2)(1995-12#1)(1995-5#1)(1996-11#3)(1996-3#1)(1996-6#2)(1997-5#2)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#3)(2008-10#61)(2008-11#7)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#7)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#17)(2012-12#1)(2012-2#2)(2012-3#12)(2013-1#17)(2013-7#2)(2013-8#3)
the incidences of##4##3##(2008-9#3)(2011-2#1)
the incident laser##3##3##(2008-3#3)
the incident light##4##3##(2008-10#2)(2008-3#2)
the incident wavelength##2##3##(2008-2#2)
the incident##21##2##(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#10)
the incidents and##2##3##(2009-10#1)(2013-1#1)
the incision##2##2##(2009-8#1)(2012-12#1)
the included articles##2##3##(2011-2#1)(2013-1#1)
the included##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
the inclusion ability of##2##4##(2008-10#2)
the inclusion complex between##2##4##(2008-10#2)
the inclusion complex##10##3##(2008-10#10)
the inclusion constant##3##3##(2008-10#3)
the inclusion criteria were##2##4##(2012-3#2)
the inclusion criteria##9##3##(2008-1#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-3#3)(2013-1#2)
the inclusion mechanism of imidazole derivatives in##2##7##(2008-10#2)
the inclusion of##17##3##(1990-8#1)(1995-12#1)(1995-5#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
the inclusion process##3##3##(2008-10#3)
the inclusion##60##2##(1990-8#1)(1995-12#1)(1995-5#1)(2008-1#1)(2008-10#39)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#2)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
the inclusions##5##2##(2008-10#5)
the incoherent##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
the incoming##5##2##(2008-10#2)(2008-3#1)(2010-7#1)(2011-1#1)
the incompatible (i##2##3##(2008-10#2)
the incomplete##3##2##(2008-10#2)(2012-2#1)
the incorporation of these##2##4##(1997-2#1)(2008-10#1)
the incorporation of##29##3##(1992-10#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-12#1)(2012-3#1)
the incorporation reaction of##2##4##(2008-10#2)
the incorporation values##2##3##(1991-6#1)(2008-11#1)
the incorporation##34##2##(1991-6#1)(1992-10#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-12#1)(2012-3#2)
the incorrect##2##2##(1997-6#1)(2008-12#1)
the increase in GFAP##2##4##(1990-7#2)
the increase in apoptosis##2##4##(2008-7#2)
the increase in body##2##4##(2011-1#1)(2013-1#1)
the increase in cell number##2##5##(1995-2#1)(1996-2#1)
the increase in mortality##2##4##(1991-3#1)(2008-8#1)
the increase in plasma##2##4##(2008-10#1)(2010-10#1)
the increase in splenic B7(+) macrophages##2##6##(2008-10#2)
the increase in the number of##2##6##(1997-2#1)(2008-5#1)
the increase in the rate of##2##6##(1994-5#1)(1995-6#1)
the increase in the##18##4##(1992-12#1)(1994-5#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
the increase in##94##3##(1990-10#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#2)(1992-12#2)(1992-3#2)(1992-6#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-7#1)(2008-1#1)(2008-10#20)(2008-11#11)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#3)
the increase of [Ca(2+)](i)##2##4##(2008-9#2)
the increase of its concentration##3##5##(2008-10#3)
the increase of the##9##4##(2008-10#7)(2008-8#1)(2011-3#1)
the increase of##51##3##(1990-12#1)(1990-2#1)(1993-8#1)(1996-2#2)(1996-3#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#4)(2009-3#1)(2009-7#2)(2010-12#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the increase was##4##3##(1992-3#1)(2008-10#3)
the increase##163##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#3)(1992-12#2)(1992-3#3)(1992-6#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-2#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#3)(1997-7#1)(2008-1#2)(2008-10#42)(2008-11#13)(2008-12#4)(2008-3#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-3#1)(2009-7#2)(2010-10#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
the increased aggressiveness of##2##4##(2008-10#2)
the increased demand##2##3##(1990-6#1)(1997-3#1)
the increased expression of##4##4##(1995-2#2)(1997-7#1)(2012-3#1)
the increased frequency of##4##4##(1991-5#1)(1991-9#1)(1992-9#1)(2008-11#1)
the increased incidence of##4##4##(1994-5#1)(1996-3#1)(2008-11#1)(2011-2#1)
the increased number of##5##4##(1991-12#1)(1991-3#1)(1994-11#1)(2008-10#1)(2008-8#1)
the increased risk of##6##4##(1994-3#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
the increased susceptibility to##2##4##(2008-10#2)
the increased susceptibility##3##3##(2008-10#3)
the increased use of##5##4##(1991-11#1)(1991-3#1)(1996-9#1)(2008-11#1)(2008-12#1)
the increased##91##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#14)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#1)
the increases in##4##3##(1997-4#1)(2008-12#1)(2008-5#1)(2008-7#1)
the increases of##2##3##(2008-9#1)(2011-2#1)
the increases##8##2##(1995-12#1)(1997-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
the increasing availability of##2##4##(2008-3#1)(2012-2#1)
the increasing demand for##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
the increasing incidence of##4##4##(1996-6#1)(2011-2#3)
the increasing number of##8##4##(1992-3#1)(1997-2#2)(2008-10#2)(2008-8#1)(2009-10#1)(2011-2#1)
the increasing of##3##3##(2008-8#1)(2008-9#2)
the increasing prevalence of##5##4##(2010-1#1)(2010-12#1)(2010-5#1)(2012-3#2)
the increasing use of##2##4##(2008-10#1)(2008-11#1)
the increasing##55##2##(1990-11#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-8#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the increasingly##2##2##(2008-11#1)(2010-10#1)
the increment in##3##3##(1990-5#1)(2010-10#2)
the increment of##3##3##(1996-2#1)(2008-10#2)
the increment##7##2##(1990-5#1)(1996-2#1)(2008-10#3)(2010-10#2)
the incremental##4##2##(1992-9#1)(2010-12#1)(2010-8#1)(2013-1#1)
the incubation buffer##3##3##(1992-3#1)(1995-8#1)(2008-10#1)
the incubation distribution##2##3##(1992-9#2)
the incubation media##5##3##(1991-2#1)(1993-6#1)(1994-2#2)(2008-10#1)
the incubation medium##5##3##(1990-11#1)(1990-5#1)(1991-5#1)(1995-11#2)
the incubation of##3##3##(1991-3#1)(2008-11#2)
the incubation period##6##3##(1991-12#1)(2008-10#5)
the incubation temperature and the##2##5##(2008-10#1)(2011-2#1)
the incubation temperature##5##3##(2008-10#4)(2011-2#1)
the incubation time##4##3##(1990-12#1)(2008-10#1)(2008-9#2)
the incubation with##2##3##(1997-8#1)(2008-11#1)
the incubation##40##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#2)(1993-6#1)(1994-2#2)(1994-5#1)(1995-11#2)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#14)(2008-11#3)(2008-9#2)(2011-2#1)
the independent action of##2##4##(2008-10#2)
the independent variable##4##3##(2008-10#2)(2008-11#2)
the independent variables##3##3##(1992-1#1)(1994-12#1)(1995-9#1)
the independent##21##2##(1990-8#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-3#1)
the independently##2##2##(2008-10#2)
the index modulation##2##3##(2007-12#1)(2008-3#1)
the index of dispersion##5##4##(2008-10#5)
the index of refraction and##2##5##(2008-3#2)
the index of refraction##6##4##(1991-9#1)(2008-2#1)(2008-3#4)
the index of##16##3##(1991-9#1)(1996-3#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-5#1)(2010-11#1)(2013-1#1)
the index values of##2##4##(1992-2#2)
the index##31##2##(1991-9#1)(1992-2#2)(1993-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#1)
the indication for this##2##4##(1997-5#1)(2013-1#1)
the indication for##7##3##(1993-6#1)(1996-11#1)(1997-4#1)(1997-5#1)(2010-12#1)(2013-1#2)
the indication##9##2##(1993-6#1)(1996-11#1)(1997-4#1)(1997-5#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
the indications for the use of##3##6##(1990-9#2)(2011-2#1)
the indications for##11##3##(1990-11#1)(1990-9#2)(2008-11#1)(2008-7#2)(2011-10#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)
the indications##15##2##(1990-11#1)(1990-3#1)(1990-9#3)(1991-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-10#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)
the indicator electrode##4##3##(2008-10#4)
the indicator reaction##2##3##(2008-10#2)
the indicator##21##2##(1990-12#1)(1990-2#1)(1997-3#1)(2008-10#16)(2008-9#2)
the indicators##3##2##(1996-2#1)(2008-10#1)(2012-12#1)
the indices of##5##3##(2008-11#1)(2008-3#2)(2008-8#1)(2013-8#1)
the indices##6##2##(2008-11#2)(2008-3#2)(2008-8#1)(2013-8#1)
the indigenous##4##2##(2008-1#1)(2008-10#3)
the indirect benefit of##2##4##(1994-2#1)(2008-8#1)
the indirect defenses of##2##4##(2009-8#2)
the indirect determination of##4##4##(2008-10#4)
the indirect method##3##3##(2008-10#1)(2008-11#2)
the indirect nature of the##2##5##(2008-10#2)
the indirect##23##2##(1991-12#2)(1994-2#1)(2008-10#10)(2008-11#2)(2008-8#2)(2008-9#1)(2009-8#2)(2011-2#2)(2012-2#1)
the indiscriminate##2##2##(2009-10#1)(2011-2#1)
the individual and##2##3##(2008-10#1)(2008-12#1)
the individual chromatographic##2##3##(2008-10#1)(2008-7#1)
the individual components of the##2##5##(2008-10#2)
the individual components of##4##4##(1992-9#1)(2008-10#2)(2008-12#1)
the individual components##6##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)
the individual countries##3##3##(1990-12#3)
the individual effects##2##3##(2008-10#1)(2008-3#1)
the individual hospital##2##3##(1992-2#1)(2008-11#1)
the individual level##2##3##(2008-8#2)
the individual patch##2##3##(2008-8#2)
the individual patient##4##3##(2010-6#1)(2013-1#2)(2013-8#1)
the individual species##3##3##(2008-10#3)
the individual##120##2##(1990-12#4)(1990-5#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#3)(1995-8#1)(1995-9#2)(1996-1#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-1#2)(2008-10#27)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#7)(2008-9#3)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-6#2)(2011-2#2)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#4)
the individual's##5##2##(2008-4#2)(2008-8#1)(2011-2#1)(2012-3#1)
the individual-based##2##2##(2008-9#2)
the individuals##9##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-6#1)
the indoor##2##2##(2010-5#2)
the indophenol-type reaction method##2##4##(2008-10#2)
the induced ossicles##2##3##(2008-12#2)
the induced##18##2##(1990-5#1)(1991-7#1)(1993-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
the inducer##3##2##(2008-10#1)(2009-8#1)(2012-3#1)
the inducible##5##2##(1995-11#3)(1995-6#1)(2008-5#1)
the inducing (IN) inoculation##2##4##(2008-10#2)
the inducing##3##2##(2008-10#3)
the induction and maintenance of##2##5##(2008-11#1)(2008-4#1)
the induction and##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
the induction medium##3##3##(2008-11#3)
the induction of LTP##4##4##(1995-12#2)(1995-2#1)(2008-7#1)
the induction of Th1-type cytokine producing cells##2##7##(2008-11#2)
the induction of apoptosis##3##4##(2008-11#1)(2008-9#1)(2009-12#1)
the induction of autogamy##2##4##(2008-12#2)
the induction of immune##2##4##(1997-8#1)(2012-3#1)
the induction of long-term potentiation (LTP)##2##6##(1995-12#1)(2008-7#1)
the induction of long-term potentiation##3##5##(1995-12#2)(2008-7#1)
the induction of long-term##4##4##(1995-12#2)(2008-7#1)(2011-2#1)
the induction of metallothionein by cadmium(II) and##2##7##(1991-5#2)
the induction of metallothionein by##3##5##(1991-5#3)
the induction of protective immunity##2##5##(2011-2#2)
the induction of systemic resistance##2##5##(2008-10#2)
the induction of systemic##3##4##(2008-10#3)
the induction of the##6##4##(1991-9#1)(1992-8#2)(2008-5#1)(2009-8#1)(2013-1#1)
the induction of##102##3##(1990-5#1)(1991-12#2)(1991-3#1)(1991-5#4)(1991-9#2)(1992-10#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#19)(2008-11#14)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#4)
the induction or##3##3##(2008-10#2)(2008-11#1)
the induction period##3##3##(2008-10#3)
the induction##123##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-5#4)(1991-9#2)(1992-10#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#28)(2008-11#20)(2008-12#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#4)
the inductive##2##2##(1995-5#1)(2008-11#1)
the inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
the inductively coupled plasma##6##4##(2008-10#6)
the inductively coupled plasma-mass spectrometry (ICP-MS)##2##6##(2008-10#2)
the inductively coupled plasma-mass##3##4##(2008-10#3)
the inductively coupled##9##3##(2008-10#9)
the industrial production of##2##4##(2011-2#1)(2012-2#1)
the industrial production##3##3##(1992-11#1)(2011-2#1)(2012-2#1)
the industrial##9##2##(1992-11#1)(2008-10#3)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
the industry has##2##3##(2008-11#1)(2008-8#1)
the industry standard##2##3##(2008-10#1)(2008-11#1)
the industry##16##2##(1991-1#1)(1991-3#1)(1992-3#1)(1995-3#1)(1996-2#2)(2008-10#2)(2008-11#6)(2008-6#1)(2008-8#1)
the inefficiencies##2##2##(1991-3#1)(1996-1#1)
the inefficiency of##2##3##(2008-3#2)
the inertial##2##2##(2008-10#1)(2008-11#1)
the infant brain processes##2##4##(2008-11#2)
the infant to##2##3##(2008-11#1)(2012-2#1)
the infant was##2##3##(1991-11#1)(2010-10#1)
the infant##20##2##(1991-11#2)(1994-3#1)(1995-3#2)(1995-6#1)(2006-5#1)(2008-10#1)(2008-11#4)(2009-12#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#4)
the infant's##3##2##(1993-3#1)(2007-11#1)(2009-11#1)
the infants were##4##3##(1991-11#1)(1991-2#1)(1993-12#1)(1994-6#1)
the infants##8##2##(1991-11#1)(1991-2#1)(1993-12#2)(1994-6#2)(2008-10#1)(2012-2#1)
the infants'##2##2##(1991-12#1)(2008-10#1)
the infarct size and the neurological deficit##2##7##(2011-2#2)
the infarct size##4##3##(2011-2#4)
the infarct##6##2##(2008-7#1)(2011-2#5)
the infarction##3##2##(1997-5#3)
the infected cells##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
the infected seeds##2##3##(2008-10#2)
the infected subdural hematoma##2##4##(2008-7#2)
the infected tissue was##2##4##(2008-10#2)
the infected tissue##3##3##(2008-10#2)(2011-2#1)
the infected##33##2##(1990-6#1)(1990-9#1)(1995-2#1)(1997-1#1)(2008-10#17)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#2)(2010-12#1)(2011-2#2)(2013-1#1)
the infection and##2##3##(1990-9#1)(2008-10#1)
the infection by##2##3##(2008-10#1)(2008-9#1)
the infection court##3##3##(2008-10#3)
the infection cycle##2##3##(2008-10#2)
the infection efficiency##2##3##(2008-10#2)
the infection from##2##3##(1996-11#1)(2008-12#1)
the infection in##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
the infection of##9##3##(2008-10#3)(2008-8#1)(2008-9#1)(2010-10#2)(2011-2#1)(2011-3#1)
the infection process and##2##4##(2008-10#2)
the infection process##5##3##(2008-10#4)(2011-10#1)
the infection site##2##3##(2008-10#2)
the infection stage##2##3##(2008-10#2)
the infection was##2##3##(1996-11#1)(2008-10#1)
the infection##71##2##(1990-9#3)(1991-6#1)(1992-6#1)(1993-3#1)(1994-5#1)(1996-11#2)(1997-1#1)(2007-12#2)(2008-10#32)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-10#2)(2011-10#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
the infections##2##2##(1994-6#1)(2008-9#1)
the infectious agents##2##3##(2011-2#1)(2012-3#1)
the infectious process##2##3##(2010-6#1)(2011-2#1)
the infectious##10##2##(1995-5#1)(2007-12#1)(2008-10#2)(2010-6#2)(2011-2#3)(2012-3#1)
the infective##3##2##(2008-10#1)(2011-2#2)
the infectoria species-group##2##3##(2008-10#2)
the infectoria##3##2##(2008-10#3)
the inference##2##2##(2008-10#1)(2012-3#1)
the inferior competitor##5##3##(2008-8#5)
the inferior vena cava##6##4##(2008-11#3)(2011-2#1)(2013-1#2)
the inferior vena##7##3##(2008-11#3)(2009-5#1)(2011-2#1)(2013-1#2)
the inferior##24##2##(1990-9#1)(1991-12#1)(1992-12#1)(1994-3#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-8#6)(2009-5#1)(2011-2#2)(2013-1#3)
the inferred##2##2##(2008-10#1)(2008-9#1)
the infertile##2##2##(1992-1#1)(2008-12#1)
the infestation with##2##3##(2008-10#2)
the infestation##3##2##(2008-10#3)
the infested soil##2##3##(2008-10#2)
the infested##3##2##(2008-10#3)
the infiltration of PMNLs and MPhi##2##6##(2010-1#2)
the infiltration of##3##3##(2008-5#1)(2010-1#2)
the infinite##2##2##(1994-9#1)(2008-12#1)
the inflammation##2##2##(2008-11#1)(2012-3#1)
the inflammatory cell infiltrates##2##4##(2013-1#2)
the inflammatory changes##2##3##(2008-1#1)(2008-7#1)
the inflammatory process##7##3##(1992-6#3)(1993-1#1)(2008-3#1)(2009-5#1)(2010-12#1)
the inflammatory processes##2##3##(2012-12#1)(2012-3#1)
the inflammatory response in the##2##5##(1994-6#1)(2008-7#1)
the inflammatory response##5##3##(1994-5#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-7#1)
the inflammatory responses of##2##4##(2008-5#1)(2013-1#1)
the inflammatory##31##2##(1992-6#3)(1993-1#1)(1994-5#1)(1994-6#1)(1995-12#1)(1997-8#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#4)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#2)(2012-12#1)(2012-3#1)(2013-1#4)
the inflection points##2##3##(2008-10#1)(2008-8#1)
the inflection##3##2##(2008-10#1)(2008-8#2)
the inflorescence##4##2##(2008-10#4)
the inflow##2##2##(1991-11#1)(1995-12#1)
the influence of a##6##4##(1990-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-5#1)
the influence of age on##4##5##(2008-8#2)(2008-9#2)
the influence of age##5##4##(1994-8#1)(2008-8#2)(2008-9#2)
the influence of different parameters##2##5##(2008-10#2)
the influence of different##11##4##(1996-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
the influence of drought##2##4##(2012-6#1)(2012-9#1)
the influence of excess demand##2##5##(1995-2#2)
the influence of pH##2##4##(2008-10#2)
the influence of several experimental##2##5##(2008-10#2)
the influence of several##5##4##(2008-10#4)(2008-11#1)
the influence of temperature on##2##5##(2008-10#2)
the influence of temperature##3##4##(2008-10#3)
the influence of the##35##4##(1990-2#1)(1994-11#1)(1996-5#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2011-2#3)(2012-9#1)
the influence of these factors##2##5##(2008-10#1)(2008-3#1)
the influence of these parameters on##2##6##(2008-10#1)(2011-2#1)
the influence of these##5##4##(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)
the influence of##219##3##(1990-12#1)(1990-2#3)(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#3)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#3)(1995-2#2)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#63)(2008-11#23)(2008-12#4)(2008-2#4)(2008-3#10)(2008-5#10)(2008-7#5)(2008-8#8)(2008-9#10)(2009-10#2)(2009-11#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#2)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-2#16)(2011-3#1)(2012-2#2)(2012-3#2)(2012-6#1)(2012-9#2)(2013-1#4)(2013-8#5)
the influence on##5##3##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
the influence that##3##3##(1995-2#1)(2008-2#1)(2008-9#1)
the influence##233##2##(1990-12#1)(1990-2#3)(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#3)(1993-2#1)(1994-11#1)(1994-3#3)(1994-8#3)(1995-2#3)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#68)(2008-11#24)(2008-12#4)(2008-2#5)(2008-3#10)(2008-5#10)(2008-7#5)(2008-8#8)(2008-9#11)(2009-10#2)(2009-11#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#2)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-2#17)(2011-3#1)(2012-2#2)(2012-3#3)(2012-6#1)(2012-9#2)(2013-1#5)(2013-8#5)
the influences of different##2##4##(2008-10#1)(2011-2#1)
the influences of##9##3##(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
the influenza##4##2##(1992-6#1)(1992-9#1)(2010-5#1)(2013-1#1)
the influx of Ca2+##2##4##(1990-5#2)
the influx of##3##3##(1990-5#2)(1997-8#1)
the information about##3##3##(2008-10#1)(2010-10#1)(2012-12#1)
the information acquired##2##3##(1991-6#1)(2008-10#1)
the information and##4##3##(1994-2#1)(1995-1#1)(1996-3#1)(2008-4#1)
the information available##3##3##(2008-4#1)(2009-5#1)(2011-2#1)
the information collected##2##3##(2008-11#1)(2012-3#1)
the information for##2##3##(1990-11#1)(1997-8#1)
the information gained in##2##4##(2008-12#1)(2010-11#1)
the information gained##3##3##(2008-10#1)(2008-12#1)(2010-11#1)
the information in the##3##4##(1997-5#1)(2009-10#1)(2011-2#1)
the information needs of##4##4##(1991-12#1)(1994-12#1)(1997-3#2)
the information obtained##2##3##(1994-2#1)(2008-10#1)
the information of##2##3##(2008-11#1)(2008-9#1)
the information on the##2##4##(2008-10#1)(2008-11#1)
the information on##3##3##(2008-10#2)(2008-11#1)
the information provided by##3##4##(2010-6#1)(2010-8#2)
the information superhighway##2##3##(1995-3#1)(1996-2#1)
the information systems##2##3##(1993-2#1)(2012-3#1)
the information technology##4##3##(1993-2#1)(1994-12#1)(1996-1#1)(1996-3#1)
the information they##2##3##(2008-9#1)(2010-5#1)
the information to##2##3##(1993-12#1)(2008-10#1)
the information##83##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#2)(1994-12#3)(1994-2#3)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#4)(1996-5#1)(1997-3#7)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-4#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)
the informed##2##2##(1995-12#1)(2010-7#1)
the infrared##5##2##(1991-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
the infraspinatus##2##2##(2008-12#2)
the infrastructure needed to##2##4##(1994-1#1)(1994-9#1)
the infrastructure##4##2##(1994-1#1)(1994-9#1)(1995-12#1)(1997-1#1)
the infusion##6##2##(1997-3#1)(2008-7#3)(2010-11#1)(2012-3#1)
the ingenuity pathway analysis##2##4##(2010-12#2)
the ingested##3##2##(2008-11#2)(2008-7#1)
the ingestion of the##2##4##(1992-2#1)(2013-8#1)
the ingestion of##4##3##(1992-2#1)(1993-6#1)(1994-5#1)(2013-8#1)
the ingredient##4##2##(2008-5#3)(2012-2#1)
the ingredients##2##2##(2008-10#1)(2008-11#1)
the inguinal##6##2##(1994-12#1)(2008-10#1)(2008-7#1)(2009-9#2)(2011-2#1)
the inhabitants##2##2##(1991-3#1)(1991-6#1)
the inhalation##2##2##(1996-3#1)(2008-10#1)
the inhaled##4##2##(1992-3#1)(1997-1#1)(2007-11#1)(2013-1#1)
the inherent characteristics of##2##4##(2008-10#1)(2011-2#1)
the inherent##16##2##(1993-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
the inheritance of resistance to##2##5##(2008-10#2)
the inheritance of resistance##3##4##(2008-10#3)
the inheritance of the##2##4##(2008-10#1)(2008-12#1)
the inheritance of##13##3##(1994-9#1)(1996-12#1)(2008-10#7)(2008-12#2)(2008-4#1)(2008-8#1)
the inheritance##14##2##(1994-9#1)(1996-12#1)(2008-10#7)(2008-12#2)(2008-4#1)(2008-8#1)(2011-2#1)
the inherited##2##2##(2008-7#2)
the inhibited##2##2##(2008-10#2)
the inhibiting##3##2##(2008-10#1)(2008-8#2)
the inhibition by the##2##4##(1994-2#1)(2008-9#1)
the inhibition by##7##3##(1993-8#1)(1994-11#1)(1994-2#1)(2008-9#4)
the inhibition effect##5##3##(2008-10#5)
the inhibition of fungal##2##4##(2008-10#2)
the inhibition of phospholipase##2##4##(1994-11#1)(1997-1#1)
the inhibition of protein##3##4##(1994-11#1)(1995-8#2)
the inhibition of the##7##4##(1990-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-9#1)
the inhibition of##81##3##(1990-5#2)(1990-8#2)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-11#3)(1994-5#1)(1994-8#2)(1995-11#4)(1995-2#1)(1995-6#2)(1995-8#3)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#9)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#6)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
the inhibition was##3##3##(1991-12#1)(1992-3#1)(1994-11#1)
the inhibition##112##2##(1990-5#2)(1990-8#2)(1991-12#5)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#3)(1994-11#5)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#4)(1995-2#2)(1995-6#2)(1995-8#3)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#17)(2008-11#9)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#5)(2008-9#11)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
the inhibitor of protein tyrosine##2##5##(2008-8#2)
the inhibitor of##4##3##(2008-8#2)(2013-1#1)(2013-8#1)
the inhibitor##16##2##(1990-5#1)(1991-3#4)(1992-12#1)(1994-11#3)(2008-8#2)(2009-12#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
the inhibitors##5##2##(1990-10#1)(1992-10#1)(1993-8#1)(1995-11#1)(1995-12#1)
the inhibitory action of the##3##5##(1990-11#1)(1994-8#1)(2008-10#1)
the inhibitory action##4##3##(1990-11#1)(1994-8#1)(2008-10#1)(2013-7#1)
the inhibitory activity of ochnaflavone##2##5##(1994-11#2)
the inhibitory activity of##3##4##(1994-11#2)(2008-5#1)
the inhibitory activity##5##3##(1990-5#1)(1994-11#2)(2008-5#2)
the inhibitory effect of##18##4##(1991-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-4#2)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-3#1)
the inhibitory effect was##3##4##(1995-6#1)(2008-10#1)(2008-9#1)
the inhibitory effect##23##3##(1991-6#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#2)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-3#1)
the inhibitory effects of##8##4##(1994-12#1)(1994-8#1)(1995-11#2)(2008-10#1)(2008-11#2)(2012-3#1)
the inhibitory effects on##2##4##(2008-10#1)(2008-11#1)
the inhibitory effects##11##3##(1994-12#1)(1994-8#1)(1995-11#3)(2008-10#2)(2008-11#3)(2012-3#1)
the inhibitory factor##3##3##(1996-2#3)
the inhibitory##63##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#4)(1995-11#4)(1995-2#1)(1995-6#1)(1996-2#5)(1996-5#1)(1997-1#1)(1997-4#2)(2008-10#11)(2008-11#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-8#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-7#1)
the inhomogeneity##2##2##(2008-3#2)
the initial analysis##2##3##(2008-10#2)
the initial and terminal##2##4##(1993-11#2)
the initial and##4##3##(1993-11#2)(2008-10#1)(2011-2#1)
the initial cleavage of##2##4##(1990-9#1)(2008-8#1)
the initial clinical##3##3##(1997-8#1)(2008-7#1)(2010-12#1)
the initial concentration of the##2##5##(2008-10#2)
the initial concentration of##4##4##(2008-10#4)
the initial concentration##5##3##(2008-10#5)
the initial development of##2##4##(2008-12#1)(2008-8#1)
the initial diagnosis##3##3##(1996-3#1)(2011-2#1)(2013-8#1)
the initial fitting session and for the following##2##8##(2008-9#2)
the initial fitting session##3##4##(2008-9#3)
the initial headspace##2##3##(2011-2#2)
the initial imaging##2##3##(2011-2#2)
the initial infection##4##3##(2008-10#4)
the initial infestation in##2##4##(1996-12#2)
the initial inoculum##3##3##(2008-10#3)
the initial operation##5##3##(2011-2#4)(2012-3#1)
the initial phase of##4##4##(2008-10#1)(2008-2#1)(2012-3#1)(2013-8#1)
the initial phase##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)(2013-8#1)
the initial population##2##3##(2008-10#1)(2008-8#1)
the initial process##2##3##(2008-11#1)(2008-2#1)
the initial pulse##2##3##(2007-12#2)
the initial rate method##2##4##(2008-10#2)
the initial rate of##3##4##(1994-5#1)(2008-10#2)
the initial rate##8##3##(1994-5#1)(2008-10#7)
the initial reduction##2##3##(2010-7#1)(2011-2#1)
the initial stage of##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
the initial stages of the##2##5##(2007-12#1)(2008-10#1)
the initial stages of##6##4##(2007-12#2)(2008-1#2)(2008-10#1)(2009-8#1)
the initial stages##7##3##(2007-12#2)(2008-1#2)(2008-10#1)(2009-8#1)(2010-12#1)
the initial state##2##3##(2008-2#1)(2008-8#1)
the initial steps##2##3##(2008-10#1)(2011-3#1)
the initial stress##3##3##(2008-5#3)
the initial therapeutic##2##3##(1993-11#1)(2008-11#1)
the initial##220##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#1)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#67)(2008-11#13)(2008-12#3)(2008-2#3)(2008-3#4)(2008-5#3)(2008-7#5)(2008-8#11)(2008-9#6)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#2)(2011-1#2)(2011-2#19)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#6)
the initially##5##2##(1996-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-7#1)
the initiation and development of##2##5##(1997-4#1)(2008-8#1)
the initiation and maintenance of##2##5##(1993-3#1)(2008-7#1)
the initiation and propagation of##2##5##(2008-2#1)(2011-1#1)
the initiation and##9##3##(1993-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
the initiation codons##2##3##(1996-8#2)
the initiation of PD therapy##2##5##(2011-2#2)
the initiation of highly active antiretroviral therapy (HAART)##2##8##(2009-7#1)(2011-2#1)
the initiation of lambda plasmid DNA replication##2##7##(1994-11#2)
the initiation of the##3##4##(2008-10#2)(2010-8#1)
the initiation of##35##3##(1990-5#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-11#2)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-5#2)(2010-8#3)(2011-2#6)(2013-1#2)
the initiation or##2##3##(1993-6#1)(2008-11#1)
the initiation sites were##2##4##(1997-6#2)
the initiation##56##2##(1990-5#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#3)(1996-8#2)(1997-4#1)(1997-6#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#7)(2013-1#4)
the initiative##6##2##(1994-12#1)(1994-3#1)(2008-1#1)(2008-11#1)(2010-1#1)(2012-2#1)
the initiator##2##2##(1990-5#1)(1990-8#1)
the injected dose##3##3##(1993-11#1)(2010-1#1)(2013-1#1)
the injected sample##3##3##(2008-10#3)
the injected##15##2##(1991-12#1)(1993-11#1)(1993-6#1)(1995-12#1)(2008-10#8)(2008-8#1)(2010-1#1)(2013-1#1)
the injection and##2##3##(1990-5#1)(2008-9#1)
the injection of a##2##4##(2008-10#2)
the injection of##17##3##(1994-5#1)(1994-8#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-8#1)(2009-12#1)(2011-2#2)(2012-3#1)
the injection site##9##3##(1990-6#1)(1994-5#1)(1996-12#1)(1997-3#2)(2008-12#1)(2008-8#1)(2011-2#2)
the injection##49##2##(1990-5#1)(1990-6#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-5#3)(1994-8#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-5#2)(2008-1#1)(2008-10#13)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#6)(2012-3#1)(2013-8#1)
the injector temperature##2##3##(2008-10#2)
the injector##3##2##(2008-10#3)
the injured spinal cord##2##4##(2008-7#2)
the injured##9##2##(1990-6#1)(1991-12#1)(1995-1#1)(1996-12#1)(1997-3#2)(2008-7#2)(2010-6#1)
the injuries##2##2##(1990-6#1)(2009-7#1)
the injury rate##3##3##(1997-2#1)(2008-11#2)
the injury##10##2##(1991-12#1)(1995-10#1)(1997-2#1)(2008-11#2)(2008-9#2)(2009-8#1)(2012-12#1)(2013-8#1)
the ink##2##2##(2008-10#2)
the innate and##2##3##(2010-1#1)(2013-8#1)
the innate immune response##2##4##(2010-1#1)(2013-8#1)
the innate immune system##3##4##(2008-10#2)(2010-1#1)
the innate immune##6##3##(2008-10#2)(2010-1#2)(2012-3#1)(2013-8#1)
the innate##11##2##(2008-10#2)(2008-11#1)(2010-1#3)(2012-3#2)(2013-1#1)(2013-8#2)
the inner cell mass of##2##5##(2008-9#2)
the inner cell mass##3##4##(2008-5#1)(2008-9#2)
the inner core##4##3##(1995-3#3)(2008-8#1)
the inner ear##5##3##(1994-9#1)(2008-9#2)(2011-1#2)
the inner filter effect and##2##5##(2008-10#1)(2008-11#1)
the inner filter effect##4##4##(2008-10#2)(2008-11#2)
the inner layer of##2##4##(2008-10#1)(2008-12#1)
the inner leaflet##2##3##(2008-11#2)
the inner lipid##2##3##(1991-5#2)
the inner membrane##6##3##(1990-2#2)(1991-10#1)(1992-7#1)(1997-8#1)(2013-8#1)
the inner mitochondrial membrane##2##4##(1990-11#1)(2012-2#1)
the inner mitochondrial##3##3##(1990-11#1)(1994-5#1)(2012-2#1)
the inner nuclear membrane##2##4##(2008-9#1)(2011-2#1)
the inner nuclear##3##3##(1991-10#1)(2008-9#1)(2011-2#1)
the inner shell##2##3##(2008-8#2)
the inner side of the##2##5##(2008-10#1)(2008-9#1)
the inner surface of the##3##5##(2008-10#2)(2008-11#1)
the inner wall of the##2##5##(2008-10#2)
the inner wall of##3##4##(2008-10#3)
the inner wall##5##3##(1997-2#1)(2008-10#3)(2008-9#1)
the inner walls of##3##4##(1997-2#1)(2008-10#2)
the inner##70##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-10#4)(1991-5#4)(1992-7#1)(1994-5#1)(1994-9#1)(1995-3#3)(1996-12#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-10#20)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#7)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#2)
the innermost GlcNAc##2##3##(1994-5#1)(2008-11#1)
the innermost##4##2##(1994-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
the innervation of##2##3##(2008-8#1)(2013-8#1)
the innovation##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
the inoculated Fusarium species##2##4##(2008-10#2)
the inoculated control##3##3##(2008-10#3)
the inoculated leaf##5##3##(2008-10#5)
the inoculated leaves##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
the inoculated##35##2##(2008-10#30)(2008-5#4)(2008-8#1)
the inoculation site##4##3##(2008-10#4)
the inoculation##12##2##(2008-10#10)(2008-11#1)(2008-8#1)
the inoculum and##2##3##(2008-10#2)
the inoculum density##5##3##(2008-10#5)
the inoculum was##2##3##(2008-10#2)
the inoculum##25##2##(1991-11#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-7#3)
the inorganic##14##2##(1990-5#1)(1995-11#1)(2008-10#9)(2008-6#1)(2008-7#1)(2010-4#1)
the inositol##4##2##(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)
the inpatient treatment##2##3##(1991-2#1)(1992-3#1)
the inpatient##5##2##(1991-2#1)(1992-3#1)(1993-2#1)(2010-12#1)(2013-1#1)
the input and the##3##4##(2008-3#3)
the input and##4##3##(2008-2#1)(2008-3#3)
the input laser##2##3##(2008-3#2)
the input layer##5##3##(2008-10#2)(2010-8#3)
the input of##3##3##(1993-2#1)(2009-11#1)(2011-3#1)
the input parameters##2##3##(2008-2#2)
the input sequences##2##3##(2008-11#1)(2008-9#1)
the input variables##3##3##(2008-10#3)
the input##39##2##(1992-6#1)(1992-9#1)(1993-2#1)(2007-11#1)(2008-10#5)(2008-11#4)(2008-2#5)(2008-3#11)(2008-6#1)(2008-9#3)(2009-11#1)(2010-5#1)(2010-8#3)(2011-3#1)
the input-output##2##2##(2008-8#1)(2012-2#1)
the inputs to##2##3##(1993-6#1)(2009-10#1)
the inputs##5##2##(1992-2#1)(1993-6#1)(2008-10#1)(2008-11#1)(2009-10#1)
the insect cell##2##3##(1993-6#1)(2008-11#1)
the insect organs##2##3##(2008-10#2)
the insect##18##2##(1992-6#1)(1993-6#1)(1995-11#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-7#1)(2008-9#1)(2012-2#1)
the insect's##3##2##(2008-10#3)
the insects##2##2##(2008-10#1)(2008-9#1)
the insensitive##2##2##(2008-10#2)
the insensitivity##3##2##(2008-10#2)(2008-7#1)
the insert##2##2##(1992-6#1)(2008-11#1)
the inserted T-DNA##2##3##(2008-10#2)
the inserted##7##2##(1997-8#4)(2008-10#2)(2008-11#1)
the insertion of the##4##4##(2008-10#2)(2008-7#1)(2008-9#1)
the insertion of##13##3##(1995-11#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
the insertion##22##2##(1995-11#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#4)(2010-6#1)(2011-2#1)(2013-1#2)
the inserts##2##2##(2008-10#2)
the inside needle capillary adsorption trap (INCAT)##2##7##(2008-10#2)
the inside needle capillary adsorption trap##3##6##(2008-10#3)
the inside of##3##3##(2008-10#1)(2008-2#1)(2009-8#1)
the inside##9##2##(2008-10#5)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)
the insoluble##4##2##(1990-5#1)(1994-11#2)(2008-10#1)
the instability of##4##3##(2008-11#1)(2008-3#1)(2011-2#1)(2011-7#1)
the instability##5##2##(2008-11#1)(2008-3#1)(2011-2#1)(2011-7#1)(2012-3#1)
the installation of a##2##4##(2008-10#2)
the installation of##3##3##(1994-3#1)(2008-10#2)
the installation##4##2##(1994-3#2)(2008-10#2)
the instantaneous##6##2##(1990-11#1)(2008-10#1)(2008-3#1)(2010-8#2)(2012-2#1)
the institution of##3##3##(1996-12#1)(1997-2#1)(2011-2#1)
the institution##12##2##(1991-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-11#1)(2010-6#1)(2011-2#3)(2012-2#1)
the institutional##2##2##(1994-12#1)(2009-4#1)
the institutionalization of##2##3##(2010-1#2)
the institutions##2##2##(2012-12#1)(2012-3#1)
the instruction of##2##3##(2009-11#1)(2011-3#1)
the instruction##3##2##(1993-8#1)(2009-11#1)(2011-3#1)
the instrument are##2##3##(2008-10#1)(2008-3#1)
the instrument is##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
the instrument was##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
the instrument##42##2##(1993-3#1)(1997-1#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-3#13)(2008-9#1)(2009-12#4)(2010-10#1)(2010-12#1)(2010-7#1)(2012-2#1)
the instrument's##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
the instrumental##14##2##(1991-3#1)(2008-10#11)(2008-3#2)
the instrumentation##2##2##(2008-10#1)(2008-8#1)
the instruments##10##2##(1995-3#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#6)
the insufficient##2##2##(2008-10#1)(2011-1#1)
the insufflation gas##2##3##(1992-12#2)
the insulin producing##2##3##(2010-11#2)
the insulin receptor gene##3##4##(1994-12#3)
the insulin receptor##7##3##(1993-8#1)(1994-12#3)(2008-4#2)(2010-12#1)
the insulin secretion##3##3##(2008-11#3)
the insulin signaling pathway##4##4##(2008-11#2)(2010-12#2)
the insulin##22##2##(1993-8#1)(1994-12#3)(1996-3#1)(2008-11#5)(2008-4#3)(2008-6#1)(2008-9#1)(2010-11#2)(2010-12#3)(2011-1#1)(2012-3#1)
the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes##3##8##(1995-8#3)
the insulin-like growth##2##3##(1992-4#1)(1997-1#1)
the insulin-stimulated##4##2##(1995-11#1)(1995-6#1)(2008-11#1)(2008-9#1)
the insult##3##2##(1994-2#1)(2008-11#1)(2008-7#1)
the insurance##8##2##(1991-12#1)(1992-1#1)(1993-12#2)(1994-1#1)(1995-1#1)(1997-3#2)
the intact murine##3##3##(2008-10#3)
the intact side of the aged##2##6##(1996-2#2)
the intact side##3##3##(1996-2#3)
the intact##32##2##(1990-2#1)(1991-2#2)(1992-3#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-2#2)(1996-2#3)(1997-8#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#3)(2013-8#1)
the intake of RS extract##3##5##(2008-11#3)
the intake of##8##3##(1991-2#1)(1994-12#1)(2008-1#1)(2008-11#3)(2009-8#1)(2011-2#1)
the integral of##2##3##(1994-6#1)(2008-7#1)
the integral##6##2##(1993-3#1)(1994-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
the integrase##3##2##(1992-6#1)(1997-3#2)
the integrated platform##4##3##(2008-10#4)
the integrated##21##2##(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-9#2)(2009-10#1)(2012-2#1)(2012-3#1)
the integration and##2##3##(2008-11#2)
the integration of multiple##2##4##(2008-11#1)(2012-3#1)
the integration of the##6##4##(1993-6#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
the integration of##32##3##(1991-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#2)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#2)
the integration process##2##3##(1997-1#2)
the integration##38##2##(1991-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#2)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#5)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
the integrative##4##2##(1994-2#1)(1994-3#1)(1996-1#1)(2013-8#1)
the integrin##6##2##(1992-2#1)(1994-5#1)(1995-6#1)(1997-2#1)(2006-6#1)(2008-5#1)
the integrity of the##13##4##(1990-2#1)(1990-5#1)(1992-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
the integrity of##23##3##(1990-2#1)(1990-5#2)(1992-3#1)(1993-3#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
the integrity##24##2##(1990-2#1)(1990-5#2)(1992-3#1)(1993-3#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
the intelligentsia##4##2##(2008-12#4)
the intended##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-6#1)
the intense##3##2##(1991-3#1)(2008-10#1)(2008-2#1)
the intensifying##2##2##(2008-10#1)(2010-12#1)
the intensities of the##2##4##(2008-10#1)(2008-8#1)
the intensity and the##2##4##(2007-12#1)(2008-10#1)
the intensity and unpleasantness of perceived dyspnea##2##7##(2008-10#2)
the intensity and##11##3##(1994-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
the intensity inside the##2##4##(2008-3#2)
the intensity of Fos-like##2##4##(1997-2#2)
the intensity of foraging##2##4##(2008-8#2)
the intensity of the contralateral stimulation##2##6##(1993-3#2)
the intensity of the##16##4##(1993-3#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#1)
the intensity of##55##3##(1992-1#1)(1993-3#2)(1994-2#1)(1995-8#1)(1996-1#1)(1997-2#3)(1997-3#2)(2007-11#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2013-8#1)
the intensity profile of##2##4##(2008-2#1)(2008-3#1)
the intensity profile##3##3##(2008-2#1)(2008-3#2)
the intensity##80##2##(1992-1#1)(1993-3#2)(1994-2#2)(1995-12#1)(1995-8#1)(1996-1#1)(1997-2#3)(1997-3#2)(2007-11#2)(2007-12#1)(2008-10#27)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
the intensive care unit##6##4##(1991-2#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
the intensive care##7##3##(1991-2#1)(1995-1#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
the intensive##10##2##(1991-2#1)(1992-5#1)(1995-1#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
the intent of the##2##4##(1994-2#1)(2009-4#1)
the intent of##5##3##(1994-1#1)(1994-2#1)(2008-12#1)(2009-4#1)(2010-5#1)
the intention of##2##3##(1995-3#1)(2008-10#1)
the intention##4##2##(1995-3#1)(2008-10#2)(2013-8#1)
the intentional##3##2##(2008-11#1)(2009-10#1)(2012-3#1)
the inter##3##2##(2008-10#1)(2012-3#2)
the inter-war period##2##3##(2008-12#2)
the inter-war##3##2##(2008-12#3)
the interacting##5##2##(2008-11#2)(2008-8#1)(2009-12#1)(2009-8#1)
the interaction between F##2##4##(2008-10#2)
the interaction between RIPs and##2##5##(2008-8#2)
the interaction between a##2##4##(2008-10#2)
the interaction between hIL-6 and##2##5##(2008-8#2)
the interaction between the two##2##5##(2008-10#1)(2012-3#1)
the interaction between the##10##4##(2008-10#6)(2008-11#1)(2008-7#1)(2010-7#1)(2012-3#1)
the interaction between two##2##4##(2008-10#2)
the interaction between##63##3##(1990-12#1)(1991-2#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(2006-6#2)(2008-1#1)(2008-10#29)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#9)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
the interaction effects of##2##4##(2008-10#1)(2008-4#1)
the interaction effects##3##3##(2008-10#2)(2008-4#1)
the interaction is##3##3##(1994-5#1)(2008-10#2)
the interaction of G##2##4##(1995-6#1)(2008-9#1)
the interaction of a##4##4##(2008-10#2)(2008-2#1)(2008-8#1)
the interaction of different##2##4##(2008-10#1)(2008-9#1)
the interaction of known##2##4##(2008-11#1)(2008-7#1)
the interaction of neutral red##2##5##(2008-10#2)
the interaction of protein kinase C##2##6##(1994-5#2)
the interaction of protein##3##4##(1994-5#2)(2008-10#1)
the interaction of proteins##2##4##(2008-10#1)(2011-2#1)
the interaction of the##5##4##(1994-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
the interaction of two##3##4##(2008-10#2)(2008-8#1)
the interaction of##86##3##(1991-1#1)(1991-5#2)(1991-9#1)(1993-6#1)(1993-8#2)(1994-5#4)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-2#1)(2008-10#42)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-7#2)(2010-5#1)(2011-2#2)(2012-2#2)
the interaction with the##3##4##(2008-10#3)
the interaction with##8##3##(1994-5#1)(1995-6#1)(2008-10#4)(2008-4#1)(2010-4#1)
the interaction##188##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-6#2)(1993-8#3)(1994-11#1)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#3)(1996-12#1)(1997-2#1)(2006-6#2)(2008-1#1)(2008-10#93)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#13)(2008-9#9)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#7)(2011-3#2)(2012-2#3)(2012-3#1)
the interactional##2##2##(2010-10#1)(2013-8#1)
the interactions among 2##2##4##(2008-10#2)
the interactions among##5##3##(1993-1#1)(2008-10#4)
the interactions between genes##2##4##(2012-3#2)
the interactions between the##5##4##(2008-10#2)(2008-8#1)(2012-12#1)(2013-8#1)
the interactions between##21##3##(1993-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#2)(2012-4#1)(2013-1#1)(2013-8#2)
the interactions of the##5##4##(1993-8#1)(2008-10#2)(2008-9#1)(2010-4#1)
the interactions of##16##3##(1991-9#1)(1993-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-4#1)(2010-9#1)
the interactions with##2##3##(2008-10#1)(2008-5#1)
the interactions within##2##3##(2008-7#1)(2012-3#1)
the interactions##55##2##(1991-9#1)(1993-1#1)(1993-8#2)(1997-2#1)(2008-10#22)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#3)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#3)(2012-4#1)(2013-1#1)(2013-8#2)
the interautogamous interval (IAI)##2##4##(2008-12#2)
the intercalary segment##2##3##(2007-12#2)
the intercalated##5##2##(1994-5#1)(2008-10#3)(2010-4#1)
the intercalation of##4##3##(1993-8#2)(2008-10#1)(2009-6#1)
the intercalation##5##2##(1993-8#2)(2008-10#1)(2009-6#1)(2010-4#1)
the intercellular space of the##2##5##(2008-10#2)
the intercellular space##3##3##(2008-10#2)(2008-5#1)
the intercellular spaces of the##3##5##(2008-10#3)
the intercellular spaces##4##3##(2008-10#4)
the intercellular##10##2##(1994-11#1)(2008-10#8)(2008-5#1)
the intercept of##2##3##(2008-10#1)(2009-8#1)
the intercept##7##2##(2008-10#6)(2009-8#1)
the interchain##2##2##(1990-5#1)(1993-6#1)
the intercorneocyte##2##2##(2008-5#2)
the intercostal fields were##2##4##(2008-10#2)
the intercostal region##2##3##(2008-10#2)
the intercostal##5##2##(2008-10#4)(2011-2#1)
the interdomain##2##2##(1993-2#1)(2009-7#1)
the interest in##6##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-12#1)
the interest of##5##3##(1994-1#2)(2008-11#1)(2008-6#1)(2010-9#1)
the interest##13##2##(1994-1#2)(1995-2#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-9#1)
the interesting##3##2##(1996-2#1)(1997-8#1)(2008-10#1)
the interests##2##2##(1992-1#1)(2013-1#1)
the interface between the##3##4##(2008-10#2)(2008-9#1)
the interface between##10##3##(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2009-10#1)
the interface of the##6##4##(1991-12#1)(2008-10#3)(2008-3#1)(2008-8#1)
the interface of##11##3##(1991-12#1)(2008-10#6)(2008-3#2)(2008-8#1)(2009-12#1)
the interface##29##2##(1991-12#1)(2008-10#16)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2013-8#1)
the interfacial properties of surface-active samples##2##6##(2008-10#2)
the interfacial properties of##3##4##(2008-10#3)
the interfacial##12##2##(1993-6#1)(2008-10#10)(2008-7#1)
the interference by##3##3##(2008-10#3)
the interference caused by##2##4##(2008-10#2)
the interference effect of##3##4##(2008-10#3)
the interference effect##4##3##(2007-12#1)(2008-10#3)
the interference effects##2##3##(2008-10#1)(2008-3#1)
the interference from other##2##4##(2008-10#2)
the interference from##9##3##(2008-10#8)(2008-3#1)
the interference of ascorbic acid##2##5##(2008-10#2)
the interference of both##2##4##(2008-10#2)
the interference of other##2##4##(2008-10#2)
the interference of the##5##4##(2008-10#3)(2008-5#1)(2013-1#1)
the interference of##34##3##(2007-12#1)(2008-10#28)(2008-2#1)(2008-5#2)(2009-12#1)(2013-1#1)
the interference##65##2##(2007-12#2)(2008-10#50)(2008-2#2)(2008-3#3)(2008-5#2)(2009-12#1)(2013-1#1)(2013-8#4)
the interferences caused by##4##4##(2008-10#4)
the interferences from##4##3##(2008-10#4)
the interferences of##2##3##(2008-10#2)
the interferences##15##2##(2008-10#15)
the interfering##6##2##(1995-3#1)(2008-10#5)
the interferometric signal##2##3##(2008-3#2)
the interferometric##3##2##(2008-3#3)
the interferon##2##2##(1997-1#1)(2009-5#1)
the interfragmentary contact##2##3##(2013-1#2)
the intergenic region##5##3##(1994-11#1)(2008-10#4)
the intergenic spacer (IGS) of the##2##6##(2008-10#2)
the intergenic spacer (IGS) region of##2##6##(2008-10#2)
the intergenic spacer (IGS)##4##4##(2008-10#4)
the intergenic spacer##6##3##(2008-10#6)
the intergenic##13##2##(1994-11#1)(2008-10#12)
the interhyoid muscle##6##3##(2011-2#6)
the interhyoid##7##2##(2011-2#7)
the interim##3##2##(2008-11#2)(2012-2#1)
the interior of##5##3##(1994-11#1)(2008-10#3)(2010-10#1)
the interior##10##2##(1992-3#1)(1994-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-10#1)(2010-10#1)
the intermediary##3##2##(1991-11#1)(2008-10#2)
the intermediate and##2##3##(1990-9#1)(2008-7#1)
the intermediate filaments##2##3##(2009-10#1)(2009-8#1)
the intermediate precision##2##3##(2008-10#2)
the intermediate##21##2##(1990-8#1)(1990-9#1)(1992-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#3)(2010-10#2)(2010-8#1)
the intermediates##3##2##(1997-4#1)(2008-10#1)(2008-4#1)
the intermolecular alignment##2##3##(2008-10#2)
the intermolecular##3##2##(2008-10#3)
the internal bladder##2##3##(2008-10#2)
the internal carotid artery##8##4##(1997-3#1)(2008-7#4)(2011-2#2)(2012-3#1)
the internal partitioning##2##3##(1991-3#2)
the internal phloem##2##3##(2008-10#2)
the internal standard method##3##4##(1993-3#1)(2008-10#2)
the internal standard##12##3##(1993-3#1)(2008-10#11)
the internal structure of the##2##5##(1991-2#1)(2009-12#1)
the internal structure##3##3##(1991-2#1)(2009-12#1)(2013-8#1)
the internal transcribed spacer (ITS) region##8##6##(2008-10#8)
the internal transcribed spacer (ITS) regions of##3##7##(2008-10#3)
the internal transcribed spacer (ITS) regions##5##6##(2008-10#5)
the internal transcribed spacer (ITS)##17##5##(2008-10#17)
the internal transcribed spacer (ITS)-1##2##5##(2008-10#2)
the internal transcribed spacer 1 region of##2##7##(2008-10#2)
the internal transcribed spacer 1 region##3##6##(2008-10#3)
the internal transcribed spacer 1##4##5##(2008-10#4)
the internal transcribed spacer region of##2##6##(2008-10#2)
the internal transcribed spacer region##6##5##(2008-10#6)
the internal transcribed spacer##35##4##(2008-10#35)
the internal transcribed##36##3##(2008-10#36)
the internal vertebral venous plexus##3##5##(2011-2#3)
the internal##117##2##(1990-2#1)(1990-3#2)(1990-9#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-3#2)(1997-4#1)(2008-10#65)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-5#1)(2011-2#7)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
the internalization of##4##3##(1997-1#1)(2008-11#3)
the internalization##6##2##(1994-8#2)(1997-1#1)(2008-11#3)
the international literature##5##3##(1991-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-3#1)
the international##23##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-9#1)(1994-8#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2010-10#1)(2010-12#1)(2011-3#1)(2012-12#1)(2013-1#2)
the internet##6##2##(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#1)(2012-3#2)
the interpersonal competence##2##3##(2012-3#2)
the interpersonal##3##2##(1991-3#1)(2012-3#2)
the interplay between##6##3##(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)
the interplay of##2##3##(2011-3#1)(2013-7#1)
the interplay##9##2##(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-3#1)(2012-3#1)(2013-7#1)
the interpolated##2##2##(2008-10#2)
the interpretation and##2##3##(1993-3#1)(2010-9#1)
the interpretation of CT##2##4##(1997-8#2)
the interpretation of the obtained results##2##6##(2008-10#2)
the interpretation of the##12##4##(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)
the interpretation of##33##3##(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-8#2)(2007-11#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#1)(2012-2#1)
the interpretation that the##2##4##(1997-9#1)(2008-11#1)
the interpretation##39##2##(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-8#2)(1997-9#1)(2007-11#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-9#1)(2012-2#1)
the interrelationship##2##2##(1995-2#1)(2008-10#1)
the interrelationships among##2##3##(2008-10#1)(2008-12#1)
the interrelationships##3##2##(2008-10#2)(2008-12#1)
the interruption##2##2##(2009-11#1)(2012-12#1)
the intersection of##2##3##(2008-11#1)(2008-3#1)
the intersection##3##2##(2008-11#1)(2008-3#2)
the interside difference of the muscle potential latency##2##8##(2008-7#2)
the interspecific##2##2##(2008-10#1)(2012-3#1)
the interstitial##4##2##(1991-12#1)(1997-2#1)(2008-10#1)(2013-8#1)
the interval between##3##3##(2008-10#2)(2008-7#1)
the interval of##5##3##(1991-2#1)(2008-5#2)(2008-7#1)(2013-8#1)
the interval##12##2##(1991-2#1)(1994-11#1)(2008-10#4)(2008-5#3)(2008-7#2)(2013-8#1)
the intervening##4##2##(2008-11#2)(2012-3#1)(2013-1#1)
the intervention and##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)
the intervention are##2##3##(2008-12#1)(2013-1#1)
the intervention group##6##3##(2008-12#2)(2010-4#3)(2013-1#1)
the intervention to##2##3##(2008-12#1)(2010-4#1)
the intervention were##4##3##(2008-12#2)(2011-1#1)(2013-1#1)
the intervention##46##2##(1995-1#1)(1997-2#1)(2008-10#1)(2008-12#14)(2008-4#5)(2008-8#4)(2008-9#1)(2010-10#2)(2010-11#1)(2010-4#4)(2011-1#2)(2011-2#1)(2011-9#1)(2012-12#1)(2013-1#7)
the interventions##11##2##(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-2#3)(2013-1#3)
the intervertebral foramen##3##3##(2011-2#1)(2013-8#2)
the intervertebral##4##2##(2011-2#1)(2012-2#1)(2013-8#2)
the interview was##2##3##(1990-12#1)(2012-3#1)
the interview##13##2##(1990-12#3)(1990-6#1)(1991-6#1)(1993-3#1)(1996-8#1)(1997-1#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#2)
the interviews were##3##3##(2008-12#1)(2011-1#1)(2011-2#1)
the interviews##6##2##(1997-3#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
the intestinal epithelial##3##3##(2008-10#1)(2008-11#2)
the intestinal epithelium##4##3##(2008-9#1)(2009-8#1)(2010-1#1)(2011-1#1)
the intestinal immune system##2##4##(2008-11#1)(2009-12#1)
the intestinal lumen##3##3##(1996-6#1)(2011-2#2)
the intestinal mucosa##4##3##(1992-12#1)(1996-3#1)(1996-6#1)(2009-8#1)
the intestinal##32##2##(1990-2#1)(1992-12#2)(1994-8#3)(1996-3#1)(1996-6#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-1#1)(2010-5#2)(2011-1#2)(2011-2#4)
the intestine and##5##3##(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#1)
the intestine##14##2##(1992-6#1)(1995-2#1)(1995-5#1)(1995-9#1)(2008-10#3)(2008-11#2)(2008-5#2)(2010-12#1)(2011-1#1)(2011-2#1)
the intimal##3##2##(2006-6#2)(2010-4#1)
the intimate##2##2##(2009-10#1)(2009-7#1)
the intra- and##5##3##(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
the intra-##6##2##(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
the intra-abdominal##2##2##(1996-11#1)(2008-10#1)
the intracavity power##2##3##(2008-10#1)(2008-3#1)
the intracavity##8##2##(2008-10#1)(2008-2#1)(2008-3#6)
the intracellular Ca2+##3##3##(1994-3#1)(1994-6#1)(1996-5#1)
the intracellular accumulation of##4##4##(1994-11#1)(1995-6#1)(2008-11#1)(2013-1#1)
the intracellular accumulation##5##3##(1994-11#1)(1995-6#1)(2008-11#2)(2013-1#1)
the intracellular concentration##2##3##(1990-5#1)(2008-7#1)
the intracellular concentrations of##3##4##(1996-6#1)(2008-11#1)(2008-7#1)
the intracellular content of##2##4##(1994-6#1)(2008-11#1)
the intracellular distribution of##2##4##(2008-11#2)
the intracellular fluorescent##2##3##(2008-4#1)(2008-9#1)
the intracellular nucleotide pools##2##4##(2008-11#2)
the intracellular nucleotide##3##3##(2008-11#3)
the intracellular pH##2##3##(2008-10#1)(2008-11#1)
the intracellular pathways of##2##4##(1995-5#1)(2008-7#1)
the intracellular trafficking##2##3##(1994-8#1)(1995-5#1)
the intracellular##68##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-3#3)(1994-6#3)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#5)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(2008-10#1)(2008-11#22)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
the intracluster correlation coefficient##2##4##(1992-9#1)(2008-10#1)
the intracluster correlation##3##3##(1992-9#1)(2008-10#2)
the intracortical##2##2##(1996-2#1)(2008-11#1)
the intracranial##5##2##(1995-11#1)(1997-3#1)(2007-9#1)(2011-2#1)(2012-2#1)
the intramolecular##5##2##(1993-2#1)(1996-5#2)(2008-10#2)
the intramuscular connective tissue##2##4##(2013-1#2)
the intramuscular##5##2##(2008-8#1)(2010-4#2)(2013-1#2)
the intraocular pressure##2##3##(1993-1#1)(2013-1#1)
the intraocular##4##2##(1993-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
the intraoperative period in##2##4##(2010-5#1)(2010-7#1)
the intraoperative period##3##3##(2010-5#1)(2010-7#1)(2011-3#1)
the intraoperative##12##2##(1993-1#1)(1996-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#2)(2011-3#1)(2011-7#1)(2013-1#1)
the intrauterine##5##2##(1991-2#1)(1994-3#1)(2009-11#2)(2013-1#1)
the intravascular##3##2##(2008-11#1)(2008-7#1)(2010-8#1)
the intravesical ureter##2##3##(1997-4#1)(2008-10#1)
the intravesical##5##2##(1993-11#1)(1997-4#2)(2008-10#2)
the intricate##2##2##(2008-10#1)(2008-9#1)
the intrinsic and extrinsic##2##4##(2009-12#1)(2011-2#1)
the intrinsic complexation constants##2##4##(2008-10#2)
the intrinsic fluorescence of the analyte##2##6##(2008-10#2)
the intrinsic fluorescence of##6##4##(1995-6#1)(2008-10#4)(2008-8#1)
the intrinsic fluorescence##8##3##(1995-6#1)(2008-10#4)(2008-3#2)(2008-8#1)
the intrinsic rate of change with respect to##2##8##(2008-10#2)
the intrinsic rate of disease##2##5##(2008-10#2)
the intrinsic rate of growth##2##5##(2008-8#2)
the intrinsic rate of##6##4##(2008-10#4)(2008-8#2)
the intrinsic viscosity of##2##4##(2008-10#2)
the intrinsic##45##2##(1991-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#5)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
the introduced##8##2##(2008-10#6)(2008-8#2)
the introduction and##3##3##(1990-3#1)(2008-12#2)
the introduction of a##7##4##(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#2)
the introduction of an##4##4##(2008-10#1)(2008-11#2)(2008-12#1)
the introduction of new##5##4##(1991-3#1)(1993-1#1)(1995-5#1)(2008-10#1)(2008-3#1)
the introduction of the first##2##5##(1991-9#1)(2008-5#1)
the introduction of the##18##4##(1991-9#1)(1992-3#1)(1997-5#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
the introduction of##88##3##(1990-5#1)(1991-12#1)(1991-3#2)(1991-9#2)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-9#3)(1994-12#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2008-1#2)(2008-10#21)(2008-11#11)(2008-12#9)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
the introduction##93##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#3)(1991-9#2)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-9#3)(1994-12#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2008-1#2)(2008-10#21)(2008-11#11)(2008-12#12)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
the intron##5##2##(1991-5#1)(1992-10#1)(1993-12#2)(2008-10#1)
the invaded##2##2##(2008-10#1)(2008-12#1)
the invading pathogen##2##3##(2008-10#2)
the invading##6##2##(2008-10#6)
the invasion and proliferation of AH109A##2##6##(2008-11#2)
the invasion and##4##3##(1990-11#1)(2008-10#1)(2008-11#2)
the invasion of AH109A cells##4##5##(2008-11#4)
the invasion of a##2##4##(2008-11#1)(2013-8#1)
the invasion of hepatoma cells##2##5##(2008-11#2)
the invasion of##15##3##(2008-10#1)(2008-11#9)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the invasion probability##2##3##(2013-8#2)
the invasion##27##2##(1990-11#1)(2008-10#5)(2008-11#13)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the invasive activity of hepatoma cells by##2##7##(2008-11#2)
the invasive activity of rat hepatoma##2##6##(2008-11#2)
the invasive activity of##4##4##(2008-11#4)
the invasive growth of##2##4##(2008-10#1)(2013-1#1)
the invasive##9##2##(2008-10#2)(2008-11#5)(2012-3#1)(2013-1#1)
the invasiveness of##2##3##(1991-2#1)(2011-2#1)
the inverse of the##2##4##(2008-10#2)
the inverse##11##2##(1995-11#1)(1997-2#1)(2008-10#4)(2008-3#3)(2008-5#1)(2008-8#1)
the inversion##5##2##(2008-3#4)(2008-7#1)
the invertebrate##2##2##(1994-11#1)(2008-8#1)
the investigated compounds##5##3##(2008-10#5)
the investigated samples##2##3##(2008-10#2)
the investigated##30##2##(1990-11#1)(1990-2#1)(1995-3#2)(2007-12#1)(2008-10#21)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
the investigation and##2##3##(2006-6#1)(2010-4#1)
the investigation of children with##2##5##(1996-6#1)(2013-1#1)
the investigation of the##7##4##(2008-10#5)(2008-4#1)(2010-12#1)
the investigation of##40##3##(1991-1#1)(1991-12#1)(1991-2#1)(1995-11#1)(1996-6#1)(1997-6#1)(1997-8#2)(2008-10#13)(2008-11#3)(2008-12#2)(2008-4#2)(2008-7#2)(2008-9#3)(2010-1#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
the investigation##52##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-3#1)(1995-11#1)(1996-6#1)(1997-6#1)(1997-8#2)(2006-6#1)(2008-10#17)(2008-11#5)(2008-12#2)(2008-4#2)(2008-7#2)(2008-9#3)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
the investigations##3##2##(1997-8#1)(2008-10#2)
the investigator##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
the investment in workers##3##4##(2008-8#3)
the investment of the '90s##2##5##(1994-3#2)
the investment##7##2##(1994-3#2)(2008-8#3)(2008-9#2)
the invitation##2##2##(1992-3#1)(2008-11#1)
the involved##12##2##(1990-8#1)(1992-12#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#3)(2008-9#1)(2011-2#1)(2013-8#1)
the involvement of PKC in##2##5##(1996-12#1)(1997-1#1)
the involvement of a##5##4##(1994-3#1)(1995-2#1)(1995-8#1)(2008-11#2)
the involvement of an##2##4##(1995-2#1)(1997-3#1)
the involvement of endogenous##3##4##(1994-8#1)(2008-11#2)
the involvement of the##8##4##(1992-3#1)(1995-11#1)(2007-12#1)(2008-11#3)(2008-6#1)(2009-9#1)
the involvement of these##2##4##(1994-5#1)(2008-10#1)
the involvement of##59##3##(1990-5#1)(1991-3#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#10)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#4)(2013-1#2)
the involvement##60##2##(1990-5#1)(1991-3#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#10)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#4)(2013-1#2)
the inward K(+) current##4##4##(2008-8#4)
the inward##5##2##(1997-2#1)(2008-8#4)
the iodate##3##2##(2008-10#3)
the iodometric##2##2##(2008-10#2)
the ion associate##5##3##(2008-10#5)
the ion associates##2##3##(2008-10#2)
the ion association##6##3##(2008-10#6)
the ion chamber##2##3##(2009-11#2)
the ion exchange##4##3##(2008-10#4)
the ion exchanger sites##3##4##(2008-10#3)
the ion exchanger##8##3##(2008-10#8)
the ion pair##7##3##(2008-10#7)
the ion##53##2##(1990-12#1)(1992-6#1)(1997-1#2)(2008-10#46)(2008-8#1)(2009-11#2)
the ion-association##2##2##(2008-10#2)
the ion-cycle##2##2##(2008-8#2)
the ion-exchange##5##2##(1997-2#1)(2008-10#3)(2008-7#1)
the ion-pair complex of##2##4##(2008-10#2)
the ion-pair complex##3##3##(2008-10#3)
the ion-pair extraction constant of##2##5##(2008-10#2)
the ion-pair extraction##4##3##(2008-10#4)
the ion-pair formation##3##3##(2008-10#3)
the ion-pair##15##2##(2008-10#15)
the ion-pairing reagent##2##3##(2008-10#2)
the ion-pairing##6##2##(2008-10#6)
the ion-transporting##2##2##(2008-7#2)
the ionic strength and##3##4##(2008-10#2)(2013-1#1)
the ionic strength of##2##4##(1997-2#1)(2008-10#1)
the ionic strength##14##3##(1997-2#3)(2008-10#10)(2013-1#1)
the ionic##31##2##(1990-2#1)(1996-2#1)(1997-2#3)(2008-10#21)(2008-11#1)(2008-3#1)(2009-5#1)(2010-7#1)(2013-1#1)
the ionisation of##3##3##(2008-10#3)
the ionisation##5##2##(2008-10#5)
the ionization##6##2##(2008-10#6)
the ionomer##2##2##(1990-2#1)(2010-4#1)
the ionophore##7##2##(2006-6#1)(2008-10#6)
the ionophores##3##2##(2008-10#3)
the ions##2##2##(2008-10#2)
the ipsilateral##22##2##(1991-2#1)(1993-3#4)(1994-12#2)(1996-12#4)(1997-3#1)(2007-12#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2013-8#1)
the iron and##3##3##(1994-5#1)(2008-10#2)
the iron atom##2##3##(1994-5#2)
the iron chalcogenide##4##3##(2008-10#4)
the iron concentration##2##3##(2008-10#2)
the iron content##2##3##(1992-3#1)(2008-10#1)
the iron##27##2##(1991-6#1)(1992-3#1)(1992-8#1)(1994-5#3)(2008-1#1)(2008-10#14)(2008-11#2)(2008-5#1)(2010-11#1)(2011-2#2)
the iron(III) ISE##2##3##(2008-10#2)
the iron(III)##3##2##(2008-10#3)
the irradiance and##2##3##(2008-3#2)
the irradiance##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
the irradiated##7##2##(1993-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#2)
the irradiation time##6##3##(2008-10#3)(2008-8#1)(2009-3#1)(2011-2#1)
the irradiation##9##2##(1991-2#1)(2008-10#5)(2008-8#1)(2009-3#1)(2011-2#1)
the irreversible##4##2##(1995-2#1)(1995-9#1)(2011-2#1)(2012-2#1)
the irrigation season##2##3##(2008-10#2)
the irrigation treatments##2##3##(2008-10#2)
the irrigation##8##2##(2008-10#8)
the irritation potential of##4##4##(2008-5#4)
the irritation##6##2##(2008-5#5)(2011-3#1)
the ischaemic cardiomyopathy group##2##4##(2008-10#2)
the ischaemic##4##2##(2008-10#4)
the ischemic##8##2##(1992-9#1)(1996-12#2)(1997-2#1)(2008-10#1)(2009-10#1)(2010-6#1)(2011-2#1)
the island of##4##3##(1995-6#1)(2008-10#2)(2011-2#1)
the island##6##2##(1995-6#1)(2008-10#2)(2011-2#1)(2013-8#2)
the islet##12##2##(1991-7#1)(1992-6#3)(1995-8#4)(2008-11#1)(2009-8#1)(2010-11#2)
the islets##7##2##(1995-2#1)(1995-8#1)(2008-11#1)(2008-5#1)(2010-11#3)
the isoalloxazine ring of##2##4##(1992-1#1)(1996-8#1)
the isocitrate##2##2##(2008-10#2)
the isocratic##2##2##(2008-10#2)
the isoelectric##4##2##(2008-10#3)(2008-11#1)
the isoflavone glucoside was##2##4##(2008-11#2)
the isolate from##2##3##(2008-10#1)(2008-7#1)
the isolate##16##2##(2008-10#14)(2008-7#1)(2011-2#1)
the isolated gamma subunit##3##4##(2008-8#3)
the isolated strains##2##3##(1991-3#2)
the isolated##43##2##(1990-2#1)(1991-11#1)(1991-3#2)(1992-11#1)(1992-6#1)(1993-6#2)(1993-8#3)(1994-5#2)(1996-12#1)(1996-2#2)(1997-4#1)(2008-10#5)(2008-11#9)(2008-5#2)(2008-8#5)(2008-9#1)(2009-10#1)(2010-6#1)(2013-1#1)(2013-8#1)
the isolates adapted to##2##4##(2008-10#2)
the isolates and##2##3##(2008-10#1)(2008-12#1)
the isolates belonged to##3##4##(2008-10#3)
the isolates could be##2##4##(2008-10#2)
the isolates from the##2##4##(2008-10#1)(2008-5#1)
the isolates from##8##3##(2008-10#6)(2008-5#2)
the isolates in VCG##4##4##(2008-10#4)
the isolates in##8##3##(2008-10#7)(2008-5#1)
the isolates into two##3##4##(2008-10#3)
the isolates into##5##3##(2008-10#5)
the isolates of F##2##4##(2008-10#2)
the isolates of##6##3##(2008-10#6)
the isolates that##3##3##(2008-10#3)
the isolates were able to##2##5##(2011-2#2)
the isolates were susceptible to##2##5##(2008-5#2)
the isolates were##21##3##(1996-12#1)(2008-10#12)(2008-5#3)(2008-7#2)(2011-2#3)
the isolates##98##2##(1991-3#1)(1996-12#2)(2008-10#74)(2008-12#4)(2008-5#6)(2008-7#3)(2011-2#7)(2012-3#1)
the isolation and analysis of##2##5##(1993-12#1)(2008-4#1)
the isolation and culture of##2##5##(2008-11#2)
the isolation and sequencing of##2##5##(1991-6#1)(1997-7#1)
the isolation and##13##3##(1991-6#1)(1993-12#2)(1997-7#1)(2008-11#4)(2008-4#4)(2008-9#1)
the isolation of M##2##4##(2008-9#1)(2011-2#1)
the isolation of a cDNA##2##5##(1994-11#1)(1995-2#1)
the isolation of a##6##4##(1994-11#2)(1994-8#1)(1995-2#1)(2008-11#1)(2008-8#1)
the isolation of the##2##4##(2008-10#2)
the isolation of##36##3##(1994-11#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#3)(2009-12#1)(2011-2#1)
the isolation##59##2##(1990-2#1)(1991-6#1)(1993-12#2)(1994-11#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#13)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#3)(2008-8#1)(2008-9#4)(2009-12#2)(2011-2#1)(2012-3#1)
the isomeric##3##2##(1992-12#1)(1996-5#1)(2008-10#1)
the isomers##3##2##(2008-10#2)(2011-10#1)
the isosteric heat##2##3##(2010-4#2)
the isosteric##3##2##(2010-4#3)
the isothermal adsorption##2##3##(1997-2#2)
the isothermal##6##2##(1997-2#4)(2008-10#1)(2009-7#1)
the isotonic solution##2##3##(2008-10#2)
the isotonic##3##2##(2008-10#3)
the isotope dilution method##3##4##(2008-10#3)
the isotope dilution##4##3##(2008-10#4)
the isotope ratio##2##3##(2008-10#2)
the isotope##7##2##(1994-5#1)(2008-10#6)
the isotopic##2##2##(2008-10#2)
the isotopomer##2##2##(2008-7#2)
the isotropic##3##2##(2008-10#1)(2008-3#2)
the isotype of##2##3##(1990-12#2)
the isotype##3##2##(1990-12#2)(2008-8#1)
the isozyme##2##2##(2008-10#1)(2012-5#1)
the issue and##3##3##(1991-3#1)(1992-1#1)(1994-1#1)
the issue of the##2##4##(2008-10#1)(2008-12#1)
the issue of##21##3##(1992-2#1)(1993-1#1)(1993-2#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-4#2)(2008-6#1)(2008-9#2)(2009-10#2)(2010-10#1)
the issue##34##2##(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-1#2)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-7#1)(2010-10#1)(2013-1#3)
the issues and##3##3##(1991-2#1)(1992-1#1)(1992-2#1)
the issues associated with the##2##5##(2008-11#2)
the issues associated with##3##4##(2008-10#1)(2008-11#2)
the issues in the process of##2##6##(2012-3#2)
the issues of training##2##4##(1993-2#2)
the issues of##7##3##(1991-1#1)(1991-3#1)(1993-2#2)(1997-4#1)(2008-12#1)(2008-5#1)
the issues raised##2##3##(1991-2#1)(2008-10#1)
the issues related to##2##4##(2008-11#1)(2008-3#1)
the issues surrounding##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
the issues that##4##3##(1997-1#1)(2008-10#1)(2008-4#2)
the issues##42##2##(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-2#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#9)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
the isthmic region of##2##4##(1996-5#2)
the isthmic##3##2##(1996-5#3)
the itching##2##2##(2008-5#2)
the item##3##2##(2010-10#1)(2012-2#2)
the items was##2##3##(2012-2#1)(2013-1#1)
the items##9##2##(1990-11#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2012-2#2)(2013-1#2)
the iterative##4##2##(2008-10#2)(2008-3#2)
the ivyleaf morning glory##2##4##(2008-8#2)
the jaw##7##2##(1997-3#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
the jaws##9##2##(2008-1#3)(2012-12#3)(2013-1#3)
the jejunum##2##2##(1990-9#1)(1991-5#1)
the jet nebulizer##3##3##(1991-1#3)
the jitter##2##2##(2008-3#2)
the job of##3##3##(1995-2#1)(1996-1#1)(2012-12#1)
the job##18##2##(1990-2#1)(1991-2#4)(1992-1#1)(1992-3#1)(1993-2#4)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(2012-12#1)
the joint##24##2##(1993-5#1)(1994-3#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-3#2)(2013-1#2)
the joint-confidence ellipse##2##3##(2008-10#2)
the journal##12##2##(1991-2#1)(1992-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-11#1)(2010-1#1)(2013-1#4)
the journey##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
the judgments of##2##3##(1993-12#1)(2008-1#1)
the judicial##3##2##(1997-6#1)(1997-8#1)(2008-12#1)
the jugular##4##2##(1996-9#1)(2011-2#2)(2012-3#1)
the juice sac area##6##4##(2008-10#6)
the juice##9##2##(2008-10#9)
the jump sign##2##3##(2008-12#2)
the jump##6##2##(2008-12#2)(2008-9#3)(2009-1#1)
the junction of the##2##4##(2007-12#2)
the junction of##5##3##(1990-5#1)(1993-9#1)(2007-12#3)
the junction##9##2##(1990-5#1)(1993-6#1)(1993-9#1)(1996-12#1)(2007-12#4)(2012-3#1)
the junctional##4##2##(1990-2#1)(1995-6#2)(1996-12#1)
the jungle##2##2##(2008-10#1)(2012-12#1)
the junior faculty##2##3##(2009-4#2)
the junior##3##2##(2009-4#3)
the junk bond##2##3##(1992-11#2)
the junk##3##2##(1992-11#3)
the jury##3##2##(1995-6#2)(1996-5#1)
the juvenile##4##2##(2008-6#1)(2008-8#2)(2011-2#1)
the juveniles##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
the kappa##4##2##(1993-9#1)(1996-12#1)(1997-8#1)(2008-11#1)
the karyosome capsule##2##3##(2008-7#2)
the karyosome##10##2##(2007-12#2)(2008-7#8)
the karyotype##2##2##(2008-12#1)(2013-8#1)
the kcat values##2##3##(1994-5#1)(1995-6#1)
the kcat##3##2##(1993-9#1)(1994-5#1)(1995-6#1)
the keratin##3##2##(1991-12#2)(2009-10#1)
the keratinocyte##2##2##(1996-2#1)(2008-9#1)
the keratinocytes##4##2##(1993-11#1)(1995-11#1)(2008-12#2)
the keto acid##2##3##(2008-10#2)
the keto##3##2##(2008-10#2)(2008-11#1)
the key characteristics of##2##4##(1994-3#1)(2012-3#1)
the key elements##3##3##(2008-11#1)(2010-8#1)(2011-1#1)
the key enzyme of##2##4##(2008-10#1)(2009-8#1)
the key enzyme##4##3##(1992-3#1)(2008-10#1)(2008-8#1)(2009-8#1)
the key factor in##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
the key factor##6##3##(1994-5#1)(2008-10#1)(2008-3#2)(2010-4#1)(2010-7#1)
the key factors that##2##4##(2008-11#2)
the key factors##4##3##(2008-11#2)(2008-3#1)(2011-2#1)
the key features of the##2##5##(1997-6#1)(2011-2#1)
the key features of##3##4##(1997-6#1)(2011-2#2)
the key issues##3##3##(1995-12#1)(1997-2#1)(2008-12#1)
the key parameters##3##3##(1992-9#1)(2008-11#1)(2013-8#1)
the key role of##4##4##(1991-7#1)(2008-9#1)(2013-1#2)
the key step##3##3##(1992-11#1)(1992-8#1)(2008-11#1)
the key to the##4##4##(1992-2#1)(1997-1#1)(2008-7#1)(2011-9#1)
the key to##15##3##(1991-1#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2011-9#1)
the key##109##2##(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-1#1)(2008-10#7)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#2)(2009-5#1)(2009-8#5)(2010-10#1)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
the keys to##2##3##(1991-12#1)(1996-1#1)
the keywords##2##2##(2008-10#1)(2013-1#1)
the kidney and##5##3##(1994-5#2)(2008-10#1)(2008-11#1)(2011-2#1)
the kidney is##3##3##(1994-5#1)(2008-10#1)(2010-10#1)
the kidney lead concentration##2##4##(1992-12#2)
the kidney to##2##3##(2010-1#1)(2011-2#1)
the kidney##41##2##(1990-2#1)(1992-12#2)(1994-11#1)(1994-5#4)(1994-8#1)(1994-9#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#6)(2009-6#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
the kidneys from##2##3##(1996-3#1)(2013-7#1)
the kidneys of##4##3##(1994-5#1)(1997-1#1)(2008-5#1)(2009-6#1)
the kidneys were##2##3##(2008-12#1)(2008-5#1)
the kidneys##13##2##(1990-11#1)(1994-5#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-12#1)(2008-5#3)(2009-6#1)(2010-11#1)(2012-12#1)(2013-7#1)
the killing##3##2##(2008-8#1)(2008-9#1)(2012-12#1)
the kinase domain##2##3##(1995-2#1)(2009-8#1)
the kinase##17##2##(1990-12#1)(1990-5#2)(1993-3#1)(1993-6#3)(1993-8#5)(1995-2#1)(1995-6#1)(2008-8#1)(2009-8#1)(2013-8#1)
the kind of##12##3##(1991-6#1)(1994-1#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
the kind##13##2##(1991-6#1)(1994-1#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
the kinds of##5##3##(1995-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
the kinetic and##2##3##(2008-10#2)
the kinetic constants##3##3##(1991-3#1)(1996-2#1)(2008-10#1)
the kinetic determination of##3##4##(2008-10#3)
the kinetic discrimination##2##3##(2008-10#2)
the kinetic energy of impacting##2##5##(2008-10#2)
the kinetic mechanism##3##3##(1991-9#1)(1995-6#2)
the kinetic method##2##3##(2008-10#2)
the kinetic parameters##6##3##(1991-9#1)(1994-5#1)(1995-12#2)(2008-10#1)(2008-3#1)
the kinetic rate processes##2##4##(2012-2#2)
the kinetic stability##2##3##(2008-10#2)
the kinetic##48##2##(1990-5#1)(1991-3#1)(1991-9#2)(1992-12#1)(1993-8#1)(1994-5#1)(1995-12#2)(1995-6#3)(1996-2#1)(1997-2#1)(2008-10#23)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#2)
the kinetics and##2##3##(1995-12#1)(2008-10#1)
the kinetics of antigen##2##4##(1990-12#1)(2008-9#1)
the kinetics of intracellular##2##4##(2008-9#2)
the kinetics of the reaction##3##5##(2008-10#3)
the kinetics of the##11##4##(1995-9#1)(2008-10#8)(2008-2#1)(2008-5#1)
the kinetics of##42##3##(1990-12#1)(1990-8#2)(1993-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-9#1)(1997-2#1)(2008-10#17)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2011-2#2)
the kinetics##46##2##(1990-12#1)(1990-8#2)(1993-3#1)(1994-5#1)(1995-12#4)(1995-2#1)(1995-9#1)(1997-2#1)(2008-10#18)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2011-2#2)
the knee and##2##3##(2009-11#1)(2013-1#1)
the knee in##4##3##(2008-8#2)(2012-3#1)(2013-1#1)
the knee is##5##3##(1997-8#4)(2013-1#1)
the knee joint##3##3##(1997-8#1)(2007-8#1)(2013-1#1)
the knee was##7##3##(1997-8#6)(2008-8#1)
the knee##43##2##(1991-6#1)(1993-3#1)(1997-8#11)(2007-8#1)(2008-11#2)(2008-12#4)(2008-8#3)(2009-11#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#10)
the knees##2##2##(2009-3#1)(2013-1#1)
the knowledge and skills##2##4##(1991-1#1)(2012-12#1)
the knowledge and##11##3##(1991-1#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)
the knowledge base##2##3##(2008-10#2)
the knowledge gained##2##3##(2008-11#1)(2008-9#1)
the knowledge of the##12##4##(1993-11#1)(2008-10#5)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
the knowledge of##23##3##(1990-5#1)(1993-11#1)(1996-12#1)(1997-3#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#1)(2013-1#3)(2013-8#1)
the knowledge on##3##3##(1991-2#1)(2012-3#2)
the knowledge##50##2##(1990-5#1)(1991-1#1)(1991-2#1)(1993-11#2)(1996-12#1)(1997-3#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#1)
the known biology of##2##4##(2008-11#1)(2013-8#1)
the known mechanisms##2##3##(2008-7#1)(2008-9#1)
the known##32##2##(1990-11#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
the kringle##2##2##(1993-8#2)
the kuruma prawn##2##3##(2008-5#1)(2008-6#1)
the l-malic acid##2##3##(2008-10#2)
the lab##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
the label to the##2##4##(2008-11#1)(2008-12#1)
the label##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
the labeled rate##3##3##(2008-10#3)
the labeled##10##2##(1994-2#1)(1994-8#1)(1995-2#1)(2008-10#6)(2008-4#1)
the labeling pattern of##3##4##(2008-10#1)(2008-7#2)
the labeling##6##2##(2008-10#2)(2008-7#2)(2009-10#1)(2013-1#1)
the labelled antibodies##2##3##(2008-10#2)
the labelled##6##2##(1995-12#1)(1996-2#2)(2008-10#3)
the labial##2##2##(2007-12#2)
the lability of##2##3##(1994-11#1)(2008-10#1)
the labor force##3##3##(1991-1#2)(1997-2#1)
the labor market and##3##4##(1994-3#1)(2011-2#1)(2012-3#1)
the labor market##4##3##(1994-3#2)(2011-2#1)(2012-3#1)
the labor##9##2##(1991-1#2)(1994-3#2)(1997-2#1)(2011-2#2)(2012-3#2)
the laboratories##5##2##(2008-10#4)(2011-1#1)
the laboratory and the field##2##5##(2008-10#1)(2008-2#1)
the laboratory and the##4##4##(1993-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
the laboratory and##9##3##(1993-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2010-10#1)(2013-1#1)
the laboratory mixer##2##3##(2008-5#2)
the laboratory population##3##3##(2008-10#3)
the laboratory results##2##3##(2008-10#1)(2011-2#1)
the laboratory strain##2##3##(2011-2#1)(2012-3#1)
the laboratory to##2##3##(2008-11#1)(2008-5#1)
the laboratory##78##2##(1990-3#1)(1992-3#1)(1993-1#1)(1994-2#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-10#36)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-8#3)(2008-9#4)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the laborers##3##2##(2009-12#3)
the labrum is not##2##4##(2007-12#2)
the labrum is##5##3##(2007-12#5)
the labrum##10##2##(2007-12#10)
the lacZ##3##2##(1997-7#1)(2008-11#1)(2009-12#1)
the lack of a##14##4##(1991-10#1)(1994-6#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#2)(2011-2#2)
the lack of adequate##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
the lack of an##5##4##(1993-12#1)(1995-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
the lack of available##2##4##(1992-1#1)(2011-2#1)
the lack of correlation##2##4##(2008-10#2)
the lack of evidence##3##4##(2008-11#1)(2008-12#1)(2011-2#1)
the lack of knowledge##2##4##(2008-11#1)(2008-5#1)
the lack of molecular markers##2##5##(2008-10#2)
the lack of significant##2##4##(2008-10#2)
the lack of specific##2##4##(2008-4#1)(2008-9#1)
the lack of understanding##2##4##(2008-11#1)(2010-3#1)
the lack of##127##3##(1991-10#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-6#1)(2008-10#30)(2008-11#14)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#9)(2012-12#1)(2012-2#4)(2013-1#7)(2013-8#4)
the lacrimal##3##2##(1995-9#1)(2011-2#1)(2013-8#1)
the lactate dehydrogenase##2##3##(2008-11#2)
the lactate dehydrogenase-B##2##3##(1990-8#2)
the lactate##6##2##(1990-8#2)(2008-10#1)(2008-11#3)
the lag period##3##3##(2008-10#3)
the lag phase##4##3##(2008-5#1)(2008-7#1)(2011-2#2)
the lag time##4##3##(1990-8#1)(2008-10#2)(2008-11#1)
the lag##16##2##(1990-8#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-7#2)(2011-2#3)
the lagging-strand Pol III core##3##5##(1992-3#3)
the lagoon##2##2##(2010-8#1)(2012-2#1)
the lagoons##2##2##(2010-8#2)
the lake##3##2##(2008-10#3)
the lambs##2##2##(1991-8#1)(1996-12#1)
the lamellae##2##2##(2008-7#2)
the lamellar scaffold##2##3##(2012-2#2)
the lamellar##8##2##(2008-5#3)(2012-2#5)
the lamin A tail##2##4##(2011-2#2)
the lamin##4##2##(2008-8#1)(2011-2#3)
the lamina propria##2##3##(1997-1#1)(2009-1#1)
the lamina##9##2##(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-7#2)(2009-1#1)(2011-2#2)
the laminar##3##2##(1997-2#2)(1997-3#1)
the laminin##4##2##(1997-1#2)(2013-8#2)
the lamprey##6##2##(1993-3#1)(1997-3#5)
the landmark##2##2##(2008-9#1)(2009-7#1)
the landscape of##5##3##(1994-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)
the landscape##10##2##(1994-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-9#1)
the language##3##2##(1997-6#1)(2009-9#1)(2013-1#1)
the lanthanide metal ions##2##4##(2008-10#2)
the lanthanide metal##3##3##(2008-10#2)(2008-4#1)
the lanthanide##4##2##(2008-10#3)(2008-4#1)
the lanthanum##2##2##(2008-10#2)
the laparoscope##3##2##(1992-1#1)(1992-12#1)(1996-3#1)
the laparoscopic##5##2##(1995-3#1)(1996-1#1)(2008-12#1)(2013-1#2)
the laparoscopy group##2##3##(1996-1#2)
the laparoscopy##3##2##(1995-3#1)(1996-1#2)
the laparotomy##2##2##(1990-2#1)(1996-1#1)
the large amount of##2##4##(2008-11#1)(2008-12#1)
the large bubble##2##3##(2008-11#2)
the large difference in##2##4##(2008-11#1)(2008-8#1)
the large difference##3##3##(1994-6#1)(2008-11#1)(2008-8#1)
the large intestine is##2##4##(1991-6#1)(2009-1#1)
the large intestine##5##3##(1990-11#1)(1991-6#1)(1995-10#1)(2009-1#1)(2011-2#1)
the large majority of##3##4##(1991-9#1)(2008-10#1)(2008-3#1)
the large number of##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
the large numbers of##2##4##(1995-8#1)(2008-11#1)
the large scale##4##3##(2008-10#1)(2008-11#3)
the large subunit##5##3##(1993-8#1)(1995-12#1)(2008-10#1)(2010-4#1)(2013-8#1)
the large variety of##2##4##(2008-10#1)(2008-3#1)
the large volume of##4##4##(2008-10#3)(2010-8#1)
the large##72##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-8#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-8#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#16)(2008-11#10)(2008-12#1)(2008-3#3)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
the large-scale##6##2##(1995-12#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)
the largely##2##2##(2009-8#1)(2013-8#1)
the larger number of##2##4##(1992-9#1)(2008-11#1)
the larger the##3##3##(2008-10#1)(2008-3#2)
the larger##28##2##(1990-11#1)(1991-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#2)(2007-12#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-10#2)(2010-11#1)(2010-7#1)(2012-5#1)(2013-1#1)
the largest absolute##2##3##(2009-4#1)(2011-2#1)
the largest and most##2##4##(2008-10#2)
the largest and##4##3##(2008-10#3)(2013-8#1)
the largest number of##5##4##(1991-5#1)(1994-9#1)(2008-10#1)(2008-9#1)(2010-12#1)
the largest relative##2##3##(2008-10#1)(2010-6#1)
the largest single##2##3##(1992-6#1)(2008-11#1)
the largest##77##2##(1990-11#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2013-1#3)(2013-8#2)
the larvae of the##2##4##(2008-7#1)(2008-8#1)
the larvae of##3##3##(2008-7#1)(2008-8#1)(2010-8#1)
the larvae were##2##3##(2008-10#1)(2008-11#1)
the larvae##10##2##(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#2)
the larval##8##2##(1990-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-8#1)
the larynx##3##2##(2008-11#1)(2010-7#1)(2013-8#1)
the lasB-lacZ fusion was##2##4##(1995-2#2)
the laser and##4##3##(1994-12#1)(2008-2#1)(2008-3#2)
the laser beam##12##3##(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#7)(2008-9#1)
the laser can##2##3##(2008-2#1)(2012-3#1)
the laser cavity##2##3##(2008-3#2)
the laser crystal##3##3##(2007-12#1)(2008-3#2)
the laser diode##2##3##(2008-3#2)
the laser energy##2##3##(2008-10#1)(2008-7#1)
the laser frequency by##2##4##(2008-3#2)
the laser frequency##3##3##(2008-3#3)
the laser intensity##2##3##(2008-3#2)
the laser irradiance##2##3##(1993-3#1)(2008-3#1)
the laser performance of a##2##5##(2007-12#1)(2008-2#1)
the laser performance##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the laser power##6##3##(1992-12#2)(2008-10#2)(2008-3#2)
the laser radiation##3##3##(2008-3#3)
the laser resonator##2##3##(2008-2#2)
the laser safety standards##2##4##(1993-3#2)
the laser wavelength is##2##4##(2008-2#1)(2008-3#1)
the laser wavelength##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the laser##96##2##(1991-1#1)(1992-12#3)(1993-3#4)(1994-12#1)(2007-12#3)(2008-10#12)(2008-2#13)(2008-3#52)(2008-7#1)(2008-9#2)(2009-5#1)(2012-3#3)
the laser's##3##2##(2008-10#1)(2008-3#2)
the lasers##2##2##(2008-3#1)(2008-7#1)
the last 10 years##11##4##(1991-6#1)(1992-5#1)(1995-12#1)(1995-9#1)(2008-10#3)(2008-11#2)(2011-1#1)(2011-2#1)
the last 10##12##3##(1991-6#1)(1992-5#1)(1995-12#1)(1995-9#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-1#1)(2011-2#1)
the last 12 months##2##4##(1994-8#1)(2010-1#1)
the last 12 years##4##4##(1993-3#1)(1997-3#1)(2008-10#1)(2010-12#1)
the last 12##6##3##(1993-3#1)(1994-8#1)(1997-3#1)(2008-10#1)(2010-1#1)(2010-12#1)
the last 14 years##2##4##(1991-11#1)(2012-3#1)
the last 15 years##7##4##(1991-11#1)(1991-9#1)(1993-11#1)(1994-6#1)(2008-10#1)(2009-3#1)(2010-12#1)
the last 18 months##2##4##(1990-6#1)(2008-11#1)
the last 2##3##3##(1990-6#1)(2008-9#1)(2012-2#1)
the last 20 years##4##4##(1994-3#1)(2008-10#2)(2009-10#1)
the last 20##8##3##(1992-6#1)(1994-12#2)(1994-3#1)(2008-10#2)(2008-8#1)(2009-10#1)
the last 25 years##4##4##(1996-1#1)(1996-11#1)(1997-5#1)(2012-3#1)
the last 3##2##3##(2008-7#1)(2013-1#1)
the last 30 years##4##4##(2008-10#2)(2009-6#1)(2010-8#1)
the last 30##5##3##(1995-6#1)(2008-10#2)(2009-6#1)(2010-8#1)
the last 5 years##5##4##(1996-11#1)(2008-10#1)(2008-12#1)(2012-3#2)
the last 50 years##5##4##(1990-6#1)(1995-2#1)(2008-10#2)(2011-2#1)
the last 50##6##3##(1990-6#1)(1995-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
the last 6 years##2##4##(1996-9#1)(1997-4#1)
the last case##4##3##(1991-8#2)(1994-9#1)(2008-7#1)
the last century##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
the last decade and##3##4##(1992-1#1)(2008-11#1)(2012-2#1)
the last decade##45##3##(1990-12#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-1#1)(1994-3#2)(1995-12#1)(1996-1#1)(1996-11#1)(1997-7#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#2)
the last decades##11##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-4#2)(2011-2#2)(2013-1#1)
the last egg##2##3##(2008-8#2)
the last few decades##7##4##(1995-1#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#2)
the last few years##19##4##(1990-11#1)(1991-3#2)(1994-6#1)(1994-9#1)(2008-10#2)(2008-11#2)(2008-5#3)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
the last few##26##3##(1990-11#1)(1991-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#4)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
the last follow up##2##4##(2009-11#1)(2013-1#1)
the last half of the##2##5##(2008-10#1)(2008-4#1)
the last half##3##3##(1994-1#1)(2008-10#1)(2008-4#1)
the last month of##2##4##(1996-12#2)
the last one##3##3##(1993-2#1)(1997-3#1)(2008-10#1)
the last part of the##2##5##(1991-12#1)(1994-8#1)
the last period of##2##4##(1993-8#1)(1994-3#1)
the last serum##2##3##(1997-5#2)
the last several years##5##4##(1992-3#1)(1995-2#1)(2008-9#1)(2010-6#1)(2011-2#1)
the last several##6##3##(1992-3#1)(1995-2#1)(1997-4#1)(2008-9#1)(2010-6#1)(2011-2#1)
the last ten years##7##4##(1990-11#1)(1990-6#1)(1991-9#1)(1992-12#1)(1996-11#1)(2008-8#1)(2012-3#1)
the last three decades##3##4##(2008-7#1)(2011-2#2)
the last three##7##3##(1991-7#1)(2008-7#1)(2009-4#1)(2011-2#4)
the last twenty years##2##4##(1995-12#1)(1996-2#1)
the last two decades##13##4##(1994-3#1)(1995-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the last two steps of##2##5##(2010-2#1)(2011-1#1)
the last two years##2##4##(1996-12#1)(1997-8#1)
the last two##24##3##(1990-8#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the last years##7##3##(2008-10#1)(2008-11#1)(2009-10#1)(2010-12#1)(2011-2#3)
the last##297##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-6#6)(1990-8#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#5)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#2)(1994-12#4)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#4)(1995-2#2)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#2)(1996-9#1)(1997-3#3)(1997-4#2)(1997-5#3)(1997-7#4)(1997-8#2)(2007-12#3)(2008-1#1)(2008-10#36)(2008-11#16)(2008-12#7)(2008-2#1)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#22)(2011-3#4)(2012-12#2)(2012-2#9)(2012-3#7)(2012-7#1)(2013-1#7)(2013-8#1)
the late 1970s and##2##4##(1996-5#1)(2008-12#1)
the late 1970s##4##3##(1995-3#1)(1996-5#1)(2008-10#1)(2008-12#1)
the late 1990s##2##3##(2008-10#2)
the late blight##6##3##(2008-10#6)
the late nineteenth century##4##4##(2010-1#3)(2011-2#1)
the late nineteenth##6##3##(2010-1#5)(2011-2#1)
the late stage of##6##4##(1991-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
the late stages of##2##4##(2008-10#1)(2012-3#1)
the late stages##4##3##(2008-10#1)(2009-12#1)(2011-3#1)(2012-3#1)
the late##63##2##(1990-6#1)(1991-12#1)(1991-5#1)(1993-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-8#2)(2008-10#14)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#4)(2009-12#1)(2010-1#5)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)
the late-onset##2##2##(1990-5#2)
the latency##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)
the latent period##3##3##(2008-10#3)
the latent periods and amplitudes of##2##6##(2008-8#2)
the latent##12##2##(2008-10#6)(2008-8#2)(2009-4#1)(2010-11#1)(2010-4#1)(2013-8#1)
the later stages of##4##4##(1990-5#1)(2008-10#1)(2009-5#1)(2013-8#1)
the later stages##6##3##(1990-5#1)(1993-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2013-8#1)
the later##16##2##(1990-5#1)(1992-5#1)(1993-9#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#1)(2013-8#2)
the lateral and##2##3##(1997-3#1)(2013-1#1)
the lateral chest radiograph##2##4##(1997-8#2)
the lateral condensation##2##3##(1991-3#1)(2013-1#1)
the lateral film##2##3##(1997-8#2)
the lateral hypothalamic area##2##4##(1993-6#1)(1994-2#1)
the lateral hypothalamus##7##3##(1991-12#1)(1993-6#4)(1996-2#1)(2009-10#1)
the lateral lemniscus##6##3##(1997-3#6)
the lateral nucleus of the amygdala##3##6##(1993-6#3)
the lateral pallidum##2##3##(2008-7#2)
the lateral recess##2##3##(2011-2#2)
the lateral sensillum styloconicum##2##4##(2008-8#2)
the lateral ventricle##4##3##(1991-12#1)(2008-7#3)
the lateral wall of the##2##5##(2007-12#1)(2011-2#1)
the lateral wall##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
the lateral##72##2##(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-6#8)(1994-2#2)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#8)(1997-8#5)(2007-12#5)(2008-10#2)(2008-11#2)(2008-7#9)(2008-8#4)(2009-10#2)(2009-7#1)(2010-10#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
the latest advances in##3##4##(2008-7#1)(2009-9#1)(2012-2#1)
the latest advances##4##3##(2008-7#1)(2009-9#1)(2011-7#1)(2012-2#1)
the latest##31##2##(1991-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-1#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-11#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-7#2)(2013-8#2)
the latex##6##2##(2008-10#5)(2008-5#1)
the latter and##3##3##(2008-8#1)(2008-9#1)(2009-8#1)
the latter are##5##3##(1996-5#1)(1997-4#1)(2008-7#1)(2010-2#1)(2011-2#1)
the latter being##6##3##(1992-2#1)(2008-12#1)(2008-8#1)(2012-2#2)(2013-1#1)
the latter by##2##3##(2008-11#1)(2008-8#1)
the latter case##15##3##(1990-2#1)(1991-2#1)(1991-8#1)(1993-9#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-8#1)
the latter group##3##3##(2008-5#1)(2008-7#1)(2011-1#1)
the latter is not##3##4##(1995-8#1)(2008-10#1)(2009-8#1)
the latter is##14##3##(1990-11#1)(1990-3#1)(1995-8#1)(1997-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-8#2)(2010-6#1)(2011-2#1)
the latter may##2##3##(1996-6#1)(2008-10#1)
the latter method##3##3##(2008-10#2)(2011-2#1)
the latter of which##2##4##(2010-8#1)(2012-2#1)
the latter part of the##2##5##(1994-2#1)(2008-12#1)
the latter part##3##3##(1994-2#1)(2008-12#1)(2008-5#1)
the latter species##3##3##(2008-10#2)(2011-2#1)
the latter technique##3##3##(2006-6#1)(2008-10#1)(2008-3#1)
the latter three##2##3##(2008-10#2)
the latter to a##2##4##(1997-4#1)(2008-11#1)
the latter to##4##3##(1993-6#1)(1997-4#1)(2008-10#1)(2008-11#1)
the latter two##5##3##(2008-10#3)(2008-8#1)(2009-7#1)
the latter was##5##3##(1992-12#1)(1994-11#1)(1995-2#1)(2008-10#1)(2012-2#1)
the latter with##3##3##(1992-1#1)(1996-3#1)(2008-6#1)
the latter##186##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-8#3)(1992-1#1)(1992-12#1)(1992-2#2)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#3)(2006-6#1)(2008-1#2)(2008-10#49)(2008-11#7)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#3)(2009-11#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#8)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#2)
the latter's##5##2##(1994-8#1)(1997-5#1)(2008-10#1)(2008-12#1)(2012-2#1)
the lattice##3##2##(1992-4#1)(1996-12#1)(2008-10#1)
the launching##2##2##(1991-12#1)(2007-12#1)
the law and##4##3##(1992-12#1)(1994-1#1)(1994-5#1)(1997-8#1)
the law of##2##3##(2008-11#1)(2012-2#1)
the law was##2##3##(1997-8#1)(2008-8#1)
the law##22##2##(1991-9#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-8#4)(2008-11#2)(2008-8#1)(2012-2#1)
the lawsuit##4##2##(1992-3#1)(1996-5#3)
the layer of##2##3##(2008-10#2)
the layer##4##2##(2008-10#4)
the layer-by-layer##3##2##(2008-10#2)(2010-9#1)
the layers##2##2##(2008-3#1)(2012-12#1)
the layout of the##2##4##(2007-12#1)(2008-9#1)
the layout of##3##3##(2007-12#1)(2008-9#1)(2009-6#1)
the leachates##2##2##(2008-10#2)
the leaching of##2##3##(2008-10#2)
the leaching##3##2##(2008-10#3)
the lead concentration##2##3##(2008-10#2)
the lead determination##2##3##(2008-10#2)
the lead##24##2##(1992-12#1)(1995-12#3)(2008-10#16)(2008-11#1)(2008-8#1)(2011-2#1)(2012-9#1)
the leader##7##2##(1991-9#1)(1992-5#1)(2008-11#1)(2008-8#3)(2008-9#1)
the leaders##2##2##(1992-5#1)(2012-2#1)
the leadership##2##2##(1994-2#1)(1997-1#1)
the leading and trailing##2##4##(2008-10#2)
the leading cause of death##5##5##(1990-6#1)(1995-11#1)(1997-1#1)(2012-2#1)(2013-8#1)
the leading cause of##10##4##(1990-6#1)(1995-11#1)(1997-1#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
the leading causes of##5##4##(2007-12#1)(2010-8#1)(2011-2#2)(2012-3#1)
the leading edge of the##2##5##(2008-10#1)(2011-2#1)
the leading edge##3##3##(2008-10#1)(2011-2#2)
the leading##29##2##(1990-6#1)(1995-11#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the leaf and##2##3##(2008-10#2)
the leaf area##2##3##(2008-10#2)
the leaf disks##2##3##(2008-10#2)
the leaf scale##2##3##(2008-10#2)
the leaf sheath##2##3##(2008-10#2)
the leaf spot isolates were##2##5##(2008-10#2)
the leaf spot isolates##3##4##(2008-10#3)
the leaf surface##8##3##(1994-11#1)(2008-10#7)
the leaf##54##2##(1994-11#1)(2008-10#46)(2008-12#2)(2008-7#1)(2008-8#2)(2009-6#2)
the leaf-drop symptom##3##3##(2008-10#3)
the leafhopper##3##2##(2008-10#3)
the leaflet and leaf levels##3##5##(2008-10#3)
the leaflet and leaf##5##4##(2008-10#5)
the leaflet##9##2##(2008-10#9)
the leakage##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
the learning and##4##3##(1997-2#1)(2008-11#2)(2012-2#1)
the learning contract marking##2##4##(2008-11#2)
the learning environment##4##3##(2008-11#3)(2008-12#1)
the learning of##4##3##(1994-1#1)(2008-11#3)
the learning opportunities##2##3##(2008-11#2)
the learning outcomes##2##3##(2008-11#2)
the learning process##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
the learning##35##2##(1992-3#1)(1993-12#1)(1994-1#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-11#16)(2008-12#5)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
the least amount##2##3##(2008-7#2)
the least effective##2##3##(2008-10#2)
the least squares##3##3##(2008-10#2)(2008-6#1)
the least##44##2##(1992-2#1)(1993-2#1)(1995-12#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#4)
the least-squares fit##2##3##(2008-3#2)
the least-squares##4##2##(2008-3#4)
the leaves increased##2##3##(2008-10#2)
the leaves of Morus alba L##2##6##(2011-3#2)
the leaves of Morus alba##3##5##(2011-3#3)
the leaves of the##2##4##(1992-2#1)(2008-10#1)
the leaves of##10##3##(1992-2#1)(2008-10#3)(2008-11#1)(2010-2#1)(2011-3#3)(2013-1#1)
the leaves were##2##3##(2008-10#2)
the leaves##24##2##(1992-2#1)(2008-10#13)(2008-11#3)(2008-12#1)(2010-2#1)(2011-10#1)(2011-3#3)(2013-1#1)
the leaving group##5##3##(1993-8#5)
the lecithin##2##2##(2008-10#2)
the lectin and##2##3##(2008-10#2)
the lectin##9##2##(1990-5#1)(1992-6#2)(1995-11#1)(2008-10#5)
the lecturer in##3##3##(2008-11#3)
the lecturer practitioner role##2##4##(2008-11#2)
the lecturer practitioner##7##3##(2008-11#5)(2008-12#2)
the lecturer##16##2##(2008-11#13)(2008-12#3)
the lecturer's##2##2##(2008-11#2)
the left and right muscle##3##5##(2011-2#3)
the left and right##5##4##(1991-2#1)(2008-11#1)(2011-2#3)
the left arm of Saccharomyces cerevisiae chromosome##2##7##(1995-9#1)(1996-3#1)
the left arm of chromosome VII##2##6##(1995-9#1)(1996-6#1)
the left arm of chromosome##8##5##(1993-9#1)(1995-9#3)(1996-3#2)(1996-6#2)
the left arm of##14##4##(1993-2#1)(1993-9#1)(1995-9#4)(1996-3#4)(1996-6#4)
the left arm##16##3##(1991-3#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-9#4)(1996-3#4)(1996-6#4)
the left breast##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
the left cardiac sympathetic nerve##3##5##(2008-9#3)
the left end of chromosome##2##5##(1996-6#1)(1997-7#1)
the left eye##9##3##(2010-10#1)(2011-2#5)(2013-1#2)(2013-8#1)
the left frontal##2##3##(2008-12#1)(2013-1#1)
the left hemisphere##2##3##(1996-2#1)(2008-11#1)
the left hemithorax##3##3##(2009-4#1)(2013-1#1)(2013-7#1)
the left iliac##2##3##(2008-12#1)(2010-6#1)
the left kidney##4##3##(1990-6#1)(2011-2#1)(2013-1#2)
the left lateral##2##3##(2008-7#1)(2013-1#1)
the left lower##6##3##(1991-3#1)(2007-8#1)(2008-7#1)(2010-11#3)
the left lumbosacral PVM##2##4##(2013-8#2)
the left lung##2##3##(1991-9#1)(2010-7#1)
the left main##3##3##(1990-9#2)(2010-2#1)
the left middle##2##3##(2008-11#1)(2013-8#1)
the left ovary##2##3##(1997-8#1)(2010-12#1)
the left pleural##3##3##(1990-5#2)(2012-3#1)
the left posterior##2##3##(1997-6#1)(2009-8#1)
the left pulmonary artery##2##4##(2012-12#2)
the left side of the##6##5##(1993-6#1)(2008-12#1)(2010-12#2)(2012-12#1)(2012-3#1)
the left side of##7##4##(1991-3#1)(1993-6#1)(2008-12#1)(2010-12#2)(2012-12#1)(2012-3#1)
the left side##12##3##(1990-3#1)(1991-3#1)(1993-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#2)(2010-9#1)(2012-12#1)(2012-3#1)
the left superior temporal##2##4##(1996-2#1)(2012-12#1)
the left superior##3##3##(1996-2#1)(2011-2#1)(2012-12#1)
the left testis##2##3##(2008-10#1)(2011-2#1)
the left thumb##3##3##(2010-6#3)
the left upper quadrant##2##4##(1991-12#1)(2012-3#1)
the left upper##4##3##(1991-12#1)(2012-3#1)(2013-1#2)
the left ventricle##11##3##(1991-3#1)(1997-8#1)(2008-10#1)(2010-5#1)(2010-6#1)(2013-1#6)
the left ventricular##10##3##(1990-9#1)(1993-12#1)(2008-10#1)(2008-12#3)(2010-8#1)(2012-2#2)(2013-1#1)
the left vertebral artery##2##4##(1996-9#1)(1997-6#1)
the left##199##2##(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-3#6)(1991-6#2)(1991-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1995-11#1)(1995-8#1)(1995-9#4)(1996-2#4)(1996-3#5)(1996-6#8)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#3)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#11)(2008-12#8)(2008-7#9)(2008-9#4)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#5)(2010-5#1)(2010-6#7)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#14)(2012-12#10)(2012-2#3)(2012-3#6)(2013-1#21)(2013-2#1)(2013-7#1)(2013-8#6)
the left-right##2##2##(2010-3#2)
the leg muscles##2##3##(2013-8#2)
the leg##6##2##(2007-12#1)(2008-12#1)(2008-5#2)(2013-8#2)
the legacy##2##2##(1992-3#1)(1995-1#1)
the legal framework##2##3##(1996-3#1)(2008-10#1)
the legal system##4##3##(1991-12#1)(1994-2#1)(1996-3#1)(2008-11#1)
the legal##14##2##(1991-12#1)(1991-2#1)(1994-1#1)(1994-2#1)(1996-3#2)(1997-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-6#1)(2010-7#1)(2013-1#1)
the legislation##4##2##(1994-1#1)(1996-5#1)(1997-3#2)
the legislative process##2##3##(1996-1#1)(2012-2#1)
the legislative##4##2##(1994-1#1)(1996-1#1)(2008-12#1)(2012-2#1)
the legs##7##2##(1997-5#1)(2007-12#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#1)
the legume##2##2##(2008-10#1)(2009-8#1)
the length and width gradient parameters##2##6##(2008-10#2)
the length and width##3##4##(2008-10#3)
the length and##9##3##(2008-10#5)(2008-9#3)(2010-7#1)
the length of hospital stay##3##5##(1991-12#1)(2013-1#1)(2013-8#1)
the length of stay##2##4##(1991-1#1)(1992-12#1)
the length of the stem##2##5##(2008-10#2)
the length of the##26##4##(1991-12#1)(1992-9#1)(1996-5#1)(1997-1#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
the length of time##3##4##(1995-12#1)(1996-12#1)(2011-3#1)
the length of##45##3##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#4)(2011-3#1)(2013-1#2)(2013-8#1)
the length scale of the##2##5##(2008-10#1)(2008-3#1)
the length scale of##3##4##(2008-10#2)(2008-3#1)
the length##61##2##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-12#2)(2008-10#16)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2013-1#2)(2013-8#1)
the lengths of##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
the lengths##5##2##(1992-12#1)(2008-10#1)(2008-8#1)(2013-8#2)
the lens##7##2##(1993-3#1)(1993-9#1)(2011-2#1)(2012-2#4)
the lesion and##5##3##(1990-3#1)(1995-8#1)(1997-6#1)(2008-7#1)(2009-1#1)
the lesion in##2##3##(2008-5#2)
the lesion was found to be##2##6##(2009-11#1)(2011-2#1)
the lesion was##6##3##(2009-11#1)(2011-2#3)(2013-1#1)(2013-8#1)
the lesion##71##2##(1990-3#1)(1990-5#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-3#3)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-2#2)(1996-3#4)(1996-9#2)(1997-3#1)(1997-6#2)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#4)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
the lesioned##4##2##(1991-2#1)(2008-11#1)(2008-7#2)
the lesions in##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
the lesions of##2##3##(1997-8#2)
the lesions were##3##3##(1991-8#1)(2008-5#1)(2010-6#1)
the lesions##33##2##(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-6#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-1#1)
the less aggressive##2##3##(2008-10#2)
the less polar##2##3##(1990-2#1)(2012-2#1)
the less stable##2##3##(2008-10#1)(2008-4#1)
the less##26##2##(1990-2#1)(1990-5#1)(1991-1#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)
the lessons learned from this unsuccessful venture##2##7##(1994-3#2)
the lessons learned from##3##4##(1994-3#2)(2013-1#1)
the lessons learned##6##3##(1994-1#1)(1994-3#2)(1995-12#1)(2009-10#1)(2013-1#1)
the lessons##10##2##(1994-1#1)(1994-3#2)(1995-12#1)(2008-12#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#2)
the lethal##4##2##(1991-5#1)(2008-10#2)(2008-11#1)
the letter##2##2##(2008-5#1)(2010-2#1)
the leucine##4##2##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
the leucite##2##2##(2009-7#2)
the leukemia##2##2##(2008-9#1)(2012-3#1)
the leukemic##2##2##(2008-11#1)(2008-9#1)
the leukotriene D4 receptor##2##4##(1993-6#2)
the level and activity of##2##5##(1996-2#1)(2008-11#1)
the level and##6##3##(1993-12#1)(1996-2#2)(2008-11#3)
the level attained##2##3##(2008-10#1)(2008-11#1)
the level in##2##3##(1993-8#1)(2008-12#1)
the level of CaSR mRNA##2##5##(2008-11#2)
the level of RNA##2##4##(2008-9#1)(2012-3#1)
the level of accuracy##2##4##(1993-5#1)(2008-10#1)
the level of active ingredient within the formulation##2##8##(2008-5#2)
the level of both##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
the level of contamination##2##4##(2008-10#2)
the level of control##2##4##(2008-10#1)(2008-11#1)
the level of disease##2##4##(2008-10#2)
the level of drug resistance##2##5##(1992-2#2)
the level of effort allocated to current reproduction should##2##9##(2008-8#2)
the level of effort##3##4##(1995-1#1)(2008-8#2)
the level of expression of the##4##6##(2008-10#1)(2008-11#2)(2011-1#1)
the level of expression##7##4##(1992-10#1)(1996-12#1)(2008-10#1)(2008-11#2)(2011-1#1)(2012-2#1)
the level of gene##2##4##(1994-12#1)(2009-8#1)
the level of mRNA##2##4##(1993-9#1)(1995-12#1)
the level of noise##2##4##(2008-9#2)
the level of occupational therapists' knowledge about patients' rights##3##9##(2013-8#3)
the level of protection##2##4##(2008-10#2)
the level of resistance##3##4##(2008-10#3)
the level of the##23##4##(1990-3#1)(1991-12#1)(1991-6#1)(1993-1#1)(1994-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#5)(2008-5#1)(2008-7#2)(2009-1#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
the level of thermal hyperalgesia##2##5##(1995-12#2)
the level of transcription of##2##5##(1996-2#1)(1997-7#1)
the level of transcription##7##4##(1993-6#1)(1993-9#2)(1994-2#1)(1996-2#1)(1997-7#1)(2008-11#1)
the level of##246##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#3)(1992-10#2)(1992-2#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#61)(2008-11#22)(2008-12#2)(2008-5#7)(2008-7#6)(2008-8#12)(2008-9#6)(2009-1#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#5)
the level set##2##3##(2008-6#1)(2008-9#1)
the level was##2##3##(2008-11#1)(2010-3#1)
the level##273##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-1#3)(1992-10#2)(1992-2#2)(1992-3#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#66)(2008-11#28)(2008-12#4)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#13)(2008-9#8)(2009-1#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#5)
the level-set##3##2##(2008-6#3)
the levels and##2##3##(1991-2#1)(2008-5#1)
the levels in the##3##4##(2008-10#1)(2009-12#1)(2011-1#1)
the levels in##5##3##(1990-2#1)(2008-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
the levels of gene##2##4##(2008-10#1)(2008-9#1)
the levels of glucose##2##4##(2008-12#2)
the levels of serum##2##4##(1994-12#1)(2009-12#1)
the levels of the##9##4##(1990-12#1)(1992-12#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#2)
the levels of urinary##3##4##(2008-10#2)(2009-6#1)
the levels of##97##3##(1990-12#2)(1991-5#2)(1992-11#1)(1992-12#3)(1992-8#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#3)(2009-6#2)(2010-12#2)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
the levels were##3##3##(1993-3#1)(2008-10#1)(2008-12#1)
the levels##114##2##(1990-12#2)(1990-2#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-8#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#32)(2008-11#7)(2008-12#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#4)(2009-6#2)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
the lexical system##2##3##(1991-2#2)
the liberated##2##2##(2008-10#1)(2013-1#1)
the liberation of##4##3##(1995-11#1)(2008-10#2)(2010-7#1)
the librarian##3##2##(1991-3#1)(1992-12#1)(1994-3#1)
the librarian's role##2##3##(1991-3#1)(1992-1#1)
the librarians##2##2##(1992-12#2)
the libraries##2##2##(1991-3#1)(1997-2#1)
the library##5##2##(1993-1#1)(1995-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
the lichen Ramalina##3##3##(2008-10#1)(2008-11#2)
the lichen##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
the lichens##3##2##(2008-10#3)
the lidar beam##3##3##(2008-3#3)
the lidar##13##2##(2008-2#3)(2008-3#10)
the life and##2##3##(2008-10#1)(2008-4#1)
the life course##2##3##(2009-10#2)
the life cycle of##5##4##(1994-11#1)(1997-7#1)(2008-10#2)(2008-8#1)
the life cycle##9##3##(1994-11#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-1#1)
the life cycles of##3##4##(2008-10#2)(2012-2#1)
the life histories of##2##4##(2008-8#1)(2009-6#1)
the life history of the##3##5##(2008-11#2)(2008-8#1)
the life history of##4##4##(2008-11#2)(2008-8#1)(2009-10#1)
the life history##6##3##(2008-11#2)(2008-8#2)(2009-10#1)(2009-12#1)
the life insurance industry##2##4##(1995-1#1)(1995-12#1)
the life insurance##3##3##(1995-1#2)(1995-12#1)
the life of the##4##4##(1995-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
the life of##11##3##(1995-5#1)(1995-6#1)(1997-7#1)(2008-7#2)(2008-9#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
the life span of High Fivetrade mark cells##2##8##(2008-7#2)
the life span of rats bearing##2##6##(1993-8#2)
the life span of##7##4##(1993-8#2)(2008-10#1)(2008-7#3)(2010-4#1)
the life span##8##3##(1993-8#2)(2008-10#2)(2008-7#3)(2010-4#1)
the life style##3##3##(1992-11#1)(2008-11#1)(2008-7#1)
the life world##2##3##(2010-10#2)
the life##63##2##(1990-3#1)(1991-8#1)(1992-11#1)(1993-8#2)(1994-11#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#8)(2008-8#5)(2008-9#2)(2009-10#3)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the life-course##2##2##(2008-12#1)(2012-3#1)
the life-history traits of the##2##5##(2008-11#1)(2008-8#1)
the life-history traits##3##3##(2008-11#1)(2008-8#2)
the life-history##5##2##(2008-11#1)(2008-8#4)
the lifecycle##2##2##(2010-5#1)(2011-2#1)
the lifespan##5##2##(2008-7#1)(2008-9#2)(2009-5#1)(2010-7#1)
the lifetime is##2##3##(2008-10#2)
the lifetime of the graphite tube##2##6##(2008-10#2)
the lifetime of the##4##4##(2008-10#4)
the lifetime of##8##3##(1992-6#1)(1994-5#1)(2008-10#5)(2008-9#1)
the lifetime##13##2##(1992-6#1)(1994-5#1)(2008-10#9)(2008-9#1)(2012-12#1)
the ligament fibers##2##3##(2009-7#2)
the ligament##4##2##(2009-7#3)(2013-1#1)
the ligand concentration##3##3##(1997-2#1)(2008-10#2)
the ligand has been##2##4##(2008-10#2)
the ligand in##2##3##(1990-11#1)(2008-10#1)
the ligand is##2##3##(2008-10#2)
the ligand was##2##3##(1993-8#1)(2008-10#1)
the ligand##38##2##(1990-11#1)(1990-8#1)(1991-12#1)(1993-8#1)(1996-12#1)(1997-2#3)(1997-7#1)(2008-10#26)(2008-8#2)(2010-12#1)
the ligand-binding domain of the##3##5##(1991-12#2)(1992-9#1)
the ligand-binding domain of##4##4##(1991-12#2)(1992-9#1)(2008-8#1)
the ligand-binding domain##6##3##(1991-12#2)(1992-9#1)(2008-8#3)
the ligand-binding##9##2##(1991-12#2)(1992-9#1)(1995-11#1)(1995-2#1)(2008-4#1)(2008-8#3)
the ligand-embedded silica##2##3##(2008-10#2)
the liganded active site##2##4##(1992-6#2)
the liganded##4##2##(1992-6#4)
the ligands and##2##3##(2008-10#1)(2008-4#1)
the ligands##3##2##(2008-10#2)(2008-4#1)
the light absorption coefficient##2##4##(2008-3#2)
the light absorption##3##3##(2008-3#3)
the light and dark##2##4##(2008-10#1)(2013-7#1)
the light and##6##3##(2008-10#1)(2008-7#3)(2009-8#1)(2013-7#1)
the light chain##3##3##(1994-11#2)(1994-5#1)
the light chains are##2##4##(1993-9#2)
the light emission##2##3##(2008-10#2)
the light of the##10##4##(1990-3#1)(1993-3#1)(1995-12#1)(1997-7#1)(2008-10#2)(2008-11#3)(2010-7#1)
the light of##34##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#2)(1992-12#1)(1993-11#1)(1993-3#2)(1995-12#1)(1997-7#1)(2008-10#8)(2008-11#7)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#3)
the light period##4##3##(1994-8#1)(1995-11#1)(1997-2#2)
the light pulses##2##3##(2008-5#2)
the light scattering intensity##2##4##(2008-10#2)
the light scattering##3##3##(2008-10#3)
the light source##10##3##(1993-3#1)(2008-10#6)(2008-3#2)(2008-5#1)
the light utilization efficiency of##2##5##(2013-8#2)
the light##96##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-2#2)(1997-6#1)(1997-7#1)(2008-10#27)(2008-11#9)(2008-3#11)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
the light-dark##2##2##(1991-9#1)(2008-11#1)
the light-harvesting##2##2##(1995-2#1)(2012-6#1)
the light-scattering##3##2##(2008-10#2)(2008-3#1)
the likelihood of a re-infarction##2##5##(2009-6#2)
the likelihood of being##2##4##(2010-10#1)(2011-2#1)
the likelihood of having##3##4##(1992-2#1)(2010-10#1)(2010-12#1)
the likelihood of their##2##4##(1995-12#1)(2008-9#1)
the likelihood of these##2##4##(2008-8#1)(2010-10#1)
the likelihood of##39##3##(1991-12#1)(1992-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1997-3#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-6#4)(2009-7#1)(2010-10#3)(2010-12#2)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
the likelihood that##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-2#1)
the likelihood##50##2##(1991-12#1)(1992-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1997-3#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#3)(2008-8#6)(2008-9#3)(2009-6#4)(2009-7#1)(2010-10#4)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
the likely cause of##2##4##(1991-12#1)(2008-10#1)
the likely##12##2##(1991-12#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
the limb bud##5##3##(1993-12#2)(1995-8#3)
the limb##13##2##(1993-12#3)(1995-8#6)(2011-3#2)(2012-3#2)
the limbic system##4##3##(1992-12#4)
the limbic##6##2##(1992-12#4)(1996-12#1)(2008-7#1)
the limbus##2##2##(2008-11#2)
the limit of detection (LOD)##2##5##(2008-10#2)
the limit of detection for##3##5##(2008-10#3)
the limit of detection is 0##4##6##(2008-10#4)
the limit of detection is##6##5##(2008-10#5)(2013-1#1)
the limit of detection of##3##5##(2008-10#1)(2009-6#1)(2011-2#1)
the limit of detection was 0##3##6##(2008-10#3)
the limit of detection was##9##5##(2008-10#9)
the limit of detection##38##4##(2008-10#33)(2009-6#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
the limit of determination##2##4##(2008-10#2)
the limit of quantification was##2##5##(2008-10#1)(2008-5#1)
the limit of quantification##11##4##(2008-10#8)(2008-5#3)
the limit of the##2##4##(2007-11#1)(2013-8#1)
the limit of##58##3##(1995-3#1)(2007-11#1)(2008-10#46)(2008-5#3)(2009-6#1)(2011-2#2)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
the limit##61##2##(1995-3#1)(2007-11#1)(2008-10#46)(2008-11#1)(2008-5#3)(2009-6#1)(2011-2#2)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#3)
the limitation of the##3##4##(1991-3#1)(2008-10#1)(2008-11#1)
the limitation of##6##3##(1991-3#1)(2008-10#4)(2008-11#1)
the limitations of existing##2##4##(2008-10#1)(2008-6#1)
the limitations of the##5##4##(1992-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
the limitations of this study##3##5##(2008-8#1)(2013-1#2)
the limitations of this##5##4##(2008-8#1)(2012-12#1)(2013-1#3)
the limitations of##21##3##(1992-3#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
the limitations##29##2##(1992-3#1)(1993-11#1)(1996-3#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
the limited number of##4##4##(1996-3#1)(2008-10#2)(2012-2#1)
the limited number##5##3##(1996-3#1)(2008-10#2)(2012-12#1)(2012-2#1)
the limited possibility of##2##4##(2008-11#2)
the limited##28##2##(1992-3#1)(1994-12#2)(1995-12#1)(1996-11#2)(1996-3#1)(2008-10#7)(2008-11#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
the limiting factor for##2##4##(2008-10#2)
the limiting factor##3##3##(2008-10#3)
the limiting##7##2##(2008-10#5)(2008-8#1)(2011-2#1)
the limits and##2##3##(2008-2#1)(2009-7#1)
the limits of detection (LOD)##3##5##(2008-10#3)
the limits of detection and##3##5##(2008-10#3)
the limits of detection for##2##5##(2008-10#2)
the limits of detection were##5##5##(2008-10#5)
the limits of detection##20##4##(2008-10#20)
the limits of quantification were 0##2##6##(2008-10#2)
the limits of the##3##4##(1994-5#1)(2008-10#1)(2010-8#1)
the limits of##34##3##(1993-3#1)(1994-5#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-8#1)
the limits##38##2##(1993-3#1)(1994-5#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-8#1)
the line in##2##3##(1991-12#1)(1995-8#1)
the line jitter of##2##4##(2008-3#2)
the line jitter##3##3##(2008-3#3)
the line of sight##2##4##(2008-3#1)(2008-6#1)
the line of##3##3##(2008-3#2)(2008-6#1)
the line strength##4##3##(2008-3#4)
the line was##2##3##(1995-8#1)(2008-10#1)
the line##29##2##(1991-1#1)(1991-12#1)(1991-3#1)(1995-8#2)(2008-10#3)(2008-2#1)(2008-3#15)(2008-6#1)(2008-8#1)(2011-2#2)(2013-8#1)
the lineage##2##2##(2008-11#1)(2010-4#1)
the linear calibration range##2##4##(2008-10#2)
the linear calibration##4##3##(2008-10#4)
the linear concentration range of##2##5##(2008-10#2)
the linear concentration range##3##4##(2008-10#3)
the linear determination ranges##2##4##(2008-10#2)
the linear dynamic range of##3##5##(2008-10#3)
the linear dynamic range was##2##5##(2008-10#2)
the linear dynamic range##9##4##(2008-10#9)
the linear dynamic##10##3##(2008-10#10)
the linear equation##2##3##(1990-5#1)(2008-10#1)
the linear isotherm approach##2##4##(2008-10#2)
the linear no-threshold##2##3##(2013-1#2)
the linear range for##2##4##(2008-10#2)
the linear range is##3##4##(2008-10#3)
the linear range of the##2##5##(2008-10#2)
the linear range of##6##4##(2008-10#6)
the linear range was from##2##5##(2008-10#2)
the linear range was##4##4##(2008-10#4)
the linear range##26##3##(2008-10#26)
the linear ranges of the calibration curves were 0##2##9##(2008-10#2)
the linear ranges of##3##4##(2008-10#3)
the linear ranges##4##3##(2008-10#4)
the linear regression equation##2##4##(2008-10#1)(2008-7#1)
the linear regression methods##2##4##(2008-10#2)
the linear regression##6##3##(2008-10#3)(2008-3#1)(2008-7#1)(2013-8#1)
the linear relationship between the##5##5##(2008-10#5)
the linear relationship between##7##4##(2008-10#7)
the linear relationship##8##3##(2008-10#8)
the linear response range##2##4##(2008-10#2)
the linear response##4##3##(2008-10#4)
the linear##93##2##(1990-5#1)(1991-5#2)(2008-10#75)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)(2010-1#1)(2013-1#3)(2013-8#1)
the linearity of##2##3##(2008-10#2)
the linearity range is##2##4##(2008-10#2)
the linearity range##4##3##(2008-10#4)
the linearity was##2##3##(2008-10#2)
the linearity##13##2##(2008-10#12)(2008-12#1)
the linearization##2##2##(2008-2#1)(2008-3#1)
the lines homozygous for the##2##5##(2008-10#2)
the lines of##3##3##(2008-3#2)(2012-3#1)
the lines##12##2##(2008-10#5)(2008-3#4)(2008-8#1)(2008-9#1)(2012-3#1)
the linewidth of a##3##4##(2008-2#3)
the linewidth of the##2##4##(2008-2#1)(2008-3#1)
the linewidth of##5##3##(2008-2#4)(2008-3#1)
the linewidth##6##2##(2008-2#4)(2008-3#2)
the linguistic and##2##3##(2010-5#1)(2013-8#1)
the linguistic##4##2##(2010-5#3)(2013-8#1)
the link between maternal##2##4##(2009-7#1)(2012-2#1)
the link between the##3##4##(1990-11#1)(2008-11#1)(2008-6#1)
the link between##19##3##(1990-11#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-6#1)(2012-2#2)(2013-1#3)(2013-8#1)
the link of##2##3##(2012-2#2)
the link to##2##3##(2008-10#1)(2009-4#1)
the link##27##2##(1990-11#1)(1991-3#1)(1993-9#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-6#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-6#1)(2012-2#4)(2013-1#3)(2013-8#1)
the linkage between##4##3##(1993-12#1)(1994-12#1)(2008-8#1)(2010-11#1)
the linkage of##2##3##(2008-10#1)(2011-2#1)
the linkage##15##2##(1993-12#1)(1994-11#1)(1994-12#1)(1996-12#4)(1996-6#2)(2008-10#2)(2008-8#2)(2010-11#1)(2011-2#1)
the linkages between##2##3##(1994-1#1)(2008-10#1)
the linked##2##2##(2008-10#1)(2008-8#1)
the linker##3##2##(1992-6#1)(2009-6#1)(2010-5#1)
the linking of##2##3##(2008-10#1)(2008-6#1)
the linking##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
the links between##3##3##(1992-12#2)(2008-11#1)
the links##4##2##(1992-12#2)(2008-11#1)(2011-2#1)
the lipase activity##2##3##(2008-10#2)
the lipase##5##2##(2008-10#2)(2008-7#1)(2009-8#1)(2012-2#1)
the lipid A##2##3##(1990-5#1)(2011-2#1)
the lipid and##2##3##(2008-3#1)(2009-8#1)
the lipid bilayer##7##3##(1991-5#1)(1992-9#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)
the lipid membrane##4##3##(1994-5#3)(2008-10#1)
the lipid peroxidation##6##3##(1991-5#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
the lipid phase##3##3##(1991-5#2)(1994-5#1)
the lipid vesicles to##2##4##(2008-11#2)
the lipid##62##2##(1990-5#3)(1991-12#1)(1991-5#5)(1992-11#1)(1992-9#1)(1993-8#2)(1994-11#1)(1994-5#6)(1996-2#2)(1996-3#1)(2008-10#9)(2008-11#6)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#3)(2013-1#1)
the lipids##6##2##(1991-5#1)(2008-10#1)(2008-5#2)(2008-9#1)(2012-12#1)
the lipophilic##12##2##(2008-10#7)(2008-5#5)
the lipoprotein##3##2##(2008-5#1)(2008-6#1)(2012-2#1)
the lipoproteins##2##2##(1995-8#1)(2008-5#1)
the liposomal surface##3##3##(2008-10#3)
the liposomal##5##2##(1990-2#1)(2008-10#4)
the liposome##3##2##(1994-5#1)(2008-10#2)
the liposomes##4##2##(1991-5#1)(1994-11#1)(2008-8#2)
the liquid chromatography##3##3##(2008-10#3)
the liquid crystalline phase##2##4##(1992-9#2)
the liquid crystalline##3##3##(1992-9#2)(2008-7#1)
the liquid junction potential##2##4##(2008-10#2)
the liquid junction##3##3##(2008-10#3)
the liquid membrane and the##2##5##(2008-10#2)
the liquid membrane##4##3##(2008-10#4)
the liquid phase was##2##4##(2008-10#2)
the liquid phase##4##3##(2008-10#4)
the liquid propanol##2##3##(2008-3#2)
the liquid sample##4##3##(2008-10#4)
the liquid soap and##2##4##(2008-10#2)
the liquid##47##2##(1992-9#2)(1995-3#1)(2008-10#31)(2008-11#1)(2008-3#7)(2008-7#1)(2009-10#1)(2010-4#1)(2010-8#1)(2012-2#1)
the liquid-air interface of##2##4##(2008-10#2)
the liquid-core##2##2##(2008-10#2)
the liquid-gas##2##2##(2008-10#1)(2008-3#1)
the liquid-liquid extraction of##3##4##(2008-10#3)
the liquid-liquid extraction##6##3##(2008-10#6)
the liquid-liquid##8##2##(2008-10#8)
the liquid-solid##2##2##(2008-3#1)(2009-8#1)
the liquid/liquid##2##2##(2008-10#2)
the list of##14##3##(1993-8#1)(1995-12#1)(1996-8#1)(1997-3#3)(2008-10#2)(2008-11#1)(2009-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
the list##17##2##(1991-11#3)(1993-8#1)(1995-12#1)(1996-8#1)(1997-3#3)(2008-10#2)(2008-11#1)(2009-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
the list-length and strength-based mirror effects##2##6##(2008-6#2)
the listed##2##2##(2008-10#1)(2008-5#1)
the literal##2##2##(2008-11#1)(2008-2#1)
the literature about##3##3##(1990-8#1)(1994-8#1)(2008-8#1)
the literature and##21##3##(1990-3#1)(1991-1#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1996-6#1)(1997-2#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
the literature as a##3##4##(2008-5#1)(2009-7#1)(2013-1#1)
the literature as##6##3##(1996-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
the literature available##2##3##(2008-10#1)(2008-11#1)
the literature before##2##3##(2010-12#1)(2012-12#1)
the literature concerning the##3##4##(1996-9#1)(2010-9#1)(2011-2#1)
the literature concerning##4##3##(1996-9#1)(2008-7#1)(2010-9#1)(2011-2#1)
the literature for the##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
the literature for##7##3##(1991-3#2)(1992-12#1)(2008-10#3)(2008-11#1)
the literature from##4##3##(1996-2#1)(2008-10#2)(2008-8#1)
the literature in##8##3##(1991-3#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-2#1)(2013-1#2)
the literature is##9##3##(1991-3#1)(1995-9#1)(1997-8#1)(2008-1#1)(2008-11#4)(2010-12#1)
the literature of##7##3##(1993-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#2)
the literature on the effects of##3##6##(1992-12#1)(1993-11#1)(2008-7#1)
the literature on the effects##4##5##(1992-12#1)(1993-11#1)(1996-3#1)(2008-7#1)
the literature on the use of##2##6##(2013-1#2)
the literature on the##15##4##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-11#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-6#1)(2011-2#1)(2013-1#2)
the literature on this topic##2##5##(1993-6#1)(2008-11#1)
the literature on this##5##4##(1990-2#1)(1993-6#1)(2008-11#1)(2008-5#1)(2010-8#1)
the literature on##35##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#3)(2012-2#3)(2013-1#2)
the literature published from##2##4##(2008-12#1)(2009-8#1)
the literature published##3##3##(2008-12#1)(2009-8#1)(2012-3#1)
the literature review##3##3##(2008-11#3)
the literature shows that##4##4##(2008-10#1)(2008-5#1)(2011-3#1)(2012-3#1)
the literature since##2##3##(2008-10#1)(2013-8#1)
the literature suggests that##3##4##(2008-11#2)(2013-1#1)
the literature suggests##4##3##(1992-2#1)(2008-11#2)(2013-1#1)
the literature surrounding##2##3##(2008-6#1)(2011-2#1)
the literature that##5##3##(2008-11#1)(2010-1#1)(2010-3#1)(2012-2#2)
the literature through##3##3##(1994-2#1)(2010-9#1)(2012-3#1)
the literature to##4##3##(2008-11#2)(2008-7#1)(2013-8#1)
the literature values##3##3##(2008-10#3)
the literature with##4##3##(1992-12#1)(2008-10#1)(2009-3#1)(2010-10#1)
the literature##386##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-6#2)(1992-1#2)(1992-12#6)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#2)(1995-2#1)(1995-9#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#3)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-5#1)(2008-1#1)(2008-10#52)(2008-11#40)(2008-12#15)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#23)(2008-8#9)(2008-9#8)(2009-1#2)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#5)(2010-3#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#22)(2011-3#2)(2012-12#4)(2012-2#16)(2012-3#14)(2013-1#32)(2013-7#1)(2013-8#5)
the lithium ions##2##3##(2008-10#2)
the lithium##5##2##(2008-10#5)
the litter##4##2##(1994-8#1)(2008-11#1)(2010-3#1)(2011-2#1)
the little finger##4##3##(2008-9#4)
the little##6##2##(2008-10#1)(2008-9#4)(2010-8#1)
the live##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
the lived experience of##4##4##(2008-11#2)(2009-5#2)
the lived experience##5##3##(2008-11#3)(2009-5#2)
the lived##6##2##(2008-11#4)(2009-5#2)
the liver and##15##3##(1991-12#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-9#1)(1997-8#1)(2008-12#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-2#2)(2013-8#1)
the liver are##2##3##(1990-11#1)(2010-12#1)
the liver as##2##3##(2008-8#1)(2010-5#1)
the liver by##4##3##(1995-2#1)(2008-11#1)(2008-5#1)(2010-5#1)
the liver in##6##3##(1990-11#1)(1991-12#1)(1992-2#1)(1993-3#1)(1995-2#1)(2010-5#1)
the liver is##4##3##(1991-12#1)(2008-1#1)(2010-12#1)(2010-7#1)
the liver of the female##2##5##(2010-5#2)
the liver of##9##3##(1990-3#2)(1991-8#1)(1995-8#1)(2008-5#1)(2010-11#1)(2010-5#2)(2013-1#1)
the liver parenchyma##2##3##(1996-2#1)(2011-2#1)
the liver to##4##3##(1995-8#1)(2008-11#1)(2008-5#1)(2010-11#1)
the liver using##2##3##(2009-12#1)(2010-7#1)
the liver was##6##3##(1990-11#1)(1993-3#1)(1993-6#1)(2008-6#1)(2011-1#2)
the liver with##4##3##(1991-7#1)(2009-1#1)(2010-12#1)(2013-1#1)
the liver##137##2##(1990-11#7)(1990-2#1)(1990-3#2)(1990-5#2)(1991-12#6)(1991-3#2)(1991-7#4)(1991-8#2)(1992-2#2)(1993-12#1)(1993-3#3)(1993-6#2)(1994-2#1)(1994-5#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-8#2)(1995-9#1)(1996-2#2)(1997-4#1)(1997-7#2)(1997-8#3)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#3)(2008-5#6)(2008-6#4)(2008-8#2)(2009-1#1)(2009-12#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#3)(2010-12#8)(2010-5#8)(2010-7#6)(2011-1#2)(2011-2#1)(2011-3#2)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
the liver-specific##2##2##(2011-2#2)
the liver]##2##2##(1991-3#1)(1992-5#1)
the lives of##9##3##(1991-2#1)(1993-8#1)(1995-6#1)(2008-11#3)(2008-8#1)(2010-10#1)(2010-8#1)
the lives##10##2##(1991-2#1)(1993-8#1)(1995-6#1)(2008-11#4)(2008-8#1)(2010-10#1)(2010-8#1)
the living embryo##2##3##(2008-11#1)(2008-9#1)
the living##11##2##(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2013-8#1)
the lizard##3##2##(2008-8#1)(2011-2#2)
the load applied on the pad##2##6##(2008-5#2)
the load##4##2##(2008-10#1)(2008-5#2)(2009-5#1)
the loaded##3##2##(2008-10#3)
the loading and##2##3##(1990-2#1)(2008-10#1)
the loading##9##2##(1990-2#1)(2008-10#5)(2009-7#2)(2013-1#1)
the local and regional##2##4##(1997-3#1)(2008-10#1)
the local and##8##3##(1990-5#1)(1991-6#1)(1997-3#1)(2008-10#1)(2008-12#2)(2010-7#1)(2011-2#1)
the local anesthetic##2##3##(1993-1#2)
the local circuit##3##3##(1996-12#1)(2008-11#2)
the local community##2##3##(2009-6#1)(2013-1#1)
the local extinction##4##3##(2008-3#1)(2008-8#3)
the local lymph node assay##2##5##(2008-5#2)
the local population##5##3##(2008-10#2)(2008-9#1)(2011-2#1)(2012-2#1)
the local populations##3##3##(2008-10#3)
the local public health##2##4##(1995-12#1)(1997-3#1)
the local scale##2##3##(2008-6#1)(2008-8#1)
the local sex ratio##2##4##(2008-9#2)
the local temperature##2##3##(2008-3#2)
the local##98##2##(1990-5#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#2)(1993-1#2)(1993-11#1)(1994-2#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-3#3)(1997-4#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#14)(2008-11#5)(2008-12#5)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#5)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the localization and##3##3##(2008-1#1)(2012-2#1)(2012-3#1)
the localization of these##2##4##(1993-3#1)(2008-10#1)
the localization of##16##3##(1993-3#1)(1997-2#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-5#1)(2010-7#1)(2012-3#1)
the localization##23##2##(1993-3#1)(1996-12#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-7#1)(2012-2#1)(2012-3#2)
the localized##4##2##(1993-5#1)(1994-2#1)(2008-10#2)
the location and##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
the location of the##11##4##(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the location of##27##3##(1994-3#1)(2008-10#7)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
the location##39##2##(1991-6#1)(1994-3#1)(2008-10#9)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
the locations of##8##3##(1990-9#1)(1994-5#1)(1997-8#1)(2008-10#3)(2008-11#2)
the locations were##3##3##(1990-8#1)(2013-8#2)
the locations##13##2##(1990-8#1)(1990-9#1)(1994-5#1)(1997-8#1)(2008-10#4)(2008-11#2)(2013-1#1)(2013-8#2)
the loci of##2##3##(1995-5#1)(1996-8#1)
the loci##6##2##(1995-11#1)(1995-5#1)(1996-8#1)(2008-10#2)(2008-9#1)
the locomotor activity##2##3##(2008-11#1)(2008-5#1)
the locomotor response to##3##4##(1993-6#3)
the locomotor rhythm##3##3##(2008-5#1)(2008-6#2)
the locomotor##11##2##(1993-3#2)(1993-6#3)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#2)
the locus coeruleus##4##3##(1996-12#1)(1996-5#1)(2008-7#2)
the locus of##5##3##(1991-2#1)(2007-12#1)(2009-10#1)(2010-8#1)(2012-3#1)
the locus##21##2##(1991-2#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(2007-12#1)(2008-10#4)(2008-7#2)(2008-8#2)(2009-10#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
the locust##8##2##(1994-2#2)(2007-12#6)
the log of##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
the log##6##2##(1995-8#1)(2008-10#3)(2008-7#1)(2008-8#1)
the log-log plots##2##3##(2008-10#2)
the log-rank test##2##3##(2011-2#1)(2012-3#1)
the log-transformed##2##2##(2008-10#1)(2009-1#1)
the logarithm of the concentration of##2##6##(2008-10#2)
the logarithm of the##7##4##(2008-10#7)
the logarithm of##19##3##(2008-10#16)(2008-8#1)(2009-7#2)
the logarithmic##3##2##(2008-10#2)(2008-3#1)
the logic of##4##3##(2008-8#2)(2009-5#1)(2010-11#1)
the logic##6##2##(1995-2#1)(2008-8#3)(2009-5#1)(2010-11#1)
the logical##2##2##(2008-11#1)(2008-7#1)
the logistic model##4##3##(2008-10#4)
the logistic regression analysis of SSR prevalence##2##7##(2008-10#2)
the logistic regression##3##3##(2008-10#3)
the logistic##13##2##(1991-12#1)(1992-9#1)(2008-10#9)(2008-7#1)(2008-9#1)
the logistics##2##2##(1995-2#1)(1995-5#1)
the long arm of chromosome##7##5##(1997-3#1)(1997-5#1)(2008-10#3)(2008-9#1)(2012-12#1)
the long arm of wheat chromosome##2##6##(2008-10#2)
the long arm of wheat##3##5##(2008-10#3)
the long arm of##13##4##(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-9#1)(2012-12#1)
the long arm##14##3##(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-9#1)(2012-12#1)
the long arms of##2##4##(1997-8#1)(2008-7#1)
the long run##6##3##(1996-1#1)(1997-3#1)(1997-5#1)(2009-12#1)(2010-4#1)(2013-8#1)
the long term##13##3##(1992-1#1)(1992-5#1)(1993-11#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
the long##56##2##(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-2#1)(1996-1#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#2)(2008-10#12)(2008-11#2)(2008-12#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#2)
the long-distance transport of##2##4##(2008-10#2)
the long-distance##5##2##(1993-2#1)(2008-10#4)
the long-term care##2##3##(1995-3#1)(1997-1#1)
the long-term clinical outcome##2##4##(2012-3#1)(2013-1#1)
the long-term clinical##3##3##(2012-3#2)(2013-1#1)
the long-term effectiveness of##2##4##(2008-11#1)(2012-2#1)
the long-term effects of##5##4##(1995-11#1)(1996-12#1)(2009-1#2)(2013-1#1)
the long-term management of##2##4##(2008-10#2)
the long-term prognosis##3##3##(1991-6#1)(2008-10#1)(2011-7#1)
the long-term results##4##3##(1991-3#1)(1992-9#1)(1994-2#1)(2013-1#1)
the long-term safety outcomes##2##4##(2012-12#2)
the long-term stability of##4##4##(2008-10#2)(2008-11#1)(2008-4#1)
the long-term##55##2##(1991-3#1)(1991-6#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#8)(2008-11#8)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-1#3)(2009-3#1)(2010-2#1)(2010-3#2)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)
the longer##10##2##(1990-2#1)(1995-8#2)(2008-10#1)(2008-5#3)(2010-1#1)(2011-2#1)(2011-3#1)
the longest##13##2##(1990-8#1)(1993-12#1)(1994-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#2)(2012-3#1)
the longevity of##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
the longevity##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
the longitudinal axis of##2##4##(2008-9#1)(2011-2#1)
the longitudinal direction##2##3##(2008-9#1)(2009-7#1)
the longitudinal effects of##2##4##(2010-7#1)(2011-1#1)
the longitudinal##13##2##(1991-12#1)(1997-3#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
the loop ligation##2##3##(1995-1#2)
the loop ligature##2##3##(1995-1#2)
the loop region##2##3##(1993-8#1)(2008-4#1)
the loop##18##2##(1992-11#1)(1992-3#2)(1993-8#1)(1995-1#5)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
the loss of B-PE fluorescence in the##2##7##(2008-10#2)
the loss of a##3##4##(1993-3#1)(2008-4#1)(2012-3#1)
the loss of function##2##4##(1997-8#1)(2011-3#1)
the loss of hormone##2##4##(1997-7#2)
the loss of its##2##4##(1997-7#1)(2008-10#1)
the loss of renal##2##4##(1990-2#1)(2011-2#1)
the loss of the##5##4##(2008-10#2)(2009-8#2)(2013-7#1)
the loss of##62##3##(1990-2#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-7#4)(1997-8#1)(2007-11#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-3#2)(2009-8#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#5)(2013-7#1)
the loss##68##2##(1990-2#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-7#4)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-3#2)(2009-8#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#5)(2013-7#1)
the losses##5##2##(2007-11#1)(2008-10#2)(2013-1#1)(2013-8#1)
the lost of##2##3##(2008-10#1)(2011-2#1)
the lost##4##2##(1995-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
the lot##3##2##(2008-10#3)
the low Mr fraction##2##4##(1990-5#2)
the low activity##2##3##(1997-7#1)(2008-7#1)
the low affinity##2##3##(2008-7#2)
the low back##4##3##(2008-12#3)(2013-8#1)
the low chemical oxygen demand##2##5##(2008-10#2)
the low concentration##3##3##(1996-3#1)(2008-9#1)(2009-8#1)
the low cost of##2##4##(1992-5#1)(2008-10#1)
the low density lipoprotein receptor##2##5##(1994-9#1)(1995-2#1)
the low density lipoprotein##4##4##(1994-9#1)(1995-2#1)(1995-8#2)
the low dose##4##3##(2008-7#3)(2010-1#1)
the low incidence of##2##4##(2010-12#1)(2011-2#1)
the low level of##5##4##(2008-10#4)(2011-7#1)
the low molecular weight form of Hsp70##2##7##(1991-9#2)
the low molecular weight##3##4##(1991-9#2)(2009-4#1)
the low pressure##2##3##(1996-3#2)
the low rate of##3##4##(1991-9#1)(1996-11#1)(2008-10#1)
the low risk of##2##4##(2011-2#1)(2012-3#1)
the low risk##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
the low sensitivity of##2##4##(1990-3#1)(2011-2#1)
the low sensitivity##3##3##(1990-3#1)(2011-2#1)(2012-12#1)
the low##125##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-9#3)(1992-12#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-9#1)(1997-2#2)(1997-7#1)(2008-1#1)(2008-10#46)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#3)
the low-CHO diet was##2##4##(2013-8#2)
the low-affinity##5##2##(1990-8#1)(1994-3#1)(1994-5#2)(1996-12#1)
the low-density lipoprotein##2##3##(2008-6#1)(2013-1#1)
the low-dose##2##2##(2008-7#1)(2013-8#1)
the low-frequency##2##2##(2008-11#1)(2013-8#1)
the low-grade##2##2##(1994-1#2)
the low-power##2##2##(2008-3#2)
the low-pressure##2##2##(1995-6#1)(2008-3#1)
the low-temperature##3##2##(2008-10#2)(2011-2#1)
the lower and upper##2##4##(2012-2#2)
the lower cell yield##2##4##(2008-11#2)
the lower cell##3##3##(2008-11#3)
the lower detection limit##2##4##(2008-10#2)
the lower end of the##3##5##(2008-10#2)(2011-2#1)
the lower esophageal sphincter##2##4##(1992-6#1)(2011-2#1)
the lower extremities##10##3##(1993-6#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#2)(2012-2#1)
the lower extremity##4##3##(2009-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the lower female genital tract##2##5##(1990-2#1)(1994-1#1)
the lower genital tract##3##4##(1994-1#1)(2011-2#2)
the lower level of##2##4##(1993-8#1)(2008-10#1)
the lower limb##3##3##(1995-2#1)(2011-2#1)(2013-1#1)
the lower limbs##7##3##(1990-3#1)(1991-11#1)(1991-3#1)(2007-8#1)(2008-8#2)(2009-3#1)
the lower limit of detection##2##5##(2008-10#2)
the lower limit of##3##4##(2008-10#3)
the lower limit##6##3##(2008-10#5)(2008-3#1)
the lower lip##4##3##(1991-8#2)(2013-1#2)
the lower rim##3##3##(1996-5#3)
the lower small intestine##2##4##(2008-5#2)
the lower spectrum of illness##2##5##(2011-2#2)
the lower temperature##3##3##(1992-10#1)(2008-10#1)(2008-11#1)
the lower the##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
the lower values##3##3##(2008-10#1)(2011-2#2)
the lower##132##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#2)(1992-10#2)(1992-12#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-1#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#4)(2007-8#1)(2008-10#38)(2008-11#8)(2008-12#4)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#2)(2009-3#1)(2010-11#1)(2010-8#2)(2011-2#15)(2012-12#3)(2012-2#4)(2013-1#8)(2013-8#1)
the lower-order structure##2##3##(2011-2#2)
the lowering of##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
the lowest blanks##2##3##(2008-10#2)
the lowest concentration##3##3##(1994-11#1)(2008-10#2)
the lowest detected##2##3##(2008-10#1)(2009-5#1)
the lowest detection##2##3##(2008-10#2)
the lowest in the##2##4##(2008-7#1)(2009-10#1)
the lowest in##5##3##(1991-6#1)(2008-10#2)(2008-7#1)(2009-10#1)
the lowest level in##2##4##(2008-10#2)
the lowest level of##2##4##(1996-12#1)(2008-10#1)
the lowest level##7##3##(1996-12#1)(2008-10#3)(2008-8#1)(2013-1#2)
the lowest levels of##2##4##(2010-5#1)(2013-1#1)
the lowest limit of detection##2##5##(2008-10#2)
the lowest local extinction probability##2##5##(2008-8#2)
the lowest numbers##2##3##(2008-10#1)(2008-12#1)
the lowest possible##2##3##(2008-11#1)(2008-6#1)
the lowest sensitivity##2##3##(2008-10#2)
the lowest values##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
the lowest##109##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-6#2)(1993-8#1)(1994-11#1)(1994-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#49)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
the luciferase gene##2##3##(2008-11#2)
the luciferase##5##2##(1997-2#1)(2008-11#3)(2008-9#1)
the lucigenin##4##2##(2008-10#4)
the lucigenin-CL system##2##3##(2008-10#2)
the lumbar spinal canal##2##4##(2008-7#2)
the lumbar spinal##4##3##(1990-5#2)(2008-7#2)
the lumbar spine##9##3##(1991-11#2)(2010-3#4)(2012-12#1)(2012-2#1)(2012-3#1)
the lumbar vein##3##3##(2011-2#3)
the lumbar##23##2##(1990-5#2)(1991-11#2)(1996-3#1)(1996-6#1)(2008-12#1)(2008-7#3)(2010-3#4)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)
the lumbosacral##6##2##(2009-9#1)(2010-6#2)(2013-8#3)
the lumen of the stylet extension and##2##7##(2008-10#2)
the lumen of the##8##4##(1997-1#1)(2007-12#2)(2008-10#2)(2008-7#1)(2011-2#2)
the lumen of##10##3##(1997-1#1)(2007-12#2)(2008-10#4)(2008-7#1)(2011-2#2)
the lumen##19##2##(1991-12#1)(1996-3#1)(1997-1#2)(2007-12#4)(2008-10#5)(2008-7#3)(2011-2#3)
the luminal surface LDL concentration was##2##6##(2008-9#2)
the luminal surface##4##3##(2008-9#4)
the luminance in##2##3##(2008-3#2)
the luminance##4##2##(2008-3#4)
the luminescence##2##2##(2008-10#2)
the luminescent##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
the luminescing##2##2##(2008-10#2)
the luminol-H(2)O(2)##2##2##(2008-10#2)
the lunate is##2##3##(2012-3#1)(2013-1#1)
the lung and##6##3##(1995-12#1)(1996-3#1)(1997-1#1)(2010-10#1)(2010-7#1)(2013-8#1)
the lung can be##2##4##(1992-12#2)
the lung cancer incidence##2##4##(1996-3#2)
the lung cancer##4##3##(1991-2#1)(1996-3#2)(2008-11#1)
the lung is##2##3##(2008-7#1)(2010-5#1)
the lung tissue##3##3##(1991-12#1)(1996-3#1)(2008-10#1)
the lung##68##2##(1990-3#1)(1991-12#5)(1991-2#1)(1992-12#4)(1992-2#3)(1992-3#2)(1994-12#3)(1995-12#1)(1995-8#1)(1996-3#4)(1997-1#7)(1997-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-1#2)(2010-10#2)(2010-5#3)(2010-7#3)(2010-8#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
the lung]##2##2##(1991-9#1)(1997-5#1)
the lungs and##8##3##(1991-12#1)(1992-3#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-5#1)(2011-2#1)
the lungs in##3##3##(2008-5#2)(2010-8#1)
the lungs of children##2##4##(1991-12#1)(1997-1#1)
the lungs of##7##3##(1991-12#1)(1994-11#1)(1997-1#1)(2008-10#2)(2013-1#2)
the lungs was##2##3##(1996-3#1)(2008-10#1)
the lungs were##2##3##(1996-3#1)(2008-10#1)
the lungs##48##2##(1990-11#1)(1991-12#3)(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#6)(1997-1#8)(1997-2#1)(2008-1#1)(2008-10#4)(2008-5#6)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
the luteal phase##2##3##(1990-8#1)(2012-2#1)
the luteal##4##2##(1990-8#1)(1992-9#1)(2012-2#2)
the lymph node##4##3##(1990-3#1)(1990-5#1)(1990-6#1)(2009-12#1)
the lymph nodes##3##3##(1990-12#1)(1996-3#1)(2012-3#1)
the lymph##7##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1996-3#1)(2009-12#1)(2012-3#1)
the lymphatic vessels##2##3##(2010-1#1)(2013-1#1)
the lymphatic##6##2##(1990-3#1)(2008-9#1)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
the lymphocyte##5##2##(1995-12#2)(2008-11#1)(2008-4#1)(2008-5#1)
the lymphocytes##2##2##(1994-12#1)(2011-2#1)
the lymphoid patches##2##3##(1992-12#2)
the lymphoid tissues##2##3##(2008-10#1)(2008-9#1)
the lymphoid##9##2##(1992-12#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
the lysates of##2##3##(1995-6#1)(2010-12#1)
the lysosomal enzyme##3##3##(1993-8#1)(1996-8#1)(1997-7#1)
the lysosomal##15##2##(1991-12#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#1)(1993-12#1)(1993-8#2)(1994-5#1)(1996-8#1)(1997-7#1)(2008-7#3)(2012-3#1)
the lysosomes of the##2##4##(1990-5#1)(1991-12#1)
the lysosomes##3##2##(1990-5#1)(1991-12#1)(1992-10#1)
the lytic##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
the m-RNA level##4##3##(1997-1#4)
the m/z 73##2##3##(2008-10#2)
the m/z##5##2##(2008-10#5)
the mAb##3##2##(2008-11#3)
the mAbs##2##2##(2008-11#1)(2008-8#1)
the mF plasmid##2##3##(1997-2#2)
the mRNA expression levels of##3##5##(2008-11#2)(2009-8#1)
the mRNA expression of##2##4##(1996-12#1)(2010-5#1)
the mRNA expression##6##3##(1996-12#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-5#1)
the mRNA for the putative##3##5##(1996-12#3)
the mRNA for the##4##4##(1996-12#4)
the mRNA for##6##3##(1992-6#1)(1996-12#4)(2008-11#1)
the mRNA level in the TS##2##6##(2008-11#2)
the mRNA level of the##2##5##(1996-12#1)(2008-11#1)
the mRNA level of##3##4##(1995-11#1)(1996-12#1)(2008-11#1)
the mRNA level##8##3##(1995-11#1)(1996-12#2)(1996-6#1)(1997-7#1)(2008-11#3)
the mRNA of##3##3##(1995-11#1)(2010-1#1)(2011-2#1)
the mRNA transcription##3##3##(2008-8#1)(2013-1#2)
the mRNA##43##2##(1992-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-12#9)(1996-2#1)(1996-6#1)(1997-7#1)(2008-11#8)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
the mRNAs##3##2##(1990-3#1)(1996-12#1)(2008-4#1)
the macaque##2##2##(1997-2#1)(2009-10#1)
the machine learning##2##3##(2010-12#2)
the machine##3##2##(2009-11#1)(2010-12#2)
the macro##2##2##(1994-12#1)(2008-11#1)
the macro-##2##2##(1997-1#1)(2008-11#1)
the macrocyclic size and##2##4##(2008-10#2)
the macrocyclic##6##2##(2008-10#6)
the macromolecular##2##2##(2008-11#1)(2008-7#1)
the macromolecules##2##2##(1996-5#1)(2008-10#1)
the macrophage respiratory burst by##2##5##(1994-6#2)
the macrophage##4##2##(1991-5#1)(1994-6#2)(1994-8#1)
the macrophages##4##2##(1992-12#1)(1992-5#1)(1995-5#1)(2011-2#1)
the macroporous##2##2##(2008-10#2)
the macroscopic and##2##3##(2008-11#1)(2009-7#1)
the macroscopic##7##2##(2008-10#1)(2008-11#2)(2008-3#2)(2009-7#2)
the macrovascular complications##3##3##(2008-1#3)
the macula##2##2##(2011-2#2)
the macular degeneration##2##3##(2011-2#2)
the magnesium##2##2##(2008-6#1)(2008-8#1)
the magnetic beads##9##3##(1990-12#1)(1995-8#1)(2008-10#7)
the magnetic field in##2##4##(2008-8#2)
the magnetic field##11##3##(2008-10#3)(2008-8#7)(2008-9#1)
the magnetic resonance imaging (MRI)##2##5##(1996-11#1)(2008-7#1)
the magnetic resonance##3##3##(1996-11#1)(2008-7#1)(2012-2#1)
the magnetic##31##2##(1990-12#1)(1993-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(2008-10#12)(2008-7#1)(2008-8#7)(2008-9#1)(2012-2#5)
the magnitude and##5##3##(1995-5#1)(1996-2#1)(2008-2#1)(2008-8#1)(2010-8#1)
the magnitude of dopamine sensing##3##5##(2008-10#3)
the magnitude of the synergistic##2##5##(2008-10#2)
the magnitude of the##35##4##(1990-12#1)(1990-5#3)(1991-12#1)(1991-8#1)(1994-3#1)(1995-12#1)(1996-3#1)(2007-11#2)(2008-10#13)(2008-3#2)(2008-7#1)(2008-8#4)(2008-9#1)(2011-2#2)(2013-8#1)
the magnitude of these##2##4##(1997-2#1)(2008-8#1)
the magnitude of##63##3##(1990-11#1)(1990-12#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-8#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-10#22)(2008-11#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#2)(2010-10#1)(2010-5#1)(2011-2#2)(2013-8#1)
the magnitude##72##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-8#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-10#23)(2008-11#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#2)(2009-10#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-8#1)
the magnitudes of the##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
the mail##2##2##(1994-3#1)(2007-12#1)
the main acidic carboxypeptidase in human platelets##2##7##(2006-6#2)
the main advantage of##2##4##(2008-10#1)(2008-3#1)
the main advantages of the##3##5##(2008-10#2)(2008-3#1)
the main advantages of##5##4##(2008-10#3)(2008-3#1)(2008-7#1)
the main advantages##7##3##(2008-10#5)(2008-3#1)(2008-7#1)
the main cause of the##2##5##(2008-8#1)(2010-12#1)
the main cause of##7##4##(1994-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
the main cause##8##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
the main causes of##2##4##(2008-1#1)(2010-11#1)
the main causes##3##3##(2008-1#1)(2010-11#1)(2011-2#1)
the main characteristics of##2##4##(1993-11#1)(2013-1#1)
the main characteristics##3##3##(1993-11#1)(2008-10#1)(2013-1#1)
the main clinical##2##3##(2013-1#1)(2013-8#1)
the main component##4##3##(2008-10#3)(2008-8#1)
the main components of##3##4##(1997-2#1)(2008-10#1)(2011-2#1)
the main components##5##3##(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
the main constituents of##3##4##(2008-10#1)(2008-11#2)
the main constituents##4##3##(2008-10#1)(2008-11#3)
the main degradation##2##3##(2008-10#2)
the main effect of##2##4##(2008-10#1)(2008-11#1)
the main factor##3##3##(1994-5#1)(2008-10#1)(2012-12#1)
the main factors in determining the##2##6##(1994-12#1)(2008-10#1)
the main factors influencing##2##4##(2008-10#1)(2008-11#1)
the main factors that##2##4##(2008-10#2)
the main factors##10##3##(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2012-3#1)
the main features of##2##4##(2008-10#1)(2008-5#1)
the main features##3##3##(2008-10#1)(2008-5#2)
the main goal of##2##4##(1991-3#1)(1991-6#1)
the main group of##3##4##(1991-9#1)(2008-10#1)(2009-8#1)
the main indication##2##3##(2008-1#1)(2008-11#1)
the main indications##2##3##(1990-3#1)(1993-3#1)
the main interfering##2##3##(2008-10#2)
the main limitation of##2##4##(2008-11#1)(2009-10#1)
the main mechanism##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
the main metabolites##2##3##(1990-11#1)(1993-12#1)
the main modes of##2##4##(2008-11#1)(2008-8#1)
the main objective of##2##4##(2008-10#1)(2012-2#1)
the main pancreatic duct##3##4##(2011-2#2)(2012-2#1)
the main peak##2##3##(2008-10#2)
the main phase transition to lower temperatures##2##7##(2008-10#2)
the main phase transition to lower##3##6##(2008-10#3)
the main points##2##3##(2008-11#1)(2011-2#1)
the main problem##2##3##(1994-6#1)(1995-3#1)
the main prognostic##2##3##(1994-6#1)(2011-2#1)
the main reason for##3##4##(2009-11#1)(2012-12#1)(2013-1#1)
the main reason##4##3##(1990-6#1)(2009-11#1)(2012-12#1)(2013-1#1)
the main role##2##3##(1990-5#1)(2008-10#1)
the main source of##2##4##(2008-10#2)
the main sources of##4##4##(2008-10#3)(2008-5#1)
the main species##4##3##(2008-10#4)
the main substrate##2##3##(1990-5#2)
the main symptom##2##3##(1996-6#1)(2008-7#1)
the main target##2##3##(1990-5#1)(2008-11#1)
the main theme##4##3##(2008-11#1)(2010-10#3)
the main types of##2##4##(2008-10#2)
the main variables affecting the##2##5##(2008-10#2)
the main variables##3##3##(2008-10#3)
the main vector##5##3##(2008-10#4)(2008-11#1)
the main work##2##3##(2008-11#1)(2008-5#1)
the main##310##2##(1990-11#3)(1990-3#2)(1990-5#6)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#3)(1991-9#2)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-3#2)(1996-6#4)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#3)(2006-6#2)(2007-11#1)(2007-12#3)(2007-8#3)(2008-1#5)(2008-10#100)(2008-11#30)(2008-12#3)(2008-3#9)(2008-5#12)(2008-7#8)(2008-8#7)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#3)(2010-11#2)(2010-12#6)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#7)(2013-8#6)
the mainstay of treatment in##2##5##(2008-11#1)(2013-1#1)
the mainstay of treatment##6##4##(2008-11#1)(2008-12#1)(2010-12#2)(2013-1#2)
the mainstay of##15##3##(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-12#4)(2011-2#1)(2013-1#2)
the mainstay##16##2##(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-5#1)(2010-12#4)(2011-2#1)(2013-1#2)
the maintenance of LTP##2##4##(1997-2#2)
the maintenance of a##4##4##(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
the maintenance of cell shape and##2##6##(2008-11#1)(2011-2#1)
the maintenance of cell##3##4##(2008-11#2)(2011-2#1)
the maintenance of nodal##2##4##(2008-7#2)
the maintenance of the##5##4##(1991-2#2)(1996-12#1)(2008-10#1)(2008-9#1)
the maintenance of variation under constant selection##2##7##(2012-3#2)
the maintenance of##56##3##(1991-2#2)(1995-12#3)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#2)(2008-10#3)(2008-11#8)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)
the maintenance phase of##2##4##(1997-2#1)(2008-1#1)
the maintenance##64##2##(1991-2#2)(1995-12#3)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#10)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)
the maize genome##2##3##(2008-10#1)(2009-10#1)
the maize##10##2##(2008-10#5)(2008-12#1)(2009-10#3)(2012-3#1)
the major AT##2##3##(1995-6#2)
the major NORs##3##3##(1993-12#3)
the major alkaloids##2##3##(2008-10#1)(2012-3#1)
the major arsenic##2##3##(2008-10#2)
the major barrier to##2##4##(1994-1#1)(1997-1#1)
the major carotenoid##2##3##(2008-10#2)
the major cause of##5##4##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
the major causes for##2##4##(2008-12#1)(2008-4#1)
the major causes of##4##4##(2008-11#2)(2009-12#1)(2011-1#1)
the major causes##7##3##(1992-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2011-1#1)
the major cellular##2##3##(1995-8#1)(2008-12#1)
the major cellulardeterminant of productivity##2##5##(2008-11#2)
the major component of##2##4##(1992-6#1)(1993-8#1)
the major component##4##3##(1992-6#1)(1993-8#1)(2008-10#2)
the major components of##2##4##(2008-10#1)(2008-5#1)
the major components##3##3##(2008-10#2)(2008-5#1)
the major constituents of##3##4##(2008-10#1)(2008-12#1)(2009-8#1)
the major constituents##4##3##(1994-8#1)(2008-10#1)(2008-12#1)(2009-8#1)
the major degradation product##2##4##(2008-10#2)
the major degradation##4##3##(2008-10#4)
the major disease##2##3##(2008-10#1)(2008-7#1)
the major elements of the##2##5##(1995-6#1)(2008-6#1)
the major elements##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
the major factor in##2##4##(2008-10#2)
the major factor##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
the major factors##3##3##(2008-10#3)
the major form of##2##4##(2008-11#1)(2008-4#1)
the major form##3##3##(1992-6#1)(2008-11#1)(2008-4#1)
the major fungal##2##3##(2008-10#2)
the major gene##2##3##(2008-10#2)
the major groove##2##3##(1992-4#1)(1994-5#1)
the major histocompatibility complex (MHC)##3##5##(1990-5#1)(1997-9#1)(2008-1#1)
the major histocompatibility complex##5##4##(1990-5#2)(1995-2#1)(1997-9#1)(2008-1#1)
the major histocompatibility##6##3##(1990-5#2)(1995-2#1)(1997-9#1)(2008-1#1)(2008-4#1)
the major issues##2##3##(1996-12#1)(2013-8#1)
the major part of the##3##5##(1997-7#1)(1997-8#1)(2013-1#1)
the major part##4##3##(1997-7#1)(1997-8#1)(2007-12#1)(2013-1#1)
the major predisposing##2##3##(2012-3#1)(2013-8#1)
the major problem##3##3##(1992-3#1)(2008-5#1)(2011-2#1)
the major problems##3##3##(1990-2#1)(1997-2#1)(2008-12#1)
the major product##2##3##(1990-12#1)(1996-5#1)
the major reason for##3##4##(2008-3#1)(2008-8#2)
the major regulation##2##3##(1993-8#1)(1994-11#1)
the major risk factors of##2##5##(2008-11#1)(2008-7#1)
the major role in##2##4##(1994-8#1)(1997-9#1)
the major role##3##3##(1994-8#1)(1997-9#1)(2012-2#1)
the major second##2##3##(1993-6#1)(2008-11#1)
the major site of##3##4##(1995-6#1)(1997-8#1)(2010-8#1)
the major source of##3##4##(2008-3#1)(2010-11#1)(2012-2#1)
the major source##5##3##(2008-11#1)(2008-3#1)(2010-11#1)(2012-2#2)
the major species##2##3##(2008-10#1)(2010-11#1)
the major sterol##2##3##(1997-2#1)(2008-10#1)
the major##308##2##(1990-12#3)(1990-2#1)(1990-5#4)(1990-6#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#2)(1993-1#2)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-6#7)(1995-8#2)(1996-12#3)(1996-2#2)(1996-5#4)(1997-1#5)(1997-2#2)(1997-7#2)(1997-8#4)(1997-9#3)(2006-6#1)(2007-12#3)(2008-1#2)(2008-10#79)(2008-11#22)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#12)(2008-5#11)(2008-6#5)(2008-7#10)(2008-8#8)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#4)
the majority of accessions##2##4##(2008-10#2)
the majority of cases are##2##5##(2008-10#1)(2008-11#1)
the majority of cases##12##4##(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
the majority of cells##2##4##(1993-8#1)(1994-2#1)
the majority of patients##6##4##(1994-5#1)(1996-2#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
the majority of the##25##4##(1991-9#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-3#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-6#2)(2012-2#1)
the majority of these##2##4##(2008-1#1)(2008-5#1)
the majority of this##2##4##(2008-6#1)(2013-1#1)
the majority of##124##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#26)(2008-11#6)(2008-12#4)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-10#1)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
the majority##140##2##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-5#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#29)(2008-11#8)(2008-12#7)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-10#1)(2011-2#6)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#2)
the making of##3##3##(2008-7#1)(2009-11#1)(2013-1#1)
the making##4##2##(1991-1#1)(2008-7#1)(2009-11#1)(2013-1#1)
the malar##2##2##(2008-5#1)(2013-1#1)
the malaria diagnosis network##2##4##(2012-12#2)
the malaria##7##2##(2010-1#1)(2012-12#6)
the male and female##8##4##(1990-5#1)(1992-3#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
the male genital appendages##2##4##(2008-8#2)
the male genital##4##3##(1993-3#1)(2008-8#2)(2012-2#1)
the male group##2##3##(2011-1#2)
the male parent##2##3##(2008-10#2)
the male population##2##3##(1993-11#1)(1995-11#1)
the male rats##3##3##(1990-11#1)(1994-2#1)(2008-7#1)
the male reproductive system##2##4##(1993-3#1)(2009-10#1)
the male reproductive##3##3##(1993-3#1)(2007-12#1)(2009-10#1)
the male stimulatory ability##2##4##(2008-8#2)
the male##56##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-2#2)(1992-3#3)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#2)(2009-8#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#4)
the male's##2##2##(2008-8#2)
the males##8##2##(1993-11#1)(1994-2#2)(1996-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)
the malformation##3##2##(1990-9#2)(1992-5#1)
the malignancy##2##2##(1990-8#1)(2011-1#1)
the malignant##11##2##(1990-5#1)(1991-8#1)(1996-6#1)(2008-11#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-3#1)(2013-8#1)
the malnourished##2##2##(1990-3#1)(2008-11#1)
the mammalian CNS##2##3##(1990-12#1)(1994-2#1)
the mammalian central nervous system##3##5##(1993-12#1)(2008-11#1)(2012-2#1)
the mammalian testis##2##3##(2012-2#2)
the mammalian##39##2##(1990-12#1)(1990-7#1)(1991-6#2)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-11#7)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#1)
the mammary gland##6##3##(1992-9#1)(1994-12#1)(1995-9#1)(2009-12#1)(2012-2#2)
the mammary##8##2##(1990-11#1)(1992-9#1)(1994-12#1)(1995-9#2)(2009-12#1)(2012-2#2)
the managed care##6##3##(1992-2#2)(1994-2#1)(1996-3#1)(1997-3#1)(2009-11#1)
the managed##7##2##(1992-2#2)(1994-2#1)(1996-3#1)(1997-3#1)(2008-8#1)(2009-11#1)
the management of Fusarium##2##4##(2008-10#2)
the management of a patient##3##5##(2008-12#2)(2008-8#1)
the management of a##8##4##(1994-12#1)(1997-2#1)(2008-12#2)(2008-8#1)(2010-8#1)(2011-2#2)
the management of acute##4##4##(1995-8#1)(2008-3#1)(2012-12#1)(2013-1#1)
the management of all##2##4##(2010-6#1)(2012-3#1)
the management of an##3##4##(1996-11#1)(1997-6#1)(2008-12#1)
the management of blood##2##4##(1991-1#1)(2008-1#1)
the management of chronic##7##4##(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#2)(2012-2#1)(2013-1#1)
the management of common##2##4##(2008-11#1)(2010-2#1)
the management of critical care units##2##6##(1996-2#2)
the management of dry skin##2##5##(2008-5#2)
the management of needle pain##2##5##(2008-11#2)
the management of patients with##13##5##(1990-8#1)(1996-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the management of severe##3##4##(1991-3#1)(2008-11#1)(2008-9#1)
the management of such##2##4##(2012-2#1)(2013-1#1)
the management of the disease##2##5##(1997-8#1)(2008-10#1)
the management of the##9##4##(1994-12#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
the management of these patients##3##5##(1991-2#1)(2011-2#1)(2013-1#1)
the management of these##4##4##(1991-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
the management of this disease##3##5##(1991-2#1)(2010-8#1)(2011-2#1)
the management of this##4##4##(1991-2#1)(2010-12#1)(2010-8#1)(2011-2#1)
the management of##193##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-9#2)(1994-12#2)(1995-11#1)(1995-8#1)(1996-1#3)(1996-11#3)(1996-2#2)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#5)(2008-10#20)(2008-11#13)(2008-12#11)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#7)(2009-1#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#15)(2011-3#2)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#14)(2013-8#3)
the management with##2##3##(2008-7#2)
the management##203##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-9#2)(1994-12#2)(1995-11#1)(1995-8#1)(1996-1#3)(1996-11#3)(1996-2#2)(1996-3#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#5)(2008-10#21)(2008-11#14)(2008-12#12)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#9)(2008-8#2)(2008-9#8)(2009-1#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#15)(2011-3#2)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#15)(2013-8#3)
the managing##2##2##(1996-3#1)(2008-11#1)
the mandible##9##2##(1997-3#1)(2008-7#1)(2011-7#1)(2012-3#1)(2013-1#5)
the mandibular nerve##2##3##(2011-2#2)
the mandibular##7##2##(1993-1#1)(2011-2#2)(2013-1#4)
the manganese##4##2##(1993-8#1)(2008-10#3)
the mangrove##3##2##(2008-11#1)(2008-7#2)
the manifestation of##8##3##(1997-8#1)(2008-11#3)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
the manifold##8##2##(2008-10#7)(2008-11#1)
the manipulation of##6##3##(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)
the manipulation##11##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-8#1)
the manner in which the##2##5##(1992-1#1)(1994-2#1)
the manner in which##4##4##(1992-1#1)(1993-2#1)(1994-2#1)(2008-10#1)
the manner of##5##3##(1995-11#1)(2008-10#2)(2008-3#1)(2008-9#1)
the manner##11##2##(1992-1#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
the mannitol permease##5##3##(1991-10#5)
the mannitol##6##2##(1991-10#6)
the mannose##3##2##(1995-6#1)(2008-10#2)
the manual and automated##2##4##(2008-10#2)
the manual methods##2##3##(1991-3#1)(2008-10#1)
the manual##16##2##(1990-5#1)(1991-3#1)(1995-3#1)(2008-10#11)(2008-4#1)(2010-10#1)
the manufacture of##5##3##(1996-9#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)
the manufacture##7##2##(1996-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)
the manufacturer to##3##3##(2008-10#1)(2008-11#1)(2010-6#1)
the manufacturer##6##2##(2008-10#4)(2008-11#1)(2010-6#1)
the manufacturer's##5##2##(1994-1#1)(2008-10#1)(2008-3#2)(2009-7#1)
the manufacturers##4##2##(1996-5#1)(2008-10#3)
the manufacturing of##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
the manufacturing process##2##3##(1995-5#1)(2008-10#1)
the manufacturing##10##2##(1995-5#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)
the manure or##2##3##(2008-10#2)
the manure##5##2##(2008-10#5)
the manuscript##2##2##(2009-4#1)(2013-1#1)
the many challenges##2##3##(1992-1#1)(2010-7#1)
the many factors##2##3##(2008-11#1)(2010-12#1)
the many##24##2##(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-7#2)(2011-1#1)(2013-1#1)
the map##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
the mapped##2##2##(1996-12#1)(2008-10#1)
the mapping of##6##3##(2008-10#2)(2008-11#1)(2013-1#3)
the mapping population##2##3##(2008-10#2)
the mapping##10##2##(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#3)
the margin of safety##2##4##(1994-3#1)(2008-11#1)
the margin of##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
the margin##5##2##(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#1)
the marginal sinus##6##3##(1996-9#6)
the marginal survival##2##3##(1995-9#2)
the marginal##14##2##(1995-9#2)(1996-9#6)(2008-7#2)(2008-8#3)(2010-1#1)
the margins##4##2##(1997-7#1)(2008-10#1)(2008-9#2)
the marinated##2##2##(2010-4#2)
the marine environment are##2##4##(2008-10#1)(2008-11#1)
the marine environment##9##3##(2008-10#2)(2008-11#7)
the marine##17##2##(2008-10#5)(2008-11#9)(2008-6#1)(2008-9#1)(2010-8#1)
the marked##8##2##(1990-8#1)(1991-11#1)(2008-10#4)(2008-12#1)(2008-5#1)
the marker##16##2##(1990-6#1)(1995-8#1)(2008-10#11)(2008-11#1)(2008-8#1)(2009-2#1)
the markers##11##2##(1995-6#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-2#2)(2013-1#1)(2013-8#1)
the market and##2##3##(1995-1#1)(1997-6#1)
the market for health##2##4##(1994-1#1)(1994-2#1)
the market for medical##2##4##(1990-6#1)(1991-12#1)
the market for##7##3##(1990-6#1)(1991-12#1)(1992-3#2)(1993-3#1)(1994-1#1)(1994-2#1)
the market in##2##3##(1996-5#1)(2008-3#1)
the market place##2##3##(1996-1#1)(2008-11#1)
the market##37##2##(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-3#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-5#1)(2012-12#2)(2012-2#1)
the marketable##2##2##(1992-1#1)(2008-10#1)
the marketplace##7##2##(1994-1#2)(1995-1#1)(1997-1#1)(2008-11#1)(2008-6#1)(2011-2#1)
the marking##3##2##(2008-11#2)(2010-8#1)
the marks##3##2##(1996-3#1)(2008-11#2)
the marriage of##2##3##(2008-11#1)(2008-6#1)
the marriage##5##2##(2008-11#4)(2008-6#1)
the masking agent##2##3##(2008-10#2)
the masking agents##3##3##(2008-10#3)
the masking##8##2##(2008-10#7)(2008-5#1)
the mass and##3##3##(2010-11#1)(2011-2#1)(2012-12#1)
the mass of the##3##4##(1990-8#1)(2008-10#1)(2008-12#1)
the mass of##10##3##(1990-8#1)(1992-2#1)(1994-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)
the mass spectra of the##2##5##(1991-5#1)(2008-10#1)
the mass spectra##4##3##(1991-5#1)(2008-10#3)
the mass spectrometer##5##3##(2008-1#1)(2008-10#3)(2010-7#1)
the mass transfer of##2##4##(1990-12#1)(2008-10#1)
the mass transfer##5##3##(1990-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
the mass transport##2##3##(2008-10#1)(2008-9#1)
the mass was found##2##4##(2011-2#1)(2013-8#1)
the mass was##7##3##(1990-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the mass##65##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-5#1)(1992-2#3)(1994-12#1)(1995-11#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-6#3)(2008-7#4)(2008-9#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#3)
the massage##8##2##(2008-10#4)(2008-12#2)(2010-7#2)
the massaged##2##2##(2008-12#1)(2009-3#1)
the masses of the##2##4##(1993-8#1)(2008-10#1)
the masses of##3##3##(1993-8#2)(2008-10#1)
the masses##4##2##(1993-8#2)(2008-10#2)
the masseter muscle##5##3##(1996-2#1)(2010-6#1)(2010-9#1)(2013-1#2)
the masseter##6##2##(1996-2#1)(2010-6#1)(2010-9#1)(2013-1#3)
the massive##2##2##(1993-2#1)(2011-2#1)
the masticatory system##3##3##(2010-9#2)(2012-12#1)
the masticatory##5##2##(1990-9#1)(2010-9#3)(2012-12#1)
the mastoid cavity##2##3##(2008-9#2)
the mastoid portion of the facial nerve##2##7##(2008-9#2)
the mastoid process##5##3##(2008-7#4)(2008-9#1)
the mastoid##13##2##(1990-12#1)(2008-7#6)(2008-9#5)(2009-1#1)
the mat1-1##3##2##(2008-10#3)
the match##2##2##(2008-8#1)(2009-8#1)
the matched##4##2##(2008-10#1)(2010-11#2)(2013-8#1)
the matching##2##2##(2008-10#2)
the mate##6##2##(2008-8#1)(2008-9#3)(2009-6#2)
the material and##2##3##(2008-10#1)(2010-10#1)
the material for##4##3##(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
the material of##3##3##(1994-3#1)(2008-10#1)(2011-3#1)
the material was##5##3##(2008-10#3)(2013-1#1)(2013-8#1)
the material##29##2##(1991-9#1)(1994-3#1)(1995-8#1)(2007-8#1)(2008-10#12)(2008-3#2)(2008-7#2)(2009-5#1)(2009-7#2)(2010-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
the materials and##2##3##(2008-9#1)(2011-2#1)
the materials used##2##3##(2012-3#2)
the materials##18##2##(1990-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-5#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
the maternal and##2##3##(1995-12#1)(2008-10#1)
the maternal genome##2##3##(1994-11#2)
the maternal parent##2##3##(2010-8#2)
the maternal##17##2##(1992-5#1)(1993-3#1)(1994-11#2)(1995-12#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#3)(2013-1#3)
the mathematical##8##2##(2008-10#5)(2008-6#1)(2009-8#1)(2011-2#1)
the mating success of##2##4##(2008-9#2)
the mating system of##2##4##(2008-9#2)
the mating system##5##3##(2008-10#1)(2008-8#1)(2008-9#3)
the mating##13##2##(1996-2#1)(2008-10#3)(2008-6#2)(2008-8#1)(2008-9#6)
the matrices##5##2##(1995-12#2)(2008-10#2)(2010-5#1)
the matrix and##7##3##(2008-10#6)(2008-5#1)
the matrix effect during the method development##2##7##(2010-11#2)
the matrix effect##9##3##(2008-10#5)(2010-11#4)
the matrix for the##2##4##(2008-10#2)
the matrix in##3##3##(2008-10#3)
the matrix influence##2##3##(2008-10#2)
the matrix interference##4##3##(2008-10#3)(2009-8#1)
the matrix is##3##3##(2008-10#3)
the matrix method##2##3##(1990-8#1)(2008-6#1)
the matrix of##4##3##(2008-10#4)
the matrix with##2##3##(2008-10#2)
the matrix##70##2##(1990-2#1)(1990-8#1)(1992-1#1)(1994-12#1)(1994-8#1)(2008-10#51)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-8#1)(2010-11#4)(2012-2#2)
the matter of##2##3##(2007-8#1)(2008-10#1)
the matter##5##2##(1994-3#1)(2007-8#1)(2008-10#2)(2010-7#1)
the maturation of##5##3##(1995-6#1)(2008-11#2)(2008-8#1)(2011-2#1)
the maturation process##2##3##(2008-10#1)(2008-5#1)
the maturation##10##2##(1995-6#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
the mature form##3##3##(1993-2#1)(1995-8#1)(1997-1#1)
the mature protein##4##3##(1990-12#1)(1990-5#1)(1991-9#1)(1993-2#1)
the mature##33##2##(1990-12#2)(1990-5#1)(1991-10#1)(1991-9#2)(1993-2#3)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-1#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2011-2#1)
the maturity of social problem-solving skills##2##6##(2009-10#2)
the maturity of##3##3##(1995-5#1)(2009-10#2)
the maxilla##2##2##(2013-1#2)
the maxillary sinus##6##3##(1993-1#1)(2008-11#1)(2011-7#1)(2013-1#3)
the maxillary##10##2##(1993-1#1)(2007-12#2)(2008-11#1)(2011-7#1)(2012-12#1)(2013-1#4)
the maxima of##2##3##(2008-10#1)(2010-8#1)
the maximal cell##2##3##(2008-11#2)
the maximal growth##2##3##(2008-6#1)(2011-1#1)
the maximal level##2##3##(1994-11#1)(2008-9#1)
the maximal##24##2##(1990-12#1)(1991-5#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
the maximization of the##2##4##(2008-7#1)(2012-2#1)
the maximization of##3##3##(2008-7#2)(2012-2#1)
the maximum RLS wavelength##2##4##(2008-10#2)
the maximum RLS##3##3##(2008-10#3)
the maximum amount of information##2##5##(2008-7#2)
the maximum amount of##3##4##(2008-10#1)(2008-7#2)
the maximum and minimum##2##4##(2008-10#2)
the maximum binding##2##3##(2008-10#2)
the maximum cell density##3##4##(1993-8#1)(2008-11#1)(2008-7#1)
the maximum cell##4##3##(1993-8#1)(2008-11#2)(2008-7#1)
the maximum current##2##3##(2008-10#1)(2009-10#1)
the maximum degree of protonation of the##2##7##(2008-10#2)
the maximum growth rate##2##4##(2008-8#1)(2011-2#1)
the maximum in##2##3##(2008-10#1)(2010-5#1)
the maximum likelihood methods##2##4##(2008-10#1)(2008-6#1)
the maximum likelihood##4##3##(2008-10#2)(2008-6#2)
the maximum load##2##3##(2013-1#2)
the maximum number of##3##4##(2008-10#3)
the maximum of##4##3##(1996-5#1)(2008-10#3)
the maximum performance##2##3##(2008-10#1)(2008-9#1)
the maximum permissible##4##3##(1993-3#1)(2008-10#2)(2013-1#1)
the maximum possible##3##3##(2008-10#2)(2008-8#1)
the maximum power##2##3##(1992-9#1)(2012-2#1)
the maximum rate##3##3##(2008-10#1)(2008-8#2)
the maximum spatial resolution##2##4##(2008-3#2)
the maximum specific growth rate##2##5##(2008-10#1)(2008-7#1)
the maximum specific##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
the maximum value##2##3##(2008-11#1)(2010-1#1)
the maximum##137##2##(1992-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#69)(2008-11#9)(2008-12#4)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
the maze##3##2##(1993-6#1)(1995-1#1)(2008-11#1)
the mean 24-hour##2##3##(1990-11#2)
the mean DGD##2##3##(2007-12#2)
the mean and standard deviation of the##2##7##(2008-10#1)(2008-3#1)
the mean and the##2##4##(2008-3#1)(2013-1#1)
the mean and##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
the mean concentration##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
the mean content of##2##4##(2008-10#1)(2008-8#1)
the mean detector response##2##4##(2010-3#2)
the mean disease##2##3##(2008-10#2)
the mean flow##2##3##(2008-11#1)(2011-2#1)
the mean flux##2##3##(2010-10#2)
the mean hair shaft##2##4##(2008-5#2)
the mean intensity##2##3##(2008-6#1)(2008-9#1)
the mean intraclass correlation##2##4##(2008-10#2)
the mean length of##2##4##(1991-12#1)(2008-7#1)
the mean level##2##3##(1992-11#1)(1993-11#1)
the mean levels of##2##4##(1997-2#1)(2008-1#1)
the mean lifetime##3##3##(2008-8#3)
the mean number of##4##4##(1991-6#1)(1997-2#1)(2008-10#1)(2009-9#1)
the mean number##5##3##(1991-6#2)(1997-2#1)(2008-10#1)(2009-9#1)
the mean of scores for the##2##6##(2011-1#2)
the mean of the##8##4##(1994-3#1)(2008-10#5)(2008-12#1)(2008-8#1)
the mean of##15##3##(1994-3#1)(1995-8#1)(2008-10#9)(2008-12#1)(2008-8#1)(2011-1#2)
the mean orientation angle and angular distribution width were##2##9##(2008-10#2)
the mean orientation angle##4##4##(2008-10#4)
the mean reading level##2##4##(2011-1#2)
the mean recovery##3##3##(1990-11#1)(2008-10#2)
the mean serum##2##3##(2008-1#2)
the mean square##2##3##(1992-9#1)(2012-2#1)
the mean time##5##3##(2008-11#1)(2008-8#2)(2008-9#1)(2009-3#1)
the mean total##2##3##(2009-10#1)(2010-12#1)
the mean value in##2##4##(2008-10#2)
the mean value of##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
the mean value##9##3##(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
the mean values of##2##4##(1993-1#1)(2008-11#1)
the mean values##3##3##(1993-1#1)(2008-10#1)(2008-11#1)
the mean##179##2##(1990-11#3)(1990-2#1)(1990-6#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#3)(1993-11#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-7#1)(1997-8#2)(2007-12#4)(2008-1#3)(2008-10#45)(2008-11#12)(2008-12#3)(2008-3#9)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#6)(2011-2#9)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
the meaning and##4##3##(1992-2#1)(2008-11#3)
the meaning of a##3##4##(1995-2#1)(1996-9#1)(2011-3#1)
the meaning of##17##3##(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2010-10#1)(2010-11#1)(2011-3#1)(2012-3#1)
the meaning##23##2##(1992-2#1)(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2008-1#1)(2008-11#6)(2008-12#3)(2010-10#1)(2010-11#1)(2011-3#1)(2012-3#1)
the means by which health##2##5##(1997-2#1)(1997-3#1)
the means by which##4##4##(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#1)
the means for##3##3##(1991-6#1)(1992-6#1)(1994-2#1)
the means of##3##3##(2011-2#3)
the means to##6##3##(2008-10#1)(2008-11#2)(2008-4#1)(2010-10#1)(2013-8#1)
the means##17##2##(1991-6#1)(1992-6#1)(1994-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-4#1)(2010-10#1)(2011-2#3)(2013-8#1)
the meantime##5##2##(1992-3#1)(1996-11#1)(2009-1#1)(2011-2#1)(2013-8#1)
the meanwhile##2##2##(2008-11#2)
the measure of multilocus correlation##2##5##(2008-10#2)
the measure of multilocus##3##4##(2008-10#3)
the measure of##7##3##(1992-12#1)(1994-9#1)(2008-10#5)
the measure##17##2##(1990-2#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-6#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2010-10#1)
the measured data##6##3##(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)
the measured frequency##2##3##(2008-2#1)(2008-3#1)
the measured parameters##2##3##(2008-3#2)
the measured potential##2##3##(2008-10#2)
the measured shape##3##3##(2008-6#3)
the measured speed of sound is too##2##7##(2008-3#2)
the measured##66##2##(1993-2#1)(1994-12#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#14)(2008-11#5)(2008-2#8)(2008-3#22)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#1)(2009-7#1)(2012-3#1)(2013-1#2)
the measurement and##4##3##(2008-1#1)(2008-10#3)
the measurement error##2##3##(2008-12#1)(2008-3#1)
the measurement of a##4##4##(2008-10#2)(2008-3#1)(2010-2#1)
the measurement of fluorescence##2##4##(2008-10#1)(2008-9#1)
the measurement of the fluorescence##2##5##(2008-10#2)
the measurement of the##17##4##(2006-6#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
the measurement of##93##3##(1990-11#1)(1990-2#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-3#1)(1997-4#1)(2006-6#2)(2008-10#51)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#1)(2008-9#4)(2009-5#1)(2009-7#2)(2010-11#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
the measurement process##3##3##(2008-10#3)
the measurement range##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
the measurement results##4##3##(2008-10#2)(2009-11#1)(2012-3#1)
the measurement step##2##3##(2008-10#2)
the measurement system##2##3##(2008-10#1)(2008-3#1)
the measurement uncertainty of analytical assays##2##6##(2008-10#2)
the measurement uncertainty of##3##4##(2008-10#3)
the measurement uncertainty##7##3##(2008-10#5)(2008-3#2)
the measurement was##5##3##(2008-10#5)
the measurement##152##2##(1990-11#1)(1990-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1997-4#1)(1997-6#1)(2006-6#2)(2008-1#1)(2008-10#88)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#16)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#4)(2013-1#2)
the measurements of##5##3##(2008-10#4)(2008-3#1)
the measurements to##2##3##(2007-12#1)(2008-10#1)
the measurements was##3##3##(2008-10#2)(2012-12#1)
the measurements##34##2##(1996-1#1)(2007-12#1)(2008-10#15)(2008-3#13)(2008-4#1)(2010-7#2)(2012-12#1)
the measures are##2##3##(1990-2#1)(2008-11#1)
the measures of multilocus correlation and association##2##7##(2008-10#2)
the measures of##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
the measures taken##2##3##(1996-6#1)(2008-11#1)
the measures##15##2##(1990-2#1)(1996-6#1)(1996-8#1)(2008-10#4)(2008-11#3)(2008-8#1)(2009-1#1)(2010-11#1)(2012-3#1)(2013-1#1)
the measuring range of the##2##5##(2008-10#2)
the measuring range of##4##4##(2008-10#4)
the measuring range##6##3##(2008-10#6)
the measuring##12##2##(2008-10#10)(2008-11#1)(2008-5#1)
the meat##10##2##(2008-10#5)(2010-4#5)
the mechanical and##2##3##(1996-3#1)(2011-2#1)
the mechanical behaviour of the##2##5##(2009-7#2)
the mechanical behaviour of##3##4##(2009-7#3)
the mechanical behaviour##4##3##(2009-7#4)
the mechanical properties of the##5##5##(2009-7#3)(2013-1#2)
the mechanical properties of##11##4##(1996-3#1)(2008-10#1)(2009-7#6)(2011-2#1)(2013-1#2)
the mechanical properties##14##3##(1996-3#1)(2008-10#1)(2009-11#1)(2009-7#7)(2011-2#1)(2012-2#1)(2013-1#2)
the mechanical##32##2##(1991-12#1)(1992-3#1)(1995-2#1)(1996-3#2)(2008-10#2)(2008-3#1)(2008-5#2)(2009-11#1)(2009-7#12)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)
the mechanics of the##2##4##(1994-3#1)(2010-1#1)
the mechanism and function of##2##5##(2008-2#1)(2010-12#1)
the mechanism and##7##3##(2008-10#3)(2008-2#1)(2008-6#1)(2008-9#1)(2010-12#1)
the mechanism by which this occurs##3##6##(1992-9#1)(2008-11#1)(2013-1#1)
the mechanism by which##14##4##(1990-11#1)(1990-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2013-1#1)
the mechanism for the##2##4##(2008-10#1)(2008-3#1)
the mechanism for##8##3##(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-3#1)(2013-8#1)
the mechanism is##2##3##(2008-8#1)(2013-8#1)
the mechanism of action of the##2##6##(2008-10#2)
the mechanism of action of##9##5##(1991-5#1)(1994-11#1)(1997-2#2)(2008-10#2)(2008-11#3)
the mechanism of action##13##4##(1991-5#1)(1994-11#1)(1997-2#2)(2008-10#2)(2008-11#3)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#1)
the mechanism of biocontrol of R##2##6##(2008-10#2)
the mechanism of interaction##3##4##(1990-2#2)(2008-10#1)
the mechanism of resistance##2##4##(2008-10#2)
the mechanism of steroid##2##4##(1990-11#1)(1996-2#1)
the mechanism of the##9##4##(1991-5#1)(1992-6#1)(1993-8#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)
the mechanism of this##4##4##(1993-9#1)(1994-8#1)(2010-5#1)(2013-8#1)
the mechanism of##91##3##(1990-11#1)(1990-2#2)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#3)(2007-11#1)(2008-1#1)(2008-10#24)(2008-11#8)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
the mechanism that##3##3##(2008-11#2)(2011-2#1)
the mechanism through which##2##4##(2008-11#1)(2008-8#1)
the mechanism underlying the##3##4##(2008-9#1)(2009-7#1)(2011-2#1)
the mechanism underlying##7##3##(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)
the mechanism##145##2##(1990-11#2)(1990-2#2)(1990-5#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#3)(2007-11#1)(2008-1#1)(2008-10#32)(2008-11#17)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#6)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
the mechanism(s) of##2##3##(1993-8#1)(2008-10#1)
the mechanism(s)##6##2##(1993-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-12#1)(2013-1#1)
the mechanisms and##7##3##(1990-8#1)(1997-7#1)(2007-12#1)(2008-10#2)(2009-8#2)
the mechanisms behind##2##3##(2008-11#2)
the mechanisms by which##18##4##(1995-6#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-3#1)(2012-2#2)
the mechanisms by##19##3##(1995-6#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-3#1)(2012-2#3)
the mechanisms governing##2##3##(2009-10#1)(2011-1#1)
the mechanisms involved in##3##4##(1993-6#1)(1995-2#1)(2008-11#1)
the mechanisms involved##7##3##(1993-6#1)(1995-2#2)(1997-3#1)(2008-11#2)(2011-2#1)
the mechanisms leading to##2##4##(1992-9#1)(1995-12#1)
the mechanisms of action##2##4##(2008-10#2)
the mechanisms of induction##2##4##(2008-8#2)
the mechanisms of the##4##4##(2008-10#1)(2008-11#1)(2009-8#2)
the mechanisms of##43##3##(1991-12#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-7#1)(2009-8#5)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
the mechanisms regulating##2##3##(2008-11#1)(2013-1#1)
the mechanisms responsible for##4##4##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
the mechanisms that control##2##4##(2008-10#1)(2008-7#1)
the mechanisms that increase##2##4##(1993-3#1)(2012-2#1)
the mechanisms that regulate##2##4##(1995-8#1)(2008-11#1)
the mechanisms that##9##3##(1993-3#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
the mechanisms through which##2##4##(2008-4#1)(2010-1#1)
the mechanisms underlying the##5##4##(1993-8#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
the mechanisms underlying these##2##4##(2008-10#1)(2013-8#1)
the mechanisms underlying##16##3##(1990-5#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the mechanisms##124##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#20)(2008-11#17)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#8)(2010-1#3)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#4)(2013-8#1)
the mechanistic basis of##2##4##(1995-8#1)(2011-2#1)
the mechanistic##6##2##(1994-12#1)(1995-8#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
the mechanosensitivity of the##2##4##(2008-12#2)
the medaka fish##2##3##(1997-9#1)(2008-6#1)
the media noise##2##3##(2008-3#2)
the media of##2##3##(1991-5#1)(1993-8#1)
the media##28##2##(1991-5#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-2#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-3#3)(2009-1#1)(2010-2#2)(2011-2#1)(2013-1#2)
the medial antebrachial cutaneous nerve##2##5##(2008-9#2)
the medial compartment##2##3##(1992-3#1)(2013-1#1)
the medial flagellum and##2##4##(2007-12#2)
the medial forebrain bundle##2##4##(1992-12#1)(1996-2#1)
the medial prefrontal cortex and##2##5##(2008-11#2)
the medial prefrontal cortex##8##4##(1994-8#1)(1996-2#2)(1997-2#1)(2008-11#4)
the medial prefrontal##10##3##(1991-2#1)(1994-8#1)(1996-2#2)(1997-2#1)(2008-11#5)
the medial superior olivary nucleus##4##5##(1997-3#4)
the medial temporal lobe##2##4##(1991-10#2)
the medial temporal##3##3##(1991-10#2)(2008-11#1)
the medial wall##2##3##(1997-8#1)(2008-9#1)
the medial##63##2##(1990-9#2)(1991-10#2)(1991-2#1)(1992-12#2)(1992-3#2)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#4)(1996-9#1)(1997-2#1)(1997-3#6)(1997-8#1)(2006-6#1)(2007-12#4)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#2)
the median P##2##3##(2008-10#2)
the median domain##6##3##(2007-12#6)
the median follow-up##2##3##(1993-11#1)(2012-12#1)
the median nerve##5##3##(2008-9#5)
the median survival##3##3##(1992-9#1)(1997-5#1)(2008-10#1)
the median value was##2##4##(2011-2#2)
the median value##3##3##(1993-11#1)(2011-2#2)
the median##40##2##(1990-12#1)(1990-3#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1994-3#1)(1995-12#1)(1995-2#1)(1997-5#2)(2007-12#6)(2008-10#5)(2008-5#1)(2008-9#5)(2010-4#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
the mediastinum##3##2##(1991-8#2)(2008-11#1)
the mediating role of##2##4##(2010-2#1)(2012-3#1)
the mediating##4##2##(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the mediator##3##2##(2008-10#3)
the mediators##2##2##(2008-10#2)
the medical and##6##3##(1991-11#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-11#1)
the medical care system##4##4##(1995-12#3)(1997-3#1)
the medical care##5##3##(1991-12#1)(1995-12#3)(1997-3#1)
the medical community##4##3##(1993-6#1)(2008-8#1)(2010-6#1)(2010-8#1)
the medical devices##2##3##(2008-11#2)
the medical disorder##2##3##(2012-2#2)
the medical group##4##3##(1993-12#1)(1993-6#1)(1994-3#2)
the medical literature##8##3##(1990-8#1)(1992-12#1)(2008-7#1)(2010-6#3)(2012-3#1)(2013-1#1)
the medical management of##2##4##(1991-2#1)(2012-2#1)
the medical management##3##3##(1991-2#1)(2008-9#1)(2012-2#1)
the medical profession##4##3##(1995-11#1)(2008-12#3)
the medical provider##3##3##(2013-1#3)
the medical record##2##3##(1992-3#1)(1996-2#1)
the medical records of##3##4##(1990-2#1)(2011-2#1)(2012-12#1)
the medical records##5##3##(1990-2#1)(1991-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
the medical school##2##3##(2008-3#1)(2013-1#1)
the medical staff##4##3##(1991-3#1)(1997-1#1)(2008-10#1)(2012-2#1)
the medical termination of##2##4##(1995-8#2)
the medical##108##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-8#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#7)(2008-12#4)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#4)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#3)
the medically##3##2##(1992-2#1)(1992-3#1)(2013-8#1)
the medication##12##2##(1995-2#1)(1997-2#1)(2007-11#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
the medications##3##2##(2008-10#2)(2011-1#1)
the medicine##4##2##(1996-3#1)(2008-11#1)(2010-8#1)(2012-3#1)
the medieval##2##2##(2008-3#1)(2013-8#1)
the mediodorsal thalamic nucleus##2##4##(1996-5#1)(1997-2#1)
the mediodorsal##3##2##(1996-5#1)(1997-2#2)
the medium and the##3##4##(2008-10#2)(2011-2#1)
the medium and##12##3##(1996-2#1)(2008-10#3)(2008-11#3)(2008-2#1)(2011-2#1)(2011-3#1)(2012-4#1)(2013-1#1)
the medium as##2##3##(1992-3#1)(2008-3#1)
the medium composition##2##3##(2008-11#2)
the medium containing human serum and basic fibroblast growth factor##2##10##(2008-11#2)
the medium containing only##3##4##(2008-11#3)
the medium containing##13##3##(1997-8#1)(2008-11#9)(2008-5#1)(2008-6#1)(2013-1#1)
the medium formulation##2##3##(2008-11#2)
the medium of##4##3##(1991-5#1)(2008-10#2)(2008-3#1)
the medium or##2##3##(1995-11#1)(2008-10#1)
the medium pH##2##3##(2008-10#2)
the medium perfusion rate##3##4##(2008-11#3)
the medium to##2##3##(2008-11#2)
the medium used##2##3##(2008-10#1)(2008-5#1)
the medium was increased##2##4##(2008-11#1)(2008-7#1)
the medium was##9##3##(1993-3#1)(1993-6#1)(1995-2#1)(2008-11#4)(2008-12#1)(2008-7#1)
the medium were##2##3##(1996-2#1)(2008-10#1)
the medium with 1##2##4##(2008-8#2)
the medium with##5##3##(2008-11#3)(2008-8#2)
the medium without##2##3##(1992-6#1)(2008-11#1)
the medium##124##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#4)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#2)(1997-2#2)(1997-8#1)(2008-10#23)(2008-11#45)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-4#1)(2012-7#1)(2013-1#2)(2013-7#1)
the medulla##3##2##(2008-5#3)
the medullary cavity##2##3##(2013-1#2)
the medullary##5##2##(1991-11#1)(1996-9#1)(2013-1#3)
the meeting of the##2##4##(2008-8#1)(2009-5#1)
the meeting##12##2##(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-8#1)(2009-5#2)(2012-3#1)
the meiosis##2##2##(2008-9#1)(2012-2#1)
the melanocytes##2##2##(1995-2#1)(2008-5#1)
the melanogenesis##2##2##(2008-11#1)(2008-5#1)
the melanogenic##3##2##(1995-2#1)(2008-11#1)(2008-5#1)
the melanoma##2##2##(2008-9#1)(2011-2#1)
the melatonin##2##2##(2008-10#1)(2008-12#1)
the melon aphid##2##3##(2008-10#2)
the melt##2##2##(2008-10#2)
the melting point##2##3##(1993-8#1)(2008-5#1)
the melting##6##2##(1992-3#1)(1993-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-8#1)
the members of the##5##4##(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
the members of##11##3##(1997-6#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
the membership##3##2##(1994-3#2)(2008-11#1)
the membrane and the##3##4##(1995-6#1)(2008-10#1)(2008-11#1)
the membrane and##11##3##(1994-5#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)
the membrane by the##3##4##(1993-8#1)(1994-8#1)(2008-10#1)
the membrane can##3##3##(2008-10#3)
the membrane electrode##2##3##(2008-10#2)
the membrane fraction##3##3##(1993-8#1)(1994-11#1)(2008-11#1)
the membrane in##3##3##(1992-12#1)(2009-9#1)(2012-2#1)
the membrane of Escherichia coli##2##5##(1991-10#1)(2008-10#1)
the membrane of the##5##4##(1990-12#2)(1993-8#1)(2008-8#1)(2008-9#1)
the membrane of##12##3##(1990-12#2)(1991-10#1)(1993-8#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-8#2)(2008-9#1)
the membrane permeability to##2##4##(1990-5#1)(2008-8#1)
the membrane potential##4##3##(1990-12#1)(1994-11#1)(1997-1#1)(2013-8#1)
the membrane recycling hypothesis##3##4##(1997-1#3)
the membrane sensor has been##2##5##(2008-10#2)
the membrane sensor has##3##4##(2008-10#3)
the membrane surface##2##3##(1994-5#1)(2012-2#1)
the membrane was##8##3##(1991-3#1)(1994-11#1)(2008-10#5)(2011-2#1)
the membrane with##2##3##(2008-10#2)
the membrane##172##2##(1990-12#3)(1990-2#2)(1990-5#6)(1991-10#2)(1991-3#1)(1991-5#5)(1992-12#3)(1993-6#1)(1993-8#8)(1994-11#3)(1994-5#5)(1994-8#5)(1995-2#2)(1995-6#4)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#4)(1997-2#1)(1997-4#1)(2008-10#75)(2008-11#4)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#5)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#3)(2011-2#2)(2012-2#5)(2013-1#1)(2013-8#2)
the membrane-bound##4##2##(1990-5#1)(1995-6#1)(1996-8#1)(2009-7#1)
the membranes of##3##3##(1990-5#1)(1996-9#1)(2008-10#1)
the membranes were##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
the membranes with##4##3##(1992-7#1)(1993-3#1)(1995-11#1)(2008-10#1)
the membranes##22##2##(1990-5#1)(1991-10#1)(1992-6#2)(1992-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#3)(1996-9#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#2)
the memory##4##2##(1992-5#1)(2008-11#1)(2008-12#1)(2010-6#1)
the meninges##2##2##(2008-7#1)(2012-3#1)
the menopause##3##2##(1991-11#1)(2008-12#1)(2011-2#1)
the menstrual##2##2##(2008-7#1)(2012-3#1)
the mental and physical##2##4##(1996-9#1)(2010-1#1)
the mental and##4##3##(1995-5#1)(1996-9#1)(2010-1#1)(2012-3#1)
the mental health user##2##4##(2008-11#2)
the mental health##16##3##(1992-1#1)(1994-1#1)(1995-1#1)(1997-3#3)(2008-11#6)(2008-12#2)(2009-6#1)(2010-12#1)
the mental illness##2##3##(2012-3#2)
the mental nerve##2##3##(2012-3#2)
the mental##28##2##(1992-1#1)(1992-2#1)(1994-1#1)(1995-1#1)(1995-5#1)(1996-9#1)(1997-3#3)(2008-11#6)(2008-12#2)(2009-6#2)(2010-1#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-3#5)
the mentally ill##4##3##(1992-1#1)(1992-3#1)(1995-2#1)(1996-1#1)
the mentally##10##2##(1991-1#2)(1992-1#1)(1992-3#1)(1994-1#2)(1995-2#1)(1996-1#1)(1997-8#2)
the mentioned##7##2##(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
the mentor##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
the mercapto ligand##2##3##(2008-10#2)
the mercapto##3##2##(2008-10#3)
the mercury drop##2##3##(2008-10#2)
the mercury electrode and##5##4##(2008-10#5)
the mercury electrode surface##4##4##(2008-10#4)
the mercury electrode##11##3##(1990-5#1)(2008-10#10)
the mercury film##3##3##(2008-10#3)
the mercury is##2##3##(2008-10#2)
the mercury surface##2##3##(2008-10#2)
the mercury##28##2##(1990-5#1)(2008-10#27)
the mere##2##2##(2009-6#1)(2013-8#1)
the merging of##2##3##(1991-3#1)(1995-2#1)
the merging-zone##2##2##(2008-10#2)
the merit##2##2##(2008-10#1)(2013-8#1)
the merits of##7##3##(1992-9#1)(1993-1#1)(1993-2#1)(2008-11#2)(2008-4#1)(2008-5#1)
the merits##8##2##(1992-9#1)(1993-1#1)(1993-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)
the mesencephalic##3##2##(1990-9#1)(1994-2#1)(1997-2#1)
the mesenchymal##4##2##(1990-5#1)(2008-11#1)(2008-9#1)(2011-2#1)
the mesenchyme##3##2##(1993-3#1)(1995-8#1)(2008-6#1)
the mesenteric lymph##2##3##(1996-12#1)(2008-5#1)
the mesenteric##7##2##(1992-3#2)(1992-5#1)(1996-12#1)(2008-5#1)(2010-12#1)(2013-1#1)
the mesentery##2##2##(1990-5#1)(1990-8#1)
the meso##2##2##(1994-5#1)(2009-5#1)
the mesocarp and##2##3##(2008-10#2)
the mesocarp##3##2##(2008-10#3)
the mesocortical DA system##3##4##(1996-5#3)
the mesopause##3##2##(2008-3#3)
the mesophyll##5##2##(2008-10#5)
the mesopores##2##2##(2008-10#2)
the mesoporous##3##2##(2008-10#2)(2010-4#1)
the mesorectum##3##2##(2009-12#3)
the mesostructured tin oxide##2##4##(2008-10#2)
the message##7##2##(1993-3#1)(1994-11#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2010-8#1)
the meta-analysis##3##2##(1996-6#1)(2008-4#1)(2009-9#1)
the metabolic and##2##3##(1994-12#1)(2009-5#1)
the metabolic characteristics of##2##4##(2008-11#1)(2011-3#1)
the metabolic pathway##2##3##(1993-2#1)(2012-5#1)
the metabolic potential##2##3##(1995-6#1)(2008-11#1)
the metabolic state of##2##4##(1996-12#1)(2010-12#1)
the metabolic syndrome and##5##4##(2008-1#1)(2008-3#1)(2008-7#1)(2010-4#2)
the metabolic syndrome are##2##4##(2008-11#1)(2008-3#1)
the metabolic syndrome has##2##4##(2008-6#1)(2011-2#1)
the metabolic syndrome in##4##4##(2008-10#1)(2008-3#3)
the metabolic syndrome is##3##4##(2008-1#1)(2008-3#1)(2008-6#1)
the metabolic syndrome##42##3##(2008-1#13)(2008-10#3)(2008-11#1)(2008-3#8)(2008-6#7)(2008-7#2)(2010-4#3)(2010-5#3)(2011-2#1)(2012-5#1)
the metabolic syndrome]##2##3##(1993-2#1)(2012-3#1)
the metabolic##84##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-2#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#2)(1996-11#1)(1996-12#1)(1997-2#1)(2008-1#13)(2008-10#6)(2008-11#4)(2008-3#9)(2008-5#1)(2008-6#9)(2008-7#4)(2008-8#4)(2009-5#1)(2010-12#1)(2010-4#3)(2010-5#3)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2012-5#2)(2013-1#1)
the metabolism and##6##3##(1993-11#1)(2008-10#1)(2008-7#2)(2013-1#2)
the metabolism of NA##2##4##(2008-8#2)
the metabolism of retinol and beta-carotene##2##6##(2009-6#2)
the metabolism of the##2##4##(1993-6#1)(2008-10#1)
the metabolism of##24##3##(1991-5#1)(1992-11#1)(1993-6#2)(1994-8#2)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#2)(2011-2#1)(2013-1#1)
the metabolism via##2##3##(2008-11#2)
the metabolism##34##2##(1991-5#1)(1992-11#1)(1993-11#1)(1993-6#2)(1994-8#2)(2008-10#6)(2008-11#6)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#2)(2011-2#1)(2012-2#1)(2013-1#3)
the metabolite##6##2##(1992-1#1)(2008-10#3)(2008-8#1)(2010-11#1)
the metabolites of##2##3##(2008-11#1)(2013-1#1)
the metabolites that are##2##4##(2008-10#2)
the metabolites##12##2##(1990-11#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-8#1)(2010-11#1)(2011-3#2)(2013-1#1)
the metabolome##3##2##(2009-8#2)(2012-5#1)
the metachromatic##2##2##(2008-9#2)
the metal M##3##3##(2008-10#3)
the metal and##3##3##(2008-10#3)
the metal binding##2##3##(2008-10#2)
the metal cations##3##3##(2008-10#3)
the metal chelate##3##3##(2008-10#3)
the metal cluster##5##3##(1994-5#5)
the metal ion in##2##4##(2008-10#2)
the metal ion is##2##4##(2008-10#2)
the metal ion##15##3##(1992-3#1)(1997-4#1)(2008-10#13)
the metal ions in##3##4##(2008-10#3)
the metal ions with##2##4##(2008-10#2)
the metal ions##26##3##(2008-10#25)(2010-11#1)
the metal species##3##3##(2008-10#2)(2010-11#1)
the metal was##3##3##(2008-10#3)
the metal##109##2##(1992-3#1)(1994-5#8)(1997-4#1)(2008-10#94)(2010-11#4)(2013-1#1)
the metallic##10##2##(2008-10#6)(2008-3#1)(2008-8#1)(2010-6#2)
the metallothionein##2##2##(2008-10#1)(2008-11#1)
the metals can be##2##4##(2008-10#2)
the metals were##2##3##(2008-10#2)
the metals##20##2##(2008-10#17)(2008-12#1)(2010-11#1)(2011-2#1)
the metapopulation##11##2##(2008-10#2)(2008-8#3)(2008-9#6)
the metastasis##2##2##(1996-6#1)(2009-10#1)
the metastatic melanoma##2##3##(1997-7#1)(2010-6#1)
the metastatic phenotype of##2##4##(1994-5#1)(2009-3#1)
the metastatic process##2##3##(1990-6#1)(1990-8#1)
the metastatic##9##2##(1990-6#1)(1990-8#1)(1991-3#1)(1994-12#1)(1994-5#1)(1997-7#1)(2009-3#1)(2010-6#1)(2013-8#1)
the metered-dose inhaler (MDI)##2##4##(1996-2#1)(1997-1#1)
the metering valve is##2##4##(1996-1#2)
the methane production##2##3##(2013-1#2)
the methane##3##2##(2008-2#1)(2013-1#2)
the methanogen was##2##3##(2008-7#2)
the methanol concentration##2##3##(2008-7#2)
the methanol extract of the##2##5##(2008-11#1)(2012-2#1)
the methanol extract of##3##4##(2008-11#1)(2012-2#1)(2013-8#1)
the methanol extract##4##3##(2008-11#2)(2012-2#1)(2013-8#1)
the methanol##10##2##(1997-7#1)(2008-10#3)(2008-11#2)(2008-7#2)(2012-2#1)(2013-8#1)
the methionine##2##2##(1997-2#1)(2013-8#1)
the method a##2##3##(2008-10#1)(2008-11#1)
the method and its##2##4##(2008-10#1)(2010-9#1)
the method and##7##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-9#1)
the method based on reaction with##2##6##(2008-10#2)
the method based on the color reaction of##2##8##(2008-10#2)
the method based on##4##4##(2008-10#4)
the method by measuring##3##4##(2008-10#1)(2008-3#2)
the method by##5##3##(2008-10#2)(2008-11#1)(2008-3#2)
the method can be##5##4##(2008-10#4)(2008-11#1)
the method can##6##3##(2008-10#4)(2008-11#1)(2008-3#1)
the method could be##2##4##(2008-10#1)(2008-11#1)
the method could effectively separate##3##5##(2008-10#3)
the method could##5##3##(2008-10#4)(2008-11#1)
the method described here##5##4##(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#2)
the method described##6##3##(2008-11#2)(2008-4#1)(2008-5#1)(2009-4#2)
the method detection##2##3##(2008-10#2)
the method developed##4##3##(2008-10#3)(2008-5#1)
the method development##3##3##(2008-10#1)(2010-11#2)
the method does not suffer##2##5##(2008-10#2)
the method enables##2##3##(2008-10#1)(2008-3#1)
the method for the determination of##3##6##(2008-10#3)
the method for the##6##4##(2008-10#6)
the method for##21##3##(2008-10#18)(2008-11#1)(2008-3#1)(2010-11#1)
the method has been applied to##3##6##(2008-10#3)
the method has been applied##4##5##(2008-10#4)
the method has been satisfactorily##2##5##(2008-10#2)
the method has been successfully applied to the##2##8##(2008-10#2)
the method has been##14##4##(2008-10#14)
the method has##16##3##(2008-10#16)
the method in##4##3##(2008-10#4)
the method is applied to##2##5##(2008-10#2)
the method is based on##2##5##(2008-10#1)(2008-2#1)
the method is free##2##4##(2008-10#2)
the method is sensitive##2##4##(2008-10#1)(2009-5#1)
the method is suitable for##4##5##(2008-10#4)
the method is##60##3##(1990-11#1)(1990-9#1)(1996-5#1)(2008-10#49)(2008-11#2)(2008-2#1)(2008-3#2)(2009-5#1)(2010-5#1)(2011-2#1)
the method of 'replenishing qi##2##5##(2013-8#2)
the method of choice for##6##5##(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
the method of choice##9##4##(1992-9#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-12#2)(2011-2#1)(2012-3#1)
the method of constant stimuli##4##5##(1990-11#4)
the method of data collection##2##5##(1993-3#1)(2008-11#1)
the method of detection##2##4##(2008-10#2)
the method of standard additions##6##5##(2008-10#6)
the method of standard##7##4##(2008-10#7)
the method of##58##3##(1990-11#4)(1990-12#1)(1991-1#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-12#1)(1997-1#1)(1997-7#1)(2008-10#22)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#4)(2010-12#3)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#1)(2013-8#2)
the method presented here is##2##5##(2008-10#2)
the method presented##4##3##(2008-10#3)(2008-3#1)
the method proposed##3##3##(2008-10#3)
the method provides##3##3##(2008-10#2)(2008-3#1)
the method showed##2##3##(2008-10#2)
the method shows a##2##4##(2008-10#2)
the method shows##3##3##(2008-10#3)
the method to be##3##4##(1990-12#1)(2008-10#2)
the method to the##8##4##(1995-12#1)(2008-10#7)
the method to##28##3##(1990-12#1)(1995-12#1)(1996-3#1)(1997-6#1)(2008-10#21)(2008-3#1)(2008-8#1)(2009-7#1)
the method used for##5##4##(2008-10#3)(2008-11#1)(2008-3#1)
the method used to##3##4##(2008-10#1)(2010-6#1)(2013-1#1)
the method used##9##3##(2008-10#5)(2008-11#1)(2008-3#1)(2010-6#1)(2013-1#1)
the method using##3##3##(2008-10#1)(2008-6#1)(2010-7#1)
the method was applicable##2##4##(2008-10#2)
the method was applied to the##2##6##(2008-10#2)
the method was applied##4##4##(2008-10#4)
the method was##69##3##(1995-11#1)(2008-10#65)(2008-8#2)(2010-4#1)
the method when applied to##2##5##(2008-10#1)(2008-3#1)
the method##470##2##(1990-11#5)(1990-12#2)(1990-3#1)(1990-9#1)(1991-1#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#351)(2008-11#18)(2008-12#4)(2008-2#2)(2008-3#16)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#3)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
the method's##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
the methodological issues##2##3##(2008-12#2)
the methodological##9##2##(1991-11#1)(1992-3#2)(2008-10#2)(2008-12#2)(2008-8#1)(2010-11#1)
the methodology based on##2##4##(2008-10#2)
the methodology developed##2##3##(2008-10#2)
the methodology of##5##3##(1993-2#1)(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#1)
the methodology to##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
the methodology##32##2##(1991-2#1)(1993-2#1)(1995-2#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
the methods and##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
the methods are##3##3##(1995-5#1)(2008-10#2)
the methods described##2##3##(2008-10#1)(2008-5#1)
the methods employed##3##3##(1991-3#1)(1994-2#1)(2008-11#1)
the methods for##5##3##(2008-10#1)(2008-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
the methods of##7##3##(1992-2#1)(1992-5#1)(1993-11#1)(2007-11#1)(2009-7#1)(2011-3#1)(2012-12#1)
the methods to##4##3##(2008-10#3)(2009-10#1)
the methods used in the##2##5##(2008-10#1)(2008-11#1)
the methods used to##3##4##(2008-1#1)(2008-11#1)(2010-5#1)
the methods used##7##3##(1991-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-5#1)
the methods were##4##3##(2008-10#4)
the methods##68##2##(1991-2#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#2)(2007-11#1)(2008-1#1)(2008-10#33)(2008-11#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-5#2)(2011-3#1)(2012-12#3)(2013-1#2)(2013-8#1)
the methoxy##2##2##(1996-5#1)(2008-10#1)
the methyl##6##2##(1992-10#1)(1992-12#1)(1994-8#1)(2008-10#3)
the methylation of##3##3##(1994-8#1)(2008-9#1)(2009-7#1)
the methylation##6##2##(1994-8#1)(1995-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
the methylene blue##2##3##(2008-10#2)
the methylene##4##2##(1997-1#2)(2008-10#2)
the methyltransferase (MTase)##2##3##(1991-9#1)(1993-9#1)
the metrics##2##2##(2008-10#1)(2011-2#1)
the miRNAs##2##2##(2010-1#1)(2011-2#1)
the mice were treated with##2##5##(2008-7#1)(2008-9#1)
the mice were##5##3##(1995-9#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
the mice##14##2##(1993-12#1)(1995-12#1)(1995-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the micellar medium##2##3##(2008-10#2)
the micellar system##5##3##(1990-5#5)
the micellar##13##2##(1990-5#5)(1996-5#1)(1997-2#1)(2008-10#6)
the micelle##3##2##(2008-10#2)(2010-7#1)
the micro##3##2##(1997-3#1)(2008-10#2)
the micro-colorimetric method##2##3##(2008-10#2)
the micro-colorimetric##3##2##(2008-10#3)
the micro-optical##2##2##(2008-2#1)(2008-3#1)
the micro-organism##2##2##(2011-2#2)
the microbe##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
the microbial complex that incites apple replant disease##2##8##(2008-10#2)
the microbial complex##3##3##(2008-10#3)
the microbial composition##2##3##(2008-10#1)(2010-5#1)
the microbial ecology of##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
the microbial##19##2##(1997-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
the microbiological##3##2##(2008-10#1)(2010-6#2)
the microbioreactor##2##2##(2008-11#2)
the microbiota of##2##3##(2011-2#1)(2012-2#1)
the microbiota##5##2##(2011-2#4)(2012-2#1)
the microcarrier##3##2##(2008-11#2)(2008-9#1)
the microcarriers##2##2##(2008-11#2)
the microcatheter##2##2##(2008-7#2)
the microchannel##4##2##(2008-10#3)(2009-9#1)
the microchip##8##2##(2007-12#1)(2008-10#7)
the microcirculation in##2##3##(1996-3#1)(2010-7#1)
the microcirculation##4##2##(1996-3#1)(2010-12#1)(2010-7#2)
the microcolumn##5##2##(2008-10#5)
the microdialysis probe##3##3##(1997-2#2)(2008-10#1)
the microelectrode##4##2##(2008-10#4)
the microenvironment of##4##3##(2008-10#3)(2009-4#1)
the microenvironment##8##2##(2008-10#4)(2009-10#1)(2009-3#2)(2009-4#1)
the microfine oxides##2##3##(2008-5#2)
the microflora in##2##3##(2008-10#1)(2012-3#1)
the microflora of##2##3##(2008-5#2)
the microflora##4##2##(2008-10#1)(2008-5#2)(2012-3#1)
the microfluidic##4##2##(2008-10#3)(2009-12#1)
the microgels##2##2##(2008-10#2)
the microgram##2##2##(2008-10#2)
the micromechanical properties of##3##4##(2010-4#3)
the micromolar concentration range##3##4##(1990-12#2)(2008-10#1)
the micromolar concentration##4##3##(1990-12#2)(2008-10#2)
the micromolar##5##2##(1990-12#2)(2008-10#3)
the micronucleus frequency##2##3##(1993-8#2)
the microorganisms##6##2##(1994-9#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
the micropylar##4##2##(2008-11#1)(2008-9#1)(2009-12#2)
the micropyle##3##2##(1994-5#1)(2007-12#1)(2009-8#1)
the microscope##4##2##(1993-11#1)(2008-9#1)(2009-12#1)(2010-1#1)
the microscopic activity##3##3##(2008-11#3)
the microscopic rate constants##2##4##(2008-5#2)
the microscopic##17##2##(1991-6#1)(1993-6#1)(1995-3#2)(1997-8#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2009-7#1)(2013-1#1)(2013-8#1)
the microshear bond strength##4##4##(2013-1#4)
the microsomal fraction of##2##4##(1993-3#1)(1994-11#1)
the microsomal fraction##4##3##(1993-3#2)(1994-11#1)(1996-3#1)
the microsomal oxidative demethylation of##2##5##(1993-8#2)
the microsomal##9##2##(1990-11#1)(1992-6#1)(1993-3#3)(1993-8#2)(1994-11#1)(1996-3#1)
the microsomes##3##2##(1991-10#1)(1994-11#1)(1994-8#1)
the microstructure of the##3##4##(2008-5#1)(2009-7#2)
the microstructure of##7##3##(2008-10#1)(2008-5#4)(2009-7#2)
the microstructure##11##2##(2008-10#1)(2008-3#2)(2008-5#4)(2009-7#4)
the microsyringe needle##2##3##(2008-10#2)
the microsyringe##3##2##(2008-10#3)
the microtubule organizing center##2##4##(2008-8#1)(2008-9#1)
the microtubule##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
the microvascular response to norepinephrine##2##5##(1994-8#2)
the microvascular##3##2##(1990-5#1)(1994-8#2)
the microvasculature##2##2##(2009-10#1)(2011-2#1)
the microvesicles##2##2##(1990-12#2)
the microvillar##2##2##(2007-12#1)(2008-7#1)
the microvilli and##2##3##(1995-2#1)(2008-7#1)
the microvilli##7##2##(1995-2#1)(2007-12#2)(2008-7#4)
the microwave digestion##2##3##(2008-10#2)
the microwave oven##2##3##(2008-10#2)
the microwave##11##2##(2008-10#9)(2010-4#1)(2012-12#1)
the microwave-assisted##4##2##(2008-10#4)
the microwaves##2##2##(2008-10#1)(2008-3#1)
the micturition reflex##2##3##(1992-3#2)
the mid##10##2##(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#2)
the mid-##3##2##(2008-10#3)
the mid-IR##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
the mid-infrared region##2##3##(2008-3#2)
the mid-infrared##6##2##(2008-2#1)(2008-3#5)
the mid-term##3##2##(2008-10#1)(2009-3#1)(2009-4#1)
the midbrain##5##2##(1996-12#1)(1997-3#1)(2008-6#1)(2008-7#2)
the middle and##4##3##(2008-7#1)(2008-9#2)(2013-1#1)
the middle cerebral artery##7##4##(2008-12#1)(2008-4#1)(2008-7#4)(2010-11#1)
the middle cerebral##8##3##(1996-2#1)(2008-12#1)(2008-4#1)(2008-7#4)(2010-11#1)
the middle deltoid##2##3##(2009-3#2)
the middle ear##6##3##(1991-3#3)(1995-5#1)(2013-1#1)(2013-7#1)
the middle fossa##2##3##(2008-7#1)(2011-2#1)
the middle meningeal artery##4##4##(1996-9#2)(2008-12#2)
the middle of the##8##4##(1993-2#1)(1993-8#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)
the middle of##13##3##(1991-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-6#2)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-3#1)
the middle phase##3##3##(2008-10#3)
the middle temporal##3##3##(1996-2#1)(2008-9#2)
the middle##66##2##(1990-11#1)(1991-12#1)(1991-3#3)(1993-2#1)(1993-8#1)(1994-11#1)(1995-5#2)(1995-6#3)(1996-2#2)(1996-3#1)(1996-9#2)(1997-6#1)(2008-10#11)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#1)(2008-7#8)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#2)(2010-11#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
the midgut and##4##3##(2008-10#3)(2008-6#1)
the midgut epithelium##3##3##(2008-12#2)(2008-7#1)
the midgut of adult##2##4##(2008-10#2)
the midgut##22##2##(1997-3#1)(2007-12#4)(2008-10#12)(2008-12#2)(2008-6#1)(2008-7#2)
the midline##4##2##(1990-8#1)(2007-12#1)(2009-1#1)(2013-1#1)
the midpoint of##2##3##(1997-2#1)(2008-12#1)
the midpoint potentials##2##3##(2008-10#2)
the midpoint##5##2##(1997-2#1)(1997-7#1)(2008-10#2)(2008-12#1)
the midrange market##2##3##(1993-2#2)
the midsagittal##2##2##(1995-5#2)
the midst of##4##3##(1993-12#2)(1993-2#1)(2008-12#1)
the migraine attack##3##3##(2008-9#3)
the migration of the##2##4##(1997-6#1)(2008-9#1)
the migration of##15##3##(1995-12#1)(1995-8#1)(1997-6#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
the migration pool##2##3##(2008-8#2)
the migration time and##4##4##(2008-10#4)
the migration time##8##3##(2008-10#8)
the migration times##2##3##(2008-10#2)
the migration##31##2##(1995-12#1)(1995-2#1)(1995-8#1)(1997-6#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
the migration/invasion abilities of breast stromal fibroblasts##2##7##(2013-1#2)
the migratory##5##2##(2008-8#2)(2009-9#1)(2011-2#1)(2012-3#1)
the mild strain##2##3##(2008-10#2)
the mild##6##2##(1996-9#1)(2008-10#4)(2008-4#1)
the military to##2##3##(1992-3#1)(1995-6#1)
the military##10##2##(1991-3#1)(1992-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-8#1)(2011-2#1)
the milk samples were##2##4##(2008-10#2)
the milk samples##3##3##(2008-10#3)
the milk##14##2##(2008-10#6)(2008-12#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
the millennium##2##2##(2008-4#2)
the minced##2##2##(2008-10#1)(2008-4#1)
the mind##4##2##(2008-12#1)(2009-10#2)(2012-2#1)
the mine##2##2##(2008-10#2)
the mineral##6##2##(2008-10#5)(2008-5#1)
the mineralization##3##2##(2008-10#1)(2009-7#2)
the mineralized##3##2##(2008-10#1)(2013-8#2)
the mineralogical##4##2##(2008-10#4)
the miniature##2##2##(2008-10#2)
the miniaturization of the##2##4##(2008-10#2)
the miniaturization##3##2##(2008-10#3)
the minicolumn##8##2##(2008-10#8)
the minima of##2##3##(2008-10#1)(2008-11#1)
the minimal amount of##2##4##(2008-10#2)
the minimal##20##2##(1990-11#1)(1991-11#1)(1992-3#1)(1992-4#1)(1993-12#2)(1995-2#3)(2008-10#6)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)
the minimally##2##2##(2008-10#1)(2013-1#1)
the minimization##3##2##(2006-6#1)(2008-10#1)(2008-3#1)
the minimum concentration of##2##4##(1993-1#1)(2008-10#1)
the minimum concentration##3##3##(1993-1#1)(2008-10#2)
the minimum error##2##3##(2008-10#2)
the minimum feature##2##3##(2008-10#1)(2008-3#1)
the minimum infective dose##2##4##(2009-6#2)
the minimum number of##3##4##(1992-9#1)(2008-11#1)(2008-8#1)
the minimum of##2##3##(2008-10#1)(2008-11#1)
the minimum required number of index subjects##2##7##(1996-3#2)
the minimum required##4##3##(1996-3#2)(2008-10#2)
the minimum##42##2##(1991-8#1)(1992-9#2)(1993-1#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-1#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-6#2)(2009-7#1)(2010-9#1)(2012-2#1)(2013-8#1)
the minor components##2##3##(2008-10#2)
the minor##19##2##(1991-11#1)(1993-1#2)(1993-12#2)(1994-5#3)(1995-6#1)(1995-8#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2010-3#1)(2013-8#1)
the minority##3##2##(1994-3#1)(2008-9#1)(2010-12#1)
the minute##2##2##(2007-12#1)(2008-10#1)
the mirror neuron system##2##4##(2008-11#2)
the mirror##5##2##(2008-11#2)(2008-2#2)(2008-3#1)
the misconceptions##3##2##(2010-3#3)
the mismatch negativity (MMN)##2##4##(1995-12#1)(2008-9#1)
the misogynist##2##2##(2009-10#2)
the missing data##2##3##(1995-12#2)
the missing##11##2##(1991-2#1)(1992-1#1)(1993-3#1)(1995-12#2)(1997-4#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-5#1)(2012-2#1)
the mitochondria and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
the mitochondria##10##2##(1995-6#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-7#2)(2011-2#1)
the mitochondrial (mt)##2##3##(1991-6#1)(1993-2#1)
the mitochondrial DNA##8##3##(1994-11#5)(1995-6#1)(1997-2#1)(2008-10#1)
the mitochondrial and##2##3##(2008-10#1)(2008-7#1)
the mitochondrial citrate synthase##2##4##(1997-4#1)(1997-8#1)
the mitochondrial cytochrome##2##3##(2008-10#1)(2010-4#1)
the mitochondrial genes##2##3##(1991-6#1)(2008-6#1)
the mitochondrial genome##4##3##(1995-6#3)(2009-8#1)
the mitochondrial membrane and##2##4##(1995-6#1)(2009-9#1)
the mitochondrial membrane potential##2##4##(2008-7#1)(2012-2#1)
the mitochondrial membrane##6##3##(1990-2#1)(1995-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)
the mitochondrial membranes##2##3##(1990-2#1)(2012-2#1)
the mitochondrial##58##2##(1990-2#2)(1990-5#1)(1991-5#1)(1991-6#2)(1992-10#2)(1993-2#2)(1994-11#5)(1995-6#5)(1997-2#2)(1997-4#2)(1997-8#1)(2008-10#8)(2008-12#1)(2008-6#3)(2008-7#5)(2008-8#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#3)(2012-2#6)(2013-8#2)
the mitochondrially##2##2##(1995-6#1)(2008-10#1)
the mitogen-activated protein kinase (MAPK) cascade##2##6##(1995-2#2)
the mitogen-activated protein kinase##3##4##(1995-2#2)(2008-11#1)
the mitogen-activated protein kinases (MAPKs)##2##5##(1995-2#1)(2010-10#1)
the mitogen-activated protein##5##3##(1995-2#3)(2008-11#1)(2010-10#1)
the mitogen-activated##6##2##(1995-2#3)(2008-11#1)(2008-7#1)(2010-10#1)
the mitogenic activity##2##3##(1990-12#1)(1994-11#1)
the mitogenic effect of##2##4##(1997-1#1)(2008-6#1)
the mitogenic effect##3##3##(1997-1#1)(2008-11#1)(2008-6#1)
the mitogenic effects of EGF##2##5##(2008-6#2)
the mitogenic effects##3##3##(2008-11#1)(2008-6#2)
the mitogenic signal##2##3##(1990-12#1)(2008-4#1)
the mitogenic##11##2##(1990-12#2)(1992-10#1)(1994-11#1)(1997-1#1)(2008-11#2)(2008-4#1)(2008-6#3)
the mitotic index##3##3##(1994-6#1)(2008-11#2)
the mitotic spindle##6##3##(2008-1#1)(2008-8#1)(2008-9#1)(2011-2#3)
the mitotic##12##2##(1994-6#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#4)(2013-1#1)
the mitral annulus##2##3##(2008-10#2)
the mitral valve and##2##4##(2013-1#2)
the mitral valve##7##3##(2008-11#1)(2010-12#1)(2013-1#5)
the mitral##12##2##(2008-10#3)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#6)
the mix of##3##3##(1992-4#1)(1993-1#1)(2008-11#1)
the mix##4##2##(1992-4#1)(1993-1#1)(2008-11#1)(2011-2#1)
the mixed cultures##4##3##(2013-1#4)
the mixed inoculum##2##3##(2008-10#2)
the mixed liquor##2##3##(2008-12#2)
the mixed solution##4##3##(2008-10#4)
the mixed strategy##2##3##(2008-8#2)
the mixed type##2##3##(1990-2#1)(1996-6#1)
the mixed##50##2##(1990-2#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-5#1)(1996-6#1)(2007-11#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#2)(2012-2#1)(2013-1#4)
the mixed-solution method##2##3##(2008-10#2)
the mixing of##2##3##(2008-10#2)
the mixing process##2##3##(2008-3#1)(2008-5#1)
the mixing time constant##3##4##(2008-7#3)
the mixing##14##2##(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#4)
the mixture is##4##3##(1990-12#1)(2008-10#2)(2008-9#1)
the mixture of 2-propanol##2##4##(2008-10#2)
the mixture of both##2##4##(1990-5#1)(2008-10#1)
the mixture of the##2##4##(2008-10#2)
the mixture of##25##3##(1990-5#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#2)(2013-1#1)
the mixture##59##2##(1990-12#1)(1990-5#2)(1995-8#1)(1997-8#1)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
the mixtures of##3##3##(2008-10#2)(2008-11#1)
the mixtures##18##2##(1993-8#2)(2008-10#15)(2008-11#1)
the mobile carrier##2##3##(2008-10#2)
the mobile phase as an##2##5##(2008-10#2)
the mobile phase as##3##4##(2008-10#3)
the mobile phase containing##2##4##(2008-10#2)
the mobile phase pH##2##4##(2008-10#2)
the mobile phase was##5##4##(2008-10#5)
the mobile phase water content##2##5##(2008-10#2)
the mobile phase were##3##4##(2008-10#3)
the mobile phase##48##3##(1991-7#1)(1993-11#1)(2008-10#45)(2011-3#1)
the mobile##55##2##(1991-7#1)(1993-11#1)(2008-10#50)(2011-2#1)(2011-3#1)(2012-12#1)
the mobility of##5##3##(2008-10#3)(2008-8#1)(2011-2#1)
the mobility##7##2##(2008-10#4)(2008-7#1)(2008-8#1)(2011-2#1)
the mobilization##3##2##(1992-3#1)(2011-2#2)
the modal##6##2##(2008-12#2)(2008-2#1)(2008-3#3)
the modality##2##2##(1992-1#1)(2008-9#1)
the mode of action of the##3##6##(1997-1#1)(1997-7#1)(2008-10#1)
the mode of action of##6##5##(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-5#1)
the mode of cell##2##4##(2008-4#1)(2008-9#1)
the mode of dissemination##2##4##(2008-10#1)(2013-1#1)
the mode of##24##3##(1993-8#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-9#3)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#2)
the mode##28##2##(1993-8#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#2)
the model CA3 pyramidal cell##2##5##(2008-11#2)
the model and##7##3##(1992-12#1)(1994-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)
the model are##3##3##(1992-12#1)(2008-10#2)
the model as a##2##4##(2008-11#1)(2013-1#1)
the model as##3##3##(1996-3#1)(2008-11#1)(2013-1#1)
the model based on the##2##5##(2008-10#1)(2011-1#1)
the model can be##5##4##(2008-10#2)(2008-3#1)(2008-6#1)(2013-8#1)
the model can##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2013-8#1)
the model developed##2##3##(1992-3#1)(2008-10#1)
the model for the##2##4##(1993-8#1)(1994-5#1)
the model for##7##3##(1992-1#1)(1993-8#1)(1994-5#2)(1995-12#1)(2008-10#1)(2010-4#1)
the model formulation##2##3##(2008-10#2)
the model group##3##3##(1990-12#3)
the model in##4##3##(2008-11#2)(2008-6#1)(2008-7#1)
the model is##15##3##(1995-5#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2011-2#1)(2013-1#1)
the model of##9##3##(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
the model or##2##3##(2008-10#1)(2010-8#1)
the model outputs##2##3##(2008-10#1)(2013-1#1)
the model parameters##4##3##(2008-10#1)(2008-7#3)
the model plant Arabidopsis thaliana##2##5##(2008-9#1)(2011-2#1)
the model plant Arabidopsis##3##4##(2008-9#1)(2009-8#1)(2011-2#1)
the model predicted##4##3##(2008-7#3)(2008-9#1)
the model prediction##2##3##(2008-3#1)(2008-7#1)
the model predictions##3##3##(2008-10#2)(2009-7#1)
the model predicts##2##3##(2008-10#1)(2008-9#1)
the model proposed##2##3##(2008-10#1)(2013-8#1)
the model results##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
the model shows that##2##4##(2008-11#2)
the model simulation and##2##4##(2008-7#2)
the model system of##2##4##(2008-11#1)(2008-8#1)
the model that##2##3##(1995-2#1)(2012-3#1)
the model to any##2##4##(2008-10#1)(2008-5#1)
the model to include##2##4##(2008-11#1)(2009-7#1)
the model to##13##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2013-8#2)
the model using##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
the model was##6##3##(1992-3#1)(1995-9#1)(2008-10#3)(2008-7#1)
the model##249##2##(1990-12#5)(1990-8#1)(1991-12#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-9#2)(1993-1#1)(1993-8#1)(1994-2#1)(1994-5#3)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#2)(2008-10#64)(2008-11#24)(2008-12#2)(2008-3#8)(2008-5#4)(2008-6#4)(2008-7#29)(2008-8#16)(2008-9#12)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#12)
the model's##3##2##(2008-8#1)(2010-8#1)(2013-8#1)
the modeling of##4##3##(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)
the modeling##10##2##(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#1)(2009-10#1)(2011-2#1)
the modelling of##3##3##(2008-10#2)(2008-11#1)
the modelling##4##2##(2008-10#2)(2008-11#1)(2010-10#1)
the models predict##2##3##(2008-8#1)(2008-9#1)
the models to##3##3##(2008-10#1)(2008-9#1)(2012-8#1)
the models were##3##3##(2008-10#3)
the models with##2##3##(2008-10#1)(2008-5#1)
the models##37##2##(1992-9#1)(1995-3#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#5)(2009-3#1)(2009-8#1)(2010-2#1)(2012-3#1)(2012-8#1)(2013-8#3)
the moderate##3##2##(2012-3#1)(2013-1#2)
the moderating##3##2##(1996-2#1)(2008-12#1)(2010-1#1)
the modern##19##2##(1991-5#1)(1994-2#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#1)(2011-3#1)(2013-1#3)
the modes of##2##3##(2008-10#1)(2009-12#1)
the modest##2##2##(1992-3#1)(2008-4#1)
the modification of the##3##4##(2008-10#2)(2008-7#1)
the modification of##17##3##(1993-12#1)(2008-10#12)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
the modification##22##2##(1993-12#1)(1993-6#1)(2008-10#15)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
the modified Quad procedure##2##4##(2013-1#2)
the modified Rankin Scale##2##4##(2012-3#2)
the modified electrode was##3##4##(2008-10#3)
the modified electrode##18##3##(2008-10#18)
the modified electrodes##5##3##(2008-10#5)
the modified enzyme##3##3##(1993-6#1)(2008-10#2)
the modified resin##4##3##(2008-10#4)
the modified screen-printed carbon electrodes##2##5##(2008-10#2)
the modified screen-printed##3##3##(2008-10#3)
the modified silica gel##3##4##(2008-10#3)
the modified silica##4##3##(2008-10#4)
the modified surface##2##3##(2008-10#2)
the modified triangular interferometer##3##4##(2008-3#3)
the modified##103##2##(1990-8#2)(1990-9#1)(1991-5#1)(1992-5#1)(1993-6#1)(1996-12#1)(1997-2#1)(2008-10#67)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#1)(2010-8#2)(2012-3#2)(2013-1#2)
the modifier##4##2##(2008-10#4)
the modifiers##5##2##(2008-10#5)
the modifying##2##2##(1990-6#1)(2008-10#1)
the modulating##4##2##(1997-1#1)(2008-10#2)(2008-3#1)
the modulation amplitude##2##3##(2008-3#2)
the modulation of the##2##4##(1997-3#1)(2008-3#1)
the modulation of##16##3##(1992-2#1)(1993-3#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
the modulation##22##2##(1992-2#1)(1993-3#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
the modulatory effect of##3##4##(1993-3#1)(1995-11#1)(2008-8#1)
the modulatory##6##2##(1993-3#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
the module##3##2##(2008-11#2)(2013-1#1)
the modules##2##2##(2008-3#1)(2012-3#1)
the modulus##3##2##(2008-5#1)(2009-7#2)
the moist samples##2##3##(2008-10#2)
the moist##4##2##(2008-10#4)
the moisture content and##2##4##(2008-12#1)(2009-7#1)
the moisture content##4##3##(2008-10#1)(2008-12#1)(2009-7#1)(2010-4#1)
the moisture##7##2##(2008-10#4)(2008-12#1)(2009-7#1)(2010-4#1)
the molar absorptivities of the##3##5##(2008-10#3)
the molar absorptivities of##4##4##(2008-10#4)
the molar absorptivities##5##3##(2008-10#5)
the molar absorptivity is##2##4##(2008-10#2)
the molar absorptivity of##2##4##(2008-10#2)
the molar absorptivity was##2##4##(2008-10#2)
the molar absorptivity##9##3##(2008-10#9)
the molar ratio of myristic acid to pyrene carboxylic acid##3##10##(2008-10#3)
the molar ratio of the##2##5##(2008-10#2)
the molar ratio of##13##4##(2008-10#10)(2008-11#1)(2011-2#2)
the molar ratio##14##3##(2008-10#11)(2008-11#1)(2011-2#2)
the molar##35##2##(1994-5#1)(2008-10#29)(2008-11#2)(2008-4#1)(2011-2#2)
the mole fraction of the##2##5##(2008-10#2)
the mole fraction of##4##4##(2008-10#4)
the mole fraction##5##3##(2008-10#5)
the mole fractions##2##3##(2008-10#1)(2008-7#1)
the mole##7##2##(2008-10#6)(2008-7#1)
the molecular analysis##2##3##(2009-8#1)(2012-2#1)
the molecular and cellular##3##4##(2008-2#1)(2008-7#1)(2010-12#1)
the molecular and##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-12#1)
the molecular basis of the##3##5##(1993-2#1)(1997-2#1)(2008-10#1)
the molecular basis of this##2##5##(2008-10#1)(2008-11#1)
the molecular basis of##20##4##(1993-2#1)(1993-3#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
the molecular basis underlying the##2##5##(2008-11#1)(2009-12#1)
the molecular basis##23##3##(1993-2#1)(1993-3#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-10#3)(2008-11#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
the molecular cloning of##2##4##(1992-8#1)(1993-12#1)
the molecular composition##2##3##(1994-11#1)(2008-11#1)
the molecular design##2##3##(2011-1#1)(2012-2#1)
the molecular events##3##3##(2008-10#1)(2009-8#1)(2010-12#1)
the molecular genetics of##3##4##(1997-7#1)(2008-4#1)(2008-7#1)
the molecular genetics##5##3##(1997-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-3#1)
the molecular interaction between the##2##5##(2008-8#1)(2008-9#1)
the molecular interaction##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
the molecular interactions between##2##4##(1992-9#1)(2008-10#1)
the molecular layer##2##3##(1994-8#1)(2013-8#1)
the molecular level##16##3##(1992-6#1)(1997-8#1)(2008-10#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2011-2#1)(2012-2#1)
the molecular markers##2##3##(2008-10#2)
the molecular mass of the##2##5##(2008-10#2)
the molecular mass##3##3##(2008-10#3)
the molecular mechanism of##9##4##(1994-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-3#1)
the molecular mechanism##12##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-2#1)
the molecular mechanisms by which##2##5##(2008-10#1)(2013-1#1)
the molecular mechanisms by##3##4##(2008-10#1)(2011-3#1)(2013-1#1)
the molecular mechanisms of##10##4##(1993-2#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#2)
the molecular mechanisms that##5##4##(2008-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)
the molecular mechanisms underlying##3##4##(2008-10#1)(2009-10#1)(2009-9#1)
the molecular mechanisms##26##3##(1991-6#1)(1993-2#1)(1996-2#1)(1997-7#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#3)(2013-1#1)
the molecular peak##2##3##(2008-10#2)
the molecular recognition event##2##4##(2009-3#2)
the molecular ruler mechanism##2##4##(2012-2#2)
the molecular signals##2##3##(2008-4#1)(2008-5#1)
the molecular structure of##3##4##(1991-3#1)(2008-10#1)(2012-2#1)
the molecular structure##4##3##(1991-3#1)(2006-6#1)(2008-10#1)(2012-2#1)
the molecular surface##2##3##(1994-8#1)(2013-1#1)
the molecular weight and##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
the molecular weight of##6##4##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)
the molecular weight##14##3##(1992-2#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
the molecular weights of##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
the molecular##203##2##(1990-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#2)(1994-8#3)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#3)(1997-2#2)(1997-6#1)(1997-7#4)(1997-8#3)(2006-6#1)(2008-10#40)(2008-11#15)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#6)(2008-7#4)(2008-8#9)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#4)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#5)(2010-12#6)(2010-4#3)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#10)(2011-3#2)(2012-2#13)(2012-3#3)(2013-1#4)(2013-8#2)
the molecule in##2##3##(2008-10#1)(2008-11#1)
the molecule is##2##3##(1990-5#1)(2008-10#1)
the molecule##31##2##(1990-5#1)(1991-5#1)(1992-9#2)(1993-1#1)(1993-8#2)(1994-11#1)(1995-11#1)(1997-8#1)(1997-9#1)(2008-10#7)(2008-11#5)(2008-4#3)(2008-5#2)(2008-8#1)(2009-7#1)(2010-5#1)
the molecules are##2##3##(2008-10#1)(2012-2#1)
the molecules in the##2##4##(1992-9#1)(2008-11#1)
the molecules in##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
the molecules which##2##3##(2008-10#1)(2008-5#1)
the molecules##25##2##(1992-9#4)(1993-8#1)(1994-8#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2012-12#1)(2012-2#2)(2013-8#1)
the molt cycle of the American crayfish##2##7##(2008-6#2)
the molt cycle##3##3##(2008-6#3)
the molt##5##2##(2008-6#4)(2008-7#1)
the molybdene blue##2##3##(2008-10#2)
the molybdenum blue method##3##4##(2008-10#3)
the molybdenum blue##5##3##(2008-10#5)
the molybdenum##9##2##(2008-10#9)
the moment of##4##3##(1990-3#1)(1990-9#1)(2013-1#1)(2013-8#1)
the moment##12##2##(1990-3#2)(1990-9#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2013-1#1)(2013-8#1)
the momentary##2##2##(2008-3#1)(2008-5#1)
the money##5##2##(1990-3#1)(1991-1#1)(1992-2#1)(1995-12#1)(1996-2#1)
the monitor##2##2##(2008-10#1)(2012-3#1)
the monitored##3##2##(1993-8#1)(2008-10#1)(2010-8#1)
the monitoring of the##3##4##(1992-3#1)(2008-10#2)
the monitoring of##26##3##(1992-3#1)(1997-2#1)(1997-6#1)(2008-10#19)(2008-11#2)(2008-4#1)(2012-2#1)
the monitoring##32##2##(1992-3#1)(1997-2#2)(1997-6#1)(2007-8#1)(2008-10#22)(2008-11#3)(2008-4#1)(2012-2#1)
the monitors##2##2##(2008-10#2)
the monkey##7##2##(1991-2#1)(1991-4#1)(1993-6#1)(1997-2#1)(2008-8#3)
the mono- and##2##3##(2008-10#1)(2008-8#1)
the monoamine neurotransmitters##3##3##(2008-10#3)
the monoamine##5##2##(1994-8#1)(1996-12#1)(2008-10#3)
the monoclonal antibodies##2##3##(2008-7#1)(2008-8#1)
the monoclonal antibody##4##3##(1990-12#1)(2008-10#1)(2008-11#2)
the monoclonal##10##2##(1990-12#1)(1991-5#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-11#1)
the monocyclic##2##2##(1993-8#1)(2008-10#1)
the monofunctional##2##2##(1993-12#1)(2008-10#1)
the monolayer culture##3##3##(2008-11#3)
the monolayer in##3##3##(1994-5#1)(2008-10#2)
the monolayer##19##2##(1990-5#2)(1991-3#1)(1994-5#1)(1997-2#2)(2008-10#7)(2008-11#6)
the monolithic columns##3##3##(2008-10#3)
the monolithic##4##2##(2008-10#4)
the monomer##14##2##(1992-12#3)(1992-4#2)(2008-10#6)(2008-11#1)(2008-8#2)
the monomer--dimer##2##2##(1993-3#2)
the monomeric and##2##3##(1994-11#1)(2008-10#1)
the monomeric form##2##3##(1994-11#1)(1997-2#1)
the monomeric##12##2##(1991-7#1)(1994-11#3)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#5)
the monomers##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
the monophyly of##3##3##(2008-10#3)
the monopolar##2##2##(1992-12#1)(2008-9#1)
the month##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
the months##2##2##(1991-12#1)(2012-3#1)
the mood##4##2##(1991-1#1)(1991-8#1)(2008-5#1)(2013-8#1)
the moral##5##2##(2008-11#3)(2008-7#1)(2012-2#1)
the morbidity and##3##3##(2012-12#2)(2012-3#1)
the morbidity of##4##3##(1993-1#1)(2008-8#1)(2010-12#1)(2012-12#1)
the morbidity##9##2##(1993-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-12#3)(2012-3#1)
the more aggressive##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
the more common##8##3##(1997-8#1)(2008-12#2)(2008-2#1)(2008-9#1)(2009-9#1)(2010-1#1)(2012-2#1)
the more conventional##2##3##(1994-5#1)(2008-3#1)
the more general##2##3##(2008-10#1)(2009-10#1)
the more important##2##3##(1992-3#1)(2008-10#1)
the more intense##2##3##(2008-10#2)
the more likely##2##3##(1991-2#1)(1994-5#1)
the more number of##2##4##(1991-2#2)
the more recent##3##3##(1997-8#1)(2008-7#1)(2010-11#1)
the more resistant C57BL/10 mice##2##5##(1996-12#2)
the more resistant##5##3##(1990-2#1)(1996-12#2)(2008-10#2)
the more sensitive##3##3##(1990-8#1)(2008-10#2)
the more severe##3##3##(1997-3#1)(2008-4#1)(2012-2#1)
the more than##2##3##(1991-12#1)(1995-12#1)
the more traditional##3##3##(1996-3#1)(2008-3#1)(2008-5#1)
the more used##2##3##(2008-10#1)(2012-3#1)
the more##108##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#2)(2008-10#30)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#3)(2012-5#2)(2013-1#1)(2013-8#2)
the morning and##2##3##(2008-10#1)(2010-5#1)
the morning##10##2##(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#2)(2010-5#1)
the morphine##4##2##(1991-1#1)(1995-12#2)(2008-10#1)
the morphogenesis##2##2##(2008-10#1)(2008-11#1)
the morphologic##4##2##(1991-2#1)(1991-6#1)(1992-9#1)(2011-2#1)
the morphological and ultrastructural changes##2##5##(2008-10#2)
the morphological and##8##3##(1992-6#1)(1993-9#1)(1994-12#1)(2008-10#3)(2011-2#1)(2012-9#1)
the morphological changes##4##3##(1994-8#1)(1997-8#1)(2008-5#1)(2008-9#1)
the morphological features##2##3##(2008-5#1)(2012-3#1)
the morphological##28##2##(1992-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-3#2)(2012-9#1)
the morphologically similar##2##3##(2008-10#2)
the morphology and##6##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-6#1)(2010-7#1)
the morphology of dorsal lips##2##5##(2011-2#2)
the morphology of the substomatal##2##5##(2008-10#2)
the morphology of the##5##4##(2007-12#1)(2008-10#3)(2008-7#1)
the morphology of##17##3##(1991-12#1)(1993-8#1)(1994-2#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#2)(2009-12#1)(2011-2#2)(2013-1#1)
the morphology##25##2##(1991-12#1)(1993-8#1)(1994-2#1)(1997-8#2)(2007-12#2)(2008-10#7)(2008-11#3)(2008-7#2)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#1)
the morphometry of##2##3##(1996-2#1)(2013-1#1)
the morphometry##3##2##(1995-8#1)(1996-2#1)(2013-1#1)
the mortality and##2##3##(2008-11#1)(2010-1#1)
the mortality associated with##2##4##(2008-10#1)(2010-7#1)
the mortality in##2##3##(2008-1#1)(2011-2#1)
the mortality of##3##3##(1997-7#1)(2008-1#1)(2008-10#1)
the mortality rate of##2##4##(2008-9#1)(2013-1#1)
the mortality rate##7##3##(1992-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-1#1)
the mortality##26##2##(1990-12#2)(1992-9#1)(1997-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
the mortar preparation did not correspond to the complex##2##9##(2008-10#2)
the morula-like cell##2##3##(2008-5#2)
the morula-like cells##2##3##(2008-5#2)
the morula-like##4##2##(2008-5#4)
the mosquito Aedes##2##3##(2008-5#1)(2011-2#1)
the mosquito##7##2##(2008-5#1)(2010-1#1)(2011-2#3)(2011-3#2)
the moss##4##2##(2008-10#2)(2008-8#2)
the most abundant and##3##4##(1992-9#1)(2010-11#1)(2013-1#1)
the most abundant protein in##2##5##(2011-2#1)(2013-8#1)
the most abundant##28##3##(1992-9#1)(1993-3#1)(1993-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the most abundantly##2##3##(2008-10#1)(2009-10#1)
the most accepted##2##3##(2008-9#1)(2012-2#1)
the most accurate##6##3##(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2013-8#1)
the most active##10##3##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(2008-11#1)(2008-7#3)(2013-1#1)(2013-8#1)
the most advanced##3##3##(1992-5#1)(2008-8#2)
the most affected##3##3##(1992-5#1)(2010-12#1)(2013-1#1)
the most aggressive##5##3##(2008-1#1)(2008-10#2)(2008-11#1)(2011-3#1)
the most appropriate diagnostic##2##4##(1990-9#1)(2012-12#1)
the most appropriate##25##3##(1990-5#1)(1990-9#1)(1993-6#1)(2008-10#11)(2010-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-9#1)(2013-1#1)
the most attractive##2##3##(1992-3#1)(2008-8#1)
the most basal##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
the most challenging##2##3##(1991-12#1)(2011-2#1)
the most characteristic##2##3##(1997-8#1)(2008-10#1)
the most common and##8##4##(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2013-1#2)
the most common benign##2##4##(2007-8#1)(2008-10#1)
the most common cancer##2##4##(2007-8#1)(2010-12#1)
the most common causative##2##4##(2006-6#1)(2012-12#1)
the most common cause of##11##5##(1993-9#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
the most common causes of##4##5##(1990-6#1)(1997-8#1)(2008-7#1)(2011-2#1)
the most common chronic##3##4##(1991-2#1)(2008-9#1)(2011-1#1)
the most common clinical##2##4##(2008-10#1)(2011-2#1)
the most common diagnoses##2##4##(1994-6#1)(2012-3#1)
the most common disease##2##4##(2010-12#1)(2011-2#1)
the most common form of##3##5##(2008-11#1)(2012-2#1)(2013-1#1)
the most common mechanism##3##4##(2010-1#1)(2010-12#1)(2011-2#1)
the most common mesenchymal##2##4##(2012-12#1)(2012-3#1)
the most common organism##2##4##(2008-5#1)(2010-6#1)
the most common primary##3##4##(2011-1#1)(2013-1#1)(2013-8#1)
the most common reasons for##2##5##(2010-8#1)(2011-2#1)
the most common sources of##2##5##(2008-11#1)(2008-12#1)
the most common species##2##4##(2008-10#1)(2010-8#1)
the most common type of##5##5##(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#2)
the most common##173##3##(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-9#1)(1994-5#1)(1994-6#1)(1997-3#1)(1997-7#1)(1997-8#3)(2006-6#1)(2007-8#2)(2008-1#3)(2008-10#20)(2008-11#10)(2008-12#6)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#15)(2009-1#1)(2009-12#3)(2009-2#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#19)(2011-3#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#3)
the most commonly used procedures##2##5##(2008-9#2)
the most commonly used##13##4##(1994-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#5)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the most commonly##23##3##(1994-12#1)(1994-9#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#5)(2009-11#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
the most complex##4##3##(1995-3#1)(2008-10#2)(2008-9#1)
the most conservative##3##3##(1992-5#1)(2008-10#1)(2013-1#1)
the most conserved##2##3##(2008-10#1)(2008-9#1)
the most consistent##2##3##(2008-10#1)(2012-2#1)
the most conspicuous##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
the most cost-effective way to##2##5##(2008-11#1)(2011-2#1)
the most cost-effective##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
the most critical part of the##2##6##(2008-10#1)(2013-8#1)
the most critical##9##3##(1991-3#1)(2008-10#3)(2008-3#1)(2008-9#1)(2012-3#2)(2013-8#1)
the most crucial##2##3##(1996-2#1)(2010-8#1)
the most damaging##2##3##(2008-10#2)
the most dangerous##2##3##(2007-11#1)(2011-2#1)
the most destructive##9##3##(2008-10#8)(2013-8#1)
the most devastating##5##3##(1997-7#1)(2008-10#3)(2012-3#1)
the most difficult to##2##4##(2008-8#1)(2011-2#1)
the most difficult##3##3##(2008-8#1)(2011-2#2)
the most direct##3##3##(1997-2#1)(2008-10#1)(2009-6#1)
the most diverse##2##3##(2008-10#2)
the most dreaded complications of##2##5##(2008-11#1)(2008-5#1)
the most economical##2##3##(1996-1#1)(2009-10#1)
the most effective agent##2##4##(1990-5#1)(1991-3#1)
the most effective and##4##4##(2008-10#2)(2008-11#1)(2012-2#1)
the most effective drugs for##2##5##(2008-7#2)
the most effective means##3##4##(2008-10#3)
the most effective use of##2##5##(2008-10#2)
the most effective##55##3##(1990-5#1)(1991-3#1)(1993-8#1)(1994-3#1)(1996-2#1)(1997-1#2)(1997-2#1)(2008-10#30)(2008-11#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2012-2#1)(2012-4#1)(2013-1#3)
the most efficient management##2##4##(1992-2#1)(2008-12#1)
the most efficient method##2##4##(2008-10#2)
the most efficient##11##3##(1992-2#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
the most enduring benefit of a common conceptual definition and measurement for CS is the bridge it provides between research and practice##2##22##(2013-1#2)
the most enduring##3##3##(2012-3#1)(2013-1#2)
the most exciting##3##3##(2008-9#1)(2009-6#1)(2010-7#1)
the most expensive##2##3##(1992-12#1)(1993-3#1)
the most extreme##2##3##(2008-8#2)
the most favorable conditions##2##4##(2008-10#2)
the most favorable##3##3##(2008-10#3)
the most frequent cause of##2##5##(2010-12#1)(2012-3#1)
the most frequent causes of##2##5##(1992-5#1)(2011-2#1)
the most frequent##32##3##(1990-3#1)(1990-9#1)(1991-8#2)(1992-5#1)(1993-2#1)(1995-11#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#7)
the most frequently detected##4##4##(2008-10#4)
the most frequently isolated##2##4##(2008-10#2)
the most frequently observed##2##4##(1997-4#1)(2010-1#1)
the most frequently prescribed##2##4##(2008-11#2)
the most frequently used##3##4##(2008-11#2)(2011-2#1)
the most frequently##17##3##(1995-2#1)(1997-4#1)(2008-10#6)(2008-11#4)(2009-3#1)(2010-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
the most general##3##3##(2007-12#1)(2010-12#1)(2012-3#1)
the most heat##2##3##(2008-10#1)(2011-2#1)
the most highly##2##3##(1993-12#1)(2008-10#1)
the most important advances in##2##5##(2010-7#1)(2013-1#1)
the most important and##5##4##(2008-12#1)(2008-4#1)(2010-10#2)(2010-7#1)
the most important aspects of##2##5##(2011-7#1)(2013-1#1)
the most important causes of##3##5##(1994-9#1)(2008-11#1)(2011-2#1)
the most important determinants##2##4##(1990-12#1)(1994-6#1)
the most important effects##2##4##(1990-12#1)(2008-10#1)
the most important factor##2##4##(1993-11#1)(2010-3#1)
the most important factors##5##4##(1994-1#2)(2008-7#1)(2013-1#1)(2013-8#1)
the most important issues##2##4##(2008-9#1)(2011-2#1)
the most important original##2##4##(2008-10#1)(2010-7#1)
the most important parameter##2##4##(2008-10#1)(2008-8#1)
the most important parameters##2##4##(2008-10#2)
the most important recent##2##4##(2008-10#1)(2008-2#1)
the most important risk##2##4##(2008-8#1)(2013-7#1)
the most important role in##2##5##(2008-10#1)(2008-12#1)
the most important variables##2##4##(2008-10#2)
the most important weather variable##2##5##(2008-10#2)
the most important##123##3##(1990-12#2)(1991-3#3)(1993-11#1)(1993-6#1)(1994-1#3)(1994-12#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#39)(2008-11#6)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-3#1)(2010-7#3)(2010-9#1)(2011-10#1)(2011-2#5)(2011-3#2)(2011-4#1)(2011-7#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
the most influential##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
the most informative##2##3##(2008-5#1)(2008-9#1)
the most intense##4##3##(2008-10#2)(2008-8#1)(2012-3#1)
the most interesting##4##3##(1991-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
the most likely cause of##2##5##(2008-1#1)(2008-7#1)
the most likely to##2##4##(1990-2#1)(2009-5#1)
the most likely##14##3##(1990-2#1)(1994-2#1)(1994-5#1)(1996-11#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-7#2)(2009-5#1)
the most meaningful##2##3##(1993-3#1)(2008-10#1)
the most modern##2##3##(1992-9#1)(2008-10#1)
the most northern##2##3##(1993-6#1)(2008-10#1)
the most of##3##3##(1994-12#2)(1996-3#1)
the most often used##2##4##(2008-5#1)(2009-8#1)
the most often##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)
the most painful##2##3##(2008-11#1)(2013-1#1)
the most part##16##3##(1991-1#1)(1991-3#1)(1994-12#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#4)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
the most popular##9##3##(1996-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2009-8#1)
the most populous##2##3##(1994-9#1)(2011-2#1)
the most positive##2##3##(1996-2#1)(1997-5#1)
the most potent inhibitors of##2##5##(1994-11#1)(1994-8#1)
the most potent##21##3##(1991-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-8#2)(1996-2#1)(1997-1#1)(2008-10#2)(2008-8#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)
the most powerful##6##3##(1996-3#1)(2008-10#3)(2008-7#1)(2011-2#1)
the most prevalent##21##3##(1990-5#1)(1992-3#1)(1994-12#1)(1997-7#1)(2008-10#6)(2008-5#4)(2009-5#1)(2009-6#1)(2012-3#1)(2013-1#3)(2013-8#1)
the most primitive##7##3##(1994-11#1)(2007-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)
the most probable precursor of##2##5##(1994-5#1)(2008-5#1)
the most probable##8##3##(1991-12#1)(1994-5#1)(1997-6#1)(2008-11#1)(2008-3#2)(2008-5#1)(2013-1#1)
the most productive##4##3##(1992-8#1)(2008-9#2)(2010-12#1)
the most prominent##7##3##(1993-8#1)(1995-8#1)(1996-11#1)(2008-10#3)(2011-2#1)
the most promising and##2##4##(2008-10#1)(2009-3#1)
the most promising##9##3##(1997-5#1)(2008-10#4)(2008-5#1)(2009-3#1)(2011-2#2)
the most pronounced##4##3##(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
the most proximal##2##3##(1997-7#1)(2008-11#1)
the most rapidly##5##3##(1996-2#1)(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
the most recent developments##2##4##(2008-10#1)(2011-2#1)
the most recent literature##2##4##(1991-2#1)(2010-9#1)
the most recent versions of the##2##6##(1997-8#1)(2011-2#1)
the most recent##26##3##(1991-12#1)(1991-2#1)(1992-1#1)(1993-1#1)(1996-11#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2013-8#1)
the most recently evolved##2##4##(2008-10#2)
the most recently##7##3##(1993-11#1)(1993-2#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)
the most relevant##12##3##(1993-2#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the most reliable##8##3##(1993-12#3)(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
the most resistant##8##3##(2008-10#7)(2012-2#1)
the most responsive##2##3##(1991-6#1)(1997-3#1)
the most robust##2##3##(2008-10#1)(2009-11#1)
the most sensible##2##3##(2008-10#1)(2008-6#1)
the most sensitive and##2##4##(2008-12#1)(2010-6#1)
the most sensitive of##2##4##(2008-10#2)
the most sensitive##25##3##(1992-9#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2012-2#1)
the most serious##13##3##(1991-11#1)(1991-3#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-2#1)
the most severe##8##3##(1995-2#1)(2008-10#4)(2008-12#1)(2012-3#1)(2013-8#1)
the most severely affected##2##4##(2008-8#1)(2011-2#1)
the most severely##4##3##(1996-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
the most significant factor##4##4##(1994-3#1)(2008-10#2)(2008-8#1)
the most significant##20##3##(1994-3#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
the most stable##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
the most striking##2##3##(1996-11#1)(2008-5#1)
the most studied##2##3##(2008-9#1)(2010-7#1)
the most successful##4##3##(1995-5#1)(1996-12#1)(2008-10#2)
the most suitable approach for##2##5##(2008-10#2)
the most suitable for the##2##5##(2008-8#1)(2009-8#1)
the most suitable for##4##4##(2008-10#2)(2008-8#1)(2009-8#1)
the most suitable##20##3##(1993-3#1)(2008-10#13)(2008-12#2)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
the most superficial layers of the##2##6##(2008-5#2)
the most superficial layers##3##4##(2008-5#3)
the most susceptible##7##3##(1994-8#1)(2008-10#6)
the most to##2##3##(2008-10#1)(2008-8#1)
the most toxic##3##3##(2008-10#3)
the most used##4##3##(2008-10#2)(2009-1#1)(2012-2#1)
the most useful##6##3##(1991-6#1)(1992-1#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-2#1)
the most valuable##2##3##(1992-2#1)(2008-9#1)
the most variable##2##3##(2008-10#2)
the most virulent##2##3##(2008-10#2)
the most widely used##15##4##(1991-3#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
the most widely##22##3##(1991-3#1)(1996-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
the most widespread##6##3##(1991-3#1)(1994-3#1)(2008-10#2)(2011-2#1)(2012-2#1)
the most##1176##2##(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#11)(1991-6#7)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#6)(1992-3#3)(1992-5#5)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#4)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#6)(1993-6#4)(1993-8#4)(1993-9#1)(1994-1#7)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#9)(1994-5#3)(1994-6#3)(1994-8#6)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#4)(1996-11#4)(1996-12#2)(1996-2#11)(1996-3#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#5)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#6)(2006-6#1)(2007-11#2)(2007-12#5)(2007-8#3)(2008-1#7)(2008-10#335)(2008-11#55)(2008-12#26)(2008-2#3)(2008-3#7)(2008-4#14)(2008-5#33)(2008-6#7)(2008-7#28)(2008-8#33)(2008-9#47)(2009-1#2)(2009-10#5)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#7)(2009-7#2)(2009-8#11)(2010-1#7)(2010-10#5)(2010-11#4)(2010-12#13)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#6)(2010-7#11)(2010-8#9)(2010-9#3)(2011-1#7)(2011-10#2)(2011-2#71)(2011-3#8)(2011-4#1)(2011-7#1)(2012-12#8)(2012-2#27)(2012-3#25)(2012-4#1)(2012-9#1)(2013-1#54)(2013-7#3)(2013-8#18)
the motA gene##2##3##(1995-2#2)
the mother and##4##3##(1997-8#1)(2008-10#1)(2010-10#1)(2012-3#1)
the mother##26##2##(1990-6#1)(1991-11#1)(1991-9#2)(1995-6#1)(1997-8#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
the mother's##2##2##(2008-11#1)(2008-8#1)
the mother-infant##2##2##(1990-12#1)(2009-11#1)
the mothers##12##2##(1990-6#1)(1991-1#1)(1991-11#1)(1993-12#1)(2008-10#1)(2009-10#1)(2011-1#4)(2011-2#1)(2012-2#1)
the motility and##2##3##(1995-8#1)(2013-8#1)
the motility##5##2##(1995-8#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
the motion of the##2##4##(2008-3#1)(2009-11#1)
the motion of##5##3##(2008-3#3)(2009-11#2)
the motion##8##2##(2008-11#1)(2008-3#4)(2008-9#1)(2009-11#2)
the motions of##2##3##(2008-11#1)(2013-1#1)
the motivation##2##2##(1995-2#1)(1997-3#1)
the motivational##7##2##(1995-2#1)(1996-5#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-10#1)(2013-8#1)
the motor cortex##4##3##(2008-7#2)(2010-7#2)
the motor nucleus##2##3##(1994-2#1)(1997-2#1)
the motor seizure stage##2##4##(1994-2#2)
the motor##25##2##(1990-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#3)(1997-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#7)(2008-9#1)(2010-1#1)(2010-7#4)(2013-1#1)
the mould##2##2##(2008-5#2)
the mountain##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
the mouse MHC##2##3##(1997-9#1)(2008-4#1)
the mouse and human##3##4##(1991-6#1)(1993-3#1)(1993-6#1)
the mouse eye lens##2##4##(1993-2#2)
the mouse model##2##3##(2008-10#1)(2012-12#1)
the mouse##75##2##(1990-12#1)(1990-8#1)(1991-6#3)(1992-3#3)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-6#5)(1994-11#1)(1994-12#2)(1994-5#2)(1994-8#1)(1995-12#2)(1995-2#3)(1995-6#4)(1995-8#1)(1996-12#3)(1996-2#1)(1997-2#3)(1997-8#1)(1997-9#2)(2008-10#6)(2008-11#3)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
the mouth corners##2##3##(2008-5#2)
the mouth in##4##3##(2008-11#2)(2008-5#1)(2013-1#1)
the mouth of the##2##4##(2008-11#1)(2010-8#1)
the mouth of##3##3##(2008-11#1)(2010-8#2)
the mouth##26##2##(1990-8#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#5)(2008-5#5)(2010-5#2)(2010-8#2)(2011-2#5)(2012-2#1)(2013-1#2)
the move##3##2##(2008-11#1)(2008-6#1)(2013-8#1)
the movement of the##2##4##(1995-12#1)(2008-10#1)
the movement of##12##3##(1991-5#1)(1995-12#1)(2008-10#4)(2008-11#2)(2008-8#1)(2009-1#1)(2009-5#1)(2011-2#1)
the movement##22##2##(1991-5#1)(1991-6#1)(1995-12#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#4)(2008-8#2)(2009-1#1)(2009-5#1)(2011-2#1)(2013-1#1)
the movements##6##2##(1993-3#1)(1995-3#1)(2008-11#2)(2010-9#1)(2012-3#1)
the moving##4##2##(2008-3#3)(2011-2#1)
the mtDNA##3##2##(1994-11#1)(1997-2#1)(2008-12#1)
the mu opioid receptor##2##4##(2008-11#2)
the mu receptor##3##3##(1992-3#1)(1995-6#2)
the mu##5##2##(1992-3#1)(1995-6#2)(2008-11#2)
the mu-##2##2##(1995-11#2)
the mu-opioid receptor##3##3##(1995-11#1)(1996-2#1)(1997-2#1)
the muIMER##2##2##(2008-10#2)
the muM##2##2##(2008-10#2)
the much greater##3##3##(1997-7#1)(2008-10#2)
the much##9##2##(1994-1#1)(1997-7#1)(2008-10#5)(2009-8#1)(2013-7#1)
the mucociliary##2##2##(1997-1#2)
the mucosa##11##2##(1990-11#1)(1990-5#1)(1990-9#2)(1997-1#1)(1997-2#1)(2008-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
the mucosal IgA response##2##4##(2008-11#2)
the mucosal layer##2##3##(2008-12#1)(2009-8#1)
the mucosal##8##2##(1990-5#1)(1996-3#1)(2008-11#4)(2008-12#1)(2009-8#1)
the mucous barrier##2##3##(1997-1#2)
the mucous layer##2##3##(1997-1#1)(1997-2#1)
the mucous##4##2##(1997-1#3)(1997-2#1)
the multi-bilinear model##2##3##(2008-10#2)
the multi-element determination in##2##4##(2008-10#2)
the multi-element determination##3##3##(2008-10#3)
the multi-element##4##2##(2008-10#4)
the multi-frequency laser##2##3##(2008-10#2)
the multichannel##2##2##(1997-6#1)(2008-3#1)
the multicommutation approach##3##3##(2008-10#3)
the multicopy plasmid##2##3##(1990-11#1)(1995-5#1)
the multidimensional##4##2##(1995-3#1)(2008-10#2)(2008-12#1)
the multidisciplinary care##2##3##(2008-10#1)(2010-11#1)
the multidisciplinary##5##2##(2008-10#1)(2008-11#1)(2010-11#1)(2013-1#2)
the multidrug resistance phenotype##2##4##(2008-11#2)
the multidrug resistance##4##3##(2008-11#4)
the multidrug transporter##2##3##(2008-11#1)(2008-7#1)
the multidrug##9##2##(2008-11#7)(2008-7#1)(2012-2#1)
the multifaceted##4##2##(2008-11#2)(2009-10#1)(2013-7#1)
the multifractal##2##2##(2008-8#2)
the multifunctional##3##2##(2008-10#1)(2008-11#2)
the multilayer##4##2##(2008-10#1)(2008-3#2)(2013-1#1)
the multimedia##2##2##(2008-11#1)(2013-8#1)
the multimerization function of NifA central domain##2##7##(2008-9#2)
the multimerization##3##2##(2008-9#3)
the multimode##2##2##(2008-3#2)
the multiphoton##3##2##(1992-11#1)(2008-10#1)(2008-3#1)
the multiple harvest process##2##4##(2008-11#2)
the multiple regression##2##3##(2008-10#2)
the multiple sites of##2##4##(1993-6#1)(2012-2#1)
the multiple##34##2##(1990-5#1)(1993-2#1)(1993-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
the multiple-scattering##2##2##(2008-2#1)(2008-3#1)
the multiple-schedule-disrupter paradigm##2##3##(2010-10#2)
the multiplex real-time PCR##2##4##(2008-10#2)
the multiplex##4##2##(2008-10#3)(2013-1#1)
the multiplicative##2##2##(1996-3#1)(2008-11#1)
the multiplicity of infection##2##4##(1997-3#1)(2008-11#1)
the multiplicity of##5##3##(1990-8#1)(1993-8#1)(1997-3#1)(2008-11#1)(2008-9#1)
the multiresolution histogram##2##3##(2008-6#2)
the multistage process##2##3##(2013-1#2)
the multivariate calibration##2##3##(2008-10#2)
the multivariate##11##2##(2008-10#8)(2008-7#1)(2009-12#1)(2009-4#1)
the multivitamin##2##2##(2009-9#2)
the municipalities##5##2##(1991-6#1)(1992-2#1)(1996-6#1)(2012-12#2)
the municipality##7##2##(1991-6#1)(1991-9#1)(1997-4#1)(2012-12#3)(2012-3#1)
the murine##18##2##(1990-5#1)(1991-6#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-4#1)(2008-9#2)(2012-2#1)(2013-8#1)
the muscarinic##2##2##(1990-9#1)(1996-2#1)
the muscle and##2##3##(1990-5#1)(1997-4#1)
the muscle potential latency in head magnetic stimulation##2##8##(2008-7#2)
the muscle potential latency##3##4##(2008-7#3)
the muscle potential##4##3##(2008-7#4)
the muscle potentials##2##3##(2008-7#2)
the muscle##22##2##(1990-5#1)(1991-2#1)(1991-6#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-7#6)(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-7#1)(2013-1#3)(2013-8#1)
the muscles of the##3##4##(2007-12#1)(2010-9#1)(2013-8#1)
the muscles of##4##3##(2007-12#1)(2010-9#1)(2013-1#1)(2013-8#1)
the muscles##6##2##(2007-12#1)(2008-12#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
the muscular##9##2##(1997-5#1)(2008-8#1)(2008-9#3)(2009-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
the musculature##2##2##(2011-2#2)
the mushroom##2##2##(2008-10#1)(2008-11#1)
the mussel##2##2##(2008-10#1)(2010-8#1)
the mutagenic##3##2##(2008-10#2)(2008-11#1)
the mutant alpha 1-PI cDNA and the##2##7##(1990-8#2)
the mutant and the wild type##2##6##(2008-10#2)
the mutant and the##3##4##(1994-11#1)(2008-10#2)
the mutant and##6##3##(1994-11#1)(2008-10#5)
the mutant characteristics and##2##4##(2008-8#1)(2013-8#1)
the mutant characteristics##3##3##(2008-8#2)(2013-8#1)
the mutant enzyme##7##3##(1990-10#2)(1995-2#2)(1995-6#2)(1997-7#1)
the mutant phenotype##3##3##(1996-3#1)(2008-10#1)(2012-3#1)
the mutant strain##4##3##(2008-10#3)(2011-2#1)
the mutant strains##4##3##(1990-5#2)(2008-10#2)
the mutant##68##2##(1990-10#2)(1990-5#3)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-3#2)(1992-9#1)(1994-11#1)(1994-5#2)(1995-2#3)(1995-6#3)(1996-2#2)(1996-3#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#22)(2008-8#6)(2008-9#2)(2009-10#1)(2011-2#2)(2012-3#1)(2013-8#2)
the mutants##19##2##(1993-8#1)(1995-2#1)(1995-6#3)(1995-9#1)(2008-10#7)(2008-12#1)(2008-9#3)(2011-1#1)(2012-3#1)
the mutated##7##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
the mutation frequency##5##3##(1997-3#5)
the mutation in the##3##4##(1995-6#1)(2008-9#1)(2012-12#1)
the mutation in##7##3##(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#2)(2008-9#1)(2012-12#1)
the mutation of##2##3##(1995-8#1)(1997-7#1)
the mutation##30##2##(1990-12#1)(1990-2#1)(1991-7#1)(1993-8#3)(1993-9#1)(1994-11#2)(1995-6#2)(1995-8#1)(1997-3#6)(1997-7#2)(2008-10#1)(2008-12#4)(2008-8#1)(2008-9#2)(2012-12#1)(2012-2#1)
the mutational effect of##2##4##(2008-7#2)
the mutations of the##2##4##(2008-10#1)(2011-1#1)
the mutations of##4##3##(1993-3#1)(1995-5#1)(2008-10#1)(2011-1#1)
the mutations##16##2##(1991-10#1)(1991-5#1)(1993-2#1)(1993-3#1)(1995-5#1)(1995-6#5)(2008-10#2)(2008-8#1)(2011-1#2)(2012-3#1)
the mutual information##2##3##(2008-7#1)(2010-8#1)
the mutual##11##2##(1990-11#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-7#1)(2008-9#2)(2010-8#1)
the mycelial##5##2##(2008-10#4)(2008-5#1)
the mycelium of##3##3##(2008-10#3)
the mycelium was##2##3##(2008-10#2)
the mycelium##11##2##(2008-10#10)(2008-7#1)
the mycobacterial##4##2##(1995-5#2)(2008-9#1)(2012-2#1)
the mycoherbicide##3##2##(2008-10#3)
the mycoparasite##4##2##(2008-10#4)
the mycorrhizal##2##2##(2008-10#1)(2011-1#1)
the mycorrhizosphere##3##2##(2008-10#3)
the mycotoxin##3##2##(2008-10#3)
the mycotoxins##2##2##(2010-3#1)(2010-7#1)
the myelin oligodendrocyte glycoprotein##2##4##(1996-12#2)
the myelin sheath##2##3##(2008-7#2)
the myelin##4##2##(1996-12#2)(2008-7#2)
the myelination##2##2##(2008-5#1)(2008-7#1)
the myeloid##2##2##(2008-11#2)
the myocardial##4##2##(2008-12#1)(2010-5#1)(2010-6#1)(2013-1#1)
the myocardium##10##2##(1990-9#2)(1992-5#1)(2008-7#3)(2008-8#1)(2010-6#1)(2011-2#2)
the myofibrils##2##2##(2009-7#2)
the myogenic factors##2##3##(1995-6#2)
the myogenic##6##2##(1990-8#1)(1993-12#1)(1993-8#1)(1995-6#2)(2008-11#1)
the myoid##2##2##(2009-10#2)
the myosin##3##2##(1990-5#1)(1992-4#1)(2008-9#1)
the myriad of##2##3##(2008-9#1)(2011-2#1)
the myristoylated##2##2##(1990-10#1)(1990-12#1)
the myristoylation##2##2##(1990-12#2)
the mystery of##2##3##(2010-8#1)(2011-2#1)
the mystery##3##2##(1990-11#1)(2010-8#1)(2011-2#1)
the n-3 PUFA content##2##4##(2013-1#2)
the n-butanol fraction##2##3##(2008-10#2)
the nafion layer##2##3##(2008-10#2)
the nafion##3##2##(2008-10#3)
the nail##5##2##(2008-5#1)(2008-9#1)(2010-5#1)(2010-6#1)(2013-1#1)
the naked##2##2##(2008-10#1)(2008-8#1)
the name of the##3##4##(1990-11#1)(1993-12#1)(1995-3#1)
the name of##6##3##(1990-11#1)(1993-12#1)(1995-3#1)(2008-10#2)(2011-2#1)
the name##30##2##(1990-11#1)(1993-12#1)(1995-3#1)(2008-10#19)(2008-11#2)(2008-6#1)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
the nano-scale##2##2##(2008-10#1)(2010-9#1)
the nanofilter##3##2##(2008-10#3)
the nanogram level of reactants##2##5##(2008-10#2)
the nanogram level##4##3##(2008-10#4)
the nanogram##5##2##(2008-10#4)(2008-4#1)
the nanomolar concentration range##2##4##(1990-12#2)
the nanomolar concentration##3##3##(1990-12#2)(2008-10#1)
the nanomolar range##2##3##(1994-5#1)(2008-10#1)
the nanomolar##5##2##(1990-12#2)(1994-5#1)(2008-10#2)
the nanoparticle##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
the nanoparticles##4##2##(2008-10#2)(2008-7#2)
the nanopore##2##2##(2009-7#2)
the nanosecond time##2##3##(1990-8#2)
the nanosecond##3##2##(1990-8#2)(2008-10#1)
the nanosensor##2##2##(2008-10#2)
the nanostructure##2##2##(2008-10#2)
the nanotube##2##2##(2008-10#2)
the naphthalene ring##2##3##(2008-10#2)
the naphthalene##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
the naphthyl##2##2##(2008-10#1)(2008-11#1)
the narcotic##3##2##(1996-12#1)(2008-10#2)
the narrative of##2##3##(2008-12#1)(2009-10#1)
the narrative##4##2##(2008-12#1)(2009-10#1)(2009-9#1)(2010-3#1)
the nasal airway##3##3##(2008-11#1)(2013-1#2)
the nasal and oral##2##4##(2008-11#2)
the nasal cavity##4##3##(1990-6#1)(1993-8#1)(2008-10#1)(2013-1#1)
the nasal mucosa##2##3##(1993-8#1)(1996-5#1)
the nasal##18##2##(1990-6#1)(1990-9#1)(1993-8#3)(1993-9#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#4)(2009-1#1)(2013-1#4)
the nasolabial fold and chin##3##5##(2008-5#3)
the nasolabial fold##4##3##(2008-5#4)
the nasolabial groove##2##3##(2008-5#2)
the nasolabial##6##2##(2008-5#6)
the nasopharyngeal##4##2##(1995-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
the natal territory##2##3##(2008-8#2)
the nation##7##2##(1991-2#1)(1991-8#1)(1997-3#1)(2008-11#2)(2008-12#1)(2011-2#1)
the nation's health##3##3##(1996-2#1)(1996-3#1)(1997-6#1)
the nation's##8##2##(1992-2#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-11#1)
the national agenda##2##3##(2008-1#1)(2008-11#1)
the national and state##2##4##(1995-1#1)(2008-11#1)
the national and##3##3##(1995-1#1)(2008-10#1)(2008-11#1)
the national average##6##3##(1992-12#1)(2008-10#4)(2008-11#1)
the national##45##2##(1990-3#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1997-1#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-3#1)
the native and##4##3##(1992-8#1)(1993-8#2)(2011-2#1)
the native enzyme##6##3##(1990-5#3)(1993-8#1)(1994-11#1)(2008-10#1)
the native fluorescence emission##2##4##(2008-10#2)
the native fluorescence of##2##4##(2008-10#2)
the native fluorescence##4##3##(2008-10#4)
the native protein##3##3##(1994-11#1)(2008-10#1)(2008-11#1)
the native##58##2##(1990-11#2)(1990-2#1)(1990-5#3)(1991-10#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#5)(1994-11#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#2)(1997-4#1)(1997-8#1)(2008-10#15)(2008-11#2)(2008-8#4)(2008-9#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)
the natural barriers##2##3##(2008-11#1)(2011-3#1)
the natural course##5##3##(1990-6#1)(1992-9#1)(1997-3#1)(2008-7#1)(2010-12#1)
the natural development of##2##4##(1993-11#1)(2008-10#1)
the natural environment##5##3##(2008-10#3)(2008-4#1)(2009-6#1)
the natural evolution of##2##4##(1991-3#1)(1997-8#1)
the natural history of 2DM##2##5##(2010-10#2)
the natural history of the disease##2##6##(1991-6#1)(1993-11#1)
the natural history of the##4##5##(1991-6#1)(1993-11#1)(1996-3#1)(1996-6#1)
the natural history of this##3##5##(1990-12#1)(1991-6#1)(2008-7#1)
the natural history of##13##4##(1990-12#1)(1991-6#2)(1993-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(2008-7#1)(2009-8#1)(2010-10#2)(2011-2#1)(2011-3#1)
the natural history##16##3##(1990-12#1)(1991-6#2)(1993-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(2008-7#2)(2009-8#2)(2010-10#2)(2011-2#1)(2011-3#1)
the natural killer##2##3##(2008-10#1)(2013-1#1)
the natural ligand##2##3##(2008-11#1)(2010-1#1)
the natural suppressiveness##2##3##(2008-10#2)
the natural variability##2##3##(2008-10#1)(2008-11#1)
the natural water samples##2##4##(2008-10#1)(2008-11#1)
the natural##108##2##(1990-11#1)(1990-12#2)(1990-6#1)(1991-3#1)(1991-6#2)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#29)(2008-11#5)(2008-12#3)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
the naturally occurring##4##3##(1991-9#1)(2008-10#2)(2008-5#1)
the naturally##6##2##(1991-9#1)(1992-12#1)(2008-10#3)(2008-5#1)
the nature and content of##2##5##(2008-10#2)
the nature and distribution of##2##5##(1994-3#1)(2010-5#1)
the nature and extent of##3##5##(1997-3#1)(2008-5#1)(2012-2#1)
the nature and the##3##4##(1991-2#1)(2008-5#1)(2010-4#1)
the nature and##24##3##(1991-2#1)(1993-1#1)(1994-1#1)(1994-3#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-5#3)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
the nature of a##3##4##(2008-10#2)(2008-2#1)
the nature of each##2##4##(1994-6#1)(2013-1#1)
the nature of the acid##2##5##(2008-10#2)
the nature of the anion##2##5##(1994-5#1)(2008-10#1)
the nature of the compounds##2##5##(2008-10#1)(2012-12#1)
the nature of the##60##4##(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#29)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
the nature of these##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
the nature of##113##3##(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#42)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
the nature##145##2##(1991-2#2)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#53)(2008-11#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
the near##29##2##(1991-1#1)(1994-12#2)(1995-12#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
the near-field##2##2##(2008-3#2)
the near-infrared spectral##3##3##(2008-3#3)
the near-infrared##10##2##(2008-10#2)(2008-2#1)(2008-3#7)
the nearby##4##2##(2008-10#4)
the nearest##8##2##(1992-12#1)(1997-4#2)(2008-10#4)(2008-6#1)
the nearly##4##2##(1992-6#1)(1996-1#1)(2008-8#1)(2009-7#1)
the nebulizer of##2##3##(2008-10#2)
the nebulizer##13##2##(1994-12#4)(1995-12#1)(1995-3#1)(1996-3#1)(2008-10#6)
the nebulizer-burner system##4##3##(2008-10#4)
the nebulizers##5##2##(1993-2#2)(1995-3#3)
the necessary##28##2##(1993-1#1)(1994-12#2)(1994-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
the necessity for a##4##4##(1993-11#1)(2008-10#2)(2009-8#1)
the necessity for##6##3##(1993-11#1)(1993-2#1)(1995-8#1)(2008-10#2)(2009-8#1)
the necessity of providing##2##4##(1995-1#1)(2008-12#1)
the necessity of##16##3##(1993-12#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#2)(2009-10#1)(2011-2#1)(2013-1#1)
the necessity to##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2010-7#1)
the necessity##26##2##(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
the neck and##2##3##(2010-12#1)(2011-2#1)
the neck region##4##3##(1992-6#2)(2008-12#1)(2010-11#1)
the neck##26##2##(1991-11#1)(1991-8#1)(1992-12#1)(1992-6#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#4)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2013-1#1)
the necropsy##2##2##(1996-12#1)(2008-5#1)
the necrosis##3##2##(1993-2#1)(2008-10#2)
the necrosis-inducing##2##2##(2008-10#2)
the necrotic area##2##3##(2008-10#1)(2011-2#1)
the necrotic areas##2##3##(2008-10#1)(2008-5#1)
the necrotic##13##2##(2008-10#8)(2008-5#1)(2009-1#1)(2011-2#2)(2012-2#1)
the necrotrophic##4##2##(2008-10#4)
the need and##2##3##(1992-1#1)(1993-3#1)
the need arises##2##3##(2008-10#1)(2008-11#1)
the need for a new##2##5##(1996-12#1)(2008-10#1)
the need for a support network for##2##7##(2011-2#2)
the need for a##33##4##(1990-6#1)(1992-1#2)(1993-12#1)(1993-3#1)(1995-1#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#2)
the need for active##2##4##(2008-10#1)(2011-2#1)
the need for additional##3##4##(2008-10#2)(2010-10#1)
the need for allogenic##2##4##(2009-3#2)
the need for an##5##4##(1991-3#1)(1994-3#1)(1994-9#1)(2008-3#1)(2008-9#1)
the need for and##2##4##(1996-1#1)(1997-3#1)
the need for any##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
the need for careful##3##4##(1991-2#1)(1995-1#1)(2009-8#1)
the need for caution##3##4##(1991-2#1)(2008-10#1)(2008-11#1)
the need for continued##2##4##(2008-9#1)(2010-1#1)
the need for further research##2##5##(2008-11#1)(2013-1#1)
the need for further##8##4##(1992-9#1)(1993-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#2)
the need for health care##2##5##(2008-11#1)(2009-5#1)
the need for immediate##3##4##(2008-10#1)(2010-10#2)
the need for increased##3##4##(2010-10#1)(2011-2#1)(2013-1#1)
the need for long-term##2##4##(1992-2#1)(2008-1#1)
the need for management##2##4##(2008-10#2)
the need for more##4##4##(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
the need for nursing##2##4##(1996-3#1)(2008-11#1)
the need for repeated##2##4##(2008-3#1)(2012-2#1)
the need for research##3##4##(1994-1#1)(1996-3#1)(1997-7#1)
the need for separation##2##4##(2008-10#1)(2008-4#1)
the need for surgical##2##4##(2008-9#1)(2011-2#1)
the need for tedious##3##4##(2008-10#3)
the need for the##9##4##(1995-11#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#2)
the need for thorough##2##4##(1991-2#1)(2008-4#1)
the need for##230##3##(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#4)(1991-3#2)(1992-1#2)(1992-2#2)(1992-9#1)(1993-1#2)(1993-12#4)(1993-3#2)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#5)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#2)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#48)(2008-11#23)(2008-12#8)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#8)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#8)(2013-8#2)
the need of a##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
the need of##11##3##(1990-3#1)(1993-2#1)(2008-10#5)(2008-11#2)(2012-3#1)(2013-1#1)
the need to address##2##4##(1991-12#1)(2008-11#1)
the need to be##2##4##(2008-12#1)(2012-3#1)
the need to consider the##2##5##(2008-7#1)(2010-12#1)
the need to consider##4##4##(2008-10#2)(2008-7#1)(2010-12#1)
the need to determine##3##4##(1990-5#1)(2008-10#1)(2010-4#1)
the need to develop##3##4##(1997-2#1)(1997-3#1)(2008-5#1)
the need to provide##2##4##(1995-2#1)(2013-8#1)
the need to put##2##4##(1991-3#1)(2010-5#1)
the need to recognize and##2##5##(2008-11#1)(2010-9#1)
the need to recognize##3##4##(2008-11#1)(2008-7#1)(2010-9#1)
the need to strengthen##2##4##(2008-11#1)(2012-12#1)
the need to take##2##4##(2008-12#1)(2009-4#1)
the need to understand##2##4##(2008-11#1)(2008-8#1)
the need to##76##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-6#1)(1992-1#2)(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#13)(2008-11#10)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
the need##328##2##(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#5)(1991-6#1)(1992-1#5)(1992-2#2)(1992-9#2)(1993-1#2)(1993-12#4)(1993-2#3)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#8)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#68)(2008-11#38)(2008-12#10)(2008-3#4)(2008-4#4)(2008-5#4)(2008-7#8)(2008-8#2)(2008-9#9)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#6)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#18)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#8)(2013-1#12)(2013-8#4)
the needle tip##2##3##(2008-10#2)
the needle##13##2##(1991-12#1)(1992-12#2)(1996-6#1)(2008-10#7)(2011-2#1)(2012-2#1)
the needs and interests of##2##5##(1997-1#1)(1997-3#1)
the needs and##5##3##(1997-1#1)(1997-3#1)(2008-7#1)(2010-10#1)(2012-12#1)
the needs for##2##3##(1991-6#1)(1993-3#1)
the needs of a##3##4##(1991-3#1)(2008-10#1)(2008-11#1)
the needs of children##3##4##(1992-3#1)(1994-1#1)(2008-11#1)
the needs of parents of##2##5##(1992-2#1)(1994-3#1)
the needs of the##13##4##(1993-1#2)(1994-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2010-7#1)(2013-1#2)
the needs of##49##3##(1991-1#1)(1991-3#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#3)(1995-1#3)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-2#1)(2013-1#3)
the needs##57##2##(1991-1#1)(1991-3#2)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#3)(1995-1#3)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-3#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#3)
the negative attitudes##2##3##(2008-11#2)
the negative binomial distribution##4##4##(2008-10#4)
the negative charge of##2##4##(1990-5#1)(2008-11#1)
the negative consequences##2##3##(2008-11#1)(2008-6#1)
the negative control##3##3##(1990-6#1)(1997-1#1)(2008-10#1)
the negative effect of##2##4##(2008-7#1)(2008-9#1)
the negative effects of socioeconomic change##2##6##(2008-12#2)
the negative effects of##3##4##(2008-12#2)(2010-7#1)
the negative feedback##2##3##(2008-11#1)(2012-2#1)
the negative impact of##3##4##(1997-1#1)(2008-9#1)(2010-7#1)
the negative phototropism##2##3##(2008-9#2)
the negative regulatory##2##3##(2008-11#2)
the negative selection of##2##4##(2008-8#2)
the negative slope##2##3##(1995-3#2)
the negative stereotype group##2##4##(2008-11#2)
the negative##68##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-6#1)(1994-3#1)(1995-3#2)(1995-9#1)(1997-1#2)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#13)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#7)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
the negatively charged##5##3##(2008-10#4)(2011-1#1)
the negatively##6##2##(2008-10#4)(2008-11#1)(2011-1#1)
the negatives##2##2##(1995-3#1)(2009-12#1)
the negligible##2##2##(1991-3#1)(1995-11#1)
the neighbor-joining method##2##3##(2008-10#2)
the neighbor-joining##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
the neighborhood##2##2##(1990-2#1)(1996-3#1)
the neighboring##2##2##(1996-5#1)(2008-5#1)
the nematode (10 per gram of soil)##2##7##(2008-10#2)
the nematode Caenorhabditis elegans##6##4##(1990-5#1)(1995-3#1)(1996-6#2)(1997-7#1)(2008-10#1)
the nematode##30##2##(1990-5#1)(1993-12#1)(1995-3#1)(1995-6#1)(1996-6#2)(1997-7#1)(2008-10#23)
the nematodes##9##2##(2008-10#7)(2008-12#1)(2008-8#1)
the neo##3##2##(1997-8#1)(2008-11#1)(2008-8#1)
the neocortex is##2##3##(1994-3#1)(2008-11#1)
the neocortex##9##2##(1994-3#1)(1997-2#1)(2008-11#4)(2009-5#1)(2010-7#2)
the neomycin-resistance##2##2##(1994-5#1)(1997-8#1)
the neonatal intensive care unit##4##5##(1993-3#1)(1997-3#1)(2008-5#1)(2010-10#1)
the neonatal intensive care##6##4##(1990-6#1)(1993-3#1)(1997-3#1)(2008-5#1)(2010-10#1)(2010-8#1)
the neonatal period##5##3##(1992-8#1)(1996-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
the neonatal##20##2##(1990-6#1)(1992-8#2)(1993-3#1)(1994-8#1)(1996-3#1)(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the neonate##5##2##(1991-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
the neonates##4##2##(1996-9#1)(2011-1#2)(2012-2#1)
the neoplasm was##2##3##(1992-9#1)(2008-7#1)
the neoplasm##7##2##(1990-3#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-6#1)(1997-8#1)(2008-7#1)
the neoplastic cells##5##3##(1992-2#2)(1997-1#1)(2009-1#1)(2009-8#1)
the neoplastic##9##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-2#2)(1997-1#1)(2009-1#1)(2009-8#1)(2013-1#1)
the neostriatum##3##2##(1993-3#2)(1994-8#1)
the neotropical##2##2##(2008-5#1)(2008-7#1)
the nerve fiber##2##3##(1991-10#1)(2010-1#1)
the nerve##18##2##(1990-5#1)(1991-10#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#4)(2010-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
the nerves##2##2##(1993-2#1)(2008-5#1)
the nervous system are##2##4##(2008-5#1)(2010-12#1)
the nervous system that##2##4##(2008-9#1)(2012-2#1)
the nervous system##30##3##(1992-9#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
the nervous##33##2##(1992-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
the nest of##2##3##(2008-8#2)
the nest##6##2##(1992-6#1)(2008-8#5)
the nested##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
the net effect of this##2##5##(2008-10#1)(2008-8#1)
the net effect of##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
the net##27##2##(1991-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-8#3)(2008-9#2)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
the network to##2##3##(2008-9#1)(2012-3#1)
the network was##2##3##(2008-10#2)
the network##25##2##(1994-3#1)(1996-3#1)(2008-10#4)(2008-11#10)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)
the networks of##2##3##(2008-9#1)(2012-2#1)
the networks##8##2##(2008-10#2)(2008-11#2)(2008-9#1)(2010-10#1)(2010-4#1)(2012-2#1)
the neural activity##2##3##(2008-11#2)
the neural basis of##2##4##(2008-11#2)
the neural circuitry underlying##2##4##(2008-11#2)
the neural circuitry##4##3##(2008-11#3)(2013-8#1)
the neural code##2##3##(2013-8#2)
the neural coding##2##3##(2008-11#1)(2008-8#1)
the neural correlates of##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
the neural mechanism##2##3##(2008-6#1)(2008-9#1)
the neural mechanisms underlying##2##4##(2008-11#1)(2008-7#1)
the neural mechanisms##4##3##(1995-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
the neural network##9##3##(1997-7#1)(2008-10#7)(2009-5#1)
the neural responses##2##3##(2008-11#2)
the neural substrates of##2##4##(2008-11#1)(2009-9#1)
the neural##61##2##(1990-11#1)(1991-2#1)(1992-6#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#25)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#4)
the neurite outgrowth##4##3##(1995-6#1)(2008-11#3)
the neuro-muscular##2##2##(2008-9#2)
the neurobiology##2##2##(2008-11#1)(2008-4#1)
the neurochemical##3##2##(1995-11#1)(2008-7#1)(2013-1#1)
the neurodynamics##2##2##(2008-11#2)
the neuroendocrine##4##2##(1997-2#1)(2008-2#1)(2008-4#1)(2012-3#1)
the neurologic##3##2##(2008-7#2)(2012-3#1)
the neurological deficit##4##3##(1997-5#1)(2011-2#3)
the neurological symptoms were##2##4##(2008-7#2)
the neurological symptoms##3##3##(1991-6#1)(2008-7#2)
the neurological##15##2##(1991-11#1)(1991-6#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-9#1)(2008-12#1)(2008-7#3)(2011-2#3)
the neuromuscular disorders##2##3##(2010-8#1)(2013-1#1)
the neuromuscular##5##2##(1995-12#1)(2008-12#1)(2009-8#1)(2010-8#1)(2013-1#1)
the neuron##3##2##(1992-12#1)(2008-5#1)(2008-7#1)
the neuronal cell##4##3##(1991-12#1)(1993-8#2)(2009-12#1)
the neuronal marker##2##3##(1994-2#1)(2009-10#1)
the neuronal##23##2##(1990-5#1)(1991-12#3)(1993-8#2)(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-5#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#1)
the neurones##2##2##(1996-5#1)(1997-3#1)
the neurons in##2##3##(2008-11#2)
the neurons of##2##3##(2008-7#1)(2009-12#1)
the neurons##10##2##(1994-2#1)(2008-11#4)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)
the neuropeptide##2##2##(1997-4#1)(2013-7#1)
the neurophysiological##3##2##(1995-8#1)(2008-9#1)(2010-1#1)
the neuroprotective effect of deprenyl##2##5##(2009-12#2)
the neuroprotective effect of##3##4##(2009-12#2)(2012-2#1)
the neurosciences##2##2##(1992-12#1)(2009-5#1)
the neurosurgical##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
the neurotoxic##2##2##(1990-7#1)(1994-2#1)
the neurotoxin 1-methyl-4-phenylpyridinium (MPP+)##2##4##(1990-5#1)(1996-12#1)
the neurotoxin##11##2##(1990-5#2)(1992-3#2)(1994-11#4)(1996-12#1)(2008-5#1)(2008-7#1)
the neurotransmitter##4##2##(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
the neutral and##2##3##(2008-10#1)(2013-1#1)
the neutral form##2##3##(2008-10#2)
the neutral marker##2##3##(2008-10#1)(2012-3#1)
the neutral##24##2##(1995-2#2)(2008-10#14)(2008-4#2)(2008-8#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the neutralization##2##2##(1995-5#1)(2008-10#1)
the neutrophil##5##2##(1992-8#1)(1993-6#1)(1993-8#1)(1994-5#1)(2008-10#1)
the new AFFFF-MALS##2##3##(2011-2#2)
the new approach and##2##4##(2008-10#2)
the new approach##5##3##(2008-10#4)(2008-11#1)
the new biology##2##3##(1995-10#1)(2008-11#1)
the new cell##2##3##(2008-11#2)
the new challenges##2##3##(1991-1#1)(1994-1#1)
the new classification##2##3##(1991-9#1)(1997-8#1)
the new convexity measure##3##4##(2008-6#3)
the new dynamic##2##3##(2008-11#1)(2008-6#1)
the new environment##3##3##(1995-5#1)(2008-6#1)(2012-2#1)
the new extractor##2##3##(2008-10#2)
the new generation of##2##4##(2008-11#1)(2008-3#1)
the new genotypes##2##3##(2008-10#2)
the new guidelines##2##3##(2008-11#1)(2008-3#1)
the new host##5##3##(2008-8#4)(2012-2#1)
the new law##2##3##(1996-5#2)
the new method for##2##4##(2008-10#1)(2008-3#1)
the new method is##2##4##(2008-10#2)
the new method##12##3##(2008-10#10)(2008-2#1)(2008-3#1)
the new millennium##2##3##(2008-11#1)(2008-4#1)
the new model##2##3##(1995-12#1)(2011-2#1)
the new one##2##3##(1996-6#2)
the new public health##2##4##(1992-1#2)
the new stationary phase##2##4##(2008-10#2)
the new system##2##3##(2008-9#1)(2010-8#1)
the new technique##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
the new technology##2##3##(2008-10#1)(2013-8#1)
the new version of##2##4##(1997-2#1)(2008-10#1)
the new##228##2##(1990-11#1)(1990-2#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#3)(1996-8#2)(1997-2#2)(1997-8#1)(2007-11#1)(2008-10#72)(2008-11#23)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#3)(2008-8#9)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#7)(2012-2#5)(2013-1#1)(2013-8#1)
the newborn screening##2##3##(2010-8#2)
the newborn##16##2##(1990-11#1)(1990-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-8#1)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
the newer##7##2##(1993-3#1)(1996-12#1)(2010-6#2)(2012-2#1)(2013-1#1)(2013-7#1)
the newest##4##2##(1991-9#1)(2008-11#1)(2010-5#1)(2011-2#1)
the newly described##7##3##(1993-6#1)(1996-2#1)(2007-12#1)(2008-10#3)(2011-1#1)
the newly designed##2##3##(2008-10#1)(2011-2#1)
the newly developed##6##3##(2008-10#5)(2010-11#1)
the newly diagnosed##3##3##(2011-2#1)(2013-1#2)
the newly established##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
the newly formed##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
the newly proposed##2##3##(2008-10#2)
the newly##39##2##(1993-6#1)(1994-12#1)(1996-2#2)(1996-6#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
the newspapers##2##2##(1992-9#2)
the next 10 years##2##4##(1990-2#1)(1997-3#1)
the next 15##2##3##(1991-12#1)(2013-8#1)
the next 3##4##3##(1991-2#1)(1996-2#1)(2008-10#2)
the next 5##2##3##(2011-2#1)(2012-12#1)
the next century##5##3##(1995-12#1)(2008-4#3)(2008-9#1)
the next day##3##3##(2007-12#1)(2007-8#1)(2013-8#1)
the next decade##8##3##(1991-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-9#3)
the next few decades##2##4##(1996-3#1)(2008-10#1)
the next few years##3##4##(1994-12#1)(2008-12#1)(2010-5#1)
the next few##5##3##(1994-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2010-5#1)
the next fifty years##3##4##(2012-3#3)
the next generation of##10##4##(1991-6#1)(1992-3#1)(2008-1#1)(2008-11#3)(2008-3#1)(2012-2#2)(2013-1#1)
the next generation##17##3##(1991-6#1)(1992-3#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-8#1)(2012-2#3)(2013-1#1)
the next millennium##3##3##(2008-4#3)
the next round of##2##4##(1996-3#1)(2008-11#1)
the next step##5##3##(1995-9#1)(2008-10#2)(2008-4#1)(2008-7#1)
the next ten years##2##4##(1993-12#1)(1993-2#1)
the next two##3##3##(1991-5#1)(1995-12#1)(2009-3#1)
the next##109##2##(1990-2#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#11)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#3)(2010-5#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#2)
the next-generation##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
the nexus between##2##3##(1991-12#1)(2010-10#1)
the ng##2##2##(2008-10#2)
the nickel complex##2##3##(2008-10#2)
the nickel##8##2##(2008-10#8)
the nickel(II)##2##2##(2008-10#2)
the nicotinic##2##2##(1995-11#2)
the nidus and##3##3##(2008-7#3)
the nidus size##2##3##(2008-7#2)
the nidus##18##2##(1991-2#1)(1996-3#1)(1997-3#1)(2008-3#1)(2008-7#13)(2012-3#1)
the night##7##2##(1991-5#2)(1997-4#1)(2008-1#1)(2008-10#2)(2010-8#1)
the nigra##5##2##(1990-5#5)
the nigrostriatal system##4##3##(1994-8#1)(1995-11#1)(2012-2#2)
the nigrostriatal##6##2##(1994-8#1)(1995-11#1)(1996-12#2)(2012-2#2)
the nine##16##2##(1992-2#2)(1996-12#1)(1996-3#1)(2008-10#8)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
the nine-amino-acid hemagglutinin peptide sequence##2##5##(1992-9#2)
the nine-amino-acid##3##2##(1992-9#3)
the nineteenth century##7##3##(1991-12#2)(2010-1#2)(2011-2#3)
the ninth##2##2##(1997-7#1)(2011-2#1)
the nipple##4##2##(1994-12#2)(1997-5#1)(2011-2#1)
the nit mutant##2##3##(2008-10#2)
the nitrate##7##2##(1993-6#1)(2008-10#5)(2010-4#1)
the nitric oxide production##2##4##(2008-11#2)
the nitric oxide##3##3##(2008-11#3)
the nitric##4##2##(2008-10#1)(2008-11#3)
the nitrite concentration##2##3##(2008-10#2)
the nitrite##5##2##(2008-10#5)
the nitro##2##2##(2008-10#2)
the nitrogen##9##2##(1992-3#1)(1993-6#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-9#3)
the nitrogen-fixing soil bacterium Azotobacter chroococcum Az12##2##7##(2008-11#2)
the nitroso##2##2##(1996-5#1)(2008-10#1)
the nitrous oxide-acetylene flame##2##4##(2008-10#2)
the nm23 antibody##2##3##(1993-8#2)
the no##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)
the no-visor group##2##3##(2010-1#2)
the nociceptive##3##2##(1997-2#1)(2008-8#1)(2009-12#1)
the nocturnal##3##2##(2008-5#1)(2013-7#2)
the nodD3##2##2##(2008-9#2)
the nodal##2##2##(2008-7#1)(2010-4#1)
the noise level is##2##4##(2008-10#1)(2008-3#1)
the noise level##4##3##(1996-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
the noise##11##2##(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-8#1)
the noise-equivalent##2##2##(2008-2#1)(2008-3#1)
the nomenclature##3##2##(2008-10#1)(2008-4#2)
the nominal##3##2##(1993-3#1)(2009-12#1)(2011-2#1)
the non irradiated##2##3##(2008-10#2)
the non##6##2##(2007-8#1)(2008-10#4)(2008-7#1)
the non-Bayesian analysis##2##3##(2008-10#2)
the non-additive effects##2##3##(2008-10#2)
the non-additive##3##2##(2008-10#3)
the non-coding##3##2##(1990-7#1)(2007-12#1)(2008-8#1)
the non-collagenous domain of type VII collagen##2##7##(1992-3#2)
the non-covalent##2##2##(1996-8#1)(2008-9#1)
the non-demented##2##2##(2008-7#2)
the non-displaced##2##2##(2013-1#2)
the non-entrapped chlorothiazide##2##3##(2008-10#2)
the non-functional iron is converted to a##2##7##(1992-8#2)
the non-invasive##3##2##(1990-11#1)(2008-1#1)(2012-2#1)
the non-ionic surfactant##4##3##(2008-10#4)
the non-ionic##6##2##(2008-10#6)
the non-linear Poisson-Boltzmann##2##3##(1997-2#2)
the non-linear##14##2##(1997-2#2)(2008-10#8)(2008-11#1)(2008-9#1)(2010-8#2)
the non-neural cholinergic system##2##4##(2010-8#2)
the non-polar##2##2##(2008-10#2)
the non-specific##3##2##(2008-10#3)
the non-transport group##3##3##(2013-1#3)
the non-treated##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
the nonalternant##2##2##(2008-10#2)
the nonautoclaved and the recolonized##2##5##(2008-10#2)
the nonclinical safety assessment##2##4##(2010-11#2)
the nonclinical##3##2##(1993-3#1)(2010-11#2)
the noncoding regions of##2##4##(2008-11#1)(2008-12#1)
the nondisabled limb##2##3##(2013-1#2)
the nondisabled##3##2##(2013-1#3)
the nonglutinous cultivar##3##3##(2008-10#3)
the nonhost##2##2##(2008-10#2)
the noninoculated control##4##3##(2008-10#4)
the noninoculated##5##2##(2008-10#5)
the nonionic##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
the nonlinear absorption##2##3##(2008-3#2)
the nonlinear susceptibility##2##3##(2007-12#1)(2008-3#1)
the nonlinear##18##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#8)(2009-8#1)(2013-8#1)
the nonobese patients##3##3##(2011-2#3)
the nonobese##5##2##(2011-2#5)
the nonparametric##3##2##(2008-10#2)(2009-10#1)
the nonpathogenic isolates##3##3##(2008-10#3)
the nonpathogenic mutant##2##3##(2008-10#2)
the nonpathogenic##8##2##(2008-10#8)
the nonpolar fraction##2##3##(2013-8#2)
the nonpolar##3##2##(2008-10#1)(2013-8#2)
the nonprofit hospital##3##3##(1991-1#1)(1992-3#1)(1996-2#1)
the nonprofit##4##2##(1991-1#1)(1992-3#1)(1996-2#1)(2008-11#1)
the nonreducing terminal##4##3##(1994-5#4)
the nonreducing##6##2##(1992-12#1)(1994-5#4)(2008-7#1)
the nonspecific##3##2##(1990-5#1)(2008-10#1)(2010-8#1)
the nonstructural##5##2##(1994-11#1)(2008-10#4)
the nontransgenic##2##2##(2008-10#2)
the nontreated##2##2##(2008-10#2)
the nonvector##2##2##(2008-10#2)
the noradrenergic##2##2##(1996-5#1)(2012-12#1)
the norm##6##2##(1992-12#1)(1997-6#1)(2008-10#1)(2008-11#2)(2012-2#1)
the normal allele##3##3##(1994-11#3)
the normal and##6##3##(1995-12#1)(1997-8#1)(2007-11#1)(2008-5#1)(2009-8#1)(2012-2#1)
the normal clinical##2##3##(1992-3#1)(2008-10#1)
the normal controls##6##3##(2008-10#3)(2008-11#1)(2008-7#2)
the normal daily##2##3##(2008-5#1)(2010-10#1)
the normal development of##2##4##(2010-1#1)(2011-1#1)
the normal growth##3##3##(1993-11#1)(1996-3#1)(2008-5#1)
the normal human##2##3##(1997-1#1)(2013-7#1)
the normal organ##2##3##(2008-10#1)(2008-11#1)
the normal plantaris muscle##2##4##(2012-2#2)
the normal population##5##3##(1994-9#1)(1995-5#1)(1996-6#1)(2008-12#1)(2010-10#1)
the normal post-operative##2##3##(2008-2#1)(2012-2#1)
the normal process of##2##4##(2008-5#1)(2012-2#1)
the normal range##7##3##(1992-9#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
the normal rat##6##3##(1996-2#2)(2008-7#2)(2008-9#2)
the normal skin##2##3##(2008-5#1)(2008-9#1)
the normal values##2##3##(2011-2#1)(2013-3#1)
the normal##131##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#2)(1991-7#2)(1992-12#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#5)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#1)(2008-5#6)(2008-7#7)(2008-8#1)(2008-9#10)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#7)(2012-3#6)(2013-1#4)(2013-3#1)(2013-7#1)
the normalized##8##2##(1993-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2013-1#1)
the normally##3##2##(1995-6#1)(2008-11#1)(2013-8#1)
the normals##2##2##(2008-6#2)
the normative##3##2##(2008-1#1)(2008-12#1)(2009-10#1)
the normothermic##4##2##(1994-2#1)(1996-12#2)(2008-7#1)
the north central United States##2##5##(2008-10#2)
the north of##5##3##(2008-10#2)(2008-12#1)(2010-7#1)(2012-2#1)
the north##14##2##(2008-10#7)(2008-12#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
the north-central region of the United States##4##7##(2008-10#4)
the north-central region##5##3##(2008-10#5)
the north-central##8##2##(2008-10#8)
the north-west of##2##3##(1996-11#2)
the north-western zone of the Bogota Savanna##3##7##(2012-12#3)
the north-western zone of the Bogota##4##6##(2012-12#4)
the northeastern United States##3##4##(1996-1#1)(2008-10#2)
the northeastern##6##2##(1996-1#1)(2008-10#2)(2008-11#2)(2009-7#1)
the northern part of##2##4##(1996-11#1)(2011-2#1)
the northern source##2##3##(2008-10#2)
the northern##18##2##(1990-11#1)(1996-11#1)(2008-10#10)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#3)
the northernmost##3##2##(1991-6#1)(2008-10#1)(2009-8#1)
the nose##7##2##(2008-5#5)(2008-7#1)(2013-1#1)
the not-for-profit##2##2##(1992-3#1)(2008-11#1)
the notable##2##2##(1990-3#1)(1991-5#1)
the notion of standard##2##4##(2009-7#2)
the notion of##12##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-3#1)(2009-7#2)(2011-1#2)(2013-8#1)
the notion that the##3##4##(1990-8#1)(1997-3#1)(2012-3#1)
the notion that##13##3##(1990-2#1)(1990-8#1)(1993-3#1)(1997-3#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#4)(2012-2#1)(2012-3#1)
the notion##26##2##(1990-2#1)(1990-8#1)(1993-3#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-5#1)(2009-3#1)(2009-7#2)(2009-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
the notochord and floor plate##3##5##(1994-12#3)
the notochord##5##2##(1993-12#1)(1994-12#3)(2008-6#1)
the novalgin##2##2##(2008-10#2)
the novel##39##2##(1991-3#1)(1992-3#1)(1994-8#2)(1995-5#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-8#4)(2008-9#4)(2010-10#1)(2011-2#3)(2011-3#1)
the novice##3##2##(1991-1#1)(2008-11#1)(2008-7#1)
the nt##3##2##(1991-6#1)(1993-2#1)(1993-6#1)
the nuclear and##2##3##(1994-8#1)(2008-12#1)
the nuclear envelope and##3##4##(2008-9#1)(2011-2#2)
the nuclear envelope##12##3##(1995-2#1)(2007-12#1)(2008-9#1)(2011-2#9)
the nuclear fraction##2##3##(1997-7#1)(2011-2#1)
the nuclear genome##3##3##(1995-6#2)(2009-10#1)
the nuclear lamina##2##3##(2008-8#2)
the nuclear localization##2##3##(1994-11#1)(2009-8#1)
the nuclear membrane##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
the nuclear pore complex and##2##5##(1994-11#2)
the nuclear pore complex##5##4##(1994-11#3)(1995-2#2)
the nuclear pore##7##3##(1994-11#3)(1995-2#2)(2011-2#2)
the nuclear rDNA##2##3##(2008-10#2)
the nuclear ribosomal DNA internal transcribed spacer##2##7##(2008-10#2)
the nuclear ribosomal DNA##5##4##(2008-10#5)
the nuclear ribosomal##10##3##(2008-10#10)
the nuclear translation elongation factor 1alpha##2##6##(2008-10#2)
the nuclear transport##2##3##(1994-11#1)(2011-2#1)
the nuclear##77##2##(1990-12#2)(1991-2#1)(1992-11#1)(1993-8#2)(1994-11#5)(1994-8#1)(1995-2#6)(1995-6#3)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#2)(2010-4#1)(2011-2#17)(2012-3#1)
the nuclei of##5##3##(1992-3#1)(1994-6#2)(2008-7#1)(2009-12#1)
the nuclei##12##2##(1990-3#1)(1992-3#1)(1994-6#2)(1996-2#1)(1997-2#1)(2008-11#2)(2008-7#1)(2008-9#2)(2009-12#1)
the nucleic acid##3##3##(1994-11#1)(2008-10#1)(2008-4#1)
the nucleic acids##3##3##(2008-10#2)(2008-9#1)
the nucleic##6##2##(1994-11#1)(2008-10#3)(2008-4#1)(2008-9#1)
the nucleocapsid (N)##4##3##(2008-10#4)
the nucleocapsid##6##2##(2008-10#5)(2008-5#1)
the nucleolar##4##2##(2008-10#1)(2008-12#1)(2008-8#2)
the nucleolar-organizing regions of##2##4##(2013-1#2)
the nucleolus##3##2##(2008-12#2)(2008-7#1)
the nucleophilic##2##2##(1995-2#1)(2008-10#1)
the nucleoside##3##2##(1994-8#1)(1996-5#1)(2008-11#1)
the nucleotide (nt) sequence of the##2##6##(1993-12#2)
the nucleotide (nt) sequence##3##4##(1993-12#3)
the nucleotide (nt)##5##3##(1993-12#3)(1993-2#1)(1993-6#1)
the nucleotide and amino acid##3##5##(1990-7#1)(1995-8#1)(2008-10#1)
the nucleotide and##5##3##(1990-7#1)(1995-8#1)(2008-10#2)(2013-8#1)
the nucleotide binding##2##3##(2008-10#2)
the nucleotide sequence of the##7##5##(1990-8#1)(1991-5#1)(1994-12#1)(1995-8#1)(1996-8#1)(2008-10#2)
the nucleotide sequence of##12##4##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-8#1)(2008-10#4)
the nucleotide sequence##20##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-8#1)(1997-6#4)(2008-10#6)(2008-5#1)
the nucleotide sequences of##4##4##(1993-12#1)(1997-8#1)(2008-10#2)
the nucleotide sequences##6##3##(1993-12#1)(1996-8#1)(1997-8#1)(2008-10#3)
the nucleotide##46##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-8#2)(1996-8#2)(1997-6#4)(1997-8#1)(2008-10#15)(2008-11#2)(2008-5#2)(2008-9#1)(2013-8#3)
the nucleotides##2##2##(1990-5#1)(2008-11#1)
the nucleus accumbens and##5##4##(1993-6#3)(1994-2#1)(2008-7#1)
the nucleus accumbens##27##3##(1993-6#10)(1994-2#4)(1994-3#1)(1994-8#2)(1995-2#2)(1996-12#2)(1996-5#1)(1997-3#3)(2008-7#2)
the nucleus and cytoplasm##2##4##(1995-8#1)(2008-10#1)
the nucleus and the##2##4##(2008-7#1)(2011-2#1)
the nucleus and##9##3##(1995-8#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-7#2)(2011-2#2)
the nucleus are##2##3##(2008-7#1)(2012-2#1)
the nucleus basalis magnocellularis##2##4##(1993-3#2)
the nucleus in addition to##2##5##(1997-1#2)
the nucleus in the##2##4##(2008-11#1)(2008-9#1)
the nucleus in##6##3##(1997-1#2)(2008-11#1)(2008-9#1)(2011-2#2)
the nucleus is##2##3##(1993-8#1)(2008-7#1)
the nucleus of##5##3##(1991-2#1)(1994-11#1)(1994-6#1)(2008-11#2)
the nucleus or##2##3##(2011-2#2)
the nucleus to##3##3##(1996-2#1)(2008-4#1)(2011-2#1)
the nucleus tractus solitarius##3##4##(1994-2#1)(1997-2#2)
the nucleus##102##2##(1990-12#1)(1990-9#1)(1991-2#1)(1992-10#1)(1993-12#1)(1993-3#2)(1993-6#10)(1993-8#2)(1994-11#2)(1994-2#6)(1994-3#1)(1994-6#2)(1994-8#2)(1995-2#3)(1995-8#1)(1996-12#4)(1996-2#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#3)(2007-12#1)(2008-10#4)(2008-11#7)(2008-4#1)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#1)(2009-8#2)(2010-5#1)(2011-2#14)(2012-2#2)(2012-3#1)(2013-1#1)
the null hypothesis of##3##4##(1995-5#1)(2008-10#2)
the null hypothesis that##2##4##(1995-9#1)(2008-10#1)
the null hypothesis##6##3##(1995-5#1)(1995-9#1)(2008-10#4)
the null model when##2##4##(2008-8#2)
the null model##3##3##(2008-8#3)
the null##9##2##(1995-5#1)(1995-9#1)(2008-10#4)(2008-8#3)
the null-direction##2##2##(2008-8#2)
the number and area##2##4##(1995-8#2)
the number and size of##5##5##(1990-5#1)(1995-8#1)(2008-10#2)(2010-12#1)
the number and the##2##4##(2008-10#2)
the number and##23##3##(1990-5#1)(1993-3#1)(1994-6#2)(1995-5#1)(1995-8#3)(1997-2#1)(2008-10#7)(2008-11#2)(2008-9#1)(2009-6#1)(2010-12#1)(2013-1#2)
the number of ICSS trains##2##5##(1991-2#2)
the number of active##2##4##(2008-10#1)(2008-4#1)
the number of adult##3##4##(1994-3#1)(1996-12#1)(2008-8#1)
the number of amniocenteses##2##4##(2012-3#2)
the number of antibody-producing##2##4##(2008-4#2)
the number of apothecia##3##4##(2008-10#3)
the number of ascospores##2##4##(2008-10#2)
the number of available##2##4##(2009-10#1)(2010-11#1)
the number of bacteria##3##4##(2008-10#3)
the number of binding sites##2##5##(1995-8#1)(2008-10#1)
the number of births##2##4##(1990-6#1)(1995-12#1)
the number of blossoms##2##4##(2008-10#2)
the number of cases##9##4##(1992-9#2)(1994-9#2)(1995-2#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#1)
the number of cells##4##4##(1997-1#1)(2008-11#1)(2008-5#1)(2008-9#1)
the number of channels##3##4##(2008-7#1)(2008-9#2)
the number of components##2##4##(2008-10#1)(2008-4#1)
the number of conidia##6##4##(2008-10#6)
the number of days##4##4##(2008-10#3)(2008-11#1)
the number of deaths##2##4##(1997-7#2)
the number of diseases##3##4##(2006-6#1)(2008-10#1)(2008-7#1)
the number of eggs##2##4##(2008-10#1)(2008-8#1)
the number of embryos##3##4##(1992-3#1)(2008-12#2)
the number of factors##7##4##(2008-10#7)
the number of false##2##4##(1997-2#1)(2008-10#1)
the number of female##2##4##(1993-9#1)(2008-10#1)
the number of fermentation cycles##2##5##(2008-7#2)
the number of foci##2##4##(2008-10#2)
the number of friends and##2##5##(2009-7#2)
the number of genes##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
the number of genotypes observed##2##5##(2008-10#2)
the number of genotypes##3##4##(2008-10#3)
the number of healthy##2##4##(2008-10#1)(2012-2#1)
the number of hours##2##4##(2008-10#2)
the number of immunizations##2##4##(1995-5#2)
the number of individuals##6##4##(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
the number of infected##6##4##(2008-10#6)
the number of intensity petals##2##5##(2007-11#2)
the number of legal abortions##2##5##(1996-11#2)
the number of lesions increased##2##5##(2008-10#2)
the number of lesions per##2##5##(2008-10#2)
the number of lesions##6##4##(2008-10#6)
the number of live##2##4##(1991-3#1)(2008-11#1)
the number of long-term##2##4##(1994-5#1)(2010-11#1)
the number of maxima##3##4##(2008-9#3)
the number of migrants##2##4##(2008-10#1)(2008-8#1)
the number of molecules of##2##5##(1995-8#1)(2008-11#1)
the number of ommatidia per eye##2##6##(2007-12#2)
the number of oospores##2##4##(2008-10#2)
the number of parameters##3##4##(1995-9#1)(2008-10#1)(2008-2#1)
the number of participants##2##4##(2010-11#1)(2010-7#1)
the number of patches##3##4##(2008-8#3)
the number of patients removed from the list##2##8##(1991-11#2)
the number of patients with##2##5##(1993-1#1)(2008-7#1)
the number of patients##9##4##(1991-11#3)(1993-1#1)(1994-12#1)(1994-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
the number of people with dementia##2##6##(2008-6#1)(2013-8#1)
the number of people##5##4##(1992-2#1)(1994-2#1)(1995-12#1)(2008-6#1)(2013-8#1)
the number of plants visited per time##2##7##(2008-10#2)
the number of potential mates##2##5##(2008-8#2)
the number of pregnancies##4##4##(2011-2#4)
the number of previous hospitalizations##2##5##(1991-2#2)
the number of previous##3##4##(1991-2#2)(2008-1#1)
the number of propagules##3##4##(2008-10#3)
the number of race-change mutants##2##5##(2008-10#2)
the number of residents##2##4##(1991-8#1)(1994-12#1)
the number of response categories##3##5##(2010-1#2)(2012-2#1)
the number of sclerotia##5##4##(2008-10#5)
the number of seeds##2##4##(2008-8#2)
the number of sessions correlated positively with the academic performance##2##10##(2013-8#2)
the number of sessions##3##4##(2013-8#3)
the number of sexual##2##4##(2008-9#1)(2013-1#1)
the number of single cells##3##5##(2008-7#3)
the number of single##4##4##(1993-12#1)(2008-7#3)
the number of species in a community##2##7##(2008-8#2)
the number of species in##3##5##(2008-10#1)(2008-8#2)
the number of species of##2##5##(2008-10#2)
the number of species##6##4##(2008-10#3)(2008-8#3)
the number of sporangia##2##4##(2008-10#2)
the number of subjects##3##4##(1995-9#2)(2013-8#1)
the number of survivors of##2##5##(2008-11#2)
the number of symptoms##2##4##(2009-9#2)
the number of tests##3##4##(1996-11#1)(2008-10#2)
the number of the##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
the number of theoretical plates##2##5##(2008-10#2)
the number of these##2##4##(2008-10#1)(2011-2#1)
the number of transfused blood units##2##6##(1991-8#2)
the number of trees to be sampled in the orchard##2##10##(2008-10#2)
the number of trees##3##4##(2008-10#3)
the number of trials##2##4##(1993-3#1)(2008-11#1)
the number of viable##2##4##(1993-3#1)(2008-11#1)
the number of vines infected at a##2##7##(2008-10#2)
the number of women##2##4##(1993-6#1)(2008-11#1)
the number of##546##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#7)(1991-3#4)(1991-8#6)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#6)(1993-3#5)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#8)(1995-2#2)(1995-5#3)(1995-8#3)(1995-9#4)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#4)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#7)(2008-1#4)(2008-10#170)(2008-11#31)(2008-12#11)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#10)(2008-6#6)(2008-7#14)(2008-8#33)(2008-9#25)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#16)(2012-12#3)(2012-2#7)(2012-3#9)(2012-4#1)(2013-1#10)(2013-8#8)
the number one cause of##2##5##(1997-6#1)(2012-2#1)
the number one##3##3##(1997-6#1)(2012-2#1)(2013-7#1)
the number who##2##3##(2008-11#1)(2008-7#1)
the number##591##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#7)(1991-3#4)(1991-8#6)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#7)(1993-3#6)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#8)(1995-2#2)(1995-3#1)(1995-5#4)(1995-8#6)(1995-9#4)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#4)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#7)(2008-1#4)(2008-10#179)(2008-11#37)(2008-12#11)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#10)(2008-6#6)(2008-7#15)(2008-8#33)(2008-9#26)(2009-10#2)(2009-3#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#17)(2012-12#4)(2012-2#8)(2012-3#9)(2012-4#1)(2013-1#12)(2013-7#1)(2013-8#11)
the numbers of##17##3##(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-9#2)
the numbers##25##2##(1993-2#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#2)(2012-2#1)(2013-1#1)(2013-8#1)
the numerator##2##2##(1995-3#1)(1996-2#1)
the numerical analysis##3##3##(2008-10#1)(2008-9#2)
the numerical data##2##3##(2008-10#1)(2008-3#1)
the numerical information##2##3##(2008-11#1)(2010-3#1)
the numerical##23##2##(2008-10#5)(2008-11#1)(2008-3#6)(2008-6#2)(2008-9#4)(2009-8#1)(2010-3#1)(2012-3#2)(2013-8#1)
the numerous##10##2##(1992-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
the nurse and the##2##4##(1994-1#1)(2010-7#1)
the nurse educator in##2##4##(2008-11#2)
the nurse##16##2##(1993-2#1)(1994-1#1)(1994-3#1)(2008-11#6)(2008-12#1)(2008-6#2)(2010-7#2)(2011-2#2)
the nurse's##3##2##(1990-2#1)(1991-1#1)(2012-3#1)
the nursery##3##2##(2008-10#3)
the nurses##16##2##(1990-2#5)(1991-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#3)
the nurses'##6##2##(1996-2#2)(2010-11#2)(2010-2#2)
the nursing and##2##3##(2008-11#1)(2010-10#1)
the nursing care of older adults##2##6##(2008-11#2)
the nursing care of##3##4##(2008-11#3)
the nursing care##4##3##(2008-11#3)(2012-3#1)
the nursing curriculum##7##3##(2008-11#4)(2008-12#3)
the nursing education##2##3##(2008-11#1)(2008-12#1)
the nursing home##10##3##(1991-1#1)(1992-1#1)(1995-3#1)(1997-2#1)(2008-11#2)(2008-12#1)(2009-3#1)(2010-10#1)(2010-11#1)
the nursing literature##3##3##(1994-3#1)(2013-1#2)
the nursing profession##2##3##(2008-11#1)(2008-12#1)
the nursing##51##2##(1990-2#2)(1991-1#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-2#1)(2008-11#21)(2008-12#9)(2009-3#1)(2010-10#2)(2010-11#1)(2012-3#5)(2013-1#2)
the nutrient##7##2##(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#2)
the nutrition##2##2##(2008-5#1)(2012-12#1)
the nutritional status of the##2##5##(2008-10#1)(2008-7#1)
the nutritional status of##5##4##(2008-10#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#1)
the nutritional status##6##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#1)
the nutritional value of the##2##5##(1994-3#1)(2010-11#1)
the nutritional value of##3##4##(1994-3#1)(2008-10#1)(2010-11#1)
the nutritional##11##2##(1994-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)
the nutritive##2##2##(2007-12#1)(2008-10#1)
the oak##4##2##(2008-10#1)(2008-5#1)(2012-6#1)(2012-9#1)
the obese patients##3##3##(2011-1#1)(2011-2#2)
the obese##12##2##(1996-12#3)(2008-10#1)(2011-1#2)(2011-2#4)(2013-1#2)
the obesity epidemic##2##3##(2012-2#2)
the object of##4##3##(1990-12#1)(1992-12#1)(1997-6#1)(2008-12#1)
the object##17##2##(1990-12#1)(1992-12#1)(1993-6#1)(1996-2#2)(1997-6#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#2)
the objective is to##2##4##(2008-10#2)
the objective is##3##3##(2008-10#3)
the objective of this study was to##3##7##(2008-10#2)(2010-9#1)
the objective of##7##3##(1994-6#1)(2008-10#3)(2008-5#1)(2010-9#1)(2012-3#1)
the objective##19##2##(1991-2#1)(1994-6#1)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#1)(2010-9#1)(2012-3#1)
the objectives##3##2##(1996-2#1)(1997-3#1)(2008-7#1)
the objects##5##2##(2008-3#3)(2009-12#1)(2010-10#1)
the obligate##2##2##(2008-10#2)
the obligation##2##2##(1993-6#1)(2008-7#1)
the obliteration##3##2##(2008-7#3)
the observation and execution of##2##5##(2008-11#2)
the observation and##3##3##(2008-11#2)(2008-12#1)
the observation height##2##3##(2008-10#2)
the observation of a##2##4##(1997-2#1)(2013-1#1)
the observation of clouds and aerosols with the##2##8##(2008-3#2)
the observation of##15##3##(1992-9#1)(1994-3#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#2)
the observation period##7##3##(1992-5#1)(1993-3#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-6#1)(2011-1#1)
the observation that the##3##4##(1995-9#1)(2008-6#1)(2009-9#1)
the observation that##12##3##(1992-4#1)(1994-5#1)(1995-9#1)(1997-3#2)(2008-10#2)(2008-6#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
the observation##48##2##(1992-4#1)(1992-5#1)(1992-9#2)(1993-3#1)(1994-3#1)(1994-5#1)(1995-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the observational##3##2##(2009-8#1)(2011-2#1)(2012-2#1)
the observations##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
the observed behavior##3##3##(2008-11#1)(2008-3#1)(2010-6#1)
the observed binding##2##3##(1997-6#1)(2008-8#1)
the observed cell cycle arrest##2##5##(1997-3#1)(1997-7#1)
the observed cell##3##3##(1997-1#1)(1997-3#1)(1997-7#1)
the observed data##5##3##(2008-10#3)(2008-8#2)
the observed decline in##2##4##(2008-11#1)(2008-7#1)
the observed differences##2##3##(1995-3#1)(2008-9#1)
the observed incidence##2##3##(2008-10#2)
the observed induced##2##3##(2008-10#2)
the observed number of##2##4##(2008-10#2)
the observed patterns of##3##4##(2008-8#2)(2009-7#1)
the observed patterns##6##3##(2008-2#1)(2008-8#3)(2009-7#1)(2009-8#1)
the observed relationship##2##3##(2008-10#1)(2012-12#1)
the observed seroprevalence##2##3##(2011-2#2)
the observed variation##2##3##(2008-10#1)(2008-5#1)
the observed variations##2##3##(2008-10#1)(2009-7#1)
the observed##125##2##(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#40)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#12)(2008-9#6)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
the observer##2##2##(2009-11#1)(2011-2#1)
the obstacles to##2##3##(2008-5#1)(2009-5#1)
the obstacles##5##2##(1995-3#1)(1996-2#1)(2008-5#1)(2009-5#1)(2012-12#1)
the obstetric and##2##3##(1990-3#1)(1992-1#1)
the obstruction##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
the obtained data##2##3##(2008-10#1)(2008-5#1)
the obtained results were used on##2##6##(2008-10#2)
the obtained results were##4##4##(2008-10#4)
the obtained results##18##3##(2008-10#18)
the obtained##40##2##(1996-8#1)(2008-10#32)(2008-5#2)(2008-8#2)(2010-12#1)(2010-4#1)(2013-8#1)
the obtention of##2##3##(1991-12#1)(2008-10#1)
the obvious##2##2##(1995-11#1)(2008-9#1)
the occasion of##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
the occasional##3##2##(2008-7#1)(2010-8#1)(2011-2#1)
the occipital##13##2##(1990-8#1)(1991-12#1)(1994-3#1)(1996-9#2)(2008-7#4)(2010-6#2)(2011-2#2)
the occluded##3##2##(1997-3#1)(1997-8#1)(2008-12#1)
the occlusion and the##3##4##(1996-6#1)(2008-11#1)(2010-9#1)
the occlusion of##2##3##(2008-10#1)(2008-12#1)
the occlusion##7##2##(1993-3#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-9#1)
the occupancy##2##2##(1993-8#1)(2008-11#1)
the occupational and##2##3##(1996-6#1)(2008-10#1)
the occupational health##3##3##(1995-2#2)(2008-11#1)
the occupational##8##2##(1995-2#2)(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
the occurrence and degree of##2##5##(1996-11#1)(2008-10#1)
the occurrence and##6##3##(1996-11#1)(2008-10#4)(2012-12#1)
the occurrence of Parkinson's disease##2##5##(2008-7#2)
the occurrence of chromosomal##2##4##(1990-8#1)(1996-12#1)
the occurrence of several##2##4##(2008-10#1)(2010-5#1)
the occurrence of the actin coronas in the embryo sac during fertilization##2##12##(2008-11#2)
the occurrence of the##9##4##(1991-11#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#1)
the occurrence of##93##3##(1990-8#1)(1991-10#1)(1991-11#2)(1992-12#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-12#2)(2008-10#30)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the occurrence##104##2##(1990-8#1)(1991-10#1)(1991-11#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-12#2)(2008-10#35)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the ocean and##2##3##(2008-2#1)(2008-3#1)
the ocean##9##2##(1990-8#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2012-2#1)
the oceans##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
the octanol phase##2##3##(1991-5#2)
the octanol/water##2##2##(1991-5#1)(1996-2#1)
the octopole##2##2##(2008-10#2)
the ocular bioavailability##2##3##(2011-3#2)
the ocular##5##2##(2008-12#1)(2011-3#3)(2012-2#1)
the odds of##4##3##(2010-12#1)(2010-6#1)(2013-1#2)
the odds ratio##2##3##(1994-9#1)(2012-3#1)
the odds that##2##3##(1993-5#1)(2011-2#1)
the odds##10##2##(1993-5#1)(1994-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
the odontoid process##3##3##(2011-2#3)
the odor##4##2##(1994-8#1)(2008-10#1)(2009-8#2)
the oesophagus##9##2##(1990-12#1)(1990-6#1)(1990-9#1)(1993-6#1)(2008-1#3)(2008-11#1)(2012-2#1)
the of##3##2##(2010-11#1)(2011-2#1)(2012-2#1)
the off-line##4##2##(2008-10#3)(2008-7#1)
the off-season is##2##3##(2008-10#2)
the office##4##2##(1991-2#1)(1994-12#1)(1995-12#1)(2008-4#1)
the official Mexican##2##3##(2008-10#1)(2008-11#1)
the official method of the##2##5##(2008-10#2)
the official method##5##3##(2008-10#5)
the official methods##3##3##(2008-10#2)(2008-11#1)
the official##17##2##(1991-9#1)(1993-5#1)(2008-10#10)(2008-11#2)(2009-10#1)(2010-7#1)(2011-2#1)
the offspring of the##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
the offspring of##5##3##(2008-10#1)(2008-7#2)(2008-8#2)
the offspring##11##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#2)
the often##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
the oil extracted from the##2##5##(2008-5#2)
the oil of H##2##4##(2008-11#2)
the oil of##3##3##(2008-11#2)(2008-12#1)
the oil palm biosolid extract for the##2##7##(2011-2#2)
the oil phase##4##3##(2008-5#4)
the oil##23##2##(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#10)(2011-2#2)
the oil-water interface##2##3##(2008-5#2)
the oil-water##4##2##(2008-10#2)(2008-5#2)
the oils##2##2##(2008-11#1)(2008-12#1)
the oily##2##2##(2008-10#1)(2008-5#1)
the ointment##2##2##(1993-11#1)(2008-12#1)
the old cuticle##2##3##(2008-7#2)
the old host##2##3##(2008-8#2)
the old##17##2##(1990-3#5)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#2)(2010-8#1)(2012-3#1)
the older animals##2##3##(1994-5#2)
the older control##3##3##(2008-10#3)
the older person##5##3##(2010-10#5)
the older workers##2##3##(2008-6#2)
the older##24##2##(1991-1#3)(1994-5#2)(1996-11#1)(1996-12#1)(2008-10#5)(2008-6#2)(2010-10#8)(2010-8#1)(2012-3#1)
the oldest age group##2##4##(2012-3#2)
the oldest patients##2##3##(1990-3#1)(2012-3#1)
the oldest##15##2##(1990-3#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-7#2)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#3)
the oleosin knockdown##3##3##(2009-10#3)
the oleosin##4##2##(2009-10#4)
the olfactory bulb and the##3##5##(2009-12#1)(2013-1#2)
the olfactory bulb and##5##4##(2008-11#1)(2009-12#2)(2013-1#2)
the olfactory bulb of##4##4##(2008-7#4)
the olfactory bulb##18##3##(1997-3#1)(2008-11#1)(2008-6#2)(2008-7#5)(2009-12#6)(2012-2#1)(2013-1#2)
the olfactory organ##4##3##(2007-12#4)
the olfactory receptor##2##3##(2009-12#2)
the olfactory system##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
the olfactory##33##2##(1994-2#1)(1994-8#1)(1997-3#1)(2007-12#7)(2008-11#1)(2008-6#2)(2008-7#6)(2009-12#8)(2009-8#1)(2012-2#3)(2013-1#2)
the oligonucleotide probe##2##3##(2008-10#1)(2008-9#1)
the oligonucleotide##6##2##(2008-10#4)(2008-9#1)(2012-3#1)
the oligosaccharide##4##2##(1990-9#1)(1992-10#1)(2008-7#2)
the oligosaccharides##6##2##(1990-9#1)(1991-12#1)(1992-10#1)(2008-10#2)(2008-11#1)
the omega-3 ethyl ester concentrate##2##5##(2008-3#2)
the omission of##2##3##(2008-1#1)(2009-8#1)
the omission##4##2##(2008-1#1)(2008-10#1)(2009-8#1)(2013-8#1)
the omnibus##2##2##(1996-3#1)(1997-2#1)
the on-column##2##2##(2008-10#2)
the on-line column##2##3##(2008-10#2)
the on-line monitoring##2##3##(2008-10#2)
the on-line photochemical##2##3##(2008-10#2)
the on-line precipitation of##2##4##(2008-10#2)
the on-line precipitation##3##3##(2008-10#3)
the on-line removal of##2##4##(2008-10#2)
the on-line wavelet transform##4##4##(2008-10#4)
the on-line##52##2##(2008-10#49)(2008-11#3)
the on-site##2##2##(2008-10#2)
the oncogenic##2##2##(1991-12#2)
the oncologist##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
the oncoprotein Bcl-2##2##3##(2012-2#2)
the one hand##18##3##(1991-2#1)(1991-3#1)(1991-6#1)(1994-1#1)(1994-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#1)(2013-1#1)
the one megabase##2##3##(1995-12#2)
the one of##2##3##(2008-10#1)(2008-9#1)
the one that##2##3##(2008-10#2)
the one with##3##3##(2008-10#2)(2013-8#1)
the one##54##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1994-1#2)(1994-12#1)(1995-12#2)(1995-8#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2008-10#15)(2008-11#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
the one-beam cross-correlation dynamic light-scattering##2##5##(2008-3#2)
the one-carbon##2##2##(1992-10#1)(2009-12#1)
the one-channel condition##2##3##(2008-9#2)
the one-dimensional##4##2##(1993-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
the oneness of##2##3##(2008-8#1)(2012-2#1)
the ones obtained by##4##4##(2008-10#4)
the ones that are##2##4##(1990-2#1)(2008-11#1)
the ones that##4##3##(1990-2#1)(2008-11#2)(2008-8#1)
the ones used##2##3##(1997-4#1)(2010-8#1)
the ones##22##2##(1990-2#1)(1992-3#1)(1997-4#1)(1997-6#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
the ongoing debate on##2##4##(1991-1#1)(2009-10#1)
the ongoing development of##2##4##(1994-12#1)(2008-11#1)
the ongoing##18##2##(1991-1#1)(1991-6#1)(1992-2#1)(1994-1#1)(1994-12#1)(1996-2#2)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-2#1)(2012-6#1)(2013-1#1)
the onion##2##2##(2008-10#2)
the online##2##2##(2008-10#1)(2011-2#1)
the only fungus##2##3##(2008-10#2)
the only genotypes##2##3##(2008-10#2)
the only known##5##3##(1991-5#1)(1996-11#1)(1997-1#1)(2008-10#1)(2012-2#1)
the only means##3##3##(1990-11#1)(1991-2#1)(2008-11#1)
the only method##2##3##(1990-6#1)(2008-10#1)
the only one which##2##4##(1991-11#1)(2008-7#1)
the only one##5##3##(1991-11#1)(1997-4#1)(2008-6#1)(2008-7#1)(2011-2#1)
the only ones with##2##4##(2008-10#2)
the only other##2##3##(1993-6#1)(2008-10#1)
the only patient##2##3##(1994-12#1)(1996-6#1)
the only significant##3##3##(1991-11#1)(1993-1#1)(2012-2#1)
the only source of##2##4##(1991-12#1)(2008-10#1)
the only species##3##3##(1990-2#1)(2010-8#1)(2011-2#1)
the only treatment##5##3##(1991-6#1)(1996-11#1)(2008-10#1)(2010-8#1)(2012-12#1)
the only two##2##3##(1990-5#1)(2011-2#1)
the only way to##2##4##(1994-9#1)(1997-5#1)
the only way##5##3##(1994-9#2)(1997-5#1)(2010-6#1)(2010-7#1)
the only##149##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#36)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#5)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#3)
the onset and##4##3##(1993-9#1)(1994-9#1)(2011-2#2)
the onset of DNA##2##4##(1994-3#1)(1994-5#1)
the onset of PD##2##4##(2008-7#1)(2011-2#1)
the onset of a##2##4##(1990-9#1)(2010-6#1)
the onset of degradation##2##4##(2008-10#2)
the onset of diabetes##2##4##(1994-12#1)(2010-10#1)
the onset of disease##3##4##(1997-3#1)(2008-10#2)
the onset of estrus##2##4##(2013-1#2)
the onset of pseudothecia maturity##3##5##(2008-10#3)
the onset of stroke##2##4##(2008-7#1)(2010-10#1)
the onset of symptoms and##5##5##(2008-7#1)(2012-12#4)
the onset of symptoms##9##4##(2007-12#1)(2008-7#2)(2009-8#1)(2010-10#1)(2012-12#4)
the onset of the AIDS epidemic##2##6##(1990-3#1)(1996-5#1)
the onset of the stationary phase##2##6##(2008-7#1)(2011-2#1)
the onset of the##12##4##(1990-3#1)(1996-5#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#3)(2011-2#1)(2013-1#1)
the onset of vitellogenesis##2##4##(2007-12#1)(2008-7#1)
the onset of##107##3##(1990-12#2)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#2)(2006-6#1)(2007-12#4)(2008-10#19)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#15)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#6)(2011-7#1)(2012-12#4)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#2)
the onset##115##2##(1990-12#2)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#2)(2006-6#1)(2007-12#4)(2008-10#19)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#15)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#9)(2011-7#1)(2012-12#4)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#2)
the ontogeny of##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
the ontogeny##4##2##(1993-12#1)(2008-10#1)(2008-11#2)
the oocyte and the##2##4##(2008-12#1)(2008-7#1)
the oocyte and##3##3##(1993-6#1)(2008-12#1)(2008-7#1)
the oocyte nucleus and##2##4##(2007-12#2)
the oocyte nucleus##6##3##(2007-12#6)
the oocyte##16##2##(1993-6#1)(1994-9#1)(2007-12#6)(2008-12#3)(2008-7#2)(2008-8#1)(2013-1#2)
the oocytes##6##2##(2007-12#1)(2008-8#5)
the oomycete##4##2##(2008-10#4)
the oospores##2##2##(2008-10#2)
the open reading frame of##4##5##(1992-6#2)(1994-11#1)(1996-12#1)
the open reading frame##9##4##(1992-6#2)(1992-8#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)
the open reading frames (ORFs)##3##5##(1995-12#1)(1996-3#1)(1997-6#1)
the open reading frames##4##4##(1995-12#1)(1996-3#2)(1997-6#1)
the open reading##13##3##(1992-6#2)(1992-8#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-6#1)(1997-7#1)(2008-10#1)
the open##29##2##(1990-5#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-8#1)(2009-10#3)(2010-12#1)(2011-2#1)(2012-12#1)
the opening angles and residual strains in##2##7##(2008-9#2)
the opening angles and residual strains##3##6##(2008-9#3)
the opening of the##3##4##(2008-6#1)(2008-7#2)
the opening of##5##3##(2008-11#2)(2008-6#1)(2008-7#2)
the opening##14##2##(1994-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#4)(2013-1#1)
the operating conditions##3##3##(2008-10#2)(2008-7#1)
the operating microscope##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
the operating parameters##2##3##(2008-10#2)
the operating ratio are##2##4##(2008-11#2)
the operating room##9##3##(1991-1#1)(1991-2#1)(1996-3#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
the operating##29##2##(1991-1#2)(1991-2#1)(1992-12#1)(1996-3#1)(2008-10#9)(2008-11#2)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-2#4)(2012-3#3)(2013-1#1)
the operation and##3##3##(1990-2#1)(1994-3#1)(2008-10#1)
the operation of an##2##4##(1996-1#1)(1996-12#1)
the operation of the##4##4##(1995-12#1)(2007-12#1)(2008-10#2)
the operation of##13##3##(1991-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#2)(2007-12#1)(2008-10#3)(2008-4#1)(2009-12#1)
the operation was##3##3##(1996-3#1)(2011-2#1)(2012-12#1)
the operation##55##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-12#1)(1993-1#2)(1994-3#3)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-3#2)(2006-6#2)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#2)
the operational and storage stability of##2##6##(2008-10#2)
the operational##8##2##(1997-3#1)(2008-10#5)(2008-7#1)(2012-3#1)
the operative findings##2##3##(1997-8#1)(2008-9#1)
the operative treatment of##4##4##(1992-2#2)(2008-10#1)(2013-1#1)
the operative##16##2##(1992-1#1)(1992-2#2)(1995-1#1)(1996-1#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
the operator in##2##3##(1991-2#1)(2008-9#1)
the operator to##2##3##(2008-11#2)
the operator##7##2##(1991-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2013-1#1)
the operator's##2##2##(2008-10#1)(2011-2#1)
the ophthalmic artery##2##3##(1996-9#1)(2012-3#1)
the ophthalmic##4##2##(1996-9#1)(2012-3#3)
the ophthalmologist##3##2##(1993-11#1)(2013-1#1)(2013-7#1)
the opinion of the nurses##2##5##(1990-2#2)
the opinion of the##3##4##(1990-2#2)(1991-3#1)
the opinion of##5##3##(1990-2#2)(1991-3#1)(1992-1#1)(2013-1#1)
the opinion that##2##3##(1995-5#1)(2011-2#1)
the opinion##10##2##(1990-2#2)(1991-3#1)(1992-1#1)(1995-5#1)(2007-12#1)(2011-2#2)(2013-1#2)
the opinions of##2##3##(1990-11#1)(2008-12#1)
the opioid receptor-like##2##3##(1996-2#1)(2008-11#1)
the opioid##5##2##(1991-1#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-7#1)
the opponent's outcomes##2##3##(2008-11#2)
the opportunistic##2##2##(2007-8#1)(2011-2#1)
the opportunities for##2##3##(1997-1#1)(2008-1#1)
the opportunity for sexual selection##3##5##(2008-8#3)
the opportunity for##11##3##(1994-12#1)(2008-10#1)(2008-11#2)(2008-8#3)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
the opportunity of##2##3##(1991-2#1)(2012-3#1)
the opportunity to##23##3##(1991-6#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-9#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#2)(2009-8#1)(2010-8#1)(2012-2#2)(2013-8#2)
the opportunity##39##2##(1991-2#2)(1991-6#1)(1993-11#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-9#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#2)
the opposite effect##2##3##(2008-11#1)(2008-3#1)
the opposite occurred##2##3##(1991-1#1)(2008-10#1)
the opposite sex##2##3##(1990-8#1)(2008-9#1)
the opposite was##2##3##(2008-7#1)(2012-2#1)
the opposite##35##2##(1990-6#1)(1990-8#1)(1991-1#1)(1991-5#2)(1993-3#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#2)(2013-8#1)
the oppositely charged##2##3##(2008-10#1)(2010-7#1)
the optic lobe##2##3##(2008-5#2)
the optic nerve##6##3##(2008-5#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-3#1)
the optic tectum##3##3##(1990-5#1)(1997-3#1)(2008-6#1)
the optic##15##2##(1990-12#1)(1990-5#1)(1997-3#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2010-5#1)(2011-2#1)(2012-3#1)
the optical analyser TURBISCAN MA 2000##2##6##(2008-10#2)
the optical and##3##3##(2008-10#2)(2008-2#1)
the optical axis##3##3##(2007-11#1)(2008-3#2)
the optical cavity##2##3##(2008-3#2)
the optical density of the##2##5##(2008-10#1)(2008-7#1)
the optical density##3##3##(2008-10#2)(2008-7#1)
the optical depth##2##3##(2008-2#1)(2008-3#1)
the optical field##4##3##(2007-12#2)(2008-3#2)
the optical interference##2##3##(2013-8#2)
the optical path difference##3##4##(2008-3#1)(2013-8#2)
the optical path of the##2##5##(2008-10#1)(2013-8#1)
the optical path##8##3##(2008-10#3)(2008-3#2)(2013-8#3)
the optical properties of the##2##5##(2007-11#1)(2008-10#1)
the optical properties of##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
the optical properties##5##3##(2007-11#1)(2008-10#2)(2008-3#2)
the optical signal##3##3##(2007-12#1)(2008-2#2)
the optical system##6##3##(2008-10#1)(2008-3#5)
the optical thickness##2##3##(2008-3#2)
the optical##84##2##(1990-8#2)(1994-5#1)(2007-11#2)(2007-12#4)(2008-10#16)(2008-2#9)(2008-3#37)(2008-7#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#5)
the optically pure##3##3##(1992-3#1)(1995-3#2)
the optically##4##2##(1992-3#1)(1995-3#2)(2007-12#1)
the optics##3##2##(2008-1#2)(2008-4#1)
the optimal choice##2##3##(2008-10#1)(2012-3#1)
the optimal concentration##2##3##(1994-11#1)(2008-8#1)
the optimal conditions for the##2##5##(2008-10#2)
the optimal conditions for##4##4##(2008-10#4)
the optimal conditions##24##3##(2008-10#24)
the optimal decision##2##3##(2008-10#1)(2012-3#1)
the optimal dosage and##2##4##(1992-9#1)(2013-1#1)
the optimal dose##2##3##(2008-7#1)(2012-12#1)
the optimal extraction##3##3##(2008-10#3)
the optimal filters is##2##4##(2008-6#2)
the optimal harvest time##2##4##(2008-11#1)(2008-7#1)
the optimal level of##3##4##(2008-10#1)(2008-8#2)
the optimal level##4##3##(1996-3#1)(2008-10#1)(2008-8#2)
the optimal medium##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
the optimal moment##2##3##(2008-10#1)(2008-5#1)
the optimal strategy##2##3##(2012-2#1)(2013-1#1)
the optimal surgical##2##3##(1994-12#1)(2008-12#1)
the optimal therapy for##2##4##(1995-2#1)(2009-8#1)
the optimal timing##2##3##(2008-9#1)(2010-12#1)
the optimal treatment##6##3##(1995-5#1)(1997-1#1)(2008-7#1)(2011-2#1)(2012-3#2)
the optimal value of##2##4##(2008-10#2)
the optimal velocity to moving##2##5##(2008-8#2)
the optimal##147##2##(1991-5#1)(1992-9#2)(1993-3#1)(1994-11#1)(1994-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#54)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#4)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#4)
the optimisation and##3##3##(2008-10#3)
the optimisation of the##3##4##(2008-10#3)
the optimisation of##6##3##(2008-10#4)(2008-11#2)
the optimisation##13##2##(2008-10#11)(2008-11#2)
the optimised BCR##3##3##(2008-10#3)
the optimised conditions the##2##4##(2008-10#2)
the optimised conditions##5##3##(2008-10#5)
the optimised##12##2##(2008-10#12)
the optimization and##2##3##(2008-10#2)
the optimization of a##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
the optimization of all##2##4##(2008-10#1)(2008-8#1)
the optimization of experimental##2##4##(2008-10#2)
the optimization of instrumental##2##4##(2008-10#2)
the optimization of metabolic pathways##2##5##(2008-7#2)
the optimization of the##6##4##(2008-10#4)(2008-9#1)(2011-1#1)
the optimization of##32##3##(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2013-8#1)
the optimization process##3##3##(2008-10#3)
the optimization##49##2##(2008-10#36)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-3#1)(2013-8#1)
the optimized condition the##2##4##(2008-10#2)
the optimized condition##3##3##(2008-10#3)
the optimized conditions of##2##4##(2008-10#2)
the optimized conditions##21##3##(2008-10#20)(2008-12#1)
the optimized##51##2##(1993-8#2)(2008-10#46)(2008-11#1)(2008-12#1)(2009-2#1)
the optimum SFE##2##3##(2008-10#2)
the optimum analytical##2##3##(2008-10#2)
the optimum at##3##3##(2008-10#3)
the optimum condition##5##3##(2008-10#5)
the optimum conditions for the##4##5##(2008-10#4)
the optimum conditions for##8##4##(2008-10#8)
the optimum conditions of##2##4##(2008-10#2)
the optimum conditions were##3##4##(2008-10#3)
the optimum conditions##59##3##(2008-10#59)
the optimum experimental conditions##6##4##(2008-10#6)
the optimum operating conditions##2##4##(2008-10#1)(2008-3#1)
the optimum pH##6##3##(2008-10#5)(2008-9#1)
the optimum reaction conditions##2##4##(2008-10#2)
the optimum separation##2##3##(2008-10#2)
the optimum temperature for##2##4##(2008-10#2)
the optimum temperature##4##3##(2008-10#4)
the optimum working conditions##4##4##(2008-10#4)
the optimum##135##2##(1996-9#1)(2007-12#1)(2008-10#114)(2008-11#2)(2008-12#1)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#1)
the optimums##2##2##(2008-10#1)(2010-10#1)
the option of##3##3##(1997-3#1)(2008-10#1)(2008-8#1)
the option to##2##3##(1994-12#1)(2012-3#1)
the option##5##2##(1994-12#1)(1997-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
the options available##2##3##(2008-11#1)(2009-5#1)
the options##6##2##(1996-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2012-2#1)
the optode##8##2##(2008-10#8)
the oracle property##2##3##(2010-1#2)
the oral administration of##3##4##(1992-9#1)(2008-11#1)(2010-10#1)
the oral and maxillofacial##3##4##(2008-7#3)
the oral and##5##3##(2008-7#3)(2011-2#1)(2013-1#1)
the oral cavity of##4##4##(1995-9#1)(2013-1#3)
the oral cavity##17##3##(1990-9#1)(1991-6#1)(1994-2#1)(1995-9#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2013-1#5)
the oral health-related quality of##2##5##(2011-2#1)(2011-7#1)
the oral##38##2##(1990-9#1)(1991-6#1)(1992-9#2)(1993-1#1)(1994-2#1)(1995-9#1)(1996-5#1)(1997-4#2)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#5)(2011-7#1)(2012-3#1)(2013-1#6)
the orange-spotted grouper##3##3##(2010-5#3)
the orbit and frontal sinus##3##5##(2011-2#3)
the orbit##8##2##(2008-9#1)(2010-10#1)(2011-2#4)(2012-3#1)(2013-1#1)
the orbitofrontal cortex##5##3##(2008-11#1)(2009-10#4)
the orbitopterional approach in##2##4##(2011-2#2)
the orchard and##3##3##(2008-10#3)
the orchard experiments##2##3##(2008-10#2)
the orchard floor##5##3##(2008-10#5)
the orchard##27##2##(2008-10#27)
the orchards and##2##3##(2008-10#2)
the orchards##5##2##(2008-10#5)
the order Spirochaetales##2##3##(2008-9#1)(2013-8#1)
the order in the##4##4##(2008-10#3)(2008-5#1)
the order of 0##2##4##(2008-10#2)
the order of 1##3##4##(2008-10#1)(2008-8#1)(2009-7#1)
the order of 10##2##4##(2008-3#1)(2009-12#1)
the order of several##3##4##(1995-3#1)(1997-6#1)(2008-3#1)
the order of the##7##4##(1991-2#1)(1996-3#1)(2008-10#3)(2010-1#1)(2011-1#1)
the order of##55##3##(1991-2#1)(1992-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-10#25)(2008-2#1)(2008-3#7)(2008-5#1)(2008-8#3)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
the order parameter##2##3##(1990-12#1)(2008-9#1)
the order##97##2##(1990-12#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-8#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-12#5)(2008-10#44)(2008-2#1)(2008-3#7)(2008-5#5)(2008-8#6)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
the ordered##3##2##(1990-11#1)(1991-5#1)(1996-12#1)
the ordering of##2##3##(2008-10#1)(2013-1#1)
the orderly##3##2##(1991-3#1)(2008-8#1)(2009-6#1)
the ordinary serous##2##3##(2008-7#2)
the ordinary##9##2##(1991-6#1)(2008-10#3)(2008-12#1)(2008-7#3)(2008-8#1)
the organ##6##2##(1990-11#1)(1993-8#1)(2008-5#2)(2008-6#1)(2010-1#1)
the organelles##2##2##(1995-6#1)(2008-7#1)
the organic acids##2##3##(1992-3#1)(2008-10#1)
the organic and##2##3##(2008-10#1)(2010-4#1)
the organic compounds##4##3##(2008-10#4)
the organic fraction of##3##4##(2008-10#3)
the organic fraction##4##3##(2008-10#4)
the organic layer##3##3##(2008-10#3)
the organic matrix##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
the organic matter##2##3##(2008-10#1)(2008-11#1)
the organic phase is##2##4##(2008-10#1)(2010-4#1)
the organic phase with##3##4##(2008-10#3)
the organic phase##26##3##(1994-8#1)(2008-10#23)(2008-7#1)(2010-4#1)
the organic solvent##9##3##(1992-3#1)(2008-10#8)
the organic##85##2##(1992-3#2)(1994-8#2)(1996-5#1)(2007-12#2)(2008-10#66)(2008-11#3)(2008-5#2)(2008-7#3)(2009-7#1)(2010-4#2)(2013-8#1)
the organisation##5##2##(1996-12#1)(2008-11#1)(2008-12#2)(2008-6#1)
the organism against##2##3##(1995-5#1)(2008-7#1)
the organism and##3##3##(1995-2#1)(2011-2#1)(2013-8#1)
the organism in##2##3##(1991-11#1)(1997-1#1)
the organism is##4##3##(2007-12#1)(2008-10#1)(2011-2#2)
the organism##49##2##(1991-11#1)(1991-6#1)(1993-2#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#3)(2008-7#7)(2008-8#2)(2008-9#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#12)(2013-8#1)
the organism's##2##2##(1994-8#1)(2011-2#1)
the organisms were##2##3##(2008-10#1)(2008-11#1)
the organisms##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
the organization and##9##3##(1990-2#1)(1993-12#1)(1993-6#1)(1995-3#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)
the organization as well as##2##5##(1995-2#1)(2009-8#1)
the organization in##2##3##(1993-12#1)(2008-10#1)
the organization is##2##3##(1993-1#1)(2008-7#1)
the organization of the central##2##5##(1995-5#1)(2007-12#1)
the organization of the gene##2##5##(1994-11#1)(2010-4#1)
the organization of the##16##4##(1992-3#2)(1994-11#1)(1994-5#1)(1995-5#3)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-4#1)(2013-8#2)
the organization of##28##3##(1992-3#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#4)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2013-8#3)
the organization##68##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-1#1)(1993-12#3)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#4)(1996-1#2)(1996-2#1)(1997-1#3)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-8#2)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#3)
the organization's bottom line##3##4##(2008-9#3)
the organization's##4##2##(2008-11#1)(2008-9#3)
the organization)##2##2##(2008-11#2)
the organizational context##2##3##(2010-8#1)(2012-3#1)
the organizational##8##2##(1992-12#1)(1993-12#1)(1995-3#1)(1996-3#1)(2008-11#2)(2010-8#1)(2012-3#1)
the organizations##2##2##(1994-12#1)(2008-11#1)
the organolithium##2##2##(1996-5#2)
the organophosphate##2##2##(2012-12#1)(2013-8#1)
the organs involved##2##3##(2008-10#1)(2010-12#1)
the organs##4##2##(2008-10#2)(2008-7#1)(2010-12#1)
the orientation and##3##3##(1991-6#1)(2008-10#1)(2008-3#1)
the orientation of caldesmon##2##4##(1994-5#2)
the orientation of the##7##4##(2007-11#3)(2007-12#1)(2008-3#2)(2013-8#1)
the orientation of##18##3##(1991-10#1)(1994-2#1)(1994-5#4)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2013-8#1)
the orientation##25##2##(1990-11#1)(1991-10#1)(1991-6#1)(1994-2#1)(1994-5#4)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
the origin and evolution of##3##5##(2008-10#1)(2008-5#1)(2008-8#1)
the origin and the##3##4##(1993-6#1)(2011-2#1)(2012-3#1)
the origin and##15##3##(1992-12#1)(1993-6#1)(1995-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#2)
the origin of the##14##4##(1993-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
the origin of this##2##4##(2008-11#1)(2013-1#1)
the origin of##43##3##(1993-3#1)(1994-8#1)(1997-8#1)(2007-12#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-6#2)(2009-8#1)(2010-1#2)(2010-4#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
the origin##63##2##(1992-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-8#1)(2007-12#2)(2008-10#16)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-6#2)(2009-8#1)(2010-1#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
the original N##2##3##(2008-10#2)
the original and the##2##4##(2008-10#1)(2008-3#1)
the original clone##3##3##(2008-11#3)
the original concentration of##2##4##(2008-10#2)
the original data##8##3##(1995-5#1)(2008-10#7)
the original description of##2##4##(2008-12#1)(2012-3#1)
the original family##2##3##(1995-5#2)
the original host##2##3##(2008-10#1)(2008-8#1)
the original hypothesis##2##3##(2008-11#1)(2008-9#1)
the original line##2##3##(2008-10#1)(2008-11#1)
the original population##2##3##(2008-10#2)
the original sample and the sample##2##6##(2008-10#2)
the original sample##7##3##(2008-10#4)(2008-11#2)(2008-12#1)
the original serum-free##2##3##(2008-11#2)
the original strain##2##3##(2008-10#2)
the original version##2##3##(2012-12#1)(2013-1#1)
the original##126##2##(1990-2#3)(1990-3#1)(1991-6#1)(1992-11#2)(1992-2#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-2#1)(1995-5#3)(1995-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#50)(2008-11#13)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#4)
the originality##2##2##(1997-2#1)(2010-7#1)
the origins of the##2##4##(2008-11#1)(2009-10#1)
the origins of##12##3##(1990-7#2)(1993-2#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
the origins##15##2##(1990-7#2)(1993-2#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
the ornamental##2##2##(2008-10#1)(2008-8#1)
the oropharynx and##2##3##(2008-8#1)(2011-2#1)
the ortho##3##2##(2008-10#1)(2008-11#2)
the orthogonal##2##2##(2008-10#2)
the ortholog##2##2##(2008-11#1)(2009-10#1)
the orthopaedic##2##2##(2010-3#1)(2012-12#1)
the orthopedic##2##2##(2008-8#1)(2011-2#1)
the orthophosphate##2##2##(2008-10#2)
the orthorhombic##3##2##(1992-12#1)(1993-8#1)(2008-8#1)
the oscillating##6##2##(2008-10#4)(2008-3#1)(2011-2#1)
the oscillation amplitude##5##3##(2008-10#5)
the oscillation period is##2##4##(2010-10#2)
the oscillation period##4##3##(2008-10#1)(2010-10#3)
the oscillation##10##2##(2008-10#7)(2010-10#3)
the oscillations##4##2##(1994-11#1)(2008-3#3)
the oscillatory behavior in continuous fermentation of Zymomonas mobilis##2##9##(2008-7#2)
the oscillatory##7##2##(1995-11#1)(1995-5#1)(1996-3#1)(2008-12#1)(2008-5#1)(2008-7#2)
the osmolarity of the growth medium##2##6##(1991-11#2)
the osmolarity of the##3##4##(1991-11#3)
the osmolarity##4##2##(1991-11#4)
the osmotic stress##2##3##(2008-11#1)(2013-1#1)
the osmotic##3##2##(2008-11#2)(2013-1#1)
the osteoblasts to##2##3##(1993-6#1)(2008-11#1)
the osteoblasts##3##2##(1993-6#2)(2008-11#1)
the osteocalcin gene##2##3##(1993-3#2)
the osteoclast##2##2##(1991-11#1)(2008-11#1)
the osteopathic##2##2##(1991-12#2)
the osteophyte##2##2##(2011-2#2)
the osteophytic##2##2##(2011-2#2)
the other 4##2##3##(2008-10#1)(2008-8#1)
the other X##2##3##(2008-10#2)
the other a##6##3##(1991-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)
the other analytes##2##3##(2008-10#2)
the other and##2##3##(1997-3#1)(2008-8#1)
the other by##2##3##(1994-11#1)(1997-7#1)
the other cations##3##3##(2008-10#3)
the other components of the##2##5##(1991-3#1)(2012-3#1)
the other components of##3##4##(1991-3#1)(2010-7#1)(2012-3#1)
the other components##5##3##(1991-3#1)(2008-10#2)(2010-7#1)(2012-3#1)
the other drugs##2##3##(2008-10#2)
the other five species##3##4##(2008-9#3)
the other five##7##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#3)(2013-8#1)
the other flow cells##2##4##(2008-10#2)
the other four##6##3##(1995-9#1)(1996-12#1)(2008-10#4)
the other from##5##3##(1990-5#1)(1996-8#1)(2008-10#3)
the other gene##2##3##(1997-2#1)(2008-10#1)
the other genotypes##2##3##(2008-10#1)(2008-8#1)
the other group##5##3##(1992-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
the other groups of##2##4##(1991-2#1)(2008-8#1)
the other groups##6##3##(1991-2#1)(1993-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-5#1)
the other hand##182##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#2)(1993-2#2)(1993-8#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#1)(1996-5#5)(1996-6#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#4)(2007-12#1)(2008-10#50)(2008-11#25)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-6#3)(2011-2#3)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
the other in a##3##4##(1991-12#1)(2008-10#1)(2012-12#1)
the other in##8##3##(1991-12#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#2)
the other is##5##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#2)
the other markers##2##3##(2008-1#1)(2012-3#1)
the other metal##2##3##(2008-10#2)
the other metals##4##3##(2008-10#3)(2010-11#1)
the other method##2##3##(2008-10#1)(2008-7#1)
the other minor##2##3##(2008-10#1)(2009-12#1)
the other one##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
the other parameters##2##3##(2008-10#1)(2008-3#1)
the other party to##2##4##(1992-2#1)(2008-8#1)
the other patients##4##3##(1990-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
the other population##2##3##(2008-8#1)(2008-9#1)
the other populations##2##3##(2008-10#1)(2008-12#1)
the other procedures##3##3##(1995-1#1)(2008-10#2)
the other reactions##2##3##(1991-3#1)(2008-7#1)
the other side##6##3##(2008-10#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)
the other six##3##3##(2008-10#2)(2008-5#1)
the other species of##2##4##(2008-6#1)(2011-2#1)
the other species##11##3##(2008-10#5)(2008-6#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-5#1)
the other students##2##3##(2008-11#2)
the other three##12##3##(1997-6#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#3)(2013-8#1)
the other treatments##2##3##(2008-10#2)
the other two cases##2##4##(2008-7#1)(2013-1#1)
the other two components##2##4##(1995-3#1)(2008-10#1)
the other two groups##6##4##(1991-11#1)(2008-10#4)(2013-1#1)
the other two methods##2##4##(2008-10#2)
the other two populations##2##4##(2008-10#2)
the other two##35##3##(1991-11#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#22)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
the other types##2##3##(2008-10#1)(2008-5#1)
the other variables##3##3##(2008-10#2)(2008-12#1)
the other was##5##3##(2008-10#2)(2008-5#1)(2013-1#2)
the other with##7##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
the other##668##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#5)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#5)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-12#4)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-6#1)(1993-8#5)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#2)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#6)(1996-2#1)(1996-3#2)(1996-5#8)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#4)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#4)(2006-6#1)(2007-12#3)(2008-1#4)(2008-10#248)(2008-11#41)(2008-12#11)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#20)(2008-6#7)(2008-7#21)(2008-8#23)(2008-9#23)(2009-10#5)(2009-11#3)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#4)(2012-3#7)(2012-5#2)(2013-1#17)(2013-8#10)
the other's##2##2##(2008-11#1)(2008-8#1)
the others for##2##3##(2008-10#1)(2008-5#1)
the others in##2##3##(2008-10#2)
the others were##3##3##(1990-11#1)(1990-5#1)(1995-2#1)
the others##30##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-5#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-10#11)(2008-5#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2013-1#2)
the otherwise##2##2##(2008-12#1)(2010-8#1)
the otolith##3##2##(2008-7#3)
the outbreak in##2##3##(2008-12#2)
the outbreak of##2##3##(1997-5#1)(2008-12#1)
the outbreak##12##2##(1996-1#1)(1997-5#1)(2008-12#5)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
the outbreaks##2##2##(1992-6#1)(2008-12#1)
the outcome for##2##3##(1994-6#1)(2008-9#1)
the outcome is##3##3##(1990-12#1)(2008-11#1)(2011-2#1)
the outcome of competition##2##4##(2008-8#1)(2008-9#1)
the outcome of the##5##4##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
the outcome of##42##3##(1990-8#1)(1990-9#1)(1993-11#2)(1994-1#3)(1994-12#1)(1995-9#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#5)
the outcome##67##2##(1990-12#2)(1990-8#1)(1990-9#1)(1991-6#1)(1993-1#1)(1993-11#2)(1994-1#3)(1994-12#1)(1994-3#1)(1994-6#2)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#8)(2012-2#1)(2012-3#2)(2013-1#7)
the outcomes and##2##3##(2008-5#1)(2013-1#1)
the outcomes model##4##3##(2008-4#4)
the outcomes of##11##3##(1995-3#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
the outcomes that##2##3##(1992-12#1)(2008-8#1)
the outcomes##22##2##(1992-12#1)(1995-3#2)(1996-2#1)(1996-3#1)(2008-11#2)(2008-4#5)(2008-5#2)(2008-8#2)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
the outer dendritic segments##2##4##(2008-7#2)
the outer layer of##2##4##(2008-12#1)(2008-7#1)
the outer layer##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
the outer layers of the##2##5##(2008-11#1)(2009-8#1)
the outer layers##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
the outer lipid##2##3##(1991-5#1)(1994-11#1)
the outer membrane##10##3##(1990-11#1)(1994-11#1)(1997-8#3)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
the outer nuclear layer##2##4##(1991-10#1)(2010-1#1)
the outer nuclear##5##3##(1991-10#1)(2008-9#2)(2010-1#1)(2011-2#1)
the outer surface of a##2##5##(2008-2#1)(2010-10#1)
the outer surface of##3##4##(1997-7#1)(2008-2#1)(2010-10#1)
the outer surface##4##3##(1994-5#1)(1997-7#1)(2008-2#1)(2010-10#1)
the outer##63##2##(1990-11#3)(1990-2#1)(1991-10#1)(1991-5#1)(1992-3#2)(1994-11#2)(1994-5#1)(1995-2#1)(1996-5#1)(1997-7#1)(1997-8#5)(2007-12#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#3)(2012-2#4)(2013-8#1)
the outermost SC layer##3##4##(2008-5#3)
the outermost layer of##2##4##(2008-5#2)
the outermost##11##2##(2008-10#4)(2008-5#7)
the outgroup A##2##3##(2008-10#2)
the outgrowth of##3##3##(2008-11#2)(2013-1#1)
the outgrowth##5##2##(2008-11#4)(2013-1#1)
the outlet of the##3##4##(2008-10#3)
the outlet of##5##3##(2008-10#5)
the outlet##6##2##(2008-10#6)
the outlook##3##2##(1993-12#1)(1993-3#1)(1996-5#1)
the outpatient clinic##2##3##(2008-11#1)(2011-2#1)
the outpatient setting##2##3##(1993-12#1)(1995-2#1)
the outpatient##10##2##(1991-9#1)(1992-12#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-11#1)(2008-11#1)(2011-2#2)
the output beam##2##3##(2008-2#1)(2008-3#1)
the output layer##7##3##(2008-10#2)(2010-8#5)
the output of a##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
the output of the##6##4##(1996-2#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)
the output of##13##3##(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-12#1)
the output power##3##3##(2008-3#3)
the output signal##3##3##(2008-10#2)(2008-7#1)
the output##54##2##(1991-12#1)(1993-6#1)(1996-2#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#3)(2008-2#4)(2008-3#18)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-8#5)(2013-1#1)
the outputs##2##2##(1992-2#1)(2008-10#1)
the outset##4##2##(1993-1#1)(1995-1#1)(2008-10#1)(2008-12#1)
the outside of the##5##4##(2008-10#2)(2008-8#1)(2012-2#2)
the outside of##6##3##(2008-10#3)(2008-8#1)(2012-2#2)
the outside##12##2##(1990-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#2)
the outstanding##4##2##(1994-5#1)(1997-8#1)(2008-10#1)(2008-5#1)
the oval##2##2##(1997-8#1)(2008-9#1)
the ovarian cyst cavity##2##4##(1992-3#2)
the ovarian follicles##3##3##(2008-12#3)
the ovarian stroma##3##3##(2008-12#3)
the ovarian surface epithelium##2##4##(1995-12#1)(2011-2#1)
the ovarian surface##3##3##(1995-12#1)(2011-2#2)
the ovarian##26##2##(1990-10#1)(1990-11#1)(1992-3#5)(1995-12#1)(1995-8#2)(1996-1#2)(2007-12#1)(2008-12#7)(2008-4#2)(2011-2#2)(2012-3#2)
the ovaries##6##2##(1992-3#2)(2007-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
the ovary and hepatopancreas##2##4##(2008-6#2)
the ovary and oviduct##2##4##(2008-12#2)
the ovary and the##2##4##(2008-10#1)(2008-6#1)
the ovary and##7##3##(1993-2#1)(2008-10#1)(2008-12#2)(2008-6#3)
the ovary##35##2##(1990-2#1)(1992-3#1)(1993-2#1)(1995-12#2)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#4)(2008-6#4)(2009-7#1)(2010-12#1)(2010-5#3)(2010-7#1)(2010-8#2)(2013-1#3)(2013-8#4)
the over-expression of##2##3##(2007-12#1)(2008-11#1)
the over-expression##3##2##(2007-12#1)(2008-11#1)(2008-4#1)
the overall aim of##2##4##(2008-11#1)(2012-2#1)
the overall average##2##3##(2008-10#1)(2011-2#1)
the overall charge of##2##4##(1991-2#1)(2011-1#1)
the overall density of prey##2##5##(2008-8#2)
the overall economy##4##3##(1992-12#1)(1992-2#1)(1995-3#1)(2008-11#1)
the overall extent of##2##4##(1991-3#1)(2008-10#1)
the overall extraction##3##3##(2008-10#3)
the overall mean##6##3##(2008-10#3)(2008-7#1)(2008-9#2)
the overall performance##2##3##(2008-12#1)(2008-5#1)
the overall population##2##3##(1995-9#1)(2008-10#1)
the overall process##3##3##(2008-10#1)(2008-12#1)(2009-3#1)
the overall quality of the##3##5##(2008-11#1)(2008-6#1)(2010-1#1)
the overall quality of##5##4##(1995-12#1)(2008-11#1)(2008-6#1)(2010-1#1)(2013-1#1)
the overall reaction##2##3##(2008-10#2)
the overall response rate (ORR)##2##5##(2008-10#2)
the overall response##3##3##(1997-1#1)(2008-10#2)
the overall stability##2##3##(2008-10#1)(2008-8#1)
the overall success of##2##4##(2013-1#2)
the overall survival##5##3##(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
the overall##169##2##(1990-3#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#4)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#42)(2008-11#13)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#6)(2013-8#1)
the overarching##3##2##(1996-2#1)(1996-3#1)(2011-2#1)
the overexpressed##4##2##(1994-12#1)(1994-5#2)(2009-8#1)
the overexpression and##2##3##(1995-6#1)(2011-2#1)
the overexpression of p53##2##4##(2008-10#1)(2010-10#1)
the overexpression of##6##3##(1995-6#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)
the overexpression##8##2##(1995-6#2)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#2)
the overlap between##2##3##(2008-10#1)(2008-11#1)
the overlap of two##2##4##(2008-10#2)
the overlap of##3##3##(2008-10#3)
the overlap##6##2##(2008-10#4)(2008-11#1)(2009-8#1)
the overlapped##2##2##(2008-10#2)
the overlapping##17##2##(1996-12#1)(1996-8#1)(2008-10#12)(2008-3#1)(2008-8#1)(2013-1#1)
the overload phenomenon##3##3##(2008-7#3)
the overload##5##2##(2008-7#5)
the overlying##3##2##(1990-6#1)(2008-10#1)(2009-1#1)
the overpotential##2##2##(2008-10#2)
the overtone##2##2##(2008-10#1)(2008-3#1)
the overweight patients##2##3##(2008-10#2)
the overweight##5##2##(1991-12#1)(2008-10#4)
the overwhelming##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
the oviduct and##2##3##(2008-11#1)(2008-5#1)
the oviduct##6##2##(1990-8#1)(2008-11#2)(2008-12#2)(2008-5#1)
the oviductal##2##2##(2008-12#2)
the ovine##2##2##(1996-12#1)(1997-3#1)
the ovipositor##3##2##(2007-12#3)
the ovoid cells##2##3##(2008-7#2)
the owner of##2##3##(1996-5#1)(2011-4#1)
the owner##3##2##(1996-5#1)(2011-4#1)(2013-8#1)
the owners##2##2##(2008-5#1)(2013-8#1)
the oxalacetate pool##2##3##(1991-3#2)
the oxalate##2##2##(2008-10#2)
the oxidant##12##2##(1995-8#2)(2008-10#8)(2008-5#1)(2009-9#1)
the oxidase##5##2##(1993-8#3)(1995-2#1)(2008-10#1)
the oxidation and reduction##2##4##(2008-10#2)
the oxidation and##3##3##(1993-9#1)(2008-10#2)
the oxidation current##2##3##(2008-10#2)
the oxidation of HSO(3)(-)##2##4##(2008-10#2)
the oxidation of NO##3##4##(2008-10#3)
the oxidation of a##2##4##(2008-10#2)
the oxidation of ammonia##2##4##(2008-10#2)
the oxidation of ascorbic acid##2##5##(2008-10#2)
the oxidation of glucose##2##4##(2008-10#2)
the oxidation of iodide##2##4##(2008-10#2)
the oxidation of luminol by##2##5##(2008-10#2)
the oxidation of luminol with hydrogen peroxide##3##7##(2008-10#3)
the oxidation of luminol##6##4##(2008-10#6)
the oxidation of the##5##4##(2008-10#5)
the oxidation of these##2##4##(2008-10#2)
the oxidation of urea with##2##5##(2008-10#2)
the oxidation of urea##3##4##(2008-10#3)
the oxidation of##104##3##(1993-9#1)(1994-5#2)(2008-10#98)(2008-11#1)(2008-5#1)(2008-9#1)
the oxidation peak potential shifts##2##5##(2008-10#2)
the oxidation peak potential##4##4##(2008-10#4)
the oxidation peak##6##3##(2008-10#6)
the oxidation peaks##2##3##(2008-10#2)
the oxidation potential##2##3##(2008-10#2)
the oxidation process##3##3##(2008-10#3)
the oxidation reaction of##10##4##(2008-10#10)
the oxidation reaction##13##3##(2008-10#13)
the oxidation state of the##3##5##(2008-10#3)
the oxidation state of##5##4##(2008-10#5)
the oxidation state##7##3##(2008-10#7)
the oxidation step##3##3##(2008-10#2)(2012-3#1)
the oxidation##154##2##(1993-9#2)(1994-5#2)(2008-10#146)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
the oxidative burst in neutrophils##2##5##(2008-10#2)
the oxidative burst in##3##4##(1995-6#1)(2008-10#2)
the oxidative burst##12##3##(1995-6#6)(2008-10#6)
the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone with N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3##2##8##(2008-10#2)
the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone##3##6##(2008-10#3)
the oxidative coupling of##6##4##(2008-10#6)
the oxidative coupling reaction of##2##5##(2008-10#2)
the oxidative coupling##8##3##(2008-10#8)
the oxidative damage##2##3##(1997-8#1)(2013-1#1)
the oxidative degradation of##2##4##(2008-10#2)
the oxidative phosphorylation##3##3##(1990-2#2)(1991-5#1)
the oxidative reaction of##2##4##(2008-10#2)
the oxidative reaction##3##3##(2008-10#3)
the oxidative reactions##2##3##(2008-10#1)(2008-5#1)
the oxidative##45##2##(1990-11#1)(1990-2#2)(1991-5#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-6#6)(1995-8#1)(1997-8#1)(2008-10#26)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
the oxides##2##2##(2008-10#1)(2012-2#1)
the oxidized form of##2##4##(2008-10#2)
the oxidized form##3##3##(2008-10#2)(2008-11#1)
the oxidized##15##2##(1993-8#1)(1994-5#1)(1996-2#1)(2008-10#7)(2008-11#3)(2009-7#2)
the oxidizing agent##4##3##(2008-10#3)(2012-3#1)
the oxidizing##5##2##(2008-10#4)(2012-3#1)
the oxygen equilibrium properties of##2##5##(1993-8#2)
the oxygen equilibrium##3##3##(1993-8#3)
the oxygen tension##2##3##(2008-11#1)(2008-9#1)
the oxygen uptake##2##3##(2013-8#2)
the oxygen##22##2##(1990-5#1)(1993-8#3)(2008-10#7)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
the oxygen-rich##2##2##(2008-10#1)(2008-11#1)
the oyster Crassostrea gigas##2##4##(2008-11#2)
the ozone layer##4##3##(1991-6#2)(1996-1#2)
the ozone##7##2##(1991-12#1)(1991-6#2)(1996-1#3)(2008-11#1)
the p16INK4a and p16beta transcripts##2##5##(1997-7#2)
the p16INK4a##3##2##(1997-7#3)
the p53 gene in##2##4##(1993-11#2)
the p53 gene##4##3##(1993-11#2)(2008-10#2)
the p53 haploinsufficient##2##3##(2008-9#2)
the p53##16##2##(1993-11#2)(1994-12#2)(1994-5#1)(1997-7#2)(2008-10#2)(2008-9#3)(2010-10#1)(2010-3#2)(2011-2#1)
the pH and ionic strength of the##2##7##(2008-10#2)
the pH and##6##3##(2008-10#6)
the pH at##2##3##(2008-10#1)(2008-11#1)
the pH change##2##3##(2008-10#2)
the pH dependence of##2##4##(1993-8#1)(2008-10#1)
the pH effect##3##3##(2008-10#3)
the pH in##3##3##(2008-10#3)
the pH of the analyte solution##2##6##(2008-10#2)
the pH of the aqueous##2##5##(2008-10#2)
the pH of the solution##2##5##(1990-5#1)(2008-10#1)
the pH of the test solution##2##6##(2008-10#2)
the pH of the##16##4##(1990-5#1)(1991-5#1)(2008-10#13)(2008-5#1)
the pH of##21##3##(1990-5#1)(1991-5#1)(2008-10#16)(2008-11#1)(2008-5#2)
the pH range 1##2##4##(2008-10#2)
the pH range 2##2##4##(2008-10#2)
the pH range 4##4##4##(2008-10#4)
the pH range from 1 to##2##6##(2008-10#2)
the pH range from 1##3##5##(2008-10#3)
the pH range from##7##4##(2008-10#7)
the pH range of 1##2##5##(2008-10#2)
the pH range of 2##4##5##(2008-10#4)
the pH range of##17##4##(2008-10#17)
the pH range##55##3##(2008-10#55)
the pH value was##3##4##(2008-10#3)
the pH value##8##3##(2008-10#7)(2009-11#1)
the pH values##3##3##(2008-10#3)
the pH was##4##3##(2008-10#4)
the pH##155##2##(1990-5#1)(1991-5#1)(1993-3#1)(1993-8#2)(1994-5#2)(1995-6#1)(2008-10#136)(2008-11#2)(2008-12#1)(2008-5#2)(2009-11#1)(2011-2#3)(2013-1#2)
the pH-value##2##2##(2013-1#2)
the pHg/pSILBAγ##2##2##(2011-1#2)
the pK##2##2##(1991-9#1)(1994-5#1)
the pK(a) of the##2##4##(2008-10#2)
the pK(a) values##4##3##(2008-10#4)
the pK(a)##9##2##(2008-10#9)
the pKa##4##2##(1993-8#2)(1994-11#1)(2008-10#1)
the pKa1##2##2##(1990-5#1)(2008-10#1)
the pMLZ-4 mRNA##2##3##(1993-2#2)
the pO(2)##2##2##(2008-11#2)
the pTC##3##2##(2012-2#3)
the pace of##4##3##(1995-2#1)(2010-4#1)(2012-2#1)(2012-3#1)
the pacemaker##2##2##(1994-11#1)(1994-2#1)
the package##3##2##(2008-12#1)(2008-4#1)(2008-7#1)
the packed-bedreactor##2##2##(2008-11#2)
the packing##2##2##(2008-10#1)(2008-9#1)
the paediatric health care##2##4##(2008-11#2)
the paediatric intensive care##2##4##(2010-7#1)(2013-1#1)
the paediatric##19##2##(1996-6#1)(1996-9#1)(2008-10#3)(2008-11#8)(2008-9#1)(2010-7#2)(2013-1#3)
the pain and##3##3##(2008-12#1)(2009-1#1)(2013-1#1)
the pain##21##2##(1990-3#1)(1991-11#1)(1992-2#2)(1993-1#2)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-4#1)(2012-2#1)(2013-1#2)
the painful area##2##3##(2010-7#2)
the painted surface##4##3##(2008-10#4)
the paired t test##2##4##(1990-12#1)(2010-10#1)
the paired t-test##6##3##(2008-10#6)
the paired##10##2##(1990-12#1)(1993-6#1)(2008-10#6)(2010-10#1)(2011-2#1)
the palea##2##2##(2008-10#2)
the palladium##3##2##(2008-10#3)
the palm##4##2##(2008-10#4)
the palmar##4##2##(2008-9#2)(2011-2#2)
the palms##3##2##(1997-3#1)(2008-10#1)(2012-3#1)
the pamphlets##7##2##(1990-2#7)
the pancreas and##2##3##(1991-3#1)(2013-1#1)
the pancreas of##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
the pancreas showed##2##3##(2010-11#1)(2013-1#1)
the pancreas##47##2##(1990-3#2)(1990-9#7)(1991-3#2)(1992-5#2)(1992-9#1)(1997-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2010-10#1)(2010-11#4)(2012-2#3)(2012-3#3)(2013-1#11)(2013-7#2)
the pancreatic acinar cells##3##4##(2008-7#1)(2009-7#2)
the pancreatic duct##2##3##(2009-7#1)(2011-2#1)
the pancreatic islet##2##3##(1991-7#1)(2008-11#1)
the pancreatic juice##2##3##(2009-7#2)
the pancreatic##17##2##(1990-9#1)(1991-3#1)(1991-7#1)(1994-12#1)(2008-11#1)(2008-7#2)(2009-7#6)(2010-10#1)(2010-12#1)(2011-2#2)
the pancreaticoduodenal##2##2##(1991-6#1)(1995-2#1)
the pancreatitis pathway##2##3##(2008-3#2)
the pandemic (H1N1) 2009 virus##2##5##(2011-2#2)
the pandemic##5##2##(2008-10#1)(2011-2#4)
the panel of##2##3##(2008-10#1)(2012-12#1)
the panel##7##2##(1995-6#1)(2008-10#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
the panelists##3##2##(2008-5#3)
the paper deals##2##3##(2008-5#1)(2009-6#1)
the paper describes the##2##4##(1992-5#1)(2008-1#1)
the paper describes##3##3##(1992-5#1)(2008-1#1)(2008-11#1)
the paper illustrates##2##3##(1992-9#1)(1996-3#1)
the paper##38##2##(1991-2#1)(1992-5#1)(1992-9#1)(1994-12#1)(1996-3#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#5)(2008-5#1)(2008-7#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#2)(2012-3#3)(2013-1#1)(2013-8#1)
the papers##5##2##(1996-1#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
the papilla##2##2##(2008-5#1)(2011-2#1)
the papillary##4##2##(1990-9#1)(2008-5#1)(2010-6#2)
the paracrine##2##2##(2008-6#1)(2013-1#1)
the paradigm for##2##3##(2011-2#1)(2012-3#1)
the paradigm of##2##3##(2008-11#1)(2008-8#1)
the paradigm##10##2##(1994-12#1)(1997-2#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the paradox of enrichment##2##4##(2008-8#1)(2008-9#1)
the paradox##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
the parallel wire construct##3##4##(2009-3#3)
the parallel##9##2##(1991-12#1)(2008-10#3)(2009-10#1)(2009-3#3)(2013-1#1)
the paramedical##2##2##(1995-1#1)(2011-2#1)
the parameter estimates for drip irrigation##2##6##(2008-10#2)
the parameter estimates##5##3##(2008-10#5)
the parameter space##3##3##(2008-11#1)(2008-6#1)(2010-10#1)
the parameter to be##2##4##(2008-10#2)
the parameter##20##2##(2007-11#1)(2008-10#11)(2008-11#3)(2008-6#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-8#1)
the parameters affecting the##3##4##(2008-10#3)
the parameters for the##2##4##(2008-10#1)(2008-3#1)
the parameters of the##11##4##(1990-2#1)(1993-3#1)(1994-9#1)(2008-10#3)(2008-3#1)(2009-8#1)(2011-2#2)(2011-3#1)
the parameters of##17##3##(1990-2#1)(1991-2#1)(1993-3#1)(1994-9#1)(2008-10#4)(2008-3#3)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-8#1)
the parameters that affect the reaction were evaluated##2##8##(2008-10#2)
the parameters that affect the##4##5##(2008-10#3)(2008-11#1)
the parameters that affect##5##4##(1992-3#1)(2008-10#3)(2008-11#1)
the parameters that characterize##2##4##(2008-10#1)(2008-3#1)
the parameters that control##2##4##(1995-9#1)(2008-8#1)
the parameters that##13##3##(1992-3#1)(1995-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)
the parameters were##2##3##(1994-8#1)(2008-7#1)
the parameters##59##2##(1990-2#1)(1991-2#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-9#2)(2008-10#26)(2008-11#1)(2008-12#3)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-8#1)
the parametric and nonparametric##3##4##(2009-10#3)
the parametric##7##2##(2007-12#1)(2008-3#2)(2009-10#3)(2010-5#1)
the paramount##2##2##(1995-12#1)(2008-5#1)
the parasite life cycle##2##4##(1997-6#1)(2012-3#1)
the parasite species##2##3##(2012-12#2)
the parasite##24##2##(1997-6#2)(1997-7#2)(2008-10#1)(2008-8#4)(2008-9#4)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
the parasite's##2##2##(2008-9#1)(2009-8#1)
the parasites##5##2##(1996-12#1)(2008-5#1)(2008-9#2)(2012-12#1)
the parasitic plants##2##3##(2009-8#2)
the parasitic##9##2##(1990-11#1)(2008-10#2)(2008-8#2)(2009-8#2)(2012-2#2)
the parasitoid wasp##2##3##(1992-6#1)(2008-8#1)
the parasitoid##3##2##(1992-6#1)(2008-8#1)(2008-9#1)
the parathyroid##3##2##(1990-9#1)(2008-5#2)
the paraventricular nucleus (P &lt##2##5##(1996-12#2)
the paraventricular nucleus##3##3##(1996-12#3)
the paraventricular##5##2##(1994-2#1)(1996-12#4)
the parenchyma##2##2##(1997-8#1)(2008-10#1)
the parenchymal##2##2##(1996-2#1)(2008-6#1)
the parent compound##7##3##(1990-12#2)(1995-6#1)(2008-11#3)(2010-11#1)
the parent compounds##2##3##(2008-10#1)(2009-12#1)
the parent drug were##2##4##(2008-10#2)
the parent drug##9##3##(2008-10#5)(2008-8#1)(2011-3#1)(2013-1#2)
the parent ion##2##3##(2008-10#2)
the parent molecule##2##3##(1992-12#1)(2008-3#1)
the parent##36##2##(1990-12#2)(1991-2#1)(1992-12#1)(1992-4#1)(1994-8#1)(1995-6#1)(1995-9#1)(2008-10#14)(2008-11#5)(2008-3#1)(2008-8#2)(2009-12#1)(2009-9#1)(2010-11#1)(2011-3#1)(2013-1#2)
the parent-child relationship##3##3##(1992-2#1)(1995-5#1)(1996-9#1)
the parental and##2##3##(2008-10#1)(2008-11#1)
the parental isolates##2##3##(2008-10#2)
the parental origin of the##2##5##(1993-1#1)(1997-3#1)
the parental strain##6##3##(2008-10#5)(2009-6#1)
the parental##33##2##(1990-8#1)(1991-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-4#1)(2011-1#2)(2012-3#1)
the parenteral##2##2##(1990-2#1)(2012-12#1)
the parents and the##2##4##(1990-12#1)(2008-10#1)
the parents and##4##3##(1990-12#1)(2008-10#3)
the parents of##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
the parents were##2##3##(1995-12#1)(2008-10#1)
the parents##23##2##(1990-12#1)(1990-6#1)(1995-12#2)(1995-5#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
the parents'##2##2##(1994-3#1)(2010-9#1)
the parietal and##2##3##(1995-6#1)(2013-8#1)
the parietal cells##2##3##(1992-6#1)(2007-12#1)
the parietal lobe##2##3##(1997-6#1)(2008-7#1)
the parietal##11##2##(1992-6#1)(1995-6#1)(1997-1#2)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-7#1)(2013-8#1)
the parish##2##2##(1993-12#2)
the parotid##5##2##(1990-11#1)(1991-6#2)(2009-3#1)(2011-2#1)
the parsimony##2##2##(2008-4#1)(2010-11#1)
the part of the##7##4##(1990-11#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-9#2)
the part of##15##3##(1990-11#1)(1992-1#1)(1994-1#1)(1995-2#1)(1995-5#2)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#1)(2012-3#1)
the part##17##2##(1990-11#1)(1992-1#1)(1994-1#1)(1995-2#1)(1995-5#2)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
the partial least squares (PLS)##2##5##(2008-10#2)
the partial least squares##3##4##(2008-10#3)
the partial least##4##3##(2008-10#4)
the partial least-squares##3##3##(2008-10#3)
the partial likelihood##2##3##(1994-9#2)
the partial molar##2##3##(1997-2#1)(2008-10#1)
the partial##31##2##(1990-3#2)(1991-2#1)(1991-3#1)(1993-12#2)(1993-2#1)(1994-9#2)(1997-2#2)(2008-10#13)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)
the partially purified##2##3##(1991-12#1)(1992-2#1)
the partially resistant##4##3##(2008-10#4)
the partially##12##2##(1991-12#1)(1992-2#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#4)(2008-5#1)(2010-12#1)
the participant##6##2##(2008-10#1)(2008-12#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
the participant's##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
the participants had##4##3##(1994-12#1)(2008-10#1)(2010-10#1)(2012-2#1)
the participants in##2##3##(2009-10#1)(2011-2#1)
the participants were##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
the participants##26##2##(1991-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
the participating hospitals##2##3##(1991-2#1)(1994-3#1)
the participating laboratories##2##3##(2008-10#1)(2008-12#1)
the participating##9##2##(1991-2#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-12#3)
the participation of patients##2##4##(2008-11#1)(2010-4#1)
the participation of the##2##4##(2008-8#1)(2009-11#1)
the participation of this##2##4##(1995-6#1)(2008-7#1)
the participation of##13##3##(1990-7#1)(1991-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-4#1)
the participation##14##2##(1990-7#1)(1991-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-4#1)
the particle boundaries##2##3##(2008-3#2)
the particle distribution##2##3##(1992-2#1)(1992-3#1)
the particle size distribution##3##4##(1992-2#1)(2008-3#1)(2008-7#1)
the particle size##9##3##(1992-2#1)(1997-2#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
the particle##27##2##(1992-2#2)(1992-3#1)(1994-11#1)(1997-2#2)(2008-10#6)(2008-2#1)(2008-3#10)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)
the particle-size##2##2##(2008-3#2)
the particles in##4##3##(2008-10#3)(2008-3#1)
the particles was##2##3##(2008-10#2)
the particles were##2##3##(1997-1#1)(2008-10#1)
the particles##21##2##(1993-8#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#1)(2012-3#1)
the particular challenges##2##3##(1992-3#1)(2008-11#1)
the particular functional##2##3##(1993-8#1)(2008-7#1)
the particular##24##2##(1992-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
the particulate attenuation at##2##4##(2008-3#2)
the particulate attenuation##3##3##(2008-3#3)
the particulate matter##3##3##(2008-10#3)
the particulate##10##2##(1996-12#1)(1997-1#1)(2008-10#3)(2008-3#5)
the partition coefficient of the substrate##2##6##(1990-5#2)
the partition coefficient of the##3##5##(1990-5#2)(2008-10#1)
the partition coefficient of##4##4##(1990-5#2)(2008-10#2)
the partition coefficient##7##3##(1990-5#2)(1996-2#1)(2008-10#4)
the partition coefficients##4##3##(2008-10#3)(2008-7#1)
the partition for various diluents##2##5##(2008-10#2)
the partition##15##2##(1990-5#2)(1996-2#1)(2008-10#10)(2008-11#1)(2008-7#1)
the partitioning of##5##3##(2008-10#3)(2008-8#2)
the partitioning##7##2##(2008-10#5)(2008-8#2)
the partners##3##2##(2008-12#2)(2010-10#1)
the parts##3##2##(2008-3#1)(2009-10#1)(2013-1#1)
the parvocellular##2##2##(1996-2#1)(1997-2#1)
the pass of##2##3##(2008-10#2)
the passage of time##2##4##(2008-11#1)(2011-2#1)
the passage of##10##3##(1995-2#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#2)(2012-2#1)
the passage to a marine##2##5##(2008-9#2)
the passage##14##2##(1995-2#1)(2008-10#4)(2008-11#2)(2008-9#3)(2010-1#1)(2011-2#2)(2012-2#1)
the passiflora##2##2##(2008-10#2)
the passions of##2##3##(2008-12#1)(2008-8#1)
the passions##3##2##(1991-3#1)(2008-12#1)(2008-8#1)
the passivation agent##2##3##(2010-4#2)
the passive sampler##2##3##(2008-10#2)
the passive##6##2##(2008-10#5)(2011-2#1)
the past 10 years##11##4##(1992-3#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#3)(2009-1#1)(2009-4#1)(2012-3#1)(2013-8#1)
the past 100 years##2##4##(1997-7#1)(2008-10#1)
the past 100##5##3##(1994-3#1)(1997-7#1)(2008-10#1)(2010-5#1)(2013-8#1)
the past 12 months##5##4##(2008-10#1)(2009-5#4)
the past 12##8##3##(1993-3#1)(2008-10#1)(2009-5#6)
the past 15 years##5##4##(2008-11#3)(2011-2#1)(2012-2#1)
the past 2 years##2##4##(1997-6#1)(2008-10#1)
the past 2##3##3##(1997-6#1)(2008-10#1)(2013-8#1)
the past 20 years in##2##5##(1995-12#1)(2008-10#1)
the past 20 years##5##4##(1995-1#1)(1995-12#1)(2008-10#1)(2010-6#1)(2010-7#1)
the past 20##6##3##(1995-1#1)(1995-12#1)(2008-10#1)(2008-8#1)(2010-6#1)(2010-7#1)
the past 25 years##2##4##(1997-1#1)(2008-7#1)
the past 3##3##3##(1995-11#1)(2008-10#1)(2010-7#1)
the past 30 years##4##4##(2008-11#1)(2010-1#1)(2010-11#1)(2011-2#1)
the past 30##6##3##(2008-11#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#2)
the past 5 years##2##4##(1995-3#1)(2008-10#1)
the past 5##3##3##(1995-3#1)(2008-10#1)(2008-6#1)
the past 50 years##3##4##(2008-11#1)(2008-7#1)(2011-1#1)
the past and##3##3##(1994-6#1)(2008-12#1)(2008-4#1)
the past century##4##3##(1997-7#1)(2008-10#2)(2011-2#1)
the past decade has##2##4##(1994-1#1)(2008-10#1)
the past decade in##2##4##(2008-10#2)
the past decade there has been##3##6##(1991-2#1)(2007-12#1)(2008-11#1)
the past decade##43##3##(1991-2#1)(1991-3#2)(1993-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#1)(2007-12#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
the past decades##6##3##(2008-10#1)(2009-5#1)(2010-10#1)(2011-2#2)(2013-1#1)
the past few decades with##2##5##(2008-10#1)(2013-1#1)
the past few decades##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
the past few years##18##4##(1992-9#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
the past few##22##3##(1992-9#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
the past four decades##2##4##(1994-3#1)(1997-1#1)
the past half century##2##4##(1997-1#1)(2009-5#1)
the past several decades##2##4##(2011-2#2)
the past several years##11##4##(1991-1#1)(1992-2#1)(1992-3#2)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)
the past several##13##3##(1991-1#1)(1992-2#1)(1992-3#2)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#2)
the past ten years##3##4##(1990-6#1)(1991-12#1)(1996-3#1)
the past three decades##6##4##(1992-12#1)(1996-2#1)(2008-1#1)(2008-11#2)(2010-8#1)
the past three years##2##4##(1993-3#1)(2012-3#1)
the past three##8##3##(1992-12#1)(1993-3#1)(1996-2#1)(2008-1#1)(2008-11#2)(2010-8#1)(2012-3#1)
the past twenty years##3##4##(1991-3#1)(1992-1#1)(2013-8#1)
the past two decades##7##4##(1995-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#2)
the past two years##3##4##(1991-2#1)(1992-12#1)(1996-8#1)
the past two##10##3##(1991-2#1)(1992-12#1)(1995-1#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#2)
the past years many##2##4##(1990-9#1)(2008-10#1)
the past years##6##3##(1990-9#1)(1996-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
the past##251##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#4)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-9#3)(1993-12#2)(1993-3#5)(1993-8#1)(1994-1#3)(1994-3#5)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#6)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#2)(2007-12#2)(2008-1#3)(2008-10#42)(2008-11#26)(2008-12#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#9)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#1)(2011-1#3)(2011-2#22)(2012-12#1)(2012-2#3)(2012-3#5)(2012-7#1)(2013-1#7)(2013-8#6)
the paste##6##2##(2008-10#6)
the patch clamp technique##2##4##(1994-11#1)(2008-8#1)
the patch occupancy framework##2##4##(2008-8#2)
the patch occupancy##3##3##(2008-8#3)
the patch##13##2##(1994-11#1)(2008-5#2)(2008-8#6)(2008-9#4)
the patch-clamp##3##2##(1993-3#1)(1995-2#1)(2008-11#1)
the patches##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
the patella##2##2##(2009-4#1)(2013-1#1)
the patellar tendon##4##3##(2009-4#2)(2013-1#2)
the patellar##6##2##(1995-8#1)(1997-8#1)(2009-4#2)(2013-1#2)
the paternal##3##2##(1997-3#1)(2008-8#1)(2008-9#1)
the paternity##2##2##(2008-12#1)(2008-6#1)
the path of##2##3##(1993-6#1)(2010-8#1)
the path to##3##3##(1996-3#1)(2010-7#1)(2011-2#1)
the path##10##2##(1993-6#1)(1996-3#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)
the pathogen Fusarium oxysporum f##2##5##(2008-10#2)
the pathogen and the##7##4##(2008-10#7)
the pathogen and##18##3##(2008-10#17)(2008-9#1)
the pathogen by##5##3##(2008-10#4)(2009-6#1)
the pathogen can be##2##4##(2008-10#2)
the pathogen can##4##3##(2008-10#4)
the pathogen did not##3##4##(2008-10#3)
the pathogen directly##2##3##(2008-10#2)
the pathogen from##3##3##(2008-10#3)
the pathogen had##2##3##(2008-10#2)
the pathogen has##4##3##(2008-10#4)
the pathogen in planta##2##4##(2008-10#2)
the pathogen in##17##3##(2008-10#16)(2008-5#1)
the pathogen is##3##3##(2008-10#2)(2008-8#1)
the pathogen multiplied abundantly through much of the##2##8##(2008-10#2)
the pathogen mycelium##4##3##(2008-10#4)
the pathogen on the##3##4##(2008-10#3)
the pathogen on##6##3##(2008-10#6)
the pathogen population from##2##4##(2008-10#2)
the pathogen population##20##3##(2008-10#19)(2008-8#1)
the pathogen to##5##3##(2008-10#5)
the pathogen was found##2##4##(2008-10#2)
the pathogen was##16##3##(2008-10#16)
the pathogen were##7##3##(2008-10#7)
the pathogen##275##2##(1995-5#2)(2008-10#253)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#5)(2009-6#2)(2011-2#3)(2012-2#2)(2012-3#2)
the pathogen's life##2##3##(2008-10#2)
the pathogen's population structure##2##4##(2008-10#2)
the pathogen's##6##2##(2008-10#6)
the pathogenesis and treatment of##2##5##(1990-11#1)(2010-10#1)
the pathogenesis and##4##3##(1990-11#1)(1991-11#1)(2010-10#1)(2013-8#1)
the pathogenesis of atherosclerosis##3##4##(1994-11#1)(1997-8#1)(2008-6#1)
the pathogenesis of cardiovascular disease##2##5##(1996-11#1)(2013-3#1)
the pathogenesis of the##5##4##(1992-6#1)(1995-5#1)(2008-1#1)(2008-7#1)(2009-1#1)
the pathogenesis of these##2##4##(2008-10#1)(2008-7#1)
the pathogenesis of##91##3##(1990-9#2)(1991-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#4)(2006-6#1)(2008-1#3)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-9#1)(2009-1#2)(2009-12#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-5#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-3#1)(2013-7#1)(2013-8#5)
the pathogenesis##99##2##(1990-11#1)(1990-9#2)(1991-11#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#4)(2006-6#1)(2008-1#3)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-9#1)(2009-1#2)(2009-12#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#4)(2010-5#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-3#1)(2013-7#1)(2013-8#6)
the pathogenesis-related##3##2##(2008-10#3)
the pathogenetic##2##2##(1997-8#1)(2010-12#1)
the pathogenic role##2##3##(2008-5#1)(2010-1#1)
the pathogenic specificity on##2##4##(2008-10#2)
the pathogenic##20##2##(1997-2#1)(2008-10#14)(2008-5#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-8#1)
the pathogenicity of the##3##4##(2008-10#2)(2008-5#1)
the pathogenicity of##11##3##(2008-10#10)(2008-5#1)
the pathogenicity##15##2##(2008-10#13)(2008-11#1)(2008-5#1)
the pathogens and##2##3##(2008-10#2)
the pathogens##16##2##(2008-10#13)(2008-12#1)(2010-4#1)(2011-2#1)
the pathologic##4##2##(1991-12#1)(2008-9#2)(2010-6#1)
the pathological changes##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)
the pathological conditions associated with##2##5##(2013-1#1)(2013-8#1)
the pathological conditions##3##3##(2008-12#1)(2013-1#1)(2013-8#1)
the pathological##20##2##(1990-6#1)(1994-5#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
the pathologist##3##2##(1992-2#1)(1997-5#1)(2009-1#1)
the pathology of##4##3##(1991-3#1)(2008-10#1)(2009-4#1)(2009-8#1)
the pathology##18##2##(1991-3#1)(1992-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
the pathophysiologic##3##2##(1993-1#1)(2008-10#1)(2011-2#1)
the pathophysiological##2##2##(2008-7#1)(2011-2#1)
the pathophysiology and##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
the pathophysiology of depression##2##4##(2008-7#2)
the pathophysiology of various##2##4##(2008-11#1)(2008-7#1)
the pathophysiology of##34##3##(1996-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#2)
the pathophysiology##41##2##(1994-6#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
the pathotype##4##2##(2008-10#4)
the pathovar##2##2##(2008-10#2)
the pathovars##2##2##(2008-10#2)
the paths##2##2##(2008-12#1)(2013-8#1)
the pathway and##2##3##(2010-11#1)(2011-3#1)
the pathway intermediates##2##3##(2008-10#1)(2008-7#1)
the pathway of##5##3##(1996-5#1)(2008-11#2)(2011-3#1)(2013-8#1)
the pathway that##2##3##(2008-11#1)(2009-8#1)
the pathway##21##2##(1990-7#1)(1994-11#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-3#5)(2013-8#1)
the pathways by which##2##4##(1997-4#1)(2008-10#1)
the pathways by##3##3##(1997-2#1)(1997-4#1)(2008-10#1)
the pathways that##2##3##(2009-12#1)(2009-9#1)
the pathways##14##2##(1996-2#2)(1997-2#1)(1997-4#1)(2008-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the patient and the##4##4##(1991-12#1)(2009-9#1)(2011-2#1)(2012-12#1)
the patient and##18##3##(1990-6#1)(1991-12#1)(1992-2#1)(1992-3#1)(1994-12#1)(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
the patient and/or##2##3##(2008-10#1)(2012-12#1)
the patient as##6##3##(1993-12#1)(1996-6#1)(2008-11#2)(2011-2#1)(2012-3#1)
the patient at##2##3##(1992-2#1)(2008-7#1)
the patient became##3##3##(1996-3#2)(2013-1#1)
the patient by##2##3##(1990-11#1)(1995-12#1)
the patient care##2##3##(1995-12#1)(2008-10#1)
the patient complained of##3##4##(2009-1#1)(2012-3#1)(2013-1#1)
the patient developed a##2##4##(2011-2#1)(2013-1#1)
the patient developed##8##3##(2008-7#1)(2009-3#2)(2010-5#1)(2011-2#3)(2013-1#1)
the patient did not##3##4##(1997-4#1)(2008-12#1)(2011-2#1)
the patient died##3##3##(1991-12#1)(2009-8#1)(2011-2#1)
the patient from##2##3##(2012-2#1)(2013-8#1)
the patient group##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
the patient had a##4##4##(1996-6#1)(2008-11#1)(2011-2#2)
the patient had an##3##4##(1991-1#1)(2010-7#1)(2012-2#1)
the patient had##16##3##(1991-1#1)(1993-8#1)(1996-6#1)(2008-11#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the patient has##8##3##(1992-3#1)(1997-5#1)(2008-11#1)(2010-6#1)(2012-12#2)(2013-1#2)
the patient in##9##3##(1990-6#1)(2008-11#2)(2008-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
the patient is referred##2##4##(2008-8#1)(2011-3#1)
the patient is the##2##4##(1992-3#1)(2013-1#1)
the patient is##27##3##(1990-11#1)(1990-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1994-3#2)(1994-9#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#5)
the patient or##2##3##(1991-2#1)(2013-8#1)
the patient population##2##3##(2010-11#1)(2010-12#1)
the patient presented with##4##4##(1997-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
the patient presented##5##3##(1997-5#1)(2010-12#1)(2012-12#1)(2013-1#2)
the patient remains asymptomatic##3##4##(2008-7#1)(2012-3#1)(2013-1#1)
the patient remains##4##3##(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
the patient returned to##2##4##(2008-1#1)(2012-12#1)
the patient returned##3##3##(2008-1#1)(2011-2#1)(2012-12#1)
the patient revealed a##2##4##(1994-11#1)(2010-11#1)
the patient should be##6##4##(1993-6#1)(1994-12#1)(1996-11#1)(2010-12#1)(2011-2#2)
the patient should##7##3##(1993-6#2)(1994-12#1)(1996-11#1)(2010-12#1)(2011-2#2)
the patient showed##2##3##(2008-7#2)
the patient suffered from##2##4##(1993-2#1)(2008-12#1)
the patient suffered##3##3##(1993-2#1)(2008-12#2)
the patient to##8##3##(1992-12#1)(1992-3#1)(1993-12#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the patient underwent a##2##4##(2009-3#1)(2010-12#1)
the patient underwent##5##3##(1991-11#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)
the patient was asymptomatic##2##4##(1996-3#1)(2013-1#1)
the patient was in##3##4##(1990-5#1)(2007-12#1)(2013-8#1)
the patient was referred##4##4##(1991-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
the patient was treated with##2##5##(2008-11#1)(2013-1#1)
the patient was treated##3##4##(2008-11#1)(2008-12#1)(2013-1#1)
the patient was##42##3##(1990-5#1)(1991-11#1)(1993-1#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#1)(2010-10#2)(2010-5#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#4)
the patient with##14##3##(1991-12#1)(1992-3#1)(1996-8#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
the patient's ability to##2##4##(1991-9#1)(2008-10#1)
the patient's age##2##3##(1997-8#1)(2012-2#1)
the patient's clinical##2##3##(2011-2#1)(2013-1#1)
the patient's culture##2##3##(2011-2#1)(2013-1#1)
the patient's health##2##3##(1997-4#1)(2008-11#1)
the patient's history##2##3##(1997-2#1)(2008-8#1)
the patient's life##4##3##(1990-5#1)(2010-5#1)(2010-8#1)(2013-8#1)
the patient's medical##2##3##(2010-8#1)(2013-1#1)
the patient's perspective##3##3##(2008-11#1)(2008-12#1)(2012-3#1)
the patient's preoperative##3##3##(1994-3#1)(2011-2#1)(2013-1#1)
the patient's symptoms##2##3##(2010-1#1)(2012-3#1)
the patient's treatment##2##3##(2009-11#2)
the patient's##101##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#4)(2008-10#6)(2008-11#4)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-11#2)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#1)
the patient-provider##2##2##(2013-1#2)
the patients and their##2##4##(2008-10#1)(2008-7#1)
the patients and##6##3##(1992-2#1)(1993-2#1)(2008-10#2)(2008-7#1)(2010-8#1)
the patients are##2##3##(1993-1#1)(1997-4#1)
the patients diagnosed in the##2##5##(2008-1#2)
the patients did not##2##4##(1990-12#1)(2011-1#1)
the patients for##2##3##(1993-6#1)(2013-8#1)
the patients from##2##3##(2008-10#1)(2012-2#1)
the patients had##16##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#2)(1993-12#1)(1993-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-8#1)
the patients have##2##3##(2008-10#1)(2010-3#1)
the patients in the##4##4##(1993-11#1)(1994-3#1)(1997-5#2)
the patients in##9##3##(1993-11#1)(1994-3#1)(1995-11#1)(1997-5#2)(2008-10#1)(2009-12#1)(2010-7#1)(2011-1#1)
the patients into##2##3##(1997-2#1)(2011-2#1)
the patients presenting##2##3##(2013-8#2)
the patients receiving##2##3##(2008-1#1)(2010-7#1)
the patients reported##3##3##(1991-3#1)(1993-2#1)(1995-12#1)
the patients survived##2##3##(1990-12#1)(2011-2#1)
the patients than in##3##4##(1994-11#1)(2008-7#1)(2011-2#1)
the patients that##2##3##(2008-8#1)(2011-2#1)
the patients they##2##3##(1991-1#1)(1991-2#1)
the patients to##4##3##(1995-11#2)(1995-6#1)(2008-10#1)
the patients treated##2##3##(2008-7#2)
the patients underwent##3##3##(1990-9#1)(1997-8#1)(2013-1#1)
the patients were##16##3##(1990-11#1)(1990-6#1)(1990-9#2)(1993-1#1)(1993-11#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#2)(2012-5#1)(2013-7#1)
the patients who died##2##4##(1997-4#1)(2012-3#1)
the patients who were##2##4##(1996-11#1)(2012-3#1)
the patients who##9##3##(1990-12#1)(1995-3#1)(1996-11#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-7#1)(2012-3#2)
the patients with a##2##4##(2008-11#1)(2011-3#1)
the patients with benign##2##4##(1990-9#1)(2011-1#1)
the patients with##28##3##(1990-9#1)(1992-11#2)(1992-5#1)(1993-2#1)(1993-8#1)(1994-12#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#4)(2008-8#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)
the patients##256##2##(1990-11#3)(1990-12#6)(1990-2#6)(1990-3#1)(1990-6#2)(1990-9#9)(1991-1#1)(1991-12#1)(1991-2#6)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-2#2)(1992-5#3)(1992-6#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#3)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#4)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#9)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#17)(2008-10#11)(2008-11#11)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#16)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-6#3)(2010-7#6)(2010-8#4)(2011-1#5)(2011-2#16)(2011-3#4)(2012-12#3)(2012-2#1)(2012-3#10)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#4)
the patients' rights##2##3##(1997-8#1)(2013-8#1)
the patients'##20##2##(1990-2#2)(1991-2#3)(1993-2#1)(1994-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
the pattern and##2##3##(1991-8#1)(2008-7#1)
the pattern of distribution##3##4##(1996-3#1)(2008-10#2)
the pattern of selection##2##4##(2008-8#2)
the pattern of the##3##4##(1990-12#1)(1994-5#1)(2008-8#1)
the pattern of##39##3##(1990-12#2)(1991-3#1)(1991-8#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#9)(2009-10#1)(2009-7#1)(2010-8#1)(2012-2#1)
the pattern##51##2##(1990-12#2)(1990-9#1)(1991-3#1)(1991-8#2)(1994-11#1)(1994-5#2)(1995-12#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#10)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)
the patterning of a##2##4##(1996-2#1)(2007-11#1)
the patterns of##11##3##(1993-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
the patterns##16##2##(1993-12#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-2#1)(2012-3#1)
the paucity of##8##3##(1991-8#1)(1995-1#1)(1997-2#1)(1997-9#1)(2008-10#2)(2010-12#1)(2011-2#1)
the payer##2##2##(1996-1#1)(2013-8#1)
the payment for##2##3##(1994-1#1)(2008-11#1)
the payment##7##2##(1992-1#1)(1992-2#1)(1994-1#1)(1994-12#2)(1996-3#1)(2008-11#1)
the payoff##2##2##(1992-2#1)(2008-8#1)
the pea lectin##3##3##(1993-8#3)
the pea##9##2##(1993-8#4)(2008-10#4)(2009-8#1)
the peak BMD##2##3##(2010-3#2)
the peak area ratios##2##4##(2008-10#2)
the peak area##8##3##(2008-10#8)
the peak at##2##3##(2008-10#1)(2008-11#1)
the peak concentration##2##3##(1992-9#1)(2008-11#1)
the peak current and##3##4##(2008-10#3)
the peak current of the##2##5##(2008-10#2)
the peak current of##4##4##(2008-10#4)
the peak current##18##3##(2008-10#18)
the peak currents are linearly proportional to the concentration of##3##10##(2008-10#3)
the peak currents are##4##4##(2008-10#4)
the peak currents##8##3##(2008-10#8)
the peak experiences of psilocybin users##2##6##(2013-8#2)
the peak frequency##2##3##(2008-11#1)(2008-2#1)
the peak height and##2##4##(2008-10#2)
the peak height##10##3##(1993-8#1)(2008-10#9)
the peak heights obtained##4##4##(2008-10#4)
the peak heights##7##3##(2008-10#6)(2008-2#1)
the peak in##3##3##(1997-7#1)(2008-9#2)
the peak intensity##2##3##(2008-2#1)(2008-3#1)
the peak of the##5##4##(1990-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
the peak of##8##3##(1990-11#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
the peak period of fruit susceptibility##2##6##(2008-10#2)
the peak position at maximum height##2##6##(2008-10#2)
the peak position##3##3##(2008-10#3)
the peak potential##3##3##(2008-10#3)
the peak potentials##4##3##(2008-10#4)
the peak time##2##3##(2008-10#1)(2011-2#1)
the peak##121##2##(1990-11#1)(1992-9#2)(1993-1#1)(1993-8#2)(1994-5#1)(1995-11#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-7#1)(2008-10#79)(2008-11#3)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2010-3#3)(2011-2#3)(2013-1#1)(2013-8#2)
the peaks corresponding to##2##4##(2008-10#2)
the peaks of the##2##4##(2008-10#2)
the peaks of##5##3##(2008-10#5)
the peaks were##2##3##(2008-10#2)
the peaks##18##2##(2008-10#18)
the pecking behavior##2##3##(2008-6#2)
the pectoralis minor##3##3##(2010-9#2)(2013-1#1)
the pectoralis##4##2##(2009-1#1)(2010-9#2)(2013-1#1)
the peculiar##2##2##(2008-3#1)(2012-2#1)
the pediatric patient##2##3##(2008-10#1)(2011-2#1)
the pediatric##12##2##(1995-5#1)(2008-10#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)
the pedicle##3##2##(2007-11#2)(2008-7#1)
the pedigree##2##2##(2008-10#2)
the peduncle##2##2##(2008-10#2)
the pedunculopontine tegmental nucleus##3##4##(1994-2#2)(2008-7#1)
the peel##3##2##(2008-10#3)
the peer-reviewed##2##2##(2010-8#2)
the pellets##2##2##(2008-10#2)
the pelvic cavity##3##3##(1992-3#1)(2008-12#1)(2008-7#1)
the pelvic nerve##2##3##(1992-3#2)
the pelvic##12##2##(1990-5#2)(1992-3#3)(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-4#1)(2011-2#1)
the pelvis and##2##3##(1991-11#1)(2013-1#1)
the pelvis##13##2##(1991-11#1)(1991-12#1)(1992-12#2)(2008-8#3)(2009-12#1)(2011-2#4)(2013-1#1)
the penetration of##2##3##(2008-5#1)(2011-2#1)
the penetration pore##2##3##(2008-10#2)
the penetration##8##2##(2008-10#5)(2008-5#2)(2011-2#1)
the penicillin##4##2##(2008-10#2)(2011-1#2)
the penis##9##2##(1990-12#2)(1991-8#1)(2008-10#4)(2013-1#1)(2013-8#1)
the pentaammine ruthenium(II)##2##3##(2008-10#2)
the pentose phosphate pathway (PPP)##2##5##(2008-7#2)
the pentose phosphate pathway##5##4##(1991-5#1)(2008-11#1)(2008-7#2)(2010-12#1)
the people are##2##3##(2010-12#1)(2011-2#1)
the people##16##2##(1991-1#1)(1991-2#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#2)(2010-8#2)(2011-2#2)(2012-12#1)
the pepper##2##2##(2008-10#2)
the peptide and##4##3##(1993-8#1)(1996-12#1)(2008-10#1)(2008-5#1)
the peptide backbone##2##3##(1990-8#1)(1992-6#1)
the peptide bond##2##3##(1995-6#1)(2008-10#1)
the peptide in##4##3##(1992-6#2)(2008-6#1)(2012-3#1)
the peptide is##2##3##(1994-5#1)(2008-8#1)
the peptide sequence##4##3##(2008-10#1)(2008-4#2)(2012-12#1)
the peptide was##4##3##(1991-5#1)(1993-8#1)(2008-10#2)
the peptide with an excess##2##5##(2008-8#2)
the peptide with##3##3##(1992-4#1)(2008-8#2)
the peptide##57##2##(1990-5#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#3)(1993-8#2)(1994-2#1)(1994-3#2)(1994-5#4)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#4)(1997-4#2)(2008-10#10)(2008-4#8)(2008-5#1)(2008-6#1)(2008-8#4)(2009-5#1)(2010-1#1)(2012-12#1)(2012-3#1)
the peptides##11##2##(1990-5#1)(1994-8#2)(1995-11#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)
the peptidolytic reaction##2##3##(1991-9#2)
the peptone##4##2##(2008-7#4)
the per capita growth##2##4##(2008-8#1)(2013-8#1)
the per capita##4##3##(2008-8#3)(2013-8#1)
the per##6##2##(1997-8#1)(2008-10#1)(2008-8#3)(2013-8#1)
the perceived prevalence of##2##4##(2013-1#2)
the perceived quality of##2##4##(2008-11#1)(2009-4#1)
the perceived social support##2##4##(1992-2#1)(2009-7#1)
the perceived value of##2##4##(1994-1#1)(2012-2#1)
the perceived##24##2##(1992-2#1)(1993-12#1)(1994-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#3)(2012-2#1)(2013-1#4)(2013-8#1)
the percent of##3##3##(1996-12#1)(1996-3#1)(2008-11#1)
the percent recoveries were increased##2##5##(2008-10#2)
the percent recovery##3##3##(2008-10#3)
the percent##13##2##(1996-12#1)(1996-3#1)(2008-10#9)(2008-11#1)(2008-4#1)
the percentage and##2##3##(2008-8#1)(2010-1#1)
the percentage content of##2##4##(2008-10#2)
the percentage extraction##2##3##(2008-10#2)
the percentage of all##2##4##(1995-3#1)(2011-2#1)
the percentage of budded cells##2##5##(1996-3#2)
the percentage of cells##3##4##(2008-10#2)(2008-4#1)
the percentage of diseased spikelets##2##5##(2008-10#2)
the percentage of diseased##4##4##(2008-10#4)
the percentage of infected##2##4##(2008-10#2)
the percentage of leaf##2##4##(2008-10#2)
the percentage of the##8##4##(1993-3#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-8#1)
the percentage of water##2##4##(2008-10#1)(2008-5#1)
the percentage of##82##3##(1990-11#1)(1990-6#1)(1991-11#3)(1991-5#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-3#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#37)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#5)
the percentage##96##2##(1990-11#2)(1990-6#1)(1991-11#3)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-3#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#44)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#5)
the percentages of the##2##4##(1993-8#1)(2008-11#1)
the percentages of##10##3##(1993-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
the perception and##2##3##(2008-11#2)
the perception of##11##3##(1992-3#1)(1995-5#1)(2008-11#3)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the perception##14##2##(1991-2#1)(1992-3#1)(1995-5#1)(2008-11#5)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the perceptions and##2##3##(2009-5#1)(2010-11#1)
the perceptions of##4##3##(2008-11#1)(2009-3#1)(2010-9#1)(2012-3#1)
the perceptions##7##2##(2008-1#1)(2008-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-9#1)(2012-3#1)
the perchlorate ion##2##3##(2008-10#2)
the perchlorate##7##2##(2008-10#7)
the percutaneous absorption of##3##4##(2008-5#1)(2011-3#2)
the percutaneous absorption##4##3##(2008-5#2)(2011-3#2)
the percutaneous##6##2##(1991-3#1)(2008-12#1)(2008-5#2)(2011-3#2)
the perennial##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
the perfect##4##2##(2008-10#1)(2008-9#1)(2013-1#2)
the perforant##2##2##(1990-5#2)
the performance and##2##3##(2008-10#1)(2008-4#1)
the performance characteristics##2##3##(2008-10#1)(2008-5#1)
the performance of a##16##4##(1993-12#1)(1995-5#1)(2008-10#1)(2008-3#10)(2008-7#1)(2008-9#1)(2013-1#1)
the performance of an##2##4##(2008-10#1)(2008-5#1)
the performance of both##2##4##(2008-10#2)
the performance of such##2##4##(2008-2#1)(2008-6#1)
the performance of the method##2##5##(2008-10#1)(2010-4#1)
the performance of the proposed##3##5##(2008-10#3)
the performance of the system were##2##6##(2008-10#2)
the performance of the system##4##5##(2008-10#4)
the performance of the two##2##5##(1991-2#1)(2008-12#1)
the performance of the##37##4##(1991-1#1)(1991-2#1)(1992-2#1)(1993-3#1)(1994-3#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the performance of these##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
the performance of this system##3##5##(2008-10#2)(2008-11#1)
the performance of this##7##4##(2008-10#4)(2008-11#1)(2008-3#1)(2012-3#1)
the performance of three##2##4##(2008-10#2)
the performance of various##2##4##(2008-10#1)(2008-3#1)
the performance of##125##3##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#49)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#19)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#4)(2009-8#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
the performance##145##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#58)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#19)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-9#4)(2009-8#2)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
the performance-based ranking within a group of##2##7##(2011-2#2)
the performance-based##3##2##(1996-2#1)(2011-2#2)
the performances of the sensor##2##5##(2008-10#2)
the performances of the##6##4##(2008-10#5)(2011-2#1)
the performances of##11##3##(1991-3#1)(2008-10#8)(2008-6#1)(2011-2#1)
the performances##12##2##(1991-3#1)(2008-10#9)(2008-6#1)(2011-2#1)
the perfusate##2##2##(1992-3#1)(2008-7#1)
the perfusion of##3##3##(1996-3#1)(2008-11#1)(2008-8#1)
the perfusion rate##3##3##(2008-11#3)
the perfusion system##3##3##(2008-11#2)(2012-2#1)
the perfusion##14##2##(1996-3#1)(2008-11#9)(2008-8#1)(2009-11#1)(2010-12#1)(2012-2#1)
the pericardium##4##2##(2008-11#1)(2008-7#1)(2008-9#2)
the pericarp##2##2##(2008-10#2)
the perikaryon##4##2##(2008-7#4)
the perinatal mortality##2##3##(1990-3#1)(1994-3#1)
the perinatal##5##2##(1990-3#1)(1991-6#1)(1991-9#1)(1994-3#1)(2012-3#1)
the perineum##2##2##(2008-10#2)
the perinuclear space##2##3##(2008-9#1)(2011-2#1)
the perinuclear##6##2##(2008-7#3)(2008-9#1)(2011-2#1)(2012-3#1)
the period 1986-1989##2##3##(1991-8#2)
the period after##2##3##(1995-12#1)(1995-3#1)
the period and cohort##2##4##(1996-3#2)
the period between##6##3##(1994-2#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)
the period from January##2##4##(2007-8#1)(2008-5#1)
the period from October##2##4##(1995-5#1)(2011-3#1)
the period from##10##3##(1992-1#1)(1994-12#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-3#1)(2012-12#1)(2013-8#1)
the period in##3##3##(1990-8#1)(2008-5#2)
the period of study##2##4##(2011-1#1)(2012-12#1)
the period of the##2##4##(1993-6#1)(2008-10#1)
the period of##30##3##(1992-3#1)(1993-6#1)(1997-4#1)(2008-10#9)(2008-11#4)(2008-5#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)
the period was##2##3##(1997-8#1)(2008-5#1)
the period when##2##3##(2008-10#1)(2008-8#1)
the period##125##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#2)(1991-6#4)(1991-8#3)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#3)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-4#3)(1997-7#1)(1997-8#3)(2007-11#1)(2007-8#2)(2008-10#17)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#7)(2008-7#4)(2008-8#4)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-4#1)(2012-7#1)(2013-1#1)(2013-8#2)
the periodate oxidation of##3##4##(2008-10#3)
the periodic##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
the periodically poled##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the periodically##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
the periodontal##4##2##(1996-2#1)(2008-1#1)(2008-11#1)(2013-1#1)
the periods##3##2##(1995-12#1)(2008-10#2)
the perioperative period##3##3##(1992-3#1)(2011-1#1)(2013-1#1)
the perioperative period]##2##3##(2008-10#1)(2009-5#1)
the perioperative##10##2##(1992-3#1)(1992-5#1)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
the periosteum##3##2##(1994-3#1)(2008-9#2)
the peripheral areas of##2##4##(2008-11#1)(2009-10#1)
the peripheral blood##10##3##(1990-3#1)(1994-11#1)(2008-10#1)(2008-7#2)(2011-2#2)(2012-3#3)
the peripheral nervous system##4##4##(1995-12#1)(1996-12#1)(1996-2#1)(2008-7#1)
the peripheral tissues##2##3##(1991-7#2)
the peripheral##40##2##(1990-3#1)(1990-8#2)(1991-7#2)(1994-11#1)(1994-12#2)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
the periphery of the##9##4##(1991-11#1)(1991-2#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)
the periphery of##14##3##(1991-11#1)(1991-2#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#2)
the periphery##23##2##(1991-11#1)(1991-2#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#2)(2012-3#1)
the periplasm of##2##3##(2008-7#1)(2009-6#1)
the periplasm##4##2##(1991-10#1)(1993-9#1)(2008-7#1)(2009-6#1)
the periplasmic##2##2##(1993-6#1)(2011-2#1)
the peristaltic##2##2##(1996-3#1)(2008-10#1)
the peritoneal cavity##7##3##(1990-2#1)(2008-1#2)(2008-10#1)(2008-12#2)(2011-2#1)
the peritoneal##13##2##(1990-2#1)(1995-3#1)(2008-1#2)(2008-10#4)(2008-12#2)(2011-2#3)
the peritoneum##3##2##(1990-2#1)(1991-12#1)(2011-2#1)
the permanence of##2##3##(2008-5#1)(2012-2#1)
the permanent calves##3##3##(1996-12#3)
the permanent##9##2##(1992-2#1)(1992-9#1)(1996-12#3)(2008-10#1)(2009-8#1)(2010-12#1)(2013-1#1)
the permeability of the##4##4##(2008-10#2)(2008-5#1)(2008-7#1)
the permeability of##11##3##(1990-5#2)(1991-5#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
the permeability##15##2##(1990-5#2)(1991-5#1)(1992-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)
the permeant diffusion coefficient##2##4##(2008-5#2)
the permeant##3##2##(1991-5#1)(2008-5#2)
the permeation of##2##3##(2008-10#1)(2011-3#1)
the peroxidase activity##2##3##(2008-10#2)
the peroxidase##5##2##(2008-10#5)
the peroxidation##2##2##(1994-5#1)(2008-5#1)
the peroxidative reaction of SOD##2##5##(1997-8#2)
the peroxisomal##3##2##(1993-9#1)(1995-2#1)(1995-9#1)
the peroxisome proliferator-activated receptor##3##4##(1994-8#1)(2008-5#2)
the peroxisome##4##2##(1994-8#2)(2008-5#2)
the perpetrator##2##2##(2008-11#1)(2011-2#1)
the persimmon tannin gel##2##4##(2008-10#2)
the persimmon##4##2##(2008-10#4)
the persistence of the##3##4##(2008-5#1)(2008-8#1)(2013-8#1)
the persistence of##9##3##(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#3)(2011-3#1)(2013-1#1)(2013-8#1)
the persistence##12##2##(1994-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
the persistent##6##2##(1997-5#1)(2007-12#1)(2008-11#3)(2008-8#1)
the person##8##2##(1991-8#1)(1994-1#1)(1994-2#1)(1996-11#1)(1996-5#1)(2008-10#1)(2010-6#1)(2012-2#1)
the personal tutor##2##3##(2008-11#2)
the personal##9##2##(1991-12#1)(2008-11#5)(2008-5#1)(2009-7#1)(2011-2#1)
the personality characteristics##2##3##(2009-5#2)
the personality trait of##2##4##(2010-6#1)(2011-2#1)
the personality##6##2##(1993-11#1)(2008-11#1)(2009-5#2)(2010-6#1)(2011-2#1)
the personnel##2##2##(1995-2#1)(1996-3#1)
the persons##2##2##(2008-10#1)(2008-7#1)
the perspective of the##4##4##(1993-12#1)(2008-11#2)(2010-3#1)
the perspective of##23##3##(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-9#2)(2009-3#1)(2010-10#4)(2010-3#1)(2010-6#1)(2011-2#1)
the perspective##24##2##(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-9#2)(2009-3#1)(2010-10#4)(2010-3#1)(2010-6#1)(2011-2#1)
the perspectives of##4##3##(1997-3#1)(2008-12#2)(2013-8#1)
the perspectives##6##2##(1996-3#1)(1997-3#1)(2008-12#2)(2009-4#1)(2013-8#1)
the pertinent##8##2##(1990-2#1)(1996-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
the perturbation of UA on the##2##6##(2008-10#2)
the perturbation of##4##3##(1997-6#1)(2008-10#3)
the perturbation##8##2##(1997-6#1)(2008-10#4)(2008-3#3)
the pertussis##2##2##(1997-7#1)(2013-1#1)
the pervasive##2##2##(2008-11#1)(2011-2#1)
the pest##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
the pesticide##14##2##(2008-10#13)(2011-3#1)
the pesticides at##2##3##(2008-10#2)
the pesticides##10##2##(2008-10#7)(2008-11#3)
the petition of##2##3##(1990-11#1)(1993-9#1)
the petition##3##2##(1990-11#1)(1993-9#1)(1995-6#1)
the petri##2##2##(2008-10#2)
the petrol##2##2##(2008-10#2)
the petrous apex cholesteatoma##2##4##(2011-2#2)
the petrous apex##4##3##(2011-2#4)
the petrous bone##2##3##(2008-7#1)(2011-2#1)
the petrous##8##2##(2008-7#2)(2011-2#6)
the petunia##2##2##(1993-6#2)
the phage display method##2##4##(2008-11#2)
the phage display##3##3##(2008-10#1)(2008-11#2)
the phage##10##2##(1991-6#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-8#1)(2012-2#1)
the phages##2##2##(2012-2#2)
the phagocytic##4##2##(1990-12#2)(1994-6#2)
the phagocytosis##2##2##(1991-5#1)(1993-6#1)
the pharmaceutical and biotechnology industries##2##5##(2008-10#1)(2008-5#1)
the pharmaceutical and##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the pharmaceutical industry and##2##4##(2009-12#1)(2011-2#1)
the pharmaceutical industry##17##3##(1991-3#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-11#5)(2008-5#1)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)
the pharmaceutical preparations##3##3##(2008-10#3)
the pharmaceutical##35##2##(1991-3#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-5#1)(2008-10#13)(2008-11#7)(2008-5#2)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#3)
the pharmacokinetic parameters were##2##4##(2008-11#1)(2008-5#1)
the pharmacokinetic profile of##2##4##(2008-10#1)(2013-8#1)
the pharmacokinetic study of 6-MP in##2##6##(2008-10#2)
the pharmacokinetic study of##3##4##(2008-10#3)
the pharmacokinetic##10##2##(1991-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
the pharmacokinetics of##4##3##(2008-10#2)(2008-11#2)
the pharmacokinetics##6##2##(1991-2#1)(2008-10#2)(2008-11#3)
the pharmacological treatment of##2##4##(1994-6#1)(2008-7#1)
the pharmacological##11##2##(1991-1#1)(1993-6#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-3#1)(2013-1#1)
the pharmacology##2##2##(1994-8#1)(2008-12#1)
the phase I##3##3##(1995-12#1)(2011-2#2)
the phase II##2##3##(2008-5#1)(2010-12#1)
the phase and the##2##4##(2007-12#1)(2008-3#1)
the phase coding##2##3##(2008-11#2)
the phase difference##2##3##(2008-3#2)
the phase distribution##2##3##(2008-10#1)(2008-3#1)
the phase function##2##3##(2008-3#2)
the phase mismatch##2##3##(2008-3#2)
the phase model##2##3##(1992-1#1)(1995-2#1)
the phase of the##3##4##(1994-2#1)(2007-11#1)(2008-10#1)
the phase of##6##3##(1994-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2009-10#1)
the phase separation and##2##4##(2008-10#1)(2008-7#1)
the phase separation##4##3##(1997-6#1)(2008-10#2)(2008-7#1)
the phase shift##2##3##(2008-2#1)(2008-3#1)
the phase transition##5##3##(1991-9#1)(2008-10#3)(2008-8#1)
the phase##54##2##(1990-6#1)(1991-9#1)(1992-1#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#15)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-8#2)
the phase-boundary##2##2##(2008-10#2)
the phase-matching##3##2##(2008-2#1)(2008-3#2)
the phase-separated PNIPAM particles##2##4##(2008-10#2)
the phases of##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
the phases##5##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-9#1)
the phenol##5##2##(1994-5#3)(2008-10#1)(2008-8#1)
the phenolic group##2##3##(1990-5#2)
the phenolic##11##2##(1990-5#2)(2008-10#6)(2008-5#1)(2010-6#1)(2011-2#1)
the phenology of##3##3##(2008-10#2)(2012-2#1)
the phenols##3##2##(2008-10#3)
the phenomena of##5##3##(2008-5#1)(2008-7#2)(2010-10#1)(2010-11#1)
the phenomena##8##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-11#1)
the phenomenon in##2##3##(2008-10#1)(2009-10#1)
the phenomenon of##16##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
the phenomenon##27##2##(1996-2#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
the phenotype of##7##3##(1994-11#1)(1994-3#1)(1995-8#1)(1997-8#1)(2008-8#2)(2009-8#1)
the phenotype##16##2##(1994-11#1)(1994-3#1)(1995-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-3#1)
the phenotypes of##6##3##(1991-9#1)(1996-2#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)
the phenotypes were##2##3##(1997-8#1)(2008-5#1)
the phenotypes##11##2##(1991-9#1)(1996-2#1)(1997-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)
the phenotypic and##2##3##(2008-10#1)(2008-8#1)
the phenotypic effects##2##3##(1993-8#1)(2007-12#1)
the phenotypic##35##2##(1991-2#1)(1992-2#1)(1993-8#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-8#2)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
the phenotypical##2##2##(1995-8#1)(2008-11#1)
the phenoxyl##2##2##(2008-10#1)(2008-8#1)
the phenyl ring##2##3##(1995-11#1)(2008-10#1)
the pheromone##3##2##(1996-2#1)(2008-10#2)
the phi##3##2##(1991-5#1)(2008-11#1)(2010-1#1)
the philosophical##3##2##(2008-12#1)(2008-4#1)(2010-11#1)
the philosophy##3##2##(1991-1#1)(2008-11#1)(2008-6#1)
the phloem and##2##3##(2008-10#2)
the phloem cells and##2##4##(2008-10#2)
the phloem cells##3##3##(2008-10#3)
the phloem of##2##3##(2008-10#1)(2008-11#1)
the phloem##15##2##(2008-10#11)(2008-11#4)
the phorbol##2##2##(1996-12#1)(1997-1#1)
the phosphatase activities##4##3##(2008-10#3)(2008-9#1)
the phosphatase activity of##3##4##(2008-10#1)(2008-9#2)
the phosphatase activity##4##3##(1997-2#1)(2008-10#1)(2008-9#2)
the phosphatase##14##2##(1992-9#3)(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#4)(2008-9#3)(2009-8#1)
the phosphate buffer##5##3##(2008-10#4)(2009-10#1)
the phosphate##11##2##(1994-11#2)(2008-10#7)(2009-10#1)(2010-10#1)
the phosphatidylserine requirement of##2##4##(1990-5#2)
the phospholipase##2##2##(1993-8#1)(1994-11#1)
the phospholipid##8##2##(1992-12#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2012-2#1)
the phospholipid-independent interaction between##2##4##(1994-5#2)
the phosphomolybdenum blue##3##3##(2008-10#3)
the phosphoproteins##2##2##(1992-10#1)(2008-4#1)
the phosphor##2##2##(2008-10#2)
the phosphorescence##7##2##(2008-10#5)(2008-3#1)(2010-4#1)
the phosphorus##2##2##(2008-10#1)(2008-11#1)
the phosphorylated form of##3##4##(1993-8#1)(1996-12#1)(1997-1#1)
the phosphorylated##10##2##(1993-8#1)(1994-11#2)(1996-12#1)(1997-1#2)(2008-1#1)(2008-8#1)(2010-12#1)(2012-2#1)
the phosphorylation of the##3##4##(1990-10#1)(1996-2#1)(1997-2#1)
the phosphorylation of##12##3##(1990-10#1)(1995-12#1)(1995-8#2)(1996-2#3)(1997-1#1)(1997-2#1)(1997-7#1)(2008-11#1)(2009-3#1)
the phosphorylation##18##2##(1990-10#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#3)(1996-2#3)(1997-1#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-8#2)(2009-3#1)
the photo standard##3##3##(2008-5#3)
the photo-oxidation of##2##3##(2008-10#2)
the photocatalytic##3##2##(2008-10#2)(2013-1#1)
the photochemical process##2##3##(2008-10#2)
the photochemical reaction##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
the photochemical##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
the photochromic reaction##2##3##(2009-8#2)
the photocycle of##2##3##(1994-5#2)
the photodegradation##4##2##(2008-10#3)(2008-5#1)
the photodiode##2##2##(2008-10#1)(2008-3#1)
the photodynamic oxidation of uric acid##2##6##(2008-5#2)
the photodynamic oxidation##3##3##(2008-5#3)
the photodynamic##7##2##(2008-5#6)(2012-3#1)
the photolysis##2##2##(1995-2#1)(2008-11#1)
the photometric##3##2##(2008-10#3)
the photon##3##2##(1992-11#1)(2007-11#1)(2008-10#1)
the photonic crystal waveguide##2##4##(2007-12#2)
the photonic##4##2##(2007-12#3)(2008-3#1)
the photoperiod sensitivity gene##2##4##(1995-6#2)
the photoproducts##2##2##(2008-10#2)
the photoreceptive##3##2##(2008-5#2)(2012-3#1)
the photorefractive effect##2##3##(2008-3#2)
the photorefractive fanning effect##2##4##(2008-2#2)
the photorefractive##5##2##(2008-2#2)(2008-3#3)
the photoresist##2##2##(2008-3#1)(2008-7#1)
the photosensitizers##3##2##(1993-11#2)(2008-11#1)
the photostability of##2##3##(2008-10#1)(2008-5#1)
the photosynthetic apparatus##4##3##(2008-10#3)(2012-6#1)
the photosynthetic##9##2##(1993-8#1)(2008-10#5)(2008-11#1)(2012-5#1)(2012-6#1)
the phyllosilicate##3##2##(2008-6#3)
the phylogenetic analyses##2##3##(2008-10#1)(2010-3#1)
the phylogenetic relationships##3##3##(2008-10#3)
the phylogenetic tree##3##3##(2008-8#1)(2013-8#2)
the phylogenetic trees##2##3##(2008-10#1)(2008-9#1)
the phylogenetic##18##2##(2008-10#8)(2008-8#1)(2008-9#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
the phylogeny##3##2##(2007-12#1)(2008-10#1)(2010-3#1)
the phylum##7##2##(2011-2#4)(2013-8#3)
the physical and chemical properties##2##5##(2011-2#1)(2011-3#1)
the physical and chemical##8##4##(2008-10#3)(2008-8#2)(2009-8#1)(2011-2#1)(2011-3#1)
the physical and mental##2##4##(1994-3#1)(2010-10#1)
the physical and##12##3##(1994-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-8#1)(2010-10#1)(2011-2#1)(2011-3#1)
the physical characteristics of##5##4##(1990-9#1)(1996-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
the physical characteristics##6##3##(1990-9#2)(1996-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
the physical distance##2##3##(2008-9#2)
the physical examination##2##3##(2008-12#1)(2010-8#1)
the physical growth and health of##2##6##(2008-11#2)
the physical growth##3##3##(2008-11#2)(2008-8#1)
the physical map of##4##4##(1995-6#2)(1997-6#1)(1997-8#1)
the physical map##6##3##(1995-6#2)(1997-6#1)(1997-8#1)(1997-9#1)(2012-3#1)
the physical optics##3##3##(2008-2#3)
the physical properties of skin##2##5##(2008-5#2)
the physical properties of the skin##2##6##(2008-5#2)
the physical properties of the##4##5##(2008-5#3)(2013-1#1)
the physical properties of##10##4##(1991-1#1)(1997-2#1)(2008-5#6)(2010-7#1)(2013-1#1)
the physical properties##11##3##(1991-1#1)(1997-2#1)(2008-5#6)(2008-8#1)(2010-7#1)(2013-1#1)
the physical space##2##3##(2008-11#1)(2013-1#1)
the physical state##2##3##(2008-4#1)(2008-5#1)
the physical therapy##2##3##(2008-12#2)
the physical##90##2##(1990-9#2)(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#10)(2008-7#2)(2008-8#7)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#6)
the physician and##2##3##(1990-9#1)(2010-7#1)
the physician for##2##3##(1991-9#1)(1997-2#1)
the physician in##2##3##(1995-2#1)(2010-12#1)
the physician is##2##3##(1990-6#1)(1993-8#1)
the physician or##2##3##(1995-12#1)(2008-12#1)
the physician##27##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-12#1)(1995-2#2)(1996-9#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-12#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-2#1)
the physician's##3##2##(1991-2#1)(1994-12#1)(2010-8#1)
the physician-patient##2##2##(2011-2#1)(2012-3#1)
the physicians will##2##3##(1992-1#1)(1994-2#1)
the physicians##8##2##(1992-1#1)(1993-11#1)(1993-12#1)(1994-2#1)(1997-3#2)(2008-1#2)
the physicians'##4##2##(1990-6#1)(1995-2#2)(1996-1#1)
the physico-chemical##4##2##(2008-10#3)(2008-5#1)
the physicochemical properties of the##2##5##(2008-5#1)(2008-8#1)
the physicochemical##6##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
the physiologic##5##2##(1991-3#1)(1994-11#1)(1994-12#1)(2010-6#2)
the physiological and##3##3##(2008-11#1)(2009-12#1)(2012-2#1)
the physiological constraints##2##3##(2008-7#2)
the physiological function of##2##4##(2010-10#1)(2012-2#1)
the physiological fusion##2##3##(2012-2#2)
the physiological mechanisms##2##3##(1990-11#1)(2008-5#1)
the physiological processes##2##3##(2008-8#1)(2011-2#1)
the physiological range of##2##4##(1993-6#1)(2008-10#1)
the physiological range##3##3##(1993-6#1)(2008-10#2)
the physiological response of the tissues under##2##7##(2013-1#2)
the physiological role of##5##4##(1995-11#1)(1997-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
the physiological role##6##3##(1995-11#1)(1997-1#1)(1997-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
the physiological significance of the##2##5##(1991-3#1)(2010-3#1)
the physiological##72##2##(1990-11#2)(1990-12#1)(1991-3#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-11#3)(1995-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#5)(2013-1#2)
the physiologically##2##2##(2008-10#2)
the physiology of the##6##4##(1990-5#1)(1996-2#1)(2008-7#1)(2009-10#1)(2011-2#2)
the physiology of##11##3##(1990-5#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)
the physiology##13##2##(1990-5#1)(1992-9#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#2)
the physiopathology##2##2##(1992-5#1)(2008-7#1)
the physiotherapist is##2##3##(1991-2#1)(1992-2#1)
the physiotherapist##3##2##(1991-2#1)(1992-12#1)(1992-2#1)
the phytochrome##2##2##(1995-2#1)(2009-8#1)
the phytopathogenic bacterium##3##3##(2008-10#3)
the phytopathogenic fungus##2##3##(1997-4#1)(2009-8#1)
the phytopathogenic##5##2##(1997-4#1)(2008-10#3)(2009-8#1)
the phytophagous##2##2##(2008-10#1)(2008-7#1)
the phytoplankton##4##2##(2008-10#1)(2008-2#3)
the phytoplasma##3##2##(2008-10#3)
the phytoplasmas##3##2##(2008-10#3)
the phytoremediation##2##2##(2008-10#1)(2008-11#1)
the phytotoxic##2##2##(2008-10#1)(2008-12#1)
the pi-pi electron interactions##2##4##(2008-10#2)
the picosecond##2##2##(1990-8#1)(2008-2#1)
the picrate##6##2##(2008-10#6)
the picture of##2##3##(2008-7#1)(2012-3#1)
the picture##5##2##(1993-12#1)(2008-7#2)(2010-9#1)(2012-3#1)
the piece##2##2##(1997-3#1)(2008-10#1)
the piecewise##2##2##(2008-10#1)(2008-6#1)
the piezoelectric quartz crystal##3##4##(2008-10#3)
the piezoelectric##8##2##(2008-10#5)(2008-3#1)(2009-5#1)(2012-12#1)
the pig##5##2##(1996-12#1)(1996-2#1)(2007-12#1)(2011-2#2)
the pigeon##3##2##(2007-12#1)(2008-8#2)
the pigment##5##2##(2008-10#3)(2008-3#1)(2008-8#1)
the pigmentation##2##2##(1991-6#1)(2008-6#1)
the pigmented##2##2##(2008-10#1)(2008-5#1)
the pigments##8##2##(2008-10#8)
the pilot study##2##3##(2011-2#1)(2012-2#1)
the pilot##6##2##(1993-1#1)(2008-11#2)(2010-9#1)(2011-2#1)(2012-2#1)
the pin##2##2##(2009-4#2)
the pine weevil##2##3##(2011-10#2)
the pine##3##2##(2008-10#1)(2011-10#2)
the pineal gland##6##3##(1994-2#2)(1995-11#1)(2008-12#1)(2008-5#1)(2013-7#1)
the pineal hormone melatonin (MLT)##2##5##(1992-12#1)(1995-9#1)
the pineal hormone melatonin as a##2##6##(1990-2#1)(1992-12#1)
the pineal hormone melatonin##6##4##(1990-2#2)(1991-6#1)(1992-12#2)(1995-9#1)
the pineal hormone##8##3##(1990-2#3)(1991-6#1)(1992-12#2)(1995-9#1)(2008-5#1)
the pineal##17##2##(1990-2#3)(1991-6#1)(1992-12#2)(1994-2#2)(1995-11#1)(1995-12#1)(1995-9#1)(2008-12#1)(2008-5#2)(2012-2#1)(2013-7#2)
the pinhole##2##2##(2008-10#1)(2008-12#1)
the pink##3##2##(2008-10#2)(2010-10#1)
the pip##2##2##(2008-4#2)
the piriform cortex##3##3##(1990-5#1)(2013-1#2)
the pistachio isolates##2##3##(2008-10#2)
the pit cell lineage##2##4##(1995-2#1)(1995-6#1)
the pitch##2##2##(2008-10#1)(2013-8#1)
the pitfalls of##3##3##(2008-11#2)(2012-2#1)
the pitfalls##7##2##(1993-1#1)(1996-12#1)(2008-11#2)(2008-9#2)(2012-2#1)
the pith##2##2##(2008-10#2)
the pits##2##2##(1997-1#1)(2007-12#1)
the pituitary gland##10##3##(1993-9#1)(1995-12#1)(1996-11#1)(1996-2#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)
the pituitary##18##2##(1990-11#1)(1992-10#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-2#2)(1997-3#1)(2008-4#2)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#2)
the pivotal role of##2##4##(2008-1#1)(2008-7#1)
the pivotal role##4##3##(2008-1#1)(2008-11#2)(2008-7#1)
the pivotal##8##2##(1995-3#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-10#2)
the pixel##2##2##(2008-3#1)(2011-2#1)
the place of##12##3##(1990-6#1)(1992-12#1)(1994-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-10#1)(2010-12#1)(2012-3#1)
the place where##2##3##(2008-10#1)(2013-1#1)
the place##16##2##(1990-6#1)(1992-12#1)(1994-6#1)(2008-10#3)(2008-11#3)(2008-12#2)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the placebo group##7##3##(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)(2012-2#2)
the placebo##10##2##(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
the placement of a##2##4##(2008-2#1)(2011-2#1)
the placement of the##2##4##(1994-5#1)(2009-10#1)
the placement of##13##3##(1990-2#1)(1991-12#1)(1994-5#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#2)(2011-2#1)(2012-12#1)
the placement##18##2##(1990-2#1)(1991-12#1)(1994-5#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-6#1)(2009-10#2)(2011-2#1)(2012-12#1)
the placenta and##2##3##(2012-12#1)(2013-1#1)
the placenta##6##2##(1990-9#1)(1995-12#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
the placental##2##2##(1995-8#1)(2008-10#1)
the placing of##2##3##(2007-12#1)(2008-11#1)
the plaintiffs##2##2##(1995-6#1)(1996-5#1)
the plan##5##2##(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1997-2#1)
the plane of the##2##4##(1995-2#1)(2008-3#1)
the plane of##4##3##(1995-2#1)(1997-6#1)(2008-3#2)
the plane##7##2##(1995-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)
the plane-parallel resonator##2##3##(2008-3#2)
the planned isocenter position during treatment##2##6##(2009-2#2)
the planned##8##2##(1992-1#1)(1992-9#2)(2009-2#2)(2010-7#1)(2012-3#1)(2013-1#1)
the planning and##4##3##(1993-3#1)(1996-2#1)(2008-10#1)(2013-1#1)
the planning process and##3##4##(1992-2#1)(1994-2#1)(1996-1#1)
the planning##12##2##(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2013-1#1)
the plant and##7##3##(2008-10#5)(2008-8#1)(2009-10#1)
the plant canopy##2##3##(2008-10#2)
the plant defense##2##3##(2008-10#2)
the plant expression vectors##2##4##(2008-8#1)(2008-9#1)
the plant genus##2##3##(2008-8#1)(2012-3#1)
the plant growth hormone##2##4##(2008-10#1)(2008-11#1)
the plant hormone##3##3##(2009-6#2)(2011-10#1)
the plant in##2##3##(2008-10#2)
the plant kingdom##6##3##(2008-10#1)(2009-12#1)(2009-8#2)(2011-2#1)(2013-8#1)
the plant pathogenic##2##3##(2008-11#1)(2009-6#1)
the plant population##2##3##(2008-10#2)
the plant species##3##3##(2008-10#2)(2008-8#1)
the plant surface##4##3##(2008-10#3)(2009-8#1)
the plant to##2##3##(2008-10#1)(2008-8#1)
the plant##104##2##(1992-3#1)(1994-11#1)(1996-3#1)(2007-12#1)(2008-10#61)(2008-11#7)(2008-12#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#4)(2009-8#7)(2010-10#1)(2010-11#1)(2011-1#1)(2011-10#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
the plant's##2##2##(2008-10#1)(2009-8#1)
the plant-pathogenic##5##2##(2008-10#5)
the plants to##4##3##(2008-10#4)
the plants were evaluated for##2##5##(2008-10#2)
the plants were##4##3##(2008-10#4)
the plants##36##2##(1995-2#1)(2008-10#31)(2008-8#2)(2008-9#1)(2011-2#1)
the plasma and##3##3##(1992-6#1)(2008-10#1)(2008-9#1)
the plasma exchange efficiency##2##4##(2011-2#2)
the plasma for##5##3##(2008-10#4)(2008-11#1)
the plasma membrane and the##3##5##(1990-12#1)(2008-11#1)(2009-8#1)
the plasma membrane and##7##4##(1990-12#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2009-9#1)
the plasma membrane by##2##4##(1995-6#1)(2009-8#1)
the plasma membrane in##2##4##(1994-3#1)(2009-10#1)
the plasma membrane of eggs##2##5##(2008-8#2)
the plasma membrane of##11##4##(1990-12#2)(1994-12#1)(1994-3#1)(2008-11#1)(2008-8#4)(2010-11#1)(2010-12#1)
the plasma membrane proteins##2##4##(1995-12#1)(2008-11#1)
the plasma membrane##44##3##(1990-12#3)(1992-12#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-6#2)(1996-3#1)(2008-10#2)(2008-11#8)(2008-8#4)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#1)(2012-3#1)
the plasma membranes##2##3##(1994-5#1)(2010-10#1)
the plasma of##5##3##(1992-6#3)(2008-10#1)(2012-2#1)
the plasma##100##2##(1990-11#1)(1990-12#3)(1992-11#1)(1992-12#2)(1992-6#4)(1992-9#2)(1993-1#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#4)(1995-6#2)(1996-3#1)(2008-10#24)(2008-11#9)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-8#3)
the plasmalemma of the##2##4##(2008-10#2)
the plasmalemma of##3##3##(2008-10#3)
the plasmalemma##8##2##(1997-7#1)(2007-12#1)(2008-10#6)
the plasmid that carried##2##4##(1993-3#2)
the plasmid vector pGEM-T##2##4##(2008-10#1)(2008-9#1)
the plasmid vector##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
the plasmid##25##2##(1992-3#1)(1993-3#2)(1994-12#1)(1995-6#1)(1996-6#1)(1997-2#2)(2008-10#4)(2008-11#5)(2008-7#1)(2008-8#3)(2008-9#2)(2010-6#1)(2012-3#1)
the plasmids##3##2##(1994-12#1)(2008-10#1)(2008-8#1)
the plastic surgery population##2##4##(2013-1#2)
the plastic type##2##3##(2008-8#2)
the plastic##10##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#2)(2013-1#3)
the plasticity of##2##3##(1996-12#1)(2012-2#1)
the plasticity##3##2##(1996-12#1)(2008-8#1)(2012-2#1)
the plasticized PVC membrane##2##4##(2008-10#2)
the plasticizer and##2##3##(2008-10#2)
the plasticizer##6##2##(2008-10#6)
the plastid##2##2##(2009-10#1)(2011-2#1)
the plate surface##2##3##(2008-8#2)
the plate##11##2##(2008-10#5)(2008-11#2)(2008-8#3)(2012-2#1)
the plateau##9##2##(1994-6#3)(2008-10#2)(2008-5#1)(2008-9#1)(2009-7#1)(2013-1#1)
the platelet count##2##3##(2006-6#2)
the platelet lysate##2##3##(2008-11#2)
the platelet##13##2##(1990-12#2)(1993-3#1)(2006-6#6)(2008-11#2)(2008-5#1)(2008-8#1)
the platelets##2##2##(1997-6#1)(2008-7#1)
the plates##5##2##(2008-10#2)(2008-11#3)
the platform##7##2##(2008-10#5)(2009-9#1)(2013-1#1)
the plating##2##2##(2008-10#1)(2008-9#1)
the platinum group elements##5##4##(2008-10#4)(2008-11#1)
the platinum##10##2##(1997-6#1)(2008-10#8)(2008-11#1)
the plausible##2##2##(2008-5#1)(2013-1#1)
the play lady legacy##2##4##(1992-12#2)
the play##4##2##(1992-12#2)(2008-9#1)(2012-2#1)
the pleckstrin homology domain##2##4##(1994-11#2)
the plethora of##2##3##(1991-1#1)(2009-6#1)
the pleura##2##2##(1991-12#2)
the pleural##2##2##(1991-8#1)(2012-2#1)
the plot##7##2##(2008-10#7)
the plot)##3##2##(2008-10#3)
the plots##5##2##(1995-9#1)(2008-10#4)
the plug test##3##3##(2013-1#3)
the plug##5##2##(1994-3#1)(2008-10#1)(2013-1#3)
the pluripotent##3##2##(1990-5#1)(2008-9#1)(2013-1#1)
the pneumococcal##3##2##(1994-9#1)(2008-10#1)(2011-2#1)
the point of care##2##4##(1997-3#1)(2010-8#1)
the point of##25##3##(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#9)(2008-11#4)(2008-7#2)(2009-12#1)(2010-8#1)(2013-8#2)
the point where##4##3##(1992-3#1)(1995-8#1)(2008-5#1)(2008-8#1)
the point##33##2##(1992-3#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#11)(2008-11#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-8#1)(2013-8#2)
the point-spread function##3##3##(2008-3#3)
the point-spread##4##2##(2008-3#4)
the points##6##2##(2008-10#2)(2008-3#1)(2008-6#1)(2009-2#1)(2013-1#1)
the pol I family##2##4##(1997-8#2)
the polar fraction##2##3##(2013-8#2)
the polar heads##2##3##(1991-5#2)
the polar lipids##2##3##(2008-11#1)(2011-2#1)
the polar##19##2##(1991-5#3)(1994-5#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#2)
the polarity of the##2##4##(2008-10#1)(2008-5#1)
the polarity of##3##3##(2008-10#2)(2008-5#1)
the polarity##4##2##(2008-10#3)(2008-5#1)
the polarizability##2##2##(1997-6#2)
the polarization of the##3##4##(2008-2#2)(2008-3#1)
the polarization of##7##3##(1990-2#1)(1991-5#1)(2008-2#2)(2008-3#2)(2008-9#1)
the polarization state of the incident##2##6##(2007-12#1)(2008-3#1)
the polarization state of##3##4##(2007-12#1)(2008-3#2)
the polarization##20##2##(1990-2#1)(1991-5#1)(2007-12#2)(2008-2#3)(2008-3#12)(2008-9#1)
the polarographic determination of benzaldehyde##2##5##(2008-10#2)
the polarographic determination of##3##4##(2008-10#3)
the polarographic method##2##3##(2008-10#2)
the polarographic##7##2##(2008-10#7)
the poles##2##2##(2008-9#1)(2009-12#1)
the police##4##2##(1997-8#4)
the policy##12##2##(1991-12#1)(1992-12#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-6#1)(2009-3#3)
the political##9##2##(1991-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
the politics of##2##3##(1992-1#1)(1994-2#1)
the pollen tube##5##3##(2008-11#3)(2009-8#2)
the pollen##8##2##(2008-10#1)(2008-11#3)(2009-8#2)(2012-7#2)
the pollinator##2##2##(2008-8#1)(2012-2#1)
the pollutant##2##2##(2008-10#2)
the pollutants##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
the poly(A)##2##2##(1991-9#1)(1994-11#1)
the polyadenylation##3##2##(1992-12#1)(1994-11#1)(2010-4#1)
the polyamine site of the NMDA receptor##2##7##(1996-2#2)
the polyamine site of##3##4##(1996-2#3)
the polyamine##4##2##(1990-7#1)(1996-2#3)
the polyclonal##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
the polycystic ovary syndrome##7##4##(2008-3#3)(2008-4#4)
the polyhedrin gene locus##2##4##(2008-11#1)(2008-8#1)
the polyhedrin gene##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
the polyhedrin promoter##3##3##(1994-11#1)(2008-11#2)
the polyhedrin##6##2##(1994-11#1)(1995-12#1)(2008-11#3)(2008-8#1)
the polymer coating##3##3##(2008-10#3)
the polymer film##2##3##(2008-10#2)
the polymer films##3##3##(2008-10#2)(2010-4#1)
the polymer heteronuclei##2##3##(2011-3#2)
the polymer matrix and##2##4##(2007-12#1)(2010-4#1)
the polymer matrix during the##2##5##(2008-10#2)
the polymer matrix##9##3##(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#2)(2010-4#1)
the polymer residue##2##3##(2008-5#2)
the polymer to##3##3##(2008-10#2)(2008-11#1)
the polymer##50##2##(1995-6#2)(2007-12#1)(2008-10#27)(2008-11#6)(2008-3#1)(2008-5#4)(2008-7#3)(2009-10#1)(2009-5#1)(2010-4#2)(2011-3#2)
the polymerase chain reaction (PCR)##6##5##(1997-7#1)(2008-10#4)(2008-9#1)
the polymerase chain reaction and##2##5##(1990-8#1)(1994-12#1)
the polymerase chain reaction to##3##5##(2008-11#1)(2011-2#2)
the polymerase chain reaction using primers##2##6##(1992-6#1)(1993-2#1)
the polymerase chain reaction##29##4##(1990-8#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
the polymerase chain reaction]##2##4##(1990-8#1)(1996-8#1)
the polymerase chain##31##3##(1990-8#2)(1991-6#2)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
the polymerase##36##2##(1990-8#3)(1991-6#2)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#4)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1995-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-12#1)
the polymeric matrix##7##3##(2008-10#6)(2010-4#1)
the polymeric##16##2##(2008-10#12)(2008-11#1)(2008-5#2)(2010-4#1)
the polymerization process##2##3##(2008-3#1)(2010-10#1)
the polymerization reaction is##2##4##(2008-2#1)(2010-7#1)
the polymerization##8##2##(2008-10#3)(2008-2#1)(2008-3#1)(2010-10#1)(2010-7#1)(2011-2#1)
the polymers and##2##3##(2008-11#2)
the polymers##10##2##(1994-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2013-1#1)
the polymorphic##4##2##(1992-6#2)(1995-6#1)(2008-10#1)
the polymorphism of##3##3##(2008-10#2)(2013-1#1)
the polymorphism##4##2##(1995-3#1)(2008-10#2)(2013-1#1)
the polypeptide chain##2##3##(1992-4#1)(2008-8#1)
the polypeptide##4##2##(1992-4#1)(1992-9#1)(1993-8#1)(2008-8#1)
the polyploidization##2##2##(1994-11#2)
the polypropylene##4##2##(2008-7#1)(2012-3#3)
the polyps##2##2##(2008-11#1)(2009-12#1)
the polypyrrole film##2##3##(2008-10#2)
the polypyrrole##5##2##(2008-10#5)
the polysynaptic##2##2##(1996-2#2)
the polyurethane foam##5##3##(2008-10#5)
the polyurethane##7##2##(2008-10#6)(2009-7#1)
the pomegranate##2##2##(2013-8#2)
the pontine nuclei##5##3##(2008-11#5)
the pontomesencephalic reticular formation##2##4##(1997-3#2)
the pool of##4##3##(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)
the pool##5##2##(1993-3#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)
the pooled comparators##2##3##(2012-3#2)
the pooled data##3##3##(2008-10#2)(2008-12#1)
the pooled##7##2##(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#2)
the poor and##2##3##(1993-3#1)(1994-2#1)
the poor prognosis##2##3##(1991-2#1)(1993-1#1)
the poor response##2##3##(2008-10#1)(2013-1#1)
the poor##23##2##(1990-6#1)(1991-2#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-10#1)(2009-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
the poorest##2##2##(1990-2#1)(2012-12#1)
the popliteal artery##2##3##(1991-3#2)
the popliteal##4##2##(1991-3#3)(2008-10#1)
the popular##4##2##(1995-3#1)(2008-5#1)(2008-8#1)(2010-9#1)
the population and##5##3##(1992-1#1)(1996-3#1)(2008-10#1)(2008-9#1)(2011-2#1)
the population at large##3##4##(1992-2#2)(2008-4#1)
the population at##4##3##(1992-2#2)(2008-4#1)(2009-6#1)
the population being##4##3##(1997-2#1)(2008-7#1)(2008-9#1)(2010-5#1)
the population biology of##3##4##(2008-10#2)(2008-8#1)
the population by##2##3##(1991-3#1)(1997-7#1)
the population data are going to be available in the EMPOP database (www##3##13##(2008-12#3)
the population densities of##3##4##(2008-10#3)
the population densities##4##3##(2008-10#4)
the population density and metabolic activity of the##2##8##(2008-10#2)
the population density of the pathogen##2##6##(2008-10#2)
the population density of the##3##5##(2008-10#3)
the population density of##6##4##(2008-10#6)
the population density##8##3##(2008-10#8)
the population during##2##3##(2008-10#2)
the population dynamics of##9##4##(2008-10#4)(2008-8#2)(2008-9#1)(2012-3#1)(2013-8#1)
the population dynamics##12##3##(2008-10#5)(2008-8#3)(2008-9#1)(2012-3#1)(2013-8#2)
the population from##2##3##(2008-10#2)
the population genetic##2##3##(2008-10#1)(2008-12#1)
the population growth rate##2##4##(2008-8#1)(2008-9#1)
the population growth##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
the population have##2##3##(1997-1#1)(2008-8#1)
the population in##5##3##(1991-12#1)(2008-11#1)(2008-5#1)(2008-6#2)
the population is##13##3##(1991-9#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#1)
the population level##7##3##(2008-10#3)(2008-11#1)(2008-8#2)(2011-2#1)
the population mean##2##3##(1991-3#1)(1992-9#1)
the population of D##3##4##(2008-10#1)(2013-8#2)
the population of Phytophthora infestans##2##5##(2008-10#2)
the population of the##4##4##(1995-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
the population of##29##3##(1990-6#1)(1994-1#1)(1995-1#1)(1996-6#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-8#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#3)
the population size of the##2##5##(2008-10#2)
the population size of##5##4##(2008-10#5)
the population size##6##3##(2008-10#5)(2008-8#1)
the population structure and the##2##5##(2008-10#2)
the population structure and##3##4##(2008-10#3)
the population structure of X##2##5##(2008-10#2)
the population structure of##4##4##(2008-10#4)
the population structure##7##3##(2008-10#7)
the population to be##2##4##(1997-2#1)(2008-10#1)
the population to##4##3##(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
the population was##2##3##(2008-10#2)
the population##226##2##(1990-6#1)(1991-12#3)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-9#1)(1993-11#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-3#4)(1996-6#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2008-1#1)(2008-10#80)(2008-11#7)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#24)(2008-9#10)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#9)(2012-12#4)(2012-2#1)(2012-3#4)(2012-4#1)(2013-1#6)(2013-8#10)
the population's##2##2##(1994-6#1)(2011-2#1)
the population-level model##2##3##(2008-9#2)
the population-level##3##2##(2008-9#3)
the population-wide##2##2##(2008-8#2)
the populations from##2##3##(2008-10#1)(2008-8#1)
the populations in##3##3##(2008-10#3)
the populations of the##2##4##(2008-10#1)(2008-8#1)
the populations of##8##3##(2008-10#5)(2008-8#2)(2012-2#1)
the populations studied##2##3##(2008-1#1)(2008-10#1)
the populations were##3##3##(1997-7#1)(2008-10#2)
the populations##36##2##(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#21)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2012-2#1)(2013-8#1)
the porcine Tex11##3##3##(2012-2#3)
the porcine##10##2##(1991-6#1)(1995-8#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-2#4)
the pore water##3##3##(2008-10#2)(2013-8#1)
the pore##7##2##(2008-10#4)(2008-8#1)(2011-2#1)(2013-8#1)
the pores of a##2##4##(2008-10#1)(2008-11#1)
the pores of the##4##4##(2008-10#4)
the pores of##6##3##(2008-10#5)(2008-11#1)
the pores##13##2##(2007-12#1)(2008-10#10)(2008-11#1)(2010-12#1)
the pork tapeworm Taenia##2##4##(1995-12#1)(2008-7#1)
the pork##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
the porosity of##2##3##(2008-10#1)(2008-7#1)
the porosity##3##2##(2008-10#1)(2008-7#1)(2009-7#1)
the porous material##3##3##(2008-3#3)
the porous##7##2##(2008-10#1)(2008-3#3)(2008-7#1)(2012-2#2)
the porphyrin system##2##3##(2008-10#2)
the porphyrin##7##2##(1991-5#1)(1994-5#1)(2008-10#5)
the port##2##2##(2008-11#1)(2011-2#1)
the portal vein##3##3##(1995-2#1)(1997-8#1)(2009-9#1)
the portal##8##2##(1993-3#1)(1995-2#1)(1997-8#1)(2008-5#1)(2009-2#1)(2009-9#2)(2010-12#1)
the portion of the##3##4##(1997-6#1)(1997-9#1)(2009-1#1)
the portion of##8##3##(1997-6#1)(1997-7#1)(1997-9#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#1)
the position of the##15##4##(1994-3#1)(1995-11#2)(1996-5#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
the position of##25##3##(1990-5#1)(1991-6#1)(1993-6#1)(1994-3#1)(1995-11#2)(1996-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-8#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
the position##32##2##(1990-12#1)(1990-5#1)(1991-6#1)(1993-6#1)(1994-3#1)(1995-11#2)(1996-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
the positional##3##2##(1995-6#1)(1996-6#1)(2008-9#1)
the positioning of the##3##4##(2008-10#1)(2008-9#2)
the positioning of##5##3##(2008-10#1)(2008-9#2)(2010-1#1)(2010-3#1)
the positions of##4##3##(1994-12#1)(1995-12#1)(1996-3#1)(2008-10#1)
the positions##6##2##(1994-1#1)(1994-12#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-9#1)
the positive and negative aspects of##2##6##(2008-11#1)(2009-12#1)
the positive and negative##4##4##(1997-2#1)(2008-11#2)(2009-12#1)
the positive and##6##3##(1997-2#1)(2008-11#2)(2009-12#1)(2010-5#1)(2013-1#1)
the positive association between##2##4##(2008-11#1)(2010-1#1)
the positive characteristics of the##2##5##(1990-9#1)(2008-11#1)
the positive control##2##3##(2008-11#1)(2013-1#1)
the positive effects##2##3##(2008-5#1)(2008-8#1)
the positive outcomes##3##3##(1995-1#1)(2008-12#1)(2010-12#1)
the positive rate was##2##4##(2011-3#1)(2013-8#1)
the positive role of##2##4##(2008-12#1)(2013-1#1)
the positive samples##2##3##(2010-6#1)(2012-12#1)
the positive stereotype group was##2##5##(2008-11#2)
the positive##73##2##(1990-3#1)(1990-6#2)(1990-9#2)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-11#12)(2008-12#2)(2008-5#3)(2008-6#1)(2008-8#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#2)(2011-3#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
the positively charged##5##3##(1995-11#1)(1997-8#1)(2008-10#2)(2008-8#1)
the positivity constraint##2##3##(2013-1#2)
the positivity of##2##3##(2008-5#1)(2013-1#1)
the positivity##5##2##(1990-8#1)(2008-5#1)(2013-1#3)
the possibilities and##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
the possibilities for##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
the possibilities of using##2##4##(2008-10#1)(2013-1#1)
the possibilities of##10##3##(1991-8#1)(2008-10#3)(2008-6#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
the possibilities##20##2##(1991-8#1)(1993-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-6#1)(2009-1#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the possibility for improvement of##2##5##(2008-10#1)(2011-2#1)
the possibility for the##2##4##(2008-10#1)(2008-7#1)
the possibility for##5##3##(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
the possibility of a##14##4##(1992-2#1)(1993-12#1)(1995-11#1)(1995-6#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
the possibility of achieving##2##4##(2008-11#1)(2008-3#1)
the possibility of an##5##4##(1990-12#1)(1997-8#1)(2008-7#1)(2009-5#1)(2013-8#1)
the possibility of developing a##2##5##(2008-10#1)(2008-5#1)
the possibility of developing##3##4##(1991-6#1)(2008-10#1)(2008-5#1)
the possibility of the##5##4##(1990-9#2)(2008-10#1)(2009-5#1)(2011-2#1)
the possibility of using a##2##5##(2007-12#1)(2008-10#1)
the possibility of using the##3##5##(2008-10#2)(2008-5#1)
the possibility of using##16##4##(1991-8#1)(1993-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2012-2#1)
the possibility of##123##3##(1990-12#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#30)(2008-11#9)(2008-12#3)(2008-3#3)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#3)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-2#4)(2012-3#6)(2013-1#5)(2013-8#3)
the possibility that an##2##4##(2008-10#1)(2008-11#1)
the possibility that it may##2##5##(1991-8#1)(2008-10#1)
the possibility that it##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
the possibility that the##7##4##(1994-8#1)(1995-9#1)(2008-10#2)(2009-10#1)(2011-2#2)
the possibility that these##3##4##(1996-12#1)(2008-11#1)(2011-2#1)
the possibility that##48##3##(1991-5#1)(1991-8#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(2008-10#7)(2008-11#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#3)(2010-4#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-8#1)
the possibility to apply##2##4##(2008-11#1)(2009-8#1)
the possibility to improve##2##4##(2008-10#1)(2008-8#1)
the possibility to##18##3##(1996-11#1)(1996-6#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
the possibility##197##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#46)(2008-11#16)(2008-12#3)(2008-3#4)(2008-5#5)(2008-7#8)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#3)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#2)(2010-4#3)(2010-8#1)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#6)(2013-8#4)
the possible adverse effects of##2##5##(2008-8#1)(2012-2#1)
the possible association between##2##4##(2008-11#1)(2013-8#1)
the possible association##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
the possible causes of##2##4##(2008-7#1)(2008-9#1)
the possible complications##2##3##(2008-7#1)(2012-12#1)
the possible effect of##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
the possible existence of##4##4##(1992-3#1)(1992-9#1)(2010-11#1)(2012-2#1)
the possible formation of##2##4##(1994-5#1)(2011-2#1)
the possible functional role of##2##5##(2009-10#1)(2013-1#1)
the possible impact of##2##4##(1995-12#1)(2008-11#1)
the possible influence of##5##4##(2006-6#2)(2008-10#1)(2012-3#1)(2013-8#1)
the possible influence##6##3##(2006-6#2)(2008-10#1)(2012-3#1)(2013-8#2)
the possible interaction of##2##4##(1994-11#1)(2012-8#1)
the possible involvement of##5##4##(1991-9#1)(1992-6#1)(1994-2#1)(1994-8#1)(2008-11#1)
the possible involvement##6##3##(1991-9#1)(1992-6#1)(1994-2#1)(1994-8#1)(2008-11#2)
the possible mechanism of the##2##5##(2008-10#1)(2011-3#1)
the possible mechanism of##6##4##(2008-10#4)(2009-12#1)(2011-3#1)
the possible mechanism##7##3##(2008-10#5)(2009-12#1)(2011-3#1)
the possible origin##2##3##(2008-5#1)(2009-7#1)
the possible relationship between##2##4##(1993-2#1)(2013-1#1)
the possible relationship with##2##4##(2008-10#1)(2013-1#1)
the possible relationship##4##3##(1993-2#1)(2008-10#1)(2013-1#2)
the possible relevance of this##2##5##(1992-12#1)(2008-9#1)
the possible relevance of##3##4##(1992-12#1)(2008-10#1)(2008-9#1)
the possible risk##2##3##(2008-1#1)(2012-2#1)
the possible role of##10##4##(1992-5#1)(1994-11#1)(1994-5#1)(1995-9#2)(1996-2#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-3#1)
the possible use of##6##4##(2008-10#3)(2008-5#2)(2009-8#1)
the possible##149##2##(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-2#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-9#2)(1996-2#2)(1997-4#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#32)(2008-11#9)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#3)(2012-4#1)(2012-5#1)(2012-8#2)(2013-1#6)(2013-8#4)
the post##4##2##(1996-8#1)(2008-11#1)(2008-12#1)(2010-7#1)
the post-cataract surgery##2##3##(2010-8#2)
the post-operative##3##2##(1990-9#1)(2008-11#1)(2013-1#1)
the post-synaptic membrane##2##3##(1997-5#1)(2008-11#1)
the post-transcriptional##2##2##(1996-12#1)(2011-2#1)
the post-translational##8##2##(1992-6#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-3#1)(2013-1#1)
the post-transplant##2##2##(2007-11#1)(2011-3#1)
the posterior cervical##2##3##(1997-6#1)(2012-3#1)
the posterior circulation##3##3##(1993-3#1)(2008-7#1)(2012-3#1)
the posterior fossa##11##3##(1996-6#2)(1996-9#1)(2008-7#5)(2011-2#3)
the posterior lobe##4##3##(1992-9#2)(1997-8#1)(2012-3#1)
the posterior mediastinum##2##3##(2010-12#2)
the posterior superior temporal##2##4##(2008-11#2)
the posterior wall of the##2##5##(1997-8#1)(2008-7#1)
the posterior walls##2##3##(1991-6#2)
the posterior##73##2##(1991-2#1)(1991-6#3)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-2#2)(1996-6#2)(1996-9#2)(1997-3#2)(1997-6#1)(1997-8#5)(2007-12#4)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#9)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#3)(2010-5#1)(2011-2#9)(2011-7#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
the postero-medial##3##2##(1993-6#3)
the posterobasal##2##2##(1991-3#1)(2013-1#1)
the posterolateral##2##2##(2008-10#1)(2011-2#1)
the postharvest pathogens##2##3##(2008-10#2)
the postharvest##5##2##(2008-10#5)
the postimplementation##4##2##(2013-1#4)
the postnatal development of##4##4##(1992-6#1)(2009-8#1)(2011-2#2)
the postnatal##11##2##(1990-5#2)(1992-6#1)(1994-11#1)(1996-12#1)(2008-10#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
the postoperative##12##2##(1990-2#1)(1991-2#1)(1994-3#1)(2008-7#2)(2010-10#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
the postsynaptic density (PSD)##3##4##(1996-12#2)(2008-11#1)
the postsynaptic membrane##3##3##(1996-12#2)(2008-11#1)
the postsynaptic neuron##3##3##(1997-7#2)(2009-8#1)
the postsynaptic##12##2##(1996-12#5)(1997-2#2)(1997-7#2)(2008-11#2)(2009-8#1)
the postulated##4##2##(1990-7#1)(2008-11#2)(2010-10#1)
the potassium channel##2##3##(1994-11#1)(1997-2#1)
the potassium##10##2##(1994-11#1)(1995-8#1)(1997-2#3)(2008-10#4)(2008-3#1)
the potato##12##2##(2008-10#12)
the potencies of##2##3##(1995-11#2)
the potency of##5##3##(1992-3#1)(1994-8#2)(1995-11#1)(2008-11#1)
the potency##9##2##(1992-3#2)(1993-12#2)(1993-8#1)(1994-8#2)(1995-11#1)(2008-11#1)
the potent##14##2##(1991-3#1)(1991-5#1)(1992-10#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#2)
the potential advantages of##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
the potential application of this##3##5##(2008-10#2)(2012-3#1)
the potential application of##4##4##(2008-10#2)(2008-8#1)(2012-3#1)
the potential benefits and##2##4##(2008-10#1)(2008-11#1)
the potential benefits of##5##4##(1994-3#1)(2008-11#1)(2009-5#1)(2010-1#1)(2013-7#1)
the potential benefits##7##3##(1994-3#1)(2008-10#1)(2008-11#2)(2009-5#1)(2010-1#1)(2013-7#1)
the potential biological##2##3##(2008-10#1)(2012-3#1)
the potential buffer##4##3##(2008-10#4)
the potential change##5##3##(2008-10#5)
the potential contribution of##2##4##(2008-10#2)
the potential effects of##2##4##(2008-11#1)(2010-8#1)
the potential for a##6##4##(1991-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
the potential for improved##2##4##(2008-3#1)(2008-9#1)
the potential for outcrossing##2##4##(2008-10#2)
the potential for the##6##4##(1992-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
the potential for using##2##4##(2008-11#2)
the potential for##79##3##(1990-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1994-11#1)(1995-1#1)(1996-12#2)(1997-1#1)(1997-6#2)(2008-10#14)(2008-11#9)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-1#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
the potential hazards##2##3##(2008-10#1)(2008-11#1)
the potential impact of##6##4##(1997-2#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-8#2)
the potential importance of##3##4##(2008-10#1)(2008-7#1)(2010-1#1)
the potential in##3##3##(2008-1#1)(2008-10#2)
the potential interference of##2##4##(2008-10#2)
the potential mechanism of##4##4##(2008-10#2)(2011-2#2)
the potential mechanism##5##3##(2008-10#2)(2011-2#2)(2012-3#1)
the potential molecular##2##3##(2008-11#1)(2012-3#1)
the potential negative##2##3##(1995-12#1)(2012-2#1)
the potential of a##2##4##(2008-10#1)(2008-5#1)
the potential of being a##3##5##(2008-10#2)(2008-7#1)
the potential of being##4##4##(2008-10#3)(2008-7#1)
the potential of the##8##4##(2008-10#6)(2009-7#1)(2010-3#1)
the potential of these##2##4##(2009-10#1)(2011-2#1)
the potential of this##3##4##(1995-8#1)(2008-3#1)(2013-1#1)
the potential of two##2##4##(2008-10#2)
the potential of using##2##4##(2008-10#2)
the potential of working electrode##2##5##(2008-10#2)
the potential of##76##3##(1993-11#1)(1993-3#1)(1993-9#1)(1994-1#1)(1995-2#1)(1995-8#1)(1996-3#1)(2008-10#33)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#4)(2013-8#1)
the potential range of##2##4##(2008-10#2)
the potential range##5##3##(2008-10#5)
the potential reasons##2##3##(2008-10#1)(2010-9#1)
the potential relationships among##2##4##(2013-8#2)
the potential risk of##5##4##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
the potential risk##8##3##(1995-5#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the potential risks##3##3##(2008-10#3)
the potential role of##6##4##(1992-12#1)(1993-3#1)(1994-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
the potential therapeutic##2##3##(1992-9#1)(2008-11#1)
the potential to be an##2##5##(2008-10#2)
the potential to be##12##4##(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#3)
the potential to differentiate into##2##5##(2008-11#2)
the potential to provide a##3##5##(2008-10#1)(2011-7#1)(2012-2#1)
the potential to provide##6##4##(1991-3#1)(2008-10#1)(2008-9#1)(2011-7#1)(2012-2#1)(2013-1#1)
the potential to significantly reduce##2##5##(2008-10#1)(2008-2#1)
the potential to significantly##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
the potential to##82##3##(1991-3#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#2)(2008-10#19)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#3)(2011-7#4)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#1)
the potential toxicity of##2##4##(2008-10#1)(2013-1#1)
the potential use of##9##4##(2008-11#3)(2008-12#1)(2008-5#2)(2008-9#3)
the potential use##11##3##(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#3)(2008-9#3)
the potential usefulness of##4##4##(2008-10#2)(2008-7#1)(2009-7#1)
the potential uses of##2##4##(1991-12#1)(2008-10#1)
the potential utility of##5##4##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2012-12#1)
the potential utility##6##3##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#1)(2012-12#1)
the potential was##2##3##(2008-10#2)
the potential##457##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-3#5)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-1#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#3)(1997-7#2)(1997-8#1)(2008-1#4)(2008-10#148)(2008-11#41)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#9)(2008-8#11)(2008-9#16)(2009-1#1)(2009-10#2)(2009-12#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#6)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#19)(2011-3#2)(2011-7#4)(2012-12#5)(2012-2#15)(2012-3#12)(2013-1#18)(2013-7#1)(2013-8#11)
the potentialities of##2##3##(2008-10#2)
the potentialities##4##2##(2008-10#2)(2009-10#1)(2009-6#1)
the potentiality of##2##3##(2008-10#1)(2010-3#1)
the potentially##7##2##(1990-5#1)(2008-10#2)(2008-11#2)(2012-2#1)(2013-1#1)
the potentials of##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
the potentials##6##2##(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)
the potentiating effect of CGRP##2##5##(1997-4#2)
the potentiating effect of##3##4##(1997-4#3)
the potentiating##4##2##(1995-11#1)(1997-4#3)
the potentiation of phagocytosis##3##4##(1993-6#3)
the potentiation of##10##3##(1992-8#1)(1993-6#4)(1995-12#1)(1996-2#1)(2008-10#1)(2008-4#2)
the potentiometric determination of##4##4##(2008-10#4)
the potentiometric response characteristics##2##4##(2008-10#2)
the potentiometric response##4##3##(2008-10#4)
the potentiometric selectivity of##5##4##(2008-10#5)
the potentiometric selectivity##8##3##(2008-10#8)
the potentiometric titration of VO(2+)##2##5##(2008-10#2)
the potentiometric titration of##13##4##(2008-10#13)
the potentiometric titration##16##3##(2008-10#16)
the potentiometric titrations##2##3##(2008-10#2)
the potentiometric##41##2##(2008-10#41)
the potting mix##4##3##(2008-10#4)
the potting##5##2##(2008-10#5)
the potyvirus##2##2##(2008-10#2)
the pouch##2##2##(2008-10#1)(2009-12#1)
the powder##6##2##(2008-10#4)(2008-5#1)(2011-2#1)
the powdery mildew##2##3##(2008-10#2)
the power and##3##3##(2008-10#1)(2010-7#1)(2012-3#1)
the power increases##2##3##(1995-12#1)(2008-3#1)
the power of the##6##4##(1996-3#3)(2008-3#1)(2009-10#1)(2010-4#1)
the power of##18##3##(1996-2#1)(1996-3#3)(1997-2#1)(2008-11#2)(2008-3#1)(2009-10#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the power spectral density##2##4##(2010-8#1)(2012-2#1)
the power to##3##3##(1992-1#1)(1993-3#1)(1994-9#1)
the power transmission##2##3##(2008-10#1)(2008-3#1)
the power##43##2##(1992-1#1)(1993-3#1)(1994-9#1)(1995-12#2)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
the power-law form of the species-area relationship##2##7##(2008-8#2)
the power-law##3##2##(2008-3#1)(2008-8#2)
the powerful##4##2##(1990-5#1)(1997-2#1)(2008-9#1)(2012-2#1)
the practical and##3##3##(1996-3#1)(2008-11#1)(2008-6#1)
the practical applicability of##2##4##(2008-10#2)
the practical application of##2##4##(1992-3#1)(1996-8#1)
the practical aspects of##3##4##(1994-12#1)(2008-10#1)(2008-11#1)
the practical aspects##4##3##(1994-12#1)(1997-5#1)(2008-10#1)(2008-11#1)
the practical difficulties##2##3##(1992-3#1)(2008-11#1)
the practical use##2##3##(1992-5#1)(2008-10#1)
the practical##35##2##(1992-3#2)(1992-5#1)(1993-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(2008-10#6)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
the practicality##2##2##(1990-2#1)(2008-7#1)
the practice of health##2##4##(1993-2#1)(2012-3#1)
the practice of physical activity##4##5##(2010-11#4)
the practice of public health##2##5##(1996-2#1)(1997-3#1)
the practice of##39##3##(1990-6#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-11#6)(2008-12#2)(2010-1#1)(2010-11#5)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)
the practice setting##3##3##(1993-2#1)(2008-11#2)
the practice##59##2##(1990-3#3)(1990-6#1)(1990-9#1)(1992-2#1)(1992-3#1)(1993-2#2)(1994-1#2)(1994-12#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-11#14)(2008-12#2)(2008-9#2)(2010-1#2)(2010-11#5)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#3)
the practitioner##7##2##(1990-6#1)(1991-12#1)(1994-1#1)(1997-4#1)(2008-12#1)(2008-4#1)(2010-10#1)
the practitioners##4##2##(2008-1#2)(2008-10#1)(2011-2#1)
the pragmatic##3##2##(2008-12#3)
the pre- and##6##3##(1991-1#1)(2008-11#1)(2010-8#1)(2012-12#2)(2012-3#1)
the pre-column##2##2##(2008-10#2)
the pre-concentration of##3##3##(2008-10#3)
the pre-concentration##7##2##(2008-10#7)
the pre-existing##4##2##(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
the pre-reflective self##2##3##(2008-11#2)
the pre-registration curricula##2##3##(2008-11#2)
the pre-registration##3##2##(2008-11#3)
the pre-treatment##4##2##(2008-10#1)(2008-2#1)(2010-9#1)(2011-2#1)
the preS1##3##2##(1993-8#2)(1994-8#1)
the preS2##2##2##(1993-8#2)
the precautionary measures##2##3##(2012-3#1)(2013-1#1)
the preceding 12 months##2##4##(2008-10#1)(2012-12#1)
the preceding 3##2##3##(2013-7#1)(2013-8#1)
the preceding 5 years##2##4##(2008-10#2)
the preceding 6 months##2##4##(2013-1#2)
the preceding sinus##2##3##(1996-6#2)
the preceding##15##2##(1996-6#2)(1997-6#1)(2008-10#5)(2008-11#1)(2009-5#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
the precious metals##2##3##(2008-10#2)
the precipitate##12##2##(2008-10#9)(2008-11#2)(2008-2#1)
the precipitated##6##2##(2008-10#1)(2008-7#2)(2013-1#3)
the precipitates were##2##3##(2008-10#2)
the precipitates##6##2##(2008-10#6)
the precipitation of##8##3##(2008-10#7)(2009-7#1)
the precipitation reaction##3##3##(2008-10#3)
the precipitation##16##2##(2008-10#11)(2008-7#3)(2009-7#1)(2012-2#1)
the precise mechanisms##2##3##(2008-9#1)(2010-7#1)
the precise molecular mechanisms##2##4##(2008-11#1)(2008-7#1)
the precise nature of the##2##5##(1994-1#1)(2008-11#1)
the precise site of##2##4##(2012-2#2)
the precise##31##2##(1991-2#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
the precision and accuracy of the##4##6##(2008-10#4)
the precision and accuracy of##6##5##(2008-10#5)(2010-11#1)
the precision and##7##3##(2008-10#5)(2008-3#1)(2010-11#1)
the precision of measurement is##2##5##(2008-10#1)(2008-3#1)
the precision of the##8##4##(2008-10#7)(2013-1#1)
the precision of this##2##4##(2008-10#1)(2008-2#1)
the precision of##22##3##(2008-10#16)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)
the precision##48##2##(2008-10#38)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
the precisions##3##2##(2008-10#3)
the preclinical and##2##3##(1995-5#1)(2010-11#1)
the preclinical evaluation of##2##4##(1991-9#1)(2008-10#1)
the preclinical stage##2##3##(1994-3#1)(2010-10#1)
the preclinical##8##2##(1991-9#1)(1994-3#1)(1995-5#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-11#1)
the precolumn##4##2##(2008-10#4)
the preconcentration and determination of##3##5##(2008-10#3)
the preconcentration and##13##3##(2008-10#13)
the preconcentration factor##2##3##(2008-10#2)
the preconcentration of Cu##2##4##(2008-10#2)
the preconcentration of the##2##4##(2008-10#2)
the preconcentration of trace metals##3##5##(2008-10#3)
the preconcentration of trace##7##4##(2008-10#7)
the preconcentration of##26##3##(2008-10#26)
the preconcentration step##2##3##(2008-10#2)
the preconcentration system##6##3##(2008-10#6)
the preconcentration time of##2##4##(2008-10#2)
the preconcentration time##3##3##(2008-10#3)
the preconcentration##67##2##(2008-10#67)
the precursor of adenoregulin##2##4##(1993-3#2)
the precursor of##6##3##(1990-8#1)(1991-7#1)(1993-3#2)(1997-1#1)(2008-10#1)
the precursor##17##2##(1990-8#1)(1991-7#2)(1992-6#1)(1993-12#1)(1993-3#3)(1994-11#2)(1995-8#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-9#1)
the precursors of##2##3##(2010-5#1)(2012-2#1)
the precursors##3##2##(2010-5#2)(2012-2#1)
the predator has a##2##4##(2008-9#2)
the predator##7##2##(2008-8#4)(2008-9#3)
the predetermination of exponential growth##2##5##(2008-7#2)
the predictability of##3##3##(2008-10#1)(2008-9#1)(2011-7#1)
the predicted amino acid##3##4##(1995-8#1)(2008-10#2)
the predicted and the##2##4##(2008-10#1)(2008-3#1)
the predicted and##3##3##(2008-10#2)(2008-3#1)
the predicted concentrations##2##3##(2008-10#2)
the predicted increase##2##3##(1991-2#1)(1992-3#1)
the predicted product of##2##4##(2008-10#1)(2008-9#1)
the predicted protein##2##3##(1993-12#1)(2008-10#1)
the predicted##48##2##(1990-5#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#14)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#3)
the prediction ability of##4##4##(2008-10#4)
the prediction of the##3##4##(1990-5#1)(2008-10#1)(2008-3#1)
the prediction of these##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
the prediction of##28##3##(1990-5#1)(1995-5#1)(1996-12#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
the prediction performance##2##3##(2008-10#1)(2013-1#1)
the prediction that##2##3##(2008-8#2)
the prediction##47##2##(1990-5#1)(1995-5#1)(1996-12#1)(1997-6#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
the predictions from##2##3##(2008-3#1)(2008-9#1)
the predictions of the##4##4##(1990-8#1)(1992-3#1)(2008-8#1)(2008-9#1)
the predictions of##7##3##(1990-8#1)(1992-3#1)(2008-10#1)(2008-8#3)(2008-9#1)
the predictions##13##2##(1990-8#1)(1992-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#3)(2010-8#1)
the predictive ability of the model##2##6##(2008-10#2)
the predictive ability of the##5##5##(2008-10#4)(2012-3#1)
the predictive ability of##7##4##(2008-10#5)(2012-12#1)(2012-3#1)
the predictive power of the##2##5##(2008-5#1)(2008-7#1)
the predictive power of##3##4##(1992-12#1)(2008-5#1)(2008-7#1)
the predictive validity of nursing home pre-admission screens##2##8##(1994-2#2)
the predictive validity of##3##4##(1994-2#2)(1994-3#1)
the predictive validity##4##3##(1994-2#2)(1994-3#1)(2013-1#1)
the predictive value of##4##4##(1991-12#1)(1996-1#1)(2009-6#1)(2011-2#1)
the predictive##21##2##(1991-12#1)(1992-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
the predictor##2##2##(1991-12#1)(2011-2#1)
the predictors of##3##3##(2008-11#2)(2009-11#1)
the predictors##6##2##(1995-12#1)(2008-11#3)(2009-11#1)(2010-5#1)
the predisposing##2##2##(1993-1#1)(1997-9#1)
the predisposition to##2##3##(1991-12#1)(1993-6#1)
the predisposition##3##2##(1991-12#2)(1993-6#1)
the predominance of##4##3##(1990-8#1)(1992-6#1)(2008-10#1)(2012-3#1)
the predominant form of##4##4##(1990-11#1)(1992-6#1)(1994-6#1)(2008-11#1)
the predominant isoform of##2##4##(1992-12#1)(1994-8#1)
the predominant species##7##3##(1994-11#1)(1996-12#1)(2008-10#4)(2013-8#1)
the predominant##51##2##(1990-11#1)(1991-11#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-12#2)(1997-4#1)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
the predominantly##3##2##(1994-8#1)(2008-10#1)(2011-1#1)
the preference of##2##3##(1996-5#1)(2008-10#1)
the preference##5##2##(1996-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
the preferential##10##2##(1990-11#1)(1992-3#1)(1993-12#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-11#3)(2011-2#1)
the preferred orientation##2##3##(2008-11#1)(2008-8#1)
the preferred##20##2##(1995-6#1)(1996-3#1)(1996-5#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-7#1)(2012-3#3)(2013-8#1)
the prefrontal area##3##3##(1994-8#1)(1996-2#1)(2011-2#1)
the prefrontal cortex (PFC)##2##4##(2008-11#1)(2013-8#1)
the prefrontal cortex##7##3##(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2013-8#2)
the prefrontal##16##2##(1993-3#2)(1994-8#2)(1996-2#2)(1997-2#1)(2008-10#1)(2008-11#4)(2011-2#1)(2013-8#3)
the pregnancy##9##2##(1990-5#1)(1991-12#2)(1992-12#1)(1993-3#1)(1996-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
the pregnant women##2##3##(1997-4#1)(2008-12#1)
the pregnant##7##2##(1997-4#1)(1997-6#1)(2008-12#1)(2008-8#3)(2009-10#1)
the preliminary data##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
the preliminary##12##2##(1990-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#3)
the premature##3##2##(1994-9#1)(2009-9#1)(2011-2#1)
the premise that##8##3##(1992-3#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
the premise##9##2##(1992-3#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
the prenatal period##2##3##(1995-5#1)(2012-2#1)
the prenatal##3##2##(1995-5#1)(2012-2#1)(2012-3#1)
the preoperative and##2##3##(1994-3#1)(2012-3#1)
the preoperative clinical##2##3##(1997-2#1)(2011-2#1)
the preoperative##19##2##(1990-11#1)(1990-9#1)(1992-9#1)(1994-3#1)(1995-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#2)
the preoptic area##5##3##(1992-1#1)(1992-3#1)(1997-3#1)(2008-8#1)(2008-9#1)
the preparation and##3##3##(2008-10#3)
the preparation of a##4##4##(2008-10#2)(2008-12#1)(2011-1#1)
the preparation of the##5##4##(1992-3#1)(2008-10#3)(2008-11#1)
the preparation of##66##3##(1990-12#1)(1992-3#1)(1996-5#4)(1997-2#1)(2008-10#23)(2008-11#7)(2008-12#3)(2008-2#1)(2008-4#10)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#3)
the preparation procedure##2##3##(2008-10#2)
the preparation##82##2##(1990-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-11#1)(1996-5#4)(1997-2#1)(2008-10#32)(2008-11#9)(2008-12#3)(2008-2#1)(2008-4#10)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#3)
the preparative##2##2##(1996-12#1)(2008-9#1)
the preparatory phase##2##3##(1996-2#1)(2010-6#1)
the preparatory##4##2##(1996-2#1)(2010-2#1)(2010-6#1)(2013-8#1)
the prepared Au-NP/SAM-modified electrodes##2##4##(2008-10#2)
the prepared ISFETs##2##3##(2008-10#2)
the prepared##14##2##(2008-10#9)(2008-11#1)(2008-5#2)(2009-11#1)(2012-2#1)
the preprophase band##2##3##(2009-10#2)
the prepubertal period##3##3##(2008-4#1)(2011-1#2)
the prepubertal##4##2##(2008-4#1)(2011-1#2)(2012-2#1)
the prerequisite##2##2##(2013-1#1)(2013-8#1)
the prescribed##6##2##(1993-11#2)(1995-2#1)(1996-3#1)(2008-10#1)(2009-11#1)
the prescribing rates##2##3##(2008-11#2)
the prescribing##4##2##(2008-11#3)(2009-3#1)
the prescription of##3##3##(1991-11#1)(2008-11#1)(2012-3#1)
the prescription##6##2##(1991-11#1)(1995-11#1)(2008-11#2)(2009-2#1)(2012-3#1)
the presence and absence of##30##5##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1997-1#1)(2008-10#11)(2008-11#3)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the presence and severity of##2##5##(1997-1#1)(1997-8#1)
the presence and##43##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1997-1#2)(1997-8#1)(2008-10#16)(2008-11#3)(2008-7#1)(2008-8#2)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
the presence in this##2##4##(1990-5#1)(2008-10#1)
the presence in##5##3##(1990-5#1)(1993-8#1)(2008-10#2)(2008-7#1)
the presence of &quot##2##4##(1990-3#1)(2009-7#1)
the presence of 0##10##4##(1991-3#1)(1993-8#1)(1995-8#2)(2008-10#4)(2008-11#2)
the presence of 10##2##4##(1995-11#1)(1997-3#1)
the presence of 10(-9) M##2##5##(1990-11#1)(1994-3#1)
the presence of 2##8##4##(1990-8#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#4)
the presence of 50##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
the presence of Ca(2+)##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
the presence of Ca2+##5##4##(1993-8#1)(1994-11#3)(1995-8#1)
the presence of Cd##2##4##(2008-10#2)
the presence of DNA##7##4##(2008-10#6)(2008-9#1)
the presence of EDTA##2##4##(2008-10#2)
the presence of Fusarium##2##4##(2008-10#2)
the presence of IGF-I##2##4##(2008-11#2)
the presence of M##2##4##(2008-10#2)
the presence of NO##3##4##(1995-11#1)(2008-10#2)
the presence of P##3##4##(2008-10#3)
the presence of T-CD4 T cells##2##6##(2012-12#2)
the presence of T1##2##4##(2008-10#1)(2012-12#1)
the presence of a cocaine use disorder##2##7##(2010-6#2)
the presence of a conspecific##2##5##(1994-8#1)(2009-6#1)
the presence of a high##3##5##(2008-10#2)(2012-12#1)
the presence of a large number of##2##7##(2008-10#2)
the presence of a large##4##5##(2008-10#4)
the presence of a positive##2##5##(1996-5#1)(2010-11#1)
the presence of a protein##2##5##(1991-5#1)(2008-8#1)
the presence of a reducing agent##2##6##(2008-10#2)
the presence of a single##5##5##(1993-2#1)(1994-11#1)(1995-11#1)(2008-10#2)
the presence of a water##2##5##(2008-10#2)
the presence of a##108##4##(1990-10#1)(1990-12#2)(1990-5#1)(1991-11#1)(1991-2#2)(1991-5#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-8#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-6#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#39)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
the presence of abnormal##2##4##(1990-12#1)(2011-2#1)
the presence of acetone##3##4##(2008-10#2)(2008-9#1)
the presence of active##3##4##(1993-12#1)(2008-11#2)
the presence of additional##3##4##(1994-8#1)(1997-3#1)(2008-10#1)
the presence of air##3##4##(1991-3#1)(2008-10#1)(2008-6#1)
the presence of all##2##4##(2008-10#1)(2012-3#1)
the presence of an androgen binding component##2##7##(1990-11#2)
the presence of an excess of##4##6##(2008-10#4)
the presence of an unstable##2##5##(2011-2#1)(2013-1#1)
the presence of an##38##4##(1990-11#2)(1991-11#1)(1991-12#1)(1991-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
the presence of any##5##4##(2008-10#3)(2008-11#1)(2010-6#1)
the presence of asci##2##4##(2008-10#2)
the presence of associated##2##4##(1997-8#1)(2008-9#1)
the presence of at least##4##5##(1990-11#1)(1990-8#1)(1995-6#1)(2012-3#1)
the presence of auxin##2##4##(2009-8#2)
the presence of bFGF and its##2##6##(1994-11#1)(1995-12#1)
the presence of bFGF and##3##5##(1994-11#2)(1995-12#1)
the presence of bacteria##2##4##(2008-10#1)(2008-12#1)
the presence of beta-cyclodextrin and##2##5##(2008-10#2)
the presence of both##8##4##(2008-10#5)(2008-11#2)(2008-7#1)
the presence of caffeine##2##4##(1990-2#1)(2008-10#1)
the presence of calcium##8##4##(1990-8#1)(1992-12#1)(1993-6#1)(1995-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
the presence of cell##4##4##(2008-10#3)(2009-8#1)
the presence of certain##3##4##(2008-10#1)(2008-11#2)
the presence of circulating##2##4##(1992-3#1)(2008-10#1)
the presence of clinical##2##4##(1992-3#1)(2011-2#1)
the presence of complex##2##4##(2008-4#1)(2008-5#1)
the presence of developmental##2##4##(1994-1#1)(2012-12#1)
the presence of dibenzo-18-crown-6##2##4##(2008-10#2)
the presence of different##7##4##(1991-5#1)(2008-10#4)(2008-5#1)(2010-4#1)
the presence of either##5##4##(1991-8#1)(1995-9#1)(1997-3#1)(2008-11#2)
the presence of endogenous##3##4##(1996-12#1)(2008-10#1)(2010-11#1)
the presence of equivalent##2##4##(2009-10#1)(2013-1#1)
the presence of excess##8##4##(1990-5#1)(1991-9#1)(1995-11#1)(2008-10#5)
the presence of four##2##4##(2008-10#2)
the presence of high levels of##2##6##(1992-9#1)(2008-10#1)
the presence of high##11##4##(1990-2#1)(1991-2#1)(1991-9#1)(1992-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-6#1)
the presence of higher##2##4##(2008-10#1)(2011-1#1)
the presence of human##3##4##(1990-12#1)(2008-10#1)(2011-2#1)
the presence of humic##3##4##(2008-10#3)
the presence of hypochlorite##2##4##(2008-10#2)
the presence of interfering##3##4##(2008-10#2)(2013-1#1)
the presence of iron##3##4##(1991-5#1)(2008-10#1)(2013-1#1)
the presence of its##4##4##(1993-8#1)(2008-10#2)(2013-7#1)
the presence of large##6##4##(2008-10#6)
the presence of local##2##4##(2008-10#1)(2008-12#1)
the presence of low##6##4##(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
the presence of more##2##4##(1991-3#1)(2008-10#1)
the presence of multiple##3##4##(1992-6#1)(2008-10#1)(2012-2#1)
the presence of nitrate##3##4##(2008-10#2)(2008-11#1)
the presence of oedema##3##4##(2008-7#2)(2013-7#1)
the presence of one##5##4##(1994-6#1)(2008-10#3)(2008-8#1)
the presence of other##15##4##(1993-8#1)(2008-10#10)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)
the presence of oxygen##7##4##(1997-1#1)(2008-10#4)(2008-9#1)(2009-3#1)
the presence of ozone##2##4##(2008-10#2)
the presence of picrotoxin##2##4##(1995-12#1)(2008-8#1)
the presence of potassium##2##4##(2008-10#2)
the presence of potential##3##4##(2008-10#2)(2011-1#1)
the presence of predators##2##4##(2008-8#2)
the presence of rDNA sites##2##5##(2010-8#2)
the presence of serum in the##2##6##(1991-5#1)(2008-11#1)
the presence of serum##5##4##(1991-5#1)(2008-10#1)(2008-11#3)
the presence of several##13##4##(1991-6#1)(1997-8#1)(2008-10#9)(2008-12#1)(2008-8#1)
the presence of significant##2##4##(1990-5#1)(2010-1#1)
the presence of sodium##19##4##(1990-11#1)(1996-12#1)(2008-10#16)(2008-9#1)
the presence of some##2##4##(1997-2#1)(2008-10#1)
the presence of specific##2##4##(1997-2#1)(2008-10#1)
the presence of strong##2##4##(2008-10#1)(2008-3#1)
the presence of surfactants##5##4##(2008-10#5)
the presence of testosterone in the##2##6##(1995-2#1)(2012-2#1)
the presence of the different##2##5##(2008-10#1)(2010-3#1)
the presence of the enzyme##2##5##(2008-10#2)
the presence of the jelly coat##2##6##(2008-8#2)
the presence of the other##3##5##(2008-10#2)(2008-12#1)
the presence of the pathogen##2##5##(2008-10#2)
the presence of the substrate##2##5##(2008-3#1)(2008-4#1)
the presence of the two##2##5##(1994-11#1)(2008-11#1)
the presence of the virus##3##5##(2008-10#3)
the presence of the##93##4##(1990-5#3)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-6#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#46)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-8#4)(2009-9#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-12#2)(2013-1#1)
the presence of these##5##4##(2008-10#1)(2010-4#1)(2011-2#2)(2013-1#1)
the presence of this##7##4##(1993-8#1)(1996-8#1)(2008-10#3)(2009-9#1)(2013-7#1)
the presence of three##3##4##(1996-12#1)(2008-10#1)(2008-7#1)
the presence of toxic##2##4##(2008-10#1)(2011-1#1)
the presence of two classes of##3##6##(1993-1#1)(1994-3#1)(1994-8#1)
the presence of two different##2##5##(2008-10#2)
the presence of two##22##4##(1990-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-8#2)(1996-2#1)(2008-10#9)(2008-7#1)(2010-2#1)(2011-2#1)(2013-7#1)
the presence of typical##2##4##(2008-5#1)(2012-3#1)
the presence of viral##2##4##(1993-8#1)(2008-11#1)
the presence of##1466##3##(1990-10#5)(1990-11#7)(1990-12#5)(1990-2#6)(1990-3#1)(1990-5#14)(1990-6#1)(1990-7#1)(1990-8#8)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#6)(1991-5#15)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#6)(1993-6#9)(1993-8#26)(1993-9#1)(1994-1#1)(1994-11#14)(1994-2#1)(1994-3#2)(1994-5#15)(1994-6#6)(1994-8#13)(1995-11#10)(1995-12#10)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#7)(1995-8#12)(1995-9#2)(1996-12#7)(1996-2#5)(1996-3#6)(1996-5#14)(1996-6#1)(1996-8#2)(1997-1#6)(1997-2#5)(1997-3#7)(1997-4#5)(1997-6#3)(1997-7#6)(1997-8#7)(2007-11#1)(2007-12#8)(2007-8#1)(2008-1#3)(2008-10#705)(2008-11#87)(2008-12#19)(2008-2#3)(2008-3#14)(2008-4#8)(2008-5#21)(2008-6#3)(2008-7#25)(2008-8#20)(2008-9#21)(2009-1#2)(2009-10#5)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#11)(2009-9#5)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#10)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#37)(2011-3#1)(2011-7#1)(2012-12#10)(2012-2#11)(2012-3#17)(2013-1#28)(2013-7#4)(2013-8#6)
the presence or absence of a##4##6##(2008-10#2)(2008-12#1)(2008-4#1)
the presence or absence of the##8##6##(1991-5#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-5#1)
the presence or absence of##49##5##(1990-5#1)(1991-11#1)(1991-5#2)(1992-1#1)(1993-3#3)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#20)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#4)(2010-7#1)(2012-12#1)(2012-2#1)
the presence or absence##50##4##(1990-5#1)(1991-11#1)(1991-5#2)(1992-1#1)(1993-3#3)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#20)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#4)(2010-7#1)(2012-12#1)(2012-2#1)
the presence or##51##3##(1990-5#1)(1991-11#1)(1991-5#2)(1992-1#1)(1993-3#3)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#20)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2010-7#1)(2012-12#1)(2012-2#1)
the presence##1576##2##(1990-10#5)(1990-11#8)(1990-12#5)(1990-2#6)(1990-3#1)(1990-5#17)(1990-6#2)(1990-7#1)(1990-8#8)(1991-11#4)(1991-12#4)(1991-2#5)(1991-3#7)(1991-5#17)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#10)(1993-6#9)(1993-8#27)(1993-9#1)(1994-1#1)(1994-11#14)(1994-2#1)(1994-3#2)(1994-5#15)(1994-6#6)(1994-8#14)(1995-11#12)(1995-12#10)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#8)(1995-8#13)(1995-9#2)(1996-12#7)(1996-2#5)(1996-3#6)(1996-5#14)(1996-6#1)(1996-8#2)(1997-1#8)(1997-2#5)(1997-3#7)(1997-4#5)(1997-6#3)(1997-7#6)(1997-8#9)(2007-11#1)(2007-12#8)(2007-8#1)(2008-1#3)(2008-10#747)(2008-11#96)(2008-12#23)(2008-2#4)(2008-3#14)(2008-4#10)(2008-5#23)(2008-6#3)(2008-7#29)(2008-8#26)(2008-9#21)(2009-1#2)(2009-10#5)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#11)(2009-9#5)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#10)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#38)(2011-3#1)(2011-7#1)(2012-12#12)(2012-2#13)(2012-3#18)(2013-1#30)(2013-7#4)(2013-8#6)
the presenceof##2##2##(2008-11#1)(2009-8#1)
the present analysis##2##3##(2008-5#1)(2008-9#1)
the present and##2##3##(1997-1#1)(2011-2#1)
the present approach##2##3##(2008-10#2)
the present article##12##3##(2008-10#2)(2008-11#5)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
the present case the##3##4##(1990-5#1)(2008-12#1)(2011-2#1)
the present case##13##3##(1990-5#1)(1996-2#1)(1997-7#1)(2008-12#1)(2008-7#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
the present data##4##3##(1991-6#1)(1993-8#1)(2011-2#1)(2013-1#1)
the present epidemiological situation##2##4##(1990-6#1)(1992-5#1)
the present experimental##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
the present experiments##4##3##(1993-3#1)(1993-6#1)(2008-10#1)(2008-5#1)
the present findings suggest that##2##5##(1994-5#1)(1996-12#1)
the present findings##3##3##(1994-5#1)(1996-12#1)(2008-5#1)
the present investigation##9##3##(1990-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-4#1)(2013-1#1)(2013-8#1)
the present knowledge of##2##4##(2008-10#1)(2008-11#1)
the present knowledge##5##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
the present method have##2##4##(1994-8#1)(2008-10#1)
the present method is##2##4##(2008-10#2)
the present method provided##2##4##(2008-10#2)
the present method were##3##4##(2008-10#3)
the present method##30##3##(1994-8#1)(1995-3#1)(2008-10#28)
the present paper develops##2##4##(2008-10#1)(2013-8#1)
the present paper we##6##4##(1991-9#1)(2008-11#2)(2008-5#1)(2009-12#1)(2012-2#1)
the present paper##35##3##(1990-8#1)(1991-9#1)(2007-12#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the present procedure##4##3##(2008-10#4)
the present report##5##3##(2008-10#1)(2008-11#1)(2011-2#3)
the present results provide##2##4##(1991-6#1)(1993-6#1)
the present results suggest that##3##5##(1993-6#1)(2008-10#1)(2011-2#1)
the present results##9##3##(1991-5#1)(1991-6#1)(1993-6#2)(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#2)
the present review##9##3##(1994-8#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the present series##2##3##(1990-12#1)(1996-2#1)
the present situation##2##3##(1991-3#1)(2008-10#1)
the present state of##3##4##(1991-3#1)(2008-11#1)(2011-3#1)
the present study demonstrated that##2##5##(1994-3#1)(2010-5#1)
the present study indicate that##3##5##(2008-10#2)(2008-12#1)
the present study indicated that##2##5##(2008-10#1)(2008-5#1)
the present study is##11##4##(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
the present study may##2##4##(2008-10#1)(2013-1#1)
the present study suggest that##3##5##(2008-10#1)(2011-2#1)(2012-5#1)
the present study that##3##4##(1994-8#1)(1995-12#1)(2008-12#1)
the present study was##53##4##(1990-8#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#9)(2008-11#2)(2008-12#4)(2008-5#4)(2008-7#1)(2009-1#1)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
the present study we have investigated the##2##7##(1995-12#1)(2012-2#1)
the present study we have investigated##3##6##(1994-2#1)(1995-12#1)(2012-2#1)
the present study we have##8##5##(1994-2#1)(1995-12#2)(1996-12#1)(2009-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
the present study we investigated##7##5##(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
the present study we##23##4##(1992-12#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#2)(2008-7#2)(2009-7#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
the present study were##5##4##(1993-3#1)(2008-10#2)(2009-8#1)(2012-2#1)
the present study##263##3##(1990-11#2)(1990-6#2)(1990-8#1)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#3)(1993-6#3)(1993-8#2)(1994-11#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#6)(1995-11#2)(1995-12#7)(1995-2#4)(1995-8#4)(1996-12#3)(1996-2#6)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(2008-10#42)(2008-11#24)(2008-12#12)(2008-3#1)(2008-5#12)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#20)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#8)(2012-5#3)(2013-1#13)(2013-8#4)
the present system##4##3##(2008-10#3)(2008-8#1)
the present time##11##3##(1992-3#2)(1993-3#1)(1994-5#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-8#1)(2008-12#1)(2008-7#1)
the present work was##9##4##(1992-12#1)(1993-11#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
the present work we##3##4##(2008-10#2)(2011-2#1)
the present work##57##3##(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#35)(2008-11#1)(2008-5#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the present##581##2##(1990-11#2)(1990-12#6)(1990-5#3)(1990-6#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#5)(1993-6#6)(1993-8#3)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-8#10)(1995-11#3)(1995-12#8)(1995-2#6)(1995-3#1)(1995-8#4)(1995-9#1)(1996-12#6)(1996-2#9)(1996-3#3)(1996-5#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#3)(1997-7#3)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#171)(2008-11#46)(2008-12#18)(2008-3#3)(2008-4#1)(2008-5#19)(2008-6#3)(2008-7#12)(2008-8#6)(2008-9#8)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#3)(2009-8#3)(2010-1#3)(2010-10#4)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#34)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#13)(2012-3#11)(2012-5#3)(2013-1#23)(2013-7#1)(2013-8#12)
the presentation and##2##3##(1995-11#1)(2011-2#1)
the presentation of##10##3##(1991-11#1)(1991-12#1)(1992-9#1)(1993-12#1)(2008-11#3)(2009-8#1)(2010-12#1)(2011-2#1)
the presentation##16##2##(1991-11#1)(1991-12#1)(1992-9#1)(1993-12#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
the presented method##2##3##(2008-10#1)(2008-11#1)
the presented##12##2##(1990-9#1)(1991-12#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)
the presenting sign of##2##4##(2008-1#1)(2010-10#1)
the presenting symptoms##2##3##(1990-6#1)(2008-12#1)
the presenting##7##2##(1990-3#1)(1990-6#1)(2008-1#1)(2008-12#1)(2009-11#1)(2010-10#1)(2010-6#1)
the preservation of the##2##4##(2008-10#1)(2008-3#1)
the preservation of this##2##4##(2008-10#1)(2008-11#1)
the preservation of##8##3##(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2011-2#1)
the preservation##11##2##(1997-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
the preservative##2##2##(2008-5#2)
the pressor response to##2##4##(1997-2#2)
the pressor##4##2##(1995-11#1)(1997-2#3)
the pressure drop##2##3##(2008-10#1)(2008-7#1)
the pressure of##2##3##(1991-12#1)(2008-10#1)
the pressure range##2##3##(2008-10#1)(2008-3#1)
the pressure##16##2##(1991-12#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)(2012-2#2)(2013-8#1)
the pressures##2##2##(1996-2#1)(2008-11#1)
the presumed##6##2##(1991-12#1)(1993-6#1)(1996-2#1)(1996-6#1)(2008-10#1)(2010-4#1)
the presumption##2##2##(1995-1#1)(2012-12#1)
the presumptive VU##2##3##(1994-12#2)
the presumptive##5##2##(1993-2#1)(1994-12#3)(1997-3#1)
the presynaptic##6##2##(1996-12#1)(1996-2#2)(1997-2#1)(1997-7#2)
the pretreated##2##2##(2008-10#1)(2013-1#1)
the pretreatment of a##2##4##(2008-8#1)(2013-1#1)
the pretreatment of the##2##4##(2008-10#2)
the pretreatment of##8##3##(2008-10#5)(2008-11#1)(2008-8#1)(2013-1#1)
the pretreatment##9##2##(2008-10#6)(2008-11#1)(2008-8#1)(2013-1#1)
the prevailing##11##2##(1992-3#2)(1996-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-8#1)
the prevalence and clinical##2##4##(2008-5#1)(2008-9#1)
the prevalence and population densities of H##2##7##(2008-10#2)
the prevalence and##12##3##(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
the prevalence of Japanese cedar pollinosis##2##6##(2012-12#2)
the prevalence of obesity##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
the prevalence of osteoporosis in##2##5##(2010-3#2)
the prevalence of osteoporosis##3##4##(2010-3#3)
the prevalence of risk factors##2##5##(1993-2#1)(2008-12#1)
the prevalence of the disease##2##5##(2008-10#2)
the prevalence of the##5##4##(2008-1#1)(2008-10#2)(2010-12#1)(2013-1#1)
the prevalence of this##2##4##(1996-12#1)(2010-5#1)
the prevalence of thyroid autoimmunity##2##5##(2008-7#2)
the prevalence of##109##3##(1990-3#1)(1990-6#2)(1991-12#2)(1992-1#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-6#2)(1994-9#2)(1995-10#2)(1996-1#2)(1996-12#3)(1997-3#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#7)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#3)
the prevalence rate of GB##2##5##(2013-8#2)
the prevalence rate##3##3##(2008-7#1)(2013-8#2)
the prevalence##135##2##(1990-3#1)(1990-6#2)(1991-12#2)(1992-1#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-6#2)(1994-9#2)(1995-10#2)(1995-12#1)(1996-1#2)(1996-12#3)(1996-3#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#9)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2011-1#1)(2011-2#12)(2011-7#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#10)(2013-8#6)
the prevalent cause of##2##4##(2008-5#1)(2008-7#1)
the prevalent trend##2##3##(1994-2#1)(2010-8#1)
the prevalent wind##2##3##(2008-5#2)
the prevalent##14##2##(1992-1#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2010-10#1)(2010-8#1)
the prevent-and-detect##2##2##(2010-7#2)
the prevention and control of##4##5##(2008-9#1)(2010-5#1)(2011-2#2)
the prevention and treatment of##5##5##(2007-7#1)(2008-10#1)(2012-12#1)(2013-1#2)
the prevention and##10##3##(1991-6#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
the prevention of obesity##4##4##(2008-10#2)(2011-2#2)
the prevention of transmission of##2##5##(1993-3#1)(2010-5#1)
the prevention of##41##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1992-9#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#2)(2009-10#3)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#1)
the prevention##52##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#3)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the preventive##7##2##(1990-9#1)(1993-9#1)(1996-2#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-8#1)
the previous 12 months##3##4##(1994-12#1)(2009-5#1)(2010-10#1)
the previous decade##3##3##(2008-5#1)(2013-1#2)
the previous dissection##2##3##(2008-11#2)
the previous passage##2##3##(2011-3#2)
the previous study##3##3##(1990-2#1)(1993-12#1)(2008-9#1)
the previous year were##2##4##(2008-10#2)
the previous year##7##3##(1991-3#1)(2008-10#6)
the previous##71##2##(1990-2#1)(1990-5#2)(1991-3#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-11#1)(1997-2#1)(1997-7#1)(2008-10#26)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-5#1)(2010-10#3)(2010-11#1)(2011-2#2)(2011-3#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
the previously characterized##4##3##(1991-9#1)(1997-4#1)(2008-10#1)(2008-7#1)
the previously described EC-2##2##4##(2008-10#2)
the previously described##19##3##(1990-5#1)(1991-5#1)(1995-11#1)(1995-9#1)(1996-6#2)(2008-10#9)(2008-11#1)(2008-3#1)(2010-11#1)(2012-3#1)
the previously developed##2##3##(1996-2#1)(2008-10#1)
the previously dominant##2##3##(2008-10#2)
the previously identified##6##3##(1993-6#1)(1996-12#1)(1996-3#1)(2008-10#1)(2009-4#1)(2012-3#1)
the previously known##2##3##(1992-3#1)(1996-6#1)
the previously published##3##3##(1993-8#1)(1995-12#1)(2010-2#1)
the previously reported##11##3##(1990-5#1)(1992-10#1)(1992-3#1)(1995-11#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-5#1)(2011-2#1)
the previously sequenced##2##3##(1991-6#1)(1997-8#1)
the previously used##2##3##(2011-2#1)(2012-3#1)
the previously##76##2##(1990-5#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-11#2)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#4)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#28)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
the previtellogenic##2##2##(2008-8#1)(2010-5#1)
the prey species##2##3##(2008-8#2)
the prey##11##2##(2008-10#1)(2008-8#4)(2008-9#5)(2012-3#1)
the prey's##3##2##(2008-8#2)(2008-9#1)
the prey-to-predator conversion efficiency##2##4##(2008-8#2)
the prg pathogens##3##3##(2008-10#3)
the price of##5##3##(1990-9#1)(1994-1#1)(1994-2#1)(2008-10#1)(2010-5#1)
the price##8##2##(1990-9#1)(1994-1#1)(1994-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)
the primary afferent##3##3##(1995-12#2)(1997-3#1)
the primary amino##2##3##(1996-12#1)(2008-10#1)
the primary and secondary##3##4##(2008-11#1)(2011-2#1)(2011-3#1)
the primary and##13##3##(1991-3#1)(1991-6#2)(1991-8#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
the primary antibody##3##3##(2008-10#3)
the primary auditory cortex##2##4##(2008-11#1)(2013-8#1)
the primary carbon##2##3##(1994-5#1)(2008-3#1)
the primary care##10##3##(1992-7#1)(1993-9#1)(1995-11#2)(2008-11#2)(2010-1#2)(2013-1#2)
the primary cause of##3##4##(1996-12#1)(2008-11#1)(2013-8#1)
the primary cause##4##3##(1996-12#1)(2008-11#1)(2008-3#1)(2013-8#1)
the primary cells##2##3##(2008-11#2)
the primary concern##2##3##(1992-8#1)(1997-2#1)
the primary electron donor##3##4##(2008-8#3)
the primary emulsifier##2##3##(2008-5#2)
the primary endosperm##3##3##(2008-9#3)
the primary factor##2##3##(2008-10#1)(2008-9#1)
the primary gene##2##3##(1990-5#1)(2009-10#1)
the primary health care##2##4##(1991-6#1)(2011-2#1)
the primary health services##2##4##(1991-6#1)(1994-6#1)
the primary health##4##3##(1991-6#2)(1994-6#1)(2011-2#1)
the primary immune response##2##4##(2008-10#1)(2008-11#1)
the primary infection##5##3##(2008-10#5)
the primary inoculum##4##3##(2008-10#4)
the primary lesion##3##3##(1992-2#1)(2008-10#1)(2013-8#1)
the primary means of##3##4##(2008-10#2)(2008-5#1)
the primary means##4##3##(2008-10#3)(2008-5#1)
the primary mechanism##2##3##(1997-3#1)(2008-10#1)
the primary particles##2##3##(2008-3#1)(2008-5#1)
the primary pathogenic##2##3##(1992-3#1)(2008-2#1)
the primary photochemical##2##3##(2008-8#1)(2011-1#1)
the primary sequence##2##3##(1993-2#2)
the primary site of the##2##5##(2012-12#1)(2012-3#1)
the primary site of##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
the primary site##4##3##(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
the primary structure of Orpotrin##2##5##(2011-2#2)
the primary structure of goat Mb##2##6##(2010-4#2)
the primary structure of the##4##5##(1990-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
the primary structure of##12##4##(1990-4#1)(1990-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#2)(2011-2#2)
the primary structures of##2##4##(1991-6#1)(1993-12#1)
the primary success rate##3##4##(1991-3#1)(2008-12#2)
the primary tumor to the##2##5##(1990-6#1)(2012-12#1)
the primary tumor##10##3##(1990-6#1)(1991-3#1)(1993-1#1)(1994-12#1)(2008-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the primary tumour##4##3##(1991-6#1)(1997-3#1)(2011-2#1)(2011-3#1)
the primary visual cortex##2##4##(2008-11#1)(2008-8#1)
the primary visual##3##3##(2008-11#1)(2008-8#2)
the primary##261##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#3)(1991-5#1)(1991-6#7)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#4)(1994-5#2)(1994-6#1)(1995-11#2)(1995-12#3)(1995-3#3)(1995-6#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#7)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#5)(2008-10#51)(2008-11#19)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#11)(2008-9#6)(2009-10#4)(2009-5#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#18)(2011-3#3)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#11)(2013-8#5)
the primate cortical visual system##2##5##(1995-5#2)
the primate endometrium##2##3##(1995-11#2)
the primate visual system##2##4##(1995-5#2)
the primate##8##2##(1995-11#2)(1995-5#4)(1997-2#2)
the prime##6##2##(1991-3#1)(1995-3#1)(1996-1#1)(2008-11#1)(2008-3#1)(2012-2#1)
the primed##2##2##(1995-2#1)(2008-11#1)
the primers##7##2##(1997-7#1)(2008-10#6)
the primitive##2##2##(2008-9#1)(2013-1#1)
the primordial##4##2##(2007-12#3)(2013-1#1)
the principal component of##2##4##(1993-11#1)(2008-10#1)
the principal component##3##3##(1993-11#1)(2008-10#1)(2011-2#1)
the principal components##2##3##(2008-10#1)(2008-6#1)
the principal plane##3##3##(2008-3#3)
the principal##40##2##(1990-9#2)(1991-1#1)(1992-3#1)(1993-11#1)(1995-5#1)(1997-3#1)(2008-10#9)(2008-11#4)(2008-3#8)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#2)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
the principle of the##3##4##(1997-6#1)(2008-12#1)(2008-5#1)
the principle of##19##3##(1992-1#1)(1996-3#1)(1997-6#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-8#1)
the principle that the##2##4##(1992-2#1)(2011-2#1)
the principle that##3##3##(1992-2#1)(2008-4#1)(2011-2#1)
the principle##33##2##(1992-1#1)(1992-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
the principles and practice of##2##5##(1993-12#1)(1997-3#1)
the principles and##6##3##(1993-11#1)(1993-12#2)(1997-3#1)(2008-11#1)(2013-1#1)
the principles discussed##2##3##(2008-4#1)(2010-8#1)
the principles guiding##2##3##(2008-10#1)(2010-12#1)
the principles of CQI##2##4##(1993-3#1)(1994-1#1)
the principles of induction##2##4##(2011-2#2)
the principles of molecular##2##4##(1997-6#1)(2010-9#1)
the principles of the##4##4##(2008-10#1)(2008-3#2)(2009-6#1)
the principles of##31##3##(1991-2#1)(1993-3#1)(1994-1#2)(1994-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
the principles underlying##2##3##(1995-1#1)(2008-11#1)
the principles##50##2##(1991-2#1)(1991-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#1)(1996-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-11#4)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-3#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
the prior##10##2##(1995-2#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-11#1)(2010-5#1)(2013-1#2)
the priorities##2##2##(1991-2#1)(2013-1#1)
the priority##4##2##(1996-1#1)(2009-4#1)(2013-1#2)
the prisms##2##2##(2008-3#2)
the pristine##2##2##(2008-10#1)(2012-2#1)
the privacy of##2##3##(1996-5#1)(1997-5#1)
the privacy rule requirements##2##4##(2007-12#2)
the privacy rule##5##3##(2007-12#5)
the privacy##9##2##(1995-6#1)(1996-5#1)(1997-5#1)(2007-12#6)
the private and public##2##4##(1994-1#1)(1995-12#1)
the private sector##10##3##(1991-1#1)(1996-3#1)(1997-5#5)(2008-1#1)(2012-2#1)(2012-3#1)
the private##18##2##(1990-6#1)(1991-1#1)(1991-2#1)(1992-2#1)(1994-1#2)(1995-12#1)(1996-1#1)(1996-3#1)(1997-5#5)(2008-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
the pro##2##2##(1995-6#2)
the pro-apoptotic##2##2##(2009-12#2)
the pro-inflammatory cytokines##2##3##(2008-10#1)(2010-1#1)
the pro-inflammatory##4##2##(2008-10#3)(2010-1#1)
the probabilities##2##2##(2008-10#1)(2012-3#1)
the probability for##2##3##(2008-11#2)
the probability of a##5##4##(1993-8#1)(2008-10#2)(2008-9#1)(2012-3#1)
the probability of being##2##4##(2008-8#1)(2010-8#1)
the probability of developing##3##4##(1992-9#2)(2012-3#1)
the probability of hospitalization##2##4##(1995-2#1)(2008-7#1)
the probability of mortality##2##4##(2008-10#2)
the probability of occurrence##2##4##(2009-10#1)(2009-8#1)
the probability of offspring survival##2##5##(2008-8#1)(2008-9#1)
the probability of surgery##2##4##(2012-3#2)
the probability of##68##3##(1990-11#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-9#2)(1993-12#1)(1993-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-2#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-3#6)
the probability that a tick infects the##2##7##(2013-8#2)
the probability that a##4##4##(1994-3#1)(2008-11#1)(2013-8#2)
the probability that caregivers##2##4##(1991-12#2)
the probability that##12##3##(1991-12#2)(1994-3#1)(1997-9#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2013-8#2)
the probability##87##2##(1990-11#1)(1990-8#1)(1991-12#3)(1992-2#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#1)(1996-2#1)(1997-9#1)(2008-10#21)(2008-11#5)(2008-3#2)(2008-7#5)(2008-8#9)(2008-9#5)(2009-10#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-3#6)(2013-8#2)
the probable##9##2##(1990-5#1)(1992-9#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-5#1)(2012-2#1)
the probably##2##2##(2008-11#1)(2012-3#1)
the proband##2##2##(2008-11#1)(2012-3#1)
the probe and##3##3##(2008-10#2)(2008-3#1)
the probe of##2##3##(2008-2#1)(2008-9#1)
the probe to##2##3##(2008-4#1)(2012-3#1)
the probe volume##2##3##(2008-3#2)
the probe##35##2##(1990-5#1)(1993-2#1)(1995-11#1)(2007-12#1)(2008-10#17)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#3)(2012-3#1)
the probes##7##2##(1994-1#1)(2008-10#3)(2008-2#2)(2008-4#1)
the probing of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the probiotic##6##2##(2009-11#1)(2011-2#2)(2013-1#3)
the problem and##4##3##(1995-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
the problem has##2##3##(1997-4#1)(2013-1#1)
the problem is##4##3##(1992-1#1)(2008-5#1)(2009-10#1)(2011-2#1)
the problem of the##3##4##(1995-5#1)(1996-3#1)(2007-12#1)
the problem of##49##3##(1990-3#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#2)(2008-9#2)(2009-10#1)(2010-1#3)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the problem that##2##3##(1993-12#1)(2008-10#1)
the problem##102##2##(1990-3#1)(1991-6#2)(1992-1#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#16)(2008-11#11)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#2)(2009-4#1)(2010-1#3)(2010-11#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
the problems and##2##3##(1997-2#1)(2008-11#1)
the problems in##2##3##(1990-6#1)(2008-10#1)
the problems of the##3##4##(1990-5#1)(1991-3#1)(1994-2#1)
the problems of##14##3##(1990-11#1)(1990-5#1)(1991-3#1)(1993-2#1)(1994-2#2)(1996-3#1)(2008-11#5)(2008-12#1)(2010-9#1)
the problems##39##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#2)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-2#2)(1996-3#2)(1996-6#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#9)(2008-12#3)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
the procathepsin L recognition##2##4##(1995-6#2)
the procathepsin L##3##3##(1995-6#3)
the procedure and##8##3##(1992-12#1)(2008-10#1)(2008-11#3)(2011-2#1)(2012-2#2)
the procedure can##3##3##(2008-10#2)(2010-5#1)
the procedure could##2##3##(1996-9#1)(2008-10#1)
the procedure developed##2##3##(2008-10#1)(2008-9#1)
the procedure for##6##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)
the procedure in##3##3##(1997-3#2)(2008-10#1)
the procedure involving##2##3##(2008-10#2)
the procedure is not##2##4##(2008-10#2)
the procedure is##16##3##(1996-12#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-3#1)
the procedure of##4##3##(1996-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
the procedure to##2##3##(2008-10#1)(2008-3#1)
the procedure was carried out##2##5##(1991-8#1)(2008-10#1)
the procedure was performed##2##4##(1995-12#1)(2008-10#1)
the procedure was##16##3##(1991-8#1)(1995-12#2)(1997-8#1)(2008-10#10)(2011-2#1)(2013-1#1)
the procedure were##4##3##(2008-10#3)(2011-2#1)
the procedure##126##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#3)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#51)(2008-11#7)(2008-12#1)(2008-3#2)(2008-7#5)(2008-8#2)(2008-9#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)
the procedures are##2##3##(2008-4#1)(2010-6#1)
the procedures for##3##3##(1991-2#1)(2008-10#1)(2012-3#1)
the procedures of##2##3##(1992-9#1)(2008-7#1)
the procedures##27##2##(1991-2#1)(1992-11#1)(1992-9#1)(1994-1#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-3#2)(2012-3#2)
the proceedings of##2##3##(2008-12#1)(2011-2#1)
the proceedings##3##2##(1995-6#1)(2008-12#1)(2011-2#1)
the process and##8##3##(1994-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)
the process are##2##3##(2008-11#1)(2008-9#1)
the process as##2##3##(1992-3#1)(2008-10#1)
the process by which a##2##5##(2008-11#1)(2010-10#1)
the process by which the##2##5##(2008-4#1)(2010-4#1)
the process by which##7##4##(1995-2#1)(2008-11#2)(2008-4#1)(2010-10#1)(2010-4#1)(2011-2#1)
the process by##9##3##(1995-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2010-10#1)(2010-4#1)(2011-2#1)
the process for##3##3##(1997-2#1)(2008-1#1)(2008-11#1)
the process has##2##3##(1993-3#1)(1995-1#1)
the process in##2##3##(2008-10#2)
the process is##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
the process of aging##2##4##(1992-9#1)(1993-12#1)
the process of care related to acute coronary##2##8##(2008-3#2)
the process of care##3##4##(1997-1#1)(2008-3#2)
the process of change##2##4##(2008-11#1)(2008-12#1)
the process of determining##2##4##(2008-11#1)(2008-4#1)
the process of reflection##2##4##(2008-11#1)(2008-12#1)
the process of the##4##4##(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#1)
the process of water##2##4##(1991-5#1)(2008-10#1)
the process of##136##3##(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#15)(2008-11#20)(2008-12#12)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#8)(2008-9#6)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#4)(2012-3#9)(2013-1#4)(2013-8#3)
the process that##2##3##(2008-10#1)(2009-8#1)
the process through which##2##4##(1993-12#1)(1996-12#1)
the process under##2##3##(1997-2#1)(2008-3#1)
the process used to##2##4##(1995-1#1)(1996-2#1)
the process used##3##3##(1995-1#1)(1996-2#2)
the process was##2##3##(2008-10#2)
the process##232##2##(1990-11#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#6)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#2)(1996-2#3)(1997-1#3)(1997-2#3)(1997-7#2)(1997-8#1)(2008-1#3)(2008-10#35)(2008-11#33)(2008-12#15)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#4)(2010-10#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#6)(2012-3#9)(2013-1#5)(2013-8#4)
the processed##4##2##(1995-6#1)(1997-6#1)(2008-10#1)(2013-1#1)
the processes and outcomes of##2##5##(1993-3#1)(2008-8#1)
the processes involved in##3##4##(1996-12#1)(2008-10#2)
the processes of ion##2##4##(2008-10#2)
the processes of##19##3##(1993-8#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
the processes taking place##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
the processes that##2##3##(2007-11#1)(2008-11#1)
the processes##42##2##(1992-12#1)(1993-3#1)(1993-8#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the processing of the##2##4##(1992-12#1)(2013-8#1)
the processing of##19##3##(1990-8#2)(1992-12#1)(1992-6#1)(1993-6#2)(1995-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#2)
the processing##27##2##(1990-8#2)(1991-10#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-6#2)(1995-2#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-8#3)
the procurement of vascular stents in interventional radiology##3##8##(2012-2#3)
the procurement##4##2##(2012-2#4)
the produced water##3##3##(2008-10#1)(2008-7#2)
the produced##16##2##(1990-5#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2012-2#1)
the producer cell line##2##4##(1990-5#1)(2008-11#1)
the producer##6##2##(1990-5#1)(1993-3#1)(2008-10#1)(2008-11#3)
the producers##2##2##(2008-10#1)(2012-12#1)
the product and##3##3##(1995-5#1)(2008-5#2)
the product has been##2##4##(2008-10#1)(2008-11#1)
the product in##2##3##(2008-7#1)(2013-1#1)
the product is##2##3##(1994-3#1)(2008-11#1)
the product of ORF7##2##4##(2008-10#2)
the product of reaction##2##4##(2008-10#2)
the product of the##12##4##(1990-5#1)(1993-8#1)(1997-3#1)(2007-12#1)(2008-10#7)(2012-12#1)
the product of which produces a sensitive##2##7##(2008-10#2)
the product of##25##3##(1990-5#1)(1993-8#2)(1996-8#1)(1997-3#1)(2007-12#1)(2008-10#15)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
the product##78##2##(1990-5#1)(1993-8#2)(1994-3#2)(1995-2#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-10#32)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#11)(2008-7#4)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#2)
the product(s)##2##2##(1990-5#1)(2008-7#1)
the production and##10##3##(2006-6#1)(2008-10#4)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
the production of Anticarsia gemmatalis##2##5##(2008-11#2)
the production of EPO in##2##5##(2008-11#2)
the production of IL-10##2##4##(1996-12#1)(2011-2#1)
the production of MDA##2##4##(1996-2#2)
the production of ROS##4##4##(1994-5#3)(2008-11#1)
the production of a specific##2##5##(2008-10#1)(2012-2#1)
the production of a##13##4##(1994-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
the production of an##3##4##(2008-10#1)(2010-6#1)(2012-3#1)
the production of antibodies##5##4##(1990-12#1)(1995-5#1)(2008-11#2)(2011-2#1)
the production of butanol##3##4##(2013-1#3)
the production of different##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
the production of high##2##4##(1994-11#1)(2008-10#1)
the production of human##2##4##(2008-11#2)
the production of inositol##2##4##(1990-8#1)(1997-1#1)
the production of monoclonal antibodies##2##5##(2008-11#1)(2008-9#1)
the production of monoclonal antibody##2##5##(2008-11#2)
the production of monoclonal##4##4##(2008-11#3)(2008-9#1)
the production of organic acids##2##5##(2008-10#2)
the production of reactive oxygen species##3##6##(1994-5#1)(2008-10#1)(2013-8#1)
the production of reactive oxygen##4##5##(1994-5#2)(2008-10#1)(2013-8#1)
the production of recombinant proteins##7##5##(2008-11#7)
the production of recombinant##14##4##(1997-7#1)(2008-11#13)
the production of secondary##3##4##(2008-10#3)
the production of singlet oxygen##3##5##(2008-10#1)(2008-5#2)
the production of the knowledge on the long-lived elderly##2##9##(2012-3#2)
the production of the##8##4##(1991-5#1)(2008-10#5)(2012-3#2)
the production of two##2##4##(1993-12#1)(2010-5#1)
the production of various##3##4##(2008-11#2)(2008-4#1)
the production of viral##2##4##(1994-11#1)(2008-11#1)
the production of##213##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#5)(1994-8#4)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-1#2)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#50)(2008-11#55)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#7)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
the production phase##3##3##(2008-11#3)
the production plant##2##3##(2008-10#1)(2012-2#1)
the production process##4##3##(2008-11#2)(2012-2#2)
the production team##2##3##(2008-11#1)(2008-12#1)
the production##253##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#5)(1994-8#5)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-1#2)(1997-7#1)(1997-8#1)(2006-6#2)(2008-10#56)(2008-11#69)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#7)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2011-3#1)(2012-2#9)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#4)
the productions##3##2##(2008-11#1)(2012-3#2)
the productivity and##2##3##(1994-12#1)(2012-3#1)
the productivity of##9##3##(2008-10#2)(2008-11#5)(2008-7#2)
the productivity per##2##3##(2008-11#2)
the productivity##16##2##(1994-12#1)(2008-10#2)(2008-11#10)(2008-7#2)(2012-3#1)
the products formed##2##3##(2008-10#2)
the products of the##4##4##(1991-12#1)(1992-12#1)(2008-10#2)
the products of##11##3##(1991-12#2)(1992-12#1)(1994-8#1)(1995-6#1)(1996-12#2)(2008-10#4)
the products##32##2##(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#1)(1994-8#1)(1995-12#1)(1995-6#3)(1996-12#2)(1996-5#1)(1996-8#1)(1997-7#1)(2008-10#10)(2008-12#2)(2008-5#3)(2011-2#2)
the profession and##4##3##(1993-1#1)(1994-12#1)(2008-12#1)(2012-3#1)
the profession of##2##3##(1996-1#1)(2008-12#1)
the profession##20##2##(1991-2#1)(1993-1#3)(1994-12#3)(1996-1#2)(2008-11#2)(2008-12#3)(2008-8#1)(2012-3#5)
the profession's##3##2##(1992-12#2)(2008-12#1)
the professional model##2##3##(1992-5#2)
the professional##20##2##(1990-2#1)(1991-1#1)(1991-3#1)(1992-3#2)(1992-5#2)(1993-1#1)(1993-3#2)(1996-3#1)(2008-11#2)(2008-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#2)
the professional's##2##2##(1991-6#1)(2012-3#1)
the professionals who##3##3##(2008-12#1)(2010-1#2)
the professionals##4##2##(1994-1#1)(2008-12#1)(2010-1#2)
the professions##2##2##(1996-3#1)(2012-2#1)
the profile and##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
the profile of the##2##4##(2008-3#1)(2012-3#1)
the profile of##10##3##(1991-2#1)(1992-2#1)(1995-11#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#3)(2013-8#1)
the profile##19##2##(1991-2#1)(1992-2#1)(1993-8#1)(1995-11#1)(1996-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-8#1)
the profiles obtained##2##3##(2008-12#1)(2008-5#1)
the profiles of##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
the profiles##7##2##(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
the profiling##2##2##(2008-10#1)(2010-5#1)
the progenies##2##2##(2008-10#1)(2008-9#1)
the progenitor of the##2##4##(1991-5#1)(2008-10#1)
the progenitor##5##2##(1991-5#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-12#1)
the progeny of the##3##4##(2008-10#3)
the progeny of##8##3##(2008-10#6)(2008-9#1)(2010-8#1)
the progeny##13##2##(2008-10#9)(2008-5#1)(2008-9#2)(2010-8#1)
the prognoses of##2##3##(2011-2#1)(2012-3#1)
the prognosis for##3##3##(2008-7#2)(2011-2#1)
the prognosis is good if##2##5##(1996-8#1)(1996-9#1)
the prognosis of these##2##4##(1994-6#1)(2010-8#1)
the prognosis of##10##3##(1993-2#1)(1994-6#1)(1996-3#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-3#1)
the prognosis was##3##3##(1991-8#1)(1994-12#1)(2008-1#1)
the prognosis##28##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-12#1)(2010-8#3)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)
the prognostic significance of##2##4##(2008-11#1)(2012-3#1)
the prognostic value of##2##4##(1997-8#1)(2008-11#1)
the prognostic value##3##3##(1997-8#1)(2008-11#1)(2012-12#1)
the prognostic##12##2##(1995-9#1)(1997-8#1)(2008-1#1)(2008-11#2)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#2)
the program during##2##3##(1993-3#1)(1997-2#1)
the program has##5##3##(1991-1#1)(1992-2#1)(1995-12#1)(1996-3#1)(2008-11#1)
the program in the past##2##5##(1992-3#1)(1995-1#1)
the program in the##3##4##(1992-3#1)(1995-1#2)
the program was##3##3##(1993-12#1)(1994-12#1)(1997-2#1)
the program with##2##3##(2008-11#1)(2008-9#1)
the program##69##2##(1991-1#3)(1991-12#3)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#3)(1997-1#1)(1997-2#5)(1997-3#1)(2008-11#7)(2008-12#2)(2008-4#2)(2008-8#2)(2008-9#2)(2010-7#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)
the program's##2##2##(2008-6#2)
the programme and##2##3##(2008-11#1)(2008-12#1)
the programme is##3##3##(2008-11#1)(2008-12#2)
the programme##21##2##(1990-11#1)(1993-6#2)(2008-10#1)(2008-11#6)(2008-12#6)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
the programming rate for the##2##5##(2008-10#2)
the programming##3##2##(2008-10#2)(2008-9#1)
the programs##14##2##(1991-1#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-3#2)(1996-1#1)(1997-2#2)(2008-6#1)(2008-9#2)(2013-1#1)
the progress made by##2##4##(2008-11#1)(2008-9#1)
the progress made##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
the progress of infection with##2##5##(2008-11#2)
the progress of##15##3##(2008-10#7)(2008-11#3)(2008-9#2)(2010-10#1)(2010-5#1)(2012-2#1)
the progress##24##2##(1991-12#1)(1996-11#1)(2008-10#7)(2008-11#4)(2008-5#3)(2008-7#1)(2008-9#3)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
the progression of cardiac dysfunction##2##5##(2011-2#2)
the progression of cell cycle##2##5##(1997-1#1)(2008-8#1)
the progression of the disease##3##5##(1993-12#1)(1994-5#1)(1996-6#1)
the progression of the##7##4##(1993-12#2)(1994-5#1)(1996-6#1)(2008-7#1)(2010-8#1)(2013-8#1)
the progression of##33##3##(1991-2#1)(1993-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-7#5)(2008-8#1)(2009-7#2)(2010-12#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
the progression##35##2##(1991-2#1)(1993-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-7#5)(2008-8#1)(2009-7#2)(2010-12#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the progressive##9##2##(1990-3#1)(1990-8#1)(1991-8#1)(1995-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
the proinflammatory##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
the proinsulin##2##2##(1995-5#1)(2008-11#1)
the project are##2##3##(1996-1#1)(2008-11#1)
the project was##4##3##(1997-4#1)(2010-5#1)(2011-9#2)
the project##32##2##(1992-2#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#4)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#9)(2008-12#1)(2008-9#2)(2009-10#1)(2010-5#2)(2010-8#1)(2011-9#2)(2013-1#1)
the projected##3##2##(2008-10#1)(2008-6#1)(2010-11#1)
the projection neurons of the##3##5##(1996-12#2)(2009-12#1)
the projection##5##2##(1996-12#2)(2008-11#1)(2009-12#1)(2011-2#1)
the projections##2##2##(1991-1#1)(2008-11#1)
the projects##2##2##(1994-1#1)(2013-1#1)
the prokaryote##2##2##(2008-10#1)(2008-9#1)
the prokaryotic##4##2##(1995-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
the prolactin requirement##2##3##(1994-11#2)
the proliferating cells##2##3##(1995-12#1)(2008-5#1)
the proliferating##4##2##(1993-8#2)(1995-12#1)(2008-5#1)
the proliferation and survival of##2##5##(2013-1#2)
the proliferation and##11##3##(1993-3#1)(1995-2#2)(2008-11#5)(2011-2#1)(2013-1#2)
the proliferation of cell##2##4##(1996-2#1)(2008-5#1)
the proliferation of malignant cells##2##5##(2010-1#2)
the proliferation of the##7##4##(2008-11#5)(2008-4#2)
the proliferation of uterine epithelial cells##3##6##(2008-6#3)
the proliferation of vascular##2##4##(1990-12#1)(1997-1#1)
the proliferation of##54##3##(1990-12#2)(1990-5#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-2#1)(1997-1#3)(2008-10#1)(2008-11#18)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#2)(2010-1#2)(2011-2#2)(2011-3#1)(2012-3#1)(2013-8#1)
the proliferation##71##2##(1990-12#2)(1990-5#1)(1992-2#1)(1993-3#2)(1994-11#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-1#3)(2008-10#1)(2008-11#26)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#2)(2010-1#2)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#3)
the proliferative activity##2##3##(1990-8#1)(2008-11#1)
the proliferative lymphocytes were##2##4##(2008-9#2)
the proliferative lymphocytes##3##3##(2008-9#3)
the proliferative response of human##2##5##(1994-8#1)(1995-12#1)
the proliferative response of##3##4##(1994-8#2)(1995-12#1)
the proliferative##18##2##(1990-8#1)(1991-3#1)(1992-3#1)(1993-11#1)(1994-8#2)(1995-12#1)(2008-11#5)(2008-9#4)(2011-2#1)(2012-2#1)
the proline##2##2##(1991-5#1)(1995-6#1)
the prolongation of the##2##4##(1991-3#1)(2008-8#1)
the prolongation of##3##3##(1991-3#1)(2008-11#1)(2008-8#1)
the prolonged##8##2##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
the prominent##4##2##(1991-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
the promise of##8##3##(1996-3#1)(2008-11#2)(2008-5#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the promise##12##2##(1996-12#1)(1996-3#1)(2008-11#3)(2008-5#1)(2008-6#1)(2009-7#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
the promises##2##2##(2008-11#1)(2010-7#1)
the promising##2##2##(2008-10#2)
the promontory stimulation test##2##4##(2008-9#2)
the promontory##3##2##(2008-9#3)
the promoter and 5' flanking##2##5##(1991-5#1)(1994-11#1)
the promoter and##4##3##(1990-11#1)(1991-5#1)(1994-11#1)(2011-2#1)
the promoter for the##2##4##(1992-8#1)(1995-2#1)
the promoter for##3##3##(1992-8#1)(1995-2#1)(1995-6#1)
the promoter of the##4##4##(1996-12#1)(2008-11#2)(2011-2#1)
the promoter of##6##3##(1996-12#1)(2008-11#2)(2008-9#2)(2011-2#1)
the promoter region of the human##2##6##(1993-3#1)(1997-2#1)
the promoter region of the##3##5##(1993-3#1)(1995-11#1)(1997-2#1)
the promoter region of##6##4##(1993-2#1)(1993-3#1)(1995-11#1)(1997-2#1)(2009-8#1)(2011-2#1)
the promoter region##9##3##(1991-6#1)(1993-2#1)(1993-3#2)(1995-11#1)(1997-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
the promoter regions of##3##4##(1993-3#1)(1997-2#2)
the promoter regions##4##3##(1993-3#1)(1997-2#2)(2012-3#1)
the promoter sequence##2##3##(2011-1#2)
the promoter##45##2##(1990-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-3#3)(1994-11#1)(1995-11#1)(1995-2#2)(1995-6#3)(1996-12#1)(1997-2#3)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-8#1)(2010-3#1)(2011-1#5)(2011-2#4)(2012-3#2)
the promoters of##2##3##(2008-9#1)(2009-8#1)
the promoters##3##2##(1994-11#1)(2008-9#1)(2009-8#1)
the promotion of##12##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
the promotion##13##2##(1991-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
the promotor##2##2##(1997-8#1)(2008-8#1)
the pronounced##2##2##(2008-10#1)(2010-4#1)
the proof of##2##3##(1997-4#1)(2011-9#1)
the proof##3##2##(1997-4#1)(2008-5#1)(2011-9#1)
the proopiomelanocortin##2##2##(1993-5#1)(2008-4#1)
the propagation constants##2##3##(2008-3#2)
the propagation of##7##3##(1990-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2011-2#1)
the propagation##17##2##(1990-5#1)(1991-12#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-9#1)(2009-12#1)(2011-2#1)
the propanol vapor##2##3##(2008-3#2)
the propellant##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
the propensity for##2##3##(1993-6#1)(2008-8#1)
the propensity to##2##3##(1993-6#1)(2008-4#1)
the propensity##5##2##(1993-6#2)(2008-4#1)(2008-8#1)(2009-7#1)
the proper assessment##2##3##(1991-3#1)(2008-11#1)
the proper name##2##3##(2013-1#2)
the proper optimum##2##3##(2008-10#2)
the proper selection of##2##4##(2008-11#1)(2010-5#1)
the proper##37##2##(1991-2#1)(1991-3#2)(1991-5#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the properties of the membrane##3##5##(1993-8#1)(2008-10#1)(2009-5#1)
the properties of the##20##4##(1991-4#1)(1992-1#1)(1992-3#1)(1993-8#2)(1996-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-5#2)(2010-4#1)
the properties of these##2##4##(2008-11#1)(2008-3#1)
the properties of##51##3##(1990-8#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-3#1)(1993-8#2)(1994-11#1)(1995-6#1)(1996-1#2)(1997-2#1)(2008-10#11)(2008-11#7)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#2)(2009-9#1)(2010-4#2)(2010-7#1)(2012-2#2)(2013-1#1)
the properties##56##2##(1990-8#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-3#1)(1993-8#3)(1994-11#1)(1995-6#1)(1996-1#2)(1997-2#1)(2008-10#13)(2008-11#8)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#2)(2009-9#1)(2010-4#2)(2010-7#1)(2012-2#3)(2013-1#1)
the property##2##2##(2008-10#2)
the prophase##2##2##(2009-10#2)
the prophylactic##3##2##(1990-2#1)(1990-5#1)(2013-1#1)
the prophylaxis and##2##3##(1990-6#1)(2010-8#1)
the prophylaxis of##3##3##(1991-3#1)(2008-7#1)(2010-11#1)
the prophylaxis##5##2##(1990-6#1)(1991-3#1)(2008-7#1)(2010-11#1)(2010-8#1)
the propofol##2##2##(1993-1#1)(2009-8#1)
the proportion of P##2##4##(2008-10#2)
the proportion of affected relatives of index##2##7##(1992-9#2)
the proportion of ascospores##2##4##(2008-10#2)
the proportion of disease##2##4##(2008-10#2)
the proportion of each##2##4##(1996-3#1)(2008-10#1)
the proportion of infested##2##4##(2008-10#2)
the proportion of leaflets##3##4##(2008-10#3)
the proportion of overwintering adult corn flea beetles infested with P##2##11##(2008-10#2)
the proportion of patients who##2##5##(2008-7#1)(2009-8#1)
the proportion of patients##3##4##(2008-7#1)(2009-8#1)(2012-12#1)
the proportion of philopatric (and thereby altruistic) individuals##2##8##(2008-8#2)
the proportion of subjects with no peristalsis##2##7##(2012-2#2)
the proportion of the##5##4##(2008-10#4)(2008-8#1)
the proportion of total##4##4##(1990-5#1)(2008-10#1)(2008-8#1)(2012-2#1)
the proportion of women##2##4##(1991-8#1)(2012-3#1)
the proportion of##101##3##(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-9#3)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#1)(1995-12#2)(1996-11#1)(1996-12#2)(1996-3#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#34)(2008-11#6)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#2)
the proportion##105##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-9#3)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#1)(1995-12#2)(1996-11#1)(1996-12#2)(1996-3#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#35)(2008-11#6)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#2)(2009-5#1)(2009-8#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#2)(2013-8#1)
the proportional##5##2##(1992-6#1)(2008-10#2)(2008-9#1)(2011-2#1)
the proportions of the##3##4##(2008-10#3)
the proportions of##7##3##(1992-9#1)(1996-2#1)(2008-10#4)(2009-7#1)
the proportions##8##2##(1992-9#1)(1996-2#1)(2008-10#5)(2009-7#1)
the proposal that##4##3##(1990-10#1)(1990-5#1)(2009-4#1)(2013-8#1)
the proposal##12##2##(1990-10#1)(1990-5#1)(1992-2#5)(2008-10#1)(2008-11#1)(2009-4#1)(2010-4#1)(2013-8#1)
the proposals##2##2##(1992-1#1)(1997-3#1)
the proposed FI##2##3##(2008-10#2)
the proposed and##2##3##(2008-10#2)
the proposed approach and##2##4##(2008-10#1)(2013-1#1)
the proposed approach##10##3##(2008-10#7)(2008-3#1)(2013-1#1)(2013-8#1)
the proposed biosensor##3##3##(2008-10#3)
the proposed diet##3##3##(2008-3#3)
the proposed electrode##3##3##(2008-10#3)
the proposed electrodes##3##3##(2008-10#3)
the proposed flow##4##3##(2008-10#4)
the proposed flow-injection##2##3##(2008-10#2)
the proposed framework##3##3##(2008-7#1)(2012-2#2)
the proposed mechanism##3##3##(2008-10#2)(2009-10#1)
the proposed method a##2##4##(2008-10#2)
the proposed method agreed##2##4##(2008-10#2)
the proposed method and the reference procedure##2##7##(2008-10#2)
the proposed method and the##7##5##(2008-10#7)
the proposed method and##15##4##(2008-10#15)
the proposed method are##7##4##(2008-10#6)(2008-3#1)
the proposed method could##3##4##(2008-10#3)
the proposed method has been applied to##2##7##(2008-10#2)
the proposed method has been##3##5##(2008-10#3)
the proposed method in##4##4##(2008-10#4)
the proposed method is##22##4##(2008-10#21)(2012-3#1)
the proposed method was##21##4##(2008-10#21)
the proposed method were##5##4##(2008-10#5)
the proposed method with those##2##5##(2008-10#2)
the proposed method yielded results##2##5##(2008-10#2)
the proposed method##150##3##(2008-10#147)(2008-3#1)(2008-9#1)(2012-3#1)
the proposed methodology was##3##4##(2008-10#3)
the proposed methodology##12##3##(2008-10#12)
the proposed methods##9##3##(2008-10#7)(2008-3#1)(2010-11#1)
the proposed model and##2##4##(2008-10#1)(2009-8#1)
the proposed model##10##3##(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2013-1#2)
the proposed models##4##3##(1996-3#1)(2008-10#2)(2009-8#1)
the proposed on-line##2##3##(2008-10#2)
the proposed procedure and##3##4##(2008-10#3)
the proposed procedure can##2##4##(2008-10#2)
the proposed procedure had##2##4##(2008-10#2)
the proposed procedure is##3##4##(2008-10#3)
the proposed procedure were##4##4##(2008-10#4)
the proposed procedure##26##3##(2008-10#25)(2008-6#1)
the proposed procedures##2##3##(2009-10#1)(2013-1#1)
the proposed sensor##5##3##(2008-10#5)
the proposed sensors##2##3##(2008-10#2)
the proposed spectrophotometric##2##3##(2008-10#2)
the proposed system##12##3##(2008-10#10)(2008-3#2)
the proposed technique##8##3##(2008-10#6)(2008-3#1)(2008-6#1)
the proposed##382##2##(1990-6#1)(1992-9#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-10#306)(2008-11#4)(2008-2#1)(2008-3#15)(2008-5#1)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-8#2)(2010-10#1)(2010-11#3)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
the proposition that the##2##4##(1991-5#1)(2012-2#1)
the proposition that##4##3##(1991-5#1)(1993-3#1)(2008-10#1)(2012-2#1)
the propriety of##2##3##(1994-3#1)(1995-5#1)
the proprioceptors##2##2##(1997-3#1)(2009-1#1)
the proregion##2##2##(1995-6#2)
the pros and cons of the##3##6##(2008-11#1)(2008-4#1)(2013-8#1)
the pros and cons of##7##5##(1992-1#1)(1996-6#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
the pros and cons##8##4##(1992-1#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
the pros##9##2##(1992-1#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
the prospect of##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
the prospective payment system (PPS)##3##5##(1991-2#1)(1992-12#2)
the prospective payment system##13##4##(1991-1#1)(1991-2#3)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#2)(2008-11#1)
the prospective payment##14##3##(1991-1#2)(1991-2#3)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#2)(2008-11#1)
the prospective##16##2##(1991-1#2)(1991-2#3)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#2)(2008-10#1)(2008-11#1)(2009-3#1)
the prospects for##5##3##(1990-11#1)(1994-12#1)(1996-12#1)(2008-10#1)(2010-11#1)
the prospects of##2##3##(1997-7#1)(2011-7#1)
the prospects##9##2##(1990-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-7#1)
the prostate gland##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
the prostate specific antigen##2##4##(1994-12#2)
the prostate##17##2##(1990-9#2)(1991-8#2)(1993-8#1)(1994-12#2)(1995-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#2)
the prostheses##2##2##(1991-3#1)(2009-1#1)
the prosthesis##8##2##(1991-2#2)(1997-6#1)(2009-1#1)(2009-4#1)(2011-2#1)(2011-7#1)(2013-1#1)
the prosthetic group##2##3##(1992-10#1)(2008-12#1)
the prosthetic##4##2##(1992-10#1)(1993-2#1)(2008-12#1)(2010-6#1)
the protease is##2##3##(1991-9#1)(2008-10#1)
the protease was##2##3##(2008-10#2)
the protease##13##2##(1991-9#1)(1992-6#3)(1993-8#1)(1994-11#1)(2008-10#5)(2008-4#1)(2008-5#1)
the proteasome##2##2##(2008-4#1)(2013-1#1)
the protectant##2##2##(2008-10#2)
the protected##4##2##(1990-11#1)(1992-12#1)(2008-10#2)
the protection against W-CI##2##4##(2008-10#2)
the protection against##7##3##(2008-10#3)(2008-11#2)(2008-5#1)(2013-8#1)
the protection and##2##3##(1997-1#1)(2013-1#1)
the protection of the##3##4##(1995-5#1)(2008-10#1)(2010-4#1)
the protection of women and children##2##6##(1990-2#2)
the protection of##12##3##(1990-2#2)(1992-3#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-3#1)
the protection was##3##3##(2008-10#2)(2013-1#1)
the protection##31##2##(1990-2#2)(1992-3#1)(1995-5#1)(1997-1#1)(2008-10#11)(2008-11#4)(2008-5#4)(2008-7#1)(2010-4#1)(2011-3#1)(2013-1#3)(2013-8#1)
the protective action of##2##4##(1996-2#1)(2008-11#1)
the protective effect of##6##4##(1993-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
the protective effect##8##3##(1993-2#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
the protective effects of family##2##5##(2010-7#1)(2013-1#1)
the protective effects of##4##4##(2009-7#1)(2010-7#1)(2012-12#1)(2013-1#1)
the protective effects##6##3##(2008-11#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-12#1)(2013-1#1)
the protective efficacy##3##3##(1995-5#1)(2008-5#2)
the protective##27##2##(1991-1#1)(1992-12#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-7#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#3)
the protein and the##3##4##(1994-3#1)(1997-2#1)(2009-3#1)
the protein and##11##3##(1990-8#1)(1993-8#1)(1994-3#1)(1994-5#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-1#1)
the protein as well as##2##5##(1990-8#1)(2011-2#1)
the protein as##5##3##(1990-5#1)(1990-8#1)(1993-12#1)(1993-3#1)(2011-2#1)
the protein band##2##3##(2010-3#2)
the protein by##2##3##(1990-5#1)(1996-3#1)
the protein coding##2##3##(1993-6#1)(1997-4#1)
the protein components of##2##4##(2008-2#1)(2010-11#1)
the protein components##3##3##(2008-2#1)(2010-11#1)(2013-8#1)
the protein composition##2##3##(1991-2#1)(2010-11#1)
the protein concentration##2##3##(1991-11#1)(2009-7#1)
the protein core##2##3##(1993-2#1)(2009-8#1)
the protein encoded by the##2##5##(1993-12#1)(1994-3#1)
the protein expression##3##3##(2008-12#1)(2010-12#1)(2013-8#1)
the protein fraction##5##3##(1994-11#2)(2008-10#2)(2011-2#1)
the protein from##2##3##(2008-10#1)(2008-8#1)
the protein has##2##3##(1995-6#1)(2009-3#1)
the protein is not##2##4##(1992-6#1)(1993-8#1)
the protein is##11##3##(1990-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-12#1)(2008-4#1)(2008-5#1)(2009-5#1)
the protein kinase C (PKC)##3##5##(1990-5#1)(1992-9#1)(1995-8#1)
the protein kinase C inhibitor##2##5##(1994-11#1)(1995-6#1)
the protein kinase C##7##4##(1990-5#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-12#1)(1995-6#1)(1995-8#1)
the protein kinase inhibitor##2##4##(1997-2#1)(2008-10#1)
the protein kinase##12##3##(1990-5#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#2)(2008-10#1)
the protein level of##2##4##(1997-1#1)(2008-9#1)
the protein level##6##3##(1994-11#1)(1997-1#1)(2008-4#1)(2008-9#1)(2011-10#1)(2013-1#1)
the protein levels of##2##4##(2008-11#1)(2011-2#1)
the protein levels##4##3##(2008-11#2)(2008-8#1)(2011-2#1)
the protein may##3##3##(1993-8#1)(2008-8#1)(2008-9#1)
the protein of interest##2##4##(2008-4#1)(2008-9#1)
the protein of##3##3##(2008-12#1)(2008-4#1)(2008-9#1)
the protein part##2##3##(2009-8#2)
the protein sequence##3##3##(2008-4#1)(2010-11#1)(2011-2#1)
the protein structure##3##3##(1997-6#1)(2008-10#1)(2008-4#1)
the protein substrate##2##3##(1995-2#2)
the protein surface##2##3##(1990-5#1)(2008-8#1)
the protein synthesis##2##3##(1991-5#1)(2008-11#1)
the protein that##3##3##(1993-12#1)(2008-11#1)(2012-2#1)
the protein to##3##3##(1991-7#1)(1995-5#1)(2008-9#1)
the protein was##3##3##(1990-5#1)(1992-7#1)(2011-2#1)
the protein with##4##3##(1991-5#1)(1994-8#1)(2008-8#1)(2012-2#1)
the protein##232##2##(1990-12#3)(1990-2#1)(1990-5#7)(1990-8#6)(1991-11#1)(1991-2#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#5)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#5)(1994-11#5)(1994-12#1)(1994-3#3)(1994-5#13)(1994-8#5)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#6)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#31)(2008-11#13)(2008-12#2)(2008-2#1)(2008-4#9)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#12)(2009-10#1)(2009-3#4)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#1)(2010-3#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#8)(2012-2#5)(2013-1#1)(2013-8#2)
the protein's##4##2##(1997-2#1)(2008-8#1)(2008-9#1)(2010-10#1)
the protein-bound##2##2##(1991-12#1)(1991-9#1)
the protein-ligand##2##2##(1997-2#1)(2011-3#1)
the proteinaceous##2##2##(2008-10#1)(2008-9#1)
the proteins of the##2##4##(2008-10#1)(2011-2#1)
the proteins of##5##3##(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
the proteins that##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
the proteins were##3##3##(1995-12#1)(1995-8#1)(1996-2#1)
the proteins##37##2##(1990-12#1)(1991-2#2)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#12)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)
the proteolytic enzyme##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
the proteolytic processing##2##3##(1990-8#1)(2007-12#1)
the proteolytic##9##2##(1990-5#1)(1990-8#1)(1992-11#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
the proteome of##3##3##(2008-10#1)(2008-11#1)(2011-3#1)
the proteome profiles of##2##4##(2009-6#2)
the proteome##7##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#2)(2011-3#1)
the proteomic##3##2##(2008-11#1)(2010-12#2)
the prothoracic glands##2##3##(1995-11#1)(2008-6#1)
the prothoracic##3##2##(1995-11#2)(2008-6#1)
the protocerebral##2##2##(2007-12#2)
the protocol is##2##3##(2008-10#1)(2008-9#1)
the protocol to##2##3##(2008-9#1)(2012-3#1)
the protocol will##2##3##(2008-10#1)(2008-9#1)
the protocol##13##2##(1991-6#1)(1997-2#1)(1997-5#1)(2008-10#3)(2008-4#1)(2008-9#3)(2009-2#2)(2012-3#1)
the protocols for##3##3##(2008-4#1)(2008-9#2)
the protocols##6##2##(2008-4#3)(2008-9#3)
the protolytic##2##2##(2008-10#2)
the proton gradient##2##3##(1990-2#1)(2008-11#1)
the proton translocation activity of F(0) vesicles##2##7##(2008-8#2)
the proton translocation##3##3##(2008-8#3)
the proton##12##2##(1990-2#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-8#3)(2008-9#1)
the protonated amino##2##3##(1995-6#1)(2008-10#1)
the protonated form##3##3##(1991-5#1)(2008-10#2)
the protonated##9##2##(1991-5#1)(1995-6#1)(2008-10#7)
the protonation constants##2##3##(2008-10#2)
the protonation of##3##3##(2008-10#3)
the protonation##8##2##(2008-10#7)(2009-9#1)
the protoporphyrine IX##3##3##(2008-11#3)
the prototype##6##2##(1997-3#1)(2008-10#3)(2008-3#2)
the prototypes##2##2##(2008-5#1)(2010-12#1)
the prototypical##3##2##(2008-7#1)(2010-12#1)(2012-2#1)
the protozoan parasite Entamoeba histolytica##2##5##(2009-7#1)(2009-8#1)
the protozoan parasite##3##3##(2009-6#1)(2009-7#1)(2009-8#1)
the protozoan##6##2##(1992-2#1)(1993-9#2)(2009-6#1)(2009-7#1)(2009-8#1)
the provenance of the cell line##2##6##(2008-11#2)
the provenance of the##3##4##(2008-10#1)(2008-11#2)
the provenance##4##2##(2008-10#2)(2008-11#2)
the provider##5##2##(1994-1#1)(1994-12#1)(1995-2#1)(1996-2#1)(2013-8#1)
the provider's##4##2##(1994-3#1)(2008-11#2)(2013-8#1)
the providers##3##2##(1996-2#1)(2011-2#1)(2013-8#1)
the providers'##3##2##(1994-1#1)(1994-2#1)(2013-8#1)
the province of##11##3##(1994-9#1)(1996-3#1)(1996-6#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#1)
the province##13##2##(1994-9#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#1)
the provinces##2##2##(2008-10#1)(2008-11#1)
the provincial##3##2##(1991-1#1)(1994-12#1)(1997-5#1)
the provision of good##2##4##(2008-11#1)(2012-12#1)
the provision of mental health##2##5##(1994-1#1)(2008-12#1)
the provision of##32##3##(1991-12#1)(1994-1#2)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#3)(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the provision##34##2##(1991-12#1)(1994-1#2)(1995-3#3)(1995-5#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#3)(2008-7#1)(2010-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the provisions of the##2##4##(1991-1#1)(1992-1#1)
the provisions##4##2##(1991-1#1)(1991-3#1)(1992-1#1)(1993-1#1)
the proximal and mid left anterior descending artery##2##8##(2008-11#2)
the proximal and##3##3##(1997-8#1)(2008-11#2)
the proximal end##2##3##(2011-2#1)(2013-8#1)
the proximal humerus of##2##4##(1996-11#1)(2012-3#1)
the proximal ligand##2##3##(1994-5#2)
the proximal part of the##2##5##(1991-5#1)(1993-12#1)
the proximal portion of##2##4##(1995-12#1)(1996-8#1)
the proximal tubular##3##3##(1994-5#1)(2007-12#1)(2011-2#1)
the proximal##43##2##(1990-8#1)(1991-5#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#6)(1995-12#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-12#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#2)(2010-12#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the proximate biochemical composition and fatty acid##2##7##(2010-11#2)
the proximate##5##2##(1991-5#1)(2008-8#1)(2010-11#2)(2013-1#1)
the proximity of the##2##4##(2008-11#1)(2011-2#1)
the proximity of##4##3##(2008-11#1)(2008-7#1)(2011-2#2)
the proximity##5##2##(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)
the psbA-trnH##2##2##(2011-2#2)
the pseudo-first-order rate##2##3##(1993-8#1)(1994-8#1)
the pseudogene##2##2##(1990-8#2)
the pseudogenes##2##2##(1990-8#2)
the psoas##6##2##(1991-3#1)(1996-6#1)(2008-10#2)(2009-2#1)(2009-4#1)
the psychiatric hospital##2##3##(1991-12#1)(1993-2#1)
the psychiatric##15##2##(1991-11#1)(1991-12#1)(1992-2#3)(1993-2#2)(1993-6#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-7#1)(2010-12#1)
the psychoanalytic##2##2##(2008-4#2)
the psychological aspects##2##3##(2008-12#1)(2010-11#1)
the psychological##15##2##(1994-12#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2009-11#1)(2010-11#1)(2012-3#1)(2012-5#1)
the psychometric properties of the##5##5##(2008-11#1)(2010-11#1)(2011-2#2)(2013-1#1)
the psychometric properties of##8##4##(2008-11#2)(2010-11#2)(2010-7#1)(2011-2#2)(2013-1#1)
the psychometric##10##2##(2008-11#2)(2010-11#2)(2010-7#1)(2011-2#3)(2013-1#2)
the psychomotor##2##2##(1993-6#1)(1994-6#1)
the psychophysiological responses to##3##4##(1992-12#3)
the psychosocial##9##2##(1991-2#2)(1992-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-2#1)
the psychotropic##2##2##(2008-10#1)(2008-4#1)
the public and private sectors to##2##6##(1996-2#1)(1997-3#1)
the public and private##3##4##(1996-2#1)(1997-3#1)(2013-7#1)
the public and##9##3##(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-3#1)(2010-8#1)(2012-3#1)(2013-7#1)
the public domain##3##3##(1996-1#1)(2009-12#1)(2013-1#1)
the public health community##4##4##(1995-12#1)(1996-3#1)(1997-1#1)(2008-7#1)
the public health impact of##2##5##(1991-3#1)(1997-3#1)
the public health message##2##4##(1996-3#1)(2008-4#1)
the public health system in##2##5##(1995-12#1)(1996-2#1)
the public health system##4##4##(1995-12#1)(1996-2#2)(1997-2#1)
the public health##30##3##(1991-2#1)(1991-3#2)(1995-12#3)(1996-2#4)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#3)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#2)
the public is##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
the public sector##2##3##(1995-3#1)(1996-12#1)
the public through##2##3##(2008-9#1)(2013-1#1)
the public to##4##3##(1992-2#1)(1994-1#1)(2008-4#1)(2008-7#1)
the public##88##2##(1991-2#1)(1991-3#2)(1992-1#2)(1992-2#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#4)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-8#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#2)(2008-7#4)(2008-9#1)(2009-12#3)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
the public's health and##2##4##(1996-3#1)(2010-7#1)
the public's##8##2##(1992-12#1)(1995-12#1)(1995-3#1)(1996-3#2)(1997-8#1)(2010-7#1)(2012-2#1)
the publication of the##3##4##(1996-2#1)(2011-1#1)(2011-2#1)
the publication of##7##3##(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
the publication##9##2##(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
the published literature##6##3##(1991-3#1)(1996-2#1)(2008-3#1)(2010-12#2)(2012-12#1)
the published##20##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-9#2)(2009-7#1)(2010-12#2)(2011-7#1)(2012-12#1)
the pulling##2##2##(1990-5#1)(2009-7#1)
the pulmonary arteries##2##3##(2008-10#1)(2010-5#1)
the pulmonary artery##7##3##(1997-8#1)(2008-11#1)(2008-12#1)(2010-10#3)(2010-5#1)
the pulmonary vascular##2##3##(2008-10#1)(2008-11#1)
the pulmonary##26##2##(1991-3#1)(1992-3#2)(1994-3#1)(1994-8#1)(1997-1#2)(1997-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2010-10#3)(2010-5#2)(2011-2#1)(2012-3#1)(2013-8#2)
the pulp##8##2##(1991-2#3)(2008-10#2)(2011-2#3)
the pulpotomy##2##2##(2011-2#2)
the pulse duration##5##3##(1991-2#3)(2008-10#1)(2008-2#1)
the pulse width##2##3##(2008-3#1)(2012-12#1)
the pulse##28##2##(1991-2#3)(1992-12#1)(1993-1#1)(2007-11#4)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2012-12#1)(2013-1#2)
the pulsed##3##2##(1991-3#1)(2008-10#1)(2008-3#1)
the pulses##3##2##(1991-5#1)(2008-3#1)(2008-5#1)
the pump and##2##3##(2008-10#1)(2008-3#1)
the pump beam##5##3##(2008-2#2)(2008-3#3)
the pump source##2##3##(2008-3#2)
the pump##25##2##(1992-1#1)(2007-11#1)(2008-10#9)(2008-2#5)(2008-3#8)(2008-5#1)
the pump's##4##2##(2008-10#3)(2008-3#1)
the pump-to-mode##2##2##(2008-3#2)
the pumping##5##2##(1997-8#1)(2008-2#3)(2008-3#1)
the pumps##2##2##(2008-10#1)(2010-9#1)
the puncture##2##2##(2011-2#2)
the pupal stage##4##3##(2007-12#4)
the pupillary response to##2##4##(2008-7#2)
the purchase##3##2##(1995-2#1)(2008-11#1)(2010-9#1)
the pure drug##3##3##(2008-10#3)
the pure stands##2##3##(2008-10#2)
the pure##18##2##(1990-8#1)(2008-10#15)(2008-12#1)(2009-3#1)
the purification of TSP-1##2##4##(2008-1#2)
the purification of recombinant##2##4##(2008-1#1)(2008-4#1)
the purification of##17##3##(1990-5#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-4#4)(2009-12#1)(2012-2#1)
the purification procedure##2##3##(2008-10#2)
the purification##22##2##(1990-5#1)(2008-1#4)(2008-10#7)(2008-11#4)(2008-4#4)(2009-12#1)(2012-2#1)
the purified enzyme##4##3##(1990-11#1)(1992-9#1)(1995-2#1)(2008-10#1)
the purified protein##4##3##(1992-3#1)(1992-8#1)(2007-12#1)(2008-10#1)
the purified recombinant##3##3##(1995-2#2)(2008-8#1)
the purified##37##2##(1990-10#1)(1990-11#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-8#2)(2008-9#1)(2012-2#1)
the purine##6##2##(1993-8#1)(2008-10#5)
the purity and##3##3##(2008-10#2)(2008-11#1)
the purity of Hb solutions##2##5##(1992-11#2)
the purity of the##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
the purity of##11##3##(1992-11#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2013-1#1)
the purity##16##2##(1992-11#2)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
the purple asFP595 and yellow zFP538##2##6##(2009-9#2)
the purple bacterium##2##3##(1993-8#2)
the purple##9##2##(1993-8#2)(1997-8#1)(2008-10#3)(2009-9#2)(2011-2#1)
the purported benefits of##2##4##(1992-2#1)(2012-3#1)
the purpose and##2##3##(1995-5#1)(2008-12#1)
the purpose for##2##3##(1992-1#1)(2008-1#1)
the purpose of assessing##2##4##(1990-8#1)(2012-2#1)
the purpose of providing##3##4##(2011-2#1)(2011-3#1)(2012-3#1)
the purpose of studying the##2##5##(1993-6#1)(2008-10#1)
the purpose of the##4##4##(1991-6#1)(1995-12#1)(2008-7#1)(2012-2#1)
the purpose of this study was to##2##7##(2008-12#2)
the purpose of this study##6##5##(2008-10#1)(2008-11#1)(2008-12#2)(2010-12#1)(2013-1#1)
the purpose of this##9##4##(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2010-12#1)(2013-1#1)
the purpose of##58##3##(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-12#1)(1996-5#2)(2008-10#15)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-1#1)(2010-10#1)(2010-12#4)(2011-2#1)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
the purpose to##2##3##(2008-10#1)(2008-11#1)
the purpose##67##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#2)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-5#2)(2008-1#1)(2008-10#17)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-1#1)(2010-10#1)(2010-12#4)(2011-2#1)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
the purposes of##7##3##(1990-3#1)(1993-3#1)(1994-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-1#1)
the purposes##8##2##(1990-3#1)(1993-1#1)(1993-3#1)(1994-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-1#1)
the pursuit of##3##3##(1993-2#1)(2008-12#1)(2011-2#1)
the purview of##2##3##(2008-2#1)(2010-7#1)
the putamen##3##2##(1995-8#1)(2008-7#2)
the putative movement protein##2##4##(2008-10#2)
the putative product##2##3##(1993-2#1)(1997-7#1)
the putative promoter##3##3##(1992-6#1)(2008-9#1)(2009-10#1)
the putative role of##5##4##(1993-3#1)(2008-10#2)(2008-12#1)(2009-8#1)
the putative roles of CRMP2 in a panoply of neurodegenerative##2##10##(2013-1#2)
the putative transposable element##2##4##(2008-10#2)
the putative vesicular transporter for acetylcholine##2##6##(1996-12#2)
the putative##60##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-12#3)(1993-2#3)(1993-3#1)(1994-5#2)(1995-2#3)(1995-8#1)(1996-12#4)(1996-6#1)(1997-7#1)(1997-9#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
the putatively##2##2##(1995-2#1)(2008-10#1)
the pyelonephritic##2##2##(2011-2#2)
the pygmy##2##2##(1995-8#1)(2011-2#1)
the pyralid##3##2##(2008-10#3)
the pyramid##3##2##(2008-10#1)(2008-6#2)
the pyrazine##2##2##(1991-6#1)(1992-10#1)
the pyridine nucleotide##3##3##(1992-1#2)(2009-9#1)
the pyridine##7##2##(1992-1#2)(1993-8#1)(1994-11#1)(2008-10#2)(2009-9#1)
the pyrolysis and atomization##2##4##(2008-10#2)
the pyrolysis of##2##3##(2008-10#2)
the pyrolysis##9##2##(2008-10#8)(2008-3#1)
the pyrrole##4##2##(1992-3#1)(1994-5#1)(1996-5#1)(2008-10#1)
the pyruvate##3##2##(1993-8#1)(2008-10#1)(2008-7#1)
the pyruvate-dehydrogenase complex is##3##4##(1991-3#3)
the pyruvate-dehydrogenase complex##4##3##(1991-3#4)
the quadrat and##2##3##(2008-10#2)
the quadrat##10##2##(2008-10#10)
the quadratic equation##2##3##(2008-10#2)
the quadratic##3##2##(2008-10#2)(2008-3#1)
the quadriceps was##2##3##(2009-3#1)(2013-1#1)
the quadriceps##4##2##(2008-4#1)(2009-3#1)(2012-3#1)(2013-1#1)
the qualitative analysis of##4##4##(1993-3#1)(2008-10#3)
the qualitative research##2##3##(1997-3#1)(2010-10#1)
the qualitative##18##2##(1993-3#1)(1994-8#1)(1997-3#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#1)
the qualitatively different##2##3##(1996-5#1)(2008-12#1)
the qualities of##2##3##(2008-10#1)(2010-11#1)
the qualities##3##2##(2008-10#1)(2008-9#1)(2010-11#1)
the quality and quantity of##2##5##(2008-11#1)(2011-10#1)
the quality and##13##3##(1992-2#1)(1993-3#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#3)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
the quality assurance##6##3##(2008-10#3)(2008-11#1)(2012-12#2)
the quality control of##10##4##(1994-1#1)(2008-10#8)(2010-4#1)
the quality control##15##3##(1994-1#1)(2008-10#11)(2008-9#1)(2010-4#1)(2010-8#1)
the quality evaluation of##2##4##(2011-2#1)(2013-8#1)
the quality improvement process##2##4##(1995-2#2)
the quality improvement##4##3##(1994-2#1)(1995-2#2)(1996-2#1)
the quality management##2##3##(1994-1#1)(1996-1#1)
the quality of bone##2##4##(1991-11#1)(2008-11#1)
the quality of care in##3##5##(1994-12#1)(1996-2#1)(1997-1#1)
the quality of care provided to##2##6##(1996-2#1)(2008-3#1)
the quality of care provided##4##5##(1996-2#1)(2008-11#1)(2008-12#1)(2008-3#1)
the quality of care they provide##2##6##(1996-2#1)(2008-11#1)
the quality of care they##3##5##(1995-2#1)(1996-2#1)(2008-11#1)
the quality of care##16##4##(1993-3#1)(1994-12#1)(1995-2#1)(1996-2#4)(1997-1#1)(1997-2#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)
the quality of clinical##2##4##(1992-2#1)(2010-4#1)
the quality of communication##2##4##(2011-2#1)(2013-1#1)
the quality of health care##3##5##(1993-2#1)(1996-2#1)(1997-4#1)
the quality of health##5##4##(1993-12#1)(1993-2#1)(1996-2#1)(1997-1#1)(1997-4#1)
the quality of hospital care##2##5##(1992-3#1)(1994-3#1)
the quality of hospital##3##4##(1991-3#1)(1992-3#1)(1994-3#1)
the quality of information##2##4##(1991-11#1)(2008-11#1)
the quality of life (QOL)##2##5##(1994-12#1)(2011-2#1)
the quality of life and##4##5##(1992-1#1)(2010-11#1)(2011-2#1)(2013-8#1)
the quality of life for##2##5##(1994-5#1)(2008-5#1)
the quality of life in##5##5##(1990-2#1)(1993-6#1)(2008-12#1)(2009-11#1)(2009-9#1)
the quality of life of patients with##2##7##(2008-7#1)(2009-1#1)
the quality of life of the##2##6##(1993-11#1)(2010-11#1)
the quality of life of##4##5##(1993-11#1)(2008-7#1)(2009-1#1)(2010-11#1)
the quality of life##26##4##(1990-12#1)(1990-2#1)(1992-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-5#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-1#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the quality of nursing care##2##5##(2008-12#1)(2012-3#1)
the quality of patient care##4##5##(1993-3#1)(1997-1#1)(2008-11#1)(2009-8#1)
the quality of the data##2##5##(2008-3#1)(2013-1#1)
the quality of the matrix##2##5##(2008-8#2)
the quality of the##30##4##(1991-6#1)(1995-11#1)(1996-3#1)(1997-8#1)(2007-11#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#3)(2008-8#4)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the quality of their##4##4##(1993-3#1)(2008-11#2)(2011-2#1)
the quality of this##2##4##(2008-10#1)(2008-11#1)
the quality of working life##2##5##(1992-3#1)(2008-11#1)
the quality of working##3##4##(1992-3#1)(2008-11#1)(2012-3#1)
the quality of##148##3##(1990-12#1)(1990-2#1)(1991-11#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#5)(1993-6#1)(1994-12#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#8)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-10#19)(2008-11#17)(2008-12#7)(2008-3#4)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#2)(2010-4#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#5)(2013-1#6)(2013-8#3)
the quality system##2##3##(2008-6#1)(2011-2#1)
the quality##207##2##(1990-12#1)(1990-2#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#7)(1993-6#1)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#9)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#37)(2008-11#23)(2008-12#7)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#2)(2010-4#3)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#9)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#8)(2013-8#4)
the quantification limit was##2##4##(2008-10#2)
the quantification limit##5##3##(2008-10#5)
the quantification of the##5##4##(2008-10#4)(2011-1#1)
the quantification of##45##3##(1990-12#2)(1992-12#1)(1994-12#2)(2008-10#31)(2008-12#1)(2008-2#3)(2008-3#1)(2009-8#1)(2010-1#1)(2011-1#1)(2013-1#1)
the quantification##51##2##(1990-12#2)(1992-12#1)(1994-12#2)(2008-10#37)(2008-12#1)(2008-2#3)(2008-3#1)(2009-8#1)(2010-1#1)(2011-1#1)(2013-1#1)
the quantitation limit was##2##4##(2008-10#2)
the quantitation of the##3##4##(1997-2#1)(2008-10#2)
the quantitation of##16##3##(1997-2#2)(2008-10#13)(2008-4#1)
the quantitation##19##2##(1997-2#2)(2008-10#15)(2008-4#1)(2008-5#1)
the quantitative analysis of the##2##5##(1997-6#1)(2012-3#1)
the quantitative analysis of##9##4##(1997-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2010-1#1)(2012-3#1)
the quantitative analysis##10##3##(1997-6#1)(2008-10#5)(2008-12#1)(2008-3#1)(2010-1#1)(2012-3#1)
the quantitative determination of##29##4##(1991-2#1)(1997-2#1)(2008-10#25)(2008-12#1)(2008-5#1)
the quantitative determination##30##3##(1991-2#1)(1997-2#1)(2008-10#26)(2008-12#1)(2008-5#1)
the quantitative evaluation of##2##4##(2008-10#1)(2013-1#1)
the quantitative extraction of metal ions##2##6##(2008-10#2)
the quantitative extraction of##3##4##(2008-10#3)
the quantitative measurement of##3##4##(2008-10#1)(2009-12#1)(2010-11#1)
the quantitative sorption of##2##4##(2008-10#2)
the quantitative sorption##3##3##(2008-10#3)
the quantitative trait loci##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
the quantitative##91##2##(1990-9#1)(1991-2#1)(1991-5#1)(1993-1#1)(1997-2#1)(1997-6#1)(2008-10#60)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#2)(2012-2#1)(2012-3#3)(2013-1#2)
the quantities of##3##3##(2008-10#3)
the quantities##4##2##(1990-8#1)(2008-10#3)
the quantity and##2##3##(2008-10#1)(2008-5#1)
the quantity of drug##2##4##(1992-3#2)
the quantity of water##2##4##(2008-10#2)
the quantity of##17##3##(1992-1#1)(1992-12#1)(1992-3#2)(1993-2#1)(2008-10#7)(2008-5#2)(2008-9#2)(2009-6#1)
the quantity##22##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#2)(2009-6#1)
the quantum yield##2##3##(2008-11#1)(2008-2#1)
the quantum##9##2##(1995-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
the quartz in near ore body rock##2##7##(2013-8#2)
the quartz in the mineralized rock##2##6##(2013-8#2)
the quartz in##5##3##(2013-8#5)
the quartz##14##2##(2008-10#6)(2013-8#8)
the quasi-static and the physical optics approximations##2##7##(2008-2#2)
the quasi-static##4##2##(2008-2#3)(2010-8#1)
the quasispecies##2##2##(1997-3#1)(2013-1#1)
the queen##2##2##(2008-5#1)(2008-8#1)
the queen's##2##2##(2008-8#2)
the quenching and VET rates##2##5##(2008-2#2)
the quenching effect of##2##4##(2008-10#2)
the quenching effect##4##3##(2008-10#4)
the quenching of the fluorescence##2##5##(2008-10#2)
the quenching of##5##3##(1991-5#1)(1995-8#1)(2008-10#3)
the quenching##17##2##(1991-5#1)(1995-8#1)(2008-10#13)(2008-2#2)
the question &quot##2##3##(1994-3#1)(2013-1#1)
the question and##2##3##(2008-12#1)(2008-8#1)
the question as to whether##2##5##(2008-10#1)(2012-3#1)
the question as to##3##4##(1995-12#1)(2008-10#1)(2012-3#1)
the question as##4##3##(1995-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
the question if##2##3##(2011-2#2)
the question of how##5##4##(2008-9#2)(2009-6#1)(2009-8#1)(2012-3#1)
the question of the##6##4##(1991-12#1)(1996-3#1)(2008-11#1)(2008-9#2)(2009-12#1)
the question of whether the##2##5##(2008-11#1)(2009-7#1)
the question of whether##9##4##(1991-3#1)(1996-2#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)
the question of##28##3##(1990-2#1)(1991-12#1)(1991-3#2)(1992-12#1)(1993-2#2)(1996-2#2)(1996-3#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
the questionnaire to##2##3##(2008-10#1)(2008-11#1)
the questionnaire##17##2##(1992-1#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
the questionnaires and##2##3##(1993-2#1)(1997-3#1)
the questionnaires##7##2##(1990-2#1)(1993-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#1)
the questions##13##2##(1990-2#1)(1991-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-11#3)(2008-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
the quick hit method##2##4##(1994-12#2)
the quick##3##2##(1994-12#2)(2008-10#1)
the quinone##3##2##(1991-5#1)(1996-5#1)(2008-10#1)
the quorum##2##2##(2008-10#1)(2009-8#1)
the quorum-quenching##2##2##(2008-9#2)
the quotient between##2##3##(2008-10#2)
the quotient##3##2##(2008-10#2)(2012-6#1)
the rDNA##7##2##(2008-10#7)
the rGO##3##2##(2013-1#3)
the rRNA##4##2##(2008-10#2)(2010-4#2)
the rabbit VLDL receptor cDNA##2##5##(1995-6#2)
the rabbit##15##2##(1990-12#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-8#2)(1995-6#3)(2008-10#2)(2008-5#1)(2008-9#2)(2013-1#1)
the rabbits were mated##2##4##(1992-3#2)
the rabbits##3##2##(1992-3#2)(2008-8#1)
the race structure##3##3##(2008-10#3)
the race##9##2##(1993-12#1)(2008-10#8)
the race-specific##2##2##(2008-10#2)
the rachis##4##2##(2008-10#4)
the racial##2##2##(2008-5#1)(2011-2#1)
the radar##3##2##(2008-3#3)
the radial access##2##3##(2011-2#2)
the radial approach##2##3##(2011-2#2)
the radial artery##7##3##(2008-11#1)(2008-7#1)(2011-2#4)(2013-1#1)
the radial##27##2##(1990-11#1)(1992-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#11)(2012-2#2)(2013-1#1)
the radiation field##2##3##(2010-7#2)
the radiation of##2##3##(2007-12#1)(2008-10#1)
the radiation oncologist##2##3##(2009-11#2)
the radiation sensitivity of##3##4##(2008-9#3)
the radiation treatment##2##3##(2008-7#2)
the radiation##24##2##(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#2)(2010-7#2)(2013-1#1)
the radiative transfer equation##2##4##(2008-3#2)
the radiative transfer##4##3##(2008-10#1)(2008-3#3)
the radiative##7##2##(2008-10#1)(2008-3#6)
the radical##8##2##(1996-5#2)(2008-10#2)(2008-11#2)(2008-2#1)(2011-1#1)
the radicals##3##2##(2008-10#2)(2008-2#1)
the radioactive##4##2##(1992-3#1)(1993-8#1)(1994-5#1)(2008-4#1)
the radioactivity of the##2##4##(1993-11#1)(2008-11#1)
the radioactivity##4##2##(1991-3#1)(1993-11#1)(2008-11#1)(2008-4#1)
the radioantigen binding assay##2##4##(1990-12#2)
the radioisotope and##2##3##(1992-2#2)
the radiolabeled##2##2##(1994-11#1)(1994-8#1)
the radiolar crown##2##3##(2011-2#2)
the radiologic literature##2##3##(1992-1#1)(1997-8#1)
the radiologic##3##2##(1992-1#1)(1996-1#1)(1997-8#1)
the radiological features of##2##4##(1992-12#1)(2012-2#1)
the radiological##9##2##(1992-12#1)(1993-3#1)(1997-8#1)(2007-8#1)(2011-2#2)(2012-2#2)(2012-3#1)
the radiologist to##3##3##(2012-2#3)
the radiologist##8##2##(1991-3#1)(1993-3#1)(2009-9#1)(2012-2#5)
the radiology department##3##3##(1996-1#1)(2009-6#1)(2012-2#1)
the radiology##6##2##(1991-1#1)(1991-12#1)(1996-1#2)(2009-6#1)(2012-2#1)
the radiometric##3##2##(2008-10#1)(2008-3#2)
the radioprotective agent 2-aminoethyl-isothiouronium bromide hydrobromide (AET)##2##7##(1994-5#2)
the radiosensitivity of head and neck cancer patients##2##8##(2008-5#2)
the radiosurgery##3##2##(2008-7#3)
the radiotherapy##3##2##(1992-12#1)(2008-10#1)(2008-5#1)
the radius of##2##3##(2008-10#1)(2008-3#1)
the radius##4##2##(1991-11#1)(2008-10#1)(2008-3#2)
the rain##3##2##(2008-10#3)
the rainbow trout (Oncorhynchus mykiss)##2##5##(2008-5#1)(2008-6#1)
the rainbow trout##6##3##(1994-5#2)(2008-5#2)(2008-6#2)
the rainbow##8##2##(1994-5#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)
the rainwater##2##2##(2008-10#2)
the rainy season##3##3##(1994-9#1)(2008-10#2)
the ramp direction of V(c)##2##5##(2008-10#2)
the ramp##3##2##(2008-10#2)(2012-2#1)
the random amplified polymorphic DNA (RAPD) technique##2##7##(2008-10#2)
the random amplified polymorphic DNA (RAPD)##3##6##(2008-10#3)
the random amplified polymorphic DNA##4##5##(2008-10#4)
the random##18##2##(1991-9#1)(1996-3#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#2)(2013-8#1)
the randomly##2##2##(2008-10#1)(2011-2#1)
the randomness##2##2##(2008-10#1)(2010-10#1)
the range 0##87##3##(1990-2#1)(1993-8#1)(2008-10#83)(2008-3#1)(2008-5#1)
the range 0-0##2##3##(2008-10#2)
the range 1##17##3##(2008-10#17)
the range 1-10##3##3##(2008-10#3)
the range 2##9##3##(2008-10#9)
the range 3##6##3##(2008-10#6)
the range 5##5##3##(2008-10#5)
the range 5-1000ngmL(-1)##2##3##(2008-10#2)
the range 6##5##3##(2008-10#5)
the range and##3##3##(1996-2#1)(2008-10#2)
the range between##8##3##(2008-10#8)
the range examined##2##3##(2008-10#2)
the range from 0 to 1##2##6##(2008-10#2)
the range from 0 to##3##5##(2008-10#3)
the range from 0##9##4##(2008-10#8)(2008-3#1)
the range from 2##2##4##(2008-10#2)
the range from##28##3##(1990-2#1)(2008-10#23)(2008-3#3)(2008-9#1)
the range of 0##77##4##(2008-10#75)(2010-11#1)(2011-2#1)
the range of 1##19##4##(2008-10#17)(2008-11#1)(2008-3#1)
the range of 10##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
the range of 2##13##4##(2008-10#13)
the range of 3##6##4##(2008-10#6)
the range of 4##7##4##(2008-10#5)(2008-11#1)(2013-1#1)
the range of 5##9##4##(2008-10#9)
the range of 7##4##4##(2008-10#4)
the range of applications##2##4##(2008-11#1)(2012-2#1)
the range of concentrations##5##4##(1994-11#1)(2008-10#4)
the range of conditions in##2##5##(2008-10#1)(2008-8#1)
the range of conditions##3##4##(2008-10#1)(2008-8#2)
the range of forces##2##4##(2007-12#2)
the range of its##2##4##(2008-8#1)(2009-12#1)
the range of motion (ROM)##2##5##(2008-12#1)(2009-1#1)
the range of motion##3##4##(2008-12#1)(2009-1#1)(2012-3#1)
the range of pH##5##4##(2008-10#5)
the range of parameters##2##4##(2008-3#1)(2008-8#1)
the range of temperatures##2##4##(2008-3#1)(2008-8#1)
the range of the##6##4##(1990-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-8#1)
the range of##340##3##(1990-11#2)(1993-1#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-2#1)(1997-6#1)(2007-12#3)(2008-10#256)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#16)(2008-9#3)(2009-1#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#2)(2011-2#6)(2011-7#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
the range pH##3##3##(2008-10#3)
the range tested##2##3##(2008-10#1)(2008-11#1)
the range##643##2##(1990-11#2)(1990-2#2)(1991-2#1)(1991-5#1)(1992-6#1)(1993-1#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-2#2)(1997-6#1)(2007-12#3)(2008-10#532)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#11)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#18)(2008-9#4)(2009-1#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#1)(2011-2#6)(2011-7#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
the range-resolved##2##2##(2008-3#2)
the ranges 0##3##3##(2008-10#3)
the ranges of##12##3##(2008-10#10)(2008-5#1)(2011-2#1)
the ranges##26##2##(2007-12#1)(2008-10#22)(2008-11#1)(2008-5#1)(2011-2#1)
the rank order of##2##4##(1995-11#2)
the rank order##4##3##(1995-11#2)(1995-8#1)(2009-4#1)
the rank##12##2##(1995-11#2)(1995-8#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-4#1)
the rank-citation profile##2##3##(2012-2#2)
the ranking##3##2##(1993-12#1)(2008-5#1)(2013-8#1)
the ranks##2##2##(1997-2#1)(2010-3#1)
the raphe nuclei##6##3##(1996-12#1)(2008-7#5)
the raphe##9##2##(1991-12#1)(1996-12#1)(1997-3#1)(2008-7#5)(2012-3#1)
the rapid adherence of##2##4##(2008-10#2)
the rapid analysis of##3##4##(2008-10#2)(2010-9#1)
the rapid and##10##3##(2008-10#8)(2008-7#1)(2008-9#1)
the rapid detection of##4##4##(2008-10#2)(2008-11#1)(2009-6#1)
the rapid detection##5##3##(1993-12#1)(2008-10#2)(2008-11#1)(2009-6#1)
the rapid determination of##10##4##(2008-10#10)
the rapid determination##11##3##(2008-10#11)
the rapid development of##4##4##(2008-10#4)
the rapid expansion of##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
the rapid identification##2##3##(2008-10#1)(2013-1#1)
the rapid increase in##3##4##(2008-10#2)(2012-2#1)
the rapid progress##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
the rapid##101##2##(1991-2#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#3)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#55)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-9#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
the rapidly growing##4##3##(1990-5#1)(1991-6#1)(2011-2#1)(2013-1#1)
the rapidly##6##2##(1990-5#1)(1991-6#1)(2008-12#1)(2011-2#1)(2013-1#2)
the rare earth elements##3##4##(2008-10#3)
the rare earth##5##3##(2008-10#5)
the rare earths and##2##4##(2008-10#2)
the rare earths##5##3##(2008-10#5)
the rare occurrence of the sexual stage of##2##8##(2008-10#2)
the rare##26##2##(1997-5#1)(2008-10#15)(2008-12#1)(2008-3#1)(2009-3#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
the rarely##2##2##(1992-5#1)(2008-11#1)
the rarity of the##2##4##(1990-5#1)(2013-1#1)
the rarity of this condition and its##2##7##(2010-12#1)(2011-2#1)
the rarity of this##4##4##(1992-5#1)(2010-12#1)(2011-2#2)
the rarity of##9##3##(1990-5#1)(1991-11#1)(1992-5#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
the ras##3##2##(1992-8#1)(1994-6#1)(1995-2#1)
the rash##2##2##(2008-11#1)(2008-8#1)
the rat adrenal gland##2##4##(1990-5#1)(1996-12#1)
the rat and human##2##4##(1992-6#1)(1993-12#1)
the rat and mouse##3##4##(1993-8#1)(1994-11#1)(2008-4#1)
the rat and##8##3##(1991-4#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(2008-11#2)(2008-4#1)
the rat at different ages##2##5##(1990-5#1)(1994-2#1)
the rat at##3##3##(1990-5#1)(1994-2#1)(2008-8#1)
the rat brain is##2##4##(1993-8#1)(2008-10#1)
the rat brain##15##3##(1992-10#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-8#1)(1996-12#5)(2008-10#2)
the rat but##3##3##(1992-12#1)(2008-8#1)(2011-2#1)
the rat cDNA##2##3##(1992-10#1)(1995-2#1)
the rat gene encoding##2##4##(1993-6#1)(1993-8#1)
the rat gene##4##3##(1991-7#1)(1993-6#1)(1993-8#1)(1994-11#1)
the rat genome##2##3##(1991-6#1)(1993-8#1)
the rat in order to##2##5##(1993-3#1)(2008-7#1)
the rat in##3##3##(1993-3#1)(1995-12#1)(2008-7#1)
the rat is##3##3##(1992-3#1)(1994-8#2)
the rat kidney##5##3##(1992-6#1)(1994-5#2)(1995-12#2)
the rat liver##5##3##(1990-5#1)(1994-11#1)(2008-10#2)(2009-8#1)
the rat mammary##2##3##(1995-11#2)
the rat medial##2##3##(1997-2#1)(2013-8#1)
the rat neuronal cell adhesion molecule-encoding gene##2##7##(1993-6#2)
the rat neuronal cell##5##4##(1993-6#2)(2008-11#3)
the rat neuronal##6##3##(1993-6#2)(2008-11#3)(2010-12#1)
the rat placenta##2##3##(1995-12#1)(2008-10#1)
the rat trachea##3##3##(2008-9#3)
the rat##224##2##(1990-12#1)(1990-3#1)(1990-5#12)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#2)(1992-12#5)(1992-3#3)(1992-6#11)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#8)(1993-6#6)(1993-8#10)(1994-11#8)(1994-2#7)(1994-3#1)(1994-5#2)(1994-8#10)(1995-11#5)(1995-12#13)(1995-2#5)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#13)(1996-2#9)(1996-5#2)(1997-2#2)(1997-4#2)(1997-7#1)(2008-10#10)(2008-11#11)(2008-12#3)(2008-4#3)(2008-7#5)(2008-8#8)(2008-9#7)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#5)(2013-1#1)(2013-8#2)
the rate and extent of##3##5##(1992-6#1)(2008-10#2)
the rate and##7##3##(1992-6#1)(2008-10#4)(2008-5#1)(2008-8#1)
the rate at which foragers##2##5##(2008-8#2)
the rate at which the##6##5##(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#1)
the rate at which##16##4##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#6)(2010-12#1)(2010-8#1)(2013-8#1)
the rate constant for the##2##5##(2008-7#1)(2008-8#1)
the rate constant##6##3##(1995-6#1)(2008-10#3)(2008-7#1)(2008-8#1)
the rate for##2##3##(1994-2#1)(1995-6#1)
the rate in##5##3##(1994-12#1)(1997-7#1)(2008-10#2)(2008-11#1)
the rate limiting##3##3##(1996-12#1)(2008-5#1)(2013-1#1)
the rate of Fe(II) uptake##2##5##(1996-2#2)
the rate of complications##2##4##(1990-9#1)(2010-7#1)
the rate of development##2##4##(2008-8#1)(2008-9#1)
the rate of disease##3##4##(2008-10#3)
the rate of gluconeogenesis##2##4##(1991-3#1)(1994-8#1)
the rate of growth in##2##5##(1992-2#1)(2013-7#1)
the rate of growth##4##4##(1992-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
the rate of hydrolysis of##2##5##(1990-5#1)(1994-11#1)
the rate of increase in##2##5##(1993-12#1)(2008-9#1)
the rate of increase##4##4##(1993-12#1)(1993-3#1)(2008-10#1)(2008-9#1)
the rate of infection##2##4##(2008-10#2)
the rate of oxygen consumption##2##5##(2008-10#1)(2010-11#1)
the rate of pustule appearance##2##5##(2008-10#2)
the rate of recovery##2##4##(2008-11#1)(2008-12#1)
the rate of release##2##4##(1992-3#1)(2008-10#1)
the rate of the propagation period##2##6##(1991-12#2)
the rate of the##10##4##(1991-12#2)(1992-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)
the rate of##154##3##(1990-5#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#2)(1992-1#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-2#2)(1997-1#3)(2006-6#1)(2008-10#45)(2008-11#10)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#7)(2008-9#4)(2009-4#1)(2009-8#2)(2010-11#3)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#7)(2013-1#2)(2013-7#1)(2013-8#2)
the rate##208##2##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#2)(1992-1#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#4)(1996-12#1)(1996-2#2)(1997-1#3)(1997-7#1)(2006-6#1)(2008-10#63)(2008-11#12)(2008-12#4)(2008-4#2)(2008-5#6)(2008-7#10)(2008-8#15)(2008-9#4)(2009-4#1)(2009-8#2)(2010-11#3)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#8)(2013-1#4)(2013-7#1)(2013-8#3)
the rate-limiting step in##2##4##(1991-5#1)(1996-2#1)
the rate-limiting step##5##3##(1991-5#1)(1996-2#1)(2008-1#1)(2012-2#2)
the rate-limiting##8##2##(1991-5#1)(1991-9#2)(1994-11#1)(1996-2#1)(2008-1#1)(2012-2#2)
the ratemeter##3##2##(1996-2#3)
the ratemeter's##2##2##(1996-2#2)
the rates and##3##3##(1990-8#1)(2012-12#2)
the rates at which##2##4##(1992-12#1)(2013-8#1)
the rates of Si increased in the soil##2##8##(2008-10#2)
the rates of##28##3##(1992-12#1)(1992-4#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#3)(2008-10#8)(2008-11#4)(2008-5#2)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
the rates##39##2##(1990-6#1)(1990-8#1)(1992-12#3)(1992-4#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#3)(1997-7#1)(2008-10#9)(2008-11#5)(2008-5#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#2)
the rather##2##2##(2008-10#1)(2008-11#1)
the rating##2##2##(1997-3#1)(2012-2#1)
the ratio 1##5##3##(2008-10#4)(2008-3#1)
the ratio between the##7##4##(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)
the ratio between##12##3##(1995-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-6#1)(2012-3#1)
the ratio derivative##2##3##(2008-10#2)
the ratio of the number of##2##6##(2008-11#1)(2010-8#1)
the ratio of the##27##4##(1991-12#1)(1992-6#1)(1994-12#1)(2008-10#11)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-8#2)
the ratio of##91##3##(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-6#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#33)(2008-11#9)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#1)
the ratio##133##2##(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#58)(2008-11#12)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#6)(2008-6#2)(2008-8#3)(2008-9#2)(2009-1#1)(2010-10#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)
the rational##4##2##(1992-1#1)(1992-5#1)(2008-10#1)(2008-11#1)
the rationale for##9##3##(1992-2#1)(1993-1#1)(1995-2#1)(2008-11#2)(2008-6#1)(2009-6#1)(2010-5#1)(2011-2#1)
the rationale##14##2##(1992-2#1)(1993-1#1)(1995-2#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#3)
the ratios##4##2##(1996-2#1)(2008-10#3)
the rats were##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
the rats##17##2##(1991-2#1)(1992-12#1)(1993-6#2)(1993-8#1)(1994-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#4)
the raw material##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
the raw materials##6##3##(1994-3#2)(2008-10#4)
the raw##21##2##(1992-5#1)(1994-3#2)(2008-10#7)(2008-3#1)(2008-4#1)(2010-4#3)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
the ray##2##2##(2008-3#1)(2013-8#1)
the ray-tracing##2##2##(2008-3#2)
the rbcS genes##2##3##(1993-12#2)
the rbcS##3##2##(1993-12#3)
the rbs##2##2##(2011-1#2)
the rdo phenotype##2##3##(2008-9#2)
the rdo##3##2##(2008-9#3)
the re-establishment##2##2##(2012-12#1)(2013-1#1)
the reactant##4##2##(2013-8#4)
the reactants##4##2##(2008-10#3)(2013-8#1)
the reacted##2##2##(2008-10#2)
the reaction and##3##3##(1996-5#1)(2008-10#2)
the reaction between the analytes and##3##6##(2008-10#3)
the reaction between the##5##4##(2008-10#5)
the reaction between##35##3##(1990-5#1)(2008-10#33)(2011-2#1)
the reaction catalyzed by##2##4##(1992-3#1)(2008-10#1)
the reaction center##2##3##(1993-8#1)(2008-8#1)
the reaction coil##3##3##(2008-10#3)
the reaction conditions##9##3##(1992-12#1)(1996-2#1)(2008-10#6)(2013-8#1)
the reaction field##2##3##(2008-10#1)(2013-1#1)
the reaction is##12##3##(1996-5#1)(2008-10#10)(2009-10#1)
the reaction media##2##3##(2008-10#2)
the reaction medium and##2##4##(2008-10#2)
the reaction medium##12##3##(1996-5#1)(2008-10#9)(2008-7#2)
the reaction mixture##8##3##(1994-5#1)(2008-10#5)(2008-8#1)(2010-4#1)
the reaction mixtures##2##3##(2008-10#2)
the reaction norm##2##3##(2008-10#1)(2008-8#1)
the reaction of cobalt##2##4##(2008-10#2)
the reaction of luminol with##4##5##(2008-10#4)
the reaction of mercury##2##4##(2008-10#2)
the reaction of the##5##4##(2008-10#5)
the reaction of##69##3##(1993-6#1)(1994-5#3)(1995-6#1)(1996-5#4)(1997-2#1)(2008-10#59)
the reaction pathways##2##3##(1997-6#1)(2008-10#1)
the reaction products##6##3##(1996-12#1)(2008-10#4)(2008-4#1)
the reaction rate was##2##4##(2008-10#2)
the reaction rate##8##3##(2008-10#6)(2008-7#1)(2011-2#1)
the reaction rates of##2##4##(2008-10#1)(2008-9#1)
the reaction rates##3##3##(2008-10#2)(2008-9#1)
the reaction system##7##3##(2008-10#5)(2009-8#1)(2011-1#1)
the reaction temperature##3##3##(2008-10#2)(2011-2#1)
the reaction time of##2##4##(1996-2#1)(2008-10#1)
the reaction time##9##3##(1996-2#1)(1996-5#1)(2008-10#7)
the reaction to##3##3##(2008-10#3)
the reaction vessel##2##3##(2008-10#1)(2008-7#1)
the reaction was also##2##4##(2008-10#2)
the reaction was investigated##2##4##(2008-10#2)
the reaction was##11##3##(1990-6#1)(1992-12#1)(1996-2#1)(2008-10#6)(2008-5#1)(2008-8#1)
the reaction were##7##3##(1997-2#1)(2008-10#5)(2008-11#1)
the reaction with##14##3##(1992-3#1)(2008-10#10)(2008-11#2)(2008-5#1)
the reaction##312##2##(1990-5#1)(1990-6#1)(1991-9#1)(1992-12#2)(1992-3#2)(1993-3#1)(1993-6#3)(1993-8#3)(1994-5#5)(1995-2#2)(1995-6#4)(1996-12#1)(1996-2#3)(1996-5#9)(1997-2#2)(1997-6#2)(2008-10#234)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#2)(2009-8#1)(2010-4#2)(2011-1#1)(2011-2#4)(2013-1#3)(2013-8#1)
the reactions are##2##3##(1997-5#1)(2008-10#1)
the reactions of the##3##4##(2008-10#2)(2012-2#1)
the reactions of##12##3##(1997-2#1)(2008-10#7)(2008-11#1)(2009-8#1)(2012-2#1)(2012-3#1)
the reactions were##3##3##(2008-10#3)
the reactions with##2##3##(1994-5#1)(2008-10#1)
the reactions##25##2##(1994-5#2)(1997-2#1)(1997-5#1)(2008-10#15)(2008-11#1)(2009-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
the reactive oxygen species (ROS)##2##5##(2008-10#2)
the reactive oxygen species##3##4##(2008-10#2)(2011-2#1)
the reactive oxygen##5##3##(1993-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
the reactive##17##2##(1993-6#1)(1995-6#1)(1995-8#1)(1997-3#2)(2008-10#7)(2008-11#2)(2009-8#1)(2011-2#1)(2013-1#1)
the reactivity of the##2##4##(1996-5#1)(2008-10#1)
the reactivity of##8##3##(1990-12#1)(1990-5#1)(1996-5#1)(2008-10#4)(2008-9#1)
the reactivity##10##2##(1990-12#2)(1990-5#1)(1996-5#1)(2008-10#4)(2008-5#1)(2008-9#1)
the reactor and##2##3##(2008-11#1)(2008-7#1)
the reactor##11##2##(2008-10#5)(2008-11#4)(2008-7#2)
the reactors##3##2##(2008-10#2)(2008-7#1)
the readability and comprehensiveness of##2##5##(2011-1#2)
the reader to##2##3##(2008-9#1)(2010-11#1)
the reader with##4##3##(2008-10#1)(2009-12#1)(2010-9#1)(2011-2#1)
the reader##14##2##(1992-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-3#1)
the reading##3##2##(2008-12#1)(2011-2#2)
the readings##2##2##(1993-1#1)(2010-7#1)
the reagent and sample##2##4##(2008-10#2)
the reagent and##5##3##(2008-10#5)
the reagent blank##5##3##(2008-10#5)
the reagent concentration##2##3##(2008-10#2)
the reagent in##2##3##(2008-10#2)
the reagent reacts with##2##4##(2008-10#2)
the reagent solution##3##3##(2008-10#3)
the reagent was##2##3##(2008-10#2)
the reagent##48##2##(2008-10#46)(2008-5#1)(2008-8#1)
the reagent-injection##2##2##(2008-10#2)
the reagents##21##2##(1994-11#1)(2008-10#17)(2008-11#1)(2008-9#1)(2010-3#1)
the real and##4##3##(1997-7#1)(2008-10#1)(2008-3#2)
the real need##2##3##(1991-2#1)(1993-12#1)
the real sample##4##3##(2008-10#4)
the real samples##7##3##(2008-10#6)(2008-5#1)
the real world##3##3##(2008-10#1)(2009-12#1)(2013-8#1)
the real##40##2##(1991-2#1)(1992-12#1)(1993-12#2)(1994-1#1)(1997-7#1)(2008-10#21)(2008-11#1)(2008-3#5)(2008-5#1)(2009-12#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
the real-time PCR##4##3##(2008-10#3)(2013-8#1)
the real-time detection##2##3##(2008-10#1)(2009-12#1)
the real-time##9##2##(2008-10#6)(2009-12#1)(2013-8#2)
the realism of role plays##2##5##(2009-11#2)
the realism of##3##3##(2009-11#3)
the realistic##3##2##(1991-12#1)(2008-11#1)(2008-5#1)
the realities of##3##3##(2008-11#2)(2010-4#1)
the reality of the##2##4##(2008-11#2)
the reality of##3##3##(1994-12#1)(2008-11#2)
the reality##6##2##(1994-12#1)(1996-3#1)(2008-11#2)(2010-10#1)(2012-3#1)
the realization of a##2##4##(2008-3#2)
the realization of##9##3##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
the realized##4##2##(2008-10#1)(2008-8#3)
the rear##4##2##(1996-12#1)(2008-10#2)(2013-1#1)
the rearing conditions##2##3##(1991-2#2)
the rearing##4##2##(1990-3#2)(1991-2#2)
the rearrangement##3##2##(1996-5#2)(2009-12#1)
the reason for the##4##4##(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
the reason for##10##3##(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#2)(2012-3#1)
the reason that##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
the reason why##2##3##(2008-10#1)(2010-6#1)
the reason##20##2##(1991-9#1)(1992-1#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2009-8#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
the reasons for non-attendance##2##4##(1991-6#2)
the reasons for the##4##4##(1996-2#1)(2008-8#1)(2009-8#1)(2013-1#1)
the reasons for their##2##4##(2008-10#1)(2008-11#1)
the reasons for this##2##4##(2008-10#2)
the reasons for##18##3##(1991-6#2)(1992-1#1)(1993-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-3#1)(2012-2#1)(2013-1#2)
the reasons why faculty choose not to participate in these courses##2##11##(2013-1#2)
the reasons why##5##3##(1991-2#1)(2008-6#1)(2012-2#1)(2013-1#2)
the reasons##26##2##(1991-2#1)(1991-6#2)(1991-9#1)(1992-1#1)(1993-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-2#2)(2013-1#4)
the recall##2##2##(2010-11#1)(2011-2#1)
the received##3##2##(2008-3#3)
the receiver##12##2##(2008-10#2)(2008-2#3)(2008-3#7)
the receiving phase##2##3##(2008-10#2)
the receiving##4##2##(2008-10#3)(2009-10#1)
the recent advances in##3##4##(2011-3#1)(2012-2#1)(2012-3#1)
the recent advances##4##3##(2011-3#1)(2012-2#1)(2012-3#2)
the recent development of##4##4##(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)
the recent emergence of##2##4##(2008-10#1)(2009-12#1)
the recent increase in##2##4##(2008-10#1)(2010-1#1)
the recent increase##3##3##(2008-10#2)(2010-1#1)
the recent literature##5##3##(1994-6#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
the recent past and##3##4##(1991-3#2)(2012-5#1)
the recent past##7##3##(1991-3#2)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-5#1)
the recent progress in the##2##5##(2010-11#1)(2013-1#1)
the recent progress##3##3##(2008-3#1)(2010-11#1)(2013-1#1)
the recent proposition that##2##4##(1995-6#1)(2008-10#1)
the recent results##2##3##(2008-4#1)(2011-2#1)
the recent years##4##3##(1997-4#1)(2008-12#1)(2012-2#1)(2012-3#1)
the recent##83##2##(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-6#1)(1996-1#1)(1996-3#1)(1997-4#1)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#1)
the recently created##2##3##(1994-12#1)(2011-2#1)
the recently described##4##3##(2008-10#2)(2008-6#1)(2012-2#1)
the recently developed##4##3##(1997-3#1)(2008-3#1)(2008-8#1)(2013-8#1)
the recently discovered##2##3##(2008-10#1)(2013-1#1)
the recently identified##2##3##(2008-10#1)(2013-7#1)
the recently introduced##4##3##(2008-10#3)(2008-11#1)
the recently proposed##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
the recently published##3##3##(2008-12#1)(2008-9#1)(2010-12#1)
the recently reported##4##3##(1993-12#1)(1995-6#1)(2006-6#1)(2008-10#1)
the recently revised##3##3##(1994-5#1)(2009-4#1)(2012-2#1)
the recently solved##2##3##(1997-7#1)(1997-9#1)
the recently##44##2##(1991-2#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-3#1)(1997-7#1)(1997-9#1)(2006-6#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
the receptacle area##5##3##(2008-10#5)
the receptacle##6##2##(2008-10#6)
the receptive fields##2##3##(2008-11#1)(2008-8#1)
the receptive##4##2##(2008-11#1)(2008-8#2)(2011-1#1)
the receptor binding##3##3##(1990-11#1)(1997-4#1)(2008-8#1)
the receptor for##5##3##(1990-11#1)(1994-5#1)(2008-7#1)(2013-1#2)
the receptor is##3##3##(1990-11#1)(1994-11#1)(1995-6#1)
the receptor of##2##3##(2008-8#2)
the receptor on##2##3##(1992-10#1)(2008-11#1)
the receptor##63##2##(1990-11#5)(1990-4#1)(1991-5#2)(1992-10#1)(1992-3#1)(1992-4#2)(1992-9#1)(1994-11#2)(1994-12#2)(1994-5#4)(1995-11#3)(1995-12#1)(1995-2#2)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(2006-6#2)(2008-10#3)(2008-11#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#5)(2009-12#1)(2009-6#1)(2013-1#3)
the receptor-bound##3##2##(1993-8#2)(1995-11#1)
the receptors for##3##3##(1993-8#1)(1996-2#1)(2008-10#1)
the receptors of##3##3##(1993-2#2)(2009-8#1)
the receptors##15##2##(1993-2#2)(1993-8#1)(1995-11#2)(1995-12#1)(1996-2#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#2)(2009-8#1)(2011-2#1)
the recessive##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
the recipient and##2##3##(2008-10#1)(2011-2#1)
the recipient##11##2##(1994-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#1)(2011-3#2)
the recipient's##2##2##(1997-5#2)
the reciprocal of##2##3##(2008-10#1)(2008-5#1)
the reciprocal##8##2##(1990-11#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
the recognition and##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
the recognition of the##3##4##(2008-11#1)(2008-6#1)(2009-1#1)
the recognition of##19##3##(1995-2#2)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
the recognition sequence##2##3##(1992-10#1)(1995-8#1)
the recognition site##2##3##(1995-6#2)
the recognition that##2##3##(1992-9#1)(2008-11#1)
the recognition##34##2##(1991-6#2)(1992-10#1)(1992-9#1)(1994-3#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
the recombinant adenovirus##2##3##(2008-8#1)(2011-2#1)
the recombinant glycoprotein##2##3##(2008-11#1)(2008-7#1)
the recombinant human##6##3##(1990-5#2)(1990-8#1)(1994-5#2)(2008-10#1)
the recombinant protein to##2##4##(2008-10#1)(2008-7#1)
the recombinant protein##14##3##(1990-11#2)(2008-10#1)(2008-11#6)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
the recombinant vaccinia virus##3##4##(2008-8#3)
the recombinant vector##2##3##(1994-5#1)(2010-4#1)
the recombinant##63##2##(1990-11#3)(1990-5#2)(1990-8#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#3)(1994-6#1)(1995-11#2)(1995-5#1)(2008-10#6)(2008-11#14)(2008-7#4)(2008-8#9)(2008-9#1)(2009-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-3#1)(2013-8#1)
the recombinants##2##2##(1995-2#1)(2008-10#1)
the recombination events##2##3##(2008-10#1)(2013-8#1)
the recombination of##2##3##(1991-3#1)(1995-8#1)
the recombination##8##2##(1991-3#1)(1995-12#1)(1995-8#1)(2008-10#1)(2013-1#1)(2013-8#3)
the recommendation of the##2##4##(1996-6#1)(2008-8#1)
the recommendation of##4##3##(1996-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
the recommendation##5##2##(1991-8#1)(1996-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
the recommendations of the##3##4##(2011-3#1)(2012-3#1)(2013-1#1)
the recommendations of##4##3##(1995-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
the recommendations##12##2##(1990-6#1)(1994-6#1)(1995-2#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
the recommended daily##2##3##(2010-6#1)(2013-1#1)
the recommended level of##2##4##(2008-1#1)(2011-2#1)
the recommended levels of HbA1c##3##5##(2011-2#3)
the recommended levels##4##3##(2011-2#4)
the recommended method##2##3##(2008-10#2)
the recommended procedure##5##3##(2008-10#5)
the recommended values##2##3##(2008-10#2)
the recommended##32##2##(1991-11#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-8#1)(2010-1#1)(2010-6#3)(2011-1#2)(2011-2#6)(2012-2#4)(2013-1#1)
the reconstituted##13##2##(1991-5#1)(1992-8#1)(1993-8#2)(1995-2#1)(1997-1#1)(2008-11#3)(2008-8#2)(2008-9#2)
the reconstitution##3##2##(1995-8#3)
the reconstructed epidermis##2##3##(2008-5#2)
the reconstructed image##3##3##(2007-11#2)(2008-3#1)
the reconstructed##14##2##(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-1#1)(2009-8#1)(2012-3#1)(2013-1#1)
the reconstruction of a##2##4##(2008-3#2)
the reconstruction of the##2##4##(2010-8#1)(2012-3#1)
the reconstruction of##11##3##(1990-5#1)(1993-6#2)(1994-3#1)(1996-8#1)(2008-3#2)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
the reconstruction##14##2##(1990-5#1)(1993-6#2)(1994-3#1)(1996-8#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
the reconstructive##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
the record of##2##3##(1997-3#1)(2008-10#1)
the record##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
the recorded##7##2##(1994-9#1)(1996-5#1)(2008-10#4)(2008-3#1)
the recording material's##2##3##(2008-3#2)
the recording of the##2##4##(2008-3#1)(2008-5#1)
the recording of##10##3##(1994-12#1)(1995-12#2)(1996-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-7#1)(2011-2#1)
the recording##20##2##(1991-12#1)(1994-12#1)(1995-12#2)(1996-6#1)(2007-12#2)(2008-10#1)(2008-3#7)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
the records of##4##3##(1995-6#1)(2008-1#1)(2008-5#1)(2011-2#1)
the records##9##2##(1994-3#4)(1995-6#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-2#1)
the recovered##8##2##(1993-8#1)(1995-6#1)(1996-2#1)(2008-10#4)(2013-8#1)
the recoveries are##4##3##(2008-10#4)
the recoveries obtained##3##3##(2008-10#3)
the recoveries of these ions are still over 92%##2##9##(2008-10#2)
the recoveries of##12##3##(2008-10#12)
the recoveries ranged##2##3##(2008-10#2)
the recoveries##26##2##(2008-10#26)
the recovery and##5##3##(2008-10#4)(2013-1#1)
the recovery of copper##2##4##(2008-10#2)
the recovery of each##2##4##(2008-10#2)
the recovery of lead in##2##5##(2008-10#2)
the recovery of the##10##4##(2008-10#9)(2008-11#1)
the recovery of##54##3##(1993-3#1)(1995-8#1)(1996-12#1)(2008-10#44)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
the recovery period##3##3##(1992-3#1)(2012-3#1)(2013-8#1)
the recovery rate##3##3##(2008-10#3)
the recovery rates were##2##4##(2008-10#2)
the recovery rates##5##3##(2008-10#5)
the recovery time##2##3##(2007-11#1)(2012-2#1)
the recovery values##2##3##(2008-10#2)
the recovery were##2##3##(2008-10#2)
the recovery##104##2##(1990-5#2)(1991-2#1)(1992-3#1)(1993-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(2007-11#1)(2008-10#79)(2008-11#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the recruitment of##4##3##(1996-2#1)(2009-6#1)(2013-1#2)
the recruitment##8##2##(1996-2#1)(2009-5#1)(2009-6#1)(2010-8#1)(2012-2#2)(2013-1#2)
the rectal##5##2##(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
the rectum and##4##3##(2007-8#1)(2009-12#1)(2012-12#2)
the rectum##13##2##(1992-5#1)(2007-12#2)(2007-8#1)(2009-11#1)(2009-12#1)(2011-2#1)(2012-12#4)(2013-8#2)
the rectus femoris muscle##3##4##(2008-12#2)(2011-2#1)
the rectus femoris##4##3##(2008-12#2)(2011-2#2)
the rectus##6##2##(1990-9#1)(1991-12#1)(2008-12#2)(2011-2#2)
the recurrence of##3##3##(2008-3#1)(2009-6#1)(2011-2#1)
the recurrence##5##2##(2008-3#1)(2009-6#1)(2011-2#2)(2013-1#1)
the recurrent nature of complications##2##5##(1995-12#2)
the recurrent##8##2##(1991-6#2)(1995-12#2)(2008-9#3)(2012-12#1)
the recycled HDPE##2##3##(2009-3#2)
the recycling of##6##3##(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-9#1)
the recycling##7##2##(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#3)(2008-9#1)
the red alga Asparagopsis armata##2##5##(2008-10#2)
the red alga##3##3##(2008-10#2)(2008-11#1)
the red blood cell##4##4##(1997-6#2)(2008-5#1)(2011-2#1)
the red blood##5##3##(1997-6#2)(2008-5#1)(2011-2#2)
the red cell##4##3##(1997-6#1)(2006-6#1)(2008-11#2)
the red poultry mite##2##4##(1997-5#2)
the red##27##2##(1994-5#1)(1997-5#2)(1997-6#3)(2006-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#3)(2011-2#2)(2012-2#1)
the redesign of the##2##4##(1997-3#1)(2008-7#1)
the redesigning##2##2##(1992-3#1)(2008-11#1)
the redifferentiation of##2##3##(2008-8#1)(2009-3#1)
the redox cycle##2##3##(1992-8#2)
the redox cycling##2##3##(1992-8#1)(2008-11#1)
the redox properties of##2##4##(2008-9#1)(2010-6#1)
the redox properties##3##3##(1994-5#1)(2008-9#1)(2010-6#1)
the redox reaction between naphthol green B and potassium bromate##2##10##(2008-10#2)
the redox reaction between##5##4##(2008-10#5)
the redox reaction##10##3##(2008-10#10)
the redox state of##2##4##(1994-3#1)(2008-10#1)
the redox##35##2##(1992-8#3)(1994-3#1)(1994-5#1)(2008-10#25)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)
the redox-active##2##2##(2008-10#2)
the reduced form of##4##4##(1994-5#1)(2008-10#3)
the reduced form##5##3##(1994-5#1)(2008-10#4)
the reduced##43##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-11#1)(1992-12#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#3)(1997-3#1)(2008-10#17)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
the reducing agent##4##3##(1995-11#1)(2008-10#2)(2011-2#1)
the reducing end##3##3##(1992-10#2)(1992-12#1)
the reducing sugars##2##3##(2008-10#2)
the reducing##13##2##(1992-10#2)(1992-12#2)(1992-5#1)(1994-5#1)(1995-11#1)(2008-10#4)(2008-7#1)(2011-2#1)
the reductase##5##2##(1993-6#1)(1996-3#2)(2008-11#2)
the reduction and##4##3##(2008-10#2)(2009-12#1)(2011-2#1)
the reduction in the##4##4##(1992-9#1)(2008-11#1)(2008-12#1)(2010-12#1)
the reduction in##20##3##(1992-9#1)(1994-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
the reduction is##2##3##(1991-1#1)(2008-10#1)
the reduction of Cr(VI)##2##4##(2008-10#1)(2011-2#1)
the reduction of hydrogen##2##4##(2008-10#2)
the reduction of nitrate to##2##5##(2008-10#2)
the reduction of oxygen##2##4##(1995-2#1)(2008-10#1)
the reduction of the##17##4##(1996-6#1)(2008-10#12)(2008-11#3)(2009-7#1)
the reduction of##81##3##(1991-1#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-10#48)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
the reduction peak current of##2##5##(2008-10#2)
the reduction peak current##3##4##(2008-10#3)
the reduction product##3##3##(2008-10#3)
the reduction reaction##2##3##(2008-10#1)(2008-8#1)
the reduction was##5##3##(1991-9#1)(2008-10#2)(2008-11#1)(2008-7#1)
the reduction##142##2##(1990-8#1)(1991-1#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-10#79)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-3#2)(2013-7#1)(2013-8#3)
the reductions##2##2##(2008-10#1)(2008-11#1)
the reductive amination of##2##4##(1996-5#2)
the reductive##3##2##(1996-5#2)(2008-11#1)
the redundant signals##2##3##(2008-10#2)
the redundant##3##2##(2008-10#2)(2008-3#1)
the reference beam##5##3##(2008-3#5)
the reference electrode##2##3##(2008-10#2)
the reference materials##4##3##(2008-10#4)
the reference method##9##3##(2008-10#9)
the reference methods##3##3##(2008-10#3)
the reference procedure##5##3##(2008-10#5)
the reference range##2##3##(1991-2#1)(1993-2#1)
the reference sequence##2##3##(2008-10#1)(2008-12#1)
the reference standard##4##3##(1991-5#1)(2008-10#3)
the reference strain of##2##4##(2008-10#2)
the reference strain##5##3##(2008-10#4)(2008-5#1)
the reference strains##2##3##(2008-10#1)(2008-5#1)
the reference wavelength##2##3##(2008-2#2)
the reference##85##2##(1991-2#1)(1991-5#1)(1993-2#1)(1995-12#1)(1997-8#1)(2008-10#53)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#2)(2009-10#2)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
the referent group##4##3##(1996-6#3)(2008-11#1)
the referred pain area##3##4##(2010-9#3)
the referred pain sensation##2##4##(2008-12#2)
the referred pain##8##3##(2008-12#2)(2008-9#1)(2010-9#5)
the referred##11##2##(1992-3#1)(2008-12#2)(2008-9#2)(2010-8#1)(2010-9#5)
the referring physician's##2##3##(1993-12#1)(1996-1#1)
the referring##5##2##(1992-3#1)(1993-12#1)(1996-1#1)(1996-3#1)(2008-12#1)
the refinement of the##2##4##(1994-2#1)(2008-10#1)
the refinement of##4##3##(1994-2#1)(1997-7#1)(2008-10#2)
the refinement##5##2##(1993-3#1)(1994-2#1)(1997-7#1)(2008-10#2)
the reflectance at##2##3##(2008-10#1)(2008-3#1)
the reflectance##8##2##(2008-10#5)(2008-3#3)
the reflected##5##2##(2008-10#1)(2008-3#3)(2010-12#1)
the reflecting##2##2##(2008-3#1)(2009-8#1)
the reflection and##2##3##(2007-12#1)(2008-3#1)
the reflection function of##2##4##(2008-3#2)
the reflection##7##2##(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#3)
the reflective##3##2##(2008-11#1)(2008-3#2)
the reflectivity of##2##3##(2008-2#2)
the reflectivity##4##2##(2008-2#2)(2008-3#2)
the refolding of##2##3##(1995-8#1)(1997-4#1)
the refolding##3##2##(1995-8#1)(1997-4#1)(2008-8#1)
the reform of##2##3##(1992-12#1)(1997-2#1)
the reform##5##2##(1992-12#1)(1992-5#1)(1994-12#1)(1997-2#2)
the reforms##2##2##(1993-2#1)(1997-5#1)
the refracted##2##2##(2008-3#2)
the refractive index n##2##4##(2008-10#1)(2008-3#1)
the refractive index of##5##4##(2008-10#3)(2008-3#2)
the refractive index##14##3##(2008-10#6)(2008-3#8)
the refractive##15##2##(2008-10#6)(2008-2#1)(2008-3#8)
the refractive-index change##3##3##(2008-3#3)
the refractive-index distribution##2##3##(2008-2#1)(2008-3#1)
the refractive-index##12##2##(2008-2#3)(2008-3#9)
the refractory##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
the regenerated gratings##4##3##(2013-8#4)
the regenerated##6##2##(2008-10#1)(2008-11#1)(2013-8#4)
the regenerating##3##2##(1993-12#1)(1996-2#1)(2008-9#1)
the regeneration capacity##2##3##(2008-9#2)
the regeneration of the##2##4##(2008-10#2)
the regeneration of##4##3##(2008-10#2)(2008-11#1)(2010-7#1)
the regeneration process##2##3##(2008-11#1)(2012-2#1)
the regeneration##9##2##(2008-10#3)(2008-11#2)(2008-9#2)(2010-7#1)(2012-2#1)
the regenerative##3##2##(2009-10#1)(2012-12#1)(2013-8#1)
the region between##3##3##(1994-11#1)(1995-12#1)(2008-9#1)
the region of the##8##4##(1992-12#1)(1994-8#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
the region of##27##3##(1990-10#1)(1992-12#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2010-6#1)(2012-3#2)(2013-1#1)
the region showed##2##3##(2008-10#2)
the region that##3##3##(2008-10#3)
the region to##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
the region was##2##3##(2008-10#1)(2008-8#1)
the region##85##2##(1990-10#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#5)(1997-9#1)(2007-12#1)(2008-10#28)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
the regional spread of##2##4##(2008-10#2)
the regional##23##2##(1990-11#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-8#1)(2009-1#1)(2010-6#1)(2011-2#1)(2012-12#1)
the regions of the##5##4##(1990-12#1)(1993-12#1)(1995-8#1)(2008-8#1)(2008-9#1)
the regions of##9##3##(1990-12#1)(1993-12#1)(1993-8#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
the regions where##2##3##(2008-11#1)(2008-4#1)
the regions##25##2##(1990-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#2)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#1)(2013-8#1)
the regioselective##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
the regioselectivity##3##2##(1994-5#1)(1996-5#1)(2008-8#1)
the register##2##2##(2008-11#1)(2008-12#1)
the registered##2##2##(1997-2#1)(2011-2#1)
the registry##2##2##(1993-5#1)(2011-2#1)
the regression analysis##3##3##(2008-10#3)
the regression coefficients##4##3##(1995-9#1)(2008-10#2)(2010-11#1)
the regression equation##4##3##(2008-10#4)
the regression lines##2##3##(2008-10#2)
the regression model##7##3##(2008-10#3)(2008-11#2)(2010-4#1)(2013-8#1)
the regression of##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
the regression triplet##2##3##(2008-10#2)
the regression##36##2##(1990-2#1)(1992-9#1)(1995-9#1)(2008-10#24)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-4#1)(2013-8#1)
the regular solution theory##4##4##(2008-10#4)
the regular use of##2##4##(2008-11#1)(2008-5#1)
the regular##11##2##(1994-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2011-2#1)(2013-7#1)
the regularized image u(x##2##4##(2008-6#2)
the regulated and constitutive secretory pathways##2##6##(1992-12#2)
the regulated##6##2##(1992-12#2)(1994-12#1)(1995-2#1)(2010-11#2)
the regulation mechanism of the##2##5##(1997-8#1)(2008-9#1)
the regulation mechanism of##3##4##(1997-8#1)(2008-11#1)(2008-9#1)
the regulation of PEPCK gene expression by insulin##2##8##(1996-2#2)
the regulation of PEPCK gene##3##5##(1996-2#3)
the regulation of energy homeostasis##2##5##(2008-10#1)(2008-4#1)
the regulation of energy##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)
the regulation of gene expression##5##5##(1991-6#1)(2008-11#2)(2008-7#1)(2013-1#1)
the regulation of mitochondrial##2##4##(2008-7#2)
the regulation of photoreceptor##2##4##(1996-2#1)(2008-7#1)
the regulation of proliferation##2##4##(2013-1#1)(2013-8#1)
the regulation of protein##2##4##(1990-5#1)(2008-11#1)
the regulation of spermatogenesis##2##4##(2012-2#2)
the regulation of the##15##4##(1992-11#1)(1993-12#1)(1993-6#2)(1995-12#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
the regulation of these##3##4##(2008-9#1)(2009-8#1)(2011-2#1)
the regulation of##139##3##(1990-5#1)(1991-12#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#6)(1992-9#1)(1993-12#2)(1993-6#3)(1993-8#3)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#9)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#6)(2013-1#4)(2013-7#2)(2013-8#2)
the regulation##149##2##(1990-5#2)(1991-12#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#6)(1992-9#1)(1993-12#2)(1993-6#3)(1993-8#3)(1994-11#6)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#9)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#13)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#5)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#6)(2013-1#4)(2013-7#2)(2013-8#2)
the regulators##2##2##(1995-5#1)(2008-9#1)
the regulatory T##2##3##(2011-2#2)
the regulatory authority##2##3##(2008-11#2)
the regulatory domain##2##3##(1995-6#1)(1997-6#1)
the regulatory mechanism##2##3##(2008-8#1)(2011-10#1)
the regulatory mechanisms of##2##4##(2011-2#2)
the regulatory network##2##3##(2008-7#1)(2010-10#1)
the regulatory networks##2##3##(2008-11#1)(2008-7#1)
the regulatory proteins of##2##4##(1993-8#1)(1995-8#1)
the regulatory region of##2##4##(1990-7#1)(2008-4#1)
the regulatory##42##2##(1990-7#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#4)(2013-8#1)
the rehabilitation of##3##3##(1992-12#1)(2011-7#1)(2012-3#1)
the rehabilitation process##2##3##(2010-10#2)
the rehabilitation##9##2##(1992-12#1)(2008-10#1)(2008-9#1)(2010-10#2)(2011-7#1)(2012-3#1)(2013-1#2)
the rehabilitative##3##2##(2008-10#2)(2013-1#1)
the reimbursement##2##2##(1992-11#1)(1993-12#1)
the reinforcement signal##2##3##(1997-7#1)(2009-8#1)
the reinforcement##3##2##(1997-7#1)(2009-10#1)(2009-8#1)
the reinforcer##2##2##(1997-7#2)
the reinforcing##3##2##(1991-1#1)(1993-6#1)(1994-2#1)
the reinnervation of##2##3##(2013-8#2)
the rejection of##3##3##(2008-10#2)(2008-8#1)
the rejections or transfers due to lack of capacity and the random length of stays##2##15##(2010-8#2)
the related##23##2##(1990-8#1)(1991-1#1)(1991-3#1)(1992-1#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-3#1)(2012-12#1)(2013-8#1)
the relation between RC teacher practices and##2##7##(2008-12#2)
the relation between RC##3##4##(2008-12#3)
the relation between the##5##4##(1991-6#1)(1995-5#1)(2008-8#2)(2010-10#1)
the relation between these##3##4##(1991-11#1)(2008-10#1)(2008-3#1)
the relation between##29##3##(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#2)(1993-11#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-5#1)(1997-1#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2013-1#1)
the relation of##3##3##(1994-3#1)(1996-2#1)(2009-5#1)
the relation##34##2##(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#2)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-5#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2013-1#2)
the relational##2##2##(2008-12#1)(2010-8#1)
the relations between the##3##4##(1996-1#1)(1996-2#1)(2010-8#1)
the relations between##6##3##(1995-5#1)(1996-1#1)(1996-2#1)(2008-11#1)(2010-8#1)(2011-2#1)
the relations##12##2##(1995-5#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-3#2)(2010-2#3)(2010-8#1)(2011-2#1)
the relationship among##5##3##(2008-10#2)(2008-2#1)(2013-1#1)(2013-8#1)
the relationship and##2##3##(2008-11#1)(2013-8#1)
the relationship between DON and IND##2##6##(2008-10#2)
the relationship between a##6##4##(1991-3#1)(1994-1#1)(2008-10#1)(2008-12#2)(2013-8#1)
the relationship between analytical precision and concentration##2##7##(2008-10#2)
the relationship between body dissatisfaction and disordered eating##2##8##(2012-2#2)
the relationship between body image##2##5##(2009-5#1)(2012-2#1)
the relationship between body##5##4##(2009-5#1)(2011-1#1)(2012-2#3)
the relationship between brain##2##4##(2008-7#1)(2012-2#1)
the relationship between burnout and health care utilization of 238 employed adults##2##12##(1996-2#1)(1997-1#1)
the relationship between burnout##3##4##(1996-2#1)(1997-1#1)(2008-11#1)
the relationship between developmental##2##4##(2008-10#1)(2008-9#1)
the relationship between disease severity and##2##6##(2008-10#2)
the relationship between executive function and social outcome in##2##9##(2009-10#2)
the relationship between executive function and social outcome##4##8##(2009-10#4)
the relationship between family functioning##2##5##(2013-1#2)
the relationship between group size and##3##6##(1994-3#2)(2008-8#1)
the relationship between home range##2##5##(2008-8#2)
the relationship between home##3##4##(1992-2#1)(2008-8#2)
the relationship between host##2##4##(2008-10#2)
the relationship between incidence##2##4##(2008-10#2)
the relationship between local##2##4##(1994-2#1)(1996-10#1)
the relationship between molecular##2##4##(2008-10#2)
the relationship between physical##2##4##(2008-10#1)(2013-1#1)
the relationship between smoking##2##4##(1996-3#1)(2013-1#1)
the relationship between social##2##4##(2009-7#1)(2013-8#1)
the relationship between species##2##4##(2008-10#1)(2008-8#1)
the relationship between the number of##2##6##(2008-12#1)(2013-8#1)
the relationship between the variables##2##5##(2008-10#2)
the relationship between the##54##4##(1991-2#1)(1992-2#1)(1992-3#1)(1994-3#1)(1994-8#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-4#1)(2011-2#5)(2012-5#1)(2013-8#4)
the relationship between##237##3##(1990-3#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1992-1#1)(1992-2#2)(1992-3#2)(1992-9#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#4)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#46)(2008-11#17)(2008-12#8)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#13)(2008-9#8)(2009-10#5)(2009-11#3)(2009-3#1)(2009-5#4)(2009-7#8)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-4#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#12)(2012-2#12)(2012-5#1)(2013-1#9)(2013-8#7)
the relationship of the##12##4##(1991-2#1)(1991-3#1)(1995-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#3)(2011-3#1)(2012-2#1)
the relationship of these##3##4##(1994-2#1)(1996-12#1)(1996-2#1)
the relationship of##34##3##(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1994-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(2008-10#9)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
the relationship was##2##3##(2008-10#2)
the relationship with their##2##4##(2008-10#2)
the relationship with##5##3##(2008-10#2)(2008-2#1)(2010-1#1)(2010-6#1)
the relationship##298##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-9#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1997-1#4)(1997-3#2)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#64)(2008-11#20)(2008-12#10)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#14)(2008-9#13)(2009-10#5)(2009-11#3)(2009-3#1)(2009-5#4)(2009-7#8)(2009-8#1)(2010-1#3)(2010-10#3)(2010-11#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#13)(2011-3#1)(2012-2#14)(2012-5#1)(2013-1#11)(2013-8#10)
the relationships among the##3##4##(2008-10#1)(2008-8#1)(2010-5#1)
the relationships among##8##3##(2008-10#1)(2008-11#1)(2008-8#2)(2010-5#1)(2010-7#1)(2011-2#2)
the relationships between physical##2##4##(2008-9#1)(2010-2#1)
the relationships between the##4##4##(1997-8#1)(2008-10#1)(2008-11#1)(2009-7#1)
the relationships between these##3##4##(2008-9#1)(2009-12#1)(2011-2#1)
the relationships between##38##3##(1992-1#1)(1992-3#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#2)(2009-7#2)(2010-1#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
the relationships of##2##3##(1996-2#1)(2008-9#1)
the relationships##56##2##(1992-1#1)(1992-3#2)(1993-11#1)(1993-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-8#1)(2008-10#9)(2008-11#4)(2008-7#1)(2008-8#4)(2008-9#5)(2009-12#2)(2009-7#2)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
the relative S##2##3##(2008-10#2)
the relative abundance and##2##4##(2008-10#1)(2012-6#1)
the relative abundance of different##2##5##(2008-10#1)(2008-8#1)
the relative abundance of##5##4##(1994-11#1)(2008-10#3)(2008-8#1)
the relative abundance##8##3##(1994-11#1)(1997-6#1)(2008-10#4)(2008-8#1)(2012-6#1)
the relative abundances of##2##4##(2008-8#1)(2008-9#1)
the relative activity of##2##4##(2008-11#1)(2010-12#1)
the relative amount of##2##4##(1992-6#1)(1994-8#1)
the relative amounts of the##2##5##(2008-7#1)(2011-3#1)
the relative amounts of##5##4##(1991-5#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-3#1)
the relative area under the##3##5##(2008-10#3)
the relative content##2##3##(1995-5#1)(2008-11#1)
the relative contribution of##5##4##(2008-10#3)(2009-1#1)(2011-2#1)
the relative contributions of##6##4##(2008-10#4)(2008-12#1)(2008-9#1)
the relative effects of##2##4##(1995-12#1)(2008-10#1)
the relative efficacy##2##3##(2008-10#1)(2008-7#1)
the relative error of##2##4##(2008-10#2)
the relative error##4##3##(2008-10#3)(2013-8#1)
the relative errors##2##3##(2008-10#2)
the relative expression levels##2##4##(2010-12#1)(2011-2#1)
the relative fluorescence intensity##2##4##(2008-10#2)
the relative fluorescence##3##3##(2008-10#3)
the relative formation##2##3##(2008-10#2)
the relative humidity (RH)##2##4##(2008-10#2)
the relative impedance##2##3##(2011-2#2)
the relative importance of habitat amount and arrangement##2##8##(2008-8#2)
the relative importance of the##4##5##(1992-2#1)(2008-10#2)(2011-1#1)
the relative importance of##20##4##(1992-2#1)(1994-2#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-3#1)
the relative importance##21##3##(1992-2#1)(1994-2#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
the relative influence of##2##4##(1996-3#1)(2008-10#1)
the relative intensity of##5##4##(2008-10#2)(2008-3#1)(2008-8#2)
the relative level of the##2##5##(1990-3#1)(1996-12#1)
the relative level of##3##4##(1990-3#1)(1996-12#1)(2008-10#1)
the relative levels of mRNA##2##5##(2008-7#2)
the relative performance of##2##4##(1994-1#1)(1994-9#1)
the relative performance##3##3##(1994-1#1)(1994-9#1)(2010-12#1)
the relative rates##2##3##(1995-6#1)(2008-10#1)
the relative risk of##2##4##(1991-7#1)(2008-5#1)
the relative risk##5##3##(1991-2#1)(1991-3#1)(1991-7#1)(1995-2#1)(2008-5#1)
the relative roles of##3##4##(2008-10#1)(2008-8#2)
the relative skin sensitizing potency of chemicals##2##7##(2008-5#2)
the relative skin sensitizing potency of##3##6##(2008-5#3)
the relative square error of prediction##2##6##(2008-10#2)
the relative standard deviation (R##17##5##(2008-10#17)
the relative standard deviation (RSD) is##2##6##(2008-10#2)
the relative standard deviation (RSD)##4##5##(2008-10#4)
the relative standard deviation for eight replicate measurements##2##8##(2008-10#2)
the relative standard deviation for eight##3##6##(2008-10#3)
the relative standard deviation for##9##5##(2008-10#9)
the relative standard deviation in##2##5##(2008-10#2)
the relative standard deviation is 4##2##6##(2008-10#2)
the relative standard deviation is##8##5##(2008-10#8)
the relative standard deviation of peak##2##6##(2008-10#2)
the relative standard deviation of##7##5##(2008-10#7)
the relative standard deviation was##8##5##(2008-10#8)
the relative standard deviation##64##4##(2008-10#64)
the relative standard deviations for##2##5##(2008-10#2)
the relative standard deviations##14##4##(2008-10#14)
the relative standard##82##3##(2008-10#82)
the relative strength of##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
the relative variation##2##3##(2008-8#1)(2009-10#1)
the relative##300##2##(1990-3#2)(1990-5#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-7#1)(1992-2#3)(1992-6#1)(1992-9#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-6#1)(2006-6#1)(2008-1#2)(2008-10#166)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#5)(2008-7#6)(2008-8#21)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-6#1)(2013-8#2)
the relatively high proportion of##2##5##(1990-12#1)(2008-9#1)
the relatively high##9##3##(1990-12#1)(1994-1#1)(1997-8#1)(2008-10#2)(2008-9#2)(2011-2#1)(2013-8#1)
the relatively large##2##3##(2008-10#1)(2008-11#1)
the relatively low##4##3##(2008-10#1)(2008-9#1)(2009-1#1)(2013-1#1)
the relatively slow##2##3##(2008-10#1)(2009-6#1)
the relatively small##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
the relatively##33##2##(1990-12#1)(1990-9#1)(1991-12#1)(1992-3#2)(1994-1#1)(1996-8#1)(1997-8#1)(2008-10#8)(2008-11#6)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
the relaxation effect##2##3##(2008-10#1)(2008-12#1)
the relaxation##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
the release and permeation of##2##5##(2008-5#2)
the release and##4##3##(2008-10#1)(2008-12#1)(2008-5#2)
the release of SPS##2##4##(2008-12#2)
the release of a##2##4##(2008-10#1)(2008-11#1)
the release of adenosine##2##4##(1996-2#2)
the release of anionic polymers##2##5##(2008-12#2)
the release of calcein##2##4##(1994-11#2)
the release of cyt c##2##5##(2011-2#2)
the release of intracellular##2##4##(2008-11#2)
the release of the##9##4##(1990-2#1)(1995-11#1)(2008-10#3)(2008-5#1)(2009-10#1)(2009-8#1)(2013-1#1)
the release of##76##3##(1990-12#3)(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-11#2)(1995-11#5)(1995-8#1)(1996-2#2)(1997-2#4)(1997-4#3)(2006-6#1)(2008-10#13)(2008-11#9)(2008-12#6)(2008-5#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#2)(2011-2#4)(2013-1#1)(2013-8#2)
the release rate and##2##4##(2008-10#1)(2008-5#1)
the release##93##2##(1990-12#3)(1990-2#1)(1990-5#3)(1991-2#1)(1991-5#1)(1992-12#2)(1992-6#2)(1993-6#1)(1993-8#1)(1994-11#2)(1995-11#5)(1995-8#1)(1996-2#2)(1997-2#4)(1997-4#3)(2006-6#1)(2008-10#18)(2008-11#10)(2008-12#7)(2008-5#10)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#2)(2011-2#4)(2013-1#2)(2013-8#2)
the released##5##2##(2008-10#2)(2008-5#2)(2008-7#1)
the relevance of such##2##4##(1992-12#1)(2008-8#1)
the relevance of the##2##4##(2008-10#1)(2011-2#1)
the relevance of these##6##4##(2008-10#2)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
the relevance of##26##3##(1990-3#1)(1992-12#1)(1993-2#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the relevance##29##2##(1990-3#1)(1992-12#1)(1993-2#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the relevant chemical##2##3##(2008-10#1)(2009-5#1)
the relevant literature##2##3##(1994-12#1)(2013-1#1)
the relevant##40##2##(1990-8#1)(1993-2#1)(1994-12#1)(1995-12#3)(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the reliability and validity of the##2##6##(1993-3#1)(2008-12#1)
the reliability and validity of##5##5##(1992-3#1)(1993-11#1)(1993-3#1)(2008-12#1)(2010-10#1)
the reliability and##7##3##(1992-3#1)(1993-11#1)(1993-3#1)(2008-12#1)(2008-3#1)(2010-10#1)(2012-3#1)
the reliability of a##4##4##(1992-12#1)(2008-10#3)
the reliability of the method##2##5##(2008-10#1)(2008-7#1)
the reliability of the##11##4##(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)
the reliability of these##2##4##(2008-10#2)
the reliability of##33##3##(1992-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-7#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-7#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
the reliability##45##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-7#1)(2008-10#15)(2008-11#3)(2008-12#6)(2008-3#1)(2008-7#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the reliable##3##2##(2008-10#2)(2011-2#1)
the relief##3##2##(2008-3#1)(2009-1#1)(2011-2#1)
the remainder of the##3##4##(1991-12#1)(1992-4#1)(2008-10#1)
the remainder##14##2##(1991-12#1)(1992-4#1)(1993-11#1)(1994-12#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
the remaining 10##2##3##(1991-3#1)(1993-3#1)
the remaining 10%##2##3##(1991-3#1)(2008-12#1)
the remaining 2##2##3##(1994-12#1)(2011-2#1)
the remaining 23 patients##2##4##(1991-3#1)(1994-9#1)
the remaining 3##2##3##(1993-12#1)(2008-8#1)
the remaining 30##2##3##(1996-1#1)(2013-1#1)
the remaining 7##2##3##(1993-6#1)(2011-2#1)
the remaining four##5##3##(1991-12#1)(1993-12#1)(2008-10#2)(2008-7#1)
the remaining part of the##2##5##(2011-2#2)
the remaining part##3##3##(2008-10#1)(2011-2#2)
the remaining seven##2##3##(1995-6#1)(2008-10#1)
the remaining##109##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-8#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(2008-10#39)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#5)(2008-8#4)(2009-8#1)(2010-3#1)(2011-10#1)(2011-2#6)(2012-3#2)(2012-4#1)(2013-1#6)(2013-8#2)
the remarkable##5##2##(2008-11#2)(2008-5#1)(2009-6#1)(2010-10#1)
the remission##4##2##(1991-2#1)(1992-2#1)(2008-10#1)(2011-2#1)
the remnant neck##3##3##(2013-1#3)
the remnant##5##2##(1991-1#2)(2013-1#3)
the removal of lead from water##2##6##(2011-2#2)
the removal of some of##2##5##(2008-5#1)(2009-12#1)
the removal of the##11##4##(1990-6#1)(1992-3#1)(2008-10#3)(2008-7#2)(2010-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
the removal of##44##3##(1990-6#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-8#2)(1995-11#1)(1995-6#1)(1996-1#1)(1997-7#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#5)(2013-1#2)(2013-7#1)
the renal parenchyma##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
the renal pelvis and##2##4##(2008-10#1)(2011-2#1)
the renal toxicity##3##3##(1994-5#3)
the renal##27##2##(1991-12#1)(1992-3#1)(1994-5#4)(1995-11#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
the reorganization##2##2##(1992-5#1)(2008-9#1)
the reorientation of the##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
the reoxidation##2##2##(2008-10#2)
the repK##2##2##(1997-6#2)
the repair of##4##3##(1992-5#1)(2008-11#2)(2011-2#1)
the repair##9##2##(1992-5#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
the repeat##4##2##(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)
the repeatability is##2##3##(2008-10#2)
the repeatability of measurements##4##4##(1996-3#1)(2008-10#3)
the repeatability of the##4##4##(2008-10#4)
the repeatability of##10##3##(1996-3#1)(2008-10#9)
the repeatability##18##2##(1996-3#1)(2008-10#17)
the repeated injection##2##3##(2008-11#1)(2008-8#1)
the repertoire of##3##3##(1991-2#1)(2008-11#1)(2011-1#1)
the repertoire##4##2##(1991-2#1)(2008-11#2)(2011-1#1)
the repertory grid technique##2##4##(2010-9#1)(2012-2#1)
the repetition of##2##3##(2011-2#2)
the repetition rate##2##3##(2008-2#1)(2008-3#1)
the repetition##4##2##(2008-2#1)(2008-3#1)(2011-2#2)
the repetitive##8##2##(1991-12#1)(2008-10#4)(2008-11#1)(2008-5#2)
the replacement of##6##3##(1993-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
the replacement##9##2##(1993-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2012-12#1)
the replicase##4##2##(2008-10#1)(2008-9#3)
the replicate analysis##2##3##(2008-10#2)
the replicate##3##2##(2008-10#3)
the replication and##2##3##(2013-1#2)
the replication fork##4##3##(1991-12#2)(1992-3#2)
the replication of HIV-1##2##4##(2011-3#2)
the replication of##8##3##(1995-2#1)(2008-10#1)(2008-11#4)(2011-3#2)
the replication terminator protein##2##4##(1993-9#2)
the replication terminator##3##3##(1993-9#3)
the replication##29##2##(1991-12#2)(1992-3#2)(1993-9#3)(1994-11#2)(1995-2#1)(1996-12#2)(2008-10#4)(2008-11#5)(2008-12#1)(2011-3#2)(2012-3#1)(2013-1#4)
the report is##2##3##(1990-11#1)(2011-2#1)
the report of##3##3##(1991-11#1)(2008-10#1)(2012-2#1)
the report##12##2##(1990-11#2)(1991-11#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
the reported cases of##2##4##(1994-9#1)(2011-2#1)
the reported cases##4##3##(1994-9#1)(2008-1#1)(2009-3#1)(2011-2#1)
the reported number of##2##4##(2008-7#1)(2013-1#1)
the reported##42##2##(1991-2#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-6#3)(1997-1#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#5)(2013-1#1)(2013-8#2)
the reporter gene##10##3##(1994-11#1)(2008-10#2)(2008-11#3)(2008-9#3)(2011-1#1)
the reporter protein##2##3##(2008-11#2)
the reporter##14##2##(1994-11#1)(2008-10#2)(2008-11#6)(2008-9#4)(2011-1#1)
the reporting of##4##3##(1997-3#1)(2010-6#1)(2013-7#1)(2013-8#1)
the reporting quality##2##3##(2011-2#2)
the reporting##12##2##(1994-2#1)(1997-3#1)(2008-10#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#3)(2013-7#1)(2013-8#1)
the reports##6##2##(1990-3#1)(1991-2#1)(2008-11#3)(2008-9#1)
the representation of space##2##4##(2009-10#2)
the representation of##6##3##(2008-10#1)(2008-11#3)(2009-10#2)
the representation##8##2##(2008-10#1)(2008-11#3)(2009-10#3)(2012-3#1)
the representative##5##2##(2008-10#4)(2013-8#1)
the repression of##4##3##(1992-8#1)(1995-12#1)(2008-10#1)(2008-11#1)
the repressor##3##2##(1992-4#1)(1994-3#1)(2008-11#1)
the reproducibility and accuracy of##2##5##(1991-3#1)(2008-10#1)
the reproducibility and##9##3##(1991-3#1)(2008-10#7)(2009-11#1)
the reproducibility is##4##3##(2008-10#4)
the reproducibility of the method##3##5##(2008-10#1)(2008-11#1)(2010-7#1)
the reproducibility of the##10##4##(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)
the reproducibility of##15##3##(2008-10#10)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2010-7#1)
the reproducibility was##4##3##(2008-10#4)
the reproducibility##39##2##(1991-3#1)(2008-10#32)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2010-5#1)(2010-7#1)
the reproducible##2##2##(2008-10#2)
the reproduction##3##2##(2008-10#2)(2010-5#1)
the reproductive organs##3##3##(2008-12#2)(2008-8#1)
the reproductive potential##2##3##(2008-10#1)(2013-8#1)
the reproductive success of##4##4##(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
the reproductive##28##2##(1991-1#1)(1991-12#1)(1993-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
the reprogramming of##2##3##(2009-3#1)(2010-7#1)
the request of##7##3##(1990-11#1)(1991-12#1)(1997-4#1)(2008-10#3)(2013-8#1)
the request##9##2##(1990-11#1)(1991-12#1)(1995-6#1)(1997-4#1)(2008-10#3)(2008-11#1)(2013-8#1)
the required level of accuracy##2##5##(2008-10#2)
the required level of confidence##2##5##(2008-10#2)
the required level of##5##4##(2008-10#4)(2008-5#1)
the required##32##2##(1991-2#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-1#1)(2008-10#9)(2008-11#4)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
the requirement for a##2##4##(1993-12#1)(2007-12#1)
the requirement for##13##3##(1992-8#1)(1993-12#1)(1996-1#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-11#2)(2008-8#1)(2010-1#1)(2010-11#1)(2010-7#1)(2013-8#1)
the requirement of##5##3##(1992-10#1)(2008-10#3)(2011-2#1)
the requirement that##2##3##(1992-9#1)(1997-8#1)
the requirement##21##2##(1992-10#1)(1992-8#1)(1992-9#1)(1993-12#1)(1996-1#1)(1997-5#1)(1997-8#2)(2007-12#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-8#1)
the requirements for the##3##4##(1990-8#1)(2008-10#1)(2013-1#1)
the requirements for##10##3##(1990-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-12#1)(2012-3#1)(2013-1#2)
the requirements of the##6##4##(1994-2#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
the requirements of##18##3##(1994-2#1)(1996-1#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#2)(2012-3#2)(2013-1#2)
the requirements to##2##3##(2013-1#1)(2013-8#1)
the requirements##35##2##(1990-8#1)(1991-1#1)(1991-12#1)(1993-11#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-9#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
the requisite##3##2##(1991-3#1)(1994-2#1)(2008-4#1)
the rescue effect##2##3##(2008-8#2)
the rescue##4##2##(1995-2#1)(2008-4#1)(2008-8#2)
the research and development##2##4##(2008-10#1)(2008-5#1)
the research and##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the research experience##2##3##(2009-4#2)
the research into##2##3##(1997-7#1)(2008-9#1)
the research literature##2##3##(2008-4#1)(2013-1#1)
the research of##5##3##(2008-11#1)(2008-9#1)(2009-5#1)(2010-12#2)
the research on##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2013-1#1)
the research participants##2##3##(1995-1#2)
the research process##4##3##(2008-12#1)(2009-4#2)(2010-8#1)
the research was##7##3##(1992-1#1)(1992-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
the research were##3##3##(2008-10#3)
the research##81##2##(1990-11#1)(1992-1#2)(1992-12#1)(1994-12#1)(1995-1#2)(1996-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#12)(2008-11#14)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-4#6)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
the researcher to##2##3##(2008-9#1)(2013-1#1)
the researcher##7##2##(1990-12#1)(1992-12#1)(1994-3#1)(2008-6#1)(2008-9#1)(2010-11#1)(2013-1#1)
the researcher's##3##2##(1997-1#1)(1997-6#1)(2008-4#1)
the researchers conducted two structured interviews per ward##2##8##(2013-1#2)
the researchers##6##2##(2008-11#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#2)
the resectability##2##2##(2008-7#1)(2013-8#1)
the resection of the##2##4##(1992-9#1)(2011-2#1)
the resection##5##2##(1990-11#1)(1991-3#1)(1992-9#1)(2008-5#1)(2011-2#1)
the reserve##2##2##(1992-12#1)(2008-10#1)
the reservoir powder inhaler##3##4##(1996-2#3)
the reservoir##11##2##(1996-2#3)(2008-10#7)(2008-12#1)
the reservoirs##2##2##(2011-2#2)
the residence##3##2##(1991-3#1)(2008-10#1)(2012-3#1)
the resident microflora##2##3##(2008-10#2)
the resident##8##2##(1995-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2013-1#1)
the residential##5##2##(1991-12#2)(1996-3#1)(2011-2#2)
the residents##3##2##(1995-3#1)(2008-1#1)(2008-12#1)
the residual##23##2##(1991-1#1)(1992-9#1)(1993-2#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-7#2)(2010-12#1)(2013-1#1)
the residue from##2##3##(2008-10#2)
the residue##6##2##(2008-10#5)(2009-5#1)
the residues##6##2##(1991-5#1)(1994-5#2)(2008-10#2)(2008-8#1)
the resin and the##4##4##(2008-10#3)(2010-4#1)
the resin and##5##3##(2008-10#4)(2010-4#1)
the resin for the##3##4##(2008-10#3)
the resin for##6##3##(2008-10#6)
the resin phase##6##3##(2008-10#6)
the resin was found##2##4##(2008-10#2)
the resin was##9##3##(2008-10#9)
the resin##56##2##(2008-10#54)(2010-4#1)(2013-1#1)
the resin-phase##4##2##(2008-10#4)
the resins##6##2##(2008-10#5)(2008-5#1)
the resistance allele##3##3##(2008-10#3)
the resistance and##3##3##(2008-10#3)
the resistance gene##11##3##(2008-10#10)(2012-3#1)
the resistance genes in##2##4##(2008-10#2)
the resistance genes##7##3##(2008-10#7)
the resistance index##2##3##(1992-6#1)(2012-3#1)
the resistance is##4##3##(2008-10#4)
the resistance locus##2##3##(2008-10#2)
the resistance mechanism##2##3##(2008-10#2)
the resistance of a##2##4##(2008-10#2)
the resistance of##18##3##(1991-5#1)(2008-10#14)(2008-9#3)
the resistance phenotype was##2##4##(2008-10#2)
the resistance to both##2##4##(2008-10#2)
the resistance to stripe rust was##2##6##(2008-10#2)
the resistance to##14##3##(1990-8#1)(1993-3#1)(1993-8#1)(2008-10#8)(2008-5#1)(2008-7#1)(2011-3#1)
the resistance was##3##3##(2008-10#3)
the resistance##92##2##(1990-8#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(2008-10#75)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)
the resistant accessions CIho##2##4##(2008-10#2)
the resistant and susceptible##4##4##(2008-10#4)
the resistant and##5##3##(2008-10#5)
the resistant cultivar##6##3##(2008-10#5)(2011-10#1)
the resistant cultivars##7##3##(2008-10#7)
the resistant cv##2##3##(2008-10#2)
the resistant cvs##2##3##(2008-10#2)
the resistant genotype##5##3##(2008-10#5)
the resistant genotypes##2##3##(2008-10#2)
the resistant line Hor2596 (CIho 1243)##2##6##(2008-10#2)
the resistant lines were##2##4##(2008-10#2)
the resistant lines##4##3##(2008-10#4)
the resistant parent##6##3##(2008-10#6)
the resistant winter##2##3##(2008-10#2)
the resistant##81##2##(1990-5#1)(1996-12#1)(2008-10#73)(2008-11#3)(2008-9#2)(2011-10#1)
the resolution and##2##3##(2008-11#1)(2010-9#1)
the resolution is##2##3##(2008-2#1)(2008-3#1)
the resolution of overlapping peaks##2##5##(2008-10#2)
the resolution of the##8##4##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)
the resolution of##26##3##(1996-12#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-3#2)(2008-7#1)(2010-3#1)
the resolution##40##2##(1996-11#1)(1996-12#1)(2007-12#1)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#1)
the resolutions##2##2##(2008-10#2)
the resolving power of the##2##5##(2008-10#2)
the resolving power##4##3##(2008-10#3)(2008-2#1)
the resolving##5##2##(2008-10#4)(2008-2#1)
the resonance##12##2##(1990-8#2)(2008-10#4)(2008-2#1)(2008-3#3)(2009-7#2)
the resonances##2##2##(1992-4#1)(2008-3#1)
the resonant frequency##2##3##(2008-10#1)(2009-5#1)
the resonant##8##2##(2008-10#2)(2008-3#5)(2009-5#1)
the resonator##6##2##(2008-2#2)(2008-3#2)(2009-5#2)
the resorption##2##2##(2008-12#1)(2008-7#1)
the resource##5##2##(1992-2#1)(2008-10#1)(2008-8#3)
the resource-based relative value scale (RBRVS)##2##6##(1994-12#2)
the resource-based relative value scale##3##5##(1992-1#1)(1994-12#2)
the resource-based##4##2##(1992-1#1)(1994-12#2)(2008-8#1)
the resources of##3##3##(1996-2#1)(2012-2#2)
the resources to##2##3##(1994-9#1)(2011-10#1)
the resources##12##2##(1994-3#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2011-10#1)(2012-2#2)
the respect##3##2##(1997-8#1)(2008-10#2)
the respective enzymes##2##3##(2010-7#1)(2011-2#1)
the respective##41##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-11#2)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-5#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
the respiratory activity of##3##4##(2008-10#1)(2008-5#2)
the respiratory burst##4##3##(1991-2#1)(1993-6#2)(1994-6#1)
the respiratory chain enzyme activities##2##5##(1994-11#2)
the respiratory chain##6##3##(1994-11#3)(1995-11#2)(1995-2#1)
the respiratory gases##2##3##(1997-1#2)
the respiratory mucosa##2##3##(1993-8#1)(1997-5#1)
the respiratory parameters##2##3##(2008-9#1)(2012-2#1)
the respiratory system##5##3##(1996-3#2)(2008-5#2)(2010-7#1)
the respiratory tract in##2##4##(1994-12#1)(2008-10#1)
the respiratory tract##13##3##(1992-3#1)(1992-9#1)(1994-12#3)(1996-1#3)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)
the respiratory##49##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#3)(1994-6#1)(1995-11#2)(1995-2#1)(1996-1#3)(1996-3#5)(1996-5#1)(1997-1#3)(1997-5#1)(2008-10#4)(2008-11#1)(2008-5#5)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)
the respondent##3##2##(2012-2#1)(2013-1#2)
the respondents##11##2##(1994-1#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2013-1#2)(2013-8#1)
the response at##3##3##(1995-11#1)(1996-12#1)(2008-10#1)
the response curve##2##3##(1997-2#1)(2008-10#1)
the response for##2##3##(2008-10#2)
the response function##2##3##(2008-10#2)
the response in##5##3##(1992-8#1)(1994-2#1)(1994-8#1)(1997-3#1)(2008-11#1)
the response induced##2##3##(1995-12#1)(1996-2#1)
the response is linear##2##4##(2008-10#1)(2008-3#1)
the response is##6##3##(2008-10#4)(2008-3#1)(2012-2#1)
the response latency for##2##4##(2008-11#2)
the response mechanism##2##3##(2008-10#2)
the response of a##2##4##(1996-2#1)(2008-10#1)
the response of endothelial cells to##2##6##(2008-11#1)(2010-1#1)
the response of the sensor to##2##6##(2008-10#2)
the response of the sensor##3##5##(2008-10#3)
the response of the##19##4##(1992-12#1)(1994-8#1)(2008-10#12)(2008-7#1)(2008-9#1)(2012-3#2)(2013-1#1)
the response of these##2##4##(2008-10#1)(2012-7#1)
the response of##70##3##(1991-3#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#34)(2008-11#6)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
the response properties of##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
the response rate##2##3##(1990-6#1)(1991-6#1)
the response surface##4##3##(2008-10#4)
the response time and##2##4##(2008-10#2)
the response time##6##3##(2008-10#6)
the response to a##2##4##(2008-11#1)(2009-8#1)
the response to the##3##4##(1997-2#1)(2008-1#1)(2008-10#1)
the response to##37##3##(1990-11#2)(1990-5#2)(1991-2#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-6#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#1)(2013-1#1)
the response was##4##3##(1995-8#1)(2008-10#2)(2008-11#1)
the response##195##2##(1990-11#2)(1990-5#3)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#5)(1996-2#3)(1997-2#2)(1997-3#3)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#89)(2008-11#16)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#7)(2008-8#8)(2008-9#3)(2009-10#3)(2009-8#2)(2010-1#1)(2011-2#2)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
the responses and##2##3##(2008-10#2)
the responses of plants to##2##5##(2008-10#1)(2008-8#1)
the responses of the##7##4##(1997-2#3)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)
the responses of##31##3##(1990-11#2)(1990-7#1)(1991-12#1)(1993-6#1)(1997-2#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#7)(2009-10#2)(2009-7#1)(2009-8#3)(2012-3#1)(2012-5#1)(2012-9#1)
the responses to##7##3##(1990-5#1)(1990-7#2)(1994-8#1)(2008-11#2)(2009-8#1)
the responses##51##2##(1990-11#2)(1990-5#1)(1990-7#3)(1991-12#1)(1991-6#1)(1993-6#1)(1994-8#1)(1997-2#3)(2008-10#10)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#4)(2010-11#1)(2012-3#1)(2012-5#1)(2012-9#1)(2013-1#1)
the responsibility for##3##3##(1992-1#1)(1993-11#1)(1994-12#1)
the responsibility of the##3##4##(1991-3#1)(1995-9#1)(2012-12#1)
the responsibility of##9##3##(1991-3#1)(1993-1#1)(1994-3#1)(1995-9#1)(2008-11#2)(2008-9#1)(2009-10#1)(2012-12#1)
the responsibility##13##2##(1991-3#1)(1992-1#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-9#1)(2008-11#2)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)
the responsible##4##2##(1990-3#1)(2008-10#2)(2008-12#1)
the responsiveness of##2##3##(1994-2#1)(1997-3#1)
the rest of the population##2##5##(2008-10#2)
the rest of the##22##4##(1991-5#1)(1991-8#2)(1992-3#1)(1993-12#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#4)(2012-9#1)(2013-1#1)
the rest of##30##3##(1991-5#1)(1991-8#2)(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#5)(2012-9#1)(2013-1#1)
the rest##43##2##(1991-1#1)(1991-5#1)(1991-8#2)(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#7)(2012-12#1)(2012-9#1)(2013-1#1)(2013-8#1)
the restenosis rate##3##3##(1992-9#1)(2008-12#2)
the resting limb##2##3##(2013-8#2)
the resting motor threshold##2##4##(2011-2#2)
the resting##10##2##(1991-3#1)(1992-6#1)(1994-3#2)(1995-5#1)(2011-2#2)(2013-8#3)
the restoration of the##4##4##(2008-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
the restoration of##12##3##(1990-12#1)(1991-5#1)(2008-10#3)(2008-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#2)
the restorative role of##3##4##(2008-12#3)
the restorative##4##2##(2008-12#3)(2013-1#1)
the restricted##5##2##(1993-12#1)(2008-10#3)(2008-5#1)
the restriction endonuclease##2##3##(1993-12#1)(1993-9#1)
the restriction fragment length##2##4##(2008-10#2)
the restriction##8##2##(1993-12#1)(1993-9#1)(1996-5#1)(2008-10#3)(2008-11#1)(2009-10#1)
the restrictive##3##2##(1995-9#1)(2011-1#1)(2012-3#1)
the restructuring##2##2##(1994-12#1)(1996-1#1)
the result for##2##3##(2008-3#1)(2013-1#1)
the result is##4##3##(1990-12#1)(1994-12#1)(2008-8#1)(2008-9#1)
the result of a##13##4##(1991-2#1)(1995-1#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#1)(2012-2#1)
the result of an increase in##2##6##(1997-1#2)
the result of both##2##4##(2008-10#1)(2008-8#1)
the result of the present study##2##6##(2009-12#1)(2012-3#1)
the result of the##12##4##(1990-2#1)(1991-12#1)(1994-5#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
the result of##75##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-2#2)(1996-5#1)(1997-1#3)(2007-12#2)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#5)(2009-12#1)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
the result that##2##3##(1992-2#1)(2011-2#1)
the result was##3##3##(2008-10#2)(2013-1#1)
the result##97##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-2#2)(1996-5#1)(1997-1#3)(2007-12#2)(2008-1#2)(2008-10#22)(2008-11#4)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#6)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
the resultant##21##2##(1991-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
the resulted##3##2##(2008-10#3)
the resulting &quot##2##3##(1991-2#1)(2009-10#1)
the resulting data##2##3##(1995-2#1)(2008-10#1)
the resulting solution is##4##4##(2008-10#4)
the resulting solution##5##3##(2008-10#5)
the resulting##111##2##(1990-12#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-8#1)(2008-10#50)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
the results achieved##3##3##(1991-3#1)(1995-2#1)(1997-6#1)
the results also##3##3##(2008-10#3)
the results and##8##3##(1994-3#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#2)(2011-3#1)
the results are##17##3##(1993-12#1)(1996-2#1)(2008-10#10)(2008-11#1)(2008-3#1)(2010-12#1)(2010-8#1)(2012-2#1)
the results based on the##2##5##(2008-2#1)(2008-3#1)
the results between##2##3##(2010-6#1)(2013-1#1)
the results by molecular replacement##2##5##(2008-8#2)
the results by##4##3##(1996-5#1)(2008-1#1)(2008-8#2)
the results cannot be##2##4##(1996-2#1)(2008-11#1)
the results demonstrated that##3##4##(2008-10#2)(2008-8#1)
the results demonstrated##4##3##(2008-10#3)(2008-8#1)
the results for each##2##4##(2008-10#1)(2008-5#1)
the results for the##2##4##(2008-10#1)(2008-3#1)
the results for##11##3##(2008-10#6)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)
the results found##2##3##(2008-10#2)
the results from a series of##2##6##(2008-10#1)(2008-11#1)
the results from the alternative##2##5##(2008-10#1)(2008-5#1)
the results from the##7##4##(1996-3#1)(2008-10#4)(2008-2#1)(2008-5#1)
the results from##14##3##(1996-3#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#1)(2013-1#1)
the results have been##2##4##(2008-10#1)(2010-8#1)
the results in##4##3##(2008-10#2)(2009-9#1)(2013-1#1)
the results indicate that##6##4##(1990-8#1)(1993-2#1)(1995-11#1)(1995-2#1)(1997-2#1)(2013-1#1)
the results indicate##8##3##(1990-8#1)(1991-6#1)(1993-2#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-1#1)(2013-1#1)
the results indicated that##3##4##(2008-8#1)(2011-3#1)(2012-2#1)
the results indicated##4##3##(2008-10#1)(2008-8#1)(2011-3#1)(2012-2#1)
the results is##5##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-7#1)
the results may##2##3##(1997-1#1)(2012-2#1)
the results obtained after##2##4##(2008-10#2)
the results obtained are##2##4##(2008-10#2)
the results obtained by means of##2##6##(2008-10#2)
the results obtained by the developed##2##6##(2008-10#2)
the results obtained by the two##2##6##(2008-10#2)
the results obtained by the##11##5##(2008-10#11)
the results obtained by this##2##5##(2008-10#2)
the results obtained by##27##4##(1990-5#1)(1993-11#1)(2008-10#25)
the results obtained for the##2##5##(2008-10#2)
the results obtained for##4##4##(2008-10#4)
the results obtained from in vivo##2##6##(2008-10#1)(2008-11#1)
the results obtained from##5##4##(1995-11#1)(2008-10#3)(2008-11#1)
the results obtained in the analysis of##2##7##(2008-10#2)
the results obtained in the##4##5##(2008-10#3)(2008-5#1)
the results obtained in this##2##5##(2008-10#1)(2011-2#1)
the results obtained in##11##4##(2008-10#6)(2008-11#1)(2008-5#2)(2011-2#1)(2013-8#1)
the results obtained showed##2##4##(2008-10#2)
the results obtained using the##3##5##(2008-10#3)
the results obtained using##5##4##(2008-10#5)
the results obtained were##3##4##(2008-10#3)
the results obtained with the##6##5##(2008-10#5)(2013-1#1)
the results obtained with##11##4##(1992-6#1)(2007-12#1)(2008-10#8)(2013-1#1)
the results obtained##87##3##(1990-5#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#70)(2008-11#2)(2008-5#3)(2011-2#2)(2013-1#1)(2013-8#1)
the results of Gram staining##2##5##(2010-6#2)
the results of Western blotting##3##5##(2008-8#1)(2008-9#2)
the results of a clinical study##2##6##(1990-5#2)
the results of a meta-analysis of##2##6##(1997-7#1)(2008-9#1)
the results of a recent survey##3##6##(1992-3#1)(1995-1#1)(1995-2#1)
the results of a study of##2##6##(1992-1#1)(2009-8#1)
the results of a study##6##5##(1992-1#1)(1993-3#1)(1996-1#1)(2008-5#1)(2009-8#1)(2010-9#1)
the results of a survey conducted##2##6##(1997-3#1)(2008-11#1)
the results of a survey of##2##6##(1994-12#1)(1994-3#1)
the results of a survey##6##5##(1993-12#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-11#1)
the results of a##45##4##(1990-5#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-3#2)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
the results of an##4##4##(1993-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
the results of clinical##2##4##(1995-1#1)(2013-1#1)
the results of different##2##4##(2008-11#1)(2008-9#1)
the results of empirical##2##4##(2008-8#1)(2008-9#1)
the results of immunohistochemical##2##4##(1997-8#1)(2008-5#1)
the results of other##3##4##(1994-2#1)(1997-4#1)(2013-8#1)
the results of our##6##4##(1990-9#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#2)
the results of previous studies##2##5##(2008-10#1)(2008-11#1)
the results of studies on##2##5##(2008-10#1)(2008-12#1)
the results of studies##4##4##(2008-10#3)(2008-12#1)
the results of such##2##4##(2013-1#1)(2013-7#1)
the results of the first##4##5##(1990-2#1)(1995-3#1)(2008-5#1)(2013-8#1)
the results of the pilot##2##5##(1993-1#1)(2010-9#1)
the results of the##38##4##(1990-2#1)(1990-9#1)(1991-3#1)(1992-5#1)(1993-1#1)(1995-12#1)(1995-3#1)(1996-6#2)(1997-3#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-7#1)(2013-1#2)(2013-8#1)
the results of their research##2##5##(1990-9#1)(1996-1#1)
the results of their##3##4##(1990-9#1)(1991-1#1)(1996-1#1)
the results of these analyses##2##5##(1995-5#1)(1996-1#1)
the results of these experiments##2##5##(2008-10#2)
the results of these##4##4##(1995-5#1)(1996-1#1)(2008-10#2)
the results of this study are##2##6##(1996-12#1)(1996-2#1)
the results of this study suggest that##2##7##(2009-4#1)(2009-7#1)
the results of this study##12##5##(1991-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2009-4#1)(2009-7#1)(2011-3#1)
the results of this##16##4##(1991-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-11#1)(2009-4#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#1)
the results of treating##2##4##(1996-11#1)(2013-1#1)
the results of two##4##4##(1991-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
the results of##239##3##(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1996-1#4)(1996-11#3)(1996-12#3)(1996-2#1)(1996-6#3)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#49)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#9)(2009-10#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-6#3)(2010-8#2)(2010-9#2)(2011-2#11)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#7)
the results provide##2##3##(1993-6#1)(1995-2#1)
the results reported in the literature##2##6##(1994-6#1)(2013-1#1)
the results reported in##4##4##(1991-2#1)(1994-6#1)(2008-10#1)(2013-1#1)
the results reported##7##3##(1990-11#1)(1991-2#1)(1994-6#1)(2008-10#2)(2008-5#1)(2013-1#1)
the results revealed that##3##4##(2008-10#2)(2010-1#1)
the results show that the##5##5##(1994-1#1)(2008-10#1)(2008-8#2)(2010-7#1)
the results show that##8##4##(1994-1#1)(2008-10#3)(2008-11#1)(2008-8#2)(2010-7#1)
the results show##10##3##(1994-1#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-8#2)(2010-7#1)
the results showed that the##3##5##(2008-10#2)(2008-8#1)
the results showed that##6##4##(2008-10#5)(2008-8#1)
the results showed##12##3##(1996-12#1)(2008-10#9)(2008-8#1)(2011-2#1)
the results strongly##2##3##(2008-10#1)(2008-8#1)
the results suggest that the##4##5##(1993-12#1)(1993-6#1)(2008-11#1)(2010-1#1)
the results suggest that##5##4##(1993-12#1)(1993-6#1)(2008-11#1)(2009-8#1)(2010-1#1)
the results suggest##6##3##(1993-12#1)(1993-6#1)(2008-11#1)(2009-8#1)(2010-1#1)(2010-4#1)
the results that##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
the results to those##2##4##(1991-3#1)(1994-2#1)
the results to##6##3##(1991-3#1)(1994-2#1)(1997-2#1)(2008-11#1)(2008-4#1)(2009-7#1)
the results using##3##3##(2008-10#2)(2008-8#1)
the results varied##2##3##(2008-10#1)(2009-12#1)
the results was##4##3##(2008-10#3)(2008-3#1)
the results were also##2##4##(2008-10#1)(2008-5#1)
the results were compared with the##2##6##(1996-3#1)(2008-10#1)
the results were compared with those obtained by##2##8##(2008-10#2)
the results were compared with those obtained##3##7##(2008-10#3)
the results were compared with those##4##6##(2008-10#4)
the results were compared with##10##5##(1996-3#1)(2008-10#8)(2012-3#1)
the results were compared##15##4##(1994-3#1)(1996-3#1)(2008-10#12)(2012-3#1)
the results were consistent with##2##5##(2008-10#1)(2008-8#1)
the results were consistent##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
the results were in good agreement with those##4##8##(2008-10#4)
the results were in good agreement with##6##7##(2008-10#6)
the results were in##11##4##(2008-10#11)
the results were similar to##2##5##(2008-10#2)
the results were similar##3##4##(2008-10#2)(2008-5#1)
the results were##51##3##(1990-12#1)(1994-3#1)(1994-5#1)(1996-3#1)(1997-2#1)(2008-10#39)(2008-5#2)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
the results with those obtained by the##2##7##(2008-10#2)
the results with those of##2##5##(2008-10#1)(2010-11#1)
the results with those##6##4##(2008-10#4)(2008-5#1)(2010-11#1)
the results with##12##3##(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)
the results within##2##3##(2008-3#1)(2010-6#1)
the results##648##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#4)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#6)(1991-6#2)(1991-9#3)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#2)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#2)(1996-1#4)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#4)(1996-6#4)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#3)(2008-1#3)(2008-10#266)(2008-11#23)(2008-12#5)(2008-2#5)(2008-3#21)(2008-4#6)(2008-5#24)(2008-6#3)(2008-7#8)(2008-8#24)(2008-9#17)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#7)(2010-7#2)(2010-8#5)(2010-9#2)(2011-2#19)(2011-3#4)(2011-7#2)(2012-12#1)(2012-2#7)(2012-3#7)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#8)
the resuscitation of##2##3##(1994-6#2)
the retailing##2##2##(1994-12#2)
the retained##10##2##(1991-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2009-12#1)
the retention and separation of##2##5##(2008-10#2)
the retention and##6##3##(2008-10#6)
the retention behavior##6##3##(2008-10#6)
the retention behaviour##2##3##(2008-10#2)
the retention mechanism##3##3##(2008-10#3)
the retention of##16##3##(1994-1#1)(1995-11#1)(1997-4#1)(2008-10#10)(2008-11#1)(2009-6#1)(2011-2#1)
the retention performance##2##3##(1994-8#1)(2008-11#1)
the retention process##2##3##(2008-10#2)
the retention time of the##2##5##(2008-10#1)(2008-11#1)
the retention time##3##3##(2008-10#2)(2008-11#1)
the retention times of##2##4##(1992-6#1)(2008-10#1)
the retention times##5##3##(1992-6#3)(2008-10#2)
the retention##52##2##(1992-6#3)(1994-1#1)(1994-8#1)(1995-11#1)(1997-4#1)(2008-10#39)(2008-11#4)(2009-6#1)(2011-2#1)
the reticular##2##2##(1996-12#1)(2013-1#1)
the retina and##2##3##(2008-1#1)(2011-2#1)
the retina of the##2##4##(2008-5#1)(2010-1#1)
the retina of##4##3##(1991-10#1)(2008-5#1)(2010-1#2)
the retina##26##2##(1991-10#1)(1993-3#1)(2008-1#1)(2008-5#7)(2008-7#2)(2009-12#2)(2010-1#5)(2011-2#3)(2011-7#2)(2012-3#1)(2013-1#1)
the retinal pigment epithelium##3##4##(2008-7#1)(2011-7#2)
the retinal pigment##4##3##(2008-7#1)(2011-2#1)(2011-7#2)
the retinal##11##2##(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#3)(2011-7#3)
the retinoic acid##2##3##(1991-9#1)(2013-1#1)
the retinol deficient group##4##4##(1994-8#4)
the retinol deficient##5##3##(1994-8#5)
the retrieval of##6##3##(2007-12#1)(2008-11#1)(2008-3#4)
the retrieval procedure##2##3##(2008-2#1)(2008-3#1)
the retrieval##13##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#10)
the retrieved##9##2##(2008-2#1)(2008-3#7)(2008-8#1)
the retrograde##2##2##(1992-12#1)(1997-2#1)
the retroperitoneal cavity##2##3##(2012-12#1)(2012-3#1)
the retroperitoneal##4##2##(2008-10#1)(2012-12#1)(2012-3#2)
the retroperitoneum##3##2##(1992-12#1)(2009-1#1)(2009-9#1)
the retrospective##3##2##(1996-11#1)(2008-11#1)(2012-3#1)
the retroviral##5##2##(1995-2#1)(2008-11#3)(2008-9#1)
the retrovirus##3##2##(2008-11#2)(2008-5#1)
the return of the##2##4##(1997-3#1)(2008-8#1)
the return##8##2##(1990-9#1)(1992-1#1)(1995-12#1)(1997-3#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)
the returning traveler##2##3##(2010-12#2)
the reusability of the##2##4##(2008-10#1)(2010-4#1)
the reverberation##2##2##(2008-11#2)
the reversal of tolerance##2##4##(1996-2#2)
the reversal of##4##3##(1996-2#2)(2009-10#1)(2012-12#1)
the reverse reaction##2##3##(1995-6#1)(2008-3#1)
the reverse##18##2##(1991-8#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-7#1)(2013-1#1)
the reversed-phase##6##2##(2008-10#6)
the reversibility of the sensor##2##5##(2008-10#2)
the reversibility of the##4##4##(2008-10#4)
the reversible inhibition of##2##4##(1993-6#1)(2008-10#1)
the reversible##9##2##(1990-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1997-2#1)(2008-10#4)
the review and##2##3##(1992-1#1)(2012-3#1)
the review of##4##3##(2008-11#2)(2009-5#1)(2010-7#1)
the review##26##2##(1992-1#2)(1994-8#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-11#8)(2008-3#1)(2009-5#1)(2010-7#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
the revised European##2##3##(2010-11#1)(2011-2#1)
the revised##15##2##(1992-1#2)(1992-2#2)(1993-6#2)(1995-12#1)(2008-3#1)(2008-9#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
the revision of the##5##4##(1992-9#1)(1993-6#1)(2008-10#1)(2011-2#1)(2011-3#1)
the revision of##6##3##(1992-9#1)(1993-6#1)(2008-10#1)(2011-2#1)(2011-3#1)(2013-1#1)
the revision##7##2##(1992-9#1)(1993-6#1)(2008-10#1)(2011-2#1)(2011-3#1)(2013-1#2)
the reward presentation##2##3##(2009-8#2)
the reward##4##2##(1993-6#1)(2009-8#2)(2010-10#1)
the rewarding##2##2##(1991-1#1)(1996-5#1)
the rhabdom##2##2##(2007-12#2)
the rheological behavior##2##3##(2008-5#2)
the rheological properties of##2##4##(2008-5#1)(2011-2#1)
the rheological properties##3##3##(2008-5#2)(2011-2#1)
the rheological##7##2##(1994-8#1)(2008-5#4)(2011-2#2)
the rheology of##2##3##(2008-5#2)
the rheology##3##2##(2008-5#3)
the rhetoric##2##2##(1995-12#1)(2008-11#1)
the rhizosphere abundance of##2##4##(2008-10#2)
the rhizosphere of apple##2##4##(2008-10#2)
the rhizosphere of wheat##4##4##(2008-10#4)
the rhizosphere of##13##3##(2008-10#13)
the rhizosphere populations of##2##4##(2008-10#2)
the rhizosphere soil and##2##4##(2008-10#2)
the rhizosphere soil##3##3##(2008-10#3)
the rhizosphere##33##2##(2008-10#30)(2008-12#2)(2009-8#1)
the rhizospheres of##4##3##(2008-10#4)
the rho##2##2##(1992-11#1)(1995-11#1)
the rhythm reversal##2##3##(2008-6#2)
the rhythm##5##2##(1994-2#1)(2008-5#2)(2008-6#2)
the rhythmic bladder contractions##2##4##(1992-3#2)
the riboflavin##3##2##(2008-9#2)(2012-3#1)
the ribosomal DNA##4##3##(2008-10#4)
the ribosomal RNA##2##3##(2008-10#2)
the ribosomal protein##2##3##(2008-11#1)(2008-8#1)
the ribosomal##12##2##(2008-10#10)(2008-11#1)(2008-8#1)
the ribosome##2##2##(1997-7#1)(2010-6#1)
the ribosome-activated ATPase activity of EF-3##2##6##(1996-2#2)
the ribosome-inactivating proteins##2##3##(1990-12#2)
the ribozyme activity##2##3##(1994-11#2)
the ribozyme##11##2##(1993-9#3)(1994-11#6)(2008-9#2)
the ribs##2##2##(1991-11#1)(2013-1#1)
the rice blast fungus##4##4##(2008-10#4)
the rice blast##5##3##(2008-10#5)
the rice genome##10##3##(1996-8#2)(2008-8#1)(2008-9#4)(2009-10#3)
the rice##29##2##(1996-8#2)(2008-10#10)(2008-8#3)(2008-9#9)(2009-10#5)
the rich##6##2##(1992-12#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#2)
the richest##2##2##(2008-10#1)(2011-3#1)
the right and left##5##4##(1996-2#1)(2008-10#1)(2010-6#1)(2013-1#2)
the right and##8##3##(1996-2#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#2)(2013-1#2)
the right anterior insula##2##4##(2008-11#2)
the right arm of chromosome##5##5##(1995-9#1)(1996-3#1)(1996-6#3)
the right arm of##6##4##(1995-9#1)(1996-3#2)(1996-6#3)
the right arm##8##3##(1995-9#1)(1996-3#2)(1996-6#4)(2010-9#1)
the right atrium and ventricle##2##5##(2008-11#1)(2012-3#1)
the right atrium and##3##4##(2008-11#1)(2012-3#1)(2013-1#1)
the right atrium##7##3##(2008-11#1)(2012-3#1)(2013-1#3)(2013-2#2)
the right breast##3##3##(1994-12#1)(2008-10#2)
the right cerebral hemisphere##2##4##(2013-8#2)
the right external##2##3##(1996-9#1)(2013-7#1)
the right eye##6##3##(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
the right foot##2##3##(2008-12#1)(2008-5#1)
the right hand##2##3##(1997-3#1)(2008-11#1)
the right hemi-brain##2##3##(2008-7#2)
the right hemisphere##4##3##(1996-2#3)(2008-11#1)
the right hepatic##2##3##(1991-6#1)(2013-1#1)
the right kidney##2##3##(1990-9#1)(1994-5#1)
the right lobe of the liver##2##6##(1993-6#1)(2012-2#1)
the right lobe of##3##4##(1993-6#1)(2008-12#1)(2012-2#1)
the right lobe##4##3##(1993-6#1)(2008-11#1)(2008-12#1)(2012-2#1)
the right lung##2##3##(2008-1#1)(2010-7#1)
the right medial malleolus##2##4##(2010-6#2)
the right middle cerebral artery##6##5##(1996-3#1)(2008-12#1)(2008-7#3)(2013-8#1)
the right middle##10##3##(1996-2#1)(1996-3#2)(2008-12#2)(2008-7#3)(2013-1#1)(2013-8#1)
the right radial##2##3##(2008-11#1)(2011-2#1)
the right side of the##2##5##(2010-4#1)(2011-2#1)
the right side##9##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#1)(2013-7#1)
the right sphenoparietal sinus##3##4##(1996-9#3)
the right subclavian##2##3##(2008-11#2)
the right superior##2##3##(1996-9#1)(2013-8#1)
the right to##5##3##(1990-11#1)(1994-2#1)(1995-12#1)(1996-5#1)(2013-1#1)
the right upper##3##3##(2010-9#1)(2011-2#1)(2013-1#1)
the right ventricle##5##3##(1995-12#1)(2008-11#1)(2009-10#1)(2010-10#1)(2012-3#1)
the right##195##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#2)(1993-1#2)(1993-12#4)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#6)(1996-3#9)(1996-5#1)(1996-6#4)(1996-9#6)(1997-1#2)(1997-3#2)(1997-5#1)(2006-6#1)(2008-1#1)(2008-10#10)(2008-11#20)(2008-12#11)(2008-5#5)(2008-7#10)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#3)(2010-9#3)(2011-1#1)(2011-2#14)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#15)(2013-2#4)(2013-7#3)(2013-8#6)
the rights of##2##3##(2008-11#1)(2009-11#1)
the rights##3##2##(1993-9#1)(2008-11#1)(2009-11#1)
the rigidity of##3##3##(2008-10#1)(2008-12#2)
the rigidity##4##2##(2008-10#1)(2008-12#3)
the rim##2##2##(1996-9#1)(2008-11#1)
the ring sinus##2##3##(2011-2#2)
the ring system##2##3##(1993-12#2)
the ring##7##2##(1993-12#2)(1994-12#1)(1996-2#1)(2011-1#1)(2011-2#2)
the ring-disk##2##2##(2008-10#2)
the rise in [Ca2+] induced by##2##6##(1991-6#2)
the rise in incidence##2##4##(1991-12#1)(1995-2#1)
the rise in temperature##2##4##(2008-2#1)(2008-3#1)
the rise in##12##3##(1990-7#1)(1991-12#1)(1991-6#2)(1993-3#1)(1994-2#1)(1995-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-8#1)
the rise of##4##3##(1994-2#2)(2008-11#1)(2010-7#1)
the rise##20##2##(1990-7#1)(1991-12#1)(1991-6#2)(1993-3#1)(1993-5#1)(1994-2#3)(1995-12#1)(1995-2#1)(2008-11#4)(2008-2#1)(2008-3#1)(2010-7#1)(2010-8#1)(2012-2#1)
the rising##2##2##(2008-10#1)(2012-3#1)
the risk analysis##3##3##(2008-10#1)(2012-2#2)
the risk assessment##5##3##(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)
the risk factor##6##3##(1991-6#1)(1992-11#1)(1994-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
the risk factors and##4##4##(1993-2#1)(2009-7#1)(2010-6#1)(2012-3#1)
the risk factors associated with##4##5##(2008-1#1)(2009-7#1)(2011-2#1)(2012-3#1)
the risk factors for##4##4##(1996-2#1)(2008-10#1)(2008-11#1)(2010-10#1)
the risk factors##15##3##(1993-2#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2009-7#2)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#2)
the risk for a##2##4##(1997-8#1)(2008-10#1)
the risk for developing##2##4##(2009-8#1)(2013-1#1)
the risk for##13##3##(1995-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-10#1)(2009-8#1)(2012-2#3)(2013-1#1)
the risk is##2##3##(2008-9#1)(2010-7#1)
the risk manager's role##2##4##(1995-1#1)(1996-1#1)
the risk of HCC in##2##5##(2008-11#2)
the risk of HIV##2##4##(1995-6#2)
the risk of PIH##2##4##(1994-3#2)
the risk of adverse##2##4##(2007-11#1)(2010-6#1)
the risk of atherosclerosis##2##4##(2008-6#2)
the risk of cancer##7##4##(1990-8#1)(1994-2#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#2)
the risk of cerebral##2##4##(2008-7#1)(2013-1#1)
the risk of complications##4##4##(1990-11#1)(2007-11#1)(2011-2#1)(2013-1#1)
the risk of contamination##3##4##(2008-10#2)(2008-11#1)
the risk of death##3##4##(1997-3#1)(2011-3#2)
the risk of developing##7##4##(1995-9#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-12#1)
the risk of early##2##4##(2011-2#1)(2012-3#1)
the risk of fracture##2##4##(2008-11#2)
the risk of gastric cancer in patients with##2##8##(2008-12#2)
the risk of gastric cancer##3##5##(1997-1#1)(2008-12#2)
the risk of haemorrhage##2##4##(1992-6#1)(1996-6#1)
the risk of human##2##4##(2008-8#1)(2010-11#1)
the risk of infection through##2##5##(2008-10#1)(2011-2#1)
the risk of infection##4##4##(1994-6#1)(2008-10#2)(2011-2#1)
the risk of major##2##4##(2008-10#1)(2010-1#1)
the risk of non-compliance##2##4##(2008-10#1)(2012-2#1)
the risk of perioperative##2##4##(2009-5#2)
the risk of postoperative##2##4##(2007-8#1)(2008-7#1)
the risk of progression##2##4##(2008-9#1)(2013-8#1)
the risk of raised ICP##2##5##(2010-5#2)
the risk of recurrence##3##4##(1992-1#1)(1996-11#1)(2011-2#1)
the risk of recurrent##2##4##(2008-8#1)(2009-12#1)
the risk of serious##2##4##(2008-11#2)
the risk of specific##2##4##(2011-3#1)(2013-1#1)
the risk of stroke##3##4##(2008-8#2)(2008-9#1)
the risk of treatment##2##4##(1993-9#1)(2008-7#1)
the risk of##188##3##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#3)(1994-6#2)(1995-1#1)(1995-6#3)(1995-9#1)(1996-11#2)(1996-3#4)(1996-6#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#16)(2008-12#9)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#10)(2008-9#6)(2009-12#4)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#2)(2010-7#1)(2011-2#16)(2011-3#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#15)(2013-8#9)
the risk to##2##3##(1991-12#1)(2010-7#1)
the risk##261##2##(1990-11#1)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-2#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-6#2)(1995-1#2)(1995-12#1)(1995-6#3)(1995-9#2)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#4)(1996-6#2)(1997-1#1)(1997-3#3)(1997-4#1)(1997-8#2)(2007-11#3)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#23)(2008-12#11)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#10)(2008-9#7)(2009-10#3)(2009-12#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#3)(2010-7#3)(2011-2#22)(2011-3#3)(2012-12#3)(2012-2#11)(2012-3#5)(2013-1#17)(2013-8#9)
the risk/benefit##2##2##(2011-1#1)(2013-1#1)
the risk/return dynamics##2##3##(2008-11#2)
the risks and benefits of##5##5##(2008-11#2)(2010-12#2)(2011-2#1)
the risks and##7##3##(1997-5#1)(2008-1#1)(2008-11#2)(2010-12#2)(2011-2#1)
the risks associated with the##2##5##(2008-10#1)(2008-11#1)
the risks associated with##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
the risks of the##2##4##(1994-6#1)(2008-4#1)
the risks of##16##3##(1993-11#1)(1994-6#2)(1996-6#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2013-1#1)
the risks posed##2##3##(2008-11#1)(2010-10#1)
the risks##42##2##(1992-3#1)(1993-11#1)(1993-2#1)(1994-6#2)(1996-6#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
the ritual##2##2##(2009-10#1)(2013-1#1)
the river water##5##3##(2008-10#5)
the river##10##2##(2008-10#9)(2010-8#1)
the rms##3##2##(1992-4#1)(2008-3#1)(2008-8#1)
the road to##2##3##(1995-1#1)(2009-12#1)
the road traffic##2##3##(2010-11#2)
the road##6##2##(1995-1#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-11#2)
the robust##8##2##(2008-1#1)(2008-10#5)(2008-12#1)(2009-8#1)
the robustness of the method##2##5##(2008-10#2)
the robustness of the##8##4##(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)
the robustness of this##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
the robustness of##20##3##(1994-9#1)(2008-10#9)(2008-11#5)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)
the robustness##23##2##(1994-9#2)(1995-11#1)(2008-10#10)(2008-11#5)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)
the rock certified materials##2##4##(2008-10#2)
the rock##3##2##(2008-10#3)
the rockwool##2##2##(2008-10#2)
the rod##5##2##(1997-2#3)(2008-12#1)(2008-8#1)
the rodent##8##2##(1995-12#1)(1995-9#2)(1997-2#1)(2008-11#2)(2010-11#2)
the rods##2##2##(2008-8#1)(2009-7#1)
the role and function of##2##5##(1990-12#1)(1993-1#1)
the role and##13##3##(1990-12#1)(1992-12#2)(1992-3#1)(1993-1#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#2)
the role by##2##3##(1995-2#1)(2012-3#1)
the role of FcgammaR##2##4##(2008-10#2)
the role of Helicobacter pylori##2##5##(1992-5#2)
the role of MTs in##2##5##(2008-11#1)(2013-7#1)
the role of TSPO in##2##5##(2012-2#2)
the role of an##3##4##(1990-9#1)(2008-7#1)(2010-4#1)
the role of attention##2##4##(1996-2#1)(2013-8#1)
the role of atypical antipsychotics in##2##6##(2008-8#2)
the role of community##2##4##(2012-12#1)(2012-2#1)
the role of complex##2##4##(1995-2#1)(2008-10#1)
the role of different##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
the role of endogenous cytokines##2##5##(1996-12#2)
the role of epigenetic factors##2##5##(2008-11#1)(2011-9#1)
the role of general cognitive style##2##6##(2010-1#2)
the role of general##3##4##(1990-12#1)(2010-1#2)
the role of genes in##2##5##(2008-2#1)(2012-3#1)
the role of genetic##2##4##(1997-8#1)(2008-8#1)
the role of health##2##4##(1993-12#1)(2008-11#1)
the role of hypocalcemia##2##4##(2011-2#2)
the role of intracellular##3##4##(1995-8#2)(2009-6#1)
the role of multiple##2##4##(2008-10#1)(2008-11#1)
the role of natural selection##2##5##(2010-4#1)(2010-5#1)
the role of oncogenes in drug resistance##2##7##(2008-11#2)
the role of public health##2##5##(1996-2#1)(1997-3#1)
the role of relatedness##2##4##(2008-8#1)(2010-4#1)
the role of social##2##4##(1991-1#1)(2011-2#1)
the role of stem cells##2##5##(2010-12#1)(2013-7#1)
the role of structural##2##4##(2008-7#1)(2011-3#1)
the role of the different##2##5##(1995-12#1)(2011-2#1)
the role of the host in##2##6##(2008-10#1)(2011-2#1)
the role of the media##2##5##(1993-12#1)(2008-11#1)
the role of the medical provider##2##6##(2013-1#2)
the role of the##64##4##(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-12#3)(1995-2#2)(1995-6#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-5#3)(2008-6#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#2)
the role of these proteins in##2##6##(1995-2#2)
the role of these##16##4##(1991-2#1)(1992-3#1)(1995-2#2)(1995-6#1)(2008-10#4)(2008-11#2)(2011-1#2)(2011-2#1)(2013-8#2)
the role of tumor##2##4##(1990-12#1)(2009-12#1)
the role of women##2##4##(1992-12#1)(1993-6#1)
the role of##407##3##(1990-12#4)(1990-2#1)(1990-6#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#2)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#3)(1992-6#2)(1992-9#2)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#6)(1995-6#2)(1995-8#5)(1996-11#1)(1996-12#3)(1996-2#3)(1997-2#4)(1997-3#2)(1997-5#2)(1997-7#2)(1997-8#3)(2006-6#2)(2007-12#1)(2008-1#3)(2008-10#42)(2008-11#37)(2008-12#13)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#13)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#5)(2009-4#2)(2009-6#5)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#2)(2010-12#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#26)(2011-3#3)(2011-9#2)(2012-12#1)(2012-2#16)(2012-3#12)(2013-1#15)(2013-2#1)(2013-7#4)(2013-8#17)
the role played by the##3##5##(2008-10#2)(2008-11#1)
the role played by##8##4##(2008-10#3)(2008-11#1)(2008-7#1)(2010-10#2)(2013-8#1)
the role that##8##3##(1993-1#1)(1993-12#1)(1993-6#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-7#1)(2013-8#1)
the role transition##2##3##(2008-11#2)
the role##461##2##(1990-12#6)(1990-2#2)(1990-6#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#2)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-5#3)(1992-6#2)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#3)(1993-6#5)(1993-8#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#7)(1995-6#2)(1995-8#5)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#1)(1997-2#6)(1997-3#3)(1997-5#2)(1997-7#2)(1997-8#3)(2006-6#2)(2007-12#1)(2008-1#4)(2008-10#46)(2008-11#44)(2008-12#18)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#15)(2008-8#13)(2008-9#8)(2009-10#5)(2009-11#3)(2009-12#5)(2009-4#2)(2009-6#5)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#28)(2011-3#3)(2011-9#2)(2012-12#2)(2012-2#16)(2012-3#14)(2013-1#16)(2013-2#1)(2013-7#4)(2013-8#19)
the roles of competition##2##4##(2008-8#1)(2008-9#1)
the roles of parents##2##4##(1990-2#1)(2010-10#1)
the roles of the##4##4##(2008-10#1)(2009-3#1)(2010-5#1)(2011-1#1)
the roles of these##2##4##(1995-3#1)(2010-12#1)
the roles of##30##3##(1990-12#1)(1990-2#1)(1992-6#1)(1994-1#1)(1995-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#3)
the roles##35##2##(1990-12#1)(1990-2#1)(1992-12#1)(1992-6#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#3)
the room temperature##3##3##(2008-10#3)
the room##4##2##(2008-10#3)(2008-9#1)
the room-temperature phosphorescence##2##3##(2008-10#2)
the root and##4##3##(2008-10#4)
the root apical meristem##2##4##(2009-8#2)
the root bark of##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
the root canal##4##3##(2013-1#4)
the root cortex##3##3##(2008-10#3)
the root epidermis and##2##4##(2008-10#2)
the root is##2##3##(2008-10#2)
the root mean square error of##2##6##(2008-10#2)
the root of Caragana sinica##2##5##(2008-10#2)
the root of##7##3##(1990-11#1)(2008-10#3)(2009-6#1)(2012-3#1)(2013-8#1)
the root surface and##2##4##(2008-10#2)
the root surface##4##3##(2008-10#4)
the root system##4##3##(2008-10#4)
the root systems##2##3##(2008-10#2)
the root tissues##3##3##(2008-10#3)
the root##64##2##(1990-11#1)(2008-10#45)(2008-11#1)(2008-12#1)(2008-9#4)(2009-6#1)(2009-8#3)(2011-1#1)(2012-3#2)(2013-1#4)(2013-8#1)
the root-knot nematode Meloidogyne javanica##4##5##(2008-10#4)
the root-knot nematode Meloidogyne##6##4##(2008-10#6)
the root-knot nematode##8##3##(2008-10#8)
the root-mean-square##2##2##(2008-10#1)(2008-8#1)
the roots and the##2##4##(2008-10#2)
the roots and##6##3##(2008-10#4)(2008-11#1)(2008-12#1)
the roots of Gordonia chrysandra##2##5##(2010-6#2)
the roots of##13##3##(2008-10#7)(2008-12#1)(2010-6#2)(2011-2#1)(2012-6#1)(2013-1#1)
the roots##40##2##(1995-9#1)(2008-10#26)(2008-11#2)(2008-12#3)(2008-9#2)(2010-6#2)(2011-2#1)(2012-5#1)(2012-6#1)(2013-1#1)
the rostral##5##2##(1990-9#1)(1993-3#1)(1996-12#1)(1997-2#1)(2008-7#1)
the rostral-caudal##2##2##(1997-3#2)
the rotation between##2##3##(1993-1#2)
the rotation##11##2##(1992-9#1)(1993-1#2)(1993-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2010-12#1)
the rotational##7##2##(1990-12#1)(2008-10#5)(2008-3#1)
the rotor##2##2##(2008-10#1)(2008-8#1)
the rotor-impeller##2##2##(2008-8#2)
the rough endoplasmic reticulum##3##4##(1992-12#1)(2008-7#2)
the rough##7##2##(1992-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)
the roughness of the##2##4##(2008-3#2)
the route by which the##2##5##(2008-10#1)(2009-5#1)
the route by which##3##4##(2008-10#2)(2009-5#1)
the route of##3##3##(1994-2#1)(2008-9#1)(2009-6#1)
the route##6##2##(1994-2#1)(2008-10#2)(2008-9#1)(2009-5#1)(2009-6#1)
the routes##4##2##(1994-5#1)(1997-7#1)(2011-2#2)
the routine analysis of##5##4##(2008-10#4)(2008-11#1)
the routine analysis##6##3##(2008-10#5)(2008-11#1)
the routine use of##6##4##(2008-11#1)(2010-11#1)(2011-2#4)
the routine##38##2##(1992-2#1)(1993-2#2)(1994-3#1)(1994-6#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#5)(2013-1#1)(2013-8#1)
the rows##2##2##(2008-10#2)
the royal##2##2##(2008-11#1)(2011-2#1)
the rps1##2##2##(2008-10#2)
the rtN236T##2##2##(2013-1#2)
the rubrerythrin##2##2##(1991-12#2)
the rubric of the##2##4##(2008-6#1)(2010-1#1)
the rubric of##3##3##(2008-11#1)(2008-6#1)(2010-1#1)
the ruggedness##2##2##(2008-10#2)
the rule in##2##3##(1997-3#1)(2008-8#1)
the rule##7##2##(1990-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-3#1)
the rules for##2##3##(2008-8#1)(2009-10#1)
the rules governing##2##3##(1995-5#1)(2008-9#1)
the rules of##5##3##(1995-6#1)(2008-11#1)(2008-4#1)(2011-2#2)
the rules##10##2##(1995-5#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#3)
the rumen##3##2##(2011-2#2)(2013-1#1)
the run buffer##2##3##(2008-10#2)
the run##3##2##(1997-2#1)(2008-10#2)
the running##4##2##(2008-10#2)(2008-3#1)(2010-7#1)
the rupture##2##2##(2008-11#1)(2011-3#1)
the rural participants##2##3##(2008-11#2)
the rural##11##2##(1991-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-3#1)(2008-11#2)(2008-3#1)(2009-10#1)(2009-7#1)(2010-5#1)
the rust fungus##4##3##(2008-10#4)
the rust##11##2##(2008-10#11)
the rusts##2##2##(2008-10#2)
the sac##4##2##(1995-11#2)(2007-12#2)
the saccharin##2##2##(2008-2#1)(2008-5#1)
the sacral##3##2##(2008-7#2)(2013-8#1)
the sacrum and##2##3##(1991-11#1)(2011-2#1)
the sacrum##5##2##(1991-11#1)(2008-8#1)(2011-2#2)(2013-8#1)
the safe harbors##2##3##(1991-1#1)(1993-1#1)
the safe##13##2##(1991-1#1)(1991-3#2)(1993-1#2)(1993-12#1)(1996-9#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#1)(2011-2#2)
the safety and effectiveness of##3##5##(2008-10#1)(2008-8#1)(2010-6#1)
the safety and efficacy of##12##5##(1994-5#1)(1996-3#1)(2008-11#5)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
the safety and##20##3##(1992-2#1)(1994-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-8#2)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
the safety aspects##2##3##(1994-6#2)
the safety of a##2##4##(1990-11#1)(2012-3#1)
the safety of acupuncture##2##4##(2008-10#2)
the safety of the##5##4##(1991-3#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
the safety of this##2##4##(2008-11#1)(2008-5#1)
the safety of##32##3##(1990-11#1)(1991-1#1)(1991-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-9#1)(2008-10#5)(2008-11#5)(2008-5#1)(2009-10#2)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
the safety profile of##2##4##(2008-10#1)(2008-8#1)
the safety##63##2##(1990-11#1)(1991-1#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-6#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(2008-10#8)(2008-11#10)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#2)(2009-12#2)(2010-12#3)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
the sagittal and##2##3##(1995-5#1)(2008-3#1)
the sagittal plane##3##3##(2008-12#1)(2010-9#1)(2013-1#1)
the sagittal##8##2##(1995-5#1)(2008-12#1)(2008-3#1)(2010-9#1)(2013-1#2)(2013-8#2)
the sake of illustration##2##4##(2008-10#2)
the sake of##5##3##(1994-12#1)(2008-10#3)(2008-12#1)
the sale of##2##3##(1992-11#1)(1992-8#1)
the salicylate##3##2##(2008-10#3)
the saline matrix##2##3##(2008-10#2)
the saline##6##2##(1991-6#1)(2008-10#3)(2013-8#2)
the saliva##3##2##(2008-10#3)
the salivary gland##7##3##(1995-8#1)(2008-11#2)(2009-1#1)(2009-3#2)(2013-1#1)
the salivary glands is##2##4##(2008-10#1)(2008-4#1)
the salivary glands of##4##4##(2008-10#3)(2008-8#1)
the salivary glands##13##3##(2008-10#9)(2008-4#2)(2008-8#1)(2011-2#1)
the salivary##24##2##(1995-8#1)(2008-10#12)(2008-11#2)(2008-4#2)(2008-8#1)(2009-1#1)(2009-3#2)(2011-2#1)(2013-1#1)(2013-8#1)
the salmon##3##2##(1992-6#1)(1993-3#1)(1995-11#1)
the salt concentration##3##3##(1990-5#1)(1997-2#1)(1997-6#1)
the salt##8##2##(1990-5#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-9#1)
the salt-free##2##2##(2008-5#2)
the salting-out##2##2##(1990-5#1)(2008-10#1)
the same AFLP##3##3##(2008-10#3)
the same AG##3##3##(2008-10#3)
the same C##2##3##(1991-12#1)(2008-10#1)
the same DNA##4##3##(1991-10#1)(1993-12#1)(2008-10#1)(2009-10#1)
the same accuracy##2##3##(1997-6#1)(2008-2#1)
the same across##2##3##(2008-4#1)(2010-11#1)
the same age and##2##4##(1991-11#1)(2013-1#1)
the same age group##4##4##(1990-2#1)(1990-6#1)(2011-2#1)(2012-12#1)
the same age##13##3##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#2)(1991-9#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
the same amino##2##3##(1991-6#1)(2008-8#1)
the same amount of##6##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
the same amount##8##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
the same analyte##3##3##(2008-10#3)
the same and##2##3##(1993-8#1)(1995-12#1)
the same antibody##2##3##(1997-2#1)(2008-7#1)
the same aphid##2##3##(2008-10#2)
the same approach##2##3##(2008-10#1)(2008-8#1)
the same area##4##3##(1993-6#1)(2008-5#3)
the same as that in##2##5##(2008-8#1)(2008-9#1)
the same as that obtained##2##5##(1993-8#1)(2008-10#1)
the same as that of the##3##6##(1993-9#1)(2008-2#1)(2008-5#1)
the same as that of##9##5##(1990-5#1)(1993-9#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
the same as that##15##4##(1990-5#1)(1993-8#1)(1993-9#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)
the same as the##9##4##(1991-5#1)(1995-12#1)(1995-2#1)(2008-10#5)(2012-3#1)
the same as those of##2##5##(1994-12#1)(1997-8#1)
the same as those##3##4##(1994-12#1)(1997-8#1)(2008-10#1)
the same as##41##3##(1990-5#1)(1991-5#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
the same assay##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
the same at##2##3##(2008-10#1)(2008-3#1)
the same biological##2##3##(1991-5#1)(2008-10#1)
the same brain##3##3##(1996-2#1)(2008-6#1)(2010-5#1)
the same broad##2##3##(1995-12#1)(2008-10#1)
the same but##2##3##(2008-10#2)
the same cell##6##3##(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-12#1)
the same cells##3##3##(1990-8#1)(2008-11#1)(2013-1#1)
the same characteristics##2##3##(2008-5#1)(2013-1#1)
the same chemical##2##3##(2008-10#2)
the same chromosome##2##3##(2008-10#1)(2008-8#1)
the same clade##4##3##(2008-10#2)(2008-6#1)(2013-8#1)
the same cluster##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
the same concentration of##3##4##(1994-8#1)(2008-10#1)(2008-8#1)
the same concentration range##2##4##(1994-8#1)(2008-10#1)
the same concentration##8##3##(1994-8#2)(2008-10#3)(2008-11#2)(2008-8#1)
the same concentrations of##2##4##(1992-7#1)(2008-10#1)
the same concentrations##6##3##(1992-7#1)(1994-8#1)(2008-10#3)(2008-11#1)
the same conditions for##2##4##(2008-10#1)(2008-12#1)
the same conditions##25##3##(1990-2#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#2)
the same cultivar##2##3##(2008-10#2)
the same day##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
the same developmental##2##3##(1994-12#1)(2007-12#1)
the same diagnosis##2##3##(2008-11#1)(2010-8#1)
the same direction##4##3##(1992-4#1)(2008-2#1)(2008-8#2)
the same domain##2##3##(1993-8#1)(2009-10#1)
the same dose##4##3##(1992-6#1)(1994-3#1)(1994-8#1)(2008-6#1)
the same doses of##2##4##(1995-12#1)(2008-10#1)
the same doses##4##3##(1995-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
the same effect on##2##4##(1995-12#1)(2008-10#1)
the same effect##4##3##(1995-12#2)(2008-10#1)(2008-9#1)
the same enzyme##3##3##(1994-8#1)(1995-6#1)(2008-11#1)
the same ethnic group##2##4##(1997-8#1)(2008-9#1)
the same experimental##6##3##(1997-2#1)(2008-10#4)(2013-8#1)
the same family##8##3##(1997-4#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-12#2)
the same final##3##3##(1997-7#1)(2008-3#1)(2010-7#1)
the same flow##2##3##(2008-10#1)(2008-9#1)
the same for all##5##4##(1994-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
the same for both##4##4##(1995-11#1)(1996-2#1)(2008-5#1)(2009-6#1)
the same for##16##3##(1992-3#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)
the same form##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
the same four##2##3##(1997-5#1)(2008-10#1)
the same frequency##4##3##(1995-12#1)(2008-10#2)(2008-3#1)
the same fungal##2##3##(2008-10#2)
the same gene##8##3##(1990-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(2008-10#4)
the same genetic##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
the same genotype##6##3##(2008-10#6)
the same group##5##3##(2008-10#3)(2010-11#1)(2011-2#1)
the same groups of##2##4##(2008-10#2)
the same health##2##3##(2008-7#1)(2010-10#1)
the same hospital##4##3##(1991-2#1)(1991-3#1)(1996-1#1)(1997-8#1)
the same host##6##3##(1997-3#1)(2008-10#4)(2008-9#1)
the same in the##2##4##(2008-10#2)
the same in##11##3##(1991-11#1)(1991-2#1)(1993-6#1)(1994-3#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#1)
the same individual##4##3##(1996-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
the same intensity##2##3##(1990-5#1)(2013-1#1)
the same is##2##3##(2008-10#2)
the same isolate##2##3##(2008-10#2)
the same level as the##3##5##(1991-11#1)(2008-10#1)(2008-5#1)
the same level as##5##4##(1991-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
the same level of##3##4##(2008-10#1)(2008-11#1)(2009-6#1)
the same level##14##3##(1990-12#1)(1991-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2011-2#1)
the same levels as##2##4##(1993-3#1)(1997-6#1)
the same life##2##3##(1995-1#1)(2008-8#1)
the same location##6##3##(2008-10#4)(2008-3#2)
the same locations##2##3##(2008-10#1)(2012-3#1)
the same locus##4##3##(2008-10#4)
the same mRNA##2##3##(1992-3#1)(2011-2#1)
the same manner##6##3##(1997-6#1)(2008-10#3)(2009-6#1)(2012-2#1)
the same mating allele##2##4##(2008-10#2)
the same mechanism##5##3##(1993-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
the same medium##3##3##(2008-10#2)(2008-11#1)
the same membrane##2##3##(2008-10#1)(2012-4#1)
the same molecular##3##3##(1990-5#1)(1994-11#1)(2009-8#1)
the same number of##5##4##(1990-11#1)(2008-10#4)
the same old##2##3##(1994-1#1)(1995-3#1)
the same on##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the same or mirror images##2##5##(1996-2#2)
the same or similar##2##4##(1991-2#1)(2008-8#1)
the same or##12##3##(1991-2#1)(1993-1#1)(1996-2#2)(2008-10#3)(2008-4#2)(2008-8#2)(2011-2#1)
the same order of magnitude as##2##6##(1991-2#1)(2008-11#1)
the same order of magnitude##3##5##(1991-2#1)(2008-11#2)
the same order of##4##4##(1991-2#1)(2008-11#2)(2008-9#1)
the same order##6##3##(1991-2#1)(1991-5#1)(2008-11#2)(2008-9#1)(2011-2#1)
the same organism##4##3##(1993-6#1)(1997-6#1)(2008-10#1)(2013-1#1)
the same orientation##2##3##(1991-9#1)(1997-6#1)
the same pH##2##3##(2008-10#2)
the same pathotype##3##3##(2008-10#3)
the same patient##8##3##(1994-12#1)(1996-3#2)(2008-8#1)(2010-12#1)(2013-1#2)(2013-8#1)
the same patients##2##3##(2008-4#1)(2013-1#1)
the same pattern as##3##4##(1997-7#1)(2008-10#2)
the same pattern of##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
the same pattern##7##3##(1994-9#1)(1995-12#1)(1997-7#1)(2008-10#3)(2008-11#1)
the same period of time##7##5##(1990-11#1)(1991-8#1)(1995-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
the same period##15##3##(1990-11#1)(1990-6#1)(1991-8#1)(1995-1#2)(1995-9#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)
the same phase##2##3##(1996-5#1)(2009-10#1)
the same phenotype##4##3##(1992-3#1)(2008-10#3)
the same plant sample##2##4##(2008-10#2)
the same plant##5##3##(2008-10#5)
the same plot##2##3##(2008-10#2)
the same point##4##3##(1992-2#1)(1993-12#1)(2007-11#1)(2008-10#1)
the same polymer##3##3##(2008-10#1)(2008-11#2)
the same population##7##3##(1992-2#1)(2008-10#5)(2012-12#1)
the same position as##3##4##(1990-2#1)(1993-2#1)(2010-3#1)
the same position##5##3##(1990-2#1)(1993-2#1)(2008-11#1)(2008-8#1)(2010-3#1)
the same precision##2##3##(2008-10#2)
the same primers##2##3##(2008-10#2)
the same procedure##3##3##(1996-3#1)(2008-8#1)(2012-12#1)
the same process##3##3##(1996-2#1)(1997-3#1)(2008-5#1)
the same protein##2##3##(1995-6#1)(1997-6#1)
the same protocol##2##3##(2008-7#1)(2009-1#1)
the same race##3##3##(2008-10#3)
the same rapid##2##3##(1990-2#1)(2008-8#1)
the same rate##5##3##(1991-2#1)(1993-6#1)(1995-8#1)(2008-10#1)(2008-11#1)
the same reaction##2##3##(2008-10#1)(2009-3#1)
the same region##8##3##(1991-3#1)(1993-8#2)(1994-11#1)(2008-10#4)
the same regions##2##3##(1995-2#1)(2009-5#1)
the same regulatory##2##3##(2009-7#2)
the same resistant##2##3##(2008-10#2)
the same results as##2##4##(1997-2#1)(2008-11#1)
the same results##6##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#2)
the same risk##2##3##(2008-1#2)
the same sample of##3##4##(2008-10#3)
the same sample##8##3##(2008-10#8)
the same samples##7##3##(2008-10#6)(2008-3#1)
the same sequence##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
the same set of##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)
the same single##2##3##(2008-10#1)(2012-3#1)
the same site##9##3##(1990-5#3)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#2)
the same sites##2##3##(1995-12#1)(2008-10#1)
the same size##6##3##(1994-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-1#1)
the same soil##3##3##(2008-10#3)
the same solid##2##3##(2008-10#1)(2008-7#1)
the same solution##2##3##(2008-10#2)
the same source##2##3##(2008-10#1)(2011-2#1)
the same species##9##3##(1995-2#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#1)
the same stimulus##4##3##(1990-5#1)(1994-3#1)(1997-1#1)(1997-2#1)
the same strain of##2##4##(2008-5#2)
the same strain##3##3##(2008-10#1)(2008-5#2)
the same strains##3##3##(1996-12#1)(2008-10#2)
the same structure##2##3##(2008-10#1)(2009-7#1)
the same students##2##3##(2008-12#1)(2013-1#1)
the same surface##2##3##(1990-12#1)(1996-2#1)
the same system##3##3##(2008-10#2)(2010-5#1)
the same time period##2##4##(1991-2#1)(2008-10#1)
the same time##82##3##(1990-11#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-12#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#22)(2008-11#4)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#2)(2009-8#1)(2010-12#2)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#4)
the same tissues##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
the same total##2##3##(1993-8#1)(2008-4#1)
the same transcriptional orientation##2##4##(1991-9#1)(1996-3#1)
the same treatment##9##3##(1993-6#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
the same two##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
the same type of##3##4##(2008-10#1)(2008-11#1)(2009-5#1)
the same type##5##3##(2008-10#1)(2008-11#2)(2008-9#1)(2009-5#1)
the same types of##3##4##(1991-12#1)(1997-3#1)(2008-10#1)
the same underlying##2##3##(2010-1#1)(2011-1#1)
the same variety##2##3##(2008-10#2)
the same viroids##2##3##(2008-10#2)
the same virus##4##3##(2008-10#2)(2008-8#2)
the same water##3##3##(1994-8#1)(2008-10#2)
the same way as##7##4##(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#4)
the same way##16##3##(1994-1#1)(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)
the same with##2##3##(2008-10#1)(2008-11#1)
the same year##2##3##(2008-10#2)
the same##1324##2##(1990-11#9)(1990-12#5)(1990-2#10)(1990-3#2)(1990-5#12)(1990-6#4)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#5)(1991-12#7)(1991-2#7)(1991-3#4)(1991-5#9)(1991-6#3)(1991-8#4)(1991-9#4)(1992-10#1)(1992-12#4)(1992-2#5)(1992-3#4)(1992-4#1)(1992-6#4)(1992-7#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#2)(1993-6#11)(1993-8#10)(1993-9#2)(1994-1#6)(1994-11#6)(1994-12#8)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#13)(1994-9#2)(1995-1#4)(1995-11#5)(1995-12#10)(1995-2#11)(1995-3#3)(1995-5#3)(1995-6#8)(1995-8#5)(1995-9#3)(1996-1#3)(1996-11#3)(1996-12#5)(1996-2#9)(1996-3#9)(1996-5#2)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#8)(1997-7#4)(1997-8#7)(2006-6#1)(2007-11#2)(2007-12#5)(2008-1#3)(2008-10#465)(2008-11#91)(2008-12#16)(2008-2#10)(2008-3#27)(2008-4#7)(2008-5#39)(2008-6#8)(2008-7#26)(2008-8#50)(2008-9#40)(2009-1#3)(2009-10#11)(2009-11#3)(2009-12#3)(2009-3#1)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#9)(2009-9#1)(2010-1#5)(2010-10#4)(2010-11#3)(2010-12#7)(2010-3#3)(2010-5#6)(2010-7#7)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#35)(2011-3#2)(2011-7#1)(2012-12#10)(2012-2#16)(2012-3#12)(2012-4#2)(2013-1#22)(2013-8#18)
the sample and the##8##4##(2008-10#8)
the sample and##25##3##(1997-2#1)(2008-10#23)(2009-8#1)
the sample and/or##2##3##(2008-10#2)
the sample by##3##3##(2008-10#3)
the sample can be##3##4##(2008-10#3)
the sample during##2##3##(1990-5#1)(2008-10#1)
the sample for##2##3##(2008-10#2)
the sample frequency was##2##4##(2008-10#2)
the sample in Study##2##4##(1991-2#2)
the sample in the##2##4##(2008-10#2)
the sample in##11##3##(1991-2#2)(2008-10#8)(2008-9#1)
the sample injected##2##3##(2008-10#2)
the sample injection##3##3##(2008-10#3)
the sample introduction system##2##4##(2008-10#2)
the sample introduction##4##3##(2008-10#4)
the sample is##12##3##(1995-12#1)(2008-10#10)(2008-3#1)
the sample matrix was##2##4##(2008-10#2)
the sample matrix##6##3##(2008-10#6)
the sample of##2##3##(2008-12#1)(2013-1#1)
the sample pH and sample flow rate##2##7##(2008-10#2)
the sample pH##3##3##(2008-10#3)
the sample plug##4##3##(2008-10#4)
the sample preparation and##2##4##(2008-10#2)
the sample preparation##6##3##(2008-10#6)
the sample size##9##3##(1994-9#1)(1995-9#2)(2008-10#3)(2009-12#1)(2010-8#1)(2011-2#1)
the sample solution containing##2##4##(2008-10#2)
the sample solution in##2##4##(2008-10#2)
the sample solution is##2##4##(2008-10#2)
the sample solution through the##2##5##(2008-10#2)
the sample solution to##2##4##(2008-10#2)
the sample solution was injected##2##5##(2008-10#2)
the sample solution was##7##4##(2008-10#7)
the sample solution##39##3##(2008-10#39)
the sample solutions##3##3##(2008-10#3)
the sample stream##2##3##(2008-10#2)
the sample surface##5##3##(1994-9#1)(2007-12#1)(2008-10#2)(2012-2#1)
the sample through##3##3##(2008-10#3)
the sample throughput##8##3##(2008-10#8)
the sample to the##2##4##(2008-10#2)
the sample to##7##3##(2008-10#7)
the sample treated by##2##4##(2008-10#1)(2008-9#1)
the sample treated##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
the sample under##2##3##(2008-3#2)
the sample using##5##3##(2008-10#5)
the sample volume was##2##4##(2008-10#2)
the sample volume##8##3##(1990-12#1)(2008-10#7)
the sample was##10##3##(1997-3#1)(2008-10#6)(2008-12#1)(2008-5#1)(2013-8#1)
the sample were##3##3##(2008-10#2)(2008-12#1)
the sample with the highest##2##5##(2008-10#1)(2008-5#1)
the sample with##6##3##(2008-10#5)(2008-5#1)
the sample zone is##4##4##(2008-10#4)
the sample zone##10##3##(2008-10#10)
the sample##355##2##(1990-12#2)(1990-5#1)(1991-2#3)(1992-12#1)(1992-2#1)(1993-1#2)(1994-9#2)(1995-12#1)(1995-9#2)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#300)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
the sample's##2##2##(2007-11#1)(2008-3#1)
the sample)##4##2##(2008-10#2)(2009-4#1)(2012-3#1)
the sampled##9##2##(2008-10#8)(2008-11#1)
the samples analyzed##4##3##(2008-10#4)
the samples and##8##3##(2008-10#7)(2008-11#1)
the samples are##4##3##(2008-10#4)
the samples by##3##3##(2008-10#3)
the samples could##2##3##(2008-10#2)
the samples for##4##3##(2008-10#4)
the samples in##7##3##(2008-10#6)(2012-2#1)
the samples of the##2##4##(1991-1#1)(2008-10#1)
the samples of##5##3##(1991-1#1)(2008-10#4)
the samples on the##2##4##(2008-10#2)
the samples studied##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
the samples to##2##3##(2008-10#1)(2010-5#1)
the samples using##2##3##(2008-10#2)
the samples was determined##2##4##(2008-10#2)
the samples was##6##3##(2008-10#6)
the samples were determined by##2##5##(2008-10#2)
the samples were digested##2##4##(2008-10#2)
the samples were inserted into the system on the day##2##10##(2010-6#2)
the samples were##21##3##(2008-10#12)(2008-12#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-6#2)(2011-3#1)(2012-2#1)
the samples##157##2##(1990-12#1)(1991-1#1)(1995-11#1)(1996-12#1)(2008-10#120)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#2)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#4)(2013-1#1)
the sampling arm##2##3##(2008-10#2)
the sampling distribution##2##3##(2008-10#2)
the sampling frequency of##2##4##(2008-10#2)
the sampling frequency was##2##4##(2008-10#2)
the sampling frequency##8##3##(2008-10#8)
the sampling loss##2##3##(2008-10#2)
the sampling rate of##2##4##(2008-10#2)
the sampling rate was##4##4##(2008-10#4)
the sampling rate##6##3##(2008-10#6)
the sampling rates##2##3##(2008-10#2)
the sampling throughput##2##3##(2008-10#2)
the sampling time##2##3##(2008-10#2)
the sampling unit##3##3##(2008-10#3)
the sampling variance of##2##4##(2008-10#1)(2008-8#1)
the sampling volume##3##3##(2008-3#3)
the sampling##57##2##(1996-12#1)(2008-10#45)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#3)(2011-2#1)(2011-3#1)(2013-1#1)
the sand##4##2##(1991-12#1)(2008-10#2)(2010-1#1)
the sandwich##2##2##(2008-10#2)
the sanitary##2##2##(2011-2#1)(2012-12#1)
the sanitation of##2##3##(2009-12#1)(2010-1#1)
the saprophyte##2##2##(2008-10#1)(2008-9#1)
the saprophytic stage##2##3##(2008-10#2)
the saprophytic##3##2##(2008-10#3)
the sapwood##2##2##(2008-10#2)
the sarcomatous##2##2##(1994-5#1)(2011-2#1)
the sarcoplasmic reticulum##5##3##(1990-2#1)(1991-9#1)(1994-8#1)(2009-7#1)(2013-8#1)
the satellite##5##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)
the satisfaction##2##2##(1992-3#1)(1992-5#1)
the satisfactory##5##2##(2008-10#2)(2008-5#1)(2010-6#1)(2013-1#1)
the saturable absorber##2##3##(2008-3#2)
the saturated fatty acids##2##4##(1991-12#1)(2008-11#1)
the saturated##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
the saturation of##2##3##(2008-10#1)(2011-2#1)
the saturation##7##2##(1991-6#1)(2008-10#1)(2008-3#4)(2011-2#1)
the savings##3##2##(1992-2#1)(1995-2#2)
the scaffold must##2##3##(2009-7#2)
the scaffold##4##2##(2009-7#4)
the scaffolding##3##2##(2008-11#2)(2009-7#1)
the scalar##2##2##(2008-3#2)
the scale of 1-5##2##4##(1990-2#2)
the scale of the##4##4##(2008-10#3)(2008-3#1)
the scale of##12##3##(1990-2#2)(1992-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
the scale up##2##3##(2008-11#2)
the scale##32##2##(1990-2#2)(1992-1#2)(1996-3#2)(2008-10#9)(2008-11#5)(2008-3#1)(2008-9#6)(2009-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
the scale-up##3##2##(2008-11#2)(2008-7#1)
the scales##2##2##(1990-5#1)(2008-11#1)
the scaling##6##2##(1993-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)
the scalp and##2##3##(2008-5#1)(2013-8#1)
the scalp##14##2##(2008-5#5)(2008-9#2)(2010-6#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
the scan rate##4##3##(2008-10#4)
the scan##6##2##(2008-10#6)
the scanning electron microscope##2##4##(2008-5#2)
the scanning##6##2##(2008-2#1)(2008-3#2)(2008-5#2)(2011-2#1)
the scaphoid##2##2##(2008-9#1)(2013-1#1)
the scarcity of##3##3##(2011-2#1)(2011-3#2)
the scattered light##2##3##(2008-3#2)
the scattered##6##2##(2008-3#4)(2009-10#1)(2009-11#1)
the scattering and microphysical properties of##2##6##(2008-3#2)
the scattering from##3##3##(2008-3#3)
the scattering matrix##2##3##(2008-3#2)
the scattering of##3##3##(2008-3#2)(2009-10#1)
the scattering pattern##3##3##(2008-3#3)
the scattering phase##2##3##(2008-3#2)
the scattering##28##2##(2008-10#3)(2008-2#3)(2008-3#21)(2009-10#1)
the scavenging##2##2##(2008-10#1)(2011-2#1)
the scenario##3##2##(1996-2#1)(2008-11#2)
the scenarios##3##2##(2008-1#1)(2008-6#1)(2009-10#1)
the scene of##3##3##(1991-8#1)(1995-11#1)(2008-10#1)
the schedule##4##2##(1991-6#1)(2008-12#1)(2008-8#1)(2013-1#1)
the scheduling##2##2##(1996-1#1)(2009-3#1)
the scheme by##2##3##(2008-10#1)(2008-3#1)
the scheme is##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
the scheme##10##2##(1991-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#1)
the schemes##3##2##(1993-12#2)(1997-3#1)
the schizophrenic##2##2##(1990-11#2)
the school system##2##3##(1991-12#1)(1993-11#1)
the school year##4##3##(2008-12#4)
the school##16##2##(1990-6#1)(1991-12#2)(1993-11#1)(1997-2#1)(2008-1#1)(2008-11#2)(2008-12#5)(2009-7#1)(2010-1#1)(2011-2#1)
the school-age##2##2##(1991-2#1)(2011-2#1)
the schools##4##2##(1991-1#1)(1991-12#2)(2008-12#1)
the sciatic nerve##4##3##(1990-5#1)(1995-12#2)(1996-2#1)
the sciatic##5##2##(1990-5#1)(1995-12#2)(1996-2#1)(1997-3#1)
the science and##2##3##(1993-11#1)(1995-1#1)
the science behind##2##3##(2008-3#1)(2011-2#1)
the science of##4##3##(1990-3#1)(2008-10#1)(2008-11#1)(2009-5#1)
the science##15##2##(1990-3#1)(1993-11#1)(1995-1#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-5#2)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#1)
the sciences##2##2##(2008-11#1)(2012-2#1)
the scientific and##2##3##(2008-10#1)(2010-7#1)
the scientific community##6##3##(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-2#2)
the scientific evidence##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
the scientific literature##9##3##(1993-12#1)(1997-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#2)(2011-2#1)
the scientific negation of##2##4##(2013-1#2)
the scientific production##2##3##(2012-3#2)
the scientific rationale##2##3##(2008-10#1)(2010-12#1)
the scientific##42##2##(1993-12#1)(1993-3#1)(1996-6#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-2#5)(2012-3#2)(2013-1#4)
the scientist##3##2##(2008-12#1)(2008-5#1)(2010-5#1)
the scolopale##2##2##(2008-7#2)
the scope and##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
the scope of the##7##4##(1991-5#1)(2008-11#2)(2008-9#1)(2010-7#1)(2012-12#1)(2012-3#1)
the scope of##17##3##(1991-5#1)(1993-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#2)
the scope##20##2##(1991-5#1)(1993-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
the score##7##2##(1991-6#1)(2008-10#2)(2008-7#1)(2012-3#2)(2013-1#1)
the scores of##2##3##(1992-1#1)(2008-1#1)
the scores##5##2##(1992-1#1)(2008-1#1)(2008-11#2)(2010-3#1)
the scoring##2##2##(2008-10#1)(2011-3#1)
the screen##3##2##(1992-12#1)(1994-5#1)(2008-11#1)
the screened##2##2##(2008-10#2)
the screening method##2##3##(2008-10#1)(2012-3#1)
the screening of a##2##4##(1990-12#1)(2008-10#1)
the screening of##15##3##(1990-12#1)(1996-12#1)(2008-10#8)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#1)
the screening process##3##3##(2008-11#2)(2010-11#1)
the screening test##2##3##(1997-2#1)(2012-3#1)
the screening##41##2##(1990-12#1)(1990-2#2)(1991-6#1)(1992-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the screw fixation group##2##4##(2009-3#2)
the screw##5##2##(2007-11#2)(2008-8#1)(2009-3#2)
the screwless fixation group##2##4##(2009-3#2)
the sd-t(t)##2##2##(2008-9#2)
the sea urchin##4##3##(1995-6#1)(2008-11#1)(2008-8#2)
the sea##15##2##(1995-6#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-7#2)(2008-8#4)
the search for a##3##4##(1993-8#1)(1994-2#1)(2008-4#1)
the search for new##5##4##(1997-7#1)(2008-1#1)(2008-10#1)(2010-7#1)(2013-1#1)
the search for solutions##2##4##(1997-7#1)(2012-2#1)
the search for the##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
the search for this##2##4##(2008-5#1)(2011-2#1)
the search for##34##3##(1991-12#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-6#1)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#3)(2008-8#2)(2009-11#1)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
the search of##4##3##(1994-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
the search##48##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-6#1)(1997-7#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#3)(2008-9#1)(2009-11#1)(2010-1#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
the season and##2##3##(2008-10#1)(2011-2#1)
the season in##2##3##(2008-10#1)(2008-8#1)
the season of ascospore##2##4##(2008-10#2)
the season of##3##3##(2008-10#2)(2008-3#1)
the season##23##2##(2008-10#13)(2008-3#1)(2008-8#7)(2011-2#1)(2012-6#1)
the seasonal and##2##3##(2008-10#2)
the seasonal variation of##3##4##(2008-10#2)(2012-2#1)
the seasonal##13##2##(2008-10#9)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
the seawater##2##2##(2008-10#2)
the sebum##3##2##(2008-5#3)
the second (external-focus) intervention##2##4##(2013-1#2)
the second amino acid##3##4##(1997-2#2)(2008-10#1)
the second and third trimesters##2##5##(1993-12#2)
the second and third##7##4##(1993-12#2)(1997-3#1)(2008-10#1)(2008-5#1)(2013-1#2)
the second assay##2##3##(2008-10#1)(2008-5#1)
the second case of##3##4##(2007-8#1)(2010-3#1)(2013-1#1)
the second case##9##3##(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
the second cause of##2##4##(1991-11#1)(2011-3#1)
the second cistron##2##3##(1997-8#1)(2008-7#1)
the second column##2##3##(2008-10#2)
the second complete genome sequence##2##5##(2011-2#2)
the second completed genome sequence of the family##2##8##(2011-2#2)
the second completed genome sequence of##6##6##(2011-2#6)
the second day of##2##4##(2011-1#1)(2012-3#1)
the second day##4##3##(2008-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
the second derivative##2##3##(2008-10#2)
the second dimension##2##3##(2008-10#2)
the second example##2##3##(2008-10#1)(2008-8#1)
the second experiment##6##3##(1996-12#1)(2008-10#4)(2008-3#1)
the second for##2##3##(2008-10#1)(2008-4#1)
the second generation##3##3##(1991-6#2)(2008-10#1)
the second group were##2##4##(2007-8#2)
the second group##8##3##(1990-2#1)(1991-5#1)(2007-8#3)(2008-10#2)(2011-2#1)
the second half of the##4##5##(1991-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
the second half of##5##4##(1991-6#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
the second half##6##3##(1991-6#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
the second harmonic (532 nm)##2##5##(2008-10#1)(2008-3#1)
the second harmonic##3##3##(2008-10#1)(2008-3#2)
the second is to##2##4##(1996-2#1)(2008-8#1)
the second is##6##3##(1996-2#1)(2008-3#2)(2008-4#1)(2008-8#2)
the second measurement##2##3##(2008-3#1)(2010-6#1)
the second messenger##3##3##(1993-6#2)(1996-2#1)
the second method##6##3##(2008-10#4)(2008-3#2)
the second most common cause of##2##6##(1996-11#1)(2008-11#1)
the second most common##6##4##(1996-11#1)(2007-12#1)(2008-11#2)(2010-11#1)(2010-8#1)
the second most frequent cause of##2##6##(2008-5#1)(2011-2#1)
the second most##12##3##(1996-11#1)(2007-12#1)(2008-11#2)(2008-5#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
the second nucleotide##2##3##(1993-12#1)(1997-2#1)
the second one##10##3##(1991-3#1)(1994-11#1)(1995-6#1)(2008-10#5)(2009-10#1)(2009-8#1)
the second order##3##3##(2008-10#1)(2008-11#2)
the second part of this##2##5##(1997-4#1)(1997-6#1)
the second part of##3##4##(1997-4#1)(1997-6#1)(2008-11#1)
the second part##7##3##(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#2)(2009-5#1)(2013-8#1)
the second peak##2##3##(2008-10#2)
the second period##4##3##(2011-2#3)(2013-1#1)
the second repeat##2##3##(2008-10#2)
the second reported case of##3##5##(2008-10#1)(2008-7#1)(2013-1#1)
the second round##2##3##(1991-6#1)(2008-3#1)
the second sampling bout##2##4##(2008-8#2)
the second sampling##3##3##(2008-10#1)(2008-8#2)
the second section##6##3##(1991-1#1)(1992-6#1)(2008-4#1)(2010-11#1)(2012-2#2)
the second stage##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
the second step##4##3##(2008-10#2)(2008-6#1)(2012-2#1)
the second week of##3##4##(1992-3#1)(2008-10#1)(2008-8#1)
the second week##4##3##(1992-3#2)(2008-10#1)(2008-8#1)
the second with a clinical nurse##2##6##(2013-1#2)
the second with##3##3##(2009-7#1)(2013-1#2)
the second year of##2##4##(1996-11#1)(2008-10#1)
the second year##7##3##(1991-8#1)(1996-11#1)(1996-12#3)(2008-10#2)
the second##355##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#5)(1991-8#4)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#7)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#10)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#5)(2008-1#1)(2008-10#97)(2008-11#15)(2008-12#5)(2008-2#1)(2008-3#16)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#12)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#23)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#17)(2013-8#3)
the second-derivative##2##2##(2008-10#2)
the second-generation##2##2##(2008-11#1)(2009-8#1)
the second-harmonic##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
the second-line##2##2##(2008-2#1)(2010-12#1)
the second-order rate constant##3##4##(1990-5#1)(1993-8#1)(2008-4#1)
the second-order##8##2##(1990-5#1)(1993-8#1)(2008-10#3)(2008-3#2)(2008-4#1)
the second-phase##2##2##(1990-2#1)(1991-5#1)
the secondary antibody##3##3##(1991-3#1)(2008-4#2)
the secondary headspot cells##3##4##(2007-12#3)
the secondary nucleus##2##3##(2008-9#2)
the secondary phloem##2##3##(2008-10#2)
the secondary structure of##5##4##(1992-8#1)(1993-8#1)(2008-10#3)
the secondary structure##6##3##(1992-8#1)(1993-8#1)(1995-11#1)(2008-10#3)
the secondary##42##2##(1990-8#1)(1991-3#1)(1992-8#1)(1993-6#1)(1993-8#1)(1995-11#1)(1996-5#1)(2006-6#1)(2007-12#4)(2008-1#2)(2008-10#15)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#5)(2011-2#1)(2012-12#1)(2012-2#1)
the secret to##2##3##(1996-2#1)(2008-11#1)
the secreted form of##2##4##(1992-12#1)(2008-11#1)
the secreted##7##2##(1992-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-3#1)(2011-2#1)
the secretion of IL-7##2##4##(2008-11#2)
the secretion of interleukin 7##2##5##(2008-11#2)
the secretion of the##2##4##(2007-12#1)(2008-11#1)
the secretion of##21##3##(1990-12#1)(1990-5#1)(1993-3#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-7#1)(2007-12#1)(2008-11#9)(2008-7#1)(2011-2#1)(2013-7#1)
the secretion##29##2##(1990-12#1)(1990-5#1)(1991-6#1)(1993-3#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-7#1)(2006-6#1)(2007-12#2)(2008-11#10)(2008-7#4)(2011-2#1)(2013-7#1)
the secretions of##2##3##(1991-5#1)(2008-5#1)
the secretions##3##2##(1991-11#1)(1991-5#1)(2008-5#1)
the secretory cycle##2##3##(2008-7#2)
the secretory pathway##5##3##(1997-1#2)(2008-11#2)(2012-2#1)
the secretory##17##2##(1991-5#1)(1992-6#1)(1995-8#1)(1997-1#2)(2007-12#2)(2008-11#3)(2008-7#5)(2011-2#1)(2012-2#1)
the section##2##2##(1990-2#1)(2008-10#1)
the sections##3##2##(2008-4#2)(2009-1#1)
the sector##3##2##(1995-3#1)(2008-10#1)(2009-10#1)
the secured##2##2##(1991-2#2)
the security and##2##3##(1993-2#1)(2010-9#1)
the security department##2##3##(1993-2#2)
the security of##4##3##(1994-3#2)(2010-8#1)(2012-3#1)
the security##14##2##(1991-1#2)(1993-12#1)(1993-2#4)(1994-12#1)(1994-2#1)(1994-3#2)(2010-8#1)(2010-9#1)(2012-3#1)
the sedentary##2##2##(2008-10#1)(2013-1#1)
the sediment##5##2##(1996-12#1)(2008-10#4)
the sedimentation rate##3##3##(1993-8#1)(2008-10#2)
the sedimented phase##2##3##(2008-10#2)
the sediments##4##2##(2008-10#4)
the seed and##2##3##(2008-10#2)
the seed beam##2##3##(2008-2#2)
the seed coat##4##3##(2008-10#4)
the seed oil##2##3##(2008-11#1)(2009-10#1)
the seed treatment##2##3##(2008-10#2)
the seed##37##2##(2007-12#1)(2008-10#25)(2008-11#3)(2008-2#3)(2008-8#1)(2009-10#2)(2013-8#2)
the seedborne##2##2##(2008-10#2)
the seeded##2##2##(1994-8#1)(2012-2#1)
the seedling and##3##3##(2008-10#3)
the seedling stage##8##3##(2008-10#8)
the seedling##13##2##(2008-10#12)(2009-10#1)
the seedlings were##3##3##(2008-10#2)(2011-10#1)
the seedlings##6##2##(2008-10#5)(2011-10#1)
the seeds of##2##3##(2010-1#1)(2011-1#1)
the seeds##5##2##(2008-10#1)(2008-5#1)(2010-1#1)(2010-5#1)(2011-1#1)
the segment of##2##3##(2008-10#1)(2008-11#1)
the segment##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)
the segmental##3##2##(2007-12#1)(2008-7#1)(2012-3#1)
the segmentation task##2##3##(2009-10#2)
the segmentation##3##2##(2009-10#3)
the segregating##2##2##(2008-10#1)(2008-8#1)
the segregation of##6##3##(2008-10#6)
the seizure##6##2##(1992-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-12#1)
the selected conditions##10##3##(2008-10#10)
the selected frequencies and powers##2##5##(2011-2#2)
the selected ion monitoring (SIM) mode##2##6##(2008-10#2)
the selected ion monitoring##4##4##(2008-10#4)
the selected treatment(s)##2##3##(2012-2#2)
the selected##50##2##(1991-12#1)(1994-5#1)(2008-10#33)(2008-11#1)(2008-4#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
the selection of a##2##4##(1993-1#1)(2008-5#1)
the selection of patients##3##4##(1994-2#1)(1997-2#1)(2008-7#1)
the selection of surfactants##2##4##(2008-10#1)(2008-5#1)
the selection of the##4##4##(2007-12#1)(2008-10#2)(2011-2#1)
the selection of treatment##2##4##(2008-12#1)(2010-1#1)
the selection of variables for the##2##6##(2008-10#2)
the selection of variables##4##4##(1995-9#1)(2008-10#3)
the selection of##47##3##(1991-11#1)(1991-12#1)(1993-1#1)(1994-2#1)(1995-9#1)(1997-2#2)(1997-9#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#4)
the selection pressure##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
the selection process##3##3##(1997-1#2)(2008-10#1)
the selection valve##2##3##(2008-10#2)
the selection##67##2##(1990-8#1)(1991-11#1)(1991-12#1)(1993-1#1)(1994-2#1)(1995-9#1)(1997-1#2)(1997-2#2)(1997-6#1)(1997-9#1)(2007-12#1)(2008-10#23)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#2)(2011-2#4)(2012-2#1)
the selective advantage of##2##4##(2008-8#1)(2012-3#1)
the selective and sensitive determination of##3##6##(2008-10#3)
the selective and##4##3##(2008-10#4)
the selective binding##3##3##(1990-12#1)(2008-10#2)
the selective determination of##7##4##(2008-10#7)
the selective extraction of##5##4##(2008-10#5)
the selective extraction##8##3##(2008-10#8)
the selective ion##2##3##(2008-10#2)
the selective##64##2##(1990-12#1)(1990-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#2)(1996-2#1)(2008-10#42)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#2)
the selectivities##4##2##(2008-10#4)
the selectivity and sensitivity of##2##5##(2008-10#2)
the selectivity and the sensitivity of##2##6##(2008-10#2)
the selectivity and##5##3##(2008-10#5)
the selectivity coefficient##2##3##(2008-10#2)
the selectivity coefficients##3##3##(2008-10#3)
the selectivity is##2##3##(2008-10#2)
the selectivity of the method##2##5##(2008-10#2)
the selectivity of the##10##4##(2008-10#10)
the selectivity of##21##3##(1995-3#1)(1995-8#1)(2008-10#19)
the selectivity ratio of acetone/acetic acid response##2##7##(2008-10#2)
the selectivity was##2##3##(2008-10#2)
the selectivity##54##2##(1995-3#1)(1995-8#1)(2008-10#52)
the selenium present##2##3##(2008-10#2)
the selenium species##2##3##(2008-10#2)
the selenium##10##2##(2008-10#9)(2008-6#1)
the self##10##2##(1990-3#1)(2008-11#6)(2008-12#1)(2008-6#1)(2012-2#1)
the self-assembled##6##2##(2008-10#6)
the self-esteem##2##2##(2008-11#2)
the self-help community and##2##4##(1994-1#1)(1996-3#1)
the self-help##4##2##(1994-1#2)(1996-3#2)
the self-reference condition##2##3##(2008-9#2)
the self-reference##4##2##(2008-10#1)(2008-9#3)
the sella turcica##2##3##(1991-6#1)(2013-1#1)
the sella##5##2##(1991-6#1)(2011-2#2)(2013-1#2)
the sellar##7##2##(2012-3#5)(2013-1#2)
the semantic content of##2##4##(2010-12#2)
the semantic##4##2##(1991-2#2)(2010-12#2)
the semi-quantitative##2##2##(2008-10#1)(2011-2#1)
the semi-solid W/O/W##2##3##(2008-5#2)
the semi-static and PGA-alginate methods##2##5##(2011-2#2)
the semiclassical##2##2##(1992-8#1)(2010-7#1)
the semiconductor##2##2##(2008-10#1)(2008-3#1)
the seminal vesicle is##2##4##(2011-2#2)
the seminal vesicle##5##3##(2008-11#2)(2011-2#3)
the seminal##9##2##(1997-8#2)(2008-11#2)(2008-9#2)(2011-2#3)
the seminiferous epithelial cycle##5##4##(2009-10#2)(2012-2#3)
the seminiferous epithelium into the##2##5##(2009-10#1)(2012-2#1)
the seminiferous epithelium via##2##4##(2009-10#1)(2012-2#1)
the seminiferous epithelium##22##3##(2009-10#13)(2012-2#9)
the seminiferous tubule##2##3##(2009-10#1)(2012-2#1)
the seminiferous tubules##4##3##(1995-6#1)(2008-7#1)(2009-10#2)
the seminiferous##33##2##(1995-6#1)(2008-7#1)(2009-10#18)(2012-2#13)
the senescent##3##2##(2013-7#3)
the sensation of##2##3##(1996-6#1)(2011-2#1)
the sense of self##2##4##(2008-11#1)(2010-6#1)
the sense of##6##3##(2008-11#2)(2008-7#2)(2010-6#1)(2012-2#1)
the sense##14##2##(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-7#2)(2008-8#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-2#1)
the sensillum##2##2##(2007-12#1)(2008-7#1)
the sensing channel##2##3##(2009-5#2)
the sensing elements##2##3##(2008-10#2)
the sensing material and##2##4##(2008-10#2)
the sensing material##3##3##(2008-10#3)
the sensing molecules##2##3##(2013-8#2)
the sensing of##2##3##(2008-10#2)
the sensing phase##3##3##(2008-10#3)
the sensing system##2##3##(2008-10#1)(2008-3#1)
the sensing##37##2##(2008-10#31)(2008-3#1)(2009-5#2)(2011-1#1)(2013-8#2)
the sensitive and##3##3##(2008-10#3)
the sensitive detection of##3##4##(2008-10#2)(2010-12#1)
the sensitive determination of##7##4##(2008-10#7)
the sensitive membrane##2##3##(2008-10#2)
the sensitive##29##2##(2008-10#22)(2008-11#1)(2008-6#1)(2008-9#3)(2010-12#1)(2011-2#1)
the sensitivities of the##2##4##(2008-10#2)
the sensitivities of##5##3##(1994-11#1)(2008-10#4)
the sensitivities##7##2##(1994-11#1)(2008-10#6)
the sensitivity and limits of detection##2##6##(2008-10#2)
the sensitivity and selectivity##2##4##(2008-10#2)
the sensitivity and specificity of the##2##6##(2008-10#1)(2012-2#1)
the sensitivity and specificity of##4##5##(1990-9#1)(2008-10#1)(2008-7#1)(2012-2#1)
the sensitivity and the##2##4##(2008-10#1)(2010-6#1)
the sensitivity and##17##3##(1990-9#1)(1993-3#1)(2008-10#12)(2008-7#1)(2010-6#1)(2012-2#1)
the sensitivity by a factor of##2##6##(2008-10#2)
the sensitivity by##5##3##(2008-10#5)
the sensitivity enhancement##2##3##(2008-10#2)
the sensitivity for##2##3##(2008-10#1)(2009-1#1)
the sensitivity from##2##3##(2008-10#2)
the sensitivity in##2##3##(2008-10#2)
the sensitivity is##2##3##(2008-10#2)
the sensitivity of a##2##4##(2008-10#2)
the sensitivity of human##2##4##(1997-7#1)(2008-5#1)
the sensitivity of measurement##2##4##(2008-3#1)(2008-4#1)
the sensitivity of melanoma cells to##2##6##(2009-4#2)
the sensitivity of neural responses##2##5##(2008-11#2)
the sensitivity of results to the##2##6##(2008-3#1)(2008-8#1)
the sensitivity of the SPR##2##5##(2008-10#2)
the sensitivity of the electrode##2##5##(2008-10#2)
the sensitivity of the method##11##5##(1990-12#1)(2008-10#10)
the sensitivity of the sensor##2##5##(2008-10#2)
the sensitivity of the##47##4##(1990-12#1)(1992-4#1)(1993-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#31)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
the sensitivity of these##2##4##(2008-10#2)
the sensitivity of this##2##4##(2009-8#1)(2013-1#1)
the sensitivity of##103##3##(1990-12#1)(1990-5#1)(1992-4#1)(1993-8#1)(1994-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-10#51)(2008-11#9)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#3)(2009-4#2)(2009-8#1)(2010-7#1)(2011-2#5)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
the sensitivity required##2##3##(2008-10#2)
the sensitivity to the##2##4##(2008-10#2)
the sensitivity to##10##3##(1995-11#1)(1995-2#1)(2008-10#6)(2008-3#1)(2008-7#1)
the sensitivity was##2##3##(2008-10#2)
the sensitivity##180##2##(1990-12#2)(1990-5#1)(1990-9#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2008-10#110)(2008-11#9)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#2)
the sensitized and##2##3##(2008-10#2)
the sensitized##3##2##(2008-10#3)
the sensitizing effect of##4##4##(2008-10#4)
the sensitizing##6##2##(1995-11#1)(2008-10#5)
the sensor can##3##3##(2008-10#3)
the sensor chip##5##3##(2008-10#5)
the sensor could be##2##4##(2008-10#2)
the sensor could##3##3##(2008-10#3)
the sensor exhibits a##3##4##(2008-10#3)
the sensor for##4##3##(2008-10#4)
the sensor has##2##3##(2008-10#2)
the sensor in##2##3##(2008-10#2)
the sensor responds##2##3##(2008-10#2)
the sensor response to##2##4##(2008-10#2)
the sensor response##9##3##(2008-10#9)
the sensor sensitivity##2##3##(2008-10#2)
the sensor showed##2##3##(2008-10#2)
the sensor signal##2##3##(2008-10#2)
the sensor surface##6##3##(2008-10#6)
the sensor system was##3##4##(2008-10#2)(2008-7#1)
the sensor system##6##3##(2008-10#5)(2008-7#1)
the sensor tip##2##3##(2008-10#2)
the sensor was found to be##2##6##(2008-10#2)
the sensor was##16##3##(2008-10#15)(2008-7#1)
the sensor##124##2##(2008-10#119)(2008-3#2)(2008-7#2)(2011-2#1)
the sensor-measured radiances##2##3##(2008-2#2)
the sensorial##2##2##(2011-1#1)(2011-2#1)
the sensors coated with##2##4##(2008-10#2)
the sensors##10##2##(2008-10#10)
the sensory properties of##2##4##(2008-10#1)(2011-2#1)
the sensory system##3##3##(2008-10#2)(2013-8#1)
the sensory##23##2##(1990-5#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-8#2)
the separate components##2##3##(1995-5#2)
the separate##9##2##(1995-5#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)
the separated##7##2##(2008-10#7)
the separately##3##2##(1995-5#2)(2011-3#1)
the separation and detection of##4##5##(2008-10#4)
the separation and detection##10##4##(2008-10#9)(2008-12#1)
the separation and determination of##14##5##(2008-10#14)
the separation and determination##15##4##(2008-10#15)
the separation and preconcentration of copper(II)##2##6##(2008-10#2)
the separation and preconcentration of the##2##6##(2008-10#2)
the separation and preconcentration of##13##5##(2008-10#13)
the separation and preconcentration##14##4##(2008-10#14)
the separation and the##2##4##(2008-10#2)
the separation and##50##3##(2008-10#48)(2008-12#2)
the separation between the##4##4##(2008-10#2)(2008-6#1)(2009-2#1)
the separation between##5##3##(2008-10#3)(2008-6#1)(2009-2#1)
the separation capillary##2##3##(2008-10#2)
the separation channel##3##3##(2008-10#3)
the separation conditions##2##3##(2008-10#2)
the separation distance##3##3##(2008-2#2)(2013-1#1)
the separation factor##2##3##(2008-10#2)
the separation of DNA fragments##2##5##(2008-10#1)(2008-4#1)
the separation of a##2##4##(2008-10#2)
the separation of basic compounds##2##5##(2008-10#2)
the separation of neutral##2##4##(2008-10#2)
the separation of six##2##4##(2008-10#2)
the separation of the three##2##5##(2008-10#2)
the separation of the##10##4##(2008-10#10)
the separation of##90##3##(1991-12#1)(1991-6#1)(1993-8#1)(2008-10#81)(2008-11#2)(2008-4#1)(2008-9#1)(2010-7#2)
the separation##184##2##(1991-12#1)(1991-6#1)(1993-8#1)(2008-10#161)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-7#3)(2011-2#1)(2013-1#1)
the separation-of-variables method##2##3##(2008-3#2)
the separations##2##2##(2008-10#2)
the septa were##3##3##(2008-7#3)
the septum##9##2##(1991-8#1)(1994-2#2)(1994-8#1)(1996-12#2)(1997-3#1)(2008-10#1)(2008-9#1)
the sequence analysis of##3##4##(2008-10#2)(2008-8#1)
the sequence and expression##2##4##(1992-9#1)(2012-2#1)
the sequence and primer##2##4##(2008-4#1)(2008-9#1)
the sequence and##5##3##(1992-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
the sequence from the##2##4##(2008-10#1)(2008-8#1)
the sequence from##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
the sequence homology##2##3##(1995-2#1)(2008-9#1)
the sequence of a##6##4##(1990-11#1)(1990-2#1)(1993-6#1)(1994-6#1)(2008-10#2)
the sequence of events##4##4##(1990-9#1)(2008-11#1)(2008-4#1)(2012-3#1)
the sequence of the##11##4##(1994-11#1)(1996-2#1)(1996-8#1)(2008-10#6)(2008-4#1)(2008-8#1)
the sequence of##42##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1992-3#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-6#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-8#1)(2008-10#13)(2008-11#2)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-4#1)(2010-6#1)(2012-3#1)
the sequence was##2##3##(1991-9#1)(1996-6#1)
the sequence##98##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-9#2)(1992-10#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#2)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#4)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-8#7)(2008-9#5)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
the sequence-specific##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
the sequenced##7##2##(1995-8#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-8#1)
the sequences in##3##3##(1996-2#1)(1997-6#1)(1997-8#1)
the sequences of 40##2##4##(1995-8#1)(1996-2#1)
the sequences of the##6##4##(1992-6#1)(1993-8#1)(1995-11#1)(1996-6#1)(2008-9#1)(2010-5#1)
the sequences of##16##3##(1992-6#1)(1993-8#1)(1995-11#1)(1995-8#2)(1996-2#2)(1996-6#2)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#1)
the sequences were##2##3##(1995-8#1)(2008-8#1)
the sequences with##2##3##(2008-10#1)(2011-3#1)
the sequences##36##2##(1991-6#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-8#4)(1996-2#3)(1996-6#3)(1997-2#1)(1997-6#2)(1997-8#2)(2008-10#4)(2008-8#2)(2008-9#3)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)
the sequencing and##2##3##(2012-2#1)(2012-3#1)
the sequencing of the##2##4##(1995-12#1)(2010-8#1)
the sequencing of##4##3##(1995-12#1)(2008-10#2)(2010-8#1)
the sequencing##8##2##(1995-12#1)(2008-10#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
the sequential determination of ammonium and nitrate##2##7##(2008-10#2)
the sequential determination of##5##4##(2008-10#5)
the sequential injection system##2##4##(2008-10#2)
the sequential injection##12##3##(2008-10#12)
the sequential methylation of##2##4##(1994-8#2)
the sequential probability ratio test##2##5##(2008-10#2)
the sequential separation of##2##4##(2008-10#2)
the sequential simplex##2##3##(2008-10#2)
the sequential structure of##2##4##(2008-11#2)
the sequential##41##2##(1993-8#1)(1994-8#2)(1995-2#2)(1995-8#1)(2008-10#30)(2008-11#2)(2008-12#2)(2011-2#1)
the sequestering##2##2##(2008-10#1)(2009-7#1)
the sera from##4##3##(1994-3#2)(2008-8#1)(2013-8#1)
the sera##14##2##(1990-12#2)(1991-5#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#4)(2008-10#1)(2008-8#2)(2013-8#1)
the serial##3##2##(1993-8#1)(2008-11#1)(2010-1#1)
the serial-transfer##3##2##(1997-6#3)
the series of experiments##2##4##(2008-7#1)(2011-2#1)
the series of##4##3##(1994-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
the series was##2##3##(1990-2#1)(2011-2#1)
the series##16##2##(1990-2#1)(1992-12#1)(1994-8#1)(1995-8#1)(2008-10#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#2)
the serine proteinase##2##3##(1993-3#1)(1995-6#1)
the serine receptor##2##3##(1994-5#2)
the serine##9##2##(1993-3#1)(1994-11#1)(1994-5#2)(1995-6#1)(1997-1#1)(2008-11#1)(2008-4#1)(2009-10#1)
the serine/threonine##2##2##(1994-11#1)(1996-2#1)
the serious##5##2##(1990-6#1)(2009-6#2)(2012-12#1)(2013-1#1)
the seriousness of##2##3##(1990-3#1)(2012-3#1)
the serogroup##2##2##(2008-5#1)(2012-2#1)
the serological##4##2##(1995-12#1)(1997-8#1)(2008-10#2)
the seroprevalence##2##2##(2011-2#2)
the serosa membrane##2##3##(2007-12#2)
the serotonergic##2##2##(2008-7#1)(2012-3#1)
the serotonin##6##2##(1993-3#1)(2008-5#2)(2008-6#1)(2012-3#2)
the serotype of##2##3##(2008-10#1)(2008-5#1)
the serotype##5##2##(2008-10#1)(2008-5#4)
the serum and##4##3##(1997-8#2)(2008-10#2)
the serum c-erbB-2 protein level##2##5##(1993-1#2)
the serum concentrations of##3##4##(1990-3#1)(1997-5#1)(2008-10#1)
the serum free##2##3##(1995-12#1)(2008-11#1)
the serum homocysteine##2##3##(2008-11#2)
the serum levels of##2##4##(2008-1#1)(2008-10#1)
the serum neutralisation##2##3##(1991-3#2)
the serum of##7##3##(1990-2#1)(1992-9#1)(1993-2#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
the serum triglyceride##3##3##(1991-12#3)
the serum##53##2##(1990-2#1)(1990-3#1)(1991-12#4)(1991-3#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-5#1)(1997-8#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the serum-free##3##2##(2008-11#2)(2008-4#1)
the serum-independent cells##2##3##(2008-11#2)
the serum-supplemented##5##2##(2008-11#5)
the service being provided##2##4##(2011-2#2)
the service##20##2##(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1995-2#3)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)
the services that##2##3##(1993-12#2)
the services##9##2##(1991-3#1)(1993-12#2)(1993-3#1)(1994-1#1)(1996-1#1)(2011-1#1)(2012-3#2)
the session##4##2##(1991-12#2)(2008-6#1)(2010-1#1)
the sessions##4##2##(2008-10#1)(2008-11#1)(2010-11#1)(2013-8#1)
the set of resources##2##4##(2008-8#2)
the set of##13##3##(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#3)(2010-1#1)(2013-1#2)
the set up##2##3##(2008-10#2)
the set##22##2##(1990-11#2)(1992-12#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#3)(2010-1#1)(2011-2#1)(2013-1#3)
the sets of##3##3##(1993-8#1)(2008-9#1)(2011-2#1)
the setting of a##3##4##(2008-4#1)(2008-9#1)(2010-10#1)
the setting of the encounters##2##5##(1991-6#2)
the setting of the##3##4##(1991-6#2)(2008-3#1)
the setting of##24##3##(1991-2#1)(1991-6#2)(1996-12#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the setting##25##2##(1991-2#1)(1991-6#2)(1994-12#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the settlement period##2##3##(2008-9#2)
the settlement##5##2##(1990-12#1)(1995-12#1)(1996-5#1)(2008-9#2)
the setup##4##2##(1994-2#1)(2008-9#1)(2010-12#1)(2013-8#1)
the seven metal ions##4##4##(2008-10#4)
the seven metals##2##3##(2008-10#2)
the seven patients##2##3##(1996-1#1)(1996-6#1)
the seven##25##2##(1994-2#1)(1996-1#1)(1996-6#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
the seventeenth century##2##3##(2010-1#1)(2013-8#1)
the seventeenth##3##2##(2010-1#1)(2011-2#1)(2013-8#1)
the seventh and eighth##2##4##(2008-10#1)(2011-2#1)
the seventh and##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
the seventh##11##2##(1993-8#1)(1994-11#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the several##6##2##(1991-5#1)(1992-1#1)(2008-10#2)(2008-12#1)(2012-3#1)
the severe##14##2##(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2010-2#1)(2013-1#1)
the severity and##6##3##(1990-12#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#2)
the severity of Fusarium wilt##3##5##(2008-10#3)
the severity of bacterial leaf spot of radish##2##8##(2008-10#2)
the severity of bacterial##3##4##(2008-10#3)
the severity of disease##4##4##(1994-9#1)(2008-10#2)(2012-3#1)
the severity of leaf##2##4##(2008-10#2)
the severity of non-randomness##2##4##(1995-12#2)
the severity of symptoms at discharge##2##6##(2011-2#2)
the severity of symptoms##4##4##(2008-10#2)(2011-2#2)
the severity of the clinical picture##2##6##(1997-6#2)
the severity of the disease##7##5##(1990-9#1)(1991-2#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-3#1)
the severity of the##20##4##(1990-9#1)(1991-2#1)(1993-1#1)(1997-2#2)(1997-6#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#4)(2012-3#1)
the severity of their##2##4##(1995-11#1)(2008-11#1)
the severity of this condition##2##5##(2010-1#1)(2011-2#1)
the severity of this disease##2##5##(2008-10#2)
the severity of this##4##4##(2008-10#2)(2010-1#1)(2011-2#1)
the severity of##79##3##(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1997-2#2)(1997-5#2)(1997-6#2)(1997-8#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-5#6)(2008-6#2)(2008-7#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#10)(2012-3#2)(2013-1#2)
the severity or##2##3##(2008-5#1)(2012-3#1)
the severity##92##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1997-2#2)(1997-5#2)(1997-6#2)(1997-8#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-5#8)(2008-6#2)(2008-7#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-7#2)(2010-8#2)(2011-2#12)(2012-3#3)(2013-1#3)(2013-8#1)
the sex differences##2##3##(2008-4#1)(2012-3#1)
the sex pheromone##3##3##(2008-10#2)(2013-8#1)
the sex ratio##4##3##(1991-11#1)(2008-9#1)(2012-3#2)
the sex##20##2##(1990-2#1)(1991-11#1)(1994-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-3#4)(2013-1#1)(2013-8#1)
the sex-related differences in liver ID1##2##6##(1995-12#2)
the sex-related differences##3##3##(1995-12#3)
the sex-specific##3##2##(2010-5#1)(2012-3#1)(2013-8#1)
the sexes##8##2##(2008-7#2)(2008-8#2)(2009-10#1)(2012-3#2)(2013-8#1)
the sexual abuse of##3##4##(1996-11#2)(2009-9#1)
the sexual behaviour of##3##4##(1990-9#1)(1996-11#1)(2008-11#1)
the sexual risk##2##3##(2008-12#2)
the sexual stage##3##3##(2008-10#3)
the sexual state##3##3##(2008-10#3)
the sexual##28##2##(1990-9#1)(1992-9#1)(1993-3#1)(1994-2#1)(1996-11#3)(1996-2#1)(1996-3#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#1)
the sexually##3##2##(1992-3#1)(1995-5#1)(2007-12#1)
the shaded##2##2##(2008-9#2)
the shadow##2##2##(2008-3#1)(2008-6#1)
the sham##2##2##(1995-11#1)(2011-2#1)
the shampoo##4##2##(2008-10#1)(2008-5#3)
the shape and##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
the shape of the##22##4##(1994-8#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2012-3#1)
the shape of##30##3##(1991-2#1)(1993-3#1)(1994-8#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2012-3#1)
the shape##36##2##(1991-2#1)(1993-3#1)(1994-8#1)(1995-9#2)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#11)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-3#1)(2012-3#1)
the shapes of the##2##4##(2008-10#1)(2008-9#1)
the shapes of these##2##4##(2008-7#1)(2008-9#1)
the shapes of##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)
the shaping##2##2##(2008-10#1)(2008-11#1)
the share of health##2##4##(1995-3#1)(1997-3#1)
the share of##6##3##(1991-2#1)(1992-12#1)(1992-2#1)(1995-3#1)(1997-3#1)(2013-1#1)
the shared##7##2##(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#3)(2010-11#1)
the sharing of##3##3##(2008-11#2)(2010-8#1)
the sharp##2##2##(2007-12#1)(2008-7#1)
the shear rate##2##3##(2009-10#1)(2013-1#1)
the shear##4##2##(2008-11#2)(2009-10#1)(2013-1#1)
the sheath##6##2##(2007-12#2)(2008-10#3)(2010-5#1)
the sheep##8##2##(1996-12#3)(1997-7#1)(2008-10#3)(2008-8#1)
the shelf life##2##3##(2008-10#1)(2010-7#1)
the shelf##5##2##(2008-10#1)(2010-7#1)(2010-8#3)
the shell and##2##3##(2008-10#1)(2008-7#1)
the shell##7##2##(1995-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2012-2#1)
the shift from##2##3##(1992-2#1)(1995-11#1)
the shift in the##2##4##(2009-2#1)(2011-2#1)
the shift in##5##3##(1993-12#1)(2008-10#1)(2009-11#1)(2009-2#1)(2011-2#1)
the shift of##5##3##(1995-2#1)(2008-10#2)(2008-11#2)
the shift to##3##3##(1997-2#1)(2008-11#2)
the shift##19##2##(1991-3#1)(1992-2#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-9#1)(2009-11#1)(2009-2#1)(2011-2#1)
the shifting##2##2##(1993-12#1)(2008-10#1)
the shifts##2##2##(1992-2#1)(2008-5#1)
the shock-probe burying##4##3##(1993-3#4)
the shock-probe##5##2##(1993-3#4)(1994-2#1)
the shoe-surface interface##3##3##(2013-1#3)
the shoot and root##2##4##(2009-8#2)
the shoot from##2##3##(2008-10#2)
the shoot##8##2##(2008-10#4)(2008-8#1)(2009-8#3)
the shooting##3##2##(1991-3#1)(1995-11#2)
the shoots##2##2##(2008-10#1)(2008-11#1)
the short arm of chromosome 5(1H)##2##6##(2008-10#2)
the short arm of chromosome##11##5##(1997-2#1)(2008-10#7)(2008-4#1)(2012-3#2)
the short arm of##18##4##(1996-2#1)(1997-2#1)(2008-10#13)(2008-4#1)(2012-3#2)
the short arm##19##3##(1996-2#1)(1997-2#1)(2008-10#14)(2008-4#1)(2012-3#2)
the short term##2##3##(1993-6#1)(2010-1#1)
the short time##2##3##(1990-9#1)(2008-10#1)
the short##43##2##(1990-9#1)(1991-12#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(1996-2#2)(1997-2#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the short- and long-term##5##4##(2011-1#1)(2012-2#1)(2013-1#3)
the short- and##7##3##(2008-3#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#3)
the short-##8##2##(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
the short-term##10##2##(1995-11#2)(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
the short-wavelength edge of##2##4##(2007-12#1)(2008-3#1)
the short-wavelength##3##2##(2007-12#1)(2008-3#2)
the shortage of##2##3##(2008-7#1)(2011-2#1)
the shorter##6##2##(1990-2#1)(1995-8#2)(2008-10#1)(2008-5#1)(2008-7#1)
the shortest##8##2##(1991-2#1)(1992-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2013-8#1)
the shoulder and##2##3##(1990-12#1)(1997-5#1)
the shoulder of##3##3##(1997-5#1)(2008-12#2)
the shoulder##18##2##(1990-12#1)(1997-5#4)(1997-6#1)(2008-12#2)(2008-8#1)(2009-1#2)(2011-2#1)(2012-2#2)(2013-1#4)
the shrinkage##3##2##(2010-10#1)(2012-2#2)
the shuttle##3##2##(2008-8#3)
the sibling##2##2##(2008-10#1)(2010-9#1)
the sickest##2##2##(1991-3#1)(2008-7#1)
the side branch##2##3##(2008-11#2)
the side chain in the protein##2##6##(2008-9#2)
the side chain of##3##4##(1992-1#1)(1994-5#1)(2008-10#1)
the side chain##6##3##(1992-1#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-9#2)
the side chains of##2##4##(1992-4#1)(1993-8#1)
the side chains##7##3##(1992-4#1)(1993-12#2)(1993-8#1)(1995-6#1)(2008-10#2)
the side effects were##2##4##(1991-8#1)(1996-11#1)
the side effects##9##3##(1991-2#1)(1991-8#1)(1992-12#1)(1993-1#1)(1996-11#1)(1997-3#1)(1997-4#1)(2008-8#1)(2010-11#1)
the side of the##3##4##(2008-10#2)(2008-6#1)
the side reaction##2##3##(2008-10#2)
the side##37##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-5#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#2)
the side-chain##2##2##(1994-5#1)(2008-8#1)
the side-effects##2##2##(1990-2#1)(2008-7#1)
the sides of##2##3##(2007-12#1)(2008-10#1)
the sight of##3##3##(1993-6#3)
the sight##4##2##(1993-6#3)(2011-2#1)
the sigma##8##2##(1991-6#1)(1992-5#1)(1993-12#1)(1995-2#2)(1995-6#1)(1996-3#1)(2012-2#1)
the sigmoid colon##5##3##(1991-6#1)(2010-12#2)(2011-2#2)
the sigmoid sinus##2##3##(1996-9#1)(2008-7#1)
the sigmoid##9##2##(1991-6#1)(1996-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#2)
the sign and magnitude of the##2##6##(2008-10#1)(2008-8#1)
the sign of the##4##4##(2007-11#1)(2008-3#1)(2008-7#1)(2009-7#1)
the sign of##5##3##(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)
the sign##7##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
the signal and the idler##2##5##(2008-2#1)(2008-3#1)
the signal and the##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
the signal and##6##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
the signal beam##2##3##(2008-3#2)
the signal becomes##2##3##(2008-3#2)
the signal for##3##3##(1993-12#1)(1995-8#1)(1996-3#1)
the signal from##3##3##(2008-12#1)(2008-4#1)(2012-2#1)
the signal height##2##3##(1993-8#1)(2008-10#1)
the signal intensities##2##3##(2008-10#1)(2012-3#1)
the signal intensity##5##3##(1996-2#1)(2008-10#2)(2008-3#2)
the signal is##3##3##(2008-10#2)(2008-3#1)
the signal of the##2##4##(2008-10#2)
the signal of##3##3##(2008-10#3)
the signal peptide##2##3##(2008-6#1)(2010-6#1)
the signal quality##2##3##(2008-10#1)(2010-8#1)
the signal recognition##2##3##(1995-6#2)
the signal response of##2##4##(2008-10#2)
the signal response##3##3##(1996-2#1)(2008-10#2)
the signal sequence and##3##4##(1991-6#1)(2008-11#2)
the signal sequence was##2##4##(1991-10#2)
the signal sequence##10##3##(1991-10#3)(1991-6#3)(2008-11#4)
the signal to noise ratio##2##5##(2008-10#2)
the signal to##5##3##(1991-3#1)(2008-10#4)
the signal transducer##2##3##(1996-2#1)(2008-8#1)
the signal transducing##2##3##(1994-11#1)(2009-4#1)
the signal transduction pathways##4##4##(1994-11#1)(2008-10#2)(2008-11#1)
the signal transduction##10##3##(1990-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)
the signal was##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
the signal##111##2##(1990-12#1)(1990-8#1)(1991-10#3)(1991-3#1)(1991-6#3)(1993-12#1)(1993-8#2)(1994-11#2)(1994-3#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-2#5)(1996-3#1)(1997-7#2)(1997-8#2)(2007-11#1)(2008-10#35)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#20)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the signal-sequence cleavage site##3##4##(1991-6#3)
the signal-to-noise ratio of##4##4##(2008-10#3)(2008-3#1)
the signal-to-noise ratio##11##3##(2007-12#1)(2008-10#4)(2008-3#5)(2012-3#1)
the signal-to-noise##13##2##(2007-12#1)(2008-10#6)(2008-3#5)(2012-3#1)
the signaler##2##2##(2008-9#2)
the signaling pathway##3##3##(1994-11#2)(2008-11#1)
the signaling pathways##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
the signaling##11##2##(1994-11#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-4#1)
the signals from##3##3##(2008-10#3)
the signals of##2##3##(2008-10#1)(2008-8#1)
the signals##13##2##(1994-6#1)(2008-10#7)(2008-3#1)(2008-8#1)(2009-7#1)(2010-7#1)(2013-7#1)
the significance level##2##3##(2008-10#1)(2008-12#1)
the significance of the##18##4##(1991-9#1)(1994-11#1)(1995-3#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2009-6#1)(2009-7#1)(2009-8#1)(2012-3#2)(2013-8#1)
the significance of this##5##4##(1993-1#1)(1993-12#1)(2009-3#1)(2011-2#1)(2012-3#1)
the significance of##52##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#3)(2013-8#2)
the significance##56##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#3)(2013-8#3)
the significant factors##3##3##(2008-10#3)
the significant increase in the##2##5##(1994-5#1)(2009-8#1)
the significant increase in##3##4##(1994-5#1)(2009-8#2)
the significant increase##4##3##(1994-5#1)(2009-8#3)
the significant role of##2##4##(2008-10#1)(2013-8#1)
the significant role##4##3##(2008-10#2)(2008-7#1)(2013-8#1)
the significant variables##2##3##(2008-10#2)
the significant##35##2##(1992-2#1)(1993-1#1)(1994-2#1)(1994-5#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-7#1)(2009-3#1)(2009-8#3)(2010-12#1)(2010-6#1)(2011-3#1)(2012-3#1)(2013-8#2)
the significantly##6##2##(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the signs of##2##3##(2008-11#1)(2013-8#1)
the signs##3##2##(1996-9#1)(2008-11#1)(2013-8#1)
the silage##2##2##(1990-6#1)(2013-1#1)
the silenced transgenic rice##2##4##(2008-9#2)
the silencing##2##2##(2008-10#1)(2011-2#1)
the silica content##2##3##(2008-10#2)
the silica gel##5##3##(2008-10#5)
the silica surface##4##3##(2008-10#4)
the silica##20##2##(2008-10#20)
the silica-based##2##2##(1997-2#2)
the silicon##7##2##(2008-10#6)(2008-8#1)
the silicone##2##2##(2008-10#1)(2008-5#1)
the silkworm##9##2##(1995-11#5)(2008-10#2)(2008-11#1)(2008-9#1)
the silver##9##2##(2008-10#8)(2008-3#1)
the similar##7##2##(1993-8#1)(1994-11#1)(2008-10#2)(2008-8#1)(2012-3#1)(2013-8#1)
the similarities between##2##3##(1993-3#1)(2008-11#1)
the similarities##3##2##(1993-3#1)(2008-11#2)
the similarity of the##4##4##(2008-10#3)(2009-8#1)
the similarity of##5##3##(2008-10#3)(2008-9#1)(2009-8#1)
the similarity to##2##3##(1993-8#1)(2008-5#1)
the similarity##9##2##(1993-8#1)(1995-6#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-8#1)
the simple determination of##2##4##(2008-10#2)
the simple##26##2##(1990-5#1)(1991-2#1)(1992-3#1)(1993-12#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
the simplest and most##3##4##(1990-5#1)(2008-10#2)
the simplest##15##2##(1990-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-8#1)
the simplex method##3##3##(2008-10#3)
the simplex##4##2##(2008-10#4)
the simplicity of this##2##4##(2008-10#2)
the simplicity##3##2##(2008-10#2)(2010-5#1)
the simulated##10##2##(2008-10#8)(2008-11#1)(2008-3#1)
the simulation experiments##2##3##(2008-10#2)
the simulation of##2##3##(2008-10#2)
the simulation##9##2##(2008-10#6)(2008-3#2)(2008-8#1)
the simulations##5##2##(1992-3#1)(2008-10#3)(2008-3#1)
the simultaneous addition of##2##4##(2008-10#1)(2009-8#1)
the simultaneous administration of##2##4##(1991-3#1)(1992-6#1)
the simultaneous analysis of##8##4##(2008-10#6)(2008-3#1)(2008-4#1)
the simultaneous and##2##3##(2008-11#1)(2008-5#1)
the simultaneous binding of##2##4##(1990-12#1)(1994-5#1)
the simultaneous detection of##10##4##(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)
the simultaneous determination of As##3##5##(2008-10#3)
the simultaneous determination of NA and OH-NA in urine##2##9##(2008-10#2)
the simultaneous determination of Vitamin D(3) and##2##7##(2008-10#2)
the simultaneous determination of both##3##5##(2008-10#3)
the simultaneous determination of copper and##2##6##(2008-10#2)
the simultaneous determination of lead##3##5##(2008-10#3)
the simultaneous determination of nitrite and nitrate in water samples##2##10##(2008-10#2)
the simultaneous determination of nitrite and nitrate in##4##8##(2008-10#4)
the simultaneous determination of nitrite and nitrate##6##7##(2008-10#6)
the simultaneous determination of the##9##5##(2008-10#9)
the simultaneous determination of three##3##5##(2008-10#3)
the simultaneous determination of trace amounts of##2##7##(2008-10#2)
the simultaneous determination of trace##5##5##(2008-10#5)
the simultaneous determination of##125##4##(1995-3#2)(2008-10#122)(2009-6#1)
the simultaneous determination##126##3##(1995-3#2)(2008-10#123)(2009-6#1)
the simultaneous identification and quantitative determination of##2##7##(2008-5#2)
the simultaneous identification and##3##4##(2008-5#2)(2008-9#1)
the simultaneous influence of##3##4##(1995-12#1)(2009-1#1)(2009-7#1)
the simultaneous multielement determination##2##4##(2008-10#2)
the simultaneous separation and##3##4##(2008-10#3)
the simultaneous separation##4##3##(2008-10#4)
the simultaneous spectrophotometric determination of##9##5##(2008-10#9)
the simultaneous##213##2##(1990-12#1)(1991-3#1)(1992-6#1)(1994-5#1)(1995-12#1)(1995-3#2)(2007-12#1)(2008-10#177)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2013-1#2)
the single application##2##3##(2008-10#2)
the single cell##5##3##(1994-8#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
the single cultures##3##3##(2013-1#3)
the single dominant gene##4##4##(2008-10#4)
the single most##5##3##(1993-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)
the single zoospore isolates##3##4##(2008-10#3)
the single##67##2##(1993-1#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-6#3)(1996-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-9#1)(2011-2#6)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#2)
the single-cell##2##2##(2008-11#1)(2009-12#1)
the single-channel##2##2##(1997-6#2)
the single-charged##3##2##(2008-10#3)
the single-ion##2##2##(2008-10#1)(2010-7#1)
the single-molecule level##2##3##(1997-6#1)(2013-8#1)
the single-pass##2##2##(1997-2#1)(2008-3#1)
the single-scattering albedo##4##3##(2008-3#4)
the single-shot##2##2##(2007-12#1)(2008-3#1)
the single-stranded DNA##2##3##(1992-3#1)(2008-10#1)
the single-stranded##7##2##(1990-5#1)(1992-3#1)(1993-1#1)(2008-10#3)(2008-11#1)
the sink##5##2##(2008-10#2)(2008-8#2)(2008-9#1)
the sinonasal##2##2##(1990-6#1)(2011-2#1)
the sinus gland##5##3##(2008-5#2)(2008-6#3)
the sinus##14##2##(1992-6#1)(1996-9#1)(1997-5#3)(2008-5#2)(2008-6#3)(2008-7#2)(2013-1#1)(2013-8#1)
the sinuses and##2##3##(2008-7#1)(2011-2#1)
the sinuses##3##2##(2008-7#1)(2011-2#2)
the sinusoidal GSH transporter##2##4##(1995-2#2)
the sinusoidal##3##2##(1995-2#2)(2008-11#1)
the sister##2##2##(2007-12#1)(2008-6#1)
the site II##2##3##(2008-10#2)
the site for##2##3##(2008-10#1)(2008-5#1)
the site had##2##3##(2008-10#1)(2012-12#1)
the site of action##2##4##(1991-2#1)(2011-2#1)
the site of application##5##4##(2008-9#5)
the site of biological##2##4##(2008-11#1)(2008-5#1)
the site of infection##8##4##(1996-8#1)(1997-1#1)(2008-10#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-12#2)
the site of inoculation##2##4##(2008-10#2)
the site of the primary##2##5##(1991-6#1)(2013-1#1)
the site of the##8##4##(1991-3#1)(1991-6#1)(1993-8#1)(2006-6#1)(2008-11#1)(2010-12#1)(2013-1#2)
the site of##59##3##(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#3)(1994-9#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#3)(2008-8#1)(2008-9#7)(2009-8#1)(2010-12#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-9#1)(2013-1#2)
the site##85##2##(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-3#2)(2008-5#4)(2008-8#3)(2008-9#7)(2009-8#1)(2010-12#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#3)(2013-8#1)
the site-directed##3##2##(2008-8#2)(2008-9#1)
the sites of##9##3##(1990-5#1)(1993-8#1)(1994-5#1)(1996-2#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-5#1)(2013-7#1)
the sites##22##2##(1990-5#1)(1990-8#1)(1992-1#1)(1993-8#1)(1994-5#3)(1996-2#1)(1997-8#1)(1997-9#1)(2008-10#6)(2008-5#3)(2011-1#1)(2013-1#1)(2013-7#1)
the situation of##2##3##(2009-5#1)(2013-8#1)
the situation##23##2##(1991-5#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-1#1)(1995-11#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
the six common apo-E genotypes##2##5##(2008-10#2)
the six##34##2##(1990-5#1)(1991-6#1)(1992-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-1#2)(2008-10#12)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#4)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
the sixth##11##2##(1990-12#1)(1993-8#1)(1995-8#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2010-9#1)(2012-12#1)(2012-2#1)
the size and the##5##4##(1996-3#1)(2008-10#2)(2008-3#2)
the size and##18##3##(1992-8#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-10#5)(2008-3#2)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
the size distribution of##4##4##(1991-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
the size distribution##8##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2009-5#1)
the size fractionation of##2##4##(2008-10#2)
the size fractionation##3##3##(2008-10#3)
the size of a##4##4##(1994-3#2)(2008-3#1)(2013-1#1)
the size of the wax matrix was##2##7##(2008-5#2)
the size of the wax matrix##4##6##(2008-5#4)
the size of the##60##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-2#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the size of##88##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1993-8#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-9#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-8#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
the size range of##3##4##(1995-3#1)(2008-3#1)(2008-7#1)
the size range##6##3##(1995-3#1)(2008-3#1)(2008-7#4)
the size##137##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#4)(1996-6#3)(1997-1#1)(1997-2#2)(1997-7#1)(1997-9#1)(2008-1#1)(2008-10#34)(2008-11#4)(2008-3#12)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
the sizes and##2##3##(1997-6#1)(2007-12#1)
the sizes of##3##3##(2008-10#1)(2008-8#1)(2010-7#1)
the sizes##5##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-7#1)
the skeletal muscle 6-phosphofructo-2-kinase reaction##2##5##(1993-8#2)
the skeletal muscle sodium channel gene##2##6##(1992-3#2)
the skeletal muscle##5##3##(1991-9#1)(1992-3#2)(1993-8#2)
the skew##2##2##(2008-8#2)
the skill of##3##3##(2008-11#3)
the skill set##3##3##(2007-12#3)
the skill##7##2##(1991-3#1)(2007-12#3)(2008-11#3)
the skills and processes##2##4##(2008-11#1)(2012-2#1)
the skills and##4##3##(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
the skills of##2##3##(2007-12#1)(2008-11#1)
the skills to##2##3##(2008-11#2)
the skills##12##2##(1994-2#1)(2007-12#2)(2008-11#4)(2008-12#3)(2011-2#1)(2012-2#1)
the skin and the##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
the skin and##15##3##(1991-11#1)(1991-8#1)(1992-6#2)(2008-1#1)(2008-10#1)(2008-5#8)(2012-2#1)
the skin are##2##3##(2008-11#1)(2008-5#1)
the skin barrier##3##3##(2008-5#3)
the skin compatibility of surfactant-based products##2##6##(2008-5#2)
the skin could be##2##4##(2008-5#2)
the skin from##2##3##(2008-10#1)(2011-2#1)
the skin has##2##3##(2008-5#2)
the skin in##3##3##(2008-10#1)(2008-5#1)(2011-3#1)
the skin infection##2##3##(2008-12#2)
the skin is##3##3##(2008-5#1)(2008-9#1)(2013-8#1)
the skin of patients##2##4##(1992-3#1)(1992-8#1)
the skin of the##5##4##(1990-6#1)(1994-5#1)(2008-5#2)(2008-7#1)
the skin of##12##3##(1990-6#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)(2008-5#3)(2008-7#1)(2011-3#1)
the skin or the##2##4##(2008-10#1)(2008-5#1)
the skin or##4##3##(1996-1#1)(2008-10#2)(2008-5#1)
the skin surface##18##3##(2008-10#1)(2008-5#17)
the skin to##2##3##(2008-5#2)
the skin type##2##3##(2008-5#1)(2011-2#1)
the skin was##3##3##(2008-11#1)(2008-5#2)
the skin with##2##3##(2008-5#2)
the skin##188##2##(1990-6#2)(1991-11#2)(1991-2#1)(1991-6#3)(1991-8#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-3#2)(1994-11#2)(1994-3#1)(1994-5#1)(1995-11#3)(1996-1#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-5#111)(2008-6#1)(2008-7#2)(2008-9#3)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-2#9)(2011-3#2)(2012-2#2)(2012-3#2)(2013-8#2)
the skin's##3##2##(2008-5#3)
the skin-color##3##2##(2008-6#3)
the skull base in##2##4##(2008-1#1)(2011-2#1)
the skull base was##2##4##(2011-2#2)
the skull base##12##3##(2008-1#2)(2008-7#3)(2011-2#7)
the skull##21##2##(1994-2#1)(2008-1#2)(2008-7#3)(2008-9#1)(2010-12#2)(2011-2#9)(2012-12#2)(2013-1#1)
the sky polarization pattern##2##4##(2007-12#2)
the sky radiometer##3##3##(2008-2#3)
the sky##7##2##(2007-12#2)(2008-2#3)(2008-3#2)
the slab##4##2##(1995-6#3)(2007-12#1)
the slag##2##2##(2008-10#2)
the sleep##4##2##(2009-8#3)(2010-8#1)
the sleeping time##2##3##(1995-12#2)
the sleeping##3##2##(1995-12#2)(2010-1#1)
the slides##4##2##(2008-10#2)(2008-12#1)(2008-4#1)
the sliding##2##2##(1990-9#1)(2008-5#1)
the slight##4##2##(1991-2#1)(1996-3#1)(2008-10#1)(2008-11#1)
the slope and intercept##2##4##(2008-10#2)
the slope and##3##3##(2008-10#3)
the slope of the calibration curve##2##6##(2008-10#2)
the slope of the calibration##4##5##(2008-10#4)
the slope of the##15##4##(1995-3#1)(1997-2#1)(2008-10#10)(2008-8#3)
the slope of##18##3##(1991-5#1)(1995-3#1)(1997-2#1)(2008-10#11)(2008-8#3)(2009-8#1)
the slope was##3##3##(1995-8#1)(2008-10#2)
the slope##36##2##(1991-5#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-10#24)(2008-2#1)(2008-8#3)(2009-8#2)(2010-8#1)(2011-2#1)
the slopes of the##3##4##(2008-10#2)(2012-3#1)
the slopes of##5##3##(2008-10#4)(2012-3#1)
the slopes##6##2##(2008-10#5)(2012-3#1)
the slow rate##2##3##(2008-9#2)
the slow variant##2##3##(1991-12#2)
the slow##20##2##(1991-12#3)(1992-2#1)(1993-12#1)(1993-8#1)(1995-2#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-12#1)
the slower##2##2##(2008-10#1)(2011-2#1)
the slowest##5##2##(1997-3#1)(2008-10#2)(2008-11#1)(2013-8#1)
the slurry and the##2##4##(2008-10#2)
the slurry sampling technique were##2##5##(2008-10#2)
the slurry sampling##3##3##(2008-10#3)
the slurry##11##2##(2008-10#11)
the small amount of##2##4##(1996-9#1)(2008-10#1)
the small and large##2##4##(1990-11#1)(1994-11#1)
the small and##6##3##(1990-11#1)(1994-11#1)(1997-8#1)(2008-10#2)(2012-3#1)
the small bowel in##3##4##(1990-8#1)(2011-2#2)
the small bowel##12##3##(1990-11#2)(1990-2#1)(1990-8#1)(2009-1#1)(2010-12#3)(2011-2#4)
the small dense LDL phenotype##2##5##(2008-3#2)
the small dense##4##3##(2008-3#4)
the small intestine##14##3##(1990-11#1)(1992-5#1)(1995-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#3)(2013-1#5)
the small intestine]##2##3##(1990-11#1)(1992-5#1)
the small molecule##2##3##(2008-11#1)(2013-8#1)
the small number of##3##4##(1994-6#1)(1995-5#1)(2008-10#1)
the small sample size##3##4##(2008-11#1)(2008-12#1)(2011-2#1)
the small size of the##2##5##(1991-5#1)(2008-12#1)
the small size of##4##4##(1991-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
the small size##5##3##(1991-5#1)(2008-10#2)(2008-12#1)(2011-2#1)
the small subunit##2##3##(1993-12#1)(2013-8#1)
the small##97##2##(1990-11#5)(1990-2#2)(1990-8#2)(1991-5#2)(1991-6#1)(1992-5#2)(1993-12#1)(1993-6#1)(1994-11#3)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-3#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2011-2#9)(2011-3#1)(2012-3#3)(2013-1#5)(2013-8#4)
the small-angle approximation##3##3##(2008-3#3)
the small-angle##4##2##(2008-3#3)(2008-5#1)
the small-scale##3##2##(1994-8#1)(2008-10#2)
the smaller hospitals##2##3##(1990-11#1)(1992-6#1)
the smaller the##2##3##(2008-3#1)(2011-2#1)
the smaller##16##2##(1990-11#2)(1992-10#1)(1992-6#1)(1993-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#2)(2012-2#1)
the smallest and##2##3##(2008-9#1)(2011-2#1)
the smallest##24##2##(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#2)(2011-2#3)(2013-1#1)
the smoke##2##2##(1996-12#1)(2008-5#1)
the smokers##3##2##(1990-6#1)(1993-2#1)(2008-10#1)
the smoking##4##2##(1991-11#1)(1996-3#2)(2013-1#1)
the smooth muscle##4##3##(1993-8#1)(1994-6#1)(1997-1#1)(1997-3#1)
the smooth##8##2##(1993-8#1)(1994-6#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-8#1)
the snail##2##2##(2008-12#1)(2009-8#1)
the snails##2##2##(2008-11#1)(2008-12#1)
the so called &quot##2##4##(2008-6#1)(2013-1#1)
the so called##3##3##(2008-6#1)(2013-1#1)(2013-8#1)
the so##4##2##(2008-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
the so-called &quot##6##3##(1993-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#2)
the so-called sandwich membrane method##2##5##(2008-10#2)
the so-called##34##2##(1990-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-8#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-1#1)(2011-2#2)(2012-2#2)
the soccer group##2##3##(1996-6#2)
the social and cultural aspects of##2##6##(1993-11#1)(2011-2#1)
the social and economic##2##4##(2008-1#1)(2008-11#1)
the social and##8##3##(1993-11#2)(1996-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
the social elite##2##3##(2008-12#2)
the social organization of##2##4##(2008-9#1)(2010-1#1)
the social spider Anelosimus eximius##2##5##(2008-9#2)
the social support##3##3##(1992-3#1)(2011-2#2)
the social welfare##2##3##(1995-3#1)(2008-11#1)
the social##60##2##(1991-3#1)(1992-3#1)(1993-11#2)(1994-12#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-1#2)(2008-11#9)(2008-12#6)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
the social-sexual crossover point##2##4##(2008-9#2)
the society##3##2##(2008-10#1)(2011-3#1)(2012-2#1)
the society's##2##2##(2012-2#2)
the socio-economic##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
the sociodemographic##3##2##(1994-1#1)(2011-2#1)(2012-12#1)
the socioeconomic and##2##3##(1992-12#1)(1996-3#1)
the socioeconomic##5##2##(1992-12#1)(1996-3#1)(1997-5#1)(2008-12#1)(2008-6#1)
the sociologists##2##2##(2008-12#2)
the socket##2##2##(2008-10#1)(2013-1#1)
the sodium chloride##2##3##(1991-12#1)(2008-10#1)
the sodium pump##2##3##(2008-7#1)(2010-1#1)
the sodium##18##2##(1990-6#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-3#2)(1994-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2010-1#1)
the soft palate##2##3##(1990-6#1)(1991-3#1)
the soft tissue##5##3##(1994-6#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
the soft tissues##4##3##(2008-12#1)(2009-4#1)(2012-2#1)(2013-1#1)
the soft##16##2##(1990-5#1)(1990-6#1)(1991-3#1)(1994-6#1)(2007-8#1)(2008-10#4)(2008-12#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
the software##14##2##(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the soil and##4##3##(2008-10#4)
the soil in##2##3##(2008-10#2)
the soil microbial community##5##4##(2008-10#5)
the soil microflora##3##3##(2008-10#3)
the soil moisture##2##3##(2008-10#1)(2012-7#1)
the soil profile##3##3##(2008-10#3)
the soil sample##3##3##(2008-10#3)
the soil samples##4##3##(2008-10#4)
the soil surface was##2##4##(2008-10#2)
the soil surface##10##3##(2008-10#9)(2008-11#1)
the soil was##3##3##(2008-10#2)(2010-3#1)
the soil with##3##3##(2008-10#3)
the soil##101##2##(1995-3#1)(2008-10#80)(2008-11#9)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-3#2)(2010-7#1)(2012-7#1)
the soilborne pathogen##2##3##(2008-10#2)
the soilborne##8##2##(2008-10#8)
the soils amended with##2##4##(2008-10#2)
the soils##13##2##(2008-10#12)(2008-11#1)
the sol##3##2##(2008-10#3)
the sol-gel##6##2##(2008-10#6)
the solar spectrum##2##3##(2008-11#1)(2008-3#1)
the solar##5##2##(2008-11#1)(2008-3#3)(2008-7#1)
the sole or##2##3##(1994-8#1)(2011-2#1)
the sole source of##4##4##(1991-12#1)(2008-10#2)(2008-7#1)
the sole##34##2##(1990-9#1)(1991-12#1)(1991-9#1)(1992-5#1)(1993-3#1)(1994-8#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-5#2)(2011-1#1)(2011-2#2)(2011-3#1)(2013-8#1)
the solid and##2##3##(2008-10#2)
the solid mass consisting of the##3##6##(2008-10#3)
the solid mass is shaken with##2##6##(2008-10#2)
the solid mass##5##3##(2008-10#5)
the solid phase extraction of##4##5##(2008-10#4)
the solid phase extraction##7##4##(2008-10#7)
the solid phase with##2##4##(2008-10#2)
the solid phase##21##3##(1990-12#1)(1990-6#1)(1991-5#1)(1993-2#1)(2008-10#17)
the solid sample##3##3##(2008-10#3)
the solid state##3##3##(2008-10#3)
the solid substrate##4##3##(2008-10#4)
the solid support##10##3##(2008-10#8)(2008-4#2)
the solid surface##2##3##(2008-10#1)(2008-11#1)
the solid viewing angle of the sky radiometer##2##8##(2008-2#2)
the solid##72##2##(1990-12#1)(1990-6#1)(1991-5#1)(1993-2#1)(2007-11#1)(2008-10#57)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)
the solid-liquid##3##2##(2008-10#2)(2008-7#1)
the solid-phase extraction##3##3##(1992-11#1)(2008-10#2)
the solid-phase##11##2##(1992-11#1)(2008-10#9)(2008-4#1)
the solid-support assisted##2##3##(2008-10#2)
the solids##2##2##(2008-10#2)
the solitary##2##2##(1992-9#1)(2008-7#1)
the solubility and##2##3##(2008-10#2)
the solubility of UV filters##2##5##(2008-5#2)
the solubility of the##3##4##(2008-10#2)(2013-1#1)
the solubility of##13##3##(2008-10#9)(2008-4#1)(2008-5#2)(2013-1#1)
the solubility parameter##2##3##(2008-10#2)
the solubility##25##2##(2008-10#18)(2008-4#2)(2008-5#2)(2013-1#3)
the solubilized membrane preparation##2##4##(1991-5#2)
the soluble and microsomal##3##4##(1992-6#3)
the soluble and##5##3##(1992-6#3)(1994-11#1)(2008-10#1)
the soluble b5##2##3##(1992-6#2)
the soluble fumarate reductase##2##4##(1996-8#2)
the soluble protein##3##3##(1994-6#1)(1994-8#1)(2008-11#1)
the soluble##25##2##(1990-2#1)(1992-6#6)(1994-11#1)(1994-6#1)(1994-8#2)(1996-2#1)(1996-8#2)(1997-2#1)(2008-10#6)(2008-11#3)(2008-9#1)
the solute##15##2##(2008-10#12)(2008-3#1)(2008-4#1)(2013-1#1)
the solutes##6##2##(2008-10#6)
the solution and the##2##4##(2008-10#2)
the solution and##5##3##(2008-10#5)
the solution containing the##2##4##(2008-10#2)
the solution containing##3##3##(2008-10#3)
the solution for##2##3##(2008-10#2)
the solution in##2##3##(1995-3#1)(2008-10#1)
the solution is##5##3##(2008-10#4)(2008-2#1)
the solution of##5##3##(2008-10#1)(2008-4#2)(2009-10#1)(2011-2#1)
the solution pH##2##3##(2008-10#2)
the solution phase##3##3##(2008-10#3)
the solution structure of##4##4##(1994-5#3)(1995-8#1)
the solution structure##7##3##(1994-5#5)(1995-8#1)(2009-7#1)
the solution to##5##3##(1993-11#1)(1995-1#1)(2008-10#3)
the solution was##8##3##(2008-10#7)(2013-1#1)
the solution were##2##3##(2008-10#2)
the solution##108##2##(1990-5#1)(1991-3#2)(1992-6#1)(1993-11#1)(1994-5#5)(1995-1#1)(1995-3#1)(1995-8#1)(1996-3#1)(2008-10#75)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-9#2)(2009-10#2)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-7#1)(2013-1#1)
the solution?##3##2##(1995-1#2)(1995-2#1)
the solutions is##2##3##(2008-10#2)
the solutions of##4##3##(2008-10#4)
the solutions to##2##3##(1996-3#1)(2011-2#1)
the solutions##22##2##(1991-1#1)(1996-3#1)(1997-4#1)(2008-10#17)(2008-5#1)(2011-2#1)
the solvation structure and##2##4##(2010-7#2)
the solvation##4##2##(2010-7#3)(2011-3#1)
the solvent and the##3##4##(1996-5#1)(2008-10#2)
the solvent extraction##5##3##(1995-2#1)(2008-10#4)
the solvent mixture##2##3##(2008-10#2)
the solvent molecules##2##3##(2008-10#2)
the solvent systems##3##3##(2008-10#3)
the solvent##48##2##(1995-2#1)(1996-5#2)(2008-10#35)(2008-11#1)(2008-3#1)(2008-7#3)(2012-2#2)(2013-1#2)(2013-8#1)
the solvents were##2##3##(1991-1#1)(2008-10#1)
the solvents##9##2##(1991-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2011-1#1)
the somatic##9##2##(1990-12#1)(1996-12#1)(2007-12#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-2#1)(2013-8#1)
the somatosensory problems##2##3##(2008-5#2)
the somatosensory##5##2##(1994-3#1)(2008-5#4)
the somatostatin##4##2##(1995-2#1)(1995-8#2)(2012-3#1)
the somatotropic axis##2##3##(2010-5#2)
the sonication##2##2##(2008-10#1)(2008-5#1)
the sorbed##3##2##(2008-10#3)
the sorbent were##3##3##(2008-10#3)
the sorbent##16##2##(2008-10#16)
the sorghum ergot pathogen##2##4##(2008-10#2)
the sorghum pathogen##2##3##(2008-10#2)
the sorghum##5##2##(2008-10#5)
the sorption and##2##3##(2008-10#2)
the sorption capacity of the##2##5##(2008-10#2)
the sorption capacity##3##3##(2008-10#3)
the sorption equilibria##2##3##(2008-10#2)
the sorption of Cu(II)##2##4##(2008-10#2)
the sorption of the##3##4##(2008-10#3)
the sorption of##24##3##(2008-10#24)
the sorption process##2##3##(2008-10#2)
the sorption significantly##2##3##(2008-10#2)
the sorption##49##2##(2008-10#49)
the sorting of##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
the sorting##5##2##(1990-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
the sound intensity##2##3##(1994-8#1)(2008-8#1)
the sound velocity##2##3##(2008-2#2)
the sound##7##2##(1994-8#1)(2008-10#1)(2008-2#3)(2008-8#1)(2013-8#1)
the sounds##2##2##(2008-11#1)(2013-8#1)
the source and the##2##4##(2008-10#1)(2008-8#1)
the source and##4##3##(2008-10#2)(2008-8#1)(2012-3#1)
the source are##2##3##(2008-3#2)
the source is##2##3##(2008-3#2)
the source of light##2##4##(1993-3#2)
the source of the##6##4##(2008-10#2)(2008-11#1)(2008-12#2)(2008-9#1)
the source of##27##3##(1992-12#1)(1992-3#1)(1993-3#2)(1994-5#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
the source phase##2##3##(2008-10#2)
the source than the##2##4##(2008-10#2)
the source than##3##3##(2008-10#3)
the source##72##2##(1992-12#1)(1992-3#1)(1993-3#2)(1994-5#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#32)(2008-11#3)(2008-12#3)(2008-3#9)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
the sources for##2##3##(1995-2#1)(2008-4#1)
the sources of##5##3##(1991-2#1)(1994-3#1)(2008-10#2)(2008-11#1)
the sources##11##2##(1990-11#1)(1991-2#1)(1994-3#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-4#1)
the south of##5##3##(2008-10#4)(2013-8#1)
the south##11##2##(1996-8#1)(2008-10#7)(2008-11#1)(2008-6#1)(2013-8#1)
the southeastern United States##7##4##(1993-1#1)(2008-10#5)(2008-5#1)
the southeastern##10##2##(1993-1#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-5#1)
the southern part of the California Current##2##7##(2010-8#2)
the southern part of##3##4##(2008-8#1)(2010-8#2)
the southern##22##2##(1990-6#1)(1995-6#1)(1996-8#2)(2008-10#5)(2008-8#2)(2010-1#2)(2010-8#5)(2011-2#3)(2012-3#1)
the southwest##2##2##(2008-10#1)(2008-9#1)
the southwestern United States##4##4##(1990-8#2)(2008-10#2)
the southwestern##5##2##(1990-8#2)(2008-10#3)
the sowing date from early spring to##2##7##(2008-10#2)
the soybean##9##2##(2008-10#8)(2008-12#1)
the space between##2##3##(2008-10#1)(2008-9#1)
the space group##2##3##(1993-8#1)(2008-8#1)
the space##18##2##(1991-2#2)(1993-8#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
the spacer in##2##3##(2008-10#2)
the spacer##7##2##(1995-8#1)(2008-10#5)(2008-3#1)
the spacing##5##2##(1994-11#1)(1996-2#1)(2008-3#2)(2011-2#1)
the spatial analysis##2##3##(2008-10#2)
the spatial and temporal##5##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)
the spatial and##8##3##(1996-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-8#1)
the spatial arrangement of##2##4##(1994-9#1)(2008-10#1)
the spatial autocorrelation depends##2##4##(2008-10#2)
the spatial beam##2##3##(2007-12#1)(2008-3#1)
the spatial coherence##2##3##(2008-3#2)
the spatial dependence##2##3##(2008-3#1)(2009-7#1)
the spatial distribution of the##2##5##(1995-3#1)(2008-8#1)
the spatial distribution of##10##4##(1994-9#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)
the spatial dynamics of##3##4##(2008-10#3)
the spatial expression##2##3##(1993-2#1)(2008-10#1)
the spatial heterogeneity##2##3##(2008-10#1)(2008-3#1)
the spatial organization of##2##4##(2009-5#2)
the spatial pattern of##11##4##(2008-10#8)(2008-8#3)
the spatial patterns of the disease and##2##7##(2008-10#2)
the spatial patterns of##6##4##(2008-10#6)
the spatial patterns##7##3##(2008-10#6)(2008-9#1)
the spatial relationships##2##3##(2008-10#1)(2008-9#1)
the spatial resolution of the##2##5##(2008-10#1)(2008-3#1)
the spatial resolution of##4##4##(2008-10#1)(2008-3#2)(2009-7#1)
the spatial resolution##5##3##(2008-10#1)(2008-3#3)(2009-7#1)
the spatial scale of##2##4##(2008-8#2)
the spatial scale##3##3##(2008-10#1)(2008-8#2)
the spatial statistics of##3##4##(2008-3#3)
the spatial structure of the##2##5##(2008-11#1)(2008-8#1)
the spatial structure of##5##4##(2008-10#1)(2008-11#1)(2008-8#3)
the spatial structure##7##3##(2008-10#2)(2008-11#1)(2008-8#4)
the spatial##105##2##(1993-2#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-6#1)(2007-12#3)(2008-10#37)(2008-11#3)(2008-2#1)(2008-3#18)(2008-8#15)(2008-9#3)(2009-10#2)(2009-5#2)(2009-7#2)(2009-8#3)(2010-10#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#3)
the spatially##8##2##(2008-3#2)(2008-8#4)(2011-2#1)(2013-1#1)
the spatio-temporal##5##2##(1995-6#1)(2008-10#2)(2008-11#1)(2009-5#1)
the spatiotemporal dynamics of word processing##2##6##(2008-11#2)
the spatiotemporal dynamics of##3##4##(2008-10#1)(2008-11#2)
the spatiotemporal##9##2##(1990-5#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)
the spawning##3##2##(2008-11#1)(2010-8#2)
the speaker##3##2##(2008-11#1)(2009-10#2)
the special care##2##3##(1993-3#1)(1994-3#1)
the special case model##3##4##(2008-8#3)
the special case##4##3##(2008-8#4)
the special considerations##2##3##(2008-4#1)(2010-6#1)
the special issues##2##3##(2009-9#1)(2010-5#1)
the special needs of##2##4##(1997-2#1)(1997-8#1)
the special needs##3##3##(1996-3#1)(1997-2#1)(1997-8#1)
the special##25##2##(1993-2#1)(1993-3#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#5)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
the specialist in##2##3##(1993-5#1)(2013-1#1)
the specialist##7##2##(1993-12#1)(1993-5#1)(1993-6#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
the specialized##4##2##(1992-6#1)(1993-1#1)(1995-6#1)(2013-1#1)
the specialty##4##2##(1993-1#1)(1997-8#1)(2008-10#1)(2012-12#1)
the speciation analysis of##2##4##(2008-10#2)
the speciation analysis##4##3##(2008-10#4)
the speciation and determination of##2##5##(2008-10#2)
the speciation and##4##3##(2008-10#3)(2008-9#1)
the speciation of As(III) and As(V) in##2##7##(2008-10#2)
the speciation of antimony in##3##5##(2008-10#3)
the speciation of antimony##4##4##(2008-10#4)
the speciation of arsenic in##3##5##(2008-10#3)
the speciation of arsenic##5##4##(2008-10#5)
the speciation of chromium in##4##5##(2008-10#4)
the speciation of chromium##6##4##(2008-10#6)
the speciation of##32##3##(2008-10#31)(2008-9#1)
the speciation##46##2##(2008-10#43)(2008-9#2)(2013-1#1)
the species and##5##3##(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
the species are##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)
the species formed##2##3##(2008-10#2)
the species in##6##3##(2008-10#3)(2008-8#2)(2012-5#1)
the species isolated##2##3##(2008-5#1)(2011-2#1)
the species level##6##3##(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-6#1)
the species number##2##3##(2008-10#1)(2008-8#1)
the species of##8##3##(1995-12#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-8#1)
the species specificity##2##3##(2008-10#2)
the species studied##2##3##(2008-8#1)(2010-5#1)
the species was##4##3##(2008-10#1)(2010-8#1)(2011-2#1)(2012-5#1)
the species were##2##3##(2008-10#2)
the species with##3##3##(2008-10#3)
the species##107##2##(1990-5#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-10#46)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#15)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#5)(2012-5#2)(2012-6#1)(2013-8#1)
the species-area relationship and##2##4##(2008-8#2)
the species-area relationship##3##3##(2008-8#3)
the species-area##4##2##(2008-8#4)
the species-specific parasitism of##2##4##(2008-10#2)
the species-specific##3##2##(2008-10#3)
the specific IgA production rate##3##5##(2008-11#3)
the specific PCR primers##2##4##(2008-10#2)
the specific PCR##3##3##(1996-8#1)(2008-10#2)
the specific activity##2##3##(1995-12#1)(2008-10#1)
the specific amplification of##2##4##(2008-10#2)
the specific amplification##3##3##(2008-10#3)
the specific binding of##6##4##(1990-12#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-11#1)(2010-7#1)
the specific binding##8##3##(1990-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-11#1)(2009-7#1)(2010-7#1)
the specific characteristics of##3##4##(2008-3#1)(2011-2#1)(2013-8#1)
the specific characteristics##4##3##(1991-3#1)(2008-3#1)(2011-2#1)(2013-8#1)
the specific detection of##2##4##(2008-10#2)
the specific energy dissipation rate and##2##6##(2008-7#2)
the specific energy dissipation rate##7##5##(2008-7#7)
the specific energy dissipation##9##4##(2008-7#9)
the specific features of##2##4##(2008-10#1)(2012-3#1)
the specific features##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
the specific glucose consumption rate##2##5##(2008-11#2)
the specific glucose##3##3##(2008-11#2)(2008-7#1)
the specific growth rate of the##2##6##(1995-9#1)(2008-11#1)
the specific growth rate of##5##5##(1995-9#1)(2008-11#1)(2008-7#2)(2010-11#1)
the specific growth rate##9##4##(1995-9#1)(2008-11#3)(2008-7#3)(2008-9#1)(2010-11#1)
the specific growth rates##2##4##(2008-11#1)(2008-7#1)
the specific growth##11##3##(1995-9#1)(2008-11#4)(2008-7#4)(2008-9#1)(2010-11#1)
the specific interaction of##2##4##(1993-3#1)(2008-10#1)
the specific monoclonal antibody production rate##2##6##(2008-11#2)
the specific process and presentation of##2##6##(2008-8#2)
the specific productivity of##2##4##(2008-11#2)
the specific productivity##3##3##(2008-11#2)(2008-7#1)
the specific rates of##2##4##(2008-11#2)
the specific recognition of##2##4##(1991-9#1)(2008-10#1)
the specific role of##3##4##(1991-9#1)(2008-11#1)(2012-2#1)
the specific##189##2##(1990-12#3)(1990-2#1)(1991-12#1)(1991-3#2)(1991-9#2)(1992-10#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-1#3)(1994-2#2)(1994-3#1)(1995-11#3)(1995-12#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-7#1)(2007-11#2)(2008-10#30)(2008-11#36)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#23)(2008-8#7)(2008-9#11)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#4)
the specification of##3##3##(1991-1#1)(1994-3#1)(2008-2#1)
the specifications##2##2##(2008-10#2)
the specificity and##2##3##(2008-10#2)
the specificity of the primers##2##5##(2008-10#2)
the specificity of the##15##4##(1990-9#1)(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#7)(2009-10#1)(2009-12#1)(2009-8#1)(2013-8#1)
the specificity of##25##3##(1990-9#1)(1993-1#1)(1993-11#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#9)(2008-11#1)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
the specificity##39##2##(1990-2#2)(1990-9#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#3)(1997-2#2)(2008-10#15)(2008-11#1)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
the specified##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
the specimen was##3##3##(2009-3#1)(2011-2#1)(2012-12#1)
the specimen##9##2##(1991-6#1)(2009-3#1)(2009-7#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the specimens##5##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
the spectra of the##4##4##(1994-11#1)(2008-10#2)(2008-8#1)
the spectra of##11##3##(1993-5#1)(1994-11#1)(2008-10#6)(2008-3#1)(2008-8#1)(2008-9#1)
the spectra##19##2##(1993-5#1)(1994-11#1)(2008-10#13)(2008-3#2)(2008-8#1)(2008-9#1)
the spectral and##2##3##(2008-10#1)(2008-3#1)
the spectral classification##2##3##(2013-8#2)
the spectral data##3##3##(2008-10#3)
the spectral overlap##2##3##(2008-10#2)
the spectral parameters##2##3##(2008-10#1)(2008-2#1)
the spectral properties##3##3##(1992-1#1)(1994-11#1)(2008-5#1)
the spectral range of##3##4##(2008-10#2)(2008-3#1)
the spectral range##5##3##(2008-10#3)(2008-3#2)
the spectral regions##2##3##(2008-10#2)
the spectral shape##2##3##(2008-3#2)
the spectral##51##2##(1992-1#1)(1994-11#1)(2007-11#2)(2007-12#3)(2008-10#21)(2008-2#4)(2008-3#9)(2008-5#4)(2008-7#1)(2008-8#1)(2011-3#1)(2013-8#3)
the spectrally##2##2##(2008-2#1)(2008-3#1)
the spectroelectrochemical##2##2##(2008-10#2)
the spectrofluorimetric determination of##4##4##(2008-10#4)
the spectrofluorimetric##6##2##(2008-10#6)
the spectrometer##12##2##(2008-10#11)(2008-2#1)
the spectrometer's##2##2##(2008-10#2)
the spectrophotometer##3##2##(2008-10#3)
the spectrophotometric and extractive behaviour of##2##6##(2008-10#2)
the spectrophotometric and##4##3##(2008-10#4)
the spectrophotometric determination of lead with##2##6##(2008-10#2)
the spectrophotometric determination of lead##5##5##(2008-10#5)
the spectrophotometric determination of nickel##4##5##(2008-10#4)
the spectrophotometric determination of zinc##2##5##(2008-10#2)
the spectrophotometric determination of##46##4##(2008-10#46)
the spectrophotometric method##5##3##(2008-10#4)(2008-5#1)
the spectrophotometric##65##2##(2008-10#64)(2008-5#1)
the spectroscopic data##2##3##(2008-10#2)
the spectroscopic##9##2##(2008-10#8)(2012-12#1)
the spectrum is##2##3##(2008-10#2)
the spectrum of free molecule##2##5##(2008-10#2)
the spectrum of the##2##4##(2011-2#1)(2012-2#1)
the spectrum of##19##3##(1991-12#1)(1994-12#1)(1994-6#1)(1997-3#2)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
the spectrum##33##2##(1991-12#1)(1994-12#1)(1994-6#1)(1997-3#2)(1997-8#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-5#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
the specular##5##2##(2008-3#4)(2011-2#1)
the speech and language skills of##2##6##(2008-9#2)
the speech processor##3##3##(2008-9#3)
the speech##9##2##(2008-2#1)(2008-9#8)
the speed of propagation of ultrasound shear waves##2##8##(2008-5#2)
the speed of sound and the thermal diffusivity##2##8##(2008-3#2)
the speed of sound and##3##5##(2008-3#3)
the speed of the##2##4##(2008-6#1)(2011-2#1)
the speed of##15##3##(1994-8#1)(2008-10#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#2)(2009-7#1)(2011-2#2)
the speed##19##2##(1994-8#1)(2008-10#4)(2008-3#4)(2008-5#2)(2008-6#1)(2008-9#2)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
the spending##3##2##(1995-12#2)(1997-2#1)
the spent beads are##2##4##(2008-10#2)
the spent culture medium##2##4##(1995-6#1)(2008-11#1)
the spent##5##2##(1995-6#1)(2008-10#2)(2008-11#2)
the sperm acrosome reaction##2##4##(2008-8#2)
the sperm acrosome##4##3##(2008-8#4)
the sperm cells##2##3##(2008-12#1)(2009-8#1)
the sperm stored in the##2##5##(2008-8#2)
the sperm##19##2##(1994-8#5)(2008-12#1)(2008-7#2)(2008-8#8)(2009-8#1)(2012-2#2)
the spermatheca##6##2##(2008-6#5)(2008-8#1)
the spermathecae##4##2##(2007-12#2)(2008-8#2)
the spermathecal ducts##2##3##(2008-8#2)
the spermathecal##3##2##(2007-12#1)(2008-8#2)
the spermatid##2##2##(2008-7#1)(2012-2#1)
the spermatozoa##5##2##(2007-12#1)(2008-7#2)(2008-8#2)
the spermogonial##2##2##(2008-10#2)
the spermosphere##3##2##(2008-10#3)
the sphenoid sinus##7##3##(2008-7#3)(2011-2#2)(2012-3#2)
the sphenoid##8##2##(2008-7#4)(2011-2#2)(2012-3#2)
the sphere##3##2##(2008-3#3)
the spherical##7##2##(1996-5#1)(2008-10#1)(2008-3#1)(2009-5#1)(2011-2#2)(2012-2#1)
the sphingomyelin pathway##2##3##(1995-12#2)
the sphingosine##2##2##(1993-8#1)(1994-3#1)
the spider##2##2##(1990-5#1)(2008-9#1)
the spike train##4##3##(2008-11#1)(2009-8#3)
the spike trains##2##3##(2008-11#1)(2009-8#1)
the spike##13##2##(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-8#5)(2013-8#1)
the spiked water##2##3##(2008-10#2)
the spiked##20##2##(2008-10#20)
the spiking procedure##2##3##(2008-10#2)
the spiking##4##2##(2008-10#3)(2013-8#1)
the spin labels##2##3##(1993-8#2)
the spin##5##2##(1993-8#3)(2009-5#2)
the spinach##5##2##(2008-10#5)
the spinal canal##4##3##(2007-11#1)(2008-12#1)(2009-3#1)(2011-2#1)
the spinal cord and##3##4##(1992-12#1)(1996-2#1)(2008-7#1)
the spinal cord##26##3##(1990-5#1)(1991-5#2)(1991-6#1)(1992-12#1)(1995-12#1)(1996-12#3)(1996-2#2)(1996-5#3)(1996-9#1)(1997-3#1)(2008-12#1)(2008-7#3)(2009-11#1)(2011-1#2)(2011-2#1)(2012-3#2)
the spinal nerves by##2##4##(2008-7#2)
the spinal##44##2##(1990-5#1)(1991-5#2)(1991-6#1)(1992-12#2)(1995-12#1)(1996-12#3)(1996-2#2)(1996-5#3)(1996-9#1)(1997-3#1)(2007-11#1)(2008-12#2)(2008-7#11)(2008-9#1)(2009-11#1)(2009-3#1)(2011-1#2)(2011-2#5)(2012-3#2)(2013-1#1)
the spindle##4##2##(2008-10#1)(2008-8#1)(2011-2#2)
the spine head volume##2##4##(2008-11#2)
the spine##17##2##(1991-11#1)(1991-6#1)(1996-6#1)(2007-11#1)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-3#1)(2011-2#2)(2013-1#1)
the spiral gradient dilution method##2##5##(2008-10#2)
the spiral##4##2##(2008-10#3)(2008-9#1)
the spiralin##2##2##(2008-10#2)
the spirit of##2##3##(1992-12#1)(2009-10#1)
the spirit##3##2##(1992-12#1)(2009-10#1)(2010-7#1)
the spiritual needs of##3##4##(2008-11#2)(2011-1#1)
the spiritual##6##2##(1995-5#1)(2008-11#2)(2008-12#1)(2011-1#2)
the splanchnic##2##2##(1996-3#1)(2008-6#1)
the spleen and##5##3##(1990-3#1)(2008-10#3)(2012-3#1)
the spleen##23##2##(1990-3#1)(1990-5#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1996-12#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#2)(2012-3#1)
the splenectomy##2##2##(1994-9#2)
the splenic PFC response to SRBCs##2##6##(1993-12#2)
the splenic artery aneurysm##2##4##(2011-2#2)
the splenic artery##3##3##(2011-2#3)
the splenic##8##2##(1993-12#3)(2008-12#1)(2011-2#4)
the splenocytes##2##2##(2008-11#1)(2008-8#1)
the splice site##2##3##(1995-12#2)
the splice##3##2##(1993-11#1)(1995-12#2)
the splicing of##3##3##(1991-5#1)(1993-8#1)(1995-6#1)
the split between##3##3##(1993-6#1)(2013-8#2)
the split##7##2##(1993-6#1)(2009-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#2)
the sponge-like mycelial mass##2##4##(2008-10#2)
the sponges##3##2##(1994-3#3)
the spontaneous##11##2##(1990-3#1)(1990-5#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)
the spontaneously hypertensive rat##2##4##(1994-8#1)(1997-2#1)
the sporadic##2##2##(1990-12#1)(2008-7#1)
the spore##13##2##(1995-6#1)(2008-10#10)(2010-1#1)(2011-2#1)
the spores##8##2##(2008-10#6)(2010-3#1)(2011-2#1)
the sporulating##2##2##(2008-10#2)
the sporulation curve##2##3##(2008-10#2)
the sporulation of##3##3##(2008-10#3)
the sporulation##11##2##(2008-10#10)(2011-2#1)
the spotlight##2##2##(2009-7#1)(2010-5#1)
the spots##2##2##(2007-12#1)(2008-10#1)
the spouse##2##2##(2009-5#2)
the spray##4##2##(1996-3#1)(2008-10#3)
the spread of AIDS in##2##5##(1997-6#2)
the spread of AIDS##5##4##(1990-6#1)(1993-9#1)(1997-6#3)
the spread of HIV##5##4##(1996-11#1)(1997-6#3)(2008-1#1)
the spread of a##2##4##(2008-10#1)(2008-9#1)
the spread of disease##3##4##(2008-10#2)(2008-8#1)
the spread of the##3##4##(1990-6#1)(1994-6#1)(2008-10#1)
the spread of##44##3##(1990-6#2)(1993-9#1)(1994-6#1)(1996-11#1)(1996-3#1)(1997-6#6)(2008-1#1)(2008-10#12)(2008-12#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-10#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the spread##48##2##(1990-6#2)(1993-9#1)(1994-6#1)(1996-11#1)(1996-3#1)(1997-6#6)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-10#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the spreading of##2##3##(2007-12#1)(2009-10#1)
the spreading panicle##2##3##(2009-10#2)
the spreading##4##2##(2007-12#1)(2009-10#3)
the spring and fall##3##4##(2008-10#3)
the spring and##6##3##(2008-10#4)(2012-3#1)(2013-1#1)
the spring of 2000##3##4##(2008-10#3)
the spring of##11##3##(1996-2#1)(2008-10#6)(2008-11#1)(2010-8#1)(2011-9#1)(2012-3#1)
the spring season##2##3##(2008-10#1)(2012-3#1)
the spring##26##2##(1996-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2010-8#3)(2011-9#1)(2012-3#3)(2013-1#1)
the sputum of a##2##4##(2011-2#2)
the sputum##4##2##(1992-5#1)(1997-1#1)(2011-2#2)
the square of the##2##4##(2008-10#1)(2008-3#1)
the square of##3##3##(2008-10#2)(2008-3#1)
the square root of the scan rate##2##7##(2008-10#2)
the square root of the##3##5##(2008-10#2)(2008-3#1)
the square root of##5##4##(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
the square wave##6##3##(2008-10#5)(2011-2#1)
the square##14##2##(2007-12#1)(2008-10#9)(2008-3#2)(2008-9#1)(2011-2#1)
the square-wave##3##2##(2008-10#3)
the ssDNA##2##2##(1991-5#1)(1995-2#1)
the sspE##2##2##(1996-8#2)
the stabilisation##3##2##(2007-8#1)(2008-10#2)
the stability and reproducibility of the##2##6##(2008-10#1)(2008-12#1)
the stability and reproducibility of##3##5##(2008-10#2)(2008-12#1)
the stability and##9##3##(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)
the stability constant for##2##4##(2008-10#2)
the stability constant of the##2##5##(2008-10#2)
the stability constant of##3##4##(2008-10#3)
the stability constant##6##3##(2008-10#6)
the stability constants of the##6##5##(2008-10#6)
the stability constants of##9##4##(2008-10#9)
the stability constants##12##3##(2008-10#12)
the stability of a##2##4##(2008-5#1)(2008-9#1)
the stability of hermaphroditism##2##4##(2008-8#2)
the stability of the electrode##2##5##(2008-10#2)
the stability of the##25##4##(1994-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#17)(2008-5#2)(2010-5#1)(2011-2#1)
the stability of these##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
the stability of##69##3##(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#33)(2008-11#3)(2008-12#1)(2008-5#5)(2008-8#5)(2008-9#3)(2009-12#1)(2009-8#2)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
the stability##103##2##(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#62)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#6)(2008-8#5)(2008-9#3)(2009-12#1)(2009-8#2)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
the stabilization of##3##3##(1991-6#1)(2008-5#1)(2009-9#1)
the stabilization##6##2##(1991-6#1)(1994-11#1)(2008-12#2)(2008-5#1)(2009-9#1)
the stabilizing##3##2##(1991-7#1)(1992-6#1)(1995-8#1)
the stable##17##2##(1991-5#1)(1995-2#2)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#1)(2013-8#1)
the stably##2##2##(2008-11#2)
the staff and##4##3##(1992-2#1)(1996-3#1)(2008-11#1)(2008-12#1)
the staff##12##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-11#2)(2008-12#3)
the stage for the##2##4##(2008-7#1)(2011-2#1)
the stage for##7##3##(1996-2#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
the stage of allantois formation##2##5##(2008-11#2)
the stage of development##2##4##(1996-8#1)(2007-12#1)
the stage of the##2##4##(1990-8#1)(2008-12#1)
the stage of##26##3##(1990-8#1)(1991-3#1)(1993-2#1)(1995-12#1)(1996-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#2)
the stage##38##2##(1990-8#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#2)
the stages of##3##3##(1993-6#1)(2008-12#1)(2013-1#1)
the stages##6##2##(1993-6#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-8#1)(2013-1#1)
the staging##3##2##(1990-12#1)(2011-2#1)(2013-1#1)
the stained##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
the staining intensity##2##3##(1991-5#1)(1996-2#1)
the staining##6##2##(1991-5#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-9#2)
the staircase procedure##2##3##(1990-11#2)
the stalk##2##2##(1997-8#1)(2008-10#1)
the stance##2##2##(2008-11#1)(2013-1#1)
the standard FVC maneuver##2##4##(2008-7#2)
the standard addition method was##2##5##(2008-10#2)
the standard addition method##16##4##(2008-10#16)
the standard addition methodology##4##4##(2008-10#4)
the standard addition technique##6##4##(1991-12#1)(2008-10#5)
the standard addition##29##3##(1991-12#1)(2008-10#28)
the standard additions method##11##4##(2008-10#11)
the standard curve was##3##4##(2008-10#3)
the standard design##2##3##(1994-9#2)
the standard deviation (S##2##4##(2008-10#2)
the standard deviation of the##16##5##(2008-10#12)(2008-3#4)
the standard deviation of##20##4##(2008-10#16)(2008-3#4)
the standard deviation##32##3##(2008-10#24)(2008-11#1)(2008-3#4)(2008-9#1)(2012-5#1)(2013-8#1)
the standard errors##2##3##(1995-9#1)(2008-10#1)
the standard method##7##3##(1992-12#1)(1996-3#1)(2008-10#3)(2011-2#2)
the standard methods##2##3##(2008-10#2)
the standard of care for##2##5##(2008-6#1)(2009-12#1)
the standard of care##4##4##(1991-12#1)(2008-6#1)(2009-12#1)(2010-12#1)
the standard of##5##3##(1991-12#1)(2008-12#1)(2008-6#1)(2009-12#1)(2010-12#1)
the standard procedure##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
the standard reference material##4##4##(2008-10#4)
the standard reference##7##3##(2008-1#1)(2008-10#5)(2010-3#1)
the standard slurries##2##3##(2008-10#2)
the standard solutions##2##3##(2008-10#2)
the standard spectrophotometric##2##3##(2008-10#2)
the standard technique##2##3##(2011-7#1)(2012-2#1)
the standard therapy##2##3##(1994-12#1)(2010-7#1)
the standard treatment for##2##4##(2011-2#1)(2012-3#1)
the standard treatment##6##3##(1991-8#1)(1995-9#1)(2008-10#1)(2011-2#1)(2012-3#2)
the standard##212##2##(1991-11#1)(1991-12#2)(1991-8#2)(1992-12#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-9#2)(1995-5#1)(1995-9#2)(1996-2#1)(1996-3#2)(1996-8#1)(2008-1#1)(2008-10#125)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#3)(2013-8#2)
the standardization of##3##3##(1996-2#1)(2006-6#1)(2008-10#1)
the standardization##6##2##(1996-2#1)(2006-6#1)(2008-10#4)
the standardized area under##2##4##(2008-10#2)
the standardized patients' rating of##2##5##(2008-8#2)
the standardized terminology provided the nurses greater ease in their selection of nursing diagnoses and interventions in planning patient care##2##20##(2013-1#2)
the standardized##14##2##(1991-3#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-8#4)(2011-2#1)(2012-2#1)(2013-1#3)
the standards for##2##3##(1996-3#1)(2008-3#1)
the standards of##3##3##(1991-3#1)(1991-8#1)(2008-9#1)
the standards##9##2##(1991-3#1)(1991-8#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)
the standing##2##2##(1997-4#1)(2008-10#1)
the starch granules##2##3##(2009-8#1)(2013-8#1)
the starch##5##2##(1995-6#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-8#1)
the start codon##3##3##(1991-6#2)(2008-8#1)
the start of a new##2##5##(1996-6#1)(2008-11#1)
the start of a##5##4##(1993-6#1)(1996-6#1)(2008-11#1)(2008-7#1)(2009-12#1)
the start of the study##2##5##(2008-5#1)(2012-2#1)
the start of the##11##4##(1991-5#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
the start of treatment##4##4##(1990-9#1)(2012-12#3)
the start of##30##3##(1990-9#1)(1991-5#1)(1991-6#2)(1992-9#1)(1993-6#1)(1994-12#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2012-12#3)(2012-2#1)(2013-1#1)
the start site of##2##4##(1991-5#1)(1992-8#1)
the start##37##2##(1990-9#1)(1991-3#1)(1991-5#2)(1991-6#4)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2012-12#3)(2012-2#1)(2013-1#1)
the starting and##2##3##(2008-10#2)
the starting material##6##3##(1996-5#1)(2008-10#3)(2008-5#1)(2009-7#1)
the starting values##2##3##(2008-2#2)
the starting##21##2##(1990-11#1)(1991-5#1)(1994-2#1)(1996-5#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-4#1)
the startle##4##2##(2008-11#4)
the state and local level##3##5##(1997-2#2)(2011-9#1)
the state and local##4##4##(1996-2#1)(1997-2#2)(2011-9#1)
the state and##7##3##(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#2)(2010-9#1)(2011-9#1)
the state in##2##3##(1995-12#1)(2012-2#1)
the state legislature##2##3##(1991-8#1)(1995-2#1)
the state of health##2##4##(1992-3#1)(1994-9#1)
the state of polarization##2##4##(2008-2#1)(2008-3#1)
the state of the art of##3##6##(2008-5#1)(2009-12#1)(2012-2#1)
the state of the art##7##5##(1993-3#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-9#1)(2012-2#1)
the state of the##11##4##(1990-2#1)(1993-3#1)(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-6#1)(2010-9#1)(2012-2#1)
the state of##40##3##(1990-2#1)(1991-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
the state public health regulations##2##5##(1995-2#2)
the state space##2##3##(2008-11#2)
the state##73##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-12#4)(1995-2#5)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2010-9#3)(2011-2#6)(2011-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
the state's##6##2##(1991-8#1)(1992-8#1)(1996-5#1)(1996-9#1)(2010-5#1)(2011-2#1)
the state-of-the-art in##2##3##(2008-10#1)(2008-11#1)
the state-of-the-art##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
the statement##4##2##(2008-6#1)(2009-8#1)(2013-1#2)
the states of##3##3##(1990-2#1)(1994-3#1)(1997-8#1)
the states##8##2##(1990-2#1)(1991-12#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)
the static culture##2##3##(2008-11#2)
the static images##2##3##(2013-1#2)
the static imaging##2##3##(2008-10#2)
the static interference##2##3##(2013-8#2)
the static mercury drop electrode##4##5##(2008-10#4)
the static##23##2##(1993-9#1)(1997-1#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#2)(2013-8#3)
the stationary phase of##2##4##(2008-10#1)(2008-11#1)
the stationary phase was##4##4##(2008-10#3)(2008-7#1)
the stationary phase##30##3##(2008-10#20)(2008-11#2)(2008-7#6)(2011-2#2)
the stationary##33##2##(2008-10#21)(2008-11#3)(2008-3#1)(2008-7#6)(2011-2#2)
the statistic##3##2##(2008-10#2)(2011-2#1)
the statistical analysis##2##3##(2008-10#1)(2008-8#1)
the statistical evaluation##2##3##(2008-11#1)(2011-2#1)
the statistical uncertainty##2##3##(2008-10#2)
the statistical##24##2##(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#2)(1997-4#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
the statistically significant##2##3##(2009-8#1)(2011-2#1)
the statistics##2##2##(1991-2#1)(2008-8#1)
the statocysts##2##2##(2008-7#1)(2011-2#1)
the status of the##6##4##(1993-11#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-12#1)(2009-12#1)
the status of these##2##4##(1994-1#1)(2008-11#1)
the status of##25##3##(1993-11#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#4)
the statute of##2##3##(1996-5#2)
the statute##4##2##(1994-2#1)(1996-5#3)
the statutory##3##2##(1992-12#1)(1995-1#1)(2008-10#1)
the stay##4##2##(1992-12#4)
the steady state##6##3##(2008-10#2)(2008-5#1)(2008-7#3)
the steady##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)
the steady-state level of##4##4##(1992-1#1)(1993-6#1)(1997-1#1)(2008-10#1)
the steady-state##10##2##(1992-1#1)(1993-6#1)(1995-6#1)(1997-1#1)(2008-10#4)(2008-3#1)(2008-8#1)
the steel##2##2##(2008-10#2)
the steep##2##2##(1995-12#1)(2008-3#1)
the steering committee##2##3##(1995-12#1)(1997-3#1)
the stem cell niche##2##4##(2009-8#1)(2012-2#1)
the stem cell population##3##4##(2008-11#2)(2010-7#1)
the stem cell##10##3##(1992-12#1)(1994-11#1)(2008-11#4)(2009-10#1)(2009-8#1)(2010-7#1)(2012-2#1)
the stem of##2##3##(2008-10#1)(2008-9#1)
the stem to##3##3##(2008-10#3)
the stem##41##2##(1992-12#1)(1992-3#2)(1994-11#1)(2008-10#21)(2008-11#7)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
the stems##3##2##(2008-10#2)(2008-11#1)
the stenosis##3##2##(1990-3#2)(2013-1#1)
the stent##2##2##(1990-8#1)(2010-12#1)
the step##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
the step-index##2##2##(2008-3#2)
the steps and##2##3##(2010-1#1)(2011-2#1)
the steps for##2##3##(2008-4#1)(2012-3#1)
the steps of the##2##4##(1995-9#1)(2008-9#1)
the steps of##3##3##(1995-9#1)(2008-4#1)(2008-9#1)
the steps taken to develop##2##5##(1993-1#1)(2010-11#1)
the steps taken##3##3##(1993-1#1)(2010-11#1)(2011-2#1)
the steps##12##2##(1993-1#1)(1995-9#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#3)(2012-3#1)
the stepwise##4##2##(2008-10#2)(2008-11#1)(2009-9#1)
the stereospecific##2##2##(1994-5#1)(2008-10#1)
the steric##5##2##(1991-5#1)(1996-5#1)(2008-10#3)
the sterile production##2##3##(2012-2#2)
the sterile##5##2##(2008-12#1)(2008-8#2)(2012-2#2)
the steroid binding domain##2##4##(1991-12#2)
the steroid binding##3##3##(1990-12#1)(1991-12#2)
the steroid##17##2##(1990-11#3)(1990-12#1)(1991-12#2)(1991-5#2)(1997-1#2)(2008-10#2)(2008-11#3)(2008-4#1)(2012-2#1)
the steroidogenic##2##2##(1990-11#1)(1995-12#1)
the steroids tested##2##3##(1990-11#1)(1996-2#1)
the sterol##2##2##(1992-3#1)(2008-10#1)
the stick##3##2##(2007-12#1)(2008-5#2)
the stiffness##5##2##(2008-5#1)(2009-7#1)(2013-1#2)(2013-7#1)
the stigma and##2##3##(2008-10#2)
the stigma##5##2##(2008-10#4)(2008-6#1)
the stigmas##2##2##(2008-10#2)
the stimulated##3##2##(1995-8#1)(1997-3#1)(2008-5#1)
the stimulating effect##3##3##(1994-8#1)(2008-11#1)(2012-3#1)
the stimulating##7##2##(1992-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-3#1)
the stimulation by##2##3##(1995-8#2)
the stimulation of gene##2##4##(1991-6#1)(1994-11#1)
the stimulation of glucose utilization##2##5##(1994-8#2)
the stimulation of##17##3##(1991-6#1)(1994-11#3)(1994-8#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-11#5)(2010-1#1)(2010-8#1)
the stimulation##32##2##(1991-6#1)(1992-12#1)(1993-3#2)(1994-11#3)(1994-2#1)(1994-8#2)(1995-8#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-9#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-8#1)
the stimulator##2##2##(2010-7#1)(2012-3#1)
the stimulatory action of L-histidine on protein synthesis##2##8##(2008-11#2)
the stimulatory actions of L-leucine and KIC##3##7##(2008-11#3)
the stimulatory effect of##3##4##(1994-5#1)(1994-6#1)(1997-8#1)
the stimulatory effect##4##3##(1994-5#1)(1994-6#1)(1997-8#1)(2008-11#1)
the stimulatory##18##2##(1990-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-2#1)(1997-8#1)(2008-11#6)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
the stimuli and##2##3##(2008-7#1)(2008-9#1)
the stimuli were##2##3##(2008-5#1)(2008-9#1)
the stimuli##7##2##(1993-3#1)(1994-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2013-8#1)
the stimulus was##2##3##(1990-5#1)(2008-5#1)
the stimulus##12##2##(1990-5#2)(1996-2#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#2)(2010-4#1)
the stir bar##2##3##(2008-10#2)
the stirred##4##2##(2008-10#1)(2008-11#3)
the stirring##2##2##(2008-10#1)(2008-11#1)
the stochastic nature of##2##4##(2008-8#1)(2008-9#1)
the stochastic##3##2##(1995-5#1)(2008-8#1)(2008-9#1)
the stoichiometric composition of the chelate is 1##2##8##(2008-10#2)
the stoichiometric##9##2##(1996-2#1)(2008-10#7)(2008-11#1)
the stoichiometry and##2##3##(2008-10#1)(2010-5#1)
the stoichiometry of the##6##4##(1993-8#1)(2008-10#4)(2008-7#1)
the stoichiometry of##10##3##(1991-5#1)(1993-8#1)(1995-11#1)(2008-10#5)(2008-4#1)(2008-7#1)
the stoichiometry##16##2##(1991-5#2)(1993-8#1)(1995-11#2)(1996-2#1)(2008-10#7)(2008-4#1)(2008-7#1)(2010-5#1)
the stolbur phytoplasma##3##3##(2008-10#3)
the stomach in##2##3##(1990-8#1)(1997-1#1)
the stomach of##2##3##(1997-1#1)(2011-2#1)
the stomach##35##2##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-6#1)(1997-1#5)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
the stomach]##2##2##(1990-11#1)(1991-11#1)
the stomata##2##2##(2008-10#2)
the stomatopod##2##2##(2007-12#2)
the stone##3##2##(1994-5#1)(2008-2#1)(2008-3#1)
the stones##2##2##(1991-3#1)(2011-2#1)
the stools##3##2##(1991-6#1)(2009-1#1)(2011-1#1)
the stop codon##2##3##(1997-7#1)(2008-9#1)
the stopped-flow and##2##3##(2008-10#2)
the stopped-flow mixing technique was used##2##6##(2008-10#2)
the stopped-flow mixing technique##5##4##(2008-10#5)
the stopped-flow##9##2##(2008-10#9)
the storage of##4##3##(2008-10#1)(2008-7#1)(2010-4#1)(2013-8#1)
the storage stability of the##2##5##(2008-10#1)(2008-5#1)
the storage time##2##3##(2008-10#1)(2008-3#1)
the storage##19##2##(2008-10#7)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-4#1)(2013-8#1)
the stored##4##2##(1994-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
the storm##3##2##(2008-11#1)(2011-2#2)
the story of##3##3##(2008-11#1)(2011-3#1)(2013-8#1)
the story##5##2##(1991-8#1)(1993-12#1)(2008-11#1)(2011-3#1)(2013-8#1)
the straight line##4##3##(2008-10#4)
the straight##6##2##(1996-6#1)(2008-10#5)
the strain T21##2##3##(2008-8#2)
the strain of##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
the strain##20##2##(1991-9#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#4)(2009-7#1)(2009-8#1)(2011-2#2)
the strains and##4##3##(2008-10#2)(2008-5#1)(2010-4#1)
the strains into##2##3##(2008-10#2)
the strains of##2##3##(2008-10#1)(2013-1#1)
the strains that were##2##4##(2008-10#2)
the strains that##3##3##(2008-10#3)
the strains was##2##3##(1991-3#1)(2008-10#1)
the strains were##6##3##(1996-12#1)(2008-10#3)(2008-12#1)(2011-2#1)
the strains##48##2##(1991-3#1)(1993-12#1)(1996-12#3)(1997-9#1)(2008-10#35)(2008-12#1)(2008-5#2)(2010-4#2)(2011-2#1)(2013-1#1)
the strains'##3##2##(2008-10#3)
the strand##2##2##(1994-9#1)(2008-10#1)
the strategic planning process of##2##5##(1994-2#1)(1996-1#1)
the strategic planning process##6##4##(1991-2#1)(1994-2#4)(1996-1#1)
the strategic planning##7##3##(1991-2#1)(1994-2#5)(1996-1#1)
the strategic##16##2##(1991-2#1)(1991-8#1)(1993-3#1)(1994-12#1)(1994-2#8)(1994-8#1)(1996-1#1)(1997-1#1)(2008-6#1)
the strategies and##2##3##(1997-7#1)(2008-11#1)
the strategies employed to##2##4##(2008-10#1)(2011-2#1)
the strategies of##2##3##(2010-8#1)(2011-3#1)
the strategies##12##2##(1991-12#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
the strategy of##5##3##(1990-6#1)(1991-1#1)(1996-3#1)(2008-10#1)(2008-7#1)
the strategy##22##2##(1990-12#1)(1990-6#1)(1991-1#1)(1992-1#1)(1993-3#1)(1994-3#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#4)(2011-2#3)
the stratification of##2##3##(2013-8#2)
the stratosphere##3##2##(1991-5#1)(1991-6#1)(2008-3#1)
the stratospheric##2##2##(1996-1#1)(2008-3#1)
the stratum corneum (SC)##5##4##(2008-10#1)(2008-5#4)
the stratum corneum lipids##4##4##(2008-5#4)
the stratum corneum of human skin##2##6##(2008-10#1)(2008-5#1)
the stratum corneum of##3##4##(2008-10#1)(2008-5#2)
the stratum corneum##41##3##(2008-10#2)(2008-5#39)
the stratum##42##2##(2008-10#2)(2008-5#40)
the stream of##4##3##(2008-10#1)(2010-10#3)
the stream was##2##3##(2008-10#2)
the stream##11##2##(1995-3#1)(2008-10#6)(2009-8#1)(2010-10#3)
the street##2##2##(1996-5#1)(2008-11#1)
the strength and direction of##2##5##(1994-8#1)(2008-8#1)
the strength and##5##3##(1994-8#1)(2008-10#1)(2008-8#1)(2009-9#1)(2013-8#1)
the strength of selection on##2##5##(2008-8#1)(2008-9#1)
the strength of selection##6##4##(2008-8#4)(2008-9#1)(2010-4#1)
the strength of the thermal lens##2##6##(2008-3#2)
the strength of the##12##4##(1993-1#1)(1997-1#1)(1997-8#2)(2008-11#2)(2008-3#2)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#1)
the strength of##37##3##(1993-1#1)(1995-5#1)(1997-1#2)(1997-8#3)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-8#10)(2008-9#3)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#1)
the strength##44##2##(1993-1#1)(1994-8#1)(1995-5#1)(1997-1#2)(1997-8#3)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#1)(2008-8#11)(2008-9#3)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#3)
the strengthening##3##2##(1997-8#1)(2009-7#2)
the strengths and challenges of##2##5##(2008-12#2)
the strengths and limitations of the##2##6##(2012-2#1)(2013-1#1)
the strengths and limitations of##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
the strengths and weakness of the##2##6##(2009-1#1)(2012-2#1)
the strengths and weaknesses of##3##5##(1992-12#1)(2008-11#1)(2011-2#1)
the strengths and##11##3##(1992-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
the strengths of the##2##4##(1996-2#1)(2008-8#1)
the strengths of##3##3##(1996-2#1)(2008-8#1)(2012-2#1)
the strengths##16##2##(1991-1#1)(1992-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-8#1)(2009-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
the streptococcal species##2##3##(2011-1#2)
the stress in##2##3##(2010-11#1)(2011-2#1)
the stress of##3##3##(1995-1#1)(2008-10#1)(2008-11#1)
the stress regimen##4##3##(2008-11#4)
the stress response to##5##4##(1995-8#3)(1997-2#1)(2008-11#1)
the stress##26##2##(1992-1#1)(1992-2#1)(1994-2#1)(1995-1#2)(1995-8#3)(1997-2#1)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
the stressed##3##2##(1995-6#1)(2008-11#1)(2009-7#1)
the stresses##2##2##(1996-9#1)(2008-4#1)
the stressful##3##2##(2008-11#2)(2012-3#1)
the stressor##4##2##(2008-11#2)(2008-4#1)(2013-8#1)
the stressosome##4##2##(2009-8#4)
the stretch##2##2##(1990-2#1)(2008-8#1)
the stretching##5##2##(2008-10#2)(2008-2#1)(2008-7#1)(2009-1#1)
the stria##3##2##(1994-2#1)(2008-9#1)(2009-8#1)
the striatal dopamine transporter##3##4##(1996-2#3)
the striatal##7##2##(1996-2#4)(1997-2#1)(2008-7#2)
the striate##2##2##(2008-11#1)(2008-8#1)
the striatum and the nucleus accumbens##4##6##(1996-12#2)(1997-3#2)
the striatum and##5##3##(1991-6#1)(1996-12#2)(1997-3#2)
the striatum##21##2##(1991-4#1)(1991-6#3)(1994-2#2)(1996-12#4)(1997-2#2)(1997-3#2)(2008-10#1)(2008-7#2)(2009-12#1)(2009-8#1)(2013-8#2)
the strict##6##2##(2008-10#1)(2008-11#3)(2008-3#1)(2012-2#1)
the stricture##2##2##(2008-2#1)(2010-12#1)
the striking##8##2##(1997-7#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)
the stringent##2##2##(1996-1#1)(2008-11#1)
the strip##3##2##(2008-10#2)(2008-5#1)
the stripping chronopotentiometric##2##3##(2008-10#2)
the stripping of##3##3##(2008-10#3)
the stripping response##2##3##(2008-10#2)
the stripping##14##2##(2008-10#14)
the stroke##4##2##(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
the stroma##2##2##(2008-11#1)(2008-12#1)
the strong influence of##2##4##(2008-10#1)(2008-11#1)
the strong spectral##2##3##(2008-10#2)
the strong##31##2##(1993-1#1)(1993-6#1)(1994-12#1)(1996-5#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-5#3)(2008-8#3)(2009-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
the stronger##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
the strongest##25##2##(1996-2#1)(1997-3#1)(2006-6#1)(2008-10#9)(2008-3#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
the strongly##3##2##(2008-10#2)(2009-5#1)
the strontium##2##2##(2008-10#2)
the structural alterations##2##3##(2008-8#1)(2011-2#1)
the structural and functional##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
the structural basis for##2##4##(1992-10#1)(1992-4#1)
the structural basis of##5##4##(1997-9#2)(2008-4#1)(2008-9#1)(2009-7#1)
the structural basis##8##3##(1992-10#1)(1992-4#1)(1993-8#1)(1997-9#2)(2008-4#1)(2008-9#1)(2009-7#1)
the structural change of the##2##5##(2008-10#1)(2008-8#1)
the structural change of##3##4##(2008-10#1)(2008-8#2)
the structural changes##3##3##(1991-3#1)(1997-6#1)(2012-12#1)
the structural characterization of the##2##5##(1997-2#1)(2008-4#1)
the structural characterization##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
the structural components##2##3##(1997-8#1)(2009-10#1)
the structural features##4##3##(1992-10#1)(1994-5#1)(2008-10#2)
the structural gene of CS3 subunit##2##6##(2008-8#2)
the structural gene##3##3##(2008-5#1)(2008-8#2)
the structural interactions##2##3##(2012-2#2)
the structural organization of the##2##5##(2008-10#1)(2009-8#1)
the structural organization of##4##4##(1993-2#1)(2008-10#1)(2009-8#1)(2010-8#1)
the structural organization##5##3##(1993-2#1)(2008-10#1)(2009-10#1)(2009-8#1)(2010-8#1)
the structural parameters of##2##4##(2008-10#1)(2008-3#1)
the structural protein##3##3##(1993-9#1)(1995-2#1)(2008-10#1)
the structural requirements for##2##4##(1992-9#1)(2011-2#1)
the structural requirements##3##3##(1992-9#1)(1994-5#1)(2011-2#1)
the structural similarity of##2##4##(1991-6#1)(2008-10#1)
the structural##72##2##(1991-3#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#2)(2008-10#16)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#2)(2009-10#3)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)
the structurally related##2##3##(2008-10#1)(2011-2#1)
the structurally##6##2##(1990-5#1)(1991-3#1)(1993-2#1)(2008-10#1)(2009-9#1)(2011-2#1)
the structure and function of the##2##6##(2008-10#1)(2008-7#1)
the structure and function of##8##5##(1992-11#1)(1995-6#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)
the structure and the##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
the structure and##28##3##(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-3#1)(1995-6#3)(1997-7#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-11#1)(2010-7#1)(2013-1#1)
the structure is##3##3##(1992-4#1)(2008-3#1)(2008-8#1)
the structure of a##5##4##(1992-9#1)(1997-8#1)(2008-12#1)(2008-4#1)(2008-7#1)
the structure of an##2##4##(1990-9#1)(2008-10#1)
the structure of both##2##4##(2008-10#1)(2008-12#1)
the structure of the##39##4##(1990-5#1)(1992-6#1)(1993-3#1)(1993-8#3)(1994-11#1)(1994-3#2)(1995-9#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-3#1)
the structure of two##2##4##(1992-4#1)(2008-3#1)
the structure of##81##3##(1990-5#1)(1990-9#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#15)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#3)
the structure##136##2##(1990-5#1)(1990-9#1)(1991-6#3)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#2)(1992-9#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#3)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#28)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#8)(2009-11#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#3)
the structure-activity##3##2##(1991-3#1)(1994-11#1)(2008-11#1)
the structured##2##2##(2008-11#1)(2010-8#1)
the structures and##2##3##(2008-3#1)(2008-9#1)
the structures of substrates##2##4##(1994-8#1)(2008-10#1)
the structures of the##2##4##(2008-10#2)
the structures of##12##3##(1992-9#1)(1994-8#1)(1996-5#1)(2008-10#5)(2008-4#1)(2008-8#2)(2010-6#1)
the structures##23##2##(1992-4#1)(1992-9#1)(1994-8#2)(1996-5#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-6#1)(2011-2#1)
the structuring##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
the student and the##2##4##(2008-11#2)
the student experience##4##3##(2008-11#4)
the student nurse##2##3##(2008-11#2)
the student##22##2##(1993-1#1)(2008-11#18)(2008-12#3)
the student's##5##2##(2008-11#4)(2009-7#1)
the students and##4##3##(2008-11#2)(2008-12#1)(2013-8#1)
the students delivered between##2##4##(2013-1#2)
the students in##4##3##(2008-11#3)(2008-12#1)
the students to##2##3##(1993-1#1)(2008-11#1)
the students were##2##3##(2008-11#1)(2008-12#1)
the students##43##2##(1991-9#1)(1993-1#1)(2008-11#24)(2008-12#4)(2010-10#1)(2012-3#1)(2013-1#7)(2013-8#4)
the students' experiences##4##3##(2008-11#2)(2008-12#1)(2009-8#1)
the students' needs##2##3##(2008-12#1)(2012-3#1)
the students' perceptions of##3##4##(2008-11#2)(2012-3#1)
the students' perceptions##4##3##(2008-11#2)(2009-7#1)(2012-3#1)
the students'##20##2##(2008-11#9)(2008-12#3)(2009-7#1)(2009-8#1)(2010-10#1)(2012-3#3)(2013-8#2)
the studied HS##2##3##(2008-10#2)
the studied compounds##3##3##(2008-10#3)
the studied conditions##2##3##(2008-10#1)(2013-1#1)
the studied drugs with##2##4##(2008-10#2)
the studied drugs##5##3##(2008-10#5)
the studied metals##3##3##(2008-10#3)
the studied population##2##3##(2009-1#1)(2013-1#1)
the studied##57##2##(1993-2#1)(1994-2#1)(2008-10#44)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-1#1)(2011-2#2)(2013-1#3)
the studies are##2##3##(1992-3#1)(2008-12#1)
the studies of##5##3##(1995-2#1)(2008-10#3)(2010-2#1)
the studies on##5##3##(1994-6#1)(2008-10#3)(2008-8#1)
the studies reported##2##3##(2008-10#1)(2011-2#1)
the studies##35##2##(1992-3#2)(1993-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#3)
the study and were##3##4##(2008-11#1)(2011-2#2)
the study and##16##3##(1991-12#1)(1992-12#1)(1992-5#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2011-2#3)(2012-3#1)(2013-1#1)
the study are##3##3##(2008-11#2)(2011-2#1)
the study areas##2##3##(1995-3#1)(2013-1#1)
the study by##3##3##(2008-10#2)(2008-12#1)
the study cohort and a##2##5##(2009-10#2)
the study cohort and##3##4##(2009-10#3)
the study cohort##4##3##(2009-10#4)
the study counties##2##3##(1991-3#2)
the study design##4##3##(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)
the study findings##2##3##(1991-12#1)(1993-12#1)
the study for##2##3##(2008-7#1)(2011-2#1)
the study group##5##3##(1991-12#1)(2008-1#1)(2011-1#2)(2013-1#1)
the study has##2##3##(1997-3#1)(2008-12#1)
the study included##3##3##(1992-2#1)(1997-8#1)(2008-11#1)
the study indicates##2##3##(1990-2#1)(2013-8#1)
the study is##14##3##(1990-2#1)(1993-3#1)(1997-3#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-3#2)(2012-3#3)(2013-1#1)(2013-8#1)
the study of a##2##4##(2008-10#1)(2012-3#1)
the study of ancient##2##4##(2008-10#2)
the study of evolution##2##4##(2008-8#1)(2010-5#1)
the study of gene expression and##2##6##(2008-4#1)(2008-9#1)
the study of gene expression##3##5##(2008-4#2)(2008-9#1)
the study of human##2##4##(2008-10#1)(2012-3#1)
the study of the mechanism of##2##6##(1991-5#1)(2008-9#1)
the study of the regulation of##2##6##(1991-9#1)(2008-11#1)
the study of the##30##4##(1991-5#1)(1991-9#1)(1994-11#2)(1996-12#1)(2008-10#13)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2011-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
the study of##151##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-11#2)(1994-5#1)(1996-1#1)(1996-12#2)(1996-3#3)(1997-7#1)(2006-6#1)(2008-1#2)(2008-10#44)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#11)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-10#1)(2011-2#4)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#2)
the study on##3##3##(2008-10#2)(2008-9#1)
the study participants##5##3##(2008-12#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
the study patients##2##3##(2008-1#1)(2013-1#1)
the study period##20##3##(1992-5#1)(1994-12#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
the study population was##3##4##(2008-1#1)(2008-7#1)(2013-1#1)
the study population##7##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
the study reported##2##3##(2011-2#1)(2013-8#1)
the study showed that##5##4##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
the study showed##6##3##(1990-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
the study site##3##3##(2008-10#2)(2008-5#1)
the study sites##3##3##(2008-12#2)(2012-12#1)
the study to##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
the study was retrospective##2##4##(2007-11#1)(2012-3#1)
the study was##57##3##(1990-2#2)(1990-8#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-12#1)(1996-6#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#6)(2008-12#4)(2008-5#5)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-3#4)(2013-1#6)(2013-8#1)
the study were##10##3##(1991-1#1)(1992-12#1)(1996-1#1)(2008-10#3)(2008-11#1)(2010-1#1)(2012-3#2)
the study##506##2##(1990-11#1)(1990-2#5)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#4)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#3)(1992-5#2)(1992-9#1)(1993-1#4)(1993-12#3)(1993-2#2)(1993-3#3)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#3)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#5)(1996-12#4)(1996-3#4)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#3)(1997-7#2)(1997-8#4)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#6)(2008-10#83)(2008-11#42)(2008-12#23)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#17)(2008-7#18)(2008-8#9)(2008-9#19)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#7)(2010-10#3)(2010-11#5)(2010-12#1)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#4)(2011-1#9)(2011-10#1)(2011-2#33)(2011-3#5)(2012-12#9)(2012-2#7)(2012-3#21)(2013-1#27)(2013-7#1)(2013-8#9)
the study's##2##2##(1995-1#2)
the sub##3##2##(2007-8#1)(2008-10#2)
the sub-isoforms of##2##3##(2008-10#2)
the sub-nanogram##2##2##(2008-10#2)
the subacute##4##2##(1994-12#1)(2008-8#1)(2011-2#2)
the subarachnoid space##5##3##(2008-7#5)
the subarachnoid##8##2##(1995-11#1)(2008-7#7)
the subcellular localization of##3##4##(1992-6#1)(2009-8#1)(2011-2#1)
the subcellular##5##2##(1992-6#1)(2009-8#1)(2010-11#1)(2011-2#2)
the subclavian artery##4##3##(1993-3#2)(2008-7#2)
the subclavian##5##2##(1993-3#2)(2008-7#3)
the subclavicular approach##2##3##(2012-12#2)
the subclavicular##3##2##(2012-12#3)
the subcutaneous##5##2##(1990-12#1)(1997-4#1)(2008-11#1)(2011-2#1)(2012-2#1)
the subfamily##2##2##(2008-12#1)(2008-8#1)
the subfields##2##2##(1995-3#2)
the subfornical organ##2##3##(1994-2#2)
the subgroup##4##2##(2008-10#3)(2008-4#1)
the subisolates##2##2##(2008-10#2)
the subject has##2##3##(2008-11#1)(2011-2#1)
the subject is##2##3##(1996-12#1)(2008-9#1)
the subject of increasing##2##4##(1996-3#1)(2011-2#1)
the subject of##19##3##(1990-2#1)(1993-6#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
the subject to relax in the later part of expiration##2##10##(2008-7#2)
the subject to##3##3##(2008-7#2)(2013-1#1)
the subject was##3##3##(1996-3#1)(2008-12#1)(2008-9#1)
the subject##48##2##(1990-2#1)(1990-6#1)(1991-2#1)(1993-6#1)(1994-1#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-9#4)(2009-1#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the subject's##4##2##(1992-1#1)(2008-11#1)(2010-7#1)(2013-8#1)
the subjective magnitude of##2##4##(1992-12#2)
the subjective night##2##3##(1994-2#1)(2008-5#1)
the subjective##12##2##(1992-12#2)(1994-2#1)(1996-9#1)(2008-5#3)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
the subjects were##5##3##(1991-2#1)(1992-1#1)(1994-12#1)(1996-2#1)(2008-12#1)
the subjects with##4##3##(2008-5#2)(2008-7#2)
the subjects##30##2##(1991-2#4)(1992-1#1)(1994-12#1)(1996-2#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#7)(2008-9#1)(2010-9#1)(2012-3#2)(2013-1#1)(2013-8#3)
the submandibular##2##2##(1995-11#1)(2011-2#1)
the submicrometer##4##2##(2008-10#2)(2008-3#2)
the suboccipital##2##2##(2008-7#1)(2010-9#1)
the suborder##2##2##(1993-3#1)(2011-2#1)
the subordinate##2##2##(2008-8#2)
the subphase##4##2##(1991-3#1)(1994-5#1)(1997-2#2)
the subpopulation##2##2##(2008-10#2)
the subpopulations##3##2##(1995-12#1)(2008-10#2)
the subregions##3##2##(2008-3#3)
the subscales##2##2##(2010-11#1)(2012-2#1)
the subsequent development of##3##4##(1991-12#1)(1993-6#1)(2008-10#1)
the subsequent oxidative##2##3##(2008-10#1)(2008-11#1)
the subsequent reaction of##2##4##(2008-10#2)
the subsequent##63##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#19)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#4)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-8#1)
the subset of##3##3##(2009-12#1)(2010-2#1)(2011-2#1)
the subset##4##2##(2009-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
the subspecies##2##2##(2008-10#2)
the substance in##2##3##(2008-10#1)(2008-5#1)
the substance##12##2##(1990-6#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
the substances##8##2##(1994-12#1)(2007-12#1)(2008-10#2)(2010-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
the substantia nigra (SN) and##2##5##(1994-2#1)(2012-2#1)
the substantia nigra and the##3##5##(1996-12#1)(2008-7#2)
the substantia nigra and##4##4##(1996-12#1)(2008-7#3)
the substantia nigra pars compacta##3##5##(1996-12#2)(2008-7#1)
the substantia nigra pars##4##4##(1995-2#1)(1996-12#2)(2008-7#1)
the substantia nigra##19##3##(1990-5#3)(1994-2#1)(1995-2#4)(1995-8#1)(1996-12#4)(1997-3#1)(2008-7#4)(2012-2#1)
the substantial##5##2##(1991-3#1)(1991-5#1)(1997-1#1)(2011-2#1)(2012-2#1)
the substituent##4##2##(1994-5#1)(2008-10#3)
the substituents##2##2##(1992-8#1)(2008-10#1)
the substituted##2##2##(1996-5#1)(2008-10#1)
the substitution of##5##3##(1992-4#1)(1993-12#1)(1995-6#1)(2008-10#1)(2011-1#1)
the substitution pattern##2##3##(2008-10#2)
the substitution reaction##2##3##(2008-10#2)
the substitution##12##2##(1992-4#1)(1993-12#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-1#1)
the substomatal##3##2##(2008-10#3)
the substrate and the##3##4##(1994-5#1)(2012-2#1)(2013-8#1)
the substrate and##9##3##(1994-5#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-8#1)
the substrate catechol##2##3##(2008-10#2)
the substrate concentration##3##3##(2008-5#2)(2010-10#1)
the substrate during##2##3##(1992-3#1)(2008-5#1)
the substrate for##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
the substrate from##2##3##(2008-10#2)
the substrate in##5##3##(1990-5#1)(1994-5#1)(2008-10#2)(2008-5#1)
the substrate of##2##3##(2008-10#2)
the substrate specificity of##3##4##(1990-5#1)(2008-7#1)(2013-1#1)
the substrate specificity##4##3##(1990-5#1)(2008-11#1)(2008-7#1)(2013-1#1)
the substrate with##2##3##(2008-10#1)(2008-3#1)
the substrate##84##2##(1990-5#4)(1990-9#1)(1991-9#1)(1992-12#1)(1992-3#5)(1992-6#2)(1993-3#1)(1993-8#2)(1994-5#4)(1994-6#1)(1997-2#1)(2008-10#26)(2008-11#2)(2008-3#6)(2008-4#3)(2008-5#7)(2008-7#8)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
the substrates##13##2##(1991-3#1)(1993-6#1)(1993-8#1)(1994-5#4)(1996-2#1)(2008-10#4)(2010-12#1)
the substratum##2##2##(2008-11#1)(2008-9#1)
the subsynovial connective tissue##2##4##(2008-9#2)
the subthalamic nucleus##2##3##(2010-12#1)(2012-2#1)
the subtle##2##2##(2010-11#1)(2013-8#1)
the subunit composition of##2##4##(1990-5#1)(1991-10#1)
the subunit##5##2##(1990-5#1)(1991-10#1)(1995-2#1)(2008-8#1)(2008-9#1)
the subunits##6##2##(1990-8#1)(1991-12#1)(1992-3#2)(2008-9#2)
the success and##3##3##(1997-6#1)(2008-7#1)(2010-11#1)
the success of a##2##4##(1991-2#1)(2008-12#1)
the success of an##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
the success of the##4##4##(1994-2#1)(2008-11#1)(2012-2#2)
the success of their##2##4##(1991-8#1)(1992-3#1)
the success of these##2##4##(2008-10#1)(2008-11#1)
the success of this##3##4##(1996-12#1)(2008-11#1)(2013-8#1)
the success of##45##3##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-12#1)(1994-2#2)(1994-9#1)(1996-12#1)(1996-3#2)(2008-10#4)(2008-11#9)(2008-12#2)(2008-8#3)(2008-9#2)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-8#3)
the success or failure of##2##5##(2008-10#2)
the success rate over##2##4##(2008-11#2)
the success rate##7##3##(1991-12#1)(1994-5#1)(2008-10#1)(2008-11#2)(2011-1#1)(2012-2#1)
the success##60##2##(1991-12#2)(1991-2#1)(1991-8#1)(1992-3#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-9#1)(1996-12#1)(1996-3#2)(1997-6#1)(2008-10#7)(2008-11#11)(2008-12#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-11#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-8#3)
the successful application of##5##4##(1995-11#1)(2008-10#2)(2008-9#1)(2012-3#1)
the successful cloning##2##3##(1991-5#1)(2010-6#1)
the successful implementation of##3##4##(1992-1#1)(2008-10#1)(2008-7#1)
the successful management of##4##4##(1994-3#1)(2008-10#1)(2011-2#2)
the successful outcome of##2##4##(1991-6#1)(2008-11#1)
the successful use of##2##4##(2008-10#1)(2008-11#1)
the successful##41##2##(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
the successive cultures##2##3##(2008-11#2)
the successive determination of##4##4##(2008-10#4)
the successive##10##2##(1995-12#1)(1996-5#1)(1997-6#1)(2008-10#5)(2008-11#2)
the successive-order-of-scattering##2##2##(2008-3#2)
the sudden infant death syndrome (SIDS)##2##6##(1991-11#1)(1993-12#1)
the sudden infant death syndrome##4##5##(1991-11#1)(1993-12#2)(2009-8#1)
the sudden##8##2##(1991-11#1)(1993-12#2)(1996-11#1)(2008-10#2)(2009-8#1)(2010-5#1)
the sufferers##2##2##(2009-7#1)(2010-8#1)
the suffering##2##2##(1991-8#1)(2008-12#1)
the sugar moiety##2##3##(1992-6#1)(1995-12#1)
the sugar##10##2##(1992-6#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2011-1#1)
the sugars##4##2##(1990-2#1)(2008-10#2)(2011-1#1)
the suggested##4##2##(2008-10#3)(2008-3#1)
the suggestion that the##2##4##(1993-12#1)(1995-6#1)
the suggestion that##8##3##(1991-10#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-12#1)
the suggestion##11##2##(1991-10#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-12#1)
the suicidal act##3##3##(2010-6#3)
the suicidal##7##2##(2010-6#7)
the suicide##3##2##(1996-1#1)(2008-9#1)(2010-6#1)
the suitability of different##2##4##(2008-10#1)(2013-1#1)
the suitability of the##9##4##(1997-6#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-4#1)
the suitability of this##2##4##(2008-10#1)(2011-2#1)
the suitability of##25##3##(1994-9#1)(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#11)(2008-11#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)
the suitable##6##2##(2008-10#5)(2008-8#1)
the sulfate anion##2##3##(2008-10#2)
the sulfate ion##4##3##(2008-10#4)
the sulfate##7##2##(2008-10#6)(2011-2#1)
the sulfhydryl##2##2##(2008-10#1)(2008-7#1)
the sulfonic##2##2##(2008-10#2)
the sulfonylureas##2##2##(1992-3#2)
the sulfur##4##2##(1996-5#1)(2008-10#2)(2008-11#1)
the sulphate##2##2##(2012-7#2)
the sulphonylureas##2##2##(1994-8#2)
the sulphur##2##2##(2008-10#2)
the sulphuric acid##2##3##(2008-10#2)
the sum of the concentrations of##2##6##(2008-10#2)
the sum of the concentrations##3##5##(2008-10#3)
the sum of the##14##4##(1990-6#1)(1991-12#1)(1995-12#1)(2008-10#7)(2008-3#1)(2008-8#1)(2009-10#1)(2010-8#1)
the sum of##28##3##(1990-6#1)(1991-12#2)(1993-2#1)(1995-12#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)
the sum##31##2##(1990-6#1)(1991-12#2)(1993-2#1)(1995-12#1)(2008-10#17)(2008-11#2)(2008-3#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#1)
the summation of##3##3##(2007-11#1)(2008-10#1)(2009-8#1)
the summer of 2000##2##4##(2008-10#1)(2008-11#1)
the summer of##6##3##(1990-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)
the summer##17##2##(1990-9#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-1#1)(2011-1#1)
the sun and##3##3##(1991-6#1)(1994-3#2)
the sun protection##2##3##(2008-5#2)
the sun##13##2##(1991-6#3)(1994-3#2)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#4)
the sunburn##2##2##(2008-5#2)
the sunflower##2##2##(2008-10#2)
the sunlight intensity##4##3##(2008-6#4)
the sunlight##6##2##(2008-5#1)(2008-6#4)(2011-2#1)
the sunscreen derived from##2##4##(2008-5#2)
the sunscreen tester##2##3##(2008-5#2)
the sunscreen##7##2##(2008-5#7)
the super modified simplex##2##4##(2008-10#2)
the super##4##2##(1991-12#1)(2008-10#2)(2009-10#1)
the superconducting##3##2##(1992-8#1)(2008-10#1)(2008-7#1)
the supercritical##2##2##(2008-10#1)(2012-2#1)
the superfamily of##3##3##(1995-12#1)(1997-7#1)(2008-11#1)
the superficial##14##2##(1990-5#1)(1994-2#1)(1996-12#1)(1997-3#1)(2008-11#2)(2008-5#3)(2008-9#1)(2011-2#2)(2011-3#1)(2013-8#1)
the superior competitor##2##3##(2008-8#2)
the superior mesenteric##5##3##(2012-3#1)(2013-1#4)
the superior sagittal sinus##2##4##(1997-3#1)(2008-7#1)
the superior temporal sulcus##3##4##(2008-11#2)(2009-10#1)
the superior##26##2##(1991-6#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#3)(2012-3#1)(2012-8#1)(2013-1#6)
the superiority of##6##3##(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
the superiority##7##2##(2008-10#2)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
the supernatant and##3##3##(2008-11#3)
the supernatant of##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
the supernatant was##6##3##(1990-2#1)(2008-10#3)(2008-11#1)(2008-5#1)
the supernatant##21##2##(1990-2#1)(2008-10#7)(2008-11#10)(2008-5#1)(2008-9#1)(2009-8#1)
the supernatants##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
the supernumerary spacing##2##3##(2008-3#2)
the supernumerary##4##2##(1990-5#1)(2008-3#3)
the superoxide anion##3##3##(2008-10#1)(2008-11#2)
the superoxide##5##2##(1992-12#1)(1994-11#1)(2008-10#1)(2008-11#2)
the superposition of##2##3##(2008-3#2)
the supervision of a##2##4##(2008-11#1)(2012-12#1)
the supervision of##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
the supine position##3##3##(2011-2#2)(2012-3#1)
the supine##4##2##(1994-3#1)(2011-2#2)(2012-3#1)
the supplement##5##2##(2008-10#1)(2013-8#4)
the supplementation of##2##3##(2008-11#2)
the supplementation##4##2##(2008-11#3)(2008-8#1)
the supply of volunteers##2##4##(1994-3#2)
the supply of##13##3##(1991-2#1)(1992-3#1)(1994-1#1)(1994-3#3)(1994-6#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-9#1)(2012-2#1)
the supply##14##2##(1991-2#1)(1992-3#1)(1994-1#2)(1994-3#3)(1994-6#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-9#1)(2012-2#1)
the support and##2##3##(1992-12#1)(1994-12#1)
the support of##8##3##(1991-2#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-6#1)(2008-4#1)(2008-5#1)(2011-2#1)
the support received##2##3##(1992-3#1)(2011-2#1)
the support##29##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#2)(1994-12#2)(1994-3#1)(1995-1#1)(1996-3#1)(1997-6#2)(2008-10#2)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#1)(2010-1#1)(2010-5#2)(2010-6#1)(2011-2#2)
the supporting electrolyte was##2##4##(2008-10#2)
the supporting electrolyte##8##3##(2008-10#8)
the supporting##15##2##(1996-1#1)(2007-8#1)(2008-10#11)(2008-6#1)(2010-5#1)
the supportive##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
the suppression of B##2##4##(2008-10#2)
the suppression of disease##3##4##(1997-8#1)(2008-10#2)
the suppression of the##6##4##(1993-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
the suppression of##34##3##(1990-12#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-10#14)(2008-11#6)(2008-5#2)(2008-8#3)(2009-8#1)(2010-1#1)
the suppression##37##2##(1990-12#1)(1993-12#3)(1994-8#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-10#15)(2008-11#7)(2008-5#2)(2008-8#3)(2009-8#1)(2010-1#1)
the suppressive effect##2##3##(2008-10#1)(2009-8#1)
the suppressive effects##2##3##(2008-10#2)
the suppressive soil##2##3##(2008-10#2)
the suppressive##7##2##(2008-10#6)(2009-8#1)
the suppressiveness of##2##3##(2008-10#2)
the supraclavicular##3##2##(1997-8#1)(2008-7#2)
the suprahepatic inferior vena cava##2##5##(1992-9#2)
the supramaximal inhibition of pancreatic##2##5##(1992-8#2)
the supramaximal##3##2##(1992-8#2)(2013-8#1)
the surface and##6##3##(1997-1#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)
the surface area of the##2##5##(1997-2#1)(2008-9#1)
the surface area##4##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-9#1)
the surface boron doped diamond electrode##2##6##(2008-10#2)
the surface characteristics of the##2##5##(1992-3#1)(2008-11#1)
the surface coverage##2##3##(2008-10#2)
the surface layers##3##3##(2008-3#1)(2008-5#2)
the surface morphology##2##3##(2008-7#1)(2009-7#1)
the surface of CCPE##2##4##(2008-10#2)
the surface of a disposable carbon screen-printed electrode##2##8##(2008-10#2)
the surface of a glassy carbon electrode##4##7##(1990-12#1)(2008-10#3)
the surface of a##20##4##(1990-12#1)(1990-5#1)(2008-10#15)(2008-4#1)(2008-8#1)(2008-9#1)
the surface of an##3##4##(2008-10#3)
the surface of human##2##4##(1994-11#1)(1995-2#1)
the surface of infected##3##4##(2008-10#3)
the surface of lipstick##2##4##(2008-5#2)
the surface of silica gel##3##5##(2008-10#3)
the surface of the cells##2##5##(2008-10#1)(2013-1#1)
the surface of the modified electrodes##2##6##(2008-10#2)
the surface of the modified##3##5##(2008-10#3)
the surface of the molecule##2##5##(2008-4#2)
the surface of the skin##2##5##(2008-5#2)
the surface of the##69##4##(1990-8#1)(1992-11#1)(1992-6#1)(1994-11#3)(2008-10#40)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the surface of zoosporangia##2##4##(2008-10#2)
the surface of##166##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#4)(1995-2#3)(1995-6#2)(1997-3#1)(2007-12#1)(2008-10#101)(2008-11#11)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#5)(2008-9#2)(2009-3#1)(2009-6#1)(2009-7#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
the surface plasmon resonance##2##4##(1995-12#1)(2008-10#1)
the surface reflectance##3##3##(2008-3#3)
the surface residues##2##3##(2008-10#2)
the surface roughness parameters##2##4##(2009-7#2)
the surface roughness##3##3##(2008-10#1)(2009-7#2)
the surface temperature##2##3##(2008-7#2)
the surface tension lowering of##2##5##(2008-10#2)
the surface tension lowering##3##4##(2008-10#3)
the surface tension##8##3##(2008-10#7)(2008-3#1)
the surface to the##2##4##(2008-3#1)(2008-6#1)
the surface was##5##3##(2008-10#4)(2008-11#1)
the surface were##2##3##(2008-11#1)(2009-7#1)
the surface which##2##3##(2008-5#1)(2013-8#1)
the surface##299##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#4)(1994-6#1)(1995-12#1)(1995-2#3)(1995-6#2)(1996-12#1)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(2006-6#1)(2007-12#2)(2008-10#149)(2008-11#19)(2008-12#1)(2008-3#14)(2008-4#3)(2008-5#21)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#4)(2009-3#2)(2009-6#1)(2009-7#8)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#4)
the surface-reflected radiance##2##3##(2008-3#2)
the surfaces of these##2##4##(2008-10#1)(2008-5#1)
the surfaces of##7##3##(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)(2010-7#1)
the surfaces##13##2##(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-10#1)(2010-7#1)
the surfactant and the##2##4##(2008-10#1)(2008-5#1)
the surfactant concentration##2##3##(2008-10#2)
the surfactant##20##2##(1997-1#1)(1997-2#1)(2008-10#14)(2008-5#4)
the surfactant-rich phase##7##3##(2008-10#5)(2008-7#2)
the surgeon to##4##3##(1992-12#2)(2010-7#1)(2012-12#1)
the surgeon##12##2##(1992-12#2)(1993-1#1)(1993-11#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
the surgeons##2##2##(2008-9#1)(2013-1#1)
the surgery and##2##3##(2008-7#1)(2011-2#1)
the surgery##14##2##(1990-9#1)(2008-5#1)(2008-7#4)(2009-7#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)
the surgical approach##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
the surgical field##2##3##(1996-1#1)(2008-9#1)
the surgical indications##3##3##(1991-6#1)(2010-12#1)(2013-1#1)
the surgical intervention##3##3##(1991-3#1)(2013-1#1)(2013-8#1)
the surgical management of breast carcinoma##2##6##(1994-12#2)
the surgical management of##8##4##(1994-12#2)(2010-12#1)(2011-2#3)(2013-1#2)
the surgical management##9##3##(1992-1#1)(1994-12#2)(2010-12#1)(2011-2#3)(2013-1#2)
the surgical outcome##2##3##(1991-2#1)(2013-8#1)
the surgical procedure##5##3##(1994-12#1)(2008-7#1)(2011-2#2)(2012-3#1)
the surgical site##2##3##(2010-3#1)(2010-6#1)
the surgical treatment by##2##4##(1990-5#1)(2010-7#1)
the surgical treatment of cancer of the##2##7##(1990-3#1)(1990-9#1)
the surgical treatment of##7##4##(1990-3#2)(1990-9#1)(1991-3#1)(2008-10#1)(2008-9#1)(2010-3#1)
the surgical treatment##14##3##(1990-3#3)(1990-5#1)(1990-9#1)(1991-3#1)(1992-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
the surgical##79##2##(1990-3#3)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-6#1)(1994-12#3)(1995-8#1)(1996-1#1)(1996-9#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-4#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-7#1)(2011-2#13)(2011-3#2)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#2)
the surgically resected##2##3##(2008-7#2)
the surgically##4##2##(1990-6#1)(1992-9#1)(2008-7#2)
the surprising##2##2##(2008-10#1)(2012-2#1)
the surrogate##2##2##(1995-6#1)(2008-10#1)
the surrounding environment##3##3##(2008-7#1)(2013-1#2)
the surrounding matrix##2##3##(2008-8#2)
the surrounding normal##2##3##(2008-12#1)(2008-7#1)
the surrounding tissue##2##3##(1990-11#1)(1997-4#1)
the surrounding tissues##3##3##(1990-6#1)(1993-11#1)(2011-2#1)
the surrounding##37##2##(1990-11#1)(1990-6#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2011-2#1)(2013-1#4)
the surveillance##9##2##(1992-9#2)(1996-11#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-8#2)
the survey##28##2##(1991-12#1)(1991-2#1)(1994-12#1)(1994-3#1)(1995-1#2)(1996-1#1)(1997-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
the survival and##9##3##(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-7#1)(2010-8#1)(2012-12#1)
the survival curve##4##3##(1995-3#4)
the survival of patients##3##4##(2008-11#1)(2008-2#1)(2010-12#1)
the survival of the##8##4##(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#2)(2011-2#1)(2013-1#1)
the survival of##40##3##(1991-3#1)(1991-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#4)(2008-8#5)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-5#1)(2013-1#1)
the survival rate##7##3##(1995-3#1)(1997-7#2)(2008-11#1)(2010-8#1)(2011-2#2)
the survival time##2##3##(1997-4#1)(2008-8#1)
the survival##73##2##(1991-3#1)(1991-6#1)(1993-8#1)(1994-12#2)(1995-12#2)(1995-3#5)(1996-12#2)(1997-4#1)(1997-7#2)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#4)(2008-8#8)(2009-10#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-5#1)(2013-1#1)
the surviving##8##2##(1992-3#1)(1993-3#1)(1994-3#1)(2008-5#1)(2008-9#3)(2010-11#1)
the survivorship##2##2##(2008-8#1)(2008-9#1)
the susceptibility of the##2##4##(2008-10#1)(2011-2#1)
the susceptibility of##11##3##(1992-9#1)(1994-5#1)(2008-10#7)(2008-7#1)(2011-2#1)
the susceptibility to##8##3##(1991-2#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#3)(2013-8#1)
the susceptibility##23##2##(1991-2#1)(1992-9#1)(1994-5#1)(1997-8#2)(2008-10#10)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#4)(2013-8#1)
the susceptible cultivar##8##3##(2008-10#8)
the susceptible cultivars##2##3##(2008-10#2)
the susceptible cv##6##3##(2008-10#6)
the susceptible genotype##3##3##(2008-10#3)
the susceptible genotypes##2##3##(2008-10#2)
the susceptible inbred B73 and##2##5##(2008-10#2)
the susceptible line##2##3##(2008-10#2)
the susceptible parent B73##2##4##(2008-10#2)
the susceptible parent##7##3##(2008-10#7)
the susceptible plants##2##3##(2008-10#2)
the susceptible##64##2##(1994-9#1)(1996-12#1)(2008-10#59)(2008-5#2)(2011-10#1)
the suspect##2##2##(1996-11#1)(2013-1#1)
the suspected##4##2##(1990-6#1)(2009-1#1)(2011-2#1)(2012-2#1)
the suspended##4##2##(2008-10#2)(2008-3#1)(2009-7#1)
the suspension culture##5##3##(2008-11#5)
the suspension##12##2##(1990-12#1)(2008-10#3)(2008-11#8)
the suspensor##2##2##(2009-8#2)
the sustainability of treatment programs##2##5##(2012-2#2)
the sustainability of##4##3##(1997-7#1)(2012-2#3)
the sustained##5##2##(1994-6#1)(1997-8#1)(2008-12#1)(2008-9#1)(2013-8#1)
the sweetness of##2##3##(2008-10#1)(2008-5#1)
the swelling##2##2##(2008-10#1)(2010-11#1)
the swim##2##2##(1990-8#1)(1997-4#1)
the swing##2##2##(2010-3#1)(2011-2#1)
the swing-bed##2##2##(1991-1#1)(1994-2#1)
the switch between##2##3##(2008-10#1)(2009-8#1)
the switch to##2##3##(2008-11#1)(2013-1#1)
the switch##6##2##(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#2)
the switched##2##2##(1992-3#1)(2008-2#1)
the switching##2##2##(2008-2#1)(2008-7#1)
the swollen lamellar##2##3##(2008-5#2)
the swollen##7##2##(2008-10#1)(2008-12#1)(2008-5#3)(2009-5#1)(2011-2#1)
the syconia of##2##3##(2008-10#2)
the symbiont##2##2##(2007-12#1)(2008-10#1)
the symbiosis##2##2##(2008-8#1)(2009-8#1)
the symbiotic##3##2##(2008-11#3)
the symmetric##3##2##(2008-10#2)(2008-3#1)
the symmetry of##2##3##(2008-8#1)(2013-8#1)
the sympathetic sprouting in the##2##5##(2008-9#2)
the sympathetic##8##2##(1993-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-2#1)
the symphysis pubis##3##3##(1994-3#1)(2012-12#2)
the symposium##3##2##(2008-10#1)(2008-5#2)
the symptom complex##2##3##(1991-11#1)(1997-2#1)
the symptom##8##2##(1991-11#1)(1997-2#1)(2008-10#1)(2011-2#3)(2013-8#2)
the symptomatic##6##2##(1993-1#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
the symptomatology##6##2##(1990-11#1)(1996-9#1)(1997-8#1)(2008-10#1)(2009-9#1)(2013-1#1)
the symptoms and signs of##2##5##(2008-10#1)(2011-3#1)
the symptoms and##7##3##(1996-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-3#2)
the symptoms disappeared##2##3##(1991-2#1)(2008-5#1)
the symptoms may##2##3##(2010-8#1)(2013-1#1)
the symptoms of##13##3##(1994-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
the symptoms##54##2##(1991-2#1)(1991-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-8#2)(2008-1#3)(2008-10#10)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#4)(2011-3#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the synapse##3##2##(2008-7#1)(2009-8#1)(2009-9#1)
the synaptic##6##2##(1996-12#1)(1996-2#2)(1997-2#1)(2008-11#1)(2013-8#1)
the synchronization of##2##3##(2008-10#1)(2008-11#1)
the synchronization##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
the synchronized##3##2##(2008-11#1)(2013-1#2)
the synchronous##2##2##(2008-10#2)
the syndrome is##2##3##(2008-7#1)(2008-8#1)
the syndrome of##3##3##(1995-5#1)(1997-3#1)(2013-8#1)
the syndrome##16##2##(1990-9#1)(1991-11#1)(1992-5#1)(1995-5#1)(1997-3#3)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the synergic effect##2##3##(2008-10#1)(2008-11#1)
the synergism##2##2##(2008-10#2)
the synergistic effect of##2##4##(2008-10#1)(2008-11#1)
the synergistic effect##4##3##(2008-10#3)(2008-11#1)
the synergistic##9##2##(2008-10#6)(2008-11#1)(2010-7#1)(2011-2#1)
the synergy between##2##3##(2008-10#1)(2008-5#1)
the synovial fluid##2##3##(2011-1#2)
the synovial joints##2##3##(2012-2#1)(2012-3#1)
the synovial##8##2##(1992-3#1)(1993-2#1)(2008-5#1)(2011-1#2)(2012-2#2)(2012-3#1)
the syntenic##2##2##(2008-10#2)
the syntheses of##3##3##(1991-6#1)(2008-10#1)(2008-12#1)
the syntheses##4##2##(1991-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
the synthesis and characterization of a##2##6##(2008-10#1)(2010-4#1)
the synthesis and characterization of##4##5##(2008-10#1)(2008-4#2)(2010-4#1)
the synthesis and degradation of##2##5##(2011-2#1)(2013-1#1)
the synthesis and release of##2##5##(1995-11#1)(2013-7#1)
the synthesis and##18##3##(1994-11#1)(1994-8#1)(1995-11#2)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
the synthesis of a series of##2##6##(2008-12#1)(2009-12#1)
the synthesis of a##6##4##(1995-6#1)(1997-1#1)(2008-10#1)(2008-12#1)(2009-12#1)(2012-2#1)
the synthesis of natural##3##4##(1992-11#2)(2009-10#1)
the synthesis of new##2##4##(2008-10#1)(2010-4#1)
the synthesis of the##8##4##(1990-11#1)(1990-5#1)(1991-10#1)(1992-12#1)(2008-10#1)(2008-4#1)(2009-6#1)(2009-8#1)
the synthesis of##95##3##(1990-11#1)(1990-5#3)(1991-10#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#5)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#8)(2008-5#1)(2008-7#6)(2008-9#1)(2009-10#4)(2009-12#2)(2009-6#2)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)
the synthesis process##3##3##(2008-10#3)
the synthesis##124##2##(1990-11#1)(1990-5#3)(1991-10#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#5)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#21)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#12)(2008-5#2)(2008-7#6)(2008-9#1)(2009-10#4)(2009-12#2)(2009-6#2)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
the synthesized WCX##2##3##(2008-10#2)
the synthesized compounds##3##3##(2008-5#1)(2012-2#1)(2012-3#1)
the synthesized proteins##2##3##(2008-1#1)(2008-7#1)
the synthesized resin##3##3##(2008-10#3)
the synthesized##20##2##(2008-1#1)(2008-10#7)(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
the synthetic peptide##2##3##(1994-5#1)(2008-4#1)
the synthetic sunscreen##4##3##(2008-5#4)
the synthetic##33##2##(1990-10#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#4)(2009-12#2)(2010-1#1)(2010-2#1)(2012-3#1)
the syrB gene##4##3##(2008-10#4)
the syringe##4##2##(2008-10#4)
the system achieved a detection limit##2##6##(2008-10#2)
the system and the##5##4##(1996-1#1)(2008-10#3)(2012-3#1)
the system and to##3##4##(2008-10#2)(2008-3#1)
the system and##11##3##(1996-1#1)(2008-10#7)(2008-3#2)(2012-3#1)
the system as##5##3##(1991-2#1)(1994-1#1)(2008-10#3)
the system by##2##3##(2008-10#1)(2008-11#1)
the system can be##2##4##(1990-2#1)(2008-10#1)
the system can##6##3##(1990-2#1)(2008-10#3)(2008-3#1)(2008-9#1)
the system could##2##3##(2008-10#2)
the system directly##2##3##(1996-1#1)(2008-5#1)
the system for##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
the system from##2##3##(2008-10#1)(2011-2#1)
the system has been##3##4##(1992-9#1)(2008-10#1)(2010-8#1)
the system has##6##3##(1992-9#1)(2008-10#3)(2010-8#1)(2013-8#1)
the system in##5##3##(1990-2#1)(1995-3#1)(2008-10#3)
the system is in##2##4##(2008-10#2)
the system is##20##3##(2008-10#12)(2008-11#3)(2008-2#2)(2008-8#1)(2009-6#1)(2011-2#1)
the system of reversed##2##4##(1990-5#2)
the system of##11##3##(1990-5#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2012-3#1)(2013-8#1)
the system over##2##3##(2008-10#2)
the system parameters##2##3##(2008-3#2)
the system to##9##3##(1992-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-10#1)
the system was illustrated##2##4##(2008-10#1)(2012-3#1)
the system was##23##3##(1995-3#1)(1997-1#1)(2008-10#18)(2010-6#1)(2012-3#1)(2013-8#1)
the system were##10##3##(1992-12#1)(2008-10#8)(2008-12#1)
the system will##2##3##(1992-12#1)(2008-10#1)
the system with delay and##2##5##(2013-8#2)
the system with##9##3##(2008-10#4)(2008-3#1)(2009-4#1)(2013-8#3)
the system without##3##3##(2008-10#3)
the system##270##2##(1990-2#3)(1990-5#3)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1996-1#3)(1996-2#4)(1996-5#2)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2008-10#142)(2008-11#14)(2008-12#3)(2008-2#3)(2008-3#13)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#3)(2010-8#1)(2011-2#3)(2012-3#7)(2013-1#2)(2013-8#6)
the system's##8##2##(1991-12#1)(1994-1#2)(2008-10#1)(2008-3#2)(2013-1#1)(2013-8#1)
the systematic##9##2##(1991-3#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-3#1)
the systemic circulation##2##3##(2008-10#1)(2010-6#1)
the systemic##22##2##(1990-11#1)(1993-12#1)(1994-2#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-3#2)
the systems under##2##3##(2008-10#2)
the systems were##2##3##(2008-10#1)(2008-8#1)
the systems##16##2##(1991-1#2)(2008-10#8)(2008-11#2)(2008-7#1)(2008-8#2)(2013-1#1)
the systolic and diastolic##5##4##(1996-3#1)(1996-6#1)(2008-12#1)(2010-4#1)(2010-7#1)
the t-PA secretion##2##3##(2008-11#2)
the t-PA##3##2##(1994-3#1)(2008-11#2)
the t-test##2##2##(2008-10#1)(2008-11#1)
the tMCAO##2##2##(2011-2#2)
the table##7##2##(1995-2#1)(2008-10#3)(2008-6#1)(2008-8#1)(2013-1#1)
the tablet##2##2##(2008-10#2)
the tablets##3##2##(2008-10#3)
the tachykinin family##2##3##(1991-5#2)
the tactile perception##2##3##(2008-5#2)
the tactile##4##2##(2008-5#3)(2009-8#1)
the tag##2##2##(1995-2#1)(2008-11#1)
the tail of the##2##4##(2008-5#1)(2013-1#1)
the tail##6##2##(1995-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-7#1)(2013-1#1)
the tail-flick response##3##3##(1992-3#3)
the tail-flick##4##2##(1992-3#4)
the talonavicular joint##2##3##(2010-3#2)
the talonavicular##3##2##(2009-10#1)(2010-3#2)
the tamarillo isolates##2##3##(2008-10#2)
the tandem##3##2##(1996-5#2)(2008-10#1)
the tangential##2##2##(2008-11#1)(2008-3#1)
the tangerine##2##2##(2008-10#2)
the tantalizing##2##2##(2009-8#1)(2012-2#1)
the tapestry chamber##2##3##(2012-2#2)
the tapestry##3##2##(2012-2#3)
the taproot##2##2##(2008-10#2)
the target DNA##5##3##(2008-10#4)(2008-4#1)
the target VOCs##2##3##(2008-10#2)
the target amount##2##3##(1993-12#2)
the target analyte##5##3##(2008-10#5)
the target analytes##4##3##(2008-10#4)
the target and##3##3##(1995-1#1)(2008-3#2)
the target area##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
the target cells##5##3##(1990-12#1)(2008-11#2)(2008-4#1)(2008-7#1)
the target compounds##5##3##(2008-10#5)
the target for##2##3##(2008-4#1)(2008-7#1)
the target gas##2##3##(2008-3#2)
the target gene as##2##4##(2008-10#2)
the target gene##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
the target genes##2##3##(2008-8#1)(2008-9#1)
the target group##2##3##(2010-12#1)(2012-2#1)
the target is##2##3##(2008-3#1)(2009-11#1)
the target of##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
the target population##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
the target protein##2##3##(1997-2#1)(2008-11#1)
the target region##2##3##(1995-12#1)(2011-2#1)
the target sequence##5##3##(2008-10#2)(2008-4#2)(2008-9#1)
the target volume##3##3##(2008-2#1)(2009-11#2)
the target word##2##3##(2009-8#2)
the target##142##2##(1990-12#1)(1990-6#1)(1993-12#2)(1993-2#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#2)(1997-7#1)(2008-10#54)(2008-11#13)(2008-2#1)(2008-3#12)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-11#5)(2009-7#1)(2009-8#4)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
the target's##2##2##(2008-11#1)(2009-10#1)
the targeted##10##2##(1994-12#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-12#1)
the targeting of##4##3##(2008-11#2)(2009-7#1)(2009-8#1)
the targeting##7##2##(2008-11#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)
the targets for##2##3##(1997-2#1)(2011-3#1)
the targets of##4##3##(1991-5#1)(2008-1#1)(2008-11#2)
the targets##9##2##(1991-5#1)(1997-2#1)(2008-1#1)(2008-11#5)(2011-3#1)
the task of##6##3##(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#2)
the task##22##2##(1991-1#1)(1991-2#1)(1993-3#1)(1994-3#1)(1994-8#4)(1995-12#1)(1995-5#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#2)(2013-8#2)
the tasks were##2##3##(1991-6#1)(2008-11#1)
the tasks##5##2##(1991-6#1)(2008-11#2)(2011-2#1)(2012-2#1)
the taste sensing##2##3##(2008-10#2)
the taste##7##2##(1991-3#2)(2008-10#5)
the tau 1 core##3##4##(1995-2#3)
the tau##4##2##(1993-6#1)(1995-2#3)
the tax##2##2##(2008-8#2)
the taxonomic##5##2##(1994-3#2)(2008-10#1)(2008-12#1)(2010-10#1)
the taxonomy of##4##3##(2008-10#2)(2008-5#1)(2010-10#1)
the tea##3##2##(1995-9#1)(2008-10#2)
the teacher's##3##2##(2008-11#2)(2011-2#1)
the teachers##3##2##(1991-12#1)(1994-6#1)(2008-11#1)
the teaching and learning of##3##5##(2008-11#2)(2008-12#1)
the teaching and learning##6##4##(2008-11#4)(2008-12#2)
the teaching and training of##2##5##(1997-7#1)(2008-11#1)
the teaching and##8##3##(1997-7#1)(2008-11#5)(2008-12#2)
the teaching of##3##3##(2008-11#2)(2010-1#1)
the teaching##18##2##(1992-1#1)(1997-7#1)(2008-10#1)(2008-11#8)(2008-12#5)(2010-1#1)(2012-3#1)
the team##15##2##(1991-2#1)(1992-2#1)(1995-1#1)(1995-2#1)(1996-1#4)(1996-3#1)(1997-2#1)(2008-11#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-8#1)
the team's##2##2##(1993-12#1)(1997-2#1)
the tear##2##2##(2013-8#2)
the technical details##2##3##(2008-9#1)(2012-3#1)
the technical##18##2##(1992-3#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
the technique allows##2##3##(2008-10#1)(2008-9#1)
the technique and##6##3##(1990-11#1)(1994-2#1)(2008-10#2)(2008-4#1)(2010-7#1)
the technique are##5##3##(1995-11#1)(1997-3#1)(2008-10#1)(2008-3#1)(2009-1#1)
the technique can be##2##4##(1993-2#1)(2008-2#1)
the technique employed##2##3##(2008-10#1)(2010-4#1)
the technique in##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
the technique is##8##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)
the technique of choice##2##4##(1995-11#1)(2012-2#1)
the technique of##20##3##(1994-2#1)(1995-11#1)(1996-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the technique proposed##2##3##(2008-10#1)(2008-3#1)
the technique to##2##3##(2008-10#1)(2008-3#1)
the technique used##4##3##(1990-9#1)(1997-5#1)(2008-10#1)(2012-2#1)
the technique was used##2##4##(2008-10#1)(2008-5#1)
the technique was##5##3##(1997-3#1)(2008-10#3)(2008-5#1)
the technique##88##2##(1990-11#1)(1990-9#1)(1992-2#1)(1993-2#1)(1994-2#2)(1995-11#2)(1996-12#1)(1996-3#1)(1997-3#2)(1997-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#1)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
the techniques and##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
the techniques are##2##3##(1991-2#1)(2008-10#1)
the techniques of##3##3##(2008-10#2)(2008-9#1)
the techniques used##3##3##(2008-10#1)(2009-10#1)(2010-8#1)
the techniques were##2##3##(2008-10#1)(2008-8#1)
the techniques##24##2##(1991-2#1)(1995-5#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2010-8#1)
the technological##4##2##(1992-11#1)(1992-2#1)(2008-11#1)(2010-7#1)
the technologies##3##2##(2008-11#2)(2011-3#1)
the technology in##2##3##(2008-10#2)
the technology is##3##3##(2008-11#2)(2011-2#1)
the technology of##2##3##(1997-5#1)(2013-8#1)
the technology to##3##3##(2008-10#2)(2008-9#1)
the technology##21##2##(1992-11#1)(1994-12#1)(1997-5#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-12#1)(2011-2#1)(2013-8#1)
the teeth##3##2##(1995-9#1)(2011-2#1)(2013-1#1)
the teicoplanin##3##2##(2008-10#3)
the telencephalon##3##2##(1996-5#2)(2008-6#1)
the telephone##3##2##(1996-5#1)(2013-1#2)
the telia##2##2##(2008-10#2)
the telomerase activity in##2##4##(2008-9#2)
the telomerase activity##3##3##(2008-9#3)
the telomerase complex##2##3##(2008-11#2)
the telomerase##5##2##(2008-11#2)(2008-9#3)
the telomere##2##2##(2008-11#1)(2008-8#1)
the telomeres##3##2##(1991-7#1)(1997-6#2)
the telomeric region of##2##4##(1994-11#1)(1995-2#1)
the telomeric region##5##3##(1994-11#1)(1995-2#1)(2008-11#2)(2010-8#1)
the telomeric##9##2##(1993-3#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-8#1)
the telomerized##2##2##(2008-11#2)
the temperate and tropical isolates##3##5##(2008-10#3)
the temperate and##4##3##(2008-10#3)(2008-8#1)
the temperate isolates##3##3##(2008-10#3)
the temperate zone##2##3##(2008-10#1)(2012-3#1)
the temperate##11##2##(2008-10#7)(2008-8#2)(2012-2#1)(2012-3#1)
the temperature and pressure##2##4##(2008-3#2)
the temperature and##7##3##(1992-2#1)(2008-10#3)(2008-3#2)(2008-5#1)
the temperature dependence of the##3##5##(1997-6#1)(2008-10#1)(2008-2#1)
the temperature distribution##3##3##(2008-3#2)(2008-7#1)
the temperature effect##4##3##(2008-10#3)(2012-5#1)
the temperature in the capillary##2##5##(2008-10#2)
the temperature is##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
the temperature of##2##3##(2008-10#2)
the temperature range##5##3##(1994-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
the temperature ranges##2##3##(2008-10#2)
the temperature rise##2##3##(2008-3#2)
the temperature sensitivity of##3##4##(2008-8#1)(2008-9#2)
the temperature sensitivity##4##3##(1995-2#1)(2008-8#1)(2008-9#2)
the temperature to##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
the temperature was##4##3##(2008-10#4)
the temperature##81##2##(1990-5#1)(1992-2#1)(1994-5#2)(1995-2#1)(1995-6#1)(1997-2#3)(1997-6#1)(2008-10#35)(2008-11#2)(2008-2#5)(2008-3#15)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2011-2#1)(2012-5#3)
the temperatures##2##2##(2008-5#1)(2011-2#1)
the template molecule##3##3##(2008-10#3)
the template##12##2##(2008-10#8)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
the temporal and geographical##2##4##(1990-8#1)(2008-10#1)
the temporal and spatial dynamics of##2##6##(2008-10#2)
the temporal and spatial##6##4##(1996-12#1)(2007-12#1)(2008-10#4)
the temporal and##10##3##(1990-8#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#1)
the temporal bone##4##3##(2008-9#2)(2011-2#2)
the temporal dynamics of##5##4##(2008-10#3)(2008-8#1)(2009-8#1)
the temporal evolution of the##4##5##(2008-10#1)(2008-2#3)
the temporal evolution of##7##4##(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)
the temporal expression##2##3##(2008-10#1)(2012-3#1)
the temporal lobe##4##3##(2008-4#1)(2008-7#1)(2011-2#2)
the temporal organization of sleep spindles##2##6##(2009-8#2)
the temporal region##3##3##(2008-9#2)(2009-1#1)
the temporal##73##2##(1990-5#1)(1990-8#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-12#2)(1996-2#2)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-1#1)(2009-3#1)(2009-8#5)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
the temporary##5##2##(1992-9#1)(1997-3#1)(2008-11#2)(2008-8#1)
the temporo-parietal##2##2##(2008-11#2)
the temporomandibular joint##2##3##(1993-1#1)(1996-2#1)
the ten##5##2##(1995-12#1)(1996-2#1)(2008-11#1)(2013-8#2)
the ten-year OS rate was##3##5##(1993-1#3)
the tenants##2##2##(1993-1#2)
the tendency to##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
the tendency##8##2##(1994-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
the tenets of##2##3##(1994-12#1)(2010-4#1)
the tensile properties of##2##4##(2009-7#2)
the tensile strength##2##3##(2008-5#1)(2008-7#1)
the tensile##6##2##(2008-5#2)(2008-7#1)(2009-7#3)
the tensions##2##2##(2009-10#2)
the tensor fasciae##2##3##(2009-3#2)
the tenth##4##2##(1996-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
the tentorium cerebelli##2##3##(1997-3#1)(2011-2#1)
the teratogenicity of##2##3##(1993-12#1)(2013-1#1)
the terbium##2##2##(2008-10#2)
the term &quot##5##3##(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
the term 'scalp'##2##3##(2008-9#2)
the term##27##2##(1993-8#2)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#7)(2008-8#1)(2008-9#3)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
the terminal differentiation##2##3##(1993-6#1)(2008-5#1)
the terminal ileum##2##3##(1997-1#1)(2008-12#1)
the terminal region of the short##2##6##(2008-7#1)(2012-3#1)
the terminal region of the##3##5##(2008-7#1)(2008-9#1)(2012-3#1)
the terminal##37##2##(1990-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1995-2#1)(1996-12#1)(1997-1#2)(1997-5#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#4)
the terminating electrolyte##2##3##(2008-10#2)
the termination of##6##3##(1995-8#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-9#1)(2011-1#1)
the termination##7##2##(1995-8#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-9#2)(2011-1#1)
the termini of##3##3##(1990-5#1)(1992-6#1)(1997-8#1)
the terms &quot##2##3##(2011-2#2)
the terms of the##3##4##(1993-12#1)(1995-12#1)(1996-1#1)
the terms of##4##3##(1993-12#1)(1995-12#1)(1996-1#1)(2008-10#1)
the terms##8##2##(1993-12#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
the ternary complex##5##3##(1993-8#1)(1994-5#1)(2008-10#3)
the ternary system##3##3##(2008-10#3)
the ternary##13##2##(1993-8#1)(1994-5#1)(2008-10#11)
the terrestrial##5##2##(1990-5#1)(1995-6#1)(2008-3#1)(2008-6#1)(2008-7#1)
the territory of##3##3##(1992-2#1)(1996-3#1)(2011-2#1)
the tertiary structure of the##2##5##(1990-5#1)(2008-10#1)
the tertiary##3##2##(1990-5#1)(2008-10#1)(2008-12#1)
the test data##2##3##(2008-10#2)
the test group##2##3##(1994-8#1)(2008-12#1)
the test material##2##3##(1990-12#1)(2008-11#1)
the test of##2##3##(1997-5#1)(2008-10#1)
the test period##2##3##(2008-10#1)(2011-1#1)
the test results##2##3##(2008-10#1)(2008-3#1)
the test sample##5##3##(2008-10#4)(2008-9#1)
the test samples##4##3##(2008-10#4)
the test set##2##3##(2008-10#2)
the test site##2##3##(2008-10#1)(2008-5#1)
the test solution##3##3##(2008-10#3)
the test solutions##3##3##(2008-10#3)
the test statistic##2##3##(1992-9#1)(1995-9#1)
the test subject##2##3##(1997-5#2)
the test subject's##2##3##(1997-5#2)
the test using##2##3##(2008-11#1)(2008-12#1)
the test was##2##3##(1996-12#1)(2008-2#1)
the test##106##2##(1990-12#1)(1990-6#1)(1992-1#1)(1992-9#2)(1993-11#1)(1993-6#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#3)(1997-3#1)(1997-5#5)(2008-1#3)(2008-10#41)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#2)(2008-9#2)(2009-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)
the test's##2##2##(1996-5#1)(2009-12#1)
the tested concentrations##2##3##(2008-11#1)(2008-7#1)
the tested samples##2##3##(2008-10#2)
the tested##37##2##(2008-10#19)(2008-11#6)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)(2013-1#2)
the tester strains##2##3##(2008-10#1)(2011-1#1)
the tester##3##2##(2008-10#2)(2011-1#1)
the testes##5##2##(1997-6#1)(2008-9#1)(2009-10#3)
the testicles##2##2##(2008-10#2)
the testicular##2##2##(2009-11#1)(2010-5#1)
the testimony##2##2##(1994-2#1)(2011-2#1)
the testing of a##2##4##(2008-10#1)(2010-2#1)
the testing of##7##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)(2012-2#1)
the testing##18##2##(1990-11#1)(1993-3#1)(1994-3#2)(1996-6#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
the testis is a##3##4##(1992-12#1)(2007-8#1)(2011-2#1)
the testis is##6##3##(1992-12#1)(2007-8#1)(2009-10#2)(2011-2#1)(2012-2#1)
the testis##36##2##(1992-12#4)(1993-12#1)(1994-11#1)(1995-6#1)(1995-8#2)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2009-10#7)(2009-11#1)(2010-5#1)(2011-2#2)(2012-2#7)
the testosterone displacement##3##3##(2008-10#3)
the testosterone##4##2##(1995-2#1)(2008-10#3)
the tests##11##2##(1996-1#1)(1996-6#1)(2008-10#4)(2008-5#2)(2008-9#1)(2012-12#1)(2012-2#1)
the tetracycline antibiotics##2##3##(2008-10#2)
the tetracycline##5##2##(1997-7#1)(2008-10#3)(2008-11#1)
the tetraheme cytochrome subunit##2##4##(1993-8#2)
the tetraheme cytochrome##3##3##(1993-8#2)(1994-5#1)
the tetramer##2##2##(2008-9#2)
the tetramerization mechanism##2##3##(1993-8#2)
the tetramerization##3##2##(1993-8#3)
the tetrapeptide##4##2##(1991-5#2)(1993-9#1)(1994-5#1)
the tetraploid##3##2##(2008-10#2)(2008-11#1)
the tetraspanin##2##2##(2009-8#2)
the text##6##2##(2008-10#3)(2009-11#1)(2009-4#1)(2011-2#1)
the thalamic##3##2##(1997-2#2)(2010-1#1)
the thalamus##3##2##(2008-7#1)(2012-3#2)
the the##5##2##(1990-5#1)(1995-6#1)(1997-6#1)(2007-8#1)(2008-7#1)
the theca interna##2##3##(1995-12#2)
the theca##4##2##(1995-12#2)(2008-12#1)(2008-8#1)
the theme of the##2##4##(2008-11#1)(2009-10#1)
the themes identified##2##3##(2008-11#2)
the themes##3##2##(2008-11#3)
the theoretical analyses##3##3##(2008-3#2)(2010-2#1)
the theoretical and empirical##2##4##(1993-3#1)(1996-6#1)
the theoretical and##4##3##(1993-3#1)(1996-6#1)(1997-4#1)(2008-3#1)
the theoretical framework##2##3##(2008-12#1)(2011-2#1)
the theoretical knowledge of holistic care##2##6##(2008-11#2)
the theoretical knowledge##3##3##(2008-11#3)
the theoretical model##2##3##(2008-3#2)
the theoretical results##2##3##(2008-8#1)(2010-5#1)
the theoretical##49##2##(1991-12#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-6#1)(1997-4#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-3#12)(2008-5#1)(2008-6#2)(2008-8#2)(2010-1#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the theories of##2##3##(2010-10#1)(2013-1#1)
the theories##3##2##(2010-1#1)(2010-10#1)(2013-1#1)
the theory and##5##3##(1990-12#1)(1997-3#1)(2008-3#1)(2008-8#1)(2012-3#1)
the theory of the##3##4##(2008-3#1)(2011-2#1)(2012-3#1)
the theory of##17##3##(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
the theory that##2##3##(2009-8#1)(2010-1#1)
the theory##37##2##(1990-11#1)(1990-12#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2010-1#2)(2011-2#2)(2012-3#3)(2013-8#3)
the theory-practice gap##7##3##(2008-11#7)
the theory-practice##8##2##(2008-11#7)(2012-3#1)
the therapeutic approach##2##3##(1990-12#1)(1990-3#1)
the therapeutic efficacy of##2##4##(1991-8#1)(2012-12#1)
the therapeutic gene##2##3##(2008-11#1)(2008-5#1)
the therapeutic milieu and##2##4##(1993-2#1)(2010-5#1)
the therapeutic milieu##3##3##(1993-2#2)(2010-5#1)
the therapeutic potential of##3##4##(2008-11#1)(2012-12#1)(2013-8#1)
the therapeutic ratio##3##3##(1992-3#1)(1997-1#1)(2008-10#1)
the therapeutic response to##2##4##(2008-10#1)(2009-11#1)
the therapeutic response##3##3##(1991-2#1)(2008-10#1)(2009-11#1)
the therapeutic use of##2##4##(1996-11#1)(2013-8#1)
the therapeutic##43##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#2)(1993-2#3)(1996-11#2)(1997-1#2)(2008-10#4)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
the therapist##3##2##(1991-12#1)(2008-12#1)(2012-2#1)
the therapy of patients##2##4##(1993-6#1)(2009-8#1)
the therapy of##12##3##(1991-3#1)(1993-6#1)(1995-2#1)(1997-1#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-2#1)(2011-3#3)
the therapy##19##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-6#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-2#1)(2011-2#1)(2011-3#3)(2013-7#2)
the thermal diffusivity##4##3##(2008-3#4)
the thermal effect in the##2##5##(2008-3#2)
the thermal effect##3##3##(2008-3#3)
the thermal lens and the##2##5##(2008-2#1)(2008-3#1)
the thermal lens##7##3##(2008-2#3)(2008-3#4)
the thermal stability of##2##4##(1993-6#1)(2011-1#1)
the thermal stability##3##3##(1993-6#1)(1994-8#1)(2011-1#1)
the thermal##40##2##(1993-6#1)(1994-8#1)(2008-10#8)(2008-2#8)(2008-3#17)(2011-1#1)(2011-2#2)(2012-6#1)(2013-8#1)
the thermal-lens interference##2##3##(2008-3#2)
the thermal-lens##3##2##(2008-10#1)(2008-3#2)
the thermodynamic activity of##2##4##(1991-11#1)(2008-5#1)
the thermodynamic data##3##3##(2008-10#3)
the thermodynamic parameters were##2##4##(1993-8#1)(2008-10#1)
the thermodynamic parameters##3##3##(1993-8#1)(2008-10#2)
the thermodynamic##21##2##(1991-11#1)(1993-8#2)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)
the thermoregulatory##2##2##(1994-2#2)
the thermostability of##2##3##(1991-5#1)(2008-10#1)
the theta parameter of the beta-binomial distribution##2##7##(2008-10#2)
the theta phase##2##3##(2008-11#2)
the theta##6##2##(2008-10#2)(2008-11#4)
the thiamine concentration##2##3##(2008-10#2)
the thick##2##2##(2008-5#1)(2011-2#1)
the thickened##2##2##(2008-5#1)(2011-2#1)
the thickness and the##2##4##(2008-10#1)(2008-3#1)
the thickness and##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
the thickness of the film##2##5##(2008-10#1)(2008-2#1)
the thickness of the unstirred layer in the##4##8##(1991-5#4)
the thickness of the unstirred##5##5##(1991-5#5)
the thickness of the##17##4##(1991-5#5)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)
the thickness of##21##3##(1991-5#5)(1994-11#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)
the thickness##28##2##(1991-5#5)(1994-11#1)(2008-10#8)(2008-2#2)(2008-3#5)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)
the thigh##5##2##(1991-6#1)(1997-3#1)(2008-12#1)(2008-5#1)(2013-1#1)
the thin film##2##3##(2008-10#2)
the thin##6##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
the thiocyanate concentration##2##3##(2008-10#2)
the thiocyanate##6##2##(2008-10#6)
the thiocyanato-complexes formed##2##3##(2008-10#2)
the thiocyanato-complexes##3##2##(2008-10#3)
the thiol groups##2##3##(2008-10#1)(2011-2#1)
the thiol##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
the thiols##4##2##(1993-12#1)(2008-10#3)
the thiopurine##2##2##(2010-12#2)
the third and fourth derivatives##2##5##(2008-10#2)
the third and fourth##4##4##(1990-8#1)(2008-10#3)
the third and##7##3##(1990-8#1)(1993-8#1)(1996-1#1)(2008-10#3)(2012-2#1)
the third brain##2##3##(2007-12#2)
the third cycle##3##3##(1990-8#1)(2012-12#2)
the third day##2##3##(1995-3#1)(1995-8#1)
the third experiment##3##3##(2008-10#3)
the third extraction##2##3##(2008-10#2)
the third generation##2##3##(2008-10#2)
the third group##2##3##(2008-10#1)(2012-3#1)
the third injection##3##3##(2013-1#1)(2013-8#2)
the third most##4##3##(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
the third part##2##3##(2009-8#1)(2013-8#1)
the third stage##2##3##(1990-3#1)(2008-12#1)
the third trimester of##2##4##(2010-6#1)(2011-2#1)
the third trimester##7##3##(1990-6#1)(1990-9#1)(1993-12#1)(1993-3#1)(1997-8#1)(2010-6#1)(2011-2#1)
the third ventricle##6##3##(1991-8#1)(2008-7#5)
the third world##3##3##(1990-12#1)(1995-6#1)(2008-10#1)
the third year of##2##4##(1992-12#1)(2008-10#1)
the third year##6##3##(1992-12#2)(2008-10#3)(2008-11#1)
the third##127##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#3)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#3)(2007-12#3)(2008-10#29)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-6#4)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#4)
the third-order##2##2##(2008-7#1)(2010-7#1)
the thirty##2##2##(1995-6#1)(2008-12#1)
the thoracic aorta##4##3##(1997-8#1)(2008-10#1)(2008-12#1)(2009-8#1)
the thoracic spine##3##3##(2008-12#1)(2008-8#2)
the thoracic stiffness##2##3##(2008-9#2)
the thoracic##16##2##(1990-3#1)(1996-3#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#2)(2012-3#1)
the thoracolumbar spine##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
the thoracolumbar##6##2##(1995-11#1)(1997-6#1)(2008-7#1)(2008-8#2)(2012-3#1)
the thorax##3##2##(1991-12#1)(1996-1#1)(2010-9#1)
the thorough##2##2##(1994-5#1)(1997-8#1)
the threat of##6##3##(1996-12#1)(2008-10#2)(2008-11#1)(2010-5#1)(2012-3#1)
the threats##2##2##(1991-1#1)(2008-10#1)
the three &quot##2##3##(1991-2#1)(1996-1#1)
the three BCTV strains##2##4##(2008-10#2)
the three age groups##2##4##(1994-11#1)(2008-7#1)
the three agents##2##3##(2008-10#1)(2008-7#1)
the three amino acid##2##4##(2008-10#1)(2008-8#1)
the three analytes##4##3##(2008-10#4)
the three bilirubins##2##3##(2008-10#2)
the three castes##3##3##(2008-8#3)
the three clades##2##3##(2008-10#1)(2009-6#1)
the three classes##2##3##(2008-11#1)(2010-8#1)
the three components##3##3##(2008-10#2)(2013-1#1)
the three conditions##3##3##(2008-11#3)
the three core functions##2##4##(1996-3#2)
the three countries##2##3##(2008-10#1)(2010-12#1)
the three criteria##2##3##(2008-8#1)(2012-2#1)
the three cultivars##2##3##(2008-10#1)(2008-12#1)
the three different methods##2##4##(2008-10#2)
the three different##8##3##(2008-10#6)(2008-3#1)(2008-7#1)
the three diseases##2##3##(2008-10#2)
the three distinct##2##3##(2008-10#2)
the three dyes##3##3##(2008-10#3)
the three environments##2##3##(2008-10#2)
the three experimental##2##3##(1997-2#1)(2008-10#1)
the three groups in##2##4##(1994-12#1)(2012-2#1)
the three groups of##4##4##(2008-10#3)(2008-5#1)
the three groups were##2##4##(1993-1#1)(2008-10#1)
the three groups##17##3##(1993-1#1)(1994-12#1)(1997-3#1)(2006-6#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-9#1)(2010-4#1)(2012-2#2)(2012-5#1)(2013-8#1)
the three human##2##3##(1993-12#1)(2008-10#1)
the three kinds of##2##4##(2008-10#1)(2008-9#1)
the three largest cities in##2##5##(2008-10#2)
the three largest##3##3##(2008-10#2)(2008-12#1)
the three main##7##3##(1994-5#1)(2008-10#2)(2009-10#1)(2009-12#1)(2012-2#1)(2012-3#1)
the three major classes of ionotropic glutamate receptors##2##8##(1995-11#2)
the three major##8##3##(1992-11#1)(1995-11#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2012-2#1)
the three metals##3##3##(2008-10#3)
the three methods are##2##4##(2008-10#2)
the three methods##8##3##(1993-2#1)(2008-10#6)(2008-12#1)
the three most##2##3##(2007-12#1)(2011-2#1)
the three other##2##3##(1996-12#1)(2008-10#1)
the three patients##2##3##(2011-2#1)(2013-1#1)
the three phases of##2##4##(1991-3#1)(2008-11#1)
the three possible##2##3##(1993-8#1)(2008-10#1)
the three practices##3##3##(2010-11#3)
the three regions##3##3##(1990-7#1)(2013-1#2)
the three remaining##2##3##(1992-5#1)(1993-2#1)
the three scales##2##3##(2008-10#2)
the three species##5##3##(2011-3#3)(2012-8#1)(2012-9#1)
the three strains##3##3##(1993-9#1)(1995-6#1)(2008-10#1)
the three studied##3##3##(2008-10#3)
the three types of##8##4##(1995-11#1)(1996-2#2)(2008-10#3)(2009-7#2)
the three uplift intervals of the##2##6##(2008-9#2)
the three viruses##2##3##(2008-10#2)
the three##357##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#4)(1991-3#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#4)(1995-3#1)(1995-5#2)(1995-6#3)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#152)(2008-11#14)(2008-12#12)(2008-3#2)(2008-4#2)(2008-5#10)(2008-7#5)(2008-8#11)(2008-9#10)(2009-10#4)(2009-12#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-11#4)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#8)(2011-3#4)(2012-2#7)(2012-3#2)(2012-5#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#10)(2013-8#6)
the three-dimensional structure of##3##4##(1993-8#1)(1995-2#1)(2008-8#1)
the three-dimensional structure##4##3##(1993-8#1)(1995-2#1)(2008-8#1)(2008-9#1)
the three-dimensional##16##2##(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2010-7#1)(2010-8#1)
the three-way data##2##3##(2008-10#2)
the three-way##3##2##(2008-10#3)
the three-year##3##2##(1997-3#1)(2008-11#1)(2008-12#1)
the threshold concentration##2##3##(1993-12#2)
the threshold for induction of##2##5##(1994-2#1)(1995-2#1)
the threshold for##10##3##(1994-2#1)(1995-11#1)(1995-2#2)(2007-12#1)(2008-10#3)(2008-3#1)(2011-2#1)
the threshold if the##2##4##(2008-10#2)
the threshold value##3##3##(2008-10#2)(2009-8#1)
the threshold##37##2##(1990-11#1)(1993-12#2)(1994-2#1)(1995-11#1)(1995-2#2)(2007-12#1)(2008-10#12)(2008-3#5)(2008-8#2)(2008-9#4)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
the thresholds##5##2##(2008-10#1)(2008-4#2)(2008-8#1)(2012-2#1)
the thrips##4##2##(2008-10#4)
the thrombogenic##2##2##(1994-5#1)(2008-8#1)
the thrombotic##4##2##(1997-1#1)(2006-6#2)(2012-3#1)
the through-thickness##3##2##(2009-7#3)
the throughput was##2##3##(2007-9#1)(2008-10#1)
the throughput##3##2##(2007-9#1)(2008-10#2)
the thumb##4##2##(2008-9#3)(2010-7#1)
the thylakoid##4##2##(1997-4#1)(2008-10#1)(2008-11#2)
the thymic##9##2##(1991-8#2)(1993-12#1)(2008-8#2)(2013-7#4)
the thymidine##4##2##(1993-11#1)(1994-3#1)(2007-11#1)(2008-4#1)
the thymine##2##2##(1991-7#1)(1992-3#1)
the thymus and##5##3##(1993-3#2)(1997-9#2)(2008-10#1)
the thymus##21##2##(1991-8#1)(1993-3#2)(1997-5#2)(1997-7#3)(1997-9#3)(2008-10#6)(2008-5#2)(2013-7#2)
the thyroid gland##11##3##(1990-3#1)(1997-2#1)(2008-12#1)(2008-7#1)(2008-9#2)(2011-1#2)(2013-1#3)
the thyroid glands of##2##4##(1990-2#1)(1995-12#1)
the thyroid##27##2##(1990-2#2)(1990-3#1)(1990-6#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-7#1)(2008-12#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#3)(2011-1#4)(2012-12#1)(2013-1#3)
the tibia##4##2##(2008-12#1)(2009-3#1)(2009-7#1)(2011-2#1)
the tibial##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
the tick##7##2##(1994-6#1)(2008-10#1)(2008-12#1)(2010-1#2)(2010-10#1)(2013-8#1)
the tight skin (TSK)##2##4##(1997-8#2)
the tight##5##2##(1997-8#2)(2008-11#1)(2008-3#1)(2009-10#1)
the tight-junctional##2##2##(2008-11#2)
the tightly##2##2##(2008-10#1)(2009-5#1)
the tillage##2##2##(2008-10#2)
the tilt of the##2##4##(1994-5#1)(2008-2#1)
the tilt##5##2##(1994-5#1)(2008-2#1)(2008-3#3)
the time after the##2##4##(1996-6#1)(2008-7#1)
the time and##10##3##(1992-12#1)(1994-1#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)
the time constants##2##3##(2008-11#1)(2008-8#1)
the time course and##2##4##(2008-9#1)(2013-1#1)
the time course of ChL##2##5##(2008-10#2)
the time course of changes##2##5##(1997-3#1)(2013-1#1)
the time course of the##6##5##(1995-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
the time course of##15##4##(1995-11#1)(1995-12#2)(1996-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
the time course##19##3##(1995-11#1)(1995-12#3)(1995-2#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#3)
the time evolution of##2##4##(2010-4#1)(2013-8#1)
the time for##3##3##(2008-10#2)(2010-9#1)
the time frame##3##3##(2008-11#1)(2010-8#1)(2012-3#1)
the time from##2##3##(2008-10#2)
the time in##3##3##(1991-12#1)(2008-8#1)(2008-9#1)
the time interval between##2##4##(2008-10#1)(2008-9#1)
the time interval##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
the time necessary for the##2##5##(2008-10#2)
the time necessary##3##3##(2008-10#3)
the time needed for##3##4##(1991-3#1)(2008-10#2)
the time needed##4##3##(1991-3#1)(1997-2#1)(2008-10#2)
the time of birth##2##4##(2008-11#1)(2012-3#1)
the time of contact##2##4##(2008-10#1)(2008-11#1)
the time of day##5##4##(2008-10#1)(2008-5#1)(2009-8#2)(2012-5#1)
the time of diagnosis##6##4##(1992-3#1)(1993-1#1)(1994-12#1)(2008-7#2)(2010-12#1)
the time of discharge##2##4##(2008-11#1)(2012-12#1)
the time of disease onset##2##5##(2008-10#2)
the time of infection##2##4##(2008-10#1)(2008-11#1)
the time of injection##2##4##(1995-5#1)(2010-7#1)
the time of onset##2##4##(1990-5#1)(2008-10#1)
the time of sampling##3##4##(1992-12#1)(2008-10#1)(2008-5#1)
the time of surgery##4##4##(1991-3#1)(1993-11#1)(2008-7#1)(2011-2#1)
the time of the whole##2##5##(2008-10#2)
the time of the##14##4##(1990-3#1)(1990-6#2)(1991-2#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-1#1)(2013-1#2)
the time of##117##3##(1990-3#1)(1990-5#1)(1990-6#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1993-1#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-12#1)(1997-3#1)(1997-8#2)(2008-1#1)(2008-10#32)(2008-11#8)(2008-3#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#5)
the time period##4##3##(2008-10#1)(2008-9#2)(2011-2#1)
the time required for the##3##5##(2008-10#3)
the time required for##9##4##(2008-10#8)(2011-2#1)
the time required to complete##2##5##(1993-12#1)(2008-10#1)
the time required to##10##4##(1993-12#1)(1995-12#1)(2008-10#4)(2008-11#2)(2011-2#2)
the time required##20##3##(1993-12#1)(1995-12#1)(2008-10#12)(2008-11#2)(2010-6#1)(2011-2#3)
the time since the##2##4##(1991-11#1)(2008-10#1)
the time spent##3##3##(2009-4#1)(2011-2#2)
the time structure##2##3##(2008-11#2)
the time taken for##2##4##(2008-10#2)
the time taken##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
the time that##2##3##(1997-2#1)(2008-10#1)
the time the##3##3##(1991-8#1)(1996-5#1)(2013-8#1)
the time to extinction of##2##5##(2008-9#2)
the time to##13##3##(1991-2#1)(2007-12#1)(2008-10#3)(2008-9#3)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
the time when##8##3##(2008-10#6)(2008-9#1)(2011-2#1)
the time##295##2##(1990-3#1)(1990-5#1)(1990-6#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#89)(2008-11#23)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#16)(2009-1#1)(2009-11#1)(2009-4#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#17)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#6)(2012-5#1)(2013-1#14)(2013-8#2)
the time- and##2##3##(2008-3#2)
the time-consuming##3##2##(1995-6#1)(2008-10#2)
the time-course##2##2##(1994-8#1)(2013-8#1)
the time-dependent##8##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-9#1)
the timecourse of responses##2##4##(2008-11#2)
the timecourse of the##2##4##(2008-11#2)
the timecourse of##4##3##(2008-11#4)
the timeline##2##2##(2008-1#1)(2008-9#1)
the timely##4##2##(1997-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
the times##4##2##(1992-2#1)(2008-10#2)(2009-9#1)
the timing and##2##3##(2010-8#1)(2013-8#1)
the timing of the##7##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)
the timing of##32##3##(1992-12#1)(1995-12#1)(1995-5#1)(1997-2#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-6#1)
the timing##37##2##(1990-5#1)(1992-12#1)(1995-12#1)(1995-5#1)(1997-2#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
the tinea unguium of the toenails##2##6##(2008-5#2)
the tinnitus##3##2##(1996-6#2)(2010-7#1)
the tiny##2##2##(1994-9#1)(2013-1#1)
the tip of a##5##4##(2008-10#4)(2008-7#1)
the tip of the breast##2##5##(1994-12#2)
the tip of the microsyringe##2##5##(2008-10#2)
the tip of the##15##4##(1991-3#1)(1992-1#1)(1994-12#2)(1994-2#1)(2007-12#1)(2008-10#6)(2010-12#1)(2010-6#1)(2010-8#1)
the tip of##24##3##(1991-3#1)(1992-1#1)(1994-12#2)(1994-2#1)(2007-12#1)(2008-10#14)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)
the tip##33##2##(1991-3#1)(1992-1#1)(1994-12#2)(1994-2#1)(1995-2#2)(2007-12#2)(2008-10#16)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-6#1)(2010-8#1)(2012-2#1)
the tip-sample##3##2##(2007-12#2)(2012-2#1)
the tipping point##2##3##(2012-2#2)
the tissue compatibility of##2##4##(2012-3#2)
the tissue specific##2##3##(1994-11#1)(2008-9#1)
the tissue was##2##3##(2008-11#1)(2008-9#1)
the tissue##36##2##(1990-5#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1997-5#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
the tissue-specific##3##2##(1993-12#1)(2008-10#1)(2010-7#1)
the tissues and##2##3##(1996-3#1)(2008-11#1)
the tissues of##4##3##(1993-12#1)(2008-12#2)(2009-7#1)
the tissues##25##2##(1991-5#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-8#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#2)(2009-7#1)(2010-7#1)(2013-1#2)(2013-8#1)
the titanium surface##2##3##(2013-1#2)
the titanium##3##2##(2008-10#1)(2013-1#2)
the titer of##2##3##(1992-12#1)(2008-9#1)
the titer##3##2##(1992-12#1)(2008-9#1)(2013-8#1)
the title compounds##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
the title##8##2##(1995-3#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#1)
the titrant solution##3##3##(2008-10#3)
the titrant##20##2##(2008-10#20)
the titrated##2##2##(2008-10#2)
the titration cell##2##3##(2008-10#2)
the titration of##4##3##(1991-9#1)(2008-10#3)
the titration to##2##3##(2008-10#2)
the titration##29##2##(1991-9#1)(2008-10#28)
the tobacco##9##2##(1992-2#1)(1993-6#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)
the tolerance amount of other##2##5##(2008-10#2)
the tolerance limits##2##3##(2008-10#2)
the tolerance##13##2##(1990-5#1)(1997-2#1)(2008-10#10)(2008-5#1)
the tolerant##4##2##(2008-10#3)(2011-10#1)
the tomato and##2##3##(2008-10#2)
the tomato##6##2##(1995-2#1)(2008-10#4)(2008-8#1)
the tongue and##4##3##(1993-1#2)(1997-6#1)(2013-1#1)
the tongue##10##2##(1993-1#3)(1995-9#1)(1997-4#1)(1997-6#1)(2010-6#1)(2013-1#3)
the tonoplast##3##2##(2008-10#2)(2008-11#1)
the tool was##2##3##(2008-11#1)(2008-12#1)
the tool##8##2##(2008-10#2)(2008-11#4)(2008-12#1)(2008-9#1)
the tools of##2##3##(2008-10#1)(2008-9#1)
the tools to##5##3##(1993-12#2)(2010-11#1)(2011-2#1)(2013-8#1)
the tools##13##2##(1993-12#2)(1996-1#2)(1997-7#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the tooth structure##2##3##(2008-7#1)(2010-10#1)
the tooth##6##2##(1991-2#1)(1996-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
the top of the##7##4##(1995-6#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-6#1)
the top of##11##3##(1995-6#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-6#1)(2013-8#1)
the top predator##2##3##(2008-8#1)(2008-9#1)
the top##29##2##(1993-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#3)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
the top-down modulation of##2##4##(2013-8#2)
the topic of##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
the topic was##2##3##(2008-10#1)(2012-3#1)
the topic##13##2##(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the topics of##2##3##(1995-2#1)(1996-2#1)
the topics##7##2##(1995-2#1)(1996-2#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)
the topographic##2##2##(2008-3#1)(2008-5#1)
the topographical##3##2##(1994-2#2)(2008-3#1)
the topography of##4##3##(1990-11#1)(2008-10#2)(2008-11#1)
the topology of##2##3##(1992-4#1)(1995-6#1)
the topology##3##2##(1992-4#1)(1995-6#1)(2008-10#1)
the torcular##2##2##(1996-9#2)
the torque##2##2##(2008-3#1)(2013-1#1)
the total Medicaid##2##3##(1991-3#1)(1992-3#1)
the total TEQ##2##3##(2008-10#2)
the total acidity##2##3##(2008-10#2)
the total amino##2##3##(2010-4#2)
the total amount of##19##4##(1991-6#1)(1995-6#1)(1996-12#3)(2008-10#8)(2008-11#2)(2008-8#3)(2010-4#1)
the total amount##20##3##(1991-6#1)(1995-6#1)(1996-12#3)(2008-10#9)(2008-11#2)(2008-8#3)(2010-4#1)
the total analysis time##2##4##(2008-10#2)
the total analytical system##2##4##(2010-7#2)
the total antioxidant activity##2##4##(2008-10#2)
the total antioxidant capacity of##2##5##(2008-10#1)(2009-6#1)
the total antioxidant capacity##3##4##(2008-10#2)(2009-6#1)
the total antioxidant##5##3##(2008-10#4)(2009-6#1)
the total arsenic##2##3##(2008-10#2)
the total bacterial##2##3##(1992-2#1)(2008-8#1)
the total biomass##3##3##(2008-7#3)
the total cell##2##3##(1994-8#1)(2008-11#1)
the total chromatography##2##3##(2008-10#2)
the total concentration of the##2##5##(2008-10#2)
the total concentration of##8##4##(2008-10#8)
the total concentration##9##3##(2008-10#9)
the total content of##2##4##(1992-6#1)(2008-10#1)
the total content##3##3##(1992-6#1)(2008-10#2)
the total decomposition##2##3##(2008-10#2)
the total density##2##3##(2008-10#1)(2008-8#1)
the total dissolved##2##3##(2008-10#2)
the total dye content##2##4##(2008-10#2)
the total energy##2##3##(2008-8#1)(2008-9#1)
the total evaporation##2##3##(2008-10#2)
the total graftectomy (TGE)##2##4##(2011-3#2)
the total group##2##3##(2008-8#1)(2009-1#1)
the total hip##2##3##(2010-3#1)(2013-1#1)
the total intracellular##2##3##(1990-12#1)(1994-3#1)
the total mass##2##3##(1994-12#1)(2008-10#1)
the total number of deaths in##2##6##(1991-9#1)(2011-3#1)
the total number of offspring##2##5##(2008-8#1)(2008-9#1)
the total number of##24##4##(1991-5#1)(1991-9#1)(1993-3#1)(1994-2#1)(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
the total of##6##3##(1991-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
the total organic##2##3##(2008-10#2)
the total population##6##3##(1994-3#1)(2008-10#3)(2008-8#1)(2008-9#1)
the total protein##3##3##(1993-12#1)(2008-10#2)
the total proteins##4##3##(1996-8#1)(2008-8#3)
the total quality management##2##4##(1994-1#1)(1995-3#1)
the total quality##3##3##(1992-12#1)(1994-1#1)(1995-3#1)
the total sample##2##3##(1994-3#1)(2008-10#1)
the total selenium content##2##4##(2008-10#2)
the total serum##2##3##(1993-2#1)(2006-6#1)
the total sulphur content##2##4##(2008-10#2)
the total surface area##2##4##(1997-1#1)(2008-3#1)
the total surfactant concentration##2##4##(2008-10#1)(2008-5#1)
the total variability##2##3##(2008-10#2)
the total variance##14##3##(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)
the total##327##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#5)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#5)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-6#2)(2007-12#1)(2008-10#149)(2008-11#19)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#16)(2008-9#5)(2009-1#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#3)(2010-8#2)(2011-10#1)(2011-2#3)(2011-3#3)(2012-2#4)(2012-3#2)(2013-1#5)
the totality of the##3##4##(1993-8#1)(1996-6#1)(2009-8#1)
the totally##2##2##(1990-3#1)(2008-9#1)
the town of Cabar##3##4##(2011-2#3)
the town of##5##3##(2008-10#1)(2011-2#3)(2012-12#1)
the town##6##2##(1990-2#1)(2008-10#1)(2011-2#3)(2012-12#1)
the tox(-) isolates##2##3##(2008-10#2)
the toxic effect##2##3##(1992-6#1)(2008-10#1)
the toxic effects of##4##4##(1994-5#1)(2008-10#1)(2008-11#2)
the toxic fraction##2##3##(2008-10#2)
the toxic potency##3##3##(1996-12#3)
the toxic##21##2##(1992-6#1)(1994-5#1)(1996-12#3)(2008-10#10)(2008-11#3)(2008-5#1)(2011-1#1)(2012-2#1)
the toxicity and##2##3##(1995-8#1)(2008-7#1)
the toxicity of##15##3##(1993-12#1)(1994-5#2)(1995-8#2)(1996-12#3)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
the toxicity##22##2##(1993-12#1)(1994-5#2)(1995-8#3)(1996-12#4)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
the toxicological##3##2##(2008-10#2)(2008-11#1)
the toxicology##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
the toxin has been##2##4##(2008-10#1)(2008-8#1)
the toxin sequence##2##3##(2010-6#2)
the toxin##20##2##(1995-8#1)(2008-10#13)(2008-11#1)(2008-8#1)(2010-6#2)(2011-2#1)(2012-12#1)
the toxins##7##2##(1990-5#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
the trace analysis of##3##4##(2008-10#2)(2008-3#1)
the trace determination of##4##4##(2008-10#4)
the trace element##3##3##(2008-10#2)(2011-2#1)
the trace elements##2##3##(2008-10#2)
the trace metal extraction by EDTA##2##6##(2008-10#2)
the trace metal##3##3##(2008-10#2)(2008-5#1)
the trace##25##2##(2008-10#20)(2008-3#1)(2008-5#3)(2011-2#1)
the trace-back operation##2##3##(2008-3#2)
the tracer##4##2##(1990-5#1)(1996-12#1)(2008-10#1)(2008-5#1)
the trachea and##3##3##(1993-8#1)(2008-9#1)(2010-10#1)
the trachea##7##2##(1993-8#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
the tracheae##2##2##(2007-12#2)
the tracheal bronchial##2##3##(1997-1#2)
the tracheal system of##2##4##(2007-12#2)
the tracheal walls##3##3##(2007-12#3)
the tracheal##11##2##(1993-8#1)(1996-3#2)(1997-1#2)(2007-12#5)(2008-10#1)
the tracheobronchial##3##2##(1996-1#1)(1997-1#1)(2010-12#1)
the tracings##2##2##(1994-3#1)(2008-4#1)
the track##3##2##(2008-3#3)
the tracked##3##2##(2008-6#1)(2009-12#2)
the tract of##2##3##(1996-12#1)(1996-3#1)
the trade-off between##5##3##(1991-5#1)(1995-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
the trade-off##6##2##(1991-5#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
the trade-offs##4##2##(1996-1#1)(2008-8#2)(2008-9#1)
the traditional financial and management subjects##2##6##(1996-1#2)
the traditional liquid-liquid separation##2##4##(2008-10#2)
the traditional methods of##2##4##(2008-10#1)(2010-11#1)
the traditional methods##3##3##(2008-10#2)(2010-11#1)
the traditional model##3##3##(2008-4#2)(2010-5#1)
the traditional relationship##2##3##(1995-1#1)(2012-2#1)
the traditional technique##3##3##(2011-2#3)
the traditional##75##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-12#2)(1996-2#1)(2008-10#24)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#4)(2009-12#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#3)
the traffic##2##2##(2008-8#2)
the trafficking of##2##3##(1997-1#1)(2008-7#1)
the trail##2##2##(2008-8#1)(2013-8#1)
the trained##4##2##(1995-1#1)(2008-10#1)(2008-12#1)(2010-8#1)
the training context##2##3##(2008-10#1)(2008-5#1)
the training data set##2##4##(2008-10#2)
the training of medical graduates##3##5##(1992-1#1)(1994-12#1)(2009-10#1)
the training of medical##6##4##(1992-1#2)(1994-12#2)(1994-6#1)(2009-10#1)
the training of##13##3##(1991-12#1)(1992-1#2)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-6#1)(1996-1#1)(1996-9#1)(2008-10#1)(2009-10#1)
the training program was##2##4##(1991-2#1)(2008-4#1)
the training set##3##3##(2008-10#2)(2008-9#1)
the training##41##2##(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#2)(1992-12#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-6#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
the trait##11##2##(2008-10#1)(2008-11#1)(2008-8#6)(2012-3#3)
the traits##7##2##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)(2012-3#1)
the trajectory at the L5-S1 than at the L4-L5 level##2##10##(1996-6#2)
the trajectory##5##2##(1996-6#3)(1997-2#1)(2011-2#1)
the trance##2##2##(2009-10#2)
the trans Golgi##2##3##(1992-12#1)(1993-6#1)
the trans isomer##4##3##(1991-5#3)(1996-5#1)
the trans##11##2##(1990-9#1)(1991-5#4)(1992-12#1)(1993-6#1)(1996-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
the trans-4-(trifluoromethyl)-2##2##2##(1996-5#2)
the trans-acting##2##2##(2008-10#1)(2008-9#1)
the trans-membrane##2##2##(2008-11#1)(2008-8#1)
the transactivation##5##2##(1993-8#3)(1995-6#2)
the transactivators##2##2##(2008-11#2)
the transconjugant##2##2##(2008-10#2)
the transcribed##3##2##(1993-6#1)(2008-11#2)
the transcript of##2##3##(1991-5#1)(2008-6#1)
the transcript##8##2##(1991-5#3)(1993-12#1)(1996-12#1)(1997-7#1)(2008-6#1)(2011-1#1)
the transcription factor##15##3##(1992-8#1)(1993-9#1)(1994-11#1)(1995-9#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
the transcription factors##4##3##(1993-6#1)(1997-7#2)(2010-1#1)
the transcription level##2##3##(2008-11#1)(2008-8#1)
the transcription of the##4##4##(1995-11#1)(1997-8#2)(2008-11#1)
the transcription of##15##3##(1992-10#1)(1995-11#1)(1997-6#1)(1997-7#2)(1997-8#2)(2008-10#1)(2008-11#2)(2008-9#2)(2010-10#1)(2011-1#1)(2011-2#1)
the transcription rate##2##3##(1992-3#1)(2008-11#1)
the transcription start point (tsp)##3##5##(1993-12#2)(1993-6#1)
the transcription start point##4##4##(1991-9#1)(1993-12#2)(1993-6#1)
the transcription start site##3##4##(1991-7#1)(1995-2#2)
the transcription start##9##3##(1991-5#1)(1991-7#1)(1991-9#1)(1993-12#2)(1993-6#2)(1995-2#2)
the transcription##58##2##(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-6#3)(1993-9#1)(1994-11#3)(1995-11#1)(1995-2#4)(1995-6#1)(1995-9#1)(1997-6#1)(1997-7#6)(1997-8#2)(2008-10#2)(2008-11#6)(2008-8#1)(2008-9#4)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)
the transcriptional activation of##3##4##(1996-12#2)(2008-10#1)
the transcriptional activator##3##3##(2012-3#2)(2013-1#1)
the transcriptional activity of##4##4##(1995-8#1)(2008-11#1)(2012-3#1)(2013-7#1)
the transcriptional co-activator##2##3##(2011-2#1)(2013-1#1)
the transcriptional induction of the##2##5##(2008-11#1)(2011-1#1)
the transcriptional regulation of the##2##5##(1993-6#1)(2008-11#1)
the transcriptional regulation of##3##4##(1993-6#1)(1996-12#1)(2008-11#1)
the transcriptional regulation##4##3##(1992-12#1)(1993-6#1)(1996-12#1)(2008-11#1)
the transcriptional start site##3##4##(1995-11#1)(1995-6#1)(1996-12#1)
the transcriptional status of##2##4##(1997-7#1)(2013-1#1)
the transcriptional##42##2##(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#4)(1997-7#1)(2008-10#2)(2008-11#5)(2008-5#2)(2008-7#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#5)(2013-7#1)
the transcriptome##5##2##(2008-10#1)(2012-2#3)(2013-8#1)
the transcripts in##2##3##(1996-8#1)(1997-7#1)
the transcripts##5##2##(1991-9#1)(1996-8#1)(1997-2#1)(1997-7#2)
the transduced genes##2##3##(1997-8#1)(2008-8#1)
the transducer surface##2##3##(2008-10#2)
the transducer##4##2##(2008-10#4)
the transducers##2##2##(2008-10#1)(2009-5#1)
the transduction of##5##3##(1990-12#1)(1994-11#1)(1995-2#1)(2010-10#2)
the transduction##6##2##(1990-12#1)(1994-11#2)(1995-2#1)(2010-10#2)
the transfectant##2##2##(1993-8#1)(1997-2#1)
the transfected##4##2##(1994-6#1)(1995-6#1)(2008-11#2)
the transfection efficiency of##2##4##(2008-11#1)(2008-9#1)
the transfection of##2##3##(2008-11#2)
the transfection##8##2##(1991-5#1)(1995-2#1)(2008-11#5)(2008-9#1)
the transfer efficiency##3##3##(2008-10#1)(2008-9#2)
the transfer of material from##2##5##(2008-3#2)
the transfer of the##2##4##(2008-10#2)
the transfer of##23##3##(1990-8#1)(1992-10#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)
the transfer samples##2##3##(2008-10#2)
the transfer##35##2##(1990-8#1)(1991-5#1)(1992-10#1)(1993-12#1)(1997-6#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)
the transferred##2##2##(2008-10#1)(2008-8#1)
the transferrin receptor##2##3##(1990-8#1)(1993-11#1)
the transformants and the wild type##2##6##(2008-10#2)
the transformants was##2##3##(1997-2#1)(2008-10#1)
the transformants##12##2##(1990-8#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-8#2)
the transformation of##7##3##(1990-5#1)(1992-8#1)(1993-2#1)(2008-10#2)(2008-9#1)(2011-1#1)
the transformation##15##2##(1990-5#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-2#2)(1996-2#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)(2011-1#1)
the transformed cell##3##3##(1993-6#1)(2008-11#1)(2008-8#1)
the transformed cells##2##3##(2008-11#2)
the transformed phenotype##4##3##(1995-6#2)(1997-1#1)(2008-8#1)
the transformed signals##2##3##(2008-10#2)
the transformed##14##2##(1990-8#1)(1993-6#1)(1995-6#2)(1997-1#1)(2008-10#3)(2008-11#3)(2008-8#2)(2011-2#1)
the transforming##6##2##(1993-2#1)(2008-10#3)(2008-11#1)(2011-2#1)
the transfusion##3##2##(1996-9#3)
the transgene in##3##3##(1995-2#1)(2008-10#2)
the transgene product##2##3##(2008-10#2)
the transgene was##2##3##(1995-2#1)(2008-12#1)
the transgene##24##2##(1993-6#1)(1995-2#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-8#2)(2012-3#1)
the transgenes and the##2##4##(2008-11#1)(2008-9#1)
the transgenes can be##2##4##(2008-10#1)(2011-1#1)
the transgenes##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
the transgenic line##2##3##(2008-10#2)
the transgenic lines##3##3##(2008-10#3)
the transgenic mice##2##3##(1995-2#2)
the transgenic##16##2##(1992-8#1)(1995-2#2)(2008-10#6)(2008-8#4)(2008-9#2)(2010-5#1)
the transient absorption##2##3##(2008-8#1)(2008-9#1)
the transient behavior##2##3##(2008-3#1)(2008-7#1)
the transient expression##2##3##(2008-11#2)
the transient nature of##2##4##(1996-2#1)(2008-10#1)
the transient potential change##2##4##(2008-10#2)
the transient response of##2##4##(2008-2#1)(2012-2#1)
the transient##30##2##(1991-3#1)(1996-2#1)(1996-5#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-2#2)
the transit of##2##3##(1992-3#1)(2012-2#1)
the transit time##2##3##(2008-10#1)(2008-11#1)
the transit##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
the transition between##3##3##(1996-6#1)(2009-7#1)(2009-8#1)
the transition from a##2##4##(1996-1#1)(1996-3#1)
the transition from stimulation to inhibition occurred when an average of##2##11##(2008-10#2)
the transition from##16##3##(1992-6#1)(1996-1#2)(1996-3#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
the transition metal##2##3##(2008-10#2)
the transition state##6##3##(1990-5#2)(1991-9#1)(1996-5#1)(2008-4#1)(2009-5#1)
the transition states##2##3##(1996-5#1)(2012-12#1)
the transition time from##2##4##(2008-11#1)(2010-5#1)
the transition to adulthood##2##4##(2009-7#2)
the transition to specialist##2##4##(2008-11#2)
the transition to##12##3##(1991-12#1)(1997-6#1)(2008-10#1)(2008-11#5)(2009-7#2)(2011-2#1)(2013-1#1)
the transition##55##2##(1990-5#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-6#1)(1995-9#1)(1996-1#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-6#1)(2008-10#5)(2008-11#10)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
the transitional##4##2##(1990-12#1)(2008-11#1)(2009-7#1)(2010-5#1)
the translation initiation site##3##4##(1997-2#2)(1997-7#1)
the translation initiation sites of##4##5##(1996-8#1)(1997-2#1)(1997-6#2)
the translation initiation sites##9##4##(1996-8#4)(1997-2#2)(1997-6#3)
the translation initiation##13##3##(1996-8#4)(1997-2#4)(1997-6#3)(1997-7#2)
the translation of the##2##4##(1997-8#1)(2012-2#1)
the translation of##8##3##(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-2#1)
the translation start site##2##4##(1997-8#1)(2008-11#1)
the translation start##3##3##(1997-8#1)(2008-11#1)(2012-2#1)
the translation##28##2##(1995-12#1)(1996-8#4)(1997-2#4)(1997-3#1)(1997-6#3)(1997-7#2)(1997-8#2)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#2)
the translational motion of##2##4##(2008-3#1)(2010-4#1)
the translational start##2##3##(1992-10#1)(2008-4#1)
the translational##7##2##(1992-10#1)(1994-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#2)
the translocated##3##2##(1993-2#2)(2011-2#1)
the translocation of the##2##4##(2008-10#1)(2012-2#1)
the translocation of##11##3##(1991-5#1)(1993-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
the translocation##16##2##(1991-5#2)(1993-8#1)(1994-11#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
the transmembrane domain##4##3##(1991-9#1)(2008-11#1)(2009-10#2)
the transmembrane##11##2##(1990-12#1)(1990-5#1)(1991-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(2008-11#2)(2008-7#1)(2009-10#2)
the transmissibility of##2##3##(2008-10#2)
the transmissible##3##2##(2008-10#3)
the transmission dynamics of HIV-1##2##5##(1992-9#2)
the transmission efficiency of##2##4##(2008-10#2)
the transmission electron microscope##2##4##(2008-7#1)(2009-7#1)
the transmission electron##3##3##(2008-5#1)(2008-7#1)(2009-7#1)
the transmission of the##2##4##(2008-10#1)(2008-3#1)
the transmission of##19##3##(2008-10#7)(2008-11#1)(2008-3#4)(2008-5#1)(2008-9#1)(2010-1#3)(2011-3#1)(2013-1#1)
the transmission phenotype##3##3##(2008-10#3)
the transmission rate##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
the transmission##50##2##(1992-9#2)(2007-12#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#10)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-1#3)(2011-3#1)(2013-1#2)(2013-8#1)
the transmittance##3##2##(2008-2#1)(2008-3#2)
the transmitted and##2##3##(2008-10#1)(2008-3#1)
the transmitted beam##2##3##(2008-2#1)(2008-3#1)
the transmitted laser##2##3##(2007-12#1)(2008-3#1)
the transmitted light##2##3##(2008-10#2)
the transmitted##10##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)
the transmitter##2##2##(2007-12#1)(2008-3#1)
the transpetrosal approach##2##3##(2008-7#2)
the transpetrosal##3##2##(2008-7#3)
the transplant team##2##3##(2007-11#1)(2011-3#1)
the transplant##6##2##(1994-6#1)(1997-8#1)(2007-11#1)(2011-3#3)
the transplantation##3##2##(1995-9#1)(1996-9#1)(2010-11#1)
the transplanted##7##2##(1992-2#2)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)
the transport activity##2##3##(1995-8#1)(2008-11#1)
the transport and##3##3##(2008-10#1)(2009-7#1)(2013-1#1)
the transport group##2##3##(2013-1#2)
the transport of##17##3##(1992-3#2)(1993-11#1)(1994-3#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-7#2)(2009-10#1)(2011-3#5)(2012-2#1)
the transport system##2##3##(1992-3#1)(2008-10#1)
the transport##37##2##(1991-5#1)(1992-3#3)(1993-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#6)(2008-11#2)(2008-7#4)(2009-10#1)(2009-7#1)(2011-3#6)(2012-2#1)(2012-8#1)(2013-1#3)
the transporter##5##2##(1994-6#1)(1995-2#1)(1995-6#1)(2008-8#2)
the transposable element##3##3##(2008-10#2)(2008-9#1)
the transposon##5##2##(1993-12#1)(2008-10#3)(2008-9#1)
the transradial access##2##3##(2011-2#2)
the transradial##5##2##(2011-2#5)
the transtheoretical model##2##3##(2013-1#2)
the transthyretin##2##2##(1992-8#2)
the transverse concentration gradient##2##4##(2008-10#2)
the transverse sinus##3##3##(1996-9#1)(2008-7#2)
the transverse##9##2##(1995-6#1)(1996-9#1)(2008-10#3)(2008-7#2)(2012-2#2)
the transversely heated graphite atomizer##2##5##(2008-10#2)
the trap and##2##3##(2008-10#1)(2009-8#1)
the trap##4##2##(2008-10#2)(2009-8#2)
the trapping of##3##3##(1992-3#1)(2008-10#1)(2008-3#1)
the trapping theory##2##3##(2008-11#2)
the trapping##7##2##(1992-3#1)(2008-10#3)(2008-11#2)(2008-3#1)
the trauma of##3##3##(1994-2#1)(2008-10#1)(2010-5#1)
the trauma##4##2##(1994-2#1)(2008-10#1)(2010-1#1)(2010-5#1)
the traveller##3##2##(1993-8#2)(2008-11#1)
the treated embryos##3##3##(2008-11#2)(2008-12#1)
the treated mice##3##3##(1995-12#1)(2008-9#2)
the treated patients##2##3##(1996-3#1)(2013-8#1)
the treated women##2##3##(1994-12#2)
the treated##26##2##(1990-11#1)(1991-5#1)(1994-12#2)(1995-12#1)(1996-3#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2009-8#1)(2012-3#1)(2013-8#2)
the treating physician##2##3##(2012-3#1)(2013-8#1)
the treating##4##2##(2008-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the treatment and prevention of##3##5##(2008-10#1)(2008-7#1)(2010-5#1)
the treatment and##14##3##(1991-11#1)(1993-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-5#2)(2010-6#2)(2011-2#1)
the treatment as##2##3##(1992-2#1)(2008-11#1)
the treatment effect##2##3##(1996-6#2)
the treatment facilities available##2##4##(1996-11#1)(1997-8#1)
the treatment for##2##3##(1997-3#1)(2010-1#1)
the treatment group had substantively and statistically significantly higher health care utilization (including primary and preventive care as well as hospitalizations)##2##21##(2013-1#2)
the treatment group selected by the lottery was about 25 percentage points more likely to have insurance than the control group that was not selected##2##25##(2013-1#2)
the treatment group##7##3##(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#4)
the treatment groups##5##3##(1991-2#1)(1994-12#3)(2008-10#1)
the treatment is##2##3##(2007-11#1)(2008-10#1)
the treatment of Crohn's disease##3##5##(1994-6#1)(2010-12#1)(2013-1#1)
the treatment of Parkinson's disease##3##5##(1992-3#1)(2008-10#1)(2008-7#1)
the treatment of RA##2##4##(2013-8#2)
the treatment of a##6##4##(1991-2#1)(1992-6#1)(1994-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
the treatment of acute##6##4##(1990-5#1)(1991-3#1)(1992-3#1)(2007-8#1)(2011-2#1)(2012-2#1)
the treatment of advanced##4##4##(1990-12#3)(2007-11#1)
the treatment of asthma##4##4##(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)
the treatment of both##2##4##(1991-3#1)(2010-1#1)
the treatment of breast cancer##4##5##(1993-1#1)(1993-11#2)(1996-11#1)
the treatment of breast##6##4##(1992-9#1)(1993-1#1)(1993-11#2)(1993-6#1)(1996-11#1)
the treatment of cancer##8##4##(2008-10#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-12#1)(2013-1#1)
the treatment of childhood obesity##2##5##(2008-3#1)(2011-2#1)
the treatment of childhood##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
the treatment of choice for##10##5##(1991-9#1)(1994-12#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-6#2)(2011-2#1)(2013-1#2)
the treatment of choice in##5##5##(1990-9#1)(1992-12#1)(1994-3#1)(2009-4#1)(2010-10#1)
the treatment of choice##19##4##(1990-9#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-3#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-6#2)(2011-2#2)(2013-1#2)
the treatment of chronic hepatitis##2##5##(2009-5#1)(2009-8#1)
the treatment of chronic myeloid leukemia##2##6##(2010-11#2)
the treatment of chronic##9##4##(1993-5#1)(2008-11#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#2)
the treatment of cocaine##2##4##(1991-1#2)
the treatment of dental##2##4##(1995-9#1)(2008-7#1)
the treatment of early##3##4##(2008-7#2)(2011-2#1)
the treatment of essential##2##4##(1990-9#1)(2008-7#1)
the treatment of heart failure##2##5##(2009-10#2)
the treatment of hypertension##5##4##(1990-6#1)(1991-5#1)(1993-11#1)(1993-3#1)(1995-11#1)
the treatment of infectious##2##4##(1990-2#1)(1996-11#1)
the treatment of inflammatory##3##4##(2009-1#1)(2011-1#2)
the treatment of ischemic heart disease##2##6##(2010-6#2)
the treatment of ischemic##3##4##(2010-6#2)(2013-1#1)
the treatment of malaria##2##4##(2009-6#1)(2011-2#1)
the treatment of metastatic##3##4##(1990-2#1)(1994-5#1)(2012-3#1)
the treatment of neuropathic pain##5##5##(1997-3#1)(2008-9#3)(2010-7#1)
the treatment of osteomyelitis##3##4##(2010-6#3)
the treatment of osteoporosis##4##4##(1991-11#1)(2008-11#1)(2008-7#1)(2012-12#1)
the treatment of patients with severe##2##6##(1992-1#1)(1993-1#1)
the treatment of patients with##8##5##(1991-6#1)(1992-1#2)(1993-1#1)(1996-11#1)(2008-1#1)(2009-8#1)(2011-2#1)
the treatment of patients##9##4##(1991-6#1)(1992-1#2)(1993-1#1)(1996-11#1)(2007-8#1)(2008-1#1)(2009-8#1)(2011-2#1)
the treatment of primary and##2##5##(1992-11#1)(2013-1#1)
the treatment of primary##3##4##(1992-11#1)(2008-4#1)(2013-1#1)
the treatment of pseudoexfoliation glaucoma##2##5##(2011-2#2)
the treatment of psychiatric##2##4##(2013-1#1)(2013-8#1)
the treatment of schizophrenia##3##4##(2008-8#2)(2009-12#1)
the treatment of several##4##4##(2008-11#2)(2009-1#1)(2011-1#1)
the treatment of severe coxarthrosis##2##5##(2013-1#2)
the treatment of severe##4##4##(1990-8#1)(2008-8#1)(2013-1#2)
the treatment of systemic##3##4##(1997-2#1)(2008-11#1)(2008-7#1)
the treatment of the##11##4##(1991-2#1)(1996-2#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-7#1)
the treatment of these##3##4##(1995-2#1)(2008-3#1)(2011-2#1)
the treatment of this disease##2##5##(1993-6#1)(2009-7#1)
the treatment of this##5##4##(1991-9#1)(1993-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
the treatment of tuberculosis##2##4##(1996-3#1)(2008-10#1)
the treatment of type##2##4##(1996-11#1)(2011-3#1)
the treatment of various diseases##2##5##(2008-10#2)
the treatment of##417##3##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#6)(1991-1#3)(1991-11#3)(1991-12#1)(1991-2#6)(1991-3#5)(1991-5#1)(1991-6#2)(1991-8#5)(1991-9#2)(1992-1#5)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-9#1)(1996-1#3)(1996-11#5)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#1)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-1#5)(2008-10#24)(2008-11#20)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#12)(2008-8#11)(2008-9#9)(2009-1#5)(2009-10#4)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#7)(2010-12#4)(2010-5#1)(2010-6#10)(2010-7#1)(2011-1#5)(2011-10#1)(2011-2#36)(2011-3#6)(2011-7#2)(2012-12#2)(2012-2#8)(2012-3#12)(2013-1#30)(2013-8#10)
the treatment options##3##3##(1993-8#1)(1996-9#1)(2008-10#1)
the treatment outcome##2##3##(2008-11#1)(2010-1#1)
the treatment period##4##3##(1990-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
the treatment plan##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
the treatment process##3##3##(1992-5#1)(2008-10#1)(2009-6#1)
the treatment program##2##3##(1993-1#1)(1994-6#1)
the treatment regimen##3##3##(1991-2#1)(1994-12#1)(2008-7#1)
the treatment was##7##3##(1992-3#1)(1994-8#1)(1995-12#1)(2010-1#1)(2012-3#2)(2013-1#1)
the treatment with the##2##4##(2008-11#1)(2008-5#1)
the treatment with##8##3##(1991-6#1)(1992-11#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
the treatment##551##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#7)(1991-1#4)(1991-11#7)(1991-12#1)(1991-2#9)(1991-3#5)(1991-5#1)(1991-6#3)(1991-8#9)(1991-9#3)(1992-1#5)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#3)(1993-11#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#4)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#5)(1995-12#4)(1995-2#3)(1995-9#1)(1996-1#3)(1996-11#7)(1996-12#2)(1996-2#2)(1996-3#4)(1996-6#3)(1996-9#5)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#3)(1997-8#3)(2007-11#3)(2007-12#1)(2007-8#4)(2008-1#6)(2008-10#36)(2008-11#23)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#14)(2008-6#4)(2008-7#19)(2008-8#12)(2008-9#13)(2009-1#5)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#5)(2010-10#4)(2010-11#10)(2010-12#7)(2010-5#3)(2010-6#12)(2010-7#2)(2011-1#5)(2011-10#1)(2011-2#47)(2011-3#6)(2011-7#2)(2012-12#3)(2012-2#10)(2012-3#17)(2013-1#39)(2013-8#11)
the treatments##18##2##(1993-3#1)(1995-11#1)(1995-8#1)(2008-10#9)(2008-12#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-5#1)(2012-9#1)
the tree canopy##7##3##(2008-10#7)
the tree##23##2##(1991-1#1)(2008-10#17)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)
the trees##6##2##(2008-10#5)(2008-8#1)
the trehalose##4##2##(1993-8#2)(2008-10#1)(2013-1#1)
the trellis diagram##2##3##(2008-3#2)
the trellis##3##2##(2008-10#1)(2008-3#2)
the trend in##4##3##(1993-2#1)(1995-12#1)(2008-11#1)(2008-8#1)
the trend##13##2##(1990-11#1)(1991-3#1)(1992-8#1)(1993-2#2)(1995-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2013-1#1)
the trends in##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
the trends##9##2##(1991-3#1)(1995-1#1)(1996-6#1)(2008-10#2)(2008-5#1)(2009-12#1)(2012-12#1)(2012-3#1)
the triad##2##2##(2008-8#1)(2010-1#1)
the trial was##2##3##(2008-8#1)(2009-4#1)
the trial##26##2##(1990-11#1)(1990-2#2)(1991-3#3)(1992-3#1)(1994-9#1)(1995-5#2)(1996-5#1)(1997-7#2)(2008-10#5)(2008-7#1)(2008-8#2)(2009-4#2)(2009-8#1)(2011-2#1)(2013-1#1)
the trials##10##2##(1994-9#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)
the triangle##5##2##(2008-6#4)(2011-2#1)
the triangular distal wedge##2##4##(2012-12#2)
the triangular##4##2##(2008-10#1)(2008-3#1)(2012-12#2)
the tricarboxylic acid cycle##4##4##(2008-7#4)
the triceps##2##2##(2008-9#1)(2012-3#1)
the tricyclic##4##2##(1996-5#3)(2008-2#1)
the trifunctional##3##2##(1993-12#2)(2008-10#1)
the trigeminal ganglion##4##3##(1996-2#1)(1997-3#2)(2008-7#1)
the trigeminal nerve##6##3##(1990-12#1)(2011-2#5)
the trigeminal##16##2##(1990-12#1)(1990-9#1)(1993-1#1)(1996-2#1)(1997-2#2)(1997-3#2)(2008-7#1)(2008-9#2)(2011-2#5)
the trigeminally induced apnoea##2##4##(1996-5#2)
the triggering of##2##3##(2008-8#1)(2010-6#1)
the triggers##2##2##(1997-1#1)(2008-11#1)
the triiodide##2##2##(2008-10#2)
the tripeptide##2##2##(1992-10#1)(2011-1#1)
the triple helix##2##3##(2009-7#2)
the triple integration##2##3##(2008-10#2)
the triple##4##2##(2008-10#2)(2009-7#2)
the triplet##2##2##(2008-10#1)(2008-8#1)
the triplex formation##2##3##(1993-8#2)
the triplex##3##2##(1993-8#3)
the triploid##2##2##(2008-5#1)(2009-12#1)
the trisaccharide##2##2##(1994-5#2)
the tritocerebral##2##2##(2007-12#2)
the trivalent cation##2##3##(1997-2#1)(2008-10#1)
the trivalent ion##2##3##(2008-10#2)
the trivalent##11##2##(1997-2#1)(2008-10#9)(2008-12#1)
the trophic##2##2##(1993-3#1)(1997-1#1)
the tropical and subtropical##3##4##(2008-10#1)(2008-11#1)(2010-5#1)
the tropical isolates##3##3##(2008-10#3)
the tropical##13##2##(1990-8#1)(2008-10#9)(2008-11#1)(2008-9#1)(2010-5#1)
the tropics and subtropics##2##4##(2011-2#1)(2012-3#1)
the tropics and##3##3##(2011-2#2)(2012-3#1)
the tropics##8##2##(1995-12#2)(2008-10#2)(2010-7#1)(2011-2#2)(2012-3#1)
the tropopause##2##2##(2008-3#2)
the true colonization incidence of blossoms##2##6##(2008-10#2)
the true lumen##2##3##(2008-11#2)
the true##31##2##(1990-6#1)(1991-5#1)(1992-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#1)
the truly##3##2##(1994-2#1)(1995-6#1)(2008-10#1)
the truncated##5##2##(1993-6#2)(1996-12#1)(1997-8#1)(2008-8#1)
the trunk and##3##3##(2008-5#1)(2010-6#1)(2011-2#1)
the trunk##8##2##(2008-10#2)(2008-5#3)(2010-6#2)(2011-2#1)
the trypsin##2##2##(1990-12#1)(1994-3#1)
the trypsin-like peptidase##2##3##(2008-5#2)
the trypsin-like##3##2##(2008-5#3)
the tryptic digest of##2##4##(1990-8#1)(1997-2#1)
the tryptic##5##2##(1990-8#1)(1992-10#1)(1993-8#1)(1997-2#1)(2008-10#1)
the tryptophan##3##2##(2008-10#2)(2008-3#1)
the tsunami##2##2##(2010-8#1)(2013-1#1)
the tsx##3##2##(1990-11#3)
the tube lifetime##2##3##(2008-10#2)
the tube##18##2##(1994-9#2)(2008-10#8)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#2)(2013-8#1)
the tubercle bacillus##2##3##(2008-9#1)(2013-1#1)
the tubes##2##2##(2012-2#2)
the tubing##3##2##(2008-10#2)(2011-1#1)
the tubular electrode##3##3##(2008-10#3)
the tubular##7##2##(2008-10#3)(2008-7#1)(2009-1#1)(2011-2#1)(2013-7#1)
the tubulin##3##2##(1993-8#2)(2008-11#1)
the tumor and the##2##4##(1993-11#1)(1996-11#1)
the tumor and##5##3##(1993-11#1)(1996-11#1)(2008-11#1)(2011-1#1)(2013-8#1)
the tumor cell##4##3##(1993-11#1)(2008-11#1)(2008-9#1)(2009-3#1)
the tumor cells##7##3##(1993-8#1)(1994-5#1)(1997-1#2)(2008-8#1)(2009-3#1)(2010-6#1)
the tumor growth##2##3##(1994-12#1)(2010-1#1)
the tumor in##2##3##(2008-10#1)(2013-1#1)
the tumor is##2##3##(1992-2#1)(2008-12#1)
the tumor microenvironment##8##3##(2009-3#1)(2010-11#1)(2013-1#5)(2013-8#1)
the tumor spheroid##3##3##(2008-11#3)
the tumor suppressor gene p53##2##5##(1994-9#1)(2008-10#1)
the tumor suppressor gene##4##4##(1994-9#1)(2008-10#1)(2011-2#2)
the tumor suppressor##6##3##(1994-9#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
the tumor was composed of##4##5##(1991-8#1)(2010-12#1)(2010-6#1)(2013-1#1)
the tumor was composed##5##4##(1991-8#1)(2008-12#1)(2010-12#1)(2010-6#1)(2013-1#1)
the tumor was##14##3##(1990-5#1)(1991-8#1)(1992-2#1)(1993-11#1)(2008-12#3)(2009-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
the tumor##105##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#3)(1991-5#1)(1991-8#3)(1992-1#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-11#5)(1993-8#1)(1994-12#3)(1994-5#3)(1994-6#1)(1994-9#1)(1996-11#1)(1997-1#3)(1997-8#1)(2008-10#2)(2008-11#6)(2008-12#6)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#4)(2009-3#3)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#3)(2011-1#1)(2011-2#10)(2012-12#1)(2012-3#3)(2013-1#16)(2013-8#3)
the tumor-bearing##2##2##(2008-8#1)(2013-8#1)
the tumors were##2##3##(1993-1#1)(2013-1#1)
the tumors##9##2##(1990-12#1)(1991-12#1)(1993-1#1)(1993-11#1)(2011-2#1)(2013-1#4)
the tumour and the##2##4##(1991-11#1)(2008-7#1)
the tumour and##3##3##(1991-11#1)(2008-7#2)
the tumour was##6##3##(2008-7#3)(2011-2#1)(2012-12#1)(2012-2#1)
the tumour##30##2##(1990-5#2)(1991-11#1)(1991-6#2)(1992-5#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-7#15)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)
the tunability##2##2##(2007-11#1)(2008-10#1)
the tunable output##3##3##(2008-2#2)(2008-3#1)
the tungsten coil##3##3##(2008-10#3)
the tungsten wire##3##3##(2008-10#3)
the tungsten##10##2##(2008-10#10)
the tunic##4##2##(2008-5#2)(2008-7#2)
the tunica propria##3##3##(2009-10#3)
the tunica##5##2##(2008-10#1)(2008-11#1)(2009-10#3)
the tunnel##3##2##(1991-12#1)(2009-10#1)(2011-3#1)
the turbid medium##2##3##(2008-3#2)
the turbid##3##2##(2008-10#1)(2008-3#2)
the turbidity of the membrane##2##5##(2008-10#2)
the turbidity of the##3##4##(1990-12#1)(2008-10#2)
the turbidity##4##2##(1990-12#1)(2008-10#2)(2008-8#1)
the turbulence##3##2##(2008-3#3)
the turbulent##2##2##(2008-7#1)(2008-8#1)
the turn of the##4##4##(1990-12#1)(1997-3#1)(2010-1#1)(2011-2#1)
the turn##6##2##(1990-12#1)(1994-5#1)(1995-6#1)(1997-3#1)(2010-1#1)(2011-2#1)
the turnover of##2##3##(1993-3#1)(2008-10#1)
the turnover##3##2##(1993-3#1)(2008-10#2)
the twentieth century##4##3##(2008-8#1)(2010-1#2)(2011-2#1)
the twentieth##6##2##(2008-10#1)(2008-8#1)(2010-1#3)(2011-2#1)
the twin##2##2##(1997-1#1)(2008-10#1)
the twisted##2##2##(1990-9#2)
the twitch responses of the electrically stimulated##2##7##(1990-5#2)
the twitch##3##2##(1990-5#2)(2013-8#1)
the two ATP-binding motifs##2##4##(1996-2#2)
the two States##3##3##(1992-3#3)
the two antibodies##2##3##(1991-2#1)(1995-6#1)
the two approaches##3##3##(2008-5#1)(2010-11#1)(2012-2#1)
the two are##2##3##(2008-3#1)(2012-3#1)
the two areas##2##3##(2008-10#1)(2008-8#1)
the two bladder##2##3##(2008-10#2)
the two case##2##3##(1993-12#1)(2008-4#1)
the two cases##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
the two cell lines were##2##5##(2008-11#1)(2008-9#1)
the two cell lines##9##4##(2008-11#3)(2008-7#1)(2008-9#4)(2011-2#1)
the two cell##11##3##(1993-3#1)(1995-11#1)(2008-11#3)(2008-7#1)(2008-9#4)(2011-2#1)
the two chromium##2##3##(2008-10#2)
the two classes of##2##4##(1995-6#1)(2008-10#1)
the two clones##2##3##(2008-10#2)
the two compounds in##2##4##(2008-10#2)
the two compounds##3##3##(2008-10#3)
the two conditions##2##3##(2008-4#1)(2009-11#1)
the two different##6##3##(1996-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-12#1)
the two diseases##7##3##(2008-10#7)
the two drugs##7##3##(1990-9#1)(2008-10#1)(2008-11#4)(2012-2#1)
the two effects##2##3##(1990-8#1)(2008-5#1)
the two electrodes##3##3##(2008-10#3)
the two enzymes##3##3##(1990-5#1)(2008-10#1)(2008-11#1)
the two examinations##2##3##(1996-11#1)(2008-11#1)
the two experiments##2##3##(2008-10#2)
the two factors##2##3##(2008-10#1)(2008-7#1)
the two first-order reactions model##3##5##(2008-10#3)
the two fish species##2##4##(2008-12#1)(2010-8#1)
the two forms of##4##4##(1991-12#1)(2008-10#2)(2010-5#1)
the two formulations of##2##4##(1996-1#2)
the two fungi##3##3##(2008-10#3)
the two genes are##2##4##(1994-11#1)(2008-10#1)
the two genes##7##3##(1990-11#1)(1991-9#1)(1993-6#1)(1994-11#1)(2008-10#1)(2008-9#1)(2009-8#1)
the two groups and##2##4##(2008-10#1)(2012-2#1)
the two groups did not differ##2##6##(2010-4#1)(2011-1#1)
the two groups in##2##4##(1990-2#1)(2008-7#1)
the two groups of isolates##2##5##(2008-10#2)
the two groups of##8##4##(1990-5#1)(2008-10#5)(2008-11#1)(2008-7#1)
the two groups were##7##4##(1992-12#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-12#1)(2013-1#1)(2013-8#1)
the two groups##58##3##(1990-2#1)(1990-5#1)(1991-11#1)(1992-12#3)(1992-3#2)(1992-9#1)(1993-1#1)(1995-12#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-11#2)(2009-12#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-2#3)(2013-1#4)(2013-8#1)
the two helices##3##3##(1993-1#3)
the two hosts##2##3##(2008-10#2)
the two indices##2##3##(2008-8#2)
the two instruments##3##3##(2008-10#1)(2008-3#2)
the two irrigation##2##3##(2008-10#2)
the two isoforms##2##3##(1995-2#1)(1995-8#1)
the two isolates of##2##4##(2008-10#1)(2008-5#1)
the two isolates were##2##4##(2008-10#2)
the two isolates##9##3##(2008-10#7)(2008-5#1)(2009-6#1)
the two kinds of NK cells##2##6##(2008-8#2)
the two kinds of##6##4##(2008-10#3)(2008-8#3)
the two largest lineages##2##4##(2008-10#2)
the two layers##3##3##(2008-12#1)(2008-3#2)
the two levels##2##3##(2008-7#1)(2008-8#1)
the two ligands##3##3##(1996-2#1)(1997-2#1)(2008-10#1)
the two locations##2##3##(2008-10#2)
the two main##6##3##(1993-8#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-8#1)
the two major production areas##2##5##(2008-10#2)
the two major##14##3##(1993-12#1)(1995-12#1)(1995-8#1)(2008-10#7)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
the two mentioned##2##3##(2008-10#1)(2008-12#1)
the two metals##5##3##(1991-5#1)(2008-10#4)
the two methods were##4##4##(2008-10#4)
the two methods##21##3##(1992-12#1)(2008-10#19)(2008-11#1)
the two modes of##2##4##(2008-11#1)(2008-9#1)
the two molecules##2##3##(1994-8#1)(2008-8#1)
the two monomers##2##3##(1992-4#1)(2012-2#1)
the two most##8##3##(1991-2#1)(2008-10#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-2#1)
the two other##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
the two pairs of phycocyanobilins##2##5##(1994-5#2)
the two parameters alpha and gamma##2##6##(2008-6#2)
the two parameters##3##3##(2008-11#1)(2008-6#2)
the two parties##2##3##(1991-6#1)(2008-8#1)
the two pathogens##4##3##(2008-10#3)(2010-4#1)
the two peptides##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the two phases##5##3##(1994-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
the two polymers##2##3##(2008-10#2)
the two populations##6##3##(2008-10#4)(2008-11#1)(2008-8#1)
the two preparations##2##3##(1992-9#1)(1996-2#1)
the two previously##2##3##(1991-12#1)(2008-9#1)
the two procedures##9##3##(1996-2#1)(2008-10#5)(2012-12#2)(2012-2#1)
the two products##3##3##(1995-6#1)(2008-10#1)(2008-5#1)
the two proteins##9##3##(1991-9#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-2#1)(2009-10#1)(2012-2#1)
the two races##2##3##(2008-10#2)
the two receptor domains##2##4##(1993-6#2)
the two receptor##3##3##(1993-6#2)(2008-11#1)
the two regions##2##3##(2008-10#1)(2008-8#1)
the two remaining##2##3##(2008-10#1)(2008-8#1)
the two resistance genes##2##4##(2008-10#2)
the two resistance##3##3##(2008-10#3)
the two seasons##2##3##(2008-10#2)
the two sets of data##2##5##(2008-10#1)(2008-11#1)
the two sets of##4##4##(2008-10#3)(2008-11#1)
the two single##2##3##(1995-6#2)
the two species and##2##4##(1991-6#1)(2008-10#1)
the two species are##2##4##(2008-10#2)
the two species of##2##4##(2008-10#1)(2008-8#1)
the two species were##3##4##(2008-10#2)(2008-6#1)
the two species##36##3##(1991-6#2)(1993-12#1)(1996-2#1)(2008-10#16)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#6)(2012-3#1)(2012-5#1)(2012-8#1)
the two strains##4##3##(2008-10#2)(2009-6#1)(2013-1#1)
the two subgroups##2##3##(1994-3#1)(2008-10#1)
the two substrate molecules##2##4##(1992-3#2)
the two substrate##3##3##(1992-3#2)(1994-5#1)
the two substrates##4##3##(1994-5#2)(2008-7#2)
the two subunits of##2##4##(1992-9#1)(1993-8#1)
the two subunits##8##3##(1991-10#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(2010-5#3)
the two surfaces was##2##4##(2010-10#2)
the two surfaces##3##3##(2008-12#1)(2010-10#2)
the two systems##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)
the two tasks##3##3##(1991-2#1)(2008-11#1)(2008-9#1)
the two taxa are##2##4##(2008-10#1)(2008-7#1)
the two techniques in##2##4##(1997-8#1)(2008-8#1)
the two techniques##7##3##(1995-5#1)(1997-8#1)(2008-10#3)(2008-8#1)(2011-2#1)
the two terrestrial##2##3##(2008-7#2)
the two tests##2##3##(1993-6#1)(1994-8#1)
the two time##2##3##(1996-11#1)(2008-3#1)
the two training approaches##2##4##(2013-8#2)
the two treatment##3##3##(1992-9#1)(1997-7#1)(2008-5#1)
the two trials##2##3##(2008-10#2)
the two types of##7##4##(1991-12#1)(1993-1#1)(1993-8#1)(2008-11#1)(2008-5#2)(2013-8#1)
the two types##8##3##(1991-12#1)(1993-1#1)(1993-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-8#1)
the two variants##3##3##(1990-6#3)
the two varieties of##2##4##(2008-10#1)(2008-5#1)
the two viruses##6##3##(2008-10#5)(2008-9#1)
the two wavelengths##2##3##(2008-2#1)(2008-3#1)
the two years##2##3##(2008-10#2)
the two##825##2##(1990-11#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#6)(1991-8#1)(1991-9#4)(1992-12#4)(1992-2#1)(1992-3#8)(1992-4#2)(1992-6#3)(1992-9#7)(1993-1#6)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#6)(1993-6#9)(1993-8#7)(1994-11#4)(1994-12#2)(1994-3#1)(1994-5#13)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-5#2)(1995-6#9)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#9)(1996-3#2)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#5)(1997-3#2)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#4)(2008-1#4)(2008-10#296)(2008-11#39)(2008-12#13)(2008-2#8)(2008-3#25)(2008-4#4)(2008-5#18)(2008-6#6)(2008-7#24)(2008-8#39)(2008-9#32)(2009-10#4)(2009-11#3)(2009-12#4)(2009-3#1)(2009-6#4)(2009-8#6)(2010-1#1)(2010-10#5)(2010-11#1)(2010-4#4)(2010-5#5)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#18)(2011-3#1)(2012-12#4)(2012-2#12)(2012-3#11)(2012-5#5)(2012-6#1)(2012-8#1)(2013-1#12)(2013-8#9)
the two-component##3##2##(1995-5#1)(1996-12#2)
the two-dimensional##9##2##(1990-9#1)(1995-2#1)(2008-10#2)(2008-3#3)(2008-8#1)(2013-8#1)
the two-hybrid##2##2##(2008-4#1)(2008-8#1)
the two-peptide lantibiotic lacticin 3147##2##5##(2011-1#2)
the two-phase##6##2##(2008-10#6)
the two-photon##3##2##(2008-2#1)(2008-3#2)
the two-stage##2##2##(2008-10#1)(2008-11#1)
the two-step##3##2##(2008-10#3)
the two-wave mixing##2##3##(2008-3#2)
the two-wave##3##2##(2008-3#3)
the two-way text##2##3##(2010-8#2)
the two-way##4##2##(2008-10#1)(2010-10#1)(2010-8#2)
the type I##5##3##(1990-2#2)(1995-2#1)(2008-11#1)(2008-3#1)
the type II##7##3##(1991-10#1)(1995-2#3)(1997-2#1)(2008-3#1)(2008-4#1)
the type and concentration of##2##5##(2008-10#2)
the type and##17##3##(1995-12#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
the type genus of the family##2##6##(2011-2#2)
the type of TH cell##2##5##(1995-5#2)
the type of diabetes##2##4##(1993-2#2)
the type of equipment##2##4##(2008-10#1)(2008-4#1)
the type of fracture##2##4##(2011-2#2)
the type of interaction##3##4##(1995-11#1)(1997-2#1)(2008-10#1)
the type of nanomaterial used##2##5##(2008-10#2)
the type of surgical##2##4##(1990-12#1)(2013-1#1)
the type of symptom##2##4##(2008-10#1)(2009-9#1)
the type of the##13##4##(1992-9#1)(1993-12#1)(1995-11#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)
the type of##103##3##(1990-12#1)(1990-3#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-3#1)(1995-11#4)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#3)(2008-10#21)(2008-11#9)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
the type or##2##3##(2008-10#1)(2009-7#1)
the type species of the genus##20##6##(1997-2#1)(2008-10#1)(2011-2#18)
the type species of the##22##5##(1997-2#1)(2008-10#1)(2011-2#20)
the type species##25##3##(1997-2#1)(2008-10#1)(2008-9#1)(2011-2#22)
the type strain of##2##4##(2008-10#1)(2011-2#1)
the type strain##5##3##(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
the type##182##2##(1990-12#1)(1990-2#2)(1990-3#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#5)(1997-3#1)(2008-10#37)(2008-11#14)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#32)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
the type(s) of##2##3##(2008-10#1)(2008-11#1)
the types and##3##3##(2008-5#1)(2010-11#1)(2011-3#1)
the types of##21##3##(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#2)(1993-1#1)(1993-8#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
the types##25##2##(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#2)(1993-1#1)(1993-8#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
the typical symptoms##2##3##(1995-2#1)(2012-12#1)
the typical##43##2##(1993-2#1)(1994-1#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-3#1)(1997-8#2)(2007-12#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-6#2)(2008-8#3)(2009-1#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
the tyrosine kinase inhibitor##2##4##(1994-6#1)(1996-12#1)
the tyrosine kinase##5##3##(1994-6#1)(1996-12#2)(2009-7#1)(2013-1#1)
the tyrosine phosphorylation and##2##4##(1995-6#1)(1996-2#1)
the tyrosine##11##2##(1994-6#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)
the ubiquitin##3##2##(2008-9#2)(2011-3#1)
the ubiquitous##5##2##(1993-8#1)(1993-9#1)(1994-11#1)(2008-10#1)(2011-2#1)
the ulcer##3##2##(1996-11#1)(2008-12#1)(2013-1#1)
the ulnar nerve##7##3##(2008-12#1)(2008-9#6)
the ulnar##10##2##(1997-3#1)(2008-12#1)(2008-9#8)
the ultimate goal##2##3##(1992-1#1)(2010-9#1)
the ultimate outcome##2##3##(1997-3#1)(2008-11#1)
the ultimate##15##2##(1992-1#1)(1995-11#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-10#1)(2010-9#1)(2012-12#1)(2012-2#1)
the ultra##2##2##(2008-10#2)
the ultrafiltration##2##2##(2011-2#2)
the ultramarathon##3##2##(2013-8#3)
the ultrasonic beam##2##3##(2007-12#2)
the ultrasonic inhaler##2##3##(1993-2#2)
the ultrasonic##17##2##(1991-1#3)(1993-2#2)(2007-12#4)(2008-10#5)(2008-11#3)
the ultrasound##5##2##(1996-11#1)(2008-10#2)(2008-12#1)(2008-5#1)
the ultrasound-assisted##2##2##(2008-10#2)
the ultrastructural level##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the ultrastructural##5##2##(1992-3#1)(2008-10#1)(2008-7#1)(2011-2#2)
the ultrastructure of the##2##4##(2007-12#1)(2008-5#1)
the ultrastructure of##7##3##(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)
the ultrastructure##8##2##(2007-12#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)
the ultratrace##2##2##(2008-10#1)(2008-3#1)
the ultraviolet zenith##2##3##(2008-3#2)
the ultraviolet##11##2##(2008-10#3)(2008-2#1)(2008-3#6)(2011-2#1)
the umbilical cord arteries##2##4##(2009-8#2)
the umbilical cord##4##3##(1997-3#1)(2009-8#3)
the umbilical##6##2##(1996-3#1)(1997-3#1)(2008-10#1)(2009-8#3)
the umbrella##7##2##(1997-8#1)(2008-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-2#1)
the unavailability of##2##3##(2011-2#1)(2012-3#1)
the unblocked##2##2##(1994-5#2)
the uncertainties##2##2##(2008-10#1)(2008-3#1)
the uncertainty associated with the##3##5##(2008-10#3)
the uncertainty associated##4##3##(2008-10#4)
the uncertainty in##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
the uncertainty of##4##3##(2008-10#3)(2008-3#1)
the uncertainty##16##2##(2008-10#12)(2008-3#3)(2008-7#1)
the uncoated TMFE##2##3##(2008-10#2)
the uncoated##4##2##(2008-10#3)(2008-2#1)
the uncomplexed tetrol I-1##2##4##(2008-10#2)
the uncomplexed tetrol##3##3##(2008-10#3)
the uncomplexed##4##2##(2008-10#4)
the unconjugated##2##2##(1992-3#1)(2008-10#1)
the uncorrected##2##2##(2008-10#1)(2008-3#1)
the under-five syntactic categories##2##4##(2008-2#2)
the under-five##3##2##(2008-2#3)
the undergraduate curriculum##4##3##(2011-2#3)(2013-1#1)
the undergraduate##9##2##(1991-1#1)(1991-6#1)(2008-11#1)(2008-12#2)(2011-2#3)(2013-1#1)
the underlined##2##2##(1995-8#1)(2008-8#1)
the underlying cause of##2##4##(2008-1#1)(2010-10#1)
the underlying cause##4##3##(2008-1#2)(2010-10#2)
the underlying collagen network##2##4##(2009-10#2)
the underlying disease##5##3##(1995-9#1)(2011-2#2)(2011-3#2)
the underlying genetics##2##3##(2008-10#1)(2008-8#1)
the underlying mechanism##4##3##(2008-7#1)(2009-8#1)(2010-7#1)(2012-2#1)
the underlying mechanisms of##3##4##(1995-12#1)(2008-10#1)(2013-1#1)
the underlying mechanisms##6##3##(1993-1#1)(1995-12#1)(2008-10#1)(2009-3#1)(2010-11#1)(2013-1#1)
the underlying pathophysiology##2##3##(2008-10#1)(2012-3#1)
the underlying principles##3##3##(2008-9#3)
the underlying##82##2##(1990-11#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-1#1)(1996-3#1)(1997-5#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#4)(2010-11#4)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#3)
the underreporting##2##2##(2012-12#2)
the understanding and treatment of##2##5##(1994-5#1)(2008-4#1)
the understanding and##5##3##(1994-5#1)(2008-11#1)(2008-4#1)(2009-12#1)(2011-2#1)
the understanding of how##2##4##(2008-10#1)(2008-7#1)
the understanding of the##18##4##(1991-2#1)(1993-11#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2009-1#1)(2009-3#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#1)
the understanding of##44##3##(1991-12#1)(1991-2#1)(1993-11#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#1)
the understanding##52##2##(1991-12#1)(1991-2#1)(1993-11#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-8#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-7#2)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
the understory##5##2##(2008-8#2)(2008-9#3)
the undesired##2##2##(2008-10#1)(2008-9#1)
the undifferentiated##3##2##(2008-11#2)(2008-9#1)
the undiluted##2##2##(1991-12#1)(2008-10#1)
the unedited##2##2##(1993-12#2)
the uneven##2##2##(1994-6#1)(2012-12#1)
the unfavorable##3##2##(1992-2#1)(2011-2#1)(2013-8#1)
the unfolded state##2##3##(1997-2#2)
the unfolding of##2##3##(2008-4#2)
the unfolding##3##2##(2008-4#2)(2008-9#1)
the unfractionated bone cells##2##4##(2008-11#2)
the unified concept##2##3##(2008-7#2)
the unified##3##2##(2008-7#2)(2010-11#1)
the uniform##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
the uniformity##4##2##(2008-12#1)(2008-3#2)(2013-1#1)
the uniformly##2##2##(2009-7#1)(2012-2#1)
the unilateral##3##2##(1996-12#2)(2008-11#1)
the unimodal##2##2##(2008-10#2)
the uninitiated##2##2##(1996-2#1)(2008-9#1)
the uninoculated control##2##3##(2008-10#2)
the uninsured and##3##3##(1994-2#1)(1995-12#1)(2008-11#1)
the uninsured##12##2##(1992-2#1)(1994-2#1)(1995-12#2)(2008-11#8)
the union of surgeon and machine##2##6##(2011-2#2)
the union##8##2##(1995-12#4)(2009-10#1)(2011-2#2)(2013-1#1)
the unique ability##2##3##(1997-1#1)(2012-2#1)
the unique advantages of##2##4##(2007-12#1)(2008-3#1)
the unique capability##2##3##(2008-4#1)(2011-7#1)
the unique characteristics of##6##4##(1990-11#1)(1996-3#1)(2008-2#1)(2011-2#1)(2013-1#2)
the unique features of##2##4##(2009-6#1)(2012-2#1)
the unique features##3##3##(2008-11#1)(2009-6#1)(2012-2#1)
the unique properties of##2##4##(2008-5#1)(2008-7#1)
the unique requirements##2##3##(2008-11#1)(2008-3#1)
the unique##53##2##(1990-11#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-5#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
the uniqueness constraint is##2##4##(2008-9#2)
the uniqueness constraint##4##3##(2008-9#4)
the uniqueness of each##2##4##(2008-11#1)(2008-9#1)
the uniqueness of the##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
the uniqueness of##5##3##(2008-10#1)(2008-11#2)(2008-9#1)(2012-3#1)
the uniqueness##10##2##(2008-10#2)(2008-11#2)(2008-9#5)(2012-3#1)
the unit cell##2##3##(1992-9#1)(2008-7#1)
the unit is##4##3##(2008-11#1)(2008-4#3)
the unit of##2##3##(1995-2#1)(2012-3#1)
the unit##19##2##(1990-9#1)(1992-9#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-4#5)(2008-7#2)(2010-2#1)(2010-8#2)(2012-2#1)(2012-3#1)
the unitary##3##2##(1997-7#1)(2008-3#1)(2008-4#1)
the units##8##2##(2008-9#2)(2010-5#3)(2011-2#3)
the unity of##2##3##(2010-4#1)(2010-8#1)
the univalent##2##2##(2008-10#2)
the universal##13##2##(2008-10#6)(2008-12#1)(2008-8#2)(2010-12#1)(2011-2#3)
the universally##2##2##(2008-11#1)(2009-6#1)
the universe##8##2##(1995-6#1)(1996-12#1)(2008-12#3)(2010-3#1)(2010-9#1)(2013-1#1)
the universities##2##2##(2008-10#1)(2013-8#1)
the university##13##2##(1991-2#1)(1993-2#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)
the unknown##10##2##(1992-2#1)(2008-10#6)(2011-2#2)(2012-3#1)
the unloaded##2##2##(1991-5#1)(2008-10#1)
the unmodified##5##2##(2008-10#4)(2009-7#1)
the unpredictable##5##2##(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)
the unprotonated##3##2##(1991-9#2)(2008-10#1)
the unquantified##3##2##(2008-4#3)
the unreinforced licks##2##3##(2008-11#2)
the unretained##3##2##(2008-10#3)
the untranslated##3##2##(1995-8#1)(2008-10#2)
the untreated control##6##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-7#1)
the untreated controls##3##3##(1997-4#2)(2008-10#1)
the untreated dwarf##2##3##(1995-12#2)
the untreated##20##2##(1992-12#1)(1995-12#2)(1995-6#2)(1996-12#1)(1997-4#2)(2008-10#5)(2008-11#3)(2008-5#2)(2013-7#2)
the unusual##14##2##(1991-3#1)(1992-9#1)(1994-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
the unusually large##2##3##(1992-12#1)(2008-10#1)
the unwanted##3##2##(1992-1#1)(2008-9#2)
the unweighted pair group method##2##5##(2008-10#2)
the unweighted##3##2##(1992-12#1)(2008-10#2)
the up-regulation of##7##3##(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#1)(2013-1#3)
the upcoming tastant##3##3##(2008-11#3)
the upcoming##4##2##(2008-11#3)(2008-3#1)
the upper and lower airways##2##5##(2012-12#2)
the upper and lower parts of the##2##7##(2008-10#2)
the upper and lower parts##3##5##(2008-10#2)(2008-12#1)
the upper and lower##8##4##(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-12#2)(2012-3#1)
the upper and##11##3##(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)
the upper chamber##2##3##(2008-11#2)
the upper extremities##2##3##(1997-4#1)(2010-3#1)
the upper extremity##3##3##(1991-11#1)(2008-12#1)(2009-5#1)
the upper gastrointestinal##2##3##(1996-3#1)(2013-1#1)
the upper layer##3##3##(2008-10#2)(2008-3#1)
the upper limb##4##3##(2008-7#1)(2008-9#1)(2009-1#2)
the upper limit of normal##2##5##(2008-1#1)(2012-3#1)
the upper limit of the##2##5##(1993-2#1)(2008-2#1)
the upper limit of##4##4##(1993-2#1)(2008-1#1)(2008-2#1)(2012-3#1)
the upper limit##7##3##(1993-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2012-3#1)
the upper lip##2##3##(1995-12#1)(2011-2#1)
the upper or lower##2##4##(2008-10#1)(2008-12#1)
the upper respiratory tract##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
the upper tail##2##3##(1993-9#2)
the upper trapezium muscle with##2##5##(2010-6#1)(2010-9#1)
the upper trapezius muscle##2##4##(2010-9#2)
the upper trapezius##5##3##(2010-9#5)
the upper urinary tract##2##4##(1991-9#1)(2011-2#1)
the upper##116##2##(1990-6#1)(1991-11#1)(1991-6#1)(1991-9#3)(1992-6#1)(1993-2#2)(1993-9#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-6#1)(2008-1#3)(2008-10#37)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#2)(2009-5#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-6#3)(2010-8#1)(2010-9#6)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#1)
the upper-half of the face##5##5##(2010-1#5)
the uppermost##2##2##(2008-10#1)(2008-5#1)
the upregulation of##6##3##(1997-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2013-1#1)
the upstream of##2##3##(1997-6#1)(2008-9#1)
the upstream##13##2##(1990-8#1)(1991-6#1)(1993-12#1)(1993-9#1)(1995-2#2)(1996-3#1)(1997-6#1)(2008-1#1)(2008-8#1)(2008-9#2)(2010-6#1)
the uptake and##7##3##(1991-5#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-9#2)
the uptake of glucose##2##4##(1992-6#1)(2008-11#1)
the uptake of the##2##4##(1997-1#1)(2008-11#1)
the uptake of##26##3##(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#2)(1996-12#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-8#1)(2008-9#2)(2012-2#1)
the uptake rates##2##3##(2008-10#2)
the uptake system##2##3##(2008-10#2)
the uptake##41##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#2)(1996-12#1)(1997-1#1)(2008-10#16)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#4)(2012-2#1)
the uranium##3##2##(2008-10#3)
the urban##13##2##(1990-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2009-10#1)(2012-12#3)(2012-3#1)
the urea##4##2##(1995-6#2)(2008-10#2)
the ureter##9##2##(1997-3#3)(1997-4#1)(2008-10#1)(2011-2#1)(2013-7#3)
the urethra and##3##3##(2008-10#2)(2013-1#1)
the urethra##7##2##(2008-10#4)(2012-3#1)(2013-1#2)
the urethral cases##2##3##(2008-10#2)
the urethral meatus##2##3##(1992-1#2)
the urethral plate##2##3##(2008-10#2)
the urethral##10##2##(1992-1#2)(1996-11#1)(2008-10#6)(2013-1#1)
the urgency##3##2##(1996-1#1)(2008-10#1)(2011-3#1)
the uridine##3##2##(1993-8#1)(1995-8#1)(2008-11#1)
the urinary bladder cancer##3##4##(2011-2#3)
the urinary bladder of##2##4##(1992-12#1)(2012-2#1)
the urinary bladder was##2##4##(1993-2#1)(2012-12#1)
the urinary bladder##15##3##(1992-12#2)(1993-2#2)(2008-10#1)(2011-2#6)(2012-12#2)(2012-2#2)
the urinary excretion of##6##4##(1990-5#1)(1991-12#1)(1994-5#4)
the urinary tract##6##3##(1990-11#2)(1992-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
the urinary##36##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-9#1)(1993-2#2)(1994-5#5)(1996-12#1)(2008-10#4)(2008-7#1)(2011-2#7)(2012-12#3)(2012-2#2)(2013-1#2)
the urine matrix##2##3##(2008-10#2)
the urine of##2##3##(1991-12#1)(1997-2#1)
the urine sample##3##3##(1990-2#1)(2008-10#2)
the urine samples##3##3##(2008-10#3)
the urine##24##2##(1990-2#1)(1991-12#2)(1994-8#2)(1995-3#1)(1997-2#1)(2008-10#14)(2008-12#1)(2012-2#1)(2013-8#1)
the urogenital##4##2##(1995-5#1)(1997-2#1)(1997-6#1)(2012-3#1)
the urothelium and##2##3##(1992-12#1)(2013-8#1)
the usage of the##3##4##(1993-6#1)(2008-10#1)(2011-2#1)
the usage of this##2##4##(2009-3#1)(2011-2#1)
the usage of##9##3##(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#2)(2009-3#1)(2011-2#2)(2012-2#1)
the use and##5##3##(1997-3#1)(2008-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
the use of DNA##2##4##(2008-10#1)(2008-11#1)
the use of GFP##2##4##(1996-6#1)(2008-11#1)
the use of KT following musculoskeletal injury##2##7##(2013-1#2)
the use of KT##3##4##(2013-1#3)
the use of Medicare##2##4##(1994-2#1)(1994-3#1)
the use of SIT##3##4##(2011-2#3)
the use of SPC##2##4##(1995-2#2)
the use of TCAM##2##4##(2009-6#2)
the use of a combination of##2##6##(2008-10#1)(2008-7#1)
the use of a set of##2##6##(2008-10#2)
the use of a single##4##5##(1995-8#1)(2008-10#2)(2008-6#1)
the use of a##75##4##(1991-2#1)(1992-1#2)(1992-2#2)(1994-3#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(2007-12#1)(2008-10#34)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
the use of an##17##4##(1994-9#1)(1996-1#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#2)
the use of animal##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
the use of appropriate##2##4##(2008-11#2)
the use of both##5##4##(1997-2#1)(2008-10#2)(2012-2#1)(2013-1#1)
the use of combined##2##4##(2008-10#2)
the use of community##2##4##(1996-1#1)(2012-12#1)
the use of computer software##2##5##(2008-9#2)
the use of conventional##2##4##(2008-10#1)(2008-11#1)
the use of data##2##4##(2010-8#1)(2011-2#1)
the use of different polyadenylation site signals##2##7##(1990-2#2)
the use of different##9##4##(1990-2#2)(2008-10#7)
the use of early##2##4##(1991-3#1)(2008-11#1)
the use of feedback##2##4##(2009-10#2)
the use of first##2##4##(1991-12#1)(2008-10#1)
the use of food##2##4##(1991-12#1)(1996-12#1)
the use of force##2##4##(1995-5#1)(1995-6#1)
the use of genetically##2##4##(2008-9#1)(2011-1#1)
the use of high##4##4##(2008-10#3)(2008-11#1)
the use of home health services##2##6##(1995-3#2)
the use of home##3##4##(1995-3#2)(2009-6#1)
the use of homologous##2##4##(1992-3#1)(2010-8#1)
the use of hospital##5##4##(1991-1#1)(1991-2#1)(1993-11#1)(1994-2#2)
the use of human##3##4##(1992-5#1)(2008-4#1)(2013-1#1)
the use of information technology in##2##6##(2008-10#2)
the use of information##4##4##(1992-2#1)(2008-10#2)(2013-1#1)
the use of laboratory tests##2##5##(1991-2#1)(1994-12#1)
the use of laboratory##4##4##(1991-2#1)(1993-2#1)(1994-12#1)(2008-10#1)
the use of laser##3##4##(1991-9#1)(2008-10#2)
the use of long-term##2##4##(1996-6#1)(2008-4#1)
the use of medical##5##4##(1992-12#1)(1996-6#1)(2008-11#2)(2008-4#1)
the use of microteaching##3##4##(2008-11#3)
the use of modified##2##4##(2008-10#1)(2011-2#1)
the use of molecular##4##4##(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
the use of more##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
the use of multidimensional##2##4##(1995-5#1)(2012-3#1)
the use of multinuclear MRS##2##5##(2012-2#2)
the use of multiple##5##4##(1991-3#1)(2008-10#3)(2008-4#1)
the use of multivariate##2##4##(2008-10#2)
the use of neoadjuvant##2##4##(2013-8#2)
the use of new##2##4##(1991-12#1)(2008-11#1)
the use of nine##2##4##(1991-1#1)(2008-10#1)
the use of one##2##4##(2008-4#1)(2012-12#1)
the use of oral contraceptives##3##5##(1991-8#1)(2008-11#2)
the use of organic##2##4##(2008-10#2)
the use of pathways##2##4##(2008-3#2)
the use of patient satisfaction##2##5##(1996-1#2)
the use of resistant cultivars##2##5##(2008-10#2)
the use of selective##2##4##(2008-10#1)(2008-12#1)
the use of services and##2##5##(1991-2#1)(1993-3#1)
the use of services##3##4##(1991-2#1)(1993-3#1)(1995-3#1)
the use of several##3##4##(2008-10#1)(2008-11#1)(2009-3#1)
the use of simple##3##4##(1992-9#1)(2008-10#1)(2008-11#1)
the use of statistical##2##4##(1993-3#1)(2009-7#1)
the use of stopped-flow##2##4##(2008-10#2)
the use of storytelling and narrative in medicine##2##8##(2008-11#2)
the use of storytelling##3##4##(2008-11#3)
the use of systemic##2##4##(1997-3#1)(2008-11#1)
the use of technology##3##4##(2008-11#2)(2008-12#1)
the use of the initial##2##5##(2009-6#2)
the use of the standard##2##5##(2008-10#2)
the use of the tool##2##5##(2008-11#2)
the use of the##84##4##(1990-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-3#1)(2007-12#3)(2008-10#39)(2008-11#8)(2008-12#1)(2008-4#4)(2008-5#2)(2008-8#2)(2008-9#1)(2009-6#2)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the use of their##2##4##(2008-10#1)(2008-5#1)
the use of these systems##2##5##(2008-10#2)
the use of these##13##4##(1991-12#1)(1992-2#1)(1997-4#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#1)
the use of this model##2##5##(2008-10#1)(2008-11#1)
the use of this technique##2##5##(2008-2#1)(2011-2#1)
the use of this##13##4##(1990-9#1)(1992-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
the use of three##2##4##(2008-10#1)(2013-1#1)
the use of three-way##2##4##(2008-10#2)
the use of time-consuming##2##4##(2008-10#1)(2008-4#1)
the use of traditional##2##4##(2008-12#2)
the use of tranilast for##2##5##(2008-5#2)
the use of two##7##4##(1990-12#1)(1991-3#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#1)
the use of unhealthy weight control methods##3##7##(2012-2#3)
the use of##901##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-9#5)(1991-1#2)(1991-12#7)(1991-2#4)(1991-3#6)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#5)(1992-12#4)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#5)(1994-1#1)(1994-12#3)(1994-2#6)(1994-3#10)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#7)(1995-5#7)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#7)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#306)(2008-11#87)(2008-12#20)(2008-2#4)(2008-3#18)(2008-4#22)(2008-5#15)(2008-6#6)(2008-7#23)(2008-8#7)(2008-9#17)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#2)(2011-10#2)(2011-2#30)(2011-3#5)(2011-7#1)(2012-12#9)(2012-2#20)(2012-3#17)(2013-1#38)(2013-8#8)
the use##919##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-9#5)(1991-1#2)(1991-12#7)(1991-2#4)(1991-3#6)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#5)(1992-12#4)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#5)(1994-1#1)(1994-12#3)(1994-2#7)(1994-3#10)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#7)(1995-5#7)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#7)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#311)(2008-11#90)(2008-12#20)(2008-2#4)(2008-3#18)(2008-4#23)(2008-5#15)(2008-6#6)(2008-7#23)(2008-8#7)(2008-9#17)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#2)(2011-10#2)(2011-2#31)(2011-3#5)(2011-7#1)(2012-12#10)(2012-2#20)(2012-3#17)(2013-1#40)(2013-8#10)
the used##7##2##(1993-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-8#1)
the useful##3##2##(2008-10#3)
the usefulness and##6##3##(1990-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)
the usefulness of US##2##4##(2010-12#1)(2012-2#1)
the usefulness of a##2##4##(2008-5#1)(2012-12#1)
the usefulness of our##2##4##(2008-11#1)(2008-3#1)
the usefulness of the proposed##2##5##(2008-10#2)
the usefulness of the##15##4##(1990-5#1)(1991-3#1)(1993-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the usefulness of this##2##4##(1997-2#1)(2008-10#1)
the usefulness of##48##3##(1990-5#2)(1991-3#2)(1992-1#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
the usefulness##54##2##(1990-2#1)(1990-5#2)(1991-3#2)(1992-1#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
the user interface##2##3##(2010-8#2)
the user may##2##3##(1993-3#1)(2008-4#1)
the user to##6##3##(2008-3#1)(2008-4#1)(2008-6#3)(2008-9#1)
the user##23##2##(1991-1#1)(1991-12#1)(1992-1#1)(1993-3#2)(2008-10#5)(2008-3#1)(2008-4#3)(2008-6#3)(2008-9#2)(2010-8#2)(2011-1#1)(2013-8#1)
the users of##2##3##(2008-11#2)
the users##7##2##(1991-1#1)(1992-1#1)(1995-2#1)(2008-11#2)(2012-2#2)
the users'##2##2##(2012-3#2)
the uses of##4##3##(1991-12#1)(1995-2#1)(2008-1#1)(2010-5#1)
the uses##5##2##(1991-12#1)(1995-2#1)(2008-1#1)(2009-9#1)(2010-5#1)
the usual complication##2##3##(1991-3#1)(2008-12#1)
the usual##36##2##(1990-5#1)(1991-1#1)(1991-3#1)(1993-2#1)(1993-8#1)(1994-2#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2008-10#10)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2012-3#1)
the usually##4##2##(1992-6#1)(2008-7#1)(2009-6#1)(2010-11#1)
the uterine cavity##3##3##(1993-12#1)(1996-1#1)(2012-3#1)
the uterine##15##2##(1990-6#2)(1991-3#1)(1993-1#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-11#2)(2008-6#1)(2009-11#2)(2012-3#1)
the uterus##11##2##(1993-1#1)(2008-1#1)(2008-10#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
the uterus)##2##2##(2011-2#2)
the utilisation of##5##3##(1993-8#1)(2008-10#3)(2008-11#1)
the utility and##2##3##(1995-1#1)(2009-8#1)
the utility of the##12##4##(1994-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
the utility of these##3##4##(2008-10#1)(2013-1#2)
the utility of this##3##4##(1994-12#1)(2008-10#1)(2010-5#1)
the utility of##50##3##(1990-5#1)(1990-9#1)(1991-1#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#6)
the utility##54##2##(1990-5#1)(1990-9#1)(1991-1#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#2)(2010-12#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#6)
the utilization of a##2##4##(2008-10#1)(2008-11#1)
the utilization of medical##2##4##(1996-2#1)(1996-6#1)
the utilization of the##2##4##(2008-10#1)(2011-2#1)
the utilization of##21##3##(1990-8#1)(1996-2#1)(1996-6#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#1)
the utilization##22##2##(1990-8#1)(1996-2#1)(1996-6#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#2)
the utmost##2##2##(2008-3#1)(2012-3#1)
the vWF gene##2##3##(2008-12#2)
the vacancy##3##2##(1993-1#1)(2008-9#2)
the vaccinated##4##2##(1995-5#1)(1995-9#2)(2008-11#1)
the vaccination##2##2##(1995-9#1)(2009-12#1)
the vaccine strain A/PER/16/09##2##4##(2013-8#2)
the vaccine strain##3##3##(2013-8#3)
the vaccine##24##2##(1990-3#1)(1990-9#1)(1993-3#1)(1994-9#3)(1995-5#5)(1995-9#1)(1996-12#1)(2008-10#1)(2008-11#2)(2011-2#3)(2013-1#2)(2013-8#3)
the vaccines##2##2##(1995-5#2)
the vacuolar component##2##3##(1995-3#2)
the vacuolar##4##2##(1994-6#1)(1995-3#2)(2008-11#1)
the vacuole##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
the vacuoles##2##2##(2008-7#2)
the vacuum disc##3##3##(2012-2#3)
the vagina##7##2##(1990-2#1)(1991-12#2)(1993-1#1)(1994-1#1)(1996-9#1)(2009-10#1)
the vaginal apex##2##3##(2009-2#1)(2010-12#1)
the vaginal sensilla##2##3##(2008-8#2)
the vaginal##13##2##(1991-12#2)(1991-3#1)(1992-12#1)(1995-1#1)(1996-9#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-2#1)(2010-12#1)
the valence##3##2##(2008-10#2)(2008-11#1)
the validated##2##2##(2008-10#1)(2013-1#1)
the validation data##2##3##(2008-10#2)
the validation of a##4##4##(1997-2#1)(2008-10#1)(2009-7#1)(2013-1#1)
the validation of##7##3##(1997-2#1)(2008-10#3)(2008-5#1)(2009-7#1)(2013-1#1)
the validation results of##2##4##(2008-10#2)
the validation set##2##3##(1995-9#1)(2008-10#1)
the validation##17##2##(1995-9#1)(1997-2#1)(2008-10#11)(2008-3#1)(2008-5#1)(2009-7#1)(2013-1#1)
the validity and##3##3##(2007-12#1)(2008-10#1)(2010-9#1)
the validity of certain of the research data identified in the articles##2##12##(2008-10#2)
the validity of results##2##4##(2008-10#1)(2008-11#1)
the validity of such an##2##5##(2008-11#1)(2008-3#1)
the validity of such##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
the validity of the method##3##5##(2008-10#3)
the validity of the two-state model##2##6##(1997-2#2)
the validity of the##17##4##(1997-2#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-7#2)(2010-8#1)(2011-2#1)
the validity of this##3##4##(2007-12#1)(2008-4#1)(2008-5#1)
the validity of##45##3##(1990-9#1)(1991-2#1)(1992-5#1)(1993-3#1)(1995-2#1)(1997-2#2)(2007-12#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
the validity##49##2##(1990-9#1)(1991-2#1)(1992-5#1)(1993-3#1)(1995-2#1)(1997-2#2)(2007-12#3)(2008-10#16)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the valley##6##2##(2008-10#6)
the value at##3##3##(1995-8#1)(2008-10#1)(2011-1#1)
the value observed in##2##4##(2008-10#2)
the value obtained##4##3##(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)
the value of future reproduction##2##5##(2008-8#2)
the value of role modelling##2##5##(2008-12#2)
the value of the##14##4##(1992-9#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-4#1)(2010-4#1)
the value of this##3##4##(1990-6#1)(2008-10#1)(2011-2#1)
the value of using##3##4##(1992-2#1)(1995-2#1)(2008-11#1)
the value of##82##3##(1990-5#1)(1990-6#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#3)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#13)(2008-12#6)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-4#3)(2011-2#1)(2012-12#1)(2012-3#2)
the value##106##2##(1990-5#1)(1990-6#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#18)(2008-11#16)(2008-12#6)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
the values are##2##3##(2008-10#2)
the values between##2##3##(2011-2#1)(2012-3#1)
the values for##9##3##(1991-5#1)(1992-11#1)(1994-5#1)(1997-2#2)(2008-5#2)(2010-12#1)(2013-1#1)
the values obtained from##4##4##(1992-2#1)(2008-10#3)
the values obtained##13##3##(1992-2#1)(2008-10#12)
the values of K(f)##2##4##(2008-10#2)
the values of the distribution##2##5##(2008-10#2)
the values of the##11##4##(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)
the values of##27##3##(1990-6#1)(1991-12#1)(1993-1#1)(1994-12#1)(2008-1#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-6#1)(2013-1#1)
the values were##3##3##(1993-2#1)(2008-10#1)(2008-11#1)
the values##71##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-5#1)(1995-3#1)(1997-2#2)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#2)
the valve##9##2##(1991-12#1)(1997-5#1)(2008-10#3)(2010-12#1)(2011-2#2)(2013-1#1)
the van der Waals surface##2##5##(2013-1#2)
the van der Waals##3##4##(1995-3#1)(2013-1#2)
the vanadium adsorption##2##3##(2008-10#2)
the vanadium##8##2##(2008-10#8)
the vanadium(V)-catalyzed##2##2##(2008-10#2)
the vanguard of##3##3##(1991-2#1)(2008-9#1)(2013-8#1)
the vapor phase##2##3##(2008-10#1)(2008-8#1)
the vapor##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)
the vaporization##4##2##(2008-10#4)
the vapour pressure of the##2##5##(2008-5#2)
the vapour pressure of##3##4##(2008-5#3)
the vapour pressure##4##3##(2008-5#4)
the vapour##6##2##(1992-11#1)(2008-10#1)(2008-5#4)
the vapours##2##2##(1991-6#1)(2008-10#1)
the var##3##2##(2008-12#1)(2008-5#2)
the variability among##2##3##(2008-10#2)
the variability and##2##3##(2008-10#2)
the variability between different tests based on the same principle##2##10##(2008-10#2)
the variability between##4##3##(2008-10#4)
the variability in disease##2##4##(2008-10#2)
the variability in the##3##4##(1991-12#1)(2008-10#2)
the variability in##8##3##(1991-12#1)(2008-10#6)(2008-8#1)
the variability of the##5##4##(1990-11#2)(2008-10#1)(2008-5#1)(2008-7#1)
the variability of##15##3##(1990-11#2)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)
the variability##40##2##(1990-11#2)(1991-12#1)(2008-10#28)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#2)
the variable region##4##3##(2008-10#3)(2008-11#1)
the variable##18##2##(1992-6#1)(1995-12#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
the variables affecting the##2##4##(2008-10#2)
the variables affecting##3##3##(2008-10#3)
the variables considered##2##3##(2008-10#1)(2012-12#1)
the variables have been##3##4##(2008-10#3)
the variables studied were##2##4##(2008-10#1)(2008-11#1)
the variables to be optimized and##2##6##(2008-10#1)(2008-11#1)
the variables to be##3##4##(2008-10#2)(2008-11#1)
the variables were##2##3##(2008-10#1)(2011-2#1)
the variables##28##2##(1994-3#1)(2008-10#19)(2008-11#3)(2011-2#3)(2012-12#1)(2013-8#1)
the variance and##2##3##(2008-10#1)(2008-8#1)
the variance in##18##3##(1994-3#1)(1995-3#1)(2008-10#3)(2008-4#1)(2008-8#2)(2008-9#2)(2009-12#4)(2010-2#1)(2012-3#2)(2013-8#1)
the variance of the number of infected plants##2##8##(2008-10#2)
the variance of the##4##4##(2008-10#4)
the variance of##5##3##(2008-10#5)
the variance##36##2##(1993-12#1)(1994-3#1)(1995-3#1)(2008-10#14)(2008-4#1)(2008-8#3)(2008-9#4)(2009-12#4)(2010-2#1)(2010-5#1)(2012-3#3)(2013-1#1)(2013-8#1)
the variances of##2##3##(2008-10#1)(2012-3#1)
the variances##3##2##(2008-10#1)(2012-3#2)
the variant##7##2##(1990-10#1)(1990-8#2)(2008-7#1)(2008-8#1)(2011-2#2)
the variation in Bragg wavelength is 0##2##7##(2013-8#2)
the variation in the##5##4##(1995-11#1)(1995-9#1)(2008-10#3)
the variation in##31##3##(1993-3#1)(1995-11#1)(1995-9#1)(1996-12#1)(2008-10#13)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-11#1)(2010-10#1)(2012-3#1)(2013-8#2)
the variation of the##5##4##(2008-10#4)(2013-1#1)
the variation of##12##3##(1991-11#1)(2008-10#6)(2008-3#1)(2013-1#1)(2013-8#3)
the variation within##2##3##(2008-10#2)
the variation##60##2##(1991-11#1)(1993-3#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-3#1)(2008-10#33)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#6)
the variations in the##4##4##(1993-2#1)(2008-10#2)(2013-8#1)
the variations in##6##3##(1990-8#1)(1991-11#1)(1993-2#1)(2008-10#2)(2013-8#1)
the variations of##3##3##(1992-3#1)(2008-10#2)
the variations##10##2##(1990-8#1)(1991-11#1)(1992-3#1)(1993-2#1)(2008-10#4)(2008-9#1)(2013-8#1)
the varicocele##2##2##(1990-3#2)
the varied##2##2##(2008-9#1)(2010-11#1)
the varieties of##2##3##(2008-10#1)(2008-12#1)
the varieties##3##2##(2008-10#2)(2008-12#1)
the variety of##9##3##(1992-1#1)(1994-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-9#1)(2012-2#2)
the variety##13##2##(1990-6#1)(1992-1#1)(1994-8#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2010-10#1)(2010-6#1)(2010-9#1)(2012-2#2)
the various anxiety disorders##2##4##(1991-2#1)(2013-8#1)
the various biological##2##3##(2011-2#1)(2013-8#1)
the various components of the##2##5##(2008-3#1)(2008-6#1)
the various components of##4##4##(1996-3#1)(2008-3#1)(2008-6#1)(2011-2#1)
the various factors##2##3##(1992-2#1)(2012-12#1)
the various isolates##2##3##(2008-10#2)
the various levels of##2##4##(1991-11#1)(2008-10#1)
the various levels##3##3##(1991-11#1)(2008-10#1)(2012-2#1)
the various methods##3##3##(1992-9#1)(2008-11#1)(2008-5#1)
the various parameters##3##3##(2008-10#2)(2011-7#1)
the various sites##2##3##(2008-10#1)(2008-5#1)
the various stages##2##3##(1993-11#1)(2009-10#1)
the various techniques##5##3##(2008-10#2)(2008-11#2)(2009-1#1)
the various types of##4##4##(1992-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
the various##144##2##(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-12#3)(1992-2#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#43)(2008-11#8)(2008-12#2)(2008-3#4)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#4)(2009-1#2)(2009-10#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#4)
the varying##4##2##(2008-10#1)(2008-11#1)(2010-11#1)(2010-7#1)
the vas deferens##7##3##(1994-8#2)(1997-8#1)(2008-10#4)
the vas##12##2##(1994-8#7)(1997-8#1)(2008-10#4)
the vascular bundles and##2##4##(2008-10#2)
the vascular bundles##4##3##(2008-10#4)
the vascular cambium##3##3##(2008-10#3)
the vascular elements##2##3##(2008-10#2)
the vascular network of##2##4##(2008-5#1)(2011-2#1)
the vascular system of the##2##5##(2008-10#2)
the vascular system##4##3##(2008-10#4)
the vascular tissue##2##3##(2008-10#2)
the vascular tissues##6##3##(2008-10#6)
the vascular##47##2##(1991-6#2)(1992-12#2)(1992-6#1)(1996-11#1)(1997-1#3)(1997-6#1)(2008-10#25)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
the vascularized##2##2##(2008-9#1)(2009-3#1)
the vasculature##2##2##(2008-7#1)(2013-1#1)
the vasodilator##2##2##(1993-3#1)(2008-10#1)
the vasopressin##3##2##(1994-11#2)(1994-2#1)
the vast amount of##2##4##(2008-10#1)(2009-12#1)
the vast majority of##11##4##(1994-3#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)
the vast##18##2##(1994-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2009-12#1)(2009-7#1)(2012-2#1)
the vastus lateralis##4##3##(2010-4#4)
the vector and the##2##4##(1994-11#1)(2008-11#1)
the vector and##3##3##(1994-11#1)(2008-10#1)(2008-11#1)
the vector specificity##3##3##(2008-10#3)
the vector##36##2##(1991-6#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(2007-11#1)(2008-10#19)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-3#1)
the vector's##2##2##(2008-8#2)
the vectors##6##2##(1993-12#2)(2008-10#1)(2008-11#1)(2012-12#2)
the vegetation##2##2##(2008-8#2)
the vegetative##8##2##(2008-10#3)(2008-11#1)(2008-8#3)(2009-12#1)
the vehicle control##5##3##(2008-9#4)(2010-1#1)
the vehicle controls##3##3##(2008-9#3)
the vehicle##20##2##(1994-8#1)(2008-11#1)(2008-5#7)(2008-9#7)(2010-1#1)(2010-10#1)(2013-8#2)
the vehicles##4##2##(1991-3#1)(2008-5#3)
the vein##2##2##(1992-12#1)(1996-6#1)
the veins##2##2##(1995-11#1)(2008-10#1)
the velocity of the##2##4##(2008-3#1)(2008-8#1)
the velocity of##6##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)
the velocity##11##2##(1992-9#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-8#1)(2009-8#1)(2011-2#1)
the vena cava##3##3##(1992-9#1)(2010-4#2)
the venom of the##2##4##(1990-5#1)(1993-6#1)
the venom of##5##3##(1990-5#1)(1993-6#1)(1994-11#1)(1995-8#1)(2008-8#1)
the venom##11##2##(1990-5#1)(1993-3#1)(1993-6#2)(1994-11#2)(1995-8#1)(2008-7#3)(2008-8#1)
the venous system##2##3##(2011-2#2)
the venous##9##2##(1994-9#1)(1996-9#3)(2008-7#1)(2011-2#3)(2011-3#1)
the ventral forearm##2##3##(2008-5#2)
the ventral nerve cord##2##4##(1997-7#1)(2008-5#1)
the ventral side of the##3##5##(2007-12#1)(2008-5#2)
the ventral striatum##5##3##(1993-6#5)
the ventral tegmental area (VTA) and##2##6##(1996-5#1)(2009-8#1)
the ventral tegmental area (VTA)##4##5##(1996-12#1)(1996-5#1)(2008-7#1)(2009-8#1)
the ventral tegmental area##7##4##(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(2008-7#1)(2009-8#1)
the ventral##37##2##(1993-6#6)(1996-12#4)(1996-5#1)(1997-2#1)(1997-3#3)(1997-7#1)(2007-12#2)(2008-10#1)(2008-5#8)(2008-7#1)(2008-9#2)(2009-8#2)(2011-2#3)(2012-3#1)(2013-8#1)
the ventricles##2##2##(2008-6#1)(2013-1#1)
the ventricular rate##2##3##(2010-12#2)
the ventricular##8##2##(1990-9#1)(1991-12#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2010-12#2)
the ventromedial prefrontal cortex##2##4##(2008-11#2)
the ventromedial##6##2##(1994-2#3)(2008-11#2)(2008-4#1)
the vernalization##2##2##(2009-8#1)(2012-3#1)
the versatility of##5##3##(2008-10#5)
the versatility##6##2##(2008-10#6)
the versican proteoglycan##2##3##(2008-11#2)
the vertebrae##4##2##(1991-11#1)(2007-11#2)(2008-7#1)
the vertebral artery##7##3##(1991-8#1)(1993-3#2)(2008-12#1)(2008-7#2)(2012-12#1)
the vertebral bodies##2##3##(1997-3#1)(2008-7#1)
the vertebral column##3##3##(2011-2#2)(2013-1#1)
the vertebral venous plexus##2##4##(2011-2#2)
the vertebral venous plexuses##2##4##(2011-2#2)
the vertebral venous##4##3##(2011-2#4)
the vertebral##22##2##(1991-11#1)(1991-8#2)(1993-3#2)(1997-3#1)(2007-11#1)(2007-8#1)(2008-12#2)(2008-7#4)(2011-2#6)(2012-12#1)(2013-1#1)
the vertebrate##8##2##(1990-5#1)(1993-3#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)
the vertebrobasilar artery##3##3##(1997-3#1)(2008-7#1)(2012-3#1)
the vertex##4##2##(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
the vertical and##2##3##(1992-2#1)(1997-6#1)
the vertical distribution of##2##4##(2008-11#1)(2008-3#1)
the vertical lobe##2##3##(2008-7#1)(2009-8#1)
the vertical profiles of##2##4##(2008-11#1)(2008-3#1)
the vertical##21##2##(1991-3#1)(1991-5#1)(1992-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)
the very early##2##3##(2008-10#1)(2009-7#1)
the very high##4##3##(1991-12#1)(1997-7#1)(2008-10#2)
the very low density lipoprotein##2##5##(1995-6#2)
the very low##7##3##(1990-6#1)(1992-10#1)(1995-6#2)(1997-2#1)(2008-10#2)
the very##34##2##(1990-6#1)(1991-12#2)(1992-10#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-9#1)(1995-6#2)(1997-2#2)(1997-7#1)(2008-10#10)(2008-7#2)(2008-9#2)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
the vesicle##2##2##(1991-10#1)(2008-11#1)
the vesicles##7##2##(1991-5#1)(1992-12#1)(2008-10#2)(2008-5#2)(2008-8#1)
the vesicular##5##2##(1991-10#1)(2008-11#1)(2008-5#1)(2009-8#2)
the vessel and##2##3##(1993-8#1)(2012-3#1)
the vessel wall##3##3##(1996-2#1)(2008-6#1)(2008-7#1)
the vessel##16##2##(1990-8#1)(1991-8#1)(1993-8#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-4#1)(2012-3#1)
the vessels##3##2##(2008-10#2)(2011-2#1)
the vestibular system##2##3##(1995-8#2)
the vestibular##4##2##(1991-2#1)(1995-8#2)(2011-2#1)
the viability and##4##3##(1990-6#1)(1992-2#1)(2008-10#1)(2008-7#1)
the viability of human##3##4##(2008-7#2)(2013-1#1)
the viability of sclerotia##3##4##(2008-10#3)
the viability of sporangia##2##4##(2008-10#2)
the viability of the cultures##2##5##(2008-11#2)
the viability of the method##3##5##(2008-10#3)
the viability of the##10##4##(1992-1#1)(1992-5#1)(1996-12#1)(2008-10#3)(2008-11#3)(2011-2#1)
the viability of using eSRT##2##5##(2008-9#2)
the viability of##26##3##(1992-1#1)(1992-5#1)(1995-12#1)(1996-12#1)(2008-10#10)(2008-11#5)(2008-7#2)(2008-9#2)(2009-12#1)(2011-2#1)(2013-1#1)
the viability was##2##3##(2008-11#2)
the viability##37##2##(1990-6#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#11)(2008-11#9)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2013-1#1)
the viable cell##5##3##(2008-11#5)
the viable##9##2##(2008-11#7)(2012-2#1)(2012-3#1)
the vibration##2##2##(2008-3#2)
the vibrational##3##2##(1990-8#1)(2008-8#1)(2010-7#1)
the vicinity of the##13##4##(1990-11#1)(1990-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-7#1)(2009-12#1)(2009-7#1)
the vicinity of##25##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-2#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-7#1)
the vicinity##27##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-11#2)(1996-2#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-7#1)
the victim##5##2##(1992-5#1)(1995-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
the victims of a mass disaster##2##6##(1995-11#2)
the victims of##4##3##(1995-11#2)(2011-2#1)(2012-12#1)
the victims##6##2##(1991-2#1)(1995-11#2)(1996-11#1)(2011-2#1)(2012-12#1)
the video##5##2##(1992-12#1)(1995-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
the videotape##2##2##(1995-12#2)
the videotapes##2##2##(1993-2#2)
the view of##4##3##(2008-11#1)(2009-7#1)(2012-3#1)(2013-8#1)
the view that the##2##4##(1990-5#1)(1997-9#1)
the view that##13##3##(1990-5#1)(1993-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-7#1)(2013-8#1)
the view to##2##3##(2008-10#1)(2011-2#1)
the view##20##2##(1990-5#1)(1993-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
the viewer##2##2##(2008-11#1)(2008-3#1)
the viewpoint##10##2##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-8#1)(2008-9#1)(2012-12#1)
the views and##2##3##(2008-11#1)(2010-10#1)
the views of##3##3##(1991-1#1)(2008-11#1)(2008-12#1)
the views##5##2##(1991-1#1)(2008-11#2)(2008-12#1)(2010-10#1)
the village of##2##3##(2008-10#1)(2012-12#1)
the vinegar##2##2##(2008-10#1)(2008-5#1)
the vines##2##2##(2008-10#2)
the vinyl group##2##3##(2008-10#2)
the vinyl##3##2##(2008-10#3)
the violation of##2##3##(2013-8#2)
the viral G protein##2##4##(1993-6#2)
the viral capsid protein##2##4##(2008-10#1)(2009-8#1)
the viral capsid##4##3##(1995-2#2)(2008-10#1)(2009-8#1)
the viral coat protein##3##4##(2008-10#2)(2008-8#1)
the viral genome##4##3##(1994-11#1)(2008-10#2)(2008-11#1)
the viral life cycle##2##4##(1995-2#1)(2010-1#1)
the viral replication##2##3##(2008-10#2)
the viral##64##2##(1992-2#1)(1992-6#1)(1993-6#2)(1994-11#2)(1994-12#1)(1995-2#7)(1997-3#1)(2008-10#31)(2008-11#2)(2008-8#3)(2008-9#2)(2009-8#2)(2010-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
the virga##3##2##(2008-6#3)
the virion##2##2##(1993-12#1)(2008-10#1)
the virtual##3##2##(2008-3#1)(2012-3#1)(2013-8#1)
the virulence and##2##3##(2008-10#2)
the virulence of a##2##4##(1996-12#1)(2008-10#1)
the virulence of the##3##4##(2008-10#2)(2008-7#1)
the virulence of##13##3##(1996-12#2)(2008-10#8)(2008-7#1)(2009-6#1)(2013-1#1)
the virulence or avirulence genes##2##5##(2008-10#2)
the virulence or##3##3##(2008-10#3)
the virulence spectrum##2##3##(2008-10#2)
the virulence##31##2##(1996-12#2)(2008-10#23)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
the virulent genotype##2##3##(2008-10#2)
the virulent isolates##3##3##(2008-10#3)
the virulent##13##2##(2008-10#11)(2008-8#1)(2008-9#1)
the virus (strain) with the##2##5##(2008-10#2)
the virus as##3##3##(1990-2#1)(2008-10#1)(2008-11#1)
the virus by##4##3##(2008-10#4)
the virus from##5##3##(1990-11#1)(2008-10#4)
the virus genome##2##3##(2008-10#2)
the virus in a##2##4##(2008-10#2)
the virus in##10##3##(2008-10#9)(2012-3#1)
the virus is##4##3##(1993-11#1)(2008-10#2)(2011-3#1)
the virus moved to##2##4##(2008-10#2)
the virus per plant visit##2##5##(2008-10#2)
the virus population##2##3##(2008-10#2)
the virus to##3##3##(2008-10#2)(2011-3#1)
the virus was##9##3##(2008-10#9)
the virus##130##2##(1990-11#1)(1990-2#2)(1993-11#1)(1993-3#2)(1993-8#1)(1995-12#1)(1996-11#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-5#1)(2008-1#1)(2008-10#89)(2008-11#6)(2008-12#1)(2008-5#5)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2011-3#3)(2012-3#1)(2013-1#4)(2013-8#1)
the viruses were##2##3##(2008-10#1)(2011-2#1)
the viruses##14##2##(1995-5#1)(2008-10#10)(2011-2#2)(2012-2#1)
the viscoelastic##2##2##(2009-7#1)(2012-2#1)
the viscoelasticity##2##2##(2008-10#2)
the viscosity and##2##3##(2008-10#1)(2008-5#1)
the viscosity of the##5##4##(2008-10#4)(2013-1#1)
the viscosity of##8##3##(1994-11#3)(2008-10#4)(2013-1#1)
the viscosity##14##2##(1994-11#3)(2008-10#8)(2008-5#2)(2013-1#1)
the visibility depth##2##3##(2008-3#2)
the visibility##3##2##(2008-3#2)(2010-7#1)
the visible absorption##2##3##(1992-1#1)(2008-10#1)
the visible region##7##3##(2008-10#5)(2008-2#1)(2008-3#1)
the visible spectrum of##2##4##(2008-10#2)
the visible spectrum##5##3##(2008-10#3)(2008-3#2)
the visible##29##2##(1992-1#1)(1994-5#1)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#10)(2009-12#1)
the vision for the##2##4##(1994-3#1)(2008-6#1)
the vision into##2##3##(1992-12#1)(2008-12#1)
the vision##9##2##(1992-12#1)(1994-3#1)(2008-12#4)(2008-6#1)(2010-8#1)(2011-2#1)
the visit##3##2##(1992-2#1)(1996-1#1)(2012-3#1)
the visual and##4##3##(2008-10#1)(2008-7#1)(2009-10#1)(2013-8#1)
the visual cortex##6##3##(1990-8#2)(1996-2#1)(2008-11#1)(2011-2#2)
the visual field##4##3##(2008-9#1)(2011-2#2)(2012-3#1)
the visual input##7##3##(1991-2#7)
the visual learning##2##3##(2008-8#2)
the visual system##9##3##(1995-5#3)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#2)
the visual##51##2##(1990-8#2)(1991-2#8)(1992-12#1)(1995-5#3)(1995-8#1)(1996-2#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#2)(2010-9#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#4)
the visualisation##2##2##(2008-10#1)(2012-2#1)
the visualization of##2##3##(1997-8#1)(2008-10#1)
the visualization##5##2##(1997-8#1)(2008-10#1)(2008-6#2)(2012-3#1)
the visually##2##2##(2008-2#1)(2008-7#1)
the vital records database##2##4##(2012-12#2)
the vital##13##2##(1993-12#1)(1994-2#2)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#2)(2012-3#1)
the vitality of the##2##4##(1990-3#1)(2008-11#1)
the vitality##4##2##(1990-3#1)(2008-1#1)(2008-11#1)(2011-2#1)
the vitamin C##2##3##(2008-10#2)
the vitamin D analogue##2##4##(1993-11#2)
the vitamin D receptor (VDR)##2##5##(1995-2#1)(2012-12#1)
the vitamin D receptor##3##4##(1995-2#2)(2012-12#1)
the vitamin D##8##3##(1992-1#1)(1993-11#2)(1995-2#2)(2008-1#1)(2011-1#1)(2012-12#1)
the vitamin##15##2##(1991-12#1)(1992-1#1)(1992-9#1)(1993-11#2)(1994-6#1)(1995-2#2)(2008-1#1)(2008-10#3)(2011-1#1)(2012-12#1)(2013-1#1)
the vitamins##3##2##(1997-8#1)(2008-10#1)(2008-5#1)
the vitelline envelope##2##3##(1994-5#1)(2008-12#1)
the vitelline##4##2##(1994-5#1)(2008-10#1)(2008-12#1)(2008-6#1)
the vitiligo-like depigmentation##2##3##(2010-6#2)
the vitreous and##2##3##(2008-1#1)(2011-2#1)
the vocabulary intervention##2##3##(2011-2#2)
the vocabulary##4##2##(2008-9#1)(2011-2#3)
the vocal pattern##2##3##(2008-8#2)
the vocal##3##2##(2008-11#1)(2008-8#2)
the voice##5##2##(2008-2#1)(2008-9#2)(2010-8#1)(2011-1#1)
the void space##2##3##(2008-11#1)(2008-7#1)
the void##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
the volar##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
the volatile compounds##3##3##(2008-10#3)
the volatile profiles of##2##4##(2011-10#2)
the volatile##14##2##(1997-4#1)(2008-10#9)(2008-11#1)(2009-8#1)(2011-10#2)
the volatiles##2##2##(2008-10#2)
the volatility of##2##3##(1991-12#1)(2008-10#1)
the voltage##2##2##(2008-10#1)(2008-11#1)
the voltammetric behavior of##3##4##(2008-10#3)
the voltammetric behavior##4##3##(2008-10#4)
the voltammetric behaviour of##2##4##(2008-10#2)
the voltammetric behaviour##3##3##(2008-10#3)
the voltammetric data##2##3##(2008-10#2)
the voltammetric determination of##4##4##(2008-10#4)
the voltammetric method##2##3##(2008-10#2)
the voltammetric peak##2##3##(2008-10#2)
the voltammetric response##4##3##(2008-10#4)
the voltammetric##33##2##(2008-10#33)
the voltammograms##3##2##(2008-10#3)
the volume flow##2##3##(2008-11#2)
the volume fraction##2##3##(2008-11#2)
the volume of ejaculate##2##4##(1997-8#2)
the volume of the##7##4##(1990-11#1)(1990-12#1)(1995-12#1)(2008-10#4)
the volume of##31##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#2)(1997-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#2)
the volume ratio##2##3##(2008-10#2)
the volume regulation of human##2##5##(1990-2#2)
the volume##53##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#2)(1997-8#2)(2007-11#1)(2008-10#17)(2008-11#6)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#2)
the volumes of##2##3##(2008-10#1)(2008-3#1)
the volumes##4##2##(2008-10#1)(2008-3#1)(2009-11#1)(2009-2#1)
the volumetric productivity##2##3##(2008-11#2)
the volumetric titration##2##3##(2008-10#2)
the volumetric##11##2##(2008-10#5)(2008-11#5)(2011-1#1)
the voluminous##2##2##(2008-11#1)(2008-12#1)
the voluntary##4##2##(1990-12#1)(1994-2#1)(1996-2#1)(1996-9#1)
the volunteer experience##2##3##(1992-3#1)(1994-3#1)
the volunteer##14##2##(1991-1#1)(1991-2#3)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#2)(1996-3#1)(2008-12#1)(2008-5#1)
the volunteers##2##2##(2008-10#1)(2008-5#1)
the von##2##2##(2008-12#1)(2008-3#1)
the vulnerability of the##2##4##(1995-11#1)(2013-7#1)
the vulnerability of##3##3##(1990-5#1)(1995-11#1)(2013-7#1)
the vulnerability to##2##3##(2008-10#1)(2013-7#1)
the vulnerability##6##2##(1990-5#1)(1995-11#1)(2008-10#1)(2009-4#1)(2013-7#2)
the vulnerable##5##2##(1996-12#1)(2008-8#1)(2012-2#3)
the vulva##7##2##(1992-3#4)(1994-1#1)(1997-7#1)(2008-10#1)
the w##3##2##(1991-5#3)
the wafer##2##2##(1992-6#2)
the waiting list##3##3##(1991-11#1)(1993-2#1)(2011-3#1)
the waiting time##3##3##(1991-11#2)(2012-2#1)
the waiting##10##2##(1991-11#5)(1993-2#1)(1996-2#1)(2008-9#1)(2011-3#1)(2012-2#1)
the waiver##11##2##(1991-1#1)(1992-2#4)(1993-1#1)(1993-9#1)(1996-12#1)(1997-2#3)
the wall of the##5##4##(1990-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
the wall of##6##3##(1990-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)
the wall shear##2##3##(2008-11#2)
the wall##19##2##(1990-11#1)(1990-9#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-7#1)(2011-2#1)(2012-2#1)
the walls of all##2##4##(2007-12#2)
the walls of the##5##4##(2008-10#3)(2008-11#1)(2008-9#1)
the walls of##12##3##(2007-12#2)(2008-10#8)(2008-11#1)(2008-9#1)
the walls##15##2##(2007-12#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#2)
the war##3##2##(2008-10#2)(2008-6#1)
the ward and##2##3##(2008-11#2)
the ward##4##2##(2008-11#2)(2010-8#2)
the wards##4##2##(2013-1#4)
the warm##2##2##(2008-10#1)(2008-9#1)
the warning##3##2##(1995-5#1)(2012-3#1)(2013-8#1)
the washed water##2##3##(2008-10#2)
the washing of##2##3##(1993-3#1)(2008-7#1)
the washing##3##2##(1993-3#1)(1997-2#1)(2008-7#1)
the waste##4##2##(1997-2#1)(2008-10#2)(2008-12#1)
the wastewater##4##2##(2008-10#4)
the water activity##2##3##(2008-7#2)
the water content in the##3##5##(2008-10#2)(2008-5#1)
the water content is##2##4##(2008-10#2)
the water content##12##3##(2008-10#11)(2008-5#1)
the water extracts of propolis##2##5##(2008-11#2)
the water fraction##2##3##(2008-10#2)
the water quality of##2##4##(2008-10#2)
the water quality##3##3##(2008-10#2)(2013-1#1)
the water sample and##2##4##(2008-10#2)
the water sample##5##3##(2008-10#5)
the water samples##6##3##(2008-10#6)
the water surface tension (gamma(H(2)O))##2##5##(2008-5#2)
the water surface##4##3##(1990-11#1)(2008-10#1)(2008-5#2)
the water##88##2##(1990-11#1)(1990-9#1)(1991-5#4)(1992-9#1)(1993-2#1)(1994-3#1)(1996-6#1)(1997-2#1)(2008-10#44)(2008-11#7)(2008-2#2)(2008-3#6)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2011-2#2)(2012-2#1)(2012-5#1)(2012-9#1)(2013-1#1)
the water-miscible##2##2##(2008-10#2)
the water-soluble fraction##4##3##(2008-11#4)
the water-soluble##6##2##(2008-10#1)(2008-11#4)(2008-5#1)
the water-vapor mixing ratio##3##4##(2008-3#3)
the water-vapor##4##2##(2008-3#4)
the wave##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
the wave-front##2##2##(2008-3#2)
the waveform##2##2##(1994-2#1)(2008-10#1)
the waveguide surface##3##3##(2008-10#3)
the waveguide##11##2##(1992-3#1)(2007-12#1)(2008-10#5)(2008-3#4)
the wavelength and##2##3##(2008-3#2)
the wavelength of the##2##4##(2008-10#1)(2008-3#1)
the wavelength of##8##3##(2008-10#6)(2008-11#1)(2008-3#1)
the wavelength range##5##3##(2008-10#3)(2008-3#2)
the wavelength##33##2##(2007-11#1)(2008-10#15)(2008-11#1)(2008-3#16)
the wavelength-dependent##3##2##(2008-2#1)(2008-3#2)
the wavelengths##5##2##(1990-2#1)(2008-10#2)(2008-2#1)(2012-2#1)
the wavelet##3##2##(2008-10#3)
the wavenumber##2##2##(2008-10#2)
the wax matrix in##2##4##(2008-5#2)
the wax matrix was##3##4##(2008-5#3)
the wax matrix##9##3##(2008-5#9)
the way for##8##3##(1992-1#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-8#2)(2011-1#1)(2011-2#1)
the way in which the##5##5##(1992-1#1)(1993-8#1)(1997-7#1)(2008-11#2)
the way in which they##2##5##(1997-4#1)(2012-2#1)
the way in which##12##4##(1992-1#1)(1993-2#1)(1993-8#1)(1997-4#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-8#1)(2012-2#2)
the way in##13##3##(1992-1#1)(1993-2#1)(1993-8#1)(1997-4#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-8#1)(2009-3#1)(2012-2#2)
the way it is##2##4##(1992-3#1)(2009-10#1)
the way it##3##3##(1992-12#1)(1992-3#1)(2009-10#1)
the way of##7##3##(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-7#1)(2010-5#1)
the way the##4##3##(2008-11#2)(2008-3#1)(2010-11#1)
the way they##4##3##(2008-12#1)(2008-8#1)(2009-7#1)(2013-8#1)
the way to##6##3##(1990-6#1)(1991-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
the way toward##2##3##(1992-12#1)(2008-8#1)
the way we##5##3##(2008-12#1)(2009-8#1)(2011-2#2)(2013-7#1)
the ways in which##9##4##(1992-12#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
the ways##11##2##(1992-12#1)(1995-3#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
the weak RLS of##2##4##(2008-10#2)
the weak##20##2##(1992-6#1)(1995-12#1)(1997-7#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
the weakened##2##2##(1995-9#1)(2008-10#1)
the weaker##3##2##(2012-12#1)(2012-3#2)
the weakest##4##2##(2008-5#1)(2008-7#1)(2012-3#2)
the weakly emetic strain IH41385##2##5##(2011-2#2)
the weakly##6##2##(2008-10#3)(2008-11#1)(2011-2#2)
the weaknesses of##3##3##(1997-3#1)(2011-1#1)(2011-2#1)
the wealth of##2##3##(1993-1#1)(2011-10#1)
the weed##3##2##(2008-10#3)
the week of##3##3##(1995-6#2)(1996-5#1)
the week##5##2##(1995-6#2)(1996-5#1)(1996-8#1)(2013-8#1)
the weekend##3##2##(1994-3#3)
the weekly##3##2##(2008-11#1)(2013-1#2)
the weevil##3##2##(2008-10#3)
the weight and##2##3##(1996-8#1)(2012-3#1)
the weight concentration##2##3##(1996-3#2)
the weight of a##2##4##(1996-8#2)
the weight of the##6##4##(2008-10#2)(2008-11#1)(2009-1#1)(2012-12#1)(2013-1#1)
the weight of##13##3##(1996-8#2)(2008-10#4)(2008-11#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
the weight##22##2##(1991-2#1)(1996-3#2)(1996-8#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
the weighted mean of##2##4##(2008-10#2)
the weighted##5##2##(1992-12#1)(2008-10#3)(2008-9#1)
the weights##3##2##(1992-12#1)(1993-1#1)(1996-12#1)
the well documented##2##3##(1992-12#1)(1995-12#1)
the well known##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
the well##16##2##(1990-2#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(2008-10#2)(2008-11#6)(2008-5#1)(2010-12#1)(2012-2#1)
the well-being of##5##3##(1992-3#2)(1995-12#1)(2010-11#1)(2010-5#1)
the well-established##3##2##(2008-10#3)
the well-known endemic##2##3##(1996-11#2)
the well-known##20##2##(1994-2#1)(1994-6#1)(1995-12#1)(1996-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2013-1#1)
the west of##4##3##(1996-11#1)(2008-10#1)(2012-12#1)(2013-8#1)
the west##8##2##(1995-10#1)(1996-11#1)(1997-3#1)(2008-10#2)(2010-8#1)(2012-12#1)(2013-8#1)
the western flower thrips (Frankliniella occidentalis)##2##6##(2008-10#1)(2009-8#1)
the western flower thrips##3##4##(2008-10#2)(2009-8#1)
the western##15##2##(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-9#1)(2009-8#1)(2013-1#1)
the wet period##2##3##(2008-10#2)
the wet##6##2##(2008-10#5)(2010-8#1)
the wetting##6##2##(2008-10#3)(2008-5#1)(2009-11#1)(2012-2#1)
the wheat cv##2##3##(2008-10#2)
the wheat germ##2##3##(2008-10#2)
the wheat leaf##2##3##(2008-10#2)
the wheat rhizosphere##5##3##(2008-10#5)
the wheat##25##2##(1991-12#1)(2008-10#21)(2008-11#1)(2008-12#1)(2013-7#1)
the wheelchair##4##2##(2009-3#1)(2013-1#3)
the white cloud mountain minnow##2##5##(2010-5#2)
the white matter##6##3##(1996-11#2)(2008-11#1)(2010-12#3)
the white pine blister rust##3##5##(2008-10#3)
the white pine##4##3##(2008-10#4)
the white rot##2##3##(2008-6#1)(2009-9#1)
the white##21##2##(1996-11#2)(1997-5#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#3)(2010-5#2)(2012-12#1)
the whitefly Bemisia tabaci##2##4##(2008-10#2)
the whitefly##5##2##(2008-10#5)
the whitening##2##2##(2008-5#1)(2011-2#1)
the whole analysis##2##3##(2008-10#2)
the whole analytical procedure##3##4##(2008-10#3)
the whole analytical##4##3##(2008-10#4)
the whole blood##3##3##(2008-10#2)(2011-2#1)
the whole body##4##3##(1992-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
the whole coding##2##3##(1997-4#1)(2008-8#1)
the whole country##3##3##(1992-2#2)(2008-10#1)
the whole family##2##3##(1997-4#1)(2008-10#1)
the whole field##2##3##(2008-3#1)(2011-2#1)
the whole genome##3##3##(2008-7#2)(2012-3#1)
the whole group##2##3##(1993-12#2)
the whole method##3##3##(2008-10#2)(2008-11#1)
the whole organism##2##3##(2008-7#1)(2010-9#1)
the whole plant##2##3##(2008-10#2)
the whole population##4##3##(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
the whole procedure##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
the whole process of##4##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
the whole processes##2##3##(1994-3#1)(2008-11#1)
the whole set of##3##4##(2008-10#2)(2008-3#1)
the whole working##2##3##(2008-10#1)(2013-8#1)
the whole##140##2##(1990-5#2)(1991-8#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#3)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2008-10#54)(2008-11#7)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#5)(2008-8#7)(2008-9#3)(2009-10#2)(2010-10#1)(2010-12#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#5)
the whole-cell##3##2##(1993-3#1)(1997-8#1)(2011-3#1)
the wide &quot##2##3##(1993-3#2)
the wide pH range##3##4##(2008-10#3)
the wide range of##4##4##(1997-7#1)(2008-10#3)
the wide range##7##3##(1997-7#1)(2008-10#6)
the wide variety of##3##4##(2008-11#1)(2008-9#1)(2012-2#1)
the wide##27##2##(1991-2#1)(1991-3#1)(1993-3#2)(1994-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2012-2#1)
the wide-angle airborne laser ranging system##2##6##(2008-3#2)
the wide-spread##2##2##(1992-6#1)(2013-8#1)
the widely used##9##3##(1994-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)
the widely##15##2##(1994-1#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#1)
the wider church##2##3##(2010-2#2)
the wider impacts of##2##4##(2011-1#2)
the wider##15##2##(1994-8#1)(1995-5#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
the widespread occurrence##2##3##(2008-10#1)(2008-9#1)
the widespread use of##3##4##(1993-12#1)(1997-8#1)(2008-7#1)
the widespread use##4##3##(1993-12#1)(1997-8#1)(2008-7#1)(2012-12#1)
the widespread##15##2##(1993-12#1)(1993-3#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-7#3)(2008-8#1)(2008-9#1)(2012-12#1)
the widest##4##2##(1995-5#1)(2008-10#2)(2009-11#1)
the width of the 95%##2##5##(2008-10#2)
the width of the##7##4##(1993-12#1)(1997-3#1)(2008-10#3)(2008-3#1)(2011-2#1)
the width of##10##3##(1993-12#1)(1994-9#1)(1997-3#1)(2008-10#4)(2008-3#1)(2011-2#1)(2013-1#1)
the width##14##2##(1993-12#1)(1994-9#1)(1997-3#1)(2008-10#5)(2008-3#2)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
the wild cell##2##3##(2008-8#2)
the wild type and the##2##5##(2008-10#1)(2008-8#1)
the wild type and##5##4##(2008-10#2)(2008-11#1)(2008-8#2)
the wild type in##2##4##(2008-10#2)
the wild type protein##2##4##(2008-11#2)
the wild type strain IRC-3##2##5##(2008-8#2)
the wild type strain##3##4##(2008-8#2)(2008-9#1)
the wild type under##2##4##(2008-10#1)(2010-10#1)
the wild type was##3##4##(1990-5#1)(2008-10#2)
the wild type##39##3##(1990-5#1)(1992-6#1)(1993-3#3)(1993-8#1)(1997-7#1)(1997-8#2)(2008-10#17)(2008-11#3)(2008-8#6)(2008-9#1)(2009-6#1)(2010-10#1)(2013-8#1)
the wild##53##2##(1990-5#1)(1992-6#1)(1993-3#3)(1993-8#1)(1997-7#1)(1997-8#2)(2008-10#24)(2008-11#3)(2008-8#8)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#3)(2010-5#1)(2012-3#1)(2013-8#1)
the wild-type A##2##3##(2008-10#2)
the wild-type Kulm##2##3##(2008-10#2)
the wild-type LCAT##2##3##(1993-8#2)
the wild-type and mutant##2##4##(2008-10#2)
the wild-type and##5##3##(1997-3#1)(2008-10#2)(2008-8#2)
the wild-type enzyme##15##3##(1990-10#4)(1991-5#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-6#6)
the wild-type isolate##4##3##(2008-10#4)
the wild-type level##3##3##(1995-2#2)(2009-6#1)
the wild-type protein##3##3##(1994-5#1)(2011-1#1)(2011-2#1)
the wild-type strain on soybean and##2##6##(2008-10#2)
the wild-type strain on##3##4##(2008-10#3)
the wild-type strain##18##3##(2008-10#16)(2008-7#1)(2009-6#1)
the wild-type strains##2##3##(2008-10#2)
the wild-type virus##3##3##(2008-10#3)
the wild-type##79##2##(1990-10#4)(1991-10#1)(1991-12#3)(1991-5#2)(1991-6#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-8#3)(1994-5#2)(1995-12#1)(1995-2#3)(1995-6#6)(1996-12#1)(1997-3#1)(2008-10#36)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#2)(2011-1#1)(2011-2#1)
the will to##2##3##(2008-11#1)(2008-4#1)
the will##3##2##(2008-11#1)(2008-4#1)(2009-11#1)
the wilt##2##2##(2008-10#2)
the wind##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
the window of##2##3##(2008-10#2)
the window##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
the wine samples##2##3##(2008-10#2)
the wine##9##2##(2008-10#9)
the winter and spring##2##4##(2008-10#1)(2008-11#1)
the winter and##3##3##(2008-10#2)(2008-11#1)
the winter of##3##3##(2008-2#1)(2008-5#1)(2010-8#1)
the winter##20##2##(1991-8#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#4)(2009-11#1)(2010-8#3)(2011-1#1)
the winters##2##2##(2008-9#1)(2010-8#1)
the wireless##4##2##(2010-2#1)(2010-8#3)
the wishes of the patient##2##5##(1990-11#1)(1991-2#1)
the withdrawal of##4##3##(1996-2#2)(2008-11#1)(2008-5#1)
the within day##2##3##(2008-10#1)(2010-12#1)
the woman##4##2##(1995-1#1)(1995-8#1)(1996-11#1)(2013-1#1)
the women were##3##3##(1996-6#1)(2008-1#1)(2008-11#1)
the women##21##2##(1990-8#2)(1994-2#1)(1995-8#1)(1996-1#2)(1996-6#2)(1997-2#1)(2008-1#2)(2008-11#3)(2008-12#1)(2009-11#1)(2009-4#2)(2010-3#1)(2011-1#2)
the women's experience of##2##4##(1996-1#1)(2008-1#1)
the women's##6##2##(1994-3#2)(1995-8#1)(1996-1#2)(2008-1#1)
the wood##7##2##(2008-10#1)(2009-8#2)(2013-8#4)
the wooden##2##2##(2008-10#1)(2013-1#1)
the wool##3##2##(2008-10#3)
the word##12##2##(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-5#2)(2008-4#1)(2008-5#2)(2009-12#1)(2013-8#2)
the work environment and##2##4##(2012-12#2)
the work force by the##2##5##(1997-2#2)
the work force##3##3##(1995-2#1)(1997-2#2)
the work of the##5##4##(1997-3#1)(2008-10#1)(2008-11#3)
the work of##24##3##(1991-6#1)(1996-1#3)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#5)(2008-12#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2012-2#3)(2012-3#1)(2013-1#3)
the work place##3##3##(1993-12#1)(1995-2#1)(2009-12#1)
the work related##2##3##(2008-11#1)(2008-12#1)
the work shows##2##3##(2008-10#1)(2008-5#1)
the work was##2##3##(2008-10#1)(2008-9#1)
the work##58##2##(1991-12#2)(1991-6#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-1#3)(1996-3#1)(1997-2#3)(1997-3#1)(1997-8#1)(2008-10#7)(2008-11#7)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)
the work-up##2##2##(2011-2#1)(2013-1#1)
the workers##4##2##(1996-3#2)(2009-12#1)(2013-1#1)
the workers'##2##2##(2008-10#1)(2008-8#1)
the workforce##8##2##(2008-12#1)(2012-12#6)(2012-2#1)
the working alliance##2##3##(2008-4#2)
the working calibration curve##2##4##(2008-10#2)
the working calibration##4##3##(2008-10#4)
the working electrode and the##2##5##(2008-10#2)
the working electrode in the##2##5##(2008-10#2)
the working electrode is##2##4##(2008-10#2)
the working electrode surface##2##4##(2008-10#2)
the working electrode##21##3##(2008-10#21)
the working electrodes##2##3##(2008-10#2)
the working potentials##2##3##(2008-10#2)
the working range of##3##4##(2008-10#3)
the working range##7##3##(2008-10#7)
the working##56##2##(1991-3#1)(1993-2#1)(1995-2#1)(2008-10#43)(2008-11#3)(2008-4#2)(2008-9#1)(2010-9#2)(2011-2#1)(2012-3#1)
the workplace and##2##3##(2008-11#1)(2012-12#1)
the workplace setting##2##3##(2008-11#1)(2008-12#1)
the workplace##26##2##(1991-12#2)(1992-2#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-6#1)(2008-9#3)(2012-12#1)(2012-3#1)
the workshop model##2##3##(1992-5#2)
the workshop on##4##3##(1992-1#1)(2008-10#3)
the workshop##15##2##(1992-1#1)(1992-12#1)(1992-5#3)(1996-2#1)(2008-10#4)(2008-11#2)(2012-2#1)(2013-8#2)
the workshops##7##2##(2008-12#6)(2011-2#1)
the world and##5##3##(2008-10#1)(2008-11#1)(2010-10#1)(2010-5#1)(2012-2#1)
the world are##2##3##(2008-11#1)(2013-1#1)
the world by the year##2##5##(1994-9#2)
the world fleet##2##3##(2008-11#2)
the world in which##2##4##(2008-11#1)(2011-2#1)
the world in##3##3##(2008-11#2)(2011-2#1)
the world is##2##3##(2009-10#1)(2011-2#1)
the world of##10##3##(1993-1#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2010-8#1)(2013-8#1)
the world over##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
the world##147##2##(1990-11#1)(1990-2#2)(1991-6#1)(1992-5#1)(1993-1#1)(1994-1#2)(1994-2#1)(1994-9#6)(1995-3#1)(1995-5#1)(1996-1#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(2008-1#3)(2008-10#34)(2008-11#15)(2008-12#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#6)(2013-8#3)
the world's most##2##3##(2008-10#1)(2008-12#1)
the world's##10##2##(1990-2#1)(1993-3#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-6#1)(2012-12#1)
the world)##3##2##(1990-6#1)(2011-3#2)
the worldwide##4##2##(2008-10#2)(2010-3#1)(2013-1#1)
the worst of times##2##4##(1991-6#1)(2008-11#1)
the worst##8##2##(1990-6#1)(1991-6#1)(1993-3#1)(1996-3#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-6#1)
the wound site##3##3##(2008-10#3)
the wound was##2##3##(1991-6#1)(2008-11#1)
the wound##17##2##(1990-2#1)(1991-3#1)(1991-6#2)(2008-10#5)(2008-11#4)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
the wounds##2##2##(2007-8#1)(2008-10#1)
the wr##2##2##(1996-12#2)
the wrist##7##2##(2008-12#1)(2008-9#4)(2011-2#1)(2012-3#1)
the writing of this##2##4##(1991-1#1)(2011-2#1)
the writing of##3##3##(1991-1#1)(2011-2#1)(2013-7#1)
the writing power##2##3##(2008-3#2)
the writing##7##2##(1991-1#1)(2008-3#2)(2010-10#2)(2011-2#1)(2013-7#1)
the written##3##2##(1993-2#1)(2008-11#1)(2009-9#1)
the wrong##3##2##(1995-6#1)(2010-11#1)(2013-8#1)
the wv##2##2##(1996-12#2)
the x-ray##4##2##(1991-6#1)(2008-3#1)(2010-1#2)
the xenografted##2##2##(2008-11#2)
the xylem vessels of##2##4##(2007-12#1)(2008-10#1)
the xylem vessels##4##3##(2007-12#2)(2008-10#2)
the xylem##13##2##(2007-12#2)(2008-10#8)(2008-11#3)
the year 2000##20##3##(1990-2#1)(1991-9#1)(1993-3#1)(1994-9#2)(1995-6#1)(1996-11#1)(1997-2#3)(1997-3#3)(1997-6#4)(2008-11#1)(2008-12#1)(2010-5#1)
the year 2005##2##3##(1996-2#1)(2008-11#1)
the year 2020##2##3##(2008-1#1)(2009-10#1)
the year and##3##3##(2008-10#2)(2008-9#1)
the year before the##2##4##(1990-12#1)(2010-12#1)
the year in##2##3##(1994-3#1)(2013-8#1)
the year of the##2##4##(2008-10#2)
the year of##5##3##(2008-10#3)(2008-12#1)(2013-8#1)
the year offollow up##2##4##(2013-8#2)
the year##82##2##(1990-12#2)(1990-2#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-6#1)(1994-9#4)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#4)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#4)(2008-3#3)(2008-5#4)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#5)
the year-end ethnic achievement gap##2##5##(2008-12#2)
the yearly##3##2##(1991-6#1)(1994-12#1)(2008-10#1)
the years to come##5##4##(1994-6#1)(1996-3#1)(1997-8#1)(2008-11#1)(2010-6#1)
the years##44##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#2)(1994-12#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-3#2)(2013-1#3)(2013-8#3)
the yeast Candida tropicalis##2##4##(1990-5#1)(1991-9#1)
the yeast Candida##5##3##(1990-5#1)(1991-9#1)(1997-2#1)(2008-10#2)
the yeast Saccharomyces cerevisiae##4##4##(1994-3#1)(1996-6#1)(1997-7#1)(2008-10#1)
the yeast cell cycle##2##4##(1991-5#1)(2010-1#1)
the yeast cell##5##3##(1991-5#1)(1993-8#1)(1994-11#1)(2008-8#1)(2010-1#1)
the yeast genome##4##3##(1993-9#1)(1996-3#1)(2008-11#1)(2012-3#1)
the yeast tubulin##2##3##(1993-8#2)
the yeast##67##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#2)(1991-9#1)(1993-12#2)(1993-8#4)(1993-9#3)(1994-11#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#3)(2008-10#16)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#2)
the yeast-phase##3##2##(2008-5#3)
the yellow-ripe##2##2##(2008-10#2)
the yet##2##2##(1995-9#1)(2011-2#1)
the yield and##2##3##(2008-10#1)(2008-11#1)
the yield components##2##3##(2008-10#1)(2008-12#1)
the yield of enzymatic hydrolysis of short cattle tendons##2##9##(2008-5#2)
the yield of recombinant protein##2##5##(1993-2#1)(2011-2#1)
the yield of the##3##4##(1994-8#1)(2008-10#1)(2009-12#1)
the yield of##16##3##(1993-2#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-4#1)
the yield strength##2##3##(2009-7#1)(2012-2#1)
the yield was##2##3##(2008-11#2)
the yield##29##2##(1993-2#1)(1994-8#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-4#1)
the yields of##4##3##(1990-8#1)(1994-1#1)(2008-10#1)(2008-12#1)
the yields##6##2##(1990-8#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-12#1)
the yolk sac##2##3##(2007-12#1)(2008-5#1)
the yolk##4##2##(2007-12#2)(2008-5#1)(2010-5#1)
the young children##2##3##(1994-12#1)(2008-9#1)
the young##19##2##(1991-11#2)(1994-12#1)(1995-3#1)(1995-8#2)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#4)(2008-8#1)(2008-9#3)(2012-2#1)(2013-7#1)
the younger##10##2##(1991-1#1)(1992-8#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#1)
the youngest leaves##2##3##(2008-10#2)
the youngest##8##2##(1996-2#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-9#1)
the zNosetrade mark##3##3##(2008-10#3)
the zebrafish##3##2##(1993-12#1)(2008-4#1)(2012-3#1)
the zenith##3##2##(2008-3#3)
the zero term##2##3##(2008-10#2)
the zero##9##2##(1991-5#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)
the zero-crossing##3##2##(2008-10#3)
the zeta potential##2##3##(2008-5#2)
the zinc extraction##3##3##(2008-10#3)
the zinc finger##2##3##(1991-10#1)(2008-8#1)
the zinc##14##2##(1991-10#1)(2008-10#9)(2008-11#2)(2008-8#1)(2009-12#1)
the zinc-finger domain##2##3##(1995-2#2)
the zircon##2##2##(2008-10#2)
the zona glomerulosa##2##3##(1990-5#1)(2008-4#1)
the zona##5##2##(1990-5#2)(2008-4#2)(2008-8#1)
the zonal##2##2##(2008-10#1)(2008-4#1)
the zone of injury##2##4##(2008-9#2)
the zone of##8##3##(1992-12#1)(2008-10#4)(2008-9#3)
the zone##13##2##(1991-3#1)(1992-12#1)(1996-2#1)(2008-10#6)(2008-9#3)(2011-2#1)
the zwitterionic##2##2##(1991-5#1)(2008-10#1)
the zymotic fluid##2##3##(2008-8#2)
the {010}##2##2##(2008-7#2)
the {110}##2##2##(2008-7#2)
the##164506##1##(1990-10#40)(1990-11#473)(1990-12#510)(1990-2#478)(1990-3#269)(1990-4#6)(1990-5#784)(1990-6#304)(1990-7#49)(1990-8#374)(1990-9#383)(1991-1#329)(1991-10#97)(1991-11#285)(1991-12#767)(1991-2#734)(1991-3#732)(1991-4#11)(1991-5#590)(1991-6#581)(1991-7#83)(1991-8#248)(1991-9#297)(1992-1#407)(1992-10#123)(1992-11#102)(1992-12#714)(1992-2#509)(1992-3#747)(1992-4#108)(1992-5#204)(1992-6#463)(1992-7#18)(1992-8#170)(1992-9#450)(1993-1#421)(1993-11#272)(1993-12#875)(1993-2#606)(1993-3#826)(1993-5#43)(1993-6#715)(1993-8#967)(1993-9#221)(1994-1#384)(1994-11#650)(1994-12#739)(1994-2#705)(1994-3#693)(1994-5#850)(1994-6#315)(1994-8#677)(1994-9#276)(1995-1#250)(1995-10#12)(1995-11#640)(1995-12#1000)(1995-2#1041)(1995-3#422)(1995-5#388)(1995-6#1006)(1995-8#566)(1995-9#230)(1996-1#419)(1996-10#1)(1996-11#269)(1996-12#1109)(1996-2#1075)(1996-3#782)(1996-5#586)(1996-6#452)(1996-8#185)(1996-9#224)(1997-1#651)(1997-2#1055)(1997-3#955)(1997-4#324)(1997-5#234)(1997-6#474)(1997-7#602)(1997-8#901)(1997-9#100)(2006-5#12)(2006-6#146)(2007-11#229)(2007-12#1039)(2007-7#1)(2007-8#120)(2007-9#23)(2008-1#713)(2008-10#51612)(2008-11#10984)(2008-12#2892)(2008-2#948)(2008-3#4128)(2008-4#1329)(2008-5#3872)(2008-6#1006)(2008-7#4280)(2008-8#4417)(2008-9#4267)(2009-1#226)(2009-10#939)(2009-11#283)(2009-12#551)(2009-2#55)(2009-3#359)(2009-4#226)(2009-5#375)(2009-6#462)(2009-7#776)(2009-8#1214)(2009-9#277)(2010-1#608)(2010-10#634)(2010-11#577)(2010-12#821)(2010-2#141)(2010-3#264)(2010-4#549)(2010-5#590)(2010-6#588)(2010-7#661)(2010-8#820)(2010-9#272)(2011-1#728)(2011-10#67)(2011-2#6434)(2011-3#546)(2011-4#23)(2011-7#109)(2011-8#5)(2011-9#15)(2012-12#1053)(2012-2#2834)(2012-3#2558)(2012-4#29)(2012-5#90)(2012-6#32)(2012-7#32)(2012-8#17)(2012-9#31)(2013-1#4442)(2013-2#13)(2013-3#11)(2013-7#210)(2013-8#2314)
the(15)N##2##1##(2008-11#2)
theadhesion##2##1##(2008-11#2)
theaflavin##2##1##(2008-11#2)
theanine##6##1##(2008-11#6)
theater##5##1##(2011-2#2)(2012-12#1)(2012-3#2)
theatre##8##1##(2008-10#1)(2008-11#4)(2009-10#1)(2012-3#2)
thebasolateral##2##1##(2008-11#2)
theca and granulosa##2##3##(1995-8#1)(2008-12#1)
theca cells of##2##3##(2008-8#1)(2008-9#1)
theca cells##3##2##(1990-8#1)(2008-8#1)(2008-9#1)
theca interna and##2##3##(1995-12#1)(1995-8#1)
theca interna##3##2##(1995-12#2)(1995-8#1)
theca layers were##2##3##(2008-12#2)
theca##11##1##(1990-8#1)(1995-12#2)(1995-8#2)(2008-12#4)(2008-8#1)(2008-9#1)
thecontrol##2##1##(2008-11#1)(2011-1#1)
theculture##2##1##(2008-11#2)
thedevelopment of##2##2##(2008-11#2)
thedevice##2##1##(2008-11#2)
theeffect of the##2##3##(2008-11#2)
theeffect of##3##2##(2008-11#3)
thefrequency##2##1##(2013-8#2)
theft##7##1##(1991-3#2)(1993-2#1)(1994-12#1)(1995-8#1)(2008-9#1)(2012-12#1)
thegdhA##3##1##(2008-8#3)
thein vitro nucleosome reconstitution##2##4##(2008-8#2)
thein vitro##3##2##(2008-8#3)
theincubation##2##1##(2008-11#2)
theinitial##2##1##(2008-11#2)
their &quot##2##2##(2008-8#1)(2012-3#1)
their 3'##2##2##(2008-10#1)(2008-8#1)
their 5' termini##2##3##(2008-4#1)(2008-8#1)
their 5'##4##2##(1993-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
their BAL fluid##2##3##(2008-10#2)
their BAL##3##2##(2008-10#3)
their C-terminus##2##2##(1994-11#1)(2008-9#1)
their DNA binding##2##3##(1995-8#1)(2013-1#1)
their DNA##4##2##(1995-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
their HIV status##2##3##(1996-5#1)(2011-2#1)
their HIV##4##2##(1994-9#1)(1996-5#1)(2011-2#1)(2013-1#1)
their ICU stay##2##3##(2011-2#2)
their Medicare##3##2##(1996-3#2)(1997-2#1)
their N-hydroxy##3##2##(1992-6#3)
their abilities to stimulate##2##4##(1992-10#1)(2009-12#1)
their abilities to##9##3##(1992-10#1)(1993-8#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-9#1)(2009-12#2)
their abilities##11##2##(1992-10#1)(1993-8#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-9#1)(2009-12#2)
their ability to be##2##4##(1994-5#1)(2008-10#1)
their ability to cause##2##4##(2008-10#2)
their ability to compete with##2##5##(1993-3#1)(2013-7#1)
their ability to detect##4##4##(2008-10#1)(2008-9#1)(2012-2#2)
their ability to extract##2##4##(2008-10#1)(2009-8#1)
their ability to grow in##2##5##(2008-10#1)(2010-4#1)
their ability to grow##3##4##(2008-10#2)(2010-4#1)
their ability to increase the##2##5##(2009-4#1)(2013-8#1)
their ability to induce##5##4##(2008-10#4)(2008-4#1)
their ability to infect##2##4##(2008-10#2)
their ability to influence##2##4##(1995-12#1)(2013-7#1)
their ability to inhibit the##3##5##(1995-11#1)(2008-10#1)(2008-11#1)
their ability to inhibit##7##4##(1992-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)
their ability to predict##2##4##(2009-4#1)(2010-1#1)
their ability to prevent##2##4##(1992-10#1)(1994-8#1)
their ability to produce##6##4##(1991-12#1)(1991-2#1)(2008-10#3)(2011-2#1)
their ability to selectively##2##4##(2012-2#1)(2013-1#1)
their ability to serve as##2##5##(1992-9#1)(2008-10#1)
their ability to transmit##5##4##(2008-10#5)
their ability to use##2##4##(2008-9#1)(2009-3#1)
their ability to##113##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#3)(1994-8#2)(1995-11#4)(1995-12#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(2008-10#39)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#5)(2013-1#2)(2013-7#2)(2013-8#2)
their ability##115##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#3)(1994-8#2)(1995-11#4)(1995-12#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(2008-10#39)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#5)(2013-1#2)(2013-7#2)(2013-8#2)
their absence##2##2##(2008-10#1)(2008-8#1)
their abundance##3##2##(2008-10#2)(2012-3#1)
their academic##3##2##(2008-12#1)(2013-8#2)
their access to##2##3##(2008-8#1)(2011-2#1)
their accuracy##4##2##(2008-10#2)(2011-7#1)(2012-2#1)
their action##3##2##(1996-12#1)(2008-11#1)(2008-9#1)
their actions##4##2##(1993-8#1)(2008-11#1)(2010-5#1)(2013-7#1)
their activation and##2##3##(2008-10#1)(2010-8#1)
their activation##3##2##(1996-2#1)(2008-10#1)(2010-8#1)
their active##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2010-8#1)
their activities##5##2##(1997-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-3#1)
their activity##6##2##(1994-6#1)(1997-8#1)(2008-10#2)(2008-5#1)(2010-5#1)
their actual##2##2##(2008-10#1)(2009-3#1)
their adequacy##2##2##(1992-12#1)(2008-5#1)
their admission to##2##3##(1990-3#1)(1995-1#1)
their admission##3##2##(1990-3#1)(1995-1#1)(2008-11#1)
their adult##4##2##(1995-1#1)(2008-11#1)(2008-7#1)(2010-9#1)
their advantages and##2##3##(2008-10#1)(2012-3#1)
their advantages##6##2##(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-3#1)
their adverse##3##2##(2009-12#1)(2011-1#1)(2012-3#1)
their affinity##2##2##(1995-11#1)(2008-10#1)
their age and##4##3##(1990-8#1)(2008-12#1)(2012-12#2)
their age##8##2##(1990-8#1)(1994-3#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
their aggressiveness##2##2##(2008-10#2)
their alcohol##2##2##(2008-11#1)(2008-12#1)
their all-trans isomers##2##3##(1991-5#2)
their amino acid##2##3##(1994-11#1)(1997-2#1)
their amino##5##2##(1991-10#1)(1994-11#1)(1997-2#1)(2008-10#2)
their amino-terminal##2##2##(1994-11#1)(1997-6#1)
their analgesic##2##2##(2008-11#1)(2010-6#1)
their analysis by##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
their analysis may##2##3##(1992-12#1)(2008-2#1)
their analysis##6##2##(1992-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2013-8#1)
their analytical##5##2##(2008-10#5)
their anatomic##2##2##(2008-12#1)(2008-9#1)
their ancestor##2##2##(2008-8#1)(2010-8#1)
their annual##3##2##(1995-2#1)(2008-11#1)(2009-10#1)
their antagonism##2##2##(2008-10#2)
their anti-tumor##2##2##(2008-11#1)(2013-1#1)
their antibiotic##2##2##(2008-10#1)(2011-2#1)
their antibody##2##2##(1995-5#1)(2008-11#1)
their antimicrobial##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
their antioxidant##3##2##(2008-10#1)(2008-11#2)
their antiviral##2##2##(1994-8#1)(2008-11#1)
their apical##5##2##(2007-12#2)(2008-6#1)(2009-8#1)(2012-2#1)
their apparent##2##2##(2008-5#1)(2008-9#1)
their appearance##2##2##(2008-11#1)(2012-2#1)
their applicability for##2##3##(1991-1#1)(2008-10#1)
their applicability##5##2##(1991-1#1)(2008-10#2)(2011-1#1)(2012-3#1)
their application for##2##3##(2008-10#2)
their application in##7##3##(2008-10#2)(2008-11#3)(2008-3#1)(2010-1#1)
their application to##12##3##(1995-3#2)(2008-10#5)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)
their application##23##2##(1995-3#2)(2008-10#9)(2008-11#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#2)(2011-2#2)
their applications to##4##3##(1992-12#1)(2008-10#2)(2008-11#1)
their applications##11##2##(1992-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#1)(2010-7#1)
their approach to##2##3##(1993-1#1)(1994-12#1)
their approach##5##2##(1993-1#1)(1994-12#1)(1995-1#1)(1996-8#1)(2008-11#1)
their approaches to##2##3##(1993-3#1)(2011-1#1)
their appropriate##2##2##(1990-2#1)(2008-10#1)
their aqueous solutions##2##3##(2008-10#2)
their aqueous##3##2##(2008-10#3)
their arrival in##2##3##(2008-5#1)(2012-2#1)
their assignment##2##2##(2008-11#1)(2009-7#1)
their associated##8##2##(1991-3#1)(1991-9#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
their association with the##2##4##(1996-12#1)(1996-2#1)
their association with##9##3##(1994-11#1)(1996-12#3)(1996-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)
their association##12##2##(1991-5#1)(1994-11#1)(1996-12#3)(1996-2#1)(2008-10#3)(2008-11#1)(2010-12#1)(2012-12#1)
their asthma##2##2##(2008-8#1)(2012-12#1)
their atomic absorption spectrometric determinations##2##5##(2008-10#2)
their atomic absorption##3##3##(2008-10#3)
their atomic##4##2##(2008-10#3)(2011-2#1)
their attention on##2##3##(1993-6#1)(2008-10#1)
their attention##3##2##(1993-6#1)(2008-10#1)(2008-12#1)
their attitudes toward##2##3##(1992-1#1)(2008-7#1)
their attitudes##5##2##(1992-1#1)(1993-3#1)(1996-6#1)(2008-7#2)
their atypical morphology##2##3##(2008-10#1)(2012-12#1)
their average##3##2##(1993-12#1)(2008-9#1)(2010-3#1)
their awareness of##2##3##(1993-12#1)(2010-8#1)
their background##2##2##(2008-10#1)(2008-11#1)
their bacterial##2##2##(2008-10#1)(2013-1#1)
their basic##2##2##(1996-12#1)(2008-10#1)
their behavior##5##2##(1991-2#2)(1997-1#1)(2008-11#1)(2008-9#1)
their being##2##2##(1995-12#1)(1995-3#1)
their beneficial##2##2##(2008-10#1)(2013-7#1)
their binding affinities##2##3##(1995-11#1)(2008-8#1)
their binding##8##2##(1995-11#1)(1995-12#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
their biochemical##2##2##(2008-10#1)(2012-2#1)
their biological activities##2##3##(2011-1#1)(2013-1#1)
their biological effects##2##3##(1994-6#1)(2009-12#1)
their biological functions##2##3##(1993-9#1)(2008-9#1)
their biological properties##2##3##(2008-10#1)(2008-11#1)
their biological##14##2##(1993-9#1)(1994-6#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-1#1)(2013-1#1)
their biophysical##3##2##(1997-6#1)(2008-10#1)(2012-3#1)
their blood##2##2##(1990-11#1)(2010-11#1)
their boards##2##2##(1994-2#1)(1995-3#1)
their bodies##5##2##(2008-10#2)(2009-5#2)(2010-10#1)
their body##3##2##(1991-11#1)(2008-11#2)
their brain##2##2##(2008-11#1)(2008-5#1)
their broad##2##2##(2008-10#2)
their brood##2##2##(2008-6#1)(2008-9#1)
their business##4##2##(1991-3#1)(1992-3#1)(1997-2#1)(2008-11#1)
their capability to##5##3##(1993-2#1)(2008-10#2)(2008-11#1)(2013-1#1)
their capacities##3##2##(1994-3#1)(2008-11#1)(2008-5#1)
their capacity to##8##3##(1990-5#1)(1991-2#1)(1994-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-1#1)
their capacity##9##2##(1990-5#1)(1991-2#1)(1994-5#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-1#1)
their care is##2##3##(2008-11#1)(2010-10#1)
their care##7##2##(1997-2#1)(2008-11#1)(2010-10#3)(2012-2#1)(2013-8#1)
their career##2##2##(2008-8#1)(2012-2#1)
their caregivers##6##2##(1992-3#1)(1996-3#1)(2011-2#1)(2013-8#3)
their caring role##2##3##(2011-1#2)
their catalytic##3##2##(1992-7#1)(1997-3#1)(2008-10#1)
their cell size##2##3##(2008-11#2)
their cell surface##2##3##(1994-3#1)(2008-11#1)
their cell##10##2##(1994-3#1)(2007-12#1)(2008-11#5)(2008-6#1)(2008-9#1)(2009-12#1)
their cellular##3##2##(2008-7#1)(2009-8#1)(2012-12#1)
their central##2##2##(2008-1#1)(2012-3#1)
their chains##2##2##(2008-10#1)(2008-8#1)
their changes in##2##3##(2008-10#1)(2010-11#1)
their changes##4##2##(2008-10#2)(2010-11#1)(2011-2#1)
their chelates##2##2##(2008-10#2)
their chemical properties##4##3##(2008-10#2)(2008-11#2)
their chemical##11##2##(1996-1#1)(2007-12#1)(2008-10#6)(2008-11#2)(2009-7#1)
their child##13##2##(1990-12#1)(1995-1#2)(1995-12#1)(1996-11#1)(1997-2#1)(2008-9#2)(2010-6#1)(2010-8#1)(2012-2#3)
their child's##13##2##(1995-1#3)(2008-11#4)(2009-6#1)(2010-6#1)(2010-9#3)(2012-2#1)
their children and##2##3##(2010-10#1)(2011-2#1)
their children##26##2##(1990-2#1)(1991-11#2)(1993-3#1)(1994-9#1)(1995-1#2)(1996-1#2)(2008-12#1)(2008-6#1)(2010-10#3)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
their children's##6##2##(1994-3#1)(1995-1#4)(1996-5#1)
their choice##4##2##(1993-6#1)(2008-9#2)(2012-3#1)
their choices##4##2##(1993-12#1)(1997-3#1)(2009-10#1)(2012-2#1)
their chromosomal##2##2##(1997-6#1)(2008-9#1)
their classification##2##2##(2008-10#1)(2008-4#1)
their clients##5##2##(1992-1#1)(1993-3#1)(2010-5#1)(2010-9#1)(2011-2#1)
their clinical and##2##3##(2008-11#1)(2011-2#1)
their clinical appearance##2##3##(1996-6#1)(2008-5#1)
their clinical effects##2##3##(2008-6#1)(2011-2#1)
their clinical implications##2##3##(2012-2#1)(2013-1#1)
their clinical manifestations##2##3##(2008-10#1)(2011-2#1)
their clinical placements##2##3##(2008-12#2)
their clinical##27##2##(1993-9#1)(1995-10#1)(1996-6#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#6)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
their coevolutionary relationship##2##3##(2009-8#1)(2012-3#1)
their cognate##3##2##(1996-12#1)(2009-10#1)(2009-9#1)
their cognitive and##2##3##(1991-2#1)(2009-10#1)
their cognitive##8##2##(1991-2#1)(2008-11#2)(2009-10#3)(2010-1#1)(2012-2#1)
their collection##2##2##(1996-12#1)(2008-12#1)
their colonization##2##2##(2008-10#1)(2008-5#1)
their colony##2##2##(2008-10#1)(2013-1#1)
their combination##5##2##(2008-10#2)(2012-5#1)(2012-7#1)(2012-9#1)
their commitment##2##2##(1993-12#1)(1994-12#1)
their common##3##2##(2008-11#1)(2008-8#1)(2010-5#1)
their communication with##2##3##(2008-12#1)(2011-2#1)
their communication##4##2##(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
their community##2##2##(1991-3#1)(1995-3#1)
their comparison with the##2##4##(2008-10#2)
their comparison with##3##3##(2008-10#2)(2008-3#1)
their comparison##5##2##(2008-10#4)(2008-3#1)
their complementary##3##2##(2008-10#2)(2011-2#1)
their complexation with##2##3##(2008-10#2)
their complexes with##5##3##(2008-10#5)
their complexes##8##2##(2008-10#7)(2010-7#1)
their component##2##2##(2008-10#1)(2008-11#1)
their components##5##2##(2008-10#5)
their composition##5##2##(1994-3#1)(2008-10#3)(2008-11#1)
their concentration is##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
their concentration##7##2##(2008-10#5)(2008-11#1)(2011-2#1)
their concentrations in##2##3##(2008-10#2)
their concentrations##10##2##(2008-10#8)(2008-11#1)(2012-2#1)
their concerns##3##2##(1991-2#1)(1995-2#1)(2011-2#1)
their conduct##2##2##(1994-3#1)(1995-3#1)
their connection##2##2##(1990-11#1)(2010-7#1)
their consent##3##2##(1995-12#1)(2009-4#2)
their consequences##3##2##(2008-1#1)(2008-11#1)(2010-8#1)
their consumption##3##2##(2008-10#1)(2009-12#1)(2011-1#1)
their content was##2##3##(1990-6#1)(2008-10#1)
their content##3##2##(1990-6#1)(2008-10#2)
their contents and##2##3##(1992-12#1)(2012-3#1)
their contents##3##2##(1992-12#1)(2008-10#1)(2012-3#1)
their continuous##2##2##(1994-12#1)(2008-11#1)
their contribution to##4##3##(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#1)
their contribution##5##2##(1994-3#1)(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#1)
their contributions##2##2##(2008-9#1)(2012-3#1)
their control##3##2##(1991-5#1)(1992-12#1)(2012-2#1)
their controls##2##2##(1991-3#1)(2008-10#1)
their correct##2##2##(2008-10#2)
their correlation with##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
their correlation##5##2##(2008-10#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
their corresponding##9##2##(1992-8#1)(1993-6#1)(2008-10#4)(2008-6#1)(2009-10#1)(2009-7#1)
their counterparts in##4##3##(1996-3#1)(2008-11#2)(2008-7#1)
their counterparts with##2##3##(2008-12#1)(2012-3#1)
their counterparts##7##2##(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2012-3#1)
their coupled##2##2##(2008-9#1)(2012-2#1)
their course##3##2##(2008-11#3)
their critical##3##2##(2008-11#2)(2012-2#1)
their culture##3##2##(1994-1#1)(2008-11#1)(2008-9#1)
their current##14##2##(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-1#1)(2009-9#1)(2010-4#1)
their curriculum##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
their customers##2##2##(1994-12#1)(1997-1#1)
their customers'##3##2##(1992-1#3)
their cytoplasm##2##2##(2008-10#1)(2008-8#1)
their cytotoxic##2##2##(1994-3#1)(2008-11#1)
their daily lives##2##3##(1993-3#1)(2008-9#1)
their daily##8##2##(1993-3#1)(2008-11#2)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
their data##2##2##(1990-5#1)(2008-7#1)
their daughters against##2##3##(2011-1#2)
their daughters##6##2##(2008-5#1)(2011-1#5)
their death by##2##3##(2008-10#1)(2011-2#1)
their death##4##2##(2008-10#2)(2010-4#1)(2011-2#1)
their decision##3##2##(1996-2#1)(2008-9#1)(2010-7#1)
their decision-making##2##2##(1992-2#1)(2010-10#1)
their decisions##2##2##(1993-12#1)(2008-11#1)
their degree of##6##3##(1991-5#1)(1995-3#1)(1997-3#1)(2008-9#2)(2013-1#1)
their derivatives##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
their descriptions of##2##3##(2008-11#1)(2008-12#1)
their design##3##2##(2010-1#1)(2011-2#1)(2012-2#1)
their detection at##2##3##(2008-10#1)(2008-11#1)
their detection limits##2##3##(2008-10#2)
their detection##13##2##(2007-12#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
their determination by electrothermal##2##4##(2008-10#2)
their determination by inductively coupled plasma atomic emission spectrometry##3##9##(2008-10#3)
their determination by inductively coupled##4##5##(2008-10#4)
their determination by##17##3##(2008-10#17)
their determination in##6##3##(2008-10#6)
their determination##27##2##(2008-10#26)(2009-8#1)
their development and##2##3##(1992-6#1)(2011-2#1)
their development is##4##3##(1997-7#1)(2007-12#1)(2008-7#1)(2010-4#1)
their development##14##2##(1992-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-4#1)(2010-9#1)(2011-2#1)
their developmental##3##2##(1991-2#1)(2008-11#1)(2008-8#1)
their diagnosis##5##2##(1996-2#1)(1996-8#1)(2010-9#1)(2012-3#2)
their diagnostic##2##2##(2008-10#1)(2012-12#1)
their diameters##2##2##(2008-3#1)(2008-7#1)
their diet##9##2##(1990-6#3)(2008-1#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-2#1)
their difference##2##2##(2008-10#2)
their different##12##2##(1992-12#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
their differential##2##2##(1995-12#1)(2010-6#1)
their differentiation##6##2##(1995-12#1)(2008-11#1)(2008-4#2)(2012-2#1)(2012-4#1)
their dimensions##2##2##(2008-10#2)
their direct determination without previous separation##2##6##(2008-10#2)
their direct##4##2##(1994-2#1)(2008-10#2)(2010-11#1)
their direction##2##2##(2008-7#1)(2010-10#1)
their discovery##2##2##(2010-5#1)(2013-1#1)
their discrimination##2##2##(2008-10#1)(2010-2#1)
their disease##6##2##(1990-6#1)(1991-2#1)(2008-10#3)(2010-12#1)
their dispersal##2##2##(2008-8#2)
their disposal##3##2##(1994-3#1)(2008-10#1)(2012-12#1)
their distal##3##2##(2008-7#2)(2012-3#1)
their distance to##2##3##(2008-11#1)(2008-9#1)
their distribution and##3##3##(2008-10#2)(2011-2#1)
their distribution in the##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
their distribution in##5##3##(1996-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2013-8#1)
their distribution is##2##3##(1995-8#1)(2008-10#1)
their distribution##15##2##(1990-5#1)(1995-8#1)(1996-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-8#1)
their diverse##3##2##(1993-1#1)(2008-10#1)(2013-8#1)
their drinking##3##2##(2008-10#2)(2010-7#1)
their dry##2##2##(2008-5#1)(2010-6#1)
their early##6##2##(1996-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#2)
their eating##2##2##(1993-6#1)(2010-7#1)
their ecological and##2##3##(2008-9#1)(2012-5#1)
their ecological##4##2##(2008-8#1)(2008-9#1)(2011-2#1)(2012-5#1)
their education##3##2##(2008-11#2)(2010-8#1)
their effect on the##8##4##(2008-10#7)(2008-11#1)
their effect on##26##3##(1991-3#1)(1992-3#1)(1995-11#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
their effect##28##2##(1991-3#1)(1992-3#1)(1995-11#1)(1996-3#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
their effectiveness as##2##3##(2008-11#1)(2013-1#1)
their effectiveness##12##2##(1993-3#1)(1994-2#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
their effects and##2##3##(2008-10#2)
their effects on LDL metabolism##2##5##(1993-6#2)
their effects on the##10##4##(1990-11#1)(1993-6#1)(1993-8#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-5#1)
their effects on##32##3##(1990-11#2)(1990-5#1)(1991-3#1)(1993-6#3)(1993-8#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#4)(2008-9#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
their effects##41##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1993-6#3)(1993-8#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#4)(2008-9#3)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
their efficacy and##3##3##(1993-11#1)(2008-5#1)(2012-2#1)
their efficacy in##5##3##(2008-10#2)(2009-7#1)(2011-2#1)(2013-7#1)
their efficacy##14##2##(1991-3#1)(1993-11#2)(2008-10#2)(2008-2#1)(2008-5#3)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
their efficiency##2##2##(2008-10#1)(2008-5#1)
their effort##2##2##(1990-12#1)(1993-12#1)
their efforts in##2##3##(1995-1#1)(2009-1#1)
their efforts to##5##3##(1995-3#1)(1996-3#2)(2009-5#1)(2010-10#1)
their efforts##10##2##(1991-8#1)(1995-1#1)(1995-3#1)(1996-3#2)(2008-1#1)(2008-10#1)(2009-1#1)(2009-5#1)(2010-10#1)
their eggs##3##2##(2007-12#1)(2013-1#2)
their electrochemical detection##2##3##(2008-10#2)
their electrochemical##5##2##(2008-10#4)(2008-8#1)
their elimination##2##2##(2008-10#1)(2008-9#1)
their employees##3##2##(1992-3#1)(1993-3#1)(2008-11#1)
their employment##2##2##(1995-1#2)
their enhanced##2##2##(1993-6#1)(2008-10#1)
their entire##2##2##(2008-11#1)(2008-5#1)
their environment to##2##3##(2008-10#2)
their environment##13##2##(1996-12#2)(2008-10#2)(2008-11#2)(2008-7#1)(2009-6#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)
their environmental##2##2##(2008-10#2)
their environments##3##2##(1991-1#1)(2008-11#1)(2008-9#1)
their enzymatic activity##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
their enzymatic##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
their epitope##2##2##(1993-1#1)(2011-2#1)
their epitopes##3##2##(1993-1#1)(2008-8#2)
their estrogen receptor##4##3##(2008-11#4)
their evaluation in##2##3##(2006-6#1)(2008-5#1)
their evaluation##5##2##(2006-6#1)(2008-11#2)(2008-5#2)
their evolutionary##2##2##(2010-5#1)(2013-8#1)
their excellent##3##2##(1997-8#1)(2009-7#1)(2010-4#1)
their exchange##2##2##(1997-1#1)(2008-10#1)
their existing##4##2##(1993-2#1)(2008-11#1)(2011-3#1)(2013-8#1)
their expectations##5##2##(1992-12#1)(2008-9#2)(2011-2#1)(2013-1#1)
their experience about##2##3##(1990-5#1)(1992-5#1)
their experience in##2##3##(1990-5#1)(1991-6#1)
their experience of##4##3##(1990-3#1)(1990-9#1)(1996-9#1)(2009-5#1)
their experience with this##2##4##(1993-3#1)(2008-11#1)
their experience with##3##3##(1991-3#1)(1993-3#1)(2008-11#1)
their experience##14##2##(1990-3#1)(1990-5#2)(1990-9#1)(1991-3#1)(1991-6#1)(1992-5#2)(1993-3#1)(1995-1#1)(1996-9#1)(2008-11#1)(2009-5#2)
their experiences in caring for##2##5##(2010-8#1)(2011-2#1)
their experiences in##3##3##(2009-12#1)(2010-8#1)(2011-2#1)
their experiences of being##2##4##(2008-11#1)(2010-10#1)
their experiences of##3##3##(1993-1#1)(2008-11#1)(2010-10#1)
their experiences with##6##3##(1995-12#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-1#1)(2013-7#1)
their experiences##16##2##(1993-1#1)(1994-1#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
their expertise##2##2##(2008-11#2)
their exposure to##3##3##(1991-12#1)(2006-5#1)(2008-2#1)
their expression in##2##3##(1993-8#1)(2011-2#1)
their expression of##5##3##(1995-12#1)(2007-12#1)(2008-11#2)(2011-2#1)
their expression patterns in##2##4##(1997-7#1)(2008-10#1)
their expression patterns##4##3##(1993-9#1)(1995-12#1)(1997-7#1)(2008-10#1)
their expression##25##2##(1990-12#1)(1993-8#2)(1993-9#1)(1994-11#2)(1995-12#2)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#3)
their external##3##2##(1993-12#1)(1995-2#1)(2007-12#1)
their extracellular##4##2##(1993-8#1)(1997-1#1)(2008-11#1)(2013-8#1)
their extraction##2##2##(2008-10#1)(2009-8#1)
their fabrication##2##2##(2008-10#1)(2008-3#1)
their facilitation##2##2##(2008-11#1)(2010-10#1)
their failure##2##2##(2008-11#1)(2008-8#1)
their families and##4##3##(1990-6#1)(1996-11#1)(2008-11#1)(2011-2#1)
their families##35##2##(1990-6#1)(1991-2#1)(1994-1#1)(1994-3#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-11#13)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
their family members##2##3##(1992-2#1)(2008-11#1)
their family##7##2##(1992-2#1)(1994-12#1)(1995-1#1)(2008-11#1)(2008-12#2)(2009-12#1)
their fatty acid##2##3##(2008-10#1)(2008-11#1)
their feeding##2##2##(2008-11#1)(2010-8#1)
their field of##2##3##(2008-5#1)(2008-6#1)
their fields##2##2##(1996-2#1)(2008-10#1)
their final##2##2##(1996-3#1)(2008-11#1)
their financial##4##2##(1995-1#1)(2008-11#1)(2010-10#2)
their findings##2##2##(1993-12#1)(1993-3#1)
their first HIV test##2##4##(2009-5#2)
their first encounter##2##3##(2008-11#2)
their first practice placement##3##4##(2008-11#3)
their first practice##4##3##(2008-11#3)(2008-9#1)
their first test##2##3##(2009-5#2)
their first year of##3##4##(1992-1#1)(2011-1#2)
their first##28##2##(1990-3#1)(1990-6#1)(1991-2#1)(1992-1#2)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-9#2)(2009-5#4)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#2)
their fitness##2##2##(2008-10#1)(2008-8#1)
their flame atomic absorption spectrometric determinations##2##6##(2008-10#2)
their flame atomic absorption spectrometric##3##5##(2008-10#3)
their flanking##2##2##(1993-8#1)(1997-7#1)
their formation##7##2##(1991-3#1)(1993-8#1)(2008-10#4)(2008-3#1)
their fragment##2##2##(2008-10#1)(2008-12#1)
their fragmentation##2##2##(2008-10#1)(2012-3#1)
their free##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
their frequency##3##2##(1994-6#1)(2008-9#1)(2013-8#1)
their friends##4##2##(1995-1#1)(2009-7#3)
their full-term peers##3##3##(2008-11#3)
their function##8##2##(1992-9#1)(1993-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#1)
their functional status##2##3##(1995-3#1)(2008-7#1)
their functional##7##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2012-2#1)
their functions and adjustments##2##4##(2008-1#1)(2008-4#1)
their functions and##3##3##(2008-1#1)(2008-4#1)(2011-1#1)
their functions##6##2##(1995-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-10#1)(2011-1#1)
their further##5##2##(1996-3#1)(2008-10#1)(2009-7#1)(2012-2#1)(2013-8#1)
their future contributions##2##3##(1993-2#2)
their future##6##2##(1993-2#2)(1996-2#1)(2012-2#2)(2013-7#1)
their gene##4##2##(2008-5#3)(2012-3#1)
their general health##2##3##(1996-6#1)(2011-2#1)
their general##4##2##(1995-12#1)(1996-6#1)(2008-10#1)(2011-2#1)
their generally##2##2##(1992-12#1)(2008-5#1)
their genes##2##2##(2008-11#1)(2008-4#1)
their genetic relationship##2##3##(2008-10#1)(2008-12#1)
their genetic##10##2##(1992-10#1)(2008-10#4)(2008-12#2)(2008-8#1)(2008-9#2)
their genome##2##2##(1996-6#1)(1997-2#1)
their genomic DNA##2##3##(1995-8#1)(2008-10#1)
their genomic##3##2##(1995-8#1)(2008-10#2)
their geographic##4##2##(2008-10#3)(2010-10#1)
their geographical##4##2##(2008-10#2)(2008-8#1)(2009-6#1)
their germination##2##2##(2008-10#1)(2011-2#1)
their good##3##2##(1995-8#1)(2008-7#1)(2010-4#1)
their group##2##2##(1990-12#1)(2011-2#1)
their growth in##2##3##(2008-10#1)(2011-2#1)
their growth promoting activities##2##4##(2008-11#1)(2008-9#1)
their growth rate##3##3##(2008-11#1)(2009-10#2)
their growth##21##2##(1992-3#1)(1996-12#1)(2008-10#3)(2008-11#9)(2008-7#1)(2008-9#1)(2009-10#2)(2009-6#1)(2011-2#1)(2012-2#1)
their health and##3##3##(1997-3#1)(2012-2#1)(2013-1#1)
their health care expenditures##2##4##(1994-1#1)(1995-2#1)
their health care##3##3##(1994-1#1)(1995-2#1)(2008-10#1)
their health status##2##3##(2010-10#2)
their health##15##2##(1994-1#1)(1994-6#1)(1995-2#1)(1997-3#2)(2008-10#1)(2010-10#3)(2010-9#3)(2011-2#1)(2012-2#1)(2013-1#1)
their healthcare##4##2##(2011-1#2)(2012-2#1)(2013-1#1)
their hearing##2##2##(2011-2#1)(2012-2#1)
their high affinity for##2##4##(2008-7#1)(2013-7#1)
their high levels of##2##4##(2008-1#1)(2010-2#1)
their high##18##2##(1995-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2013-1#1)(2013-7#1)
their higher##4##2##(1990-11#1)(2008-8#1)(2009-12#1)(2013-8#1)
their histologic##2##2##(1990-2#1)(1994-1#1)
their home##5##2##(1990-12#1)(2008-11#2)(2008-12#1)(2010-4#1)
their homes and##2##3##(2009-9#1)(2012-2#1)
their homes##6##2##(1990-12#1)(1991-12#1)(2008-9#1)(2009-9#1)(2012-2#2)
their homologous##2##2##(2008-10#1)(2008-9#1)
their homologues##2##2##(1995-8#1)(2011-2#1)
their hospital##2##2##(1992-1#1)(1995-2#1)
their host##10##2##(2008-10#5)(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
their hosts##15##2##(1997-7#2)(2008-10#4)(2008-8#4)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
their ideas##2##2##(2008-12#1)(2013-1#1)
their identification and##2##3##(2008-11#1)(2009-4#1)
their identification##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2009-4#1)(2011-3#1)
their identity##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
their illness##4##2##(1993-3#1)(2008-11#1)(2012-3#1)(2013-1#1)
their immature##2##2##(2006-5#1)(2009-7#1)
their immediate##2##2##(1996-2#2)
their immunoglobulin##2##2##(1994-3#1)(1995-2#1)
their impact on the##9##4##(1994-5#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-7#1)(2013-1#1)
their impact on##26##3##(1992-1#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(2007-12#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-1#2)
their impact##28##2##(1992-1#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#3)(1996-3#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-1#2)
their implementation##7##2##(1991-1#1)(1994-2#1)(1997-7#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
their implications for##8##3##(2008-10#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)
their implications##10##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
their importance in##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
their importance##8##2##(1993-3#1)(1995-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
their in vitro growth##2##4##(2008-10#2)
their in vitro##6##3##(2008-10#3)(2010-5#1)(2011-2#1)(2013-1#1)
their in vivo##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
their in##10##2##(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
their inability to##2##3##(2010-8#1)(2011-2#1)
their income##2##2##(2008-1#1)(2008-12#1)
their increasing use##2##3##(2008-11#1)(2008-8#1)
their increasing##5##2##(1994-3#2)(2008-11#1)(2008-8#1)(2010-7#1)
their individual##8##2##(1992-1#1)(1994-5#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)
their induction##2##2##(1994-8#1)(2011-2#1)
their infants##5##2##(1991-11#1)(1991-2#1)(1992-12#1)(2009-11#1)(2009-9#1)
their infection##2##2##(2008-10#1)(2010-11#1)
their influence on##4##3##(1994-8#1)(2008-10#3)
their influence##8##2##(1994-8#1)(2008-10#5)(2008-9#1)(2010-6#1)
their influences on##2##3##(2008-8#1)(2013-1#1)
their inherent##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
their inhibitory effects on##2##4##(2008-10#1)(2011-2#1)
their inhibitory##7##2##(1992-6#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
their initial##9##2##(1993-12#1)(1994-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-8#1)
their institutions##2##2##(1994-1#1)(1994-3#1)
their integration##3##2##(2008-11#2)(2011-7#1)
their intended##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
their interaction with nuclear##2##4##(2008-10#1)(2011-2#1)
their interaction with##12##3##(1990-5#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
their interaction##22##2##(1990-5#1)(1995-2#1)(1995-6#1)(2008-10#10)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-2#1)
their interactions with##6##3##(2008-10#1)(2008-4#2)(2008-9#1)(2010-5#1)(2011-2#1)
their interactions##16##2##(1994-9#1)(2008-10#8)(2008-4#3)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)
their interest##2##2##(2010-9#1)(2013-8#1)
their internal##2##2##(1994-3#1)(2008-6#1)
their interpretation##6##2##(1993-3#1)(1995-5#1)(2008-10#2)(2008-8#1)(2013-8#1)
their interpretations##2##2##(2008-11#2)
their intrinsic##4##2##(2008-10#1)(2009-3#1)(2009-8#1)(2010-10#1)
their introduction in##2##3##(2008-7#1)(2010-12#1)
their introduction##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
their invasion##2##2##(2008-11#2)
their investment in sexual reproduction##2##5##(2012-3#2)
their involvement in##5##3##(1994-12#1)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#1)
their involvement##9##2##(1994-12#1)(1995-3#2)(2008-11#2)(2008-12#1)(2009-10#1)(2009-8#1)(2011-2#1)
their ionized##2##2##(2008-10#2)
their job satisfaction##3##3##(1995-1#1)(1995-2#1)(2013-1#1)
their job##8##2##(1990-12#2)(1991-11#2)(1995-1#1)(1995-2#1)(2010-9#1)(2013-1#1)
their jobs##5##2##(1991-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)
their joint##2##2##(2008-11#1)(2008-7#1)
their journey##2##2##(2008-10#1)(2013-1#1)
their kinetic##3##2##(1993-8#1)(2008-10#2)
their knowledge and skills in##2##5##(2008-11#1)(2008-7#1)
their knowledge and##7##3##(2008-11#3)(2008-7#1)(2011-3#1)(2011-7#1)(2012-12#1)
their knowledge of##5##3##(1996-6#1)(2008-11#1)(2011-1#1)(2013-1#2)
their knowledge##21##2##(1996-6#1)(1997-3#1)(2008-11#7)(2008-12#1)(2008-7#2)(2009-5#1)(2010-9#1)(2011-1#1)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
their lack of toxicity##2##4##(1991-12#1)(2008-10#1)
their lack of##3##3##(1991-12#1)(2008-10#2)
their large##6##2##(1993-6#1)(2008-10#2)(2008-8#1)(2012-3#1)(2013-1#1)
their last##3##2##(1990-6#1)(1994-2#1)(1994-9#1)
their learning needs##3##3##(1992-12#1)(2008-11#1)(2012-3#1)
their learning##15##2##(1992-12#1)(2008-11#7)(2008-12#3)(2011-2#2)(2012-3#2)
their legal##2##2##(1995-1#1)(2008-11#1)
their length##2##2##(2008-9#1)(2012-2#1)
their lesion##2##2##(1991-1#1)(1995-11#1)
their level of resistance##2##4##(2008-10#2)
their level of##11##3##(1993-2#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-5#1)(2013-8#2)
their levels of##4##3##(1995-2#1)(1996-12#1)(2008-10#2)
their life span##2##3##(2008-10#1)(2010-8#1)
their life##8##2##(2008-10#1)(2008-7#2)(2008-9#1)(2010-8#2)(2011-2#2)
their lifetime##5##2##(1990-6#2)(1990-8#1)(2009-5#1)(2010-10#1)
their ligands##5##2##(2008-11#1)(2008-4#2)(2008-5#1)(2013-1#1)
their likelihood of##2##3##(2008-11#1)(2008-8#1)
their likelihood##3##2##(2008-11#1)(2008-8#1)(2010-3#1)
their limitations##8##2##(2008-11#2)(2008-9#1)(2009-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
their limited##2##2##(1997-9#1)(2011-2#1)
their limits##2##2##(2008-8#1)(2012-2#1)
their lipid##2##2##(2008-11#1)(2008-4#1)
their lives as##2##3##(2008-11#1)(2013-1#1)
their lives##12##2##(1990-2#1)(1992-1#1)(1994-9#1)(1995-1#1)(1997-8#1)(2008-11#2)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#2)
their living##3##2##(2009-6#1)(2011-2#2)
their local##3##2##(1996-3#1)(2008-11#1)(2008-8#1)
their location##4##2##(1997-6#1)(2008-12#1)(2008-9#1)(2010-6#1)
their locations##3##2##(2009-7#1)(2010-10#1)(2013-1#1)
their long##4##2##(1993-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
their long-term##8##2##(2008-10#2)(2008-7#1)(2009-7#1)(2011-3#1)(2012-3#2)(2013-1#1)
their longitudinal##2##2##(2010-1#1)(2013-1#1)
their low##5##2##(2008-10#1)(2008-11#2)(2008-9#1)(2009-7#1)
their mRNA##2##2##(1995-2#1)(2008-9#1)
their main##8##2##(1995-1#1)(2008-10#5)(2008-11#1)(2008-12#1)
their maintenance##3##2##(1991-12#1)(2008-4#1)(2013-1#1)
their management##7##2##(1995-12#1)(2008-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2013-8#1)
their mate##2##2##(2008-8#1)(2009-6#1)
their mates##3##2##(2008-9#2)(2012-3#1)
their matrix##3##2##(2008-10#1)(2012-2#2)
their mature##2##2##(1995-2#1)(2008-8#1)
their maximum##2##2##(2008-10#1)(2012-2#1)
their mechanism of action##2##4##(1993-8#1)(2011-2#1)
their mechanism of##4##3##(1993-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
their mechanism##5##2##(1993-8#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
their mechanisms of action and##3##5##(2008-10#1)(2008-5#1)(2012-3#1)
their mechanisms of action are##2##5##(1995-12#1)(2008-7#1)
their mechanisms of action##8##4##(1995-12#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
their mechanisms of##9##3##(1995-12#1)(1995-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
their mechanisms##11##2##(1995-12#1)(1995-5#1)(2008-10#4)(2008-5#2)(2008-7#1)(2012-3#1)(2013-1#1)
their medical staff##2##3##(1991-1#1)(1994-3#1)
their medical##3##2##(1991-1#1)(1994-3#1)(1996-2#1)
their medication##7##2##(1993-11#1)(2008-11#4)(2010-1#1)(2012-12#1)
their membrane##2##2##(2011-1#2)
their mental health##2##3##(2008-12#1)(2012-3#1)
their mental##3##2##(2008-12#1)(2012-2#1)(2012-3#1)
their merits and##3##3##(2008-8#1)(2010-12#1)(2013-1#1)
their metabolic##5##2##(1993-1#1)(2008-11#1)(2008-6#1)(2009-7#1)(2011-1#1)
their metabolites are##3##3##(2008-10#1)(2008-11#2)
their metabolites##10##2##(1997-3#1)(2008-10#5)(2008-11#4)
their metal##6##2##(2008-10#6)
their migration into the##2##4##(1997-8#1)(2008-11#1)
their migration##4##2##(1997-8#1)(2008-11#1)(2008-7#1)(2010-8#1)
their mixture##6##2##(2008-10#6)
their mixtures##5##2##(2008-10#5)
their mobility##2##2##(2008-11#1)(2010-1#1)
their mode of##2##3##(2008-9#1)(2011-2#1)
their molecular##11##2##(1990-12#1)(1991-7#1)(1992-6#2)(1995-6#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
their monitoring in##2##3##(2008-10#2)
their more##6##2##(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#3)
their morphological##3##2##(1996-12#1)(2008-10#1)(2008-12#1)
their morphologies##2##2##(2008-11#2)
their morphology##5##2##(2008-11#3)(2011-2#1)(2013-1#1)
their most##6##2##(1991-2#1)(1994-1#1)(1996-1#1)(2009-5#1)(2011-2#1)(2013-1#1)
their mother##3##2##(1994-2#1)(1997-3#1)(2008-8#1)
their mothers##4##2##(1990-2#1)(2008-11#1)(2009-11#1)(2011-1#1)
their motility##2##2##(1997-7#1)(2013-8#1)
their motivations##2##2##(1993-12#2)
their multiple##2##2##(1993-12#1)(2008-9#1)
their muscle##2##2##(2008-11#1)(2008-7#1)
their mutual##4##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
their natal##2##2##(2008-8#1)(2008-9#1)
their native##6##2##(2008-10#1)(2008-2#1)(2008-8#3)(2011-2#1)
their natural##7##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-7#1)
their nature and##4##3##(1995-1#1)(1996-2#1)(2008-10#1)(2012-2#1)
their nature##5##2##(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
their needs in##2##3##(1993-2#1)(2012-12#1)
their needs##9##2##(1993-2#1)(1994-1#1)(1997-3#1)(2008-11#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
their negative##3##2##(1991-6#1)(1992-2#1)(1995-2#1)
their new##5##2##(1991-3#1)(1992-1#1)(2008-11#1)(2010-4#1)(2013-1#1)
their newborn##2##2##(2007-12#1)(2008-8#1)
their normal counterparts##2##3##(2008-9#1)(2010-7#1)
their normal##13##2##(1995-2#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
their nuclei##2##2##(1992-3#1)(2008-8#1)
their nucleotide sequences##3##3##(1997-6#1)(1997-8#1)(2008-8#1)
their nucleotide##5##2##(1993-6#1)(1997-6#1)(1997-8#1)(2008-8#1)(2013-8#1)
their number and##2##3##(1995-12#1)(2008-10#1)
their number##4##2##(1995-12#1)(1996-9#1)(2008-10#1)(2008-9#1)
their nursing actions##2##3##(2008-11#1)(2012-3#1)
their nursing##5##2##(2008-11#2)(2008-12#2)(2012-3#1)
their objections to##2##3##(1995-5#1)(2008-11#1)
their observations##2##2##(1994-2#1)(2008-9#1)
their occupational##2##2##(1991-3#1)(2009-12#1)
their offspring##9##2##(2008-7#1)(2008-8#4)(2008-9#2)(2010-8#1)(2012-2#1)
their operations##2##2##(1993-2#1)(1994-3#1)
their opinion of##2##3##(1990-5#1)(1991-2#1)
their opinion##3##2##(1990-5#1)(1991-2#1)(1992-2#1)
their optical##5##2##(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)
their optimal##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
their organic##2##2##(2008-10#2)
their organization##3##2##(1994-1#1)(1996-3#1)(2010-9#1)
their organizations to##2##3##(1995-3#1)(1997-1#1)
their organizations##5##2##(1994-1#1)(1995-3#1)(1996-3#2)(1997-1#1)
their orientation##5##2##(1991-5#1)(2008-10#1)(2008-11#2)(2008-8#1)
their origin and##2##3##(2008-10#1)(2008-7#1)
their origin##10##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)
their original##7##2##(1992-9#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-6#1)
their origins##4##2##(2008-10#1)(2008-11#2)(2012-5#1)
their outer##3##2##(1995-12#2)(2008-7#1)
their overall health##2##3##(2008-7#1)(2013-8#1)
their overall stability constants##2##4##(2008-10#2)
their overall##11##2##(1991-2#1)(1993-2#1)(2008-10#4)(2008-7#1)(2011-1#1)(2012-2#1)(2012-4#1)(2013-8#1)
their overexpression##2##2##(2013-1#2)
their own health##6##3##(1991-12#1)(1994-2#1)(1994-6#1)(1996-6#3)
their own homes##5##3##(1991-8#2)(1996-5#1)(2010-10#2)
their own personal##2##3##(2008-11#2)
their own professional##2##3##(2008-11#2)
their own right##4##3##(1990-12#1)(1992-2#1)(2010-10#1)(2010-7#1)
their own use##2##3##(1994-12#1)(2008-11#1)
their own values##2##3##(2008-12#2)
their own##118##2##(1990-12#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-1#1)(1992-2#2)(1992-3#2)(1992-6#2)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-5#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#14)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#1)(2010-10#4)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#2)
their oxidation##4##2##(2008-10#4)
their pain##4##2##(2008-9#1)(2010-6#3)
their parasitic##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
their parent##2##2##(2008-10#1)(2008-11#1)
their parental##7##2##(1995-12#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-5#1)
their parents##19##2##(1990-12#2)(1991-2#1)(1993-2#1)(1995-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#2)
their partners from##2##3##(2008-12#2)
their partners##7##2##(2008-12#3)(2008-6#1)(2008-7#2)(2009-5#1)
their pastoral##2##2##(1991-2#1)(2010-9#1)
their pathogenic potential##2##3##(2008-10#1)(2011-1#1)
their pathogenicity on##3##3##(2008-10#3)
their pathogenicity##6##2##(2008-10#6)
their pathotype##2##2##(2008-10#2)
their patient##4##2##(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)
their patients and##4##3##(1995-3#1)(2008-11#1)(2009-9#1)(2013-1#1)
their patients##29##2##(1990-2#2)(1990-6#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-12#2)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1997-4#1)(2008-1#1)(2008-11#3)(2008-6#1)(2009-9#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
their patients'##5##2##(1994-2#1)(1997-2#1)(2008-7#2)(2008-8#1)
their pattern of##2##3##(2008-11#1)(2012-3#1)
their patterns of##5##3##(1994-2#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-2#1)
their peak experiences##2##3##(2013-8#2)
their peak##6##2##(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#3)
their peers##5##2##(2008-11#2)(2009-7#1)(2013-1#2)
their pension plans##2##3##(1993-3#2)
their perceived##6##2##(2008-11#3)(2010-9#2)(2011-2#1)
their perception of##3##3##(1991-2#1)(1993-2#1)(2010-8#1)
their perception##4##2##(1991-2#1)(1993-2#1)(2008-11#1)(2010-8#1)
their perceptions and##2##3##(1992-2#1)(2012-3#1)
their perceptions of the##3##4##(2009-4#1)(2010-12#1)(2010-9#1)
their perceptions of##9##3##(1992-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)
their perceptions##11##2##(1992-1#1)(1992-2#1)(2008-11#1)(2008-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
their percutaneous##2##2##(2008-5#1)(2010-12#1)
their performance in##7##3##(1991-2#1)(1993-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)
their performance on##2##3##(1996-2#1)(2008-10#1)
their performance was##2##3##(2008-7#1)(2008-8#1)
their performance##23##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1996-2#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)
their peripheral##2##2##(1991-3#1)(2008-5#1)
their personal experience##2##3##(1990-5#1)(1990-9#1)
their personal##10##2##(1990-5#1)(1990-9#1)(1993-1#1)(1994-1#1)(1995-12#1)(1996-1#1)(2008-11#2)(2008-12#1)(2009-5#1)
their perspective##3##2##(1994-1#1)(2008-12#1)(2011-1#1)
their pharmaceutical##6##2##(2008-10#6)
their physical##5##2##(1991-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-12#1)
their physician##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
their physicians for##2##3##(2006-5#1)(2008-11#1)
their physicians##10##2##(1990-8#1)(1991-1#1)(2006-5#1)(2008-11#2)(2008-6#1)(2009-5#2)(2010-8#1)(2012-3#1)
their physico-chemical properties##3##3##(2008-10#1)(2008-5#2)
their physiological##5##2##(1996-2#1)(2008-9#2)(2009-1#1)(2012-2#1)
their place in##2##3##(1994-3#1)(2008-11#1)
their place of##2##3##(2008-10#1)(2010-10#1)
their place##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-10#1)
their poor##2##2##(2008-10#1)(2013-8#1)
their population density##2##3##(2008-9#1)(2013-8#1)
their population##3##2##(2008-9#1)(2010-8#1)(2013-8#1)
their populations##2##2##(1995-3#1)(2008-10#1)
their position in##2##3##(1994-3#1)(2013-8#1)
their position##4##2##(1994-3#1)(2011-2#2)(2013-8#1)
their positive##2##2##(1995-6#1)(2008-10#1)
their possibility##2##2##(2008-10#1)(2013-1#1)
their possible role##2##3##(2010-4#1)(2011-2#1)
their possible##15##2##(1993-1#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
their potencies to##2##3##(1993-12#1)(1995-11#1)
their potencies##3##2##(1993-12#1)(1995-11#1)(2009-10#1)
their potential applications##3##3##(2009-4#1)(2009-5#1)(2013-1#1)
their potential for##5##3##(2007-12#1)(2008-11#2)(2008-5#1)(2013-1#1)
their potential role in##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
their potential to##4##3##(1993-9#1)(1996-1#1)(2008-10#1)(2013-1#1)
their potential toxic##2##3##(2008-10#2)
their potential##36##2##(1990-6#1)(1993-6#1)(1993-9#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2012-4#1)(2013-1#3)
their practical##2##2##(2008-8#1)(2009-10#1)
their practice patterns##2##3##(1994-2#1)(2008-11#1)
their practice##11##2##(1994-2#1)(1996-1#1)(2008-1#1)(2008-11#5)(2008-12#2)(2010-8#1)
their practices##8##2##(1993-12#1)(1994-12#1)(2008-11#1)(2008-6#2)(2008-9#3)
their precise##3##2##(1993-6#1)(2012-2#1)(2012-3#1)
their predicted##2##2##(1993-1#1)(1993-9#1)
their predominant##2##2##(2008-10#1)(2008-12#1)
their preferences##2##2##(2008-8#1)(2010-2#1)
their preferred##2##2##(2008-9#1)(2009-6#1)
their prescribed##2##2##(2008-11#1)(2010-1#1)
their prescribing##2##2##(2008-11#2)
their presence in##4##3##(1996-1#1)(2007-12#1)(2008-9#1)(2013-8#1)
their presence##9##2##(1994-5#1)(1995-3#1)(1996-1#2)(2007-12#1)(2008-10#2)(2008-9#1)(2013-8#1)
their presumed##2##2##(1997-3#1)(2007-12#1)
their previous##5##2##(1994-9#1)(2008-10#1)(2008-11#2)(2011-10#1)
their primary##10##2##(1991-2#1)(1991-3#1)(1995-2#1)(1997-9#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
their processes##3##2##(1992-6#1)(2008-4#1)(2008-7#1)
their production as##2##3##(1991-12#1)(1997-7#1)
their production##10##2##(1991-12#1)(1995-5#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#1)(2012-2#1)
their products##5##2##(1994-1#1)(2008-10#2)(2008-5#1)(2009-7#1)
their profession##3##2##(1992-1#1)(2008-7#1)(2012-2#1)
their professional development##2##3##(2008-11#1)(2013-8#1)
their professional##11##2##(2008-1#1)(2008-11#6)(2010-1#1)(2010-10#1)(2013-1#1)(2013-8#1)
their prognostic##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
their programs##2##2##(1992-3#1)(2008-10#1)
their project##2##2##(1991-1#2)
their propagation##2##2##(1993-12#1)(2008-9#1)
their proper##3##2##(1994-9#1)(2008-11#1)(2011-2#1)
their properties##5##2##(2007-12#1)(2008-10#1)(2008-8#2)(2011-2#1)
their protective##3##2##(1995-12#1)(2008-7#1)(2009-8#1)
their providers##2##2##(2008-12#1)(2013-1#1)
their purification##4##2##(1995-12#1)(2008-4#3)
their putative##2##2##(1992-5#1)(2008-11#1)
their quality of life##5##4##(2008-6#1)(2009-9#1)(2011-2#2)(2013-8#1)
their quality of##6##3##(2008-6#1)(2009-9#1)(2011-2#2)(2013-8#2)
their quality##10##2##(1991-6#1)(1997-6#1)(2008-10#1)(2008-6#1)(2009-9#1)(2011-2#3)(2013-8#2)
their quantification##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
their rank order##2##3##(1990-11#1)(2009-12#1)
their rapid##3##2##(1992-10#1)(2008-10#1)(2010-7#1)
their rate of##2##3##(2008-10#1)(2008-11#1)
their rate##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
their rates of##3##3##(1991-11#1)(1996-2#1)(2013-8#1)
their reaction with##6##3##(2008-10#5)(2008-5#1)
their reaction##7##2##(2008-10#6)(2008-5#1)
their reactions to##2##3##(2008-10#2)
their reactions with##4##3##(2008-10#1)(2008-11#3)
their reactions##8##2##(1996-6#1)(2008-10#4)(2008-11#3)
their reactivity with##2##3##(2008-10#1)(2010-11#1)
their reactivity##3##2##(2008-10#2)(2010-11#1)
their recently##2##2##(2008-9#1)(2012-3#1)
their receptors in the##2##4##(1996-12#1)(2009-8#1)
their receptors in##3##3##(1996-12#1)(2009-8#1)(2013-1#1)
their receptors##9##2##(1990-11#1)(1996-12#1)(2008-11#1)(2008-4#1)(2009-8#2)(2011-2#2)(2013-1#1)
their reduction##5##2##(1990-5#1)(1993-8#1)(1995-8#1)(2008-10#2)
their regenerative##2##2##(2008-7#1)(2010-8#1)
their regulation##8##2##(1993-12#1)(1995-12#1)(2008-10#3)(2008-8#1)(2012-2#1)(2013-7#1)
their regulatory##2##2##(2009-10#1)(2010-1#1)
their relations with##2##3##(2010-1#1)(2010-6#1)
their relations##3##2##(2008-11#1)(2010-1#1)(2010-6#1)
their relationship to##12##3##(1990-11#1)(1990-9#1)(1993-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)(2013-8#1)
their relationship with##7##3##(1994-8#1)(2008-10#3)(2012-2#1)(2012-9#1)(2013-1#1)
their relationship##21##2##(1990-11#1)(1990-9#1)(1993-1#1)(1994-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#2)(2012-9#1)(2013-1#2)(2013-8#1)
their relationships with##5##3##(1994-12#1)(1995-9#1)(1997-2#1)(2008-7#1)(2012-3#1)
their relationships##8##2##(1994-12#1)(1995-9#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
their relative contributions##2##3##(2012-3#1)(2013-8#1)
their relative importance##2##3##(2008-8#2)
their relative##23##2##(1990-3#1)(1990-5#1)(1992-12#1)(1993-1#1)(2008-10#5)(2008-4#1)(2008-8#6)(2008-9#1)(2009-10#1)(2010-1#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
their relatives##3##2##(1991-6#1)(1997-3#1)(2008-11#1)
their release##3##2##(1991-2#1)(2008-8#1)(2008-9#1)
their relevance to##3##3##(2008-11#1)(2008-8#2)
their relevance##4##2##(1996-1#1)(2008-11#1)(2008-8#2)
their reliability##2##2##(2008-10#1)(2008-9#1)
their remarkable##4##2##(1996-1#1)(2008-10#1)(2008-5#1)(2012-3#1)
their removal##3##2##(1990-2#1)(1995-2#1)(2008-11#1)
their reproducibility##2##2##(2008-10#2)
their reproductive##5##2##(2008-8#2)(2010-8#1)(2013-8#2)
their research##6##2##(1990-9#1)(1996-1#1)(2008-11#2)(2008-12#1)(2012-2#1)
their resistance to the##2##4##(1993-2#1)(2012-3#1)
their resistance to##5##3##(1993-2#1)(2008-10#3)(2012-3#1)
their resistance##7##2##(1993-2#1)(2008-10#5)(2012-3#1)
their resolution##2##2##(2008-10#1)(2011-2#1)
their respective##38##2##(1990-5#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-11#1)(1996-12#1)(1996-3#1)(2008-10#16)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#1)(2011-4#1)(2013-1#3)
their response to the##2##4##(2008-10#1)(2013-8#1)
their response to##9##3##(1990-11#1)(2008-10#2)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#2)
their response##14##2##(1990-11#1)(2008-10#4)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#2)
their responses to##4##3##(1995-11#1)(2008-10#2)(2010-8#1)
their responses##6##2##(1995-11#1)(2008-10#2)(2008-12#1)(2010-10#1)(2010-8#1)
their responsiveness to##3##3##(1990-7#1)(1994-5#1)(1995-12#1)
their results##2##2##(1995-12#1)(2009-9#1)
their retention times##2##3##(2008-10#2)
their retention##6##2##(2008-10#6)
their right to##2##3##(1995-2#1)(2008-1#1)
their right##3##2##(1995-2#1)(2008-1#1)(2013-1#1)
their rights##2##2##(2008-11#1)(2008-12#1)
their risk##5##2##(1995-9#3)(2008-11#1)(2012-2#1)
their role as##3##3##(1993-6#1)(2008-11#1)(2010-1#1)
their role in the transmission of##2##6##(2010-1#2)
their role in the##5##4##(1993-11#1)(2008-10#1)(2008-5#1)(2010-1#2)
their role in##23##3##(1993-11#1)(1995-8#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#2)(2010-2#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
their role##34##2##(1990-12#1)(1993-11#1)(1993-6#1)(1995-8#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-1#3)(2010-11#1)(2010-2#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
their roles in##9##3##(1994-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
their roles##12##2##(1993-2#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-1#1)(2011-2#2)
their roots and##2##3##(2008-10#1)(2008-12#1)
their roots##5##2##(2008-10#4)(2008-12#1)
their safety##4##2##(1994-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
their satisfaction with##4##3##(1993-12#1)(1996-2#1)(2010-2#2)
their satisfaction##6##2##(1990-12#1)(1993-12#1)(1996-2#1)(2010-2#2)(2011-2#1)
their school##3##2##(2008-11#1)(2009-7#1)(2010-8#1)
their search##3##2##(2008-11#1)(2008-8#2)
their second##5##2##(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
their selectivity##3##2##(2008-10#3)
their sensibility to auxin##2##4##(2008-8#2)
their sensing##2##2##(2008-10#2)
their sensitivity to mutation##2##4##(1994-5#1)(1997-3#1)
their sensitivity to##14##3##(1994-5#1)(1995-12#1)(1997-3#1)(2008-10#7)(2008-11#3)(2010-1#1)
their sensitivity##17##2##(1994-5#1)(1995-12#1)(1997-3#1)(2008-10#8)(2008-11#3)(2008-12#1)(2010-1#1)(2013-8#1)
their separation and##2##3##(2008-10#2)
their separation from##2##3##(2008-10#2)
their separation##5##2##(2008-10#5)
their sequence##4##2##(1995-12#2)(2008-6#1)(2012-2#1)
their sequences##2##2##(1995-6#1)(2008-10#1)
their serum-cholesterol##4##2##(1990-6#4)
their service##3##2##(1992-1#1)(1992-12#1)(2012-3#1)
their services##5##2##(1992-3#1)(1996-1#1)(1997-2#2)(2008-11#1)
their severity##2##2##(1995-12#1)(2013-1#1)
their sexual##3##2##(2008-11#1)(2008-12#1)(2009-5#1)
their sibling##3##2##(2008-12#3)
their side effects##2##3##(2008-10#1)(2008-12#1)
their significance##6##2##(1990-9#1)(1991-11#1)(1993-2#1)(2008-10#1)(2008-12#2)
their significant##2##2##(2008-11#1)(2012-12#1)
their similarity to##2##3##(1995-12#1)(1995-3#1)
their similarity##3##2##(1995-12#1)(1995-3#1)(2008-8#1)
their simultaneous##5##2##(1993-8#1)(2008-10#4)
their size and##3##3##(1992-3#1)(1994-9#1)(1995-3#1)
their size##9##2##(1991-6#1)(1992-3#1)(1994-9#1)(1995-3#1)(2008-10#4)(2008-9#1)
their sizes##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
their skills and##2##3##(1993-1#1)(1993-3#1)
their skills in##2##3##(2008-12#1)(2008-9#1)
their skills##6##2##(1993-1#1)(1993-3#1)(1994-3#1)(2008-11#1)(2008-12#1)(2008-9#1)
their skin##4##2##(2008-5#4)
their smoking status##2##3##(2011-2#2)
their smoking##3##2##(1991-11#1)(2011-2#2)
their social and##2##3##(2009-7#1)(2013-8#1)
their social##9##2##(1992-3#1)(1995-1#1)(2008-1#1)(2008-11#3)(2009-7#1)(2011-2#1)(2013-8#1)
their solubility##2##2##(2008-10#1)(2008-5#1)
their solution##2##2##(1991-3#1)(2008-9#1)
their solutions##4##2##(2008-10#2)(2008-9#2)
their sorption##2##2##(2008-10#2)
their sources##3##2##(1995-3#1)(1997-3#1)(1997-6#1)
their spatial##5##2##(2008-10#3)(2010-10#1)(2013-8#1)
their special##2##2##(2008-10#1)(2009-8#1)
their speciality##2##2##(2008-11#1)(2008-2#1)
their speciation##2##2##(2008-10#2)
their specific##12##2##(1993-3#1)(2006-6#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
their specificity##3##2##(2008-10#2)(2008-7#1)
their spectra##2##2##(2008-10#1)(2008-3#1)
their spectral##3##2##(1994-3#1)(2008-10#2)
their stability and##2##3##(2008-11#1)(2012-2#1)
their stability constants##4##3##(2008-10#3)(2008-5#1)
their stability##11##2##(2008-10#5)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#2)
their staff##3##2##(1994-6#1)(1996-1#1)(2009-11#1)
their stage of##3##3##(1993-11#1)(1996-2#1)(2008-4#1)
their stay##3##2##(1992-1#1)(2013-1#2)
their stimulatory##3##2##(2008-11#2)(2008-8#1)
their strengths and weaknesses##2##4##(2008-6#1)(2008-9#1)
their strong##2##2##(1995-8#1)(1997-2#1)
their structural##4##2##(2008-10#2)(2008-5#1)(2010-1#1)
their structure and function##2##4##(1995-2#1)(2009-8#1)
their structure and##3##3##(1995-2#1)(1996-12#1)(2009-8#1)
their structure##6##2##(1995-2#1)(1996-12#1)(2008-10#1)(2008-4#2)(2009-8#1)
their structures##5##2##(1995-2#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-2#1)
their students##7##2##(2008-11#1)(2008-12#6)
their studies##2##2##(2008-11#1)(2008-8#1)
their study##6##2##(1992-3#1)(1993-6#1)(2008-10#2)(2008-11#1)(2009-7#1)
their subsequent reaction with##2##4##(2008-10#2)
their subsequent##13##2##(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#2)(2009-12#1)(2009-5#1)(2011-2#1)
their success##2##2##(2008-11#1)(2011-3#1)
their suitability for##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
their superior##2##2##(1997-1#1)(2011-2#1)
their surgery##3##2##(1994-2#1)(1995-1#1)(2012-3#1)
their surrounding##2##2##(2008-12#1)(2009-8#1)
their survival##9##2##(1995-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2012-7#1)
their susceptibility to##8##3##(1994-5#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-10#1)
their susceptibility##10##2##(1994-5#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2011-10#1)(2013-1#1)
their symptoms##3##2##(1993-11#1)(2008-10#1)(2011-2#1)
their synthesis##2##2##(2008-10#1)(2008-8#1)
their synthetic##2##2##(2008-10#1)(2008-5#1)
their target cells##2##3##(1995-2#1)(2009-8#1)
their target genes##2##3##(2011-2#1)(2012-3#1)
their target##6##2##(1995-2#1)(2008-10#1)(2009-8#1)(2011-2#2)(2012-3#1)
their targets##3##2##(1993-9#1)(2009-8#1)(2012-2#1)
their teachers##3##2##(2008-12#3)
their teaching##2##2##(2008-11#2)
their technical##2##2##(1990-11#1)(1995-1#1)
their teeth##3##2##(1991-6#1)(1995-9#1)(1997-2#1)
their temporal##2##2##(2008-10#1)(2008-11#1)
their ternary chelates##2##3##(2008-10#2)
their therapeutic##5##2##(2007-11#1)(2008-11#1)(2009-12#1)(2009-3#1)(2013-1#1)
their three##4##2##(1997-9#1)(2008-9#1)(2009-7#1)(2012-12#1)
their threshold##2##2##(1993-12#1)(2008-10#1)
their thyroid function##2##3##(2008-7#1)(2011-1#1)
their thyroid##3##2##(1991-5#1)(2008-7#1)(2011-1#1)
their time and##2##3##(1991-12#1)(1994-1#1)
their time##10##2##(1990-12#1)(1991-12#1)(1994-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-8#2)
their tolerance to##2##3##(2012-5#2)
their tolerance##4##2##(2008-10#1)(2008-12#1)(2012-5#2)
their total##9##2##(1996-3#3)(1997-2#1)(2008-10#5)
their toxicity to##2##3##(2008-10#2)
their toxicity##6##2##(1997-1#1)(2008-10#4)(2008-11#1)
their traditional##3##2##(1996-1#2)(2008-1#1)
their training##6##2##(1992-12#1)(1994-3#2)(2008-11#3)
their transcription##2##2##(1997-7#2)
their transfection##2##2##(2008-9#1)(2010-8#1)
their transfer##2##2##(1997-8#1)(2008-10#1)
their transition##2##2##(1991-5#1)(2008-3#1)
their treatment##8##2##(1991-2#1)(1992-5#1)(1995-1#1)(1997-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-8#1)
their two##2##2##(1993-6#1)(2007-12#1)
their ultimate##2##2##(2007-12#1)(2011-2#1)
their understanding of the##2##4##(1994-12#1)(2008-12#1)
their understanding of##6##3##(1994-12#1)(2008-12#5)
their understanding##7##2##(1994-12#1)(2008-12#5)(2009-12#1)
their undifferentiated##2##2##(2011-2#1)(2013-1#1)
their unique combination of##3##4##(1996-1#1)(2012-2#1)(2013-1#1)
their unique properties##2##3##(1993-3#1)(2008-10#1)
their unique requirements##2##3##(2010-7#1)(2010-8#1)
their unique##11##2##(1993-3#2)(1994-2#1)(1996-1#1)(2008-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
their usage in##2##3##(2008-10#2)
their usage##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
their use as##8##3##(1992-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
their use for##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2013-8#1)
their use in the##4##4##(1991-12#1)(2008-10#1)(2008-12#1)(2012-12#1)
their use in##14##3##(1991-12#1)(1992-3#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2012-12#1)(2013-1#1)
their use is##2##3##(2011-2#1)(2011-3#1)
their use of##4##3##(1990-9#1)(2008-11#2)(2011-2#1)
their use##51##2##(1990-9#1)(1991-12#2)(1992-3#2)(1994-12#1)(2008-10#5)(2008-11#11)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
their usefulness in##5##3##(1990-3#1)(1991-6#1)(1994-3#1)(2008-11#1)(2013-1#1)
their usefulness##8##2##(1990-3#1)(1991-6#1)(1994-3#1)(1996-11#1)(2008-11#2)(2013-1#2)
their usual##2##2##(2008-11#1)(2008-4#1)
their utility and##2##3##(2008-10#1)(2010-4#1)
their utility for##2##3##(1993-12#1)(2008-10#1)
their utility##5##2##(1993-12#1)(2008-10#2)(2010-4#1)(2011-2#1)
their validity##8##2##(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#4)
their variability##2##2##(2008-12#1)(2008-7#1)
their varietal origin##2##3##(2008-10#2)
their various##2##2##(2008-10#1)(2008-4#1)
their very##2##2##(2008-10#2)
their viability and##2##3##(2008-10#1)(2008-7#1)
their viability##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
their view##2##2##(1993-1#1)(2008-6#1)
their views##3##2##(1995-12#1)(2008-12#2)
their virulence##3##2##(2008-10#2)(2013-1#1)
their virus-free##2##2##(2008-10#2)
their water##4##2##(2008-10#2)(2008-5#2)
their way##5##2##(1992-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2013-8#1)
their ways##2##2##(2010-10#1)(2010-9#1)
their well being##2##3##(1995-1#1)(2008-1#1)
their wide##2##2##(2008-10#1)(2011-2#1)
their wild##2##2##(2008-10#1)(2008-11#1)
their wild-type##2##2##(2008-10#1)(2008-8#1)
their work and##2##3##(1996-1#1)(2008-7#1)
their work##11##2##(1991-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#3)(1997-1#1)(2008-7#1)(2010-9#1)(2012-2#1)
their working##2##2##(2008-10#1)(2008-9#1)
their workplace##3##2##(1991-2#1)(2008-11#1)(2008-7#1)
their writing##2##2##(2008-11#1)(2010-6#1)
their yield##2##2##(2009-7#1)(2011-10#1)
their younger##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
their##5064##1##(1990-11#13)(1990-12#19)(1990-2#11)(1990-3#6)(1990-5#22)(1990-6#24)(1990-7#2)(1990-8#5)(1990-9#10)(1991-1#10)(1991-10#1)(1991-11#9)(1991-12#23)(1991-2#39)(1991-3#25)(1991-5#10)(1991-6#15)(1991-7#4)(1991-8#5)(1991-9#4)(1992-1#28)(1992-10#4)(1992-12#28)(1992-2#12)(1992-3#23)(1992-5#7)(1992-6#17)(1992-7#1)(1992-8#6)(1992-9#5)(1993-1#24)(1993-11#8)(1993-12#29)(1993-2#28)(1993-3#32)(1993-6#19)(1993-8#26)(1993-9#9)(1994-1#19)(1994-11#16)(1994-12#24)(1994-2#26)(1994-3#40)(1994-5#12)(1994-6#10)(1994-8#13)(1994-9#9)(1995-1#41)(1995-10#2)(1995-11#14)(1995-12#40)(1995-2#38)(1995-3#32)(1995-5#7)(1995-6#15)(1995-8#15)(1995-9#6)(1996-1#37)(1996-11#4)(1996-12#34)(1996-2#26)(1996-3#33)(1996-5#9)(1996-6#14)(1996-8#2)(1996-9#4)(1997-1#17)(1997-2#29)(1997-3#28)(1997-4#8)(1997-5#1)(1997-6#14)(1997-7#20)(1997-8#16)(1997-9#3)(2006-5#3)(2006-6#4)(2007-11#4)(2007-12#44)(2007-8#2)(2008-1#22)(2008-10#1053)(2008-11#486)(2008-12#148)(2008-2#12)(2008-3#32)(2008-4#62)(2008-5#123)(2008-6#32)(2008-7#113)(2008-8#157)(2008-9#159)(2009-1#5)(2009-10#43)(2009-11#10)(2009-12#33)(2009-2#1)(2009-3#13)(2009-4#15)(2009-5#28)(2009-6#15)(2009-7#35)(2009-8#40)(2009-9#14)(2010-1#30)(2010-10#52)(2010-11#13)(2010-12#16)(2010-2#13)(2010-3#13)(2010-4#26)(2010-5#25)(2010-6#22)(2010-7#23)(2010-8#44)(2010-9#28)(2011-1#58)(2011-10#5)(2011-2#210)(2011-3#13)(2011-4#1)(2011-7#4)(2011-9#1)(2012-12#31)(2012-2#113)(2012-3#91)(2012-4#5)(2012-5#7)(2012-7#2)(2012-9#3)(2013-1#170)(2013-7#10)(2013-8#86)
theirs##2##1##(1991-9#1)(2011-3#1)
thelytokous populations from leek##2##4##(2008-10#2)
thelytokous populations##3##2##(2008-10#3)
them &quot##2##2##(2008-10#1)(2010-5#1)
them a##7##2##(1993-12#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)
them about##3##2##(1996-6#1)(2010-5#1)(2012-2#1)
them against##5##2##(1994-3#1)(2008-10#1)(2008-5#1)(2013-1#2)
them all##2##2##(1993-2#1)(1994-8#1)
them an##2##2##(1997-1#1)(2010-12#1)
them and a##2##3##(1991-12#1)(2008-12#1)
them and the##3##3##(1994-2#1)(2008-12#1)(2008-5#1)
them and their##2##3##(2008-11#1)(2013-1#1)
them and##16##2##(1990-6#1)(1991-12#1)(1994-2#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2013-1#1)(2013-8#1)
them are##15##2##(1990-6#1)(1991-5#1)(1995-12#1)(1996-11#1)(1996-9#1)(2008-10#4)(2008-5#1)(2008-9#2)(2010-8#1)(2012-12#1)(2013-1#1)
them as a##2##3##(2008-10#1)(2010-10#1)
them as the##3##3##(1993-12#1)(1995-2#1)(2008-10#1)
them as##17##2##(1993-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
them at##4##2##(1992-1#1)(2008-10#2)(2008-11#1)
them attractive##3##2##(2008-10#1)(2011-2#2)
them being##8##2##(1990-6#1)(1995-11#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2013-1#1)
them by##5##2##(1995-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)
them develop##3##2##(1993-2#1)(1997-8#1)(2010-10#1)
them easily##2##2##(2008-11#1)(2010-12#1)
them for the##2##3##(1994-9#1)(2008-12#1)
them for their##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
them for##9##2##(1994-9#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2011-1#1)
them from the##2##3##(1997-7#1)(2008-2#1)
them from##14##2##(1995-2#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
them has yet##2##3##(2008-10#1)(2009-5#1)
them has##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
them have been##4##3##(1990-3#1)(1997-8#1)(2008-3#1)(2010-1#1)
them have##7##2##(1990-3#1)(1997-8#1)(2008-3#1)(2008-9#1)(2010-1#1)(2013-1#1)(2013-8#1)
them having##2##2##(1993-2#1)(2011-2#1)
them immediately##2##2##(2008-10#1)(2013-1#1)
them in a##6##3##(1994-3#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-8#1)
them in the##8##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-6#1)(2010-7#1)
them in their##2##3##(1994-3#1)(2008-10#1)
them in##35##2##(1992-1#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-3#3)(1995-1#1)(1996-2#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-9#1)(2013-8#1)
them into the##2##3##(2008-11#1)(2008-7#1)
them into##10##2##(1991-3#1)(1993-12#1)(1993-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)
them is##7##2##(1996-11#1)(1997-5#1)(2008-10#3)(2009-3#1)(2011-2#1)
them more##4##2##(1994-9#1)(2008-12#1)(2008-4#1)(2008-8#1)
them on a##2##3##(2008-10#1)(2008-7#1)
them on the##2##3##(1996-3#1)(2009-9#1)
them on##5##2##(1996-3#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-6#1)
them or with##2##3##(2008-10#1)(2008-3#1)
them or##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
them successfully##2##2##(1991-2#1)(2008-11#1)
them suitable for##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
them suitable##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)
them the##7##2##(1994-3#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#2)
them their##2##2##(2008-10#1)(2010-9#1)
them there##2##2##(1992-5#1)(1993-6#1)
them through the##3##3##(1992-12#1)(2008-10#1)(2008-6#1)
them through##5##2##(1992-12#1)(2008-10#2)(2008-4#1)(2008-6#1)
them to a##3##3##(2008-10#1)(2009-12#1)(2011-1#1)
them to be##7##3##(1991-5#1)(2008-10#3)(2008-11#2)(2011-3#1)
them to become##3##3##(1997-3#1)(2008-7#1)(2010-9#1)
them to develop##2##3##(1997-2#1)(2010-3#1)
them to examine##2##3##(1993-12#1)(2008-12#1)
them to the##9##3##(1991-1#1)(1991-12#1)(1991-7#1)(1997-6#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
them to their##2##3##(1992-1#1)(2008-12#1)
them to##73##2##(1990-2#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-12#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
them useful##4##2##(1990-2#1)(2008-10#1)(2008-4#1)(2010-7#1)
them was##7##2##(1994-11#1)(1995-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
them well##2##2##(2008-10#2)
them were##25##2##(1990-3#1)(1991-12#1)(1993-2#1)(1995-12#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
them while##3##2##(1995-6#1)(2008-10#1)(2010-10#1)
them with a##2##3##(1991-8#1)(2008-10#1)
them with the##5##3##(1997-1#1)(2008-10#2)(2008-9#1)(2011-2#1)
them with##26##2##(1991-8#1)(1992-2#1)(1992-3#1)(1994-11#2)(1997-1#1)(1997-2#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-4#1)
them without##2##2##(1995-5#1)(2008-8#1)
them##760##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-6#6)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#5)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#9)(1993-2#13)(1993-3#6)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#3)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#11)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#2)(1995-12#11)(1995-2#9)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#4)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#7)(1997-3#4)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#3)(1997-9#1)(2006-5#1)(2006-6#1)(2007-12#2)(2008-1#6)(2008-10#149)(2008-11#46)(2008-12#16)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#20)(2008-6#9)(2008-7#23)(2008-8#22)(2008-9#26)(2009-10#4)(2009-11#2)(2009-12#7)(2009-3#2)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#4)(2010-1#4)(2010-10#6)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#4)(2010-9#5)(2011-1#5)(2011-2#33)(2011-3#3)(2012-12#11)(2012-2#12)(2012-3#20)(2012-4#2)(2013-1#28)(2013-7#4)(2013-8#12)
them)##2##1##(2008-10#1)(2009-6#1)
thematic analysis of##2##3##(2008-11#1)(2012-2#1)
thematic analysis##8##2##(2008-11#2)(2008-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#2)
thematic area##2##2##(2010-10#2)
thematic areas##2##2##(2010-10#2)
thematic content analysis##6##3##(2008-11#2)(2008-12#1)(2009-10#1)(2009-3#1)(2010-10#1)
thematic focus##2##2##(2011-2#2)
thematic##24##1##(2008-11#4)(2008-12#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-10#5)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#3)
theme in##4##2##(2008-11#1)(2009-7#1)(2009-8#1)(2012-12#1)
theme of the##3##3##(2008-11#1)(2008-12#1)(2009-10#1)
theme of##7##2##(1995-3#1)(2008-11#3)(2008-12#2)(2009-10#1)
theme that##2##2##(2009-10#2)
theme##30##1##(1991-2#1)(1992-3#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-5#1)(2009-10#6)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
themedium##2##1##(2008-11#2)
themes and##2##2##(2008-12#1)(2010-9#1)
themes are##5##2##(2008-11#2)(2009-10#3)
themes emerged from the##4##4##(1994-12#1)(2008-11#1)(2010-7#1)(2013-1#1)
themes emerged from##5##3##(1994-12#1)(2008-11#2)(2010-7#1)(2013-1#1)
themes emerged##11##2##(1994-12#1)(2008-11#4)(2008-12#2)(2010-10#1)(2010-11#1)(2010-7#1)(2013-1#1)
themes identified##4##2##(1993-3#1)(2008-11#3)
themes in##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
themes include##2##2##(1996-2#1)(1997-1#1)
themes related to##2##3##(2010-11#1)(2011-2#1)
themes that##3##2##(1996-2#1)(2008-11#1)(2013-8#1)
themes to##2##2##(2008-11#1)(2008-12#1)
themes were identified##6##3##(1992-2#1)(2008-11#2)(2009-6#1)(2011-1#1)(2012-3#1)
themes were##9##2##(1992-2#1)(1995-3#1)(2008-11#2)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-3#1)
themes##66##1##(1991-2#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-12#1)(1995-3#1)(1996-2#2)(1997-1#1)(2008-11#17)(2008-12#7)(2009-10#5)(2009-4#1)(2009-5#5)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
themselves and their##4##3##(1992-1#1)(2008-12#2)(2012-2#1)
themselves and##8##2##(1992-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2010-3#1)(2012-2#1)
themselves are##3##2##(1997-9#1)(2008-10#1)(2008-11#1)
themselves as being##2##3##(2009-12#1)(2010-2#1)
themselves as##12##2##(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)
themselves at risk##2##3##(1990-3#1)(2009-12#1)
themselves can##2##2##(2008-10#1)(2008-11#1)
themselves for##2##2##(1997-1#1)(2006-6#1)
themselves from##2##2##(2009-5#1)(2012-2#1)
themselves in the##4##3##(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
themselves in##8##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2013-1#1)(2013-8#1)
themselves may be##3##3##(2008-1#1)(2010-1#1)(2012-2#1)
themselves on##3##2##(1994-8#2)(2008-12#1)
themselves or##3##2##(1990-6#1)(1991-12#1)(2008-10#1)
themselves to##6##2##(1991-3#1)(1995-1#1)(2008-12#1)(2008-5#1)(2009-7#1)(2012-2#1)
themselves##149##1##(1990-3#1)(1990-6#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-3#2)(1994-1#3)(1994-12#4)(1994-6#1)(1994-8#2)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#15)(2008-11#25)(2008-12#8)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-12#2)(2009-5#2)(2009-7#5)(2009-8#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
then 100##2##2##(2008-3#1)(2011-2#1)
then a##8##2##(1992-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)
then accomplished by##2##3##(1996-5#1)(2008-10#1)
then act as a##2##4##(2008-10#1)(2008-7#1)
then added to the##2##4##(2008-11#2)
then added to##4##3##(2008-11#2)(2008-8#2)
then added##5##2##(2008-11#2)(2008-6#1)(2008-8#2)
then after##5##2##(1996-2#1)(2008-10#2)(2008-5#1)(2013-1#1)
then aggregate##2##2##(2008-7#1)(2008-8#1)
then allows##2##2##(2008-10#1)(2008-3#1)
then also##2##2##(1994-5#1)(2008-10#1)
then an##4##2##(2008-10#3)(2008-11#1)
then analyzed by##2##3##(2008-10#2)
then analyzed##4##2##(2008-10#3)(2008-4#1)
then answered##2##2##(1993-2#2)
then appear##2##2##(1993-2#1)(2008-7#1)
then applied to the##8##4##(1996-3#1)(2008-10#5)(2008-3#1)(2008-4#1)
then applied to##16##3##(1996-3#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2012-2#2)
then applied##18##2##(1996-3#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-4#1)(2012-2#2)
then asked##3##2##(1996-5#1)(2008-10#1)(2008-9#1)
then assessed##5##2##(2008-10#3)(2013-1#2)
then at##2##2##(2008-10#1)(2013-1#1)
then be##26##2##(1990-11#1)(1992-3#1)(1993-12#1)(2007-12#1)(2008-10#10)(2008-4#3)(2008-9#4)(2009-10#1)(2010-11#2)(2012-3#1)(2013-1#1)
then by##6##2##(1992-3#1)(1995-2#1)(2008-10#2)(2008-12#1)(2013-1#1)
then calculated##2##2##(1992-9#1)(2008-10#1)
then carried##2##2##(2008-10#2)
then cells are##3##3##(2008-8#3)
then classified by##2##3##(2008-10#1)(2008-5#1)
then collected##2##2##(2008-10#2)
then compared to the##2##4##(2008-10#2)
then compared to##4##3##(1993-11#1)(2008-10#2)(2008-7#1)
then compared##8##2##(1993-11#1)(2008-10#4)(2008-7#1)(2009-4#1)(2012-2#1)
then confirmed by##3##3##(2008-8#1)(2010-12#1)(2012-12#1)
then confirmed##5##2##(2008-12#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-12#1)
then considered##2##2##(1991-1#1)(2010-11#1)
then converted to##3##3##(1994-12#1)(1994-3#1)(2008-10#1)
then could be##2##3##(2008-10#1)(2008-3#1)
then covered##2##2##(2008-10#1)(2008-9#1)
then declined##10##2##(2008-10#10)
then decreased significantly##3##3##(2008-10#1)(2008-12#1)(2010-5#1)
then decreased##10##2##(1992-5#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-8#2)(2010-5#2)
then describe##4##2##(1997-2#1)(2008-11#1)(2010-12#1)(2012-2#1)
then described##2##2##(1994-2#1)(2008-3#1)
then describes##2##2##(1994-1#1)(2013-1#1)
then determined by##7##3##(2008-10#7)
then determined##13##2##(2008-10#12)(2008-11#1)
then developed##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
then diluted##2##2##(1990-12#1)(2008-10#1)
then discussed##2##2##(1991-12#1)(2009-12#1)
then eluted from the##2##4##(2008-10#2)
then eluted from##3##3##(2008-10#3)
then eluted with 1 M##2##5##(2008-10#2)
then eluted with##5##3##(2008-10#5)
then eluted##11##2##(1990-12#1)(2008-10#10)
then evaluated in##2##3##(2008-11#2)
then evaluated##6##2##(2008-10#2)(2008-11#4)
then examined##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
then expanded to##2##3##(2008-10#1)(2008-12#1)
then exposed to##3##3##(1991-5#1)(2009-9#1)(2012-2#1)
then extracted by##3##3##(2008-10#3)
then extracted with##2##3##(2008-10#1)(2008-11#1)
then extracted##9##2##(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)
then followed the##2##3##(1995-11#1)(2010-1#1)
then followed##5##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)
then fused##2##2##(2008-11#1)(2010-5#1)
then generated##2##2##(2007-11#1)(2011-2#1)
then given##2##2##(1993-12#1)(1997-7#1)
then gradually decreased##2##3##(2008-11#1)(2008-7#1)
then gradually##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
then he##2##2##(1991-2#1)(2013-1#1)
then identified##3##2##(1997-7#1)(2010-11#1)(2011-2#1)
then in the presence of##2##5##(2008-10#2)
then in the##3##3##(2008-10#3)
then in##12##2##(2008-10#6)(2008-11#1)(2008-12#2)(2008-9#1)(2011-2#2)
then incorporated##2##2##(2008-10#1)(2008-3#1)
then increased to##2##3##(1995-12#1)(2011-2#1)
then increased##8##2##(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
then inserted##2##2##(1991-12#1)(2008-8#1)
then introduced##2##2##(2008-10#1)(2008-8#1)
then is##6##2##(2008-10#5)(2012-2#1)
then it##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2013-1#1)
then its##2##2##(2008-10#2)
then labeled with##2##3##(1997-2#1)(2008-8#1)
then loaded##2##2##(2008-10#1)(2013-1#1)
then made##2##2##(2008-11#1)(2011-2#1)
then measured##5##2##(1990-12#2)(1991-3#1)(2008-10#1)(2008-5#1)
then merged with##4##3##(2008-10#4)
then mixed with##4##3##(2008-10#3)(2011-3#1)
then modified##2##2##(1996-2#1)(2008-9#1)
then monitored spectrophotometrically##2##3##(2008-10#2)
then monitored##4##2##(2008-10#4)
then moved to the##2##4##(2008-5#1)(2008-8#1)
then obtained##2##2##(2008-11#1)(2008-5#1)
then one has a##3##4##(2008-10#3)
then passed through a##2##4##(2008-10#2)
then passed through##3##3##(2008-10#3)
then performed with a##2##4##(1997-7#1)(2011-2#1)
then performed##9##2##(1997-7#1)(2008-10#3)(2008-11#1)(2011-2#3)(2012-3#1)
then placed##3##2##(2008-10#2)(2008-11#1)
then present##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
then presented##2##2##(2007-12#1)(2009-4#1)
then produced##2##2##(1990-2#1)(2010-5#1)
then provided##2##2##(2008-12#1)(2008-4#1)
then provides##2##2##(1996-5#1)(2008-11#1)
then purified##4##2##(1994-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
then quantified##3##2##(1996-6#1)(2008-10#2)
then quantitatively##3##2##(2008-10#3)
then rapidly##3##2##(1993-12#1)(2007-12#1)(2008-5#1)
then rated##2##2##(2008-5#1)(2009-4#1)
then reached##2##2##(2008-5#1)(2011-2#1)
then react with##2##3##(2008-10#1)(2012-2#1)
then received##2##2##(2008-10#1)(2011-2#1)
then recorded##2##2##(2008-10#2)
then reduced at##2##3##(2008-10#2)
then reduced##3##2##(2008-10#3)
then repeated in##2##3##(1993-2#1)(2008-10#1)
then repeated##4##2##(1993-2#1)(2008-10#3)
then required##2##2##(2008-9#1)(2011-2#1)
then returned to the##2##4##(1994-5#1)(2008-10#1)
then review##3##2##(2008-7#1)(2013-8#2)
then selected##2##2##(2008-8#1)(2012-2#1)
then selectively##2##2##(2008-10#1)(2011-1#1)
then sent##2##2##(2008-10#1)(2010-8#1)
then separated by##2##3##(1997-2#1)(2008-10#1)
then separated##4##2##(1995-2#1)(1997-2#1)(2008-10#2)
then sequentially##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
then show how##2##3##(1993-12#1)(2008-10#1)
then show##5##2##(1993-12#1)(2008-10#1)(2008-3#1)(2010-3#1)(2013-8#1)
then stained##2##2##(1990-12#1)(2011-2#1)
then stripped from the disk with a minimal amount of##2##10##(2008-10#2)
then stripped from the disk##3##5##(2008-10#3)
then subjected to a##2##4##(1995-6#1)(2008-12#1)
then subjected to##5##3##(1991-5#1)(1995-6#2)(2008-12#1)(2009-7#1)
then taken##2##2##(2008-5#1)(2012-12#1)
then tested##6##2##(1991-9#1)(2008-10#3)(2008-5#2)
then the formaldehyde##2##3##(2008-10#2)
then the##45##2##(1993-2#1)(1993-8#2)(1995-2#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-6#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#4)(2009-10#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
then they were concentrated##2##4##(2008-10#2)
then they##3##2##(2008-10#3)
then to the##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
then to##19##2##(1993-2#1)(1995-11#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#3)
then transfected##2##2##(2008-11#1)(2008-5#1)
then transferred to##4##3##(1994-5#1)(2008-10#2)(2013-1#1)
then transferred##6##2##(1994-5#1)(2008-10#3)(2008-11#1)(2013-1#1)
then treated with ammonium##2##4##(2008-10#2)
then treated with##5##3##(2008-10#3)(2008-7#1)(2011-2#1)
then undergoes##2##2##(1991-12#1)(2009-7#1)
then underwent##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
then used as##3##3##(1997-7#1)(2008-3#1)(2008-9#1)
then used for##5##3##(1992-6#1)(2008-10#2)(2010-8#1)(2011-1#1)
then used to##18##3##(1992-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2012-2#1)
then used##31##2##(1992-12#1)(1992-6#1)(1997-6#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
then was developed##2##3##(2008-10#1)(2008-11#1)
then was##11##2##(1993-11#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)
then were##9##2##(1993-11#1)(1993-8#1)(2008-10#3)(2008-9#3)(2009-3#1)
then with##4##2##(2008-10#3)(2008-9#1)
then##966##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-5#2)(1990-8#2)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#4)(1992-9#5)(1993-11#4)(1993-12#8)(1993-2#9)(1993-3#3)(1993-8#5)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#3)(1995-2#8)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#3)(1996-5#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#3)(1997-6#4)(1997-7#7)(1997-8#2)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#353)(2008-11#69)(2008-12#23)(2008-2#3)(2008-3#17)(2008-4#11)(2008-5#27)(2008-6#9)(2008-7#23)(2008-8#46)(2008-9#30)(2009-10#3)(2009-11#2)(2009-12#4)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#5)(2010-10#1)(2010-11#5)(2010-12#3)(2010-3#4)(2010-4#1)(2010-5#7)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#38)(2011-3#3)(2012-12#5)(2012-2#20)(2012-3#12)(2013-1#28)(2013-7#2)(2013-8#11)
thenar flap##4##2##(2008-9#4)
thenar##7##1##(2008-9#6)(2009-1#1)
thenoyltrifluoroacetone##2##1##(2008-10#2)
theobromine and##2##2##(2008-10#2)
theobromine##3##1##(2008-10#3)
theological##3##1##(2009-11#2)(2013-1#1)
theology##2##1##(2008-12#1)(2013-1#1)
theophylline in##3##2##(2008-10#3)
theophylline##14##1##(2008-10#13)(2010-11#1)
theorem##3##1##(1995-2#1)(2008-9#1)(2013-8#1)
theorems##7##1##(1990-12#1)(2010-3#6)
theoretic##5##1##(1991-12#1)(2008-10#1)(2008-8#2)(2013-1#1)
theoretical advantages##3##2##(1993-1#1)(1997-3#1)(2010-11#1)
theoretical analyses##4##2##(2008-3#3)(2010-2#1)
theoretical analysis of##3##3##(1993-9#1)(2007-11#1)(2008-3#1)
theoretical analysis##9##2##(1993-12#1)(1993-9#1)(2007-11#1)(2008-3#6)
theoretical and clinical##3##3##(1993-3#1)(2008-11#2)
theoretical and empirical##5##3##(1993-3#1)(1996-3#1)(1996-6#1)(2008-8#1)(2008-9#1)
theoretical and experimental##3##3##(2008-2#1)(2008-3#2)
theoretical and practical##3##3##(1997-4#1)(2008-10#1)(2008-12#1)
theoretical and professional##2##3##(2010-10#2)
theoretical and##21##2##(1993-3#2)(1996-3#1)(1996-6#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#2)(2008-9#1)(2010-10#2)(2012-2#1)
theoretical approach##2##2##(1995-3#1)(2008-5#1)
theoretical approaches##4##2##(1996-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
theoretical aspects of##2##3##(2008-10#1)(2009-12#1)
theoretical aspects##3##2##(2008-10#2)(2009-12#1)
theoretical assessment of##2##3##(2008-10#2)
theoretical basis for##3##3##(1992-3#1)(2013-8#2)
theoretical basis##4##2##(1992-3#1)(1997-3#1)(2013-8#2)
theoretical calculation##2##2##(2008-2#1)(2008-3#1)
theoretical concepts##2##2##(1996-3#1)(2008-12#1)
theoretical consequences##2##2##(2008-8#2)
theoretical considerations##7##2##(2008-10#4)(2008-3#1)(2010-10#1)(2010-12#1)
theoretical context##2##2##(1995-1#1)(2008-11#1)
theoretical derivation##2##2##(2008-3#2)
theoretical description##2##2##(2008-2#1)(2008-3#1)
theoretical design##2##2##(2008-3#2)
theoretical expansion##2##2##(2008-3#2)
theoretical expectations##2##2##(2008-9#1)(2011-2#1)
theoretical formalism##2##2##(2008-3#2)
theoretical foundation##2##2##(2008-8#1)(2010-1#1)
theoretical framework for##2##3##(2008-8#2)
theoretical framework##6##2##(2008-12#1)(2008-8#3)(2010-1#1)(2011-2#1)
theoretical frameworks##2##2##(2008-12#1)(2010-9#1)
theoretical issues##2##2##(1991-12#1)(1993-12#1)
theoretical knowledge of holistic care into practice##2##7##(2008-11#2)
theoretical knowledge of holistic care into##3##6##(2008-11#3)
theoretical knowledge of holistic care##4##5##(2008-11#4)
theoretical knowledge of##6##3##(1997-4#1)(2008-11#4)(2010-10#1)
theoretical knowledge##8##2##(1997-4#1)(2008-11#6)(2010-10#1)
theoretical maximum##2##2##(2008-10#2)
theoretical model of the##2##4##(2008-3#1)(2008-9#1)
theoretical model of##3##3##(2008-3#1)(2008-9#1)(2009-11#1)
theoretical model was##2##3##(2008-10#1)(2008-12#1)
theoretical model##18##2##(1990-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#8)(2008-5#1)(2008-9#1)(2009-11#1)
theoretical models of##2##3##(2008-8#1)(2012-2#1)
theoretical models##9##2##(1990-12#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
theoretical notions##2##2##(1992-3#1)(2008-12#1)
theoretical perspectives##2##2##(2008-9#1)(2010-7#1)
theoretical plate##2##2##(2008-10#2)
theoretical plates was##3##3##(2008-10#3)
theoretical plates##5##2##(2008-10#5)
theoretical prediction##2##2##(2008-3#1)(2012-3#1)
theoretical predictions##13##2##(1995-2#1)(2008-10#3)(2008-3#5)(2008-9#1)(2012-3#2)(2013-1#1)
theoretical principles of##2##3##(2008-10#1)(2008-11#1)
theoretical profiles##2##2##(2008-3#2)
theoretical rationale##2##2##(2008-6#2)
theoretical relation##2##2##(2008-10#1)(2008-7#1)
theoretical result##2##2##(2008-8#1)(2010-7#1)
theoretical results indicate that##2##4##(2008-2#1)(2008-8#1)
theoretical results of##2##3##(2008-11#1)(2008-2#1)
theoretical results##7##2##(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#2)(2010-5#1)
theoretical simulations##2##2##(2008-10#2)
theoretical skin##2##2##(2008-5#2)
theoretical studies have##2##3##(2008-11#1)(2008-8#1)
theoretical studies##6##2##(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)
theoretical study of##2##3##(2008-3#1)(2008-8#1)
theoretical study##7##2##(1991-9#1)(2008-10#1)(2008-3#3)(2008-8#1)(2010-10#1)
theoretical value##2##2##(2008-10#2)
theoretical values##2##2##(2008-10#1)(2008-3#1)
theoretical##290##1##(1990-12#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#3)(1993-1#2)(1993-12#2)(1993-3#2)(1993-9#1)(1994-12#1)(1995-1#2)(1995-2#3)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#2)(2007-11#1)(2007-12#3)(2008-10#51)(2008-11#20)(2008-12#11)(2008-2#9)(2008-3#58)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#21)(2008-9#12)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#5)(2010-10#6)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#11)(2013-1#5)(2013-7#1)(2013-8#5)
theoretically and experimentally##5##3##(2008-10#2)(2008-3#3)
theoretically and##6##2##(1997-6#1)(2008-10#2)(2008-3#3)
theoretically estimated##2##2##(2008-2#1)(2008-3#1)
theoretically expected##2##2##(2008-10#1)(2008-3#1)
theoretically for the##2##3##(2007-11#1)(2008-10#1)
theoretically for##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
theoretically predicted##2##2##(2008-10#2)
theoretically that the##2##3##(1997-1#1)(2008-10#1)
theoretically##45##1##(1995-1#1)(1997-1#1)(1997-2#2)(1997-6#2)(2007-11#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#10)(2008-5#1)(2008-8#6)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
theories about##4##2##(1995-1#1)(2008-11#1)(2010-1#1)(2010-8#1)
theories and practices##2##3##(1992-2#1)(2009-8#1)
theories and##7##2##(1992-2#1)(2008-10#1)(2008-2#2)(2009-8#1)(2010-1#1)(2013-8#1)
theories can be##2##3##(2008-6#1)(2010-6#1)
theories for improvement##2##3##(1994-12#2)
theories have##2##2##(2009-12#1)(2010-10#1)
theories of prosody##2##3##(2010-9#2)
theories of##19##2##(1993-6#1)(1995-1#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-9#2)(2013-1#1)
theories that##2##2##(2008-9#1)(2010-9#1)
theories were##2##2##(2008-11#1)(2010-1#1)
theories##60##1##(1992-2#1)(1993-6#1)(1994-1#3)(1994-12#2)(1994-3#1)(1995-1#2)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#4)(2010-10#3)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-2#1)(2013-1#6)(2013-8#2)
theorists##4##1##(1995-3#1)(2008-12#1)(2009-10#2)
theorize##3##1##(2009-10#2)(2009-6#1)
theorized##4##1##(2009-10#1)(2010-10#1)(2012-2#1)(2013-8#1)
theorizing##2##1##(2008-12#1)(2010-10#1)
theory and applications##3##3##(2010-11#1)(2012-3#1)(2013-1#1)
theory and experiment##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
theory and its##2##3##(1997-6#1)(2008-11#1)
theory and practice##13##3##(1997-3#2)(2008-11#4)(2008-12#4)(2008-8#1)(2012-3#2)
theory and research##3##3##(1991-12#1)(2008-11#1)(2008-5#1)
theory and suggest that##2##4##(2011-2#1)(2013-1#1)
theory and the##4##3##(1990-12#1)(2008-3#1)(2009-6#1)(2012-3#1)
theory and##54##2##(1990-12#1)(1991-12#1)(1991-2#1)(1993-12#3)(1993-2#1)(1993-3#2)(1997-3#2)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#5)(2009-6#3)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#4)(2013-1#3)
theory approach##5##2##(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2012-3#1)
theory are##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2010-10#1)
theory based##2##2##(2011-2#1)(2013-8#1)
theory by using##2##3##(2008-3#1)(2008-9#1)
theory by##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
theory can be##2##3##(2008-11#1)(2008-7#1)
theory can##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
theory for the##3##3##(2008-12#1)(2008-3#1)(2008-8#1)
theory for##16##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-8#2)(2010-1#1)(2010-4#1)
theory has##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)
theory in practice##2##3##(2008-12#2)
theory in##7##2##(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2013-1#1)
theory indicates that the##2##4##(1991-11#1)(2008-8#1)
theory into practice##2##3##(1997-4#1)(2008-11#1)
theory is applied##2##3##(2008-2#1)(2008-3#1)
theory is presented##2##3##(2008-10#1)(2008-3#1)
theory is proposed##2##3##(1990-5#1)(2013-8#1)
theory is##12##2##(1990-5#1)(1995-9#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-10#1)(2009-6#1)(2013-8#1)
theory methods##2##2##(2010-7#1)(2013-1#1)
theory of energy coding##2##4##(2008-11#2)
theory of knowledge##2##3##(1996-1#2)
theory of mind##4##3##(2008-11#2)(2008-12#2)
theory of stochastic##2##3##(2008-10#1)(2008-8#1)
theory of the inalienable right to life and liberty is enforced by the Thirteenth Amendment##2##15##(2011-2#2)
theory of the inalienable right to life and liberty##3##9##(2011-2#3)
theory of the speckle velocimeter##2##5##(2008-3#2)
theory of the##9##3##(2008-3#5)(2011-2#3)(2012-3#1)
theory of##63##2##(1990-12#1)(1990-5#1)(1991-6#1)(1993-2#1)(1996-1#3)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#8)(2008-6#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
theory on##4##2##(2008-4#1)(2008-8#1)(2010-4#1)(2010-9#1)
theory predicts that##2##3##(2008-8#1)(2012-3#1)
theory predicts##4##2##(1993-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
theory provides##2##2##(2008-2#1)(2009-3#1)
theory shows that##2##3##(2008-3#1)(2012-3#1)
theory suggests that##2##3##(2008-8#1)(2011-2#1)
theory that##8##2##(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
theory to practice in##2##4##(2008-11#2)
theory to practice##11##3##(1996-2#1)(2008-11#8)(2008-12#1)(2008-6#1)
theory to the##2##3##(2008-11#1)(2008-2#1)
theory to##26##2##(1993-3#2)(1996-1#1)(1996-2#1)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#5)(2008-9#1)(2010-9#1)
theory was##2##2##(1990-5#1)(2008-11#1)
theory with practice##2##3##(1991-2#1)(2008-11#1)
theory with##5##2##(1991-2#1)(1993-5#1)(2008-11#2)(2012-12#1)
theory##402##1##(1990-11#1)(1990-12#3)(1990-5#5)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-3#1)(1992-8#2)(1993-12#3)(1993-2#2)(1993-3#5)(1993-5#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#5)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(2007-11#3)(2007-12#4)(2008-1#3)(2008-10#39)(2008-11#44)(2008-12#21)(2008-2#14)(2008-3#47)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#7)(2008-8#40)(2008-9#16)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#8)(2009-7#3)(2009-8#4)(2010-1#5)(2010-10#6)(2010-11#1)(2010-3#1)(2010-4#5)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#14)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#13)(2013-1#14)(2013-8#9)
theory's##2##1##(1995-2#1)(2008-10#1)
theory-based problem-solving approach##2##3##(2010-10#2)
theory-based##7##1##(1995-3#1)(1997-1#1)(2010-10#2)(2013-1#3)
theory-driven##3##1##(2008-2#1)(2011-1#2)
theory-practice gap##8##2##(2008-11#8)
theory-practice##9##1##(2008-11#8)(2012-3#1)
theory?##2##1##(2008-8#1)(2010-1#1)
theother two carriers##2##3##(2008-11#2)
theother##3##1##(2008-11#3)
thepresence of##4##2##(2008-11#4)
thepresence##6##1##(2008-11#5)(2013-8#1)
theprimary cells##2##2##(2008-11#2)
theproduction of##2##2##(2008-11#2)
theranostic agents##2##2##(2012-12#2)
therapeutic activity of##2##3##(1990-2#1)(2013-1#1)
therapeutic activity##3##2##(1990-2#1)(1996-3#1)(2013-1#1)
therapeutic advantage in##2##3##(1990-12#1)(1994-12#1)
therapeutic advantages##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
therapeutic agent##6##2##(1992-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)
therapeutic agents for the##2##4##(2009-12#1)(2009-6#1)
therapeutic agents for##3##3##(1994-11#1)(2009-12#1)(2009-6#1)
therapeutic agents##12##2##(1990-9#1)(1994-11#1)(1995-2#1)(1996-8#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-7#1)
therapeutic alliance##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
therapeutic alternatives##2##2##(2007-8#1)(2013-8#1)
therapeutic and##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-1#1)
therapeutic antibodies are##2##3##(2008-11#1)(2013-8#1)
therapeutic antibodies on##2##3##(2008-11#2)
therapeutic antibodies##10##2##(2008-11#9)(2013-8#1)
therapeutic antibody##2##2##(2010-11#1)(2013-8#1)
therapeutic application##2##2##(1997-1#1)(2011-2#1)
therapeutic applications##7##2##(1997-8#1)(2008-11#2)(2008-4#1)(2009-3#1)(2013-1#2)
therapeutic approach for##3##3##(1992-12#1)(2008-7#1)(2010-6#1)
therapeutic approach in##2##3##(1990-6#1)(1996-11#1)
therapeutic approach to##4##3##(1990-3#1)(1992-12#1)(1992-9#1)(1996-3#1)
therapeutic approach##23##2##(1990-12#2)(1990-3#2)(1990-6#1)(1992-12#3)(1992-9#1)(1994-5#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-8#2)(2008-7#1)(2009-1#1)(2010-6#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
therapeutic approaches to##3##3##(2008-1#1)(2008-4#1)(2013-1#1)
therapeutic approaches which##2##3##(1991-7#1)(2008-5#1)
therapeutic approaches##17##2##(1991-7#1)(1992-5#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
therapeutic aspects and##2##3##(1990-9#1)(2007-8#1)
therapeutic aspects##8##2##(1990-9#2)(1992-5#1)(1993-6#1)(2007-8#2)(2008-12#1)(2012-3#1)
therapeutic benefit of##2##3##(2008-11#1)(2013-1#1)
therapeutic benefit##9##2##(1990-6#1)(1996-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2013-1#3)(2013-8#1)
therapeutic challenge##2##2##(1997-7#1)(2010-11#1)
therapeutic choices##2##2##(2007-11#1)(2012-3#1)
therapeutic communication skills as##2##4##(2008-11#2)
therapeutic communication##4##2##(2008-11#4)
therapeutic communities##2##2##(2008-6#1)(2012-2#1)
therapeutic compliance##3##2##(1993-11#3)
therapeutic compounds##2##2##(1994-5#1)(2008-11#1)
therapeutic decision##3##2##(1990-2#1)(1993-11#1)(2012-3#1)
therapeutic decisions in##2##3##(2010-12#2)
therapeutic decisions##5##2##(2010-11#1)(2010-12#2)(2011-2#1)(2013-8#1)
therapeutic doses##6##2##(1991-11#2)(1992-11#1)(2008-7#1)(2008-8#2)
therapeutic drug monitoring##3##3##(2008-6#1)(2010-11#2)
therapeutic drug##4##2##(2008-6#2)(2010-11#2)
therapeutic drugs##3##2##(2008-11#1)(2009-6#1)(2010-12#1)
therapeutic effect of##2##3##(1996-3#1)(2008-9#1)
therapeutic effect##8##2##(1991-2#1)(1992-3#1)(1996-3#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)
therapeutic effectiveness##3##2##(2008-11#1)(2009-3#1)(2013-8#1)
therapeutic effects##9##2##(1991-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#2)
therapeutic efficacy and##2##3##(1990-2#1)(1991-6#1)
therapeutic efficacy of##4##3##(1991-8#1)(2008-5#1)(2009-12#1)(2012-12#1)
therapeutic efficacy##11##2##(1990-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1994-8#1)(2007-11#1)(2008-5#1)(2009-12#1)(2009-8#1)(2012-12#1)(2013-1#1)
therapeutic endoscopy##2##2##(1990-2#1)(1991-11#1)
therapeutic environments has##2##3##(2012-2#2)
therapeutic exercise##2##2##(2008-12#2)
therapeutic failure##3##2##(1993-11#1)(2008-10#1)(2012-2#1)
therapeutic genes##2##2##(1993-2#1)(2008-8#1)
therapeutic group##3##2##(2008-11#3)
therapeutic implications for##3##3##(1991-7#1)(2008-11#1)(2011-2#1)
therapeutic implications##11##2##(1991-3#1)(1991-7#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
therapeutic intervention of##2##3##(2010-12#1)(2012-2#1)
therapeutic intervention##7##2##(1996-3#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
therapeutic interventions##8##2##(2008-11#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#2)
therapeutic management##4##2##(1995-11#2)(2011-2#1)(2012-3#1)
therapeutic medical##2##2##(1994-2#1)(2007-8#1)
therapeutic methods##3##2##(1990-6#1)(2009-8#1)(2013-1#1)
therapeutic milieu##4##2##(1993-2#2)(2010-5#1)(2013-1#1)
therapeutic modalities are##2##3##(2008-2#1)(2009-4#1)
therapeutic modalities##5##2##(1993-1#1)(2008-11#1)(2008-2#1)(2009-4#1)(2013-1#1)
therapeutic modality##2##2##(2010-10#1)(2010-6#1)
therapeutic needs##2##2##(1992-3#1)(2012-3#1)
therapeutic option for##2##3##(2011-3#2)
therapeutic option##6##2##(2010-12#3)(2011-3#2)(2013-8#1)
therapeutic options for##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
therapeutic options##11##2##(1990-12#1)(1992-12#1)(1993-11#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#3)
therapeutic outcomes##2##2##(2010-10#1)(2013-8#1)
therapeutic parameters##3##2##(2010-8#3)
therapeutic plasma exchange##2##3##(2011-2#2)
therapeutic potential of##6##3##(2008-11#3)(2012-12#2)(2013-8#1)
therapeutic potential##12##2##(1990-9#1)(1997-1#1)(2008-11#3)(2009-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
therapeutic principle##2##2##(1993-11#1)(1994-6#1)
therapeutic procedures##3##2##(1991-9#1)(1993-3#1)(2012-12#1)
therapeutic products##5##2##(2008-10#1)(2008-11#4)
therapeutic protein in##2##3##(2008-11#2)
therapeutic protein##6##2##(2008-10#2)(2008-11#3)(2008-7#1)
therapeutic proteins##7##2##(1996-1#1)(2008-10#1)(2008-11#4)(2013-8#1)
therapeutic purposes##3##2##(2008-11#1)(2008-4#1)(2013-1#1)
therapeutic regimens##2##2##(2011-2#1)(2012-3#1)
therapeutic resistance##2##2##(1993-1#2)
therapeutic response to##3##3##(1997-1#1)(2008-10#1)(2009-11#1)
therapeutic response##4##2##(1991-2#1)(1997-1#1)(2008-10#1)(2009-11#1)
therapeutic results##2##2##(2009-5#1)(2012-3#1)
therapeutic role##2##2##(2013-1#1)(2013-7#1)
therapeutic services##2##2##(1993-2#1)(2008-11#1)
therapeutic strategies for the treatment of##2##6##(2011-2#1)(2013-1#1)
therapeutic strategies for the##3##4##(2011-2#1)(2011-9#1)(2013-1#1)
therapeutic strategies for##4##3##(2009-7#1)(2011-2#1)(2011-9#1)(2013-1#1)
therapeutic strategies have been##2##4##(2010-11#1)(2013-1#1)
therapeutic strategies to##2##3##(2008-5#1)(2008-6#1)
therapeutic strategies##23##2##(1992-3#1)(1995-2#1)(1996-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2011-9#1)(2012-2#2)(2013-1#4)(2013-8#1)
therapeutic strategy for##5##3##(2010-7#1)(2011-2#3)(2012-2#1)
therapeutic strategy##9##2##(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
therapeutic study##2##2##(1993-11#1)(1994-2#1)
therapeutic success##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
therapeutic target for the treatment of##3##6##(2008-1#1)(2012-2#1)(2013-1#1)
therapeutic target for##5##3##(2008-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
therapeutic target##9##2##(2008-1#1)(2008-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
therapeutic targets in human##2##4##(2010-12#1)(2012-2#1)
therapeutic targets in##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
therapeutic targets##10##2##(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
therapeutic tool for##2##3##(1990-5#1)(1994-6#1)
therapeutic tool##3##2##(1990-5#1)(1994-6#1)(2008-6#1)
therapeutic treatment##2##2##(2008-1#1)(2008-3#1)
therapeutic use of##4##3##(1992-9#1)(1996-11#1)(2013-8#2)
therapeutic use##9##2##(1992-9#1)(1993-8#1)(1996-11#1)(2008-11#3)(2012-2#1)(2013-8#2)
therapeutic vaccine##2##2##(1993-3#1)(2007-12#1)
therapeutic vaccines##3##2##(2007-12#1)(2008-4#1)(2013-8#1)
therapeutic value##3##2##(1993-2#1)(2009-8#1)(2012-3#1)
therapeutic##556##1##(1990-11#1)(1990-12#5)(1990-2#5)(1990-3#3)(1990-5#1)(1990-6#5)(1990-8#1)(1990-9#5)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#7)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#3)(1993-11#8)(1993-12#1)(1993-2#6)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#7)(1996-2#1)(1996-3#6)(1996-8#1)(1997-1#7)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-11#4)(2007-12#2)(2007-8#4)(2008-1#5)(2008-10#21)(2008-11#71)(2008-12#12)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#14)(2008-6#9)(2008-7#11)(2008-8#6)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#5)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#6)(2010-10#2)(2010-11#8)(2010-12#11)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#37)(2011-3#6)(2011-7#1)(2011-9#1)(2012-12#7)(2012-2#31)(2012-3#16)(2012-5#1)(2013-1#45)(2013-7#5)(2013-8#19)
therapeutical##4##1##(1990-5#1)(2008-1#1)(2008-5#1)(2009-10#1)
therapeutically relevant##2##2##(1997-1#1)(2008-12#1)
therapeutically to##2##2##(2008-1#1)(2008-10#1)
therapeutically##11##1##(1995-2#1)(1997-1#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
therapeutics for##4##2##(2010-5#1)(2011-2#1)(2012-2#2)
therapeutics is##2##2##(2008-10#1)(2011-3#1)
therapeutics to##3##2##(2008-11#2)(2013-1#1)
therapeutics##41##1##(1991-9#1)(1994-5#1)(1997-1#1)(2007-11#1)(2008-10#7)(2008-11#5)(2008-4#2)(2008-5#3)(2010-12#2)(2010-5#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#4)
therapies and##6##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
therapies are##13##2##(1993-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
therapies based on the##2##4##(1994-9#1)(2008-11#1)
therapies by##2##2##(2012-3#1)(2013-1#1)
therapies can##2##2##(2012-2#1)(2013-1#1)
therapies for the treatment of##3##5##(2008-4#1)(2010-11#1)(2011-2#1)
therapies for the##4##3##(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
therapies for##21##2##(1995-10#1)(1996-2#1)(1997-7#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
therapies has##2##2##(2010-6#1)(2011-2#1)
therapies have##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
therapies in##7##2##(2008-11#2)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#2)
therapies including##2##2##(2010-12#1)(2013-1#1)
therapies into##2##2##(2008-6#1)(2009-11#1)
therapies may be##3##3##(1993-2#1)(2010-12#1)(2013-8#1)
therapies of##4##2##(1995-11#2)(2011-2#1)(2013-1#1)
therapies on##4##2##(1993-2#2)(2008-10#1)(2008-7#1)
therapies such as##2##3##(2008-8#1)(2009-10#1)
therapies targeting##2##2##(2008-4#1)(2009-12#1)
therapies that##6##2##(1995-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
therapies to##5##2##(2008-11#1)(2009-1#1)(2010-7#1)(2011-2#1)(2013-8#1)
therapies##194##1##(1990-3#1)(1992-1#1)(1993-1#2)(1993-11#2)(1993-2#6)(1994-12#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#6)(2008-11#20)(2008-12#2)(2008-4#6)(2008-5#5)(2008-6#9)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#3)(2009-10#1)(2009-11#1)(2009-12#6)(2009-4#2)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#6)(2010-12#12)(2010-5#1)(2010-6#4)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#22)(2011-3#1)(2012-2#8)(2012-3#4)(2013-1#24)(2013-8#6)
therapist##12##1##(1991-12#1)(2008-10#2)(2008-12#3)(2008-4#1)(2010-9#1)(2012-2#4)
therapists and##2##2##(2013-8#2)
therapists are##2##2##(1992-3#2)
therapists have##2##2##(1992-3#1)(2008-12#1)
therapists in##4##2##(1992-3#1)(1993-2#1)(2008-12#1)(2012-2#1)
therapists were##2##2##(2010-7#1)(2013-1#1)
therapists who##2##2##(1991-12#1)(2012-2#1)
therapists with##2##2##(1991-12#1)(2008-12#1)
therapists##46##1##(1990-12#1)(1991-12#3)(1991-2#1)(1992-3#5)(1993-1#2)(1993-2#1)(1993-3#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-12#6)(2008-4#4)(2010-7#1)(2011-2#1)(2012-2#9)(2013-1#2)(2013-8#4)
therapists'##5##1##(2008-10#1)(2008-12#1)(2013-8#3)
therapy (CRT)##2##2##(2008-10#1)(2010-6#1)
therapy (PDT)##6##2##(1994-1#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-8#2)
therapy (PT)##2##2##(2012-2#1)(2013-8#1)
therapy -##2##2##(2007-8#1)(2008-11#1)
therapy a##2##2##(1995-2#1)(2007-11#1)
therapy after##4##2##(2008-11#1)(2008-8#1)(2010-7#1)(2011-3#1)
therapy against##2##2##(2008-10#1)(2013-8#1)
therapy alone##5##2##(1991-6#1)(2008-1#1)(2008-7#2)(2010-12#1)
therapy also##3##2##(2008-12#1)(2008-9#1)(2011-2#1)
therapy and a##2##3##(1997-4#1)(2008-8#1)
therapy and avoidance of##2##4##(2008-10#1)(2011-2#1)
therapy and for##2##3##(2009-9#1)(2013-1#1)
therapy and its##3##3##(1994-6#1)(1996-11#1)(2013-7#1)
therapy and management##2##3##(2012-2#1)(2012-3#1)
therapy and the##3##3##(1992-5#1)(2011-2#2)
therapy and use of##2##4##(1990-11#1)(2010-6#1)
therapy and vaccination##2##3##(2008-11#2)
therapy and volume treatment in elective##2##6##(1990-11#2)
therapy and##89##2##(1990-11#3)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-6#3)(2010-8#1)(2010-9#2)(2011-2#11)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#1)
therapy approach##4##2##(1994-5#1)(1995-2#1)(2013-1#1)(2013-8#1)
therapy are##13##2##(1990-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-6#1)(1994-5#1)(1996-3#1)(2008-10#2)(2010-6#2)(2012-2#1)(2012-3#1)
therapy as a##5##3##(1991-8#1)(1996-3#1)(2008-11#1)(2013-8#2)
therapy as the##2##3##(2009-8#1)(2013-1#1)
therapy as##14##2##(1991-8#1)(1994-6#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-11#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#2)
therapy at##2##2##(1995-2#1)(1996-3#1)
therapy based on the##2##4##(2008-8#1)(2011-2#1)
therapy based on##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
therapy based##6##2##(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
therapy but##3##2##(1993-8#1)(1993-9#1)(2010-11#1)
therapy by##10##2##(1994-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
therapy can be##3##3##(1997-2#1)(2008-6#1)(2012-2#1)
therapy can##4##2##(1997-2#1)(2008-6#1)(2008-7#1)(2012-2#1)
therapy clinical trial for##2##4##(1994-5#1)(2010-10#1)
therapy could##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
therapy due to##2##3##(2008-10#1)(2011-2#1)
therapy during##3##2##(1990-5#1)(2008-11#1)(2013-1#1)
therapy following##4##2##(1994-12#1)(1994-3#2)(2011-2#1)
therapy for active##2##3##(2010-12#2)
therapy for advanced##2##3##(1994-12#1)(2010-12#1)
therapy for chronic##3##3##(2009-8#1)(2010-3#1)(2011-2#1)
therapy for early##3##3##(1994-12#1)(1997-7#1)(2010-12#1)
therapy for fistulizing##2##3##(2010-12#2)
therapy for patients with##7##4##(1997-7#1)(2008-11#3)(2008-8#1)(2009-11#1)(2011-2#1)
therapy for patients##9##3##(1997-7#2)(2008-10#1)(2008-11#3)(2008-8#1)(2009-11#1)(2011-2#1)
therapy for primary##3##3##(1992-12#1)(2010-12#1)(2012-2#1)
therapy for recurrent##2##3##(1994-1#1)(2013-1#1)
therapy for the treatment of##3##5##(2008-8#1)(2010-6#1)(2011-2#1)
therapy for the##8##3##(1992-2#2)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)
therapy for wound and scar management##2##6##(2012-3#2)
therapy for##119##2##(1991-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-5#5)(1994-6#3)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#3)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#7)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#14)(2010-3#1)(2010-6#1)(2011-2#13)(2011-3#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#2)
therapy had##3##2##(1994-12#1)(2008-7#1)(2012-12#1)
therapy has been##5##3##(1991-6#1)(1996-3#1)(1997-1#1)(2011-2#2)
therapy has##15##2##(1990-11#1)(1991-6#1)(1993-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2010-12#2)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
therapy have##7##2##(1992-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#2)(2011-2#1)
therapy in Parkinson's disease##2##4##(2008-7#2)
therapy in a large##2##4##(1996-3#1)(2009-9#1)
therapy in a##5##3##(1994-6#1)(1996-3#1)(2009-11#1)(2009-9#1)(2010-7#1)
therapy in breast##2##3##(1993-11#1)(2013-8#1)
therapy in chronic hepatitis##2##4##(1995-10#1)(2013-1#1)
therapy in chronic##5##3##(1991-6#1)(1995-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
therapy in clinical##2##3##(2011-2#1)(2013-1#1)
therapy in metastatic colorectal cancer##2##5##(1990-2#1)(1992-12#1)
therapy in metastatic##3##3##(1990-2#1)(1992-12#1)(2011-3#1)
therapy in osteomyelitis##2##3##(2010-6#2)
therapy in patients with severe##2##5##(2009-6#1)(2013-1#1)
therapy in patients with##9##4##(1994-12#1)(1997-7#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
therapy in patients##11##3##(1994-12#1)(1997-7#1)(2008-10#1)(2009-6#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
therapy in postmenopausal##2##3##(2012-3#2)
therapy in selected patients##2##4##(1994-6#1)(2011-3#1)
therapy in selected##3##3##(1994-6#1)(2010-12#1)(2011-3#1)
therapy in severe##2##3##(2010-12#1)(2011-2#1)
therapy in the Netherlands##2##4##(2008-12#2)
therapy in the use of##2##5##(2009-6#2)
therapy in the##13##3##(1990-3#1)(1991-8#1)(2008-10#2)(2008-12#2)(2009-6#2)(2011-2#3)(2011-3#1)(2013-1#1)
therapy in this age group##2##5##(1997-1#2)
therapy in this setting##2##4##(2011-2#1)(2013-1#1)
therapy in this##5##3##(1997-1#2)(2008-11#1)(2011-2#1)(2013-1#1)
therapy in women##2##3##(2008-7#1)(2012-3#1)
therapy in##138##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-11#5)(1993-2#1)(1993-3#1)(1994-12#3)(1994-6#3)(1994-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-11#5)(1996-2#1)(1996-3#2)(1997-1#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#4)(2008-7#6)(2008-8#2)(2009-10#4)(2009-11#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-10#4)(2010-11#1)(2010-12#7)(2010-6#2)(2010-7#2)(2010-9#1)(2011-2#16)(2011-3#4)(2012-12#1)(2012-3#8)(2013-1#5)(2013-7#1)(2013-8#6)
therapy included##2##2##(1994-12#1)(2008-11#1)
therapy including##4##2##(1990-12#1)(2008-10#1)(2008-12#1)(2010-6#1)
therapy interventions##2##2##(2008-12#1)(2013-1#1)
therapy is a promising##3##4##(1991-9#1)(2008-11#1)(2008-6#1)
therapy is a##7##3##(1990-11#1)(1990-12#1)(1991-9#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-3#1)
therapy is an##2##3##(2008-11#1)(2012-3#1)
therapy is emphasized##2##3##(1991-11#1)(1995-2#1)
therapy is initiated##2##3##(2008-7#1)(2011-2#1)
therapy is the mainstay of##2##5##(1997-1#1)(2010-12#1)
therapy is the##5##3##(1993-8#1)(1997-1#1)(2010-12#2)(2011-2#1)
therapy is##44##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-6#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-10#1)(2010-12#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
therapy management of##2##3##(2008-12#2)
therapy management##4##2##(2008-12#4)
therapy may be##6##3##(1997-7#1)(2008-11#1)(2008-4#1)(2010-10#1)(2012-3#2)
therapy may have##2##3##(1997-1#1)(2011-2#1)
therapy may##15##2##(1994-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)
therapy might be##2##3##(2008-11#1)(2012-3#1)
therapy must be##3##3##(1997-5#1)(2010-12#1)(2011-2#1)
therapy must##5##2##(1994-6#1)(1996-1#1)(1997-5#1)(2010-12#1)(2011-2#1)
therapy of CVI##2##3##(2011-3#2)
therapy of acute##4##3##(1990-9#1)(1991-3#1)(1994-2#2)
therapy of brain##2##3##(1995-2#1)(2008-7#1)
therapy of breast cancer##4##4##(1993-11#2)(1993-2#1)(1996-11#1)
therapy of cancer##3##3##(1994-5#1)(2008-8#2)
therapy of chronic##3##3##(1997-1#1)(2008-1#1)(2011-2#1)
therapy of oral##2##3##(1990-2#1)(2009-12#1)
therapy of these##2##3##(1995-2#1)(2010-1#1)
therapy of this##3##3##(2008-8#1)(2012-12#1)(2012-3#1)
therapy of##95##2##(1990-12#1)(1990-2#1)(1990-9#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-11#1)(1997-1#2)(1997-4#2)(1997-8#1)(2007-11#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#7)(2008-8#6)(2008-9#1)(2009-12#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#2)(2011-2#7)(2011-3#7)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
therapy on the##6##3##(1992-6#1)(1993-2#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
therapy on##19##2##(1992-6#1)(1993-2#1)(1994-5#1)(1996-2#1)(2008-11#3)(2008-7#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
therapy or the##2##3##(1991-8#1)(2011-2#1)
therapy or##8##2##(1991-8#1)(1992-3#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)
therapy outcome in##2##3##(2010-12#1)(2012-2#1)
therapy outcome##5##2##(2010-12#1)(2012-2#4)
therapy over##3##2##(1996-2#1)(2008-11#1)(2013-1#1)
therapy planning##3##2##(2012-2#3)
therapy practices##3##2##(1991-12#2)(2010-9#1)
therapy predicts##2##2##(2008-9#1)(2011-2#1)
therapy products##3##2##(2008-11#1)(2013-1#2)
therapy program##2##2##(1995-3#1)(1996-3#1)
therapy progress##6##2##(2012-2#6)
therapy protocol with##2##3##(1994-5#1)(2011-2#1)
therapy protocol##4##2##(1994-5#2)(2007-11#1)(2011-2#1)
therapy proves##2##2##(1994-6#1)(2011-2#1)
therapy requires##2##2##(2010-10#1)(2012-2#1)
therapy response##2##2##(2008-4#1)(2010-12#1)
therapy results in##2##3##(2011-1#1)(2011-2#1)
therapy seems to be##2##4##(2008-11#1)(2008-8#1)
therapy seems##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
therapy services##2##2##(1996-3#1)(2013-8#1)
therapy sessions##2##2##(2013-1#2)
therapy should be considered##2##4##(2009-8#1)(2010-12#1)
therapy should be##6##3##(2009-8#2)(2010-12#1)(2011-2#3)
therapy should##10##2##(1993-2#1)(1996-6#1)(2009-8#2)(2010-12#2)(2011-2#4)
therapy since##4##2##(1990-9#2)(1993-1#1)(2013-8#1)
therapy than##2##2##(2008-11#1)(2008-2#1)
therapy that##6##2##(1990-12#1)(1992-3#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
therapy to be##3##3##(2008-11#2)(2008-5#1)
therapy to improve##2##3##(1994-12#1)(2011-2#1)
therapy to the##2##3##(2008-12#1)(2013-1#1)
therapy to treat##2##3##(1997-1#1)(2008-7#1)
therapy to##17##2##(1992-3#1)(1994-12#1)(1996-6#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
therapy trials##4##2##(1997-1#1)(2007-11#1)(2008-8#2)
therapy using##9##2##(1993-11#2)(2008-5#1)(2010-10#1)(2011-2#2)(2012-3#2)(2013-8#1)
therapy was initiated and##2##4##(2012-3#1)(2013-8#1)
therapy was initiated##3##3##(2008-4#1)(2012-3#1)(2013-8#1)
therapy was started##2##3##(2011-2#1)(2013-8#1)
therapy was##24##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-2#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-8#2)
therapy were##9##2##(1990-12#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-3#1)(2013-1#2)
therapy when##2##2##(1992-1#1)(2008-11#1)
therapy which##3##2##(1995-12#1)(2010-7#1)(2010-8#1)
therapy will##3##2##(2008-7#1)(2009-8#1)(2010-3#1)
therapy with a##2##3##(2011-2#1)(2013-1#1)
therapy with intravenous##2##3##(2008-5#1)(2013-1#1)
therapy with mechanical##2##3##(2008-12#1)(2013-1#1)
therapy with recombinant##2##3##(1996-8#1)(2011-2#1)
therapy with the##2##3##(1995-2#1)(2010-12#1)
therapy with##53##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-6#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#11)(2013-8#2)
therapy within##2##2##(2008-12#1)(2010-10#1)
therapy would be##2##3##(2011-1#1)(2011-2#1)
therapy##1528##1##(1990-11#12)(1990-12#9)(1990-2#6)(1990-3#2)(1990-5#5)(1990-6#5)(1990-8#1)(1990-9#8)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#9)(1991-3#7)(1991-4#1)(1991-6#11)(1991-8#10)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#8)(1992-2#5)(1992-3#9)(1992-5#4)(1992-6#4)(1992-7#1)(1992-9#2)(1993-1#6)(1993-11#19)(1993-12#2)(1993-2#13)(1993-3#5)(1993-6#7)(1993-8#9)(1993-9#5)(1994-1#2)(1994-12#18)(1994-2#5)(1994-3#10)(1994-5#23)(1994-6#19)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#12)(1995-3#3)(1995-5#3)(1995-6#1)(1996-1#3)(1996-11#19)(1996-2#5)(1996-3#26)(1996-6#8)(1996-8#1)(1996-9#3)(1997-1#17)(1997-2#12)(1997-3#3)(1997-4#7)(1997-5#4)(1997-6#5)(1997-7#10)(1997-8#8)(2007-11#13)(2007-12#2)(2007-7#2)(2007-8#5)(2008-1#20)(2008-10#49)(2008-11#92)(2008-12#44)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#15)(2008-6#14)(2008-7#61)(2008-8#35)(2008-9#20)(2009-1#2)(2009-10#12)(2009-11#8)(2009-12#8)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#7)(2009-8#22)(2009-9#5)(2010-1#13)(2010-10#15)(2010-11#9)(2010-12#66)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#23)(2010-7#7)(2010-8#2)(2010-9#10)(2011-1#7)(2011-10#1)(2011-2#156)(2011-3#21)(2011-7#1)(2012-10#1)(2012-12#16)(2012-2#57)(2012-3#53)(2012-4#2)(2012-5#2)(2013-1#97)(2013-7#6)(2013-8#57)
therapy) and##2##2##(1994-8#1)(1996-11#1)
therapy)##5##1##(1994-8#1)(1996-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
therapy?##4##1##(1994-8#1)(2008-11#1)(2009-12#1)(2011-2#1)
therapy]##20##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-2#2)(1992-11#1)(1992-3#1)(1993-3#1)(1995-11#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-8#1)(2008-1#1)(2008-10#1)(2011-3#1)(2012-3#1)
there a place for##3##4##(1995-1#1)(2008-11#2)
there a relationship between##2##4##(1992-2#1)(1995-12#1)
there a##32##2##(1991-3#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
there also exists a##2##4##(1994-12#1)(2008-9#1)
there also##3##2##(1994-12#1)(1996-2#1)(2008-9#1)
there any##4##2##(1991-3#1)(1991-8#1)(2009-5#1)(2010-12#1)
there appeared to be##2##4##(2008-12#1)(2011-2#1)
there appears to be a##2##5##(1990-5#1)(2012-2#1)
there appears to be little##2##5##(2008-11#1)(2008-12#1)
there appears to be##7##4##(1990-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
there are 3##2##3##(1994-2#1)(2008-11#1)
there are a number of##6##5##(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)
there are a wide##2##4##(2008-4#1)(2008-5#1)
there are a##11##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2012-12#1)(2012-3#1)
there are additional##2##3##(2008-9#1)(2010-5#1)
there are also##4##3##(1995-3#1)(2008-1#1)(2010-6#1)(2011-2#1)
there are any##2##3##(2008-10#1)(2012-2#1)
there are at least##4##4##(2008-10#1)(2008-11#1)(2012-2#2)
there are certain##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
there are challenges##2##3##(2008-12#1)(2013-8#1)
there are concerns that##2##4##(2008-11#1)(2009-3#1)
there are concerns##3##3##(1997-1#1)(2008-11#1)(2009-3#1)
there are currently##2##3##(1996-1#1)(2010-12#1)
there are differences in##3##4##(1993-2#1)(2008-10#1)(2009-3#1)
there are differences##4##3##(1993-2#1)(2008-10#1)(2009-3#1)(2010-7#1)
there are different##2##3##(1997-7#1)(2008-10#1)
there are few data##2##4##(2010-12#1)(2012-3#1)
there are few##11##3##(1993-2#2)(1993-6#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-3#1)
there are functional##2##3##(1994-2#1)(2012-3#1)
there are important##2##3##(1995-5#1)(2011-10#1)
there are insufficient##2##3##(1997-6#1)(2008-11#1)
there are many factors##2##4##(1991-12#1)(2009-1#1)
there are many##19##3##(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-1#1)(2011-2#1)(2013-1#1)
there are more##3##3##(1996-3#1)(2008-4#1)(2009-8#1)
there are multiple##3##3##(2009-3#1)(2010-6#1)(2011-2#1)
there are nine##2##3##(2008-5#1)(2008-8#1)
there are no##29##3##(1990-2#1)(1990-9#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-9#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
there are now##3##3##(2008-7#1)(2010-11#1)(2013-1#1)
there are only a few##3##5##(2007-12#1)(2008-11#1)(2013-1#1)
there are only few##2##4##(2008-11#1)(2011-2#1)
there are only isolated##2##4##(2008-10#1)(2013-8#1)
there are only##9##3##(2007-12#1)(2008-10#2)(2008-11#2)(2011-2#2)(2013-1#1)(2013-8#1)
there are other##3##3##(1994-1#1)(1996-11#1)(2012-3#1)
there are several##12##3##(1993-3#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
there are significant differences##2##4##(1992-2#1)(2010-12#1)
there are significant##5##3##(1992-2#1)(2008-1#1)(2008-12#1)(2010-12#1)(2012-3#1)
there are some##9##3##(1992-3#1)(1995-3#1)(2008-11#3)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
there are still few##2##4##(2008-10#1)(2010-10#1)
there are still many##3##4##(1990-11#1)(2008-10#1)(2008-11#1)
there are still##10##3##(1990-11#1)(1997-7#1)(2008-10#3)(2008-11#1)(2010-10#2)(2013-1#2)
there are three##5##3##(1993-12#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-5#1)
there are two different##2##4##(2008-10#2)
there are two types of##2##5##(2008-3#1)(2008-7#1)
there are two types##3##4##(1993-12#1)(2008-3#1)(2008-7#1)
there are two##19##3##(1992-3#1)(1993-12#2)(1994-5#2)(1995-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)(2011-3#1)
there are unique##2##3##(2010-12#1)(2013-1#1)
there are##294##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#5)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#4)(2008-10#40)(2008-11#21)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#13)(2008-9#13)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#4)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#6)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#15)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#8)(2012-5#1)(2013-1#13)(2013-8#5)
there be##4##2##(1993-12#1)(2008-11#1)(2011-1#1)(2011-2#1)
there can be##4##3##(1992-2#1)(2008-12#1)(2008-8#2)
there could be##2##3##(1997-6#1)(2009-12#1)
there differences##3##2##(2007-11#1)(2012-12#1)(2012-2#1)
there exist##6##2##(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
there exists a##4##3##(1990-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
there exists##7##2##(1990-5#1)(1997-2#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
there for##4##2##(2008-10#1)(2010-11#2)(2012-12#1)
there has been a great deal of##2##7##(1992-9#1)(2008-10#1)
there has been a resurgence##2##5##(1997-7#1)(2008-11#1)
there has been a significant increase in##2##7##(1995-1#1)(2011-2#1)
there has been a substantial##2##5##(2008-5#1)(2011-2#1)
there has been a##23##4##(1990-11#1)(1992-9#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-4#1)(2012-12#1)
there has been an increase in##2##6##(2008-11#1)(2012-3#1)
there has been an increase##3##5##(2008-11#1)(2012-2#1)(2012-3#1)
there has been an increasing interest in##2##7##(2008-10#1)(2012-12#1)
there has been an##8##4##(2008-10#1)(2008-11#2)(2012-12#1)(2012-2#1)(2012-3#3)
there has been considerable##3##4##(1992-1#1)(2008-11#1)(2009-1#1)
there has been growing interest in the##3##7##(2008-11#1)(2008-7#2)
there has been increasing interest in the##2##7##(2008-3#1)(2008-7#1)
there has been increasing interest in##3##6##(1991-2#1)(2008-3#1)(2008-7#1)
there has been limited##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
there has been little##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
there has been no##9##4##(1990-6#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2012-3#2)
there has been only##2##4##(2008-9#1)(2010-6#1)
there has been recent##2##4##(1997-8#1)(2010-1#1)
there has been##69##3##(1990-11#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-4#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#2)
there has##75##2##(1990-11#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#13)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-9#3)(2009-1#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-4#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#4)
there have been a number of##3##6##(2008-11#1)(2008-7#1)(2013-1#1)
there have been a##4##4##(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
there have been few reports##2##5##(2012-12#1)(2012-3#1)
there have been few##4##4##(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
there have been no significant##2##5##(2013-1#1)(2013-7#1)
there have been no##9##4##(1994-2#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
there have been several reports##2##5##(2010-6#1)(2012-3#1)
there have been significant developments in##2##6##(2008-11#1)(2013-8#1)
there have been significant##4##4##(1990-11#1)(2008-11#2)(2013-8#1)
there have been##35##3##(1990-11#1)(1992-2#1)(1994-2#1)(1994-9#1)(1997-8#1)(2008-10#3)(2008-11#6)(2008-12#3)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
there is a brief##2##4##(2009-9#2)
there is a clear##2##4##(2008-10#1)(2010-7#1)
there is a considerable##4##4##(1997-5#1)(1997-8#1)(2008-10#1)(2010-9#1)
there is a correlation between##2##5##(2008-10#1)(2011-2#1)
there is a cost##2##4##(2008-10#1)(2008-8#1)
there is a dearth of##3##5##(2008-11#2)(2008-12#1)
there is a decrease in##2##5##(2008-10#1)(2011-2#1)
there is a gradual##2##4##(1994-8#1)(2009-11#1)
there is a great need##2##5##(1994-9#1)(2008-10#1)
there is a great##3##4##(1994-9#1)(2008-10#2)
there is a growing body of##3##6##(2008-12#1)(2010-8#1)(2012-2#1)
there is a growing interest in##2##6##(2008-11#1)(2013-1#1)
there is a growing need##2##5##(2008-11#1)(2010-12#1)
there is a growing##9##4##(1996-1#1)(2008-11#2)(2008-12#2)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
there is a high##6##4##(1997-3#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-11#1)
there is a higher##3##4##(1996-3#1)(2009-1#1)(2011-2#1)
there is a lack of##5##5##(2008-11#3)(2008-12#1)(2011-2#1)
there is a marked##2##4##(1992-3#1)(2008-9#1)
there is a need for more##2##6##(1995-2#1)(2008-12#1)
there is a need for##14##5##(1993-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2011-1#2)(2011-2#1)(2013-1#4)
there is a need to develop##2##6##(2012-2#2)
there is a need to solidify the terminology of and measurements for CS in nursing##2##15##(2013-1#2)
there is a need to##19##5##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
there is a need##33##4##(1993-12#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
there is a paucity of##3##5##(2008-11#1)(2008-7#1)(2013-8#1)
there is a possibility of##2##5##(2011-2#1)(2012-12#1)
there is a progressive##2##4##(2007-12#1)(2013-7#1)
there is a real##2##4##(1995-12#1)(2008-11#1)
there is a reasonable##2##4##(1991-1#1)(1991-9#1)
there is a risk of##2##5##(1997-3#1)(2010-5#1)
there is a risk##3##4##(1997-3#1)(2008-10#1)(2010-5#1)
there is a significant##5##4##(1994-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
there is a strong correlation between##2##6##(1997-1#1)(2011-2#1)
there is a strong##7##4##(1995-5#1)(1997-1#1)(2008-12#1)(2008-3#2)(2010-8#1)(2011-2#1)
there is a threshold##4##4##(2008-10#1)(2008-8#2)(2010-1#1)
there is a very##2##4##(1995-5#1)(2008-10#1)
there is a weak##2##4##(2009-5#1)(2010-3#1)
there is a wide##2##4##(2008-12#1)(2008-5#1)
there is a##195##3##(1990-11#1)(1990-2#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#20)(2008-11#16)(2008-12#9)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#1)(2009-9#4)(2010-1#3)(2010-10#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#11)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#3)
there is also a##2##4##(2008-10#1)(2008-8#1)
there is also an##2##4##(1996-8#1)(2011-2#1)
there is also some##3##4##(1990-2#1)(1991-6#1)(2008-8#1)
there is also##7##3##(1990-2#1)(1991-6#1)(1996-8#1)(2008-10#1)(2008-8#2)(2011-2#1)
there is an increase in the##2##6##(2008-11#1)(2010-12#1)
there is an increased##2##4##(1994-5#1)(2009-12#1)
there is an urgent need for##2##6##(2008-10#1)(2008-11#1)
there is an urgent need to##2##6##(2008-1#1)(2008-11#1)
there is an urgent need##4##5##(2008-1#1)(2008-10#1)(2008-11#2)
there is an urgent##5##4##(2008-1#1)(2008-10#1)(2008-11#3)
there is an##33##3##(1990-3#1)(1990-8#1)(1992-12#1)(1993-3#1)(1994-5#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-12#1)
there is clear##2##3##(2008-6#1)(2010-11#1)
there is considerable##8##3##(1994-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#2)
there is controversy about##2##4##(2010-11#1)(2011-2#1)
there is currently no##2##4##(1996-1#1)(2011-2#1)
there is currently##4##3##(1996-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
there is emerging evidence##2##4##(1994-5#1)(2008-4#1)
there is evidence of an##2##5##(1996-5#1)(2008-11#1)
there is evidence of##5##4##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)
there is evidence that##5##4##(1992-7#1)(1995-12#1)(2008-10#1)(2008-11#1)(2010-1#1)
there is evidence##13##3##(1992-7#1)(1995-12#1)(1996-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2010-1#1)(2010-10#1)(2012-2#1)(2012-3#1)
there is good##3##3##(2008-10#2)(2008-7#1)
there is hope##2##3##(1990-2#1)(2008-12#1)
there is increasing interest in##2##5##(2010-10#1)(2010-7#1)
there is increasing##4##3##(2008-7#1)(2010-10#1)(2010-7#1)(2012-2#1)
there is lack of##2##4##(2008-5#1)(2011-10#1)
there is limited##4##3##(1992-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
there is little consensus##2##4##(2008-10#1)(2008-11#1)
there is little evidence to##2##5##(2008-5#1)(2011-2#1)
there is little experimental evidence##2##5##(2008-10#1)(2008-8#1)
there is little##16##3##(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#3)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
there is more##3##3##(1994-3#1)(2008-11#1)(2012-3#1)
there is much##2##3##(1994-1#1)(2009-12#1)
there is no &quot##2##4##(1993-8#1)(2008-10#1)
there is no consensus regarding the##2##6##(1994-12#1)(2008-11#1)
there is no consensus regarding##3##5##(1994-12#1)(2008-11#1)(2013-8#1)
there is no consensus##5##4##(1994-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2013-8#1)
there is no cure##2##4##(2010-11#2)
there is no definitive##2##4##(2008-9#1)(2010-12#1)
there is no effective##2##4##(1990-2#1)(2012-2#1)
there is no evidence for an##2##6##(2008-11#1)(2012-3#1)
there is no evidence of##3##5##(1990-2#1)(2009-7#1)(2013-1#1)
there is no evidence that##2##5##(2008-10#1)(2012-12#1)
there is no evidence##10##4##(1990-2#1)(1992-2#1)(1995-11#1)(2008-10#2)(2008-11#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
there is no information##2##4##(2008-10#2)
there is no known##3##4##(1995-6#1)(2011-1#1)(2013-1#1)
there is no need##2##4##(2008-10#2)
there is no significant difference##3##5##(2008-10#2)(2008-9#1)
there is no significant##5##4##(1990-2#1)(2008-10#2)(2008-9#1)(2009-5#1)
there is no specific treatment##2##5##(2011-2#1)(2013-1#1)
there is no##112##3##(1990-2#3)(1990-6#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-8#1)(1994-12#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-3#3)(1997-1#2)(1997-5#1)(1997-7#1)(2008-1#3)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-12#1)(2009-5#2)(2009-7#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#2)
there is not a##2##4##(2008-11#1)(2011-2#1)
there is not##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
there is now##4##3##(1990-2#1)(1992-5#1)(2010-1#1)(2011-2#1)
there is one##2##3##(1994-9#1)(2008-8#1)
there is only one##2##4##(2008-3#1)(2013-8#1)
there is only##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
there is potential##2##3##(2008-10#2)
there is significant##2##3##(2008-10#2)
there is some##5##3##(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#1)
there is still a need for##3##6##(2008-10#1)(2008-5#1)(2013-1#1)
there is still a need##4##5##(2008-10#2)(2008-5#1)(2013-1#1)
there is still a##7##4##(1997-2#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-6#1)(2013-1#1)
there is still much##3##4##(1990-9#1)(2008-11#1)(2009-1#1)
there is still no##2##4##(2008-7#1)(2013-1#1)
there is still##17##3##(1990-9#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#2)
there is strong evidence that##2##5##(2008-1#1)(2008-8#1)
there is strong evidence##3##4##(2008-1#1)(2008-8#1)(2013-1#1)
there is strong##8##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#3)(2009-8#1)(2013-1#1)
there is substantial##2##3##(1994-3#1)(2012-2#1)
there is surprisingly little##2##4##(2008-11#1)(2009-4#1)
there is the need##2##4##(2008-10#1)(2008-11#1)
there is the##3##3##(1990-3#1)(2008-10#1)(2008-11#1)
there is value in##2##4##(2009-1#1)(2012-12#1)
there is variation##2##3##(2008-10#1)(2012-3#1)
there is very little##4##4##(2008-7#2)(2008-8#1)(2009-8#1)
there is##547##2##(1990-11#2)(1990-2#7)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#2)(1992-7#1)(1993-1#2)(1993-12#3)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-5#2)(1995-6#3)(1996-1#2)(1996-2#4)(1996-3#6)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#4)(1997-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#8)(2008-10#64)(2008-11#43)(2008-12#19)(2008-2#3)(2008-3#15)(2008-4#3)(2008-5#13)(2008-6#7)(2008-7#15)(2008-8#30)(2008-9#20)(2009-1#3)(2009-10#4)(2009-11#2)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#4)(2009-8#3)(2009-9#4)(2010-1#7)(2010-10#6)(2010-11#5)(2010-12#7)(2010-2#1)(2010-3#2)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#5)(2011-10#1)(2011-2#26)(2011-3#1)(2012-12#8)(2012-2#17)(2012-3#15)(2013-1#32)(2013-7#1)(2013-8#8)
there may be a##8##4##(1991-2#1)(1993-3#1)(1993-8#1)(1996-12#1)(2008-1#1)(2008-9#1)(2013-7#1)(2013-8#1)
there may be other##2##4##(1997-1#1)(1997-7#1)
there may be##21##3##(1991-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
there may##24##2##(1991-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#4)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
there might be##4##3##(2008-8#1)(2009-10#1)(2010-10#1)(2012-2#1)
there must be##6##3##(1997-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-3#1)
there no##2##2##(2010-6#1)(2012-3#1)
there other##2##2##(1996-1#1)(2010-12#1)
there remain significant##2##3##(2008-6#2)
there remain##4##2##(2008-11#1)(2008-12#1)(2008-6#2)
there remains considerable##2##3##(2008-11#1)(2008-7#1)
there remains##3##2##(2008-11#1)(2008-7#1)(2009-10#1)
there seems to be a##5##5##(1993-3#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-8#1)
there seems to be##6##4##(1993-3#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-10#1)
there seems##7##2##(1993-3#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-10#1)(2010-7#1)
there should be a##2##4##(1995-2#1)(2008-7#1)
there should be##4##3##(1992-12#1)(1992-2#1)(1995-2#1)(2008-7#1)
there to##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
there was a decrease in##2##5##(1993-12#1)(1995-12#1)
there was a delay##2##4##(2008-10#1)(2012-6#1)
there was a direct relationship between##2##6##(2008-10#2)
there was a graded reduction in the rate of##2##9##(2008-5#2)
there was a high##3##4##(1990-5#1)(1994-12#1)(2008-12#1)
there was a higher##2##4##(2008-9#1)(2012-3#1)
there was a large##2##4##(1994-2#1)(2008-7#1)
there was a linear##2##4##(2008-10#1)(2008-12#1)
there was a little difference in##2##6##(2008-11#1)(2013-8#1)
there was a marked##2##4##(2007-12#1)(2008-11#1)
there was a reduction in##2##5##(1990-5#1)(2013-8#1)
there was a reduction of##2##5##(2008-10#1)(2013-1#1)
there was a reduction##4##4##(1990-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
there was a significant decrease in##2##6##(2012-2#1)(2013-8#1)
there was a significant increase in##2##6##(2008-10#1)(2013-1#1)
there was a significant increase of##2##6##(1995-8#1)(2012-2#1)
there was a significant increase##4##5##(1995-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
there was a significant reduction in##2##6##(1993-1#1)(1996-1#1)
there was a significant reduction##3##5##(1993-1#1)(1996-1#1)(1996-12#1)
there was a significant##17##4##(1990-5#1)(1993-1#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(2008-10#4)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
there was a statistically significant difference##2##6##(2007-12#1)(2013-8#1)
there was a statistically significant##3##5##(2007-12#1)(2011-2#1)(2013-8#1)
there was a strong correlation##3##5##(1991-6#1)(1994-8#1)(2008-10#1)
there was a strong##6##4##(1991-6#1)(1994-8#2)(2008-10#1)(2008-9#1)(2010-6#1)
there was a substantial##2##4##(1991-6#1)(1992-2#1)
there was a tendency##2##4##(1991-2#1)(2008-11#1)
there was a trend toward##2##5##(2008-10#1)(2009-3#1)
there was a trend##4##4##(1996-6#1)(2008-10#1)(2009-3#2)
there was a##117##3##(1990-2#1)(1990-5#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-6#1)(2007-12#3)(2008-10#22)(2008-11#9)(2008-12#4)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#5)(2009-3#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-6#2)(2010-7#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#4)(2013-8#5)
there was also##2##3##(1994-8#1)(2008-11#1)
there was an increase in the##3##6##(2008-11#1)(2008-9#1)(2013-8#1)
there was an increase in##5##5##(2008-10#1)(2008-11#2)(2008-9#1)(2013-8#1)
there was an##15##3##(1992-2#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-8#1)
there was considerable##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
there was evidence of##2##4##(1992-5#1)(1995-5#1)
there was gradual##2##3##(2008-10#1)(2011-2#1)
there was great##2##3##(1994-3#1)(2009-7#1)
there was greater##2##3##(2008-10#2)
there was little##12##3##(1990-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)
there was minimal##2##3##(1993-12#1)(2008-11#1)
there was no change in the##3##6##(1990-5#1)(1991-2#1)(1996-12#1)
there was no change in##5##5##(1990-5#1)(1991-2#1)(1996-12#2)(2013-8#1)
there was no change##6##4##(1990-5#1)(1991-2#1)(1996-12#2)(2012-3#1)(2013-8#1)
there was no clear##4##4##(1992-3#1)(2008-10#1)(2008-11#1)(2011-1#1)
there was no correlation between##3##5##(1993-2#1)(2011-2#2)
there was no correlation##4##4##(1993-2#1)(2011-2#3)
there was no difference in the##2##6##(2008-8#1)(2013-8#1)
there was no difference in##8##5##(1994-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#2)
there was no difference##11##4##(1990-2#1)(1992-12#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#2)
there was no effect##3##4##(1990-5#1)(1995-2#1)(2008-10#1)
there was no evidence of carcinogenic activity of##3##8##(2008-9#3)
there was no evidence of##11##5##(1991-1#1)(1991-6#1)(2008-10#4)(2008-9#3)(2013-1#2)
there was no evidence that##2##5##(1996-3#1)(2008-9#1)
there was no evidence##14##4##(1991-1#1)(1991-6#1)(1996-3#1)(2008-10#4)(2008-9#4)(2011-2#1)(2013-1#2)
there was no indication of##2##5##(1990-5#1)(2008-10#1)
there was no mortality##2##4##(1997-8#1)(2008-7#1)
there was no reduction of##2##5##(1992-12#1)(1996-12#1)
there was no reduction##3##4##(1992-12#1)(1996-12#1)(2008-10#1)
there was no relationship between the##3##6##(1991-11#1)(2008-12#1)(2008-8#1)
there was no relationship between##4##5##(1991-11#1)(2008-10#1)(2008-12#1)(2008-8#1)
there was no significant correlation##2##5##(2006-6#1)(2008-10#1)
there was no significant difference among##2##6##(2008-10#1)(2013-1#1)
there was no significant difference between the##3##7##(1997-8#1)(2008-10#1)(2008-9#1)
there was no significant difference between##6##6##(1991-8#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
there was no significant difference in the##2##7##(2011-2#1)(2012-3#1)
there was no significant difference in##8##6##(1994-2#1)(1994-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
there was no significant difference##17##5##(1991-8#1)(1994-2#1)(1994-3#1)(1997-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
there was no significant interaction##2##5##(2008-10#2)
there was no significant##28##4##(1991-8#1)(1994-2#1)(1994-3#1)(1997-8#1)(2006-6#1)(2008-10#8)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)
there was no statistically significant difference in##2##7##(2008-11#1)(2008-12#1)
there was no##129##3##(1990-2#1)(1990-5#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-12#3)(1996-2#3)(1996-3#1)(1997-3#1)(1997-8#3)(2006-6#1)(2008-10#36)(2008-11#6)(2008-12#3)(2008-7#6)(2008-8#3)(2008-9#8)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-12#2)(2012-3#4)(2013-1#9)(2013-8#4)
there was not a##2##4##(2008-10#1)(2008-12#1)
there was only##2##3##(1994-8#1)(1997-1#1)
there was significant##5##3##(2008-10#2)(2009-4#1)(2010-4#1)(2013-1#1)
there was some##4##3##(1991-12#1)(2008-9#1)(2010-8#1)(2013-1#1)
there was##364##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#6)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-6#3)(1991-8#2)(1992-12#3)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#6)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#3)(1996-1#1)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#1)(1996-6#1)(1997-1#2)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#4)(2006-6#2)(2007-11#1)(2007-12#3)(2008-10#94)(2008-11#29)(2008-12#9)(2008-4#1)(2008-5#6)(2008-7#10)(2008-8#8)(2008-9#18)(2009-3#3)(2009-4#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#2)(2011-10#1)(2011-2#14)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#10)(2012-6#1)(2013-1#17)(2013-8#11)
there were a##3##3##(2008-5#1)(2008-9#2)
there were any##2##3##(1994-12#1)(2008-11#1)
there were differences in the##2##5##(1996-2#1)(2008-10#1)
there were few##2##3##(1995-3#1)(2008-10#1)
there were fewer##2##3##(2008-10#2)
there were four##2##3##(2008-10#2)
there were increased incidences of##2##5##(2008-9#2)
there were many##6##3##(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#2)
there were no differences in##3##5##(2008-10#1)(2008-7#1)(2013-8#1)
there were no differences##4##4##(2008-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
there were no significant differences in##6##6##(1991-2#1)(1993-1#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
there were no significant differences##8##5##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
there were no significant##12##4##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
there were no signs of##3##5##(1993-1#1)(1993-6#1)(2011-2#1)
there were no statistically significant differences between transdermal and oral granisetron##2##11##(2010-12#2)
there were no statistically significant differences between##3##7##(2010-12#2)(2013-1#1)
there were no treatment-related##2##4##(2008-9#2)
there were no##34##3##(1991-2#1)(1991-5#1)(1993-1#2)(1993-6#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#3)(2010-12#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
there were several##2##3##(2008-1#1)(2008-5#1)
there were significant difference##2##4##(2008-12#1)(2008-7#1)
there were significant differences among##2##5##(1993-2#1)(2013-8#1)
there were significant differences between##3##5##(2008-10#1)(2008-12#1)(2009-12#1)
there were significant differences##6##4##(1993-2#1)(1995-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2013-8#1)
there were significant interactions##2##4##(2008-10#2)
there were significant##15##3##(1993-12#1)(1993-2#1)(1994-8#2)(1995-12#1)(2008-10#3)(2008-12#2)(2008-7#2)(2009-12#1)(2010-1#1)(2013-8#1)
there were some differences##2##4##(2008-5#1)(2012-12#1)
there were statistically significant##2##4##(2008-7#1)(2011-2#1)
there were two##2##3##(2008-10#1)(2008-9#1)
there were##131##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#2)(1994-12#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#25)(2008-11#3)(2008-12#6)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#11)(2009-11#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#4)
there will be##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
there would be no##2##4##(1992-12#1)(2008-10#1)
there would be##3##3##(1992-12#1)(2008-10#1)(2011-2#1)
there would##4##2##(1992-12#1)(2008-10#2)(2011-2#1)
there##1646##1##(1990-11#7)(1990-12#1)(1990-2#10)(1990-3#3)(1990-5#9)(1990-6#3)(1990-8#1)(1990-9#3)(1991-1#4)(1991-11#3)(1991-12#5)(1991-2#10)(1991-3#7)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-12#9)(1992-2#12)(1992-3#8)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#7)(1993-12#12)(1993-2#8)(1993-3#7)(1993-6#7)(1993-8#7)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#9)(1994-2#11)(1994-3#9)(1994-5#7)(1994-6#3)(1994-8#13)(1994-9#4)(1995-1#3)(1995-11#4)(1995-12#10)(1995-2#9)(1995-3#5)(1995-5#6)(1995-6#3)(1995-8#3)(1996-1#8)(1996-11#5)(1996-12#15)(1996-2#14)(1996-3#13)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#11)(1997-2#4)(1997-3#10)(1997-4#2)(1997-5#6)(1997-6#4)(1997-7#8)(1997-8#13)(1997-9#1)(2006-6#3)(2007-11#5)(2007-12#9)(2007-8#1)(2008-1#15)(2008-10#255)(2008-11#135)(2008-12#52)(2008-2#5)(2008-3#21)(2008-4#8)(2008-5#34)(2008-6#13)(2008-7#59)(2008-8#68)(2008-9#77)(2009-1#6)(2009-10#12)(2009-11#4)(2009-12#9)(2009-3#10)(2009-4#4)(2009-5#5)(2009-7#10)(2009-8#8)(2009-9#5)(2010-1#14)(2010-10#11)(2010-11#10)(2010-12#21)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#12)(2010-7#7)(2010-8#11)(2010-9#3)(2011-1#10)(2011-10#3)(2011-2#77)(2011-3#3)(2011-4#1)(2012-12#23)(2012-2#44)(2012-3#49)(2012-5#1)(2012-6#1)(2013-1#73)(2013-7#4)(2013-8#30)
there's##3##1##(1991-11#1)(1993-12#1)(2008-9#1)
thereafter to##2##2##(2008-3#1)(2011-2#1)
thereafter with##2##2##(1993-11#1)(2012-2#1)
thereafter##40##1##(1991-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
thereby acting as a platform for communication between peers and the wider public##3##13##(2010-12#3)
thereby allowing##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
thereby creating##2##2##(2008-11#1)(2012-3#1)
thereby decreasing##2##2##(1992-1#1)(1993-8#1)
thereby demonstrating##2##2##(1990-5#1)(2008-10#1)
thereby enabling##2##2##(2008-10#1)(2008-5#1)
thereby enhancing##5##2##(1997-7#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
thereby generating##3##2##(1992-12#1)(2008-10#1)(2008-2#1)
thereby identifying##2##2##(1997-7#1)(2012-2#1)
thereby increasing##2##2##(1994-8#1)(2013-8#1)
thereby indicating##2##2##(1995-6#1)(2010-8#1)
thereby killing all distal leaves##2##5##(2008-10#2)
thereby leading to the##2##4##(2011-2#1)(2013-8#1)
thereby leading to##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
thereby limiting the##2##3##(2008-10#1)(2012-2#1)
thereby limiting##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
thereby preventing##5##2##(2008-10#1)(2008-8#1)(2009-7#1)(2013-1#2)
thereby providing a##2##3##(2008-12#1)(2010-11#1)
thereby providing the##2##3##(2011-2#1)(2013-8#1)
thereby providing##8##2##(1993-6#1)(1994-11#1)(2008-12#1)(2008-8#1)(2010-11#1)(2011-2#2)(2013-8#1)
thereby reduce##2##2##(2008-8#1)(2013-1#1)
thereby reducing the risk of##2##5##(2008-10#1)(2011-2#1)
thereby reducing the##5##3##(1997-7#1)(2008-10#2)(2010-11#1)(2011-2#1)
thereby reducing##10##2##(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
thereby##154##1##(1990-12#1)(1990-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2008-10#28)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#5)(2008-7#3)(2008-8#12)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#4)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#10)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#8)(2013-8#4)
therefore a##12##2##(1993-11#1)(1993-2#1)(2008-10#3)(2008-6#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
therefore all##2##2##(1996-1#1)(2008-7#1)
therefore appears##4##2##(1990-5#1)(1992-3#1)(1992-6#1)(2008-10#1)
therefore be beneficial##2##3##(1990-10#1)(2013-1#1)
therefore be useful in##2##4##(1990-8#1)(2008-12#1)
therefore be useful##4##3##(1990-8#1)(2008-11#1)(2008-12#1)(2010-7#1)
therefore be##33##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-11#1)(1996-11#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
therefore been##11##2##(2008-10#1)(2008-11#7)(2008-7#1)(2010-10#1)(2012-3#1)
therefore can be##4##3##(2008-10#1)(2008-2#1)(2009-8#1)(2011-2#1)
therefore can##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)
therefore cannot##2##2##(2012-2#2)
therefore concluded that##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
therefore has##4##2##(2008-11#1)(2008-7#1)(2011-7#1)(2013-1#1)
therefore have##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
therefore it is necessary to##2##5##(2008-11#1)(2013-8#1)
therefore it is##5##3##(2008-11#1)(2008-12#1)(2008-7#1)(2012-7#1)(2013-8#1)
therefore it##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-7#1)(2013-8#1)
therefore its value as a##2##5##(1991-12#1)(2009-8#1)
therefore its##4##2##(1991-12#1)(2009-8#2)(2012-6#1)
therefore likely to be##2##4##(1991-6#1)(2008-10#1)
therefore likely to##4##3##(1991-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
therefore likely##5##2##(1991-6#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)
therefore more likely to##2##4##(1992-3#1)(2011-3#1)
therefore more##4##2##(1992-3#1)(2008-10#2)(2011-3#1)
therefore necessary that##2##3##(1991-3#1)(2012-3#1)
therefore necessary##3##2##(1990-3#1)(1991-3#1)(2012-3#1)
therefore not##5##2##(1992-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2010-7#1)
therefore of##3##2##(2008-3#1)(2009-1#1)(2009-7#1)
therefore offers a##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
therefore provide##3##2##(2008-11#1)(2008-3#1)(2009-5#1)
therefore recommended##2##2##(1992-6#1)(2011-2#1)
therefore represents a##2##3##(2008-10#1)(2013-1#1)
therefore represents an##2##3##(2008-11#1)(2009-5#1)
therefore represents##4##2##(2008-10#1)(2008-11#1)(2009-5#1)(2013-1#1)
therefore required##2##2##(2008-10#1)(2011-2#1)
therefore requires##2##2##(2008-10#1)(2008-11#1)
therefore should##2##2##(2008-10#1)(2009-4#1)
therefore suggested##2##2##(2008-8#1)(2008-9#1)
therefore that the##2##3##(2008-5#1)(2013-1#1)
therefore that##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
therefore the prosthesis##2##3##(1991-2#2)
therefore the##15##2##(1990-3#1)(1991-2#2)(1991-3#1)(1992-9#1)(1993-6#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-5#2)(2013-8#1)
therefore to##5##2##(1990-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2013-8#1)
therefore##523##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-3#5)(1990-4#2)(1990-5#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#6)(1991-2#4)(1991-3#5)(1991-6#4)(1991-8#2)(1992-12#1)(1992-3#3)(1992-6#4)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1995-11#3)(1995-12#3)(1995-2#6)(1995-5#3)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-5#1)(1996-6#3)(1997-1#2)(1997-3#3)(1997-4#2)(1997-7#5)(2006-6#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#116)(2008-11#44)(2008-12#10)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#10)(2008-6#9)(2008-7#14)(2008-8#13)(2008-9#19)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#9)(2010-3#3)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#29)(2011-3#3)(2011-7#1)(2012-12#2)(2012-2#13)(2012-3#11)(2012-6#1)(2012-7#2)(2013-1#18)(2013-8#10)
therein##2##1##(2008-3#1)(2008-9#1)
therelative##2##1##(2008-11#2)
thereof##15##1##(1995-2#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
thermal analgesia and##2##3##(2013-8#2)
thermal analgesia##3##2##(2013-8#3)
thermal analysis of##3##3##(2008-10#3)
thermal analysis##9##2##(2008-10#9)
thermal and##5##2##(2008-10#3)(2008-3#1)(2009-5#1)
thermal annealing##3##2##(2008-2#2)(2012-2#1)
thermal asymmetric interlaced PCR (TAIL-PCR) technique##2##6##(2008-10#1)(2008-8#1)
thermal behaviour##2##2##(2008-10#2)
thermal boundary##2##2##(1995-6#1)(2008-3#1)
thermal characteristics of##2##3##(2008-2#1)(2008-3#1)
thermal conditions##3##2##(1996-5#1)(2008-6#2)
thermal conductivity of##2##3##(2008-3#2)
thermal conductivity##6##2##(2008-10#3)(2008-3#3)
thermal constraint on activity##2##4##(2008-8#2)
thermal constraints on activity##2##4##(2008-8#2)
thermal constraints##3##2##(2008-8#3)
thermal damage##4##2##(1991-2#1)(2008-3#2)(2012-2#1)
thermal decomposition of a##2##4##(2008-10#2)
thermal decomposition of##4##3##(2008-10#4)
thermal decomposition##9##2##(2008-10#9)
thermal deformations are##2##3##(2008-3#2)
thermal deformations of mirror##3##4##(2008-3#3)
thermal deformations of##4##3##(2008-3#4)
thermal deformations##7##2##(2008-3#7)
thermal degradation of the##2##4##(2008-10#1)(2008-3#1)
thermal degradation of##3##3##(2008-10#2)(2008-3#1)
thermal denaturation##5##2##(1991-5#1)(1993-8#2)(2008-9#2)
thermal desorption##7##2##(2008-10#7)
thermal diffusivity##5##2##(2008-3#5)
thermal effects##6##2##(1995-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#1)
thermal emission##3##2##(1991-5#1)(2008-3#2)
thermal energy##3##2##(2008-11#1)(2009-10#1)(2012-6#1)
thermal equilibrium##2##2##(2008-11#1)(2008-3#1)
thermal expansion##2##2##(2008-10#1)(2008-3#1)
thermal gradient##2##2##(2008-3#2)
thermal hyperalgesia##5##2##(1995-12#5)
thermal inactivation of the##2##4##(1995-8#1)(2008-10#1)
thermal inactivation of##6##3##(1995-8#1)(2008-10#4)(2010-4#1)
thermal inactivation##8##2##(1995-8#1)(2008-10#6)(2010-4#1)
thermal induced digestion##2##3##(2008-10#2)
thermal injury##6##2##(1995-1#1)(2008-9#5)
thermal ionization mass spectrometry##2##4##(2008-10#2)
thermal lens and##4##3##(2008-2#1)(2008-3#3)
thermal lens spectrometer##3##3##(2008-10#3)
thermal lens spectrometry (TLS)##2##4##(2008-10#2)
thermal lens spectrometry##8##3##(2008-10#8)
thermal lens##24##2##(2008-10#13)(2008-2#3)(2008-3#8)
thermal lensing in##2##3##(2008-10#1)(2008-3#1)
thermal lensing##16##2##(2007-12#1)(2008-10#6)(2008-3#9)
thermal loading##2##2##(2008-2#2)
thermal method of##2##3##(2008-10#1)(2013-1#1)
thermal noise##2##2##(1991-2#1)(2008-3#1)
thermal or##2##2##(2009-10#1)(2009-12#1)
thermal oxidation of##2##3##(2008-10#2)
thermal process##2##2##(2011-2#2)
thermal processing of##2##3##(2011-2#2)
thermal processing##5##2##(2008-2#1)(2011-2#4)
thermal refractive-index coefficients of 7##2##5##(2008-2#2)
thermal stabilisation##2##2##(2008-10#2)
thermal stability and##2##3##(1994-8#1)(2008-2#1)
thermal stability of the##3##4##(1993-6#1)(2008-10#1)(2011-2#1)
thermal stability of##7##3##(1993-6#1)(1995-8#1)(2008-10#3)(2011-1#1)(2011-2#1)
thermal stability##19##2##(1993-6#1)(1994-8#2)(1995-8#2)(2008-10#8)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#2)
thermal stabilization of tellurium in graphite furnaces##2##7##(2008-10#2)
thermal stabilization of##4##3##(2008-10#4)
thermal stabilization##5##2##(2008-10#5)
thermal time##2##2##(2008-10#2)
thermal treatment##2##2##(1996-5#1)(2008-10#1)
thermal##283##1##(1991-2#3)(1991-5#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#4)(1994-8#2)(1995-1#1)(1995-12#5)(1995-2#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(2007-12#1)(2008-10#111)(2008-11#4)(2008-2#16)(2008-3#63)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#7)(2008-9#8)(2009-10#2)(2009-12#2)(2009-3#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#3)(2013-8#5)
thermal-lens##5##1##(2008-10#2)(2008-3#3)
thermally denatured##2##2##(2008-10#2)
thermally desorbed##3##2##(2008-10#3)
thermally induced##6##2##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#3)
thermally##23##1##(1994-5#1)(2008-10#15)(2008-2#1)(2008-3#3)(2008-7#1)(2009-12#1)(2009-5#1)
thermo##2##1##(2008-10#1)(2011-2#1)
thermo-chemical pre-treatments##3##2##(2013-1#3)
thermo-chemical##4##1##(2013-1#4)
thermo-optical properties##2##2##(2008-3#2)
thermo-optical##4##1##(2008-10#1)(2008-3#3)
thermo-sensitive genic male-sterile##2##3##(2008-8#2)
thermocellum cell extracts##2##3##(2008-6#2)
thermocellum##7##1##(1991-5#3)(2008-6#4)
thermocouple measurements##2##2##(2008-3#2)
thermocouple##7##1##(2008-10#2)(2008-3#5)
thermocycling##2##1##(1997-6#1)(2008-12#1)
thermodynamic and kinetic constants##2##4##(2008-10#2)
thermodynamic and kinetic parameters##2##4##(1993-8#1)(2008-4#1)
thermodynamic and kinetic##4##3##(1993-8#1)(2008-10#2)(2008-4#1)
thermodynamic and##6##2##(1993-8#1)(2008-10#4)(2008-4#1)
thermodynamic characteristics##2##2##(1993-8#1)(2008-10#1)
thermodynamic constants of##2##3##(2008-10#2)
thermodynamic constants##3##2##(2008-10#3)
thermodynamic data##9##2##(1991-6#1)(2008-10#8)
thermodynamic dissociation constant##3##3##(2008-10#3)
thermodynamic dissociation##4##2##(2008-10#4)
thermodynamic equilibrium##2##2##(2008-10#2)
thermodynamic functions##2##2##(2008-10#2)
thermodynamic model of inorganic arsenic##3##5##(2008-10#3)
thermodynamic model##5##2##(2008-10#5)
thermodynamic parameters for the##3##4##(1992-3#1)(1997-2#1)(2008-10#1)
thermodynamic parameters for##6##3##(1992-3#1)(1997-2#1)(2008-10#4)
thermodynamic parameters of##4##3##(1992-3#1)(2008-10#3)
thermodynamic parameters were calculated##2##4##(2008-10#2)
thermodynamic parameters were##4##3##(1993-8#1)(2008-10#3)
thermodynamic parameters##23##2##(1992-3#2)(1993-8#1)(1997-2#1)(2008-10#19)
thermodynamic properties of##2##3##(1991-5#1)(2008-10#1)
thermodynamic properties##4##2##(1991-5#2)(2008-10#2)
thermodynamic quantities##2##2##(2008-10#2)
thermodynamic stability of##3##3##(2008-10#2)(2008-9#1)
thermodynamic stability##4##2##(2008-10#2)(2008-9#2)
thermodynamic study##2##2##(2008-10#2)
thermodynamic##98##1##(1990-9#1)(1991-11#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#2)(1993-8#4)(1995-6#1)(1997-2#3)(2008-10#71)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)
thermodynamically##5##1##(2008-10#2)(2008-7#1)(2008-9#1)(2010-4#1)
thermodynamics of the##3##3##(1993-3#1)(2008-10#2)
thermodynamics of##8##2##(1993-3#1)(2008-10#3)(2008-8#2)(2008-9#1)(2010-7#1)
thermodynamics##13##1##(1993-12#1)(1993-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-7#1)
thermogenesis and##2##2##(2013-1#2)
thermogenesis in##2##2##(2013-1#2)
thermogenesis##10##1##(1995-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#5)
thermogenic nutritional supplement##4##3##(2013-8#4)
thermogenic response##2##2##(1994-2#2)
thermogenic##7##1##(1994-2#2)(2009-8#1)(2013-8#4)
thermogram##4##1##(1993-11#3)(2008-10#1)
thermograms##7##1##(1993-11#6)(2011-3#1)
thermographic results##5##2##(1993-11#5)
thermographic##6##1##(1993-11#6)
thermography in##2##2##(1990-2#1)(2008-10#1)
thermography is##2##2##(1993-11#2)
thermography##8##1##(1990-2#3)(1993-11#3)(2008-10#2)
thermogravimetric analysis (TGA) and##3##4##(2008-10#2)(2009-3#1)
thermogravimetric analysis (TGA)##5##3##(2008-10#4)(2009-3#1)
thermogravimetric analysis##7##2##(2008-10#6)(2009-3#1)
thermogravimetric measurements##2##2##(2008-10#2)
thermogravimetric##12##1##(2008-10#10)(2009-3#1)(2010-4#1)
thermolabile##4##1##(1992-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
thermolysin have been##2##3##(1994-5#2)
thermolysin##9##1##(1993-8#1)(1994-5#8)
thermolysis##3##1##(1996-5#1)(2008-10#2)
thermolytic##2##1##(2008-10#1)(2008-4#1)
thermometry is##2##2##(2008-3#2)
thermometry##4##1##(2008-3#4)
thermophila##3##1##(2008-10#1)(2012-3#2)
thermophilic genus##2##2##(2011-2#2)
thermophilic##8##1##(1990-3#1)(1996-3#1)(2008-7#1)(2008-8#2)(2011-2#3)
thermoregulation##8##1##(1992-3#1)(2008-5#1)(2008-9#2)(2009-8#3)(2013-1#1)
thermoregulatory effects of##2##3##(1994-2#2)
thermoregulatory responses##2##2##(1992-3#2)
thermoregulatory##7##1##(1992-3#2)(1994-2#5)
thermospray flame furnace atomic absorption spectrometry##2##6##(2008-10#2)
thermostability of##3##2##(1991-5#1)(2008-10#1)(2011-1#1)
thermostability##5##1##(1991-5#1)(2008-10#3)(2011-1#1)
thermostable D-hydantoinase##2##2##(2008-7#2)
thermostable DNA##2##2##(1995-8#1)(2008-9#1)
thermostable polymerase##2##2##(1994-11#1)(1995-8#1)
thermostable##14##1##(1994-11#1)(1995-12#1)(1995-8#2)(2008-10#3)(2008-7#2)(2008-9#2)(2011-1#2)(2011-2#1)
thermotherapy##2##1##(2008-10#1)(2008-12#1)
thermotolerance development in##2##3##(1994-8#2)
thermotolerance development##3##2##(1994-8#3)
thermotolerance##4##1##(1994-8#3)(2011-2#1)
thermotropic phase behavior##2##3##(1993-8#1)(2008-8#1)
thermotropic##5##1##(1993-8#1)(2008-10#2)(2008-5#1)(2008-8#1)
these 10##2##2##(2008-10#1)(2008-11#1)
these 2##6##2##(1992-2#1)(1993-12#1)(1997-2#1)(2008-7#1)(2009-1#1)(2011-2#1)
these 5##2##2##(1992-9#1)(2011-2#1)
these BI-BS-resistant isolates##2##3##(2008-10#2)
these CFC replacements##2##3##(1992-3#2)
these DNA##3##2##(1995-6#1)(2008-10#2)
these DNA-lipids##2##2##(2008-10#2)
these MDIs##2##2##(1992-3#1)(1996-1#1)
these ORFs##4##2##(1991-9#1)(1995-12#1)(1995-9#1)(2008-10#1)
these QTL##2##2##(2008-10#1)(2012-3#1)
these RNAs##2##2##(1997-3#1)(2008-10#1)
these abnormalities##2##2##(1996-6#1)(2008-4#1)
these actions##3##2##(1994-11#1)(1997-2#1)(2008-11#1)
these active##2##2##(2008-10#1)(2008-5#1)
these activities##6##2##(1990-11#1)(1994-3#1)(1996-2#1)(1997-7#1)(2008-9#1)(2011-3#1)
these advances##2##2##(2012-2#1)(2013-8#1)
these adverse##2##2##(2008-10#2)
these agents are##2##3##(1991-3#1)(2013-1#1)
these agents in##3##3##(1995-11#1)(2008-7#1)(2008-9#1)
these agents##30##2##(1991-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-2#2)(1997-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
these agonists##2##2##(1993-6#1)(1995-11#1)
these aims##4##2##(2008-11#2)(2010-8#1)(2012-2#1)
these alkaloids##2##2##(2008-10#1)(2011-3#1)
these allegations##4##2##(2008-10#4)
these alleles##2##2##(2008-10#1)(2008-12#1)
these alterations in##2##3##(1996-12#1)(2008-2#1)
these alterations##4##2##(1996-12#1)(2008-2#2)(2010-12#1)
these alternative##2##2##(2008-10#1)(2010-11#1)
these analyses##8##2##(1994-1#1)(1995-5#1)(1996-1#1)(2008-10#3)(2008-11#1)(2009-10#1)
these analytes##5##2##(2008-10#5)
these and other##12##3##(1992-12#1)(1992-2#1)(1992-9#1)(1995-12#2)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
these and the##2##3##(2008-10#1)(2013-8#1)
these and##24##2##(1992-12#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
these angiogenic inhibitors##2##3##(2008-1#2)
these animals##12##2##(1992-1#1)(1994-2#1)(1994-3#1)(1996-12#4)(1996-2#1)(2008-10#1)(2008-5#2)(2008-9#1)
these antibodies are##3##3##(1991-2#1)(1995-12#1)(2008-10#1)
these antibodies##11##2##(1991-2#1)(1991-5#1)(1994-11#1)(1995-12#2)(1996-11#2)(2006-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
these antiestrogen binding sites##2##4##(2008-11#2)
these antigens##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
these antioxidants##3##2##(2008-10#2)(2008-11#1)
these applications##3##2##(1997-7#1)(2008-11#1)(2010-12#1)
these approaches are##2##3##(2008-10#1)(2008-4#1)
these approaches to##2##3##(1995-5#1)(2008-11#1)
these approaches##17##2##(1995-5#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#1)
these are discussed##2##3##(2008-1#1)(2012-2#1)
these are important##2##3##(2008-10#1)(2009-12#1)
these are the##2##3##(2010-11#1)(2012-2#1)
these are##30##2##(1991-3#2)(1994-2#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#2)(2010-11#2)(2011-1#1)(2012-2#4)(2012-3#1)(2013-8#1)
these areas##14##2##(1994-1#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
these arrays##2##2##(2008-3#1)(2008-8#1)
these articles##3##2##(1994-12#1)(1997-2#1)(2011-2#1)
these aspects##6##2##(2008-10#3)(2008-11#2)(2013-1#1)
these assays is##2##3##(2008-9#2)
these assays##18##2##(1992-3#1)(1992-9#1)(1996-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#4)(2011-1#1)
these assessments##2##2##(1995-5#1)(2008-11#1)
these associations were between##2##4##(2008-10#2)
these associations were##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
these associations##7##2##(1997-2#1)(2008-10#2)(2009-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
these assumptions##2##2##(2008-3#1)(2008-9#1)
these attitudes##3##2##(1990-11#1)(1996-2#1)(2010-10#1)
these attributes##3##2##(2008-10#1)(2008-8#1)(2009-12#1)
these authors##2##2##(2008-4#1)(2009-3#1)
these bacteria were not##2##4##(2008-10#1)(2008-11#1)
these bacteria were##3##3##(2008-10#2)(2008-11#1)
these bacteria##15##2##(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-9#1)(2011-2#1)
these bands##4##2##(2008-10#2)(2008-12#1)(2010-11#1)
these barriers##7##2##(2008-10#1)(2009-11#1)(2010-11#2)(2011-1#1)(2013-1#2)
these basic##2##2##(1993-12#1)(2008-11#1)
these behaviors##4##2##(1993-6#1)(1994-2#1)(2008-4#1)(2010-9#1)
these being##2##2##(1995-2#1)(2011-2#1)
these beneficial effects##2##3##(2008-7#2)
these benefits##3##2##(1995-1#1)(2008-8#1)(2010-1#1)
these binding##3##2##(1995-8#1)(2010-7#1)(2011-2#1)
these biogeological##2##2##(1995-3#2)
these biological##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
these brain regions are##2##4##(2010-5#1)(2010-6#1)
these cDNA clones##2##3##(2008-11#1)(2008-8#1)
these calibration##2##2##(2008-10#2)
these can be##3##3##(2008-5#2)(2012-2#1)
these can##6##2##(2008-10#1)(2008-5#2)(2009-10#1)(2012-12#1)(2012-2#1)
these cancers##5##2##(1990-8#1)(2008-11#1)(2008-4#2)(2013-1#1)
these case reports##2##3##(2008-11#1)(2011-2#1)
these case studies##2##3##(2008-10#1)(2008-11#1)
these case##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
these cases should be##2##4##(2008-10#1)(2010-8#1)
these cases##38##2##(1991-12#2)(1991-8#1)(1992-12#1)(1993-2#1)(1993-6#1)(1995-10#1)(1997-2#1)(1997-6#1)(2008-10#8)(2008-11#3)(2008-7#3)(2008-8#1)(2008-9#2)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
these categories of##2##3##(1995-6#1)(2008-11#1)
these categories##7##2##(1991-2#1)(1995-6#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)
these cell lines are##2##4##(1992-4#1)(2008-4#1)
these cell lines##7##3##(1992-4#1)(1992-8#1)(1993-3#1)(1995-6#1)(2008-11#2)(2008-4#1)
these cell##12##2##(1991-5#1)(1992-4#1)(1992-8#1)(1993-3#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#3)(2008-4#1)
these cells and##2##3##(1994-11#1)(2008-10#1)
these cells are##4##3##(2008-4#1)(2008-9#2)(2009-10#1)
these cells could##2##3##(2008-10#1)(2013-1#1)
these cells in a##3##4##(2008-11#2)(2010-1#1)
these cells in##7##3##(1992-9#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-11#2)(2010-1#1)
these cells is##2##3##(1992-12#1)(2008-11#1)
these cells may##2##3##(1990-8#1)(2010-1#1)
these cells showed that##2##4##(1995-6#1)(2008-7#1)
these cells that##3##3##(1995-2#1)(2008-11#1)(2010-11#1)
these cells to##3##3##(1994-11#1)(1996-2#1)(2008-10#1)
these cells was##3##3##(1994-6#1)(1995-8#1)(2008-8#1)
these cells were shown to##2##5##(2008-8#1)(2013-1#1)
these cells were##10##3##(1992-6#1)(1993-3#1)(1996-12#1)(2008-11#1)(2008-8#2)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)
these cells with##2##3##(1992-9#1)(2008-11#1)
these cells##116##2##(1990-2#4)(1990-5#1)(1990-8#1)(1991-5#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#4)(1994-3#2)(1994-6#3)(1994-8#1)(1995-2#7)(1995-3#1)(1995-6#2)(1995-8#3)(1996-12#3)(1996-2#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#27)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#3)(2010-11#1)(2012-2#2)(2013-1#3)
these challenges##7##2##(1996-2#2)(1997-1#2)(2008-1#1)(2008-11#1)(2008-6#1)
these changes and##2##3##(2009-8#1)(2013-8#1)
these changes are##3##3##(1992-6#1)(2012-2#1)(2013-8#1)
these changes in##3##3##(1990-3#1)(2008-7#1)(2011-2#1)
these changes occurred##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
these changes were##3##3##(1996-12#1)(2011-1#1)(2011-2#1)
these changes##32##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#2)
these channels##3##2##(1994-11#3)
these characteristics##7##2##(1991-3#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-3#1)
these characters##2##2##(2008-8#1)(2008-9#1)
these chemical##2##2##(2008-10#1)(2008-2#1)
these chemicals in##3##3##(1993-3#1)(2008-10#2)
these chemicals##11##2##(1993-3#1)(2008-10#7)(2008-11#3)
these children and##2##3##(1995-3#1)(2008-11#1)
these children##13##2##(1990-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2011-2#1)
these chromosomes##4##2##(1996-12#1)(1996-3#1)(1997-6#1)(2008-7#1)
these circumstances##8##2##(1993-12#1)(1994-8#1)(1996-3#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-12#1)
these classes##2##2##(1997-2#1)(2008-10#1)
these clinical##6##2##(1994-12#1)(1997-2#1)(2008-5#1)(2010-6#1)(2013-7#2)
these clones##5##2##(1991-12#1)(1996-6#1)(1997-8#2)(2008-11#1)
these clusters##2##2##(2008-10#1)(2008-7#1)
these coated##2##2##(1995-2#1)(2008-10#1)
these cohorts of##2##3##(2013-1#2)
these cohorts##3##2##(2008-10#1)(2013-1#2)
these colonies##2##2##(2008-10#1)(2009-8#1)
these columns##2##2##(1997-3#1)(2008-10#1)
these combinations##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
these common##3##2##(1991-5#1)(1993-12#1)(2008-7#1)
these communities##2##2##(2008-10#1)(2010-9#1)
these comparisons##4##2##(1995-1#1)(1996-1#1)(2008-10#1)(2008-7#1)
these complex##2##2##(2008-10#1)(2008-11#1)
these complexes are##2##3##(2008-10#2)
these complexes have been determined##2##5##(1992-9#1)(2008-10#1)
these complexes##12##2##(1992-9#2)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#6)(2008-11#1)
these complications##3##2##(1996-2#1)(2008-7#1)(2010-12#1)
these components are##2##3##(2008-11#1)(2011-2#1)
these components##21##2##(1994-1#1)(1994-5#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-1#1)(2011-2#2)
these compounds and##4##3##(1990-7#1)(2008-10#2)(2009-8#1)
these compounds are##9##3##(2006-6#1)(2008-10#5)(2008-8#1)(2012-3#1)(2013-1#1)
these compounds by##2##3##(2008-10#2)
these compounds can##2##3##(2008-10#1)(2008-11#1)
these compounds in##16##3##(1994-2#1)(2008-10#12)(2008-5#2)(2010-5#1)
these compounds is##2##3##(2008-10#2)
these compounds to##2##3##(2008-10#2)
these compounds was determined by##2##5##(2008-10#1)(2012-2#1)
these compounds was##10##3##(2008-10#7)(2008-11#2)(2012-2#1)
these compounds were##8##3##(1990-11#1)(1991-5#1)(1993-12#1)(2008-10#3)(2008-11#1)(2011-2#1)
these compounds with##3##3##(1991-5#1)(2008-10#2)
these compounds##101##2##(1990-11#2)(1990-12#1)(1990-7#2)(1991-5#2)(1991-6#1)(1993-12#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(2006-6#1)(2007-11#1)(2008-10#63)(2008-11#8)(2008-5#2)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
these concentrations##3##2##(2008-10#1)(2008-11#2)
these concepts##5##2##(1997-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-8#1)
these concerns is##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
these concerns##6##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
these conclusions##3##2##(1990-11#1)(1993-12#1)(2008-9#1)
these conditions##71##2##(1990-5#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-3#3)(1993-8#1)(1995-2#2)(1995-9#2)(2008-10#34)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)
these conidia##2##2##(2008-10#2)
these connections##2##2##(2008-11#1)(2009-8#1)
these conserved##2##2##(1995-2#1)(1995-6#1)
these constants##4##2##(2008-10#4)
these constructs##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
these contexts##2##2##(2010-9#1)(2012-3#1)
these contrasting##2##2##(2008-11#1)(2013-8#1)
these controversies?##2##2##(2008-11#2)
these correlations were##2##3##(2008-10#1)(2011-10#1)
these costs##2##2##(1995-11#1)(2008-8#1)
these countries##7##2##(1992-5#1)(1994-12#1)(1996-9#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-2#1)
these courses##5##2##(1992-12#1)(1994-12#2)(2013-1#2)
these criteria##8##2##(1993-8#1)(1997-8#1)(2008-6#1)(2008-9#1)(2010-12#2)(2010-2#1)(2013-8#1)
these critical##2##2##(2011-1#1)(2013-1#1)
these cultures were##2##3##(2008-11#2)
these cultures##6##2##(1995-12#1)(2008-11#5)
these curricula##2##2##(2008-12#1)(2011-2#1)
these curves##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
these data are##2##3##(1997-2#1)(2009-4#1)
these data demonstrate that##3##4##(1995-12#1)(1997-1#1)(2009-6#1)
these data highlight##2##3##(2012-2#1)(2013-8#1)
these data is##2##3##(1995-9#1)(2013-1#1)
these data provide evidence that##2##5##(2008-10#1)(2008-9#1)
these data provide##3##3##(2008-10#2)(2008-9#1)
these data show##2##3##(1991-6#1)(2011-2#1)
these data suggest that##7##4##(1994-9#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
these data suggest##9##3##(1990-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
these data to##4##3##(1994-2#1)(1996-12#1)(2008-8#2)
these data##63##2##(1990-5#1)(1990-8#1)(1991-12#2)(1991-6#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
these databases##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
these deaths##2##2##(1990-6#1)(1992-6#1)
these decisions##3##2##(1993-2#1)(1994-3#2)
these derivatives##2##2##(1997-2#1)(2012-3#1)
these devices are##2##3##(2008-6#1)(2010-11#1)
these devices##8##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#2)(2010-7#1)
these dietary##2##2##(2010-1#1)(2012-12#1)
these diets##2##2##(1996-12#1)(2008-10#1)
these differences and##3##3##(1994-5#1)(2008-10#1)(2012-2#1)
these differences can##2##3##(1991-12#1)(2010-8#1)
these differences in##6##3##(1992-3#1)(1993-12#1)(2008-8#3)(2011-2#1)
these differences may be##2##4##(1997-7#1)(2008-10#1)
these differences##28##2##(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-2#2)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
these different##10##2##(1990-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-12#2)(2011-2#1)(2013-8#1)
these difficulties##2##2##(2009-10#1)(2011-2#1)
these direct##2##2##(2008-3#1)(2008-4#1)
these disciplines##2##2##(1996-12#1)(2008-11#1)
these diseased##2##2##(1993-2#1)(2008-10#1)
these diseases are##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
these diseases##17##2##(1990-11#1)(1995-5#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#3)(2009-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
these disorders are##2##3##(2008-8#1)(2012-3#1)
these disorders##15##2##(1992-1#1)(1992-12#1)(1997-3#2)(1997-8#1)(2008-6#2)(2008-8#1)(2011-2#2)(2012-3#4)(2013-8#1)
these disparate##2##2##(2008-9#1)(2013-8#1)
these diverse##5##2##(1991-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
these domains##2##2##(1992-4#1)(2008-12#1)
these doses##2##2##(1995-12#1)(2008-11#1)
these drawbacks##3##2##(2008-7#1)(2010-6#1)(2013-1#1)
these drugs are##3##3##(2009-12#1)(2011-2#1)(2013-1#1)
these drugs have##2##3##(2010-5#1)(2012-12#1)
these drugs in the##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
these drugs in##6##3##(1991-8#1)(2007-11#1)(2008-10#2)(2012-2#1)(2013-1#1)
these drugs may##4##3##(1993-2#1)(1993-8#1)(1995-2#1)(2008-10#1)
these drugs##46##2##(1991-1#2)(1991-8#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-5#3)(1995-2#1)(1996-11#1)(1997-1#1)(2007-11#1)(2008-10#12)(2008-11#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-5#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
these dyes##3##2##(2008-10#2)(2008-9#1)
these dysfunctions##2##2##(1993-2#1)(2008-10#1)
these early##2##2##(1994-6#1)(2011-2#1)
these effects and##3##3##(2008-5#1)(2008-8#2)
these effects are not##2##4##(2008-10#1)(2008-7#1)
these effects are##6##3##(1990-11#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-2#1)
these effects of##3##3##(2008-10#2)(2008-8#1)
these effects were##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
these effects##41##2##(1990-11#1)(1990-6#1)(1992-9#1)(2007-12#1)(2008-10#10)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#2)(2009-11#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#2)
these efforts##5##2##(1992-3#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-2#1)
these eight##4##2##(2008-10#2)(2008-7#1)(2011-3#1)
these electrodes in##2##3##(2008-10#2)
these electrodes##9##2##(2008-10#9)
these elements are##3##3##(1995-8#1)(2008-10#1)(2013-1#1)
these elements were##2##3##(2008-10#1)(2012-3#1)
these elements##25##2##(1993-6#1)(1995-8#2)(2008-10#15)(2008-3#1)(2008-7#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
these entities##4##2##(1993-1#1)(1996-3#1)(2008-3#1)(2010-7#1)
these enzymes in##2##3##(2006-6#1)(2008-11#1)
these enzymes##16##2##(1990-3#1)(1990-8#1)(1994-8#3)(2006-6#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
these epidemics##2##2##(2008-10#2)
these equations##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
these esters##2##2##(1993-8#1)(2008-5#1)
these estimates##4##2##(1993-1#1)(2008-12#1)(2008-9#1)(2010-10#1)
these events are##2##3##(2008-10#1)(2008-9#1)
these events##8##2##(1993-3#1)(2008-10#3)(2008-9#3)(2012-2#1)
these experiences##2##2##(2013-8#2)
these experimental conditions##3##3##(2008-10#3)
these experimental results##2##3##(1991-12#1)(2008-10#1)
these experimental##6##2##(1991-12#1)(2008-10#5)
these experiments suggest##2##3##(1992-10#1)(2007-12#1)
these experiments##26##2##(1990-12#1)(1992-10#1)(1994-2#1)(1994-3#1)(1995-6#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)
these explosives##3##2##(2008-10#3)
these exposures##3##2##(2008-11#1)(2008-9#1)(2009-12#1)
these facial##3##2##(1993-1#2)(2008-11#1)
these facilities##2##2##(1992-12#1)(2009-11#1)
these factors and##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2013-8#1)
these factors are##7##3##(2008-10#1)(2008-11#2)(2008-12#1)(2009-4#1)(2011-2#1)(2013-1#1)
these factors can##2##3##(2010-4#1)(2012-3#1)
these factors have##2##3##(2008-10#2)
these factors in##3##3##(1991-2#1)(2011-2#1)(2013-8#1)
these factors is##3##3##(2008-10#1)(2008-11#1)(2009-10#1)
these factors to##3##3##(1996-12#2)(2008-9#1)
these factors were##3##3##(2008-11#1)(2008-12#2)
these factors##49##2##(1991-11#2)(1991-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-11#1)(1996-12#2)(1996-2#1)(2008-10#10)(2008-11#8)(2008-12#4)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
these facts##2##2##(2008-10#1)(2008-11#1)
these families are##2##3##(2010-8#1)(2011-2#1)
these families##7##2##(1994-9#1)(1997-9#1)(2006-6#1)(2008-5#1)(2010-8#1)(2010-9#1)(2011-2#1)
these features##9##2##(1991-12#1)(1991-2#1)(1994-6#1)(2007-12#1)(2008-10#4)(2008-3#1)
these fields##3##2##(1993-3#1)(2008-1#1)(2010-7#1)
these films##3##2##(2008-10#3)
these findings and##3##3##(2008-11#2)(2009-9#1)
these findings are discussed##5##4##(1991-2#1)(1994-2#1)(2009-5#1)(2009-7#1)(2010-9#1)
these findings are##8##3##(1991-2#1)(1994-2#1)(1994-8#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-1#1)
these findings could be##2##4##(2011-1#1)(2012-2#1)
these findings illustrate##3##3##(2008-8#1)(2012-2#2)
these findings in the##2##4##(2008-10#1)(2009-8#1)
these findings in##6##3##(1996-3#1)(2008-10#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)
these findings indicate that##4##4##(1993-3#1)(1996-12#1)(2008-7#1)(2008-9#1)
these findings suggest that the##2##5##(1991-2#1)(2008-11#1)
these findings suggest that##7##4##(1990-7#1)(1991-2#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
these findings suggest##8##3##(1990-7#1)(1991-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
these findings the##2##3##(2008-10#2)
these findings to the##2##4##(1994-2#1)(2008-10#1)
these findings to##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
these findings were##2##3##(2008-11#1)(2010-1#1)
these findings##94##2##(1990-7#1)(1991-2#3)(1991-5#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#11)(2008-11#11)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-2#10)(2013-1#1)(2013-8#4)
these five##8##2##(1993-8#1)(1995-6#1)(2008-10#4)(2008-12#1)(2013-1#1)
these forms##4##2##(1990-2#1)(1991-12#1)(2008-3#1)(2008-9#1)
these formulations##2##2##(2008-5#2)
these four##17##2##(1993-1#1)(1993-6#1)(1995-12#1)(2008-10#9)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
these fractions##4##2##(1997-2#1)(2008-10#2)(2008-11#1)
these fractures##4##2##(1991-9#2)(2013-1#2)
these fragments##2##2##(2008-11#1)(2008-8#1)
these from##2##2##(2008-1#1)(2008-8#1)
these functional##2##2##(2010-12#1)(2012-2#1)
these functions##9##2##(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
these fungi##12##2##(1993-2#1)(2008-10#9)(2008-8#1)(2013-1#1)
these gaze##2##2##(2008-11#1)(2010-10#1)
these genera##3##2##(2008-10#2)(2008-12#1)
these genes and##2##3##(2008-10#2)
these genes are##4##3##(2009-8#2)(2011-2#1)(2013-8#1)
these genes as##2##3##(1991-6#1)(1993-12#1)
these genes can be##3##4##(1997-8#1)(2008-11#1)(2008-9#1)
these genes in##8##3##(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#2)(2009-8#1)
these genes is##2##3##(2008-9#1)(2009-8#1)
these genes may##3##3##(2008-10#1)(2008-9#2)
these genes were##7##3##(1996-8#1)(2008-10#3)(2008-8#1)(2010-4#1)(2013-8#1)
these genes##65##2##(1991-6#1)(1992-6#2)(1992-9#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-9#1)(1995-12#4)(1996-12#1)(1996-8#1)(1997-2#1)(1997-8#3)(2008-10#15)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#2)(2009-8#5)(2010-4#1)(2010-5#1)(2011-2#3)(2013-1#1)(2013-8#3)
these genotypes##3##2##(2008-10#3)
these giant neurons##2##3##(2007-12#2)
these girls##2##2##(2008-1#1)(2008-4#1)
these goals##5##2##(1993-1#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
these groups at##2##3##(2008-11#1)(2008-7#1)
these groups in##2##3##(1995-3#1)(1997-7#1)
these groups of##2##3##(2008-10#1)(2008-11#1)
these groups##23##2##(1990-6#1)(1991-12#2)(1992-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#2)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)
these guidelines to##2##3##(1993-12#1)(1996-12#1)
these guidelines##8##2##(1993-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#3)
these had##7##2##(1990-6#1)(1996-11#4)(2008-5#1)(2010-12#1)
these have##7##2##(1994-9#1)(2008-11#1)(2008-7#2)(2008-9#2)(2009-8#1)
these health##3##2##(1990-2#1)(1996-12#1)(2008-4#1)
these high##2##2##(2008-10#1)(2008-11#1)
these highly##7##2##(1993-1#1)(1995-2#1)(2008-10#1)(2008-5#3)(2011-2#1)
these hormones##5##2##(1990-3#1)(1992-10#1)(1995-11#1)(1996-12#1)(2008-1#1)
these hospitals##4##2##(1992-12#1)(1992-2#1)(1993-12#1)(2012-2#1)
these hosts##4##2##(2008-10#3)(2008-8#1)
these human##3##2##(1990-5#1)(1994-5#1)(1994-8#1)
these hybrids##2##2##(2008-10#1)(2010-4#1)
these hypotheses##6##2##(2008-8#2)(2008-9#3)(2012-3#1)
these ideas##4##2##(1993-3#1)(2008-7#1)(2008-8#2)
these imaging##2##2##(1991-12#1)(2013-8#1)
these immortalized T cell lines##2##5##(2008-11#2)
these important##4##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
these include##2##2##(2008-11#1)(2008-9#1)
these increases##5##2##(1990-10#1)(1992-3#1)(2008-10#2)(2011-2#1)
these indicators##2##2##(1994-2#2)
these indices##4##2##(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
these individual##2##2##(2008-10#1)(2008-11#1)
these individuals in##2##3##(1995-1#1)(2008-11#1)
these individuals##13##2##(1991-11#1)(1991-12#2)(1995-1#1)(1995-3#1)(1997-7#1)(1997-8#1)(2008-11#4)(2010-11#1)(2012-3#1)
these induced##3##2##(1995-11#1)(2008-7#1)(2009-10#1)
these infections are##2##3##(2010-6#1)(2011-2#1)
these infections##10##2##(2008-10#2)(2008-11#1)(2010-6#2)(2011-2#4)(2013-8#1)
these inhibitors##4##2##(1992-6#1)(1994-12#1)(2006-6#1)(2008-1#1)
these initiatives##2##2##(1995-3#1)(1996-2#1)
these injuries##5##2##(1990-6#1)(1991-3#1)(1994-3#2)(2013-1#1)
these instruments##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
these interactions##18##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-9#1)(1994-5#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
these interventions##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#4)
these into##3##2##(1991-12#1)(2008-10#1)(2008-8#1)
these investigations##4##2##(1997-2#1)(2008-10#1)(2010-7#1)(2011-1#1)
these investments##2##2##(1994-2#1)(1996-1#1)
these ions are##3##3##(2008-10#3)
these ions in##3##3##(2008-10#3)
these ions with##2##3##(2008-10#2)
these ions##16##2##(2008-10#16)
these is##4##2##(1997-1#1)(2008-10#1)(2008-4#1)(2008-6#1)
these islands##4##2##(1990-5#1)(2008-8#1)(2008-9#2)
these isolates in the##2##4##(2008-10#2)
these isolates were##6##3##(2008-10#5)(2013-8#1)
these isolates##31##2##(1995-12#1)(2008-10#28)(2008-5#1)(2013-8#1)
these issues and##4##3##(2008-11#1)(2008-7#1)(2009-9#1)(2010-11#1)
these issues with##2##3##(2010-5#1)(2012-2#1)
these issues##30##2##(1990-6#1)(1991-2#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
these key##3##2##(1993-1#1)(2009-8#1)(2010-8#1)
these kinases##2##2##(1996-2#1)(2008-11#1)
these kinds of##2##3##(2008-11#2)
these kinetic##2##2##(1995-6#1)(1995-8#1)
these large##6##2##(1992-12#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
these last##4##2##(1990-5#1)(2008-10#2)(2011-2#1)
these latter##3##2##(2008-10#1)(2008-7#1)(2009-3#1)
these lesions is presented##2##4##(1991-6#1)(2008-7#1)
these lesions is##5##3##(1991-6#1)(2008-7#2)(2011-2#1)(2012-2#1)
these lesions##20##2##(1991-3#1)(1991-6#1)(1992-2#1)(1994-6#1)(1995-2#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-12#1)(2011-2#4)(2012-2#2)
these levels of##2##3##(2008-10#1)(2008-11#1)
these levels were##2##3##(2008-10#2)
these levels##7##2##(1990-5#1)(1996-2#1)(2008-10#3)(2008-11#1)(2013-1#1)
these libraries##2##2##(1993-1#2)
these ligands##2##2##(1993-8#1)(2008-10#1)
these light##2##2##(1993-9#1)(2011-7#1)
these limitations##6##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
these lines##8##2##(1992-12#1)(2008-10#5)(2008-11#1)(2012-3#1)
these loci##8##2##(1993-6#1)(1994-9#1)(2008-10#4)(2009-10#1)(2013-8#1)
these losses##2##2##(2008-10#2)
these low##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
these mAbs##2##2##(1994-5#1)(1996-12#1)
these machines##2##2##(2008-2#1)(2008-3#1)
these major##2##2##(2008-10#1)(2008-7#1)
these markers##10##2##(1991-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
these materials is##2##3##(2008-3#1)(2009-7#1)
these materials##15##2##(1995-3#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#2)(2009-7#2)(2010-10#1)(2010-7#1)(2012-2#1)
these matrices##3##2##(2008-10#3)
these may be##2##3##(2008-10#1)(2008-11#1)
these may##8##2##(2008-10#1)(2008-11#3)(2008-5#1)(2009-1#1)(2010-5#1)(2012-3#1)
these measurements to##2##3##(2008-9#1)(2013-1#1)
these measurements##7##2##(2008-3#5)(2008-9#1)(2013-1#1)
these measures are##2##3##(1992-9#1)(1995-2#1)
these measures##7##2##(1990-2#1)(1992-9#1)(1995-2#1)(2008-9#2)(2011-2#2)
these mechanisms may##2##3##(2008-11#1)(2011-2#1)
these mechanisms##18##2##(1993-9#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#5)(2012-2#2)
these media##6##2##(2008-10#1)(2008-12#2)(2010-6#1)(2012-2#2)
these mediators##2##2##(1990-9#1)(2010-5#1)
these medical##2##2##(1990-11#1)(2008-11#1)
these medicaments##2##2##(1997-2#2)
these membranes##5##2##(1991-5#1)(1992-7#1)(2008-10#2)(2009-8#1)
these men##3##2##(1996-11#2)(2009-12#1)
these mental##2##2##(1991-8#1)(2013-8#1)
these metabolic##2##2##(2008-11#2)
these metabolites##6##2##(1991-5#1)(1994-8#2)(2008-10#1)(2008-11#1)(2012-2#1)
these metal ions are##4##4##(2008-10#4)
these metal ions in##5##4##(2008-10#5)
these metal ions is##2##4##(2008-10#2)
these metal ions were##5##4##(2008-10#5)
these metal ions with##2##4##(2008-10#2)
these metal ions##25##3##(2008-10#25)
these metal##26##2##(2008-10#25)(2010-11#1)
these metals##16##2##(2008-10#14)(2011-1#2)
these methodological##2##2##(2008-12#1)(2011-1#1)
these methodologies##2##2##(1990-8#1)(1994-12#1)
these methods are##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
these methods can##2##3##(2008-10#1)(2008-8#1)
these methods have##2##3##(2008-10#1)(2011-2#1)
these methods in##3##3##(2009-11#1)(2010-12#1)(2013-8#1)
these methods is##2##3##(2008-9#1)(2011-2#1)
these methods provide##2##3##(1991-2#1)(2009-11#1)
these methods were##3##3##(2008-10#3)
these methods##42##2##(1991-2#1)(1992-1#1)(1992-9#1)(1994-5#1)(1994-9#1)(2008-10#18)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#3)(2010-12#3)(2011-2#2)(2012-12#1)(2013-8#1)
these miRNAs##2##2##(2010-7#1)(2013-8#1)
these mice##7##2##(1993-12#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-2#1)(2009-6#1)(2013-1#1)
these microbes##3##2##(2008-10#2)(2011-2#1)
these microorganisms##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
these microvesicles##2##2##(1990-12#1)(1997-3#1)
these mines##3##2##(2008-10#3)
these modalities##2##2##(2008-1#1)(2013-1#1)
these model##2##2##(1995-9#1)(2008-10#1)
these models are##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
these models was##2##3##(2008-10#1)(2008-5#1)
these models##29##2##(1992-9#1)(1993-12#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-9#1)(2012-2#4)(2012-4#1)
these modifications##3##2##(1991-12#1)(2008-10#2)
these modified##7##2##(2008-10#4)(2008-4#1)(2008-9#1)(2010-3#1)
these molecules##16##2##(1991-2#1)(1991-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#3)(2009-10#1)(2013-8#1)
these motifs##2##2##(1993-12#1)(2008-4#1)
these multiple##3##2##(2008-9#1)(2009-9#1)(2013-1#1)
these muscles##2##2##(1994-11#1)(2009-1#1)
these mutant strains##2##3##(2009-10#1)(2012-3#1)
these mutant##3##2##(1994-5#1)(2009-10#1)(2012-3#1)
these mutants##12##2##(1992-6#1)(1995-2#1)(1995-8#2)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)
these mutations were##2##3##(1993-3#1)(1997-3#1)
these mutations##15##2##(1990-5#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-11#2)(2008-7#3)(2009-4#1)(2012-3#1)
these natural##4##2##(1992-3#1)(2008-11#1)(2008-5#1)(2008-8#1)
these needs##5##2##(1991-12#1)(1993-3#1)(1994-2#1)(2009-12#1)(2013-1#1)
these nematodes##2##2##(2008-9#2)
these neo-epitopes##2##2##(2013-8#2)
these neoplasms##4##2##(1990-5#2)(2012-2#1)(2013-1#1)
these neurons##11##2##(1991-12#1)(1992-3#1)(1994-2#1)(1996-12#1)(1996-2#1)(2008-11#4)(2009-10#1)(2013-8#1)
these new methods##2##3##(2008-10#1)(2010-1#1)
these new retroviral vectors##2##4##(1997-8#2)
these new technologies##2##3##(2008-11#1)(2010-7#1)
these new##29##2##(1990-5#1)(1991-1#1)(1995-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(1997-9#1)(2008-10#4)(2008-11#6)(2008-3#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
these nine##3##2##(1996-3#1)(2008-10#2)
these normal variants##2##3##(2010-1#2)
these novel inclusions##3##3##(2008-10#3)
these novel proteolysis##2##3##(2012-3#2)
these novel##11##2##(1995-6#1)(1997-8#1)(2008-10#5)(2008-4#1)(2012-3#2)(2013-1#1)
these nuclear##2##2##(2007-12#1)(2012-3#1)
these numbers##2##2##(2009-8#1)(2013-1#1)
these nurses##4##2##(2008-1#1)(2008-7#1)(2010-10#1)(2010-8#1)
these objectives##3##2##(1995-2#1)(1997-3#1)(2008-7#1)
these observations##14##2##(1993-3#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-9#1)(2011-2#1)
these obstacles##2##2##(1996-3#1)(2008-11#1)
these occurred##2##2##(2008-9#1)(2009-8#1)
these often##2##2##(2008-12#1)(2008-9#1)
these oligonucleotides##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
these options##4##2##(1997-7#1)(2008-1#2)(2008-10#1)
these organelles##2##2##(1994-5#1)(2009-8#1)
these organisms##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#3)(2012-2#1)
these organizations##5##2##(1991-3#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-3#1)
these organs##6##2##(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)
these oscillations##2##2##(2013-8#2)
these outcomes##3##2##(2009-11#1)(2009-7#1)(2013-1#1)
these parameter values##2##3##(2008-10#1)(2008-7#1)
these parameters are##2##3##(2008-5#1)(2008-7#1)
these parameters in##3##3##(2007-8#1)(2008-10#1)(2012-3#1)
these parameters of##2##3##(1997-2#1)(2008-10#1)
these parameters were##2##3##(1991-5#1)(2008-10#1)
these parameters##32##2##(1990-4#1)(1991-5#1)(1992-3#1)(1994-3#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-3#1)
these parasites##4##2##(2007-12#1)(2012-2#1)(2013-8#2)
these participants##2##2##(2010-8#1)(2013-1#1)
these particles##2##2##(2008-10#1)(2008-11#1)
these pathogens are##3##3##(2008-10#2)(2008-9#1)
these pathogens##19##2##(1995-5#2)(2007-12#1)(2008-10#10)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#2)(2013-7#1)
these pathologies##3##2##(2010-11#1)(2010-12#1)(2012-2#1)
these pathways##8##2##(1995-12#1)(1996-2#1)(2008-11#1)(2008-4#1)(2009-1#1)(2009-6#1)(2011-3#1)(2012-3#1)
these patient groups##2##3##(1993-2#1)(2009-10#1)
these patient##3##2##(1993-2#1)(1995-2#1)(2009-10#1)
these patients and their##2##4##(1991-6#1)(2009-9#1)
these patients and##4##3##(1991-6#1)(2009-9#1)(2011-2#2)
these patients are##5##3##(1990-6#1)(1990-9#1)(1997-8#1)(2008-7#1)(2013-1#1)
these patients does not##2##4##(2012-2#1)(2013-1#1)
these patients is##3##3##(1990-9#1)(2008-11#1)(2009-12#1)
these patients to##2##3##(2008-1#1)(2010-6#1)
these patients was##4##3##(1994-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
these patients were##6##3##(1990-9#1)(1991-2#1)(1991-3#1)(1994-9#1)(2008-9#1)(2013-1#1)
these patients##122##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#2)(1990-9#3)(1991-11#2)(1991-2#5)(1991-3#1)(1991-6#2)(1992-12#4)(1992-2#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-9#2)(1995-2#3)(1996-11#1)(1996-9#1)(1997-4#1)(1997-8#3)(2008-1#7)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-7#14)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#3)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#7)(2013-8#1)
these patterns##9##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-8#1)
these peptides in##2##3##(1994-8#1)(2009-6#1)
these peptides were##2##3##(1991-5#1)(1994-8#1)
these peptides##14##2##(1991-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-3#1)(1996-12#1)(2008-10#1)(2009-6#1)(2011-1#1)(2011-2#1)
these persons##5##2##(1991-6#1)(1994-2#1)(1994-9#1)(2012-2#2)
these phenomena##10##2##(1993-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2009-7#1)(2013-1#1)
these plants were##3##3##(2008-10#3)
these plants##15##2##(2008-10#13)(2009-8#1)(2011-1#1)
these plots##4##2##(2008-10#3)(2010-12#1)
these policies##4##2##(1993-3#1)(1995-1#2)(1997-7#1)
these polymers##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
these polymorphic##3##2##(1996-8#1)(2008-9#1)(2013-8#1)
these polypeptides##2##2##(1995-6#1)(2008-11#1)
these populations are##4##3##(2008-10#3)(2008-8#1)
these populations was##3##3##(2008-10#2)(2013-1#1)
these populations##20##2##(2008-1#1)(2008-10#14)(2008-8#1)(2010-10#1)(2012-3#1)(2012-7#1)(2013-1#1)
these positions##2##2##(1993-8#1)(2009-10#1)
these possibilities##3##2##(1992-12#1)(1994-5#1)(2009-8#1)
these potential##4##2##(1992-3#1)(1994-5#1)(2008-7#1)(2013-1#1)
these precursors##2##2##(2008-5#1)(2013-1#1)
these predictions##3##2##(2008-11#1)(2008-6#1)(2008-8#1)
these preliminary results##4##3##(1990-12#1)(1992-6#1)(2008-10#1)(2010-12#1)
these preliminary##5##2##(1990-12#1)(1992-6#1)(1995-2#1)(2008-10#1)(2010-12#1)
these primers##5##2##(1993-12#1)(2008-10#4)
these principles##5##2##(1992-2#1)(1993-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
these problems by##2##3##(1991-3#1)(2008-10#1)
these problems##20##2##(1991-3#2)(1993-12#1)(1994-12#1)(1994-2#1)(1996-3#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#2)(2011-2#1)
these procedures are##4##3##(2008-10#3)(2008-4#1)
these procedures##19##2##(1991-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-9#2)(2009-9#1)(2012-12#1)(2012-2#1)
these processes and##2##3##(2010-10#1)(2010-12#1)
these processes are##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
these processes at the molecular level##2##6##(2011-2#1)(2012-2#1)
these processes is##2##3##(2008-11#1)(2011-2#1)
these processes##29##2##(1995-12#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#3)
these product##2##2##(2008-5#1)(2009-7#1)
these products##14##2##(1992-10#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)
these professionals##3##2##(1993-2#2)(2008-11#1)
these programmes##2##2##(2008-11#1)(2008-12#1)
these programs are##2##3##(1994-2#1)(2013-1#1)
these programs##14##2##(1993-1#1)(1994-12#2)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-3#2)(2013-1#4)
these projections##2##2##(2008-7#1)(2009-8#1)
these properties##11##2##(1991-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#2)
these protein##5##2##(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2013-1#1)
these proteins and##2##3##(2009-8#2)
these proteins are##8##3##(1993-2#1)(1994-11#1)(1994-5#1)(1997-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
these proteins in##4##3##(1995-2#2)(2008-11#1)(2012-3#1)
these proteins was##2##3##(1993-6#1)(1997-6#1)
these proteins were##2##3##(1995-12#1)(1995-6#1)
these proteins##42##2##(1990-11#1)(1991-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(1997-6#2)(1997-7#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#2)(2008-9#2)(2009-8#2)(2009-9#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
these protocols##5##2##(1994-3#1)(2008-2#2)(2008-4#1)(2008-9#1)
these providers##3##2##(1997-1#1)(1997-2#2)
these purposes##2##2##(2008-10#1)(2011-2#1)
these putative##3##2##(2008-10#2)(2008-11#1)
these quality##2##2##(2008-5#1)(2012-2#1)
these quantitative traits##2##3##(2008-10#1)(2008-12#1)
these quantitative##3##2##(1996-11#1)(2008-10#1)(2008-12#1)
these quantities##2##2##(1990-8#1)(2008-3#1)
these questions are##2##3##(1996-1#1)(2008-8#1)
these questions##6##2##(1991-3#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-11#1)(2008-8#1)
these rates##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
these rats##2##2##(1991-6#1)(1994-8#1)
these reaction##2##2##(1996-5#1)(2008-11#1)
these reactions in##2##3##(2008-10#2)
these reactions##10##2##(1995-6#1)(2008-10#6)(2008-4#1)(2008-7#1)(2010-8#1)
these reagents##4##2##(2008-10#1)(2008-11#2)(2008-4#1)
these recent##2##2##(2008-3#1)(2010-7#1)
these receptors and##2##3##(1993-2#1)(1996-2#1)
these receptors is##2##3##(1996-12#1)(2008-4#1)
these receptors was##2##3##(1995-12#1)(2008-10#1)
these receptors##13##2##(1991-12#1)(1993-2#2)(1995-12#1)(1996-12#2)(1996-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
these recombinant viruses##2##3##(2008-10#2)
these recombinant##4##2##(2008-10#2)(2012-3#2)
these recommendations##2##2##(1994-2#1)(2008-12#1)
these reference materials##2##3##(2008-10#2)
these reference##3##2##(2008-10#3)
these regions##16##2##(1991-10#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(2008-10#4)(2008-8#1)(2010-5#3)
these regulatory elements in##2##4##(1993-12#2)
these regulatory##4##2##(1993-12#2)(2008-11#1)(2011-2#1)
these relationships were##2##3##(2009-4#1)(2010-1#1)
these relationships##17##2##(1996-2#1)(2008-10#6)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-3#1)
these reported##2##2##(2009-8#1)(2011-2#1)
these reports to##2##3##(1991-1#1)(2013-1#1)
these reports##7##2##(1991-1#1)(1991-3#1)(1994-3#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
these requirements##8##2##(1991-12#1)(1992-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2013-1#1)
these research##2##2##(2008-9#1)(2012-3#1)
these residues##3##2##(1992-4#1)(1993-8#1)(1994-5#1)
these resistant##2##2##(2008-10#2)
these resources##4##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)
these responses##5##2##(1990-5#1)(1994-3#1)(2008-10#2)(2008-9#1)
these results and the##3##4##(1990-2#1)(1992-6#1)(2008-10#1)
these results and##6##3##(1990-2#1)(1992-6#1)(1993-8#1)(2008-10#2)(2009-8#1)
these results are##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
these results demonstrate that the##2##5##(1994-3#1)(1995-12#1)
these results demonstrate that##4##4##(1994-3#1)(1995-12#1)(2008-10#1)(2009-10#1)
these results demonstrate##6##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#2)(2009-10#1)
these results indicate that the##3##5##(1994-8#1)(2008-10#2)
these results indicate that##14##4##(1993-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)
these results indicate##16##3##(1993-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-2#1)
these results provide##4##3##(1991-2#1)(1992-3#2)(1997-2#1)
these results show that##2##4##(1993-8#1)(2008-7#1)
these results suggest that a##3##5##(1993-6#1)(1996-3#1)(2009-10#1)
these results suggest that the##4##5##(1993-6#1)(1996-2#1)(2008-11#1)(2012-3#1)
these results suggest that##21##4##(1990-2#1)(1993-6#2)(1994-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
these results suggest##24##3##(1990-2#1)(1992-3#1)(1993-6#2)(1994-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
these results to##3##3##(1994-3#1)(2008-10#1)(2013-7#1)
these results we##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
these results were##3##3##(2008-11#2)(2012-12#1)
these results with##4##3##(1993-8#1)(2008-10#1)(2008-9#1)(2011-1#1)
these results##166##2##(1990-2#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#4)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#4)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#2)(1995-2#3)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#48)(2008-11#14)(2008-12#2)(2008-3#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#1)
these rice##3##2##(1996-8#1)(2008-10#1)(2009-10#1)
these risk factors##3##3##(2010-6#1)(2011-1#1)(2011-2#1)
these risk##4##2##(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
these risks##4##2##(1993-3#1)(2008-11#1)(2008-7#1)(2010-3#1)
these roles##7##2##(2008-11#1)(2008-12#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
these routes of##2##3##(2008-5#1)(2012-12#1)
these routes##3##2##(2008-5#1)(2011-2#1)(2012-12#1)
these same##15##2##(1991-5#1)(1992-2#2)(1993-6#1)(1993-8#1)(1994-2#1)(1995-1#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-5#1)
these samples by##2##3##(2008-10#2)
these samples was##4##3##(2008-10#4)
these samples were##3##3##(2008-10#3)
these samples##26##2##(1991-12#1)(1994-11#1)(1994-8#1)(2008-10#19)(2008-11#1)(2010-4#1)(2013-1#1)(2013-8#1)
these seaweeds##3##2##(2008-11#3)
these sensors##6##2##(2008-10#6)
these sequences to##2##3##(2008-10#2)
these sequences were##2##3##(2008-10#1)(2010-10#1)
these sequences##11##2##(1993-6#1)(1996-12#2)(2008-10#6)(2010-10#1)(2012-2#1)
these services##11##2##(1992-3#1)(1994-1#3)(1995-2#2)(1997-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
these settings##5##2##(1991-1#1)(1996-12#1)(2010-10#1)(2010-12#1)(2012-2#1)
these seven##6##2##(1991-12#1)(2008-10#5)
these sex##2##2##(1997-3#1)(2008-10#1)
these short-term##2##2##(1995-11#1)(2008-10#1)
these should be##2##3##(2009-4#1)(2010-1#1)
these signal##2##2##(2008-9#1)(2011-3#1)
these signaling##4##2##(2008-3#1)(2008-9#1)(2009-9#1)(2013-8#1)
these signalling##2##2##(1996-2#1)(2009-3#1)
these signals##4##2##(1995-12#1)(2008-10#1)(2008-9#1)(2010-8#1)
these signatures##2##2##(2009-6#1)(2013-1#1)
these sites##10##2##(1990-8#1)(1990-9#1)(1991-12#1)(1994-11#1)(1995-12#1)(1996-3#1)(2008-10#2)(2012-12#1)(2012-2#1)
these six##4##2##(1991-3#1)(1993-12#1)(2008-12#1)(2011-3#1)
these small##2##2##(2008-2#1)(2008-5#1)
these societies##3##2##(1992-1#1)(2008-10#1)(2009-12#1)
these soils##2##2##(2008-10#2)
these solutions are##2##3##(2008-3#1)(2008-8#1)
these solutions##7##2##(1997-4#1)(2008-10#4)(2008-3#1)(2008-8#1)
these solvents can be##2##4##(2008-10#2)
these solvents##7##2##(2008-10#6)(2008-3#1)
these sources##3##2##(2008-1#1)(2008-10#1)(2009-10#1)
these species and##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
these species are##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
these species##32##2##(1993-12#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#1)
these specific##8##2##(1994-2#2)(1994-6#1)(2008-10#1)(2008-11#3)(2010-8#1)
these stages##4##2##(2008-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
these statistics##2##2##(1995-3#1)(2008-10#1)
these steps and##2##3##(2008-4#1)(2008-9#1)
these steps##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
these steroids##3##2##(1990-11#1)(1995-12#1)(2012-3#1)
these sterols##2##2##(1997-2#1)(2008-10#1)
these strains are##3##3##(1993-9#1)(2008-10#1)(2012-3#1)
these strains were##3##3##(2008-10#3)
these strains##24##2##(1993-12#1)(1993-9#1)(1994-2#1)(2008-10#14)(2008-8#1)(2009-6#1)(2012-3#2)(2013-8#3)
these strategies##9##2##(1991-6#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#2)(2011-3#1)
these structural and functional##2##4##(1995-6#1)(2008-1#1)
these structures##12##2##(1990-12#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-2#2)
these students##5##2##(2008-11#4)(2013-8#1)
these studies are##5##3##(1991-9#1)(1997-1#1)(2008-11#1)(2009-8#1)(2012-2#1)
these studies can be used##2##5##(2008-10#1)(2011-2#1)
these studies demonstrated##2##3##(1991-3#1)(2008-10#1)
these studies have##3##3##(1991-2#1)(2008-9#1)(2009-3#1)
these studies indicate##2##3##(2008-1#1)(2008-10#1)
these studies provide##2##3##(1991-9#1)(2008-10#1)
these studies revealed##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
these studies suggest that##3##4##(1994-3#1)(2008-10#2)
these studies the##2##3##(1994-2#1)(2008-10#1)
these studies##66##2##(1990-11#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-3#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1997-1#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
these subgroups##2##2##(1996-3#1)(2010-12#1)
these subjects##6##2##(1995-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
these substances##8##2##(1991-9#1)(1994-3#1)(1994-8#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-6#1)
these substitutions##2##2##(1994-5#1)(2008-10#1)
these substrates##5##2##(1991-9#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-3#1)
these symptoms in##2##3##(2008-10#1)(2011-2#1)
these symptoms##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
these syndromes##4##2##(1996-6#1)(2008-3#1)(2009-12#2)
these synthetic##3##2##(1993-8#1)(2008-10#1)(2008-6#1)
these systems and##2##3##(1996-1#1)(2010-10#1)
these systems in##4##3##(1994-1#1)(1997-1#1)(2008-3#1)(2008-8#1)
these systems is##3##3##(2008-11#1)(2008-9#1)(2011-7#1)
these systems##36##2##(1994-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#4)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2010-10#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
these targets##3##2##(2009-12#3)
these tasks##4##2##(2008-11#2)(2010-5#1)(2010-8#1)
these taxa##3##2##(2008-10#1)(2010-3#2)
these techniques are##4##3##(1991-9#1)(2008-10#1)(2008-3#1)(2008-9#1)
these techniques can##2##3##(2008-10#1)(2008-9#1)
these techniques have been##2##4##(2010-8#1)(2010-9#1)
these techniques is##3##3##(2008-10#1)(2009-11#1)(2010-11#1)
these techniques##30##2##(1991-3#1)(1991-9#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2010-11#1)(2010-8#1)(2010-9#2)(2012-2#1)(2012-3#2)
these technologies for##2##3##(2008-11#2)
these technologies##5##2##(2008-11#3)(2010-1#1)(2010-7#1)
these terms##2##2##(2011-2#2)
these test##2##2##(1997-4#1)(2008-10#1)
these tests##9##2##(1991-6#1)(2008-10#4)(2008-12#2)(2008-5#2)
these themes are probably##2##4##(2009-10#2)
these themes##3##2##(2009-10#3)
these theoretical##2##2##(2010-3#1)(2012-3#1)
these therapies##7##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
these three aspects##2##3##(1994-12#1)(2012-3#1)
these three hosts##3##3##(2008-10#3)
these three ions##2##3##(2008-10#2)
these three lineages##2##3##(2008-10#2)
these three##53##2##(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-1#1)(1997-7#2)(2008-10#28)(2008-11#5)(2008-12#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
these thresholds##2##2##(2008-4#2)
these tissues##11##2##(1990-11#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-7#1)(2012-2#2)(2013-1#2)
these to##5##2##(1994-1#2)(2008-10#1)(2008-8#1)(2013-8#1)
these traits is##2##3##(2012-3#2)
these traits##7##2##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#3)
these transcription factors##2##3##(1995-12#1)(2008-9#1)
these transcription##3##2##(1995-12#1)(2008-9#1)(2011-2#1)
these transcripts##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
these transducers##2##2##(2008-10#1)(2009-5#1)
these transfected##2##2##(2008-11#1)(2008-8#1)
these transformations##2##2##(1995-2#1)(2011-1#1)
these transformed##2##2##(1995-2#2)
these transgenic##3##2##(2008-10#3)
these transitions##2##2##(1994-8#1)(2008-11#1)
these treatments##7##2##(1996-12#1)(2008-10#3)(2009-7#1)(2010-1#2)
these trees##3##2##(2008-10#2)(2012-6#1)
these trials##4##2##(2008-6#1)(2010-6#1)(2012-2#1)(2013-1#1)
these tumors##16##2##(1991-8#1)(1992-5#1)(1993-6#1)(1995-2#1)(1997-1#1)(2008-7#2)(2010-11#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
these two approaches##4##3##(2008-10#1)(2008-9#1)(2009-12#1)(2013-1#1)
these two dimeric impurities##2##4##(2010-2#2)
these two disciplines##2##3##(1996-1#1)(2008-11#1)
these two diseases##2##3##(2008-10#1)(2012-3#1)
these two factors##5##3##(1993-12#1)(2008-10#1)(2008-11#2)(2008-6#1)
these two families of##2##4##(1993-12#1)(1994-5#1)
these two functions##2##3##(1991-12#1)(2008-11#1)
these two genera##4##3##(2008-10#4)
these two genes##4##3##(1991-5#1)(1991-9#1)(1993-12#1)(1994-11#1)
these two groups were##3##4##(1990-2#1)(1992-11#1)(2008-10#1)
these two groups##7##3##(1990-2#1)(1992-11#1)(1992-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
these two lines##2##3##(1997-8#1)(2008-10#1)
these two measures##2##3##(2008-9#2)
these two methods##6##3##(1995-9#1)(2008-10#4)(2008-6#1)
these two molecules##2##3##(2008-7#1)(2010-10#1)
these two parameters##3##3##(2008-10#2)(2008-7#1)
these two phenomena##3##3##(2008-10#2)(2008-11#1)
these two populations##4##3##(2008-10#2)(2008-11#2)
these two processes##3##3##(1995-2#1)(2009-8#1)(2011-2#1)
these two proteins were##2##4##(1995-2#1)(2008-5#1)
these two proteins##5##3##(1990-8#1)(1993-12#1)(1995-2#1)(1997-7#1)(2008-5#1)
these two regions##2##3##(2008-10#1)(2008-7#1)
these two sites##2##3##(2008-5#2)
these two species##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
these two systems##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
these two variables##3##3##(2008-10#2)(2013-8#1)
these two viruses##2##3##(2008-10#2)
these two##195##2##(1990-2#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#5)(1993-2#1)(1994-11#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-9#1)(1996-1#4)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#4)(1997-7#3)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#60)(2008-11#16)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#4)(2009-12#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#4)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#2)
these type of##3##3##(1991-3#1)(1996-6#1)(2008-10#1)
these type##4##2##(1991-3#1)(1996-6#1)(2008-10#2)
these types of data##2##4##(2008-1#2)
these types of##7##3##(1991-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
these types##8##2##(1991-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
these unique##4##2##(1997-2#1)(2008-10#1)(2008-6#1)(2012-2#1)
these units##3##2##(1995-5#1)(1995-9#1)(2008-10#1)
these vaccines##2##2##(2008-11#1)(2011-2#1)
these values are##3##3##(2008-10#2)(2008-3#1)
these values were##4##3##(1992-12#1)(1996-12#1)(2008-10#1)(2013-1#1)
these values with##2##3##(2008-10#1)(2008-3#1)
these values##17##2##(1990-12#1)(1991-3#1)(1992-12#1)(1996-12#1)(2008-10#7)(2008-3#3)(2008-4#1)(2008-5#1)(2013-1#1)
these variables and##3##3##(2008-10#2)(2008-8#1)
these variables are##2##3##(2008-10#1)(2008-4#1)
these variables to##2##3##(2008-4#1)(2012-2#1)
these variables were##4##3##(1996-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
these variables will##2##3##(1993-1#1)(2008-5#1)
these variables##27##2##(1992-3#1)(1993-1#1)(1993-2#1)(1994-8#1)(1996-12#1)(1996-3#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
these variants##4##2##(1990-6#1)(1995-6#2)(1997-7#1)
these variations##3##2##(1993-1#1)(2008-8#1)(2013-1#1)
these varieties##2##2##(2008-12#1)(2009-10#1)
these various##6##2##(2008-10#3)(2008-6#1)(2011-2#1)(2012-2#1)
these vectors##3##2##(1993-12#1)(1993-2#1)(2008-10#1)
these very##2##2##(1997-2#1)(2009-6#1)
these viruses##15##2##(1995-2#1)(2008-10#11)(2008-11#1)(2013-1#1)(2013-8#1)
these volatiles in##2##3##(1990-11#2)
these volatiles##3##2##(1990-11#2)(2008-10#1)
these was##2##2##(2008-11#1)(2013-8#1)
these waveguides had high##2##4##(2008-2#2)
these were applied to##2##4##(2008-10#1)(2011-2#1)
these were found to##4##4##(1995-12#1)(1997-2#1)(2008-10#2)
these were##36##2##(1990-12#1)(1992-2#2)(1995-1#1)(1995-12#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-8#1)(2008-9#3)(2009-12#1)(2011-2#1)(2012-2#1)
these will be##3##3##(2008-11#3)
these will##4##2##(2008-11#3)(2009-5#1)
these wines##2##2##(2008-10#2)
these with the##2##3##(1992-12#1)(2008-3#1)
these with##3##2##(1992-12#1)(2008-3#1)(2011-1#1)
these women##7##2##(1991-9#1)(1994-12#1)(1994-2#2)(1995-1#1)(2009-9#2)
these workers##4##2##(1991-12#1)(1997-2#1)(2009-12#2)
these years##5##2##(1992-5#1)(1997-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
these yeasts##3##2##(2008-5#1)(2013-1#2)
these youth##2##2##(2008-11#1)(2013-8#1)
these##5455##1##(1990-10#1)(1990-11#18)(1990-12#16)(1990-2#15)(1990-3#6)(1990-4#1)(1990-5#22)(1990-6#12)(1990-7#3)(1990-8#14)(1990-9#8)(1991-1#10)(1991-10#2)(1991-11#8)(1991-12#36)(1991-2#23)(1991-3#29)(1991-5#25)(1991-6#14)(1991-8#6)(1991-9#12)(1992-1#8)(1992-10#7)(1992-11#1)(1992-12#26)(1992-2#18)(1992-3#31)(1992-4#5)(1992-5#3)(1992-6#14)(1992-7#1)(1992-8#2)(1992-9#19)(1993-1#19)(1993-11#5)(1993-12#42)(1993-2#23)(1993-3#24)(1993-6#22)(1993-8#31)(1993-9#8)(1994-1#15)(1994-11#27)(1994-12#21)(1994-2#35)(1994-3#35)(1994-5#31)(1994-6#11)(1994-8#29)(1994-9#16)(1995-1#12)(1995-10#1)(1995-11#18)(1995-12#37)(1995-2#64)(1995-3#13)(1995-5#15)(1995-6#29)(1995-8#13)(1995-9#11)(1996-1#17)(1996-11#14)(1996-12#50)(1996-2#35)(1996-3#27)(1996-5#12)(1996-6#10)(1996-8#5)(1996-9#5)(1997-1#15)(1997-2#46)(1997-3#29)(1997-4#11)(1997-5#1)(1997-6#7)(1997-7#23)(1997-8#32)(1997-9#3)(2006-6#7)(2007-11#5)(2007-12#33)(2007-8#1)(2008-1#41)(2008-10#1410)(2008-11#437)(2008-12#79)(2008-2#28)(2008-3#87)(2008-4#66)(2008-5#128)(2008-6#33)(2008-7#155)(2008-8#142)(2008-9#159)(2009-1#7)(2009-10#55)(2009-11#15)(2009-12#45)(2009-3#8)(2009-4#6)(2009-5#10)(2009-6#17)(2009-7#27)(2009-8#54)(2009-9#18)(2010-1#27)(2010-10#26)(2010-11#26)(2010-12#30)(2010-2#10)(2010-3#13)(2010-4#15)(2010-5#21)(2010-6#19)(2010-7#19)(2010-8#26)(2010-9#16)(2011-1#41)(2011-10#3)(2011-2#221)(2011-3#20)(2011-7#4)(2012-12#25)(2012-2#132)(2012-3#83)(2012-4#1)(2012-6#1)(2012-7#3)(2012-9#1)(2013-1#144)(2013-3#1)(2013-7#5)(2013-8#84)
thesecretion##2##1##(2008-11#2)
thesis##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
theta 0##4##2##(1995-5#4)
theta parameter of the beta-binomial distribution##3##6##(2008-10#3)
theta parameter of the beta-binomial##4##5##(2008-10#4)
theta phase precession in##3##4##(2008-11#3)
theta phase precession##5##3##(2008-11#5)
theta phase##8##2##(2008-11#8)
theta rhythm##4##2##(2008-11#4)
theta##44##1##(1991-12#1)(1995-5#4)(1996-3#4)(2008-10#11)(2008-11#15)(2008-3#1)(2008-8#2)(2010-7#1)(2012-2#1)(2013-8#4)
theta(i)##3##1##(2008-2#1)(2008-3#2)
thetaiotaomicron##2##1##(1997-2#2)
they accumulate##2##2##(2008-10#1)(2008-11#1)
they act in##2##3##(2008-8#1)(2009-8#1)
they act##3##2##(2008-5#1)(2008-8#1)(2009-8#1)
they actually##2##2##(1994-3#1)(2008-5#1)
they affect##3##2##(1991-3#1)(2008-10#1)(2012-3#1)
they aggregate##2##2##(1995-8#1)(2008-10#1)
they all##4##2##(2008-10#2)(2008-12#1)(2011-7#1)
they allow##5##2##(1992-3#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
they also##13##2##(1990-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-12#3)(2008-5#1)(2008-7#1)(2010-10#1)(2010-2#1)
they analyze##2##2##(1993-3#1)(2008-12#1)
they and the##2##3##(1996-2#1)(2007-12#1)
they and##5##2##(1994-3#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-9#1)
they appear to##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
they are a##4##3##(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
they are able to##3##4##(2008-8#1)(2010-10#1)(2011-2#1)
they are also##8##3##(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-6#1)(2013-1#2)
they are applied##3##3##(1991-8#1)(2008-10#1)(2008-3#1)
they are associated with##2##4##(2008-10#1)(2011-2#1)
they are characterized by##2##4##(2008-10#1)(2009-1#1)
they are considered##3##3##(1993-8#1)(2009-4#1)(2013-8#1)
they are difficult to##3##4##(2008-4#1)(2012-2#2)
they are effective##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)
they are fairly##2##3##(2008-4#1)(2010-11#1)
they are generally##2##3##(1996-2#1)(2008-10#1)
they are homologous to##2##4##(2008-10#2)
they are in the##2##4##(1997-1#1)(2008-8#1)
they are in##5##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
they are incorporated into##2##4##(2008-10#1)(2008-12#1)
they are introduced##3##3##(1995-5#1)(2008-8#2)
they are likely to be##2##5##(1992-6#1)(2008-10#1)
they are likely to##3##4##(1992-6#1)(2008-10#1)(2011-2#1)
they are likely##4##3##(1992-6#1)(1995-12#1)(2008-10#1)(2011-2#1)
they are more##4##3##(1997-8#1)(2007-12#1)(2008-7#1)(2010-12#1)
they are morphologically##2##3##(2008-11#1)(2010-3#1)
they are most##3##3##(2008-8#2)(2009-8#1)
they are much more##2##4##(1990-11#1)(2009-12#1)
they are not##10##3##(1991-12#1)(1992-12#1)(1994-3#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-7#1)(2012-3#1)(2013-1#2)
they are properly##2##3##(1995-12#1)(1996-3#1)
they are quite##3##3##(1993-12#1)(2008-10#1)(2010-12#1)
they are regarded as##2##4##(2012-2#2)
they are regulated in##2##4##(1997-2#1)(2011-2#1)
they are separated##2##3##(2008-10#1)(2008-4#1)
they are suitable##2##3##(2008-10#1)(2009-11#1)
they are taken##2##3##(2008-9#1)(2011-3#1)
they are the##3##3##(1996-2#1)(2008-11#1)(2008-7#1)
they are to be##2##4##(1996-3#1)(2012-2#1)
they are to##10##3##(1994-2#2)(1994-9#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-12#2)(2012-2#1)
they are unable to##2##4##(2008-11#1)(2013-1#1)
they are used##3##3##(1991-12#1)(2009-12#1)(2010-12#1)
they are useful##2##3##(2008-11#1)(2010-11#1)
they are usually##2##3##(2007-8#1)(2012-3#1)
they are very##2##3##(2008-8#1)(2008-9#1)
they are##267##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#5)(1997-4#1)(1997-7#1)(1997-8#3)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#39)(2008-11#15)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#8)(2008-6#5)(2008-7#8)(2008-8#15)(2008-9#6)(2009-1#1)(2009-11#2)(2009-12#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-2#12)(2011-3#2)(2011-7#2)(2012-2#8)(2012-3#7)(2013-1#11)(2013-8#3)
they attach to##2##3##(2008-11#2)
they avoided##2##2##(2008-12#2)
they be##2##2##(1991-12#1)(2009-8#1)
they became##4##2##(1990-2#1)(2008-10#1)(2008-7#1)(2010-11#1)
they become##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-4#1)
they believe##3##2##(1990-2#1)(1993-1#1)(1995-1#1)
they belong to a##2##4##(2008-4#1)(2008-8#1)
they belong to##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
they belong##5##2##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
they bind##2##2##(2007-12#1)(2008-4#1)
they both##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
they calculated##2##2##(1993-2#1)(1996-6#1)
they can also be##2##4##(2008-10#1)(2008-4#1)
they can also##3##3##(1993-11#1)(2008-10#1)(2008-4#1)
they can be used##5##4##(1992-8#1)(1995-6#1)(2009-7#1)(2012-3#1)(2013-1#1)
they can be##26##3##(1990-12#1)(1992-8#1)(1994-3#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
they can easily be##2##4##(1994-3#1)(2008-10#1)
they can expect##2##3##(2009-9#1)(2013-1#1)
they can##61##2##(1990-12#1)(1990-9#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
they cannot##2##2##(1994-12#1)(1997-5#1)
they carry##3##2##(1996-2#1)(2008-10#1)(2012-3#1)
they cause##7##2##(1990-9#1)(1997-7#1)(2008-10#3)(2011-2#2)
they connect##2##2##(2008-8#1)(2009-7#1)
they consider##2##2##(2008-11#1)(2008-8#1)
they contain##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
they continue to##2##3##(2008-10#1)(2013-1#1)
they could be##10##3##(1996-9#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
they could not##2##3##(1996-6#1)(2013-8#1)
they could potentially##2##3##(2008-10#1)(2009-7#1)
they could##25##2##(1990-2#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
they deemed##2##2##(2008-1#1)(2008-5#1)
they delay##2##2##(2008-1#1)(2010-12#1)
they demonstrate that##2##3##(2008-7#1)(2008-9#1)
they demonstrate##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
they describe##2##2##(1990-5#1)(1991-3#1)
they develop##3##2##(1993-1#1)(1996-1#1)(2008-10#1)
they did not##12##3##(1993-12#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-12#3)
they did##14##2##(1993-12#1)(1993-6#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#1)(2009-10#1)(2012-12#3)
they differ##2##2##(2008-10#1)(2010-11#1)
they displayed##2##2##(1993-6#1)(2008-11#1)
they do it##2##3##(2008-6#1)(2009-8#1)
they do not act##2##4##(1993-8#1)(2010-10#1)
they do not give##2##4##(2008-10#1)(2012-3#1)
they do not provide##2##4##(1992-3#1)(2008-10#1)
they do not##23##3##(1992-12#1)(1992-3#2)(1993-8#1)(1996-12#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-10#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
they do##34##2##(1991-2#1)(1992-12#2)(1992-3#2)(1993-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-8#1)(2010-10#2)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
they either##2##2##(2008-11#1)(2008-4#1)
they emerge##2##2##(2008-10#1)(2010-7#1)
they emphasize the##2##3##(1992-5#1)(1996-6#1)
they emphasize##3##2##(1992-5#1)(1996-6#1)(2010-12#1)
they enable##2##2##(2008-10#1)(2011-2#1)
they encounter##3##2##(1996-1#1)(2008-6#1)(2010-8#1)
they enhance##2##2##(1996-11#1)(2011-2#1)
they exert##2##2##(2008-4#1)(2010-10#1)
they exhibit a##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
they exhibit##8##2##(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
they exhibited##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
they experienced##4##2##(2008-11#1)(2009-5#1)(2010-11#1)(2010-4#1)
they explore##2##2##(1993-12#1)(2008-12#1)
they face##3##2##(1994-2#1)(2008-11#1)(2012-3#1)
they failed##2##2##(1996-5#1)(2010-8#1)
they fall##2##2##(1993-3#1)(2008-11#1)
they felt##4##2##(1994-3#1)(2008-1#1)(2008-11#2)
they followed##2##2##(1994-3#1)(2008-12#1)
they form a##2##3##(1994-3#1)(2008-10#1)
they form##4##2##(1994-3#1)(1995-2#1)(1997-1#1)(2008-10#1)
they formed a##2##3##(2008-11#1)(2008-7#1)
they formed##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
they function##5##2##(1993-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)
they gained##2##2##(2008-11#1)(2011-1#1)
they generate##3##2##(1995-2#1)(1996-2#1)(2008-9#1)
they go##2##2##(2010-5#1)(2011-2#1)
they had been##2##3##(1992-2#1)(1995-9#1)
they had##35##2##(1991-8#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-9#1)(1996-2#1)(1996-3#3)(1997-3#1)(1997-5#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#4)(2009-3#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#3)(2013-1#3)(2013-7#1)
they have a##9##3##(1990-8#1)(1991-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2013-1#1)
they have an##4##3##(1997-2#1)(2008-5#1)(2008-7#1)(2012-3#1)
they have become##2##3##(2008-1#1)(2008-11#1)
they have been##16##3##(1990-11#1)(1990-9#1)(1991-12#1)(1996-11#1)(1997-2#2)(1997-5#1)(2008-10#3)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
they have evolved##2##3##(2008-8#1)(2008-9#1)
they have fundamentally some problems in different features##2##8##(2013-1#2)
they have received##2##3##(1994-12#1)(2010-4#1)
they have the##3##3##(1992-1#1)(2011-2#1)(2013-8#1)
they have to be replaced##2##5##(1996-11#1)(2008-10#1)
they have to be##3##4##(1996-11#1)(2008-10#1)(2012-2#1)
they have to##5##3##(1996-11#1)(1997-6#1)(2008-10#2)(2012-2#1)
they have##82##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#2)(1995-1#2)(1995-11#1)(1996-11#2)(1996-2#2)(1996-8#1)(1997-2#5)(1997-5#1)(1997-6#1)(1997-8#1)(2008-1#4)(2008-10#9)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
they held##2##2##(2008-12#1)(2010-3#1)
they help##2##2##(1995-3#1)(2008-11#1)
they include##3##2##(1997-3#1)(2008-11#2)
they increase the##3##3##(1990-12#1)(1991-2#1)(2008-10#1)
they increase##4##2##(1990-12#1)(1991-2#1)(2007-12#1)(2008-10#1)
they induce##6##2##(1994-6#1)(1995-5#1)(2008-10#3)(2010-10#1)
they infect##2##2##(2008-10#1)(2008-11#1)
they inhibit the##2##3##(1994-11#1)(1995-8#1)
they inhibit##3##2##(1994-11#1)(1995-8#1)(1997-1#1)
they inhibited the##2##3##(1990-8#1)(1997-1#1)
they inhibited##4##2##(1990-8#1)(1995-3#1)(1997-1#1)(2008-10#1)
they interact##4##2##(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)
they lack##2##2##(2008-5#1)(2012-2#1)
they lacked the##2##3##(2008-10#1)(2008-8#1)
they lacked##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
they lay##2##2##(2008-12#1)(2008-8#1)
they leach from supply pipes into drinking water and##2##9##(2008-10#2)
they live##2##2##(2008-11#1)(2012-3#1)
they lived##2##2##(2008-7#1)(2013-1#1)
they made##4##2##(1995-12#1)(1997-3#1)(2008-9#1)(2010-9#1)
they make##4##2##(1991-2#1)(1993-1#1)(1995-2#1)(2008-1#1)
they may also be##2##4##(2008-4#1)(2010-5#1)
they may also serve as a transformative model for emerging EMR/EHR requirements##2##12##(2010-8#2)
they may also##5##3##(2008-4#1)(2008-5#1)(2010-5#1)(2010-8#2)
they may be the##2##4##(2008-9#1)(2010-12#1)
they may be##12##3##(1991-3#1)(1992-1#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)
they may become symptomatic##2##4##(2008-10#1)(2010-12#1)
they may have##4##3##(1992-2#1)(1993-3#1)(2008-5#1)(2009-8#1)
they may increase##2##3##(2008-7#2)
they may not be##2##4##(2008-4#1)(2011-2#1)
they may play a role in##2##6##(1992-6#1)(2008-10#1)
they may play a##3##4##(1992-6#1)(2008-10#1)(2008-11#1)
they may##51##2##(1991-3#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
they might be##3##3##(1994-3#1)(2009-11#1)(2012-2#1)
they might not##2##3##(1996-3#1)(2008-10#1)
they might##6##2##(1994-3#1)(1996-3#1)(2008-10#2)(2009-11#1)(2012-2#1)
they must##8##2##(1991-7#1)(1992-3#1)(1993-3#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
they need to##3##3##(1996-1#1)(2008-11#1)(2010-5#1)
they need##5##2##(1996-1#1)(2008-11#2)(2010-5#1)(2012-12#1)
they offer##2##2##(1991-1#1)(2009-4#1)
they often##4##2##(1993-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
they only##2##2##(2013-1#2)
they originate##2##2##(1997-1#1)(2008-7#1)
they ought to##2##3##(1992-12#1)(2008-7#1)
they overlap##2##2##(2008-10#1)(2008-8#1)
they participate##2##2##(1993-1#1)(1995-8#1)
they perceived as##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
they perceived##5##2##(1992-2#1)(2008-11#1)(2010-7#1)(2011-2#1)(2013-8#1)
they performed##2##2##(1991-2#1)(1996-2#1)
they play##3##2##(2010-11#1)(2012-2#1)(2012-3#1)
they possess##3##2##(1991-6#1)(2008-7#2)
they preferred##3##2##(2008-8#1)(2009-9#1)(2013-1#1)
they present##4##2##(2008-1#1)(2008-4#1)(2009-10#1)(2011-2#1)
they presented a##2##3##(2008-10#1)(2008-5#1)
they presented##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
they produce##4##2##(2008-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
they produced##2##2##(1993-8#1)(2008-10#1)
they provide a##2##3##(2008-10#1)(2010-9#1)
they provide##15##2##(1992-2#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#3)(2010-9#2)(2011-2#1)(2012-3#1)
they raise##2##2##(1995-5#1)(2010-11#1)
they rarely##2##2##(1994-1#1)(1996-9#1)
they reached##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
they react with##2##3##(2008-10#2)
they read##2##2##(2013-1#1)(2013-8#1)
they really##2##2##(2008-5#1)(2013-8#1)
they receive at##2##3##(1992-3#1)(1995-2#1)
they receive##5##2##(1992-3#1)(1995-2#1)(1995-6#1)(2008-12#1)(2013-1#1)
they reduce##4##2##(1993-8#1)(1994-11#1)(2008-8#1)(2008-9#1)
they relate to##6##3##(1991-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)
they remained in the##2##4##(1993-3#1)(2008-9#1)
they remained##3##2##(1993-3#1)(2008-5#1)(2008-9#1)
they represent a##2##3##(1993-6#1)(1995-2#1)
they represent##8##2##(1993-6#1)(1995-2#1)(2008-10#2)(2008-5#1)(2010-7#1)(2011-2#2)
they require##4##2##(1994-3#1)(1996-2#1)(2012-2#1)(2013-1#1)
they respond##3##2##(1994-5#1)(2008-7#1)(2010-10#1)
they reveal##3##2##(1991-12#1)(2008-10#1)(2012-3#1)
they seem to##2##3##(2008-12#1)(2012-5#1)
they serve as##2##3##(1991-2#1)(1996-1#1)
they serve##6##2##(1991-2#2)(1991-3#1)(1994-2#1)(1996-1#1)(2008-11#1)
they share##5##2##(1995-2#1)(2007-12#1)(2008-10#3)
they shared##4##2##(1996-11#1)(2008-10#2)(2010-11#1)
they should be used##2##4##(2008-11#1)(2011-2#1)
they should be##9##3##(1992-3#1)(1994-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2010-7#1)(2011-2#2)
they should##10##2##(1992-3#1)(1994-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2010-7#1)(2011-2#2)(2012-2#1)
they show##4##2##(1991-1#1)(1995-12#1)(2008-10#2)
they showed a##3##3##(1993-3#1)(1994-8#1)(2008-11#1)
they showed different##2##3##(2008-10#2)
they showed the##2##3##(2008-11#1)(2011-2#1)
they showed##8##2##(1993-3#1)(1994-8#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-1#1)
they significantly##2##2##(1997-1#1)(2008-8#1)
they spare##2##2##(2008-11#1)(2008-8#1)
they specifically##2##2##(1997-1#1)(2012-2#1)
they start##2##2##(2009-12#1)(2010-5#1)
they still##6##2##(1994-1#1)(1995-9#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-3#1)
they subsequently##2##2##(1997-3#1)(2010-8#1)
they suggest that##2##3##(2008-11#1)(2008-4#1)
they suggest##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
they support the##3##3##(1991-2#1)(2010-5#1)(2012-2#1)
they tend to##2##3##(2008-11#1)(2013-8#1)
they tend##3##2##(2008-11#1)(2011-3#1)(2013-8#1)
they thought##2##2##(1997-4#1)(2010-4#1)
they told##2##2##(1995-6#1)(2009-10#1)
they trigger##2##2##(2011-2#1)(2012-3#1)
they undergo##3##2##(1997-7#1)(2008-1#1)(2008-11#1)
they underline##2##2##(1991-6#1)(1993-6#1)
they understood##2##2##(1993-12#1)(2008-11#1)
they underwent##2##2##(2007-8#1)(2013-1#1)
they use##5##2##(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
they used##2##2##(1993-2#1)(2008-10#1)
they usually##4##2##(2008-10#1)(2011-2#2)(2012-3#1)
they varied##2##2##(2008-11#1)(2012-3#1)
they want##2##2##(1994-12#1)(1997-2#1)
they were able##2##3##(2008-11#1)(2008-9#1)
they were also##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
they were applied##2##3##(2009-10#1)(2011-2#1)
they were contaminated##2##3##(2008-11#2)
they were employed##2##3##(2008-10#1)(2008-11#1)
they were found to be##2##5##(2008-5#1)(2010-7#1)
they were found##3##3##(2008-5#1)(2010-7#1)(2013-1#1)
they were further##2##3##(2008-10#1)(2008-5#1)
they were in##4##3##(2008-10#1)(2008-5#2)(2009-12#1)
they were inoculated##2##3##(2008-10#2)
they were isolated from##2##4##(2008-10#1)(2008-5#1)
they were isolated##4##3##(2008-10#3)(2008-5#1)
they were managing##2##3##(1994-1#2)
they were more##2##3##(2008-10#1)(2013-1#1)
they were not##9##3##(1993-2#1)(2008-10#3)(2008-11#1)(2009-8#1)(2013-1#3)
they were satisfied with##2##4##(1990-2#1)(2008-9#1)
they were tested for their##2##5##(1993-6#1)(2008-10#1)
they were tested##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
they were the##4##3##(1995-12#1)(1996-2#1)(2008-7#1)(2009-11#1)
they were used for##2##4##(2008-10#2)
they were used in##2##4##(2008-10#1)(2008-11#1)
they were used##6##3##(2008-10#5)(2008-11#1)
they were##194##2##(1990-2#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#1)(1994-1#2)(1994-3#1)(1994-5#2)(1995-1#1)(1995-12#3)(1995-3#1)(1995-6#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#3)(2008-1#2)(2008-10#66)(2008-11#15)(2008-12#3)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2011-7#1)(2013-1#10)(2013-8#3)
they will be##8##3##(1991-12#1)(1992-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)
they will##16##2##(1991-12#1)(1992-2#1)(1994-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)
they work##4##2##(1995-3#1)(2008-11#1)(2009-6#1)(2010-12#1)
they would be##2##3##(1994-9#1)(2010-8#1)
they would like to##3##4##(1991-2#1)(2010-10#1)(2011-1#1)
they would##17##2##(1990-6#2)(1991-2#1)(1992-2#1)(1993-12#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-4#4)(2010-8#1)(2011-1#1)(2011-2#1)
they##1566##1##(1990-11#3)(1990-12#3)(1990-2#7)(1990-3#2)(1990-5#4)(1990-6#4)(1990-8#2)(1990-9#4)(1991-1#6)(1991-11#1)(1991-12#13)(1991-2#15)(1991-3#10)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#9)(1992-2#13)(1992-3#13)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#9)(1993-11#2)(1993-12#15)(1993-2#10)(1993-3#11)(1993-6#7)(1993-8#7)(1993-9#1)(1994-1#6)(1994-11#3)(1994-12#11)(1994-2#7)(1994-3#22)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#8)(1995-10#1)(1995-11#2)(1995-12#12)(1995-2#15)(1995-3#7)(1995-5#4)(1995-6#8)(1995-8#3)(1995-9#2)(1996-1#14)(1996-11#5)(1996-12#9)(1996-2#14)(1996-3#10)(1996-5#3)(1996-6#7)(1996-8#4)(1996-9#5)(1997-1#18)(1997-2#20)(1997-3#13)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#7)(2007-11#1)(2007-12#8)(2007-8#3)(2008-1#18)(2008-10#257)(2008-11#125)(2008-12#44)(2008-2#2)(2008-3#12)(2008-4#24)(2008-5#38)(2008-6#14)(2008-7#52)(2008-8#67)(2008-9#42)(2009-1#2)(2009-10#6)(2009-11#6)(2009-12#8)(2009-3#1)(2009-4#6)(2009-5#5)(2009-6#6)(2009-7#6)(2009-8#13)(2009-9#5)(2010-1#7)(2010-10#12)(2010-11#14)(2010-12#15)(2010-2#1)(2010-3#2)(2010-4#13)(2010-5#7)(2010-6#2)(2010-7#13)(2010-8#17)(2010-9#5)(2011-1#7)(2011-2#67)(2011-3#4)(2011-7#4)(2012-12#6)(2012-2#30)(2012-3#30)(2012-5#1)(2013-1#54)(2013-7#2)(2013-8#21)
they're##2##1##(1992-11#1)(2010-9#1)
thiabendazole and fuberidazole##2##3##(2008-10#2)
thiabendazole##11##1##(2008-10#11)
thiacrown ether##2##2##(2008-10#2)
thiamin transport##3##2##(1990-2#3)
thiamin##7##1##(1990-2#5)(2008-10#1)(2010-9#1)
thiamine disulfide##2##2##(1994-11#2)
thiamine##29##1##(1994-11#2)(2008-10#24)(2008-7#1)(2012-4#2)
thiamine[Symbol##2##1##(2008-11#2)
thiazide diuretics and##2##3##(1992-11#1)(1994-12#1)
thiazide##3##1##(1992-11#1)(1994-12#1)(2008-10#1)
thiazole##2##1##(2006-6#1)(2008-10#1)
thick and##2##2##(2008-7#1)(2009-5#1)
thick collagenous capsule##2##3##(2011-2#2)
thick film semiconductor sensor##2##4##(2008-10#2)
thick film##5##2##(2008-10#4)(2008-12#1)
thick insulating coatings##2##3##(2008-10#2)
thick layers##2##2##(2008-10#1)(2008-7#1)
thick nasal discharge##2##3##(2011-2#2)
thick polymer films##2##3##(2008-10#2)
thick polymer##3##2##(2008-10#3)
thick##54##1##(1991-12#1)(1992-6#1)(1992-9#1)(1997-3#2)(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#4)(2010-3#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#1)
thick)##2##1##(2008-10#2)
thick-film carbon##4##2##(2008-10#4)
thick-film semiconductor sensor##2##3##(2008-10#2)
thick-film##6##1##(2008-10#6)
thick-walled##3##1##(2008-10#1)(2010-3#1)(2013-1#1)
thickened##8##1##(1991-3#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)
thickening and##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
thickening of the##6##3##(1996-3#2)(1997-5#1)(2008-5#2)(2012-2#1)
thickening of##8##2##(1996-3#2)(1997-5#1)(2008-10#2)(2008-5#2)(2012-2#1)
thickening was##2##2##(2008-10#1)(2011-2#1)
thickening##26##1##(1991-12#3)(1994-8#1)(1995-8#1)(1996-3#2)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#6)(2008-5#2)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
thicker##11##1##(1991-2#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-5#1)(2010-10#1)(2011-2#2)(2012-3#1)
thickness and##27##2##(1995-3#1)(1995-5#1)(2008-10#7)(2008-11#2)(2008-3#4)(2008-5#4)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#3)(2011-7#1)(2013-1#1)
thickness for##6##2##(1995-3#1)(2008-10#2)(2008-12#1)(2008-3#2)
thickness in##7##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2013-1#3)
thickness is##6##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
thickness of the unstirred layer in the##5##7##(1991-5#5)
thickness of the unstirred##6##4##(1991-5#6)
thickness of the##32##3##(1990-12#1)(1991-5#6)(1992-6#1)(1993-8#1)(2008-10#7)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-9#1)(2011-2#2)(2013-8#1)
thickness of##54##2##(1990-12#1)(1991-5#6)(1992-6#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-11#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#14)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#2)(2009-5#2)(2009-9#1)(2011-2#4)(2013-1#2)(2013-8#1)
thickness on##4##2##(2008-10#4)
thickness was found to##2##4##(2008-10#2)
thickness was##9##2##(1995-3#1)(2008-10#5)(2011-2#2)(2013-1#1)
thickness were##2##2##(2008-10#2)
thickness##195##1##(1990-12#1)(1990-8#1)(1991-5#6)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#4)(1995-5#1)(1996-11#1)(1997-3#1)(1997-8#2)(2006-6#1)(2007-11#4)(2007-12#1)(2008-10#54)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#20)(2008-5#14)(2008-7#5)(2008-8#1)(2008-9#9)(2009-1#2)(2009-11#1)(2009-5#5)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#15)(2011-7#1)(2012-2#5)(2013-1#15)(2013-8#3)
thickness)##2##1##(1993-12#1)(2008-3#1)
thicknesses##10##1##(2008-10#4)(2008-2#3)(2008-3#3)
thigh pain##2##2##(2012-3#1)(2013-1#1)
thigh##19##1##(1991-6#1)(1997-3#1)(2008-12#5)(2008-5#3)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
thiirane##2##1##(1996-5#2)
thimerosal##6##1##(1995-5#1)(1997-2#2)(2008-10#2)(2008-5#1)
thin and##6##2##(2008-10#1)(2008-5#3)(2008-7#1)(2013-1#1)
thin cirrus clouds##3##3##(2008-3#3)
thin coronary sections were obtained##2##5##(2012-3#2)
thin coronary sections##3##3##(2012-3#3)
thin filaments##4##2##(1991-5#1)(1995-2#2)(2008-7#1)
thin film electrode##6##3##(2008-10#5)(2008-12#1)
thin film electrodes##5##3##(2008-10#5)
thin film of##7##3##(2008-10#7)
thin film##37##2##(2008-10#30)(2008-12#1)(2008-3#5)(2012-3#1)
thin films constructed of nanowires of small organic molecules##2##9##(2009-11#2)
thin films##27##2##(1990-8#1)(1992-8#1)(2008-10#15)(2008-2#1)(2008-3#4)(2009-11#2)(2010-7#1)(2011-2#1)(2012-2#1)
thin glass-ceramic rod##2##3##(2008-10#2)
thin layer chromatography and the##2##5##(2008-10#1)(2008-11#1)
thin layer chromatography and##4##4##(2008-10#2)(2008-11#1)(2012-2#1)
thin layer chromatography##13##3##(1992-3#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#2)
thin layer on the##2##4##(2008-10#1)(2008-6#1)
thin layer on##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
thin layer##22##2##(1992-3#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
thin layers##3##2##(2008-10#3)
thin membrane##2##2##(2007-12#1)(2008-10#1)
thin mercury film electrode##2##4##(2008-10#2)
thin mercury film electrodes is demonstrated##2##6##(2008-10#2)
thin mercury film electrodes##4##4##(2008-10#4)
thin mercury film##6##3##(2008-10#6)
thin metal film##2##3##(2007-12#2)
thin polymer films##2##3##(1990-8#1)(2008-10#1)
thin sections##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
thin tissue sections##2##3##(2010-11#2)
thin##194##1##(1990-8#2)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-2#2)(1997-3#1)(1997-6#2)(2007-12#4)(2008-10#89)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#22)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#2)(2009-11#4)(2009-8#1)(2009-9#1)(2010-11#2)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#5)(2012-3#6)(2013-1#2)
thin-film OWG##2##2##(2008-10#2)
thin-film deposition##2##2##(2008-3#1)(2010-5#1)
thin-film interference##3##2##(2008-3#2)(2008-5#1)
thin-film##17##1##(1990-8#1)(2008-10#8)(2008-3#5)(2008-5#1)(2008-7#1)(2010-5#1)
thin-films##2##1##(2008-10#2)
thin-layer chromatography (TLC)##2##3##(2008-10#1)(2008-4#1)
thin-layer chromatography##8##2##(2008-10#4)(2008-4#1)(2008-9#1)(2009-6#1)(2012-2#1)
thin-layer chromatography-densitometric##2##2##(2012-3#2)
thin-layer radial flow##2##3##(2008-10#2)
thin-layer##23##1##(2008-10#15)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#2)
thin-layered dual-band electrochemical cell##2##4##(2008-10#2)
thin-section electron microscopy##2##3##(2008-10#1)(2008-11#1)
thin-section##4##1##(1997-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
thin-sectioned##2##1##(2008-9#2)
thin-walled##3##1##(2007-12#1)(2008-10#1)(2008-7#1)
things to##2##2##(1991-8#1)(1995-2#1)
things##18##1##(1990-2#1)(1991-2#1)(1991-3#2)(1991-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-7#2)(2009-10#1)(2012-3#2)
think of##2##2##(1996-11#1)(2013-8#1)
think that the##3##3##(1990-11#1)(1995-6#1)(2011-2#1)
think that##6##2##(1990-11#1)(1992-5#1)(1995-6#1)(1997-3#1)(2011-2#1)(2012-3#1)
think##25##1##(1990-11#1)(1992-5#1)(1993-5#1)(1994-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#2)
thinkers##2##1##(1993-3#1)(1995-1#1)
thinking about##6##2##(2008-11#1)(2008-8#2)(2010-5#1)(2011-2#1)(2013-8#1)
thinking and##5##2##(1992-3#1)(2008-11#2)(2008-12#1)(2012-2#1)
thinking into##2##2##(1991-12#1)(2008-8#1)
thinking is a##2##3##(2008-12#1)(2013-1#1)
thinking is##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
thinking may##2##2##(2008-12#1)(2009-7#1)
thinking of##3##2##(2008-10#1)(2008-11#2)
thinking on##3##2##(1994-1#1)(1995-1#1)(2009-8#1)
thinking within##2##2##(2008-12#1)(2010-11#1)
thinking##73##1##(1991-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-10#2)(2008-11#26)(2008-12#16)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
thinner than those of##2##4##(1991-12#1)(2011-1#1)
thinner than##4##2##(1991-12#1)(2008-5#1)(2011-1#1)(2011-3#1)
thinner##11##1##(1991-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#2)(2013-1#2)
thinning and##2##2##(2011-2#1)(2013-8#1)
thinning of the##2##3##(2008-9#1)(2012-2#1)
thinning of##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
thinning##13##1##(1996-1#1)(2008-10#2)(2008-5#4)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
thioacetate 11##2##2##(1996-5#2)
thioacetyl styrene##2##2##(2008-12#2)
thioamide##4##1##(2008-10#3)(2011-2#1)
thiobarbituric acid reactive substances (TBARS)##2##5##(1993-2#1)(2008-10#1)
thiobarbituric acid reactive substances in##2##5##(1992-3#1)(2008-10#1)
thiobarbituric acid reactive substances##5##4##(1992-3#2)(1993-2#1)(2008-10#2)
thiobarbituric acid reactive##6##3##(1992-3#2)(1993-2#1)(2008-10#2)(2010-5#1)
thiobarbituric acid##9##2##(1992-11#1)(1992-3#2)(1993-2#1)(2008-10#3)(2008-11#1)(2010-5#1)
thiobarbituric##10##1##(1992-11#1)(1992-3#2)(1993-2#1)(2008-10#3)(2008-11#1)(2010-5#1)(2012-5#1)
thiocarbohydrazide##2##1##(2008-10#2)
thiocarbonohydrazide (PSTH) immobilized on an anion-exchange resin##2##7##(2008-10#2)
thiocarbonohydrazide and##2##2##(2008-10#2)
thiocarbonohydrazide##5##1##(2008-10#5)
thiochrome##3##1##(2008-10#3)
thioctic acid##3##2##(2008-10#3)
thiocyanate and##3##2##(1996-2#1)(2008-10#2)
thiocyanate complex##2##2##(2008-10#2)
thiocyanate complexes##3##2##(2008-10#3)
thiocyanate concentration##3##2##(2008-10#3)
thiocyanate in##6##2##(2008-10#6)
thiocyanate ion##3##2##(2008-10#3)
thiocyanate ions##4##2##(2008-10#4)
thiocyanate solution##5##2##(2008-10#5)
thiocyanate which##2##2##(2008-10#2)
thiocyanate with##3##2##(2008-10#3)
thiocyanate##64##1##(1991-12#1)(1993-2#1)(1996-2#1)(1996-5#1)(2008-10#58)(2008-12#2)
thiocyanate-selective##3##1##(2008-10#3)
thiocyanates##2##1##(2008-10#2)
thiocyanato-complexes formed##3##2##(2008-10#3)
thiocyanato-complexes##6##1##(2008-10#6)
thioester##4##1##(1990-5#2)(1994-8#2)
thioesters##2##1##(1990-5#1)(1994-8#1)
thioether methyltransferase##3##2##(1994-8#3)
thioether##5##1##(1994-8#5)
thioglycolate##2##1##(2008-5#2)
thioglycolic acid##4##2##(2008-10#3)(2012-3#1)
thioglycollic acid##2##2##(1996-2#1)(2008-10#1)
thioglycosides##2##1##(2008-12#2)
thiohemiacetal##3##1##(1991-5#3)
thiol and##2##2##(2008-10#1)(2008-9#1)
thiol compounds##4##2##(2008-10#4)
thiol derivatives##3##2##(2008-10#3)
thiol groups of##2##3##(2008-10#1)(2011-2#1)
thiol groups##11##2##(1992-3#1)(2008-1#1)(2008-10#7)(2008-4#1)(2011-2#1)
thiol methyltransferase##3##2##(1994-8#3)
thiol##45##1##(1992-3#4)(1994-8#6)(1995-8#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
thiol-activated##2##1##(1991-3#1)(1996-12#1)
thiol-containing drugs##2##2##(2008-10#2)
thiol-containing##4##1##(2008-10#4)
thiol-functionalized mesoporous sorbent##3##3##(2008-10#3)
thiolactic acid##2##2##(2008-10#2)
thiolated##3##1##(2008-10#3)
thiolates##2##1##(2008-10#2)
thiolic##3##1##(2008-10#3)
thiols amperometric##2##2##(2008-10#2)
thiols associated with##2##3##(1993-12#2)
thiols oxidation##2##2##(2008-10#2)
thiols##31##1##(1991-3#2)(1993-12#2)(1994-5#1)(2008-10#20)(2008-11#2)(2008-8#1)(2008-9#1)(2009-9#2)
thionin##2##1##(2008-10#1)(2008-4#1)
thionine##2##1##(2008-10#2)
thiopental##2##1##(2008-10#1)(2011-2#1)
thiophanate-methy1##5##1##(2008-10#5)
thiophanate-methyl##7##1##(2008-10#7)
thiophene##3##1##(1992-10#1)(2008-10#2)
thiophosphate##2##1##(2008-4#1)(2012-2#1)
thiophosphorus insecticides##2##2##(2008-10#2)
thiopurine##3##1##(2010-12#3)
thioredoxin reductase activity##2##3##(2009-9#2)
thioredoxin reductase##4##2##(2009-9#2)(2010-11#1)(2012-2#1)
thioredoxin reductases##2##2##(2009-9#2)
thioredoxin##9##1##(1993-9#1)(2009-9#5)(2010-11#1)(2012-2#2)
thioredoxin-2##2##1##(2012-2#2)
thioridazine##2##1##(2008-10#2)
thiorphan##3##1##(1996-2#2)(1997-4#1)
thiosemicarbazone##7##1##(2008-10#7)
thiosulfate and##3##2##(2008-10#3)
thiosulfate##10##1##(1992-12#1)(2008-10#9)
thiosulfinates##2##1##(2008-10#2)
thiosulphate in the##2##3##(2008-10#2)
thiosulphate##5##1##(2008-10#5)
thiotaurine##2##1##(2008-5#2)
thiotrophic##2##1##(2009-8#2)
thiourea and##3##2##(2008-10#3)
thiourea for##2##2##(2008-10#2)
thiourea from the##2##3##(2008-10#2)
thiourea##29##1##(1993-8#1)(2008-10#25)(2011-2#3)
thiourea)##2##1##(2008-10#2)
thiram##6##1##(2008-10#6)
third ORF##3##2##(1996-6#1)(2008-10#2)
third and fourth##5##3##(1990-8#1)(2008-10#4)
third and##8##2##(1990-8#1)(1993-8#1)(1996-1#1)(2008-10#4)(2012-2#1)
third component##4##2##(1991-8#1)(1994-5#1)(2008-10#2)
third generation##7##2##(1990-3#1)(1996-11#3)(2008-10#2)(2012-2#1)
third grade##4##2##(2008-12#3)(2012-3#1)
third group##6##2##(2008-10#2)(2011-2#1)(2012-3#2)(2013-1#1)
third harmonic##2##2##(2008-3#2)
third in a series##2##4##(1993-12#1)(2008-4#1)
third is##2##2##(2008-8#1)(2012-3#1)
third line hormonotherapy##3##3##(1993-1#3)
third line therapies##2##3##(1993-1#2)
third line##6##2##(1992-2#1)(1993-1#5)
third member of the##2##4##(1993-12#1)(2008-2#1)
third molar##4##2##(2011-2#1)(2013-1#3)
third month for two years##2##5##(1997-8#2)
third occipital condyle##3##3##(2013-1#3)
third of the##11##3##(1997-4#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
third of##23##2##(1990-5#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#3)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
third part##3##2##(2009-8#1)(2012-2#1)(2013-8#1)
third party##3##2##(1991-1#1)(1995-2#1)(2010-6#1)
third patient##5##2##(2008-1#1)(2008-7#1)(2009-1#1)(2012-12#1)(2013-1#1)
third phase##3##2##(1993-12#1)(2008-10#2)
third stage##3##2##(1990-3#1)(2008-12#1)(2013-1#1)
third study##2##2##(2008-10#1)(2011-2#1)
third the##2##2##(1994-9#1)(2008-7#1)
third to##2##2##(1992-6#1)(2008-2#1)
third trimester of pregnancy##3##4##(2008-12#2)(2011-2#1)
third trimester of##4##3##(2008-12#2)(2010-6#1)(2011-2#1)
third trimester##12##2##(1990-6#1)(1990-9#1)(1993-12#1)(1993-3#1)(1997-8#1)(2008-12#2)(2010-6#1)(2011-2#1)(2013-1#3)
third type##3##2##(1997-3#1)(2010-12#1)(2011-2#1)
third were##2##2##(2008-10#1)(2012-3#1)
third year student nurses##2##4##(2008-11#2)
third year##10##2##(1992-12#2)(2008-10#3)(2008-11#4)(2008-12#1)
third##299##1##(1990-11#2)(1990-12#1)(1990-3#4)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#7)(1993-12#10)(1993-2#1)(1993-3#1)(1993-8#3)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-8#5)(2007-12#3)(2008-1#1)(2008-10#61)(2008-11#12)(2008-12#14)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#5)(2009-1#2)(2009-10#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-5#2)(2010-6#6)(2010-8#2)(2011-1#1)(2011-2#12)(2012-12#4)(2012-2#5)(2012-3#6)(2012-5#1)(2012-9#1)(2013-1#26)(2013-8#5)
third-generation##4##1##(2008-10#1)(2011-2#2)(2013-1#1)
third-harmonic##4##1##(2008-3#4)
third-level##2##1##(1990-11#1)(1994-5#1)
third-order optical nonlinearities##2##3##(2008-10#2)
third-order##8##1##(1993-8#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-7#1)(2010-7#1)
third-party payers##2##2##(1994-12#1)(1995-1#1)
third-party reimbursement for##2##3##(1997-1#2)
third-party##4##1##(1994-12#1)(1995-1#1)(1997-1#2)
third-year orchard block##2##3##(2008-10#2)
third-year orchard##3##2##(2008-10#3)
third-year##5##1##(1994-3#1)(2008-10#3)(2010-8#1)
thirdly##4##1##(1995-5#1)(2008-11#2)(2008-12#1)
thirds of the##6##3##(1992-3#1)(1995-11#1)(1996-6#1)(1997-6#1)(2008-10#1)(2009-4#1)
thirds of##7##2##(1992-3#1)(1995-11#1)(1996-6#1)(1997-6#1)(2008-10#1)(2009-4#1)(2011-2#1)
thirds##8##1##(1992-3#1)(1995-11#1)(1996-6#1)(1997-6#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
thirteen##17##1##(1992-6#2)(1994-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
thirtieth##2##1##(2010-8#1)(2013-1#1)
thirty minutes##2##2##(1991-12#2)
thirty years##3##2##(1996-3#1)(2008-9#1)(2013-1#1)
thirty##16##1##(1991-12#2)(1994-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
thirty-eight##2##1##(2008-10#1)(2011-2#1)
thirty-four clinical samples##2##3##(2013-8#2)
thirty-three##2##1##(1993-1#1)(2008-10#1)
this &quot##17##2##(1991-8#1)(1993-1#1)(1994-2#3)(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
this 5##2##2##(2008-12#1)(2008-8#1)
this A2 population##2##3##(2008-10#2)
this CRE##2##2##(2013-1#2)
this DNA fragment##3##3##(2008-10#1)(2008-8#2)
this DNA##5##2##(1993-8#1)(2008-10#2)(2008-8#2)
this ELISA##2##2##(2008-11#2)
this N-glycosylation##2##2##(2013-1#2)
this ORF##2##2##(1996-8#2)
this QTL##2##2##(2008-10#2)
this ToLCV is##2##3##(2008-10#2)
this a##2##2##(2008-10#1)(2008-3#1)
this ability is##2##3##(2006-6#1)(2008-10#1)
this ability##9##2##(1990-11#1)(1995-2#1)(1995-5#1)(2006-6#1)(2008-10#1)(2008-8#1)(2008-9#3)
this abnormal##3##2##(1992-1#1)(2008-7#2)
this acid##2##2##(2008-10#2)
this action of##3##3##(1992-6#1)(1995-12#2)
this action was##2##3##(1993-3#1)(1995-2#1)
this action##5##2##(1992-6#1)(1993-3#1)(1995-12#2)(1995-2#1)
this activation##5##2##(1990-5#1)(1994-2#1)(1996-12#1)(2012-12#1)(2013-8#1)
this activity has##2##3##(1994-8#1)(2008-7#1)
this activity##10##2##(1992-10#1)(1994-8#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-7#2)(2011-2#1)
this added##2##2##(1992-3#1)(1997-8#1)
this addendum##8##2##(2009-8#8)
this affects##2##2##(1991-3#1)(2013-1#1)
this age group##8##3##(1991-8#1)(1992-11#1)(1995-12#1)(1997-1#4)(2008-8#1)
this age##16##2##(1991-8#1)(1992-11#1)(1995-12#2)(1997-1#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)
this agent##6##2##(1990-10#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-11#1)
this aim##4##2##(1991-2#1)(2008-10#1)(2010-8#1)(2012-12#1)
this allows##3##2##(2008-10#2)(2008-11#1)
this also##2##2##(2008-10#1)(2010-3#1)
this alternative##2##2##(1993-8#1)(2008-5#1)
this analysis is##3##3##(1995-12#1)(2008-12#1)(2010-11#1)
this analysis were##2##3##(2008-10#1)(2008-11#1)
this analysis##31##2##(1990-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-11#2)(2010-12#1)(2010-9#1)(2011-2#1)
this analytical procedure##2##3##(2008-10#2)
this analytical technique##2##3##(2008-10#2)
this analytical##7##2##(2008-10#7)
this ancient##2##2##(2008-9#1)(2009-8#1)
this and other##7##3##(1993-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2013-1#1)
this and similar##2##3##(2010-10#1)(2011-2#1)
this and##12##2##(1990-8#1)(1993-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-10#1)(2011-2#2)(2013-1#1)
this animal##3##2##(1992-12#1)(2008-12#1)(2011-2#1)
this anomaly##7##2##(1991-8#1)(1991-9#1)(2008-11#2)(2008-7#1)(2013-1#1)(2013-2#1)
this antagonism##2##2##(2008-10#1)(2012-3#1)
this antibody##5##2##(1993-12#1)(1995-12#1)(2008-10#1)(2013-1#2)
this antigen##4##2##(1991-11#1)(2008-11#2)(2008-8#1)
this apparatus##2##2##(2008-10#1)(2008-3#1)
this apparent##3##2##(1994-11#1)(2009-6#1)(2009-9#1)
this apparently##3##2##(1997-1#1)(2008-10#2)
this application##5##2##(2008-10#3)(2008-12#1)(2010-6#1)
this approach and##2##3##(2008-4#1)(2013-8#1)
this approach are##4##3##(1994-3#1)(2008-10#1)(2008-12#1)(2010-11#1)
this approach can be##2##4##(2008-11#1)(2011-2#1)
this approach can##4##3##(1995-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
this approach for the##2##4##(1994-5#1)(2009-10#1)
this approach for##4##3##(1992-9#1)(1994-5#1)(2009-10#1)(2010-8#1)
this approach has##3##3##(1997-7#1)(2012-2#1)(2013-1#1)
this approach in the##2##4##(2008-10#1)(2008-5#1)
this approach in##4##3##(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)
this approach is less##2##4##(2008-8#1)(2011-2#1)
this approach is limited##2##4##(2012-3#2)
this approach is not##2##4##(2008-10#1)(2010-8#1)
this approach is##19##3##(1990-5#1)(1992-3#1)(1992-9#1)(1995-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
this approach to learning##2##4##(2008-11#2)
this approach to##8##3##(2008-10#2)(2008-11#2)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
this approach we##3##3##(2008-3#2)(2008-5#1)
this approach with##3##3##(2008-11#2)(2010-9#1)
this approach##112##2##(1990-5#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#18)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-2#7)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#2)(2013-8#2)
this approximation##5##2##(2008-3#4)(2013-1#1)
this are discussed##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
this are##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
this area and##3##3##(1990-5#1)(2008-11#1)(2008-12#1)
this area in##4##3##(1993-8#1)(1995-2#1)(2008-10#1)(2008-2#1)
this area is##4##3##(1994-1#1)(2008-10#1)(2011-2#1)(2012-9#1)
this area of influence was somewhat elliptical##2##7##(2008-10#2)
this area of##13##3##(1997-8#1)(2008-10#4)(2008-11#4)(2008-2#1)(2010-7#1)(2012-2#2)
this area to##2##3##(2008-10#1)(2013-1#1)
this area##87##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-1#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#13)(2008-12#5)(2008-2#4)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#1)(2010-10#2)(2010-11#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#4)(2011-9#1)(2012-12#2)(2012-2#3)(2012-9#1)(2013-1#2)(2013-8#2)
this article I##3##3##(1992-2#1)(2009-6#1)(2010-3#1)
this article addresses##2##3##(1994-12#1)(2008-9#1)
this article are##5##3##(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)(2013-1#1)
this article describes##2##3##(1992-12#1)(2012-3#1)
this article discusses##2##3##(2008-7#1)(2010-7#1)
this article examines##3##3##(1995-1#1)(1995-3#1)(2012-2#1)
this article explores the##2##4##(1996-12#1)(2008-11#1)
this article focuses on the##2##5##(1992-12#1)(1993-2#1)
this article include##3##3##(1996-2#1)(1997-1#1)(2010-7#1)
this article includes##2##3##(1991-1#1)(2008-12#1)
this article is an##7##4##(1992-1#1)(2008-11#5)(2012-3#1)
this article is on##3##4##(2008-10#1)(2008-12#1)(2010-2#1)
this article is to##40##4##(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
this article is##52##3##(1992-1#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
this article presents##2##3##(1996-1#1)(2008-5#1)
this article the##2##3##(2008-11#1)(2012-3#1)
this article was##7##3##(1991-2#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-7#1)(2012-2#1)
this article will address##2##4##(1996-1#1)(2008-1#1)
this article will##8##3##(1995-12#1)(1996-1#2)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
this article##346##2##(1990-11#1)(1990-9#1)(1991-1#7)(1991-12#3)(1991-2#8)(1991-3#6)(1992-1#7)(1992-12#9)(1992-2#8)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#3)(1994-1#6)(1994-12#2)(1994-2#3)(1994-3#4)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#4)(1996-1#7)(1996-12#1)(1996-2#7)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#3)(2008-1#3)(2008-10#20)(2008-11#36)(2008-12#7)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#13)(2008-9#10)(2009-1#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#3)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#7)(2010-8#1)(2010-9#7)(2011-1#1)(2011-2#18)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#20)(2012-3#13)(2013-1#12)(2013-8#4)
this as a##4##3##(1995-11#1)(2008-11#1)(2012-3#2)
this aspect of##5##3##(1994-3#1)(1995-5#1)(2008-5#1)(2008-6#1)(2012-2#1)
this aspect##6##2##(1994-3#1)(1995-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)
this assay is 0##2##4##(2008-10#1)(2008-11#1)
this assay##26##2##(1990-12#2)(1991-12#1)(1991-9#2)(1992-12#1)(1995-11#1)(2008-10#9)(2008-11#4)(2008-4#2)(2008-5#2)(2008-7#1)(2011-3#1)
this assertion##2##2##(2008-9#1)(2011-2#1)
this assessment##5##2##(1995-1#1)(2008-10#2)(2008-11#1)(2011-3#1)
this assignment##2##2##(1997-6#1)(2013-1#1)
this association is##2##3##(1997-1#1)(2013-1#1)
this association was not statistically significant##2##6##(2012-12#2)
this association was##3##3##(2008-12#1)(2012-12#2)
this association##13##2##(1991-12#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-10#1)(2012-12#2)(2013-1#3)
this assumption##6##2##(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)
this bacterial##4##2##(2008-10#3)(2008-5#1)
this bacterium was##2##3##(2008-10#1)(2011-2#1)
this bacterium##7##2##(1993-8#1)(2008-10#4)(2008-9#1)(2011-2#1)
this balance##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
this band was##2##3##(1995-11#2)
this barrier##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
this basic##2##2##(2008-9#1)(2010-9#1)
this basis##7##2##(1992-3#1)(1995-6#1)(2008-10#3)(2009-4#1)(2011-2#1)
this be##2##2##(2009-10#1)(2012-12#1)
this behavior##7##2##(1992-12#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
this behavioral##2##2##(1991-2#1)(1991-3#1)
this behaviour##4##2##(2008-10#1)(2008-11#2)(2010-8#1)
this being the##2##3##(1992-9#1)(2008-5#1)
this being##3##2##(1992-9#1)(2008-5#1)(2008-8#1)
this belief##2##2##(2008-10#1)(2013-1#1)
this beneficial effect##2##3##(1995-3#1)(2008-10#1)
this beneficial##3##2##(1995-3#1)(2008-10#2)
this benefit##2##2##(2008-3#1)(2011-2#1)
this binding is##2##3##(1995-2#1)(2008-10#1)
this binding was##2##3##(1991-12#1)(1996-12#1)
this binding##8##2##(1990-5#1)(1991-12#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
this bioassay##2##2##(2008-10#1)(2008-12#1)
this biochemical##3##2##(1990-8#1)(1992-12#1)(2011-2#1)
this biological control##2##3##(2008-10#2)
this biosensor##2##2##(2008-10#2)
this book##2##2##(2008-10#2)
this brief##3##2##(2006-6#1)(2008-5#1)(2013-1#1)
this by##3##2##(1993-12#1)(2008-8#1)(2012-2#1)
this cDNA##3##2##(1991-5#1)(2008-6#1)(2008-8#1)
this calibration technique##2##3##(2008-10#2)
this calibration##5##2##(2008-10#4)(2010-3#1)
this can be##4##3##(1991-3#1)(1993-9#1)(2008-4#1)(2010-10#1)
this can##9##2##(1991-3#1)(1993-9#1)(1996-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-2#1)
this cancer##7##2##(2008-5#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-8#1)
this capability##2##2##(2012-2#1)(2013-1#1)
this carrier##2##2##(1995-6#1)(2008-10#1)
this case are presented##2##4##(2008-10#1)(2011-2#1)
this case as##2##3##(2008-7#1)(2010-6#1)
this case because##2##3##(2008-12#1)(2008-8#1)
this case is##3##3##(2008-1#1)(2010-6#1)(2013-7#1)
this case of##2##3##(2008-7#1)(2010-2#1)
this case report##11##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
this case series##2##3##(2008-12#1)(2013-1#1)
this case study##9##3##(1991-1#1)(1992-3#1)(1993-1#2)(1994-1#2)(1996-1#1)(2010-5#1)(2012-12#1)
this case the##5##3##(1995-12#1)(1995-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
this case##112##2##(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-3#2)(1993-1#2)(1993-12#1)(1994-1#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#3)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
this causes##2##2##(2008-10#1)(2008-11#1)
this ceiling##2##2##(2008-11#1)(2013-7#1)
this cell line was##2##4##(2008-11#2)
this cell line##8##3##(1990-5#2)(2008-11#6)
this cell##15##2##(1990-5#2)(1991-2#1)(1993-6#1)(1997-1#1)(2008-10#1)(2008-11#7)(2008-3#1)(2011-2#1)
this cellular##2##2##(1995-2#1)(2011-2#1)
this century##2##2##(1997-5#1)(2008-11#1)
this challenge##3##2##(1993-12#1)(1994-12#1)(1997-1#1)
this change in##3##3##(2008-10#2)(2008-7#1)
this change is##2##3##(2008-10#1)(2011-3#1)
this change##14##2##(1992-3#1)(1994-1#1)(1996-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-3#1)
this channel##2##2##(2009-12#1)(2009-8#1)
this chapter##9##2##(2008-4#1)(2008-9#2)(2009-10#1)(2010-4#1)(2010-5#2)(2013-1#2)
this character##2##2##(2008-11#1)(2008-8#1)
this chemical##3##2##(2008-10#2)(2008-11#1)
this chemically##2##2##(1994-9#1)(2008-10#1)
this child##2##2##(2008-9#1)(2011-2#1)
this chromatographic##3##2##(2008-10#2)(2008-5#1)
this chromosomal##2##2##(1997-2#1)(2009-10#1)
this chromosome##5##2##(1995-12#1)(1997-6#1)(2008-10#3)
this chronic##2##2##(1993-8#1)(2009-11#1)
this circulation##2##2##(1996-1#2)
this claim##2##2##(2008-10#1)(2008-8#1)
this class of compounds##3##4##(1993-8#2)(2008-10#1)
this class of##16##3##(1991-12#1)(1993-2#1)(1993-8#2)(1995-5#1)(1996-3#1)(2008-10#2)(2008-11#3)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
this class##18##2##(1991-11#1)(1991-12#1)(1993-2#1)(1993-8#2)(1995-5#1)(1996-3#1)(2008-10#3)(2008-11#3)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
this classification##3##2##(1990-11#1)(1992-7#1)(1997-8#1)
this client group##2##3##(2008-11#1)(2008-7#1)
this clinical##5##2##(1990-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
this clone is##2##3##(1993-6#2)
this clone was##2##3##(1995-2#1)(2008-8#1)
this clone##11##2##(1990-2#1)(1990-7#1)(1992-3#1)(1993-6#2)(1994-8#2)(1995-2#2)(2008-10#1)(2008-8#1)
this cluster##2##2##(1992-12#1)(2008-12#1)
this cohort##4##2##(1994-12#1)(1997-8#1)(2008-9#1)(2012-3#1)
this collaboration##2##2##(1991-2#1)(1996-3#1)
this column##3##2##(2008-10#2)(2011-2#1)
this combination##7##2##(1995-5#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
this combined##2##2##(2008-10#1)(2012-3#1)
this commentary##2##2##(2009-5#1)(2012-2#1)
this common##4##2##(2008-11#1)(2009-8#1)(2010-5#1)(2013-8#1)
this communication##7##2##(1991-5#1)(1992-2#1)(1994-11#1)(1996-3#1)(2008-10#2)(2009-10#1)
this comparative##2##2##(1993-12#1)(2011-2#1)
this comparison##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
this compensatory##2##2##(2010-11#1)(2010-7#1)
this complex is##2##3##(2008-10#2)
this complex##20##2##(1990-5#1)(1992-6#1)(1994-5#1)(1995-2#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
this complexity##4##2##(2008-4#1)(2008-5#1)(2012-3#1)(2013-8#1)
this complication is##2##3##(1991-3#1)(2013-1#1)
this complication##15##2##(1991-3#1)(1991-8#1)(1992-9#1)(1997-3#1)(2008-12#1)(2008-7#2)(2009-1#1)(2011-2#2)(2011-3#1)(2013-1#4)
this component of##2##3##(1996-2#1)(2008-5#1)
this component##5##2##(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
this composite polymer##2##3##(2008-10#2)
this composite##3##2##(2008-10#2)(2008-3#1)
this compound in##4##3##(1990-8#1)(2008-10#2)(2011-2#1)
this compound was##3##3##(2008-10#2)(2012-2#1)
this compound##20##2##(1990-8#1)(1991-5#1)(1993-1#1)(1995-2#1)(1997-1#1)(2008-10#12)(2008-5#1)(2011-2#1)(2012-2#1)
this concentration of##2##3##(1993-3#1)(2008-10#1)
this concentration range##3##3##(1992-3#1)(2008-10#2)
this concentration##9##2##(1992-12#1)(1992-3#1)(1993-3#1)(2008-10#6)
this concept has##2##3##(1992-1#1)(1992-12#1)
this concept in##2##3##(2008-11#1)(2009-5#1)
this concept is##2##3##(2008-3#1)(2008-8#1)
this concept##12##2##(1992-1#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
this concern##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
this conclusion##2##2##(2008-9#1)(2012-3#1)
this condition and##4##3##(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
this condition can##2##3##(2008-10#1)(2008-11#1)
this condition in##2##3##(1996-11#1)(2010-11#1)
this condition is##6##3##(2009-11#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
this condition may##2##3##(2008-10#1)(2013-1#1)
this condition should##2##3##(2008-12#1)(2008-4#1)
this condition##49##2##(1991-3#1)(1991-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#6)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#6)
this conference##3##2##(1997-8#1)(2009-5#1)(2010-4#1)
this configuration##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
this conflict is##2##3##(1995-5#1)(2008-8#1)
this conflict##4##2##(1995-5#1)(2008-8#3)
this consensus##2##2##(2008-8#1)(2013-1#1)
this construct##4##2##(1995-2#1)(1997-8#1)(2012-2#1)(2013-1#1)
this context##29##2##(1994-3#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2009-8#4)(2010-8#2)(2011-2#3)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
this continuum##2##2##(1991-12#1)(2011-2#1)
this contribution##3##2##(2008-10#3)
this control##2##2##(1990-6#1)(2008-11#1)
this controversy##2##2##(1991-5#1)(2008-9#1)
this conversion##2##2##(1992-8#1)(2009-12#1)
this correlation##5##2##(1991-6#1)(2008-10#1)(2008-12#2)(2013-8#1)
this cost##4##2##(1991-1#1)(1991-12#1)(1994-2#1)(2008-9#1)
this could be##4##3##(1993-1#1)(1996-1#1)(1996-2#1)(2012-12#1)
this could##7##2##(1993-1#1)(1994-1#1)(1996-1#1)(1996-2#1)(2008-10#1)(2010-8#1)(2012-12#1)
this country##16##2##(1992-5#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-11#1)(1996-3#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2010-6#1)(2012-12#1)
this course##2##2##(2008-1#1)(2008-11#1)
this critical##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2010-7#1)
this crop##4##2##(2008-10#2)(2010-10#2)
this cross##4##2##(2008-10#4)
this cross-sectional study##4##3##(2008-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
this current##3##2##(1996-2#1)(2008-12#1)(2013-1#1)
this data##11##2##(1996-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)
this database##3##2##(2008-10#1)(2010-5#2)
this day##3##2##(1991-1#1)(2010-12#1)(2010-8#1)
this decision##3##2##(1991-12#1)(1992-2#1)(1994-3#1)
this decline was##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
this decline##8##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2013-1#1)
this decrease in##2##3##(2008-10#1)(2009-6#1)
this decrease##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
this deficit##3##2##(1994-3#1)(2008-9#1)(2013-1#1)
this degradation##2##2##(2008-10#2)
this deletion##2##2##(1993-12#1)(2012-12#1)
this dependence##2##2##(2008-3#1)(2009-8#1)
this descriptive##2##2##(2010-4#1)(2012-12#1)
this design##3##2##(1992-9#1)(2008-10#1)(2008-3#1)
this detection system##2##3##(2008-10#2)
this detection##5##2##(2008-10#5)
this detector##3##2##(2008-10#3)
this determination##4##2##(1991-11#1)(2008-10#3)
this devastating disease process##2##4##(2008-11#2)
this devastating disease##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
this devastating##6##2##(2008-10#1)(2008-11#2)(2008-7#2)(2010-3#1)
this development##2##2##(2008-11#1)(2008-12#1)
this developmental##2##2##(2009-8#1)(2011-2#1)
this device in##2##3##(2008-10#1)(2008-9#1)
this device##10##2##(1996-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
this diagnosis##9##2##(1991-9#2)(1997-8#2)(2008-11#1)(2009-9#1)(2013-1#3)
this dichotomy##2##2##(2008-8#1)(2009-8#1)
this did not appear to##2##5##(2008-11#1)(2008-9#1)
this did not##6##3##(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
this difference in##2##3##(2008-10#1)(2009-12#1)
this difference is##2##3##(2008-8#1)(2011-2#1)
this difference was not statistically significant (P&gt##2##7##(2009-3#2)
this difference was not##4##4##(2008-10#1)(2009-3#2)(2010-12#1)
this difference was##5##3##(1993-2#1)(2008-10#1)(2009-3#2)(2010-12#1)
this difference##12##2##(1991-11#1)(1993-2#1)(2008-10#3)(2008-8#1)(2009-12#1)(2009-3#2)(2010-12#1)(2011-2#1)(2012-3#1)
this difficulty##2##2##(2010-12#1)(2012-2#1)
this direction##3##2##(1997-6#1)(2012-2#1)(2012-3#1)
this discipline##2##2##(1994-12#1)(2013-8#1)
this discussion##6##2##(2008-10#1)(2008-11#4)(2010-3#1)
this disease and##3##3##(1993-3#1)(2008-10#2)
this disease are##3##3##(1990-12#1)(1997-8#1)(2008-10#1)
this disease is##5##3##(1991-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2011-3#1)
this disease was##3##3##(2008-10#3)
this disease##83##2##(1990-12#2)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-8#4)(2008-1#1)(2008-10#28)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#5)(2009-5#3)(2009-7#2)(2009-8#2)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#1)
this disinfecting treatment leads to the formation of halogenated by-products##2##10##(2008-10#2)
this disorder are##2##3##(1997-2#1)(2008-7#1)
this disorder is##3##3##(2008-8#1)(2011-2#2)
this disorder##21##2##(1992-3#1)(1997-2#1)(2008-12#1)(2008-4#2)(2008-7#5)(2008-8#1)(2009-10#2)(2009-9#1)(2011-2#5)(2013-1#2)
this distinction##3##2##(2008-11#3)
this diverse##2##2##(2008-10#1)(2013-8#1)
this does not##2##3##(1990-8#1)(2008-5#1)
this domain##4##2##(1991-10#1)(1991-3#1)(1996-1#1)(2008-10#1)
this donor site##2##3##(2008-7#1)(2011-2#1)
this dose of##2##3##(1992-3#1)(1994-8#1)
this dose##7##2##(1990-6#1)(1992-12#1)(1992-3#1)(1994-8#1)(1997-8#1)(2009-6#1)(2013-1#1)
this drawback##2##2##(2008-10#2)
this drug was##2##3##(2008-5#1)(2012-3#1)
this drug##17##2##(1991-12#1)(1997-2#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
this dsRNA##5##2##(2008-10#5)
this dual-image mode for gated##2##5##(2008-3#2)
this dynamic##2##2##(2008-8#1)(2009-12#1)
this early##2##2##(1990-5#1)(1991-2#1)
this editorial##2##2##(2010-12#1)(2010-5#1)
this effect in##4##3##(1990-6#1)(1991-1#1)(2008-9#1)(2013-8#1)
this effect is dependent on##2##5##(1992-8#1)(1997-2#1)
this effect is mediated##2##4##(1993-3#1)(2008-8#1)
this effect is##13##3##(1991-9#1)(1992-8#1)(1993-3#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-8#2)(2009-4#1)(2009-8#1)(2012-3#1)
this effect may##2##3##(1996-2#1)(2008-5#1)
this effect might##2##3##(1991-2#1)(2008-7#1)
this effect of##4##3##(1990-12#1)(1991-1#1)(1995-12#1)(2008-9#1)
this effect on##2##3##(2008-10#1)(2008-11#1)
this effect was not##4##4##(2008-10#1)(2008-12#1)(2010-10#1)(2012-2#1)
this effect was reversed##2##4##(1990-5#1)(2009-11#1)
this effect was##19##3##(1990-5#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#2)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
this effect##80##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#3)
this effort##6##2##(1990-6#1)(1992-1#1)(1995-3#1)(2008-1#1)(2008-10#1)(2011-2#1)
this electrode and##2##3##(2008-10#2)
this electrode is##3##3##(2008-10#3)
this electrode##19##2##(2008-10#19)
this element##13##2##(1995-6#1)(2008-10#11)(2009-9#1)
this embryonic##2##2##(2008-11#1)(2013-1#1)
this emerging##2##2##(2008-10#1)(2012-2#1)
this end##28##2##(1993-11#1)(1993-8#1)(1994-2#1)(1996-2#1)(1997-8#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
this enhanced##2##2##(1993-3#1)(1995-5#1)
this enhancement##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
this enormous##2##2##(2011-2#1)(2013-8#1)
this entity##5##2##(2008-10#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
this environment##3##2##(2008-8#2)(2008-9#1)
this enzymatic##2##2##(2011-1#2)
this enzyme activity##2##3##(2008-10#1)(2008-6#1)
this enzyme in##5##3##(1991-5#1)(1994-8#1)(2008-10#1)(2008-5#1)(2011-3#1)
this enzyme is not##3##4##(1992-10#1)(1995-6#1)(2012-6#1)
this enzyme is##4##3##(1992-10#1)(1992-9#1)(1995-6#1)(2012-6#1)
this enzyme to##2##3##(1994-8#1)(2008-10#1)
this enzyme was##3##3##(1992-6#1)(2008-6#1)(2008-7#1)
this enzyme##39##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-10#2)(1992-6#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-6#2)(1995-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#3)(2009-7#1)(2011-3#1)(2012-2#1)(2012-6#1)
this equation##3##2##(2008-10#1)(2008-2#2)
this era of##2##3##(1995-2#1)(1997-3#1)
this essay##2##2##(2008-12#1)(2009-6#1)
this evaluation##5##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#2)
this event##7##2##(1993-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
this evidence##3##2##(2008-12#1)(2009-10#1)(2010-4#1)
this evolutionary##2##2##(2008-8#1)(2008-9#1)
this examination##3##2##(1992-12#1)(2008-10#1)(2013-8#1)
this example##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
this excess##2##2##(1991-11#1)(1991-12#1)
this exercise##5##2##(1993-2#1)(2008-10#2)(2008-12#1)(2008-7#1)
this expansion##2##2##(1991-3#1)(2009-8#1)
this experience##8##2##(1994-3#1)(1996-11#1)(2008-11#4)(2008-12#1)(2012-3#1)
this experiment##12##2##(1992-1#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
this experimental model##2##3##(1993-2#1)(1994-2#1)
this experimental##8##2##(1993-2#1)(1994-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
this exploratory study##3##3##(2008-10#1)(2010-6#1)(2013-8#1)
this exposure##2##2##(2008-12#1)(2010-11#1)
this expression##3##2##(1995-12#1)(1996-2#1)(2008-11#1)
this extra##2##2##(2008-11#1)(2011-2#1)
this extract##4##2##(2008-11#1)(2008-5#3)
this fact##5##2##(1997-5#1)(2008-10#2)(2011-2#1)(2013-1#1)
this factor##8##2##(1992-6#1)(1994-12#1)(1995-12#1)(2008-10#4)(2008-2#1)
this failure##2##2##(2008-10#1)(2009-10#1)
this family into##2##3##(2008-6#1)(2010-1#1)
this family is##2##3##(1997-3#1)(2008-10#1)
this family of compounds##2##4##(2008-6#1)(2010-5#1)
this family of##7##3##(1990-5#1)(2008-4#1)(2008-6#2)(2009-9#2)(2010-5#1)
this family##24##2##(1990-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-3#2)(2008-10#2)(2008-4#1)(2008-6#4)(2008-7#1)(2009-9#2)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
this feature is##2##3##(2008-6#1)(2011-2#1)
this feature##5##2##(1996-9#1)(2008-6#1)(2010-5#1)(2011-2#2)
this field is presented##2##4##(1997-7#1)(2008-11#1)
this field is##4##3##(1992-9#1)(1997-7#1)(2008-11#1)(2010-12#1)
this field##30##2##(1992-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-7#1)(2013-1#1)(2013-8#2)
this figure##3##2##(1990-6#1)(2008-1#1)(2012-3#1)
this finding in##2##3##(2009-6#1)(2012-2#1)
this finding may##2##3##(2008-11#1)(2012-3#1)
this finding##18##2##(1990-12#1)(1990-6#1)(1992-2#1)(1993-6#1)(1994-11#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-8#2)
this first##3##2##(2011-1#1)(2013-1#2)
this fish##2##2##(1990-8#1)(2012-3#1)
this flow##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
this form of##8##3##(1990-5#1)(1990-9#1)(1993-6#1)(1994-6#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
this form##10##2##(1990-5#2)(1990-9#1)(1993-6#1)(1994-6#1)(1995-1#1)(2008-10#1)(2008-11#2)(2008-7#1)
this formula##3##2##(2008-2#1)(2008-5#2)
this fraction##3##2##(1992-3#1)(1997-1#1)(2011-2#1)
this fracture##3##2##(1991-9#1)(2009-1#1)(2013-1#1)
this fragment as##2##3##(2008-8#2)
this fragment##5##2##(1996-8#1)(2008-10#1)(2008-12#1)(2008-8#2)
this framework##5##2##(1990-6#1)(1991-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
this function##4##2##(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)
this functional##4##2##(2008-10#2)(2011-1#1)(2013-8#1)
this fungal##3##2##(2008-10#3)
this fungus in##2##3##(2008-10#2)
this fungus##17##2##(2008-10#14)(2008-5#1)(2009-9#1)(2011-1#1)
this gap##3##2##(2008-11#1)(2008-7#1)(2010-9#1)
this gene in##4##3##(1997-7#1)(2008-10#2)(2013-1#1)
this gene is##6##3##(1990-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(2008-10#1)
this gene may##2##3##(1993-8#1)(2008-2#1)
this gene was##7##3##(2008-10#2)(2008-12#1)(2008-8#4)
this gene##41##2##(1990-12#1)(1992-3#1)(1993-12#1)(1993-2#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#2)(1996-2#1)(1997-3#1)(1997-7#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#5)(2008-9#1)(2009-6#1)(2009-8#1)(2013-1#1)
this genetic##5##2##(1996-12#2)(2008-10#1)(2008-11#1)(2013-1#1)
this genomic sequence##2##3##(2008-8#2)
this genus##6##2##(2008-10#3)(2008-9#1)(2010-10#2)
this gland##2##2##(1993-8#1)(2012-12#1)
this goal is##2##3##(1995-3#1)(1996-1#1)
this goal##9##2##(1992-12#1)(1995-3#1)(1996-1#1)(2006-6#1)(2008-11#3)(2008-12#1)(2010-3#1)
this gradient##2##2##(2008-10#1)(2008-2#1)
this group of children##2##4##(2008-9#1)(2012-2#1)
this group of##10##3##(1990-2#1)(1991-2#1)(1992-2#1)(1993-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-3#1)(2012-2#1)
this group was##2##3##(1990-9#1)(2008-9#1)
this group##56##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#3)(1996-11#2)(1997-8#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
this grouping was##2##3##(2008-10#2)
this grouping##4##2##(2008-10#3)(2010-12#1)
this growth##2##2##(1997-7#1)(2008-11#1)
this habitat##2##2##(2008-5#1)(2013-1#1)
this has been##5##3##(1994-2#1)(2006-5#1)(2008-11#2)(2013-1#1)
this has not been##2##4##(1993-2#1)(2013-8#1)
this has##13##2##(1993-2#1)(1994-2#1)(1997-7#1)(2006-5#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
this health##2##2##(2010-12#1)(2011-1#1)
this high##2##2##(2008-11#1)(2013-1#1)
this highly##6##2##(1991-1#1)(1992-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-2#1)
this hormone##3##2##(1991-6#1)(1993-6#1)(2008-10#1)
this host##4##2##(2008-10#4)
this human##3##2##(1992-10#1)(1994-11#1)(2008-10#1)
this hypothesis by##4##3##(1993-6#1)(2008-8#1)(2009-10#1)(2009-7#1)
this hypothesis##35##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-3#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
this idea is##2##3##(1995-6#1)(2011-2#1)
this idea##6##2##(1995-6#1)(2008-2#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
this illness##2##2##(1990-9#1)(2011-1#1)
this imaging modality##2##3##(2010-8#1)(2013-1#1)
this imaging technique##2##3##(2008-3#1)(2013-1#1)
this imaging##4##2##(2008-3#1)(2010-8#1)(2013-1#2)
this imbalance##2##2##(2010-12#1)(2013-8#1)
this impairment##3##2##(1991-2#1)(2008-11#1)(2008-7#1)
this important##13##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#3)(2012-12#1)(2013-1#1)
this impression##2##2##(2008-11#1)(2008-8#1)
this improvement##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
this in terms of the##2##5##(1997-3#1)(2008-8#1)
this in turn##2##3##(2008-12#1)(2010-4#1)
this in vitro model##2##4##(2008-10#1)(2008-5#1)
this in vitro##8##3##(2008-10#2)(2008-11#3)(2008-5#2)(2011-2#1)
this in vivo##2##3##(1995-2#1)(2008-5#1)
this in##19##2##(1990-11#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#1)(2010-4#1)(2011-2#1)
this increase in##6##3##(1990-10#1)(1991-2#1)(1994-3#1)(2008-11#1)(2009-7#1)(2013-1#1)
this increase is##3##3##(1991-3#1)(2008-11#2)
this increase was##2##3##(1990-11#1)(2012-2#1)
this increase##18##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-3#1)(2007-12#2)(2008-11#4)(2008-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
this increased##8##2##(1994-11#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)
this indication##4##2##(2008-5#1)(2008-9#2)(2010-12#1)
this indicator##2##2##(2013-1#2)
this induced##2##2##(1991-3#1)(2008-11#1)
this induction##2##2##(1994-11#1)(1995-12#1)
this infection##6##2##(2008-1#1)(2008-2#2)(2010-12#1)(2012-2#1)(2013-1#1)
this information in##2##3##(1991-11#1)(2008-11#1)
this information to##3##3##(1997-7#1)(2008-10#1)(2008-3#1)
this information##24##2##(1991-11#1)(1993-12#1)(1997-7#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#4)
this infrequent##2##2##(1990-12#1)(2012-3#1)
this inhibition by##2##3##(1995-8#1)(2008-11#1)
this inhibition was##2##3##(1991-5#1)(1994-11#1)
this inhibition##7##2##(1991-5#1)(1991-9#1)(1993-8#1)(1994-11#1)(1995-8#1)(1997-3#1)(2008-11#1)
this inhibitor##2##2##(1992-9#2)
this inhibitory##3##2##(1995-11#1)(2008-10#2)
this initiative##4##2##(1991-12#1)(2008-11#1)(2009-3#1)(2013-8#1)
this innovative##2##2##(2008-11#1)(2008-12#1)
this insect##4##2##(2007-12#1)(2008-7#2)(2011-10#1)
this institution##2##2##(2008-8#2)
this instruction##2##2##(1991-12#1)(2008-12#1)
this instrument##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-11#1)
this integrative##2##2##(1994-2#1)(2008-9#1)
this inter-organ##2##2##(2010-11#2)
this interaction in##3##3##(2008-9#1)(2009-8#1)(2012-2#1)
this interaction is##2##3##(2008-10#2)
this interaction##14##2##(1990-2#1)(1994-2#1)(1995-2#2)(1995-6#1)(2008-10#2)(2008-6#1)(2008-9#2)(2009-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
this interdependence##2##2##(2009-8#2)
this interesting##2##2##(1993-8#1)(2008-3#1)
this international##2##2##(2011-10#1)(2011-2#1)
this interval##3##2##(1991-2#1)(2008-8#1)(2008-9#1)
this intervention##9##2##(1995-1#2)(1997-2#1)(1997-5#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-7#1)(2012-12#1)
this interview##2##2##(2010-6#1)(2010-8#1)
this invertebrate##2##2##(2008-10#1)(2013-1#1)
this investigation to##2##3##(2008-10#1)(2008-11#1)
this investigation was##6##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-8#1)
this investigation##34##2##(1990-6#1)(1991-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
this involvement##3##2##(1993-3#1)(2007-12#1)(2008-4#1)
this ion##4##2##(1994-8#1)(2008-10#3)
this is a##17##3##(1990-11#1)(1991-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
this is achieved##2##3##(2008-9#1)(2010-4#1)
this is an##6##3##(1991-12#1)(1993-1#1)(2008-1#1)(2008-10#2)(2011-2#1)
this is due to##3##4##(1997-6#1)(2008-10#1)(2012-3#1)
this is due##5##3##(1997-6#1)(2008-10#2)(2012-3#2)
this is found as a single transcript of 1##2##9##(1996-6#2)
this is not a##2##4##(2011-2#1)(2012-3#1)
this is not##9##3##(1997-8#1)(2008-11#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-8#1)
this is now##2##3##(2010-12#1)(2013-1#1)
this is taken##2##3##(2007-12#1)(2008-10#1)
this is the case##4##4##(2008-1#1)(2008-10#2)(2008-11#1)
this is the first case of##3##6##(1997-8#1)(2010-3#1)(2012-3#1)
this is the first case##4##5##(1997-8#1)(2010-3#1)(2012-3#2)
this is the first demonstration of##2##6##(2008-10#2)
this is the first description of##2##6##(2008-10#2)
this is the first report concerning the##2##7##(1995-11#1)(2008-5#1)
this is the first report concerning##3##6##(1995-11#1)(2008-5#1)(2011-1#1)
this is the first report describing##2##6##(1994-12#1)(2008-10#1)
this is the first report of a##5##7##(2008-10#3)(2008-11#1)(2008-9#1)
this is the first report of the##4##7##(2008-10#3)(2013-1#1)
this is the first report of##15##6##(2008-10#9)(2008-11#1)(2008-9#2)(2012-3#2)(2013-1#1)
this is the first report on the##5##7##(2008-10#3)(2008-12#1)(2008-9#1)
this is the first report on##7##6##(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)
this is the first report##30##5##(1994-12#1)(1995-11#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#3)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
this is the first reported case of##4##7##(2008-10#1)(2010-11#1)(2010-3#1)(2010-9#1)
this is the first reported##5##5##(2008-10#2)(2010-11#1)(2010-3#1)(2010-9#1)
this is the first##51##4##(1994-12#1)(1995-11#1)(1997-3#1)(1997-8#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-9#3)(2009-12#1)(2010-11#1)(2010-3#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
this is the most##3##4##(2008-10#2)(2012-2#1)
this is the only##2##4##(2010-7#1)(2011-2#1)
this is the second##2##4##(2011-2#1)(2013-1#1)
this is the##67##3##(1994-12#1)(1995-11#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-1#1)(2009-12#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
this is##157##2##(1990-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-6#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#44)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#6)(2009-1#3)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#13)(2011-3#2)(2012-2#3)(2012-3#8)(2013-1#3)(2013-8#2)
this isolate##5##2##(2008-10#3)(2008-7#1)(2012-2#1)
this issue in##2##3##(1997-8#1)(2008-11#1)
this issue of Molecular Ecology##2##5##(2013-1#2)
this issue of##7##3##(1994-12#1)(1997-2#1)(1997-3#2)(2009-9#1)(2013-1#2)
this issue##44##2##(1990-11#1)(1991-3#1)(1992-3#1)(1993-1#2)(1994-12#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-8#1)(2008-10#2)(2008-11#12)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
this it##2##2##(2008-10#1)(2008-6#1)
this journal##2##2##(1992-2#1)(1993-11#1)
this key##2##2##(1994-3#1)(2010-11#1)
this kinase##2##2##(1994-8#1)(1995-6#1)
this kind of sample##2##4##(2008-10#2)
this kind of treatment##2##4##(1993-3#1)(2008-12#1)
this kind of##30##3##(1990-6#1)(1991-3#1)(1993-3#3)(1994-12#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#2)(2008-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
this kind##37##2##(1990-6#1)(1991-3#1)(1993-3#3)(1994-12#1)(1995-5#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-3#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#2)
this knowledge has##2##3##(2011-2#1)(2012-2#1)
this knowledge in a##2##4##(1990-6#1)(2007-12#1)
this knowledge may##2##3##(2013-1#2)
this knowledge to##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
this knowledge##14##2##(1990-6#1)(1991-2#1)(1995-5#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#2)(2013-1#2)
this laboratory demonstrated##2##3##(1995-12#1)(2008-10#1)
this laboratory##9##2##(1990-11#1)(1991-3#1)(1992-8#1)(1994-8#1)(1995-12#1)(2008-10#3)(2008-6#1)
this lack##2##2##(2011-2#1)(2013-8#1)
this large##5##2##(2008-10#2)(2008-11#1)(2011-2#2)
this laser##5##2##(2008-2#2)(2008-3#2)(2009-5#1)
this last##4##2##(2008-10#3)(2013-8#1)
this latter group##3##3##(1992-5#1)(2008-10#1)(2008-7#1)
this latter##9##2##(1992-5#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
this leads to##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
this leads##4##2##(1997-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
this led to##2##3##(2008-3#1)(2008-9#1)
this lesion##12##2##(1990-9#1)(1991-6#2)(1994-8#1)(2008-7#2)(2010-6#1)(2011-2#2)(2013-1#3)
this letter##3##2##(2008-10#2)(2009-5#1)
this level of##4##3##(1996-1#1)(2008-10#1)(2008-5#1)(2010-1#1)
this level##8##2##(1996-1#2)(2008-10#4)(2008-5#1)(2010-1#1)
this library##3##2##(1997-8#1)(2008-8#1)(2011-1#1)
this ligand##3##2##(2006-6#1)(2008-10#2)
this limitation##6##2##(1994-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)
this limited##3##2##(2008-5#1)(2008-6#1)(2013-1#1)
this line##3##2##(1991-5#1)(2008-10#2)
this link##3##2##(1993-9#1)(2008-10#1)(2008-2#1)
this lipid##2##2##(1994-11#1)(2008-10#1)
this list##2##2##(1996-3#1)(2008-10#1)
this literature##7##2##(1993-1#1)(1995-3#1)(2008-10#2)(2008-11#2)(2009-5#1)
this local##4##2##(2008-10#1)(2009-8#1)(2010-11#1)(2012-7#1)
this localization##3##2##(1994-12#1)(2011-2#1)(2012-2#1)
this location##3##2##(1996-9#1)(2008-10#2)
this locus##8##2##(1995-2#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-12#1)
this loss of##2##3##(1990-5#2)
this low##3##2##(2008-10#3)
this lower##2##2##(2008-7#1)(2010-1#1)
this mRNA##2##2##(1992-6#1)(1994-11#1)
this major##3##2##(2008-11#2)(2009-6#1)
this malformation##2##2##(2008-10#1)(2008-7#1)
this malignancy##2##2##(2012-2#1)(2012-3#1)
this manuscript##8##2##(2008-10#1)(2009-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
this marker##3##2##(1990-2#1)(2008-10#2)
this material is##2##3##(1991-12#1)(2008-10#1)
this material were##2##3##(2008-10#1)(2011-2#1)
this material##15##2##(1990-9#2)(1991-12#1)(1995-12#1)(1997-3#1)(2008-10#6)(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
this may affect##2##3##(1997-3#1)(2008-5#1)
this may be difficult##2##4##(1992-3#1)(2011-1#1)
this may be##15##3##(1990-5#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-8#1)(1995-12#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
this may have##4##3##(1990-6#1)(1997-5#1)(2008-10#1)(2012-2#1)
this may lead to##2##4##(2008-10#2)
this may reflect##2##3##(1996-12#1)(2008-11#1)
this may##37##2##(1990-5#1)(1990-6#1)(1991-5#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2006-6#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
this mechanism are##2##3##(1995-8#1)(2011-2#1)
this mechanism of##2##3##(1997-6#1)(2008-11#1)
this mechanism##11##2##(1990-12#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#1)
this media##2##2##(2008-10#2)
this medication##2##2##(1996-8#1)(2010-5#1)
this medium##4##2##(2008-10#3)(2008-11#1)
this meeting##6##2##(2008-5#3)(2009-4#2)(2011-2#1)
this membrane##7##2##(1990-8#1)(1997-1#1)(2008-10#5)
this metabolic pathway##2##3##(1994-8#1)(2008-11#1)
this metabolic##3##2##(1994-8#1)(1995-9#1)(2008-11#1)
this metabolism##3##2##(1992-10#1)(2008-11#1)(2008-7#1)
this metal##4##2##(2008-10#4)
this method and the results##2##5##(2008-10#2)
this method and the##3##4##(1992-4#1)(2008-10#2)
this method and##4##3##(1992-4#1)(2008-10#3)
this method are##9##3##(1992-4#1)(2008-10#7)(2008-3#1)
this method can be applied to##2##6##(2008-10#2)
this method can be##6##4##(1992-5#1)(2008-10#4)(2008-11#1)
this method could##2##3##(2008-10#1)(2008-11#1)
this method does not##3##4##(1996-3#1)(2008-10#2)
this method due to##2##4##(1997-2#1)(2008-10#1)
this method for the##5##4##(1994-5#1)(2008-10#3)(2008-12#1)
this method for##8##3##(1994-5#1)(2008-10#6)(2008-12#1)
this method has##4##3##(2008-10#3)(2008-2#1)
this method in##3##3##(2008-10#2)(2008-12#1)
this method is 0##2##4##(2008-10#2)
this method is##27##3##(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-3#1)(2010-11#1)(2010-7#1)(2013-8#1)
this method may##2##3##(2010-7#1)(2012-2#1)
this method might##3##3##(1990-9#1)(2008-10#1)(2008-11#1)
this method of##5##3##(2008-10#1)(2008-11#2)(2008-3#1)(2011-2#1)
this method reduces the##2##4##(1991-2#1)(2008-10#1)
this method requires##2##3##(2008-10#1)(2008-3#1)
this method showed good##2##4##(2008-10#2)
this method the##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
this method to the##2##4##(2008-10#2)
this method to##11##3##(1995-5#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)
this method was##19##3##(1990-2#1)(2008-10#16)(2008-11#1)(2008-8#1)
this method were better than those obtained##2##7##(2008-10#2)
this method were compared with##3##5##(2008-10#3)
this method were in good agreement with the##2##8##(2008-10#2)
this method were in good agreement with##3##7##(2008-10#3)
this method were in##4##4##(2008-10#3)(2008-5#1)
this method were##12##3##(1990-2#1)(2008-10#10)(2008-5#1)
this method will##2##3##(2008-11#1)(2011-2#1)
this method with##3##3##(2008-10#3)
this method##230##2##(1990-12#1)(1990-2#4)(1990-3#1)(1990-9#2)(1991-2#1)(1991-3#2)(1992-2#1)(1992-4#2)(1992-5#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#140)(2008-11#14)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#2)
this methodology##16##2##(1992-12#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)
this microchip##2##2##(2008-10#2)
this microorganism##3##2##(2009-3#1)(2011-1#1)(2013-1#1)
this might explain##2##3##(2008-10#1)(2008-8#1)
this might##5##2##(1991-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)
this minimum##3##2##(1992-9#1)(1997-3#1)(2008-3#1)
this missing##2##2##(2008-8#1)(2010-5#1)
this mixture##4##2##(2008-10#3)(2010-11#1)
this mode of##3##3##(1994-6#1)(1996-2#1)(2008-10#1)
this mode##4##2##(1994-6#1)(1996-2#1)(2008-10#2)
this model and##3##3##(1993-2#1)(2009-10#1)(2013-1#1)
this model has##2##3##(2008-12#1)(2009-7#1)
this model is that##2##4##(1995-1#1)(2008-10#1)
this model is##6##3##(1995-1#1)(2008-10#3)(2008-4#1)(2011-3#1)
this model of##2##3##(2008-10#1)(2008-11#1)
this model system##3##3##(2008-11#1)(2008-9#1)(2010-1#1)
this model to the##2##4##(2008-2#1)(2011-2#1)
this model to##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
this model was##2##3##(2008-10#1)(2008-5#1)
this model##68##2##(1990-8#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#14)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
this modeling##2##2##(2008-8#1)(2009-12#1)
this modern##2##2##(2008-4#1)(2008-5#1)
this modification##4##2##(1991-2#1)(2008-10#2)(2008-4#1)
this modified electrode were##2##4##(2008-10#2)
this modified electrode##5##3##(2008-10#5)
this modified##6##2##(2008-10#6)
this molecular##4##2##(2008-10#2)(2008-8#1)(2009-8#1)
this molecule has##2##3##(1993-2#1)(1993-3#1)
this molecule##7##2##(1993-2#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
this morbid condition##2##3##(1997-8#2)
this more##2##2##(2008-10#1)(2008-5#1)
this motif##4##2##(1991-7#1)(1992-4#1)(1995-6#1)(2009-7#1)
this mouse model##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
this multivariate regression##2##3##(2008-10#2)
this mutant##3##2##(1991-2#1)(1993-12#1)(1994-11#1)
this mutation##7##2##(1991-12#1)(1995-2#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
this mycotoxin##2##2##(2008-10#1)(2011-2#1)
this need##4##2##(1992-3#1)(1997-2#1)(2008-11#1)(2008-9#1)
this neoplasm##2##2##(1992-2#1)(1992-5#1)
this neural##2##2##(1994-11#1)(2010-11#1)
this new detector##2##3##(2008-10#2)
this new gene##2##3##(2008-10#2)
this new method##6##3##(2008-10#4)(2010-9#1)(2013-8#1)
this new sensor##2##3##(2008-10#2)
this new technique##3##3##(1990-9#1)(2008-10#1)(2013-1#1)
this new technology##4##3##(2008-11#1)(2010-7#1)(2011-2#1)(2011-7#1)
this new##73##2##(1990-9#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-10#25)(2008-11#7)(2008-12#2)(2008-3#3)(2008-5#1)(2008-8#5)(2009-5#1)(2009-7#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#3)(2011-7#2)(2012-2#5)(2013-1#1)(2013-8#1)
this newly developed method##7##4##(2008-10#7)
this newly identified gene (or allele)##2##6##(2008-10#2)
this newly identified##3##3##(2008-10#2)(2008-7#1)
this newly##12##2##(2008-10#11)(2008-7#1)
this novel##19##2##(1993-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2013-8#1)
this number##2##2##(1990-12#1)(2010-10#1)
this objective##3##2##(1993-2#1)(2008-5#2)
this observation##9##2##(1990-12#1)(1991-11#1)(1991-6#1)(1993-6#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-2#1)
this occurs##9##2##(1992-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
this oil##2##2##(2008-12#1)(2008-5#1)
this one##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
this operation##2##2##(2008-3#1)(2009-12#1)
this opportunity##2##2##(1993-12#1)(1995-12#1)
this optimal##2##2##(2008-5#1)(2008-8#1)
this optimized##2##2##(2008-10#1)(2008-11#1)
this optimum##3##2##(2008-10#2)(2008-8#1)
this option##2##2##(1992-2#1)(1993-11#1)
this organelle##4##2##(2008-11#3)(2008-9#1)
this organism are##2##3##(2008-10#1)(2010-4#1)
this organism##25##2##(1993-2#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-10#2)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#14)
this organization##3##2##(1991-2#1)(2008-11#1)(2009-10#1)
this outcome is##2##3##(1992-2#1)(2013-1#1)
this outcome##4##2##(1992-2#1)(2008-12#1)(2008-8#1)(2013-1#1)
this overview##3##2##(2008-11#1)(2008-4#1)(2011-1#1)
this pair##2##2##(1993-3#1)(2008-3#1)
this paper I##3##3##(1995-12#1)(1995-9#1)(2013-1#1)
this paper a##6##3##(2008-10#5)(2008-11#1)
this paper are##6##3##(1992-9#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-3#1)(2013-8#1)
this paper argues that##2##4##(2008-12#1)(2013-1#1)
this paper as##5##3##(2008-12#1)(2011-2#4)
this paper describes##2##3##(1996-3#1)(2008-12#1)
this paper discusses##2##3##(1991-12#1)(2012-3#1)
this paper examines the##2##4##(2008-10#1)(2008-11#1)
this paper explores##2##3##(2008-11#1)(2008-12#1)
this paper investigates##2##3##(2008-10#1)(2008-11#1)
this paper is that##2##4##(2008-11#2)
this paper is the##3##4##(2008-10#2)(2010-10#1)
this paper is to##35##4##(1992-1#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-5#1)(2009-10#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)
this paper is##48##3##(1992-1#1)(1992-3#2)(1993-1#1)(1994-1#1)(1996-3#1)(2008-10#5)(2008-11#11)(2008-12#2)(2008-5#1)(2009-10#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
this paper proposes a##2##4##(2008-6#1)(2012-2#1)
this paper the##9##3##(1992-9#2)(1993-3#1)(1995-1#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-3#1)
this paper to##3##3##(1994-5#1)(1995-12#1)(2008-10#1)
this paper was##7##3##(1992-2#1)(2008-10#2)(2008-11#1)(2009-8#2)(2011-2#1)
this paper we describe##6##4##(1990-12#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
this paper we##40##3##(1990-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-10#2)(2011-2#2)(2012-2#3)(2013-1#6)(2013-8#5)
this paper will##3##3##(2008-11#1)(2008-12#2)
this paper##441##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#3)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#4)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#5)(1996-12#2)(1996-3#4)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#167)(2008-11#48)(2008-12#24)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#9)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#6)(2009-11#1)(2009-3#5)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#2)(2011-2#14)(2011-3#3)(2012-2#10)(2012-3#9)(2013-1#18)(2013-7#1)(2013-8#10)
this paradigm##5##2##(1993-3#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
this parameter##9##2##(1990-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)
this part of the##3##4##(1996-12#1)(2007-12#1)(2008-1#1)
this part##4##2##(1996-12#1)(2007-12#1)(2008-1#1)(2012-3#1)
this particular group of##3##4##(1990-8#1)(1996-2#1)(2008-11#1)
this particular type of##2##4##(1990-11#1)(2009-1#1)
this particular##15##2##(1990-11#1)(1990-8#1)(1993-1#1)(1995-5#1)(1996-2#1)(2008-10#3)(2008-11#2)(2009-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
this particulate##2##2##(1995-5#1)(2008-3#1)
this pathogen can##2##3##(2008-10#2)
this pathogen have##3##3##(2008-10#3)
this pathogen in##3##3##(2008-10#2)(2008-9#1)
this pathogen##28##2##(2008-10#25)(2008-9#1)(2009-8#2)
this pathogenic##2##2##(2008-10#2)
this pathology##10##2##(1991-11#1)(1991-3#1)(1991-6#1)(1993-6#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#3)
this pathovar##3##2##(2008-10#3)
this pathway include##2##3##(2008-10#1)(2008-8#1)
this pathway may##2##3##(1995-12#1)(2011-2#1)
this pathway##13##2##(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#2)(2011-3#1)
this patient group##3##3##(1996-3#1)(2008-7#1)(2013-1#1)
this patient with##2##3##(2011-2#2)
this patient##29##2##(1992-5#1)(1993-1#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-2#1)
this patient's##2##2##(1997-6#1)(2010-3#1)
this pattern is##2##3##(2008-7#1)(2012-3#1)
this pattern##5##2##(1997-7#1)(2008-7#1)(2008-9#2)(2012-3#1)
this peak##2##2##(2008-10#2)
this peculiar##2##2##(2008-10#1)(2008-11#1)
this peptide was##2##3##(1997-8#1)(2008-10#1)
this peptide##13##2##(1992-4#1)(1992-6#2)(1993-3#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-10#4)(2008-5#2)
this percentage##3##2##(1990-2#1)(1990-5#1)(1992-6#1)
this perception##3##2##(1991-2#1)(1996-6#1)(2013-1#1)
this period and##2##3##(2008-11#1)(2012-3#1)
this period showed##2##3##(2008-11#1)(2008-7#1)
this period##29##2##(1990-5#1)(1990-6#1)(1992-12#1)(1994-12#1)(1994-6#1)(1995-3#2)(1997-1#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#2)(2010-5#1)(2011-2#6)(2011-9#1)(2012-2#1)(2012-3#1)
this perspective##5##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
this phase II##2##3##(2008-10#1)(2012-2#1)
this phase##8##2##(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-2#1)
this phenolic substance##2##3##(2008-5#2)
this phenomenon has been##2##4##(2008-10#1)(2008-8#1)
this phenomenon has##3##3##(2008-10#2)(2008-8#1)
this phenomenon in##4##3##(1995-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
this phenomenon is##5##3##(1992-8#1)(1992-9#1)(2008-11#1)(2008-9#1)(2009-7#1)
this phenomenon may##2##3##(1991-6#1)(1992-2#1)
this phenomenon was##2##3##(2008-10#1)(2008-9#1)
this phenomenon##47##2##(1990-11#1)(1990-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-6#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
this phenotype is##2##3##(2012-3#2)
this phenotype##4##2##(1994-11#1)(2012-3#3)
this phenotypic##3##2##(1995-2#1)(2008-9#1)(2012-3#1)
this photograding##2##2##(2008-5#2)
this phylum##3##2##(2008-10#1)(2013-8#2)
this pilot study##11##3##(2008-11#1)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#1)
this pilot##12##2##(1996-1#1)(2008-11#1)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#1)
this plant##6##2##(2008-11#2)(2009-12#1)(2011-1#1)(2011-10#1)(2011-3#1)
this plasmid##3##2##(1993-9#1)(2008-10#2)
this platform##3##2##(2008-10#1)(2008-11#2)
this point is##2##3##(2008-10#1)(2010-6#1)
this point##12##2##(1990-8#1)(1992-2#1)(1995-11#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-6#1)
this policy##4##2##(1992-1#1)(1997-3#1)(2008-11#1)(2013-1#1)
this polymorphism##4##2##(2006-6#2)(2008-12#1)(2008-6#1)
this population and##2##3##(2008-10#1)(2010-2#1)
this population is##5##3##(1994-2#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
this population may##3##3##(2008-10#1)(2011-2#2)
this population of##2##3##(1995-11#1)(2008-10#1)
this population was##4##3##(1991-6#1)(2008-10#2)(2008-7#1)
this population##52##2##(1991-12#1)(1991-2#1)(1991-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-11#2)(1996-1#2)(2008-10#13)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#1)(2009-5#2)(2010-10#1)(2010-2#1)(2011-2#4)(2012-3#2)(2013-1#5)
this position in##2##3##(1995-2#1)(1997-3#1)
this position##9##2##(1993-8#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)
this possibility##7##2##(1990-5#1)(1996-12#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#1)(2013-8#1)
this potential##6##2##(2008-1#1)(2008-10#1)(2008-8#2)(2009-12#1)(2013-1#1)
this potentially##3##2##(1992-12#1)(2009-12#1)(2011-2#1)
this practice##3##2##(1990-2#1)(2008-11#1)(2013-8#1)
this prediction##7##2##(2007-12#1)(2008-4#1)(2008-8#3)(2008-9#1)(2013-8#1)
this preliminary investigation##4##3##(1995-2#1)(2008-9#2)(2011-2#1)
this preliminary study##3##3##(2008-10#2)(2013-1#1)
this preliminary##9##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#1)(2013-1#1)
this present study##2##3##(2008-10#2)
this present##3##2##(2008-10#2)(2008-8#1)
this presentation##2##2##(2008-7#1)(2011-2#1)
this previously unknown##2##3##(2008-3#1)(2010-4#1)
this principle##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
this probability##2##2##(1991-12#1)(2008-10#1)
this probe##2##2##(2008-10#2)
this problem by##3##3##(2008-10#1)(2010-10#1)(2011-2#1)
this problem is##3##3##(1993-12#1)(2008-10#1)(2010-11#1)
this problem##44##2##(1990-9#1)(1992-8#1)(1993-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#4)(2012-2#1)(2013-8#1)
this procedure is##7##3##(2008-10#5)(2008-11#1)(2013-1#1)
this procedure should##2##3##(2008-11#1)(2008-9#1)
this procedure were##2##3##(2008-10#2)
this procedure##43##2##(1990-2#1)(1990-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
this process has been##2##4##(2008-1#1)(2011-2#1)
this process has not been##2##5##(1995-8#1)(2008-11#1)
this process has##4##3##(1995-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
this process in##5##3##(2007-12#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
this process is##11##3##(1991-1#1)(1991-3#1)(1994-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)
this process may##2##3##(2008-5#1)(2010-12#1)
this process were##4##3##(1991-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
this process##67##2##(1991-1#1)(1991-3#2)(1991-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-5#5)(2008-7#4)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
this product##4##2##(2008-10#2)(2008-5#2)
this production##2##2##(1997-2#1)(2008-11#1)
this profession##2##2##(1990-2#1)(1994-12#1)
this professional paper##7##3##(1993-1#1)(1994-3#2)(1997-1#4)
this program##9##2##(1990-12#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#2)(2009-3#1)
this programme##4##2##(1990-11#1)(2008-11#2)(2008-12#1)
this progress##2##2##(1990-11#1)(2008-11#1)
this project was##5##3##(1991-9#1)(1994-3#1)(1997-4#1)(2008-11#1)(2012-2#1)
this project##10##2##(1991-9#1)(1994-3#1)(1995-3#1)(1997-4#1)(2008-11#2)(2008-12#2)(2010-7#1)(2012-2#1)
this proliferation##2##2##(1995-2#1)(2008-11#1)
this promoter##6##2##(1993-12#1)(1993-9#1)(1995-6#2)(1996-6#1)(2008-10#1)
this property##8##2##(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)
this proposal##4##2##(1991-2#1)(1994-12#1)(2008-10#1)(2013-8#1)
this proposed method##2##3##(2008-10#2)
this proposed technique##2##3##(2008-10#2)
this proposed##11##2##(2008-10#8)(2008-11#1)(2008-5#1)(2009-9#1)
this prospective cohort study##2##4##(2008-12#1)(2010-5#1)
this prospective##12##2##(1997-3#2)(2008-10#1)(2008-12#2)(2010-5#1)(2011-2#4)(2012-12#1)(2012-3#1)
this protection##3##2##(2008-10#2)(2011-2#1)
this protective##2##2##(2008-7#1)(2010-5#1)
this protein and##2##3##(1994-11#1)(1995-2#1)
this protein in##3##3##(1990-5#1)(1993-1#1)(2008-10#1)
this protein to##3##3##(1990-5#1)(1992-12#1)(2008-10#1)
this protein##34##2##(1990-5#3)(1990-7#1)(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#3)(1994-11#2)(1994-3#1)(1994-5#2)(1995-2#1)(1995-6#3)(1996-12#1)(2008-10#6)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2013-1#2)
this proteolytic##2##2##(1992-12#1)(2008-5#1)
this protocol is##2##3##(2008-4#1)(2008-9#1)
this protocol##9##2##(1990-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#3)
this pseudogene##4##2##(1993-2#1)(1993-6#2)(1994-11#1)
this purpose##81##2##(1990-2#1)(1991-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#37)(2008-11#6)(2008-3#3)(2008-4#1)(2008-5#7)(2008-7#3)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#5)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#3)(2013-8#1)
this qualitative study##4##3##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#1)
this qualitative##5##2##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)
this quantitative approach##2##3##(2008-10#2)
this quantitative##3##2##(1991-11#1)(2008-10#2)
this question##12##2##(1991-12#1)(1994-11#1)(1994-3#1)(2008-11#3)(2008-8#2)(2009-6#1)(2010-10#1)(2013-1#1)(2013-8#1)
this randomized##4##2##(2009-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
this range##7##2##(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
this rapidly##2##2##(2010-5#1)(2013-1#1)
this rare##17##2##(1991-6#1)(1994-2#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
this rate##3##2##(1993-9#1)(2008-8#1)(2011-1#1)
this ratio##3##2##(1993-8#1)(1995-12#1)(2008-11#1)
this reaction##20##2##(1994-8#1)(1995-6#1)(2008-10#15)(2008-4#1)(2009-10#2)
this reagent was##2##3##(2008-10#1)(2012-2#1)
this reagent##7##2##(1996-5#1)(2008-10#5)(2012-2#1)
this realignment##2##2##(1991-3#1)(1993-3#1)
this reason##21##2##(1991-2#1)(1992-2#1)(1992-3#1)(1995-12#1)(1996-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2009-1#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
this receptor##12##2##(1990-2#1)(1991-5#3)(1993-11#1)(1993-3#1)(1994-8#3)(1995-11#1)(2008-5#2)
this recognition##2##2##(1995-2#1)(2008-11#1)
this recombinant##3##2##(1995-11#1)(2008-11#1)(2010-11#1)
this recommendation##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
this reduction##6##2##(1991-6#1)(1993-11#1)(1995-5#1)(2008-10#1)(2008-11#2)
this regard##18##2##(1992-5#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-6#1)(2009-11#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#1)
this region in##6##3##(1990-6#1)(1994-2#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)
this region is##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
this region of the##2##4##(1994-5#1)(2008-10#1)
this region of##5##3##(1994-5#1)(1995-6#1)(2008-10#2)(2008-5#1)
this region were##2##3##(2008-1#1)(2008-12#1)
this region##66##2##(1990-6#1)(1992-10#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
this regular##3##2##(1991-2#1)(1992-2#1)(2009-8#1)
this regulation is##2##3##(1996-2#1)(2009-8#1)
this regulation##5##2##(1991-5#1)(1994-2#1)(1995-11#1)(1996-2#1)(2009-8#1)
this regulatory##6##2##(1991-2#1)(1991-5#1)(1995-8#1)(1997-9#1)(2008-11#1)(2011-1#1)
this relation##2##2##(2008-12#1)(2013-8#1)
this relationship are##3##3##(1995-1#1)(1995-3#1)(2008-10#1)
this relationship is##3##3##(2008-4#1)(2008-8#1)(2009-5#1)
this relationship##15##2##(1995-1#1)(1995-3#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-9#1)(2012-2#2)
this relatively##3##2##(1992-5#1)(2008-10#1)(2013-8#1)
this remains a##2##3##(2008-11#1)(2012-2#1)
this remains##3##2##(2008-11#1)(2009-11#1)(2012-2#1)
this report an##2##3##(2008-10#2)
this report are##2##3##(1991-12#1)(2008-10#1)
this report is##6##3##(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-3#1)
this report reviews##2##3##(1991-2#1)(2011-10#1)
this report the##3##3##(1994-11#1)(2008-5#1)(2013-1#1)
this report was##2##3##(1993-3#1)(2011-2#1)
this report we##14##3##(1990-5#1)(1990-8#1)(1991-3#1)(1992-7#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-9#1)(2008-12#1)(2008-7#1)(2012-3#4)
this report will##2##3##(2008-7#1)(2008-9#1)
this report##71##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1995-2#3)(1996-12#2)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#11)(2008-11#4)(2008-12#3)(2008-5#2)(2008-7#5)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-6#2)(2011-10#1)(2011-2#5)(2012-3#7)(2013-1#2)(2013-8#1)
this represents one of the most##2##6##(2008-10#1)(2008-5#1)
this represents the##2##3##(2008-10#1)(2010-5#1)
this represents##5##2##(2008-10#2)(2008-5#1)(2010-5#1)(2010-9#1)
this requirement##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)
this research was##17##3##(1994-3#1)(2008-10#6)(2008-12#1)(2008-5#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
this research##54##2##(1991-2#1)(1992-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#7)(2008-3#1)(2008-5#2)(2008-9#1)(2009-5#2)(2010-1#1)(2010-10#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
this residue to##2##3##(1993-8#1)(1995-6#1)
this residue##5##2##(1991-3#1)(1993-8#2)(1994-5#1)(1995-6#1)
this resin##2##2##(2008-10#1)(2008-7#1)
this resistance can be##2##4##(2008-10#1)(2009-9#1)
this resistance##8##2##(2008-10#5)(2008-11#1)(2009-9#1)(2012-3#1)
this respect##11##2##(1991-6#1)(1994-9#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-11#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
this response is not##2##4##(1991-5#1)(1992-8#1)
this response was##2##3##(1994-3#1)(2010-8#1)
this response##15##2##(1991-3#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-8#2)
this result in the##3##4##(1991-3#1)(1992-3#1)(2008-9#1)
this result is##3##3##(1996-5#1)(2008-10#1)(2008-9#1)
this result##24##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-9#1)(1996-5#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#4)(2009-12#1)(2010-5#1)(2011-2#1)
this resulted in the##2##4##(1992-6#1)(2008-9#1)
this resulted in##4##3##(1992-6#1)(2008-11#2)(2008-9#1)
this results in a##2##4##(2008-10#2)
this results in##3##3##(2008-10#3)
this retrospective analysis##3##3##(1996-11#1)(2011-1#1)(2011-2#1)
this retrospective study##7##3##(2007-8#1)(2011-1#1)(2011-2#3)(2012-3#2)
this retrospective##12##2##(1996-11#1)(2007-8#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#2)
this review are##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
this review article##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
this review we provide##2##4##(2011-2#1)(2012-2#1)
this review we##23##3##(2008-10#1)(2008-11#3)(2008-7#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#1)
this review will##5##3##(2008-10#2)(2008-6#1)(2008-7#1)(2013-8#1)
this review##172##2##(1990-11#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#21)(2008-11#20)(2008-12#3)(2008-3#3)(2008-4#1)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#3)(2010-5#3)(2010-6#2)(2010-7#6)(2010-9#1)(2011-1#3)(2011-2#14)(2011-3#4)(2012-12#1)(2012-2#13)(2012-3#5)(2013-1#12)(2013-8#8)
this rise##2##2##(1997-8#1)(2010-12#1)
this risk analysis##2##3##(1997-4#1)(2012-2#1)
this risk is##2##3##(2008-10#1)(2011-2#1)
this risk##9##2##(1997-4#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
this role is##2##3##(1993-3#1)(2012-2#1)
this role##7##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2012-2#1)
this route##6##2##(1993-11#1)(1994-9#1)(2008-10#1)(2011-2#2)(2012-12#1)
this rust##2##2##(2008-10#2)
this same##6##2##(1990-11#1)(2008-10#4)(2008-8#1)
this sample##9##2##(1997-2#1)(2008-10#5)(2008-7#1)(2011-2#1)(2013-8#1)
this sampling##2##2##(2008-10#2)
this scenario##2##2##(2008-10#1)(2008-7#1)
this schedule of##2##3##(1990-2#1)(2008-8#1)
this schedule##4##2##(1990-2#1)(1990-8#1)(1991-6#1)(2008-8#1)
this scheme##6##2##(1994-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-7#1)
this search##2##2##(2011-2#2)
this second##4##2##(1994-1#1)(1994-3#1)(2010-8#1)(2012-2#1)
this sector##2##2##(1991-12#1)(2009-3#1)
this segment##4##2##(2007-12#1)(2009-10#2)(2011-2#1)
this selection##2##2##(2008-11#1)(2008-8#1)
this sense##3##2##(2008-10#2)(2008-11#1)
this sensing##2##2##(2008-10#2)
this sensor can be##2##4##(2008-10#2)
this sensor can##3##3##(2008-10#2)(2008-2#1)
this sensor system##2##3##(2008-10#2)
this sensor was##2##3##(2008-10#1)(2008-7#1)
this sensor were##2##3##(2008-10#2)
this sensor##14##2##(2008-10#12)(2008-2#1)(2008-7#1)
this sensory##3##2##(2009-12#2)(2011-2#1)
this separation##3##2##(2008-10#2)(2011-2#1)
this sequence is##2##3##(1995-6#1)(2008-8#1)
this sequence##14##2##(1992-10#1)(1992-6#1)(1993-3#1)(1995-6#1)(1996-12#3)(1997-9#1)(2008-10#3)(2008-8#1)(2009-10#1)(2011-2#1)
this series of##4##3##(1995-8#1)(1997-1#1)(2008-10#1)(2008-5#1)
this series##19##2##(1992-2#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
this serious problem##2##3##(1995-5#1)(2011-2#1)
this serious##5##2##(1995-5#1)(2010-12#1)(2011-2#2)(2013-1#1)
this set of##2##3##(2008-10#1)(2010-1#1)
this set##3##2##(2008-10#2)(2010-1#1)
this setting##15##2##(1992-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-11#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
this shift in##2##3##(1993-6#1)(2008-7#1)
this shift##5##2##(1993-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
this short review##2##3##(2008-7#2)
this short##8##2##(1993-12#1)(1994-12#1)(1995-1#1)(1997-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
this should be##2##3##(1997-4#1)(2011-2#1)
this side##2##2##(1992-1#1)(2008-11#1)
this signaling##2##2##(2009-6#1)(2011-1#1)
this simple##5##2##(1997-1#1)(2008-10#2)(2008-5#1)(2010-3#1)
this single##4##2##(1996-12#1)(2009-8#2)(2013-1#1)
this site##8##2##(1990-5#1)(1993-3#1)(1996-3#1)(2008-10#1)(2008-12#2)(2008-5#1)(2012-2#1)
this situation##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
this skin##2##2##(2008-5#1)(2011-2#1)
this small study##2##3##(2008-11#2)
this small##6##2##(1996-9#1)(2008-11#3)(2010-5#1)(2012-3#1)
this social##2##2##(2008-11#1)(2008-9#1)
this solution##8##2##(2008-10#7)(2008-9#1)
this solvent##2##2##(2008-5#1)(2008-7#1)
this sort##2##2##(1992-3#1)(1995-3#1)
this source##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
this special##6##2##(1991-6#1)(1997-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
this specialized##2##2##(2008-10#1)(2008-11#1)
this species are##4##3##(1994-8#1)(2008-8#2)(2013-1#1)
this species has a##2##4##(1992-10#1)(2008-8#1)
this species in##2##3##(2008-10#1)(2008-11#1)
this species is##7##3##(2008-10#1)(2008-12#3)(2008-8#1)(2009-8#1)(2012-6#1)
this species##57##2##(1990-11#1)(1992-10#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#15)(2008-11#2)(2008-12#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#1)(2009-8#3)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#1)
this specific##7##2##(1993-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-5#1)
this spectral region##2##3##(1991-5#1)(2007-12#1)
this spectral##3##2##(1991-5#1)(2007-12#1)(2008-3#1)
this stage##10##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
this standard##3##2##(1992-9#1)(2008-10#2)
this state##2##2##(1997-2#1)(2008-10#1)
this stimulation##2##2##(1995-2#1)(1995-8#1)
this strain was##2##3##(2008-10#1)(2012-2#1)
this strain##15##2##(1992-5#1)(1995-6#1)(2008-10#9)(2008-12#1)(2008-8#1)(2012-2#2)
this strategy and##2##3##(2008-6#1)(2008-9#1)
this strategy to##2##3##(1993-12#1)(2008-8#1)
this strategy##16##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
this stress##4##2##(1992-12#2)(2008-11#1)(2011-2#1)
this structural##3##2##(1992-6#1)(1993-8#1)(2008-8#1)
this structure##5##2##(1991-5#2)(1993-6#1)(2008-10#1)(2008-11#1)
this study a##4##3##(2008-10#3)(2010-8#1)
this study also##3##3##(1991-12#1)(1997-2#1)(2008-10#1)
this study and the##2##4##(2008-10#1)(2008-5#1)
this study and##9##3##(1991-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2013-1#1)
this study are##16##3##(1993-1#1)(1993-3#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)
this study can be##2##4##(1995-9#1)(2008-12#1)
this study can##3##3##(1995-9#1)(2008-12#1)(2013-1#1)
this study clearly##2##3##(2008-10#1)(2008-11#1)
this study could##4##3##(2008-10#2)(2013-1#2)
this study demonstrate that##3##4##(2008-10#2)(2008-5#1)
this study demonstrate##4##3##(1997-3#1)(2008-10#2)(2008-5#1)
this study demonstrated that##2##4##(2008-9#1)(2010-3#1)
this study demonstrates the##2##4##(2009-12#1)(2009-5#1)
this study demonstrates##3##3##(2008-11#1)(2009-12#1)(2009-5#1)
this study enabled us to##2##5##(2008-10#2)
this study examined##3##3##(2009-11#1)(2009-4#1)(2009-5#1)
this study examines the##2##4##(1994-2#1)(2009-5#1)
this study examines##3##3##(1994-2#1)(2008-12#1)(2009-5#1)
this study explores##2##3##(2008-1#1)(2010-10#1)
this study had##3##3##(1990-6#1)(1992-2#1)(2013-8#1)
this study has##7##3##(1997-2#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
this study have##6##3##(2008-10#4)(2009-8#1)(2011-2#1)
this study in##2##3##(1995-3#1)(2011-2#1)
this study indicate that the##3##5##(1996-3#1)(2006-6#1)(2009-7#1)
this study indicate that##12##4##(1990-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#3)(2009-7#1)(2011-2#1)
this study indicate##13##3##(1990-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#3)(2008-11#1)(2009-7#1)(2011-2#1)
this study indicated##2##3##(2008-11#1)(2010-8#1)
this study indicates##2##3##(2008-10#1)(2010-8#1)
this study is an##2##4##(1997-3#1)(2008-11#1)
this study is the##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
this study is##60##3##(1992-2#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#4)(2011-2#8)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#4)
this study it##3##3##(1994-11#1)(1996-12#1)(2008-11#1)
this study may be##3##4##(1996-2#1)(2008-10#1)(2013-1#1)
this study may##6##3##(1996-2#1)(2008-10#2)(2008-12#1)(2010-12#1)(2013-1#1)
this study of##2##3##(1992-3#1)(1996-1#1)
this study provides further##2##4##(1994-8#1)(2008-7#1)
this study provides##7##3##(1994-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
this study revealed that##5##4##(1997-8#1)(2008-10#2)(2008-5#1)(2009-7#1)
this study revealed##6##3##(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-7#1)
this study should be useful##2##5##(2008-10#1)(2010-4#1)
this study should be##4##4##(1995-5#1)(1996-8#1)(2008-10#1)(2010-4#1)
this study should##5##3##(1995-5#1)(1996-8#1)(2008-10#2)(2010-4#1)
this study show that##4##4##(2008-10#2)(2010-7#1)(2013-1#1)
this study showed that##3##4##(2008-10#2)(2013-8#1)
this study showed##8##3##(2008-10#4)(2008-12#2)(2013-8#2)
this study shows that##2##4##(2008-5#1)(2013-1#1)
this study shows##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
this study suggest that this##2##5##(1996-1#1)(2008-3#1)
this study suggest that##20##4##(1994-12#1)(1994-2#1)(1996-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2013-1#1)
this study suggested that##3##4##(1992-2#1)(2008-6#1)(2011-3#1)
this study suggested##4##3##(1992-2#1)(2008-6#1)(2009-5#1)(2011-3#1)
this study suggests that the##2##5##(2008-8#1)(2011-2#1)
this study suggests that##4##4##(1995-5#1)(2008-5#1)(2008-8#1)(2011-2#1)
this study the##14##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-3#1)(2012-2#1)(2012-3#1)
this study to identify##2##4##(1990-11#1)(2010-11#1)
this study to##13##3##(1990-11#1)(1990-2#1)(1996-12#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-12#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-7#1)
this study was conducted##2##4##(2008-10#2)
this study was done to##2##5##(2008-5#1)(2010-7#1)
this study was planned to##2##5##(2012-3#1)(2013-1#1)
this study was that##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
this study was the##2##4##(2008-10#1)(2013-1#1)
this study was##289##3##(1990-11#1)(1990-2#2)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-8#6)(2007-8#1)(2008-1#3)(2008-10#39)(2008-11#20)(2008-12#17)(2008-3#1)(2008-4#1)(2008-5#19)(2008-7#12)(2008-8#2)(2008-9#15)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#26)(2011-7#1)(2012-12#2)(2012-2#10)(2012-3#8)(2012-4#1)(2013-1#24)(2013-3#1)(2013-8#7)
this study we##38##3##(1990-11#1)(1990-5#1)(1991-3#1)(1992-10#1)(1993-11#1)(1993-8#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-7#2)(2009-7#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-5#1)(2012-7#1)(2013-1#3)
this study were##43##3##(1991-2#1)(1993-12#1)(1997-8#2)(2008-10#11)(2008-11#7)(2008-12#3)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2013-1#6)
this study will facilitate##2##4##(2008-10#2)
this study will##7##3##(2008-10#3)(2008-5#2)(2010-1#1)(2010-11#1)
this study with##3##3##(2008-11#1)(2008-12#1)(2009-5#1)
this study##1163##2##(1990-11#3)(1990-12#3)(1990-2#3)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#6)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#6)(1994-3#1)(1994-5#2)(1994-8#5)(1995-1#4)(1995-12#4)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#2)(1996-1#4)(1996-12#13)(1996-2#6)(1996-3#2)(1996-6#3)(1996-8#3)(1997-1#2)(1997-2#4)(1997-3#9)(1997-4#1)(1997-8#16)(2006-6#1)(2007-12#2)(2007-8#2)(2008-1#7)(2008-10#292)(2008-11#94)(2008-12#51)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#40)(2008-6#4)(2008-7#30)(2008-8#17)(2008-9#30)(2009-10#6)(2009-11#7)(2009-12#2)(2009-2#5)(2009-3#6)(2009-4#3)(2009-5#11)(2009-6#3)(2009-7#8)(2009-8#6)(2009-9#2)(2010-1#5)(2010-10#7)(2010-11#6)(2010-12#7)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#8)(2010-7#12)(2010-8#18)(2010-9#3)(2011-1#12)(2011-10#1)(2011-2#71)(2011-3#4)(2011-7#1)(2012-12#9)(2012-2#30)(2012-3#32)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#72)(2013-3#1)(2013-7#1)(2013-8#20)
this subject is##2##3##(2009-6#1)(2013-8#1)
this subject##10##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2009-6#1)(2009-8#1)(2013-8#1)
this subpopulation##2##2##(1995-11#1)(2008-12#1)
this subset of patients##2##4##(2008-12#1)(2010-12#1)
this subset##5##2##(1995-2#1)(2008-12#1)(2008-9#2)(2010-12#1)
this substance##5##2##(2008-11#3)(2010-5#1)(2013-8#1)
this substrate##5##2##(1994-5#1)(2008-10#3)(2008-11#1)
this subunit##2##2##(1993-12#1)(2012-2#1)
this suggested##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
this suggests that##2##3##(1992-3#1)(1997-9#1)
this suggests##3##2##(1992-3#1)(1997-9#1)(2008-11#1)
this superfamily##2##2##(1995-2#1)(2011-1#1)
this surgery##2##2##(2012-12#1)(2012-2#1)
this survey##11##2##(1991-12#1)(1991-3#1)(1992-1#1)(1993-2#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-12#1)(2013-1#2)
this suspicion##2##2##(1995-5#1)(2013-1#1)
this switch##2##2##(1992-12#1)(2008-8#1)
this syndrome in##2##3##(2008-1#1)(2008-12#1)
this syndrome##17##2##(1994-12#1)(1995-12#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-12#4)(2008-7#3)(2011-2#1)(2012-2#1)(2013-1#3)
this system allowed the##2##4##(2008-10#2)
this system are##3##3##(2008-10#2)(2008-8#1)
this system can##2##3##(2008-10#1)(2008-2#1)
this system for##2##3##(1994-12#1)(2008-10#1)
this system is##4##3##(1997-3#1)(2008-10#2)(2009-8#1)
this system provided##2##3##(1995-12#1)(2008-10#1)
this system was##5##3##(1997-8#1)(2008-10#3)(2008-12#1)
this system were##4##3##(2008-10#3)(2008-11#1)
this system##82##2##(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-2#2)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#39)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#2)
this systematic review##2##3##(2013-1#1)(2013-8#1)
this systematic##4##2##(2008-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
this task was##2##3##(1994-3#1)(2009-10#1)
this task##17##2##(1991-2#1)(1993-3#2)(1994-2#1)(1994-3#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-9#1)
this technique and##4##3##(1995-1#1)(1997-1#1)(2008-11#1)(2008-7#1)
this technique are##4##3##(1991-3#1)(2008-11#1)(2008-2#1)(2008-3#1)
this technique as a##3##4##(2008-10#2)(2008-7#1)
this technique can be##2##4##(2008-10#1)(2008-3#1)
this technique can##5##3##(2008-10#3)(2008-3#1)(2013-8#1)
this technique for##7##3##(2008-10#5)(2008-11#1)(2013-1#1)
this technique has been##2##4##(1991-11#1)(2008-10#1)
this technique has##5##3##(1991-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
this technique is also##2##4##(2008-10#2)
this technique is##10##3##(1990-9#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2010-5#1)(2011-2#1)
this technique the##2##3##(2008-9#1)(2012-2#1)
this technique to##7##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2013-8#1)
this technique##108##2##(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-3#1)(2008-10#33)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2010-10#1)(2010-5#1)(2010-7#3)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
this technology and##2##3##(2008-4#1)(2011-2#1)
this technology in##2##3##(2008-10#1)(2008-11#1)
this technology is##2##3##(2008-11#1)(2012-3#1)
this technology to##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
this technology##26##2##(1993-12#2)(2008-10#6)(2008-11#4)(2008-4#2)(2008-5#1)(2008-6#1)(2010-8#4)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
this term##2##2##(2011-2#2)
this territory##2##2##(1996-3#1)(2011-2#1)
this test##13##2##(1993-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#2)(2012-3#3)
this the##7##2##(2008-10#1)(2008-11#2)(2008-8#1)(2009-10#1)(2009-7#1)(2013-1#1)
this theoretical##2##2##(1993-1#1)(2010-10#1)
this theory##11##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
this therapeutic method##2##3##(1995-5#1)(2013-1#1)
this therapeutic##3##2##(1992-12#1)(1995-5#1)(2013-1#1)
this therapy##7##2##(1993-11#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-8#2)
this third##2##2##(2008-4#1)(2012-2#1)
this threshold##3##2##(2008-10#2)(2008-3#1)
this time point##2##3##(2008-5#1)(2009-8#1)
this time the##3##3##(1995-8#1)(2008-11#1)(2013-1#1)
this time##34##2##(1990-2#1)(1991-1#1)(1993-6#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-6#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-8#1)(2010-1#2)(2011-2#1)(2011-4#1)(2013-1#2)(2013-8#1)
this tissue##6##2##(1990-12#1)(1990-8#1)(1992-9#1)(1993-3#1)(2008-7#1)(2013-1#1)
this to be achieved##2##4##(1992-9#1)(2008-11#1)
this to be##5##3##(1992-9#1)(2008-11#2)(2008-9#1)(2011-2#1)
this to##10##2##(1992-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#2)(2009-12#1)(2011-2#1)
this tool##4##2##(1995-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
this topic##11##2##(1993-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
this toxic##2##2##(2008-10#2)
this toxicity##2##2##(2008-10#2)
this toxin is##2##3##(1995-8#1)(2008-10#1)
this toxin##3##2##(1995-8#1)(2008-10#2)
this trace##2##2##(2008-12#1)(2008-5#1)
this trade-off##4##2##(2008-8#4)
this traditional##2##2##(1995-2#2)
this trajectory##2##2##(2011-7#1)(2013-1#1)
this transition##4##2##(1994-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
this transport##2##2##(1997-1#1)(1997-7#1)
this transporter##2##2##(1995-6#1)(1995-8#1)
this treatment and##2##3##(2008-10#1)(2012-12#1)
this treatment is##2##3##(1993-6#1)(2010-10#1)
this treatment with##2##3##(1995-2#1)(2008-9#1)
this treatment##21##2##(1992-1#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#2)(2012-12#1)(2012-3#1)(2013-1#1)
this trend was##2##3##(2012-2#1)(2012-3#1)
this trend##4##2##(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
this trial##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
this tripeptide##2##2##(1992-10#1)(2011-1#1)
this tumor##14##2##(1992-12#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-1#1)(2009-5#1)(2011-2#1)(2013-1#2)
this tumour##3##2##(1990-6#1)(1992-5#1)(2011-2#1)
this two##2##2##(2011-2#1)(2012-12#1)
this type of alkaloid##2##4##(2011-3#2)
this type of education##2##4##(2008-11#1)(2008-12#1)
this type of event##2##4##(1993-3#1)(2012-2#1)
this type of reagent##2##4##(2008-10#2)
this type of research##3##4##(2008-11#1)(2008-9#1)(2009-4#1)
this type of treatment##2##4##(1991-11#1)(1992-3#1)
this type of tumor##2##4##(1990-2#1)(2011-2#1)
this type of##82##3##(1990-2#1)(1990-8#1)(1991-11#2)(1992-3#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-6#1)(1996-3#1)(1997-5#1)(1997-8#2)(2008-10#14)(2008-11#7)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
this type##91##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#3)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-5#1)(1994-6#1)(1996-3#1)(1997-5#1)(1997-8#2)(2008-10#15)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-6#1)(2010-8#2)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
this typically##2##2##(2008-12#1)(2008-7#1)
this unique population##2##3##(2013-1#2)
this unique##8##2##(1997-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#2)
this unit describes##2##3##(2008-4#2)
this unit is##15##3##(2008-4#8)(2008-9#6)(2010-8#1)
this unit##92##2##(1990-11#1)(2008-2#3)(2008-4#56)(2008-9#29)(2010-7#1)(2010-8#1)(2012-3#1)
this unusual##5##2##(2008-10#1)(2008-8#1)(2009-3#1)(2010-6#1)(2013-1#1)
this use##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
this valuable##2##2##(1993-1#1)(2008-10#1)
this value was##2##3##(1997-8#1)(2008-11#1)
this value##5##2##(1991-5#1)(1997-8#1)(2008-10#2)(2008-11#1)
this variability##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
this variable##4##2##(2008-10#4)
this variant##4##2##(1991-12#1)(2008-9#1)(2009-12#1)(2010-12#1)
this variation can##2##3##(1993-3#1)(2008-8#1)
this variation##10##2##(1993-3#1)(1997-3#1)(2008-10#6)(2008-8#1)(2011-3#1)
this vector##4##2##(1996-12#1)(2008-11#1)(2008-8#2)
this very##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
this video##2##2##(2008-10#1)(2008-8#1)
this view##4##2##(1995-2#1)(2008-10#1)(2008-11#2)
this viral##2##2##(1995-2#1)(1997-3#1)
this virus is##2##3##(2008-10#1)(2008-12#1)
this virus may be##2##4##(2008-10#1)(2008-11#1)
this virus##13##2##(2008-10#10)(2008-11#2)(2008-12#1)
this voltammetric method##3##3##(2008-10#3)
this voltammetric peak##2##3##(2008-10#2)
this voltammetric##5##2##(2008-10#5)
this volume##3##2##(1992-6#1)(2008-11#2)
this vulnerable population##2##3##(2009-5#1)(2009-9#1)
this was a##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
this was associated with##2##4##(2008-11#1)(2008-7#1)
this was confirmed##2##3##(1995-2#1)(2008-7#1)
this was due to##2##4##(2008-10#1)(2008-11#1)
this was not##6##3##(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
this was the##3##3##(1992-2#1)(2011-2#2)
this was##49##2##(1990-5#1)(1992-2#1)(1993-1#1)(1993-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#14)(2008-11#7)(2008-12#4)(2008-7#3)(2008-9#1)(2009-10#1)(2010-6#1)(2011-2#4)(2012-12#2)(2013-1#3)(2013-7#1)
this water-soluble##2##2##(1994-5#1)(2008-10#1)
this wavelength##2##2##(2008-10#1)(2008-3#1)
this way the##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
this way##59##2##(1990-9#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#18)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#1)
this we##5##2##(1993-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)
this will allow##2##3##(2008-10#1)(2008-5#1)
this will be##4##3##(2008-11#2)(2008-12#1)(2008-5#1)
this will help##2##3##(2008-7#1)(2011-2#1)
this will##15##2##(1992-3#1)(1995-2#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
this with##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
this work a##6##3##(2008-10#5)(2011-2#1)
this work has##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
this work in##3##3##(2008-10#2)(2010-11#1)
this work is##17##3##(2008-10#9)(2008-4#1)(2008-7#2)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
this work shows that##2##4##(2008-10#1)(2008-5#1)
this work was##28##3##(1993-12#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#6)(2009-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
this work we##17##3##(1990-5#1)(2008-10#7)(2008-11#5)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
this work##251##2##(1990-5#2)(1992-11#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#160)(2008-11#12)(2008-12#2)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2011-3#3)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#2)
this would##5##2##(1994-5#1)(1997-1#1)(2008-10#2)(2008-11#1)
this year##2##2##(1993-5#1)(2008-5#1)
this yeast##2##2##(1996-12#1)(2008-7#1)
this zone##2##2##(2011-2#1)(2012-12#1)
this zoonosis##2##2##(2012-12#1)(2013-1#1)
this##9515##1##(1990-10#2)(1990-11#29)(1990-12#25)(1990-2#25)(1990-3#6)(1990-5#43)(1990-6#23)(1990-7#2)(1990-8#18)(1990-9#16)(1991-1#19)(1991-10#3)(1991-11#19)(1991-12#48)(1991-2#48)(1991-3#48)(1991-4#1)(1991-5#21)(1991-6#25)(1991-7#5)(1991-8#14)(1991-9#10)(1992-1#23)(1992-10#11)(1992-11#6)(1992-12#44)(1992-2#34)(1992-3#36)(1992-4#10)(1992-5#11)(1992-6#22)(1992-7#2)(1992-8#11)(1992-9#23)(1993-1#31)(1993-11#19)(1993-12#55)(1993-2#31)(1993-3#50)(1993-5#1)(1993-6#34)(1993-8#52)(1993-9#12)(1994-1#21)(1994-11#35)(1994-12#42)(1994-2#38)(1994-3#44)(1994-5#26)(1994-6#11)(1994-8#41)(1994-9#9)(1995-1#21)(1995-10#1)(1995-11#30)(1995-12#48)(1995-2#74)(1995-3#21)(1995-5#33)(1995-6#40)(1995-8#23)(1995-9#12)(1996-1#41)(1996-11#14)(1996-12#54)(1996-2#46)(1996-3#37)(1996-5#9)(1996-6#20)(1996-8#10)(1996-9#7)(1997-1#54)(1997-2#41)(1997-3#52)(1997-4#13)(1997-5#8)(1997-6#17)(1997-7#24)(1997-8#66)(1997-9#5)(2006-5#1)(2006-6#13)(2007-11#12)(2007-12#38)(2007-8#12)(2007-9#1)(2008-1#46)(2008-10#2362)(2008-11#778)(2008-12#288)(2008-2#46)(2008-3#147)(2008-4#125)(2008-5#269)(2008-6#65)(2008-7#244)(2008-8#245)(2008-9#258)(2009-1#18)(2009-10#66)(2009-11#16)(2009-12#42)(2009-2#5)(2009-3#39)(2009-4#15)(2009-5#40)(2009-6#30)(2009-7#45)(2009-8#100)(2009-9#30)(2010-1#33)(2010-10#50)(2010-11#51)(2010-12#61)(2010-2#13)(2010-3#26)(2010-4#31)(2010-5#50)(2010-6#39)(2010-7#59)(2010-8#64)(2010-9#29)(2011-1#58)(2011-10#5)(2011-2#451)(2011-3#36)(2011-4#1)(2011-7#10)(2011-9#2)(2012-12#66)(2012-2#216)(2012-3#192)(2012-4#1)(2012-5#4)(2012-6#3)(2012-7#3)(2012-8#1)(2012-9#2)(2013-1#340)(2013-2#2)(2013-3#1)(2013-7#9)(2013-8#154)
thistle##3##1##(2008-10#3)
thomasi##5##1##(2007-12#5)
thoracic CT scanning##2##3##(1991-3#2)
thoracic CT##3##2##(1991-3#2)(1997-8#1)
thoracic and abdominal##2##3##(2011-2#1)(2013-3#1)
thoracic and##6##2##(1991-6#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-3#1)
thoracic aorta and abdominal aorta) in##2##6##(1997-8#2)
thoracic aorta and##3##3##(1997-8#2)(2013-3#1)
thoracic aorta##12##2##(1997-8#4)(2008-10#2)(2008-12#1)(2009-7#1)(2009-8#2)(2010-12#1)(2013-3#1)
thoracic aortic##3##2##(2008-11#1)(2010-12#2)
thoracic computed tomography (CT)##2##4##(2008-7#1)(2012-2#1)
thoracic duct##2##2##(2012-3#2)
thoracic kidney##2##2##(2011-2#2)
thoracic radiation##2##2##(2008-10#2)
thoracic region##3##2##(1996-3#1)(2008-11#1)(2012-3#1)
thoracic scoliosis##2##2##(2007-8#2)
thoracic spinal cord##2##3##(2008-12#1)(2008-7#1)
thoracic spinal##6##2##(2008-12#3)(2008-7#1)(2012-12#1)(2013-1#1)
thoracic spine thrust manipulation and##2##5##(2008-12#2)
thoracic spine##9##2##(2008-12#6)(2008-8#2)(2012-12#1)
thoracic stiffness##3##2##(2008-9#3)
thoracic surgery in##2##3##(1990-12#1)(1991-2#1)
thoracic surgery##5##2##(1990-12#1)(1991-2#2)(2011-2#1)(2012-3#1)
thoracic trauma##3##2##(2007-11#1)(2012-2#2)
thoracic vertebrae##2##2##(2007-11#1)(2011-2#1)
thoracic##116##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-2#2)(1991-3#5)(1991-6#1)(1993-12#2)(1993-9#1)(1994-3#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#9)(2007-11#2)(2007-8#2)(2008-10#6)(2008-11#2)(2008-12#12)(2008-7#5)(2008-8#4)(2008-9#3)(2009-3#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-5#1)(2010-9#2)(2011-2#12)(2011-3#1)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#3)(2013-3#4)(2013-8#2)
thoracic/thoracolumbar level##4##2##(2012-3#4)
thoracic/thoracolumbar##6##1##(2012-3#6)
thoracoabdominal##3##1##(2008-12#1)(2009-4#1)(2011-3#1)
thoracolumbar and lumbar scoliosis##2##4##(2008-8#2)
thoracolumbar and lumbar##4##3##(2008-8#4)
thoracolumbar##10##1##(1995-11#1)(1997-6#1)(2008-7#1)(2008-8#5)(2010-8#1)(2012-3#1)
thoracolumbosacral##2##1##(2012-3#2)
thoracoscopic and abdominal open surgery##2##5##(2011-2#2)
thoracoscopic surgery##3##2##(2007-8#1)(2012-3#1)(2013-7#1)
thoracoscopic##8##1##(1997-4#1)(2007-8#2)(2010-11#1)(2011-2#2)(2012-3#1)(2013-7#1)
thoracotomy and##3##2##(1993-3#1)(2010-12#1)(2012-3#1)
thoracotomy##7##1##(1990-12#2)(1993-3#1)(2008-11#1)(2008-12#1)(2010-12#1)(2012-3#1)
thorax##7##1##(1991-12#1)(1991-6#1)(1996-1#1)(2008-12#1)(2010-5#1)(2010-9#1)(2013-1#1)
thorium and uranium##2##3##(2008-10#2)
thorium and##6##2##(2008-10#6)
thorium content##2##2##(2008-10#2)
thorium##26##1##(2008-10#24)(2013-1#2)
thorium(IV) and uranium(VI)##3##3##(2008-10#3)
thorium(IV) in##2##2##(2008-10#2)
thorium(IV)##9##1##(2008-10#9)
thorough evaluation of patients##2##4##(1991-2#1)(2008-7#1)
thorough investigation of##2##3##(2008-10#1)(2012-2#1)
thorough understanding of the##3##4##(2008-7#1)(2008-8#1)(2011-2#1)
thorough understanding of##6##3##(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#1)
thorough##35##1##(1990-2#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-5#1)(2008-10#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
thoroughly investigated##4##2##(2008-10#4)
thoroughly studied##3##2##(1990-5#1)(2008-3#1)(2012-2#1)
thoroughly##29##1##(1990-5#1)(1991-1#1)(1995-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
thoroughness##2##1##(1990-6#1)(1996-1#1)
those achieved by##6##3##(1993-6#1)(2008-10#4)(2008-12#1)
those achieved using##3##3##(1991-3#1)(2008-10#2)
those achieved with##3##3##(1991-3#1)(2008-10#2)
those achieved##12##2##(1991-3#2)(1993-6#1)(2008-10#8)(2008-12#1)
those aged##4##2##(1990-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
those approaches##2##2##(2008-10#1)(2009-5#1)
those are##2##2##(2011-2#1)(2012-3#1)
those associated with the##2##4##(2008-10#1)(2008-2#1)
those associated with##4##3##(2008-10#1)(2008-2#1)(2009-12#1)(2013-1#1)
those at a##2##3##(1994-3#1)(2008-11#1)
those at the##3##3##(1996-6#1)(2008-5#1)(2013-8#1)
those at##11##2##(1992-12#1)(1994-3#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#2)
those attending##2##2##(1995-12#1)(2008-9#1)
those based on##8##3##(2008-10#6)(2008-5#2)
those being##2##2##(2008-3#1)(2010-12#1)
those belonging to##2##3##(1993-3#1)(1996-12#1)
those between##5##2##(1995-6#1)(2008-9#1)(2009-10#3)
those born##3##2##(1992-2#1)(2008-11#1)(2011-1#1)
those by the##4##3##(2008-10#4)
those by##8##2##(2008-10#8)
those calculated using##2##3##(1992-12#1)(2008-8#1)
those calculated##4##2##(1990-5#1)(1992-12#1)(2008-10#1)(2008-8#1)
those cases##4##2##(1994-9#1)(1995-11#1)(2007-8#1)(2008-5#1)
those caused by##8##3##(1996-12#1)(2008-10#7)
those cells##4##2##(1996-9#1)(1997-3#1)(2008-10#1)(2008-9#1)
those collected##5##2##(2008-10#4)(2008-3#1)
those coming from##2##3##(1992-3#1)(2008-10#1)
those conditions##2##2##(2008-10#2)
those consisting##2##2##(2007-12#1)(2008-5#1)
those containing##7##2##(1990-2#1)(2008-10#4)(2008-9#1)(2010-4#1)
those covered##2##2##(1996-2#1)(2008-5#1)
those cultured in##2##3##(2008-11#2)
those currently##4##2##(1994-1#1)(2008-10#2)(2008-11#1)
those derived from##4##3##(2008-10#3)(2010-7#1)
those described##3##2##(1994-11#1)(2008-10#2)
those detected in##4##3##(1995-12#2)(2008-10#2)
those determined by the##2##4##(2008-10#2)
those determined by##4##3##(2008-10#4)
those determined using##3##3##(2008-10#3)
those determined##11##2##(1990-9#1)(1992-9#2)(2008-10#8)
those developing##2##2##(1992-12#1)(2009-12#1)
those differences##3##2##(1991-9#1)(1994-12#1)(2008-10#1)
those discharged##3##2##(1995-3#2)(2008-10#1)
those due to##3##3##(2008-10#2)(2008-11#1)
those elements##2##2##(2008-10#2)
those elicited by the##2##4##(1995-5#1)(2008-10#1)
those encoding the##2##3##(2008-10#1)(2008-11#1)
those encoding##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
those encountered in##2##3##(2006-6#1)(2012-2#1)
those estimated##3##2##(2008-10#3)
those expected##4##2##(1996-12#1)(2008-8#1)(2008-9#2)
those expenses##2##2##(1991-9#1)(1992-12#1)
those exposed to##5##3##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#2)
those expressed##2##2##(1992-10#1)(2008-9#1)
those factors##2##2##(2008-11#1)(2011-2#1)
those fed a##2##3##(2008-11#2)
those findings##2##2##(2008-6#1)(2009-5#1)
those flanking the##2##3##(1991-6#1)(1994-5#1)
those for the reference method##2##5##(2008-10#2)
those for the##9##3##(1991-1#1)(1993-8#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2010-8#1)
those for##22##2##(1991-1#1)(1992-3#1)(1993-8#1)(1995-6#3)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#1)
those found by##7##3##(2008-10#7)
those found in other##2##4##(2008-11#1)(2010-12#1)
those found in the##3##4##(1991-9#1)(2008-10#1)(2008-7#1)
those found in##14##3##(1990-2#1)(1991-9#1)(1993-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
those found on crabgrass##2##4##(2008-10#2)
those found on##5##3##(2008-10#4)(2008-5#1)
those found##28##2##(1990-2#1)(1991-9#1)(1993-2#1)(1996-2#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
those from a##4##3##(1992-9#1)(2008-10#2)(2011-2#1)
those from conventional##4##3##(2008-10#3)(2008-11#1)
those from mice##2##3##(2008-11#2)
those from other##2##3##(2008-10#2)
those from the##10##3##(1995-12#1)(2008-10#5)(2008-11#1)(2009-11#1)(2010-5#1)(2012-3#1)
those from##55##2##(1991-12#1)(1991-5#1)(1992-8#1)(1992-9#1)(1995-12#3)(1995-5#1)(1995-6#2)(1996-12#2)(2008-10#28)(2008-11#7)(2008-5#1)(2008-8#2)(2009-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
those functions##2##2##(1996-2#1)(2011-2#1)
those generally##2##2##(1991-3#1)(2008-5#1)
those generated by##3##3##(1995-8#1)(2008-10#1)(2013-1#1)
those generated##4##2##(1995-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
those genes##4##2##(2008-10#3)(2012-3#1)
those given by the##3##4##(1994-9#1)(2008-10#2)
those given by##7##3##(1994-9#1)(2008-10#5)(2008-3#1)
those given##9##2##(1994-9#1)(1995-5#1)(2008-10#6)(2008-3#1)
those groups##3##2##(1994-1#2)(2008-7#1)
those grown in##4##3##(1996-12#1)(2008-10#2)(2009-12#1)
those grown##6##2##(1996-12#1)(2008-10#3)(2008-11#1)(2009-12#1)
those having##10##2##(1992-1#2)(1995-3#1)(1997-4#1)(2008-10#3)(2008-7#1)(2008-8#2)
those identified##3##2##(2008-10#1)(2010-4#1)(2012-12#1)
those implanted##2##2##(2008-9#2)
those in Group 2##2##4##(2011-1#1)(2011-2#1)
those in Group##4##3##(1992-11#1)(2011-1#1)(2011-2#2)
those in a##2##3##(1991-2#1)(2008-10#1)
those in group##2##3##(1996-3#1)(2010-7#1)
those in other##5##3##(1990-5#1)(1993-3#1)(2008-10#3)
those in the control group##2##5##(2011-1#1)(2011-2#1)
those in the control##3##4##(2011-1#1)(2011-2#2)
those in the group of##2##5##(2008-7#1)(2013-1#1)
those in the group##3##4##(1994-12#1)(2008-7#1)(2013-1#1)
those in the##42##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-3#2)(1997-8#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
those in which##2##3##(2008-8#1)(2008-9#1)
those in##110##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-12#3)(1995-6#1)(1995-8#3)(1996-3#2)(1997-2#3)(1997-3#3)(1997-8#1)(2008-10#30)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)
those induced by MHT##2##4##(2011-2#2)
those induced by the##2##4##(2008-10#1)(2008-8#1)
those induced by##9##3##(1991-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#2)
those infected with##2##3##(2009-8#1)(2011-2#1)
those infected##4##2##(2008-10#2)(2009-8#1)(2011-2#1)
those interested in##5##3##(1991-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
those involved in the##2##4##(2008-11#1)(2009-10#1)
those involved in##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)
those involved##7##2##(1996-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)
those involving the##2##3##(2008-10#1)(2008-8#1)
those involving##10##2##(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)
those likely to##2##3##(2008-5#1)(2011-2#1)
those made##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2010-4#1)
those managing##2##2##(1994-1#1)(2008-11#1)
those measured##3##2##(1990-11#1)(2008-10#2)
those mediated by type I AMPA receptors were##2##8##(1996-2#2)
those medical##2##2##(1995-12#1)(2010-1#1)
those modified##2##2##(2008-10#2)
those normally used##2##3##(2008-3#1)(2010-1#1)
those normally##3##2##(1994-9#1)(2008-3#1)(2010-1#1)
those not##10##2##(1990-6#1)(1992-12#1)(1993-1#3)(2008-10#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-2#1)
those now##2##2##(1992-2#1)(1992-6#1)
those observed after##2##3##(1995-5#1)(1997-2#1)
those observed during##2##3##(1994-3#1)(2013-7#1)
those observed for##3##3##(2008-10#2)(2008-5#1)
those observed in##16##3##(1990-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-8#2)(2008-10#8)(2011-2#2)
those observed with##4##3##(1992-12#1)(2008-10#2)(2012-3#1)
those observed##31##2##(1990-12#1)(1992-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-8#2)(2008-10#12)(2008-5#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-7#1)
those obtained at the##2##4##(2008-10#2)
those obtained at##3##3##(2008-10#3)
those obtained by HPLC##3##4##(2008-10#3)
those obtained by ICP-AES##2##4##(2008-10#2)
those obtained by conventional##4##4##(2008-10#3)(2008-5#1)
those obtained by gas chromatography##2##5##(2008-10#2)
those obtained by high performance liquid chromatography (HPLC)##3##8##(2008-10#3)
those obtained by inductively coupled plasma##2##6##(2008-10#2)
those obtained by other##3##4##(2008-10#2)(2008-5#1)
those obtained by the conventional##3##5##(2008-10#3)
those obtained by the reference##3##5##(2008-10#3)
those obtained by the standard##3##5##(2008-10#3)
those obtained by the traditional##2##5##(2008-10#1)(2008-11#1)
those obtained by the##39##4##(2008-10#37)(2008-11#2)
those obtained by using a##2##5##(2008-10#2)
those obtained by using##5##4##(2008-10#5)
those obtained by##116##3##(2008-10#108)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#1)
those obtained for the##3##4##(1993-8#1)(2008-10#2)
those obtained for##4##3##(1993-8#1)(2008-10#3)
those obtained from the##2##4##(2008-10#2)
those obtained from##15##3##(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
those obtained in a##4##4##(2008-10#1)(2008-11#2)(2013-1#1)
those obtained in the##3##4##(2008-10#3)
those obtained in##15##3##(1990-5#2)(1994-2#1)(2008-10#9)(2008-11#2)(2013-1#1)
those obtained on##2##3##(2008-10#1)(2008-5#1)
those obtained previously##2##3##(1992-3#1)(2008-10#1)
those obtained using a##5##4##(2008-10#5)
those obtained using the##5##4##(2008-10#5)
those obtained using##20##3##(1995-6#1)(2008-10#19)
those obtained with a##7##4##(2008-10#6)(2008-3#1)
those obtained with the##10##4##(2008-10#9)(2008-11#1)
those obtained with##37##3##(2008-10#33)(2008-11#1)(2008-2#1)(2008-3#2)
those obtained##221##2##(1990-5#2)(1992-3#1)(1993-8#1)(1994-2#1)(1995-6#1)(2008-10#194)(2008-11#7)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#2)(2011-2#1)(2013-1#2)
those occurring##2##2##(2008-10#1)(2012-12#1)
those of F##2##3##(2008-10#2)
those of PAH##2##3##(2008-11#2)
those of TSWV and INSV##2##5##(2008-10#2)
those of WT##2##3##(2008-9#1)(2013-8#1)
those of a##15##3##(1994-8#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-3#1)(2012-2#2)
those of adult##2##3##(1993-3#1)(1997-7#1)
those of an##2##3##(2008-10#2)
those of authentic##2##3##(2008-10#2)
those of commercial##2##3##(2008-10#1)(2010-4#1)
those of control##3##3##(1993-1#1)(1995-3#1)(2008-10#1)
those of controls##2##3##(1996-11#1)(2008-9#1)
those of conventional##3##3##(1992-3#1)(2008-10#2)
those of glutathione reductase##2##4##(1992-1#2)
those of group II##3##4##(2008-10#3)
those of group##4##3##(2008-10#4)
those of healthy##2##3##(2008-10#2)
those of human##2##3##(1991-3#1)(2008-10#1)
those of known##2##3##(2008-10#2)
those of mammalian##2##3##(1993-6#1)(1997-4#1)
those of morphine were##2##4##(1995-11#2)
those of normal##2##3##(1994-12#1)(2010-11#1)
those of other tospoviruses##3##4##(2008-10#3)
those of other##22##3##(1994-5#1)(1996-1#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#1)
those of others are##2##4##(1996-3#1)(2009-9#1)
those of previous##5##3##(2008-10#2)(2008-2#1)(2010-8#1)(2011-2#1)
those of the 15-##2##4##(1994-3#2)
those of the 25 degrees C-grown##3##6##(2008-5#3)
those of the control groups##5##5##(2008-9#5)
those of the control##6##4##(1994-3#1)(2008-9#5)
those of the controls##2##4##(2008-10#1)(2008-9#1)
those of the conventional##3##4##(2008-10#2)(2010-4#1)
those of the first##2##4##(2008-3#1)(2010-8#1)
those of the more##2##4##(2008-3#1)(2008-8#1)
those of the normal controls##4##5##(2008-10#2)(2008-7#2)
those of the other##4##4##(1997-2#1)(2008-10#2)(2008-9#1)
those of the standard##2##4##(2008-12#1)(2010-11#1)
those of the vehicle control##3##5##(2008-9#3)
those of the vehicle##5##4##(2008-9#5)
those of the wild type##2##5##(1997-8#1)(2013-8#1)
those of the wild-type##5##4##(1990-10#1)(1993-8#1)(2008-10#3)
those of the##111##3##(1990-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-2#2)(1993-8#2)(1994-11#1)(1994-3#3)(1994-5#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#31)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#12)(2009-7#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
those of their##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
those of tospoviruses##2##3##(2008-10#2)
those of wild-type##3##3##(1992-1#1)(2008-10#1)(2008-8#1)
those of##420##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#5)(1991-6#1)(1992-1#5)(1992-2#2)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#6)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#3)(2007-11#1)(2007-12#4)(2008-10#145)(2008-11#16)(2008-12#4)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#15)(2008-6#3)(2008-7#11)(2008-8#12)(2008-9#18)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#2)(2010-11#4)(2010-4#7)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#6)(2011-2#14)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#5)
those on the##4##3##(2008-11#1)(2008-5#2)(2008-9#1)
those on##16##2##(1991-3#1)(1993-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2008-9#1)
those originating##2##2##(1990-8#1)(2008-10#1)
those oscillations##2##2##(2013-8#2)
those papers##2##2##(2011-2#1)(2012-3#1)
those parameters##2##2##(2008-5#1)(2012-2#1)
those pathways##2##2##(2010-4#1)(2012-3#1)
those patients at##2##3##(2011-2#1)(2013-1#1)
those patients who##5##3##(1991-2#1)(2011-2#1)(2012-3#2)(2013-1#1)
those patients##14##2##(1991-2#1)(2011-1#1)(2011-2#5)(2012-3#4)(2013-1#2)(2013-8#1)
those performing##2##2##(2008-10#2)
those policies##2##2##(2008-12#1)(2012-3#1)
those predicted by the##2##4##(2008-3#1)(2008-8#1)
those predicted by##4##3##(2008-10#1)(2008-3#1)(2008-8#2)
those predicted##5##2##(1994-8#1)(2008-10#1)(2008-3#1)(2008-8#2)
those prepared##3##2##(2008-10#2)(2008-11#1)
those present in the##2##4##(2008-11#1)(2008-7#1)
those present in##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
those present##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
those presenting with acute##2##4##(2008-7#2)
those presenting##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
those previously obtained##2##3##(2008-10#2)
those previously reported##4##3##(1994-11#1)(2008-10#3)
those previously##10##2##(1991-6#1)(1994-11#1)(1995-6#1)(2008-10#6)(2011-1#1)
those problems##4##2##(1997-1#1)(2012-3#1)(2013-1#2)
those produced by##4##3##(2008-10#3)(2008-11#1)
those produced in##3##3##(2008-10#3)
those produced on##2##3##(2008-10#2)
those produced##9##2##(2008-10#8)(2008-11#1)
those programs##2##2##(1994-3#1)(2008-12#1)
those proposed##2##2##(2008-12#1)(2013-1#1)
those provided by the##3##4##(2008-10#3)
those provided by##4##3##(2008-10#4)
those receiving##4##2##(1994-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
those regions##3##2##(1991-6#1)(1994-2#1)(2011-2#1)
those related to the##2##4##(2008-10#1)(2008-8#1)
those related to##6##3##(1991-6#1)(2008-10#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-3#1)
those relationships##2##2##(1997-1#2)
those reported by##3##3##(2008-10#3)
those reported in literature##2##4##(2008-10#2)
those reported in the literature##4##5##(2008-10#2)(2008-11#1)(2008-8#1)
those reported in##9##3##(1991-3#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-8#1)
those reported previously##2##3##(2008-10#2)
those reported##18##2##(1991-3#1)(1995-12#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-8#1)(2010-6#1)
those required for##3##3##(1994-3#1)(2009-8#1)(2013-1#1)
those required to##2##3##(1995-2#1)(2008-10#1)
those required##6##2##(1994-3#1)(1995-2#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
those resulting from##2##3##(2008-10#1)(2012-3#1)
those resulting##3##2##(2008-10#2)(2012-3#1)
those samples that##3##3##(2008-10#3)
those samples##5##2##(2008-10#5)
those seeking##2##2##(1992-1#1)(1995-12#1)
those seen in the##2##4##(1994-5#1)(2008-7#1)
those seen in##4##3##(1994-5#1)(1995-12#1)(2008-4#1)(2008-7#1)
those seen with##2##3##(2008-5#1)(2008-7#1)
those seen##10##2##(1991-6#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(2008-4#1)(2008-5#1)(2008-7#2)
those services##2##2##(1993-12#1)(1997-2#1)
those showing##2##2##(2008-7#1)(2009-8#1)
those species##4##2##(2008-10#2)(2008-8#1)(2010-4#1)
those specimens##2##2##(2009-7#1)(2013-8#1)
those stimuli that act &quot##2##5##(1997-1#2)
those studies##2##2##(1996-12#2)
those taken##2##2##(2008-10#1)(2010-7#1)
those targeting##2##2##(2008-10#1)(2009-12#1)
those tested##2##2##(1990-5#1)(2008-10#1)
those that applied##2##3##(2008-10#2)
those that are##7##3##(1996-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
those that have##3##3##(1993-3#1)(2008-10#1)(2009-10#1)
those that were##3##3##(1992-6#1)(2008-10#2)
those that##50##2##(1991-5#2)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#2)(2009-3#2)(2009-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
those three##2##2##(1995-2#1)(2008-10#1)
those treated with##8##3##(1991-3#1)(1993-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
those treated##11##2##(1991-3#1)(1992-9#1)(1993-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
those two##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
those under##2##2##(1991-12#1)(2008-10#1)
those undergoing##3##2##(1991-3#1)(2008-7#2)
those used for##3##3##(1990-11#1)(2008-11#1)(2011-2#1)
those used in the##2##4##(2008-11#1)(2009-3#1)
those used in##4##3##(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)
those used##7##2##(1990-11#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)
those using##9##2##(1992-1#1)(1997-3#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-7#1)(2010-6#1)
those were##4##2##(2008-10#2)(2010-8#1)(2012-2#1)
those where##2##2##(2008-9#1)(2009-7#1)
those which are##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
those which##8##2##(1994-2#1)(1997-2#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#1)
those who are not##2##4##(1995-12#1)(2008-11#1)
those who are##11##3##(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-10#1)(2013-1#1)
those who continued##2##3##(1991-3#1)(2008-11#1)
those who did not##2##4##(2008-11#1)(2013-1#1)
those who do##2##3##(1994-3#1)(2008-12#1)
those who had no##2##4##(2008-11#1)(2012-3#1)
those who had not##3##4##(1993-1#1)(1995-2#1)(2008-9#1)
those who had##11##3##(1990-6#1)(1993-1#1)(1995-2#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#2)(2013-1#3)
those who have##3##3##(1993-12#1)(2008-11#1)(2008-8#1)
those who initiated PT on##2##5##(2012-2#2)
those who need to##2##4##(1993-2#1)(2008-3#1)
those who need##4##3##(1991-3#1)(1993-2#1)(1995-1#1)(2008-3#1)
those who received##3##3##(1990-6#2)(2008-11#1)
those who reported##3##3##(1993-1#1)(1994-1#1)(2013-8#1)
those who were##10##3##(1993-1#1)(1997-8#1)(2008-1#1)(2008-6#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
those who work##3##3##(1996-12#1)(2010-10#1)(2013-1#1)
those who##104##2##(1990-6#4)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#3)(1992-1#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#1)(1994-1#4)(1994-12#1)(1994-2#2)(1994-3#4)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#11)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#12)(2013-8#3)
those whose##5##2##(1992-3#1)(1995-5#1)(2008-10#1)(2008-7#1)(2013-8#1)
those wishing to##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
those with 1##2##3##(2008-10#1)(2008-11#1)
those with a##12##3##(1997-8#1)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#2)
those with an##4##3##(1991-8#1)(2008-11#1)(2011-2#1)(2013-7#1)
those with early##2##3##(2009-8#1)(2011-2#1)
those with higher##3##3##(1991-1#1)(2008-10#1)(2008-9#1)
those with low##2##3##(1991-2#1)(1994-8#1)
those with no##5##3##(1991-2#1)(1993-1#1)(2010-10#1)(2010-4#1)(2013-8#1)
those with normal##3##3##(1991-12#1)(2008-11#1)(2012-3#1)
those with physical illnesses##2##4##(2009-4#1)(2010-12#1)
those with stable##2##3##(1990-2#1)(1994-8#1)
those with strong##3##3##(1993-12#2)(1996-2#1)
those with the##7##3##(2008-10#4)(2008-8#1)(2012-2#2)
those with very##2##3##(2010-11#1)(2011-1#1)
those with##125##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#3)(1994-12#1)(1994-8#3)(1996-2#1)(1996-3#2)(1997-3#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#12)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
those without previous##2##3##(1996-12#1)(2013-8#1)
those without thyroid disorders##2##4##(2013-1#2)
those without##27##2##(1990-8#1)(1991-12#1)(1993-8#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#4)
those working in##2##3##(2008-12#1)(2011-2#1)
those working##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
those##2032##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#1)(1990-5#9)(1990-6#8)(1990-8#6)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#13)(1991-2#9)(1991-3#16)(1991-5#9)(1991-6#9)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#14)(1992-10#1)(1992-11#2)(1992-12#10)(1992-2#6)(1992-3#12)(1992-6#5)(1992-8#2)(1992-9#5)(1993-1#9)(1993-11#3)(1993-12#13)(1993-2#9)(1993-3#12)(1993-6#3)(1993-8#10)(1993-9#1)(1994-1#12)(1994-11#4)(1994-12#15)(1994-2#9)(1994-3#17)(1994-5#8)(1994-6#2)(1994-8#8)(1994-9#3)(1995-1#3)(1995-11#6)(1995-12#18)(1995-2#10)(1995-3#9)(1995-5#7)(1995-6#12)(1995-8#6)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#19)(1996-2#14)(1996-3#9)(1996-5#2)(1996-6#1)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#14)(1997-3#17)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#13)(2006-6#3)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#7)(2008-10#709)(2008-11#110)(2008-12#28)(2008-2#6)(2008-3#31)(2008-4#6)(2008-5#54)(2008-6#8)(2008-7#49)(2008-8#53)(2008-9#57)(2009-10#9)(2009-11#6)(2009-12#7)(2009-3#5)(2009-4#4)(2009-5#6)(2009-6#10)(2009-7#10)(2009-8#15)(2009-9#3)(2010-1#9)(2010-10#8)(2010-11#11)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#16)(2010-5#3)(2010-6#4)(2010-7#7)(2010-8#10)(2010-9#1)(2011-1#14)(2011-2#81)(2011-3#2)(2012-12#18)(2012-2#31)(2012-3#28)(2012-5#1)(2012-9#1)(2013-1#50)(2013-7#3)(2013-8#26)
though a##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
though it has##2##3##(2008-11#1)(2008-9#1)
though it is##5##3##(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#2)
though it was##3##3##(1991-1#1)(1992-6#1)(2008-10#1)
though it##17##2##(1991-1#1)(1992-6#1)(1994-3#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-2#1)
though less##2##2##(2008-10#1)(2012-3#1)
though more##3##2##(1993-1#1)(1994-3#1)(2011-2#1)
though not##4##2##(2008-10#2)(2008-12#1)(2008-8#1)
though some##2##2##(2008-10#1)(2008-12#1)
though the##35##2##(1990-12#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1996-5#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
though there is##2##3##(2008-1#1)(2013-8#1)
though there##3##2##(2008-1#1)(2013-8#2)
though these##4##2##(1991-12#1)(1991-3#1)(2009-7#1)(2012-2#1)
though they##4##2##(1993-12#1)(1993-2#1)(2008-10#1)(2010-10#1)
though this##8##2##(1993-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-11#1)(2010-8#2)(2012-2#1)
though to##2##2##(1993-8#1)(2008-10#1)
though##174##1##(1990-12#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#2)(1995-11#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#2)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#45)(2008-11#9)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-8#3)(2010-9#1)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#5)
thought about##2##2##(2008-7#1)(2010-10#1)
thought and##7##2##(1995-12#1)(1997-3#1)(2008-11#1)(2009-4#1)(2011-2#1)(2013-8#2)
thought in##2##2##(1994-8#1)(2008-10#1)
thought intrusion##2##2##(2012-3#2)
thought of as##2##3##(2008-10#2)
thought of##6##2##(2008-10#2)(2008-11#1)(2009-10#1)(2010-5#1)(2011-2#1)
thought processes##2##2##(2011-2#1)(2013-8#1)
thought suppression##4##2##(2012-3#4)
thought that the##6##3##(1990-2#1)(1990-3#1)(1997-2#1)(2007-12#1)(2008-3#1)(2011-2#1)
thought that##12##2##(1990-2#2)(1990-3#1)(1996-11#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-6#1)(2011-2#1)
thought to act##2##3##(1993-9#1)(1996-12#1)
thought to be a##6##4##(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-8#1)
thought to be an##4##4##(1991-7#1)(1993-3#1)(2011-2#1)(2012-12#1)
thought to be caused by##2##5##(1990-11#1)(2009-6#1)
thought to be due to##2##5##(2011-1#1)(2012-2#1)
thought to be important##4##4##(1990-11#1)(2008-7#1)(2008-8#2)
thought to be involved in##3##5##(2008-10#2)(2008-7#1)
thought to be involved##5##4##(2008-10#2)(2008-7#2)(2009-10#1)
thought to be of importance##3##5##(2006-6#1)(2011-2#2)
thought to be the only##2##5##(1994-9#1)(2010-12#1)
thought to be the##5##4##(1990-11#1)(1994-9#1)(2008-11#1)(2008-7#1)(2010-12#1)
thought to be useful##2##4##(1993-1#1)(2008-11#1)
thought to be##65##3##(1990-11#3)(1990-5#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-8#1)(2006-6#1)(2008-10#8)(2008-11#8)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
thought to have a##2##4##(1997-1#1)(2012-3#1)
thought to have##3##3##(1997-1#1)(2010-6#1)(2012-3#1)
thought to involve##3##3##(2008-9#1)(2009-1#1)(2013-8#1)
thought to mediate##2##3##(1995-2#1)(2008-6#1)
thought to occur##4##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
thought to play a##3##4##(1993-3#1)(2008-10#1)(2011-2#1)
thought to play##6##3##(1993-3#1)(2008-10#1)(2008-4#1)(2011-2#2)(2013-1#1)
thought to reflect the##2##4##(1997-1#1)(2008-2#1)
thought to represent the##2##4##(2008-10#1)(2013-1#1)
thought to represent##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
thought to result from##3##4##(1995-6#1)(2008-9#1)(2011-2#1)
thought to result##4##3##(1995-6#1)(1997-8#1)(2008-9#1)(2011-2#1)
thought to underlie##2##3##(2009-8#1)(2013-8#1)
thought to##127##2##(1990-11#3)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#3)(1995-6#1)(1996-11#1)(1996-12#2)(1997-1#3)(1997-8#2)(2006-6#1)(2008-10#15)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
thought were##2##2##(2008-12#1)(2010-4#1)
thought##193##1##(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-11#2)(1996-12#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2006-6#1)(2007-12#1)(2008-10#21)(2008-11#19)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#3)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#14)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#9)(2013-1#5)(2013-7#2)(2013-8#9)
thoughtful##3##1##(2008-11#1)(2008-12#1)(2011-2#1)
thoughts about##4##2##(1991-12#1)(2009-7#1)(2010-11#1)(2011-2#1)
thoughts and behaviors##3##3##(2008-11#2)(2009-9#1)
thoughts and feelings about physical activity and##2##7##(2009-6#2)
thoughts and feelings##3##3##(2009-6#2)(2013-1#1)
thoughts and##9##2##(2008-11#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
thoughts on how##2##3##(1997-3#1)(2010-11#1)
thoughts on##4##2##(1993-2#1)(1997-3#1)(2008-6#1)(2010-11#1)
thoughts##27##1##(1991-12#1)(1993-2#1)(1995-1#1)(1996-9#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-6#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-11#2)(2010-6#2)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
thousand##13##1##(1990-12#1)(1994-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
thousands of genes##3##3##(2008-10#1)(2008-4#1)(2011-3#1)
thousands of##27##2##(1991-2#1)(1996-11#1)(2008-10#6)(2008-11#2)(2008-4#3)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-10#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)
thousands##29##1##(1991-2#1)(1996-11#1)(2008-10#6)(2008-11#2)(2008-4#3)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-10#2)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)
thread##4##1##(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)
threads##2##1##(1991-2#1)(1993-12#1)
threat from##2##2##(2008-10#1)(2008-8#1)
threat in the##2##3##(2009-10#1)(2011-2#1)
threat in##4##2##(2007-12#1)(2009-10#1)(2011-2#2)
threat of##11##2##(1991-3#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-11#1)(2010-5#1)(2012-3#1)
threat stimuli##2##2##(2009-4#2)
threat to lettuce##2##3##(2008-10#2)
threat to the##4##3##(1992-1#1)(1996-3#1)(2008-10#2)
threat to##18##2##(1990-6#1)(1992-1#1)(1996-3#1)(1997-5#1)(2008-10#10)(2008-11#1)(2010-1#1)(2011-2#1)(2011-3#1)
threat was##3##2##(1996-12#1)(2010-1#1)(2012-2#1)
threat##52##1##(1990-11#1)(1990-6#2)(1991-3#1)(1992-1#1)(1995-6#1)(1996-12#3)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#19)(2008-11#3)(2008-4#1)(2008-8#1)(2009-10#3)(2009-4#2)(2010-1#2)(2010-5#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)
threaten the##2##2##(1996-2#1)(2008-11#1)
threaten##7##1##(1994-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-8#1)
threatened by##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
threatened the##2##2##(2008-10#1)(2010-1#1)
threatened##17##1##(1990-12#1)(1990-2#1)(1991-9#1)(1993-12#1)(1993-6#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
threatening##23##1##(1994-12#1)(1995-5#1)(1996-5#1)(2008-10#3)(2008-12#2)(2009-11#2)(2009-4#1)(2010-10#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#2)
threatens the##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2011-3#1)
threatens##8##1##(1995-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2009-3#1)(2011-3#1)
threats to##7##2##(1991-3#1)(1992-12#1)(2008-10#1)(2008-11#1)(2012-2#2)(2013-1#1)
threats##17##1##(1991-1#2)(1991-2#1)(1991-3#1)(1992-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
three &quot##3##2##(1991-2#1)(1991-3#1)(1996-1#1)
three 2-min exposures to##2##4##(1994-3#2)
three Army##2##2##(2012-2#2)
three B##2##2##(2008-10#1)(2008-11#1)
three DNA##3##2##(2008-10#2)(2008-8#1)
three European oak species (Quercus robur##2##6##(2012-5#1)(2012-7#1)
three F(2)##2##2##(2008-10#2)
three Finnish patients##2##3##(1991-7#2)
three Finnish##3##2##(1991-7#3)
three French##2##2##(2008-10#2)
three Fusarium species##2##3##(2008-10#2)
three QTL##2##2##(2008-10#1)(2012-3#1)
three QTLs for##2##3##(2008-8#1)(2008-9#1)
three T-flask tests##2##3##(2008-11#2)
three activities##2##2##(1992-12#1)(1997-3#1)
three additional##5##2##(2008-10#4)(2012-2#1)
three affected##2##2##(1997-7#1)(2011-2#1)
three after##4##2##(1995-3#1)(1997-8#2)(2012-3#1)
three age groups##3##3##(1994-11#1)(2008-7#2)
three agents##7##2##(2008-10#6)(2008-7#1)
three ages##2##2##(1996-2#1)(2008-10#1)
three alternative##2##2##(2009-3#1)(2012-2#1)
three amino acid residues of##2##5##(2008-11#1)(2008-8#1)
three amino acid residues##3##4##(2008-11#1)(2008-8#2)
three amino acid##5##3##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
three amino##6##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
three amphiphilic forms##2##3##(1990-5#2)
three analytes##11##2##(2008-10#11)
three and four##2##3##(2008-10#1)(2013-8#1)
three and six months after##2##5##(1993-3#1)(2011-2#1)
three and two##2##3##(2006-6#1)(2008-10#1)
three and##11##2##(1993-3#1)(2006-6#1)(2008-10#3)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
three antibodies##2##2##(1995-12#1)(1996-12#1)
three approaches##2##2##(2008-10#1)(2012-2#1)
three are##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
three areas in the##2##4##(2008-10#1)(2008-12#1)
three areas##4##2##(1993-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
three arsenic species in##2##4##(2008-10#2)
three arsenic species##3##3##(2008-10#3)
three articles##2##2##(2011-2#1)(2012-12#1)
three aspects of##2##3##(2012-3#2)
three aspects##3##2##(1994-12#1)(2012-3#2)
three assessment methods##2##3##(2008-10#2)
three basic##4##2##(1991-6#1)(2008-7#1)(2013-1#2)
three batches##3##2##(2008-11#2)(2013-1#1)
three bays##2##2##(2008-10#2)
three beta##2##2##(2008-11#1)(2010-12#1)
three biosensors##2##2##(2008-10#2)
three bond coupling constants##2##4##(1992-4#2)
three broad##2##2##(1991-2#1)(2011-2#1)
three case studies##2##3##(1996-1#1)(2010-5#1)
three cases of##10##3##(1991-11#1)(1997-8#2)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
three cases##35##2##(1991-11#1)(1991-12#1)(1991-6#1)(1994-12#1)(1995-11#1)(1997-3#3)(1997-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
three categories of##5##3##(1995-2#1)(2008-10#3)(2008-11#1)
three categories##11##2##(1994-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-12#2)(2011-2#1)
three cations##3##2##(2008-10#3)
three cephalosporin antibiotics##2##3##(2008-10#2)
three channels##3##2##(2008-10#3)
three clades##4##2##(2008-10#3)(2009-6#1)
three classes of##7##3##(1992-9#1)(1995-2#2)(1995-8#1)(1997-2#1)(2008-11#1)(2008-4#1)
three classes##11##2##(1992-9#1)(1995-2#2)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#2)
three clonal lineages##2##3##(2008-10#2)
three clones##2##2##(1994-11#1)(1997-7#1)
three colorants##3##2##(2008-10#3)
three commercial##7##2##(1992-2#1)(2008-10#6)
three common##2##2##(2008-10#1)(2009-9#1)
three compatible hosts##2##3##(2008-10#2)
three component##2##2##(2008-10#1)(2011-3#1)
three components of the##2##4##(2008-10#1)(2008-8#1)
three components of##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
three components##10##2##(1992-12#1)(1994-3#1)(2008-10#4)(2008-8#2)(2012-3#1)(2013-1#1)
three compounds##9##2##(2008-10#4)(2008-11#1)(2008-9#2)(2011-1#1)(2011-2#1)
three concentration levels of##2##4##(2008-10#2)
three concentration levels##4##3##(2008-10#3)(2011-3#1)
three conditions##7##2##(2008-11#5)(2011-2#1)(2013-8#1)
three configurations##2##2##(2008-10#2)
three consecutive years##2##3##(2008-10#1)(2008-5#1)
three consecutive##10##2##(1991-3#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
three conserved##2##2##(1995-6#1)(1996-12#1)
three copies of the##2##4##(1994-11#1)(2008-10#1)
three copies of##3##3##(1994-11#1)(2008-10#2)
three core functions##3##3##(1996-3#2)(1997-2#1)
three countries##6##2##(2008-10#1)(2009-3#1)(2009-7#1)(2010-12#3)
three cowpea cultivars##2##3##(2008-12#2)
three cultivars##5##2##(2008-10#4)(2008-12#1)
three daily##2##2##(2008-7#1)(2013-1#1)
three dairy##2##2##(1992-2#1)(2012-12#1)
three databases##2##2##(1994-3#2)
three days after##3##3##(1990-12#1)(2008-5#1)(2013-1#1)
three days of##4##3##(2007-12#2)(2008-5#1)(2012-2#1)
three days##12##2##(1990-12#1)(1991-5#1)(2007-12#3)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
three decades##12##2##(1992-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)
three dependent variables##2##3##(1995-12#2)
three detection##2##2##(2008-10#1)(2008-3#1)
three differences##2##2##(1990-8#1)(1993-6#1)
three different batches##2##3##(2008-11#2)
three different groups of##2##4##(1997-2#1)(2008-7#1)
three different groups##4##3##(1997-2#1)(2008-10#2)(2008-7#1)
three different hosts##3##3##(2008-10#3)
three different methods##5##3##(1996-5#1)(2008-10#3)(2009-8#1)
three different production##2##3##(2008-11#1)(2012-2#1)
three different types of##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
three different ways##2##3##(1995-6#1)(2008-10#1)
three different##126##2##(1990-9#1)(1992-3#2)(1992-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#60)(2008-11#14)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-12#1)(2010-3#2)(2011-1#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
three diketopiperazines##2##2##(2008-10#2)
three dimensional##6##2##(2008-11#2)(2008-4#1)(2012-3#3)
three dimensions of##2##3##(2008-10#1)(2012-12#1)
three dimensions##7##2##(1994-3#1)(1995-1#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
three distinct clades##3##3##(2008-10#2)(2009-8#1)
three distinct clusters were##2##4##(2008-10#2)
three distinct clusters##3##3##(2008-10#3)
three distinct groups of##2##4##(1996-2#1)(2009-4#1)
three distinct groups##4##3##(1996-2#1)(2008-10#1)(2009-4#1)(2011-2#1)
three distinct subgroups##2##3##(2008-10#2)
three distinct##28##2##(1994-5#1)(1996-2#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
three domains##5##2##(1992-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)
three dots##3##2##(1996-8#1)(2008-10#2)
three drugs##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
three dyes##5##2##(2008-10#5)
three elements##4##2##(2008-10#3)(2008-4#1)
three environments##3##2##(1997-7#1)(2008-10#2)
three enzymes##4##2##(2008-10#3)(2008-7#1)
three essential##3##2##(1991-2#1)(2008-8#1)(2012-2#1)
three evidence-based postoperative pain assessment practices##2##6##(2010-11#2)
three examples of##2##3##(1994-1#1)(2008-10#1)
three examples##3##2##(1994-1#1)(2008-10#1)(2008-11#1)
three exons##2##2##(1992-10#1)(1993-2#1)
three experimental groups##3##3##(1996-2#1)(1997-2#1)(2011-2#1)
three experimental##5##2##(1996-2#1)(1997-2#1)(2008-10#1)(2010-10#1)(2011-2#1)
three experiments##6##2##(2008-10#4)(2008-11#1)(2008-9#1)
three factors##6##2##(2008-10#3)(2008-11#1)(2008-8#2)
three field##4##2##(2008-10#3)(2013-8#1)
three fluoroquinolones##2##2##(2008-10#2)
three for##2##2##(2008-9#2)
three formulations##2##2##(2008-10#1)(2008-5#1)
three fractions##2##2##(1991-5#1)(2008-10#1)
three functional##2##2##(1995-2#1)(2008-4#1)
three fungicides##3##2##(2008-10#3)
three further##2##2##(2008-11#1)(2011-2#1)
three genera##2##2##(1995-2#1)(2010-7#1)
three genes##5##2##(1995-12#1)(1995-8#1)(2008-10#2)(2011-2#1)
three genetic##2##2##(2008-10#2)
three genetically##2##2##(2008-10#2)
three genotypic##3##2##(2008-10#3)
three geographic##2##2##(2008-10#2)
three geographical##2##2##(2008-10#2)
three groups according to the##3##5##(1996-6#1)(2008-10#2)
three groups did not differ##2##5##(2009-9#1)(2010-7#1)
three groups in##3##3##(1994-12#1)(2009-11#1)(2012-2#1)
three groups of##11##3##(1993-1#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
three groups on##2##3##(2008-10#1)(2013-8#1)
three groups were##4##3##(1993-1#1)(1995-5#1)(2008-10#1)(2012-5#1)
three groups##55##2##(1991-1#1)(1993-1#2)(1994-12#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-6#1)(2006-6#1)(2008-10#20)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2012-5#3)(2013-1#1)(2013-8#3)
three guilds##2##2##(2008-8#2)
three habitats##2##2##(2008-10#2)
three had##3##2##(1991-12#1)(1992-3#1)(1997-5#1)
three haptens##2##2##(2008-10#2)
three have##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
three herbicides##2##2##(2008-10#2)
three highly##3##2##(1995-2#1)(2008-10#2)
three hospitals in##2##3##(2008-10#1)(2012-3#1)
three host##2##2##(2008-10#1)(2010-4#1)
three hours##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2011-1#1)
three human##6##2##(1993-12#1)(2008-10#3)(2008-11#2)
three hundred##2##2##(2011-2#1)(2013-8#1)
three ilarviruses##2##2##(2008-10#2)
three important##3##2##(2008-10#2)(2008-11#1)
three in##4##2##(1996-6#1)(2008-10#3)
three incoherent feed-forward##2##3##(2008-11#2)
three independent analysis of a##2##5##(2008-10#2)
three independent##17##2##(1991-12#1)(1995-6#2)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#3)
three individuals tossed a ball##2##5##(2008-11#2)
three individuals##4##2##(2008-11#2)(2008-8#1)(2012-12#1)
three interrelated##2##2##(1992-12#1)(2013-1#1)
three introns and##2##3##(1993-6#1)(1994-11#1)
three introns##5##2##(1993-2#1)(1993-6#1)(1994-11#1)(1997-2#1)(2010-5#1)
three islands##2##2##(2008-10#2)
three isolates of T##2##4##(2008-10#2)
three isolates of nucleopolyhedrovirus of Helicoverpa armigera##2##7##(2008-12#2)
three isolates of##7##3##(2008-10#4)(2008-12#2)(2013-1#1)
three isolates##18##2##(2008-10#15)(2008-12#2)(2013-1#1)
three key##5##2##(1991-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2011-3#1)
three kinds of media##2##4##(2008-10#2)
three kinds of##7##3##(2008-10#5)(2008-5#1)(2008-9#1)
three kinds##8##2##(2008-10#5)(2008-5#1)(2008-9#2)
three known##2##2##(2008-5#1)(2009-7#1)
three layer##3##2##(2008-10#2)(2009-5#1)
three layers of nodes was trained##4##6##(2008-10#4)
three layers##8##2##(2008-10#6)(2010-8#2)
three leafhopper species##2##3##(2008-10#2)
three levels of##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)
three levels##7##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-11#1)(2013-8#1)
three light##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
three locations##3##2##(2008-10#3)
three loci##4##2##(2008-10#4)
three main##17##2##(1994-5#1)(2008-10#4)(2008-11#4)(2008-5#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)
three major##26##2##(1991-2#1)(1991-9#1)(1992-11#1)(1995-11#2)(1996-5#1)(1997-8#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-6#2)(2009-10#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
three males##2##2##(1992-9#1)(2010-8#1)
three markers##2##2##(1997-8#1)(2008-11#1)
three measurement##2##2##(2010-10#1)(2010-7#1)
three measures of durability##2##4##(2008-10#2)
three measures of##3##3##(2008-10#2)(2008-4#1)
three measures##5##2##(1995-12#1)(2008-10#2)(2008-4#1)(2010-11#1)
three media##3##2##(2008-10#3)
three members of the##3##4##(1996-12#1)(2009-6#1)(2013-1#1)
three members of##4##3##(1996-12#2)(2009-6#1)(2013-1#1)
three members##5##2##(1993-12#1)(1996-12#2)(2009-6#1)(2013-1#1)
three metal ions##2##3##(2008-10#2)
three metals##5##2##(2008-10#5)
three methods of##2##3##(2008-10#2)
three methods were##3##3##(1993-2#1)(1994-12#1)(2008-10#1)
three methods##18##2##(1991-3#1)(1993-2#3)(1994-12#2)(2008-10#9)(2008-12#2)(2008-6#1)
three methylxanthines##2##2##(2008-10#2)
three minor##2##2##(2008-11#1)(2009-10#1)
three models##3##2##(2008-5#1)(2008-8#1)(2010-12#1)
three modes##2##2##(1992-3#1)(2013-1#1)
three molecular##2##2##(2008-10#2)
three molecules##2##2##(1992-4#2)
three months after##3##3##(1991-11#1)(1992-9#1)(1993-3#1)
three months and##6##3##(1990-12#1)(1991-11#1)(1993-3#1)(2008-11#2)(2008-12#1)
three months of##3##3##(1991-8#1)(2008-11#1)(2009-7#1)
three months##28##2##(1990-12#2)(1991-11#4)(1991-3#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-3#2)(1996-3#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#2)(2009-7#1)(2011-2#2)(2012-3#2)(2013-1#2)
three morphological types##2##3##(1996-6#1)(2008-12#1)
three most common##2##3##(2011-2#1)(2013-1#1)
three most##5##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
three mutants was##2##3##(2008-10#2)
three mutants##4##2##(1995-6#1)(2008-10#2)(2008-9#1)
three natural##2##2##(2008-10#2)
three neurotrophic factors##2##3##(2013-1#2)
three new##10##2##(1991-2#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-10#5)(2012-2#1)
three novel##3##2##(1996-6#1)(2008-10#1)(2010-1#1)
three oak species##2##3##(2012-6#1)(2012-9#1)
three occasions##2##2##(1993-1#1)(2013-1#1)
three of five##2##3##(2008-10#2)
three of four##6##3##(2008-10#4)(2011-2#2)
three of the four##7##4##(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
three of the six##2##4##(1991-6#1)(2008-5#1)
three of the##24##3##(1990-6#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-12#1)(1997-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)
three of them##4##3##(1991-5#1)(1992-3#1)(1997-9#1)(2008-7#1)
three of these##9##3##(1991-12#1)(1993-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)
three of which were##3##4##(2008-10#3)
three of which##8##3##(2008-10#5)(2008-5#1)(2008-8#1)(2010-7#1)
three of whom##2##3##(1991-11#1)(2008-9#1)
three of##57##2##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-5#1)(1996-12#1)(1997-9#2)(2008-10#22)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2010-7#1)(2011-2#3)
three open reading frames##2##4##(2008-10#2)
three operationalizations of burnout phase##2##5##(1997-1#2)
three operationalizations##3##2##(1997-1#3)
three opioid##2##2##(1996-12#2)
three optical##2##2##(2008-3#1)(2013-8#1)
three options##4##2##(1995-1#1)(1997-4#2)(2008-10#1)
three or five##3##3##(1991-3#1)(2008-10#2)
three or more##5##3##(2008-10#3)(2011-1#1)(2013-8#1)
three or##12##2##(1991-3#1)(1995-12#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
three orchards##2##2##(2008-10#2)
three orders in the magnitude##2##5##(2008-10#1)(2008-11#1)
three orders of magnitude and the##3##6##(2008-10#3)
three orders of magnitude##16##4##(1991-5#1)(2008-10#14)(2008-7#1)
three orders of##17##3##(1991-5#1)(2008-10#14)(2008-3#1)(2008-7#1)
three orders##19##2##(1991-5#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-7#1)
three organ##2##2##(2008-8#2)
three organizations##2##2##(1996-1#2)
three other##10##2##(1993-6#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-11#1)(2011-2#1)
three out of five##2##4##(1996-12#1)(2008-11#1)
three out of##3##3##(1996-12#1)(2008-11#1)(2008-5#1)
three oxysterols##2##2##(1993-6#2)
three pH values##2##3##(2008-10#1)(2008-5#1)
three pairs##2##2##(1994-5#1)(2008-10#1)
three parallel##2##2##(1995-3#1)(2008-10#1)
three parameters##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
three parts##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
three passes##2##2##(2008-10#1)(2008-7#1)
three pathogenic##2##2##(2008-10#1)(2008-11#1)
three pathotypes of##2##3##(2008-10#2)
three patients who##3##3##(2008-11#2)(2013-1#1)
three patients with##8##3##(1990-8#1)(1993-11#1)(1996-9#2)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
three patients##33##2##(1990-8#2)(1990-9#2)(1993-11#1)(1993-2#1)(1994-3#1)(1996-11#1)(1996-6#1)(1996-9#3)(1997-4#1)(1997-5#1)(1997-8#1)(2008-11#3)(2008-5#1)(2008-7#4)(2010-10#1)(2010-11#1)(2011-2#5)(2013-1#3)
three peptides##3##2##(1996-12#1)(1997-4#1)(2008-6#1)
three percent of##3##3##(2008-10#1)(2008-12#1)(2010-7#1)
three pesticides##4##2##(2008-10#4)
three pharmaceutical##2##2##(2008-10#2)
three phase fluidized bed reactor##2##5##(2008-7#2)
three phases in##2##3##(1992-6#1)(2009-7#1)
three phases of##3##3##(1991-3#1)(1993-12#1)(2008-11#1)
three phases##9##2##(1991-2#1)(1991-3#1)(1992-6#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-8#1)
three planes##2##2##(2008-6#1)(2008-9#1)
three plant species##2##3##(2008-10#2)
three plant##3##2##(2008-10#3)
three plants##2##2##(2008-10#1)(2008-9#1)
three populations##8##2##(1997-3#1)(2008-10#4)(2012-7#2)(2013-8#1)
three positively charged residues##2##4##(1997-8#2)
three possible##4##2##(1993-8#1)(2008-10#2)(2008-8#1)
three potato##2##2##(2008-10#2)
three potential##2##2##(2007-11#1)(2008-11#1)
three previously sequenced##2##3##(1996-6#1)(2008-10#1)
three previously##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
three primary##3##2##(2008-10#1)(2008-11#1)(2009-11#1)
three primer##2##2##(2008-10#1)(2008-5#1)
three primers##3##2##(2008-10#1)(2010-4#2)
three proteases##2##2##(2008-10#1)(2008-11#1)
three protein##4##2##(1991-6#1)(1994-6#1)(1995-2#1)(2009-8#1)
three proteins##4##2##(1995-11#1)(1995-12#1)(2008-10#1)(2010-12#1)
three quarters##2##2##(1997-8#1)(2012-2#1)
three questions##2##2##(1996-1#1)(2008-8#1)
three races##2##2##(2008-10#2)
three randomized##3##2##(2008-8#1)(2012-12#2)
three reaction##2##2##(2008-10#1)(2008-3#1)
three real samples##3##3##(2008-10#3)
three real##5##2##(2008-10#4)(2008-6#1)
three regions of the##2##4##(1994-12#1)(1997-2#1)
three regions of##6##3##(1990-5#1)(1990-7#1)(1994-12#1)(1994-8#1)(1997-2#1)(2011-2#1)
three regions##14##2##(1990-5#1)(1990-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-9#2)(2011-2#1)(2013-1#2)
three related##3##2##(2008-10#3)
three remaining##3##2##(1992-5#1)(1993-2#1)(2008-10#1)
three replicates##4##2##(2008-10#4)
three replications##5##2##(2008-10#2)(2008-12#2)(2010-4#1)
three representative##3##2##(1996-5#1)(2008-11#1)(2013-1#1)
three resistance##2##2##(2008-10#1)(2008-8#1)
three restriction fragment length polymorphism (RFLP) markers##2##7##(1995-6#1)(2008-9#1)
three restriction fragment length polymorphism (RFLP)##3##6##(1995-6#1)(2008-10#1)(2008-9#1)
three restriction##4##2##(1995-6#1)(2008-10#2)(2008-9#1)
three rounds of##2##3##(2008-10#1)(2009-6#1)
three rounds##3##2##(2008-10#2)(2009-6#1)
three samples##2##2##(2008-10#2)
three scales of##2##3##(2008-10#2)
three scales##3##2##(2008-10#3)
three scenarios##2##2##(2008-8#1)(2012-2#1)
three seasons##2##2##(1994-3#1)(2008-10#1)
three segments##4##2##(1991-5#1)(2007-12#1)(2008-3#1)(2013-8#1)
three separate##8##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
three sets of##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
three sets##4##2##(2008-10#2)(2008-7#1)(2010-5#1)
three shampoos##2##2##(2008-5#2)
three short##3##2##(1993-2#1)(1997-4#1)(2010-11#1)
three showed##2##2##(1991-3#1)(2013-1#1)
three signals##2##2##(1997-3#2)
three sites##5##2##(1992-3#1)(1995-6#1)(2008-10#1)(2010-5#1)(2012-3#1)
three soils##6##2##(2008-10#6)
three sources##3##2##(1997-6#1)(2008-10#2)
three species in##2##3##(2011-2#1)(2012-8#1)
three species of##5##3##(2007-12#2)(2008-10#2)(2010-8#1)
three species were##4##3##(2008-10#2)(2011-3#1)(2012-8#1)
three species##24##2##(2007-12#2)(2008-10#11)(2008-11#1)(2010-8#1)(2011-2#1)(2011-3#5)(2012-8#2)(2012-9#1)
three spectroscopic##2##2##(2008-10#2)
three stages##3##2##(2008-4#1)(2011-2#1)(2013-8#1)
three standard reference materials##2##4##(2008-10#2)
three standard##7##2##(2008-10#6)(2012-2#1)
three step##2##2##(2008-1#1)(2008-10#1)
three steps from##2##3##(1993-12#1)(2008-10#1)
three steps##5##2##(1993-12#1)(1996-12#1)(2008-10#2)(2010-9#1)
three strains of##7##3##(1994-2#1)(2008-10#4)(2008-11#1)(2008-8#1)
three strains were##2##3##(2008-10#2)
three strains##15##2##(1993-9#1)(1994-2#3)(1995-6#1)(2008-10#7)(2008-11#2)(2008-8#1)
three studied##4##2##(2008-10#4)
three subgroups##2##2##(1995-12#1)(2008-5#1)
three subjects##3##2##(2008-7#1)(2008-9#1)(2009-3#1)
three subpopulations##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
three substrates##4##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
three subtypes##3##2##(2007-12#1)(2010-12#1)(2013-8#1)
three successive years##3##3##(2008-10#3)
three successive##7##2##(2008-10#6)(2008-11#1)
three techniques##2##2##(2008-10#2)
three test emulsions##3##3##(2008-5#3)
three test##4##2##(1996-8#1)(2008-5#3)
three tests##3##2##(1996-3#1)(2008-10#1)(2008-12#1)
three themes##3##2##(2008-11#1)(2010-11#1)(2012-3#1)
three times a week for##2##5##(1991-3#1)(2010-4#1)
three times a##4##3##(1991-3#1)(2008-10#1)(2010-4#1)(2012-2#1)
three times as##2##3##(1991-2#1)(1995-2#1)
three times before##2##3##(1996-5#1)(2008-10#1)
three times during the##4##4##(2008-10#3)(2008-12#1)
three times greater than##2##4##(1990-9#1)(2008-10#1)
three times greater##3##3##(1990-9#1)(2008-10#2)
three times more##5##3##(1991-2#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
three times per week##2##4##(2008-1#1)(2008-10#1)
three times per##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
three times standard deviation of the blank##2##7##(2008-10#2)
three times the standard deviation of the blank##5##8##(2008-10#5)
three times the standard deviation of the##9##7##(2008-10#9)
three times the standard deviation of##12##6##(2008-10#12)
three times the standard deviation##13##5##(2008-10#13)
three times the##16##3##(1992-3#1)(2008-10#13)(2008-2#1)(2008-8#1)
three times##72##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
three to five times##2##4##(2008-10#2)
three to five##5##3##(1992-5#1)(1994-9#1)(2008-10#2)(2009-8#1)
three to four##4##3##(1991-8#1)(2008-10#3)
three to##13##2##(1991-8#1)(1992-5#1)(1993-6#1)(1994-9#1)(1997-3#1)(2008-10#6)(2008-5#1)(2009-8#1)
three tomato##4##2##(2008-10#4)
three traits##4##2##(2008-10#2)(2008-12#1)(2008-8#1)
three transcription factors##2##3##(2008-11#1)(2013-8#1)
three treatment##3##2##(1997-3#1)(2009-7#1)(2010-11#1)
three treatments were##2##3##(2008-10#2)
three treatments##3##2##(2008-10#2)(2008-5#1)
three trials on##2##3##(2008-10#1)(2008-12#1)
three trials##7##2##(2008-10#3)(2008-12#3)(2010-8#1)
three types of friends##2##4##(2009-7#2)
three types of##33##3##(1991-5#1)(1995-11#2)(1996-2#3)(2007-12#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#3)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
three types##36##2##(1991-5#1)(1995-11#2)(1996-2#3)(1996-6#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-7#3)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
three units##2##2##(1991-2#2)
three unrelated##3##2##(1991-12#1)(2008-10#2)
three variables##3##2##(1995-1#1)(2008-12#1)(2008-7#1)
three varieties of##2##3##(2008-12#1)(2008-9#1)
three varieties##4##2##(2008-12#3)(2008-9#1)
three villages##2##2##(2008-10#2)
three viruses##4##2##(2008-10#4)
three was##3##2##(2008-10#3)
three week##2##2##(1994-6#1)(2008-5#1)
three weeks##11##2##(1991-3#1)(1991-6#1)(1995-2#1)(1996-3#1)(1996-6#1)(2008-5#2)(2008-9#1)(2011-2#2)(2012-12#1)
three were##7##2##(1997-8#1)(2008-10#5)(2008-5#1)
three wheat##2##2##(2008-10#2)
three with##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
three workshops##2##2##(2008-12#2)
three years in##2##3##(1990-8#1)(1991-6#1)
three years later##2##3##(1991-6#2)
three years of age##3##4##(2008-11#1)(2008-9#1)(2012-3#1)
three years of##5##3##(1995-1#2)(2008-11#1)(2008-9#1)(2012-3#1)
three years##20##2##(1990-8#1)(1991-6#4)(1993-3#1)(1993-9#1)(1994-6#1)(1995-1#2)(1996-9#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#2)
three##2425##1##(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#3)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#3)(1991-11#7)(1991-12#9)(1991-2#17)(1991-3#11)(1991-5#10)(1991-6#16)(1991-7#5)(1991-8#3)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#8)(1992-4#7)(1992-5#4)(1992-6#3)(1992-9#4)(1993-1#3)(1993-11#3)(1993-12#8)(1993-2#11)(1993-3#6)(1993-6#14)(1993-8#6)(1993-9#4)(1994-1#4)(1994-11#4)(1994-12#9)(1994-2#6)(1994-3#11)(1994-5#9)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#5)(1995-11#6)(1995-12#20)(1995-2#15)(1995-3#5)(1995-5#5)(1995-6#14)(1995-8#7)(1995-9#2)(1996-1#8)(1996-11#3)(1996-12#20)(1996-2#12)(1996-3#5)(1996-5#6)(1996-6#12)(1996-8#5)(1996-9#7)(1997-1#9)(1997-2#8)(1997-3#16)(1997-4#5)(1997-5#4)(1997-6#6)(1997-7#6)(1997-8#17)(1997-9#4)(2006-6#2)(2007-11#2)(2007-12#16)(2008-1#7)(2008-10#943)(2008-11#140)(2008-12#56)(2008-2#5)(2008-3#28)(2008-4#14)(2008-5#73)(2008-6#13)(2008-7#52)(2008-8#63)(2008-9#68)(2009-1#1)(2009-10#11)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#2)(2009-5#3)(2009-6#5)(2009-7#13)(2009-8#10)(2009-9#2)(2010-1#3)(2010-10#9)(2010-11#15)(2010-12#18)(2010-2#2)(2010-3#2)(2010-4#9)(2010-5#7)(2010-6#5)(2010-7#7)(2010-8#17)(2010-9#3)(2011-1#12)(2011-2#71)(2011-3#11)(2012-12#13)(2012-2#43)(2012-3#35)(2012-5#5)(2012-6#2)(2012-7#3)(2012-8#2)(2012-9#3)(2013-1#57)(2013-8#35)
three- to##2##2##(1993-2#1)(1997-3#1)
three-##5##1##(1993-2#1)(1997-3#1)(2008-10#2)(2008-9#1)
three-by-three-tree quadrats##2##2##(2008-10#2)
three-channel##2##1##(1995-3#1)(2008-10#1)
three-color##3##1##(2008-4#1)(2008-9#2)
three-component##3##1##(2008-10#2)(2012-3#1)
three-day##3##1##(1991-2#1)(1997-8#1)(2011-2#1)
three-dimensional (3-D)##9##2##(2008-11#1)(2008-3#3)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
three-dimensional (3D) structure of##2##4##(2008-8#2)
three-dimensional (3D)##14##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#2)(2009-11#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#1)(2012-4#1)
three-dimensional CT angiography##2##3##(2008-7#2)
three-dimensional aggregate##2##2##(2008-10#1)(2008-11#1)
three-dimensional arrangement of##2##3##(1995-6#1)(2008-7#1)
three-dimensional cultures##2##2##(2008-11#1)(2012-4#1)
three-dimensional display##2##2##(2008-3#2)
three-dimensional growth and##3##3##(2008-10#1)(2008-11#2)
three-dimensional hematopoietic##2##2##(2008-11#2)
three-dimensional imaging##4##2##(2008-10#1)(2008-2#2)(2008-9#1)
three-dimensional model##2##2##(1991-6#1)(2008-5#1)
three-dimensional network##2##2##(2008-7#1)(2012-2#1)
three-dimensional object##2##2##(2008-3#2)
three-dimensional quantitative##2##2##(2009-3#1)(2011-3#1)
three-dimensional reconstruction##2##2##(2008-3#1)(2011-7#1)
three-dimensional structure of the##2##4##(1993-8#1)(2008-7#1)
three-dimensional structure of##7##3##(1991-12#1)(1993-6#1)(1993-8#1)(1995-2#1)(2008-7#1)(2008-8#1)(2013-8#1)
three-dimensional structure##11##2##(1991-12#1)(1992-1#1)(1993-6#1)(1993-8#1)(1995-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
three-dimensional structures##2##2##(2008-3#1)(2008-9#1)
three-dimensional ultrasonography##2##2##(2013-1#2)
three-dimensional##139##1##(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-2#4)(1997-6#1)(2007-12#2)(2008-10#11)(2008-11#14)(2008-2#3)(2008-3#26)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#12)(2011-3#1)(2011-7#2)(2012-2#6)(2012-3#3)(2012-4#2)(2013-1#8)(2013-8#1)
three-drug##2##1##(1996-11#2)
three-electrode cell##2##2##(2008-10#2)
three-electrode system##3##2##(2008-10#3)
three-electrode##6##1##(2008-10#5)(2009-9#1)
three-fold##7##1##(1996-3#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)
three-fourths of the##4##3##(1994-1#1)(1995-1#1)(1997-2#1)(1997-5#1)
three-generation##4##1##(2008-10#3)(2009-12#1)
three-hole chromatomembrane cell##2##3##(2008-10#2)
three-hole##3##1##(2008-10#3)
three-judge panel##2##2##(1995-12#1)(1995-6#1)
three-layer##4##1##(2008-10#2)(2008-11#1)(2011-2#1)
three-layered##3##1##(2008-10#2)(2008-12#1)
three-level##5##1##(1994-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
three-line manifold##2##2##(2008-10#2)
three-mirror cavity##2##2##(2008-3#2)
three-mirror##3##1##(2008-3#3)
three-month##3##1##(1993-11#1)(1997-4#1)(2012-3#1)
three-parameter##2##1##(1992-1#1)(2008-6#1)
three-phase##2##1##(2008-10#1)(2013-1#1)
three-quarters##2##1##(1996-3#1)(2013-8#1)
three-spined##3##1##(2008-9#1)(2010-8#2)
three-step process##2##2##(2008-10#1)(2011-2#1)
three-step sequential extraction procedure for the fractionation of##2##8##(2008-10#2)
three-step sequential extraction procedure##4##4##(2008-10#4)
three-step sequential extraction##5##3##(2008-10#5)
three-step##11##1##(2008-10#7)(2008-8#1)(2011-2#2)(2013-1#1)
three-stranded##2##1##(1997-9#2)
three-wavelength Raman-lidar observations##2##3##(2008-3#2)
three-wavelength##4##1##(2008-3#4)
three-way data##7##2##(2008-10#7)
three-way partial least squares##2##4##(2008-10#2)
three-way solenoid valves##6##3##(2008-10#6)
three-way##31##1##(2008-10#30)(2013-1#1)
three-year educational programme##2##3##(2008-11#2)
three-year educational##3##2##(2008-11#3)
three-year period##2##2##(1997-3#1)(2012-2#1)
three-year##15##1##(1990-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-11#6)(2008-12#2)(2012-2#1)
threefold##12##1##(2008-10#5)(2008-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
three months##2##1##(2012-2#2)
threonine and##2##2##(1993-8#1)(1994-11#1)
threonine##18##1##(1991-12#1)(1993-8#2)(1994-11#2)(1996-2#1)(1997-8#6)(2008-10#3)(2008-4#1)(2008-5#1)(2013-7#1)
threshold and the##2##3##(2008-11#1)(2008-8#1)
threshold and##3##2##(1996-2#1)(2008-11#1)(2008-8#1)
threshold as##4##2##(2007-12#1)(2008-8#2)(2010-11#1)
threshold concentration of##3##3##(1993-12#1)(1995-11#1)(2008-10#1)
threshold concentration##7##2##(1990-8#1)(1992-9#1)(1993-12#3)(1995-11#1)(2008-10#1)
threshold concentrations##4##2##(1993-12#2)(2008-10#2)
threshold conditions##2##2##(2008-10#1)(2008-8#1)
threshold current##3##2##(2008-3#3)
threshold dose##2##2##(2008-10#1)(2012-12#1)
threshold effect##7##2##(2008-10#1)(2008-3#2)(2008-8#2)(2010-1#2)
threshold effects##2##2##(2008-7#1)(2008-9#1)
threshold for##16##2##(1994-2#1)(1995-11#1)(1995-2#2)(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#2)
threshold in##3##2##(2008-10#2)(2013-8#1)
threshold is##7##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#2)(2008-9#1)
threshold level##4##2##(2008-10#3)(2010-10#1)
threshold levels##3##2##(2008-10#2)(2008-9#1)
threshold limit##2##2##(1991-12#1)(2008-10#1)
threshold migration rate##2##3##(2008-8#2)
threshold of the##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
threshold of##19##2##(2008-10#8)(2008-3#5)(2009-11#1)(2011-2#2)(2012-2#1)(2012-9#1)(2013-1#1)
threshold value##7##2##(2008-10#6)(2009-8#1)
threshold values##4##2##(2008-10#4)
threshold was##6##2##(1996-2#1)(2008-10#5)
threshold##226##1##(1990-11#3)(1990-8#1)(1991-11#1)(1991-12#1)(1992-9#1)(1993-12#5)(1994-2#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-2#2)(1997-2#1)(2007-12#4)(2008-10#79)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#26)(2008-4#4)(2008-7#5)(2008-8#20)(2008-9#13)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#7)(2012-9#1)(2013-1#4)(2013-8#5)
thresholding##2##1##(2008-3#1)(2010-8#1)
thresholds and the##2##3##(2008-10#1)(2008-8#1)
thresholds and##5##2##(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#2)
thresholds are##4##2##(2008-4#1)(2008-8#1)(2012-2#2)
thresholds for##7##2##(1996-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)
thresholds in##2##2##(2011-2#1)(2013-8#1)
thresholds of##6##2##(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#2)
thresholds to##4##2##(1993-1#3)(2008-10#1)
thresholds##56##1##(1993-1#4)(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#10)(2008-7#1)(2008-8#5)(2008-9#8)(2010-10#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
thrips produced on##2##3##(2008-10#2)
thrips resistance##2##2##(2008-10#2)
thrips species##3##2##(2008-10#3)
thrips that##2##2##(2008-10#2)
thrips were##3##2##(2008-10#3)
thrips##42##1##(2007-12#1)(2008-10#38)(2009-8#3)
thrive in the##2##3##(1996-1#1)(1997-1#1)
thrive##11##1##(1992-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2010-6#2)(2011-1#1)(2012-2#1)(2012-3#1)
thriving##2##1##(1994-12#1)(2012-2#1)
throat specialists##3##2##(1990-12#1)(1993-2#2)
throat swabs were collected from##2##5##(2013-8#2)
throat##11##1##(1990-12#1)(1992-6#1)(1993-2#2)(1996-12#1)(2008-10#1)(2008-9#3)(2013-8#2)
thrombectomy with##2##2##(1996-6#1)(2013-8#1)
thrombectomy##7##1##(1996-6#1)(2011-2#4)(2013-8#2)
thrombendarterectomy##3##1##(2011-2#3)
thrombi##6##1##(1995-8#1)(2008-7#1)(2009-7#1)(2010-10#1)(2013-8#2)
thrombin binding##2##2##(1994-11#1)(2009-12#1)
thrombin inhibitor##3##2##(1994-5#1)(2008-5#1)(2013-1#1)
thrombin receptor##4##2##(1992-4#1)(1997-7#3)
thrombin stimulation##3##2##(1992-12#1)(1993-8#1)(1997-7#1)
thrombin##41##1##(1990-5#1)(1991-9#3)(1992-12#1)(1992-4#6)(1992-6#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#5)(1995-11#1)(1995-3#1)(1995-6#1)(1997-7#6)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2013-1#1)
thrombin-antithrombin##2##1##(1991-3#2)
thrombin-stimulated##4##1##(1993-8#2)(1995-11#1)(2008-8#1)
thrombo-embolic##4##1##(1997-6#2)(2008-12#1)(2008-7#1)
thrombocytes##5##1##(2013-1#5)
thrombocytopaenia##2##1##(2008-7#1)(2008-8#1)
thrombocytopenia and##3##2##(1991-11#1)(2008-10#1)(2013-1#1)
thrombocytopenia in##3##2##(1996-11#1)(2008-11#1)(2008-8#1)
thrombocytopenia##23##1##(1990-10#1)(1991-11#1)(1991-6#1)(1994-3#1)(1996-11#1)(2006-6#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#6)(2010-3#2)(2012-12#1)(2013-1#1)
thrombocytopenic purpura##2##2##(2006-6#1)(2009-7#1)
thrombocytopenic##3##1##(2006-6#2)(2009-7#1)
thromboembolic complications##4##2##(1990-9#1)(1997-6#1)(2013-1#2)
thromboembolic disease##4##2##(1996-3#1)(2010-10#1)(2012-2#2)
thromboembolic events##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
thromboembolic pulmonary hypertension##3##3##(2009-10#1)(2010-10#1)(2013-1#1)
thromboembolic pulmonary##4##2##(2009-10#1)(2010-10#2)(2013-1#1)
thromboembolic##20##1##(1990-9#1)(1992-9#1)(1994-3#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-10#4)(2010-3#1)(2012-2#2)(2013-1#4)(2013-8#1)
thromboembolism in##4##2##(2008-12#2)(2010-11#2)
thromboembolism##15##1##(1996-11#3)(2008-12#2)(2010-11#3)(2010-6#1)(2010-7#1)(2012-3#1)(2013-1#3)(2013-8#1)
thrombogenesis##3##1##(2006-6#2)(2013-1#1)
thrombogenic##5##1##(1994-5#1)(1996-9#2)(2008-6#1)(2008-8#1)
thrombolysis in##4##2##(1996-6#1)(2008-8#1)(2009-11#1)(2009-6#1)
thrombolysis of##2##2##(1997-3#1)(2013-8#1)
thrombolysis##13##1##(1996-6#5)(1997-3#1)(2008-5#1)(2008-8#1)(2009-11#2)(2009-6#1)(2013-8#2)
thrombolysis'##2##1##(2008-11#2)
thrombolytic agent##2##2##(2008-7#1)(2012-2#1)
thrombolytic therapy for patients with##4##5##(2008-11#3)(2009-11#1)
thrombolytic therapy in##2##3##(1994-6#1)(2008-8#1)
thrombolytic therapy##10##2##(1994-6#1)(1995-3#1)(1997-3#1)(2008-11#4)(2008-7#1)(2008-8#1)(2009-11#1)
thrombolytic##12##1##(1994-6#1)(1995-3#1)(1997-3#1)(2008-11#4)(2008-7#2)(2008-8#1)(2009-11#1)(2012-2#1)
thrombopoietin##2##1##(2008-8#2)
thromboprophylaxis##3##1##(2010-11#1)(2013-1#2)
thrombosed##4##1##(1995-11#1)(1996-3#1)(1997-3#2)
thromboses##5##1##(1997-5#1)(2010-1#1)(2011-2#3)
thrombosis and##11##2##(1992-12#1)(2006-6#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
thrombosis in a##2##3##(2009-1#1)(2013-1#1)
thrombosis in the##3##3##(2006-6#1)(2008-1#1)(2011-2#1)
thrombosis in vivo##2##3##(2006-6#1)(2008-9#1)
thrombosis in##14##2##(1992-9#1)(1996-6#1)(2006-6#2)(2008-1#1)(2008-9#3)(2009-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
thrombosis is##5##2##(1992-9#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-8#1)
thrombosis may##2##2##(1996-9#1)(2008-7#1)
thrombosis occurring##2##2##(2008-11#1)(2012-3#1)
thrombosis of a major trunk (MCA##2##6##(1997-3#2)
thrombosis of the##3##3##(1991-11#1)(1996-6#1)(1997-6#1)
thrombosis of##9##2##(1991-11#1)(1994-6#1)(1996-6#2)(1997-3#2)(1997-6#2)(2011-2#1)
thrombosis related to##2##3##(1994-3#1)(2010-6#1)
thrombosis##94##1##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#2)(1994-3#2)(1994-6#2)(1996-6#4)(1996-9#1)(1997-3#5)(1997-6#4)(2006-6#5)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#9)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#2)
thrombospondin 1##6##2##(1994-5#6)
thrombospondin##7##1##(1994-5#6)(2009-7#1)
thrombotic complications##2##2##(2008-5#1)(2011-2#1)
thrombotic endocarditis##4##2##(1996-11#4)
thrombotic occlusions##3##2##(2011-2#3)
thrombotic response##2##2##(2006-6#1)(2008-4#1)
thrombotic risk##3##2##(2008-12#1)(2010-11#1)(2010-3#1)
thrombotic vegetation##2##2##(2006-6#2)
thrombotic##27##1##(1996-11#4)(1997-1#1)(2006-6#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#6)(2012-3#1)(2013-8#3)
thromboxane A2##3##2##(1990-8#1)(1991-5#1)(2008-8#1)
thromboxane B2 concentration##2##3##(1990-12#2)
thromboxane B2##8##2##(1990-12#5)(1994-8#1)(1995-11#1)(2008-5#1)
thromboxane synthase##3##2##(1991-5#3)
thromboxane##19##1##(1990-12#6)(1990-8#1)(1991-5#4)(1992-12#1)(1993-3#2)(1994-8#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
thrombus formation at##2##3##(2006-6#2)
thrombus formation##12##2##(2006-6#8)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
thrombus in the##4##3##(2011-2#4)
thrombus in##7##2##(2008-7#1)(2008-9#1)(2011-2#5)
thrombus##33##1##(1992-9#1)(1997-6#1)(2006-6#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#5)(2008-9#2)(2009-2#1)(2011-2#8)(2012-2#1)(2013-1#1)(2013-8#1)
through &quot##2##2##(2008-8#1)(2013-7#1)
through 1984##3##2##(1990-6#1)(1991-3#1)(1993-3#1)
through 1986##4##2##(1991-12#2)(1991-2#1)(1991-3#1)
through 1987 for##2##3##(1991-12#1)(1993-12#1)
through 1987##4##2##(1991-12#1)(1993-1#1)(1993-12#2)
through 1988##6##2##(1990-5#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-3#1)(1996-3#1)
through 1989##3##2##(1992-12#2)(1994-2#1)
through 1996##5##2##(2008-10#4)(2008-9#1)
through 2001##2##2##(2008-10#2)
through 2003##2##2##(2008-10#1)(2008-7#1)
through 6##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
through April##2##2##(1992-6#1)(2008-10#1)
through August 1994##2##3##(1994-9#2)
through August##4##2##(1994-9#2)(2008-10#2)
through D)##2##2##(2008-10#1)(2012-2#1)
through December##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
through July##3##2##(2008-10#2)(2010-9#1)
through October##2##2##(2008-10#1)(2012-12#1)
through September##2##2##(1991-3#1)(2011-2#1)
through X-ray##2##2##(2008-10#1)(2013-8#1)
through a 0##2##3##(2008-10#2)
through a PTFE membrane into an acceptor stream##2##8##(2008-10#2)
through a case study##2##4##(2008-10#1)(2008-3#1)
through a combination of##4##4##(1994-3#1)(2008-10#1)(2008-11#2)
through a comparison with##2##4##(2008-10#1)(2013-1#1)
through a continuous##2##3##(1993-3#1)(2008-10#1)
through a critical##2##3##(2008-11#1)(2009-9#1)
through a detailed##2##3##(2008-10#1)(2011-7#1)
through a direct##2##3##(2008-8#1)(2008-9#1)
through a formal##2##3##(1994-12#2)
through a glass##2##3##(2008-10#2)
through a liquid membrane##3##4##(2008-10#3)
through a long##2##3##(2008-10#1)(2008-7#1)
through a mechanism##2##3##(2008-7#1)(2008-9#1)
through a membrane##2##3##(2008-10#2)
through a modification##2##3##(2008-10#2)
through a national##3##3##(1993-12#1)(1995-12#1)(2008-11#1)
through a novel##2##3##(2008-10#1)(2013-8#1)
through a post-transcriptional mechanism##2##4##(1992-1#2)
through a posterior##2##3##(2008-9#1)(2012-12#1)
through a posterolateral##2##3##(2010-12#1)(2010-3#1)
through a process that##3##4##(1994-2#1)(2008-10#2)
through a range of##2##4##(2008-11#1)(2008-12#1)
through a reaction coil to a##2##6##(2008-10#2)
through a reaction coil##3##4##(2008-10#3)
through a receptor##4##3##(1991-5#1)(1993-8#2)(1995-2#1)
through a retrospective##2##3##(1995-12#1)(2010-7#1)
through a sample##2##3##(2007-11#1)(2008-10#1)
through a series of##4##4##(1993-3#1)(1996-3#1)(2012-2#1)(2013-1#1)
through a single##2##3##(2008-10#2)
through a small##2##3##(1991-12#1)(2011-2#1)
through a variety of##3##4##(1994-12#1)(2008-11#1)(2008-9#1)
through a volar approach##2##4##(2008-9#2)
through a working##2##3##(2008-10#2)
through a##252##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-11#1)(1996-3#4)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#2)(2008-10#84)(2008-11#17)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#9)(2011-3#2)(2011-7#1)(2011-9#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#3)
through activation of##5##3##(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
through an analysis of##2##4##(2008-12#1)(2009-5#1)
through an electrochemical##2##3##(2008-10#2)
through an example##2##3##(2008-4#1)(2010-6#1)
through an experimental##2##3##(2008-3#2)
through an incision##2##3##(2012-12#2)
through an increase in##3##4##(1995-11#1)(1997-1#1)(2008-4#1)
through an interaction##2##3##(1992-6#1)(1995-2#1)
through an##69##2##(1990-11#1)(1992-6#1)(1992-8#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#3)
through analysis of##3##3##(2009-10#1)(2012-3#1)(2013-1#1)
through animal##2##2##(2008-10#1)(2011-2#1)
through anthesis##2##2##(2008-10#2)
through application##2##2##(2008-10#1)(2012-3#1)
through artificial##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
through behavioural testing##2##3##(2008-9#2)
through better##2##2##(2009-11#1)(2013-8#1)
through binding to the##3##4##(1995-2#2)(2008-9#1)
through binding to##4##3##(1995-2#2)(2008-11#1)(2008-9#1)
through binding##5##2##(1995-2#2)(2008-11#2)(2008-9#1)
through both the##2##3##(2008-10#1)(2009-7#1)
through both##9##2##(1990-12#1)(1991-3#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-2#1)
through breast milk##4##3##(2011-1#1)(2012-2#2)(2013-1#1)
through bulk potting mix##2##4##(2008-10#2)
through bulk##3##2##(2008-10#3)
through caecal microflora of rats##2##5##(1993-8#2)
through cell##5##2##(2008-10#3)(2008-11#1)(2011-3#1)
through changes in##5##3##(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
through charge##2##2##(1994-5#1)(2008-10#1)
through chemical##3##2##(2008-10#2)(2008-4#1)
through chimneys##3##2##(2008-9#3)
through community##2##2##(1996-3#1)(2008-11#1)
through community-based##2##2##(1995-1#1)(2008-10#1)
through comparison##2##2##(2008-10#2)
through comparisons##3##2##(2008-3#1)(2011-3#1)(2013-1#1)
through competitive exclusion##2##3##(2008-10#2)
through competitive##4##2##(1993-3#1)(2008-10#2)(2008-8#1)
through complex##2##2##(2008-10#1)(2011-2#1)
through continuous##2##2##(1993-1#1)(2012-7#1)
through correlation of##2##3##(2008-11#2)
through critical##2##2##(2008-11#1)(2010-10#1)
through cyclic voltammetry##2##3##(2008-10#2)
through different mechanisms##3##3##(1995-2#1)(1995-8#1)(2008-11#1)
through different##4##2##(1995-2#1)(1995-8#1)(2008-11#1)(2008-6#1)
through direct##4##2##(2008-10#3)(2008-11#1)
through directly##2##2##(1996-3#1)(2008-10#1)
through down-regulation of##2##3##(1993-6#1)(2011-2#1)
through drinking water##2##3##(2008-10#1)(2008-9#1)
through drip irrigation systems##4##4##(2008-10#4)
through early April##2##3##(1992-6#2)
through early##3##2##(1992-6#2)(2009-6#1)
through education##2##2##(1991-1#1)(2008-12#1)
through educational##2##2##(2008-11#2)
through effective##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
through either##3##2##(1993-8#1)(2008-8#1)(2010-8#1)
through endothelial cell monolayers##2##4##(2008-10#2)
through endothelial##3##2##(2008-10#3)
through enhancement of##2##3##(2008-11#1)(2010-10#1)
through ether-type polyurethane membrane##2##4##(2008-10#2)
through evolution##2##2##(2008-10#1)(2011-2#1)
through examining##2##2##(2008-11#1)(2011-1#1)
through expert##2##2##(2008-7#1)(2011-2#1)
through family##2##2##(2010-7#1)(2013-8#1)
through field##2##2##(2008-10#1)(2008-11#1)
through four##3##2##(1994-3#1)(1996-3#1)(2008-11#1)
through full sib-pair mating##2##4##(2012-3#2)
through genetic##4##2##(2008-10#3)(2011-2#1)
through health care##2##3##(1991-3#1)(1995-2#1)
through health##3##2##(1991-3#1)(1994-1#1)(1995-2#1)
through homologous##2##2##(2008-8#1)(2011-2#1)
through improved##2##2##(1993-12#1)(1995-2#1)
through in##4##2##(2009-10#1)(2009-7#1)(2009-9#1)(2010-8#1)
through incorporation##2##2##(2008-10#1)(2008-11#1)
through increased##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
through increasing##2##2##(1991-5#1)(2008-8#1)
through induced##2##2##(1991-3#1)(2008-10#1)
through induction of##2##3##(1993-8#1)(2008-10#1)
through induction##3##2##(1993-8#1)(1997-1#1)(2008-10#1)
through inhibition of##3##3##(1994-11#1)(2013-1#2)
through intact##3##2##(2008-5#2)(2008-9#1)
through integrating##2##2##(2011-2#1)(2012-2#1)
through interaction with the##2##4##(1994-12#1)(1996-2#1)
through interaction with##3##3##(1993-6#1)(1994-12#1)(1996-2#1)
through its effects on##2##4##(2008-12#1)(2012-3#1)
through its##20##2##(1990-12#1)(1991-5#2)(1992-2#1)(1993-6#1)(1994-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-3#1)(2013-1#1)
through large##2##2##(2007-11#1)(2011-2#1)
through large-core optical fibers##2##4##(2008-3#2)
through loss of##2##3##(1996-5#1)(2012-3#1)
through loss##3##2##(1996-5#1)(2011-2#1)(2012-3#1)
through male##2##2##(2008-8#2)
through many##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
through measurement of##2##3##(2008-3#1)(2009-5#1)
through measuring the##2##3##(1995-3#1)(2008-10#1)
through measuring##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
through mechanisms such as##2##4##(1997-2#1)(2008-11#1)
through mechanisms that##2##3##(2008-11#1)(2013-1#1)
through mechanisms##5##2##(1997-2#1)(2008-10#1)(2008-11#2)(2013-1#1)
through membrane##3##2##(2008-10#3)
through metabolic##2##2##(2008-11#1)(2009-5#1)
through minimally invasive##2##3##(2008-9#1)(2013-1#1)
through mitosis##2##2##(1995-2#1)(2009-8#1)
through modification of##2##3##(2008-10#1)(2013-1#1)
through modulation of##4##3##(1992-6#2)(2012-3#1)(2013-8#1)
through molecular##5##2##(1991-5#1)(2008-10#3)(2012-2#1)
through monitoring##2##2##(2008-10#2)
through more than##2##3##(2008-5#1)(2010-1#1)
through more##3##2##(2008-11#1)(2008-5#1)(2010-1#1)
through most##2##2##(1992-5#1)(2013-8#1)
through mouth and##2##3##(2008-11#1)(2011-2#1)
through multiple##6##2##(1992-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-10#1)
through multivariate##2##2##(2008-10#1)(2009-4#1)
through new##2##2##(1991-1#1)(2010-4#1)
through novel##2##2##(2008-10#1)(2008-8#1)
through nuclear##4##2##(1994-6#1)(2008-11#1)(2011-2#2)
through numerous##2##2##(1996-9#1)(2011-1#1)
through observation##2##2##(1991-1#1)(2012-3#1)
through octadecyl silica membrane disks modified with##2##7##(2008-10#2)
through one##2##2##(1997-6#1)(2008-10#1)
through ontogeny##3##2##(2010-8#3)
through optical##2##2##(2008-2#1)(2008-5#1)
through oral##2##2##(2008-11#1)(2008-7#1)
through orange to red (very##2##5##(2012-2#2)
through other##2##2##(1997-2#1)(2008-10#1)
through pH##2##2##(2008-10#1)(2008-9#1)
through partnership working##2##3##(2008-11#2)
through passive neutral membranes##2##4##(2008-10#2)
through passive##3##2##(2008-10#2)(2012-12#1)
through periodic##3##2##(1991-12#1)(2007-12#1)(2008-10#1)
through phosphorylation##2##2##(1997-1#1)(2008-11#1)
through plaque##2##2##(2013-8#2)
through pollen##3##2##(2008-10#1)(2008-8#2)
through primary##2##2##(1991-8#1)(2008-7#1)
through professional##2##2##(1994-12#1)(2013-8#1)
through protein##2##2##(1992-11#1)(2011-2#1)
through protein-protein##2##2##(2008-4#1)(2011-3#1)
through quality##2##2##(1993-12#1)(1995-12#1)
through recent##2##2##(2008-7#1)(2009-10#1)
through recombination##2##2##(2008-10#1)(2011-2#1)
through reduced##2##2##(2008-5#1)(2008-9#1)
through reflection##2##2##(2008-11#2)
through reflective##2##2##(2008-11#2)
through regulation##3##2##(1991-3#1)(2011-2#1)(2013-1#1)
through research##4##2##(1992-1#1)(2008-1#1)(2008-12#1)(2008-4#1)
through restructuring##2##2##(1995-1#1)(2008-6#1)
through retrospective##2##2##(1996-6#1)(2012-3#1)
through seed##3##2##(2008-10#2)(2008-8#1)
through selection in##2##3##(2008-8#2)
through selection##3##2##(1995-5#1)(2008-8#2)
through selective##4##2##(1993-6#1)(1995-11#1)(2008-10#1)(2008-8#1)
through several##4##2##(1994-3#1)(2008-10#2)(2010-9#1)
through sexual##2##2##(2008-10#1)(2008-8#1)
through signaling##2##2##(2008-11#1)(2012-2#1)
through soil##3##2##(2008-10#3)
through specific##3##2##(1990-5#1)(1995-6#1)(2011-1#1)
through stomata##3##2##(2008-10#3)
through studies of##2##3##(2008-10#2)
through suppression of##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
through systemic##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
through targeting##2##2##(2007-11#1)(2008-11#1)
through the ASA##2##3##(1997-6#2)
through the Internet##3##3##(2008-10#1)(2010-8#2)
through the Shc SH2 domain##2##5##(1997-7#2)
through the action of##2##4##(1994-3#1)(2008-11#1)
through the activation of a##2##5##(1992-8#1)(1995-6#1)
through the activation of##3##4##(1992-8#1)(1995-6#1)(2009-12#1)
through the activity of##2##4##(2009-3#1)(2012-3#1)
through the addition of##2##4##(2008-10#1)(2009-9#1)
through the analysis of##4##4##(1992-9#1)(2008-10#3)
through the application of##4##4##(1992-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
through the authors'##2##3##(2008-11#1)(2009-11#1)
through the cell cycle##3##4##(1993-8#1)(2008-11#1)(2008-9#1)
through the cell##8##3##(1993-8#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-9#1)
through the column##6##3##(2008-10#5)(2008-9#1)
through the combination of##5##4##(2008-10#3)(2008-11#1)(2008-3#1)
through the course of##2##4##(1997-6#1)(2008-10#1)
through the cuticle and##2##4##(2008-10#2)
through the cuticle##3##3##(2007-12#1)(2008-10#2)
through the deployment of##2##4##(2008-10#2)
through the detector##2##3##(2008-10#2)
through the determination of the##3##5##(2008-10#3)
through the determination of##5##4##(2008-10#5)
through the development of##2##4##(1993-12#1)(2008-11#1)
through the development##3##3##(1993-12#1)(2008-11#2)
through the device##2##3##(2008-10#2)
through the effects of##2##4##(1992-3#1)(2008-8#1)
through the entire##2##3##(1992-6#1)(1996-6#1)
through the epidermal##2##3##(2008-10#2)
through the epidermis##2##3##(2008-10#2)
through the eyes##2##3##(2008-1#1)(2009-10#1)
through the fiber##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
through the flood water##2##4##(2008-10#2)
through the flow cell##3##4##(2008-10#3)
through the flow##4##3##(2008-10#4)
through the food chain##2##4##(2008-10#1)(2013-8#1)
through the formation of a##2##5##(2008-10#2)
through the formation of##5##4##(2008-10#5)
through the implementation of##3##4##(1997-7#1)(2008-10#1)(2008-11#1)
through the inclusion of##2##4##(2008-10#1)(2010-1#1)
through the inhibition of##4##4##(1993-11#1)(1993-8#1)(2008-11#1)(2009-12#1)
through the interaction##2##3##(2008-10#1)(2012-3#1)
through the interpretation##2##3##(1995-12#1)(2010-9#1)
through the introduction of##2##4##(2008-10#2)
through the left##2##3##(1991-12#1)(2008-12#1)
through the liquid membrane##2##4##(2008-10#2)
through the loss of##2##4##(2008-10#1)(2008-11#1)
through the membrane##5##3##(1995-6#1)(2008-10#4)
through the microcolumn##2##3##(2008-10#2)
through the microdialysis probe##2##4##(1997-2#1)(2008-10#1)
through the ovarian stroma##2##4##(2008-12#2)
through the ovarian##3##3##(2008-12#3)
through the peritoneal membrane##3##4##(2008-10#3)
through the plant##2##3##(2008-10#2)
through the plasma##2##3##(1994-3#1)(2010-10#1)
through the population##3##3##(2009-6#1)(2012-3#1)(2013-8#1)
through the process of##3##4##(2008-11#1)(2008-9#1)(2012-2#1)
through the production of##3##4##(2008-10#2)(2012-3#1)
through the promotion of##2##4##(2008-10#1)(2013-1#1)
through the provision of##2##4##(1997-2#1)(2010-10#1)
through the reaction##3##3##(2008-10#2)(2011-2#1)
through the right##2##3##(2008-11#2)
through the root##2##3##(2008-10#2)
through the rotation of##2##4##(1993-3#1)(2008-8#1)
through the sensing##2##3##(2008-10#1)(2009-5#1)
through the skin##3##3##(2008-10#2)(2008-5#1)
through the specific##2##3##(2008-10#1)(2009-7#1)
through the stem##3##3##(2008-10#3)
through the strong##2##3##(2008-10#2)
through the study of##2##4##(2008-10#1)(2008-7#1)
through the stylar canal and##2##5##(2008-10#2)
through the stylar canal##3##4##(2008-10#3)
through the surface##2##3##(2008-10#1)(2008-3#1)
through the test section##3##4##(2008-3#3)
through the two##2##3##(2008-10#2)
through the use of a##2##5##(2008-10#1)(2008-4#1)
through the use of an##2##5##(1996-1#1)(2008-10#1)
through the use of##22##4##(1991-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#3)(2010-7#1)(2011-3#1)
through the use##23##3##(1991-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#3)(2010-7#1)(2011-3#1)(2012-12#1)
through the waveguide##2##3##(2008-3#2)
through the year 2000##2##4##(1991-9#1)(1995-6#1)
through the year##4##3##(1991-9#1)(1995-6#1)(1996-2#1)(2008-9#1)
through the##509##2##(1990-11#2)(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-3#4)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#4)(1993-8#2)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#2)(1995-6#4)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#2)(1997-1#6)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#9)(1997-7#7)(1997-8#2)(2007-12#6)(2008-1#2)(2008-10#182)(2008-11#27)(2008-12#17)(2008-2#1)(2008-3#16)(2008-4#4)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#17)(2011-3#2)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#12)(2013-8#6)
through their ability to##2##4##(1996-1#1)(2011-2#1)
through their roots showed##2##4##(2008-10#2)
through their roots##3##3##(2008-10#3)
through their##22##2##(1990-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-2#1)(2008-10#7)(2008-5#2)(2008-8#2)(2010-6#1)(2010-8#1)(2011-2#2)
through these##4##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
through thin##2##2##(1997-6#1)(2008-3#1)
through this##10##2##(1992-8#1)(1994-2#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-8#1)(2011-10#1)
through three##6##2##(1995-12#1)(1996-1#1)(2008-10#2)(2008-8#1)(2009-8#1)
through time##9##2##(2008-10#5)(2008-5#2)(2008-8#1)(2011-2#1)
through time)##2##2##(1992-9#1)(2008-10#1)
through to##4##2##(1995-3#1)(2010-11#1)(2010-12#1)(2013-1#1)
through tunnels##2##2##(2009-10#2)
through two##5##2##(1997-4#1)(2008-10#2)(2008-7#1)(2011-3#1)
through ultrasound##2##2##(2012-3#1)(2013-1#1)
through use of##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
through various##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
through vertical##2##2##(2008-2#1)(2008-3#1)
through videoconferencing##2##2##(2008-11#2)
through volume and limit of detection##3##6##(2008-10#3)
through volume##4##2##(2008-10#4)
through water##3##2##(2008-10#2)(2008-8#1)
through which the##5##3##(2008-10#4)(2012-2#1)
through which##25##2##(1990-8#1)(1993-12#2)(1994-5#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
through wounds##2##2##(2008-10#2)
through##2024##1##(1990-11#4)(1990-12#6)(1990-2#3)(1990-5#5)(1990-6#1)(1990-8#1)(1991-1#7)(1991-10#1)(1991-11#1)(1991-12#12)(1991-2#4)(1991-3#14)(1991-5#7)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#8)(1992-11#4)(1992-12#7)(1992-2#1)(1992-3#5)(1992-5#3)(1992-6#11)(1992-8#3)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#13)(1993-3#16)(1993-5#1)(1993-6#5)(1993-8#10)(1993-9#1)(1994-1#9)(1994-11#11)(1994-12#15)(1994-2#12)(1994-3#16)(1994-5#6)(1994-6#3)(1994-8#7)(1994-9#3)(1995-1#8)(1995-11#8)(1995-12#16)(1995-2#18)(1995-3#7)(1995-5#1)(1995-6#14)(1995-8#6)(1995-9#1)(1996-1#10)(1996-11#3)(1996-12#4)(1996-2#9)(1996-3#15)(1996-5#11)(1996-6#3)(1996-9#1)(1997-1#16)(1997-2#10)(1997-3#7)(1997-4#3)(1997-6#12)(1997-7#9)(1997-8#7)(2006-6#1)(2007-11#4)(2007-12#22)(2007-9#2)(2008-1#10)(2008-10#592)(2008-11#134)(2008-12#51)(2008-2#8)(2008-3#48)(2008-4#22)(2008-5#43)(2008-6#12)(2008-7#37)(2008-8#72)(2008-9#56)(2009-1#1)(2009-10#15)(2009-11#4)(2009-12#7)(2009-3#3)(2009-4#4)(2009-5#7)(2009-6#4)(2009-7#13)(2009-8#14)(2009-9#9)(2010-1#8)(2010-10#14)(2010-11#5)(2010-12#5)(2010-3#2)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#11)(2010-8#17)(2010-9#8)(2011-1#5)(2011-10#1)(2011-2#80)(2011-3#10)(2011-7#2)(2011-9#1)(2012-10#1)(2012-12#16)(2012-2#36)(2012-3#36)(2012-7#2)(2013-1#65)(2013-7#3)(2013-8#34)
through-put of##2##2##(2008-10#2)
through-thickness##4##1##(2009-7#4)
throughout Europe##2##2##(2008-10#1)(2008-7#1)
throughout India##2##2##(2008-10#1)(2011-2#1)
throughout Russia##2##2##(1997-1#1)(2008-12#1)
throughout a##8##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
throughout all##3##2##(1997-2#1)(2008-9#1)(2011-2#1)
throughout an##4##2##(1993-12#1)(2008-10#1)(2008-5#1)(2010-10#1)
throughout both studies##3##3##(2008-9#3)
throughout both##5##2##(1991-12#1)(1997-7#1)(2008-9#3)
throughout childhood##2##2##(2009-8#1)(2013-8#1)
throughout development##4##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-9#1)
throughout each##3##2##(2008-10#1)(2013-8#2)
throughout evolution##5##2##(1993-12#2)(2008-7#1)(2011-2#1)(2012-2#1)
throughout its##2##2##(2008-10#1)(2008-2#1)
throughout life##3##2##(2010-11#1)(2010-9#1)(2012-2#1)
throughout most of##2##3##(2008-10#1)(2008-9#1)
throughout much of##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
throughout pregnancy##2##2##(1994-3#1)(1996-11#1)
throughout the United States and##2##5##(2008-10#2)
throughout the United States##7##4##(1995-12#1)(1996-12#1)(2008-10#4)(2013-1#1)
throughout the United##8##3##(1995-12#1)(1996-12#1)(2008-10#4)(2013-1#1)(2013-8#1)
throughout the body##3##3##(1996-1#1)(1997-1#1)(2008-12#1)
throughout the cell##2##3##(1995-2#1)(2009-8#1)
throughout the country##6##3##(1995-1#1)(1996-1#1)(2008-11#2)(2013-1#2)
throughout the course and##2##4##(2008-11#2)
throughout the course##5##3##(1992-6#1)(2008-11#3)(2008-7#1)
throughout the culture period##2##4##(2008-11#2)
throughout the culture##3##3##(2008-11#3)
throughout the cytoplasm##2##3##(2008-11#1)(2013-1#1)
throughout the entire##5##3##(1992-12#1)(1996-12#2)(2008-10#1)(2008-3#1)
throughout the experiment##3##3##(2008-10#2)(2008-11#1)
throughout the genome##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
throughout the grazing period##2##4##(1996-12#2)
throughout the grazing##3##3##(1996-12#3)
throughout the growing season##6##4##(2008-10#6)
throughout the life##2##3##(2008-10#1)(2008-7#1)
throughout the organization##5##3##(1992-12#1)(1994-1#1)(1995-1#1)(1996-1#1)(1997-1#1)
throughout the period##2##3##(1992-3#1)(2008-5#1)
throughout the plant##2##3##(2008-10#2)
throughout the plot##2##3##(2008-10#2)
throughout the procedure##3##3##(1992-1#1)(2010-7#2)
throughout the range of##2##4##(2008-3#1)(2012-3#1)
throughout the research##2##3##(2010-8#1)(2013-1#1)
throughout the soil profile##2##4##(2008-10#2)
throughout the study period##3##4##(2008-10#2)(2008-8#1)
throughout the study##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
throughout the system##2##3##(1992-1#1)(1994-1#1)
throughout the world##22##3##(1990-11#1)(1994-9#1)(1996-1#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)
throughout the year with##3##4##(2008-10#3)
throughout the year##9##3##(1991-12#1)(2008-10#6)(2008-5#1)(2013-8#1)
throughout the##209##2##(1990-11#1)(1991-12#3)(1991-5#2)(1992-1#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#6)(1996-12#7)(1996-2#3)(1997-1#4)(1997-3#3)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#63)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#10)(2008-8#5)(2008-9#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#7)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#7)(2013-8#4)
throughout their##4##2##(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
throughout this paper##2##3##(1992-12#1)(2008-11#1)
throughout this##5##2##(1991-5#1)(1992-12#1)(1995-2#1)(2008-11#1)(2010-10#1)
throughout##314##1##(1990-11#1)(1990-3#1)(1991-12#4)(1991-5#3)(1992-1#3)(1992-12#3)(1992-3#2)(1992-6#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-8#1)(1994-1#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#7)(1996-11#1)(1996-12#7)(1996-2#3)(1997-1#5)(1997-2#2)(1997-3#3)(1997-7#3)(2007-12#2)(2008-1#1)(2008-10#90)(2008-11#21)(2008-12#9)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#15)(2008-8#9)(2008-9#9)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#15)(2012-12#1)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#7)(2013-8#11)
throughput analysis of##2##3##(2008-10#1)(2008-4#1)
throughput and##6##2##(2008-10#5)(2009-4#1)
throughput for the##2##3##(2008-10#2)
throughput is##5##2##(2008-10#5)
throughput of 10h(-1)##3##3##(2008-10#3)
throughput of 20 samples##2##4##(2008-10#2)
throughput of 20##4##3##(2008-10#4)
throughput of 25h(-1)##2##3##(2008-10#2)
throughput of 40##3##3##(2008-10#3)
throughput of 50##2##3##(2008-10#2)
throughput of 60##2##3##(2008-10#2)
throughput of the##4##3##(2008-10#4)
throughput of##48##2##(2008-10#47)(2008-11#1)
throughput rate##4##2##(2008-10#4)
throughput screening##4##2##(2008-10#4)
throughput technologies##2##2##(2008-11#1)(2012-3#1)
throughput was 20##2##3##(2008-10#2)
throughput was##16##2##(2007-9#1)(2008-10#15)
throughput##139##1##(1992-11#1)(1997-6#1)(2007-11#1)(2007-9#1)(2008-10#119)(2008-11#5)(2008-4#2)(2009-4#2)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#3)
throughputs##3##1##(2008-10#3)
throw light on##2##3##(1992-8#1)(2010-3#1)
throw##4##1##(1992-8#1)(2008-10#1)(2008-11#1)(2010-3#1)
thrown##3##1##(2008-11#1)(2009-10#1)(2011-2#1)
thrush##2##1##(2008-9#2)
thrust manipulation and##3##3##(2008-12#3)
thrust manipulation##5##2##(2008-12#5)
thrust##13##1##(1994-1#1)(1994-9#1)(1997-7#1)(2008-12#6)(2008-2#1)(2010-8#2)(2013-1#1)
thulium-doped##3##1##(2008-2#1)(2008-3#2)
thumb spica##2##2##(2008-9#2)
thumb##24##1##(1995-12#1)(1996-2#2)(2008-12#1)(2008-8#3)(2008-9#10)(2009-10#1)(2010-6#4)(2010-7#2)
thumbs##2##1##(2008-12#1)(2012-3#1)
thuringiensis##10##1##(1993-12#2)(1993-8#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-9#1)
thus a##13##2##(1991-5#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
thus aiding##2##2##(2008-11#1)(2010-12#1)
thus allowing##7##2##(1993-12#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-12#1)
thus also##3##2##(2008-3#1)(2008-8#2)
thus apparently##2##2##(2008-10#1)(2010-2#1)
thus appear to##3##3##(1992-6#1)(2007-11#1)(2008-10#1)
thus appears to##3##3##(1990-5#1)(1993-12#1)(1993-9#1)
thus appears##4##2##(1990-5#1)(1993-12#1)(1993-9#1)(2008-7#1)
thus assuring##2##2##(2008-10#1)(2008-5#1)
thus avoiding the##3##3##(2008-10#2)(2010-8#1)
thus avoiding##5##2##(1991-8#1)(2008-10#3)(2010-8#1)
thus be used for##2##4##(2008-10#2)
thus be used##4##3##(2008-10#3)(2008-11#1)
thus be##13##2##(1994-11#1)(1995-3#1)(2008-10#5)(2008-11#3)(2011-2#1)(2012-2#1)(2013-1#1)
thus become##2##2##(2006-6#1)(2008-10#1)
thus been##2##2##(1990-2#1)(1995-6#1)
thus being##2##2##(2008-10#1)(2012-3#1)
thus can be used##3##4##(2008-11#2)(2012-3#1)
thus can be##5##3##(2008-11#2)(2008-5#1)(2008-8#1)(2012-3#1)
thus can##6##2##(1993-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2012-3#1)
thus confirming##3##2##(1994-6#1)(2008-10#1)(2012-6#1)
thus considered to##2##3##(2008-11#1)(2010-3#1)
thus constitute##2##2##(1990-11#1)(2009-10#1)
thus constructed##2##2##(2008-11#1)(2008-8#1)
thus contribute to##2##3##(2008-10#1)(2008-5#1)
thus contributing to##2##3##(2008-10#1)(2013-1#1)
thus creating a##2##3##(1991-6#1)(2008-10#1)
thus creating##3##2##(1990-5#1)(1991-6#1)(2008-10#1)
thus decreasing the##2##3##(2008-10#1)(2008-3#1)
thus decreasing##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
thus demonstrating the##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
thus determined##5##2##(1993-11#1)(1994-5#1)(2008-10#3)
thus do not##2##3##(2008-11#1)(2012-3#1)
thus eliminating the##2##3##(2008-10#1)(2010-1#1)
thus enabling##3##2##(2008-10#2)(2008-11#1)
thus ensuring##3##2##(2008-12#1)(2008-3#1)(2010-7#1)
thus established##2##2##(2008-10#1)(2008-11#1)
thus examined##2##2##(1995-2#1)(2008-7#1)
thus facilitating the##2##3##(2008-10#1)(2008-7#1)
thus facilitating##7##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
thus far in the##2##4##(2008-10#1)(2011-2#1)
thus far in##4##3##(2008-10#2)(2009-8#1)(2011-2#1)
thus far reported##3##3##(1993-6#1)(2008-10#1)(2008-2#1)
thus far##20##2##(1991-12#1)(1993-6#1)(1994-12#1)(1996-2#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
thus formed##4##2##(2008-10#3)(2008-7#1)
thus forming##2##2##(1994-5#1)(2009-8#1)
thus generated##2##2##(1995-12#1)(2008-11#1)
thus giving##2##2##(2008-10#1)(2009-1#1)
thus greatly##2##2##(2008-10#1)(2008-3#1)
thus has##2##2##(2008-10#1)(2010-5#1)
thus have##3##2##(1993-8#1)(2007-9#1)(2008-8#1)
thus identifying##2##2##(1995-9#1)(2011-3#1)
thus illustrating the##2##3##(1997-2#1)(2008-10#1)
thus implying##2##2##(2008-11#1)(2008-8#1)
thus improving##5##2##(1994-6#1)(2008-10#2)(2008-11#1)(2012-2#1)
thus increasing the##4##3##(1993-2#1)(1995-1#1)(1997-1#1)(2008-10#1)
thus increasing##5##2##(1993-2#1)(1995-1#1)(1997-1#1)(2008-10#2)
thus indicate that##3##3##(1990-5#1)(1995-2#1)(2008-10#1)
thus indicate##5##2##(1990-5#1)(1995-2#2)(1996-5#1)(2008-10#1)
thus indicating a##3##3##(1992-12#1)(1995-11#1)(2008-10#1)
thus indicating the possibility of using mild conditions for sample preparation instead of intensive treatments inherent with the digestion##2##19##(2008-10#2)
thus indicating the possibility of using##3##6##(2008-10#3)
thus indicating the##4##3##(2008-10#4)
thus indicating##9##2##(1991-5#1)(1992-12#1)(1995-11#1)(2008-10#5)(2010-6#1)
thus it##7##2##(1994-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-12#1)
thus leading to##2##3##(2011-2#2)
thus leading##5##2##(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#2)
thus likely to have##2##4##(1995-5#1)(2008-8#1)
thus likely##4##2##(1994-12#1)(1995-5#1)(2008-8#1)(2011-2#1)
thus limiting##2##2##(1997-1#1)(1997-2#1)
thus making it##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
thus making the##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
thus making##12##2##(1991-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
thus many##2##2##(1991-6#1)(2008-11#1)
thus may be##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
thus may##6##2##(1995-11#1)(1995-9#1)(1996-2#1)(2008-10#1)(2008-8#1)(2012-3#1)
thus minimizing##3##2##(2008-10#2)(2011-9#1)
thus not##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
thus obtained was##2##3##(1991-5#1)(2008-10#1)
thus obtained##8##2##(1990-3#1)(1991-5#1)(1996-5#1)(2008-10#5)
thus offering##2##2##(2008-5#1)(2011-2#1)
thus overcoming##3##2##(2008-10#2)(2008-4#1)
thus permitting##4##2##(2008-10#3)(2008-7#1)
thus playing a##2##3##(2009-9#1)(2013-1#1)
thus possible to##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
thus preventing##3##2##(1991-2#1)(2008-10#1)(2012-2#1)
thus proposed##2##2##(2008-8#1)(2011-2#1)
thus provide the##2##3##(1995-8#1)(2008-4#1)
thus provide##5##2##(1995-8#1)(2008-4#1)(2008-8#1)(2009-10#1)(2013-1#1)
thus provided##2##2##(2008-10#1)(2008-8#1)
thus provides a##2##3##(1995-6#1)(2008-10#1)
thus provides##4##2##(1995-6#1)(1997-6#1)(2008-10#1)(2012-2#1)
thus providing a##5##3##(1995-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)
thus providing evidence that##3##4##(2008-10#2)(2008-11#1)
thus providing##14##2##(1995-1#1)(1995-3#1)(2008-10#5)(2008-11#4)(2008-9#1)(2010-10#1)(2012-2#1)
thus realized##2##2##(2008-10#2)
thus reducing the##2##3##(2008-10#1)(2009-8#1)
thus reducing##3##2##(2008-10#2)(2009-8#1)
thus rendering the##2##3##(2008-10#1)(2008-7#1)
thus rendering##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
thus representing a##2##3##(2008-5#1)(2008-8#1)
thus representing##3##2##(1996-5#1)(2008-5#1)(2008-8#1)
thus requiring an##2##3##(2008-10#2)
thus restricting##2##2##(2010-4#1)(2013-1#1)
thus showing the##2##3##(2008-10#1)(2011-2#1)
thus showing##4##2##(1993-8#1)(2008-10#1)(2011-2#2)
thus suggesting that the##2##4##(1995-2#1)(2008-7#1)
thus suggesting that##5##3##(1994-5#1)(1995-2#1)(1995-8#1)(2008-7#2)
thus suggesting##8##2##(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-7#3)(2012-3#1)
thus the##19##2##(1991-3#1)(1993-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#2)
thus they##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
thus to##7##2##(1996-12#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
thus was##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
thus##612##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#5)(1991-6#3)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#6)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#2)(1996-12#5)(1996-2#2)(1996-5#5)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-6#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#168)(2008-11#48)(2008-12#9)(2008-2#3)(2008-3#9)(2008-4#7)(2008-5#16)(2008-6#4)(2008-7#17)(2008-8#24)(2008-9#12)(2009-1#1)(2009-10#5)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#5)(2009-8#10)(2009-9#1)(2010-1#3)(2010-10#4)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#20)(2011-3#5)(2011-9#1)(2012-12#5)(2012-2#16)(2012-3#12)(2012-4#1)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#13)
thylakoid bioassay##3##2##(2008-11#3)
thylakoid membrane protein##3##3##(2008-8#3)
thylakoid membranes was##2##3##(1997-4#2)
thylakoid membranes##6##2##(1994-11#1)(1997-4#4)(2009-10#1)
thylakoid redox##2##2##(2009-10#2)
thylakoid##18##1##(1994-11#1)(1997-4#4)(2008-10#2)(2008-11#3)(2008-8#4)(2009-10#4)
thylakoids##3##1##(2008-11#1)(2009-10#1)(2009-7#1)
thymectomy and##2##2##(1997-5#1)(2008-5#1)
thymi##2##1##(1995-12#1)(2008-10#1)
thymic atrophy##4##2##(2008-10#4)
thymic dendritic cells##4##3##(2008-8#4)
thymic epithelial##2##2##(2008-8#1)(2012-12#1)
thymic involution##4##2##(1993-12#1)(2013-7#3)
thymic lymphosarcoma##2##2##(1995-11#2)
thymic medulla##2##2##(2008-8#2)
thymic##36##1##(1991-8#2)(1993-12#2)(1995-11#2)(1997-9#1)(2008-10#7)(2008-8#11)(2008-9#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-7#6)
thymidine analogue##2##2##(1993-11#1)(2013-1#1)
thymidine into##2##2##(1991-5#2)
thymidine kinase 1##2##3##(2011-2#2)
thymidine kinase##6##2##(1992-8#1)(1993-8#2)(2007-11#1)(2011-2#2)
thymidine##22##1##(1991-5#6)(1992-8#1)(1993-11#1)(1993-8#2)(1994-3#3)(2007-11#1)(2008-11#2)(2008-4#1)(2008-9#2)(2011-2#2)(2013-1#1)
thymidylate synthase inhibitor##2##3##(1994-8#2)
thymine and##3##2##(1992-3#1)(1996-5#1)(2008-10#1)
thymine dimer repair-enhancing##2##3##(2008-11#2)
thymine was also##2##3##(1991-5#1)(2008-10#1)
thymine##14##1##(1991-12#1)(1991-5#1)(1991-7#1)(1992-3#4)(1996-5#2)(2008-10#2)(2008-11#3)
thymocyte apoptosis##2##2##(2008-10#2)
thymocyte development##2##2##(2008-10#1)(2008-8#1)
thymocyte proliferation##2##2##(2008-10#2)
thymocyte subpopulations##2##2##(2008-10#2)
thymocyte##16##1##(1990-5#1)(1995-8#1)(2008-10#13)(2008-8#1)
thymocytes and##4##2##(1994-3#1)(1997-7#1)(2008-9#1)(2013-7#1)
thymocytes from##2##2##(2008-10#2)
thymocytes to##3##2##(1995-2#1)(1995-8#1)(2008-10#1)
thymocytes were##2##2##(2008-10#1)(2008-8#1)
thymocytes##46##1##(1990-12#1)(1990-5#5)(1994-3#2)(1995-12#2)(1995-2#1)(1995-8#3)(1997-7#3)(2008-10#8)(2008-8#13)(2008-9#5)(2012-12#2)(2013-7#1)
thymol and carvacrol in honey##2##5##(2008-10#2)
thymol and carvacrol##3##3##(2008-10#3)
thymol and##4##2##(1997-2#1)(2008-10#3)
thymol blue and##2##3##(2008-10#2)
thymol blue##8##2##(2008-10#8)
thymol##18##1##(1997-2#2)(2008-10#13)(2008-12#2)(2012-2#1)
thymopentin##6##1##(1991-3#6)
thymulin##2##1##(2013-7#2)
thymus after##2##2##(2008-10#2)
thymus and spleen were##2##4##(1993-3#1)(2010-7#1)
thymus and spleen##4##3##(1993-3#1)(1995-12#2)(2010-7#1)
thymus and##12##2##(1993-12#1)(1993-3#2)(1995-12#2)(1997-9#2)(2008-10#1)(2008-11#1)(2008-5#2)(2010-7#1)
thymus atrophy##3##2##(2008-10#1)(2008-5#2)
thymus in##2##2##(1997-7#1)(2008-5#1)
thymus involution##3##2##(2008-10#2)(2013-7#1)
thymus lymphocytes##3##2##(1994-3#3)
thymus##73##1##(1991-8#1)(1993-12#1)(1993-3#2)(1994-3#3)(1994-5#1)(1995-12#5)(1995-2#1)(1997-5#2)(1997-7#3)(1997-9#3)(2008-10#32)(2008-11#1)(2008-5#10)(2008-8#3)(2008-9#1)(2010-7#1)(2013-7#3)
thyrocytes and C cells##3##4##(2012-3#3)
thyrocytes to##2##2##(2012-3#2)
thyrocytes##7##1##(1991-8#1)(2012-3#6)
thyroglobulin##2##1##(1995-12#1)(2013-1#1)
thyroid autoimmunity and##2##3##(2008-7#2)
thyroid autoimmunity##3##2##(2008-7#3)
thyroid cancer##10##2##(1990-3#1)(1990-6#1)(2008-12#2)(2011-2#1)(2013-1#5)
thyroid carcinoma and##2##3##(2008-7#1)(2013-1#1)
thyroid carcinoma cells##3##3##(1992-6#2)(1993-8#1)
thyroid carcinoma in a##2##4##(1990-6#2)
thyroid carcinoma in##5##3##(1990-6#2)(2012-3#3)
thyroid carcinoma##22##2##(1990-3#1)(1990-6#3)(1992-6#2)(1993-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#9)(2013-1#3)
thyroid disease##3##2##(1990-6#1)(2011-1#1)(2013-1#1)
thyroid diseases##3##2##(2013-1#3)
thyroid disorders##7##2##(2013-1#7)
thyroid doses##3##2##(1993-9#3)
thyroid dysfunction was##2##3##(1991-8#1)(2008-7#1)
thyroid dysfunction##9##2##(1991-8#1)(2008-6#3)(2008-7#2)(2012-12#1)(2013-1#2)
thyroid function in##5##3##(2008-11#1)(2008-4#2)(2008-7#1)(2013-1#1)
thyroid function test##2##3##(2008-4#1)(2011-1#1)
thyroid function tests##3##3##(2008-4#1)(2008-7#1)(2011-1#1)
thyroid function##21##2##(2008-11#1)(2008-4#4)(2008-6#3)(2008-7#7)(2011-1#2)(2012-12#1)(2013-1#3)
thyroid gland in##2##3##(2008-12#1)(2008-7#1)
thyroid gland##17##2##(1990-3#1)(1993-9#1)(1997-2#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#4)(2011-1#2)(2013-1#3)
thyroid glands##3##2##(1990-2#1)(1995-12#1)(2011-2#1)
thyroid homeostasis##3##2##(2013-1#3)
thyroid hormone levels##2##3##(2008-7#2)
thyroid hormone receptor##3##3##(1993-3#1)(1993-8#2)
thyroid hormone replacement##2##3##(2011-1#2)
thyroid hormone##25##2##(1990-3#1)(1992-11#1)(1993-3#1)(1993-8#3)(1995-12#1)(1995-2#2)(1995-8#3)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#4)(2011-1#2)(2012-2#1)(2013-1#2)(2013-7#1)
thyroid hormones and prostaglandin E2##2##5##(2011-2#2)
thyroid hormones and##5##3##(1995-8#1)(2011-2#2)(2012-2#2)
thyroid hormones##12##2##(1990-3#2)(1995-8#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-2#4)
thyroid hyperplasia##2##2##(2008-4#1)(2012-12#1)
thyroid in##4##2##(1994-11#1)(2008-6#1)(2009-3#1)(2011-1#1)
thyroid is##2##2##(2008-12#1)(2012-3#1)
thyroid lobectomy##2##2##(2012-12#2)
thyroid mass##3##2##(2008-12#2)(2009-3#1)
thyroid morphology##2##2##(2008-7#2)
thyroid nodule##4##2##(1992-9#1)(1994-5#1)(2008-12#1)(2011-1#1)
thyroid nodules##8##2##(1997-2#1)(2011-1#4)(2012-3#3)
thyroid parenchyma##2##2##(2008-12#1)(2008-7#1)
thyroid remnant ablation##2##3##(2013-1#2)
thyroid response##2##2##(1991-7#1)(1994-11#1)
thyroid slices##2##2##(1994-11#2)
thyroid stimulating##3##2##(1991-5#1)(1995-12#1)(2008-6#1)
thyroid tissue##4##2##(1991-8#1)(1994-11#1)(2008-11#1)(2008-12#1)
thyroid tumors##2##2##(1990-2#1)(1990-3#1)
thyroid tumours##2##2##(1994-11#2)
thyroid##236##1##(1990-2#3)(1990-3#7)(1990-6#6)(1990-8#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-6#4)(1992-9#1)(1993-3#1)(1993-8#4)(1993-9#6)(1994-11#8)(1994-12#2)(1994-5#1)(1995-12#7)(1995-2#2)(1995-8#4)(1996-11#1)(1997-2#2)(1997-7#1)(2008-10#4)(2008-11#4)(2008-12#13)(2008-4#7)(2008-6#10)(2008-7#28)(2008-9#4)(2009-3#5)(2010-12#2)(2010-8#1)(2011-1#14)(2011-2#4)(2012-12#7)(2012-2#5)(2012-3#17)(2013-1#42)(2013-7#1)
thyroidectomized##3##1##(1995-12#1)(2008-7#2)
thyroidectomy is the##3##3##(1990-9#1)(1993-6#1)(2011-2#1)
thyroidectomy is##4##2##(1990-9#1)(1993-6#1)(2011-2#1)(2012-12#1)
thyroidectomy##16##1##(1990-9#4)(1992-5#1)(1993-6#1)(2009-3#1)(2011-2#6)(2012-12#3)
thyroiditis and##4##2##(1991-8#1)(1995-12#1)(2008-12#1)(2009-3#1)
thyroiditis in##2##2##(1995-12#2)
thyroiditis##14##1##(1991-8#3)(1995-12#4)(2008-12#5)(2009-3#1)(2011-2#1)
thyroiditis]##2##1##(1991-11#1)(2013-1#1)
thyroids of fasted##2##3##(2008-7#2)
thyroids of##3##2##(2008-7#3)
thyroids##5##1##(1994-11#1)(1995-12#1)(2008-7#3)
thyropathic women with##2##3##(2013-1#2)
thyropathic women##3##2##(2013-1#3)
thyrotoxicosis##4##1##(2008-7#3)(2011-2#1)
thyrotropin (TSH)##3##2##(1991-5#1)(2011-1#1)(2013-1#1)
thyrotropin receptor (TSHr)##2##3##(1994-11#1)(2008-4#1)
thyrotropin receptor##6##2##(1991-5#1)(1994-11#2)(1995-12#2)(2008-4#1)
thyrotropin##19##1##(1991-5#2)(1992-10#1)(1992-6#1)(1993-8#1)(1994-11#5)(1995-12#3)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
thyrotropin-releasing hormone##5##2##(1992-8#1)(1993-8#2)(2008-4#1)(2013-7#1)
thyroxine (T4)##3##2##(2008-6#2)(2008-7#1)
thyroxine##8##1##(1997-5#1)(2008-11#2)(2008-6#2)(2008-7#2)(2012-3#1)
thérapeutique##3##1##(2011-2#1)(2013-1#2)
tiapride##2##1##(2008-10#2)
tiazofurin##3##1##(1990-10#1)(1993-8#2)
tibia##13##1##(1992-3#1)(2008-12#1)(2009-3#2)(2009-7#1)(2010-11#2)(2010-12#2)(2011-2#2)(2012-12#1)(2013-1#1)
tibial artery##3##2##(2008-12#1)(2013-1#2)
tibial osteotomy##3##2##(2011-2#2)(2013-1#1)
tibial plateau fractures##3##3##(2009-4#1)(2013-1#2)
tibial plateau leveling osteotomy##2##4##(2012-3#2)
tibial plateau##7##2##(2008-10#1)(2009-4#1)(2012-3#2)(2013-1#3)
tibial tendon insufficiency##2##3##(2008-8#2)
tibial translation##5##2##(2008-12#2)(2012-3#3)
tibial##39##1##(1990-11#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#4)(2009-3#4)(2009-4#1)(2010-11#2)(2011-2#4)(2012-2#2)(2012-3#5)(2013-1#7)
tibialis anterior##4##2##(1995-12#1)(2012-3#2)(2013-8#1)
tibialis##6##1##(1995-12#1)(1995-2#1)(2008-4#1)(2012-3#2)(2013-8#1)
tibiocalcaneal fusion##3##2##(2009-3#3)
tic##2##1##(2008-12#1)(2011-2#1)
tick and##2##2##(1997-7#1)(2013-8#1)
tick vector##2##2##(1994-6#1)(2008-8#1)
tick##28##1##(1994-6#1)(1996-11#2)(1996-12#5)(1997-7#2)(2008-10#1)(2008-12#1)(2008-8#5)(2010-1#3)(2010-10#3)(2013-1#1)(2013-8#4)
tick-borne diseases##3##2##(2010-1#2)(2013-8#1)
tick-borne pathogen##3##2##(2013-8#3)
tick-borne##8##1##(2008-11#1)(2010-1#3)(2013-8#4)
ticketing##5##1##(2013-8#5)
ticks and##3##2##(1997-7#1)(2013-1#2)
ticks on##2##2##(1996-12#2)
ticks##23##1##(1996-11#2)(1996-12#4)(1997-7#1)(2008-10#2)(2008-12#1)(2010-1#6)(2010-10#1)(2011-2#1)(2013-1#3)(2013-8#2)
ticlopidine##3##1##(1996-11#1)(1996-3#1)(2008-3#1)
tics or tourettism##2##3##(2008-7#2)
tics##4##1##(2008-7#3)(2011-2#1)
tidal volume##4##2##(1996-2#2)(1996-5#1)(2012-2#1)
tidal##6##1##(1991-12#1)(1996-2#2)(1996-5#1)(2010-8#1)(2012-2#1)
tide of suicide in##2##4##(2009-5#2)
tie##8##1##(1993-12#1)(1995-1#1)(1996-2#1)(2011-2#5)
tied to the##2##3##(2010-11#1)(2011-2#1)
tied to##8##2##(1992-3#1)(1996-5#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#1)
tied##11##1##(1992-3#1)(1995-5#1)(1996-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#3)(2012-12#1)
tier##6##1##(1990-12#1)(1990-3#4)(2008-10#1)
tiered approach##2##2##(2008-5#2)
ties##7##1##(1994-2#1)(1995-3#1)(1996-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
tight and##2##2##(2008-11#1)(2009-10#1)
tight control##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
tight junction disruption during##2##4##(2011-2#2)
tight junction disruption##3##3##(2011-2#3)
tight junction##5##2##(2008-11#1)(2011-2#3)(2012-2#1)
tight junctions and##2##3##(2008-11#1)(2009-10#1)
tight junctions##8##2##(2008-11#1)(2008-7#1)(2009-10#2)(2011-2#3)(2012-2#1)
tight##41##1##(1994-8#1)(1995-2#1)(1995-6#2)(1997-8#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#4)(2009-8#2)(2010-12#2)(2011-10#1)(2011-2#6)(2012-2#4)(2012-3#1)(2013-8#1)
tight-binding##3##1##(1991-5#1)(2008-10#2)
tightly associated##2##2##(1994-12#1)(2008-10#1)
tightly bound to##3##3##(1990-5#2)(1995-6#1)
tightly bound##6##2##(1990-10#1)(1990-5#3)(1994-5#1)(1995-6#1)
tightly control##3##2##(1996-1#1)(2008-11#1)(2009-8#1)
tightly coupled to##3##3##(1997-1#1)(2008-11#1)(2012-3#1)
tightly coupled##4##2##(1995-6#1)(1997-1#1)(2008-11#1)(2012-3#1)
tightly focused##2##2##(2008-3#1)(2009-5#1)
tightly linked to the##4##4##(1995-6#1)(2008-10#1)(2013-7#1)(2013-8#1)
tightly linked to##8##3##(1995-2#1)(1995-6#1)(2008-10#4)(2013-7#1)(2013-8#1)
tightly linked##12##2##(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#7)(2013-7#1)(2013-8#1)
tightly packed##5##2##(1994-5#1)(2008-5#1)(2008-9#3)
tightly regulated##8##2##(1995-2#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
tightly to##2##2##(2008-10#1)(2008-9#1)
tightly##63##1##(1990-10#1)(1990-5#3)(1991-12#1)(1991-5#1)(1992-4#1)(1994-12#1)(1994-5#3)(1995-2#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#7)(2009-3#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
tightness##3##1##(2008-10#1)(2010-9#1)(2013-7#1)
tiles##2##1##(2008-10#2)
tiling##5##1##(1997-2#1)(2007-12#1)(2008-7#1)(2012-3#2)
till the end of##2##4##(1996-3#1)(2008-10#1)
till the last##2##3##(2008-10#1)(2013-1#1)
till the##10##2##(1991-2#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-1#1)
till today##2##2##(2011-3#1)(2013-1#1)
till##21##1##(1991-2#1)(1991-5#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
tillage and soil texture##3##4##(2008-10#3)
tillage and##9##2##(2008-10#9)
tillage in##2##2##(2008-10#2)
tillage information##3##2##(2008-10#3)
tillage on##3##2##(2008-10#3)
tillage practices##6##2##(2008-10#6)
tillage system##2##2##(2008-10#2)
tillage systems##6##2##(2008-10#6)
tillage than in##2##3##(2008-10#2)
tillage treatment##3##2##(2008-10#3)
tillage treatments##6##2##(2008-10#6)
tillage was##2##2##(2008-10#2)
tillage x texture interaction##2##4##(2008-10#2)
tillage##76##1##(2008-10#75)(2008-12#1)
tilled fields##3##2##(2008-10#3)
tilled##10##1##(2008-10#10)
tiller elongation##2##2##(2008-10#2)
tiller##5##1##(2008-10#4)(2008-9#1)
tillering##6##1##(2008-10#5)(2008-9#1)
tillers##4##1##(2008-10#2)(2008-9#2)
tilt angle##2##2##(2008-3#2)
tilt of the##3##3##(1994-5#1)(2008-2#1)(2008-3#1)
tilt sensing error##2##3##(2008-3#2)
tilt towards the##2##3##(1991-2#2)
tilt##22##1##(1991-2#2)(1993-1#5)(1994-5#1)(2008-2#1)(2008-3#11)(2008-9#2)
tilted implants##2##2##(2011-7#2)
tilted planar waveguide gratings##2##4##(2008-3#2)
tilted##11##1##(2008-2#1)(2008-3#6)(2011-7#3)(2013-1#1)
tilting##4##1##(2008-3#2)(2011-2#1)(2011-7#1)
timber value##2##2##(2008-10#1)(2008-9#1)
timber##5##1##(2008-10#2)(2008-9#3)
timbre##4##1##(2013-1#2)(2013-8#2)
time &lt##3##2##(2008-10#3)
time (&gt##2##2##(2008-10#1)(2008-7#1)
time (10 min)##2##3##(2008-10#1)(2008-11#1)
time (10##3##2##(2008-10#2)(2008-11#1)
time (15##2##2##(1995-11#1)(2008-10#1)
time (2##2##2##(2008-10#1)(2011-2#1)
time (5##3##2##(2008-10#3)
time (6##2##2##(1996-2#1)(2008-10#1)
time (RT)##5##2##(2008-11#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)
time (i##2##2##(2008-10#2)
time (t(1/2))##3##2##(2008-10#3)
time (time##2##2##(2008-5#1)(2010-8#1)
time 3##3##2##(2008-11#3)
time a##6##2##(1993-3#1)(2008-10#3)(2009-8#1)(2012-2#1)
time according to##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
time after planting##2##3##(2008-10#2)
time after the##3##3##(1996-6#1)(2008-7#1)(2011-2#1)
time after##20##2##(1990-9#1)(1992-3#1)(1993-8#1)(1994-5#1)(1996-6#1)(2008-10#10)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
time analysis##2##2##(2008-10#2)
time and a##4##3##(2008-10#2)(2008-11#1)(2009-7#1)
time and applied##2##3##(2008-10#2)
time and cost of##2##4##(2008-10#1)(2013-1#1)
time and cost##5##3##(2008-10#2)(2009-8#1)(2013-1#2)
time and costs##2##3##(2008-10#2)
time and effort##3##3##(1994-3#1)(1996-3#1)(2008-10#1)
time and energy##2##3##(1992-3#1)(2008-8#1)
time and flow rate##2##4##(2008-10#2)
time and flow##3##3##(2008-10#3)
time and from##2##3##(2008-10#2)
time and good##2##3##(2008-10#2)
time and in##3##3##(1991-11#1)(2008-10#2)
time and mass##2##3##(2008-10#1)(2008-5#1)
time and number of##2##4##(2008-10#1)(2010-8#1)
time and peak##4##3##(2008-10#4)
time and physical##2##3##(2008-10#1)(2013-1#1)
time and solvent##4##3##(2008-10#4)
time and space##5##3##(2008-10#2)(2008-11#1)(2010-11#1)(2013-1#1)
time and staff##2##3##(1992-3#1)(2008-11#1)
time and temperature were##2##4##(2008-10#2)
time and temperature##6##3##(2008-10#5)(2008-11#1)
time and the##15##3##(1991-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
time and with##3##3##(1990-12#1)(2008-11#1)(2008-3#1)
time and##207##2##(1990-12#2)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(2008-10#118)(2008-11#14)(2008-12#1)(2008-3#4)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#9)(2013-8#2)
time approximately##3##2##(2008-10#2)(2010-1#1)
time are##8##2##(1991-2#1)(1992-1#1)(2007-11#1)(2008-10#3)(2008-3#1)(2013-8#1)
time as a##2##3##(1996-2#1)(2008-10#1)
time as the##2##3##(2008-10#1)(2008-11#1)
time as##13##2##(1996-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)
time at which##4##3##(1996-12#1)(1996-3#1)(2008-10#2)
time at##13##2##(1990-5#1)(1994-3#1)(1996-12#1)(1996-3#1)(2008-10#6)(2008-8#1)(2010-8#1)(2012-2#1)
time available to escape##2##4##(1996-12#2)
time available##4##2##(1996-12#2)(2008-8#2)
time based on##2##3##(2013-1#2)
time because of##2##3##(1992-9#1)(2008-10#1)
time because##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
time before the onset of##2##5##(1990-3#1)(1990-8#1)
time before##4##2##(1990-3#1)(1990-8#1)(1996-3#1)(1997-8#1)
time between 5 and##2##4##(2008-10#2)
time between implants##2##3##(2012-2#2)
time between the##5##3##(2008-10#2)(2008-11#1)(2012-12#1)(2013-8#1)
time between##15##2##(1995-6#1)(2008-10#8)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
time but##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
time by a##6##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-11#1)
time by##23##2##(1991-11#1)(1992-12#1)(1993-11#1)(1994-12#1)(1996-5#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-8#1)(2009-11#1)(2010-8#1)(2013-1#1)
time can be##5##3##(2008-10#3)(2008-11#1)(2008-6#1)
time cells##2##2##(2008-11#1)(2008-8#1)
time compared##2##2##(2008-10#1)(2010-1#1)
time constant##6##2##(2008-11#1)(2008-7#4)(2011-2#1)
time constants##6##2##(1997-2#1)(2008-10#2)(2008-11#2)(2008-8#1)
time constraints##2##2##(2008-11#1)(2008-12#1)
time consuming and##3##3##(2008-10#2)(2011-2#1)
time consuming##17##2##(1990-2#1)(1993-8#1)(1994-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
time consumption##2##2##(2008-10#2)
time corresponding to the##2##4##(1990-8#1)(2008-10#1)
time course and##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
time course of cell physiology##2##5##(2008-11#2)
time course of changes in##2##5##(1997-3#1)(2009-11#1)
time course of changes##3##4##(1997-3#1)(2009-11#1)(2013-1#1)
time course of the##8##4##(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
time course of##28##3##(1990-5#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-3#2)(2008-10#4)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
time course studies##2##3##(1995-12#1)(2008-11#1)
time course to that of##2##5##(1995-2#1)(2008-10#1)
time course to that##3##4##(1995-2#1)(2008-10#1)(2013-1#1)
time course##45##2##(1990-5#1)(1990-8#2)(1991-5#1)(1995-11#1)(1995-12#3)(1995-2#2)(1996-2#1)(1997-3#2)(2008-10#8)(2008-11#7)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#5)(2013-8#1)
time courses##4##2##(1991-2#1)(1995-6#1)(2008-10#1)(2008-11#1)
time curve##4##2##(1996-3#1)(2008-12#1)(2008-6#1)(2008-7#1)
time curves##2##2##(2008-10#1)(2008-11#1)
time data##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
time decreased##2##2##(2008-10#1)(2010-8#1)
time delay and##2##3##(2008-10#1)(2013-8#1)
time delay##7##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-10#1)(2013-8#1)
time delays are##2##3##(2008-3#2)
time delays##4##2##(1997-2#1)(2008-3#2)(2010-9#1)
time dependence##3##2##(1994-8#1)(2008-10#2)
time dependency##2##2##(2008-10#2)
time dependent and##4##3##(2008-10#3)(2008-7#1)
time dependent##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
time domain by##2##3##(2008-2#1)(2010-8#1)
time domain##5##2##(2008-10#1)(2008-2#2)(2009-10#1)(2010-8#1)
time due to##2##3##(2008-10#1)(2009-8#1)
time duration of##2##3##(2008-10#2)
time duration##3##2##(1995-3#1)(2008-10#2)
time during the##3##3##(2008-9#1)(2009-11#1)(2013-1#1)
time during##5##2##(2008-10#1)(2008-9#1)(2009-1#1)(2009-11#1)(2013-1#1)
time elapsed##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
time evolution##3##2##(2008-3#1)(2010-4#1)(2013-8#1)
time factor in##2##3##(2008-10#2)
time for a##2##3##(2008-10#1)(2008-12#1)
time for analysis##2##3##(2008-10#2)
time for one##3##3##(2008-10#3)
time for patients##2##3##(1991-11#1)(1997-4#1)
time for the##11##3##(1991-11#1)(1997-4#1)(2008-10#6)(2008-5#1)(2011-2#1)(2012-12#1)
time for##66##2##(1990-12#1)(1991-11#4)(1991-12#1)(1992-12#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-4#2)(2008-10#30)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-6#1)(2010-5#2)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
time frame##10##2##(1992-3#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
time frames##3##2##(1993-1#1)(2008-11#1)(2012-2#1)
time from renal failure to##2##5##(1995-12#2)
time from the##3##3##(2010-2#1)(2011-2#1)(2013-1#1)
time from##21##2##(1990-5#1)(1995-12#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
time has a##2##3##(1995-12#1)(2008-10#1)
time has##6##2##(1991-2#1)(1995-12#1)(2008-10#4)
time have been##3##3##(2008-10#3)
time horizon##3##2##(2008-9#2)(2009-8#1)
time in a##2##3##(1990-5#1)(2012-3#1)
time in comparison to##2##4##(2008-10#1)(2008-12#1)
time in medical##2##3##(2008-5#1)(2011-2#1)
time in relation to##2##4##(2008-10#1)(2013-1#1)
time in the United States##2##5##(2008-10#1)(2010-12#1)
time in the##25##3##(1990-11#1)(1990-12#1)(1992-3#2)(1993-12#1)(1996-3#1)(1997-2#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2012-12#1)
time in which##2##3##(1991-12#1)(2008-11#1)
time in##87##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-3#3)(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1996-3#1)(1997-2#2)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#20)(2008-11#6)(2008-12#6)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#7)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
time induced by##2##3##(1995-12#1)(2010-9#1)
time interactions were##2##3##(2013-1#2)
time interval between the##2##4##(2008-9#1)(2011-2#1)
time interval between##5##3##(2008-10#1)(2008-9#3)(2011-2#1)
time interval from##4##3##(1994-3#1)(2008-9#1)(2013-1#2)
time interval##17##2##(1994-3#3)(1997-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-9#4)(2009-7#1)(2011-2#1)(2013-1#2)
time intervals after##3##3##(2008-10#2)(2008-5#1)
time intervals##19##2##(1994-3#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
time into##3##2##(1994-3#1)(2008-5#1)(2008-9#1)
time is 3##2##3##(2008-10#2)
time is##32##2##(1991-11#1)(1992-9#1)(1993-3#1)(1996-3#1)(2008-10#14)(2008-11#4)(2008-3#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#4)
time it takes##2##3##(1993-3#1)(2008-3#1)
time it##6##2##(1990-3#1)(1993-3#1)(1993-6#2)(2008-3#1)(2008-9#1)
time lag##2##2##(1997-3#1)(2008-8#1)
time lags##2##2##(2008-8#2)
time lapse##2##2##(2008-10#2)
time locking##2##2##(2008-10#2)
time management effectiveness##3##3##(1992-2#3)
time management##4##2##(1992-2#4)
time may be##2##3##(1994-9#1)(2008-9#1)
time measurements##2##2##(1990-2#1)(2008-5#1)
time necessary for the##3##4##(2008-10#3)
time necessary to##4##3##(2008-10#3)(2013-1#1)
time necessary##7##2##(2008-10#6)(2013-1#1)
time needed for##4##3##(1991-3#1)(2008-10#2)(2012-3#1)
time needed##5##2##(1991-3#1)(1997-2#1)(2008-10#2)(2012-3#1)
time of 1##3##3##(2008-10#3)
time of 10 min##3##4##(2008-10#1)(2008-11#2)
time of 10##5##3##(2008-10#2)(2008-11#2)(2013-1#1)
time of 10min##3##3##(2008-10#3)
time of 120 s##6##4##(2008-10#6)
time of 15##3##3##(2008-10#2)(2008-9#1)
time of 2##2##3##(1997-3#1)(2008-10#1)
time of 20 s##3##4##(2008-10#2)(2008-3#1)
time of 20##5##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)
time of 3 min##2##4##(2008-10#2)
time of 3##5##3##(2008-10#5)
time of 30 min##2##4##(2008-10#2)
time of 30##3##3##(2008-10#3)
time of 30s and##2##4##(2008-10#2)
time of 4 h##2##4##(1996-2#1)(2008-10#1)
time of 4##4##3##(1996-2#1)(2008-10#3)
time of 40##2##3##(1990-9#1)(2008-3#1)
time of 5 min##5##4##(2008-10#5)
time of 5##6##3##(2008-10#5)(2008-11#1)
time of 60 s##3##4##(2008-10#3)
time of 60##4##3##(2008-10#3)(2008-6#1)
time of 8##2##3##(2008-10#1)(2008-3#1)
time of 9##2##3##(2008-10#1)(2008-7#1)
time of X##2##3##(2008-10#2)
time of a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
time of about##7##3##(2008-10#6)(2008-11#1)
time of analysis and##2##4##(2008-10#2)
time of analysis##6##3##(2008-10#6)
time of approximately##4##3##(2008-10#3)(2008-2#1)
time of contact##5##3##(2008-10#4)(2008-11#1)
time of day##7##3##(1992-3#1)(2008-10#1)(2008-5#1)(2009-8#2)(2010-7#1)(2012-5#1)
time of diagnosis##7##3##(1992-3#1)(1992-5#1)(1993-1#1)(1994-12#1)(2008-7#2)(2010-12#1)
time of exposure##4##3##(1996-12#1)(2008-10#1)(2012-2#1)(2012-4#1)
time of flight mass spectrometry##5##5##(2008-10#3)(2008-11#2)
time of follow-up was##2##4##(2009-3#1)(2013-1#1)
time of infection##5##3##(2008-10#4)(2008-11#1)
time of initial##3##3##(1992-2#1)(2008-11#1)(2012-3#1)
time of injury##2##3##(1993-2#1)(2011-2#1)
time of inoculation##4##3##(2008-10#4)
time of onset of##2##4##(1990-5#1)(2008-5#1)
time of onset##4##3##(1990-5#1)(2008-10#2)(2008-5#1)
time of referral##2##3##(2008-1#1)(2008-11#1)
time of sampling##4##3##(1992-12#1)(2008-10#2)(2008-5#1)
time of the first##2##4##(1995-12#1)(2008-10#1)
time of the proposed##2##4##(2008-10#2)
time of the##49##3##(1990-12#1)(1990-3#2)(1990-6#2)(1991-2#1)(1994-6#1)(1995-12#1)(2008-10#27)(2008-11#4)(2008-3#3)(2008-5#1)(2008-8#2)(2009-1#1)(2012-5#1)(2013-1#2)
time of year##2##3##(2008-10#1)(2010-3#1)
time of##378##2##(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-12#2)(1996-2#3)(1996-3#2)(1997-2#1)(1997-3#4)(1997-8#2)(2008-1#2)(2008-10#204)(2008-11#25)(2008-12#1)(2008-2#1)(2008-3#9)(2008-5#8)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-3#2)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#7)(2012-4#1)(2012-5#2)(2013-1#10)
time on the determination of##2##5##(2008-10#2)
time on the##8##3##(2008-10#6)(2008-5#1)(2011-2#1)
time on##17##2##(1991-2#1)(1994-9#1)(1996-3#1)(2008-10#8)(2008-5#4)(2010-1#1)(2011-2#1)
time or##9##2##(1991-3#1)(1993-11#1)(1995-2#1)(1997-8#1)(2008-10#4)(2008-11#1)
time over##2##2##(2010-11#1)(2010-8#1)
time per sample##3##3##(2008-10#3)
time per##5##2##(2008-10#3)(2008-7#1)(2010-8#1)
time period of##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
time period##19##2##(1991-2#1)(1996-3#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-9#4)(2009-7#1)(2010-8#1)(2011-2#2)
time periods##15##2##(1991-11#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
time point at which##2##4##(2008-11#1)(2008-7#1)
time point##15##2##(1995-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#1)
time points and##4##3##(2008-7#1)(2010-2#1)(2011-2#1)(2012-4#1)
time points in##2##3##(2010-1#1)(2013-7#1)
time points##31##2##(1992-9#1)(1993-11#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#3)(2010-2#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2012-4#2)(2013-1#1)(2013-7#1)
time ranged from##2##3##(2008-9#1)(2012-12#1)
time release##2##2##(2008-5#2)
time required for the analysis of##2##6##(2008-10#2)
time required for the analysis##3##5##(2008-10#3)
time required for the##9##4##(1997-3#1)(2008-10#8)
time required for##25##3##(1996-12#1)(1997-3#1)(2008-10#18)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#2)
time required to exchange##2##4##(2011-2#2)
time required to gather##2##4##(2011-2#2)
time required to##17##3##(1993-12#2)(1995-12#1)(2008-10#7)(2008-11#2)(2008-9#1)(2011-2#4)
time required##47##2##(1993-12#2)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#26)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#4)(2010-7#1)(2011-2#6)
time resolution##2##2##(2008-10#1)(2008-3#1)
time resolved##2##2##(1991-3#1)(2008-10#1)
time resulted in##2##3##(2008-11#1)(2008-7#1)
time revealed##2##2##(2008-11#1)(2009-1#1)
time scale##11##2##(1990-2#2)(1990-8#2)(1991-3#1)(1994-5#1)(1995-3#1)(2008-11#2)(2008-4#1)(2010-8#1)
time scales##11##2##(1990-8#1)(1995-5#1)(2008-10#1)(2008-3#3)(2009-7#2)(2009-8#1)(2013-8#2)
time schedule##2##2##(1993-11#1)(2008-6#1)
time series analysis##5##3##(1997-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
time series data##3##3##(1993-3#1)(2008-7#1)(2008-8#1)
time series methods##2##3##(2010-7#1)(2010-8#1)
time series of##6##3##(1992-9#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#2)
time series##26##2##(1992-9#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#4)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#3)
time since the##3##3##(1991-11#1)(2008-10#2)
time since##8##2##(1990-9#1)(1991-11#1)(1991-12#1)(2008-10#3)(2008-9#1)(2010-11#1)
time span##4##2##(2008-10#2)(2008-11#1)(2009-7#1)
time spent in a##3##4##(2008-8#3)
time spent in the##2##4##(1993-2#1)(2011-2#1)
time spent in##6##3##(1993-2#1)(2008-11#1)(2008-8#3)(2011-2#1)
time spent##10##2##(1993-2#1)(2008-10#1)(2008-11#2)(2008-8#3)(2009-4#1)(2011-2#2)
time step##3##2##(2008-10#2)(2008-6#1)
time t##2##2##(1995-12#1)(2008-10#1)
time taken##6##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)(2013-1#1)
time than the##2##3##(2008-10#1)(2008-3#1)
time than##9##2##(1991-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
time that the##6##3##(2008-10#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
time that##25##2##(1991-3#1)(1992-12#1)(1992-8#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-9#3)(2011-2#3)(2012-2#4)(2013-8#1)
time the##29##2##(1991-5#1)(1991-8#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-5#1)(2008-10#4)(2008-11#3)(2008-5#2)(2008-6#2)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
time there has been a##2##5##(1990-11#1)(1997-1#1)
time there##3##2##(1990-11#1)(1997-1#1)(1997-4#1)
time they##3##2##(1991-9#1)(2008-11#1)(2013-1#1)
time to AT##2##3##(2013-1#2)
time to a##3##3##(1995-12#1)(1995-9#1)(2008-10#1)
time to achieve a target weight##2##6##(2013-1#2)
time to achieve a##3##4##(2008-10#1)(2013-1#2)
time to be##5##3##(1994-12#1)(2008-10#2)(2008-9#1)(2013-1#1)
time to determine the##2##4##(2008-10#2)
time to diagnosis##2##3##(2011-2#2)
time to disease##2##3##(2008-10#2)
time to event##2##3##(1995-9#1)(2011-2#1)
time to exhaustion##4##3##(2013-8#4)
time to extinction of##3##4##(2008-9#3)
time to extinction##5##3##(2008-9#5)
time to growth##2##3##(2011-2#2)
time to inflection point (t(ip))##2##5##(2008-10#2)
time to initial symptoms##2##4##(2008-10#2)
time to learn new##2##4##(1993-12#1)(1996-3#1)
time to progression was##3##4##(1993-1#1)(2008-10#1)(2013-1#1)
time to progression##4##3##(1993-1#1)(2008-10#2)(2013-1#1)
time to provide##2##3##(1993-2#1)(2008-12#1)
time to reach##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
time to the##4##3##(2007-11#1)(2008-10#1)(2010-3#1)(2012-3#1)
time to time##3##3##(1997-7#1)(2008-10#1)(2012-2#1)
time to##132##2##(1991-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-12#1)(1995-12#2)(1995-9#2)(1996-3#3)(1996-5#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#10)(2009-10#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#6)(2012-8#1)(2013-1#12)(2013-8#6)
time travel is##2##3##(2013-8#2)
time travel##6##2##(2013-8#6)
time trend##2##2##(1990-12#1)(2008-11#1)
time trends##2##2##(1993-12#1)(1997-7#1)
time until##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
time up to##3##3##(1992-12#1)(2008-10#1)(2008-11#1)
time use##3##2##(2013-1#3)
time used for##2##3##(1992-3#1)(2008-10#1)
time used##3##2##(1992-3#1)(2008-10#2)
time using a##2##3##(2008-10#2)
time using##9##2##(1995-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
time variation##2##2##(2008-10#1)(2011-2#1)
time varying##3##2##(2008-11#1)(2008-3#1)(2010-8#1)
time was &lt##2##3##(2008-10#2)
time was 15 minutes##2##4##(1991-1#1)(1994-9#1)
time was 50##2##3##(1994-2#1)(2008-10#1)
time was 6 min##2##4##(1996-1#1)(2008-10#1)
time was less than##3##4##(2008-10#2)(2012-3#1)
time was lower than##2##4##(2008-10#2)
time was much##2##3##(1990-2#1)(2008-10#1)
time was reduced##4##3##(2008-10#3)(2009-7#1)
time was##61##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#2)(2008-10#33)(2008-11#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
time were evaluated and##2##4##(2008-10#2)
time were investigated##3##3##(2008-10#3)
time were optimised##2##3##(2008-10#2)
time were optimized##3##3##(2008-10#3)
time were studied##2##3##(2008-10#2)
time were##26##2##(2008-10#17)(2008-11#2)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
time when the##4##3##(1997-2#1)(2008-10#2)(2008-9#1)
time when##23##2##(1993-12#1)(1996-12#1)(1997-2#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-9#2)(2010-1#1)(2011-2#1)(2013-8#1)
time which##2##2##(1996-9#1)(2008-9#1)
time while##2##2##(2007-12#1)(2008-10#1)
time window##4##2##(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
time with the##5##3##(2008-10#4)(2008-11#1)
time with##18##2##(1990-5#1)(1992-12#1)(2008-10#9)(2008-11#2)(2008-7#1)(2010-7#1)(2011-1#1)(2011-3#1)(2013-8#1)
time##2928##1##(1990-11#6)(1990-12#10)(1990-2#12)(1990-3#5)(1990-5#11)(1990-6#2)(1990-8#9)(1990-9#5)(1991-1#5)(1991-11#18)(1991-12#8)(1991-2#14)(1991-3#12)(1991-5#3)(1991-6#6)(1991-8#5)(1991-9#1)(1992-1#1)(1992-12#10)(1992-2#8)(1992-3#17)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#6)(1993-1#5)(1993-11#7)(1993-12#14)(1993-2#5)(1993-3#8)(1993-6#4)(1993-8#5)(1994-1#6)(1994-11#5)(1994-12#8)(1994-2#3)(1994-3#14)(1994-5#5)(1994-6#7)(1994-8#5)(1994-9#5)(1995-1#3)(1995-10#2)(1995-11#6)(1995-12#27)(1995-2#7)(1995-3#6)(1995-5#4)(1995-6#5)(1995-8#2)(1995-9#5)(1996-1#5)(1996-11#4)(1996-12#16)(1996-2#11)(1996-3#22)(1996-5#5)(1996-6#6)(1996-9#2)(1997-1#3)(1997-2#13)(1997-3#11)(1997-4#3)(1997-6#4)(1997-7#4)(1997-8#8)(2007-11#7)(2007-12#8)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#1183)(2008-11#202)(2008-12#46)(2008-2#11)(2008-3#60)(2008-4#8)(2008-5#67)(2008-6#12)(2008-7#63)(2008-8#68)(2008-9#97)(2009-1#4)(2009-10#10)(2009-11#8)(2009-12#2)(2009-3#9)(2009-4#6)(2009-5#5)(2009-6#2)(2009-7#15)(2009-8#24)(2009-9#3)(2010-1#18)(2010-10#8)(2010-11#6)(2010-12#16)(2010-2#3)(2010-3#7)(2010-4#9)(2010-5#9)(2010-6#12)(2010-7#13)(2010-8#29)(2010-9#7)(2011-1#11)(2011-10#1)(2011-2#97)(2011-3#13)(2011-4#1)(2011-7#1)(2012-12#14)(2012-2#51)(2012-3#49)(2012-4#3)(2012-5#2)(2012-7#1)(2012-8#2)(2013-1#102)(2013-7#1)(2013-8#41)
time&quot##2##1##(2008-8#1)(2011-2#1)
time) and##3##2##(2008-10#3)
time) are optimized##2##3##(2008-10#2)
time) of##2##2##(1995-12#1)(2008-10#1)
time) showed##2##2##(2008-10#1)(2008-7#1)
time) was##2##2##(2008-10#1)(2008-11#1)
time) were investigated##2##3##(2008-10#2)
time) were##4##2##(2008-10#4)
time)##35##1##(1992-3#1)(1992-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
time- and dose-dependent##7##3##(1991-5#1)(1992-8#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(2010-1#1)
time- and##18##2##(1990-6#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-1#1)
time-##19##1##(1990-6#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-1#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-1#1)
time-based flow injection (FI) method for on-line preconcentration and determination of##2##11##(2008-10#2)
time-based flow injection (FI)##3##4##(2008-10#3)
time-based flow##5##2##(2008-10#5)
time-based technique##2##2##(2008-10#2)
time-based##16##1##(2008-10#15)(2008-5#1)
time-consuming and do not##2##4##(2008-10#1)(2012-2#1)
time-consuming and##11##2##(1995-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-9#1)(2012-2#1)
time-consuming##38##1##(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#19)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-2#1)
time-correlated##2##1##(2007-12#2)
time-course gene expression data##2##4##(2010-1#1)(2010-10#1)
time-course##14##1##(1993-3#1)(1994-11#1)(1994-8#2)(1995-2#1)(2008-10#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-10#1)(2013-8#2)
time-delay and##2##2##(2008-2#1)(2008-3#1)
time-delay##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
time-delayed##2##1##(2008-10#1)(2008-11#1)
time-dependent decrease##2##2##(1994-8#1)(2011-2#1)
time-dependent factors##2##2##(2008-10#2)
time-dependent inactivation##2##2##(1991-5#1)(1991-9#1)
time-dependent manner##11##2##(1996-2#2)(1997-8#1)(2008-10#1)(2008-11#4)(2008-9#1)(2011-2#1)(2012-12#1)
time-dependent response of##2##3##(2008-10#1)(2012-2#1)
time-dependent##54##1##(1990-6#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#2)(1997-8#1)(2006-6#1)(2008-10#7)(2008-11#8)(2008-2#2)(2008-3#4)(2008-8#2)(2008-9#3)(2009-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
time-division multiplexed##2##2##(2008-3#2)
time-domain##14##1##(2007-12#2)(2008-2#1)(2008-3#7)(2009-12#1)(2011-7#3)
time-frequency domain##2##2##(2008-10#1)(2010-8#1)
time-frequency##8##1##(2007-12#2)(2008-10#2)(2008-3#1)(2010-8#3)
time-independent##2##1##(2008-3#1)(2012-2#1)
time-integrative##2##1##(2008-3#2)
time-lapse microscopy##3##2##(2008-11#3)
time-lapse studies##4##2##(1995-9#2)(2008-11#1)(2008-9#1)
time-lapse##10##1##(1995-9#2)(2008-11#6)(2008-9#1)(2012-12#1)
time-of-flight (TOF)##3##2##(1997-2#1)(2008-10#2)
time-of-flight mass spectrometer##3##3##(2008-10#2)(2008-3#1)
time-of-flight mass spectrometry (GC x GC-IDTOFMS)##2##6##(2008-10#2)
time-of-flight mass spectrometry##13##3##(2008-10#10)(2008-11#1)(2011-2#1)(2011-3#1)
time-of-flight mass##17##2##(2008-10#13)(2008-11#1)(2008-3#1)(2011-2#1)(2011-3#1)
time-of-flight##25##1##(1997-2#1)(2008-10#18)(2008-11#2)(2008-3#1)(2010-7#1)(2011-2#1)(2011-3#1)
time-point##2##1##(2012-3#1)(2013-1#1)
time-range##2##1##(2008-3#2)
time-resolved Shpol'skii spectrometry##4##3##(2008-10#4)
time-resolved fluorescence spectra##2##3##(2008-10#1)(2008-8#1)
time-resolved fluorescence spectroscopy##2##3##(2008-10#1)(2008-3#1)
time-resolved fluorescence##7##2##(2008-10#4)(2008-3#1)(2008-8#2)
time-resolved fluoroimmunoassay##5##2##(2008-10#5)
time-resolved##36##1##(1990-8#2)(1991-5#1)(2007-12#2)(2008-10#21)(2008-11#3)(2008-3#3)(2008-8#2)(2009-3#2)
time-response##2##1##(1994-9#1)(2008-7#1)
time-scales##2##1##(2008-11#1)(2010-10#1)
time-series##8##1##(1992-12#1)(1994-3#1)(1995-1#1)(1997-1#1)(2008-3#1)(2008-9#1)(2009-11#2)
time-temperature##2##1##(1995-3#1)(2011-2#1)
time-tested##2##1##(2008-9#1)(2009-4#1)
time-varying magnetic fields##3##3##(1992-3#3)
time-varying##8##1##(1992-3#4)(2008-3#1)(2008-6#1)(2010-1#1)(2011-2#1)
time-window##2##1##(1994-8#1)(2008-8#1)
time?##5##1##(1992-2#1)(1993-5#1)(2008-12#1)(2008-9#1)(2013-8#1)
time?]##2##1##(1991-11#1)(1994-6#1)
time]##2##1##(1996-3#1)(2013-1#1)
timed##7##1##(1990-5#1)(1993-9#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-9#1)(2012-2#1)
timeline##4##1##(2008-1#1)(2008-9#1)(2010-1#1)(2010-11#1)
timeliness##2##1##(2008-11#1)(2009-3#1)
timely and##4##2##(1997-3#1)(2008-10#2)(2012-12#1)
timely diagnosis##2##2##(2008-12#1)(2011-2#1)
timely information on##2##3##(1996-1#1)(1997-3#1)
timely information##3##2##(1996-1#1)(1997-3#1)(2008-11#1)
timely intervention##2##2##(1997-2#1)(1997-7#1)
timely manner##4##2##(1993-1#1)(1994-12#1)(1997-3#1)(2008-10#1)
timely referral to##3##3##(2008-7#1)(2008-8#1)(2010-9#1)
timely source##2##2##(1997-3#1)(2011-2#1)
timely to##2##2##(2008-10#1)(2008-11#1)
timely use of##2##3##(2008-11#1)(2008-7#1)
timely##56##1##(1991-6#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#2)(1996-1#2)(1996-2#1)(1997-2#2)(1997-3#5)(1997-7#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)
timer##3##1##(2008-10#2)(2009-1#1)
times (15##2##2##(1993-6#1)(2013-1#1)
times (versus##2##2##(2008-10#2)
times 1##2##2##(1992-6#1)(2008-11#1)
times a day for##2##4##(1990-9#1)(1996-2#1)
times a day##4##3##(1990-9#1)(1996-2#1)(2007-11#1)(2012-2#1)
times a day)##2##3##(1992-11#1)(2011-1#1)
times a week for 6##2##5##(2008-5#1)(2009-1#1)
times a week for##4##4##(1991-3#1)(2008-5#1)(2009-1#1)(2010-4#1)
times a week##5##3##(1991-3#1)(2008-5#1)(2009-1#1)(2010-4#1)(2013-1#1)
times a year##2##3##(1997-4#1)(2008-10#1)
times a##13##2##(1990-9#1)(1991-3#1)(1992-11#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
times after##11##2##(1994-1#1)(1994-5#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)
times and an increase in##2##5##(2008-10#1)(2011-1#1)
times and the##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
times and##34##2##(1993-11#1)(1993-3#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-9#1)(2009-3#2)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#2)
times are##9##2##(1993-2#1)(1995-2#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)
times as likely to##2##4##(1995-2#2)
times as many##2##3##(1991-2#1)(1992-9#1)
times as much##2##3##(1994-9#1)(2008-10#1)
times as##10##2##(1991-2#1)(1992-9#1)(1994-9#1)(1995-2#2)(1997-3#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-8#1)
times at##7##2##(1990-2#1)(1993-6#1)(2008-10#3)(2008-11#1)(2013-1#1)
times before##4##2##(1994-8#1)(1996-5#1)(2008-10#1)(2010-8#1)
times below##2##2##(2008-10#1)(2010-9#1)
times better##3##2##(2007-12#1)(2008-10#2)
times between##5##2##(1995-9#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-12#1)
times by##4##2##(2008-10#1)(2008-11#2)(2010-8#1)
times daily##2##2##(1991-12#1)(2007-11#1)
times during the season##2##4##(2008-10#1)(2008-8#1)
times during the##6##3##(2008-10#4)(2008-12#1)(2008-8#1)
times during##11##2##(1993-9#1)(1994-12#1)(2008-10#6)(2008-12#1)(2008-8#1)(2010-7#1)
times each##2##2##(2008-10#2)
times faster than between two##2##5##(2008-11#2)
times faster than##7##3##(1994-1#1)(2008-10#3)(2008-11#2)(2008-6#1)
times faster##12##2##(1994-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#2)
times for Mn2+##2##3##(1995-6#2)
times for the formation of##2##5##(2008-10#2)
times for the##3##3##(2008-10#3)
times for##23##2##(1995-6#3)(2008-10#14)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
times from the##2##3##(2008-5#1)(2008-8#1)
times from##7##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
times greater for##2##3##(2008-10#1)(2013-8#1)
times greater in##2##3##(2008-10#2)
times greater than the##3##4##(1991-2#1)(1996-2#1)(2008-10#1)
times greater than those##2##4##(1993-1#1)(2008-5#1)
times greater than##11##3##(1990-9#1)(1991-2#1)(1992-3#1)(1993-1#1)(1996-2#1)(2008-10#5)(2008-5#1)
times greater##20##2##(1990-9#1)(1991-2#1)(1992-3#1)(1993-1#1)(1996-2#1)(2008-10#10)(2008-11#2)(2008-5#1)(2012-3#1)(2013-8#1)
times higher among##3##3##(1995-12#2)(2012-3#1)
times higher in##2##3##(2008-10#1)(2008-3#1)
times higher than in##2##4##(1992-8#1)(2012-3#1)
times higher than that for##2##5##(2008-2#1)(2008-3#1)
times higher than that of the culture under 5% CO(2) supply##2##11##(2008-11#2)
times higher than that of the##3##6##(2008-11#2)(2011-3#1)
times higher than that of##6##5##(2008-10#2)(2008-11#2)(2008-8#1)(2011-3#1)
times higher than that##11##4##(1995-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-3#1)
times higher than the##4##4##(2008-10#1)(2008-7#3)
times higher than those from##2##5##(2008-11#2)
times higher than those of##3##5##(1993-3#1)(1993-8#1)(1997-8#1)
times higher than those##6##4##(1993-3#1)(1993-8#1)(1997-8#1)(2008-11#3)
times higher than##28##3##(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#1)(1997-8#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2011-3#1)(2012-3#1)(2013-8#1)
times higher##47##2##(1990-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-12#4)(1997-8#1)(2008-10#15)(2008-11#7)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-8#2)
times in each##2##3##(1994-2#1)(2008-10#1)
times in the past##2##4##(1992-12#1)(2008-12#1)
times in the##5##3##(1992-12#1)(1995-8#1)(2008-12#1)(2008-3#1)(2012-3#1)
times in##24##2##(1990-5#1)(1992-12#1)(1994-2#1)(1995-8#2)(1996-5#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-12#3)(2011-2#1)(2012-3#1)
times increase in##2##3##(2008-11#1)(2008-8#1)
times increase##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
times larger than that##2##4##(2008-10#2)
times larger than##5##3##(1997-6#1)(2008-10#3)(2009-5#1)
times larger##7##2##(1997-6#1)(2007-12#1)(2008-10#4)(2009-5#1)
times less##6##2##(1990-8#1)(1995-8#1)(2008-10#3)(2011-2#1)
times longer##4##2##(1993-1#1)(2008-10#2)(2008-11#1)
times lower than that##2##4##(2008-10#1)(2011-2#1)
times lower than the##2##4##(1990-11#1)(2008-10#1)
times lower than those of##3##5##(1990-6#1)(2008-10#1)(2008-11#1)
times lower than those##5##4##(1990-6#1)(2008-10#2)(2008-11#2)
times lower than##11##3##(1990-11#1)(1990-6#1)(2008-10#5)(2008-11#3)(2011-2#1)
times lower##12##2##(1990-11#1)(1990-6#1)(2008-10#5)(2008-11#3)(2008-7#1)(2011-2#1)
times more dead##2##3##(2008-10#2)
times more efficient than##2##4##(1990-5#1)(2008-8#1)
times more frequent##2##3##(1990-8#1)(1997-3#1)
times more likely to have##2##5##(2008-9#1)(2011-2#1)
times more likely to##5##4##(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
times more potent than the##2##5##(1992-4#1)(1994-5#1)
times more sensitive than the##3##5##(2008-10#3)
times more sensitive than##5##4##(2008-10#5)
times more than the##2##4##(2008-8#1)(2013-1#1)
times more than##5##3##(1991-2#1)(1992-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
times more##35##2##(1990-5#1)(1990-8#1)(1991-2#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
times of 2##2##3##(2008-10#1)(2008-3#1)
times of 30 and##3##4##(2008-10#3)
times of tarabine PFS and adriblastina were##2##7##(2008-10#2)
times of that##3##3##(2008-11#2)(2008-9#1)
times of the##11##3##(1994-3#2)(2008-10#5)(2008-11#2)(2008-2#1)(2011-3#1)
times of##49##2##(1992-6#1)(1993-2#1)(1993-6#1)(1994-3#2)(1996-3#1)(1997-2#1)(2008-10#23)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#2)(2010-1#1)(2010-8#1)(2011-3#1)(2013-8#1)
times on test items##2##4##(2009-12#2)
times on##4##2##(2008-10#2)(2009-12#2)
times over the##4##3##(1997-6#1)(2008-10#2)(2009-12#1)
times over##5##2##(1997-6#1)(2008-10#2)(2008-12#1)(2009-12#1)
times per week for 2 h per day##2##8##(2008-10#2)
times per week for##3##4##(2008-10#2)(2013-8#1)
times per week##6##3##(2008-1#1)(2008-10#2)(2011-1#1)(2013-1#1)(2013-8#1)
times per##9##2##(2008-1#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
times ranging##2##2##(2008-10#2)
times reported by Mills##2##4##(2008-10#2)
times reported##3##2##(2008-10#3)
times required for infection##2##4##(2008-10#2)
times required for##3##3##(2008-10#2)(2008-3#1)
times required to##2##3##(2008-10#1)(2011-2#1)
times required##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
times smaller than##3##3##(1994-5#1)(2008-10#1)(2009-5#1)
times stronger than that of##2##5##(1996-2#1)(2008-8#1)
times stronger than##4##3##(1996-2#1)(2008-11#2)(2008-8#1)
times than##6##2##(2008-10#2)(2012-3#3)(2013-1#1)
times that in the medium containing only FCS##2##8##(2008-11#2)
times that in the##3##4##(2008-11#3)
times that of chromium(VI)##2##4##(2008-10#2)
times that of the##4##4##(1991-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
times that of##13##3##(1991-9#1)(1993-3#1)(1994-8#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
times that##21##2##(1991-12#1)(1991-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-3#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)
times the control##3##3##(2008-10#1)(2010-3#2)
times the level##2##3##(1992-3#1)(2009-4#1)
times the standard deviation of the reagent blank) is##2##9##(2008-10#2)
times the standard deviation of the##10##6##(2008-10#10)
times the standard deviation of##13##5##(2008-10#13)
times the standard deviation##14##4##(2008-10#14)
times the##38##2##(1990-6#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1997-5#1)(2007-12#1)(2008-10#21)(2008-2#2)(2008-3#1)(2008-8#1)(2009-4#1)(2010-3#2)(2011-2#1)(2013-1#2)
times those##2##2##(1990-5#1)(2008-8#1)
times through##2##2##(2008-10#2)
times to##10##2##(1990-12#2)(2008-10#4)(2008-5#1)(2008-9#2)(2013-8#1)
times was##2##2##(2008-10#2)
times were##16##2##(1993-6#1)(2008-10#9)(2008-11#2)(2008-5#2)(2010-8#1)(2012-12#1)
times which##2##2##(1994-3#1)(1995-3#1)
times with the##2##3##(2008-11#1)(2009-3#1)
times with##8##2##(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)
times within##4##2##(1997-8#1)(2008-11#1)(2010-12#1)(2012-2#1)
times without##2##2##(2008-10#2)
times##747##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#3)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#6)(1992-8#1)(1992-9#4)(1993-1#3)(1993-11#1)(1993-2#3)(1993-3#4)(1993-6#6)(1993-8#4)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#4)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#3)(2007-11#2)(2007-12#4)(2008-1#2)(2008-10#289)(2008-11#62)(2008-12#10)(2008-2#5)(2008-3#17)(2008-4#1)(2008-5#13)(2008-6#5)(2008-7#12)(2008-8#24)(2008-9#16)(2009-1#1)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#5)(2012-12#5)(2012-2#4)(2012-3#14)(2013-1#19)(2013-8#14)
times)##7##1##(2008-10#4)(2008-9#2)(2009-2#1)
timescale##5##1##(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#2)
timescales##11##1##(2008-10#1)(2008-8#3)(2008-9#5)(2013-1#2)
timetables##3##1##(2008-11#3)
timing and##8##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-8#1)(2013-8#1)
timing for##3##2##(2007-11#1)(2010-12#1)(2013-1#1)
timing of diagnosis and##2##4##(1991-11#1)(2010-12#1)
timing of the##10##3##(1993-12#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)
timing of##64##2##(1991-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-2#2)(2008-10#13)(2008-11#9)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-10#2)(2010-12#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#3)(2012-6#1)(2013-1#1)(2013-8#1)
timing##107##1##(1990-5#1)(1991-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1996-3#1)(1997-2#2)(2007-11#4)(2008-10#20)(2008-11#12)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#1)(2010-10#2)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#5)(2013-8#2)
timings##2##1##(2008-10#2)
timopheevii subsp##7##2##(2008-10#7)
tin (ll) etiopurpurin dichloride##2##4##(1992-1#2)
tin and nickel##3##3##(2008-10#3)
tin and titanium##2##3##(2008-10#2)
tin and##6##2##(2008-10#6)
tin determination##2##2##(2008-10#2)
tin in marine materials##2##4##(2008-10#2)
tin in##11##2##(2008-10#11)
tin is##3##2##(2008-10#3)
tin oxide thin films##2##4##(2008-10#2)
tin oxide thin##3##3##(2008-10#3)
tin oxide with high##2##4##(2008-10#2)
tin oxide##15##2##(2008-10#12)(2008-12#2)(2009-12#1)
tin protoporphyrin##2##2##(1995-2#2)
tin slag samples##2##3##(2008-10#2)
tin##68##1##(1992-1#2)(1995-2#2)(1995-3#1)(1997-3#1)(2008-10#57)(2008-12#2)(2009-12#2)(2010-11#1)
tin(II)##5##1##(2008-10#5)
tin(II)-strong phosphoric##2##2##(2008-10#2)
tin(IV)##5##1##(2008-10#5)
tinctorius##3##1##(2008-11#2)(2012-12#1)
tinea capitis in##2##3##(2008-5#2)
tinea capitis##5##2##(2008-5#5)
tinea corporis gladiatorum##2##3##(2012-3#2)
tinea corporis##4##2##(2008-5#2)(2012-3#2)
tinea unguium of the toenails##3##5##(2008-5#3)
tinea unguium##5##2##(2008-5#5)
tinea##21##1##(2008-5#18)(2012-3#3)
tinman##2##1##(1995-6#2)
tinnitus and##3##2##(1994-9#1)(1996-6#1)(2012-3#1)
tinnitus patients##2##2##(1996-6#1)(2012-12#1)
tinnitus##18##1##(1994-9#1)(1996-6#5)(2008-7#2)(2010-7#7)(2012-12#1)(2012-3#1)(2013-1#1)
tiny##12##1##(1991-9#1)(1993-12#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
tiopronin##4##1##(1994-5#4)
tip and##7##2##(1994-9#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-7#1)
tip blight disease##2##3##(2008-10#2)
tip by##2##2##(2008-10#2)
tip growth##2##2##(2008-10#2)
tip in a##2##3##(2007-12#1)(2008-10#1)
tip in##5##2##(1992-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
tip is##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
tip necrosis##2##2##(2008-10#2)
tip of a##7##3##(2008-10#6)(2008-7#1)
tip of the##19##3##(1991-3#1)(1992-1#1)(1994-12#2)(1994-2#1)(2007-12#2)(2008-10#9)(2010-12#1)(2010-6#1)(2010-8#1)
tip of##32##2##(1991-3#1)(1992-1#1)(1993-12#1)(1994-12#2)(1994-2#1)(1995-8#1)(2007-12#2)(2008-10#19)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)
tip shapes by##2##3##(2008-10#2)
tip to##2##2##(2008-10#1)(2009-7#1)
tip##117##1##(1991-3#1)(1992-1#2)(1993-12#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-8#1)(1997-3#2)(1997-6#3)(2007-12#4)(2008-10#52)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#3)(2009-7#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#3)
tip)##2##1##(2008-6#1)(2012-3#1)
tip-sample distance##2##2##(2007-12#2)
tip-sample##4##1##(2007-12#3)(2012-2#1)
tip-to-surface##2##1##(2008-5#2)
tipburn##3##1##(2008-10#3)
tipped##2##1##(2008-3#1)(2012-3#1)
tipping##3##1##(2012-2#3)
tips are##2##2##(1995-2#1)(2008-10#1)
tips for##5##2##(1995-12#1)(1995-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
tips of the##2##3##(2008-7#2)
tips of##10##2##(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-6#1)
tips##48##1##(1994-9#1)(1995-12#1)(1995-2#5)(1997-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-7#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#3)
tirotropin releasing hormone##3##3##(1991-3#3)
tissue (NIST SRM##2##3##(2008-10#2)
tissue DNA##2##2##(1996-12#1)(2011-2#1)
tissue V content and##3##4##(2011-2#3)
tissue V content##4##3##(2011-2#4)
tissue acidification##2##2##(2008-10#2)
tissue after##6##2##(1994-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-3#1)
tissue also##2##2##(2008-10#1)(2008-5#1)
tissue and its##3##3##(1990-9#1)(2007-8#1)(2013-1#1)
tissue and the##3##3##(1995-6#1)(2008-9#1)(2013-1#1)
tissue and##57##2##(1990-12#1)(1990-2#2)(1990-9#2)(1991-11#1)(1993-3#1)(1994-2#1)(1995-6#2)(1996-12#1)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
tissue are##4##2##(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
tissue as a##2##3##(2008-10#1)(2013-1#1)
tissue as the##2##3##(1992-12#1)(2008-10#1)
tissue as##6##2##(1991-12#1)(1992-12#1)(2008-10#2)(2008-4#1)(2013-1#1)
tissue at the##3##3##(1992-12#1)(2008-10#1)(2008-11#1)
tissue at##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
tissue based on##2##3##(2008-10#1)(2009-10#1)
tissue based##4##2##(2008-10#3)(2009-10#1)
tissue block radiography##3##3##(1997-8#3)
tissue block##4##2##(1997-8#3)(2013-1#1)
tissue blocks##2##2##(1997-8#1)(2009-8#1)
tissue blot##3##2##(2008-10#3)
tissue by inhibiting##2##3##(1990-2#1)(2008-10#1)
tissue by##16##2##(1990-2#1)(1992-12#1)(2007-12#1)(2008-10#11)(2010-11#1)(2012-2#1)
tissue collagenase##2##2##(1994-3#2)
tissue collapse was##2##3##(2008-10#2)
tissue colonization##2##2##(2008-10#2)
tissue compatibility##3##2##(2012-3#3)
tissue concentrations##2##2##(1994-5#1)(2012-2#1)
tissue contains##3##2##(2008-11#1)(2008-3#1)(2010-4#1)
tissue content##3##2##(1996-12#2)(2013-7#1)
tissue contrast##2##2##(2010-12#1)(2012-12#1)
tissue culture cells##4##3##(2008-4#3)(2008-9#1)
tissue culture media##2##3##(2008-10#1)(2008-9#1)
tissue culture of##2##3##(1991-2#1)(2008-11#1)
tissue culture plates##2##3##(2008-10#1)(2008-11#1)
tissue culture##35##2##(1991-2#1)(1993-11#3)(1997-1#1)(2008-10#5)(2008-11#13)(2008-12#1)(2008-4#3)(2008-9#3)(2011-2#2)(2011-3#1)(2012-3#1)(2012-5#1)
tissue cultures##4##2##(2008-11#2)(2012-3#1)(2013-1#1)
tissue damage is##2##3##(2010-4#1)(2013-1#1)
tissue damage##11##2##(1990-12#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2012-3#1)(2013-1#1)
tissue destruction##3##2##(1990-11#1)(1992-12#1)(2011-2#1)
tissue development##6##2##(1993-6#1)(2011-2#2)(2012-2#3)
tissue diagnosis##4##2##(1995-1#1)(1995-3#1)(2008-1#1)(2010-11#1)
tissue discs##2##2##(2008-10#2)
tissue diseases##3##2##(1991-9#1)(1995-5#2)
tissue disorder##2##2##(2008-5#1)(2010-6#1)
tissue disorders##3##2##(1992-1#1)(2010-3#1)(2012-3#1)
tissue distribution##7##2##(1990-5#1)(1995-6#1)(1996-12#1)(2008-4#1)(2008-7#1)(2010-5#2)
tissue due to##2##3##(1992-3#1)(2008-10#1)
tissue during##4##2##(1990-11#1)(1991-2#1)(2008-10#1)(2010-3#1)
tissue engineering and cell##2##4##(2011-3#1)(2013-1#1)
tissue engineering and regenerative medicine##3##5##(2009-7#1)(2012-5#2)
tissue engineering and##7##3##(2009-7#1)(2011-3#2)(2012-5#2)(2013-1#2)
tissue engineering applications##2##3##(2008-10#1)(2008-11#1)
tissue engineering in##2##3##(2008-11#1)(2009-7#1)
tissue engineering##39##2##(2008-10#1)(2008-11#8)(2009-12#1)(2009-7#9)(2010-10#1)(2010-9#3)(2011-2#2)(2011-3#2)(2012-2#5)(2012-5#3)(2013-1#4)
tissue extracts##8##2##(1990-11#1)(1990-5#1)(1994-8#1)(2008-10#4)(2008-11#1)
tissue factor##2##2##(1992-10#1)(2010-3#1)
tissue for the##2##3##(2008-10#1)(2008-11#1)
tissue for##9##2##(1991-2#1)(1992-12#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)
tissue formation##2##2##(2009-12#1)(2010-9#1)
tissue from the##3##3##(2008-10#2)(2009-7#1)
tissue from##13##2##(1991-2#1)(1992-3#1)(1994-11#2)(2008-10#7)(2008-11#1)(2009-7#1)
tissue growth##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
tissue have##2##2##(1994-8#1)(2013-1#1)
tissue homeostasis and##2##3##(2008-5#1)(2008-7#1)
tissue homeostasis##4##2##(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)
tissue homogenate and gelatin##2##4##(2008-10#2)
tissue homogenate##13##2##(2008-10#9)(2008-5#2)(2010-8#2)
tissue homogenates##4##2##(1994-2#1)(2008-4#3)
tissue in a##2##3##(1995-9#1)(2008-10#1)
tissue in response to##2##4##(2008-1#1)(2008-7#1)
tissue in the##7##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
tissue in##26##2##(1991-12#1)(1995-12#1)(1995-9#1)(1996-12#2)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
tissue included##3##2##(2008-10#2)(2010-10#1)
tissue indicated##2##2##(2008-10#1)(2008-7#1)
tissue indicating##2##2##(2009-4#1)(2011-2#1)
tissue inflammation##3##2##(1997-2#1)(2008-12#2)
tissue inhibitor of metalloproteinase##5##4##(1990-8#2)(2008-5#1)(2008-9#1)(2010-1#1)
tissue inhibitor of##10##3##(1990-8#2)(2008-5#2)(2008-9#2)(2010-1#2)(2010-6#1)(2013-1#1)
tissue injury##7##2##(1990-2#2)(1994-11#1)(1997-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
tissue interactions##2##2##(2008-6#2)
tissue into##3##2##(1993-12#1)(2008-10#1)(2012-2#1)
tissue is described##2##3##(2008-12#1)(2008-4#1)
tissue is##9##2##(1994-5#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)
tissue lesions##5##2##(1994-5#1)(2009-11#1)(2012-2#3)
tissue level##2##2##(1992-1#1)(2013-1#1)
tissue levels of##2##3##(1995-11#1)(2008-4#1)
tissue levels##3##2##(1995-11#1)(2008-4#1)(2008-5#1)
tissue loss##3##2##(2008-6#2)(2011-2#1)
tissue may be##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
tissue microstructure##2##2##(2010-4#1)(2012-2#1)
tissue mineralization##2##2##(2008-11#2)
tissue model##2##2##(1992-3#1)(2008-11#1)
tissue nitrogen##3##2##(2008-10#3)
tissue obtained from##2##3##(1993-3#1)(2012-2#1)
tissue obtained##5##2##(1992-12#1)(1993-3#2)(2012-2#1)(2013-7#1)
tissue of the##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
tissue of transgenic tomato##2##4##(2008-10#2)
tissue of transgenic##3##3##(2008-10#2)(2008-9#1)
tissue of##27##2##(1994-11#2)(1995-6#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)
tissue on##2##2##(1990-10#1)(2008-11#1)
tissue or##7##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-8#2)
tissue organization and##2##3##(2008-5#1)(2009-5#1)
tissue organization##3##2##(2008-5#1)(2009-5#1)(2013-1#1)
tissue overgrowth##2##2##(2008-9#2)
tissue oxygen##2##2##(1996-3#2)
tissue plasminogen activator##12##3##(2007-9#1)(2008-11#1)(2008-7#6)(2009-11#1)(2009-6#1)(2010-3#1)(2013-8#1)
tissue plasminogen##13##2##(2007-9#1)(2008-11#2)(2008-7#6)(2009-11#1)(2009-6#1)(2010-3#1)(2013-8#1)
tissue polypeptide antigen##2##3##(1990-8#2)
tissue preservation##3##2##(1996-3#1)(2008-10#2)
tissue procurement##2##2##(2010-9#2)
tissue protein biomarkers##2##3##(2010-9#2)
tissue protein##3##2##(2010-9#3)
tissue regeneration and##3##3##(2010-3#1)(2012-3#2)
tissue regeneration##12##2##(1990-9#1)(2008-10#1)(2009-12#2)(2009-5#1)(2010-3#1)(2012-3#2)(2013-1#3)(2013-8#1)
tissue remained##2##2##(2008-10#2)
tissue remains##2##2##(1991-2#1)(2010-9#1)
tissue remodeling##2##2##(2012-2#1)(2012-3#1)
tissue repair##5##2##(2008-4#1)(2009-12#1)(2013-1#3)
tissue resident effector memory CD8+##2##5##(2013-8#2)
tissue resident##3##2##(2013-8#3)
tissue sample##2##2##(2007-12#1)(2009-8#1)
tissue samples of##2##3##(2009-4#1)(2010-12#1)
tissue samples##13##2##(1996-12#1)(2008-10#4)(2008-12#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#1)(2011-2#1)
tissue scaffolds##2##2##(2009-7#1)(2010-9#1)
tissue sections of##3##3##(2008-4#1)(2010-11#1)(2012-2#1)
tissue sections##13##2##(1993-11#1)(2008-10#3)(2008-4#4)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#1)
tissue selenium##3##2##(1993-12#3)
tissue showed##3##2##(1991-8#1)(2008-10#1)(2011-2#1)
tissue site##2##2##(1991-3#1)(2009-9#1)
tissue slices##3##2##(2008-8#1)(2011-3#2)
tissue sources (e##2##3##(2008-4#2)
tissue sparing##2##2##(1994-12#1)(2009-4#1)
tissue specific##7##2##(1993-11#1)(1994-11#1)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)
tissue specificity of##2##3##(1993-6#1)(2008-9#1)
tissue specificity##5##2##(1991-5#1)(1993-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
tissue specimens##5##2##(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)
tissue structure##3##2##(2007-11#2)(2012-2#1)
tissue surface##2##2##(2013-1#2)
tissue survival##2##2##(2008-7#1)(2008-9#1)
tissue susceptibility to##3##3##(2008-10#2)(2008-8#1)
tissue than##3##2##(2008-10#2)(2013-1#1)
tissue that is##2##3##(2008-5#1)(2008-7#1)
tissue that##9##2##(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
tissue thickness##2##2##(2008-5#2)
tissue to##12##2##(1990-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1996-2#1)(2008-10#2)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
tissue tropisms##3##2##(2008-10#1)(2008-5#2)
tissue tumors##4##2##(1994-6#1)(2011-2#3)
tissue type##2##2##(2008-11#1)(2008-12#1)
tissue types##6##2##(1993-2#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
tissue uptake of##2##3##(1993-11#1)(1994-5#1)
tissue uptake##3##2##(1992-9#1)(1993-11#1)(1994-5#1)
tissue using a##3##3##(1990-2#1)(2008-10#2)
tissue using both conventional##2##4##(2008-9#2)
tissue using##7##2##(1990-2#1)(2008-10#3)(2008-11#1)(2008-9#2)
tissue vaporized##2##2##(1991-2#2)
tissue was associated with##2##4##(2008-10#2)
tissue was studied##2##3##(2008-10#1)(2011-2#1)
tissue was##27##2##(1992-3#1)(1993-3#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#3)(2011-2#3)(2012-2#1)(2012-3#3)
tissue water content##2##3##(2008-10#1)(2012-12#1)
tissue water##3##2##(2008-10#2)(2012-12#1)
tissue were##7##2##(1990-2#1)(2008-10#6)
tissue with high##2##3##(2008-10#1)(2008-11#1)
tissue with the##2##3##(2008-10#2)
tissue with##17##2##(1993-12#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-5#1)(2011-2#1)
tissue within##2##2##(2008-10#1)(2009-5#1)
tissue without##5##2##(1997-5#1)(2008-10#3)(2013-8#1)
tissue##1233##1##(1990-10#1)(1990-11#7)(1990-12#4)(1990-2#14)(1990-5#6)(1990-8#6)(1990-9#3)(1991-11#2)(1991-12#5)(1991-2#13)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-12#15)(1992-2#3)(1992-3#9)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#4)(1993-1#6)(1993-11#13)(1993-12#7)(1993-2#2)(1993-3#8)(1993-6#3)(1993-9#3)(1994-11#11)(1994-12#1)(1994-2#5)(1994-3#6)(1994-5#5)(1994-6#1)(1994-8#4)(1995-1#1)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#5)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#12)(1996-2#2)(1996-3#5)(1997-1#4)(1997-2#1)(1997-3#6)(1997-4#3)(1997-5#3)(1997-8#6)(2007-11#5)(2007-12#8)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#289)(2008-11#77)(2008-12#27)(2008-2#1)(2008-3#8)(2008-4#32)(2008-5#35)(2008-6#10)(2008-7#30)(2008-8#12)(2008-9#53)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#5)(2009-3#12)(2009-4#6)(2009-5#7)(2009-6#3)(2009-7#15)(2009-8#10)(2009-9#4)(2010-1#5)(2010-10#2)(2010-11#9)(2010-12#6)(2010-3#8)(2010-4#5)(2010-5#3)(2010-6#17)(2010-7#2)(2010-8#10)(2010-9#17)(2011-2#56)(2011-3#5)(2012-12#5)(2012-2#49)(2012-3#25)(2012-5#4)(2013-1#59)(2013-7#4)(2013-8#20)
tissue)##2##1##(2008-12#1)(2010-12#1)
tissue-##4##1##(1994-5#1)(2008-5#1)(2008-7#1)(2012-2#1)
tissue-engineered##4##1##(2008-10#1)(2010-5#1)(2011-3#1)(2012-2#1)
tissue-isolated##2##1##(2013-7#2)
tissue-like##5##1##(2008-11#1)(2010-12#4)
tissue-specific and##2##2##(1993-12#1)(1993-6#1)
tissue-specific expression of##2##3##(2008-10#1)(2008-9#1)
tissue-specific expression##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
tissue-specific manner##3##2##(1995-8#1)(1996-2#1)(1997-7#1)
tissue-specific##23##1##(1992-6#3)(1993-12#3)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#2)(2010-7#1)
tissue-type plasminogen activator##5##3##(1995-6#1)(1995-8#1)(1997-1#1)(2008-11#1)(2008-8#1)
tissue-type plasminogen##7##2##(1995-6#2)(1995-8#2)(1997-1#1)(2008-11#1)(2008-8#1)
tissue-type##8##1##(1994-3#1)(1995-6#2)(1995-8#2)(1997-1#1)(2008-11#1)(2008-8#1)
tissue?##2##1##(1990-8#1)(2009-10#1)
tissues (liver##2##2##(1990-11#1)(2008-10#1)
tissues adjacent to##2##3##(2008-10#2)
tissues after##3##2##(1992-9#1)(1996-12#1)(2008-10#1)
tissues and cell lines##2##4##(1993-8#1)(2008-9#1)
tissues and cells##3##3##(1992-9#1)(2008-7#1)(2013-8#1)
tissues and for##2##3##(2008-11#1)(2013-1#1)
tissues and is##3##3##(1995-6#1)(2008-10#1)(2010-12#1)
tissues and organs##4##3##(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
tissues and the##2##3##(2009-10#1)(2013-1#1)
tissues and##59##2##(1992-9#2)(1993-3#2)(1993-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-12#4)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
tissues are##7##2##(2008-10#1)(2008-4#1)(2009-7#1)(2009-8#2)(2010-8#1)(2013-1#1)
tissues around the##2##3##(2009-4#1)(2013-8#1)
tissues as well as##2##4##(1997-1#1)(2008-11#1)
tissues as##7##2##(1991-6#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
tissues at##4##2##(1994-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
tissues based on##2##3##(2008-11#1)(2012-12#1)
tissues but##3##2##(2008-10#1)(2008-9#2)
tissues by Northern blot analysis##2##5##(1993-2#1)(1995-6#1)
tissues by flow cytometry##2##4##(2008-11#1)(2008-9#1)
tissues by high-performance liquid chromatography##2##5##(2008-10#1)(2009-8#1)
tissues by##16##2##(1991-5#1)(1993-11#1)(1993-2#1)(1995-6#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-9#1)(2009-8#1)
tissues can be##5##3##(1994-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
tissues can##7##2##(1994-5#1)(2008-10#4)(2008-11#1)(2013-8#1)
tissues collected##2##2##(2008-10#2)
tissues compared##2##2##(2010-12#1)(2013-1#1)
tissues containing##3##2##(2008-10#2)(2008-11#1)
tissues during##4##2##(1990-5#1)(1994-5#1)(2010-5#1)(2012-2#1)
tissues examined##6##2##(1991-5#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-9#1)
tissues except##3##2##(1996-3#1)(2010-5#1)(2011-2#1)
tissues for##5##2##(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)
tissues from##12##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-6#1)(1993-3#1)(2008-10#3)(2010-12#1)(2011-2#1)(2012-3#1)
tissues have##5##2##(1991-2#1)(2008-11#1)(2010-12#1)(2010-4#1)(2012-12#1)
tissues in the##5##3##(1990-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
tissues in##16##2##(1990-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
tissues including the##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-3#1)
tissues including##6##2##(1995-8#1)(2008-10#1)(2008-11#2)(2010-5#1)(2012-3#1)
tissues infected with##2##3##(2008-10#2)
tissues involved##2##2##(1990-3#1)(2010-6#1)
tissues is##11##2##(1991-2#1)(1991-7#1)(1994-8#1)(2008-10#4)(2008-12#1)(2010-8#2)(2011-1#1)
tissues may be##2##3##(2008-10#1)(2008-12#1)
tissues may##3##2##(2008-10#2)(2008-12#1)
tissues of Astacus##2##3##(2008-12#2)
tissues of snails##2##3##(2008-12#2)
tissues of the infected##2##4##(2008-10#1)(2008-9#1)
tissues of the##13##3##(1994-5#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-12#4)(2008-9#1)(2010-6#1)(2010-9#1)
tissues of transgenic##2##3##(1993-12#1)(2008-11#1)
tissues of##49##2##(1990-11#2)(1990-5#1)(1991-12#1)(1992-3#3)(1993-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#13)(2008-11#1)(2008-12#12)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-6#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
tissues on##2##2##(1992-1#1)(1993-12#1)
tissues or organs##3##3##(2008-11#1)(2009-12#1)(2010-9#1)
tissues or##7##2##(1991-3#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-9#1)
tissues revealed##4##2##(1992-12#1)(2008-10#2)(2012-2#1)
tissues showed##2##2##(1991-12#1)(2008-10#1)
tissues studied##3##2##(1990-11#1)(1990-3#1)(2008-5#1)
tissues such as##10##3##(1990-11#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#1)
tissues surrounding##2##2##(2008-10#1)(2008-12#1)
tissues tested##2##2##(1993-6#1)(1994-11#1)
tissues than##3##2##(1992-9#1)(2008-10#1)(2010-12#1)
tissues that have##2##3##(2008-9#1)(2012-2#1)
tissues that##5##2##(1992-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
tissues to##5##2##(1993-12#1)(1994-11#1)(2008-6#1)(2008-9#1)(2013-1#1)
tissues under##3##2##(2012-2#1)(2013-1#2)
tissues using a##3##3##(1991-5#1)(1991-9#1)(1994-11#1)
tissues using##9##2##(1990-11#1)(1991-5#1)(1991-9#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
tissues was##10##2##(1993-11#1)(1994-5#1)(1995-8#1)(2008-10#5)(2008-6#1)(2010-12#1)
tissues were also##2##3##(1990-11#1)(2009-12#1)
tissues were##13##2##(1990-11#1)(1990-3#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#2)
tissues when##3##2##(2010-12#2)(2013-1#1)
tissues which##2##2##(2008-10#1)(2010-8#1)
tissues with##7##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)
tissues within##3##2##(2008-10#2)(2008-7#1)
tissues would##2##2##(1997-8#1)(2013-1#1)
tissues##671##1##(1990-11#11)(1990-12#8)(1990-2#2)(1990-3#3)(1990-5#5)(1990-6#1)(1991-12#7)(1991-2#4)(1991-3#2)(1991-5#6)(1991-6#3)(1991-7#3)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#5)(1992-6#1)(1992-9#8)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#8)(1993-6#2)(1993-8#6)(1994-11#9)(1994-12#2)(1994-3#2)(1994-5#4)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-6#6)(1995-8#4)(1996-12#1)(1996-2#4)(1996-3#3)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#4)(1997-9#1)(2008-1#3)(2008-10#207)(2008-11#38)(2008-12#21)(2008-3#2)(2008-4#10)(2008-5#12)(2008-6#5)(2008-7#13)(2008-8#8)(2008-9#28)(2009-10#5)(2009-12#3)(2009-4#1)(2009-6#1)(2009-7#5)(2009-8#11)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#16)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#3)(2011-10#1)(2011-2#18)(2011-3#1)(2012-12#7)(2012-2#21)(2012-3#10)(2013-1#21)(2013-7#1)(2013-8#8)
tissues)##3##1##(2008-10#1)(2012-12#2)
tissular##4##1##(1990-5#1)(1992-12#1)(2008-11#2)
tit##6##1##(2008-5#1)(2008-8#3)(2008-9#2)
titania##4##1##(2008-10#3)(2010-4#1)
titanium and tin##2##3##(2008-10#2)
titanium and##4##2##(2008-10#2)(2008-11#1)(2009-7#1)
titanium bearing##3##2##(2008-10#3)
titanium dental##2##2##(2009-7#2)
titanium determination##2##2##(2008-10#2)
titanium dioxide (TiO(2))##2##3##(2008-10#1)(2008-5#1)
titanium dioxide by##2##3##(2008-10#2)
titanium dioxide##17##2##(2008-10#14)(2008-5#3)
titanium in##3##2##(2008-10#3)
titanium mesh##5##2##(2008-7#2)(2011-2#3)
titanium oxide##2##2##(2008-10#2)
titanium trichloride##4##2##(2008-10#4)
titanium##74##1##(2008-10#50)(2008-11#2)(2008-5#3)(2008-7#2)(2009-7#6)(2010-4#1)(2011-2#3)(2012-2#2)(2013-1#5)
titanium(IV) from##2##2##(2008-10#2)
titanium(IV) has##2##2##(2008-10#2)
titanium(IV)##6##1##(2008-10#6)
titer against ND##2##3##(2008-12#2)
titer against##3##2##(2008-12#3)
titer and PFC##2##3##(2008-11#2)
titer and##7##2##(1995-11#1)(2008-10#2)(2008-11#4)
titer could##2##2##(2008-10#1)(2008-11#1)
titer for##2##2##(2008-9#1)(2012-3#1)
titer in##2##2##(2008-10#1)(2008-4#1)
titer of##8##2##(1992-12#1)(1995-5#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
titer was determined##2##3##(2008-10#1)(2013-8#1)
titer was##7##2##(2008-10#1)(2008-11#3)(2010-1#1)(2012-3#1)(2013-8#1)
titer##62##1##(1990-11#1)(1991-8#1)(1992-12#2)(1995-11#3)(1995-5#1)(1997-8#1)(2008-10#10)(2008-11#25)(2008-12#5)(2008-4#2)(2008-8#2)(2008-9#2)(2010-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
titer) and##2##2##(2008-10#1)(2011-3#1)
titers against##2##2##(2008-12#1)(2012-3#1)
titers by##3##2##(2008-10#1)(2008-11#2)
titers for canine parvovirus type-2##2##5##(2012-3#2)
titers in the##2##3##(2008-6#1)(2011-2#1)
titers in##3##2##(2008-12#1)(2008-6#1)(2011-2#1)
titers of antibodies##2##3##(2009-12#1)(2012-3#1)
titers of##11##2##(1995-11#1)(1996-11#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-7#1)(2012-3#1)
titers were##5##2##(1995-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
titers##43##1##(1994-12#2)(1995-11#2)(1995-5#1)(1996-11#1)(2008-10#4)(2008-11#15)(2008-12#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#4)
title compound##2##2##(2008-10#2)
title compounds##4##2##(1997-4#1)(2008-10#1)(2011-3#1)(2012-3#1)
title##15##1##(1991-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#3)(2008-5#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
titles##3##1##(2008-11#2)(2011-2#1)
titrant and##3##2##(2008-10#3)
titrant are##2##2##(2008-10#2)
titrant concentration##3##2##(2008-10#3)
titrant containing a lipophilic##2##4##(2008-10#2)
titrant flow##2##2##(2008-10#2)
titrant is##3##2##(2008-10#3)
titrant to##2##2##(2008-10#2)
titrant##44##1##(2008-10#42)(2008-11#2)
titratable acidity##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
titrated bases##2##2##(2008-10#2)
titrated with##4##2##(1994-5#1)(2008-10#3)
titrated##18##1##(1994-5#2)(2008-10#14)(2010-4#1)(2013-8#1)
titrating##3##1##(2008-10#3)
titration and the##2##3##(2008-10#2)
titration and##11##2##(2008-10#11)
titration as well##2##3##(2008-10#2)
titration at##2##2##(2008-10#2)
titration calorimetry##4##2##(1992-10#1)(1994-5#1)(1997-2#1)(2008-10#1)
titration cell##3##2##(2008-10#3)
titration curve##3##2##(2008-10#3)
titration curves were obtained##2##4##(2008-10#2)
titration curves##4##2##(2008-10#4)
titration data##6##2##(2008-10#6)
titration end-point##3##2##(2008-10#3)
titration for the determination of##2##5##(2008-10#2)
titration for##4##2##(2008-10#4)
titration has been##4##3##(2008-10#4)
titration in##3##2##(2008-10#3)
titration is described##2##3##(2008-10#2)
titration is##8##2##(2008-10#8)
titration method for determination of##2##5##(2008-10#2)
titration method for##4##3##(2008-10#4)
titration method is##2##3##(2008-10#2)
titration method##18##2##(2008-10#18)
titration of copper##2##3##(2008-10#2)
titration of some##2##3##(2008-10#2)
titration of the##4##3##(2008-10#4)
titration of thiocyanate##2##3##(2008-10#2)
titration of weak acids in##2##5##(2008-10#2)
titration of weak acids##3##4##(2008-10#3)
titration of##59##2##(1991-9#1)(2008-10#54)(2008-11#2)(2008-4#1)(2008-9#1)
titration protocols##2##2##(2008-10#2)
titration rate##2##2##(2008-10#2)
titration system for the determination of##2##6##(2008-10#2)
titration system##4##2##(2008-10#4)
titration time##2##2##(2008-10#2)
titration to##3##2##(2008-10#2)(2008-7#1)
titration using an##2##3##(2008-10#2)
titration using##4##2##(2008-10#4)
titration was used##2##3##(2008-10#2)
titration was##6##2##(2008-10#6)
titration were##4##2##(2008-10#4)
titration with##12##2##(2008-10#10)(2008-7#2)
titration##234##1##(1990-9#1)(1991-9#1)(1992-10#1)(1994-5#1)(1997-2#1)(1997-7#1)(2008-10#220)(2008-11#2)(2008-4#2)(2008-7#3)(2008-9#1)
titration)##4##1##(2008-10#4)
titration-reagent##2##1##(2008-10#2)
titrations and the##2##3##(2008-10#2)
titrations and##4##2##(2008-10#4)
titrations are##2##2##(2008-10#2)
titrations in##3##2##(2008-10#3)
titrations is##2##2##(2008-10#2)
titrations made in##2##3##(2008-10#2)
titrations of calcium##2##3##(2008-10#2)
titrations of non-growing cells##2##4##(1991-11#2)
titrations of phenothiazine derivatives in aqueous micellar##2##7##(2008-10#2)
titrations of##14##2##(1991-11#2)(1996-12#1)(2008-10#11)
titrations the pH##2##3##(2008-10#2)
titrations were##5##2##(2008-10#5)
titrations with a##2##3##(2008-10#2)
titrations with##6##2##(2008-10#6)
titrations##65##1##(1991-11#2)(1991-5#1)(1994-5#1)(1996-12#1)(2008-10#60)
titre##13##1##(1995-12#1)(1996-12#1)(2008-11#10)(2012-2#1)
titres of##2##2##(1994-12#1)(1996-12#1)
titres##11##1##(1991-12#1)(1994-12#1)(1994-8#1)(1996-12#2)(2008-11#2)(2008-5#1)(2009-6#2)(2011-2#1)
titrimetric method##5##2##(2008-10#5)
titrimetric methods##2##2##(2008-10#2)
titrimetric##15##1##(2008-10#15)
tits (Parus##2##2##(2008-5#2)
tits Parus##2##2##(2008-8#2)
tits were##3##2##(2008-5#3)
tits##21##1##(2008-5#15)(2008-8#6)
to $12##2##2##(1992-1#1)(1994-2#1)
to $2##2##2##(1994-1#1)(2008-10#1)
to &gt##18##2##(1995-6#1)(1997-3#2)(2008-10#10)(2008-11#2)(2008-5#1)(2008-8#1)(2012-3#1)
to &lt##13##2##(2008-10#9)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
to &quot##29##2##(1990-9#1)(1991-2#1)(1991-3#2)(1992-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#2)
to (1)##6##2##(1994-12#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-12#1)(2013-1#1)
to (a)##4##2##(1997-2#1)(2008-7#1)(2010-4#1)(2013-8#1)
to (i) distinguish##2##3##(2008-10#2)
to (i)##14##2##(2008-10#10)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
to +/-##2##2##(1992-11#2)
to +0##3##2##(2008-10#3)
to -0##11##2##(2008-10#7)(2010-4#3)(2013-1#1)
to -100 is essential for##2##5##(1995-6#2)
to -100##3##2##(1995-6#3)
to -4##2##2##(1995-2#1)(2008-10#1)
to -5##2##2##(1995-2#1)(2011-1#1)
to 0 degrees##2##3##(2008-10#1)(2009-3#1)
to 0##256##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#1)(1996-2#1)(1996-3#1)(2008-10#159)(2008-11#13)(2008-12#1)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#4)(2010-6#3)(2011-2#5)(2012-2#5)(2012-3#2)(2013-1#15)(2013-8#5)
to 06##2##2##(2008-10#1)(2012-12#1)
to 1 January##2##3##(1996-1#2)
to 1 g##2##3##(2008-10#1)(2008-11#1)
to 1 mg l(-1)##2##4##(2008-10#2)
to 1 microM##3##3##(1990-2#2)(1993-8#1)
to 1 ml of##2##4##(2008-10#1)(2008-12#1)
to 1 ml##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
to 1 mol##2##3##(1990-2#1)(2010-4#1)
to 1 mug##2##3##(2008-10#2)
to 1 x##3##3##(2008-10#2)(2008-2#1)
to 1 year##2##3##(1990-12#1)(2008-10#1)
to 1##274##2##(1990-11#1)(1990-12#2)(1990-2#3)(1991-11#1)(1991-6#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-5#1)(1996-1#2)(1996-2#2)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#174)(2008-11#15)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-11#2)(2009-12#2)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#4)
to 1%##5##2##(2008-10#4)(2012-3#1)
to 1-2##2##2##(1992-9#1)(1994-3#1)
to 10 and##3##3##(2008-10#2)(2008-5#1)
to 10 days after inoculation##2##5##(2008-10#2)
to 10 days##4##3##(1992-12#1)(2008-10#2)(2010-8#1)
to 10 mM##2##3##(1995-11#1)(2008-10#1)
to 10 microM##3##3##(1991-5#1)(1994-5#1)(1995-11#1)
to 10 mm in diameter)##2##5##(2008-10#2)
to 10 mm in##4##4##(1990-2#2)(2008-10#2)
to 10 months##2##3##(1991-8#1)(2008-10#1)
to 10 muM##4##3##(2008-10#3)(2008-7#1)
to 10 mug##3##3##(2008-10#2)(2008-11#1)
to 10 percent of the##2##5##(1992-3#1)(1995-6#1)
to 10 times higher##2##4##(1995-11#1)(2013-8#1)
to 10 years##5##3##(1996-5#1)(2008-10#2)(2010-2#1)(2012-12#1)
to 10##104##2##(1990-2#3)(1991-5#1)(1991-8#1)(1992-11#2)(1992-12#3)(1992-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#54)(2008-11#9)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
to 10% of##4##3##(1990-2#1)(1993-6#1)(1996-12#1)(2009-12#1)
to 10%##16##2##(1990-2#1)(1990-6#1)(1993-6#1)(1994-11#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-8#1)
to 10%)##3##2##(2008-10#3)
to 10(-1) M##2##3##(2008-10#2)
to 10(-1)##4##2##(2008-10#4)
to 10(-1)M##2##2##(2008-10#2)
to 10(-2)moll(-1) for##2##3##(2008-10#2)
to 10(-5) M##3##3##(1997-4#1)(2008-10#2)
to 10(-5)##4##2##(1997-4#1)(2008-10#2)(2011-2#1)
to 10(-7) M##3##3##(1991-5#1)(2008-10#2)
to 10(-7)##5##2##(1991-5#1)(1997-4#2)(2008-10#2)
to 10(-8)##2##2##(1997-4#1)(2009-6#1)
to 10(4)##3##2##(1995-9#1)(2008-10#2)
to 10(5) cgs##2##3##(2008-10#2)
to 10(5)##6##2##(2008-10#5)(2008-11#1)
to 10(6)##5##2##(1995-2#1)(2008-10#4)
to 10(7) CFU##2##3##(2008-10#2)
to 10(7)##4##2##(2008-10#4)
to 100 and##2##3##(2008-10#2)
to 100 mM##2##3##(1992-7#1)(2008-10#1)
to 100 mug l(-1)##3##4##(2008-10#3)
to 100 mug##6##3##(2008-10#6)
to 100 ng/ml)##2##3##(2008-6#2)
to 100##60##2##(1990-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-11#1)(1994-6#1)(1997-2#1)(2008-10#34)(2008-11#5)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#1)
to 100% and##2##3##(2008-10#1)(2011-2#1)
to 100% for##7##3##(2008-10#5)(2008-5#1)(2011-2#1)
to 100% nucleotide##2##3##(2008-10#1)(2008-5#1)
to 100% of the##2##4##(1993-8#1)(2008-10#1)
to 100% of##5##3##(1993-8#1)(2008-10#3)(2008-9#1)
to 100% were##2##3##(2008-10#2)
to 100% with##2##3##(2008-10#2)
to 100%##48##2##(1990-11#1)(1991-2#1)(1993-2#1)(1993-8#1)(1997-2#1)(2008-10#35)(2008-11#1)(2008-5#2)(2008-9#2)(2011-2#3)
to 100%)##6##2##(2008-10#5)(2010-6#1)
to 100)##2##2##(2008-10#1)(2010-8#1)
to 1000 ppm##2##3##(2008-10#2)
to 1000 times##2##3##(1997-5#1)(2008-12#1)
to 1000##13##2##(1994-8#1)(1997-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)
to 101##8##2##(2008-10#8)
to 101%##5##2##(2008-10#5)
to 102##5##2##(2008-10#5)
to 102% for##3##3##(2008-10#3)
to 102%##7##2##(2008-10#7)
to 103##2##2##(1992-11#1)(2008-10#1)
to 103% for Sb(V)##2##4##(2008-10#2)
to 103% for##4##3##(2008-10#4)
to 103%##10##2##(2008-10#10)
to 104##3##2##(2008-10#3)
to 104%##8##2##(2008-10#8)
to 105##3##2##(1990-2#1)(2008-10#2)
to 105% for##2##3##(2008-10#2)
to 105%##4##2##(2008-10#4)
to 106##5##2##(1997-8#1)(2008-10#3)(2008-11#1)
to 106% for##3##3##(2008-10#3)
to 106%##4##2##(2008-10#4)
to 107%##2##2##(2008-10#2)
to 108##6##2##(1990-6#1)(1994-8#1)(2008-10#4)
to 11 and##2##3##(2008-10#2)
to 11 degrees C##2##4##(2008-10#2)
to 11 degrees##3##3##(2008-10#3)
to 11##24##2##(1992-5#1)(1995-12#1)(2008-10#19)(2008-3#1)(2012-3#2)
to 11%##4##2##(1991-2#1)(2008-1#1)(2008-10#2)
to 110##6##2##(1992-12#1)(2008-10#4)(2013-1#1)
to 110%##5##2##(2008-10#5)
to 1100##2##2##(2008-11#2)
to 112##2##2##(2008-10#2)
to 112%##3##2##(2008-10#3)
to 117% for##2##3##(2008-10#2)
to 12 h after##2##4##(2008-10#2)
to 12 h##3##3##(2008-10#3)
to 12 km##2##3##(2008-2#2)
to 12 mg##2##3##(2008-10#2)
to 12 months##3##3##(2008-1#1)(2008-10#1)(2009-10#1)
to 12 weeks##2##3##(1997-5#1)(2008-10#1)
to 12##43##2##(1991-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-3#1)(1997-5#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
to 12%##2##2##(2008-3#1)(2008-5#1)
to 120 cm in##2##4##(2008-10#2)
to 120 cm##4##3##(2008-10#4)
to 120##13##2##(1993-1#1)(2008-10#9)(2008-3#1)(2008-7#1)(2008-8#1)
to 120%##5##2##(2008-10#5)
to 1200##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
to 121%##2##2##(2008-10#2)
to 125##2##2##(2008-11#1)(2008-9#1)
to 13 months##2##3##(1992-5#1)(2012-3#1)
to 13##18##2##(1992-12#1)(1992-5#1)(1995-11#1)(2008-10#11)(2008-7#1)(2010-9#1)(2012-3#1)(2013-8#1)
to 130##3##2##(1993-11#1)(2008-10#1)(2008-6#1)
to 14 days##3##3##(2008-10#3)
to 14 years of age##2##5##(2012-12#1)(2013-1#1)
to 14 years##4##3##(1991-2#1)(2009-3#1)(2012-12#1)(2013-1#1)
to 14##28##2##(1990-6#1)(1991-2#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#3)
to 140##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
to 144##2##2##(2008-10#2)
to 15 and##2##3##(1990-6#1)(2010-8#1)
to 15 days##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
to 15 degrees C##2##4##(2008-10#2)
to 15 degrees##3##3##(2008-10#3)
to 15 mM##2##3##(1990-5#1)(2008-7#1)
to 15 mg##2##3##(2008-10#2)
to 15 mug##2##3##(2008-10#2)
to 15 years##2##3##(2008-10#1)(2009-7#1)
to 15##43##2##(1990-5#1)(1990-6#1)(1991-8#1)(1994-8#1)(1995-12#1)(1997-2#1)(2008-10#23)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
to 15% for##2##3##(2008-10#1)(2012-2#1)
to 15%##10##2##(1991-5#1)(2008-10#4)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
to 150##8##2##(1993-1#1)(2008-10#4)(2008-11#2)(2008-9#1)
to 1500##3##2##(1991-5#1)(2008-8#1)(2009-7#1)
to 16 days##2##3##(2008-10#2)
to 16 h of##2##4##(2008-10#1)(2008-11#1)
to 16##18##2##(1990-12#1)(1991-12#1)(1993-12#1)(1994-12#1)(1997-3#1)(2008-10#8)(2008-11#2)(2013-1#2)(2013-8#1)
to 16-fold##2##2##(1994-11#1)(2008-11#1)
to 160##2##2##(2008-12#1)(2008-3#1)
to 16q12##2##2##(1997-2#2)
to 17 years##2##3##(2012-12#2)
to 17##15##2##(1994-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2012-12#2)
to 17%##3##2##(1993-3#1)(2010-6#1)(2013-1#1)
to 170##2##2##(2008-10#1)(2012-12#1)
to 175##2##2##(1994-2#1)(2008-3#1)
to 18 days##3##3##(2008-10#2)(2008-11#1)
to 18 degrees C but not at##2##7##(2008-10#2)
to 18 degrees C##5##4##(2008-10#5)
to 18 h##3##3##(1995-11#1)(2008-10#2)
to 18##24##2##(1993-3#1)(1995-11#1)(1996-11#1)(2008-10#15)(2008-11#2)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
to 180 days##2##3##(1990-12#1)(2008-10#1)
to 180##3##2##(1990-12#1)(2008-10#2)
to 1800##2##2##(2008-10#1)(2008-3#1)
to 19 years##2##3##(2008-1#1)(2008-11#1)
to 19##16##2##(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-8#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to 19%##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
to 195##2##2##(2008-3#1)(2010-4#1)
to 1981##2##2##(1991-9#1)(1994-1#1)
to 1986##2##2##(1991-2#1)(2008-10#1)
to 1987##5##2##(1991-2#1)(1992-1#1)(1992-5#1)(1994-2#1)(1995-9#1)
to 1988 were##2##3##(1990-3#1)(1993-12#1)
to 1988##8##2##(1990-12#3)(1990-3#1)(1990-5#1)(1991-8#1)(1993-12#1)(1993-6#1)
to 1989##9##2##(1991-12#1)(1991-9#2)(1993-8#1)(1994-3#1)(1996-3#1)(1997-8#1)(2008-10#2)
to 1990##4##2##(1991-12#1)(1993-3#1)(1994-2#1)(2008-10#1)
to 1991##5##2##(1993-2#1)(1994-3#1)(2008-10#3)
to 1992##11##2##(1993-12#2)(1993-6#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(1996-5#1)(2008-10#2)
to 1993##8##2##(1994-3#1)(1995-12#1)(1995-3#2)(1996-3#1)(1996-6#1)(2008-10#1)(2011-2#1)
to 1994##4##2##(1995-12#1)(2008-10#3)
to 1995 and##2##3##(2008-10#2)
to 1995##10##2##(1997-3#1)(1997-8#1)(2008-10#8)
to 1996##21##2##(1994-1#1)(1996-11#3)(1996-9#1)(1997-6#3)(2008-10#12)(2008-7#1)
to 1997 were##2##3##(2008-10#2)
to 1997##18##2##(2007-12#1)(2008-10#17)
to 1998 were##2##3##(2008-9#1)(2011-2#1)
to 1998##18##2##(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-9#2)(2011-2#1)
to 1998)##2##2##(2008-10#2)
to 1999 and##3##3##(2008-10#3)
to 1999 were##3##3##(2008-10#2)(2008-9#1)
to 1999##18##2##(2008-10#16)(2008-9#2)
to 1x10(-1)moldm(-3) and -58##2##4##(2008-10#2)
to 1x10(-1)moldm(-3) and##5##3##(2008-10#5)
to 1x10(-2) M##3##3##(2008-10#3)
to 1x10(-2)##4##2##(2008-10#4)
to 1x10(-3)##2##2##(2008-10#2)
to 1x10(-3)M with slopes of##2##5##(2008-10#2)
to 1x10(-5) g ml(-1) for##2##5##(2008-10#2)
to 1x10(-5)##7##2##(2008-10#7)
to 1x10(-6)molL(-1)##2##2##(2008-10#2)
to 2 h after##2##4##(1991-2#1)(2008-10#1)
to 2 h##4##3##(1991-2#1)(2008-10#3)
to 2 mg l(-1)##2##4##(2008-10#2)
to 2 months##4##3##(1996-12#2)(2008-10#1)(2012-12#1)
to 2 weeks##4##3##(1990-12#1)(2008-10#2)(2013-1#1)
to 2 x##2##3##(2008-10#1)(2008-11#1)
to 2##144##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#2)(1991-5#2)(1992-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-12#2)(1996-2#2)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#79)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2010-11#1)(2010-6#1)(2010-8#2)(2012-12#3)(2012-2#2)(2013-1#6)(2013-8#2)
to 2%##5##2##(1993-8#1)(2008-10#4)
to 2-cm##2##2##(2008-10#1)(2008-5#1)
to 2-phosphoenolpyruvate##2##2##(1990-5#2)
to 20 and##2##3##(2008-10#1)(2008-3#1)
to 20 days##2##3##(2008-10#2)
to 20 degrees C)##2##4##(2008-10#2)
to 20 degrees##5##3##(2008-10#4)(2013-1#1)
to 20 mg##2##3##(1991-2#1)(2008-10#1)
to 20 muM##2##3##(2008-10#1)(2008-11#1)
to 20 samples##2##3##(2008-10#2)
to 20 years##2##3##(1991-12#1)(1996-5#1)
to 20##42##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-3#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-10#23)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
to 20% of##3##3##(2008-11#1)(2009-12#1)(2013-1#1)
to 20%##14##2##(1997-3#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#2)
to 20-30%##2##2##(1994-5#1)(2008-12#1)
to 20/100##2##2##(2010-10#1)(2010-9#1)
to 200##13##2##(1990-2#1)(1992-3#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#2)
to 200-fold##4##2##(1994-8#1)(1997-8#1)(2008-10#1)(2008-5#1)
to 2000 were##2##3##(2008-10#2)
to 2000##20##2##(2008-10#17)(2009-7#1)(2010-12#1)(2013-1#1)
to 2001##8##2##(2008-10#6)(2010-8#1)(2011-2#1)
to 2002##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
to 2003##7##2##(2008-10#5)(2008-11#1)(2011-2#1)
to 2004##5##2##(2008-10#4)(2008-11#1)
to 2004)##3##2##(2008-10#3)
to 2005##13##2##(2008-10#3)(2008-11#3)(2008-12#3)(2010-8#3)(2011-2#1)
to 2006##3##2##(2008-10#1)(2010-8#1)(2012-12#1)
to 2007##6##2##(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-8#1)
to 2008##12##2##(2010-12#2)(2010-4#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-8#2)
to 2009##4##2##(2011-9#2)(2012-12#1)(2012-2#1)
to 200muM##3##2##(2008-10#3)
to 2010##8##2##(2011-7#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
to 2012##2##2##(2013-1#1)(2013-8#1)
to 21 days##2##3##(2008-10#2)
to 21 degrees C##3##4##(2008-10#2)(2008-5#1)
to 21##13##2##(1994-11#1)(2008-10#6)(2008-5#2)(2008-7#1)(2012-2#1)(2013-1#2)
to 21-day##2##2##(2008-10#2)
to 210 +/-##2##3##(2008-10#2)
to 210##3##2##(2008-10#3)
to 22 degrees C##5##4##(2008-10#4)(2008-11#1)
to 22##15##2##(1991-8#2)(1994-3#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2012-12#2)
to 22%##3##2##(2008-10#3)
to 23##6##2##(1992-3#1)(1997-2#1)(2008-10#2)(2008-3#1)(2013-8#1)
to 23%##2##2##(1996-3#1)(2010-6#1)
to 230##2##2##(2008-10#2)
to 24 degrees C##2##4##(2008-10#1)(2008-5#1)
to 24 h of##2##4##(2008-10#2)
to 24 h##8##3##(2008-10#8)
to 24 months##2##3##(2008-11#1)(2012-3#1)
to 24 weeks##2##3##(2008-10#1)(2010-4#1)
to 24##27##2##(1994-6#1)(1995-11#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-3#2)(2013-8#1)
to 24% of##2##3##(1994-3#1)(2008-10#1)
to 24-h##4##2##(1995-11#1)(2008-10#2)(2011-2#1)
to 24-hour##2##2##(1990-11#1)(1991-12#1)
to 240##3##2##(2008-10#1)(2009-11#1)(2009-3#1)
to 25 degrees C and##2##5##(2008-10#2)
to 25 degrees C for##2##5##(2008-10#2)
to 25 degrees C##14##4##(2008-10#14)
to 25 degrees##15##3##(2008-10#15)
to 25 months##2##3##(1991-8#1)(1997-5#1)
to 25 mug##2##3##(2008-10#1)(2008-11#1)
to 25##35##2##(1991-8#1)(1993-1#1)(1993-8#1)(1997-5#1)(2008-10#26)(2008-11#2)(2008-3#1)(2009-1#1)(2013-8#1)
to 25%##7##2##(1997-5#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-7#1)
to 250##6##2##(1996-3#1)(2008-10#4)(2008-5#1)
to 2500##2##2##(2008-10#1)(2008-3#1)
to 25nM##2##2##(2008-10#2)
to 26##14##2##(1994-12#1)(1996-3#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2010-8#1)
to 26% of##2##3##(1996-1#1)(2007-12#1)
to 26%##7##2##(1994-12#2)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
to 27##8##2##(1992-1#2)(2008-10#4)(2008-11#1)(2008-12#1)
to 28 degrees C##6##4##(2008-10#5)(2011-2#1)
to 28##17##2##(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#8)(2009-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
to 28% of the##2##4##(2008-10#1)(2008-11#1)
to 28%##4##2##(1993-9#1)(1994-12#1)(2008-10#1)(2008-11#1)
to 280##2##2##(2007-12#1)(2008-10#1)
to 29 in##2##3##(1993-6#1)(1997-4#1)
to 29##5##2##(1993-12#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-11#1)
to 2mugL(-1)##2##2##(2008-10#2)
to 2x10(-3) M for##3##4##(2008-10#3)
to 3 and##2##3##(2008-10#2)
to 3 days##9##3##(2008-10#6)(2008-11#1)(2008-7#2)
to 3 mM##2##3##(2008-10#1)(2011-2#1)
to 3 weeks##2##3##(2008-10#1)(2009-5#1)
to 3 x 10(7)##2##4##(2008-10#1)(2008-11#1)
to 3 x##3##3##(2008-10#2)(2008-11#1)
to 3##104##2##(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-8#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-3#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#59)(2008-11#8)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#6)(2013-8#1)
to 3%##5##2##(1990-7#1)(2008-10#2)(2008-3#1)(2008-5#1)
to 3' end##3##3##(2008-10#1)(2008-8#2)
to 3)##3##2##(1990-12#1)(1992-4#1)(2008-10#1)
to 3-fold##4##2##(1990-12#1)(1994-11#1)(1995-2#1)(2008-11#1)
to 3-fold)##2##2##(1994-5#1)(1995-11#1)
to 3-pentadecylcatechol##2##2##(2008-10#2)
to 30 days##5##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
to 30 degrees C and##2##5##(2008-10#2)
to 30 degrees C##9##4##(2008-10#9)
to 30 mg##2##3##(2008-10#2)
to 30 min##4##3##(1997-8#1)(2008-10#3)
to 30 min)##2##3##(2012-3#2)
to 30 mug l(-1)##2##4##(2008-10#2)
to 30 mul##2##3##(2008-10#2)
to 30##61##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-11#1)(1997-1#2)(1997-8#3)(2007-12#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-8#1)(2012-3#2)(2013-1#1)
to 30% in##4##3##(1996-12#1)(2008-10#2)(2008-8#1)
to 30% of the##4##4##(1991-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
to 30% of##5##3##(1991-5#1)(2008-10#1)(2011-2#1)(2013-1#2)
to 30%##14##2##(1991-5#1)(1996-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
to 300##7##2##(1990-12#1)(1992-11#1)(1994-11#1)(1996-12#1)(2008-10#3)
to 31 degrees C##2##4##(2008-10#1)(2008-11#1)
to 31##9##2##(1990-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
to 32 degrees C##8##4##(1991-2#1)(2008-10#5)(2008-11#2)
to 32 samples##2##3##(2008-10#2)
to 32##25##2##(1991-2#1)(1993-11#1)(1993-3#1)(1995-6#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
to 32%##4##2##(2008-10#4)
to 33##4##2##(1994-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
to 33%##2##2##(2008-10#1)(2008-11#1)
to 334 AA##2##3##(2008-8#2)
to 34##7##2##(1992-9#1)(2008-10#3)(2008-11#2)(2013-1#1)
to 35 degrees C##4##4##(2008-10#4)
to 35 degrees C)##2##4##(2008-10#2)
to 35 degrees##6##3##(2008-10#6)
to 35##17##2##(1991-3#1)(1997-1#1)(2008-10#10)(2009-3#1)(2010-10#1)(2013-1#3)
to 35% of##2##3##(1990-5#1)(2008-10#1)
to 35%##4##2##(1990-5#1)(2008-10#2)(2009-7#1)
to 350##2##2##(2008-10#1)(2012-2#1)
to 36 h##2##3##(2008-10#1)(2008-11#1)
to 36 months##2##3##(1990-6#1)(2011-2#1)
to 36##12##2##(1990-6#1)(1993-3#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
to 36%##3##2##(2008-10#2)(2008-7#1)
to 366 mOsmol kg-1##3##4##(2008-11#3)
to 366 mOsmol##4##3##(2008-11#4)
to 366##5##2##(1992-10#1)(2008-11#4)
to 37 degrees C##8##4##(1993-9#2)(1996-12#1)(2008-10#3)(2008-11#2)
to 37 degrees##9##3##(1993-9#2)(1996-12#1)(2008-10#4)(2008-11#2)
to 37##18##2##(1993-12#1)(1993-8#1)(1993-9#2)(1996-12#1)(1997-6#1)(2008-10#6)(2008-11#2)(2009-7#1)(2011-2#2)(2013-1#1)
to 37%##3##2##(1991-11#1)(2008-11#1)(2013-8#1)
to 38##5##2##(1993-12#1)(2008-10#3)(2009-7#1)
to 38%##4##2##(1997-2#1)(2008-10#3)
to 380##3##2##(1997-4#2)(2008-10#1)
to 39##9##2##(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#5)(2008-5#1)
to 3D##3##2##(2008-3#1)(2009-11#1)(2013-1#1)
to 4 days##3##3##(2008-10#3)
to 4 groups##2##3##(2008-12#1)(2013-1#1)
to 4 months##7##3##(1991-1#1)(2008-10#1)(2008-11#2)(2010-5#1)(2013-1#2)
to 4 weeks##9##3##(2008-10#7)(2008-11#1)(2008-5#1)
to 4 years##3##3##(1996-11#1)(2008-10#1)(2008-9#1)
to 4##96##2##(1990-8#1)(1991-1#2)(1992-3#1)(1992-5#1)(1993-6#1)(1995-5#1)(1996-11#1)(1997-2#1)(2008-10#43)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#8)
to 4%##4##2##(1990-6#1)(2008-10#2)(2010-12#1)
to 4)##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
to 40##19##2##(1995-8#1)(2007-11#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-9#1)(2013-1#1)
to 40% in##3##3##(1995-1#1)(2008-10#1)(2008-2#1)
to 40% of##2##3##(2008-8#1)(2012-12#1)
to 40%##11##2##(1995-1#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2012-12#1)(2013-8#1)
to 400 nm##2##3##(2008-10#2)
to 400##12##2##(1992-8#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)
to 41##6##2##(1997-1#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-3#1)
to 41%##3##2##(2008-10#2)(2009-12#1)
to 410##2##2##(2008-10#1)(2009-11#1)
to 42 degrees##2##3##(2008-10#2)
to 42##9##2##(2008-10#5)(2008-11#1)(2010-8#2)(2013-8#1)
to 43##3##2##(1991-8#1)(1995-12#1)(2012-3#1)
to 43%##2##2##(2008-5#1)(2008-7#1)
to 44##4##2##(2008-10#4)
to 440##2##2##(2008-10#1)(2008-11#1)
to 45 years##2##3##(1997-4#1)(2013-1#1)
to 45##13##2##(1997-4#1)(2008-10#7)(2008-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
to 45%##3##2##(2008-10#1)(2012-3#2)
to 450##2##2##(2008-10#2)
to 46##4##2##(1991-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
to 47##2##2##(1995-12#1)(2012-2#1)
to 47% of##2##3##(1992-6#1)(1993-8#1)
to 47%##3##2##(1992-6#1)(1993-8#1)(2012-3#1)
to 48 h##6##3##(2008-10#6)
to 48##20##2##(1991-5#1)(1993-12#1)(1996-5#2)(2008-10#12)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
to 49##4##2##(1992-9#1)(1995-9#1)(2008-7#1)(2012-8#1)
to 49%##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
to 495##2##2##(2008-10#1)(2012-12#1)
to 5 cm##3##3##(1992-5#1)(2013-1#2)
to 5 days##3##3##(2008-10#3)
to 5 km##2##3##(2008-2#1)(2008-3#1)
to 5 ml##2##3##(2008-10#2)
to 5 months##3##3##(2008-10#1)(2013-1#2)
to 5 ng/ml##2##3##(1990-12#1)(2008-10#1)
to 5 weeks##5##3##(2008-10#4)(2011-2#1)
to 5 x##2##3##(2008-10#2)
to 5 years##5##3##(1991-2#1)(2008-10#1)(2012-12#3)
to 5##123##2##(1990-11#2)(1990-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-6#2)(1994-12#1)(1994-8#1)(1996-3#1)(2008-10#74)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-1#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
to 5% of the##2##4##(2008-10#2)
to 5% of##4##3##(2008-10#3)(2008-5#1)
to 5%##12##2##(1996-1#1)(2008-10#7)(2008-11#1)(2008-5#2)(2009-12#1)
to 5%)##3##2##(1995-3#1)(2008-10#1)(2012-3#1)
to 5-HT##2##2##(1994-2#1)(1996-12#1)
to 5-fluorouracil##2##2##(1990-12#1)(1993-1#1)
to 5-fold##3##2##(1990-12#1)(1994-6#1)(2010-1#1)
to 50 and##3##3##(2008-10#2)(2008-5#1)
to 50 days##2##3##(2008-10#2)
to 50 degrees C and##2##5##(1990-2#1)(2008-10#1)
to 50 degrees C for##2##5##(2008-10#1)(2008-7#1)
to 50 degrees C##8##4##(1990-2#1)(1991-5#1)(2008-10#4)(2008-3#1)(2008-7#1)
to 50 muM##4##3##(2008-10#4)
to 50##46##2##(1990-2#2)(1991-2#1)(1991-5#1)(1992-2#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-3#3)(2008-5#4)(2008-7#1)(2010-11#1)(2011-2#1)
to 50% in##2##3##(2008-10#1)(2008-5#1)
to 50% of plants##2##4##(2008-10#2)
to 50% of##6##3##(2008-10#3)(2008-11#1)(2013-8#2)
to 50%##21##2##(1993-3#1)(1995-3#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#3)
to 500 mg##3##3##(2008-10#2)(2008-11#1)
to 500 nm##2##3##(2008-10#1)(2008-2#1)
to 500##18##2##(1990-2#1)(1994-11#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-9#1)
to 500ngml(-1)##2##2##(2008-10#2)
to 52##2##2##(2008-10#2)
to 52%##2##2##(1993-8#1)(2010-6#1)
to 53##2##2##(1995-6#1)(2008-10#1)
to 53%##5##2##(1994-1#1)(2008-10#4)
to 54##7##2##(1995-3#1)(2008-1#1)(2008-10#3)(2011-2#1)(2013-1#1)
to 54%##2##2##(2008-8#1)(2010-8#1)
to 55 degrees C##3##4##(2008-10#3)
to 55 degrees##4##3##(2008-10#3)(2008-9#1)
to 55##8##2##(2008-10#5)(2008-2#1)(2008-9#1)(2011-2#1)
to 550##3##2##(1993-1#1)(2008-10#2)
to 56##6##2##(2008-10#4)(2008-9#1)(2013-1#1)
to 56%##4##2##(2008-10#3)(2013-1#1)
to 57##2##2##(1991-4#1)(2009-7#1)
to 570##2##2##(2008-10#1)(2011-2#1)
to 58##3##2##(1996-1#1)(2008-11#1)(2009-8#1)
to 6 days##7##3##(2008-10#3)(2008-11#4)
to 6 months##5##3##(2008-10#2)(2010-6#1)(2013-1#2)
to 6 weeks after##2##4##(1996-8#1)(2008-10#1)
to 6 weeks postbloom##3##4##(2008-10#3)
to 6 weeks##8##3##(1996-8#1)(2008-10#6)(2008-5#1)
to 6 x##2##3##(1990-12#1)(2008-10#1)
to 6 years##2##3##(1996-12#1)(2013-1#1)
to 6##72##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#37)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#2)(2010-6#1)(2011-2#1)(2013-1#4)
to 6%##2##2##(2008-10#2)
to 6)##2##2##(2008-10#1)(2011-2#1)
to 60 days##2##3##(2006-5#1)(2013-1#1)
to 60 degrees C##5##4##(2008-10#4)(2008-6#1)
to 60 degrees##7##3##(2008-10#5)(2008-6#1)(2008-9#1)
to 60 years##3##3##(1997-4#1)(2010-7#1)(2013-1#1)
to 60##34##2##(1992-12#1)(1993-1#2)(1997-1#1)(1997-4#1)(2006-5#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#2)
to 60% of the##3##4##(1996-6#1)(1997-2#1)(2008-10#1)
to 60% of##6##3##(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
to 60%##18##2##(1990-6#1)(1992-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
to 600 mg##2##3##(2008-10#1)(2008-9#1)
to 600 nm##2##3##(1994-5#1)(2008-10#1)
to 600##9##2##(1991-2#1)(1994-5#1)(2008-10#6)(2008-9#1)
to 61##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
to 61%##2##2##(1995-11#1)(2013-8#1)
to 62##3##2##(1993-3#1)(2008-10#1)(2008-12#1)
to 63##6##2##(1991-7#1)(2008-10#4)(2011-2#1)
to 64##7##2##(1992-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-3#1)
to 65 deg##2##3##(2008-3#2)
to 65##15##2##(1991-11#2)(1991-5#1)(1992-6#1)(2008-10#2)(2008-12#1)(2008-3#3)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
to 65% of##2##3##(1993-11#1)(2008-10#1)
to 65%##4##2##(1993-11#1)(2008-10#2)(2008-9#1)
to 650##2##2##(2008-10#2)
to 66##5##2##(1990-6#1)(1996-1#1)(2008-10#3)
to 66%##4##2##(2008-10#2)(2008-11#1)(2008-2#1)
to 67##2##2##(2008-10#2)
to 67% for##2##3##(1995-3#1)(2008-11#1)
to 67%##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
to 67%)##3##2##(1994-8#1)(2008-10#2)
to 68##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
to 68%##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
to 69 years##3##3##(1996-2#1)(2012-12#2)
to 69##6##2##(1990-8#1)(1996-2#1)(2008-10#1)(2012-12#2)(2013-8#1)
to 7 days##3##3##(1997-5#1)(2008-10#2)
to 7 weeks##3##3##(2008-10#3)
to 7 years##2##3##(1996-11#1)(1996-5#1)
to 7##51##2##(1990-11#1)(1990-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#29)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#2)
to 7% of##2##3##(2008-10#1)(2010-1#1)
to 7%##5##2##(2008-10#2)(2008-3#1)(2010-1#1)(2012-12#1)
to 70 degrees C##2##4##(2008-10#2)
to 70 percent##2##3##(1994-3#1)(1995-3#1)
to 70##9##2##(1992-9#1)(1994-3#1)(1995-3#1)(2008-10#5)(2008-8#1)
to 70% of the##2##4##(2008-10#2)
to 70% of##6##3##(1996-1#1)(2008-1#1)(2008-10#2)(2013-8#2)
to 70%##10##2##(1996-1#1)(2008-1#1)(2008-10#5)(2011-2#1)(2013-8#2)
to 700##2##2##(2008-10#1)(2008-3#1)
to 71##3##2##(1990-5#1)(2008-11#1)(2009-3#1)
to 71%##2##2##(2008-10#1)(2011-1#1)
to 72 h after##3##4##(2008-10#3)
to 72 h##4##3##(2008-10#4)
to 72 hours##3##3##(1990-6#1)(1992-2#1)(1993-11#1)
to 72##14##2##(1990-6#1)(1992-2#2)(1993-11#1)(1995-1#1)(1996-12#1)(2008-10#7)(2010-8#1)
to 72%##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
to 73##4##2##(1992-2#1)(1995-3#1)(2008-10#1)(2013-8#1)
to 73%##5##2##(2008-10#4)(2012-3#1)
to 730##2##2##(2008-10#1)(2008-3#1)
to 74##4##2##(2008-10#2)(2008-7#2)
to 74%##4##2##(1996-9#1)(2008-10#2)(2011-2#1)
to 75 microM##2##3##(1993-6#2)
to 75##9##2##(1991-6#1)(1993-6#2)(2008-10#5)(2013-1#1)
to 75%##6##2##(1993-1#1)(2008-10#3)(2010-1#1)(2013-1#1)
to 75%)##2##2##(2008-10#1)(2013-8#1)
to 76##4##2##(1993-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
to 76%##3##2##(1997-1#1)(2008-10#1)(2008-7#1)
to 77##2##2##(2008-10#2)
to 77% in##2##3##(2008-10#1)(2011-2#1)
to 77%##4##2##(2008-10#3)(2011-2#1)
to 78##5##2##(1990-2#1)(1992-9#1)(2008-10#3)
to 78%##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
to 79##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
to 8 days after inoculation##2##5##(2008-10#2)
to 8 days##4##3##(1997-3#1)(2008-10#3)
to 8 h##3##3##(1992-10#1)(1995-11#1)(2008-10#1)
to 8 mM##2##3##(1993-8#1)(1994-11#1)
to 8 weeks of##3##4##(1992-11#1)(2008-10#1)(2011-2#1)
to 8 weeks##9##3##(1992-11#1)(2008-10#5)(2009-11#1)(2009-5#1)(2011-2#1)
to 8 years##2##3##(2010-11#1)(2012-12#1)
to 8##62##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#31)(2008-11#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-4#2)(2011-2#2)(2012-12#1)
to 8%##6##2##(1991-5#1)(1993-11#1)(2008-10#2)(2008-11#1)(2013-8#1)
to 80 degrees C for##2##5##(2008-10#2)
to 80 degrees##3##3##(2008-10#3)
to 80 min##3##3##(1997-1#1)(2008-11#1)(2012-12#1)
to 80##13##2##(1996-1#1)(1997-1#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-9#2)(2012-12#1)
to 80% of##2##3##(2008-10#1)(2013-1#1)
to 80%##9##2##(1994-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#2)(2013-1#1)
to 80%)##2##2##(2008-10#2)
to 800##6##2##(1990-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
to 800muM##2##2##(2008-10#2)
to 81##3##2##(2008-10#2)(2008-9#1)
to 81%##3##2##(2008-10#2)(2010-6#1)
to 82 years##2##3##(1990-6#1)(2011-2#1)
to 82##5##2##(1990-6#1)(1995-3#1)(2010-8#1)(2011-2#2)
to 83##2##2##(2008-10#1)(2013-8#1)
to 83%##2##2##(1996-12#1)(2008-10#1)
to 84 years##2##3##(2011-2#1)(2013-1#1)
to 84##7##2##(1990-11#1)(1996-12#1)(2008-1#1)(2008-10#1)(2011-2#2)(2013-1#1)
to 84%##2##2##(2008-10#2)
to 85##6##2##(1993-2#1)(2008-10#1)(2008-11#2)(2012-3#1)(2013-1#1)
to 85% in##2##3##(2009-8#1)(2010-5#1)
to 85% relative humidity##3##4##(2008-10#1)(2008-2#2)
to 85%##9##2##(2008-10#4)(2008-2#2)(2008-5#1)(2009-8#1)(2010-5#1)
to 86%##3##2##(2008-10#3)
to 860##2##2##(2009-7#1)(2011-7#1)
to 87 years##2##3##(1997-3#1)(1997-8#1)
to 87##6##2##(1990-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-11#1)(2011-2#1)
to 87%##2##2##(2008-10#1)(2009-7#1)
to 89##4##2##(1990-8#1)(1991-11#1)(2008-10#1)(2012-3#1)
to 8x10(-5) M##2##3##(2008-10#2)
to 9 days##2##3##(1995-11#1)(2008-10#1)
to 9 months##3##3##(1995-2#1)(2011-2#1)(2012-3#1)
to 9##43##2##(1992-8#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(2007-12#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
to 9% of##2##3##(2010-6#1)(2011-2#1)
to 9%##4##2##(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
to 90 days##2##3##(1990-12#1)(2008-10#1)
to 90 h##2##3##(1994-12#1)(2008-10#1)
to 90 min##2##3##(1994-2#1)(2008-11#1)
to 90 nM##2##3##(1990-2#2)
to 90##27##2##(1990-12#1)(1990-2#2)(1991-3#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-6#1)(2008-10#7)(2008-11#4)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
to 90% of the##5##4##(1990-9#1)(2008-10#3)(2008-11#1)
to 90% of##6##3##(1990-9#1)(2008-10#4)(2008-11#1)
to 90% with##2##3##(1991-5#1)(1993-6#1)
to 90%##16##2##(1990-9#1)(1991-5#1)(1993-6#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-5#1)
to 91##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
to 91%##3##2##(2008-10#1)(2008-6#1)(2010-5#1)
to 92##4##2##(1993-8#1)(2008-1#1)(2008-10#1)(2008-12#1)
to 92% of the##4##4##(1995-8#2)(1996-6#1)(2008-11#1)
to 93##6##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-11#1)
to 93%##4##2##(2008-10#3)(2011-2#1)
to 94##5##2##(2008-10#3)(2009-9#1)(2010-9#1)
to 94%##5##2##(1990-11#1)(2008-10#3)(2008-12#1)
to 95 percent##2##3##(1992-12#1)(1995-3#1)
to 95##5##2##(1992-12#1)(1995-3#1)(2008-10#2)(2008-7#1)
to 95% and##2##3##(2008-10#2)
to 95% of##2##3##(1993-1#1)(2011-2#1)
to 95%##6##2##(1993-1#1)(2008-10#4)(2011-2#1)
to 96 h##6##3##(2008-10#5)(2008-12#1)
to 96##11##2##(1993-8#1)(2008-10#9)(2008-12#1)
to 96%##2##2##(2008-10#2)
to 960##2##2##(1997-6#1)(2008-10#1)
to 97##6##2##(2008-10#3)(2012-3#1)(2013-1#1)(2013-8#1)
to 97%##2##2##(2008-10#1)(2008-9#1)
to 98##11##2##(1992-11#2)(2008-10#8)(2013-1#1)
to 98% nucleotide identities and##2##5##(2008-10#2)
to 98% of##2##3##(2008-10#2)
to 98%##11##2##(2008-10#11)
to 99##10##2##(2008-10#9)(2013-1#1)
to 99% for##2##3##(2008-10#2)
to 99% of the##2##4##(2008-10#2)
to 99% of##4##3##(2008-10#4)
to 99%##9##2##(2008-10#9)
to 99%)##2##2##(2008-10#2)
to A beta##5##3##(1994-11#2)(1995-12#1)(1996-12#1)(1996-2#1)
to A##22##2##(1992-8#1)(1994-11#2)(1995-12#1)(1996-12#2)(1996-2#1)(2008-10#13)(2008-8#1)(2011-2#1)
to AA##2##2##(1992-12#1)(2008-10#1)
to ABA##2##2##(2009-8#2)
to AChE##2##2##(1994-5#2)
to AD##2##2##(2008-7#1)(2009-10#1)
to ADP##3##2##(2008-7#1)(2013-1#2)
to ADR##2##2##(1990-2#1)(2008-11#1)
to AG-6##2##2##(2008-10#2)
to AH##2##2##(1993-8#1)(2009-7#1)
to AIDS##9##2##(1990-11#1)(1990-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-9#1)(1997-3#1)(1997-6#2)
to ALL-1##2##2##(1997-7#2)
to ANN##2##2##(2008-10#2)
to ASA##2##2##(2008-10#1)(2010-7#1)
to AT(1) receptor##2##3##(2008-9#2)
to ATP##6##2##(1990-5#2)(1993-8#1)(1995-2#2)(1997-8#1)
to Aflatoxin Contamination by Aspergillus flavus##2##6##(2008-10#2)
to Aflatoxin##3##2##(2008-10#3)
to African##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
to African-American hair##3##3##(2008-5#3)
to African-American##4##2##(2008-11#1)(2008-5#3)
to Ala##2##2##(1995-2#1)(1995-6#1)
to Alternaria##2##2##(2008-10#2)
to Alzheimer's disease##3##3##(1992-12#1)(2008-7#1)(2013-8#1)
to Anaplasma marginale##2##3##(1996-12#2)
to Aphanomyces root rot##4##4##(2008-10#4)
to Aphanomyces##5##2##(2008-10#5)
to Apple##2##2##(2008-10#2)
to April 2008##2##3##(2009-8#1)(2011-2#1)
to April##6##2##(1991-2#1)(1994-6#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
to Arabidopsis##3##2##(2012-2#2)(2012-3#1)
to As##2##2##(2008-10#2)
to As(III)##5##2##(2008-10#5)
to As(V)##4##2##(2008-10#4)
to Asn##3##2##(1992-10#1)(1995-2#1)(2008-8#1)
to Aspergillus flavus##3##3##(2008-10#3)
to Aspergillus##7##2##(2008-10#7)
to Assess the##3##3##(1994-12#1)(2008-10#1)(2012-12#1)
to Assess##6##2##(1994-12#1)(2008-10#4)(2012-12#1)
to August##2##2##(1995-12#1)(2011-2#1)
to B##12##2##(1995-5#1)(2008-10#10)(2011-2#1)
to B-MYB##3##2##(2011-2#3)
to BGYMV-MX##2##2##(2008-10#2)
to BPMV##2##2##(2008-10#2)
to BSA and##2##3##(2008-10#2)
to BSA##7##2##(2008-10#6)(2008-3#1)
to BTH##2##2##(2008-10#2)
to BYDV##4##2##(2008-10#2)(2008-8#2)
to Bacillus##2##2##(2008-10#1)(2011-2#1)
to Bacterial Wilt Caused by Ralstonia solanacearum##3##7##(2008-10#3)
to Bacterial##5##2##(2008-10#5)
to Be?##2##2##(2009-3#1)(2012-3#1)
to Bean common mosaic necrosis virus##2##6##(2008-10#2)
to Bean common mosaic##3##4##(2008-10#3)
to Bean##4##2##(2008-10#4)
to Beet curly top virus##2##5##(2008-10#2)
to Beet##3##2##(2008-10#3)
to Bipolaris##2##2##(2008-10#2)
to Borrelia burgdorferi##2##3##(1990-2#1)(2011-2#1)
to Botrytis cinerea in##2##4##(2008-10#2)
to Botrytis cinerea##4##3##(2008-10#4)
to Botrytis##5##2##(2008-10#5)
to Brassica##2##2##(2008-10#2)
to C##29##2##(1996-12#1)(2007-12#1)(2008-10#18)(2008-12#4)(2008-5#2)(2008-7#1)(2013-1#2)
to C923##2##2##(2008-10#2)
to CA-CRC##2##2##(2011-2#2)
to CAA##2##2##(1994-8#2)
to CAV in##2##3##(2008-5#2)
to CAV##4##2##(2008-5#4)
to CC##3##2##(2008-11#3)
to CCSV NP##2##3##(2008-10#2)
to CCSV##3##2##(2008-10#3)
to CD127##3##2##(2013-1#3)
to CD40##2##2##(2008-10#1)(2012-2#1)
to CDC##3##2##(1992-6#2)(1997-2#1)
to CDV##3##2##(2008-12#3)
to CFA##2##2##(2012-2#2)
to CGRP##2##2##(1992-6#2)
to CMV##3##2##(1994-11#1)(2008-10#2)
to CNS##3##2##(1990-9#1)(1991-12#1)(1997-3#1)
to CO##4##2##(1990-5#1)(1992-2#1)(2008-10#2)
to CO(2)##3##2##(2008-10#3)
to COPD##2##2##(2008-1#1)(2012-12#1)
to COX-2 selective and non-selective NSAIDs##2##6##(2011-2#2)
to CPT##2##2##(1994-8#2)
to Ca(2+)##3##2##(2008-10#3)
to Ca2+##6##2##(1994-5#1)(1995-11#2)(1995-6#1)(1996-2#2)
to California##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
to Canadian##2##2##(1993-12#1)(1994-1#1)
to Cercospora##2##2##(2008-10#1)(2012-3#1)
to Cereal yellow dwarf virus##2##5##(2008-10#2)
to Class##2##2##(1996-3#1)(2008-11#1)
to Clinic##2##2##(1995-6#1)(2008-10#1)
to Clostridium##2##2##(2011-2#2)
to Clover yellow vein virus##2##5##(2008-10#2)
to Colletotrichum truncatum##2##3##(2008-10#2)
to Colletotrichum##5##2##(2008-10#5)
to Colonization by##2##3##(2008-10#2)
to Congress on##2##3##(1991-1#1)(1993-3#1)
to Congress##7##2##(1991-1#2)(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)
to Control##4##2##(1994-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
to Cp1##2##2##(2008-10#2)
to Cp2##2##2##(2008-10#2)
to Cr(III)##4##2##(2008-10#3)(2011-2#1)
to Cr(VI) by##2##3##(2008-10#2)
to Cr(VI)##8##2##(2008-10#8)
to Cr1##3##2##(2008-10#3)
to Cr2##4##2##(2008-10#4)
to Cronartium quercuum f##2##4##(2008-10#2)
to Cronartium##5##2##(2008-10#5)
to Cu##2##2##(2013-8#2)
to Cu(2+)##2##2##(2008-10#1)(2008-12#1)
to Cu(II)##5##2##(2008-10#5)
to Cucumber##2##2##(2008-10#2)
to D##2##2##(2008-10#1)(2009-8#1)
to D-amphetamine##2##2##(1993-6#2)
to DBA/1 mice##2##3##(2008-11#2)
to DCA##2##2##(2008-10#2)
to DHD##2##2##(1994-3#2)
to DNA and##3##3##(1996-2#1)(1997-2#1)(2008-10#1)
to DNA damage##5##3##(2008-8#1)(2011-2#3)(2013-1#1)
to DNA##40##2##(1990-5#2)(1991-8#2)(1992-7#1)(1993-8#3)(1993-9#2)(1995-2#1)(1995-8#2)(1996-2#2)(1997-2#1)(2008-10#9)(2008-11#2)(2008-4#2)(2008-8#4)(2008-9#2)(2011-2#3)(2013-1#2)
to DNA-damaging agents##5##3##(1992-12#3)(1995-8#2)
to December 1989##2##3##(1991-6#1)(1992-5#1)
to December 1990##2##3##(1994-1#1)(1995-3#1)
to December 2006##2##3##(2011-2#2)
to December 2010##2##3##(2011-7#1)(2013-1#1)
to December##13##2##(1990-9#1)(1991-6#1)(1992-5#1)(1994-1#1)(1995-3#2)(2010-6#1)(2011-2#3)(2011-7#1)(2013-1#1)(2013-7#1)
to Delta(7)-PGA(1) methyl ester##2##4##(2008-11#2)
to Detect and Quantify##2##4##(2008-10#2)
to Didymella rabiei##2##3##(2008-10#2)
to Different##2##2##(2008-10#1)(2010-12#1)
to Dr##2##2##(1995-12#1)(2008-7#1)
to E##12##2##(1993-12#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#1)
to E1 and E3##2##4##(2008-10#2)
to E1 and##3##3##(2008-10#2)(2008-11#1)
to E2##5##2##(1990-11#4)(2008-10#1)
to ECII##3##2##(2008-11#3)
to ESRD##4##2##(1995-1#1)(1996-2#1)(2008-1#2)
to ETAAS##3##2##(2008-10#3)
to Escherichia coli##3##3##(1994-5#1)(1996-12#1)(1996-6#1)
to Europe##4##2##(2008-10#1)(2008-11#1)(2008-8#2)
to European##6##2##(2008-1#1)(2008-10#4)(2010-10#1)
to F##14##2##(1997-8#1)(2008-10#13)
to FHB was##2##3##(2008-10#2)
to FHB##10##2##(2008-10#8)(2011-10#2)
to FIA##4##2##(2008-10#4)
to FISH##2##2##(2008-9#2)
to FR1064##2##2##(2008-10#2)
to Fe oxides##2##3##(2008-10#2)
to Fe##3##2##(1996-2#1)(2008-10#2)
to Fe(II) by##2##3##(2008-10#2)
to Fe(II)##9##2##(2008-10#9)
to Fe(III)##6##2##(2008-10#6)
to February 2009##2##3##(2011-2#2)
to February##8##2##(1990-12#1)(1991-2#1)(1997-8#1)(2008-1#1)(2008-7#2)(2011-2#2)
to Fusarium graminearum##3##3##(2008-10#3)
to Fusarium head blight##2##4##(2008-10#2)
to Fusarium wilt##8##3##(2008-10#8)
to Fusarium##16##2##(2008-10#16)
to G##7##2##(1990-8#1)(1991-5#1)(1992-3#1)(2008-10#2)(2008-12#1)(2008-6#1)
to GC##4##2##(1996-12#1)(2008-10#2)(2008-12#1)
to GC-MS##2##2##(2008-10#2)
to GPIb does not##2##4##(1993-3#2)
to GRH##2##2##(1992-6#2)
to Germany##2##2##(2008-10#1)(2008-4#1)
to Grapevine berry inner necrosis virus##2##6##(2008-10#2)
to Grapevine##3##2##(2008-10#3)
to Group##3##2##(1995-12#1)(2011-2#2)
to Guignardia bidwellii##2##3##(2008-10#2)
to H##2##2##(1996-12#1)(2011-10#1)
to HBV##2##2##(2008-10#1)(2009-8#1)
to HCV##2##2##(1995-10#1)(2013-8#1)
to HCl##3##2##(2008-10#1)(2009-10#2)
to HG##4##2##(2008-10#1)(2008-7#3)
to HIV##7##2##(1990-6#1)(1991-5#1)(1996-11#1)(1996-5#2)(2008-5#1)(2013-8#1)
to HIV/AIDS##2##2##(1995-2#1)(1997-6#1)
to HNG##2##2##(2012-12#2)
to HPLC##7##2##(2008-10#7)
to Hashimoto's##3##2##(2011-2#2)(2013-1#1)
to Hawaii##2##2##(1992-2#1)(2008-10#1)
to Health##5##2##(2008-10#1)(2008-11#3)(2012-2#1)
to Helicobacter pylori##2##3##(1997-1#1)(2011-2#1)
to Hg##2##2##(1990-5#1)(2008-10#1)
to Hospital##2##2##(2008-12#1)(2013-8#1)
to I##3##2##(2008-5#1)(2008-6#2)
to IB-49##3##2##(2008-10#3)
to IBV##2##2##(2008-5#2)
to IC-17 was conferred by a single dominant gene##2##9##(2008-10#2)
to IC-17 was##3##3##(2008-10#3)
to IC-17##4##2##(2008-10#4)
to ICAM-1##2##2##(1995-2#1)(1995-6#1)
to ICU##2##2##(2009-5#1)(2012-3#1)
to ICs and##2##3##(2008-8#2)
to ICs##4##2##(2008-8#4)
to IFN##3##2##(2008-11#2)(2009-8#1)
to IL-1 beta-induced anorexia##2##4##(1996-12#2)
to IL-1##3##2##(1990-5#1)(1996-12#2)
to IP##2##2##(1992-7#1)(2008-7#1)
to IPO323##2##2##(2008-10#2)
to IR interference##2##3##(2011-2#2)
to IR##3##2##(2008-3#1)(2011-2#2)
to IS##2##2##(2012-3#1)(2012-5#1)
to IVF##2##2##(1994-12#1)(2008-11#1)
to IgG##2##2##(1996-3#1)(2008-10#1)
to Ile)##2##2##(1992-8#1)(1995-6#1)
to Improve##2##2##(2011-2#1)(2012-2#1)
to Infection##2##2##(2008-10#2)
to January##6##2##(1991-8#1)(1994-9#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
to Japanese##4##2##(1996-5#1)(2008-10#1)(2008-12#1)(2012-12#1)
to July##7##2##(1990-2#1)(2008-10#2)(2011-3#1)(2012-6#2)(2013-1#1)
to June##7##2##(2007-11#1)(2008-10#1)(2008-11#2)(2010-6#1)(2011-2#2)
to KB cell line##2##4##(2008-12#2)
to KLH##4##2##(2008-10#3)(2008-9#1)
to L##2##2##(2008-10#1)(2010-8#1)
to L-glutamate##2##2##(1997-2#2)
to LDL oxidation during copper-catalyzed oxidative modification and its##2##9##(1991-12#2)
to LDL oxidation during copper-catalyzed oxidative modification##3##7##(1991-12#3)
to LPS##5##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-9#1)
to LSD##3##2##(2008-10#3)
to Leaf##2##2##(2008-10#2)
to Leptosphaeria maculans##6##3##(2008-10#6)
to Lys##2##2##(1993-12#1)(2008-10#1)
to M##30##2##(2007-12#1)(2008-10#20)(2008-6#1)(2008-7#1)(2010-6#1)(2011-10#2)(2011-2#1)(2012-2#3)
to MBT##2##2##(2008-10#2)
to MCI##2##2##(2008-5#2)
to MPTP##2##2##(1990-7#2)
to MRI fields##2##3##(1992-3#2)
to MS##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#1)
to MT##3##2##(2008-10#3)
to MTBE##2##2##(2008-12#2)
to Magnaporthe grisea##3##3##(2008-10#3)
to Magnaporthe##4##2##(2008-10#3)(2013-8#1)
to Maori##2##2##(2008-1#2)
to March##8##2##(1993-12#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-12#1)(2009-6#1)(2012-3#1)(2013-8#1)
to May##9##2##(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
to MeOH##2##2##(2008-10#2)
to Medicaid##5##2##(1991-3#1)(1994-2#1)(1995-12#1)(1996-1#2)
to Medicare and Medicaid beneficiaries##2##5##(1991-3#1)(1996-2#1)
to Medicare beneficiaries##6##3##(1991-2#1)(1991-3#3)(1992-2#1)(1994-12#1)
to Medicare##14##2##(1991-2#1)(1991-3#5)(1992-2#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-11#1)
to Medicare's##2##2##(1991-1#1)(1997-2#1)
to Melampsora larici-populina##5##3##(2008-10#5)
to Melampsora medusae##2##3##(2008-10#2)
to Melampsora##7##2##(2008-10#7)
to Mn(2+)##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
to Monitor##2##2##(2008-10#1)(2010-7#1)
to Mycobacterium tuberculosis##2##3##(1996-11#1)(2010-5#1)
to Mycosphaerella graminicola in##2##4##(2008-10#1)(2011-10#1)
to Mycosphaerella graminicola##4##3##(2008-10#3)(2011-10#1)
to Mycosphaerella##5##2##(2008-10#4)(2011-10#1)
to N##3##2##(2008-10#3)
to N-methyl-D-aspartate##2##2##(1990-7#1)(1992-8#1)
to N2O##2##2##(1992-3#1)(1993-1#1)
to NA##3##2##(2008-10#1)(2008-8#2)
to NEM##2##2##(1995-8#2)
to NGF##3##2##(1991-12#1)(1997-2#1)(2008-11#1)
to NH(3)##2##2##(2008-10#2)
to NL-3 K##3##3##(2008-10#3)
to NO##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
to NaCl and##2##3##(2009-10#1)(2013-1#1)
to NaCl##4##2##(2008-10#2)(2009-10#1)(2013-1#1)
to Nafion-coated##2##2##(2008-10#2)
to NeutrAvidin##3##2##(2008-10#3)
to New Zealand##3##3##(2008-8#3)
to New##6##2##(1996-5#1)(2008-10#1)(2008-8#3)(2009-5#1)
to North##2##2##(2008-10#2)
to Norwegian##2##2##(1991-2#1)(1997-8#1)
to November##3##2##(1996-12#1)(2011-2#1)(2012-3#1)
to OA##2##2##(1992-3#1)(1994-11#1)
to ONOO(-)##2##2##(2008-7#2)
to October##10##2##(1991-12#1)(1996-1#1)(2008-10#3)(2008-11#1)(2012-12#3)(2013-8#1)
to Other##2##2##(2008-10#2)
to P##40##2##(2008-10#36)(2008-5#1)(2008-8#1)(2009-6#1)(2010-3#1)
to PAEC##3##2##(2008-8#3)
to PBL##2##2##(1995-12#1)(2011-1#1)
to PCR##4##2##(1996-12#1)(1996-8#1)(2008-10#2)
to PD##4##2##(2008-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
to PIP(3)##2##2##(2008-11#2)
to PMA##2##2##(1994-8#1)(1997-1#1)
to PPARgamma##3##2##(2008-5#3)
to PSV subgroup##2##3##(2008-10#2)
to PSV##3##2##(2008-10#3)
to PSV-W##2##2##(2008-10#2)
to PVC ratio##2##3##(2008-10#2)
to PVC##3##2##(2008-10#3)
to PVY##2##2##(2008-10#2)
to Pb(2+)##2##2##(2008-10#2)
to Pd(2 +)##2##3##(2008-10#2)
to Pepper##2##2##(2008-10#2)
to Philippine##2##2##(2008-10#2)
to Physical##2##2##(2010-3#1)(2012-3#1)
to Phytophthora root rot##2##4##(2008-10#2)
to Phytophthora##4##2##(2008-10#4)
to Postharvest##2##2##(2008-10#2)
to Powdery Mildew##2##3##(2008-10#2)
to Professor##2##2##(2008-10#1)(2012-3#1)
to Protect##2##2##(2008-10#2)
to Pseudomonas syringae##2##3##(2008-10#2)
to Pseudomonas##3##2##(2008-10#3)
to Ptr ToxA in##2##4##(2008-10#2)
to Ptr ToxA##5##3##(2008-10#5)
to Puccinia sorghi##2##3##(2008-10#2)
to Puccinia##5##2##(2008-10#5)
to Pyrenophora tritici-repentis Race##2##4##(2008-10#2)
to Pythium##4##2##(2008-10#4)
to Quantify##3##2##(2008-10#3)
to R##11##2##(2008-10#10)(2008-3#1)
to R1881##2##2##(1990-11#2)
to RA##2##2##(2010-12#1)(2012-3#1)
to RH##3##2##(2008-10#3)
to RNA from##2##3##(1994-11#1)(2008-10#1)
to RNA##6##2##(1994-11#1)(1995-2#1)(1997-3#2)(2008-10#2)
to RTSV##2##2##(2008-10#2)
to Resistance##2##2##(2008-10#2)
to Rhizoctonia##3##2##(2008-10#3)
to Rpc1##2##2##(2008-10#2)
to S##21##2##(1992-9#1)(1993-12#1)(1994-5#1)(2008-10#13)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
to SA##5##2##(1993-6#1)(2008-10#4)
to SACI##2##2##(2008-11#2)
to SCMV##2##2##(2008-10#2)
to SDS-PAGE##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
to SFE##2##2##(2008-10#2)
to SMV##2##2##(2008-10#2)
to SP##2##2##(1997-3#1)(2008-11#1)
to SRBC##2##2##(2008-10#2)
to Saccharomyces cerevisiae##2##3##(1996-6#1)(2008-2#1)
to Salmonella##3##2##(1990-3#1)(2008-10#1)(2011-2#1)
to Sb(3+)##2##2##(2008-10#2)
to Sb(III)##4##2##(2008-10#4)
to Sclerotinia sclerotiorum##3##3##(2008-10#3)
to Sclerotinia trifoliorum##7##3##(2008-10#7)
to Sclerotinia##10##2##(2008-10#10)
to Sclerotium rolfsii in##3##4##(2008-10#3)
to Sclerotium rolfsii##6##3##(2008-10#6)
to Se##2##2##(2008-10#1)(2012-2#1)
to Se(IV)##9##2##(2008-10#9)
to Sepharose##2##2##(2008-4#1)(2011-2#1)
to September##5##2##(1996-12#1)(2008-10#3)(2013-8#1)
to Septoria tritici blotch##2##4##(2008-10#2)
to Septoria tritici##3##3##(2008-10#3)
to Septoria##6##2##(2008-10#6)
to SilicoSec##2##2##(2008-12#2)
to Sitisi##2##2##(2008-1#2)
to South##3##2##(2008-10#1)(2010-1#1)(2013-8#1)
to Spain##2##2##(1993-8#1)(2009-10#1)
to Spodoptera frugiperda 21##2##4##(2008-11#2)
to States##2##2##(1991-2#1)(1994-3#1)
to Stewart's##3##2##(2008-10#3)
to Study##2##2##(2008-10#2)
to T cells##2##3##(2008-4#1)(2008-9#1)
to T##12##2##(1991-12#1)(1995-6#1)(1996-2#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-9#2)
to T-toxin##2##2##(2008-10#2)
to T2##3##2##(2008-12#1)(2009-3#1)(2012-12#1)
to T60 for##2##3##(2013-8#2)
to TCDD##2##2##(2008-10#2)
to TCE##2##2##(2008-10#2)
to TGF beta##2##3##(1992-8#1)(1995-12#1)
to TMA##2##2##(2008-10#2)
to TMV##2##2##(2008-10#2)
to TNDR selection##2##3##(2008-10#2)
to TNF alpha##3##3##(1994-6#1)(1995-2#2)
to TNF cytotoxicity##2##3##(1992-7#2)
to TNF##7##2##(1992-7#2)(1994-6#1)(1995-2#2)(2011-2#2)
to TPA##3##2##(1991-8#1)(1993-8#1)(1994-6#1)
to TPO1 and##2##3##(1995-12#2)
to TRAIL##3##2##(2009-9#2)(2012-2#1)
to TRAIL-induced apoptosis##2##3##(2009-9#2)
to TRH##2##2##(1991-6#1)(1994-2#1)
to TSWV infection##2##3##(2008-10#2)
to TSWV##5##2##(2008-10#5)
to TYLCV##3##2##(2008-10#3)
to Takayasu's arteritis##2##3##(1997-8#2)
to Tapesia yallundae##2##3##(2008-10#2)
to Th2##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
to Thr##2##2##(1993-3#1)(2008-8#1)
to Tomato bushy stunt virus (TBSV)##2##6##(2008-10#2)
to Tomato yellow leaf curl virus (TYLCV)##3##7##(2008-10#3)
to Tomato##7##2##(2008-10#7)
to Trp##2##2##(1993-11#1)(1993-9#1)
to US##2##2##(1997-2#1)(2008-8#1)
to USEPA##2##2##(2008-10#2)
to UV light##5##3##(1997-3#1)(2008-10#2)(2008-5#2)
to UV radiation##3##3##(1993-3#2)(2008-5#1)
to UV##10##2##(1993-3#2)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#3)(2011-2#1)
to UVB##3##2##(2008-5#3)
to Uncover##2##2##(2008-10#1)(2008-11#1)
to V##11##2##(2008-10#10)(2009-8#1)
to VCG##4##2##(2008-10#4)
to VIP##3##2##(1995-11#3)
to VOCs##2##2##(2008-10#2)
to VPA##2##2##(2008-7#1)(2011-1#1)
to Verticillium wilt##2##3##(2008-10#2)
to Verticillium##4##2##(2008-10#4)
to W##3##2##(2008-10#3)
to WHO##2##2##(1996-11#1)(2011-2#1)
to WSMoV##2##2##(2008-10#2)
to WT##2##2##(2012-3#1)(2013-1#1)
to Water##2##2##(2008-10#2)
to Watermelon mosaic virus##2##4##(2008-10#2)
to Watermelon silver mottle virus##2##5##(2008-10#2)
to Watermelon##4##2##(2008-10#4)
to Wheat##2##2##(2008-10#2)
to X##7##2##(1993-6#1)(2008-10#6)
to X-ray##2##2##(2008-10#1)(2008-5#1)
to Xa21 and##2##3##(2008-10#2)
to Xa21##6##2##(2008-10#6)
to Xanthomonas campestris pv##4##4##(2008-10#4)
to Xanthomonas##5##2##(2008-10#5)
to ZP##3##2##(2013-1#3)
to a &quot##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2010-7#1)
to a 1##4##3##(1992-6#1)(1997-4#1)(2008-10#1)(2011-2#1)
to a 10%##2##3##(1997-3#1)(2008-10#1)
to a 15##2##3##(1994-2#1)(2008-10#1)
to a 3##3##3##(1995-6#1)(2008-10#2)
to a 5##2##3##(1996-1#1)(2008-10#1)
to a Pyrenophora##2##3##(2008-10#2)
to a basic##3##3##(2008-10#2)(2009-8#1)
to a better understanding of the##4##6##(2008-10#2)(2008-5#1)(2009-12#1)
to a better understanding of##7##5##(2008-10#4)(2008-11#1)(2008-5#1)(2009-12#1)
to a better##12##3##(1993-1#1)(2008-10#4)(2008-11#3)(2008-5#1)(2009-12#1)(2011-2#2)
to a biotinylated##2##3##(2008-10#2)
to a body##2##3##(2008-11#1)(2009-8#1)
to a broad range of##7##5##(2008-10#3)(2008-11#3)(2008-8#1)
to a broad spectrum of##2##5##(2008-10#1)(2008-11#1)
to a broad##9##3##(2008-10#4)(2008-11#4)(2008-8#1)
to a candidate##2##3##(1992-3#1)(1995-2#1)
to a capillary##2##3##(1997-2#1)(2008-10#1)
to a carrier##2##3##(1995-5#1)(2008-4#1)
to a cell##2##3##(2008-11#2)
to a central##2##3##(1991-3#1)(2008-10#1)
to a certain degree##2##4##(1990-11#1)(2008-12#1)
to a certain##7##3##(1990-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-9#1)
to a certified reference##2##4##(2008-10#2)
to a change in the##2##5##(1993-8#1)(2008-10#1)
to a change in##4##4##(1990-11#1)(1993-8#1)(2008-10#1)(2008-11#1)
to a change of the##2##5##(2008-10#1)(2008-11#1)
to a change##6##3##(1990-11#1)(1993-8#1)(2008-10#2)(2008-11#2)
to a changing environment##2##4##(1996-3#1)(2008-7#1)
to a changing##3##3##(1992-11#1)(1996-3#1)(2008-7#1)
to a chronic##3##3##(1994-5#1)(2008-12#1)(2013-1#1)
to a class##2##3##(2008-5#1)(2008-8#1)
to a clinical##2##3##(1992-12#1)(2010-2#1)
to a combination of a##2##5##(2008-10#1)(2008-11#1)
to a combination of##7##4##(1991-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-1#1)
to a commercial##2##3##(1990-3#1)(2008-10#1)
to a common##7##3##(1993-12#1)(1993-2#1)(2008-10#2)(2012-2#1)(2013-1#2)
to a community-based##2##3##(1993-12#1)(2010-9#1)
to a complete##3##3##(1997-5#1)(2008-10#1)(2011-2#1)
to a comprehensive##2##3##(2008-10#1)(2008-11#1)
to a computer##2##3##(2008-10#1)(2008-7#1)
to a concentration of 3##3##5##(1990-5#1)(2008-11#1)(2011-1#1)
to a concentration of##11##4##(1990-5#1)(1991-5#1)(2008-10#5)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
to a concentration##14##3##(1990-5#1)(1991-5#1)(2008-10#7)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)
to a constant##2##3##(1991-9#1)(2009-7#1)
to a control group of##2##5##(2012-3#1)(2013-8#1)
to a control group##5##4##(2008-12#1)(2008-9#1)(2012-3#1)(2013-8#2)
to a control##7##3##(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
to a conventional##6##3##(2008-10#5)(2008-11#1)
to a correlation between##2##4##(2008-10#1)(2009-10#1)
to a corresponding##3##3##(2008-5#1)(2011-2#2)
to a critical##2##3##(2008-10#1)(2012-2#1)
to a crystallographic R-factor of##2##5##(1992-4#1)(1993-8#1)
to a data##2##3##(2008-10#1)(2008-11#1)
to a decrease in the##9##5##(1990-5#1)(1992-8#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-3#1)(2008-5#2)
to a decrease in##18##4##(1990-5#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(2008-10#5)(2008-3#1)(2008-5#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
to a decrease of##2##4##(2008-7#1)(2010-1#1)
to a decrease##21##3##(1990-5#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
to a deficiency in the##2##5##(1993-3#1)(2013-1#1)
to a deficiency in##4##4##(1993-3#1)(2013-1#3)
to a detailed##2##3##(1991-12#1)(2008-9#1)
to a diagnosis of##2##4##(2010-7#1)(2011-2#1)
to a different##8##3##(1994-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)
to a direct action##2##4##(1991-6#1)(1992-6#1)
to a direct##8##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-6#1)(2008-10#3)(2008-11#1)
to a discipline##2##3##(2008-10#1)(2013-8#1)
to a disease##2##3##(1997-5#1)(2008-10#1)
to a distinct##3##3##(2008-10#2)(2008-7#1)
to a diverse array of##2##5##(2011-9#1)(2012-2#1)
to a diverse##3##3##(1997-3#1)(2011-9#1)(2012-2#1)
to a dose of##2##4##(1997-3#1)(2009-11#1)
to a dose##3##3##(1997-3#1)(2008-10#1)(2009-11#1)
to a failure##2##3##(2008-5#1)(2012-12#1)
to a few##7##3##(2008-10#4)(2008-3#1)(2010-8#1)(2013-1#1)
to a fixed amount of##2##5##(1991-5#2)
to a fixed##4##3##(1991-5#2)(1994-2#1)(2010-1#1)
to a flame##4##3##(2008-10#4)
to a flattop beam##2##4##(2008-3#2)
to a flow##5##3##(2008-10#4)(2008-3#1)
to a flow-cell##2##3##(2008-10#2)
to a flow-injection##3##3##(2008-10#3)
to a form of##2##4##(1991-9#1)(2011-2#1)
to a form that##2##4##(1991-5#1)(1992-8#1)
to a form##4##3##(1991-5#1)(1991-9#1)(1992-8#1)(2011-2#1)
to a full##2##3##(1992-8#1)(2012-2#1)
to a functional##3##3##(1992-8#1)(2008-5#1)(2013-1#1)
to a gas##2##3##(2008-10#2)
to a gene##2##3##(1993-3#1)(1996-6#1)
to a generalized##2##3##(2008-3#1)(2012-12#1)
to a genetic##3##3##(1993-6#1)(2008-10#2)
to a geriatric##2##3##(1990-3#1)(1992-12#1)
to a given##8##3##(1990-11#1)(1991-5#1)(2008-10#2)(2008-11#1)(2008-9#3)
to a good##3##3##(1991-1#1)(2008-12#1)(2008-3#1)
to a great extent##9##4##(1990-12#2)(1995-8#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-6#2)
to a great##10##3##(1990-12#2)(1995-8#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-6#2)
to a greater degree than##3##5##(1991-6#1)(1995-11#1)(2008-10#1)
to a greater degree##4##4##(1991-6#1)(1993-11#1)(1995-11#1)(2008-10#1)
to a greater extent than##5##5##(1990-9#1)(1994-8#1)(1995-11#1)(2009-8#1)(2009-9#1)
to a greater extent##9##4##(1990-3#1)(1990-9#1)(1991-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(2009-8#1)(2009-9#1)(2013-1#1)
to a greater frequency of##2##5##(2008-5#1)(2010-11#1)
to a greater understanding of##3##5##(2008-11#1)(2008-7#1)(2012-2#1)
to a greater##22##3##(1990-3#1)(1990-9#1)(1991-6#3)(1993-11#1)(1994-11#1)(1994-8#1)(1995-11#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-11#1)(2012-2#2)(2013-1#1)
to a greenhouse##2##3##(2008-10#2)
to a group of##9##4##(1994-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-8#1)
to a group##10##3##(1994-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-8#1)
to a growing##4##3##(2008-10#1)(2008-11#2)(2013-8#1)
to a half of##2##4##(2013-1#2)
to a health##3##3##(1994-12#1)(1994-9#1)(2013-1#1)
to a heterologous promoter##2##4##(1997-3#2)
to a high degree of##4##5##(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
to a high degree##6##4##(1995-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
to a high level##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
to a high mortality rate##2##5##(2010-12#1)(2011-2#1)
to a high rate of##2##5##(1991-9#1)(2010-11#1)
to a high##23##3##(1991-9#1)(1995-2#1)(1996-9#1)(1997-6#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
to a higher level##2##4##(2008-10#1)(2008-12#1)
to a higher##15##3##(1991-6#1)(1993-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#1)(2010-7#1)(2013-1#1)
to a highly sensitive##2##4##(2008-10#1)(2008-2#1)
to a highly##6##3##(1995-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
to a hospital##3##3##(1993-12#1)(1995-11#1)(2008-11#1)
to a host##3##3##(2008-10#2)(2008-8#1)
to a hypotonic challenge##2##4##(1990-2#2)
to a hypotonic##4##3##(1990-2#4)
to a key##2##3##(1992-11#1)(2009-8#1)
to a known##2##3##(2008-10#1)(2011-1#1)
to a lack of information##2##5##(2008-6#1)(2012-2#1)
to a lack of##9##4##(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
to a large degree##2##4##(2008-10#1)(2008-9#1)
to a large extent##5##4##(1996-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
to a large number of##5##5##(1994-5#1)(2008-10#3)(2008-8#1)
to a large##26##3##(1990-12#1)(1994-5#1)(1996-8#1)(2007-8#1)(2008-10#9)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
to a larger extent than##2##5##(2009-8#1)(2011-2#1)
to a larger extent##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
to a larger##7##3##(1993-6#1)(1996-1#1)(2008-10#3)(2009-8#1)(2011-2#1)
to a less invasive test##2##5##(2013-1#2)
to a less##4##3##(1994-5#1)(2011-2#1)(2013-1#2)
to a lesser degree##9##4##(1991-12#1)(1994-6#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
to a lesser extent than##4##5##(1991-12#1)(1995-8#1)(2008-10#1)(2012-2#1)
to a lesser extent##37##4##(1991-12#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-9#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)
to a lesser##47##3##(1991-12#2)(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-9#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)
to a lethal##2##3##(1995-5#1)(2008-12#1)
to a level##7##3##(1997-3#1)(2008-10#3)(2008-11#2)(2008-7#1)
to a line##2##3##(2008-10#1)(2008-3#1)
to a linear##2##3##(2008-10#1)(2008-11#1)
to a local##3##3##(1993-1#2)(2008-10#1)
to a long##2##3##(2008-11#1)(2010-6#1)
to a longer##2##3##(1994-8#1)(2008-7#1)
to a loss of##4##4##(1990-5#1)(1992-12#1)(2008-11#2)
to a low level##2##4##(2008-10#1)(2008-9#1)
to a low##6##3##(1995-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-11#1)
to a lower temperature##2##4##(1995-8#1)(2008-7#1)
to a lower##10##3##(1990-3#1)(1995-8#1)(2008-10#2)(2008-11#4)(2008-7#2)
to a major gene##3##4##(2008-10#2)(2008-8#1)
to a major quantitative trait locus##2##6##(2008-10#2)
to a major##10##3##(1991-5#1)(1991-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-12#1)(2010-5#1)
to a managed care##2##4##(1996-12#1)(1996-2#1)
to a marked##2##3##(1995-8#1)(2008-10#1)
to a mass spectrometer##2##4##(2008-10#2)
to a mass##4##3##(2008-10#3)(2012-2#1)
to a maximum of##6##4##(1990-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-9#1)
to a maximum##11##3##(1990-3#1)(1993-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2009-9#1)
to a medical##2##3##(2007-9#1)(2008-3#1)
to a membrane##4##3##(1991-5#1)(1996-2#1)(2008-10#1)(2008-4#1)
to a minimum##4##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
to a mixed meal##2##4##(1994-12#1)(2012-3#1)
to a model##4##3##(1993-8#1)(2008-10#2)(2008-3#1)
to a molar##2##3##(1992-12#1)(2011-2#1)
to a monoclonal##2##3##(1993-8#1)(2008-5#1)
to a more##21##3##(1990-3#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1994-2#1)(1995-11#1)(1995-2#2)(1997-1#1)(2008-10#4)(2008-11#3)(2009-3#2)(2012-12#1)(2012-2#1)
to a much lesser extent##2##5##(1990-11#1)(2008-11#1)
to a much##4##3##(1990-11#1)(1993-8#1)(2008-11#2)
to a multimode##2##3##(2007-11#1)(2008-3#1)
to a mutation in##2##4##(2008-10#1)(2008-9#1)
to a mutation##3##3##(2008-10#2)(2008-9#1)
to a negative##2##3##(1990-8#1)(2008-8#1)
to a negligible##3##3##(2008-3#2)(2009-10#1)
to a new and##2##4##(2008-11#2)
to a new level of##2##5##(1994-2#1)(1997-3#1)
to a new##26##3##(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
to a normal##2##3##(1991-5#1)(2009-7#1)
to a novel##6##3##(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-8#1)(2013-1#1)
to a nuclear##2##3##(1997-7#1)(2008-7#1)
to a number of factors##2##5##(2008-10#1)(2008-7#1)
to a number of##22##4##(1991-3#1)(1992-12#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
to a nursing home##2##4##(1994-2#1)(2010-10#1)
to a pair of##2##4##(2008-11#1)(2008-3#1)
to a parallel##2##3##(1991-5#1)(2013-1#1)
to a partial##3##3##(1995-2#1)(1996-8#1)(2008-9#1)
to a particular##16##3##(1993-12#1)(1995-5#1)(1996-2#1)(2008-10#2)(2008-12#2)(2008-4#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
to a patient with##4##4##(2008-11#3)(2012-3#1)
to a patient's##2##3##(2008-9#1)(2012-3#1)
to a pediatric##2##3##(2010-11#1)(2011-2#1)
to a peptide##2##3##(1990-5#1)(1995-6#1)
to a person##2##3##(2010-8#1)(2011-2#1)
to a personal computer##2##4##(1997-2#1)(2008-10#1)
to a physical##2##3##(1997-2#1)(2008-12#1)
to a population##2##3##(1995-2#1)(2008-10#1)
to a positive##3##3##(1997-6#1)(2008-11#1)(2011-1#1)
to a predator##4##3##(2008-6#1)(2008-8#2)(2010-8#1)
to a previously##5##3##(1992-3#1)(1992-6#1)(1994-3#1)(2008-10#2)
to a primary##2##3##(2008-10#1)(2013-8#1)
to a progressive##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
to a protein##4##3##(1995-5#1)(2008-1#1)(2008-10#1)(2008-4#1)
to a psychiatric##2##3##(2009-7#1)(2011-2#1)
to a putative##2##3##(1996-6#1)(2008-7#1)
to a pyrethroid##2##3##(1997-5#2)
to a questionnaire##2##3##(1990-6#1)(2008-9#1)
to a random sample of##2##5##(2009-4#1)(2011-1#1)
to a random##3##3##(1991-12#1)(2009-4#1)(2011-1#1)
to a range of##11##4##(1992-6#1)(2008-10#6)(2008-11#2)(2008-4#1)(2010-5#1)
to a rapid and##2##4##(1997-1#1)(2010-6#1)
to a rapid##3##3##(1997-1#1)(2008-11#1)(2010-6#1)
to a rapidly##2##3##(1994-12#1)(2013-8#1)
to a rare##2##3##(2008-11#1)(2008-12#1)
to a recent##4##3##(1990-6#1)(2008-10#1)(2009-12#1)(2010-12#1)
to a recently##2##3##(1991-7#1)(1992-8#1)
to a recipient strain##2##4##(2008-10#2)
to a reduced##2##3##(2008-5#1)(2011-2#1)
to a reduction in the##7##5##(1994-5#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
to a reduction in##13##4##(1990-11#1)(1991-7#1)(1992-2#1)(1994-5#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#3)(2013-8#1)
to a reduction of##2##4##(2008-10#2)
to a reduction##15##3##(1990-11#1)(1991-7#1)(1992-2#1)(1994-5#1)(1994-8#1)(1995-5#1)(2008-10#3)(2008-11#2)(2008-3#3)(2013-8#1)
to a reference##2##3##(2008-10#1)(2009-10#1)
to a region of##3##4##(1990-5#1)(1994-11#1)(1995-6#1)
to a region##4##3##(1990-5#1)(1994-11#1)(1995-6#1)(2008-10#1)
to a relative##2##3##(2008-10#1)(2009-5#1)
to a response##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
to a restricted##2##3##(1994-2#1)(2008-3#1)
to a retained##2##3##(2008-12#1)(2012-2#1)
to a review of##2##4##(2008-10#1)(2008-11#1)
to a rise in##2##4##(1994-12#1)(2013-8#1)
to a river##2##3##(2008-10#1)(2008-8#1)
to a ruptured##2##3##(2008-7#1)(2013-8#1)
to a sample of##3##4##(1994-9#1)(2008-10#1)(2008-11#1)
to a sample##8##3##(1993-11#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-9#1)
to a second##7##3##(1990-11#1)(1992-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
to a sensitive##2##3##(2008-10#2)
to a separate##2##3##(2008-10#1)(2008-7#1)
to a sequence of##2##4##(1995-6#1)(1996-2#1)
to a sequence##6##3##(1992-8#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#2)
to a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides##2##5##(2008-10#2)
to a series of##4##4##(1995-5#1)(2008-10#3)
to a series##5##3##(1995-5#1)(2008-10#3)(2010-11#1)
to a set of##6##4##(1995-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#2)
to a severe##3##3##(2008-2#1)(2011-1#1)(2013-1#1)
to a sharp##2##3##(1993-3#1)(2009-6#1)
to a shear stress##3##4##(2008-11#2)(2010-1#1)
to a shear##4##3##(2008-11#3)(2010-1#1)
to a shift##2##3##(1994-5#1)(2008-10#1)
to a short##2##3##(2008-12#1)(2008-7#1)
to a significant decrease in##3##5##(2008-10#1)(2008-11#1)(2009-11#1)
to a significant degree##2##4##(2008-11#1)(2008-4#1)
to a significant improvement##2##4##(2008-10#1)(2013-1#1)
to a significant increase##2##4##(2008-11#1)(2013-8#1)
to a significant reduction in##3##5##(2008-10#1)(2009-4#1)(2011-10#1)
to a significant reduction of##2##5##(2008-10#1)(2008-6#1)
to a significant reduction##5##4##(2008-10#2)(2008-6#1)(2009-4#1)(2011-10#1)
to a significant##17##3##(1991-6#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-6#1)(2009-11#1)(2009-4#1)(2011-10#1)(2013-1#3)(2013-8#1)
to a significantly##2##3##(1997-9#1)(2008-5#1)
to a similar degree##4##4##(1996-2#1)(2008-10#2)(2008-11#1)
to a similar extent##3##4##(1990-8#1)(1995-11#1)(2013-8#1)
to a similar##12##3##(1990-12#1)(1990-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2009-12#1)(2013-1#1)(2013-8#1)
to a simple##6##3##(1991-3#1)(1992-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)
to a simulated##3##3##(2009-7#1)(2012-3#1)(2013-1#1)
to a single##23##3##(1993-2#1)(1994-2#1)(1994-5#1)(1996-12#1)(2008-10#11)(2008-8#3)(2008-9#2)(2010-12#1)(2011-10#1)(2013-1#1)
to a small area of##2##5##(1991-8#1)(2008-5#1)
to a small area##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
to a small molecule target##2##5##(2008-4#2)
to a small number of##2##5##(2008-10#1)(2008-8#1)
to a small##13##3##(1991-8#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
to a smaller extent##2##4##(1995-11#1)(2008-10#1)
to a smaller##3##3##(1995-11#1)(2008-10#1)(2012-2#1)
to a solution##2##3##(1994-12#1)(2008-11#1)
to a species##3##3##(1992-10#1)(2008-10#2)
to a specific region##2##4##(1993-9#1)(2011-2#1)
to a specific target##2##4##(2008-7#1)(2008-9#1)
to a specific##18##3##(1990-5#1)(1993-9#1)(1994-8#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
to a stable##4##3##(1990-11#1)(1993-8#1)(1994-5#1)(2008-8#1)
to a standard##5##3##(1996-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
to a stimulation##2##3##(2008-5#2)
to a strong##2##3##(2008-10#2)
to a structure##2##3##(1993-8#1)(2008-6#1)
to a substantial##4##3##(1992-2#1)(1993-6#1)(2008-10#1)(2011-2#1)
to a substrate##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
to a suitable##2##3##(2008-10#1)(2008-8#1)
to a surface##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
to a system##4##3##(2008-10#3)(2008-11#1)
to a systematic##2##3##(2009-8#1)(2010-4#1)
to a temperature##2##3##(2008-10#2)
to a theoretical##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
to a threshold##2##3##(2008-8#1)(2009-8#1)
to a total##2##3##(1991-2#1)(1997-2#1)
to a toxicant##2##3##(2008-9#2)
to a transient##2##3##(1997-1#1)(2008-10#1)
to a unique##4##3##(1991-11#1)(1992-3#1)(2008-4#1)(2012-2#1)
to a variable##2##3##(1993-6#1)(1997-3#1)
to a variety of##24##4##(1993-2#1)(1993-8#1)(1995-12#1)(1997-7#1)(2008-10#4)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-4#1)(2012-3#1)
to a very stable##2##4##(2008-10#2)
to a very##6##3##(2008-10#5)(2010-10#1)
to a visual##3##3##(1996-2#1)(2008-10#2)
to a warm##2##3##(2012-4#1)(2012-6#1)
to a wide range of##6##5##(1990-2#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
to a wide spectrum of##2##5##(2008-7#1)(2011-2#1)
to a wide variety of other##2##6##(2008-10#1)(2011-3#1)
to a wide variety of##3##5##(2008-10#2)(2011-3#1)
to a wide##16##3##(1990-2#1)(1991-12#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#2)(2011-3#1)
to a wider##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
to a##1856##2##(1990-10#1)(1990-11#8)(1990-12#5)(1990-2#7)(1990-3#8)(1990-5#12)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#9)(1991-2#2)(1991-3#9)(1991-5#10)(1991-6#11)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#5)(1992-4#1)(1992-6#8)(1992-7#1)(1992-8#8)(1992-9#3)(1993-1#4)(1993-11#4)(1993-12#14)(1993-2#8)(1993-3#10)(1993-6#10)(1993-8#17)(1993-9#2)(1994-1#2)(1994-11#6)(1994-12#9)(1994-2#14)(1994-3#8)(1994-5#11)(1994-6#4)(1994-8#8)(1994-9#3)(1995-11#9)(1995-12#9)(1995-2#16)(1995-3#2)(1995-5#8)(1995-6#16)(1995-8#9)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#4)(1996-2#11)(1996-3#8)(1996-5#7)(1996-6#7)(1996-8#5)(1996-9#3)(1997-1#14)(1997-2#13)(1997-3#17)(1997-4#5)(1997-5#4)(1997-6#8)(1997-7#9)(1997-8#1)(1997-9#2)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#508)(2008-11#150)(2008-12#24)(2008-2#6)(2008-3#47)(2008-4#22)(2008-5#58)(2008-6#10)(2008-7#58)(2008-8#49)(2008-9#48)(2009-1#2)(2009-10#11)(2009-11#7)(2009-12#5)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#5)(2009-7#8)(2009-8#11)(2009-9#4)(2010-1#7)(2010-10#8)(2010-11#11)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#8)(2010-7#8)(2010-8#7)(2010-9#8)(2011-1#9)(2011-10#2)(2011-2#62)(2011-3#2)(2011-9#1)(2012-12#17)(2012-2#29)(2012-3#21)(2012-4#1)(2012-6#1)(2013-1#63)(2013-7#1)(2013-8#38)
to abandon their##2##3##(1996-6#1)(2008-9#1)
to abandon##3##2##(1993-9#1)(1996-6#1)(2008-9#1)
to abdominal##4##2##(1993-12#1)(1993-3#1)(1995-3#1)(2010-8#1)
to aberrant##2##2##(1995-9#1)(2009-12#1)
to abnormal##7##2##(1994-9#1)(1997-7#2)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
to about 0##3##3##(2008-10#3)
to about 2##2##3##(2008-10#1)(2008-11#1)
to about 4##2##3##(2008-10#1)(2012-12#1)
to about 40%##2##3##(1994-8#1)(2010-8#1)
to about##32##2##(1991-2#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#2)(2009-8#2)(2010-12#2)(2010-6#1)(2010-8#1)(2012-12#1)(2013-8#1)
to abrogate##2##2##(2008-11#1)(2008-8#1)
to absorb##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
to absorption of##2##3##(2008-3#2)
to absorption##3##2##(2008-10#1)(2008-3#2)
to abuse##3##2##(1993-12#1)(1995-5#1)(1996-2#1)
to academic achievement##2##3##(2009-7#1)(2010-1#1)
to academic##3##2##(1996-3#1)(2009-7#1)(2010-1#1)
to accelerate the##7##3##(2008-10#5)(2008-2#1)(2010-5#1)
to accelerate##10##2##(2008-10#5)(2008-2#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-3#1)
to accept the##5##3##(1992-3#1)(1994-9#1)(1995-11#1)(1996-6#1)(2008-11#1)
to accept##13##2##(1992-3#1)(1993-1#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)
to acceptable##2##2##(2008-12#1)(2008-5#1)
to accepted##4##2##(1994-3#2)(2008-12#1)(2008-7#1)
to acceptor##2##2##(1994-5#1)(2009-10#1)
to access and##2##3##(2008-11#1)(2010-8#1)
to access the##4##3##(2008-1#1)(2008-10#2)(2010-5#1)
to access to##2##3##(1996-3#1)(2008-1#1)
to access##26##2##(1995-12#1)(1995-3#1)(1996-3#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#4)(2008-4#1)(2009-7#1)(2010-5#1)(2010-8#2)(2011-2#2)(2013-1#1)
to accommodate a##2##3##(2008-11#1)(2012-3#1)
to accommodate the##4##3##(1994-3#2)(2011-3#1)(2013-8#1)
to accommodate these##2##3##(1992-1#1)(2008-10#1)
to accommodate##26##2##(1992-1#1)(1992-2#1)(1992-3#1)(1994-1#1)(1994-3#3)(1995-6#2)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
to accomplish the##3##3##(2008-10#2)(2013-1#1)
to accomplish this##2##3##(1994-2#1)(2008-9#1)
to accomplish##12##2##(1991-1#1)(1992-1#1)(1994-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
to account for changes in##2##5##(2008-10#2)
to account for differences in##2##5##(1991-3#1)(2012-2#1)
to account for most##2##4##(1995-6#1)(2008-10#1)
to account for multiple##2##4##(2008-3#2)
to account for the effects of##2##6##(2008-10#2)
to account for the##20##4##(1991-3#1)(1992-12#1)(1992-3#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
to account for varying##2##4##(2008-10#1)(2010-11#1)
to account for##39##3##(1991-12#1)(1991-3#2)(1992-12#1)(1992-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
to accounts##2##2##(1994-2#1)(2011-1#1)
to accredit##2##2##(1994-12#1)(2008-11#1)
to accumulate in the food chain##2##6##(2008-10#2)
to accumulate in the##3##4##(2008-10#2)(2011-2#1)
to accumulate in##6##3##(2008-10#3)(2008-11#1)(2009-3#1)(2011-2#1)
to accumulate##20##2##(1995-12#1)(1996-2#1)(2008-10#12)(2008-11#1)(2008-12#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
to accumulation of##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
to accumulation##4##2##(1994-8#1)(2008-10#2)(2008-11#1)
to accuracy##3##2##(2008-10#3)
to accurate##2##2##(2008-10#1)(2008-7#1)
to accurately assess##2##3##(2011-2#1)(2013-1#1)
to accurately determine##3##3##(1994-3#1)(2008-10#1)(2012-2#1)
to accurately predict the##2##4##(2008-10#1)(2013-1#1)
to accurately predict##4##3##(1992-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
to accurately##19##2##(1992-3#1)(1994-3#1)(1994-6#1)(2008-10#6)(2008-7#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#1)
to acetaldehyde##3##2##(1994-5#1)(2008-10#1)(2009-8#1)
to acetoin##3##2##(2013-1#3)
to achieve a high##3##4##(2008-11#2)(2013-1#1)
to achieve a suitable##2##4##(2011-2#2)
to achieve a therapeutic##2##4##(1992-3#1)(2010-6#1)
to achieve a##24##3##(1992-3#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-7#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#3)
to achieve accurate##2##3##(1994-2#1)(2008-2#1)
to achieve adequate##2##3##(2008-8#1)(2009-8#1)
to achieve all##2##3##(2008-11#1)(2012-2#1)
to achieve an##8##3##(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)
to achieve and##3##3##(2008-11#2)(2010-12#1)
to achieve appropriate##2##3##(2008-10#1)(2013-1#1)
to achieve better##2##3##(1997-8#1)(2013-1#1)
to achieve complete##3##3##(2008-11#1)(2010-12#1)(2011-2#1)
to achieve early detection of##2##5##(2008-10#1)(2009-4#1)
to achieve greater##3##3##(1993-1#1)(2008-11#1)(2008-3#1)
to achieve high##7##3##(1990-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
to achieve improved##2##3##(1996-2#1)(2013-1#1)
to achieve in##2##3##(2008-11#1)(2013-1#1)
to achieve maximum##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
to achieve more##2##3##(1992-3#1)(2010-11#1)
to achieve optimal##2##3##(1996-2#1)(2008-11#1)
to achieve satisfactory results##2##4##(2010-12#2)
to achieve satisfactory##3##3##(2008-7#1)(2010-12#2)
to achieve successful##2##3##(2008-9#1)(2013-1#1)
to achieve the best##6##4##(1990-3#1)(2008-10#3)(2008-4#1)(2013-8#1)
to achieve the goal of##2##5##(2008-11#1)(2008-3#1)
to achieve the necessary##2##4##(1994-12#1)(2008-11#1)
to achieve the##25##3##(1990-11#1)(1990-3#1)(1993-1#1)(1993-6#1)(1994-12#1)(1995-1#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
to achieve this##4##3##(1991-3#1)(2008-11#1)(2008-12#1)(2008-5#1)
to achieve##179##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-12#1)(1991-3#2)(1992-2#2)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#2)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-8#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#36)(2008-11#25)(2008-12#6)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#7)(2012-2#4)(2012-3#4)(2013-1#12)(2013-8#4)
to achieving##7##2##(1994-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
to acid hydrolysis##2##3##(1992-12#1)(2008-10#1)
to acid##10##2##(1992-12#1)(1992-6#1)(1996-9#1)(2008-10#5)(2008-8#1)(2011-2#1)
to acid-base##3##2##(2008-10#3)
to acidic##6##2##(1990-7#1)(2008-10#4)(2012-9#1)
to acknowledge##5##2##(1994-12#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-12#1)
to acquire a##6##3##(1992-12#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
to acquire and##4##3##(1994-3#1)(2008-10#1)(2008-4#1)(2012-3#1)
to acquire the##5##3##(1990-9#1)(2008-10#3)(2008-4#1)
to acquire##34##2##(1990-9#1)(1992-12#1)(1993-6#1)(1994-3#2)(1996-1#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#2)
to act as a##3##4##(1995-2#1)(2008-3#1)(2013-1#1)
to act as an##2##4##(2008-11#1)(2008-9#1)
to act as##15##3##(1990-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#2)
to act in##2##3##(2008-10#1)(2008-8#1)
to act on the##2##4##(1993-9#1)(2007-11#1)
to act##30##2##(1990-11#1)(1990-5#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
to actin##13##2##(1991-5#1)(1992-4#1)(1993-8#5)(1994-12#1)(1994-5#3)(2008-6#1)(2011-2#1)
to action##7##2##(1991-2#1)(1992-2#1)(1993-12#2)(1997-2#1)(2009-1#1)(2009-5#1)
to activate a##3##3##(1996-2#1)(1996-3#1)(2009-8#1)
to activate amygdala neurons##2##4##(1997-7#2)
to activate human##2##3##(2008-10#1)(2013-1#1)
to activate the##11##3##(1990-5#1)(1992-4#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#3)(2010-9#1)(2012-12#1)(2012-3#1)
to activate##40##2##(1990-5#1)(1990-6#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-2#2)(1995-8#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#2)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to activated##4##2##(1995-12#1)(1997-3#1)(2008-4#1)(2012-2#1)
to activation of the##4##4##(1992-12#1)(1992-6#1)(2008-11#2)
to activation of##12##3##(1990-5#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-2#1)(2008-11#2)(2008-12#1)(2008-8#1)(2012-3#1)
to activation##16##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
to active##8##2##(1993-11#1)(1994-11#1)(2008-11#2)(2009-8#1)(2010-12#2)(2012-2#1)
to actively##8##2##(1995-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#1)
to activin A##3##3##(1992-6#3)
to activity of##2##3##(1992-3#1)(2009-8#1)
to activity##7##2##(1992-3#1)(1993-6#1)(2008-10#1)(2009-3#2)(2009-8#1)(2013-1#1)
to actual##3##2##(1992-12#1)(2008-10#1)(2008-2#1)
to acuity##2##2##(1996-1#1)(2011-2#1)
to acute psychological stress##2##4##(2008-11#1)(2011-2#1)
to acute##19##2##(1991-3#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-8#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
to adapt the##3##3##(2008-10#2)(2008-3#1)
to adapt their##3##3##(2008-11#2)(2011-1#1)
to adapt to the##4##4##(2008-10#1)(2008-8#2)(2012-6#1)
to adapt to##10##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-8#3)(2009-6#1)(2012-2#1)(2012-6#1)
to adapt##17##2##(1996-1#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-8#3)(2009-6#1)(2011-1#1)(2012-2#1)(2012-6#1)
to adaptation to##2##3##(2011-2#1)(2012-3#1)
to add a##2##3##(1997-3#1)(2008-12#1)
to add in the##2##4##(2008-10#1)(2009-9#1)
to add to##2##3##(2008-7#1)(2008-9#1)
to add##11##2##(1997-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2012-3#2)
to addition of##2##3##(1993-6#1)(2008-11#1)
to addition##3##2##(1993-6#1)(2007-12#1)(2008-11#1)
to additional##5##2##(1996-5#1)(1997-1#1)(2008-3#1)(2012-2#1)(2013-8#1)
to address issues##3##3##(2008-1#1)(2010-5#1)(2012-3#1)
to address specific##3##3##(1992-1#1)(2008-12#1)(2013-1#1)
to address the issue##2##4##(1992-1#1)(2013-1#1)
to address the issues##2##4##(1991-1#1)(1997-3#1)
to address the problem##2##4##(1997-1#1)(1997-3#1)
to address the question##2##4##(1991-12#1)(2008-12#1)
to address the questions of##2##5##(2008-11#1)(2012-3#1)
to address the##28##3##(1991-1#1)(1991-12#1)(1992-1#2)(1993-1#1)(1994-12#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-3#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2012-3#1)(2013-1#2)(2013-8#2)
to address these issues##2##4##(2008-11#1)(2013-1#1)
to address these##10##3##(1996-3#1)(1997-2#1)(2008-11#2)(2008-12#3)(2008-3#1)(2011-10#1)(2013-1#1)
to address this issue##5##4##(1995-8#1)(1996-1#1)(2008-11#2)(2012-3#1)
to address this need##2##4##(1997-2#1)(2008-11#1)
to address this question##2##4##(2008-11#1)(2008-8#1)
to address this##16##3##(1995-8#1)(1996-1#1)(1997-2#1)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
to address varying##2##3##(2008-10#1)(2010-8#1)
to address##95##2##(1990-11#1)(1991-1#1)(1991-12#1)(1992-1#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#3)(2008-1#1)(2008-10#3)(2008-11#12)(2008-12#11)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#3)
to addressing##2##2##(1997-2#2)
to adequately##3##2##(2008-10#2)(2010-11#1)
to adhere to the##2##4##(2008-10#1)(2008-4#1)
to adhere to##11##3##(1995-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#4)
to adhere##14##2##(1995-9#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#4)(2011-2#1)
to adiposity and##2##3##(1996-11#1)(2012-5#1)
to adjacent##8##2##(1993-3#1)(2008-10#6)(2012-2#1)
to adjust for##4##3##(1990-8#1)(1991-2#1)(1994-3#1)(2008-2#1)
to adjust the##8##3##(1991-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2011-3#1)
to adjust##19##2##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1993-3#1)(1994-3#1)(1997-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-3#1)
to adjuvant##2##2##(1992-12#1)(1993-11#1)
to administer and##2##3##(1997-2#1)(2010-7#1)
to administer##9##2##(1992-3#1)(1997-2#1)(1997-3#1)(2008-12#1)(2008-7#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
to admit##3##2##(1991-12#1)(1992-6#1)(1994-3#1)
to adolescent##3##2##(2009-7#2)(2013-1#1)
to adolescents##4##2##(1995-12#1)(1996-6#1)(2013-1#2)
to adopt PBL##2##3##(2008-12#2)
to adopt a##5##3##(2008-10#2)(2008-11#2)(2012-3#1)
to adopt an##2##3##(1993-1#1)(2010-11#1)
to adopt the##4##3##(1990-2#2)(1995-6#1)(2008-12#1)
to adopt them for##2##4##(2008-10#1)(2008-11#1)
to adopt##30##2##(1990-2#2)(1993-1#1)(1994-5#1)(1995-6#1)(1997-1#2)(2008-10#4)(2008-11#6)(2008-12#3)(2009-3#1)(2009-5#1)(2010-11#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
to adrenalectomy##2##2##(2012-12#2)
to adriamycin plus##2##3##(1993-8#2)
to adriamycin##3##2##(1990-2#1)(1993-8#2)
to adsorb##2##2##(2008-10#2)
to adult##3##2##(1996-1#1)(2008-7#1)(2012-2#1)
to adulthood##7##2##(2008-8#1)(2009-7#2)(2011-2#3)(2012-2#1)
to adults##5##2##(2008-10#1)(2008-6#1)(2008-9#1)(2012-2#2)
to advance our understanding of##2##5##(2010-5#1)(2013-1#1)
to advance the##4##3##(1994-12#1)(2008-11#2)(2013-1#1)
to advance##12##2##(1994-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-7#1)(2013-1#2)
to advances in##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
to adverse##8##2##(1996-3#1)(2007-11#1)(2007-12#1)(2008-11#3)(2010-12#1)(2011-2#1)
to advise##2##2##(1995-6#1)(1996-3#1)
to advocating##2##2##(1991-1#1)(2008-10#1)
to aerial##2##2##(2008-10#2)
to aerosol##3##2##(1992-3#1)(1997-2#1)(2008-3#1)
to aerosols##3##2##(1992-3#1)(2008-11#1)(2008-2#1)
to affect a##3##3##(2008-5#1)(2010-12#1)(2013-7#1)
to affect sexual##3##3##(1993-8#1)(2012-3#2)
to affect the##16##3##(1990-5#1)(1991-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
to affect##54##2##(1990-5#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-3#2)(1995-12#1)(1995-8#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-3#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#1)
to affected##2##2##(2009-8#1)(2012-12#1)
to affirm##2##2##(1991-12#1)(1996-3#1)
to afford the##2##3##(1997-6#1)(2008-11#1)
to afford##9##2##(1994-2#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#3)(2009-12#1)(2012-12#1)
to aflatoxin##10##2##(2008-10#8)(2013-1#2)
to agarose##2##2##(1993-8#2)
to age and##2##3##(1992-2#1)(2013-1#1)
to age at##3##3##(1994-6#1)(2008-9#2)
to age##15##2##(1991-2#1)(1992-12#1)(1992-2#1)(1994-6#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
to aggression##3##2##(2008-11#3)
to aging##3##2##(1990-3#1)(2008-10#1)(2012-2#1)
to agree with##5##3##(2008-11#2)(2008-2#1)(2008-3#2)
to agree##9##2##(1991-12#1)(1992-2#1)(2008-11#2)(2008-2#1)(2008-3#4)
to agricultural##3##2##(2008-10#2)(2008-11#1)
to agriculture##2##2##(1990-2#1)(2010-4#1)
to aid clinical##2##3##(2008-5#1)(2011-2#1)
to aid in the##2##4##(1992-3#1)(2012-2#1)
to aid in##5##3##(1992-3#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
to aid the development of##2##5##(2008-9#1)(2009-12#1)
to aid the##5##3##(1992-9#1)(2008-4#1)(2008-9#2)(2009-12#1)
to aid##23##2##(1992-3#1)(1992-9#1)(1993-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
to air warming and##2##4##(2012-5#1)(2012-6#1)
to air warming##4##3##(2012-5#1)(2012-6#2)(2012-9#1)
to air##12##2##(1995-3#2)(2008-10#3)(2008-11#2)(2008-3#1)(2012-5#1)(2012-6#2)(2012-9#1)
to airway epithelial cells##2##4##(1994-11#2)
to airway##5##2##(1994-11#2)(1995-12#1)(1997-1#1)(2010-7#1)
to alanine##5##2##(1994-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
to albumin and##2##3##(2008-10#2)
to albumin##5##2##(1990-12#1)(1995-5#1)(2008-10#2)(2008-11#1)
to alcohol##6##2##(1991-1#1)(1992-12#1)(2008-10#1)(2008-11#2)(2010-7#1)
to alcoholism##2##2##(1996-11#1)(2008-11#1)
to aldosterone##2##2##(2008-4#2)
to alert the##2##3##(1992-2#1)(2008-9#1)
to alert##4##2##(1992-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
to alfalfa depends on##2##4##(2008-10#2)
to alfalfa##3##2##(2008-10#3)
to align##3##2##(2008-3#1)(2008-4#1)(2013-1#1)
to alkali and alkaline##2##4##(2008-10#2)
to alkali##6##2##(1994-3#1)(2008-10#5)
to alkaline hydrolysis##2##3##(2008-10#1)(2008-11#1)
to alkaline phosphatase##4##3##(1990-12#1)(1991-10#1)(2008-10#1)(2008-11#1)
to alkaline##8##2##(1990-12#1)(1991-10#1)(2008-10#3)(2008-11#2)(2008-9#1)
to alkylating agents##4##3##(2008-11#4)
to all areas of the##2##5##(1996-1#1)(2008-12#1)
to all health##2##3##(1996-3#1)(2008-11#1)
to all isolates##2##3##(2008-10#2)
to all of the##4##4##(1995-5#1)(2008-10#2)(2008-5#1)
to all other##4##3##(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)
to all patients##4##3##(1994-3#1)(2008-3#1)(2008-7#1)(2008-8#1)
to all races##4##3##(2008-10#4)
to all tested##2##3##(2008-10#2)
to all the offspring##2##4##(2008-8#2)
to all the##9##3##(1993-1#1)(1995-8#1)(2008-10#3)(2008-8#2)(2009-12#1)(2013-1#1)
to all three fungicides##2##4##(2008-10#2)
to all three##7##3##(1991-7#1)(1995-12#1)(1996-1#1)(2008-10#3)(2008-5#1)
to all types of##4##4##(2008-11#2)(2011-2#1)(2013-1#1)
to all##112##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-2#2)(1994-1#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#35)(2008-11#9)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#8)(2013-1#3)
to alleviate the##2##3##(1992-8#1)(2007-12#1)
to alleviate##7##2##(1991-2#2)(1992-8#1)(1993-3#1)(1995-12#1)(2007-12#1)(2010-3#1)
to allocate##2##2##(1992-12#1)(2008-10#1)
to allow a##2##3##(2008-10#2)
to allow an##2##3##(2008-10#1)(2009-12#1)
to allow for the##5##4##(2008-10#1)(2008-4#1)(2008-7#2)(2013-8#1)
to allow for##12##3##(1992-3#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2013-8#2)
to allow sequential##2##3##(2008-10#2)
to allow simultaneous##2##3##(2008-11#1)(2009-10#1)
to allow the##16##3##(1992-12#1)(1992-3#1)(1995-12#1)(1996-2#1)(1997-6#1)(2008-10#6)(2008-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
to allow##76##2##(1992-12#1)(1992-3#2)(1993-2#1)(1994-5#2)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-6#2)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
to almost complete##2##3##(1995-8#1)(2008-10#1)
to almost##7##2##(1995-8#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
to alpha##4##2##(1992-10#1)(1993-8#1)(2008-8#1)(2009-7#1)
to alpha-amylase##3##2##(1990-3#3)
to alpha-lactalbumin##2##2##(2008-10#2)
to alpha-tomatine##2##2##(2008-10#2)
to already##2##2##(2008-10#1)(2009-7#1)
to also consider##2##3##(2011-3#1)(2012-2#1)
to also##4##2##(2008-10#1)(2010-10#1)(2011-3#1)(2012-2#1)
to alter the##16##3##(1994-5#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#2)(2012-2#2)
to alter##29##2##(1990-2#1)(1992-1#1)(1992-12#2)(1992-6#1)(1993-11#1)(1994-5#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#2)(2010-5#1)(2012-2#2)(2012-3#1)
to alteration in##2##3##(2009-8#1)(2012-2#1)
to alteration##3##2##(2009-10#1)(2009-8#1)(2012-2#1)
to alterations in the##2##4##(1995-3#1)(1997-2#1)
to alterations in##3##3##(1995-3#1)(1997-2#1)(2008-7#1)
to alterations##4##2##(1995-3#1)(1997-2#1)(2008-11#1)(2008-7#1)
to altered##8##2##(1990-5#1)(1997-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-10#1)(2012-7#1)(2013-8#1)
to alternating##2##2##(2008-10#1)(2008-9#1)
to alternative models of##2##4##(2007-12#1)(2008-10#1)
to alternative##8##2##(1992-2#1)(1992-6#1)(1993-5#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-9#1)
to ambient conditions##2##3##(1993-12#1)(2008-10#1)
to ambient##9##2##(1993-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-9#1)(2012-7#1)
to ambulatory##2##2##(1995-12#1)(2011-2#1)
to ameliorate the##2##3##(2010-7#1)(2011-2#1)
to ameliorate##4##2##(2008-7#2)(2010-7#1)(2011-2#1)
to amensal##2##2##(2008-12#2)
to amidoxime groups##2##3##(2008-10#2)
to amiloride##3##2##(1991-5#3)
to amino acid changes##2##4##(2008-5#1)(2013-1#1)
to amino acid##5##3##(1991-10#1)(1992-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
to amino acids##2##3##(1992-12#1)(1994-8#1)
to amino##7##2##(1991-10#1)(1992-12#2)(1994-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
to aminoglycosides##2##2##(2008-12#1)(2009-8#1)
to ammonia and##2##3##(2008-10#2)
to ammonia in##2##3##(2008-10#1)(2011-2#1)
to ammonia##6##2##(1993-8#1)(2008-10#3)(2008-7#1)(2011-2#1)
to ammonium ion##2##3##(2008-10#2)
to ammonium##3##2##(2008-10#3)
to amperometric detection of##3##4##(2008-10#3)
to amperometric##4##2##(2008-10#4)
to amphotericin B##3##3##(2008-5#3)
to ampicillin and##2##3##(2008-10#1)(2012-3#1)
to ampicillin##4##2##(2007-12#1)(2008-10#1)(2012-3#2)
to amplify DNA##3##3##(2008-10#3)
to amplify a##4##3##(2008-10#3)(2009-8#1)
to amplify sequences##2##3##(1992-6#1)(2008-10#1)
to amplify the##7##3##(1991-7#1)(2008-10#4)(2008-11#1)(2008-8#1)
to amplify##30##2##(1991-7#1)(1992-6#1)(1993-12#1)(1994-11#1)(1997-3#1)(2008-10#19)(2008-11#2)(2008-4#1)(2008-8#1)(2009-8#1)(2013-8#1)
to an MDI##2##3##(1996-1#1)(1997-1#1)
to an accelerated##2##3##(2008-10#2)
to an acceptor stream##2##4##(2008-10#2)
to an accumulation of##2##4##(1995-6#1)(2009-10#1)
to an accuracy##2##3##(2008-2#1)(2008-3#1)
to an acidic##3##3##(2008-10#3)
to an activation##2##3##(2008-4#1)(2008-5#1)
to an acute##2##3##(1994-5#1)(2010-12#1)
to an alternative##2##3##(1997-7#1)(2008-10#1)
to an antigen##2##3##(2008-10#2)
to an apparent##2##3##(1990-12#1)(1994-5#1)
to an appropriate##2##3##(1996-3#1)(2008-10#1)
to an aqueous##2##3##(2008-10#2)
to an arbitrary##2##3##(1997-2#1)(2008-6#1)
to an artificial##2##3##(2008-10#1)(2011-2#1)
to an atomic##2##3##(2008-10#1)(2008-2#1)
to an autosomal##2##3##(2008-12#1)(2011-3#1)
to an average##2##3##(2008-6#1)(2008-9#1)
to an electrostatic##2##3##(1996-5#1)(2008-10#1)
to an end##2##3##(2008-9#1)(2013-8#1)
to an endemic##3##3##(2008-10#2)(2011-2#1)
to an enhanced##2##3##(1995-12#1)(2012-12#1)
to an enhancement##2##3##(1995-3#1)(2008-10#1)
to an entire##2##3##(2008-3#1)(2011-2#1)
to an enzyme##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
to an established##2##3##(2008-10#1)(2011-2#1)
to an estimated##4##3##(1991-11#1)(1995-2#2)(2011-2#1)
to an experimental##2##3##(2008-12#1)(2008-4#1)
to an exponential##2##3##(2008-10#1)(2012-2#1)
to an extent that##2##4##(1994-6#1)(2008-10#1)
to an extent##6##3##(1990-9#1)(1994-6#1)(1995-2#1)(2008-10#2)(2008-11#1)
to an immunological##2##3##(1990-5#1)(1991-2#1)
to an improved##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
to an improvement of the##2##5##(2008-10#2)
to an improvement##4##3##(1990-2#1)(2008-10#2)(2008-2#1)
to an increase in the##6##5##(1990-5#1)(2008-10#2)(2008-11#2)(2009-8#1)
to an increase in##15##4##(1990-5#1)(1992-11#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2009-1#1)(2009-8#1)(2011-3#1)(2013-1#1)
to an increase of the##3##5##(2008-10#1)(2008-11#1)(2009-11#1)
to an increase of##8##4##(1991-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-11#1)(2011-2#1)
to an increase##23##3##(1990-5#1)(1991-6#1)(1992-11#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-3#1)(2009-1#1)(2009-11#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
to an increased##8##3##(1990-8#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-7#1)
to an inductively coupled plasma##2##5##(2008-10#2)
to an infection##2##3##(2008-11#1)(2010-6#1)
to an inhibition of##2##4##(1990-8#2)
to an initial##2##3##(1991-6#1)(2010-6#1)
to an integrated##2##3##(2008-10#1)(2012-3#1)
to an interaction##2##3##(1994-5#1)(2008-10#1)
to an internal##2##3##(2008-7#1)(2008-8#1)
to an investigation##2##3##(2008-10#1)(2008-12#1)
to an ion##2##3##(1994-8#1)(2008-10#1)
to an isolate##2##3##(2008-10#2)
to an optimum##2##3##(1991-3#1)(2008-10#1)
to an organic##2##3##(2008-10#2)
to an understanding of##2##4##(2008-9#2)
to an##365##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#2)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2007-12#1)(2007-8#1)(2008-10#101)(2008-11#23)(2008-12#7)(2008-2#6)(2008-3#12)(2008-4#7)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#8)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#2)(2011-2#14)(2011-3#2)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#1)
to analyse the##16##3##(1993-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-5#1)
to analyse##45##2##(1991-6#1)(1992-12#2)(1993-2#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
to analysis by##3##3##(2008-10#3)
to analysis of##13##3##(2008-10#10)(2008-9#1)(2012-12#1)(2013-8#1)
to analysis##24##2##(2008-10#21)(2008-9#1)(2012-12#1)(2013-8#1)
to analytical##8##2##(2008-10#5)(2008-5#1)(2010-7#1)(2011-1#1)
to analyze a##4##3##(2008-10#3)(2008-8#1)
to analyze and##3##3##(2008-10#1)(2008-11#2)
to analyze in##2##3##(1997-3#1)(2013-1#1)
to analyze some##2##3##(2008-3#1)(2009-10#1)
to analyze the data##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
to analyze the dynamics of##2##5##(1997-1#1)(2008-8#1)
to analyze the effect of##4##5##(1995-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
to analyze the results of##2##5##(2012-3#1)(2013-1#1)
to analyze the results##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
to analyze the variability##2##4##(2008-10#2)
to analyze the##63##3##(1992-1#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#1)(2010-12#2)(2010-9#1)(2011-2#6)(2011-7#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)
to analyze##145##2##(1990-11#1)(1992-1#1)(1992-5#1)(1993-3#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#44)(2008-11#14)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-7#1)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-9#1)(2011-2#9)(2011-7#1)(2012-2#4)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#1)
to analyzing##4##2##(2008-4#2)(2008-9#1)(2009-4#1)
to anatomical##5##2##(1991-12#2)(2009-9#1)(2010-6#1)(2011-2#1)
to anchor##4##2##(1991-2#1)(1994-12#1)(2008-10#2)
to and from the##2##4##(2008-10#1)(2008-3#1)
to and from##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2010-10#1)
to and##51##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-9#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#3)(1997-3#2)(2007-11#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#1)(2010-11#2)(2011-2#1)
to androgens##2##2##(1995-12#2)
to angiotensin##2##2##(1994-2#1)(2008-9#1)
to animal##8##2##(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#2)
to animals##2##2##(2008-5#1)(2008-9#1)
to annotate##2##2##(2008-9#1)(2013-1#1)
to annual##2##2##(1994-2#1)(2008-10#1)
to anomalous##3##2##(1992-8#1)(2008-3#1)(2012-2#1)
to another in a##2##4##(1991-3#1)(2009-10#1)
to another##36##2##(1991-3#1)(1995-1#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
to answer questions##2##3##(1991-3#1)(2008-11#1)
to answer the following questions##2##5##(1994-8#1)(1997-3#1)
to answer the question##2##4##(2009-8#1)(2011-2#1)
to answer the##5##3##(1994-8#1)(1997-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
to answer##13##2##(1991-3#1)(1992-2#1)(1994-1#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-11#4)(2009-8#1)(2011-2#2)
to antagonize##4##2##(1997-2#1)(2008-10#1)(2010-10#1)(2013-7#1)
to anterior##5##2##(2008-7#3)(2011-2#2)
to anthesis##8##2##(2008-10#8)
to anthracnose resistance##2##3##(2008-10#2)
to anthracnose##8##2##(2008-10#8)
to antibacterial##2##2##(1991-3#1)(1992-5#1)
to antibiotic##2##2##(2008-12#1)(2011-1#1)
to antibiotics##7##2##(1997-4#2)(2009-6#1)(2011-2#1)(2012-3#2)(2013-7#1)
to antibodies##2##2##(2008-7#1)(2010-7#1)
to anticancer drugs##2##3##(2008-11#1)(2009-6#1)
to anticancer##4##2##(1992-2#1)(2008-11#2)(2009-6#1)
to anticipate##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
to antidepressant##2##2##(2008-4#1)(2008-6#1)
to antigen##2##2##(1991-5#1)(1997-1#1)
to antigenic stimulation##2##3##(1997-1#1)(2008-11#1)
to antigens##2##2##(1996-12#1)(2008-10#1)
to antiinflammatory##2##2##(2008-10#1)(2011-2#1)
to antimicrobial##2##2##(2008-7#1)(2013-1#1)
to antineoplastic drugs##3##3##(2013-1#3)
to antineoplastic##4##2##(2008-11#1)(2013-1#3)
to antiretroviral##2##2##(2010-11#1)(2011-3#1)
to ants##2##2##(2008-10#2)
to any known##2##3##(1996-12#1)(2008-10#1)
to any major##2##3##(2008-10#1)(2011-2#1)
to any of the##3##4##(2008-10#3)
to any other##7##3##(1993-12#1)(1996-12#2)(1996-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
to any reported genes##3##4##(1995-8#2)(1996-2#1)
to any##51##2##(1991-1#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#2)(1996-12#3)(1996-2#1)(1996-6#2)(2008-10#16)(2008-11#4)(2008-4#3)(2008-5#2)(2008-9#3)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
to anyone##3##2##(1992-1#1)(1993-12#1)(1995-1#1)
to aortic##2##2##(1991-6#1)(2009-6#1)
to apo B-containing##2##3##(1995-8#2)
to apoptosis induced by##3##4##(1994-11#1)(2008-11#1)(2013-1#1)
to apoptosis induction##2##3##(2008-8#2)
to apoptosis##15##2##(1993-8#1)(1994-11#1)(1995-2#1)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#2)(2010-3#1)(2011-2#1)(2013-1#1)
to appeal to the##2##4##(1991-2#1)(2012-2#1)
to appear##5##2##(1995-8#1)(2008-10#2)(2008-2#1)(2011-2#1)
to apple##8##2##(2008-10#8)
to application of the##2##4##(2008-10#2)
to application of##6##3##(1990-7#1)(2008-10#4)(2012-3#1)
to application##8##2##(1990-7#1)(2008-10#5)(2011-2#1)(2012-3#1)
to applications##2##2##(2008-10#1)(2008-4#1)
to apply a##7##3##(1991-1#1)(2008-10#3)(2008-11#2)(2008-5#1)
to apply for##3##3##(1991-3#1)(2013-1#2)
to apply the principles of##2##5##(2008-11#2)
to apply the principles##3##4##(2008-11#2)(2013-1#1)
to apply the##11##3##(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)(2010-10#1)(2013-1#1)
to apply their knowledge in##2##5##(1997-3#1)(2008-12#1)
to apply their##3##3##(1997-3#1)(2008-10#1)(2008-12#1)
to apply these##3##3##(1996-3#1)(2008-10#1)(2013-7#1)
to apply this method##3##4##(2008-10#2)(2008-4#1)
to apply this##7##3##(2008-10#4)(2008-11#2)(2008-4#1)
to apply to##3##3##(2008-6#1)(2008-8#1)(2010-8#1)
to apply##64##2##(1991-1#1)(1991-3#1)(1992-3#1)(1994-12#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-7#2)(2008-10#20)(2008-11#9)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#2)(2009-1#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
to appraise##2##2##(1993-12#1)(2008-10#1)
to appreciate the##2##3##(1991-12#1)(2010-4#1)
to approach the##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
to approach##5##2##(1991-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
to appropriate##6##2##(1991-1#1)(2008-1#1)(2008-10#2)(2008-11#2)
to appropriately##2##2##(2008-10#1)(2012-2#1)
to approximate the##5##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
to approximately 0##5##3##(1991-11#2)(2008-10#1)(2008-11#1)(2008-3#1)
to approximately 10%##2##3##(1992-6#1)(2008-10#1)
to approximately 15##2##3##(1993-8#1)(2008-10#1)
to approximately 50%##2##3##(2008-10#2)
to approximately three##2##3##(1995-5#1)(2008-2#1)
to approximately##42##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#2)(1992-12#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#17)(2008-11#7)(2008-2#2)(2008-3#1)(2008-7#1)(2012-12#1)
to aquatic##2##2##(2008-10#1)(2008-12#1)
to aqueous solution##2##3##(2008-10#2)
to aqueous##4##2##(2008-10#4)
to arachidonic acid##2##3##(1994-5#1)(1995-11#1)
to areas of##3##3##(2007-12#1)(2008-11#1)(2010-5#1)
to areas##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-5#1)
to argon##4##2##(1993-1#2)(2008-10#2)
to argue##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
to arise from the##3##4##(2008-5#1)(2010-5#1)(2013-7#1)
to arise from##4##3##(2008-10#1)(2008-5#1)(2010-5#1)(2013-7#1)
to arise##10##2##(1990-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
to arrange##2##2##(1990-12#1)(1996-11#1)
to arrest the##2##3##(1996-12#1)(2008-9#1)
to arrest##4##2##(1996-12#1)(1997-3#1)(2006-6#1)(2008-9#1)
to arrive at the correct diagnosis##2##6##(2010-12#1)(2013-1#1)
to arrive at the##3##4##(1995-1#1)(2010-12#1)(2013-1#1)
to arrive at##5##3##(1995-1#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
to arrive##6##2##(1995-1#1)(1997-7#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
to arsenate##2##2##(2008-10#2)
to arsenic##2##2##(2008-10#2)
to arsenosugars##2##2##(2008-10#2)
to arterial##5##2##(1995-8#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-12#1)
to articles##2##2##(2008-10#1)(2013-8#1)
to articulate knowing in practice##2##5##(2008-12#2)
to articulate the##2##3##(2008-5#1)(2012-2#1)
to articulate##6##2##(2008-11#1)(2008-12#3)(2008-5#1)(2012-2#1)
to artificial selection##2##3##(2008-8#1)(2008-9#1)
to artificial##7##2##(1992-12#1)(2008-10#2)(2008-8#2)(2008-9#1)(2012-7#1)
to as high as##3##4##(2008-10#1)(2008-3#2)
to as the &quot##6##4##(1991-2#1)(1996-1#1)(1996-12#1)(2008-11#1)(2009-10#1)(2011-2#1)
to as the##9##3##(1991-2#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)
to as##67##2##(1991-2#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to asbestos in the##2##4##(1991-12#1)(1997-5#1)
to asbestos in##4##3##(1991-12#3)(1997-5#1)
to asbestos used in railroads##3##5##(1991-12#3)
to asbestos used in##4##4##(1991-12#4)
to asbestos##12##2##(1991-12#10)(1995-2#1)(1997-5#1)
to ascertain how##3##3##(1994-1#1)(1995-3#1)(1996-9#1)
to ascertain the effect of##2##5##(2008-11#1)(2013-8#1)
to ascertain the##10##3##(2008-10#4)(2008-11#2)(2008-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to ascertain their##2##3##(2008-10#1)(2008-12#1)
to ascertain##23##2##(1992-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-9#1)(1997-7#1)(2006-6#1)(2008-10#7)(2008-11#4)(2008-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
to ascospore progeny under##2##4##(2008-10#2)
to ascospore##3##2##(2008-10#3)
to asexual reproduction##2##3##(2008-10#1)(2012-3#1)
to ask##3##2##(1994-1#1)(1994-2#1)(2008-10#1)
to assay the##3##3##(2008-10#3)
to assay##17##2##(1991-5#2)(1993-1#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-9#1)
to assemble a##2##3##(1993-8#1)(2008-10#1)
to assemble##6##2##(1993-8#1)(2008-10#3)(2008-8#1)(2011-2#1)
to asses##2##2##(2008-12#1)(2011-1#1)
to assess QoL##2##3##(2008-10#1)(2011-2#1)
to assess airway##2##3##(1997-1#1)(2008-10#1)
to assess and##2##3##(1996-2#1)(2008-5#1)
to assess both##2##3##(2008-10#2)
to assess cell##2##3##(2008-11#1)(2012-2#1)
to assess changes in##3##4##(1996-2#1)(2008-10#1)(2008-9#1)
to assess differences in##2##4##(1991-1#1)(2008-10#1)
to assess differences##3##3##(1991-1#1)(2008-10#1)(2011-2#1)
to assess efficacy of##2##4##(2008-10#1)(2008-5#1)
to assess exposure##2##3##(2010-5#1)(2011-2#1)
to assess genetic##2##3##(2008-10#2)
to assess how##2##3##(2010-6#1)(2010-8#1)
to assess in vitro the##2##5##(2008-5#1)(2008-9#1)
to assess in vitro##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
to assess its##5##3##(2008-10#1)(2008-11#2)(2009-4#1)(2013-1#1)
to assess local##2##3##(1993-1#1)(1995-12#1)
to assess our##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
to assess patient##2##3##(1997-2#1)(2013-1#1)
to assess patients##2##3##(2012-2#1)(2013-1#1)
to assess potential##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
to assess the ability of pre-registration nursing students' to##2##9##(2008-11#2)
to assess the ability of##4##5##(2008-10#1)(2008-11#2)(2008-9#1)
to assess the accuracy of##2##5##(1994-3#1)(2008-10#1)
to assess the applicability of##2##5##(1995-1#1)(1995-11#1)
to assess the contribution of##2##5##(2008-10#1)(2013-1#1)
to assess the current##2##4##(1994-12#1)(2008-10#1)
to assess the degree of##4##5##(2008-10#4)
to assess the degree##5##4##(2008-10#4)(2010-6#1)
to assess the effect of##9##5##(1996-6#1)(1997-1#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to assess the effectiveness of##5##5##(1990-2#1)(1995-3#1)(2008-10#1)(2011-2#1)(2011-3#1)
to assess the effects of##6##5##(2008-10#3)(2008-5#1)(2008-8#1)(2012-2#1)
to assess the efficacy of##2##5##(1992-9#1)(2009-2#1)
to assess the efficacy##5##4##(1992-9#1)(2008-5#2)(2008-8#1)(2009-2#1)
to assess the evidence##2##4##(2008-2#1)(2013-8#1)
to assess the extent of##2##5##(2008-8#1)(2013-1#1)
to assess the extent##3##4##(1995-3#1)(2008-8#1)(2013-1#1)
to assess the feasibility of##2##5##(1995-11#1)(2008-11#1)
to assess the feasibility##3##4##(1992-2#1)(1995-11#1)(2008-11#1)
to assess the general##2##4##(2008-3#1)(2008-7#1)
to assess the genetic diversity##2##5##(2008-10#1)(2008-7#1)
to assess the impact of##11##5##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#1)(2013-8#1)
to assess the impact##13##4##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
to assess the influence of##6##5##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2013-1#1)
to assess the possibility of##2##5##(2012-3#1)(2013-1#1)
to assess the possible##3##4##(2008-11#1)(2012-3#1)(2012-8#1)
to assess the potential##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
to assess the presence of##2##5##(2008-5#1)(2010-1#1)
to assess the presence##3##4##(2008-5#1)(2010-1#1)(2012-2#1)
to assess the prevalence of##3##5##(2008-1#1)(2011-2#1)(2012-3#1)
to assess the prevalence##4##4##(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
to assess the quality of##3##5##(1991-3#1)(2008-10#2)
to assess the relative importance of##3##6##(2008-10#1)(2008-7#1)(2009-4#1)
to assess the relative##7##4##(1995-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-4#1)
to assess the sand/rub resistance of##2##6##(2008-5#2)
to assess the severity of##2##5##(1995-11#1)(2013-1#1)
to assess the true##2##4##(1995-12#1)(2012-3#1)
to assess the usefulness##2##4##(1990-5#1)(2011-2#1)
to assess the##198##3##(1990-2#2)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#4)(1995-12#2)(1995-3#2)(1996-1#1)(1996-6#2)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#48)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#16)(2008-7#7)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#12)(2012-8#1)(2013-1#11)(2013-8#5)
to assess their##7##3##(1993-12#1)(1993-9#1)(1996-12#1)(1997-3#1)(2011-2#2)(2013-1#1)
to assess to what##2##4##(2008-11#2)
to assess whether the##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
to assess whether##15##3##(1994-3#1)(1995-11#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to assess##393##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-1#2)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#4)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#95)(2008-11#29)(2008-12#11)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#24)(2008-6#1)(2008-7#13)(2008-8#6)(2008-9#13)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#22)(2011-3#1)(2011-8#1)(2012-12#8)(2012-2#12)(2012-3#15)(2012-8#1)(2013-1#22)(2013-8#8)
to assessing##4##2##(1991-1#1)(1997-2#1)(2008-10#1)(2008-8#1)
to assessment##4##2##(1992-1#1)(1993-1#1)(2008-11#1)(2008-9#1)
to assign##4##2##(1996-2#1)(1996-5#1)(1997-6#1)(2012-3#1)
to assimilate##3##2##(2008-11#2)(2008-12#1)
to assist in the##2##4##(2008-4#1)(2012-12#1)
to assist in##13##3##(1993-12#1)(1993-8#1)(1996-2#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
to assist the##7##3##(2008-10#3)(2008-11#1)(2008-12#1)(2010-12#1)(2011-7#1)
to assist##50##2##(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#6)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)
to assisting##2##2##(1991-12#1)(2008-10#1)
to associate a##3##3##(1993-6#1)(2008-10#1)(2009-8#1)
to associate##10##2##(1990-11#1)(1993-6#2)(1993-9#1)(2008-10#3)(2009-8#3)
to associated##2##2##(2008-10#1)(2008-7#1)
to association##2##2##(2008-8#1)(2013-1#1)
to associations between##2##3##(2008-12#1)(2012-3#1)
to assume that##6##3##(1991-6#2)(1992-12#1)(2008-11#2)(2008-5#1)
to assume##11##2##(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)
to assure a##2##3##(2010-11#1)(2010-9#1)
to assure that##4##3##(1994-2#1)(1996-3#1)(1997-8#1)(2008-1#1)
to assure the##4##3##(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
to assure##16##2##(1991-2#1)(1994-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)
to asthma##2##2##(1992-3#1)(2008-8#1)
to at least 100 ng ml(-1)##2##6##(2008-10#2)
to at least 100##4##4##(2008-10#4)
to at least##19##3##(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#12)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
to at##20##2##(1992-12#1)(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#12)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
to atherosclerosis##3##2##(1995-2#1)(1995-8#1)(1997-8#1)
to athletes' health##2##3##(1993-3#1)(2010-7#1)
to atmospheric##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
to atomic absorption or atomic##2##5##(2008-10#2)
to atomic absorption##3##3##(2008-10#3)
to atomic##6##2##(2008-10#5)(2008-4#1)
to atrial fibrillation##2##3##(2008-12#1)(2010-4#1)
to attach to the##2##4##(2008-10#1)(2011-1#1)
to attach##4##2##(2008-10#2)(2008-9#1)(2011-1#1)
to attack##5##2##(2008-10#2)(2009-10#1)(2010-1#1)(2011-10#1)
to attain a##3##3##(1993-3#1)(1997-8#1)(2008-8#1)
to attain the##6##3##(2008-10#5)(2008-3#1)
to attain##12##2##(1993-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
to attempt to##4##3##(1992-2#1)(2008-10#1)(2008-7#1)(2009-8#1)
to attempt##6##2##(1992-2#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-8#1)
to attend to the##2##4##(1997-8#1)(2008-11#1)
to attend##11##2##(1992-2#1)(1992-5#1)(1993-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
to attention##2##2##(1996-2#1)(2008-11#1)
to attenuate the##5##3##(1992-8#1)(1993-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
to attenuate##9##2##(1990-5#1)(1992-8#1)(1993-8#1)(1997-1#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
to attitudes##2##2##(2010-12#1)(2013-1#1)
to attract##9##2##(1990-2#1)(1994-1#2)(1995-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2013-1#1)
to augment the##2##3##(1994-8#1)(2008-11#1)
to augment##9##2##(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
to autoimmune##3##2##(2008-10#2)(2011-2#1)
to automate##3##2##(2008-10#2)(2010-10#1)
to automated##6##2##(1997-2#1)(2008-10#2)(2008-4#1)(2008-9#2)
to automatically##2##2##(2008-10#1)(2012-2#1)
to auxin##4##2##(2008-8#3)(2009-8#1)
to available##3##2##(2009-4#1)(2013-1#1)(2013-8#1)
to average##7##2##(2008-10#2)(2008-9#5)
to avian##4##2##(2008-5#2)(2008-8#1)(2012-3#1)
to avirulent##2##2##(1995-2#1)(2008-10#1)
to avoid a##4##3##(1994-2#1)(2008-6#1)(2011-2#1)(2013-8#1)
to avoid and##2##3##(2008-10#1)(2008-11#1)
to avoid complications##2##3##(1991-6#1)(2011-2#1)
to avoid interferences##2##3##(2008-10#2)
to avoid or##3##3##(1991-12#1)(1991-6#1)(2008-10#1)
to avoid postoperative retroauricular deformity##3##5##(2008-7#3)
to avoid the negative##2##4##(2008-11#1)(2008-9#1)
to avoid the use of##2##5##(2008-7#1)(2011-2#1)
to avoid the##21##3##(1992-5#1)(1993-3#1)(1993-8#1)(1996-11#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)
to avoid them##2##3##(1995-2#1)(2011-2#1)
to avoid##114##2##(1991-1#1)(1991-12#4)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-11#2)(1996-3#1)(1997-2#3)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#5)(2009-8#3)(2010-11#1)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
to azoles##2##2##(2008-5#2)
to azoxymethane##2##2##(1993-11#1)(2011-2#1)
to b##2##2##(2008-10#2)
to bFGF##3##2##(1995-12#1)(2008-11#2)
to background##2##2##(1995-12#1)(2008-9#1)
to bacteria##3##2##(2008-10#1)(2010-1#1)(2012-3#1)
to bacterial blight##5##3##(2008-10#3)(2008-8#1)(2009-10#1)
to bacterial canker##7##3##(2008-10#7)
to bacterial pathogens##4##3##(2008-10#4)
to bacterial##30##2##(1991-3#1)(1992-8#1)(1997-7#1)(2008-10#22)(2008-11#1)(2008-8#1)(2009-10#1)(2013-8#2)
to balance both##2##3##(2010-5#1)(2012-6#1)
to balance the##3##3##(1995-6#1)(2008-11#1)(2008-3#1)
to balance##6##2##(1992-12#1)(1995-6#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-6#1)
to balloon##2##2##(1997-8#1)(2008-11#1)
to band##3##2##(2008-12#1)(2013-1#1)(2013-7#1)
to bariatric surgery##2##3##(1993-3#1)(2010-8#1)
to barley in the##2##4##(2008-10#2)
to barley##7##2##(2008-10#7)
to baroreceptor##2##2##(1990-5#2)
to basal levels##2##3##(1996-12#1)(2008-10#1)
to basal##7##2##(1991-12#1)(1991-3#1)(1991-6#1)(1996-12#1)(1997-1#1)(2008-10#1)(2012-3#1)
to base##11##2##(1997-1#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)
to baseline at##2##3##(1990-7#1)(2013-1#1)
to baseline values##2##3##(2013-1#1)(2013-8#1)
to baseline##11##2##(1990-10#1)(1990-7#1)(1993-1#1)(1994-3#1)(2012-2#1)(2013-1#3)(2013-8#3)
to basic##7##2##(2007-8#1)(2008-10#3)(2010-1#1)(2011-2#1)(2013-1#1)
to batch cultures##2##3##(2008-11#2)
to batch##4##2##(2008-11#3)(2008-7#1)
to bcl-2##2##2##(1993-3#1)(1994-3#1)
to be &gt##5##3##(2008-10#4)(2008-8#1)
to be &lt##6##3##(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#2)
to be &quot##2##3##(2008-11#1)(2013-1#1)
to be 0##50##3##(1990-6#1)(2008-10#44)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)
to be 1##30##3##(1995-11#1)(2008-10#26)(2008-11#1)(2008-12#1)(2013-1#1)
to be 10##7##3##(1990-12#1)(2008-10#5)(2008-8#1)
to be 100%##4##3##(1994-12#1)(1995-12#1)(1996-12#1)(2008-9#1)
to be 2##31##3##(1992-3#1)(1996-5#1)(2008-10#28)(2011-1#1)
to be 21##2##3##(2008-10#1)(2012-3#1)
to be 3##13##3##(1993-8#1)(2008-10#10)(2008-3#1)(2012-2#1)
to be 4##16##3##(1993-1#1)(1994-5#1)(1995-12#1)(1997-8#1)(2008-10#11)(2012-3#1)
to be 5##9##3##(1997-2#1)(2008-10#6)(2008-5#1)(2008-8#1)
to be 6##6##3##(1991-2#1)(2008-10#3)(2008-11#1)(2013-8#1)
to be 7##5##3##(1991-5#1)(2008-10#4)
to be 8##3##3##(1994-5#1)(2008-10#1)(2008-3#1)
to be 9##3##3##(1991-5#1)(2008-10#2)
to be 99##6##3##(1996-12#1)(2008-10#5)
to be F##2##3##(2008-10#2)
to be Neisseria##2##3##(2013-1#2)
to be a &quot##2##4##(2008-10#1)(2009-7#1)
to be a beneficial##2##4##(1997-1#1)(2010-12#1)
to be a benign tumor##2##5##(2008-10#1)(2008-12#1)
to be a better##2##4##(1996-1#1)(2008-10#1)
to be a central##2##4##(2010-10#1)(2013-1#1)
to be a common feature##2##5##(1991-10#1)(2008-10#1)
to be a common##5##4##(1991-10#1)(2008-10#1)(2009-8#1)(2010-1#1)(2011-1#1)
to be a constant##2##4##(1992-12#1)(2007-12#1)
to be a cost-effective##2##4##(2008-10#1)(2008-7#1)
to be a crucial##2##4##(1991-12#1)(2010-12#1)
to be a fast and##3##5##(2008-10#1)(2008-11#1)(2009-12#1)
to be a function of the##2##6##(1991-5#1)(2008-7#1)
to be a function of##4##5##(1991-5#1)(2008-10#2)(2008-7#1)
to be a general##3##4##(2008-10#1)(2008-8#2)
to be a good tool##2##5##(2008-7#1)(2009-8#1)
to be a good##9##4##(1994-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2013-1#1)
to be a high##3##4##(1994-5#1)(2008-11#1)(2008-8#1)
to be a highly##2##4##(2008-10#2)
to be a key##3##4##(2008-11#2)(2013-8#1)
to be a major cause of##2##6##(1991-12#1)(1995-3#1)
to be a major##9##4##(1990-8#1)(1991-12#1)(1992-1#1)(1993-11#1)(1995-3#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-3#1)
to be a more potent##2##5##(1994-11#1)(2008-5#1)
to be a more##8##4##(1994-11#1)(1994-5#1)(2008-10#5)(2008-5#1)
to be a novel##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
to be a potent##5##4##(1991-5#1)(1992-3#1)(1993-12#1)(1995-12#1)(2008-11#1)
to be a powerful tool##3##5##(1993-2#1)(2008-10#1)(2008-11#1)
to be a powerful##8##4##(1993-2#1)(1993-8#1)(2008-10#1)(2008-11#4)(2008-3#1)
to be a primary##2##4##(1995-1#1)(2008-10#1)
to be a promising##4##4##(2008-5#1)(2008-9#1)(2009-8#1)(2011-7#1)
to be a reliable technique##2##5##(1996-6#1)(2012-2#1)
to be a reliable##5##4##(1994-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
to be a robust##2##4##(2008-10#1)(2012-2#1)
to be a safe and##2##5##(1990-11#1)(2011-2#1)
to be a safe##5##4##(1990-11#1)(1992-2#1)(2010-7#1)(2011-2#2)
to be a sensitive and##2##5##(1994-11#1)(2008-10#1)
to be a sensitive##5##4##(1994-11#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
to be a serious##2##4##(2008-12#1)(2009-9#1)
to be a significant predictor of##2##6##(1991-3#1)(1996-3#1)
to be a significant source of##2##6##(1995-3#1)(2012-2#1)
to be a significant##7##4##(1991-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
to be a simple##2##4##(2008-10#2)
to be a source of##2##5##(2008-10#1)(2010-6#1)
to be a specific##2##4##(1992-6#1)(2010-1#1)
to be a suitable replacement for##2##6##(2008-11#1)(2008-5#1)
to be a suitable##5##4##(2008-10#3)(2008-11#1)(2008-5#1)
to be a useful tool for##2##6##(1990-2#1)(1995-11#1)
to be a useful tool in##4##6##(1991-11#1)(1996-9#1)(2008-10#1)(2010-7#1)
to be a useful tool to##2##6##(2008-10#1)(2011-2#1)
to be a useful tool##8##5##(1990-2#1)(1991-11#1)(1995-11#1)(1996-9#1)(2008-10#2)(2010-7#1)(2011-2#1)
to be a useful##11##4##(1990-2#1)(1991-11#1)(1994-12#1)(1995-11#1)(1996-9#1)(2008-10#3)(2008-11#1)(2010-7#1)(2011-2#1)
to be a valuable##2##4##(2008-11#1)(2010-7#1)
to be a very##9##4##(1990-11#1)(1990-9#1)(1994-12#1)(2008-10#3)(2008-11#1)(2012-2#2)
to be a viable alternative to##2##6##(2008-10#2)
to be a viable##5##4##(2008-10#3)(2008-11#1)(2013-1#1)
to be a##306##3##(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#2)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-1#2)(1996-12#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#4)(2007-12#1)(2008-10#79)(2008-11#29)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#3)(2010-12#4)(2010-3#1)(2010-6#5)(2010-7#5)(2011-1#1)(2011-2#12)(2011-7#1)(2012-12#1)(2012-2#11)(2012-3#6)(2013-1#8)(2013-8#6)
to be able to bind##2##5##(1994-11#1)(2008-10#1)
to be able to make##2##5##(1996-3#1)(2008-12#1)
to be able to provide##2##5##(2008-10#1)(2013-8#1)
to be able to##19##4##(1990-2#1)(1993-12#1)(1994-11#1)(1996-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2010-10#1)(2011-2#1)(2013-8#2)
to be able##21##3##(1990-2#1)(1993-12#1)(1994-11#1)(1996-3#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-5#1)(2009-12#1)(2010-10#1)(2011-2#1)(2013-8#2)
to be abnormal in##2##4##(1991-12#1)(2008-12#1)
to be about##5##3##(1990-6#1)(1994-8#1)(2008-10#2)(2008-8#1)
to be acceptable##2##3##(2008-8#1)(2010-10#1)
to be accessible##2##3##(1995-2#1)(2012-3#1)
to be accommodated##2##3##(1997-3#1)(2008-11#1)
to be accurate##8##3##(1995-11#1)(2007-12#1)(2008-10#4)(2010-11#1)(2012-2#1)
to be accurately##2##3##(2008-10#1)(2008-9#1)
to be achieved in##2##4##(1992-9#1)(2013-1#1)
to be achieved##9##3##(1992-2#1)(1992-9#1)(1994-8#1)(2008-10#3)(2008-11#2)(2013-1#1)
to be activated by the##2##5##(1995-6#1)(2008-11#1)
to be activated by##5##4##(1994-5#1)(1995-6#2)(2008-11#1)(2013-8#1)
to be activated##6##3##(1994-5#1)(1995-6#2)(2008-11#1)(2010-7#1)(2013-8#1)
to be active##4##3##(1992-10#1)(2008-10#1)(2008-11#1)(2011-1#1)
to be adapted to##2##4##(2008-10#1)(2009-8#1)
to be adapted##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
to be addressed are##2##4##(2008-11#1)(2011-2#1)
to be addressed in the##2##5##(1992-9#1)(1994-12#1)
to be addressed in##5##4##(1992-9#1)(1994-1#1)(1994-12#1)(1997-2#1)(2011-1#1)
to be addressed##17##3##(1992-9#1)(1994-1#3)(1994-12#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)
to be adequate for##2##4##(2008-10#2)
to be adequate##3##3##(2008-10#3)
to be advantageous##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
to be affected by##6##4##(1993-6#1)(1994-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-10#1)
to be affected in##2##4##(1992-3#1)(1997-1#1)
to be affected##9##3##(1992-3#1)(1993-6#1)(1994-11#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-10#1)
to be also useful##2##4##(2008-10#1)(2008-11#1)
to be also##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
to be altered in##3##4##(1990-6#1)(1996-12#1)(2008-11#1)
to be altered##5##3##(1990-6#1)(1993-12#1)(1996-12#1)(2008-11#1)(2012-2#1)
to be among the most##3##5##(1994-9#1)(2008-11#1)(2008-5#1)
to be among the##4##4##(1994-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
to be amongst the##2##4##(2008-7#1)(2011-2#1)
to be an attractive alternative##2##5##(2008-10#1)(2008-11#1)
to be an effective method of##2##6##(1991-7#1)(2008-10#1)
to be an effective method##3##5##(1991-7#1)(2008-10#1)(2011-2#1)
to be an effective tool##2##5##(2008-10#2)
to be an effective##14##4##(1991-4#1)(1991-7#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#1)(2011-2#2)
to be an efficient##3##4##(2007-12#1)(2008-5#1)(2012-2#1)
to be an essential component of##3##6##(1991-6#1)(1992-1#1)(2013-8#1)
to be an essential##4##4##(1991-6#1)(1992-1#1)(1996-2#1)(2013-8#1)
to be an excellent##2##4##(2008-10#1)(2012-2#1)
to be an important determinant of##2##6##(1990-12#1)(1994-5#1)
to be an important factor##2##5##(1996-12#1)(2009-11#1)
to be an important mechanism##3##5##(1993-2#1)(2008-10#2)
to be an important##13##4##(1990-12#1)(1992-1#1)(1993-2#1)(1994-5#1)(1996-12#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-11#1)(2013-8#1)
to be an overview##2##4##(2008-12#1)(2008-4#1)
to be an##74##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#4)(1992-2#2)(1992-3#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#19)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#3)
to be analysed##2##3##(2008-11#1)(2008-5#1)
to be analyzed##3##3##(2008-10#2)(2008-4#1)
to be answered##4##3##(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#1)
to be any##2##3##(2010-6#1)(2012-2#1)
to be applicable for##4##4##(2008-10#2)(2008-5#1)(2009-10#1)
to be applicable to a##2##5##(2008-10#2)
to be applicable to the##2##5##(2008-10#1)(2008-5#1)
to be applicable to##5##4##(2008-10#4)(2008-5#1)
to be applicable##11##3##(2008-10#7)(2008-5#2)(2008-7#1)(2009-10#1)
to be applied to the##5##5##(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)
to be applied to##7##4##(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#2)
to be applied##17##3##(1993-6#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-3#2)(2010-8#4)
to be approached##2##3##(1991-12#1)(2008-10#1)
to be appropriate for##2##4##(2010-12#2)
to be appropriate##4##3##(2008-10#1)(2010-12#3)
to be approximately##14##3##(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
to be around##2##3##(2008-10#2)
to be as effective as##4##5##(1991-3#1)(1992-12#1)(1996-1#1)(2008-10#1)
to be as important as##2##5##(2008-11#2)
to be as important##3##4##(1995-6#1)(2008-11#2)
to be as##13##3##(1991-3#1)(1992-12#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2011-2#1)
to be ascertained##3##3##(1991-2#1)(1995-12#1)(2013-8#1)
to be assessed##2##3##(1995-11#1)(2008-10#1)
to be associated with a##8##5##(1994-12#1)(1995-6#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to be associated with the##2##5##(1994-5#1)(1995-6#1)
to be associated with##36##4##(1991-12#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#2)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
to be associated##38##3##(1991-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#2)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
to be at##11##3##(1991-5#1)(1993-3#2)(1996-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
to be attained##2##3##(1990-5#1)(2008-12#1)
to be automated##2##3##(2008-10#2)
to be available##9##3##(1996-1#1)(2007-12#1)(2008-10#1)(2008-12#3)(2009-1#1)(2011-1#1)(2011-3#1)
to be avoided##7##3##(1992-3#1)(2008-10#2)(2008-3#1)(2009-4#1)(2013-1#1)(2013-8#1)
to be aware of the##4##5##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
to be aware of##6##4##(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2012-3#1)
to be aware##7##3##(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#2)(2012-3#1)
to be based on a##2##5##(1991-2#2)
to be based on##5##4##(1991-2#2)(1994-12#1)(2008-10#1)(2008-11#1)
to be beneficial##3##3##(1995-2#1)(2011-3#1)(2013-8#1)
to be better than##6##4##(2008-10#4)(2008-3#1)(2008-5#1)
to be better##10##3##(2008-10#6)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
to be between##9##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#1)
to be borne##2##3##(1994-9#1)(2008-1#1)
to be both effective and##2##5##(1991-11#1)(2008-10#1)
to be both##6##3##(1991-11#1)(2008-10#3)(2009-5#1)(2011-2#1)
to be capable of##9##4##(2008-10#4)(2008-11#2)(2008-9#1)(2011-2#1)(2012-2#1)
to be captured##2##3##(2007-12#1)(2008-12#1)
to be carefully controlled##2##4##(2008-10#1)(2008-7#1)
to be carefully##6##3##(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#2)
to be carried out by##2##5##(2008-10#2)
to be carried out##7##4##(2008-10#6)(2010-12#1)
to be catalysed by##2##4##(1991-2#1)(2008-10#1)
to be caused by a##3##5##(2008-10#1)(2008-11#1)(2009-6#1)
to be caused by the##2##5##(2008-10#1)(2010-3#1)
to be caused by##11##4##(1990-11#1)(2008-10#3)(2008-11#2)(2008-8#2)(2009-6#1)(2010-3#1)(2011-2#1)
to be caused##12##3##(1990-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#2)(2009-6#1)(2010-3#1)(2011-2#1)
to be challenging##2##3##(1995-3#1)(2009-12#1)
to be changed##2##3##(1991-12#1)(2009-12#1)
to be characteristic##2##3##(2008-10#1)(2009-4#1)
to be characterized by a##2##5##(1990-4#1)(2008-11#1)
to be characterized by##3##4##(1990-4#1)(2008-11#1)(2013-8#1)
to be characterized##7##3##(1990-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2013-8#3)
to be chemically##2##3##(1994-5#1)(2008-10#1)
to be clarified##2##3##(2009-6#1)(2011-2#1)
to be classified##4##3##(2008-10#2)(2008-4#1)(2010-8#1)
to be clinically##2##3##(1995-5#1)(2009-11#1)
to be clonal lineages##2##4##(2008-10#2)
to be cloned##3##3##(1997-2#1)(2008-4#2)
to be close to the##2##5##(1990-11#1)(1995-3#1)
to be close to##6##4##(1990-11#1)(1995-11#1)(1995-3#1)(2008-10#2)(2009-5#1)
to be closely##4##3##(1995-6#1)(1995-8#1)(2008-10#1)(2008-8#1)
to be collected##2##3##(2008-10#1)(2011-2#1)
to be colonized by##2##4##(1991-3#1)(2008-10#1)
to be colonized##3##3##(1991-3#1)(2008-10#1)(2008-9#1)
to be combined with##2##4##(2011-2#1)(2013-1#1)
to be combined##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
to be common##2##3##(1991-7#1)(2008-12#1)
to be comparable with the##2##5##(2008-10#1)(2008-5#1)
to be comparable with##4##4##(2008-10#3)(2008-5#1)
to be comparable##10##3##(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)
to be compatible with the##2##5##(2008-10#1)(2008-7#1)
to be compatible with##3##4##(2008-10#2)(2008-7#1)
to be compensated by a##2##5##(1995-5#1)(2008-10#1)
to be compensated##3##3##(1995-5#1)(2008-10#2)
to be complicated##2##3##(1992-11#1)(2010-3#1)
to be concentrated##4##3##(1991-12#1)(2008-10#1)(2008-12#1)(2009-8#1)
to be conducted on##2##4##(2008-9#1)(2011-2#1)
to be conducted##4##3##(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
to be confirmed by##2##4##(2008-12#1)(2009-12#1)
to be connected to##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
to be connected##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
to be considered as##4##4##(1994-9#1)(2008-10#1)(2011-2#1)(2011-3#1)
to be considered in any##2##5##(1993-11#1)(2008-11#1)
to be considered in##6##4##(1992-9#1)(1993-11#1)(2008-11#2)(2011-2#1)(2012-3#1)
to be considered when##5##4##(1993-2#2)(2008-10#2)(2009-1#1)
to be considered##28##3##(1992-9#1)(1993-11#2)(1993-2#2)(1994-9#1)(1996-8#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-3#1)
to be consistent with##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
to be consistent##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)
to be constructed##2##3##(2008-10#1)(2009-5#1)
to be controlled by a single##2##6##(2008-10#1)(2008-5#1)
to be controlled by##4##4##(1994-3#1)(1995-12#1)(2008-10#1)(2008-5#1)
to be controlled##10##3##(1994-3#1)(1995-12#1)(1997-1#1)(2008-10#3)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
to be correlated with the##2##5##(1991-6#1)(2008-10#1)
to be correlated with##4##4##(1991-6#2)(2008-10#2)
to be correlated##5##3##(1991-6#2)(2008-10#2)(2008-11#1)
to be covalently bound to##2##5##(1990-2#1)(1993-6#1)
to be covalently##3##3##(1990-2#1)(1993-6#1)(2008-5#1)
to be covered##2##3##(1994-3#1)(2008-11#1)
to be critical for##2##4##(1997-9#1)(2008-11#1)
to be critical##4##3##(1995-6#1)(1997-9#1)(2008-10#1)(2008-11#1)
to be critically##2##3##(2008-1#1)(2008-10#1)
to be crucial##2##3##(2008-10#1)(2009-6#1)
to be debated##2##3##(2008-11#1)(2008-8#1)
to be decreased##4##3##(1993-3#1)(2008-11#1)(2012-2#2)
to be defined and##2##4##(2012-2#1)(2013-1#1)
to be defined##4##3##(1997-8#1)(2008-12#1)(2012-2#1)(2013-1#1)
to be delivered to the##2##5##(2008-3#1)(2008-5#1)
to be delivered##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
to be dependent on the presence of##2##7##(1991-3#1)(2008-11#1)
to be dependent on the##7##5##(1991-3#1)(1991-5#1)(1995-6#1)(2008-10#2)(2008-11#2)
to be dependent on##14##4##(1991-3#1)(1991-5#1)(1993-8#1)(1995-3#1)(1995-6#1)(1995-9#1)(2008-10#4)(2008-11#3)(2011-2#1)
to be dependent upon the##3##5##(2008-10#2)(2008-11#1)
to be dependent upon##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
to be dependent##18##3##(1991-3#1)(1991-5#1)(1993-8#1)(1995-3#1)(1995-6#1)(1995-9#1)(2008-10#6)(2008-11#4)(2011-2#2)
to be depleted##2##3##(2008-5#1)(2008-7#1)
to be deposited##2##3##(1996-9#1)(2008-11#1)
to be derived from a##2##5##(1996-2#1)(2008-11#1)
to be derived from##7##4##(1993-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
to be derived##10##3##(1993-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
to be detected and##2##4##(2008-10#2)
to be detected with##3##4##(1991-3#1)(2008-8#1)(2010-1#1)
to be detected##11##3##(1991-3#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-8#1)(2010-1#1)(2013-8#1)
to be determined by##3##4##(2008-10#2)(2008-3#1)
to be determined from##2##4##(2008-10#1)(2011-2#1)
to be determined##31##3##(1994-8#1)(1995-2#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#3)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#2)
to be detrimental to##2##4##(1992-2#1)(2008-11#1)
to be developed to##2##4##(2008-11#1)(2008-3#1)
to be developed##12##3##(1992-12#1)(1995-1#1)(1996-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)
to be diagnosed##2##3##(1990-9#1)(2010-9#1)
to be different from##4##4##(2008-10#2)(2008-11#1)(2010-10#1)
to be different##10##3##(1993-12#1)(1994-8#1)(1997-4#1)(2008-10#5)(2008-11#1)(2010-10#1)
to be differentially##4##3##(1995-2#1)(2008-10#2)(2009-9#1)
to be differentiated##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
to be difficult##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
to be directed##2##3##(1997-8#1)(2011-2#1)
to be directly##3##3##(2008-10#2)(2010-1#1)
to be discovered##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
to be distinguished##4##3##(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
to be done to##3##4##(1991-1#1)(2009-1#1)(2011-2#1)
to be done##8##3##(1991-1#1)(1992-3#1)(1994-3#1)(2008-10#2)(2009-1#1)(2009-7#1)(2011-2#1)
to be dose dependent##2##4##(1992-5#1)(2008-5#1)
to be dramatically##2##3##(2008-10#1)(2008-3#1)
to be due to a##3##5##(2008-11#1)(2008-4#1)(2011-2#1)
to be due to the##4##5##(2008-10#2)(2008-11#1)(2008-9#1)
to be due to##19##4##(1992-12#1)(1993-1#1)(1993-9#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
to be due##22##3##(1990-2#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-9#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
to be durable##2##3##(2008-10#2)
to be easily##2##3##(1994-11#1)(2008-5#1)
to be effective for##3##4##(2008-11#1)(2010-5#1)(2012-2#1)
to be effective in##10##4##(1992-12#2)(1992-3#1)(1992-9#1)(2008-11#2)(2010-7#1)(2011-2#2)(2013-1#1)
to be effective##30##3##(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#7)(2008-6#1)(2008-7#1)(2009-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
to be efficient for##2##4##(2008-10#2)
to be efficient##8##3##(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
to be efficiently analyzed by high-performance liquid chromatography##2##8##(2008-10#2)
to be efficiently##3##3##(2008-10#2)(2008-9#1)
to be either##4##3##(1995-11#1)(1996-3#1)(1997-1#1)(2008-10#1)
to be eliminated##2##3##(2008-10#1)(2010-1#1)
to be elucidated##10##3##(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-9#1)(2009-7#2)(2009-8#1)(2013-1#1)
to be employed as##2##4##(2008-1#1)(2008-10#1)
to be employed for##2##4##(2008-10#1)(2009-7#1)
to be employed##6##3##(2008-1#1)(2008-10#2)(2009-5#1)(2009-7#1)(2013-1#1)
to be encouraged##2##3##(1991-8#1)(2010-11#1)
to be enriched##3##3##(1994-11#1)(2008-10#2)
to be equal to##5##4##(1991-5#1)(2008-10#3)(2010-12#1)
to be equally effective##3##4##(1993-6#1)(1996-2#1)(2010-7#1)
to be equally##4##3##(1993-2#1)(1993-6#1)(1996-2#1)(2010-7#1)
to be equivalent to##3##4##(2008-10#2)(2008-11#1)
to be equivalent##4##3##(1996-2#1)(2008-10#2)(2008-11#1)
to be especially##2##3##(2008-7#1)(2009-10#1)
to be essential for the##2##5##(1990-5#1)(2008-5#1)
to be essential for##15##4##(1990-5#1)(1992-12#1)(1993-12#1)(1995-11#2)(1997-7#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
to be essential##16##3##(1990-5#1)(1992-12#1)(1993-12#1)(1995-11#2)(1997-7#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
to be established in##2##4##(1991-2#1)(2008-11#1)
to be established##16##3##(1991-2#1)(1991-9#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
to be estimated##5##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)
to be evaluated##8##3##(1991-6#1)(2008-10#4)(2008-8#1)(2010-7#1)(2012-2#1)
to be even more##2##4##(1990-9#1)(1993-12#1)
to be examined##3##3##(1994-8#1)(2008-9#1)(2013-1#1)
to be excluded##3##3##(1996-8#1)(2008-1#1)(2008-10#1)
to be expanded##2##3##(2008-11#1)(2011-1#1)
to be expected##2##3##(2007-12#1)(2008-3#1)
to be explored##5##3##(2008-10#1)(2008-12#1)(2013-1#2)(2013-7#1)
to be exposed to##2##4##(2008-10#1)(2011-2#1)
to be expressed at##3##4##(1991-6#1)(1996-12#1)(2008-11#1)
to be expressed in##7##4##(1994-11#1)(1995-6#1)(2008-10#1)(2010-5#2)(2011-1#2)
to be expressed##17##3##(1991-6#1)(1992-11#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-7#1)(2010-5#2)(2011-1#2)
to be extended##3##3##(2008-10#2)(2008-11#1)
to be extremely sensitive##2##4##(1996-2#1)(2008-10#1)
to be extremely##5##3##(1996-2#1)(1997-2#1)(2008-10#2)(2008-3#1)
to be familiar with##2##4##(2008-11#1)(2008-2#1)
to be far##2##3##(2008-10#1)(2008-11#1)
to be feasible and##2##4##(2008-11#1)(2010-7#1)
to be feasible##4##3##(2008-11#2)(2008-3#1)(2010-7#1)
to be filled with##2##4##(2008-10#1)(2008-9#1)
to be followed##3##3##(2008-10#3)
to be formed in##2##4##(2008-10#1)(2008-11#1)
to be formed##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
to be found##5##3##(1997-3#1)(2008-10#2)(2008-12#1)(2010-12#1)
to be free from##2##4##(2008-10#2)
to be free##3##3##(1993-12#1)(2008-10#2)
to be from##3##3##(2008-11#2)(2009-7#1)
to be fully elucidated##2##4##(2008-12#1)(2011-2#1)
to be fully##9##3##(2008-10#2)(2008-11#2)(2008-12#2)(2009-10#1)(2011-2#2)
to be functional##4##3##(1995-9#1)(2008-11#1)(2009-10#2)
to be functionally##2##3##(2008-10#1)(2008-11#1)
to be further##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
to be gained from##2##4##(2010-10#1)(2011-10#1)
to be gained##3##3##(2009-12#1)(2010-10#1)(2011-10#1)
to be general##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
to be generally##5##3##(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#2)
to be generated in##2##4##(1991-5#1)(2008-10#1)
to be generated##5##3##(1991-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
to be genetically##4##3##(1991-12#1)(1996-12#1)(2008-10#1)(2008-9#1)
to be given##4##3##(2008-5#1)(2011-1#1)(2013-1#2)
to be good##7##3##(1990-6#1)(1997-8#1)(2008-10#5)
to be greater for##3##4##(1993-6#1)(1994-3#1)(2008-10#1)
to be greater than##3##4##(1990-12#1)(2008-10#1)(2008-2#1)
to be greater##8##3##(1990-12#1)(1993-6#1)(1994-3#1)(1996-12#1)(2008-10#3)(2008-2#1)
to be high##3##3##(1990-3#1)(1990-6#1)(2008-10#1)
to be higher than that##2##5##(1994-11#1)(2008-11#1)
to be higher than the##2##5##(2011-2#1)(2013-1#1)
to be higher than##6##4##(1994-11#1)(2008-11#2)(2008-2#1)(2011-2#1)(2013-1#1)
to be higher##10##3##(1994-11#1)(1996-1#1)(2008-11#5)(2008-2#1)(2011-2#1)(2013-1#1)
to be highest##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
to be highly resistant to##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
to be highly selective##2##4##(2008-10#2)
to be highly sensitive##2##4##(1992-12#1)(2008-10#1)
to be highly##27##3##(1990-2#1)(1992-12#1)(1993-3#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#3)(2012-3#1)
to be homologous to##2##4##(1995-2#1)(2008-8#1)
to be homologous##4##3##(1991-12#1)(1995-2#1)(1996-12#1)(2008-8#1)
to be hospitalized##3##3##(1995-2#1)(1995-6#1)(2008-3#1)
to be identical to that of##2##6##(1996-12#1)(1997-8#1)
to be identical to that##3##5##(1996-12#1)(1997-8#1)(2008-10#1)
to be identical to##5##4##(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#2)
to be identical##7##3##(1990-8#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)
to be identified and##2##4##(2008-4#1)(2011-1#1)
to be identified as##2##4##(2008-10#2)
to be identified##16##3##(1991-6#1)(1995-12#1)(1995-2#1)(1997-7#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#2)(2010-11#1)(2011-1#2)(2011-2#1)
to be impaired in##2##4##(2008-10#1)(2008-7#1)
to be impaired##4##3##(1990-11#1)(2008-10#1)(2008-7#2)
to be implemented##6##3##(1992-1#1)(1994-12#1)(1996-3#1)(2007-11#1)(2008-11#1)(2011-2#1)
to be important determinants of##2##5##(2008-8#1)(2009-7#1)
to be important factors##2##4##(2008-10#1)(2008-11#1)
to be important for the##2##5##(1994-8#1)(1996-2#1)
to be important for##5##4##(1994-8#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-7#1)
to be important in the##4##5##(1990-2#1)(1992-8#1)(1993-12#1)(2008-10#1)
to be important in##7##4##(1990-2#1)(1992-8#1)(1993-12#1)(2008-10#2)(2008-8#1)(2011-3#1)
to be important##25##3##(1990-11#1)(1990-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2011-3#1)(2012-3#1)
to be improved significantly##2##4##(2009-3#1)(2010-8#1)
to be improved##8##3##(1992-12#1)(2008-10#2)(2008-7#1)(2009-3#2)(2010-8#1)(2011-1#1)
to be in a##5##4##(1994-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2009-3#1)
to be in good agreement with##4##6##(2008-10#3)(2008-8#1)
to be in good agreement##5##5##(2008-10#4)(2008-8#1)
to be in good##6##4##(2008-10#5)(2008-8#1)
to be in place##2##4##(2008-12#1)(2011-2#1)
to be in the range of##7##6##(2008-10#7)
to be in the range##9##5##(2008-10#9)
to be in the##15##4##(1990-12#1)(1996-2#1)(1997-4#1)(2008-10#11)(2013-1#1)
to be in##42##3##(1990-12#1)(1991-2#1)(1992-6#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#21)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
to be inadequate##2##3##(2010-11#2)
to be included in##2##4##(2008-11#1)(2010-11#1)
to be included##4##3##(2008-11#2)(2010-11#2)
to be incompatible##2##3##(2008-5#1)(2008-9#1)
to be incomplete and##2##4##(1993-12#1)(2008-11#1)
to be incomplete##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
to be incorporated in##2##4##(2008-11#1)(2008-12#1)
to be incorporated into##2##4##(2008-3#1)(2012-12#1)
to be incorporated##6##3##(1991-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-12#1)
to be increased in##5##4##(1990-2#1)(1994-8#1)(2008-10#2)(2013-8#1)
to be increased##9##3##(1990-2#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-10#3)(2008-5#1)(2013-8#1)
to be increasing##3##3##(1994-6#1)(2011-2#1)(2013-8#1)
to be independent of the##5##5##(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
to be independent of##8##4##(1991-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)
to be independent##9##3##(1990-12#1)(1991-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)
to be independently##2##3##(1992-9#1)(2012-3#1)
to be induced##3##3##(1994-11#1)(2008-10#1)(2012-2#1)
to be ineffective##4##3##(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#1)
to be infected##6##3##(2008-10#4)(2008-9#1)(2011-2#1)
to be influenced by the##5##5##(1994-5#1)(1996-12#1)(1997-7#1)(2008-10#2)
to be influenced by##9##4##(1993-6#1)(1994-5#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2010-2#1)
to be informed##2##3##(1992-2#1)(1996-1#1)
to be initiated##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
to be injected##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
to be insensitive to##3##4##(2008-10#3)
to be intact##2##3##(2008-10#1)(2008-11#1)
to be integral##2##3##(1995-8#1)(2012-3#1)
to be internalized##2##3##(1994-8#1)(1997-7#1)
to be introduced##5##3##(1996-1#1)(2008-10#1)(2008-3#1)(2008-7#2)
to be invalid##2##3##(1995-2#1)(2013-1#1)
to be investigated##9##3##(1997-5#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
to be involved in binding##2##5##(1994-5#1)(1996-12#1)
to be involved in signal transduction##2##6##(1995-6#1)(2008-11#1)
to be involved in the pathogenesis of##3##7##(2008-1#1)(2010-10#1)(2013-8#1)
to be involved in the##18##5##(1994-2#1)(1997-1#1)(2008-1#1)(2008-10#8)(2008-11#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-8#2)
to be involved in##42##4##(1991-7#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#1)(2011-2#4)(2013-8#2)
to be involved with##3##4##(2007-12#1)(2009-10#1)(2009-7#1)
to be involved##51##3##(1991-7#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-5#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-2#4)(2013-8#2)
to be irreversible##2##3##(1990-2#1)(1992-9#1)
to be isolated##2##3##(2008-5#1)(2008-6#1)
to be kept in mind##2##5##(2008-7#1)(2011-3#1)
to be kept##3##3##(2008-11#1)(2008-7#1)(2011-3#1)
to be largely##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
to be larger than##2##4##(2008-11#1)(2010-11#1)
to be larger##4##3##(2008-11#1)(2008-8#2)(2010-11#1)
to be launched in##2##4##(2008-3#1)(2008-5#1)
to be learned from the##2##5##(1991-11#1)(1992-2#1)
to be learned##4##3##(1991-11#1)(1992-2#1)(2008-12#1)(2008-8#1)
to be less likely to##2##5##(2008-9#2)
to be less than those of the##2##7##(2008-11#1)(2008-9#1)
to be less than##11##4##(2008-10#6)(2008-11#1)(2008-3#2)(2008-9#1)(2012-3#1)
to be less##27##3##(1990-12#1)(1992-12#1)(1995-6#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-7#2)(2008-9#4)(2011-2#1)(2012-3#1)(2013-8#1)
to be limited to##2##4##(1995-11#1)(2008-10#1)
to be linear in the range of##4##7##(2008-10#4)
to be linear over the##3##5##(2008-10#3)
to be linear##11##3##(2008-10#9)(2008-11#1)(2012-2#1)
to be linked to##6##4##(2008-10#3)(2008-11#1)(2008-5#1)(2012-3#1)
to be little##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
to be localized##4##3##(1995-2#1)(1995-6#1)(2008-5#1)(2009-10#1)
to be located in the##2##5##(2008-8#1)(2010-8#1)
to be located on the##2##5##(2008-11#1)(2010-12#1)
to be located##8##3##(1990-9#1)(1995-8#1)(1997-6#1)(2008-11#2)(2008-8#1)(2010-12#1)(2010-8#1)
to be lost##2##3##(2008-10#1)(2008-5#1)
to be low##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
to be lower in the##2##5##(2008-10#1)(2008-7#1)
to be lower##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
to be made on the##3##5##(1993-11#1)(2008-8#1)(2009-10#1)
to be made to##2##4##(1996-3#1)(2008-9#1)
to be made##15##3##(1992-9#1)(1993-11#1)(1994-1#1)(1996-1#1)(1996-3#1)(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)
to be mainly related to the##2##6##(2008-11#1)(2008-5#1)
to be mainly##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
to be maintained in##2##4##(2008-9#1)(2013-8#1)
to be maintained##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2013-8#1)
to be malignant##2##3##(1997-2#1)(2012-3#1)
to be measured##6##3##(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
to be mediated by a##2##5##(2008-11#1)(2009-1#1)
to be mediated by##7##4##(1996-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-1#1)(2009-10#1)(2013-8#1)
to be mediated through##2##4##(1994-11#1)(2009-8#1)
to be mediated##9##3##(1994-11#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-8#1)(2013-8#1)
to be merely##2##3##(1994-12#1)(1997-8#1)
to be met##5##3##(1995-12#1)(1996-2#1)(2008-11#2)(2013-8#1)
to be mindful of##2##4##(1991-2#1)(2008-11#1)
to be minimized##4##3##(1993-12#1)(1995-5#1)(2008-10#2)
to be moderately resistant to powdery mildew##2##7##(2008-10#2)
to be moderately##3##3##(2008-10#3)
to be modified##5##3##(1991-2#1)(1992-3#1)(1993-1#1)(2008-3#1)(2008-9#1)
to be monitored##3##3##(1997-1#1)(2008-11#1)(2013-1#1)
to be more effective for##2##5##(2010-4#2)
to be more effective in##3##5##(2008-10#2)(2008-11#1)
to be more effective##9##4##(1992-5#1)(2008-10#3)(2008-11#1)(2010-4#2)(2012-2#2)
to be more efficient##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
to be more intense##2##4##(2008-8#1)(2012-2#1)
to be more prevalent##2##4##(2008-1#1)(2012-12#1)
to be more sensitive##4##4##(1990-12#1)(2008-10#2)(2008-11#1)
to be more stable than the##2##6##(2009-10#1)(2009-8#1)
to be more than##2##4##(2008-11#1)(2008-3#1)
to be more vulnerable##4##4##(1990-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
to be more##62##3##(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#6)(2012-7#1)(2013-1#2)(2013-8#1)
to be most useful##2##4##(2008-11#1)(2012-2#1)
to be most##9##3##(1993-12#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-6#1)(2012-2#1)
to be mostly##2##3##(2008-10#1)(2012-3#1)
to be much more##2##4##(1993-2#1)(2008-11#1)
to be much##8##3##(1993-2#1)(2008-10#4)(2008-11#1)(2009-7#1)(2011-2#1)
to be nearly identical to##2##5##(1996-8#1)(2008-10#1)
to be necessary for a##2##5##(1996-3#1)(2008-9#1)
to be necessary for##7##4##(1993-9#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#1)
to be necessary##12##3##(1993-9#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#1)
to be negatively##2##3##(1991-5#1)(2011-2#1)
to be negligible##4##3##(1997-7#1)(2008-10#3)
to be new##3##3##(1997-2#1)(2008-3#2)
to be no##7##3##(1992-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-7#1)(2013-1#1)
to be normal##3##3##(1992-9#1)(1996-11#1)(2008-10#1)
to be obtained##11##3##(2008-10#6)(2008-3#1)(2008-4#2)(2011-2#1)(2012-2#1)
to be of the##2##4##(1991-5#1)(2008-10#1)
to be of value in##2##5##(1992-1#1)(2008-9#1)
to be of##26##3##(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-2#1)(1993-6#1)(1995-11#1)(1997-6#1)(2006-6#1)(2008-10#6)(2008-7#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
to be older##3##3##(1992-3#1)(1994-12#1)(2008-10#1)
to be on##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
to be one of the most important##2##7##(1990-12#1)(2008-11#1)
to be one of the most##4##6##(1990-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
to be one of the##7##5##(1990-12#1)(2008-11#2)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
to be one of##9##4##(1990-12#1)(1997-3#1)(2008-11#3)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
to be one##11##3##(1990-12#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
to be only about##2##4##(1990-11#1)(2008-10#1)
to be only##8##3##(1990-11#1)(1992-6#1)(1993-6#1)(2008-10#3)(2008-8#1)(2012-2#1)
to be optimized##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
to be over##2##3##(2008-10#1)(2008-5#1)
to be overcome##4##3##(1990-6#1)(2008-11#1)(2010-7#1)(2012-12#1)
to be pH##2##3##(1992-9#1)(2008-10#1)
to be paid to##2##4##(2008-1#1)(2008-10#1)
to be paid##3##3##(2008-1#1)(2008-10#1)(2008-12#1)
to be part of a##2##5##(1992-3#1)(2008-11#1)
to be part of##5##4##(1992-3#1)(1992-6#1)(2008-11#1)(2010-11#1)(2012-2#1)
to be partially##2##3##(1993-9#1)(2008-10#1)
to be particularly##7##3##(1991-1#1)(1991-3#1)(1995-12#1)(2008-10#3)(2013-8#1)
to be partly##2##3##(1991-11#1)(2008-10#1)
to be pathogenic on##2##4##(2008-10#2)
to be pathogenic##3##3##(2008-10#2)(2011-2#1)
to be perceived by##2##4##(2009-8#1)(2012-3#1)
to be performed on##2##4##(1995-1#1)(2008-3#1)
to be performed##5##3##(1993-11#1)(1993-12#1)(1995-1#1)(2008-3#1)(2010-12#1)
to be phased##2##3##(1992-1#1)(1996-2#1)
to be phosphorylated##2##3##(1995-6#1)(2011-2#1)
to be phylogenetically##2##3##(1997-2#1)(2008-10#1)
to be placed##2##3##(2008-11#2)
to be polygenic##2##3##(2008-10#1)(2011-2#1)
to be positive##2##3##(2012-12#1)(2013-8#1)
to be positively##5##3##(1991-12#1)(1995-11#1)(2008-8#1)(2009-11#1)(2009-7#1)
to be possible##2##3##(2008-5#1)(2013-8#1)
to be potent##2##3##(1991-5#1)(2008-10#1)
to be potentially##4##3##(1994-3#1)(2009-7#1)(2010-1#1)(2013-8#1)
to be practical##2##3##(1994-12#1)(2008-10#1)
to be predominant in##2##4##(2008-10#2)
to be predominant##4##3##(1990-6#1)(2008-10#2)(2008-11#1)
to be preferable for##3##4##(2008-10#3)
to be preferable to##2##4##(1993-3#1)(2008-10#1)
to be preferable##6##3##(1993-3#1)(2008-10#4)(2008-11#1)
to be preferred##2##3##(1993-11#1)(2008-3#1)
to be prescribed##2##3##(2008-11#1)(2008-8#1)
to be present at the##2##5##(1996-8#1)(2008-7#1)
to be present in a##2##5##(1991-6#1)(2008-10#1)
to be present in##11##4##(1991-6#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-9#1)
to be present mainly##2##4##(1991-5#1)(2008-10#1)
to be present on##2##4##(1995-2#1)(2008-4#1)
to be present##20##3##(1991-5#2)(1991-6#1)(1994-12#1)(1995-2#2)(1996-8#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)
to be processed to##2##4##(1990-5#1)(1995-2#1)
to be produced##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
to be promising##3##3##(2008-10#1)(2008-11#2)
to be properly##3##3##(2008-10#2)(2008-12#1)
to be proportional to the##2##5##(1990-3#1)(2008-10#1)
to be protected by##2##4##(2008-10#1)(2010-1#1)
to be protected##4##3##(1995-5#1)(2008-10#1)(2009-11#1)(2010-1#1)
to be protective##2##3##(2008-12#1)(2008-8#1)
to be quite##7##3##(1994-2#1)(1995-6#1)(2008-10#3)(2008-11#1)(2010-11#1)
to be rapid##3##3##(2008-10#2)(2008-8#1)
to be reached##2##3##(2008-10#1)(2012-2#1)
to be reactive##2##3##(1990-12#1)(2008-11#1)
to be readily##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
to be realized##2##3##(1995-12#1)(2012-2#1)
to be recognized##2##3##(1995-11#1)(2011-2#1)
to be recommended for##2##4##(1990-8#1)(2008-10#1)
to be recommended##5##3##(1990-8#1)(1991-3#1)(1992-11#1)(2008-10#1)(2011-2#1)
to be recorded##2##3##(1996-6#1)(2008-9#1)
to be reduced by##2##4##(1992-2#1)(2008-2#1)
to be reduced##5##3##(1992-2#1)(2008-10#1)(2008-2#2)(2013-8#1)
to be regulated by a##2##5##(1997-1#1)(2009-8#1)
to be regulated by the##2##5##(1997-2#1)(2008-10#1)
to be regulated by##7##4##(1993-8#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-8#1)
to be regulated##9##3##(1993-8#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-3#1)(2011-2#1)
to be related to a##2##5##(1992-6#1)(1994-8#1)
to be related to its##2##5##(1997-1#1)(2008-7#1)
to be related to the##11##5##(1990-3#1)(1991-6#1)(1994-5#1)(2006-6#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)
to be related to##29##4##(1990-3#1)(1991-6#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-8#1)(1997-1#2)(2006-6#1)(2008-10#7)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
to be related##33##3##(1990-3#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-1#2)(2006-6#1)(2008-10#8)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-7#1)(2011-2#1)(2012-3#2)(2013-7#1)
to be relatively##13##3##(1994-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-7#1)(2012-2#1)
to be released##5##3##(1991-2#1)(1997-4#1)(2007-12#1)(2008-10#2)
to be relevant##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
to be reliable##4##3##(1992-3#2)(1996-3#1)(2008-10#1)
to be remarkably##2##3##(2008-10#1)(2008-11#1)
to be removed by##2##4##(2008-10#1)(2011-2#1)
to be removed##8##3##(2008-10#3)(2008-12#1)(2011-2#4)
to be replaced##3##3##(1993-2#1)(1996-11#1)(2008-10#1)
to be reported in##4##4##(1992-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
to be reported##8##3##(1990-5#1)(1992-6#1)(2008-10#3)(2008-12#2)(2013-1#1)
to be required for##4##4##(1996-8#1)(2008-10#1)(2008-9#1)(2010-3#1)
to be required##7##3##(1996-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#1)
to be resistant to##2##4##(2008-10#2)
to be resistant##3##3##(2008-10#3)
to be resolved##5##3##(1991-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
to be responsible for the##6##5##(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)(2011-1#1)
to be responsible for##14##4##(1997-2#1)(1997-8#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
to be restored##3##3##(1996-2#1)(2013-1#2)
to be restricted to##2##4##(2008-7#2)
to be restricted##4##3##(2008-7#2)(2013-1#2)
to be reversible and##2##4##(2008-10#1)(2011-2#1)
to be reversible##4##3##(1995-12#1)(2008-10#1)(2010-5#1)(2011-2#1)
to be safe and##2##4##(1995-5#1)(2008-11#1)
to be safe##5##3##(1995-5#1)(1996-2#1)(2008-11#1)(2009-1#1)(2013-1#1)
to be sampled##4##3##(2008-10#4)
to be satisfactory##3##3##(2008-10#3)
to be seen##3##3##(1994-9#1)(2008-11#1)(2008-8#1)
to be selected##3##3##(1996-3#1)(2008-10#1)(2012-9#1)
to be selective##2##3##(2008-10#1)(2008-5#1)
to be sensitive to##5##4##(1994-2#1)(1997-2#1)(2008-3#2)(2012-2#1)
to be sensitive##7##3##(1994-2#1)(1997-2#1)(2008-10#2)(2008-3#2)(2012-2#1)
to be sequenced##2##3##(2008-10#1)(2011-2#1)
to be served by##2##4##(1991-11#1)(1997-2#1)
to be set##3##3##(1996-2#1)(2009-10#1)(2013-8#1)
to be shown##4##3##(1991-7#1)(2008-10#2)(2013-8#1)
to be significant##7##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
to be significantly affected by##2##5##(2008-10#1)(2010-4#1)
to be significantly associated with##3##5##(2008-8#1)(2010-11#1)(2012-2#1)
to be significantly lower##2##4##(1993-8#1)(2013-7#1)
to be significantly related to##2##5##(1996-1#1)(2008-7#1)
to be significantly##24##3##(1992-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1996-1#2)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-7#1)
to be similar in##3##4##(1991-5#1)(1995-5#1)(2008-10#1)
to be similar to those##2##5##(2008-9#1)(2011-2#1)
to be similar to##5##4##(1990-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
to be similar##12##3##(1990-2#1)(1991-5#1)(1995-5#2)(2008-10#5)(2008-3#1)(2008-9#1)(2011-2#1)
to be simple##3##3##(1996-2#1)(2008-10#2)
to be slightly higher than##2##5##(1993-2#1)(2008-2#1)
to be slightly more effective than##2##6##(1993-12#1)(2008-5#1)
to be slightly more##3##4##(1990-12#1)(1993-12#1)(2008-5#1)
to be slightly##6##3##(1990-12#1)(1993-12#1)(1993-2#1)(2008-2#1)(2008-5#1)(2008-7#1)
to be solved##2##3##(1990-2#1)(2010-1#1)
to be specific for##2##4##(1997-7#1)(2008-11#1)
to be specific##4##3##(1993-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
to be specifically##3##3##(1992-8#1)(1993-9#1)(2008-11#1)
to be stable in the##2##5##(1992-6#1)(2008-10#1)
to be stable##9##3##(1990-5#1)(1992-6#1)(2008-10#2)(2008-11#3)(2008-3#2)
to be statistically significant##4##4##(1990-2#2)(2008-5#2)
to be statistically##9##3##(1990-2#2)(2008-10#2)(2008-5#2)(2010-7#1)(2010-8#1)(2011-2#1)
to be stimulated by##2##4##(1990-5#1)(1995-6#1)
to be strongly dependent on the##2##6##(2008-7#1)(2009-3#1)
to be strongly##7##3##(1991-12#1)(1996-2#1)(2008-10#2)(2008-7#1)(2009-3#1)(2011-2#1)
to be structurally##2##3##(1990-8#1)(1994-5#1)
to be studied##6##3##(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-11#1)
to be successful even where there was severe overlap of spectra##2##11##(2008-10#2)
to be successful for##2##4##(2008-10#1)(2010-5#1)
to be successful in##6##4##(1991-2#1)(1994-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)
to be successful##16##3##(1991-2#1)(1992-12#1)(1994-1#1)(1994-9#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-5#1)
to be successfully##2##3##(2008-12#1)(2009-6#1)
to be sufficient for##4##4##(1995-2#1)(1996-3#1)(2008-3#1)(2009-12#1)
to be sufficient##5##3##(1995-2#1)(1996-3#1)(2008-3#1)(2009-12#1)(2011-2#1)
to be suitable for the##6##5##(1990-12#1)(2008-10#3)(2008-11#1)(2009-7#1)
to be suitable for##8##4##(1990-12#1)(2008-10#5)(2008-11#1)(2009-7#1)
to be suitable##13##3##(1990-12#1)(1991-9#1)(2008-10#9)(2008-11#1)(2009-7#1)
to be superior to the##4##5##(1996-2#1)(1997-2#1)(2008-10#1)(2013-1#1)
to be superior to##6##4##(1996-2#1)(1997-2#1)(2008-10#2)(2008-4#1)(2013-1#1)
to be superior##9##3##(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-4#1)(2013-1#1)
to be supported by##3##4##(1991-11#1)(2008-11#1)(2008-12#1)
to be sure##2##3##(1993-1#1)(2011-2#1)
to be susceptible##2##3##(2008-10#2)
to be synonymous##2##3##(2008-10#1)(2010-3#1)
to be synthesized##2##3##(1991-6#1)(1997-1#1)
to be tailored##2##3##(2008-10#1)(2013-8#1)
to be taken into account in##2##6##(2008-10#1)(2008-5#1)
to be taken into account##6##5##(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
to be taken##23##3##(1994-12#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2010-12#3)(2011-2#1)(2012-2#2)(2013-8#1)
to be tested for HIV antibodies##2##6##(1995-12#1)(1996-5#1)
to be tested in##3##4##(1995-5#1)(1997-4#1)(2008-10#1)
to be tested##12##3##(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-5#1)
to be the best therapeutic##2##5##(1994-6#1)(2009-7#1)
to be the best##15##4##(1990-9#1)(1994-5#1)(1994-6#1)(2008-10#6)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)
to be the case##2##4##(1990-6#1)(2008-9#1)
to be the cause of##3##5##(1990-11#1)(1991-6#1)(1994-3#1)
to be the cause##4##4##(1990-11#1)(1991-6#1)(1994-3#1)(2008-10#1)
to be the dominant##2##4##(1997-1#1)(2009-3#1)
to be the first##7##4##(1992-12#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-3#2)(2012-2#1)
to be the key##2##4##(2008-10#1)(2010-8#1)
to be the main##11##4##(2007-8#1)(2008-10#2)(2008-11#4)(2008-5#2)(2008-8#1)(2009-11#1)
to be the major##9##4##(1994-8#1)(2008-10#4)(2008-11#1)(2008-7#3)
to be the most common##2##5##(2008-9#1)(2013-8#1)
to be the most effective##6##5##(1990-5#1)(2008-10#3)(2008-11#1)(2008-8#1)
to be the most important##2##5##(1994-12#1)(1994-6#1)
to be the most sensitive##3##5##(2008-10#2)(2008-12#1)
to be the most significant##2##5##(2008-10#1)(2008-9#1)
to be the most suitable for##3##6##(2008-10#2)(2009-8#1)
to be the most suitable##5##5##(2008-10#3)(2009-8#1)(2012-2#1)
to be the most useful##2##5##(1992-1#1)(2009-12#1)
to be the most##29##4##(1990-5#1)(1992-1#1)(1994-12#1)(1994-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
to be the only##4##4##(1994-9#1)(2009-8#1)(2010-12#1)(2011-2#1)
to be the result of a##2##6##(2008-7#1)(2008-9#1)
to be the result of##7##5##(1992-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
to be the same as##3##5##(1995-2#1)(2008-10#1)(2008-8#1)
to be the same##5##4##(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)
to be the sum##2##4##(2008-10#1)(2009-3#1)
to be the##143##3##(1990-11#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#43)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#6)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#5)(2012-3#2)(2013-7#1)(2013-8#1)
to be to##2##3##(1992-5#1)(2012-2#1)
to be tolerant##3##3##(2008-10#2)(2008-8#1)
to be tolerated##2##3##(2008-11#1)(2012-3#1)
to be toxic and carcinogenic##2##5##(2008-10#2)
to be toxic##3##3##(1992-12#1)(2008-10#2)
to be trained in##2##4##(2008-10#1)(2008-11#1)
to be trained##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
to be transcribed from##2##4##(2008-11#1)(2008-8#1)
to be transcribed##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
to be transient##2##3##(2008-8#1)(2010-10#1)
to be transported##2##3##(2008-10#1)(2008-7#1)
to be treated with##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
to be treated##9##3##(1990-9#1)(1994-12#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
to be true##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
to be unaffected by##2##4##(2008-10#1)(2012-4#1)
to be under##3##3##(1992-10#1)(2008-10#2)
to be understood##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
to be unique##5##3##(1992-5#1)(2008-10#2)(2008-4#1)(2013-8#1)
to be uniquely##2##3##(1991-12#1)(2009-8#1)
to be used as a##5##5##(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
to be used as the##3##5##(1994-3#1)(2008-10#2)
to be used as##15##4##(1993-12#1)(1994-3#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2009-3#1)(2009-9#1)(2011-2#1)
to be used for the##2##5##(1991-3#1)(2008-11#1)
to be used for##9##4##(1991-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-9#1)
to be used in a##3##5##(2008-10#3)
to be used in the##4##5##(2008-10#2)(2008-11#1)(2013-1#1)
to be used in##22##4##(1992-3#1)(1997-1#1)(1997-6#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
to be used to##6##4##(2008-10#2)(2008-4#1)(2008-6#1)(2011-1#1)(2013-8#1)
to be used with##2##4##(1997-7#1)(2011-2#1)
to be used##69##3##(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#24)(2008-11#5)(2008-3#3)(2008-4#6)(2008-5#1)(2008-6#2)(2008-9#3)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
to be useful as a##2##5##(1993-1#1)(2008-10#1)
to be useful for the##2##5##(2008-10#2)
to be useful for##14##4##(2008-10#10)(2008-11#3)(2011-1#1)
to be useful in selecting##2##5##(2008-10#1)(2008-8#1)
to be useful in the area of##2##7##(2008-10#1)(2009-10#1)
to be useful in##8##4##(1996-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
to be useful##32##3##(1992-2#1)(1993-1#1)(1996-6#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2012-2#3)(2013-1#1)
to be utilized##2##3##(2008-10#1)(2008-4#1)
to be vaccinated##2##3##(1996-11#1)(2009-5#1)
to be valuable in##2##4##(1990-11#1)(2011-7#1)
to be valuable##4##3##(1990-11#1)(1991-2#1)(2008-8#1)(2011-7#1)
to be very effective##4##4##(2008-10#1)(2011-2#1)(2013-1#2)
to be very important##2##4##(2008-10#2)
to be very sensitive##2##4##(2008-10#1)(2008-7#1)
to be very suitable for the##2##6##(2008-10#2)
to be very suitable##3##4##(2008-10#3)
to be very useful in##2##5##(1997-8#1)(2008-11#1)
to be very useful##4##4##(1994-2#1)(1997-8#1)(2008-10#1)(2008-11#1)
to be very##35##3##(1992-11#1)(1993-9#1)(1994-2#1)(1995-12#1)(1997-8#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
to be viable##3##3##(1992-1#1)(1996-8#1)(1997-1#1)
to be weighed against##2##4##(2008-11#1)(2010-12#1)
to be well suited for##2##5##(2008-10#2)
to be well tolerated##2##4##(1996-2#1)(2008-5#1)
to be well##8##3##(1993-1#1)(1996-2#2)(2008-10#2)(2008-5#1)(2008-8#1)(2009-9#1)
to be within##2##3##(2008-10#1)(2008-3#1)
to be written##3##3##(2008-12#1)(2009-4#1)(2010-8#1)
to be##3772##2##(1990-11#11)(1990-12#15)(1990-2#19)(1990-3#4)(1990-4#1)(1990-5#12)(1990-6#9)(1990-8#7)(1990-9#8)(1991-1#2)(1991-10#1)(1991-11#8)(1991-12#20)(1991-2#18)(1991-3#13)(1991-4#3)(1991-5#17)(1991-6#13)(1991-7#7)(1991-8#4)(1991-9#3)(1992-1#14)(1992-10#4)(1992-11#6)(1992-12#19)(1992-2#12)(1992-3#19)(1992-4#1)(1992-5#4)(1992-6#12)(1992-8#3)(1992-9#13)(1993-1#10)(1993-11#13)(1993-12#27)(1993-2#14)(1993-3#12)(1993-6#10)(1993-8#15)(1993-9#9)(1994-1#6)(1994-11#18)(1994-12#22)(1994-2#13)(1994-3#16)(1994-5#17)(1994-6#7)(1994-8#20)(1994-9#9)(1995-1#3)(1995-11#22)(1995-12#24)(1995-2#25)(1995-3#11)(1995-5#10)(1995-6#25)(1995-8#8)(1995-9#2)(1996-1#13)(1996-11#7)(1996-12#20)(1996-2#24)(1996-3#24)(1996-5#8)(1996-6#7)(1996-8#9)(1996-9#4)(1997-1#23)(1997-2#25)(1997-3#13)(1997-4#7)(1997-5#4)(1997-6#8)(1997-7#15)(1997-8#23)(1997-9#1)(2006-6#2)(2007-11#4)(2007-12#16)(2007-8#1)(2007-9#1)(2008-1#14)(2008-10#1166)(2008-11#313)(2008-12#74)(2008-2#16)(2008-3#82)(2008-4#35)(2008-5#75)(2008-6#16)(2008-7#102)(2008-8#93)(2008-9#84)(2009-1#6)(2009-10#18)(2009-11#7)(2009-12#13)(2009-2#1)(2009-3#11)(2009-4#9)(2009-5#14)(2009-6#11)(2009-7#20)(2009-8#25)(2009-9#8)(2010-1#10)(2010-10#15)(2010-11#25)(2010-12#20)(2010-2#1)(2010-3#13)(2010-4#6)(2010-5#13)(2010-6#7)(2010-7#20)(2010-8#17)(2010-9#3)(2011-1#20)(2011-10#1)(2011-2#148)(2011-3#7)(2011-4#1)(2011-7#3)(2012-12#11)(2012-2#83)(2012-3#50)(2012-4#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#87)(2013-7#5)(2013-8#60)
to bean##4##2##(2008-10#2)(2008-8#2)
to bear on##2##3##(1994-2#1)(2010-1#1)
to bear##5##2##(1994-2#2)(1996-5#1)(2010-1#1)(2013-1#1)
to become a##7##3##(1996-5#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
to become active##2##3##(2008-4#1)(2013-1#1)
to become an##4##3##(2008-10#1)(2009-9#1)(2010-11#1)(2011-7#1)
to become infected##2##3##(2008-10#2)
to become involved##2##3##(1994-1#1)(2008-11#1)
to become more##2##3##(1997-3#1)(2008-11#1)
to become part of##2##4##(1992-1#1)(2010-9#1)
to become the##4##3##(1994-12#1)(1994-9#1)(1995-3#1)(2007-12#1)
to become##54##2##(1990-2#1)(1991-6#1)(1992-1#1)(1993-12#2)(1994-1#1)(1994-12#3)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2008-10#7)(2008-11#10)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#3)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
to becoming a##3##3##(2008-11#2)(2008-8#1)
to becoming##5##2##(2008-11#2)(2008-8#1)(2012-12#1)(2013-8#1)
to bed and##2##3##(1995-11#1)(2008-9#1)
to begin shortly##2##3##(1996-5#1)(2008-10#1)
to begin to##4##3##(1994-6#1)(2008-1#1)(2010-9#1)(2013-1#1)
to begin##16##2##(1990-3#1)(1994-6#1)(1996-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
to behavioral##2##2##(2008-2#1)(2008-8#1)
to being##9##2##(1991-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#2)
to believe that##8##3##(1993-12#1)(1994-6#1)(1995-1#1)(2008-12#1)(2008-9#3)(2012-2#1)
to believe##9##2##(1993-12#1)(1994-6#1)(1995-1#1)(2008-12#1)(2008-9#3)(2012-2#1)(2013-1#1)
to belong to the##5##4##(2008-10#3)(2008-5#1)(2008-8#1)
to belong to##10##3##(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
to below##5##2##(1991-6#1)(1994-12#1)(1994-6#1)(2008-10#1)(2010-4#1)
to benefit by the end of therapy##2##7##(2012-2#2)
to benefit from##11##3##(1997-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
to benefit##16##2##(1997-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#1)
to benefits##2##2##(1995-12#1)(1997-2#1)
to benign##2##2##(2008-11#1)(2012-3#1)
to benomyl at##3##3##(2008-10#3)
to benomyl##4##2##(2008-10#4)
to benzene##4##2##(2008-10#2)(2008-11#2)
to best##6##2##(1992-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-8#1)
to beta##2##2##(2008-10#1)(2008-3#1)
to beta-CCE##2##2##(1996-2#2)
to beta-CD##2##2##(2008-10#1)(2008-11#1)
to better define the##5##4##(1990-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
to better define##6##3##(1990-6#1)(2008-10#3)(2011-2#1)(2013-1#1)
to better identify##2##3##(2010-1#1)(2010-9#1)
to better interventions##2##3##(2010-10#1)(2012-3#1)
to better results##2##3##(2008-10#1)(2008-11#1)
to better than##4##3##(1992-11#1)(2008-3#3)
to better understand and##2##4##(2008-12#1)(2010-10#1)
to better understand how##2##4##(2008-11#1)(2010-9#1)
to better understand the dynamics and##2##6##(2012-3#2)
to better understand the dynamics##3##5##(2008-10#1)(2012-3#2)
to better understand the##18##4##(1990-8#1)(1993-8#1)(1997-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#4)(2013-1#1)
to better understand##25##3##(1990-8#1)(1993-8#1)(1997-9#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#4)(2013-1#2)
to better##73##2##(1990-2#1)(1990-6#2)(1990-8#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1997-9#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-3#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#6)(2012-7#1)(2013-1#5)(2013-8#1)
to between##3##2##(1990-5#2)(2008-7#1)
to bias##2##2##(1997-8#1)(2008-8#1)
to bilateral##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
to bind the##4##3##(1993-6#1)(1995-2#1)(2008-10#2)
to bind to the##3##4##(1993-8#1)(1994-5#1)(2013-1#1)
to bind to##21##3##(1990-12#1)(1990-5#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
to bind##46##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#2)(1991-5#2)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-5#2)(1995-12#1)(1995-2#3)(1995-6#3)(1995-8#2)(1997-7#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
to binding of##2##3##(1993-3#1)(2012-2#1)
to binding to the##2##4##(1990-12#1)(2008-9#1)
to binding to##3##3##(1990-12#1)(2008-10#1)(2008-9#1)
to binding##7##2##(1990-12#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
to biological control##2##3##(2008-10#2)
to biological##10##2##(1992-3#1)(1993-1#1)(1994-9#1)(2008-10#4)(2008-11#1)(2012-3#2)
to biomarker##2##2##(2010-5#1)(2010-7#1)
to biomass##4##2##(2008-10#1)(2008-7#3)
to biopsy##3##2##(2008-9#1)(2012-2#2)
to bioreactor##2##2##(2008-11#2)
to biotinylated##2##2##(1993-6#2)
to black currant reversion associated virus##2##6##(2008-10#2)
to black##6##2##(1994-9#1)(2008-10#4)(2008-3#1)
to bladder##2##2##(2008-10#1)(2008-12#1)
to blast##8##2##(2008-10#7)(2012-2#1)
to blend##3##2##(2009-7#2)(2013-8#1)
to block the##5##3##(1991-1#1)(1995-11#1)(1995-6#1)(1997-1#1)(2009-8#1)
to block##22##2##(1991-1#2)(1995-11#1)(1995-12#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#3)(2009-7#1)(2009-8#2)(2009-9#1)(2011-2#1)(2013-1#1)
to blood##8##2##(1990-12#1)(1990-5#1)(1995-12#1)(2008-11#1)(2009-10#1)(2009-7#1)(2011-2#2)
to bloom##3##2##(2008-10#3)
to blue##4##2##(2008-10#3)(2008-8#1)
to blunt##2##2##(2009-2#1)(2012-2#1)
to body##6##2##(1990-5#1)(1994-12#1)(1994-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
to bone and##2##3##(1994-12#1)(2011-2#1)
to bone##8##2##(1994-12#2)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
to boost##3##2##(1994-3#2)(1994-5#1)
to both a##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
to both fungicides##4##3##(2008-10#4)
to both local##2##3##(1994-2#2)
to both microtubules and##2##4##(1995-2#2)
to both natural##2##3##(2008-10#1)(2008-8#1)
to both peptides##2##3##(1990-5#2)
to both races##2##3##(2008-10#2)
to both students and##2##4##(1996-1#1)(2008-12#1)
to both the standard##2##4##(1994-9#1)(2008-10#1)
to both the##21##3##(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(1996-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#1)
to both##155##2##(1990-12#1)(1990-5#4)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#5)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#51)(2008-11#6)(2008-12#6)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-5#5)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to bottom##2##2##(2008-10#1)(2013-8#1)
to bovine brain membranes##2##4##(1990-8#2)
to bovine lactoferrin##2##3##(1996-12#2)
to bovine serum albumin (BSA)##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
to bovine##11##2##(1990-8#2)(1992-6#1)(1993-2#1)(1995-8#1)(1996-12#3)(2008-10#1)(2008-11#1)(2008-3#1)
to brain PI##2##3##(1996-2#2)
to brain and##2##3##(2009-6#1)(2011-2#1)
to brain injury##2##3##(1991-11#1)(1997-3#1)
to brain regions##2##3##(1997-2#1)(2009-10#1)
to brain##11##2##(1991-11#1)(1991-5#1)(1996-2#2)(1997-2#2)(1997-3#1)(2009-10#1)(2009-6#1)(2011-2#2)
to break the##3##3##(1992-12#1)(2008-10#2)
to break this##2##3##(1994-12#1)(2008-11#1)
to break##10##2##(1990-11#1)(1992-12#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-8#1)
to breakdown##3##2##(1991-5#1)(2008-12#1)(2008-3#1)
to breast cancer##5##3##(1990-8#1)(1993-1#1)(1997-1#1)(2008-4#1)(2011-2#1)
to breast##8##2##(1990-8#1)(1993-1#1)(1997-1#2)(1997-7#1)(2008-4#1)(2011-2#1)(2011-3#1)
to breathe##2##2##(1993-3#1)(2011-2#1)
to breed##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
to breeding##3##2##(2008-8#3)
to bridge the gap between evidence and##2##7##(1993-12#1)(2008-3#1)
to bridge the gap between##4##5##(1993-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
to bridge the##7##3##(1993-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)
to bridge##11##2##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-2#1)
to bring about##4##3##(1997-3#1)(2008-11#2)(2010-1#1)
to bring the##5##3##(1992-1#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#1)
to bring together##2##3##(1993-3#1)(2011-1#1)
to bring##20##2##(1992-1#1)(1993-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#6)(2008-6#1)(2010-1#1)(2011-1#1)
to broaden##3##2##(1995-5#1)(1996-2#1)(2008-11#1)
to brown stem rot##3##4##(2008-10#3)
to brown##8##2##(2008-10#6)(2008-12#1)(2011-1#1)
to bud##3##2##(2008-10#2)(2012-8#1)
to build a##14##3##(1993-12#1)(1994-2#2)(1995-12#1)(1996-3#2)(1997-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-3#1)(2010-8#1)(2011-2#1)
to build and##2##3##(2008-4#1)(2011-7#1)
to build the##4##3##(2008-10#3)(2008-12#1)
to build up a##2##4##(2008-10#2)
to build##31##2##(1993-12#1)(1994-2#2)(1995-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-8#1)(2011-2#1)(2011-7#1)(2013-1#1)
to bulk##3##2##(1992-11#1)(2008-10#1)(2013-8#1)
to burnout##4##2##(1992-1#1)(2008-10#2)(2013-1#1)
to business##2##2##(1991-2#1)(1993-2#1)
to but##3##2##(2009-10#1)(2009-7#1)(2009-8#1)
to buy##4##2##(1991-9#1)(1992-8#1)(1993-5#1)(1995-2#1)
to by##2##2##(1994-3#1)(2011-2#1)
to bypass the##2##3##(2008-9#1)(2012-3#1)
to bypass##4##2##(1995-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
to cDNA##3##2##(1995-11#1)(2008-4#1)(2008-9#1)
to cadmium and##2##3##(2008-10#1)(2008-11#1)
to cadmium##4##2##(1993-12#1)(2008-10#2)(2008-11#1)
to calcium##2##2##(1994-3#1)(2010-11#1)
to calculate a##2##3##(2008-10#1)(2009-8#1)
to calculate the corresponding##2##4##(2008-10#2)
to calculate the net##2##4##(2008-11#1)(2011-2#1)
to calculate the relative##2##4##(1996-3#1)(2008-10#1)
to calculate the##50##3##(1993-3#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#2)
to calculate##77##2##(1991-11#1)(1993-3#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-8#2)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
to calibrate##5##2##(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)
to calibration##2##2##(2008-10#1)(2010-11#1)
to call##3##2##(2008-12#1)(2010-2#1)(2012-12#1)
to calorie restriction##2##3##(2008-4#2)
to calreticulin##2##2##(1994-11#2)
to cancer cell##2##3##(2008-11#1)(2009-4#1)
to cancer in##2##3##(1990-9#1)(1997-1#1)
to cancer of##2##3##(1994-2#1)(2012-3#1)
to cancer patients##2##3##(1992-3#1)(1995-2#1)
to cancer##23##2##(1990-9#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-2#1)(1995-9#2)(1996-10#1)(1997-1#1)(2008-11#3)(2008-4#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
to cancers##2##2##(2008-11#2)
to capital##2##2##(1992-2#1)(1997-6#1)
to capitalize on##3##3##(1995-2#1)(2010-9#1)(2011-2#1)
to capitation##3##2##(1995-2#1)(1997-1#1)(1997-2#1)
to capsaicin##2##2##(1992-6#1)(2008-11#1)
to capture the##7##3##(1990-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-8#1)
to capture##21##2##(1990-12#1)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#3)(2013-8#1)
to capturing##2##2##(2008-11#1)(2013-8#1)
to carbon catabolite repression by##2##5##(1993-12#1)(2008-10#1)
to carbon dioxide##2##3##(1993-12#1)(2008-10#1)
to carbon##7##2##(1993-12#2)(2008-10#5)
to cardiac hypertrophy##2##3##(2008-12#2)
to cardiac##10##2##(1992-3#1)(1995-11#1)(2008-11#3)(2008-12#2)(2010-6#1)(2011-2#2)
to cardiovascular complications##2##3##(2008-12#1)(2012-3#1)
to cardiovascular disease##2##3##(2008-9#1)(2010-12#1)
to cardiovascular events##2##3##(2010-9#1)(2011-2#1)
to cardiovascular##9##2##(1990-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#1)
to care for bereaved parents##2##5##(2008-11#2)
to care for children##3##4##(2012-2#2)(2013-8#1)
to care for people with mental health problems##2##8##(2008-11#2)
to care for the##3##4##(1996-3#1)(1997-2#1)(2008-8#1)
to care for##20##3##(1991-2#1)(1992-12#1)(1993-11#1)(1995-12#2)(1996-3#1)(1997-2#1)(2008-11#6)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-8#1)
to care of the older person##3##6##(2010-10#3)
to care##40##2##(1991-2#1)(1992-12#1)(1993-11#1)(1994-1#1)(1995-12#9)(1996-3#5)(1997-2#1)(1997-4#1)(2008-11#6)(2008-7#2)(2008-8#1)(2010-10#3)(2010-7#1)(2011-2#3)(2012-2#3)(2013-8#1)
to carefully##2##2##(1992-11#1)(2013-1#1)
to caregivers##5##2##(1991-1#1)(1994-1#1)(1996-1#1)(2008-1#1)(2013-8#1)
to carry out analyses of##2##5##(1996-3#1)(2008-10#1)
to carry out the calibration for the##2##7##(2008-2#2)
to carry out the##11##4##(1995-12#1)(1997-7#1)(2008-10#5)(2008-2#3)(2010-12#1)
to carry out##33##3##(1990-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-6#1)(1997-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
to carry the##2##3##(2008-10#2)
to carry##43##2##(1990-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-6#1)(1997-7#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
to case##4##2##(1996-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
to cases##3##2##(2008-8#1)(2008-9#1)(2009-3#1)
to catabolize##3##2##(1993-3#1)(2008-10#2)
to catalytic##2##2##(1996-5#1)(2008-10#1)
to catalyze the##5##3##(2008-10#2)(2009-12#1)(2009-6#1)(2012-2#1)
to catalyze##10##2##(1992-6#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-10#2)(2009-12#1)(2009-6#1)(2012-2#1)
to catch##3##2##(1995-1#1)(1995-3#1)(2008-8#1)
to catechol##3##2##(2008-10#3)
to categorize##3##2##(1995-2#1)(2008-11#1)(2012-3#1)
to cation##2##2##(2008-10#1)(2008-8#1)
to cations##3##2##(1990-5#2)(2008-7#1)
to cattle##3##2##(1990-6#1)(1997-7#1)(2011-2#1)
to causal##2##2##(1997-3#1)(2009-10#1)
to cause a reduction##2##4##(1991-12#1)(2008-10#1)
to cause a##8##3##(1991-12#1)(1995-8#1)(2008-10#4)(2009-12#1)(2011-1#1)
to cause an##2##3##(2008-7#1)(2011-2#1)
to cause big-vein##2##3##(2008-10#2)
to cause severe##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
to cause the##3##3##(1993-2#1)(2008-12#1)(2010-10#1)
to cause##65##2##(1991-12#1)(1993-12#2)(1993-2#2)(1993-8#1)(1995-6#1)(1995-8#1)(1996-3#1)(2006-6#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
to cavity##2##2##(1991-2#1)(2008-3#1)
to cell culture##2##3##(2008-11#2)
to cell cultures##3##3##(2008-5#3)
to cell death##6##3##(2008-10#1)(2008-11#2)(2009-6#1)(2009-8#1)(2012-2#1)
to cell growth##2##3##(2008-11#1)(2011-1#1)
to cell proliferation##2##3##(2008-11#1)(2009-9#1)
to cell surface##2##3##(1995-2#1)(1996-2#1)
to cell##36##2##(1990-5#1)(1995-2#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#12)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#2)(2009-8#2)(2009-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)
to cell-cycle##3##2##(2008-11#2)(2013-8#1)
to cells cultured in##2##4##(1992-8#1)(2008-11#1)
to cells with##2##3##(2008-9#1)(2012-3#1)
to cells##14##2##(1992-7#1)(1992-8#1)(1994-8#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-3#1)
to cellular stresses##2##3##(1996-2#2)
to cellular##13##2##(1991-5#1)(1994-12#1)(1996-2#3)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
to cellulose##2##2##(2008-10#2)
to center layer##2##3##(2013-8#2)
to central##3##2##(1994-11#2)(2008-5#1)
to cerebral##6##2##(1996-3#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
to certain other##2##3##(1990-5#1)(2008-5#1)
to certain##21##2##(1990-3#1)(1990-5#2)(1991-5#1)(1992-2#1)(1994-9#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
to certify the##2##3##(2008-11#1)(2013-1#1)
to cervical##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
to challenge the##4##3##(1996-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
to challenge##12##2##(1990-11#1)(1993-12#1)(1995-3#1)(1996-5#1)(2008-10#3)(2008-7#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-3#1)
to change and##2##3##(1992-12#1)(2008-11#1)
to change from##2##3##(2010-6#1)(2011-2#1)
to change in##7##3##(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
to change the##11##3##(1991-1#2)(1994-1#1)(1996-2#1)(2008-10#4)(2008-3#1)(2008-8#1)(2012-2#1)
to change their##3##3##(1992-2#1)(1994-2#1)(2008-11#1)
to change to##2##3##(2008-10#1)(2011-2#1)
to change##71##2##(1991-1#4)(1991-12#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-11#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#3)(2009-12#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-8#4)
to changes in the rate of returning##2##7##(2008-8#2)
to changes in the##12##4##(1993-6#1)(1994-6#1)(2008-10#4)(2008-8#2)(2009-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
to changes in variables##2##4##(2008-10#2)
to changes in##40##3##(1991-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#2)
to changes##41##2##(1991-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-10#12)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#2)
to changing environments##2##3##(2008-7#1)(2009-6#1)
to changing##11##2##(1991-1#1)(1992-2#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-6#2)(2012-5#1)
to characterise the##7##3##(1994-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2013-8#1)
to characterise##16##2##(1994-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
to characteristics of the##2##4##(2008-11#1)(2010-10#1)
to characterize a##2##3##(2008-10#1)(2008-4#1)
to characterize and to##2##4##(1997-3#1)(2013-1#1)
to characterize and##6##3##(1997-3#1)(2008-11#2)(2008-3#1)(2008-5#1)(2013-1#1)
to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig##2##15##(1994-8#2)
to characterize pathogenic##2##3##(2008-10#2)
to characterize the baseline##2##4##(2008-10#1)(2008-11#1)
to characterize the effects of##2##5##(1994-2#1)(2008-10#1)
to characterize the performance of##2##5##(2008-10#1)(2008-6#1)
to characterize the##58##3##(1990-5#1)(1990-7#1)(1992-3#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#28)(2008-11#4)(2008-12#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-4#2)(2011-2#2)
to characterize their abilities as##2##5##(2008-10#2)
to characterize their##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)
to characterize##129##2##(1990-5#1)(1990-7#1)(1992-3#1)(1993-1#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2007-11#1)(2008-1#2)(2008-10#54)(2008-11#11)(2008-12#3)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-4#2)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#2)
to characterizing##2##2##(2008-10#1)(2008-8#1)
to charge##6##2##(1990-5#1)(1991-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
to check the##11##3##(1991-2#1)(2008-10#5)(2008-12#3)(2008-5#1)(2008-9#1)
to check##23##2##(1991-2#1)(1991-3#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2012-7#1)
to chemical and##2##3##(1997-2#1)(2008-3#1)
to chemical##13##2##(1993-3#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2010-7#1)
to chemically##2##2##(1995-11#1)(2008-10#1)
to chemotherapeutic agents##3##3##(1997-7#1)(2008-11#2)
to chemotherapeutic drugs##3##3##(1997-7#2)(2008-11#1)
to chemotherapeutic##6##2##(1997-7#3)(2008-11#3)
to chemotherapy##13##2##(1997-7#1)(2008-11#2)(2008-7#1)(2008-8#2)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
to chicken##4##2##(1991-3#2)(1993-6#1)(2008-5#1)
to child##2##2##(1994-6#1)(2013-1#1)
to children and their##2##4##(2008-11#2)
to children and##4##3##(2008-11#2)(2008-8#1)(2010-4#1)
to children in##3##3##(1991-6#1)(1994-6#1)(2012-3#1)
to children with##2##3##(2008-11#1)(2010-7#1)
to children##19##2##(1991-6#1)(1992-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(2008-11#6)(2008-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
to children's perceptions##4##3##(2008-12#3)(2009-4#1)
to children's##5##2##(2008-12#3)(2009-4#1)(2010-12#1)
to chiral##2##2##(1995-6#2)
to chloramphenicol##2##2##(2008-12#1)(2011-2#1)
to chlorine##4##2##(1992-5#1)(2008-10#3)
to chlorophyll##2##2##(2008-10#1)(2008-9#1)
to chloroquine##2##2##(1992-6#1)(1993-8#1)
to choice##2##2##(2008-9#1)(2013-1#1)
to cholesterol##3##2##(1992-9#1)(1997-2#1)(2008-6#1)
to cholinergic##2##2##(2008-11#1)(2008-7#1)
to choose a##2##3##(1993-11#1)(2012-3#1)
to choose##15##2##(1992-2#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#2)
to chromatographic##4##2##(2008-10#4)
to chromium##3##2##(2008-10#3)
to chromium(VI) by##2##3##(2008-10#2)
to chromosome 2##2##3##(2008-8#1)(2011-1#1)
to chromosome breakage##2##3##(2012-3#2)
to chromosome##17##2##(1990-8#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-6#2)(1997-7#3)(2008-11#1)(2008-8#2)(2011-1#1)(2012-3#3)
to chromosomes##3##2##(1993-12#1)(1996-12#1)(2008-10#1)
to chronic daily##2##3##(1994-2#2)
to chronic inflammation##2##3##(1997-8#1)(2009-8#1)
to chronic##26##2##(1991-6#1)(1994-2#2)(1994-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#2)(2009-8#1)(2009-9#2)(2010-4#1)(2011-2#2)(2013-1#3)
to cigarette smoke##5##3##(1993-8#1)(2008-5#4)
to ciprofloxacin##3##2##(2008-7#1)(2012-3#2)
to circadian rhythms##2##3##(1996-2#1)(2013-7#1)
to circadian##3##2##(1996-2#1)(2008-5#1)(2013-7#1)
to circulate##2##2##(1991-5#1)(1997-2#1)
to circulating##2##2##(1996-12#1)(2010-5#1)
to circumvent the##3##3##(2010-1#1)(2010-3#1)(2012-2#1)
to circumvent this##2##3##(2008-10#2)
to circumvent##8##2##(2008-10#4)(2008-11#1)(2010-1#1)(2010-3#1)(2012-2#1)
to cisplatin##3##2##(1993-1#1)(2008-9#2)
to citrus##3##2##(2008-10#3)
to claim##2##2##(1990-11#1)(2008-12#1)
to clarify the effects of##2##5##(2011-2#1)(2012-3#1)
to clarify the mechanism of##2##5##(2009-7#1)(2011-2#1)
to clarify the mechanism##3##4##(1993-3#1)(2009-7#1)(2011-2#1)
to clarify the mechanisms##2##4##(2008-11#1)(2011-2#1)
to clarify the relationship between##2##5##(1991-12#1)(2009-11#1)
to clarify the relationship##3##4##(1991-12#1)(2009-11#1)(2013-8#1)
to clarify the role of##2##5##(2008-10#1)(2013-8#1)
to clarify the role##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
to clarify the##28##3##(1991-12#1)(1993-3#1)(1994-2#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#3)
to clarify whether##4##3##(1991-3#1)(2008-11#1)(2008-5#2)
to clarify##41##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-8#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#3)
to classical##10##2##(1997-4#1)(2008-10#4)(2008-9#2)(2010-7#2)(2012-2#1)
to classify a##2##3##(1993-12#1)(2008-10#1)
to classify and##2##3##(2008-10#1)(2009-8#1)
to classify the##4##3##(2008-10#3)(2008-11#1)
to classify these##2##3##(1996-9#1)(2008-10#1)
to classify##33##2##(1993-12#1)(1995-12#1)(1995-2#1)(1996-9#1)(2008-10#19)(2008-11#2)(2008-4#1)(2008-5#4)(2008-9#1)(2009-8#1)(2012-2#1)
to clean up##2##3##(1996-5#1)(2008-10#1)
to clean##7##2##(1996-5#1)(2008-10#3)(2008-6#1)(2010-8#1)(2013-8#1)
to clear##2##2##(1996-12#1)(2013-8#1)
to clearly##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
to cleave the##2##3##(1991-10#1)(2008-8#1)
to cleave##5##2##(1991-10#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
to clients##2##2##(1996-3#1)(2010-5#1)
to climate change##3##3##(2008-9#1)(2009-12#1)(2012-7#1)
to climate##5##2##(2008-9#1)(2009-12#1)(2012-7#2)(2012-9#1)
to clinical and##2##3##(1994-1#1)(2011-1#1)
to clinical data##2##3##(2008-5#1)(2011-2#1)
to clinical evaluation##2##3##(1990-2#1)(2008-5#1)
to clinical practice##18##3##(1993-3#2)(2008-11#2)(2008-6#1)(2009-4#1)(2010-10#9)(2010-11#3)
to clinical trials##4##3##(1997-3#1)(2008-11#1)(2009-12#1)(2010-11#1)
to clinical##57##2##(1990-2#1)(1991-6#1)(1992-12#2)(1993-11#2)(1993-3#3)(1994-1#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#2)(2010-10#10)(2010-11#4)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to clinically##3##2##(1997-1#1)(2008-4#2)
to clinicians##5##2##(1995-2#1)(1995-5#1)(1997-1#1)(2009-5#1)(2009-8#1)
to clone##6##2##(1993-12#1)(1993-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-4#1)
to close the##3##3##(1992-3#1)(2008-11#1)(2010-10#1)
to close##9##2##(1992-3#2)(1994-9#1)(1997-7#1)(2008-11#3)(2008-5#1)(2010-10#1)
to clotrimazole##2##2##(2008-5#2)
to cluster##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
to coagulase-negative##2##2##(1991-3#1)(2010-12#1)
to coat the##2##3##(2008-10#2)
to coat##3##2##(2008-10#3)
to cocaine##5##2##(1991-1#3)(2008-11#1)(2010-11#1)
to cochlear implant##2##3##(2008-9#2)
to cochlear##3##2##(2008-9#3)
to coexist##4##2##(1995-5#2)(2008-8#2)
to coexistence##3##2##(2008-8#3)
to coffee production in Africa##2##5##(2008-10#2)
to coffee##3##2##(2008-10#2)(2008-5#1)
to cognitive##7##2##(1992-12#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
to cohere##2##2##(1991-7#2)
to coherence##2##2##(1991-7#1)(2008-3#1)
to coincide with##2##3##(2008-11#2)
to coincide##3##2##(2008-11#2)(2009-10#1)
to cold##2##2##(2009-8#1)(2013-8#1)
to collaborate with the##2##4##(2008-11#1)(2013-1#1)
to collaborative##4##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-12#1)
to collagen##3##2##(2008-8#3)
to collagen-coated##2##2##(2008-11#2)
to collapse of the##2##4##(2008-11#1)(2008-8#1)
to collapse##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
to collect REL data##2##4##(2013-1#2)
to collect and analyze##2##4##(1997-3#1)(2011-2#1)
to collect and##4##3##(1997-3#1)(2008-10#1)(2010-8#1)(2011-2#1)
to collect data from##2##4##(1994-2#1)(2008-11#1)
to collect data##9##3##(1992-2#1)(1994-2#1)(2008-11#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
to collect information##2##3##(2008-11#1)(2012-3#1)
to collect##39##2##(1992-2#1)(1994-2#1)(1997-1#1)(1997-3#2)(2008-10#6)(2008-11#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)
to colonization and##2##3##(2008-10#2)
to colonization by##2##3##(2008-10#2)
to colonization##7##2##(2008-10#7)
to colonize the##4##3##(2008-10#3)(2011-1#1)
to colonize##6##2##(2008-10#5)(2011-1#1)
to colorectal##3##2##(1995-9#1)(2009-12#2)
to combat AIDS##2##3##(1990-11#1)(1991-2#1)
to combat the##3##3##(1996-11#1)(2008-10#2)
to combat##18##2##(1990-11#1)(1991-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
to combination##2##2##(1997-7#1)(2010-11#1)
to combine the##4##3##(1995-5#1)(2008-10#2)(2013-1#1)
to combine##14##2##(1993-2#1)(1995-5#2)(1996-3#1)(1996-6#2)(2008-10#3)(2008-11#1)(2009-12#1)(2013-1#3)
to come from##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
to come to##2##3##(2008-12#1)(2012-2#1)
to come##19##2##(1991-8#1)(1993-2#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2010-11#1)(2010-6#1)(2012-2#1)
to commence##2##2##(1992-9#1)(1994-9#1)
to commercial##13##2##(1996-3#2)(2008-10#10)(2011-1#1)
to commercially available##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
to common bean (Phaseolus vulgaris L##2##6##(2008-12#2)
to common bean (Phaseolus##3##4##(2008-10#1)(2008-12#2)
to common bean##4##3##(2008-10#2)(2008-12#2)
to common##18##2##(1990-5#1)(1992-9#1)(2008-10#9)(2008-11#1)(2008-12#2)(2009-9#1)(2011-2#1)(2012-2#2)
to commonly used##2##3##(2008-10#1)(2012-3#1)
to commonly##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
to communicate##15##2##(1992-2#1)(1993-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
to communication and##2##3##(2011-1#1)(2013-1#1)
to community##7##2##(1994-1#1)(1995-3#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-12#1)
to comparable##2##2##(1997-2#1)(2012-2#1)
to comparative##2##2##(2008-10#2)
to comparatively##2##2##(2008-9#1)(2011-1#1)
to compare and##3##3##(2008-10#2)(2008-9#1)
to compare both##2##3##(1994-5#1)(2010-8#1)
to compare clinical##2##3##(1997-8#1)(2011-2#1)
to compare differences##3##3##(1995-2#1)(2008-12#1)(2011-2#1)
to compare our##3##3##(1994-3#2)(2008-7#1)
to compare the data##2##4##(1994-3#1)(2008-10#1)
to compare the efficacy of##2##5##(2010-7#1)(2013-1#1)
to compare the genetic##2##4##(2008-10#2)
to compare the influence##2##4##(2008-2#1)(2008-7#1)
to compare the results obtained##2##5##(2008-10#1)(2013-1#1)
to compare the results##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
to compare the##64##3##(1991-12#2)(1993-12#2)(1994-3#2)(1994-6#1)(1996-2#1)(1996-3#2)(1997-8#1)(2006-6#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
to compare their##5##3##(1994-12#1)(2008-10#1)(2010-10#1)(2013-1#2)
to compare them##3##3##(1991-7#1)(2008-10#1)(2012-12#1)
to compare these##4##3##(1996-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
to compare two##3##3##(1994-12#1)(2008-4#1)(2008-8#1)
to compare with##3##3##(2008-10#1)(2012-3#2)
to compare##147##2##(1990-2#1)(1990-9#1)(1991-12#2)(1991-7#1)(1992-3#1)(1993-12#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-8#3)(2006-6#1)(2008-10#30)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#14)(2013-8#2)
to comparing##4##2##(2008-11#2)(2008-4#2)
to compensate for the##6##4##(2008-3#3)(2008-5#1)(2011-1#1)(2012-2#1)
to compensate for##10##3##(2008-10#2)(2008-11#1)(2008-3#4)(2008-5#1)(2011-1#1)(2012-2#1)
to compensate the##2##3##(2008-10#2)
to compensate##15##2##(1997-1#1)(2008-10#6)(2008-11#1)(2008-3#4)(2008-5#1)(2011-1#1)(2012-2#1)
to compete for##3##3##(1993-8#1)(1995-2#1)(2008-8#1)
to compete with##5##3##(1993-3#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-7#1)
to compete##11##2##(1993-3#1)(1993-8#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-8#2)(2012-2#1)(2013-7#1)
to competition between##2##3##(1993-8#1)(2008-8#1)
to competition##4##2##(1993-8#1)(2008-10#1)(2008-8#2)
to competitive##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
to competitively##2##2##(2008-10#1)(2011-2#1)
to compile##3##2##(1996-12#1)(2008-9#1)(2013-1#1)
to complement a##2##3##(1996-3#1)(1996-6#1)
to complement the##8##3##(1993-12#1)(1994-12#1)(2008-10#3)(2008-8#1)(2010-5#1)(2010-8#1)
to complement##16##2##(1993-12#1)(1994-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-8#1)(2012-3#1)
to complete a questionnaire##2##4##(1992-12#1)(2010-8#1)
to complete a##6##3##(1990-11#1)(1992-12#1)(1997-2#1)(2008-12#1)(2010-8#1)(2013-7#1)
to complete the##12##3##(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#2)
to complete##48##2##(1990-11#1)(1991-5#2)(1992-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#2)
to completely block##2##3##(2008-10#1)(2010-4#1)
to completely##10##2##(1995-2#1)(1997-3#1)(2008-10#6)(2008-7#1)(2010-4#1)
to completion##2##2##(2008-7#1)(2010-4#1)
to complex##6##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
to comply with a##2##4##(2008-10#1)(2008-11#1)
to comply with the##3##4##(1995-2#1)(2008-1#1)(2013-1#1)
to comply with##6##3##(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
to composite##2##2##(2009-6#1)(2013-1#1)
to comprehend the##3##3##(2008-12#1)(2009-6#1)(2010-10#1)
to comprehend##4##2##(1996-3#1)(2008-12#1)(2009-6#1)(2010-10#1)
to comprehensive##3##2##(1993-3#1)(1997-2#1)(1997-7#1)
to comprehensively assess##2##3##(2008-10#1)(2012-3#1)
to comprehensively##3##2##(2008-10#1)(2010-11#1)(2012-3#1)
to compression of the##3##4##(1992-9#1)(2007-8#1)(2008-7#1)
to compression##4##2##(1992-9#1)(2007-8#1)(2008-5#1)(2008-7#1)
to compute the##9##3##(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-3#1)
to compute##16##2##(2008-3#6)(2008-4#3)(2008-6#4)(2008-7#1)(2008-8#1)(2011-3#1)
to computers##2##2##(1996-1#1)(2008-11#1)
to conceive of##2##3##(1995-3#1)(2010-8#1)
to conceive##4##2##(1995-3#1)(2010-12#1)(2010-8#1)(2012-3#1)
to concentrate in the##2##4##(1990-12#1)(2011-2#1)
to concentrate##11##2##(1990-12#1)(1997-7#2)(2008-10#6)(2008-7#1)(2011-2#1)
to concentration of##4##3##(2008-10#4)
to concentration##9##2##(2008-10#9)
to concentrations of##4##3##(1996-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
to conclude that the##3##4##(1993-8#1)(1995-3#1)(2008-10#1)
to conclude that##10##3##(1991-3#1)(1993-8#1)(1994-8#1)(1995-3#1)(2008-10#5)(2011-2#1)
to conclude##13##2##(1991-3#1)(1993-8#1)(1994-8#1)(1995-3#1)(2008-10#7)(2008-12#1)(2011-2#1)
to condition##2##2##(2008-10#2)
to conditions##2##2##(1997-2#1)(2008-5#1)
to conduct a##4##3##(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
to conduct such##2##3##(1991-2#1)(2012-2#1)
to conduct##19##2##(1991-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
to conducting##2##2##(2008-10#2)
to confer a##2##3##(1993-11#1)(2008-10#1)
to confer resistance##2##3##(2008-10#2)
to confer##17##2##(1992-7#1)(1993-11#1)(1993-8#2)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2011-2#1)
to confidently##2##2##(2008-4#1)(2011-2#1)
to confirm its##5##3##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
to confirm or exclude##2##4##(1990-2#1)(2008-1#1)
to confirm or##3##3##(1990-2#1)(1991-11#1)(2008-1#1)
to confirm that the##3##4##(2008-3#1)(2010-6#1)(2013-8#1)
to confirm that##7##3##(1992-3#1)(2008-10#1)(2008-3#1)(2010-6#1)(2013-1#2)(2013-8#1)
to confirm the diagnosis of##2##5##(2008-11#1)(2008-5#1)
to confirm the diagnosis##8##4##(1990-9#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to confirm the presence of##3##5##(1990-6#1)(2008-10#1)(2011-2#1)
to confirm the stability of##2##5##(1997-6#1)(2011-2#1)
to confirm the##36##3##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-12#1)(1994-2#1)(1996-12#1)(1997-6#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
to confirm these findings##3##4##(2008-4#1)(2009-7#1)(2011-2#1)
to confirm these##6##3##(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#3)
to confirm this hypothesis##3##4##(1991-11#1)(2008-10#1)(2008-12#1)
to confirm this##4##3##(1991-11#1)(2008-10#1)(2008-12#1)(2008-8#1)
to confirm whether the##2##4##(2008-10#2)
to confirm whether##3##3##(2008-10#3)
to confirm##81##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
to conflict##2##2##(1994-6#1)(2008-8#1)
to conform to##3##3##(1991-12#1)(2008-11#1)(2012-2#1)
to conformational##2##2##(1991-5#1)(2008-8#1)
to confounding##3##2##(1992-3#1)(2008-7#1)(2008-9#1)
to confusion##3##2##(1991-2#1)(1995-5#1)(2013-1#1)
to congenital limb deformity in humans##2##6##(2009-3#2)
to congenital##5##2##(1990-5#1)(1994-3#1)(2009-3#2)(2010-11#1)
to conidial germination and##2##4##(2008-10#2)
to conidial germination##3##3##(2008-10#3)
to conidial inoculations##3##3##(2008-10#3)
to conidial##7##2##(2008-10#7)
to conjugate##2##2##(1995-5#1)(2008-10#1)
to connect##5##2##(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
to conservative management##2##3##(2013-1#2)
to conservative treatment##4##3##(1993-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
to conservative##8##2##(1993-11#1)(1994-3#1)(2010-3#1)(2011-2#1)(2013-1#4)
to conserve##3##2##(1992-2#1)(2008-10#1)(2010-4#1)
to consider before##2##3##(1997-4#1)(2008-10#1)
to consider how##2##3##(2008-10#1)(2013-1#1)
to consider in##5##3##(1993-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)
to consider that##4##3##(2008-7#1)(2010-11#1)(2012-3#1)(2013-8#1)
to consider the##12##3##(1997-1#1)(1997-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#1)(2013-8#2)
to consider their##2##3##(1994-5#1)(2008-11#1)
to consider when##5##3##(1991-12#1)(1995-2#1)(2008-11#2)(2009-10#1)
to considerable##4##2##(1990-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
to consist of a##2##4##(1993-6#1)(2008-11#1)
to consist of two##2##4##(1991-10#1)(2008-3#1)
to consist of##9##3##(1991-10#1)(1993-6#1)(2008-10#4)(2008-11#1)(2008-3#2)
to consistent##2##2##(2008-7#1)(2008-9#1)
to consistently##7##2##(1995-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-2#1)
to consolidate##2##2##(2008-10#1)(2008-11#1)
to conspecific##2##2##(1995-12#1)(2010-8#1)
to constant##6##2##(1996-8#1)(2008-10#3)(2008-3#1)(2012-4#1)
to constantly##2##2##(1993-2#1)(2008-8#1)
to constitute a##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
to constitute the##3##3##(1995-12#1)(1995-8#1)(2008-10#1)
to constitute##8##2##(1990-5#1)(1995-12#1)(1995-8#1)(2008-10#3)(2008-11#1)(2013-8#1)
to constitutively##2##2##(1993-12#1)(1995-12#1)
to constrain##2##2##(1991-12#1)(2008-9#1)
to construct a##26##3##(1992-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-6#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-3#1)(2012-2#1)
to construct an##5##3##(1997-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-5#1)
to construct the calibration##2##4##(2008-10#2)
to construct the##5##3##(2008-10#3)(2008-8#2)
to construct##57##2##(1992-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#20)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
to consult##4##2##(2008-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
to consume##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
to consumer##3##2##(1991-3#1)(1997-3#1)(2013-1#1)
to consumers and##2##3##(1994-2#1)(1996-2#1)
to consumers##5##2##(1992-1#1)(1994-2#1)(1996-2#1)(1997-3#2)
to consumption##2##2##(2008-11#1)(2008-8#1)
to contact##10##2##(1992-3#1)(1995-2#1)(2008-10#4)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
to contain a##4##3##(1992-12#1)(1993-9#1)(2008-10#1)(2008-11#1)
to contain an##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
to contain costs##3##3##(1991-1#1)(1992-12#1)(1994-3#1)
to contain the##10##3##(1991-12#1)(1991-5#2)(1993-6#1)(1994-9#1)(1996-12#1)(2008-10#4)
to contain##55##2##(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#3)(2008-10#17)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
to contamination##9##2##(1997-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)
to contemporary##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
to continue to##5##3##(1995-2#1)(1996-12#1)(2009-4#1)(2009-5#1)(2013-1#1)
to continue##24##2##(1991-3#1)(1993-12#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#2)
to continuing##2##2##(1993-3#1)(2008-10#1)
to continuous quality improvement##3##4##(1994-2#2)(1996-1#1)
to continuous##11##2##(1990-8#1)(1991-3#1)(1994-2#2)(1996-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-6#1)
to continuously generate##2##3##(2009-8#2)
to continuously##4##2##(1994-12#1)(2008-10#1)(2009-8#2)
to contract with##2##3##(1992-11#1)(1992-3#1)
to contract##5##2##(1992-11#1)(1992-3#1)(1992-4#1)(2009-1#1)(2011-2#1)
to contribute significantly to the##2##5##(2008-3#1)(2011-2#1)
to contribute to a##2##4##(2008-10#1)(2008-11#1)
to contribute to the##14##4##(1992-12#1)(1994-11#1)(1996-12#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)
to contribute to##29##3##(1991-5#1)(1992-12#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#3)(2009-12#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
to contribute##31##2##(1991-5#1)(1992-12#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-12#1)(2010-1#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)
to control a##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
to control and##3##3##(2008-12#1)(2011-3#1)(2012-6#1)
to control blue##2##3##(2008-10#2)
to control cell##2##3##(2008-11#1)(2009-10#1)
to control cells##3##3##(1994-3#1)(1994-8#1)(2008-11#1)
to control for the##3##4##(1993-2#1)(2008-9#1)(2012-2#1)
to control for##5##3##(1993-2#1)(1994-1#1)(2008-2#1)(2008-9#1)(2012-2#1)
to control health care##2##4##(1994-12#1)(1997-2#1)
to control late blight##2##4##(2008-10#2)
to control levels##5##3##(1994-5#1)(1995-12#1)(1996-12#2)(2010-5#1)
to control of##6##3##(1996-2#1)(2008-10#4)(2012-2#1)
to control pain and improve##2##5##(2008-10#1)(2010-11#1)
to control pain##4##3##(2008-10#2)(2010-11#2)
to control plant diseases##2##4##(2008-10#2)
to control take-all of wheat##2##5##(2008-10#2)
to control the disease##4##4##(2008-10#1)(2011-2#2)(2012-3#1)
to control the effect of##2##5##(2008-10#1)(2008-11#1)
to control the pH##2##4##(2008-10#2)
to control the rate##2##4##(2008-10#1)(2008-5#1)
to control the##45##3##(1992-12#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-7#2)(2008-10#15)(2008-11#6)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
to control their##2##3##(1994-8#1)(2008-5#1)
to control this##2##3##(2008-10#1)(2011-1#1)
to control values##4##3##(1991-5#1)(1994-5#1)(1995-8#1)(2013-1#1)
to control##185##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#6)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#4)(1997-7#3)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#54)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#8)(2008-7#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2012-6#1)(2012-8#1)(2013-1#6)(2013-8#2)
to controlling##3##2##(1994-1#1)(1997-1#1)(2008-11#1)
to controls with##2##3##(2008-11#1)(2010-4#1)
to controls##21##2##(1990-11#1)(1990-5#1)(1990-8#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
to conventional HPLC##2##3##(2008-10#2)
to conventional methods for##2##4##(2008-10#1)(2012-2#1)
to conventional methods##3##3##(2008-10#2)(2012-2#1)
to conventional therapy##3##3##(1993-11#1)(2011-2#1)(2012-12#1)
to conventional treatment##2##3##(2008-12#1)(2011-2#1)
to conventional##49##2##(1990-5#1)(1993-11#1)(1994-3#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to converge on a##2##4##(2008-9#1)(2009-6#1)
to convergent##2##2##(1997-7#1)(2011-2#1)
to convert the##5##3##(1995-11#1)(1997-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
to convert##16##2##(1993-12#2)(1995-11#1)(1995-12#1)(1997-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
to convey##3##2##(1997-3#1)(1997-4#1)(2008-11#1)
to cooperate with##4##3##(1990-2#1)(1996-2#1)(2009-10#1)(2011-1#1)
to cooperate##6##2##(1990-2#1)(1993-9#1)(1996-2#2)(2009-10#1)(2011-1#1)
to coordinate the##4##3##(1992-1#1)(2009-10#1)(2009-6#1)(2012-2#1)
to coordinate##10##2##(1991-7#1)(1992-1#1)(1995-12#2)(1997-2#1)(2008-9#1)(2009-10#1)(2009-6#2)(2012-2#1)
to copABCD##2##2##(2008-10#2)
to cope with the##3##4##(2008-10#1)(2008-11#2)
to cope with##11##3##(1994-12#1)(2008-10#1)(2008-11#5)(2008-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
to cope##16##2##(1994-12#1)(1995-9#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#5)(2008-7#1)(2010-10#3)(2011-2#1)(2013-8#1)
to copper and##2##3##(2008-10#1)(2013-8#1)
to copper##5##2##(2008-10#4)(2013-8#1)
to corn##2##2##(2008-10#2)
to coronary##4##2##(1991-12#1)(2008-11#2)(2010-9#1)
to correct for the##5##4##(1991-3#1)(2008-11#1)(2008-2#1)(2008-3#2)
to correct for##7##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-8#1)
to correct the##8##3##(1992-8#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)
to correct##28##2##(1991-3#1)(1992-8#1)(1995-12#1)(1997-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#6)(2008-6#1)(2009-8#1)(2012-2#3)(2013-8#1)
to correctly##6##2##(1993-12#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#2)
to correlate this##2##3##(2008-10#2)
to correlate with the risk of##2##6##(2008-9#1)(2009-12#1)
to correlate with the##3##4##(2008-10#1)(2008-9#1)(2009-12#1)
to correlate with##17##3##(1994-2#1)(1996-12#1)(2008-10#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#3)(2013-7#1)
to correlate##30##2##(1991-8#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-11#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-9#1)(2013-7#1)
to correspond to those##2##4##(1994-5#1)(2008-10#1)
to correspond to##10##3##(1991-11#2)(1994-5#1)(2008-10#6)(2008-11#1)
to corroborate##4##2##(2008-10#1)(2008-12#1)(2009-10#1)(2010-7#1)
to cortisol##2##2##(1997-1#1)(2010-2#1)
to cost##5##2##(1991-2#1)(1993-5#1)(1993-8#1)(1994-3#1)(1997-2#1)
to cost-effective##2##2##(1993-12#1)(2008-10#1)
to counsel##4##2##(1990-6#1)(2008-11#1)(2013-1#2)
to counter##3##2##(1996-8#1)(2008-5#1)(2008-6#1)
to counteract the##3##3##(1990-9#1)(2008-10#2)
to counteract##5##2##(1990-9#1)(1996-2#1)(2008-10#2)(2008-11#1)
to country##3##2##(1993-2#1)(1994-1#1)(2008-10#1)
to couple the##3##3##(2008-10#2)(2008-2#1)
to couple##10##2##(2008-10#3)(2008-2#1)(2009-8#1)(2010-4#1)(2012-2#4)
to coupling##2##2##(1992-3#1)(2008-10#1)
to covalent binding of##2##4##(1990-7#1)(2012-12#1)
to covalently##2##2##(1990-2#1)(2008-10#1)
to cover the##7##3##(1990-2#1)(1992-3#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-8#1)
to cover##15##2##(1990-2#1)(1991-2#2)(1992-3#1)(1993-3#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-7#1)
to create a new##3##4##(1991-1#1)(1992-1#1)(2008-11#1)
to create a##21##3##(1991-1#1)(1992-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-2#1)(2011-9#2)(2013-1#1)(2013-8#1)
to create an##5##3##(1997-3#1)(2008-10#2)(2010-10#1)(2012-2#1)
to create and##5##3##(1991-12#1)(2008-11#2)(2010-10#1)(2010-9#1)
to create awareness among##2##4##(2012-3#1)(2013-8#1)
to create awareness##4##3##(1992-12#1)(1997-6#1)(2012-3#1)(2013-8#1)
to create models##2##3##(2010-4#1)(2010-8#1)
to create new##2##3##(1996-3#1)(2010-4#1)
to create scale##2##3##(2008-8#1)(2009-11#1)
to create the##6##3##(1991-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-7#1)
to create##77##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-7#1)(2010-10#2)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-9#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
to creating##2##2##(1997-1#1)(2008-10#1)
to criminal##2##2##(2008-11#1)(2011-2#1)
to criterion##2##2##(1991-2#1)(1993-3#1)
to critical##5##2##(1993-3#1)(1997-2#1)(2008-11#2)(2008-9#1)
to critically review the##2##4##(2008-11#1)(2009-7#1)
to critically##6##2##(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-7#1)(2013-1#1)
to crop##4##2##(2007-8#1)(2008-10#2)(2008-12#1)
to crops##2##2##(2008-10#1)(2012-2#1)
to cross the##4##3##(2008-10#1)(2009-8#2)(2011-2#1)
to cross##9##2##(1992-12#1)(1992-9#1)(2008-10#3)(2009-8#2)(2011-2#1)(2013-1#1)
to crosslinking##2##2##(2008-10#1)(2012-2#1)
to crown rust were##2##4##(2008-10#2)
to crown rust##4##3##(2008-10#4)
to crown-7##2##2##(2008-10#2)
to crown-8##2##2##(2008-10#2)
to crystalline silica##2##3##(2009-12#2)
to cucumber##2##2##(2008-10#2)
to cues##2##2##(1993-6#1)(2010-8#1)
to cultivar##3##2##(2008-10#2)(2011-10#1)
to cultivars##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
to cultivate##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
to cultivated##3##2##(2008-10#2)(2008-12#1)
to cultural##2##2##(2008-1#1)(2008-11#1)
to culture the##3##3##(1992-5#2)(2008-10#1)
to culture##5##2##(1992-5#2)(2008-10#1)(2008-11#1)(2008-8#1)
to cultured##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
to cultures of##2##3##(1993-9#1)(2008-11#1)
to cultures##4##2##(1990-11#1)(1993-9#1)(2008-10#1)(2008-11#1)
to cumulative##3##2##(2008-10#3)
to cure##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
to current reproduction##3##3##(2008-8#3)
to current##20##2##(1996-1#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#5)(2009-7#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#4)
to currently##4##2##(1990-6#1)(2008-10#1)(2010-5#1)(2012-2#1)
to cut##3##2##(1991-9#1)(2008-10#1)(2008-9#1)
to cyclic##4##2##(2008-10#1)(2009-7#2)(2010-4#1)
to cyclists##3##2##(1990-6#3)
to cyclophosphamide##3##2##(1993-2#1)(2008-10#1)(2008-12#1)
to cystic##2##2##(1992-9#1)(2012-2#1)
to cytochrome##4##2##(1990-5#1)(1994-5#1)(2008-10#2)
to cytokine##2##2##(1996-12#1)(2008-10#1)
to cytoplasmic##3##2##(2008-10#2)(2008-9#1)
to cytosine##2##2##(1991-12#1)(1991-2#1)
to cytotoxic drugs##2##3##(2008-11#2)
to cytotoxic##6##2##(2008-11#4)(2008-7#1)(2013-1#1)
to d-lactic acid##2##3##(2008-11#2)
to daily activities##2##3##(2009-6#1)(2009-8#1)
to daily##4##2##(2008-10#1)(2009-6#1)(2009-8#1)(2010-12#1)
to damage in##2##3##(1996-12#1)(2008-10#1)
to damage the##2##3##(1996-1#1)(1996-2#1)
to damage##9##2##(1990-12#1)(1993-6#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)
to dark brown##2##3##(2008-10#2)
to dark skin##2##3##(2008-11#1)(2008-5#1)
to dark##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
to dasatinib##2##2##(2012-2#2)
to data from##2##3##(2008-7#1)(2008-9#1)
to data of##2##3##(1993-1#1)(2012-3#1)
to data on##2##3##(1995-3#1)(2008-8#1)
to data##24##2##(1991-3#1)(1993-1#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-6#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2012-3#2)
to date and##2##3##(2008-10#1)(2009-6#1)
to date have been##3##4##(1995-2#1)(2008-10#1)(2010-8#1)
to date have not##2##4##(2008-12#1)(2011-2#1)
to date have##8##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2010-8#1)(2011-2#2)
to date most##2##3##(2008-7#1)(2008-8#1)
to date of##2##3##(2008-4#1)(2013-1#1)
to date on the##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
to date on##4##3##(2008-10#2)(2008-4#1)(2012-2#1)
to date##91##2##(1990-11#1)(1990-12#1)(1990-6#2)(1991-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-9#1)(2007-11#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
to day 14##2##3##(2008-8#1)(2011-2#1)
to day##10##2##(1997-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#4)(2011-2#1)
to deal with a##2##4##(2008-3#2)
to deal with many of the##2##6##(1996-1#1)(2008-10#1)
to deal with students##2##4##(2008-11#1)(2012-3#1)
to deal with the##7##4##(1994-2#1)(1995-6#1)(1995-9#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-3#1)
to deal with these##4##4##(1996-1#1)(2008-11#2)(2010-10#1)
to deal with##33##3##(1991-3#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(2008-10#3)(2008-11#5)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
to deal##35##2##(1991-3#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
to death##14##2##(1990-11#1)(1991-12#1)(1995-1#1)(1995-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2010-8#1)(2011-2#1)(2013-1#1)
to debate##2##2##(2008-11#1)(2011-2#1)
to decay##2##2##(2008-10#2)
to decentralize##2##2##(2012-3#2)
to decentralized##2##2##(1992-12#1)(1994-2#1)
to decide the##2##3##(2008-10#1)(2008-11#1)
to decide whether the##2##4##(1993-2#1)(2008-11#1)
to decide whether##6##3##(1993-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
to decide##12##2##(1993-2#1)(1995-2#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-8#1)(2010-7#1)(2012-2#1)
to decipher the##3##3##(1997-9#1)(2008-10#1)(2009-8#1)
to decipher##5##2##(1997-9#1)(2008-10#2)(2009-8#1)(2010-8#1)
to decline in the##2##4##(1997-2#1)(2011-2#1)
to decline##8##2##(1990-2#1)(1995-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2010-10#1)(2011-2#1)
to decompose##6##2##(2008-10#4)(2008-11#1)(2008-8#1)
to decrease in the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
to decrease in##8##3##(1994-12#1)(1994-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)
to decrease the detection limit##3##5##(2008-10#3)
to decrease the incidence of##2##5##(1993-3#1)(2011-2#1)
to decrease the incidence##3##4##(1993-3#1)(2008-10#1)(2011-2#1)
to decrease the number of##2##5##(2011-2#1)(2012-3#1)
to decrease the risk of##4##5##(1991-2#1)(2008-12#1)(2008-4#1)(2008-6#1)
to decrease the##27##3##(1990-5#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-2#3)(2011-7#1)(2012-2#1)(2012-3#1)
to decrease with##4##3##(1996-3#1)(2008-10#2)(2008-5#1)
to decrease##73##2##(1990-5#3)(1991-2#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-11#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#5)(2011-7#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
to decreased##7##2##(1994-5#1)(1997-7#1)(2008-8#1)(2009-6#2)(2010-1#1)(2013-1#1)
to decreasing##4##2##(1994-5#1)(2008-1#1)(2009-8#1)(2010-7#1)
to dedifferentiate##2##2##(2008-11#1)(2008-9#1)
to deduce the##3##3##(2008-10#1)(2008-8#1)(2010-7#1)
to deduce##9##2##(1993-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2010-7#1)
to deep##2##2##(1992-3#1)(2013-8#1)
to defend themselves##2##3##(1993-3#1)(2008-10#1)
to defense and##2##3##(2008-8#1)(2009-8#1)
to define a##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
to define and##2##3##(1997-3#1)(2011-2#1)
to define specific##2##3##(1990-11#1)(2013-8#1)
to define the role of##2##5##(1990-12#1)(1995-2#1)
to define the role##3##4##(1990-12#1)(1992-12#1)(1995-2#1)
to define the##33##3##(1990-12#2)(1991-1#1)(1992-12#1)(1994-2#2)(1995-2#3)(1996-2#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-10#2)(2011-2#2)(2012-3#2)(2013-1#2)
to define##69##2##(1990-11#1)(1990-12#2)(1991-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#3)(1996-11#1)(1996-2#2)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#4)(2013-8#1)
to defined##6##2##(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
to defining##3##2##(1991-6#1)(1997-1#1)(1997-4#1)
to deform##2##2##(2009-7#2)
to deglycosylated##2##2##(1990-8#1)(1991-12#1)
to degradation by##2##3##(1993-3#1)(1995-8#1)
to degradation##7##2##(1990-5#1)(1993-3#1)(1995-8#1)(2008-10#2)(2008-3#1)(2008-4#1)
to degrade##12##2##(1990-2#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#2)
to delay or##2##3##(2008-10#1)(2011-2#1)
to delay the##4##3##(1995-12#1)(1996-3#1)(2008-5#1)(2012-3#1)
to delay##12##2##(1994-2#1)(1995-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
to delayed##7##2##(1997-3#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
to delays##2##2##(2008-5#1)(2009-8#1)
to delimit##2##2##(2008-10#2)
to delineate the##2##3##(1990-6#1)(2012-2#1)
to delineate##5##2##(1990-6#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
to deliver a##4##3##(2008-10#1)(2009-2#1)(2010-10#1)(2011-2#1)
to deliver and##2##3##(2008-8#1)(2010-10#1)
to deliver high##2##3##(1997-1#2)
to deliver the##4##3##(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
to deliver therapy##2##3##(2009-10#1)(2011-2#1)
to deliver##45##2##(1991-1#1)(1992-12#1)(1993-2#1)(1994-11#1)(1996-1#2)(1996-2#2)(1997-1#3)(1997-3#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#3)(2009-11#1)(2009-2#1)(2010-10#3)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)
to delivery##2##2##(1994-3#1)(2007-12#1)
to demand##3##2##(1990-9#1)(1995-12#1)(2008-11#1)
to demethylation inhibitor fungicides##2##4##(2008-10#2)
to demonstrate a##4##3##(1990-12#1)(1995-5#1)(2008-7#1)(2012-3#1)
to demonstrate how##4##3##(1992-2#1)(2008-4#1)(2008-6#1)(2008-8#1)
to demonstrate statistically##2##3##(1997-5#1)(2008-1#1)
to demonstrate that PptT##2##4##(2013-1#2)
to demonstrate that the##6##4##(1991-3#1)(1997-1#1)(2008-10#3)(2012-3#1)
to demonstrate that##20##3##(1991-2#1)(1991-3#2)(1991-5#1)(1994-2#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#3)(2013-8#1)
to demonstrate the antibacterial##2##4##(2008-5#2)
to demonstrate the applicability##2##4##(2008-10#1)(2008-3#1)
to demonstrate the capability##2##4##(2008-10#1)(2008-5#1)
to demonstrate the feasibility of the##3##6##(2008-11#1)(2008-3#2)
to demonstrate the feasibility of##8##5##(2008-10#4)(2008-11#1)(2008-3#2)(2013-1#1)
to demonstrate the high##2##4##(2008-10#2)
to demonstrate the performance of the##2##6##(2008-10#2)
to demonstrate the potential##3##4##(2008-12#1)(2008-3#1)(2008-8#1)
to demonstrate the reliability##2##4##(2008-10#1)(2012-3#1)
to demonstrate the use of##2##5##(1995-2#1)(2008-11#1)
to demonstrate the##49##3##(1990-5#1)(1994-11#1)(1995-2#1)(1995-5#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
to demonstrate their##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
to demonstrate whether##2##3##(2008-10#1)(2008-9#1)
to demonstrate##110##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-5#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#30)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
to density##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
to dental##3##2##(1991-6#1)(2008-1#1)(2011-2#1)
to dentin##2##2##(1990-2#1)(2013-1#1)
to deny##3##2##(1991-2#1)(1994-12#1)(2009-11#1)
to depend on the##8##4##(1991-1#1)(1992-12#1)(1994-11#1)(2008-10#3)(2008-7#1)(2008-8#1)
to depend on##14##3##(1991-1#1)(1992-12#1)(1992-5#1)(1994-11#1)(1995-2#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
to depend##16##2##(1991-1#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
to depict the##4##3##(1991-1#1)(2010-10#1)(2010-12#2)
to depict##5##2##(1991-1#1)(2010-10#1)(2010-12#2)(2012-12#1)
to deplete##2##2##(1995-12#1)(2008-9#1)
to depletion of##2##3##(2008-7#1)(2012-2#1)
to deploy##4##2##(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)
to depolarization##2##2##(1994-2#1)(2008-10#1)
to deposit the##2##3##(1994-12#1)(2008-10#1)
to deposit##4##2##(1994-12#1)(2008-10#3)
to depression##3##2##(2008-12#1)(2008-7#1)(2010-10#1)
to derivatize##2##2##(2008-10#2)
to derive a##5##3##(2007-12#1)(2008-10#3)(2011-2#1)
to derive the##7##3##(1995-9#1)(2008-11#1)(2008-3#3)(2008-8#1)(2012-2#1)
to derive##28##2##(1992-6#1)(1993-1#1)(1993-12#1)(1995-9#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-3#6)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
to describe a##8##3##(1990-9#1)(1994-1#1)(1994-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
to describe and##5##3##(1992-12#2)(2008-10#2)(2008-11#1)
to describe how##2##3##(1994-3#1)(2013-1#1)
to describe the basic##2##4##(2008-3#1)(2011-2#1)
to describe the dynamics of##2##5##(2008-10#1)(2012-3#1)
to describe the relationship between##2##5##(2008-10#1)(2010-8#1)
to describe the type##2##4##(2009-3#1)(2011-2#1)
to describe the##71##3##(1990-11#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-10#13)(2008-11#10)(2008-12#1)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
to describe their##3##3##(1993-1#1)(2008-12#1)(2012-2#1)
to describe this##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
to describe##144##2##(1990-11#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-8#2)(2007-8#1)(2008-10#26)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#7)(2011-3#1)(2011-7#1)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#1)
to describing##2##2##(1994-12#1)(2008-8#1)
to design a##6##3##(1992-3#1)(1993-12#1)(2008-10#3)(2008-5#1)
to design an##2##3##(1996-1#1)(2008-10#1)
to design and##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
to design new##3##3##(1997-3#1)(1997-6#1)(2008-5#1)
to design species-specific##2##3##(2008-10#2)
to design the##6##3##(1995-5#1)(2008-10#3)(2010-11#1)(2010-8#1)
to design##50##2##(1992-3#1)(1993-1#1)(1993-12#2)(1994-2#1)(1995-5#1)(1996-1#1)(1997-3#1)(1997-6#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-5#6)(2008-7#1)(2008-9#1)(2010-11#2)(2010-8#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to designate##2##2##(1991-3#1)(2008-9#1)
to desorb and##2##3##(2008-10#2)
to desorb##4##2##(2008-10#4)
to destabilize##2##2##(1991-9#1)(2012-2#1)
to destroy the##4##3##(2008-10#2)(2008-11#1)(2010-1#1)
to destroy##5##2##(1992-1#1)(2008-10#2)(2008-11#1)(2010-1#1)
to destruction of the##2##4##(1990-12#1)(2008-10#1)
to detached##2##2##(2008-10#2)
to detachment##2##2##(1996-9#1)(2008-11#1)
to detail##2##2##(2011-2#1)(2012-3#1)
to detect DNA of agents of human granulocytic anaplasmosis and monocytic##2##11##(2013-1#2)
to detect DNA##6##3##(1997-3#1)(2008-10#1)(2008-4#2)(2013-1#2)
to detect M##3##3##(2008-10#3)
to detect OTA in##2##4##(2008-10#2)
to detect P##3##3##(2008-10#2)(2008-12#1)
to detect PLRV##2##3##(2008-10#2)
to detect a given##2##4##(1992-9#1)(2008-7#1)
to detect a##7##3##(1992-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-3#1)
to detect all##2##3##(1996-12#1)(2008-10#1)
to detect an##4##3##(1992-8#1)(1992-9#1)(2008-1#1)(2010-10#1)
to detect and analyze##2##4##(2008-11#1)(2009-8#1)
to detect and quantify the##3##5##(2008-10#3)
to detect and quantify##10##4##(2008-10#9)(2008-5#1)
to detect and##26##3##(1991-6#1)(1993-2#1)(1994-3#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#2)(2013-8#1)
to detect any##8##3##(1993-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
to detect as little as 0##2##6##(2008-10#2)
to detect as little as##4##5##(2008-10#3)(2013-1#1)
to detect both##2##3##(2008-10#1)(2008-4#1)
to detect cell##2##3##(2008-4#1)(2008-9#1)
to detect changes in##2##4##(2008-10#1)(2008-3#1)
to detect changes##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
to detect fungal##2##3##(2008-10#2)
to detect latent##2##3##(2008-10#1)(2010-6#1)
to detect nitrite##2##3##(2008-10#2)
to detect or##2##3##(1991-2#1)(2008-4#1)
to detect small##3##3##(2008-10#3)
to detect specific##2##3##(1990-5#1)(2009-3#1)
to detect the DNA##3##4##(2008-10#2)(2013-1#1)
to detect the hybridization##2##4##(2008-10#2)
to detect the lead content in##2##6##(2008-10#2)
to detect the presence of##2##5##(2008-10#1)(2008-11#1)
to detect the##40##3##(1991-12#2)(1991-5#1)(1996-12#1)(2008-10#25)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)(2013-1#2)(2013-8#1)
to detect these##3##3##(1995-10#1)(2007-12#1)(2008-10#1)
to detect two##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
to detect##292##2##(1990-3#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-2#2)(1993-6#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-12#4)(1996-2#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#134)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#10)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#11)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#2)
to detection limit##2##3##(2008-10#2)
to detection of##3##3##(2008-10#2)(2013-1#1)
to detection##8##2##(2008-10#6)(2008-5#1)(2013-1#1)
to deter##2##2##(1993-12#1)(2012-2#1)
to determination of these##2##4##(2008-10#2)
to determination of trace##2##4##(2008-10#2)
to determination of##23##3##(2008-10#23)
to determination##26##2##(2008-10#26)
to determinations##2##2##(2008-10#2)
to determine Cys##2##3##(2008-10#2)
to determine a##5##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
to determine absolute##2##3##(2008-9#1)(2010-11#1)
to determine all the##2##4##(2008-10#2)
to determine aluminum##2##3##(2008-10#2)
to determine amounts of##2##4##(2008-10#2)
to determine an##2##3##(1992-12#1)(2008-10#1)
to determine and##2##3##(2009-8#1)(2010-8#1)
to determine aniline##2##3##(2008-10#2)
to determine any##3##3##(2008-10#2)(2009-8#1)
to determine both##5##3##(2008-10#4)(2008-3#1)
to determine by##2##3##(1993-9#1)(2008-10#1)
to determine changes in##2##4##(1991-2#1)(2008-10#1)
to determine chromium##3##3##(2008-10#3)
to determine compounds##2##3##(2008-10#2)
to determine copper##3##3##(2008-10#3)
to determine diclofenac in##2##4##(2008-10#2)
to determine diclofenac##3##3##(2008-10#3)
to determine effective##2##3##(1996-2#1)(2008-10#1)
to determine furosemide in##2##4##(2008-10#2)
to determine furosemide##3##3##(2008-10#3)
to determine genetic relationships##2##4##(2008-10#2)
to determine genetic##3##3##(2008-10#2)(2008-8#1)
to determine how well##3##4##(1995-5#1)(2007-12#1)(2010-1#1)
to determine how##20##3##(1990-3#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-2#1)(1995-5#1)(1996-1#1)(2007-12#3)(2008-10#6)(2008-11#3)(2010-1#1)
to determine if a##4##4##(1992-3#1)(1997-3#1)(2008-12#1)(2008-9#1)
to determine if the##16##4##(1990-2#1)(1991-2#1)(1992-2#1)(1994-2#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#2)(2013-8#1)
to determine if there is##2##5##(2010-1#1)(2012-3#1)
to determine if there##3##4##(2008-10#1)(2010-1#1)(2012-3#1)
to determine if these##3##4##(1997-3#1)(2008-10#2)
to determine if they##2##4##(1996-5#1)(2009-11#1)
to determine if##59##3##(1990-2#1)(1991-2#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#3)(1995-3#1)(1996-5#1)(1997-3#3)(1997-5#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
to determine its##3##3##(1994-11#1)(2008-10#1)(2012-3#1)
to determine mercury##3##3##(2008-10#3)
to determine optimum##2##3##(2008-10#1)(2008-3#1)
to determine organic pollutants##2##4##(2008-10#2)
to determine organic##3##3##(2008-10#3)
to determine possible##2##3##(2008-10#1)(2013-1#1)
to determine sites of##2##4##(1992-2#1)(2008-10#1)
to determine the ability of##2##5##(2008-11#1)(2012-3#1)
to determine the accuracy of##2##5##(1990-9#1)(2012-2#1)
to determine the active##2##4##(2008-10#2)
to determine the amino acid##2##5##(2008-10#1)(2010-4#1)
to determine the amount of##5##5##(2008-10#5)
to determine the apparent##2##4##(2008-10#2)
to determine the appropriate##2##4##(1994-12#1)(2008-5#1)
to determine the best##3##4##(2008-10#2)(2008-12#1)
to determine the characteristics of##2##5##(1995-12#1)(1996-9#1)
to determine the characteristics##3##4##(1995-12#1)(1996-9#1)(2011-2#1)
to determine the chromosomal##2##4##(2008-10#1)(2008-4#1)
to determine the composition of the##2##6##(1992-1#1)(2008-10#1)
to determine the composition of##5##5##(1990-9#1)(1992-1#1)(2008-10#2)(2008-3#1)
to determine the concentration of##9##5##(1991-12#1)(2008-10#7)(2008-9#1)
to determine the content of##4##5##(2008-10#4)
to determine the correlation##2##4##(1992-3#1)(2008-1#1)
to determine the critical##2##4##(2008-10#2)
to determine the degree of##2##5##(2008-10#1)(2008-5#1)
to determine the effect of the##2##6##(1997-1#1)(2013-1#1)
to determine the effect of##19##5##(1991-8#1)(1995-12#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2009-7#1)(2010-8#1)(2011-2#2)(2013-1#2)
to determine the effect on##2##5##(1997-8#1)(2008-10#1)
to determine the effect##21##4##(1991-8#1)(1995-12#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-12#3)(2009-7#1)(2010-8#1)(2011-2#2)(2013-1#2)
to determine the effects of a##2##6##(2008-1#1)(2012-3#1)
to determine the effects of the##2##6##(2008-5#1)(2011-2#1)
to determine the effects of##14##5##(1990-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to determine the exact##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
to determine the extent of##2##5##(2008-11#1)(2008-12#1)
to determine the extent##3##4##(1996-3#1)(2008-11#1)(2008-12#1)
to determine the factors##3##4##(1990-6#1)(1995-3#2)
to determine the function of##2##5##(2008-9#1)(2009-10#1)
to determine the genetic##4##4##(2008-10#4)
to determine the identity and##2##5##(2008-10#1)(2012-2#1)
to determine the identity##3##4##(1992-9#1)(2008-10#1)(2012-2#1)
to determine the impact of##5##5##(1993-2#1)(1995-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
to determine the in vitro##2##5##(2008-5#1)(2008-8#1)
to determine the in##3##4##(1994-5#1)(2008-5#1)(2008-8#1)
to determine the incidence##2##4##(1991-11#1)(2013-1#1)
to determine the indices of refraction of liquids##2##8##(2008-3#2)
to determine the influence of different##2##6##(2008-10#1)(2011-2#1)
to determine the influence of the##3##6##(1996-5#1)(2008-11#1)(2011-2#1)
to determine the influence of##10##5##(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#4)
to determine the interactions##2##4##(2008-10#2)
to determine the kinetic parameters##2##5##(1994-5#1)(2008-10#1)
to determine the kinetics##2##4##(1995-12#1)(2008-9#1)
to determine the level of##4##5##(1993-3#1)(1994-6#1)(2008-10#1)(2013-8#1)
to determine the levels of##2##5##(1993-3#1)(2008-12#1)
to determine the long-term##2##4##(1996-12#1)(2008-8#1)
to determine the most##2##4##(2008-10#2)
to determine the number and##2##5##(2008-10#2)
to determine the number of##7##5##(1993-3#1)(1994-5#1)(2008-10#2)(2008-4#2)(2013-1#1)
to determine the number##9##4##(1993-3#1)(1994-5#1)(2008-10#4)(2008-4#2)(2013-1#1)
to determine the optimal##5##4##(2008-10#3)(2008-11#1)(2012-3#1)
to determine the optimum conditions for the##2##7##(2008-10#2)
to determine the optimum conditions for##3##6##(2008-10#3)
to determine the optimum##4##4##(2008-10#4)
to determine the overall##3##4##(2008-10#3)
to determine the potential##2##4##(2008-7#1)(2013-8#1)
to determine the presence of##4##5##(1994-11#1)(2008-10#1)(2008-2#1)(2010-1#1)
to determine the presence##5##4##(1994-11#1)(2008-10#2)(2008-2#1)(2010-1#1)
to determine the prevalence of##9##5##(1996-12#1)(2008-10#1)(2008-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to determine the proportion##2##4##(2012-12#2)
to determine the rate##3##4##(2008-10#2)(2013-1#1)
to determine the relationship between the##3##6##(2008-10#2)(2008-12#1)
to determine the relationship between##5##5##(2008-10#3)(2008-12#2)
to determine the relationship##6##4##(2008-10#3)(2008-12#2)(2011-1#1)
to determine the relationships between##2##5##(1995-2#1)(2010-2#1)
to determine the relative contributions of##2##6##(2008-10#1)(2008-9#1)
to determine the relative##6##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
to determine the relevance of##3##5##(1990-3#1)(1996-2#1)(2008-10#1)
to determine the requirements##2##4##(2008-10#1)(2013-1#1)
to determine the resistance to##2##5##(2008-5#1)(2008-7#1)
to determine the role of##4##5##(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
to determine the role that##2##5##(1993-1#1)(1996-3#1)
to determine the role##7##4##(1993-1#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
to determine the sensitivity##2##4##(1993-3#1)(2012-6#1)
to determine the spatial##3##4##(2008-10#3)
to determine the stability constants of the MA and MA(2) complex species formed##2##13##(2008-10#2)
to determine the stability constants of the##3##7##(2008-10#3)
to determine the stability##4##4##(2008-10#4)
to determine the structural##2##4##(1993-2#1)(2008-9#1)
to determine the structure of##2##5##(1992-9#1)(1995-8#1)
to determine the trends##2##4##(2008-10#1)(2012-12#1)
to determine the value##2##4##(1993-2#1)(2008-10#1)
to determine the##429##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#5)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#174)(2008-11#14)(2008-12#15)(2008-2#6)(2008-3#15)(2008-4#6)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#11)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#16)(2012-12#3)(2012-2#7)(2012-3#7)(2012-6#1)(2013-1#19)(2013-3#1)(2013-8#7)
to determine their concentrations##2##4##(2008-10#1)(2012-2#1)
to determine their efficacy in##2##5##(2011-2#1)(2013-7#1)
to determine their functional##2##4##(2007-12#1)(2012-2#1)
to determine their genetic##2##4##(2008-10#2)
to determine their morphological##2##4##(2008-10#1)(2008-12#1)
to determine their##28##3##(1990-5#1)(1991-2#1)(1995-10#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#1)
to determine thermodynamic##2##3##(1993-8#1)(2008-10#1)
to determine these##3##3##(2008-10#3)
to determine this##2##3##(2008-10#1)(2008-2#1)
to determine to what extent##2##5##(2008-10#1)(2011-1#1)
to determine total##2##3##(2008-10#2)
to determine trace##5##3##(2008-10#5)
to determine traces of##3##4##(2008-10#3)
to determine what##7##3##(1991-2#1)(1994-12#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
to determine when##2##3##(2008-10#1)(2008-12#1)
to determine whether a##2##4##(1996-6#1)(2009-12#1)
to determine whether different##2##4##(2010-2#1)(2012-3#1)
to determine whether it is##2##5##(2008-5#1)(2008-6#1)
to determine whether such##2##4##(2008-10#1)(2013-1#1)
to determine whether the##15##4##(1990-8#1)(1992-10#1)(1993-8#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)
to determine whether there was##2##5##(1995-12#1)(2007-12#1)
to determine whether there##4##4##(1995-12#1)(2007-12#1)(2008-7#1)(2010-7#1)
to determine whether these##2##4##(1997-7#1)(2008-12#1)
to determine whether this##3##4##(1991-8#1)(2008-8#1)(2013-1#1)
to determine whether##83##3##(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-2#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#2)
to determine which operational parameters should be included in the optimization##2##11##(2008-10#2)
to determine which##16##3##(1991-6#1)(1994-2#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
to determine##969##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#6)(1990-6#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#7)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#6)(1993-3#6)(1993-8#7)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#6)(1994-2#5)(1994-3#4)(1994-5#3)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#3)(1996-12#6)(1996-2#2)(1996-3#5)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#4)(2008-10#446)(2008-11#41)(2008-12#25)(2008-2#11)(2008-3#20)(2008-4#10)(2008-5#24)(2008-6#6)(2008-7#16)(2008-8#11)(2008-9#17)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#6)(2011-1#4)(2011-2#32)(2012-12#3)(2012-2#15)(2012-3#11)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#29)(2013-3#1)(2013-7#3)(2013-8#13)
to determining the##4##3##(2008-10#2)(2008-8#1)(2010-11#1)
to determining##5##2##(2008-10#3)(2008-8#1)(2010-11#1)
to detoxify##2##2##(1994-11#1)(2010-5#1)
to develop a better understanding of##2##6##(2008-7#1)(2010-9#1)
to develop a better##3##4##(2008-7#1)(2010-9#1)(2012-2#1)
to develop a comprehensive##2##4##(1994-12#1)(2013-1#1)
to develop a detailed##2##4##(2008-8#1)(2009-12#1)
to develop a fully##2##4##(2008-10#1)(2008-9#1)
to develop a method for##2##5##(2009-8#1)(2012-4#1)
to develop a model for##2##5##(1996-3#1)(2008-10#1)
to develop a new##7##4##(2008-10#2)(2008-5#1)(2008-6#1)(2009-7#1)(2012-2#1)(2013-1#1)
to develop a novel##2##4##(2008-10#2)
to develop a rapid##3##4##(2008-10#3)
to develop a reliable##3##4##(1990-5#1)(2008-10#1)(2013-1#1)
to develop a simple and##2##5##(2008-10#1)(2008-5#1)
to develop a simple##7##4##(2008-10#5)(2008-5#2)
to develop a solid##2##4##(2008-10#2)
to develop a vaccine against##2##5##(2009-6#1)(2010-1#1)
to develop a##92##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-6#1)(2008-10#27)(2008-11#13)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-4#1)(2013-1#4)(2013-8#1)
to develop an efficient##3##4##(2008-10#1)(2008-11#2)
to develop an##32##3##(1991-9#1)(1993-3#2)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-6#1)(2010-8#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
to develop and apply##2##4##(2008-10#1)(2012-12#1)
to develop and evaluate a##2##5##(2008-10#1)(2010-7#1)
to develop and evaluate##4##4##(2008-10#1)(2008-11#2)(2010-7#1)
to develop and implement a##3##5##(1991-12#1)(1995-2#1)(2013-1#1)
to develop and##19##3##(1991-12#1)(1991-3#1)(1995-2#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
to develop clinical##2##3##(1993-12#1)(2008-12#1)
to develop critical##2##3##(2008-12#2)
to develop effective##2##3##(2008-10#1)(2008-12#1)
to develop efficient##2##3##(2008-10#1)(2009-8#1)
to develop fully##2##3##(1997-2#1)(2008-11#1)
to develop methods##3##3##(1991-12#1)(2008-12#1)(2012-12#1)
to develop molecular##3##3##(1994-5#1)(2008-10#1)(2010-3#1)
to develop more##5##3##(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#2)
to develop new agents##2##4##(2008-10#2)
to develop new drugs##2##4##(2009-6#1)(2010-12#1)
to develop new##8##3##(1992-3#1)(1994-5#1)(2008-10#2)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#1)
to develop novel##2##3##(2008-10#1)(2008-5#1)
to develop on##2##3##(2008-10#2)
to develop preventive##2##3##(2008-10#1)(2012-2#1)
to develop skills##3##3##(1993-12#1)(2008-11#2)
to develop strategies for##2##4##(2008-10#1)(2008-11#1)
to develop strategies##3##3##(2008-10#2)(2008-11#1)
to develop such a##2##4##(2008-10#1)(2013-1#1)
to develop such##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
to develop the instrument##2##4##(2008-10#2)
to develop the##16##3##(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-8#1)
to develop their competencies##2##4##(2008-12#1)(2013-1#1)
to develop their professional##2##4##(2008-1#1)(2008-11#1)
to develop their##5##3##(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#1)
to develop therapeutics##2##3##(2008-5#1)(2013-1#1)
to develop therapies##2##3##(2008-11#1)(2008-7#1)
to develop this##2##3##(2008-10#2)
to develop training##2##3##(1996-3#1)(2008-12#1)
to develop two##2##3##(2008-10#1)(2008-11#1)
to develop##353##2##(1990-12#2)(1990-5#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#2)(1994-1#1)(1994-12#2)(1994-3#4)(1994-5#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#3)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-6#1)(2008-1#2)(2008-10#100)(2008-11#44)(2008-12#17)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#15)(2012-3#2)(2012-4#1)(2013-1#11)(2013-8#6)
to developing a##2##3##(1993-2#1)(2008-11#1)
to developing##14##2##(1993-2#1)(1996-3#1)(2008-10#1)(2008-11#3)(2010-12#2)(2010-8#2)(2011-1#1)(2012-2#2)(2013-1#1)
to development of##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
to development##10##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
to developmental##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2010-9#1)
to devise a##2##3##(2008-10#2)
to devise strategies that would minimize incidence of this complication in the future##2##13##(2013-1#2)
to devise##6##2##(1994-1#1)(2008-10#2)(2008-11#1)(2013-1#2)
to devote##3##2##(1994-1#1)(2008-7#1)(2008-8#1)
to diabetes##6##2##(1994-12#1)(1994-6#1)(2008-11#1)(2010-5#1)(2012-3#1)(2013-8#1)
to diabetic##2##2##(1995-9#1)(1997-8#1)
to diagnose and treat##2##4##(1995-5#1)(2011-2#1)
to diagnose and##7##3##(1995-5#1)(1997-1#1)(2008-10#2)(2011-2#2)(2013-8#1)
to diagnose or##2##3##(2010-5#1)(2011-2#1)
to diagnose this syndrome##2##4##(1994-12#1)(2011-2#1)
to diagnose this##3##3##(1994-12#1)(2009-12#1)(2011-2#1)
to diagnose##42##2##(1990-6#1)(1992-12#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#1)(2008-10#7)(2008-7#3)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#6)(2012-3#3)(2013-1#2)(2013-8#1)
to diagnosis and treatment##2##4##(2008-7#1)(2011-2#1)
to diagnosis and##4##3##(2008-7#1)(2009-9#1)(2011-2#2)
to diagnosis##12##2##(1990-12#1)(1990-6#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#5)(2013-1#1)
to diagnostic##5##2##(1991-12#1)(1993-12#1)(1997-6#1)(2008-2#1)(2013-1#1)
to dialysis##4##2##(1994-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
to dibutyltin dichloride##2##3##(2008-10#2)
to dichloroacetic acid##9##3##(2008-9#9)
to die as##2##3##(1995-2#1)(2008-10#1)
to die##9##2##(1994-2#1)(1995-10#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-8#1)
to dietary##8##2##(1991-2#1)(1994-2#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#2)
to differ between##2##3##(1991-5#1)(1993-8#1)
to differ from##3##3##(2008-10#2)(2011-2#1)
to differ in their##2##4##(1996-12#1)(2009-12#1)
to differ##8##2##(1991-11#1)(1991-5#1)(1993-8#1)(1996-12#1)(2008-10#2)(2009-12#1)(2011-2#1)
to differences among##2##3##(2008-10#2)
to differences between##2##3##(2008-10#2)
to differences in the##5##4##(1991-11#1)(1993-11#1)(1997-2#1)(2008-10#1)(2009-12#1)
to differences in their##2##4##(2008-10#2)
to differences in##24##3##(1991-11#1)(1993-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#2)(2012-3#1)
to differences##31##2##(1991-11#1)(1993-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#16)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-7#2)(2012-3#2)
to different concentrations of##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
to different degrees for##2##4##(1994-5#1)(2008-10#1)
to different degrees##3##3##(1994-5#1)(2008-10#1)(2008-12#1)
to different environments##3##3##(2008-9#1)(2011-2#2)
to different extent##2##3##(1995-12#1)(2008-9#1)
to different extents##2##3##(2008-10#1)(2008-7#1)
to different hosts##3##3##(2008-10#3)
to different kinds of##2##4##(1996-6#1)(2008-10#1)
to different levels##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
to different pathogens##3##3##(2006-5#1)(2008-10#2)
to different physiological##2##3##(2008-10#1)(2010-12#1)
to different##116##2##(1990-8#1)(1991-1#2)(1991-7#1)(1992-6#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-7#2)(2006-5#1)(2008-10#41)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#1)
to differential##9##2##(1991-5#1)(2008-10#3)(2008-2#4)(2010-12#1)
to differentiate among##4##3##(1994-1#1)(2008-10#3)
to differentiate and##2##3##(2008-10#1)(2008-8#1)
to differentiate between##8##3##(1994-9#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-10#1)
to differentiate by##2##3##(1993-3#1)(2008-12#1)
to differentiate in vitro into##2##5##(2008-11#2)
to differentiate in vitro##3##4##(1995-2#1)(2008-11#2)
to differentiate in##4##3##(1995-2#1)(2008-11#2)(2013-1#1)
to differentiate into basophils##2##4##(2008-11#2)
to differentiate into##10##3##(2008-11#5)(2008-7#1)(2008-9#2)(2010-11#1)(2012-4#1)
to differentiate it from other##2##5##(1994-6#1)(2012-3#1)
to differentiate spontaneously##2##3##(1990-5#2)
to differentiate the##9##3##(2008-10#5)(2008-12#1)(2009-10#1)(2012-5#1)(2013-1#1)
to differentiate these##2##3##(2008-11#1)(2008-9#1)
to differentiate##68##2##(1990-5#2)(1991-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#18)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-4#1)(2012-5#2)(2013-1#3)
to differentiation##4##2##(2008-4#1)(2008-8#1)(2011-2#2)
to diffusion##3##2##(1997-1#1)(2008-10#1)(2008-9#1)
to digital##2##2##(2011-1#1)(2011-2#1)
to diminish##2##2##(1991-8#1)(1995-3#1)
to direct stimulation of##2##4##(2008-10#1)(2008-11#1)
to direct sunlight##2##3##(1994-1#1)(2008-10#1)
to direct the##5##3##(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)
to direct transcription of##2##4##(1993-12#1)(1994-2#1)
to direct##38##2##(1990-2#1)(1991-6#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#2)(2010-11#2)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
to directional##2##2##(2008-11#1)(2008-3#1)
to directly determine##2##3##(2008-10#2)
to directly measure##3##3##(1992-9#1)(2008-10#1)(2008-4#1)
to directly target the##2##4##(1997-1#1)(2010-7#1)
to directly##20##2##(1992-9#2)(1994-11#1)(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)
to disaggregate##2##2##(1992-12#1)(2008-10#1)
to disappear##2##2##(2008-11#2)
to discern##5##2##(2008-10#2)(2008-9#1)(2013-1#2)
to discharge service members##2##4##(1995-6#1)(1996-5#1)
to discharge##6##2##(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-4#1)
to disclose##4##2##(1990-12#1)(1991-12#1)(1995-2#1)(2008-12#1)
to discomfort##2##2##(2008-12#1)(2009-1#1)
to discontinue##6##2##(1991-2#1)(1991-3#1)(1993-12#1)(2008-7#1)(2009-7#1)(2012-2#1)
to discount the##2##3##(2009-7#1)(2009-9#1)
to discover the##4##3##(1993-1#1)(1995-3#1)(2008-11#1)(2012-3#1)
to discover##15##2##(1993-1#1)(1994-12#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-12#1)(2010-5#2)(2012-2#1)(2012-3#2)
to discrete##4##2##(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#1)
to discriminate against##4##3##(1994-2#1)(1994-3#1)(2008-8#2)
to discriminate between the##2##4##(2008-10#1)(2008-11#1)
to discriminate between##14##3##(1991-3#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#1)
to discriminate symmetry##2##3##(2008-8#2)
to discriminate##43##2##(1991-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-12#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)
to discuss some##2##3##(1991-1#1)(2008-7#1)
to discuss the##14##3##(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
to discuss##33##2##(1991-1#1)(1996-2#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-4#1)(2010-7#1)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
to discussion##2##2##(1994-12#1)(2008-10#1)
to discussions##2##2##(1996-8#1)(2008-11#1)
to disease and##4##3##(1997-7#1)(2008-10#2)(2008-8#1)
to disease development##4##3##(2008-10#4)
to disease incidence##4##3##(2008-10#4)
to disease management programs##2##4##(2008-10#1)(2008-11#1)
to disease management##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
to disease risk assessment##2##4##(2008-10#2)
to disease severity##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
to disease suppression##4##3##(2008-10#4)
to disease##48##2##(1994-9#2)(1997-7#1)(2007-12#1)(2008-10#30)(2008-11#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)
to diseases##3##2##(2008-10#1)(2008-8#1)(2010-1#1)
to disentangle the##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
to disentangle##4##2##(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
to dismantle##2##2##(1993-5#1)(1994-12#1)
to dismiss##3##2##(1995-12#1)(1995-6#1)(1996-5#1)
to disparate##2##2##(1997-9#1)(2008-7#1)
to dispense a##3##3##(1995-1#2)(1996-1#1)
to dispense##4##2##(1995-1#2)(1996-1#1)(1997-7#1)
to dispersal##3##2##(2008-8#3)
to disperse##4##2##(2008-10#2)(2008-8#2)
to displace##4##2##(1992-3#1)(1994-12#1)(2008-8#2)
to displacement##2##2##(2008-8#2)
to display##15##2##(1990-12#1)(1995-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#3)(2012-2#2)
to disrupt the##6##3##(1990-7#1)(1991-3#1)(1994-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
to disrupt##9##2##(1990-7#1)(1991-2#1)(1991-3#1)(1994-11#1)(1994-9#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
to dissect the##2##3##(2009-8#1)(2011-2#1)
to disseminate##3##2##(1991-1#1)(2008-11#1)(2013-1#1)
to dissociate##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
to dissolve##2##2##(1994-8#1)(2008-9#1)
to distal##3##2##(2010-1#1)(2012-3#1)(2013-3#1)
to distance and##2##3##(2008-10#1)(2011-2#1)
to distance##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
to distinct##10##2##(1992-4#1)(1993-3#1)(1994-5#1)(1995-2#1)(2007-12#1)(2008-10#2)(2010-5#1)(2010-8#1)(2013-1#1)
to distinguish a##3##3##(2008-3#1)(2008-5#2)
to distinguish among##4##3##(1993-6#1)(2008-10#1)(2008-8#2)
to distinguish and##2##3##(2008-4#1)(2010-4#1)
to distinguish between the##3##4##(2008-10#2)(2009-12#1)
to distinguish between##20##3##(1993-2#1)(1994-3#1)(2008-10#11)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
to distinguish the two##2##4##(2008-10#1)(2008-11#1)
to distinguish the##7##3##(2008-10#5)(2008-11#1)(2008-12#1)
to distinguish whether##2##3##(2008-10#1)(2011-2#1)
to distinguish##71##2##(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-3#2)(1997-3#1)(2008-10#33)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#3)
to distinguishing##2##2##(1991-1#1)(2008-10#1)
to distress##2##2##(1990-12#1)(2013-7#1)
to distributed##2##2##(2007-11#1)(2012-2#1)
to disturbance##7##2##(2008-8#7)
to divalent ions##2##3##(2008-10#2)
to divalent##3##2##(1990-5#1)(2008-10#2)
to diverge##3##2##(1993-12#1)(2008-9#1)(2010-12#1)
to divergent##4##2##(1993-12#1)(1997-7#1)(2011-2#1)(2012-3#1)
to diverse##8##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)
to diversify##2##2##(2008-11#2)
to diversity##3##2##(1994-12#1)(2008-10#2)
to do a##2##3##(2008-8#1)(2013-8#1)
to do it##2##3##(1994-1#1)(1995-12#1)
to do so##11##3##(1993-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-11#3)(2008-8#1)(2008-9#1)(2012-2#1)(2012-6#1)
to do the##2##3##(2008-10#1)(2012-2#1)
to do this##3##3##(2008-10#2)(2008-11#1)
to do with the##2##4##(2008-5#1)(2010-12#1)
to do with##6##3##(1991-1#1)(1994-3#1)(1997-5#1)(2008-5#1)(2008-9#1)(2010-12#1)
to do##44##2##(1991-1#2)(1991-3#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-1#3)(1997-5#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-9#2)(2010-12#2)(2012-12#1)(2012-2#3)(2012-6#1)(2013-8#1)
to document and##2##3##(1995-3#1)(2008-10#1)
to document the presence of##2##5##(2010-6#1)(2011-2#1)
to document the##5##3##(1996-6#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)
to document##11##2##(1995-3#1)(1996-3#1)(1996-6#1)(2008-10#4)(2008-11#1)(2010-1#1)(2010-6#1)(2011-2#1)
to dodine##3##2##(2008-10#3)
to dominate the##2##3##(2008-10#1)(2008-11#1)
to donate##2##2##(1992-8#1)(2009-3#1)
to dopamine##7##2##(1992-12#1)(1994-2#1)(1995-8#1)(1996-2#1)(2008-10#1)(2009-12#1)(2010-12#1)
to doping##2##2##(2008-10#1)(2009-11#1)
to dose##3##2##(1997-2#1)(2008-10#2)
to double##3##2##(1996-12#1)(2009-10#1)(2012-3#1)
to double-stranded##2##2##(1995-11#1)(2008-10#1)
to downy mildew##4##3##(2008-10#4)
to doxorubicin##3##2##(1990-2#1)(1991-6#1)(2008-11#1)
to drain##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
to dramatically##2##2##(2008-10#1)(2010-12#1)
to draw attention to##3##4##(1990-9#1)(2011-1#1)(2011-2#1)
to draw the##2##3##(1991-6#1)(1994-12#1)
to draw up##2##3##(1997-5#1)(2008-11#1)
to draw##15##2##(1990-9#1)(1991-6#1)(1992-11#1)(1994-12#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-11#2)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-8#1)
to drink##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
to drinking water##9##3##(1992-5#1)(1993-8#1)(2008-10#1)(2008-9#6)
to drive the##8##3##(2008-10#2)(2008-11#2)(2008-8#2)(2009-8#1)(2010-5#1)
to drive##17##2##(1997-8#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-8#3)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-3#1)
to drop##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
to drought and##2##3##(2012-5#1)(2012-7#1)
to drought##11##2##(2008-10#1)(2008-12#2)(2008-8#1)(2012-5#2)(2012-7#3)(2012-8#2)
to drug treatment##2##3##(1996-9#1)(2008-11#1)
to drug##10##2##(1991-3#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-3#2)(2012-2#1)
to drugs##8##2##(1991-2#1)(1993-11#1)(1994-9#1)(1997-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
to dry out##2##3##(2008-10#1)(2008-9#1)
to dry wines##2##3##(2008-10#2)
to dry##9##2##(2008-10#8)(2008-9#1)
to drying##2##2##(2010-7#1)(2012-2#1)
to dryness on a##2##4##(2008-10#2)
to dryness##12##2##(2008-10#12)
to duplex##2##2##(1991-3#1)(2008-12#1)
to dural##2##2##(2008-7#1)(2012-3#1)
to duration of##2##3##(1992-2#1)(1996-12#1)
to dye##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
to dynamic##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
to dynamical##2##2##(2008-8#1)(2010-8#1)
to each electrical##2##3##(1994-2#1)(1997-4#1)
to each individual##2##3##(2008-10#1)(2010-8#1)
to each of the three##2##5##(2008-10#2)
to each of the##15##4##(1993-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-9#1)(2008-10#6)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
to each of these##4##4##(2008-10#3)(2008-7#1)
to each of##19##3##(1993-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-9#1)(2008-10#9)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
to each other and to the##2##6##(2008-10#1)(2013-1#1)
to each other and##10##4##(1993-3#1)(1996-3#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
to each other but##3##4##(1995-2#1)(1997-3#1)(2008-10#1)
to each other than are##2##5##(1993-6#1)(2008-8#1)
to each other than##4##4##(1993-6#1)(2008-10#2)(2008-8#1)
to each other##42##3##(1991-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#2)(2006-6#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
to each patient##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
to each##111##2##(1990-12#2)(1991-12#1)(1991-2#1)(1991-6#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(1997-9#1)(2006-6#1)(2008-10#37)(2008-11#11)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
to ear##2##2##(2008-10#2)
to earlier##5##2##(1993-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
to early stages of##2##4##(1997-8#1)(2008-10#1)
to early##18##2##(1992-9#1)(1993-8#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-5#2)(2009-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#2)
to ease##2##2##(2008-9#1)(2009-9#1)
to easily##5##2##(1992-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
to eat it##3##3##(1993-6#3)
to eat##7##2##(1992-9#1)(1993-6#3)(2010-4#1)(2010-7#1)(2011-2#1)
to economic##4##2##(1994-2#1)(1997-2#1)(2008-11#1)(2011-2#1)
to edges##2##2##(2008-9#2)
to editorial##5##2##(1993-12#1)(1993-9#1)(2010-12#3)
to educate and##2##3##(1995-12#1)(1997-6#1)
to educate patients##2##3##(2007-9#1)(2010-4#1)
to educate##16##2##(1993-12#2)(1994-1#2)(1995-12#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-9#1)(2008-11#1)(2008-12#4)(2010-4#1)(2010-5#1)
to education##3##2##(1995-2#1)(2008-11#1)(2008-12#1)
to effect##7##2##(1992-3#1)(1994-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-9#1)
to effective therapeutic##2##3##(1994-11#1)(2008-7#1)
to effective##9##2##(1990-9#1)(1994-1#1)(1994-11#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
to effectively produce##2##3##(2008-10#1)(2008-11#1)
to effectively represent the##2##4##(2008-11#1)(2013-1#1)
to effectively##26##2##(1992-9#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-5#1)(2007-11#2)(2008-10#4)(2008-11#5)(2008-3#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-3#1)(2012-2#1)(2013-1#2)
to effects##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
to effectuate##2##2##(1990-11#1)(2008-10#1)
to efficacy##2##2##(1995-5#1)(2008-5#1)
to efficient##4##2##(1996-2#1)(1996-3#1)(2008-10#1)(2008-6#1)
to efficiently##6##2##(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)
to efforts##2##2##(2008-11#1)(2011-2#1)
to egg##2##2##(2008-10#1)(2008-8#1)
to eggs##4##2##(2007-12#1)(2008-10#1)(2008-8#2)
to eight different##2##3##(2008-10#2)
to eight##14##2##(1997-2#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-9#2)
to eightfold##2##2##(1997-7#1)(2008-10#1)
to either a##6##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#1)
to either enhance or suppress##2##5##(2009-8#1)(2011-2#1)
to either enhance##3##3##(2009-7#1)(2009-8#1)(2011-2#1)
to either the##9##3##(1994-5#2)(1997-6#1)(2008-10#3)(2008-11#2)(2009-11#1)
to either##63##2##(1990-12#3)(1991-12#2)(1991-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-11#1)(1996-5#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
to ejaculation##2##2##(1992-12#1)(1994-2#1)
to elaborate##2##2##(2008-10#1)(2010-1#1)
to elder abuse##2##3##(1991-2#2)
to elder##3##2##(1991-2#2)(1994-2#1)
to electric##2##2##(1997-6#1)(2008-7#1)
to electrical stimulation##3##3##(1990-5#1)(1993-3#1)(2008-7#1)
to electrical##7##2##(1990-5#1)(1990-9#1)(1991-5#1)(1993-3#1)(1994-8#1)(2008-10#1)(2008-7#1)
to electrochemical##2##2##(2008-10#2)
to electrode##3##2##(2008-10#3)
to electron##3##2##(1991-5#2)(1992-12#1)
to electronic##4##2##(2008-10#1)(2008-11#2)(2010-1#1)
to electrophoretic homogeneity##3##3##(1993-8#1)(1994-8#1)(2008-10#1)
to electrophoretic##4##2##(1993-8#1)(1994-8#1)(1997-2#1)(2008-10#1)
to elemental##2##2##(2008-10#2)
to elevate the##3##3##(1993-12#1)(2008-10#1)(2008-6#1)
to elevate##8##2##(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-8#1)(2008-10#2)(2008-6#1)
to elevated##6##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-7#1)(2013-8#1)
to elicit a##2##3##(1993-12#1)(1995-11#1)
to elicit the##4##3##(1991-2#1)(2008-11#1)(2009-5#1)(2013-8#1)
to elicit##23##2##(1991-2#1)(1992-2#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-12#2)(2008-10#3)(2008-11#3)(2008-5#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
to elicitins##2##2##(2008-10#2)
to eliminate or##2##3##(2007-12#1)(2010-11#1)
to eliminate sample matrix interferences##2##5##(2008-10#2)
to eliminate the##10##3##(2007-12#1)(2008-10#6)(2008-3#1)(2008-8#1)(2010-11#1)
to eliminate##29##2##(1994-12#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
to elimination##2##2##(1996-5#1)(2011-2#1)
to elite##2##2##(2008-10#1)(2009-1#1)
to elucidate the functional role of##2##6##(1993-3#1)(1995-6#1)
to elucidate the functional##3##4##(1993-3#1)(1994-3#1)(1995-6#1)
to elucidate the influence of##2##5##(2009-7#1)(2012-6#1)
to elucidate the mechanism##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
to elucidate the mechanisms of##2##5##(2008-10#1)(2012-12#1)
to elucidate the mechanisms##5##4##(1995-8#1)(1997-3#1)(2008-10#2)(2012-12#1)
to elucidate the molecular##2##4##(1997-7#1)(2008-10#1)
to elucidate the nature of##3##5##(1995-6#1)(2008-10#1)(2008-11#1)
to elucidate the role of different##2##6##(2008-10#1)(2009-8#1)
to elucidate the role of the##2##6##(1992-3#1)(1992-6#1)
to elucidate the role of these##2##6##(1995-2#1)(2008-10#1)
to elucidate the role of##6##5##(1992-3#1)(1992-6#1)(1995-2#1)(2008-10#2)(2009-8#1)
to elucidate the##53##3##(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#2)(2012-6#1)
to elucidate##73##2##(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#29)(2008-11#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#2)(2012-6#1)
to elute##2##2##(1990-5#1)(2008-10#1)
to embark on##2##3##(1994-2#1)(2008-12#1)
to embrace##3##2##(1994-1#1)(2010-7#1)(2010-8#1)
to emerge from##2##3##(2008-11#2)
to emerge##11##2##(1995-12#1)(1995-9#1)(1996-5#1)(2008-11#2)(2008-7#2)(2011-1#1)(2011-2#2)(2013-1#1)
to emergency##3##2##(1997-8#1)(2008-11#1)(2008-6#1)
to emerging health##2##3##(2008-7#1)(2012-2#1)
to emerging##4##2##(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
to emotional well-being##2##3##(2012-12#1)(2013-1#1)
to emotional##6##2##(2008-11#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
to emphasize that##3##3##(1997-1#1)(2008-4#1)(2012-2#1)
to emphasize the importance of##2##5##(2008-12#1)(2008-8#1)
to emphasize the##5##3##(1996-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)
to emphasize##9##2##(1992-3#1)(1996-5#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)
to empirical##2##2##(2008-8#2)
to employ a##2##3##(2008-10#1)(2013-1#1)
to employ in the##2##4##(2012-12#1)(2013-8#1)
to employ##12##2##(1990-2#1)(1990-9#1)(1994-6#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
to employee##3##2##(1993-2#1)(1996-5#1)(1997-3#1)
to employees##3##2##(1991-2#1)(1993-3#1)(1994-1#1)
to enable a##2##3##(2008-11#1)(2013-1#1)
to enable students##2##3##(2008-11#1)(2008-12#1)
to enable the sensitive##2##4##(2008-10#2)
to enable the##9##3##(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)
to enable##37##2##(1991-11#1)(1993-12#1)(1994-9#2)(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#9)(2008-11#8)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#2)(2013-1#1)
to enact##3##2##(1991-2#1)(1995-12#1)(2008-11#1)
to encode a protein of##3##5##(1993-12#1)(1996-6#1)(2008-10#1)
to encode a##10##3##(1992-4#1)(1993-12#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-8#1)
to encode the##2##3##(1994-12#1)(2011-2#1)
to encode##23##2##(1990-8#1)(1992-10#1)(1992-4#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
to encompass##2##2##(1995-6#1)(1997-2#1)
to encounter##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
to encourage nursing##2##3##(2008-11#1)(2010-10#1)
to encourage##27##2##(1991-1#1)(1991-2#1)(1993-1#1)(1994-1#1)(1995-11#1)(1997-6#1)(2008-11#6)(2008-12#1)(2008-4#4)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to end##10##2##(1992-6#1)(1993-5#1)(1995-12#2)(1996-3#1)(1997-4#1)(2008-1#1)(2008-11#1)(2012-12#2)
to end-stage##2##2##(2010-10#2)
to endocrine##4##2##(1996-6#1)(2008-11#1)(2010-11#1)(2013-1#1)
to endogenous##4##2##(1994-12#1)(2008-10#2)(2010-11#1)
to endophytic sites##2##3##(2008-10#2)
to endoscopic##4##2##(1993-6#1)(2007-8#1)(2012-12#1)(2012-3#1)
to endothelial cells##4##3##(1994-5#1)(1997-1#2)(2009-3#1)
to endothelial dysfunction##2##3##(2009-10#1)(2010-10#1)
to endothelial##7##2##(1994-5#1)(1997-1#2)(1997-8#1)(2009-10#1)(2009-3#1)(2010-10#1)
to endothelium##4##2##(1992-12#2)(1995-2#2)
to energy##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
to energy-matched continuous exercise##2##4##(2013-8#2)
to enforce##3##2##(1992-1#1)(2008-11#1)(2013-1#1)
to engage consumers##2##3##(2013-1#2)
to engage in treatment##2##4##(2013-1#2)
to engage in##8##3##(1990-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2013-1#3)
to engage##17##2##(1990-2#1)(1993-3#1)(1994-11#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#2)(2012-2#3)(2013-1#5)
to engineer a##2##3##(2008-11#2)
to engineer##6##2##(2008-10#1)(2008-11#3)(2008-7#1)(2011-2#1)
to engraft##3##2##(2008-11#1)(2010-11#2)
to enhance a##2##3##(1994-3#1)(1997-8#1)
to enhance an##2##3##(2008-10#1)(2008-5#1)
to enhance cell growth and##2##5##(2008-11#2)
to enhance learning##2##3##(2008-11#1)(2012-2#1)
to enhance medication##2##3##(2011-1#1)(2013-8#1)
to enhance patient care##2##4##(2008-10#1)(2008-11#1)
to enhance student learning##2##4##(2008-11#1)(2008-12#1)
to enhance student##3##3##(2008-11#2)(2008-12#1)
to enhance the CL##2##4##(2008-10#2)
to enhance the accuracy##2##4##(2008-10#2)
to enhance the cell##2##4##(1993-8#1)(2008-11#1)
to enhance the efficiency of##2##5##(2008-10#1)(2010-5#1)
to enhance the sensitivity of##3##5##(2008-10#2)(2009-4#1)
to enhance the##64##3##(1990-2#1)(1991-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-12#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#12)(2008-12#5)(2008-3#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)
to enhance their##6##3##(2008-10#1)(2008-12#2)(2008-6#1)(2010-1#1)(2012-3#1)
to enhance##148##2##(1990-2#2)(1991-2#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-12#1)(1996-2#2)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#40)(2008-11#25)(2008-12#10)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-4#1)(2013-1#4)(2013-8#2)
to enhanced##10##2##(1992-8#1)(1993-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2012-5#1)
to enjoy##3##2##(1991-12#1)(2008-11#1)(2008-9#1)
to enrich##6##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)
to ensure a##4##3##(1996-3#1)(2008-6#1)(2009-5#1)(2012-3#1)
to ensure appropriate##2##3##(1994-3#1)(2008-10#1)
to ensure complete##3##3##(2008-10#1)(2008-11#2)
to ensure its##3##3##(1994-9#1)(2008-10#2)
to ensure optimal##2##3##(2008-10#1)(2010-10#1)
to ensure that a##2##4##(2008-11#1)(2013-1#1)
to ensure that all##2##4##(2012-3#1)(2013-1#1)
to ensure that the##5##4##(1994-3#1)(1997-8#1)(2008-11#2)(2008-5#1)
to ensure that they are##2##5##(2008-12#1)(2011-2#1)
to ensure that they##3##4##(2008-12#1)(2011-2#2)
to ensure that##29##3##(1994-3#1)(1995-12#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-3#2)(2013-1#4)
to ensure the best##2##4##(2008-10#1)(2013-1#1)
to ensure the safety of##2##5##(1991-1#1)(2011-2#1)
to ensure the##18##3##(1991-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-9#1)(2013-1#1)
to ensure they##2##3##(1994-2#1)(2013-1#1)
to ensure##102##2##(1991-1#1)(1991-2#1)(1992-11#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#17)(2008-11#20)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#5)(2012-9#1)(2013-1#7)
to ensuring##4##2##(1996-11#1)(1997-2#1)(2008-10#2)
to enter the##4##3##(1991-2#1)(1997-2#1)(2008-10#1)(2011-2#1)
to enter##6##2##(1991-2#2)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
to enumerate##2##2##(2008-4#1)(2010-8#1)
to environmental changes##3##3##(2009-6#1)(2012-3#1)(2013-8#1)
to environmental factors##4##3##(2008-10#3)(2012-5#1)
to environmental fluctuations##2##3##(2008-8#2)
to environmental samples##4##3##(2008-10#3)(2011-2#1)
to environmental##30##2##(1996-1#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#4)(2009-6#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)(2012-9#1)(2013-8#2)
to envisage##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
to enzymatic##3##2##(1993-2#1)(1994-3#1)(2009-8#1)
to enzyme##5##2##(1990-11#1)(1993-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
to epidemic##3##2##(2008-10#2)(2012-12#1)
to epidemiologists##2##2##(2008-10#1)(2008-11#1)
to epidemiology##3##2##(1997-7#1)(2010-12#1)(2011-2#1)
to epidermal##2##2##(2008-10#1)(2009-4#1)
to epiphyseal##2##2##(1990-11#1)(2011-2#1)
to epithelial cells##3##3##(2008-10#1)(2008-5#2)
to epithelial##5##2##(2008-10#1)(2008-5#3)(2013-8#1)
to equal##3##2##(1995-1#1)(2008-10#2)
to equilibrium##2##2##(2008-10#1)(2008-11#1)
to equip##3##2##(2008-10#1)(2008-11#1)(2010-3#1)
to equivalent##2##2##(1996-1#1)(2008-7#1)
to equivocal##2##2##(1991-3#1)(2009-10#1)
to eradicate polio##3##3##(1994-9#3)
to eradicate the disease##3##4##(1994-9#2)(2011-2#1)
to eradicate##7##2##(1994-9#5)(1997-7#1)(2011-2#1)
to erectile dysfunction##2##3##(2012-12#1)(2013-8#1)
to error##2##2##(2008-10#2)
to errors in##2##3##(2008-3#1)(2011-2#1)
to errors##3##2##(2008-12#1)(2008-3#1)(2011-2#1)
to escape from the##2##4##(1996-12#1)(2008-8#1)
to escape##3##2##(1996-12#2)(2008-8#1)
to essential hypertension##4##3##(2008-9#3)(2010-4#1)
to essential##7##2##(2008-5#1)(2008-9#3)(2010-4#1)(2010-6#1)(2012-2#1)
to establish a good##2##4##(1991-1#1)(2008-11#1)
to establish a##28##3##(1991-1#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to establish an##4##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
to establish and##4##3##(1991-1#1)(2008-11#1)(2008-12#1)(2012-2#1)
to establish baseline##2##3##(1993-1#1)(2008-11#1)
to establish correlations between##2##4##(2008-10#2)
to establish its##2##3##(1990-2#1)(2008-10#1)
to establish suitable##2##3##(2008-10#1)(2011-2#1)
to establish surgical##2##3##(1997-7#1)(2012-12#1)
to establish systemic##2##3##(2008-10#2)
to establish that##2##3##(1995-9#1)(2008-3#1)
to establish the best##2##4##(2008-10#2)
to establish the extent##2##4##(1991-6#1)(2007-12#1)
to establish the impact of enquiry based learning##2##8##(2008-11#2)
to establish the optimum##2##4##(1996-9#1)(2008-10#1)
to establish the##45##3##(1991-6#1)(1992-1#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
to establish their##2##3##(2008-10#1)(2013-1#1)
to establish whether the##2##4##(2009-10#1)(2011-2#1)
to establish whether##6##3##(1997-4#1)(2008-11#1)(2009-10#1)(2011-2#2)(2013-7#1)
to establish##151##2##(1990-2#1)(1991-1#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#35)(2008-11#20)(2008-12#4)(2008-2#2)(2008-3#4)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#8)(2011-7#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
to established##5##2##(1997-8#1)(2008-10#1)(2008-11#2)(2010-10#1)
to establishing and##2##3##(1992-3#1)(2010-7#1)
to establishing##4##2##(1992-3#1)(1997-3#1)(2010-7#1)(2012-12#1)
to estimate DNA##2##3##(2008-10#2)
to estimate a##2##3##(2008-10#1)(2011-2#1)
to estimate parameters##2##3##(2008-10#1)(2011-3#1)
to estimate relative##2##3##(2008-10#1)(2008-11#1)
to estimate survival##2##3##(1990-9#1)(2008-10#1)
to estimate the amount of##3##5##(2008-10#1)(2010-8#2)
to estimate the apparent##2##4##(2008-10#2)
to estimate the cell##2##4##(1995-9#1)(2008-11#1)
to estimate the concentration of##2##5##(2008-10#2)
to estimate the contribution of##4##5##(1992-12#1)(2008-10#2)(2010-11#1)
to estimate the importance of##2##5##(1994-3#1)(2008-10#1)
to estimate the mean##2##4##(2008-10#1)(2008-3#1)
to estimate the parameters##2##4##(2008-10#1)(2008-3#1)
to estimate the potential##4##4##(1991-3#1)(2008-10#3)
to estimate the prevalence of##2##5##(1994-9#1)(1995-10#1)
to estimate the prevalence##3##4##(1994-9#1)(1995-10#1)(2008-11#1)
to estimate the rates##2##4##(2008-11#1)(2013-8#1)
to estimate the relative##2##4##(2008-10#1)(2008-8#1)
to estimate the specific growth rate##2##6##(2008-7#2)
to estimate the survival##2##4##(1995-12#1)(2008-8#1)
to estimate the total##2##4##(2008-10#1)(2008-7#1)
to estimate the##98##3##(1991-3#1)(1992-12#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-9#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#9)(2008-5#1)(2008-7#9)(2008-8#2)(2009-8#2)(2010-11#1)(2010-3#2)(2010-6#1)(2010-8#3)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#1)
to estimate zinc##2##3##(2008-10#2)
to estimate##164##2##(1990-9#1)(1991-3#2)(1992-12#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-9#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-10#62)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#12)(2008-5#1)(2008-7#9)(2008-8#7)(2008-9#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#7)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#8)(2013-8#2)
to estimates of##3##3##(1991-2#2)(2008-10#1)
to estrogen##5##2##(1992-9#1)(2008-10#1)(2008-11#2)(2008-7#1)
to estrogens##2##2##(2011-1#2)
to ethanol##10##2##(1992-7#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-6#2)(2012-3#1)(2013-1#1)
to ethical##2##2##(2008-12#2)
to ethics##3##2##(1995-3#1)(2008-11#2)
to ethylene##3##2##(1992-3#1)(2008-10#1)(2009-8#1)
to evacuate##2##2##(2008-7#2)
to evade##2##2##(2008-10#2)
to evaluate a##12##3##(1991-1#1)(1996-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
to evaluate and validate##2##4##(2010-7#1)(2013-8#1)
to evaluate and##6##3##(1993-1#1)(1996-2#1)(2008-10#1)(2010-6#1)(2010-7#1)(2013-8#1)
to evaluate changes in##3##4##(1994-12#1)(2008-12#1)(2012-2#1)
to evaluate differences in##2##4##(1994-3#1)(2008-10#1)
to evaluate disease##2##3##(2008-10#2)
to evaluate each##2##3##(2008-10#2)
to evaluate estrogenic potency of dietary phytoestrogens##2##7##(2008-10#2)
to evaluate estrogenic potency##3##4##(2008-10#3)
to evaluate how##3##3##(1993-2#1)(2008-12#1)(2013-8#1)
to evaluate if##2##3##(2008-4#1)(2013-1#1)
to evaluate its##5##3##(1990-2#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-12#1)
to evaluate oxidative##2##3##(2008-10#1)(2013-1#1)
to evaluate platelet##2##3##(2008-9#2)
to evaluate possible##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
to evaluate postoperative##2##3##(1992-3#1)(2011-2#1)
to evaluate the ability of this##2##6##(1990-2#1)(1995-5#1)
to evaluate the ability of##3##5##(1990-2#1)(1995-5#1)(2008-9#1)
to evaluate the consequences##2##4##(1993-3#1)(2008-9#1)
to evaluate the content of##2##5##(2008-10#2)
to evaluate the contribution of##3##5##(1994-1#1)(2008-9#1)(2009-4#1)
to evaluate the course##2##4##(2008-11#1)(2011-1#1)
to evaluate the degree of##2##5##(1996-1#1)(2008-10#1)
to evaluate the effect of a##2##6##(1997-4#1)(2012-3#1)
to evaluate the effect of the##3##6##(2008-1#1)(2008-10#1)(2008-12#1)
to evaluate the effect of##17##5##(1997-4#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-5#1)(2008-7#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to evaluate the effect##18##4##(1997-4#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to evaluate the effectiveness of a##3##6##(1996-11#1)(2008-4#1)(2008-9#1)
to evaluate the effectiveness of the##2##6##(2008-10#1)(2011-1#1)
to evaluate the effectiveness of##10##5##(1994-6#1)(1996-11#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
to evaluate the effects of##16##5##(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-11#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
to evaluate the effects##17##4##(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-5#2)(2009-11#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
to evaluate the efficacy of a##4##6##(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
to evaluate the efficacy of##11##5##(1993-1#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
to evaluate the efficacy##12##4##(1993-1#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
to evaluate the extent to which##2##6##(2008-11#1)(2008-3#1)
to evaluate the extent##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
to evaluate the feasibility of##3##5##(1992-12#1)(2008-10#1)(2011-2#1)
to evaluate the frequency of##3##5##(1994-12#1)(2007-8#1)(2013-8#1)
to evaluate the impact of##5##5##(2008-10#1)(2008-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
to evaluate the incidence of##2##5##(2010-2#1)(2013-1#1)
to evaluate the incidence##3##4##(2008-10#1)(2010-2#1)(2013-1#1)
to evaluate the influence of the##2##6##(1990-2#1)(2008-12#1)
to evaluate the influence of##6##5##(1990-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)
to evaluate the long-term##3##4##(2010-3#1)(2011-7#1)(2012-3#1)
to evaluate the performance of##2##5##(2008-11#1)(2008-3#1)
to evaluate the possible##4##4##(2008-1#1)(2008-5#1)(2012-8#1)(2013-1#1)
to evaluate the quality of##3##5##(2008-10#1)(2008-11#1)(2012-3#1)
to evaluate the relationship between##3##5##(1995-8#1)(2008-10#1)(2012-2#1)
to evaluate the reproducibility of##2##5##(2008-10#2)
to evaluate the reproducibility##3##4##(2008-10#2)(2009-11#1)
to evaluate the role of##6##5##(2008-10#2)(2008-7#1)(2010-10#1)(2011-2#2)
to evaluate the safety and efficacy of the##2##8##(2008-11#2)
to evaluate the safety and efficacy of##4##7##(2008-11#3)(2010-12#1)
to evaluate the safety##5##4##(2008-11#4)(2010-12#1)
to evaluate the significance of##2##5##(1993-12#1)(2011-2#1)
to evaluate the spatial##2##4##(1994-3#1)(2008-10#1)
to evaluate the stability##2##4##(1992-2#1)(2008-12#1)
to evaluate the suitability of##2##5##(2008-10#2)
to evaluate the therapeutic##3##4##(1990-2#1)(2008-10#1)(2013-8#1)
to evaluate the usefulness of##2##5##(2008-11#1)(2008-6#1)
to evaluate the##281##3##(1990-11#1)(1990-12#1)(1990-2#4)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#6)(2007-8#1)(2008-1#4)(2008-10#76)(2008-11#15)(2008-12#12)(2008-3#6)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#8)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#18)(2011-7#1)(2012-12#1)(2012-2#8)(2012-3#11)(2012-8#1)(2013-1#23)(2013-8#4)
to evaluate their experiences##2##4##(2008-10#2)
to evaluate their##9##3##(1994-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2013-8#1)
to evaluate this##5##3##(1993-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-3#1)
to evaluate to##2##3##(1994-3#1)(2008-10#1)
to evaluate whether the##5##4##(1993-8#2)(1997-3#1)(2008-10#1)(2013-1#1)
to evaluate whether##15##3##(1993-8#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
to evaluate which##2##3##(2008-11#1)(2011-1#1)
to evaluate##453##2##(1990-11#2)(1990-12#1)(1990-2#5)(1990-5#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-7#1)(1991-8#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#4)(1994-3#4)(1994-5#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#3)(1996-6#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#8)(2007-8#1)(2008-1#6)(2008-10#118)(2008-11#26)(2008-12#17)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#19)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#13)(2009-11#2)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#4)(2010-7#3)(2010-8#4)(2011-1#8)(2011-2#28)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#12)(2012-3#15)(2012-8#1)(2013-1#33)(2013-8#9)
to evaluating##2##2##(1995-12#1)(2007-12#1)
to even##2##2##(2008-10#1)(2008-5#1)
to every##3##2##(1991-3#1)(1996-1#1)(2011-2#1)
to evidence-based practice##4##3##(2013-1#4)
to evidence-based##5##2##(2013-1#5)
to evolution##5##2##(1997-6#1)(2008-8#1)(2012-2#1)(2012-3#2)
to evolutionary##2##2##(2008-8#1)(2010-3#1)
to evolve and##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
to evolve in##3##3##(1994-12#1)(2008-8#1)(2011-2#1)
to evolve##23##2##(1994-12#2)(1997-3#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-10#3)(2011-2#4)(2013-1#2)
to evolving##2##2##(2008-9#2)
to ex vivo##2##3##(2008-11#1)(2011-3#1)
to ex##3##2##(2008-11#1)(2009-8#1)(2011-3#1)
to examine and##2##3##(1993-12#1)(2010-9#1)
to examine how##5##3##(1993-2#1)(1995-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
to examine if##2##3##(2008-11#1)(2008-9#1)
to examine nursing##2##3##(2008-12#1)(2010-10#1)
to examine possible##2##3##(2008-11#1)(2010-7#1)
to examine the association between##4##5##(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)
to examine the association##5##4##(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
to examine the consequences of##2##5##(1995-6#1)(2008-8#1)
to examine the crack##2##4##(2009-7#2)
to examine the demographic##2##4##(2008-8#1)(2012-3#1)
to examine the development of##2##5##(2008-11#1)(2008-5#1)
to examine the effect of##8##5##(1991-10#1)(1992-6#1)(1996-12#1)(2008-11#1)(2008-12#2)(2010-11#1)(2010-6#1)
to examine the effects of##9##5##(1991-12#1)(2008-10#1)(2008-8#2)(2009-3#1)(2012-2#1)(2013-8#3)
to examine the experiences of##2##5##(1995-1#1)(2008-12#1)
to examine the expression##2##4##(1991-5#1)(1994-6#1)
to examine the extent to which##2##6##(2008-8#1)(2012-2#1)
to examine the feasibility of##2##5##(2008-11#1)(2008-9#1)
to examine the functional##2##4##(1996-5#1)(2008-11#1)
to examine the impact of##2##5##(1991-3#1)(2011-2#1)
to examine the possible role of##2##6##(1994-11#1)(1996-2#1)
to examine the possible##4##4##(1994-11#1)(1996-2#1)(2011-2#1)(2013-1#1)
to examine the prevalence##2##4##(2009-5#1)(2010-3#1)
to examine the psychometric properties of the##2##7##(2010-11#1)(2013-1#1)
to examine the relationship between body##2##6##(2009-5#1)(2011-1#1)
to examine the relationship between##8##5##(1992-2#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
to examine the relationship##9##4##(1992-2#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to examine the relationships between##4##5##(1997-2#1)(2008-10#1)(2009-12#1)(2011-2#1)
to examine the role of##2##5##(1996-2#1)(1997-3#1)
to examine the spatial##2##4##(2008-10#2)
to examine the##141##3##(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#4)(1992-6#1)(1992-8#1)(1994-11#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#17)(2008-11#17)(2008-12#7)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#5)(2008-8#10)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-11#2)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#6)
to examine their##4##3##(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)
to examine these##2##3##(1993-12#1)(2008-6#1)
to examine whether a##2##4##(2008-10#1)(2010-5#1)
to examine whether the##3##4##(1993-12#1)(2008-5#1)(2011-1#1)
to examine whether##10##3##(1993-12#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
to examine##226##2##(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#5)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#27)(2008-11#31)(2008-12#11)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#13)(2008-9#9)(2009-10#4)(2009-12#3)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#3)(2010-11#3)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#7)
to exceed##5##2##(1994-12#1)(2008-10#3)(2008-3#1)
to excellent##5##2##(2008-10#1)(2009-12#1)(2010-7#2)(2010-8#1)
to excess##3##2##(1993-1#1)(2008-10#1)(2008-11#1)
to excessive##4##2##(1996-2#1)(2008-11#1)(2010-6#1)(2013-1#1)
to exchange the##2##3##(1997-1#1)(2008-10#1)
to exchange##10##2##(1997-1#2)(1997-8#1)(2008-10#2)(2010-8#3)(2011-2#2)
to excite##3##2##(1991-3#1)(2008-3#1)(2008-9#1)
to excited##2##2##(2008-10#1)(2010-1#1)
to exclude a##3##3##(1991-12#1)(2008-12#1)(2008-8#1)
to exclude an##2##3##(2008-1#1)(2011-2#1)
to exclude the##3##3##(1991-12#1)(2008-1#1)(2011-2#1)
to exclude##15##2##(1990-12#1)(1990-5#1)(1991-12#2)(1995-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
to excrete##2##2##(2008-7#1)(2010-1#1)
to execute the##2##3##(2008-11#1)(2012-3#1)
to execute##5##2##(1991-3#1)(2008-11#2)(2011-2#1)(2012-3#1)
to exercise on##2##3##(2009-1#1)(2012-2#1)
to exercise##9##2##(2008-11#1)(2009-1#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#3)
to exercise-induced##2##2##(1992-9#1)(2010-1#1)
to exert a##4##3##(1990-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
to exert its##3##3##(2011-1#1)(2012-2#2)
to exert##14##2##(1990-12#1)(1990-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-8#1)
to exhaustion##9##2##(2011-2#3)(2013-8#6)
to exhibit a##4##3##(2008-10#4)
to exhibit an##2##3##(1996-3#1)(2009-12#1)
to exhibit the##3##3##(1994-11#1)(2008-11#1)(2008-5#1)
to exhibit##21##2##(1993-12#1)(1994-11#2)(1995-2#2)(1996-3#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2009-12#1)(2009-5#1)(2012-3#1)(2013-8#1)
to exist as##2##3##(2008-10#1)(2011-3#1)
to exist in the##3##4##(2008-10#2)(2008-9#1)
to exist in##8##3##(1993-8#1)(1995-11#1)(1996-3#1)(2008-10#2)(2008-9#2)(2012-2#1)
to exist##22##2##(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-8#1)(2008-9#2)(2011-3#1)(2012-2#1)
to existing##12##2##(1993-8#1)(1994-1#1)(1997-7#1)(2008-10#5)(2008-6#1)(2009-9#1)(2012-12#1)(2013-1#1)
to exogenous hormones##2##3##(2008-7#1)(2008-8#1)
to exogenous##11##2##(1994-3#2)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2013-7#1)
to expand the##8##3##(1994-2#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-2#1)
to expand their##2##3##(2008-8#1)(2009-5#1)
to expand##22##2##(1992-2#1)(1993-5#1)(1994-2#1)(1995-12#2)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2012-2#2)(2013-1#2)
to expect##3##2##(1994-3#1)(1996-2#1)(2010-4#1)
to expectations##3##2##(1996-2#1)(2008-10#1)(2008-3#1)
to expected##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
to expedite##2##2##(2008-11#1)(2008-12#1)
to experience the##2##3##(1996-9#1)(2008-9#1)
to experience##10##2##(1992-3#1)(1994-5#1)(1996-9#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-3#1)(2013-1#1)
to experienced##2##2##(1997-1#1)(2008-11#1)
to experiment##3##2##(1991-3#1)(1992-9#1)(2008-12#1)
to experimental data##3##3##(2008-7#2)(2013-1#1)
to experimental##10##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
to experimentally test##2##3##(2009-11#1)(2013-1#1)
to experimentally##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
to experiments##2##2##(2008-10#1)(2008-7#1)
to expert##2##2##(1994-2#1)(2010-10#1)
to experts##2##2##(1995-6#1)(2008-12#1)
to explain how##5##3##(1993-2#1)(2008-10#1)(2008-3#2)(2009-11#1)
to explain that##2##3##(1996-5#1)(2012-2#1)
to explain the current##2##4##(2008-10#1)(2008-11#1)
to explain the effect##2##4##(1994-5#1)(2008-3#1)
to explain the maintenance of##2##5##(1997-7#1)(2008-8#1)
to explain the observed##2##4##(2008-11#1)(2008-5#1)
to explain the##47##3##(1990-3#1)(1990-8#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#14)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
to explain these##2##3##(2009-12#1)(2012-2#1)
to explain this##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)
to explain why##3##3##(2008-8#1)(2009-12#1)(2013-8#1)
to explain##90##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-11#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#24)(2008-11#7)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#4)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#1)(2013-8#1)
to explaining##2##2##(2008-8#2)
to explicate##2##2##(2008-12#1)(2010-10#1)
to exploit the##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2009-8#1)
to exploit##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)
to exploitation##2##2##(1995-5#1)(2011-2#1)
to explore alternative##2##3##(2008-11#1)(2008-12#1)
to explore and##6##3##(2008-10#1)(2008-11#2)(2009-8#1)(2010-10#1)(2010-7#1)
to explore how##2##3##(1997-3#1)(2008-11#1)
to explore some of the##3##5##(2008-7#1)(2010-5#1)(2012-2#1)
to explore the feasibility##2##4##(2008-10#1)(2010-10#1)
to explore the possibility of using##2##6##(1993-3#1)(2008-11#1)
to explore the possibility of##3##5##(1993-3#1)(2008-11#1)(2012-3#1)
to explore the potential##2##4##(2008-10#1)(2008-11#1)
to explore the relationship between##2##5##(2008-7#1)(2010-11#1)
to explore the relationships between##2##5##(2010-8#1)(2012-2#1)
to explore the use of##2##5##(2008-10#2)
to explore the##38##3##(1992-5#1)(1993-3#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#3)
to explore their##3##3##(1994-6#1)(2010-8#1)(2011-2#1)
to explore this##3##3##(2008-8#2)(2009-10#1)
to explore##88##2##(1992-5#1)(1993-3#1)(1994-6#1)(1996-2#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#8)(2008-11#13)(2008-12#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#7)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-2#2)(2012-3#5)(2013-1#5)
to expose the##3##3##(2008-11#1)(2008-12#1)(2012-3#1)
to expose##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
to exposure of##2##3##(1991-2#1)(2011-2#1)
to exposure to##8##3##(1996-3#1)(2008-10#2)(2008-5#1)(2008-9#2)(2011-2#2)
to exposure##14##2##(1990-5#1)(1991-2#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2009-9#1)(2011-2#3)
to express a##2##3##(2007-12#1)(2008-11#1)
to express and##2##3##(2008-4#1)(2012-2#1)
to express both the##2##4##(2008-11#1)(2008-5#1)
to express recombinant human##2##4##(2008-11#2)
to express recombinant##3##3##(2008-11#2)(2008-7#1)
to express the##8##3##(1994-11#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
to express##40##2##(1992-10#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#4)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
to expression of##3##3##(1995-2#1)(2008-10#2)
to extend the##18##3##(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#1)
to extend their##2##3##(1993-3#1)(2008-11#1)
to extend##35##2##(1993-3#1)(1995-3#1)(1995-6#3)(1996-2#1)(2007-11#1)(2008-10#14)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
to extended##3##2##(1994-2#1)(2008-8#1)(2011-2#1)
to extensive##3##2##(1994-5#1)(2008-10#2)
to external pressures##2##3##(2008-11#1)(2008-7#1)
to external stimuli##2##3##(2008-11#1)(2010-10#1)
to external##14##2##(1993-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-10#2)(2011-2#1)(2012-2#1)
to extinction##10##2##(2008-8#3)(2008-9#7)
to extracellular##5##2##(1993-3#1)(1996-2#2)(2008-7#1)(2012-2#1)
to extract and##5##3##(2008-10#5)
to extract information about##2##4##(2008-10#1)(2009-8#1)
to extract the##12##3##(2008-10#8)(2008-3#2)(2009-7#1)(2011-2#1)
to extract##56##2##(1997-2#1)(1997-6#1)(2008-10#42)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
to extraction##4##2##(2008-10#3)(2011-2#1)
to extrapolate from##2##3##(2008-11#1)(2010-8#1)
to extrapolate##3##2##(2008-11#2)(2010-8#1)
to extreme##2##2##(2008-11#1)(2011-2#1)
to extremely##3##2##(2008-11#1)(2008-12#2)
to eye opening##2##3##(2008-7#2)
to eye##3##2##(2008-5#1)(2008-7#2)
to fabricate a##2##3##(2008-10#2)
to fabricate##11##2##(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#2)(2009-11#1)(2013-1#1)
to face the##2##3##(2008-6#1)(2013-1#1)
to face##12##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-10#2)(2010-12#1)(2013-1#1)(2013-8#1)
to facilitate and##2##3##(2008-12#1)(2010-8#1)
to facilitate its##2##3##(2008-10#1)(2013-8#1)
to facilitate learning##3##3##(2008-12#3)
to facilitate nonlinear calibration##3##4##(2008-10#3)
to facilitate preleptotene spermatocyte migration##2##5##(2009-10#2)
to facilitate surgical##2##3##(1996-3#1)(2008-9#1)
to facilitate the development of new##2##6##(1992-1#1)(2008-11#1)
to facilitate the development of##6##5##(1992-1#1)(2008-11#3)(2008-12#2)
to facilitate the dissolution of##2##5##(2008-10#2)
to facilitate the##24##3##(1991-5#1)(1992-1#1)(1993-8#1)(1994-1#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-7#1)(2008-9#1)(2011-2#1)
to facilitate##95##2##(1991-10#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#2)(1996-1#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#15)(2008-11#16)(2008-12#10)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
to factors##2##2##(1991-2#1)(2009-8#1)
to fail##6##2##(1995-1#1)(2008-3#1)(2008-8#2)(2009-7#1)(2011-2#1)
to failure in##4##3##(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
to failure##10##2##(2008-10#1)(2008-11#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
to fall into three##2##4##(2008-10#1)(2011-2#1)
to fall##9##2##(1990-2#1)(1990-5#1)(1994-3#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)
to families##2##2##(1995-1#1)(2008-11#1)
to family##14##2##(1991-2#1)(2008-10#4)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2013-1#2)(2013-8#1)
to farnesylate##2##2##(1995-2#2)
to fast##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
to faster##4##2##(1995-1#1)(2007-8#1)(2008-11#1)(2008-7#1)
to fat##2##2##(2008-10#1)(2012-2#1)
to fatigue##2##2##(2008-10#1)(2009-7#1)
to favor the##3##3##(1996-3#1)(2008-10#1)(2008-8#1)
to favor##7##2##(1996-3#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#1)
to favorable##2##2##(2008-10#1)(2012-3#1)
to fear##4##2##(1996-6#1)(2008-11#1)(2012-2#1)(2013-8#1)
to feed on##2##3##(2008-10#1)(2009-6#1)
to feed##7##2##(2008-10#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-8#1)
to feeding##3##2##(2009-8#1)(2010-6#1)(2011-2#1)
to feel##4##2##(1992-3#2)(1997-4#1)(2007-12#1)
to female##14##2##(1990-12#2)(1990-2#1)(1991-6#1)(1993-9#1)(1997-7#1)(2008-11#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-8#1)
to females in##2##3##(2007-12#1)(2009-8#1)
to females##10##2##(1990-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#3)(2012-2#1)
to femoral##2##2##(2011-2#2)
to ferricyanide##2##2##(2008-10#2)
to fertilize##2##2##(2008-8#2)
to fetal bovine serum (FBS)##2##5##(2008-11#2)
to fetal bovine serum##3##4##(2008-11#3)
to fetal##6##2##(1992-12#1)(2008-10#1)(2008-11#4)
to few##2##2##(2008-10#2)
to fewer##2##2##(2008-10#1)(2008-11#1)
to fibronectin##2##2##(1990-8#1)(1992-10#1)
to fibrosis##2##2##(2011-2#1)(2012-12#1)
to field##4##2##(2008-10#3)(2011-2#1)
to fight against##2##3##(1993-6#1)(2012-2#1)
to fight##11##2##(1993-11#1)(1993-12#2)(1993-6#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
to fill in##2##3##(2008-10#1)(2010-11#1)
to fill the sampling##2##4##(2008-10#2)
to fill the##5##3##(2008-1#1)(2008-10#3)(2013-1#1)
to fill##11##2##(1991-2#1)(2008-1#1)(2008-10#5)(2010-11#1)(2010-6#1)(2010-9#1)(2013-1#1)
to filter the##2##3##(2008-10#1)(2009-12#1)
to filter##6##2##(2008-10#3)(2008-4#1)(2008-9#1)(2009-12#1)
to filtered##2##2##(2008-10#1)(2013-1#1)
to final##3##2##(2008-10#2)(2011-1#1)
to finally##2##2##(2008-10#1)(2009-8#1)
to finance##3##2##(1991-2#1)(1992-2#1)(1996-3#1)
to financial##4##2##(2010-10#3)(2010-5#1)
to find a possible##2##4##(2011-2#1)(2012-3#1)
to find a##13##3##(1996-2#1)(1997-6#2)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)
to find an##3##3##(2008-10#1)(2009-6#1)(2012-12#1)
to find and##2##3##(1994-1#1)(1996-8#1)
to find its##2##3##(1992-5#1)(1996-1#1)
to find more##3##3##(1992-12#1)(2011-2#2)
to find optimal##2##3##(2008-10#1)(2008-3#1)
to find out the##3##4##(1990-2#1)(2013-1#2)
to find out whether##3##4##(1991-11#1)(2009-6#1)(2012-2#1)
to find out##14##3##(1990-2#2)(1990-6#1)(1991-11#1)(1991-6#1)(1993-6#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
to find specific##2##3##(2011-2#1)(2012-2#1)
to find suitable##2##3##(2008-10#1)(2008-8#1)
to find the best##3##4##(2008-10#2)(2009-7#1)
to find the conditions##2##4##(2008-3#1)(2008-5#1)
to find the optimal##2##4##(2008-10#1)(2008-3#1)
to find the##21##3##(1990-12#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-7#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#1)
to find ways to##2##4##(1992-12#1)(1995-9#1)
to find##102##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-6#3)(2007-11#1)(2008-10#24)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)
to finding##3##2##(2008-10#1)(2009-12#1)(2012-12#1)
to findings##2##2##(2012-3#1)(2013-8#1)
to fine##3##2##(1997-2#1)(2008-10#1)(2008-9#1)
to fire##3##2##(2008-10#2)(2009-8#1)
to first##6##2##(1994-1#1)(2008-10#2)(2008-3#1)(2010-10#1)(2010-7#1)
to fit the##6##3##(2008-10#2)(2008-12#1)(2008-9#2)(2012-3#1)
to fit##20##2##(1991-5#1)(1994-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-10#1)(2011-2#1)(2012-3#2)(2013-8#1)
to five days##2##3##(1992-5#1)(1997-4#1)
to five times##3##3##(1993-1#1)(2008-10#2)
to five years##2##3##(1994-9#1)(2008-11#1)
to five##22##2##(1992-5#1)(1993-1#1)(1994-9#1)(1997-4#1)(2008-10#13)(2008-11#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)
to fivefold higher##2##3##(1993-2#1)(2008-10#1)
to fix##2##2##(2008-11#2)
to fixate##2##2##(2008-10#1)(2008-2#1)
to flame atomic absorption spectrometry (FAAS)##3##6##(2008-10#3)
to flame atomic absorption##6##4##(2008-10#6)
to flame##8##2##(2008-10#8)
to flat##2##2##(1993-8#1)(2008-10#1)
to flooding##2##2##(2012-5#2)
to flour##3##2##(1990-3#2)(2008-10#1)
to flow cytometry##2##3##(2008-4#1)(2008-9#1)
to flow injection (FI)##3##4##(2008-10#3)
to flow injection##6##3##(2008-10#6)
to flow##11##2##(2008-10#7)(2008-4#1)(2008-7#2)(2008-9#1)
to flower##2##2##(2008-10#2)
to flowering##2##2##(2008-10#1)(2008-12#1)
to flowers##3##2##(2008-10#1)(2008-8#1)(2009-5#1)
to fluconazole and amphotericin B in##2##6##(2008-5#2)
to fluconazole and##3##3##(2008-5#3)
to fluconazole##6##2##(2008-10#1)(2008-5#5)
to fluctuating##2##2##(2008-10#1)(2010-7#1)
to fluctuations in the##2##4##(2008-3#1)(2008-7#1)
to fluid##4##2##(1995-3#1)(2008-8#1)(2010-1#1)(2012-2#1)
to fluorescent##2##2##(2008-10#2)
to fluoride##3##2##(2008-10#2)(2008-12#1)
to fluoroquinolones##2##2##(2008-7#2)
to fluorouracil##4##2##(1990-2#4)
to flusilazole##2##2##(2008-10#2)
to fly##2##2##(1994-3#1)(2008-3#1)
to focal##2##2##(1990-9#1)(2011-2#1)
to focus more##2##3##(1997-1#1)(2012-2#1)
to focus on the##7##4##(1994-1#1)(1994-2#1)(2008-11#2)(2009-5#1)(2010-5#1)(2013-1#1)
to focus on##11##3##(1990-11#1)(1991-6#1)(1994-1#1)(1994-2#1)(1995-12#1)(1997-2#1)(2008-11#2)(2009-5#1)(2010-5#1)(2013-1#1)
to focus##20##2##(1990-11#1)(1991-6#1)(1992-2#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
to foliar##4##2##(2008-10#3)(2013-8#1)
to follicular growth##2##3##(2008-12#2)
to follicular##4##2##(1995-12#1)(2008-12#2)(2008-8#1)
to follow a##4##3##(1997-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to follow the evolution of##2##5##(2008-10#2)
to follow the##16##3##(1990-11#1)(1991-12#1)(1992-12#1)(1994-12#1)(1995-9#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)
to follow up the##2##4##(2008-10#1)(2009-10#1)
to follow up##5##3##(1993-12#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-10#1)
to follow##47##2##(1990-11#2)(1991-12#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-9#1)(1996-12#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
to follow-up##4##2##(1996-3#1)(2008-11#1)(2012-2#1)(2013-1#1)
to food samples were quantitative##2##5##(2008-10#2)
to food samples##3##3##(2008-10#3)
to food##12##2##(1993-6#1)(1994-12#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#2)(2011-2#1)
to forage##2##2##(2008-9#1)(2010-8#1)
to force him##2##3##(1996-5#2)
to force##4##2##(1996-5#2)(2008-10#1)(2008-8#1)
to forced swim##2##3##(2008-11#2)
to forecast##4##2##(2008-1#1)(2008-10#1)(2009-8#1)(2013-8#1)
to foreign##5##2##(1990-3#1)(1995-8#1)(2008-7#1)(2008-9#1)(2013-1#1)
to forensic##4##2##(1997-2#1)(2008-10#2)(2008-12#1)
to forest trees##2##3##(2008-10#1)(2008-8#1)
to forest##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
to forget##2##2##(1991-2#1)(2012-12#1)
to form a 1##10##4##(1995-11#1)(2008-10#9)
to form a blue##2##4##(1990-2#1)(2008-10#1)
to form a chelate##2##4##(2008-10#2)
to form a colored complex##3##5##(2008-10#3)
to form a colored compound##2##5##(2008-10#2)
to form a colored##8##4##(2008-10#8)
to form a complex##3##4##(2008-10#2)(2008-9#1)
to form a precipitate##2##4##(2008-10#2)
to form a specific##2##4##(2008-10#2)
to form a violet##2##4##(2008-10#2)
to form a yellow##3##4##(2008-10#3)
to form a##91##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-2#3)(1995-6#1)(2007-12#2)(2008-10#60)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
to form an##12##3##(2008-10#9)(2008-11#1)(2008-8#1)(2011-2#1)
to form complexes with##4##4##(2008-10#2)(2009-8#1)(2010-11#1)
to form ion##2##3##(2008-10#2)
to form large##2##3##(2008-10#1)(2008-11#1)
to form many##2##3##(2008-11#1)(2008-3#1)
to form oospores in##2##4##(2008-10#2)
to form particles##2##3##(1994-12#1)(1995-5#1)
to form red##2##3##(2008-10#2)
to form site-specific cross-links##2##4##(2008-4#2)
to form spheroids##2##3##(2008-11#2)
to form stable complexes with##2##5##(2008-10#1)(2010-11#1)
to form stable##7##3##(1993-6#1)(2008-10#5)(2010-11#1)
to form the corresponding##5##4##(2008-10#5)
to form the##22##3##(1991-9#1)(1997-2#1)(2007-12#2)(2008-10#13)(2008-3#1)(2008-9#2)(2011-1#1)(2012-2#1)
to form two##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
to form##255##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-10#4)(1992-6#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-5#4)(1995-11#1)(1995-2#4)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#6)(2008-10#134)(2008-11#15)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#11)(2008-9#6)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#2)
to formaldehyde##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
to formation of##2##3##(2008-10#2)
to formulate the##2##3##(2008-2#1)(2008-5#1)
to formulate##13##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-3#1)(2009-7#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
to forskolin##2##2##(1995-8#1)(1997-2#1)
to fortify##2##2##(2008-10#1)(2008-11#1)
to foster a##2##3##(1990-11#1)(2008-4#1)
to foster##12##2##(1990-11#1)(1991-12#1)(1995-3#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-1#1)
to fouling##3##2##(2008-10#2)(2013-1#1)
to found##2##2##(1994-12#1)(2011-4#1)
to four cycles of##2##4##(2008-10#1)(2009-8#1)
to four days##2##3##(2008-10#1)(2008-11#1)
to four different##4##3##(1995-12#1)(2008-10#3)
to four years##2##3##(1990-11#1)(1991-8#1)
to four##46##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-8#1)(1995-12#1)(1996-6#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-8#3)(2012-12#1)(2013-8#2)
to fourfold##2##2##(1997-3#1)(2008-7#1)
to fractionate##4##2##(2008-11#2)(2008-4#1)(2008-7#1)
to fraud##2##2##(1993-12#1)(1994-2#1)
to free##10##2##(1993-11#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-9#1)
to freeze##2##2##(1993-3#1)(2008-10#1)
to freezing##2##2##(2009-8#1)(2011-1#1)
to frequency##2##2##(2008-10#1)(2010-2#1)
to fresh##2##2##(2008-10#1)(2010-8#1)
to freshwater##4##2##(2010-8#3)(2012-2#1)
to fruit##8##2##(2008-10#8)
to fruition##2##2##(2008-10#1)(2010-10#1)
to fuel##4##2##(2008-1#1)(2008-10#1)(2009-8#1)(2010-4#1)
to fulfil##4##2##(1991-3#1)(1997-2#1)(2008-11#1)(2012-2#1)
to fulfill##3##2##(1995-1#1)(1995-11#1)(2008-6#1)
to full##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
to full-length##2##2##(1993-8#1)(1997-2#1)
to fully understand##2##3##(1990-12#1)(2012-12#1)
to fully##13##2##(1990-12#1)(1993-8#1)(1997-8#1)(2008-10#2)(2008-11#2)(2009-1#2)(2009-6#1)(2009-7#1)(2012-12#1)(2012-3#1)
to fumigated field##2##3##(2008-10#2)
to fumonisin##4##2##(2008-10#4)
to function as a##6##4##(2008-10#3)(2008-8#1)(2009-6#1)(2010-10#1)
to function as##13##3##(1993-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2012-2#1)
to function in##4##3##(1991-2#1)(1994-9#1)(1995-12#1)(2012-2#1)
to function##25##2##(1990-2#1)(1991-2#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2012-2#2)(2013-1#1)
to functional changes##2##3##(2012-2#1)(2013-1#1)
to functional##14##2##(1991-3#1)(1991-5#1)(1992-8#1)(1994-1#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-12#2)(2011-1#1)(2012-2#1)(2013-1#1)
to functionally##2##2##(2009-12#1)(2011-2#1)
to functions##2##2##(2009-6#1)(2012-2#1)
to fund the##2##3##(1991-1#1)(1997-1#1)
to fund##4##2##(1991-1#1)(1991-12#1)(1991-9#1)(1997-1#1)
to fundamental##4##2##(1994-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
to fungal attack##3##3##(2008-10#3)
to fungal pathogens##2##3##(2008-10#2)
to fungal##10##2##(2008-10#9)(2011-10#1)
to fungicide##2##2##(2008-10#2)
to fungicides##3##2##(2008-10#3)
to furnish##5##2##(1991-1#1)(1996-5#1)(1997-3#2)(2010-7#1)
to further characterize the##4##4##(1992-12#1)(1993-3#1)(2008-10#1)(2008-11#1)
to further characterize##5##3##(1992-12#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-11#1)
to further clarify the##3##4##(2008-10#2)(2010-12#1)
to further develop##2##3##(2008-11#1)(2008-12#1)
to further elucidate##2##3##(2008-11#1)(2008-5#1)
to further enhance##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
to further evaluate the##2##4##(2010-8#1)(2011-2#1)
to further evaluate##4##3##(2008-5#1)(2010-8#1)(2011-2#2)
to further explore##2##3##(2008-11#1)(2011-2#1)
to further improve the##2##4##(1995-6#1)(2008-11#1)
to further improve##4##3##(1995-6#1)(2008-11#2)(2008-6#1)
to further investigate the##2##4##(1995-11#1)(2008-10#1)
to further investigate##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
to further our understanding of##2##5##(2008-7#2)
to further our##3##3##(1994-1#1)(2008-7#2)
to further reduce the##2##4##(2008-10#1)(2012-12#1)
to further study the##4##4##(2008-10#2)(2008-9#2)
to further test##2##3##(1992-2#1)(2010-6#1)
to further the##5##3##(2008-11#1)(2008-12#2)(2008-7#1)(2009-6#1)
to further understand the##2##4##(2008-11#1)(2008-9#1)
to further understand this##2##4##(2008-10#1)(2009-9#1)
to further understand##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)
to further##74##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#17)(2008-11#14)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
to fusarium##4##2##(2008-10#4)
to fuse with the##2##4##(1992-12#1)(2008-10#1)
to fusion##2##2##(2008-10#1)(2008-8#1)
to future studies##2##3##(2008-10#1)(2008-7#1)
to future##12##2##(1993-12#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
to gain a deeper##2##4##(1993-8#1)(2010-9#1)
to gain a##5##3##(1993-8#1)(1996-12#1)(2008-10#1)(2010-9#1)(2011-1#1)
to gain access to the##2##5##(2008-10#1)(2008-12#1)
to gain an##3##3##(2008-11#1)(2008-8#1)(2009-6#1)
to gain deeper##2##3##(2009-8#1)(2013-8#1)
to gain insight into the##2##5##(2009-4#1)(2010-12#1)
to gain insight into##5##4##(1993-6#1)(2008-10#2)(2009-4#1)(2010-12#1)
to gain insight##6##3##(1993-6#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-12#1)
to gain knowledge of##2##4##(1992-2#1)(2012-2#1)
to gain knowledge##4##3##(1992-2#1)(2008-11#1)(2008-9#1)(2012-2#1)
to gain more insight into the##2##6##(2008-10#1)(2008-11#1)
to gain more##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
to gain the##5##3##(1994-2#1)(1994-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
to gain valuable##2##3##(1997-8#1)(2008-11#1)
to gain##52##2##(1992-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#3)(1996-12#1)(1996-9#1)(1997-8#1)(2008-10#10)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
to gaps##2##2##(1996-3#1)(2008-10#1)
to gas chromatography##2##3##(2008-10#2)
to gas##3##2##(2007-12#1)(2008-10#2)
to gastric##7##2##(1990-9#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-12#1)(2007-11#1)(2012-5#1)
to gastrin##2##2##(1997-1#2)
to gather data on##2##4##(2008-10#1)(2010-11#1)
to gather data##4##3##(2008-10#1)(2008-11#2)(2010-11#1)
to gather firewood##2##3##(2011-2#2)
to gather information##2##3##(1991-1#1)(1996-2#1)
to gather##14##2##(1991-1#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#5)(2012-12#1)
to gauge the##5##3##(2008-1#1)(2008-6#1)(2012-2#1)(2013-1#2)
to gauge##7##2##(1996-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#2)
to gaze shifts##3##3##(2008-11#3)
to gel##2##2##(2008-9#1)(2011-2#1)
to gender and##2##3##(2011-1#2)
to gender##6##2##(1994-6#1)(2008-9#1)(2009-10#1)(2011-1#2)(2013-1#1)
to gene##8##2##(1994-5#1)(1995-2#1)(2008-10#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
to gene-for-gene##2##2##(2008-10#1)(2008-9#1)
to general practitioners##3##3##(1992-5#1)(2008-8#1)(2011-2#1)
to general##12##2##(1992-5#1)(1993-6#1)(1994-12#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
to generalize the##2##3##(1996-3#1)(2009-7#1)
to generalize##4##2##(1995-5#1)(1996-3#1)(2008-6#1)(2009-7#1)
to generalized##2##2##(2008-11#1)(2008-5#1)
to generate CL##2##3##(2008-10#2)
to generate a##20##3##(1991-9#1)(1993-12#1)(1994-8#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2009-3#1)(2009-8#2)(2010-5#1)(2010-7#1)(2012-3#1)
to generate an##4##3##(2008-10#2)(2008-2#1)(2008-6#1)
to generate antibody##2##3##(1993-2#1)(2011-2#1)
to generate both##2##3##(2008-10#1)(2008-6#1)
to generate different##2##3##(2008-10#1)(2008-7#1)
to generate human mAbs##2##4##(2008-11#2)
to generate hypotheses##2##3##(2008-10#1)(2012-2#1)
to generate the mature##2##4##(1993-8#1)(1997-7#1)
to generate the##10##3##(1993-8#1)(1995-2#2)(1997-7#2)(2008-10#3)(2008-3#1)(2010-5#1)
to generate transgenic##2##3##(2008-4#1)(2012-3#1)
to generate variants##2##3##(2008-11#1)(2009-6#1)
to generate##122##2##(1990-5#2)(1991-9#1)(1993-12#4)(1993-2#1)(1993-8#2)(1994-1#1)(1994-3#1)(1994-8#1)(1995-2#3)(1996-12#1)(1997-2#1)(1997-7#2)(1997-8#1)(2008-1#2)(2008-10#31)(2008-11#17)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-5#2)(2010-7#4)(2011-2#3)(2011-3#2)(2012-2#3)(2012-3#3)(2013-8#1)
to generation of##2##3##(1997-8#1)(2012-2#1)
to generation##3##2##(1996-5#1)(1997-8#1)(2012-2#1)
to genes and gene##2##4##(2008-9#1)(2012-2#1)
to genes##7##2##(1996-12#1)(1997-7#1)(2008-10#2)(2008-9#1)(2009-6#1)(2012-2#1)
to genetic and environmental factors##2##5##(2008-10#1)(2008-11#1)
to genetic##15##2##(2008-10#7)(2008-11#1)(2008-2#1)(2008-8#2)(2009-3#1)(2011-1#1)(2012-3#2)
to genetically##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
to genomic DNA from##2##4##(1993-2#1)(1993-8#1)
to genomic DNA##3##3##(1993-2#1)(1993-8#1)(2011-10#1)
to genomic##5##2##(1993-2#1)(1993-8#1)(2008-10#1)(2011-10#1)(2012-3#1)
to genomospecies 1##3##3##(2008-10#3)
to genomospecies##4##2##(2008-10#4)
to genotoxic##2##2##(1993-3#1)(2011-2#1)
to genotype##7##2##(2008-10#4)(2008-8#2)(2013-8#1)
to geographical##4##2##(2008-10#3)(2010-6#1)
to germ##3##2##(2008-10#2)(2009-10#1)
to germinate and##3##3##(2008-10#2)(2011-2#1)
to germinate##6##2##(2008-10#5)(2011-2#1)
to get a##10##3##(2008-10#3)(2008-7#1)(2009-8#1)(2010-10#1)(2013-8#4)
to get an insight into##2##5##(2008-11#1)(2010-12#1)
to get an##5##3##(1994-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
to get better##2##3##(2008-10#1)(2012-2#1)
to get information##2##3##(2008-10#1)(2008-5#1)
to get the##8##3##(1994-3#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-7#1)(2013-8#1)
to get to##2##3##(1992-8#1)(2008-11#1)
to get##54##2##(1990-11#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-3#1)(2012-2#2)(2013-7#1)(2013-8#6)
to girls##3##2##(2012-2#1)(2013-1#2)
to give a##19##3##(1991-2#1)(1992-6#1)(1993-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2009-11#1)(2011-3#1)
to give an overview of##2##5##(2008-11#1)(2011-2#1)
to give an##7##3##(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
to give and##2##3##(1994-3#1)(2011-2#1)
to give higher##2##3##(2008-10#1)(2008-11#1)
to give information##2##3##(1991-5#1)(2008-11#1)
to give low##2##3##(1996-5#1)(2008-10#1)
to give more##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
to give rise to##3##4##(1995-5#1)(2008-11#1)(2012-2#1)
to give rise##4##3##(1995-5#1)(2008-11#1)(2008-12#1)(2012-2#1)
to give satisfactory##3##3##(2008-10#3)
to give the best##2##4##(1996-12#1)(2008-10#1)
to give the highest##2##4##(2008-11#1)(2008-5#1)
to give the##22##3##(1992-2#1)(1996-12#1)(1996-5#3)(2008-10#9)(2008-11#5)(2008-5#2)(2008-9#1)
to give##116##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-1#2)(1993-2#1)(1994-3#1)(1995-1#1)(1995-5#2)(1996-12#1)(1996-5#9)(1997-2#2)(2008-1#2)(2008-10#45)(2008-11#15)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#1)(2010-2#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
to glass beads##2##3##(2008-10#1)(2008-7#1)
to glass surfaces than the##2##5##(2008-10#2)
to glass##7##2##(2008-10#6)(2008-7#1)
to global warming##2##3##(2012-5#1)(2012-8#1)
to global##7##2##(2008-10#1)(2009-9#1)(2011-2#1)(2012-5#1)(2012-8#1)(2013-3#1)(2013-8#1)
to glucagon##2##2##(1995-8#1)(1996-2#1)
to glucose and##5##3##(1995-8#2)(1996-3#1)(2008-10#1)(2008-11#1)
to glucose at##2##3##(2008-10#2)
to glucose##21##2##(1991-7#1)(1993-8#2)(1995-3#1)(1995-8#3)(1996-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2010-11#2)(2010-12#1)
to glycine##3##2##(1997-1#2)(1997-2#1)
to glycogen##4##2##(1995-8#3)(2008-10#1)
to go##11##2##(1991-2#1)(1993-1#1)(1995-3#1)(1995-9#1)(1996-6#1)(2008-11#4)(2008-7#1)(2012-2#1)
to goal##3##2##(2008-11#1)(2010-2#1)(2010-6#1)
to goat##2##2##(1990-12#1)(2008-10#1)
to good yields##2##3##(2008-5#1)(2010-6#1)
to good##5##2##(1992-5#1)(2008-11#1)(2008-5#1)(2010-3#1)(2010-6#1)
to government##2##2##(2009-4#1)(2012-2#1)
to grade##2##2##(1991-8#1)(2008-7#1)
to graft##2##2##(2013-1#2)
to grant##4##2##(1995-6#2)(1996-2#1)(1996-5#1)
to grasp##2##2##(1996-2#2)
to gravity##4##2##(2008-10#1)(2008-11#3)
to gray leaf spot##4##4##(2008-10#4)
to gray##5##2##(2008-10#5)
to great##2##2##(2008-10#1)(2008-8#1)
to greater##14##2##(1994-2#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#2)(2013-1#2)
to greatly##2##2##(1994-12#1)(2008-10#1)
to ground##2##2##(2008-10#2)
to groundwater##2##2##(2008-10#1)(2011-2#1)
to group A##2##3##(2008-10#1)(2011-2#1)
to group I##4##3##(2008-10#2)(2009-3#2)
to group III##2##3##(2008-10#1)(2008-9#1)
to group patients##2##3##(1995-12#1)(2010-12#1)
to group the##2##3##(2008-10#1)(2008-5#1)
to group##16##2##(1993-12#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
to grow and##5##3##(1993-1#1)(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
to grow at##6##3##(1991-12#1)(2008-10#2)(2008-11#1)(2011-2#2)
to grow by##2##3##(1991-1#1)(2011-2#1)
to grow in the presence of##2##6##(2008-11#1)(2010-4#1)
to grow in the##3##4##(2008-11#1)(2008-7#1)(2010-4#1)
to grow in##13##3##(2008-10#2)(2008-11#8)(2008-7#1)(2008-9#1)(2010-4#1)
to grow on##7##3##(1997-3#1)(2008-10#5)(2008-8#1)
to grow well##2##3##(2008-10#1)(2008-11#1)
to grow##57##2##(1991-1#1)(1991-12#1)(1993-1#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#13)(2008-11#18)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#5)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)
to growing##2##2##(2013-1#2)
to growth and##3##3##(2008-8#1)(2009-7#1)(2011-2#1)
to growth factors##8##3##(1990-12#1)(1991-5#1)(1992-10#1)(1994-5#1)(1994-8#1)(1995-6#1)(2006-6#1)(2008-5#1)
to growth hormone-releasing hormone 1-44 NH2##2##6##(1992-9#2)
to growth of##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
to growth stimulation##3##3##(1992-12#1)(2008-11#2)
to growth##33##2##(1990-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#2)(1994-5#1)(1994-8#1)(1995-6#1)(2006-6#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#5)(2009-7#1)(2011-2#5)(2012-5#1)(2013-1#1)
to guarantee##2##2##(2008-10#1)(2008-7#1)
to guide the choice of##3##5##(2008-10#1)(2008-9#1)(2013-1#1)
to guide the process of##2##5##(2008-11#1)(2008-12#1)
to guide the selection of##2##5##(2008-10#2)
to guide the##16##3##(1994-1#1)(1994-3#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-9#1)(2010-7#1)(2013-1#1)
to guide##45##2##(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#3)(1996-2#1)(1997-8#1)(2008-10#5)(2008-11#7)(2008-12#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#3)(2012-3#2)(2013-1#5)
to guidelines##3##2##(1996-11#1)(2008-11#1)(2008-8#1)
to hVEGF(165)##2##2##(2008-8#2)
to habitat loss##4##3##(2008-9#2)(2009-8#2)
to habitat##8##2##(2008-10#1)(2008-8#3)(2008-9#2)(2009-8#2)
to hair##3##2##(2008-5#2)(2011-2#1)
to half of##2##3##(1990-9#1)(2013-1#1)
to half##3##2##(1990-9#1)(2008-5#1)(2013-1#1)
to halogen)##2##2##(2008-10#2)
to hand hygiene##2##3##(2008-12#2)
to hand##5##2##(1994-8#1)(1996-1#1)(2008-11#1)(2008-12#2)
to handle and##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
to handle##20##2##(1991-1#1)(2008-10#6)(2008-11#4)(2008-4#3)(2008-6#1)(2009-12#1)(2011-3#1)(2012-2#2)(2013-8#1)
to happen##2##2##(2008-10#1)(2009-3#1)
to harbor##3##2##(2008-10#2)(2012-3#1)
to harmful##2##2##(2009-12#1)(2011-2#1)
to harness the##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
to harness##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
to harvest##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
to have 4##2##3##(1990-2#1)(2008-12#1)
to have CP##2##3##(2011-2#1)(2012-2#1)
to have a beneficial effect on##2##6##(1991-11#1)(2012-3#1)
to have a high##2##4##(2008-10#1)(2008-5#1)
to have a higher##2##4##(1996-9#1)(2013-8#1)
to have a large##2##4##(2008-3#2)
to have a low##2##4##(1997-1#1)(2009-7#1)
to have a more##2##4##(1990-2#1)(2008-11#1)
to have a novel##2##4##(1993-3#2)
to have a positive effect on##2##6##(2008-12#1)(2012-2#1)
to have a positive##4##4##(2008-12#1)(2008-6#1)(2012-2#1)(2013-8#1)
to have a role in##2##5##(1996-2#1)(2013-8#1)
to have a significant##4##4##(2008-1#1)(2008-2#1)(2008-5#1)(2012-2#1)
to have a wide##2##4##(2008-10#1)(2008-7#1)
to have a##89##3##(1990-2#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-6#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#4)
to have accumulated##2##3##(2008-10#1)(2011-2#1)
to have active##2##3##(1997-8#1)(2008-10#1)
to have an adverse effect on##2##6##(1997-2#1)(2008-10#1)
to have an increased risk##3##5##(2008-12#1)(2009-7#1)(2012-3#1)
to have an influence on the##2##6##(2008-10#1)(2008-11#1)
to have an##26##3##(1990-12#1)(1991-5#1)(1991-8#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-8#1)(2012-3#1)
to have anti-inflammatory##2##3##(2011-3#1)(2013-8#1)
to have any##4##3##(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#1)
to have arisen##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
to have at least##2##4##(1994-12#1)(2008-12#1)
to have been plagiarized from##3##5##(2008-10#3)
to have been present##2##4##(1990-3#1)(2008-9#1)
to have been##18##3##(1990-11#1)(1990-3#2)(1992-2#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#6)(2008-9#2)(2010-5#1)
to have better##5##3##(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
to have chronic##2##3##(1997-8#1)(2013-1#1)
to have considerable##2##3##(2008-10#1)(2008-7#1)
to have elevated##2##3##(2011-2#1)(2013-1#1)
to have good##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
to have great##2##3##(1996-5#1)(2008-10#1)
to have had##3##3##(1995-8#1)(1996-1#1)(2008-11#1)
to have high##2##3##(2008-10#2)
to have higher antioxidant activity than##2##6##(2013-8#2)
to have little##3##3##(1991-7#1)(1993-2#1)(2012-3#1)
to have lost##2##3##(2007-12#1)(2008-10#1)
to have low##2##3##(2008-4#1)(2013-1#1)
to have lower##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
to have more##3##3##(1994-3#1)(1995-2#1)(2008-10#1)
to have no effect on the##2##6##(1994-8#1)(2008-10#1)
to have no effect on##3##5##(1994-8#1)(2008-10#1)(2012-2#1)
to have no##9##3##(1990-11#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
to have normal##2##3##(2006-6#1)(2008-9#1)
to have occurred##3##3##(1994-11#1)(1995-2#1)(2009-8#1)
to have only##2##3##(1994-5#1)(2010-1#1)
to have received##3##3##(1995-2#1)(2008-9#1)(2009-5#1)
to have responded to##2##4##(2008-9#1)(2011-2#1)
to have significant##7##3##(1991-12#1)(1992-3#1)(1993-2#1)(1994-8#1)(2008-10#3)
to have similar##2##3##(2008-10#1)(2012-12#1)
to have substantially higher##2##4##(1993-1#1)(1995-2#1)
to have taken##2##3##(1991-9#1)(1995-11#1)
to have the greatest##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
to have the lowest##2##4##(1990-5#1)(2010-8#1)
to have the same##2##4##(1993-6#1)(2008-8#1)
to have the##18##3##(1990-5#1)(1992-12#1)(1993-11#1)(1993-6#1)(1996-2#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)
to have their##3##3##(1990-2#1)(2008-11#2)
to have two to##2##4##(2008-10#2)
to have two##5##3##(1990-11#1)(2008-10#2)(2008-7#1)(2009-9#1)
to have##390##2##(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#5)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-5#3)(1995-8#1)(1996-1#1)(1996-2#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#60)(2008-11#30)(2008-12#14)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#15)(2009-10#5)(2009-11#2)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#16)(2011-3#5)(2011-7#1)(2012-12#4)(2012-2#11)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#9)
to having##7##2##(1997-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
to head trauma##2##3##(2012-2#1)(2013-1#1)
to head##5##2##(1990-11#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
to heading##2##2##(2008-10#2)
to heal##2##2##(1996-1#1)(2010-6#1)
to health and##3##3##(1994-12#1)(2008-12#1)(2012-2#1)
to health care workers in##2##5##(1993-2#1)(1996-12#1)
to health care workers##3##4##(1993-2#1)(1995-2#1)(1996-12#1)
to health care##25##3##(1990-2#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-2#2)(1996-12#1)(1996-2#1)(1997-2#3)(2008-11#3)(2010-11#1)(2012-2#1)
to health maintenance organizations (HMOs)##2##5##(1991-1#1)(1993-3#1)
to health maintenance organizations##5##4##(1991-1#2)(1991-3#1)(1993-1#1)(1993-3#1)
to health services##5##3##(1992-2#2)(1995-12#1)(1997-3#1)(2008-11#1)
to health systems##2##3##(2008-7#1)(2012-2#1)
to health##63##2##(1990-2#1)(1991-1#2)(1991-2#1)(1991-3#1)(1992-2#2)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#3)(1994-1#2)(1994-12#2)(1994-2#2)(1995-1#1)(1995-12#3)(1995-2#3)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(2008-1#2)(2008-10#1)(2008-11#8)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#3)(2010-11#1)(2012-12#1)(2012-2#4)
to healthcare##4##2##(1991-1#1)(2009-3#1)(2010-12#1)(2013-8#1)
to healthy controls##3##3##(1993-2#1)(2009-6#1)(2013-1#1)
to healthy seedlings##2##3##(2008-10#2)
to healthy subjects##2##3##(2010-12#1)(2013-1#1)
to healthy##16##2##(1993-2#1)(2008-10#7)(2008-7#1)(2009-6#2)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#2)
to heart failure##2##3##(2008-7#1)(2013-1#1)
to heart##6##2##(1990-11#1)(1994-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)
to heat and acid##2##4##(1994-11#2)
to heat and to##2##4##(2008-10#1)(2008-8#1)
to heat and##4##3##(1994-11#2)(2008-10#1)(2008-8#1)
to heat##13##2##(1994-11#3)(1997-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
to heavy metals##6##3##(2008-10#4)(2013-1#2)
to heavy##10##2##(1993-2#1)(2008-10#6)(2008-11#1)(2013-1#2)
to help clarify the##2##4##(2008-5#1)(2011-2#1)
to help determine##2##3##(1996-6#1)(2009-12#1)
to help ensure##2##3##(1996-9#1)(2010-5#1)
to help guide the##2##4##(2008-10#1)(2010-8#1)
to help identify##4##3##(1991-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
to help improve##2##3##(1994-12#1)(2013-7#1)
to help in##2##3##(2008-10#1)(2010-8#1)
to help individuals##2##3##(1995-9#1)(2008-7#1)
to help manage##5##3##(1991-1#1)(1997-2#1)(2008-10#2)(2010-7#1)
to help patients##3##3##(2008-11#1)(2011-2#2)
to help prevent##4##3##(1991-7#1)(2008-12#1)(2010-1#1)(2010-12#1)
to help reduce##2##3##(2008-12#1)(2009-5#1)
to help researchers##2##3##(2008-10#1)(2008-4#1)
to help the##5##3##(1991-2#1)(1992-2#1)(2008-10#1)(2008-11#2)
to help them develop##2##4##(1993-2#1)(2010-10#1)
to help them##4##3##(1991-2#1)(1993-2#1)(2008-6#1)(2010-10#1)
to help##87##2##(1991-1#1)(1991-2#3)(1991-6#1)(1991-7#1)(1992-2#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
to hemodialysis##4##2##(2008-10#1)(2009-3#1)(2011-2#2)
to hemolytic anemia##2##3##(1997-6#2)
to hemolytic##3##2##(1997-6#2)(2013-1#1)
to heparin##3##2##(1994-3#1)(1997-1#2)
to hepatic##3##2##(1997-8#1)(2011-1#1)(2012-3#1)
to hepatitis B surface##2##4##(1994-11#1)(2009-12#1)
to hepatitis B##4##3##(1994-11#1)(2009-12#2)(2013-1#1)
to hepatitis##5##2##(1994-11#1)(2008-6#1)(2009-12#2)(2013-1#1)
to her##6##2##(1995-12#1)(2008-12#2)(2008-7#1)(2011-2#1)(2013-8#1)
to herbivore##3##2##(2008-8#2)(2008-9#1)
to here as##4##3##(2008-3#1)(2008-4#2)(2011-2#1)
to heterogeneity in##2##3##(2008-10#1)(2009-6#1)
to heterogeneity of##2##3##(2006-6#1)(2013-8#1)
to heterogeneity##4##2##(2006-6#1)(2008-10#1)(2009-6#1)(2013-8#1)
to heterosis##2##2##(2012-3#2)
to hexaploid##2##2##(2008-10#2)
to hierarchically##2##2##(2008-10#1)(2009-11#1)
to high doses of##2##4##(2008-7#1)(2010-10#1)
to high levels of##3##4##(2008-10#1)(2008-11#1)(2009-3#1)
to high molecular weight##2##4##(2008-10#1)(2008-7#1)
to high performance liquid chromatography##2##5##(2008-10#2)
to high performance liquid##3##4##(2008-10#3)
to high risk##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
to high temperatures##3##3##(2008-10#2)(2008-12#1)
to high##57##2##(1991-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-8#2)(1994-11#1)(2008-10#20)(2008-11#9)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#2)
to high-affinity##2##2##(1993-8#1)(2008-9#1)
to high-dose##2##2##(2008-8#1)(2011-1#1)
to high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
to high-performance liquid chromatography##3##4##(1991-7#1)(2008-10#2)
to higher levels of##3##4##(1993-3#1)(2008-7#1)(2009-7#1)
to higher levels##4##3##(1993-3#1)(2008-10#1)(2008-7#1)(2009-7#1)
to higher quality##2##3##(1992-11#1)(1992-3#1)
to higher than expected##2##4##(1990-5#1)(2008-10#1)
to higher##31##2##(1990-2#1)(1990-5#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-2#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to highest##2##2##(2008-9#1)(2010-12#1)
to highlight the##11##3##(2006-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
to highlight##23##2##(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
to highly pleasurable##2##3##(2012-2#2)
to highly resistant##3##3##(2008-10#3)
to highly##11##2##(1995-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-2#2)(2013-8#1)
to hip##2##2##(2008-11#1)(2011-2#1)
to his physician##2##3##(1990-6#1)(2013-1#1)
to his right##2##3##(1996-2#1)(2010-10#1)
to his##15##2##(1990-6#1)(1992-2#1)(1993-12#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
to histamine##2##2##(1997-1#1)(2008-10#1)
to histidine##2##2##(1992-6#1)(1997-3#1)
to histologic##2##2##(1990-3#1)(1991-2#1)
to hold##8##2##(1990-12#1)(1992-1#1)(1995-3#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
to home care##2##3##(1995-3#2)
to home##9##2##(1991-12#1)(1991-2#2)(1993-12#1)(1995-3#2)(2008-8#1)(2010-5#1)(2011-2#1)
to homogeneity by##6##3##(1991-12#1)(1992-8#1)(1993-8#1)(2008-8#1)(2009-3#1)(2010-4#1)
to homogeneity##23##2##(1990-10#1)(1990-11#2)(1990-5#1)(1991-12#1)(1991-7#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#4)(2009-3#1)(2010-4#1)
to homogeneous##3##2##(2008-10#1)(2008-3#2)
to homologous##2##2##(2008-10#1)(2008-9#1)
to horseradish peroxidase##2##3##(1997-3#1)(2008-7#1)
to hospice care##4##3##(1993-12#3)(2012-12#1)
to hospital care##3##3##(1992-2#2)(1996-2#1)
to hospital in##2##3##(1990-9#1)(2010-7#1)
to hospital with##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
to hospital##30##2##(1990-2#1)(1990-9#1)(1991-11#2)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-8#1)(1993-2#2)(1994-12#1)(1994-3#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#3)(2013-1#1)
to hospitalization##4##2##(1991-2#2)(1992-1#1)(1995-5#1)
to hospitals and##2##3##(1995-1#1)(2008-11#1)
to hospitals##9##2##(1991-3#1)(1992-1#1)(1993-1#1)(1993-5#1)(1994-1#1)(1995-1#1)(2008-11#3)
to host cells##2##3##(2008-10#2)
to host resistance##2##3##(2008-10#2)
to host size##3##3##(2008-10#1)(2008-9#2)
to host species##2##3##(2008-10#2)
to host##26##2##(1990-8#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#1)
to hot wax##2##3##(1992-6#2)
to hot##3##2##(1992-6#2)(2008-12#1)
to how they##3##3##(1996-1#1)(2010-9#2)
to how##17##2##(1990-2#1)(1991-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(2008-10#4)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-9#2)(2011-2#1)
to human and animal##3##4##(2008-10#2)(2008-9#1)
to human and##5##3##(1995-8#1)(2008-10#2)(2008-9#1)(2013-8#1)
to human antithrombin##2##3##(1992-10#2)
to human brain##2##3##(1990-8#1)(2013-1#1)
to human cancer##2##3##(2008-8#1)(2009-4#1)
to human chromosome##6##3##(1994-12#2)(1997-7#1)(1997-8#2)(2008-9#1)
to human health##13##3##(1992-2#1)(1994-3#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
to human immunodeficiency##2##3##(1991-9#1)(1992-12#1)
to human serum albumin (HSA)##2##5##(2008-10#2)
to human serum albumin##4##4##(1990-12#1)(2008-10#3)
to human serum##5##3##(1990-12#1)(2008-10#3)(2008-12#1)
to human##86##2##(1990-12#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-10#11)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#5)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-9#1)(2013-1#3)(2013-8#3)
to humans and##2##3##(2009-8#1)(2011-2#1)
to humans##18##2##(1991-12#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
to humic acid##2##3##(2008-10#2)
to humic##3##2##(2008-10#3)
to humidity##2##2##(2008-10#2)
to humoral immunity##2##3##(2008-11#1)(2008-12#1)
to hundreds of##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
to hybrid##2##2##(2008-10#1)(2012-3#1)
to hybridize##2##2##(2008-10#1)(2008-8#1)
to hydride generation##2##3##(2008-10#2)
to hydrogen ion##3##3##(2008-10#3)
to hydrogen peroxide##2##3##(2008-10#2)
to hydrogen##9##2##(2008-10#9)
to hydrolyse##2##2##(2009-3#1)(2011-1#1)
to hydrolysis and##2##3##(1994-11#1)(2008-10#1)
to hydrolysis by##2##3##(1990-2#1)(1994-11#1)
to hydrolysis##8##2##(1990-2#1)(1993-8#1)(1994-11#2)(2008-10#1)(2008-5#1)(2013-1#2)
to hydrolyze##3##2##(1993-8#1)(2008-10#2)
to hydroxyapatite cement##2##3##(2011-2#2)
to hydroxyapatite##4##2##(2008-11#2)(2011-2#2)
to hygromycin B##3##3##(2008-10#3)
to hygromycin##5##2##(2008-10#5)
to hypertension##4##2##(2008-12#1)(2009-7#2)(2013-1#1)
to hyperventilation##3##2##(2008-7#3)
to hypoxia##6##2##(1991-2#1)(1994-2#1)(1994-5#2)(2008-11#1)(2010-11#1)
to hypoxic##2##2##(2008-7#1)(2010-11#1)
to hysterectomy##3##2##(1991-3#1)(1994-12#1)(2008-8#1)
to ideal##2##2##(2008-12#1)(2008-9#1)
to identification of##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
to identification##4##2##(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
to identify &quot##2##3##(1995-1#1)(2008-10#1)
to identify a##9##3##(1990-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
to identify all##3##3##(2011-2#1)(2012-12#1)(2012-3#1)
to identify and differentiate##2##4##(2008-10#2)
to identify and purify##2##4##(1993-8#1)(2008-9#1)
to identify and quantify##4##4##(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
to identify and##30##3##(1993-3#1)(1993-8#1)(1994-8#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
to identify any##3##3##(1995-1#1)(2008-9#1)(2011-1#1)
to identify apoptotic##2##3##(2008-7#1)(2008-9#1)
to identify areas##2##3##(2008-11#2)
to identify candidate genes##2##4##(2008-10#2)
to identify candidates##3##3##(1993-12#2)(2012-12#1)
to identify cases##2##3##(2009-10#1)(2012-12#1)
to identify cells that##2##4##(2008-4#1)(2008-9#1)
to identify changes##4##3##(2008-11#1)(2010-11#1)(2013-1#2)
to identify common##2##3##(2008-11#1)(2011-2#1)
to identify deletion##2##3##(2012-3#2)
to identify differentially expressed##2##4##(2008-2#1)(2010-12#1)
to identify diseases##2##3##(1997-3#1)(2008-10#1)
to identify dominant##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
to identify factors that influence the##2##6##(2008-9#1)(2013-8#1)
to identify factors that influence##3##5##(2008-9#1)(2013-1#1)(2013-8#1)
to identify factors that##5##4##(2008-9#1)(2013-1#2)(2013-8#2)
to identify factors##10##3##(2008-11#1)(2008-9#1)(2010-11#1)(2013-1#3)(2013-8#4)
to identify family##2##3##(1992-1#1)(2013-8#1)
to identify genes that##4##4##(1992-9#1)(2008-7#1)(2011-2#1)(2012-3#1)
to identify genes##10##3##(1992-9#1)(1995-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#2)
to identify genetic##3##3##(2008-10#1)(2012-3#2)
to identify individuals with##2##4##(2008-10#1)(2008-3#1)
to identify informative##3##3##(2010-12#1)(2011-3#2)
to identify molecular markers for##2##5##(2008-10#2)
to identify molecular markers##3##4##(2008-10#3)
to identify molecular##5##3##(2008-10#3)(2012-2#1)(2013-8#1)
to identify novel##3##3##(2008-10#1)(2010-11#1)(2010-6#1)
to identify patients with##5##4##(1992-11#1)(2008-11#1)(2008-8#1)(2011-2#2)
to identify patients##8##3##(1992-11#1)(2008-11#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
to identify possible##2##3##(2008-10#1)(2013-8#1)
to identify potential##10##3##(1990-8#1)(1993-2#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#2)(2012-3#2)
to identify predictors of##2##4##(2009-5#1)(2012-3#1)
to identify published reports##2##4##(2012-12#1)(2013-1#1)
to identify quantitative trait loci (QTL)##3##6##(2008-10#3)
to identify quantitative trait loci##5##5##(2008-10#3)(2012-3#2)
to identify relevant##3##3##(1993-12#1)(2011-8#1)(2013-1#1)
to identify research gaps##2##4##(2009-3#2)
to identify resistance##3##3##(2008-10#3)
to identify risk factors##3##4##(1996-12#1)(2008-7#1)(2013-1#1)
to identify risk##4##3##(1996-12#1)(2008-7#1)(2010-9#1)(2013-1#1)
to identify significant##2##3##(2008-8#1)(2010-2#1)
to identify similar##2##3##(2008-4#1)(2012-2#1)
to identify solutions to clinical practice problems##3##7##(2010-11#3)
to identify specific##6##3##(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-2#2)
to identify strategies##2##3##(1993-2#1)(2008-11#1)
to identify studies##5##3##(2012-12#3)(2013-1#2)
to identify suitable husbandry conditions for maintaining multi-generation populations##2##9##(2008-11#2)
to identify suitable##3##3##(2008-11#2)(2013-1#1)
to identify the best##2##4##(1993-12#1)(1995-2#1)
to identify the cause of##2##5##(2008-11#1)(2010-4#1)
to identify the factors##2##4##(2008-10#1)(2010-12#1)
to identify the gene##3##4##(1995-6#1)(2008-9#1)(2011-3#1)
to identify the main##4##4##(2008-10#3)(2012-3#1)
to identify the metabolites##2##4##(1990-11#1)(2008-10#1)
to identify the most##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
to identify the optimal##4##4##(2008-10#1)(2010-10#1)(2010-8#1)(2011-1#1)
to identify the##110##3##(1990-11#1)(1990-2#2)(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-2#1)(2008-1#2)(2008-10#26)(2008-11#8)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#8)(2013-8#3)
to identify their##2##3##(2008-11#1)(2011-1#1)
to identify these##3##3##(1992-12#1)(2009-10#1)(2009-8#1)
to identify those##3##3##(1993-3#1)(2011-2#1)(2013-8#1)
to identify two##3##3##(2008-10#2)(2008-9#1)
to identify unknown##2##3##(2008-10#1)(2009-9#1)
to identify whether##2##3##(2008-10#1)(2011-2#1)
to identify which##3##3##(1995-5#1)(1995-6#1)(2008-10#1)
to identify##485##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-7#2)(2007-12#2)(2008-1#2)(2008-10#103)(2008-11#44)(2008-12#17)(2008-2#3)(2008-3#4)(2008-4#11)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#20)(2009-1#2)(2009-10#7)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#10)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-2#20)(2011-3#4)(2011-8#1)(2012-12#12)(2012-2#13)(2012-3#29)(2012-8#1)(2013-1#27)(2013-8#18)
to identifying##4##2##(1995-2#1)(2008-11#1)(2010-7#1)(2011-2#1)
to ignore##3##2##(1990-6#1)(1995-5#1)(2008-4#1)
to illness##2##2##(1995-2#1)(2012-12#1)
to illumination from below##2##4##(1991-2#2)
to illumination##3##2##(1991-2#2)(1993-3#1)
to illusory contours##2##3##(2008-8#2)
to illustrate how##4##3##(1994-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
to illustrate some of##2##4##(2008-4#1)(2012-2#1)
to illustrate the potential##2##4##(1990-8#1)(2008-11#1)
to illustrate the usefulness##2##4##(2008-10#1)(2012-2#1)
to illustrate the##37##3##(1990-8#1)(1992-9#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#4)(2013-1#2)(2013-8#1)
to illustrate their##2##3##(2010-1#1)(2010-4#1)
to illustrate##56##2##(1990-8#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#2)
to image the##4##3##(2008-10#1)(2008-2#1)(2010-12#1)(2011-7#1)
to image##10##2##(1990-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-7#1)(2012-2#1)
to imaging##2##2##(1991-1#1)(1997-4#1)
to immediate##5##2##(1990-9#1)(2008-11#2)(2013-1#2)
to immobilize DNA##2##3##(2008-10#2)
to immobilize##10##2##(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)
to immobilized##6##2##(1997-2#1)(2008-10#4)(2008-4#1)
to immortalize primary##2##3##(2008-11#1)(2008-2#1)
to immortalize##4##2##(2008-11#3)(2008-2#1)
to immune##2##2##(2009-8#1)(2012-3#1)
to immunize##2##2##(2008-4#1)(2011-2#1)
to immunoprecipitate##2##2##(1992-2#1)(1992-9#1)
to impact##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
to impair##4##2##(1993-9#1)(2008-10#1)(2008-4#1)(2012-3#1)
to impaired##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
to impairments in##2##3##(2008-11#1)(2008-7#1)
to impede##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
to implant##6##2##(2008-9#3)(2010-6#1)(2012-12#1)(2012-3#1)
to implement a##6##3##(1994-9#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
to implement and##2##3##(1995-2#1)(2008-8#1)
to implement continuous quality improvement##2##5##(1994-3#2)
to implement strategies##2##3##(2008-11#1)(2012-3#1)
to implement such##2##3##(1991-2#1)(2012-12#1)
to implement the multicommutation approach##2##5##(2008-10#2)
to implement the##10##3##(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2010-9#1)
to implement total quality management (TQM)##2##6##(1993-12#1)(1994-1#1)
to implement##56##2##(1991-2#1)(1992-1#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#3)(1994-9#1)(1995-12#1)(1995-2#2)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#11)(2008-11#9)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#2)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
to implementation of the##2##4##(1994-3#1)(1996-2#1)
to implementation of##4##3##(1993-3#1)(1994-3#1)(1996-2#1)(2013-1#1)
to implementation##7##2##(1993-3#1)(1994-3#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-6#1)(2013-1#1)
to implementing##3##2##(1995-11#1)(2008-11#1)(2008-12#1)
to import##2##2##(2008-10#1)(2008-4#1)
to important##4##2##(1997-2#1)(2009-10#1)(2011-2#1)(2013-1#1)
to improve accuracy##3##3##(2010-7#1)(2012-12#1)(2012-3#1)
to improve antibiotic##2##3##(1993-11#1)(2010-4#1)
to improve blood pressure control##2##5##(2008-8#1)(2013-1#1)
to improve care##9##3##(1994-2#1)(2008-6#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#4)
to improve clinical##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
to improve cognition##2##3##(2009-8#2)
to improve crop##2##3##(2010-10#1)(2012-2#1)
to improve diagnostic accuracy##2##4##(1991-3#1)(2010-12#1)
to improve diagnostic##3##3##(1991-3#1)(2008-10#1)(2010-12#1)
to improve dyspnea##2##3##(2013-8#2)
to improve health care##2##4##(1993-3#1)(2008-6#1)
to improve hospital##3##3##(1991-1#1)(1997-8#1)(2008-11#1)
to improve immunization##2##3##(1996-12#2)
to improve in##2##3##(2011-2#1)(2013-1#1)
to improve on##2##3##(1991-4#1)(2011-2#1)
to improve our understanding of the##2##6##(2008-10#1)(2008-11#1)
to improve our understanding of##3##5##(1993-12#1)(2008-10#1)(2008-11#1)
to improve outcomes##5##3##(2008-11#2)(2008-6#1)(2013-1#1)(2013-8#1)
to improve patient##4##3##(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
to improve quality and##2##4##(1994-2#1)(2010-8#1)
to improve quality of care##2##5##(2008-3#2)
to improve quality of##4##4##(1993-12#1)(2008-1#1)(2008-3#2)
to improve quality##7##3##(1993-12#1)(1994-2#1)(2008-1#1)(2008-3#2)(2010-8#1)(2013-1#1)
to improve resistance##2##3##(2008-10#1)(2012-5#1)
to improve satisfaction with##2##4##(2008-11#1)(2008-9#1)
to improve selectivity##2##3##(2008-10#1)(2008-11#1)
to improve survival and##2##4##(1994-6#1)(2011-3#1)
to improve survival##4##3##(1994-6#1)(2011-2#1)(2011-3#1)(2012-3#1)
to improve the accuracy of##2##5##(2008-10#1)(2008-3#1)
to improve the accuracy##3##4##(2008-10#2)(2008-3#1)
to improve the detection##3##4##(2008-10#2)(2008-3#1)
to improve the efficiency of##2##5##(2008-5#1)(2010-8#1)
to improve the health of the##2##6##(1991-6#1)(2013-1#1)
to improve the health of##4##5##(1991-6#1)(1993-3#1)(1995-1#1)(2013-1#1)
to improve the method##2##4##(2008-10#1)(2008-11#1)
to improve the performance of a##2##6##(1993-12#1)(2008-3#1)
to improve the performance of##5##5##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
to improve the performance##6##4##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
to improve the prediction##2##4##(2008-10#1)(2013-1#1)
to improve the process of##2##5##(1993-3#1)(2008-3#1)
to improve the production##2##4##(2008-11#2)
to improve the quality and##2##5##(1993-3#1)(2008-10#1)
to improve the quality of care provided##2##7##(2008-12#1)(2008-3#1)
to improve the quality of patient care##2##7##(1993-3#1)(2009-8#1)
to improve the quality of##12##5##(1990-2#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#1)(2008-10#1)(2008-12#2)(2008-3#1)(2009-8#1)(2010-4#1)(2013-1#1)
to improve the quality##14##4##(1990-2#1)(1992-2#1)(1992-3#1)(1993-3#2)(1994-3#1)(2008-10#2)(2008-12#2)(2008-3#1)(2009-8#1)(2010-4#1)(2013-1#1)
to improve the sensitivity of the##2##6##(2008-10#2)
to improve the sensitivity of##4##5##(2008-10#4)
to improve the sensitivity##5##4##(2008-10#5)
to improve the separation and##2##5##(2008-10#2)
to improve the separation##3##4##(2008-10#3)
to improve the stability of##2##5##(2008-10#1)(2013-1#1)
to improve the survival##2##4##(2008-11#1)(2010-12#1)
to improve the##136##3##(1990-11#1)(1990-2#2)(1991-11#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#5)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#2)(2007-12#1)(2007-8#1)(2008-10#45)(2008-11#17)(2008-12#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-2#4)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#9)(2013-8#2)
to improve their##12##3##(1993-2#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-2#3)(2012-3#1)
to improve understanding of##2##4##(2008-10#1)(2011-2#1)
to improve##356##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-1#3)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#2)(1992-11#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#9)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#3)(1996-12#5)(1996-2#4)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#68)(2008-11#45)(2008-12#6)(2008-3#11)(2008-4#1)(2008-5#6)(2008-6#6)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#18)(2011-3#1)(2011-9#1)(2012-12#2)(2012-2#8)(2012-3#6)(2012-5#1)(2012-8#1)(2013-1#27)(2013-7#1)(2013-8#8)
to improved##15##2##(1990-9#1)(1991-12#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
to improvement##3##2##(1993-3#1)(1995-3#1)(1997-8#1)
to improvements in##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
to improvements##5##2##(2008-11#2)(2008-3#1)(2009-6#1)(2009-8#1)
to improving the##4##3##(1993-3#1)(1996-2#1)(2008-11#1)(2010-9#1)
to improving##15##2##(1991-2#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
to in situ##2##3##(2008-10#1)(2008-2#1)
to in vitro##4##3##(1993-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
to in vivo##7##3##(1996-12#1)(1996-2#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-7#1)
to in##15##2##(1993-1#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#2)(2010-7#1)(2011-1#1)(2013-1#1)
to in-situ##2##2##(2008-10#1)(2013-8#1)
to inactivate 95% of the sporangia##2##6##(2008-10#2)
to inactivate the##2##3##(1995-2#1)(2008-10#1)
to inactivate##10##2##(1993-8#1)(1995-2#1)(2008-10#6)(2012-2#2)
to inactivation##2##2##(1990-5#1)(2007-12#1)
to inadequate care##2##3##(1992-2#1)(2008-10#1)
to inadequate##8##2##(1992-2#1)(1993-11#1)(1993-9#1)(2008-10#3)(2008-11#1)(2012-3#1)
to incidence##2##2##(2008-10#2)
to include a##11##3##(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-7#2)(2010-6#1)(2012-2#1)(2013-1#2)
to include the##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)
to include three##2##3##(1993-2#1)(2012-2#1)
to include##52##2##(1991-3#2)(1991-9#2)(1992-3#2)(1993-12#2)(1993-2#1)(1994-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-6#1)(2010-8#1)(2012-2#4)(2013-1#4)
to incomplete##7##2##(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)
to inconsistent##4##2##(2009-10#1)(2009-4#1)(2012-12#2)
to incorporate a##2##3##(1994-12#1)(2008-8#1)
to incorporate new##2##3##(1992-1#1)(2008-10#1)
to incorporate short term event time information##2##7##(2013-1#2)
to incorporate the##2##3##(2008-11#1)(2008-4#1)
to incorporate##26##2##(1992-1#1)(1992-3#1)(1994-12#1)(1995-2#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-4#1)(2008-6#2)(2008-8#1)(2009-11#1)(2010-7#1)(2011-1#2)(2013-1#3)
to incorporation##2##2##(1991-5#1)(2008-5#1)
to increase and##3##3##(2007-12#1)(2010-6#1)(2012-3#1)
to increase as the##2##4##(2008-12#1)(2008-7#1)
to increase as##4##3##(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
to increase both##2##3##(1993-6#1)(2008-10#1)
to increase efficiency##2##3##(2008-11#1)(2008-12#1)
to increase for##2##3##(1991-12#1)(2008-10#1)
to increase in the##3##4##(1994-6#1)(2008-9#1)(2011-2#1)
to increase in##8##3##(1994-3#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
to increase its##2##3##(2008-10#1)(2008-7#1)
to increase our understanding of##2##5##(2008-8#1)(2013-1#1)
to increase our understanding##3##4##(2008-8#1)(2011-2#1)(2013-1#1)
to increase oxygen delivery##2##4##(1996-3#1)(2010-7#1)
to increase productivity and##2##4##(1993-3#1)(2008-11#1)
to increase proportionally##2##3##(2008-10#1)(2012-2#1)
to increase recombinant protein production in##2##6##(2008-11#1)(2011-2#1)
to increase sample##2##3##(2008-10#2)
to increase sensitivity and##2##4##(2008-10#2)
to increase sensitivity##5##3##(2008-10#5)
to increase significantly##2##3##(2008-10#1)(2011-2#1)
to increase the awareness##2##4##(2011-2#1)(2012-3#1)
to increase the expression##2##4##(1996-2#1)(2009-4#1)
to increase the level of##2##5##(2008-10#1)(2008-5#1)
to increase the likelihood of##2##5##(2008-9#1)(2010-10#1)
to increase the likelihood##3##4##(2008-9#1)(2010-10#2)
to increase the physical activity of healthcare workers in a public hospital in South Africa##2##15##(2013-1#2)
to increase the probability of##3##5##(2008-3#1)(2008-7#2)
to increase the sensitivity and##2##5##(2008-10#2)
to increase the sensitivity##6##4##(2008-10#6)
to increase the##70##3##(1993-3#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
to increase their##4##3##(1990-12#1)(1992-12#1)(1996-3#1)(2011-7#1)
to increase understanding##2##3##(2008-12#2)
to increase with increasing##2##4##(1996-6#1)(2008-9#1)
to increase with the##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
to increase with time##3##4##(1991-2#1)(2008-10#2)
to increase with##9##3##(1991-2#1)(1996-6#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#2)
to increase##233##2##(1990-12#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#3)(1995-5#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#5)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#4)(2008-10#55)(2008-11#16)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#3)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#12)(2013-8#2)
to increased drug##2##3##(1997-3#1)(2013-1#1)
to increased risk of##3##4##(2008-8#1)(2013-1#1)(2013-8#1)
to increased##64##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#3)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#5)(2013-7#1)(2013-8#2)
to increases in##5##3##(1991-2#1)(1994-5#1)(2008-10#2)(2008-12#1)
to increasethe##2##2##(2008-11#2)
to increasing the##2##3##(2008-10#1)(2008-9#1)
to increasing##12##2##(1992-5#1)(1992-6#1)(1993-8#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#1)(2012-4#1)
to incubate##2##2##(1990-12#1)(2008-8#1)
to incubation##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
to independent living##3##3##(2008-12#1)(2009-10#1)(2013-1#1)
to independent##4##2##(2008-11#1)(2008-12#1)(2009-10#1)(2013-1#1)
to independently##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
to index##2##2##(2008-3#1)(2008-4#1)
to indicate a##3##3##(1994-8#1)(2008-7#1)(2009-10#1)
to indicate that##9##3##(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-11#1)(2010-12#1)(2013-1#1)
to indicate the##7##3##(1992-6#1)(2008-10#4)(2008-11#1)(2008-12#1)
to indicate##26##2##(1991-6#1)(1992-6#1)(1994-8#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
to indirect effects##2##3##(2008-11#1)(2012-2#1)
to indirect##3##2##(2008-11#2)(2012-2#1)
to indirectly##2##2##(2008-10#1)(2008-4#1)
to individual##24##2##(1991-1#1)(1994-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)
to individualize##2##2##(1997-4#1)(2010-10#1)
to individuals with##2##3##(1992-12#1)(1994-2#1)
to induce DNA ISC##2##4##(2008-11#2)
to induce DNA damage##2##4##(1993-12#1)(2008-5#1)
to induce DNA##5##3##(1993-12#1)(2008-11#3)(2008-5#1)
to induce a hypersensitive##2##4##(2008-10#2)
to induce a##14##3##(1994-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)
to induce an##2##3##(1993-3#1)(2008-10#1)
to induce antibody##2##3##(1995-5#1)(2008-11#1)
to induce apoptosis##3##3##(1994-9#1)(2008-8#1)(2009-12#1)
to induce cell##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
to induce differentiation##2##3##(1997-3#1)(2008-11#1)
to induce ectopic##2##3##(2008-4#1)(2011-2#1)
to induce fluorescence##2##3##(2008-10#2)
to induce intrinsic##2##3##(1997-7#1)(2011-2#1)
to induce lysosomal storage of##2##5##(1993-12#2)
to induce lysosomal##3##3##(1993-12#3)
to induce platelet activation##2##4##(2006-6#2)
to induce resistance in##3##4##(2008-10#3)
to induce resistance##5##3##(2008-10#5)
to induce systemic resistance in tobacco##2##6##(2008-10#2)
to induce systemic resistance in##5##5##(2008-10#5)
to induce systemic resistance##7##4##(2008-10#7)
to induce systemic##8##3##(2008-10#8)
to induce the##7##3##(1996-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-7#1)
to induce tumors in##2##4##(2008-10#1)(2008-12#1)
to induce##147##2##(1990-5#1)(1991-5#5)(1992-12#1)(1993-12#5)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#3)(2006-6#2)(2008-10#46)(2008-11#16)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#3)(2010-11#1)(2010-7#3)(2011-2#7)(2012-2#1)(2013-1#4)
to induced##5##2##(2008-10#1)(2008-7#2)(2008-9#1)(2013-1#1)
to induction of apoptosis in##2##5##(2008-11#1)(2008-9#1)
to induction of##6##3##(1993-3#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
to induction##7##2##(1993-3#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
to inductively coupled plasma##5##4##(2008-10#5)
to industrial##2##2##(1995-2#1)(2008-10#1)
to infant##2##2##(1990-12#1)(2009-9#1)
to infant's##2##2##(1990-12#2)
to infect a##2##3##(2008-10#2)
to infect different##2##3##(2008-10#2)
to infect its host##2##4##(2008-10#2)
to infect sclerotia##2##3##(2008-10#2)
to infect the##3##3##(2008-10#2)(2008-8#1)
to infect##42##2##(1997-1#1)(2008-10#36)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
to infected##6##2##(1990-9#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
to infection and##3##3##(2008-10#3)
to infection at##2##3##(2008-10#2)
to infection by M##2##4##(2008-10#2)
to infection by##15##3##(2008-10#14)(2010-7#1)
to infection of##2##3##(2008-10#1)(2009-6#1)
to infection was##3##3##(2008-10#3)
to infection with##6##3##(1995-5#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)
to infection##65##2##(1993-12#1)(1995-5#1)(2008-10#52)(2008-7#2)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#4)(2012-3#1)
to infections in##3##3##(1990-9#1)(2008-10#1)(2008-9#1)
to infections##8##2##(1990-9#1)(2007-8#1)(2008-10#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
to infectious diseases##4##3##(1997-8#1)(2008-10#3)
to infectious##8##2##(1997-8#2)(2008-10#4)(2008-5#1)(2008-8#1)
to infer climate##2##3##(2008-10#1)(2012-7#1)
to infer the##5##3##(2008-11#1)(2008-3#3)(2008-8#1)
to infer##17##2##(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#2)(2008-8#1)(2010-3#1)(2012-7#1)(2012-9#1)(2013-1#1)(2013-8#1)
to infestation with##3##3##(1996-12#1)(2008-10#2)
to infestation##4##2##(1996-12#1)(2008-10#3)
to infiltrate##2##2##(2008-10#1)(2010-12#1)
to infiltration of##3##3##(2008-10#2)(2009-5#1)
to inflammation##5##2##(1990-5#2)(1992-6#1)(2012-2#1)(2013-8#1)
to inflammatory##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
to influence eating habits##2##4##(2010-1#2)
to influence the degree##2##4##(2008-7#1)(2009-7#1)
to influence the##20##3##(1990-9#1)(1995-11#1)(1995-12#3)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)
to influence their##2##3##(1997-1#1)(2008-8#1)
to influence##48##2##(1990-9#1)(1991-6#1)(1993-6#1)(1995-11#1)(1995-12#4)(1996-1#1)(1996-12#2)(1997-1#3)(1997-3#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-5#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
to influenza##5##2##(1992-6#2)(2008-5#1)(2011-2#2)
to inform and##2##3##(1994-1#1)(2012-3#1)
to inform the##4##3##(1992-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
to inform them##2##3##(1996-6#1)(2012-3#1)
to inform##33##2##(1992-1#2)(1994-1#1)(1996-1#1)(1996-6#1)(1997-3#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
to information##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
to infrared##2##2##(2008-10#1)(2011-2#1)
to inherit##4##2##(2008-8#4)
to inhibit growth of##3##4##(1993-1#1)(2010-11#1)(2011-2#1)
to inhibit growth##4##3##(1993-1#1)(1995-2#1)(2010-11#1)(2011-2#1)
to inhibit human##2##3##(1992-8#1)(2008-10#1)
to inhibit proliferation##2##3##(1997-3#1)(2013-7#1)
to inhibit the binding of##2##5##(1994-8#1)(1995-11#1)
to inhibit the expression of##3##5##(1995-11#1)(2008-9#1)(2010-1#1)
to inhibit the formation of##2##5##(1994-5#1)(1996-3#1)
to inhibit the growth of##5##5##(2008-10#5)
to inhibit the##29##3##(1990-9#1)(1991-5#1)(1992-6#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-11#5)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)
to inhibit this##2##3##(1995-11#1)(2008-11#1)
to inhibit thrombin formation##2##4##(1994-5#2)
to inhibit tumor##2##3##(2008-11#1)(2008-9#1)
to inhibit##84##2##(1990-4#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-6#4)(1992-8#1)(1993-1#1)(1993-8#3)(1994-11#1)(1994-5#3)(1994-8#5)(1995-11#9)(1995-2#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#2)(2008-1#1)(2008-10#13)(2008-11#6)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-12#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
to inhibition by##5##3##(1994-8#1)(1995-8#2)(1997-1#1)(2013-7#1)
to inhibition of 5-HT##2##4##(2008-7#2)
to inhibition of##9##3##(1994-12#1)(1995-8#1)(2008-10#1)(2008-7#2)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
to inhibition##19##2##(1992-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#3)(1997-1#1)(2008-10#4)(2008-7#2)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
to inhibitors##2##2##(2008-10#1)(2013-1#1)
to initial##10##2##(1996-1#1)(2008-10#6)(2008-8#1)(2008-9#1)(2010-11#1)
to initially##2##2##(2008-10#1)(2012-12#1)
to initiate a biological weapons program##2##6##(1992-12#2)
to initiate a biological weapons##3##5##(1992-12#3)
to initiate a##6##3##(1992-12#3)(2008-10#1)(2009-9#1)(2012-2#1)
to initiate the##7##3##(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)
to initiate transcription##2##3##(1995-2#1)(1996-2#1)
to initiate treatment##2##3##(2010-12#1)(2013-8#1)
to initiate##34##2##(1992-12#3)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-2#2)(1997-2#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
to initiating##3##2##(2012-12#1)(2012-2#1)(2013-1#1)
to initiation of##4##3##(1991-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
to initiation##5##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
to inject##2##2##(2008-10#1)(2013-8#1)
to injection##4##2##(1995-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
to injury##12##2##(1990-7#2)(1992-9#1)(1995-11#2)(2008-1#3)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
to inoculate a##2##3##(2008-10#1)(2008-11#1)
to inoculate##8##2##(2008-10#7)(2008-11#1)
to inoculation with##7##3##(2008-10#7)
to inoculation##14##2##(2008-10#13)(2008-8#1)
to inoculum or##2##3##(2008-10#2)
to inoculum##8##2##(2008-10#8)
to inorganic mercury##3##3##(2008-10#3)
to inorganic##5##2##(1990-5#1)(2008-10#3)(2008-3#1)
to inositol 1##2##3##(1993-8#2)
to inositol##5##2##(1993-8#2)(2008-8#3)
to insect feeding##4##3##(2009-8#4)
to insecticides##2##2##(2012-12#2)
to insert in##2##3##(2008-10#1)(2013-1#1)
to insert##5##2##(1996-2#1)(2008-10#1)(2010-7#1)(2013-1#2)
to inspect##2##2##(1997-5#1)(2008-6#1)
to instill##2##2##(2008-12#2)
to institutional care##2##3##(1993-3#1)(1995-3#1)
to insufficient##7##2##(1990-5#1)(1994-12#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-8#1)
to insulin##10##2##(1991-7#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-9#1)(2012-5#1)
to insure##4##2##(1994-3#1)(1997-2#1)(2008-10#1)(2008-9#1)
to intact cells##2##3##(1994-11#1)(1997-1#1)
to intact##6##2##(1991-5#1)(1994-11#1)(1994-8#1)(1997-1#1)(2008-10#2)
to integrate and##2##3##(1994-12#1)(1995-1#1)
to integrate the##4##3##(1993-2#1)(2008-11#1)(2008-7#1)(2012-3#1)
to integrate this##3##3##(1997-2#1)(2008-10#1)(2010-12#1)
to integrate##31##2##(1991-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1997-2#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)
to integrated treatment at 12 months##2##6##(2012-3#2)
to integrated treatment##4##3##(2012-3#4)
to integrated##7##2##(1997-7#1)(2008-10#1)(2008-2#1)(2012-3#4)
to integrating##5##2##(1994-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2009-6#1)
to integration##2##2##(2008-11#1)(2012-2#1)
to intensify##3##2##(2008-11#2)(2010-10#1)
to intensive care##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
to intensive##5##2##(2008-11#1)(2012-3#1)(2013-1#3)
to interact directly##3##3##(1995-6#2)(2008-4#1)
to interact in##2##3##(1993-6#1)(1994-5#1)
to interact with a##3##4##(1995-2#1)(2009-3#1)(2012-2#1)
to interact with proteins##2##4##(2008-10#1)(2009-8#1)
to interact with the##7##4##(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2010-5#1)(2012-3#2)
to interact with##30##3##(1993-3#1)(1993-8#1)(1994-5#2)(1995-11#1)(1995-2#3)(1995-6#1)(1996-6#1)(2008-10#8)(2008-11#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
to interact##36##2##(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#4)(1995-11#1)(1995-2#3)(1995-6#3)(1996-6#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
to interaction##2##2##(1994-2#1)(2008-3#1)
to interactions##4##2##(1991-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
to intercalate##3##2##(1991-6#1)(2008-10#1)(2008-6#1)
to intercellular junctions##2##3##(2009-10#2)
to intercellular##3##2##(2008-10#1)(2009-10#2)
to interdisciplinary##2##2##(1992-11#1)(1993-2#1)
to interest##3##2##(1993-1#1)(1994-12#1)(2008-10#1)
to interface##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
to interfere with##13##3##(1994-8#1)(1995-2#1)(1997-1#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#1)
to interfere##17##2##(1994-8#1)(1995-2#1)(1997-1#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#1)(2013-1#1)
to interference from##3##3##(2008-10#3)
to interference##4##2##(2008-10#4)
to interferences##6##2##(1991-7#1)(2008-10#5)
to interleukin-1##2##2##(1990-10#1)(1992-6#1)
to intermediate##2##2##(1991-1#1)(1993-9#1)
to internal membranes##2##3##(1990-5#2)
to internal##7##2##(1990-5#2)(1992-12#1)(1993-9#1)(1995-8#1)(2008-11#2)
to international##2##2##(1992-12#1)(2012-3#1)
to interpret results##2##3##(1991-3#1)(2008-10#1)
to interpret the data##2##4##(2008-9#1)(2012-3#1)
to interpret the##7##3##(1995-3#1)(2008-10#1)(2008-9#3)(2012-2#1)(2012-3#1)
to interpret##21##2##(1991-11#1)(1991-3#1)(1993-2#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
to interrogate##3##2##(2008-10#2)(2011-2#1)
to interspecific interactions##2##3##(2008-8#2)
to interspecific##3##2##(2008-10#1)(2008-8#2)
to intervene at##2##3##(2006-6#1)(2008-1#1)
to intervene##6##2##(1995-6#1)(2006-6#1)(2008-1#1)(2008-12#3)
to interventions##4##2##(2008-1#1)(2008-6#1)(2009-9#1)(2013-1#1)
to intestinal##4##2##(2008-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
to intracellular##3##2##(1995-8#1)(2008-11#1)(2009-1#1)
to intravenous##2##2##(1992-2#1)(1997-2#1)
to introduce 20 mul volumes into the##2##7##(2008-10#2)
to introduce a##3##3##(1997-8#1)(2008-4#1)(2009-8#1)
to introduce investigators to the types of##2##7##(2008-4#2)
to introduce the##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2009-1#1)
to introduce##28##2##(1993-8#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2009-1#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
to introduction of the##2##4##(2008-10#2)
to invade a##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
to invade the##2##3##(2008-10#2)
to invade##10##2##(2008-10#4)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
to invasion##4##2##(2008-10#3)(2008-8#1)
to invasive ALM over a##2##5##(2010-6#2)
to invasive##4##2##(1995-8#1)(2010-6#2)(2011-2#1)
to invest##2##2##(1992-8#1)(1993-12#1)
to investigate a##2##3##(2008-11#1)(2013-1#1)
to investigate any##2##3##(2008-11#1)(2010-8#1)
to investigate factors##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
to investigate how##6##3##(1994-12#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
to investigate its##4##3##(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
to investigate key##2##3##(1993-8#1)(2008-11#1)
to investigate possible##3##3##(2008-10#1)(2008-8#1)(2010-6#1)
to investigate some##2##3##(1993-8#1)(2008-11#1)
to investigate the association between the##2##6##(2008-3#1)(2011-2#1)
to investigate the association between##3##5##(2008-3#1)(2011-2#1)(2013-1#1)
to investigate the cellular##2##4##(1994-8#1)(2008-4#1)
to investigate the characteristics of##2##5##(2008-3#1)(2011-3#1)
to investigate the effect of##19##5##(2008-10#4)(2008-12#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
to investigate the effectiveness of##3##5##(2008-10#1)(2013-1#2)
to investigate the effects and##2##5##(2008-3#1)(2011-3#1)
to investigate the effects of##13##5##(1992-2#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
to investigate the effects##15##4##(1992-2#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
to investigate the efficacy of##2##5##(2009-8#1)(2013-1#1)
to investigate the expression##3##4##(2008-10#2)(2008-9#1)
to investigate the factors##2##4##(1994-12#1)(2008-7#1)
to investigate the genetic diversity##2##5##(2008-10#1)(2013-8#1)
to investigate the impact of##2##5##(2012-3#1)(2013-8#1)
to investigate the influence of the##3##6##(2008-10#2)(2011-2#1)
to investigate the influence of##10##5##(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#3)
to investigate the mechanism of##4##5##(1994-8#1)(2008-6#1)(2010-12#1)(2011-2#1)
to investigate the mechanisms##2##4##(2008-11#1)(2012-3#1)
to investigate the molecular basis of##2##6##(1996-12#1)(1996-2#1)
to investigate the molecular##3##4##(1996-12#1)(1996-2#1)(2008-9#1)
to investigate the neural##2##4##(2008-11#1)(2008-9#1)
to investigate the origin of##2##5##(1997-8#1)(2008-10#1)
to investigate the possibility of##3##5##(1994-8#1)(2008-11#1)(2012-3#1)
to investigate the possible##2##4##(2008-5#1)(2012-2#1)
to investigate the potential##2##4##(2011-2#1)(2012-3#1)
to investigate the putative##2##4##(2008-10#1)(2008-11#1)
to investigate the relationship between the##6##6##(1991-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
to investigate the relationship between##14##5##(1991-2#1)(1994-3#2)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
to investigate the relationship##16##4##(1991-2#1)(1994-3#2)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
to investigate the relationships between##5##5##(1992-1#1)(2008-10#1)(2008-9#1)(2010-6#1)(2010-8#1)
to investigate the role of the##2##6##(2008-10#2)
to investigate the role of##8##5##(1993-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2011-2#2)
to investigate the role##9##4##(1993-12#1)(1993-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2011-2#2)
to investigate the##218##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#4)(1995-12#1)(1995-2#1)(1996-12#4)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#48)(2008-11#14)(2008-12#7)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#10)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#15)(2011-3#4)(2012-12#2)(2012-2#4)(2012-3#12)(2013-1#7)(2013-8#5)
to investigate their##10##3##(1990-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)
to investigate this##3##3##(1996-1#1)(2008-11#1)(2008-5#1)
to investigate whether the##2##4##(2008-10#1)(2008-8#1)
to investigate whether there is##2##5##(1992-12#1)(2011-2#1)
to investigate whether##15##3##(1992-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
to investigate##338##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#2)(1994-12#4)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#5)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#70)(2008-11#36)(2008-12#11)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#13)(2008-6#2)(2008-7#12)(2008-8#10)(2008-9#13)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#23)(2011-3#4)(2012-12#2)(2012-2#8)(2012-3#17)(2012-5#1)(2013-1#11)(2013-8#6)
to investigated##2##2##(2008-7#1)(2012-3#1)
to investigation##5##2##(2008-11#4)(2010-10#1)
to involve the##6##3##(1995-6#1)(1997-8#1)(2008-10#2)(2011-2#2)
to involve##23##2##(1991-2#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-9#1)(2009-1#1)(2010-9#1)(2011-2#2)(2013-8#1)
to iodate##3##2##(2008-10#3)
to iodine##6##2##(2008-10#5)(2011-1#1)
to ion chromatographic##2##3##(2008-10#2)
to ion##6##2##(2008-10#5)(2012-3#1)
to ion-pair##2##2##(2008-10#2)
to ionizing radiation##6##3##(1995-12#1)(1995-6#1)(1997-7#1)(2008-7#1)(2008-9#2)
to ionizing##8##2##(1995-12#1)(1995-5#1)(1995-6#1)(1997-7#2)(2008-7#1)(2008-9#2)
to ions##2##2##(1990-5#1)(2008-8#1)
to iprodione##6##2##(2008-10#6)
to iron(II)##2##2##(2008-10#2)
to iron(III) by##2##3##(2008-10#2)
to iron(III)##3##2##(2008-10#3)
to irradiate##2##2##(2008-10#1)(2008-8#1)
to ischemia##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
to ischemic##4##2##(1996-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
to islet##2##2##(2010-11#2)
to isolate MG2##3##3##(2008-10#3)
to isolate MG96-36##3##3##(2008-10#3)
to isolate a##2##3##(1991-5#1)(2008-10#1)
to isolate and quantify##3##4##(1997-2#1)(2008-10#2)
to isolate and##5##3##(1990-2#1)(1993-8#1)(1997-2#1)(2008-10#2)
to isolate the##7##3##(1992-6#1)(1997-2#2)(2008-10#2)(2008-4#1)(2012-2#1)
to isolate##48##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1996-6#1)(1997-2#4)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
to isolated##4##2##(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)
to isolates from##3##3##(2008-10#3)
to isolates of the##2##4##(2008-10#2)
to isolates of##6##3##(2008-10#6)
to isolates##13##2##(2008-10#13)
to issues of##2##3##(1991-12#1)(2008-12#1)
to issues that##2##3##(1997-2#1)(2008-11#1)
to issues##7##2##(1991-12#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-12#1)
to it##15##2##(1992-12#1)(1993-1#1)(1995-5#1)(1996-6#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
to items##2##2##(2008-9#1)(2012-2#1)
to iterative##2##2##(2008-10#2)
to its ability to##5##4##(1993-3#1)(1997-2#1)(2008-10#2)(2011-2#1)
to its central##2##3##(2008-10#1)(2011-2#1)
to its consistency##2##3##(2008-10#1)(2012-2#1)
to its determination by##4##4##(2008-10#4)
to its determination in##2##4##(2008-10#2)
to its determination##6##3##(2008-10#6)
to its effect on##4##4##(1993-8#1)(1995-11#1)(2008-10#1)(2010-4#1)
to its effect##5##3##(1993-8#1)(1995-11#1)(2008-10#2)(2010-4#1)
to its functional##2##3##(2011-2#2)
to its high##6##3##(1993-3#1)(2008-10#3)(2008-12#1)(2009-12#1)
to its implementation##2##3##(1995-3#1)(2008-3#1)
to its importance##2##3##(2008-10#1)(2008-5#1)
to its inhibition of##2##4##(1992-9#1)(1993-8#1)
to its low##2##3##(1997-7#1)(2008-10#1)
to its molecular##2##3##(1991-2#1)(2008-4#1)
to its native##3##3##(2008-10#2)(2008-9#1)
to its natural##2##3##(2008-10#1)(2008-8#1)
to its rarity##2##3##(2008-10#1)(2011-2#1)
to its receptor##9##3##(1991-12#1)(1992-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(2008-5#1)(2008-7#1)(2008-9#1)
to its simplicity##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
to its unparalleled##2##3##(2010-7#1)(2013-1#1)
to its wide availability and its##2##6##(2009-1#2)
to its wide##3##3##(2008-10#1)(2009-1#2)
to its##233##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-3#3)(1993-8#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#4)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(2007-12#1)(2008-10#64)(2008-11#14)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#12)(2008-7#2)(2008-8#6)(2008-9#5)(2009-1#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-10#1)(2011-2#14)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
to jasmonic acid##2##3##(2008-5#1)(2012-2#1)
to jasmonic##3##2##(2008-5#1)(2009-6#1)(2012-2#1)
to job##2##2##(1996-2#1)(2009-10#1)
to join##4##2##(2008-8#1)(2008-9#1)(2009-4#1)(2012-2#1)
to joint##2##2##(2008-10#1)(2012-3#1)
to journal##2##2##(1991-12#1)(1993-12#1)
to judge whether##2##3##(1996-2#1)(2008-8#1)
to judge##6##2##(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
to just##3##2##(1992-9#1)(2008-10#2)
to justify the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
to justify##6##2##(1995-5#1)(2008-10#2)(2008-11#2)(2011-2#1)
to keep in mind that##2##5##(1992-3#1)(2009-12#1)
to keep in mind##3##4##(1992-3#1)(2009-1#1)(2009-12#1)
to keep in##4##3##(1992-3#1)(2008-11#1)(2009-1#1)(2009-12#1)
to keep pace##2##3##(1995-1#1)(1996-2#1)
to keep the##7##3##(1992-1#1)(1992-3#1)(1994-3#1)(1997-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
to keep their##3##3##(1993-1#1)(2009-10#1)(2010-7#1)
to keep them##2##3##(1993-6#1)(2010-4#1)
to keep##35##2##(1990-3#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)
to keratinocytes##3##2##(1996-2#1)(2012-2#2)
to key##2##2##(2008-1#1)(2008-11#1)
to kidney##3##2##(1995-12#2)(2008-10#1)
to kill##11##2##(1995-2#3)(1997-5#1)(2008-10#3)(2008-11#2)(2009-6#1)(2011-2#1)
to killing by##2##3##(1995-8#1)(2012-2#1)
to kinetic data##2##3##(2008-10#1)(2008-4#1)
to kinetic##3##2##(2008-10#2)(2008-4#1)
to know if##2##3##(1993-3#1)(2008-11#1)
to know that##2##3##(1995-9#1)(1997-5#1)
to know the incidence of##2##5##(2008-11#1)(2013-8#1)
to know the##17##3##(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
to know what##2##3##(2008-11#1)(2008-4#1)
to know whether##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
to know##34##2##(1993-3#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
to knowledge in##2##3##(2008-11#1)(2013-8#1)
to knowledge##8##2##(1993-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-10#1)(2011-1#1)(2013-8#1)
to known genes##6##3##(1995-12#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-8#2)
to known proteins##4##3##(1995-12#1)(1995-9#1)(1996-8#1)(1997-7#1)
to known##26##2##(1991-5#1)(1991-6#1)(1993-6#1)(1995-12#2)(1995-8#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#9)(2008-11#1)(2008-5#1)
to label the##3##3##(2008-11#1)(2008-9#2)
to label##11##2##(1997-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#4)(2012-2#1)(2013-1#1)
to laboratory##2##2##(2008-10#1)(2011-2#1)
to lack of a##2##4##(1993-12#1)(1993-2#1)
to lack of##15##3##(1993-12#1)(1993-2#1)(1996-11#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#2)(2012-12#1)(2013-1#2)
to lack##18##2##(1991-5#1)(1993-12#1)(1993-2#1)(1996-11#1)(1997-7#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#2)(2012-12#1)(2013-1#2)
to lamin##2##2##(2008-8#1)(2011-2#1)
to laparoscopic surgery##2##3##(2009-8#1)(2013-1#1)
to laparoscopic##3##2##(1994-2#1)(2009-8#1)(2013-1#1)
to laparotomy##5##2##(1993-3#1)(1994-2#1)(1995-3#1)(1996-1#1)(2012-3#1)
to large scale##3##3##(2008-11#1)(2008-7#2)
to large##17##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2013-1#1)
to large-scale##6##2##(1990-5#1)(1996-12#1)(2008-4#2)(2008-9#1)(2012-2#1)
to larger##2##2##(1995-6#1)(2008-10#1)
to laser##4##2##(1993-3#1)(1994-3#1)(2008-3#1)(2013-1#1)
to last##2##2##(2009-12#1)(2013-1#1)
to late adolescence##2##3##(2009-7#2)
to late blight##3##3##(2008-10#3)
to late##17##2##(1990-11#1)(1991-2#1)(2006-6#1)(2008-10#7)(2009-7#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
to latent infection##4##3##(2008-10#4)
to latent##6##2##(2008-10#5)(2008-9#1)
to later##4##2##(2008-1#1)(2008-10#2)(2009-11#1)
to launch##2##2##(2008-3#1)(2008-5#1)
to lay the foundation for##3##5##(2008-4#1)(2012-12#1)(2013-8#1)
to lay##7##2##(1994-1#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#1)(2013-8#1)
to layer##2##2##(2008-11#1)(2008-7#1)
to lead a##2##3##(1994-9#1)(2013-8#1)
to lead the##2##3##(2009-6#1)(2009-7#1)
to lead to greater##2##4##(2009-7#1)(2011-2#1)
to lead to the##2##4##(2008-8#1)(2011-2#1)
to lead to##10##3##(1993-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2013-1#1)
to lead##22##2##(1993-2#1)(1993-3#1)(1994-9#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#2)(2011-2#2)(2013-1#2)(2013-8#1)
to leaf blast##3##3##(2008-10#3)
to leaf rust and##4##4##(2008-10#4)
to leaf rust##11##3##(2008-10#11)
to leaf spot disease##2##4##(2008-10#2)
to leaf spot##3##3##(2008-10#3)
to leaf##29##2##(2008-10#28)(2012-9#1)
to lean##2##2##(2008-9#1)(2012-3#1)
to learn about their##2##4##(2011-2#1)(2012-2#1)
to learn about##4##3##(1994-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
to learn and##3##3##(1994-3#1)(2008-11#1)(2010-11#1)
to learn from##2##3##(2008-11#1)(2008-4#1)
to learn how to##3##4##(1991-3#1)(1994-1#1)(1995-9#1)
to learn how##4##3##(1991-3#1)(1994-1#1)(1995-9#1)(2012-2#1)
to learn more about the##2##5##(1993-11#1)(2010-11#1)
to learn of##2##3##(1993-12#1)(1996-5#1)
to learn the##3##3##(1994-12#1)(2008-8#1)(2013-1#1)
to learn to##3##3##(1991-2#1)(1996-12#1)(2008-8#1)
to learn##35##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-11#5)(2008-4#1)(2008-8#2)(2010-11#3)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#1)
to learning in a##2##4##(2008-11#1)(2011-1#1)
to learning in##5##3##(2008-11#4)(2011-1#1)
to learning##18##2##(2008-11#9)(2011-1#8)(2011-2#1)
to leave the nest##2##4##(2008-8#2)
to leave the##4##3##(1995-6#1)(2008-8#2)(2008-9#1)
to leave their practices##2##4##(2008-9#2)
to leave their##3##3##(2008-9#3)
to leave##12##2##(1993-6#1)(1995-6#1)(2008-8#3)(2008-9#5)(2013-1#1)(2013-8#1)
to leaves##7##2##(2008-10#7)
to left##3##2##(2009-10#2)(2012-2#1)
to lenticels##2##2##(2008-10#2)
to leprosis##3##2##(2008-10#3)
to less positive values##2##4##(2008-10#2)
to less than 0##3##4##(1991-6#1)(2008-10#1)(2008-3#1)
to less than 1##2##4##(1991-10#1)(2008-9#1)
to less than 50%##2##4##(1994-3#1)(2008-5#1)
to less than##16##3##(1990-5#1)(1991-10#1)(1991-2#1)(1991-6#1)(1994-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-2#1)
to less##23##2##(1990-5#1)(1991-10#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-3#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
to lessen##2##2##(1997-2#1)(2009-9#1)
to lesser##3##2##(1993-8#2)(1995-6#1)
to let the##2##3##(1994-1#1)(1995-6#1)
to lettuce##4##2##(2008-10#4)
to levamisole##2##2##(2008-1#2)
to levels comparable to##2##4##(1990-2#1)(1993-12#1)
to levels of##3##3##(1995-8#1)(1996-2#1)(2008-10#1)
to levels significantly lower than##2##5##(2008-10#1)(2008-8#1)
to levels##12##2##(1990-2#1)(1993-12#1)(1995-8#2)(1996-2#1)(2008-10#3)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#1)
to levodopa##2##2##(2008-7#2)
to liberate##3##2##(2008-10#2)(2008-6#1)
to lie##3##2##(1994-5#1)(2008-10#2)
to life and##6##3##(1993-11#1)(1996-12#1)(2011-2#4)
to life in##2##3##(2009-8#1)(2011-2#1)
to life##16##2##(1993-11#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#6)(2013-1#1)
to life-threatening##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
to lift##3##2##(1994-2#1)(1997-3#1)(2008-11#1)
to ligand##4##2##(1995-2#1)(2008-10#3)
to light##17##2##(1994-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)
to limit the risk of##2##5##(2008-11#1)(2011-3#1)
to limit the spread of##2##5##(1990-6#1)(2011-2#1)
to limit the##12##3##(1990-6#1)(1991-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2009-4#1)(2011-2#1)(2011-3#1)
to limit##24##2##(1990-6#1)(1991-1#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-7#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#1)
to limitations##2##2##(2008-11#1)(2008-12#1)
to link population##2##3##(1994-9#1)(2008-10#1)
to link the##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
to link them##2##3##(1993-2#1)(2008-6#1)
to link theory##2##3##(2008-11#1)(2008-12#1)
to link##19##2##(1992-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
to lipid##3##2##(1991-12#1)(1994-5#1)(2008-4#1)
to lipopolysaccharide##3##2##(1990-5#2)(1997-1#1)
to lipoprotein##2##2##(1991-12#1)(1995-2#1)
to liquid##4##2##(1995-11#1)(2008-10#2)(2008-9#1)
to literature##4##2##(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#1)
to lithium##4##2##(2008-10#3)(2009-8#1)
to live with##3##3##(1994-2#1)(1995-9#1)(2008-8#1)
to live##10##2##(1993-12#1)(1994-2#1)(1995-9#1)(1997-2#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-10#1)(2013-8#1)
to liver##10##2##(1990-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(2008-11#1)(2011-2#4)(2013-1#1)
to livestock and##2##3##(2008-10#2)
to livestock##4##2##(1997-7#1)(2008-10#3)
to local##17##2##(1990-11#1)(1991-2#1)(1992-9#1)(1994-1#1)(1994-6#1)(1996-2#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-11#1)(2013-1#1)
to localise##2##2##(2008-11#1)(2012-2#1)
to localised##2##2##(2008-11#1)(2012-2#1)
to localize and##3##3##(1994-9#1)(2008-10#1)(2011-2#1)
to localize the##5##3##(1990-11#1)(1993-8#1)(1995-2#1)(1996-12#1)(2013-1#1)
to localize##22##2##(1990-11#1)(1990-2#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
to localized##3##2##(1993-3#1)(2008-10#1)(2012-12#1)
to locally##2##2##(2008-10#1)(2008-3#1)
to locate the##2##3##(1994-9#1)(2008-10#1)
to locate##11##2##(1990-11#2)(1992-3#1)(1994-9#1)(1995-12#3)(2008-10#3)(2011-2#1)
to location of the##2##4##(2008-10#1)(2008-5#1)
to log K(ex)##2##3##(2008-10#2)
to log##3##2##(2008-10#2)(2008-5#1)
to long##2##2##(2008-9#1)(2009-8#1)
to long-term##7##2##(1994-5#1)(1996-2#1)(1997-4#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-3#1)
to longer wavelengths##2##3##(2008-10#1)(2008-3#1)
to longer##5##2##(2008-10#3)(2008-3#1)(2008-4#1)
to longitudinal##2##2##(1993-12#1)(2008-10#1)
to look at##5##3##(1993-2#1)(1994-2#1)(1996-3#1)(1997-3#1)(2010-10#1)
to look for the##2##4##(2008-12#1)(2008-5#1)
to look for##6##3##(1991-11#1)(1992-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
to look up##2##3##(1992-3#1)(2008-6#1)
to look##16##2##(1991-11#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)
to loose##2##2##(2012-12#1)(2013-1#1)
to loosen##2##2##(1995-2#1)(2010-1#1)
to lose weight##2##3##(1993-1#1)(2010-8#1)
to lose##6##2##(1993-1#1)(2008-10#3)(2008-8#1)(2010-8#1)
to loss of##8##3##(1991-12#1)(1992-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
to loss##9##2##(1991-12#1)(1992-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
to low P##2##3##(2012-3#2)
to low dose##2##3##(2008-7#2)
to low doses of##4##4##(2008-10#1)(2008-7#3)
to low doses##6##3##(2008-10#1)(2008-5#1)(2008-7#4)
to low levels##2##3##(2007-12#1)(2008-11#1)
to low molecular weight##2##4##(2008-10#2)
to low temperature##4##3##(2008-11#2)(2011-1#2)
to low##39##2##(1990-2#1)(1991-9#1)(1992-12#1)(1993-1#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-5#1)(2008-7#6)(2009-10#1)(2009-8#2)(2009-9#1)(2011-1#3)(2011-2#1)(2012-3#3)(2013-1#2)
to low-molecular weight##2##3##(1991-12#1)(2008-10#1)
to low-molecular##4##2##(1990-5#1)(1991-12#1)(2008-10#2)
to lower temperature##2##3##(1992-8#1)(2008-10#1)
to lower##24##2##(1992-8#1)(1993-2#1)(1994-2#1)(1996-1#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#1)(2009-7#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
to lung cancer##4##3##(1996-3#1)(2008-11#1)(2011-3#1)(2013-1#1)
to lung transplant##2##3##(2011-3#2)
to lung##16##2##(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#2)(2011-2#1)(2011-3#3)(2013-1#1)(2013-8#1)
to lyse##4##2##(1994-3#1)(1994-5#1)(1995-2#1)(2009-6#1)
to lysis by##3##3##(1992-2#2)(2008-9#1)
to mRNA##2##2##(2010-4#1)(2012-2#1)
to macromolecular##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
to macromolecules##2##2##(1996-5#1)(2008-7#1)
to macrophages##2##2##(1990-12#1)(1995-2#1)
to macroscopic##2##2##(2008-10#2)
to macular##3##2##(2011-2#1)(2013-1#2)
to main##3##2##(2008-10#3)
to maintain a high##2##4##(1991-6#1)(2011-2#1)
to maintain a##9##3##(1991-1#1)(1991-6#1)(1993-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
to maintain an##3##3##(2008-11#1)(2008-6#1)(2012-3#1)
to maintain cell##2##3##(2011-2#1)(2013-1#1)
to maintain control##2##3##(2008-7#1)(2013-7#1)
to maintain its##2##3##(2008-11#2)
to maintain spermatogenesis##3##3##(1992-12#2)(2012-2#1)
to maintain the delicate balance between##2##6##(2008-9#2)
to maintain the quality of##2##5##(1994-12#1)(2008-11#1)
to maintain the same##2##4##(2008-11#1)(2011-2#1)
to maintain the##23##3##(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-9#2)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
to maintain their##2##3##(1997-6#1)(2009-6#1)
to maintain##88##2##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#7)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-6#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
to maintaining a##2##3##(2010-7#1)(2011-2#1)
to maintaining##3##2##(2010-7#1)(2011-2#2)
to maize leaves##2##3##(2008-10#2)
to maize##8##2##(1991-10#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
to major resistance genes in##2##5##(2008-10#2)
to major resistance genes##3##4##(2008-10#3)
to major##10##2##(1994-12#1)(2008-10#5)(2008-8#1)(2009-10#1)(2011-3#1)(2012-3#1)
to make a diagnosis of##3##5##(1997-8#1)(2012-2#1)(2013-8#1)
to make a##29##3##(1992-3#1)(1994-1#3)(1994-2#1)(1997-3#1)(1997-8#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#3)
to make an##2##3##(2007-9#1)(2008-7#1)
to make appropriate##3##3##(2009-8#1)(2013-1#1)(2013-8#1)
to make communication##2##3##(1995-12#1)(1996-1#1)
to make comparisons##2##3##(1991-12#1)(2008-10#1)
to make decisions##4##3##(1992-2#1)(1994-9#1)(2010-8#1)(2011-8#1)
to make information accessible##2##4##(1995-12#1)(1996-1#1)
to make it##5##3##(1993-9#1)(1994-9#1)(2008-11#1)(2010-8#1)(2011-3#1)
to make medical##2##3##(1995-12#1)(2010-8#1)
to make more##4##3##(1997-3#2)(2008-10#1)(2008-8#1)
to make smart##2##3##(1996-3#1)(2010-12#1)
to make some##2##3##(1995-2#1)(1996-5#1)
to make substantial##2##3##(1993-12#1)(1994-12#1)
to make such##2##3##(1991-1#1)(2008-10#1)
to make sure that the##3##5##(1993-1#1)(1995-9#1)(2008-10#1)
to make sure that##5##4##(1993-1#2)(1993-3#1)(1995-9#1)(2008-10#1)
to make sure the##2##4##(1995-6#1)(2008-10#1)
to make sure##7##3##(1993-1#2)(1993-3#1)(1995-6#1)(1995-9#1)(2008-10#2)
to make the correct##2##4##(1996-6#1)(2012-2#1)
to make the system##2##4##(2008-10#2)
to make the##14##3##(1994-1#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
to make them##2##3##(1991-1#1)(2008-11#1)
to make these##2##3##(1993-9#1)(2008-11#1)
to make this##2##3##(1997-8#1)(2008-11#1)
to make use of##2##4##(1996-3#1)(2008-10#1)
to make##161##2##(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-9#2)(1994-1#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#5)(1995-2#3)(1995-6#2)(1995-9#1)(1996-1#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#6)(1997-7#1)(1997-8#4)(2007-9#1)(2008-10#18)(2008-11#13)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#4)(2008-9#4)(2009-11#1)(2009-4#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#3)(2011-2#8)(2011-3#1)(2011-8#1)(2012-12#3)(2012-2#6)(2013-1#7)(2013-8#5)
to making##4##2##(1993-3#1)(1996-1#1)(2008-11#1)(2012-2#1)
to malaria in##2##3##(1995-12#1)(2010-1#1)
to malaria##3##2##(1995-12#1)(2010-1#1)(2013-8#1)
to male##13##2##(1990-5#1)(1992-9#1)(1997-7#1)(2008-11#3)(2008-8#1)(2008-9#4)(2012-3#2)
to males and approximately##2##4##(2008-9#2)
to males and##4##3##(2008-9#4)
to males##10##2##(2008-11#1)(2008-8#1)(2008-9#6)(2012-3#1)(2013-8#1)
to malignancy##2##2##(1990-2#1)(2008-11#1)
to malignant##7##2##(1990-2#1)(1993-2#1)(1997-8#1)(2008-12#1)(2011-2#2)(2013-8#1)
to malnutrition##3##2##(1993-12#1)(1996-3#1)(2012-2#1)
to mammalian cells##2##3##(1994-5#1)(2008-9#1)
to mammalian##9##2##(1994-5#1)(1995-6#1)(1996-2#1)(1996-6#2)(2008-11#2)(2008-4#1)(2008-9#1)
to mammals##2##2##(2008-7#1)(2009-6#1)
to man##3##2##(1995-2#1)(1995-6#1)(2010-7#1)
to manage the##9##3##(1993-12#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-11#1)(2013-1#1)
to manage their child's asthma##2##5##(2010-9#2)
to manage their##5##3##(1994-1#2)(2010-9#2)(2013-1#1)
to manage this##4##3##(1994-3#2)(2008-10#1)(2008-7#1)
to manage##56##2##(1990-3#1)(1993-12#2)(1994-1#2)(1994-2#1)(1994-3#3)(1995-12#2)(1996-2#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#8)(2008-11#5)(2008-7#4)(2008-8#1)(2010-11#3)(2010-9#2)(2011-10#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#7)
to managed care in##2##4##(1995-12#1)(1996-2#1)
to managed care##5##3##(1991-12#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-2#1)
to management of##4##3##(2008-7#2)(2010-12#1)(2012-12#1)
to management##15##2##(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(2008-10#2)(2008-7#3)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)
to managing##5##2##(1991-12#1)(2008-10#1)(2008-11#2)(2008-12#1)
to mandate##2##2##(1997-3#1)(2008-3#1)
to manifest##2##2##(2009-3#1)(2009-9#1)
to manipulate objects##2##3##(2008-11#1)(2012-2#1)
to manipulate the##4##3##(1995-5#1)(2008-12#1)(2011-7#1)(2013-8#1)
to manipulate##19##2##(1994-8#1)(1995-5#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#2)(2011-7#1)(2012-2#1)(2013-8#2)
to mankind##2##2##(1994-5#1)(2008-10#1)
to manufacture##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2010-9#1)
to many countries##2##3##(2008-1#1)(2010-7#1)
to many different##4##3##(1997-6#1)(2008-11#1)(2008-9#1)(2013-8#1)
to many of the##2##4##(1992-2#1)(2008-9#1)
to many of##4##3##(1991-3#1)(1992-2#1)(2008-5#1)(2008-9#1)
to many other##4##3##(2008-10#2)(2010-1#1)(2011-2#1)
to many types of##5##4##(1992-2#1)(1994-3#1)(2008-4#1)(2009-1#1)(2010-1#1)
to many##48##2##(1990-8#1)(1991-3#1)(1992-2#2)(1992-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-6#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#6)(2009-1#1)(2009-11#1)(2010-1#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
to map genes##2##3##(2008-10#1)(2008-12#1)
to map the gene##2##4##(1995-2#1)(2008-10#1)
to map the##9##3##(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
to map##25##2##(1990-11#1)(1991-8#1)(1995-2#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
to marine##2##2##(2008-9#1)(2010-5#1)
to mark the##2##3##(2008-4#1)(2012-5#1)
to mark##4##2##(2008-10#1)(2008-4#1)(2009-8#1)(2012-5#1)
to marked##4##2##(2008-10#2)(2009-3#1)(2012-2#1)
to markedly##4##2##(1991-5#1)(2008-12#1)(2011-2#1)(2013-8#1)
to market##8##2##(1990-5#1)(1992-8#1)(1995-1#1)(1997-2#1)(2008-11#1)(2008-5#1)(2009-9#1)(2011-2#1)
to markets##2##2##(2011-2#1)(2013-1#1)
to mask the##2##3##(2008-10#1)(2008-12#1)
to mask##6##2##(1995-6#1)(2008-10#3)(2008-12#1)(2008-3#1)
to mass spectrometry##3##3##(2008-10#2)(2012-3#1)
to mass##7##2##(2008-10#4)(2008-9#1)(2012-3#2)
to mass-produce##2##2##(2008-10#1)(2008-11#1)
to match the##7##3##(1991-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)
to match##14##2##(1991-3#1)(1994-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-7#1)(2012-3#1)(2013-8#2)
to mate##2##2##(2008-8#1)(2008-9#1)
to maternal##3##2##(1993-6#1)(2009-10#1)(2010-11#1)
to mating##2##2##(1991-5#1)(2008-10#1)
to matrix interference##2##3##(2008-10#2)
to matrix##5##2##(2008-10#3)(2008-5#1)(2008-8#1)
to maturation##2##2##(1996-3#1)(2008-10#1)
to mature##6##2##(1995-5#1)(1995-6#1)(2008-11#1)(2008-5#2)(2013-8#1)
to maturity##3##2##(1991-12#1)(2008-11#1)(2008-9#1)
to maximal##4##2##(1994-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
to maximise##6##2##(2008-10#1)(2008-11#2)(2010-12#1)(2013-8#2)
to maximize the##13##3##(1993-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)
to maximize##34##2##(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#5)(2010-8#2)(2012-2#1)
to maximum##5##2##(1994-3#1)(1995-6#1)(2008-10#2)(2008-11#1)
to mean that the##2##4##(2008-10#1)(2010-3#1)
to mean that##3##3##(2008-10#2)(2010-3#1)
to mean##4##2##(1996-5#1)(2008-10#2)(2010-3#1)
to measure MT##2##3##(2008-10#2)
to measure all##2##3##(2008-10#1)(2008-4#1)
to measure and##2##3##(2008-11#1)(2012-3#1)
to measure blood##3##3##(2008-1#1)(2008-10#2)
to measure both##2##3##(2007-12#1)(2008-10#1)
to measure disease##3##3##(2008-10#2)(2008-7#1)
to measure patient satisfaction##2##4##(1997-1#1)(2011-2#1)
to measure protein##2##3##(1990-12#1)(1991-5#1)
to measure quality##2##3##(1997-1#1)(2011-2#1)
to measure sensitivity##2##3##(2008-10#2)
to measure temperature##2##3##(2008-3#2)
to measure the concentration of##2##5##(2008-10#2)
to measure the extent of##2##5##(1994-5#1)(2008-10#1)
to measure the free concentration of##2##6##(2008-10#2)
to measure the impact of these##2##6##(2008-9#1)(2013-1#1)
to measure the impact of##3##5##(1992-12#1)(2008-9#1)(2013-1#1)
to measure the##70##3##(1990-12#1)(1991-2#1)(1992-12#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#6)(2009-12#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-7#3)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)
to measure their##2##3##(2008-9#1)(2010-7#1)
to measure these##3##3##(2008-12#1)(2008-9#1)(2010-11#1)
to measure total##2##3##(2008-9#1)(2012-12#1)
to measure##217##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#3)(1992-3#2)(1993-1#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#3)(2008-1#2)(2008-10#45)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#23)(2008-4#6)(2008-5#7)(2008-7#5)(2008-8#2)(2008-9#14)(2009-1#1)(2009-10#1)(2009-12#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#5)(2010-9#1)(2011-2#7)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#7)(2013-7#1)
to measured##2##2##(1991-5#1)(2008-6#1)
to measurement of##2##3##(2008-10#2)
to measurement##6##2##(2008-10#3)(2008-11#1)(2008-3#1)(2010-1#1)
to measurements##4##2##(2008-10#2)(2008-3#2)
to measures of##2##3##(2010-3#1)(2013-8#1)
to measures##3##2##(2008-11#1)(2010-3#1)(2013-8#1)
to measuring##3##2##(1992-3#1)(1996-2#1)(2008-4#1)
to mechanical stimulation##2##3##(2008-11#1)(2008-12#1)
to mechanical##10##2##(1990-8#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#1)
to mechanisms##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
to media##2##2##(1991-3#1)(2008-3#1)
to mediate the##4##3##(1994-5#1)(2008-6#1)(2008-7#1)(2009-10#1)
to mediate##18##2##(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-8#3)(2010-7#1)
to medical care##3##3##(1996-1#1)(1996-5#1)(1997-3#1)
to medical practice##2##3##(1992-12#1)(2008-3#1)
to medical students##2##3##(1994-12#1)(2008-3#1)
to medical therapy##3##3##(1993-3#1)(1994-2#1)(1996-11#1)
to medical treatment##5##3##(1991-11#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-12#1)
to medical##33##2##(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
to medication management##2##3##(2008-11#2)
to medication##3##2##(2008-11#2)(2011-2#1)
to medium and##2##3##(1993-8#1)(2008-12#1)
to medium##9##2##(1993-8#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
to meet and##2##3##(1994-2#1)(1995-3#1)
to meet changing##2##3##(1995-1#1)(1995-5#1)
to meet current##2##3##(1994-2#1)(2009-3#1)
to meet emerging##2##3##(1997-3#2)
to meet in##2##3##(1992-1#1)(2008-11#1)
to meet its##2##3##(1995-12#1)(1995-3#1)
to meet the demand##2##4##(2008-11#1)(2008-9#1)
to meet the demands of##3##5##(1994-2#1)(1995-2#1)(2012-3#1)
to meet the national##2##4##(2008-11#1)(2009-12#1)
to meet the needs of a##2##6##(1991-3#1)(2008-10#1)
to meet the needs of the##2##6##(1994-2#1)(1997-1#1)
to meet the needs of##11##5##(1991-3#1)(1993-1#1)(1994-1#2)(1994-2#2)(1996-2#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-6#1)
to meet the new##2##4##(1994-1#1)(2010-7#1)
to meet the##41##3##(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#1)(1994-1#3)(1994-12#1)(1994-2#4)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#3)
to meet their needs##2##4##(1994-1#1)(2008-11#1)
to meet their##4##3##(1994-1#1)(2008-11#3)
to meet these requirements##2##4##(1992-12#1)(2008-3#1)
to meet these##4##3##(1992-12#1)(1993-3#1)(2008-11#1)(2008-3#1)
to meet your##2##3##(1992-1#1)(1995-2#1)
to meet##79##2##(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#3)(1992-12#2)(1993-1#1)(1993-3#1)(1994-1#5)(1994-12#1)(1994-2#6)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#2)(2008-10#6)(2008-11#17)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#3)
to meeting##2##2##(1993-1#1)(2013-1#1)
to mefenoxam##5##2##(2008-10#5)
to melanoma##3##2##(1997-7#1)(2011-2#1)(2012-3#1)
to members of the##3##4##(1996-1#1)(1997-8#1)(2008-10#1)
to members of##5##3##(1995-6#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)
to membrane##6##2##(1992-3#1)(1993-8#1)(2008-10#1)(2008-7#2)(2008-8#1)
to membrane-bound polysomes##2##3##(2008-11#2)
to membrane-bound##3##2##(1995-6#1)(2008-11#2)
to membranes and##2##3##(1995-6#1)(2008-7#1)
to membranes##7##2##(1995-11#2)(1995-6#1)(2008-10#1)(2008-7#2)(2012-2#1)
to memorize##3##2##(2008-6#3)
to memory##3##2##(1997-2#1)(2008-10#1)(2008-12#1)
to men##2##2##(1991-8#1)(2009-5#1)
to mental health services##2##4##(1996-3#2)
to mental health##5##3##(1996-3#2)(2008-11#2)(2008-12#1)
to mental##9##2##(1991-12#1)(1996-3#2)(2008-11#2)(2008-12#1)(2009-10#1)(2010-6#1)(2013-8#1)
to mention##2##2##(2009-10#1)(2011-2#1)
to merge##2##2##(1992-8#1)(2009-9#1)
to metabolic##2##2##(2008-7#1)(2012-3#1)
to metabolize epicatechin showed##2##4##(2008-10#2)
to metabolize##6##2##(2008-10#2)(2008-5#1)(2009-9#1)(2011-1#1)(2012-3#1)
to metal##9##2##(2008-10#7)(2012-12#2)
to metalaxyl##9##2##(2008-10#9)
to metaphase##2##2##(2008-4#1)(2013-1#1)
to methods##2##2##(1994-2#1)(1997-3#1)
to methotrexate##2##2##(1990-8#1)(2013-1#1)
to methyl##5##2##(2008-10#4)(2013-8#1)
to methylate##2##2##(1992-3#1)(1994-8#1)
to mice##5##2##(1990-6#1)(1995-11#1)(1996-2#1)(2008-11#2)
to microbial##2##2##(2008-10#2)
to microbiology##2##2##(2008-9#2)
to micromolar##2##2##(2008-10#1)(2008-7#1)
to microsclerotia##3##2##(2008-10#3)
to microsomal##2##2##(1993-8#1)(1994-5#1)
to mid##2##2##(1992-9#1)(2008-12#1)
to midbrain dopaminergic neurons in##2##5##(2008-7#2)
to middle##3##2##(1991-6#1)(1997-2#1)(2009-7#1)
to migrate##5##2##(1994-11#1)(1997-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
to migration##2##2##(2008-10#1)(2011-2#1)
to mild##6##2##(1991-1#1)(1994-11#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
to mildly##2##2##(2008-10#1)(2011-2#1)
to military##2##2##(1992-3#1)(1995-6#1)
to mimic the##8##3##(1992-4#1)(2008-10#1)(2008-11#2)(2009-12#2)(2009-7#1)(2012-4#1)
to mimic##15##2##(1992-1#1)(1992-4#1)(1994-5#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-12#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-4#1)
to mind##2##2##(2009-9#1)(2013-8#1)
to mineral##3##2##(1995-8#1)(2008-10#2)
to mineralized##2##2##(2008-10#1)(2013-8#1)
to minimise the##4##3##(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
to minimise##7##2##(2008-1#1)(2008-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
to minimize matrix##2##3##(2008-10#2)
to minimize the effect of##2##5##(1995-3#1)(2008-10#1)
to minimize the interference##2##4##(2008-10#2)
to minimize the risks##2##4##(1997-5#1)(2013-1#1)
to minimize the##26##3##(1992-12#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-5#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#2)
to minimize these##2##3##(2008-11#1)(2008-3#1)
to minimize##56##2##(1991-12#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
to minimizing##2##2##(1995-12#1)(2008-10#1)
to minimum##2##2##(2008-10#2)
to minor##2##2##(2008-4#1)(2013-8#1)
to misleading##3##2##(1997-2#1)(2008-12#1)(2012-2#1)
to missing##2##2##(1994-9#1)(1997-2#1)
to mitigate the##2##3##(2008-11#1)(2008-3#1)
to mitigate##7##2##(1992-1#1)(1994-3#1)(2008-11#1)(2008-3#2)(2009-5#1)(2011-2#1)
to mitochondria##3##2##(1994-5#1)(2008-7#1)(2011-2#1)
to mitogenic##2##2##(1992-6#1)(1996-2#1)
to mitosis##2##2##(2008-9#1)(2009-10#1)
to mitoxantrone##2##2##(1991-6#2)
to mixed##2##2##(2008-10#1)(2010-10#1)
to mixtures of##2##3##(2008-10#2)
to mobilize##3##2##(1996-2#1)(2008-7#1)(2013-1#1)
to model and##3##3##(2008-10#1)(2010-4#1)(2010-7#1)
to model predictions##2##3##(2008-10#1)(2008-9#1)
to model the##17##3##(1994-5#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)
to model##37##2##(1992-2#1)(1994-5#1)(1995-2#1)(1997-6#1)(2008-10#11)(2008-11#2)(2008-3#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-3#1)
to modeling##5##2##(2008-10#2)(2008-3#1)(2008-8#1)(2013-8#1)
to models that##2##3##(2008-8#1)(2011-2#1)
to models##4##2##(1994-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
to moderate climate##2##3##(2012-5#2)
to moderate the##2##3##(2009-7#2)
to moderate##21##2##(1995-10#1)(1995-2#1)(1996-1#1)(1997-8#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-6#1)(2012-5#3)(2013-1#1)(2013-8#1)
to modern##3##2##(1990-6#1)(2008-10#1)(2012-3#1)
to modification##3##2##(1993-3#1)(1997-1#1)(2008-12#1)
to modify a##2##3##(2008-10#1)(2008-11#1)
to modify the##11##3##(1990-6#1)(1991-12#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-12#1)
to modify##27##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1995-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
to modulate cell##2##3##(1995-8#1)(1996-2#1)
to modulate the expression of##4##5##(1994-11#1)(2008-11#1)(2008-4#1)(2008-5#1)
to modulate the##18##3##(1993-8#1)(1994-11#2)(2007-12#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#1)(2009-8#1)(2013-7#1)
to modulate##32##2##(1993-6#1)(1993-8#1)(1994-11#2)(1995-8#1)(1995-9#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#8)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
to modulation of##2##3##(1994-6#1)(1995-8#1)
to moisture##4##2##(1996-5#1)(2008-10#3)
to molecular##14##2##(2008-10#7)(2008-11#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
to monitor and control##2##4##(2008-11#1)(2011-1#1)
to monitor and##8##3##(1992-3#1)(1994-1#2)(1997-2#1)(2008-10#2)(2008-11#1)(2011-1#1)
to monitor blending##2##3##(2008-10#2)
to monitor growth##2##3##(2008-10#1)(2009-8#1)
to monitor lymphocyte migration##2##4##(2008-4#2)
to monitor patients##3##3##(1990-2#1)(1993-12#1)(2008-10#1)
to monitor the changes in##2##5##(2008-10#2)
to monitor the concentration of l-cysteine##2##6##(2008-10#2)
to monitor the concentration of##3##5##(2008-10#2)(2008-11#1)
to monitor the conformational##2##4##(1992-6#1)(2008-10#1)
to monitor the effect of##2##5##(2008-5#1)(2013-8#1)
to monitor the level of##2##5##(1993-3#1)(2008-10#1)
to monitor the##49##3##(1991-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-5#2)(2012-12#1)(2013-8#1)
to monitor their##2##3##(2008-11#1)(2008-9#1)
to monitor##110##2##(1990-2#1)(1991-12#2)(1991-5#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-2#2)(1994-5#1)(1994-9#1)(1997-2#2)(2008-1#1)(2008-10#52)(2008-11#8)(2008-12#1)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
to monitoring##6##2##(1997-6#1)(2008-10#2)(2008-11#2)(2010-10#1)
to monoamine##2##2##(1994-2#2)
to monolayer cell cultures##2##4##(2008-2#1)(2008-5#1)
to monotone##2##2##(2008-11#2)
to monovalent##5##2##(1990-3#1)(2008-10#4)
to months##2##2##(1993-2#1)(2008-11#1)
to more efficient##3##3##(2010-7#1)(2011-2#1)(2012-3#1)
to more favorable##2##3##(2008-10#1)(2013-8#1)
to more fully##2##3##(2010-4#1)(2012-2#1)
to more internal##2##3##(1994-11#2)
to more negative##2##3##(2008-10#2)
to more positive values##2##4##(2008-10#2)
to more severe##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
to more than 1##2##4##(2008-10#1)(2008-9#1)
to more than 50%##2##4##(1994-11#1)(1995-11#1)
to more than##15##3##(1994-11#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#6)(2008-9#1)(2011-2#1)(2012-2#1)
to more traditional##2##3##(2008-8#1)(2010-1#1)
to more##81##2##(1990-11#1)(1993-12#1)(1993-6#1)(1994-11#3)(1994-8#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#24)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#6)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#3)
to morphine##6##2##(1994-2#1)(1995-12#3)(1996-2#1)(1997-2#1)
to morphological##2##2##(1992-6#1)(1994-8#1)
to morphologically##3##2##(2008-11#1)(2008-5#1)(2010-3#1)
to mortality##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
to most effectively##2##3##(1992-3#1)(2008-9#1)
to most of the##4##4##(1996-2#1)(2008-10#2)(2008-11#1)
to most of##5##3##(1991-3#1)(1996-2#1)(2008-10#2)(2008-11#1)
to most##20##2##(1991-3#1)(1992-3#1)(1994-6#1)(1995-1#1)(1996-2#1)(1996-5#1)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
to mothers##2##2##(1995-1#1)(2013-1#1)
to mothers'##3##2##(2008-11#1)(2009-10#1)(2010-10#1)
to motor##4##2##(1991-1#1)(2007-12#1)(2010-12#1)(2012-2#1)
to mount a##2##3##(1997-6#1)(2008-10#1)
to mouse##10##2##(1995-2#2)(1997-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2013-8#1)
to move beyond##4##3##(1993-12#1)(1994-1#1)(2009-8#1)(2013-1#1)
to move from##4##3##(2008-10#2)(2008-5#1)(2012-3#1)
to move into##2##3##(1994-5#1)(2008-8#1)
to move toward##2##3##(1995-2#1)(2008-10#1)
to move##20##2##(1993-12#1)(1994-1#1)(1994-5#1)(1995-2#1)(1996-1#1)(1997-1#2)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#1)
to moving##3##2##(2008-8#3)
to much##3##2##(1994-3#1)(2008-11#1)(2008-7#1)
to multiple sclerosis##2##3##(2008-11#1)(2010-12#1)
to multiple##17##2##(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
to multiply in##4##3##(1995-2#1)(2008-10#2)(2013-8#1)
to multiply##7##2##(1995-2#1)(2008-10#3)(2009-10#1)(2009-8#1)(2013-8#1)
to multivariate##7##2##(2008-10#5)(2008-7#1)(2009-4#1)
to murine##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
to muscarinic##2##2##(1995-11#1)(1996-2#1)
to muscle##4##2##(1997-8#1)(2008-4#1)(2008-7#1)(2010-8#1)
to music after implantation##2##4##(2008-9#2)
to music##4##2##(1991-12#1)(2008-9#3)
to mutation##3##2##(1994-5#1)(1997-3#2)
to mutations in the##2##4##(1994-11#1)(2008-11#1)
to mutations in##5##3##(1994-11#1)(2008-11#2)(2009-8#1)(2013-1#1)
to my##2##2##(1997-2#1)(2013-8#1)
to myelin##2##2##(1995-12#1)(2012-2#1)
to myocardial##3##2##(1996-3#1)(2010-5#1)(2012-2#1)
to n-3##2##2##(2013-1#2)
to name a##2##3##(2008-4#1)(2008-9#1)
to naringenin##3##2##(2008-11#3)
to narrow the##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-12#1)
to narrow##7##2##(1993-12#1)(1997-1#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
to national##7##2##(1994-3#4)(2008-10#1)(2013-1#2)
to native uPA##3##3##(2008-11#3)
to native##5##2##(2008-11#3)(2009-8#1)(2009-9#1)
to natural and##2##3##(2008-10#1)(2012-3#1)
to natural water samples##2##4##(2008-10#2)
to natural##15##2##(1990-12#1)(1994-9#1)(2008-10#9)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
to nature##2##2##(2008-8#2)
to navigate##2##2##(1997-3#1)(2008-4#1)
to near homogeneity##6##3##(1990-5#1)(1990-8#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-8#1)
to near zero##3##3##(2008-10#2)(2008-9#1)
to near##15##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#2)
to nearby##2##2##(1991-2#1)(2008-8#1)
to nearly##3##2##(2008-10#1)(2008-6#1)(2011-1#1)
to necrotic##2##2##(2008-10#1)(2012-2#1)
to necrotrophic##2##2##(2008-10#2)
to need##2##2##(2010-10#1)(2012-2#1)
to negative##5##2##(2008-5#1)(2009-7#3)(2013-1#1)
to negatively##4##2##(1995-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
to negotiate##2##2##(1994-1#1)(1996-5#1)
to neighboring##3##2##(2008-10#3)
to neighbors##4##2##(2008-8#4)
to neoadjuvant##4##2##(1993-11#1)(2010-12#2)(2010-7#1)
to neonatal##3##2##(2008-11#3)
to neoplasia##2##2##(1992-9#1)(2011-1#1)
to nephrology##2##2##(2008-1#2)
to nerve##2##2##(2008-11#2)
to nest##3##2##(2008-8#2)(2008-9#1)
to net##2##2##(2008-10#1)(2008-9#1)
to neural##8##2##(1990-5#1)(1990-9#1)(1993-6#1)(1996-12#1)(2008-11#1)(2009-10#1)(2012-2#1)(2013-8#1)
to neurodegenerative disorders##2##3##(2009-8#1)(2010-11#1)
to neurological##2##2##(1997-6#1)(2011-7#1)
to neuronal cell death##2##4##(1995-12#1)(2009-12#1)
to neuronal##5##2##(1995-12#2)(1995-8#1)(2009-12#1)(2011-2#1)
to neurons##3##2##(2008-11#3)
to neuropathic pain##2##3##(2008-12#1)(2010-4#1)
to neurosurgeons##2##2##(2008-7#1)(2013-1#1)
to neutral##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
to neutralize HF in the microwave-assisted acid dissolution of ceramic glazes for their chemical analysis##2##15##(2008-10#2)
to neutralize##3##2##(2008-10#3)
to new applications##2##3##(2008-3#1)(2008-9#1)
to new therapies##3##3##(2008-11#1)(2008-6#2)
to new##35##2##(1992-1#1)(1992-6#1)(1995-9#1)(1996-3#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#5)(2012-3#1)(2013-8#2)
to newborn##2##2##(2008-10#1)(2012-3#1)
to nickel##2##2##(2008-10#2)
to nicotine##3##2##(1990-7#1)(2011-2#1)(2013-1#1)
to night temperatures##2##3##(2012-5#2)
to nine##11##2##(1996-9#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)
to nipple feeding##4##3##(2010-5#4)
to nitrate##5##2##(2008-10#5)
to nitric acid##2##3##(2008-10#2)
to nitric oxide (NO)##2##4##(2008-10#2)
to nitric oxide##3##3##(2008-10#3)
to nitric##5##2##(2008-10#5)
to nitrite##10##2##(2008-10#10)
to nitrogen dioxide##2##3##(2008-10#2)
to nitrogen##3##2##(1996-5#1)(2008-10#2)
to no##6##2##(1991-6#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-2#1)(2012-3#1)
to noise and##2##3##(2008-3#2)
to noise ratio##7##3##(2008-10#6)(2008-9#1)
to noise##18##2##(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#3)(2010-8#1)
to non##2##2##(1996-12#1)(2008-10#1)
to non-compliance##2##2##(1996-3#1)(2011-2#1)
to non-host##2##2##(2007-12#1)(2009-6#1)
to non-invasively##2##2##(2009-12#1)(2010-12#1)
to non-polar##2##2##(2008-10#1)(2009-7#1)
to non-specific##2##2##(1994-2#1)(2008-10#1)
to nonlinear##2##2##(2008-3#2)
to normal and##2##3##(2008-4#1)(2011-2#1)
to normal breast##2##3##(1990-12#1)(1993-11#1)
to normal fibroblasts##2##3##(1992-8#2)
to normal human##3##3##(1994-8#1)(2008-11#1)(2008-5#1)
to normal skin##3##3##(2008-5#3)
to normal values##2##3##(2008-12#1)(2013-1#1)
to normal##57##2##(1990-12#1)(1990-2#1)(1991-6#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-3#2)(1994-11#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-2#2)(2013-1#4)
to normalize##5##2##(1991-7#1)(2008-10#1)(2010-11#1)(2010-8#1)(2012-3#1)
to normoxia##2##2##(1994-5#1)(1996-12#1)
to not##3##2##(1994-11#1)(2008-12#1)(2012-3#1)
to note##4##2##(1992-2#1)(2008-11#1)(2010-10#1)(2012-3#1)
to novel##7##2##(1993-6#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
to now##7##2##(1992-9#1)(1996-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)
to noxious##2##2##(1997-2#2)
to nuclear##3##2##(2007-11#1)(2011-2#2)
to nucleic acid##2##3##(2008-4#1)(2008-9#1)
to nucleic acids##2##3##(1991-8#1)(2008-4#1)
to nucleic##4##2##(1991-8#1)(2008-4#2)(2008-9#1)
to nucleoside##3##2##(1991-5#1)(1994-8#1)(1996-2#1)
to nucleotide##3##2##(1996-12#1)(1997-8#1)(2008-9#1)
to nucleus##6##2##(1991-2#2)(2008-8#1)(2008-9#3)
to number of##2##3##(2008-10#2)
to numerous##3##2##(1997-1#1)(2008-10#1)(2010-7#1)
to nurse education##2##3##(2008-11#1)(2008-12#1)
to nurse##5##2##(2008-11#2)(2008-12#1)(2013-8#2)
to nurses and##3##3##(2008-7#1)(2013-1#2)
to nurses##5##2##(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#2)
to nursing home##2##3##(1993-12#1)(2008-11#1)
to nursing homes##5##3##(1990-12#1)(1994-12#2)(1994-2#1)(1995-1#1)
to nursing##14##2##(1990-12#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(2008-11#4)(2008-12#3)
to nutrient##4##2##(2008-10#2)(2008-12#1)(2008-7#1)
to nutrition##2##2##(2010-5#1)(2010-8#1)
to nutritional##2##2##(1993-9#1)(2012-2#1)
to nystatin##2##2##(2008-5#2)
to obesity##3##2##(2008-1#1)(2008-10#1)(2010-10#1)
to objectively assess patients'##2##4##(2008-11#1)(2009-1#1)
to objectively##4##2##(2008-11#1)(2009-1#1)(2010-7#1)(2012-3#1)
to observe a##2##3##(1997-4#1)(2008-3#1)
to observe and##2##3##(2008-10#1)(2010-6#1)
to observe the effect##2##4##(2008-10#1)(2011-2#1)
to observe the##26##3##(1994-8#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#1)
to observe##45##2##(1993-3#1)(1994-11#1)(1994-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#3)
to observed##4##2##(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
to obtain a given##2##4##(1995-9#1)(2008-10#1)
to obtain a homogeneous##3##4##(2008-10#2)(2009-7#1)
to obtain a result##3##4##(1991-3#3)
to obtain a stable##2##4##(2008-10#1)(2008-5#1)
to obtain a suitable##2##4##(2008-10#2)
to obtain a##53##3##(1991-2#1)(1991-3#3)(1991-5#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-12#2)(2007-8#1)(2008-10#22)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#5)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
to obtain accurate results##3##4##(2008-10#3)
to obtain accurate##7##3##(1990-8#1)(2008-10#5)(2013-8#1)
to obtain an appropriate##2##4##(2008-10#1)(2011-2#1)
to obtain an improvement##2##4##(1991-2#1)(2008-10#1)
to obtain an##15##3##(1991-2#1)(1992-5#1)(1994-5#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-5#1)(2009-7#1)(2011-2#2)
to obtain better##5##3##(2008-10#3)(2008-7#1)(2012-3#1)
to obtain by##3##3##(1991-2#1)(2008-10#1)(2008-2#1)
to obtain extract##3##3##(2008-11#3)
to obtain feedback from##4##4##(2013-1#4)
to obtain good##3##3##(2008-10#1)(2008-9#1)(2010-7#1)
to obtain high##5##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
to obtain information on##4##4##(1991-1#1)(1997-3#1)(2006-6#1)(2008-7#1)
to obtain information##5##3##(1991-1#1)(1997-3#1)(2006-6#1)(2008-11#1)(2008-7#1)
to obtain insights into the##2##5##(2008-7#1)(2011-2#1)
to obtain its##2##3##(1991-2#1)(2009-3#1)
to obtain maximum sensitivity##2##4##(2008-10#2)
to obtain maximum##5##3##(2008-10#3)(2008-4#2)
to obtain milligram amounts of enzymatically active##2##7##(2008-4#2)
to obtain more##2##3##(1993-12#1)(2010-1#1)
to obtain new##2##3##(2008-8#1)(2011-3#1)
to obtain particular##2##3##(2008-10#1)(2008-4#1)
to obtain pure##2##3##(2008-10#1)(2008-11#1)
to obtain quantitative##3##3##(2008-10#3)
to obtain reliable##2##3##(2008-10#1)(2010-12#1)
to obtain some##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
to obtain the analytical##3##4##(2007-11#1)(2008-10#2)
to obtain the average##2##4##(2008-2#1)(2008-7#1)
to obtain the best##2##4##(2008-10#2)
to obtain the corresponding##2##4##(2008-10#1)(2010-7#1)
to obtain the maximum##3##4##(2008-10#3)
to obtain the optimum##3##4##(2008-10#3)
to obtain the##55##3##(1993-8#2)(1994-3#1)(2007-11#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to obtain their##2##3##(1994-1#1)(2008-10#1)
to obtain##300##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#4)(1991-5#1)(1992-12#4)(1992-2#1)(1992-5#1)(1993-12#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#4)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#120)(2008-11#19)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#13)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#11)(2013-8#3)
to obtaining positive samples from the##2##6##(2010-6#2)
to obtaining##4##2##(2009-12#1)(2010-6#2)(2012-2#1)
to occlude##2##2##(1997-3#1)(2008-7#1)
to occupational##3##2##(1997-5#1)(2010-9#1)(2013-1#1)
to occupy a##2##3##(1994-2#1)(2008-9#1)
to occupy##5##2##(1994-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
to occur as##2##3##(2008-11#1)(2008-5#1)
to occur by##2##3##(1994-2#1)(2008-7#1)
to occur if##2##3##(2008-10#1)(2008-8#1)
to occur in a##3##4##(2008-10#2)(2009-8#1)
to occur in the##5##4##(1995-10#1)(2008-10#2)(2008-7#1)(2013-1#1)
to occur in##20##3##(1990-11#1)(1990-6#1)(1991-12#1)(1995-10#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-8#1)(2011-2#1)(2013-1#1)
to occur through##2##3##(1994-8#1)(2008-10#1)
to occur throughout the##2##4##(2008-10#2)
to occur when##2##3##(1996-11#1)(2008-5#1)
to occur with##4##3##(1990-11#2)(2008-9#1)(2010-1#1)
to occur##60##2##(1990-11#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-10#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-8#1)(2008-10#14)(2008-11#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#3)(2013-8#1)
to octopamine##2##2##(2008-7#2)
to offer a##7##3##(1991-3#1)(1993-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
to offer##33##2##(1991-3#2)(1992-3#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-7#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)
to offset##2##2##(1992-12#1)(2008-10#1)
to offspring##4##2##(2007-12#1)(2008-9#2)(2012-2#1)
to oil##2##2##(2008-10#2)
to olanzapine##2##2##(2010-2#2)
to older ages##2##3##(2009-7#2)
to older people##4##3##(2008-6#1)(2010-10#2)(2013-8#1)
to older##13##2##(1991-12#1)(1992-1#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#2)(2010-10#2)(2013-8#1)
to on-line##5##2##(2008-10#5)
to one another##7##3##(1990-11#1)(1992-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
to one in which##2##4##(1991-9#1)(1995-8#1)
to one molecule##2##3##(1990-9#1)(2008-8#1)
to one of four groups##3##5##(1992-1#1)(2011-2#2)
to one of four##4##4##(1992-1#1)(2011-2#2)(2012-9#1)
to one of the two##2##5##(2008-5#1)(2010-4#1)
to one of the##8##4##(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-4#1)(2010-7#1)(2012-3#1)
to one of three##3##4##(1991-1#1)(2008-4#1)(2010-11#1)
to one of##22##3##(1991-1#1)(1992-1#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-3#1)(2012-9#1)(2013-7#1)
to one or both##2##4##(2008-10#2)
to one or more of the##2##6##(1992-5#1)(2008-10#1)
to one or more##6##4##(1992-5#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#2)
to one or##8##3##(1992-5#1)(2008-10#3)(2008-11#1)(2013-1#1)(2013-8#2)
to one side of##2##4##(2008-10#1)(2008-3#1)
to one third##2##3##(2008-10#1)(2008-12#1)
to one year##2##3##(1991-9#1)(1996-1#1)
to one##75##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(2007-11#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#4)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
to one's##2##2##(1994-12#1)(2008-11#1)
to onion##3##2##(2008-10#3)
to only one##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
to only partially##2##3##(1994-6#1)(2010-3#1)
to only##16##2##(1990-6#1)(1990-8#1)(1994-3#1)(1994-6#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)
to onset of##2##3##(2008-10#1)(2012-3#1)
to open##12##2##(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
to operate and##5##3##(1996-2#1)(2008-10#3)(2008-11#1)
to operate in##4##3##(1997-1#1)(2008-11#1)(2008-4#1)(2010-4#1)
to operate to##2##3##(1994-3#1)(2008-10#1)
to operate##24##2##(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#1)
to operation##3##2##(1990-3#1)(2008-11#1)(2008-7#1)
to opioid##3##2##(2008-6#1)(2009-7#2)
to opium poppy##3##3##(2008-10#3)
to oppose##2##2##(2008-11#1)(2012-3#1)
to optic##3##2##(2008-7#1)(2008-9#2)
to optically##2##2##(1995-3#1)(2008-10#1)
to optimal conditions for##2##4##(2008-10#2)
to optimal##7##2##(2008-10#2)(2008-12#1)(2008-8#1)(2010-7#1)(2013-1#1)(2013-8#1)
to optimally##2##2##(1993-11#1)(2008-4#1)
to optimise the reaction conditions##2##5##(2008-10#2)
to optimise the##5##3##(2008-10#5)
to optimise these##2##3##(2008-10#1)(2008-11#1)
to optimise##14##2##(1990-3#1)(2008-10#9)(2008-11#3)(2008-7#1)
to optimization of##2##3##(2008-10#1)(2008-11#1)
to optimization##3##2##(2008-10#1)(2008-11#1)(2009-2#1)
to optimize and##2##3##(2008-10#1)(2009-1#1)
to optimize long-term outcomes##2##4##(2009-8#2)
to optimize the care##2##4##(2008-1#1)(2010-8#1)
to optimize the conditions for the##3##6##(2008-10#3)
to optimize the conditions for##9##5##(2008-10#9)
to optimize the extraction##3##4##(2008-10#3)
to optimize the system##2##4##(2008-10#1)(2008-9#1)
to optimize the##40##3##(2008-1#1)(2008-10#26)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#2)
to optimize##77##2##(1995-2#1)(2008-1#1)(2008-10#36)(2008-11#6)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
to optimizing##3##2##(1993-3#1)(2008-3#1)(2013-1#1)
to or from##2##3##(1993-12#1)(2008-11#1)
to or greater than that##2##5##(1990-12#1)(2008-10#1)
to or greater than##4##4##(1990-12#1)(1991-2#1)(2008-10#1)(2008-8#1)
to or larger than##3##4##(1995-9#1)(2007-11#1)(2008-8#1)
to or##24##2##(1990-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-8#2)(2012-3#1)(2013-1#2)
to oral##6##2##(1993-1#1)(1994-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
to order##3##2##(1995-12#1)(1995-6#1)(2008-11#1)
to ordinary##3##2##(1995-3#1)(2008-10#2)
to organ##4##2##(1992-1#1)(2008-6#1)(2012-12#1)(2012-2#1)
to organic amine##2##3##(2008-10#2)
to organic solvents##4##3##(1990-8#2)(2008-10#1)(2011-1#1)
to organic##16##2##(1990-8#2)(1994-3#1)(2008-10#9)(2008-11#2)(2009-8#1)(2011-1#1)
to organisms##2##2##(2008-11#1)(2008-8#1)
to organizational##3##2##(1992-1#1)(1994-12#1)(1994-2#1)
to organize the##5##3##(2008-1#1)(2009-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
to organize their##2##3##(1991-3#1)(2009-4#1)
to organize##11##2##(1991-3#1)(1992-1#1)(1994-3#1)(1997-6#1)(2008-1#1)(2009-4#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
to originate from##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
to originate##5##2##(1997-4#1)(2008-10#2)(2008-7#1)(2011-2#1)
to orthopedic##2##2##(2010-3#1)(2012-2#1)
to osmotic stress##2##3##(1997-8#1)(2009-8#1)
to osteomyelitis##2##2##(2010-6#2)
to osteoporosis##2##2##(1993-11#1)(2008-12#1)
to other anions##2##3##(2008-10#2)
to other antigens##2##3##(1995-5#1)(2012-12#1)
to other countries##2##3##(2008-12#2)
to other disciplines##2##3##(1994-12#1)(2008-12#1)
to other forms of##2##4##(2008-11#1)(2012-3#1)
to other groups##2##3##(2008-10#1)(2012-2#1)
to other important##2##3##(1992-3#1)(2008-10#1)
to other known##4##3##(1995-2#1)(1996-12#2)(1996-6#1)
to other metal cations##2##4##(2008-10#2)
to other models##2##3##(2008-10#1)(2009-6#1)
to other organisms##2##3##(2008-8#1)(2012-2#1)
to other parts of##2##4##(2008-12#1)(2010-11#1)
to other physical##2##3##(1996-6#1)(2008-10#1)
to other plant##2##3##(2008-10#1)(2008-9#1)
to other reported##3##3##(1990-7#1)(1992-8#1)(2008-10#1)
to other species##3##3##(2008-10#2)(2010-8#1)
to other types of##5##4##(1990-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
to other viruses##2##3##(2008-10#2)
to other##182##2##(1990-11#3)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-6#3)(1994-11#1)(1994-12#1)(1994-5#3)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#3)(1997-3#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#49)(2008-11#12)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#7)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
to others##5##2##(1990-2#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
to our attention##2##3##(1991-3#1)(2008-10#1)
to our department##4##3##(1997-8#1)(2008-12#1)(2011-2#2)
to our experience##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
to our hospital for##4##4##(1991-12#1)(2011-2#2)(2013-8#1)
to our hospital with##3##4##(1993-6#1)(2011-2#1)(2012-12#1)
to our hospital##14##3##(1990-9#1)(1991-12#1)(1993-6#1)(2008-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
to our institution##3##3##(2008-12#1)(2008-8#1)(2013-1#1)
to our knowledge the first##5##5##(2007-12#2)(2008-10#1)(2008-2#2)
to our knowledge the##6##4##(2007-12#2)(2008-10#1)(2008-2#3)
to our knowledge this is the first##2##7##(1997-8#1)(2008-9#1)
to our knowledge##40##3##(1995-2#1)(1995-6#1)(1997-8#2)(2007-11#2)(2007-12#4)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#13)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
to our previous##2##3##(2008-10#1)(2008-7#1)
to our study##3##3##(2008-5#1)(2011-7#2)
to our understanding of the##2##5##(2008-11#2)
to our##113##2##(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#3)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#11)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#15)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#7)(2011-3#1)(2011-7#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#2)
to outcome##2##2##(1997-1#1)(2008-11#1)
to outcomes##2##2##(2012-12#1)(2013-1#1)
to outdoor##4##2##(1996-3#2)(2008-10#1)(2012-3#1)
to outline the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
to outline##6##2##(1994-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2012-2#1)
to outpatient##6##2##(1991-1#2)(1991-12#1)(1992-2#1)(1993-1#1)(2012-2#1)
to ovalbumin and##3##3##(1990-5#1)(1995-2#1)(1995-6#1)
to ovarian##3##2##(2008-4#1)(2008-9#1)(2010-12#1)
to over##6##2##(1991-7#1)(1993-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2012-3#1)
to overall##7##2##(1991-6#1)(1993-1#1)(1993-12#1)(1995-6#1)(2008-11#1)(2008-5#1)(2008-8#1)
to overcome many of##2##4##(2008-9#1)(2010-8#1)
to overcome resistance##3##3##(2008-10#2)(2008-11#1)
to overcome some of##2##4##(2008-1#1)(2008-5#1)
to overcome the effects##2##4##(2008-10#1)(2008-6#1)
to overcome the##22##3##(1991-2#1)(1995-5#1)(1997-1#1)(1997-3#1)(2008-10#10)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#2)(2013-1#2)
to overcome these barriers##2##4##(2013-1#2)
to overcome these limitations##2##4##(2008-10#1)(2008-7#1)
to overcome these problems##2##4##(1996-3#1)(2008-11#1)
to overcome these##10##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-7#1)(2013-1#2)
to overcome this##5##3##(2008-10#2)(2008-5#1)(2010-11#1)(2012-12#1)
to overcome##68##2##(1990-12#1)(1991-2#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(2008-1#2)(2008-10#20)(2008-11#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#3)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
to overcrowding of the##2##4##(2008-8#1)(2008-9#1)
to overestimate disease##2##3##(2008-10#2)
to overestimate##3##2##(1992-6#1)(2008-10#2)
to overestimation##2##2##(1992-9#1)(2008-10#1)
to overexpress##3##2##(1993-1#1)(1995-2#1)(2008-11#1)
to overlapping##2##2##(2008-10#2)
to overlying##2##2##(2010-3#1)(2011-2#1)
to overturn##2##2##(1992-11#1)(1995-6#1)
to overweight and obesity##2##4##(2011-2#2)
to oxalate##2##2##(2008-10#2)
to oxidation of the##2##4##(2008-10#1)(2009-9#1)
to oxidation of##3##3##(2008-10#2)(2009-9#1)
to oxidation##7##2##(1991-12#1)(2008-10#3)(2008-5#1)(2009-9#1)(2013-1#1)
to oxidative stress##10##3##(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
to oxidative##15##2##(1991-5#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
to oxidize##2##2##(2008-10#1)(2011-2#1)
to oxidized LDL##2##3##(1996-2#1)(2013-7#1)
to oxidized##3##2##(1994-5#1)(1996-2#1)(2013-7#1)
to oxygen radicals##2##3##(1990-5#1)(2010-7#1)
to oxygen##7##2##(1990-12#1)(1990-5#1)(1990-8#1)(1995-11#1)(2008-10#2)(2010-7#1)
to ozone depletion and##2##4##(1991-6#1)(1996-1#1)
to ozone##3##2##(1991-6#1)(1996-1#1)(2008-10#1)
to p##2##2##(2008-10#1)(2008-11#1)
to p-aminophenol##2##2##(2008-10#2)
to p53##2##2##(1994-12#2)
to pH 2##4##3##(2008-10#4)
to pH 3##4##3##(2008-10#4)
to pH 4##4##3##(2008-10#2)(2008-5#2)
to pH 5##4##3##(2008-10#3)(2008-11#1)
to pH 6##3##3##(2008-10#2)(2008-7#1)
to pH 8##2##3##(2008-10#2)
to pH##37##2##(1993-12#1)(2008-10#28)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#1)(2013-1#1)
to pain management among##2##4##(2009-12#1)(2010-11#1)
to pain management##3##3##(2009-12#1)(2010-11#2)
to pain or##2##3##(2008-4#1)(2011-2#1)
to pain relief##2##3##(2008-9#1)(2009-12#1)
to pain##14##2##(2008-12#2)(2008-4#1)(2008-9#1)(2009-12#3)(2010-11#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
to paint##2##2##(2008-10#1)(2009-8#1)
to palladium##2##2##(2008-10#2)
to palliative##2##2##(1990-12#1)(2008-11#1)
to pancreatic##8##2##(1990-4#1)(1992-3#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-1#2)(2013-1#1)
to panicle blast##3##3##(2008-10#3)
to parasite##2##2##(1997-7#1)(2012-2#1)
to parasitism##4##2##(2008-8#4)
to parasitize##4##2##(2008-10#3)(2008-8#1)
to parathyroid hormone##2##3##(2010-6#1)(2013-7#1)
to parathyroid##3##2##(1990-9#1)(2010-6#1)(2013-7#1)
to parent##3##2##(1990-12#1)(1995-1#1)(2008-11#1)
to parental##3##2##(1994-11#1)(1994-8#1)(2010-1#1)
to parents##4##2##(1995-2#1)(1996-5#1)(1997-7#1)(2008-8#1)
to part of##2##3##(1993-6#1)(2010-8#1)
to partial##3##2##(1996-9#1)(2008-10#1)(2009-7#1)
to partially##7##2##(1990-5#1)(1991-5#1)(1993-9#1)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#1)
to participants##7##2##(1995-2#1)(2008-1#2)(2008-11#1)(2009-11#1)(2009-4#1)(2010-11#1)
to participate in a##4##4##(2008-1#2)(2008-11#1)(2012-12#1)
to participate in the study##4##5##(1994-12#1)(2008-11#1)(2010-1#1)(2010-6#1)
to participate in the##9##4##(1994-12#1)(1994-2#1)(2008-11#2)(2010-1#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
to participate in this##2##4##(1991-2#1)(2008-11#1)
to participate in##32##3##(1991-2#1)(1991-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-2#1)(2008-1#3)(2008-11#6)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
to participate##38##2##(1990-2#1)(1991-2#1)(1991-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-2#1)(2008-1#3)(2008-11#8)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
to participation##3##2##(1994-12#1)(2009-4#1)(2011-9#1)
to particle size##2##3##(1997-2#1)(2008-3#1)
to particle##4##2##(1997-2#1)(2008-10#1)(2008-3#2)
to particles with sharp edges##2##5##(2008-3#2)
to particles##3##2##(1996-12#1)(2008-3#2)
to particular##6##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
to particulate matter##2##3##(2008-10#1)(2013-8#1)
to partner with##2##3##(2010-10#1)(2012-2#1)
to partner##3##2##(2008-6#1)(2010-10#1)(2012-2#1)
to pass through##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
to pass##8##2##(1991-11#1)(1994-2#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
to passive##2##2##(2011-2#1)(2012-9#1)
to pasture##2##2##(1994-1#1)(2010-4#1)
to patch##2##2##(2008-3#1)(2008-8#1)
to pathogen control##2##3##(2008-10#2)
to pathogen##12##2##(2008-10#12)
to pathogenic##2##2##(2008-10#1)(2011-2#1)
to pathogenicity##2##2##(2008-10#2)
to pathogens##4##2##(1997-7#1)(2008-10#2)(2008-7#1)
to pathotype 1##3##3##(2008-10#3)
to pathotype 2##2##3##(2008-10#2)
to pathotype##6##2##(2008-10#6)
to patient care##4##3##(1997-1#1)(2008-11#2)(2012-12#1)
to patient##16##2##(1992-1#1)(1992-3#1)(1993-11#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-11#3)(2010-2#1)(2011-2#4)(2012-12#1)(2013-1#1)
to patients in##2##3##(1995-12#2)
to patients is##2##3##(1995-2#1)(2010-2#1)
to patients who##3##3##(1992-3#1)(2008-11#1)(2013-1#1)
to patients with the##2##4##(2008-1#1)(2011-2#1)
to patients with##16##3##(1997-1#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#9)(2013-1#1)
to patients##42##2##(1990-11#1)(1990-2#3)(1991-2#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-2#10)(2012-3#1)(2013-1#2)
to patients'##2##2##(1991-3#1)(1991-8#1)
to pattern##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
to patterns##2##2##(2008-11#1)(2008-9#1)
to pay $1 million to##2##5##(1995-12#2)
to pay for##5##3##(1994-2#1)(1995-1#1)(1995-12#1)(1996-2#1)(2008-10#1)
to pay##18##2##(1994-2#3)(1995-1#1)(1995-12#4)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-2#1)(2008-10#1)(2008-6#1)(2010-4#1)(2013-1#1)
to peak##6##2##(2008-10#3)(2008-11#2)(2008-7#1)
to peanut##2##2##(2008-10#2)
to pear and##2##3##(2008-10#2)
to pear##4##2##(2008-10#4)
to pediatric medical##2##3##(1994-3#1)(2009-6#1)
to pediatric##4##2##(1994-1#1)(1994-3#1)(2009-6#1)(2010-5#1)
to pegylated##2##2##(2011-2#2)
to penetrate the cuticle##2##4##(2008-10#2)
to penetrate the##7##3##(1996-9#1)(1997-1#1)(2008-10#2)(2008-8#2)(2013-1#1)
to penetrate through##2##3##(2008-10#1)(2008-7#1)
to penetrate to the##2##4##(2008-10#1)(2008-6#1)
to penetrate##17##2##(1996-3#1)(1996-9#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#2)(2013-1#1)
to penetration##3##2##(2008-10#2)(2012-2#1)
to penicillin G##2##3##(2008-10#1)(2013-8#1)
to penicillin##7##2##(2008-10#1)(2008-12#3)(2011-1#1)(2011-2#1)(2013-8#1)
to people aged##2##3##(2012-3#1)(2013-1#1)
to people who##2##3##(1995-6#1)(1996-12#1)
to people with mental illness##3##5##(2011-1#3)
to people with##10##3##(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-12#1)(2009-6#1)(2011-1#3)(2013-1#1)
to people##15##2##(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-1#3)(2012-3#1)(2013-1#2)
to people's##4##2##(2010-2#3)(2010-4#1)
to pepper##2##2##(2008-10#2)
to peptides##2##2##(2008-11#1)(2008-4#1)
to perceive and##2##3##(2008-7#1)(2011-10#1)
to perceive##8##2##(2008-7#2)(2008-8#1)(2009-8#2)(2011-10#1)(2012-3#1)(2013-1#1)
to perceived##3##2##(2009-4#1)(2010-10#1)(2011-2#1)
to percent##2##2##(2008-10#2)
to perceptions##2##2##(2010-12#1)(2011-2#1)
to perform a biopsy for##2##5##(2012-2#2)
to perform a biopsy##3##4##(2012-2#2)(2013-8#1)
to perform a##19##3##(1993-11#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
to perform an##4##3##(2008-10#2)(2010-11#1)(2012-3#1)
to perform and##5##3##(1990-2#1)(2008-4#1)(2009-10#1)(2009-5#1)(2011-2#1)
to perform both##2##3##(2008-10#1)(2008-6#1)
to perform the calculations##2##4##(2008-10#2)
to perform the calibration##2##4##(2008-10#2)
to perform the##19##3##(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
to perform their##2##3##(1991-3#1)(2008-7#1)
to perform##121##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1996-11#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#48)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#3)(2009-10#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#7)(2011-3#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#3)
to performance##3##2##(1996-2#1)(1996-6#1)(2009-10#1)
to permanent##3##2##(1997-6#1)(2008-8#1)(2013-1#1)
to permit the##2##3##(1993-12#1)(2008-10#1)
to permit##15##2##(1993-11#2)(1993-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-9#1)(2011-2#1)
to peroxide-induced haemolysis##2##3##(1991-12#2)
to peroxisomes##2##2##(2009-10#2)
to persist in##3##3##(1990-11#1)(2008-8#2)
to persist##7##2##(1990-11#1)(1991-2#1)(2008-2#1)(2008-8#3)(2011-3#1)
to persons with##2##3##(1996-1#1)(1996-2#1)
to persons##3##2##(1991-8#1)(1996-1#1)(1996-2#1)
to persuade##2##2##(1995-6#1)(1996-1#1)
to perturb the##2##3##(1994-5#1)(1995-9#1)
to perturbations##3##2##(2008-11#2)(2010-11#1)
to pertussis##4##2##(1993-8#1)(1995-5#2)(1997-2#1)
to pests##2##2##(2008-10#2)
to phage##2##2##(1995-2#1)(2012-2#1)
to pharmaceutical formulations##4##3##(2008-10#4)
to pharmaceutical##7##2##(2008-10#5)(2010-8#1)(2012-2#1)
to pharmacology##2##2##(1997-2#1)(2008-12#1)
to phase##8##2##(1994-2#1)(1996-1#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
to phenol##2##2##(2008-10#2)
to phenotype R(T)R(V)##2##3##(2008-10#2)
to phenotype##5##2##(2008-10#4)(2012-2#1)
to phenotypic##3##2##(2008-8#2)(2012-3#1)
to phenylalanine##2##2##(1997-7#1)(2008-10#1)
to phenylamide fungicides##2##3##(2008-10#2)
to phenytoin##3##2##(1994-2#2)(2008-8#1)
to phorbol ester##4##3##(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)
to phosphatidylinositol##2##2##(1997-8#1)(2009-7#1)
to phosphine##2##2##(1990-8#1)(2008-11#1)
to photo-symbiotic clams##2##3##(2008-5#2)
to phylogenetic##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
to physical and mental##2##4##(2008-12#1)(2009-11#1)
to physical and##3##3##(2008-11#1)(2008-12#1)(2009-11#1)
to physical therapy##2##3##(1996-1#1)(2008-12#1)
to physical##19##2##(1992-12#1)(1994-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
to physically##3##2##(1995-11#1)(2008-10#2)
to physician##2##2##(1993-3#1)(2008-8#1)
to physicians and##4##3##(1993-3#1)(1994-12#2)(2013-1#1)
to physicians in##2##3##(2010-7#1)(2011-2#1)
to physicians##16##2##(1992-1#1)(1993-3#1)(1994-12#3)(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
to physico-chemical##2##2##(2008-10#2)
to physiologic##2##2##(1997-2#1)(2008-10#1)
to physiological##3##2##(2008-7#1)(2009-8#1)(2010-1#1)
to physiotherapy##3##2##(1992-2#1)(1995-3#1)(2011-2#1)
to picture##2##2##(1995-2#1)(2009-9#1)
to pilot##4##2##(1994-3#3)(2008-10#1)
to pin##2##2##(2009-3#1)(2012-3#1)
to pinpoint the##2##3##(2009-6#1)(2013-1#1)
to pinpoint##4##2##(2008-10#1)(2008-9#1)(2009-6#1)(2013-1#1)
to pistachio##3##2##(2008-10#3)
to pitch canker##2##3##(2008-10#2)
to pituitary adenomas##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
to place the##5##3##(2008-1#1)(2008-10#3)(2008-7#1)
to place them in the context of the##2##8##(2008-12#1)(2010-7#1)
to place them in##4##4##(1993-9#1)(1995-1#1)(2008-12#1)(2010-7#1)
to place##19##2##(1993-1#1)(1993-9#1)(1995-1#1)(1995-9#1)(1996-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-6#1)(2010-7#1)(2012-2#1)
to plan and implement##2##4##(1996-3#1)(2008-11#1)
to plan for the##2##4##(1992-2#1)(1993-1#1)
to plan for##4##3##(1992-12#1)(1992-2#1)(1993-1#1)(2008-11#1)
to plan the##2##3##(2008-10#1)(2009-11#1)
to plan##16##2##(1992-12#1)(1992-2#1)(1993-1#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2009-11#1)(2010-12#1)(2010-5#1)(2012-3#2)(2013-1#1)
to planning##2##2##(1993-3#1)(2008-6#1)
to plant disease##2##3##(2008-10#2)
to plant##18##2##(2008-10#11)(2008-8#3)(2008-9#2)(2011-1#1)(2011-2#1)
to planting##6##2##(2008-10#6)
to plants##14##2##(1993-2#1)(1997-3#1)(2008-10#8)(2008-11#1)(2011-2#1)(2013-8#2)
to plasma TG levels alone##2##5##(2008-3#2)
to plasma membrane##2##3##(2008-11#1)(2009-8#1)
to plasma##9##2##(1995-12#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-12#1)
to plastic##2##2##(2008-11#1)(2012-4#1)
to platelet##3##2##(1991-12#1)(1992-12#1)(1993-3#1)
to platelets##4##2##(1993-3#1)(2006-6#2)(2009-3#1)
to play a critical role in##5##6##(1990-11#1)(1994-2#1)(2011-2#2)(2013-7#1)
to play a critical role##6##5##(1990-11#1)(1994-2#1)(2008-11#1)(2011-2#2)(2013-7#1)
to play a crucial role##2##5##(1992-10#1)(1993-8#1)
to play a crucial##3##4##(1992-10#1)(1993-8#1)(2008-10#1)
to play a major role in##2##6##(2008-10#1)(2013-1#1)
to play a pivotal role in##3##6##(2008-11#2)(2012-2#1)
to play a role in the##2##6##(1992-6#1)(2012-2#1)
to play a role in##10##5##(1990-5#1)(1992-12#1)(1992-6#2)(1993-3#1)(1996-2#1)(2008-10#1)(2010-10#1)(2012-2#1)(2012-7#1)
to play a significant role in##5##6##(2008-10#2)(2008-7#1)(2012-2#1)(2013-8#1)
to play a##34##3##(1990-11#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-2#1)(1996-2#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-7#1)(2010-10#1)(2011-2#3)(2012-2#3)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#3)
to play an important role in the##3##7##(1994-2#1)(1996-12#1)(1996-2#1)
to play an important role in##16##6##(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#3)(1996-2#1)(1997-8#1)(2008-4#1)(2008-7#2)(2008-9#2)(2010-12#1)(2011-2#2)
to play an important role##17##5##(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#3)(1996-2#1)(1997-8#1)(2008-4#2)(2008-7#2)(2008-9#2)(2010-12#1)(2011-2#2)
to play an important##18##4##(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#3)(1996-2#1)(1997-8#1)(2008-4#2)(2008-7#2)(2008-9#2)(2010-12#1)(2011-2#2)
to play an##19##3##(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#3)(1996-2#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-9#2)(2010-12#1)(2011-2#2)
to play important roles in##3##5##(2008-7#1)(2008-9#1)(2011-2#1)
to play important##5##3##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
to play##78##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#2)(1995-12#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#10)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#3)(2009-10#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#3)
to pneumonia##2##2##(1992-6#1)(2013-8#1)
to point out##2##3##(2008-10#1)(2009-7#1)
to point to##2##3##(2010-5#1)(2012-3#1)
to point##4##2##(2008-10#1)(2009-7#1)(2010-5#1)(2012-3#1)
to poisoning##2##2##(1997-3#2)
to polarization##2##2##(2008-1#1)(2008-3#1)
to policy makers and##2##4##(1997-2#1)(2013-1#1)
to policy##6##2##(1991-2#1)(1993-3#1)(1997-2#1)(2008-1#1)(2008-12#1)(2013-1#1)
to pollen##3##2##(2009-10#1)(2009-8#1)(2013-1#1)
to polymer##2##2##(2008-10#1)(2011-2#1)
to poor##11##2##(2008-10#1)(2008-11#2)(2008-9#2)(2009-4#1)(2009-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
to popular belief##2##3##(1993-1#1)(2009-9#1)
to population##10##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#3)(2013-1#1)
to populations##4##2##(1997-1#1)(2008-10#2)(2010-5#1)
to porcine##2##2##(1997-5#1)(2008-5#1)
to pose##4##2##(1995-6#1)(2008-10#1)(2008-11#2)
to position themselves##2##3##(1994-12#1)(1997-1#1)
to position##7##2##(1993-8#1)(1994-12#1)(1996-1#1)(1997-1#2)(2008-2#1)(2010-7#1)
to positive or negative##2##4##(2008-10#2)
to positive##8##2##(2008-10#4)(2008-9#1)(2009-11#1)(2012-12#1)(2013-8#1)
to positively##4##2##(1995-12#1)(2008-10#3)
to possess both##2##3##(1990-5#1)(2008-10#1)
to possess the##5##3##(1993-8#1)(2008-10#3)(2008-11#1)
to possess##18##2##(1990-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-1#1)(2008-10#6)(2008-11#3)(2008-8#1)(2009-2#1)(2013-1#2)
to possible##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
to posterior##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
to postnatal day##2##3##(1993-3#1)(2008-7#1)
to posttest##2##2##(2008-12#1)(2010-10#1)
to posttranscriptional##3##2##(1994-8#1)(1995-2#1)(1996-12#1)
to postulate##5##2##(1990-8#1)(1992-6#1)(1995-3#1)(2008-10#1)(2008-12#1)
to potato and tomato##2##4##(2008-10#2)
to potato and##3##3##(2008-10#3)
to potato late blight of##2##5##(2008-10#2)
to potato##11##2##(2008-10#11)
to potential mechanisms of##2##4##(2008-11#1)(2008-5#1)
to potential##14##2##(1993-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2012-2#1)(2012-3#1)
to potentially##2##2##(2011-2#1)(2013-1#1)
to potentiate the##2##3##(1990-12#1)(1993-6#1)
to potentiate##5##2##(1990-12#1)(1993-6#3)(2008-7#1)
to potentiometric##2##2##(2008-10#2)
to powdery mildew in##3##4##(2008-10#3)
to powdery mildew##15##3##(2008-10#15)
to practical##4##2##(1992-9#1)(1996-1#1)(2008-10#1)(2008-2#1)
to practice and##2##3##(2008-12#1)(2010-10#1)
to practice in##4##3##(2008-11#3)(2008-12#1)
to practice it##2##3##(2008-10#1)(2008-11#1)
to practice##36##2##(1993-1#1)(1993-12#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#14)(2008-12#4)(2008-6#1)(2008-9#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-1#6)(2013-8#1)
to practice'##2##2##(2008-11#1)(2008-12#1)
to pre-treat##2##2##(2008-10#2)
to precede the##2##3##(1994-3#1)(2013-8#1)
to precede##3##2##(1994-3#1)(2009-10#1)(2013-8#1)
to precipitate the##2##3##(1993-8#1)(2008-4#1)
to precipitate##5##2##(1993-8#1)(1996-2#1)(2008-10#2)(2008-4#1)
to precisely##7##2##(2008-10#3)(2009-8#2)(2011-2#1)(2012-12#1)
to preconcentrate##8##2##(2008-10#8)
to predation risk##2##3##(2008-9#1)(2010-8#1)
to predation##4##2##(2008-9#1)(2010-8#2)(2012-3#1)
to predators##4##2##(2008-8#2)(2008-9#1)(2013-1#1)
to predict Fusarium##2##3##(2008-10#2)
to predict a##2##3##(2008-10#1)(2009-4#1)
to predict how##2##3##(2008-5#1)(2011-2#1)
to predict in##2##3##(2008-11#1)(2009-8#1)
to predict risk##2##3##(2010-7#1)(2013-1#1)
to predict the concentration##2##4##(2008-10#1)(2010-4#1)
to predict the consequences of##2##5##(1992-3#1)(2008-7#1)
to predict the effect of##5##5##(2008-3#2)(2008-7#2)(2012-2#1)
to predict the immune##2##4##(2008-10#2)
to predict the impact of##2##5##(2008-10#1)(2008-8#1)
to predict the likelihood of##2##5##(2009-6#1)(2012-12#1)
to predict the presence of##3##5##(2008-10#1)(2012-3#2)
to predict the severity of##2##5##(2008-10#1)(2010-8#1)
to predict the##59##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-4#1)(1996-12#1)(1997-9#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#7)(2008-8#3)(2009-6#1)(2009-7#2)(2010-4#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to predict vaccine equivalence##2##4##(1995-5#2)
to predict##142##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-3#3)(1992-4#1)(1993-2#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-12#2)(1996-8#2)(1997-2#1)(1997-8#1)(1997-9#1)(2007-8#1)(2008-10#42)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#3)(2009-10#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#2)(2010-8#2)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
to predicted##2##2##(1992-3#1)(2008-12#1)
to predicting##3##2##(1995-5#2)(2008-11#1)
to predictions##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
to predominate in##2##3##(2008-10#2)
to prefer##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
to preferentially##3##2##(1997-1#1)(2008-10#1)(2013-1#1)
to pregnancy##3##2##(1996-11#1)(2008-11#1)(2009-1#1)
to premature##4##2##(1994-3#1)(2007-11#1)(2008-4#1)(2008-5#1)
to prenatal care##2##3##(2008-10#1)(2008-11#1)
to prenatal##4##2##(1997-3#1)(2008-10#2)(2008-11#1)
to preoperative##6##2##(1991-2#1)(2008-7#2)(2009-12#1)(2011-2#2)
to preparation##2##2##(2008-10#1)(2008-9#1)
to preparative##2##2##(2008-10#2)
to prepare &quot##2##3##(1990-12#1)(1991-12#1)
to prepare a##7##3##(1990-11#1)(1993-12#1)(2008-10#4)(2010-7#1)
to prepare an##2##3##(2008-10#2)
to prepare and##4##3##(2008-10#3)(2010-7#1)
to prepare for the##2##4##(2007-12#1)(2012-3#1)
to prepare nurses##2##3##(2008-11#2)
to prepare the##8##3##(1995-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-2#1)
to prepare##59##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#2)(1993-12#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#4)(2011-3#2)(2012-2#2)(2012-3#1)(2013-8#1)
to preparing##2##2##(2008-11#1)(2008-12#1)
to prescribe antibiotics##2##3##(1997-4#2)
to prescribe##5##2##(1996-11#1)(1996-8#1)(1997-4#2)(2008-11#1)
to present a major challenge to##2##6##(2008-10#1)(2010-1#1)
to present a##12##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
to present the##8##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#2)
to present to##2##3##(1996-6#1)(2012-2#1)
to present##47##2##(1990-5#1)(1992-1#1)(1992-4#1)(1993-12#1)(1994-2#2)(1994-8#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)
to presenting##2##2##(2008-12#1)(2013-1#1)
to preserve the##9##3##(2008-10#3)(2008-3#1)(2008-5#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
to preserve their##2##3##(2010-4#1)(2013-1#1)
to preserve these##2##3##(2008-10#1)(2008-5#1)
to preserve##23##2##(1995-12#1)(2008-10#4)(2008-3#3)(2008-5#4)(2008-6#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#3)
to preserved##2##2##(2008-10#1)(2013-1#1)
to preserving##2##2##(1991-3#1)(1997-8#1)
to press##2##2##(2008-10#1)(2008-8#1)
to pressure##4##2##(1997-3#1)(2008-11#1)(2009-1#1)(2010-4#1)
to prevent HIV##2##3##(1997-6#1)(2008-10#1)
to prevent a &quot##2##4##(1993-1#1)(1995-2#1)
to prevent a##4##3##(1993-1#1)(1995-2#1)(2008-10#1)(2009-5#1)
to prevent adhesion##2##3##(2008-7#2)
to prevent and control##3##4##(2007-12#1)(2012-2#1)(2013-8#1)
to prevent and cure##2##4##(2008-10#1)(2008-8#1)
to prevent and relieve##2##4##(2008-11#1)(2012-3#1)
to prevent and treat##3##4##(2008-11#1)(2013-1#2)
to prevent and##12##3##(1993-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
to prevent cancer##2##3##(1997-1#1)(2013-7#1)
to prevent childhood##2##3##(2010-8#1)(2012-2#1)
to prevent contamination##2##3##(2008-10#2)
to prevent disease##2##3##(2013-7#2)
to prevent early##2##3##(2013-1#1)(2013-8#1)
to prevent germination##2##3##(2008-7#1)(2011-2#1)
to prevent interference from##2##4##(2008-10#1)(2008-3#1)
to prevent interference##3##3##(2008-10#2)(2008-3#1)
to prevent low##2##3##(1995-12#1)(1997-7#1)
to prevent or delay##2##4##(2010-10#2)
to prevent or relieve the##2##5##(2008-9#1)(2010-9#1)
to prevent or treat##2##4##(2008-10#2)
to prevent or##12##3##(1994-2#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)
to prevent possible##2##3##(1990-5#1)(2010-4#1)
to prevent postoperative##2##3##(1992-3#1)(2010-7#1)
to prevent premature##2##3##(1991-6#1)(2011-3#1)
to prevent radial artery occlusion and radial artery spasm##2##9##(2011-2#2)
to prevent serious##3##3##(2008-10#1)(2010-1#1)(2010-10#1)
to prevent the binding of##2##5##(1990-11#1)(1990-5#1)
to prevent the disease##2##4##(1994-9#1)(1996-6#1)
to prevent the spread of##2##5##(1997-6#2)
to prevent the##28##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-2#1)(1994-9#1)(1996-6#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-7#2)(2008-9#1)(2009-12#2)(2010-6#1)(2013-1#1)
to prevent them##3##3##(2008-11#1)(2010-11#1)(2013-1#1)
to prevent this##4##3##(1993-11#1)(1995-8#1)(2009-10#1)(2013-1#1)
to prevent unnecessary##2##3##(2008-10#1)(2011-2#1)
to prevent##185##2##(1990-11#1)(1990-5#2)(1990-9#1)(1991-3#1)(1991-6#3)(1992-10#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2007-12#2)(2008-1#3)(2008-10#32)(2008-11#9)(2008-12#3)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#2)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#11)(2013-7#3)(2013-8#4)
to preventing##3##2##(2008-10#1)(2008-8#1)(2009-11#1)
to prevention and##3##3##(1996-3#1)(1997-2#1)(2010-12#1)
to previous reports##5##3##(1992-3#1)(1993-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
to previous studies##4##3##(2007-12#1)(2008-3#1)(2009-6#1)(2012-12#1)
to previous##22##2##(1992-3#1)(1993-6#1)(1993-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#1)
to previously described##2##3##(1995-9#1)(2008-10#1)
to previously##10##2##(1993-1#1)(1995-9#1)(1997-8#1)(2008-10#5)(2008-11#1)(2013-1#1)
to price##2##2##(1993-2#1)(1994-12#1)
to primary open angle glaucoma##2##5##(2011-2#2)
to primary prevention##3##3##(1995-3#1)(1995-5#1)(1997-1#1)
to primary##15##2##(1995-3#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-1#2)
to prime##3##2##(1995-2#2)(2008-11#1)
to principal components##2##3##(2008-10#2)
to principal##3##2##(2008-10#2)(2008-11#1)
to prioritize##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
to private##4##2##(1992-11#1)(1995-3#1)(1996-3#1)(2008-8#1)
to proactively##2##2##(1992-1#1)(2010-10#1)
to probe DNA##2##3##(1992-4#1)(2008-10#1)
to probe RNA##2##3##(1991-12#1)(2008-4#1)
to probe the##12##3##(1990-8#1)(1991-3#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-6#1)(2008-10#3)(2008-4#1)(2009-10#1)(2009-12#1)
to probe their##2##3##(2008-10#1)(2012-2#1)
to probe##25##2##(1990-8#1)(1991-12#2)(1991-3#1)(1992-4#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-8#2)(2009-10#1)(2009-12#1)(2012-2#1)
to problem##2##2##(2008-12#1)(2010-11#1)
to problems##6##2##(1991-6#1)(1993-2#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-5#1)
to proceed with##2##3##(1996-5#1)(2008-10#1)
to proceed##6##2##(1996-5#1)(2008-10#3)(2011-3#1)(2012-2#1)
to process a##3##3##(2008-9#1)(2009-7#1)(2010-11#1)
to process monitoring##2##3##(2008-10#2)
to process the##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
to process##22##2##(1995-3#2)(1996-2#1)(2008-10#5)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-11#1)(2013-1#2)(2013-8#1)
to processes##2##2##(2008-8#1)(2009-10#1)
to processing##3##2##(2008-10#2)(2008-3#1)
to produce SA##3##3##(2008-10#3)
to produce a continuous##2##4##(2008-10#1)(2008-5#1)
to produce a large##2##4##(2008-10#2)
to produce a more##2##4##(2008-10#1)(2008-11#1)
to produce a red complex##2##5##(2008-10#2)
to produce a##46##3##(1991-1#1)(1991-3#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-12#1)(1997-7#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#2)(2012-3#2)
to produce an##12##3##(1990-8#1)(1995-9#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-7#1)(2012-2#1)
to produce and secrete##2##4##(1995-2#1)(2008-10#1)
to produce and##3##3##(1995-2#1)(2008-1#1)(2008-10#1)
to produce apothecia##2##3##(2008-10#2)
to produce ascites##2##3##(1991-12#2)
to produce both##2##3##(2008-10#1)(2010-6#1)
to produce fluorescent##2##3##(2008-10#2)
to produce infectious##2##3##(1990-5#1)(2008-10#1)
to produce large amounts of##2##5##(2008-10#1)(2008-11#1)
to produce large quantities of##2##5##(2008-10#1)(2008-11#1)
to produce large##6##3##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)
to produce light emission##2##4##(2008-10#2)
to produce more##3##3##(1993-11#1)(1994-2#1)(2008-8#1)
to produce novel##2##3##(2008-7#1)(2009-11#1)
to produce oospores in potato tuber tissue##2##7##(2008-10#2)
to produce oospores in##3##4##(2008-10#3)
to produce oospores##6##3##(2008-10#6)
to produce recombinant##2##3##(1995-5#1)(2008-11#1)
to produce sufficient##2##3##(1997-7#1)(2008-11#1)
to produce the##16##3##(1992-3#1)(1993-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#1)(2011-3#1)
to produce these##2##3##(1992-9#1)(2011-1#1)
to produce this##2##3##(2008-10#1)(2008-8#1)
to produce valid##2##3##(1991-12#1)(2008-12#1)
to produce##261##2##(1990-2#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-7#2)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#96)(2008-11#26)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#4)(2009-11#1)(2009-12#2)(2009-5#4)(2009-7#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#3)
to produce)##2##2##(2008-9#2)
to product##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
to production in##2##3##(2008-10#1)(2008-7#1)
to production of##6##3##(1993-6#1)(2008-10#2)(2008-11#3)
to production##10##2##(1992-12#1)(1993-6#1)(2008-10#3)(2008-11#4)(2008-7#1)
to products##2##2##(1997-1#1)(2008-10#1)
to professional##7##2##(1991-12#1)(1993-1#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-12#1)(2012-2#1)
to profile##2##2##(1995-3#1)(2008-10#1)
to profound##3##2##(2008-4#1)(2008-9#2)
to progesterone##2##2##(1995-11#1)(2008-7#1)
to prognosis##2##2##(1990-8#1)(2010-11#1)
to progress in##2##3##(1996-11#1)(2008-11#1)
to progress##6##2##(1996-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2013-8#1)
to progression##5##2##(1993-1#1)(2008-1#1)(2008-10#2)(2013-1#1)
to progressive##4##2##(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
to proliferate and##3##3##(2008-11#2)(2008-4#1)
to proliferate in##2##3##(2008-10#1)(2008-11#1)
to proliferate##11##2##(1990-12#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-9#1)
to proliferation##2##2##(1991-3#1)(2008-11#1)
to prolong the##2##3##(1991-3#1)(2013-8#1)
to prolong##8##2##(1990-12#1)(1991-2#1)(1991-3#1)(2008-5#2)(2008-8#1)(2012-2#1)(2013-8#1)
to prolonged##5##2##(1997-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
to promote a##2##3##(2008-10#2)
to promote and evaluate critical thinking##2##6##(2008-12#2)
to promote and##5##3##(1996-2#1)(2008-12#2)(2008-5#1)(2012-3#1)
to promote cell growth##2##4##(2008-7#1)(2013-1#1)
to promote cell##4##3##(1995-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
to promote children's##2##3##(2012-2#1)(2013-1#1)
to promote culturally##2##3##(1997-2#1)(2013-8#1)
to promote or##2##3##(2013-1#2)
to promote quality improvement##2##4##(1996-2#1)(1997-1#1)
to promote the adoption of##2##5##(2008-4#1)(2010-11#1)
to promote the development of##2##5##(2008-11#1)(2011-2#1)
to promote the formation of##3##5##(1995-2#2)(2008-9#1)
to promote the##24##3##(1990-6#1)(1991-3#1)(1995-2#3)(1995-8#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-9#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to promote##100##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-3#2)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#1)
to promoters##2##2##(1994-3#1)(2012-3#1)
to promoting##2##2##(2008-11#1)(2013-8#1)
to propagate##2##2##(1997-7#1)(2008-3#1)
to properly manage##2##3##(1993-2#1)(2012-12#1)
to properly##5##2##(1993-2#1)(2008-10#1)(2008-7#2)(2012-12#1)
to properties of##2##3##(2007-12#1)(2009-8#1)
to propiconazole##5##2##(2008-10#5)
to propose a##3##3##(2008-10#1)(2008-3#2)
to propose an##2##3##(2008-10#1)(2008-11#1)
to propose that##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
to propose##15##2##(1991-3#1)(1993-11#1)(1994-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2009-3#1)(2009-8#2)
to prospective payment##2##3##(1991-1#1)(1992-1#1)
to prospective##3##2##(1991-1#1)(1992-1#1)(2008-12#1)
to prostate cancer##2##3##(2008-6#1)(2011-2#1)
to proteases##3##2##(1992-6#1)(2008-10#2)
to protect against##7##3##(1991-6#3)(2008-5#1)(2011-2#2)(2011-9#1)
to protect all##2##3##(1995-3#1)(2009-12#1)
to protect immunodeficient##2##3##(2008-5#2)
to protect the artificial##2##4##(2008-5#2)
to protect the##16##3##(1994-3#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(2008-11#4)(2008-5#3)(2009-5#1)(2010-7#1)(2011-2#1)
to protect their##2##3##(1992-3#1)(2009-10#1)
to protect them against##2##4##(1994-3#1)(2013-1#1)
to protect women##2##3##(1990-2#2)
to protect##63##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-12#1)(1991-6#4)(1992-3#1)(1994-3#3)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(2008-10#4)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#7)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-7#2)(2011-10#1)(2011-2#4)(2011-9#1)(2012-2#2)(2013-1#2)
to protection##3##2##(1995-5#2)(2013-7#1)
to protein##13##2##(1990-5#1)(1991-2#1)(1993-12#1)(1993-6#1)(1994-11#1)(1997-3#1)(2008-10#4)(2008-4#1)(2008-9#2)
to protein-free##2##2##(2008-11#2)
to proteinase K##2##3##(1990-5#1)(1996-12#1)
to proteins from##2##3##(1991-12#1)(1992-8#1)
to proteins##8##2##(1991-12#1)(1992-2#1)(1992-8#1)(2008-10#5)
to proteolysis and##2##3##(1995-8#1)(2011-1#1)
to proteolysis##4##2##(1991-10#1)(1995-6#1)(1995-8#1)(2011-1#1)
to proteolytic##2##2##(1993-8#1)(2008-10#1)
to prove that##2##3##(2008-10#1)(2008-6#1)
to prove the##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
to prove##13##2##(1997-4#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-5#1)
to provide a brief##3##4##(1996-2#1)(2010-10#1)(2013-1#1)
to provide a broader##2##4##(2008-11#1)(2008-7#1)
to provide a comprehensive##4##4##(1993-12#1)(2008-7#1)(2010-6#1)(2013-8#1)
to provide a description of##2##5##(1991-12#1)(2009-7#1)
to provide a foundation##2##4##(1996-2#1)(2008-12#1)
to provide a fundamental##2##4##(2008-11#1)(2008-5#1)
to provide a general##3##4##(1997-3#1)(2008-4#1)(2008-6#1)
to provide a good##2##4##(2008-10#1)(2008-3#1)
to provide a profile of##2##5##(1991-12#1)(1995-2#1)
to provide a rational approach to the##2##7##(1996-3#1)(2011-2#1)
to provide a reliable##2##4##(2011-7#1)(2012-2#1)
to provide a safe##2##4##(2008-10#1)(2008-11#1)
to provide a##79##3##(1991-11#1)(1991-12#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-2#3)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#2)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#3)
to provide additional support##2##4##(2008-12#1)(2013-1#1)
to provide additional##5##3##(2008-10#2)(2008-12#1)(2010-12#1)(2013-1#1)
to provide adequate##6##3##(1996-5#1)(1997-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
to provide an overview of the##2##6##(2008-10#1)(2008-9#1)
to provide an overview of##5##5##(1995-3#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-12#1)
to provide an overview##6##4##(1995-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)
to provide an##22##3##(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)
to provide any##2##3##(1991-2#1)(1995-11#1)
to provide better##3##3##(2008-3#1)(2008-9#1)(2013-8#1)
to provide care##4##3##(1993-12#1)(2008-11#1)(2008-6#1)(2008-8#1)
to provide data for##2##4##(1990-2#1)(2010-7#1)
to provide data##4##3##(1990-2#1)(2008-5#1)(2010-7#1)(2011-2#1)
to provide estimates of##2##4##(1997-3#1)(2008-10#1)
to provide evidence##5##3##(1996-12#1)(2008-11#2)(2008-12#1)(2012-12#1)
to provide for a##2##4##(2008-10#1)(2013-1#1)
to provide for##8##3##(1991-3#1)(1992-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2013-1#2)
to provide guidance for##2##4##(2013-1#1)(2013-8#1)
to provide guidance##3##3##(2008-11#1)(2013-1#1)(2013-8#1)
to provide guidelines##2##3##(1992-3#1)(2008-10#1)
to provide high##2##3##(2008-10#1)(2008-11#1)
to provide in the##2##4##(2009-7#1)(2010-10#1)
to provide increased##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
to provide information about the##2##5##(1993-12#1)(2008-10#1)
to provide information about##5##4##(1992-2#1)(1993-12#1)(2008-10#2)(2011-3#1)
to provide information##7##3##(1992-2#1)(1993-12#1)(1996-6#1)(2008-10#2)(2009-5#1)(2011-3#1)
to provide insight into##2##4##(2009-9#1)(2012-3#1)
to provide insight##3##3##(2009-9#1)(2012-3#1)(2013-1#1)
to provide insights into the##4##5##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
to provide insights into##5##4##(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
to provide insights##6##3##(2008-10#2)(2008-11#1)(2010-10#1)(2012-2#1)(2013-1#1)
to provide insurance##2##3##(1991-2#2)
to provide mental health##2##4##(1991-1#1)(2013-1#1)
to provide more##4##3##(1990-3#1)(1992-3#1)(2008-10#1)(2011-2#1)
to provide new##4##3##(1996-1#1)(2008-10#1)(2008-3#1)(2010-11#1)
to provide opportunities for##2##4##(1993-6#1)(2009-11#1)
to provide protection##2##3##(2008-10#1)(2008-5#1)
to provide quality##2##3##(2008-11#2)
to provide quantitative##2##3##(2008-10#2)
to provide rapid##2##3##(2008-10#1)(2011-2#1)
to provide recommendations for##2##4##(2008-11#1)(2012-3#1)
to provide services##3##3##(1994-1#2)(2008-11#1)
to provide significant##2##3##(2008-7#1)(2012-3#1)
to provide some##2##3##(1991-3#1)(2008-7#1)
to provide such##2##3##(1996-3#1)(2008-11#1)
to provide the best##4##4##(2008-10#3)(2010-11#1)
to provide the reader with##2##5##(2008-10#1)(2010-9#1)
to provide the##31##3##(1990-11#1)(1990-12#1)(1992-6#1)(1995-12#2)(2008-10#8)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
to provide their##2##3##(1997-2#1)(2008-9#1)
to provide to##2##3##(2010-8#1)(2013-1#1)
to provide useful##2##3##(2008-4#1)(2010-11#1)
to provide##356##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#2)(1992-2#4)(1992-3#3)(1992-6#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#3)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#58)(2008-11#41)(2008-12#9)(2008-2#2)(2008-3#12)(2008-4#8)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#8)(2010-11#8)(2010-12#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#3)(2011-7#2)(2012-12#7)(2012-2#14)(2012-3#5)(2013-1#12)(2013-3#1)(2013-8#12)
to provider##2##2##(1995-2#1)(1997-1#1)
to providing##6##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)
to psychiatric##5##2##(1993-12#1)(1997-3#1)(1997-8#1)(2008-4#1)(2009-8#1)
to psychological##3##2##(1995-1#1)(2008-12#1)(2010-2#1)
to public health practice##3##4##(1996-1#1)(1996-3#1)(2012-2#1)
to public health surveillance systems##2##5##(2008-7#2)
to public health surveillance##3##4##(1997-3#1)(2008-7#2)
to public health##17##3##(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#4)(2008-10#2)(2008-7#2)(2012-2#3)(2013-1#2)
to public health's##2##3##(1996-2#1)(1996-3#1)
to public##23##2##(1992-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#4)(2008-10#2)(2008-7#3)(2010-12#1)(2012-2#4)(2013-1#2)
to publish##6##2##(1991-12#1)(1991-2#1)(1993-12#1)(2010-12#3)
to published##5##2##(1993-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
to pull the##2##3##(1994-3#1)(2008-11#1)
to pull##3##2##(1994-3#1)(2008-11#1)(2008-7#1)
to pulmonary##7##2##(1994-5#1)(1996-12#1)(2007-8#1)(2008-12#1)(2011-2#2)(2013-8#1)
to purchase##4##2##(1993-12#1)(1994-3#1)(1997-3#1)(2008-4#1)
to pure##5##2##(1994-3#1)(2008-10#4)
to purified##3##2##(1993-3#1)(2008-9#1)(2011-2#1)
to purify this##2##3##(1994-11#1)(1997-7#1)
to purify##6##2##(1990-11#1)(1991-7#1)(1994-11#1)(1997-7#1)(2008-10#1)(2008-4#1)
to pursue a##3##3##(1992-1#1)(2008-10#1)(2009-5#1)
to pursue the##2##3##(2008-11#1)(2008-9#1)
to pursue##12##2##(1992-1#1)(1995-1#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
to put more##2##3##(1997-2#1)(2008-10#1)
to put##8##2##(1990-11#1)(1990-3#1)(1991-3#1)(1995-2#1)(1997-2#1)(2008-10#1)(2010-5#1)(2011-2#1)
to pyrolysis##2##2##(2008-10#2)
to quadrat size##2##3##(2008-10#2)
to quality and##2##3##(1997-5#1)(2007-8#1)
to quality improvement##3##3##(1995-1#1)(1995-2#1)(1997-8#1)
to quality of##2##3##(1995-3#1)(2013-1#1)
to quality##14##2##(1991-3#1)(1993-12#1)(1994-1#2)(1995-1#1)(1995-2#1)(1995-3#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-1#2)
to quantify and##3##3##(2008-10#2)(2008-11#1)
to quantify the degree of##2##5##(2008-10#1)(2010-3#1)
to quantify the effect of##2##5##(2008-10#2)
to quantify the effects of##3##5##(2008-10#2)(2008-11#1)
to quantify the hydrolysis##2##4##(2008-10#1)(2013-1#1)
to quantify the size##2##4##(2008-7#1)(2010-10#1)
to quantify the##37##3##(1990-7#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#2)
to quantify##94##2##(1990-7#1)(1991-12#1)(1993-6#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-12#1)(1996-6#1)(2008-10#47)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#4)(2013-1#3)
to quantifying##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
to quantitate enantiomeric mixtures##2##4##(2008-10#2)
to quantitate the##6##3##(1991-9#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
to quantitate##16##2##(1990-12#1)(1991-9#1)(1992-12#2)(1994-8#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-9#1)(2012-2#1)
to quantitative analysis##2##3##(2008-10#1)(2008-9#1)
to quantitative##4##2##(2008-10#3)(2008-9#1)
to quantitatively assess##2##3##(2008-10#2)
to quantitatively##10##2##(1995-12#1)(2008-10#7)(2008-4#1)(2011-7#1)
to quartz surfaces##2##3##(2008-10#2)
to quench##3##2##(1992-9#1)(2008-8#1)(2008-9#1)
to query##2##2##(2008-4#2)
to question the##3##3##(1993-2#1)(2008-12#1)(2010-6#1)
to question##4##2##(1993-2#1)(2008-12#1)(2009-6#1)(2010-6#1)
to questions about##2##3##(1991-2#1)(1992-12#1)
to questions##5##2##(1991-2#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
to quickly##2##2##(2008-10#1)(2008-9#1)
to quit smoking##4##3##(2013-8#4)
to quit using##2##3##(2008-4#2)
to quit##15##2##(1991-12#1)(2008-4#2)(2010-2#2)(2011-2#2)(2013-1#2)(2013-8#6)
to race 1 isolates##2##4##(2008-10#2)
to race 1##7##3##(2008-10#7)
to race 2##6##3##(2008-10#6)
to race 3##3##3##(2008-10#3)
to race 4##2##3##(2008-10#2)
to race##21##2##(2008-10#20)(2011-2#1)
to races 1 and 4 was##2##6##(2008-10#2)
to races 1 and 4##4##5##(2008-10#4)
to races 1 and 8##2##5##(2008-10#2)
to races 1 and##9##4##(2008-10#9)
to races 1##11##3##(2008-10#11)
to radial##2##2##(1997-3#1)(2011-2#1)
to radiation sensitive##2##3##(1993-9#2)
to radiation therapy##2##3##(1994-12#1)(1997-3#1)
to radiation##11##2##(1993-2#1)(1993-9#2)(1994-12#1)(1997-3#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
to radical##2##2##(2008-11#1)(2010-11#1)
to radiolabel##3##2##(1991-3#1)(1996-2#1)(2008-11#1)
to radiology##2##2##(1991-2#1)(1994-1#1)
to raindrop##2##2##(2008-3#2)
to raise the##5##3##(1991-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
to raise##15##2##(1991-5#1)(1993-1#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#3)
to random##4##2##(1995-12#1)(1995-6#1)(2008-10#2)
to randomly##2##2##(2008-9#1)(2012-2#1)
to range from 0##2##4##(1995-5#1)(2008-10#1)
to range from##7##3##(1995-5#1)(2008-10#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
to range##8##2##(1995-5#1)(2008-10#2)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
to ranges of##2##3##(2008-3#2)
to rank the##2##3##(2008-5#1)(2011-2#1)
to rank##7##2##(2008-10#1)(2008-11#3)(2008-5#1)(2010-12#1)(2011-2#1)
to rapid##7##2##(1991-3#1)(1992-9#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-11#1)
to rapidly detect##3##3##(2008-10#1)(2012-2#2)
to rapidly screen##2##3##(2008-11#1)(2008-9#1)
to rapidly##19##2##(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#1)(2008-10#3)(2008-11#5)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
to rare##2##2##(2008-11#1)(2012-2#1)
to rarely##2##2##(1996-2#1)(2008-7#1)
to rat liver##2##3##(1991-5#1)(1992-6#1)
to rat##7##2##(1990-5#1)(1991-5#1)(1992-3#2)(1992-6#2)(1993-2#1)
to rate how##2##3##(2009-10#2)
to rate the##3##3##(1995-3#1)(2008-10#1)(2013-8#1)
to rate##10##2##(1991-2#1)(1991-6#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#2)(2010-8#1)(2013-8#1)
to rates##2##2##(1993-12#1)(2009-8#1)
to rationalize the##2##3##(1996-5#1)(2008-7#1)
to ratios of##2##3##(2008-10#2)
to rats and##2##3##(1995-11#1)(2008-4#1)
to rats produced##2##3##(1996-12#1)(2012-2#1)
to rats##13##2##(1990-5#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
to re-evaluate##2##2##(2008-11#1)(2008-7#1)
to re-examine##5##2##(1992-12#1)(1996-3#1)(2008-1#1)(2008-11#2)
to reach a##7##3##(1993-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-3#1)
to reach an##2##3##(1996-3#1)(2008-8#1)
to reach clinical##2##3##(2008-11#1)(2008-5#1)
to reach its##2##3##(1992-3#1)(2008-11#1)
to reach steady state##2##4##(2008-10#2)
to reach the##17##3##(1990-12#1)(1990-5#1)(1995-11#1)(1996-1#1)(1997-1#1)(1997-3#2)(2008-10#7)(2008-11#1)(2011-2#2)
to reach this##2##3##(2008-10#1)(2012-12#1)
to reach##57##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#2)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to react with o-phthalaldehyde (OPA)##2##5##(2008-10#2)
to react with##11##3##(2008-10#11)
to react##18##2##(1994-9#1)(2008-10#14)(2008-11#1)(2008-5#1)(2010-12#1)
to reaction##3##2##(1996-5#1)(2008-10#1)(2008-7#1)
to reactive oxygen species (ROS)##2##5##(2008-10#1)(2011-10#1)
to reactive##6##2##(1991-11#1)(1991-5#1)(2008-10#1)(2009-8#1)(2011-10#1)(2013-7#1)
to read##6##2##(1990-12#1)(2008-12#1)(2008-3#1)(2009-12#1)(2012-2#1)(2013-1#1)
to readily##2##2##(1997-3#1)(2008-1#1)
to real samples##10##3##(2008-10#10)
to real##23##2##(2008-10#17)(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
to realise the##3##3##(2008-11#2)(2008-12#1)
to realise##5##2##(2008-10#1)(2008-11#3)(2008-12#1)
to realize a##2##3##(2010-5#1)(2013-8#1)
to realize the##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
to realize##14##2##(1991-2#1)(1994-12#1)(1996-3#1)(2008-10#4)(2008-12#1)(2008-9#2)(2010-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
to rearing##2##2##(2008-11#1)(2008-9#1)
to receive a##5##3##(1994-3#1)(1995-12#1)(2009-4#1)(2010-12#1)(2012-3#1)
to receive either##3##3##(2009-6#1)(2010-7#1)(2013-1#1)
to receive influenza##3##3##(2012-3#3)
to receive information##2##3##(1996-1#1)(2009-5#1)
to receive the##5##3##(1990-2#1)(1994-9#1)(1997-3#1)(2008-1#1)(2011-2#1)
to receive##42##2##(1990-2#2)(1991-3#1)(1993-1#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-2#4)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#1)
to recent findings##2##3##(2008-11#2)
to recent##7##2##(2007-12#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-8#1)
to recently##2##2##(2011-2#2)
to receptor##2##2##(1990-4#1)(1994-6#1)
to recipient##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
to recognise##6##2##(1996-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
to recognize a##3##3##(1991-2#1)(1997-1#1)(2008-7#1)
to recognize and##9##3##(1993-1#1)(1994-1#1)(1995-11#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
to recognize it##2##3##(1995-5#1)(2008-11#1)
to recognize sexual abuse##2##4##(2009-9#2)
to recognize target##2##3##(1995-8#1)(2008-10#1)
to recognize that##2##3##(1995-11#1)(2009-8#1)
to recognize the##11##3##(1990-2#1)(1994-2#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
to recognize these##2##3##(2008-11#1)(2010-1#1)
to recognize##51##2##(1990-2#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#5)(2009-8#1)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#3)(2013-7#1)
to recombinant##2##2##(2008-10#1)(2008-11#1)
to recombination##2##2##(2008-10#1)(2008-12#1)
to recombine##2##2##(1991-3#1)(1992-12#1)
to recommend##10##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-3#1)(1996-3#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
to recommended##2##2##(2008-8#1)(2011-2#1)
to reconcile the##2##3##(2008-11#1)(2009-3#1)
to reconcile these##2##3##(2008-11#1)(2013-8#1)
to reconcile##5##2##(1995-5#1)(2008-11#2)(2009-3#1)(2013-8#1)
to reconsider##2##2##(2008-12#1)(2008-8#1)
to reconstitute##2##2##(1992-3#1)(1993-6#1)
to reconstruct large##2##3##(1994-6#1)(2010-6#1)
to reconstruct the##6##3##(2008-12#1)(2008-3#2)(2012-3#1)(2013-1#1)(2013-8#1)
to reconstruct##15##2##(1994-6#1)(1995-5#1)(2008-12#1)(2008-3#4)(2008-6#1)(2008-8#2)(2010-6#1)(2012-3#2)(2013-1#1)(2013-8#1)
to record the##8##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-6#1)(2011-3#1)(2013-8#1)
to record##15##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-6#1)(2011-3#1)(2013-8#1)
to recover and##2##3##(2013-1#2)
to recover the##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
to recover##16##2##(1991-12#1)(1995-12#2)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#2)
to recovery##6##2##(2008-6#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-3#1)
to recruit##10##2##(1993-1#1)(1993-6#1)(1995-2#1)(2008-11#3)(2008-5#1)(2009-5#1)(2012-2#1)(2013-1#1)
to recruitment##4##2##(1990-2#1)(2008-11#1)(2008-8#1)(2010-10#1)
to rectal##3##2##(1991-7#1)(1993-6#1)(1996-3#1)
to recur##2##2##(1993-11#1)(2013-1#1)
to recurrence##2##2##(2008-7#1)(2011-2#1)
to recurrent##3##2##(1992-9#1)(2008-11#1)(2013-1#1)
to red##6##2##(2008-10#3)(2008-8#1)(2012-2#2)
to redefine##2##2##(1994-3#1)(2008-7#1)
to redesign##3##2##(1995-2#1)(1996-1#1)(1997-1#1)
to redox##3##2##(2008-10#3)
to redress the##2##3##(2008-11#1)(2008-5#1)
to redress##3##2##(2008-11#1)(2008-5#1)(2010-12#1)
to reduce CVD##2##3##(2010-12#1)(2012-12#1)
to reduce a##3##3##(1993-1#1)(2008-10#1)(2013-1#1)
to reduce and##2##3##(1993-8#1)(2012-3#1)
to reduce bacterial##2##3##(2008-10#1)(2013-8#1)
to reduce blood pressure adequately##2##5##(1990-11#1)(1995-2#1)
to reduce blood pressure##3##4##(1990-11#1)(1995-2#1)(2008-8#1)
to reduce cardiovascular risk##2##4##(2008-6#1)(2010-12#1)
to reduce cardiovascular##3##3##(1993-11#1)(2008-6#1)(2010-12#1)
to reduce costs##2##3##(1991-12#1)(1996-1#1)
to reduce development##3##3##(1994-6#1)(2008-11#1)(2011-2#1)
to reduce disease##2##3##(2008-10#1)(2011-2#1)
to reduce drastically the##2##4##(2008-10#2)
to reduce health##2##3##(1994-12#1)(2010-5#1)
to reduce or##5##3##(1992-2#1)(2008-10#1)(2008-11#2)(2013-1#1)
to reduce risks##2##3##(1991-3#2)
to reduce the amount of##3##5##(2008-10#1)(2008-11#2)
to reduce the burden of##3##5##(2007-12#1)(2011-2#1)(2012-3#1)
to reduce the clinical##2##4##(2008-8#1)(2013-1#1)
to reduce the impact of##2##5##(2008-10#1)(2008-11#1)
to reduce the incidence of##7##5##(1991-12#1)(1992-12#2)(1997-8#1)(2008-10#2)(2011-2#1)
to reduce the interference##2##4##(2008-10#2)
to reduce the number of##5##5##(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
to reduce the production of##3##5##(2008-10#1)(2008-9#1)(2011-1#1)
to reduce the risk of##9##5##(1990-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-1#1)(2013-8#3)
to reduce the risks of##2##5##(2008-12#1)(2008-9#1)
to reduce the##91##3##(1990-2#1)(1991-12#2)(1991-6#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-6#3)(1996-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#7)
to reduce their##5##3##(1991-6#1)(1996-9#1)(2008-11#1)(2008-7#1)(2008-9#1)
to reduce thermal##2##3##(1991-2#1)(2007-12#1)
to reduce these##2##3##(2008-11#1)(2008-8#1)
to reduce this##2##3##(2008-10#1)(2013-8#1)
to reduce variation##2##3##(1993-3#1)(1996-1#1)
to reduce##241##2##(1990-11#1)(1990-2#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-6#3)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#4)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#55)(2008-11#19)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#7)(2009-2#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#17)(2013-8#10)
to reduced bacterial##2##3##(2008-10#2)
to reduced melanogenesis##2##3##(2008-5#2)
to reduced##16##2##(1990-2#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2012-3#1)(2013-1#1)
to reducing the##6##3##(1992-12#1)(1995-5#1)(2008-10#2)(2008-8#1)(2012-3#1)
to reducing##12##2##(1992-12#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to reduction of##2##3##(1994-11#1)(2008-2#1)
to reduction##3##2##(1994-11#1)(2008-10#1)(2008-2#1)
to reductions in dietary##2##4##(2012-2#2)
to reductions in the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
to reductions in##8##3##(1995-2#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
to refer to##4##3##(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
to refer##7##2##(1991-11#1)(1995-9#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
to reference##5##2##(1992-12#1)(1994-12#1)(2008-10#2)(2008-5#1)
to refine the##7##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-2#2)
to refine##9##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#2)
to reflect on##4##3##(1994-9#1)(2008-11#1)(2012-3#2)
to reflect that##2##3##(2008-11#1)(2008-12#1)
to reflect the presence##2##4##(1997-1#1)(2008-7#1)
to reflect the##10##3##(1995-2#1)(1997-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2010-1#1)(2012-3#1)
to reflect##35##2##(1991-2#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
to reform##2##2##(1995-2#1)(1997-3#1)
to refuse##6##2##(1990-11#1)(1994-12#1)(1995-12#2)(1995-2#1)(2008-11#1)
to regard##4##2##(1995-6#1)(1997-7#1)(2008-11#1)(2013-8#1)
to regenerate the##3##3##(2008-10#1)(2008-5#2)
to regenerate##8##2##(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-12#1)(2012-2#1)
to region##2##2##(1992-2#1)(2008-10#1)
to regional##7##2##(1994-12#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)
to register##3##2##(1990-11#1)(1991-2#1)(2008-11#1)
to registered##3##2##(1995-8#1)(2008-11#1)(2008-12#1)
to regular##2##2##(1997-2#1)(2008-3#1)
to regularly##2##2##(2008-12#1)(2012-12#1)
to regulate a wide##2##4##(2008-11#1)(2008-9#1)
to regulate actin##2##3##(2012-2#2)
to regulate development##2##3##(1993-3#1)(1994-12#1)
to regulate neuronal##2##3##(1995-2#1)(2013-8#1)
to regulate telomere length##2##4##(2012-3#2)
to regulate the cell##2##4##(2008-11#1)(2012-3#1)
to regulate the expression of the##2##6##(1993-12#1)(2008-11#1)
to regulate the expression of##5##5##(1993-12#1)(1995-9#1)(2008-11#1)(2008-4#1)(2011-2#1)
to regulate the##12##3##(1993-12#1)(1995-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
to regulate transcription##3##3##(1995-2#1)(2008-9#1)(2011-2#1)
to regulate##46##2##(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-2#3)(1995-9#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#5)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#2)(2010-11#1)(2011-2#3)(2012-2#8)(2012-3#3)(2013-1#1)(2013-8#1)
to regulation of##2##3##(2008-8#1)(2009-8#1)
to regulation##3##2##(1993-8#1)(2008-8#1)(2009-8#1)
to regulatory##2##2##(2008-11#1)(2013-7#1)
to reimburse##2##2##(1993-3#1)(1997-2#1)
to reinforce and##3##3##(1994-2#1)(2011-2#1)(2012-2#1)
to reinforce the##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
to reinforce##10##2##(1994-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
to reinforcement##2##2##(2008-10#1)(2008-5#1)
to reject the interference##2##4##(2008-10#2)
to reject the##3##3##(2008-10#2)(2008-7#1)
to reject##7##2##(1995-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
to relapse##2##2##(1994-5#1)(2010-12#1)
to relate the observed##2##4##(1997-2#1)(2008-10#1)
to relate the##10##3##(1990-3#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-9#1)(2012-2#1)
to relate##29##2##(1990-3#1)(1994-2#1)(1997-2#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
to relatedness##2##2##(2008-8#1)(2008-9#1)
to relatively small##2##3##(2008-5#1)(2008-7#1)
to relatively##6##2##(1990-12#1)(1996-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
to release the##6##3##(1994-8#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
to release##16##2##(1994-8#2)(1997-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-8#1)
to relevant##2##2##(1990-12#1)(2008-11#1)
to reliably detect##2##3##(2008-10#1)(2008-3#1)
to reliably##7##2##(1993-6#1)(1997-8#1)(2008-10#3)(2008-3#1)(2013-1#1)
to relieve the##2##3##(1995-8#1)(2011-2#1)
to relieve##9##2##(1993-3#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#2)
to religious##2##2##(2009-10#1)(2010-2#1)
to relocate the##2##3##(2008-10#1)(2009-4#1)
to rely on##3##3##(1997-7#1)(2011-2#1)(2013-1#1)
to rely##6##2##(1994-3#1)(1997-7#1)(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
to remain in their##2##4##(2008-9#1)(2010-10#1)
to remain in##4##3##(1991-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
to remain intact##2##3##(1996-5#1)(1996-6#1)
to remain stable##2##3##(2008-10#1)(2008-7#1)
to remain susceptible to##2##4##(2008-10#2)
to remain the##2##3##(1993-1#1)(2008-10#1)
to remain viable##2##3##(1994-12#1)(1997-3#1)
to remain##28##2##(1991-1#2)(1991-3#1)(1992-8#1)(1993-1#1)(1994-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-5#1)(2013-1#2)
to remedy the##2##3##(2008-11#1)(2010-11#1)
to remember##4##2##(1991-11#1)(2008-11#2)(2013-1#1)
to remote primary##2##3##(1997-4#1)(2008-10#1)
to remote sensing of##2##4##(2008-10#1)(2008-3#1)
to remote##5##2##(1997-4#1)(2008-10#2)(2008-3#2)
to remove residual##3##3##(2008-10#1)(2008-8#2)
to remove silicon##2##3##(2008-10#2)
to remove the most##2##4##(1993-3#1)(2008-10#1)
to remove the##26##3##(1990-11#1)(1993-3#1)(2008-10#18)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
to remove traces of##3##4##(2008-10#3)
to remove##68##2##(1990-11#1)(1990-12#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-2#1)(2008-10#34)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#4)(2011-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
to renal##6##2##(1995-11#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
to render the##2##3##(2008-10#1)(2010-8#1)
to render##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
to repair or##2##3##(2008-11#1)(2009-9#1)
to repair##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2013-8#1)
to repeated##5##2##(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
to repetitive##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
to replace Ca2+ in##2##4##(1995-11#2)
to replace the##6##3##(1990-2#1)(1992-3#1)(2008-11#2)(2009-5#1)(2012-3#1)
to replace##26##2##(1990-2#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#2)(1996-2#1)(2008-10#4)(2008-11#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-7#1)(2012-3#2)
to replicate##3##2##(1997-3#1)(2008-5#1)(2010-12#1)
to replication##2##2##(2008-5#1)(2012-3#1)
to report and discuss the##2##5##(2008-9#1)(2009-10#1)
to report on the##2##4##(2008-11#1)(2008-12#1)
to report on##4##3##(2008-11#2)(2008-12#1)(2013-1#1)
to report the##7##3##(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
to report##36##2##(1991-2#1)(1993-3#1)(1995-12#2)(1997-2#1)(2008-11#6)(2008-12#4)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#2)(2010-11#2)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
to reported genes##2##3##(1995-8#1)(1996-6#1)
to reported##3##2##(1995-8#1)(1996-6#2)
to represent a significant##2##4##(2008-10#1)(2010-6#1)
to represent a##13##3##(1991-12#1)(1991-2#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-6#1)(2011-2#2)(2013-8#1)
to represent early##2##3##(1991-12#1)(2008-9#1)
to represent the##13##3##(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
to represent##43##2##(1991-12#3)(1991-2#1)(1995-2#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
to repress##2##2##(2008-11#1)(2008-7#1)
to reproduce a##2##3##(2008-11#1)(2013-8#1)
to reproduce the##5##3##(2008-10#2)(2008-8#2)(2008-9#1)
to reproduce##16##2##(1992-9#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-8#3)(2008-9#1)(2009-5#1)(2013-8#2)
to reproducible##2##2##(1996-1#1)(2009-8#1)
to reproducibly##3##2##(2008-11#2)(2009-8#1)
to reproduction##2##2##(2008-8#1)(2008-9#1)
to reproduction)##2##2##(2008-8#2)
to require the##4##3##(1995-2#1)(1995-6#2)(2013-8#1)
to require##10##2##(1991-3#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-6#2)(2008-11#1)(2008-7#1)(2009-9#1)(2013-8#1)
to rescue the##4##3##(1993-9#1)(2008-10#1)(2008-11#1)(2013-8#1)
to rescue##7##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2013-8#1)
to research utilisation is##2##4##(2008-11#2)
to research##12##2##(1992-11#1)(1992-12#2)(1995-2#1)(2008-11#2)(2009-4#3)(2010-1#2)(2010-11#1)
to research-based##2##2##(2008-11#1)(2008-12#1)
to researchers##2##2##(2008-10#1)(2008-9#1)
to resemble##2##2##(1995-11#1)(2008-12#1)
to residential##3##2##(1995-2#1)(2012-12#2)
to residual##5##2##(1996-2#1)(2008-10#3)(2008-11#1)
to residues##8##2##(1992-4#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(2008-8#1)(2010-5#2)
to resist##6##2##(2008-10#1)(2008-11#1)(2008-8#2)(2010-4#1)(2013-1#1)
to resistance genes##2##3##(2008-10#2)
to resistance in##3##3##(2008-10#3)
to resistance to##3##3##(2008-10#3)
to resistance##15##2##(2008-10#13)(2013-1#2)
to resolve such##2##3##(2008-3#1)(2009-5#1)
to resolve the##9##3##(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-5#1)
to resolve this serious##2##4##(1995-5#1)(2013-1#1)
to resolve##29##2##(1990-12#1)(1995-5#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2013-1#2)
to respective##2##2##(2008-1#1)(2008-11#1)
to respiratory##8##2##(1993-8#1)(1996-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
to respond more to##2##4##(2008-11#2)
to respond to a##2##4##(2008-7#2)
to respond to the##6##4##(1991-12#1)(1995-1#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)
to respond to these##4##4##(1991-12#1)(1994-12#1)(2008-10#2)
to respond to##37##3##(1990-11#1)(1990-2#2)(1991-12#2)(1994-12#2)(1994-3#1)(1995-1#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-3#2)
to respond with##2##3##(2008-9#1)(2009-8#1)
to respond without prejudice##2##4##(2008-11#2)
to respond##52##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-12#2)(1994-12#2)(1994-3#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#2)(2010-4#1)(2010-5#2)(2010-8#2)(2011-2#1)(2012-3#3)(2013-1#1)
to response##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
to rest##2##2##(1993-12#1)(2013-1#1)
to restore the##6##3##(1993-3#1)(1995-6#1)(2008-8#1)(2008-9#2)(2012-2#1)
to restore##16##2##(1990-2#1)(1993-3#1)(1995-6#1)(1996-3#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
to restrain##2##2##(2011-2#1)(2013-1#1)
to restrict the##2##3##(2008-11#1)(2012-2#1)
to restrict their##2##3##(1996-5#1)(2010-6#1)
to restrict##7##2##(1991-3#1)(1996-5#1)(2008-11#1)(2008-3#1)(2010-6#1)(2011-10#1)(2012-2#1)
to restriction##2##2##(2008-10#1)(2008-12#1)
to restrictions##2##2##(1992-3#1)(2008-5#1)
to restructure##5##2##(1994-1#1)(1994-2#1)(1994-3#2)(1995-3#1)
to restructuring##4##2##(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)
to result from a##3##4##(1994-3#1)(1994-8#1)(1995-11#1)
to result from the##5##4##(1990-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
to result from##16##3##(1990-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)
to result in a##3##4##(1997-1#1)(2008-3#1)(2009-9#1)
to result in an increase of##2##6##(1994-9#1)(2008-10#1)
to result in an##3##4##(1994-9#1)(1997-8#1)(2008-10#1)
to result in high##2##4##(2008-10#2)
to result in##21##3##(1994-9#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#2)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
to result##43##2##(1990-11#1)(1991-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#1)(1997-1#1)(1997-8#1)(2008-10#10)(2008-11#5)(2008-3#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-9#2)(2010-10#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
to results obtained##2##3##(2008-10#2)
to results that##2##3##(2008-10#1)(2013-8#1)
to results##8##2##(1990-6#1)(2008-10#4)(2008-3#2)(2013-8#1)
to resume##4##2##(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to resuscitate##2##2##(2008-10#1)(2010-7#1)
to retain the##4##3##(1997-7#1)(2008-10#2)(2008-8#1)
to retain##13##2##(1993-12#1)(1994-6#1)(1995-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
to retard##2##2##(2008-10#1)(2008-11#1)
to retention##2##2##(2008-10#1)(2008-8#1)
to rethink##2##2##(2011-2#1)(2011-3#1)
to retinal##3##2##(1993-8#1)(2009-6#2)
to retract##2##2##(2010-9#1)(2013-1#1)
to retrieve the##7##3##(1997-3#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)
to retrieve##18##2##(1994-3#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
to retrospectively##2##2##(1992-12#1)(2011-2#1)
to return the##2##3##(1995-5#1)(2008-11#1)
to return to work##2##4##(1993-12#1)(2012-12#1)
to return to##9##3##(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#3)(2012-12#1)
to return##19##2##(1993-1#3)(1993-12#2)(1993-6#1)(1994-3#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#5)(2012-12#1)
to revascularize##2##2##(2008-9#2)
to reveal a##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
to reveal effects##2##3##(2008-10#1)(2008-9#1)
to reveal the##5##3##(1994-6#1)(2008-10#2)(2012-2#2)
to reveal##31##2##(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-2#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#2)(2011-2#1)(2012-2#2)(2013-1#1)
to reverse the trend##2##4##(1991-3#1)(1992-8#1)
to reverse the##5##3##(1991-3#1)(1992-8#1)(1996-5#2)(2008-7#1)
to reverse##15##2##(1990-2#1)(1990-9#1)(1991-3#1)(1992-8#1)(1993-12#1)(1996-5#2)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-3#1)(2013-1#1)
to review a##2##3##(1997-3#1)(2008-11#1)
to review and##3##3##(2012-2#1)(2013-1#2)
to review some of the##2##5##(2008-11#1)(2008-4#1)
to review the management of##2##5##(2008-10#1)(2011-2#1)
to review the##24##3##(1991-12#1)(1991-2#1)(1993-3#1)(1994-3#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-8#2)(2009-1#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
to review##43##2##(1991-12#1)(1991-2#1)(1993-3#1)(1994-3#1)(1995-6#2)(1997-3#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#3)(2009-1#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2011-7#1)(2012-2#3)(2012-3#1)(2013-1#4)
to revise##2##2##(2008-10#1)(2012-3#1)
to revision##2##2##(1993-1#1)(2008-8#1)
to revisit##2##2##(1997-8#1)(2008-4#1)
to revolutionize##2##2##(2008-11#1)(2008-4#1)
to reward##3##2##(1991-3#1)(1993-6#1)(1995-2#1)
to rheumatoid arthritis##2##3##(2012-3#1)(2013-8#1)
to rhizosphere##2##2##(2008-10#2)
to rhythm##2##2##(2008-10#1)(2010-12#1)
to rice blast in##2##4##(2008-10#1)(2012-2#1)
to rice blast##7##3##(2008-10#6)(2012-2#1)
to rice telomeric##2##3##(2008-8#2)
to rice##14##2##(2008-10#10)(2008-8#2)(2009-10#1)(2012-2#1)
to right##5##2##(1996-2#2)(2011-2#1)(2012-2#1)(2013-8#1)
to rigorous##4##2##(1992-1#1)(2008-9#1)(2012-3#2)
to rise in##2##3##(2012-2#1)(2013-8#1)
to rise with the##2##4##(1993-3#1)(2013-1#1)
to rise##10##2##(1992-2#1)(1993-3#1)(1994-12#2)(1996-3#1)(2008-10#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
to rising##2##2##(2012-2#1)(2012-6#1)
to risk assessment##2##3##(1996-3#1)(2010-12#1)
to risk##10##2##(1990-6#1)(1992-12#1)(1996-3#2)(2008-12#1)(2010-12#1)(2010-8#2)(2012-3#1)(2013-1#1)
to road traffic##2##3##(2008-10#1)(2010-11#1)
to road##4##2##(2008-10#1)(2009-10#1)(2009-7#1)(2010-11#1)
to root coverage treatment##2##4##(2013-1#2)
to root##7##2##(2008-10#4)(2013-1#3)
to roots of##2##3##(2008-10#2)
to roots##8##2##(2008-10#8)
to rotate about the##2##4##(2008-3#2)
to rotate##3##2##(2008-3#2)(2008-7#1)
to routine analyses##2##3##(2008-10#2)
to routine analysis##2##3##(2008-10#2)
to routine clinical##2##3##(2008-10#1)(2008-11#1)
to routine##7##2##(2008-10#6)(2008-11#1)
to rubisco activase##2##3##(1991-9#2)
to rule out PE##2##4##(2012-2#2)
to rule out##12##3##(1995-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to rule##14##2##(1995-5#1)(1996-5#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to run##10##2##(1992-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)
to rupture##2##2##(1996-3#1)(2012-2#1)
to rural##7##2##(1991-1#1)(1993-2#2)(1994-1#2)(2010-10#1)(2010-7#1)
to sacrifice##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
to safety##2##2##(1991-3#1)(1996-12#1)
to saikogenin E##2##3##(2008-11#2)
to saline##4##2##(1993-1#1)(1995-12#1)(1995-2#1)(2009-8#1)
to salinity##2##2##(2008-12#2)
to salt stress##2##3##(1997-8#1)(2008-8#1)
to salt##4##2##(1993-8#1)(1997-8#1)(2008-8#1)(2008-9#1)
to sample size##3##3##(2008-10#2)(2013-1#1)
to sample the##2##3##(2008-10#2)
to sample##24##2##(1995-9#1)(2008-10#15)(2008-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
to samples of##3##3##(1995-2#1)(2008-10#2)
to samples prepared in##2##4##(2008-10#2)
to samples##12##2##(1990-2#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-5#1)
to sampling##6##2##(1996-12#2)(2008-10#4)
to satisfactorily##2##2##(2008-10#2)
to satisfactory##3##2##(2008-10#2)(2008-11#1)
to satisfy the##6##3##(1994-2#1)(1996-1#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
to satisfy##14##2##(1993-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
to saturate##3##2##(2008-10#1)(2008-3#2)
to saturated##2##2##(1996-5#1)(2010-4#1)
to save lives##2##3##(2010-11#1)(2010-8#1)
to save the##4##3##(1990-5#1)(1997-7#1)(2008-9#1)(2010-8#1)
to save##15##2##(1990-5#1)(1991-8#1)(1994-2#2)(1996-11#1)(1996-12#2)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-8#2)
to say about##2##3##(1992-8#1)(2012-2#1)
to say that##2##3##(1991-3#1)(2008-7#1)
to say##5##2##(1991-3#1)(1992-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
to scab##4##2##(2008-10#4)
to scale up##3##3##(2008-11#2)(2008-7#1)
to scale##4##2##(2008-11#2)(2008-3#1)(2008-7#1)
to scale-up the##2##3##(2008-11#2)
to scanning##2##2##(2008-11#1)(2011-7#1)
to schedule##2##2##(1995-6#1)(1996-1#1)
to school##4##2##(1996-1#1)(1996-8#1)(2008-7#1)(2011-1#1)
to schools##2##2##(2008-10#1)(2010-5#1)
to science##2##2##(1990-8#1)(2011-2#1)
to scientists##2##2##(2008-4#1)(2013-7#1)
to screen for##8##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to screen the##3##3##(1996-9#1)(1997-8#1)(2008-8#1)
to screen##37##2##(1993-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#6)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to screening for##2##3##(2008-4#1)(2011-2#1)
to screening##10##2##(1995-9#1)(1997-1#2)(2008-10#1)(2008-11#3)(2008-4#2)(2011-2#1)
to scrutiny##2##2##(2008-11#2)
to search a##3##3##(2008-12#1)(2008-9#2)
to search for new##2##4##(2008-10#1)(2013-1#1)
to search for the##3##4##(2008-10#1)(2009-12#2)
to search for##15##3##(1992-2#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-12#2)(2011-2#1)(2013-1#2)
to search the database##2##4##(1991-12#1)(1993-8#1)
to search the##6##3##(1991-12#2)(1993-8#1)(1997-6#1)(2008-4#1)(2013-1#1)
to search##30##2##(1991-12#2)(1991-2#1)(1992-12#2)(1992-2#1)(1993-8#1)(1994-3#2)(1997-1#1)(1997-6#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2008-9#3)(2009-12#2)(2011-2#1)(2013-1#3)
to seasonal##2##2##(2008-10#2)
to second order in##2##4##(2008-3#2)
to second##4##2##(2008-10#1)(2008-12#1)(2008-3#2)
to secondary infection##2##3##(2008-1#1)(2008-10#1)
to secondary##6##2##(1997-6#2)(2008-1#1)(2008-10#1)(2008-12#1)(2012-3#1)
to secrete human##3##3##(2008-11#1)(2008-5#2)
to secrete##13##2##(2008-10#3)(2008-11#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
to secure the wheelchair##2##4##(2013-1#2)
to secure the##4##3##(1996-12#1)(2008-10#1)(2013-1#2)
to secure##9##2##(1992-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-5#1)(2013-1#2)
to sediment##2##2##(2008-10#2)
to see an##3##3##(1992-1#1)(1995-12#1)(1997-4#1)
to see how##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
to see if##5##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
to see that##2##3##(1994-12#1)(1994-9#1)
to see the incidence##2##4##(2012-3#2)
to see the##9##3##(1992-3#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#3)
to see this##2##3##(1992-3#1)(2009-10#1)
to see whether##3##3##(2008-12#1)(2008-8#1)(2010-10#1)
to see##37##2##(1992-1#1)(1992-3#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-3#3)(2013-8#1)
to seed##6##2##(1995-3#1)(2008-10#1)(2008-8#2)(2008-9#2)
to seedlings of##2##3##(2008-10#2)
to seedlings##5##2##(2008-10#5)
to seek a##2##3##(1997-7#1)(2010-7#1)
to seek##19##2##(1990-12#1)(1990-6#1)(1991-2#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-7#1)(2012-12#2)
to segregate##2##2##(2008-10#2)
to seizure generation##2##3##(2009-8#2)
to select a##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
to select an appropriate##2##4##(1993-3#1)(1997-2#1)
to select appropriate##2##3##(1991-2#1)(2010-5#1)
to select for##4##3##(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
to select one##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
to select the best##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
to select the most appropriate##2##5##(2008-10#2)
to select the most##4##4##(1990-12#1)(2008-10#2)(2013-1#1)
to select the optimum##2##4##(2008-10#2)
to select the##22##3##(1990-12#1)(1992-12#1)(1993-11#1)(1997-6#1)(2008-10#12)(2008-11#1)(2008-5#1)(2009-12#1)(2012-3#1)(2013-1#2)
to select their##2##3##(1997-7#1)(2013-1#1)
to select those##3##3##(2008-10#1)(2009-7#1)(2013-8#1)
to select##64##2##(1990-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-3#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#28)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
to selected##4##2##(2008-10#1)(2010-4#1)(2010-7#1)(2011-1#1)
to selection for##3##3##(2008-8#1)(2008-9#2)
to selection of##2##3##(2008-10#1)(2008-8#1)
to selection was##2##3##(2008-8#1)(2008-9#1)
to selection##23##2##(2008-10#6)(2008-8#10)(2008-9#4)(2012-3#3)
to selective serotonin reuptake inhibitors##2##5##(2008-6#1)(2012-3#1)
to selective##5##2##(2008-10#2)(2008-6#1)(2008-8#1)(2012-3#1)
to selectively detect##2##3##(2008-10#2)
to selectively remove##2##3##(2008-10#2)
to selectively##15##2##(1992-6#1)(1993-11#1)(2008-10#10)(2009-8#1)(2012-2#1)(2013-1#1)
to selenate##2##2##(2008-10#2)
to selenite##2##2##(2008-10#2)
to self##5##2##(1990-11#1)(1993-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
to self-determination##5##2##(1991-2#2)(1997-8#3)
to semi-structured interviews##2##3##(1996-1#1)(2008-1#1)
to sense##5##2##(2008-10#2)(2008-3#1)(2009-8#2)
to sensitive##6##2##(2007-12#1)(2008-10#3)(2011-2#1)(2012-2#1)
to sensitization##2##2##(2008-8#1)(2008-9#1)
to sensors##2##2##(2008-10#2)
to sensory##3##2##(1997-3#2)(2008-4#1)
to separate and identify##2##4##(2008-10#2)
to separate and##4##3##(2008-10#4)
to separate the species##2##4##(2008-10#2)
to separate the##11##3##(1997-2#1)(2008-10#5)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
to separate these compounds##2##4##(2008-10#2)
to separate##56##2##(1992-12#1)(1997-2#1)(2008-10#44)(2008-11#2)(2008-3#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
to separately##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
to separation##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
to sequence analysis##2##3##(2008-10#1)(2012-2#1)
to sequence##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
to sequences##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
to sequester the##2##3##(2008-10#1)(2009-12#1)
to sequester##4##2##(2008-10#2)(2009-12#1)(2010-6#1)
to serine##3##2##(1993-8#1)(2008-10#2)
to serious##7##2##(1997-1#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-7#1)(2011-2#1)
to serotypes 1##2##3##(1996-12#2)
to serum albumin##2##3##(1990-8#1)(2008-7#1)
to serum##9##2##(1990-8#2)(1993-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
to serum-free conditions##2##3##(2008-11#2)
to serum-free medium##2##3##(2008-11#2)
to serum-free##5##2##(2008-11#5)
to serve as a##8##4##(1991-12#1)(2008-10#6)(2010-11#1)
to serve as##19##3##(1991-12#1)(1992-9#1)(1994-8#1)(1995-12#1)(1997-2#1)(2008-10#13)(2010-11#1)
to serve more##2##3##(1993-12#1)(2012-2#1)
to serve##29##2##(1991-12#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#13)(2008-2#1)(2008-5#1)(2010-11#2)(2012-2#2)
to service##7##2##(1993-1#1)(1993-12#1)(1995-1#1)(1996-12#1)(2008-11#2)(2008-12#1)
to services##5##2##(1992-8#1)(1993-1#1)(1994-1#1)(1997-5#1)(2009-6#1)
to set the##2##3##(2008-3#1)(2012-2#1)
to set up a##2##4##(2008-5#1)(2012-2#1)
to set up and##3##4##(1996-1#1)(2008-4#1)(2013-8#1)
to set up##7##3##(1991-3#1)(1996-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
to set##19##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#2)(2009-6#1)(2010-10#1)(2012-2#2)(2013-8#1)
to settle##3##2##(1990-6#1)(1995-6#1)(2008-5#1)
to seven##9##2##(1991-12#1)(1991-6#1)(1997-5#1)(2008-10#1)(2008-11#2)(2010-8#1)(2012-3#1)(2013-1#1)
to several diseases##2##3##(2008-10#1)(2013-1#1)
to several hours##2##3##(1997-6#1)(2008-10#1)
to several meters##2##3##(2008-3#2)
to several other studies##2##4##(2008-5#1)(2008-6#1)
to several other##3##3##(2008-5#1)(2008-6#1)(2012-2#1)
to several##58##2##(1990-5#1)(1991-8#1)(1992-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#25)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#2)
to severe##22##2##(1991-6#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2010-7#1)(2012-7#1)(2013-1#1)(2013-8#1)
to severity of##2##3##(2008-12#1)(2013-1#1)
to sewage##2##2##(2008-10#2)
to sex and##2##3##(2008-5#1)(2008-7#1)
to sex##5##2##(1994-6#1)(2008-5#2)(2008-7#1)(2009-7#1)
to sexual changes##3##3##(2008-7#3)
to sexual##9##2##(2008-12#3)(2008-7#3)(2008-9#2)(2013-1#1)
to sexually transmitted##2##3##(2012-2#1)(2012-3#1)
to shake the##2##3##(1996-12#1)(2008-10#1)
to sham##5##2##(1993-6#1)(1995-11#2)(1996-12#1)(2012-2#1)
to shape the##2##3##(2008-12#1)(2009-8#1)
to shape##4##2##(2008-12#2)(2009-8#1)(2012-3#1)
to share information##2##3##(1996-2#1)(2008-11#1)
to share their##2##3##(2008-11#1)(2011-2#1)
to share##18##2##(1992-3#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
to shear stress##3##3##(2008-11#1)(2010-1#2)
to shear##6##2##(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#2)(2012-2#1)
to sheath blight##2##3##(2008-10#2)
to shed light on##2##4##(1997-9#1)(2009-10#1)
to shed##3##2##(1997-9#1)(2008-11#1)(2009-10#1)
to sheep red blood cells##6##5##(1993-12#1)(2008-10#5)
to sheep##8##2##(1993-12#1)(1996-12#1)(2008-10#6)
to shift from##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
to shift the##3##3##(1997-2#1)(2008-3#1)(2013-8#1)
to shift to##2##3##(2008-10#1)(2008-5#1)
to shift##12##2##(1995-2#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
to short##11##2##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-9#1)(2012-2#2)(2013-8#1)
to short-term##2##2##(2008-10#1)(2008-12#1)
to shorten the##4##3##(2008-10#2)(2009-8#1)(2011-2#1)
to shorten##7##2##(1992-1#1)(2007-9#1)(2008-10#3)(2009-8#1)(2011-2#1)
to show a##12##3##(1994-2#1)(1994-3#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
to show an interaction##2##4##(2009-8#1)(2013-8#1)
to show an##7##3##(1993-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-8#1)(2013-8#1)
to show excellent##2##3##(2008-10#1)(2011-2#1)
to show how the##2##4##(2008-10#1)(2012-2#1)
to show how##8##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-2#2)
to show some of##2##4##(2008-11#1)(2009-10#1)
to show that the##6##4##(1991-12#1)(1995-5#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
to show that there is##2##5##(2008-3#1)(2012-2#1)
to show that there##3##4##(2008-3#1)(2009-10#1)(2012-2#1)
to show that these##2##4##(1996-5#1)(2008-10#1)
to show that##34##3##(1990-6#1)(1991-12#1)(1991-3#1)(1992-3#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-5#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to show the capability of##2##5##(2009-5#1)(2013-1#1)
to show the role of##2##5##(1991-6#1)(2011-1#1)
to show the##23##3##(1990-5#1)(1991-6#1)(1993-1#1)(1993-3#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-3#1)
to show##104##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-5#2)(1996-3#1)(1996-5#4)(1997-3#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-8#6)(2009-10#3)(2009-12#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#2)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-3#1)(2013-8#2)
to shrink##2##2##(1994-8#1)(2012-3#1)
to signal##3##2##(2008-10#1)(2008-8#2)
to signals##2##2##(1995-5#1)(2009-8#1)
to significant##17##2##(2008-10#5)(2008-12#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
to significantly affect##2##3##(1994-11#1)(2008-8#1)
to significantly alter##2##3##(1997-2#1)(2011-2#1)
to significantly decrease##2##3##(1990-12#1)(1994-12#1)
to significantly enhance the##2##4##(2008-10#1)(2008-11#1)
to significantly enhance##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
to significantly higher##3##3##(2008-10#2)(2012-5#1)
to significantly increase##2##3##(1991-12#1)(2008-11#1)
to significantly reduce##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2009-7#1)
to significantly##29##2##(1990-12#1)(1991-12#1)(1994-11#1)(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-5#1)
to signs##2##2##(1997-2#1)(2008-7#1)
to silica and##2##3##(2008-10#1)(2009-12#1)
to silica gel##3##3##(2008-10#3)
to silica##6##2##(2008-10#5)(2009-12#1)
to silver(I) ion over alkali##2##5##(2008-10#2)
to similar levels##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
to similar##8##2##(1997-3#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-3#1)
to similarly##2##2##(1997-2#1)(2008-10#1)
to simple##9##2##(1991-12#1)(1992-2#1)(2008-10#2)(2008-4#2)(2008-7#2)(2009-6#1)
to simplicity##4##2##(2008-10#3)(2008-11#1)
to simplify##6##2##(1993-12#1)(1996-12#1)(2008-10#3)(2008-11#1)
to simulate the behavior of##3##5##(2008-11#1)(2008-3#2)
to simulate the##15##3##(2008-10#4)(2008-11#4)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
to simulate##33##2##(1990-11#1)(1994-12#1)(1995-3#1)(2008-10#10)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#2)
to simulated##8##2##(1994-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
to simultaneous determination of##4##4##(2008-10#4)
to simultaneous determination##5##3##(2008-10#5)
to simultaneous##8##2##(2008-10#7)(2013-8#1)
to simultaneously detect##2##3##(2008-10#1)(2013-8#1)
to simultaneously determine the apparent binding constants and thermodynamic parameters##2##10##(2008-10#2)
to simultaneously determine##3##3##(2008-10#3)
to simultaneously measure##2##3##(1994-2#1)(2008-9#1)
to simultaneously##13##2##(1994-2#1)(2008-10#7)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
to single out##2##3##(2008-11#1)(2008-3#1)
to single##9##2##(1992-6#1)(1994-2#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2013-1#1)
to sink##2##2##(1997-2#1)(2008-8#1)
to sinks planted##2##3##(2008-10#2)
to sinus rhythm##2##3##(1990-9#1)(2013-1#1)
to site##5##2##(2008-10#2)(2008-11#2)(2008-7#1)
to sites of##3##3##(1992-12#1)(2009-7#1)(2013-1#1)
to sites##5##2##(1992-12#1)(2008-10#2)(2009-7#1)(2013-1#1)
to situations##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
to six different##3##3##(2008-10#3)
to six months##3##3##(1993-6#1)(1997-3#1)(2008-10#1)
to six##23##2##(1990-6#1)(1991-2#1)(1993-6#1)(1997-3#1)(2008-10#10)(2008-11#3)(2008-5#1)(2008-8#2)(2009-12#1)(2010-12#2)
to size##6##2##(1996-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-3#1)
to size-asymmetric competition##2##3##(2008-8#2)
to skeletal muscle##3##3##(1990-8#1)(2008-3#1)(2008-4#1)
to skilled nursing facility##2##4##(1991-1#2)
to skilled nursing##3##3##(1991-1#2)(1991-2#1)
to skin and##2##3##(2008-5#2)
to skin##12##2##(1992-8#2)(1995-1#1)(1997-2#1)(2008-5#6)(2008-9#1)(2009-9#1)
to sleep##2##2##(1990-5#1)(2012-3#1)
to slightly##2##2##(2008-10#1)(2008-11#1)
to slow the growth##2##4##(1992-2#2)
to slow##3##2##(1992-2#2)(2011-1#1)
to small##16##2##(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
to smaller##3##2##(2008-10#2)(2009-7#1)
to smoke##3##2##(1991-11#1)(1997-1#1)(2010-2#1)
to smoking##5##2##(1990-6#1)(1994-3#1)(2010-2#2)(2013-1#1)
to social and##2##3##(1990-3#1)(2008-11#1)
to social phobia##3##3##(2008-4#3)
to social##14##2##(1990-3#1)(1996-1#1)(2008-11#1)(2008-4#4)(2008-8#1)(2009-6#2)(2010-1#1)(2010-8#1)(2012-3#2)
to society##5##2##(1995-11#2)(1996-2#1)(1997-4#1)(2008-11#1)
to socioeconomic status##2##3##(1991-6#1)(1994-6#1)
to socioeconomic##4##2##(1991-6#1)(1994-6#2)(2008-1#1)
to sodium bromate in##2##4##(2008-9#2)
to sodium bromate##4##3##(2008-9#4)
to sodium dodecyl##2##3##(2008-10#2)
to sodium fluoride##2##3##(2008-12#2)
to sodium##17##2##(1995-8#2)(1996-12#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-9#4)
to soft dough##2##3##(2008-10#2)
to soft##5##2##(2007-11#1)(2008-10#4)
to soil at##4##3##(2008-10#4)
to soil drought##3##3##(2012-5#1)(2012-6#1)(2012-8#1)
to soil##21##2##(2008-10#17)(2010-3#1)(2012-5#1)(2012-6#1)(2012-8#1)
to solar ultraviolet##2##3##(2011-2#2)
to solar##3##2##(1990-9#1)(2011-2#2)
to solid##4##2##(2008-10#3)(2008-4#1)
to solubilize carbon nanotubes##2##4##(2009-10#2)
to soluble##2##2##(2008-7#1)(2012-4#1)
to solve a##2##3##(2008-6#1)(2010-7#1)
to solve the problem##2##4##(2008-10#2)
to solve the radiative transfer##2##5##(2008-3#2)
to solve the##13##3##(1992-9#1)(2008-10#5)(2008-3#4)(2008-9#2)(2011-2#1)
to solve these problems##2##4##(2008-10#2)
to solve this problem##3##4##(1997-1#1)(2008-5#1)(2009-10#1)
to solve##33##2##(1990-12#1)(1992-9#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-7#1)(2011-2#1)
to solvent extraction##4##3##(2008-10#3)(2008-5#1)
to somatic##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
to somatostatin##2##2##(1994-11#2)
to some degree##2##3##(2008-10#1)(2008-8#1)
to some extent##14##3##(1990-5#1)(1993-8#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2011-3#1)
to some form of##2##4##(2009-6#1)(2012-3#1)
to some of the##3##4##(1996-12#1)(2008-10#1)(2012-12#1)
to some of##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
to some strains##2##3##(1991-3#1)(2008-10#1)
to some##52##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-6#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
to sort##2##2##(1991-12#1)(2011-2#1)
to southern##4##2##(2008-10#4)
to soybean production in the##2##5##(2008-10#2)
to soybean##5##2##(2008-10#5)
to space group##2##3##(1992-11#1)(2008-8#1)
to space##4##2##(1992-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
to span the##2##3##(1993-8#1)(2008-4#1)
to spatial heterogeneity##2##3##(2008-8#2)
to spatial##10##2##(2008-10#1)(2008-3#1)(2008-8#4)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
to spatially variable##2##3##(2008-8#2)
to spatially##6##2##(2008-8#2)(2009-8#2)(2010-4#1)(2013-8#1)
to speak##3##2##(1991-2#1)(2008-7#1)(2010-4#1)
to specialist##4##2##(2008-11#2)(2008-8#1)(2009-8#1)
to specialized##3##2##(1992-6#1)(2013-1#2)
to speciate##2##2##(2008-10#2)
to species level##2##3##(2008-10#1)(2008-5#1)
to species##9##2##(1991-3#1)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#1)
to specific stages##2##3##(2010-5#1)(2012-2#1)
to specific##52##2##(1990-2#1)(1990-8#2)(1991-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-7#2)(2008-1#1)(2008-10#13)(2008-11#4)(2008-4#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2010-1#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-2#3)(2012-3#1)(2012-7#1)
to specifically detect##3##3##(2008-10#3)
to specifically target##3##3##(2008-12#1)(2010-5#1)(2010-8#1)
to specifically##13##2##(1991-7#1)(2008-10#7)(2008-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
to specified##2##2##(2008-10#1)(2008-5#1)
to specify the##5##3##(1994-12#1)(2008-10#1)(2009-10#1)(2010-11#1)(2013-8#1)
to specify##9##2##(1990-8#1)(1991-5#1)(1994-12#1)(2008-10#2)(2009-10#1)(2010-11#1)(2011-1#1)(2013-8#1)
to specimens##2##2##(2008-10#1)(2013-1#1)
to spectral##4##2##(2008-10#3)(2008-7#1)
to spectrally##3##2##(1995-3#1)(2007-11#1)(2008-3#1)
to spectrophotometric determination of##4##4##(2008-10#4)
to spectrophotometric##6##2##(2008-10#6)
to speculate that##3##3##(1994-2#1)(2008-11#1)(2013-8#1)
to speculate##5##2##(1994-2#2)(2008-11#1)(2011-3#1)(2013-8#1)
to speech##2##2##(2008-9#2)
to speed up computations##2##4##(2008-3#2)
to speed up the##3##4##(1997-2#1)(2008-10#2)
to speed up##7##3##(1990-11#1)(1997-2#1)(2008-10#2)(2008-3#3)
to speed##12##2##(1990-11#1)(1997-1#1)(1997-2#2)(2008-10#4)(2008-3#3)(2012-3#1)
to spend in##2##3##(2008-11#1)(2011-2#1)
to spend time##2##3##(1991-2#1)(2013-8#1)
to spend##6##2##(1991-2#1)(1994-12#1)(2008-11#1)(2011-2#2)(2013-8#1)
to spinal##3##2##(1990-11#1)(1996-2#1)(1997-8#1)
to split##2##2##(1995-12#1)(2008-10#1)
to spontaneously##2##2##(1990-2#1)(2008-10#1)
to spore germination##2##3##(2008-10#1)(2011-2#1)
to spore##3##2##(2008-10#2)(2011-2#1)
to sporulate##5##2##(1995-9#1)(2008-10#3)(2012-3#1)
to spread and##2##3##(2008-5#1)(2011-2#1)
to spread in##2##3##(2008-10#2)
to spread into##2##3##(2008-10#2)
to spread of scab within##3##5##(2008-10#3)
to spread##16##2##(1997-6#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
to stabilize the##7##3##(1994-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
to stabilize##18##2##(1994-5#1)(1994-9#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
to stable##5##2##(1995-3#2)(1997-3#1)(2008-8#1)(2012-2#1)
to stably##2##2##(2008-11#1)(2008-8#1)
to staff and##2##3##(1991-2#1)(1996-3#1)
to staff##7##2##(1991-2#1)(1994-3#1)(1996-3#1)(2008-11#2)(2013-1#2)
to stage of##2##3##(1991-8#1)(2008-11#1)
to stage##4##2##(1991-8#2)(2008-10#1)(2008-11#1)
to stall##2##2##(1991-9#1)(1997-3#1)
to stand##2##2##(2008-10#1)(2012-3#1)
to standard methods##2##3##(2008-10#1)(2008-12#1)
to standard solutions##3##3##(2008-10#3)
to standard##26##2##(1990-12#1)(1990-8#1)(1995-12#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
to standardise the##2##3##(2008-1#1)(2008-10#1)
to standardize the##2##3##(2010-4#1)(2012-2#1)
to standardize##6##2##(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2012-2#2)
to standing##4##2##(2008-10#1)(2008-7#3)
to start of##2##3##(2008-10#1)(2010-10#1)
to start with##2##3##(1994-12#1)(2010-6#1)
to start##17##2##(1990-2#1)(1994-12#1)(1994-9#1)(1995-12#2)(1997-2#1)(1997-3#1)(2008-10#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
to starting##2##2##(2008-4#1)(2013-1#1)
to state##2##2##(1994-2#1)(2008-11#1)
to static##2##2##(2013-8#2)
to statistical##2##2##(2008-1#1)(2008-10#1)
to statistically##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
to stay healthy##2##3##(1994-12#1)(2011-2#1)
to stay open##2##3##(1996-12#1)(2008-3#1)
to stay##10##2##(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)
to steady##2##2##(1994-11#1)(2008-11#1)
to stem##5##2##(2008-10#3)(2008-11#1)(2008-9#1)
to stenosis##2##2##(2008-1#1)(2008-7#1)
to stent occlusion##2##3##(1990-8#1)(2013-1#1)
to stereoselective##2##2##(1994-5#1)(2008-10#1)
to steric##4##2##(2008-10#4)
to steroid##2##2##(1994-6#1)(1996-2#1)
to steroids##2##2##(1997-8#1)(2008-11#1)
to stimulate DNA synthesis##2##4##(1990-11#1)(1992-3#1)
to stimulate a##2##3##(1993-6#1)(2008-10#1)
to stimulate both##2##3##(1992-3#1)(1997-1#1)
to stimulate glucose##2##3##(1994-8#1)(2008-11#1)
to stimulate or inhibit##2##4##(1994-8#1)(2008-9#1)
to stimulate production of##2##4##(1991-12#2)
to stimulate sustained##2##3##(2008-10#1)(2009-12#1)
to stimulate the##14##3##(1991-6#1)(1993-12#1)(1993-8#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-8#1)(2010-7#1)
to stimulate transcription in##2##4##(1993-8#1)(2011-1#1)
to stimulate transcription##3##3##(1993-8#1)(1994-2#1)(2011-1#1)
to stimulate##63##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-6#1)(1992-10#2)(1992-3#2)(1992-7#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-8#3)(1995-2#4)(1995-8#1)(1996-12#2)(1997-1#4)(2008-10#4)(2008-11#4)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to stimulating sound-pulses##2##3##(2008-8#2)
to stimulating##3##2##(2008-1#1)(2008-8#2)
to stimulation of##8##3##(1992-6#1)(1994-8#1)(1995-11#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-1#1)
to stimulation##16##2##(1991-6#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2011-1#1)
to stimulatory molecules##2##3##(1995-12#2)
to stimuli##4##2##(1995-12#1)(1995-8#1)(1996-2#1)(2010-1#1)
to stochastic##3##2##(2008-8#2)(2009-8#1)
to stop the##4##3##(1995-6#1)(1996-9#1)(1997-6#1)(2012-2#1)
to stop##12##2##(1991-12#1)(1991-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-9#1)(1997-6#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-2#1)
to storage##5##2##(1991-3#1)(1994-3#2)(2008-8#2)
to store##6##2##(1997-6#1)(2008-3#1)(2008-4#3)(2008-7#1)
to strain##5##2##(1993-9#1)(2008-10#4)
to strains##2##2##(2008-10#1)(2010-7#1)
to strategic##5##2##(1994-2#2)(1994-3#1)(1997-1#1)(2012-3#1)
to strategies for##2##3##(2008-10#1)(2008-6#1)
to strategies##4##2##(1991-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
to strawberry##4##2##(2008-10#4)
to streamline##2##2##(1994-3#1)(1997-3#1)
to strengthen the public health##2##5##(1996-2#1)(1997-2#1)
to strengthen the##6##3##(1996-2#1)(1997-2#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
to strengthen##15##2##(1992-3#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-10#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
to streptomycin##2##2##(2008-10#2)
to stress and##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
to stress in##3##3##(2008-10#1)(2008-11#2)
to stress the##2##3##(1990-9#1)(2008-7#1)
to stress##19##2##(1990-9#1)(1996-2#3)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-7#3)(2008-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
to stretching##2##2##(2008-10#1)(2009-3#1)
to striga emergence##2##3##(2008-10#2)
to strike##2##2##(1996-5#2)
to stripe rust##9##3##(2008-10#9)
to stroke##2##2##(2010-12#1)(2012-3#1)
to strong##6##2##(1994-8#1)(2008-10#3)(2008-9#2)
to stronger##2##2##(2011-2#1)(2013-8#1)
to strongly influence the##2##4##(2008-10#1)(2008-9#1)
to strongly##8##2##(1990-12#1)(1995-6#1)(2008-10#4)(2008-9#1)(2009-4#1)
to structural changes##3##3##(1991-5#1)(1993-8#1)(1994-5#1)
to structural##12##2##(1991-5#1)(1993-8#1)(1994-5#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-4#2)(2011-3#1)
to structure##4##2##(1997-1#1)(2007-12#1)(2012-2#2)
to structures##2##2##(1990-11#1)(1995-3#1)
to student nurses##2##3##(2008-11#1)(2008-12#1)
to student##6##2##(2008-11#3)(2008-12#3)
to students from##2##3##(2008-11#1)(2011-2#1)
to students##7##2##(1996-1#1)(2008-11#3)(2008-12#1)(2011-2#1)(2012-3#1)
to studies of##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
to studies##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
to study (1)##2##3##(2008-4#1)(2008-9#1)
to study a##4##3##(1993-11#1)(1996-6#1)(2008-10#1)(2010-6#1)
to study basic##3##3##(2008-4#1)(2008-9#1)(2010-7#1)
to study both the##3##4##(1993-6#1)(2013-1#2)
to study both##4##3##(1993-6#1)(2010-6#1)(2013-1#2)
to study cancer##2##3##(1995-9#1)(2008-11#1)
to study cell##2##3##(2008-10#1)(2008-4#1)
to study competition for nutrients##2##5##(2008-10#2)
to study gene expression##2##4##(2008-10#1)(2008-8#1)
to study how##2##3##(2008-10#1)(2008-8#1)
to study its effects on##2##5##(1995-8#1)(2013-7#1)
to study its##4##3##(1995-8#1)(2008-10#2)(2013-7#1)
to study mechanisms of##2##4##(2008-10#1)(2013-1#1)
to study of##2##3##(2008-10#2)
to study plant##2##3##(2009-10#1)(2013-8#1)
to study the adsorption of##2##5##(2008-10#2)
to study the adsorption##3##4##(2008-10#3)
to study the antioxidant##2##4##(1993-2#1)(2011-2#1)
to study the distribution of##2##5##(1991-5#1)(2008-11#1)
to study the dynamics of##2##5##(2008-1#1)(2008-10#1)
to study the effect of##16##5##(1991-6#1)(1992-3#1)(1993-8#1)(1994-5#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
to study the effects of initial##2##6##(2008-10#2)
to study the effects of##11##5##(1992-6#1)(1993-1#1)(1997-3#1)(2006-6#1)(2008-10#4)(2008-5#1)(2012-2#1)(2012-3#1)
to study the effects##12##4##(1992-6#1)(1993-1#1)(1993-12#1)(1997-3#1)(2006-6#1)(2008-10#4)(2008-5#1)(2012-2#1)(2012-3#1)
to study the influence of##6##5##(1994-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
to study the inheritance of##2##5##(2008-10#2)
to study the interaction##3##4##(2008-10#2)(2008-9#1)
to study the kinetic##3##4##(2008-10#2)(2008-11#1)
to study the kinetics of##3##5##(1990-12#1)(2008-11#1)(2008-2#1)
to study the mechanism of##2##5##(2008-1#1)(2008-11#1)
to study the mechanisms##2##4##(2008-10#1)(2008-11#1)
to study the molecular basis of the##2##7##(1997-2#1)(2008-10#1)
to study the molecular##3##4##(1997-2#1)(2008-10#2)
to study the population##2##4##(2008-10#1)(2008-8#1)
to study the process of##2##5##(2008-11#1)(2009-12#1)
to study the regulation of##2##5##(1994-8#1)(2008-4#1)
to study the relationship between##3##5##(1991-11#1)(2008-10#2)
to study the relationship of the SSCT##2##7##(2008-9#2)
to study the relationship of##3##5##(2008-7#1)(2008-9#2)
to study the relationship##6##4##(1991-11#1)(2008-10#2)(2008-7#1)(2008-9#2)
to study the role of##5##5##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
to study the separation##2##4##(2008-10#2)
to study the spread of##2##5##(2008-10#2)
to study the structure##3##4##(1993-3#1)(2010-5#1)(2013-1#1)
to study the susceptibility##2##4##(1992-9#1)(2008-5#1)
to study the variability##2##4##(2008-10#2)
to study the##184##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#3)(1994-11#1)(1994-5#4)(1994-6#1)(1994-8#2)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#2)(1997-3#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#70)(2008-11#15)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#5)(2008-8#7)(2008-9#9)(2009-1#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-10#1)(2011-2#6)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
to study their##2##3##(2008-10#2)
to study these##2##3##(2008-11#1)(2009-7#1)
to study this##5##3##(1991-12#1)(1993-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
to study various aspects##2##4##(1990-9#1)(2010-6#1)
to study##329##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-5#4)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-2#2)(1997-3#1)(2006-6#1)(2007-12#1)(2008-1#3)(2008-10#106)(2008-11#32)(2008-12#5)(2008-2#4)(2008-3#5)(2008-4#11)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#11)(2008-9#16)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#3)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#7)(2012-9#1)(2013-1#9)(2013-7#1)(2013-8#3)
to studying the##2##3##(2008-9#1)(2013-8#1)
to studying##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2013-8#1)
to sub-ppb##2##2##(2008-10#2)
to subgroup I##2##3##(2008-10#2)
to subgroup##5##2##(2008-10#5)
to subgroups##3##2##(1994-9#1)(1996-2#1)(2008-10#1)
to subjects##5##2##(1991-6#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#1)
to submit##5##2##(1996-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
to subsequent##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2013-1#1)
to substantial##4##2##(1997-8#3)(2013-1#1)
to substantially##4##2##(1996-3#1)(1997-1#1)(2008-10#2)
to substantiate the##2##3##(2008-11#2)
to substantiate##4##2##(2008-11#2)(2008-5#1)(2008-8#1)
to substitute for##4##3##(1993-3#1)(1995-2#1)(1996-3#1)(2008-10#1)
to substitute the##2##3##(2008-11#1)(2008-8#1)
to substitute##8##2##(1993-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
to substituted##2##2##(2008-10#1)(2008-8#1)
to substrate##2##2##(1995-8#1)(2008-7#1)
to succeed##3##2##(2008-8#2)(2011-2#1)
to successful##5##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
to successfully meet the##2##4##(1991-1#1)(1997-1#1)
to successfully##17##2##(1991-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2013-1#1)(2013-8#2)
to such a##2##3##(1993-12#1)(2008-2#1)
to such conditions##2##3##(2008-11#1)(2008-7#1)
to such##22##2##(1990-11#1)(1990-2#1)(1991-12#1)(1993-12#1)(1995-6#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#3)
to sue the##2##3##(1995-12#1)(1996-5#1)
to sue##4##2##(1995-12#1)(1996-5#3)
to suffer from a##2##4##(2008-7#1)(2009-6#1)
to suffer from##3##3##(2008-7#2)(2009-6#1)
to suffer##4##2##(1991-8#1)(2008-7#2)(2009-6#1)
to sugar beet##3##3##(2008-10#3)
to sugarcane mosaic virus##2##4##(2008-10#1)(2008-9#1)
to sugarcane##4##2##(2008-10#3)(2008-9#1)
to suggest a##3##3##(2007-12#1)(2008-11#1)(2012-2#1)
to suggest that the##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
to suggest that their##2##4##(1995-3#1)(2008-10#1)
to suggest that##15##3##(1993-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)(2012-12#1)
to suggest the##3##3##(1991-2#1)(2008-12#1)(2011-2#1)
to suggest##29##2##(1991-2#1)(1991-3#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#3)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
to suicide##5##2##(1993-3#1)(1996-1#2)(1997-3#1)(2010-6#1)
to suit##4##2##(1993-12#1)(1994-3#1)(1996-6#1)(2008-10#1)
to sulfate##5##2##(2008-10#4)(2008-6#1)
to sulfide##4##2##(1993-8#1)(2008-10#3)
to sulphide##2##2##(2008-10#2)
to summarize some##2##3##(2008-4#1)(2009-10#1)
to summarize the##7##3##(2008-10#1)(2009-4#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
to summarize##20##2##(1993-3#1)(1995-12#1)(1996-12#1)(2008-10#4)(2008-11#4)(2008-4#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
to sun##4##2##(1991-6#1)(2008-5#1)(2011-2#2)
to sunlight##6##2##(2008-5#2)(2011-2#4)
to supplement the##4##3##(1996-3#1)(1997-2#1)(2008-10#1)(2008-8#1)
to supplement##7##2##(1996-3#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-8#1)(2010-8#1)
to supply the##2##3##(1997-1#1)(2008-11#1)
to supply##10##2##(1992-3#1)(1995-12#1)(1997-1#1)(2008-11#3)(2008-7#2)(2008-8#1)(2009-7#1)
to support CQI##2##3##(1994-2#1)(1994-3#1)
to support a##9##3##(1993-11#1)(1994-1#2)(2008-11#1)(2012-2#2)(2012-3#1)(2013-1#2)
to support and##2##3##(2008-12#1)(2011-2#1)
to support cell growth##2##4##(2008-11#2)
to support cell##3##3##(2008-11#2)(2009-7#1)
to support claims##2##3##(2008-5#2)
to support environmental##2##3##(2008-11#2)
to support its##2##3##(2009-8#1)(2013-8#1)
to support learning in practice##2##5##(2008-11#2)
to support long-term##2##3##(2008-11#1)(2009-6#1)
to support our##2##3##(2008-10#1)(2012-5#1)
to support patients##2##3##(1995-2#1)(2011-1#1)
to support such##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
to support teaching##2##3##(2008-11#1)(2012-3#1)
to support the development##2##4##(1994-2#1)(2012-3#1)
to support the growth##2##4##(2008-11#2)
to support the hypothesis that##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
to support the use of##4##5##(2008-9#1)(2012-12#1)(2013-1#2)
to support the##37##3##(1991-5#1)(1992-12#1)(1992-2#1)(1994-2#1)(1995-8#1)(2007-12#1)(2008-10#7)(2008-11#11)(2008-2#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
to support their##2##3##(1993-12#1)(2010-5#1)
to support this##6##3##(1993-3#1)(2008-10#2)(2008-8#2)(2013-1#1)
to support##139##2##(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-2#2)(1995-8#1)(1997-1#3)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#22)(2008-11#30)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#7)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#11)(2013-8#2)
to suppose that##2##3##(1990-5#1)(2008-10#1)
to suppress Fusarium wilt##2##4##(2008-10#2)
to suppress disease##3##3##(2008-10#3)
to suppress the disease##2##4##(2008-10#2)
to suppress the##16##3##(1992-12#1)(1995-12#1)(1995-2#1)(2008-10#6)(2008-11#4)(2008-5#1)(2009-8#1)(2010-7#1)
to suppress##47##2##(1991-7#1)(1992-12#1)(1993-2#2)(1993-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(2008-10#27)(2008-11#4)(2008-3#3)(2008-5#2)(2009-8#1)(2010-7#1)
to suppression of##3##3##(2008-10#2)(2008-11#1)
to supraconducive##3##2##(2008-10#3)
to surface##9##2##(1990-12#1)(1997-6#1)(2008-10#5)(2008-6#1)(2011-2#1)
to surfaces##7##2##(1990-2#2)(2008-10#2)(2008-6#1)(2013-1#1)(2013-8#1)
to surfactants##2##2##(1996-2#1)(2008-5#1)
to surgery and##2##3##(1991-2#1)(2010-7#1)
to surgery or##4##3##(2008-10#1)(2008-7#2)(2008-9#1)
to surgery##21##2##(1991-2#1)(1991-3#1)(1991-8#1)(1993-3#1)(1994-9#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#2)
to surgical management##2##3##(1991-3#1)(2013-1#1)
to surgical stimuli##2##3##(2011-2#2)
to surgical trauma##3##3##(2008-12#1)(2012-12#2)
to surgical##20##2##(1990-3#2)(1991-3#1)(1993-1#1)(1997-6#1)(1997-8#2)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#1)
to surrounding##3##2##(1991-2#1)(2008-11#1)(2011-2#1)
to surveillance##2##2##(1997-1#1)(2011-2#1)
to survey for##2##3##(2008-10#2)
to survey the##3##3##(2008-10#1)(2009-12#1)(2013-1#1)
to survey##6##2##(2008-10#3)(2009-12#1)(2011-10#1)(2013-1#1)
to survival##8##2##(1992-9#2)(1994-12#1)(2008-10#3)(2011-2#1)(2012-3#1)
to survive and##3##3##(1992-3#1)(2007-12#1)(2013-1#1)
to survive in the##2##4##(2008-10#1)(2011-2#1)
to survive in##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
to survive##18##2##(1992-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(2007-12#1)(2008-10#4)(2008-8#2)(2010-11#1)(2011-2#3)(2013-1#1)
to susceptible##3##2##(2008-10#3)
to suspect a##2##3##(2008-10#1)(2011-2#1)
to suspect##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
to sustain the##3##3##(1990-2#1)(2012-12#1)(2012-2#1)
to sustain##15##2##(1990-2#1)(1993-6#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
to sweeteners##3##2##(2008-2#3)
to swell##2##2##(2008-10#1)(2008-9#1)
to switch##5##2##(1992-9#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-8#1)
to sympathovagal##2##2##(2009-11#1)(2012-2#1)
to symptom##2##2##(2008-10#1)(2010-5#1)
to symptoms##6##2##(1992-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
to synchronize##4##2##(2008-10#1)(2008-11#2)(2009-8#1)
to synchronous##2##2##(1996-8#1)(2008-10#1)
to synergize with##2##3##(1993-12#1)(2009-12#1)
to synthesis##3##2##(1995-3#1)(2007-11#1)(2008-10#1)
to synthesize and##3##3##(1993-3#1)(2008-6#1)(2013-8#1)
to synthesize the##3##3##(2008-12#1)(2008-4#1)(2008-9#1)
to synthesize##23##2##(1990-5#1)(1993-3#1)(1993-8#1)(1994-9#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-9#4)(2009-10#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to synthetic##6##2##(2008-10#3)(2008-11#1)(2008-4#1)(2009-5#1)
to systematic errors##2##3##(2008-3#2)
to systematic##3##2##(2008-3#2)(2008-9#1)
to systematically##4##2##(1993-2#1)(2008-6#2)(2013-1#1)
to systemic##8##2##(1990-8#1)(1994-12#2)(2008-10#4)(2013-1#1)
to systemically##3##2##(2008-10#3)
to tackle this##2##3##(1995-5#1)(2011-2#1)
to tackle##7##2##(1991-11#1)(1994-3#1)(1995-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
to tag##5##2##(1997-8#1)(2008-10#2)(2008-9#2)
to tailor##4##2##(2009-12#1)(2010-4#1)(2013-1#2)
to take a##4##3##(1990-6#1)(1991-3#1)(1993-2#1)(2008-11#1)
to take account of##2##4##(2008-3#1)(2010-10#1)
to take account##3##3##(2008-3#1)(2010-10#1)(2013-8#1)
to take action##3##3##(2008-11#1)(2008-6#1)(2012-2#1)
to take advantage of##8##4##(1990-11#1)(1993-12#1)(1994-3#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-9#1)(2009-4#1)
to take into account the actual three-dimensional geometry##2##8##(2008-3#2)
to take into account the##12##5##(1993-2#1)(1995-12#1)(1995-5#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#2)
to take into##13##3##(1993-2#1)(1995-12#2)(1995-5#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#2)
to take measures##2##3##(2008-12#1)(2010-5#1)
to take more##2##3##(1993-12#1)(2008-11#1)
to take part in##2##4##(1996-11#1)(2008-10#1)
to take part##4##3##(1996-11#1)(2008-10#1)(2008-11#2)
to take place at##2##4##(1996-2#1)(2008-10#1)
to take place in##5##4##(2008-10#2)(2010-7#1)(2010-8#1)(2013-8#1)
to take place##9##3##(1996-2#1)(2008-10#4)(2008-7#1)(2010-7#1)(2010-8#1)(2013-8#1)
to take precautions##2##3##(1996-5#2)
to take steps to##2##4##(1993-1#1)(2008-11#1)
to take the lead##2##4##(1995-12#2)
to take the##6##3##(1995-12#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
to take up##2##3##(2008-9#1)(2009-12#1)
to take##73##2##(1990-11#1)(1990-6#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-3#1)(1995-12#4)(1995-5#3)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#3)(1997-2#1)(2008-10#10)(2008-11#12)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#5)(2009-12#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#4)
to take-all##3##2##(2008-10#3)
to talk to##2##3##(1997-1#1)(2009-7#1)
to tall fescue##2##3##(2008-10#2)
to tall##3##2##(2008-10#2)(2013-1#1)
to tamoxifen##7##2##(1990-2#1)(1991-8#2)(1993-1#2)(2008-10#2)
to tap water and##3##4##(2008-10#3)
to tap water##5##3##(2008-10#5)
to tap##6##2##(2008-10#6)
to target cells##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
to target human##2##3##(2008-10#1)(2010-1#1)
to target the##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
to target##38##2##(1991-6#1)(1992-12#1)(1993-11#1)(1995-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
to targeted##2##2##(1996-11#1)(2008-9#1)
to targets defined by proximity##2##5##(2008-9#2)
to targets defined by##3##4##(2008-9#3)
to targets##5##2##(2008-9#3)(2010-5#1)(2011-2#1)
to tasks##3##2##(2008-11#1)(2009-7#1)(2009-8#1)
to teach and##2##3##(2008-11#1)(2008-12#1)
to teach##13##2##(1993-12#2)(1995-12#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#5)(2008-12#1)(2009-11#1)
to teaching and##2##3##(2008-11#1)(2011-2#1)
to teaching##11##2##(1994-12#1)(2008-11#5)(2009-8#1)(2011-2#3)(2013-1#1)
to teams##2##2##(1997-2#2)
to technical##5##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
to techniques and##2##3##(1991-3#1)(2009-9#1)
to tell##2##2##(1991-2#1)(2013-8#1)
to temperature and relative humidity##2##5##(2008-10#2)
to temperature and##6##3##(1994-8#1)(2008-10#3)(2008-3#2)
to temperature##20##2##(1991-2#1)(1994-8#1)(2008-10#10)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-6#2)
to temperatures##6##2##(2008-10#4)(2008-6#1)(2010-4#1)
to ten##8##2##(1990-10#1)(1992-1#1)(1992-5#1)(2008-10#4)(2008-5#1)
to tenofovir##2##2##(2013-1#2)
to term##3##2##(1990-5#2)(1992-12#1)
to terminate the##2##3##(1992-6#1)(2008-11#1)
to terminate##4##2##(1992-6#1)(1995-8#1)(1996-6#1)(2008-11#1)
to terms with##2##3##(1995-11#1)(2008-11#1)
to test a model##2##4##(2008-12#1)(2012-3#1)
to test a##8##3##(1993-12#1)(1996-6#1)(2008-10#4)(2008-12#1)(2012-3#1)
to test an##2##3##(1997-3#1)(2009-3#1)
to test and##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
to test for the##2##4##(2008-11#1)(2010-8#1)
to test for##11##3##(1996-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
to test hypotheses about the##2##5##(2008-10#1)(2008-8#1)
to test hypotheses about##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
to test hypotheses##4##3##(2008-10#2)(2008-8#1)(2012-3#1)
to test if##2##3##(2008-10#1)(2008-11#1)
to test its##2##3##(1997-1#1)(2008-12#1)
to test such##2##3##(1992-9#1)(2011-2#1)
to test the effect of##2##5##(2008-10#1)(2012-2#1)
to test the effects of##6##5##(1992-1#1)(2008-10#1)(2008-11#2)(2010-11#1)(2012-2#1)
to test the feasibility of##3##5##(1996-2#1)(1997-8#1)(2011-2#1)
to test the feasibility##4##4##(1996-2#1)(1997-8#1)(2008-11#1)(2011-2#1)
to test the hypothesis of##2##5##(1991-2#1)(2008-10#1)
to test the hypothesis that the##3##6##(2008-11#1)(2008-7#1)(2009-7#1)
to test the hypothesis that##10##5##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)(2012-5#1)
to test the hypothesis##12##4##(1990-8#1)(1991-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)(2012-5#1)
to test the null hypothesis##2##5##(1995-5#1)(2008-10#1)
to test the prediction##2##4##(2008-12#1)(2008-8#1)
to test the validity of the##2##6##(1997-2#1)(2008-10#1)
to test the validity of##4##5##(1997-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
to test the##61##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-1#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#5)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-5#2)(2013-1#1)(2013-8#1)
to test their##2##3##(2008-10#1)(2013-8#1)
to test these##3##3##(2008-3#1)(2008-8#2)
to test this hypothesis##2##4##(2008-7#1)(2008-8#1)
to test this##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
to test whether this##2##4##(2008-9#1)(2012-3#1)
to test whether##10##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#2)
to test which##2##3##(2008-8#1)(2009-8#1)
to test##136##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#39)(2008-11#12)(2008-12#4)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#13)(2008-9#3)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-8#3)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#3)(2012-5#2)(2013-1#4)(2013-8#2)
to testing##5##2##(1997-2#1)(2008-10#2)(2008-5#2)
to tetracycline##2##2##(2008-10#2)
to tetrahydroaminoacridine and##2##3##(1992-8#2)
to that achieved##2##3##(1993-2#1)(2008-10#1)
to that associated with the##2##5##(1993-12#1)(2008-2#1)
to that associated with##4##4##(1993-12#2)(2008-10#1)(2008-2#1)
to that at##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
to that described for##3##4##(1990-5#1)(2007-12#1)(2008-10#1)
to that for the picrate one##2##6##(2008-10#2)
to that for the##3##4##(2008-10#3)
to that for##7##3##(1993-8#1)(1994-5#1)(2008-10#4)(2008-9#1)
to that found in the##2##5##(2008-11#1)(2012-12#1)
to that found##5##3##(1991-3#1)(1991-5#1)(2007-11#1)(2008-11#1)(2012-12#1)
to that habitat##2##3##(2008-8#2)
to that in a##2##4##(2008-10#1)(2008-11#1)
to that in infected##2##4##(2008-10#2)
to that in the##5##4##(1994-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
to that in water##2##4##(2008-10#2)
to that in young##2##4##(2008-7#1)(2013-7#1)
to that in##24##3##(1991-11#1)(1994-2#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2013-7#1)
to that induced by##3##4##(1995-3#1)(1995-9#1)(2008-10#1)
to that known##3##3##(1996-2#1)(1997-4#2)
to that observed for##3##4##(2008-10#2)(2008-7#1)
to that observed in the##3##5##(1995-12#1)(2008-10#1)(2009-12#1)
to that observed in##17##4##(1991-12#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-7#1)(2009-12#1)(2013-1#1)
to that observed with##3##4##(2008-10#3)
to that observed##25##3##(1991-12#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#10)(2008-7#2)(2009-12#1)(2009-5#1)(2013-1#1)
to that obtained at##2##4##(2008-10#1)(2008-11#1)
to that obtained in##4##4##(1992-12#1)(2008-10#1)(2008-11#2)
to that obtained with##3##4##(2008-10#3)
to that obtained##12##3##(1992-12#1)(1993-12#1)(2008-10#6)(2008-11#3)(2008-6#1)
to that of M##2##4##(2008-10#1)(2011-2#1)
to that of a##12##4##(1996-12#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-7#1)(2012-12#1)
to that of control##5##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#2)
to that of controls##2##4##(1990-11#1)(2008-11#1)
to that of human##2##4##(1995-2#1)(2008-6#1)
to that of insulin##2##4##(1992-10#1)(2008-8#1)
to that of its##3##4##(1990-5#1)(1997-7#1)(2008-9#1)
to that of other##11##4##(1993-2#1)(1994-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
to that of rat##4##4##(1990-5#1)(1996-12#1)(2008-11#2)
to that of the control##4##5##(1994-8#1)(2008-9#2)(2011-2#1)
to that of the host##2##5##(1994-2#1)(2013-8#1)
to that of the native##2##5##(1995-11#1)(2008-11#1)
to that of the rat gene##2##6##(1991-7#1)(1994-11#1)
to that of the rat##3##5##(1991-7#1)(1994-11#1)(2011-2#1)
to that of the wild type##2##6##(1990-5#1)(1993-3#1)
to that of the yeast##3##5##(1991-6#1)(1996-2#1)(1997-8#1)
to that of the##63##4##(1990-12#1)(1990-5#3)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-6#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#4)(2011-2#2)(2013-1#1)(2013-8#2)
to that of their##2##4##(2008-10#1)(2008-11#1)
to that of##199##3##(1990-11#1)(1990-12#2)(1990-5#5)(1990-8#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#3)(1995-11#1)(1995-2#4)(1996-12#5)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#50)(2008-11#14)(2008-12#3)(2008-3#2)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#9)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
to that offered##2##3##(1991-2#1)(1995-11#1)
to that on##2##3##(2008-10#2)
to that population##2##3##(1995-12#1)(2008-8#1)
to that previously##2##3##(1990-2#1)(2010-8#1)
to that seen##7##3##(1994-5#2)(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
to that used##3##3##(2008-10#2)(2010-10#1)
to that##354##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#6)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#2)(1992-10#1)(1992-12#4)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#4)(1993-3#1)(1993-6#3)(1993-8#6)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#6)(1994-8#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#6)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#5)(1997-4#4)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#101)(2008-11#28)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#10)(2008-6#4)(2008-7#12)(2008-8#16)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-3#1)(2010-7#1)(2010-8#2)(2011-10#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
to the &quot##13##3##(1990-11#1)(1995-2#2)(1996-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#2)(2012-2#1)(2013-8#1)
to the 0##2##3##(1996-8#1)(2008-10#1)
to the 1##2##3##(2008-10#2)
to the 1985##2##3##(1996-2#1)(2011-2#1)
to the 20##3##3##(1993-1#1)(2008-10#2)
to the 3' end of the##4##6##(1992-3#1)(1992-6#1)(1997-2#1)(2008-11#1)
to the 3' end of##5##5##(1992-3#1)(1992-6#1)(1997-2#1)(2008-11#1)(2008-8#1)
to the 3'##7##3##(1992-3#1)(1992-6#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-8#2)
to the 3D##2##3##(1996-2#1)(2008-10#1)
to the 5'##4##3##(1991-5#1)(1997-2#1)(2008-10#2)
to the 50%##2##3##(2012-2#1)(2013-1#1)
to the 9th##2##3##(1991-9#1)(2008-11#1)
to the A##2##3##(1994-5#1)(2008-10#1)
to the ACL##2##3##(1997-8#1)(2013-1#1)
to the AVM##2##3##(1997-6#1)(2008-7#1)
to the American##2##3##(2008-3#1)(2010-6#1)
to the Andean##2##3##(2008-10#2)
to the B##3##3##(1991-3#1)(1994-5#1)(2008-10#1)
to the BTB##2##3##(2012-2#2)
to the British##2##3##(1995-8#1)(2008-10#1)
to the C##2##3##(1995-2#1)(2008-10#1)
to the C-terminal##4##3##(1990-2#1)(1995-2#1)(1995-6#1)(2008-9#1)
to the CL intensity##3##4##(2008-10#3)
to the CL##4##3##(2008-10#4)
to the COOH-terminal##2##3##(1992-9#1)(1995-6#1)
to the CRE##2##3##(2013-1#2)
to the Clinic##2##3##(1995-9#1)(2011-2#1)
to the Co-4##2##3##(2008-10#2)
to the Convention##2##3##(1992-12#2)
to the D##4##3##(1995-2#1)(2008-10#3)
to the DNA##6##3##(1991-5#1)(1994-5#1)(1995-6#1)(1997-3#1)(2008-9#1)(2013-1#1)
to the Department of##2##4##(1997-8#1)(2012-12#1)
to the ER##6##3##(1994-12#2)(1997-7#1)(2008-11#3)
to the European##3##3##(1993-5#1)(2008-10#2)
to the FI system##2##4##(2008-10#2)
to the Fc region##2##4##(2008-11#2)
to the Fc##4##3##(1990-12#2)(2008-11#2)
to the Future##2##3##(2008-10#1)(2013-1#1)
to the G##2##3##(2008-10#1)(2008-6#1)
to the GCN4 motif##2##4##(2008-9#2)
to the HIV-1##3##3##(1997-3#1)(2008-4#1)(2013-1#1)
to the HLA##2##3##(1991-11#1)(2008-10#1)
to the HPLC##2##3##(2008-10#2)
to the IC##2##3##(2008-10#2)
to the ICP-MS##2##3##(2008-10#2)
to the ICRP##2##3##(1997-8#1)(2013-1#1)
to the ICU##2##3##(2010-5#1)(2012-3#1)
to the Internet##2##3##(1994-3#1)(1996-2#1)
to the Italian##3##3##(1991-12#1)(1994-2#1)(2008-10#1)
to the LC##2##3##(2008-10#2)
to the Leptosphaeria maculans-Brassica napus##2##5##(2008-10#2)
to the M##2##3##(1997-3#1)(2008-10#1)
to the Medicare##3##3##(1991-1#1)(1992-12#1)(1992-2#1)
to the Middle Ages##2##4##(2009-10#1)(2013-8#1)
to the N-terminal##3##3##(2006-6#1)(2008-11#1)(2011-1#1)
to the NADH##2##3##(1993-6#1)(2008-10#1)
to the NZ##2##3##(2008-11#1)(2008-8#1)
to the National##6##3##(1991-2#1)(1992-12#1)(1996-5#2)(2008-3#1)(2010-12#1)
to the Norwegian##3##3##(1994-9#1)(1997-8#1)(2011-2#1)
to the Ontario##2##3##(1991-2#1)(1994-1#1)
to the P##2##3##(1990-5#1)(2008-10#1)
to the PFC##2##3##(1996-5#1)(1997-2#1)
to the PSD##2##3##(1996-12#1)(2008-3#1)
to the RNA-dependent RNA polymerase##2##5##(2008-10#2)
to the RRE with##2##4##(1993-8#2)
to the RRE##3##3##(1993-8#3)
to the S##6##3##(1996-6#1)(2008-10#4)(2008-11#1)
to the SH2##2##3##(1995-6#2)
to the SI##4##3##(2008-10#1)(2012-2#3)
to the SPE##2##3##(2008-10#2)
to the Senate##2##3##(1995-6#2)
to the Slump Test##2##4##(2008-12#2)
to the South##2##3##(2011-2#2)
to the TATA box##2##4##(1993-6#1)(1993-8#1)
to the TATA##3##3##(1993-6#1)(1993-8#1)(1995-2#1)
to the TCRAC##2##3##(1997-9#2)
to the U##5##3##(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#2)
to the UK##2##3##(2008-10#1)(2008-12#1)
to the US##5##3##(1995-6#1)(1995-8#1)(1997-2#1)(2008-8#1)(2012-2#1)
to the UV##3##3##(2008-10#2)(2011-2#1)
to the United States##4##4##(2008-10#2)(2008-11#1)(2012-12#1)
to the United##6##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
to the University of##2##4##(1996-1#1)(2011-2#1)
to the University##3##3##(1996-1#1)(2011-2#2)
to the VLDL receptor##2##4##(1995-6#2)
to the WHO##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
to the World Health Organization (WHO)##3##6##(1997-6#1)(2008-12#1)(2010-6#1)
to the World Health Organization##4##5##(1997-6#2)(2008-12#1)(2010-6#1)
to the X##3##3##(2008-10#1)(2008-8#2)
to the X-chromosome##2##3##(1990-8#1)(2008-12#1)
to the Z line##3##4##(2008-6#3)
to the abdomen##2##3##(1997-3#1)(2013-8#1)
to the ability of##8##4##(1991-12#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-8#1)
to the ability to##3##4##(1994-3#1)(2008-10#1)(2008-9#1)
to the ability##11##3##(1991-12#1)(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2013-8#1)
to the above##8##3##(1991-1#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
to the above-mentioned##3##3##(2008-10#2)(2008-7#1)
to the absence of##8##4##(1991-6#1)(2008-11#1)(2008-6#1)(2008-8#2)(2010-8#1)(2011-2#1)(2013-1#1)
to the absolute##3##3##(2008-10#2)(2008-8#1)
to the absorption maximum##2##4##(1994-5#1)(2008-10#1)
to the absorption##8##3##(1994-5#1)(2008-10#5)(2008-3#2)
to the accumulation of##10##4##(1990-5#1)(1995-2#1)(2008-10#3)(2008-7#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-3#1)
to the accumulation##11##3##(1990-5#1)(1995-2#1)(2008-10#4)(2008-7#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-3#1)
to the accuracy##2##3##(2008-10#2)
to the acid##2##3##(2008-10#2)
to the acquisition##2##3##(1994-8#1)(2009-3#1)
to the action of##8##4##(1994-11#2)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
to the activated##3##3##(1997-7#1)(2008-10#1)(2009-10#1)
to the activation of##5##4##(1991-2#1)(1993-12#1)(1994-6#1)(1995-6#1)(2008-8#1)
to the activation##6##3##(1991-2#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-6#1)(2008-8#1)
to the active site of##2##5##(1994-5#2)
to the active##6##3##(1994-5#3)(1995-11#1)(2008-10#1)(2009-8#1)
to the activity of##2##4##(1992-12#1)(2008-10#1)
to the activity##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
to the addition of##5##4##(1996-1#1)(2008-10#3)(2008-11#1)
to the addition##6##3##(1996-1#1)(2008-10#3)(2008-11#1)(2009-8#1)
to the adjacent##2##3##(1994-11#1)(2013-1#1)
to the administration of##2##4##(1995-12#1)(2008-9#1)
to the adoption of the##2##5##(2008-1#1)(2008-8#1)
to the adoption of##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
to the adult##2##3##(2008-10#1)(2010-8#1)
to the advancement of##2##4##(2008-10#1)(2010-5#1)
to the advantages##3##3##(1993-12#1)(2008-10#2)
to the adverse##3##3##(1992-3#1)(2009-4#1)(2009-9#1)
to the aerosol##2##3##(1996-3#1)(2008-3#1)
to the aetiology of##3##4##(1997-1#1)(2011-2#2)
to the affected##3##3##(1993-3#1)(2008-1#1)(2011-2#1)
to the age of the##2##5##(1994-11#1)(2008-10#1)
to the age of##4##4##(1990-6#1)(1994-11#1)(1995-1#1)(2008-10#1)
to the age##7##3##(1990-6#1)(1994-11#1)(1995-1#1)(2008-10#1)(2008-12#1)(2012-3#2)
to the agent##2##3##(1991-3#1)(2008-10#1)
to the air##2##3##(2008-10#1)(2008-11#1)
to the airway##2##3##(1997-1#1)(2010-7#1)
to the airways##2##3##(1992-3#1)(1996-12#1)
to the alfalfa biomass##2##4##(2008-10#2)
to the alpha##7##3##(1991-5#1)(1992-2#1)(1993-8#3)(1994-5#1)(1995-6#1)
to the amino acid sequence##2##5##(1992-6#1)(1996-12#1)
to the amino terminus of##2##5##(1991-10#1)(1995-2#1)
to the amino##6##3##(1991-10#1)(1992-6#2)(1995-2#1)(1996-12#1)(2008-10#1)
to the amount of##8##4##(1994-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)
to the amount##9##3##(1994-11#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)
to the amounts of##2##4##(2008-10#1)(2013-1#1)
to the analyses of##5##4##(2008-10#5)
to the analyses##6##3##(2008-10#6)
to the analysis of natural water##3##6##(2008-10#3)
to the analysis of natural##4##5##(2008-10#4)
to the analysis of pharmaceutical##2##5##(2008-10#2)
to the analysis of real##4##5##(2008-10#3)(2008-2#1)
to the analysis of river##2##5##(2008-10#2)
to the analysis of several##2##5##(2008-10#1)(2009-10#1)
to the analysis of some##4##5##(2008-10#4)
to the analysis of the##6##5##(1995-8#1)(2008-10#4)(2011-2#1)
to the analysis of these herbicides in##2##7##(2008-10#2)
to the analysis of these##4##5##(2008-10#4)
to the analysis of##100##4##(1990-3#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#86)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#2)(2009-12#1)(2011-2#2)
to the analysis##105##3##(1990-3#1)(1994-6#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#89)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#1)(2011-2#2)
to the analyte##4##3##(2008-10#4)
to the analytes##2##3##(2008-10#2)
to the analytical column##2##4##(2008-10#2)
to the analytical##6##3##(2008-10#6)
to the animals##3##3##(2008-12#1)(2010-1#1)(2011-2#1)
to the antagonistic##2##3##(2008-10#1)(2008-12#1)
to the anterior##5##3##(1993-12#1)(2008-7#1)(2009-1#1)(2011-2#1)(2011-7#1)
to the anti-inflammatory##2##3##(2008-10#1)(2009-1#1)
to the antibiotic##2##3##(1993-2#1)(2008-10#1)
to the antibody##2##3##(2008-10#1)(2008-11#1)
to the antiestrogen##2##3##(1993-1#1)(2008-11#1)
to the apex##2##3##(2009-2#1)(2013-1#1)
to the apical##5##3##(2008-10#1)(2008-11#2)(2009-10#1)(2012-2#1)
to the apoptotic##2##3##(1995-2#1)(2011-2#1)
to the apparent##3##3##(1991-12#1)(1993-2#1)(2008-10#1)
to the appearance of the##3##5##(1991-6#1)(1996-6#1)(2012-2#1)
to the appearance of##5##4##(1991-6#1)(1992-12#1)(1996-6#1)(2012-2#1)(2012-3#1)
to the appendix##2##3##(2009-7#1)(2011-2#1)
to the application of a##2##5##(1995-5#1)(2008-10#1)
to the application of##5##4##(1995-5#1)(2008-10#3)(2011-1#1)
to the application##6##3##(1995-5#1)(2008-10#3)(2009-11#1)(2011-1#1)
to the approach##2##3##(1993-12#1)(2012-2#1)
to the appropriate##3##3##(1994-12#1)(2008-10#1)(2013-8#1)
to the aqueous phase##5##4##(1990-5#1)(2008-10#3)(2008-5#1)
to the aqueous##9##3##(1990-5#1)(2008-10#7)(2008-5#1)
to the area under##2##4##(2008-10#2)
to the area##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
to the areas##2##3##(1993-8#1)(2008-10#1)
to the arrangement of##2##4##(2008-7#2)
to the array##2##3##(2008-10#2)
to the assay of##3##4##(2008-10#3)
to the assessment of##4##4##(2008-10#1)(2008-5#1)(2009-1#1)(2010-5#1)
to the assessment##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-1#1)(2010-5#1)
to the assignment##2##3##(2008-10#1)(2008-11#1)
to the associated##2##3##(2008-10#1)(2008-2#1)
to the atmosphere##4##3##(1991-3#1)(1995-3#1)(2008-10#1)(2008-3#1)
to the author##6##3##(1991-1#2)(1991-12#1)(1991-3#2)(2008-11#1)
to the author's##2##3##(2011-2#1)(2013-1#1)
to the authors'##2##3##(1993-3#1)(2007-11#1)
to the availability of##5##4##(1992-2#1)(1994-3#1)(2008-10#1)(2009-5#1)(2012-2#1)
to the available##2##3##(1994-3#1)(2011-2#1)
to the average temperature##2##4##(2008-8#2)
to the average##7##3##(1993-1#1)(2008-10#3)(2008-8#2)(2012-3#1)
to the avirulence##3##3##(2008-10#3)
to the axial##2##3##(2008-10#1)(2011-2#1)
to the axis##2##3##(2008-11#1)(2008-2#1)
to the back##3##3##(2008-9#1)(2013-1#2)
to the background##4##3##(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)
to the backscattering##2##3##(2008-3#2)
to the balance of##2##4##(1994-11#1)(2008-5#1)
to the basal lamina##2##4##(2008-12#1)(2009-10#1)
to the basal##6##3##(1996-5#1)(1997-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)
to the base##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
to the baseline##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
to the basic##3##3##(1992-1#1)(1993-2#1)(2008-8#1)
to the batch##2##3##(2008-10#1)(2008-11#1)
to the beet##2##3##(2008-10#1)(2008-12#1)
to the beginning of the##2##5##(1994-5#1)(2008-11#1)
to the behavior observed##2##4##(2008-10#1)(2008-7#1)
to the behavior##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
to the benefit of##4##4##(2008-10#1)(2008-11#2)(2011-1#1)
to the best of our knowledge##3##6##(2008-1#1)(2008-6#1)(2013-1#1)
to the best##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
to the binding##6##3##(1995-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-2#1)
to the binuclear##2##3##(1995-2#1)(1997-7#1)
to the biological##6##3##(2008-10#3)(2008-4#1)(2010-12#1)(2012-3#1)
to the bladder##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
to the blood##2##3##(2008-11#1)(2008-7#1)
to the body##4##3##(1995-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
to the bone##2##3##(2008-9#1)(2013-8#1)
to the bottom##4##3##(2008-11#1)(2008-4#1)(2008-9#2)
to the brain##4##3##(1997-4#1)(2007-12#1)(2008-7#1)(2013-1#1)
to the breast##2##3##(1993-2#1)(2011-2#1)
to the broad##2##3##(2008-12#1)(2012-2#1)
to the buffer solution##2##4##(1994-3#1)(2008-8#1)
to the buffer##5##3##(1991-5#1)(1994-3#2)(2008-10#1)(2008-8#1)
to the bulk##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
to the cDNA##2##3##(1993-8#2)
to the calibration##2##3##(2008-10#2)
to the cancer##2##3##(1990-5#1)(2008-7#1)
to the carbohydrate##2##3##(1996-5#1)(2008-11#1)
to the carbon paste##2##4##(2008-10#2)
to the carbon##3##3##(1991-3#1)(2008-10#2)
to the cardiologists##2##3##(2008-11#1)(2011-2#1)
to the care of older people##2##6##(2010-10#2)
to the care of##3##4##(2008-11#1)(2010-10#2)
to the care##7##3##(1992-2#1)(1994-12#1)(2008-11#1)(2010-10#2)(2013-1#2)
to the carrier##2##3##(2008-10#2)
to the case of##2##4##(2008-2#1)(2008-3#1)
to the case##4##3##(2008-2#1)(2008-3#2)(2008-8#1)
to the catalytic site of the##2##6##(1994-5#2)
to the catalytic site##3##4##(1994-5#2)(2009-7#1)
to the catalytic##9##3##(1992-3#1)(1992-6#1)(1994-5#2)(1995-2#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-2#1)
to the category##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
to the cell body##2##4##(2008-7#2)
to the cell membrane##5##4##(1990-2#1)(1993-12#1)(1997-1#1)(2008-11#1)(2008-9#1)
to the cell surface of Colo201 cells##2##7##(2008-11#2)
to the cell surface##7##4##(1990-5#1)(1997-1#1)(2008-11#3)(2008-2#1)(2008-7#1)
to the cell##20##3##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1993-12#1)(1997-1#2)(2008-11#5)(2008-2#1)(2008-7#4)(2008-9#1)(2012-3#1)(2013-1#1)
to the cells##9##3##(1991-9#1)(1992-8#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-11#3)(2008-6#1)
to the cellular##2##3##(1994-11#1)(1994-2#1)
to the central or peripheral nervous system##2##7##(2008-7#1)(2010-7#1)
to the central or##3##4##(1994-12#1)(2008-7#1)(2010-7#1)
to the central##9##3##(1990-3#1)(1991-11#2)(1992-6#1)(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)
to the centromeric region of chromosome##2##6##(1996-8#1)(2008-10#1)
to the cerebral##2##3##(2008-11#1)(2008-7#1)
to the cervical spinal cord##2##5##(2010-5#2)
to the challenges##2##3##(1996-1#1)(1996-2#1)
to the change##3##3##(1990-8#1)(2008-3#1)(2009-12#1)
to the changes in the##2##5##(2008-10#1)(2008-5#1)
to the changes in##4##4##(1992-3#1)(2008-10#2)(2008-5#1)
to the changes##6##3##(1992-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)
to the characteristic##3##3##(1990-11#1)(2008-5#1)(2010-10#1)
to the characteristics of the##3##5##(1996-9#1)(2008-10#1)(2009-7#1)
to the characterization of##3##4##(1991-2#1)(2008-10#1)(2011-1#1)
to the chemical##8##3##(2008-10#5)(2008-5#1)(2010-1#1)(2012-2#1)
to the chemotherapy##3##3##(1991-8#1)(2008-11#1)(2008-8#1)
to the child##11##3##(1993-3#1)(1997-8#1)(2006-5#5)(2008-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
to the children##2##3##(1990-11#1)(2008-3#1)
to the children's##2##3##(1991-2#1)(2011-2#1)
to the choice of##6##4##(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
to the chromatographic##3##3##(2008-10#3)
to the chronic##2##3##(1992-2#1)(1996-12#1)
to the circular muscle of the guinea-pig##2##7##(1997-4#2)
to the circular muscle of##3##5##(1997-4#3)
to the circulation##2##3##(1993-6#1)(2009-10#1)
to the citizens##2##3##(2009-3#1)(2012-3#1)
to the class of##3##4##(1995-12#1)(2008-11#1)(2009-12#1)
to the classic##2##3##(2009-1#1)(2011-2#1)
to the classical##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2009-8#1)
to the classification of##3##4##(1990-3#1)(2008-10#1)(2010-12#1)
to the classification##5##3##(1990-3#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
to the cleavage furrow##3##4##(2009-8#3)
to the cleavage of##2##4##(1995-6#1)(2008-10#1)
to the cleavage##5##3##(1995-6#1)(2008-10#1)(2009-8#3)
to the client with hypertension##2##5##(2012-3#2)
to the climate##2##3##(2012-5#1)(2012-9#1)
to the clinic##5##3##(1996-6#1)(2008-11#2)(2010-8#1)(2011-7#1)
to the clinical##14##3##(1990-5#1)(1991-6#1)(1992-1#1)(1996-11#1)(1997-4#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)
to the clinician##4##3##(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
to the cognitive##2##3##(2008-11#1)(2010-10#1)
to the cohort##2##3##(2008-6#1)(2008-8#1)
to the collection##2##3##(2008-10#2)
to the column##3##3##(1992-6#1)(2008-10#2)
to the combination of##3##4##(1990-2#1)(2008-10#1)(2010-7#1)
to the combination##4##3##(1990-2#1)(1995-5#1)(2008-10#1)(2010-7#1)
to the combined##3##3##(2008-10#2)(2008-11#1)
to the common##8##3##(1990-9#1)(1992-12#1)(2008-10#5)(2010-11#1)
to the community##5##3##(1995-1#1)(1996-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
to the complete##3##3##(2008-10#2)(2008-7#1)
to the complex##8##3##(2008-10#3)(2008-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-2#1)
to the complexity of the##4##5##(1997-3#1)(2008-10#2)(2011-2#1)
to the complexity of##5##4##(1997-3#1)(2008-10#2)(2009-8#1)(2011-2#1)
to the complexity##6##3##(1997-3#1)(2008-10#2)(2009-8#1)(2011-2#2)
to the compression##2##3##(1993-3#1)(2013-8#1)
to the computer##2##3##(2008-10#2)
to the concave side of##2##5##(2012-2#2)
to the concentration of formaldehyde##2##5##(2008-10#2)
to the concentration of nucleic acids in the range##2##9##(2008-10#2)
to the concentration of nucleic acids##3##6##(2008-10#3)
to the concentration of the##5##5##(2008-10#4)(2010-3#1)
to the concentration of vanadium##2##5##(2008-10#2)
to the concentration of##52##4##(1990-8#1)(1994-8#1)(2008-10#48)(2008-12#1)(2010-3#1)
to the concentration##58##3##(1990-8#1)(1994-8#1)(2008-10#53)(2008-12#1)(2008-5#1)(2010-3#1)
to the concentrations of##2##4##(2008-10#2)
to the concentrations##3##3##(2008-10#2)(2008-11#1)
to the concept of##3##4##(1996-1#1)(2008-9#1)(2010-8#1)
to the concept##4##3##(1996-1#1)(2008-7#1)(2008-9#1)(2010-8#1)
to the conclusion that the##4##5##(1992-9#1)(2008-10#2)(2008-3#1)
to the conclusion that##10##4##(1990-6#1)(1992-3#1)(1992-5#1)(1992-9#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-12#1)
to the conclusion##11##3##(1990-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-12#1)
to the configuration##2##3##(2008-10#1)(2008-8#1)
to the consensus##3##3##(1991-5#1)(1996-6#1)(2008-10#1)
to the conserved region##2##4##(1992-6#1)(2008-8#1)
to the conserved##4##3##(1992-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
to the consumer##2##3##(2008-5#2)
to the contamination of##2##4##(1994-3#1)(2008-10#1)
to the contamination##4##3##(1994-3#1)(2008-10#2)(2012-2#1)
to the content of##4##4##(1993-6#1)(2008-10#2)(2008-11#1)
to the contrary##3##3##(1991-6#1)(1993-6#1)(1995-2#1)
to the contribution##2##3##(2008-3#1)(2010-4#1)
to the control group##8##4##(1991-12#1)(1994-8#1)(2008-10#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
to the control level##3##4##(2008-11#1)(2008-6#2)
to the control of##5##4##(1992-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2013-8#1)
to the control##34##3##(1991-12#1)(1991-6#1)(1992-12#1)(1994-11#2)(1994-8#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#2)(2008-6#2)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-6#2)(2013-8#2)
to the controls##3##3##(1992-12#1)(1994-5#1)(2008-8#1)
to the conventional technique##2##4##(2011-2#1)(2011-7#1)
to the conventional##15##3##(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-4#1)(2011-2#1)(2011-7#1)(2013-1#2)
to the core##2##3##(2008-5#1)(2008-8#1)
to the coronary##5##3##(2008-10#1)(2008-3#1)(2012-3#1)(2013-2#2)
to the correct##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
to the corresponding##16##3##(1991-6#1)(1995-2#1)(1996-5#3)(1996-6#1)(2008-10#4)(2008-8#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
to the cortical##3##3##(1990-9#2)(2008-7#1)
to the cost of##2##4##(1995-6#1)(2008-10#1)
to the cost##3##3##(1995-6#1)(2008-10#1)(2013-1#1)
to the craniocervical junction##4##4##(2011-2#4)
to the creation of##5##4##(1991-3#1)(1992-1#1)(1997-1#1)(1997-3#1)(2010-1#1)
to the critical##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)
to the culture media##2##4##(2008-11#2)
to the culture medium##14##4##(1991-5#1)(1995-12#1)(2008-11#8)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)
to the culture of##2##4##(2008-11#1)(2008-9#1)
to the culture##26##3##(1991-5#1)(1995-12#1)(2008-11#17)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)
to the current nursing##2##4##(1991-2#1)(2008-12#1)
to the current##13##3##(1991-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
to the cytoplasm##3##3##(1995-12#1)(1995-2#1)(2011-2#1)
to the cytoplasmic##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
to the cytosolic##3##3##(1996-2#1)(1996-3#1)(2007-12#1)
to the damaged##2##3##(1990-11#1)(2009-6#1)
to the data obtained##2##4##(2008-10#1)(2011-1#1)
to the data##7##3##(2007-12#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#1)
to the debate##3##3##(1993-12#1)(1996-8#1)(2008-6#1)
to the decrease##3##3##(2008-10#2)(2008-8#1)
to the degree of##15##4##(1991-1#1)(1991-7#1)(1993-3#1)(1993-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2009-5#1)(2010-11#1)
to the delay##2##3##(1991-2#1)(2012-12#1)
to the deleterious effects of##2##5##(2008-1#1)(2008-4#1)
to the delivery##2##3##(1994-1#1)(1994-3#1)
to the density of the##2##5##(2008-10#1)(2008-3#1)
to the department##4##3##(1990-12#1)(1997-4#1)(2008-11#1)(2013-1#1)
to the deposition of##2##4##(2008-10#1)(2008-7#1)
to the descending##2##3##(2008-11#1)(2011-2#1)
to the design and##2##4##(2008-12#1)(2010-9#1)
to the design of the##2##5##(2008-11#1)(2008-5#1)
to the design of##8##4##(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)
to the design##11##3##(1996-1#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
to the desired##4##3##(1993-2#1)(1997-4#1)(2008-10#1)(2010-4#1)
to the detection of low##2##5##(2008-10#1)(2008-5#1)
to the detection of##10##4##(1996-12#1)(2008-10#7)(2008-2#1)(2008-5#1)
to the detection##13##3##(1996-12#1)(2008-10#10)(2008-2#1)(2008-5#1)
to the detector##5##3##(2008-10#5)
to the determination of Captopril##3##5##(2008-10#3)
to the determination of Cr(III) and Cr(VI) in##2##8##(2008-10#2)
to the determination of Cr(III) and##3##6##(2008-10#3)
to the determination of Fe and##2##6##(2008-10#1)(2013-8#1)
to the determination of Pb and Zn in tapwater and human hair##2##12##(2008-10#2)
to the determination of Se(IV)##2##5##(2008-10#2)
to the determination of ammonia in##2##6##(2008-10#2)
to the determination of ammonium##2##5##(2008-10#2)
to the determination of benzoyl peroxide in wheat flour##2##9##(2008-10#2)
to the determination of chromium in##4##6##(2008-10#4)
to the determination of chromium##5##5##(2008-10#5)
to the determination of dopamine in##2##6##(2008-10#2)
to the determination of glucose in##3##6##(2008-10#3)
to the determination of iron in##4##6##(2008-10#4)
to the determination of iron##5##5##(2008-10#5)
to the determination of manganese in##2##6##(2008-10#2)
to the determination of nitrite in##4##6##(2008-10#4)
to the determination of palladium in##2##6##(2008-10#2)
to the determination of perchlorate in##2##6##(2008-10#2)
to the determination of sodium##2##5##(2008-10#2)
to the determination of sulfide in##3##6##(2008-10#3)
to the determination of the##19##5##(2008-10#18)(2009-8#1)
to the determination of these compounds in##5##7##(2008-10#5)
to the determination of these##16##5##(2008-10#16)
to the determination of trace amount of##4##7##(2008-10#4)
to the determination of trace amounts of##6##7##(2008-10#6)
to the determination of trace##26##5##(2008-10#26)
to the determination of vanadium in##6##6##(2008-10#6)
to the determination of zinc##2##5##(2008-10#2)
to the determination of##350##4##(1994-8#1)(2008-10#344)(2008-3#1)(2008-5#1)(2009-8#1)(2012-4#1)(2013-8#1)
to the determination##358##3##(1994-8#1)(2008-10#352)(2008-3#1)(2008-5#1)(2009-8#1)(2012-4#1)(2013-8#1)
to the development and maintenance of##2##6##(2008-12#1)(2008-4#1)
to the development and##9##4##(1992-12#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#1)
to the development of a##12##5##(1995-1#1)(1996-1#1)(2008-10#6)(2008-4#1)(2011-2#2)(2012-12#1)
to the development of insulin resistance##2##6##(2008-9#1)(2012-5#1)
to the development of new strategies##2##6##(2010-5#1)(2011-10#1)
to the development of new##4##5##(2010-12#1)(2010-5#1)(2011-1#1)(2011-10#1)
to the development of resistance##2##5##(1994-8#1)(2011-3#1)
to the development of restrictive lung function##2##7##(1991-12#2)
to the development of specific##2##5##(1994-1#1)(2008-10#1)
to the development of the##4##5##(2008-10#1)(2008-12#1)(2008-3#2)
to the development of this##3##5##(1995-9#1)(1997-8#1)(2008-5#1)
to the development of##78##4##(1991-12#2)(1992-1#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-8#2)(2008-1#2)(2008-10#11)(2008-11#9)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-4#1)(2012-5#1)
to the development##88##3##(1991-12#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-8#2)(2008-1#2)(2008-10#14)(2008-11#10)(2008-12#8)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-4#1)(2012-5#1)
to the diagnosis and##2##4##(1992-5#1)(2011-2#1)
to the diagnosis of##4##4##(1996-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
to the diagnosis##6##3##(1992-5#1)(1996-3#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
to the diagnosis-related##2##3##(1991-3#1)(1993-1#1)
to the diagnostic##2##3##(1996-1#1)(2013-1#1)
to the diaphragm and##2##4##(1990-2#1)(2010-9#1)
to the diet##3##3##(1991-2#1)(1991-6#1)(1994-8#1)
to the difference in the##2##5##(2008-10#1)(2008-9#1)
to the difference in##6##4##(2008-10#1)(2008-7#2)(2008-9#1)(2012-2#1)(2012-3#1)
to the difference##9##3##(1990-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#2)(2012-2#1)(2012-3#1)
to the differences in the##2##5##(2008-10#1)(2009-11#1)
to the differences##3##3##(2008-10#1)(2009-11#1)(2010-8#1)
to the different##11##3##(1997-6#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-7#3)(2008-9#1)(2009-10#1)(2013-8#1)
to the differential diagnosis of##2##5##(1992-2#1)(2011-2#1)
to the differential diagnosis##3##4##(1992-2#1)(2011-2#2)
to the differentiation##3##3##(1996-3#1)(2008-10#2)
to the difficulty##2##3##(2008-10#1)(2008-11#1)
to the diffusion of##2##4##(1993-8#1)(2012-2#1)
to the dimethyl sulfonium ion##2##5##(1994-8#2)
to the direct##19##3##(1991-5#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
to the disabled##2##3##(1997-2#1)(2009-6#1)
to the discovery of the##4##5##(2008-11#1)(2010-7#1)(2011-3#1)(2013-8#1)
to the discovery of##6##4##(1995-8#1)(2008-11#1)(2010-12#1)(2010-7#1)(2011-3#1)(2013-8#1)
to the discovery##7##3##(1995-8#1)(2008-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-3#1)(2013-8#1)
to the discussion##2##3##(2011-2#2)
to the disease##9##3##(2008-10#7)(2008-12#1)(2008-7#1)
to the dish##2##3##(2008-11#2)
to the disorder##4##3##(1991-12#1)(2008-10#1)(2010-11#1)(2012-2#1)
to the distal##3##3##(2008-8#1)(2009-4#1)(2013-1#1)
to the distance between##2##4##(2008-10#2)
to the distinct##2##3##(1994-2#1)(2008-10#1)
to the distribution##4##3##(1991-6#1)(1992-9#1)(1997-2#1)(2008-5#1)
to the diverse##3##3##(2008-10#1)(2010-5#1)(2011-3#1)
to the diversity of##4##4##(2008-10#3)(2009-5#1)
to the diversity##5##3##(2008-10#4)(2009-5#1)
to the donor##2##3##(2008-10#1)(2011-3#1)
to the dopamine##3##3##(1995-11#1)(1996-12#1)(1996-2#1)
to the dorsal##6##3##(1993-6#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-5#1)
to the dose of##2##4##(1992-12#1)(2013-1#1)
to the dose##4##3##(1992-12#1)(1993-6#1)(2009-8#1)(2013-1#1)
to the double layer of iridophores in the##2##8##(2008-5#2)
to the double##3##3##(2008-10#1)(2008-5#2)
to the double-stranded##2##3##(2008-10#2)
to the downstream##2##3##(1994-2#1)(1997-3#1)
to the draw direction##2##4##(2010-4#2)
to the drug##3##3##(2008-10#2)(2008-5#1)
to the duration of the##2##5##(2008-10#1)(2011-2#1)
to the duration of##4##4##(2008-10#3)(2011-2#1)
to the dye##2##3##(2008-10#2)
to the dynamic##2##3##(2008-10#2)
to the dynamics of##3##4##(1996-1#1)(2008-3#1)(2008-8#1)
to the early stages of##2##5##(2008-11#1)(2008-7#1)
to the early##11##3##(1994-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-3#1)
to the ecological##2##3##(2008-10#2)
to the editor##17##3##(1996-9#1)(1997-3#1)(2008-11#3)(2008-12#8)(2008-9#2)(2010-2#1)(2011-2#1)
to the education of##2##4##(2008-11#1)(2008-12#1)
to the education##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
to the effect of##9##4##(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-10#1)
to the effective##2##3##(2008-10#1)(2009-4#1)
to the effects of a##2##5##(2008-10#1)(2012-3#1)
to the effects of##9##4##(1990-6#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-9#1)(2012-2#1)(2012-3#2)
to the effects##10##3##(1990-6#1)(1994-2#1)(1994-3#1)(1997-7#1)(2008-10#2)(2008-9#1)(2012-2#1)(2012-3#2)
to the efficiency##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
to the efficient##3##3##(2008-10#3)
to the egg##2##3##(2008-6#1)(2008-9#1)
to the ejection##2##3##(1990-9#2)
to the elderly##4##3##(1991-3#1)(1994-1#2)(2008-5#1)
to the electrochemical##3##3##(2008-10#3)
to the electrode surface##3##4##(2008-10#3)
to the electrode##4##3##(1995-6#1)(2008-10#3)
to the electrostatic##3##3##(2008-10#3)
to the elements of##2##4##(1994-3#2)
to the elements##3##3##(1994-3#2)(2008-10#1)
to the elevation##2##3##(2008-10#1)(2009-7#1)
to the elimination of##2##4##(1990-11#1)(1996-3#1)
to the elucidation of##2##4##(1997-8#1)(2008-5#1)
to the embryo##2##3##(2008-10#1)(2008-11#1)
to the emergence of drug-resistant##2##5##(2011-3#1)(2013-1#1)
to the emergence of##6##4##(2008-11#1)(2009-12#1)(2011-3#1)(2013-1#2)(2013-8#1)
to the emergency department with##3##5##(2009-9#1)(2011-2#1)(2013-1#1)
to the emergency department##9##4##(2008-11#1)(2008-3#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
to the emergency room##4##4##(2007-12#2)(2010-12#1)(2013-1#1)
to the emergency##15##3##(1993-2#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
to the emerging##2##3##(2008-11#1)(2009-8#1)
to the emission##5##3##(2008-10#4)(2010-7#1)
to the empirical##2##3##(1996-2#1)(2013-1#1)
to the end of the study##2##6##(2008-9#2)
to the end of the##5##5##(1993-9#1)(2008-5#1)(2008-9#2)(2011-2#1)
to the end of##8##4##(1993-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-1#1)
to the end##9##3##(1993-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-2#1)(2013-1#1)
to the endogenous##2##3##(2008-11#1)(2008-7#1)
to the endoplasmic reticulum##7##4##(1994-12#2)(1997-7#1)(2008-11#3)(2009-7#1)
to the energy transfer##4##4##(2008-10#2)(2008-8#2)
to the energy##7##3##(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)
to the enhanced##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
to the enhancement of##5##4##(1990-6#1)(2008-10#2)(2008-11#1)(2008-9#1)
to the entire##5##3##(1991-3#1)(2008-11#1)(2008-6#1)(2011-2#2)
to the environment and##2##4##(2008-10#1)(2008-5#1)
to the environment##8##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#3)
to the environmental##4##3##(1991-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
to the enzyme##15##3##(1991-3#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-6#1)(2008-10#8)(2008-7#1)(2009-8#1)
to the enzyme-substrate##2##3##(1990-9#1)(1994-5#1)
to the epidemic##2##3##(1995-12#1)(2008-10#1)
to the epidermis and##4##4##(2008-10#4)
to the epidermis##5##3##(2008-10#4)(2008-5#1)
to the epithelium##2##3##(2011-1#1)(2013-1#1)
to the equilibrium##2##3##(2008-10#2)
to the eradication##2##3##(2008-11#1)(2012-12#1)
to the establishment of the##3##5##(1991-6#1)(1994-5#1)(1996-9#1)
to the establishment of##7##4##(1991-6#1)(1994-5#1)(1996-9#1)(2008-1#1)(2008-11#3)
to the establishment##8##3##(1991-6#1)(1994-5#1)(1996-9#1)(2008-1#1)(2008-11#3)(2011-2#1)
to the estrogen receptor##3##4##(2008-11#3)
to the estrogen##5##3##(1992-6#1)(2008-11#4)
to the evaluation and##2##4##(2006-5#1)(2009-3#1)
to the evaluation of the##2##5##(1996-12#1)(2013-1#1)
to the evaluation of##5##4##(1991-12#1)(1996-12#1)(2008-10#2)(2013-1#1)
to the evaluation##8##3##(1991-12#1)(1996-12#1)(2006-5#1)(2008-10#2)(2008-12#1)(2009-3#1)(2013-1#1)
to the evolution of new traits##2##6##(2010-4#2)
to the evolution of##11##4##(2008-8#5)(2010-4#2)(2012-3#1)(2013-1#2)(2013-8#1)
to the exclusion of##3##4##(1995-11#1)(2008-10#1)(2008-9#1)
to the existence of##6##4##(2007-12#2)(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#1)
to the existing##7##3##(1994-1#1)(1996-1#2)(1996-11#1)(2008-10#1)(2008-8#1)(2011-1#1)
to the expected##10##3##(1991-12#1)(1991-6#1)(1992-11#1)(1993-8#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
to the experience of##2##4##(1993-6#1)(2008-12#1)
to the experimental##5##3##(1995-3#1)(2008-11#1)(2008-2#1)(2008-3#2)
to the exponential##2##3##(2008-6#1)(2011-2#1)
to the exposure##3##3##(1991-12#1)(1995-6#1)(2011-2#1)
to the expression of##9##4##(1992-6#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
to the expression##11##3##(1992-6#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
to the extensive##2##3##(2012-2#1)(2012-3#1)
to the extent of##4##4##(2008-10#3)(2008-11#1)
to the extent##6##3##(1997-5#1)(2008-10#4)(2008-11#1)
to the external##8##3##(1991-5#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
to the extracellular matrix##2##4##(1997-3#1)(2011-1#1)
to the extracellular##5##3##(1991-6#1)(1993-8#1)(1997-3#1)(2009-9#1)(2011-1#1)
to the extraction of##3##4##(2008-10#3)
to the extraction##13##3##(2008-10#13)
to the fabrication of##2##4##(2008-3#1)(2009-3#1)
to the face##2##3##(1996-2#1)(2008-5#1)
to the facial##2##3##(1992-4#1)(2008-9#1)
to the facilitation of##2##4##(2008-11#2)
to the fact that a##2##5##(1990-11#1)(2008-3#1)
to the fact that it is##2##6##(1994-9#1)(2008-10#1)
to the fact that the##5##5##(1990-8#1)(1992-3#1)(2008-11#2)(2012-3#1)
to the fact that they##2##5##(2012-2#1)(2012-3#1)
to the fact that##20##4##(1990-11#1)(1990-8#1)(1992-3#1)(1994-9#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#2)
to the fact##21##3##(1990-11#1)(1990-8#1)(1992-3#1)(1994-9#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#2)
to the factors##2##3##(2008-10#1)(2011-1#1)
to the facts that##2##4##(2008-10#1)(2010-7#1)
to the families##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
to the family of##4##4##(1993-6#1)(1995-6#1)(2007-12#1)(2009-7#1)
to the family##13##3##(1993-6#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
to the features##2##3##(1993-12#1)(2008-7#1)
to the female##4##3##(1990-8#1)(2007-12#1)(2008-10#1)(2009-10#1)
to the fiber##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
to the field of##2##4##(1992-3#1)(2008-10#1)
to the field##7##3##(1992-3#1)(1996-2#2)(2008-10#2)(2008-12#1)(2010-1#1)
to the fight##2##3##(1993-12#1)(2008-10#1)
to the final diagnosis of##2##5##(2008-5#1)(2010-6#1)
to the final##6##3##(1994-3#1)(1996-5#1)(1997-8#1)(2008-5#1)(2008-7#1)(2010-6#1)
to the finding##4##3##(1994-8#1)(2010-12#1)(2010-7#1)(2012-2#1)
to the findings of##2##4##(2008-10#1)(2008-11#1)
to the first coding exon##2##5##(1990-8#2)
to the first##14##3##(1990-12#1)(1990-8#2)(1994-11#1)(1994-6#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
to the five##2##3##(2008-10#1)(2008-11#1)
to the flexor##2##3##(2008-9#2)
to the floor##2##3##(1995-6#1)(2008-7#1)
to the flow cell##3##4##(2008-10#3)
to the flow of##2##4##(2008-10#1)(2008-11#1)
to the flow##8##3##(2008-10#7)(2008-11#1)
to the flow-injection determination of##2##5##(2008-10#2)
to the foliage##2##3##(2008-10#2)
to the following##7##3##(1993-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-6#1)
to the food##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
to the forefront##2##3##(1994-1#1)(1997-8#1)
to the foreign##2##3##(1990-3#1)(2011-2#1)
to the formal##2##3##(1995-2#1)(2010-7#1)
to the formation and##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
to the formation of a##5##5##(2008-10#3)(2008-11#1)(2008-7#1)
to the formation of the##7##5##(1992-12#1)(1996-5#1)(1997-8#1)(2008-10#3)(2009-8#1)
to the formation of##40##4##(1992-12#1)(1994-2#1)(1996-5#2)(1997-1#1)(1997-8#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#2)
to the formation##44##3##(1992-12#1)(1994-2#1)(1996-5#2)(1997-1#1)(1997-8#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-2#1)
to the former##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
to the formulation of##2##4##(2010-1#1)(2011-3#1)
to the four categories of the QOL-ACE##2##7##(1994-12#2)
to the four##6##3##(1992-3#1)(1994-12#2)(2008-10#3)
to the fourth##2##3##(2008-10#1)(2012-2#1)
to the fragment##2##3##(1997-6#1)(2008-2#1)
to the framework##3##3##(1997-6#1)(2008-4#2)
to the free##2##3##(2008-10#1)(2010-7#1)
to the frequency of##3##4##(1994-6#1)(2008-10#2)
to the frequency##5##3##(1994-6#1)(2008-10#3)(2008-3#1)
to the fruit##4##3##(2008-10#4)
to the full##7##3##(1995-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)
to the full-length##3##3##(1993-8#1)(2008-10#1)(2008-7#1)
to the function of the##3##5##(2008-4#1)(2008-7#1)(2012-3#1)
to the function of##6##4##(1996-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2012-3#1)
to the functional role of##2##5##(1994-8#1)(2011-2#1)
to the functional##3##3##(1993-12#1)(1994-8#1)(2011-2#1)
to the fungal##3##3##(2008-10#3)
to the fungicide metalaxyl##2##4##(2008-10#2)
to the fungicide##5##3##(2008-10#5)
to the fungicides##8##3##(2008-10#8)
to the fungus##3##3##(2008-10#2)(2011-10#1)
to the further##2##3##(2008-9#1)(2010-10#1)
to the future development of##2##5##(2008-11#1)(2011-2#1)
to the future##8##3##(1991-1#1)(1991-12#1)(1994-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
to the gas phase##2##4##(2008-10#2)
to the gas##4##3##(1995-11#1)(1996-12#1)(2008-10#2)
to the gastric##2##3##(2009-8#1)(2011-2#1)
to the gastrointestinal##2##3##(1997-3#1)(2013-1#1)
to the gene encoding##2##4##(1991-12#1)(1991-6#1)
to the gene##6##3##(1991-12#1)(1991-6#1)(2008-10#1)(2008-9#1)(2011-2#2)
to the genera##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
to the general population##3##4##(1997-3#1)(2008-11#1)(2012-12#1)
to the general##7##3##(1992-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2012-12#1)
to the generation of##7##4##(1993-6#1)(1995-9#1)(1997-8#1)(1997-9#1)(2008-11#1)(2008-4#1)(2011-9#1)
to the generation##8##3##(1993-6#1)(1995-9#1)(1997-8#1)(1997-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-9#1)
to the genes of##2##4##(1995-12#1)(2008-8#1)
to the genes##3##3##(1995-12#1)(1996-6#1)(2008-8#1)
to the genetic diversity##2##4##(2008-10#2)
to the genetic regression##2##4##(2008-9#2)
to the genetic structure of##2##5##(2008-10#2)
to the genetic##9##3##(1997-2#1)(2008-10#4)(2008-12#1)(2008-9#2)(2012-3#1)
to the genus Tospovirus##2##4##(2008-10#2)
to the genus##7##3##(2008-10#6)(2011-2#1)
to the geographic##2##3##(1991-12#1)(2008-10#1)
to the geometric##2##3##(2008-10#1)(2008-3#1)
to the geometry of##2##4##(1990-5#1)(2008-10#1)
to the glandular##2##3##(1997-1#1)(2007-12#1)
to the glass##3##3##(2008-10#2)(2008-3#1)
to the glassy carbon electrode##3##5##(2008-10#3)
to the global##4##3##(1991-12#1)(2008-10#1)(2008-8#1)(2010-4#1)
to the glucose##5##3##(2008-10#5)
to the graft##2##3##(1996-2#1)(2010-3#1)
to the greater##3##3##(1994-5#1)(2008-10#2)
to the ground##2##3##(2008-10#1)(2008-3#1)
to the group of##3##4##(1991-9#1)(2008-10#2)
to the growing number of##2##5##(1991-1#1)(2009-10#1)
to the growing##8##3##(1991-1#1)(1997-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-5#1)(2013-1#1)
to the growth of##3##4##(2008-10#1)(2008-9#1)(2009-10#1)
to the growth##9##3##(1992-4#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)
to the guidance of the##2##5##(2009-3#1)(2009-8#1)
to the hand##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
to the head##2##3##(1995-11#1)(2012-2#1)
to the headspace##2##3##(2008-10#2)
to the health care##5##4##(1991-2#1)(1993-12#2)(2008-11#1)(2011-1#1)
to the health of##2##4##(1991-1#1)(2013-8#1)
to the health services##2##4##(1996-11#2)
to the health##12##3##(1991-1#1)(1991-2#1)(1993-12#2)(1996-11#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2011-1#1)(2013-8#1)
to the healthcare##2##3##(2008-11#1)(2013-1#1)
to the healthy##2##3##(2008-11#1)(2010-12#1)
to the heart##3##3##(1993-1#1)(1994-2#1)(2008-12#1)
to the heme iron##2##4##(1991-9#1)(1994-5#1)
to the heme##5##3##(1990-8#1)(1991-9#1)(1994-5#3)
to the heterologous##3##3##(1993-8#1)(2008-10#2)
to the high sensitivity of this##2##6##(2008-10#1)(2013-8#1)
to the high sensitivity of##3##5##(2008-10#2)(2013-8#1)
to the high##27##3##(1990-5#1)(1990-9#1)(1992-5#1)(1993-6#1)(1994-8#1)(1996-5#1)(2008-10#13)(2008-7#2)(2009-9#2)(2010-5#1)(2012-3#2)(2013-8#1)
to the higher##10##3##(1994-2#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
to the highest##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
to the highly##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
to the hippocampus##3##3##(2008-11#1)(2013-8#2)
to the historical##4##3##(1996-3#1)(2008-10#1)(2008-4#1)(2009-10#1)
to the home##2##3##(1990-11#1)(1991-1#1)
to the homologous##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
to the hospital and##2##4##(2011-2#2)
to the hospital with a##2##5##(2012-12#1)(2013-1#1)
to the hospital with##3##4##(2008-12#1)(2012-12#1)(2013-1#1)
to the hospital##21##3##(1990-9#1)(1991-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-6#1)(1995-2#1)(1996-5#1)(2008-12#1)(2009-10#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to the host##8##3##(1993-6#1)(2008-10#4)(2008-9#2)(2009-8#1)
to the human hsp27##2##4##(1993-6#2)
to the human##16##3##(1991-6#1)(1991-9#1)(1992-6#1)(1993-6#2)(1993-8#1)(1996-6#1)(1997-9#1)(2008-10#1)(2008-11#2)(2009-10#1)(2009-5#1)(2011-2#2)(2013-1#1)
to the hydrophobic##2##3##(2008-10#2)
to the hypothesis that##6##4##(1991-12#1)(1991-6#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-8#1)
to the hypothetical##2##3##(1996-6#1)(2008-9#1)
to the idea that##2##4##(1992-3#1)(2012-12#1)
to the ideal##3##3##(1995-6#1)(2008-8#1)(2009-5#1)
to the identification of the##3##5##(2008-10#2)(2008-11#1)
to the identification of##10##4##(1991-9#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-4#1)(2011-2#1)
to the identification##11##3##(1991-9#1)(2008-10#2)(2008-11#4)(2008-7#2)(2009-4#1)(2011-2#1)
to the image of##2##4##(2008-12#2)
to the image##3##3##(2008-12#3)
to the immediate##2##3##(1994-12#1)(2008-11#1)
to the impact of##2##4##(2007-12#1)(2008-2#1)
to the impact##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
to the implementation of the##2##5##(1994-3#1)(2008-10#1)
to the implementation of##4##4##(1994-3#1)(2008-10#1)(2010-10#1)(2011-2#1)
to the importance of##6##4##(1992-3#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-9#1)
to the improved##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
to the improvement##3##3##(1991-6#1)(2008-10#1)(2008-9#1)
to the in situ##2##4##(2008-10#1)(2008-3#1)
to the in vivo##3##4##(1991-1#1)(1997-1#1)(2008-10#1)
to the in##6##3##(1991-1#1)(1997-1#1)(2008-10#3)(2008-3#1)
to the incidence of##3##4##(1995-12#1)(2008-10#1)(2008-8#1)
to the incidence##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
to the inclusion##3##3##(2008-10#2)(2009-8#1)
to the increase in##7##4##(1992-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)
to the increase of##5##4##(2008-10#3)(2009-3#1)(2010-12#1)
to the increase##13##3##(1992-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2009-3#1)(2010-12#1)(2012-2#1)
to the increased##15##3##(1991-12#1)(1991-3#1)(1994-11#1)(1994-5#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#2)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
to the increasing##6##3##(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
to the index##2##3##(2008-3#1)(2008-9#1)
to the individual##6##3##(1994-1#1)(1995-12#1)(2008-12#1)(2010-1#1)(2010-6#1)(2013-8#1)
to the induction of##4##4##(1994-6#1)(1994-8#1)(2008-10#2)
to the inductively coupled plasma-mass##2##5##(2008-10#2)
to the infant##3##3##(1995-3#1)(1995-6#1)(2006-5#1)
to the infection##3##3##(2008-10#3)
to the inferior##4##3##(1994-3#1)(1995-5#1)(2008-10#1)(2011-2#1)
to the inflammatory##2##3##(2008-1#1)(2012-12#1)
to the influence of the##2##5##(2008-10#1)(2008-9#1)
to the influence of##5##4##(1990-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-9#1)
to the influence##6##3##(1990-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-9#1)
to the information##2##3##(1996-3#1)(2012-12#1)
to the inherent##2##3##(2008-10#1)(2008-12#1)
to the inhibition of the##3##5##(1992-9#1)(1993-8#1)(2008-9#1)
to the inhibition of ubiquitin-proteasome pathway##3##6##(2008-9#3)
to the inhibition of##16##4##(1990-5#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-9#4)(2010-3#1)
to the inhibition##17##3##(1990-5#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-9#5)(2010-3#1)
to the inhibitory effect of##2##5##(2008-10#1)(2008-7#1)
to the inhibitory##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2013-7#1)
to the initial clinical##2##4##(2008-7#1)(2010-12#1)
to the initial##10##3##(1995-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)
to the initiation and##2##4##(1993-3#1)(1997-4#1)
to the initiation##3##3##(1993-3#1)(1993-6#1)(1997-4#1)
to the injection##2##3##(1997-3#1)(2008-1#1)
to the inner membrane##2##4##(1991-10#1)(1992-7#1)
to the inner##8##3##(1991-10#2)(1992-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
to the inoculated##2##3##(2008-10#2)
to the inoculation##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
to the input variables##2##4##(2008-10#2)
to the input##6##3##(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)
to the insensitivity##2##3##(2008-10#1)(2008-7#1)
to the inside##2##3##(2008-12#1)(2009-8#1)
to the instrument##2##3##(2008-10#1)(2008-3#1)
to the intact##2##3##(1997-8#1)(2008-10#1)
to the integrated##2##3##(1997-7#1)(2012-3#1)
to the intensity of##3##4##(1996-1#1)(1997-3#1)(2008-2#1)
to the intensity##4##3##(1996-1#1)(1997-3#1)(2008-10#1)(2008-2#1)
to the interaction between##2##4##(2008-10#1)(2008-8#1)
to the interaction of##3##4##(2008-10#2)(2009-7#1)
to the interaction##7##3##(1994-5#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-7#1)
to the intercellular##2##3##(2008-10#2)
to the interference##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
to the interferences##2##3##(2008-10#2)
to the internal##6##3##(1991-3#1)(2008-10#1)(2009-12#1)(2011-2#2)(2013-1#1)
to the interpretation of##2##4##(2008-10#2)
to the intervention##5##3##(2008-12#2)(2008-8#1)(2011-1#1)(2013-1#1)
to the intrinsic##2##3##(2008-10#2)
to the introduction of##2##4##(1991-12#1)(2008-12#1)
to the introduction##3##3##(1991-12#1)(2008-12#2)
to the inverse##2##3##(2008-5#1)(2008-8#1)
to the investigation of##5##4##(1991-12#1)(1991-2#1)(2008-10#3)
to the involvement of##2##4##(2008-11#2)
to the ion##2##3##(2008-10#2)
to the ionic##2##3##(2008-10#2)
to the ionization##2##3##(2008-10#2)
to the ionophore##2##3##(2008-10#2)
to the ischemic##2##3##(1996-12#1)(1997-2#1)
to the isolates##2##3##(2008-10#2)
to the isolation##2##3##(2008-10#1)(2008-11#1)
to the joint##2##3##(2008-9#1)(2009-11#1)
to the journal##2##3##(1996-9#1)(2008-11#1)
to the junctional##2##3##(1990-2#1)(1996-12#1)
to the kinetics of##2##4##(2008-10#2)
to the knowledge of the##2##5##(1993-11#1)(2013-8#1)
to the knowledge of##3##4##(1990-5#1)(1993-11#1)(2013-8#1)
to the known##2##3##(2008-11#1)(2012-2#1)
to the laboratory##6##3##(2008-10#2)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)
to the lack of a##2##5##(1991-10#1)(2008-10#1)
to the lack of adequate##2##5##(2008-10#1)(2008-9#1)
to the lack of proper##2##5##(2008-10#1)(2011-2#1)
to the lack of the##2##5##(2010-5#1)(2011-2#1)
to the lack of##28##4##(1991-10#1)(1995-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-5#1)(2011-2#5)(2012-12#1)(2013-1#1)
to the large difference##2##4##(1994-6#1)(2008-11#1)
to the large##7##3##(1994-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-8#1)(2012-2#1)
to the largest##2##3##(2009-7#1)(2013-8#1)
to the laser##2##3##(2008-2#1)(2008-9#1)
to the last##3##3##(1991-8#1)(1992-12#1)(1992-6#1)
to the lateral##2##3##(2007-12#1)(2012-3#1)
to the latter##3##3##(2008-10#1)(2012-2#1)(2012-6#1)
to the law##2##3##(1996-5#1)(1997-8#1)
to the leaf surface##2##4##(1994-11#1)(2008-10#1)
to the leaf##5##3##(1994-11#1)(2008-10#4)
to the left##12##3##(1993-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-12#1)
to the length and##2##4##(2008-9#1)(2010-7#1)
to the length of the##2##5##(2008-10#1)(2008-9#1)
to the length of##3##4##(1990-8#1)(2008-10#1)(2008-9#1)
to the length##7##3##(1990-8#1)(2008-10#3)(2008-9#2)(2010-7#1)
to the lesion##5##3##(1993-3#1)(1996-2#2)(1997-3#1)(1997-6#1)
to the less##3##3##(1995-11#1)(2008-4#1)(2009-12#1)
to the level of##9##4##(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
to the level##15##3##(1993-8#2)(1996-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
to the levels of##3##4##(1997-8#1)(2008-10#1)(2011-2#1)
to the levels##6##3##(1997-8#1)(2008-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
to the limited##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
to the linear##3##3##(2008-10#2)(2008-2#1)
to the lines of the grating##2##6##(2008-3#2)
to the lines##3##3##(2008-3#3)
to the link between##2##4##(2012-2#1)(2013-1#1)
to the lipid##4##3##(1990-5#1)(1993-8#1)(1994-5#1)(2008-5#1)
to the liposomal surface##2##4##(2008-10#2)
to the liposomal##3##3##(2008-10#3)
to the liquid##3##3##(1992-9#1)(2008-10#2)
to the list of##4##4##(1995-12#1)(2008-10#1)(2008-11#1)(2009-1#1)
to the list##5##3##(1991-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-1#1)
to the literature values##2##4##(2008-10#2)
to the literature##9##3##(1996-6#1)(1997-4#1)(2008-10#3)(2008-11#3)(2010-9#1)
to the liver##7##3##(1993-3#1)(1994-2#1)(1997-4#1)(2008-6#1)(2010-5#1)(2012-2#2)
to the living##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
to the local##6##3##(1993-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)
to the location of the##2##5##(2008-10#1)(2008-11#1)
to the location of##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
to the location##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
to the logarithm of the##2##5##(2008-10#2)
to the logarithm of##4##4##(2008-10#3)(2009-7#1)
to the long##5##3##(1991-3#1)(1992-1#1)(1995-2#1)(2008-9#1)(2009-10#1)
to the long-term##3##3##(2008-10#1)(2010-3#1)(2012-3#1)
to the loss of##4##4##(1993-3#1)(1997-7#1)(2008-5#1)(2011-2#1)
to the low oral##2##4##(2008-8#2)
to the low##16##3##(1991-9#1)(1995-2#1)(1997-2#1)(2008-10#7)(2008-12#1)(2008-8#3)(2011-2#1)(2013-1#1)
to the lower##7##3##(1991-3#1)(1992-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
to the lowest##4##3##(2008-10#3)(2008-8#1)
to the lung##8##3##(1992-2#2)(1996-3#1)(1997-1#1)(2008-10#3)(2013-8#1)
to the lungs and##2##4##(1994-5#1)(1997-1#1)
to the lungs##5##3##(1994-5#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-5#1)
to the lytic##2##3##(2008-10#1)(2008-11#1)
to the mRNA##3##3##(1996-12#2)(2011-2#1)
to the magnitude of the##3##5##(1990-5#1)(2008-10#1)(2013-8#1)
to the magnitude of##7##4##(1990-11#1)(1990-5#1)(1990-8#1)(2008-10#2)(2010-5#1)(2013-8#1)
to the main##6##3##(1991-9#1)(1994-6#1)(2008-10#3)(2008-11#1)
to the maintenance of##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
to the major##6##3##(1990-12#1)(1992-4#1)(1995-8#1)(1997-9#1)(2008-10#1)(2008-2#1)
to the mammalian##2##3##(2008-4#1)(2010-12#1)
to the management of##11##4##(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-6#1)(2010-12#1)(2010-6#1)
to the mannose##2##3##(1995-6#1)(2008-10#1)
to the manual##2##3##(2008-10#2)
to the many##4##3##(1993-3#1)(2008-7#1)(2008-9#1)(2010-7#1)
to the market##2##3##(1997-1#1)(2008-10#1)
to the marketplace##2##3##(1994-1#1)(2008-11#1)
to the mass of##2##4##(1990-8#1)(1996-3#1)
to the mass##3##3##(1990-8#1)(1996-3#1)(2008-6#1)
to the matrix effect##2##4##(2008-10#2)
to the matrix##6##3##(2008-10#6)
to the maximum of##2##4##(1996-5#1)(2008-10#1)
to the maximum##8##3##(1994-5#1)(1996-5#1)(2008-10#5)(2011-2#1)
to the mean##5##3##(2008-10#3)(2011-2#1)(2013-8#1)
to the measured##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
to the measurement of##6##4##(2008-10#4)(2008-2#1)(2009-7#1)
to the measurement##8##3##(2008-10#4)(2008-2#1)(2009-7#1)(2010-3#1)(2012-3#1)
to the media##4##3##(2008-11#3)(2008-3#1)
to the medial##7##3##(1997-3#1)(2008-11#1)(2008-9#2)(2009-1#1)(2009-2#1)(2011-2#1)
to the median##2##3##(1997-5#1)(2008-10#1)
to the medical care system##2##5##(1995-12#2)
to the medical##5##3##(1992-3#1)(1995-12#2)(2008-9#1)(2012-2#1)
to the medication##3##3##(1995-2#1)(2008-11#2)
to the medium containing##2##4##(1997-8#1)(2008-5#1)
to the medium##11##3##(1991-2#1)(1993-3#2)(1993-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)
to the membrane plane##2##4##(1993-8#1)(2008-10#1)
to the membrane##14##3##(1990-5#1)(1992-12#1)(1993-8#5)(1996-3#1)(2008-10#2)(2008-7#2)(2008-8#1)(2013-8#1)
to the mental health##3##4##(2008-11#3)
to the metal cations##2##4##(2008-10#2)
to the metal##7##3##(2008-10#7)
to the metastatic##2##3##(1990-8#1)(1991-3#1)
to the method of##3##4##(1997-7#1)(2008-10#2)
to the method##7##3##(1997-7#1)(2008-10#5)(2013-1#1)
to the methodology##2##3##(2008-10#1)(2008-11#1)
to the microchip##2##3##(2008-10#2)
to the mitochondria and##2##4##(2008-11#1)(2011-2#1)
to the mitochondria##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
to the mitochondrial##3##3##(1995-6#1)(1997-2#1)(2009-8#1)
to the mobile phase##2##4##(2008-10#2)
to the model##4##3##(2008-12#1)(2008-7#1)(2012-3#2)
to the modified##3##3##(1990-8#1)(2008-10#1)(2010-10#1)
to the molecular basis of##2##5##(1993-3#1)(2011-1#1)
to the molecular structure of##2##5##(2008-10#1)(2012-2#1)
to the molecular##9##3##(1992-2#1)(1993-3#1)(2008-10#3)(2011-1#1)(2012-2#3)
to the monitoring of##6##4##(1992-3#1)(2008-10#5)
to the monoclonal antibody##2##4##(1990-12#1)(2008-10#1)
to the monomer##2##3##(2008-10#1)(2008-11#1)
to the more##6##3##(2008-10#3)(2008-4#1)(2011-2#1)(2013-8#1)
to the morphological and##2##4##(1992-6#1)(2012-9#1)
to the morphological##4##3##(1992-6#1)(2008-10#1)(2009-8#1)(2012-9#1)
to the mortality##2##3##(2008-8#1)(2008-9#1)
to the most recent##2##4##(2010-7#1)(2011-3#1)
to the most##15##3##(1992-12#1)(1993-8#1)(1996-2#1)(1996-3#1)(2008-10#5)(2008-8#1)(2008-9#2)(2010-2#1)(2010-7#1)(2011-3#1)
to the mouse##4##3##(1994-5#1)(1997-9#1)(2008-4#1)(2012-3#1)
to the much##4##3##(1994-1#1)(2008-10#2)(2013-7#1)
to the multiple##2##3##(2008-7#1)(2011-1#1)
to the mutant##3##3##(2008-10#1)(2008-8#2)
to the mutation##2##3##(1990-12#1)(2008-10#1)
to the native##5##3##(1990-11#1)(1997-4#1)(2008-10#2)(2010-5#1)
to the natural##2##3##(1996-3#1)(2012-3#1)
to the nature and##2##4##(1994-3#1)(2012-2#1)
to the nature of the##5##5##(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)
to the nature of##7##4##(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
to the nature##9##3##(1994-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the nearest##4##3##(1992-12#1)(2008-10#2)(2008-6#1)
to the nebulizer##2##3##(2008-10#2)
to the neck##2##3##(1992-6#1)(2008-10#1)
to the need for a##2##5##(2008-12#1)(2011-2#1)
to the need for##9##4##(1994-2#1)(1995-5#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
to the need to##4##4##(1997-2#1)(2007-12#1)(2008-3#1)(2009-8#1)
to the need##14##3##(1994-2#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-8#2)(2011-2#1)(2012-12#2)(2012-2#1)
to the needs of the##2##5##(1995-1#1)(1996-3#1)
to the needs of##5##4##(1994-1#1)(1995-1#2)(1996-2#1)(1996-3#1)
to the needs##6##3##(1994-1#1)(1995-1#2)(1996-2#1)(1996-3#1)(2008-7#1)
to the negative element##2##4##(2008-11#2)
to the negative##9##3##(1990-6#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-11#4)(2009-8#1)
to the nematode##2##3##(2008-10#2)
to the nematodes##2##3##(2008-10#1)(2008-12#1)
to the neuronal##3##3##(1991-12#2)(1996-12#1)
to the neutral##2##3##(2008-10#1)(2008-4#1)
to the new##11##3##(1991-1#1)(1991-3#1)(1994-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
to the next generation##2##4##(1997-8#1)(2008-8#1)
to the next##12##3##(1993-6#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2009-4#1)(2012-2#1)
to the nitrite##2##3##(2008-10#2)
to the nonlinear##2##3##(2007-11#1)(2008-3#1)
to the norm##2##3##(2008-11#2)
to the normal##13##3##(1991-7#1)(1994-9#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-9#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-3#1)
to the north##2##3##(2008-10#1)(2009-10#1)
to the novel##3##3##(2008-5#1)(2008-8#2)
to the nuclear envelope and##2##5##(2008-9#1)(2011-2#1)
to the nuclear envelope##3##4##(2008-9#1)(2011-2#2)
to the nuclear##5##3##(1995-6#1)(2008-7#1)(2008-9#1)(2011-2#2)
to the nucleotide##3##3##(2008-10#2)(2013-8#1)
to the nucleus and##2##4##(1995-8#1)(2008-7#1)
to the nucleus##7##3##(1990-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-6#1)(2008-7#1)
to the number of maxima in the ACE strategy##2##9##(2008-9#2)
to the number of##21##4##(1990-8#1)(1994-11#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-8#2)(2008-9#6)(2011-2#2)
to the number##22##3##(1990-8#1)(1994-11#1)(1997-6#1)(2008-10#6)(2008-11#3)(2008-8#2)(2008-9#6)(2011-2#2)
to the numbers##2##3##(2012-2#1)(2013-1#1)
to the nursing home##2##4##(1992-1#1)(2010-10#1)
to the nursing##3##3##(1992-1#1)(2008-11#1)(2010-10#1)
to the observed data##3##4##(2008-10#2)(2008-8#1)
to the observed##9##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)
to the occipital##2##3##(1996-9#1)(2008-7#1)
to the occurrence of##7##4##(2008-10#4)(2008-7#2)(2009-8#1)
to the odor of##2##4##(1994-8#1)(2009-8#1)
to the official##3##3##(1991-9#1)(2008-10#2)
to the old##2##3##(2008-8#1)(2012-3#1)
to the one##3##3##(1992-1#1)(2008-10#1)(2010-7#1)
to the ones##3##3##(2008-11#2)(2008-4#1)
to the ongoing##2##3##(2009-10#1)(2012-6#1)
to the onset and progression of##2##6##(1993-9#1)(2011-2#1)
to the onset of##8##4##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-2#1)
to the onset##10##3##(1993-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
to the operating room##2##4##(2010-12#1)(2012-3#1)
to the operating##3##3##(2008-7#1)(2010-12#1)(2012-3#1)
to the operation of the##2##5##(1995-12#1)(2007-12#1)
to the operative##3##3##(1996-1#1)(1997-8#1)(2008-10#1)
to the opposite##3##3##(1990-8#1)(1995-2#1)(2008-10#1)
to the optical##3##3##(2008-3#1)(2010-1#1)(2012-2#1)
to the optically pure##2##4##(1995-3#2)
to the optimization of##2##4##(2008-10#1)(2008-5#1)
to the optimization##3##3##(2008-10#1)(2008-5#1)(2009-2#1)
to the optimum##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
to the order##5##3##(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
to the ordinary##2##3##(1991-6#1)(2008-7#1)
to the organic##5##3##(2008-10#4)(2008-5#1)
to the organism##3##3##(2009-8#1)(2010-4#1)(2011-2#1)
to the organization##5##3##(1994-12#1)(1994-2#1)(1995-2#2)(2011-1#1)
to the original location##2##4##(2008-10#1)(2009-4#1)
to the original##12##3##(1990-2#2)(1995-5#1)(2008-10#5)(2008-11#2)(2009-4#1)(2013-1#1)
to the other two##2##4##(2008-10#2)
to the other##35##3##(1990-12#1)(1991-3#1)(1992-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(2008-10#18)(2008-11#4)(2008-5#3)(2008-7#1)(2009-11#1)(2009-8#1)(2010-2#1)
to the others##2##3##(2008-10#2)
to the outcome##2##3##(2008-10#1)(2013-1#1)
to the outer nuclear membrane##2##5##(2008-9#2)
to the outer##4##3##(1994-5#1)(2008-12#1)(2008-9#2)
to the outpatient##2##3##(1993-12#1)(2011-2#1)
to the outside of the##2##5##(2008-10#1)(2008-8#1)
to the outside##5##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)
to the ovary##3##3##(2008-1#1)(2008-12#1)(2013-8#1)
to the overall##18##3##(1990-3#1)(1991-5#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
to the overlying##2##3##(2008-10#1)(2009-1#1)
to the oxidation of##2##4##(2008-10#2)
to the oxidative##3##3##(1995-6#1)(1997-8#1)(2009-8#1)
to the oxidized##2##3##(1994-5#1)(2008-11#1)
to the paediatric##4##3##(1996-9#1)(2008-11#1)(2010-7#1)(2013-1#1)
to the pancreas##2##3##(2008-1#1)(2013-1#1)
to the pancreatic##2##3##(1994-12#1)(2008-11#1)
to the parent##2##3##(2008-10#1)(2008-11#1)
to the parental##4##3##(1991-12#1)(1993-3#1)(2008-10#1)(2011-1#1)
to the particular##5##3##(1995-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-10#1)
to the pathogen##12##3##(2008-10#10)(2008-8#1)(2012-3#1)
to the pathogenesis of##2##4##(2008-7#1)(2011-2#1)
to the pathogenesis##3##3##(1997-3#1)(2008-7#1)(2011-2#1)
to the pathological##2##3##(2008-1#1)(2008-6#1)
to the patient and##4##4##(1997-2#1)(2008-8#1)(2012-12#1)(2012-3#1)
to the patient##24##3##(1990-2#1)(1991-11#1)(1991-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-9#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)
to the patient's##14##3##(1990-5#1)(1991-2#1)(1994-5#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
to the patients##5##3##(1990-2#1)(1993-2#1)(1994-5#1)(2009-12#1)(2010-8#1)
to the patients'##2##3##(1990-2#1)(2013-1#1)
to the peak##4##3##(1994-5#1)(2008-8#1)(2008-9#2)
to the pelvis##2##3##(2008-8#2)
to the people##2##3##(1991-1#1)(2012-12#1)
to the peptide##5##3##(1990-8#2)(2008-4#3)
to the performance of##4##4##(1990-11#1)(2008-10#1)(2008-6#1)(2013-1#1)
to the peripheral parts of the##2##6##(1994-12#1)(1996-3#1)
to the peripheral##3##3##(1994-12#1)(1996-3#1)(2013-1#1)
to the periphery of the##2##5##(1997-8#1)(2008-7#1)
to the periphery of##3##4##(1997-8#1)(2008-7#1)(2008-8#1)
to the persistence of the##2##5##(2008-5#1)(2013-8#1)
to the persistence of##4##4##(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
to the persistence##5##3##(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
to the persistent##2##3##(2008-11#2)
to the pharmaceutical##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
to the phase##2##3##(2008-3#1)(2008-5#1)
to the phenomenon##2##3##(2008-10#1)(2009-10#1)
to the physical##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
to the physician##4##3##(1993-3#1)(1997-4#1)(2010-6#1)(2011-1#1)
to the physiological##2##3##(1990-11#1)(2010-10#1)
to the pituitary gland##2##4##(1993-9#1)(2012-3#1)
to the pituitary##3##3##(1993-9#1)(2012-3#1)(2013-1#1)
to the placement##2##3##(2008-11#1)(2008-12#1)
to the planned##2##3##(1992-9#2)
to the plant##4##3##(2008-11#1)(2008-8#1)(2009-8#1)(2011-10#1)
to the plants##3##3##(2008-10#2)(2011-2#1)
to the plasma membrane and##2##5##(1994-11#1)(1995-6#1)
to the plasma membrane through##2##5##(1996-3#1)(2009-7#1)
to the plasma membrane##8##4##(1990-12#1)(1994-11#2)(1995-6#2)(1996-3#1)(2008-11#1)(2009-7#1)
to the plasma##10##3##(1990-12#1)(1994-11#2)(1994-5#1)(1995-6#2)(1996-3#1)(2008-10#1)(2008-11#1)(2009-7#1)
to the point of##2##4##(2008-10#1)(2010-8#1)
to the point where##2##4##(1992-3#1)(1995-8#1)
to the point##4##3##(1992-3#1)(1995-8#1)(2008-10#1)(2010-8#1)
to the population##2##3##(2013-1#1)(2013-8#1)
to the porphyrin##2##3##(2008-10#2)
to the portion of the##2##5##(1997-9#1)(2009-1#1)
to the portion of##3##4##(1997-9#2)(2009-1#1)
to the position##2##3##(2008-3#1)(2009-10#1)
to the positive##3##3##(1990-9#1)(1997-7#1)(2008-11#1)
to the possibility of##3##4##(1996-12#1)(2008-7#1)(2012-3#1)
to the possibility that##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
to the possibility##8##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-3#1)
to the possible##3##3##(2008-10#2)(2008-7#1)
to the posterior##2##3##(2009-10#1)(2013-1#1)
to the potent##2##3##(2008-10#1)(2008-5#1)
to the potential of##3##4##(2008-10#2)(2012-12#1)
to the potential##7##3##(2008-10#6)(2012-12#1)
to the potting##2##3##(2008-10#2)
to the power##3##3##(2008-10#2)(2009-10#1)
to the practical##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
to the practice of##4##4##(2008-11#1)(2008-12#1)(2010-11#1)(2012-3#1)
to the practicing##2##3##(2011-2#1)(2013-1#1)
to the precipitation##2##3##(2008-10#1)(2012-2#1)
to the precise##2##3##(1994-1#1)(2008-11#1)
to the precision of##2##4##(2008-10#1)(2008-7#1)
to the preconcentration of##4##4##(2008-10#4)
to the preconcentration##7##3##(2008-10#7)
to the predicted##2##3##(2008-10#1)(2009-8#1)
to the preparation of##3##4##(1996-5#2)(2008-10#1)
to the presence of an##2##5##(1997-3#1)(2008-10#1)
to the presence of endogenous##2##5##(1996-12#1)(2010-11#1)
to the presence of other##2##5##(2008-10#2)
to the presence of the##2##5##(2008-10#1)(2011-2#1)
to the presence of##44##4##(1992-3#1)(1994-1#1)(1994-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#22)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
to the presence##47##3##(1992-3#1)(1994-1#1)(1994-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#24)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
to the present day##2##4##(2008-10#1)(2012-3#1)
to the present time##2##4##(1997-8#1)(2008-12#1)
to the present##9##3##(1990-5#1)(1997-8#1)(2008-10#2)(2008-12#2)(2008-7#1)(2011-2#1)(2012-3#1)
to the prevailing##4##3##(1992-3#2)(1996-9#1)(2011-9#1)
to the prevalence of##2##4##(1996-12#1)(2008-10#1)
to the prevalence##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
to the prevention of##3##4##(1991-1#1)(2008-7#1)(2009-10#1)
to the previous##4##3##(1997-7#1)(2008-11#1)(2008-5#2)
to the previously described##3##4##(2008-10#3)
to the previously identified##4##4##(1996-12#1)(1996-3#1)(2008-10#1)(2009-4#1)
to the previously reported##3##4##(1992-10#1)(2008-10#1)(2011-2#1)
to the previously##14##3##(1992-10#1)(1992-3#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#7)(2009-4#1)(2011-2#1)
to the primary tumour##2##4##(1997-3#1)(2011-2#1)
to the primary##12##3##(1990-4#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
to the principles of##2##4##(1994-2#1)(2008-9#1)
to the private##2##3##(2008-10#1)(2012-2#1)
to the probability that##2##4##(2008-8#1)(2008-9#1)
to the probability##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)
to the probe##2##3##(2008-2#1)(2008-9#1)
to the problem of##3##4##(1991-6#1)(2008-12#1)(2010-1#1)
to the problem##10##3##(1991-6#1)(1994-9#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2010-1#1)
to the problems##4##3##(1990-11#1)(1991-3#1)(2008-12#1)(2011-2#1)
to the procedure##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
to the process of##4##4##(1993-12#1)(1996-2#1)(2008-11#2)
to the process##10##3##(1993-12#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#3)(2012-2#2)
to the processes##3##3##(2008-10#2)(2010-5#1)
to the processing of##2##4##(1992-12#1)(1993-6#1)
to the procurement of vascular stents in interventional radiology##2##9##(2012-2#2)
to the production of the##2##5##(2008-10#2)
to the production of##10##4##(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)
to the production##11##3##(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-3#1)
to the progress##2##3##(2011-2#1)(2012-2#1)
to the progression of##2##4##(1993-12#1)(2009-7#1)
to the proliferation of##2##4##(2008-8#1)(2008-9#1)
to the proper##2##3##(1996-12#1)(2009-8#1)
to the properties of the##3##5##(1992-3#1)(2008-2#1)(2009-5#1)
to the properties of##4##4##(1992-3#1)(2008-11#1)(2008-2#1)(2009-5#1)
to the proposed##3##3##(2008-10#2)(2008-5#1)
to the prostate##2##3##(1990-9#1)(1993-8#1)
to the protease##2##3##(1992-6#1)(1993-8#1)
to the protection of##2##4##(2008-10#2)
to the protective##3##3##(1991-1#1)(1995-5#1)(1996-2#1)
to the protein therapeutic##2##4##(2008-10#1)(2008-11#1)
to the protein##10##3##(1990-5#1)(1991-2#1)(1991-9#1)(1994-8#1)(2008-10#2)(2008-11#2)(2009-8#1)(2012-2#1)
to the proteins##2##3##(2008-10#1)(2008-5#1)
to the provincial##2##3##(1991-1#1)(1997-5#1)
to the provision of##2##4##(1996-3#1)(2012-2#1)
to the psoas muscle##2##4##(2008-10#1)(2009-2#1)
to the psychological##2##3##(1994-12#1)(1996-1#1)
to the public##6##3##(1992-9#1)(1993-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
to the public's##2##3##(1995-12#1)(2010-7#1)
to the published##2##3##(2008-3#1)(2008-9#1)
to the pulmonary##3##3##(1992-3#1)(1997-1#1)(2011-2#1)
to the putative##4##3##(1993-2#1)(1994-5#1)(1995-2#1)(2008-10#1)
to the quadratic##2##3##(2008-10#1)(2008-3#1)
to the quality assurance##3##4##(2008-10#2)(2008-11#1)
to the quality control of##2##5##(2008-10#2)
to the quality of##2##4##(1995-11#1)(1996-2#1)
to the quality##7##3##(1995-11#1)(1996-2#1)(2008-10#4)(2008-11#1)
to the quantitation##3##3##(2008-10#3)
to the quantitative##3##3##(2008-10#2)(2009-10#1)
to the quartz##3##3##(2008-10#2)(2013-8#1)
to the question of the##2##5##(1996-3#1)(2008-9#1)
to the question of##4##4##(1993-2#1)(1996-3#1)(2008-9#1)(2011-2#1)
to the radiation##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-10#1)
to the range of##2##4##(1993-1#1)(2008-10#1)
to the range##3##3##(1991-5#1)(1993-1#1)(2008-10#1)
to the rank of species##4##5##(2008-10#4)
to the rank##5##3##(2008-10#5)
to the rapid##8##3##(1993-9#1)(1996-2#1)(2008-10#6)
to the rarity of this##2##5##(2010-12#1)(2011-2#1)
to the rarity of##3##4##(2010-12#1)(2011-2#1)(2013-1#1)
to the rat and##2##4##(1993-12#1)(1994-11#1)
to the rat##5##3##(1993-12#2)(1994-11#2)(1995-12#1)
to the rate of##2##4##(1991-12#1)(2008-10#1)
to the rates##2##3##(1992-12#2)
to the ratio of##2##4##(2008-10#2)
to the ratio##3##3##(2008-10#2)(2008-5#1)
to the rats in the##2##5##(2011-2#2)
to the reaction medium##2##4##(2008-10#1)(2008-7#1)
to the reaction##6##3##(1997-2#1)(2008-10#4)(2008-7#1)
to the reactive##2##3##(2008-10#1)(2013-1#1)
to the reagent##2##3##(2008-10#2)
to the reagents##2##3##(2008-10#2)
to the real##2##3##(2008-10#2)
to the realization of##2##4##(2008-11#1)(2008-7#1)
to the receiver##2##3##(2008-10#1)(2008-2#1)
to the recent##5##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-7#1)
to the recently reported##2##4##(1993-12#1)(2008-10#1)
to the recently##6##3##(1993-12#1)(1993-9#1)(2008-10#3)(2012-2#1)
to the receptor##5##3##(1992-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)
to the recognition##2##3##(2008-10#1)(2008-8#1)
to the recombinant##2##3##(1994-6#1)(1995-5#1)
to the recovery of##3##4##(2008-10#3)
to the recovery##6##3##(2008-10#6)
to the recruitment##2##3##(1996-2#1)(2012-2#1)
to the rectum##2##3##(2007-12#1)(2011-2#1)
to the redox##3##3##(2008-10#2)(2008-11#1)
to the reduction in##2##4##(1992-9#1)(2008-10#1)
to the reduction of the##4##5##(2008-10#4)
to the reduction of##15##4##(2008-10#11)(2008-3#1)(2012-3#1)(2013-8#2)
to the reduction##17##3##(1992-9#1)(2008-10#12)(2008-3#1)(2012-3#1)(2013-8#2)
to the reference##10##3##(2008-10#6)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
to the region of the##2##5##(1992-12#1)(1994-8#1)
to the region of##3##4##(1992-12#1)(1994-8#1)(2008-5#1)
to the region##4##3##(1992-12#1)(1994-8#1)(1996-6#1)(2008-5#1)
to the regulation of##3##4##(2010-8#1)(2011-2#2)
to the regulation##4##3##(1994-11#1)(2010-8#1)(2011-2#2)
to the regulatory##2##3##(2008-11#1)(2013-8#1)
to the relationship between##3##4##(1992-3#1)(1995-2#1)(2008-8#1)
to the relationship##5##3##(1992-3#1)(1995-2#1)(2008-10#1)(2008-8#2)
to the relationships##2##3##(2008-11#1)(2011-2#1)
to the relative##7##3##(2008-10#4)(2008-3#1)(2008-9#1)(2009-12#1)
to the relatively##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
to the release of##4##4##(1990-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
to the release##5##3##(1990-2#1)(1992-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
to the relevant##2##3##(1995-12#1)(2008-9#1)
to the remaining##4##3##(1997-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
to the renal##2##3##(2010-12#1)(2011-2#1)
to the requirements of##2##4##(2013-1#2)
to the requirements##3##3##(2008-10#1)(2013-1#2)
to the research##5##3##(2008-11#2)(2008-6#1)(2008-9#1)(2009-4#1)
to the reservoir##3##3##(1996-2#1)(2008-10#2)
to the resilience of##2##4##(2009-7#2)
to the resistance##4##3##(2008-10#4)
to the resistant##2##3##(2008-10#2)
to the resolution of##2##4##(2008-10#2)
to the respective##2##3##(2011-1#1)(2012-2#1)
to the respiratory tract##3##4##(1994-12#1)(1996-1#1)(1996-3#1)
to the respiratory##7##3##(1994-11#1)(1994-12#1)(1996-1#1)(1996-3#2)(2010-12#1)(2012-12#1)
to the response##3##3##(1994-2#1)(2008-10#2)
to the rest of##3##4##(1992-3#1)(1997-6#1)(2011-2#1)
to the rest##4##3##(1992-3#1)(1997-6#1)(2010-4#1)(2011-2#1)
to the resulting##2##3##(1995-3#1)(2013-8#1)
to the results obtained##2##4##(2008-10#1)(2008-11#1)
to the results of the##2##5##(1996-6#1)(2008-2#1)
to the results of##5##4##(1994-2#1)(1996-6#1)(2008-11#1)(2008-2#1)(2008-8#1)
to the results##18##3##(1990-6#1)(1990-9#1)(1994-2#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2013-1#2)
to the retina##2##3##(2008-7#1)(2013-1#1)
to the right##15##3##(1990-9#1)(1993-12#1)(1994-11#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2009-12#1)(2011-2#1)(2013-1#1)
to the rise in##2##4##(2008-11#2)
to the rise##3##3##(2008-11#3)
to the risk of##3##4##(1996-6#1)(2008-12#1)(2008-9#1)
to the risk##5##3##(1996-6#1)(1997-3#1)(2008-12#1)(2008-9#1)(2012-2#1)
to the role of##7##4##(1993-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)
to the role##8##3##(1993-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)
to the root##2##3##(2008-10#1)(2011-1#1)
to the roots##3##3##(2008-10#3)
to the routine##4##3##(1994-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
to the rural##2##3##(1991-1#1)(2008-3#1)
to the sacrum##2##3##(2008-8#1)(2013-8#1)
to the sagittal sinus##2##4##(2013-8#2)
to the salivary glands##2##4##(2008-10#2)
to the salivary##3##3##(2008-10#2)(2009-1#1)
to the same extent as##6##5##(1993-6#1)(2008-10#2)(2008-3#1)(2012-12#1)(2013-8#1)
to the same extent in##2##5##(2008-10#2)
to the same extent##9##4##(1991-8#1)(1993-6#1)(2008-10#4)(2008-3#1)(2012-12#1)(2013-8#1)
to the same hospital##2##4##(1991-2#1)(1991-3#1)
to the same region##4##4##(1993-8#2)(1994-11#1)(2008-10#1)
to the same selective##2##4##(2008-8#2)
to the same vision##2##4##(1996-1#2)
to the same##64##3##(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#3)(1996-1#2)(1997-6#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#4)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
to the sample in##2##4##(1991-2#1)(2008-10#1)
to the sample solution##4##4##(2008-10#4)
to the sample surface##2##4##(2008-10#1)(2012-2#1)
to the sample##14##3##(1991-2#1)(2008-10#11)(2012-2#2)
to the scale##2##3##(2008-11#1)(2008-9#1)
to the scalp##5##3##(2008-5#2)(2010-6#2)(2013-8#1)
to the search##3##3##(2008-10#2)(2008-9#1)
to the second##7##3##(1991-6#2)(1994-12#1)(2008-10#2)(2008-6#1)(2008-8#1)
to the secondary##2##3##(1993-6#1)(2008-10#1)
to the seed##4##3##(2008-10#3)(2008-8#1)
to the selection of##2##4##(2008-10#2)
to the selective##7##3##(1990-2#1)(2008-10#4)(2008-7#1)(2008-8#1)
to the sella##2##3##(1991-6#1)(2011-2#1)
to the sensing interface##2##4##(2008-10#2)
to the sensing##4##3##(2008-10#3)(2009-5#1)
to the sensitive##2##3##(2008-10#1)(2011-2#1)
to the sensitivity of##2##4##(1990-5#1)(2008-10#1)
to the sensitivity##6##3##(1990-12#1)(1990-5#1)(1995-11#1)(2008-10#3)
to the sensory##2##3##(2008-7#1)(2008-8#1)
to the separately##2##3##(1995-5#2)
to the separation and preconcentration of##2##6##(2008-10#2)
to the separation and##3##4##(2008-10#3)
to the separation of##5##4##(2008-10#4)(2008-11#1)
to the separation##8##3##(2008-10#7)(2008-11#1)
to the sequence of a##3##5##(1990-2#1)(1993-6#1)(1994-6#1)
to the sequence of##5##4##(1990-2#1)(1993-6#1)(1994-6#1)(2008-10#2)
to the sequence##8##3##(1990-2#1)(1993-6#1)(1994-6#1)(1996-8#1)(2006-6#1)(2008-10#2)(2008-12#1)
to the serum##2##3##(1991-3#1)(1995-12#1)
to the set of##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
to the severity of the##3##5##(2008-5#1)(2008-6#1)(2008-7#1)
to the severity of##5##4##(1992-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
to the severity##7##3##(1990-12#1)(1992-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
to the short arm of##4##5##(2008-10#4)
to the short##6##3##(1995-2#1)(2008-10#4)(2008-11#1)
to the shot##2##3##(1997-8#1)(2008-3#1)
to the side##4##3##(1992-12#1)(2008-6#1)(2013-1#2)
to the sight of objects##2##5##(1993-6#2)
to the sigma##2##3##(1995-2#1)(1995-6#1)
to the signal##4##3##(2008-10#1)(2008-3#2)(2010-7#1)
to the significance of##2##4##(1997-8#1)(2011-2#1)
to the significant##5##3##(1994-2#1)(2008-10#1)(2008-12#1)(2009-8#1)(2012-3#1)
to the silica##2##3##(2008-10#2)
to the similar##3##3##(1994-11#1)(2012-3#1)(2013-8#1)
to the simultaneous determination of##25##5##(2008-10#25)
to the simultaneous##35##3##(2008-10#33)(2008-5#1)(2013-1#1)
to the single##5##3##(2008-10#2)(2008-2#1)(2012-6#1)(2013-1#1)
to the site of infection##2##5##(1997-1#1)(2012-12#1)
to the site of the##2##5##(2013-1#2)
to the site of##7##4##(1994-9#1)(1997-1#1)(1997-7#1)(2008-5#1)(2012-12#1)(2013-1#2)
to the site##9##3##(1994-9#1)(1997-1#1)(1997-7#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
to the situation##2##3##(1991-5#1)(2008-11#1)
to the size of the##4##5##(1990-7#1)(1991-11#1)(1996-12#1)(2008-10#1)
to the size of##6##4##(1990-7#1)(1991-11#1)(1996-12#1)(1997-1#1)(2008-10#1)(2010-8#1)
to the size##9##3##(1990-7#1)(1991-11#1)(1993-2#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-3#1)(2010-8#1)
to the skin surface##4##4##(2008-10#1)(2008-5#3)
to the skin##18##3##(1991-11#1)(1991-6#1)(1996-1#1)(2008-10#1)(2008-5#10)(2010-5#1)(2010-6#2)(2013-8#1)
to the slow##2##3##(2008-10#2)
to the small##9##3##(2008-10#6)(2008-12#1)(2011-2#2)
to the social##3##3##(2008-11#1)(2009-7#1)(2011-2#1)
to the soil##4##3##(2008-10#3)(2008-11#1)
to the soils##2##3##(2008-10#2)
to the solid##2##3##(2008-10#1)(2008-11#1)
to the solution##11##3##(2008-10#8)(2009-10#1)(2011-2#1)(2011-3#1)
to the solutions##2##3##(2008-10#2)
to the solvent##2##3##(2008-10#1)(2013-1#1)
to the sound##2##3##(2008-10#1)(2008-2#1)
to the source##3##3##(1993-3#1)(2008-10#1)(2008-3#1)
to the south##3##3##(2008-10#2)(2008-11#1)
to the spatial##5##3##(1994-9#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
to the special##6##3##(1997-8#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
to the speciation analysis##2##4##(2008-10#2)
to the speciation of##8##4##(2008-10#8)
to the speciation##11##3##(2008-10#11)
to the species##4##3##(1994-3#1)(2008-8#1)(2009-10#1)(2011-2#1)
to the specific energy dissipation rate##4##6##(2008-7#4)
to the specific##12##3##(1995-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#4)(2009-8#1)(2011-2#1)(2012-2#1)
to the specificity##2##3##(2008-10#2)
to the spectrophotometric determination of##4##5##(2008-10#4)
to the spectrophotometric method##2##4##(2008-10#1)(2008-5#1)
to the spectrophotometric##7##3##(2008-10#6)(2008-5#1)
to the spectrum of##2##4##(2008-10#1)(2011-2#1)
to the spinal cord##3##4##(1996-5#2)(2008-7#1)
to the spinal##4##3##(1996-5#2)(2008-7#2)
to the spread of##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
to the square root of the##2##6##(2008-10#1)(2008-3#1)
to the square root of##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
to the square##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
to the stabilization##2##3##(1994-11#1)(2009-9#1)
to the stage of##4##4##(1995-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
to the standard##12##3##(1993-2#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-2#1)(2011-7#1)(2012-3#1)
to the standards##2##3##(1991-3#1)(2008-5#1)
to the start##2##3##(1992-8#1)(2008-10#1)
to the state##4##3##(1996-3#1)(1997-2#1)(2008-10#1)(2011-2#1)
to the stationary phase##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
to the stem##2##3##(2008-10#2)
to the stimulation of##2##4##(1994-11#1)(1994-8#1)
to the stimulation##3##3##(1994-11#1)(1994-2#1)(1994-8#1)
to the stomach##2##3##(1990-3#1)(1992-6#1)
to the storage##2##3##(2008-3#2)
to the stratum corneum##2##4##(2008-5#2)
to the strength of##5##4##(2008-3#1)(2008-8#3)(2010-10#1)
to the strength##6##3##(2008-10#1)(2008-3#1)(2008-8#3)(2010-10#1)
to the stress regimen##2##4##(2008-11#2)
to the stress##3##3##(2008-11#3)
to the strong##5##3##(1996-5#1)(2008-10#2)(2009-5#1)(2011-2#1)
to the structural organization of##2##5##(2009-8#1)(2010-8#1)
to the structural##6##3##(1995-8#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-8#1)
to the structure##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
to the students##2##3##(2008-11#1)(2013-8#1)
to the study of the##4##5##(2008-10#2)(2008-11#1)(2009-9#1)
to the study of##21##4##(1997-7#1)(2006-6#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)
to the study##24##3##(1997-5#1)(1997-7#1)(2006-6#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)
to the subsequent##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
to the substitution##3##3##(2008-10#2)(2011-1#1)
to the substrate and##3##4##(1994-6#1)(2008-7#1)(2012-2#1)
to the substrate##7##3##(1992-12#1)(1994-6#1)(2008-10#2)(2008-7#2)(2012-2#1)
to the success of any##2##5##(2008-11#2)
to the success of##12##4##(1991-8#1)(1994-12#1)(1996-3#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
to the successful##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
to the sum of##3##4##(2008-10#3)
to the superior##2##3##(1996-12#1)(2013-1#1)
to the suppression of##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
to the suppression##4##3##(1993-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
to the suprascapular nerve and##2##5##(2008-9#2)
to the surface of a##2##5##(2008-10#2)
to the surface of the##3##5##(1994-11#2)(2008-10#1)
to the surface of##9##4##(1994-11#2)(1995-2#1)(2008-10#5)(2008-5#1)
to the surface##16##3##(1991-3#1)(1994-11#2)(1995-2#1)(2008-10#5)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#1)
to the surfactant-rich phase##3##4##(2008-10#3)
to the surgery##3##3##(2008-5#1)(2008-7#1)(2011-3#1)
to the surgical##8##3##(1993-6#1)(1995-8#1)(1996-9#1)(2008-3#1)(2008-7#2)(2010-3#1)(2011-2#1)
to the surrounding##3##3##(1990-6#1)(1993-6#1)(2008-7#1)
to the survey##4##3##(1995-1#1)(2008-12#1)(2012-12#1)(2012-2#1)
to the survival and##2##4##(2008-10#1)(2012-12#1)
to the survival##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
to the susceptible##3##3##(2008-10#2)(2008-5#1)
to the synthesis of##4##4##(2008-11#1)(2009-10#1)(2009-12#1)(2011-2#1)
to the synthetic##2##3##(2008-10#1)(2008-11#1)
to the system using a multisyringe burette coupled with##2##9##(2008-10#2)
to the system##12##3##(1990-5#1)(1995-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)
to the target sequence##3##4##(2008-4#2)(2008-9#1)
to the target##16##3##(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
to the task of##2##4##(2008-10#1)(2013-1#1)
to the task##3##3##(1994-3#1)(2008-10#1)(2013-1#1)
to the taste panel test##2##5##(2008-10#2)
to the taste##3##3##(1991-3#1)(2008-10#2)
to the technique##2##3##(1997-3#2)
to the telencephalon##2##3##(1996-5#2)
to the temporal##2##3##(2012-12#1)(2012-2#1)
to the test##4##3##(2008-10#3)(2009-12#1)
to the testis##2##3##(2008-11#1)(2009-10#1)
to the theoretical##4##3##(2008-10#2)(2010-1#1)(2013-1#1)
to the theory of##2##4##(2008-10#1)(2008-11#1)
to the theory##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
to the therapeutic##2##3##(1993-2#1)(1996-11#1)
to the third##3##3##(2008-10#1)(2013-8#2)
to the thoracic spine##2##4##(2008-12#1)(2008-8#1)
to the thoracic##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
to the three##21##3##(1991-2#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)
to the time of##3##4##(2008-10#1)(2008-3#1)(2012-5#1)
to the time when the##2##5##(2008-10#2)
to the time when##3##4##(2008-10#3)
to the time##9##3##(1992-2#1)(2008-10#6)(2008-3#1)(2012-5#1)
to the tip of the##2##5##(2008-10#1)(2010-6#1)
to the tip of##3##4##(2008-10#2)(2010-6#1)
to the tissues##3##3##(1996-3#1)(2008-10#1)(2010-7#1)
to the top##2##3##(2008-4#1)(2010-11#1)
to the total number of##3##5##(1993-3#1)(2008-10#1)(2008-11#1)
to the total of##2##4##(2008-10#1)(2010-8#1)
to the total##28##3##(1990-5#1)(1991-12#2)(1991-3#1)(1993-3#1)(2006-6#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)
to the toxic##3##3##(1992-6#1)(2008-10#2)
to the toxin##7##3##(2008-10#7)
to the trace##2##3##(2008-10#1)(2008-3#1)
to the track##2##3##(2008-3#2)
to the traditional##12##3##(1996-1#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-3#1)
to the transcription start site##2##5##(1995-2#2)
to the transcription start##3##4##(1993-12#1)(1995-2#2)
to the transcription##4##3##(1993-12#1)(1995-2#2)(1995-6#1)
to the transcriptional##2##3##(1996-12#1)(2011-1#1)
to the transfer of##3##4##(1992-10#1)(2008-10#1)(2012-3#1)
to the transfer##5##3##(1992-10#1)(1997-6#1)(2008-10#2)(2012-3#1)
to the translation start##2##4##(1997-8#1)(2012-2#1)
to the transmembrane domain##2##4##(2008-11#1)(2009-10#1)
to the transmission of##3##4##(2008-10#1)(2008-11#1)(2010-1#1)
to the transmission##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2010-1#1)
to the treatment of##13##4##(1990-9#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1996-3#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)
to the treatment regimen##2##4##(1991-2#1)(1994-12#1)
to the treatment with##3##4##(1991-6#1)(2008-10#1)(2008-5#1)
to the treatment##26##3##(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-3#2)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#2)(2010-7#1)(2011-2#1)
to the treatments##3##3##(1995-8#1)(2008-10#1)(2012-9#1)
to the trivalent state##4##4##(2008-10#4)
to the tropics##2##3##(1995-12#1)(2011-2#1)
to the tumor##4##3##(1997-8#1)(2008-12#1)(2008-9#1)(2010-12#1)
to the two Mn ions##2##5##(2008-8#2)
to the two##14##3##(1991-5#1)(2008-10#8)(2008-2#1)(2008-8#2)(2008-9#1)(2011-2#1)
to the type of operation##2##5##(1990-3#2)
to the type of treatment##2##5##(1993-11#1)(1993-6#1)
to the type of##10##4##(1990-3#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-3#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
to the type##13##3##(1990-3#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
to the typical##2##3##(2010-6#1)(2011-2#1)
to the tyrosine##2##3##(1995-6#1)(1995-8#1)
to the underlying##4##3##(1991-2#1)(1996-1#1)(2008-10#1)(2008-5#1)
to the understanding of gene##3##5##(2008-7#1)(2010-10#1)(2012-3#1)
to the understanding of the##7##5##(1993-11#1)(1997-8#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
to the understanding of##16##4##(1991-12#1)(1993-11#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#2)
to the understanding##17##3##(1991-12#1)(1993-11#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#2)
to the unexposed##2##3##(2008-3#1)(2008-9#1)
to the unique##5##3##(1991-5#1)(1993-2#1)(2008-10#1)(2009-11#1)(2013-8#1)
to the uniqueness of##2##4##(2008-11#1)(2008-9#1)
to the upper##3##3##(1992-6#1)(2008-11#1)(2008-5#1)
to the upper-half of the face##2##6##(2010-1#2)
to the upregulation of##2##4##(2009-8#1)(2010-11#1)
to the urgency##2##3##(1996-1#1)(2008-10#1)
to the use of a##2##5##(2008-10#1)(2008-5#1)
to the use of the##2##5##(2008-10#1)(2008-12#1)
to the use of##28##4##(1990-2#1)(1994-12#1)(1994-8#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#2)
to the use##29##3##(1990-2#1)(1994-12#1)(1994-8#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#2)
to the user##2##3##(2008-10#1)(2008-4#1)
to the usual##4##3##(1997-8#1)(2008-10#2)(2008-3#1)
to the validity of##2##4##(2008-11#1)(2008-7#1)
to the value of##4##4##(1996-12#1)(2008-3#1)(2008-8#2)
to the value##7##3##(1992-3#1)(1995-11#1)(1996-12#1)(2008-3#1)(2008-8#2)(2011-1#1)
to the values obtained from##2##5##(1992-2#1)(2008-10#1)
to the values of the##2##5##(2008-10#2)
to the values##7##3##(1992-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
to the var##2##3##(2008-5#2)
to the variance##2##3##(2008-8#1)(2008-9#1)
to the variety##2##3##(1990-6#1)(1994-8#1)
to the various##5##3##(1990-5#1)(2008-10#3)(2013-1#1)
to the vascular tissues##2##4##(2008-10#2)
to the vascular##7##3##(1991-6#1)(1992-6#1)(2008-10#4)(2008-8#1)
to the vehicle##2##3##(2008-5#1)(2008-9#1)
to the ventral striatum##2##4##(1993-6#2)
to the ventral##3##3##(1993-6#2)(1997-7#1)
to the very##2##3##(1995-6#1)(2012-2#1)
to the view of##2##4##(2012-3#1)(2013-8#1)
to the view##3##3##(2012-3#1)(2013-8#2)
to the vinyl##2##3##(2008-10#2)
to the viral##3##3##(2008-10#2)(2008-9#1)
to the virus##8##3##(1993-8#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
to the visual##2##3##(1992-12#1)(2009-12#1)
to the voltammetric##2##3##(2008-10#2)
to the volume of##4##4##(1997-8#1)(2008-10#3)
to the wall##3##3##(1990-11#1)(2008-10#1)(2011-2#1)
to the water##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
to the waveguide##2##3##(2008-10#1)(2008-3#1)
to the wavelength##2##3##(2008-10#1)(2008-3#1)
to the weight of##2##4##(2008-10#1)(2009-1#1)
to the weight##3##3##(1996-3#1)(2008-10#1)(2009-1#1)
to the well##2##3##(1995-12#1)(2008-5#1)
to the well-known##5##3##(1995-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)
to the whole##3##3##(1993-12#1)(2008-10#2)
to the wide##5##3##(1991-2#1)(1991-3#1)(1996-12#1)(2008-10#1)(2008-9#1)
to the wild type##2##4##(2008-10#1)(2008-11#1)
to the wild-type##5##3##(1990-10#1)(1996-12#1)(2008-10#2)(2009-6#1)
to the wind##2##3##(2008-11#1)(2008-5#1)
to the work of##4##4##(2008-11#1)(2008-12#1)(2010-5#1)(2010-9#1)
to the workshop##2##3##(1992-5#1)(2008-10#1)
to the world of##2##4##(1995-3#1)(1995-5#1)
to the wound##2##3##(1991-6#1)(2008-10#1)
to the year 2018##2##4##(2008-11#2)
to the year##3##3##(2008-11#2)(2009-7#1)
to the yeast##3##3##(1991-6#1)(2008-10#1)(2010-1#1)
to the young##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
to the z axis##2##4##(2008-3#2)
to the zero##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
to the##8059##2##(1990-10#1)(1990-11#20)(1990-12#31)(1990-2#25)(1990-3#14)(1990-4#1)(1990-5#36)(1990-6#9)(1990-7#3)(1990-8#33)(1990-9#15)(1991-1#22)(1991-10#9)(1991-11#14)(1991-12#45)(1991-2#32)(1991-3#43)(1991-5#25)(1991-6#33)(1991-7#4)(1991-8#13)(1991-9#13)(1992-1#18)(1992-10#11)(1992-11#1)(1992-12#36)(1992-2#25)(1992-3#40)(1992-4#3)(1992-5#8)(1992-6#35)(1992-7#1)(1992-8#6)(1992-9#11)(1993-1#16)(1993-11#9)(1993-12#48)(1993-2#31)(1993-3#35)(1993-5#2)(1993-6#47)(1993-8#51)(1993-9#8)(1994-1#18)(1994-11#42)(1994-12#37)(1994-2#22)(1994-3#37)(1994-5#54)(1994-6#14)(1994-8#31)(1994-9#11)(1995-1#9)(1995-11#24)(1995-12#50)(1995-2#69)(1995-3#16)(1995-5#19)(1995-6#59)(1995-8#31)(1995-9#9)(1996-1#34)(1996-11#8)(1996-12#58)(1996-2#40)(1996-3#48)(1996-5#39)(1996-6#32)(1996-8#12)(1996-9#10)(1997-1#32)(1997-2#42)(1997-3#39)(1997-4#21)(1997-5#10)(1997-6#30)(1997-7#37)(1997-8#45)(1997-9#9)(2006-5#7)(2006-6#11)(2007-11#9)(2007-12#42)(2007-8#2)(2007-9#4)(2008-1#35)(2008-10#2665)(2008-11#519)(2008-12#138)(2008-2#47)(2008-3#188)(2008-4#63)(2008-5#192)(2008-6#47)(2008-7#200)(2008-8#195)(2008-9#199)(2009-1#15)(2009-10#53)(2009-11#6)(2009-12#26)(2009-2#6)(2009-3#13)(2009-4#13)(2009-5#13)(2009-6#20)(2009-7#36)(2009-8#69)(2009-9#12)(2010-1#25)(2010-10#29)(2010-11#18)(2010-12#34)(2010-2#8)(2010-3#7)(2010-4#23)(2010-5#33)(2010-6#21)(2010-7#33)(2010-8#37)(2010-9#7)(2011-1#44)(2011-10#5)(2011-2#274)(2011-3#23)(2011-7#4)(2011-9#2)(2012-12#51)(2012-2#145)(2012-3#125)(2012-4#2)(2012-5#5)(2012-6#5)(2012-7#1)(2012-9#4)(2013-1#167)(2013-2#2)(2013-7#6)(2013-8#93)
to their ability to##7##4##(1994-11#2)(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)(2013-7#1)
to their behavior##2##3##(1991-2#2)
to their children##5##3##(1990-2#1)(1995-1#1)(2010-10#2)(2012-12#1)
to their children's##3##3##(1994-3#1)(1995-1#2)
to their clinical##3##3##(1993-9#1)(2008-10#1)(2010-11#1)
to their complexity##2##3##(2008-10#1)(2011-2#1)
to their current##2##3##(2008-12#1)(2009-1#1)
to their death##2##3##(2008-10#2)
to their determination##14##3##(2008-10#14)
to their different##2##3##(2008-10#1)(2008-8#1)
to their effect on##2##4##(2008-10#1)(2008-5#1)
to their effectiveness##3##3##(2008-5#1)(2008-7#1)(2010-1#1)
to their effects on##2##4##(1993-6#2)
to their effects##3##3##(1993-6#2)(2008-10#1)
to their environment##3##3##(1996-12#2)(2009-6#1)
to their excellent##2##3##(1997-8#1)(2009-7#1)
to their financial##2##3##(2010-10#2)
to their high##6##3##(2008-10#4)(2013-1#1)(2013-7#1)
to their host##2##3##(2008-10#1)(2008-9#1)
to their incorporation##2##3##(2008-10#2)
to their jobs##2##3##(1995-3#1)(1996-1#1)
to their learning##2##3##(2008-11#2)
to their natural##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
to their need##2##3##(1992-3#1)(2010-2#1)
to their normal##3##3##(2008-10#1)(2008-7#1)(2010-7#1)
to their original##2##3##(2008-10#2)
to their own##4##3##(1993-1#1)(2008-11#1)(2008-4#1)(2009-7#1)
to their patients##7##3##(1990-2#1)(1991-6#1)(1992-12#1)(1994-1#2)(2008-11#1)(2012-3#1)
to their primary##2##3##(1995-2#1)(2013-1#1)
to their relationship with##2##4##(1994-8#1)(2008-10#1)
to their respective##8##3##(2008-10#6)(2008-7#1)(2010-5#1)
to their response##2##3##(2008-10#1)(2013-1#1)
to their role in##3##4##(2008-10#1)(2008-7#2)
to their specific##2##3##(2008-10#1)(2008-11#1)
to their unique##2##3##(1993-3#1)(2012-2#1)
to their use##3##3##(2008-11#2)(2011-1#1)
to their##376##2##(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#4)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#7)(1995-12#4)(1995-2#4)(1995-3#2)(1996-1#2)(1996-12#3)(1996-2#4)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(1997-8#1)(2006-5#1)(2007-12#1)(2008-10#114)(2008-11#29)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#14)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#16)(2011-9#1)(2012-12#3)(2012-2#10)(2012-3#9)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#2)
to them and##2##3##(2008-12#1)(2008-8#1)
to them##27##2##(1990-12#1)(1992-12#2)(1992-3#1)(1993-11#1)(1995-1#1)(1995-9#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#3)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
to themselves##4##2##(1990-6#1)(1991-12#1)(2008-11#1)(2010-10#1)
to theoretical##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
to therapeutic##6##2##(1992-3#1)(1993-1#1)(1993-11#1)(2008-11#2)(2012-2#1)
to therapists##2##2##(2012-2#2)
to therapy in##4##3##(1993-11#3)(2011-2#1)
to therapy##22##2##(1991-2#2)(1993-11#3)(1995-12#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-11#4)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to thermal##4##2##(2008-11#1)(2008-3#2)(2012-2#1)
to thermographic results##3##3##(1993-11#3)
to these agents##2##3##(2008-11#2)
to these and other##2##4##(1992-12#1)(2013-1#1)
to these cells##2##3##(1993-8#1)(1995-2#1)
to these compounds##4##3##(1990-7#1)(1991-6#1)(2008-10#2)
to these concerns##2##3##(1994-12#1)(2013-1#1)
to these functions##2##3##(2008-11#1)(2013-8#1)
to these patients##2##3##(1994-3#1)(2010-7#1)
to these signals##2##3##(1995-12#1)(2008-9#1)
to these species##2##3##(2008-10#1)(2008-8#1)
to these tests##2##3##(2008-10#1)(2008-12#1)
to these two##6##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)
to these variables##2##3##(2008-8#1)(2013-8#1)
to these##120##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#2)(1995-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#31)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#3)(2008-9#4)(2009-1#2)(2009-10#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
to thin##2##2##(1995-2#1)(1997-6#1)
to think about##5##3##(2009-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2013-8#1)
to think##8##2##(1995-3#1)(1996-11#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
to thiocyanate##2##2##(2008-10#2)
to thiophanate-methy1 and##3##3##(2008-10#3)
to thiophanate-methy1##4##2##(2008-10#4)
to thiophanate-methyl but##2##3##(2008-10#2)
to thiophanate-methyl##4##2##(2008-10#4)
to third##3##2##(2008-10#2)(2012-2#1)
to this effect##2##3##(1991-1#1)(1991-3#1)
to this end##2##3##(2008-1#1)(2008-10#1)
to this model##2##3##(2008-3#1)(2008-5#1)
to this new##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
to this pathogen##2##3##(2008-10#2)
to this phenomenon##2##3##(1995-11#1)(2008-8#1)
to this population##2##3##(2008-9#1)(2009-5#1)
to this problem##3##3##(1994-9#1)(1997-3#1)(2010-11#1)
to this procedure##2##3##(1994-3#1)(2008-10#1)
to this question##2##3##(1994-3#1)(2013-1#1)
to this region##5##3##(1996-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
to this system##2##3##(2008-10#1)(2008-8#1)
to this theory##2##3##(2008-10#1)(2008-6#1)
to this toxin##2##3##(2008-10#2)
to this type of##3##4##(1996-3#1)(2008-10#2)
to this##162##2##(1990-11#3)(1990-5#3)(1991-1#1)(1991-12#1)(1991-3#3)(1992-1#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#5)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#40)(2008-11#14)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#5)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-10#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#2)
to thoracic##2##2##(2012-3#2)
to those achieved by the##2##5##(1993-6#1)(2008-12#1)
to those achieved by##3##4##(1993-6#1)(2008-10#1)(2008-12#1)
to those achieved using##2##4##(1991-3#1)(2008-10#1)
to those achieved with##2##4##(2008-10#2)
to those achieved##7##3##(1991-3#1)(1993-6#1)(2008-10#4)(2008-12#1)
to those described##2##3##(1994-11#1)(2008-10#1)
to those determined using##2##4##(2008-10#2)
to those determined##3##3##(2008-10#3)
to those estimated##2##3##(2008-10#2)
to those for the##3##4##(1995-6#1)(1997-8#1)(2008-10#1)
to those found in the##2##5##(1991-9#1)(2008-7#1)
to those found in##7##4##(1990-2#1)(1991-9#1)(1993-2#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
to those found on##2##4##(2008-10#2)
to those found##10##3##(1990-2#1)(1991-9#1)(1993-2#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)
to those from conventional##2##4##(2008-10#2)
to those from##5##3##(2008-10#4)(2008-11#1)
to those grown in##2##4##(2008-10#2)
to those identified##2##3##(2008-10#1)(2010-4#1)
to those in Group##3##4##(1992-11#1)(2011-1#1)(2011-2#1)
to those in other##2##4##(1990-5#1)(2008-10#1)
to those in the##9##4##(1990-8#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-5#1)
to those in##21##3##(1990-5#1)(1990-8#1)(1992-11#1)(1993-12#1)(1993-6#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-5#1)
to those induced by##5##4##(1991-6#1)(2008-10#2)(2008-12#1)(2011-2#1)
to those observed in the##5##5##(1996-2#1)(1997-8#1)(2008-10#3)
to those observed in##13##4##(1994-5#1)(1996-2#1)(1997-8#2)(2008-10#8)(2011-2#1)
to those observed with##3##4##(1992-12#1)(2008-10#1)(2012-3#1)
to those observed##20##3##(1992-12#2)(1994-5#1)(1996-2#1)(1997-2#1)(1997-8#2)(2008-10#9)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
to those obtained at##2##4##(2008-10#2)
to those obtained by the##5##5##(2008-10#5)
to those obtained by using##2##5##(2008-10#2)
to those obtained by##14##4##(2008-10#14)
to those obtained for##2##4##(1993-8#1)(2008-10#1)
to those obtained from##2##4##(2008-10#1)(2013-1#1)
to those obtained in the##2##5##(2008-10#2)
to those obtained in##8##4##(1990-5#2)(1994-2#1)(2008-10#5)
to those obtained using the##2##5##(2008-10#2)
to those obtained using##4##4##(2008-10#4)
to those obtained with the##4##5##(2008-10#3)(2008-11#1)
to those obtained with##12##4##(2008-10#11)(2008-11#1)
to those obtained##45##3##(1990-5#2)(1992-3#1)(1993-8#1)(1994-2#1)(2008-10#38)(2008-11#1)(2013-1#1)
to those of a##2##4##(2008-10#2)
to those of acute##2##4##(2008-7#1)(2009-8#1)
to those of conventional##2##4##(1992-3#1)(2008-10#1)
to those of other##5##4##(1994-5#1)(1996-1#1)(2008-10#3)
to those of the##28##4##(1990-10#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#2)
to those of##102##3##(1990-10#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#2)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#27)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-5#1)(2009-7#1)(2009-8#2)(2010-4#3)(2011-1#2)(2011-2#3)(2012-3#1)(2013-8#3)
to those on##2##3##(1997-3#1)(2008-11#1)
to those prepared##2##3##(2008-10#2)
to those previously##6##3##(1991-6#1)(1995-6#1)(2008-10#3)(2011-1#1)
to those produced##2##3##(2008-10#1)(2008-11#1)
to those reported in##4##4##(1997-2#1)(2008-10#3)
to those reported##6##3##(1997-2#1)(2008-10#4)(2010-6#1)
to those seen##3##3##(1991-6#1)(1995-12#1)(2008-5#1)
to those that##3##3##(1994-2#1)(2008-10#1)(2009-5#1)
to those treated with##2##4##(1991-3#1)(2008-11#1)
to those used in##2##4##(2008-6#1)(2008-7#1)
to those used##4##3##(1990-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
to those who need##2##4##(1993-2#1)(1995-1#1)
to those who##6##3##(1993-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-12#1)(2008-10#1)
to those with strong physician examiner systems##2##7##(1993-12#2)
to those with##6##3##(1993-12#2)(2008-11#1)(2008-7#2)(2011-2#1)
to those without##6##3##(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
to those##341##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#1)(1993-1#1)(1993-12#5)(1993-2#4)(1993-3#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#4)(1996-1#1)(1996-12#3)(1996-2#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#2)(1997-8#3)(2007-11#1)(2007-12#2)(2008-10#136)(2008-11#10)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#13)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-4#4)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#9)(2012-12#1)(2012-3#4)(2012-5#1)(2013-1#5)(2013-8#4)
to thousands of##3##3##(1991-2#1)(2008-10#1)(2008-4#1)
to three different##7##3##(2008-10#5)(2012-3#1)(2013-1#1)
to three groups of##2##4##(1993-1#1)(2008-10#1)
to three groups##5##3##(1993-1#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)
to three of##2##3##(1991-12#1)(2008-11#1)
to three regions of##2##4##(1994-12#1)(2011-2#1)
to three regions##3##3##(1994-12#1)(2008-9#1)(2011-2#1)
to three times the standard deviation of the blank##4##9##(2008-10#4)
to three times the standard deviation of the##5##8##(2008-10#5)
to three times the standard deviation of##6##7##(2008-10#6)
to three times the##7##4##(1992-3#1)(2008-10#6)
to three times##10##3##(1992-3#1)(2008-10#8)(2012-2#1)
to three weeks##2##3##(1991-3#1)(1995-2#1)
to three##73##2##(1991-12#1)(1991-3#2)(1991-9#1)(1992-3#1)(1993-1#1)(1994-1#2)(1994-12#1)(1995-2#2)(1996-8#1)(2007-12#1)(2008-10#36)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
to three-dimensional##4##2##(1996-2#1)(2008-3#2)(2009-3#1)
to threefold##2##2##(2008-10#1)(2010-4#1)
to thrips feeding##2##3##(2009-8#2)
to thrips##3##2##(2008-10#1)(2009-8#2)
to thrive##6##2##(1992-3#1)(1994-3#1)(2010-6#2)(2011-1#1)(2012-3#1)
to thrombotic##2##2##(2008-10#1)(2009-7#1)
to throw##2##2##(2008-11#1)(2010-3#1)
to thyroid hormone##4##3##(1992-11#1)(1995-8#3)
to tie##2##2##(1995-1#1)(1996-2#1)
to tight##2##2##(2011-2#1)(2013-8#1)
to time##8##2##(1997-7#1)(2008-10#4)(2008-5#2)(2012-2#1)
to time-consuming##2##2##(2008-10#2)
to tissue##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
to tissues##2##2##(2012-2#1)(2013-1#1)
to to##2##2##(1993-6#1)(1995-2#1)
to tobacco and##2##3##(1996-1#1)(1997-1#1)
to tobacco##14##2##(1990-8#1)(1991-11#1)(1992-6#2)(1996-1#1)(1997-1#3)(2008-10#5)(2013-1#1)
to tolerate a##3##3##(1993-2#1)(2008-11#2)
to tolerate##6##2##(1993-2#1)(2008-10#1)(2008-11#2)(2008-8#2)
to toluene##2##2##(2008-10#1)(2008-7#1)
to tomato plants##4##3##(2008-10#4)
to tomato spotted wilt virus##2##5##(2008-10#2)
to tomato##19##2##(2008-10#15)(2008-8#4)
to topical application##3##3##(2008-12#2)(2013-1#1)
to topical##6##2##(2008-12#2)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
to total quality management##2##4##(1994-2#1)(1994-3#1)
to total##17##2##(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#2)(1996-2#1)(2008-10#5)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
to touch##2##2##(1996-2#1)(2008-11#1)
to toxic##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
to toxicants##2##2##(2008-9#1)(2012-2#1)
to toxicity##2##2##(2008-5#1)(2013-1#1)
to toxin##2##2##(1994-5#1)(2008-10#1)
to toxins##2##2##(2008-9#1)(2013-8#1)
to trace##5##2##(2008-10#5)
to track a moving target##3##5##(2008-11#3)
to track the##4##3##(1996-5#1)(2008-10#2)(2009-11#1)
to track##13##2##(1995-12#1)(1996-5#1)(2008-10#3)(2008-11#4)(2009-11#1)(2011-2#1)(2012-2#2)
to traditional methods##2##3##(1990-9#1)(2008-10#1)
to traditional##25##2##(1990-9#1)(1992-1#2)(1992-5#1)(1993-12#1)(1994-9#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#3)
to traffic##2##2##(2008-3#1)(2010-11#1)
to train##6##2##(1992-12#1)(1994-6#1)(1997-1#1)(1997-3#1)(2008-10#2)
to training##4##2##(1991-1#1)(1996-3#1)(2008-11#1)(2011-2#1)
to trans-replicate##2##2##(2008-10#2)
to transcription##2##2##(1995-6#1)(2008-10#1)
to transcriptional##2##2##(1996-12#1)(2013-1#1)
to transduce##4##2##(1992-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
to transfect##3##2##(1993-8#1)(2008-11#2)
to transfer genes into cells from##2##6##(1990-5#2)
to transfer genes to##2##4##(1994-11#1)(2008-10#1)
to transfer genes##4##3##(1990-5#2)(1994-11#1)(2008-10#1)
to transfer the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
to transfer##17##2##(1990-5#3)(1992-6#1)(1994-11#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-8#1)
to transform the##5##3##(1992-12#1)(2008-10#2)(2008-3#1)(2009-4#1)
to transform##12##2##(1990-5#1)(1992-12#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)
to transformation by##2##3##(1993-11#1)(2008-10#1)
to transformation##3##2##(1993-11#1)(2008-10#1)(2013-8#1)
to transgenic plants##3##3##(1995-6#1)(2008-11#1)(2013-8#1)
to transient##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
to translate##3##2##(1993-2#1)(2010-1#1)(2010-11#1)
to translocate##3##2##(1994-5#1)(2008-11#1)(2009-10#1)
to transmit TSWV##3##3##(2008-10#3)
to transmit Tomato##2##3##(2008-10#2)
to transmit both##2##3##(2008-10#2)
to transmit the virus##2##4##(2008-10#2)
to transmit the##4##3##(2008-10#4)
to transmit virus##2##3##(2008-10#2)
to transmit##21##2##(1990-5#1)(2008-10#19)(2012-12#1)
to transplantation##3##2##(1995-12#2)(2010-6#1)
to transport##7##2##(1990-2#1)(1991-10#1)(1995-11#1)(1996-1#1)(2008-11#1)(2008-7#1)(2008-8#1)
to trap##5##2##(1993-6#1)(1995-3#1)(2008-10#3)
to trastuzumab and##2##3##(2012-3#1)(2013-1#1)
to trastuzumab##5##2##(2012-3#3)(2013-1#2)
to trauma##8##2##(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
to traumatic##2##2##(2009-3#1)(2012-3#1)
to travel##2##2##(2008-8#1)(2008-9#1)
to traverse the##2##3##(1990-5#1)(2008-10#1)
to treat a wide##2##4##(2008-10#1)(2010-2#1)
to treat a##6##3##(1992-1#1)(1993-2#1)(2008-10#2)(2008-8#1)(2010-2#1)
to treat and##2##3##(2008-7#1)(2011-2#1)
to treat bipolar disorder##2##4##(2008-8#2)
to treat cancer##2##3##(2008-9#1)(2011-2#1)
to treat hypertension##5##3##(1996-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)
to treat patients with##3##4##(2007-9#1)(2009-8#1)(2013-1#1)
to treat patients##5##3##(1994-1#1)(1997-1#1)(2007-9#1)(2009-8#1)(2013-1#1)
to treat people with HIV##2##5##(1995-6#2)
to treat people with##3##4##(1995-6#2)(1996-1#1)
to treat the##16##3##(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
to treat these##3##3##(1991-11#1)(2010-3#1)(2010-6#1)
to treat this##4##3##(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
to treat##108##2##(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-1#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-12#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
to treatment and##5##3##(1991-3#1)(1997-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
to treatment are##3##3##(1996-8#1)(2008-6#1)(2013-8#1)
to treatment by##3##3##(1993-3#1)(2008-10#1)(2010-12#1)
to treatment of##5##3##(1993-8#1)(2007-11#1)(2008-10#1)(2011-7#1)(2013-8#1)
to treatment was##4##3##(1991-8#1)(1996-6#1)(2008-6#2)
to treatment with drugs##2##4##(1994-6#1)(1994-9#1)
to treatment with the##2##4##(2008-10#1)(2008-8#1)
to treatment with##8##3##(1990-2#1)(1992-2#1)(1994-6#1)(1994-9#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-12#1)
to treatment##62##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-8#2)(1994-6#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#6)
to treatments##2##2##(2008-10#1)(2008-7#1)
to trees##5##2##(2008-10#4)(2010-4#1)
to tremolite##2##2##(1991-12#2)
to trends in##2##3##(1995-1#1)(2008-4#1)
to trial##2##2##(1995-12#1)(1995-6#1)
to trifluoperizine##2##2##(1995-11#2)
to trigger the##2##3##(2008-10#1)(2013-8#1)
to trigger##10##2##(1994-8#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-7#1)(2013-8#1)
to triggering##2##2##(2008-8#1)(2009-8#1)
to trim##2##2##(1992-8#1)(1993-5#1)
to triple##2##2##(2008-9#1)(2011-1#1)
to trolox##2##2##(2008-10#2)
to true biological##2##3##(2008-10#1)(2010-7#1)
to true##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
to try to##4##3##(1994-8#1)(1997-5#1)(1997-7#1)(2008-9#1)
to tumor cells##5##3##(1990-5#1)(1997-2#2)(2008-9#2)
to tumor formation##2##3##(2008-10#1)(2013-1#1)
to tumor##16##2##(1990-5#1)(1991-12#1)(1993-11#2)(1997-2#2)(2008-1#1)(2008-10#1)(2008-9#2)(2009-4#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
to tumorigenesis##2##2##(1994-12#1)(2011-2#1)
to tumors##3##2##(1993-11#2)(2011-2#1)
to tumour##4##2##(1997-4#1)(2008-7#1)(2009-4#1)(2013-1#1)
to tune the##2##3##(2008-10#1)(2008-11#1)
to tune##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
to turn##6##2##(1994-3#2)(1996-8#1)(2008-10#1)(2008-8#2)
to twice##2##2##(1994-2#1)(2008-10#1)
to twins##2##2##(1997-7#1)(2011-2#1)
to two decades##2##3##(2008-10#1)(2012-2#1)
to two different##5##3##(2008-10#4)(2008-8#1)
to two major##3##3##(1990-5#1)(1997-1#1)(2008-10#1)
to two methods for##2##4##(2008-10#2)
to two possible##2##3##(1992-4#1)(2008-10#1)
to two years##2##3##(1992-11#1)(2008-11#1)
to two##75##2##(1990-5#1)(1992-11#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-11#1)(1995-2#2)(1997-1#1)(1997-9#1)(2007-12#1)(2008-10#38)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
to type I##3##3##(2008-11#2)(2010-5#1)
to type of##4##3##(1991-3#1)(2008-10#1)(2010-6#1)(2011-2#1)
to type##10##2##(1990-8#1)(1991-3#1)(2008-10#1)(2008-11#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)
to typical##2##2##(2008-10#1)(2012-2#1)
to ubiquitin##2##2##(1991-1#1)(1993-8#1)
to ultrasound##6##2##(1993-8#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
to ultraviolet##3##2##(2008-10#2)(2011-2#1)
to unacceptable##2##2##(1990-2#1)(2013-1#1)
to uncover the##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)
to uncover##6##2##(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-9#1)
to under##3##2##(1994-9#1)(2008-10#2)
to undergo HIV-antibody testing##2##4##(1996-5#2)
to undergo apoptosis in##2##4##(1995-2#1)(2008-10#1)
to undergo apoptosis##6##3##(1995-2#3)(2008-10#1)(2008-9#1)(2009-8#1)
to undergo the##3##3##(2011-2#1)(2012-3#2)
to undergo this##2##3##(1994-12#1)(2008-7#1)
to undergo##29##2##(1992-9#1)(1993-8#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#3)(1996-5#3)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-3#2)(2013-1#2)
to undergraduate##2##2##(2008-11#2)
to underlie the##2##3##(1995-8#1)(1996-2#1)
to underlie##5##2##(1995-8#1)(1996-2#1)(2009-8#1)(2010-2#1)(2013-8#1)
to underpin##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
to understand and control##3##4##(2008-5#1)(2010-7#1)(2011-1#1)
to understand and##12##3##(1991-9#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-1#1)(2013-1#1)
to understand how the##8##4##(1992-3#1)(1997-6#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
to understand how##14##3##(1992-3#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)
to understand more about##2##4##(2008-11#2)
to understand that##3##3##(1991-1#1)(2008-11#1)(2009-9#1)
to understand the complex##2##4##(2008-11#1)(2013-8#1)
to understand the factors##2##4##(2008-10#1)(2012-2#1)
to understand the function of##2##5##(1997-8#1)(2008-9#1)
to understand the genetic##2##4##(2008-10#1)(2008-8#1)
to understand the mechanisms##3##4##(1995-2#1)(2008-10#2)
to understand the molecular mechanisms##2##5##(2008-10#1)(2008-4#1)
to understand the molecular##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
to understand the nature and##2##5##(2008-10#1)(2008-5#1)
to understand the potential##2##4##(1994-5#1)(2008-10#1)
to understand the role of##2##5##(2009-7#1)(2012-3#1)
to understand the##56##3##(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#2)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
to understand their##7##3##(1993-1#1)(1993-2#1)(1994-3#1)(2008-10#1)(2008-4#1)(2009-6#1)(2013-8#1)
to understand these##2##3##(2008-10#1)(2011-2#1)
to understand this phenomenon##2##4##(2009-9#1)(2013-8#1)
to understand this##3##3##(2009-9#1)(2013-8#2)
to understand what##3##3##(1996-6#1)(2009-10#1)(2013-8#1)
to understand whether##2##3##(2008-5#1)(2013-1#1)
to understand##144##2##(1990-2#1)(1991-1#1)(1991-9#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#5)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#20)(2008-11#14)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#2)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#4)(2013-8#5)
to understanding the##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)
to understanding##18##2##(1990-5#1)(1992-12#1)(1992-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-9#1)(2013-1#1)
to undertake a##2##3##(2008-10#1)(2008-11#1)
to undertake further##2##3##(2008-11#1)(2008-12#1)
to undertake the##2##3##(2008-11#1)(2012-3#1)
to undertake##12##2##(1991-3#1)(1992-1#1)(1992-9#1)(1994-1#1)(2008-10#1)(2008-11#4)(2008-12#2)(2012-3#1)
to undetectable levels##3##3##(2008-10#3)
to undetectable##4##2##(2008-10#4)
to unequal##3##2##(1991-12#1)(2008-10#2)
to uneven##2##2##(2008-10#1)(2013-1#1)
to unfamiliar##2##2##(2008-11#1)(2008-12#1)
to uninfected##4##2##(1991-5#1)(1994-9#1)(2008-8#1)(2012-3#1)
to uniquely##2##2##(2008-10#1)(2008-9#1)
to universal##3##2##(2008-10#1)(2008-11#2)
to universities##3##2##(1994-12#1)(1997-5#1)(2008-11#1)
to unnecessary##2##2##(1991-11#1)(2008-10#1)
to unravel the##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
to unravel##8##2##(1995-11#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-6#1)
to unrelated##2##2##(2011-2#1)(2013-1#1)
to unroof the##2##3##(2008-7#2)
to unwanted##2##2##(1997-5#1)(2008-10#1)
to up to##6##3##(2008-10#3)(2009-7#1)(2010-8#1)(2011-1#1)
to update the##3##3##(1994-1#1)(2008-6#1)(2009-8#1)
to update##8##2##(1991-3#1)(1994-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-8#1)(2011-2#2)
to uptake##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
to uranium##2##2##(2008-10#1)(2013-1#1)
to urea##2##2##(2008-10#2)
to uric acid was##2##4##(2008-10#2)
to uric acid##3##3##(2008-10#3)
to urinary catheters##2##3##(1996-12#2)
to urinary##4##2##(1996-12#2)(2008-7#1)(2010-5#1)
to urine samples##2##3##(2008-10#2)
to us for##2##3##(2008-11#1)(2008-8#1)
to us with##3##3##(2012-3#1)(2013-1#2)
to us##13##2##(1995-11#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-5#1)(2012-3#1)(2013-1#3)
to use a##8##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2010-7#1)(2011-2#1)
to use as##2##3##(1997-8#1)(2008-12#1)
to use condoms##4##3##(1990-6#1)(2008-4#3)
to use for##2##3##(2008-10#2)
to use in##5##3##(1991-1#1)(2008-10#2)(2012-3#2)
to use it for the##2##5##(1997-3#1)(2008-11#1)
to use it##3##3##(1997-3#1)(2008-11#1)(2009-7#1)
to use multiple##2##3##(2008-10#1)(2010-11#1)
to use of##4##3##(1993-9#1)(2007-11#1)(2008-10#1)(2008-9#1)
to use research in##2##4##(2008-11#1)(2009-3#1)
to use such##2##3##(2009-9#1)(2013-1#1)
to use the##24##3##(1990-2#2)(1991-1#1)(1993-11#2)(1994-3#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
to use their own ventilators or##2##6##(2011-1#2)
to use them to##3##4##(1993-12#1)(2008-10#1)(2013-7#1)
to use these##3##3##(1994-2#1)(2008-10#2)
to use this##6##3##(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#1)(2012-3#1)
to use when##2##3##(2008-9#1)(2010-10#1)
to use##187##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-9#1)(1994-1#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#4)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#17)(2008-12#8)(2008-3#4)(2008-4#12)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#11)(2009-10#3)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#3)
to user##2##2##(2008-10#1)(2011-2#1)
to users##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
to using mice##2##3##(2008-6#2)
to using##7##2##(2008-11#1)(2008-5#1)(2008-6#2)(2009-10#1)(2011-2#1)(2013-1#1)
to usual##2##2##(2008-4#1)(2008-5#1)
to utilise##2##2##(2006-6#1)(2008-10#1)
to utilization##2##2##(1991-12#1)(1995-12#1)
to utilize the##3##3##(1995-2#1)(2008-11#1)(2008-3#1)
to utilize this##2##3##(1994-3#1)(2008-5#1)
to utilize##20##2##(1991-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to vaccinate their daughters##4##4##(2011-1#4)
to vaccinate##6##2##(1996-12#1)(2011-1#4)(2011-2#1)
to vaccination in##2##3##(2010-4#1)(2011-2#1)
to vaccination##6##2##(1990-11#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#2)
to vaccine##3##2##(1995-5#1)(2011-2#2)
to validate a##4##3##(1996-2#1)(2008-10#3)
to validate the developed##2##4##(2008-10#1)(2011-2#1)
to validate the impact of##2##5##(2011-2#1)(2013-1#1)
to validate the model##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
to validate the##29##3##(1991-5#1)(1997-2#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#7)(2013-1#1)
to validate##38##2##(1991-5#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#7)(2013-1#2)
to values below##2##3##(2008-10#1)(2012-3#1)
to values##8##2##(1990-12#1)(1990-5#1)(1992-2#1)(1996-2#1)(2008-10#2)(2008-8#1)(2012-3#1)
to vapor##2##2##(2008-10#2)
to variable##2##2##(1990-12#1)(2008-8#1)
to variances in##2##3##(2008-11#1)(2008-9#1)
to variation in##7##3##(2008-10#3)(2008-8#2)(2008-9#1)(2011-2#1)
to variation##9##2##(2008-10#4)(2008-8#2)(2008-9#2)(2011-2#1)
to variations in the##3##4##(1992-3#1)(1993-3#1)(2008-10#1)
to variations in##5##3##(1992-3#1)(1993-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
to variations##6##2##(1992-3#1)(1993-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
to various water samples##3##4##(2008-10#3)
to various##50##2##(1990-3#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-7#1)
to vary in##2##3##(2008-10#2)
to vary with##2##3##(1997-3#1)(2008-8#1)
to vary##14##2##(1992-12#1)(1995-3#1)(1997-3#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-8#1)(2009-7#1)
to varying degrees##2##3##(1993-1#1)(2008-9#1)
to varying extents##2##3##(1992-11#1)(2008-10#1)
to varying##8##2##(1992-11#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-3#1)
to vascular endothelial growth factor##3##5##(2008-8#2)(2010-1#1)
to vascular endothelial##5##3##(1997-1#1)(2008-8#2)(2010-1#1)(2013-8#1)
to vascular muscle##3##3##(1991-6#3)
to vascular##12##2##(1991-6#3)(1995-2#1)(1997-1#1)(2008-10#2)(2008-8#2)(2010-1#1)(2011-3#1)(2013-8#1)
to vector##2##2##(2010-1#1)(2011-2#1)
to vectors##2##2##(2008-10#1)(2011-2#1)
to vegetative##4##2##(2008-10#1)(2008-8#1)(2011-2#2)
to vehicle##2##2##(1991-10#1)(1996-12#1)
to venous##3##2##(1996-9#1)(1997-1#1)(2011-2#1)
to ventricular##2##2##(2008-8#1)(2009-10#1)
to verbs##2##2##(1991-2#1)(2008-11#1)
to verify a##2##3##(1996-3#1)(2008-12#1)
to verify if##2##3##(2008-10#2)
to verify its feasibility##2##4##(2008-10#2)
to verify that##2##3##(2008-10#1)(2008-9#1)
to verify the effect of##2##5##(1997-2#1)(2008-7#1)
to verify the##25##3##(1990-5#1)(1992-3#1)(1997-2#1)(2008-10#9)(2008-3#3)(2008-7#3)(2008-9#2)(2009-2#1)(2010-5#2)(2010-6#1)(2011-2#1)
to verify whether##2##3##(2008-11#1)(2010-9#1)
to verify##46##2##(1990-5#1)(1990-6#1)(1991-9#1)(1992-3#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#4)(2008-7#4)(2008-9#3)(2009-2#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#2)
to vertebrate##3##2##(1995-2#1)(2008-7#1)(2008-9#1)
to vertebrates##2##2##(2008-12#1)(2012-3#1)
to very good##4##3##(1990-9#1)(1991-3#1)(2008-4#2)
to very high##2##3##(1997-6#1)(2010-6#1)
to very low##2##3##(1993-3#1)(2012-2#1)
to very stable##2##3##(2008-10#2)
to very##14##2##(1990-9#1)(1991-3#1)(1993-3#1)(1997-6#1)(2008-10#3)(2008-4#2)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#1)
to vesicle##2##2##(1997-1#1)(2008-11#1)
to vessels##2##2##(1997-4#1)(2006-6#1)
to victims of##2##3##(1995-12#1)(2012-12#1)
to view the##6##3##(1993-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
to view##11##2##(1992-3#1)(1993-1#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
to vinclozolin (S(T)R(V))##4##3##(2008-10#4)
to vinclozolin##10##2##(2008-10#10)
to vincristine and##2##3##(1993-8#2)
to vincristine plus##2##3##(1993-8#2)
to vincristine##4##2##(1993-8#4)
to violations of the##2##4##(1994-9#1)(2010-2#1)
to violations of##4##3##(1994-9#2)(2008-8#1)(2010-2#1)
to viral RNA##2##3##(2008-10#2)
to viral infections##2##3##(2008-1#1)(2008-7#1)
to viral##11##2##(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-8#1)
to virulence to##2##3##(2008-10#2)
to virulence##4##2##(2008-10#4)
to virus infection##3##3##(2008-10#2)(2008-11#1)
to virus transmission##2##3##(2008-10#2)
to virus##10##2##(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#1)
to viruses in##2##3##(2007-11#1)(2008-10#1)
to viruses##4##2##(2006-5#1)(2007-11#1)(2008-10#2)
to visit##6##2##(1992-12#1)(1993-8#1)(1995-6#1)(2008-11#1)(2008-8#2)
to visual##7##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-7#1)
to visualise##4##2##(2008-11#1)(2008-8#1)(2012-2#2)
to visualize and##2##3##(2008-11#1)(2012-2#1)
to visualize the##3##3##(1994-5#1)(2009-7#1)(2013-8#1)
to visualize##10##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-6#1)(2012-2#1)(2013-8#2)
to vitamin A##2##3##(1991-8#1)(2008-11#1)
to vitamin C##2##3##(2008-5#1)(2012-2#1)
to vitamin D##2##3##(1995-8#1)(2011-2#1)
to vitamin##7##2##(1991-8#1)(1994-5#1)(1995-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
to voltammetric##2##2##(2008-10#2)
to volume##3##2##(1991-2#1)(2008-7#1)(2009-3#1)
to volunteer##3##2##(1994-2#1)(1994-3#1)(1995-2#1)
to wait##2##2##(1994-1#1)(1995-12#1)
to walk##2##2##(1991-9#1)(2013-1#1)
to war##2##2##(1993-9#1)(1994-9#1)
to warrant##2##2##(2008-10#2)
to waste##5##2##(1993-1#1)(2008-10#3)(2011-2#1)
to watch##2##2##(2008-10#1)(2011-2#1)
to water analysis##4##3##(2008-10#4)
to water and##3##3##(1995-2#1)(2008-10#2)
to water deficit##2##3##(2009-8#2)
to water samples##8##3##(2008-10#8)
to water stress##4##3##(2009-8#2)(2012-7#2)
to water vapor##3##3##(1997-1#1)(2008-10#2)
to water##35##2##(1991-5#1)(1995-2#1)(1997-1#1)(2008-10#20)(2008-5#3)(2008-6#1)(2009-8#4)(2012-12#1)(2012-7#2)(2013-1#1)
to weather variables##2##3##(2008-10#2)
to weather##5##2##(2008-10#4)(2013-8#1)
to web##2##2##(2010-4#1)(2011-2#1)
to weeks##3##2##(1997-1#1)(2008-9#1)(2009-12#1)
to weigh##2##2##(1991-9#1)(2008-10#1)
to well##2##2##(2008-10#1)(2008-11#1)
to wet digestion##2##3##(2008-10#2)
to wet##4##2##(2008-10#3)(2011-2#1)
to what can be##2##4##(2008-11#1)(2012-3#1)
to what extent the##6##4##(1997-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-2#1)
to what extent##15##3##(1992-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-2#2)
to what has##2##3##(2008-10#1)(2009-5#1)
to what is##7##3##(1995-12#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2013-1#1)
to what was observed##2##4##(2008-11#1)(2012-3#1)
to what##43##2##(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-6#2)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#5)(2008-12#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)
to wheat (Triticum aestivum)##2##4##(2008-10#2)
to wheat leaf rust##2##4##(2008-10#2)
to wheat or##2##3##(2008-10#2)
to wheat##14##2##(1990-3#1)(2008-10#10)(2008-12#1)(2008-8#1)(2008-9#1)
to when##2##2##(1997-8#1)(2008-8#1)
to whether the##4##3##(1990-6#1)(1994-12#1)(2008-11#1)(2008-12#1)
to whether##11##2##(1990-6#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
to which a different toxicity and therefore##2##7##(2008-10#2)
to which a##5##3##(2008-10#4)(2008-11#1)
to which it is##2##4##(1994-12#1)(2008-10#1)
to which it##3##3##(1994-12#1)(2008-10#1)(2009-11#1)
to which other##2##3##(1995-2#1)(2009-9#1)
to which the##24##3##(1991-12#1)(1993-3#1)(1994-5#1)(1996-3#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
to which their##2##3##(2008-9#1)(2009-7#1)
to which these##2##3##(2009-8#1)(2010-9#1)
to which they belong##2##4##(2008-9#1)(2011-2#1)
to which they had##2##4##(2008-8#1)(2010-4#1)
to which they have been##2##5##(1991-12#1)(2011-2#1)
to which they have##3##4##(1991-12#1)(2008-8#1)(2011-2#1)
to which they##14##3##(1991-12#1)(1996-2#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)
to which##110##2##(1991-12#2)(1992-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#3)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#1)(2008-10#26)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
to white##9##2##(2008-10#8)(2010-11#1)
to whole##3##2##(1995-5#1)(1997-7#1)(2008-10#1)
to whom##3##2##(1994-3#1)(1996-2#1)(2011-3#1)
to wide##2##2##(2008-3#1)(2011-2#1)
to widen the##2##3##(2008-10#1)(2008-12#1)
to widespread##2##2##(2008-10#1)(2011-3#1)
to wild type##4##3##(1995-2#1)(1997-7#1)(2009-8#1)(2011-1#1)
to wild-type Mb##2##3##(1994-5#2)
to wild-type##12##2##(1993-8#2)(1994-5#2)(1996-3#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#2)
to win##3##2##(1992-2#1)(1996-1#1)(2008-8#1)
to wine##3##2##(2008-10#3)
to winter##3##2##(2008-10#3)
to withdraw##4##2##(1995-12#1)(2008-10#1)(2010-12#1)(2012-3#1)
to within 0##2##3##(2008-3#2)
to within 1%##2##3##(2008-3#2)
to within a##2##3##(2008-2#1)(2008-3#1)
to within the##2##3##(1991-2#1)(2008-10#1)
to within##18##2##(1991-2#1)(1991-5#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#9)(2011-2#1)
to withstand##4##2##(1993-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
to women who are##2##4##(1997-1#1)(2012-3#1)
to women##9##2##(1991-3#1)(1991-8#1)(1996-9#1)(1997-1#1)(2008-11#1)(2011-2#1)(2012-3#2)(2013-8#1)
to women's health##2##3##(1996-11#1)(2008-11#1)
to women's##3##2##(1995-1#1)(1996-11#1)(2008-11#1)
to wood##2##2##(1990-6#1)(2008-10#1)
to work and##3##3##(1994-3#1)(2008-11#1)(2012-12#1)
to work as a##2##4##(2008-10#1)(2008-11#1)
to work in partnership to##2##5##(1996-2#1)(2008-11#1)
to work in partnership with##3##5##(2008-11#1)(2008-12#2)
to work in partnership##5##4##(1996-2#1)(2008-11#2)(2008-12#2)
to work in##8##3##(1996-2#1)(2008-10#2)(2008-11#3)(2008-12#2)
to work together##2##3##(1991-12#1)(2012-2#1)
to work well##2##3##(2008-10#2)
to work with##6##3##(1992-12#1)(1994-1#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-7#1)
to work##43##2##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-6#1)(2008-10#6)(2008-11#8)(2008-12#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)
to wound##4##2##(2008-7#3)(2013-1#1)
to write##3##2##(2008-11#1)(2009-4#1)(2010-7#1)
to writing##2##2##(1995-11#1)(1996-6#1)
to xylem##2##2##(2008-10#1)(2008-11#1)
to year and##4##3##(2008-10#3)(2013-1#1)
to year##11##2##(1993-2#1)(2008-10#4)(2008-12#1)(2008-8#3)(2011-2#1)(2013-1#1)
to years##4##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
to yeast##7##2##(1995-9#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-9#1)
to yellow rust##2##3##(2008-10#2)
to yellow##3##2##(2008-10#3)
to yield a detection limit of##2##6##(2008-10#2)
to yield a##12##3##(1995-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)
to yield deconvolution##3##3##(2008-10#3)
to yield the##10##3##(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
to yield##64##2##(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
to young##8##2##(1992-3#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-7#1)(2010-10#1)(2013-1#1)(2013-7#1)
to younger patients##2##3##(1991-12#1)(2008-7#1)
to younger##3##2##(1991-12#1)(1996-2#1)(2008-7#1)
to your clinical##2##3##(1997-2#1)(2011-2#1)
to your##7##2##(1992-3#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2011-2#1)
to zearalenone##3##2##(2008-10#1)(2013-1#2)
to zero at an##2##4##(1991-11#1)(2008-10#1)
to zero##13##2##(1991-11#1)(1994-11#1)(2008-10#6)(2008-11#1)(2008-9#2)(2012-2#1)(2013-8#1)
to zidovudine) from replicating with EC50##2##6##(2011-3#2)
to zinc##2##2##(1992-6#2)
to##61229##1##(1990-10#18)(1990-11#180)(1990-12#196)(1990-2#205)(1990-3#83)(1990-4#5)(1990-5#252)(1990-6#94)(1990-7#23)(1990-8#131)(1990-9#100)(1991-1#141)(1991-10#25)(1991-11#92)(1991-12#309)(1991-2#277)(1991-3#263)(1991-4#9)(1991-5#188)(1991-6#181)(1991-7#45)(1991-8#82)(1991-9#71)(1992-1#136)(1992-10#48)(1992-11#44)(1992-12#285)(1992-2#185)(1992-3#255)(1992-4#25)(1992-5#57)(1992-6#171)(1992-7#12)(1992-8#82)(1992-9#128)(1993-1#190)(1993-11#108)(1993-12#377)(1993-2#201)(1993-3#287)(1993-5#14)(1993-6#243)(1993-8#313)(1993-9#82)(1994-1#159)(1994-11#209)(1994-12#304)(1994-2#308)(1994-3#335)(1994-5#288)(1994-6#116)(1994-8#209)(1994-9#128)(1995-1#127)(1995-10#12)(1995-11#202)(1995-12#417)(1995-2#447)(1995-3#170)(1995-5#171)(1995-6#323)(1995-8#190)(1995-9#76)(1996-1#223)(1996-10#1)(1996-11#81)(1996-12#396)(1996-2#356)(1996-3#307)(1996-5#208)(1996-6#141)(1996-8#59)(1996-9#55)(1997-1#308)(1997-2#392)(1997-3#345)(1997-4#120)(1997-5#68)(1997-6#161)(1997-7#223)(1997-8#287)(1997-9#24)(2006-5#11)(2006-6#40)(2007-11#71)(2007-12#237)(2007-7#1)(2007-8#33)(2007-9#17)(2008-1#290)(2008-10#18091)(2008-11#4636)(2008-12#1245)(2008-2#292)(2008-3#1183)(2008-4#645)(2008-5#1322)(2008-6#366)(2008-7#1490)(2008-8#1603)(2008-9#1664)(2009-1#74)(2009-10#328)(2009-11#123)(2009-12#242)(2009-2#22)(2009-3#136)(2009-4#111)(2009-5#132)(2009-6#187)(2009-7#305)(2009-8#469)(2009-9#149)(2010-1#214)(2010-10#316)(2010-11#302)(2010-12#320)(2010-2#62)(2010-3#107)(2010-4#201)(2010-5#225)(2010-6#213)(2010-7#301)(2010-8#355)(2010-9#104)(2011-1#329)(2011-10#41)(2011-2#2317)(2011-3#146)(2011-4#2)(2011-6#1)(2011-7#42)(2011-8#3)(2011-9#18)(2012-12#436)(2012-2#1299)(2012-3#1122)(2012-4#16)(2012-5#49)(2012-6#25)(2012-7#21)(2012-8#16)(2012-9#22)(2013-1#1909)(2013-2#2)(2013-3#5)(2013-7#93)(2013-8#921)
to)##2##1##(2009-7#1)(2013-1#1)
tobacco (Nicotiana tabacum)##2##3##(2008-10#2)
tobacco (Nicotiana##3##2##(2008-10#3)
tobacco and alcohol##3##3##(1996-1#1)(2008-10#1)(2013-1#1)
tobacco and##15##2##(1993-11#1)(1996-1#2)(1997-1#1)(2008-10#10)(2013-1#1)
tobacco blue mold##2##3##(2008-10#2)
tobacco can##2##2##(1992-6#1)(2008-9#1)
tobacco cells exhibited##2##3##(2009-6#2)
tobacco cells##6##2##(2008-10#1)(2009-6#5)
tobacco cessation intervention##2##3##(2008-4#2)
tobacco cessation##5##2##(2008-4#3)(2009-9#1)(2012-2#1)
tobacco consumption##2##2##(1994-6#2)
tobacco dependence##4##2##(1997-3#1)(2010-11#2)(2013-7#1)
tobacco exhibiting##2##2##(2008-10#2)
tobacco in##5##2##(1992-6#1)(2008-1#2)(2008-10#2)
tobacco industry##2##2##(2009-7#2)
tobacco ingredients##2##2##(2009-7#2)
tobacco leaf##2##2##(2008-10#2)
tobacco leaves##4##2##(2008-10#4)
tobacco markets and##2##3##(2009-7#2)
tobacco mosaic virus isolated from##2##5##(2008-8#1)(2008-9#1)
tobacco mosaic virus##10##3##(1997-3#1)(2008-10#4)(2008-7#2)(2008-8#1)(2008-9#2)
tobacco mosaic##11##2##(1997-3#1)(2008-10#5)(2008-7#2)(2008-8#1)(2008-9#2)
tobacco plants in##2##3##(2008-10#2)
tobacco plants were##2##3##(2008-10#2)
tobacco plants with##2##3##(2008-10#2)
tobacco plants##22##2##(2008-10#17)(2008-8#2)(2009-8#2)(2011-10#1)
tobacco protoplasts##9##2##(2008-10#4)(2008-11#1)(2008-8#4)
tobacco samples##2##2##(2008-10#2)
tobacco smoke and##2##3##(1996-3#1)(2008-10#1)
tobacco smoke components##2##3##(2013-1#2)
tobacco smoke##8##2##(1991-3#1)(1993-11#1)(1996-3#2)(2008-10#1)(2013-1#3)
tobacco suspension cell##2##3##(2008-10#2)
tobacco suspension##3##2##(2008-10#2)(2008-8#1)
tobacco use and##2##3##(1997-1#1)(2008-4#1)
tobacco use control##2##3##(1997-1#2)
tobacco use##11##2##(1994-3#1)(1997-1#6)(2008-11#1)(2008-4#2)(2008-9#1)
tobacco was##2##2##(1994-12#1)(2008-9#1)
tobacco##242##1##(1990-2#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-2#1)(1992-6#8)(1992-9#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-2#1)(1996-1#6)(1996-3#2)(1996-8#1)(1997-1#8)(1997-3#2)(1997-8#1)(2008-1#3)(2008-10#120)(2008-11#5)(2008-4#9)(2008-7#4)(2008-8#13)(2008-9#7)(2009-10#1)(2009-5#1)(2009-6#5)(2009-7#10)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2011-10#2)(2012-12#1)(2012-2#3)(2013-1#7)(2013-7#1)
tobacco-free##2##1##(2008-6#2)
tobacco-related morbidity and mortality##2##4##(1997-1#1)(2008-6#1)
tobacco-related##3##1##(1997-1#2)(2008-6#1)
tobacco-specific##2##1##(1993-11#1)(2013-8#1)
tobaccos##2##1##(2008-8#2)
tobamovirus##7##1##(1995-2#1)(1997-3#1)(2008-10#5)
tobamoviruses##3##1##(1997-3#1)(2008-10#2)
tobe##3##1##(2008-11#3)
tobramycin##2##1##(1991-3#1)(2008-7#1)
tocochromanol##2##1##(2008-11#2)
tocopherol acetate into SLN##3##4##(2008-5#3)
tocopherol acetate##5##2##(2008-5#5)
tocopherol##14##1##(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#9)(2009-8#1)
tocopherols in##2##2##(2008-10#1)(2008-5#1)
tocopherols##5##1##(1992-9#1)(2008-10#3)(2008-5#1)
tocopheroxyl##2##1##(1992-9#2)
tocopheryl O-glycosides##2##2##(2009-8#2)
tocotrienols##3##1##(1992-9#2)(2008-11#1)
today and in the future##2##5##(2008-12#1)(2008-4#1)
today and to##2##3##(1994-5#1)(2013-8#1)
today and##9##2##(1994-5#1)(1996-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2011-3#1)(2012-9#1)(2013-8#1)
today as##2##2##(1997-3#1)(2008-7#1)
today in##2##2##(2011-2#2)
today is##6##2##(1991-1#1)(1991-2#2)(1993-6#1)(1994-1#1)(2011-2#1)
today than##2##2##(2008-11#1)(2008-5#1)
today that##2##2##(1990-8#1)(1993-6#1)
today the##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
today to##2##2##(1994-1#1)(2008-5#1)
today##94##1##(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#2)(1991-3#3)(1991-6#2)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#3)(1994-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#3)(2008-10#10)(2008-11#9)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-5#1)(2011-2#6)(2011-3#3)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
today's changing##2##2##(1994-3#1)(1997-1#1)
today's health care##5##3##(1991-12#1)(1991-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
today's##37##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-12#1)(1992-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#3)(1997-3#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
today?]##2##1##(1997-3#1)(1997-4#1)
toddlers##8##1##(1992-12#2)(2011-2#1)(2012-2#5)
toe deformity##2##2##(2010-11#1)(2010-3#1)
toe nails##2##2##(2008-5#2)
toe##14##1##(1993-12#1)(1996-8#1)(2008-5#2)(2010-11#4)(2010-3#3)(2010-6#1)(2012-3#1)(2013-1#1)
toes##5##1##(1997-3#2)(2010-6#1)(2012-12#1)(2012-3#1)
toffee##2##1##(2008-10#2)
together a number of##2##4##(1994-12#1)(2008-4#1)
together a##3##2##(1994-12#1)(2008-4#1)(2011-2#1)
together and form a##2##4##(2007-12#1)(2008-10#1)
together and that##2##3##(2008-10#1)(2008-7#1)
together and were##2##3##(2008-10#2)
together and##11##2##(1996-1#2)(2007-12#1)(2008-10#5)(2008-12#1)(2008-7#1)(2012-2#1)
together are##2##2##(1995-2#1)(2008-10#1)
together as##3##2##(2008-11#2)(2009-10#1)
together at##2##2##(2008-10#2)
together by a##2##3##(2008-4#1)(2008-8#1)
together different##2##2##(2008-11#1)(2010-3#1)
together for##5##2##(2008-10#2)(2008-11#1)(2008-6#2)
together health##2##2##(2008-1#1)(2011-9#1)
together in a##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
together in the##2##3##(2008-10#1)(2012-7#1)
together in##12##2##(2008-10#5)(2008-7#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-7#1)(2013-1#2)
together into a##3##3##(2008-10#2)(2008-5#1)
together into##4##2##(1996-12#1)(2008-10#2)(2008-5#1)
together make##2##2##(2008-9#1)(2011-2#1)
together many##2##2##(2008-5#1)(2008-9#1)
together some##2##2##(2008-8#1)(2010-5#1)
together the##7##2##(1991-5#1)(1996-1#1)(1997-3#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-3#1)
together these##3##2##(1990-8#1)(1993-3#1)(1993-6#1)
together to develop a##2##4##(1997-2#1)(2010-7#1)
together to##13##2##(1991-2#1)(1992-11#1)(1995-1#1)(1996-3#1)(1997-2#1)(2008-11#2)(2008-3#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-8#1)
together with a highly##2##4##(1993-2#1)(1994-12#1)
together with a new##2##4##(1993-6#1)(2009-7#1)
together with a reduction of##2##5##(1993-12#1)(2008-10#1)
together with a review of the##2##6##(1991-2#1)(2011-2#1)
together with a unique##2##4##(1997-8#1)(2008-5#1)
together with a##34##3##(1991-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-12#1)(1997-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
together with an excellent discussion of the##2##7##(2008-9#2)
together with an##7##3##(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#2)
together with genetic##2##3##(2008-5#1)(2013-8#1)
together with its##4##3##(2008-10#2)(2009-5#1)(2011-1#1)
together with other##8##3##(1990-11#1)(1993-9#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
together with oxygen##2##3##(2008-10#2)
together with previous##4##3##(1991-9#1)(1994-12#1)(2008-11#1)(2012-3#1)
together with some##2##3##(2008-10#1)(2008-12#1)
together with the application of##2##5##(2008-10#1)(2010-11#1)
together with the complete genome sequence and annotation##10##8##(2011-2#10)
together with the complete genome sequence##19##6##(2011-2#19)
together with the complete##20##4##(2011-2#20)
together with the results of##2##5##(1996-11#1)(2008-3#1)
together with the##78##3##(1990-12#1)(1991-6#1)(1993-12#2)(1995-2#3)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-11#2)(2010-5#1)(2011-2#27)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
together with their##5##3##(2008-10#4)(2012-4#1)
together with those##2##3##(1994-11#1)(2008-10#1)
together with two##3##3##(1994-11#1)(2011-3#1)(2012-2#1)
together with##247##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#6)(1994-6#2)(1995-2#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-6#2)(2007-8#1)(2008-1#3)(2008-10#78)(2008-11#16)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#31)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#4)(2012-4#1)(2012-9#1)(2013-1#2)(2013-7#2)(2013-8#2)
together##476##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-8#3)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-7#1)(1993-12#6)(1993-2#3)(1993-3#4)(1993-6#3)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#7)(1994-3#2)(1994-6#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-6#3)(2007-12#3)(2007-8#1)(2008-1#4)(2008-10#132)(2008-11#34)(2008-12#7)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#15)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#13)(2009-10#4)(2009-11#1)(2009-12#4)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2010-11#4)(2010-12#1)(2010-3#2)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#39)(2011-3#2)(2011-9#1)(2012-12#1)(2012-2#14)(2012-3#7)(2012-4#1)(2012-7#2)(2012-9#1)(2013-1#6)(2013-7#2)(2013-8#6)
toilet##3##1##(2008-10#1)(2010-10#1)(2010-11#1)
toiletry##2##1##(2008-5#2)
tokamak##3##1##(1992-8#1)(1993-5#1)(1994-2#1)
tokarensis##2##1##(2008-6#2)
told to##3##2##(1991-8#1)(1992-8#1)(2008-11#1)
told you##2##2##(2008-10#1)(2011-2#1)
told##14##1##(1990-6#1)(1991-8#1)(1992-8#1)(1995-6#2)(2008-1#1)(2008-10#3)(2008-11#1)(2009-10#2)(2011-2#1)(2012-2#1)
tolerability and efficacy of##2##4##(2008-10#1)(2010-12#1)
tolerability and immunogenicity of##2##4##(2007-11#1)(2013-1#1)
tolerability and##11##2##(1991-3#1)(1996-1#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-12#1)(2013-1#1)
tolerability of the##2##3##(1990-2#1)(1996-1#1)
tolerability of##10##2##(1990-2#1)(1990-3#1)(1994-12#1)(1996-1#1)(1997-8#3)(2008-3#1)(2012-3#2)
tolerability##33##1##(1990-2#1)(1990-3#1)(1991-3#1)(1994-12#1)(1996-1#3)(1997-3#1)(1997-8#5)(2007-11#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#1)(2010-11#1)(2010-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
tolerable##13##1##(1992-2#1)(2008-10#11)(2011-2#1)
tolerance and its##2##3##(2008-10#2)
tolerance and the##2##3##(1991-3#1)(2008-5#1)
tolerance and##17##2##(1991-3#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2010-10#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
tolerance at##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
tolerance breaking##2##2##(2008-10#2)
tolerance for most##2##3##(2008-10#2)
tolerance for##5##2##(1995-12#1)(2008-10#4)
tolerance in the##2##3##(1991-1#1)(2008-10#1)
tolerance in##13##2##(1991-1#1)(1995-11#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-9#2)(2013-8#2)
tolerance induction##3##2##(2008-11#2)(2011-3#1)
tolerance interval##2##2##(2008-10#2)
tolerance is the##2##3##(2008-11#1)(2013-8#1)
tolerance is##7##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
tolerance limit of##2##3##(2008-10#2)
tolerance limit##4##2##(2008-10#3)(2008-12#1)
tolerance limits for##3##3##(2008-10#3)
tolerance limits of##6##3##(2008-10#6)
tolerance limits##11##2##(2008-10#11)
tolerance of the##2##3##(2008-10#1)(2011-1#1)
tolerance of##18##2##(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-4#3)(2011-1#2)
tolerance or##2##2##(1994-12#1)(2011-2#1)
tolerance target##2##2##(2009-7#2)
tolerance test##7##2##(1994-12#1)(2008-10#2)(2008-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
tolerance to barley yellow dwarf virus##2##6##(2008-10#2)
tolerance to drought##2##3##(2012-5#1)(2012-7#1)
tolerance to the##5##3##(1992-3#1)(1995-2#2)(1997-2#1)(2008-10#1)
tolerance to##39##2##(1991-1#2)(1992-3#1)(1995-2#2)(1996-2#1)(1997-2#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-8#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-10#2)(2011-2#3)(2012-5#3)(2012-7#2)
tolerance was##3##2##(1992-3#1)(2008-11#1)(2012-5#1)
tolerance##233##1##(1990-5#1)(1991-1#3)(1991-11#1)(1991-3#2)(1992-3#2)(1993-12#1)(1994-12#4)(1995-11#1)(1995-12#2)(1995-2#3)(1996-12#1)(1996-2#4)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#88)(2008-11#14)(2008-12#8)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#2)(2008-8#3)(2008-9#5)(2009-6#1)(2009-7#6)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#4)(2011-1#7)(2011-10#7)(2011-2#11)(2011-3#1)(2012-12#1)(2012-3#8)(2012-5#6)(2012-7#3)(2012-9#1)(2013-1#3)(2013-8#7)
tolerance)##3##1##(2008-11#1)(2008-5#1)(2008-8#1)
tolerances##3##1##(2008-3#2)(2008-7#1)
tolerant CD4 T cells##2##4##(2008-11#2)
tolerant cv##2##2##(2008-10#2)
tolerant host##2##2##(2008-10#2)
tolerant of UVB radiation##2##4##(2008-11#2)
tolerant of##5##2##(2008-10#3)(2008-11#2)
tolerant rats##4##2##(1996-2#3)(1997-2#1)
tolerant to the##2##3##(2008-10#1)(2012-9#1)
tolerant to##8##2##(1994-5#1)(1997-2#1)(2008-10#4)(2008-8#1)(2012-9#1)
tolerant zucchini##2##2##(2008-10#2)
tolerant##42##1##(1994-5#1)(1996-2#3)(1997-2#2)(2008-10#23)(2008-11#4)(2008-12#3)(2008-8#2)(2011-10#2)(2012-9#1)(2013-1#1)
tolerate the##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
tolerate##12##1##(1991-6#1)(1992-3#1)(1993-2#1)(2008-10#4)(2008-11#3)(2008-8#2)
tolerated all##2##2##(2010-7#2)
tolerated and##6##2##(2007-11#1)(2008-10#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
tolerated at##6##2##(1990-11#1)(1997-3#1)(2008-10#4)
tolerated by##7##2##(1992-11#1)(1992-12#1)(2007-8#1)(2008-5#1)(2009-4#1)(2012-3#1)(2012-5#1)
tolerated in considerable amounts##3##4##(2008-10#3)
tolerated in##9##2##(1996-1#1)(2008-10#5)(2008-11#2)(2008-9#1)
tolerated##76##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1991-11#1)(1992-11#1)(1992-12#2)(1994-12#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-3#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#17)(2008-11#5)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#2)
tolerates##3##1##(2008-10#3)
tolerization##3##1##(1995-2#1)(2008-8#2)
tolerized##3##1##(1995-2#1)(2008-11#2)
toll-like receptor##2##2##(2009-8#1)(2012-3#1)
toll-like##3##1##(2009-3#1)(2009-8#1)(2012-3#1)
tolnaftate##4##1##(2008-10#4)
toluene and methyl methacrylate##2##4##(1994-8#2)
toluene and p-xylene were obtained##2##5##(2008-10#2)
toluene and p-xylene##3##3##(2008-10#3)
toluene and xylene##2##3##(2008-10#2)
toluene and##10##2##(1994-8#2)(2008-10#8)
toluene in##2##2##(2008-10#1)(2008-7#1)
toluene or xylene##3##3##(2008-10#3)
toluene solubility##2##2##(2008-10#2)
toluene##63##1##(1994-8#3)(2008-10#50)(2008-7#9)(2012-2#1)
toluene)##2##1##(2008-10#1)(2008-7#1)
toluidine blue O##5##3##(2008-10#5)
toluidine blue and##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
toluidine blue o##2##3##(2008-10#2)
toluidine blue##11##2##(1992-12#1)(2008-10#8)(2008-5#1)(2011-2#1)
toluidine##13##1##(1992-12#1)(2008-10#9)(2008-5#2)(2011-2#1)
tomatine##2##1##(2008-8#2)
tomato (Lycopersicon esculentum) and##2##4##(2008-10#2)
tomato (Lycopersicon esculentum)##6##3##(2008-10#6)
tomato (Lycopersicon##7##2##(2008-10#7)
tomato DC3000 hrp mutants##2##4##(2008-10#2)
tomato DC3000##5##2##(2008-10#5)
tomato and potato crops##2##4##(2008-10#2)
tomato and potato##11##3##(2008-10#11)
tomato and##26##2##(2008-10#26)
tomato as a host##2##4##(2008-8#1)(2011-2#1)
tomato by##4##2##(2008-10#4)
tomato caused by Fusarium oxysporum f##2##6##(2008-10#2)
tomato caused by##3##3##(2008-10#3)
tomato crops##5##2##(2008-10#5)
tomato cultivars##7##2##(2008-10#7)
tomato fields and##2##3##(2008-10#2)
tomato fields##4##2##(2008-10#4)
tomato fruits##4##2##(2008-10#2)(2011-2#2)
tomato genotypes that exhibit different levels of##2##7##(2008-10#2)
tomato genotypes##4##2##(2008-10#4)
tomato in the##2##3##(2008-10#2)
tomato in##9##2##(2008-10#9)
tomato isolate##2##2##(2008-10#2)
tomato isolates##5##2##(2008-10#5)
tomato late blight##3##3##(2008-10#3)
tomato leaf curl virus##2##4##(2008-10#2)
tomato leaf tissue##2##3##(2008-10#2)
tomato leaf##7##2##(2008-10#7)
tomato leaves##6##2##(2008-10#6)
tomato lines##3##2##(2008-10#3)
tomato mottle##3##2##(2008-10#3)
tomato or##2##2##(2008-10#2)
tomato pathogens##4##2##(2008-10#4)
tomato plant##2##2##(2008-10#2)
tomato plants and##2##3##(2008-10#2)
tomato plants from##2##3##(2008-10#2)
tomato plants grown in##3##4##(2008-10#3)
tomato plants treated with##2##4##(2008-10#2)
tomato plants##42##2##(2008-10#41)(2009-8#1)
tomato population##2##2##(2008-8#2)
tomato production areas##2##3##(2008-10#2)
tomato production##6##2##(2008-10#6)
tomato race 1 (T1)##2##4##(2008-10#2)
tomato race##5##2##(2008-10#5)
tomato resistance##2##2##(2008-10#2)
tomato root##2##2##(2008-10#1)(2008-11#1)
tomato roots was##2##3##(2008-10#2)
tomato roots##10##2##(2008-10#10)
tomato seedlings##3##2##(2008-10#3)
tomato seeds##2##2##(2008-10#2)
tomato spotted wilt virus (TSWV)##2##5##(2008-10#2)
tomato spotted wilt virus##4##4##(2008-10#4)
tomato spotted wilt##5##3##(2008-10#5)
tomato stem##2##2##(2008-10#2)
tomato than##3##2##(2008-10#1)(2008-8#2)
tomato transplants##2##2##(2008-10#2)
tomato was##3##2##(2008-10#3)
tomato were tested for##2##4##(2008-10#2)
tomato were##7##2##(2008-10#7)
tomato yellow leaf curl virus##2##5##(2008-10#2)
tomato yellow leaf curl##3##4##(2008-10#3)
tomato##344##1##(1992-8#1)(1993-12#1)(1995-2#2)(2008-10#323)(2008-11#1)(2008-8#10)(2008-9#1)(2009-8#1)(2011-2#4)
tomato-growing areas##2##2##(2008-10#2)
tomato-growing##4##1##(2008-10#4)
tomato-infecting##2##1##(2008-10#2)
tomatoes and##2##2##(2008-10#2)
tomatoes are grown##3##3##(2008-10#3)
tomatoes##15##1##(2007-12#1)(2008-10#12)(2008-2#2)
tombusvirus species and##2##3##(2008-10#2)
tombusvirus##5##1##(2008-10#5)
tomentosa##2##1##(2012-2#2)
tomographic and##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
tomographic angiography##4##2##(2010-9#1)(2011-2#1)(2013-1#2)
tomographic imaging##2##2##(2007-12#1)(2013-1#1)
tomographic severity##2##2##(1990-3#1)(2009-8#1)
tomographic##32##1##(1990-3#1)(1991-2#1)(1993-6#1)(1995-8#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#5)(2009-10#2)(2009-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#8)
tomography (CT) and magnetic resonance##2##5##(2011-2#2)
tomography (CT) and##6##3##(2008-9#1)(2011-2#2)(2012-2#3)
tomography (CT) is##4##3##(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
tomography (CT) scan##9##3##(1996-9#1)(2008-12#1)(2008-7#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
tomography (CT) scans##4##3##(2008-7#2)(2011-2#1)(2013-8#1)
tomography (CT)##42##2##(1991-3#1)(1996-9#1)(2008-12#4)(2008-7#5)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-7#1)(2011-2#7)(2011-3#1)(2012-2#10)(2012-3#2)(2013-1#3)(2013-8#2)
tomography (HRCT)##4##2##(1991-12#2)(2011-2#2)
tomography (PET)##6##2##(1990-8#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-7#1)(2011-2#1)
tomography (PET/CT)##2##2##(2009-2#1)(2012-12#1)
tomography and magnetic resonance imaging scans##2##6##(2008-9#1)(2011-2#1)
tomography and magnetic resonance imaging##8##5##(1990-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#3)
tomography and##17##2##(1990-12#1)(1991-11#1)(1994-3#1)(2007-9#1)(2008-2#1)(2008-7#3)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#5)
tomography examination##2##2##(2008-1#1)(2010-3#1)
tomography for##2##2##(2008-3#1)(2011-7#1)
tomography in patients##3##3##(1991-3#1)(2008-12#1)(2012-2#1)
tomography in the diagnosis##3##4##(2011-7#2)(2012-2#1)
tomography in the##5##3##(2008-7#1)(2010-12#1)(2011-7#2)(2012-2#1)
tomography in##18##2##(1990-11#1)(1991-3#1)(1994-1#1)(1996-2#1)(2007-12#1)(2008-12#3)(2008-7#2)(2010-12#1)(2011-2#1)(2011-7#3)(2012-2#2)(2013-2#1)
tomography is##3##2##(2008-3#3)
tomography of the##2##3##(1997-8#1)(2007-8#1)
tomography of##4##2##(1993-11#1)(1997-8#1)(2007-8#1)(2010-12#1)
tomography revealed##2##2##(2010-10#1)(2013-1#1)
tomography scan##8##2##(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
tomography scans##6##2##(2008-11#3)(2008-7#2)(2009-8#1)
tomography showed a##2##3##(2008-12#1)(2013-8#1)
tomography showed bilateral##2##3##(1990-3#1)(1997-3#1)
tomography showed##6##2##(1990-3#1)(1997-3#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
tomography were##2##2##(2012-2#1)(2013-1#1)
tomography with##4##2##(1993-9#1)(1997-8#1)(2008-3#1)(2008-7#1)
tomography##244##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#2)(1993-11#1)(1993-9#1)(1994-1#2)(1994-3#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#3)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#7)(2008-12#17)(2008-2#3)(2008-3#14)(2008-5#1)(2008-7#17)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#4)(2010-12#9)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#34)(2011-3#1)(2011-7#19)(2012-12#4)(2012-2#23)(2012-3#5)(2013-1#14)(2013-2#1)(2013-7#1)(2013-8#5)
tomography]##2##1##(1990-3#1)(2007-8#1)
tomorrow##7##1##(1990-2#1)(1993-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-12#1)(2011-3#1)
tomorrow's health##2##2##(1994-1#1)(1997-3#1)
tomorrow's##5##1##(1993-3#2)(1994-1#1)(1996-1#1)(1997-3#1)
tomotherapy##2##1##(2008-11#2)
ton/ha##2##1##(2008-10#2)
tone and##2##2##(1997-4#1)(2010-10#1)
tone of##4##2##(1995-2#2)(2008-11#1)(2008-5#1)
tone patterns##2##2##(1995-12#2)
tone was##2##2##(1995-12#1)(1995-2#1)
tone##44##1##(1991-1#1)(1992-9#1)(1995-12#4)(1995-2#12)(1997-4#4)(2006-6#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-1#1)(2010-10#1)(2011-2#1)(2012-3#1)(2012-4#1)
tone)##2##1##(2008-3#1)(2008-5#1)
tones and##4##2##(2008-11#1)(2008-9#2)(2011-1#1)
tones##7##1##(1995-12#2)(2008-11#1)(2008-9#3)(2011-1#1)
tongue and##5##2##(1993-1#2)(1997-6#1)(2008-5#1)(2013-1#1)
tongue based on##3##3##(2008-10#3)
tongue##36##1##(1993-1#3)(1995-8#1)(1995-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(2008-10#12)(2008-5#1)(2010-1#1)(2010-6#1)(2010-7#2)(2013-1#8)(2013-8#2)
tonic##11##1##(1994-2#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2011-2#2)
tonically##2##1##(1994-2#1)(1997-2#1)
tonometry##5##1##(2012-3#3)(2013-1#1)(2013-3#1)
tonoplast##5##1##(2008-10#2)(2008-11#3)
tons of##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
tons##4##1##(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
tonsil##2##1##(2008-5#1)(2008-8#1)
tonsillar##3##1##(1990-6#2)(1995-12#1)
tonsillectomy##8##1##(1995-1#1)(1995-11#1)(2013-1#6)
tonsillitis##6##1##(1993-8#1)(1997-4#1)(2011-2#4)
tonsurans was##2##2##(2008-5#2)
tonsurans##7##1##(2008-5#6)(2012-3#1)
too are##2##2##(1996-1#1)(2008-5#1)
too close to##2##3##(2008-10#2)
too costly to##3##3##(2008-10#1)(2008-9#2)
too different##2##2##(2008-10#1)(2013-1#1)
too early to##3##3##(2008-1#1)(2008-5#1)(2011-3#1)
too expensive##6##2##(1995-12#1)(1996-5#1)(1997-6#1)(2008-11#1)(2010-11#1)(2013-1#1)
too far##2##2##(1993-3#1)(1995-12#1)
too great##3##2##(2008-8#2)(2008-9#1)
too have##2##2##(1994-8#1)(1996-1#1)
too high##7##2##(1991-6#1)(1992-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
too large to##5##3##(1993-12#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
too large##7##2##(1993-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
too late##5##2##(1995-6#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)
too limited##2##2##(1991-6#1)(1994-3#1)
too little##2##2##(2009-3#1)(2010-10#1)
too long##2##2##(2008-11#1)(2011-2#1)
too low to##2##3##(2008-10#1)(2008-8#1)
too low##9##2##(1992-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)
too many##3##2##(1993-2#1)(2010-12#1)(2011-2#1)
too much##5##2##(1997-2#1)(2009-3#2)(2011-2#1)(2013-1#1)
too often##3##2##(1996-12#1)(1996-2#1)(1997-5#1)
too simple##2##2##(2010-2#1)(2010-8#1)
too small to be##2##4##(1991-3#2)
too small to##5##3##(1991-3#2)(1994-12#1)(1994-9#1)(2008-10#1)
too small##7##2##(1991-3#2)(1994-12#1)(1994-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
too variable##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
too wide##2##2##(2008-8#2)
too young##2##2##(2012-3#1)(2013-1#1)
too##135##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#19)(2008-11#8)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#7)(2009-3#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
took 1##2##2##(1995-11#1)(2008-11#1)
took a##4##2##(2008-10#3)(2013-1#1)
took advantage of##3##3##(2008-12#1)(2008-9#1)(2009-10#1)
took into account##3##3##(1992-9#1)(2008-10#2)
took longer##2##2##(2008-10#1)(2008-8#1)
took more##2##2##(2008-10#1)(2013-1#1)
took part in the study##2##5##(2008-11#1)(2008-7#1)
took part in the##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
took part in this study##2##5##(2008-10#1)(2008-7#1)
took part in this##4##4##(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
took part in##10##3##(1996-11#1)(2008-10#3)(2008-11#2)(2008-7#2)(2011-2#1)(2013-1#1)
took part##11##2##(1996-11#1)(2008-10#3)(2008-11#2)(2008-7#2)(2011-2#1)(2011-7#1)(2013-1#1)
took place at##2##3##(2008-11#1)(2008-6#1)
took place between##2##3##(1997-3#1)(2010-3#1)
took place in the##5##4##(1992-1#1)(1993-3#1)(1996-3#1)(2008-11#1)(2010-10#1)
took place in##14##3##(1992-1#1)(1993-3#2)(1996-3#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
took place under##3##3##(2008-10#1)(2011-2#2)
took place##35##2##(1992-1#1)(1993-3#2)(1995-3#1)(1996-3#1)(1997-3#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
took##84##1##(1991-3#1)(1991-6#1)(1992-1#2)(1992-9#1)(1993-1#1)(1993-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-10#22)(2008-11#10)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#6)(2013-8#1)
tool and##3##2##(1996-1#1)(2008-11#1)(2013-1#1)
tool as a##2##3##(2008-11#2)
tool as##5##2##(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)
tool available##2##2##(2008-1#1)(2013-1#1)
tool between##2##2##(1996-1#1)(2008-11#1)
tool for a##2##3##(1994-6#1)(1997-6#1)
tool for accelerating##2##3##(2010-11#1)(2013-8#1)
tool for analysis of##2##4##(2008-1#1)(2011-3#1)
tool for analyzing##2##3##(1997-3#1)(2008-3#1)
tool for assessing the##2##4##(2008-4#1)(2008-5#1)
tool for cancer##2##3##(2008-7#1)(2009-12#1)
tool for characterizing##2##3##(2008-10#1)(2008-5#1)
tool for diagnosis##2##3##(2008-9#1)(2011-2#1)
tool for early##2##3##(2008-10#1)(2010-9#1)
tool for evaluating##3##3##(1990-8#1)(2011-2#1)(2012-2#1)
tool for examining##2##3##(1995-11#1)(2008-9#1)
tool for health care##2##4##(1993-3#1)(2009-8#1)
tool for identifying##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
tool for in##2##3##(2008-10#2)
tool for leaders##2##3##(1996-1#1)(1997-1#1)
tool for measuring##2##3##(2008-11#1)(2010-10#1)
tool for molecular##2##3##(1995-11#1)(2008-9#1)
tool for monitoring##2##3##(2009-12#1)(2011-2#1)
tool for studies of##2##4##(2008-10#1)(2008-11#1)
tool for studies##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
tool for studying##5##3##(1991-6#1)(1993-6#1)(2008-11#1)(2008-5#1)(2008-8#1)
tool for the detection of##4##5##(2008-10#3)(2008-11#1)
tool for the detection##5##4##(2008-10#4)(2008-11#1)
tool for the determination of##2##5##(2008-10#1)(2010-11#1)
tool for the evaluation of##3##5##(1996-12#1)(2008-10#1)(2009-1#1)
tool for the rapid##2##4##(2008-10#2)
tool for the study of##3##5##(2008-11#1)(2008-4#1)(2008-9#1)
tool for the##35##3##(1990-2#1)(1991-2#1)(1992-12#1)(1996-12#1)(2008-10#18)(2008-11#3)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2013-1#1)
tool for understanding##2##3##(1996-1#1)(2008-8#1)
tool for##174##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-11#2)(1996-1#2)(1996-12#1)(1997-1#2)(1997-3#2)(1997-6#2)(2008-1#3)(2008-10#57)(2008-11#20)(2008-12#2)(2008-3#6)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#6)(2009-1#1)(2009-12#4)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
tool has not been##2##4##(1994-1#1)(2008-11#1)
tool has##3##2##(1994-1#1)(2008-11#1)(2008-5#1)
tool in clinical##2##3##(2008-12#1)(2008-9#1)
tool in the diagnosis##2##4##(1992-2#1)(2008-12#1)
tool in the evaluation##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
tool in the management of##4##5##(2008-10#1)(2008-12#1)(2011-1#1)(2013-1#1)
tool in the treatment of##4##5##(1990-11#1)(1991-1#1)(1996-9#1)(2008-9#1)
tool in the##28##3##(1990-11#1)(1991-1#1)(1992-2#1)(1996-9#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-9#5)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
tool in##63##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-2#1)(1996-3#1)(1996-9#1)(2008-10#14)(2008-11#7)(2008-12#5)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#9)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
tool is##4##2##(1990-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
tool of##4##2##(1991-3#1)(1994-12#1)(2008-10#1)(2008-11#1)
tool that##7##2##(1993-3#1)(1995-2#1)(2008-10#1)(2008-12#2)(2008-3#1)(2011-2#1)
tool to aid##2##3##(2011-2#1)(2012-2#1)
tool to assess the##2##4##(2008-12#1)(2013-1#1)
tool to assess##5##3##(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#2)
tool to characterize##2##3##(1990-7#1)(2010-1#1)
tool to develop##2##3##(2008-10#1)(2008-5#1)
tool to elucidate##2##3##(2008-10#1)(2008-11#1)
tool to evaluate##2##3##(2008-11#2)
tool to guide##2##3##(2008-9#1)(2009-10#1)
tool to identify##5##3##(2008-11#1)(2008-2#1)(2009-10#1)(2010-9#1)(2012-2#1)
tool to improve##2##3##(1996-12#1)(2013-1#1)
tool to investigate the##4##4##(1997-2#1)(2008-11#1)(2012-3#1)(2013-8#1)
tool to investigate##7##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-8#1)
tool to measure##2##3##(2008-4#1)(2010-12#1)
tool to monitor##2##3##(2008-10#1)(2008-4#1)
tool to predict##2##3##(2008-5#1)(2011-2#1)
tool to quantify##2##3##(2008-10#2)
tool to##84##2##(1990-7#1)(1992-12#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#5)(2008-9#3)(2009-10#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
tool was##7##2##(2008-11#3)(2008-12#2)(2012-12#1)(2013-8#1)
tool with##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
tool##442##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#1)(1996-1#6)(1996-12#4)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-6#2)(2008-1#5)(2008-10#111)(2008-11#57)(2008-12#19)(2008-2#2)(2008-3#11)(2008-4#13)(2008-5#13)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#23)(2009-1#1)(2009-10#6)(2009-12#5)(2009-5#3)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#5)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#4)(2011-2#12)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#10)
toolkit##6##1##(2008-10#1)(2008-12#1)(2009-12#3)(2013-8#1)
toolkits##2##1##(2008-12#1)(2012-2#1)
tools and analyses##2##3##(1994-3#1)(2010-10#1)
tools and the##3##3##(2008-10#1)(2008-8#1)(2010-10#1)
tools and##22##2##(1993-3#2)(1994-2#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
tools are the##2##3##(1991-3#1)(1994-2#1)
tools are##7##2##(1991-3#1)(1994-1#1)(1994-2#1)(2008-2#1)(2008-8#1)(2010-11#1)(2013-8#1)
tools available##2##2##(2008-4#1)(2011-2#1)
tools can##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)
tools for detection and quantification of##2##6##(2008-10#2)
tools for future##2##3##(2010-11#1)(2012-3#1)
tools for the##10##3##(2008-10#4)(2008-11#3)(2008-4#1)(2010-11#1)(2012-2#1)
tools for understanding##2##3##(1994-12#1)(2008-11#1)
tools for##52##2##(1990-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(2008-10#12)(2008-11#9)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-11#4)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
tools have been##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
tools have##6##2##(1996-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-12#1)
tools in cell##2##3##(2008-11#1)(2008-4#1)
tools in the##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
tools in##27##2##(1993-3#1)(1995-3#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-4#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
tools is##3##2##(1997-7#1)(2008-10#1)(2013-1#1)
tools may##2##2##(2012-3#1)(2013-8#1)
tools of TQM##2##3##(1993-12#1)(1994-1#1)
tools of##7##2##(1993-12#1)(1994-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-5#1)
tools or##2##2##(2008-10#1)(2010-12#1)
tools such as a##2##4##(2008-10#2)
tools such as##5##3##(1990-3#1)(2008-10#2)(2008-11#1)(2008-6#1)
tools that are##6##3##(1994-12#1)(2008-12#1)(2009-10#1)(2010-11#1)(2011-3#1)(2012-3#1)
tools that can##2##3##(2008-12#1)(2013-1#1)
tools that may##2##3##(2008-10#1)(2008-7#1)
tools that##14##2##(1994-12#1)(2008-10#3)(2008-12#2)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
tools to assess##3##3##(2008-10#2)(2012-3#1)
tools to create##3##3##(1996-1#1)(2008-11#1)(2010-7#1)
tools to evaluate##2##3##(2008-10#1)(2011-2#1)
tools to further##2##3##(2008-11#1)(2008-6#1)
tools to help the##2##4##(1991-2#1)(2008-10#1)
tools to help##3##3##(1991-2#2)(2008-10#1)
tools to measure##2##3##(1992-12#1)(2008-9#1)
tools to##36##2##(1991-2#2)(1992-12#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#2)(2008-9#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
tools used##3##2##(1990-12#1)(1992-2#1)(2008-2#1)
tools were##3##2##(2008-10#3)
tools##299##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#3)(1991-3#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-1#5)(1994-12#2)(1994-2#3)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#8)(1996-12#1)(1997-2#1)(1997-3#3)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#66)(2008-11#29)(2008-12#7)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#8)(2009-10#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#6)(2010-11#11)(2010-12#4)(2010-4#1)(2010-5#3)(2010-7#4)(2010-8#7)(2010-9#4)(2011-1#3)(2011-2#13)(2011-3#3)(2012-12#3)(2012-2#7)(2012-3#9)(2013-1#14)(2013-8#5)
toosendanin##3##1##(2008-11#3)
tooth brushing frequency and##2##4##(2012-2#2)
tooth brushing##3##2##(2012-2#3)
tooth erosion around orthodontic brackets##2##5##(2013-1#2)
tooth germs##3##2##(2009-3#2)(2013-1#1)
tooth preparation##2##2##(1991-2#1)(2013-1#1)
tooth stains##5##2##(2013-1#5)
tooth structure##4##2##(1991-2#2)(2008-7#1)(2010-10#1)
tooth supported##2##2##(2013-1#2)
tooth##47##1##(1991-2#5)(1996-2#1)(1996-3#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-3#2)(2009-7#2)(2010-10#3)(2011-2#2)(2012-2#3)(2013-1#23)
tooth-row##2##1##(2008-8#2)
toothpaste##10##1##(2008-5#4)(2011-2#6)
toothpastes containing##2##2##(2008-5#1)(2011-2#1)
toothpastes##10##1##(2008-5#8)(2011-2#2)
toothpick causing pseudotumor of the first metatarsal##2##7##(2008-12#2)
toothpick##6##1##(2008-10#1)(2008-12#5)
top of an##2##3##(2008-10#1)(2008-4#1)
top of the##9##3##(1995-6#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-6#1)
top of##18##2##(1995-6#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#1)(2010-6#1)(2013-8#1)
top trophic##2##2##(2008-8#1)(2008-9#1)
top##75##1##(1990-12#1)(1991-6#1)(1993-12#1)(1993-3#2)(1994-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-7#1)(2007-11#1)(2008-10#34)(2008-11#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-11#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
top-down modulation of##3##3##(2008-11#1)(2013-8#2)
top-down##8##1##(2008-11#3)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#2)
top-managers and##2##2##(1990-12#2)
top-of-the-atmosphere##2##1##(2008-3#2)
topic and##3##2##(2008-10#1)(2009-12#1)(2013-1#1)
topic in##6##2##(2008-10#3)(2008-3#1)(2009-5#1)(2012-12#1)
topic is##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
topic of the##3##3##(2008-12#2)(2011-2#1)
topic of##11##2##(2008-10#1)(2008-11#4)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
topic with##2##2##(2008-12#1)(2013-8#1)
topic##53##1##(1990-9#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-6#1)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#3)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
topical administration of##2##3##(2008-5#1)(2011-2#1)
topical administration##3##2##(2008-5#1)(2010-12#1)(2011-2#1)
topical agents##2##2##(2008-5#1)(2011-2#1)
topical and##2##2##(2007-12#1)(2008-12#1)
topical antifungal therapy##2##3##(2012-3#2)
topical antifungal##3##2##(2011-2#1)(2012-3#2)
topical application of##8##3##(1992-8#2)(1996-10#1)(2008-5#3)(2011-2#1)(2013-1#1)
topical application##13##2##(1992-8#2)(1996-10#1)(2008-12#2)(2008-5#6)(2011-2#1)(2013-1#1)
topical corticosteroids##2##2##(2007-11#1)(2012-3#1)
topical therapy##3##2##(1991-8#1)(2008-5#1)(2010-12#1)
topical treatment of##2##3##(1997-8#1)(2008-5#1)
topical treatment##3##2##(1993-11#1)(1997-8#1)(2008-5#1)
topical##58##1##(1990-11#1)(1991-3#1)(1991-8#1)(1992-8#2)(1993-1#2)(1993-11#2)(1996-10#1)(1996-2#1)(1997-2#1)(1997-8#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#3)(2008-5#16)(2008-8#1)(2010-12#3)(2010-3#1)(2011-2#7)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
topically active##2##2##(1993-1#1)(2008-5#1)
topically applied##11##2##(1992-1#1)(2008-5#10)
topically##19##1##(1992-1#1)(1993-1#2)(2008-12#2)(2008-5#14)
topics addressed##2##2##(1997-2#1)(2008-5#1)
topics and##2##2##(1995-3#1)(2008-11#1)
topics are considered##2##3##(1995-12#1)(2008-10#1)
topics are##5##2##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-11#1)
topics as##2##2##(2008-11#1)(2008-9#1)
topics in##2##2##(1992-3#1)(2008-10#1)
topics of interest##2##3##(2008-12#1)(2010-5#1)
topics of##9##2##(1993-1#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
topics such as##4##3##(1994-12#1)(2008-9#1)(2010-12#1)(2011-2#1)
topics that are##2##3##(1997-2#1)(2008-3#1)
topics that##4##2##(1997-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
topics to##2##2##(2010-4#1)(2012-3#1)
topics will##2##2##(1992-9#1)(2008-10#1)
topics##58##1##(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-12#2)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#4)(1997-2#2)(2007-11#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)
topographic##10##1##(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2013-1#1)
topographical organization##3##2##(1994-2#1)(2008-11#2)
topographical##11##1##(1992-5#1)(1994-2#2)(1995-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2013-1#1)
topography analysis##2##2##(1991-12#1)(2008-5#1)
topography and##2##2##(1994-5#1)(2008-2#1)
topography of the##2##3##(1995-3#1)(2008-10#1)
topography of##7##2##(1990-11#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-6#1)
topography##23##1##(1990-11#1)(1991-12#1)(1994-5#2)(1995-2#1)(1995-3#1)(1997-3#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
topoisomerase I##15##2##(1990-7#2)(1993-8#7)(1994-8#2)(2008-11#4)
topoisomerase II beta##5##3##(1995-6#5)
topoisomerase II in##2##3##(1993-8#2)
topoisomerase II##20##2##(1993-8#6)(1994-8#1)(1995-6#9)(2008-11#3)(2008-8#1)
topoisomerase##37##1##(1990-7#2)(1993-8#13)(1994-8#3)(1995-6#10)(2008-11#7)(2008-8#1)(2008-9#1)
topological ordering##2##2##(2012-2#2)
topological##13##1##(1993-5#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-6#2)(2009-3#1)(2012-2#3)
topologically##3##1##(1994-12#1)(2007-12#1)(2008-6#1)
topologies##7##1##(2008-10#3)(2008-6#1)(2010-10#1)(2012-3#2)
topology and##2##2##(2008-10#1)(2008-11#1)
topology by##2##2##(2008-11#1)(2008-6#1)
topology of the##4##3##(1994-5#1)(1995-6#1)(2008-11#1)(2011-2#1)
topology of##6##2##(1992-4#1)(1994-5#1)(1995-6#1)(2008-11#1)(2008-6#1)(2011-2#1)
topology##19##1##(1992-4#3)(1992-7#1)(1994-5#2)(1994-9#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-6#2)(2008-9#1)(2011-2#1)(2012-3#1)
topsoil##3##1##(2008-10#3)
tora##2##1##(2008-11#2)
torch with##2##2##(2008-10#2)
torch##12##1##(2008-10#12)
torquatus##3##1##(2008-7#3)
torque between##3##2##(2013-1#3)
torque in##2##2##(2008-12#1)(2010-3#1)
torque##23##1##(2008-12#5)(2008-3#1)(2009-7#4)(2010-3#1)(2010-7#3)(2012-2#1)(2013-1#7)(2013-8#1)
torques##3##1##(2008-3#1)(2011-2#1)(2013-1#1)
torsion in##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
torsion of the##2##3##(1997-3#2)
torsion of##4##2##(1997-3#2)(2011-2#1)(2012-2#1)
torsion##29##1##(1997-3#2)(2008-10#18)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-2#2)
torsional angles##4##2##(1992-12#3)(1992-4#1)
torsional##9##1##(1992-12#3)(1992-4#1)(1992-9#1)(1994-5#1)(2008-10#2)(2008-3#1)
torso##4##1##(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
torted##2##1##(2008-10#2)
tortuosity##2##1##(2008-11#1)(2011-2#1)
tortuous##6##1##(1996-9#1)(1997-3#2)(2012-3#1)(2013-1#2)
torture##7##1##(1990-6#1)(1995-11#4)(1996-11#1)(2013-1#1)
tortured refugees##2##2##(2013-1#2)
tortured##4##1##(1995-11#1)(2013-1#3)
tospoviral##2##1##(2008-10#2)
tospovirus species##8##2##(2008-10#8)
tospovirus##15##1##(2008-10#15)
tospoviruses from##2##2##(2008-10#2)
tospoviruses in##2##2##(2008-10#2)
tospoviruses##24##1##(2008-10#24)
toss##3##1##(2011-2#3)
total APP##4##2##(1996-12#4)
total As and Sb##2##4##(2008-10#2)
total As##7##2##(2008-10#7)
total BTs##2##2##(2008-11#2)
total CSF##2##2##(1991-2#1)(2008-7#1)
total Cr##4##2##(2008-10#4)
total DNA extracted from##2##4##(2008-10#2)
total DNA of##2##3##(2008-10#1)(2008-9#1)
total DNA##8##2##(1994-8#1)(2008-10#6)(2008-9#1)
total Fe##2##2##(2008-10#2)
total Hg##2##2##(2008-10#2)
total Ig##2##2##(1990-12#2)
total Ins 1##5##3##(1997-1#5)
total Mallet score##2##3##(2013-1#2)
total Medicaid spending##2##3##(1994-1#2)
total Medicaid##5##2##(1991-3#1)(1992-3#2)(1994-1#2)
total Pb##2##2##(2008-10#2)
total RNA was##2##3##(2008-9#1)(2011-2#1)
total RNA##19##2##(1993-2#1)(1994-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#3)(2009-12#3)(2011-2#1)(2012-3#1)
total RNAs##2##2##(1992-6#1)(2008-10#1)
total SA concentration##2##3##(2008-12#2)
total SA##3##2##(2008-12#3)
total Se determination##2##3##(2008-10#2)
total Se##4##2##(2008-10#4)
total abdominal hysterectomy and vaginal hysterectomy##2##6##(1993-12#2)
total abdominal hysterectomy##6##3##(1993-12#2)(1994-2#1)(2013-1#2)(2013-8#1)
total abdominal##9##2##(1993-12#5)(1994-2#1)(2013-1#2)(2013-8#1)
total acidity in soft drinks##2##5##(2008-10#2)
total acidity##5##2##(2008-10#5)
total activity##2##2##(2008-8#1)(2009-8#1)
total aerobic energy##2##3##(2013-8#2)
total amino acids for 1##2##5##(1990-12#2)
total amino acids##7##3##(1990-12#3)(2008-5#3)(2010-4#1)
total amino##8##2##(1990-12#3)(2008-5#3)(2010-4#2)
total amount of##26##3##(1991-6#1)(1993-1#1)(1995-6#1)(1996-12#3)(2008-10#13)(2008-11#3)(2008-8#3)(2010-4#1)
total amount##28##2##(1991-6#1)(1993-1#1)(1995-6#1)(1996-12#3)(2008-10#14)(2008-11#4)(2008-8#3)(2010-4#1)
total amounts of##2##3##(2008-10#2)
total analysis systems (muTAS)##2##4##(2008-10#2)
total analysis systems##3##3##(2008-10#2)(2010-11#1)
total analysis time##7##3##(2008-10#7)
total analysis##11##2##(2008-10#10)(2010-11#1)
total analyte##3##2##(2008-10#3)
total and LDL cholesterol as##2##5##(1992-11#1)(2012-2#1)
total and mercury species determination in##2##6##(2008-10#2)
total and protein-bound homocysteine##4##4##(2008-10#4)
total and##19##2##(1991-2#1)(1992-11#1)(1992-3#1)(1995-3#1)(2008-10#11)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
total anionic##3##2##(2008-10#3)
total ankle replacements##2##3##(2009-7#2)
total ankle##3##2##(2009-7#3)
total anomalous pulmonary venous connection##2##5##(2008-11#2)
total antimony##2##2##(2008-10#2)
total antioxidant activity of##2##4##(2008-10#2)
total antioxidant activity##4##3##(2008-10#3)(2011-2#1)
total antioxidant capacity (TAC)##2##4##(2008-10#2)
total antioxidant capacity##8##3##(2008-10#7)(2009-6#1)
total antioxidant##13##2##(2008-10#10)(2009-6#1)(2009-8#1)(2011-2#1)
total arsenic content##2##3##(2008-10#2)
total arsenic in##5##3##(2008-10#5)
total arsenic##20##2##(1995-11#1)(2008-10#19)
total arsenic) were##2##3##(2008-10#2)
total arsenic)##3##2##(2008-10#3)
total atmospheric##2##2##(1991-6#1)(2008-10#1)
total bacterial count##3##3##(1992-2#3)
total bacterial populations on##2##4##(2008-10#2)
total bacterial##7##2##(1992-2#3)(2008-10#3)(2008-8#1)
total bilirubin in##2##3##(2008-10#1)(2012-3#1)
total bilirubin##10##2##(2007-12#1)(2008-10#3)(2012-3#2)(2013-1#4)
total binding##4##2##(1993-6#3)(1996-2#1)
total biomass##4##2##(2008-10#1)(2008-7#3)
total body irradiation##2##3##(1993-9#2)
total body##13##2##(1992-1#1)(1992-2#1)(1993-9#2)(1997-1#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-1#1)(2013-1#1)
total calcium##2##2##(2008-10#2)
total carbon##4##2##(2008-10#3)(2008-12#1)
total cardiovascular##3##2##(1993-12#2)(2013-1#1)
total carnitine##2##2##(1991-2#2)
total carotenoids and total antioxidants in##2##6##(2011-2#2)
total cationic and total anionic arsenic##2##6##(2008-10#2)
total cationic##3##2##(2008-10#3)
total cell densities##2##3##(2008-11#1)(2008-7#1)
total cell number##2##3##(2008-11#1)(2008-5#1)
total cell protein content##2##4##(1992-8#1)(2008-11#1)
total cell protein##5##3##(1992-8#2)(2008-11#3)
total cell##16##2##(1992-8#2)(1994-8#1)(1995-11#1)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#2)(2009-3#1)
total cells##6##2##(2008-10#3)(2008-7#3)
total cellular protein##2##3##(1990-5#1)(2008-9#1)
total cellular##5##2##(1990-5#1)(1990-8#1)(1994-8#1)(2008-4#1)(2008-9#1)
total chlorophyll##4##2##(2008-10#1)(2008-12#2)(2008-9#1)
total cholesterol (p&lt##2##3##(2008-10#2)
total cholesterol and triglycerides##2##4##(1990-8#2)
total cholesterol and##5##3##(1990-8#2)(1991-11#1)(2008-12#1)(2011-2#1)
total cholesterol levels##2##3##(1994-3#1)(1996-11#1)
total cholesterol##22##2##(1990-8#3)(1991-11#2)(1993-11#1)(1994-12#1)(1994-3#1)(1996-11#1)(2008-10#2)(2008-12#4)(2008-3#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
total chromium in##5##3##(2008-10#5)
total chromium##8##2##(2008-10#8)
total circulating##2##2##(1991-6#1)(2006-6#1)
total collagen##2##2##(2008-5#1)(2010-4#1)
total concentration of the##3##4##(2008-10#3)
total concentration of##11##3##(2008-10#10)(2012-2#1)
total concentration##16##2##(2008-10#13)(2008-11#1)(2011-10#1)(2012-2#1)
total concentrations of##2##3##(2008-10#2)
total content of##5##3##(1992-6#1)(2008-10#4)
total content##7##2##(1992-6#1)(2008-10#6)
total coronary heart disease risk level##2##6##(1991-6#2)
total cost of##3##3##(1990-12#1)(1993-12#1)(1996-11#1)
total cost##5##2##(1990-12#1)(1992-12#2)(1993-12#1)(1996-11#1)
total costs##2##2##(1992-12#2)
total daily##2##2##(1990-12#1)(2008-9#1)
total darkness##2##2##(2008-10#2)
total decomposition of soil##2##4##(2008-10#2)
total decomposition##4##2##(2008-10#4)
total density dependence in##2##4##(2008-8#2)
total density##3##2##(2008-10#1)(2008-8#2)
total determination##2##2##(2008-10#2)
total diet and##2##3##(1994-3#1)(2008-10#1)
total dietary##2##2##(1990-8#1)(2012-2#1)
total discharge##2##2##(1990-12#1)(1991-6#1)
total disease incidence##2##3##(2008-10#2)
total disease##5##2##(2008-10#5)
total dissolution of##2##3##(2008-10#2)
total dissolved##10##2##(2008-10#10)
total dose of##6##3##(1991-11#1)(1991-2#2)(1992-11#1)(2008-11#1)(2013-1#1)
total dose##9##2##(1991-11#1)(1991-2#2)(1992-11#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
total dry weight ha(-1)##2##4##(2008-12#2)
total edentulous patient##2##3##(2013-1#2)
total energy intake##2##3##(2008-4#1)(2012-2#1)
total energy##6##2##(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
total episode##2##2##(1994-2#2)
total episodes of##2##3##(1994-2#1)(2013-1#1)
total error##4##2##(2008-10#1)(2008-3#3)
total evaporation technique##2##3##(2008-10#2)
total evaporation##4##2##(2008-10#3)(2008-5#1)
total excision of the cerebellar##2##5##(2012-3#1)(2013-1#1)
total extraction##2##2##(2008-10#2)
total fatty acids in the##2##5##(2010-4#2)
total fatty##3##2##(2008-7#1)(2010-4#2)
total fears##2##2##(2011-2#2)
total flora##3##2##(2011-2#3)
total flow##2##2##(2008-10#2)
total fluorine##4##2##(2008-10#4)
total fungal spore##2##3##(2008-5#2)
total gastrectomy##3##2##(1990-9#1)(1992-9#1)(2013-1#1)
total gene diversity##2##3##(2008-10#1)(2012-5#1)
total gene##3##2##(2008-10#1)(2010-1#1)(2012-5#1)
total genetic variability##2##3##(2008-10#1)(2008-8#1)
total genetic##7##2##(2008-10#6)(2008-8#1)
total genomic DNA##4##3##(2008-10#4)
total global##2##2##(2010-12#1)(2010-6#1)
total glutathione##2##2##(2008-11#2)
total glycoalkaloids##5##2##(2008-10#5)
total hPRL and##2##3##(2008-11#2)
total health care##3##3##(1993-12#1)(1995-2#1)(1997-2#1)
total health##4##2##(1992-2#1)(1993-12#1)(1995-2#1)(1997-2#1)
total healthcare expenditures##2##3##(2013-1#2)
total hip and total knee##2##5##(1994-3#1)(2009-3#1)
total hip arthroplasty (THA)##5##4##(1994-3#1)(2009-3#1)(2012-2#1)(2013-1#2)
total hip arthroplasty##16##3##(1994-3#1)(1997-6#1)(2008-8#2)(2009-3#2)(2009-4#1)(2012-2#4)(2013-1#5)
total hip or knee##2##4##(2013-1#2)
total hip replacement and##2##4##(1996-1#1)(2010-10#1)
total hip replacement##15##3##(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#2)(2010-10#8)(2013-1#2)
total hip##40##2##(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-1#2)(1996-9#1)(1997-6#1)(2008-8#2)(2009-3#3)(2009-4#2)(2010-1#1)(2010-10#8)(2010-3#2)(2012-2#4)(2013-1#9)
total homocysteine##4##2##(2008-8#4)
total hospital costs##2##3##(1992-2#1)(2012-3#1)
total hospital##5##2##(1991-12#1)(1992-2#1)(1993-1#2)(2012-3#1)
total hours of##2##3##(2008-10#2)
total hours##3##2##(2008-10#3)
total hydrocarbon contents and##2##4##(2008-10#2)
total hydrocarbon##3##2##(2008-10#3)
total infection##2##2##(2008-10#2)
total inorganic As##2##3##(2008-10#2)
total inorganic Se##2##3##(2008-10#2)
total inorganic arsenic##5##3##(2008-10#5)
total inorganic iron##3##3##(2008-10#3)
total inorganic phosphates##5##3##(2008-10#5)
total inorganic##23##2##(2008-10#23)
total internal reflection##2##3##(2008-10#1)(2008-3#1)
total intracellular##4##2##(1990-12#1)(1994-11#1)(1994-3#1)(2008-10#1)
total ionic concentration##2##3##(2008-10#2)
total ionic##4##2##(2008-10#4)
total iron and vanadium##2##4##(2008-10#2)
total iron in##2##3##(2008-10#2)
total iron##10##2##(2008-10#10)
total isolates recovered)##2##3##(2008-10#2)
total isolates##4##2##(1991-3#1)(2008-10#3)
total joint arthroplasty##4##3##(2008-9#1)(2009-3#1)(2012-12#2)
total joint replacement##2##3##(2008-10#1)(2012-3#1)
total joint##7##2##(2008-10#1)(2008-9#1)(2009-3#1)(2012-12#2)(2012-3#2)
total knee arthroplasty (TKA) with##2##5##(2009-3#2)
total knee arthroplasty (TKA)##5##4##(1994-3#1)(2009-3#2)(2013-1#2)
total knee arthroplasty##12##3##(1994-3#2)(2008-8#2)(2009-3#3)(2012-12#1)(2013-1#4)
total knee replacement (TKR)##2##4##(2007-8#1)(2008-8#1)
total knee replacement##5##3##(1994-12#1)(1995-2#1)(2007-8#1)(2008-8#1)(2009-3#1)
total knee##20##2##(1994-12#1)(1994-3#2)(1995-2#1)(1996-9#1)(2007-8#1)(2008-8#5)(2009-3#4)(2012-12#1)(2013-1#4)
total length of the##5##4##(1996-6#1)(1997-6#1)(1997-8#2)(2012-12#1)
total length of##9##3##(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#2)(2012-12#1)(2013-8#2)
total length##10##2##(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#2)(2010-8#1)(2012-12#1)(2013-8#2)
total life##2##2##(1995-12#1)(2008-7#1)
total lipids##3##2##(2008-11#1)(2008-12#1)(2010-11#1)
total load of##2##3##(2008-10#2)
total lung capacity##2##3##(1996-2#2)
total lung##3##2##(1996-2#2)(1996-3#1)
total mean##2##2##(1991-6#1)(2013-1#1)
total measurement time)##2##3##(2008-3#2)
total measurement##3##2##(2008-3#3)
total mercury##14##2##(2008-10#14)
total metal##2##2##(2008-10#2)
total mitochondrial##2##2##(1990-2#1)(1991-5#1)
total nitrogen determination in animal feed##2##6##(2008-10#2)
total nitrogen##5##2##(2008-10#4)(2008-11#1)
total nucleated cells##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
total nucleic##2##2##(1996-12#1)(2008-9#1)
total number of##45##3##(1991-5#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)
total nutrient uptake##2##3##(2008-12#2)
total obliteration##3##2##(1997-6#1)(2008-7#2)
total occlusion of the##3##4##(2008-7#1)(2010-3#1)(2013-8#1)
total occlusion of##4##3##(2008-12#1)(2008-7#1)(2010-3#1)(2013-8#1)
total occlusion##9##2##(1997-3#1)(2008-11#3)(2008-12#2)(2008-7#1)(2010-3#1)(2013-8#1)
total occlusion)##2##2##(2008-7#2)
total of 1##7##3##(1990-9#2)(1991-6#1)(1996-11#1)(2008-10#2)(2012-12#1)
total of 10##6##3##(2008-10#3)(2008-11#1)(2010-11#1)(2013-1#1)
total of 100##4##3##(1995-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
total of 104##3##3##(1994-2#1)(1997-3#1)(2011-2#1)
total of 11##4##3##(1993-8#1)(2008-10#3)
total of 13##2##3##(1997-8#1)(2008-11#1)
total of 156##2##3##(2008-11#1)(2011-2#1)
total of 16##2##3##(2008-11#1)(2008-7#1)
total of 179##2##3##(1992-9#1)(2011-1#1)
total of 185##2##3##(2010-4#1)(2011-2#1)
total of 19##9##3##(1991-11#1)(1997-8#1)(2008-5#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
total of 2##4##3##(1996-3#1)(2008-10#1)(2010-10#1)(2011-2#1)
total of 20##6##3##(1990-8#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-12#1)
total of 200##2##3##(1994-12#1)(2013-8#1)
total of 21##2##3##(1990-3#1)(2008-10#1)
total of 225##2##3##(1997-8#1)(2008-10#1)
total of 25##3##3##(1990-11#1)(2012-2#1)(2013-1#1)
total of 27##2##3##(1990-11#1)(2010-6#1)
total of 3##5##3##(1991-9#1)(1993-1#1)(1996-6#1)(2008-10#1)(2013-1#1)
total of 30##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
total of 33##2##3##(2008-10#2)
total of 36##2##3##(1993-2#1)(2011-2#1)
total of 40 patients##2##4##(2008-5#1)(2013-1#1)
total of 40##5##3##(2008-10#1)(2008-5#1)(2013-1#3)
total of 43##2##3##(2008-10#1)(2010-12#1)
total of 5##2##3##(2013-1#1)(2013-8#1)
total of 50##3##3##(1994-12#1)(2008-11#1)(2008-8#1)
total of 605##2##3##(1991-11#1)(2008-10#1)
total of 82##2##3##(1995-6#1)(1996-12#1)
total of 9##3##3##(1997-4#1)(2008-7#1)(2011-2#1)
total of four##2##3##(2008-10#2)
total of the##2##3##(2008-10#1)(2008-3#1)
total of##323##2##(1990-11#2)(1990-12#4)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-3#3)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#1)(1997-8#5)(2008-1#5)(2008-10#74)(2008-11#15)(2008-12#12)(2008-3#1)(2008-5#7)(2008-7#14)(2008-8#5)(2008-9#5)(2009-1#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#25)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#9)(2013-1#26)(2013-3#1)(2013-7#2)(2013-8#13)
total or partial##2##3##(2008-10#1)(2010-9#1)
total or##5##2##(2008-10#2)(2008-7#1)(2010-7#1)(2010-9#1)
total organic carbon##2##3##(2008-10#2)
total organic##5##2##(2008-10#5)
total parenteral nutrition (TPN)##3##4##(1992-9#2)(2008-10#1)
total parenteral nutrition##6##3##(1991-6#1)(1992-9#2)(2008-10#1)(2009-5#1)(2011-2#1)
total parenteral##7##2##(1991-6#1)(1992-9#2)(2008-10#1)(2009-5#1)(2009-9#1)(2011-2#1)
total phenol##2##2##(2008-10#1)(2013-1#1)
total phenolic content of the##2##5##(2008-10#1)(2008-11#1)
total phenolic content of##3##4##(2008-10#2)(2008-11#1)
total phenolic content##4##3##(2008-10#3)(2008-11#1)
total phenolic##6##2##(2008-10#3)(2008-11#1)(2013-8#2)
total phenotypic variation for resistance##3##5##(2008-10#3)
total phenotypic variation##4##3##(2008-10#4)
total phenotypic##6##2##(2008-10#6)
total phosphorus in##4##3##(2008-10#4)
total phosphorus##7##2##(2008-10#7)
total phosphorylation 0##2##3##(2010-12#2)
total plasma volume##2##3##(2011-2#2)
total plasma##5##2##(1993-11#1)(2008-5#1)(2008-7#1)(2011-2#2)
total plastic strain##3##3##(2009-7#3)
total pollen##2##2##(2008-5#2)
total polyphenol index##2##3##(2008-10#2)
total polyphenol##3##2##(2008-10#3)
total population##8##2##(1992-6#1)(1994-3#1)(1997-3#1)(2008-10#3)(2008-8#1)(2008-9#1)
total power of##2##3##(2008-10#1)(2010-8#1)
total power##3##2##(2008-10#1)(2010-12#1)(2010-8#1)
total precipitation##2##2##(2008-10#2)
total preconcentration time##4##3##(2008-10#4)
total pressure##2##2##(2008-3#1)(2008-7#1)
total proctectomy with##2##3##(2007-8#2)
total protein (r =##2##4##(1993-2#1)(2011-2#1)
total protein amount##2##3##(2008-11#2)
total protein and##3##3##(1992-6#1)(1997-8#1)(2012-2#1)
total protein assay##2##3##(2008-10#2)
total protein in human serum##4##5##(2008-10#4)
total protein##25##2##(1992-6#1)(1993-12#1)(1993-2#2)(1997-8#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
total proteins in##4##3##(2008-10#1)(2008-8#3)
total proteins##10##2##(1994-8#1)(1996-8#1)(2008-10#4)(2008-8#3)(2008-9#1)
total pulse width##2##3##(2008-10#2)
total quality management (TQM)##7##4##(1993-12#1)(1993-3#3)(1994-1#1)(1994-2#1)(1995-3#1)
total quality management process##2##4##(1994-1#1)(1994-2#1)
total quality management##19##3##(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#7)(1994-2#3)(1994-3#1)(1995-3#3)
total quality##23##2##(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#8)(1994-2#3)(1994-3#1)(1995-3#4)
total recovery of##2##3##(2008-10#2)
total recovery##3##2##(2008-10#3)
total reflectance infrared##3##3##(2008-10#3)
total reflectance##8##2##(2008-10#8)
total reflection Fourier transform infrared##2##5##(2008-10#2)
total reflection Fourier transform##3##4##(2008-10#2)(2008-5#1)
total reflection Fourier##4##3##(2008-10#3)(2008-5#1)
total reflection##12##2##(2008-10#11)(2008-5#1)
total relative standard error##2##4##(2008-10#2)
total removal of the##3##4##(2008-12#1)(2008-7#2)
total removal of##5##3##(2008-10#1)(2008-12#1)(2008-7#3)
total removal##9##2##(2008-10#1)(2008-12#1)(2008-7#5)(2012-3#2)
total reproductive success##2##3##(2008-8#2)
total reproductive##4##2##(2008-8#3)(2012-3#1)
total resection of the##2##4##(2008-12#1)(2012-3#1)
total resection of##4##3##(2008-12#1)(2008-7#2)(2012-3#1)
total resection##7##2##(2008-12#1)(2008-7#5)(2012-3#1)
total respiration##2##2##(2008-7#1)(2008-9#1)
total retrieval##2##2##(2008-3#2)
total root tip##2##3##(2008-10#2)
total sample##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
total score##6##2##(2010-10#1)(2010-2#1)(2012-3#2)(2013-1#2)
total screen##2##2##(1991-6#1)(2008-11#1)
total seed##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
total selenium##6##2##(2008-10#5)(2010-11#1)
total serum cholesterol##2##3##(1991-6#1)(2008-3#1)
total serum##7##2##(1991-6#1)(1993-2#1)(2006-6#1)(2008-10#1)(2008-3#2)(2011-2#1)
total sialic acid##2##3##(2008-12#2)
total sialic acids##3##3##(2008-11#3)
total sialic##5##2##(2008-11#3)(2008-12#2)
total sleep time##2##3##(1994-8#1)(2010-7#1)
total soluble phenolic compounds##3##4##(2008-10#3)
total soluble protein in##2##4##(1993-9#1)(1994-5#1)
total soluble protein##3##3##(1993-9#1)(1994-5#1)(2008-9#1)
total soluble##8##2##(1993-9#1)(1994-5#1)(2008-10#4)(2008-9#1)(2011-2#1)
total sulfide##2##2##(2008-10#2)
total sulfur##7##2##(2008-10#7)
total sulphur dioxide##5##3##(2008-10#5)
total sulphur##10##2##(2008-10#10)
total surface##3##2##(1997-1#1)(2008-10#1)(2008-3#1)
total surgical##3##2##(1992-12#1)(1994-5#1)(2010-11#1)
total survival time##2##3##(1995-12#1)(2013-8#1)
total suspended##2##2##(2008-10#2)
total thyroidectomy is the##2##4##(1990-9#1)(1993-6#1)
total thyroidectomy##10##2##(1990-9#2)(1992-5#1)(1993-6#1)(2009-3#1)(2011-2#5)
total time for##2##3##(2008-10#2)
total time interval##2##3##(1994-3#2)
total time of##3##3##(2008-10#3)
total time##12##2##(1994-3#3)(2008-10#8)(2011-1#1)
total treatment duration##4##3##(1996-11#1)(2011-2#3)
total treatment##8##2##(1991-12#1)(1993-9#2)(1996-11#1)(2009-9#1)(2011-2#3)
total trivalent arsenic##2##3##(2008-10#2)
total value##2##2##(2008-10#2)
total variation##4##2##(2008-10#3)(2008-8#1)
total viable counts##2##3##(1997-5#2)
total vitamin E (P=0##2##4##(2008-10#2)
total volume of##3##3##(1990-5#1)(1992-12#1)(2008-10#1)
total volume##5##2##(1990-5#1)(1992-12#1)(2008-10#3)
total water##2##2##(2008-10#1)(2008-5#1)
total worm burden##2##3##(1996-12#2)
total worm##3##2##(1996-12#3)
total x-ray absorption coefficient##2##4##(2012-2#2)
total zirconia##2##2##(2008-10#2)
total##1857##1##(1990-11#2)(1990-12#14)(1990-2#2)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#7)(1990-9#8)(1991-1#1)(1991-11#8)(1991-12#7)(1991-2#8)(1991-3#6)(1991-5#4)(1991-6#17)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#10)(1992-2#8)(1992-3#8)(1992-5#1)(1992-6#6)(1992-8#2)(1992-9#4)(1993-1#8)(1993-11#2)(1993-12#17)(1993-2#9)(1993-3#4)(1993-6#7)(1993-8#3)(1993-9#5)(1994-1#12)(1994-11#6)(1994-12#11)(1994-2#11)(1994-3#17)(1994-5#8)(1994-6#2)(1994-8#11)(1994-9#1)(1995-11#4)(1995-12#3)(1995-2#5)(1995-3#7)(1995-6#3)(1995-8#2)(1996-1#5)(1996-11#6)(1996-12#18)(1996-2#9)(1996-3#10)(1996-6#3)(1996-8#3)(1996-9#2)(1997-1#9)(1997-2#8)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#9)(1997-7#1)(1997-8#10)(2006-6#2)(2007-11#1)(2007-12#3)(2007-8#3)(2008-1#7)(2008-10#684)(2008-11#87)(2008-12#53)(2008-2#7)(2008-3#22)(2008-4#9)(2008-5#24)(2008-6#4)(2008-7#60)(2008-8#55)(2008-9#32)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#6)(2009-3#11)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#11)(2009-8#2)(2009-9#4)(2010-1#5)(2010-10#12)(2010-11#10)(2010-12#8)(2010-2#4)(2010-3#4)(2010-4#12)(2010-5#1)(2010-6#3)(2010-7#6)(2010-8#8)(2010-9#2)(2011-1#9)(2011-10#3)(2011-2#71)(2011-3#5)(2012-12#9)(2012-2#23)(2012-3#30)(2012-5#1)(2012-7#1)(2013-1#93)(2013-3#1)(2013-7#3)(2013-8#29)
total) were##3##2##(2008-10#3)
total)##12##1##(1992-12#1)(1995-11#1)(2008-10#10)
total- and LDL-cholesterol##2##3##(2008-10#2)
total-Fe##3##1##(2008-10#3)
total-body##2##1##(2008-7#1)(2010-11#1)
totaled##3##1##(2008-10#1)(2008-11#2)
totality##4##1##(1993-8#1)(1996-6#1)(2009-8#1)(2011-2#1)
totalling##4##1##(1993-2#1)(1994-6#1)(2008-10#1)(2010-10#1)
totally different##2##2##(2008-10#1)(2008-9#1)
totally in##2##2##(2008-12#1)(2008-4#1)
totally removed and the##2##4##(2008-7#2)
totally removed and##3##3##(2008-7#3)
totally removed##6##2##(2008-7#5)(2012-3#1)
totally##45##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-6#1)(1993-3#1)(1996-1#1)(1996-11#2)(1997-8#1)(2008-10#11)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#8)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
tothe##3##1##(2008-11#3)
totipotent cells##2##2##(2008-11#1)(2008-12#1)
touch and vestibular##2##3##(1995-8#2)
touch and##4##2##(1995-8#2)(2010-9#1)(2012-2#1)
touch by##2##2##(2008-12#1)(2008-9#1)
touch##18##1##(1991-3#1)(1995-12#1)(1995-8#4)(1996-11#1)(1996-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
touched##2##1##(2008-5#1)(2012-2#1)
touches##2##1##(1993-11#1)(1995-2#1)
touching##3##1##(1995-12#1)(1996-3#1)(2008-10#1)
tough##7##1##(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-6#1)(2010-11#1)
toughness##4##1##(2009-7#3)(2010-4#1)
tourniquet##3##1##(2008-1#1)(2011-2#1)(2013-8#1)
tours##4##1##(1992-12#4)
toward B##2##2##(2008-10#2)
toward H(2)O(2)##2##2##(2008-10#1)(2013-1#1)
toward a global##2##3##(2008-9#1)(2010-7#1)
toward a more##4##3##(1993-1#1)(1997-1#1)(2008-9#1)(2011-2#1)
toward a##19##2##(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-9#4)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
toward an##3##2##(1996-11#1)(2008-10#1)(2008-8#1)
toward better##3##2##(1995-11#1)(2008-11#1)(2009-3#1)
toward both##2##2##(2008-10#1)(2008-11#1)
toward control##2##2##(1993-8#1)(2013-8#1)
toward developing a##2##3##(2008-10#1)(2008-6#1)
toward developing##4##2##(2008-10#1)(2008-6#1)(2010-4#1)(2010-7#1)
toward either##2##2##(2008-10#2)
toward extinction##2##2##(2008-8#2)
toward fluoride##4##2##(2008-10#4)
toward greater##5##2##(1991-3#1)(1994-1#1)(1997-2#1)(2008-10#2)
toward health##2##2##(1993-12#1)(2009-5#1)
toward higher##2##2##(2008-10#1)(2008-11#1)
toward identifying the##2##3##(1995-2#1)(1997-2#1)
toward identifying##3##2##(1995-2#1)(1997-2#1)(2008-11#1)
toward improving##3##2##(1995-6#1)(2013-1#1)(2013-8#1)
toward increased##2##2##(1996-3#1)(2008-10#1)
toward less positive##2##3##(2008-10#2)
toward lower##2##2##(2008-10#1)(2013-1#1)
toward making##2##2##(1995-2#1)(1997-3#1)
toward nanotechnology##3##2##(2010-12#3)
toward one##2##2##(1991-3#1)(2008-10#1)
toward parent participation##2##3##(1994-3#2)
toward potassium##2##2##(2008-10#2)
toward providing care##2##3##(1996-2#1)(2011-1#1)
toward providing##5##2##(1996-2#1)(2011-1#4)
toward real-time##2##2##(2011-7#2)
toward resistance##3##2##(2008-10#3)
toward shorter##2##2##(1995-6#1)(2012-3#1)
toward the HCO and its services##2##6##(2011-2#2)
toward the development of##2##4##(2008-3#1)(2009-1#1)
toward the elderly##2##3##(1994-1#1)(2008-11#1)
toward the end of the##2##5##(1992-12#1)(2008-8#1)
toward the oxidation of##2##4##(2008-10#2)
toward the##61##2##(1990-2#1)(1991-2#1)(1991-5#1)(1992-12#2)(1993-1#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-5#2)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#2)(1997-8#2)(2007-11#1)(2008-10#15)(2008-11#4)(2008-3#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#5)(2012-2#1)(2013-8#1)
toward their##5##2##(1992-12#1)(1994-3#1)(1996-2#2)(2009-5#1)
toward this##2##2##(1996-1#1)(2008-9#1)
toward understanding the##2##3##(1991-12#1)(2011-2#1)
toward understanding##3##2##(1991-12#1)(2009-10#1)(2011-2#1)
toward##337##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#6)(1991-5#1)(1992-1#5)(1992-12#4)(1992-6#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#2)(1994-1#2)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#3)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#5)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#5)(1997-7#1)(1997-8#2)(2007-11#1)(2008-10#97)(2008-11#21)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#16)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#6)
towards Cu(II)##3##2##(2008-10#3)
towards H(2)O(2)##2##2##(2008-10#2)
towards HIV infection##2##3##(1994-5#1)(1997-5#1)
towards Hg(2+)##2##2##(2008-10#2)
towards Hg(II)##3##2##(2008-10#3)
towards a##15##2##(1992-9#1)(1996-1#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
towards achieving##2##2##(2008-1#1)(2008-10#1)
towards an increased##2##3##(1997-2#1)(2008-10#1)
towards an##9##2##(1993-1#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)
towards clinical##3##2##(2008-5#3)
towards developing##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
towards different##4##2##(1990-5#1)(2008-10#1)(2009-3#1)(2011-1#1)
towards high##2##2##(2008-10#1)(2008-12#1)
towards higher##3##2##(1990-2#1)(2011-2#2)
towards improvement in##2##3##(2009-3#1)(2011-2#1)
towards improvement##3##2##(2009-3#2)(2011-2#1)
towards in situ##2##3##(2008-10#2)
towards iron supplementation in hemodialysis patients treated##2##7##(2008-1#2)
towards many##2##2##(2008-10#1)(2008-11#1)
towards meeting the##2##3##(2008-12#1)(2008-5#1)
towards more##3##2##(2009-4#1)(2009-7#1)(2010-3#1)
towards other##2##2##(2008-11#1)(2009-6#1)
towards people##2##2##(2008-11#1)(2009-11#1)
towards practice##2##2##(2008-11#2)
towards screening##3##2##(1992-2#2)(1994-11#1)
towards some##2##2##(2008-10#2)
towards the detection of##3##4##(2008-10#2)(2008-11#1)
towards the development of##2##4##(2008-10#2)
towards the end of##3##4##(2008-12#1)(2013-1#2)
towards the goal of##2##4##(2008-10#1)(2012-2#1)
towards the identification of##2##4##(2011-2#1)(2013-1#1)
towards the most##2##3##(1995-5#1)(2008-5#1)
towards the next##2##3##(2009-10#1)(2012-2#1)
towards the oxidation of NO##2##5##(2008-10#2)
towards the oxidation of##5##4##(2008-10#5)
towards the oxidation##6##3##(2008-10#6)
towards the two##2##3##(2008-10#1)(2008-5#1)
towards the##83##2##(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#25)(2008-11#6)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#3)(2013-1#6)(2013-8#2)
towards this##3##2##(2008-11#1)(2012-12#1)(2012-2#1)
towards understanding##3##2##(1997-6#1)(2008-10#1)(2012-2#1)
towards##347##1##(1990-2#1)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#5)(2008-10#103)(2008-11#34)(2008-12#8)(2008-5#10)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#12)(2011-3#3)(2012-12#2)(2012-2#12)(2012-3#1)(2013-1#20)(2013-8#5)
tower##2##1##(2008-10#1)(2008-12#1)
town of Cabar##6##3##(2011-2#6)
town of##9##2##(2008-10#1)(2009-10#1)(2011-2#6)(2012-12#1)
town##16##1##(1990-2#1)(1990-6#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#2)(2011-2#6)(2012-12#1)
towns##5##1##(1993-2#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-11#1)
township in##2##2##(2013-8#2)
township##3##1##(2013-8#3)
tox(-)##3##1##(2008-10#3)
toxic and##11##2##(1990-12#1)(1991-6#1)(1994-11#1)(2007-12#1)(2008-10#5)(2008-8#1)(2008-9#1)
toxic arsenic##3##2##(2008-10#3)
toxic chemicals##5##2##(1994-8#1)(2008-11#3)(2011-1#1)
toxic compounds having##2##3##(2008-11#2)
toxic compounds##7##2##(2008-10#4)(2008-11#3)
toxic effect of##3##3##(1991-8#1)(1992-6#1)(2008-8#1)
toxic effect##5##2##(1991-8#1)(1992-6#1)(2008-10#2)(2008-8#1)
toxic effects of##6##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-7#1)
toxic effects on##3##3##(1996-3#1)(2011-1#1)(2011-2#1)
toxic effects##19##2##(1990-5#1)(1992-3#3)(1993-11#1)(1994-5#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-6#1)
toxic elements##2##2##(2008-10#2)
toxic equivalent##2##2##(2008-10#2)
toxic equivalents (TEQ)##2##3##(2008-10#2)
toxic equivalents##3##2##(2008-10#3)
toxic form of##3##3##(2008-10#2)(2012-3#1)
toxic fraction##3##2##(2008-10#3)
toxic gases##2##2##(1996-12#2)
toxic goitre##2##2##(1990-9#2)
toxic metabolite##4##2##(2008-10#4)
toxic metal##3##2##(2008-10#3)
toxic metals##3##2##(2008-10#3)
toxic or##4##2##(1992-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
toxic potency##4##2##(1996-12#4)
toxic protein##2##2##(1995-11#1)(1995-12#1)
toxic shock##3##2##(1993-3#1)(2011-2#2)
toxic substances##11##2##(2008-10#3)(2008-11#6)(2010-7#1)(2013-8#1)
toxic than##7##2##(1990-5#1)(1990-6#1)(1994-5#2)(2008-10#2)(2008-11#1)
toxic thyroid##2##2##(2008-4#2)
toxic to microsclerotia##2##3##(2008-10#2)
toxic to##17##2##(1990-5#1)(1992-12#1)(1993-12#1)(1995-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)
toxic##216##1##(1990-12#1)(1990-2#1)(1990-5#6)(1990-6#1)(1990-9#2)(1991-12#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#2)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#10)(1996-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#87)(2008-11#24)(2008-12#5)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#8)(2008-8#2)(2008-9#3)(2009-8#1)(2010-7#3)(2011-1#5)(2011-2#6)(2012-2#2)(2012-3#1)(2012-6#1)(2013-7#1)(2013-8#2)
toxicant exposure##2##2##(2008-10#1)(2008-9#1)
toxicant##9##1##(2008-10#5)(2008-9#4)
toxicants##11##1##(2008-10#5)(2008-11#3)(2008-9#1)(2012-2#2)
toxicities and##4##2##(1993-12#1)(1994-5#1)(2008-7#1)(2012-3#1)
toxicities of##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
toxicities recorded during##2##3##(2008-10#2)
toxicities were##4##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
toxicities##22##1##(1990-12#1)(1990-5#1)(1993-12#1)(1994-5#1)(2008-10#6)(2008-11#3)(2008-7#3)(2010-1#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
toxicity against dopaminergic##3##3##(2008-7#3)
toxicity against##5##2##(2008-11#1)(2008-7#4)
toxicity and Ca depletion##2##4##(2009-6#2)
toxicity and carcinogenicity##2##3##(2008-9#2)
toxicity and##24##2##(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#3)(2008-9#2)(2009-6#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#4)
toxicity and/or##2##2##(1997-1#1)(2011-2#1)
toxicity assessment##6##2##(2008-10#5)(2008-5#1)
toxicity at##3##2##(1993-1#1)(2008-12#1)(2013-1#1)
toxicity but##2##2##(1990-11#1)(2009-12#1)
toxicity by##2##2##(1995-9#1)(2008-7#1)
toxicity concerns##2##2##(2008-5#2)
toxicity due to##2##3##(1992-2#1)(2012-7#1)
toxicity during induction##2##3##(2008-10#2)
toxicity during##4##2##(2008-10#4)
toxicity has been##2##3##(1991-12#1)(2010-1#1)
toxicity in male##2##3##(1993-12#1)(2011-2#1)
toxicity in the##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
toxicity in##18##2##(1993-12#3)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#3)(2013-1#2)
toxicity induced by##2##3##(1994-5#1)(2010-12#1)
toxicity is##8##2##(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
toxicity level##4##2##(2008-10#4)
toxicity may##2##2##(1994-11#1)(1995-8#1)
toxicity of MTBE##2##3##(2008-12#2)
toxicity of a weathered oil##2##5##(2008-11#2)
toxicity of a##6##3##(1991-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
toxicity of aromatic nitrocompounds##2##4##(1995-8#2)
toxicity of certain##2##3##(2008-10#1)(2008-9#1)
toxicity of the##5##3##(1990-6#1)(1996-12#1)(2008-10#1)(2008-11#2)
toxicity of these##2##3##(2008-5#1)(2008-7#1)
toxicity of this##2##3##(1990-12#1)(2008-10#1)
toxicity of##51##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-8#1)(1993-12#3)(1994-5#6)(1994-8#1)(1995-8#3)(1996-12#3)(2008-10#12)(2008-11#8)(2008-12#3)(2008-5#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
toxicity on##2##2##(2008-11#1)(2013-8#1)
toxicity studies##3##2##(2011-2#3)
toxicity study##2##2##(2008-10#1)(2010-1#1)
toxicity test##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
toxicity testing of##2##3##(1992-3#1)(2008-11#1)
toxicity testing##7##2##(1992-3#1)(1996-12#2)(2008-10#2)(2008-11#2)
toxicity tests based on##2##4##(2008-10#2)
toxicity tests##5##2##(1996-12#1)(2008-10#4)
toxicity to##6##2##(2008-10#4)(2008-5#1)(2008-7#1)
toxicity was##10##2##(1991-8#1)(1994-8#1)(1996-1#1)(1996-3#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)
toxicity were##7##2##(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)(2011-2#2)
toxicity with##2##2##(2008-7#1)(2011-2#1)
toxicity##313##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-6#1)(1991-1#3)(1991-12#2)(1991-8#3)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#7)(1993-2#1)(1994-11#2)(1994-12#1)(1994-5#10)(1994-8#4)(1995-11#1)(1995-8#6)(1995-9#1)(1996-1#2)(1996-12#11)(1996-3#1)(1997-1#4)(1997-2#2)(1997-3#1)(2008-10#79)(2008-11#28)(2008-12#9)(2008-5#15)(2008-7#21)(2008-8#2)(2008-9#14)(2009-12#1)(2009-6#2)(2010-1#4)(2010-11#4)(2010-12#4)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#19)(2011-3#1)(2012-2#3)(2012-3#4)(2012-7#2)(2013-1#20)(2013-8#3)
toxicokinetics##2##1##(1993-12#1)(2011-2#1)
toxicological analysis##2##2##(1997-2#1)(2011-2#1)
toxicological studies##2##2##(2008-11#1)(2011-1#1)
toxicological##23##1##(1990-8#1)(1994-5#1)(1996-1#2)(1996-2#1)(1997-2#1)(2008-10#8)(2008-11#5)(2008-5#2)(2011-1#1)(2011-2#1)
toxicologically##4##1##(2008-10#4)
toxicology and##4##2##(1994-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
toxicology into cosmetic ingredient##2##4##(2008-5#2)
toxicology into##3##2##(2008-5#2)(2010-7#1)
toxicology studies##5##2##(2008-10#1)(2008-5#1)(2008-9#3)
toxicology study##2##2##(2008-10#2)
toxicology##26##1##(1991-6#1)(1994-12#1)(1995-11#2)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-5#5)(2008-7#1)(2008-9#3)(2010-7#1)(2012-3#1)(2013-1#1)
toxicus##4##1##(2008-10#4)
toxigenic fungi##2##2##(2010-7#2)
toxigenic in the duckling tests##3##5##(2008-10#3)
toxigenic##10##1##(1996-11#1)(2008-10#6)(2010-7#2)(2011-2#1)
toxigenicity##2##1##(2008-10#1)(2011-2#1)
toxin B subunit##5##3##(2008-11#3)(2008-8#1)(2008-9#1)
toxin also##2##2##(2008-10#2)
toxin and##7##2##(1990-8#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#2)
toxin assay##2##2##(2008-10#2)
toxin can##2##2##(1995-2#1)(2011-2#1)
toxin from##4##2##(2008-10#2)(2008-8#1)(2012-12#1)
toxin has been used##2##4##(2008-8#1)(2011-2#1)
toxin has been##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
toxin has##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
toxin in##2##2##(2008-10#1)(2009-5#1)
toxin injections##2##2##(2008-7#1)(2008-8#1)
toxin insensitivity##2##2##(2008-10#2)
toxin is##4##2##(1995-8#1)(2008-10#2)(2012-3#1)
toxin levels##2##2##(2011-2#2)
toxin production##8##2##(1992-12#1)(2008-10#3)(2011-2#4)
toxin reaction##3##2##(2008-10#3)
toxin sensitivity##2##2##(2008-10#2)
toxin synthesis##4##2##(2008-10#2)(2011-2#2)
toxin that is##2##3##(1990-8#1)(2008-10#1)
toxin that##4##2##(1990-8#1)(2008-10#2)(2008-5#1)
toxin was found to##2##4##(1992-3#1)(2008-10#1)
toxin was##6##2##(1992-3#1)(2008-10#4)(2009-4#1)
toxin##177##1##(1990-7#1)(1990-8#3)(1991-1#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-9#2)(1993-12#4)(1993-8#4)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#5)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-7#1)(2008-10#77)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#12)(2008-9#2)(2009-10#2)(2009-4#2)(2009-5#1)(2010-1#2)(2010-6#2)(2011-2#20)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
toxin-catalyzed ADP-ribosylation of##3##3##(1992-9#3)
toxin-catalyzed ADP-ribosylation##5##2##(1992-9#4)(1993-8#1)
toxin-induced##3##1##(1994-2#1)(2008-10#1)(2011-2#1)
toxin-insensitive##3##1##(2008-10#3)
toxin-sensitive##6##1##(1995-11#1)(1997-1#2)(1997-2#1)(2008-10#2)
toxins are##4##2##(1990-5#1)(2008-10#2)(2008-7#1)
toxins have##2##2##(2008-10#1)(2008-5#1)
toxins in##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
toxins of##3##2##(1993-12#1)(1993-6#1)(1994-5#1)
toxins or##2##2##(2008-7#1)(2008-9#1)
toxins was##2##2##(2008-10#2)
toxins were##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
toxins##59##1##(1990-5#2)(1990-8#1)(1990-9#1)(1993-12#5)(1993-6#3)(1994-5#3)(2008-10#23)(2008-11#4)(2008-5#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#1)(2011-2#4)(2012-12#2)(2013-8#1)
toxoid##4##1##(1995-5#1)(2011-2#3)
toxoplasmosis in##3##2##(1996-3#1)(2007-12#1)(2011-2#1)
toxoplasmosis##14##1##(1990-9#4)(1992-2#1)(1995-9#1)(1996-11#3)(1996-3#1)(2007-12#3)(2011-2#1)
trabeculae in##2##2##(2009-7#1)(2011-2#1)
trabeculae were##2##2##(2009-7#1)(2013-1#1)
trabeculae##7##1##(2009-7#3)(2011-2#3)(2013-1#1)
trabecular bone##5##2##(2007-8#1)(2008-7#1)(2009-7#3)
trabecular##10##1##(1991-11#2)(1994-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-7#4)
trace Au(III)##2##2##(2008-10#2)
trace CS##4##2##(2008-5#4)
trace Cu(2+)##2##2##(2008-10#2)
trace amount of##27##3##(2008-10#26)(2008-8#1)
trace amount##28##2##(2008-10#27)(2008-8#1)
trace amounts in##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
trace amounts of copper##6##4##(2008-10#6)
trace amounts of copper(II)##3##4##(2008-10#3)
trace amounts of lead##4##4##(2008-10#4)
trace amounts of zinc##3##4##(2008-10#3)
trace amounts of##103##3##(2008-10#102)(2008-11#1)
trace amounts##109##2##(1993-6#1)(2008-10#105)(2008-11#2)(2008-5#1)
trace analysis of##7##3##(2008-10#6)(2008-3#1)
trace analysis##12##2##(2008-10#11)(2008-3#1)
trace analytes##2##2##(2008-10#2)
trace and rare earth elements in##2##6##(2008-10#2)
trace and ultra trace##2##4##(2008-10#2)
trace and##10##2##(1994-9#1)(2008-10#8)(2008-5#1)
trace concentration##4##2##(2008-10#3)(2008-3#1)
trace concentrations of##3##3##(2008-10#3)
trace concentrations##4##2##(2008-10#4)
trace constituents##3##2##(2008-10#3)
trace copper in river##2##4##(2008-10#2)
trace copper##5##2##(2008-10#5)
trace determination of##11##3##(2008-10#11)
trace determination##13##2##(2008-10#13)
trace element analysis##2##3##(2008-10#2)
trace element concentrations##2##3##(1993-2#1)(2008-10#1)
trace element determination##4##3##(2008-10#4)
trace element partitioning##2##3##(2008-10#2)
trace element##24##2##(1993-2#2)(2008-10#16)(2008-12#1)(2011-2#3)(2012-2#2)
trace elemental##2##2##(2008-10#2)
trace elements (As##3##3##(2008-10#3)
trace elements and##2##3##(1990-2#1)(2008-10#1)
trace elements are##2##3##(2008-10#2)
trace elements determination in##2##4##(2008-10#2)
trace elements in water##2##4##(2008-10#2)
trace elements in##22##3##(2008-10#21)(2011-2#1)
trace elements of##2##3##(2008-10#1)(2013-8#1)
trace elements was##2##3##(2008-10#2)
trace elements were##4##3##(2008-10#4)
trace elements##61##2##(1990-2#1)(2008-10#56)(2010-11#1)(2011-2#1)(2013-8#2)
trace elements)##2##2##(2008-10#1)(2008-11#1)
trace enrichment of##5##3##(2008-10#5)
trace enrichment##8##2##(2008-10#8)
trace gases##8##2##(2008-10#2)(2008-11#1)(2008-3#5)
trace heavy metals##6##3##(2008-10#6)
trace iron##3##2##(2008-10#3)
trace lead in water##5##4##(2008-10#5)
trace lead##9##2##(2008-10#9)
trace level determination of##3##4##(2008-10#3)
trace level##11##2##(2008-10#11)
trace levels in##6##3##(2008-10#6)
trace levels of lead##2##4##(2008-10#2)
trace levels of##25##3##(2008-10#25)
trace levels##50##2##(2008-10#50)
trace mercury##9##2##(2008-10#9)
trace metal analysis##2##3##(2008-10#2)
trace metal in##2##3##(2008-10#1)(2008-5#1)
trace metal ion##2##3##(2008-10#2)
trace metal ions##7##3##(2008-10#7)
trace metal##23##2##(2008-10#21)(2008-5#2)
trace metals analysis##2##3##(2008-10#2)
trace metals in seawater##2##4##(2008-10#2)
trace metals in water by##2##5##(2008-10#2)
trace metals in water##3##4##(2008-10#3)
trace metals in##20##3##(2008-10#20)
trace metals##49##2##(2008-10#43)(2008-11#3)(2008-5#2)(2012-2#1)
trace molybdenum##4##2##(2008-10#4)
trace of##5##2##(2008-10#4)(2008-9#1)
trace or##4##2##(2008-10#3)(2008-5#1)
trace quantities##3##2##(2008-10#2)(2010-7#1)
trace rare earth elements##2##4##(2008-10#2)
trace stimulus##2##2##(2008-5#2)
trace the##2##2##(1996-2#1)(2008-10#1)
trace water##4##2##(2008-10#4)
trace##616##1##(1990-2#1)(1993-2#2)(1993-6#1)(1994-9#1)(1996-2#1)(2008-10#557)(2008-11#10)(2008-12#1)(2008-3#12)(2008-5#15)(2008-8#2)(2008-9#2)(2010-11#1)(2010-7#1)(2011-2#4)(2012-2#3)(2013-8#2)
trace-back##3##1##(1993-2#1)(2008-3#2)
trace-gas##4##1##(2008-2#2)(2008-3#2)
traceability##3##1##(2008-10#3)
traced by##2##2##(2008-10#1)(2012-3#1)
traced to the##3##3##(2008-10#2)(2012-2#1)
traced to##7##2##(1994-12#1)(2008-10#3)(2008-7#1)(2009-9#1)(2012-2#1)
traced##19##1##(1993-8#1)(1994-12#1)(2008-10#12)(2008-7#1)(2009-6#1)(2009-9#1)(2012-2#1)(2012-3#1)
tracer aerosols##2##2##(1994-12#2)
tracer and##2##2##(1996-12#2)
tracer into the##2##3##(2008-11#1)(2008-7#1)
tracer##34##1##(1990-5#3)(1991-12#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-8#1)(1994-12#2)(1994-2#2)(1996-12#4)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)
tracers for##5##2##(2008-1#1)(2008-11#2)(2010-6#2)
tracers through a##2##3##(2008-10#2)
tracers##21##1##(1990-5#1)(1992-3#1)(1993-8#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-6#1)(2010-6#3)(2010-7#1)(2012-2#1)
traces in##4##2##(2008-10#3)(2008-5#1)
traces of aluminium##2##3##(2008-10#2)
traces of nickel(II)##3##3##(2008-10#3)
traces of silver ions##3##4##(2008-10#3)
traces of##42##2##(2008-10#41)(2008-11#1)
traces the##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
traces##65##1##(1997-8#1)(2007-11#1)(2008-10#57)(2008-11#3)(2008-5#1)(2010-7#1)(2012-2#1)
trachea and lungs##2##3##(1993-8#1)(2011-1#1)
trachea and##5##2##(1993-8#1)(2008-9#2)(2010-10#1)(2011-1#1)
trachea##19##1##(1990-8#1)(1993-8#1)(1996-3#1)(1997-1#3)(2008-10#1)(2008-5#2)(2008-9#7)(2010-10#1)(2010-7#1)(2011-1#1)
tracheae##10##1##(1993-8#1)(2007-12#9)
tracheal bronchial vasculature##2##3##(1997-1#2)
tracheal bronchial##3##2##(1997-1#3)
tracheal intubation##2##2##(1991-11#1)(1996-6#1)
tracheal system of harvestmen##2##4##(2007-12#2)
tracheal system of##3##3##(2007-12#3)
tracheal##34##1##(1990-3#1)(1991-11#1)(1991-5#1)(1993-8#1)(1994-11#3)(1995-11#2)(1996-3#2)(1996-6#1)(1997-1#4)(2007-12#7)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-7#3)(2012-3#2)(2013-1#1)
tracheobronchial##5##1##(1992-5#2)(1996-1#1)(1997-1#1)(2010-12#1)
tracheoesophageal fistula##5##2##(1997-3#2)(2008-11#1)(2008-8#1)(2012-12#1)
tracheomycosis of##2##2##(2008-10#2)
tracheostomy and ventilator##2##3##(2012-2#2)
tracheostomy and##3##2##(1995-2#1)(2012-2#2)
tracheostomy##6##1##(1995-2#1)(2012-2#5)
tracheosyringeal##2##1##(2008-8#2)
tracheotomy##2##1##(2008-10#1)(2013-1#1)
trachomatis infection##2##2##(2012-3#1)(2013-1#1)
trachomatis serovars##3##2##(1993-9#3)
trachomatis##15##1##(1990-5#2)(1993-9#5)(1995-11#1)(2009-8#1)(2012-3#4)(2013-1#1)(2013-8#1)
tracing##7##1##(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-3#2)(2011-3#1)
track for##2##2##(1997-2#1)(2008-10#1)
track of##2##2##(2008-12#1)(2008-8#1)
track provides##2##2##(1992-3#2)
track the##6##2##(1996-5#1)(2008-10#3)(2009-11#1)(2010-5#1)
track##37##1##(1992-3#2)(1995-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#3)(2009-11#1)(2009-6#2)(2010-12#2)(2010-5#2)(2011-2#1)(2012-2#3)(2013-1#1)
tracked by##2##2##(2008-10#1)(2012-12#1)
tracked the##3##2##(1997-3#1)(2008-11#1)(2013-8#1)
tracked##13##1##(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#2)(2010-8#1)(2012-12#1)(2013-8#1)
tracker##3##1##(2008-3#1)(2008-6#1)(2009-12#1)
trackers##3##1##(2009-12#3)
tracking devices##3##2##(2009-12#3)
tracking of the number and content of physician performance reports##2##10##(2013-1#2)
tracking of the##5##3##(1995-9#1)(2008-2#1)(2013-1#3)
tracking of##10##2##(1991-12#1)(1994-12#1)(1995-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-1#3)
tracking systems##2##2##(1996-12#1)(2008-1#1)
tracking the##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
tracking##44##1##(1990-11#1)(1991-12#2)(1994-12#1)(1995-5#1)(1995-9#1)(1996-12#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#1)(2008-6#2)(2009-10#1)(2009-12#4)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#8)
tracks for##2##2##(1992-3#1)(2008-11#1)
tracks##9##1##(1992-3#1)(1994-2#1)(1994-9#1)(1997-2#1)(2008-11#2)(2008-3#2)(2011-1#1)
tract and the##2##3##(2008-10#1)(2008-11#1)
tract and##9##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#3)
tract are##3##2##(1994-12#1)(2011-2#1)(2012-2#1)
tract by a##2##3##(1992-9#1)(1994-12#1)
tract can be##2##3##(1991-9#1)(2013-1#1)
tract disease in##2##3##(2011-2#2)
tract disease##4##2##(2011-2#4)
tract have been##2##3##(1990-8#1)(1997-8#1)
tract in##5##2##(1990-11#1)(1992-9#2)(1994-12#1)(2008-10#1)
tract infection (UTI)##3##3##(2008-7#1)(2011-2#2)
tract infection in##2##3##(2008-7#1)(2011-2#1)
tract infection##16##2##(1990-11#1)(1994-2#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-7#3)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
tract infections in##4##3##(1993-2#1)(2008-11#1)(2009-5#1)(2012-12#1)
tract infections##17##2##(1993-2#3)(2008-10#5)(2008-11#2)(2009-5#1)(2011-2#4)(2012-12#1)(2013-1#1)
tract is a##2##3##(1996-1#1)(2009-1#1)
tract is##5##2##(1990-11#1)(1996-1#1)(2009-1#1)(2009-8#1)(2012-12#1)
tract of the##3##3##(1990-9#1)(1996-3#1)(2011-2#1)
tract of##12##2##(1990-9#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#2)(2013-1#3)
tract transection in neonatal rats##2##5##(2013-1#2)
tract transection##4##2##(2013-1#4)
tract was##2##2##(1996-3#1)(2013-1#1)
tract##211##1##(1990-11#5)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#5)(1990-9#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#2)(1992-9#9)(1993-11#1)(1993-2#4)(1993-8#1)(1994-1#3)(1994-12#4)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#3)(1996-12#2)(1996-3#4)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#8)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#2)(2009-12#2)(2009-2#1)(2009-5#4)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#33)(2012-12#6)(2012-2#11)(2012-3#7)(2013-1#17)(2013-2#1)(2013-7#1)(2013-8#5)
tractable in##2##2##(2008-11#1)(2012-3#1)
tractable##6##1##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#2)(2013-8#1)
traction##6##1##(2008-9#3)(2009-4#1)(2013-1#2)
tracts and##2##2##(2008-1#1)(2009-4#1)
tracts of##2##2##(2008-11#1)(2008-5#1)
tracts##15##1##(1992-6#1)(1994-2#1)(2008-1#1)(2008-11#2)(2008-5#2)(2008-7#2)(2009-4#2)(2010-7#1)(2011-1#1)(2011-2#2)
tractus solitarius##4##2##(1991-3#1)(1994-2#1)(1997-2#2)
trade agreements##2##2##(2008-1#2)
trade in##3##2##(1994-3#1)(1997-7#1)(2007-12#1)
trade off between##2##3##(2008-2#1)(2008-3#1)
trade off##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
trade routes##3##2##(2011-2#3)
trade##22##1##(1992-8#1)(1994-3#1)(1995-6#1)(1996-3#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#5)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#4)
trade-off between competitive ability and##2##5##(2008-8#2)
trade-off between competitive##3##3##(2008-8#3)
trade-off between##18##2##(1991-5#1)(1995-2#2)(2008-10#1)(2008-3#1)(2008-8#9)(2008-9#2)(2012-2#1)(2012-3#1)
trade-off can##2##2##(2008-8#2)
trade-off in##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
trade-off to##2##2##(2008-8#2)
trade-off##44##1##(1991-5#1)(1995-2#2)(2008-10#3)(2008-3#1)(2008-8#28)(2008-9#4)(2010-10#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
trade-off)##2##1##(2008-9#2)
trade-offs between the##2##3##(1996-1#1)(2008-9#1)
trade-offs between##6##2##(1996-1#1)(2008-8#3)(2008-9#1)(2012-3#1)
trade-offs in##3##2##(2008-10#1)(2008-9#2)
trade-offs##29##1##(1992-2#1)(1994-2#1)(1994-3#2)(1996-1#1)(2008-10#1)(2008-8#13)(2008-9#8)(2012-3#2)
trademark##2##1##(1995-3#1)(2008-10#1)
trades##2##1##(2008-10#1)(2009-8#1)
trading##3##1##(1990-2#1)(2007-12#1)(2009-12#1)
tradition and##2##2##(1995-12#1)(2011-2#1)
tradition##9##1##(1991-2#1)(1992-12#1)(1995-1#1)(1995-12#1)(1997-7#1)(2008-12#1)(2008-4#1)(2011-2#2)
traditional Chinese medicine##14##3##(2008-10#4)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#4)
traditional Chinese medicine)##2##3##(2010-10#2)
traditional Chinese medicines##5##3##(2008-10#1)(2011-2#1)(2011-3#3)
traditional Chinese##31##2##(1997-2#2)(2008-10#9)(2008-9#1)(2010-10#2)(2011-2#5)(2011-3#5)(2012-2#2)(2013-1#5)
traditional RP-LC##2##2##(2008-10#2)
traditional air##2##2##(2008-11#2)
traditional and##3##2##(1994-6#1)(2008-10#1)(2011-2#1)
traditional approach##2##2##(1995-2#1)(2008-11#1)
traditional approaches to##2##3##(1997-3#1)(2008-5#1)
traditional approaches##4##2##(1997-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
traditional areas of##2##3##(2010-7#1)(2011-2#1)
traditional assessment##3##2##(2008-11#1)(2011-2#2)
traditional biological##2##2##(2008-8#1)(2012-2#1)
traditional clinical##3##2##(1994-1#1)(1996-1#2)
traditional concepts##2##2##(1992-1#1)(1993-3#1)
traditional fermented##3##2##(2009-11#2)(2010-4#1)
traditional health##3##2##(1990-11#1)(1992-1#1)(1993-6#1)
traditional linear##2##2##(2008-10#1)(2008-8#1)
traditional liquid-liquid##3##2##(2008-10#3)
traditional medical##2##2##(1994-1#1)(1997-3#1)
traditional medicinal##2##2##(1991-6#1)(2013-1#1)
traditional medicine##5##2##(1992-5#1)(2008-1#2)(2008-11#1)(2013-1#1)
traditional method##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
traditional methods for##2##3##(2008-10#2)
traditional methods of##5##3##(1990-9#1)(2008-10#2)(2008-6#1)(2010-11#1)
traditional methods##15##2##(1990-9#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-11#1)
traditional models##2##2##(2008-11#2)
traditional off-line live cell counting##2##5##(2008-11#2)
traditional practices##4##2##(1992-1#1)(1997-7#3)
traditional process##2##2##(1994-3#1)(2008-11#1)
traditional risk factors##4##3##(1993-12#2)(2010-12#1)(2013-1#1)
traditional role##2##2##(1991-2#1)(1996-1#1)
traditional sensory assessment##3##3##(2008-5#3)
traditional stereotype##2##2##(1993-2#1)(2012-3#1)
traditional surgical##2##2##(1993-3#1)(2010-6#1)
traditional survey##2##2##(2010-1#1)(2010-8#1)
traditional technique##4##2##(2011-2#3)(2013-1#1)
traditional techniques##6##2##(1993-2#1)(2008-10#3)(2008-12#1)(2008-6#1)
traditional therapy##2##2##(1997-2#2)
traditional total abdominal and vaginal hysterectomies##2##6##(1993-12#2)
traditional total abdominal and##3##4##(1993-12#3)
traditional treatment##2##2##(1994-9#1)(2007-8#1)
traditional treatments##3##2##(1991-2#1)(2008-10#1)(2010-6#1)
traditional vaginal hysterectomy##2##3##(1993-12#1)(1993-2#1)
traditional way##2##2##(2008-3#1)(2012-2#1)
traditional##347##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-6#2)(1992-1#7)(1992-12#2)(1992-5#3)(1992-6#1)(1993-12#7)(1993-2#5)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#3)(1996-1#5)(1996-12#3)(1996-2#4)(1996-3#2)(1997-1#2)(1997-2#7)(1997-3#2)(1997-7#5)(1997-8#1)(2007-8#1)(2008-1#5)(2008-10#75)(2008-11#22)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#7)(2008-6#6)(2008-7#3)(2008-8#7)(2008-9#15)(2009-10#1)(2009-11#3)(2009-12#3)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-4#2)(2010-5#1)(2010-6#6)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#20)(2011-3#6)(2011-7#1)(2012-12#1)(2012-2#11)(2012-3#4)(2013-1#15)(2013-8#5)
traditionally been##14##2##(1991-2#1)(1991-3#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#2)(2013-1#1)
traditionally considered to##2##3##(2008-11#1)(2012-8#1)
traditionally considered##3##2##(2008-11#1)(2008-3#1)(2012-8#1)
traditionally has been##2##3##(1994-12#1)(2008-11#1)
traditionally have##2##2##(2008-10#1)(2008-3#1)
traditionally used##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
traditionally##56##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-1#1)(1994-12#2)(1994-9#1)(1997-1#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-11#7)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-4#1)(2009-8#3)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#2)
traditions##10##1##(1991-3#1)(1991-8#1)(1993-3#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
traffic and##5##2##(2008-11#2)(2010-11#2)(2010-3#1)
traffic in the##2##3##(2008-10#1)(2008-11#1)
traffic injuries##3##2##(1990-6#1)(2008-10#2)
traffic is##3##2##(2008-8#3)
traffic lights##3##2##(2011-2#3)
traffic safety##2##2##(2010-11#2)
traffic##71##1##(1990-6#1)(1990-9#1)(1992-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(2008-10#11)(2008-11#11)(2008-3#3)(2008-5#3)(2008-8#10)(2008-9#1)(2009-8#1)(2010-11#12)(2010-3#4)(2011-2#9)
traffic-related injuries##3##2##(2011-2#3)
traffic-related##6##1##(2008-5#1)(2011-2#5)
trafficking and##8##2##(1994-8#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-7#1)(2009-8#1)
trafficking from the##2##3##(2009-7#1)(2012-2#1)
trafficking is##3##2##(1993-6#1)(2008-7#1)(2011-2#1)
trafficking of the##2##3##(1997-1#1)(2008-4#1)
trafficking of##7##2##(1997-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-3#1)(2012-2#1)
trafficking patterns of liposomal##2##4##(1995-5#2)
trafficking route##2##2##(2009-8#1)(2012-2#1)
trafficking##38##1##(1992-12#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-5#2)(1997-1#2)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-7#3)(2009-8#6)(2011-2#2)(2011-3#1)(2012-2#4)(2013-1#1)
tragedy##3##1##(1992-2#1)(2008-11#1)(2010-1#1)
trail in two hatches##2##4##(2008-12#2)
trail of##2##2##(1991-1#1)(2013-8#1)
trail##8##1##(1991-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)(2013-8#1)
trailer of##2##2##(2008-8#2)
trailer##6##1##(2008-8#6)
trailing##5##1##(1994-1#2)(2008-10#2)(2011-2#1)
trails##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
train and##2##2##(2008-10#1)(2008-11#1)
train of##3##2##(2007-12#1)(2008-3#2)
train physicians##2##2##(1992-12#1)(1997-3#1)
train##35##1##(1990-12#1)(1991-2#1)(1992-12#2)(1993-1#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#5)(2008-3#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#3)(2013-8#1)
trained a##2##2##(2008-10#1)(2008-11#1)
trained and##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
trained by back-propagation##3##3##(2008-10#3)
trained by##11##2##(2008-10#8)(2008-6#2)(2010-8#1)
trained in##12##2##(1991-2#1)(1991-3#1)(1992-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#2)(2012-2#1)
trained on the##2##3##(1997-2#1)(2010-8#1)
trained on##4##2##(1993-3#2)(1997-2#1)(2010-8#1)
trained to##11##2##(1992-3#1)(1993-6#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
trained violinists##2##2##(2013-8#2)
trained with the##3##3##(2008-10#2)(2010-8#1)
trained##90##1##(1990-11#3)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#2)(2007-8#1)(2008-10#22)(2008-11#6)(2008-12#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-7#4)(2010-8#4)(2011-2#3)(2012-2#3)(2013-1#5)(2013-8#3)
trainee##2##1##(1994-12#1)(2008-12#1)
trainees##9##1##(1993-11#1)(1994-12#2)(1996-8#1)(2008-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
trainers##3##1##(1994-2#1)(1994-3#1)(2013-1#1)
training (i##2##2##(2011-2#1)(2013-1#1)
training (n = 30)##3##4##(2013-8#3)
training alone##2##2##(2013-1#1)(2013-8#1)
training and at##2##3##(2012-2#1)(2013-8#1)
training and education of##2##4##(1995-5#1)(2008-11#1)
training and education##4##3##(1995-5#1)(1997-6#1)(2008-11#2)
training and prediction##2##3##(2008-10#2)
training and research##2##3##(1993-11#1)(2013-1#1)
training and testing##2##3##(2008-10#1)(2010-8#1)
training and the##3##3##(2008-10#1)(2009-3#1)(2010-8#1)
training and tools##2##3##(2008-8#1)(2009-3#1)
training and##54##2##(1990-2#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#3)(2008-8#1)(2009-1#2)(2009-10#1)(2009-3#2)(2009-5#1)(2010-1#1)(2010-5#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
training are##3##2##(1993-1#1)(1996-6#1)(1997-5#1)
training as well as##2##4##(1993-6#1)(2008-10#1)
training as##3##2##(1993-6#1)(2008-10#1)(2013-8#1)
training at##3##2##(1990-11#1)(1997-2#1)(2008-11#1)
training available##2##2##(1991-1#1)(2008-9#1)
training by##3##2##(1996-3#2)(2008-11#1)
training can##2##2##(1993-2#1)(2008-11#1)
training center for##2##3##(2008-11#1)(2008-8#1)
training content##2##2##(2008-9#1)(2010-10#1)
training course in##3##3##(2008-11#3)
training course##5##2##(2008-11#5)
training courses##2##2##(2008-10#1)(2011-2#1)
training data set##3##3##(2008-10#3)
training data##6##2##(2008-10#5)(2013-8#1)
training for nurses##2##3##(2008-11#1)(2008-9#1)
training for##17##2##(1991-2#1)(1991-3#1)(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-2#1)(2008-11#3)(2008-6#1)(2008-9#1)(2012-2#2)(2013-1#2)
training group (n= 10)##3##4##(2013-1#3)
training group (β=##3##3##(2013-1#3)
training group##6##2##(2013-1#6)
training in blood pressure monitoring##2##5##(2008-1#2)
training in the use of##2##5##(1993-3#1)(2008-11#1)
training in the##5##3##(1993-3#1)(2008-11#2)(2008-12#1)(2008-4#1)
training in##40##2##(1991-1#2)(1991-8#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#3)(2008-11#5)(2008-12#6)(2008-4#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
training intensity##3##2##(2010-1#2)(2013-1#1)
training is##8##2##(1994-12#2)(1994-6#1)(1997-2#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
training method##2##2##(2013-1#2)
training modality##2##2##(2013-8#2)
training must##2##2##(1994-12#1)(2013-1#1)
training needs##3##2##(1996-1#1)(2008-11#1)(2008-9#1)
training of clinical biochemists##2##4##(1994-12#2)
training of clinical##3##3##(1994-12#3)
training of hospital security##2##4##(1991-12#1)(1996-12#1)
training of medical##7##3##(1992-1#2)(1994-12#3)(1994-6#1)(2009-10#1)
training of the neural##2##4##(2007-8#1)(2010-8#1)
training of the##6##3##(1994-12#2)(2007-8#1)(2008-5#1)(2010-8#1)(2012-2#1)
training of##39##2##(1990-3#1)(1991-12#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#9)(1994-3#2)(1994-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2009-10#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
training on gait performance##2##4##(2013-1#2)
training on the##4##3##(1992-12#1)(1997-2#1)(2009-6#1)(2010-12#1)
training on##18##2##(1992-12#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-1#1)(2009-3#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
training or##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
training parameters##2##2##(2008-10#1)(2008-11#1)
training processes##2##2##(1993-3#1)(2013-1#1)
training program in##2##3##(1992-2#1)(2008-7#1)
training program##18##2##(1991-12#3)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
training programme##7##2##(1994-12#1)(2008-12#3)(2009-4#1)(2013-1#2)
training programmes for##2##3##(1994-12#1)(2011-2#1)
training programmes##4##2##(1994-12#1)(2008-12#1)(2011-2#1)(2013-1#1)
training programs for clinical##2##4##(1994-12#1)(2008-12#1)
training programs that##2##3##(1996-3#1)(2008-11#1)
training programs to##2##3##(1997-2#1)(1997-6#1)
training programs##12##2##(1992-1#2)(1994-12#2)(1996-3#3)(1997-2#1)(1997-6#1)(2008-11#1)(2008-12#1)(2011-1#1)
training required##2##2##(1996-3#1)(2008-11#1)
training requirements##3##2##(1991-12#1)(1994-12#2)
training session##2##2##(2009-1#1)(2010-7#1)
training set and##2##3##(2008-10#2)
training set of##3##3##(2008-10#2)(2009-3#1)
training set##14##2##(1995-9#1)(2008-10#11)(2008-9#1)(2009-3#1)
training should be##2##3##(1996-3#1)(2013-1#1)
training the##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2010-1#1)
training through a##2##3##(1994-12#2)
training time##3##2##(2013-8#3)
training to##8##2##(2008-11#2)(2008-4#1)(2010-10#1)(2012-12#1)(2013-1#3)
training trials##5##2##(1993-6#4)(2008-5#1)
training was##6##2##(2008-1#1)(2008-10#2)(2008-12#1)(2009-1#1)(2011-2#1)
training with##2##2##(2008-11#1)(2010-10#1)
training##514##1##(1990-11#1)(1990-2#1)(1990-3#2)(1991-1#5)(1991-12#6)(1991-2#4)(1991-3#10)(1991-6#1)(1991-8#2)(1992-1#6)(1992-12#5)(1992-2#5)(1992-3#2)(1992-5#1)(1993-1#5)(1993-11#2)(1993-12#3)(1993-2#7)(1993-3#10)(1993-6#6)(1994-1#2)(1994-12#32)(1994-2#1)(1994-3#11)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#14)(1996-6#1)(1996-8#4)(1996-9#1)(1997-2#8)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-8#1)(2008-1#7)(2008-10#43)(2008-11#53)(2008-12#22)(2008-4#4)(2008-5#5)(2008-6#7)(2008-7#6)(2008-8#4)(2008-9#8)(2009-1#10)(2009-10#3)(2009-11#2)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#9)(2010-10#3)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#18)(2012-12#4)(2012-2#11)(2012-3#5)(2013-1#41)(2013-8#27)
trains with##2##2##(2008-3#1)(2013-8#1)
trains##21##1##(1990-5#2)(1991-2#4)(1995-2#1)(1996-5#1)(2008-11#5)(2008-3#3)(2009-8#3)(2013-8#2)
trait Loci mapping##3##3##(2008-10#3)
trait Loci##8##2##(2008-10#8)
trait affects##2##2##(2008-8#2)
trait and##5##2##(2008-11#1)(2008-8#1)(2008-9#2)(2013-1#1)
trait associations##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
trait evolution##2##2##(2012-3#2)
trait expression##4##2##(2008-8#1)(2012-3#3)
trait in##3##2##(2008-8#1)(2008-9#2)
trait inferences##4##2##(2008-11#4)
trait is##2##2##(2008-9#2)
trait loci (QTL)##26##3##(2008-10#23)(2008-8#1)(2012-3#2)
trait loci (QTLs) were##2##4##(2008-10#2)
trait loci (QTLs)##7##3##(2008-10#3)(2008-8#2)(2008-9#1)(2009-10#1)
trait loci##40##2##(2008-10#28)(2008-8#3)(2008-9#2)(2009-10#2)(2012-3#5)
trait locus##16##2##(2008-10#13)(2010-4#1)(2012-3#1)(2013-8#1)
trait of##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
trait that##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
trait##169##1##(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#57)(2008-11#13)(2008-12#3)(2008-4#1)(2008-8#32)(2008-9#19)(2009-10#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-6#4)(2011-2#3)(2012-12#1)(2012-3#26)(2013-1#1)(2013-8#1)
trait-mediated##3##1##(2008-9#3)
trait-specific##2##1##(2008-11#1)(2012-3#1)
traitement médical##2##2##(2011-2#2)
traitement par ľaciclovir injectable##2##4##(2013-1#2)
traitement##10##1##(2011-2#5)(2013-1#5)
traits affecting##3##2##(2008-8#2)(2008-9#1)
traits and growth##2##3##(2012-3#2)
traits and the##3##3##(2008-8#1)(2008-9#1)(2009-10#1)
traits and##16##2##(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-10#1)(2012-3#4)
traits are##8##2##(2008-11#1)(2008-8#2)(2008-9#2)(2010-4#2)(2012-3#1)
traits can also be##3##4##(2010-4#2)(2012-2#1)
traits can be##2##3##(2008-10#1)(2012-3#1)
traits can##8##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#2)(2012-2#1)(2012-3#2)
traits for##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
traits in an##2##3##(2008-1#1)(2008-9#1)
traits in response to##2##4##(2008-8#2)
traits in the##2##3##(2008-8#2)
traits in##23##2##(2008-1#3)(2008-10#3)(2008-12#1)(2008-8#11)(2008-9#3)(2009-8#1)(2011-4#1)
traits including##2##2##(2009-8#1)(2010-10#1)
traits involved in##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
traits is##6##2##(2008-8#3)(2012-3#3)
traits may##2##2##(2008-9#2)
traits of C24 and##2##4##(2012-3#2)
traits of interest##2##3##(2008-8#1)(2012-2#1)
traits of the##7##3##(1990-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-9#1)
traits of##23##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#3)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2012-7#1)(2012-9#1)(2013-8#1)
traits on the##3##3##(2008-8#2)(2008-9#1)
traits on##9##2##(2007-12#1)(2008-8#3)(2008-9#3)(2012-3#2)
traits such as##4##3##(2008-10#1)(2008-8#3)
traits that are##7##3##(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#2)(2012-5#1)
traits that##15##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#5)(2008-9#1)(2012-3#4)(2012-5#1)
traits to##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
traits were significantly##2##3##(2008-10#1)(2008-8#1)
traits were##9##2##(2008-10#4)(2008-12#1)(2008-8#4)
traits whose##2##2##(2008-8#1)(2008-9#1)
traits with##4##2##(2008-8#1)(2008-9#2)(2012-3#1)
traits##275##1##(1990-5#1)(1994-3#1)(1994-9#3)(1995-2#1)(1997-3#1)(2007-12#2)(2008-1#4)(2008-10#35)(2008-11#8)(2008-12#6)(2008-3#1)(2008-7#2)(2008-8#85)(2008-9#42)(2009-10#2)(2009-8#6)(2010-10#5)(2010-4#9)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#4)(2011-4#1)(2012-12#1)(2012-2#4)(2012-3#37)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#1)(2013-8#3)
trajectories and##4##2##(2008-11#2)(2008-12#1)(2009-7#1)
trajectories of a##2##3##(2008-12#1)(2012-2#1)
trajectories of##7##2##(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
trajectories that##3##2##(2008-11#2)(2008-8#1)
trajectories##32##1##(1992-8#1)(2008-11#10)(2008-12#4)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)
trajectory of##4##2##(1992-9#1)(1997-2#1)(2010-12#1)(2012-12#1)
trajectory patterns##2##2##(2013-1#2)
trajectory to##3##2##(1995-12#1)(1996-6#1)(2011-2#1)
trajectory##23##1##(1992-9#1)(1995-12#2)(1996-6#3)(1997-2#1)(2008-10#1)(2008-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#3)(2011-7#1)(2012-12#1)(2013-1#3)
tramadol##7##1##(2007-8#1)(2008-10#5)(2008-9#1)
trance##5##1##(2009-10#5)
tranilast##8##1##(1995-11#3)(2008-5#5)
tranquillisers##3##1##(2008-7#3)
trans conformation##2##2##(2008-8#2)
trans isomers##2##2##(1990-9#1)(1995-6#1)
trans##28##1##(1990-9#3)(1991-12#1)(1991-5#7)(1992-12#2)(1993-12#1)(1993-6#1)(1994-5#1)(1995-6#2)(1996-5#1)(1996-6#1)(2008-10#4)(2008-7#2)(2008-8#2)
trans- and cis-resveratrol##2##3##(2008-10#2)
trans- and##3##2##(2008-10#2)(2009-9#1)
trans-##4##1##(1996-5#1)(2008-10#2)(2009-9#1)
trans-BPIC##2##1##(2008-10#2)
trans-Golgi##2##1##(1997-2#1)(2007-12#1)
trans-acting factor##2##2##(1993-12#2)
trans-acting factors##2##2##(1993-12#1)(1993-6#1)
trans-acting regulation system was##2##4##(2008-9#2)
trans-acting regulation system##3##3##(2008-9#3)
trans-acting replication specificity##2##3##(2008-10#2)
trans-acting##11##1##(1993-12#3)(1993-6#1)(1995-2#1)(2008-10#2)(2008-9#3)(2010-5#1)
trans-activating factors##3##2##(2008-9#3)
trans-activating##6##1##(1994-5#1)(2008-9#4)(2010-10#1)
trans-columella access##2##2##(1990-9#2)
trans-dominant##2##1##(1990-12#1)(2008-10#1)
trans-facet##2##1##(2012-3#2)
trans-flupenthixol##4##1##(1993-6#4)
trans-lucens##2##1##(2008-10#2)
trans-membrane##3##1##(1991-10#1)(2008-11#1)(2008-8#1)
trans-radial##2##1##(2008-11#1)(2011-2#1)
trans-replicate##4##1##(2008-10#4)
trans-splicing##2##1##(2011-3#1)(2012-2#1)
trans-tamoxifen##6##1##(2008-11#6)
transabdominal pre-peritoneal##2##2##(2012-12#2)
transabdominal##6##1##(1995-1#1)(1996-1#2)(2009-4#1)(2012-12#2)
transaction##6##1##(1992-12#1)(1993-1#1)(1993-3#1)(2008-11#3)
transactions##5##1##(1993-1#1)(2008-11#1)(2008-9#1)(2010-5#1)(2012-3#1)
transactivate##3##1##(1995-8#2)(2008-8#1)
transactivated by##2##2##(1994-11#1)(2008-11#1)
transactivates##3##1##(1993-8#2)(2013-1#1)
transactivating##3##1##(1990-5#1)(1994-5#1)(2008-11#1)
transactivation axis##2##2##(2008-11#2)
transactivation domain##3##2##(1993-8#1)(1995-2#2)
transactivation in##2##2##(1995-2#1)(2012-12#1)
transactivation of##5##2##(1993-8#1)(1994-11#1)(2008-10#2)(2008-9#1)
transactivation##26##1##(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#1)(1995-2#4)(1995-6#4)(2008-10#3)(2008-11#3)(2008-9#2)(2012-12#2)
transactivator##3##1##(1994-11#1)(2008-8#1)(2013-1#1)
transactivators##5##1##(1995-8#1)(1997-3#1)(2008-11#3)
transaminase levels##3##2##(1992-5#1)(1995-2#1)(1997-3#1)
transaminase##9##1##(1992-5#1)(1995-2#1)(1997-3#1)(2008-11#3)(2010-6#1)(2013-1#2)
transaminases##6##1##(1992-5#1)(1996-11#1)(2008-1#1)(2012-12#1)(2013-1#2)
transarterial##7##1##(1996-3#1)(1996-9#1)(1997-3#2)(2008-7#1)(2013-7#1)(2013-8#1)
transaxial##2##1##(1995-5#1)(1997-8#1)
transbronchial biopsy##3##2##(2011-2#3)
transbronchial##4##1##(2011-2#3)(2012-12#1)
transcarbamylase##2##1##(2009-8#2)
transcatheter##3##1##(1997-8#1)(2008-11#2)
transcend##2##1##(2009-10#1)(2012-2#1)
transcendence##2##1##(2010-8#1)(2013-8#1)
transcendent##2##1##(2008-12#1)(2012-2#1)
transcervical##2##1##(1991-2#1)(2011-2#1)
transconjugant##4##1##(2008-10#4)
transconjugants##2##1##(2008-10#2)
transcortin##2##1##(1990-12#2)
transcortin-bound##2##1##(1990-12#2)
transcranial Doppler##2##2##(1996-2#1)(1996-6#1)
transcranial direct current stimulation (tDCS)##2##5##(2010-7#1)(2012-2#1)
transcranial direct current stimulation##5##4##(2010-7#3)(2012-2#2)
transcranial direct current##6##3##(2010-7#4)(2012-2#2)
transcranial magnetic stimulation##9##3##(2010-5#2)(2010-7#4)(2011-2#3)
transcranial magnetic##10##2##(1996-6#1)(2010-5#2)(2010-7#4)(2011-2#3)
transcranial resection of pituitary##2##4##(2011-2#2)
transcranial resection##3##2##(2011-2#3)
transcranial stimulation##3##2##(1996-2#3)
transcranial##29##1##(1996-2#5)(1996-3#2)(1996-6#2)(2010-5#2)(2010-7#8)(2011-2#8)(2012-2#2)
transcribed and##2##2##(1997-7#1)(2009-10#1)
transcribed as polycistronic##2##3##(2008-8#1)(2012-2#1)
transcribed at##3##2##(1993-2#1)(1993-3#1)(1993-9#1)
transcribed by##2##2##(1992-3#1)(1993-12#1)
transcribed from a##2##3##(1995-6#1)(1996-2#1)
transcribed from the##2##3##(1997-8#1)(2008-8#1)
transcribed from##7##2##(1995-6#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
transcribed genes##2##2##(1993-12#1)(2009-10#1)
transcribed in vitro with##2##4##(1993-8#1)(2008-8#1)
transcribed in##6##2##(1993-8#1)(1995-12#1)(1996-6#1)(2008-8#3)
transcribed open reading frames##2##4##(1996-6#2)
transcribed or not##2##3##(2008-11#2)
transcribed spacer (ITS) region##16##4##(2008-10#16)
transcribed spacer (ITS) sequences##3##4##(2008-10#2)(2008-9#1)
transcribed spacer (ITS)##39##3##(2008-10#38)(2008-9#1)
transcribed spacer region##14##3##(2008-10#13)(2008-9#1)
transcribed spacer regions of##3##4##(2008-10#3)
transcribed spacer regions##4##3##(2008-10#4)
transcribed spacer##78##2##(2008-10#74)(2008-12#1)(2008-8#1)(2008-9#2)
transcribed verbatim and##2##3##(2008-11#2)
transcribed##135##1##(1992-3#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1995-12#1)(1995-6#2)(1996-2#2)(1996-6#4)(1997-3#1)(1997-7#3)(1997-8#1)(2008-10#78)(2008-11#8)(2008-12#2)(2008-8#9)(2008-9#3)(2009-10#3)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)
transcript (1##2##2##(1994-11#1)(2008-5#1)
transcript abundance##2##2##(2008-11#1)(2012-3#1)
transcript accumulation##2##2##(2008-10#1)(2008-9#1)
transcript and##2##2##(1993-8#1)(1993-9#1)
transcript expression##5##2##(1995-8#1)(2011-2#4)
transcript from a##2##3##(2008-10#2)
transcript from the##2##3##(1994-12#1)(2008-10#1)
transcript from##4##2##(1994-12#1)(2008-10#3)
transcript in the##3##3##(1995-12#1)(1996-12#1)(2008-9#1)
transcript in##4##2##(1995-12#1)(1995-2#1)(1996-12#1)(2008-9#1)
transcript is present in L1 larvae and at the##2##9##(1993-12#2)
transcript is##7##2##(1991-5#1)(1993-12#3)(2008-8#1)(2009-10#1)(2013-1#1)
transcript levels of##3##3##(2008-10#2)(2011-1#1)
transcript of 1##3##3##(1996-6#3)
transcript of##14##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-6#1)(1996-6#3)(2008-10#1)(2008-6#1)(2008-8#3)(2009-8#1)(2010-7#1)
transcript was detected by##3##4##(2008-10#3)
transcript was detected##5##3##(1996-6#1)(1997-7#1)(2008-10#3)
transcript was expressed##2##3##(1995-6#1)(2008-9#1)
transcript was##9##2##(1994-11#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-10#3)(2008-9#1)
transcript##103##1##(1991-5#4)(1991-6#2)(1992-8#2)(1993-12#5)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#1)(1995-12#2)(1995-2#4)(1995-6#2)(1995-8#1)(1996-12#2)(1996-6#5)(1996-8#1)(1997-2#3)(1997-6#1)(1997-7#6)(2008-10#15)(2008-11#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#5)(2009-10#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-3#6)(2013-1#1)
transcriptase (RT)##3##2##(1991-9#1)(2008-11#1)(2013-1#1)
transcriptase polymerase chain reaction (RT-PCR)##2##5##(1996-12#1)(2012-2#1)
transcriptase polymerase chain reaction##4##4##(1996-12#1)(1997-1#1)(2011-2#1)(2012-2#1)
transcriptase##34##1##(1991-9#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#8)(2008-4#1)(2008-5#1)(2011-2#8)(2011-3#9)(2012-2#1)(2013-1#1)
transcriptase-PCR##2##1##(2009-6#1)(2009-7#1)
transcriptase-polymerase chain reaction (RT-PCR)##2##4##(1995-12#1)(2008-5#1)
transcriptase-polymerase chain reaction##8##3##(1994-11#1)(1995-12#1)(1996-12#1)(1997-9#1)(2008-10#2)(2008-5#1)(2012-3#1)
transcription activator##4##2##(1991-5#1)(1993-9#1)(1995-6#1)(2008-9#1)
transcription and analysis of the##2##5##(1993-9#1)(1996-3#1)
transcription and protein##2##3##(1995-12#1)(2008-8#1)
transcription and##22##2##(1992-12#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-12#2)(1996-3#1)(1997-3#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#2)
transcription at or near##2##4##(1994-11#2)
transcription at##3##2##(1994-11#2)(1995-2#1)
transcription bubble&quot##2##2##(1995-2#2)
transcription by##11##2##(1992-8#1)(1993-6#1)(1995-6#3)(1996-2#1)(1997-1#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
transcription complex##3##2##(1993-2#1)(1995-2#2)
transcription elongation##2##2##(2012-12#2)
transcription factor 1##2##3##(2009-3#1)(2010-5#1)
transcription factor NF-kappa B##3##4##(1995-2#1)(1995-6#1)(2008-9#1)
transcription factor binding##2##3##(1994-11#1)(2008-9#1)
transcription factor controlling##2##3##(2012-2#2)
transcription factor genes##2##3##(2008-10#1)(2009-10#1)
transcription factor in##2##3##(1990-5#1)(2009-10#1)
transcription factor is##2##3##(2010-11#1)(2011-2#1)
transcription factor that##3##3##(1994-11#1)(1996-12#1)(2013-1#1)
transcription factor##84##2##(1990-5#1)(1991-9#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#2)(1994-8#1)(1995-2#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-7#1)(2008-10#3)(2008-11#9)(2008-9#7)(2009-10#2)(2009-3#1)(2009-8#7)(2010-11#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#8)(2012-2#3)(2012-3#2)(2013-1#3)
transcription factors and##8##3##(1995-2#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
transcription factors binding##4##3##(1990-5#1)(2008-7#1)(2008-9#2)
transcription factors by##2##3##(2008-11#1)(2009-8#1)
transcription factors can##2##3##(1994-3#1)(2011-1#1)
transcription factors is##3##3##(2008-7#1)(2009-8#1)(2011-2#1)
transcription factors of##2##3##(2008-1#1)(2013-8#1)
transcription factors that regulate##2##4##(1995-8#1)(2011-2#1)
transcription factors that##6##3##(1995-8#1)(2011-2#1)(2012-2#1)(2012-3#3)
transcription factors were##2##3##(2008-11#2)
transcription factors which##2##3##(1993-9#1)(1997-7#1)
transcription factors##87##2##(1990-5#2)(1991-5#1)(1992-12#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#4)(1995-12#1)(1995-2#2)(1995-8#2)(1996-12#3)(1997-7#3)(2008-1#1)(2008-10#4)(2008-11#7)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-6#1)(2009-8#6)(2010-1#1)(2010-10#2)(2011-1#4)(2011-2#7)(2012-2#6)(2012-3#9)(2013-1#1)(2013-8#1)
transcription following##2##2##(1993-6#1)(2008-11#1)
transcription from a##2##3##(1993-6#1)(2008-9#1)
transcription from##4##2##(1993-6#1)(1993-9#1)(2008-9#1)(2012-3#1)
transcription in##14##2##(1991-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1997-1#1)(2008-11#2)(2008-8#2)(2011-1#1)(2012-12#1)(2012-3#1)
transcription initiation by##2##3##(1995-6#1)(1997-7#1)
transcription initiation site)##2##3##(1995-6#1)(1997-3#1)
transcription initiation##10##2##(1992-6#1)(1995-2#3)(1995-6#2)(1997-3#1)(1997-7#1)(1997-8#1)(2008-4#1)
transcription is##9##2##(1994-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
transcription level##4##2##(1997-6#1)(1997-8#1)(2008-11#1)(2008-8#1)
transcription levels of##3##3##(1996-2#1)(1997-7#1)(2008-10#1)
transcription levels##7##2##(1996-2#1)(1997-7#2)(2008-10#3)(2009-12#1)
transcription machinery##2##2##(1995-6#1)(2013-1#1)
transcription may##2##2##(1993-12#1)(2011-2#1)
transcription observed##2##2##(1992-8#1)(1995-6#1)
transcription of XBP1##2##3##(2011-2#2)
transcription of a number of##2##5##(2011-1#2)
transcription of a##4##3##(1996-6#1)(2008-10#1)(2011-1#2)
transcription of an##2##3##(1997-7#1)(2008-5#1)
transcription of genes##3##3##(1995-6#1)(2008-7#1)(2008-9#1)
transcription of several##2##3##(1996-2#1)(2008-10#1)
transcription of the##20##3##(1992-1#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-6#2)(1996-12#2)(1996-2#1)(1997-2#1)(1997-7#2)(1997-8#2)(2008-11#2)(2010-10#1)
transcription of##63##2##(1990-12#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-12#2)(1993-6#2)(1994-11#2)(1994-2#1)(1995-11#2)(1995-2#3)(1995-6#4)(1996-12#3)(1996-2#2)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#4)(1997-8#2)(2008-10#4)(2008-11#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2010-10#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)
transcription or##2##2##(2010-10#1)(2012-3#1)
transcription polymerase chain reaction and##2##5##(2008-10#2)
transcription polymerase chain reaction##8##4##(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-9#1)(2013-8#1)
transcription rates of##2##3##(2008-10#2)
transcription sites of rRNA genes##2##5##(2008-8#2)
transcription sites##3##2##(2008-8#3)
transcription start point (tsp) of##2##5##(1993-12#1)(1993-6#1)
transcription start point (tsp)##5##4##(1993-12#3)(1993-6#1)(1993-9#1)
transcription start point##11##3##(1990-5#1)(1991-6#1)(1991-9#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#2)
transcription start points##3##3##(1990-11#1)(1993-2#1)(1993-6#1)
transcription start site was##2##4##(1991-7#2)
transcription start site##5##3##(1991-7#2)(1995-11#1)(1995-2#2)
transcription start sites##3##3##(1993-8#1)(1994-11#1)(2008-4#1)
transcription start##23##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1993-12#3)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1995-11#1)(1995-2#2)(2008-4#1)
transcription terminators##2##2##(1990-5#1)(2008-7#1)
transcription through##2##2##(1995-2#1)(1995-6#1)
transcription to##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
transcription units##2##2##(1993-6#2)
transcription was##7##2##(1993-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#2)
transcription when##3##2##(1991-10#1)(1993-12#1)(1994-2#1)
transcription##520##1##(1990-11#1)(1990-12#1)(1990-5#6)(1991-10#2)(1991-5#5)(1991-6#1)(1991-7#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#4)(1992-3#3)(1992-6#2)(1992-8#4)(1993-12#13)(1993-2#6)(1993-6#16)(1993-8#5)(1993-9#10)(1994-11#13)(1994-12#4)(1994-2#5)(1994-3#5)(1994-8#3)(1995-11#4)(1995-12#3)(1995-2#33)(1995-6#21)(1995-8#5)(1995-9#1)(1996-12#10)(1996-2#11)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-6#2)(1997-7#14)(1997-8#4)(1997-9#1)(2008-1#1)(2008-10#25)(2008-11#39)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#9)(2008-8#17)(2008-9#33)(2009-10#5)(2009-12#1)(2009-3#1)(2009-6#3)(2009-8#16)(2010-1#2)(2010-10#6)(2010-11#6)(2010-3#1)(2010-4#2)(2010-5#8)(2010-7#1)(2011-1#13)(2011-2#36)(2012-12#5)(2012-2#16)(2012-3#18)(2013-1#9)(2013-8#2)
transcription)##4##1##(1992-3#1)(1996-2#1)(2008-1#1)(2012-2#1)
transcription-PCR##7##1##(1993-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-9#1)(2010-11#1)(2013-8#1)
transcription-coupled repair##2##2##(2008-11#2)
transcription-polymerase chain reaction and##3##4##(1995-12#1)(2008-10#2)
transcription-polymerase chain reaction using##2##4##(2008-10#1)(2008-7#1)
transcription-polymerase chain reaction##39##3##(1993-12#1)(1993-3#1)(1994-11#2)(1995-12#1)(1997-1#1)(1997-7#1)(2008-10#23)(2008-11#2)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#2)(2013-1#1)
transcription-polymerase chain reactions##2##3##(2008-10#2)
transcription-polymerase chain##42##2##(1993-12#1)(1993-3#1)(1994-11#2)(1995-12#1)(1997-1#1)(1997-7#1)(2008-10#25)(2008-11#2)(2008-7#1)(2008-9#3)(2010-1#1)(2011-2#2)(2013-1#1)
transcription-polymerase##43##1##(1993-12#1)(1993-3#1)(1994-11#2)(1995-12#1)(1997-1#1)(1997-7#1)(2008-10#25)(2008-11#3)(2008-7#1)(2008-9#3)(2010-1#1)(2011-2#2)(2013-1#1)
transcription/translation##2##1##(1997-2#1)(2008-1#1)
transcriptional activation by##3##3##(1993-8#2)(1993-9#1)
transcriptional activation in##2##3##(1994-11#1)(1997-2#1)
transcriptional activation is##2##3##(1994-11#2)
transcriptional activation of ori lambda##2##5##(1994-11#2)
transcriptional activation of##7##3##(1992-8#1)(1994-11#2)(1996-12#2)(2008-10#1)(2009-8#1)
transcriptional activation##21##2##(1992-8#1)(1993-8#2)(1993-9#1)(1994-11#6)(1995-8#1)(1996-12#2)(1997-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
transcriptional activator##9##2##(1991-5#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-9#1)(2010-10#1)(2012-3#2)(2013-1#1)
transcriptional activity in##2##3##(1994-11#1)(2012-3#1)
transcriptional activity of##8##3##(1992-8#1)(1995-6#1)(1995-8#2)(2008-11#1)(2008-8#1)(2012-3#1)(2013-7#1)
transcriptional activity was##2##3##(1993-12#1)(2011-2#1)
transcriptional activity##23##2##(1992-8#1)(1993-12#1)(1994-11#1)(1995-6#1)(1995-8#2)(2008-11#2)(2008-5#2)(2008-8#2)(2009-10#3)(2011-2#1)(2012-3#6)(2013-7#1)
transcriptional and post-transcriptional levels##2##4##(1991-6#1)(2009-8#1)
transcriptional and post-transcriptional##3##3##(1991-6#1)(1995-6#1)(2009-8#1)
transcriptional and translational##2##3##(1993-2#1)(1993-8#1)
transcriptional and##9##2##(1991-6#1)(1993-2#1)(1993-8#1)(1995-6#1)(1995-8#1)(2008-11#2)(2009-8#1)(2012-12#1)
transcriptional changes##6##2##(1996-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-2#2)
transcriptional co-activator##3##2##(2011-2#1)(2013-1#2)
transcriptional control elements##2##3##(1993-12#1)(1993-2#1)
transcriptional control of a##2##4##(1995-2#1)(2008-7#1)
transcriptional control of the##2##4##(1993-8#1)(2010-10#1)
transcriptional control of##6##3##(1993-8#1)(1995-2#1)(2008-7#2)(2010-10#1)(2011-2#1)
transcriptional control##13##2##(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(2008-11#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-2#1)
transcriptional enhancers##2##2##(2008-8#2)
transcriptional events##3##2##(1995-11#1)(2009-8#1)(2010-1#1)
transcriptional expression##2##2##(2008-8#1)(2010-10#1)
transcriptional factor and##2##3##(2008-9#2)
transcriptional factor that##2##3##(2008-6#1)(2013-1#1)
transcriptional factor##10##2##(1993-2#1)(1993-3#2)(1997-8#1)(2008-6#1)(2008-9#4)(2013-1#1)
transcriptional factors##6##2##(2008-5#2)(2008-9#3)(2012-2#1)
transcriptional fusion##3##2##(1993-12#1)(2008-10#2)
transcriptional induction of##4##3##(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
transcriptional initiation##5##2##(1993-3#1)(1995-2#1)(1995-6#2)(2008-9#1)
transcriptional level##10##2##(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
transcriptional networks##2##2##(2009-8#2)
transcriptional orientation##3##2##(1991-9#1)(1996-3#1)(2008-8#1)
transcriptional process##2##2##(1996-12#1)(2011-3#1)
transcriptional profiles##2##2##(2008-7#1)(2010-11#1)
transcriptional regulation by##2##3##(1992-12#1)(2012-2#1)
transcriptional regulation of the##4##4##(1993-6#1)(1997-1#1)(2008-11#2)
transcriptional regulation of##11##3##(1993-6#1)(1993-8#1)(1996-12#1)(1997-1#1)(2008-11#4)(2008-8#1)(2008-9#1)(2011-2#1)
transcriptional regulation##23##2##(1992-12#1)(1992-8#1)(1993-6#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#6)(2008-8#1)(2008-9#3)(2011-2#1)(2012-2#1)(2012-3#2)
transcriptional regulator##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
transcriptional regulatory elements##3##3##(1993-12#2)(1993-6#1)
transcriptional regulatory##6##2##(1991-10#1)(1992-3#1)(1993-12#2)(1993-6#1)(2008-9#1)
transcriptional repressor##2##2##(1991-10#1)(2009-6#1)
transcriptional repressors##2##2##(1991-5#1)(2009-8#1)
transcriptional response##2##2##(2010-7#1)(2011-2#1)
transcriptional responses to##2##3##(1991-7#1)(2012-12#1)
transcriptional responses##3##2##(1991-7#1)(2012-12#1)(2012-2#1)
transcriptional start site##4##3##(1994-11#1)(1995-11#1)(1995-6#1)(1996-12#1)
transcriptional start sites##2##3##(1994-11#2)
transcriptional start##6##2##(1994-11#3)(1995-11#1)(1995-6#1)(1996-12#1)
transcriptional trans-activating factors##2##3##(2008-9#2)
transcriptional trans-activating##3##2##(2008-9#3)
transcriptional unit##3##2##(1993-2#1)(2008-10#2)
transcriptional##225##1##(1991-10#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-12#6)(1993-2#4)(1993-3#3)(1993-6#2)(1993-8#7)(1993-9#1)(1994-11#10)(1994-12#1)(1995-11#2)(1995-2#3)(1995-6#7)(1995-8#6)(1996-12#7)(1996-2#2)(1996-3#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#18)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#19)(2009-10#3)(2009-6#2)(2009-8#9)(2010-1#2)(2010-10#4)(2010-11#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#11)(2012-3#13)(2013-1#9)(2013-7#1)
transcriptionally activated##2##2##(1996-3#1)(2009-8#1)
transcriptionally active##7##2##(1990-7#3)(1995-6#1)(2008-10#1)(2011-1#1)(2011-2#1)
transcriptionally##17##1##(1990-7#3)(1993-2#1)(1994-11#2)(1995-6#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
transcriptome analysis of##2##3##(2009-12#1)(2013-1#1)
transcriptome analysis##7##2##(2009-12#2)(2009-8#2)(2011-2#1)(2013-1#2)
transcriptome level##3##2##(2011-2#2)(2012-2#1)
transcriptome meta-analysis##2##2##(2009-10#2)
transcriptome of##2##2##(2009-10#1)(2010-7#1)
transcriptome studies##2##2##(2008-7#1)(2013-1#1)
transcriptome##25##1##(2008-10#1)(2008-7#1)(2009-10#3)(2009-12#4)(2009-8#2)(2010-7#1)(2011-2#3)(2012-2#4)(2013-1#4)(2013-8#2)
transcriptomes##2##1##(2009-10#1)(2012-2#1)
transcripts accumulated##2##2##(2008-8#1)(2008-9#1)
transcripts and##7##2##(1992-12#1)(1997-6#4)(2008-10#1)(2011-2#1)
transcripts are##6##2##(1993-6#1)(1994-11#2)(2008-10#1)(2012-2#1)(2013-1#1)
transcripts derived from##2##3##(1997-2#1)(2008-10#1)
transcripts encoding##2##2##(2008-10#2)
transcripts for##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
transcripts from the##2##3##(1994-11#1)(2011-1#1)
transcripts from##6##2##(1992-6#1)(1994-11#1)(2008-10#2)(2011-1#1)(2012-2#1)
transcripts have also been##2##4##(1995-11#1)(2010-4#1)
transcripts in the##2##3##(1996-8#1)(2008-9#1)
transcripts in##16##2##(1994-11#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
transcripts may be##2##3##(1997-7#1)(2008-10#1)
transcripts of mrr##2##3##(2008-11#2)
transcripts of the##6##3##(1997-2#1)(1997-6#1)(2008-10#2)(2008-8#2)
transcripts of##19##2##(1993-3#1)(1997-2#1)(1997-6#2)(1997-7#1)(2008-10#5)(2008-11#5)(2008-8#3)(2012-2#1)
transcripts revealed##2##2##(2008-9#1)(2009-5#1)
transcripts to##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
transcripts was##3##2##(2008-10#2)(2008-8#1)
transcripts were analyzed##2##3##(1993-2#1)(2008-10#1)
transcripts were detectable##2##3##(1997-8#1)(2008-5#1)
transcripts were detected##3##3##(1994-11#1)(2008-11#1)(2009-7#1)
transcripts were first detected##2##4##(1993-3#1)(1995-11#1)
transcripts were##22##2##(1992-3#1)(1993-2#1)(1993-3#1)(1994-11#3)(1995-11#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-7#1)
transcripts with the##2##3##(2008-11#1)(2008-8#1)
transcripts with##6##2##(1997-6#1)(2008-11#2)(2008-8#1)(2010-4#1)(2012-2#1)
transcripts##170##1##(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#11)(1994-12#1)(1994-2#1)(1995-11#3)(1995-12#4)(1995-6#3)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-6#7)(1997-7#8)(1997-8#2)(2008-10#33)(2008-11#10)(2008-12#1)(2008-2#3)(2008-5#3)(2008-8#10)(2008-9#5)(2009-10#3)(2009-5#1)(2009-7#1)(2010-4#5)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#8)(2012-3#7)(2013-1#3)(2013-8#1)
transcritical##2##1##(2008-8#2)
transcultural encounters##2##2##(2008-11#1)(2010-8#1)
transcultural##3##1##(2008-11#2)(2010-8#1)
transcutaneous oxygen pressure##2##3##(2013-1#2)
transcutaneous##6##1##(1995-8#1)(2008-11#1)(2010-1#1)(2011-2#1)(2013-1#2)
transcytosis##4##1##(1995-2#2)(2009-12#1)(2012-2#1)
transdermal delivery##2##2##(2008-5#1)(2010-12#1)
transdermal granisetron##5##2##(2010-12#5)
transdermal patch##2##2##(2011-2#2)
transdermal##15##1##(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#10)(2011-2#2)
transdifferentiation of##2##2##(2009-3#1)(2013-8#1)
transdifferentiation##3##1##(2008-10#1)(2009-3#1)(2013-8#1)
transduce a##2##2##(2008-11#2)
transduce exogenous genepCEP-p21 ( WAF-1 ) into##2##7##(2008-8#2)
transduce signals##2##2##(2008-11#1)(2009-8#1)
transduce##8##1##(1992-12#1)(1993-9#1)(2008-11#3)(2008-8#2)(2009-8#1)
transduced cells##3##2##(1994-5#1)(2008-11#1)(2008-9#1)
transduced with##3##2##(1994-5#2)(2008-9#1)
transduced##13##1##(1994-5#3)(1997-8#1)(2008-11#3)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)
transducer (LSST) for##2##3##(2008-10#2)
transducer and the##2##3##(2008-10#2)
transducer and##5##2##(2008-10#3)(2008-8#1)(2012-3#1)
transducer in##2##2##(2008-3#1)(2009-8#1)
transducer of##3##2##(1995-2#1)(2008-8#1)(2008-9#1)
transducer was##3##2##(2008-10#2)(2009-5#1)
transducer##31##1##(1995-2#1)(1996-2#2)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
transducers and activators of transcription (STAT)##3##6##(2011-2#2)(2012-3#1)
transducers and activators of transcription##4##5##(1996-2#1)(2011-2#2)(2012-3#1)
transducers and activators of##5##4##(1996-2#1)(2008-1#1)(2011-2#2)(2012-3#1)
transducers and##6##2##(1996-2#1)(2008-1#1)(2009-1#1)(2011-2#2)(2012-3#1)
transducers for##2##2##(2008-10#1)(2009-5#1)
transducers of##2##2##(2008-10#1)(2013-1#1)
transducers##30##1##(1990-8#1)(1996-12#3)(1996-2#1)(2008-1#1)(2008-10#11)(2009-1#1)(2009-12#1)(2009-5#6)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
transduces##2##1##(2012-2#1)(2013-1#1)
transducing material for##2##3##(2008-10#2)
transducing##10##1##(1993-8#2)(1994-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)
transduction and##5##2##(1996-2#1)(2008-11#2)(2008-9#2)
transduction by##3##2##(1992-12#1)(1994-12#1)(2008-10#1)
transduction during##2##2##(2008-8#1)(2008-9#1)
transduction efficiency##2##2##(2008-11#1)(2011-3#1)
transduction in##11##2##(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-3#1)(2013-1#1)
transduction of the##3##3##(1990-12#1)(2008-11#1)(2008-8#1)
transduction of##16##2##(1990-12#1)(1994-11#2)(1994-5#1)(1995-2#1)(2008-11#2)(2008-4#2)(2008-8#2)(2008-9#1)(2010-10#2)(2010-5#1)(2013-1#1)
transduction pathway##16##2##(1994-11#2)(1994-3#1)(1995-8#1)(1997-7#2)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2009-4#1)(2011-3#1)
transduction pathways##17##2##(1994-11#1)(1995-2#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#3)
transduction system##2##2##(1992-8#1)(1994-6#1)
transduction was##2##2##(1997-2#1)(2008-9#1)
transduction with a reverse fragment to a cDNA encoding human 6A8 alpha-mannosidase##2##12##(2008-8#2)
transduction with##4##2##(1990-11#2)(2008-8#2)
transduction##138##1##(1990-11#3)(1990-12#2)(1990-5#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-8#3)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-11#3)(1995-12#1)(1995-2#6)(1995-6#2)(1995-8#3)(1996-12#1)(1996-2#5)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-8#1)(2008-10#14)(2008-11#12)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#11)(2008-9#11)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#4)(2010-5#2)(2010-7#1)(2011-2#2)(2011-3#6)(2012-2#1)(2012-3#3)(2013-1#4)
transductional##2##1##(2008-11#1)(2008-6#1)
transect##4##1##(2008-10#4)
transected##4##1##(1990-5#1)(2008-9#1)(2013-1#2)
transection of the##2##3##(2008-11#1)(2012-3#1)
transection of##3##2##(1993-3#1)(2008-11#1)(2012-3#1)
transection##16##1##(1993-3#2)(1996-12#5)(2008-11#1)(2008-9#1)(2009-2#1)(2012-3#1)(2013-1#5)
transects in##2##2##(2008-11#1)(2008-9#1)
transects##5##1##(2008-10#3)(2008-11#1)(2008-9#1)
transendothelial migration by##2##3##(1995-2#1)(2008-5#1)
transendothelial migration##6##2##(1995-2#4)(2008-5#1)(2009-10#1)
transendothelial##7##1##(1995-2#4)(2008-5#1)(2009-10#1)(2013-8#1)
transepidermal water loss (TEWL) and##2##5##(2008-5#2)
transepidermal water loss (TEWL)##4##4##(2008-5#4)
transepidermal water loss##6##3##(2008-5#6)
transepidermal##7##1##(2008-5#7)
transepithelial electrical resistance (TER)##2##4##(2008-11#2)
transepithelial electrical resistance##3##3##(2008-11#2)(2008-12#1)
transepithelial electrical##4##2##(2008-11#2)(2008-12#2)
transepithelial potential##2##2##(1991-5#1)(2008-12#1)
transepithelial##7##1##(1991-5#1)(2008-11#2)(2008-12#3)(2011-2#1)
transesophageal echocardiography##7##2##(2008-11#1)(2008-7#2)(2009-10#1)(2011-2#2)(2012-3#1)
transesophageal##11##1##(2008-10#2)(2008-11#1)(2008-7#2)(2009-10#1)(2011-2#2)(2012-3#2)(2013-1#1)
transesterification and##2##2##(2008-7#2)
transesterification of##2##2##(2008-10#1)(2010-4#1)
transesterification reaction##2##2##(2008-10#2)
transesterification##8##1##(2008-10#3)(2008-7#4)(2010-4#1)
transfectable##2##1##(1994-5#1)(2008-11#1)
transfectant##3##1##(1993-8#1)(1997-2#1)(2008-11#1)
transfectants of##2##2##(1997-9#1)(2008-11#1)
transfectants##19##1##(1993-1#5)(1993-8#3)(1997-9#1)(2008-11#10)
transfected CHO cells##2##3##(2008-11#2)
transfected CHO##3##2##(2008-11#3)
transfected Drosophila S2 cells##2##4##(2008-11#2)
transfected by##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
transfected cell lines##3##3##(1994-2#1)(2008-11#2)
transfected cell##4##2##(1994-2#1)(2008-11#3)
transfected cells##21##2##(1990-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#8)(2008-8#2)(2010-5#1)
transfected human##3##2##(1993-8#1)(1995-12#1)(2008-8#1)
transfected into a##2##3##(1991-6#1)(1994-6#1)
transfected into##18##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-8#1)(1993-3#2)(1994-6#2)(2008-11#4)(2008-8#4)(2008-9#2)
transfected with PD-L1##2##3##(2012-3#2)
transfected with a vector##2##4##(2008-11#1)(2008-7#1)
transfected with a##7##3##(1995-12#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-11#1)
transfected with sense construct##2##4##(2008-8#2)
transfected with the gene##2##4##(1995-11#1)(2008-5#1)
transfected with the human##3##4##(1994-8#1)(2008-11#1)(2008-4#1)
transfected with the##17##3##(1994-11#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#2)(2008-8#2)
transfected with troutCYP1A-CAT##2##3##(2008-11#2)
transfected with##62##2##(1993-1#2)(1994-11#5)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#5)(1995-8#2)(1996-2#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-11#19)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-8#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-3#2)
transfected##153##1##(1990-5#2)(1990-8#2)(1991-5#1)(1991-6#1)(1992-8#1)(1993-1#3)(1993-3#4)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#2)(1995-11#4)(1995-12#2)(1995-2#9)(1995-6#7)(1995-8#3)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#2)(1997-9#1)(2008-10#4)(2008-11#51)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#16)(2008-9#7)(2009-8#1)(2010-11#4)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
transfecting##10##1##(1997-7#2)(2008-11#6)(2008-8#1)(2008-9#1)
transfection activity of the lipopolylysine##3##5##(1991-5#3)
transfection activity##4##2##(1991-5#4)
transfection and##5##2##(2008-11#4)(2008-9#1)
transfection assays with##2##3##(1992-8#1)(1993-6#1)
transfection assays##6##2##(1991-10#1)(1992-8#1)(1993-6#1)(1995-2#1)(1995-6#1)(1995-8#1)
transfection can##2##2##(1996-12#1)(2008-11#1)
transfection complexes were##2##3##(2008-11#2)
transfection efficiencies of##2##3##(2008-11#2)
transfection efficiencies##4##2##(2008-11#4)
transfection efficiency and##2##3##(2008-11#2)
transfection efficiency in##2##3##(2008-11#2)
transfection efficiency of##5##3##(2008-11#4)(2008-9#1)
transfection efficiency##15##2##(2008-11#12)(2008-2#1)(2008-9#2)
transfection experiments##2##2##(1995-8#1)(2008-11#1)
transfection fate##2##2##(2008-11#2)
transfection has##2##2##(1996-2#1)(2008-9#1)
transfection in##5##2##(1991-5#2)(1996-12#1)(1996-2#1)(2008-11#1)
transfection is##2##2##(2008-11#2)
transfection method##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
transfection of NIH 3T3##2##4##(1992-7#1)(1995-2#1)
transfection of a##2##3##(1997-1#1)(2008-11#1)
transfection of the##3##3##(1990-5#1)(1995-6#1)(2008-11#1)
transfection of##21##2##(1990-5#1)(1992-7#1)(1993-6#1)(1994-5#1)(1995-2#3)(1995-6#1)(1996-12#1)(1997-1#1)(2008-11#8)(2011-2#1)(2012-2#2)
transfection reagent##2##2##(2008-11#2)
transfection reagents##3##2##(2008-11#3)
transfection system based on##2##4##(1995-2#1)(2008-11#1)
transfection system##6##2##(1995-2#1)(2008-11#5)
transfection techniques##2##2##(2008-11#2)
transfection was##3##2##(2008-11#3)
transfection with##4##2##(2008-11#1)(2008-8#1)(2008-9#2)
transfection##150##1##(1990-5#1)(1991-10#1)(1991-5#8)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#2)(1994-5#1)(1995-2#11)(1995-6#2)(1995-8#2)(1996-12#7)(1996-2#3)(1997-1#1)(1997-3#1)(1997-7#2)(2008-11#81)(2008-2#3)(2008-8#5)(2008-9#10)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)
transfections##3##1##(1993-6#1)(2008-11#1)(2008-2#1)
transfemoral approach##4##2##(2011-2#4)
transfemoral##6##1##(2011-2#4)(2013-1#2)
transfer RNA##3##2##(1993-1#1)(1993-8#1)(2008-9#1)
transfer across the##2##3##(1991-5#1)(2008-10#1)
transfer agent##3##2##(2008-10#1)(2008-12#2)
transfer and expression of##2##4##(2008-5#1)(2008-8#1)
transfer and expression##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
transfer and the##2##3##(2008-10#2)
transfer and##21##2##(1994-5#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-11#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)
transfer are##2##2##(2008-3#1)(2008-8#1)
transfer between the##4##3##(2008-10#2)(2009-11#1)(2013-1#1)
transfer between##19##2##(1996-12#1)(2008-10#9)(2008-7#2)(2008-8#3)(2009-11#1)(2010-5#1)(2012-2#1)(2013-1#1)
transfer by##2##2##(1993-8#1)(2011-2#1)
transfer can be##2##3##(2008-12#1)(2012-12#1)
transfer can##4##2##(2008-12#1)(2008-8#1)(2009-9#1)(2012-12#1)
transfer cells##2##2##(2008-11#2)
transfer coefficient were##2##3##(2008-10#1)(2008-11#1)
transfer coefficient##8##2##(1991-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)
transfer complexes##3##2##(2008-10#2)(2008-9#1)
transfer depends##2##2##(2008-10#1)(2013-8#1)
transfer efficiency and##2##3##(1997-8#1)(2008-9#1)
transfer efficiency##4##2##(1997-8#1)(2008-10#1)(2008-9#2)
transfer electrons##2##2##(2008-10#1)(2008-11#1)
transfer episodes##3##2##(1993-12#3)
transfer excitor##2##2##(2008-5#2)
transfer experiments##5##2##(1996-6#1)(2008-11#2)(2008-4#1)(2008-8#1)
transfer for##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-9#1)
transfer from a##2##3##(2008-10#2)
transfer from the##4##3##(2008-10#2)(2009-8#1)(2013-1#1)
transfer from##15##2##(1991-12#1)(1993-9#1)(1994-5#1)(1997-7#1)(2008-10#7)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
transfer function##9##2##(2008-10#2)(2008-3#4)(2008-8#1)(2011-2#2)
transfer function)##3##2##(2008-10#2)(2011-2#1)
transfer functions were used in the hidden and output layers##3##10##(2008-10#3)
transfer functions##4##2##(2008-10#3)(2011-2#1)
transfer hydrogenation##2##2##(2010-7#2)
transfer in a##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
transfer in the##8##3##(1991-5#4)(2008-10#3)(2008-3#1)
transfer in##31##2##(1991-5#4)(1991-9#2)(1992-8#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#8)(2008-11#3)(2008-3#4)(2008-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
transfer into primary rat hepatocytes##3##5##(2008-9#3)
transfer into##10##2##(1994-5#2)(1995-2#1)(2008-11#2)(2008-8#1)(2008-9#3)(2010-11#1)
transfer is##8##2##(1997-7#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-3#1)(2012-2#1)
transfer kinetics of##2##3##(1990-5#1)(2008-8#1)
transfer method##2##2##(2008-11#1)(2008-9#1)
transfer models##2##2##(2008-2#1)(2008-3#1)
transfer occurred##3##2##(2008-10#2)(2008-3#1)
transfer occurs##2##2##(2008-10#2)
transfer of PGCs##4##3##(2008-11#4)
transfer of a##4##3##(1992-10#1)(1997-6#1)(2008-10#1)(2008-5#1)
transfer of an##5##3##(1994-5#1)(2008-10#3)(2008-11#1)
transfer of knowledge##2##3##(2008-11#1)(2010-10#1)
transfer of the##16##3##(1990-12#1)(1991-5#1)(1994-5#1)(1995-2#1)(1996-5#2)(2008-10#5)(2008-11#1)(2009-10#1)(2009-8#2)(2013-1#1)
transfer of this##2##3##(2008-10#1)(2009-10#1)
transfer of transposable elements##2##4##(2009-6#2)
transfer of##100##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#31)(2008-11#14)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#3)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)
transfer patients##2##2##(1992-6#1)(1993-12#1)
transfer procedures##2##2##(2008-10#1)(2008-9#1)
transfer process##2##2##(2008-10#1)(2008-8#1)
transfer processes##8##2##(1990-8#1)(2008-10#4)(2008-8#2)(2012-2#1)
transfer protein##2##2##(1992-7#1)(1995-8#1)
transfer protocols##2##2##(1996-2#1)(2008-11#1)
transfer rate constant (k(s))##2##4##(2008-10#2)
transfer rate constant##5##3##(2008-10#5)
transfer rate constants##3##3##(1991-5#1)(2008-10#2)
transfer rate##12##2##(1991-5#1)(2008-10#9)(2008-7#1)(2008-8#1)
transfer reaction##4##2##(2008-10#4)
transfer reactions##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
transfer resistance##3##2##(2008-10#1)(2012-2#2)
transfer system##3##2##(1994-5#1)(2008-11#1)(2008-3#1)
transfer technique##3##2##(1995-12#1)(1997-6#1)(2008-10#1)
transfer the##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
transfer this##2##2##(1997-7#1)(2008-10#1)
transfer through##3##2##(2008-10#3)
transfer to a##2##3##(2011-2#1)(2012-4#1)
transfer to the##6##3##(1992-1#1)(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
transfer to##24##2##(1990-12#1)(1990-2#2)(1992-1#1)(1994-11#1)(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-4#1)
transfer treatment##2##2##(2008-10#2)
transfer was##9##2##(1991-5#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-8#2)
transfer were##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
transfer with##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
transfer##576##1##(1990-12#4)(1990-2#4)(1990-5#6)(1990-8#5)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#10)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#5)(1993-8#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#17)(1994-8#1)(1995-12#2)(1995-2#9)(1995-3#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#4)(1997-8#3)(2007-12#4)(2008-10#179)(2008-11#59)(2008-12#10)(2008-2#4)(2008-3#33)(2008-4#11)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#36)(2008-9#22)(2009-10#5)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#15)(2011-3#2)(2012-12#3)(2012-2#12)(2012-3#4)(2012-4#1)(2013-1#8)(2013-8#5)
transfer-proof formulae##2##2##(2008-5#2)
transfer-to-orbit experiment##2##2##(2008-3#2)
transferability of##2##2##(2008-11#1)(2012-2#1)
transferable to##3##2##(1994-6#1)(1996-3#1)(2008-10#1)
transferable##7##1##(1992-12#1)(1994-6#1)(1996-3#1)(2008-10#2)(2008-2#1)(2011-2#1)
transferase activity##3##2##(1994-11#1)(1994-8#1)(2006-6#1)
transferase and##3##2##(1992-10#1)(2008-4#1)(2013-1#1)
transferase inhibitor##2##2##(1991-5#1)(2010-12#1)
transferase##33##1##(1991-5#2)(1992-10#1)(1992-6#1)(1994-11#3)(1994-6#1)(1994-8#1)(1996-12#1)(1997-3#2)(1997-7#3)(1997-9#2)(2006-6#2)(2008-10#2)(2008-11#6)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
transferases##3##1##(1992-3#1)(2011-1#1)(2013-1#1)
transference of theoretical knowledge of holistic care into##2##8##(2008-11#2)
transference of##3##2##(2008-10#1)(2008-11#2)
transference##7##1##(1994-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)
transferred across##2##2##(2012-2#1)(2013-1#1)
transferred and##3##2##(2008-11#1)(2008-9#2)
transferred directly into##2##3##(2008-11#1)(2008-2#1)
transferred from##11##2##(1994-6#1)(1997-3#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#2)
transferred in the##2##3##(2008-10#2)
transferred in##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
transferred into a##2##3##(2008-10#2)
transferred into papaya##2##3##(2008-10#2)
transferred into the##4##3##(1993-8#1)(2008-10#2)(2008-11#1)
transferred into wheat##2##3##(2008-8#2)
transferred into##29##2##(1993-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#2)(2008-8#9)(2008-9#1)(2010-6#1)
transferred the##3##2##(1994-5#1)(2008-10#1)(2008-9#1)
transferred to a##8##3##(2008-10#2)(2008-11#2)(2008-5#1)(2013-1#1)(2013-8#2)
transferred to other hexasaccharides##2##4##(1994-5#2)
transferred to the##13##3##(1995-6#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-8#1)(2013-1#3)
transferred to##47##2##(1990-9#1)(1994-2#1)(1994-5#2)(1995-6#2)(1996-8#1)(1997-2#1)(2008-10#17)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-8#1)(2013-1#4)(2013-8#2)
transferred##127##1##(1990-2#1)(1990-5#1)(1990-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#3)(1994-6#1)(1995-6#3)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#46)(2008-11#12)(2008-12#5)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#15)(2008-9#9)(2009-1#1)(2009-8#1)(2010-6#2)(2010-8#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
transferrin (Tf)##2##2##(2010-11#1)(2013-7#1)
transferrin and##3##2##(2008-10#1)(2008-11#1)(2013-7#1)
transferrin in##6##2##(1993-12#2)(2008-11#4)
transferrin into##2##2##(1994-5#1)(2008-11#1)
transferrin receptor##12##2##(1990-8#5)(1991-6#4)(1993-11#2)(1994-5#1)
transferrin receptors##3##2##(1990-8#2)(1993-11#1)
transferrin reduction##2##2##(1994-3#2)
transferrin##58##1##(1990-8#7)(1991-6#4)(1992-1#1)(1993-11#6)(1993-12#2)(1994-3#4)(1994-5#2)(1995-11#1)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#15)(2008-5#3)(2008-7#1)(2010-11#1)(2013-7#2)
transferring flavoenzymes##2##2##(2008-11#2)
transferring the##2##2##(2008-9#1)(2009-10#1)
transferring##19##1##(1996-11#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
transfers and##2##2##(1991-2#1)(1997-6#1)
transfers are##4##2##(1993-12#1)(1996-2#1)(2008-7#1)(2009-6#1)
transfers of##3##2##(1996-8#1)(2008-10#1)(2009-6#1)
transfers the##2##2##(1995-6#1)(2008-7#1)
transfers##26##1##(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#2)(1995-6#1)(1996-2#2)(1996-8#1)(1997-6#1)(2008-10#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#3)(2010-8#3)
transfilter experiments##2##2##(2008-6#2)
transform IR spectrometers##2##3##(2008-3#2)
transform IR##3##2##(2008-3#2)(2010-4#1)
transform algorithm and##2##3##(2008-10#1)(2008-3#1)
transform algorithm##4##2##(2008-10#1)(2008-3#3)
transform infrared spectrometric determination of##2##5##(2008-10#2)
transform infrared spectrometric##4##3##(2008-10#4)
transform infrared spectrometry and##2##4##(1997-2#1)(2008-5#1)
transform infrared spectrometry##12##3##(1997-2#2)(2008-10#9)(2008-5#1)
transform infrared spectroscopy##18##3##(2008-10#16)(2009-10#1)(2013-1#1)
transform infrared##58##2##(1997-2#2)(2008-10#50)(2008-5#2)(2008-8#1)(2009-10#1)(2010-4#1)(2013-1#1)
transform is##2##2##(2008-10#1)(2008-3#1)
transform optical##2##2##(2008-3#2)
transform spectrometer##6##2##(2008-3#6)
transform spectrum##2##2##(2013-8#2)
transform to##2##2##(2008-10#1)(2013-8#1)
transform##147##1##(1990-5#2)(1991-2#1)(1992-12#1)(1996-1#1)(1997-2#2)(1997-7#2)(2008-1#1)(2008-10#79)(2008-11#2)(2008-12#1)(2008-3#28)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#3)(2009-10#1)(2009-4#1)(2010-1#1)(2010-4#2)(2012-2#2)(2013-1#3)(2013-8#6)
transform-based Fourier deconvolution##2##3##(2008-10#2)
transform-based##3##1##(2008-10#2)(2008-3#1)
transform-limited pedestal-free##2##2##(2007-11#2)
transform-limited##3##1##(2007-11#2)(2007-12#1)
transformant cells##4##2##(1995-12#4)
transformant##12##1##(1995-12#5)(2008-10#6)(2008-8#1)
transformants and the##3##3##(2008-10#3)
transformants and##4##2##(2008-10#4)
transformants containing##2##2##(2008-10#1)(2008-5#1)
transformants in##2##2##(1991-9#1)(2008-10#1)
transformants obtained with##2##3##(2008-10#2)
transformants of##4##2##(2008-10#4)
transformants per##2##2##(2008-10#2)
transformants showed##2##2##(2008-10#2)
transformants were##7##2##(1990-5#1)(1991-9#1)(1993-12#1)(2008-10#4)
transformants with##4##2##(2008-10#2)(2008-8#1)(2011-1#1)
transformants##63##1##(1990-5#2)(1990-8#1)(1991-9#2)(1993-12#3)(1995-3#1)(1997-2#1)(1997-8#2)(2008-10#42)(2008-5#1)(2008-8#6)(2011-1#1)(2013-1#1)
transformation (DRIFT) spectroscopy##2##3##(2008-10#2)
transformation and the##2##3##(1995-2#1)(2008-10#1)
transformation and##12##2##(1993-9#2)(1995-2#1)(1995-5#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)
transformation by the##2##3##(2008-10#2)
transformation by##7##2##(1990-8#2)(1993-11#1)(2008-10#2)(2008-11#1)(2009-5#1)
transformation event##2##2##(2008-10#2)
transformation frequencies##2##2##(2008-10#2)
transformation frequency##2##2##(2008-10#2)
transformation from##3##2##(2008-3#1)(2011-2#1)(2013-8#1)
transformation has been##2##3##(2008-10#1)(2008-7#1)
transformation has##3##2##(1997-1#1)(2008-10#1)(2008-7#1)
transformation in the##2##3##(1990-5#1)(2008-7#1)
transformation in##14##2##(1990-5#2)(1995-9#1)(1996-2#1)(2007-12#2)(2008-11#1)(2008-7#3)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
transformation into##3##2##(1992-12#1)(2008-5#1)(2009-8#1)
transformation is##4##2##(1995-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
transformation of a##2##3##(1992-9#1)(2009-1#1)
transformation of cells##2##3##(2008-2#1)(2011-2#1)
transformation of incidence##3##3##(2008-10#3)
transformation of the fluorescent pseudomonad##2##5##(2008-10#2)
transformation of the##7##3##(1993-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(2008-10#2)(2008-3#1)
transformation of##37##2##(1990-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-7#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
transformation procedure##2##2##(2008-10#1)(2008-8#1)
transformation system##3##2##(1990-5#1)(2008-10#1)(2012-3#1)
transformation to colorectal carcinoma##2##4##(2009-12#2)
transformation to##6##2##(2008-10#1)(2008-8#2)(2009-12#2)(2010-7#1)
transformation was##5##2##(1993-2#1)(1993-9#1)(2008-10#2)(2008-7#1)
transformation with##5##2##(1993-2#1)(2008-10#3)(2008-2#1)
transformation zone##7##2##(1990-6#1)(1991-2#1)(1994-12#1)(1994-2#2)(2012-3#2)
transformation##202##1##(1990-5#4)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#7)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-5#1)(1995-6#1)(1995-9#3)(1996-1#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#3)(1997-7#3)(2007-12#3)(2007-8#1)(2008-10#44)(2008-11#18)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#3)(2009-5#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#2)
transformational##3##1##(1992-1#1)(2008-11#2)
transformations are##3##2##(2008-12#1)(2008-3#2)
transformations have been##2##3##(2008-10#2)
transformations have##3##2##(2008-10#3)
transformations in##4##2##(2008-10#1)(2008-12#2)(2013-1#1)
transformations of##3##2##(2008-10#2)(2010-1#1)
transformations##35##1##(1995-2#1)(1996-5#2)(2008-10#12)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-6#3)(2009-10#1)(2010-1#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
transformative##8##1##(1996-1#1)(2008-12#2)(2010-8#4)(2013-1#1)
transformed and untransformed cells##2##4##(1993-2#1)(2011-2#1)
transformed and##3##2##(1993-2#1)(1993-6#1)(2011-2#1)
transformed by the##3##3##(1991-5#1)(1997-7#1)(2008-8#1)
transformed by##9##2##(1991-2#1)(1991-5#1)(1997-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2013-8#1)
transformed cell lines##4##3##(1993-6#1)(1995-12#1)(1995-2#1)(2008-11#1)
transformed cell##9##2##(1993-6#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-11#3)(2008-8#1)(2011-2#1)
transformed cells##18##2##(1990-6#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-2#4)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-9#1)(2010-3#1)(2011-2#2)
transformed human##5##2##(1992-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(2008-10#1)
transformed infrared##4##2##(2008-10#4)
transformed into a##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
transformed into an##2##3##(2008-10#1)(2008-11#1)
transformed into the gaseous##2##4##(2008-10#2)
transformed into the##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
transformed into##19##2##(1996-5#3)(1997-1#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2013-1#1)
transformed migraine##2##2##(2008-9#2)
transformed phenotype in##2##3##(1995-6#1)(2011-2#1)
transformed phenotype of##2##3##(1995-6#1)(2008-11#1)
transformed phenotype##8##2##(1995-6#2)(1995-9#1)(1997-1#1)(2008-11#1)(2008-8#2)(2011-2#1)
transformed to##10##2##(2008-10#2)(2008-11#5)(2008-8#1)(2010-10#1)(2013-1#1)
transformed with a##9##3##(1993-2#1)(1995-6#1)(2008-10#6)(2010-6#1)
transformed with the coat protein (CP)##2##6##(2008-10#2)
transformed with the##7##3##(2008-10#7)
transformed with two##2##3##(1997-7#1)(2008-10#1)
transformed with##28##2##(1993-2#1)(1995-6#1)(1997-7#1)(2008-10#18)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#2)
transformed##164##1##(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-6#3)(1993-8#2)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#6)(1995-6#3)(1995-9#2)(1996-12#1)(1996-5#3)(1997-1#4)(1997-7#3)(2007-12#2)(2008-10#44)(2008-11#24)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#8)(2008-9#6)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-6#1)(2011-2#9)(2011-7#1)(2013-1#4)(2013-8#1)
transformer oil##5##2##(2008-10#5)
transformer##10##1##(2007-12#2)(2008-10#8)
transformer-2##5##1##(2007-12#5)
transforming growth factor (TGF)-beta##2##4##(2008-11#2)
transforming growth factor beta (TGF-beta)##4##5##(2008-1#1)(2008-11#2)(2008-12#1)
transforming growth factor beta##8##4##(1990-5#1)(1993-12#1)(1995-2#1)(2008-1#1)(2008-11#3)(2008-12#1)
transforming growth factor##18##3##(1990-5#1)(1990-8#1)(1993-12#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#3)
transforming growth factor-beta (TGF-beta)##3##4##(1990-2#1)(2008-11#2)
transforming growth factor-beta 1##3##4##(1990-2#2)(1991-12#1)
transforming growth factor-beta##9##3##(1990-2#3)(1991-12#1)(1995-11#1)(2008-11#2)(2008-9#1)(2013-1#1)
transforming growth##27##2##(1990-2#3)(1990-5#1)(1990-8#1)(1991-12#1)(1993-12#1)(1995-11#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-11#7)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#3)(2013-1#1)
transforming the##5##2##(1994-3#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
transforming##50##1##(1990-2#3)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#4)(2013-1#2)(2013-8#1)
transforms the##2##2##(2008-3#2)
transforms##14##1##(1992-8#1)(1993-12#1)(1993-8#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-8#1)
transfused##7##1##(1991-8#2)(1996-3#1)(1996-9#1)(1997-5#1)(2011-2#2)
transfusion associated##2##2##(2008-10#2)
transfusion in##5##2##(1995-12#1)(2009-3#1)(2011-2#1)(2013-1#2)
transfusion medicine]##2##2##(2008-10#2)
transfusion of##4##2##(1996-9#1)(2008-11#1)(2008-12#1)(2013-1#1)
transfusion practice##2##2##(2008-12#2)
transfusion response##2##2##(2011-2#2)
transfusion therapy and##2##3##(1990-11#1)(2012-3#1)
transfusion therapy##4##2##(1990-11#3)(2012-3#1)
transfusion volume &gt##2##3##(2011-2#2)
transfusion##61##1##(1990-11#3)(1990-3#2)(1991-3#1)(1991-8#1)(1992-3#1)(1995-12#3)(1995-6#1)(1996-3#1)(1996-9#7)(2006-6#1)(2008-10#8)(2008-11#1)(2008-12#5)(2008-9#2)(2009-3#2)(2010-11#2)(2011-2#13)(2012-2#2)(2012-3#1)(2013-1#4)
transfusions and##3##2##(1990-5#1)(2007-8#1)(2008-1#1)
transfusions were##2##2##(1996-3#1)(2011-2#1)
transfusions##25##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-3#2)(1991-6#1)(1995-12#1)(1995-6#1)(1996-3#4)(2007-8#1)(2008-1#2)(2008-11#2)(2010-11#1)(2011-2#6)(2013-1#1)
transgastric peritoneoscopy##2##2##(2009-8#2)
transgene expression##7##2##(1994-3#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-11#2)(2011-1#1)
transgene frequency##2##2##(2008-8#2)
transgene in##4##2##(1995-2#1)(2008-10#2)(2008-8#1)
transgene integration##3##2##(2008-11#3)
transgene is##2##2##(1996-12#1)(2008-10#1)
transgene transcript##2##2##(2008-10#2)
transgene transmission##2##2##(2008-12#2)
transgene was##4##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
transgene##66##1##(1993-6#2)(1994-3#3)(1995-2#4)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#24)(2008-11#10)(2008-12#3)(2008-8#8)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-3#2)
transgene-mediated##2##1##(2008-10#2)
transgene-transgene junctions##2##2##(1993-6#2)
transgenerational marking##2##2##(2010-8#2)
transgenes and##3##2##(2008-11#1)(2008-9#2)
transgenes could##2##2##(2008-8#1)(2008-9#1)
transgenes in##3##2##(1993-6#2)(1994-5#1)
transgenes##19##1##(1993-6#2)(1994-3#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#4)(2008-8#2)(2008-9#4)(2011-1#1)(2012-3#1)(2013-1#1)
transgenesis##5##1##(2008-11#1)(2008-4#2)(2012-3#2)
transgenic N##2##2##(2008-10#1)(2012-3#1)
transgenic and##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2010-7#1)
transgenic animals##9##2##(1992-8#3)(1993-12#2)(1993-6#1)(1995-2#1)(1995-6#1)(2008-11#1)
transgenic approach##3##2##(2008-4#2)(2009-8#1)
transgenic flies##3##2##(1993-9#1)(1995-6#1)(2008-8#1)
transgenic hybrids##2##2##(2008-10#2)
transgenic hypovirulent strain##2##3##(2008-10#2)
transgenic hypovirulent strains##4##3##(2008-10#4)
transgenic hypovirulent##6##2##(2008-10#6)
transgenic line##4##2##(2008-10#4)
transgenic lines were obtained##2##4##(2008-10#1)(2008-8#1)
transgenic lines were##7##3##(2008-10#5)(2008-8#1)(2009-10#1)
transgenic lines with##2##3##(2008-10#1)(2008-8#1)
transgenic lines##25##2##(2008-10#17)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#2)(2012-3#1)
transgenic livestock##3##2##(2008-11#3)
transgenic maize plants##3##3##(2008-8#3)
transgenic maize##5##2##(1995-6#1)(2008-10#1)(2008-8#3)
transgenic mice expressing##3##3##(1997-7#1)(2008-4#1)(2013-8#1)
transgenic mice for##2##3##(2008-11#1)(2008-4#1)
transgenic mice that##3##3##(1994-5#1)(1995-2#1)(1995-6#1)
transgenic mice were##3##3##(1996-12#1)(2008-9#2)
transgenic mice##51##2##(1992-8#2)(1994-5#1)(1995-2#7)(1995-6#5)(1996-12#2)(1997-7#2)(2008-10#1)(2008-11#6)(2008-4#9)(2008-9#6)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#2)
transgenic mouse model for##2##4##(1995-2#1)(1995-6#1)
transgenic mouse model of##2##4##(1996-5#1)(2008-10#1)
transgenic mouse model##5##3##(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2010-8#1)
transgenic mouse##7##2##(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-9#1)(2010-8#1)
transgenic or##2##2##(2008-4#1)(2011-2#1)
transgenic plant##6##2##(2008-10#4)(2008-9#2)
transgenic plantlets##3##2##(2008-9#3)
transgenic plants are##2##3##(2008-10#1)(2013-8#1)
transgenic plants could be##2##4##(2008-10#1)(2008-8#1)
transgenic plants expressing a##2##4##(2008-10#2)
transgenic plants expressing the##2##4##(2008-10#2)
transgenic plants expressing##7##3##(2008-10#5)(2009-8#1)(2011-10#1)
transgenic plants was##3##3##(2008-10#2)(2008-8#1)
transgenic plants##38##2##(1995-6#1)(2008-10#19)(2008-11#1)(2008-8#7)(2008-9#5)(2009-8#1)(2011-10#1)(2011-2#1)(2013-8#2)
transgenic potato plants##2##3##(2008-10#1)(2008-8#1)
transgenic potato##4##2##(2008-10#1)(2008-8#3)
transgenic rabbits##5##2##(2008-11#2)(2008-12#3)
transgenic release##2##2##(2008-8#2)
transgenic resistance to##2##3##(2008-10#2)
transgenic resistance##3##2##(2008-10#3)
transgenic rice plants##2##3##(2008-10#1)(2008-9#1)
transgenic rice variety Zhong 8215##2##5##(2008-9#2)
transgenic rice##9##2##(2008-10#1)(2008-8#1)(2008-9#7)
transgenic soybean plants##2##3##(2008-10#2)
transgenic tobacco plants##5##3##(2008-10#2)(2008-8#2)(2011-10#1)
transgenic tobacco protoplasts was##2##4##(2008-8#2)
transgenic tobacco protoplasts##3##3##(2008-8#3)
transgenic tobacco##12##2##(2008-10#3)(2008-8#6)(2008-9#1)(2011-10#2)
transgenic tomato##4##2##(2008-10#4)
transgenic##272##1##(1992-8#5)(1993-12#3)(1993-6#1)(1993-9#1)(1994-3#2)(1994-5#1)(1995-2#11)(1995-6#10)(1996-12#4)(1996-5#1)(1997-7#2)(2008-10#92)(2008-11#17)(2008-12#5)(2008-2#1)(2008-4#16)(2008-8#36)(2008-9#29)(2009-10#2)(2009-8#5)(2009-9#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-10#4)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#6)
transgenically##2##1##(2008-10#1)(2010-11#1)
transglutaminase##9##1##(1994-11#3)(2008-10#1)(2008-5#4)(2008-9#1)
transglutaminase-mediated##2##1##(2008-5#2)
transient absorption spectra of##2##4##(2008-9#2)
transient absorption##6##2##(2008-10#3)(2008-8#1)(2008-9#2)
transient and##5##2##(1991-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2013-1#1)
transient elevation of##3##3##(1991-12#1)(1991-5#1)(2008-7#1)
transient exposure##2##2##(1992-8#1)(2012-3#1)
transient expression assay##2##3##(1995-6#1)(2008-11#1)
transient expression of the##3##4##(1994-11#1)(2008-11#1)(2008-4#1)
transient expression of##5##3##(1994-11#1)(1997-7#1)(2008-11#1)(2008-4#2)
transient expression system##4##3##(1994-11#1)(2008-11#1)(2011-2#2)
transient expression##19##2##(1992-9#1)(1993-8#2)(1994-11#2)(1995-6#1)(1997-7#1)(2008-11#6)(2008-2#1)(2008-4#2)(2011-2#2)(2011-3#1)
transient forebrain ischemia##4##3##(1990-5#1)(1996-12#3)
transient formation of##2##3##(2008-10#2)
transient gene expression in##3##4##(2008-11#3)
transient gene expression##5##3##(2008-11#5)
transient gene##6##2##(2008-11#6)
transient increase in##7##3##(1993-3#1)(1995-8#1)(1996-12#2)(2008-10#1)(2010-12#1)(2012-3#1)
transient increase##8##2##(1992-9#1)(1993-3#1)(1995-8#1)(1996-12#2)(2008-10#1)(2010-12#1)(2012-3#1)
transient increases in##2##3##(1990-10#1)(2008-9#1)
transient increases of##2##3##(1990-12#1)(1995-11#1)
transient increases##4##2##(1990-10#1)(1990-12#1)(1995-11#1)(2008-9#1)
transient ischemic attacks##3##3##(1991-3#1)(2007-7#1)(2012-3#1)
transient ischemic##4##2##(1991-3#1)(2007-7#1)(2012-3#1)(2013-8#1)
transient or##2##2##(2011-1#2)
transient paralysis was found in three##2##6##(2008-7#2)
transient phase##2##2##(1991-5#1)(1994-2#1)
transient photoelectromotive force effects##2##4##(2008-3#2)
transient potential change##4##3##(2008-10#4)
transient radiative transfer##2##3##(2008-3#2)
transient responses##2##2##(2008-10#1)(2008-9#1)
transient seropositivity##2##2##(2008-5#2)
transient short-pulse##2##2##(2008-3#2)
transient signal##2##2##(1996-2#1)(2008-10#1)
transient signals##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
transient transfection assays##2##3##(1991-10#1)(1992-8#1)
transient transfection system##2##3##(2008-11#2)
transient transfection##10##2##(1991-10#1)(1992-8#1)(2008-11#7)(2012-2#1)
transient up-regulation##2##2##(1997-7#1)(2010-10#1)
transient##229##1##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#2)(1992-12#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#2)(1997-1#4)(1997-6#1)(1997-7#4)(2007-7#1)(2008-1#1)(2008-10#30)(2008-11#34)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#3)(2008-5#3)(2008-7#9)(2008-8#8)(2008-9#8)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-3#2)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#8)(2011-3#1)(2012-2#4)(2012-3#6)(2013-1#5)(2013-8#1)
transiently expressed##5##2##(1994-11#1)(2008-11#1)(2008-8#2)(2008-9#1)
transiently transfected with the##2##4##(1994-11#2)
transiently transfected##4##2##(1994-11#2)(2008-11#1)(2008-7#1)
transiently##27##1##(1994-11#4)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#2)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2010-11#1)(2013-1#1)
transients in##2##2##(2008-3#1)(2008-8#1)
transients of##2##2##(2008-10#1)(2008-3#1)
transients##9##1##(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#2)(2010-8#2)
transin##2##1##(1992-6#2)
transistor (ISFET)##3##2##(2008-10#3)
transistor##10##1##(1995-8#1)(2008-10#8)(2009-5#1)
transit of##3##2##(1992-3#1)(1997-6#1)(2012-2#1)
transit##13##1##(1992-3#2)(1995-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-2#3)(2013-1#2)
transition and heavy metal ions##8##5##(2008-10#8)
transition and the##2##3##(2008-11#1)(2012-2#1)
transition and##14##2##(1991-6#1)(2008-10#9)(2008-11#2)(2011-2#1)(2012-2#1)
transition at 1##2##3##(2008-3#2)
transition at nucleotide position##2##4##(1994-11#1)(2008-10#1)
transition at nucleotide##3##3##(1994-11#2)(2008-10#1)
transition at##10##2##(1992-8#1)(1993-8#1)(1994-11#2)(2008-10#1)(2008-3#5)
transition between the##3##3##(1996-6#1)(2007-12#1)(2008-10#1)
transition between##8##2##(1995-3#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)
transition by##2##2##(1993-8#1)(1994-2#1)
transition element##2##2##(2008-10#1)(2008-3#1)
transition for##2##2##(1992-1#1)(2008-11#1)
transition from hospital to residential care##2##6##(2012-12#2)
transition from hospital to##3##4##(2011-2#1)(2012-12#2)
transition from the##4##3##(1995-1#1)(1996-2#1)(2008-11#1)(2008-7#1)
transition from##32##2##(1991-1#1)(1992-10#1)(1992-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#3)(1996-2#2)(1996-3#1)(2008-10#2)(2008-11#4)(2008-7#2)(2008-9#1)(2009-6#2)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
transition in the##4##3##(1994-3#1)(2008-3#1)(2009-8#1)(2010-12#1)
transition in##15##2##(1990-12#1)(1991-12#1)(1991-9#1)(1994-3#1)(1995-3#2)(2008-11#1)(2008-3#4)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
transition is##2##2##(2008-10#1)(2008-11#1)
transition losses##4##2##(2008-3#4)
transition matrix##2##2##(2008-3#2)
transition metal and##2##3##(2008-10#1)(2010-11#1)
transition metal cations##3##3##(2008-10#3)
transition metal complexes##3##3##(2008-10#2)(2010-7#1)
transition metal ions and##3##4##(2008-10#3)
transition metal ions##16##3##(2008-10#14)(2008-12#1)(2010-11#1)
transition metal##27##2##(2008-10#23)(2008-12#1)(2010-11#2)(2010-7#1)
transition metals and##2##3##(2008-10#2)
transition metals in##5##3##(2008-10#2)(2008-5#1)(2010-11#2)
transition metals##23##2##(2008-10#15)(2008-5#3)(2009-10#1)(2010-11#2)(2011-1#2)
transition of a##2##3##(2008-11#1)(2010-7#1)
transition of atomic##2##3##(2008-2#1)(2008-3#1)
transition of lambda-DNA induced by cationic surfactant##2##7##(2008-8#2)
transition of the##5##3##(1994-3#1)(2008-10#1)(2008-3#2)(2011-10#1)
transition of##18##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#3)(2010-10#1)(2010-7#1)(2011-10#1)(2011-2#1)(2013-8#1)
transition peak at##2##3##(1992-10#2)
transition period##2##2##(1996-3#1)(2011-2#1)
transition points and transition intervals of##3##6##(2008-10#3)
transition points##4##2##(2008-10#3)(2008-4#1)
transition probability matrices##2##3##(2011-2#2)
transition state##7##2##(1990-5#2)(1991-5#1)(1991-9#1)(1996-5#1)(2008-4#1)(2009-5#1)
transition states##5##2##(1991-6#1)(1996-5#3)(2012-12#1)
transition temperature of the##2##4##(2008-10#1)(2008-3#1)
transition temperature##8##2##(1995-3#2)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)
transition temperatures##4##2##(1995-3#1)(2008-10#3)
transition to##17##2##(1990-8#1)(1991-12#1)(1997-6#1)(2008-10#5)(2008-11#5)(2009-7#2)(2011-2#1)(2013-1#1)
transition with a##2##3##(1995-6#1)(2008-1#1)
transition##310##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#5)(1992-12#1)(1992-6#1)(1992-8#2)(1993-5#1)(1993-8#4)(1994-11#3)(1994-2#3)(1994-3#4)(1995-1#2)(1995-2#1)(1995-3#7)(1995-6#4)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#4)(1996-5#4)(1996-6#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#86)(2008-11#21)(2008-12#4)(2008-2#5)(2008-3#32)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#5)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#11)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#2)
transition-state analog##2##2##(1995-2#2)
transition-state##5##1##(1994-5#2)(1995-2#2)(2008-5#1)
transitional cell carcinoma##4##3##(1990-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
transitional cell##5##2##(1990-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
transitional day hospital##2##3##(1993-2#2)
transitional funding##3##2##(1991-12#2)(1993-1#1)
transitional stage##2##2##(2009-10#1)(2009-7#1)
transitional##27##1##(1990-12#1)(1990-6#1)(1991-12#2)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#2)(1996-3#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
transitioned##2##1##(2010-12#1)(2011-2#1)
transitioning##5##1##(1997-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-8#1)
transitions and##3##2##(2009-5#1)(2010-11#1)(2011-2#1)
transitions between##5##2##(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)
transitions for##2##2##(2008-3#1)(2010-10#1)
transitions have##2##2##(2008-11#1)(2008-3#1)
transitions in##7##2##(1991-9#2)(1992-8#1)(1993-5#1)(2008-11#1)(2008-3#1)(2008-8#1)
transitions is##3##2##(1995-3#1)(2008-3#1)(2009-10#1)
transitions near##2##2##(2007-11#1)(2008-3#1)
transitions of the##2##3##(2008-3#2)
transitions of##6##2##(1990-2#1)(2008-10#1)(2008-3#4)
transitions to##3##2##(2008-11#1)(2008-2#1)(2008-8#1)
transitions were##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
transitions##69##1##(1990-2#1)(1990-8#1)(1991-9#2)(1992-8#1)(1993-5#1)(1994-5#1)(1994-8#2)(1995-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#15)(2008-5#1)(2008-8#8)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-7#1)(2011-2#5)(2011-3#1)
transitory increase##2##2##(2008-11#1)(2013-1#1)
transitory##9##1##(1990-9#1)(1991-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-6#1)(2013-1#1)
transjugular##2##1##(1991-11#1)(2009-9#1)
transketolase-catalyzed condensation##2##2##(2008-7#2)
transketolase-catalyzed##3##1##(2008-7#3)
translabyrinthine##2##1##(2011-2#2)
translatable and##2##2##(1997-3#1)(2008-10#1)
translatable##3##1##(1997-3#2)(2008-10#1)
translate into##5##2##(1991-5#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
translate##11##1##(1991-5#1)(1993-2#1)(1995-12#1)(2008-10#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
translated in##3##2##(1995-6#1)(2008-10#1)(2012-2#1)
translated into a protein##2##4##(1990-11#1)(1995-12#1)
translated into a##5##3##(1990-11#1)(1995-12#1)(2008-10#2)(2008-7#1)
translated into clinical##2##3##(2012-12#1)(2012-2#1)
translated into##17##2##(1990-11#1)(1991-12#1)(1993-11#1)(1995-12#2)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#2)
translated protein##2##2##(1997-2#1)(2008-10#1)
translated##35##1##(1990-11#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-4#1)(2012-12#1)(2012-2#4)
translates the##2##2##(1994-1#1)(2007-11#1)
translates##4##1##(1991-12#1)(1994-1#1)(2007-11#1)(2008-10#1)
translating research##3##2##(2008-11#1)(2013-1#2)
translating the##3##2##(2008-10#1)(2008-12#1)(2009-10#1)
translating##15##1##(1991-3#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-11#1)(2013-1#3)
translation and expression##2##3##(2008-1#2)
translation and##6##2##(2008-1#2)(2008-4#1)(2010-10#1)(2012-2#1)(2013-1#1)
translation as well as##2##4##(2008-9#1)(2010-4#1)
translation elongation factor 1-alpha##2##4##(2008-10#2)
translation elongation factor 1alpha##4##4##(2008-10#4)
translation elongation factor##8##3##(2008-10#7)(2008-8#1)
translation elongation##9##2##(2008-10#8)(2008-8#1)
translation in##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
translation initiation site##5##3##(1997-2#3)(1997-6#1)(1997-7#1)
translation initiation sites of##5##4##(1996-8#1)(1997-2#1)(1997-6#3)
translation initiation sites on the genome of Synechocystis sp##3##9##(1996-8#1)(1997-2#1)(1997-6#1)
translation initiation sites on##4##4##(1996-8#1)(1997-2#2)(1997-6#1)
translation initiation sites##15##3##(1996-8#4)(1997-2#5)(1997-6#6)
translation initiation##25##2##(1995-6#1)(1996-8#4)(1997-1#1)(1997-2#8)(1997-6#7)(1997-7#2)(2008-9#1)(2010-12#1)
translation into##2##2##(2008-9#1)(2011-2#1)
translation is##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
translation of the##12##3##(1993-6#1)(1995-6#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2012-2#2)
translation of##28##2##(1993-6#1)(1995-12#2)(1995-2#1)(1995-6#2)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-8#1)
translation product was##2##3##(1997-8#1)(2008-10#1)
translation product##6##2##(1991-5#1)(1995-6#1)(1997-8#1)(2008-10#3)
translation regulation##3##2##(2008-9#2)(2010-12#1)
translation system##2##2##(1991-10#1)(1995-2#1)
translation termination##2##2##(2008-9#2)
translation##155##1##(1990-5#1)(1991-10#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-12#2)(1995-2#2)(1995-6#6)(1996-8#4)(1997-1#2)(1997-2#8)(1997-3#4)(1997-6#8)(1997-7#3)(1997-8#3)(2008-1#4)(2008-10#22)(2008-11#9)(2008-12#4)(2008-2#1)(2008-4#5)(2008-6#2)(2008-8#4)(2008-9#15)(2009-10#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#4)(2010-5#2)(2010-8#2)(2011-2#5)(2012-2#9)(2012-3#5)(2013-1#3)(2013-8#1)
translational initiation##3##2##(1994-11#1)(2008-8#2)
translational negative feedback##2##3##(2010-10#2)
translational research##4##2##(2008-11#1)(2008-9#1)(2010-10#2)
translational start##3##2##(1992-10#1)(2008-4#1)(2008-9#1)
translational temperature##2##2##(2008-2#2)
translational##48##1##(1991-9#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-9#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-8#5)(2008-9#2)(2010-10#4)(2010-4#2)(2010-5#3)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
translationally##3##1##(1993-9#1)(2010-12#2)
translations##4##1##(2009-6#1)(2010-1#2)(2012-2#1)
translations)##2##1##(2013-1#2)
translocase##2##1##(1995-2#1)(2012-2#1)
translocate##6##1##(1994-5#1)(1997-1#1)(2008-11#1)(2009-10#2)(2011-3#1)
translocated across the cytoplasmic membrane and##2##6##(1991-10#2)
translocated across the##3##3##(1991-10#3)
translocated from the##3##3##(1991-12#1)(1992-6#1)(2011-2#1)
translocated into the nucleus##2##4##(1996-12#1)(2009-8#1)
translocated onto##2##2##(1992-6#1)(2009-10#1)
translocated to the##4##3##(1993-2#1)(1993-8#1)(2008-10#1)(2011-2#1)
translocated##21##1##(1991-10#3)(1991-12#1)(1992-6#2)(1993-2#3)(1993-8#1)(1996-12#1)(2008-10#4)(2009-10#1)(2009-8#1)(2011-2#4)
translocates##4##1##(1992-12#1)(1995-2#1)(2008-10#1)(2011-2#1)
translocation activity of F(0)##3##4##(2008-8#3)
translocation activity of##5##3##(1997-8#1)(2008-8#4)
translocation activity##6##2##(1997-8#1)(2008-8#5)
translocation and##4##2##(1994-6#1)(2008-10#1)(2009-8#1)(2012-3#1)
translocation by##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
translocation from##5##2##(1991-2#1)(1994-11#1)(2008-10#2)(2008-9#1)
translocation in##5##2##(1993-2#1)(1994-11#1)(1997-8#1)(2008-10#1)(2008-9#1)
translocation into the endoplasmic reticulum##2##5##(1991-2#2)
translocation into the##3##3##(1991-2#3)
translocation into##4##2##(1991-2#3)(1997-8#1)
translocation line##2##2##(2008-8#2)
translocation of PKCalpha from both mitochondria and cytosol to nucleus##2##10##(2008-9#2)
translocation of PKCalpha##3##3##(2008-9#3)
translocation of a##4##3##(1997-8#2)(2008-10#1)(2011-2#1)
translocation of glucose transporter 4##2##5##(2008-11#2)
translocation of rac p21s##4##4##(1993-8#4)
translocation of the##4##3##(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)
translocation of##40##2##(1991-12#1)(1991-5#1)(1992-8#1)(1993-8#6)(1994-11#3)(1995-11#1)(1996-12#1)(1997-1#1)(1997-8#2)(2008-10#4)(2008-11#5)(2008-8#3)(2008-9#3)(2009-5#1)(2010-10#2)(2010-11#2)(2011-2#2)(2012-2#1)
translocation points##2##2##(1996-6#2)
translocation through##2##2##(1991-5#1)(2009-7#1)
translocation to the##3##3##(1993-8#1)(2008-11#2)
translocation to##5##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#2)
translocation was##2##2##(1990-5#1)(1994-6#1)
translocation with##2##2##(2008-10#1)(2010-10#1)
translocation##120##1##(1990-5#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-5#4)(1991-9#1)(1992-8#1)(1993-2#3)(1993-8#8)(1994-11#9)(1994-5#1)(1994-6#2)(1995-10#1)(1995-11#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#3)(1997-1#1)(1997-8#5)(2008-10#14)(2008-11#7)(2008-8#14)(2008-9#6)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#7)(2010-11#3)(2011-2#2)(2011-3#2)(2012-2#3)(2012-3#6)
translocations##12##1##(1997-7#2)(2008-10#1)(2008-9#1)(2009-10#1)(2010-1#4)(2011-2#1)(2012-3#1)(2013-8#1)
translocator protein (TSPO)##5##3##(2012-2#5)
translucency##4##1##(1991-11#1)(2008-11#2)(2013-1#1)
translucens and##3##2##(2008-10#3)
translucens population size##2##3##(2008-10#2)
translucens population##3##2##(2008-10#3)
translucens pv##15##2##(2008-10#15)
translucens strains##3##2##(2008-10#3)
translucens##39##1##(2008-10#39)
translucent##2##1##(2007-12#1)(2008-10#1)
transluminal angioplasty##5##2##(1993-8#1)(2008-11#1)(2008-7#2)(2011-2#1)
transluminal coronary angioplasty (PTCA)##4##4##(1992-9#1)(2008-5#2)(2013-8#1)
transluminal coronary angioplasty##7##3##(1992-9#1)(1995-2#1)(2008-11#2)(2008-5#2)(2013-8#1)
transluminal coronary##8##2##(1991-3#1)(1992-9#1)(1995-2#1)(2008-11#2)(2008-5#2)(2013-8#1)
transluminal##14##1##(1991-3#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-2#1)(2008-11#3)(2008-5#2)(2008-7#2)(2011-2#1)(2013-8#1)
transmastoid approach##2##2##(2011-2#2)
transmastoid##4##1##(2011-2#4)
transmembrane H+##3##2##(1994-6#3)
transmembrane domain and##2##3##(1993-8#1)(2008-11#1)
transmembrane domain##9##2##(1991-9#1)(1993-8#2)(2008-11#2)(2009-10#2)(2012-2#1)(2013-1#1)
transmembrane domains##5##2##(1995-8#1)(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
transmembrane electron##2##2##(1994-3#1)(2009-9#1)
transmembrane helices##3##2##(1990-5#1)(1993-3#2)
transmembrane helix of##2##3##(1994-12#1)(2008-8#1)
transmembrane helix##4##2##(1994-12#1)(1995-2#1)(2008-8#2)
transmembrane protein##4##2##(1993-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
transmembrane proteins that##2##3##(2008-9#1)(2012-3#1)
transmembrane proteins with##2##3##(2009-1#1)(2009-8#1)
transmembrane proteins##9##2##(1994-12#1)(1995-9#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-8#3)(2012-3#1)
transmembrane segment##2##2##(1993-8#1)(2008-8#1)
transmembrane segments##3##2##(1990-5#1)(1996-12#1)(1996-3#1)
transmembrane signaling##4##2##(1991-12#1)(1993-1#1)(1994-5#1)(2008-9#1)
transmembrane##78##1##(1990-12#1)(1990-5#2)(1991-10#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#3)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-8#4)(2009-9#3)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
transmigration of##2##2##(2008-10#2)
transmigration##3##1##(2008-10#3)
transmissibility of##3##2##(1996-12#1)(2008-10#2)
transmissibility##8##1##(1996-12#1)(2008-10#6)(2011-3#1)
transmissible and nontransmissible##2##3##(2008-10#2)
transmissible by the whitefly vector##2##5##(2008-10#2)
transmissible from##2##2##(2008-10#2)
transmissible##13##1##(1996-8#1)(2008-10#9)(2008-5#1)(2010-5#1)(2013-8#1)
transmission activity##2##2##(1996-2#2)
transmission among##4##2##(1991-1#1)(2012-2#1)(2013-8#2)
transmission and to##2##3##(2009-8#1)(2013-1#1)
transmission and##27##2##(1992-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
transmission are##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
transmission at##4##2##(1996-2#1)(1997-2#1)(2008-9#1)(2009-7#1)
transmission but##2##2##(2008-10#1)(2008-8#1)
transmission by the##2##3##(2008-10#2)
transmission by##17##2##(1995-6#1)(2008-10#14)(2010-1#1)(2012-3#1)
transmission characteristics of##2##3##(2008-10#1)(2008-3#1)
transmission characteristics##3##2##(2008-10#1)(2008-3#2)
transmission classes##2##2##(2008-10#2)
transmission coefficient for##2##3##(2007-12#1)(2008-3#1)
transmission efficiency of the##2##4##(2008-10#2)
transmission efficiency of##4##3##(2008-10#4)
transmission efficiency##6##2##(2008-10#6)
transmission electron microscope (TEM)##3##4##(2008-8#1)(2009-11#1)(2009-7#1)
transmission electron microscope##7##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)
transmission electron microscopy (TEM)##8##4##(2008-10#4)(2008-5#1)(2009-7#2)(2011-2#1)
transmission electron microscopy and##4##4##(2008-10#3)(2009-11#1)
transmission electron microscopy showed##2##4##(2008-7#1)(2008-8#1)
transmission electron microscopy to##4##4##(2008-10#3)(2008-5#1)
transmission electron microscopy were##2##4##(2008-10#1)(2008-7#1)
transmission electron microscopy##49##3##(1997-3#1)(2007-12#5)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#8)(2008-8#1)(2009-11#1)(2009-7#3)(2011-2#1)(2013-1#1)
transmission electron##58##2##(1991-12#1)(1997-3#1)(2007-12#6)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#6)(2008-7#10)(2008-8#2)(2009-11#2)(2009-7#4)(2011-2#1)(2013-1#1)
transmission for the##2##3##(2008-3#1)(2008-7#1)
transmission for##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
transmission from##4##2##(1996-5#1)(2008-10#2)(2013-1#1)
transmission functions for##2##3##(2008-2#2)
transmission in the##11##3##(1990-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(2008-5#1)(2008-7#2)(2011-3#1)(2012-3#1)(2013-8#1)
transmission in##21##2##(1990-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2011-3#2)(2012-3#1)(2013-8#4)
transmission is favored##2##3##(2008-9#2)
transmission is not##2##3##(2011-3#1)(2012-3#1)
transmission is##10##2##(1997-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#3)(2011-3#1)(2012-3#1)
transmission line##2##2##(2007-11#1)(2008-4#1)
transmission measurements##4##2##(2008-2#1)(2008-3#2)(2008-5#1)
transmission mechanism##2##2##(2008-10#2)
transmission mode##2##2##(2008-9#2)
transmission network##2##2##(2013-1#2)
transmission occurred##2##2##(2008-10#2)
transmission of HIV##4##3##(1993-3#1)(1996-5#1)(2012-2#1)(2013-1#1)
transmission of TSWV##2##3##(2008-10#2)
transmission of TYMV in##2##4##(2008-10#2)
transmission of a##2##3##(2008-10#1)(2008-3#1)
transmission of both##2##3##(1994-11#1)(2008-10#1)
transmission of infection##3##3##(2010-5#2)(2013-8#1)
transmission of information##2##3##(2008-5#1)(2010-8#1)
transmission of the virus##2##4##(1996-11#1)(2008-10#1)
transmission of the##7##3##(1996-11#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-3#1)
transmission of this##2##3##(2008-10#2)
transmission of two##2##3##(2008-3#1)(2008-9#1)
transmission of virus##2##3##(2008-10#2)
transmission of##82##2##(1990-6#1)(1991-10#1)(1993-3#1)(1994-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-10#35)(2008-11#3)(2008-12#1)(2008-3#6)(2008-5#4)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#4)(2010-5#2)(2010-8#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
transmission or##4##2##(1995-12#1)(1995-2#1)(2007-9#1)(2008-10#1)
transmission over##3##2##(2007-12#2)(2008-9#1)
transmission rate of the##2##4##(2008-8#1)(2008-9#1)
transmission rate##8##2##(2008-10#5)(2008-8#2)(2008-9#1)
transmission rates##3##2##(2008-10#2)(2013-8#1)
transmission spectra##2##2##(2007-12#1)(2008-3#1)
transmission spectroscopy##2##2##(2008-10#1)(2008-5#1)
transmission spectrum##2##2##(2008-2#1)(2008-3#1)
transmission system##2##2##(2007-12#1)(2013-1#1)
transmission that##2##2##(1993-12#1)(2008-3#1)
transmission through seed was##2##4##(2008-10#2)
transmission through the##2##3##(2008-3#1)(2011-2#1)
transmission through##10##2##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-1#1)(2011-2#1)
transmission to the##2##3##(1995-6#1)(1997-4#1)
transmission to##13##2##(1992-12#1)(1995-6#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
transmission was##7##2##(1997-2#1)(1997-3#1)(2008-10#4)(2011-2#1)
transmission within the##2##3##(2011-3#2)
transmission within##3##2##(2008-8#1)(2011-3#2)
transmission##494##1##(1990-5#1)(1990-6#1)(1991-1#2)(1991-10#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#4)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#5)(1996-5#4)(1997-2#5)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#2)(2007-11#3)(2007-12#17)(2007-9#1)(2008-1#2)(2008-10#176)(2008-11#10)(2008-12#5)(2008-2#9)(2008-3#43)(2008-4#1)(2008-5#20)(2008-7#15)(2008-8#14)(2008-9#20)(2009-11#2)(2009-5#1)(2009-7#6)(2009-8#3)(2009-9#2)(2010-1#8)(2010-11#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#10)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#8)(2013-1#15)(2013-8#13)
transmission)##2##1##(2008-10#2)
transmissions##6##1##(1996-2#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#2)
transmissive##4##1##(2008-3#4)
transmit TSWV##4##2##(2008-10#4)
transmit the virus##4##3##(2008-10#4)
transmit the##6##2##(2008-10#6)
transmit##35##1##(1990-5#1)(1996-5#1)(2008-10#26)(2008-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
transmits##3##1##(2008-10#1)(2008-3#1)(2008-8#1)
transmittance and##4##2##(2008-3#4)
transmittance of the##2##3##(2008-2#1)(2008-3#1)
transmittance of##3##2##(2008-2#1)(2008-3#2)
transmittance##18##1##(2008-10#3)(2008-2#3)(2008-3#10)(2008-5#2)
transmitted PPV to##2##3##(2008-10#2)
transmitted PPV##3##2##(2008-10#3)
transmitted and##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
transmitted beam##3##2##(2008-2#1)(2008-3#2)
transmitted by the##11##3##(2008-10#9)(2010-1#1)(2011-2#1)
transmitted by whiteflies##2##3##(2008-10#2)
transmitted by##34##2##(1996-11#1)(1996-2#1)(2008-10#27)(2008-3#1)(2010-1#1)(2011-2#2)(2012-2#1)
transmitted disease##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
transmitted diseases##7##2##(1990-11#1)(1990-3#1)(1993-9#1)(1996-6#1)(1996-9#1)(1997-6#1)(2009-12#1)
transmitted from the##3##3##(2008-11#1)(2008-7#2)
transmitted from##12##2##(1990-3#1)(1990-9#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#1)
transmitted in the##2##3##(2008-10#1)(2008-7#1)
transmitted in##5##2##(2008-10#4)(2008-7#1)
transmitted infection##2##2##(2008-11#1)(2008-12#1)
transmitted infections##11##2##(2008-11#2)(2008-12#2)(2009-5#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
transmitted only##2##2##(2008-10#2)
transmitted the##3##2##(2008-10#3)
transmitted through##8##2##(1996-5#3)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
transmitted to humans##2##3##(2011-2#1)(2013-8#1)
transmitted to##7##2##(1990-5#1)(1995-9#1)(2007-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
transmitted vertically##2##2##(1995-9#1)(2007-12#1)
transmitted with##2##2##(1997-6#1)(2008-10#1)
transmitted##160##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-9#1)(1992-3#1)(1993-1#2)(1993-9#1)(1995-11#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-5#4)(1996-6#2)(1996-9#1)(1997-6#2)(1997-8#1)(2007-12#3)(2007-9#1)(2008-10#70)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#11)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-1#2)(2011-2#12)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
transmitter and receiver##2##3##(2008-3#2)
transmitter and##4##2##(2008-3#4)
transmitter in##2##2##(2008-7#2)
transmitter release##2##2##(1995-11#2)
transmitter##15##1##(1992-6#1)(1995-11#3)(1996-12#2)(2007-12#2)(2008-11#1)(2008-3#4)(2008-7#2)
transmitters (up to##2##3##(2008-10#2)
transmitters##8##1##(1992-6#1)(1995-11#2)(1997-2#1)(1997-4#1)(2008-10#2)(2009-12#1)
transmitting the virus##2##3##(2008-10#2)
transmitting the##3##2##(2008-10#3)
transmitting##14##1##(1992-9#1)(1995-12#1)(1997-2#1)(2008-10#6)(2008-2#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
transmural##4##1##(1990-5#1)(1991-3#1)(2012-2#1)(2013-1#1)
transnasal approach to the##2##4##(2011-2#2)
transnasal approach##3##2##(2011-2#3)
transnasal endoscopic##2##2##(2011-2#2)
transnasal##7##1##(1991-1#1)(2011-2#5)(2013-1#1)
transoral##4##1##(2008-12#1)(2011-2#3)
transovarial transmission##3##2##(2008-10#3)
transovarial##4##1##(2008-10#4)
transpalpebral##3##1##(2011-2#3)
transpapillary##4##1##(1990-3#2)(1991-3#1)(2013-1#1)
transparency and##4##2##(1993-5#1)(2008-11#1)(2008-3#1)(2010-4#1)
transparency of the##2##3##(2008-5#1)(2008-7#1)
transparency of##3##2##(2008-5#1)(2008-7#1)(2013-7#1)
transparency##17##1##(1993-5#1)(2008-10#2)(2008-11#3)(2008-3#3)(2008-5#2)(2008-7#1)(2010-4#1)(2012-3#1)(2013-7#1)(2013-8#2)
transparent and##4##2##(1994-3#1)(1995-5#1)(2008-11#1)(2013-7#1)
transparent##36##1##(1994-3#1)(1995-5#1)(1997-6#1)(2007-11#2)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-7#1)
transpedicular screws##3##2##(2007-11#3)
transpedicular##9##1##(2007-11#9)
transpeptidase##3##1##(1995-11#2)(2007-12#1)
transperitoneal##2##1##(2008-10#1)(2012-12#1)
transpetrosal approach##3##2##(2008-7#3)
transpetrosal##4##1##(2008-7#4)
transphosphorylation of##2##2##(1995-2#2)
transpiration##8##1##(2008-10#7)(2012-7#1)
transplant experiment##3##2##(2008-8#1)(2008-9#2)
transplant for##2##2##(1992-3#1)(1994-5#1)
transplant outcome##2##2##(1997-8#1)(2010-5#1)
transplant patients##10##2##(1994-5#3)(2006-6#1)(2008-1#1)(2008-10#3)(2010-7#1)(2013-1#1)
transplant recipient##2##2##(2008-6#1)(2011-3#1)
transplant recipients##8##2##(1997-2#1)(2007-11#1)(2008-10#2)(2008-6#2)(2010-12#1)(2011-2#1)
transplant rejection##2##2##(2008-10#1)(2012-3#1)
transplant was##2##2##(1997-3#1)(2010-11#1)
transplant##82##1##(1992-3#1)(1994-3#1)(1994-5#4)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-6#4)(2008-8#4)(2008-9#4)(2009-3#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-5#1)(2010-7#2)(2011-2#3)(2011-3#8)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
transplantable##4##1##(1992-1#2)(1992-8#1)(1994-1#1)
transplantation (n = 1)##2##4##(1994-3#2)
transplantation and##7##2##(2008-10#1)(2010-10#2)(2011-3#1)(2012-2#2)(2012-3#1)
transplantation are##3##2##(1994-6#1)(1997-5#1)(2011-2#1)
transplantation as immunotherapy for##2##4##(2008-11#2)
transplantation can be##2##3##(2011-3#1)(2012-12#1)
transplantation can##3##2##(1997-3#1)(2011-3#1)(2012-12#1)
transplantation for the treatment of##2##5##(2010-12#1)(2013-1#1)
transplantation for##9##2##(1991-11#2)(2010-10#2)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#2)
transplantation has been##3##3##(2008-11#2)(2010-11#1)
transplantation has##5##2##(2007-11#1)(2008-11#2)(2010-11#1)(2011-3#1)
transplantation in a patient with##2##5##(1992-12#1)(2011-2#1)
transplantation in the##2##3##(2011-2#2)
transplantation in##12##2##(1992-12#1)(1994-3#1)(1997-5#2)(2008-10#2)(2010-11#1)(2011-2#3)(2012-12#2)
transplantation into##2##2##(2008-11#1)(2008-7#1)
transplantation is an##2##3##(1997-8#1)(2010-10#1)
transplantation is##13##2##(1993-2#1)(1994-6#1)(1997-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2011-3#4)(2012-2#1)(2013-1#1)(2013-7#1)
transplantation of##9##2##(2008-10#2)(2010-12#1)(2011-2#2)(2012-10#1)(2012-3#1)(2013-1#2)
transplantation or##3##2##(1993-2#1)(2008-11#2)
transplantation therapy##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
transplantation to##2##2##(1994-3#2)
transplantation using##2##2##(1995-12#1)(2010-10#1)
transplantation was##4##2##(1995-2#1)(2010-6#1)(2011-2#1)(2012-2#1)
transplantation with##4##2##(1994-3#1)(2010-10#1)(2010-12#1)(2012-12#1)
transplantation##233##1##(1990-8#1)(1991-11#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#5)(1994-1#1)(1994-3#8)(1994-5#5)(1994-6#3)(1995-10#1)(1995-12#6)(1995-2#3)(1995-9#1)(1996-11#2)(1996-2#1)(1996-9#1)(1997-3#4)(1997-5#6)(1997-7#1)(1997-8#3)(2007-11#3)(2008-1#3)(2008-10#8)(2008-11#16)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#12)(2010-11#17)(2010-12#8)(2010-4#1)(2010-6#2)(2010-7#2)(2011-2#28)(2011-3#19)(2012-10#1)(2012-12#10)(2012-2#6)(2012-3#8)(2013-1#14)(2013-7#1)(2013-8#2)
transplantation]##4##1##(1994-5#1)(2008-10#1)(2012-3#1)(2013-8#1)
transplantations have been performed##2##4##(1995-2#1)(1997-5#1)
transplantations##11##1##(1995-2#1)(1995-9#1)(1997-5#2)(2011-2#2)(2011-3#3)(2012-12#1)(2012-3#1)
transplanted F344##2##2##(2011-2#2)
transplanted in##3##2##(1994-5#1)(2008-11#1)(2008-8#1)
transplanted into##12##2##(2008-10#3)(2008-11#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#3)(2013-1#2)
transplanted kidney##3##2##(1992-2#2)(2012-12#1)
transplanted to##2##2##(2008-10#1)(2008-11#1)
transplanted tumor##3##2##(2008-9#3)
transplanted with##2##2##(2008-11#1)(2011-3#1)
transplanted##47##1##(1992-2#2)(1994-5#1)(2008-10#9)(2008-11#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2010-10#1)(2010-11#5)(2011-2#7)(2011-3#3)(2012-12#1)(2013-1#4)(2013-7#1)
transplanting##6##1##(2008-10#4)(2008-8#1)(2008-9#1)
transplants in the field##2##4##(2008-10#2)
transplants##14##1##(1991-2#1)(1994-5#1)(1995-2#1)(2008-10#6)(2008-5#2)(2009-3#1)(2010-12#1)(2013-1#1)
transplasma membrane electron transfer##2##4##(2009-9#2)
transplasma membrane##3##2##(2009-9#3)
transport a##2##2##(2008-7#1)(2011-2#1)
transport across##2##2##(2008-10#2)
transport activity of##2##3##(2008-11#1)(2008-8#1)
transport activity##8##2##(1994-8#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-8#2)(2011-2#2)
transport and the##2##3##(1990-12#1)(2009-9#1)
transport and##29##2##(1990-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-6#1)(1997-1#2)(2008-10#4)(2008-11#3)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#2)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
transport between##2##2##(1992-12#1)(1995-11#1)
transport by arachidonic acid##2##4##(1995-11#2)
transport by##8##2##(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-8#1)(2008-10#1)(2008-11#1)
transport can be##2##3##(1997-6#1)(2008-10#1)
transport can##3##2##(1994-3#1)(1997-6#1)(2008-10#1)
transport capacity##2##2##(1995-6#1)(2008-10#1)
transport characteristics##2##2##(1990-2#1)(1991-5#1)
transport competent##2##2##(1994-11#2)
transport experiments##3##2##(1990-2#1)(2008-10#1)(2011-2#1)
transport from the##4##3##(2008-11#2)(2008-3#1)(2009-8#1)
transport from##6##2##(1991-2#1)(2008-11#3)(2008-3#1)(2009-8#1)
transport in the##10##3##(1995-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)
transport in##25##2##(1990-2#1)(1991-12#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-7#1)(2011-2#2)(2013-1#1)
transport inhibitor##2##2##(2008-7#2)
transport inhibitors##2##2##(1991-5#1)(1994-6#1)
transport inside##2##2##(2008-3#1)(2011-2#1)
transport into the myotubes##2##4##(1994-11#2)
transport into the nucleus##2##4##(1994-11#1)(2012-2#1)
transport into the##5##3##(1994-11#3)(1994-5#1)(2012-2#1)
transport into##13##2##(1992-12#1)(1994-11#6)(1994-5#1)(2008-1#2)(2008-3#1)(2012-2#2)
transport is critical##2##3##(2009-8#1)(2010-7#1)
transport is##13##2##(1991-3#1)(1991-5#1)(1994-3#1)(2008-10#2)(2008-11#1)(2009-8#4)(2010-4#1)(2010-7#2)
transport machinery is##3##3##(2009-10#1)(2011-2#2)
transport machinery##5##2##(2008-11#1)(2009-10#1)(2011-2#2)(2012-2#1)
transport mechanism##4##2##(2008-10#4)
transport model with##2##3##(2008-10#2)
transport model##3##2##(2008-10#2)(2013-1#1)
transport of 5-methyltetrahydrofolate##3##3##(1994-6#3)
transport of lithium##2##3##(2008-10#2)
transport of the Eu(III)##2##4##(2008-10#2)
transport of the##7##3##(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2010-8#1)
transport of β-actin mRNA##3##4##(2012-2#3)
transport of##77##2##(1990-2#1)(1990-9#1)(1991-2#1)(1992-3#2)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#4)(1995-11#1)(1995-6#1)(1996-2#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-10#20)(2008-11#7)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#5)(2012-2#4)(2013-1#1)(2013-8#2)
transport pathways##5##2##(1995-6#1)(2008-11#2)(2012-8#2)
transport process##2##2##(1991-5#1)(2008-7#1)
transport processes##5##2##(1992-3#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#1)
transport protein##3##2##(1993-11#1)(1994-8#1)(1995-6#1)
transport proteins##8##2##(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#4)(2012-2#1)
transport rate of##2##3##(2008-11#1)(2008-9#1)
transport rate##6##2##(1994-8#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
transport system and##2##3##(1990-2#1)(2013-1#1)
transport system for##3##3##(1990-2#1)(1992-3#1)(1995-12#1)
transport system in##2##3##(1990-5#1)(2008-11#1)
transport system is##2##3##(1991-5#1)(1995-8#1)
transport system##20##2##(1990-2#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#2)(1994-8#1)(1995-12#2)(1995-8#2)(2008-10#1)(2008-11#2)(2010-5#1)(2013-1#1)
transport system)##2##2##(1996-12#2)
transport systems##6##2##(1990-8#4)(1995-8#1)(2011-2#1)
transport through the##4##3##(1994-11#2)(2008-10#2)
transport through##8##2##(1994-11#2)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
transport to the##5##3##(2008-10#3)(2008-7#1)(2012-5#1)
transport to##13##2##(2007-9#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#4)(2012-2#1)(2012-5#1)
transport was inhibited by##2##4##(1994-11#1)(1995-8#1)
transport was observed with##2##4##(2008-10#2)
transport was##11##2##(1990-2#1)(1991-5#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-10#3)(2011-2#1)
transport were##2##2##(2008-10#1)(2013-1#1)
transport##453##1##(1990-12#2)(1990-2#11)(1990-5#2)(1990-8#5)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#10)(1991-9#2)(1992-12#2)(1992-3#7)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-8#1)(1993-9#2)(1994-11#14)(1994-12#1)(1994-3#5)(1994-5#1)(1994-6#9)(1994-8#9)(1995-10#2)(1995-11#8)(1995-12#3)(1995-2#9)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#9)(1996-1#3)(1996-12#8)(1996-2#4)(1996-8#1)(1996-9#1)(1997-1#11)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#4)(2007-12#1)(2007-9#2)(2008-1#3)(2008-10#70)(2008-11#40)(2008-12#3)(2008-3#7)(2008-4#2)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#9)(2009-10#7)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#10)(2009-9#6)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#5)(2010-8#1)(2011-1#2)(2011-2#32)(2011-3#8)(2012-2#14)(2012-5#1)(2012-8#2)(2013-1#10)(2013-7#1)(2013-8#4)
transport)##3##1##(2008-10#1)(2008-5#1)(2012-5#1)
transport-dependent##2##1##(2009-6#2)
transportable##3##1##(2008-10#1)(2008-3#1)(2010-8#1)
transportation and##5##2##(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#2)
transportation is##2##2##(2013-1#2)
transportation of##5##2##(1994-9#1)(2008-10#1)(2009-10#2)(2013-1#1)
transportation##27##1##(1994-1#1)(1994-9#1)(2008-10#7)(2008-9#1)(2009-10#3)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#1)
transported by a##3##3##(1994-8#1)(2008-7#1)(2010-4#1)
transported by means of a##2##5##(2008-10#2)
transported by##8##2##(1993-8#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-4#1)
transported from the##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
transported from##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
transported into##5##2##(1993-8#2)(1994-11#1)(2008-10#1)(2012-2#1)
transported to an##2##3##(2008-10#2)
transported to the##9##3##(1990-5#1)(1991-12#2)(1994-11#1)(1995-6#1)(2008-10#4)
transported to##13##2##(1990-5#1)(1991-12#2)(1994-11#1)(1995-6#1)(1997-7#1)(2008-10#6)(2008-11#1)
transported with##2##2##(1994-12#1)(2008-10#1)
transported##50##1##(1990-5#1)(1990-9#1)(1991-12#2)(1993-8#3)(1994-11#4)(1994-12#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-10#22)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#2)(2012-2#1)
transporter (DAT)##2##2##(1996-12#2)
transporter (SERT)##2##2##(1996-12#2)
transporter 1##3##2##(1993-8#2)(2013-1#1)
transporter 2 (GLUT 2)##2##4##(1994-2#2)
transporter and##2##2##(1994-6#1)(2008-7#1)
transporter as##2##2##(2008-6#1)(2008-7#1)
transporter by##2##2##(1995-11#1)(1995-8#1)
transporter could##2##2##(1996-12#2)
transporter family##2##2##(2008-7#1)(2011-2#1)
transporter for##3##2##(1996-12#2)(2011-2#1)
transporter gene##2##2##(1993-8#1)(2010-7#1)
transporter in the##3##3##(1994-2#1)(1994-8#1)(1997-7#1)
transporter in##9##2##(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-12#1)(1997-7#1)(2012-3#1)
transporter is encoded by##2##4##(1994-8#1)(1995-6#1)
transporter is##5##2##(1994-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-2#1)
transporter mRNA in the##2##4##(1994-2#2)
transporter mRNAs##2##2##(1996-2#2)
transporter of##3##2##(1995-6#1)(1995-8#1)(2011-1#1)
transporter protein##2##2##(1995-6#2)
transporter proteins##2##2##(1996-12#1)(2008-11#1)
transporter that##2##2##(1995-2#1)(2011-2#1)
transporter##110##1##(1992-3#1)(1992-7#1)(1993-12#2)(1993-8#4)(1994-11#2)(1994-2#5)(1994-6#4)(1994-8#6)(1995-11#2)(1995-2#7)(1995-6#7)(1995-8#6)(1996-12#20)(1996-2#9)(1997-7#2)(2008-10#1)(2008-11#9)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-3#2)(2013-1#1)
transporters and##2##2##(1995-6#1)(2013-8#1)
transporters in the##3##3##(2008-11#1)(2008-7#2)
transporters in##5##2##(1990-11#1)(2008-11#1)(2008-7#3)
transporters##38##1##(1990-11#1)(1992-3#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-11#7)(2008-7#11)(2008-8#7)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
transporting##11##1##(1994-12#1)(2007-12#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-8#1)(2012-2#1)(2013-1#3)
transposa and vacuma##4##3##(2008-10#4)
transposa and##5##2##(2008-10#5)
transposa isolates##3##2##(2008-10#3)
transposa##9##1##(2008-10#9)
transposable element in##2##3##(2008-10#1)(2012-3#1)
transposable element##9##2##(2008-10#5)(2008-9#1)(2012-3#3)
transposable elements and##3##3##(2009-10#1)(2009-6#2)
transposable elements##17##2##(2008-10#6)(2009-10#3)(2009-6#5)(2010-5#1)(2010-8#1)(2012-3#1)
transposable##30##1##(1995-12#2)(2008-10#12)(2008-9#1)(2009-10#3)(2009-6#5)(2010-5#1)(2010-8#2)(2012-3#4)
transposase##6##1##(1996-12#2)(1996-6#1)(2008-10#1)(2012-3#2)
transposed##4##1##(1992-9#1)(2008-10#1)(2008-9#2)
transposing##2##1##(1993-1#1)(2008-10#1)
transposition and##2##2##(2008-10#1)(2008-9#1)
transposition frequency##4##2##(2012-3#4)
transposition in##2##2##(1997-7#1)(2008-10#1)
transposition of a##2##3##(1994-12#1)(1995-2#1)
transposition of the great arteries##2##5##(2009-10#1)(2010-6#1)
transposition of the great##3##4##(1996-11#1)(2009-10#1)(2010-6#1)
transposition of##7##2##(1994-12#1)(1995-2#1)(1996-11#1)(2008-10#1)(2009-10#1)(2010-6#1)(2012-3#1)
transposition rates##2##2##(2012-3#2)
transposition##27##1##(1994-12#1)(1995-2#3)(1996-11#1)(1996-5#1)(1997-7#2)(2008-10#7)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2012-3#8)
transposon insertion##2##2##(2008-10#1)(2009-10#1)
transposon mutagenesis##3##2##(2008-10#1)(2008-9#2)
transposon##20##1##(1993-12#1)(1995-9#1)(1996-12#1)(2008-10#8)(2008-9#3)(2009-10#2)(2010-4#1)(2010-5#3)
transposons##2##1##(2008-10#1)(2010-5#1)
transracial adoption##2##2##(2008-5#2)
transracial##4##1##(2008-5#4)
transradial access##3##2##(2011-2#3)
transradial approach for coronary##2##4##(2011-2#2)
transradial approach for percutaneous coronary##2##5##(2011-2#2)
transradial approach for##6##3##(2011-2#6)
transradial approach##16##2##(2008-11#3)(2011-2#13)
transradial coronary angiography##2##3##(2011-2#2)
transradial coronary##4##2##(2011-2#4)
transradial interventions##2##2##(2011-2#2)
transradial procedure##2##2##(2011-2#2)
transradial##36##1##(2008-11#3)(2011-2#33)
transrectal##5##1##(1997-8#1)(2011-2#3)(2013-1#1)
transsphenoidal approach to##2##3##(2011-2#2)
transsphenoidal approach##6##2##(2011-2#6)
transsphenoidal##11##1##(1991-6#1)(2008-7#2)(2011-2#8)
transtheoretical model (TTM)##2##3##(2008-12#1)(2013-1#1)
transtheoretical model##3##2##(2008-12#1)(2013-1#2)
transtheoretical##4##1##(2008-12#1)(2012-2#1)(2013-1#2)
transthoracic##3##1##(1993-3#1)(2008-11#1)(2009-10#1)
transthyretin (prealbumin) in human cerebrospinal fluid##2##6##(1991-2#2)
transthyretin gene##2##2##(1992-8#2)
transthyretin##10##1##(1991-2#7)(1992-8#3)
transtibial prostheses##3##2##(2013-1#3)
transtibial##5##1##(2011-2#1)(2013-1#4)
transtrapezium approach##3##2##(2008-9#3)
transurethral prostate##2##2##(1990-11#2)
transurethral resection of the##2##4##(2012-12#1)(2012-3#1)
transurethral resection of##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
transurethral resection##5##2##(1991-9#1)(2008-10#1)(2012-12#2)(2012-3#1)
transurethral##8##1##(1990-11#2)(1991-9#1)(2008-10#1)(2008-11#1)(2012-12#2)(2012-3#1)
transvaginal color Doppler##4##3##(1995-3#4)
transvaginal##9##1##(1995-3#5)(1996-1#2)(2011-2#2)
transvenous##5##1##(1996-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)
transversal##2##1##(2011-3#1)(2012-3#1)
transversally heated##2##2##(2008-10#2)
transversally into##2##2##(2008-12#1)(2013-1#1)
transversally##5##1##(2008-10#2)(2008-12#1)(2008-2#1)(2013-1#1)
transverse colon##2##2##(1991-6#1)(2008-11#1)
transverse diameter of the aberrant pancreatic tissue##2##7##(2012-2#2)
transverse myelitis and neuromyelitis optica##2##5##(2012-3#2)
transverse myelitis and##3##3##(2012-3#3)
transverse myelitis##6##2##(2012-3#6)
transverse sections##4##2##(2008-5#2)(2008-7#1)(2011-2#1)
transverse sinus##7##2##(1996-6#2)(1996-9#2)(2008-7#3)
transverse##51##1##(1990-5#1)(1991-6#1)(1992-2#2)(1995-6#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#4)(2008-9#2)(2009-3#1)(2009-7#2)(2011-2#2)(2012-2#4)(2012-3#6)(2013-1#2)
transverse-sigmoid sinus dural arteriovenous malformations##2##5##(2008-7#2)
transversely heated graphite atomizer (THGA)##2##5##(2008-10#2)
transversely heated graphite atomizer##4##4##(2008-10#4)
transversely heated graphite##7##3##(2008-10#7)
transversely##11##1##(2007-12#1)(2008-10#9)(2008-3#1)
transversion at##2##2##(1994-11#1)(2008-10#1)
transversion##8##1##(1991-7#1)(1992-8#1)(1993-6#1)(1994-11#1)(2008-10#4)
transvesical##2##1##(2011-2#1)(2013-1#1)
trap and##4##2##(2008-10#3)(2009-8#1)
trap for##2##2##(2008-10#2)
trap mass spectrometer##4##3##(2008-10#4)
trap mass spectrometry##8##3##(2008-10#5)(2008-8#2)(2010-11#1)
trap mass##13##2##(2008-10#10)(2008-8#2)(2010-11#1)
trap plants##5##2##(2008-10#5)
trap system##2##2##(2008-10#1)(2008-9#1)
trap##65##1##(1993-6#1)(1994-2#1)(1995-3#1)(2008-10#40)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#3)(2009-5#2)(2009-8#2)(2010-11#2)(2010-7#2)(2012-12#1)(2012-2#1)(2013-8#1)
trapezius and##2##2##(2010-9#2)
trapezius muscle##3##2##(2010-9#3)
trapezius##11##1##(2010-9#11)
trapped by##5##2##(1992-5#1)(2008-10#4)
trapped flow analysis system (ByT-FAS)##3##5##(2008-10#3)
trapped flow##4##2##(2008-10#4)
trapped in a##3##3##(2008-10#2)(2008-3#1)
trapped in the##10##3##(2008-10#9)(2008-2#1)
trapped in##19##2##(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
trapped within##2##2##(2008-3#1)(2012-2#1)
trapped##51##1##(1991-3#1)(1992-5#1)(1994-11#2)(2008-10#35)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-12#2)(2010-4#1)(2012-2#2)
trapped-flow analysis##3##2##(2008-10#3)
trapper##2##1##(1997-2#2)
trapping and atomisation efficiency##2##4##(2008-10#2)
trapping and atomisation temperatures##2##4##(2008-10#2)
trapping and atomisation##5##3##(2008-10#5)
trapping and release of the magnetic beads in the flow cell were controlled by##2##14##(2008-10#2)
trapping and##13##2##(2008-10#10)(2008-3#1)(2008-8#1)(2009-12#1)
trapping by the##2##3##(2008-10#1)(2010-7#1)
trapping of##11##2##(1991-6#1)(1992-3#1)(1996-5#2)(2008-10#5)(2008-3#2)
trapping solution##2##2##(2008-10#2)
trapping with##3##2##(2008-10#2)(2008-5#1)
trapping##68##1##(1991-6#1)(1992-3#1)(1995-8#1)(1996-2#1)(1996-5#3)(1997-2#1)(2008-10#43)(2008-11#2)(2008-3#6)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-4#1)(2010-7#1)(2013-8#1)
traps were##2##2##(2008-10#1)(2010-8#1)
traps##14##1##(1993-1#1)(1995-12#1)(1997-7#1)(2008-10#8)(2010-5#1)(2010-7#1)(2010-8#1)
trastuzumab##20##1##(2008-11#1)(2008-7#1)(2012-12#4)(2012-3#6)(2013-1#8)
trastuzumab-resistant##2##1##(2012-3#2)
trastuzumab-sensitive##2##1##(2012-3#1)(2013-1#1)
trastuzumab-unresponsive##2##1##(2013-1#2)
trategies##2##1##(2008-11#2)
trauma and allows##2##3##(2008-9#1)(2012-12#1)
trauma and##11##2##(1990-9#1)(1991-2#1)(2007-11#1)(2008-12#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
trauma assessment##2##2##(2008-6#2)
trauma can##2##2##(2008-5#1)(2008-7#1)
trauma centers##2##2##(2008-11#2)
trauma exposure##2##2##(2009-4#2)
trauma following##2##2##(2012-2#1)(2013-1#1)
trauma has##2##2##(1992-2#1)(2012-2#1)
trauma in##2##2##(1994-2#1)(2013-1#1)
trauma is##6##2##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
trauma life support##3##3##(1992-5#2)(2009-3#1)
trauma or##4##2##(2008-1#1)(2008-7#1)(2009-5#1)(2011-2#1)
trauma patients##2##2##(2008-11#1)(2012-2#1)
trauma research##2##2##(2009-4#2)
trauma to the primary predecessors##2##5##(2013-1#2)
trauma to the##10##3##(1991-11#1)(1993-1#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#2)
trauma to##12##2##(1991-11#1)(1993-1#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#3)
trauma was##2##2##(2010-7#1)(2013-8#1)
trauma with##3##2##(1991-6#1)(2008-12#1)(2010-1#1)
trauma##149##1##(1990-11#1)(1990-2#2)(1990-9#3)(1991-11#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-8#1)(1993-1#1)(1994-2#2)(1996-2#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#8)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#5)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#1)(2009-6#1)(2010-1#4)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#5)(2010-9#4)(2011-2#13)(2012-12#4)(2012-2#12)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#10)
trauma-focused research with##2##3##(2009-4#2)
trauma-focused research##6##2##(2009-4#6)
trauma-focused##7##1##(2009-4#7)
trauma-related##7##1##(2009-11#1)(2009-4#4)(2012-2#2)
trauma]##4##1##(1990-2#1)(1990-9#2)(1991-6#1)
traumas##4##1##(1991-3#1)(1991-6#1)(2009-3#1)(2009-4#1)
traumatic brachial plexus##2##3##(2008-8#2)
traumatic brain injuries##2##3##(2012-2#1)(2013-1#1)
traumatic brain injury (TBI)##3##4##(2009-10#1)(2010-9#1)(2013-1#1)
traumatic brain injury##29##3##(1990-12#3)(1991-12#3)(1994-12#2)(1997-2#3)(2008-10#1)(2008-7#6)(2009-10#2)(2010-1#2)(2010-5#2)(2010-9#2)(2013-1#2)(2013-8#1)
traumatic brain##33##2##(1990-12#4)(1991-12#3)(1994-12#3)(1997-2#3)(2008-10#1)(2008-7#6)(2009-10#2)(2010-1#2)(2010-5#2)(2010-9#2)(2012-2#1)(2013-1#3)(2013-8#1)
traumatic injury##2##2##(2012-2#1)(2012-3#1)
traumatic leptomeningeal##2##2##(2013-8#2)
traumatic or##2##2##(2008-11#1)(2013-1#1)
traumatic pseudoaneurysm of the##2##4##(2008-12#2)
traumatic rupture of##2##3##(2008-11#1)(2008-12#1)
traumatic stress disorder##3##3##(1991-2#1)(2008-11#1)(2013-8#1)
traumatic stress##4##2##(1991-2#1)(2008-1#1)(2008-11#1)(2013-8#1)
traumatic##83##1##(1990-12#4)(1990-3#1)(1991-12#3)(1991-2#1)(1991-6#1)(1994-12#3)(1997-2#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#7)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-12#3)(2010-2#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-2#4)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#4)
traumatica##2##1##(1990-12#2)
traumatology##5##1##(2007-8#2)(2011-2#1)(2013-1#2)
travail##3##1##(2011-2#1)(2013-1#2)
travel and##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
travel history##2##2##(2011-2#2)
travel time##4##2##(1995-3#1)(2008-8#2)(2008-9#1)
travel times##2##2##(2008-8#2)
travel##34##1##(1990-6#1)(1991-8#1)(1995-3#1)(1997-6#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-8#5)(2008-9#2)(2009-2#1)(2010-3#1)(2010-5#4)(2010-8#1)(2011-2#3)(2013-8#6)
traveled by##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
traveled##5##1##(1993-8#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
traveler##3##1##(1996-8#1)(2010-12#2)
travelers##13##1##(1996-8#2)(2008-10#2)(2010-12#2)(2011-2#7)
traveling##4##1##(1992-12#1)(2008-3#1)(2011-2#2)
travelled to##2##2##(1997-7#1)(2007-12#1)
travelled##3##1##(1997-7#1)(2007-12#1)(2010-1#1)
traveller##4##1##(1993-8#2)(2008-10#1)(2008-11#1)
travellers to##2##2##(1997-4#1)(2008-10#1)
travellers##5##1##(1997-4#1)(2008-10#1)(2010-5#3)
travelling##6##1##(1991-12#1)(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
travels##2##1##(1995-1#1)(2010-1#1)
traversal##4##1##(2008-6#1)(2008-8#3)
traverse the##5##2##(1990-5#1)(1997-6#1)(2008-10#2)(2009-10#1)
traversing the##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
tray##4##1##(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
trays##6##1##(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
trazodone##2##1##(2008-10#2)
treadmill exercise##3##2##(2010-12#2)(2013-1#1)
treadmill running##5##2##(2008-12#3)(2013-1#2)
treadmill##17##1##(1994-8#1)(2008-10#1)(2008-12#3)(2010-12#2)(2012-2#1)(2013-1#6)(2013-8#3)
treament##2##1##(1996-9#1)(2008-5#1)
treat and##3##2##(1994-3#1)(2008-7#1)(2011-2#1)
treat both##2##2##(1997-3#1)(2011-2#1)
treat it##3##2##(1992-5#1)(1995-5#1)(2012-3#1)
treat patients with##5##3##(1995-12#1)(2007-9#1)(2008-11#1)(2009-8#1)(2013-1#1)
treat patients##8##2##(1994-1#1)(1995-12#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)
treat the##20##2##(1995-11#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
treat them##2##2##(2013-1#2)
treat these patients##2##3##(1991-11#1)(2013-8#1)
treat these##5##2##(1991-11#1)(2008-10#1)(2010-3#1)(2010-6#1)(2013-8#1)
treat this##5##2##(1995-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
treat two##2##2##(1995-6#1)(2010-6#1)
treat##143##1##(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#8)(2008-9#3)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#4)
treatable##9##1##(1996-11#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-3#1)
treated HCC##4##2##(2008-10#4)
treated KU812 cells##5##3##(2008-11#5)
treated according to##2##3##(1993-11#1)(2008-9#1)
treated and control##4##3##(1995-8#1)(2008-10#1)(2008-9#1)(2011-10#1)
treated and untreated##4##3##(1990-2#1)(1995-6#1)(2008-10#2)
treated and##18##2##(1990-2#1)(1991-11#1)(1995-6#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#1)(2011-10#1)(2011-2#1)(2013-8#1)
treated animals##6##2##(1993-12#1)(1996-12#1)(2006-6#1)(2008-8#1)(2011-2#2)
treated as a##4##3##(2008-3#1)(2008-9#2)(2013-1#1)
treated as##14##2##(1990-9#2)(1991-6#1)(2006-6#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#2)(2011-1#1)(2013-1#1)
treated at our institution##2##4##(2011-2#1)(2013-1#1)
treated at our##5##3##(1990-6#1)(1990-9#1)(2011-2#2)(2013-1#1)
treated at the##6##3##(1990-6#1)(1991-6#1)(1993-6#1)(2008-10#1)(2011-2#1)(2012-12#1)
treated at##14##2##(1990-6#2)(1990-9#1)(1991-6#1)(1993-6#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
treated between##2##2##(2012-3#1)(2013-1#1)
treated by Molndal technique##2##4##(2011-2#2)
treated by a##5##3##(1990-12#1)(1996-11#1)(1997-3#1)(2008-10#2)
treated by both##2##3##(2008-10#1)(2008-9#1)
treated by either##2##3##(1994-12#1)(2008-9#1)
treated by endoscopic##2##3##(1997-8#1)(2008-12#1)
treated by external##2##3##(1990-6#1)(1993-11#1)
treated by open##2##3##(1997-8#1)(2009-4#1)
treated by percutaneous##2##3##(1991-8#1)(1993-8#1)
treated by radical exeresis##2##4##(1994-6#2)
treated by radiosurgery##3##3##(2008-7#2)(2011-2#1)
treated by radiotherapy##2##3##(1990-12#1)(1991-8#1)
treated by surgery##2##3##(1992-5#1)(2008-7#1)
treated by the##5##3##(1995-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
treated by##104##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-8#4)(1992-3#1)(1992-5#2)(1992-9#3)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-6#2)(1995-11#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#4)(2008-3#1)(2008-7#14)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-2#7)(2012-3#4)(2013-1#2)(2013-8#1)
treated cells##6##2##(1991-5#3)(1994-6#1)(2008-11#2)
treated chronically with##2##3##(1990-5#1)(1997-2#1)
treated conservatively and##2##3##(2013-1#2)
treated conservatively##10##2##(1997-8#1)(2008-12#1)(2008-7#3)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#2)
treated daily with##2##3##(2008-10#1)(2010-6#1)
treated during##5##2##(1991-9#1)(1992-9#1)(2008-7#1)(2012-3#2)
treated early##2##2##(2010-8#1)(2012-3#1)
treated first##2##2##(1996-5#1)(2008-10#1)
treated for bronchial asthma##2##4##(2010-2#2)
treated for hypertension##2##3##(1994-6#1)(2008-10#1)
treated for##35##2##(1990-2#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1996-3#2)(1997-5#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-2#2)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
treated from##2##2##(2008-5#1)(2008-9#1)
treated group##2##2##(1990-11#1)(2008-9#1)
treated groups##5##2##(1994-8#2)(2008-12#1)(2009-7#1)(2012-2#1)
treated hypertensives##3##2##(2008-10#3)
treated in a single##2##4##(1997-5#1)(2010-10#1)
treated in a##3##3##(1997-5#1)(2010-10#1)(2011-2#1)
treated in our department##2##4##(1993-6#1)(2013-1#1)
treated in our##4##3##(1991-2#1)(1993-6#1)(2011-2#1)(2013-1#1)
treated in the first##2##4##(1993-3#1)(2008-7#1)
treated in the##8##3##(1993-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
treated in##32##2##(1991-2#1)(1991-3#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-11#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-10#1)(2011-2#4)(2012-3#1)(2013-1#3)
treated it##2##2##(2009-1#1)(2012-2#1)
treated leaf##2##2##(2008-10#2)
treated male rats##2##3##(2008-11#2)
treated mice were##2##3##(2008-9#1)(2012-2#1)
treated mice##6##2##(1995-12#1)(2008-9#3)(2011-2#1)(2012-2#1)
treated multiple##2##2##(1996-8#1)(2011-2#1)
treated of##2##2##(2008-9#1)(2013-1#1)
treated on##2##2##(1995-2#1)(2008-10#1)
treated or not treated with##2##5##(2008-10#1)(2011-2#1)
treated or not##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
treated or##4##2##(1990-8#1)(2008-10#2)(2011-2#1)
treated orally with##2##3##(1993-12#1)(1996-6#1)
treated patients and##2##3##(2012-3#1)(2013-8#1)
treated patients with##4##3##(1994-12#1)(2008-7#1)(2010-10#1)(2011-2#1)
treated patients##18##2##(1991-2#1)(1991-6#1)(1992-2#1)(1994-12#1)(1994-2#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-7#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
treated plants##8##2##(2008-10#5)(2008-11#2)(2008-12#1)
treated rats##7##2##(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-2#1)
treated simultaneously##3##2##(2008-10#2)(2008-7#1)
treated successfully by##2##3##(1990-9#1)(2011-2#1)
treated successfully with##5##3##(1995-2#1)(2009-11#1)(2009-4#1)(2010-5#1)(2013-1#1)
treated successfully##11##2##(1990-9#1)(1995-2#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
treated surgically at##2##3##(2009-1#1)(2010-1#1)
treated surgically by##2##3##(2008-8#1)(2013-1#1)
treated surgically##16##2##(1990-12#2)(1997-2#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-1#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#3)
treated two##2##2##(1994-1#1)(2010-12#1)
treated up to##2##3##(1993-8#1)(1996-6#1)
treated using this##2##3##(1990-3#1)(2008-8#1)
treated using##12##2##(1990-3#1)(1991-2#1)(1991-3#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#3)(2013-1#1)
treated waste water##2##3##(2008-10#2)
treated wastewater##3##2##(2008-10#3)
treated with 0##4##3##(2008-10#3)(2011-2#1)
treated with 1##4##3##(1993-8#1)(1996-12#1)(2008-10#1)(2012-12#1)
treated with 10##2##3##(2008-10#1)(2008-7#1)
treated with 300##2##3##(1990-2#1)(2011-1#1)
treated with 4##3##3##(2008-10#2)(2013-1#1)
treated with Ad-HGF##3##3##(2008-9#3)
treated with BNR##2##3##(2008-10#2)
treated with GM1##2##3##(1993-3#1)(2008-10#1)
treated with H2O2##2##3##(1995-8#2)
treated with Lyprinol(R)##2##3##(2008-10#2)
treated with MH##2##3##(2008-9#2)
treated with Microsphaeropsis sp##3##4##(2008-10#3)
treated with a new##2##4##(1992-3#1)(1993-2#1)
treated with a variety of##2##5##(1991-3#1)(2008-7#1)
treated with a##23##3##(1991-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-2#1)(1995-11#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#4)
treated with an##6##3##(1990-8#1)(2008-10#2)(2008-7#1)(2010-10#1)(2013-1#1)
treated with androgen##2##3##(2012-3#1)(2013-8#1)
treated with band ligation and sclerotherapy##2##6##(2013-1#2)
treated with band ligation##3##4##(2013-1#3)
treated with both##4##3##(2008-10#2)(2008-11#2)
treated with cyclophosphamide##4##3##(1991-8#1)(1997-8#1)(2008-1#1)(2008-10#1)
treated with different##4##3##(2008-5#1)(2013-1#3)
treated with drugs##3##3##(1993-2#1)(1994-6#1)(2008-10#1)
treated with either##4##3##(1994-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
treated with ethanol extract##2##4##(2008-10#1)(2012-2#1)
treated with ethanol##4##3##(1996-2#1)(2008-10#2)(2012-2#1)
treated with fungicides##3##3##(2008-10#3)
treated with high doses of##2##5##(1994-3#1)(2012-2#1)
treated with high##5##3##(1990-6#1)(1994-3#1)(1994-6#1)(2012-2#1)(2013-1#1)
treated with home mechanical ventilation##2##5##(1995-2#2)
treated with inhaled##4##3##(2007-11#3)(2010-2#1)
treated with intravenous##4##3##(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
treated with low##2##3##(1997-8#1)(2008-7#1)
treated with no##2##3##(1997-3#1)(1997-6#1)
treated with one of##2##4##(2008-10#1)(2012-2#1)
treated with oral##4##3##(1990-11#1)(1990-3#1)(1991-4#1)(1996-6#1)
treated with potassium##3##3##(1996-5#1)(1996-6#1)(2008-10#1)
treated with potent topical##2##4##(2012-3#2)
treated with radical##2##3##(2011-2#2)
treated with radiotherapy and##2##4##(2008-11#1)(2008-7#1)
treated with radiotherapy##3##3##(2008-11#2)(2008-7#1)
treated with recombinant##3##3##(1991-8#1)(2011-2#1)(2012-2#1)
treated with resveratrol##2##3##(2008-10#1)(2012-4#1)
treated with sclerotherapy and##2##4##(2013-1#2)
treated with sodium##2##3##(1991-11#1)(2008-10#1)
treated with surgery alone##3##4##(1995-5#1)(2012-3#2)
treated with surgery and##2##4##(2011-2#1)(2012-3#1)
treated with surgery##7##3##(1995-5#1)(2008-7#1)(2011-2#1)(2012-3#3)(2013-8#1)
treated with surgical##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
treated with systemic antibiotics alone##2##5##(1994-12#1)(2013-8#1)
treated with systemic##4##3##(1994-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
treated with the combination of##2##5##(1997-7#1)(2008-10#1)
treated with the##19##3##(1991-5#1)(1997-3#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-3#1)
treated with these agents##2##4##(2008-10#1)(2008-11#1)
treated with these drugs##2##4##(1994-5#1)(2008-11#1)
treated with these##5##3##(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#2)
treated with this##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
treated with two##3##3##(1997-7#2)(2012-12#1)
treated with varying##2##3##(1994-11#1)(2008-11#1)
treated with##500##2##(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#3)(1991-9#3)(1992-12#4)(1992-3#2)(1992-5#2)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#6)(1993-3#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#2)(1995-11#5)(1995-12#2)(1995-2#4)(1995-5#1)(1995-8#9)(1996-1#4)(1996-11#5)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#3)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#5)(1997-4#5)(1997-6#1)(1997-7#3)(1997-8#7)(2007-11#5)(2007-8#2)(2008-1#4)(2008-10#99)(2008-11#31)(2008-12#6)(2008-3#1)(2008-5#14)(2008-6#4)(2008-7#27)(2008-8#14)(2008-9#15)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#29)(2012-12#6)(2012-2#5)(2012-3#9)(2012-4#2)(2013-1#37)(2013-7#1)(2013-8#9)
treated##1047##1##(1990-11#5)(1990-12#9)(1990-2#5)(1990-3#4)(1990-5#3)(1990-6#5)(1990-8#3)(1990-9#12)(1991-1#1)(1991-11#6)(1991-12#2)(1991-2#11)(1991-3#10)(1991-4#1)(1991-5#4)(1991-6#9)(1991-8#11)(1991-9#6)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-5#5)(1992-6#1)(1992-9#6)(1993-1#3)(1993-11#3)(1993-12#5)(1993-2#8)(1993-3#4)(1993-6#4)(1993-8#4)(1994-1#2)(1994-11#1)(1994-12#11)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#7)(1994-8#4)(1994-9#1)(1995-11#8)(1995-12#3)(1995-2#7)(1995-5#1)(1995-6#1)(1995-8#10)(1995-9#1)(1996-1#4)(1996-11#11)(1996-12#6)(1996-2#2)(1996-3#7)(1996-5#4)(1996-6#9)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#8)(1997-4#10)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#14)(2006-6#2)(2007-11#6)(2007-8#4)(2008-1#7)(2008-10#199)(2008-11#57)(2008-12#22)(2008-3#5)(2008-4#2)(2008-5#20)(2008-6#7)(2008-7#68)(2008-8#24)(2008-9#34)(2009-1#3)(2009-10#1)(2009-11#3)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#3)(2010-1#4)(2010-10#6)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#3)(2010-5#3)(2010-6#8)(2010-7#2)(2010-8#2)(2011-1#6)(2011-10#1)(2011-2#73)(2011-3#1)(2012-12#9)(2012-2#11)(2012-3#25)(2012-4#2)(2013-1#63)(2013-7#1)(2013-8#15)
treated-Pennisetum##3##1##(2008-10#3)
treatedwith##2##1##(2008-11#2)
treating HIV##2##2##(1995-6#1)(2008-6#1)
treating a variety of##2##4##(2011-2#1)(2013-1#1)
treating a##5##2##(1995-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
treating acute##2##2##(2012-12#1)(2013-1#1)
treating chronic##3##2##(1995-2#1)(2009-10#1)(2009-8#1)
treating concomitant##2##2##(2012-12#2)
treating hypertension##2##2##(1994-12#1)(2008-11#1)
treating patients with##4##3##(1991-8#1)(2009-8#1)(2010-12#2)
treating patients##8##2##(1991-8#1)(2008-10#1)(2008-8#2)(2009-8#1)(2010-12#2)(2012-3#1)
treating prostate##2##2##(2008-10#1)(2008-7#1)
treating the symptoms##2##3##(2008-7#1)(2011-2#1)
treating the##9##2##(1992-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
treating these##3##2##(1991-9#1)(2008-10#1)(2013-1#1)
treating this##2##2##(2008-7#1)(2011-2#1)
treating women##2##2##(2008-6#1)(2011-2#1)
treating##134##1##(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-10#14)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#1)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-6#1)(2011-2#14)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#2)
treatment (0##2##2##(2011-2#1)(2012-12#1)
treatment (10##2##2##(1996-2#1)(2012-3#1)
treatment (50##2##2##(1994-2#1)(1994-8#1)
treatment (P = 0##3##4##(2012-3#1)(2013-1#2)
treatment (P##4##2##(2011-3#1)(2012-3#1)(2013-1#2)
treatment A##2##2##(1996-6#1)(2011-2#1)
treatment adherence##8##2##(2008-11#1)(2008-7#1)(2010-11#5)(2011-2#1)
treatment after##6##2##(2007-8#1)(2008-12#1)(2009-1#1)(2009-11#1)(2009-9#1)(2010-12#1)
treatment against##2##2##(1991-2#1)(2010-4#1)
treatment aimed at##3##3##(2009-12#1)(2010-1#1)(2010-9#1)
treatment algorithm##2##2##(2008-8#1)(2013-8#1)
treatment alone##11##2##(1992-6#1)(1993-12#1)(1996-12#1)(2008-10#3)(2008-11#2)(2009-7#1)(2009-8#1)(2011-2#1)
treatment also##7##2##(1993-9#1)(1997-5#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)
treatment and 1##2##3##(2008-10#1)(2011-2#1)
treatment and 2##2##3##(1991-6#1)(2013-1#1)
treatment and at##2##3##(1991-3#1)(2009-9#1)
treatment and control##2##3##(2008-9#1)(2012-3#1)
treatment and following##2##3##(1996-9#1)(2011-2#1)
treatment and in##2##3##(2008-10#1)(2009-8#1)
treatment and intervention##2##3##(2012-2#2)
treatment and its##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
treatment and outcome of##2##4##(2008-7#1)(2013-7#1)
treatment and outcome##4##3##(1993-3#1)(2008-7#2)(2013-7#1)
treatment and outcomes##2##3##(2008-11#1)(2011-1#1)
treatment and pharmacotherapy##2##3##(1991-2#1)(2013-1#1)
treatment and prevention of##6##4##(1993-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)
treatment and prevention##9##3##(1993-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-2#1)
treatment and prognosis of##2##4##(2010-8#1)(2011-2#1)
treatment and prognosis##8##3##(1991-8#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#3)
treatment and prophylaxis##3##3##(1994-6#1)(2010-6#2)
treatment and research##3##3##(2008-6#1)(2010-11#1)(2012-3#1)
treatment and supportive##2##3##(2008-7#1)(2012-3#1)
treatment and the results##2##4##(2008-10#1)(2011-2#1)
treatment and the##12##3##(1991-2#1)(1991-6#1)(1996-12#1)(1997-3#1)(2008-10#3)(2011-2#2)(2012-12#1)(2013-1#2)
treatment and was##2##3##(2008-10#2)
treatment and were##3##3##(2008-10#2)(2008-5#1)
treatment and##164##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1996-11#3)(1996-12#3)(1996-9#1)(1997-3#2)(1997-4#1)(2008-10#31)(2008-11#6)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#4)(2009-12#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-5#4)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#4)
treatment appeared to be##2##4##(1990-2#1)(2008-10#1)
treatment approach is##2##3##(2012-12#1)(2013-8#1)
treatment approach that##2##3##(2008-12#1)(2013-8#1)
treatment approach to##2##3##(2008-7#1)(2013-8#1)
treatment approach##13##2##(1992-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-1#2)(2012-12#1)(2012-3#2)(2013-8#3)
treatment approaches##6##2##(1997-1#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-3#1)
treatment are described##3##3##(1993-6#1)(1996-8#1)(2013-1#1)
treatment are##27##2##(1990-12#1)(1990-9#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#1)
treatment as an##2##3##(1997-8#1)(2012-2#1)
treatment as recommended by the##2##5##(1990-6#1)(2011-2#1)
treatment as well as##4##4##(2008-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
treatment as##16##2##(1990-6#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#1)(1997-8#1)(2008-11#1)(2008-9#2)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
treatment at a##2##3##(1995-12#1)(2009-9#1)
treatment at the##5##3##(1990-8#1)(2007-9#1)(2008-10#1)(2010-4#1)(2012-2#1)
treatment at##23##2##(1990-8#1)(1991-12#2)(1994-2#1)(1995-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
treatment based on##3##3##(1995-2#1)(1997-3#1)(2008-10#1)
treatment be##2##2##(1990-11#1)(1991-2#1)
treatment benefit##2##2##(2010-12#2)
treatment but##4##2##(2008-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
treatment by electrical stimulation of the auditory cortex##2##8##(2010-7#2)
treatment by##23##2##(1990-5#1)(1991-2#1)(1992-3#1)(1993-3#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-7#3)(2013-1#1)
treatment can be##6##3##(1993-6#1)(1996-11#1)(1997-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
treatment can##15##2##(1990-6#1)(1993-6#1)(1996-11#2)(1997-3#1)(2008-11#1)(2008-5#2)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#2)
treatment cannot be##2##3##(1991-11#1)(2012-3#1)
treatment cannot##4##2##(1991-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
treatment capacity##2##2##(1991-11#2)
treatment caused##3##2##(1996-12#1)(2008-10#1)(2008-12#1)
treatment center##3##2##(1991-8#1)(2007-9#1)(2008-8#1)
treatment centers##2##2##(2010-11#1)(2013-8#1)
treatment centres##2##2##(1996-11#1)(2008-11#1)
treatment challenges##2##2##(2008-5#1)(2013-1#1)
treatment combined with##2##3##(1991-2#1)(1996-2#1)
treatment compared to##2##3##(2012-2#1)(2012-6#1)
treatment compared##3##2##(1997-5#1)(2012-2#1)(2012-6#1)
treatment completion##2##2##(2008-10#1)(2008-6#1)
treatment compliance##2##2##(1997-4#1)(2012-3#1)
treatment condition##2##2##(2011-1#2)
treatment consisted of##3##3##(1990-3#1)(1991-6#1)(1997-5#1)
treatment consists of##3##3##(1991-6#1)(2008-7#1)(2012-12#1)
treatment cost##2##2##(2008-1#1)(2012-12#1)
treatment costs##2##2##(2008-10#1)(2009-12#1)
treatment could##2##2##(1993-12#1)(2008-10#1)
treatment course##3##2##(2008-10#2)(2011-2#1)
treatment decision##2##2##(1994-1#1)(2010-8#1)
treatment decision-making##2##2##(2008-9#1)(2011-2#1)
treatment decisions##6##2##(2008-10#1)(2008-4#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
treatment decreased##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
treatment delay##3##2##(2010-11#3)
treatment delivery##4##2##(1995-2#1)(2009-11#1)(2013-1#2)
treatment depends on##4##3##(1993-6#1)(2008-12#1)(2010-12#1)(2011-2#1)
treatment did not affect##2##4##(1996-3#1)(2008-10#1)
treatment did not##5##3##(1994-2#1)(1996-3#1)(2008-10#3)
treatment differences##2##2##(1995-12#1)(2008-10#1)
treatment discontinuation##2##2##(2008-11#2)
treatment does not##2##3##(1994-2#1)(1997-1#1)
treatment due to##2##3##(2009-8#1)(2013-1#1)
treatment duration##8##2##(1996-11#2)(2008-8#1)(2009-8#1)(2011-2#4)
treatment duration&quot##2##2##(2009-9#2)
treatment during pregnancy##2##3##(1995-12#2)
treatment during the##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
treatment during##8##2##(1995-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-11#1)(2012-3#1)
treatment early##2##2##(2011-2#1)(2013-8#1)
treatment effect##6##2##(1996-3#2)(1996-6#2)(2012-2#1)(2013-1#1)
treatment effectiveness##5##2##(1991-1#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-4#1)
treatment effects in##3##3##(1992-9#1)(2008-11#1)(2009-8#1)
treatment effects of##2##3##(2008-10#1)(2011-2#1)
treatment effects##16##2##(1992-9#1)(1996-6#1)(2008-10#1)(2008-11#3)(2009-8#3)(2009-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-6#1)
treatment efficacy##7##2##(1992-9#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)
treatment even##3##2##(1996-9#1)(2008-7#1)(2012-3#1)
treatment exerted##2##2##(1995-12#1)(2008-7#1)
treatment facilities##6##2##(1995-6#1)(1996-11#1)(1997-8#1)(2008-10#2)(2013-1#1)
treatment facility##2##2##(2008-6#1)(2009-5#1)
treatment failure##8##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-5#1)(2013-8#2)
treatment failures##4##2##(1996-11#3)(2010-12#1)
treatment followed by##2##3##(2008-11#2)
treatment followed##3##2##(2008-11#2)(2013-8#1)
treatment following##3##2##(1994-8#1)(2008-1#1)(2011-3#1)
treatment for AVMs##2##3##(1997-3#1)(1997-6#1)
treatment for PDA##3##3##(2012-2#3)
treatment for a##2##3##(2011-2#1)(2012-3#1)
treatment for alcohol##2##3##(1990-2#1)(1993-3#1)
treatment for allergic rhinitis##2##4##(2008-5#1)(2013-1#1)
treatment for breast cancer##3##4##(1990-12#1)(1992-7#1)(2010-7#1)
treatment for breast##4##3##(1990-11#1)(1990-12#1)(1992-7#1)(2010-7#1)
treatment for cerebral##2##3##(1993-1#1)(1996-3#1)
treatment for children##2##3##(2013-1#1)(2013-8#1)
treatment for chronic##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
treatment for depression##3##3##(1991-10#1)(2013-8#2)
treatment for diabetes##2##3##(2008-5#1)(2010-11#1)
treatment for each##2##3##(2012-3#1)(2013-1#1)
treatment for patients with##5##4##(2008-11#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#1)
treatment for patients##6##3##(2008-11#1)(2008-12#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#1)
treatment for the##10##3##(1990-12#1)(1994-9#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-3#1)
treatment for this##5##3##(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
treatment for unruptured AVMs in##2##5##(2008-7#2)
treatment for##154##2##(1990-11#2)(1990-12#3)(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1996-11#1)(1996-3#2)(1997-3#2)(1997-6#1)(1997-8#2)(2007-11#1)(2007-8#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#4)(2010-3#2)(2010-7#3)(2011-2#12)(2011-3#2)(2011-7#1)(2012-2#8)(2012-3#9)(2013-1#17)(2013-8#9)
treatment from the##2##3##(1997-8#1)(2013-8#1)
treatment from##4##2##(1997-8#1)(2008-10#1)(2008-12#1)(2013-8#1)
treatment goal##2##2##(2011-7#1)(2013-1#1)
treatment goals##2##2##(2008-6#1)(2013-1#1)
treatment group receiving##3##3##(1991-1#2)(1991-2#1)
treatment group##28##2##(1990-2#1)(1991-1#2)(1991-2#2)(1992-3#1)(1992-6#1)(1993-12#1)(1994-5#2)(1994-9#2)(1996-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#5)
treatment groups in##2##3##(2008-4#1)(2012-2#1)
treatment groups were##2##3##(1991-1#1)(2012-3#1)
treatment groups##26##2##(1991-1#1)(1991-2#1)(1993-1#1)(1994-12#3)(1994-5#1)(1994-9#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
treatment guidelines##5##2##(1990-9#1)(1997-2#1)(2008-10#1)(2011-10#1)(2011-2#1)
treatment had##7##2##(1997-4#2)(1997-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
treatment has been##3##3##(2008-7#1)(2010-11#1)(2011-3#1)
treatment has##13##2##(1993-1#1)(1993-11#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-4#2)(2008-7#2)(2009-12#1)(2010-11#1)(2011-3#1)
treatment have##4##2##(1991-8#1)(2008-12#1)(2008-7#1)(2012-2#1)
treatment improved##2##2##(2011-2#1)(2013-1#1)
treatment in a##5##3##(1996-3#1)(2009-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
treatment in adults with##2##4##(2008-12#1)(2012-3#1)
treatment in adults##3##3##(1996-11#1)(2008-12#1)(2012-3#1)
treatment in all##2##3##(1991-10#1)(2011-2#1)
treatment in order to##2##4##(1993-11#1)(2008-12#1)
treatment in patients with##9##4##(1990-3#1)(1993-11#2)(1993-6#1)(1994-12#2)(2008-10#1)(2008-7#1)(2009-7#1)
treatment in specialized##2##3##(1995-11#2)
treatment in the##11##3##(1990-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
treatment in this##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
treatment in##93##2##(1990-11#3)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-12#2)(1993-11#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#3)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-5#2)(2010-6#3)(2010-8#1)(2011-2#6)(2012-12#4)(2012-3#4)(2012-7#1)(2013-1#4)(2013-8#2)
treatment including##2##2##(1992-5#1)(2013-8#1)
treatment increased##2##2##(1994-2#1)(2011-2#1)
treatment indicates that##2##3##(1996-5#1)(2008-10#1)
treatment induced##3##2##(2010-6#1)(2011-10#1)(2012-3#1)
treatment induces##2##2##(2008-12#1)(2010-7#1)
treatment interval##3##2##(1991-6#1)(2008-12#2)
treatment intervention##3##2##(2010-1#1)(2012-3#2)
treatment interventions##2##2##(1996-6#1)(2008-6#1)
treatment is a##4##3##(1990-12#1)(2008-10#1)(2009-6#1)(2009-9#1)
treatment is always##2##3##(2008-7#1)(2011-2#1)
treatment is associated with##3##4##(2008-6#1)(2008-7#1)(2010-6#1)
treatment is discussed##2##3##(1992-2#1)(2013-8#1)
treatment is indicated##4##3##(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
treatment is necessary##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
treatment is not##2##3##(1991-2#1)(2008-11#1)
treatment is similar to that##2##5##(2008-10#1)(2013-1#1)
treatment is technically##2##3##(1997-5#1)(2013-1#1)
treatment is the##4##3##(1997-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
treatment is to##2##3##(1993-3#1)(2008-7#1)
treatment is##91##2##(1990-12#4)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-6#1)(1995-2#1)(1995-5#1)(1995-9#2)(1996-11#2)(1996-3#1)(1997-2#3)(1997-5#2)(2007-11#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#10)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#9)(2013-8#1)
treatment lead##2##2##(2008-5#1)(2012-3#1)
treatment leads to##3##3##(2008-10#2)(2013-1#1)
treatment led to##2##3##(2008-10#1)(2013-7#1)
treatment may be##3##3##(1990-6#1)(1993-6#1)(2008-10#1)
treatment may##14##2##(1990-6#1)(1991-12#1)(1993-6#1)(1997-8#1)(2008-10#2)(2008-6#1)(2009-6#1)(2010-10#1)(2012-3#4)(2013-1#1)
treatment method##7##2##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)
treatment methods##4##2##(1992-9#1)(2007-8#1)(2012-2#1)(2012-3#1)
treatment modalities and##3##3##(1995-5#1)(2008-10#1)(2011-2#1)
treatment modalities have been##2##4##(1995-1#1)(1997-8#1)
treatment modalities have##3##3##(1995-1#1)(1997-8#1)(2008-9#1)
treatment modalities of##3##3##(1993-8#1)(1994-2#1)(2010-8#1)
treatment modalities##26##2##(1991-9#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#4)(2013-1#2)
treatment modality for##4##3##(1990-11#1)(1997-1#1)(2011-2#1)(2013-1#1)
treatment modality##9##2##(1990-11#1)(1991-9#1)(1997-1#1)(2008-12#1)(2008-7#2)(2011-2#2)(2013-1#1)
treatment models##2##2##(2008-10#1)(2008-6#1)
treatment most##2##2##(1996-11#1)(2008-5#1)
treatment must be##4##3##(1991-11#1)(1991-2#1)(2010-12#1)(2012-3#1)
treatment must##5##2##(1991-11#1)(1991-2#1)(1994-5#1)(2010-12#1)(2012-3#1)
treatment need##3##2##(2008-1#1)(2008-5#1)(2013-8#1)
treatment needs to be##2##4##(1995-2#1)(2008-7#1)
treatment needs##4##2##(1995-2#1)(2008-1#1)(2008-7#1)(2012-3#1)
treatment of Alzheimer's disease##2##4##(2008-11#1)(2008-5#1)
treatment of Alzheimer's##3##3##(1991-8#1)(2008-11#1)(2008-5#1)
treatment of BII phobia##2##4##(2012-2#2)
treatment of DME##2##3##(2011-7#2)
treatment of GHF##2##3##(2011-2#2)
treatment of HCV##2##3##(2008-10#2)
treatment of HIV##2##3##(1995-12#1)(1995-6#1)
treatment of PC12 cells with##2##5##(2008-11#2)
treatment of Parkinson's disease##4##4##(1992-3#1)(2008-10#2)(2008-7#1)
treatment of a congenital splenic cyst with##2##7##(1997-8#2)
treatment of a variety of##2##5##(2008-11#1)(2013-8#1)
treatment of a wide##2##4##(2010-12#1)(2011-2#1)
treatment of a##23##3##(1991-1#1)(1991-2#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1996-6#1)(1997-8#3)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#3)(2013-1#2)(2013-8#1)
treatment of acute##12##3##(1990-5#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-3#1)(2007-8#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
treatment of adults with##2##4##(1997-8#1)(2008-11#1)
treatment of adults##3##3##(1996-11#1)(1997-8#1)(2008-11#1)
treatment of advanced##5##3##(1990-12#3)(1994-12#1)(2007-11#1)
treatment of airway##2##3##(1995-12#1)(2009-1#1)
treatment of alcoholic chronic pancreatitis##3##5##(2009-7#3)
treatment of alcoholic##4##3##(1995-11#1)(2009-7#3)
treatment of allergic##2##3##(2011-2#1)(2013-1#1)
treatment of an##5##3##(1997-5#1)(2008-10#1)(2010-11#1)(2011-3#1)(2012-3#1)
treatment of aorta##2##3##(2008-10#1)(2013-8#1)
treatment of arterial hypertension]##2##4##(1993-11#1)(1993-2#1)
treatment of arteriovenous##2##3##(1996-9#1)(2008-7#1)
treatment of arthritis##2##3##(1991-8#1)(2008-5#1)
treatment of asthma##5##3##(1992-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)
treatment of atrial fibrillation##2##4##(2008-7#1)(2012-3#1)
treatment of autoimmune##2##3##(2012-2#1)(2012-3#1)
treatment of axillary##2##3##(1991-8#1)(2008-5#1)
treatment of bacterial meningitis##2##4##(2008-11#1)(2010-12#1)
treatment of bacterial##4##3##(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
treatment of benign##3##3##(1990-5#1)(2008-5#1)(2011-2#1)
treatment of breast cancer in##2##5##(1993-1#1)(2010-8#1)
treatment of breast cancer##8##4##(1990-11#2)(1993-1#1)(1993-11#3)(1996-11#1)(2010-8#1)
treatment of breast##11##3##(1990-11#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-6#1)(1996-11#1)(1997-7#1)(2010-8#1)
treatment of cancer during pregnancy##2##5##(2013-1#2)
treatment of cancer##16##3##(1990-3#1)(1990-9#1)(1992-3#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-7#1)(2009-11#1)(2009-12#1)(2010-7#1)(2013-1#2)
treatment of carcinoma##2##3##(1991-3#1)(1991-9#1)
treatment of cat-scratch disease with ciprofloxacin##2##6##(1991-4#2)
treatment of cells with##5##4##(1995-6#1)(2008-11#3)(2008-8#1)
treatment of cells##6##3##(1995-6#2)(2008-11#3)(2008-8#1)
treatment of cervical intraepithelial neoplasia##4##5##(1991-2#2)(1994-12#1)(2012-3#1)
treatment of cervical##7##3##(1991-1#1)(1991-2#2)(1992-2#1)(1994-12#1)(1996-3#1)(2012-3#1)
treatment of children and adolescents##3##5##(1991-2#1)(1993-1#1)(2008-4#1)
treatment of children with##3##4##(1994-6#1)(2009-3#1)(2011-2#1)
treatment of children##6##3##(1991-2#1)(1993-1#1)(1994-6#1)(2008-4#1)(2009-3#1)(2011-2#1)
treatment of choice##20##3##(1990-9#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-6#2)(2011-2#2)(2013-1#2)
treatment of chronic hepatitis B##2##5##(2009-8#2)
treatment of chronic hepatitis##3##4##(2009-5#1)(2009-8#2)
treatment of chronic##17##3##(1991-11#1)(1993-5#1)(1995-2#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
treatment of cocaine abuse##2##4##(1991-1#2)
treatment of cocaine##3##3##(1991-1#3)
treatment of colorectal##3##3##(1994-2#1)(2012-3#2)
treatment of congenital heart defects##2##5##(1997-8#2)
treatment of congenital##3##3##(1990-9#1)(1997-8#2)
treatment of coronary##2##3##(2008-11#1)(2011-2#1)
treatment of data##2##3##(2008-10#2)
treatment of depression##6##3##(2008-4#3)(2008-6#1)(2008-8#1)(2012-2#1)
treatment of diabetic##3##3##(2007-7#1)(2008-1#1)(2013-1#1)
treatment of disease##2##3##(2008-11#1)(2011-2#1)
treatment of drug##2##3##(2009-8#1)(2012-3#1)
treatment of end-stage##2##3##(2010-6#1)(2011-2#1)
treatment of epilepsy##2##3##(2008-11#1)(2011-1#1)
treatment of essential hypertension##2##4##(1993-2#1)(2008-7#1)
treatment of essential##3##3##(1990-9#1)(1993-2#1)(2008-7#1)
treatment of gastroesophageal reflux##2##4##(1992-11#1)(1992-3#1)
treatment of head and neck##3##5##(2007-11#1)(2011-2#1)(2013-8#1)
treatment of heart failure##3##4##(2009-10#2)(2010-6#1)
treatment of hematological malignancies##2##4##(2008-10#1)(2013-1#1)
treatment of hepatic##2##3##(1991-8#1)(2013-1#1)
treatment of hepatitis C##2##4##(2008-10#1)(2009-7#1)
treatment of high##3##3##(1992-1#2)(1993-2#1)
treatment of human##4##3##(1994-5#1)(2012-2#1)(2013-1#2)
treatment of hypertension in the##3##5##(1993-3#1)(1997-5#1)(2008-7#1)
treatment of hypertension##15##3##(1990-6#1)(1991-5#1)(1993-11#1)(1993-2#2)(1993-3#2)(1994-6#1)(1995-11#1)(1997-5#1)(1997-8#1)(2008-7#2)(2008-8#1)(2009-1#1)
treatment of infected##2##3##(1990-7#1)(2011-2#1)
treatment of inflammatory diseases##3##4##(2008-10#1)(2011-1#2)
treatment of inflammatory##4##3##(2008-10#1)(2009-1#1)(2011-1#2)
treatment of intracranial aneurysms##2##4##(1997-3#1)(2008-7#1)
treatment of invasive##2##3##(2008-10#1)(2011-2#1)
treatment of kidney##2##3##(2008-12#1)(2012-12#1)
treatment of lithiasis##2##3##(1990-5#1)(1991-3#1)
treatment of lung##2##3##(2008-10#1)(2008-11#1)
treatment of malaria##5##3##(1993-8#2)(2009-6#1)(2011-2#1)(2012-12#1)
treatment of malignant##9##3##(1991-2#1)(1991-6#1)(1992-12#2)(1992-2#1)(1993-6#1)(1993-9#1)(1997-5#1)(2011-2#1)
treatment of many##5##3##(2008-8#1)(2008-9#1)(2009-8#1)(2011-3#1)(2013-1#1)
treatment of migraine##2##3##(2008-6#1)(2008-9#1)
treatment of mood disorders##3##4##(2008-7#2)(2013-8#1)
treatment of mucormycosis##3##3##(2011-2#3)
treatment of multiple##3##3##(1994-12#1)(2012-12#1)(2013-1#1)
treatment of nephrolithiasis##2##3##(2008-10#1)(2012-12#1)
treatment of nerve##2##3##(2012-2#2)
treatment of neurodegenerative##2##3##(2008-11#2)
treatment of neuropathic pain with##2##5##(1997-3#1)(2008-9#1)
treatment of neuropathic pain##6##4##(1997-3#1)(2008-9#4)(2010-7#1)
treatment of neuropathic##7##3##(1997-3#1)(2008-10#1)(2008-9#4)(2010-7#1)
treatment of non-toxic multinodular goitre##2##5##(1993-6#2)
treatment of normal##2##3##(1990-2#1)(2008-5#1)
treatment of obesity##2##3##(2008-5#1)(2012-3#1)
treatment of orofacial##2##3##(2009-10#1)(2013-1#1)
treatment of osteoporosis in##2##4##(2008-7#2)
treatment of osteoporosis##6##3##(1990-11#1)(1991-11#1)(2008-11#1)(2008-7#2)(2012-12#1)
treatment of pain##2##3##(2008-11#1)(2010-1#1)
treatment of patients with cardiovascular##2##5##(2010-4#1)(2011-2#1)
treatment of patients with##14##4##(1991-6#1)(1992-1#2)(1993-1#1)(1996-11#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)
treatment of patients##19##3##(1991-6#1)(1992-1#2)(1993-1#1)(1993-2#1)(1994-12#1)(1996-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)
treatment of pediatric##2##3##(2010-12#1)(2013-1#1)
treatment of persistent##2##3##(2008-11#1)(2011-2#1)
treatment of primary##7##3##(1992-11#1)(1997-5#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#2)
treatment of prostate cancer##5##4##(2008-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
treatment of psoriasis##4##3##(1993-11#1)(2007-11#1)(2008-6#2)
treatment of rat##2##3##(1991-5#1)(2008-8#1)
treatment of rats with##3##4##(1990-12#1)(1997-1#1)(2012-2#1)
treatment of rats##4##3##(1990-12#1)(1997-1#1)(2008-10#1)(2012-2#1)
treatment of rectal##2##3##(2009-12#2)
treatment of recurrent##2##3##(2012-3#1)(2013-1#1)
treatment of renal oncocytoma##2##4##(1992-5#2)
treatment of renal##4##3##(1992-5#2)(1994-9#1)(2008-10#1)
treatment of severe##5##3##(1990-8#1)(2008-11#1)(2008-8#1)(2013-1#2)
treatment of small##2##3##(1995-12#1)(2010-12#1)
treatment of spinal##2##3##(2008-7#2)
treatment of spontaneous##2##3##(2008-11#1)(2008-7#1)
treatment of superficial##3##3##(2008-5#2)(2012-3#1)
treatment of the cells with##2##5##(1995-12#1)(2008-11#1)
treatment of the data##3##4##(2008-10#3)
treatment of the most##2##4##(1993-2#1)(1996-2#1)
treatment of the sample##2##4##(2008-10#2)
treatment of the##63##3##(1990-11#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-3#2)(2013-1#2)
treatment of these##4##3##(1995-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
treatment of this condition##2##4##(2008-5#1)(2013-1#1)
treatment of this disease##4##4##(1993-6#1)(2009-7#1)(2011-2#1)(2011-7#1)
treatment of this rare##2##4##(2012-12#1)(2012-2#1)
treatment of this##17##3##(1991-9#1)(1992-5#1)(1993-6#1)(1995-2#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#3)
treatment of tomato plants with##2##5##(2008-10#2)
treatment of tubal##2##3##(1994-12#1)(1994-3#1)
treatment of tuberculosis##3##3##(1990-6#1)(1996-3#1)(2008-10#1)
treatment of type##3##3##(1996-11#1)(2008-9#1)(2011-3#1)
treatment of ureteral##3##3##(1991-11#1)(2009-1#1)(2013-1#1)
treatment of urinary##2##3##(1996-3#1)(2008-10#1)
treatment of various##4##3##(2008-10#2)(2013-7#1)(2013-8#1)
treatment of venous##2##3##(1990-3#1)(1990-6#1)
treatment of women##2##3##(2008-11#1)(2009-9#1)
treatment of##973##2##(1990-10#1)(1990-11#10)(1990-12#6)(1990-2#7)(1990-3#3)(1990-5#5)(1990-6#6)(1990-7#2)(1990-8#1)(1990-9#10)(1991-1#5)(1991-10#1)(1991-11#7)(1991-12#1)(1991-2#10)(1991-3#6)(1991-4#2)(1991-5#2)(1991-6#4)(1991-8#8)(1991-9#6)(1992-1#9)(1992-11#3)(1992-12#6)(1992-2#5)(1992-3#9)(1992-5#5)(1992-6#2)(1992-7#2)(1992-9#2)(1993-1#3)(1993-11#7)(1993-12#1)(1993-2#10)(1993-3#5)(1993-5#1)(1993-6#9)(1993-8#6)(1993-9#7)(1994-1#2)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#5)(1994-5#5)(1994-6#5)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#6)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#8)(1996-12#2)(1996-2#3)(1996-3#8)(1996-6#2)(1996-9#4)(1997-1#4)(1997-2#2)(1997-3#6)(1997-4#2)(1997-5#6)(1997-6#2)(1997-7#2)(1997-8#14)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#7)(2008-10#82)(2008-11#50)(2008-12#8)(2008-2#1)(2008-3#5)(2008-4#11)(2008-5#24)(2008-6#9)(2008-7#36)(2008-8#17)(2008-9#16)(2009-1#7)(2009-10#7)(2009-11#1)(2009-12#6)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#4)(2009-7#7)(2009-8#9)(2009-9#3)(2010-1#3)(2010-10#8)(2010-11#9)(2010-12#10)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#16)(2010-7#7)(2010-8#2)(2010-9#5)(2011-1#10)(2011-10#1)(2011-2#81)(2011-3#8)(2011-7#6)(2012-12#10)(2012-2#16)(2012-3#28)(2013-1#72)(2013-7#1)(2013-8#18)
treatment offers##2##2##(1992-9#1)(2008-10#1)
treatment on the##13##3##(1992-9#1)(1994-2#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#2)
treatment on##32##2##(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-3#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-8#1)(2013-1#2)(2013-8#1)
treatment only##4##2##(1995-12#1)(1996-3#1)(1997-8#1)(2010-3#1)
treatment option for##6##3##(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
treatment option##13##2##(1994-3#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
treatment options are##3##3##(2008-12#1)(2010-6#1)(2013-1#1)
treatment options for##8##3##(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#2)(2013-1#3)
treatment options in##2##3##(2008-7#1)(2012-3#1)
treatment options##34##2##(1993-1#1)(1993-8#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
treatment or##16##2##(1990-6#1)(1992-1#1)(1995-12#2)(1997-4#1)(2008-10#4)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
treatment outcome in##2##3##(2010-1#1)(2013-1#1)
treatment outcome##6##2##(1994-12#1)(2008-11#2)(2010-1#1)(2013-1#2)
treatment outcomes of##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
treatment outcomes##9##2##(1992-12#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#2)
treatment over##6##2##(1996-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2012-12#1)(2013-1#1)
treatment paradigms##3##2##(2008-11#1)(2010-12#2)
treatment period##9##2##(1990-11#1)(1992-3#1)(1994-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
treatment plan for##2##3##(2011-2#2)
treatment plan##5##2##(1993-3#1)(2010-12#1)(2011-2#2)(2013-1#1)
treatment planning for##2##3##(2009-11#2)
treatment planning is##2##3##(2009-11#1)(2009-2#1)
treatment planning of##3##3##(1994-12#1)(2009-11#1)(2009-2#1)
treatment planning##19##2##(1991-12#2)(1993-1#1)(1994-12#1)(2008-11#2)(2009-11#5)(2009-2#3)(2009-3#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
treatment plans##2##2##(1993-1#1)(2013-1#1)
treatment plant##8##2##(2008-10#5)(2008-12#3)
treatment portals##2##2##(2009-2#2)
treatment practices##2##2##(1997-3#1)(2008-6#1)
treatment preferences##4##2##(2009-11#2)(2010-4#2)
treatment prevented##3##2##(1994-11#1)(2008-10#1)(2013-1#1)
treatment prior to##2##3##(1996-12#1)(2008-10#1)
treatment procedures##5##2##(1992-1#1)(1997-8#1)(2008-10#2)(2012-2#1)
treatment process##5##2##(1992-5#1)(2007-8#1)(2008-10#2)(2009-6#1)
treatment program##12##2##(1991-2#2)(1993-1#1)(1994-6#1)(1996-11#1)(1996-3#2)(1997-2#2)(2008-11#1)(2008-12#1)(2008-6#1)
treatment programme##2##2##(1990-11#1)(1991-2#1)
treatment programs and##2##3##(2012-2#1)(2013-8#1)
treatment programs can##2##3##(2008-6#2)
treatment programs to##2##3##(1993-2#1)(2010-9#1)
treatment programs##22##2##(1993-2#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-6#8)(2010-9#1)(2012-2#5)(2013-8#2)
treatment protocol##5##2##(1992-5#1)(2008-12#1)(2008-4#1)(2012-3#1)(2013-8#1)
treatment protocols for##2##3##(2012-12#1)(2012-3#1)
treatment protocols##6##2##(1995-8#1)(1997-8#1)(2008-11#1)(2009-7#1)(2012-12#1)(2012-3#1)
treatment provided to elderly##2##4##(2012-3#2)
treatment provided##3##2##(1992-5#1)(2012-3#2)
treatment recommendations##3##2##(2008-8#1)(2009-7#1)(2011-2#1)
treatment recommended by the##2##4##(1996-11#1)(2008-12#1)
treatment recommended##3##2##(1996-11#1)(2008-10#1)(2008-12#1)
treatment reduced the##2##3##(2009-1#1)(2011-2#1)
treatment reduced##4##2##(1995-8#1)(2008-10#1)(2009-1#1)(2011-2#1)
treatment regimen for##2##3##(1997-1#1)(2010-12#1)
treatment regimen##10##2##(1991-2#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-8#1)
treatment regimens##7##2##(1991-2#1)(2008-10#1)(2008-5#1)(2010-6#2)(2012-3#1)(2013-1#1)
treatment remains##3##2##(2008-7#2)(2012-3#1)
treatment requires##2##2##(1997-4#1)(2013-1#1)
treatment response and##3##3##(1997-8#1)(2009-11#2)
treatment response##14##2##(1991-8#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-11#2)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#1)
treatment resulted in a##2##4##(2008-10#1)(2013-8#1)
treatment resulted in##6##3##(1993-9#1)(1996-2#1)(2008-10#1)(2008-7#1)(2013-8#2)
treatment results in##3##3##(1996-11#1)(1996-12#1)(2009-8#1)
treatment results of##3##3##(1996-9#1)(2008-7#1)(2013-1#1)
treatment results##8##2##(1996-11#1)(1996-12#1)(1996-9#1)(2008-7#2)(2009-8#1)(2011-3#1)(2013-1#1)
treatment retention##3##2##(2008-6#1)(2013-8#2)
treatment satisfaction##3##2##(1993-2#1)(1995-2#1)(2009-12#1)
treatment schedule##3##2##(1991-8#2)(1993-11#1)
treatment selection##5##2##(2009-9#1)(2012-2#4)
treatment sequence##2##2##(1995-10#1)(2008-6#1)
treatment services##4##2##(1991-1#1)(2008-11#1)(2008-6#2)
treatment session##2##2##(2008-12#1)(2010-8#1)
treatment sessions##2##2##(1996-11#1)(2013-1#1)
treatment should be continued for##2##5##(1990-9#1)(1992-11#1)
treatment should be##9##3##(1990-9#1)(1991-9#1)(1992-11#1)(2008-10#3)(2008-7#1)(2012-12#1)(2013-1#1)
treatment should##11##2##(1990-11#1)(1990-9#1)(1991-9#1)(1992-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
treatment showed significant##2##3##(1991-5#1)(2012-2#1)
treatment showed that##2##3##(1991-12#1)(2010-8#1)
treatment showed##6##2##(1991-12#1)(1991-5#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
treatment significantly##9##2##(1996-12#1)(2008-10#3)(2010-1#1)(2011-10#1)(2011-2#1)(2013-1#2)
treatment so##2##2##(1992-11#1)(2008-1#1)
treatment started##2##2##(2008-10#2)
treatment status##2##2##(2008-11#2)
treatment strategies and##2##3##(2008-11#1)(2010-11#1)
treatment strategies for##4##3##(1994-5#1)(2010-11#1)(2012-3#2)
treatment strategies that##3##3##(2008-9#1)(2012-3#1)(2013-8#1)
treatment strategies##22##2##(1994-1#1)(1994-5#1)(1996-11#1)(1996-6#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#2)(2010-11#3)(2010-12#1)(2012-3#4)(2013-8#4)
treatment strategy for##2##3##(1996-3#1)(2012-12#1)
treatment strategy##11##2##(1996-3#1)(1997-8#1)(2008-7#1)(2009-6#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
treatment studies##3##2##(2008-5#2)(2008-9#1)
treatment study##3##2##(2010-1#1)(2012-3#2)
treatment success##2##2##(2008-7#1)(2013-8#1)
treatment suggests##2##2##(2008-10#2)
treatment targets##2##2##(2010-1#1)(2012-2#1)
treatment team##2##2##(1992-3#1)(2008-11#1)
treatment teens##2##2##(2013-1#2)
treatment than##4##2##(1990-9#1)(1993-8#1)(2008-4#1)(2013-1#1)
treatment that is##2##3##(1996-2#1)(2008-7#1)
treatment that was##2##3##(2008-10#1)(2013-1#1)
treatment that##9##2##(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
treatment the##7##2##(1990-2#1)(1990-9#1)(1994-3#2)(1996-3#1)(2008-5#2)
treatment through##3##2##(1991-6#1)(1996-3#1)(2013-1#1)
treatment time##2##2##(2008-10#1)(2008-9#1)
treatment to patients##2##3##(1994-2#1)(1995-12#1)
treatment to##18##2##(1992-12#1)(1992-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#2)(2012-2#1)(2012-3#2)(2013-8#1)
treatment tools##3##2##(2008-6#2)(2010-5#1)
treatment trial##3##2##(1996-11#1)(2011-10#1)(2013-1#1)
treatment used##2##2##(1992-9#1)(2010-11#1)
treatment using the##2##3##(1996-3#1)(1997-3#1)
treatment using##11##2##(1995-5#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-10#2)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
treatment versus##2##2##(2010-10#1)(2013-1#1)
treatment was 2##2##3##(1993-6#1)(2008-12#1)
treatment was administered##2##3##(2008-5#1)(2013-1#1)
treatment was conservative##2##3##(1993-6#1)(2013-1#1)
treatment was correlated with##2##4##(2008-10#1)(2013-1#1)
treatment was delayed##2##3##(1990-6#1)(2011-2#1)
treatment was found##3##3##(2008-3#1)(2009-7#1)(2009-8#1)
treatment was given##2##3##(1990-11#1)(2012-3#1)
treatment was higher##2##3##(2012-3#1)(2012-6#1)
treatment was not##4##3##(1994-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
treatment was performed##2##3##(1990-6#1)(1994-12#1)
treatment was stopped##3##3##(1993-1#1)(2010-1#2)
treatment was to##2##3##(1991-6#1)(2008-10#1)
treatment was well tolerated##3##4##(1992-12#1)(2007-11#1)(2012-3#1)
treatment was well##4##3##(1992-12#1)(1994-8#1)(2007-11#1)(2012-3#1)
treatment was##77##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-6#2)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#7)(2012-6#1)(2013-1#6)(2013-8#1)
treatment were developed##2##3##(2010-12#1)(2012-3#1)
treatment were observed##2##3##(1990-6#1)(1996-12#1)
treatment were##22##2##(1990-6#1)(1990-9#1)(1993-8#1)(1995-12#1)(1996-12#3)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
treatment which##3##2##(1991-12#1)(2013-1#1)(2013-8#1)
treatment while##2##2##(1996-3#1)(2008-7#1)
treatment will be##4##3##(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)
treatment will##6##2##(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
treatment with 0##3##3##(1994-8#1)(1995-8#1)(2008-10#1)
treatment with 100 nM alpha-MSH##2##5##(1995-2#2)
treatment with 50##3##3##(1995-8#2)(2008-10#1)
treatment with CO2 laser##2##4##(1991-6#1)(1995-2#1)
treatment with L-arginine##2##3##(1997-2#2)
treatment with Metalaxyl##2##3##(2008-10#2)
treatment with R-PIA##2##3##(1997-1#2)
treatment with T##2##3##(2008-10#2)
treatment with TPA##2##3##(1990-12#1)(1994-6#1)
treatment with VPA##4##3##(2011-2#4)
treatment with a combination of##2##5##(1994-8#1)(2013-8#1)
treatment with a##11##3##(1990-11#1)(1993-2#1)(1994-8#1)(1995-12#1)(2008-10#4)(2011-2#1)(2013-1#1)(2013-8#1)
treatment with an##8##3##(1991-11#1)(1992-3#1)(1997-6#1)(2008-10#3)(2011-2#2)
treatment with antibiotics##2##3##(1991-4#1)(2011-2#1)
treatment with calcium##2##3##(1995-12#1)(1996-6#1)
treatment with either praziquantel or oxamniquine##2##6##(2010-12#2)
treatment with either##6##3##(1994-2#1)(1996-6#1)(1997-1#1)(2010-12#3)
treatment with mitoxantrone##2##3##(1991-6#1)(1994-12#1)
treatment with pegylated##2##3##(2009-7#1)(2011-2#1)
treatment with prednisone##2##3##(1992-2#1)(2008-7#1)
treatment with sodium##4##3##(1991-11#1)(1991-12#1)(1994-11#1)(2008-10#1)
treatment with the##19##3##(1991-12#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)(2012-3#2)
treatment with these drugs##3##4##(2010-5#2)(2012-2#1)
treatment with##284##2##(1990-11#1)(1990-12#5)(1990-2#3)(1991-11#6)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#7)(1995-2#7)(1995-6#1)(1995-8#5)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#5)(1997-1#4)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-9#1)(2008-10#52)(2008-11#11)(2008-12#3)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#5)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-12#4)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#1)(2011-10#1)(2011-2#15)(2012-12#1)(2012-2#2)(2012-3#12)(2013-1#11)(2013-7#1)(2013-8#4)
treatment within##2##2##(1994-9#1)(2011-3#1)
treatment without##3##2##(1994-3#1)(1995-8#1)(2013-1#1)
treatment##4010##1##(1990-10#5)(1990-11#26)(1990-12#27)(1990-2#21)(1990-3#7)(1990-5#10)(1990-6#17)(1990-7#3)(1990-8#2)(1990-9#26)(1991-1#20)(1991-10#3)(1991-11#26)(1991-12#17)(1991-2#42)(1991-3#19)(1991-4#3)(1991-5#5)(1991-6#28)(1991-8#28)(1991-9#15)(1992-1#20)(1992-11#9)(1992-12#20)(1992-2#15)(1992-3#30)(1992-5#16)(1992-6#6)(1992-7#3)(1992-8#3)(1992-9#19)(1993-1#18)(1993-11#21)(1993-12#6)(1993-2#37)(1993-3#14)(1993-5#2)(1993-6#26)(1993-8#18)(1993-9#21)(1994-1#6)(1994-11#8)(1994-12#30)(1994-2#20)(1994-3#21)(1994-5#16)(1994-6#19)(1994-8#13)(1994-9#12)(1995-1#3)(1995-10#3)(1995-11#25)(1995-12#37)(1995-2#26)(1995-3#3)(1995-5#6)(1995-6#10)(1995-8#10)(1995-9#5)(1996-1#13)(1996-11#45)(1996-12#23)(1996-2#12)(1996-3#40)(1996-5#11)(1996-6#28)(1996-8#3)(1996-9#13)(1997-1#18)(1997-2#14)(1997-3#28)(1997-4#14)(1997-5#17)(1997-6#6)(1997-7#6)(1997-8#39)(2007-11#12)(2007-12#4)(2007-7#1)(2007-8#17)(2007-9#5)(2008-1#23)(2008-10#476)(2008-11#180)(2008-12#79)(2008-2#2)(2008-3#17)(2008-4#28)(2008-5#75)(2008-6#72)(2008-7#161)(2008-8#56)(2008-9#55)(2009-1#12)(2009-10#11)(2009-11#24)(2009-12#22)(2009-2#7)(2009-3#10)(2009-4#9)(2009-5#11)(2009-6#14)(2009-7#23)(2009-8#37)(2009-9#20)(2010-1#23)(2010-10#17)(2010-11#41)(2010-12#74)(2010-3#12)(2010-4#15)(2010-5#16)(2010-6#39)(2010-7#21)(2010-8#16)(2010-9#12)(2011-1#27)(2011-10#8)(2011-2#250)(2011-3#25)(2011-7#10)(2012-12#51)(2012-2#75)(2012-3#162)(2012-5#2)(2012-6#4)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#277)(2013-7#6)(2013-8#104)
treatment&quot##2##1##(1996-11#1)(2008-10#1)
treatment(s)##3##1##(2012-2#3)
treatment) and##2##2##(2008-12#1)(2010-5#1)
treatment)##18##1##(1990-12#1)(1992-3#1)(1994-3#1)(1994-8#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-2#1)
treatment- and##2##2##(2008-12#1)(2009-5#1)
treatment-based classification##2##2##(2008-12#2)
treatment-effectiveness##2##1##(1992-1#2)
treatment-induced##5##1##(1990-2#1)(1997-2#1)(2008-7#1)(2009-7#1)(2010-12#1)
treatment-naïve##2##1##(2012-2#1)(2013-1#1)
treatment-refractory##3##1##(1992-3#1)(2008-11#1)(2008-3#1)
treatment-related death occurred##2##3##(1991-6#1)(1992-2#1)
treatment-related neoplasms##3##2##(2008-9#3)
treatment-related##11##1##(1991-6#1)(1992-2#1)(1997-1#1)(2008-7#1)(2008-9#7)
treatment-seeking##3##1##(2007-12#1)(2008-8#1)(2009-9#1)
treatment?##5##1##(1991-8#1)(1994-1#2)(1995-1#1)(2008-11#1)
treatment]##20##1##(1990-11#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-2#2)(1993-8#1)(1994-5#1)(1994-8#1)(1996-11#1)(1996-6#2)(1997-4#1)(1997-5#2)(2008-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
treatments and the##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)
treatments and##23##2##(1991-2#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#3)
treatments applied##3##2##(2008-10#2)(2008-5#1)
treatments are available##3##3##(2008-11#1)(2010-10#1)(2011-10#1)
treatments are not##2##3##(2008-11#1)(2008-4#1)
treatments are required##2##3##(2008-10#1)(2012-3#1)
treatments are##15##2##(1993-2#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2010-10#1)(2011-10#1)(2012-12#1)(2012-3#2)(2013-1#2)
treatments at##3##2##(1995-11#1)(2008-10#2)
treatments can##3##2##(2008-3#1)(2013-1#2)
treatments compared with##2##3##(2008-10#1)(2012-12#1)
treatments could be##2##3##(2008-10#1)(2008-5#1)
treatments during the##2##3##(2008-10#2)
treatments during##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
treatments for adolescent##2##3##(2009-7#1)(2013-1#1)
treatments for##31##2##(1991-1#1)(1993-3#2)(2008-10#5)(2008-11#1)(2008-4#3)(2008-6#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
treatments given##2##2##(2008-10#1)(2011-2#1)
treatments have been##3##3##(1993-1#1)(2009-7#1)(2010-7#1)
treatments have##10##2##(1993-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#2)
treatments in a##2##3##(2010-4#1)(2012-3#1)
treatments in the##2##3##(1993-1#1)(2008-4#1)
treatments in##16##2##(1990-2#1)(1993-1#1)(1996-6#1)(2008-10#5)(2008-4#1)(2009-10#2)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
treatments including##2##2##(2008-12#1)(2008-5#1)
treatments increased##2##2##(2008-10#2)
treatments involving##2##2##(1995-2#1)(2008-10#1)
treatments is##3##2##(1992-9#1)(1995-9#1)(2013-1#1)
treatments of experiment##2##3##(2008-10#2)
treatments of the##3##3##(2008-10#2)(2008-3#1)
treatments of##14##2##(1990-6#1)(1993-3#1)(1994-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2010-1#1)
treatments on the##2##3##(1995-12#1)(2008-10#1)
treatments on##4##2##(1995-12#1)(2008-10#2)(2011-2#1)
treatments remains##2##2##(1997-5#1)(2008-11#1)
treatments resulted in##6##3##(1991-3#1)(2008-10#2)(2008-5#1)(2010-9#1)(2013-1#1)
treatments should##2##2##(2011-2#2)
treatments significantly reduced##2##3##(2008-10#2)
treatments such as##4##3##(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
treatments tested##2##2##(2008-10#1)(2008-6#1)
treatments than##2##2##(2008-10#1)(2012-9#1)
treatments that prevent##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
treatments that##13##2##(1994-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-4#2)(2012-12#1)(2013-1#1)(2013-8#1)
treatments to##6##2##(1991-2#1)(1995-12#1)(2008-10#3)(2009-8#1)
treatments used##2##2##(2008-7#1)(2011-2#1)
treatments was##6##2##(2008-10#6)
treatments were applied##2##3##(2008-10#1)(2012-8#1)
treatments were##20##2##(1996-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-8#1)
treatments when##2##2##(2008-10#2)
treatments which##4##2##(1994-2#1)(2008-11#1)(2009-7#1)(2012-3#1)
treatments with different##2##3##(2008-10#1)(2012-3#1)
treatments with##24##2##(1994-2#1)(1996-11#1)(2008-10#15)(2008-9#1)(2011-2#2)(2012-2#2)(2012-3#2)
treatments##438##1##(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#2)(1991-3#4)(1992-12#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#4)(1994-11#1)(1994-12#1)(1994-2#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-6#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-10#156)(2008-11#14)(2008-12#14)(2008-2#2)(2008-3#4)(2008-4#10)(2008-5#15)(2008-6#6)(2008-7#11)(2008-8#3)(2008-9#12)(2009-10#3)(2009-11#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#6)(2009-8#2)(2009-9#2)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#22)(2011-3#2)(2012-12#6)(2012-2#8)(2012-3#14)(2012-4#1)(2012-5#2)(2012-6#1)(2012-8#1)(2012-9#3)(2013-1#23)(2013-8#5)
treats##5##1##(1991-2#1)(1993-1#1)(2009-5#1)(2010-4#1)(2010-7#1)
tredecaurelia##2##1##(2008-12#2)
tree and##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
tree based on##3##3##(2008-10#3)
tree by##3##2##(1994-9#1)(2008-10#1)(2012-3#1)
tree canopies##3##2##(2008-10#3)
tree canopy##8##2##(2008-10#8)
tree constructed##2##2##(2008-10#1)(2008-8#1)
tree diseases##2##2##(2008-10#2)
tree growth##3##2##(1990-8#1)(2008-10#1)(2010-4#1)
tree holes##5##2##(2008-9#5)
tree in##3##2##(2008-10#2)(2012-12#1)
tree of life##2##3##(2011-2#1)(2012-3#1)
tree of the##3##3##(1991-6#1)(1997-2#1)(1997-7#1)
tree of##9##2##(1991-6#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-8#3)(2011-2#1)(2012-3#1)
tree or##2##2##(2008-10#1)(2009-8#1)
tree pathogens##2##2##(2008-10#2)
tree sparrows##2##2##(2008-5#2)
tree species to##2##3##(2008-10#1)(2009-8#1)
tree species##12##2##(2008-10#2)(2008-8#3)(2008-9#1)(2009-8#3)(2012-6#2)(2012-9#1)
tree susceptibility##3##2##(2008-10#3)
tree was constructed##2##3##(2008-12#1)(2013-8#1)
tree was##6##2##(2008-10#2)(2008-12#1)(2010-7#1)(2013-8#2)
tree##192##1##(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-2#1)(1994-2#2)(1994-9#1)(1995-12#2)(1996-1#1)(1997-1#1)(1997-2#2)(1997-7#1)(2008-10#97)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#5)(2008-8#15)(2008-9#12)(2009-10#3)(2009-12#1)(2009-8#5)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#10)(2012-6#2)(2012-9#1)(2013-1#1)(2013-8#6)
tree)##4##1##(2008-10#2)(2012-3#2)
tree-based decision model to##2##4##(2010-8#2)
tree-based##3##1##(2010-8#2)(2012-3#1)
trees affected##2##2##(2008-10#1)(2013-1#1)
trees and shrubs##2##3##(2008-10#2)
trees and##18##2##(2008-10#15)(2012-3#1)(2012-9#1)(2013-8#1)
trees are##2##2##(2008-10#1)(2008-8#1)
trees at##3##2##(2008-10#3)
trees by##5##2##(2008-10#5)
trees derived from##2##3##(2008-10#2)
trees during the##2##3##(2008-10#1)(2008-12#1)
trees during##4##2##(2008-10#3)(2008-12#1)
trees for all##2##3##(2008-10#2)
trees for##6##2##(2008-10#6)
trees from 15##2##3##(2008-10#2)
trees from##6##2##(2008-10#5)(2011-10#1)
trees generated##3##2##(2008-10#2)(2008-9#1)
trees grafted on trifoliate orange##2##5##(2008-10#2)
trees had##2##2##(2008-10#2)
trees have##2##2##(2008-10#2)
trees in a##4##3##(2008-10#3)(2008-9#1)
trees in all directions##2##4##(2008-10#2)
trees in the field##3##4##(2008-10#3)
trees in the##10##3##(2008-10#10)
trees in##34##2##(2008-10#31)(2008-5#1)(2008-9#1)(2013-1#1)
trees infected with##7##3##(2008-10#7)
trees infected##8##2##(2008-10#8)
trees inoculated with##2##3##(2008-10#2)
trees is##3##2##(2008-10#2)(2008-8#1)
trees located##2##2##(2008-10#2)
trees occurred##2##2##(2008-10#2)
trees of the##2##3##(2008-10#1)(2008-5#1)
trees of##4##2##(2008-10#2)(2008-5#1)(2010-3#1)
trees on the##3##3##(2008-10#3)
trees on##5##2##(2008-10#5)
trees or##2##2##(2008-10#2)
trees produced##2##2##(2008-10#1)(2008-9#1)
trees showed##2##2##(2008-10#2)
trees that##3##2##(2008-10#1)(2008-8#1)(2012-7#1)
trees to##5##2##(2008-10#4)(2012-8#1)
trees treated##2##2##(2008-10#2)
trees using##2##2##(2008-4#1)(2008-9#1)
trees was##6##2##(2008-10#5)(2012-9#1)
trees were removed##2##3##(2008-10#2)
trees were treated##2##3##(2008-10#2)
trees were##20##2##(2008-10#17)(2008-8#1)(2011-2#1)(2012-6#1)
trees with##8##2##(2008-10#5)(2008-4#1)(2012-3#2)
trees within##5##2##(2008-10#5)
trees##321##1##(1995-11#1)(2008-10#261)(2008-11#1)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-8#12)(2008-9#8)(2009-8#2)(2010-3#1)(2010-4#3)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#5)(2012-6#2)(2012-7#1)(2012-8#2)(2012-9#2)(2013-1#2)(2013-8#4)
trees)##4##1##(2008-10#3)(2012-6#1)
trehalose and##2##2##(1993-8#2)
trehalose supplementation##2##2##(2013-1#2)
trehalose##20##1##(1993-8#3)(2008-10#8)(2008-11#3)(2008-6#1)(2013-1#5)
trehalose-supplemented diet##4##2##(2013-1#4)
tremendous##18##1##(1991-3#1)(1992-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#1)
tremolite &quot##2##2##(1991-12#2)
tremolite##22##1##(1991-12#22)
tremor (ET)##2##2##(2008-7#1)(2013-1#1)
tremor and##3##2##(2008-7#3)
tremor in patients##2##3##(2008-7#2)
tremor in##3##2##(2008-7#2)(2012-3#1)
tremor was##2##2##(2008-7#1)(2012-3#1)
tremor##26##1##(1997-2#1)(2008-7#19)(2010-12#1)(2012-3#4)(2013-1#1)
trench##6##1##(1991-2#2)(2008-3#3)(2009-9#1)
trend and##2##2##(1990-11#1)(1996-2#1)
trend emerged##2##2##(1990-12#1)(2008-12#1)
trend for the##2##3##(2008-10#1)(2009-6#1)
trend for##9##2##(1990-2#1)(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-8#1)(2013-1#1)
trend in the##4##3##(1990-6#1)(1994-2#1)(1996-11#1)(2012-12#1)
trend in##20##2##(1990-3#1)(1990-6#1)(1991-8#1)(1993-2#1)(1994-2#2)(1995-12#1)(1996-11#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-8#2)(2011-2#3)(2012-12#2)
trend is##3##2##(1991-3#1)(1992-3#1)(2013-1#1)
trend of##13##2##(1990-3#1)(1995-3#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-12#1)(2012-2#1)(2012-7#1)(2013-8#1)
trend to##5##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
trend toward greater##2##3##(1997-2#1)(2008-10#1)
trend toward##12##2##(1992-9#1)(1993-2#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-10#2)(2009-3#1)(2010-7#1)(2011-2#2)
trend towards more##2##3##(2009-4#1)(2010-3#1)
trend towards##11##2##(1990-6#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-3#2)(2009-4#1)(2010-11#1)(2010-3#1)
trend was observed##3##3##(2008-10#2)(2012-12#1)
trend was##11##2##(1990-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
trend within##2##2##(1991-3#1)(1996-6#1)
trend##124##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#2)(1991-2#1)(1991-3#3)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#2)(1994-1#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#17)(2008-11#11)(2008-12#5)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#5)(2012-2#4)(2012-3#3)(2012-7#1)(2012-9#1)(2013-1#2)(2013-8#3)
trended##4##1##(1996-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
trends and correlates##2##3##(1993-3#1)(2013-1#1)
trends and##9##2##(1991-2#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-7#1)(2010-3#1)(2013-1#1)
trends are##6##2##(1991-3#1)(1992-1#1)(1994-5#1)(1997-2#1)(2008-1#1)(2008-7#1)
trends for##7##2##(1991-1#1)(1991-2#1)(1991-3#1)(1993-3#1)(1996-2#1)(2009-11#1)(2012-12#1)
trends from##4##2##(1996-3#1)(2008-11#1)(2008-9#1)(2010-12#1)
trends in females##2##3##(1994-6#1)(1996-3#1)
trends in health care facility construction##2##6##(1991-2#2)
trends in hospital##2##3##(1993-12#1)(1996-1#1)
trends in the use of##2##5##(1991-3#1)(1993-12#1)
trends in the##16##3##(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-3#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
trends in##68##2##(1991-1#2)(1991-2#4)(1991-3#4)(1991-9#1)(1992-12#1)(1992-9#2)(1993-1#3)(1993-12#2)(1993-3#1)(1994-12#2)(1994-6#2)(1994-9#1)(1995-1#1)(1996-1#3)(1996-3#7)(1997-2#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
trends of##5##2##(1994-12#1)(2008-1#1)(2008-3#1)(2012-12#1)(2013-1#1)
trends over time##2##3##(2008-10#1)(2009-7#1)
trends promoting##2##2##(1997-3#1)(2008-11#1)
trends were found##2##3##(2008-10#1)(2008-11#1)
trends were##7##2##(1993-1#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
trends within the##2##3##(1991-3#1)(2010-3#1)
trends within##3##2##(1991-3#1)(1997-2#1)(2010-3#1)
trends##159##1##(1991-1#4)(1991-12#1)(1991-2#7)(1991-3#7)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-9#2)(1993-1#5)(1993-12#3)(1993-3#5)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#3)(1996-1#5)(1996-2#2)(1996-3#8)(1996-6#1)(1997-2#5)(1997-3#2)(1997-7#1)(2008-1#5)(2008-10#17)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-2#3)(2011-9#1)(2012-12#6)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#1)
trends)##2##1##(1994-12#1)(2008-8#1)
trends]##2##1##(1990-2#1)(2013-1#1)
tri- and##3##2##(2008-10#3)
tri-##5##1##(2008-10#5)
tri-colour light emitting diode##2##4##(2008-10#2)
tri-colour##4##1##(2008-10#4)
tri-iodide##2##1##(2008-10#2)
tri-n-butyl phosphate (TBP) and##2##4##(2008-10#2)
tri-n-butylphosphate (TBP)##2##2##(2008-10#2)
triacetal oxa cages##2##3##(1996-5#2)
triacetate##5##1##(1990-9#2)(2008-10#3)
triacylglycerol##3##1##(1990-5#1)(2011-2#1)(2012-2#1)
triacylglycerols in##2##2##(1996-6#1)(2008-5#1)
triacylglycerols##6##1##(1996-6#2)(2008-10#1)(2008-11#1)(2008-5#2)
triacyloglycerides##2##1##(2008-12#2)
triad in##2##2##(2010-1#2)
triad of fever##2##3##(2008-8#1)(2009-11#1)
triad of##5##2##(1992-3#1)(1995-2#1)(2008-8#1)(2009-11#1)(2010-6#1)
triad##14##1##(1992-3#2)(1995-2#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-1#4)(2010-6#1)
triadic##2##1##(1994-3#1)(1995-6#1)
triadimenol##2##1##(2008-10#2)
triads##2##1##(1993-2#1)(2008-10#1)
triage##4##1##(2008-11#1)(2008-3#1)(2010-8#1)(2013-1#1)
trial (RCT)##3##2##(2008-10#1)(2013-1#2)
trial and##10##2##(1995-11#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
trial are##3##2##(1994-9#1)(1996-3#1)(2011-3#1)
trial comparing##6##2##(1993-1#2)(1993-11#1)(1994-8#1)(1995-12#1)(2008-4#1)
trial conducted in a##2##4##(1990-11#1)(2008-10#1)
trial conducted in##4##3##(1990-11#1)(2008-10#2)(2010-11#1)
trial data##5##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
trial design##2##2##(2010-7#1)(2013-1#1)
trial designs##2##2##(1994-9#1)(2011-2#1)
trial for counterbalance order##3##4##(2013-8#3)
trial for##9##2##(1994-5#1)(1995-9#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#3)
trial has##2##2##(1996-12#1)(2013-1#1)
trial in the##2##3##(1995-9#1)(2010-11#1)
trial in which##2##3##(2013-1#1)(2013-7#1)
trial in##16##2##(1992-12#1)(1994-8#1)(1995-9#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#1)(2010-11#1)(2010-6#1)(2013-1#1)(2013-7#1)
trial is the##3##3##(1993-12#1)(1996-6#1)(2011-2#1)
trial is##8##2##(1993-12#1)(1996-6#2)(2008-7#1)(2010-12#1)(2011-2#2)(2013-8#1)
trial judge##2##2##(1995-12#1)(1996-5#1)
trial of a##4##3##(1994-9#1)(1995-5#1)(2008-12#1)(2008-3#1)
trial of acyclovir for##2##4##(1991-12#1)(1994-3#1)
trial of the##3##3##(1990-2#1)(2008-10#1)(2012-2#1)
trial of##37##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-3#1)(1993-12#3)(1993-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-5#2)(1997-7#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)
trial on the##2##3##(1993-5#1)(2012-3#1)
trial on##6##2##(1993-11#1)(1993-5#1)(1995-12#1)(2012-3#1)(2013-1#2)
trial one-dimensional##2##2##(2008-3#2)
trial or##2##2##(1995-2#1)(1996-6#1)
trial recruitment##2##2##(2010-11#2)
trial should##2##2##(1996-6#2)
trial showed##2##2##(2008-6#1)(2010-12#1)
trial site##2##2##(2008-10#2)
trial that##4##2##(1995-9#1)(2008-7#1)(2008-8#1)(2013-1#1)
trial to determine##2##3##(1990-6#1)(2010-6#1)
trial to evaluate the##2##4##(2008-7#1)(2010-3#1)
trial to evaluate##4##3##(1994-12#1)(2008-5#1)(2008-7#1)(2010-3#1)
trial to test the##2##4##(1995-5#1)(2010-10#1)
trial to##13##2##(1990-6#1)(1994-12#1)(1995-5#2)(1995-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-6#1)
trial using##2##2##(2011-2#1)(2012-12#1)
trial was conducted on##2##4##(2013-1#2)
trial was conducted##4##3##(1991-2#1)(2010-8#1)(2013-1#2)
trial was performed##3##3##(1991-3#1)(1992-12#1)(2008-3#1)
trial was to##2##3##(2012-2#1)(2013-1#1)
trial was##15##2##(1991-2#2)(1991-3#1)(1992-12#1)(1996-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#4)
trial with##6##2##(1994-6#1)(2008-10#2)(2008-6#1)(2008-8#1)(2013-1#1)
trial##348##1##(1990-10#1)(1990-11#2)(1990-2#3)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#6)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-12#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#6)(1995-6#1)(1995-8#1)(1995-9#5)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#15)(1997-1#1)(1997-2#1)(1997-7#4)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#33)(2008-11#8)(2008-12#3)(2008-3#5)(2008-4#4)(2008-5#17)(2008-6#3)(2008-7#9)(2008-8#12)(2009-10#2)(2009-12#3)(2009-2#1)(2009-4#5)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#7)(2010-11#5)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#6)(2010-7#2)(2010-8#4)(2011-10#1)(2011-2#19)(2011-3#1)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#30)(2013-7#1)(2013-8#11)
trial)##2##1##(2008-10#1)(2009-10#1)
trial]##2##1##(1991-2#1)(1991-3#1)
trialists##3##1##(1993-12#1)(1994-9#1)(2008-10#1)
trialkyl##3##1##(1996-5#1)(2008-10#2)
trials (RCTs)##5##2##(1993-12#1)(2008-10#2)(2010-11#1)(2011-2#1)
trials (n =##2##3##(1993-12#2)
trials (p##2##2##(2013-8#2)
trials (phase##2##2##(2008-11#1)(2010-12#1)
trials across##2##2##(2008-10#1)(2008-12#1)
trials against##2##2##(2008-11#1)(2013-1#1)
trials and meta-analyses##4##3##(1991-3#1)(1993-12#1)(1996-6#2)
trials and other##3##3##(1996-3#1)(2007-11#1)(2008-11#1)
trials and registries##2##3##(2009-10#1)(2011-2#1)
trials and##31##2##(1990-9#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-12#2)(1995-2#2)(1995-9#1)(1996-3#1)(1996-6#2)(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-12#2)
trials are needed to##3##4##(2011-2#2)(2013-1#1)
trials are needed##4##3##(2009-7#1)(2011-2#2)(2013-1#1)
trials are##21##2##(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-9#1)(1996-6#1)(1997-4#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-7#2)(2011-2#3)(2012-3#1)(2013-1#2)
trials as##5##2##(2008-5#3)(2008-8#1)(2013-1#1)
trials at##2##2##(2008-10#1)(2009-6#1)
trials by##2##2##(1996-9#1)(2008-11#1)
trials compared with##2##3##(2008-10#2)
trials comparing##2##2##(2008-10#1)(2010-5#1)
trials could##2##2##(2008-10#1)(2010-1#1)
trials during##2##2##(2010-8#1)(2013-1#1)
trials for##7##2##(1995-5#1)(2008-11#1)(2008-5#2)(2009-4#1)(2010-10#1)(2013-8#1)
trials had##2##2##(2008-10#2)
trials has##2##2##(1993-12#1)(1996-6#1)
trials have suggested that##2##4##(1996-3#1)(2012-12#1)
trials have##9##2##(1996-3#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
trials in both##2##3##(2008-11#1)(2008-5#1)
trials in humans##2##3##(2006-6#1)(2011-2#1)
trials in the##3##3##(2008-11#1)(2008-5#2)
trials in##43##2##(1991-6#1)(1991-8#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-2#4)(1994-8#1)(2006-6#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-5#9)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
trials include##2##2##(2008-9#1)(2011-2#1)
trials is##6##2##(1993-12#1)(1993-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2013-7#1)
trials of a##2##3##(1995-5#1)(2008-10#1)
trials of combination##2##3##(1995-5#1)(2010-10#1)
trials of new##2##3##(2008-4#1)(2011-2#1)
trials of the##4##3##(1993-2#1)(1996-6#1)(2008-10#1)(2008-11#1)
trials of##35##2##(1991-10#1)(1993-2#1)(1994-5#2)(1994-9#1)(1995-5#3)(1996-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)
trials on##12##2##(1994-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#1)(2011-2#1)(2013-8#1)
trials over##2##2##(2008-10#2)
trials per##3##2##(1990-11#1)(1992-12#1)(1994-3#1)
trials revealed that##2##3##(2008-10#1)(2011-1#1)
trials should be##3##3##(1996-6#1)(2010-4#1)(2010-8#1)
trials should##4##2##(1993-12#1)(1996-6#1)(2010-4#1)(2010-8#1)
trials show that##2##3##(1991-12#1)(2010-5#1)
trials showed##2##2##(2008-10#2)
trials testing##2##2##(2008-11#1)(2010-12#1)
trials than##2##2##(2008-5#1)(2013-8#1)
trials that have##2##3##(1993-12#1)(2008-6#1)
trials that##5##2##(1993-12#1)(2008-12#1)(2008-6#1)(2010-2#1)(2012-3#1)
trials to##9##2##(1992-12#1)(1993-3#1)(1995-9#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
trials using##5##2##(2008-10#2)(2010-12#1)(2012-3#1)(2013-8#1)
trials was##6##2##(1992-12#1)(1993-3#1)(2008-10#2)(2008-12#1)(2008-5#1)
trials were conducted##2##3##(2008-10#2)
trials were##6##2##(2008-10#3)(2009-9#1)(2010-12#1)(2012-3#1)
trials which##3##2##(1996-6#2)(2012-12#1)
trials will##3##2##(1994-9#1)(1995-12#1)(2013-7#1)
trials with an##2##3##(2008-11#1)(2011-2#1)
trials with two##2##3##(1992-9#1)(2008-10#1)
trials with##13##2##(1991-2#1)(1992-9#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
trials##523##1##(1990-11#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#2)(1992-12#5)(1992-2#1)(1992-9#7)(1993-11#2)(1993-12#18)(1993-2#2)(1993-3#6)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#7)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#11)(1995-1#1)(1995-12#6)(1995-2#2)(1995-5#7)(1995-9#2)(1996-3#5)(1996-6#18)(1996-9#1)(1997-1#4)(1997-3#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-10#93)(2008-11#40)(2008-12#12)(2008-4#3)(2008-5#39)(2008-6#4)(2008-7#10)(2008-8#11)(2008-9#6)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#11)(2010-12#9)(2010-2#5)(2010-4#1)(2010-5#8)(2010-6#5)(2010-8#5)(2011-1#3)(2011-2#22)(2011-3#2)(2011-7#1)(2012-12#9)(2012-2#9)(2012-3#14)(2013-1#23)(2013-7#2)(2013-8#12)
trials)##4##1##(1994-2#1)(2010-4#1)(2010-5#1)(2013-8#1)
triamcinolone acetonide##5##2##(1990-11#2)(2010-12#2)(2011-2#1)
triamcinolone in##2##2##(1991-2#1)(2011-2#1)
triamcinolone##11##1##(1990-11#2)(1991-2#1)(1996-3#1)(2008-10#1)(2010-12#2)(2011-2#4)
triamterene##6##1##(2008-10#6)
triangle and##4##2##(2008-6#3)(2011-2#1)
triangle formed by the##2##4##(2010-8#1)(2011-2#1)
triangle mesh##2##2##(2012-3#2)
triangle programmed coulometric flow titration##2##5##(2008-10#2)
triangle##27##1##(1992-12#1)(2008-10#2)(2008-6#15)(2010-8#2)(2011-2#5)(2012-3#2)
triangle)##2##1##(2008-6#1)(2010-8#1)
triangles##2##1##(2008-6#2)
triangular design##2##2##(2008-10#2)
triangular waves##3##2##(2008-10#3)
triangular##21##1##(2008-10#8)(2008-3#8)(2008-9#1)(2010-6#2)(2012-12#2)
triangulated irregular##2##2##(2008-6#2)
triangulated##5##1##(2008-6#3)(2010-10#1)(2013-1#1)
triangulation##6##1##(2008-2#2)(2008-3#3)(2013-1#1)
triangulation-based##2##1##(2010-7#2)
triantennary##4##1##(1994-5#2)(1995-2#1)(2008-8#1)
triazine##6##1##(1997-2#1)(2008-10#5)
triazines##8##1##(2008-10#8)
triazolam##2##1##(1996-12#2)
triazoles for##2##2##(2011-2#2)
triazoles##4##1##(2011-2#4)
tribe##2##1##(1994-9#1)(2007-12#1)
tribes##3##1##(2008-12#1)(2008-8#2)
tribromoarsenazo-cetylpyridinium##2##1##(2008-10#2)
tributaries##5##1##(2009-9#1)(2010-8#4)
tributary##2##1##(1991-6#1)(2010-8#1)
tribute to##3##2##(2008-11#2)(2008-3#1)
tributyl phosphate (TBP)##2##3##(2008-10#2)
tributyl phosphate##3##2##(2008-10#3)
tributyl##4##1##(2008-10#4)
tributyltin##3##1##(2008-10#2)(2008-11#1)
tributyrin##4##1##(1990-6#3)(1992-3#1)
tricarboxylic acid cycle##5##3##(2008-7#4)(2008-8#1)
triceps brachii##2##2##(2012-3#2)
triceps##5##1##(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#2)
trichinosis##3##1##(2008-10#3)
trichlorfon and##3##2##(2008-10#3)
trichlorfon##8##1##(2008-10#8)
trichloroacetaldehyde hydrate (TCAH)##2##3##(2008-10#2)
trichloroacetic acid (TCA) and##2##4##(2008-10#2)
trichloroacetic acid (TCA)##3##3##(2008-10#3)
trichloroacetic acid##7##2##(1995-12#1)(2008-10#6)
trichloroacetic##8##1##(1995-12#1)(2008-10#7)
trichloroethanol##2##1##(2012-2#2)
trichloroethene##2##1##(2008-10#2)
trichloroethylene (TCE)##4##2##(2008-10#3)(2010-4#1)
trichloroethylene##15##1##(2008-10#13)(2008-7#1)(2010-4#1)
trichloroisocyanuric acid##2##2##(2008-10#2)
trichloromethane##3##1##(2008-10#3)
trichocarpa F(1) progeny##2##3##(2008-10#2)
trichocarpa and##2##2##(2008-10#2)
trichocarpa##8##1##(2008-10#8)
trichomoniasis##4##1##(1992-2#1)(2008-5#2)(2011-2#1)
trichosanthin##3##1##(2008-10#2)(2008-8#1)
trichothecene##5##1##(2008-10#2)(2008-11#3)
trichothecenes##4##1##(2008-10#3)(2010-7#1)
trichovirus##2##1##(2008-10#2)
trichrome stain##2##2##(2008-11#1)(2010-12#1)
trichrome##6##1##(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-3#1)
tricks##4##1##(1990-5#1)(1995-12#1)(1996-3#1)(2011-2#1)
triclosan##4##1##(2008-5#4)
tricortical##3##1##(2008-7#1)(2009-10#2)
tricuspid##3##1##(2008-11#1)(2010-10#1)(2012-12#1)
tricyclic antidepressants##11##2##(1991-11#2)(1991-8#1)(1997-8#4)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
tricyclic##19##1##(1990-11#1)(1991-11#3)(1991-8#1)(1996-5#3)(1997-8#4)(2008-10#2)(2008-2#1)(2008-9#1)(2009-12#1)(2010-1#1)(2012-2#1)
tricyclics##3##1##(2008-11#2)(2012-2#1)
tried smoking##2##2##(1991-9#1)(2013-1#1)
tried to##20##2##(1990-12#1)(1990-9#1)(1991-1#1)(1994-3#2)(1996-5#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2012-3#1)
tried##33##1##(1990-12#1)(1990-9#1)(1991-1#1)(1991-9#2)(1993-3#1)(1994-3#2)(1995-12#1)(1996-2#1)(1996-5#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2012-3#1)(2013-1#1)
trienzymatic##2##1##(2008-10#2)
trienzyme##4##1##(2008-10#3)(2009-8#1)
triepoxides##2##1##(1996-5#2)
tries to##5##2##(1993-3#1)(1995-5#1)(2008-11#1)(2009-10#1)(2009-8#1)
triethanolamine (TEA) as##3##3##(2008-10#3)
triethanolamine (TEA)##5##2##(2008-10#5)
triethanolamine##7##1##(2008-10#7)
triethylamine (TEA) and##2##3##(2008-10#2)
triethylamine and##3##2##(1996-5#1)(2008-10#2)
triethylamine##19##1##(1996-5#3)(2008-10#13)(2008-7#3)
triethylenetetramine##4##1##(2008-10#4)
trifloxystrobin##3##1##(2008-10#3)
trifluoperazine and##2##2##(2008-10#2)
trifluoperazine##3##1##(1996-2#1)(2008-10#2)
trifluoroacetic acid##2##2##(2008-10#2)
trifluoroacetic##3##1##(1991-12#1)(2008-10#2)
trifluoroethanol and##2##2##(1991-5#1)(2009-8#1)
trifluoroethanol##6##1##(1991-5#1)(1995-2#2)(2009-8#2)(2010-7#1)
triflupromazine##3##1##(2008-10#3)
trifoliata)##2##1##(2008-10#2)
trifoliate orange (Poncirus##2##3##(2008-10#2)
trifoliate orange adjacent to P##2##5##(2008-10#2)
trifoliate orange##11##2##(2008-10#11)
trifolii strain##2##2##(2011-2#2)
trifolii##6##1##(2010-3#2)(2011-2#4)
trifunctional protein##2##2##(1993-12#2)
trifunctional silane##2##2##(2008-10#2)
trifunctional##8##1##(1992-10#1)(1993-12#5)(2008-10#2)
trigeminal artery##2##2##(1991-6#2)
trigeminal cistern##2##2##(1993-1#2)
trigeminal ganglion neurons##3##3##(1996-12#3)
trigeminal ganglion##8##2##(1996-12#3)(1996-2#1)(1997-3#3)(2008-7#1)
trigeminal motor nucleus##2##3##(1990-9#1)(1997-2#1)
trigeminal nerve##7##2##(1990-12#1)(2011-2#6)
trigeminal neuralgia##11##2##(2008-5#1)(2008-7#2)(2011-2#7)(2013-1#1)
trigeminal##42##1##(1990-12#1)(1990-9#3)(1991-6#2)(1992-2#1)(1993-1#3)(1996-12#3)(1996-2#1)(1997-2#4)(1997-3#3)(2008-5#1)(2008-7#3)(2008-9#2)(2011-2#13)(2013-1#2)
trigeminally induced apnoea##3##3##(1996-5#3)
trigger and##2##2##(1994-8#1)(2009-6#1)
trigger for##6##2##(1997-3#1)(2008-11#2)(2008-9#1)(2012-2#1)(2012-3#1)
trigger germination##2##2##(2008-10#1)(2011-2#1)
trigger of##2##2##(1995-2#1)(2011-2#1)
trigger point##2##2##(2009-3#1)(2013-1#1)
trigger points##7##2##(2008-12#3)(2010-12#2)(2010-9#2)
trigger the##5##2##(1991-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2013-8#1)
trigger##60##1##(1990-11#1)(1991-2#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)(1997-6#1)(2008-10#8)(2008-11#6)(2008-12#3)(2008-4#1)(2008-9#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-9#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
triggered a##2##2##(1995-6#1)(1996-3#1)
triggered by fire##4##3##(2009-10#4)
triggered by the##3##3##(1997-3#1)(2009-8#1)(2010-7#1)
triggered by##39##2##(1990-12#1)(1990-8#1)(1992-8#1)(1994-6#2)(1995-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-7#2)(2008-9#1)(2009-10#4)(2009-4#1)(2009-6#1)(2009-8#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
triggered release of##2##3##(2008-10#2)
triggered release##3##2##(1995-11#1)(2008-10#2)
triggered the##3##2##(2008-10#2)(2012-3#1)
triggered when##2##2##(2008-10#1)(2008-8#1)
triggered##67##1##(1990-11#1)(1990-12#1)(1990-8#1)(1992-8#1)(1994-11#1)(1994-6#2)(1995-11#2)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#15)(2008-11#7)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#4)(2009-4#1)(2009-6#1)(2009-8#2)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
triggering in the##2##3##(2011-1#2)
triggering mechanism of##2##3##(2008-8#1)(2009-8#1)
triggering of the##2##3##(2008-10#1)(2008-8#1)
triggering of##7##2##(2008-10#1)(2008-8#4)(2009-8#1)(2010-6#1)
triggering the##2##2##(2008-10#1)(2011-2#1)
triggering##29##1##(1990-5#1)(1995-11#1)(1995-8#1)(2006-6#1)(2008-10#3)(2008-8#5)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-6#1)(2011-1#4)(2011-2#4)
triggers a##3##2##(2008-7#1)(2009-6#1)(2012-3#1)
triggers resistance##2##2##(2008-10#1)(2009-8#1)
triggers the##3##2##(1994-11#1)(2009-12#1)(2013-7#1)
triggers##33##1##(1994-11#2)(1994-3#1)(1994-6#1)(1995-12#1)(1997-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#5)(2010-1#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
triglyceride and##4##2##(1994-11#1)(1997-8#1)(2008-11#1)(2011-1#1)
triglyceride levels##4##2##(2008-10#3)(2008-11#1)
triglyceride##28##1##(1991-12#5)(1994-11#1)(1994-12#2)(1996-11#1)(1997-8#1)(2008-10#6)(2008-11#4)(2008-3#4)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
triglyceride-rich lipoproteins##5##2##(1995-6#5)
triglyceride-rich##7##1##(1994-11#1)(1995-6#5)(2008-6#1)
triglyceride/total##2##1##(1991-12#2)
triglycerides and##2##2##(2008-7#1)(2008-8#1)
triglycerides in##3##2##(1991-12#1)(1992-11#1)(2013-1#1)
triglycerides were##3##2##(1990-8#2)(1991-12#1)
triglycerides##31##1##(1990-8#3)(1991-12#3)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-4#5)(2012-2#1)(2013-1#1)
trigonelline##3##1##(2008-10#3)
trihalomethanes (THMs)##3##2##(2008-10#3)
trihalomethanes##13##1##(2008-10#12)(2008-9#1)
trihedral junctions##2##2##(2008-6#2)
triiodide ion##2##2##(2008-10#2)
triiodide##9##1##(2008-10#9)
triiodothyronine (T3)##2##2##(2008-6#1)(2008-7#1)
triiodothyronine##5##1##(1995-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
triisooctylamine##2##1##(2008-10#2)
trilinear##4##1##(2008-10#4)
trillion by##2##2##(1993-3#1)(2008-10#1)
trillion##8##1##(1993-3#2)(2008-10#5)(2008-12#1)
trimellitic anhydride (TMA)##3##3##(1995-11#1)(2008-10#2)
trimellitic anhydride##4##2##(1995-11#1)(2008-10#3)
trimellitic##6##1##(1995-11#1)(2008-10#5)
trimeperidine and##3##2##(2012-3#3)
trimeperidine##5##1##(2012-3#5)
trimer##3##1##(1994-5#1)(2008-11#1)(2008-8#1)
trimeric##5##1##(1994-12#1)(1994-5#1)(2008-1#1)(2008-8#2)
trimers##2##1##(2008-11#1)(2008-8#1)
trimester for##3##2##(1993-3#3)
trimester of##5##2##(1990-6#1)(2008-12#2)(2010-6#1)(2011-2#1)
trimester##35##1##(1990-6#2)(1990-9#2)(1991-3#1)(1991-6#1)(1993-12#1)(1993-3#4)(1994-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#2)(2010-12#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-3#4)(2013-1#7)
trimesters of gestation##2##3##(1993-12#2)
trimesters##5##1##(1993-12#3)(2010-12#2)
trimestre##5##1##(2011-2#1)(2013-1#4)
trimethoprim in##2##2##(2008-11#2)
trimethoprim##6##1##(2008-10#3)(2008-11#3)
trimethyl##5##1##(1994-8#1)(1996-5#2)(2008-10#2)
trimethylamine (TMA)##3##2##(2008-10#3)
trimethylamine microcarriers##5##2##(2008-11#5)
trimethylamine##14##1##(2008-10#8)(2008-11#6)
trimethylammonium##3##1##(2008-10#2)(2008-6#1)
trimethylarsine oxide##3##2##(2008-10#3)
trimethylselenonium ion##2##2##(2008-10#2)
trimethylselenonium##3##1##(2008-10#3)
trimethylsilyl##2##1##(1996-5#1)(2008-10#1)
trimmed##3##1##(2008-10#2)(2008-8#1)
trims##2##1##(1992-8#1)(2012-2#1)
trinitrate##2##1##(2008-8#2)
trinitrotoluene##4##1##(2008-10#4)
trinuclear##3##1##(2008-10#3)
trinucleotide repeat##2##2##(2008-7#2)
trinucleotide##5##1##(1991-9#1)(2008-11#1)(2008-7#2)(2010-7#1)
trioctylphosphine oxide##3##2##(2008-10#3)
triolein and##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
trioxide##4##1##(2008-10#1)(2008-8#2)(2013-1#1)
trip by##2##2##(2008-2#1)(2008-3#1)
tripartite leader##2##2##(1997-3#1)(1997-8#1)
tripartite##10##1##(1991-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-8#1)
tripeptide##11##1##(1992-10#2)(1992-6#2)(1993-9#1)(2008-10#1)(2009-8#1)(2011-1#2)(2011-2#1)(2013-7#1)
tripeptides##5##1##(1994-5#4)(1995-6#1)
triphosphatase##3##1##(1994-8#1)(2013-1#2)
triphosphate to##2##2##(1995-11#1)(2008-9#1)
triphosphate##15##1##(1995-11#2)(1997-6#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-8#1)(2011-1#1)
triphosphates##3##1##(1993-8#1)(2008-9#1)(2010-8#1)
triple quadrupole##2##2##(2008-10#1)(2013-8#1)
triple##33##1##(1991-9#1)(1993-1#1)(1993-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#2)(2009-7#3)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
triple&quot##2##1##(2011-2#2)
triple-antibody sandwich##3##2##(2008-10#3)
triple-antibody##4##1##(2008-10#4)
triple-decker##2##1##(2008-12#2)
triple-resonance ionization spectroscopy##2##3##(2008-3#2)
triple-resonance##4##1##(2008-3#2)(2009-7#2)
triple-stage##2##1##(2008-10#2)
triplet##8##1##(1995-12#1)(1995-8#1)(1996-5#1)(2008-10#4)(2008-8#1)
triplets##6##1##(1996-9#1)(2008-10#1)(2008-12#2)(2008-6#1)(2012-3#1)
triplex formation##9##2##(1993-8#8)(2008-9#1)
triplex##13##1##(1993-8#9)(2008-4#1)(2008-9#3)
triplexes##2##1##(1993-8#1)(2008-4#1)
triplicate measurements##2##2##(2008-10#2)
triplicate##6##1##(2008-10#5)(2008-12#1)
triplication of##2##2##(1997-2#1)(2012-3#1)
tripling##3##1##(2011-2#2)(2012-3#1)
triploid crucian carp##4##3##(2010-5#4)
triploid ginbuna##2##2##(2008-5#2)
triploid##8##1##(2008-5#2)(2009-12#2)(2010-5#4)
tripod##4##1##(1994-12#2)(2008-10#2)
tripodal compound##2##2##(2008-10#2)
tripodal##3##1##(2008-10#3)
tripropylamine##5##1##(2008-10#4)(2010-7#1)
trips##3##1##(2008-12#1)(2013-1#2)
triptan##4##1##(2008-9#4)
triptolide##2##1##(2008-11#1)(2013-8#1)
tris##3##1##(2008-10#3)
tris(2##17##1##(2008-10#17)
tris(2-ethylhexyl) phosphate##3##2##(2008-10#3)
tris(2-ethylhexyl)phosphate (TEHP)##2##2##(2008-10#2)
tris(3##3##1##(2008-10#3)
tris(trimethylsilyl)silanes##2##1##(2009-5#2)
tris-(2##3##1##(2008-10#3)
trisaccharide##3##1##(1994-5#3)
trisaccharides##3##1##(1992-12#2)(1994-5#1)
triseriatus##4##1##(2008-12#4)
trisomic mice##2##2##(2012-2#2)
trisomic##3##1##(1997-2#1)(2012-2#2)
trisomies were##2##2##(1997-4#1)(2010-1#1)
trisomy 18##2##2##(1997-4#1)(2012-3#1)
trisomy 21##6##2##(1991-12#1)(1996-2#1)(1997-4#3)(2012-3#1)
trisomy##13##1##(1991-12#1)(1996-2#1)(1997-2#1)(1997-4#4)(2010-1#1)(2012-3#5)
trisphosphate##15##1##(1990-8#5)(1991-12#3)(1993-3#3)(1993-6#3)(1995-2#1)
tristeza virus (CTV) and##2##4##(2008-10#2)
tristeza virus (CTV)##9##3##(2008-10#9)
tristeza virus##18##2##(2008-10#18)
tristeza##19##1##(2008-10#19)
tristimulus colorimetry##5##2##(2008-10#4)(2008-5#1)
triterpene components##2##2##(2011-3#2)
triterpene##4##1##(2008-11#1)(2011-3#2)(2012-2#1)
triterpenes##5##1##(2008-11#5)
triterpenic derivatives##3##2##(2008-5#3)
triterpenic##4##1##(2008-5#4)
triterpenoid glycosides##2##2##(2010-6#2)
triterpenoid##3##1##(2010-6#2)(2012-2#1)
triterpenoids##4##1##(2012-2#3)(2012-3#1)
trithorax##3##1##(1997-7#3)
tritiated water##3##2##(2008-11#3)
tritiated##8##1##(1993-8#2)(1996-2#1)(2008-11#3)(2008-9#2)
tritici and##2##2##(2008-10#2)
tritici attack##2##2##(2008-10#2)
tritici blotch of wheat##2##4##(2008-10#2)
tritici blotch of##3##3##(2008-10#3)
tritici blotch##8##2##(2008-10#8)
tritici was##2##2##(2008-10#2)
tritici##51##1##(2008-10#51)
tritici)##7##1##(2008-10#7)
tritici-repentis in##3##2##(2008-10#3)
tritici-repentis race##3##2##(2008-10#3)
tritici-repentis were##2##2##(2008-10#2)
tritici-repentis##40##1##(2008-10#40)
triticina from Ethiopia##2##3##(2008-10#2)
triticina from durum wheat from South America##2##7##(2008-10#2)
triticina from durum wheat from##3##5##(2008-10#3)
triticina from durum wheat##4##4##(2008-10#4)
triticina from##10##2##(2008-10#10)
triticina isolates from##2##3##(2008-10#2)
triticina isolates##3##2##(2008-10#3)
triticina on##3##2##(2008-10#3)
triticina##43##1##(2008-10#43)
tritium##6##1##(1991-5#3)(1993-8#1)(1994-5#1)(2008-11#1)
tritocerebral##3##1##(2007-12#3)
tritrophic food##3##2##(2008-9#3)
tritrophic##5##1##(2008-9#4)(2009-8#1)
trityl##2##1##(1992-12#2)
trivalent and##2##2##(2008-10#1)(2008-12#1)
trivalent arsenic##3##2##(2008-10#3)
trivalent cations##5##2##(2008-10#5)
trivalent form##2##2##(2008-10#1)(2008-12#1)
trivalent metal ions##3##3##(1993-6#1)(2008-10#2)
trivalent metal##4##2##(1993-6#1)(2008-10#3)
trivalent state##5##2##(2008-10#5)
trivalent##39##1##(1993-6#1)(1995-5#1)(1997-2#1)(2008-10#32)(2008-12#2)(2008-9#2)
trivial##5##1##(1994-1#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-11#1)
trizma-chloranilate##2##1##(2008-10#2)
trk receptors##3##2##(1996-12#3)
trk##5##1##(1996-12#5)
trkA##6##1##(1996-12#4)(1997-2#2)
trkA-##2##1##(1995-8#2)
trkB##11##1##(1996-12#11)
trkB-##2##1##(1995-8#2)
trkC##3##1##(1996-12#3)
trkC-like proteins IR##2##3##(1995-8#2)
trkC-like proteins##3##2##(1995-8#3)
trkC-like##4##1##(1995-8#4)
trks##2##1##(1996-12#2)
trnL intron##2##2##(2008-12#2)
trocar and sleeve is inserted##2##5##(1991-12#2)
trocar##5##1##(1990-8#1)(1991-12#2)(1995-3#1)(2008-12#1)
trochanter##2##1##(2007-12#1)(2008-9#1)
trochlear nerve##2##2##(2011-2#2)
trolox##4##1##(2008-10#4)
tropeolin##2##1##(2008-10#2)
tropes##2##1##(2009-10#2)
tropharium##2##1##(2007-12#1)(2008-12#1)
trophectoderm##3##1##(2008-11#1)(2008-5#1)(2008-9#1)
trophic action##2##2##(1992-6#1)(1993-3#1)
trophic cascades in terrestrial##2##4##(2008-8#2)
trophic cascades##6##2##(2008-8#6)
trophic guilds##3##2##(2010-8#3)
trophic level##7##2##(2008-8#3)(2008-9#4)
trophic levels##11##2##(2008-8#4)(2008-9#6)(2013-1#1)
trophic structure##2##2##(2008-9#2)
trophic##48##1##(1990-3#1)(1991-12#1)(1992-6#1)(1993-3#1)(1996-12#1)(1997-1#1)(2008-6#1)(2008-7#3)(2008-8#14)(2008-9#14)(2009-8#1)(2010-8#7)(2012-3#1)(2013-1#1)
trophoblast##2##1##(1995-8#1)(2013-1#1)
trophoblastic##3##1##(1995-8#2)(2008-9#1)
trophocytes##2##1##(2007-12#2)
tropic##4##1##(1992-6#1)(2008-10#1)(2008-9#1)(2009-8#1)
tropica in a##2##3##(2012-2#2)
tropica##3##1##(2012-2#3)
tropical and sub-tropical regions##2##4##(1991-11#1)(1994-9#1)
tropical and subtropical areas##2##4##(2008-10#2)
tropical and subtropical##6##3##(2008-10#4)(2008-11#1)(2010-5#1)
tropical and##8##2##(1991-11#1)(1994-9#1)(2008-10#4)(2008-11#1)(2010-5#1)
tropical disease##2##2##(2006-5#1)(2013-8#1)
tropical diseases##5##2##(2011-2#2)(2012-2#3)
tropical environment##2##2##(2008-10#2)
tropical isolates grouped together##2##4##(2008-10#2)
tropical isolates than##2##3##(2008-10#2)
tropical isolates##14##2##(2008-10#14)
tropical medicine and##2##3##(2010-1#2)
tropical medicine##4##2##(2010-1#4)
tropical rain##2##2##(2008-8#1)(2008-9#1)
tropical river humic substances##3##4##(2008-10#3)
tropical understory plants##2##3##(2008-8#2)
tropical##87##1##(1990-8#1)(1991-11#1)(1992-11#2)(1994-9#1)(1996-11#1)(2006-5#1)(2008-1#1)(2008-10#45)(2008-11#2)(2008-5#1)(2008-8#9)(2008-9#3)(2009-8#2)(2010-1#4)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-8#1)
tropicalis and##2##2##(2008-5#2)
tropicalis##11##1##(1990-5#2)(1991-9#4)(1995-3#1)(2008-10#2)(2008-5#2)
tropicamide##2##1##(2008-7#2)
tropics##12##1##(1995-12#2)(2008-10#4)(2010-7#3)(2011-2#2)(2012-3#1)
tropism##4##1##(1992-9#1)(1995-2#1)(2008-5#1)(2013-1#1)
tropisms##5##1##(2008-10#1)(2008-5#2)(2009-8#2)
tropocollagen molecule##2##2##(2009-7#2)
tropocollagen molecules##2##2##(2009-7#2)
tropocollagen##4##1##(2009-7#4)
tropomyosin##7##1##(1992-9#4)(1994-5#1)(1996-8#1)(2010-12#1)
troponin I##14##2##(2008-10#8)(2008-7#1)(2010-12#3)(2010-6#1)(2011-2#1)
troponin T##3##2##(1996-8#1)(2008-3#1)(2008-7#1)
troponin##22##1##(1996-8#1)(2008-10#9)(2008-3#1)(2008-6#1)(2008-7#2)(2010-12#3)(2010-6#1)(2011-2#1)(2012-3#3)
troposphere and##3##2##(2008-3#3)
troposphere##5##1##(2008-2#1)(2008-3#4)
tropospheric water-vapor##3##2##(2008-2#2)(2008-3#1)
tropospheric##10##1##(2008-11#2)(2008-2#2)(2008-3#5)(2012-2#1)
trouble in##2##2##(1990-3#1)(2008-10#1)
trouble##10##1##(1990-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-3#1)
trouble-shooting##2##1##(2008-6#1)(2008-9#1)
troubled##5##1##(1990-8#1)(1993-5#1)(1995-1#1)(1996-3#1)(2008-11#1)
troubles de##2##2##(2008-11#1)(2013-1#1)
troubles##3##1##(2008-11#2)(2013-1#1)
troubleshoot##2##1##(1994-2#1)(2008-11#1)
troubleshooting##3##1##(2008-4#1)(2008-9#1)(2011-2#1)
troublesome##6##1##(1996-11#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-6#1)
trough the##2##2##(2008-9#1)(2012-2#1)
trough##3##1##(2008-10#1)(2008-9#1)(2012-2#1)
troughs##2##1##(2008-10#2)
trout Onchorhynchus##2##2##(2010-8#2)
trout Oncorhynchus##3##2##(2010-8#3)
trout##28##1##(1992-6#2)(1994-11#2)(1994-5#3)(1997-9#4)(2008-11#3)(2008-5#4)(2008-6#2)(2009-6#2)(2010-8#6)
troutCYP1A-CAT construct##2##2##(2008-11#2)
troutCYP1A-CAT##5##1##(2008-11#5)
trouve##2##1##(2013-1#2)
trp##6##1##(1993-12#1)(1994-3#3)(1996-12#1)(2008-10#1)
trpC promoter##2##2##(2008-10#2)
trpC##3##1##(2008-10#2)(2011-1#1)
truckloads exceeding 20 ng/g##2##4##(2008-10#2)
truckloads##3##1##(2008-10#3)
true cut biopsy##2##3##(2011-2#2)
true for patients with##2##4##(1997-8#1)(2010-12#1)
true for the##2##3##(2007-12#1)(2008-11#1)
true for##13##2##(1990-12#1)(1993-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
true in##7##2##(1992-1#1)(1992-9#1)(1994-12#1)(2008-4#1)(2008-8#1)(2010-11#1)(2012-3#1)
true incidence of##2##3##(2008-8#1)(2011-2#1)
true incidence##4##2##(1994-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
true leaf##3##2##(2008-9#3)
true leaves##6##2##(2008-10#6)
true lumen##4##2##(2008-11#4)
true of##2##2##(2008-9#1)(2013-7#1)
true positive##2##2##(1990-6#1)(2008-10#1)
true positives##3##2##(2008-10#1)(2008-12#1)(2009-3#1)
true refusers##2##2##(1991-6#2)
true when the##2##3##(2008-10#1)(2011-3#1)
true##144##1##(1990-12#1)(1990-5#1)(1990-6#3)(1991-5#1)(1991-6#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#10)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#7)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-7#1)(2013-1#4)(2013-7#1)
trueness##2##1##(2008-10#2)
truly##22##1##(1991-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
truncated and##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
truncated derivatives##2##2##(1994-5#2)
truncated forms of##3##3##(1994-11#1)(1995-6#1)(1997-4#1)
truncated mutant##3##2##(2008-9#3)
truncated peptides##3##2##(1995-2#2)(1997-4#1)
truncated##41##1##(1990-7#1)(1991-10#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-2#2)(1995-6#2)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#5)(2010-4#1)(2011-2#1)(2013-8#1)
truncation of the##3##3##(2008-10#2)(2008-2#1)
truncation##5##1##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)
truncations##2##1##(1994-1#1)(2009-6#1)
truncatula##12##1##(2008-10#8)(2009-10#1)(2009-8#2)(2011-2#1)
truncatum##3##1##(2008-10#3)
trunk and breast##2##3##(1994-6#2)
trunk and##8##2##(1994-6#2)(1996-3#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#2)
trunk in the##2##3##(2007-12#1)(2008-10#1)
trunk of the##3##3##(1997-3#1)(2008-12#2)
trunk of##4##2##(1997-3#1)(2008-12#2)(2008-5#1)
trunk strength and stability on##2##5##(2008-12#2)
trunk strength and stability##3##4##(2008-12#3)
trunk##38##1##(1993-9#1)(1994-1#1)(1994-6#2)(1996-3#2)(1997-3#4)(1997-8#1)(2007-12#1)(2008-10#5)(2008-12#6)(2008-5#3)(2008-7#2)(2008-9#1)(2010-6#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
trunks##4##1##(1997-3#1)(2008-10#3)
trust in##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
trust##23##1##(1991-1#1)(1993-11#1)(1993-12#1)(1994-12#1)(1997-3#1)(1997-4#2)(2008-11#4)(2008-12#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2011-9#1)(2013-1#1)(2013-8#2)
trusted##4##1##(1992-1#1)(2008-11#1)(2010-4#1)(2011-2#1)
trustee##4##1##(1992-3#1)(1993-1#1)(1994-1#1)(1996-12#1)
trustees##3##1##(1993-3#1)(1995-3#1)(2012-2#1)
trusting##2##1##(1994-12#1)(2008-12#1)
trusts##3##1##(2008-11#2)(2009-7#1)
trustworthy##4##1##(1992-3#1)(2008-10#2)(2010-10#1)
truth about##3##2##(1995-1#1)(2008-11#1)(2008-8#1)
truth telling in##2##3##(2013-1#2)
truth##7##1##(1994-2#1)(1995-1#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#2)
truths about##2##2##(1991-1#1)(2011-2#1)
try to explain the##2##4##(2008-10#1)(2009-11#1)
try to explain##3##3##(2008-10#1)(2009-11#2)
try to understand how the##2##5##(1992-3#1)(2009-10#1)
try to##22##2##(1991-12#1)(1992-3#1)(1993-6#1)(1994-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#3)(2009-11#2)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
try##24##1##(1991-12#1)(1992-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#3)(2009-11#2)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
trying to develop##2##3##(1994-3#1)(2008-12#1)
trying to prevent##2##3##(2009-12#1)(2010-9#1)
trying to understand##2##3##(1995-1#1)(2009-10#1)
trying to##23##2##(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-9#1)
trying##26##1##(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-3#1)
trypan blue dye exclusion assay##2##5##(2008-11#2)
trypan blue##9##2##(2008-10#1)(2008-11#6)(2010-7#1)(2013-1#1)
trypan##10##1##(2008-10#2)(2008-11#6)(2010-7#1)(2013-1#1)
trypanosomatid parasites of plants##3##4##(2008-10#3)
trypanosomatid parasites##4##2##(2008-10#4)
trypanosome cells##2##2##(1993-9#2)
trypanosome##3##1##(1993-9#3)
trypanosomosis##2##1##(1997-7#2)
trypsin digestion##3##2##(1990-2#1)(1990-5#1)(2008-9#1)
trypsin inhibitor##9##2##(1990-3#1)(1990-5#2)(1994-3#2)(2008-10#4)
trypsin or##2##2##(1995-6#1)(2008-10#1)
trypsin treatment##3##2##(1990-5#2)(2008-7#1)
trypsin##48##1##(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#5)(1993-3#1)(1993-8#2)(1994-3#2)(1994-8#1)(1995-6#2)(1997-1#1)(1997-2#3)(2008-10#10)(2008-11#5)(2008-7#1)(2008-8#4)(2008-9#1)
trypsin)##3##1##(2008-10#3)
trypsin-like serine##2##2##(1995-6#2)
trypsin-like##5##1##(1995-6#2)(2008-5#3)
trypsinization of##2##2##(1990-2#1)(2008-11#1)
trypsinization##3##1##(1990-2#1)(2008-11#2)
trypsins##2##1##(1990-12#2)
tryptase##2##1##(1993-3#1)(2008-7#1)
tryptic digest of##3##3##(1990-8#1)(1997-2#1)(2008-8#1)
tryptic digestion##2##2##(1993-8#2)
tryptic fragments##2##2##(1993-8#1)(2008-10#1)
tryptic phosphopeptide##2##2##(1992-10#1)(1995-2#1)
tryptic##15##1##(1990-8#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-8#3)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-8#1)
tryptophan (Trp)##2##2##(2008-10#1)(2008-11#1)
tryptophan and##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)
tryptophan column##3##2##(2011-2#3)
tryptophan in##2##2##(2008-10#1)(2009-8#1)
tryptophan methyl ester hydrochloride##3##4##(2008-10#3)
tryptophan methyl##4##2##(2008-10#4)
tryptophan residue##3##2##(1992-6#2)(2008-10#1)
tryptophan residues##5##2##(1992-6#3)(1995-2#1)(2008-10#1)
tryptophan was##2##2##(1992-6#1)(2009-8#1)
tryptophan##53##1##(1991-5#1)(1992-6#7)(1995-2#1)(1996-12#1)(2008-10#20)(2008-11#5)(2008-3#4)(2008-8#1)(2009-10#1)(2009-8#4)(2010-6#1)(2011-2#3)(2011-3#2)(2012-2#2)
tryptophan-rich##2##1##(1992-8#1)(1993-12#1)
tryptophane and tyrosine##2##3##(2008-10#2)
tryptophane and##3##2##(2008-10#3)
tryptophane##4##1##(2008-10#3)(2008-9#1)
très##4##1##(2009-10#1)(2013-1#3)
ts##2##1##(1995-9#1)(2008-8#1)
tsetse flies##4##2##(2010-1#1)(2010-4#1)(2013-8#2)
tsetse##6##1##(1997-7#1)(2010-1#1)(2010-4#2)(2013-8#2)
tsp##3##1##(1993-12#1)(1993-9#1)(1995-11#1)
tsunami##4##1##(1990-11#1)(2010-8#1)(2013-1#2)
tsx gene##4##2##(1990-11#4)
tsx##6##1##(1990-11#6)
tub2##2##1##(2008-10#2)
tubal anastomosis##2##2##(1991-3#2)
tubal disease##2##2##(1991-12#1)(1993-1#1)
tubal ectopic pregnancy##2##3##(1993-3#1)(2009-5#1)
tubal obstruction##2##2##(1993-1#2)
tubal occlusion##3##2##(1991-12#2)(1993-1#1)
tubal sterilization##3##2##(1993-3#2)(1995-1#1)
tubal##32##1##(1991-12#3)(1991-3#4)(1992-1#1)(1993-1#5)(1993-12#1)(1993-3#3)(1994-12#5)(1994-3#2)(1995-1#2)(1995-12#1)(1996-3#3)(2009-5#1)(2011-2#1)
tube (PMT)##2##2##(2008-10#2)
tube and##7##2##(2008-10#4)(2008-7#1)(2010-1#1)(2012-12#1)
tube as##2##2##(2008-10#1)(2008-4#1)
tube at##4##2##(2008-10#4)
tube atomizer is##2##3##(2008-10#2)
tube atomizer##7##2##(2008-10#7)
tube cells##2##2##(2009-8#2)
tube filled with##2##3##(2008-10#2)
tube for##5##2##(2008-10#5)
tube formation##2##2##(2010-6#1)(2013-8#1)
tube furnace##2##2##(2008-3#2)
tube growth##9##2##(2008-10#8)(2008-11#1)
tube is##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
tube length##4##2##(2008-10#4)
tube lifetime##5##2##(2008-10#5)
tube of##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
tube packed with##3##3##(2008-10#3)
tube placement##4##2##(2009-5#1)(2010-7#3)
tube voltage##3##2##(1997-8#2)(2013-8#1)
tube was inserted to##2##4##(2010-12#1)(2011-2#1)
tube was##7##2##(1991-3#1)(2008-10#4)(2010-12#1)(2011-2#1)
tube were##2##2##(2008-10#2)
tube with a##2##3##(2008-10#2)
tube with an##2##3##(1994-9#1)(2008-10#1)
tube with##5##2##(1994-9#1)(2008-10#4)
tube##198##1##(1990-12#2)(1990-8#1)(1991-3#3)(1992-1#3)(1992-12#2)(1992-3#1)(1993-1#2)(1993-2#1)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#5)(1995-3#1)(1996-3#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#106)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#3)(2009-11#2)(2009-5#1)(2009-8#6)(2010-1#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#5)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
tube)##2##1##(2008-10#1)(2013-8#1)
tube-like##2##1##(1997-6#1)(2008-7#1)
tuber tissue was##2##3##(2008-10#2)
tuber tissue##3##2##(2008-10#3)
tuber yield##3##2##(2008-10#3)
tuber##20##1##(2008-10#19)(2008-9#1)
tubercle##7##1##(1993-6#1)(1996-12#1)(1997-3#2)(2008-9#1)(2012-2#1)(2013-1#1)
tubercular##6##1##(1995-10#1)(1997-8#2)(2008-7#1)(2010-8#1)(2012-12#1)
tuberculin skin test##2##3##(1990-6#1)(1997-4#1)
tuberculin##8##1##(1990-6#7)(1997-4#1)
tuberculosis (TB) is##2##3##(2010-5#1)(2012-12#1)
tuberculosis (TB)##10##2##(1996-3#4)(2008-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
tuberculosis and##8##2##(1995-2#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-7#2)(2010-5#1)(2012-2#1)
tuberculosis are##2##2##(1995-2#1)(2008-12#1)
tuberculosis at Biosafety Level 3 containment are also discussed##3##9##(2008-9#3)
tuberculosis at##4##2##(2008-9#3)(2011-2#1)
tuberculosis case##2##2##(1996-3#1)(2013-8#1)
tuberculosis control##3##2##(2010-5#1)(2013-8#2)
tuberculosis directly observed therapy##2##4##(1996-3#2)
tuberculosis in a##2##3##(1990-6#1)(2013-1#1)
tuberculosis in children##2##3##(2011-2#1)(2012-3#1)
tuberculosis in patients##2##3##(1996-3#1)(2008-10#1)
tuberculosis in the##2##3##(1995-2#1)(1996-3#1)
tuberculosis in##15##2##(1990-6#1)(1995-2#1)(1996-3#2)(2008-1#1)(2008-10#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
tuberculosis infection is##2##3##(1990-6#2)
tuberculosis infection##7##2##(1990-6#3)(2008-10#2)(2010-11#1)(2011-2#1)
tuberculosis is##4##2##(1995-10#1)(1997-8#1)(2008-12#1)(2012-3#1)
tuberculosis mycolic acids##2##3##(2008-9#2)
tuberculosis patients in##2##3##(2011-2#1)(2013-8#1)
tuberculosis patients##5##2##(1993-11#1)(1996-3#2)(2011-2#1)(2013-8#1)
tuberculosis surveillance##2##2##(2011-2#1)(2013-8#1)
tuberculosis testing and treatment program##2##5##(1997-2#2)
tuberculosis testing and treatment##3##4##(1997-2#3)
tuberculosis the##2##2##(1996-11#1)(2011-2#1)
tuberculosis was##3##2##(2008-10#1)(2012-3#2)
tuberculosis were##2##2##(1995-10#2)
tuberculosis with atlantoaxial dislocation##2##4##(2008-12#2)
tuberculosis with##5##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-12#2)
tuberculosis##189##1##(1990-12#1)(1990-6#6)(1991-3#1)(1993-11#2)(1995-10#6)(1995-2#9)(1995-5#1)(1996-11#7)(1996-3#18)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#2)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#6)(2008-5#1)(2008-7#12)(2008-9#14)(2009-6#5)(2009-7#4)(2010-11#2)(2010-5#4)(2010-8#1)(2011-2#23)(2012-12#3)(2012-2#7)(2012-3#10)(2013-1#10)(2013-8#9)
tuberculosis]##5##1##(1992-2#1)(1996-11#1)(1996-3#1)(2009-5#2)
tuberculous epididymo-orchitis##2##2##(2011-2#2)
tuberculous infection##2##2##(1990-12#1)(1990-6#1)
tuberculous##13##1##(1990-12#1)(1990-6#1)(2008-1#1)(2008-7#2)(2010-1#1)(2011-2#5)(2013-7#2)
tuberis##2##1##(2008-6#2)
tuberosum##6##1##(1993-12#1)(2008-10#5)
tuberous roots##2##2##(2008-11#1)(2008-9#1)
tuberous sclerosis##3##2##(1993-12#1)(1997-8#1)(2010-6#1)
tuberous##5##1##(1993-12#1)(1997-8#1)(2008-11#1)(2008-9#1)(2010-6#1)
tubers and##2##2##(2008-10#1)(2013-8#1)
tubers collected##2##2##(2008-10#2)
tubers examined##2##2##(2008-10#2)
tubers of##3##2##(2008-10#3)
tubers was##3##2##(2008-10#3)
tubers were##6##2##(2008-10#6)
tubers##42##1##(2008-10#41)(2013-8#1)
tubes and##4##2##(1991-1#1)(2008-10#2)(2008-7#1)
tubes from##2##2##(1990-11#1)(2008-10#1)
tubes in##2##2##(1991-3#1)(2008-10#1)
tubes of##6##2##(2008-10#4)(2008-8#2)
tubes on##2##2##(2008-10#2)
tubes were##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
tubes with##2##2##(2008-10#1)(2013-1#1)
tubes##70##1##(1990-11#1)(1991-1#1)(1991-12#2)(1991-3#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#43)(2008-11#1)(2008-12#2)(2008-7#3)(2008-8#3)(2008-9#1)(2012-2#5)(2013-1#4)
tubing##26##1##(1991-3#1)(1992-1#1)(1997-3#3)(2008-10#15)(2008-5#1)(2009-7#1)(2011-1#4)
tubular adenomas##2##2##(2009-1#2)
tubular and##3##2##(1993-2#1)(1995-11#1)(2007-12#1)
tubular atrophy##2##2##(1993-3#1)(2013-8#1)
tubular cells##6##2##(1992-3#1)(1993-11#1)(1995-11#1)(1996-12#1)(2008-6#1)(2011-2#1)
tubular electrode##4##2##(2008-10#4)
tubular epithelial cells##2##3##(1992-3#1)(1994-5#1)
tubular fluid##2##2##(1995-6#2)
tubular interstitial changes##2##3##(1993-2#2)
tubular interstitial##3##2##(1993-2#3)
tubular necrosis in the##2##4##(1994-5#1)(1996-12#1)
tubular necrosis##3##2##(1994-5#1)(1996-12#1)(2012-2#1)
tubular or##2##2##(1993-2#1)(2008-6#1)
tubular structures##2##2##(2008-7#2)
tubular##82##1##(1990-12#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#6)(1993-3#2)(1994-5#4)(1995-11#4)(1995-6#2)(1996-12#2)(1996-2#1)(1996-6#2)(2007-12#4)(2008-1#2)(2008-10#19)(2008-11#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-9#1)(2009-1#4)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
tubule cells##3##2##(1991-5#1)(2008-11#1)(2008-7#1)
tubule##19##1##(1991-5#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-11#4)(2008-12#1)(2008-7#2)(2008-9#2)(2009-10#2)(2011-2#1)(2012-2#1)(2012-4#1)(2013-8#1)
tubules and##3##2##(1994-8#1)(2007-12#1)(2008-12#1)
tubules from##2##2##(1995-6#1)(2008-7#1)
tubules in##2##2##(2008-10#1)(2009-10#1)
tubules with##5##2##(1997-1#1)(2007-12#2)(2008-7#1)(2011-2#1)
tubules##33##1##(1994-8#1)(1995-6#2)(1996-12#1)(1997-1#5)(2007-12#5)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#7)(2008-9#1)(2009-10#2)(2010-5#1)(2011-2#1)(2012-2#2)
tubulin from the budding yeast Saccharomyces cerevisiae##2##7##(1993-8#2)
tubulin polymerization##2##2##(1993-8#1)(2008-8#1)
tubulin##21##1##(1993-6#3)(1993-8#10)(2008-11#2)(2008-8#1)(2009-12#1)(2009-7#2)(2010-7#2)
tubulovesicles##2##1##(1997-1#2)
tuf gene##2##2##(2008-10#2)
tuf##5##1##(2008-10#5)
tuft##2##1##(2007-12#1)(2010-6#1)
tulip##2##1##(2009-12#1)(2013-1#1)
tumefaciens cells present during##2##4##(2008-10#2)
tumefaciens cells##5##2##(2008-10#5)
tumefaciens##15##1##(2008-10#12)(2008-9#1)(2011-2#2)
tumor 14##2##2##(2011-2#2)
tumor and embryonic##2##3##(2009-3#2)
tumor and the##4##3##(1993-1#1)(1993-11#2)(1996-11#1)
tumor and##23##2##(1990-2#1)(1991-8#1)(1993-1#1)(1993-11#2)(1994-12#1)(1995-12#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-3#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
tumor angiogenesis##4##2##(1994-12#1)(2009-3#1)(2011-2#1)(2013-8#1)
tumor antigen##4##2##(1991-12#1)(1993-11#1)(2008-4#1)(2008-8#1)
tumor antigens##3##2##(1991-12#2)(2008-5#1)
tumor are##2##2##(1994-12#1)(2013-1#1)
tumor arising from##2##3##(1992-12#1)(2012-12#1)
tumor arising in the##2##4##(1990-2#1)(2009-1#1)
tumor arising in##3##3##(1990-2#1)(1994-12#1)(2009-1#1)
tumor arising##5##2##(1990-2#1)(1992-12#1)(1994-12#1)(2009-1#1)(2012-12#1)
tumor at##2##2##(1992-1#1)(2013-1#1)
tumor bearing##2##2##(2011-2#1)(2012-2#1)
tumor biology##5##2##(2008-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-3#1)
tumor cell adhesion to##2##4##(2009-3#2)
tumor cell apoptosis##3##3##(2010-1#3)
tumor cell growth in##2##4##(2012-3#1)(2013-1#1)
tumor cell growth##4##3##(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
tumor cell invasion##2##3##(2008-11#2)
tumor cell line##6##3##(1990-12#1)(1994-8#1)(1995-10#1)(1995-6#1)(2008-11#2)
tumor cell lines and##2##4##(1994-5#1)(2008-8#1)
tumor cell lines in##2##4##(1994-5#1)(1995-6#1)
tumor cell lines##17##3##(1990-12#1)(1992-2#1)(1993-9#1)(1994-5#3)(1995-12#1)(1995-6#1)(1997-7#1)(2008-11#3)(2008-8#1)(2008-9#3)(2011-2#1)
tumor cell migration##5##3##(2008-11#1)(2011-2#4)
tumor cell##55##2##(1990-12#2)(1990-5#2)(1991-2#1)(1992-2#1)(1993-11#2)(1993-9#1)(1994-5#3)(1994-8#1)(1995-10#1)(1995-12#1)(1995-6#2)(1997-7#2)(2008-11#10)(2008-5#2)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#4)(2010-1#3)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
tumor cells after##2##3##(1991-2#1)(2008-9#1)
tumor cells and the##2##4##(1992-3#1)(2010-11#1)
tumor cells and##6##3##(1990-5#1)(1992-3#1)(2008-9#1)(2010-11#1)(2013-1#1)(2013-8#1)
tumor cells by##3##3##(2008-11#1)(2008-9#2)
tumor cells in vitro##2##4##(2009-3#1)(2009-4#1)
tumor cells in##6##3##(1990-12#1)(1990-5#1)(2008-11#2)(2009-3#1)(2009-4#1)
tumor cells or##2##3##(1995-2#1)(2008-9#1)
tumor cells to##5##3##(1994-5#1)(2008-11#2)(2008-5#1)(2009-9#1)
tumor cells were##8##3##(1990-2#1)(1990-8#1)(1994-12#1)(1994-5#2)(2008-11#2)(2010-6#1)
tumor cells##111##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#11)(1995-2#2)(1995-6#1)(1997-1#2)(1997-2#3)(1997-7#1)(2008-11#26)(2008-4#4)(2008-5#3)(2008-8#2)(2008-9#13)(2009-3#5)(2009-4#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#4)
tumor classification##2##2##(1994-12#1)(2013-1#1)
tumor development##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2013-8#1)
tumor diagnosis##2##2##(2008-12#1)(2011-2#1)
tumor during##2##2##(1990-6#1)(2011-1#1)
tumor emboli##4##2##(2011-2#4)
tumor engraftment##2##2##(2013-1#2)
tumor foci##2##2##(2010-11#2)
tumor formation in##3##3##(2011-2#1)(2013-1#2)
tumor formation##9##2##(1991-12#1)(2008-10#1)(2009-10#1)(2011-2#2)(2013-1#3)(2013-8#1)
tumor gene##2##2##(1991-10#1)(2007-12#1)
tumor grade##2##2##(2010-5#1)(2011-2#1)
tumor growth and metastasis##6##4##(1994-12#2)(2009-3#3)(2013-8#1)
tumor growth and##12##3##(1994-12#2)(1994-6#1)(2008-9#1)(2009-3#4)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
tumor growth in##3##3##(1990-11#1)(1994-6#1)(2013-7#1)
tumor growth rate##2##3##(1993-11#2)
tumor growth##48##2##(1990-11#1)(1993-1#3)(1993-11#3)(1994-12#2)(1994-6#6)(2008-1#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#5)(2010-1#3)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#5)
tumor had##2##2##(1994-12#1)(2008-12#1)
tumor immunotherapy##5##2##(1994-5#1)(2009-3#2)(2011-2#2)
tumor in a##2##3##(1994-2#1)(2009-11#1)
tumor in all##2##3##(2007-8#1)(2013-1#1)
tumor in the left##2##4##(2008-10#1)(2013-1#1)
tumor in the##6##3##(2008-10#2)(2011-2#1)(2012-3#1)(2013-1#2)
tumor in##17##2##(1992-3#1)(1994-2#1)(1996-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
tumor incidence##3##2##(1990-6#1)(1993-11#1)(2013-1#1)
tumor invasion and metastasis##2##4##(2008-5#1)(2008-8#1)
tumor invasion and##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)
tumor invasion##7##2##(2008-11#2)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
tumor involution##2##2##(1990-12#2)
tumor is##7##2##(1990-12#1)(1992-2#1)(1997-1#3)(2008-12#1)(2009-1#1)
tumor location##2##2##(2008-11#1)(2012-3#1)
tumor lysis syndrome##3##3##(2008-7#3)
tumor malignancy##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
tumor marker##7##2##(1990-8#2)(1991-8#1)(1993-1#2)(2009-4#1)(2011-2#1)
tumor markers##4##2##(1990-8#1)(1991-8#1)(1996-3#1)(2008-10#1)
tumor mass##3##2##(1993-11#1)(2011-2#1)(2013-8#1)
tumor masses##2##2##(2010-7#1)(2011-2#1)
tumor may be##2##3##(1997-1#1)(2012-3#1)
tumor microenvironment##10##2##(2009-3#2)(2010-11#1)(2012-2#1)(2013-1#5)(2013-8#1)
tumor model##2##2##(1993-1#1)(2008-8#1)
tumor models##2##2##(1994-12#1)(2013-1#1)
tumor multiplicity##3##2##(1994-5#2)(2011-2#1)
tumor necrosis factor (TNF)##6##4##(1992-12#1)(1994-8#1)(1997-4#1)(2008-4#1)(2012-3#2)
tumor necrosis factor alpha (TNF)##2##5##(1990-5#1)(1992-7#1)
tumor necrosis factor alpha and##3##5##(1994-8#1)(2008-11#1)(2011-2#1)
tumor necrosis factor alpha##8##4##(1990-5#1)(1992-7#1)(1994-8#1)(2008-11#2)(2008-8#2)(2011-2#1)
tumor necrosis factor##25##3##(1990-5#1)(1992-12#1)(1992-7#2)(1994-8#2)(1996-12#1)(1997-2#1)(1997-4#1)(2008-11#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#2)(2012-3#4)
tumor necrosis factor-alpha (TNF-alpha)##10##4##(1992-8#1)(1995-12#1)(1995-9#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-7#1)(2012-2#1)
tumor necrosis factor-alpha and##3##4##(1995-10#1)(2008-5#1)(2008-7#1)
tumor necrosis factor-alpha##20##3##(1992-8#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#3)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
tumor necrosis factor-α inhibitors##2##4##(2013-1#2)
tumor necrosis factor-α##5##3##(2010-12#1)(2011-2#1)(2013-1#3)
tumor necrosis##56##2##(1990-5#1)(1991-6#2)(1992-12#1)(1992-7#2)(1992-8#2)(1994-8#3)(1995-10#1)(1995-12#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#1)
tumor of infancy was##2##4##(2008-10#2)
tumor of infancy##4##3##(2008-10#4)
tumor of the breast##2##4##(1994-12#1)(1994-6#1)
tumor of the##15##3##(1992-5#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-12#2)(2009-3#3)(2009-5#1)(2011-2#4)(2012-3#1)
tumor of##25##2##(1992-5#1)(1994-12#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-9#1)(2009-3#3)(2009-5#1)(2011-2#5)(2012-3#1)(2013-1#1)
tumor or a##2##3##(2009-1#1)(2010-12#1)
tumor originating from##2##3##(1993-6#1)(2010-12#1)
tumor position##5##2##(2009-11#5)
tumor presence##2##2##(2012-3#2)
tumor progression##14##2##(1991-2#1)(1991-5#1)(1994-8#1)(2008-11#1)(2009-3#4)(2009-6#1)(2011-2#2)(2012-3#2)(2013-1#1)
tumor promoter##5##2##(1991-5#1)(1993-8#1)(2007-12#2)(2012-3#1)
tumor promoting##3##2##(1994-11#3)
tumor promotion in##3##3##(1992-8#2)(1993-8#1)
tumor promotion##4##2##(1992-8#2)(1993-8#2)
tumor protein##2##2##(2010-12#2)
tumor recurrence##5##2##(2008-2#1)(2009-1#1)(2011-2#2)(2013-8#1)
tumor regression in##3##3##(1992-12#1)(2009-4#1)(2011-2#1)
tumor regression##8##2##(1991-8#2)(1992-12#2)(1994-5#1)(2008-11#1)(2009-4#1)(2011-2#1)
tumor remission##2##2##(1991-8#1)(2013-8#1)
tumor resection##10##2##(1997-7#1)(2010-3#1)(2011-2#5)(2012-3#2)(2013-1#1)
tumor response and##2##3##(1993-9#1)(2013-1#1)
tumor response was##2##3##(1991-2#1)(1991-6#1)
tumor response##5##2##(1991-2#1)(1991-6#1)(1992-2#1)(1993-9#1)(2013-1#1)
tumor samples##2##2##(2008-9#1)(2010-7#1)
tumor should be##2##3##(2008-10#1)(2008-5#1)
tumor showed##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
tumor sites##2##2##(2008-11#2)
tumor size and##2##3##(1991-8#1)(1994-12#1)
tumor size##9##2##(1990-12#1)(1990-8#1)(1991-8#1)(1994-12#1)(1997-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
tumor specimens##2##2##(1994-12#1)(2012-3#1)
tumor spheroids##3##2##(2008-11#3)
tumor stage##6##2##(1990-12#2)(1991-6#1)(1991-8#1)(2008-1#1)(2008-2#1)
tumor suppression##3##2##(2011-2#2)(2013-1#1)
tumor suppressor and##2##3##(1994-5#1)(2008-9#1)
tumor suppressor gene##16##3##(1990-12#1)(1991-10#1)(1994-9#1)(2008-10#1)(2008-9#3)(2009-9#2)(2011-2#5)(2013-1#2)
tumor suppressor genes##9##3##(1990-12#1)(1993-12#1)(1997-2#1)(2008-7#1)(2011-2#5)
tumor suppressor proteins##2##3##(1995-6#1)(2008-11#1)
tumor suppressor##43##2##(1990-12#2)(1991-10#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#4)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#5)(2009-9#2)(2011-2#13)(2012-2#1)(2013-1#5)(2013-8#1)
tumor targeting##4##2##(1993-11#2)(2010-6#1)(2012-2#1)
tumor that##2##2##(2009-1#1)(2013-8#1)
tumor therapy##2##2##(1991-2#1)(2013-8#1)
tumor thrombus in the##2##4##(2011-2#2)
tumor thrombus in##3##3##(2011-2#3)
tumor thrombus##4##2##(2011-2#4)
tumor tissue##9##2##(1990-2#1)(1992-3#1)(1993-11#1)(1994-2#1)(1997-8#1)(2009-4#1)(2010-12#2)(2012-2#1)
tumor tissues##4##2##(2008-11#1)(2008-9#2)(2010-7#1)
tumor to##3##2##(1990-6#1)(2012-12#1)(2012-3#1)
tumor type##2##2##(1997-7#1)(2011-2#1)
tumor types##6##2##(1991-8#1)(1997-8#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
tumor uptake##4##2##(2010-6#2)(2013-1#2)
tumor vascularization##2##2##(2008-11#2)
tumor virus##4##2##(1994-11#2)(1994-12#1)(2008-10#1)
tumor volume##3##2##(2009-2#2)(2010-11#1)
tumor volumes##2##2##(1994-12#1)(2013-1#1)
tumor was##26##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-8#2)(1992-2#1)(1993-11#1)(2008-10#1)(2008-12#5)(2009-1#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
tumor weight##2##2##(2008-8#1)(2011-2#1)
tumor were##3##2##(1991-8#1)(2008-10#1)(2012-3#1)
tumor with a##6##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-3#1)
tumor with the##2##3##(1994-12#1)(2013-1#1)
tumor with##19##2##(1993-3#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2009-1#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#2)
tumor##969##1##(1990-11#2)(1990-12#12)(1990-2#9)(1990-3#1)(1990-5#7)(1990-6#10)(1990-8#10)(1990-9#1)(1991-10#3)(1991-12#8)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#4)(1991-8#14)(1992-1#3)(1992-12#5)(1992-2#6)(1992-3#4)(1992-5#3)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#9)(1993-11#23)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#3)(1994-11#5)(1994-12#25)(1994-2#3)(1994-3#1)(1994-5#23)(1994-6#11)(1994-8#8)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#4)(1995-2#5)(1995-6#7)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#9)(1997-2#5)(1997-3#2)(1997-4#1)(1997-7#6)(1997-8#6)(2007-11#1)(2007-12#11)(2007-8#3)(2008-1#6)(2008-10#32)(2008-11#74)(2008-12#23)(2008-2#3)(2008-4#10)(2008-5#11)(2008-7#8)(2008-8#18)(2008-9#42)(2009-1#10)(2009-10#3)(2009-11#10)(2009-12#5)(2009-2#2)(2009-3#32)(2009-4#9)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#8)(2010-11#8)(2010-12#12)(2010-2#2)(2010-3#4)(2010-5#2)(2010-6#12)(2010-7#8)(2010-8#1)(2011-1#3)(2011-2#107)(2012-12#3)(2012-2#15)(2012-3#30)(2013-1#89)(2013-7#4)(2013-8#40)
tumor)##2##1##(2008-4#1)(2010-3#1)
tumor-associated antigen##3##2##(1995-9#1)(2008-11#2)
tumor-associated antigens##4##2##(1993-11#1)(2008-11#1)(2009-3#1)(2011-2#1)
tumor-associated##11##1##(1993-11#1)(1994-12#1)(1994-5#1)(1995-9#1)(2008-11#5)(2009-3#1)(2011-2#1)
tumor-bearing mice##8##2##(1994-3#1)(2008-11#1)(2008-8#2)(2008-9#2)(2013-1#1)(2013-8#1)
tumor-bearing##11##1##(1990-2#1)(1994-3#1)(2008-11#1)(2008-8#2)(2008-9#2)(2010-1#1)(2013-1#1)(2013-8#2)
tumor-infiltrating##2##1##(1994-5#1)(2013-1#1)
tumor-promoting##3##1##(1993-8#1)(2010-4#1)(2013-1#1)
tumor-related##2##1##(1990-12#1)(2010-12#1)
tumor-selective##2##1##(1994-5#1)(2010-7#1)
tumor-specific##8##1##(1993-8#1)(1994-5#3)(2008-5#1)(2008-9#1)(2013-1#2)
tumor-suppressor##2##1##(2008-9#1)(2012-2#1)
tumor/nontumor##2##1##(1993-11#2)
tumor]##2##1##(1994-5#1)(1996-3#1)
tumoral spheroids##2##2##(2011-2#2)
tumoral##6##1##(1991-6#2)(2011-2#3)(2012-2#1)
tumorigenesis induced by PEUs##2##4##(2008-11#2)
tumorigenesis induced by biomaterials##2##4##(2008-11#2)
tumorigenesis induced by##4##3##(2008-11#4)
tumorigenesis of##2##2##(1995-10#1)(2011-2#1)
tumorigenesis##25##1##(1990-6#2)(1992-8#1)(1992-9#1)(1994-12#1)(1995-10#1)(1995-9#4)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#3)(2012-12#1)(2013-1#2)
tumorigenic cell lines##2##3##(1997-1#2)
tumorigenic cell##3##2##(1997-1#3)
tumorigenic potential##2##2##(2008-11#1)(2009-3#1)
tumorigenic##12##1##(1990-8#1)(1993-1#1)(1994-5#1)(1995-11#1)(1995-9#1)(1997-1#3)(2008-10#1)(2008-11#1)(2009-3#2)
tumorigenicity of##2##2##(1990-12#1)(1993-1#1)
tumorigenicity##4##1##(1990-12#1)(1993-1#1)(2008-9#1)(2013-1#1)
tumorous lymphoblasts##2##2##(2008-5#2)
tumorous##4##1##(2008-11#1)(2008-5#2)(2013-8#1)
tumors and its##2##3##(2008-11#1)(2012-12#1)
tumors and the##3##3##(1992-12#1)(2008-4#1)(2012-2#1)
tumors and##25##2##(1990-12#1)(1990-8#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
tumors are also##2##3##(2008-4#1)(2008-7#1)
tumors are rare##2##3##(1992-9#1)(2013-1#1)
tumors are##19##2##(1992-9#2)(1994-2#1)(1996-11#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
tumors as well as##2##4##(2009-11#1)(2011-2#1)
tumors as well##3##3##(2009-11#1)(2011-2#2)
tumors as##4##2##(2009-11#1)(2011-2#2)(2013-8#1)
tumors by endoscopic ultrasonography##2##4##(1992-7#1)(2013-1#1)
tumors by##7##2##(1992-7#1)(1993-1#1)(1994-12#1)(1994-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
tumors can be##2##3##(2008-11#1)(2010-11#1)
tumors can##4##2##(2008-11#2)(2010-11#1)(2011-2#1)
tumors composed of##2##3##(2011-2#1)(2013-1#1)
tumors developing in##2##3##(2011-2#1)(2013-1#1)
tumors did not##2##3##(1993-11#1)(2008-10#1)
tumors found in##2##3##(1990-2#1)(1994-6#1)
tumors from patients with##2##4##(1993-11#2)
tumors from##5##2##(1993-11#3)(2010-1#1)(2013-1#1)
tumors had a##2##3##(2012-3#1)(2013-1#1)
tumors had##4##2##(1991-2#1)(1993-1#1)(2012-3#1)(2013-1#1)
tumors have##5##2##(1993-11#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
tumors in adults##2##3##(2008-2#1)(2013-8#1)
tumors in nude mice##2##4##(1993-1#1)(2008-8#1)
tumors in the##9##3##(1990-9#1)(1993-11#1)(2008-11#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-3#1)
tumors in vivo##2##3##(1992-8#1)(1994-5#1)
tumors in##33##2##(1990-9#2)(1991-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-9#1)(1994-2#1)(1994-5#2)(1995-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
tumors is a##2##3##(1997-7#1)(2011-2#1)
tumors is##9##2##(1991-2#1)(1997-7#2)(1997-8#2)(2008-7#1)(2009-6#1)(2011-2#1)(2013-7#1)
tumors may##3##2##(1997-7#1)(1997-8#1)(2009-5#1)
tumors of other##2##3##(1990-2#1)(1992-12#1)
tumors of the##15##3##(1990-5#2)(1990-9#1)(1991-8#1)(1992-5#1)(1994-6#1)(1995-11#1)(2007-8#2)(2008-11#1)(2010-3#1)(2012-12#2)(2013-1#1)(2013-8#1)
tumors of##32##2##(1990-2#2)(1990-5#2)(1990-9#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#2)(2009-4#1)(2010-3#1)(2010-5#2)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
tumors that are##3##3##(1993-11#1)(2011-2#2)
tumors that occur##2##3##(1990-12#1)(2012-3#1)
tumors that##13##2##(1990-12#1)(1993-11#1)(2008-10#2)(2010-6#1)(2011-2#7)(2012-3#1)
tumors to the##2##3##(1992-10#1)(2011-2#1)
tumors to##5##2##(1992-10#1)(2011-2#2)(2013-7#2)
tumors was##3##2##(1990-6#1)(1993-11#1)(2013-1#1)
tumors were observed in##2##4##(1994-5#1)(2008-10#1)
tumors were observed##3##3##(1992-5#1)(1994-5#1)(2008-10#1)
tumors were studied##2##3##(1990-6#1)(2009-11#1)
tumors were##20##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-6#1)(1992-5#1)(1993-1#3)(1994-12#1)(1994-5#2)(1997-1#1)(2008-10#2)(2009-11#1)(2013-1#3)(2013-8#1)
tumors with high##2##3##(1993-11#1)(2010-6#1)
tumors with respect to##2##4##(2009-4#1)(2011-1#1)
tumors with##18##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-1#1)(1993-11#2)(2008-11#1)(2008-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#5)
tumors##432##1##(1990-11#3)(1990-12#6)(1990-2#9)(1990-3#1)(1990-5#2)(1990-6#7)(1990-8#2)(1990-9#3)(1991-12#4)(1991-2#8)(1991-3#1)(1991-6#2)(1991-8#4)(1992-1#2)(1992-10#1)(1992-12#3)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#8)(1993-1#11)(1993-11#15)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#9)(1994-2#2)(1994-5#10)(1994-6#3)(1994-8#1)(1995-11#1)(1995-2#4)(1995-9#1)(1996-10#1)(1996-11#1)(1997-1#3)(1997-7#4)(1997-8#9)(2007-11#1)(2007-12#3)(2007-8#3)(2008-10#14)(2008-11#24)(2008-12#5)(2008-2#4)(2008-4#6)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#7)(2009-11#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#3)(2010-11#3)(2010-12#6)(2010-3#3)(2010-5#2)(2010-6#2)(2010-7#5)(2011-1#2)(2011-2#69)(2012-12#5)(2012-2#7)(2012-3#21)(2013-1#44)(2013-7#4)(2013-8#12)
tumors]##8##1##(1990-9#1)(1991-3#1)(1991-6#1)(1993-2#1)(1996-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
tumour and##8##2##(1991-11#1)(1997-3#1)(2008-10#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-7#1)
tumour bed##2##2##(2011-2#2)
tumour cell line##5##3##(1990-6#2)(2008-11#3)
tumour cell##8##2##(1990-6#2)(1994-3#1)(1997-7#1)(2008-11#4)
tumour cells and##2##3##(2011-2#1)(2013-7#1)
tumour cells##11##2##(1990-6#2)(1991-6#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#2)(2013-7#1)(2013-8#1)
tumour excision##2##2##(1995-5#1)(2008-7#1)
tumour formation##2##2##(2009-4#1)(2011-3#1)
tumour grade##4##2##(2011-2#4)
tumour growth##3##2##(1993-8#1)(2008-7#2)
tumour in the##5##3##(2008-12#1)(2008-7#4)
tumour in##10##2##(2008-12#1)(2008-7#5)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
tumour induced by##2##3##(1995-11#1)(2008-5#1)
tumour is a##3##3##(1993-3#1)(2008-7#1)(2012-2#1)
tumour is##5##2##(1993-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
tumour kill##4##2##(2008-7#4)
tumour mimics##2##2##(2012-2#2)
tumour necrosis factor-alpha##2##3##(1996-12#1)(2008-7#1)
tumour necrosis##7##2##(1996-12#1)(1996-2#2)(2008-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
tumour of the cystic duct##2##5##(2008-12#2)
tumour of the##11##3##(2008-10#2)(2008-12#2)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
tumour of##15##2##(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
tumour progression##2##2##(2013-1#2)
tumour removal##2##2##(2008-7#2)
tumour size##5##2##(1992-5#1)(1995-5#1)(1997-3#1)(1997-8#1)(2011-2#1)
tumour spread##4##2##(2008-1#1)(2012-2#3)
tumour suppressor genes##2##3##(2009-4#1)(2011-2#1)
tumour suppressor##3##2##(1997-7#1)(2009-4#1)(2011-2#1)
tumour types##4##2##(1995-2#1)(2008-2#1)(2011-2#1)(2013-1#1)
tumour volume##3##2##(1997-4#2)(2011-3#1)
tumour was##9##2##(1991-6#1)(2008-7#4)(2011-2#1)(2012-12#2)(2012-2#1)
tumour##215##1##(1990-11#2)(1990-5#4)(1990-6#5)(1991-11#1)(1991-5#1)(1991-6#5)(1991-9#1)(1992-5#3)(1992-9#1)(1993-3#4)(1993-8#2)(1994-3#1)(1995-11#1)(1995-2#2)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#2)(2008-1#2)(2008-10#13)(2008-11#8)(2008-12#4)(2008-2#3)(2008-5#4)(2008-7#49)(2008-9#3)(2009-4#4)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#26)(2011-3#5)(2012-12#7)(2012-2#13)(2013-1#7)(2013-7#3)(2013-8#5)
tumour-associated##2##1##(1993-2#2)
tumourigenesis##2##1##(2011-2#1)(2013-1#1)
tumourous##2##1##(2008-5#1)(2008-7#1)
tumours (n=4)##3##2##(2008-12#3)
tumours and the##2##3##(1997-3#1)(2008-1#1)
tumours and##10##2##(1991-6#1)(1992-11#2)(1994-11#1)(1997-2#1)(1997-3#2)(2008-1#1)(2011-2#1)(2012-2#1)
tumours are##6##2##(1990-2#1)(1991-6#1)(2008-1#1)(2008-2#1)(2008-7#2)
tumours display##2##2##(2008-11#2)
tumours from##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
tumours had raised##2##3##(1992-11#2)
tumours have been##2##3##(1995-2#1)(2008-7#1)
tumours in a##2##3##(1990-12#1)(2012-3#1)
tumours in the##3##3##(1997-6#1)(2012-2#1)(2013-1#1)
tumours in##9##2##(1990-12#1)(1997-6#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
tumours is##4##2##(1990-2#1)(1991-6#1)(2008-2#1)(2011-3#1)
tumours of the##4##3##(1994-9#1)(2008-7#1)(2011-2#1)(2012-2#1)
tumours of##5##2##(1994-3#1)(1994-9#1)(2008-7#1)(2011-2#1)(2012-2#1)
tumours on the##2##3##(1991-6#1)(2011-3#1)
tumours that##2##2##(2012-2#1)(2013-1#1)
tumours was found##2##3##(1991-6#1)(1992-11#1)
tumours was##5##2##(1991-6#2)(1992-11#1)(2008-7#2)
tumours were##4##2##(1990-12#2)(2008-7#1)(2011-2#1)
tumours when##2##2##(2008-7#1)(2011-2#1)
tumours with##3##2##(1992-9#1)(2008-5#1)(2011-3#1)
tumours##152##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#1)(1991-11#1)(1991-6#9)(1991-9#3)(1992-11#10)(1992-9#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-2#2)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#8)(2008-10#2)(2008-11#5)(2008-12#6)(2008-2#5)(2008-5#5)(2008-7#23)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#21)(2011-3#3)(2012-12#3)(2012-2#10)(2012-3#2)(2013-1#6)
tuna fish##2##2##(2011-2#2)
tuna##4##1##(1994-5#2)(2011-2#2)
tunability of the##2##3##(2008-10#1)(2008-2#1)
tunability of##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
tunability##10##1##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)
tunable continuous-wave##2##2##(2008-2#1)(2008-3#1)
tunable control over the##3##4##(2008-12#3)
tunable control over##4##3##(2008-12#4)
tunable diode laser spectrometer##2##4##(2008-3#2)
tunable diode laser##3##3##(2008-3#3)
tunable diode lasers##2##3##(2008-3#2)
tunable diode##5##2##(2008-3#5)
tunable filter##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
tunable from##2##2##(2008-2#1)(2008-3#1)
tunable laser##3##2##(2008-3#3)
tunable output power##2##3##(2008-2#2)
tunable output##4##2##(2008-2#3)(2008-3#1)
tunable over##3##2##(2007-11#1)(2008-2#2)
tunable##65##1##(2007-11#2)(2007-12#3)(2008-10#7)(2008-12#4)(2008-2#19)(2008-3#29)(2009-8#1)
tundra##2##1##(2008-9#1)(2011-2#1)
tune the##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
tune##9##1##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-8#1)
tuned over##3##2##(2007-12#1)(2008-3#2)
tuned the##2##2##(2008-3#2)
tuned to##6##2##(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2013-1#1)
tuned##22##1##(1992-12#1)(2007-11#1)(2007-12#3)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2013-1#1)
tungro disease##2##2##(2008-10#2)
tungro##5##1##(2008-10#5)
tungstate##4##1##(2007-12#1)(2008-10#3)
tungsten coil atomizer##5##3##(2008-10#5)
tungsten coil electrothermal atomic absorption spectrometry##6##6##(2008-10#6)
tungsten coil electrothermal atomic absorption##7##5##(2008-10#7)
tungsten coil##15##2##(2008-10#15)
tungsten electrode##2##2##(2008-10#2)
tungsten in##6##2##(2008-10#6)
tungsten oxide##3##2##(2008-10#3)
tungsten oxide-based##2##2##(2008-10#2)
tungsten plus noble metal##2##4##(2008-10#2)
tungsten wire preconcentration##2##3##(2008-10#2)
tungsten wire##10##2##(2008-10#9)(2009-5#1)
tungsten with##2##2##(2008-10#2)
tungsten##64##1##(2008-10#62)(2009-5#1)(2010-4#1)
tungsten(VI)##5##1##(2008-10#5)
tunic granulocytes##3##2##(2008-7#3)
tunic##10##1##(2008-5#2)(2008-7#8)
tunica vaginalis##2##2##(2008-10#2)
tunica##6##1##(2008-10#2)(2008-11#1)(2009-10#3)
tunicamycin##5##1##(1993-6#1)(1994-8#1)(2008-11#1)(2013-1#2)
tuning and spectral properties of distributed feedback##2##7##(2008-3#2)
tuning and##4##2##(2008-3#3)(2008-9#1)
tuning curve##2##2##(1996-2#1)(2008-11#1)
tuning curves##2##2##(2008-11#1)(2008-8#1)
tuning in##2##2##(2007-12#1)(2008-11#1)
tuning of the##4##3##(2007-12#1)(2008-3#2)(2008-8#1)
tuning of##8##2##(2007-12#1)(2008-11#1)(2008-3#3)(2008-8#2)(2011-2#1)
tuning properties##2##2##(2008-11#2)
tuning range of##2##3##(2008-3#2)
tuning range##5##2##(2008-2#2)(2008-3#3)
tuning the##2##2##(2007-12#1)(2008-10#1)
tuning width##2##2##(2008-11#1)(2008-2#1)
tuning##48##1##(1996-2#2)(2007-12#4)(2008-10#1)(2008-11#9)(2008-2#7)(2008-3#17)(2008-6#1)(2008-8#3)(2008-9#3)(2011-2#1)
tunnel diode##5##2##(2008-3#5)
tunnel infection##3##2##(2011-2#2)(2011-3#1)
tunnel length from 2##2##4##(2013-1#2)
tunnel length##3##2##(2013-1#3)
tunnel surface area##2##3##(2013-1#2)
tunnel surface##3##2##(2013-1#3)
tunnel syndrome##17##2##(1996-2#1)(2008-12#6)(2008-9#8)(2010-8#2)
tunnel##60##1##(1991-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#7)(2008-3#8)(2008-9#18)(2009-10#2)(2009-6#1)(2010-8#2)(2011-2#3)(2011-3#1)(2013-1#11)
tunneling cantilevers##2##2##(2008-3#2)
tunneling microscope (STM)##2##3##(2008-8#1)(2010-7#1)
tunneling microscope##9##2##(1990-11#1)(1991-5#1)(2007-12#3)(2008-3#1)(2008-8#2)(2010-7#1)
tunneling spectroscopy##2##2##(2010-7#2)
tunneling##23##1##(1990-11#1)(1990-12#1)(1991-5#1)(1992-11#3)(2007-12#5)(2008-10#1)(2008-3#5)(2008-8#2)(2010-7#4)
tunnels##12##1##(2008-9#1)(2009-10#7)(2011-2#1)(2013-1#3)
turanose##2##1##(1992-12#2)
turbid coastal and inland waters##2##5##(2008-3#2)
turbid media##4##2##(1994-2#1)(2008-3#2)(2009-10#1)
turbid medium##5##2##(2008-3#5)
turbid##17##1##(1994-2#1)(1994-3#1)(2008-10#1)(2008-3#13)(2009-10#1)
turbidimetric determination of##2##3##(2008-10#2)
turbidimetric##4##1##(2008-10#3)(2008-12#1)
turbidity of the##4##3##(1990-12#1)(2008-10#3)
turbidity of##5##2##(1990-12#1)(2008-10#3)(2009-9#1)
turbidity##19##1##(1990-12#1)(2008-10#10)(2008-3#1)(2008-8#1)(2009-6#2)(2009-9#4)
turbimetric##2##1##(2009-9#2)
turbinate region##2##2##(2008-11#1)(2013-1#1)
turbo##2##1##(2011-2#2)
turbot Psetta maxima red blood cells##2##6##(2010-8#2)
turbot##7##1##(2010-5#5)(2010-8#2)
turbulence outer scale##2##3##(2008-3#2)
turbulence parameters##2##2##(2008-3#2)
turbulence promoter##2##2##(2008-7#2)
turbulence##25##1##(1992-11#1)(1992-8#1)(1993-5#1)(2008-12#1)(2008-3#15)(2008-7#2)(2008-8#2)(2012-2#1)(2013-1#1)
turbulence-induced index of refraction fluctuations##2##5##(2008-3#2)
turbulent diffusion is too##2##4##(2008-8#2)
turbulent diffusion##3##2##(2008-8#3)
turbulent flow##2##2##(2008-3#1)(2008-9#1)
turbulent flows##3##2##(2008-3#2)(2008-9#1)
turbulent patterns##3##2##(2008-3#3)
turbulent##19##1##(1993-12#1)(2008-3#10)(2008-7#1)(2008-8#4)(2008-9#3)
turcica##8##1##(1991-6#1)(2008-10#6)(2013-1#1)
turcicum##2##1##(2008-10#2)
turcicum)##2##1##(2008-10#2)
turf grass##2##2##(2008-10#2)
turf on##2##2##(2008-10#1)(2013-1#1)
turf##16##1##(1993-5#1)(2008-10#10)(2008-11#2)(2013-1#3)
turfgrass##4##1##(2008-10#4)
turfgrasses##4##1##(2008-10#4)
turgidiscabies##5##1##(2008-10#5)
turgidum no##2##2##(2008-10#2)
turgidum sp##3##2##(2008-10#3)
turgidum subsp##4##2##(2012-3#4)
turgidum##11##1##(2008-10#5)(2008-8#1)(2012-3#5)
turgidum)##2##1##(2008-10#2)
turkey embryos##4##2##(2008-5#4)
turkey poults##4##2##(2008-5#4)
turkey##11##1##(1992-6#1)(2007-8#1)(2008-5#9)
turkeys##3##1##(2007-8#3)
turkmenica##3##1##(2011-2#3)
turmeric feeding on brain##2##4##(1994-8#2)
turmeric##8##1##(1994-8#7)(2008-11#1)
turn containing Cys-34##2##3##(1994-5#2)
turn is##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)
turn of the##5##3##(1990-12#1)(1997-3#1)(2008-9#1)(2010-1#1)(2011-2#1)
turn of##6##2##(1990-12#1)(1997-3#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
turn off##2##2##(1995-2#1)(1995-6#1)
turn out to be##2##4##(2013-1#2)
turn over##2##2##(2008-8#1)(2011-2#1)
turn to##4##2##(1992-3#1)(1992-8#1)(2008-10#1)(2010-2#1)
turn##137##1##(1990-12#1)(1990-2#1)(1990-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#4)(1995-12#2)(1995-2#4)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#20)(2008-11#11)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#10)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#6)(2013-1#7)(2013-7#2)(2013-8#1)
turnaroud time##2##2##(2013-1#2)
turnaround time (TAT)##2##3##(2010-6#1)(2011-2#1)
turnaround time##3##2##(2008-1#1)(2010-6#1)(2011-2#1)
turnaround##5##1##(1994-9#1)(2008-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
turned on##2##2##(2008-10#2)
turned out to be a##2##5##(1997-6#1)(2008-11#1)
turned out to be##14##4##(1990-3#1)(1990-5#1)(1991-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2010-5#1)(2011-2#1)(2013-1#1)
turned out to##15##3##(1990-3#1)(1990-5#1)(1991-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2010-5#1)(2011-2#1)(2013-1#1)
turned out##16##2##(1990-3#2)(1990-5#1)(1991-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2010-5#1)(2011-2#1)(2013-1#1)
turned to##7##2##(1991-8#1)(1995-12#1)(1996-12#1)(2008-11#2)(2009-12#1)(2010-1#1)
turned##37##1##(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-8#2)(1992-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#6)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-5#2)(2011-2#1)(2013-1#1)
turner##2##1##(2009-12#2)
turning into##3##2##(2008-9#3)
turning movement##2##2##(1993-3#2)
turning point##2##2##(2008-11#1)(2008-12#1)
turning to##2##2##(2008-11#1)(2009-11#1)
turning##16##1##(1993-3#2)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#5)(2009-10#1)(2009-11#1)
turnings##4##1##(2008-10#4)
turnip mosaic potyvirus##2##3##(2008-10#2)
turnip mosaic##5##2##(2008-10#5)
turnip yellow mosaic virus##2##4##(1997-3#2)
turnip##14##1##(1997-3#3)(2008-10#10)(2009-8#1)
turnover and regional attrition among physiotherapists in##2##7##(1994-3#2)
turnover and regional attrition##4##4##(1994-3#4)
turnover and##11##2##(1991-12#1)(1993-3#1)(1994-3#5)(2007-12#1)(2008-11#1)(2011-2#2)
turnover for##2##2##(2008-10#1)(2008-3#1)
turnover in the olfactory organ of##2##6##(2007-12#2)
turnover in the##5##3##(1992-10#2)(2007-12#2)(2008-10#1)
turnover in##11##2##(1991-2#1)(1992-10#2)(1992-9#1)(2007-12#3)(2008-10#2)(2008-11#1)(2013-1#1)
turnover is##4##2##(1996-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
turnover markers##3##2##(2010-10#1)(2011-2#1)(2013-8#1)
turnover of the##3##3##(1992-1#1)(1993-8#1)(2008-10#1)
turnover of##17##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2012-2#1)(2013-1#1)
turnover rate##6##2##(1991-2#1)(1995-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)
turnover rates##2##2##(1991-2#1)(2008-10#1)
turnover##92##1##(1990-2#3)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-3#6)(1995-11#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#3)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#3)(2013-8#2)
turns out that##2##3##(2008-10#1)(2013-8#1)
turns out to be##6##4##(2008-10#2)(2008-9#1)(2009-5#1)(2012-2#2)
turns out##8##2##(2008-10#3)(2008-9#1)(2009-5#1)(2012-2#2)(2013-8#1)
turns to##3##2##(2008-9#1)(2010-8#1)(2011-1#1)
turns##19##1##(1993-2#1)(1995-12#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
turtle##4##1##(2008-8#2)(2013-1#2)
tussilaginis##2##1##(2008-10#2)
tutor role##3##2##(2008-11#3)
tutor##9##1##(1994-12#1)(2008-11#6)(2008-12#2)
tutorial support##7##2##(2008-11#7)
tutorial##15##1##(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#7)(2008-12#1)(2009-2#1)
tutorials##2##1##(1991-3#1)(2008-11#1)
tutors to##2##2##(2008-12#2)
tutors##7##1##(2008-10#1)(2008-11#2)(2008-12#4)
tweezer-type dithiocarbamoyl##2##2##(2008-10#2)
tweezer-type##5##1##(2008-10#5)
tweezers to##2##2##(2009-12#1)(2012-2#1)
tweezers##10##1##(2008-10#2)(2008-8#1)(2009-12#4)(2009-5#2)(2012-2#1)
twelve species of##2##3##(2008-8#2)
twelve##26##1##(1991-6#1)(1993-2#2)(1994-6#1)(1995-2#1)(1996-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#4)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#2)(2013-1#2)(2013-7#1)
twentieth century##8##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#3)(2011-2#1)(2012-12#1)
twentieth##13##1##(2008-10#2)(2008-12#1)(2008-8#1)(2010-1#6)(2011-2#1)(2012-12#1)(2013-1#1)
twenty years ago##2##3##(1993-12#1)(2011-2#1)
twenty years##8##2##(1991-3#1)(1992-1#1)(1993-12#1)(1995-12#1)(1996-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
twenty##20##1##(1990-3#1)(1991-2#1)(1991-3#2)(1992-1#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#2)(2013-8#1)
twenty-first century##5##2##(1994-2#1)(1997-1#3)(2008-12#1)
twenty-five##5##1##(1990-3#1)(1993-2#1)(2008-7#1)(2010-12#1)(2012-12#1)
twenty-four hours##2##2##(1990-5#1)(2008-9#1)
twenty-four##3##1##(1990-3#1)(1990-5#1)(2008-9#1)
twenty-one##2##1##(1991-2#1)(1996-1#1)
twenty-seven##2##1##(1996-8#1)(2008-10#1)
twenty-six##3##1##(2008-10#1)(2008-12#1)(2012-3#1)
twenty-two##2##1##(2008-10#1)(2008-7#1)
twice a day for eight##2##5##(1996-12#1)(2013-1#1)
twice a day##4##3##(1993-1#1)(1996-12#1)(2011-2#1)(2013-1#1)
twice a week for##3##4##(2008-10#1)(2008-11#1)(2010-1#1)
twice a week##4##3##(2008-10#1)(2008-11#1)(2010-1#1)(2013-1#1)
twice a year##2##3##(1994-9#1)(2013-8#1)
twice a##12##2##(1993-1#1)(1994-9#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
twice and##3##2##(2008-12#2)(2010-3#1)
twice as great##2##3##(2008-4#1)(2012-2#1)
twice as high as in the##2##6##(2008-11#2)
twice as high as##4##4##(2008-10#1)(2008-11#3)
twice as high##7##3##(2008-10#2)(2008-11#4)(2013-1#1)
twice as large as the##2##5##(1992-3#1)(1993-1#1)
twice as likely##2##3##(2008-11#1)(2011-2#1)
twice as many##5##3##(1993-1#1)(1994-6#1)(2008-10#2)(2009-11#1)
twice as##24##2##(1992-3#1)(1993-1#2)(1994-6#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
twice daily for##2##3##(1993-11#1)(2008-10#1)
twice daily in##2##3##(1996-1#1)(2008-3#1)
twice daily##13##2##(1991-4#1)(1993-11#1)(1996-1#2)(1996-11#3)(1996-2#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
twice that in##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
twice that of##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
twice that##6##2##(1991-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
twice the##22##2##(1990-11#1)(1993-3#1)(1994-2#1)(1994-8#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#2)
twice weekly from##2##3##(2008-12#1)(2012-6#1)
twice weekly##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2012-6#1)
twice##114##1##(1990-11#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-1#3)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#3)(1997-4#1)(1997-6#1)(1997-8#3)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#22)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#6)(2013-8#2)
twice-daily##5##1##(1997-2#1)(2008-5#2)(2011-2#2)
twice-weekly##2##1##(1992-8#1)(2008-10#1)
twig lesions##4##2##(2008-10#4)
twig##13##1##(2008-10#9)(2008-9#2)(2012-5#2)
twigs formed during the experimental period##2##6##(2012-5#2)
twigs##5##1##(2008-10#1)(2012-5#4)
twin gestation##3##2##(2009-6#2)(2013-1#1)
twin pairs##2##2##(2008-12#1)(2008-7#1)
twin pregnancy##2##2##(2010-8#1)(2011-2#1)
twin studies##2##2##(2008-7#1)(2010-12#1)
twin##41##1##(1990-6#4)(1991-3#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#5)(2009-5#1)(2009-6#2)(2010-1#1)(2010-12#3)(2010-8#3)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#3)
twinned aragonite##2##2##(2008-7#2)
twinned##3##1##(2008-7#2)(2010-8#1)
twinning##8##1##(2008-11#1)(2008-7#3)(2012-2#1)(2013-1#3)
twins and##3##2##(1997-7#2)(2010-1#1)
twins in##3##2##(2008-12#3)
twins##36##1##(1990-6#1)(1997-7#5)(2008-10#1)(2008-11#5)(2008-12#6)(2008-7#4)(2008-8#1)(2009-5#1)(2009-7#1)(2010-1#5)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-3#1)
twins'##2##1##(2008-9#1)(2010-7#1)
twist in##3##2##(1991-2#1)(2008-12#1)(2012-2#1)
twist##6##1##(1990-8#1)(1991-2#1)(2008-12#1)(2011-2#2)(2012-2#1)
twisted##7##1##(1990-9#2)(1992-4#1)(2008-7#2)(2008-8#1)(2010-9#1)
twisting##4##1##(2008-10#1)(2008-12#1)(2012-2#2)
twitch contraction##3##2##(1990-2#1)(2013-8#2)
twitch##8##1##(1990-2#1)(1990-5#2)(1997-4#1)(2008-12#1)(2013-8#3)
twitching##2##1##(1990-5#1)(2009-9#1)
two &quot##2##2##(1995-3#1)(2008-10#1)
two (3##2##2##(2012-3#2)
two 500 mg/kg##2##3##(2008-9#2)
two 6##2##2##(1991-9#1)(2009-3#1)
two ATP-binding motifs##3##3##(1996-2#3)
two ATP-binding##4##2##(1995-9#1)(1996-2#3)
two CO(2)##3##2##(2008-10#2)(2008-3#1)
two Dutch##2##2##(2008-10#2)
two European##2##2##(2008-10#1)(2008-7#1)
two H(2)O molecules##2##3##(2008-8#2)
two Italian##4##2##(2008-10#2)(2012-5#2)
two LEDs##2##2##(2008-10#2)
two N-terminally##2##2##(1994-8#2)
two NIST##2##2##(2008-10#2)
two P##2##2##(2008-10#2)
two QTL##3##2##(2008-10#2)(2012-3#1)
two QTLs for##2##3##(2008-8#2)
two Quercus species##2##3##(2012-5#2)
two S##4##2##(2008-10#4)
two Ssh7##2##2##(2008-9#2)
two T##2##2##(2008-10#1)(2008-11#1)
two X##2##2##(2008-10#1)(2008-4#1)
two actin monomers##3##3##(1991-5#3)
two active##5##2##(1997-7#1)(2008-10#3)(2008-5#1)
two acute##2##2##(1993-2#1)(2011-1#1)
two additional##7##2##(1991-2#1)(1991-9#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-7#1)
two adjacent##5##2##(1994-5#1)(2008-10#3)(2010-12#1)
two adsorbents##2##2##(2008-10#2)
two adult##3##2##(1994-2#1)(2008-5#1)(2010-7#1)
two age-matched subgroups of##2##4##(2008-7#1)(2013-1#1)
two age-matched##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
two alleles##4##2##(1991-11#1)(1993-6#2)(1995-5#1)
two alternate protocols##2##3##(2008-4#1)(2008-9#1)
two alternate##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
two alternative##10##2##(1995-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#3)(2010-8#1)(2012-2#1)
two alternatively spliced##2##3##(1995-2#1)(1997-7#1)
two amino acid substitutions##2##4##(2008-10#1)(2010-4#1)
two amino acid##6##3##(1997-9#1)(2008-10#4)(2010-4#1)
two amino acids##2##3##(1995-8#1)(2008-10#1)
two amino##8##2##(1995-8#1)(1997-9#1)(2008-10#5)(2010-4#1)
two analogs##2##2##(1993-8#1)(1994-11#1)
two analytes##5##2##(2008-10#5)
two analytical##3##2##(2008-10#3)
two and three##9##3##(1992-9#1)(1993-3#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-5#1)
two and##17##2##(1991-6#1)(1992-9#1)(1993-3#1)(1995-9#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-5#1)
two animals##2##2##(2008-12#1)(2008-5#1)
two antibodies##4##2##(1991-2#1)(1995-6#1)(2008-7#2)
two antigens##3##2##(1990-12#1)(2008-10#1)(2008-4#1)
two antioxidants##2##2##(2008-10#1)(2008-5#1)
two approaches are##2##3##(2008-9#1)(2010-11#1)
two approaches to##4##3##(1994-2#1)(1995-2#1)(2008-5#1)(2012-2#1)
two approaches##14##2##(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-8#1)(2012-2#2)(2013-1#1)
two approximate methods##2##3##(2008-3#1)(2008-7#1)
two are##4##2##(2008-3#1)(2008-8#2)(2012-3#1)
two areas##10##2##(1994-2#1)(2008-10#5)(2008-8#1)(2013-1#3)
two aspects of##2##3##(2008-10#1)(2012-3#1)
two aspects##4##2##(1996-5#1)(2008-10#1)(2011-2#1)(2012-3#1)
two assays##4##2##(1993-11#1)(2008-10#2)(2012-2#1)
two atomic detectors##2##3##(2008-10#2)
two atomic##3##2##(2008-10#3)
two atypical isolates##2##3##(2008-10#2)
two authors##2##2##(2010-2#1)(2013-1#1)
two bacteria##2##2##(2008-10#1)(2008-8#1)
two bands##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
two base##2##2##(1993-9#1)(2008-10#1)
two beta polypeptides##2##3##(1994-5#2)
two binding##2##2##(2008-10#1)(2008-9#1)
two birds##2##2##(2011-2#1)(2012-3#1)
two bladder##3##2##(2008-10#3)
two blocks##2##2##(1996-3#1)(2007-12#1)
two broad##3##2##(2008-10#1)(2008-12#1)(2010-10#1)
two cDNA clones##3##3##(1990-8#1)(1993-2#1)(2008-11#1)
two calibration##3##2##(2008-10#3)
two carriers##3##2##(2008-10#1)(2008-11#2)
two case reports##2##3##(1990-12#1)(2008-11#1)
two case studies presented##2##4##(1995-2#1)(2008-4#1)
two case studies##5##3##(1995-2#1)(2008-10#2)(2008-4#1)(2009-6#1)
two case##8##2##(1990-12#1)(1993-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-6#1)
two cases and##7##3##(1992-12#1)(2007-12#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)
two cases had##2##3##(2008-7#1)(2013-1#1)
two cases in which##3##4##(1996-5#1)(2008-10#1)(2011-2#1)
two cases in##4##3##(1995-5#1)(1996-5#1)(2008-10#1)(2011-2#1)
two cases of malignant##2##4##(1991-12#1)(1993-6#1)
two cases of##37##3##(1991-12#1)(1992-5#1)(1993-6#1)(1993-9#1)(1996-9#1)(1997-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-9#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
two cases that##2##3##(2009-1#1)(2013-1#1)
two cases were##2##3##(2008-10#1)(2010-2#1)
two cases with##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
two cases##82##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-12#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#12)(2008-8#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-3#5)(2013-1#9)(2013-8#2)
two cases]##3##2##(2009-5#1)(2013-1#2)
two categories of##2##3##(2008-10#1)(2011-2#1)
two categories##7##2##(2008-10#3)(2008-11#1)(2010-11#1)(2010-12#1)(2011-2#1)
two cations##3##2##(2008-10#3)
two cell lines##13##3##(2008-11#7)(2008-7#1)(2008-9#4)(2011-2#1)
two cell types##3##3##(1993-3#1)(2008-11#2)
two cell##19##2##(1993-3#1)(1995-11#1)(1995-2#1)(2008-11#9)(2008-7#1)(2008-9#5)(2011-2#1)
two cells##2##2##(1994-12#1)(2008-12#1)
two certified materials##3##3##(2008-10#3)
two certified reference materials##5##4##(2008-10#5)
two certified reference##6##3##(2008-10#6)
two certified##9##2##(2008-10#9)
two channel flow cells##2##4##(2008-10#2)
two channels##2##2##(2008-10#1)(2008-3#1)
two characteristics##2##2##(2008-10#1)(2008-5#1)
two children with##2##3##(1990-12#1)(2008-9#1)
two children##7##2##(1990-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-3#1)(2013-1#1)
two clades##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
two classes of##8##3##(1993-1#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
two classes##9##2##(1993-1#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
two clinical##5##2##(1992-9#1)(1993-3#1)(2008-11#3)
two cloned##4##2##(1996-12#1)(2008-10#1)(2008-9#2)
two clones##8##2##(1990-5#1)(1993-8#1)(2008-10#3)(2008-11#3)
two closely related##8##3##(2008-10#3)(2008-5#1)(2008-8#2)(2009-8#1)(2012-3#1)
two closely##10##2##(2008-10#5)(2008-5#1)(2008-8#2)(2009-8#1)(2012-3#1)
two clusters of##5##3##(1994-5#1)(1995-12#1)(1996-6#1)(2008-10#2)
two clusters##6##2##(1994-5#1)(1995-12#1)(1996-6#1)(2008-10#3)
two cohorts of##3##3##(2008-11#1)(2013-1#2)
two cohorts##4##2##(2008-11#2)(2013-1#2)
two collections##2##2##(2008-10#2)
two columns##2##2##(1997-2#1)(2008-10#1)
two commercial##7##2##(2008-10#6)(2008-3#1)
two common haplotypes##2##3##(2008-10#1)(2008-2#1)
two common##9##2##(1997-3#1)(2008-10#7)(2008-2#1)
two commonly used methods##2##4##(2008-10#1)(2008-9#1)
two commonly used##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)
two compared##2##2##(1996-6#1)(2008-10#1)
two compartments##3##2##(1992-10#1)(1995-2#1)(2008-5#1)
two competing effects##2##3##(2008-10#1)(2008-3#1)
two competing species in##2##4##(2008-8#2)
two competing##6##2##(1994-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#2)
two complementary##5##2##(1992-6#1)(1993-6#1)(1995-5#1)(2008-12#1)(2008-2#1)
two complex##2##2##(2010-1#1)(2010-3#1)
two complexes##4##2##(1992-4#1)(2008-10#2)(2012-12#1)
two component##6##2##(2008-10#4)(2008-8#1)(2012-3#1)
two components of##3##3##(2008-8#1)(2008-9#1)(2012-12#1)
two components##12##2##(1991-2#1)(1995-3#1)(1996-2#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)
two compounds in##3##3##(2008-10#2)(2011-3#1)
two compounds##10##2##(1992-6#1)(1994-11#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-3#1)
two concentrations of tetrol I-1##2##5##(2008-10#2)
two concentrations of##3##3##(2008-10#3)
two concentrations##4##2##(2008-10#4)
two conditions##6##2##(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#1)
two consecutive years##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
two consecutive##18##2##(1994-12#1)(1996-12#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-12#2)(2013-1#1)
two conserved##2##2##(1997-4#1)(2008-10#1)
two constants##2##2##(2008-10#2)
two constructs##2##2##(2008-10#1)(2009-12#1)
two contexts##2##2##(1993-1#1)(2009-10#1)
two control measures##3##3##(2008-10#3)
two copies each##2##3##(1994-5#1)(2011-2#1)
two copies of##4##3##(1993-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
two copies##6##2##(1993-6#1)(1994-5#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
two countries##2##2##(1993-3#1)(1997-8#1)
two critical##2##2##(1993-2#1)(2011-2#1)
two crystal forms##2##3##(2008-8#2)
two cultivars of##3##3##(2008-10#2)(2008-12#1)
two cultivars##8##2##(2008-10#7)(2008-12#1)
two culture##2##2##(2008-11#2)
two cutaneous##2##2##(2008-5#1)(2011-2#1)
two cycles of##3##3##(1990-6#1)(2008-10#2)
two cycles##4##2##(1990-6#1)(2008-10#2)(2008-5#1)
two cyclic##2##2##(2008-10#2)
two datasets##2##2##(2008-6#1)(2013-8#1)
two days##10##2##(1991-3#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-2#1)
two decades and##2##3##(2008-10#1)(2012-12#1)
two decades of research##2##4##(2008-6#1)(2012-2#1)
two decades of##3##3##(2008-12#1)(2008-6#1)(2012-2#1)
two decades##33##2##(1991-5#1)(1992-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(2006-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
two degradation products##2##3##(2008-10#2)
two developmental##2##2##(1993-9#1)(2009-8#1)
two dicots##2##2##(1991-6#1)(2008-10#1)
two dietary##2##2##(2008-3#1)(2010-6#1)
two different approaches to##2##4##(2008-12#1)(2008-9#1)
two different approaches##4##3##(1995-5#1)(2008-10#1)(2008-12#1)(2008-9#1)
two different forms of##2##4##(2010-5#1)(2012-12#1)
two different levels of##3##4##(1990-2#1)(2008-10#1)(2008-7#1)
two different levels##4##3##(1990-2#1)(1991-6#1)(2008-10#1)(2008-7#1)
two different methods##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
two different procedures##2##3##(2008-10#2)
two different sizes##2##3##(1995-8#1)(2008-10#1)
two different stages##2##3##(2008-12#1)(2008-4#1)
two different timescales##2##3##(2008-9#2)
two different types of##5##4##(1993-8#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
two different ways##3##3##(1992-11#1)(2011-2#1)(2012-2#1)
two different##172##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#3)(1993-8#2)(1994-11#3)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#77)(2008-11#10)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
two dimensional##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
two dimensions##9##2##(1996-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#1)(2012-3#1)(2013-8#1)
two direct##2##2##(1995-6#1)(2008-10#1)
two discrete##2##2##(1993-3#1)(1993-8#1)
two diseases##10##2##(2008-10#8)(2008-11#1)(2012-3#1)
two disorders##2##2##(2008-10#1)(2012-3#1)
two distant##2##2##(2008-10#1)(2008-5#1)
two distinct clusters of##2##4##(2008-10#2)
two distinct clusters that##2##4##(2008-10#2)
two distinct clusters##6##3##(2008-10#6)
two distinct groups##6##3##(2008-10#5)(2013-1#1)
two distinct mechanisms##3##3##(1996-2#2)(2008-10#1)
two distinct types##2##3##(2008-10#1)(2010-1#1)
two distinct##52##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-8#2)(1994-12#1)(1995-12#1)(1996-2#2)(1997-7#1)(2008-10#27)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-6#1)(2013-1#1)(2013-8#1)
two distinctive##2##2##(2008-10#1)(2008-11#1)
two districts of##2##3##(1994-6#1)(2008-10#1)
two districts##4##2##(1994-6#1)(2008-10#2)(2010-3#1)
two disulfide bonds##2##3##(1993-8#2)
two divergent##2##2##(1995-2#1)(2008-10#1)
two domains##4##2##(1995-6#1)(1997-3#1)(2008-9#1)(2012-2#1)
two dominant##2##2##(2008-10#1)(2008-3#1)
two dose##2##2##(1991-3#1)(2008-9#1)
two doses##2##2##(1995-5#1)(2010-5#1)
two droplets##3##2##(2008-3#3)
two drugs simultaneously##2##3##(1993-8#1)(2012-2#1)
two drugs##10##2##(1990-9#1)(1993-8#1)(1995-12#1)(2008-10#2)(2008-11#4)(2012-2#1)
two each##2##2##(2008-9#1)(2012-2#1)
two earlier##2##2##(2008-10#1)(2008-11#1)
two effects##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
two electrochemical##2##2##(2008-10#1)(2008-4#1)
two electrode##2##2##(2008-10#2)
two electrons##2##2##(2008-10#2)
two elemental##2##2##(2008-10#1)(2008-11#1)
two elements##4##2##(1990-5#1)(1993-6#1)(1993-9#1)(2008-11#1)
two environments##4##2##(2008-10#3)(2010-5#1)
two enzyme##2##2##(1993-11#1)(2008-10#1)
two enzymes##7##2##(1990-5#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-7#2)
two episodes of##2##3##(2008-11#1)(2008-12#1)
two equivalents of##2##3##(2008-11#1)(2010-5#1)
two events##2##2##(1995-6#1)(2011-2#1)
two examinations##3##2##(1996-11#1)(2008-11#1)(2008-9#1)
two examples##2##2##(1992-9#1)(2010-5#1)
two exhibited##2##2##(2008-10#2)
two exons##3##2##(1993-2#1)(1993-8#1)(2008-9#1)
two experimental##7##2##(2008-10#4)(2008-7#1)(2013-1#2)
two experiments##11##2##(1994-2#1)(2008-10#5)(2008-5#1)(2008-6#2)(2009-6#1)(2013-1#1)
two expression##2##2##(1995-5#1)(2008-10#1)
two extreme##4##2##(1995-12#1)(2008-10#1)(2008-11#2)
two extremes##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)
two factors were##2##3##(2008-10#2)
two factors##17##2##(1991-6#1)(1993-12#1)(2008-10#9)(2008-11#2)(2008-6#1)(2008-7#3)
two families of##4##3##(1993-12#1)(1994-5#1)(2008-7#1)(2009-11#1)
two families##6##2##(1991-12#2)(1993-12#1)(1994-5#1)(2008-7#1)(2009-11#1)
two features##2##2##(2008-10#1)(2008-4#1)
two female patients##3##3##(1996-8#1)(2008-7#1)(2009-8#1)
two field locations##3##3##(2008-10#2)(2008-11#1)
two field sites##2##3##(2008-10#2)
two field trials##3##3##(2008-10#3)
two field##11##2##(2008-10#10)(2008-11#1)
two fields in##2##3##(2008-10#2)
two fields##6##2##(1991-2#1)(2008-10#5)
two fingers##2##2##(1991-12#1)(1996-8#1)
two flow##3##2##(1997-2#1)(2008-10#2)
two fluorescent##4##2##(1993-8#1)(2008-10#3)
two fold##4##2##(2008-11#3)(2008-8#1)
two folds##2##2##(2008-11#1)(2008-12#1)
two for##7##2##(1991-2#1)(2008-10#1)(2008-9#3)(2009-7#1)(2013-8#1)
two formae speciales##2##3##(2008-10#2)
two forms of the##2##4##(2008-10#1)(2008-3#1)
two forms of##13##3##(1991-12#1)(1992-6#1)(1996-2#1)(2008-10#3)(2008-3#1)(2009-9#1)(2010-5#4)(2012-3#1)
two forms##18##2##(1991-12#1)(1991-5#1)(1992-6#1)(1993-8#1)(1996-2#1)(2008-10#4)(2008-3#1)(2009-7#1)(2009-9#1)(2010-5#4)(2012-3#1)(2013-1#1)
two formulations##3##2##(1996-1#2)(2008-10#1)
two fragments##6##2##(1990-5#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-4#1)
two from groups of##2##4##(1996-12#2)
two from##7##2##(1995-6#1)(1996-12#2)(2008-10#3)(2008-5#1)
two functions##3##2##(1991-12#1)(2008-11#1)(2008-8#1)
two fungal##2##2##(2008-10#1)(2012-3#1)
two fungi##6##2##(2008-10#6)
two fungicide##2##2##(2008-10#2)
two further##2##2##(1994-2#1)(2008-10#1)
two genera##5##2##(2008-10#4)(2012-12#1)
two general##3##2##(1991-2#1)(1995-5#1)(2008-7#1)
two generations##2##2##(1990-11#1)(2009-5#1)
two genes for##2##3##(2008-10#2)
two genes of the##2##4##(2008-10#2)
two genes with additive effects##2##5##(2008-10#2)
two genes##29##2##(1990-11#1)(1991-5#1)(1991-6#1)(1991-9#2)(1993-12#1)(1993-6#1)(1994-11#2)(1997-7#1)(1997-9#1)(2008-10#11)(2008-11#1)(2008-9#3)(2009-10#1)(2009-8#1)(2012-3#1)
two genetically distinct##2##3##(1995-6#1)(2008-6#1)
two genetically##3##2##(1995-6#1)(2008-10#1)(2008-6#1)
two genotypes of##3##3##(2008-10#3)
two genotypes##7##2##(2008-10#7)
two geographically##2##2##(2008-10#2)
two groups according to the##2##5##(1996-12#1)(2008-10#1)
two groups and##4##3##(1993-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
two groups by##3##3##(1992-12#1)(1995-12#1)(2008-10#1)
two groups in##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
two groups of patients##3##4##(1990-5#1)(1991-3#1)(2013-1#1)
two groups of students##2##4##(1997-2#1)(2008-11#1)
two groups of##24##3##(1990-5#1)(1991-3#2)(1996-8#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#3)(2009-3#1)(2010-7#1)(2013-1#1)
two groups using##2##3##(2012-2#2)
two groups were also##2##4##(2008-10#1)(2008-6#1)
two groups were compared##3##4##(2009-12#1)(2011-1#1)(2011-2#1)
two groups were##13##3##(1990-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(2008-10#2)(2008-6#1)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
two groups with##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
two groups##145##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-9#1)(1993-1#1)(1993-2#1)(1995-12#3)(1995-3#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#32)(2008-11#3)(2008-12#5)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-8#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#15)(2011-3#1)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#2)
two growing seasons##5##3##(2008-10#5)
two habitat##2##2##(2008-8#2)
two had##2##2##(1996-6#1)(2009-8#1)
two halves of##2##3##(2008-11#1)(2011-3#1)
two halves##3##2##(2007-12#1)(2008-11#1)(2011-3#1)
two haplotypes##2##2##(2008-10#2)
two have##2##2##(2008-10#1)(2013-8#1)
two health##3##2##(1997-4#1)(2009-11#1)(2011-2#1)
two herds##2##2##(1990-6#1)(1992-2#1)
two high##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
two highly##6##2##(1992-2#1)(1992-6#1)(2008-10#2)(2008-11#1)(2011-1#1)
two homologous##2##2##(1994-5#1)(1997-7#1)
two hormones##3##2##(2008-11#2)(2011-2#1)
two hospitals in##3##3##(1993-6#1)(2008-11#1)(2012-12#1)
two hospitals##5##2##(1990-2#1)(1993-6#1)(2008-11#1)(2010-8#1)(2012-12#1)
two host species##2##3##(2008-8#1)(2008-9#1)
two host##3##2##(2008-8#1)(2008-9#2)
two hours of##2##3##(1990-9#1)(2010-7#1)
two hours##8##2##(1990-9#1)(1997-3#1)(2008-11#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)
two human##7##2##(1991-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-4#1)
two hybridizable##2##2##(2008-9#2)
two hybrids##2##2##(2008-10#2)
two hypotheses##3##2##(2008-8#1)(2008-9#1)(2009-8#1)
two identical##4##2##(1993-6#1)(1997-2#1)(2007-11#1)(2013-1#1)
two immiscible phases##2##3##(2008-10#2)
two immiscible##6##2##(1993-8#1)(2008-10#4)(2008-8#1)
two important aspects##2##3##(2008-11#1)(2013-1#1)
two important##11##2##(1995-2#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
two in the##4##3##(2008-10#2)(2010-8#1)(2011-3#1)
two in vitro models##2##4##(1992-12#1)(2008-5#1)
two in vitro##4##3##(1992-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
two in##13##2##(1992-12#1)(1996-6#1)(2008-10#7)(2008-5#1)(2010-8#1)(2011-3#1)(2012-2#1)
two independent conformations##2##3##(1991-3#2)
two independent##18##2##(1991-3#2)(1994-11#1)(1994-8#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
two independently##3##2##(1995-12#1)(2009-7#1)(2011-2#1)
two indexes##2##2##(2008-10#1)(2011-2#1)
two individuals##2##2##(2008-10#1)(2012-3#1)
two instruments##5##2##(2008-10#2)(2008-3#2)(2012-2#1)
two insulin##2##2##(1992-10#1)(1994-6#1)
two interacting##3##2##(2009-8#2)(2011-2#1)
two introns##9##2##(1993-2#2)(1993-6#1)(1993-8#2)(1995-9#1)(2008-10#1)(2008-6#1)(2010-5#1)
two inverted repeat sequences##2##4##(2008-8#2)
two is##2##2##(1991-3#1)(2007-8#1)
two isoforms of##5##3##(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#2)
two isoforms##8##2##(1993-12#2)(1994-11#1)(1994-8#1)(1995-2#3)(1995-8#1)
two isolates of R##3##4##(2008-10#3)
two isolates of##12##3##(2008-10#11)(2008-5#1)
two isolates that##2##3##(2008-10#2)
two isolates were##3##3##(2008-10#3)
two isolates##35##2##(1997-8#1)(2008-10#31)(2008-5#2)(2009-6#1)
two joint##2##2##(1992-3#1)(2008-8#1)
two key factors##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
two key##12##2##(1997-2#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
two kinds of perturbations##2##4##(2008-10#2)
two kinds of##18##3##(1993-3#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#4)(2011-3#1)
two kinds##19##2##(1993-3#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#1)(2011-3#1)
two large##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
two largest lineages##3##3##(2008-10#3)
two largest##5##2##(2008-10#5)
two lateral##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
two latter##2##2##(1996-2#1)(2008-10#1)
two layers##5##2##(2008-10#2)(2008-12#1)(2008-3#2)
two leaf##2##2##(2008-10#2)
two learning##2##2##(1996-3#1)(2008-12#1)
two lesions##2##2##(2012-12#1)(2012-3#1)
two level factorial##2##3##(2008-10#2)
two level##4##2##(2008-10#3)(2008-7#1)
two levels for##2##3##(1994-12#1)(2008-11#1)
two levels of##3##3##(2008-10#1)(2009-4#1)(2012-3#1)
two levels##12##2##(1992-9#1)(1994-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2012-3#1)
two ligands##5##2##(1996-2#1)(1997-2#1)(2008-10#3)
two ligated species##2##3##(1990-8#2)
two light##2##2##(2008-10#2)
two limiting cases##2##3##(2008-10#1)(2008-7#1)
two lineages##2##2##(2008-8#2)
two linear##5##2##(1995-2#1)(2008-10#3)(2011-2#1)
two lines##3##2##(1997-8#1)(2008-10#2)
two lipophilic##2##2##(1994-5#1)(2008-10#1)
two locations in##5##3##(2008-10#5)
two locations##17##2##(2008-10#14)(2008-11#1)(2008-5#1)(2012-12#1)
two loci##6##2##(1993-6#1)(2008-10#3)(2008-9#1)(2012-3#1)
two long##5##2##(1991-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
two low##2##2##(2008-10#1)(2008-7#1)
two lower##2##2##(1993-9#1)(2008-10#1)
two mRNA species##2##3##(1990-2#2)
two mRNA##4##2##(1990-2#3)(2008-8#1)
two main clusters##2##3##(2008-10#2)
two main groups##2##3##(2008-10#2)
two main reasons##2##3##(1996-1#1)(1996-6#1)
two main##28##2##(1992-9#1)(1993-8#1)(1996-1#1)(1996-6#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
two maize##3##2##(2008-12#3)
two major NORs##2##3##(1993-12#2)
two major groups of##3##4##(1990-5#1)(2008-10#2)
two major groups##5##3##(1990-5#1)(2008-10#4)
two major pathways##2##3##(2008-9#1)(2011-2#1)
two major protein##2##3##(2008-7#1)(2008-8#1)
two major##56##2##(1990-2#1)(1990-5#1)(1993-12#3)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-2#1)
two male##2##2##(1992-3#1)(2008-11#1)
two males##3##2##(2008-8#2)(2008-9#1)
two materials##2##2##(2008-10#1)(2013-1#1)
two maternal##2##2##(1997-7#1)(2009-9#1)
two mathematical##2##2##(2008-10#2)
two mating types##2##3##(2008-10#2)
two measures of##3##3##(1994-8#1)(1997-7#1)(2008-11#1)
two measures##7##2##(1994-8#1)(1997-7#1)(2008-11#2)(2008-9#2)(2010-3#1)
two mechanisms for##2##3##(2008-10#2)
two mechanisms##7##2##(2008-10#3)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)
two medical##2##2##(1996-1#1)(1996-6#1)
two meiotic##2##2##(2008-10#1)(2012-2#1)
two membranes##5##2##(1997-8#1)(2008-10#2)(2008-11#1)(2009-6#1)
two mesocosms##2##2##(2010-8#2)
two metabolic##2##2##(1997-6#1)(2008-7#1)
two metal ions##2##3##(2008-10#2)
two metal##3##2##(2008-10#3)
two metals##7##2##(1991-5#1)(2008-10#6)
two methodologies for##2##3##(1992-3#1)(2008-10#1)
two methods are##5##3##(1997-2#1)(2008-10#3)(2008-4#1)
two methods for##5##3##(2008-10#4)(2008-4#1)
two methods of##5##3##(1997-2#1)(2008-10#2)(2008-2#1)(2010-6#1)
two methods to##2##3##(2008-3#1)(2008-9#1)
two methods were##5##3##(2008-10#4)(2008-7#1)
two methods##53##2##(1992-12#1)(1995-9#1)(1997-2#3)(2008-10#37)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)
two minor##7##2##(1993-12#1)(1994-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
two miscible##2##2##(2008-2#1)(2011-2#1)
two models of##3##3##(2008-5#1)(2008-8#1)(2009-8#1)
two models##12##2##(1991-2#1)(1995-8#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-8#1)
two modes of##5##3##(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)
two modules##2##2##(2008-11#1)(2008-3#1)
two molecular##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
two molecules in the##2##4##(1992-9#1)(2008-8#1)
two molecules of##4##3##(1990-9#1)(1992-3#1)(1993-12#1)(1994-5#1)
two molecules##9##2##(1990-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-8#1)(2008-7#1)(2008-8#1)(2010-10#1)
two monoclonal antibodies (MAbs)##2##4##(1990-12#1)(2008-10#1)
two monoclonal antibodies directed against the##2##6##(1992-12#1)(1992-2#1)
two monoclonal antibodies##7##3##(1990-12#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-5#1)(1995-6#1)(2008-10#1)
two monoclonal##8##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-5#1)(1995-6#1)(2008-10#1)
two months after the##2##4##(1995-9#1)(2010-10#1)
two months after##4##3##(1991-3#1)(1995-9#1)(2008-10#1)(2010-10#1)
two months of##3##3##(2008-8#1)(2013-1#2)
two months##15##2##(1991-2#1)(1991-3#1)(1995-9#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)(2012-2#1)(2013-1#2)
two more##3##2##(1996-2#1)(2008-5#2)
two morphological##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
two morphologically##2##2##(2007-12#1)(2008-10#1)
two most important##2##3##(1991-2#1)(1993-1#1)
two most##10##2##(1991-2#1)(1993-1#1)(2008-10#3)(2008-9#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-2#1)
two motifs##2##2##(1997-7#1)(2012-3#1)
two multigenic families##2##3##(1997-9#2)
two mutants##2##2##(1997-7#1)(2008-9#1)
two mutations were##2##3##(1993-11#1)(1995-6#1)
two mutations##4##2##(1993-11#1)(1994-12#1)(1995-6#1)(2010-4#1)
two natural##4##2##(1996-5#1)(2008-10#1)(2008-5#1)(2012-6#1)
two naturally##2##2##(2008-10#1)(2008-11#1)
two near-infrared wavelengths##2##3##(2008-2#2)
two new cases##2##3##(2008-10#2)
two new genotypes##2##3##(2008-10#2)
two new tospovirus species##2##4##(2008-10#2)
two new##39##2##(1992-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-3#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)
two newly described##2##3##(2008-10#2)
two normal##2##2##(1992-3#1)(2012-3#1)
two novel genes##2##3##(1993-8#1)(1997-2#1)
two novel##11##2##(1993-6#1)(1993-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#2)(2011-2#1)
two nuclei##2##2##(2008-10#2)
two nucleotide##2##2##(1996-12#1)(2008-11#1)
two nutritional##2##2##(2008-11#1)(2013-7#1)
two observations##2##2##(1995-9#1)(2008-11#1)
two occasions##4##2##(1997-4#1)(2008-12#1)(2008-7#1)(2008-9#1)
two of four##4##3##(2008-10#4)
two of the four##5##4##(1992-3#1)(2008-10#3)(2008-5#1)
two of the three##5##4##(1991-3#1)(1994-5#1)(2008-10#2)(2008-8#1)
two of the##35##3##(1991-3#1)(1991-6#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2008-10#13)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
two of them##8##3##(1991-5#1)(2008-10#2)(2008-5#2)(2008-9#2)(2012-3#1)
two of these were##2##4##(1996-3#1)(1997-8#1)
two of these##10##3##(1992-9#1)(1993-8#1)(1994-12#1)(1996-11#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-7#1)(2013-1#1)
two of three experiments##2##4##(2008-10#2)
two of three##4##3##(2008-10#4)
two of which##6##3##(1996-3#1)(2008-10#3)(2008-5#1)(2008-8#1)
two of##82##2##(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-8#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-10#29)(2008-11#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
two open reading frames (ORFs)##2##5##(1996-6#1)(2008-10#1)
two open reading frames##5##4##(1991-9#1)(1996-6#1)(2008-10#3)
two optical##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
two or more groups##3##4##(1994-9#1)(2008-10#1)(2008-9#1)
two or more pathogens##2##4##(2008-10#2)
two or more##24##3##(1991-2#1)(1993-2#2)(1994-9#1)(1997-2#1)(2008-10#9)(2008-3#1)(2008-9#4)(2010-1#1)(2010-12#2)(2011-1#1)(2013-8#1)
two or three times##2##4##(1994-1#1)(2008-5#1)
two or three##9##3##(1990-8#1)(1994-1#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)
two or##38##2##(1990-8#1)(1991-2#1)(1993-2#2)(1994-1#1)(1994-9#1)(1995-12#1)(1996-12#2)(1997-2#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#5)(2009-10#1)(2010-1#1)(2010-12#2)(2011-1#1)(2013-8#1)
two orchid##4##2##(2008-10#4)
two orders of magnitude##15##4##(1990-11#1)(2008-10#13)(2008-9#1)
two organic##3##2##(2008-10#1)(2009-10#2)
two orthogonal##2##2##(2007-11#1)(2008-3#1)
two other species##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
two other##32##2##(1990-5#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-6#3)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
two others##4##2##(1993-1#1)(2008-10#2)(2008-8#1)
two out of three##2##4##(1991-12#1)(2008-5#1)
two out of##3##3##(1991-12#1)(2008-5#1)(2011-2#1)
two outer ring electrodes##2##4##(2008-10#2)
two overlapping##3##2##(1992-6#1)(1996-6#1)(1997-8#1)
two paediatric##2##2##(2008-9#1)(2010-7#1)
two pairs of degenerate primers##2##5##(2008-10#2)
two pairs of##6##3##(1994-5#2)(2007-12#1)(2008-10#3)
two parallel##2##2##(2008-10#1)(2011-1#1)
two parameters##16##2##(1994-3#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#1)
two partial##4##2##(1990-8#1)(1991-5#1)(1995-12#1)(1997-7#1)
two partially##4##2##(2008-10#1)(2008-8#1)(2009-6#1)(2010-10#1)
two pathogenic species##2##3##(2008-10#2)
two pathogenic##3##2##(2008-10#3)
two pathogenicity groups##2##3##(2008-10#2)
two pathogens##8##2##(2008-10#6)(2008-9#1)(2010-4#1)
two pathotypes##2##2##(2008-10#2)
two pathways##3##2##(1994-11#1)(2008-8#1)(2012-3#1)
two patient##2##2##(1993-12#1)(2008-10#1)
two patients had##2##3##(1991-4#1)(2008-10#1)
two patients suffering from##2##4##(1997-6#1)(2013-1#1)
two patients were##2##3##(2008-9#1)(2012-3#1)
two patients who##5##3##(1993-1#1)(1997-8#1)(2008-1#1)(2008-7#1)(2012-12#1)
two patients with##15##3##(1990-9#1)(1991-11#1)(1991-3#1)(1994-11#1)(1995-10#1)(1996-9#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2010-7#1)(2011-1#1)
two patients##52##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-1#2)(1993-2#2)(1994-11#1)(1995-10#1)(1995-12#1)(1996-9#4)(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
two pattern recognition methods##2##4##(2008-10#2)
two patterns of##2##3##(1992-5#1)(2012-2#1)
two pea##2##2##(2008-10#2)
two peaks were identified##2##4##(2008-10#1)(2008-11#1)
two peaks were##3##3##(2008-10#2)(2008-11#1)
two peaks##7##2##(2008-10#5)(2008-11#1)(2013-1#1)
two peanut genotypes##2##3##(2008-10#2)
two peptides##6##2##(1992-9#1)(1995-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
two periods##2##2##(1996-3#1)(2012-3#1)
two phase##2##2##(1994-9#1)(2008-5#1)
two phase-systems##2##2##(2008-10#2)
two phases of##2##3##(1994-12#1)(2008-11#1)
two phases##16##2##(1993-12#1)(1994-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
two phenol sulphotransferase genes##2##4##(1994-11#2)
two phenomena##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
two phosphonic acids##2##3##(2008-10#2)
two plant species##2##3##(2008-10#1)(2009-3#1)
two plant##4##2##(2008-10#2)(2008-9#1)(2009-3#1)
two plants were##2##3##(2008-10#1)(2008-8#1)
two plants##3##2##(2008-10#2)(2008-8#1)
two plots were treated##2##4##(2008-10#2)
two polar nuclei##2##3##(2009-12#2)
two polar##4##2##(1996-12#1)(2008-10#1)(2009-12#2)
two polyclonal##2##2##(1991-7#1)(1994-11#1)
two polymerase chain##2##3##(2008-10#2)
two populations of I##2##4##(2008-6#1)(2013-8#1)
two populations of##7##3##(1990-5#1)(1994-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2013-8#2)
two populations##24##2##(1990-5#1)(1994-5#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2012-2#1)(2013-8#2)
two portions##2##2##(2008-10#2)
two positions##2##2##(1994-5#1)(2013-1#1)
two possible scenarios##2##3##(1996-3#1)(2008-10#1)
two possible##5##2##(1992-4#1)(1993-3#1)(1996-3#1)(2008-10#2)
two potential##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
two previous##3##2##(2008-10#2)(2011-2#1)
two previously##5##2##(1991-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
two prey species##2##3##(2008-8#2)
two prey##3##2##(2008-8#3)
two primary##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
two primer pairs##2##3##(2008-10#1)(2008-11#1)
two primer##3##2##(2008-10#2)(2008-11#1)
two principal components##2##3##(2008-10#2)
two probes##3##2##(1990-5#1)(2008-10#2)
two processes are##2##3##(1995-2#2)
two processes##7##2##(1995-2#2)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#1)
two products##5##2##(1995-6#1)(2008-10#3)(2008-5#1)
two prospective##2##2##(2008-11#1)(2008-7#1)
two protein bands##2##3##(1993-3#1)(2008-10#1)
two protein##3##2##(1993-3#1)(2008-10#1)(2008-9#1)
two proteins are##2##3##(1990-8#1)(1991-9#1)
two proteins that##2##3##(2008-12#1)(2010-12#1)
two proteins##19##2##(1990-8#1)(1991-9#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
two protocols##6##2##(2008-4#4)(2008-9#2)
two putative##9##2##(1993-12#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-8#1)
two quail strains and their reciprocal crosses##2##7##(2008-12#2)
two questions##3##2##(2008-8#1)(2010-12#1)(2013-8#1)
two races of##3##3##(2008-10#3)
two races##4##2##(2008-10#4)
two random amplified polymorphic DNA (RAPD) markers##2##7##(2008-10#2)
two random##3##2##(2008-10#2)(2008-3#1)
two rare##2##2##(1993-3#1)(2012-3#1)
two reaction##2##2##(2008-10#1)(2008-3#1)
two reactions##3##2##(2008-10#3)
two reactors##3##2##(2008-10#3)
two reagent##2##2##(2008-10#2)
two reagents##2##2##(2008-10#1)(2008-11#1)
two reasons##3##2##(1991-1#1)(1994-6#1)(2008-3#1)
two recently##2##2##(2008-11#1)(2013-1#1)
two recessive genes were detected in##3##6##(2008-10#3)
two recessive genes##5##3##(2008-10#5)
two recombinant##2##2##(1995-12#1)(2008-7#1)
two redox##2##2##(2008-10#2)
two reduction peaks##2##3##(2008-10#2)
two reference##7##2##(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)
two regions are##2##3##(2008-10#1)(2008-8#1)
two regions##11##2##(1992-9#1)(1995-11#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2012-2#1)
two related##4##2##(1993-12#1)(1994-11#1)(2008-10#2)
two remaining##3##2##(2008-10#2)(2008-8#1)
two replications##3##2##(1993-2#1)(2008-10#2)
two reports##2##2##(2008-9#1)(2013-1#1)
two representative##5##2##(2008-10#3)(2008-9#1)(2010-10#1)
two reproductive##2##2##(2008-8#2)
two resins##4##2##(2008-10#4)
two resistant##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
two restriction##2##2##(2008-10#1)(2008-2#1)
two rival##2##2##(2008-11#1)(2008-12#1)
two rounds##3##2##(2008-10#2)(2008-11#1)
two routes##2##2##(2009-10#1)(2011-2#1)
two sample portions##2##3##(2008-10#2)
two sample##4##2##(2008-10#4)
two samples of##3##3##(2008-10#2)(2009-4#1)
two samples ranged from##3##4##(2008-10#3)
two samples##15##2##(2008-10#11)(2009-4#2)(2010-1#1)(2013-8#1)
two sampling##4##2##(2008-10#4)
two scales##2##2##(1993-2#1)(2008-10#1)
two scenarios##3##2##(1996-3#1)(2008-11#1)(2008-8#1)
two screening##2##2##(2008-10#2)
two seasons##10##2##(2008-10#9)(2012-8#1)
two sections##3##2##(2008-10#2)(2008-4#1)
two selected##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
two separate experiments##2##3##(2008-10#1)(2008-11#1)
two separate genes##2##3##(1992-6#1)(1993-9#1)
two separate studies##2##3##(1991-11#1)(2009-11#1)
two separate##27##2##(1991-11#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-6#2)(1993-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2011-3#1)
two sequences##5##2##(1992-4#1)(1996-12#1)(2008-10#1)(2008-4#2)
two series of##5##3##(2008-10#4)(2008-5#1)
two serotypes##2##2##(2008-10#2)
two sets of##20##3##(1992-3#1)(1993-12#2)(1993-8#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
two sets##22##2##(1992-3#1)(1993-12#2)(1993-8#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)
two shampoos##2##2##(2008-10#1)(2008-5#1)
two sibling yeast species##2##4##(1996-6#2)
two sibling##3##2##(1996-6#2)(2008-9#1)
two sides of the##2##4##(2008-10#1)(2011-2#1)
two sides##4##2##(1995-1#1)(2008-10#2)(2011-2#1)
two signals##2##2##(2008-3#1)(2008-7#1)
two similar##3##2##(2008-11#1)(2010-6#1)(2013-8#1)
two simple##2##2##(1994-8#1)(2008-3#1)
two single##7##2##(1995-6#2)(1997-3#1)(2008-10#1)(2008-11#1)(2011-3#1)(2013-1#1)
two sites in the##2##4##(1997-3#1)(2008-10#1)
two sites in##3##3##(1997-3#1)(2008-10#2)
two sites##13##2##(1994-5#1)(1995-11#1)(1997-3#1)(2008-10#7)(2008-5#2)(2008-8#1)
two situations##2##2##(2008-10#1)(2010-6#1)
two small##5##2##(1995-3#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
two smaller##3##2##(1990-5#1)(1997-6#1)(2012-3#1)
two soil##3##2##(2008-10#1)(2008-11#1)(2012-5#1)
two soils##5##2##(2008-10#4)(2008-11#1)
two solid##2##2##(2008-10#1)(2008-7#1)
two solitudes##2##2##(1995-1#1)(1996-1#1)
two sources##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
two spatial scales##2##3##(2008-10#1)(2008-8#1)
two spatial##4##2##(2008-10#2)(2008-8#2)
two spatially##2##2##(2008-10#1)(2008-7#1)
two specialists##2##2##(2008-5#1)(2008-8#1)
two species and##3##3##(1991-6#1)(2008-10#2)
two species are##3##3##(2008-10#2)(2008-7#1)
two species of halacarid mites##2##5##(2007-12#2)
two species of##16##3##(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2013-1#2)
two species that##3##3##(1992-10#1)(2008-8#1)(2010-3#1)
two species##68##2##(1991-6#2)(1992-10#1)(1993-12#2)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#25)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#10)(2009-8#1)(2010-3#1)(2010-8#1)(2012-3#1)(2012-5#1)(2012-8#1)(2013-1#2)
two species-specific##2##2##(1995-12#1)(2008-12#1)
two specific##5##2##(1994-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
two stage##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
two stages##5##2##(2008-11#2)(2008-12#1)(2008-5#1)(2010-8#1)
two standard reference materials##4##4##(2008-10#4)
two standard##6##2##(1992-1#1)(2008-10#5)
two stem##2##2##(2007-12#1)(2009-8#1)
two steps of##5##3##(1993-2#1)(1993-8#1)(2008-10#1)(2010-2#1)(2011-1#1)
two steps##18##2##(1991-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-2#1)(2008-10#10)(2010-10#1)(2010-2#1)(2011-1#1)
two strains of##7##3##(2008-10#5)(2008-11#1)(2013-8#1)
two strains that##3##3##(2008-10#3)
two strains##20##2##(1996-12#1)(2008-10#14)(2008-11#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
two strategies##5##2##(1996-1#1)(2008-10#2)(2008-8#1)(2010-7#1)
two streams of##2##3##(2008-10#1)(2008-8#1)
two streams##4##2##(1995-5#1)(2008-10#2)(2008-8#1)
two strikingly##2##2##(2008-11#1)(2008-7#1)
two strongest##2##2##(2008-10#1)(2013-8#1)
two strongly##2##2##(2008-5#1)(2008-8#1)
two structurally##2##2##(1994-11#1)(2011-2#1)
two structures##2##2##(1993-6#1)(2008-10#1)
two studies##8##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2012-2#1)(2013-1#1)
two study##3##2##(1991-11#1)(2010-4#1)(2011-2#1)
two subgroups according to the##2##5##(2008-10#1)(2011-2#1)
two subgroups of##2##3##(1994-3#1)(2008-10#1)
two subgroups##15##2##(1990-8#1)(1994-3#1)(2008-10#8)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
two subplots (furrow and##2##4##(2008-10#2)
two subpopulations of##2##3##(2008-10#1)(2008-11#1)
two subpopulations##5##2##(2008-10#3)(2008-11#2)
two subsequent##2##2##(2008-10#1)(2009-6#1)
two substances##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
two substrates in a##2##4##(1994-5#2)
two substrates##9##2##(1992-10#1)(1994-5#4)(2008-10#1)(2008-7#3)
two subtypes of##2##3##(1994-12#1)(2008-8#1)
two subtypes##4##2##(1994-12#1)(1997-8#1)(2007-12#1)(2008-8#1)
two subunits of##3##3##(1992-9#1)(1993-8#1)(1995-6#1)
two subunits##14##2##(1991-10#2)(1991-12#2)(1992-6#1)(1992-9#1)(1993-8#1)(1995-2#1)(1995-6#1)(2008-9#2)(2010-5#3)
two successful##2##2##(1996-8#1)(2008-11#1)
two successive injections##2##3##(2008-10#1)(2012-12#1)
two successive##8##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
two such##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
two sulfonylureas##2##2##(1992-3#2)
two surface integration approaches##2##4##(2008-3#2)
two surface##5##2##(2008-3#4)(2008-9#1)
two surgical techniques##2##3##(2011-2#2)
two survived##2##2##(1994-9#2)
two susceptible##2##2##(2008-10#2)
two sympatric##3##2##(2008-10#1)(2012-3#2)
two synthetic##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#2)
two systems##9##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#1)
two tandem##3##2##(1991-9#1)(2008-8#1)(2008-9#1)
two teachers##2##2##(1991-12#1)(2008-11#1)
two techniques for the##2##4##(1994-12#1)(2008-10#1)
two techniques have##2##3##(2008-12#1)(2010-7#1)
two techniques##16##2##(1994-12#1)(1995-5#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-2#1)
two terms##2##2##(2008-10#1)(2008-2#1)
two test##4##2##(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#1)
two tests##5##2##(1993-6#1)(1994-2#1)(1994-8#1)(2008-10#2)
two thirds of the##3##4##(1992-3#1)(1995-11#1)(2009-4#1)
two thirds of##4##3##(1992-3#1)(1995-11#1)(2009-4#1)(2011-2#1)
two tier##3##2##(1990-3#3)
two tightly linked loci##2##4##(2008-10#2)
two time periods##4##3##(1996-11#1)(2008-11#1)(2011-2#1)(2012-2#1)
two time##9##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
two times as##2##3##(1995-2#1)(2012-2#1)
two times faster##2##3##(2008-10#1)(2008-5#1)
two times##9##2##(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-5#2)(2011-2#1)(2012-2#1)
two to five##2##3##(2008-10#1)(2012-2#1)
two to four##10##3##(1990-11#1)(2008-10#5)(2008-11#1)(2010-8#2)(2013-8#1)
two to seven##2##3##(1997-5#1)(2008-11#1)
two to six##2##3##(2008-10#1)(2009-12#1)
two to three times##3##4##(1992-3#1)(2008-10#1)(2012-2#1)
two to three##9##3##(1992-3#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2012-2#1)
two to##32##2##(1990-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1996-2#1)(1997-5#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-8#2)(2012-2#2)(2013-8#1)
two tones##2##2##(1995-12#2)
two tools for##2##3##(1994-12#1)(2008-4#1)
two traits##2##2##(2008-9#2)
two transcripts##3##2##(1997-3#1)(1997-6#1)(2008-8#1)
two transgene##2##2##(1993-6#1)(2011-2#1)
two treatment groups##2##3##(1993-1#1)(1997-7#1)
two treatment methods##2##3##(1992-9#1)(2012-2#1)
two treatment studies##2##3##(2008-5#2)
two treatment##8##2##(1992-9#1)(1993-1#1)(1997-7#1)(2008-5#2)(2012-2#1)(2012-3#1)(2012-5#1)
two treatments##10##2##(1992-9#1)(1993-11#1)(1995-9#3)(1996-12#1)(2008-12#1)(2008-9#2)(2009-6#1)
two trials##3##2##(1994-3#1)(2008-10#2)
two tributaries of the##2##4##(2010-8#2)
two tropical##2##2##(2008-10#2)
two tryptophan residues##2##3##(1992-6#2)
two types of PD##2##4##(2008-7#2)
two types of binding sites##2##5##(1990-12#1)(2008-10#1)
two types of cells##3##4##(1993-1#1)(1997-1#1)(2008-11#1)
two types of homologous DNA pairing activity in mouse##2##9##(1992-6#2)
two types of optical##2##4##(2008-10#1)(2008-3#1)
two types of study##2##4##(2008-11#1)(2012-2#1)
two types of##66##3##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-12#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#5)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2012-2#2)(2012-3#2)(2013-8#3)
two types##72##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-2#1)(1997-1#1)(1997-2#2)(1997-7#2)(2007-12#2)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#6)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2012-2#2)(2012-3#2)(2013-8#3)
two typical##2##2##(1997-7#1)(2008-9#1)
two unbranched neurons##2##3##(2007-12#2)
two underwent##2##2##(2011-2#1)(2013-8#1)
two unique##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
two units##2##2##(1993-2#1)(2008-10#1)
two unknown##3##2##(2008-10#2)(2008-5#1)
two unrelated##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
two upstream##2##2##(1990-8#1)(2008-10#1)
two urban##3##2##(2008-11#1)(2008-9#1)(2010-1#1)
two used##2##2##(2008-10#2)
two valleys##2##2##(2008-10#2)
two values##2##2##(1990-12#1)(2008-11#1)
two variables##5##2##(1995-3#1)(2008-10#2)(2008-7#1)(2013-8#1)
two variants##4##2##(1990-6#3)(1995-5#1)
two varieties##4##2##(2008-10#3)(2008-5#1)
two vectors##2##2##(2008-8#1)(2011-3#1)
two very##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
two views##3##2##(1995-5#1)(2008-6#2)
two vineyards##2##2##(2008-10#2)
two viruses##11##2##(1995-2#1)(2008-10#9)(2008-9#1)
two wavelengths##11##2##(2008-10#4)(2008-2#1)(2008-3#5)(2008-9#1)
two ways##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
two week##2##2##(1997-3#1)(2008-11#1)
two weeks after##4##3##(1995-12#1)(1995-2#1)(2011-2#1)(2013-8#1)
two weeks and##3##3##(1990-3#1)(1991-9#1)(2008-5#1)
two weeks of##3##3##(1993-3#1)(1994-6#1)(2012-2#1)
two weeks##22##2##(1990-3#1)(1990-9#1)(1991-9#1)(1992-3#2)(1993-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-8#1)
two well resolved##2##3##(2009-9#2)
two were treated by##2##4##(2008-7#2)
two were##14##2##(1993-2#1)(1996-5#1)(1997-3#2)(2008-10#3)(2008-7#2)(2008-8#3)(2011-2#1)(2012-3#1)
two wheat DH##2##3##(2008-8#2)
two wild-type##2##2##(2008-10#1)(2012-3#1)
two willows##2##2##(2012-3#2)
two with##5##2##(1992-7#1)(1997-8#1)(2008-11#2)(2008-9#1)
two within isolates of C##2##5##(2008-10#2)
two women##2##2##(2008-11#1)(2013-1#1)
two years (2007 and##2##4##(2013-1#1)(2013-8#1)
two years after##4##3##(1994-3#1)(1996-3#1)(2011-2#1)(2013-1#1)
two years and##3##3##(1997-8#1)(2012-2#1)(2013-8#1)
two years in##3##3##(1997-2#1)(2008-10#2)
two years of age##3##4##(1994-9#1)(1996-1#1)(2012-12#1)
two years of the study##2##5##(1997-8#1)(2008-10#1)
two years of the##3##4##(1997-8#1)(2008-10#1)(2012-3#1)
two years of##9##3##(1994-9#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#1)
two years##54##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-8#2)(1997-2#1)(1997-8#4)(2008-10#8)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2010-10#1)(2010-11#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
two yeasts##2##2##(2008-10#1)(2013-1#1)
two##4836##1##(1990-11#12)(1990-12#16)(1990-2#9)(1990-3#10)(1990-5#20)(1990-6#9)(1990-8#14)(1990-9#10)(1991-1#4)(1991-10#4)(1991-11#10)(1991-12#25)(1991-2#19)(1991-3#18)(1991-4#1)(1991-5#16)(1991-6#19)(1991-7#2)(1991-8#3)(1991-9#16)(1992-1#4)(1992-10#6)(1992-11#5)(1992-12#14)(1992-2#10)(1992-3#23)(1992-4#7)(1992-5#4)(1992-6#14)(1992-7#1)(1992-8#1)(1992-9#22)(1993-1#20)(1993-11#9)(1993-12#45)(1993-2#28)(1993-3#16)(1993-6#32)(1993-8#28)(1993-9#10)(1994-1#2)(1994-11#31)(1994-12#18)(1994-2#14)(1994-3#12)(1994-5#38)(1994-6#5)(1994-8#16)(1994-9#11)(1995-1#3)(1995-10#1)(1995-11#12)(1995-12#29)(1995-2#34)(1995-3#7)(1995-5#16)(1995-6#28)(1995-8#18)(1995-9#13)(1996-1#15)(1996-11#4)(1996-12#32)(1996-2#31)(1996-3#19)(1996-5#14)(1996-6#17)(1996-8#7)(1996-9#10)(1997-1#2)(1997-2#26)(1997-3#17)(1997-4#5)(1997-5#1)(1997-6#7)(1997-7#23)(1997-8#27)(1997-9#4)(2006-6#4)(2007-11#9)(2007-12#47)(2007-8#7)(2008-1#13)(2008-10#1637)(2008-11#260)(2008-12#89)(2008-2#27)(2008-3#112)(2008-4#42)(2008-5#130)(2008-6#38)(2008-7#130)(2008-8#187)(2008-9#176)(2009-1#5)(2009-10#26)(2009-11#9)(2009-12#14)(2009-3#14)(2009-4#8)(2009-5#6)(2009-6#17)(2009-7#7)(2009-8#32)(2009-9#13)(2010-1#13)(2010-10#16)(2010-11#11)(2010-12#13)(2010-2#9)(2010-3#7)(2010-4#15)(2010-5#22)(2010-6#11)(2010-7#20)(2010-8#26)(2010-9#1)(2011-1#23)(2011-10#3)(2011-2#132)(2011-3#15)(2012-12#24)(2012-2#70)(2012-3#71)(2012-4#1)(2012-5#10)(2012-6#2)(2012-8#2)(2012-9#1)(2013-1#95)(2013-7#3)(2013-8#56)
two- and one-dimensional##2##3##(2008-3#2)
two- and##3##2##(2008-3#2)(2013-1#1)
two- to##3##2##(1994-5#1)(1996-3#1)(2008-10#1)
two-##10##1##(1994-5#1)(1996-3#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-9#1)(2013-1#1)
two-beam interference##2##2##(2008-3#2)
two-beam##4##1##(2008-3#4)
two-celled##2##1##(2008-10#1)(2009-12#1)
two-channel manifold##2##2##(2008-10#2)
two-channel##4##1##(2008-10#4)
two-color measurement##2##2##(2008-3#2)
two-color##8##1##(1996-2#1)(1997-3#1)(2008-3#4)(2008-4#2)
two-color-change##2##1##(2008-10#2)
two-component signal transducers in##2##4##(1996-12#2)
two-component signal transducers##3##3##(1996-12#3)
two-component signal##4##2##(1996-12#4)
two-component system##5##2##(1997-7#1)(2009-6#4)
two-component systems##3##2##(1996-12#1)(1997-7#1)(2008-10#1)
two-component##18##1##(1995-5#2)(1996-12#6)(1997-7#2)(2008-10#3)(2009-6#4)(2011-1#1)
two-dimension##2##1##(2008-10#1)(2011-3#1)
two-dimensional (2-D)##3##2##(1993-9#1)(2008-10#1)(2008-11#1)
two-dimensional (2D)##6##2##(2008-11#1)(2008-3#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-4#1)
two-dimensional 1H NMR##2##3##(1990-9#1)(1994-5#1)
two-dimensional NMR techniques##3##3##(1990-9#1)(2008-8#1)(2008-9#1)
two-dimensional and axisymmetric##2##3##(2008-3#2)
two-dimensional echocardiography##2##2##(1991-11#2)
two-dimensional electrophoresis and##2##3##(1997-2#1)(2008-4#1)
two-dimensional electrophoresis##4##2##(1996-8#1)(1997-2#1)(2008-4#2)
two-dimensional gas chromatography with##2##4##(2008-10#2)
two-dimensional gas chromatography##3##3##(2008-10#3)
two-dimensional gas##4##2##(2008-10#4)
two-dimensional gel electrophoresis##7##3##(1993-8#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-10#2)(2010-12#1)
two-dimensional gel##8##2##(1993-8#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-4#1)(2010-12#1)
two-dimensional images##2##2##(2008-3#2)
two-dimensional polyacrylamide gel electrophoresis##2##4##(1995-12#1)(1997-2#1)
two-dimensional polyacrylamide##3##2##(1995-12#1)(1997-2#2)
two-dimensional space##4##2##(2008-11#3)(2013-8#1)
two-dimensional##114##1##(1990-11#2)(1990-5#1)(1990-9#3)(1991-11#2)(1991-9#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#3)(2007-12#3)(2008-1#1)(2008-10#16)(2008-11#13)(2008-2#1)(2008-3#29)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#4)(2011-7#1)(2012-2#1)(2012-4#1)(2013-8#2)
two-electrode##2##1##(2008-10#1)(2008-8#1)
two-electron irreversible cathodic peak##2##4##(2008-10#2)
two-electron irreversible##3##2##(2008-10#3)
two-electron##9##1##(1992-1#1)(1993-8#1)(2008-10#6)(2008-11#1)
two-factor##2##1##(1993-6#1)(2008-5#1)
two-fold after##2##2##(1992-8#1)(1995-9#1)
two-fold##7##1##(1991-12#1)(1992-8#1)(1995-9#1)(1996-2#1)(2008-11#1)(2009-9#1)(2013-1#1)
two-generation##3##1##(2008-10#2)(2010-1#1)
two-hybrid assay##2##2##(2008-4#1)(2008-9#1)
two-hybrid system to##2##3##(2008-8#1)(2008-9#1)
two-hybrid system##16##2##(1997-7#1)(2008-8#9)(2008-9#6)
two-hybrid##22##1##(1997-7#1)(2008-10#1)(2008-4#2)(2008-8#10)(2008-9#8)
two-laser##2##1##(1996-5#1)(2008-3#1)
two-layer##3##1##(2008-10#1)(2008-3#2)
two-level full factorial##2##3##(2008-10#2)
two-level##7##1##(2008-10#5)(2008-7#1)(2012-3#1)
two-line##2##1##(2008-10#1)(2008-3#1)
two-locus##2##1##(2008-8#1)(2011-2#1)
two-mode##2##1##(2007-12#1)(2013-1#1)
two-node model##3##2##(1992-3#3)
two-part article##2##2##(1994-2#1)(1994-3#1)
two-part##5##1##(1993-2#1)(1994-2#1)(1994-3#1)(2008-5#1)(2012-3#1)
two-patch##2##1##(2008-8#2)
two-phase process##2##2##(2008-10#1)(2008-12#1)
two-phase system is##2##3##(2008-10#2)
two-phase system of tetrabutylammonium bromide##3##5##(2008-10#3)
two-phase system of##5##3##(2008-10#5)
two-phase system##14##2##(2008-10#12)(2011-2#2)
two-phase systems##8##2##(2008-10#4)(2008-7#3)(2010-4#1)
two-phase##32##1##(1992-12#1)(1996-5#1)(2008-10#20)(2008-12#1)(2008-7#3)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-3#1)
two-photon absorption##5##2##(2007-11#2)(2008-3#1)(2010-7#2)
two-photon coherent excitation##2##3##(2007-12#2)
two-photon excitation##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
two-photon laser scanning microscopy and confocal laser scanning microscopy##2##9##(2008-10#1)(2008-8#1)
two-photon laser-induced fluorescence##2##3##(2008-2#1)(2008-3#1)
two-photon microscopy##3##2##(2007-12#1)(2008-11#2)
two-photon photorefractive effect##2##3##(2008-3#2)
two-photon transition##2##2##(2008-3#2)
two-photon##32##1##(1992-8#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#12)(2008-8#2)(2010-1#1)(2010-7#3)
two-point affected sibpair linkage analysis##2##5##(2008-9#2)
two-point discrimination##2##2##(2008-9#2)
two-point##5##1##(2008-10#1)(2008-9#4)
two-pore domain##2##2##(2012-2#1)(2013-8#1)
two-row##2##1##(2008-10#2)
two-site##4##1##(1992-9#1)(2008-10#1)(2009-7#1)(2013-8#1)
two-species##2##1##(2008-8#1)(2008-9#1)
two-stage procedure##3##2##(1991-12#1)(2008-10#1)(2013-1#1)
two-stage process##2##2##(2008-11#2)
two-stage randomized trials with##2##4##(2012-3#2)
two-stage##31##1##(1991-12#2)(2008-10#11)(2008-11#6)(2008-2#1)(2008-4#1)(2008-8#2)(2009-10#2)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#2)
two-staged##2##1##(2008-7#1)(2011-2#1)
two-state##5##1##(1992-10#1)(1993-8#1)(1994-5#1)(1997-2#2)
two-step PCR##2##2##(2008-10#1)(2011-1#1)
two-step leaching method##2##3##(2008-10#2)
two-step reaction##2##2##(1996-5#1)(2008-10#1)
two-step sequential leaching procedure##3##4##(2008-10#3)
two-step sol-gel##3##2##(2008-10#3)
two-step##33##1##(1990-2#1)(1991-9#1)(1996-5#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-9#3)(2010-8#1)(2011-1#1)(2012-3#1)
two-third of##2##2##(2008-1#1)(2008-12#1)
two-thirds of the##8##3##(1991-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2012-3#1)
two-thirds of##15##2##(1991-12#1)(1991-2#1)(1991-8#1)(1994-9#1)(1995-6#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
two-thirds the##2##2##(1995-6#1)(2008-10#1)
two-thirds##21##1##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-9#2)(1995-6#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#1)
two-tone##2##1##(1992-12#1)(2008-11#1)
two-wave coupling##3##2##(2008-3#3)
two-wave mixing in##3##3##(2008-3#3)
two-wave mixing##8##2##(2008-3#8)
two-wave##11##1##(2008-3#11)
two-wavelength lidar inversion techniques##2##4##(2008-3#2)
two-wavelength lidar##4##2##(2008-2#1)(2008-3#3)
two-wavelength##5##1##(2008-2#1)(2008-3#4)
two-way active avoidance##2##3##(1991-2#1)(2008-4#1)
two-way factorial##2##2##(2008-10#1)(2008-9#1)
two-way sexters##3##2##(2013-1#3)
two-way text pagers##3##3##(2010-8#3)
two-way text paging systems##2##4##(2010-8#2)
two-way text paging##3##3##(2010-8#3)
two-way text##8##2##(2010-8#8)
two-way##23##1##(1991-2#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#8)(2011-2#1)(2013-1#3)
two-week##3##1##(1990-11#1)(2008-10#1)(2011-3#1)
two-year##5##1##(1991-1#1)(1995-5#1)(1996-2#1)(2008-12#1)(2011-2#1)
two?##3##1##(1993-9#1)(2008-12#1)(2013-8#1)
twofold axis in the##2##4##(1991-12#2)
twofold increase in##4##3##(1994-2#1)(2008-7#2)(2009-8#1)
twofold increase##5##2##(1994-2#1)(1996-12#1)(2008-7#2)(2009-8#1)
twofold or##2##2##(2008-10#2)
twofold##28##1##(1991-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#2)(2010-8#1)
tying##3##1##(1995-1#2)(1996-2#1)
tyloses##2##1##(2008-10#2)
tymovirus##3##1##(1997-3#1)(2008-10#2)
tymoviruses##3##1##(2008-10#3)
tympanic membrane##5##2##(1991-3#2)(2009-7#3)
tympanoplasty##2##1##(2008-9#1)(2010-7#1)
tympanotomy##3##1##(2008-9#3)
type (DAT)##2##2##(1996-11#1)(2008-6#1)
type (P##2##2##(2008-10#2)
type (n =##2##3##(2010-8#2)
type 1 (HIV-1) infection##4##4##(2008-2#4)
type 1 (HIV-1)##7##3##(1995-2#1)(2008-11#1)(2008-2#4)(2011-2#1)
type 1 5' long terminal repeat##2##6##(1993-8#2)
type 1 and type 2 immune responses##2##7##(2008-10#2)
type 1 and type 2##8##5##(1993-2#2)(1997-3#1)(2008-10#2)(2011-2#1)(2012-4#2)
type 1 and##12##3##(1993-2#2)(1994-11#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-4#2)
type 1 angiotensin II receptor##2##5##(1992-3#2)
type 1 angiotensin II##3##4##(1992-3#3)
type 1 delta protein phosphatase##2##5##(1993-6#2)
type 1 diabetes mellitus##4##4##(1991-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
type 1 diabetes##11##3##(1991-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#2)(2012-3#1)(2012-4#2)
type 1 diabetic patients##3##4##(2010-12#1)(2012-4#2)
type 1 protein##2##3##(1993-6#1)(2013-1#1)
type 1 receptor##2##3##(1992-3#1)(2012-2#1)
type 1##72##2##(1991-12#1)(1991-9#2)(1992-3#4)(1992-6#1)(1993-2#3)(1993-6#3)(1993-8#2)(1994-11#1)(1994-9#1)(1995-12#2)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#5)(2008-5#1)(2008-9#1)(2009-1#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#5)(2012-4#6)(2013-1#2)
type 1-diabetes##3##2##(2008-11#1)(2010-11#2)
type 16##4##2##(1994-1#2)(1995-2#2)
type 2 DM##2##3##(2012-2#2)
type 2 diabetes and##4##4##(2008-1#1)(2008-11#1)(2012-4#1)(2013-1#1)
type 2 diabetes in##3##4##(1994-12#1)(2009-12#1)(2010-10#1)
type 2 diabetes mellitus##9##4##(2008-1#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-10#1)(2012-5#1)
type 2 diabetes patients##3##4##(2008-11#1)(2011-2#2)
type 2 diabetes should##2##4##(1996-11#2)
type 2 diabetes treated##2##4##(2011-2#1)(2012-4#1)
type 2 diabetes##60##3##(1994-12#1)(1996-11#3)(2008-1#7)(2008-10#3)(2008-11#2)(2008-3#9)(2008-6#1)(2008-7#1)(2009-1#1)(2009-12#1)(2010-1#1)(2010-10#4)(2010-12#2)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#2)(2012-4#4)(2012-5#3)(2013-1#2)(2013-8#1)
type 2 diabetic patients##5##4##(1993-2#3)(2011-2#2)
type 2 diabetic##7##3##(1993-2#3)(2011-2#2)(2012-3#1)(2012-5#1)
type 2##94##2##(1992-6#1)(1993-11#1)(1993-2#5)(1994-11#2)(1994-12#2)(1996-11#3)(1997-1#1)(1997-3#1)(2008-1#7)(2008-10#8)(2008-11#2)(2008-3#9)(2008-6#1)(2008-7#1)(2009-1#1)(2009-12#1)(2010-1#1)(2010-10#4)(2010-12#3)(2010-3#1)(2011-1#4)(2011-2#12)(2012-12#1)(2012-2#5)(2012-3#3)(2012-4#4)(2012-5#5)(2013-1#4)(2013-8#1)
type 2)##2##2##(1992-7#1)(1993-2#1)
type 3 MT##2##3##(2008-10#2)
type 3 repeats##2##3##(1994-5#2)
type 3##11##2##(1994-5#2)(1994-6#1)(1995-8#1)(2008-10#2)(2008-11#3)(2008-7#1)(2011-1#1)
type 5 receptor##2##3##(1994-11#2)
type 5##6##2##(1994-11#2)(1995-2#1)(1997-8#1)(2008-9#1)(2010-12#1)
type 9##4##2##(1992-9#2)(2013-1#2)
type A receptor blocker##2##4##(1994-2#2)
type A##19##2##(1993-6#1)(1994-2#3)(1995-2#1)(2007-12#1)(2008-10#6)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
type B receptor blocker##2##4##(1994-2#2)
type B receptors##2##3##(1994-2#2)
type B##18##2##(1993-6#1)(1994-2#5)(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-8#1)(2013-1#1)
type C##6##2##(1992-3#3)(2008-10#1)(2008-4#1)(2009-5#1)
type I AOD with gross instability##2##6##(2012-3#2)
type I AOD##3##3##(2012-3#3)
type I IFNs##3##3##(1995-12#3)
type I SHG##2##3##(2008-2#2)
type I alpha regulatory subunit##3##5##(1990-2#3)
type I and type II##3##5##(1995-2#1)(2008-5#2)
type I and type##4##4##(1995-2#1)(2008-4#1)(2008-5#2)
type I collagen in##2##4##(2008-11#1)(2008-9#1)
type I collagen##11##3##(1997-1#2)(1997-7#3)(2008-1#1)(2008-11#1)(2008-9#2)(2009-7#1)(2013-8#1)
type I diabetes mellitus##2##4##(2011-2#1)(2013-1#1)
type I diabetes##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
type I error##5##3##(1994-9#1)(2008-10#3)(2011-2#1)
type I hypersensitivity##2##3##(2008-8#2)
type I keratin##2##3##(1996-2#2)
type I malformation##2##3##(1992-2#1)(2008-7#1)
type I second-harmonic generation##2##4##(2008-2#2)
type I##100##2##(1990-2#3)(1991-5#1)(1991-7#2)(1992-2#1)(1992-9#1)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#5)(1996-12#1)(1996-2#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#2)(2008-1#2)(2008-10#4)(2008-11#10)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#3)(2008-9#5)(2009-7#1)(2010-5#1)(2011-2#6)(2012-3#7)(2013-1#4)(2013-8#3)
type II and type##2##4##(1995-12#1)(2008-11#1)
type II and##3##3##(1995-12#2)(2008-11#1)
type II collagen##3##3##(1991-5#1)(2008-11#2)
type II diabetes mellitus##3##4##(1991-7#1)(1996-11#1)(2008-7#1)
type II diabetes##5##3##(1991-7#1)(1995-8#1)(1996-11#2)(2008-7#1)
type II hair keratins##2##4##(2008-5#2)
type II inosine 5'-monophosphate dehydrogenase##2##5##(1994-11#2)
type II pneumocytes##3##3##(1994-5#3)
type II receptor##2##3##(1997-2#2)
type II sIL-1R##2##3##(1995-2#2)
type II##60##2##(1991-10#2)(1991-5#1)(1991-7#1)(1992-3#1)(1994-11#3)(1994-5#4)(1995-11#1)(1995-12#2)(1995-2#8)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#3)(1997-2#2)(1997-8#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-2#1)
type II)##3##2##(1995-11#1)(2011-2#1)(2013-8#1)
type III and IV collagen##2##5##(2013-8#2)
type III secretion system##3##4##(2008-9#1)(2009-8#1)(2011-2#1)
type III secretion##7##3##(2008-10#1)(2008-9#3)(2009-8#1)(2011-2#1)(2013-8#1)
type III sub-populations##2##3##(2008-8#2)
type III##20##2##(1993-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-8#2)(2008-9#4)(2009-3#1)(2009-8#1)(2011-2#4)(2013-8#4)
type IIIa##2##2##(1997-7#1)(2011-3#1)
type IV and##2##3##(1992-6#1)(2011-3#1)
type IV collagenase##5##3##(2008-11#1)(2008-8#4)
type IV##11##2##(1992-6#2)(2008-11#3)(2008-8#5)(2011-3#1)
type IV)##2##2##(2008-5#1)(2008-8#1)
type P##3##2##(1996-12#1)(2008-10#2)
type STMV##4##2##(2008-10#4)
type VI collagen##7##3##(1993-3#7)
type VIII collagen##4##3##(1990-8#4)
type W##3##2##(2008-10#3)
type affected the##2##3##(2008-10#1)(2008-5#1)
type and concentration of##4##4##(2008-10#4)
type and extent of##2##4##(1995-12#1)(2008-4#1)
type and its##2##3##(2008-10#2)
type and least amount of eluent for elution of##2##9##(2008-10#2)
type and least amount of eluent for##3##7##(2008-10#3)
type and least amount of##5##5##(2008-10#5)
type and the##4##3##(2008-10#2)(2008-5#1)(2008-8#1)
type and volume of##2##4##(2008-10#2)
type and volume##3##3##(2008-10#3)
type and##72##2##(1993-8#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#37)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
type are##4##2##(1994-5#1)(1996-2#1)(2008-10#1)(2008-8#1)
type by##2##2##(2008-10#1)(2008-11#1)
type can be##2##3##(2008-10#1)(2008-8#1)
type classification##2##2##(2008-5#1)(2008-6#1)
type contained##3##2##(1997-3#3)
type cystomas##2##2##(1990-2#2)
type de##2##2##(2011-2#1)(2013-1#1)
type did not affect##2##4##(2008-10#2)
type distribution##2##2##(1990-12#1)(2011-2#1)
type epithelium##2##2##(1990-2#1)(2008-7#1)
type for the##2##3##(2008-2#1)(2008-3#1)
type glutamate receptor antagonist##2##4##(2008-11#2)
type had##2##2##(2008-10#1)(2008-11#1)
type has##2##2##(1991-11#1)(2008-10#1)
type hypersensitivity##2##2##(2008-10#2)
type in the##2##3##(2008-10#1)(2010-8#1)
type in##15##2##(1990-6#1)(1995-6#1)(1997-8#2)(2008-1#1)(2008-10#5)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#2)
type is the##3##3##(2008-3#1)(2008-8#1)(2012-3#1)
type is##14##2##(1990-5#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-8#3)(2012-3#2)(2013-1#1)
type isolates of##2##3##(2008-10#2)
type isolates##3##2##(2008-10#3)
type of abuse##2##3##(2012-12#2)
type of amyloidosis##2##3##(2011-2#2)
type of analysis##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
type of cancer##2##3##(2013-1#1)(2013-8#1)
type of dislocation##2##3##(2010-3#1)(2012-12#1)
type of dural arteriovenous shunts##2##5##(1996-9#2)
type of exercise##2##3##(2008-10#1)(2013-1#1)
type of genetic##3##3##(2008-7#1)(2008-9#1)(2012-3#1)
type of health##2##3##(1994-1#1)(2008-7#1)
type of hemocyte was##2##4##(2008-5#2)
type of information##2##3##(2008-10#1)(2008-11#1)
type of injury##2##3##(2013-1#2)
type of insurance##2##3##(1992-1#1)(1996-3#1)
type of irrational beliefs##2##4##(2010-5#2)
type of laser##2##3##(1994-2#1)(2010-1#1)
type of latex##2##3##(1990-12#1)(2008-10#1)
type of leadership style##2##4##(1992-2#2)
type of malignancy##2##3##(2008-10#1)(2008-7#1)
type of matrix##2##3##(2008-10#2)
type of mineralization##2##3##(2008-10#2)
type of model##2##3##(1997-2#1)(2008-5#1)
type of mutation##2##3##(1990-8#1)(2013-1#1)
type of operation##3##3##(1990-3#2)(1991-11#1)
type of optical##2##3##(2008-2#1)(2008-3#1)
type of research##4##3##(1993-1#1)(2008-11#1)(2008-9#1)(2009-4#1)
type of sample##3##3##(2008-10#2)(2008-4#1)
type of samples##2##3##(2008-10#2)
type of services##2##3##(1993-2#1)(2011-1#1)
type of stationary phase##2##4##(2008-10#1)(2008-11#1)
type of sterilization##2##3##(1991-3#2)
type of structural change##2##4##(2007-12#1)(2008-7#1)
type of structural##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
type of study##4##3##(1992-9#1)(2010-6#1)(2012-3#1)(2013-1#1)
type of surgery##4##3##(1993-12#1)(2008-11#1)(2009-5#1)(2010-6#1)
type of surgical intervention##2##4##(2009-12#1)(2013-1#1)
type of surgical##6##3##(1990-12#1)(2008-2#1)(2009-12#1)(2012-2#2)(2013-1#1)
type of the disease##2##4##(1991-11#1)(1996-3#1)
type of the##21##3##(1991-11#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)
type of transplant##2##3##(2011-2#2)
type of treatment##7##3##(1991-11#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-3#1)(2008-10#1)(2011-2#1)
type of tumor##3##3##(1990-2#1)(1993-11#1)(2011-2#1)
type of vector##2##3##(2008-10#1)(2008-11#1)
type of visual##2##3##(2011-2#2)
type of##432##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#4)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-5#3)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#2)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2007-12#2)(2008-1#2)(2008-10#106)(2008-11#32)(2008-12#10)(2008-2#3)(2008-3#6)(2008-4#8)(2008-5#15)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#8)(2009-1#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#4)(2010-8#5)(2011-1#4)(2011-2#22)(2011-3#3)(2012-12#6)(2012-2#10)(2012-3#10)(2013-1#23)(2013-8#10)
type on the##3##3##(1997-3#1)(2008-2#1)(2008-7#1)
type on##8##2##(1997-3#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#1)
type or##7##2##(1995-6#1)(2008-10#3)(2009-7#1)(2012-2#1)(2012-3#1)
type plasminogen activator##2##3##(1990-8#1)(2008-11#1)
type plasminogen##3##2##(1990-8#1)(1995-6#1)(2008-11#1)
type species of the genus##21##5##(1997-2#1)(2008-10#1)(2011-2#19)
type species of the##24##4##(1997-2#1)(2008-10#1)(2008-6#1)(2011-2#21)
type species##31##2##(1997-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#27)
type specific##6##2##(1997-7#1)(2008-11#2)(2008-12#2)(2009-8#1)
type strain genome from##2##4##(2011-2#2)
type strain of the species##2##5##(2011-2#2)
type strain of##4##3##(2008-10#1)(2011-2#3)
type strain was##2##3##(2008-12#1)(2012-2#1)
type strain##56##2##(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#2)(2011-2#39)(2012-2#1)(2012-3#2)
type strains of##2##3##(2008-10#2)
type strains##4##2##(1990-5#1)(1997-8#1)(2008-10#2)
type that##3##2##(2008-2#1)(2008-9#1)(2011-2#1)
type three secretion system##2##4##(2008-11#2)
type under##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
type used##2##2##(1997-3#1)(2008-7#1)
type using##2##2##(2008-10#1)(2008-7#1)
type was the##2##3##(2008-3#1)(2013-8#1)
type was##13##2##(1990-5#1)(2008-10#8)(2008-3#1)(2011-2#1)(2013-8#2)
type were##14##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-8#1)(1995-2#1)(2007-12#1)(2008-10#7)(2008-11#1)
type when##2##2##(2008-10#2)
type with##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#1)
type##1613##1##(1990-11#2)(1990-12#7)(1990-2#13)(1990-3#2)(1990-5#8)(1990-6#1)(1990-8#8)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#6)(1991-2#4)(1991-3#5)(1991-5#6)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#2)(1992-2#3)(1992-3#13)(1992-6#9)(1992-7#1)(1992-9#5)(1993-1#2)(1993-11#5)(1993-12#3)(1993-2#15)(1993-3#15)(1993-5#1)(1993-6#7)(1993-8#7)(1994-1#5)(1994-11#11)(1994-12#5)(1994-2#10)(1994-3#4)(1994-5#9)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#9)(1995-12#15)(1995-2#23)(1995-3#1)(1995-5#8)(1995-6#4)(1995-8#5)(1995-9#1)(1996-1#3)(1996-11#6)(1996-12#4)(1996-2#10)(1996-3#5)(1996-5#1)(1996-6#3)(1996-9#2)(1997-1#8)(1997-2#9)(1997-3#16)(1997-4#2)(1997-5#1)(1997-7#9)(1997-8#17)(2007-11#1)(2007-12#12)(2008-1#15)(2008-10#398)(2008-11#109)(2008-12#23)(2008-2#23)(2008-3#22)(2008-4#17)(2008-5#47)(2008-6#8)(2008-7#33)(2008-8#52)(2008-9#32)(2009-1#7)(2009-10#2)(2009-12#2)(2009-3#8)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#14)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#7)(2010-12#8)(2010-3#6)(2010-4#3)(2010-5#7)(2010-6#4)(2010-8#10)(2010-9#2)(2011-1#15)(2011-2#143)(2011-3#9)(2012-12#9)(2012-2#21)(2012-3#34)(2012-4#10)(2012-5#5)(2012-6#1)(2012-9#4)(2013-1#53)(2013-8#29)
type&quot##2##1##(1997-8#1)(2008-9#1)
type) and##3##2##(2008-10#1)(2008-5#2)
type) were##2##2##(1997-3#1)(2008-10#1)
type)##12##1##(1995-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#1)
type-1##12##1##(1994-11#1)(1996-6#3)(1997-3#1)(2008-11#1)(2008-5#2)(2009-7#1)(2012-3#2)(2013-7#1)
type-2 diabetes##2##2##(2008-8#1)(2012-2#1)
type-2 plasmids##2##2##(1996-6#2)
type-2##11##1##(1994-6#1)(1996-6#4)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#3)
type-I polyketide synthases##2##3##(2013-1#2)
type-I##5##1##(2008-10#1)(2008-11#1)(2013-1#3)
type-II cells##7##2##(1994-3#7)
type-II##8##1##(1994-11#1)(1994-3#7)
type-IV##2##1##(2008-11#1)(2011-2#1)
type-specific##9##1##(1992-9#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#1)(2009-9#1)(2012-3#1)(2013-8#2)
typeI##2##1##(2007-11#2)
typeII##2##1##(2007-11#2)
typed##4##1##(1997-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
types I and III##3##4##(2008-11#1)(2008-7#2)
types I and##5##3##(1994-12#1)(2008-11#1)(2008-7#2)(2011-2#1)
types I##6##2##(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
types IV and VII collagens##2##5##(2008-5#2)
types after##2##2##(2008-11#1)(2008-5#1)
types and least amount of eluent##2##6##(2008-10#2)
types and levels of##2##4##(1997-3#1)(2008-10#1)
types and six VCGs##3##4##(2008-10#3)
types and sizes of##2##4##(2009-1#1)(2010-8#1)
types and sizes##3##3##(2009-1#1)(2010-8#2)
types and##37##2##(1990-5#1)(1994-12#1)(1997-3#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-7#2)(2010-8#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
types are##10##2##(1992-3#1)(1994-1#1)(1995-9#1)(2007-12#2)(2008-12#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-1#1)
types at##2##2##(1995-12#1)(2008-12#1)
types based on##2##3##(2008-10#2)
types by##2##2##(2008-10#1)(2008-3#1)
types can##2##2##(1996-9#1)(2012-3#1)
types did not##3##3##(2008-10#2)(2011-2#1)
types for##5##2##(1997-8#1)(2008-10#2)(2008-12#1)(2012-3#1)
types found in##2##3##(2008-10#1)(2008-11#1)
types from##3##2##(2008-10#2)(2008-4#1)
types have been##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
types have##6##2##(1992-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
types in a##2##3##(2008-11#1)(2011-2#1)
types in populations of C##2##5##(2008-10#2)
types in the##6##3##(2008-10#2)(2008-11#1)(2009-8#2)(2010-11#1)
types in##24##2##(1992-11#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-5#1)
types including##3##2##(2008-11#1)(2008-7#1)(2009-3#1)
types is##5##2##(2008-11#2)(2008-7#1)(2010-8#1)(2011-2#1)
types may##2##2##(2008-7#1)(2012-9#1)
types of CWP##3##3##(2008-10#3)
types of SPME fiber##2##4##(2008-10#1)(2009-8#1)
types of accidents and##2##4##(1990-6#1)(2011-2#1)
types of cancer##11##3##(1990-8#1)(1992-9#1)(1993-12#1)(2008-11#1)(2008-7#3)(2010-1#1)(2010-10#1)(2013-1#1)(2013-8#1)
types of cancers##3##3##(1994-3#1)(2011-2#2)
types of cells##11##3##(1993-1#2)(1993-3#1)(1993-8#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
types of commercial##3##3##(2008-10#3)
types of data##6##3##(2008-1#2)(2008-11#2)(2008-4#1)(2011-2#1)
types of diabetes##2##3##(1995-5#1)(2013-1#1)
types of disease##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
types of electrodes##2##3##(2008-10#2)
types of environmental##2##3##(2008-10#1)(2011-1#1)
types of fluorescence##2##3##(1994-5#2)
types of friends were##2##4##(2009-7#2)
types of friends##3##3##(2009-7#3)
types of gas media##2##4##(2008-10#2)
types of genetic##2##3##(2008-10#1)(2011-3#1)
types of glands##2##3##(2007-12#2)
types of grey cast iron##2##5##(2008-10#2)
types of headache##2##3##(1994-9#1)(2008-5#1)
types of hemocytes##2##3##(2008-5#2)
types of honey##2##3##(2008-10#2)
types of human adenovirus have been##2##6##(2013-8#2)
types of human adenovirus##4##4##(2013-8#4)
types of human##7##3##(2008-9#1)(2011-2#1)(2013-8#5)
types of injuries##2##3##(1997-2#1)(2013-1#1)
types of injury##2##3##(2012-2#2)
types of isoflavones##2##3##(2010-3#2)
types of junctions##2##3##(2008-7#1)(2009-10#1)
types of lesion##3##3##(1996-9#2)(2008-6#1)
types of medical##3##3##(1995-3#1)(1997-3#1)(2008-1#1)
types of microbes##3##3##(2011-2#1)(2012-2#2)
types of models##2##3##(2008-10#1)(2010-1#1)
types of multiple##2##3##(1991-12#1)(2012-3#1)
types of natural##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
types of neurons##5##3##(1997-2#1)(2008-11#2)(2009-8#2)
types of organelles##2##3##(2008-4#1)(2009-10#1)
types of pain##2##3##(2008-9#1)(2009-8#1)
types of plywood##2##3##(2008-7#2)
types of porouscarriers##2##3##(2008-11#2)
types of procedures##2##3##(1995-2#1)(2008-4#1)
types of progenitor cells##2##4##(2008-9#2)
types of raw materials##2##4##(2008-10#2)
types of reactions##2##3##(2008-10#2)
types of reactors##2##3##(2008-10#2)
types of receptors##3##3##(1990-11#1)(1995-11#1)(1997-1#1)
types of regression##2##3##(1992-9#1)(2008-10#1)
types of samples##4##3##(2008-10#3)(2012-2#1)
types of sensilla##2##3##(2007-12#2)
types of soils##2##3##(2008-10#2)
types of solid##2##3##(2008-10#1)(2008-11#1)
types of sounds##2##3##(2010-8#1)(2011-1#1)
types of surgery##2##3##(1991-3#1)(1994-12#1)
types of synaptic##2##3##(1997-3#1)(2008-11#1)
types of technical change##2##4##(1992-1#2)
types of the##6##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)
types of these##2##3##(2008-10#1)(2010-10#1)
types of tumors##4##3##(2008-11#3)(2011-2#1)
types of water##2##3##(2008-10#2)
types of##546##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#1)(1992-1#3)(1992-12#5)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#8)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1996-1#1)(1996-2#5)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#4)(1997-2#10)(1997-3#4)(1997-7#3)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#9)(2008-1#4)(2008-10#137)(2008-11#42)(2008-12#6)(2008-2#2)(2008-3#11)(2008-4#12)(2008-5#17)(2008-6#3)(2008-7#19)(2008-8#16)(2008-9#12)(2009-1#2)(2009-10#6)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#8)(2009-8#6)(2010-1#5)(2010-10#4)(2010-11#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#3)(2011-2#18)(2011-3#2)(2011-7#1)(2012-2#13)(2012-3#14)(2012-8#1)(2012-9#1)(2013-1#17)(2013-8#15)
types showed##2##2##(2008-10#1)(2012-3#1)
types such as##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
types tested##2##2##(1991-5#1)(1997-1#1)
types that were##2##3##(2008-10#2)
types that##8##2##(1996-1#1)(2008-10#5)(2011-1#1)(2011-2#1)
types to the##2##3##(1997-8#1)(2008-10#1)
types to##4##2##(1997-8#1)(2008-10#3)
types used##3##2##(2008-11#2)(2008-9#1)
types using##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
types was##5##2##(1990-2#1)(2008-10#2)(2010-6#1)(2011-2#1)
types were observed##2##3##(1992-6#1)(2011-2#1)
types were present in##2##4##(2008-10#2)
types were##23##2##(1991-8#1)(1992-6#1)(1994-5#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
types with high##2##3##(2008-10#1)(2008-8#1)
types with the##2##3##(1994-1#1)(2013-8#1)
types with##5##2##(1994-1#1)(2008-10#2)(2008-8#1)(2013-8#1)
types##908##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#6)(1991-2#3)(1991-3#2)(1991-5#2)(1991-8#1)(1992-1#3)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#4)(1992-6#5)(1992-8#2)(1992-9#2)(1993-1#3)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#4)(1993-8#8)(1994-1#3)(1994-11#3)(1994-12#7)(1994-2#2)(1994-3#4)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#7)(1996-3#2)(1996-6#3)(1996-9#3)(1997-1#6)(1997-2#13)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#5)(2006-6#3)(2007-11#1)(2007-12#11)(2008-1#4)(2008-10#241)(2008-11#80)(2008-12#12)(2008-2#5)(2008-3#17)(2008-4#16)(2008-5#32)(2008-6#5)(2008-7#33)(2008-8#26)(2008-9#25)(2009-1#3)(2009-10#7)(2009-12#6)(2009-2#1)(2009-3#2)(2009-6#3)(2009-7#9)(2009-8#13)(2010-1#5)(2010-10#6)(2010-11#3)(2010-12#3)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#4)(2011-2#34)(2011-3#3)(2011-7#1)(2012-12#1)(2012-2#21)(2012-3#24)(2012-4#1)(2012-5#2)(2012-8#1)(2012-9#2)(2013-1#27)(2013-8#17)
types) and##2##2##(1991-2#1)(2008-12#1)
types)##3##1##(1991-2#1)(2008-12#1)(2013-1#1)
typhimurium strain##2##2##(2008-10#1)(2008-9#1)
typhimurium##16##1##(1991-12#1)(1993-8#1)(1996-3#1)(1996-6#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#4)(2010-4#2)(2011-1#1)
typhoid##2##1##(1992-2#1)(2011-2#1)
typical Michaelis-Menten##2##2##(2008-10#1)(2012-2#1)
typical adult##2##2##(2008-10#1)(2008-11#1)
typical and##2##2##(2008-10#1)(2009-12#1)
typical case##3##2##(1994-12#1)(2008-1#1)(2012-3#1)
typical clinical##4##2##(1995-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
typical concentrations##2##2##(2008-10#2)
typical environmental##2##2##(2008-10#1)(2013-1#1)
typical error##2##2##(2008-12#2)
typical examples##2##2##(2008-10#1)(2008-11#1)
typical features of##3##3##(1993-2#1)(2007-12#1)(2012-2#1)
typical findings##2##2##(2008-5#1)(2010-6#1)
typical for the##2##3##(2007-12#1)(2008-12#1)
typical for##12##2##(1991-2#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
typical form of##2##3##(1997-8#1)(2010-6#1)
typical language development##2##3##(2009-8#1)(2011-1#1)
typical leaf##2##2##(2008-10#2)
typical of a##2##3##(1997-2#1)(2008-10#1)
typical of strains##2##3##(2008-10#1)(2008-5#1)
typical of the##5##3##(1994-11#1)(2008-10#2)(2008-11#1)(2008-12#1)
typical of##59##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1997-2#1)(2007-12#1)(2008-10#21)(2008-11#3)(2008-12#4)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#2)(2011-2#2)
typical problems##2##2##(2008-10#2)
typical root##2##2##(2008-10#2)
typical symptoms and##2##3##(1995-2#1)(2008-10#1)
typical symptoms of##3##3##(2008-10#2)(2012-12#1)
typical symptoms##8##2##(1991-4#1)(1995-2#1)(2008-10#5)(2012-12#1)
typical##322##1##(1990-12#1)(1990-3#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-2#3)(1993-3#2)(1993-8#2)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#3)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#5)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#108)(2008-11#17)(2008-12#10)(2008-3#11)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#2)(2009-5#1)(2009-7#3)(2009-8#6)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#3)(2010-6#6)(2010-9#1)(2011-1#2)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#3)
typical&quot##2##1##(1993-12#1)(2009-11#1)
typically affects the##2##3##(2011-2#1)(2012-3#1)
typically are##3##2##(2008-10#2)(2012-2#1)
typically based on##2##3##(1996-6#1)(2008-3#1)
typically be##2##2##(2008-10#1)(2010-12#1)
typically carried##2##2##(2008-11#1)(2012-3#1)
typically contained##2##2##(2008-10#1)(2009-7#1)
typically developing##3##2##(2008-12#1)(2010-9#1)(2011-2#1)
typically exhibit##3##2##(1993-9#1)(1996-3#1)(2008-10#1)
typically found in##2##3##(2008-10#1)(2011-2#1)
typically have##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
typically in the##2##3##(2008-10#1)(2009-1#1)
typically increase##2##2##(1995-12#1)(2011-2#1)
typically low##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
typically observed in##3##3##(2008-11#1)(2013-1#2)
typically performed##2##2##(2008-10#1)(2012-3#1)
typically present##2##2##(2009-8#1)(2012-2#1)
typically require##2##2##(1995-9#1)(2012-3#1)
typically results in##2##3##(2008-8#2)
typically the##2##2##(2008-10#1)(2012-3#1)
typically used in##3##3##(2008-9#1)(2010-12#1)(2010-9#1)
typically used##4##2##(2008-4#1)(2008-9#1)(2010-12#1)(2010-9#1)
typically##139##1##(1991-9#1)(1992-12#1)(1993-9#1)(1994-3#1)(1995-12#3)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(2008-1#1)(2008-10#33)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#11)(2008-9#5)(2009-1#1)(2009-4#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-9#2)(2011-2#11)(2012-12#2)(2012-2#5)(2012-3#8)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
typified by##2##2##(2008-10#1)(2009-7#1)
typing a##2##2##(1993-9#1)(2008-9#1)
typing and##2##2##(2008-5#1)(2012-2#1)
typing assays##2##2##(2008-10#1)(2008-12#1)
typing in##2##2##(1997-8#1)(2011-2#1)
typing of##7##2##(1997-8#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
typing system##2##2##(1995-11#1)(1997-8#1)
typing to##2##2##(2008-10#2)
typing##44##1##(1991-6#1)(1993-9#2)(1995-11#1)(1997-8#8)(2008-10#12)(2008-11#1)(2008-12#4)(2008-5#1)(2008-9#1)(2011-2#9)(2012-2#2)(2012-3#1)(2013-8#1)
typology of##2##2##(1991-6#1)(2013-8#1)
typology##4##1##(1991-6#1)(2008-5#1)(2010-12#1)(2013-8#1)
tyramide##2##1##(2008-10#1)(2008-4#1)
tyramine##5##1##(1995-6#1)(2008-10#2)(2008-7#2)
tyrosinase activity##3##2##(1995-2#1)(2008-5#1)(2013-1#1)
tyrosinase and horse-radish peroxidase##4##4##(2008-10#4)
tyrosinase and##5##2##(1995-2#1)(2008-10#4)
tyrosinase biosensor##3##2##(2008-10#3)
tyrosinase electrode##2##2##(2008-10#2)
tyrosinase enzyme##2##2##(2008-10#2)
tyrosinase inhibition##2##2##(2008-10#1)(2008-5#1)
tyrosinase inhibitor##2##2##(2013-1#2)
tyrosinase mRNA##2##2##(2008-5#2)
tyrosinase##45##1##(1995-2#2)(2008-10#26)(2008-5#13)(2013-1#4)
tyrosinase-based carbon paste electrode##2##4##(2008-10#2)
tyrosinate fluorescence##4##2##(1991-5#4)
tyrosinate##5##1##(1991-5#5)
tyrosine and##3##2##(1995-2#1)(1996-2#1)(2008-10#1)
tyrosine at##3##2##(1997-3#1)(2008-10#2)
tyrosine hydroxylase (TH)##6##3##(1990-7#1)(1996-12#2)(1997-3#1)(2008-11#1)(2011-2#1)
tyrosine hydroxylase##8##2##(1990-7#1)(1996-12#3)(1996-5#1)(1997-3#1)(2008-11#1)(2011-2#1)
tyrosine into##2##2##(2008-11#1)(2008-5#1)
tyrosine kinase PYK2##2##3##(1995-8#2)
tyrosine kinase activity##13##3##(1990-12#3)(1992-7#3)(1993-8#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-4#1)(2009-7#1)(2011-1#1)
tyrosine kinase and##2##3##(1992-7#1)(2013-1#1)
tyrosine kinase in the##2##4##(1993-8#1)(1995-8#1)
tyrosine kinase inhibitor methyl 2##2##5##(1996-12#2)
tyrosine kinase inhibitor##4##3##(1994-6#1)(1996-12#2)(2010-11#1)
tyrosine kinase inhibitors##4##3##(2010-5#2)(2011-3#1)(2013-1#1)
tyrosine kinase receptors##2##3##(1995-2#1)(2012-3#1)
tyrosine kinase that is##2##4##(1995-8#1)(1997-7#1)
tyrosine kinase##51##2##(1990-12#3)(1992-7#9)(1993-8#5)(1994-6#2)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#6)(1996-12#3)(1997-1#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-3#1)(2012-3#2)(2013-1#3)
tyrosine kinases and##2##3##(1996-2#1)(2011-2#1)
tyrosine kinases##14##2##(1993-8#2)(1994-11#1)(1995-2#1)(1995-6#1)(1996-2#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
tyrosine phosphatase (PTPase)##2##3##(1997-7#1)(2008-8#1)
tyrosine phosphatase epsilon##2##3##(2009-6#2)
tyrosine phosphatase##12##2##(1994-11#1)(1994-6#1)(1995-2#3)(1995-9#1)(1997-7#2)(2008-8#1)(2009-6#2)(2009-7#1)
tyrosine phosphatases##2##2##(1995-8#1)(2008-4#1)
tyrosine phosphorylated##2##2##(1996-2#2)
tyrosine phosphorylation and respiratory-burst activity triggered by PMA##2##8##(1994-6#2)
tyrosine phosphorylation and respiratory-burst activity##4##5##(1994-6#4)
tyrosine phosphorylation and##11##3##(1994-6#8)(1995-6#1)(1996-12#1)(1996-2#1)
tyrosine phosphorylation of IRS-I##2##4##(1997-1#2)
tyrosine phosphorylation of Shc##3##4##(1995-8#1)(1997-7#2)
tyrosine phosphorylation of##9##3##(1992-10#2)(1993-8#1)(1995-8#1)(1997-1#2)(1997-7#2)(2008-8#1)
tyrosine phosphorylation was##2##3##(1994-6#1)(1997-1#1)
tyrosine phosphorylation##38##2##(1992-10#3)(1992-4#1)(1993-8#1)(1993-9#1)(1994-6#11)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#3)(1997-1#6)(1997-7#2)(2008-8#1)(2011-1#2)
tyrosine residues in##3##3##(1993-6#1)(1995-8#1)(2008-8#1)
tyrosine residues##14##2##(1993-6#1)(1994-11#3)(1995-6#1)(1995-8#1)(1996-2#1)(1997-9#1)(2008-1#1)(2008-7#1)(2008-8#3)(2011-2#1)
tyrosine##171##1##(1990-12#3)(1990-7#1)(1990-8#1)(1992-1#1)(1992-10#3)(1992-12#1)(1992-4#1)(1992-7#9)(1992-9#1)(1993-6#1)(1993-8#8)(1993-9#1)(1994-11#5)(1994-6#14)(1994-8#2)(1995-2#7)(1995-6#7)(1995-8#10)(1995-9#1)(1996-12#9)(1996-2#10)(1996-5#1)(1997-1#7)(1997-3#2)(1997-7#6)(1997-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)
tyrosine-phosphorylated peptides##4##2##(2008-1#2)(2008-4#2)
tyrosine-phosphorylated##6##1##(1995-8#1)(2008-1#2)(2008-4#2)(2008-8#1)
tyrosyl##3##1##(1990-2#1)(1997-7#1)(2008-8#1)
u##13##1##(1991-5#6)(1994-9#2)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#1)
u-PA##5##1##(1994-3#2)(2008-11#3)
uM)##2##1##(2008-11#2)
uPA that##2##2##(2008-11#2)
uPA##15##1##(2008-11#15)
uberis##2##1##(1996-8#2)
ubiquinone##4##1##(1993-12#1)(1994-11#1)(1995-3#1)(1995-8#1)
ubiquitin ligase##4##2##(2009-10#2)(2011-3#2)
ubiquitin promoter##2##2##(2008-9#2)
ubiquitin##17##1##(1991-1#1)(1993-6#1)(1993-8#2)(2008-4#2)(2008-9#3)(2009-10#3)(2009-7#1)(2011-3#2)(2012-2#1)(2013-1#1)
ubiquitin-like##2##1##(1993-6#1)(1993-8#1)
ubiquitin-proteasome##7##1##(2008-9#5)(2011-2#1)(2012-3#1)
ubiquitin-protein conjugates##2##2##(1994-11#1)(2008-4#1)
ubiquitination##8##1##(2008-4#2)(2008-9#4)(2009-10#1)(2009-7#1)
ubiquitous in the##4##3##(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)
ubiquitous in##8##2##(2008-10#3)(2008-9#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)
ubiquitous presence##2##2##(2011-2#1)(2013-1#1)
ubiquitous##39##1##(1990-12#1)(1992-10#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-11#2)(1996-8#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
ubiquitously expressed##8##2##(1992-6#1)(1995-8#1)(1997-7#1)(1997-8#1)(2009-8#1)(2011-2#2)(2013-8#1)
ubiquitously##13##1##(1992-6#1)(1994-11#1)(1995-6#1)(1995-8#1)(1997-7#2)(1997-8#1)(2009-8#1)(2010-7#1)(2011-2#2)(2013-8#2)
ubiquity##2##1##(1993-3#1)(2008-9#1)
udder##2##1##(1990-6#1)(2011-2#1)
ug ml(-1)##3##2##(2008-11#3)
uidA##3##1##(2008-10#2)(2008-8#1)
ulcer and##5##2##(1992-11#2)(2010-8#1)(2011-2#1)(2012-3#1)
ulcer disease##11##2##(1992-9#2)(1993-2#1)(1996-11#1)(1997-1#3)(1997-3#1)(2009-8#1)(2010-12#1)(2011-2#1)
ulcer healing in the colon##2##5##(2008-12#2)
ulcer in##2##2##(2011-2#1)(2012-3#1)
ulcer is a##4##3##(1990-3#1)(1996-11#1)(2008-9#1)(2010-8#1)
ulcer is##8##2##(1990-3#1)(1992-11#1)(1993-6#1)(1996-11#1)(2008-12#1)(2008-9#1)(2010-8#1)(2013-1#1)
ulcer may be##2##3##(2008-12#1)(2011-2#1)
ulcer model##3##2##(2012-2#3)
ulcer of the##3##3##(1990-3#1)(2008-11#1)(2011-2#1)
ulcer of##4##2##(1990-11#1)(1990-3#1)(2008-11#1)(2011-2#1)
ulcer patients##4##2##(1992-9#1)(1997-1#2)(1997-3#1)
ulcer was##2##2##(2008-12#1)(2011-2#1)
ulcer wound##2##2##(2013-1#2)
ulcer##84##1##(1990-11#1)(1990-3#4)(1991-2#1)(1992-11#4)(1992-5#1)(1992-6#2)(1992-9#3)(1993-2#1)(1993-6#1)(1995-10#2)(1996-11#4)(1997-1#5)(1997-3#2)(2007-11#1)(2008-11#4)(2008-12#13)(2008-9#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-2#6)(2012-2#5)(2012-3#7)(2013-1#7)
ulcer]##4##1##(1993-6#1)(1994-3#1)(1997-3#1)(2012-3#1)
ulcerated##5##1##(1990-6#1)(2012-3#1)(2013-1#3)
ulceration in##2##2##(1991-8#1)(2013-1#1)
ulceration of##2##2##(1996-8#2)
ulceration##9##1##(1991-8#1)(1996-8#2)(1997-1#1)(2010-12#1)(2010-8#1)(2013-1#3)
ulcerative colitis##20##2##(1992-9#1)(1994-6#1)(1995-10#3)(1995-8#1)(1997-8#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#7)(2011-2#1)(2013-1#2)
ulcerative colitis]##3##2##(1990-6#1)(1993-2#1)(2008-12#1)
ulcerative rectocolitis##3##2##(1990-3#1)(1992-3#2)
ulcerative##28##1##(1990-3#1)(1990-6#1)(1991-3#1)(1992-3#3)(1992-9#1)(1993-2#1)(1994-6#1)(1995-10#3)(1995-8#1)(1997-8#1)(2008-12#2)(2008-5#1)(2010-11#1)(2010-12#7)(2011-2#1)(2013-1#2)
ulcers and##2##2##(1995-2#1)(2010-12#1)
ulcers are##3##2##(1990-5#1)(2013-1#2)
ulcers in the##2##3##(1990-11#1)(2010-12#1)
ulcers in##3##2##(1990-11#1)(2010-12#1)(2013-1#1)
ulcers of##2##2##(1990-3#1)(2012-2#1)
ulcers often##2##2##(1997-3#1)(2013-1#1)
ulcers that##2##2##(1991-11#1)(2013-1#1)
ulcers were##2##2##(1996-11#1)(2012-3#1)
ulcers##50##1##(1990-11#1)(1990-3#5)(1990-5#2)(1990-6#1)(1991-11#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1995-2#1)(1996-11#2)(1997-1#1)(1997-3#2)(2007-8#1)(2008-1#1)(2008-12#3)(2008-4#1)(2010-10#2)(2010-12#6)(2010-6#1)(2012-2#2)(2012-3#2)(2013-1#11)
ulcus##2##1##(1992-5#2)
ulna in##4##2##(2007-8#1)(2011-2#2)(2013-8#1)
ulna was##2##2##(2007-8#2)
ulna##8##1##(2007-8#4)(2011-2#2)(2013-1#1)(2013-8#1)
ulnar digits##2##2##(2008-9#2)
ulnar nerve compression##2##3##(2008-9#2)
ulnar nerve##9##2##(2008-12#1)(2008-9#8)
ulnar##17##1##(1997-3#2)(2008-12#1)(2008-9#12)(2011-2#1)(2013-8#1)
ulnar-positive##2##1##(2008-9#2)
ultimate function##2##2##(2009-10#1)(2012-3#1)
ultimate goal is to##2##4##(2008-11#1)(2012-3#1)
ultimate goal is##3##3##(1992-1#1)(2008-11#1)(2012-3#1)
ultimate goal##4##2##(1992-1#1)(2008-11#1)(2010-9#1)(2012-3#1)
ultimate goals in##2##3##(2008-10#2)
ultimate outcome##3##2##(1991-12#1)(1997-3#1)(2008-11#1)
ultimate tensile strength##2##3##(2012-2#2)
ultimate##33##1##(1991-12#1)(1991-5#1)(1992-1#1)(1993-3#1)(1995-11#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
ultimately be##2##2##(1993-2#1)(2011-2#1)
ultimately leading to##2##3##(2010-1#1)(2011-2#1)
ultimately to the##2##3##(2008-11#1)(2009-8#1)
ultimately to##4##2##(2008-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
ultimately will##2##2##(1992-12#1)(2012-2#1)
ultimately##75##1##(1990-3#1)(1992-10#1)(1992-12#1)(1993-1#2)(1993-2#1)(1994-1#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
ultimum and##5##2##(2008-10#5)
ultimum on##3##2##(2008-10#3)
ultimum##36##1##(2008-10#36)
ultra high##5##2##(1992-3#2)(2008-10#1)(2009-3#1)(2010-4#1)
ultra trace amounts of##9##4##(2008-10#9)
ultra trace analysis##3##3##(2008-10#3)
ultra trace##22##2##(2008-10#22)
ultra violet##2##2##(2008-10#1)(2008-9#1)
ultra##37##1##(1992-3#3)(2008-10#28)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#1)
ultra-dilute solutions##2##2##(2008-10#2)
ultra-high resolution##2##2##(2011-7#2)
ultra-high##8##1##(2008-10#2)(2008-11#1)(2011-7#2)(2012-2#1)(2013-1#2)
ultra-low protein##2##2##(2008-11#2)
ultra-pure water##2##2##(2008-10#2)
ultra-pure##4##1##(2008-10#4)
ultra-sensitive##5##1##(2008-10#4)(2009-12#1)
ultra-slow##3##1##(2011-2#3)
ultra-trace amounts of Cr(VI)##2##4##(2008-10#2)
ultra-trace levels of##3##3##(2008-10#3)
ultra-trace##16##1##(2008-10#16)
ultra-violet##3##1##(2008-10#1)(2008-5#1)(2012-2#1)
ultrabrief bilateral ECT##2##3##(2012-12#2)
ultrabrief pulse##4##2##(2012-12#4)
ultrabrief##7##1##(2012-12#7)
ultracentrifugation and##2##2##(2008-11#1)(2011-2#1)
ultracentrifugation##8##1##(1992-12#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
ultraendurance runners##4##2##(2013-8#4)
ultraendurance##5##1##(2013-8#5)
ultrafast laser##2##2##(2008-3#2)
ultrafast##7##1##(2007-12#2)(2008-3#4)(2008-8#1)
ultrafiltered urines##2##2##(2008-12#2)
ultrafiltrate##3##1##(2008-11#2)(2011-2#1)
ultrafiltration and##3##2##(2008-10#3)
ultrafiltration is##2##2##(2008-10#2)
ultrafiltration process##2##2##(2008-10#2)
ultrafiltration##44##1##(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#30)(2008-11#1)(2008-7#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
ultrahigh vacuum##2##2##(1990-11#1)(2013-8#1)
ultrahigh##4##1##(1990-11#1)(2007-12#1)(2011-2#1)(2013-8#1)
ultralow frequency##2##2##(2008-9#2)
ultralow##3##1##(2008-9#2)(2010-4#1)
ultramarathon##6##1##(2013-8#6)
ultramarine##2##1##(2008-10#2)
ultramicroelectrode was##2##2##(2008-10#2)
ultramicroelectrode##5##1##(1995-6#1)(2008-10#4)
ultramicrosensors based on electropolymerized films of##2##6##(2008-10#2)
ultramicrosensors##4##1##(2008-10#4)
ultrapure water##2##2##(2008-10#2)
ultrapurified water##2##2##(2008-10#2)
ultrarapid##3##1##(2008-10#3)
ultrasensitive##4##1##(2008-10#2)(2008-3#1)(2009-5#1)
ultrashort laser pulses##2##3##(2008-2#1)(2008-3#1)
ultrashort pulse##3##2##(2007-12#1)(2008-3#2)
ultrashort##7##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
ultrasonic agitation and vortex mixing##2##5##(2008-10#2)
ultrasonic agitation##4##2##(2008-10#4)
ultrasonic and##4##2##(1991-1#1)(1993-2#1)(2013-1#2)
ultrasonic assisted##2##2##(2008-10#2)
ultrasonic bath and##3##3##(2008-10#3)
ultrasonic bath##12##2##(2008-10#12)
ultrasonic beam##3##2##(2007-12#3)
ultrasonic extraction and##3##3##(2008-10#2)(2013-8#1)
ultrasonic extraction##4##2##(2008-10#3)(2013-8#1)
ultrasonic field##2##2##(2008-10#2)
ultrasonic inhaler##3##2##(1993-2#3)
ultrasonic nebulization##8##2##(1991-1#1)(2008-10#7)
ultrasonic nebulizer##6##2##(1991-1#3)(1993-2#2)(2008-10#1)
ultrasonic nebulizers##3##2##(1991-1#1)(1993-2#1)(1996-2#1)
ultrasonic slurry sampling electrothermal##2##4##(2008-10#2)
ultrasonic slurry sampling##4##3##(2008-10#4)
ultrasonic slurry##5##2##(2008-10#5)
ultrasonic treatment##3##2##(1993-2#2)(2009-12#1)
ultrasonic vocalization##4##2##(1994-8#3)(2008-4#1)
ultrasonic##100##1##(1990-12#1)(1991-1#6)(1993-2#10)(1994-8#3)(1994-9#1)(1996-2#1)(2007-12#5)(2008-10#55)(2008-11#5)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
ultrasonic-assisted extraction of##2##3##(2008-10#2)
ultrasonic-assisted extraction##4##2##(2008-10#4)
ultrasonic-assisted##5##1##(2008-10#5)
ultrasonic-based sample treatment##2##3##(2008-10#2)
ultrasonically##2##1##(2008-11#1)(2012-3#1)
ultrasonication##6##1##(1997-2#1)(2008-10#4)(2010-4#1)
ultrasonographic findings##2##2##(1997-7#1)(2008-12#1)
ultrasonographic##10##1##(1990-9#2)(1993-12#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)(2013-8#1)
ultrasonography (US)##3##2##(2008-1#1)(2010-12#1)(2012-2#1)
ultrasonography and##7##2##(2008-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
ultrasonography as##2##2##(1991-6#1)(1996-11#1)
ultrasonography for##2##2##(2010-11#1)(2012-3#1)
ultrasonography in##2##2##(1992-9#1)(2010-12#1)
ultrasonography is##3##2##(1990-9#1)(1994-6#1)(2011-2#1)
ultrasonography or##2##2##(2011-2#1)(2013-1#1)
ultrasonography was##2##2##(1996-11#1)(2011-1#1)
ultrasonography##48##1##(1990-9#2)(1991-6#1)(1992-7#1)(1992-9#3)(1993-2#1)(1994-6#2)(1996-11#3)(1996-2#1)(1996-3#3)(1997-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#5)
ultrasound (CEUS)##5##2##(2010-12#2)(2012-2#3)
ultrasound (EUS)##3##2##(2008-2#1)(2010-12#1)(2013-1#1)
ultrasound (US)##5##2##(2008-9#1)(2010-12#3)(2011-2#1)
ultrasound amplitude##3##2##(2008-10#3)
ultrasound and##9##2##(1994-5#1)(1995-3#1)(2008-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
ultrasound assisted pseudo-digestion##3##3##(2008-10#3)
ultrasound assisted##5##2##(2008-10#5)
ultrasound bath##2##2##(2008-10#2)
ultrasound can##2##2##(2011-2#2)
ultrasound contrast##2##2##(2012-2#2)
ultrasound detection##3##2##(2007-11#1)(2009-5#2)
ultrasound energy##4##2##(2008-10#4)
ultrasound examination##11##2##(1990-9#1)(1991-6#1)(1994-6#1)(1995-8#1)(1996-11#3)(1997-8#1)(2011-2#1)(2012-3#2)
ultrasound finding##2##2##(2013-1#2)
ultrasound findings##3##2##(1996-11#1)(2008-10#1)(2008-12#1)
ultrasound guidance##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
ultrasound guided##2##2##(1996-3#1)(2008-11#1)
ultrasound has##2##2##(1991-6#1)(2012-2#1)
ultrasound imaging in##3##3##(2008-5#1)(2010-12#2)
ultrasound in the presence of the photosensitizing drug Photofrin II##2##10##(1993-8#2)
ultrasound in the##7##3##(1993-8#2)(2008-2#1)(2009-6#3)(2010-12#1)
ultrasound in##16##2##(1992-6#1)(1993-8#2)(1994-6#1)(1997-3#1)(2008-2#1)(2009-6#3)(2010-12#1)(2011-2#1)(2011-5#1)(2012-2#2)(2012-3#2)
ultrasound is##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
ultrasound of the##2##3##(1997-8#1)(2012-2#1)
ultrasound on the##2##3##(2008-10#1)(2011-2#1)
ultrasound on##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
ultrasound or##2##2##(2008-10#1)(2012-2#1)
ultrasound probes##2##2##(1992-12#1)(2009-12#1)
ultrasound scan##6##2##(1995-10#1)(1997-3#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
ultrasound scanning##2##2##(1996-1#1)(2008-7#1)
ultrasound screening##3##2##(1994-6#1)(2008-11#1)(2012-3#1)
ultrasound shear##3##2##(2008-5#3)
ultrasound to##4##2##(1992-12#1)(1992-5#1)(1993-8#1)(2011-2#1)
ultrasound with##2##2##(2008-12#1)(2008-8#1)
ultrasound##205##1##(1990-11#1)(1990-9#1)(1991-3#1)(1991-6#3)(1992-12#4)(1992-5#1)(1992-6#1)(1993-1#1)(1993-8#4)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#6)(1995-10#1)(1995-3#2)(1995-8#1)(1996-1#2)(1996-11#4)(1996-3#2)(1997-3#2)(1997-8#4)(2007-11#1)(2007-12#1)(2008-10#40)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#5)(2009-6#6)(2009-8#1)(2010-12#14)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#16)(2011-5#1)(2012-12#2)(2012-2#16)(2012-3#9)(2013-1#13)(2013-8#4)
ultrasound-assisted acid leaching##3##3##(2008-10#3)
ultrasound-assisted extraction and microwave-assisted digestion##2##5##(2008-10#2)
ultrasound-assisted extraction and##3##3##(2008-10#3)
ultrasound-assisted extraction procedure##2##3##(2008-10#2)
ultrasound-assisted extraction##7##2##(2008-10#7)
ultrasound-assisted pseudo-digestion##2##2##(2008-10#2)
ultrasound-assisted##14##1##(2008-10#14)
ultrasound-guided regional anesthesia##3##3##(2012-2#3)
ultrasound-guided##11##1##(1993-11#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#6)(2013-1#1)
ultrasound-modulated##2##1##(2007-12#2)
ultrasound]##3##1##(1996-3#1)(1996-6#1)(2013-1#1)
ultrasounds##4##1##(1994-8#1)(2008-10#2)(2008-5#1)
ultrastructural analysis##2##2##(2008-7#1)(2008-9#1)
ultrastructural and biochemical##2##3##(2008-10#1)(2008-7#1)
ultrastructural and##5##2##(1992-3#1)(2007-12#1)(2008-10#2)(2008-7#1)
ultrastructural changes in##2##3##(2008-10#1)(2008-12#1)
ultrastructural changes##7##2##(2008-10#6)(2008-12#1)
ultrastructural evidence##2##2##(1997-2#1)(2009-7#1)
ultrastructural examination##4##2##(1992-2#1)(1992-9#1)(2007-12#1)(2008-11#1)
ultrastructural features of the##3##4##(1991-8#1)(2007-12#1)(2008-7#1)
ultrastructural features##5##2##(1991-8#1)(1992-12#1)(2007-12#1)(2008-7#2)
ultrastructural level##4##2##(2008-10#1)(2008-7#2)(2011-2#1)
ultrastructural localization of##3##3##(1992-3#1)(2008-5#1)(2011-2#1)
ultrastructural studies on##2##3##(2008-5#1)(2008-7#1)
ultrastructural studies##7##2##(1992-2#1)(1993-11#1)(1994-8#1)(2007-12#1)(2008-5#1)(2008-7#2)
ultrastructural study of##2##3##(2008-5#1)(2008-7#1)
ultrastructural study##6##2##(1993-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-7#1)
ultrastructural##63##1##(1991-8#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-9#1)(1993-11#2)(1994-11#1)(1994-8#2)(1995-3#1)(1997-2#1)(2007-12#5)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#13)(2008-9#2)(2009-7#2)(2010-8#1)(2011-2#3)
ultrastructurally investigated##2##2##(2008-10#2)
ultrastructurally##7##1##(1991-8#1)(1994-12#1)(2008-10#3)(2008-5#1)(2013-8#1)
ultrastructure and##4##2##(2007-12#3)(2008-10#1)
ultrastructure of the##3##3##(2007-12#1)(2008-12#1)(2008-5#1)
ultrastructure of##20##2##(2007-12#3)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#8)(2008-8#1)(2009-10#2)(2010-12#1)
ultrastructure##29##1##(2007-12#6)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#2)(2010-12#2)(2012-2#1)
ultrathin films##2##2##(2008-10#1)(2008-12#1)
ultrathin polymer films##2##3##(2008-10#2)
ultrathin polymer##3##2##(2008-10#3)
ultrathin sections of##2##3##(2008-10#1)(2008-7#1)
ultrathin sections##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
ultrathin##14##1##(1997-2#2)(2008-10#9)(2008-12#2)(2008-7#1)
ultratrace amounts of Hg(II)##2##4##(2008-10#2)
ultratrace amounts of##8##3##(2008-10#8)
ultratrace analysis##2##2##(2008-10#2)
ultratrace##17##1##(2008-10#16)(2008-3#1)
ultraviolet (UV) radiation##4##3##(2008-10#1)(2008-5#2)(2011-2#1)
ultraviolet (UV)##8##2##(1991-6#1)(2008-10#3)(2008-3#1)(2008-5#2)(2011-2#1)
ultraviolet (UV)-induced##2##2##(2008-10#1)(2008-5#1)
ultraviolet absorbance##2##2##(2008-10#2)
ultraviolet and##3##2##(2008-10#2)(2011-2#1)
ultraviolet detection##10##2##(1997-2#1)(2008-10#9)
ultraviolet irradiation##5##2##(1992-6#1)(2008-10#2)(2008-3#1)(2013-1#1)
ultraviolet laser##2##2##(2008-10#1)(2008-3#1)
ultraviolet light is##2##3##(2008-5#1)(2011-2#1)
ultraviolet light##13##2##(1996-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#2)(2011-2#1)
ultraviolet or visible##2##3##(2008-10#2)
ultraviolet radiation##6##2##(1997-7#1)(2008-11#1)(2008-2#1)(2011-2#3)
ultraviolet region##4##2##(2008-10#4)
ultraviolet spectrophotometry##2##2##(2008-10#2)
ultraviolet##83##1##(1991-6#1)(1992-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#39)(2008-11#2)(2008-2#5)(2008-3#11)(2008-5#9)(2008-9#2)(2011-2#7)(2013-1#1)
ultraviolet-B (UVB)##2##2##(2008-11#2)
ultraviolet-B##3##1##(2008-11#3)
ultraviolet-visible (UV-vis)##3##2##(2008-10#2)(2009-11#1)
ultraviolet-visible##9##1##(2008-10#8)(2009-11#1)
ultravoilet##2##1##(2008-5#2)
um##2##1##(1996-2#2)
umbilical artery##2##2##(1994-3#1)(2008-11#1)
umbilical cord arteries##4##3##(2009-8#4)
umbilical cord blood##6##3##(2008-11#2)(2008-8#2)(2011-2#1)(2012-12#1)
umbilical cord##21##2##(1994-3#1)(1995-2#1)(1997-3#1)(2008-11#5)(2008-8#2)(2008-9#1)(2009-8#6)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
umbilical evagination of the bladder##2##5##(2008-10#2)
umbilical vein##21##2##(1991-5#1)(1993-6#1)(1994-8#2)(1996-3#1)(1997-1#2)(2008-10#1)(2008-11#5)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
umbilical veins##3##2##(1994-6#1)(2008-8#1)(2008-9#1)
umbilical##56##1##(1990-11#2)(1991-5#1)(1993-3#1)(1993-6#1)(1994-3#4)(1994-6#1)(1994-8#2)(1995-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(2008-10#4)(2008-11#11)(2008-8#5)(2008-9#5)(2009-8#6)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
umbrella##13##1##(1994-9#2)(1997-8#3)(2008-1#1)(2008-12#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-2#1)
un syndrome##5##2##(2013-1#5)
un##21##1##(2008-11#3)(2011-2#2)(2013-1#16)
un- or underphosphorylated##2##3##(1996-2#2)
un- or##3##2##(1996-2#2)(2008-11#1)
unabated##2##1##(2008-10#1)(2013-1#1)
unable to afford##2##3##(1997-6#1)(2008-11#1)
unable to identify##2##3##(2008-11#1)(2008-12#1)
unable to penetrate the##2##4##(1996-9#1)(2008-10#1)
unable to provide##3##3##(1990-11#1)(2012-2#2)
unable to recognize##2##3##(1997-6#1)(2008-10#1)
unable to secrete##2##3##(2008-10#1)(2012-2#1)
unable to sustain the##2##4##(1990-2#1)(2012-2#1)
unable to##74##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-2#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#5)(2013-1#2)
unable##75##1##(1990-11#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-2#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#5)(2013-1#2)
unacceptable and##2##2##(1992-2#1)(2008-7#1)
unacceptable in##2##2##(1996-8#1)(2013-1#1)
unacceptable##17##1##(1990-2#1)(1991-3#1)(1992-2#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#3)
unacceptably high##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
unacceptably##4##1##(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
unaccustomed to##2##2##(1991-2#1)(1994-3#1)
unacknowledged##3##1##(2008-11#1)(2009-9#1)(2010-10#1)
unaddressed##2##1##(2008-11#1)(2010-1#1)
unaffected by the##7##3##(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#4)
unaffected by treatment with##2##4##(1991-12#1)(1995-12#1)
unaffected by##39##2##(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#12)(2008-11#2)(2008-8#1)(2009-9#1)(2012-4#1)(2013-1#1)
unaffected controls##2##2##(2013-1#2)
unaffected or##2##2##(1990-5#1)(2008-10#1)
unaffected##66##1##(1990-5#1)(1991-10#1)(1991-12#2)(1993-12#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-4#2)(1997-8#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#3)(2011-2#1)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#3)
unaltered by##3##2##(2008-10#1)(2008-11#2)
unaltered##22##1##(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1996-12#1)(2008-10#5)(2008-11#7)(2008-7#1)(2008-8#1)(2012-2#1)
unambiguous##8##1##(1991-2#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-4#1)
unambiguously identified##2##2##(2008-10#2)
unambiguously that##2##2##(1991-3#1)(2008-10#1)
unambiguously##16##1##(1991-3#1)(1995-12#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)(2010-6#1)
unamended soil##2##2##(2008-10#2)
unamended##3##1##(2008-10#3)
unanesthetized##4##1##(1997-2#3)(2008-4#1)
unanimously##4##1##(1993-3#1)(1993-8#1)(1995-6#1)(2008-11#1)
unanswered questions##3##2##(1996-12#1)(2011-2#1)(2012-2#1)
unanswered##9##1##(1992-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
unanticipated##3##1##(1996-2#1)(2008-11#1)(2010-5#1)
unappreciated##2##1##(1991-2#1)(2013-1#1)
unassisted##3##1##(1995-1#1)(2008-6#1)(2008-8#1)
unattached##2##1##(2008-8#1)(2010-3#1)
unattended operation##2##2##(2008-10#2)
unattended##5##1##(2008-10#4)(2008-11#1)
unavailability of##4##2##(2008-1#1)(2011-2#1)(2012-3#2)
unavailable to##2##2##(2008-11#1)(2012-12#1)
unavailable##11##1##(1995-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
unavoidable##5##1##(2008-10#2)(2008-2#1)(2008-5#1)(2012-3#1)
unaware of##4##2##(1995-12#1)(1997-2#1)(2011-2#1)(2012-12#1)
unaware##5##1##(1995-12#1)(1996-9#1)(1997-2#1)(2011-2#1)(2012-12#1)
unbalanced translocations##2##2##(2010-1#2)
unbalanced##11##1##(1995-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-1#2)(2011-2#1)(2012-2#1)
unbiased##10##1##(1991-3#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-11#1)(2010-3#1)(2012-2#1)(2012-3#1)
unbound##5##1##(2008-10#3)(2008-11#1)(2008-4#1)
unbranched neurons##3##2##(2007-12#3)
unbranched##4##1##(1994-5#1)(2007-12#3)
unbuffered##3##1##(2008-10#2)(2009-12#1)
uncapped RNAs##2##2##(2008-10#2)
uncapped viral RNAs##2##3##(2008-10#2)
uncapped##6##1##(2008-10#6)
uncemented##3##1##(2009-3#1)(2009-4#1)(2013-1#1)
uncensored data##3##2##(1995-9#3)
uncertain##39##1##(1990-9#1)(1993-2#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-6#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#4)(2008-8#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
uncertainties for##2##2##(2008-10#1)(2008-3#1)
uncertainties in speciation##2##3##(2008-10#2)
uncertainties in the##5##3##(2008-11#1)(2008-3#4)
uncertainties in##11##2##(2008-10#5)(2008-11#1)(2008-3#5)
uncertainties on the##2##3##(1993-9#1)(2008-10#1)
uncertainties on##3##2##(1993-9#1)(2008-10#2)
uncertainties still##2##2##(2008-11#1)(2008-7#1)
uncertainties that are due to##2##5##(2008-3#2)
uncertainties##36##1##(1991-12#1)(1992-12#1)(1993-9#1)(2008-10#12)(2008-11#2)(2008-3#14)(2008-7#1)(2009-11#2)(2011-2#1)(2013-8#1)
uncertainty U##2##2##(2008-10#2)
uncertainty about the##4##3##(1992-9#1)(1994-1#1)(2008-10#1)(2010-11#1)
uncertainty about##6##2##(1992-9#1)(1994-1#1)(1996-11#1)(2008-10#1)(2008-12#1)(2010-11#1)
uncertainty and##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
uncertainty are##3##2##(2008-10#3)
uncertainty as##2##2##(2008-11#1)(2009-8#1)
uncertainty associated with the##5##4##(2008-10#4)(2009-11#1)
uncertainty associated with##6##3##(2008-10#5)(2009-11#1)
uncertainty associated##7##2##(2008-10#6)(2009-11#1)
uncertainty budget##4##2##(2008-10#4)
uncertainty for the##2##3##(2008-10#1)(2008-3#1)
uncertainty for##3##2##(2008-10#1)(2008-3#2)
uncertainty in parameter##2##3##(2008-10#2)
uncertainty in the##5##3##(2008-10#1)(2008-3#1)(2008-7#2)(2013-1#1)
uncertainty in volumetric operations##2##4##(2008-10#2)
uncertainty in##19##2##(2008-10#11)(2008-3#2)(2008-7#3)(2010-10#1)(2011-2#1)(2013-1#1)
uncertainty intervals##6##2##(2008-10#6)
uncertainty is##5##2##(1993-3#1)(2008-10#2)(2008-7#1)(2012-12#1)
uncertainty of analytical assays##3##4##(2008-10#3)
uncertainty of less than 0##2##5##(2008-10#1)(2008-3#1)
uncertainty of the analytical##2##4##(2008-10#2)
uncertainty of the##7##3##(2008-10#4)(2008-2#1)(2012-12#2)
uncertainty of##23##2##(1992-9#1)(2008-10#12)(2008-2#3)(2008-3#5)(2012-12#2)
uncertainty on the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
uncertainty on##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
uncertainty regarding##2##2##(2008-12#1)(2011-2#1)
uncertainty source##2##2##(2008-10#1)(2008-3#1)
uncertainty with##3##2##(2008-12#1)(2009-8#1)(2010-10#1)
uncertainty##151##1##(1991-12#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#3)(1993-12#2)(1993-3#4)(1994-1#1)(1996-11#1)(1997-3#1)(2008-10#73)(2008-11#7)(2008-12#5)(2008-2#4)(2008-3#13)(2008-7#10)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#1)(2011-2#5)(2012-12#4)(2013-1#4)
uncertified home care agencies##2##4##(1995-3#2)
uncertified##3##1##(1995-3#2)(2013-8#1)
unchanged as##2##2##(2008-10#1)(2012-3#1)
unchanged during the##2##3##(2008-5#1)(2008-7#1)
unchanged during##3##2##(1995-2#1)(2008-5#1)(2008-7#1)
unchanged for##3##2##(1991-11#1)(1995-8#1)(2009-12#1)
unchanged from##2##2##(1993-3#1)(2009-2#1)
unchanged in the##4##3##(1991-6#1)(1996-12#1)(2011-2#1)(2012-6#1)
unchanged in##10##2##(1990-5#1)(1991-6#1)(1996-1#1)(1996-12#1)(2008-10#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-6#1)(2013-1#1)
unchanged on day 3##2##4##(1994-2#2)
unchanged or decreased##2##3##(2008-10#1)(2008-11#1)
unchanged or##3##2##(2008-10#2)(2008-11#1)
unchanged throughout the##2##3##(2008-7#1)(2008-9#1)
unchanged when##3##2##(1993-6#1)(1993-8#1)(2008-8#1)
unchanged##90##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-1#1)(2007-12#1)(2008-10#18)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#7)(2012-6#1)(2013-1#1)(2013-8#1)
uncharacterized proteins##2##2##(2008-4#1)(2009-8#1)
uncharacterized virus was isolated from##2##5##(2008-10#2)
uncharacterized##17##1##(1995-8#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#3)
uncharged##4##1##(2008-10#2)(2008-5#1)(2008-7#1)
uncinate##2##1##(2008-7#2)
uncinulatum##5##1##(2008-10#5)
unclassified isolates##2##2##(2008-10#2)
unclassified##4##1##(2008-1#1)(2008-10#2)(2009-8#1)
unclear how the##2##3##(2008-8#1)(2011-2#1)
unclear how##6##2##(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
unclear if patients##2##3##(2010-5#1)(2012-12#1)
unclear if##5##2##(2010-5#1)(2012-12#1)(2013-1#2)(2013-8#1)
unclear to##2##2##(2008-11#1)(2012-2#1)
unclear what##3##2##(2009-8#1)(2012-12#1)(2013-1#1)
unclear whether the##5##3##(2008-10#1)(2008-8#2)(2012-3#1)(2013-8#1)
unclear whether these##2##3##(2010-5#1)(2012-2#1)
unclear whether##15##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-10#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
unclear why##2##2##(2008-10#1)(2009-8#1)
unclear##106##1##(1991-2#1)(1993-12#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-3#2)(1997-7#1)(2008-10#11)(2008-11#11)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#6)
uncleaved##3##1##(1990-5#1)(1991-10#1)(2008-4#1)
unclosed##2##1##(1992-2#1)(2011-1#1)
uncoated fused-silica capillary##3##3##(2008-10#3)
uncoated probes##2##2##(2008-2#2)
uncoated##17##1##(2007-12#2)(2008-10#10)(2008-2#4)(2008-3#1)
uncoils##2##1##(2009-7#2)
uncomfortable##3##1##(2010-8#1)(2011-2#1)(2013-8#1)
uncommon and##4##2##(1990-8#1)(1992-5#1)(2013-1#2)
uncommon but##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
uncommon case of##3##3##(1992-9#1)(1993-6#1)(2011-2#1)
uncommon cause of##6##3##(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2012-3#1)
uncommon cause##7##2##(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-3#1)
uncommon clinical entities##2##3##(2013-1#2)
uncommon clinical##4##2##(2008-7#1)(2011-2#1)(2013-1#2)
uncommon condition##3##2##(2008-7#1)(2011-2#1)(2013-7#1)
uncommon disease which occurs##2##4##(2008-1#2)
uncommon disease##3##2##(2008-1#2)(2008-12#1)
uncommon in##7##2##(1996-11#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#2)
uncommon location##2##2##(2012-12#1)(2013-1#1)
uncommon##107##1##(1990-12#1)(1990-8#1)(1991-6#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-2#1)(1995-5#1)(1996-11#2)(1996-9#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#5)(2008-5#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#3)
uncompensated##3##1##(1992-11#1)(2008-10#1)(2008-9#1)
uncomplexed tetrol I-1##3##3##(2008-10#3)
uncomplexed tetrol##4##2##(2008-10#4)
uncomplexed##8##1##(2008-10#6)(2010-12#2)
uncomplicated cases##2##2##(1992-5#1)(2011-3#1)
uncomplicated procedure##2##2##(1992-12#1)(1996-9#1)
uncomplicated urinary tract##2##3##(2008-11#1)(2011-2#1)
uncomplicated##20##1##(1990-9#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-6#1)(1994-12#1)(1996-9#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#5)(2011-3#1)(2013-1#1)
unconditional##3##1##(1993-1#1)(2008-11#2)
unconditioned stimulus##2##2##(1997-7#1)(2008-5#1)
unconditioned##4##1##(1996-2#1)(1997-7#1)(2008-11#1)(2008-5#1)
unconfirmed##2##1##(2008-10#1)(2008-12#1)
unconjugated Fib75##3##2##(1990-12#3)
unconjugated bile##2##2##(1992-3#1)(2008-11#1)
unconjugated##10##1##(1990-12#3)(1992-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-5#1)(2013-1#1)
unconscious##10##1##(1991-12#1)(2008-11#2)(2008-12#3)(2010-1#1)(2010-7#1)(2012-2#1)(2012-3#1)
unconsciousness##5##1##(2010-1#2)(2010-7#1)(2012-12#1)(2012-3#1)
unconstitutional##2##1##(1994-2#1)(1997-7#1)
unconstrained##2##1##(2009-10#1)(2012-12#1)
uncontaminated##3##1##(2008-10#2)(2008-11#1)
uncontrollable##4##1##(2008-11#1)(2008-7#1)(2011-3#1)(2012-12#1)
uncontrolled diabetes##2##2##(2008-12#1)(2013-8#1)
uncontrolled##15##1##(1991-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
unconventional##2##1##(1992-8#1)(1994-6#1)
uncorrected bias##2##2##(2008-10#2)
uncorrected##5##1##(2008-10#3)(2008-3#1)(2011-2#1)
uncorrelated##4##1##(2008-10#2)(2008-11#1)(2010-2#1)
uncouple##2##1##(2008-11#1)(2009-8#1)
uncoupled##3##1##(1991-11#1)(2008-3#1)(2009-8#1)
uncoupling protein##2##2##(2008-10#2)
uncoupling##4##1##(2008-10#2)(2008-9#1)(2009-8#1)
uncover the##5##2##(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)
uncover##9##1##(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-9#1)(2012-3#1)(2013-8#1)
uncovered a##3##2##(2008-11#1)(2008-8#2)
uncovered by##2##2##(1995-2#1)(2008-1#1)
uncovered##22##1##(1991-11#1)(1991-2#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
uncovering##3##1##(1995-5#1)(2008-5#1)(2008-7#1)
uncovers##2##1##(2010-8#1)(2012-2#1)
uncrosslinked##2##1##(1995-2#2)
uncultivated##2##1##(2008-10#1)(2013-1#1)
unculturable##2##1##(1996-8#1)(2008-9#1)
uncultured##2##1##(2008-10#2)
und##4##1##(1997-4#1)(2008-10#2)(2008-11#1)
undamaged plants##4##2##(2008-8#4)
undamaged##6##1##(2008-8#5)(2013-1#1)
undecimpunctata subsp##2##2##(2008-10#2)
undecose##2##1##(1997-4#2)
undefined##14##1##(1990-12#1)(1990-6#1)(1993-12#1)(2008-10#7)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
undegraded 125IUdR##2##2##(1993-11#2)
under 0##2##2##(2008-11#2)
under 18 months of age##2##5##(2008-9#2)
under 2 years##2##3##(2008-9#1)(2010-12#1)
under 5##2##2##(2008-10#1)(2012-12#1)
under 5% CO(2)##4##3##(2008-11#4)
under 5%##5##2##(2008-10#1)(2008-11#4)
under 6##2##2##(2012-12#1)(2013-1#1)
under 60##2##2##(2008-7#1)(2013-8#1)
under 65##2##2##(1991-12#1)(1995-12#1)
under 70##2##2##(2008-10#1)(2008-7#1)
under E##2##2##(1995-11#2)
under Medicaid##4##2##(1991-1#1)(1992-2#2)(1997-2#1)
under Medicare##10##2##(1991-1#1)(1991-2#3)(1991-3#1)(1992-2#2)(1994-1#2)(1996-2#1)
under PPS##4##2##(1992-2#3)(1993-3#1)
under UV irradiation##2##3##(2008-10#1)(2009-7#1)
under UV##4##2##(2008-10#2)(2008-9#1)(2009-7#1)
under a variety of##5##4##(1990-2#1)(1995-2#1)(2008-10#1)(2008-6#1)(2011-2#1)
under a wide range of##5##5##(2008-10#2)(2008-11#1)(2008-8#2)
under a wide##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)
under a##47##2##(1990-2#1)(1991-5#1)(1992-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#13)(2008-11#6)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2010-11#1)(2011-2#3)(2012-9#1)(2013-1#2)
under acidic conditions##6##3##(2008-10#6)
under acidic##9##2##(2008-10#9)
under actual##2##2##(1991-12#1)(2008-10#1)
under aerobic conditions##2##3##(2008-10#2)
under age##3##2##(1994-9#1)(1997-3#2)
under alkaline conditions##4##3##(1991-7#1)(1996-5#1)(2008-10#2)
under alkaline##5##2##(1991-7#1)(1996-5#1)(2008-10#3)
under all conditions##5##3##(1990-8#1)(2008-10#3)(2008-3#1)
under all##10##2##(1990-8#1)(1991-2#1)(1993-12#1)(1997-1#1)(2008-10#4)(2008-3#1)(2013-8#1)
under ambient CO(2)##2##3##(2008-10#2)
under ambient conditions##5##3##(2008-10#3)(2009-12#1)(2012-2#1)
under ambient##9##2##(1992-8#1)(2008-10#6)(2009-12#1)(2012-2#1)
under an##7##2##(1994-12#1)(1994-9#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)
under anaerobic##3##2##(2008-10#2)(2008-7#1)
under anaerobiosis##3##2##(2008-10#1)(2008-6#2)
under anaesthesia##2##2##(1995-5#1)(2010-7#1)
under analysis##2##2##(2008-10#1)(2010-10#1)
under anesthesia##2##2##(1994-2#1)(2011-7#1)
under any##4##2##(2008-10#1)(2008-3#1)(2009-10#1)(2011-3#1)
under artificial inoculation##2##3##(2008-10#2)
under basal conditions##2##3##(1997-2#1)(2008-11#1)
under basal##3##2##(1991-5#1)(1997-2#1)(2008-11#1)
under batch equilibrium binding conditions##2##5##(1997-2#2)
under batch equilibrium##3##3##(1997-2#3)
under batch##4##2##(1997-2#3)(2008-10#1)
under both anchorage-dependent and anchorage-independent conditions##2##6##(1997-1#2)
under both normal and##2##4##(1995-11#1)(2011-2#1)
under both pH conditions##2##4##(1991-5#1)(1994-8#1)
under both##18##2##(1991-5#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-1#2)(2008-10#6)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
under cardiopulmonary bypass##2##3##(2008-7#1)(2013-1#1)
under certain circumstances##6##3##(1990-3#1)(1994-3#1)(1995-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
under certain conditions##4##3##(1994-6#1)(2008-5#1)(2008-8#1)(2008-9#1)
under certain environmental conditions##3##4##(1993-2#1)(2008-10#1)(2012-3#1)
under certain##17##2##(1990-3#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-8#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
under circumstances where##2##3##(1991-12#1)(1993-12#1)
under circumstances##3##2##(1991-12#1)(1993-12#1)(2008-11#1)
under combined##2##2##(1993-8#1)(2010-7#1)
under commercial conditions##2##3##(2008-10#2)
under commercial##4##2##(2008-10#4)
under compression##3##2##(2009-3#1)(2009-7#1)(2011-2#1)
under conditions of poor chromatographic resolution##3##6##(2008-10#3)
under conditions of##25##3##(1992-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-9#2)(2009-9#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
under conditions that##7##3##(2008-10#1)(2008-11#3)(2008-3#1)(2009-10#1)(2012-2#1)
under conditions where##5##3##(1992-3#1)(1992-7#1)(1994-6#1)(2008-10#1)(2008-4#1)
under conditions##47##2##(1992-3#4)(1992-7#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#13)(2008-11#5)(2008-3#3)(2008-4#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-7#1)(2011-2#4)(2012-2#3)(2012-3#1)
under conservative##2##2##(2009-11#1)(2013-1#1)
under consideration as##2##3##(1992-3#1)(2012-2#1)
under consideration by the##2##4##(1994-12#1)(1995-12#1)
under consideration##6##2##(1992-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-7#1)(2012-2#1)
under constant##8##2##(1992-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#2)
under constraints##2##2##(2008-11#2)
under continuous flow##3##3##(2008-10#2)(2008-11#1)
under continuous##8##2##(2007-12#1)(2008-10#5)(2008-11#1)(2009-11#1)
under control of the##7##4##(1990-11#1)(1991-5#1)(1996-3#1)(1997-7#2)(2008-10#1)(2011-10#1)
under control of##9##3##(1990-11#1)(1991-5#1)(1996-3#1)(1997-7#2)(2008-10#1)(2008-11#1)(2009-4#1)(2011-10#1)
under control##15##2##(1990-11#1)(1991-5#2)(1996-2#1)(1996-3#1)(1997-7#2)(1997-8#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-12#1)(2011-10#1)
under controlled conditions and##2##4##(2008-10#2)
under controlled conditions##17##3##(1993-8#1)(2008-10#14)(2008-11#1)(2013-8#1)
under controlled environmental conditions##4##4##(2008-10#4)
under controlled##26##2##(1993-8#1)(2008-10#23)(2008-11#1)(2013-8#1)
under conventional##2##2##(2008-10#2)
under defined conditions##2##3##(2008-4#1)(2008-7#1)
under defined##3##2##(2008-4#1)(2008-7#2)
under denaturing conditions##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
under development and##2##3##(2008-10#2)
under development as a##2##4##(2008-11#1)(2009-9#1)
under development by##9##3##(2008-5#9)
under development##23##2##(1991-12#1)(1991-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#9)(2008-8#2)(2009-9#1)(2010-10#2)(2010-8#1)
under diagnosis##2##2##(1990-12#1)(1997-8#1)
under different conditions##5##3##(1993-12#1)(2008-10#2)(2008-7#2)
under different dietary conditions##2##4##(2008-10#2)
under different environmental conditions##4##4##(2008-10#3)(2008-8#1)
under different moisture##2##3##(2008-10#1)(2008-12#1)
under different pH##3##3##(2008-10#2)(2010-12#1)
under different##46##2##(1990-8#1)(1991-2#2)(1993-12#1)(1996-2#1)(1997-2#1)(1997-9#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-6#1)(2010-12#1)(2010-5#1)(2013-1#1)
under differential##2##2##(2008-7#1)(2010-12#1)
under direct##2##2##(1991-12#1)(2011-2#1)
under discussion##3##2##(1992-11#1)(1992-5#1)(2008-11#1)
under disease progress curve##2##4##(2008-10#2)
under distinct genetic control##2##4##(2011-2#2)
under double##2##2##(2008-11#1)(2011-2#1)
under drip irrigation than under furrow irrigation##2##7##(2008-10#2)
under dry conditions##2##3##(2008-10#2)
under dry##3##2##(2008-10#3)
under dynamic conditions##2##3##(2008-10#1)(2012-4#1)
under dynamic##4##2##(2008-10#2)(2008-7#1)(2012-4#1)
under each##2##2##(1994-9#1)(2013-1#1)
under elevated CO(2) concentrations##3##4##(2008-10#3)
under elevated CO(2)##5##3##(2008-10#5)
under elevated##7##2##(2008-10#6)(2010-10#1)
under environmental##2##2##(2008-8#1)(2010-4#1)
under evaluation in##2##3##(2011-2#1)(2013-1#1)
under evaluation##7##2##(1997-2#1)(2008-10#2)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
under experimental conditions##8##3##(1993-3#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-7#1)(2009-8#1)
under extreme##2##2##(2008-10#1)(2010-4#1)
under field conditions at##3##4##(2008-10#3)
under field conditions##22##3##(2008-10#20)(2013-8#2)
under field##23##2##(2008-10#20)(2008-9#1)(2013-8#2)
under five##6##2##(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)
under flow conditions##2##3##(2008-11#1)(2009-10#1)
under flow##4##2##(2008-10#2)(2008-11#1)(2009-10#1)
under four##3##2##(1990-12#1)(1991-2#1)(2012-6#1)
under furrow and##2##3##(2008-10#2)
under furrow irrigation##7##3##(2008-10#7)
under furrow##9##2##(2008-10#9)
under general anaesthesia##4##3##(1997-6#1)(2010-7#3)
under general anesthesia##7##3##(1992-12#2)(1993-1#1)(1994-12#1)(1995-3#1)(2011-2#2)
under general##11##2##(1992-12#2)(1993-1#1)(1994-12#1)(1995-3#1)(1997-6#1)(2010-7#3)(2011-2#2)
under glucose##2##2##(2010-10#1)(2012-2#1)
under greenhouse conditions were##2##4##(2008-10#2)
under greenhouse conditions##11##3##(2008-10#11)
under greenhouse##12##2##(2008-10#12)
under growth chamber##2##3##(2008-10#2)
under health care reform##2##4##(1994-2#1)(1995-12#1)
under high concentration conditions##2##4##(2008-9#2)
under high glucose##2##3##(1992-8#1)(2011-2#1)
under high pressure##3##3##(1996-1#1)(2007-11#1)(2008-10#1)
under high##19##2##(1992-8#1)(1996-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#1)
under hypoxic##3##2##(2008-11#1)(2010-7#1)(2011-2#1)
under ideal conditions##2##3##(2008-10#1)(2008-3#1)
under identical conditions##3##3##(1990-5#1)(1993-8#1)(2008-10#1)
under identical experimental conditions##2##4##(1997-2#1)(2008-10#1)
under identical##5##2##(1990-5#1)(1993-8#1)(1997-2#1)(2008-10#2)
under in##2##2##(1993-2#1)(2009-3#1)
under increased##2##2##(2008-11#1)(2009-8#1)
under induced##2##2##(2011-1#2)
under intensive##2##2##(2011-3#1)(2012-3#1)
under inverse sampling##3##3##(1995-9#1)(1996-3#2)
under investigation##17##2##(1994-5#1)(1997-6#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
under isocratic condition##2##3##(2008-10#1)(2008-5#1)
under lab conditions##2##3##(2008-10#2)
under laboratory conditions##5##3##(2008-10#3)(2008-12#1)(2011-10#1)
under laboratory##6##2##(1994-3#1)(2008-10#3)(2008-12#1)(2011-10#1)
under light##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
under local anaesthesia##3##3##(1991-9#1)(1994-2#1)(2008-12#1)
under local anesthesia and##2##4##(1992-12#1)(1993-1#1)
under local anesthesia##6##3##(1992-12#5)(1993-1#1)
under local##9##2##(1991-9#1)(1992-12#5)(1993-1#1)(1994-2#1)(2008-12#1)
under long daylengths##2##3##(2012-3#2)
under low concentration conditions##2##4##(2008-9#2)
under low##7##2##(1996-5#1)(2008-10#2)(2008-12#1)(2008-9#2)(2013-1#1)
under lower temperatures##2##3##(2008-10#2)
under lower##3##2##(2008-10#2)(2008-9#1)
under managed care##4##3##(1995-2#2)(1997-2#2)
under many##2##2##(2008-10#1)(2008-8#1)
under mild conditions##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
under mild##7##2##(1996-5#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)
under more##3##2##(2008-11#2)(2008-5#1)
under most conditions##2##3##(2008-8#1)(2008-9#1)
under most##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
under mouth conditions##2##3##(2008-10#2)
under multiple##2##2##(2008-10#1)(2008-9#1)
under natural conditions and##2##4##(2008-10#2)
under natural conditions##9##3##(2008-10#6)(2008-9#1)(2013-1#2)
under natural field conditions##3##4##(2008-10#3)
under natural inoculum pressure##2##4##(2008-10#2)
under natural##18##2##(2008-10#14)(2008-8#1)(2008-9#1)(2013-1#2)
under no CO(2) supply was##3##5##(2008-11#3)
under no CO(2) supply##4##4##(2008-11#4)
under non-isothermal conditions##2##3##(2011-2#2)
under normal conditions##4##3##(1994-11#1)(2008-8#1)(2008-9#1)(2010-10#1)
under normal##10##2##(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
under one##3##2##(1992-6#1)(2010-4#1)(2013-8#1)
under optimal conditions##8##3##(1991-5#1)(2008-10#6)(2009-7#1)
under optimal reaction conditions##2##4##(2008-10#1)(2008-8#1)
under optimal##13##2##(1991-5#1)(2008-10#9)(2008-8#1)(2009-10#1)(2009-7#1)
under optimized conditions##2##3##(2008-10#2)
under optimized##4##2##(2008-10#4)
under optimum conditions##6##3##(2008-10#5)(2008-11#1)
under optimum##8##2##(2008-10#7)(2008-11#1)
under orchard conditions##2##3##(2008-10#2)
under osmotic stress##3##3##(2008-9#3)
under pH##2##2##(2008-11#1)(2008-6#1)
under phase##2##2##(2008-5#1)(2013-1#1)
under photopic##2##2##(2011-2#2)
under physiologic and##2##3##(1993-12#1)(1995-2#1)
under physiological conditions##9##3##(1997-3#1)(2008-10#5)(2008-5#1)(2008-7#2)
under physiological##10##2##(1997-3#1)(2008-10#6)(2008-5#1)(2008-7#2)
under pre- and post-maximal clenching effort conditions##2##7##(2010-9#2)
under proper##2##2##(2008-10#1)(2008-11#1)
under real##2##2##(2008-10#1)(2008-8#1)
under reduced##6##2##(2008-10#1)(2008-11#3)(2008-7#1)(2013-1#1)
under reducing conditions##3##3##(1995-8#1)(1997-8#1)(2008-10#1)
under rice-wheat system##2##3##(2008-12#2)
under routine##2##2##(1997-2#1)(2008-10#1)
under selection for##2##3##(2008-8#2)
under selection##4##2##(2008-8#3)(2010-4#1)
under septic##2##2##(1994-11#1)(2008-11#1)
under serum free conditions##2##4##(1990-5#1)(2008-11#1)
under serum-free conditions##4##3##(1993-3#1)(2008-11#3)
under serum-free##6##2##(1993-3#1)(1995-11#1)(2008-11#4)
under several different##4##3##(1994-12#1)(2008-10#1)(2008-11#2)
under several##9##2##(1994-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
under similar conditions##8##3##(1990-9#1)(1995-2#1)(2008-10#5)(2009-7#1)
under similar##11##2##(1990-9#1)(1991-2#1)(1995-2#1)(1996-5#1)(2008-10#5)(2008-11#1)(2009-7#1)
under simulated##2##2##(2008-10#1)(2008-9#1)
under six##2##2##(2008-10#1)(2013-1#1)
under snow cover##2##3##(2008-10#2)
under some##3##2##(1992-3#1)(2009-11#1)(2010-10#1)
under specific conditions##3##3##(2008-11#1)(2008-6#1)(2011-3#1)
under specific##6##2##(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)
under sperm-limited conditions##3##3##(2008-8#3)
under standard conditions##4##3##(1993-12#1)(1995-8#1)(2008-11#1)(2008-7#1)
under standard##8##2##(1990-8#1)(1993-12#1)(1995-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-8#1)
under stationary conditions##2##3##(2008-10#1)(2008-7#1)
under stationary##3##2##(2008-10#2)(2008-7#1)
under stressful conditions##2##3##(2012-3#2)
under strict##2##2##(2008-6#1)(2008-8#1)
under strictly controlled conditions##2##4##(2008-12#1)(2010-1#1)
under stringent##2##2##(1991-12#1)(2009-7#1)
under strong##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
under study in##2##3##(2008-10#2)
under study was comprised of##2##5##(2008-10#2)
under study##26##2##(1997-2#1)(2008-10#17)(2008-3#2)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)
under subsurface drip irrigation##6##4##(2008-10#6)
under subsurface-drip irrigation##2##3##(2008-10#2)
under test##2##2##(2007-11#1)(2008-10#1)
under the ADA##2##3##(1995-6#1)(1996-5#1)
under the Americans with Disabilities Act (ADA)##3##7##(1995-12#3)
under the Americans with Disabilities Act##4##6##(1995-12#4)
under the Boren Amendment##2##4##(1993-12#2)
under the European##2##3##(2008-10#1)(2008-12#1)
under the Health Care Quality Improvement Act##2##7##(1991-1#1)(1994-1#1)
under the Medicare fee schedule##2##5##(1994-1#2)
under the Medicare program##4##4##(1991-1#1)(1994-3#1)(1995-1#1)(1997-3#1)
under the Medicare##8##3##(1991-1#1)(1991-2#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-1#1)(1997-3#1)
under the Tax Equity and Fiscal Responsibility Act (TEFRA) of 1982 (Public Law 97-248)##2##14##(1993-12#1)(1994-3#1)
under the United##2##3##(2009-11#1)(2012-2#1)
under the action of a##2##5##(2008-10#1)(2008-3#1)
under the age of 3##2##5##(2009-5#1)(2011-2#1)
under the age of##5##4##(1995-12#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)
under the assumption of##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
under the assumption that##2##4##(1995-9#1)(2008-5#1)
under the assumption##5##3##(1995-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
under the auspices of the Better Beginnings##2##7##(1995-3#2)
under the auspices of the##5##5##(1994-12#1)(1995-3#2)(2008-10#1)(2008-11#1)
under the auspices of##6##4##(1994-12#1)(1995-3#2)(1996-2#1)(2008-10#1)(2008-11#1)
under the condition of##2##4##(1996-6#1)(2008-10#1)
under the conditions employed##2##4##(2008-10#2)
under the conditions of##4##4##(1990-6#1)(2008-10#2)(2010-7#1)
under the conditions used##2##4##(1996-2#1)(1997-1#1)
under the conditions##12##3##(1990-6#1)(1993-6#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-7#2)(2010-7#1)
under the control of a##3##5##(1992-10#1)(1995-6#1)(2008-10#1)
under the control of its own promoter##2##7##(1995-2#1)(2008-10#1)
under the control of the cauliflower mosaic virus##2##8##(2008-10#2)
under the control of the lac promoter##2##7##(1995-2#1)(2008-10#1)
under the control of the##18##5##(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-7#1)
under the control of##40##4##(1992-10#1)(1993-6#1)(1994-11#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1997-1#1)(2008-10#9)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2011-2#1)(2013-7#1)(2013-8#1)
under the control##41##3##(1992-10#1)(1993-6#1)(1994-11#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1997-1#1)(2008-10#9)(2008-11#6)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2011-2#1)(2013-7#1)(2013-8#1)
under the current##2##3##(1997-1#1)(2009-7#1)
under the curve of 0##2##5##(2012-3#1)(2013-1#1)
under the curve of##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
under the curve##11##3##(1992-9#1)(1994-12#2)(2008-10#3)(2008-11#1)(2010-8#1)(2012-3#2)(2013-1#1)
under the disease progress curve (AUDPC)##9##6##(2008-10#9)
under the disease progress curve and##3##6##(2008-10#3)
under the disease progress curve##18##5##(2008-10#18)
under the disease progress##20##4##(2008-10#20)
under the effect of cocaine##2##5##(2013-8#2)
under the effect of##4##4##(2012-2#1)(2013-8#3)
under the following##3##3##(2008-10#2)(2010-12#1)
under the influence of moisture##2##5##(2008-10#2)
under the influence of psilocybin##3##5##(2013-8#3)
under the influence of##14##4##(1990-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#3)
under the name##2##3##(2008-10#1)(2011-2#1)
under the optimal conditions##4##4##(2008-10#4)
under the optimized conditions##3##4##(2008-10#3)
under the optimized##4##3##(2008-10#4)
under the optimum conditions##4##4##(2008-10#4)
under the optimum##7##3##(2008-10#7)
under the present experimental##2##4##(2008-10#1)(2008-5#1)
under the prospective payment system##2##5##(1992-12#1)(1993-1#1)
under the same chromatographic conditions##2##5##(2008-10#2)
under the same conditions as##2##5##(1996-2#1)(2008-5#1)
under the same conditions##17##4##(1990-2#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#7)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
under the same experimental conditions##3##5##(1997-2#1)(2008-10#2)
under the same##28##3##(1990-2#1)(1991-12#1)(1991-5#1)(1993-6#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)
under the transcriptional control of##2##5##(1995-2#1)(2011-2#1)
under the umbrella of##6##4##(2008-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-2#1)
under the##334##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#6)(1993-6#4)(1993-8#1)(1994-1#3)(1994-11#3)(1994-12#4)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#4)(1995-3#6)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#110)(2008-11#24)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#14)(2012-12#2)(2012-2#5)(2012-3#3)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#11)
under these conditions##17##3##(1990-5#1)(1991-5#1)(1992-10#1)(1993-3#1)(1995-2#1)(1995-9#2)(2008-10#5)(2008-11#2)(2008-7#2)(2009-10#1)
under these##26##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-10#1)(1993-3#1)(1995-2#1)(1995-9#2)(1996-5#1)(2008-10#6)(2008-11#3)(2008-7#3)(2009-10#1)(2009-6#1)(2010-11#1)(2010-4#1)
under this##7##2##(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
under three different sets of conditions##2##6##(2008-10#1)(2008-4#1)
under three##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
under transcriptional control of##2##4##(2008-7#1)(2010-10#1)
under treatment with##2##3##(1991-11#1)(2010-12#1)
under treatment##6##2##(1991-11#1)(1994-9#1)(1996-11#1)(1996-3#1)(2008-10#1)(2010-12#1)
under two different##2##3##(2008-11#1)(2008-7#1)
under two##9##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
under ultraviolet light##2##3##(2008-5#1)(2008-9#1)
under vacuum packaging##2##3##(2011-2#2)
under vacuum##4##2##(2010-1#1)(2011-2#3)
under variable##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
under various conditions of##3##4##(2008-10#3)
under various conditions##4##3##(2008-10#4)
under various growth conditions##2##4##(1996-6#1)(1997-1#1)
under various##15##2##(1993-6#1)(1996-6#1)(1997-1#1)(2008-10#8)(2008-3#2)(2008-8#1)(2008-9#1)
under varying conditions of##2##4##(2008-10#1)(2008-9#1)
under varying conditions##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
under varying##10##2##(1992-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)
under very##3##2##(2008-10#2)(2008-11#1)
under water stress##3##3##(2008-12#1)(2008-8#2)
under water##4##2##(2008-10#1)(2008-12#1)(2008-8#2)
under well defined##2##3##(2008-11#1)(2008-2#1)
under wet conditions##2##3##(2008-10#2)
under what##2##2##(1994-12#1)(2012-3#1)
under which the##6##3##(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#2)(2013-8#1)
under which##21##2##(1995-2#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-8#7)(2009-6#1)(2010-10#1)(2012-2#2)(2013-8#1)
under working conditions##2##3##(2008-10#2)
under##1711##1##(1990-11#2)(1990-12#7)(1990-2#4)(1990-3#2)(1990-5#5)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#7)(1991-11#2)(1991-12#9)(1991-2#17)(1991-3#4)(1991-5#10)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#11)(1992-2#12)(1992-3#7)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#5)(1993-12#13)(1993-2#2)(1993-3#6)(1993-6#6)(1993-8#7)(1993-9#1)(1994-1#6)(1994-11#7)(1994-12#9)(1994-2#7)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#8)(1995-1#3)(1995-11#8)(1995-12#17)(1995-2#12)(1995-3#8)(1995-5#3)(1995-6#7)(1995-8#6)(1995-9#4)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#9)(1996-3#8)(1996-5#11)(1996-6#4)(1997-1#8)(1997-2#18)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#5)(1997-9#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#4)(2008-10#581)(2008-11#131)(2008-12#17)(2008-2#7)(2008-3#34)(2008-4#8)(2008-5#46)(2008-6#13)(2008-7#49)(2008-8#58)(2008-9#41)(2009-1#1)(2009-10#13)(2009-11#6)(2009-12#4)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#8)(2009-8#9)(2009-9#5)(2010-1#7)(2010-10#14)(2010-11#6)(2010-12#10)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#4)(2010-7#14)(2010-8#7)(2010-9#2)(2011-1#6)(2011-10#3)(2011-2#62)(2011-3#6)(2011-7#1)(2012-12#6)(2012-2#28)(2012-3#21)(2012-4#1)(2012-6#3)(2012-7#1)(2012-9#2)(2013-1#42)(2013-7#2)(2013-8#30)
under-##2##1##(2008-10#1)(2008-9#1)
under-appreciated##2##1##(2008-9#1)(2009-8#1)
under-diagnosis##2##1##(2010-12#1)(2011-2#1)
under-explored##2##1##(2010-8#1)(2012-9#1)
under-five mortality##5##2##(2009-6#5)
under-five##9##1##(2008-2#4)(2009-6#5)
under-recognised and##2##2##(1996-8#1)(2010-10#1)
under-recognized##2##1##(2008-10#1)(2009-5#1)
under-studied##3##1##(2011-2#1)(2013-1#1)(2013-8#1)
underage drinking##3##2##(2010-7#3)
underappreciated##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
underarm##4##1##(2008-5#4)
undercompensation##2##1##(2008-8#2)
underdeveloped and##2##2##(1997-2#1)(2013-1#1)
underdeveloped countries##2##2##(1990-2#2)
underdeveloped##5##1##(1990-2#2)(1997-2#1)(1997-5#1)(2013-1#1)
underdiagnosed##2##1##(2008-7#1)(2008-8#1)
underdominance##3##1##(2008-10#3)
underestimate the##5##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-11#1)
underestimate##8##1##(1991-12#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-11#1)(2011-2#1)
underestimated and##3##2##(1992-9#1)(1995-2#1)(2012-3#1)
underestimated in##2##2##(2008-10#1)(2009-7#1)
underestimated##15##1##(1992-9#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
underestimates the##3##2##(1997-3#1)(2008-1#1)(2008-10#1)
underestimates##4##1##(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)
underestimation of##2##2##(2008-3#1)(2011-2#1)
underestimation##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
underexpanded##2##1##(2008-3#2)
underexplored##4##1##(2008-10#1)(2010-1#1)(2013-1#2)
undergo HIV-antibody testing##3##3##(1996-5#3)
undergo a##14##2##(1991-1#1)(1993-8#1)(1994-3#1)(1994-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-1#1)(2010-7#2)(2012-2#1)(2013-1#1)
undergo an AIDS test##2##4##(1992-9#2)
undergo an##5##2##(1992-9#2)(1993-3#1)(1994-5#1)(2007-11#1)
undergo further##2##2##(2008-10#1)(2011-8#1)
undergo proteolytic processing##2##3##(1993-6#1)(2008-11#1)
undergo rapid##2##2##(1996-2#1)(2010-5#1)
undergo spontaneous##2##2##(1995-12#1)(2008-7#1)
undergo the##8##2##(1995-6#2)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-3#2)
undergo this##3##2##(1994-12#1)(2008-7#2)
undergo two##2##2##(2008-10#1)(2010-11#1)
undergo##117##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-9#3)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#3)(1995-12#2)(1995-2#3)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#5)(1997-7#2)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#3)(2009-3#2)(2009-5#4)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#3)(2011-2#8)(2011-8#1)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#4)
undergoes a##7##2##(1996-5#2)(2007-11#1)(2008-10#3)(2013-1#1)
undergoes autophosphorylation##2##2##(1993-6#1)(1994-11#1)
undergoes hydrolysis##2##2##(2008-10#1)(2009-8#1)
undergoes rapid##2##2##(2008-5#1)(2009-8#1)
undergoes the##2##2##(2008-8#1)(2011-3#1)
undergoes##39##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-10#1)(1993-6#1)(1994-11#1)(1996-5#4)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-5#1)(2011-2#3)(2011-3#1)(2013-1#1)
undergoing a##7##2##(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
undergoing an##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
undergoing angioplasty##2##2##(2008-11#1)(2008-5#1)
undergoing cardiac##2##2##(2008-12#1)(2011-2#1)
undergoing cardiopulmonary##2##2##(2008-5#1)(2013-8#1)
undergoing clinical trials##2##3##(1991-3#1)(1994-8#1)
undergoing clinical##3##2##(1991-3#1)(1992-3#1)(1994-8#1)
undergoing dialysis##2##2##(2008-1#1)(2011-2#1)
undergoing elective##3##2##(2012-3#2)(2013-1#1)
undergoing laparoscopic##4##2##(1991-3#1)(1994-3#1)(2010-5#1)(2012-3#1)
undergoing the##2##2##(2008-10#1)(2008-12#1)
undergoing thoracic/thoracolumbar level fusion##2##4##(2012-3#2)
undergoing total joint arthroplasty##2##4##(2012-12#2)
undergoing total##3##2##(2009-3#1)(2012-12#2)
undergoing treatment for##3##3##(2008-10#2)(2013-1#1)
undergoing treatment##7##2##(1990-8#1)(2008-10#3)(2008-5#1)(2010-7#1)(2013-1#1)
undergoing##158##1##(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-2#1)(1992-3#2)(1993-1#4)(1993-12#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#14)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#4)(2009-5#1)(2009-8#1)(2010-10#5)(2010-11#3)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#13)(2012-12#5)(2012-2#5)(2012-3#13)(2013-1#9)(2013-8#5)
undergone RP##2##2##(2010-10#2)
undergone a##8##2##(1992-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#3)
undergone by##2##2##(2008-10#2)
undergone major##2##2##(2008-12#1)(2010-6#1)
undergone rapid##2##2##(1996-3#1)(2010-12#1)
undergone##61##1##(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#2)(1993-6#1)(1994-12#2)(1994-3#4)(1994-9#1)(1995-12#1)(1996-3#3)(1996-6#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-4#1)(2008-7#2)(2008-9#4)(2009-11#1)(2010-10#2)(2010-12#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)
undergraduate and postgraduate##2##3##(1994-12#1)(2008-11#1)
undergraduate and##5##2##(1994-12#1)(2008-11#2)(2008-12#2)
undergraduate course##2##2##(2008-11#1)(2012-3#1)
undergraduate courses##2##2##(2008-11#1)(2010-9#1)
undergraduate curriculum##5##2##(2008-12#1)(2011-2#3)(2013-1#1)
undergraduate education##4##2##(1991-1#1)(2010-3#2)(2013-1#1)
undergraduate health administration##2##3##(1991-1#1)(1993-2#1)
undergraduate health##3##2##(1991-1#1)(1993-2#1)(2008-12#1)
undergraduate nurse education##2##3##(2008-12#2)
undergraduate nurse##4##2##(2008-11#1)(2008-12#3)
undergraduate nurses##5##2##(2008-12#5)
undergraduate nursing curriculum##2##3##(2008-11#1)(2008-12#1)
undergraduate nursing education##2##3##(2008-11#2)
undergraduate nursing students and##2##4##(2008-12#2)
undergraduate nursing students##12##3##(2008-11#8)(2008-12#4)
undergraduate nursing##20##2##(2008-11#12)(2008-12#8)
undergraduate programs##4##2##(1991-1#4)
undergraduate students of nursing##2##4##(2008-12#2)
undergraduate students were##2##3##(2009-11#1)(2012-2#1)
undergraduate students##8##2##(2008-11#1)(2008-12#3)(2009-11#1)(2010-7#1)(2012-2#2)
undergraduate students'##2##2##(2008-11#2)
undergraduate##88##1##(1991-1#7)(1991-6#1)(1993-2#1)(1994-12#1)(2008-11#29)(2008-12#28)(2009-11#1)(2009-4#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
undergraduates##7##1##(1996-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2010-10#1)(2012-2#1)
underground##5##1##(2008-10#5)
underinsured##4##1##(2008-11#4)
underivatized amino acids##7##3##(2008-10#7)
underivatized##8##1##(2008-10#8)
underlie the##10##2##(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)
underlie these##2##2##(1990-8#1)(2008-11#1)
underlie this##2##2##(2008-11#1)(2009-8#1)
underlie##32##1##(1990-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#2)(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#3)(2012-12#1)(2013-8#1)
underlies the##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
underlies##9##1##(1990-5#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
underline that##2##2##(1993-6#1)(1996-3#1)
underline the importance of##5##4##(1990-11#1)(1990-9#1)(1991-6#1)(2008-11#1)(2008-7#1)
underline the potential of##2##4##(2008-10#1)(2008-11#1)
underline the##11##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-12#1)
underline##16##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-6#1)(1993-6#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
underlined and##2##2##(1990-5#1)(1991-6#1)
underlined the##2##2##(1991-6#1)(2013-1#1)
underlined##13##1##(1990-5#1)(1990-9#1)(1991-6#2)(1992-9#1)(1995-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#1)
underlines the##9##2##(1991-3#1)(1992-5#1)(1996-12#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#1)
underlining the##5##2##(1990-5#1)(1994-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
underlining##6##1##(1990-5#1)(1994-11#1)(1994-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
underlying assumptions##4##2##(1992-3#1)(1996-3#1)(2010-10#1)(2012-2#1)
underlying biological##2##2##(2008-11#1)(2009-8#1)
underlying cause for##2##3##(2008-1#1)(2013-8#1)
underlying cause##5##2##(2008-1#2)(2010-10#2)(2013-8#1)
underlying conditions##3##2##(1994-3#1)(2008-5#1)(2010-12#1)
underlying disease and##2##3##(1994-9#1)(2011-3#1)
underlying disease##10##2##(1994-9#1)(1995-9#1)(2008-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
underlying diseases##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
underlying etiology##2##2##(2008-12#1)(2013-7#1)
underlying heart##2##2##(2008-7#1)(2010-10#1)
underlying mechanism of##2##3##(2009-8#1)(2010-7#1)
underlying mechanism##9##2##(2008-10#1)(2008-7#1)(2009-8#2)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
underlying mechanisms are##2##3##(2008-3#1)(2010-11#1)
underlying mechanisms for##3##3##(1990-2#1)(2008-11#1)(2013-1#1)
underlying mechanisms of##6##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
underlying mechanisms##18##2##(1990-2#1)(1993-1#1)(1995-12#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2013-1#3)
underlying molecular##2##2##(1995-11#1)(2012-2#1)
underlying natural##2##2##(2008-11#2)
underlying pathology##2##2##(1996-1#1)(2008-12#1)
underlying pathophysiology##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
underlying processes of language##2##4##(2011-1#2)
underlying processes of##3##3##(2008-10#1)(2011-1#2)
underlying processes##4##2##(2008-10#1)(2009-11#1)(2011-1#2)
underlying reasons##2##2##(1990-3#1)(1996-2#1)
underlying regulatory mechanisms##2##3##(1994-8#1)(2008-11#1)
underlying sex change##2##3##(2010-5#2)
underlying social##4##2##(1994-1#1)(2008-4#1)(2008-8#1)(2013-8#1)
underlying synaptic##2##2##(2008-11#1)(2009-9#1)
underlying the HR##2##3##(2008-10#2)
underlying the association between##2##4##(1991-8#1)(2009-6#1)
underlying the regulation of##2##4##(2008-11#1)(2011-2#1)
underlying the##46##2##(1991-8#1)(1992-12#1)(1993-8#1)(1994-3#1)(1996-12#1)(1996-2#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
underlying their##3##2##(2009-3#1)(2010-8#1)(2013-1#1)
underlying these##5##2##(2008-1#1)(2008-10#1)(2011-3#1)(2012-3#1)(2013-8#1)
underlying this##4##2##(1995-1#1)(2008-10#1)(2008-9#1)(2010-11#1)
underlying tissue##3##2##(1991-2#1)(1991-5#1)(2010-6#1)
underlying##288##1##(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#3)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#7)(2008-10#20)(2008-11#29)(2008-12#9)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#14)(2009-10#9)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#8)(2010-11#6)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#16)(2011-3#3)(2012-12#3)(2012-2#15)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#8)
undermine the##4##2##(1993-12#1)(2008-11#1)(2008-8#1)(2012-2#1)
undermine##7##1##(1993-12#2)(1995-1#1)(2008-11#1)(2008-8#2)(2012-2#1)
undermined##2##1##(2008-12#1)(2008-8#1)
undermines##2##1##(1992-2#1)(2008-7#1)
underneath the surface##2##3##(2008-5#2)
underneath the##4##2##(2008-11#2)(2008-5#2)
undernourished##2##1##(1990-2#1)(2008-7#1)
underphosphorylated##3##1##(1993-8#1)(1996-2#2)
underpin##5##1##(2008-10#1)(2008-11#2)(2010-9#1)(2012-3#1)
underpinned by##3##2##(2008-10#1)(2008-12#2)
underpinned##4##1##(2008-10#1)(2008-12#3)
underpinning##5##1##(2008-11#2)(2008-7#1)(2009-10#1)(2011-2#1)
underpinnings of the##2##3##(1996-3#1)(2008-11#1)
underpinnings of##5##2##(1991-2#1)(1993-2#1)(1996-3#1)(2008-11#1)(2013-1#1)
underpinnings##8##1##(1991-2#1)(1993-2#1)(1996-3#1)(2008-11#3)(2009-1#1)(2013-1#1)
underreporting of Lyme disease##2##4##(1997-3#2)
underreporting of##4##2##(1997-3#2)(2009-10#1)(2012-12#1)
underreporting##11##1##(1991-6#1)(1994-6#1)(1997-3#3)(2009-10#2)(2012-12#4)
underscore the importance of##5##4##(1990-6#1)(1991-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
underscore the need for##2##4##(1995-1#1)(2010-1#1)
underscore the need##3##3##(1991-6#1)(1995-1#1)(2010-1#1)
underscore the potential##2##3##(2008-7#1)(2013-1#1)
underscore the##15##2##(1990-6#1)(1991-2#1)(1991-6#1)(1992-11#1)(1995-1#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
underscore##17##1##(1990-6#1)(1991-2#1)(1991-6#1)(1992-11#1)(1995-1#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
underscores the importance of##4##4##(1990-8#1)(2008-10#2)(2013-1#1)
underscores the need to##2##4##(1997-3#1)(2013-1#1)
underscores the##11##2##(1990-8#1)(1995-3#1)(1997-3#2)(2008-10#2)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#2)
underscores##12##1##(1990-8#1)(1995-3#1)(1997-3#2)(2008-10#2)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
underscoring the##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
underscoring##5##1##(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
underserved areas##2##2##(2008-1#1)(2010-11#1)
underserved women##3##2##(1996-2#1)(2011-2#2)
underserved##11##1##(1996-2#1)(1997-1#2)(2008-1#1)(2008-11#1)(2010-11#2)(2011-2#2)(2012-2#2)
understand and##14##2##(1991-9#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-1#1)(2013-1#1)
understand how the##9##3##(1992-3#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
understand how##21##2##(1992-3#1)(1997-6#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
understand its##2##2##(2008-5#1)(2010-7#1)
understand that##7##2##(1991-1#1)(1992-3#1)(1993-3#1)(2008-11#2)(2009-10#1)(2009-9#1)
understand the basis##2##3##(1997-7#1)(2008-10#1)
understand the behavior of##2##4##(2008-3#1)(2011-2#1)
understand the concept of##2##4##(2009-7#1)(2012-3#1)
understand the consequences##2##3##(1994-2#1)(2009-5#1)
understand the contribution of##2##4##(1994-3#1)(2010-5#1)
understand the development##3##3##(2008-10#1)(2008-12#2)
understand the epidemiology of##2##4##(2008-10#1)(2008-11#1)
understand the function of##5##4##(1996-12#1)(1997-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
understand the genetic##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
understand the impact of##2##4##(1995-12#1)(2008-10#1)
understand the mechanism of##4##4##(1992-6#1)(1994-11#1)(2008-10#1)(2008-11#1)
understand the mechanism##5##3##(1992-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
understand the mechanisms##5##3##(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)
understand the microbial##2##3##(2008-5#1)(2012-2#1)
understand the molecular##4##3##(2008-10#1)(2008-4#1)(2012-2#2)
understand the nature of##2##4##(2008-10#2)
understand the nature##4##3##(2008-10#3)(2008-5#1)
understand the relationship between##2##4##(1995-2#1)(2008-10#1)
understand the response##2##3##(2008-10#1)(2012-2#1)
understand the role of##5##4##(2008-10#1)(2008-11#2)(2009-7#1)(2012-3#1)
understand the structural basis##2##4##(1993-8#1)(1997-9#1)
understand the##138##2##(1990-8#1)(1992-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#30)(2008-11#16)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#4)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#4)(2013-8#2)
understand their##12##2##(1990-12#1)(1993-1#1)(1993-2#2)(1994-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-6#1)(2013-8#1)
understand these##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
understand this phenomenon##3##3##(2009-9#1)(2012-2#1)(2013-8#1)
understand this##10##2##(1994-2#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-9#2)(2012-2#1)(2013-8#2)
understand what##5##2##(1996-6#1)(2008-9#1)(2009-10#1)(2009-7#1)(2013-8#1)
understand whether##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
understand which##2##2##(1991-3#1)(2008-11#1)
understand##285##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#6)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-1#2)(2008-10#42)(2008-11#32)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#7)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#9)(2012-12#3)(2012-2#12)(2012-3#13)(2013-1#8)(2013-8#6)
understandable##4##1##(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
understanding about##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
understanding and##26##2##(1991-12#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
understanding as##2##2##(1993-1#1)(2008-12#1)
understanding biological##2##2##(2008-5#1)(2009-12#1)
understanding how##3##2##(2009-5#1)(2011-2#1)(2012-2#1)
understanding in this##2##3##(1992-9#1)(1997-1#1)
understanding in##4##2##(1992-9#1)(1997-1#1)(2008-5#1)(2008-9#1)
understanding is##4##2##(1997-3#1)(2008-12#1)(2008-9#1)(2013-1#1)
understanding its##2##2##(2011-1#1)(2013-1#1)
understanding long-term##2##2##(2009-9#1)(2010-2#1)
understanding mechanisms of##4##3##(2007-12#1)(2008-8#1)(2012-2#2)
understanding mechanisms##5##2##(2007-12#1)(2008-11#1)(2008-8#1)(2012-2#2)
understanding of all##2##3##(1995-12#1)(2010-7#1)
understanding of bacterial##2##3##(2008-10#2)
understanding of cancer##2##3##(2007-11#1)(2009-6#1)
understanding of community##2##3##(1993-1#1)(2008-12#1)
understanding of disease##3##3##(1997-7#1)(2008-10#1)(2011-7#1)
understanding of function##2##3##(2008-12#1)(2009-12#1)
understanding of fundamental##2##3##(2008-11#1)(2009-8#1)
understanding of how parents##2##4##(1993-12#1)(2010-9#1)
understanding of how these##3##4##(2008-7#1)(2008-9#1)(2011-2#1)
understanding of how##21##3##(1993-1#1)(1993-12#1)(1994-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-6#1)(2010-9#2)(2011-2#3)(2012-12#1)
understanding of its role in##2##5##(2011-2#1)(2013-1#1)
understanding of its##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
understanding of mechanisms##2##3##(1997-5#1)(2012-2#1)
understanding of mental##2##3##(2008-12#2)
understanding of molecular##2##3##(2008-11#1)(2011-2#1)
understanding of such##2##3##(2008-8#1)(2009-5#1)
understanding of the basic mechanisms##2##5##(2010-10#1)(2013-1#1)
understanding of the biological##2##4##(2012-2#1)(2013-8#1)
understanding of the biology of##4##5##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
understanding of the biology##5##4##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
understanding of the clinical##2##4##(2008-11#2)
understanding of the dynamics of the##3##6##(2008-10#2)(2008-11#1)
understanding of the ecology of SNC##2##6##(2008-10#2)
understanding of the ecology of##3##5##(2008-10#3)
understanding of the ecology##4##4##(2008-10#3)(2008-9#1)
understanding of the evolution of##2##5##(2008-7#1)(2010-5#1)
understanding of the genetic##2##4##(2008-10#2)
understanding of the interrelationships##2##4##(2008-10#1)(2008-12#1)
understanding of the mechanisms of##3##5##(2008-7#1)(2008-9#1)(2011-2#1)
understanding of the mechanisms##7##4##(2008-7#2)(2008-9#1)(2009-1#1)(2010-12#1)(2011-2#2)
understanding of the molecular basis of##2##6##(2008-11#1)(2011-2#1)
understanding of the molecular##4##4##(2008-11#2)(2011-2#2)
understanding of the nature of##2##5##(2008-11#1)(2008-6#1)
understanding of the nature##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
understanding of the pathogenesis of##2##5##(1990-9#1)(2013-1#1)
understanding of the pathology##2##4##(2008-10#1)(2010-3#1)
understanding of the pathophysiology##3##4##(2013-1#1)(2013-7#1)(2013-8#1)
understanding of the physiological##3##4##(1997-8#1)(2008-4#1)(2008-9#1)
understanding of the process##3##4##(1994-12#1)(1995-1#1)(2012-3#1)
understanding of the relationship between##2##5##(2009-5#1)(2012-5#1)
understanding of the relationship##3##4##(2009-5#1)(2010-10#1)(2012-5#1)
understanding of the role of##8##5##(1995-12#1)(2008-8#1)(2009-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
understanding of the role##10##4##(1995-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
understanding of the underlying##3##4##(2008-10#1)(2008-9#1)(2012-3#1)
understanding of the##178##3##(1990-11#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#2)(1996-11#1)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#30)(2008-11#21)(2008-12#7)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#7)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#13)(2012-2#3)(2012-3#8)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#7)
understanding of their##5##3##(1995-5#1)(1995-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
understanding of these##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)
understanding of this##7##3##(1991-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
understanding of tree##2##3##(2008-10#1)(2010-4#1)
understanding of what##3##3##(1992-9#1)(2008-11#1)(2008-12#1)
understanding of##375##2##(1990-11#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#2)(1992-12#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-1#5)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#2)(2008-1#1)(2008-10#52)(2008-11#41)(2008-12#27)(2008-3#1)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#17)(2008-8#9)(2008-9#17)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#4)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#4)(2011-10#1)(2011-2#28)(2011-7#2)(2012-12#1)(2012-2#17)(2012-3#13)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#9)
understanding on the##3##3##(2009-12#1)(2009-9#1)(2011-2#1)
understanding on##4##2##(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)
understanding or##2##2##(2013-1#2)
understanding regarding##3##2##(2008-4#1)(2010-3#1)(2013-1#1)
understanding that##2##2##(1996-3#1)(2008-9#1)
understanding the evolution of##3##4##(2008-11#1)(2008-6#1)(2008-8#1)
understanding the function of##4##4##(2007-12#1)(2008-9#2)(2009-6#1)
understanding the impact of##2##4##(1994-1#1)(2010-1#1)
understanding the mechanism##2##3##(2008-10#1)(2008-9#1)
understanding the mechanisms of##2##4##(1991-12#1)(2009-8#1)
understanding the mechanisms underlying##2##4##(1990-5#1)(2013-1#1)
understanding the mechanisms##5##3##(1990-5#1)(1991-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
understanding the molecular basis of##3##5##(2008-11#2)(2008-9#1)
understanding the molecular##4##3##(2008-11#3)(2008-9#1)
understanding the process of##2##4##(2008-12#1)(2009-12#1)
understanding the relationship between##2##4##(1992-2#1)(2011-2#1)
understanding the social##2##3##(2008-11#1)(2008-6#1)
understanding the##78##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#9)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
understanding their##3##2##(1990-5#1)(2008-10#1)(2012-2#1)
understanding these##2##2##(2011-2#1)(2012-2#1)
understanding this##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
understanding why##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
understanding##602##1##(1990-11#1)(1990-5#2)(1990-9#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-6#2)(1991-7#1)(1992-12#1)(1992-2#3)(1992-9#3)(1993-1#4)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#4)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1997-1#6)(1997-2#3)(1997-3#6)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#75)(2008-11#62)(2008-12#38)(2008-3#4)(2008-4#12)(2008-5#16)(2008-6#5)(2008-7#18)(2008-8#16)(2008-9#27)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#12)(2009-3#3)(2009-4#8)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#9)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#5)(2011-1#9)(2011-10#1)(2011-2#41)(2011-7#3)(2012-12#4)(2012-2#31)(2012-3#15)(2012-5#2)(2012-9#1)(2013-1#25)(2013-7#2)(2013-8#14)
understandings of the##2##3##(2008-11#1)(2010-5#1)
understandings##6##1##(1990-12#1)(1994-12#1)(2008-11#1)(2010-1#1)(2010-10#1)(2010-5#1)
understands the##2##2##(1994-2#1)(2008-11#1)
understood about the##2##3##(1997-3#1)(2007-12#1)
understood and supported##2##3##(1993-2#1)(2008-1#1)
understood and##11##2##(1993-2#1)(1994-2#1)(1996-6#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#2)
understood as##4##2##(2008-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
understood by##6##2##(1992-3#1)(1994-1#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-9#1)
understood how##2##2##(2008-4#1)(2013-1#1)
understood in##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
understood that the##2##3##(1991-12#1)(2012-3#1)
understood that##5##2##(1991-12#1)(1993-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
understood the##3##2##(1996-9#2)(2008-11#1)
understood their##2##2##(1996-1#1)(2008-11#1)
understood to##2##2##(2009-1#1)(2012-3#1)
understood##151##1##(1990-5#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#3)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#17)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#3)(2009-5#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#9)(2012-12#1)(2012-2#8)(2012-3#11)(2013-1#7)(2013-8#6)
understory##12##1##(2008-10#1)(2008-8#5)(2008-9#6)
understudied##2##1##(2008-10#1)(2012-2#1)
undersupplied##2##1##(2008-9#2)
undertake a##4##2##(2008-10#1)(2008-11#3)
undertake this##2##2##(2008-11#2)
undertake##19##1##(1991-3#1)(1992-1#1)(1992-9#1)(1993-12#1)(1994-1#1)(2008-10#1)(2008-11#8)(2008-12#3)(2010-1#1)(2012-3#1)
undertaken and##2##2##(2008-10#2)
undertaken at a##2##3##(1993-11#1)(1993-12#1)
undertaken at the##2##3##(2008-11#1)(2008-5#1)
undertaken at##6##2##(1993-11#1)(1993-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
undertaken by alliances##2##3##(2013-1#2)
undertaken by an##2##3##(1991-3#1)(1993-9#1)
undertaken by the##2##3##(1994-12#1)(2008-10#1)
undertaken by##10##2##(1991-3#1)(1993-9#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)
undertaken for##5##2##(2008-10#1)(2012-12#4)
undertaken in support of the##2##5##(1994-12#1)(2008-10#1)
undertaken in##14##2##(1992-2#1)(1994-12#1)(1996-2#1)(2008-10#2)(2008-11#4)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
undertaken on##4##2##(1990-12#1)(2010-12#1)(2012-2#1)(2012-3#1)
undertaken to characterize the##2##4##(1994-2#1)(2008-10#1)
undertaken to control##2##3##(2008-11#1)(2011-2#1)
undertaken to determine if##3##4##(1993-11#1)(2008-7#1)(2012-3#1)
undertaken to determine the##4##4##(1995-12#1)(1996-12#1)(2008-12#1)(2008-7#1)
undertaken to determine##9##3##(1993-11#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2012-3#1)
undertaken to examine how##2##4##(1993-2#1)(2011-2#1)
undertaken to examine the##2##4##(1994-6#1)(2008-7#1)
undertaken to examine##6##3##(1993-2#1)(1994-6#1)(2008-5#1)(2008-7#1)(2011-2#2)
undertaken to investigate##5##3##(1991-2#1)(1994-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
undertaken to##58##2##(1991-12#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(2008-10#11)(2008-11#8)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#5)(2010-10#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
undertaken using##5##2##(1992-9#1)(2008-10#3)(2008-7#1)
undertaken with##6##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-10#1)
undertaken within##3##2##(2008-11#3)
undertaken##158##1##(1990-12#3)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#31)(2008-11#24)(2008-12#6)(2008-5#6)(2008-6#1)(2008-7#7)(2008-9#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#1)
undertaking a##8##2##(1993-12#1)(2008-10#1)(2008-11#5)(2008-12#1)
undertaking the##3##2##(2008-11#1)(2008-12#2)
undertaking##25##1##(1991-12#1)(1993-12#1)(1994-1#1)(1996-3#1)(2008-10#3)(2008-11#13)(2008-12#4)(2008-9#1)
undertook a study##2##3##(1990-5#1)(2009-6#1)
undertook a##3##2##(1990-5#1)(1991-11#1)(2009-6#1)
undertook the##2##2##(1997-2#1)(2008-1#1)
undertook##8##1##(1990-5#1)(1991-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-8#1)
underused##2##1##(2008-12#1)(2009-3#1)
underutilization of##2##2##(1996-1#1)(2010-4#1)
underutilization##3##1##(1996-1#1)(1997-2#1)(2010-4#1)
underutilized in##2##2##(2008-11#1)(2012-3#1)
underutilized##5##1##(1992-1#1)(1992-12#1)(2008-11#1)(2008-4#1)(2012-3#1)
underwater##8##1##(2008-10#3)(2008-2#1)(2008-3#4)
underway in##2##2##(1992-1#1)(1997-3#1)
underway to##3##2##(1994-5#1)(2009-1#1)(2012-2#1)
underway##13##1##(1992-1#1)(1992-12#1)(1994-1#1)(1994-5#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-1#1)(2010-12#1)(2012-2#1)
underweight and overweight##2##3##(1991-12#2)
underweight##9##1##(1991-12#3)(2010-6#2)(2010-7#1)(2011-1#2)(2013-1#1)
underwent RRT##2##2##(2012-3#2)
underwent TMS in##2##3##(2011-2#2)
underwent a combined##2##3##(2008-11#1)(2008-9#1)
underwent a modified radical##2##4##(1994-12#1)(2008-9#1)
underwent a new##2##3##(1991-9#1)(2007-8#1)
underwent a total##4##3##(2007-8#1)(2009-3#1)(2012-12#1)(2013-1#1)
underwent a##42##2##(1990-9#1)(1991-5#1)(1991-9#1)(1994-12#1)(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#3)(2008-9#7)(2009-3#2)(2010-12#1)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
underwent adjuvant##2##2##(2010-6#1)(2011-2#1)
underwent an##17##2##(1990-5#1)(1990-6#1)(1994-12#1)(1995-1#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#1)(2011-2#2)(2013-1#4)
underwent apoptosis##2##2##(2008-11#2)
underwent appendectomy##2##2##(1997-8#1)(2008-10#1)
underwent biopsy##3##2##(2008-7#1)(2010-11#1)(2012-3#1)
underwent bone##2##2##(1991-11#1)(2011-2#1)
underwent cervicotomy##2##2##(2013-1#2)
underwent correction of##2##3##(2008-9#1)(2009-10#1)
underwent embolization##2##2##(1991-2#1)(2008-7#1)
underwent emergency##2##2##(1992-5#1)(2008-11#1)
underwent endoscopic##2##2##(2007-8#1)(2011-2#1)
underwent incisional biopsy##2##3##(1997-6#1)(2010-11#1)
underwent laparoscopic##3##2##(1993-12#1)(1994-2#1)(2008-12#1)
underwent lung transplantation##2##3##(1994-3#1)(2010-10#1)
underwent magnetic resonance imaging##2##4##(2010-3#1)(2011-2#1)
underwent multielemental##2##2##(2008-10#2)
underwent open reduction##2##3##(2008-12#1)(2013-1#1)
underwent open##4##2##(2008-10#1)(2008-12#1)(2013-1#2)
underwent partial##3##2##(2011-2#1)(2012-3#1)(2013-7#1)
underwent radical surgery##3##3##(1990-6#1)(1990-9#1)(1997-7#1)
underwent radical surgical treatment##2##4##(2011-2#2)
underwent radical##6##2##(1990-3#1)(1990-6#1)(1990-9#1)(1997-7#1)(2011-2#2)
underwent radiotherapy##2##2##(2007-8#1)(2011-2#1)
underwent spinal##2##2##(2008-7#1)(2012-3#1)
underwent successful##2##2##(2008-12#1)(2013-1#1)
underwent surgery and##2##3##(1992-12#1)(2011-1#1)
underwent surgery at##2##3##(2011-1#1)(2011-2#1)
underwent surgery for##2##3##(2008-8#1)(2011-2#1)
underwent surgery##14##2##(1992-12#1)(1997-3#1)(2008-7#2)(2008-8#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#2)
underwent surgical##7##2##(1993-6#1)(1996-3#1)(2008-12#1)(2010-12#1)(2011-2#2)(2012-3#1)
underwent the##6##2##(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
underwent this procedure##3##3##(1990-2#1)(2008-11#1)(2012-3#1)
underwent this##4##2##(1990-2#1)(2008-11#2)(2012-3#1)
underwent total##2##2##(1992-12#1)(2013-1#1)
underwent transient##2##2##(2008-10#1)(2010-10#1)
underwent two##3##2##(2007-12#2)(2009-6#1)
underwent upper##2##2##(2008-11#1)(2011-2#1)
underwent##322##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#3)(1996-5#2)(1996-9#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#5)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#6)(2008-1#3)(2008-10#15)(2008-11#21)(2008-12#11)(2008-3#2)(2008-5#1)(2008-7#20)(2008-8#4)(2008-9#16)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#5)(2009-6#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#53)(2011-3#2)(2012-12#7)(2012-2#4)(2012-3#19)(2013-1#31)(2013-7#1)(2013-8#4)
underwriters##4##1##(1993-12#2)(1995-3#1)(1997-2#1)
underwriting factors##5##2##(1993-3#5)
underwriting##14##1##(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#6)(1994-2#1)(1995-1#2)(1996-2#1)
undescended testis##3##2##(2008-10#2)(2012-12#1)
undescended##5##1##(2008-10#4)(2012-12#1)
undescribed species##4##2##(2008-10#3)(2008-6#1)
undescribed##21##1##(1995-6#1)(2007-12#1)(2008-10#15)(2008-6#1)(2011-1#1)(2012-3#2)
undesirable and##2##2##(2008-5#1)(2012-2#1)
undesirable side##2##2##(1993-11#1)(2008-7#1)
undesirable##14##1##(1993-11#1)(1993-3#1)(1994-3#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
undesired##8##1##(1993-2#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)
undetectable in##9##2##(1990-11#2)(1991-5#1)(1992-3#1)(1994-11#1)(1995-6#1)(1996-12#1)(2013-1#2)
undetectable level##2##2##(1990-9#1)(1994-3#1)
undetectable levels##7##2##(1997-2#2)(2008-10#5)
undetectable on##4##2##(1991-12#1)(1995-6#1)(2008-7#1)(2008-8#1)
undetectable viral##2##2##(2008-10#1)(2013-1#1)
undetectable##37##1##(1990-11#2)(1990-9#1)(1991-12#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-6#2)(1996-12#1)(1997-1#1)(1997-2#2)(2008-10#9)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#3)
undetected and##3##2##(1995-12#1)(2008-10#1)(2009-6#1)
undetected##13##1##(1990-2#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-9#1)(2009-6#1)(2012-12#1)
undetermined##5##1##(1992-2#1)(1993-1#1)(2008-11#1)(2008-9#1)(2012-3#1)
undeveloped##2##1##(2010-9#1)(2011-2#1)
undiagnosed##13##1##(1996-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-5#1)(2013-1#4)
undifferentiated PC12 cell deaths at##2##5##(2013-8#2)
undifferentiated PC12##3##2##(2013-8#3)
undifferentiated carcinoma##3##2##(1991-8#2)(1995-10#1)
undifferentiated embryonic stem cells##2##4##(2008-11#2)
undifferentiated hESC##2##2##(2008-11#1)(2008-9#1)
undifferentiated state##2##2##(2008-11#1)(2013-1#1)
undifferentiated##28##1##(1990-3#1)(1991-8#2)(1991-9#1)(1995-10#1)(2008-10#1)(2008-11#8)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#5)(2013-1#1)(2013-8#4)
undigested##5##1##(1992-12#2)(2008-10#2)(2008-12#1)
undiluted samples##3##2##(2008-10#3)
undiluted##10##1##(1991-12#1)(2008-10#9)
undiscovered##4##1##(1994-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
undissolved##2##1##(2008-10#2)
undisturbed##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
undoped PbO(2)##2##2##(2008-10#2)
undoped##8##1##(2008-10#4)(2008-2#4)
undoubtedly##14##1##(1991-12#1)(1991-8#1)(1992-9#1)(1994-3#1)(1995-12#1)(1996-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)
undue burden##2##2##(1995-9#1)(1997-7#1)
undue##6##1##(1992-3#1)(1994-12#1)(1995-9#1)(1996-5#1)(1997-7#1)(2008-11#1)
undulosa##6##1##(2008-10#6)
une complication##2##2##(2011-2#2)
une pathologie##3##2##(2011-2#1)(2013-1#2)
une##32##1##(2008-11#3)(2008-5#1)(2011-2#6)(2013-1#22)
unemployed##4##1##(1995-12#1)(2010-11#1)(2013-1#2)
unemployment##10##1##(1991-11#2)(1992-11#1)(1993-3#1)(2008-1#1)(2008-11#2)(2008-12#2)(2010-6#1)
unenhanced transcription##2##2##(1995-6#2)
unenhanced##4##1##(1995-6#3)(2010-12#1)
unequal competitors##2##2##(2008-8#2)
unequal sample sizes##2##3##(1991-12#1)(1996-3#1)
unequal sister chromatid##2##3##(1993-12#2)
unequal##18##1##(1991-12#1)(1992-12#1)(1993-12#2)(1993-6#1)(1995-12#1)(1996-3#2)(1997-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#3)(2012-2#1)
unequivocal##9##1##(1990-6#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-8#1)(2011-2#1)(2011-3#1)
unequivocally##9##1##(1992-9#1)(1994-1#1)(2008-10#3)(2008-7#3)(2011-2#1)
unesterified##2##1##(1990-8#2)
unethical##4##1##(1992-12#1)(2008-12#3)
uneven distribution of the##2##4##(1994-6#1)(2008-10#1)
uneven distribution of##5##3##(1993-6#1)(1994-6#1)(2008-10#2)(2013-1#1)
uneven##16##1##(1992-5#1)(1993-6#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
unevenly distributed across##2##3##(1995-2#1)(2008-10#1)
unevenly distributed##3##2##(1995-2#1)(2008-10#2)
unevenly##5##1##(1995-2#1)(2008-1#1)(2008-10#3)
uneventful##21##1##(1991-11#1)(1993-2#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-12#2)(2010-12#1)(2010-7#2)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#3)
uneventfully##3##1##(2008-7#1)(2013-1#2)
unexpected and##3##2##(1994-3#1)(1996-6#1)(2008-11#1)
unexpected death##3##2##(1991-11#1)(2008-12#1)(2008-7#1)
unexpected findings##2##2##(2008-10#1)(2012-2#1)
unexpected##58##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#7)(2012-3#3)(2013-1#1)
unexpectedly high##2##2##(2008-7#1)(2011-2#1)
unexpectedly##20##1##(1991-9#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-9#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#3)(2013-1#1)
unexplained recurrent##2##2##(2012-3#2)
unexplained##15##1##(1991-12#1)(1994-12#1)(1996-2#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-6#1)(2010-1#1)(2010-11#1)(2012-3#2)
unexploited##2##1##(2009-3#2)
unexplored##8##1##(1992-12#1)(2006-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#2)
unexposed zones is##2##3##(2008-3#2)
unexposed##9##1##(1992-6#1)(1994-11#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-9#1)
unfamiliar##9##1##(1992-2#1)(1994-8#1)(2008-11#3)(2008-12#2)(2008-4#2)
unfavorable outcome##6##2##(2008-11#1)(2012-12#1)(2012-3#4)
unfavorable##24##1##(1990-8#1)(1992-2#1)(1993-2#1)(1994-3#2)(1997-1#1)(2008-10#2)(2008-11#2)(2009-12#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#2)
unfavourable##9##1##(1992-2#1)(1995-2#1)(2008-10#2)(2008-5#1)(2011-3#1)(2012-12#1)(2013-1#2)
unfeasible##2##1##(1997-2#1)(2008-10#1)
unfertilized eggs##2##2##(1993-6#2)
unfertilized##5##1##(1993-6#2)(1994-11#3)
unfiltered##3##1##(2007-12#1)(2008-10#2)
unfinished##2##1##(2008-11#1)(2008-7#1)
unfit for##2##2##(2008-11#1)(2008-3#1)
unfit##4##1##(2008-11#1)(2008-3#1)(2010-5#1)(2013-8#1)
unfixed cells##2##2##(2008-4#2)
unfixed##4##1##(2008-4#4)
unfold##3##1##(1993-12#1)(1993-9#1)(2008-10#1)
unfolded and##2##2##(2008-10#1)(2008-3#1)
unfolded protein response##3##3##(2009-8#1)(2011-2#1)(2012-3#1)
unfolded state and##2##3##(1997-2#2)
unfolded state##3##2##(1997-2#3)
unfolded##10##1##(1992-9#1)(1997-2#3)(2008-10#1)(2008-3#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
unfolding of RNA##2##3##(2008-4#2)
unfolding of the##2##3##(1991-6#1)(2008-4#1)
unfolding of##7##2##(1991-6#2)(1997-2#1)(2008-4#4)
unfolding##19##1##(1991-6#2)(1992-10#1)(1995-3#1)(1997-2#3)(2008-10#2)(2008-4#5)(2008-9#2)(2009-7#1)(2011-1#1)(2012-6#1)
unfortunate##4##1##(1993-3#1)(1994-9#1)(1995-2#1)(2008-11#1)
unfortunately##4##1##(1994-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
unfounded and##2##2##(1990-2#1)(2011-2#1)
unfractionated bone cells##3##3##(2008-11#3)
unfractionated bone##4##2##(2008-11#3)(2010-6#1)
unfractionated##7##1##(2008-11#3)(2008-3#1)(2008-4#1)(2010-3#1)(2010-6#1)
unfragmented##4##1##(1995-3#1)(2008-8#2)(2008-9#1)
unfused##2##1##(1993-6#1)(1994-2#1)
unglycosylated##2##1##(1992-3#1)(2008-11#1)
unguarded seedlings##2##2##(2008-10#2)
unguiculata)##2##1##(2008-10#2)
ungulate and bird introductions to New Zealand##2##7##(2008-8#2)
ungulate##4##1##(2008-8#3)(2008-9#1)
ungulates##3##1##(1991-3#1)(2008-8#2)
unhealthy assimilation&quot##2##2##(2010-12#2)
unhealthy diet##4##2##(2010-6#4)
unhealthy weight control##4##3##(2012-2#4)
unhealthy weight##6##2##(2008-11#2)(2012-2#4)
unhealthy##22##1##(1993-2#1)(1994-8#1)(1997-6#1)(2008-11#4)(2008-3#1)(2010-12#2)(2010-6#5)(2011-2#3)(2012-2#4)
unhelpful in##2##2##(1997-8#1)(2008-9#1)
unhelpful##5##1##(1997-8#1)(2008-11#1)(2008-9#1)(2009-11#1)(2012-3#1)
uniaxial orientation##2##2##(2010-4#2)
uniaxial##6##1##(2008-3#1)(2010-4#2)(2011-2#3)
unicellular##7##1##(1995-6#1)(1995-8#1)(1996-6#3)(2008-12#1)(2008-8#1)
unicolor laccase-modified##2##2##(2008-10#2)
unicolor##3##1##(2008-10#3)
unidentified##35##1##(1992-2#1)(1992-4#1)(1993-3#1)(1994-8#1)(1995-8#2)(1995-9#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#2)
unidimensional##3##1##(2010-2#1)(2011-2#1)(2012-2#1)
unidimensionality##2##1##(2011-2#1)(2012-2#1)
unidirectional##5##1##(2008-8#2)(2010-8#1)(2011-2#1)(2012-3#1)
unidirectionally##2##1##(1995-8#1)(2008-7#1)
unification##3##1##(1994-12#1)(2008-12#1)(2009-10#1)
unified method for##2##3##(1993-12#1)(1994-9#1)
unified##15##1##(1990-12#1)(1992-1#1)(1993-12#1)(1994-9#1)(1995-1#1)(1997-3#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#2)(2013-1#1)(2013-8#1)
unifies##3##1##(2008-3#1)(2011-2#1)(2012-3#1)
uniform and##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
uniform claims##2##2##(1992-2#1)(1997-3#1)
uniform connectedness##2##2##(2008-9#2)
uniform data##2##2##(1996-2#1)(1997-3#1)
uniform distribution of##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
uniform distribution##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)
uniform in##4##2##(2008-10#3)(2013-8#1)
uniform irradiance and phase##2##4##(2008-2#2)
uniform irradiance##3##2##(2008-2#3)
uniform shell designs##2##3##(2008-10#2)
uniform spatial##2##2##(2008-8#2)
uniform##102##1##(1991-1#1)(1991-8#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#3)
uniformed##2##1##(1995-6#2)
uniformis and B##2##3##(1997-2#2)
uniformis##3##1##(1997-2#3)
uniformity and##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
uniformity in##2##2##(1996-8#1)(2008-10#1)
uniformity of##2##2##(2008-10#1)(2008-3#1)
uniformity##21##1##(1995-3#1)(1996-8#1)(2008-10#10)(2008-12#1)(2008-3#5)(2008-5#1)(2013-1#1)(2013-8#1)
uniformly and##3##2##(2008-10#2)(2008-4#1)
uniformly distributed##5##2##(1990-5#1)(2008-10#3)(2008-8#1)
uniformly high##2##2##(2008-10#2)
uniformly throughout the##2##3##(1994-8#1)(2008-10#1)
uniformly##42##1##(1990-5#1)(1991-2#1)(1994-8#2)(1995-12#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2012-2#2)
unify##2##1##(2008-10#1)(2008-9#1)
unifying##6##1##(1993-12#1)(2008-11#3)(2008-8#1)(2010-7#1)
unigenes##2##1##(2008-10#1)(2010-5#1)
unilamellar vesicles (LUVs)##2##3##(2008-10#1)(2008-5#1)
unilamellar vesicles##10##2##(1994-5#2)(2008-10#3)(2008-11#2)(2008-5#1)(2012-2#2)
unilamellar##11##1##(1993-8#1)(1994-5#2)(2008-10#3)(2008-11#2)(2008-5#1)(2012-2#2)
unilateral 6-hydroxydopamine##2##2##(1997-2#1)(2012-2#1)
unilateral STN DBS##2##3##(2012-2#2)
unilateral and##2##2##(2008-7#1)(2008-8#1)
unilateral chyluria##2##2##(2008-10#2)
unilateral illumination##2##2##(1991-2#2)
unilateral neglect##2##2##(1996-2#1)(2009-10#1)
unilateral or bilateral##2##3##(1990-5#1)(2008-12#1)
unilateral rubella retinopathy in##2##4##(2011-2#2)
unilateral##70##1##(1990-5#2)(1991-2#4)(1992-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-12#4)(1996-2#4)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#3)
unilaterally in##3##2##(1996-12#3)
unilaterally nominated##2##2##(2009-7#2)
unilaterally##9##1##(1990-6#1)(1995-12#1)(1996-12#3)(2008-7#1)(2008-9#1)(2009-7#2)
unimodal function of##2##3##(2008-8#2)
unimodal##6##1##(2008-10#2)(2008-8#3)(2012-2#1)
unimodality##2##1##(2008-10#2)
unimodally##2##1##(2008-8#2)
unimpacted##2##1##(2009-7#2)
unimpaired##2##1##(1991-2#1)(2009-10#1)
unimpeded##2##1##(2008-10#1)(2012-2#1)
unimportant##5##1##(1995-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)
uninduced##2##1##(1994-8#1)(2011-1#1)
uninfected control##2##2##(1993-6#1)(2011-2#1)
uninfected females##3##2##(2012-3#3)
uninfected tissue##2##2##(1994-11#1)(2008-10#1)
uninfected women##2##2##(1994-9#2)
uninfected##43##1##(1990-12#1)(1991-5#1)(1993-6#3)(1994-11#1)(1994-5#1)(1994-9#2)(1995-6#1)(1996-12#1)(1996-5#2)(1997-3#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-3#3)
uninformative##3##1##(2008-10#2)(2011-2#1)
uninitiated##3##1##(1996-2#1)(2008-9#1)(2011-1#1)
uninjured##2##1##(2012-3#1)(2013-1#1)
uninoculated controls##2##2##(2008-10#2)
uninoculated leaves of##2##3##(2008-10#2)
uninoculated leaves##8##2##(2008-10#8)
uninoculated upper leaves##2##3##(2008-10#2)
uninoculated##17##1##(2008-10#16)(2008-5#1)
uninsured and underinsured##3##3##(2008-11#3)
uninsured and##6##2##(1994-2#1)(1995-12#1)(2008-11#3)(2011-2#1)
uninsured persons##2##2##(1991-2#1)(1997-2#1)
uninsured##29##1##(1991-2#1)(1992-2#2)(1993-3#1)(1994-2#1)(1995-12#3)(1997-2#2)(1997-3#3)(2008-10#1)(2008-11#10)(2011-2#3)(2013-1#2)
unintended pregnancies##3##2##(2008-11#1)(2013-1#2)
unintended##10##1##(1992-12#1)(1992-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2013-1#2)
unintentional##9##1##(1991-12#1)(2008-10#1)(2009-1#1)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
uninterrupted##5##1##(1994-11#1)(2008-10#3)(2008-8#1)
union involvement##2##2##(1996-3#2)
union was observed after##2##4##(2013-1#2)
union was observed##3##3##(2013-1#3)
union was##4##2##(2009-10#1)(2013-1#3)
union##32##1##(1991-2#1)(1992-2#1)(1995-12#4)(1996-3#2)(1997-2#1)(1997-6#1)(2007-8#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#4)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#5)
unionized##3##1##(1996-3#2)(2012-2#1)
uniparental##2##1##(2008-10#1)(2008-12#1)
unipolar stimulation##2##2##(2013-8#2)
unipolar##5##1##(1993-12#1)(1996-3#1)(2008-7#1)(2013-8#2)
uniporter##2##1##(2008-8#2)
unique AFLP profiles##2##3##(2008-10#2)
unique AFLP##5##2##(2008-10#5)
unique DNA fingerprints##2##3##(2008-10#2)
unique DNA##4##2##(1997-9#1)(2008-10#3)
unique ability to##3##3##(2008-11#1)(2009-8#1)(2012-2#1)
unique ability##4##2##(1997-1#1)(2008-11#1)(2009-8#1)(2012-2#1)
unique advantages##4##2##(2007-12#1)(2008-3#1)(2011-3#1)(2013-1#1)
unique among##7##2##(1992-10#1)(1995-8#1)(2008-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
unique and##10##2##(1992-1#1)(1996-12#1)(2008-11#2)(2008-9#2)(2009-10#1)(2010-9#1)(2011-3#1)(2012-3#1)
unique approach to##3##3##(1995-2#1)(1996-3#1)(2009-8#1)
unique approach##4##2##(1995-2#1)(1996-3#1)(2008-7#1)(2009-8#1)
unique aspects of##2##3##(2008-10#1)(2010-8#1)
unique case of##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
unique case##4##2##(2008-11#1)(2008-4#1)(2010-11#1)(2013-1#1)
unique challenges##5##2##(1997-2#1)(2008-4#1)(2009-6#1)(2010-10#1)(2011-2#1)
unique characteristics##9##2##(1990-11#1)(1991-5#1)(1996-3#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#2)
unique chemical and physical properties##2##5##(2008-10#1)(2010-7#1)
unique chemical##4##2##(2008-10#3)(2010-7#1)
unique clinical##4##2##(1993-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
unique combination of##5##3##(1996-1#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
unique distribution patterns##2##3##(2008-6#2)
unique environments##2##2##(1994-2#1)(2008-11#1)
unique enzyme##2##2##(1997-9#1)(2011-2#1)
unique family##3##2##(1995-3#1)(2008-4#1)(2008-7#1)
unique feature of the##2##4##(2008-10#1)(2008-9#1)
unique feature of##6##3##(2008-10#4)(2008-9#1)(2012-2#1)
unique feature##7##2##(2008-10#4)(2008-7#1)(2008-9#1)(2012-2#1)
unique features of this##2##4##(2008-10#1)(2009-6#1)
unique features of##5##3##(2008-10#2)(2009-6#1)(2011-2#1)(2012-2#1)
unique features##8##2##(1997-2#1)(2008-10#3)(2008-11#1)(2009-6#1)(2011-2#1)(2012-2#1)
unique for##3##2##(1993-11#1)(2008-10#2)
unique genes##3##2##(1997-6#2)(2008-10#1)
unique genomic##2##2##(2012-2#1)(2013-8#1)
unique genotypes##4##2##(2008-10#4)
unique in that it##4##4##(1993-6#1)(1995-9#1)(2009-8#1)(2013-8#1)
unique in that##7##3##(1993-6#1)(1994-5#1)(1995-9#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-8#1)
unique in##13##2##(1990-4#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2009-9#1)(2013-8#2)
unique macronutrient composition##3##3##(2008-3#3)
unique macronutrient##4##2##(2008-3#4)
unique management##2##2##(2010-6#1)(2013-8#1)
unique marker##3##2##(1993-8#1)(2008-10#1)(2012-12#1)
unique mechanism for##2##3##(1995-8#1)(2008-11#1)
unique mechanism##3##2##(1995-8#1)(2008-11#1)(2009-8#1)
unique natural##2##2##(2008-12#1)(2010-7#1)
unique needs##3##2##(1994-3#3)
unique nucleotide##2##2##(1993-8#1)(2010-10#1)
unique opportunity to##5##3##(1997-8#1)(2008-12#1)(2009-6#1)(2012-3#1)(2013-8#1)
unique opportunity##6##2##(1991-2#1)(1997-8#1)(2008-12#1)(2009-6#1)(2012-3#1)(2013-8#1)
unique or##2##2##(2008-10#2)
unique physical and chemical##2##4##(2008-10#1)(2009-8#1)
unique physical##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
unique position##4##2##(1996-1#2)(2008-11#1)(2010-4#1)
unique potential##2##2##(2008-11#1)(2012-2#1)
unique problems##2##2##(2008-10#1)(2009-10#1)
unique properties of##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
unique properties##9##2##(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)
unique property of the##2##4##(1996-2#1)(2008-10#1)
unique property of##3##3##(1996-2#1)(2008-10#1)(2012-2#1)
unique regulatory##2##2##(2011-2#1)(2012-3#1)
unique requirements for##2##3##(2008-3#1)(2010-8#1)
unique requirements##4##2##(2008-11#1)(2008-3#1)(2010-7#1)(2010-8#1)
unique restriction##2##2##(2008-10#2)
unique risk##2##2##(2010-6#1)(2011-2#1)
unique roles in##2##3##(1992-10#1)(2013-1#1)
unique sequence##3##2##(1993-12#1)(2012-2#1)(2013-1#1)
unique sequences##5##2##(1995-8#2)(1997-7#1)(2008-7#1)(2008-9#1)
unique species##2##2##(2008-10#1)(2010-4#1)
unique specificity##2##2##(2008-10#1)(2008-11#1)
unique structural##2##2##(1993-8#1)(2012-2#1)
unique substrate##2##2##(1995-2#1)(2011-1#1)
unique system##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
unique to a##3##3##(2008-10#1)(2008-9#2)
unique to the##8##3##(1996-12#1)(2008-10#3)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)
unique to this##3##3##(1992-6#1)(1995-6#1)(2008-11#1)
unique to##40##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1995-12#1)(1995-6#2)(1996-12#1)(1997-3#1)(2008-10#10)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
unique virulence##2##2##(2008-10#2)
unique##499##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#8)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#6)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#4)(1996-12#5)(1996-2#2)(1996-3#5)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#2)(1997-9#2)(2007-11#1)(2007-12#4)(2008-10#113)(2008-11#33)(2008-12#3)(2008-2#1)(2008-3#13)(2008-4#13)(2008-5#7)(2008-6#8)(2008-7#9)(2008-8#8)(2008-9#12)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#4)(2009-8#9)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#7)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#17)(2011-3#3)(2011-7#2)(2012-12#2)(2012-2#27)(2012-3#15)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#15)
uniquely expressed##2##2##(1996-12#1)(2011-2#1)
uniquely positioned to##2##3##(1992-1#1)(2010-4#1)
uniquely positioned##3##2##(1992-1#1)(1992-4#1)(2010-4#1)
uniquely shared by##2##3##(2013-8#2)
uniquely##34##1##(1990-5#1)(1991-12#1)(1992-1#1)(1992-4#2)(1993-8#3)(1994-8#1)(1994-9#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-9#3)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-8#4)
uniqueness of the##4##3##(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
uniqueness of##7##2##(2008-10#1)(2008-11#2)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#1)
uniqueness##19##1##(2008-10#2)(2008-11#3)(2008-3#1)(2008-9#5)(2009-10#1)(2010-10#2)(2012-3#1)(2013-8#4)
unirradiated##2##1##(1995-6#1)(2008-10#1)
unit activity##3##2##(1993-6#1)(1994-2#1)(2008-4#1)
unit addresses##3##2##(2008-4#2)(2008-9#1)
unit also##5##2##(2008-1#2)(2008-4#1)(2008-9#2)
unit and the##2##3##(1992-9#1)(2008-10#1)
unit and##12##2##(1992-4#1)(1992-9#1)(2008-10#6)(2008-11#2)(2008-7#1)(2012-3#1)
unit are##9##2##(1992-4#1)(2008-4#3)(2008-9#3)(2010-7#1)(2012-3#1)
unit area##4##2##(2008-10#3)(2008-8#1)
unit at a##2##3##(1992-3#1)(2012-3#1)
unit at##4##2##(1990-9#1)(1992-3#1)(1992-4#1)(2012-3#1)
unit by##2##2##(2008-9#1)(2012-3#1)
unit can be##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
unit cell##7##2##(1992-9#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)
unit consists of##2##3##(1995-6#1)(2008-5#1)
unit containing##3##2##(1993-2#1)(1994-5#1)(2008-7#1)
unit contains##3##2##(1992-4#1)(2008-1#1)(2008-9#1)
unit costs##2##2##(1992-12#1)(1995-3#1)
unit covers##6##2##(2008-4#3)(2008-9#3)
unit describes a##22##3##(2008-1#1)(2008-4#7)(2008-9#14)
unit describes preparation##2##3##(2008-4#1)(2008-9#1)
unit describes the basic##2##4##(2008-9#2)
unit describes the##38##3##(2008-1#3)(2008-4#23)(2008-9#12)
unit describes##120##2##(2008-1#7)(2008-4#61)(2008-9#52)
unit details##5##2##(2008-4#2)(2008-9#3)
unit discusses many of the##2##5##(2008-4#1)(2008-9#1)
unit discusses the##8##3##(2008-1#1)(2008-4#3)(2008-9#4)
unit discusses##15##2##(2008-1#1)(2008-4#6)(2008-9#8)
unit focuses on the##3##4##(2008-4#3)
unit focuses on##8##3##(2008-4#5)(2008-9#3)
unit for##10##2##(1991-11#1)(1997-8#1)(2008-10#4)(2008-4#2)(2010-12#1)(2010-2#1)
unit has##2##2##(2008-4#1)(2011-7#1)
unit illustrates how to##2##4##(2008-4#1)(2008-9#1)
unit in a public##2##4##(1991-3#1)(1993-1#1)
unit in a##4##3##(1991-3#1)(1993-1#1)(2008-3#2)
unit in an##3##3##(1992-2#1)(2010-11#1)(2012-3#1)
unit in the##4##3##(1992-12#1)(1997-6#1)(2008-8#2)
unit in##14##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-1#1)(1997-6#1)(2008-11#1)(2008-3#2)(2008-8#3)(2008-9#1)(2010-11#1)(2012-3#1)
unit includes##5##2##(2008-4#1)(2008-9#4)
unit is the##2##3##(2008-4#2)
unit is to##5##3##(2008-11#1)(2008-4#1)(2008-9#3)
unit is##30##2##(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#13)(2008-7#1)(2008-9#6)(2010-8#1)(2011-2#1)
unit mass of the gel##2##5##(2008-10#2)
unit mass##3##2##(2008-10#3)
unit of the##7##3##(1991-2#1)(1994-3#1)(2008-10#4)(2012-2#1)
unit of##33##2##(1991-2#1)(1993-12#2)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
unit on##6##2##(2008-10#1)(2008-9#4)(2012-2#1)
unit operations##2##2##(2008-11#1)(2012-2#1)
unit outlines a##2##3##(2008-9#2)
unit outlines##3##2##(2008-4#1)(2008-9#2)
unit patients##2##2##(2010-10#1)(2011-2#1)
unit presents a##12##3##(2008-2#1)(2008-4#4)(2008-9#7)
unit presents an alternative to differential display that allows the quantification of transcripts##3##13##(2008-2#3)
unit presents an overview of##3##5##(2008-4#2)(2008-9#1)
unit presents an##6##3##(2008-2#3)(2008-4#2)(2008-9#1)
unit presents protocols for##9##4##(2008-4#1)(2008-9#8)
unit presents protocols##10##3##(2008-4#1)(2008-9#9)
unit presents the##5##3##(2008-4#1)(2008-9#4)
unit presents##51##2##(2008-2#5)(2008-4#10)(2008-9#36)
unit provides a##14##3##(2008-4#11)(2008-9#3)
unit provides an excellent##3##4##(2008-9#3)
unit provides an overview of##6##5##(2008-4#6)
unit provides an##10##3##(2008-1#1)(2008-4#6)(2008-9#3)
unit provides basic##2##3##(2008-4#2)
unit provides detailed##3##3##(2008-4#1)(2008-9#2)
unit provides##36##2##(2008-1#1)(2008-4#24)(2008-9#11)
unit should be##3##3##(1996-12#1)(2008-9#2)
unit that##3##2##(1995-6#1)(2009-10#1)(2011-2#1)
unit to##2##2##(2008-10#2)
unit was##12##2##(1990-9#1)(1994-3#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#1)(2011-3#1)
unit were##2##2##(1992-12#1)(1995-1#1)
unit which##2##2##(1994-2#1)(2010-1#1)
unit will##2##2##(2008-10#1)(2008-9#1)
unit with##3##2##(2008-7#1)(2008-9#2)
unit##677##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1992-12#4)(1992-2#4)(1992-3#1)(1992-4#4)(1992-9#3)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#4)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-8#2)(2007-11#2)(2008-1#13)(2008-10#75)(2008-11#23)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#195)(2008-5#3)(2008-7#12)(2008-8#10)(2008-9#187)(2009-10#1)(2009-11#1)(2010-1#1)(2010-10#5)(2010-11#7)(2010-12#1)(2010-2#4)(2010-7#2)(2010-8#4)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#9)(2013-1#7)
unit's##2##1##(1992-2#1)(2008-10#1)
unit) for water in##2##4##(2008-10#2)
unit]##3##1##(1990-6#1)(1991-3#1)(2012-3#1)
unitary##5##1##(1994-11#1)(1997-7#1)(2008-3#1)(2008-4#1)(2008-9#1)
unite##2##1##(1994-1#1)(1995-1#1)
united the##2##2##(1996-3#1)(2008-11#1)
united##8##1##(1996-3#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
unites##2##1##(2008-8#1)(2011-2#1)
units (the##2##2##(2008-10#2)
units and the##5##3##(1991-2#1)(2008-10#2)(2010-7#1)(2013-8#1)
units and##17##2##(1991-2#1)(1994-11#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-7#1)(2013-1#2)(2013-8#1)
units are##10##2##(1995-12#1)(1995-5#1)(1996-5#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2010-5#1)
units at##5##2##(1997-8#1)(2007-8#2)(2008-7#1)(2010-8#1)
units by##2##2##(2008-4#1)(2008-8#1)
units can##3##2##(1992-9#1)(1996-12#1)(2009-11#1)
units for##4##2##(1993-6#1)(1994-1#1)(2008-3#1)(2008-9#1)
units had##3##2##(1995-9#1)(2008-12#1)(2011-1#1)
units higher##2##2##(2008-10#2)
units in the case of##3##5##(2008-10#3)
units in the##10##3##(1991-2#1)(1995-6#1)(1997-6#1)(2008-10#3)(2008-8#1)(2009-10#2)(2011-1#1)
units in this chapter##2##4##(2008-9#2)
units in##24##2##(1991-2#1)(1991-7#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-10#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2011-1#1)
units is##3##2##(2008-7#1)(2009-10#1)(2010-8#1)
units may##2##2##(2011-1#1)(2013-8#1)
units need to##2##3##(1994-6#1)(2011-1#1)
units of the##2##3##(2008-10#1)(2013-8#1)
units of time(-1))##2##3##(2008-10#2)
units of##21##2##(1990-2#1)(1990-6#1)(1993-2#1)(1994-5#1)(1995-3#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
units on##2##2##(2008-10#1)(2010-5#1)
units per##5##2##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
units such as##2##3##(2008-11#1)(2008-12#1)
units that##3##2##(2007-12#1)(2008-7#1)(2009-8#1)
units there##3##2##(2008-10#2)(2010-5#1)
units to##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)
units was##6##2##(1995-9#1)(1997-3#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
units were##11##2##(1995-3#1)(1997-3#1)(2008-10#3)(2008-12#1)(2009-9#1)(2011-2#3)(2013-8#1)
units with##8##2##(1990-11#1)(1994-3#1)(2008-10#2)(2009-10#1)(2012-2#2)(2013-1#1)
units within the ODN-chains##3##4##(2008-10#3)
units within the##6##3##(1992-4#1)(2008-10#4)(2010-10#1)
units##305##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#6)(1991-7#1)(1991-8#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1995-11#1)(1995-12#4)(1995-3#2)(1995-5#1)(1995-6#4)(1995-9#3)(1996-11#1)(1996-12#2)(1996-2#4)(1996-5#5)(1996-9#1)(1997-1#1)(1997-3#5)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2007-12#9)(2007-8#2)(2008-10#82)(2008-11#16)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#9)(2008-8#6)(2008-9#6)(2009-10#5)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-5#4)(2010-7#2)(2010-8#3)(2011-1#7)(2011-2#10)(2012-2#6)(2012-3#2)(2013-1#11)(2013-8#8)
units'##2##1##(2008-11#1)(2011-2#1)
units)##12##1##(1991-6#1)(1992-12#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#3)(2013-1#1)
units/mg##2##1##(1992-3#2)
units/ml##3##1##(2008-10#3)
unity among##2##2##(1990-11#1)(1990-6#1)
unity of##3##2##(1994-3#1)(2010-4#1)(2010-8#1)
unity##10##1##(1990-11#1)(1990-6#1)(1993-3#1)(1994-3#1)(1996-12#1)(2008-12#1)(2010-1#1)(2010-4#1)(2010-8#1)(2013-8#1)
univalent metal##4##2##(2008-10#4)
univalent##6##1##(2008-10#6)
univariate analyses##3##2##(1994-12#1)(2011-2#1)(2013-8#1)
univariate analysis##2##2##(1990-8#1)(1991-2#1)
univariate and multivariate analyses##2##4##(2008-7#1)(2013-8#1)
univariate and multivariate##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
univariate and##4##2##(2008-10#2)(2008-7#1)(2013-8#1)
univariate calibration##7##2##(2008-10#7)
univariate method##5##2##(2008-10#5)
univariate##28##1##(1990-8#1)(1991-2#1)(1994-12#1)(2008-10#19)(2008-7#1)(2009-4#2)(2011-2#1)(2013-8#2)
universal access to##2##3##(2008-6#1)(2012-12#1)
universal access##3##2##(1994-2#1)(2008-6#1)(2012-12#1)
universal and##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
universal coverage##2##2##(1995-12#1)(1996-1#1)
universal detection##3##2##(2008-10#2)(2011-2#1)
universal health insurance##4##3##(1991-2#4)
universal health##6##2##(1991-2#4)(1996-2#1)(2007-12#1)
universal human##2##2##(2008-11#1)(2009-10#1)
universal insurance coverage##2##3##(1994-1#1)(1995-12#1)
universal liposomal nanovesicles for immunoassays##2##5##(2008-10#2)
universal personal##2##2##(2008-1#2)
universal precautions##2##2##(1991-12#2)
universal primer##3##2##(2008-10#3)
universal primers##4##2##(1996-8#1)(2008-10#2)(2008-8#1)
universal protein G-liposomal nanovesicles##3##4##(2008-10#3)
universal reagent for##3##3##(2008-10#3)
universal reagents for##2##3##(2008-10#2)
universal testing machine##2##3##(2009-7#1)(2013-1#1)
universal##97##1##(1990-12#1)(1991-12#2)(1991-2#4)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#28)(2008-11#8)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#2)(2009-4#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
universalist##2##1##(2008-12#2)
universally available##2##2##(1994-9#1)(2011-2#1)
universally##19##1##(1992-10#1)(1992-2#1)(1994-9#1)(1996-1#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
universe and##2##2##(1995-6#1)(2008-12#1)
universe##13##1##(1995-6#1)(1996-12#1)(2008-12#4)(2009-10#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#3)
universities and##3##2##(1997-5#1)(2008-11#2)
universities were##2##2##(1997-5#1)(2008-11#1)
universities##21##1##(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1997-3#1)(1997-5#3)(2008-10#3)(2008-11#4)(2008-12#2)(2013-1#3)(2013-8#1)
university and##4##2##(1996-1#1)(2008-11#1)(2010-10#1)(2013-1#1)
university campus##2##2##(1996-12#1)(2013-1#1)
university center##2##2##(2011-2#1)(2013-8#1)
university education##3##2##(1994-12#2)(2012-3#1)
university hospital in##2##3##(1990-12#1)(1993-1#1)
university hospital##9##2##(1990-12#1)(1992-5#1)(1993-1#1)(2009-1#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
university hospitals##5##2##(1990-12#2)(1991-2#1)(1993-6#1)(1997-8#1)
university in##4##2##(1997-3#1)(2008-11#1)(2008-12#1)(2012-3#1)
university teaching##4##2##(1990-3#1)(2008-12#1)(2011-2#1)(2013-1#1)
university training##2##2##(1992-3#1)(2008-11#1)
university##85##1##(1990-12#3)(1990-3#1)(1990-9#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#3)(1995-11#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#18)(2008-12#9)(2008-5#1)(2008-7#1)(2009-1#1)(2010-1#2)(2010-10#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#2)
university-affiliated##2##1##(1994-12#1)(2011-1#1)
unknown analytical##2##2##(2008-10#2)
unknown and##4##2##(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
unknown arsenic species##2##3##(2008-10#2)
unknown aspects of##2##3##(1994-2#1)(2008-7#1)
unknown at present##2##3##(1992-9#1)(2010-4#1)
unknown at##3##2##(1992-9#1)(2008-11#1)(2010-4#1)
unknown but##5##2##(1990-12#1)(1990-3#1)(1996-3#1)(2012-3#1)(2013-8#1)
unknown chemical##2##2##(2008-11#1)(2008-5#1)
unknown class##2##2##(2009-10#1)(2012-3#1)
unknown compounds were##2##3##(2008-10#2)
unknown concentration##2##2##(2008-10#2)
unknown etiology##12##2##(1991-2#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2010-11#2)(2011-2#1)(2012-3#1)
unknown function##14##2##(1992-9#1)(1994-6#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-9#2)(2009-10#1)(2009-9#1)
unknown genes##3##2##(1997-6#1)(2008-9#1)(2012-3#1)
unknown in##3##2##(1995-2#1)(2008-7#1)(2013-1#1)
unknown mechanism##2##2##(1995-8#1)(2010-10#1)
unknown number of##2##3##(2008-9#1)(2010-10#1)
unknown or##4##2##(2008-10#2)(2008-11#1)(2009-9#1)
unknown parameters##2##2##(2008-10#2)
unknown peaks##2##2##(2008-10#2)
unknown primary##2##2##(1992-12#1)(1992-2#1)
unknown protein##2##2##(2008-10#1)(2010-4#1)
unknown proteins##4##2##(1996-6#1)(2008-10#2)(2008-11#1)
unknown viruses##2##2##(1994-6#1)(2008-10#1)
unknown whether##5##2##(2008-11#2)(2008-7#1)(2012-2#1)(2013-8#1)
unknown##316##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-6#4)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#80)(2008-11#21)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#5)(2008-9#11)(2009-10#4)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#4)(2009-9#4)(2010-10#3)(2010-11#2)(2010-3#1)(2010-4#2)(2010-8#2)(2011-2#14)(2011-7#1)(2012-12#2)(2012-2#11)(2012-3#18)(2013-1#7)(2013-8#10)
unlabeled##14##1##(1990-11#1)(1990-12#1)(1991-12#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-6#1)(1995-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
unlabelled cells##3##2##(1991-5#3)
unlabelled##9##1##(1990-12#1)(1990-8#1)(1991-5#3)(1994-8#1)(1997-1#2)(2008-11#1)
unladen##4##1##(2008-8#1)(2008-9#3)
unlesioned##2##1##(2012-2#2)
unless a##3##2##(1991-3#1)(2008-7#1)(2009-11#1)
unless it is##2##3##(2010-8#1)(2012-12#1)
unless the##9##2##(2008-10#4)(2008-3#3)(2008-5#1)(2008-7#1)
unless there is##2##3##(2011-3#1)(2013-1#1)
unless there##4##2##(2008-11#1)(2008-7#1)(2011-3#1)(2013-1#1)
unless they##2##2##(1991-12#1)(2008-4#1)
unless we assume##2##3##(2012-3#2)
unless##38##1##(1990-11#1)(1991-12#1)(1991-3#1)(1994-1#1)(1995-2#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
unlike in##4##2##(1995-11#1)(2008-11#1)(2008-7#1)(2010-6#1)
unlike other##2##2##(2008-10#1)(2011-2#1)
unlike the##8##2##(1995-11#1)(1996-2#2)(1996-8#1)(2008-10#3)(2009-8#1)
unlike those##2##2##(1991-1#1)(2013-1#1)
unlike##37##1##(1991-1#1)(1991-5#1)(1993-8#1)(1994-9#1)(1995-11#3)(1996-2#2)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-6#2)(2010-7#1)(2011-2#1)(2013-1#1)
unlikely that a##2##3##(1993-9#1)(1996-12#1)
unlikely that##12##2##(1993-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2010-2#1)
unlikely to be##15##3##(1992-6#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-1#2)(2013-8#1)
unlikely to benefit from##2##4##(2009-8#1)(2012-2#1)
unlikely to increase##2##3##(1997-6#1)(2008-8#1)
unlikely to##37##2##(1992-6#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-12#2)(1997-6#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
unlikely##68##1##(1990-11#1)(1991-12#2)(1992-6#1)(1993-12#1)(1993-9#2)(1994-5#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-5#5)(2008-7#3)(2008-8#6)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
unlimited calorie diet##2##3##(2008-3#2)
unlimited life time##2##3##(2008-10#2)
unlimited##13##1##(1993-2#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)
unlinked to##3##2##(1994-9#1)(2008-10#1)(2012-3#1)
unlinked##6##1##(1994-9#1)(2008-10#3)(2012-3#2)
unloaded by the##2##3##(2013-1#2)
unloaded##7##1##(1991-5#1)(2008-10#2)(2013-1#4)
unloading##7##1##(1995-2#1)(2008-10#3)(2010-3#2)(2010-6#1)
unlucky##2##1##(2009-6#1)(2012-3#1)
unmarried##4##1##(1990-12#1)(1991-6#1)(2010-4#1)(2012-3#1)
unmask##2##1##(2008-4#1)(2008-7#1)
unmasked by##3##2##(2008-12#1)(2008-7#1)(2010-12#1)
unmasked##6##1##(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)
unmatched##5##1##(1992-9#1)(2010-7#2)(2011-2#1)(2013-1#1)
unmet##8##1##(1993-2#1)(1995-1#1)(1995-12#1)(2008-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
unmethylated##2##1##(2008-4#1)(2009-10#1)
unmodified ODNs##2##2##(2008-4#2)
unmodified and##2##2##(2008-10#2)
unmodified carbon##3##2##(2008-10#3)
unmodified##26##1##(1995-12#1)(2008-10#17)(2008-4#4)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
unmulched##2##1##(2008-10#2)
unmutated IgV(H)##3##2##(2008-9#3)
unnamed Trichoderma anamorphs##2##3##(2008-10#2)
unnamed##5##1##(2008-10#4)(2010-10#1)
unnatural amino##2##2##(1992-11#1)(1992-3#1)
unnatural##8##1##(1992-11#1)(1992-12#1)(1992-3#1)(2008-4#4)(2008-7#1)
unneccessary and##2##2##(2012-12#2)
unnecessarily##2##1##(1995-3#1)(2012-3#1)
unnecessary hospital##2##2##(2009-6#2)
unnecessary surgical##3##2##(1992-9#1)(2011-2#2)
unnecessary##31##1##(1991-11#1)(1991-12#2)(1991-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(2008-10#8)(2009-10#1)(2009-6#2)(2010-1#1)(2010-11#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
unnoticed##3##1##(1991-3#1)(2008-7#2)
unobserved##6##1##(2008-10#1)(2009-5#2)(2010-10#1)(2011-2#1)(2012-3#1)
unopposed##2##1##(1992-8#1)(2011-2#1)
unorthodox##2##1##(1990-12#1)(2010-2#1)
unpackaged ssDNA contains##2##3##(1991-5#2)
unpackaged ssDNA##3##2##(1991-5#3)
unpackaged##5##1##(1991-5#5)
unpaired electron-spin density##2##3##(1994-5#2)
unpaired##10##1##(1993-2#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-5#2)(2007-12#1)(2008-5#1)(2012-3#1)
unpalatable##2##1##(2012-3#1)(2013-1#1)
unparasitized penultimate##2##2##(1992-6#2)
unphosphorylated##3##1##(2008-4#1)(2010-12#2)
unplanned##6##1##(1993-3#1)(1994-3#1)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)
unpleasant##7##1##(1992-2#2)(1992-5#1)(1994-5#1)(2008-4#1)(2008-6#1)(2012-3#1)
unpleasantness of##3##2##(2008-10#3)
unpleasantness##6##1##(2008-10#5)(2013-8#1)
unpolarized light##3##2##(2008-10#1)(2008-3#2)
unpopular##2##1##(2008-11#2)
unpracticed##2##1##(1990-11#1)(2010-7#1)
unprecedented##10##1##(1995-2#1)(1996-2#1)(1997-1#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
unpredictable##16##1##(1993-12#1)(1994-3#1)(1996-6#1)(2008-10#2)(2008-11#3)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#3)(2013-1#1)
unpretreated##2##1##(2008-10#2)
unprimed##2##1##(1994-6#1)(1995-2#1)
unproductive##2##1##(1990-2#1)(2010-8#1)
unprotected exposure to##2##3##(1992-6#1)(2011-2#1)
unprotected receptive##2##2##(2008-12#1)(2011-2#1)
unprotected sex##4##2##(1996-5#1)(2010-9#1)(2013-1#2)
unprotected sexual##2##2##(2008-1#1)(2012-2#1)
unprotected##16##1##(1991-7#1)(1992-6#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-12#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#3)
unprotonated##5##1##(1991-9#2)(2008-10#3)
unproven##4##1##(1991-3#1)(1995-6#1)(2008-12#1)(2009-11#1)
unpublished##3##1##(2008-9#1)(2010-1#1)(2010-12#1)
unpurified##2##1##(1994-8#1)(2008-10#1)
unquantified##4##1##(2008-11#1)(2008-4#3)
unravel the##6##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
unravel##10##1##(1995-11#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-6#1)
unraveling of the##3##3##(2008-7#1)(2013-7#1)(2013-8#1)
unraveling of##6##2##(1994-3#2)(2008-10#1)(2008-7#1)(2013-7#1)(2013-8#1)
unraveling##10##1##(1994-3#2)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-7#1)(2013-8#1)
unreacted##3##1##(2008-10#3)
unreactive##2##1##(2008-10#2)
unrealistic and##2##2##(1994-12#1)(2008-7#1)
unrealistic##8##1##(1994-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2013-1#1)
unreasonable##2##1##(1990-12#1)(1994-12#1)
unreasonably high##2##2##(1992-3#1)(2008-10#1)
unrecognised in##2##2##(2008-7#1)(2010-12#1)
unrecognised##6##1##(1992-9#1)(1994-3#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-12#1)
unrecognized##20##1##(1993-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
unreinforced##3##1##(2008-11#3)
unrelated MLD alleles##2##3##(1997-3#2)
unrelated causes##2##2##(1994-12#1)(2013-1#1)
unrelated control##2##2##(1997-7#1)(2008-12#1)
unrelated cord blood##2##3##(2010-11#1)(2013-1#1)
unrelated cord##3##2##(2010-11#2)(2013-1#1)
unrelated females##2##2##(1993-6#1)(2008-8#1)
unrelated individuals from##4##3##(2008-12#4)
unrelated individuals##9##2##(2008-12#7)(2008-8#1)(2012-3#1)
unrelated patients##2##2##(1991-12#2)
unrelated plant viruses##2##3##(2008-10#2)
unrelated to any##3##3##(1995-8#1)(1996-12#1)(1996-2#1)
unrelated to either##2##3##(1992-6#1)(2008-12#1)
unrelated to the##8##3##(1991-8#1)(2008-10#3)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
unrelated to##28##2##(1991-3#1)(1991-8#1)(1992-6#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#2)
unrelated##86##1##(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-3#6)(1997-7#1)(1997-8#3)(2008-10#17)(2008-11#3)(2008-12#11)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-12#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
unreliable##9##1##(1991-11#1)(1993-9#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-10#1)
unrelieved pain##2##2##(2008-7#2)
unrelieved##3##1##(1990-3#1)(2008-7#2)
unremarkable##6##1##(1995-11#1)(2008-11#2)(2012-3#1)(2013-1#2)
unreported##7##1##(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2013-8#1)
unresectable##10##1##(1992-3#1)(1993-9#1)(1994-2#1)(2008-7#1)(2013-1#5)(2013-8#1)
unresected choledochal##2##2##(2009-9#2)
unresected##3##1##(2009-9#3)
unresolved cases##2##2##(2010-3#1)(2011-2#1)
unresolved issues##3##2##(1994-12#1)(1995-12#1)(1996-1#1)
unresolved##25##1##(1992-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
unresponsive to##7##2##(1996-9#1)(1997-1#1)(2008-11#1)(2008-7#1)(2011-2#3)
unresponsive##11##1##(1996-9#1)(1997-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-11#1)(2011-2#4)
unresponsiveness##4##1##(2008-11#4)
unrest##3##1##(1991-3#1)(1993-2#1)(1994-2#1)
unrestrained rats##2##2##(1995-2#1)(2008-4#1)
unrestrained##4##1##(1991-3#1)(1995-2#1)(1997-1#1)(2008-4#1)
unrestricted##5##1##(1992-4#1)(2008-7#2)(2009-4#1)(2011-2#1)
unretained##4##1##(2008-10#4)
unruptured aneurysm##2##2##(1995-11#1)(2013-8#1)
unruptured arteriovenous malformations##2##3##(2008-7#2)
unruptured##9##1##(1995-11#2)(1995-8#1)(2008-7#4)(2009-7#1)(2013-8#1)
unsafe abortions##3##2##(2008-11#3)
unsafe##9##1##(1994-9#1)(1995-12#1)(2008-11#6)(2008-5#1)
unsalvageable##2##1##(2008-10#1)(2011-2#1)
unsatisfactory results##2##2##(2008-10#1)(2008-12#1)
unsatisfactory##14##1##(1995-12#1)(1996-6#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2012-5#1)(2013-1#1)
unsatisfied##2##1##(2010-2#1)(2011-7#1)
unsaturated FA##2##2##(2009-3#2)
unsaturated fatty acids##8##3##(1991-6#1)(1993-3#1)(1994-8#1)(1995-11#1)(1996-3#2)(2008-10#1)(2008-11#1)
unsaturated fatty##9##2##(1991-6#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-3#2)(2008-10#1)(2008-11#1)
unsaturated ketones##2##2##(1996-5#2)
unsaturated##21##1##(1991-6#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-11#1)(1996-3#2)(1996-5#2)(2008-10#4)(2008-11#2)(2008-5#1)(2009-3#2)(2010-4#1)
unsaturation percentage##2##2##(2008-10#2)
unsaturation##9##1##(1995-11#2)(2008-10#5)(2008-9#1)(2010-4#1)
unscheduled##4##1##(1991-2#1)(2008-11#1)(2009-6#1)(2012-2#1)
unscientific##2##1##(1990-2#1)(2008-7#1)
unseeded##3##1##(2008-3#3)
unsegmented##2##1##(2008-10#2)
unselected##6##1##(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#2)
unsensitized##2##1##(2008-10#2)
unsolved##3##1##(1990-12#1)(2009-8#1)(2012-3#1)
unspecific##7##1##(1990-11#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#2)
unspecified##3##1##(1996-5#1)(2008-11#1)(2012-3#1)
unspiked##3##1##(2008-10#3)
unspliced##3##1##(1993-12#1)(1993-8#1)(2011-3#1)
unsprayed areas##2##2##(2008-10#2)
unsprayed##6##1##(2008-10#6)
unstable aberrations##2##2##(2013-8#2)
unstable and##4##2##(1992-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
unstable angina and##2##3##(2008-3#1)(2008-5#1)
unstable angina pectoris##4##3##(1990-12#3)(2011-2#1)
unstable angina##13##2##(1990-12#3)(1992-9#1)(2008-10#1)(2008-3#3)(2008-5#2)(2010-12#1)(2011-2#1)(2013-1#1)
unstable in##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
unstable resonator##6##2##(2008-2#2)(2008-3#4)
unstable resonators with a##2##4##(2008-3#2)
unstable resonators##7##2##(2008-2#1)(2008-3#6)
unstable to##2##2##(1994-11#1)(1996-5#1)
unstable##88##1##(1990-12#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-3#1)(1996-5#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#17)(2008-5#3)(2008-8#6)(2008-9#4)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#6)
unsteady##7##1##(1994-3#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)(2013-8#1)
unsteamed##2##1##(2008-10#2)
unsterilized##2##1##(2008-10#2)
unstimulated and##2##2##(1997-8#1)(2012-2#1)
unstimulated##4##1##(1997-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
unstirred##10##1##(1991-5#7)(2008-10#1)(2008-11#1)(2008-8#1)
unstratified##2##1##(1994-9#1)(1995-9#1)
unstressed##2##1##(1997-2#1)(2008-11#1)
unstructured absorption spectra##3##3##(2008-3#3)
unstructured interviews##3##2##(2008-11#2)(2010-10#1)
unstructured##20##1##(1995-2#1)(2008-11#3)(2008-3#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-8#2)(2013-1#5)
unsubstituted##2##1##(2008-10#2)
unsuccessful in##2##2##(1992-9#1)(2008-11#1)
unsuccessful##24##1##(1991-1#1)(1992-9#1)(1994-3#2)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
unsuccessfully treated with##2##3##(2010-2#1)(2013-1#1)
unsuccessfully treated##3##2##(2010-2#2)(2013-1#1)
unsuccessfully##4##1##(2008-10#1)(2010-2#2)(2013-1#1)
unsuitable as##2##2##(2008-10#2)
unsuitable for use in##2##4##(2008-10#1)(2008-9#1)
unsuitable for##11##2##(1991-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#2)(2011-2#1)
unsuitable##21##1##(1991-6#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
unsupervised pattern recognition##2##3##(2008-10#2)
unsupervised##7##1##(2008-10#5)(2009-12#1)(2010-7#1)
unsupplemented##2##1##(2011-2#2)
unsure##3##1##(2008-11#3)
unsuspected##8##1##(1994-2#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#2)(2012-3#1)
unsustained##2##1##(2009-10#2)
unsymmetrical##4##1##(2008-10#4)
untapped##3##1##(1992-1#1)(1995-12#1)(2008-11#1)
untested##3##1##(1993-12#1)(2008-5#1)(2009-8#1)
until 12##2##2##(1995-11#1)(1997-3#1)
until 1991##2##2##(2008-10#1)(2008-7#1)
until 1993##2##2##(1995-12#1)(1997-5#1)
until 2##2##2##(2008-10#2)
until 3 to 5 weeks##2##5##(2008-10#2)
until 4 weeks##2##3##(2008-10#1)(2013-8#1)
until 4##4##2##(1996-12#1)(2008-10#2)(2013-8#1)
until 5##2##2##(2008-1#1)(2008-10#1)
until 6 to##2##3##(1997-3#1)(2008-10#1)
until 8##2##2##(1996-12#1)(2008-10#1)
until December 2008##2##3##(2011-2#1)(2013-1#1)
until July##3##2##(1996-5#1)(1997-2#1)(2008-10#1)
until June##5##2##(1996-5#1)(2008-10#2)(2011-2#1)(2013-8#1)
until May##2##2##(1995-6#1)(2008-10#1)
until a##4##2##(2008-10#3)(2013-1#1)
until about##2##2##(1996-3#2)
until adulthood##2##2##(2008-10#2)
until day##3##2##(1994-8#1)(2008-11#1)(2008-5#1)
until harvest##8##2##(2008-10#8)
until his##3##2##(2008-7#2)(2010-3#1)
until it##4##2##(2008-10#1)(2008-11#1)(2010-1#1)(2013-1#1)
until late in##3##3##(2008-10#3)
until late##5##2##(2008-10#5)
until later in##2##3##(1995-2#1)(1997-5#1)
until more##2##2##(2008-10#1)(2008-9#1)
until now has##2##3##(1992-11#1)(2008-7#1)
until now##14##2##(1992-11#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-7#1)
until puberty and##2##3##(1995-12#1)(2008-5#1)
until reaching##2##2##(2008-11#1)(2008-5#1)
until recently##12##2##(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#3)(2011-7#1)(2012-2#1)(2012-3#1)
until resolution##2##2##(1991-8#1)(2010-1#1)
until stage##2##2##(2008-10#1)(2012-2#1)
until the end of the##2##5##(1992-8#1)(2008-9#1)
until the end of##6##4##(1992-8#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#2)
until the last##2##3##(1994-3#1)(2008-7#1)
until the##42##2##(1991-12#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-3#2)(1997-1#1)(1997-6#1)(2008-10#12)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#2)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#2)
until their##3##2##(2008-1#1)(2009-12#1)(2011-2#1)
until there is##2##3##(1993-3#2)
until there was##2##3##(1994-8#1)(2008-10#1)
until there##4##2##(1993-3#2)(1994-8#1)(2008-10#1)
until they##4##2##(1990-2#1)(1996-12#1)(2010-8#1)(2011-2#1)
until##261##1##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-12#3)(1994-3#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#82)(2008-11#8)(2008-12#3)(2008-3#1)(2008-5#11)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#6)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-2#20)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#2)(2013-1#8)(2013-8#3)
untouched##2##1##(2010-5#1)(2012-3#1)
untoward##2##1##(1994-2#1)(1997-7#1)
untrained limb##2##2##(2013-8#2)
untrained##5##1##(1995-12#1)(2010-7#1)(2013-8#3)
untransfected control##2##2##(2008-11#1)(2008-8#1)
untransfected##3##1##(2008-11#1)(2008-8#1)(2012-3#1)
untransformed cells##4##2##(1993-2#2)(1995-8#1)(2011-2#1)
untransformed##8##1##(1991-9#1)(1993-2#2)(1995-5#1)(1995-8#1)(1997-4#1)(2008-10#1)(2011-2#1)
untranslated region (UTR)##2##3##(2008-10#2)
untranslated region is##2##3##(1991-9#1)(2008-8#1)
untranslated region of##4##3##(1994-11#1)(1995-2#1)(1995-8#1)(1997-8#1)
untranslated region that##2##3##(1996-12#1)(2008-10#1)
untranslated region##16##2##(1991-9#1)(1993-12#1)(1993-6#1)(1994-11#2)(1995-2#2)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-8#2)
untranslated regions of the##3##4##(1990-5#1)(1993-2#1)(2011-2#1)
untranslated regions##8##2##(1990-5#1)(1993-12#2)(1993-2#1)(1994-11#1)(1997-8#1)(2008-10#1)(2011-2#1)
untranslated##27##1##(1990-5#1)(1991-9#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#3)(1995-2#2)(1995-8#2)(1996-12#1)(1997-8#2)(2008-10#6)(2008-8#2)(2011-2#1)
untreatable##3##1##(2008-10#1)(2010-5#1)(2012-3#1)
untreated J774##2##2##(1996-12#2)
untreated L-TGF-beta 1##2##3##(1990-2#2)
untreated and##7##2##(1990-6#1)(1995-11#1)(1995-8#3)(2008-10#1)(2010-11#1)
untreated cells##2##2##(1993-8#1)(2008-9#1)
untreated control plots##3##3##(2008-10#3)
untreated control##14##2##(1992-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#2)(2013-7#1)
untreated control)##2##2##(2008-10#1)(2008-11#1)
untreated controls##7##2##(1995-12#1)(1995-2#1)(1997-4#3)(2008-10#1)(2008-11#1)
untreated disease##2##2##(2009-12#1)(2011-2#1)
untreated dwarf rats##2##3##(1995-12#2)
untreated dwarf##4##2##(1995-12#4)
untreated fields##2##2##(1995-6#2)
untreated hair##2##2##(2008-5#2)
untreated islets##2##2##(2010-11#2)
untreated mice##2##2##(2008-12#1)(2013-7#1)
untreated or treated##2##3##(2008-11#1)(2008-9#1)
untreated or##4##2##(1994-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
untreated patients with##3##3##(1990-12#2)(1990-9#1)
untreated patients##5##2##(1990-12#2)(1990-6#2)(1990-9#1)
untreated plants##3##2##(2008-10#2)(2008-11#1)
untreated soil##3##2##(2008-10#3)
untreated wheat##2##2##(2008-10#1)(2008-12#1)
untreated wool fibre##2##3##(2008-5#2)
untreated##124##1##(1990-12#2)(1990-2#3)(1990-6#3)(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-6#3)(1995-8#3)(1996-12#5)(1997-4#3)(2008-10#38)(2008-11#9)(2008-12#3)(2008-5#10)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-6#1)(2010-11#4)(2011-2#3)(2012-2#2)(2012-3#5)(2013-7#2)(2013-8#1)
untwisting rate peak##2##3##(2011-2#2)
untwisting rate##4##2##(2011-2#4)
untwisting##5##1##(2011-2#5)
unused##2##1##(1994-6#1)(2008-10#1)
unusual aetiologies##2##2##(2012-2#2)
unusual and##5##2##(1990-6#1)(1995-12#1)(1997-8#1)(2008-9#1)(2013-1#1)
unusual case of##17##3##(1997-5#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#6)
unusual case##19##2##(1997-5#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#6)
unusual cause of##7##3##(1993-6#1)(2009-10#1)(2009-8#1)(2013-1#3)(2013-8#1)
unusual cause##9##2##(1993-6#1)(2009-10#1)(2009-3#1)(2009-8#2)(2013-1#3)(2013-8#1)
unusual clinical presentation##2##3##(2008-11#2)
unusual clinical##6##2##(1990-3#1)(1990-9#1)(2008-11#2)(2008-5#1)(2008-7#1)
unusual disease outburst##2##3##(2008-10#2)
unusual disease##3##2##(1997-3#1)(2008-10#2)
unusual diseases##2##2##(1992-2#2)
unusual features##2##2##(2008-1#1)(2009-8#1)
unusual for##2##2##(1990-8#1)(1995-3#1)
unusual form of##4##3##(1991-11#1)(1991-3#1)(2009-6#1)(2012-2#1)
unusual in##2##2##(2008-7#1)(2009-7#1)
unusual location##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
unusual neoplasm##3##2##(1994-6#1)(2008-10#1)(2009-3#1)
unusual pattern of##2##3##(1992-12#1)(2008-7#1)
unusual presentation in a##2##4##(2010-11#1)(2012-3#1)
unusual presentation of##3##3##(2010-11#1)(2013-1#1)(2013-7#1)
unusual presentation with##2##3##(2008-7#1)(2009-1#1)
unusual presentation##13##2##(1997-8#1)(2008-7#2)(2009-1#1)(2009-8#1)(2010-11#2)(2010-5#1)(2012-3#1)(2013-1#3)(2013-7#1)
unusual tumor##2##2##(1991-8#2)
unusual##175##1##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-11#1)(1991-3#3)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#8)(2008-5#1)(2008-7#16)(2008-8#5)(2008-9#6)(2009-1#2)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#11)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#4)
unusually high##2##2##(1993-2#1)(2008-10#1)
unusually large##4##2##(1991-2#1)(1992-12#1)(2008-10#1)(2009-7#1)
unusually long##2##2##(2008-10#1)(2008-8#1)
unusually##23##1##(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#2)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)
unvaccinated##7##1##(1994-9#1)(1995-5#1)(1995-9#1)(1996-1#1)(2008-12#2)(2009-5#1)
unveiled##6##1##(2008-9#1)(2010-1#1)(2012-3#2)(2013-7#2)
unveils##2##1##(1991-9#1)(1995-6#1)
unwanted cells##2##2##(2008-9#2)
unwanted effects##3##2##(2008-10#1)(2008-9#2)
unwanted pregnancies and##2##3##(1993-3#1)(2008-1#1)
unwanted pregnancies##5##2##(1993-3#1)(2008-1#1)(2008-11#2)(2012-2#1)
unwanted side effects##2##3##(1991-3#1)(2009-12#1)
unwanted##34##1##(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-3#1)(1995-2#1)(1996-9#1)(1997-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#5)(2009-12#2)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)
unwarranted##2##1##(2008-5#1)(2012-2#1)
unweighted pair group method with arithmetic##3##6##(2008-10#3)
unweighted pair group method##4##4##(2008-10#4)
unweighted pair-group method with arithmetic average cluster analysis##2##8##(2008-10#2)
unweighted pair-group method with arithmetic average##3##6##(2008-10#3)
unweighted pair-group method with arithmetic##4##5##(2008-10#4)
unweighted pair-group method##5##3##(2008-10#5)
unweighted##14##1##(1991-12#1)(1992-12#1)(2008-10#10)(2008-4#1)(2012-2#1)
unwilling to##2##2##(1994-3#1)(2011-2#1)
unwooded Chardonnay##2##2##(2008-10#2)
unwounded##2##1##(2008-10#2)
unwrapping##5##1##(2008-3#5)
up a major##2##3##(2008-11#1)(2009-4#1)
up a##22##2##(1992-1#1)(1994-1#1)(1996-6#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#2)(2009-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-8#1)
up after the##2##3##(1997-2#1)(2013-8#1)
up after##4##2##(1997-2#1)(1997-8#1)(2013-1#1)(2013-8#1)
up an##2##2##(2008-6#1)(2012-3#1)
up and down states##2##4##(2008-11#2)
up and down##3##3##(2008-11#3)
up and##22##2##(1995-6#1)(1996-1#1)(1996-5#1)(2008-10#4)(2008-11#5)(2008-4#2)(2008-7#1)(2008-9#3)(2009-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
up as##4##2##(1994-2#1)(2008-10#3)
up at##8##2##(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)
up by a##6##3##(1990-2#1)(1990-8#1)(2008-10#3)(2008-5#1)
up by the##6##3##(1991-11#1)(2008-10#2)(2008-11#2)(2008-5#1)
up by##23##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1995-6#2)(2008-10#8)(2008-11#3)(2008-5#3)(2008-7#2)(2013-1#1)
up for the##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
up for##18##2##(1991-9#1)(1992-1#1)(1995-3#1)(1996-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
up from##6##2##(1992-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)
up in the##5##3##(1992-3#1)(1995-12#1)(2008-11#1)(2008-7#1)(2009-6#1)
up in##13##2##(1992-3#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-6#1)(2011-2#2)
up into the##2##3##(1997-3#2)
up into##6##2##(1990-11#1)(1992-3#1)(1997-3#2)(2008-4#1)(2009-8#1)
up new perspectives##2##3##(2008-10#1)(2011-3#1)
up new##9##2##(1993-2#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-3#1)
up of this##2##3##(2008-11#1)(2013-1#1)
up of##39##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#2)(1993-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
up or##3##2##(1996-3#1)(2008-11#1)(2008-2#1)
up the release of##2##4##(1997-2#2)
up the##33##2##(1994-9#1)(1995-11#1)(1996-11#1)(1996-5#1)(1997-2#2)(2008-10#6)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#2)
up to 0##21##3##(2008-10#16)(2008-11#1)(2008-3#2)(2008-8#1)(2012-2#1)
up to 1 month##2##4##(2008-10#1)(2008-7#1)
up to 1##26##3##(1993-8#1)(1997-6#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
up to 1%##2##3##(2008-10#2)
up to 10 mg l(-1)##2##5##(2008-10#2)
up to 10 mg##3##4##(2008-10#2)(2008-5#1)
up to 10##17##3##(1990-2#2)(1991-5#1)(1992-11#2)(1992-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2013-8#1)
up to 10%##3##3##(2008-3#2)(2010-8#1)
up to 10(3)##2##3##(2008-11#1)(2013-8#1)
up to 10(5)##3##3##(2008-10#2)(2008-11#1)
up to 100 muM##2##4##(2008-10#2)
up to 100##12##3##(1990-12#1)(1993-11#1)(2008-10#8)(2008-11#1)(2008-7#1)
up to 100%##3##3##(1993-2#1)(2008-10#2)
up to 1000##3##3##(1994-8#1)(1997-5#1)(2008-10#1)
up to 11##4##3##(2008-10#3)(2008-3#1)
up to 12##6##3##(2008-10#3)(2008-3#1)(2008-9#1)(2009-10#1)
up to 14##2##3##(1997-2#1)(2008-10#1)
up to 140##2##3##(2008-8#1)(2010-8#1)
up to 15##9##3##(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)
up to 15%##2##3##(2008-10#1)(2011-2#1)
up to 150##2##3##(2008-10#2)
up to 16##2##3##(1997-3#1)(2008-11#1)
up to 18##4##3##(2008-10#2)(2008-11#2)
up to 19##2##3##(2008-8#2)
up to 19%##2##3##(2008-11#1)(2013-1#1)
up to 2 weeks##3##4##(1990-12#1)(2008-10#2)
up to 2 years##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)
up to 2##20##3##(1990-12#1)(1991-2#1)(1993-8#1)(1994-8#1)(1996-12#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-2#1)
up to 20##9##3##(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#1)
up to 20%##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
up to 200-fold##3##3##(1994-8#1)(1997-8#1)(2008-10#1)
up to 24##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
up to 270##2##3##(2008-10#1)(2008-5#1)
up to 3 days##5##4##(2008-10#2)(2008-11#1)(2008-7#2)
up to 3##12##3##(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#2)
up to 30 days##3##4##(2008-10#1)(2008-5#1)(2010-8#1)
up to 30 min##2##4##(1997-8#1)(2008-10#1)
up to 30##13##3##(1991-5#1)(1997-1#1)(1997-8#1)(2008-10#7)(2008-5#2)(2010-8#1)
up to 30% of the##2##5##(2008-10#1)(2011-2#1)
up to 30%##6##3##(1996-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)
up to 32##2##3##(1993-3#1)(2008-10#1)
up to 35%##3##3##(2008-10#2)(2009-7#1)
up to 4 months after treatment##2##6##(2013-1#2)
up to 4 months after##3##5##(2010-5#1)(2013-1#2)
up to 4 months##5##4##(2008-11#2)(2010-5#1)(2013-1#2)
up to 4##11##3##(1990-8#1)(1993-6#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-5#1)(2013-1#2)
up to 40##2##3##(2008-10#1)(2008-11#1)
up to 40% in##2##4##(2008-10#1)(2008-2#1)
up to 40%##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
up to 41##2##3##(1997-1#1)(2008-10#1)
up to 45##2##3##(2008-10#1)(2011-2#1)
up to 48##3##3##(1996-5#2)(2008-10#1)
up to 5##9##3##(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#1)
up to 5%##3##3##(1996-1#1)(2008-10#2)
up to 50##11##3##(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)
up to 50%##2##3##(2008-10#1)(2008-5#1)
up to 500##3##3##(2008-10#3)
up to 56##2##3##(2008-10#2)
up to 6 months of##2##5##(2008-10#1)(2010-6#1)
up to 6 months##3##4##(2008-10#2)(2010-6#1)
up to 6##14##3##(1990-10#1)(1994-5#1)(1995-6#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-8#1)(2010-6#1)
up to 60##8##3##(1992-12#1)(1997-1#1)(2008-10#4)(2008-6#1)(2013-1#1)
up to 60% of the##2##5##(1996-6#1)(2008-10#1)
up to 60% of##3##4##(1996-6#1)(2008-10#1)(2008-11#1)
up to 60%##4##3##(1996-6#1)(2008-10#1)(2008-11#2)
up to 63##2##3##(2008-10#2)
up to 7##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
up to 70##2##3##(2008-10#1)(2008-8#1)
up to 70%##2##3##(2008-1#1)(2008-10#1)
up to 72##4##3##(1993-11#1)(1995-1#1)(1996-12#1)(2008-10#1)
up to 73%##2##3##(2008-10#2)
up to 8 h##2##4##(1992-10#1)(1995-11#1)
up to 8##9##3##(1991-11#1)(1992-10#1)(1994-11#1)(1995-11#1)(2008-10#4)(2008-11#1)
up to 80##3##3##(1997-1#1)(2008-10#2)
up to 80%##2##3##(1994-3#1)(2008-10#1)
up to 9##3##3##(1995-11#1)(1995-2#1)(2008-3#1)
up to 90##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2009-7#1)
up to 90% of the##2##5##(2008-10#2)
up to 90%##4##3##(1991-5#1)(2008-10#3)
up to 900 degrees C for Cd##2##7##(2008-10#2)
up to 900##4##3##(1997-2#1)(2008-10#3)
up to 95##2##3##(1992-12#1)(2008-7#1)
up to a concentration of 3##2##6##(1990-5#1)(2008-11#1)
up to a concentration of##7##5##(1990-5#1)(1991-5#1)(2008-10#4)(2008-11#1)
up to a concentration##8##4##(1990-5#1)(1991-5#1)(2008-10#5)(2008-11#1)
up to a factor of##3##5##(1990-11#1)(1995-12#1)(2008-3#1)
up to a##33##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#1)(1994-2#1)(1995-11#1)(1995-12#1)(1997-3#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#2)(2010-9#1)(2011-2#3)(2013-1#1)
up to about##6##3##(1997-6#1)(2008-10#5)
up to an##3##3##(2007-12#1)(2008-10#2)
up to approximately##4##3##(2008-10#3)(2008-11#1)
up to at least 100##3##5##(2008-10#3)
up to at least##7##4##(2008-10#6)(2008-7#1)
up to date##4##3##(1990-6#1)(2008-10#1)(2008-9#1)(2013-7#1)
up to eight##2##3##(2008-10#1)(2008-9#1)
up to five##2##3##(2008-10#1)(2008-8#1)
up to four##6##3##(1991-5#1)(1992-3#1)(2008-10#4)
up to nine##2##3##(2008-10#1)(2009-12#1)
up to now##4##3##(2008-10#1)(2008-5#1)(2011-2#2)
up to one##4##3##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
up to several##4##3##(1997-6#1)(2008-10#1)(2008-12#1)(2008-4#1)
up to six times##2##4##(2008-11#1)(2010-12#1)
up to six##4##3##(2008-10#1)(2008-11#1)(2010-12#2)
up to the year##2##4##(2008-11#1)(2009-7#1)
up to the##26##3##(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#2)(1992-2#1)(1993-6#1)(1994-5#1)(1996-6#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
up to three##4##3##(1991-3#1)(2008-10#2)(2008-11#1)
up to##620##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#3)(1991-5#5)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#5)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#6)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#7)(1997-8#3)(2007-12#4)(2008-1#1)(2008-10#286)(2008-11#55)(2008-12#9)(2008-2#6)(2008-3#21)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#16)(2008-8#16)(2008-9#6)(2009-10#1)(2009-12#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#16)(2011-7#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#4)
up was##6##2##(2008-10#2)(2009-11#1)(2010-3#1)(2011-2#2)
up with##12##2##(1995-1#1)(1996-6#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-7#1)(2013-8#1)
up##1032##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#5)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#7)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#2)(1992-3#5)(1992-5#3)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#3)(1994-1#2)(1994-11#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#2)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#6)(1995-6#4)(1995-9#2)(1996-1#4)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#6)(1996-5#5)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#1)(1997-5#3)(1997-6#9)(1997-8#6)(2006-6#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#3)(2008-10#363)(2008-11#102)(2008-12#15)(2008-2#8)(2008-3#26)(2008-4#6)(2008-5#25)(2008-6#7)(2008-7#41)(2008-8#25)(2008-9#19)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#9)(2010-9#2)(2011-1#4)(2011-2#36)(2011-3#1)(2011-7#1)(2012-12#7)(2012-2#12)(2012-3#8)(2013-1#29)(2013-7#2)(2013-8#20)
up&quot##2##1##(1995-12#1)(2013-1#1)
up-regulate##2##1##(2008-7#1)(2008-9#1)
up-regulated and##3##2##(2008-10#1)(2008-9#1)(2010-6#1)
up-regulated by##3##2##(2008-11#1)(2008-8#1)(2009-6#1)
up-regulated during##2##2##(1995-8#1)(2011-2#1)
up-regulated genes##2##2##(2008-10#2)
up-regulated in resistant##2##3##(2008-10#2)
up-regulated in##13##2##(1995-11#2)(2008-10#5)(2008-11#2)(2008-4#1)(2011-2#2)(2011-3#1)
up-regulated##34##1##(1995-11#2)(1995-8#1)(1997-7#1)(2008-10#9)(2008-11#5)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
up-regulating##2##1##(2008-11#1)(2013-7#1)
up-regulation in the##4##3##(1997-7#3)(2013-1#1)
up-regulation in##6##2##(1996-12#2)(1997-7#3)(2013-1#1)
up-regulation of##17##2##(1991-5#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#2)(2008-10#2)(2008-11#2)(2008-9#1)(2010-11#1)(2010-12#1)(2013-1#4)
up-regulation##28##1##(1991-5#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#5)(1997-7#3)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2013-1#6)
up-to-date information##2##2##(1991-1#1)(2008-7#1)
up-to-date##10##1##(1991-1#1)(1992-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2011-2#1)
upcoming##7##1##(2008-10#1)(2008-11#3)(2008-3#1)(2010-12#1)(2012-2#1)
upconversion##7##1##(2007-11#2)(2008-3#5)
update of##6##2##(1994-3#1)(2008-11#1)(2008-9#1)(2012-2#2)(2012-3#1)
update on recent##2##3##(1991-3#1)(2008-11#1)
update on the##4##3##(2011-1#1)(2012-12#1)(2013-1#2)
update on##10##2##(1991-3#1)(1994-1#1)(1995-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-12#1)(2013-1#2)
update to##2##2##(2008-5#1)(2012-3#1)
update##59##1##(1991-1#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#4)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#4)
updated for##2##2##(1995-9#1)(2008-10#1)
updated in##2##2##(1994-12#1)(2010-12#1)
updated information##2##2##(1996-6#1)(2011-2#1)
updated to include##2##3##(1991-9#1)(2008-4#1)
updated to##4##2##(1991-9#1)(2008-4#1)(2008-7#1)(2013-1#1)
updated##29##1##(1991-9#1)(1993-1#1)(1993-3#2)(1994-12#1)(1995-9#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-6#2)(2008-7#2)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
updates##5##1##(1991-1#2)(1992-12#1)(2010-5#1)(2011-2#1)
updating of##3##2##(1995-9#2)(2011-2#1)
updating##14##1##(1992-12#2)(1994-2#2)(1995-9#3)(2008-11#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
upfield##2##1##(1993-8#1)(2008-10#1)
upgrade##5##1##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
upgraded##2##1##(1996-3#1)(2008-3#1)
upgrades##4##1##(1993-2#1)(1993-3#1)(2008-10#1)(2012-2#1)
upgrading of the##2##3##(1993-1#1)(1993-12#1)
upgrading of##3##2##(1993-1#1)(1993-12#1)(2008-10#1)
upheld a##2##2##(1995-12#1)(1996-5#1)
upheld##5##1##(1995-12#4)(1996-5#1)
upholds##5##1##(1990-2#1)(1992-11#1)(1995-6#3)
upland rice##2##2##(2008-10#2)
upland##9##1##(2008-10#7)(2008-9#2)
uplift of##2##2##(2008-9#2)
uplift##4##1##(2008-9#4)
uplifting##2##1##(2008-11#1)(2008-5#1)
uploaded##2##1##(2008-10#1)(2008-11#1)
upon DNA damage##2##3##(2011-2#2)
upon HBV##2##2##(2012-3#2)
upon a##18##2##(1993-6#1)(1993-8#1)(1995-11#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#2)(2009-6#1)
upon acquisition##2##2##(1991-2#1)(2008-10#1)
upon activation##2##2##(1992-12#1)(2012-12#1)
upon adding##2##2##(1994-3#1)(2008-10#1)
upon addition of the##2##4##(1991-5#1)(2008-10#1)
upon addition of##6##3##(1991-5#1)(1992-8#1)(2008-10#4)
upon admission##3##2##(1991-2#1)(2008-3#1)(2008-7#1)
upon an##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
upon binding of##2##3##(1995-6#1)(2008-11#1)
upon binding##5##2##(1992-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
upon by##6##2##(1990-11#1)(1990-5#1)(2008-10#1)(2009-10#1)(2009-9#1)(2011-2#1)
upon cell##2##2##(1992-6#1)(2008-10#1)
upon chromosome##2##2##(2008-11#1)(2012-3#1)
upon clinical##2##2##(1990-3#1)(2008-12#1)
upon completion of##2##3##(1991-11#1)(2013-8#1)
upon complex formation##2##3##(2008-10#1)(2009-7#1)
upon encountering##2##2##(1993-12#1)(1995-5#1)
upon excitation at##2##3##(2008-10#2)
upon excitation##3##2##(2008-10#3)
upon existing##2##2##(1990-2#1)(2010-1#1)
upon exposure to##5##3##(1990-5#1)(1992-1#1)(2008-10#2)(2011-2#1)
upon for##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
upon heating##3##2##(1996-5#1)(2008-10#1)(2010-4#1)
upon hybridization##2##2##(2008-4#1)(2012-3#1)
upon increasing the##3##3##(1993-6#1)(1997-2#1)(2008-10#1)
upon increasing##4##2##(1993-6#1)(1997-2#1)(2008-10#2)
upon infection##3##2##(2008-10#3)
upon interaction with##2##3##(2008-10#1)(2011-2#1)
upon interaction##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
upon irradiation with UV light##2##5##(2008-10#1)(2008-5#1)
upon irradiation##3##2##(2008-10#2)(2008-5#1)
upon its##4##2##(1992-6#1)(1994-12#1)(2008-10#2)
upon learning##2##2##(1991-2#1)(2008-11#1)
upon our##3##2##(1995-12#1)(1997-1#1)(2011-2#1)
upon oxidation of##2##3##(2008-10#2)
upon pH##2##2##(1990-5#1)(1995-2#1)
upon performance##2##2##(1992-1#1)(2008-12#1)
upon previous##2##2##(1992-3#1)(2010-11#1)
upon prolonged##2##2##(1993-6#1)(1997-1#1)
upon seed##2##2##(2008-10#1)(2008-7#1)
upon stimulation with##5##3##(1991-5#1)(1992-6#1)(1993-6#1)(1995-6#1)(2008-11#1)
upon stimulation##6##2##(1991-5#1)(1992-6#1)(1993-6#1)(1995-6#1)(1996-2#1)(2008-11#1)
upon the addition of##2##4##(1993-3#1)(2008-10#1)
upon the apparent##2##3##(1990-5#1)(2008-10#1)
upon the binding of##2##4##(1995-6#1)(2008-11#1)
upon the concentration of##2##4##(1990-2#1)(2008-10#1)
upon the most##2##3##(2008-10#1)(2008-12#1)
upon the nature of the##4##5##(1991-3#1)(2008-10#2)(2011-1#1)
upon the nature##5##3##(1991-3#1)(2008-10#2)(2008-11#1)(2011-1#1)
upon the presence of##3##4##(1993-12#1)(2008-10#1)(2012-2#1)
upon the presence##4##3##(1993-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
upon the reaction##2##3##(2008-10#2)
upon the severity##2##3##(1991-2#1)(2010-7#1)
upon the##138##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-3#3)(1992-2#2)(1992-3#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#2)(1996-3#3)(1996-5#3)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#35)(2008-11#17)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#5)(2008-7#4)(2008-9#2)(2009-10#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
upon their interactions with##2##4##(2008-4#1)(2010-5#1)
upon their##8##2##(1990-3#1)(1991-7#1)(1995-2#1)(2008-12#1)(2008-4#2)(2008-7#1)(2010-5#1)
upon these##2##2##(2008-11#1)(2008-4#1)
upon this##4##2##(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
upon tissue##2##2##(2008-9#1)(2013-1#1)
upon to develop##3##3##(1996-2#1)(2008-11#1)(2008-12#1)
upon to##9##2##(1992-3#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)
upon treatment with TGF-beta##2##4##(2008-11#2)
upon treatment with##3##3##(2008-11#3)
upon treatment##4##2##(2008-11#3)(2011-2#1)
upon upshift to 37 degrees C##2##6##(1993-9#2)
upon which##9##2##(1997-3#1)(2008-10#4)(2010-12#1)(2012-2#2)(2013-8#1)
upon##535##1##(1990-11#6)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#8)(1991-3#6)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#8)(1992-5#1)(1992-6#5)(1992-8#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#8)(1993-8#3)(1993-9#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-9#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-5#3)(1995-6#5)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#4)(1997-1#7)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#133)(2008-11#58)(2008-12#12)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#15)(2008-7#18)(2008-8#5)(2008-9#9)(2009-10#3)(2009-12#1)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#15)(2012-12#3)(2012-2#9)(2012-3#8)(2013-1#10)(2013-7#1)(2013-8#10)
upper GI bleeding##2##3##(2012-3#2)
upper GI##4##2##(2008-11#1)(2011-2#1)(2012-3#2)
upper abdomen and##2##3##(1995-10#1)(2009-8#1)
upper abdomen##4##2##(1995-10#1)(2009-8#1)(2010-12#1)(2013-1#1)
upper abdominal##2##2##(1991-12#1)(2012-2#1)
upper airway##3##2##(1990-6#1)(1996-12#1)(2008-11#1)
upper airways##4##2##(1991-6#1)(1996-6#1)(1997-4#1)(2012-12#1)
upper and lower detection limits##2##5##(2008-10#2)
upper and lower##14##3##(2008-1#1)(2008-10#6)(2008-12#1)(2008-7#1)(2010-1#1)(2010-9#1)(2012-12#2)(2012-3#1)
upper and##18##2##(2008-1#1)(2008-10#8)(2008-12#2)(2008-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
upper arm##3##2##(2011-2#1)(2013-8#2)
upper body##2##2##(2010-1#1)(2010-6#1)
upper bound##2##2##(2008-6#1)(2009-5#1)
upper brachial plexus##2##3##(2008-9#2)
upper cervical##3##2##(2008-12#2)(2008-7#1)
upper digestive##2##2##(1991-11#1)(2011-2#1)
upper end of##2##3##(1994-9#1)(2013-1#1)
upper endoscopic examination##2##3##(1997-8#1)(2008-11#1)
upper endoscopy##2##2##(2009-8#1)(2010-12#1)
upper extremities##4##2##(1997-4#1)(2010-3#1)(2013-1#1)(2013-8#1)
upper extremity##9##2##(1991-11#1)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)
upper gastrointestinal (GI)##2##3##(1994-12#1)(2008-11#1)
upper gastrointestinal endoscopy##6##3##(1995-10#2)(1996-3#1)(2008-1#1)(2011-2#1)(2012-2#1)
upper gastrointestinal##16##2##(1991-8#1)(1994-12#1)(1995-10#2)(1996-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#4)(2012-2#2)(2013-1#1)
upper healthy##2##2##(2008-10#2)
upper leaves##8##2##(2008-10#8)
upper limb##7##2##(2008-7#1)(2008-9#2)(2009-1#2)(2011-2#1)(2013-1#1)
upper limit of the##3##4##(1993-2#1)(2008-10#1)(2008-2#1)
upper limit of##8##3##(1991-5#1)(1993-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-3#1)
upper limit##13##2##(1991-5#1)(1993-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#2)(2012-3#1)
upper limits of##2##3##(1993-2#1)(2008-10#1)
upper lobe##3##2##(1991-9#1)(1997-3#1)(2013-1#1)
upper or lower##3##3##(2008-10#1)(2008-12#1)(2010-5#1)
upper phase##9##2##(2008-10#9)
upper pole##2##2##(2011-2#1)(2013-1#1)
upper quadrant##3##2##(1991-12#1)(2012-3#1)(2013-1#1)
upper respiratory disease##2##3##(2013-8#2)
upper respiratory symptoms##3##3##(2009-4#1)(2013-8#2)
upper respiratory tract##4##3##(2008-10#1)(2008-5#1)(2009-5#1)(2013-8#1)
upper respiratory##10##2##(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#1)(2013-8#6)
upper spinal cord##2##3##(2010-12#2)
upper surface##2##2##(2008-10#1)(2008-5#1)
upper trapezius##6##2##(2010-9#6)
upper uninoculated leaves##2##3##(2008-10#2)
upper##249##1##(1990-6#1)(1991-11#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-6#1)(1993-2#3)(1993-9#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2008-1#4)(2008-10#68)(2008-11#9)(2008-12#9)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#8)(2009-1#2)(2009-2#1)(2009-4#1)(2009-5#4)(2009-8#3)(2009-9#1)(2010-1#2)(2010-12#6)(2010-3#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#9)(2011-2#15)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#13)(2013-3#1)(2013-8#9)
upper-half of the face##6##4##(2010-1#6)
upper-stream-limitation##2##1##(2008-8#2)
upregulate##2##1##(2011-2#1)(2013-1#1)
upregulated by##5##2##(1995-12#1)(1997-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
upregulated during##3##2##(2008-11#1)(2009-8#2)
upregulated in adenoma tissues when compared with##2##7##(2010-12#2)
upregulated in the##4##3##(1996-12#1)(2008-10#1)(2013-1#1)(2013-7#1)
upregulated in##15##2##(1996-12#1)(2008-10#2)(2009-4#2)(2009-7#1)(2010-12#4)(2013-1#4)(2013-7#1)
upregulated##33##1##(1995-12#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2009-4#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#4)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#1)
upregulates the##3##2##(2010-10#1)(2010-5#1)(2013-1#1)
upregulating##5##1##(1997-3#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
upregulation and##3##2##(2009-9#1)(2011-2#1)(2012-2#1)
upregulation of ADK##3##3##(2009-8#3)
upregulation of OPN promoter activity##2##5##(2010-11#2)
upregulation of OPN##3##3##(2010-11#3)
upregulation of##28##2##(1992-8#2)(1994-11#1)(1995-2#1)(1995-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2009-8#5)(2010-10#1)(2010-11#5)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
upregulation##32##1##(1992-8#2)(1994-11#1)(1995-2#1)(1995-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-12#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#5)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#2)
upright##3##1##(1994-8#2)(2008-10#1)
ups##3##1##(1995-3#1)(2008-6#1)(2013-1#1)
upset##2##1##(1993-1#1)(2008-12#1)
upsets the##2##2##(1996-8#1)(2008-8#1)
upshift##3##1##(1993-9#2)(2008-7#1)
upside-down taper lens end##2##4##(2008-2#2)
upside-down##3##1##(2008-2#2)(2010-9#1)
upstate New York##2##3##(1996-3#1)(2013-1#1)
upstream activating sequence##2##3##(1993-9#1)(1996-3#1)
upstream and downstream##4##3##(2008-3#1)(2008-8#2)(2012-2#1)
upstream exons##2##2##(1990-8#2)
upstream from a##2##3##(1990-11#1)(1994-11#1)
upstream from the start codon##2##5##(1991-6#2)
upstream from the##10##3##(1991-6#2)(1992-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1997-2#1)(1997-7#1)
upstream from##15##2##(1990-11#1)(1991-6#2)(1991-9#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-6#1)(1997-2#1)(1997-7#1)
upstream migration##2##2##(2010-8#2)
upstream of the K##2##4##(1997-7#2)
upstream of the exon##2##4##(1993-8#1)(1995-6#1)
upstream of the##17##3##(1990-8#1)(1993-3#2)(1993-8#2)(1994-2#1)(1995-6#3)(1997-2#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-1#1)
upstream of##31##2##(1990-8#1)(1993-3#2)(1993-8#2)(1994-2#1)(1995-6#3)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)
upstream or downstream##3##3##(1992-3#1)(2008-8#1)(2012-2#1)
upstream region of##5##3##(1992-3#1)(1996-3#1)(2008-8#2)(2008-9#1)
upstream region was##2##3##(1993-12#1)(1994-2#1)
upstream region##11##2##(1992-3#1)(1993-12#1)(1994-2#2)(1995-2#2)(1996-3#1)(1997-7#1)(2008-8#2)(2008-9#1)
upstream regions of##4##3##(1993-6#1)(2008-10#1)(2008-9#2)
upstream regulators##2##2##(2012-2#1)(2013-1#1)
upstream sequences##2##2##(1990-8#1)(1992-3#1)
upstream##106##1##(1990-11#1)(1990-8#4)(1991-6#3)(1991-9#3)(1992-10#1)(1992-3#4)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#3)(1995-2#5)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#6)(2008-1#1)(2008-10#5)(2008-11#7)(2008-3#1)(2008-8#6)(2008-9#6)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-2#5)(2013-1#1)
uptake after##2##2##(1993-11#1)(2008-10#1)
uptake and binding sites in the##2##6##(2008-7#2)
uptake and metabolism of 4-n-nonylphenol##2##5##(2008-11#2)
uptake and metabolism##3##3##(2008-11#2)(2013-8#1)
uptake and release of##2##4##(2008-10#1)(2008-8#1)
uptake and release##5##3##(2008-10#4)(2008-8#1)
uptake and##44##2##(1991-5#1)(1993-8#1)(1995-11#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#9)(2008-11#15)(2008-7#3)(2008-8#1)(2008-9#2)(2013-1#2)(2013-8#2)
uptake as##4##2##(1991-5#1)(2008-12#1)(2010-10#2)
uptake between##3##2##(1992-3#1)(2013-8#2)
uptake by the##2##3##(1991-7#1)(2010-1#1)
uptake by yeast cells##2##4##(2008-10#2)
uptake by##16##2##(1990-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-3#1)(1996-2#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-1#1)(2013-8#1)
uptake for##2##2##(2008-10#1)(2008-12#1)
uptake from the##3##3##(1997-1#1)(2007-12#1)(2008-11#1)
uptake from##4##2##(1996-2#1)(1997-1#1)(2007-12#1)(2008-11#1)
uptake has##2##2##(2009-8#1)(2010-10#1)
uptake in a##4##3##(1991-10#1)(1995-11#1)(2013-1#1)(2013-8#1)
uptake in rat##2##3##(1997-1#1)(2008-8#1)
uptake in the midgut##2##4##(2008-10#2)
uptake in the##8##3##(1993-11#1)(1994-5#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-8#1)(2011-2#1)
uptake in##28##2##(1991-10#2)(1993-11#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-8#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
uptake into##6##2##(1990-7#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)
uptake is##5##2##(1992-3#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-8#1)
uptake of 2##2##3##(1994-5#2)
uptake of bile acids##2##4##(1992-3#1)(2008-11#1)
uptake of iron##2##3##(2008-10#1)(2009-9#1)
uptake of the##4##3##(1992-3#1)(1997-1#1)(2008-11#2)
uptake of##66##2##(1990-8#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-3#7)(1992-6#1)(1993-11#3)(1993-3#1)(1994-3#1)(1994-5#4)(1994-8#2)(1996-12#1)(1996-2#1)(1997-1#5)(1997-7#1)(2008-10#15)(2008-11#11)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-10#1)(2012-2#1)
uptake on the##2##3##(2008-10#1)(2013-1#1)
uptake process##2##2##(2008-10#1)(2008-7#1)
uptake processes##2##2##(1992-3#1)(1994-3#1)
uptake properties##2##2##(2008-10#1)(2008-5#1)
uptake rate and##3##3##(2008-11#2)(2008-7#1)
uptake rate##11##2##(2008-10#2)(2008-11#7)(2008-7#2)
uptake rates are##2##3##(2008-10#1)(2008-7#1)
uptake rates##12##2##(2008-10#6)(2008-11#3)(2008-7#2)(2008-8#1)
uptake sites##2##2##(2008-7#2)
uptake stimulated by##2##3##(1994-8#1)(2008-11#1)
uptake system##9##2##(1995-11#4)(1996-8#1)(1997-7#1)(2008-10#2)(2011-2#1)
uptake than##3##2##(1997-1#1)(2010-6#2)
uptake to##2##2##(2008-6#1)(2013-8#1)
uptake via##2##2##(1997-1#1)(2012-2#1)
uptake was inhibited by##2##4##(1990-2#2)
uptake was observed##3##3##(1997-1#1)(2008-11#1)(2013-1#1)
uptake was obtained##2##3##(2008-11#1)(2008-12#1)
uptake was##26##2##(1990-2#4)(1992-3#6)(1994-2#1)(1994-5#1)(1997-1#2)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
uptake were##3##2##(1993-3#1)(2008-12#1)(2013-8#1)
uptake##355##1##(1990-2#4)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#3)(1991-5#3)(1991-7#1)(1991-9#3)(1992-3#24)(1992-6#1)(1992-9#1)(1993-11#5)(1993-3#5)(1993-8#9)(1994-2#1)(1994-3#2)(1994-5#8)(1994-8#3)(1995-11#8)(1995-3#1)(1995-6#2)(1996-12#3)(1996-2#10)(1996-3#1)(1996-8#2)(1997-1#15)(1997-7#4)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#64)(2008-11#58)(2008-12#11)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#8)(2008-9#5)(2009-11#1)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#6)(2010-4#1)(2010-6#4)(2011-2#7)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#8)(2013-8#22)
uptakes##2##1##(1997-7#1)(2008-10#1)
upto##6##1##(2008-10#4)(2008-7#2)
upward to##2##2##(2008-10#1)(2009-7#1)
upward##15##1##(1990-5#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-9#2)
upwardly##2##1##(2008-11#2)
upwards of##2##2##(1994-2#1)(2008-11#1)
upwards##4##1##(1994-2#1)(1996-9#1)(2008-11#1)(2009-12#1)
uracil##8##1##(1992-3#3)(1996-5#1)(2008-10#4)
uralensis Fisch was##2##3##(2008-11#2)
uralensis Fisch##3##2##(2008-11#3)
uranium and mixed rare-earth elements##2##5##(2008-10#2)
uranium and##7##2##(2008-10#6)(2013-1#1)
uranium by##4##2##(2008-10#4)
uranium carbide##3##2##(2008-10#3)
uranium from aqueous solution##2##4##(2008-10#2)
uranium from##8##2##(2008-10#8)
uranium in the##2##3##(2008-10#2)
uranium in##10##2##(2008-10#10)
uranium is important##2##3##(2008-10#2)
uranium isotopes in##2##3##(2008-10#2)
uranium isotopes##4##2##(2008-10#4)
uranium with##2##2##(2008-10#2)
uranium##76##1##(2008-10#69)(2010-5#1)(2013-1#6)
uranium(VI) and thorium(IV) prior to##3##5##(2008-10#3)
uranium(VI) and thorium(IV)##4##3##(2008-10#4)
uranium(VI) and zinc(II)##3##3##(2008-10#3)
uranium(VI) and##7##2##(2008-10#7)
uranium(VI) from##2##2##(2008-10#2)
uranium(VI) on##2##2##(2008-10#2)
uranium(VI) with##2##2##(2008-10#2)
uranium(VI)##23##1##(2008-10#23)
uranyl ion##8##2##(2008-10#8)
uranyl membrane sensor with##2##4##(2008-10#2)
uranyl nitrate##2##2##(2008-10#2)
uranyl##20##1##(1992-4#1)(2008-10#19)
urate oxidase and##3##3##(2008-10#3)
urate oxidase##8##2##(2008-10#8)
urate##17##1##(1993-2#2)(2008-10#15)
urban Canadian municipalities##2##3##(2013-8#2)
urban adolescent girls##2##3##(2009-10#1)(2013-1#1)
urban adolescents of color##2##4##(2009-7#2)
urban adolescents##4##2##(2009-7#3)(2013-1#1)
urban air quality##5##3##(2008-11#5)
urban air##6##2##(2008-11#6)
urban and rural areas##4##4##(1991-3#1)(1994-1#1)(1994-2#1)(1994-3#1)
urban and rural hospitals##2##4##(1992-12#1)(1992-2#1)
urban and rural##13##3##(1991-3#1)(1992-12#3)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#2)(2012-3#1)
urban and##18##2##(1991-12#1)(1991-3#1)(1992-12#4)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-3#1)
urban area of##7##3##(2008-11#1)(2008-7#1)(2009-10#2)(2012-12#3)
urban area##13##2##(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#2)(2012-12#3)(2012-3#1)
urban areas##12##2##(1992-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-7#1)(2011-1#1)
urban beneficiaries##5##2##(1994-2#2)(1996-3#3)
urban community##2##2##(1992-12#1)(1996-3#1)
urban dust##2##2##(2008-10#2)
urban enrollees##2##2##(1994-2#2)
urban environment##2##2##(1994-1#1)(2008-10#1)
urban environments##2##2##(2008-11#1)(2010-1#1)
urban hospitals##4##2##(1990-2#1)(1992-12#3)
urban ozone##2##2##(2008-11#2)
urban particulate matter##4##3##(2008-10#4)
urban population of##5##3##(1991-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2010-10#1)
urban population##8##2##(1990-2#1)(1991-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-10#1)(2011-2#1)
urban sites in##2##3##(2008-10#1)(2008-11#1)
urban sites##3##2##(2008-10#1)(2008-11#2)
urban teaching##2##2##(1996-3#1)(2012-3#1)
urban teens##2##2##(2013-1#2)
urban waste samples##2##3##(2008-10#2)
urban wastewater##2##2##(2008-10#2)
urban youth##2##2##(2009-7#1)(2010-9#1)
urban##173##1##(1990-2#2)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#13)(1992-2#1)(1993-12#1)(1994-1#2)(1994-2#10)(1994-3#2)(1995-1#1)(1995-5#1)(1996-1#1)(1996-3#9)(1997-4#1)(2008-1#1)(2008-10#30)(2008-11#25)(2008-12#4)(2008-3#8)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#6)(2009-7#6)(2009-8#1)(2010-1#3)(2010-10#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#12)(2013-8#9)
urban-rural##3##1##(1992-12#1)(1994-2#1)(2008-11#1)
urceolata##3##1##(2008-8#1)(2008-9#2)
urea and thiourea##2##3##(2008-10#2)
urea and##8##2##(1995-3#1)(2008-10#6)(2011-2#1)
urea biosensor##4##2##(2008-10#4)
urea concentration##2##2##(2008-10#2)
urea cycle##2##2##(2009-8#2)
urea determination in##2##3##(2008-10#2)
urea determination##3##2##(2008-10#3)
urea enzyme##2##2##(2008-10#2)
urea in the mobile phase##2##5##(2008-10#2)
urea in the##4##3##(2008-10#4)
urea in##8##2##(2008-10#8)
urea production##3##2##(2008-11#3)
urea sensor has##2##3##(2008-10#2)
urea sensor##3##2##(2008-10#3)
urea transport##2##2##(1995-6#2)
urea transporter##2##2##(1995-6#2)
urea were##3##2##(1995-3#1)(2008-11#1)(2011-2#1)
urea##94##1##(1990-2#1)(1993-8#1)(1994-5#2)(1995-11#1)(1995-3#6)(1995-6#5)(2007-12#1)(2008-10#57)(2008-11#5)(2009-3#1)(2009-5#1)(2009-8#2)(2010-8#1)(2011-2#8)(2012-2#2)
urea-functionalized##2##1##(2008-10#2)
ureafaciens##2##1##(1994-11#2)
urealyticum in semen of infertile##2##5##(2008-12#2)
urealyticum##10##1##(2008-12#7)(2011-2#2)(2013-8#1)
ureaplasma##3##1##(2007-12#1)(2011-2#1)(2013-8#1)
urease on the##2##3##(2008-10#2)
urease test##2##2##(1992-5#1)(2012-12#1)
urease##26##1##(1990-2#1)(1992-5#1)(1994-11#2)(1995-3#3)(2008-10#17)(2011-2#1)(2012-12#1)
uredinia##7##1##(2008-10#7)
uredinial density and latent period##2##5##(2008-10#2)
uredinial density and##3##3##(2008-10#3)
uredinial density##4##2##(2008-10#4)
uredinial diameter##3##2##(2008-10#3)
uredinial##7##1##(2008-10#7)
urediniospore germination##4##2##(2008-10#4)
urediniospore##6##1##(2008-10#6)
urediniospores and##3##2##(2008-10#3)
urediniospores of##2##2##(2008-10#2)
urediniospores##9##1##(2008-10#9)
urediospore##2##1##(2008-10#2)
uredospore production##4##2##(2008-10#4)
uremia and##2##2##(1993-2#1)(2010-3#1)
uremia##5##1##(1993-2#1)(1994-9#1)(1997-4#1)(2010-3#1)(2011-2#1)
uremic oxalosis##2##2##(2011-2#2)
uremic parathyroid hyperplasia##5##3##(2008-5#5)
uremic##16##1##(1991-6#1)(2008-10#3)(2008-11#2)(2008-5#5)(2011-2#3)(2013-1#2)
ureter and the##2##3##(2008-10#2)
ureter and##5##2##(1997-4#1)(2008-10#2)(2011-2#1)(2012-3#1)
ureter is##2##2##(2008-10#1)(2008-7#1)
ureter##26##1##(1996-3#1)(1997-3#5)(1997-4#4)(2008-10#7)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#4)
ureteral arteries##2##2##(1997-4#2)
ureteral strictures##3##2##(2013-1#3)
ureteral valves##2##2##(2008-10#2)
ureteral##24##1##(1990-11#1)(1991-11#1)(1991-6#1)(1997-4#6)(2008-10#7)(2009-1#1)(2010-11#1)(2013-1#6)
ureteric bud##2##2##(2008-10#2)
ureteric obstruction##3##2##(2008-10#3)
ureteric stricture##2##2##(2013-1#2)
ureteric##18##1##(1991-9#1)(1997-3#2)(2008-10#12)(2009-5#1)(2013-1#2)
ureteropelvic junction obstruction##4##3##(2008-10#4)
ureterosigmoidostomy##2##1##(1996-3#2)
ureters with##5##2##(2008-10#5)
ureters##9##1##(1996-3#1)(2008-10#7)(2011-2#1)
urethane##5##1##(1994-5#2)(2008-10#1)(2008-12#1)(2013-1#1)
urethra and##5##2##(1997-8#1)(2008-10#3)(2013-1#1)
urethra in##2##2##(1994-3#1)(2008-10#1)
urethra##24##1##(1994-3#1)(1997-8#1)(2008-10#15)(2010-11#2)(2012-3#2)(2013-1#3)
urethral and##2##2##(2008-10#1)(2013-8#1)
urethral cases##3##2##(2008-10#3)
urethral catheter##3##2##(1990-11#2)(2008-10#1)
urethral diverticulum in a female##2##5##(2008-10#2)
urethral diverticulum##3##2##(2008-10#3)
urethral duplication##3##2##(2008-10#3)
urethral meatus##3##2##(1992-1#2)(2010-11#1)
urethral realignment##2##2##(2013-8#2)
urethral valve##8##2##(2008-10#5)(2011-2#3)
urethral valves##6##2##(2008-10#6)
urethral##54##1##(1990-11#2)(1992-1#5)(1996-11#1)(2008-10#34)(2010-11#1)(2011-2#3)(2013-1#1)(2013-8#7)
urethritis and##3##2##(2011-2#2)(2013-1#1)
urethritis##6##1##(2008-12#1)(2011-2#4)(2013-1#1)
urethrogenital##2##1##(1994-2#2)
urethroplasty##4##1##(2008-10#2)(2013-8#2)
urge##5##1##(1992-11#1)(1993-9#2)(1997-6#1)(2008-12#1)
urged##5##1##(1995-2#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-8#1)
urgency and##2##2##(2011-2#1)(2011-3#1)
urgency in##2##2##(2008-10#1)(2008-11#1)
urgency of##4##2##(1996-1#2)(2008-9#1)(2010-7#1)
urgency##12##1##(1990-3#1)(1990-5#1)(1996-1#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2011-3#1)
urgent clinical##2##2##(2008-3#1)(2012-12#1)
urgent need for##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
urgent need##9##2##(2008-1#1)(2008-10#1)(2008-11#4)(2010-5#1)(2011-2#2)
urgent##31##1##(1990-2#1)(1994-12#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-3#2)
urgently needed##5##2##(1995-2#1)(2008-10#1)(2011-2#2)(2013-1#1)
urgently##17##1##(1991-3#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-12#1)(2010-1#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#1)
urges##4##1##(1991-9#1)(1994-2#1)(2009-10#1)(2012-3#1)
uric acid (UA)##6##3##(2008-10#6)
uric acid and ascorbic acid##3##5##(2008-10#3)
uric acid and creatinine##3##4##(2008-10#3)
uric acid and##12##3##(2008-10#10)(2009-6#2)
uric acid biosensor##2##3##(2008-10#2)
uric acid by##3##3##(2008-10#3)
uric acid concentration##2##3##(2008-10#2)
uric acid in the presence of##2##6##(1997-2#1)(2008-10#1)
uric acid in##9##3##(1997-2#2)(2008-10#7)
uric acid##73##2##(1995-3#1)(1997-2#2)(2008-10#58)(2008-5#3)(2008-7#2)(2009-6#4)(2010-4#2)(2013-1#1)
uric##78##1##(1995-3#1)(1997-2#2)(2008-10#63)(2008-5#3)(2008-7#2)(2009-6#4)(2010-4#2)(2013-1#1)
uricase##5##1##(1995-3#1)(1997-2#1)(2008-10#3)
uridine diphosphate##3##2##(1995-8#2)(2008-5#1)
uridine transport##7##2##(1995-10#2)(1995-8#5)
uridine##18##1##(1993-2#1)(1993-8#2)(1995-10#2)(1995-8#8)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#2)
urinalysis##7##1##(1993-2#4)(2007-12#1)(2008-10#1)(2011-2#1)
urinary 8OHdG##3##2##(2008-10#3)
urinary Gla##3##2##(1991-12#3)
urinary albumin excretion in clinical##2##5##(2013-1#2)
urinary albumin excretion##3##3##(2013-1#3)
urinary albumin##4##2##(2013-1#4)
urinary and fecal##3##3##(1994-5#1)(1996-12#1)(2011-2#1)
urinary and##5##2##(1994-5#1)(1996-12#1)(2008-10#1)(2009-12#1)(2011-2#1)
urinary arsenic##3##2##(1995-11#2)(2008-10#1)
urinary bladder tumour##2##3##(2012-12#2)
urinary bladder##28##2##(1992-12#3)(1993-2#2)(1994-8#1)(2008-10#3)(2008-12#1)(2011-2#9)(2012-12#6)(2012-2#2)(2012-3#1)
urinary catheters##4##2##(1996-12#3)(2011-2#1)
urinary creatinine##2##2##(2008-10#1)(2009-6#1)
urinary cytokine levels##3##3##(1996-12#3)
urinary derivation##2##2##(1990-9#2)
urinary diversion##3##2##(2008-10#3)
urinary dolichol##3##2##(1991-12#3)
urinary dolichols##6##2##(1991-12#6)
urinary dysfunction##2##2##(2008-7#2)
urinary endotoxin##2##2##(1996-12#2)
urinary excretion of##13##3##(1990-5#1)(1991-12#1)(1994-5#4)(1995-11#7)
urinary flow##3##2##(2008-10#3)
urinary gamma-carboxyglutamic acid##2##3##(1991-12#2)
urinary incontinence in##3##3##(2008-10#3)
urinary incontinence##9##2##(1992-8#1)(1996-2#1)(2008-10#4)(2009-3#1)(2010-10#1)(2011-2#1)
urinary infection##2##2##(2008-10#1)(2011-1#1)
urinary infections##3##2##(1990-3#1)(2008-10#2)
urinary lead##2##2##(2008-10#2)
urinary metabolites##2##2##(1991-5#1)(2010-5#1)
urinary protein##2##2##(1997-8#2)
urinary proteins##2##2##(1990-12#1)(2013-8#1)
urinary pseudouridine and 1-methyladenosine##3##4##(1992-3#3)
urinary sample##2##2##(2008-10#2)
urinary symptoms##3##2##(2007-12#1)(2012-12#1)(2012-3#1)
urinary tract infection (UTI)##2##4##(2011-2#2)
urinary tract infection##12##3##(1990-11#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-7#1)(2011-2#3)(2012-12#2)(2013-1#1)
urinary tract infections##11##3##(1993-2#2)(2008-10#5)(2008-11#1)(2011-2#2)(2013-1#1)
urinary tract##43##2##(1990-11#3)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#2)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-7#2)(2011-2#8)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
urinary##231##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#3)(1991-12#15)(1991-5#1)(1991-9#1)(1992-12#4)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-8#1)(1995-11#9)(1996-1#1)(1996-12#11)(1996-2#1)(1996-3#1)(1997-2#6)(1997-5#1)(1997-8#2)(2007-12#1)(2007-7#1)(2008-10#58)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#7)(2009-12#1)(2009-3#1)(2009-6#5)(2010-10#1)(2010-5#3)(2011-1#1)(2011-2#24)(2012-12#11)(2012-2#2)(2012-3#5)(2013-1#9)(2013-8#3)
urine DPD##3##2##(2008-10#3)
urine after##6##2##(1993-2#1)(2008-10#4)(2008-11#1)
urine and detergents##2##3##(2008-10#2)
urine and hair samples##3##4##(2008-10#3)
urine and pharmaceuticals##3##3##(2008-10#3)
urine and saliva of##2##4##(2008-10#1)(2008-12#1)
urine and saliva##3##3##(2008-10#2)(2008-12#1)
urine and serum samples##4##4##(2008-10#4)
urine and serum##20##3##(1990-2#2)(1995-8#1)(2008-10#17)
urine and##50##2##(1990-2#2)(1993-12#1)(1995-8#1)(2008-10#44)(2008-12#1)(2012-2#1)
urine as##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
urine by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
urine by##26##2##(1990-11#1)(1992-11#1)(1994-8#1)(2008-10#21)(2008-11#1)(2013-1#1)
urine culture##2##2##(2011-2#2)
urine cultures##2##2##(2007-12#1)(2008-5#1)
urine cytology##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
urine derivation##2##2##(2011-2#2)
urine for##2##2##(2008-10#2)
urine from##3##2##(1993-2#1)(2008-10#1)(2012-3#1)
urine has been developed##4##4##(2008-10#4)
urine has been##5##3##(2008-10#5)
urine have##2##2##(1994-12#1)(2008-10#1)
urine in##3##2##(1993-2#1)(2008-10#1)(2012-3#1)
urine is##6##2##(1990-2#1)(2008-10#5)
urine matrix##4##2##(2008-10#4)
urine media##3##2##(2008-10#3)
urine of healthy##2##3##(1991-12#1)(2008-10#1)
urine of patients with##2##4##(1997-2#2)
urine of patients##3##3##(1997-2#2)(2008-10#1)
urine of##10##2##(1991-12#2)(1993-12#1)(1997-2#2)(2008-10#5)
urine or##2##2##(1994-8#1)(2008-11#1)
urine protein##2##2##(1995-8#1)(2011-3#1)
urine sample##13##2##(1990-2#1)(2008-10#10)(2013-1#2)
urine samples after a##2##4##(2008-10#2)
urine samples and in##2##4##(2008-10#2)
urine samples and##7##3##(2008-10#7)
urine samples are##3##3##(2008-10#3)
urine samples by##5##3##(2008-10#4)(2010-11#1)
urine samples containing##2##3##(2008-10#2)
urine samples from##7##3##(1990-2#1)(2008-10#6)
urine samples is##3##3##(2008-10#3)
urine samples of##3##3##(2008-10#3)
urine samples to##2##3##(2008-10#1)(2008-12#1)
urine samples was##2##3##(2008-10#2)
urine samples were##9##3##(1993-11#1)(2008-10#8)
urine samples with##2##3##(1997-2#1)(2008-10#1)
urine samples##88##2##(1990-2#1)(1991-12#1)(1993-11#1)(1997-2#1)(2008-10#81)(2008-12#2)(2010-11#1)
urine specimens by##3##3##(2008-10#3)
urine specimens##6##2##(2008-10#6)
urine using##6##2##(1991-12#1)(2008-10#5)
urine volume##5##2##(1993-2#2)(2008-5#1)(2011-3#1)(2012-2#1)
urine was##8##2##(2008-10#8)
urine were##6##2##(2008-10#6)
urine with##8##2##(1990-2#1)(2008-10#6)(2011-2#1)
urine##435##1##(1990-11#1)(1990-12#7)(1990-2#11)(1991-12#7)(1992-11#1)(1992-9#4)(1993-11#1)(1993-12#6)(1993-2#8)(1994-12#3)(1994-3#1)(1994-8#3)(1995-3#1)(1995-8#2)(1996-12#2)(1997-2#6)(2007-12#1)(2008-10#325)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#2)(2009-9#2)(2010-11#2)(2010-5#1)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#4)
urines##3##1##(2008-10#1)(2008-12#2)
urinoma##7##1##(2008-10#5)(2011-2#2)
urocanic acid##2##2##(2008-10#1)(2011-2#1)
urodele##2##1##(1996-5#1)(1997-3#1)
urodynamic studies##3##2##(2008-10#3)
urodynamic##7##1##(1994-3#1)(2008-10#4)(2008-7#1)(2012-12#1)
urogenital infections##2##2##(1991-11#1)(2013-7#1)
urogenital ridges##2##2##(1994-11#2)
urogenital tract##5##2##(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2013-1#1)
urogenital##16##1##(1991-11#1)(1992-6#1)(1994-11#3)(1995-5#1)(1997-2#1)(1997-6#2)(2008-10#4)(2012-3#1)(2013-1#1)(2013-7#1)
urography##3##1##(1990-11#1)(2011-2#2)
urokinase##6##1##(1992-6#1)(1993-11#1)(1993-8#1)(1995-3#1)(1995-6#1)(1997-3#1)
urokinase-type plasminogen activator##3##3##(1995-6#1)(2008-11#2)
urokinase-type##4##1##(1994-3#1)(1995-6#1)(2008-11#2)
urolithiasis##5##1##(1991-3#1)(1992-9#2)(2008-10#1)(2012-2#1)
urologic surgery##2##2##(1991-9#1)(2008-10#1)
urologic##8##1##(1990-12#1)(1991-9#1)(1992-1#1)(2008-10#4)(2013-1#1)
urological##9##1##(1991-8#1)(1996-9#1)(2008-10#6)(2012-3#1)
urologist with##2##2##(2008-10#1)(2012-12#1)
urologists##4##1##(2008-10#3)(2012-12#1)
urology##11##1##(1992-1#1)(2008-10#9)(2012-12#1)
uropathy in##2##2##(2008-10#2)
uropathy##5##1##(2008-10#5)
urosepsis##3##1##(1996-12#2)(2013-1#1)
urothelial##3##1##(2011-2#2)(2013-8#1)
urothelium##5##1##(1992-12#1)(2008-10#2)(2013-8#2)
ursolic acid##2##2##(2008-5#1)(2012-3#1)
urticaria and##3##2##(2013-1#3)
urticaria syndrome##2##2##(1990-6#2)
urticaria##12##1##(1990-6#3)(2008-5#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-1#4)
us a new##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
us a##7##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)(2012-2#1)
us about##8##2##(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)
us for the##2##3##(2008-10#1)(2009-7#1)
us for##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2012-3#1)
us from##2##2##(1996-6#1)(2009-8#1)
us in the##2##3##(2008-10#2)
us in##4##2##(2008-10#2)(2010-7#1)(2011-2#1)
us of the##2##3##(2008-12#1)(2012-3#1)
us of##3##2##(2008-12#1)(2008-8#1)(2012-3#1)
us that##2##2##(2008-11#1)(2012-3#1)
us the##2##2##(2009-12#1)(2012-2#1)
us to assess the##2##4##(2008-10#1)(2008-8#1)
us to avoid##2##3##(1991-6#1)(2008-3#1)
us to be##2##3##(1991-2#1)(1992-1#1)
us to better understand the##2##5##(2008-10#1)(2010-5#1)
us to calculate##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
us to conclude that the##2##5##(1993-8#1)(2008-10#1)
us to conclude that##4##4##(1993-8#1)(1994-8#1)(2008-10#2)
us to conclude##5##3##(1993-8#1)(1994-8#1)(2008-10#3)
us to construct and##2##4##(1995-6#1)(2008-10#1)
us to describe##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
us to determine the##5##4##(2008-10#5)
us to determine##11##3##(1996-12#1)(2008-10#8)(2009-8#2)
us to develop##4##3##(2008-10#2)(2012-3#2)
us to differentiate the##2##4##(2008-10#1)(2009-10#1)
us to differentiate##4##3##(2008-10#2)(2008-8#1)(2009-10#1)
us to establish##2##3##(2008-10#1)(2009-10#1)
us to examine##2##3##(2009-10#1)(2010-7#1)
us to extract##2##3##(2008-10#1)(2009-8#1)
us to generate##2##3##(1993-2#1)(2010-7#1)
us to identify##3##3##(1995-6#1)(2008-10#1)(2008-9#1)
us to interpret##2##3##(2008-10#1)(2010-3#1)
us to investigate##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
us to isolate and##2##4##(1990-2#1)(1993-8#1)
us to make##3##3##(2008-10#2)(2010-12#1)
us to obtain##3##3##(1997-8#1)(2008-10#2)
us to perform##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
us to postulate##2##3##(1992-6#1)(1995-3#1)
us to process##2##3##(2008-10#1)(2008-3#1)
us to propose a##2##4##(2008-10#1)(2008-3#1)
us to propose that##2##4##(2008-11#1)(2009-8#1)
us to propose##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)
us to quantify##2##3##(1994-8#1)(2008-10#1)
us to relate the##2##4##(2008-2#1)(2008-5#1)
us to relate##3##3##(2008-2#1)(2008-5#1)(2008-7#1)
us to study the influence of##2##6##(2008-10#1)(2012-2#1)
us to study the##6##4##(1993-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
us to test the##3##4##(2008-3#1)(2008-8#2)
us to test##5##3##(2008-3#1)(2008-8#4)
us to understand##3##3##(1994-11#1)(2009-7#1)(2010-4#1)
us to##184##2##(1990-2#3)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#4)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-12#2)(2008-10#52)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#11)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#1)(2009-10#3)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#4)(2011-10#1)(2011-2#6)(2012-2#3)(2012-3#5)(2013-8#2)
us with a##3##3##(1992-1#1)(2008-11#1)(2008-6#1)
us with an##2##3##(1997-3#1)(2012-3#1)
us with##10##2##(1992-1#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#3)
us##278##1##(1990-2#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#4)(1994-1#2)(1994-11#1)(1994-2#5)(1994-3#1)(1994-8#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#62)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#12)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#6)(2008-8#13)(2008-9#4)(2009-1#1)(2009-10#6)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#4)(2009-8#6)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#11)(2012-12#1)(2012-2#7)(2012-3#10)(2013-1#5)(2013-8#2)
us?##2##1##(2009-10#1)(2012-3#1)
usability of##2##2##(2010-10#1)(2012-12#1)
usability##6##1##(2008-6#2)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
usable##9##1##(1991-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-11#1)(2013-7#1)(2013-8#1)
usage and the##2##3##(2008-5#1)(2008-9#1)
usage and##11##2##(1993-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
usage as##2##2##(2009-12#1)(2009-3#1)
usage for##3##2##(2008-10#2)(2011-2#1)
usage in##3##2##(2008-10#2)(2008-11#1)
usage of the##6##3##(1993-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
usage of traditional##2##3##(1997-2#1)(2008-1#1)
usage of##28##2##(1991-7#1)(1993-6#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
usage to##2##2##(1997-8#1)(2008-7#1)
usage tracking##2##2##(1991-12#2)
usage##77##1##(1990-6#1)(1991-1#1)(1991-12#2)(1991-7#1)(1993-1#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#3)(2007-11#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#2)(2008-5#5)(2008-7#3)(2008-9#3)(2009-12#1)(2009-3#2)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#7)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
usagers##2##1##(2013-1#2)
use a combination of##2##4##(2008-10#2)
use a different##2##3##(2008-8#1)(2008-9#1)
use a model##2##3##(2008-10#1)(2008-11#1)
use a simple##4##3##(2008-10#2)(2008-3#2)
use a##39##2##(1991-3#1)(1993-12#1)(1995-12#1)(1995-9#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
use against##3##2##(1993-2#1)(2008-10#2)
use alcohol##2##2##(2012-12#2)
use all available##2##3##(1992-9#1)(2012-3#1)
use among peers##3##3##(2013-1#3)
use among##15##2##(1992-1#1)(1992-12#1)(1996-6#1)(2008-11#2)(2009-7#1)(2012-12#1)(2013-1#5)(2013-8#3)
use an##7##2##(1992-3#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-8#1)
use and (ii)##2##3##(2008-10#1)(2008-7#1)
use and abuse##4##3##(1991-1#1)(2008-11#2)(2010-7#1)
use and communication##2##3##(2008-9#1)(2009-5#1)
use and expenditures##3##3##(1991-12#1)(1991-3#1)(1994-2#1)
use and its##2##3##(2008-1#2)
use and misuse##2##3##(1991-12#1)(2008-11#1)
use and offer##2##3##(1991-12#1)(2013-1#1)
use and other##3##3##(1997-6#1)(2008-1#1)(2013-1#1)
use and the risk of##2##5##(2008-11#1)(2008-8#1)
use and the##5##3##(2008-11#1)(2008-8#1)(2009-10#1)(2010-5#1)(2013-1#1)
use and trends##3##3##(2012-12#3)
use and##88##2##(1991-1#2)(1991-12#3)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-3#1)(1997-6#2)(2008-1#3)(2008-10#6)(2008-11#12)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#10)(2013-8#5)
use appears to be##2##4##(2008-5#1)(2009-8#1)
use are##12##2##(1990-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2013-8#1)
use as a##15##3##(1994-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
use as an##6##3##(1993-12#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)
use as##39##2##(1992-3#1)(1993-12#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)(2013-8#2)
use at the##3##3##(1990-12#1)(1993-12#1)(2008-10#1)
use at##8##2##(1990-12#2)(1991-2#1)(1993-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
use available##2##2##(2008-10#1)(2008-11#1)
use because##3##2##(1992-11#1)(2008-10#1)(2012-12#1)
use behaviors##7##2##(1994-2#2)(1996-1#4)(2013-1#1)
use but##3##2##(2008-10#1)(2009-5#1)(2010-6#1)
use by the##2##3##(2008-5#1)(2011-1#1)
use by##20##2##(1992-12#1)(1992-3#1)(1995-12#2)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
use can##2##2##(1996-11#1)(2013-8#1)
use causes##2##2##(2008-11#1)(2013-1#1)
use clusters##2##2##(2012-3#1)(2013-1#1)
use data from##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
use data##4##2##(2011-2#2)(2012-3#1)(2013-1#1)
use deterministic##2##2##(1996-3#1)(2008-9#1)
use different##5##2##(1995-1#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
use disorder##8##2##(2009-11#2)(2010-6#2)(2012-12#1)(2012-3#1)(2013-8#2)
use disorders in##3##3##(2008-6#1)(2012-3#2)
use disorders##10##2##(1997-5#1)(2008-11#1)(2008-6#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-3#4)
use due to##2##3##(1991-12#1)(2013-1#1)
use during##12##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-1#1)(2009-7#1)(2010-7#2)(2010-8#1)(2011-1#1)(2013-8#1)
use early in##2##3##(2008-11#1)(2009-7#1)
use efficiency##3##2##(2008-10#2)(2008-9#1)
use electrical##2##2##(2011-2#2)
use for the##8##3##(1995-3#1)(2008-10#5)(2008-11#1)(2010-8#1)
use for##49##2##(1990-3#1)(1991-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-1#1)(2008-10#19)(2008-11#7)(2008-6#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
use has been##4##3##(1992-2#1)(2008-11#2)(2008-7#1)
use has##7##2##(1992-2#1)(2008-11#2)(2008-7#1)(2010-7#1)(2012-3#1)(2013-1#1)
use have##2##2##(2008-10#1)(2008-11#1)
use in MDIs will##2##4##(1992-3#1)(1996-1#1)
use in a##13##3##(1990-2#1)(1991-1#1)(1992-12#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-8#2)
use in aerosol##2##3##(1994-1#1)(1994-12#1)
use in an##2##3##(2008-11#1)(2008-7#1)
use in both##2##3##(2008-10#1)(2008-11#1)
use in clinical practice##3##4##(2009-12#1)(2011-2#1)(2012-3#1)
use in clinical##4##3##(2009-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
use in combination with##2##4##(2008-10#2)
use in cosmetic##2##3##(2008-5#2)
use in cosmetics##2##3##(2008-5#2)
use in gene therapy##2##4##(2010-1#2)
use in gene##3##3##(2008-10#1)(2010-1#2)
use in industrial##2##3##(2008-7#1)(2012-2#1)
use in patients##2##3##(2010-12#1)(2012-3#1)
use in pediatric##2##3##(2011-1#1)(2011-2#1)
use in practice##2##3##(2008-10#1)(2008-11#1)
use in the##33##3##(1991-1#2)(1991-12#1)(1993-1#1)(1995-5#1)(1996-1#1)(1997-1#2)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#3)(2009-12#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
use in these##2##3##(2008-10#2)
use in this##2##3##(1996-2#1)(2010-6#1)
use in##202##2##(1990-2#1)(1991-1#5)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-9#1)(1995-1#1)(1995-5#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-5#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#48)(2008-11#17)(2008-12#3)(2008-3#6)(2008-4#2)(2008-5#9)(2008-7#5)(2008-9#3)(2009-10#2)(2009-12#3)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#5)
use information##2##2##(2010-8#1)(2011-2#1)
use is associated with##2##4##(2010-12#1)(2013-1#1)
use is##24##2##(1990-2#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-9#2)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
use it##6##2##(1996-1#1)(1997-3#1)(2008-11#2)(2009-7#1)(2013-8#1)
use its##2##2##(2008-5#1)(2012-2#1)
use may##2##2##(2011-7#1)(2013-1#1)
use measurements##2##2##(2008-3#1)(2008-5#1)
use morphological##2##2##(2007-12#1)(2008-8#1)
use multiple##4##2##(2008-10#1)(2008-8#1)(2010-11#1)(2011-1#1)
use new##2##2##(1997-2#1)(2012-3#1)
use of 0##2##3##(2008-10#1)(2013-1#1)
use of 123-I MIBG imaging##2##5##(2012-2#2)
use of BPA##2##3##(2010-9#2)
use of Bacillus-based BCAs##2##4##(2008-10#2)
use of CEUS##2##3##(2010-12#2)
use of CT##2##3##(1992-12#1)(2013-1#1)
use of GFP##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
use of Medicare's##2##3##(1994-12#1)(1994-2#1)
use of SPME##3##3##(2008-10#3)
use of VCT services was##2##5##(2013-1#2)
use of a 5x10(-4) M Fe(III)-1x10(-3) M Fe(II) buffer containing 0##2##11##(2008-10#2)
use of a set of##3##5##(1993-9#1)(2008-10#2)
use of a simple##2##4##(2008-3#2)
use of a single##8##4##(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-6#1)
use of a small##2##4##(2008-3#1)(2008-9#1)
use of a spiritually based##2##5##(2010-10#2)
use of a wide##2##4##(1996-11#1)(1996-3#1)
use of a##197##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-1#2)(1992-2#2)(1993-2#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-3#1)(2007-11#3)(2007-12#4)(2008-10#64)(2008-11#8)(2008-12#3)(2008-2#10)(2008-3#42)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-9#7)(2009-1#1)(2009-8#1)(2010-10#2)(2010-8#2)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
use of aerosol##2##3##(1997-1#1)(2008-10#1)
use of alcohol##3##3##(1991-9#2)(2013-8#1)
use of alternative##3##3##(1997-7#1)(1997-8#1)(2008-12#1)
use of amiodarone##2##3##(1993-6#1)(2008-11#1)
use of an assistive device##2##5##(2008-12#1)(2012-2#1)
use of an##41##3##(1993-12#1)(1993-2#1)(1994-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#11)(2008-5#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
use of analgesics##2##3##(2008-11#1)(2010-11#1)
use of and##2##3##(1991-2#1)(1991-3#1)
use of animals##2##3##(2008-10#2)
use of antibiotic##2##3##(1993-11#1)(1996-11#1)
use of anticoagulants##2##3##(2012-12#2)
use of antimicrobial##2##3##(2012-3#1)(2013-1#1)
use of any##2##3##(2008-10#1)(2008-4#1)
use of appropriate##7##3##(1993-2#1)(2008-11#3)(2008-6#1)(2009-8#1)(2011-2#1)
use of artificial##2##3##(2008-10#2)
use of available##3##3##(1991-12#1)(1992-2#1)(2013-1#1)
use of bacterial##2##3##(1990-2#1)(2012-2#1)
use of bone##2##3##(1994-9#1)(2010-6#1)
use of both##11##3##(1997-2#2)(2008-10#2)(2009-7#1)(2010-10#1)(2012-2#3)(2013-1#2)
use of calcium##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
use of cannabis##3##3##(2009-7#1)(2013-8#2)
use of carbon##2##3##(1992-1#1)(2008-5#1)
use of case studies as##2##5##(2008-11#2)
use of central venous##2##4##(2008-7#2)
use of chemical##4##3##(2008-11#2)(2008-9#1)(2012-2#1)
use of chromatographic##2##3##(2008-10#2)
use of cigarettes and alcohol##2##5##(1991-9#2)
use of cimetidine##2##3##(2008-11#2)
use of clinical##2##3##(1993-12#2)
use of cocaine##3##3##(1991-1#1)(2010-11#1)(2013-8#1)
use of combination therapy##2##4##(2010-10#2)
use of combination##3##3##(2008-6#1)(2010-10#2)
use of combined##3##3##(2008-10#2)(2013-1#1)
use of computed##2##3##(1990-3#1)(1997-4#1)
use of computer##4##3##(2008-11#1)(2008-12#1)(2008-9#2)
use of computers and##2##4##(1996-2#1)(2008-12#1)
use of consumer##2##3##(1996-2#2)
use of contraceptives was##2##4##(1996-6#2)
use of contraceptives##3##3##(1996-6#2)(2012-2#1)
use of conventional##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
use of data from##2##4##(1996-6#1)(2011-2#1)
use of data##3##3##(1996-6#1)(2010-8#1)(2011-2#1)
use of diagnostic##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
use of different##15##3##(1990-2#2)(2008-10#8)(2008-2#1)(2008-3#3)(2008-9#1)
use of digital##2##3##(1992-9#1)(2007-12#1)
use of doll therapy in dementia##3##6##(2013-8#3)
use of drops##2##3##(2008-10#2)
use of drugs##6##3##(1995-1#1)(1996-6#2)(1997-2#1)(2008-11#1)(2008-7#1)
use of effective##2##3##(2008-10#1)(2008-11#1)
use of either##2##3##(1996-2#1)(2008-10#1)
use of electrically##2##3##(1995-3#1)(2008-9#1)
use of electronic##3##3##(2008-11#1)(2010-8#2)
use of existing##3##3##(2008-3#1)(2012-3#2)
use of fast##2##3##(2008-10#1)(2008-3#1)
use of flow##3##3##(2008-10#1)(2008-9#2)
use of fungicides##2##3##(2008-10#2)
use of genetic##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
use of habitual##2##3##(2008-11#2)
use of hazardous##3##3##(1996-5#1)(2008-10#1)(2008-9#1)
use of health##3##3##(1993-12#1)(1994-2#1)(2008-11#1)
use of high temperature##2##4##(2008-10#2)
use of high##6##3##(2008-10#4)(2008-11#2)
use of host##2##3##(2008-10#2)
use of human##7##3##(1992-5#2)(2008-11#1)(2008-4#2)(2008-5#1)(2013-1#1)
use of independent##2##3##(1993-9#1)(1994-3#1)
use of information technology##3##4##(2008-10#2)(2011-1#1)
use of information##6##3##(1992-2#1)(2008-10#2)(2010-8#1)(2011-1#1)(2013-1#1)
use of interpreters##2##3##(2013-8#2)
use of laparoscopic##3##3##(1993-2#1)(1993-3#1)(2008-10#1)
use of large##2##3##(2008-12#1)(2013-1#1)
use of laser##6##3##(1991-1#1)(1991-9#1)(2008-10#3)(2008-3#1)
use of learning resources##2##4##(2008-11#2)
use of liposomes as analytical##2##5##(2008-10#2)
use of low##2##3##(2007-11#1)(2008-11#1)
use of mammography##2##3##(1990-12#1)(1991-8#1)
use of medical##6##3##(1992-12#1)(1996-6#1)(2008-11#3)(2008-4#1)
use of medications##2##3##(2008-10#1)(2008-8#1)
use of medicines in a general population sample##2##8##(2008-11#2)
use of medicines in a##3##5##(2008-11#2)(2011-2#1)
use of medicines##8##3##(1992-2#1)(2008-11#5)(2009-3#1)(2011-2#1)
use of microarray##2##3##(2008-7#1)(2009-10#1)
use of mixed##2##3##(2008-10#2)
use of mixtures##2##3##(2008-10#2)
use of model##2##3##(1991-5#1)(2008-10#1)
use of modern##2##3##(1990-6#1)(2008-10#1)
use of modified##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
use of molecular markers##2##4##(1997-7#1)(2008-10#1)
use of molecular##6##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
use of monoclonal antibodies##3##4##(2008-11#2)(2009-8#1)
use of more##5##3##(2008-11#2)(2011-2#2)(2013-1#1)
use of multiple##7##3##(1991-3#1)(2008-10#4)(2008-3#1)(2008-4#1)
use of multivariate##5##3##(2008-10#4)(2008-3#1)
use of near infrared spectroscopy##2##5##(2008-10#2)
use of near##3##3##(2008-10#3)
use of nematicides##2##3##(2008-10#2)
use of new##3##3##(1991-12#1)(1996-11#1)(2008-11#1)
use of nonpharmacological##2##3##(2013-1#1)(2013-8#1)
use of one##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
use of opioids in FMS##2##5##(2011-2#2)
use of opioids in##3##4##(2011-2#3)
use of optical##4##3##(2007-11#1)(2008-10#1)(2011-7#2)
use of oral contraceptives##4##4##(1991-2#1)(1991-8#1)(2008-11#2)
use of oral##7##3##(1991-12#1)(1991-2#1)(1991-8#1)(1997-4#1)(2008-11#2)(2010-6#1)
use of organic solvents##3##4##(2008-10#3)
use of organic##4##3##(2008-10#4)
use of other##4##3##(1992-12#1)(2008-10#2)(2012-2#1)
use of our##2##3##(1995-12#1)(2008-10#1)
use of outcome measures##2##4##(2008-11#2)
use of partially resistant##2##4##(2008-10#2)
use of personal##2##3##(1994-3#1)(2009-12#1)
use of pharmacotherapy##2##3##(2008-4#1)(2013-1#1)
use of physician##3##3##(1991-12#1)(1995-12#2)
use of prenatal care##3##4##(1992-2#2)(1995-12#1)
use of professional##2##3##(1993-2#1)(2008-11#1)
use of radiosurgery##2##3##(1995-12#1)(2008-7#1)
use of rapid##2##3##(1995-6#1)(2008-8#1)
use of readily available##3##4##(2008-10#2)(2008-5#1)
use of recombinant##2##3##(2008-11#1)(2008-7#1)
use of reflection##3##3##(2008-11#2)(2008-12#1)
use of reflective##2##3##(2008-11#1)(2008-3#1)
use of research##3##3##(2008-12#1)(2010-11#1)(2010-4#1)
use of resources##4##3##(1991-2#1)(1995-12#1)(1997-5#1)(2008-10#1)
use of rhodium##2##3##(2008-10#2)
use of selective media##2##4##(2008-10#2)
use of selective##4##3##(2008-10#3)(2008-12#1)
use of sensors##2##3##(2008-10#2)
use of services##5##3##(1991-2#1)(1993-3#1)(1995-3#1)(1997-8#1)(2012-2#1)
use of several##5##3##(2008-10#2)(2008-11#1)(2009-3#1)(2010-1#1)
use of similar##2##3##(2008-10#1)(2012-2#1)
use of simulations##3##3##(2008-12#2)(2008-3#1)
use of social##4##3##(1992-2#1)(1997-3#1)(2012-2#2)
use of some##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
use of stable##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
use of standard##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
use of such##6##3##(1992-1#1)(2008-10#2)(2008-11#2)(2008-9#1)
use of supercritical##2##3##(2008-10#2)
use of surface##2##3##(2008-10#1)(2010-6#1)
use of synchronous##2##3##(2008-10#2)
use of synthetic##2##3##(2008-4#1)(2010-7#1)
use of technology in##3##4##(2008-10#1)(2008-12#2)
use of technology##8##3##(1994-12#1)(2008-10#1)(2008-11#3)(2008-12#3)
use of telemedicine##2##3##(1996-3#1)(2013-1#1)
use of the CO 2##2##5##(1992-3#2)
use of the argon##2##4##(1994-3#1)(2008-10#1)
use of the automated##3##4##(2008-10#3)
use of the benefit and in##2##6##(1994-2#1)(1995-3#1)
use of the device in##2##5##(2008-11#1)(2010-6#1)
use of the low##2##4##(2008-10#1)(2008-3#1)
use of the name##2##4##(2008-10#2)
use of the oil##2##4##(2008-5#1)(2011-2#1)
use of the proposed##2##4##(2008-10#2)
use of the system##4##4##(1992-12#1)(1993-1#1)(2008-10#2)
use of the##193##3##(1990-9#2)(1991-11#1)(1992-1#2)(1992-12#1)(1992-3#3)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#3)(2008-10#72)(2008-11#16)(2008-12#3)(2008-2#5)(2008-3#21)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-6#2)(2010-5#1)(2010-6#3)(2010-9#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
use of thermal##2##3##(2008-10#1)(2008-3#1)
use of these drugs##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
use of these techniques##2##4##(2008-11#1)(2008-4#1)
use of these##33##3##(1991-12#1)(1991-3#1)(1991-9#1)(1992-2#1)(1997-4#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
use of this technique##3##4##(2008-2#2)(2011-2#1)
use of this##26##3##(1990-9#1)(1991-12#1)(1992-1#1)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
use of traditional##3##3##(2008-12#2)(2011-2#1)
use of tricyclic##2##3##(1990-11#1)(2012-2#1)
use of tumor necrosis##2##4##(2011-2#1)(2013-1#1)
use of two##13##3##(1990-12#1)(1991-3#1)(1997-6#1)(2008-10#5)(2008-12#1)(2008-3#4)
use of ultrasonography##3##3##(2009-8#1)(2011-2#2)
use of urban##2##3##(1992-12#2)
use of urinary##2##3##(1991-12#1)(2010-5#1)
use of various##2##3##(2008-10#1)(2010-12#1)
use of vitamin##2##3##(1992-9#2)
use of##1913##2##(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#3)(1990-8#1)(1990-9#8)(1991-1#4)(1991-11#3)(1991-12#14)(1991-2#8)(1991-3#9)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#9)(1992-1#9)(1992-12#8)(1992-2#9)(1992-3#13)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#8)(1993-1#3)(1993-11#4)(1993-12#9)(1993-2#11)(1993-3#8)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#2)(1994-12#11)(1994-2#13)(1994-3#11)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#9)(1995-2#11)(1995-3#11)(1995-5#8)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#6)(1996-11#7)(1996-12#3)(1996-2#7)(1996-3#9)(1996-5#2)(1996-6#13)(1996-9#3)(1997-1#5)(1997-2#8)(1997-3#9)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#8)(1997-8#7)(2006-6#1)(2007-11#9)(2007-12#18)(2008-1#5)(2008-10#548)(2008-11#188)(2008-12#42)(2008-2#27)(2008-3#147)(2008-4#32)(2008-5#27)(2008-6#12)(2008-7#44)(2008-8#15)(2008-9#45)(2009-1#3)(2009-10#8)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#5)(2009-8#6)(2010-1#2)(2010-10#9)(2010-11#9)(2010-12#8)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#12)(2010-7#6)(2010-8#13)(2010-9#5)(2011-1#8)(2011-10#2)(2011-2#66)(2011-3#6)(2011-7#5)(2012-12#14)(2012-2#35)(2012-3#26)(2013-1#73)(2013-8#22)
use on##11##2##(1991-2#1)(1997-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2013-1#1)(2013-8#1)
use one##2##2##(1993-2#1)(2008-10#1)
use only##3##2##(1991-3#1)(1993-6#1)(2010-9#1)
use or##9##2##(1996-2#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-12#1)
use patterns##6##2##(1991-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#2)
use rates##3##2##(1994-2#2)(2010-8#1)
use remains##3##2##(1997-1#1)(2008-11#1)(2011-2#1)
use research##4##2##(1997-2#1)(2008-11#1)(2008-12#1)(2009-3#1)
use should be##2##3##(2011-2#1)(2012-2#1)
use some##5##2##(1996-2#1)(2008-10#1)(2008-4#1)(2013-1#2)
use such##3##2##(1995-9#1)(2009-9#1)(2013-1#1)
use than##6##2##(1992-3#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-2#1)
use that##4##2##(2008-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
use the current##2##3##(2008-3#1)(2008-4#1)
use the relative EC50/IC50##3##4##(2012-2#3)
use the same##2##3##(1994-12#1)(2008-11#1)
use the##63##2##(1990-2#2)(1991-1#1)(1992-2#1)(1992-5#1)(1993-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-9#1)(1996-2#1)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-3#6)(2008-4#5)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#1)
use their##5##2##(1992-2#1)(2007-12#1)(2008-11#1)(2011-1#2)
use them##6##2##(1993-12#1)(1994-12#1)(2008-1#1)(2008-10#1)(2010-1#1)(2013-7#1)
use these data to##2##4##(1994-2#1)(2008-8#1)
use these##9##2##(1991-1#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-8#2)
use this method##2##3##(2008-10#1)(2008-7#1)
use this technique##2##3##(2008-10#1)(2008-3#1)
use this##14##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-3#1)
use to##27##2##(1992-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#4)
use two##5##2##(1993-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
use under##3##2##(1992-3#1)(2008-6#1)(2010-6#1)
use various##3##2##(2008-3#1)(2008-4#1)(2008-9#1)
use was##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
use were##7##2##(1996-11#1)(2008-10#1)(2008-11#3)(2008-5#1)(2013-1#1)
use when##4##2##(2008-8#1)(2008-9#1)(2010-10#1)(2010-9#1)
use will##3##2##(2010-12#1)(2011-7#1)(2012-12#1)
use with the##3##3##(2008-10#2)(2012-3#1)
use with##21##2##(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
use within the##2##3##(2008-10#1)(2008-11#1)
use within##7##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#3)
use without##3##2##(1993-2#1)(2008-11#1)(2010-11#1)
use##3316##1##(1990-11#3)(1990-12#9)(1990-2#8)(1990-3#4)(1990-5#4)(1990-6#6)(1990-8#1)(1990-9#10)(1991-1#20)(1991-11#4)(1991-12#24)(1991-2#13)(1991-3#18)(1991-5#2)(1991-6#9)(1991-7#1)(1991-8#4)(1991-9#13)(1992-1#12)(1992-11#1)(1992-12#18)(1992-2#16)(1992-3#28)(1992-4#1)(1992-5#5)(1992-6#1)(1992-7#1)(1992-9#13)(1993-1#10)(1993-11#6)(1993-12#22)(1993-2#18)(1993-3#12)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#7)(1994-11#1)(1994-12#20)(1994-2#27)(1994-3#18)(1994-5#5)(1994-6#3)(1994-8#3)(1994-9#5)(1995-1#8)(1995-11#4)(1995-12#17)(1995-2#18)(1995-3#14)(1995-5#13)(1995-6#4)(1995-8#4)(1995-9#6)(1996-1#21)(1996-11#13)(1996-12#7)(1996-2#14)(1996-3#14)(1996-5#3)(1996-6#18)(1996-9#8)(1997-1#16)(1997-2#16)(1997-3#16)(1997-4#5)(1997-5#6)(1997-6#4)(1997-7#10)(1997-8#9)(2006-6#1)(2007-11#11)(2007-12#23)(2007-8#1)(2008-1#27)(2008-10#770)(2008-11#330)(2008-12#68)(2008-2#29)(2008-3#180)(2008-4#63)(2008-5#63)(2008-6#21)(2008-7#67)(2008-8#42)(2008-9#90)(2009-1#4)(2009-10#16)(2009-11#10)(2009-12#10)(2009-2#1)(2009-3#9)(2009-4#5)(2009-5#13)(2009-6#11)(2009-7#21)(2009-8#13)(2009-9#3)(2010-1#10)(2010-10#16)(2010-11#20)(2010-12#14)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#10)(2010-6#22)(2010-7#17)(2010-8#27)(2010-9#18)(2011-1#19)(2011-10#2)(2011-2#117)(2011-3#10)(2011-7#9)(2012-12#34)(2012-2#77)(2012-3#66)(2013-1#166)(2013-7#2)(2013-8#65)
use)##6##1##(2008-10#2)(2010-1#2)(2010-9#1)(2011-2#1)
use]##3##1##(1991-6#1)(1994-8#1)(1996-9#1)
used BAC transgenic##2##3##(2008-4#1)(2013-8#1)
used DNA##2##2##(2008-11#1)(2010-5#1)
used UV##2##2##(2008-10#1)(2008-5#1)
used a combination of##5##4##(2008-11#2)(2008-5#1)(2009-8#1)(2011-10#1)
used a novel##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
used a single##2##3##(2008-9#1)(2013-1#1)
used a visual##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
used a##88##2##(1990-2#1)(1990-8#1)(1991-2#2)(1992-1#1)(1993-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#16)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#2)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
used after##4##2##(1990-6#1)(1995-9#1)(2008-10#1)(2011-2#1)
used alone as a##2##4##(2008-10#1)(2008-12#1)
used alone or in combination##2##5##(1993-6#1)(2013-1#1)
used alone##14##2##(1991-1#1)(1993-6#1)(1995-5#1)(2008-10#6)(2008-11#1)(2008-12#2)(2011-2#1)(2013-1#1)
used along with##2##3##(1993-2#1)(2008-3#1)
used an##11##2##(1993-12#1)(1993-3#1)(1994-6#1)(1996-5#1)(2008-10#3)(2008-2#1)(2010-1#1)(2011-1#1)(2012-2#1)
used analytical##2##2##(2008-10#1)(2008-4#1)
used and compared##3##3##(2008-10#3)
used and evaluated##2##3##(2008-11#1)(2010-4#1)
used and the##14##3##(1991-2#1)(1994-12#1)(1997-1#1)(2008-10#10)(2009-10#1)
used and##46##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-9#1)(1994-12#1)(1995-11#1)(1997-1#1)(1997-3#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2009-10#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-3#2)(2012-2#2)(2013-1#2)
used animal model for##2##4##(2010-12#1)(2011-2#1)
used approach for##2##3##(2008-10#1)(2012-2#1)
used approach##3##2##(2008-10#1)(2012-2#2)
used appropriately##2##2##(1994-12#1)(2010-11#1)
used are##11##2##(2008-1#1)(2008-10#4)(2008-11#2)(2008-9#1)(2010-8#1)(2013-1#2)
used as a DNA##2##4##(1990-5#1)(1991-5#1)
used as a basis for##4##5##(1991-6#1)(1993-12#1)(1997-6#1)(2008-10#1)
used as a basis##5##4##(1991-6#1)(1993-12#1)(1997-6#1)(2008-10#1)(2008-9#1)
used as a biological##2##4##(2008-10#2)
used as a biomarker##2##4##(2008-10#1)(2012-2#1)
used as a candidate##2##4##(2008-12#1)(2012-3#1)
used as a carrier##3##4##(1993-11#1)(1996-12#1)(2008-10#1)
used as a chiral##2##4##(2008-10#2)
used as a component of##2##5##(2008-10#1)(2013-8#1)
used as a control##5##4##(1993-8#1)(1995-12#1)(2008-11#2)(2008-5#1)
used as a detector for##2##5##(2008-10#2)
used as a detector##4##4##(2008-10#4)
used as a fast##2##4##(2008-12#1)(2008-3#1)
used as a functional##3##4##(2008-10#1)(2010-4#1)(2010-6#1)
used as a general##2##4##(2008-10#1)(2008-11#1)
used as a guide to##2##5##(2009-10#1)(2011-2#1)
used as a guide##4##4##(1996-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
used as a marker for##2##5##(1994-2#1)(2008-11#1)
used as a marker##3##4##(1994-2#1)(2008-11#1)(2009-12#1)
used as a measure of##2##5##(1990-2#1)(2008-10#1)
used as a method##2##4##(2008-10#1)(2013-8#1)
used as a model of##2##5##(1991-5#1)(2010-1#1)
used as a model system##3##5##(2008-10#2)(2008-9#1)
used as a model##11##4##(1991-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-8#1)
used as a new##8##4##(2008-10#4)(2008-5#3)(2008-9#1)
used as a novel##4##4##(2008-10#3)(2008-9#1)
used as a probe to##2##5##(1993-2#1)(1997-1#1)
used as a probe##5##4##(1991-6#1)(1993-2#1)(1997-1#1)(2008-10#1)(2008-8#1)
used as a reagent for##2##5##(2008-10#1)(2008-9#1)
used as a reference##5##4##(2008-10#4)(2008-12#1)
used as a reporter##2##4##(1991-5#1)(1997-8#1)
used as a single##2##4##(2008-10#1)(2009-12#1)
used as a solid support##2##5##(2008-10#2)
used as a solid##3##4##(2008-10#3)
used as a substrate##2##4##(2008-10#2)
used as a target for##2##5##(1997-7#1)(2008-8#1)
used as a working electrode in##3##6##(2008-10#3)
used as a working electrode##5##5##(2008-10#5)
used as a##222##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#3)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1994-2#1)(1995-12#1)(1995-9#1)(1996-12#3)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#103)(2008-11#16)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
used as an activator##2##4##(2008-10#1)(2008-5#1)
used as an active##2##4##(1992-3#1)(2008-10#1)
used as an additional##2##4##(2008-11#1)(2011-2#1)
used as an adjunct to##2##5##(2012-2#1)(2013-1#1)
used as an adjunct##3##4##(2008-7#1)(2012-2#1)(2013-1#1)
used as an aid##3##4##(1991-11#1)(2008-10#1)(2010-4#1)
used as an alternative method to##2##6##(2008-10#2)
used as an alternative##6##4##(2008-10#6)
used as an amperometric sensor for##2##6##(2008-10#2)
used as an amperometric##4##4##(2008-10#4)
used as an analytical##2##4##(2008-10#1)(2008-9#1)
used as an antigen##2##4##(2008-10#1)(2010-6#1)
used as an excellent##2##4##(2008-10#2)
used as an index##2##4##(2008-11#2)
used as an indicator electrode in potentiometric titration of##6##9##(2008-10#6)
used as an indicator electrode in the potentiometric titration of##3##10##(2008-10#3)
used as an indicator electrode in the potentiometric##4##8##(2008-10#4)
used as an indicator electrode in##10##6##(2008-10#10)
used as an indicator electrode##11##5##(2008-10#11)
used as an indicator for##2##5##(2008-11#1)(2008-7#1)
used as an indicator of the##2##6##(2008-10#2)
used as an indicator of##3##5##(2008-10#2)(2008-3#1)
used as an indicator##16##4##(2008-10#13)(2008-11#1)(2008-3#1)(2008-7#1)
used as an indirect##2##4##(1997-1#1)(2008-11#1)
used as an##90##3##(1990-2#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-3#2)(1993-9#1)(1996-8#1)(1997-1#1)(2008-10#53)(2008-11#8)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#2)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
used as analytical##2##3##(2008-10#2)
used as carrier##2##3##(2008-10#2)
used as chemical modifier##5##4##(2008-10#5)
used as chemical##8##3##(2008-10#8)
used as excitation##2##3##(2008-10#2)
used as experimental##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
used as fuel##2##3##(2008-10#1)(2009-8#1)
used as indicator##2##3##(2008-10#2)
used as indices##2##3##(1992-3#1)(2008-10#1)
used as inoculum##2##3##(2008-10#2)
used as input for##3##4##(2008-10#1)(2008-3#1)(2012-12#1)
used as internal standard##4##4##(2008-10#4)
used as internal standards##3##4##(2008-10#3)
used as internal##8##3##(2008-10#8)
used as ionophores##2##3##(2008-10#2)
used as matrix modifiers##2##4##(2008-10#2)
used as mobile phase##2##4##(2008-10#2)
used as model##5##3##(1997-6#1)(2008-10#4)
used as one of the##2##5##(2008-10#1)(2008-9#1)
used as part of a##2##5##(2010-5#1)(2010-6#1)
used as part of##3##4##(2008-10#1)(2010-5#1)(2010-6#1)
used as primary##2##3##(1990-11#1)(2010-1#1)
used as reference##9##3##(2008-1#1)(2008-10#5)(2008-11#1)(2010-10#1)(2012-3#1)
used as screening##3##3##(2008-10#2)(2011-3#1)
used as selective##3##3##(2008-10#2)(2008-12#1)
used as sensing##2##3##(2008-10#2)
used as solid phase##3##4##(1992-9#1)(2008-10#2)
used as sorbent##3##3##(2008-10#3)
used as standard##2##3##(2008-10#2)
used as standards##3##3##(2008-10#3)
used as starting##3##3##(2008-10#1)(2008-11#2)
used as substrates##4##3##(1994-5#2)(1994-8#1)(2008-10#1)
used as supporting##2##3##(2008-10#2)
used as template##4##3##(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
used as test##4##3##(1995-8#1)(2008-10#2)(2008-11#1)
used as the analytical##3##4##(2008-10#3)
used as the basis for##5##5##(2008-10#3)(2008-3#1)(2010-3#1)
used as the basis##6##4##(1994-3#1)(2008-10#3)(2008-3#1)(2010-3#1)
used as the detector##3##4##(2008-10#3)
used as the light source and the##2##7##(2008-10#2)
used as the mobile phase##2##5##(2008-10#2)
used as the model##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
used as the reference##2##4##(2008-10#1)(2008-11#1)
used as the response variable##2##5##(2008-10#2)
used as the source##2##4##(2008-10#2)
used as the working electrode##2##5##(2008-10#2)
used as the##82##3##(1991-12#1)(1992-6#1)(1994-3#1)(2008-10#62)(2008-11#4)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-9#1)(2013-8#1)
used as therapeutics##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
used as##694##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#3)(1991-6#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#381)(2008-11#45)(2008-12#14)(2008-2#6)(2008-3#13)(2008-4#4)(2008-5#17)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#16)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#6)(2010-7#2)(2010-8#4)(2011-2#12)(2011-3#4)(2012-12#1)(2012-2#9)(2012-3#5)(2012-6#1)(2012-9#1)(2013-1#11)(2013-8#7)
used at a##2##3##(2008-10#2)
used at least##2##3##(2008-10#2)
used at the##4##3##(1991-2#1)(1993-3#1)(2008-10#1)(2013-1#1)
used at##18##2##(1991-2#1)(1993-3#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2013-1#1)
used because it##2##3##(1997-2#1)(2008-10#1)
used because of its##2##4##(2008-5#1)(2013-1#1)
used because of##3##3##(1997-1#1)(2008-5#1)(2013-1#1)
used because##6##2##(1997-1#1)(1997-2#1)(2008-10#2)(2008-5#1)(2013-1#1)
used both##5##2##(2008-10#2)(2009-8#1)(2012-2#2)
used but##2##2##(1990-12#1)(1995-11#1)
used by Medicare and##2##4##(1993-3#1)(1997-3#1)
used by both##2##3##(1995-12#1)(2008-12#1)
used by clinicians to##2##4##(1991-1#1)(2013-1#1)
used by general practitioners##2##4##(1997-4#2)
used by health care organizations##2##5##(1994-2#1)(2008-11#1)
used by many##3##3##(2008-11#2)(2012-2#1)
used by medical##3##3##(2008-10#1)(2009-6#2)
used by the elderly##2##4##(1993-3#2)
used by the##17##3##(1991-2#1)(1993-3#2)(1995-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-1#2)
used by##84##2##(1990-11#1)(1990-12#4)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-3#4)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-9#1)(2007-8#1)(2008-10#15)(2008-11#5)(2008-12#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#2)
used clinically##2##2##(2010-7#1)(2012-2#1)
used commercially##4##2##(2008-10#3)(2008-12#1)
used conventional pesticide##2##3##(2008-10#2)
used correctly##2##2##(1991-9#1)(2013-8#1)
used data##4##2##(1995-12#1)(2008-11#1)(2010-8#1)(2012-2#1)
used detection technique##2##3##(2008-10#2)
used detection##3##2##(2008-10#2)(2008-9#1)
used directly##5##2##(1995-6#1)(2008-10#2)(2008-5#1)(2011-1#1)
used drugs##3##2##(1994-12#1)(2008-11#1)(2010-12#1)
used during##10##2##(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
used effectively##4##2##(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
used extensively in##3##3##(1995-12#1)(1997-3#1)(2008-10#1)
used extensively to##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)
used extensively##9##2##(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-9#1)
used extraction##2##2##(2008-10#2)
used fewer##2##2##(1991-12#1)(1995-3#1)
used focus##2##2##(1994-12#1)(2011-2#1)
used for MT##2##3##(2008-10#2)
used for a period of##4##5##(2008-10#4)
used for a##15##3##(1994-1#1)(1996-8#1)(2008-1#1)(2008-10#9)(2008-9#1)(2010-10#1)(2012-2#1)
used for all##3##3##(1996-1#1)(2008-10#1)(2008-3#1)
used for analysing##2##3##(1994-3#1)(2011-2#1)
used for analysis of##5##4##(2008-10#4)(2010-1#1)
used for analysis##8##3##(2008-10#5)(2010-1#1)(2010-6#1)(2012-12#1)
used for animal##2##3##(2008-10#1)(2010-1#1)
used for assessment##2##3##(2008-10#1)(2013-8#1)
used for at least##15##4##(2008-10#15)
used for biological##2##3##(2008-10#1)(2008-7#1)
used for both##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)
used for building##2##3##(2008-10#2)
used for calibration##6##3##(2008-10#5)(2008-9#1)
used for carrying out##2##4##(2008-10#1)(2008-9#1)
used for clinical##3##3##(2008-7#1)(2010-11#1)(2013-8#1)
used for column##2##3##(2008-10#2)
used for comparison##7##3##(2008-10#4)(2008-5#1)(2010-8#2)
used for constructing##3##3##(2008-10#3)
used for creating##2##3##(2008-10#1)(2008-8#1)
used for designing a##2##4##(2008-4#1)(2012-12#1)
used for detecting##2##3##(2008-10#1)(2008-9#1)
used for detection##4##3##(2008-10#4)
used for determination of##19##4##(2008-10#18)(2008-7#1)
used for determining the##5##4##(2008-3#4)(2008-5#1)
used for determining##11##3##(2008-10#4)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)
used for diagnosis and##2##4##(1990-3#1)(1991-6#1)
used for diagnosis##3##3##(1990-3#1)(1991-6#1)(2011-2#1)
used for direct determination of##2##5##(2008-10#2)
used for direct##5##3##(2008-10#4)(2008-4#1)
used for each##4##3##(1990-5#1)(2008-10#3)
used for enhancing##2##3##(2008-10#2)
used for enrichment##2##3##(2008-10#2)
used for estimation of##2##4##(2008-3#1)(2013-1#1)
used for evaluating##3##3##(2008-10#2)(2011-2#1)
used for evaluation of##4##4##(2008-10#1)(2008-7#2)(2008-9#1)
used for evaluation##9##3##(1996-9#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
used for examining##2##3##(2008-10#1)(2008-11#1)
used for extraction##3##3##(2008-10#3)
used for fixation##3##3##(2008-10#2)(2009-3#1)
used for further##3##3##(2008-10#2)(2008-9#1)
used for identification##3##3##(1997-7#1)(2008-10#2)
used for in vitro##3##4##(2008-11#1)(2008-4#1)(2008-5#1)
used for in##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
used for isolation of##2##4##(2008-9#1)(2011-2#1)
used for its determination##4##4##(1997-2#2)(2008-10#2)
used for its##6##3##(1997-2#2)(2008-10#2)(2011-2#2)
used for mammalian##2##3##(2008-11#1)(2008-9#1)
used for many##2##3##(2007-8#1)(2008-7#1)
used for measuring the##3##4##(1996-6#1)(2008-10#1)(2008-8#1)
used for measuring##7##3##(1990-11#1)(1992-1#1)(1996-6#1)(2008-10#2)(2008-3#1)(2008-8#1)
used for metal##2##3##(2008-10#1)(2008-8#1)
used for microbial##2##3##(2008-11#2)
used for modeling the##2##4##(2008-10#1)(2013-1#1)
used for modeling##3##3##(2008-10#1)(2013-1#2)
used for monitoring##4##3##(2008-10#4)
used for more than##11##4##(2008-10#10)(2011-2#1)
used for more##12##3##(2008-10#11)(2011-2#1)
used for numerical##2##3##(2008-10#1)(2008-3#1)
used for on-line##2##3##(2008-10#2)
used for preconcentration of##4##4##(2008-10#4)
used for preparation of##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
used for prevention##2##3##(1996-11#1)(2012-3#1)
used for propagating##2##3##(2008-3#1)(2008-4#1)
used for providing##2##3##(1997-3#1)(2012-12#1)
used for quantification of##3##4##(2008-10#3)
used for quantification##6##3##(2008-10#5)(2008-11#1)
used for quantitative analysis##3##4##(2008-10#3)
used for quantitative##5##3##(2008-10#5)
used for rapid##3##3##(2008-10#1)(2008-4#1)(2010-6#1)
used for reliable##2##3##(1993-2#1)(2008-10#1)
used for sample##3##3##(2008-10#3)
used for screening##2##3##(2008-8#1)(2012-2#1)
used for selecting##2##3##(2008-10#1)(2008-9#1)
used for selection of##2##4##(2008-10#1)(2011-2#1)
used for sensitive##3##3##(2008-10#2)(2008-3#1)
used for simultaneous determination##2##4##(2008-10#2)
used for simultaneous##5##3##(2008-10#3)(2008-9#1)(2011-3#1)
used for statistical analysis##2##4##(1996-12#1)(2012-3#1)
used for statistical##4##3##(1996-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
used for studying##6##3##(1994-11#1)(1996-2#1)(2008-10#4)
used for such##2##3##(2008-8#1)(2012-2#1)
used for surface##2##3##(2008-10#2)
used for synthesis of##2##4##(2008-4#2)
used for the amplification of##2##5##(1993-2#1)(2008-10#1)
used for the analysis of##3##5##(2008-10#3)
used for the analysis##4##4##(2008-10#4)
used for the assay of##5##5##(2008-10#5)
used for the assessment of##2##5##(2008-10#2)
used for the calculations##2##4##(2008-10#2)
used for the construction of##2##5##(2008-10#2)
used for the control of##2##5##(2008-10#2)
used for the design of##3##5##(2008-11#1)(2009-3#1)(2011-2#1)
used for the detection of##7##5##(2008-10#7)
used for the determination of Cu(II)##2##6##(2008-10#2)
used for the determination of Se##2##6##(2008-10#2)
used for the determination of the##5##6##(2008-10#5)
used for the determination of these##2##6##(2008-10#2)
used for the determination of trace##6##6##(2008-10#6)
used for the determination of##63##5##(2008-10#61)(2008-7#1)(2013-1#1)
used for the development of##3##5##(2008-10#3)
used for the diagnosis and##2##5##(2008-4#1)(2010-12#1)
used for the diagnosis##3##4##(1997-8#1)(2008-4#1)(2010-12#1)
used for the estimation of##3##5##(2008-10#2)(2008-4#1)
used for the evaluation of##4##5##(1990-11#1)(2008-10#3)
used for the extraction of##3##5##(2008-10#3)
used for the extraction##4##4##(2008-10#4)
used for the first time to study##2##7##(2008-10#2)
used for the first time to##3##6##(2008-10#3)
used for the first time##4##5##(2008-10#4)
used for the identification of##4##5##(2008-10#3)(2008-9#1)
used for the identification##5##4##(2008-10#4)(2008-9#1)
used for the investigation of the##2##6##(2008-10#1)(2010-12#1)
used for the optimization of##2##5##(2008-10#1)(2008-3#1)
used for the preconcentration and separation of##2##7##(2008-10#2)
used for the preconcentration and##3##5##(2008-10#3)
used for the preconcentration of##3##5##(2008-10#3)
used for the preconcentration##6##4##(2008-10#6)
used for the preparation of##2##5##(2008-8#1)(2012-3#1)
used for the production of recombinant proteins##3##7##(2008-11#3)
used for the production of##6##5##(2008-11#5)(2008-8#1)
used for the purification##2##4##(2008-10#2)
used for the quantification of##3##5##(1990-12#1)(2008-10#2)
used for the quantitative determination of##4##6##(2008-10#4)
used for the quantitative##5##4##(2008-10#5)
used for the rapid##2##4##(2008-10#1)(2010-9#1)
used for the same##2##4##(2008-10#2)
used for the selective##4##4##(2008-10#4)
used for the sensitive determination of##2##6##(2008-10#2)
used for the separation and##2##5##(2008-10#2)
used for the separation of##3##5##(2008-10#2)(2008-11#1)
used for the separation##6##4##(2008-10#5)(2008-11#1)
used for the simultaneous determination of##4##6##(2008-10#4)
used for the simultaneous##6##4##(2008-10#6)
used for the spectrophotometric determination of##2##6##(2008-10#2)
used for the study of##3##5##(2008-10#3)
used for the study##4##4##(2008-10#3)(2011-2#1)
used for the synthesis of##2##5##(2008-7#1)(2009-10#1)
used for the treatment of breast##2##6##(1992-9#1)(1993-1#1)
used for the vanadium##2##4##(2008-10#2)
used for the##276##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-3#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#215)(2008-11#17)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#3)(2010-8#2)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
used for their##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
used for this purpose##9##4##(1995-5#1)(2008-10#6)(2008-11#1)(2012-2#1)
used for this##15##3##(1993-3#1)(1995-5#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
used for training##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
used for treating##4##3##(1992-3#1)(2008-10#1)(2009-8#1)(2012-2#1)
used for treatment of##5##4##(1992-1#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-6#1)
used for treatment##6##3##(1992-1#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-6#1)(2013-8#1)
used for viral##2##3##(2008-8#1)(2011-3#1)
used for##905##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#3)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#5)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#535)(2008-11#56)(2008-12#11)(2008-2#4)(2008-3#24)(2008-4#21)(2008-5#13)(2008-6#1)(2008-7#17)(2008-8#12)(2008-9#19)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#5)(2010-3#1)(2010-4#1)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#26)(2011-3#2)(2012-12#5)(2012-2#9)(2012-3#6)(2013-1#16)(2013-8#7)
used four##4##2##(2008-10#2)(2013-1#1)(2013-8#1)
used from##3##2##(2008-10#1)(2009-12#1)(2010-6#1)
used functional magnetic##2##3##(2008-11#2)
used had##3##2##(2008-10#1)(2009-7#1)(2012-3#1)
used have##2##2##(2008-10#1)(2011-2#1)
used here was##2##3##(1993-1#1)(2012-3#1)
used here##13##2##(1993-1#1)(1994-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
used implant##2##2##(2011-2#2)
used implants##2##2##(2011-2#2)
used in 7##2##3##(2008-7#1)(2012-2#1)
used in Japan##4##3##(2008-10#2)(2008-11#1)(2010-6#1)
used in PVC pipe production##2##5##(2008-10#2)
used in a model for##2##5##(1996-3#1)(2008-7#1)
used in a multiplex##2##4##(2008-10#2)
used in a variety of##4##5##(1996-1#1)(1997-3#1)(2010-1#1)(2010-4#1)
used in a##50##3##(1993-6#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#29)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
used in all##9##3##(2008-10#5)(2008-7#1)(2011-2#2)(2011-7#1)
used in an##9##3##(1994-5#1)(1996-9#1)(2008-10#6)(2008-3#1)
used in apple breeding programs##2##5##(2008-10#2)
used in association##2##3##(2008-10#2)
used in both##5##3##(1992-12#1)(1993-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
used in clinical practice##4##4##(2008-11#1)(2010-11#1)(2010-12#1)(2011-1#1)
used in clinical##11##3##(1992-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)
used in combination with a##2##5##(2008-10#1)(2008-2#1)
used in combination with##9##4##(1992-1#1)(1993-3#1)(2008-10#4)(2008-2#1)(2010-7#1)(2013-1#1)
used in combination##13##3##(1992-1#1)(1993-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2010-11#1)(2010-7#1)(2013-1#1)
used in conjunction with a##3##5##(1992-9#1)(2008-10#1)(2008-3#1)
used in conjunction with an##2##5##(1996-2#1)(2008-3#1)
used in conjunction with the##2##5##(2008-10#2)
used in conjunction with##19##4##(1992-9#1)(1996-2#1)(1996-9#1)(1997-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)
used in connection with##3##4##(2008-10#3)
used in cosmetics##3##3##(2008-5#3)
used in current##2##3##(2008-2#1)(2011-2#1)
used in determination of nickel and##2##6##(2008-10#2)
used in determination of##3##4##(2008-10#3)
used in developing##2##3##(1997-3#1)(2008-10#1)
used in diabetes##2##3##(2010-7#2)
used in different studies##2##4##(2012-2#2)
used in different##5##3##(2008-10#1)(2008-11#1)(2010-9#1)(2012-2#2)
used in each##3##3##(1994-3#1)(2008-10#2)
used in food##3##3##(1994-3#1)(2008-10#1)(2012-2#1)
used in high##2##3##(2008-12#1)(2012-12#1)
used in industry##2##3##(1994-12#1)(2008-11#1)
used in isolation##2##3##(2008-10#1)(2008-7#1)
used in many##2##3##(2008-10#1)(2008-3#1)
used in mate##2##3##(2008-8#1)(2008-9#1)
used in measuring##2##3##(1997-1#1)(2008-10#1)
used in optical##2##3##(2008-10#1)(2010-12#1)
used in order to##15##4##(1991-6#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)
used in our##5##3##(1995-1#1)(2008-3#2)(2010-6#1)(2013-8#1)
used in pictorial works of art prior to conservation or restoration##2##11##(2008-10#2)
used in pictorial works of art##3##6##(2008-10#3)
used in place of the##2##5##(2008-10#1)(2012-2#1)
used in practice##2##3##(1994-9#1)(2013-8#1)
used in prevention of##2##4##(2011-3#1)(2012-3#1)
used in rice##2##3##(2008-10#1)(2009-10#1)
used in skin##2##3##(2009-6#1)(2012-3#1)
used in some##2##3##(2008-10#1)(2011-2#1)
used in studies of##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
used in such##2##3##(2008-10#1)(2008-12#1)
used in the United States##2##5##(2011-2#1)(2012-3#1)
used in the analysis##6##4##(1990-2#1)(1992-3#1)(2008-10#2)(2008-4#1)(2008-6#1)
used in the calibration##4##4##(2008-10#4)
used in the community##2##4##(2008-11#1)(2009-3#1)
used in the context of##2##5##(2009-6#1)(2010-11#1)
used in the determination of##6##5##(2008-10#6)
used in the development of##2##5##(2008-10#2)
used in the diagnosis of##2##5##(1997-8#1)(2011-2#1)
used in the diagnosis##3##4##(1997-8#1)(2011-2#1)(2012-2#1)
used in the evaluation of##2##5##(1990-5#1)(2010-10#1)
used in the field of##3##5##(2008-10#2)(2011-2#1)
used in the field##4##4##(1995-12#1)(2008-10#2)(2011-2#1)
used in the hidden##6##4##(2008-10#4)(2010-8#2)
used in the identification##3##4##(1995-11#1)(2008-10#1)(2012-2#1)
used in the management of##2##5##(2008-1#1)(2011-2#1)
used in the manufacture of##2##5##(1996-9#1)(2008-11#1)
used in the model##2##4##(2008-10#2)
used in the potentiometric titration of Cu(2+) with EDTA##2##9##(2008-10#2)
used in the potentiometric titration of##4##6##(2008-10#4)
used in the preparation of##3##5##(2008-10#2)(2008-12#1)
used in the present##3##4##(2008-10#2)(2013-8#1)
used in the same sample treatment)##2##6##(2008-10#2)
used in the separation##2##4##(2008-10#2)
used in the study##7##4##(1990-6#1)(1996-1#1)(2008-10#3)(2010-8#1)(2013-1#1)
used in the treatment of##14##5##(1992-3#1)(1994-5#1)(1995-11#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-12#1)(2013-1#1)
used in the##191##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-3#3)(1992-6#2)(1993-1#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#90)(2008-11#12)(2008-12#3)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#4)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#1)
used in these experiments##2##4##(2008-10#2)
used in these studies##2##4##(2008-11#1)(2008-9#1)
used in these##5##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
used in this field##2##4##(2008-10#2)
used in this investigation##2##4##(2008-10#1)(2008-11#1)
used in this manual##3##4##(2008-9#3)
used in this method##2##4##(2008-10#2)
used in this study##29##4##(1993-8#1)(1996-12#1)(1996-8#2)(1997-8#2)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
used in this work##6##4##(2008-10#6)
used in this##50##3##(1993-8#1)(1996-12#1)(1996-8#2)(1997-8#2)(2008-10#20)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-2#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
used in traditional##2##3##(2008-10#1)(2013-1#1)
used in various##2##3##(2008-9#2)
used in vitro##2##3##(1990-12#1)(2011-3#1)
used in##730##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#3)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#3)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-6#2)(1996-1#3)(1996-12#5)(1996-2#2)(1996-3#3)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2007-12#1)(2008-1#3)(2008-10#286)(2008-11#44)(2008-12#14)(2008-2#4)(2008-3#25)(2008-4#9)(2008-5#16)(2008-6#6)(2008-7#16)(2008-8#11)(2008-9#23)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#4)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#4)(2010-10#3)(2010-11#7)(2010-12#5)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#6)(2010-8#9)(2010-9#1)(2011-1#4)(2011-2#21)(2011-3#3)(2011-7#1)(2012-12#4)(2012-2#18)(2012-3#16)(2013-1#20)(2013-8#8)
used included##3##2##(1996-8#1)(2008-12#2)
used increasingly##3##2##(1992-3#1)(1992-5#1)(2008-10#1)
used individually##2##2##(1996-1#1)(2008-10#1)
used instead of##4##3##(1990-11#1)(2008-10#2)(2011-2#1)
used instead##6##2##(1990-11#1)(2008-10#4)(2011-2#1)
used is a##3##3##(2008-10#2)(2008-11#1)
used is##9##2##(1994-3#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)
used it to##3##3##(1991-12#1)(2008-11#1)(2012-3#1)
used it##4##2##(1991-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
used lubricating oil##2##3##(2008-10#2)
used lubricating oils by##3##4##(2008-10#3)
used lubricating oils##5##3##(2008-10#5)
used lubricating##7##2##(2008-10#7)
used mainly##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
used many##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
used measures of##2##3##(2008-10#1)(2010-11#1)
used medicines classified##2##3##(2008-11#2)
used method##3##2##(2008-4#1)(2008-9#1)(2013-8#1)
used methods that##2##3##(2008-10#1)(2008-2#1)
used methods to##2##3##(2008-4#1)(2008-9#1)
used methods##10##2##(2008-10#6)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
used misoprostol##2##2##(2008-11#2)
used modality##2##2##(2012-12#1)(2012-3#1)
used models##2##2##(1993-12#1)(2008-8#1)
used molecular##3##2##(1992-9#1)(2008-10#2)
used more often##2##3##(2008-11#1)(2009-12#1)
used more##7##2##(1994-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)
used multiple##2##2##(2008-10#1)(2010-11#1)
used new##2##2##(2008-10#1)(2011-2#1)
used not only##3##3##(2008-10#2)(2011-2#1)
used on the##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
used on##15##2##(1992-12#1)(1995-5#1)(1996-12#1)(1997-4#1)(2008-10#6)(2008-2#1)(2008-5#1)(2009-5#1)(2013-8#2)
used once##2##2##(2008-11#1)(2008-5#1)
used one##2##2##(2008-10#1)(2010-1#1)
used only as##2##3##(1994-12#1)(2008-5#1)
used only##8##2##(1992-12#1)(1993-2#1)(1994-12#1)(2008-10#2)(2008-5#1)(2012-2#2)
used or##6##2##(2008-10#2)(2008-8#1)(2010-5#1)(2012-12#2)
used organic##2##2##(2008-10#1)(2008-5#1)
used over a period of##3##5##(2008-10#3)
used over a##5##3##(2008-10#5)
used pesticides##2##2##(2008-10#2)
used previously##3##2##(2008-10#2)(2011-3#1)
used primarily to##3##3##(1991-6#1)(2008-10#1)(2013-1#1)
used primarily##6##2##(1991-6#1)(1995-1#1)(2008-10#2)(2008-8#1)(2013-1#1)
used prior to##5##3##(1992-2#1)(2008-10#3)(2010-8#1)
used psilocybin##2##2##(2013-8#2)
used qualitative##2##2##(2009-5#1)(2013-1#1)
used quantitative##2##2##(2008-12#1)(2012-3#1)
used repeatedly for##2##3##(2008-10#2)
used reverse##2##2##(1994-11#1)(2010-5#1)
used rockwool##6##2##(2008-10#6)
used rodent##2##2##(2008-11#1)(2012-3#1)
used routinely##2##2##(2008-10#1)(2013-1#1)
used safely##3##2##(1995-8#1)(2010-6#1)(2012-12#1)
used significantly##2##2##(2008-10#1)(2008-7#1)
used since##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
used solely##2##2##(2011-2#1)(2011-3#1)
used solid##2##2##(2008-10#2)
used successfully for the##4##4##(1997-2#1)(2008-10#3)
used successfully for##8##3##(1997-2#1)(2008-10#5)(2008-2#1)(2009-3#1)
used successfully in the##2##4##(2008-10#1)(2009-10#1)
used successfully in##4##3##(2008-10#2)(2009-10#1)(2010-11#1)
used successfully to##2##3##(2008-5#1)(2012-2#1)
used successfully##14##2##(1997-2#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-2#1)
used test##3##2##(2008-5#2)(2012-12#1)
used the in##2##3##(1994-8#1)(1996-2#1)
used the same##5##3##(1994-1#1)(2008-10#2)(2008-3#1)(2011-2#1)
used the##57##2##(1990-7#1)(1991-3#1)(1992-2#1)(1992-9#1)(1994-1#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(2008-10#13)(2008-11#9)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
used their##3##2##(2010-8#1)(2010-9#1)(2013-8#1)
used them##2##2##(1991-3#1)(2008-8#1)
used these##3##2##(1994-3#1)(2008-11#1)(2008-8#1)
used this##12##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2012-2#3)(2013-1#1)
used three##2##2##(2008-10#1)(2013-8#1)
used throughout the##2##3##(2008-4#1)(2011-2#1)
used throughout##5##2##(2008-10#3)(2008-4#1)(2011-2#1)
used to ablate##2##3##(1991-2#1)(2013-1#1)
used to achieve the##2##4##(2008-11#1)(2013-8#1)
used to achieve##9##3##(2008-10#5)(2008-11#2)(2012-3#1)(2013-8#1)
used to address##4##3##(1995-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
used to aid##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
used to amplify a##2##4##(2008-10#2)
used to amplify the##5##4##(1991-7#1)(2008-10#3)(2008-8#1)
used to amplify##11##3##(1991-7#1)(1992-6#1)(2008-10#8)(2008-8#1)
used to analyse the##3##4##(1993-2#1)(2008-12#1)(2010-11#1)
used to analyse##8##3##(1993-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-11#1)
used to analyze the data##2##5##(2008-10#1)(2011-2#1)
used to analyze the##13##4##(1992-1#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
used to analyze##28##3##(1990-11#1)(1992-1#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
used to ascertain##2##3##(2008-10#2)
used to assay##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
used to assess a##2##4##(2008-10#1)(2008-11#1)
used to assess its##2##4##(2008-11#2)
used to assess the impact of##3##6##(1992-2#1)(2008-10#1)(2008-11#1)
used to assess the##20##4##(1992-2#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
used to assess whether the##2##5##(2008-10#1)(2013-1#1)
used to assess##52##3##(1990-7#1)(1992-2#1)(1993-1#1)(1995-2#1)(1997-2#1)(2008-10#16)(2008-11#6)(2008-5#4)(2008-7#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
used to assign##2##3##(1996-2#1)(1996-5#1)
used to assist in##2##4##(1996-2#1)(2008-10#1)
used to be##4##3##(1996-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
used to calculate the##22##4##(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-7#1)
used to calculate##31##3##(1994-12#1)(1995-9#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-8#2)(2010-7#1)
used to calibrate##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
used to carry out the##2##5##(2008-10#2)
used to carry out##3##4##(2008-10#2)(2012-2#1)
used to carry##4##3##(2008-10#3)(2012-2#1)
used to characterise the##2##4##(2008-10#2)
used to characterise##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
used to characterize the##15##4##(1994-5#1)(1995-12#1)(2008-1#1)(2008-10#10)(2008-3#2)
used to characterize##30##3##(1994-11#1)(1994-5#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-3#3)(2008-7#1)(2008-9#1)(2012-2#1)
used to classify##4##3##(1993-12#1)(1995-2#1)(2008-11#1)(2008-5#1)
used to clean##2##3##(2008-10#2)
used to cleave##2##3##(2008-11#1)(2008-8#1)
used to collect data##6##4##(1992-2#1)(2008-11#2)(2010-10#1)(2012-3#2)
used to collect the##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
used to collect##13##3##(1992-2#1)(2008-10#2)(2008-11#4)(2008-9#1)(2010-10#1)(2010-8#1)(2012-3#3)
used to compare the##10##4##(1993-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)
used to compare##19##3##(1993-12#1)(1994-5#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#2)(2010-9#2)(2011-1#1)
used to complete##2##3##(2008-10#1)(2008-8#1)
used to compute the##2##4##(2008-3#1)(2008-8#1)
used to compute##5##3##(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)
used to concentrate##4##3##(2008-10#4)
used to confirm QTL associations detected in the##2##8##(2008-10#2)
used to confirm the presence of##2##6##(2008-10#1)(2011-2#1)
used to confirm the##4##4##(2008-10#2)(2011-2#1)(2012-2#1)
used to confirm##8##3##(2008-10#5)(2008-5#1)(2011-2#1)(2012-2#1)
used to construct a##11##4##(1992-3#1)(1996-6#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-1#1)
used to construct the##2##4##(2008-10#1)(2008-8#1)
used to construct##18##3##(1992-3#1)(1996-6#1)(1997-2#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#1)
used to control for the##2##5##(2008-9#1)(2012-2#1)
used to control##14##3##(1994-12#1)(1996-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
used to convert##2##3##(2008-2#1)(2008-3#1)
used to create the##2##4##(2008-10#1)(2009-7#1)
used to create##8##3##(1993-2#1)(1995-6#1)(2008-10#3)(2009-11#1)(2009-7#1)(2010-4#1)
used to deduce##2##3##(1997-6#1)(2008-8#1)
used to define the##4##4##(1994-2#1)(1997-3#1)(2008-11#1)(2010-10#1)
used to define##6##3##(1990-11#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-10#1)
used to deliver##4##3##(2008-5#1)(2009-10#2)(2009-2#1)
used to demonstrate that##5##4##(1991-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
used to demonstrate the feasibility of##3##6##(2008-10#2)(2008-11#1)
used to demonstrate the##11##4##(1994-11#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-9#1)
used to demonstrate##17##3##(1990-11#1)(1991-2#1)(1994-11#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)
used to derive the##2##4##(2008-11#1)(2008-3#1)
used to derive##9##3##(2008-10#1)(2008-11#3)(2008-3#3)(2008-9#1)(2011-2#1)
used to describe the##10##4##(1994-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2010-12#1)
used to describe##21##3##(1990-11#1)(1990-9#1)(1991-2#1)(1993-3#1)(1994-2#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#4)(2008-3#2)(2008-9#1)(2010-12#1)(2013-1#1)
used to design primers for##2##5##(2008-10#1)(2008-11#1)
used to design primers##3##4##(2008-10#2)(2008-11#1)
used to design##11##3##(1993-12#1)(2008-10#9)(2008-11#1)
used to detect DNA##2##4##(2008-4#2)
used to detect P##2##4##(2008-10#2)
used to detect and##3##4##(2008-10#2)(2008-2#1)
used to detect microbial##2##4##(2008-11#2)
used to detect the##7##4##(2008-10#6)(2009-5#1)
used to detect##46##3##(1996-2#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-9#3)(2009-3#1)(2009-5#1)(2010-6#1)
used to determination of##2##4##(2008-10#2)
used to determine both metals in##2##6##(2008-10#2)
used to determine both##3##4##(2008-10#2)(2008-3#1)
used to determine that##3##4##(1993-8#1)(2008-10#1)(2008-3#1)
used to determine the composition of##2##6##(1990-9#1)(1992-1#1)
used to determine the concentration of##5##6##(1991-12#1)(2008-10#3)(2008-9#1)
used to determine the effects of##2##6##(2008-1#1)(2011-2#1)
used to determine the low##2##5##(2008-10#2)
used to determine the nature of the##2##7##(1991-2#1)(2008-10#1)
used to determine the relative##2##5##(2008-11#1)(2008-5#1)
used to determine the##62##4##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#32)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#2)
used to determine whether the##2##5##(1993-8#1)(2008-2#1)
used to determine whether##8##4##(1993-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2013-8#1)
used to determine##143##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#92)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
used to develop a simple##2##5##(2008-10#2)
used to develop a##8##4##(1990-12#1)(1994-5#1)(1996-3#1)(2008-10#4)(2008-3#1)
used to develop an##7##4##(1993-3#1)(2008-10#4)(2008-12#1)(2013-1#1)
used to develop the##7##4##(2008-10#4)(2008-11#1)(2008-12#1)(2013-8#1)
used to develop##37##3##(1990-12#1)(1993-3#2)(1994-5#2)(1995-1#1)(1996-2#1)(1996-3#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
used to diagnose##5##3##(1997-3#2)(2008-10#2)(2013-1#1)
used to differentiate##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-5#1)
used to direct the##2##4##(2008-7#2)
used to directly##5##3##(1995-3#1)(2008-10#3)(2008-7#1)
used to discover##2##3##(2008-10#1)(2008-9#1)
used to discriminate##3##3##(2008-10#2)(2008-7#1)
used to distinguish##6##3##(1993-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2013-8#1)
used to draw##2##3##(1990-9#1)(2010-3#1)
used to drive the##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
used to effectively##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
used to eliminate##2##3##(2008-10#1)(2008-8#1)
used to elucidate the##3##4##(2008-10#2)(2009-7#1)
used to elucidate##4##3##(2008-10#3)(2009-7#1)
used to enhance the##9##4##(2008-10#5)(2008-3#2)(2009-10#1)(2012-2#1)
used to enhance##13##3##(2008-10#6)(2008-11#3)(2008-3#2)(2009-10#1)(2012-2#1)
used to establish a##2##4##(2008-11#2)
used to establish the calibration##2##5##(2008-10#2)
used to establish the##3##4##(2008-10#3)
used to establish##12##3##(1991-1#1)(2008-10#4)(2008-11#4)(2008-3#1)(2011-2#1)(2012-2#1)
used to estimate the potential##3##5##(1991-3#1)(2008-10#2)
used to estimate the##30##4##(1991-3#1)(1994-3#1)(1995-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#3)(2008-7#3)(2010-6#1)(2011-2#1)
used to estimate##44##3##(1990-9#1)(1991-3#1)(1994-3#1)(1995-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#3)(2008-8#3)(2010-6#1)(2010-8#1)(2011-2#2)
used to evaluate the association between##2##6##(2013-1#2)
used to evaluate the relative##2##5##(2008-10#1)(2011-2#1)
used to evaluate the##29##4##(1991-1#1)(1993-1#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#14)(2008-11#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
used to evaluate##41##3##(1991-1#1)(1991-3#1)(1993-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#18)(2008-11#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
used to examine the effect of##2##6##(1991-10#1)(1996-12#1)
used to examine the relationships between##2##6##(2008-10#1)(2009-12#1)
used to examine the##19##4##(1991-10#1)(1991-5#1)(1994-11#1)(1995-3#1)(1996-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-1#1)
used to examine whether##2##4##(2008-10#1)(2008-12#1)
used to examine##32##3##(1991-10#1)(1991-5#1)(1994-11#1)(1995-3#1)(1996-12#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
used to expand##2##3##(2008-10#1)(2008-5#1)
used to explain the##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
used to explain##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
used to explore the##5##4##(2008-1#1)(2009-12#1)(2009-5#1)(2010-10#1)(2012-2#1)
used to explore##9##3##(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2012-2#1)
used to express##6##3##(1993-6#1)(2008-11#2)(2008-7#2)(2008-9#1)
used to extend the##3##4##(2008-10#2)(2009-3#1)
used to extract the##2##4##(2008-10#2)
used to extract##13##3##(2008-10#13)
used to fabricate##5##3##(2008-10#1)(2008-12#1)(2008-7#2)(2013-1#1)
used to find the##4##4##(2008-10#4)
used to find##10##3##(2008-10#8)(2008-3#1)(2011-2#1)
used to fit the models##2##5##(2008-9#2)
used to fit the##3##4##(2008-10#1)(2008-9#2)
used to fit##5##3##(2008-10#2)(2008-11#1)(2008-9#2)
used to follow the##3##4##(1991-12#1)(2008-10#2)
used to follow##9##3##(1990-11#1)(1991-12#1)(1996-12#1)(2008-10#6)
used to form##3##3##(2008-10#2)(2008-2#1)
used to further##4##3##(2008-10#3)(2008-3#1)
used to generate a##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
used to generate the##3##4##(1995-2#1)(2008-10#1)(2010-5#1)
used to generate##18##3##(1995-2#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2009-8#1)(2010-5#1)(2011-3#1)(2012-2#1)
used to give##2##3##(2008-10#1)(2008-3#1)
used to grow##3##3##(2008-10#1)(2008-7#2)
used to guide the choice of##2##6##(2008-10#1)(2013-1#1)
used to guide##4##3##(2008-10#1)(2013-1#3)
used to help##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)
used to identify and##4##4##(1993-3#1)(1994-8#1)(2008-10#1)(2011-2#1)
used to identify molecular markers##2##5##(2008-10#2)
used to identify the##16##4##(1995-2#1)(2008-10#4)(2008-12#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
used to identify##73##3##(1990-11#1)(1993-12#2)(1993-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1997-3#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#2)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#6)(2013-8#3)
used to illustrate the##6##4##(1992-9#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-4#1)
used to illustrate##8##3##(1992-9#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-4#2)
used to image##3##3##(1990-11#1)(2008-2#1)(2012-2#1)
used to implement the##2##4##(1995-2#1)(2008-3#1)
used to implement##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
used to improve the##9##4##(1994-3#1)(2008-10#5)(2008-3#1)(2009-6#1)(2013-1#1)
used to improve##12##3##(1994-3#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-10#1)(2009-6#1)(2013-1#1)
used to increase the##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-3#1)
used to increase##6##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-3#1)
used to indicate the##2##4##(1992-6#1)(2008-12#1)
used to indicate##3##3##(1991-6#1)(1992-6#1)(2008-12#1)
used to induce##4##3##(2008-11#1)(2008-3#1)(2008-8#2)
used to infect##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
used to infer##3##3##(2008-3#1)(2010-3#1)(2013-8#1)
used to inhibit the##2##4##(2008-3#1)(2008-8#1)
used to inoculate##5##3##(2008-10#5)
used to interpret##2##3##(2008-10#1)(2008-9#1)
used to introduce##3##3##(1994-5#1)(2008-10#2)
used to investigate the effects of##3##6##(2008-2#1)(2008-8#1)(2009-8#1)
used to investigate the feasibility of##2##6##(2008-10#1)(2008-3#1)
used to investigate the role of##2##6##(2008-11#1)(2011-2#1)
used to investigate the##34##4##(1990-2#1)(1991-5#1)(1992-12#1)(1994-5#2)(1996-12#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-8#2)
used to investigate##46##3##(1990-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-5#2)(1994-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#2)(2010-6#1)(2011-2#2)(2012-3#2)(2013-8#2)
used to isolate##6##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-8#1)
used to know##2##3##(2008-10#1)(2008-11#1)
used to label##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
used to maintain##4##3##(2008-10#3)(2008-7#1)
used to make##4##3##(2008-10#1)(2008-9#1)(2010-10#1)(2013-1#1)
used to manage##4##3##(2008-10#3)(2013-1#1)
used to manufacture##2##3##(2008-10#1)(2008-3#1)
used to map quantitative trait loci (QTL)##2##7##(2008-10#2)
used to map##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
used to measure the##15##4##(1990-12#1)(1992-12#1)(1994-5#1)(1994-9#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-3#1)
used to measure##47##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-5#1)(1994-9#1)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-3#1)(2013-1#3)
used to mimic##2##3##(1994-5#1)(2008-10#1)
used to minimize the##2##4##(1992-12#1)(2008-11#1)
used to minimize##3##3##(1992-12#1)(2008-11#1)(2008-12#1)
used to model the##6##4##(1994-5#1)(2008-10#4)(2009-7#1)
used to model##11##3##(1994-5#1)(2008-10#5)(2008-3#1)(2009-7#1)(2010-6#1)(2011-2#2)
used to modify the##2##4##(1992-9#1)(2009-7#1)
used to modify##5##3##(1992-9#1)(2008-10#2)(2009-7#1)(2013-8#1)
used to modulate the##2##4##(2008-11#1)(2008-3#1)
used to monitor the growth##2##5##(2008-10#1)(2008-11#1)
used to monitor the reaction##2##5##(1994-5#1)(2008-10#1)
used to monitor the##18##4##(1994-5#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-4#1)
used to monitor##37##3##(1990-2#1)(1991-5#1)(1994-5#1)(2008-10#24)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-5#1)
used to observe the##4##4##(2008-10#3)(2010-8#1)
used to observe##7##3##(1993-3#1)(2008-10#4)(2010-8#1)(2013-1#1)
used to obtain the analytical##2##5##(2007-11#1)(2008-10#1)
used to obtain the##7##4##(1993-8#1)(2007-11#1)(2008-10#3)(2008-8#1)(2013-8#1)
used to obtain##24##3##(1991-11#1)(1993-8#1)(1994-3#1)(1994-5#1)(2007-11#2)(2008-10#11)(2008-12#1)(2008-3#2)(2008-8#2)(2009-11#1)(2013-8#1)
used to optimize the##5##4##(2008-10#4)(2008-3#1)
used to optimize##7##3##(2008-10#4)(2008-3#1)(2008-5#2)
used to overcome##3##3##(1996-3#1)(2008-10#1)(2012-2#1)
used to parameterize##2##3##(2008-8#1)(2009-11#1)
used to perform a##2##4##(2008-2#1)(2012-2#1)
used to perform the##2##4##(2008-10#1)(2013-8#1)
used to perform##9##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
used to place the PVA isolates into##2##7##(2008-10#2)
used to place##3##3##(2008-10#2)(2009-11#1)
used to plot calibration curves##2##5##(2008-10#2)
used to precipitate##2##3##(2008-10#2)
used to preconcentrate##2##3##(2008-10#2)
used to predict the##9##4##(1992-4#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-6#1)(2013-8#1)
used to predict##25##3##(1992-4#1)(1996-1#1)(1996-12#1)(1997-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
used to prepare the##4##4##(2008-10#4)
used to prepare##11##3##(1990-11#1)(1991-2#2)(2008-10#7)(2012-2#1)
used to present the##2##4##(2008-10#2)
used to prevent##5##3##(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
used to probe the##5##4##(1990-8#1)(1992-6#1)(1995-6#1)(2008-10#2)
used to probe##10##3##(1990-8#1)(1991-12#2)(1992-6#1)(1995-6#1)(2008-10#4)(2008-8#1)
used to process##2##3##(2008-7#1)(2009-7#1)
used to produce a##2##4##(1992-9#1)(2008-2#1)
used to produce the##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2011-3#1)
used to produce##23##3##(1992-9#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#2)(2009-12#1)(2009-5#1)(2010-3#1)(2011-3#1)
used to promote##2##3##(2008-10#1)(2008-12#1)
used to protect##2##3##(1994-3#1)(2009-5#1)
used to prove##2##3##(2008-10#1)(2008-5#1)
used to provide a##4##4##(1997-8#1)(2008-11#1)(2008-2#1)(2008-4#1)
used to provide##9##3##(1991-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)
used to purify the##2##4##(1990-11#1)(1991-7#1)
used to purify##3##3##(1990-11#1)(1991-7#1)(1997-7#1)
used to quantify the##4##4##(1990-7#1)(2008-11#1)(2008-2#1)(2008-7#1)
used to quantify##19##3##(1990-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#2)
used to quantitate##5##3##(1990-12#1)(1992-12#1)(2008-10#1)(2008-4#2)
used to quantitatively##2##3##(2008-10#2)
used to rapidly##4##3##(2008-10#1)(2011-2#1)(2012-2#2)
used to reconstruct##3##3##(2008-3#1)(2008-8#1)(2010-6#1)
used to record##3##3##(2008-3#2)(2010-6#1)
used to recover##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
used to reduce the##5##4##(1991-12#1)(1995-12#1)(2008-10#2)(2012-2#1)
used to reduce##7##3##(1991-12#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2012-2#1)
used to refine##2##3##(2008-10#1)(2008-6#1)
used to relate##4##3##(2008-10#4)
used to reliably##2##3##(2008-10#1)(2008-3#1)
used to remove the##3##4##(2008-10#3)
used to remove##10##3##(1990-12#1)(1991-6#1)(2008-10#6)(2008-6#1)(2011-2#1)
used to represent##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
used to resolve##2##3##(2008-10#1)(2008-11#1)
used to retrieve##2##3##(2008-2#1)(2013-1#1)
used to reveal##2##3##(2008-10#2)
used to sample##4##3##(2008-10#4)
used to screen the##2##4##(1997-8#1)(2008-8#1)
used to screen##10##3##(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#3)(2008-9#2)(2013-8#1)
used to search for##2##4##(2008-10#1)(2013-1#1)
used to search##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
used to select##13##3##(2008-10#9)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
used to selectively##2##3##(2008-10#2)
used to separate##11##3##(1992-12#1)(2008-10#10)
used to set##3##3##(1991-2#1)(1992-2#1)(1997-3#1)
used to show that the##2##5##(2008-10#1)(2008-11#1)
used to show that##6##4##(1991-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-8#1)
used to show##7##3##(1991-3#1)(1994-9#1)(2008-10#3)(2008-11#1)(2008-8#1)
used to simulate the##2##4##(2008-3#1)(2008-6#1)
used to simulate##4##3##(1990-11#1)(2008-3#1)(2008-6#1)(2010-5#1)
used to solve##4##3##(2008-11#1)(2008-9#1)(2009-12#1)(2010-7#1)
used to stabilize##2##3##(1994-9#1)(2008-10#1)
used to study basic##2##4##(2008-9#1)(2010-7#1)
used to study the effect of##5##6##(1992-3#1)(1993-8#1)(2008-7#2)(2008-8#1)
used to study the interactions of##2##6##(2008-9#2)
used to study the interactions##3##5##(2008-9#2)(2011-2#1)
used to study the kinetic##2##5##(2008-10#2)
used to study the relationship##3##5##(2008-10#2)(2008-9#1)
used to study the##50##4##(1990-12#1)(1992-3#1)(1992-6#1)(1993-8#3)(1994-5#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#4)(2010-7#1)(2011-2#1)(2013-8#1)
used to study##77##3##(1990-12#1)(1990-9#2)(1991-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-1#2)(2008-10#30)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#6)(2010-7#2)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
used to successfully##3##3##(2008-10#3)
used to support the##2##4##(2008-10#2)
used to support##7##3##(1994-6#1)(2008-10#3)(2008-9#1)(2011-2#1)(2011-9#1)
used to suppress##2##3##(2008-10#2)
used to synthesize##5##3##(1993-8#1)(1994-9#1)(2008-4#1)(2008-9#1)(2012-2#1)
used to tailor##3##3##(2009-12#1)(2010-4#1)(2013-1#1)
used to teach##3##3##(2008-11#1)(2008-12#1)(2009-11#1)
used to test a##2##4##(2008-10#1)(2008-12#1)
used to test the##12##4##(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
used to test whether##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
used to test##26##3##(1995-6#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-5#2)(2008-8#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
used to the determination of##3##5##(2008-10#3)
used to the##6##3##(2008-10#6)
used to track the##2##4##(2008-10#2)
used to track##3##3##(2008-10#3)
used to train##2##3##(2008-10#2)
used to transfect##2##3##(1993-8#1)(2008-11#1)
used to transfer##3##3##(1990-5#1)(2008-10#2)
used to transform##4##3##(1990-5#1)(1997-7#1)(2008-10#1)(2008-8#1)
used to treat a myriad of##2##6##(2008-10#1)(2008-8#1)
used to treat a##4##4##(1992-1#1)(1993-2#1)(2008-10#1)(2008-8#1)
used to treat hypertension##2##4##(2008-11#1)(2008-12#1)
used to treat the##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)
used to treat##21##3##(1991-9#1)(1992-1#1)(1993-11#1)(1993-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
used to understand##3##3##(2008-10#2)(2010-7#1)
used to validate the##9##4##(2008-10#6)(2011-2#3)
used to verify the##3##4##(2008-10#1)(2010-5#2)
used to verify##4##3##(2008-10#1)(2008-9#1)(2010-5#2)
used to visualise##2##3##(2008-8#1)(2012-2#1)
used to visualize##3##3##(2008-10#1)(2009-7#1)(2013-8#1)
used to##1890##2##(1990-11#10)(1990-12#6)(1990-2#4)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#7)(1991-2#11)(1991-3#5)(1991-5#4)(1991-6#2)(1991-7#3)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#6)(1992-4#1)(1992-6#4)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#5)(1993-3#6)(1993-6#3)(1993-8#12)(1993-9#1)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#7)(1994-5#15)(1994-6#2)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#10)(1995-3#3)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#9)(1996-2#7)(1996-3#6)(1996-5#3)(1996-6#1)(1997-1#3)(1997-2#7)(1997-3#7)(1997-6#4)(1997-7#3)(1997-8#5)(1997-9#1)(2007-11#6)(2007-12#4)(2007-8#1)(2008-1#10)(2008-10#807)(2008-11#125)(2008-12#29)(2008-2#20)(2008-3#75)(2008-4#33)(2008-5#33)(2008-6#8)(2008-7#45)(2008-8#56)(2008-9#56)(2009-10#7)(2009-11#7)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#7)(2009-6#3)(2009-7#10)(2009-8#10)(2010-1#3)(2010-10#6)(2010-11#6)(2010-12#3)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#8)(2010-6#12)(2010-7#10)(2010-8#7)(2010-9#5)(2011-1#6)(2011-2#42)(2011-3#5)(2011-9#1)(2012-12#3)(2012-2#33)(2012-3#21)(2012-5#1)(2013-1#47)(2013-7#1)(2013-8#25)
used today##2##2##(1991-6#1)(1994-5#1)
used together with##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
used together##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
used two##4##2##(1995-2#1)(2008-11#1)(2008-12#1)(2008-5#1)
used under##2##2##(2008-10#2)
used was##19##2##(1997-1#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-5#1)(2010-6#1)(2012-12#1)(2012-2#2)
used were##12##2##(2008-10#6)(2008-11#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
used when##10##2##(2008-1#2)(2008-10#4)(2008-12#1)(2010-12#1)(2011-2#2)
used which##2##2##(2008-10#1)(2012-12#1)
used widely##4##2##(1993-11#1)(2008-10#2)(2010-10#1)
used with a##5##3##(1991-2#1)(2008-11#1)(2008-3#1)(2011-2#2)
used with the##4##3##(1992-9#1)(2008-1#1)(2008-10#1)(2011-2#1)
used with##46##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-2#1)(1996-3#1)(1997-1#1)(1997-7#2)(2008-1#2)(2008-10#13)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
used without##2##2##(2008-10#2)
used##5824##1##(1990-11#21)(1990-12#19)(1990-2#14)(1990-3#5)(1990-5#11)(1990-6#6)(1990-7#3)(1990-8#5)(1990-9#11)(1991-1#6)(1991-10#1)(1991-11#3)(1991-12#21)(1991-2#22)(1991-3#13)(1991-5#10)(1991-6#11)(1991-7#3)(1991-9#3)(1992-1#15)(1992-10#1)(1992-11#3)(1992-12#16)(1992-2#14)(1992-3#23)(1992-4#2)(1992-5#3)(1992-6#10)(1992-8#1)(1992-9#14)(1993-1#9)(1993-11#8)(1993-12#16)(1993-2#16)(1993-3#23)(1993-6#7)(1993-8#19)(1993-9#3)(1994-1#7)(1994-11#11)(1994-12#22)(1994-2#10)(1994-3#18)(1994-5#25)(1994-6#10)(1994-8#14)(1994-9#5)(1995-1#8)(1995-11#12)(1995-12#18)(1995-2#25)(1995-3#4)(1995-5#5)(1995-6#8)(1995-8#11)(1995-9#5)(1996-1#16)(1996-11#3)(1996-12#31)(1996-2#19)(1996-3#18)(1996-5#10)(1996-6#11)(1996-8#6)(1996-9#7)(1997-1#19)(1997-2#27)(1997-3#20)(1997-4#6)(1997-5#3)(1997-6#10)(1997-7#12)(1997-8#15)(1997-9#3)(2006-6#4)(2007-11#8)(2007-12#11)(2007-8#3)(2008-1#28)(2008-10#2521)(2008-11#390)(2008-12#97)(2008-2#42)(2008-3#187)(2008-4#89)(2008-5#118)(2008-6#25)(2008-7#115)(2008-8#115)(2008-9#154)(2009-1#3)(2009-10#17)(2009-11#10)(2009-12#18)(2009-2#5)(2009-3#15)(2009-4#2)(2009-5#11)(2009-6#10)(2009-7#19)(2009-8#29)(2009-9#6)(2010-1#15)(2010-10#16)(2010-11#29)(2010-12#29)(2010-2#4)(2010-3#9)(2010-4#15)(2010-5#17)(2010-6#32)(2010-7#24)(2010-8#37)(2010-9#13)(2011-1#20)(2011-10#3)(2011-2#174)(2011-3#19)(2011-7#1)(2011-9#1)(2012-12#32)(2012-2#105)(2012-3#86)(2012-5#1)(2012-6#2)(2012-9#1)(2013-1#164)(2013-7#1)(2013-8#77)
used)##3##1##(2008-10#2)(2008-3#1)
usedfor##2##1##(2008-11#2)
useful adjunct##3##2##(1997-8#1)(2008-9#1)(2010-11#1)
useful agent##2##2##(1993-3#1)(2008-7#1)
useful agents##2##2##(1992-6#1)(2010-1#1)
useful alternative for##2##3##(2008-10#2)
useful alternative##3##2##(2008-10#2)(2012-3#1)
useful and##12##2##(1991-3#1)(1993-12#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#2)(2011-2#1)(2013-1#1)
useful as a##19##3##(1990-6#1)(1993-1#1)(1995-12#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#10)(2008-11#2)(2010-12#1)
useful as an##2##3##(2008-10#1)(2010-7#1)
useful as##33##2##(1990-6#1)(1992-3#1)(1993-1#1)(1995-12#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#18)(2008-11#4)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#1)
useful because##2##2##(1993-12#1)(1996-9#1)
useful biological##2##2##(2008-5#1)(2010-11#1)
useful biomarkers##2##2##(2010-12#1)(2010-7#1)
useful both##2##2##(1992-12#1)(2013-1#1)
useful but##2##2##(1992-12#1)(2013-8#1)
useful clinical tool##3##3##(1993-12#2)(2008-12#1)
useful clinical##4##2##(1993-12#2)(2006-6#1)(2008-12#1)
useful data##2##2##(1994-5#1)(2008-10#1)
useful diagnostic tools##2##3##(2010-7#1)(2012-12#1)
useful diagnostic##3##2##(2008-12#1)(2010-7#1)(2012-12#1)
useful drug##2##2##(1990-9#1)(2011-2#1)
useful drugs##2##2##(1992-3#1)(2008-5#1)
useful even##2##2##(2011-2#1)(2013-1#1)
useful for application##2##3##(2008-10#1)(2008-5#1)
useful for classifying##2##3##(2008-10#1)(2012-12#1)
useful for detection of##2##4##(2008-10#1)(2011-2#1)
useful for diagnosing##2##3##(2011-2#2)
useful for estimating##2##3##(1994-9#1)(2008-10#1)
useful for examining the##2##4##(1995-2#1)(2008-4#1)
useful for examining##3##3##(1995-2#1)(2008-4#2)
useful for further##3##3##(2008-10#2)(2011-1#1)
useful for grouping##2##3##(2008-10#2)
useful for identifying##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
useful for in vivo##2##4##(2008-4#2)
useful for in##4##3##(1996-12#1)(2008-3#1)(2008-4#2)
useful for marker-assisted selection##2##4##(2008-10#2)
useful for measuring##3##3##(2008-4#2)(2010-7#1)
useful for monitoring##5##3##(2008-10#4)(2008-11#1)
useful for predicting##2##3##(2008-10#1)(2008-8#1)
useful for producing##2##3##(2008-10#1)(2008-2#1)
useful for providing##2##3##(2008-2#1)(2012-3#1)
useful for screening##3##3##(1997-1#1)(2008-10#2)
useful for studies##2##3##(2008-1#2)
useful for studying the##8##4##(1995-11#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
useful for studying##12##3##(1993-9#1)(1995-11#1)(1995-2#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
useful for the determination of##2##5##(2008-10#2)
useful for the diagnosis of##2##5##(2008-10#1)(2008-5#1)
useful for the evaluation of##2##5##(2008-10#1)(2008-5#1)
useful for the measurement##2##4##(2008-10#2)
useful for the study of##2##5##(1996-12#1)(2008-4#1)
useful for the treatment of##2##5##(2008-11#1)(2011-1#1)
useful for the##26##3##(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
useful for this##2##3##(2008-10#1)(2009-7#1)
useful for treatment##2##3##(2008-1#1)(2011-2#1)
useful for understanding##2##3##(2008-10#1)(2013-8#1)
useful for##189##2##(1990-12#1)(1990-8#2)(1992-1#1)(1993-12#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#3)(1996-12#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#2)(2007-11#1)(2008-1#3)(2008-10#71)(2008-11#17)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#11)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#3)
useful genetic##3##2##(2008-10#2)(2008-8#1)
useful in a variety of##2##5##(2008-11#1)(2008-5#1)
useful in a##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
useful in assessing##2##3##(2010-10#1)(2011-2#1)
useful in determining##4##3##(1996-2#1)(2008-10#1)(2008-4#1)(2010-4#1)
useful in differentiating##2##3##(2012-2#2)
useful in further studies on##2##5##(1993-1#1)(1993-8#1)
useful in further##3##3##(1993-1#1)(1993-8#1)(2012-3#1)
useful in future studies of##2##5##(2008-10#1)(2013-1#1)
useful in identifying##6##3##(1994-6#1)(2008-11#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
useful in making##2##3##(1990-2#1)(2008-3#1)
useful in measuring##2##3##(1994-12#1)(2007-11#1)
useful in modeling##2##3##(2008-11#1)(2013-8#1)
useful in monitoring##2##3##(2008-10#1)(2008-7#1)
useful in patients with##3##4##(1991-8#1)(1992-12#1)(1997-1#1)
useful in predicting##4##3##(1992-3#1)(1996-6#1)(2008-5#1)(2013-1#1)
useful in preventing##3##3##(2008-11#1)(2010-1#1)(2013-7#1)
useful in providing##2##3##(2008-10#1)(2008-11#1)
useful in screening for##3##4##(1996-3#1)(2008-10#1)(2008-7#1)
useful in screening##4##3##(1996-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
useful in selecting a##2##4##(1995-9#1)(2008-10#1)
useful in selecting##3##3##(1995-9#1)(2008-10#1)(2008-8#1)
useful in some patients##2##4##(1997-1#1)(1997-8#1)
useful in studying##4##3##(1993-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
useful in that##2##3##(2008-10#1)(2011-2#1)
useful in the detection##2##4##(1994-12#1)(2008-10#1)
useful in the development of##2##5##(1994-11#1)(2008-10#1)
useful in the diagnosis and##2##5##(2008-12#1)(2011-2#1)
useful in the diagnosis of##3##5##(1996-11#1)(2010-6#1)(2011-2#1)
useful in the diagnosis##5##4##(1996-11#1)(2008-12#1)(2010-6#1)(2011-2#2)
useful in the treatment of##2##5##(1991-11#1)(2008-10#1)
useful in the##30##3##(1991-11#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1996-11#1)(1997-8#2)(2008-10#7)(2008-12#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#2)
useful in understanding##3##3##(1996-12#1)(2008-10#2)
useful in##163##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-8#4)(2007-11#1)(2008-10#36)(2008-11#12)(2008-12#5)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#8)(2011-3#1)(2011-7#1)(2012-2#7)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
useful information about the##3##4##(1991-2#1)(2010-8#1)(2012-3#1)
useful information about##4##3##(1991-2#1)(2008-10#1)(2010-8#1)(2012-3#1)
useful information for##7##3##(1992-5#1)(2008-10#4)(2008-2#1)(2010-5#1)
useful information##21##2##(1991-2#1)(1992-5#1)(1994-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#2)(2009-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
useful instrument##2##2##(1992-1#1)(1995-2#1)
useful lifetime of##3##3##(2008-10#3)
useful markers to##2##3##(2008-12#1)(2009-8#1)
useful markers##4##2##(2008-11#1)(2008-12#1)(2009-6#1)(2009-8#1)
useful method for##4##3##(1990-12#1)(2008-10#2)(2008-11#1)
useful method##5##2##(1990-12#1)(2008-10#2)(2008-11#1)(2010-6#1)
useful methods##3##2##(1993-2#1)(2008-10#1)(2013-8#1)
useful model for##4##3##(1990-5#1)(1995-12#1)(2008-10#1)(2008-11#1)
useful model##5##2##(1990-5#1)(1990-8#1)(1995-12#1)(2008-10#1)(2008-11#1)
useful models for##2##3##(1991-9#1)(1995-11#1)
useful molecular##2##2##(2008-10#1)(2008-9#1)
useful parameter to##3##3##(1992-12#1)(2008-10#1)(2010-7#1)
useful predictor variables##3##3##(2008-10#3)
useful procedure##2##2##(2012-3#1)(2013-1#1)
useful range##2##2##(2008-7#2)
useful screening##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
useful signals##2##2##(2008-10#2)
useful strategy##3##2##(2008-10#1)(2009-12#1)(2010-10#1)
useful technique##5##2##(1997-3#1)(2008-9#2)(2010-7#1)(2013-8#1)
useful to assess the effect of##2##6##(1996-6#1)(1997-1#1)
useful to assess the##3##4##(1990-2#1)(1996-6#1)(1997-1#1)
useful to assess##5##3##(1990-2#1)(1996-6#2)(1997-1#1)(2008-4#1)
useful to control##2##3##(1990-12#1)(2008-10#1)
useful to determine##4##3##(1992-2#1)(2008-10#1)(2008-11#2)
useful to predict the risk of##2##6##(2011-2#1)(2013-1#1)
useful to predict the##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
useful to##66##2##(1990-12#1)(1990-2#1)(1992-2#3)(1993-3#1)(1996-1#1)(1996-6#2)(1997-1#2)(1997-3#3)(2008-1#1)(2008-10#16)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
useful tool for the##5##4##(1990-2#1)(1991-2#1)(1992-12#1)(2008-10#2)
useful tool for##15##3##(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1995-11#2)(2008-10#4)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)
useful tool in the treatment of##2##6##(1990-11#1)(1996-9#1)
useful tool in the##5##4##(1990-11#1)(1996-9#1)(2008-10#2)(2010-4#1)
useful tool in##10##3##(1990-11#1)(1991-11#1)(1996-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)
useful tool to investigate the##2##5##(2008-11#1)(2013-8#1)
useful tool to##8##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)(2013-8#1)
useful tool##33##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1995-11#2)(1996-9#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-8#1)
useful tools for##2##3##(1995-12#1)(2008-5#1)
useful tools in##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
useful tools##5##2##(1995-12#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-2#1)
useful when there##2##3##(2008-10#1)(2008-4#1)
useful when##6##2##(2008-10#1)(2008-11#1)(2008-4#3)(2010-10#1)
useful##791##1##(1990-11#1)(1990-12#5)(1990-2#5)(1990-5#1)(1990-6#1)(1990-8#5)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#6)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#6)(1992-3#7)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#3)(1995-2#5)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#5)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#5)(1997-3#7)(1997-5#2)(1997-8#7)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#212)(2008-11#76)(2008-12#21)(2008-2#7)(2008-3#11)(2008-4#37)(2008-5#16)(2008-7#20)(2008-8#10)(2008-9#21)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#2)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#6)(2010-11#5)(2010-12#5)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#10)(2010-8#5)(2011-1#7)(2011-10#1)(2011-2#37)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#19)(2012-3#15)(2013-1#12)(2013-7#1)(2013-8#13)
usefulness and##10##2##(1990-2#2)(1996-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#2)
usefulness for##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)
usefulness in##9##2##(1990-3#1)(1991-3#1)(1991-6#1)(1994-2#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
usefulness of a##4##3##(1993-9#1)(2008-10#1)(2008-5#1)(2012-12#1)
usefulness of an##2##3##(2008-10#1)(2012-12#1)
usefulness of the proposed##3##4##(2008-10#3)
usefulness of the##33##3##(1990-5#1)(1991-3#1)(1993-3#1)(1995-12#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
usefulness of these##2##3##(2008-10#1)(2008-4#1)
usefulness of this drug##2##4##(1997-2#1)(2008-5#1)
usefulness of this##7##3##(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)
usefulness of##97##2##(1990-3#1)(1990-5#2)(1991-3#3)(1991-8#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#31)(2008-11#9)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
usefulness##134##1##(1990-2#2)(1990-3#2)(1990-5#2)(1991-3#4)(1991-6#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#40)(2008-11#12)(2008-12#4)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#3)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#3)
useless##8##1##(1991-6#1)(1992-2#1)(1995-12#1)(1997-6#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-12#1)
user and##4##2##(1991-3#1)(2008-12#2)(2009-6#1)
user friendly##2##2##(2008-10#1)(2011-2#1)
user interface##7##2##(2008-4#1)(2008-9#1)(2010-8#5)
user involvement and##2##3##(2008-12#2)
user involvement in##2##3##(2008-11#1)(2008-12#1)
user involvement##6##2##(2008-11#1)(2008-12#5)
user##75##1##(1991-1#1)(1991-12#3)(1991-3#2)(1992-1#1)(1993-3#4)(1994-6#1)(1997-3#1)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#7)(2008-3#1)(2008-4#5)(2008-6#5)(2008-9#6)(2009-6#3)(2010-5#1)(2010-8#5)(2011-1#2)(2011-2#7)(2013-1#1)(2013-8#1)
user's##2##1##(2008-10#1)(2008-12#1)
user-friendly##7##1##(1991-3#1)(1997-8#1)(2007-9#1)(2008-10#3)(2008-11#1)
users aged##2##2##(2012-2#1)(2013-8#1)
users and carers##4##3##(2009-6#4)
users and the##2##3##(1995-2#1)(1996-2#1)
users and##22##2##(1992-9#1)(1993-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-9#1)(2009-6#4)(2013-1#1)(2013-8#4)
users are##3##2##(1991-3#1)(1992-12#1)(1994-3#1)
users at##2##2##(1992-12#1)(1993-3#1)
users can##2##2##(2008-9#1)(2013-1#1)
users compared to##2##3##(2013-8#2)
users do##2##2##(1991-3#1)(2008-9#1)
users in##16##2##(1991-1#1)(1995-3#1)(1996-11#2)(1996-12#1)(2008-12#6)(2011-2#3)(2012-3#1)(2013-8#1)
users may##2##2##(2008-9#1)(2013-8#1)
users of NSAIDs##2##3##(2008-8#2)
users of meloxicam##3##3##(2008-11#3)
users of such##2##3##(2008-11#1)(2009-5#1)
users of the##5##3##(1997-8#1)(2008-9#3)(2012-3#1)
users of##31##2##(1991-1#1)(1991-12#1)(1991-3#1)(1993-3#1)(1995-1#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-11#8)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-5#1)(2011-2#1)(2012-3#3)(2013-8#3)
users through##2##2##(2008-11#1)(2008-4#1)
users to##10##2##(1993-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#3)(2010-8#1)(2011-3#1)
users using##2##2##(2008-9#1)(2013-8#1)
users was##2##2##(2008-11#1)(2013-8#1)
users were more likely to##4##5##(2008-11#2)(2012-12#2)
users were##9##2##(1991-1#2)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-12#2)
users who##6##2##(2008-11#1)(2010-5#1)(2012-2#1)(2013-8#3)
users will##2##2##(1991-12#1)(1991-3#1)
users with##4##2##(2008-11#1)(2008-9#2)(2010-10#1)
users##220##1##(1990-12#1)(1990-8#1)(1991-1#8)(1991-12#3)(1991-3#6)(1992-1#2)(1992-12#5)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#5)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#1)(1995-3#3)(1995-5#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#4)(1997-8#1)(2008-10#3)(2008-11#29)(2008-12#14)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#35)(2009-5#2)(2009-6#6)(2010-1#2)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#3)(2013-8#22)
users' perspective##2##2##(1996-1#1)(2009-3#1)
users'##8##1##(1996-1#1)(2008-11#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#2)
uses a##44##2##(1991-3#2)(1994-12#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#1)
uses an##13##2##(1993-12#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#4)(2009-7#1)(2012-2#1)(2012-3#1)
uses and##2##2##(2009-9#1)(2010-12#1)
uses of the Internet##2##4##(1996-2#1)(2009-5#1)
uses of the##5##3##(1991-12#1)(1996-2#1)(2008-3#1)(2009-5#1)(2010-5#1)
uses of##20##2##(1991-12#2)(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-11#1)(2010-5#3)(2011-2#1)(2013-1#2)
uses only##2##2##(1990-12#1)(2008-8#1)
uses the##23##2##(1992-12#1)(1994-12#1)(1994-6#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
uses three##2##2##(1997-3#1)(2008-10#1)
uses two monoclonal antibodies##2##4##(1992-12#1)(1993-2#1)
uses two##6##2##(1992-12#1)(1993-2#1)(2008-3#3)(2008-8#1)
uses##206##1##(1990-12#1)(1990-2#1)(1991-12#3)(1991-2#1)(1991-3#2)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#3)(1993-3#3)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#3)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#2)(1997-2#1)(1997-3#5)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#44)(2008-11#7)(2008-2#4)(2008-3#27)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-9#1)(2010-11#3)(2010-12#1)(2010-5#4)(2010-7#1)(2010-8#2)(2011-2#4)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#1)
usher in##2##2##(1995-6#1)(2011-7#1)
ushered##4##1##(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#1)
using &quot##3##2##(1997-7#1)(2008-10#1)(2008-6#1)
using (1)D at##2##3##(2008-10#2)
using (31)P##2##2##(2008-10#1)(2012-2#1)
using (i)##3##2##(2008-10#2)(2009-12#1)
using 0##16##2##(2008-10#13)(2008-11#1)(2008-5#1)(2013-1#1)
using 1##16##2##(1991-5#1)(1993-3#2)(2008-10#12)(2008-11#1)
using 1-(2-pyridylazo)-2-naphthol##2##2##(2008-10#2)
using 1-nitroso-2-naphthol##3##2##(2008-10#3)
using 10##5##2##(1994-11#1)(2008-10#3)(2012-2#1)
using 11##2##2##(2008-10#2)
using 12##2##2##(2008-10#2)
using 15##2##2##(2008-10#1)(2008-12#1)
using 16##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
using 18##3##2##(2008-10#2)(2013-1#1)
using 19F##2##2##(1994-8#1)(1996-2#1)
using 2##11##2##(1990-2#1)(2008-10#8)(2008-6#1)(2011-2#1)
using 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##2##2##(2008-10#2)
using 20##2##2##(2008-10#2)
using 23Na nuclear magnetic resonance##2##5##(1994-3#2)
using 3##5##2##(1991-2#1)(2008-10#3)(2009-10#1)
using 3D##2##2##(2008-6#1)(2010-8#1)
using 4##2##2##(2008-10#2)
using 5 ml##3##3##(2008-10#3)
using 5##8##2##(2008-10#7)(2012-2#1)
using 50##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
using 500##2##2##(2008-11#1)(2008-9#1)
using 8##5##2##(2008-10#3)(2008-8#1)(2009-10#1)
using AAS##2##2##(2008-10#2)
using AFLP##2##2##(2008-10#2)
using Amberlite XAD-16##2##3##(2008-10#2)
using Amberlite XAD-2##2##3##(2008-10#2)
using Amberlite##4##2##(2008-10#4)
using C##3##2##(1993-9#1)(2008-10#1)(2008-6#1)
using C(18)##2##2##(2008-10#2)
using C18##2##2##(2008-10#2)
using COS-1 cells##2##3##(1994-11#1)(1995-6#1)
using COS-1##3##2##(1994-11#1)(1995-6#1)(2008-11#1)
using COX-2##2##2##(2011-2#1)(2013-8#1)
using Chinese##2##2##(2008-11#1)(2011-1#1)
using Codessa Pro##2##3##(2009-3#2)
using DNA from##2##3##(2008-10#2)
using DNA##12##2##(1995-11#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2012-2#1)
using Doehlert##3##2##(2008-10#3)
using Doppler##2##2##(2010-10#1)(2013-1#1)
using Dsquame(R)##2##2##(2008-5#2)
using EDTA as##3##3##(2008-10#3)
using ELISA##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
using FAAS##2##2##(2008-10#2)
using FT-IR spectroscopy##3##3##(2008-10#3)
using FTIR##2##2##(2008-10#2)
using Fourier transform infrared##2##4##(2008-10#2)
using GC-FID##2##2##(2008-10#2)
using GC-MS##2##2##(2008-10#1)(2008-11#1)
using Gene-Fizz##2##2##(1996-12#2)
using Giemsa##2##2##(2008-12#2)
using HIC##2##2##(2008-10#2)
using HPLC and##3##3##(2008-10#2)(2008-7#1)
using HPLC separation##2##3##(2008-10#2)
using HPLC##11##2##(1992-2#1)(1994-8#1)(2008-10#7)(2008-11#1)(2008-7#1)
using HeLa##2##2##(1993-6#1)(2008-11#1)
using ICP-AES##2##2##(2008-10#2)
using ICP-MS##3##2##(2008-10#3)
using ISFETs##2##2##(2008-10#2)
using ITS##2##2##(2008-10#2)
using MR##2##2##(2008-10#1)(2011-2#1)
using MTT##2##2##(1994-5#1)(1995-8#1)
using Medicare##2##2##(1994-1#1)(1995-3#1)
using Medline##2##2##(2008-10#1)(2008-7#1)
using Monte Carlo simulation##2##4##(2011-2#2)
using Monte Carlo##3##3##(2008-10#1)(2011-2#2)
using N##7##2##(2008-10#7)
using N-methylpyridinium as##2##3##(2008-10#2)
using NMR##3##2##(1994-3#1)(2008-10#1)(2009-6#1)
using P##2##2##(2008-10#1)(2012-12#1)
using PBL in##3##3##(2008-12#3)
using PBMC##4##2##(2011-2#4)
using PCR amplification##2##3##(1993-12#1)(2008-4#1)
using PCR##7##2##(1993-12#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
using PCR-RFLP##2##2##(2008-10#1)(2008-8#1)
using PLS##3##2##(2008-10#2)(2008-5#1)
using PLS-1##2##2##(2008-10#2)
using PTFE##2##2##(2008-10#2)
using PUF##2##2##(2008-11#2)
using Poisson regression##2##3##(2008-10#1)(2010-1#1)
using Protein##2##2##(1990-11#1)(2008-11#1)
using PubMed##2##2##(2008-12#1)(2013-1#1)
using R##2##2##(2008-10#1)(2013-1#1)
using RAPD##2##2##(2008-10#1)(2008-8#1)
using RFLP and##2##3##(2008-10#2)
using RFLP##3##2##(1996-12#1)(2008-10#2)
using RNA##2##2##(1991-9#1)(2008-5#1)
using RT-PCR##4##2##(1996-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
using Rasch##2##2##(2012-2#2)
using SEM##2##2##(2008-7#1)(2008-8#1)
using SF-CO(2) at##2##3##(2008-10#2)
using SF-CO(2)##3##2##(2008-10#3)
using SPME##3##2##(2008-10#3)
using SPSS##2##2##(2010-11#1)(2013-1#1)
using Student's t-test##5##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
using Student's##6##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
using TGS##2##2##(2008-10#2)
using TaqMan##3##2##(2008-10#3)
using USP##2##2##(2012-2#2)
using UV detection##2##3##(2008-10#2)
using UV##7##2##(2008-10#5)(2008-5#1)(2013-8#1)
using W-Rh##2##2##(2008-10#2)
using X-ray diffraction##3##3##(2008-10#3)
using X-ray##5##2##(2008-10#5)
using Zeeman effect background correction##2##5##(2008-10#2)
using a &quot##2##3##(2008-10#1)(2012-3#1)
using a 0##3##3##(1995-11#1)(2008-10#2)
using a 1##3##3##(2008-10#2)(2008-11#1)
using a 2##2##3##(2008-10#1)(2013-1#1)
using a 20 mM borate buffer (pH##2##7##(2008-10#2)
using a 4##2##3##(1990-12#1)(2008-10#1)
using a 5##4##3##(2008-10#3)(2013-1#1)
using a 60 s preconcentration time##2##6##(2008-10#2)
using a 60##3##3##(2008-10#2)(2008-5#1)
using a C(18) column##2##4##(2008-10#2)
using a C(18)##3##3##(2008-10#2)(2009-8#1)
using a Neyman-Scott cluster process##2##5##(2008-10#2)
using a PTFE##2##3##(2008-10#2)
using a UV detector##2##4##(2008-10#2)
using a UV##4##3##(1995-11#1)(2008-10#3)
using a baculovirus expression system##2##5##(1992-10#1)(1993-6#1)
using a battery of##2##4##(2009-10#2)
using a binary##2##3##(1992-9#1)(2008-10#1)
using a cDNA array##2##4##(2008-10#1)(2008-9#1)
using a calculator##2##3##(2008-11#2)
using a canine##3##3##(2009-8#1)(2010-4#1)(2012-3#1)
using a capillary##2##3##(2008-10#2)
using a carbon paste electrode modified with##4##7##(2008-10#4)
using a carbon paste electrode modified##6##6##(2008-10#6)
using a carbon##7##3##(2008-10#7)
using a central composite design##4##5##(2008-10#4)
using a central composite##5##4##(2008-10#4)(2008-11#1)
using a chromatographic##2##3##(2008-10#2)
using a column##4##3##(2008-10#4)
using a combination of##22##4##(1993-12#1)(1995-11#1)(1996-2#1)(1997-3#1)(2008-10#10)(2008-11#2)(2008-8#2)(2009-8#1)(2011-2#3)
using a combined##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
using a commercial##6##3##(1993-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-5#1)
using a commercially available##3##4##(2008-10#3)
using a common spectrofluorometer##4##4##(2008-10#4)
using a common##7##3##(2008-10#6)(2008-11#1)
using a comparative##3##3##(2008-10#2)(2012-3#1)
using a competitive##2##3##(1991-9#1)(2008-10#1)
using a complex##3##3##(2008-10#2)(2008-8#1)
using a composite##2##3##(2008-10#1)(2008-2#1)
using a computer##3##3##(1990-3#1)(2008-10#1)(2010-8#1)
using a constant##3##3##(2008-10#2)(2008-11#1)
using a continuous glucose monitoring##2##5##(2008-1#1)(2012-4#1)
using a continuous##8##3##(1992-1#2)(2008-1#1)(2008-10#4)(2012-4#1)
using a conventional##7##3##(2008-10#5)(2009-10#1)(2009-8#1)
using a cross-linked##2##3##(2008-10#1)(2008-5#1)
using a direct##4##3##(2008-10#3)(2010-6#1)
using a dual##2##3##(1997-2#1)(2008-10#1)
using a dynamic##3##3##(2008-10#2)(2008-12#1)
using a factorial design##2##4##(2008-10#1)(2010-4#1)
using a factorial##3##3##(2008-10#2)(2010-4#1)
using a fast##2##3##(2008-10#2)
using a fiber optic##3##4##(2008-10#2)(2010-6#1)
using a fixed##2##3##(2008-10#2)
using a flow injection system with##3##6##(2008-10#3)
using a flow injection system##6##5##(2008-10#6)
using a flow injection##10##4##(2008-10#10)
using a flow##11##3##(2008-10#11)
using a flow-injection##2##3##(2008-10#2)
using a flow-through##2##3##(2008-10#2)
using a fluoride##2##3##(2008-10#2)
using a fluoride-selective electrode##2##4##(2008-10#2)
using a focalized##3##3##(2008-10#3)
using a fully automated##2##4##(2008-10#1)(2008-11#1)
using a function##2##3##(2008-10#2)
using a genome-wide##2##3##(2008-9#1)(2013-1#1)
using a glassy carbon electrode##3##5##(2008-10#3)
using a glassy carbon##4##4##(2008-10#4)
using a gold binding polypeptide##2##5##(2008-10#2)
using a gold##4##3##(2008-10#3)(2008-12#1)
using a gradient flow##2##4##(2008-10#2)
using a graphite##2##3##(2008-10#2)
using a hanging mercury drop electrode##4##6##(2008-10#4)
using a heating##2##3##(2008-10#2)
using a high frequency dielectric method##2##6##(2008-10#2)
using a high##7##3##(1990-12#1)(2008-10#4)(2008-11#1)(2009-12#1)
using a high-volume sampler##2##4##(2008-10#2)
using a highly sensitive##2##4##(2011-2#1)(2013-1#1)
using a highly##4##3##(1994-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
using a human##2##3##(2008-11#1)(2012-3#1)
using a laser scanning cytometer##2##5##(2008-9#2)
using a laser##5##3##(2008-10#1)(2008-9#2)(2009-7#1)(2013-8#1)
using a lateral##2##3##(2008-10#1)(2009-10#1)
using a light microscope##2##4##(2008-9#1)(2011-2#1)
using a linear##6##3##(2008-10#4)(2008-3#1)(2008-7#1)
using a liquid##2##3##(2008-10#2)
using a long-term##2##3##(2008-10#1)(2008-8#1)
using a low##2##3##(2008-10#1)(2008-11#1)
using a magnetic##2##3##(2008-10#1)(2008-8#1)
using a manual##2##3##(1991-12#1)(2008-10#1)
using a mathematical##2##3##(1992-2#1)(2008-10#1)
using a mechanical stapler##2##4##(1992-9#2)
using a method##2##3##(2008-10#1)(2008-12#1)
using a micro-column packed with##2##5##(2008-10#2)
using a mini-column##2##3##(2008-10#2)
using a mixed WO(3)-based##2##4##(2008-10#2)
using a mixture of##15##4##(2008-10#15)
using a mobile phase##3##4##(2008-10#3)
using a model in which##2##5##(2008-8#1)(2008-9#1)
using a model##8##3##(1994-8#1)(1995-9#1)(2008-10#3)(2008-8#1)(2008-9#2)
using a modified version of the##2##6##(2008-10#1)(2008-4#1)
using a modified##14##3##(1994-11#1)(1996-5#1)(2008-10#6)(2008-4#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
using a monoclonal antibody##4##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
using a monoclonal##5##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)
using a more##2##3##(1994-12#1)(2008-11#1)
using a multifunctional anaesthesia##2##4##(2011-2#2)
using a multimode##2##3##(2008-10#1)(2010-4#1)
using a multisyringe##3##3##(2008-10#3)
using a multivariate##3##3##(1991-3#1)(1993-12#1)(2008-10#1)
using a nested##2##3##(2010-6#1)(2011-2#1)
using a new chelating##2##4##(2008-10#2)
using a new particle-mediated immunoassay##2##5##(2008-10#2)
using a new##19##3##(1997-2#1)(2008-10#15)(2008-5#1)(2009-7#1)(2011-2#1)
using a newly developed##3##4##(1994-11#2)(1994-12#1)
using a newly synthesized##2##4##(2008-10#2)
using a newly##7##3##(1994-11#2)(1994-12#1)(2008-10#2)(2011-2#2)
using a non-detachable balloon catheter to##2##6##(1997-3#2)
using a novel##8##3##(2008-10#3)(2008-11#2)(2008-3#1)(2010-11#1)(2010-8#1)
using a pH 2##2##4##(2008-10#2)
using a pH##3##3##(2008-10#3)
using a partial least##2##4##(2008-10#2)
using a partial least-squares##2##4##(2008-10#2)
using a partial##5##3##(2008-10#4)(2008-8#1)
using a peristaltic pump##2##4##(2008-10#1)(2008-11#1)
using a photodiode array detector##2##5##(2008-10#2)
using a polyurethane foam##2##4##(2008-10#1)(2008-11#1)
using a polyvinyl##2##3##(2008-10#2)
using a portable##3##3##(2008-10#2)(2009-1#1)
using a potentiometric sensor immobilized in a graphite matrix##2##9##(2008-10#2)
using a potentiometric##4##3##(2008-10#4)
using a preconcentration time of##3##5##(2008-10#3)
using a previous preconcentration step##2##5##(2008-10#2)
using a principal component##2##4##(2008-10#2)
using a probe for##2##4##(1990-8#1)(1997-3#1)
using a probe##3##3##(1990-8#1)(1991-6#1)(1997-3#1)
using a program##2##3##(2008-10#2)
using a prototype##2##3##(2008-2#1)(2008-6#1)
using a pulsed laser##2##4##(2008-10#1)(2012-2#1)
using a pulsed##4##3##(1990-2#1)(2008-10#2)(2012-2#1)
using a purge-and-trap system##2##4##(2008-10#2)
using a qualitative##2##3##(2008-11#1)(2013-1#1)
using a quantitative descriptive##2##4##(2008-10#1)(2010-4#1)
using a quantitative##3##3##(1997-2#1)(2008-10#1)(2010-4#1)
using a quartz crystal microbalance##2##5##(2008-10#2)
using a quartz##3##3##(2008-10#3)
using a questionnaire##8##3##(1992-1#1)(1993-3#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-6#1)(2010-8#1)(2012-12#1)
using a rabbit##2##3##(1991-10#1)(2008-10#1)
using a random##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
using a randomized##3##3##(2008-8#1)(2013-1#2)
using a rapid##2##3##(2008-10#2)
using a real-time PCR##2##4##(2008-10#1)(2010-6#1)
using a recently##3##3##(2008-10#3)
using a relatively small##2##4##(1996-3#1)(2008-10#1)
using a repeated##2##3##(1993-3#1)(2008-11#1)
using a sample of##3##4##(1995-3#1)(2008-10#1)(2008-11#1)
using a sample volume of##2##5##(2008-10#2)
using a sample##6##3##(1995-3#1)(2008-10#4)(2008-11#1)
using a sensitive##2##3##(2008-10#2)
using a sequential injection analysis##2##5##(2008-10#2)
using a sequential injection system##3##5##(2008-10#3)
using a sequential injection##6##4##(2008-10#6)
using a sequential##8##3##(2008-10#8)
using a series of##2##4##(2008-10#1)(2008-8#1)
using a serum-free##2##3##(2008-11#1)(2008-7#1)
using a set of##7##4##(1995-8#1)(2008-10#4)(2008-8#1)(2009-10#1)
using a similar##3##3##(1990-2#1)(1991-3#1)(2009-10#1)
using a simple and##2##4##(2008-10#2)
using a simple model##3##4##(1992-4#1)(1992-9#1)(2008-7#1)
using a simple##17##3##(1992-4#1)(1992-9#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2011-2#1)
using a simplified##2##3##(2008-10#1)(2008-8#1)
using a single extraction##2##4##(2008-10#2)
using a single##11##3##(1992-3#1)(1995-12#1)(2008-10#7)(2008-12#1)(2010-11#1)
using a solid##4##3##(2008-10#4)
using a solid-phase attachment##2##4##(2008-10#2)
using a solid-phase extraction (SPE)##2##5##(2008-10#2)
using a solid-phase##5##3##(2008-10#5)
using a spatially##2##3##(2008-9#1)(2011-2#1)
using a special##2##3##(1994-6#1)(2008-11#1)
using a specific##7##3##(1990-5#1)(1993-8#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2013-1#1)
using a spectrophotometric##2##3##(2008-10#2)
using a square-wave##2##3##(2008-10#2)
using a standard curve##2##4##(1996-12#1)(2008-10#1)
using a standard##13##3##(1996-12#1)(1997-8#1)(2008-10#8)(2008-11#1)(2009-5#1)(2011-2#1)
using a standardized##3##3##(2008-10#1)(2008-12#1)(2009-9#1)
using a structured questionnaire##2##4##(2008-11#1)(2013-1#1)
using a structured##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
using a surface plasmon resonance (SPR) biosensor##2##7##(2008-10#1)(2008-4#1)
using a surface plasmon resonance##3##5##(2008-10#2)(2008-4#1)
using a surface##4##3##(2008-10#3)(2008-4#1)
using a survey##3##3##(1993-12#1)(2008-10#1)(2013-8#1)
using a synthetic##3##3##(1995-6#1)(2008-5#1)(2011-2#1)
using a system##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
using a technique##2##3##(2008-10#2)
using a thin##2##3##(2008-10#2)
using a total of##2##4##(1990-11#1)(1994-5#1)
using a total##3##3##(1990-11#1)(1994-5#1)(2008-3#1)
using a traditional##2##3##(2008-10#2)
using a two-stage##2##3##(2008-11#1)(2011-2#1)
using a validated##3##3##(2010-3#1)(2010-7#1)(2012-12#1)
using a variety of methods##3##5##(1993-3#1)(2008-10#1)(2008-12#1)
using a variety of##10##4##(1992-1#1)(1992-9#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-4#1)
using a video##2##3##(1993-12#1)(2013-1#1)
using a virtual learning environment (VLE)##2##6##(2008-12#2)
using a water mobile phase##3##5##(2008-10#3)
using a well##2##3##(2008-7#1)(2013-1#1)
using a##1171##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#7)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#2)(1992-9#8)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-11#5)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#7)(1997-6#2)(1997-7#3)(1997-8#2)(2007-12#4)(2007-9#1)(2008-1#2)(2008-10#621)(2008-11#66)(2008-12#12)(2008-2#3)(2008-3#15)(2008-4#7)(2008-5#33)(2008-6#4)(2008-7#25)(2008-8#18)(2008-9#26)(2009-1#2)(2009-10#13)(2009-11#1)(2009-12#4)(2009-3#4)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#13)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#3)(2010-3#4)(2010-4#6)(2010-6#8)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#5)(2011-2#38)(2011-3#2)(2012-12#8)(2012-2#9)(2012-3#13)(2012-4#1)(2012-5#1)(2013-1#25)(2013-8#10)
using absorbance##3##2##(2008-10#1)(2010-11#1)(2012-2#1)
using acellular dermis##2##3##(2008-9#2)
using acid##2##2##(2008-10#1)(2008-8#1)
using acidic##2##2##(2008-10#1)(2012-3#1)
using acidified##2##2##(2008-10#2)
using adsorptive##2##2##(2008-10#2)
using alkaline##3##2##(2008-10#2)(2008-5#1)
using all three##3##3##(2008-10#2)(2008-11#1)
using all##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
using allograft##3##2##(2009-10#2)(2012-3#1)
using alternative##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
using ammonium##3##2##(2008-10#3)
using amniotic membranes##2##3##(1993-1#2)
using amperometric biosensors##2##3##(2008-10#2)
using amperometric##3##2##(2008-10#3)
using amperometry##2##2##(2008-10#2)
using amplified fragment length polymorphism (AFLP) and##3##7##(2008-10#3)
using amplified fragment length polymorphism (AFLP) markers##2##7##(2008-10#2)
using amplified fragment length polymorphism (AFLP)##6##6##(2008-10#6)
using amplified fragment length polymorphism##8##5##(2008-10#8)
using amplified fragment length##9##4##(2008-10#9)
using amplified##10##2##(2008-10#9)(2008-11#1)
using amylose as a substrate##2##5##(1990-9#2)
using an ELISA##2##3##(2008-10#1)(2008-12#1)
using an HPLC system##2##4##(2008-10#2)
using an HPLC##3##3##(2008-10#3)
using an acetate buffer as a carrier##2##7##(2008-10#2)
using an acid##3##3##(2008-10#3)
using an affinity##2##3##(2008-10#1)(2012-2#1)
using an alternative##3##3##(1992-3#1)(2008-12#1)(2009-8#1)
using an amperometric##2##3##(2008-10#2)
using an anion##2##3##(1996-12#1)(2008-10#1)
using an anion-exchange##2##3##(2008-10#2)
using an aqueous solution##2##4##(2008-10#2)
using an aqueous##4##3##(2008-10#4)
using an artificial neural network##2##5##(2008-10#1)(2008-8#1)
using an artificial##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
using an atomic absorption##2##4##(2008-10#2)
using an automated##6##3##(2008-10#4)(2008-11#1)(2010-7#1)
using an automatic##2##3##(1991-12#1)(2008-10#1)
using an avocado##2##3##(2008-10#2)
using an electrochemical##2##3##(2008-10#2)
using an electronic nose##2##4##(2008-10#1)(2008-11#1)
using an electronic portal imaging device##2##6##(1993-9#1)(2009-2#1)
using an electronic##5##3##(1993-9#1)(2008-10#1)(2008-11#1)(2009-2#1)(2013-1#1)
using an enzymatic##5##3##(1992-11#1)(2008-10#4)
using an enzyme-linked immunosorbent assay##2##5##(2008-10#2)
using an experimental design approach##2##5##(2008-10#2)
using an experimental design##4##4##(2008-10#4)
using an image##2##3##(1991-6#1)(1995-8#1)
using an in vitro##5##4##(1994-11#1)(2008-10#1)(2008-11#2)(2008-7#1)
using an in##7##3##(1994-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)
using an indirect##2##3##(2008-10#1)(2008-11#1)
using an integrated##3##3##(2008-10#2)(2008-9#1)
using an ion##3##3##(2008-10#3)
using an on-line##5##3##(2008-10#5)
using an online##2##3##(2008-10#1)(2011-2#1)
using an optical##3##3##(1995-12#1)(2008-10#2)
using an ultrasonic##2##3##(2008-10#1)(2008-11#1)
using an##236##2##(1990-12#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-6#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1997-1#2)(1997-2#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#128)(2008-11#16)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
using analytical##2##2##(1992-2#1)(1993-3#1)
using and##3##2##(1991-2#1)(2008-4#1)(2009-8#1)
using anodic##2##2##(2008-10#2)
using another##2##2##(2008-10#2)
using anthropometric##2##2##(2008-11#1)(2011-1#1)
using anti##2##2##(2008-12#1)(2008-5#1)
using antibodies against##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
using antibodies##8##2##(1993-6#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#1)(2012-3#1)
using antisera##3##2##(1993-9#1)(2008-10#2)
using any##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
using appropriate##2##2##(1990-12#1)(2012-2#1)
using aqueous##8##2##(2008-10#7)(2011-2#1)
using artificial intelligence techniques##2##4##(2010-8#2)
using artificial neural networks (ANN)##2##5##(2008-10#1)(2010-8#1)
using artificial neural networks##9##4##(1995-5#2)(2008-10#6)(2010-8#1)
using artificial neural##10##3##(1995-5#2)(2008-10#7)(2010-8#1)
using artificial##12##2##(1995-5#2)(2008-10#7)(2010-8#3)
using as probes##2##3##(1993-2#1)(1994-11#1)
using as##7##2##(1993-2#1)(1994-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
using ascorbic acid##2##3##(2008-10#2)
using atomic absorption##5##3##(2008-10#5)
using atomic##6##2##(2008-10#6)
using autologous rib##3##3##(2012-3#3)
using autologous##6##2##(2008-11#1)(2011-2#1)(2012-3#3)(2013-1#1)
using automated##2##2##(1997-6#1)(2008-10#1)
using automatic##2##2##(2008-10#2)
using bacterial##2##2##(2008-10#1)(2008-4#1)
using batch##2##2##(2008-10#2)
using beta-correction##3##2##(2008-10#3)
using biotinylated estradiol##2##3##(2008-10#2)
using biotinylated##3##2##(1997-3#1)(2008-10#2)
using borate##2##2##(2008-10#2)
using boron-doped diamond##2##3##(2008-10#2)
using both a##4##3##(2008-10#4)
using both the##3##3##(2008-10#2)(2010-6#1)
using both virulence##2##3##(2008-10#2)
using both##46##2##(1994-6#1)(1995-12#1)(2008-10#30)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-6#1)(2012-2#2)(2013-1#1)
using bovine##3##2##(1994-5#1)(2008-10#1)(2008-7#1)
using bromate##2##2##(2008-10#2)
using bromocresol##2##2##(2008-10#2)
using bulk##2##2##(2008-10#1)(2008-3#1)
using bulked segregant analysis##3##4##(1995-6#1)(2008-10#2)
using cDNA##2##2##(2008-10#1)(2008-4#1)
using calibrated##3##2##(2006-6#1)(2008-5#1)(2009-11#1)
using capillary electrophoresis with##2##4##(2008-10#2)
using capillary electrophoresis##4##3##(1997-2#1)(2008-10#3)
using capillary zone electrophoresis (CZE)##4##5##(2008-10#4)
using capillary##9##2##(1997-2#1)(2008-10#8)
using carbon dioxide##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
using carbon##5##2##(2008-10#3)(2012-2#1)(2012-3#1)
using case##2##2##(1995-2#1)(2008-11#1)
using catalytic##2##2##(2008-10#2)
using celestial cues##2##3##(1994-3#2)
using cell##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
using cells##3##2##(2008-11#2)(2008-7#1)
using cellulose-azure##2##2##(2008-10#2)
using certified##3##2##(2008-10#3)
using chelating##2##2##(2008-10#2)
using chemical##5##2##(2008-10#5)
using chemically modified##2##3##(2008-10#2)
using chemically##3##2##(1995-12#1)(2008-10#2)
using chemometric##2##2##(2008-10#2)
using chemometrics##3##2##(2008-10#3)
using claims data##2##3##(1996-1#1)(2009-9#1)
using classical methods##2##3##(2008-10#2)
using classical##5##2##(1990-2#1)(2008-10#4)
using cloned##4##2##(1995-11#1)(2008-10#2)(2008-9#1)
using cochlear implants##7##3##(2008-9#7)
using colloidal##3##2##(2008-10#3)
using colorimetric##2##2##(2008-10#1)(2009-8#1)
using columns##2##2##(2008-10#1)(2011-2#1)
using combined##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
using commercial##5##2##(1995-3#1)(2008-10#1)(2011-2#1)(2011-7#1)(2012-2#1)
using commercially available##4##3##(1991-3#1)(2008-10#2)(2008-12#1)
using common##4##2##(1993-2#1)(2008-9#2)(2013-1#1)
using competing##2##2##(2008-7#1)(2013-1#1)
using competition##2##2##(2008-4#1)(2012-3#1)
using composite##2##2##(2008-10#2)
using computed tomography##2##3##(2010-1#1)(2011-2#1)
using computer technology##2##3##(2008-9#2)
using computer##4##2##(2008-1#1)(2008-9#2)(2012-3#1)
using computerized##6##2##(1992-9#1)(2008-11#3)(2008-5#1)(2009-12#1)
using concentrated##2##2##(2008-10#1)(2008-9#1)
using condoms##5##2##(1997-6#2)(2010-7#3)
using confocal microscopy##6##3##(1997-1#1)(2008-11#2)(2008-9#2)(2011-2#1)
using confocal##10##2##(1997-1#1)(2008-10#1)(2008-11#3)(2008-9#2)(2009-6#1)(2010-8#1)(2011-2#1)
using conserved##2##2##(2008-10#2)
using continuous##3##2##(1995-11#1)(2008-10#2)
using controlled##2##2##(2008-7#1)(2012-4#1)
using conventional and##2##3##(2008-10#1)(2008-9#1)
using conventional##14##2##(1993-12#1)(2008-10#6)(2008-11#1)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)
using copper ions##2##3##(2008-10#2)
using copper##4##2##(2008-10#4)
using copper(II)-neocuproine##2##2##(2008-10#2)
using corona discharge ion mobility spectrometry##2##6##(2008-10#2)
using coupled##2##2##(2008-10#2)
using covalent##2##2##(2008-10#2)
using culture##2##2##(2008-7#1)(2011-2#1)
using current##2##2##(1992-2#1)(2008-10#1)
using cyclic and square-wave voltammetry##2##5##(2008-10#2)
using cyclic and##3##3##(2008-10#3)
using cyclic voltammetry (CV) and##3##5##(2008-10#3)
using cyclic voltammetry (CV)##4##4##(2008-10#4)
using cyclic voltammetry and##3##4##(2008-10#3)
using cyclic voltammetry##14##3##(2008-10#13)(2009-9#1)
using cyclic##20##2##(2008-10#19)(2009-9#1)
using data collected from##4##4##(2008-10#4)
using data from a##4##4##(1992-9#1)(2008-8#1)(2008-9#1)(2009-10#1)
using data from the National##2##5##(1995-12#1)(2009-7#1)
using data from the##7##4##(1994-6#1)(1995-12#1)(1995-9#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-2#1)
using data from##23##3##(1990-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-3#1)(2008-10#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2011-2#2)(2012-2#1)
using data on##2##3##(2008-8#1)(2010-8#1)
using data##34##2##(1990-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-3#1)(2008-10#10)(2008-12#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
using degenerate oligonucleotides designed##2##4##(1996-8#1)(2008-10#1)
using degenerate oligonucleotides##3##3##(1993-8#1)(1996-8#1)(2008-10#1)
using degenerate primers##3##3##(2008-10#3)
using degenerate##6##2##(1993-8#1)(1996-8#1)(2008-10#4)
using density##2##2##(2008-10#1)(2008-7#1)
using derivative spectrophotometry and##3##4##(2008-10#3)
using derivative spectrophotometry##4##3##(2008-10#4)
using derivative##7##2##(2008-10#7)
using diagnosis-related groups##2##3##(1991-1#1)(1991-12#1)
using diagnosis-related##3##2##(1991-1#1)(1991-12#1)(1995-2#1)
using different cell##2##3##(2008-10#1)(2008-11#1)
using different types of##2##4##(2008-10#1)(2011-2#1)
using different##51##2##(1990-5#1)(1994-3#1)(1995-5#1)(1997-1#1)(2008-1#1)(2008-10#25)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
using differential display##2##3##(2008-8#1)(2010-12#1)
using differential pulse polarography##4##4##(2008-10#4)
using differential pulse##5##3##(2008-10#5)
using differential##10##2##(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
using diffuse reflectance spectroscopy##2##4##(2008-10#2)
using diffuse reflectance##4##3##(2008-10#4)
using digital##2##2##(2008-10#1)(2009-12#1)
using dilute##2##2##(2008-10#1)(2013-1#1)
using dimethyl-beta-cyclodextrin##2##2##(2008-10#2)
using dimethylsulfoxide##3##2##(2008-10#2)(2008-5#1)
using direct LA-ICP-MS##2##3##(2008-10#2)
using direct##8##2##(2008-10#5)(2008-5#1)(2010-7#1)(2012-3#1)
using discrete##2##2##(2008-10#1)(2013-8#1)
using disposable##2##2##(1992-12#1)(2008-8#1)
using distance##2##2##(2008-11#1)(2012-3#1)
using dithizone##3##2##(2008-10#3)
using dot blot hybridization##2##4##(1994-1#1)(2008-10#1)
using double##3##2##(2008-10#2)(2008-11#1)
using dual##4##2##(1994-11#1)(2008-10#3)
using dual-energy X-ray absorptiometry##2##4##(2008-10#1)(2008-7#1)
using duplex oligomers containing##2##4##(2008-11#2)
using duplex##3##2##(2008-11#2)(2013-1#1)
using each##3##2##(2008-10#2)(2008-11#1)
using ecological##2##2##(2010-1#1)(2011-2#1)
using eight primer##2##3##(2008-10#2)
using eight##3##2##(2008-10#3)
using either a##3##3##(1992-5#1)(2008-10#2)
using either##18##2##(1990-11#1)(1992-5#1)(1993-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(2008-10#7)(2008-4#2)(2008-8#1)(2008-9#1)(2013-1#1)
using electrical##2##2##(2008-12#1)(2008-5#1)
using electrochemical##5##2##(2008-10#3)(2008-5#1)(2009-10#1)
using electrolytic deposition##2##3##(2008-10#2)
using electron microscopy##3##3##(1997-7#1)(2008-11#2)
using electron paramagnetic resonance##2##4##(2008-10#1)(2008-5#1)
using electron##7##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
using electronic##3##2##(1993-12#1)(1996-1#1)(2013-8#1)
using electrospray##2##2##(2008-10#2)
using electrothermal atomic absorption spectrometry (ETAAS)##2##6##(2008-10#2)
using electrothermal atomic absorption spectrometry with slurry##2##7##(2008-10#2)
using electrothermal atomic absorption spectrometry with##3##6##(2008-10#3)
using electrothermal atomic absorption spectrometry##6##5##(2008-10#6)
using empirical equations##2##3##(2008-10#2)
using endoscopic##3##2##(2008-10#2)(2013-1#1)
using environmental##2##2##(1996-3#1)(2008-9#1)
using error-prone PCR##2##3##(2008-8#1)(2011-1#1)
using europium##2##2##(2008-10#2)
using evidence##3##2##(2008-11#1)(2009-11#1)(2009-3#1)
using examples from##2##3##(2008-10#2)
using excitation-emission matrix##2##3##(2008-10#2)
using exfoliated graphite##2##3##(2008-10#2)
using experimental design methodology##2##4##(2008-10#2)
using experimental design##3##3##(2008-10#3)
using experimental##4##2##(2008-10#4)
using external calibration##3##3##(2008-10#3)
using external##5##2##(2007-12#1)(2008-10#3)(2008-9#1)
using extracellular##2##2##(2008-11#1)(2009-10#1)
using extracts##2##2##(2008-10#1)(2009-6#1)
using factor analysis##2##3##(2008-10#1)(2011-2#1)
using factorial design and##2##4##(2008-10#2)
using factorial design for optimization##2##5##(2008-10#2)
using factorial design##6##3##(2008-10#6)
using factorial##8##2##(2008-10#8)
using fibronectin-coated dishes##2##3##(2008-11#2)
using field##2##2##(2011-2#2)
using five##6##2##(2008-10#4)(2008-11#1)(2013-8#1)
using flame AAS##2##3##(2008-10#2)
using flame atomic absorption spectrometry (FAAS)##3##6##(2008-10#3)
using flame atomic absorption spectrometry##5##5##(2008-10#5)
using flame atomic absorption##7##4##(2008-10#7)
using flame##10##2##(2008-10#10)
using flow cytometric##2##3##(2008-10#1)(2008-11#1)
using flow cytometry##8##3##(1993-8#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-6#1)(2011-2#1)
using flow electroporation##2##3##(2008-11#2)
using flow injection (FI)##2##4##(2008-10#2)
using flow injection analysis (FIA)##2##5##(2008-10#2)
using flow injection analysis with tris(2##3##6##(2008-10#3)
using flow injection analysis with##8##5##(2008-10#8)
using flow injection analysis##16##4##(2008-10#16)
using flow injection##33##3##(2008-10#33)
using flow##46##2##(1993-8#2)(2008-10#35)(2008-11#4)(2008-4#1)(2008-9#2)(2009-6#1)(2011-2#1)
using flow-injection analysis##3##3##(2008-10#3)
using flow-injection##9##2##(2008-10#9)
using fluorescein isothiocyanate##2##3##(2008-10#1)(2008-4#1)
using fluorescence in situ hybridisation##2##5##(2008-12#2)
using fluorescence in situ##3##4##(2008-11#1)(2008-12#2)
using fluorescence microscopy##3##3##(1994-5#1)(2008-11#1)(2009-12#1)
using fluorescence resonance energy transfer##2##5##(1994-5#1)(2008-4#1)
using fluorescence spectroscopy##2##3##(1991-3#1)(2008-10#1)
using fluorescence##18##2##(1991-3#1)(1994-5#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2009-12#1)
using fluorescent##2##2##(2008-10#2)
using fluorimetric detection##2##3##(2008-10#2)
using focus group##2##3##(2008-11#1)(2010-10#1)
using focus##4##2##(2008-11#2)(2008-12#1)(2010-10#1)
using follistatin##2##2##(1992-6#2)
using four##9##2##(1991-9#1)(2008-10#5)(2008-9#1)(2010-4#1)(2013-1#1)
using free##3##2##(1996-2#1)(2008-10#1)(2008-7#1)
using frequency##2##2##(1991-2#1)(2008-7#1)
using full##3##2##(2008-10#3)
using functional##3##2##(2008-11#1)(2008-5#1)(2010-7#1)
using galvanostatic##2##2##(2008-10#1)(2009-10#1)
using gas chromatography with##2##4##(2008-10#2)
using gas chromatography##7##3##(2007-12#1)(2008-10#6)
using gas chromatography-mass spectrometry##2##4##(1994-2#1)(2008-10#1)
using gas##10##2##(1994-2#1)(2007-12#1)(2008-10#8)
using gel filtration##5##3##(1990-2#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
using gel##8##2##(1990-2#1)(1992-9#1)(2008-10#3)(2008-11#1)(2008-8#2)
using gene##3##2##(2008-10#1)(2008-8#1)(2010-10#1)
using generalized##2##2##(1990-12#1)(2008-10#1)
using genetic##8##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
using glassy carbon##3##3##(2008-10#3)
using glucose##3##2##(2008-10#2)(2008-6#1)
using glutaraldehyde and fixed on a pretreated##2##7##(2008-10#2)
using glutaraldehyde and fixed on##3##5##(2008-10#3)
using glutaraldehyde##6##2##(1997-2#1)(2008-10#5)
using gold##4##2##(2008-10#2)(2009-7#1)(2010-1#1)
using gradient##2##2##(2008-10#2)
using graphite furnace atomic absorption spectrometry##3##6##(2008-10#3)
using graphite furnace atomic absorption##4##5##(2008-10#4)
using group##3##2##(2008-10#2)(2011-2#1)
using hanging mercury drop electrode##2##5##(2008-10#2)
using headspace##3##2##(2008-10#3)
using heat-inactivated##2##2##(2008-10#1)(2008-5#1)
using heteropolyacid montmorillonite clay-modified##2##4##(2008-10#2)
using high performance liquid chromatography##4##5##(1993-2#1)(2008-10#2)(2012-2#1)
using high performance liquid##6##4##(1990-12#1)(1993-2#1)(2008-10#3)(2012-2#1)
using high pressure liquid chromatography##2##5##(2008-10#1)(2011-1#1)
using high resolution##4##3##(2008-10#2)(2008-8#1)(2010-4#1)
using high##21##2##(1990-12#1)(1993-2#1)(2008-10#8)(2008-11#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
using high-performance liquid chromatography (HPLC)##3##5##(1992-11#1)(2008-10#1)(2008-5#1)
using high-performance liquid chromatography with fluorescence detection and##2##8##(2008-10#2)
using high-performance liquid chromatography##7##4##(1992-11#1)(2008-10#5)(2008-5#1)
using high-performance liquid##8##3##(1992-11#1)(2008-10#6)(2008-5#1)
using high-purity##2##2##(2008-10#2)
using high-throughput##2##2##(2009-7#1)(2011-2#1)
using higher##2##2##(2008-11#1)(2010-12#1)
using highly##3##2##(2008-10#2)(2008-5#1)
using historical##2##2##(1994-1#1)(2008-10#1)
using horseradish peroxidase and##2##4##(1990-12#1)(2008-9#1)
using horseradish peroxidase##3##3##(1990-12#1)(2008-4#1)(2008-9#1)
using human##10##2##(1993-3#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-5#1)
using hydride##2##2##(2008-10#2)
using hydrogen##2##2##(2008-10#1)(2008-6#1)
using hydrophilic##2##2##(2012-2#2)
using hyphenated##2##2##(2008-10#2)
using iliac##2##2##(2008-12#2)
using image guidance system##2##4##(2011-2#2)
using image##4##2##(1995-12#1)(2008-5#1)(2011-2#2)
using immobilized##7##2##(1995-2#1)(2008-10#2)(2008-6#1)(2008-7#3)
using immunocapture##2##2##(2011-2#2)
using immunofluorescence##2##2##(2008-10#1)(2008-5#1)
using immunohistochemistry##4##2##(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
using implicit##2##2##(1993-1#1)(2009-12#1)
using in situ synthesized##2##4##(2008-10#2)
using in situ##4##3##(1996-12#1)(2008-10#3)
using in the##2##3##(2008-10#1)(2012-3#1)
using in vitro assays##2##4##(2008-10#1)(2010-4#1)
using in vitro##7##3##(2008-1#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-4#1)
using in vivo##3##3##(1994-2#1)(1997-8#1)(2008-10#1)
using in##16##2##(1994-2#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-9#1)(2010-4#1)(2012-3#1)
using inbred##2##2##(2012-3#2)
using indirect##2##2##(1997-2#1)(2008-10#1)
using individual##4##2##(1992-6#1)(2008-12#1)(2010-7#1)(2011-1#1)
using individual-based##2##2##(2008-8#1)(2008-9#1)
using inductively coupled plasma atomic emission spectrometry (ICP-AES)##4##8##(2008-10#4)
using inductively coupled plasma mass spectrometry (ICP-MS)##2##7##(2008-10#2)
using inductively coupled plasma mass spectrometry##4##6##(2008-10#4)
using inductively coupled plasma##8##4##(2008-10#8)
using inductively coupled plasma-optical emission spectrometry (ICP-OES)##2##7##(2008-10#2)
using inductively coupled##12##3##(2008-10#12)
using information##4##2##(1993-2#1)(1997-7#1)(2008-10#2)
using infrared spectroscopy and##2##4##(2008-10#2)
using infrared spectroscopy##3##3##(2008-10#3)
using infrared##6##2##(2008-10#5)(2008-5#1)
using innovative##2##2##(1997-1#1)(2008-10#1)
using intact##3##2##(1994-8#1)(2008-10#2)
using interaction##2##2##(2008-9#1)(2009-10#1)
using internal standard##2##3##(2008-10#2)
using internal standardization##2##3##(2008-10#2)
using internal##6##2##(1997-2#1)(2008-10#5)
using iodide##2##2##(2008-10#2)
using ion chromatography (IC)##2##4##(2008-10#2)
using ion chromatography##4##3##(2008-10#4)
using ion exchange##5##3##(1997-2#1)(2008-10#3)(2013-1#1)
using ion mobility spectrometry (IMS)##2##5##(2008-10#2)
using ion mobility spectrometry##5##4##(2008-10#5)
using ion pairing##2##3##(2008-10#2)
using ion##17##2##(1997-2#1)(2008-10#15)(2013-1#1)
using ion-selective electrodes (ISEs)##2##4##(2008-10#2)
using ion-spray mass spectrometry##2##4##(1994-5#2)
using isolated##2##2##(2008-11#1)(2012-2#1)
using isolates##2##2##(2008-10#2)
using isotope dilution##2##3##(2008-10#2)
using it as a##2##4##(2008-10#1)(2013-8#1)
using it as##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
using it##5##2##(2008-10#1)(2008-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
using its##5##2##(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)
using knotted##2##2##(2008-10#2)
using laccase##2##2##(2008-6#2)
using large-scale##2##2##(1991-8#1)(2009-8#1)
using laser ablation inductively coupled plasma##2##6##(2008-10#2)
using laser##5##2##(2008-10#5)
using layer-by-layer##2##2##(2008-10#2)
using less##2##2##(2008-10#1)(2010-8#1)
using light and electron microscopy##3##5##(2008-10#3)
using light microscopy##5##3##(1996-3#1)(2007-12#1)(2008-10#3)
using light##12##2##(1996-3#1)(2007-12#1)(2008-10#9)(2008-12#1)
using limited##2##2##(1995-3#1)(2012-3#1)
using linear sweep stripping##2##4##(2008-10#2)
using linear sweep##3##3##(2008-10#3)
using linear##8##2##(2008-10#5)(2008-12#1)(2009-8#1)(2010-8#1)
using lipoprotein subclass analysis##2##4##(2008-3#2)
using liposomes##2##2##(2008-10#2)
using liquid chromatography and##2##4##(2008-1#1)(2008-10#1)
using liquid chromatography##4##3##(2008-1#1)(2008-10#3)
using liquid##7##2##(2008-1#1)(2008-10#6)
using liquid-liquid extraction##2##3##(2008-10#2)
using living##3##2##(2008-10#3)
using local##2##2##(2008-10#1)(2008-11#1)
using logistic regression##2##3##(2011-2#1)(2012-12#1)
using logistic##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
using long##2##2##(1993-3#1)(2008-10#1)
using low melt agarose##2##4##(2008-11#2)
using low##7##2##(1990-5#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-4#1)(2013-8#1)
using low-cost##2##2##(2008-6#1)(2008-7#1)
using magnetic beads##2##3##(2008-4#2)
using magnetic microbeads##2##3##(2008-10#2)
using magnetic nanoparticles##2##3##(2011-2#1)(2012-2#1)
using magnetic resonance##3##3##(1996-2#1)(2008-11#1)(2008-7#1)
using magnetic##12##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
using manual##2##2##(1991-3#1)(1993-1#1)
using mass##3##2##(2008-11#1)(2011-2#2)
using material##2##2##(2008-11#1)(2008-9#1)
using mean##3##2##(1992-9#1)(2008-10#2)
using measures of##2##3##(1994-2#1)(2008-10#1)
using mechanical##3##2##(2008-10#3)
using membrane mass spectrometry##2##4##(2008-11#2)
using membrane##4##2##(2008-11#3)(2010-4#1)
using mercaptosephadex##2##2##(2008-10#2)
using message-driven parallel quantum and classical dynamics##2##7##(2013-1#2)
using metal##2##2##(2008-10#2)
using metallic##2##2##(2008-10#2)
using methanol as##2##3##(2008-10#2)
using methanol##3##2##(2008-10#3)
using methyl##2##2##(1995-5#1)(2008-10#1)
using mice as##2##3##(2008-12#1)(2008-6#1)
using mice##7##2##(1994-8#1)(2008-11#1)(2008-12#1)(2008-6#3)(2009-8#1)
using micellar##4##2##(2008-10#4)
using microarray and##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
using microarray##6##2##(2008-10#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#1)(2012-3#1)
using microarrays##3##2##(2009-6#1)(2012-3#1)(2013-1#1)
using microgravimetric quartz-crystal-microbalance##2##3##(2008-10#2)
using microsatellite markers and##2##4##(2008-10#2)
using microsatellite markers##3##3##(2008-10#3)
using microsatellite##4##2##(2008-10#3)(2008-11#1)
using microtiter##2##2##(2008-11#1)(2010-11#1)
using microwave heating##2##3##(2008-10#2)
using microwave##6##2##(2008-10#5)(2009-7#1)
using microwaves##2##2##(2008-10#2)
using mixed ion-pairing##2##3##(2008-10#2)
using mixed##4##2##(2008-10#4)
using mixtures of##6##3##(2008-10#5)(2011-1#1)
using model##5##2##(2008-10#4)(2012-3#1)
using models##2##2##(2008-10#1)(2008-8#1)
using modern##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
using modified##7##2##(2008-10#3)(2008-4#2)(2008-9#1)(2013-1#1)
using molecular beacons##2##3##(2008-10#1)(2008-9#1)
using molecular##10##2##(2008-10#5)(2008-9#1)(2009-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
using molybdenum containing chemical modifiers##2##5##(2008-10#2)
using molybdenum##4##2##(2008-10#4)
using monoclonal antibodies##3##3##(1992-3#1)(1993-9#1)(2008-7#1)
using monoclonal antibody##2##3##(1990-11#1)(1995-6#1)
using monoclonal##6##2##(1990-11#1)(1992-3#1)(1993-9#1)(1995-6#1)(2008-7#1)(2012-3#1)
using monolithic column chromatography##2##4##(2008-10#2)
using more##3##2##(1993-3#1)(1997-3#1)(2009-7#1)
using morphological criteria##2##3##(2008-10#2)
using morphological##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
using multiple linear regression##2##4##(2008-10#2)
using multiple regression with##2##4##(2008-10#2)
using multiple regression##3##3##(2008-10#3)
using multiple##20##2##(1993-12#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-3#1)
using multivariate calibration methods##3##4##(2008-10#3)
using multivariate calibration##6##3##(2008-10#6)
using multivariate##9##2##(1991-1#1)(2008-10#8)
using multiwalled carbon nanotubes as##2##5##(2008-10#2)
using natural##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
using naturally##2##2##(2008-10#2)
using near-infrared##3##2##(2008-10#3)
using negative##2##2##(2008-10#2)
using network##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
using new materials##2##3##(2012-3#1)(2013-1#1)
using new##4##2##(1995-9#1)(2008-10#1)(2012-3#1)(2013-1#1)
using newer##2##2##(2011-2#2)
using nine##2##2##(2008-10#1)(2013-8#1)
using non##3##2##(2008-10#3)
using non-parametric statistics##2##3##(2012-12#1)(2013-1#1)
using nuclear##2##2##(1994-5#1)(1995-6#1)
using o-phenylenediamine as##2##3##(2008-10#2)
using octadecyl silica membrane disks modified by##5##7##(2008-10#5)
using octadecyl##6##2##(2008-10#6)
using of##5##2##(2008-10#4)(2012-3#1)
using on-line electrogenerated##2##3##(2008-10#2)
using on-line##8##2##(2008-10#8)
using one of##2##3##(2008-10#1)(2011-2#1)
using one##10##2##(1995-12#1)(1997-3#1)(2008-10#6)(2010-7#1)(2011-2#1)
using one-way ANOVA and##2##4##(2011-2#1)(2013-1#1)
using one-way##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
using online##2##2##(2008-10#1)(2008-11#1)
using only one##2##3##(2008-10#2)
using only##10##2##(2008-10#8)(2008-8#1)(2008-9#1)
using optical##8##2##(1993-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-7#1)(2010-8#1)
using oral##3##2##(1991-12#1)(2008-11#1)(2008-9#1)
using orthopaedic##2##2##(2007-8#2)
using other##9##2##(1994-12#1)(1994-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)
using our##3##2##(2008-10#2)(2009-11#1)
using outpatient##3##2##(1995-1#1)(1995-2#2)
using packed column supercritical fluid chromatography (SFC)##2##7##(2008-10#2)
using packed column supercritical fluid chromatography##3##6##(2008-10#3)
using parsimony##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
using partial least squares (PLS) regression##2##6##(2008-10#2)
using partial least squares (PLS)##4##5##(2008-10#4)
using partial least squares multivariate calibration##2##6##(2008-10#2)
using partial least squares regression##2##5##(2008-10#2)
using partial least squares##13##4##(2008-10#13)
using partial least-squares (PLS)##2##4##(2008-10#2)
using partial least-squares##6##3##(2008-10#6)
using partial##19##2##(2008-10#19)
using patch-clamp##2##2##(1994-11#1)(2011-2#1)
using path##2##2##(1994-2#1)(2012-3#1)
using pathways##2##2##(2008-3#2)
using pattern recognition##2##3##(2008-10#2)
using pea##2##2##(2008-10#2)
using peak##4##2##(2008-10#4)
using peripheral blood mononuclear cells##2##5##(2008-11#1)(2011-2#1)
using permanent modifiers##3##3##(2008-10#3)
using permanganate##2##2##(2008-10#2)
using phosphate##2##2##(2008-10#1)(2012-2#1)
using phosphoric##2##2##(2008-10#2)
using photo diode array##2##4##(2008-10#2)
using photoactivated##2##2##(2008-10#1)(2012-2#1)
using plasmid##2##2##(2008-8#1)(2008-9#1)
using playback##2##2##(2008-8#2)
using polyamine##2##2##(2008-10#1)(2008-12#1)
using polyclonal##3##2##(2008-10#2)(2008-5#1)
using polyethylene glycol##2##3##(2008-10#1)(2008-9#1)
using polyethylenimine##2##2##(2008-10#1)(2008-11#1)
using polymer##3##2##(2008-10#2)(2009-5#1)
using polymerase chain reaction (PCR)##4##5##(2008-10#4)
using polymerase chain reaction##10##4##(1990-2#1)(2008-10#7)(2010-4#1)(2013-1#1)
using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)##2##8##(1997-8#1)(2008-10#1)
using polymerase chain##15##3##(1990-2#1)(1997-8#3)(2008-10#9)(2010-4#1)(2013-1#1)
using polystyrene latex particles##2##4##(2010-6#2)
using polytetrafluoroethylene##3##2##(2008-10#3)
using porous graphitic carbon##2##4##(2008-10#2)
using porous##3##2##(2008-10#3)
using positive##2##2##(2008-10#1)(2008-9#1)
using potassium##3##2##(2008-10#3)
using potentiometric and##2##3##(2008-10#2)
using potentiometric titration##3##3##(2008-10#3)
using potentiometric##9##2##(2008-10#9)
using primary##3##2##(1990-5#1)(1995-12#1)(2008-11#1)
using primers flanking the##2##4##(2008-11#1)(2010-4#1)
using primers specific for##2##4##(2008-10#2)
using primers##11##2##(1992-6#1)(1993-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-4#1)
using principal component analysis##7##4##(2008-10#6)(2008-11#1)
using principal component##8##3##(2008-10#7)(2008-11#1)
using principal components analysis (PCA)##2##5##(2008-10#2)
using principal components analysis##3##4##(2008-10#3)
using principal components##4##3##(2008-10#4)
using principal##12##2##(2008-10#11)(2008-11#1)
using probe##3##2##(1993-3#2)(2008-10#1)
using probes##2##2##(2008-4#1)(2008-9#1)
using propidium iodide##2##3##(2008-4#1)(2009-6#1)
using protein##3##2##(1997-2#1)(2008-10#1)(2010-6#1)
using published##2##2##(2008-10#1)(2008-6#1)
using pulse##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
using pulsed##4##2##(1996-11#1)(2008-10#3)
using pure##2##2##(2008-10#1)(2008-4#1)
using purified##8##2##(1991-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2011-1#1)(2012-2#1)
using pyrene carboxylic acid##3##4##(2008-10#3)
using pyrene##4##2##(2008-10#4)
using pyrosequencing##2##2##(2009-8#1)(2012-2#1)
using qualitative and quantitative##2##4##(2008-1#1)(2008-11#1)
using qualitative content analysis##3##4##(2008-12#1)(2010-10#2)
using qualitative##6##2##(2008-1#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)
using quantitative real-time##2##3##(2010-7#1)(2011-2#1)
using quantitative##10##2##(1994-2#1)(2008-10#3)(2008-11#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
using quartz crystal##2##3##(2008-10#2)
using questionnaires and##2##3##(2008-12#1)(2013-1#1)
using radiolabeled##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
using random amplified polymorphic DNA (RAPD) markers##2##7##(2008-10#2)
using random amplified polymorphic DNA (RAPD)##3##6##(2008-10#3)
using random amplified##4##3##(2008-10#4)
using random##7##2##(2008-10#6)(2013-8#1)
using rats##2##2##(2008-10#2)
using reaction cell and hydride generation##2##6##(2008-10#2)
using readily available##2##3##(1992-9#1)(2008-4#1)
using real-time PCR##2##3##(2008-10#2)
using real-time polymerase chain reaction##2##5##(2008-10#1)(2013-1#1)
using real-time quantitative##2##3##(2008-10#2)
using real-time##7##2##(2008-10#6)(2013-1#1)
using realistic##2##2##(2008-10#1)(2010-12#1)
using recombinant##4##2##(1991-5#1)(1995-11#1)(2008-10#2)
using reduced##2##2##(2008-11#1)(2008-12#1)
using reference##4##2##(2008-10#3)(2008-2#1)
using reflection##2##2##(2008-12#2)
using regression##3##2##(2008-10#1)(2008-11#1)(2009-9#1)
using repeated##2##2##(2008-10#1)(2009-3#1)
using resonance Rayleigh scattering (RRS)##2##5##(2008-10#2)
using resonance light scattering##2##4##(2008-10#2)
using resonance##4##2##(2008-10#4)
using restriction fragment length polymorphism (RFLP)##2##6##(1996-12#1)(2008-10#1)
using restriction fragment length polymorphism markers##3##6##(2008-10#3)
using restriction fragment length polymorphism##6##5##(1996-12#1)(2008-10#5)
using restriction fragment length##7##4##(1996-12#1)(2008-10#6)
using restriction##9##2##(1995-12#1)(1996-12#1)(2008-10#7)
using reverse transcription-polymerase chain reaction (RT-PCR)##2##6##(1997-7#1)(2008-10#1)
using reverse transcription-polymerase chain reaction##3##5##(1997-7#1)(2008-10#1)(2011-2#1)
using reverse##6##2##(1993-12#1)(1997-7#1)(2008-10#3)(2011-2#1)
using reversed-phase high-performance liquid chromatography##2##5##(1995-11#1)(2008-10#1)
using reversed-phase liquid chromatography##2##4##(2008-10#2)
using reversed-phase##7##2##(1995-11#1)(2008-10#6)
using rhodamine S##2##3##(2008-10#2)
using rhodamine##4##2##(2008-10#4)
using role-play as##2##3##(2008-11#2)
using routine##2##2##(2008-10#1)(2008-9#1)
using salicylate##2##2##(2008-10#2)
using samples of##3##3##(2008-10#2)(2013-8#1)
using samples##4##2##(2008-10#3)(2013-8#1)
using scanning electron microscopy (SEM)##2##5##(2008-10#1)(2013-8#1)
using scanning electron microscopy##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
using scanning electron##4##3##(2008-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
using scanning##5##2##(2008-10#1)(2008-7#1)(2009-3#1)(2013-1#1)(2013-8#1)
using scenario-based design##2##3##(2010-8#2)
using selected##3##2##(2008-10#3)
using selective##6##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
using semi-quantitative##3##2##(1994-11#1)(1994-2#1)(2011-2#1)
using sensitive##2##2##(2008-4#1)(2008-9#1)
using sequence##2##2##(1995-6#1)(2010-4#1)
using sequences of the##2##4##(2008-10#1)(2008-9#1)
using sequential injection analysis##2##4##(2008-10#2)
using sequential injection##4##3##(2008-10#4)
using sequential##9##2##(1992-9#1)(2008-10#7)(2008-11#1)
using serological##2##2##(2008-10#1)(2011-2#1)
using serum##5##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
using serum-free##2##2##(2008-11#1)(2008-7#1)
using seven##3##2##(1996-6#1)(2008-10#1)(2008-5#1)
using several different##4##3##(1994-5#1)(2008-10#1)(2011-2#2)
using several##11##2##(1992-12#1)(1994-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#2)
using short##6##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
using silica gel loaded with##4##5##(2008-10#4)
using silica gel##7##3##(2008-10#6)(2008-11#1)
using silver and##2##3##(2008-10#2)
using silver##4##2##(2008-10#4)
using similar##2##2##(2008-11#1)(2012-2#1)
using simple##9##2##(2007-12#1)(2008-10#4)(2008-4#1)(2008-9#1)(2011-2#2)
using simulated##4##2##(2008-10#3)(2008-3#1)
using single##4##2##(1991-6#1)(1994-8#1)(2008-3#1)(2013-8#1)
using site-directed mutagenesis##3##3##(1994-5#1)(1995-2#1)(2008-9#1)
using slurry sampling##5##3##(2008-10#5)
using small volumes##2##3##(2008-10#2)
using small##5##2##(2008-10#5)
using sodium 3-(2-pyridyl)-5##2##3##(2008-10#2)
using sodium##9##2##(2008-10#8)(2008-12#1)
using soft##2##2##(2008-10#2)
using software##3##2##(2008-10#2)(2013-1#1)
using solid phase extraction##5##4##(2008-10#4)(2008-11#1)
using solid phase##6##3##(2008-10#5)(2008-11#1)
using solid##11##2##(2008-10#10)(2008-11#1)
using solid-phase extraction and##2##4##(2008-10#2)
using solid-phase extraction##4##3##(2008-10#3)(2013-8#1)
using solid-phase microextraction##3##3##(2008-10#3)
using solid-phase##8##2##(2008-10#7)(2013-8#1)
using soluble##2##2##(2008-10#1)(2009-12#1)
using somatic##2##2##(1997-9#1)(2008-10#1)
using some of these##2##4##(2008-10#1)(2008-5#1)
using some##6##2##(1997-4#1)(2008-10#3)(2008-5#1)(2013-1#1)
using species-specific##2##2##(2008-10#1)(2011-2#1)
using specific primers##3##3##(1994-11#1)(2008-7#1)(2013-1#1)
using specific##17##2##(1990-11#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
using spectral##3##2##(2008-10#1)(2008-2#1)(2009-10#1)
using spectrophotometric##7##2##(2008-10#7)
using spiked##2##2##(2008-10#2)
using spiro form rhodamine B hydrazide##2##6##(2008-10#2)
using spot##2##2##(2008-10#2)
using square wave voltammetry##3##4##(2008-10#3)
using square wave##6##3##(2008-10#6)
using square-wave##3##2##(2008-10#3)
using stabilized##3##2##(1996-12#1)(2008-10#2)
using stable##3##2##(1991-5#1)(2008-10#2)
using standard addition method##2##4##(2008-10#2)
using standard addition##3##3##(2008-10#3)
using standard procedures##2##3##(2008-10#2)
using standard##25##2##(1990-6#1)(1991-3#1)(1995-12#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)
using standardized##4##2##(1996-2#1)(2008-11#1)(2012-3#1)(2013-1#1)
using statistical software##2##3##(2008-10#2)
using statistical##4##2##(1994-2#1)(2008-10#2)(2008-5#1)
using steady-state##3##2##(2008-10#2)(2008-8#1)
using stochastic##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
using strain##2##2##(2008-10#1)(2008-12#1)
using strain-specific monoclonal##2##3##(2008-10#2)
using strategy of gene disruption##2##5##(2008-8#2)
using structured##2##2##(2008-11#1)(2010-2#1)
using student##2##2##(1997-2#2)
using such a##2##3##(2007-12#1)(2008-7#1)
using such##5##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
using supercritical fluid extraction##2##4##(2008-10#2)
using supercritical##4##2##(2008-10#3)(2012-2#1)
using surface plasmon resonance##2##4##(2008-10#2)
using surface##7##2##(1997-8#1)(2008-10#3)(2010-6#1)(2011-2#2)
using synchrotron radiation##3##3##(2008-10#2)(2008-5#1)
using synchrotron##4##2##(2008-10#2)(2008-5#2)
using synthetic##8##2##(1990-4#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)
using systematic##2##2##(2008-10#1)(2011-2#1)
using techniques##3##2##(2008-4#1)(2008-5#1)(2008-8#1)
using technology##3##2##(2008-11#3)
using temperature modulated SnO(2) gas sensor##2##6##(2008-10#2)
using temperature##4##2##(2008-10#3)(2011-2#1)
using tetra-3##2##2##(2008-10#2)
using tetrazolium##2##2##(2008-10#1)(2008-11#1)
using the &quot##4##3##(2008-10#2)(2008-8#1)(2010-12#1)
using the 2##2##3##(2008-10#2)
using the Affymetrix##2##3##(2009-10#1)(2010-11#1)
using the BDD electrode##2##4##(2008-10#2)
using the Beads technique##2##4##(1996-12#2)
using the Bentall and##2##4##(2012-2#2)
using the CE##2##3##(2008-10#2)
using the CO 2 laser##4##5##(1992-1#3)(1992-3#1)
using the CO2 laser##2##4##(1994-12#2)
using the Cavitron##2##3##(1995-12#2)
using the ELISA technique##2##4##(2008-6#1)(2013-1#1)
using the GROC and##2##4##(2008-12#2)
using the Ilizarov##2##3##(2009-3#1)(2009-4#1)
using the Internet##2##3##(2008-10#1)(2009-5#1)
using the Keystone action plan criteria##2##6##(2011-1#2)
using the Parafac2 model##2##4##(2013-1#2)
using the SPSS##2##3##(2010-6#1)(2012-3#1)
using the University of##2##4##(1996-3#1)(2008-11#1)
using the Wilcoxon signed rank test##2##6##(1997-8#1)(2010-6#1)
using the Zeeman modulation technique##2##5##(2008-3#2)
using the appropriate##3##3##(2008-10#2)(2008-11#1)
using the available##2##3##(1994-5#1)(2008-10#1)
using the bacteriophage##2##3##(1996-2#1)(2008-2#1)
using the batch injection analysis (BIA) technique##2##7##(2008-10#2)
using the best##2##3##(2008-11#1)(2010-8#1)
using the biosensor developed##2##4##(2008-10#2)
using the carbon dioxide laser##2##5##(1991-12#2)
using the catalytic hydrogen wave##2##5##(2008-10#2)
using the chloramphenicol acetyltransferase (CAT) gene as##2##7##(1992-6#1)(1997-8#1)
using the classical##2##3##(2008-10#1)(2008-8#1)
using the cloned##2##3##(1994-11#2)
using the computer program GenMark##2##5##(1995-12#2)
using the computer program##4##4##(1995-12#2)(1997-2#1)(2008-11#1)
using the computer##6##3##(1995-12#2)(1997-2#1)(2008-11#1)(2008-12#1)(2012-12#1)
using the constant##2##3##(2008-10#1)(2008-11#1)
using the conventional method##2##4##(2008-10#2)
using the conventional##5##3##(1992-3#1)(2008-10#3)(2008-7#1)
using the correlation coefficient##2##4##(2008-10#1)(2011-3#1)
using the corresponding##2##3##(1993-2#1)(2008-10#1)
using the developed##5##3##(2008-10#5)
using the different##2##3##(2008-10#1)(2008-9#1)
using the differential pulse##2##4##(2008-10#2)
using the direct##2##3##(2008-10#1)(2010-6#1)
using the discrete##2##3##(2008-2#1)(2008-6#1)
using the dual grid##2##4##(2013-1#2)
using the dynamic##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
using the electrochemical quartz crystal microbalance##2##6##(2008-10#2)
using the electrode##3##3##(2008-10#2)(2008-9#1)
using the established##2##3##(2008-10#2)
using the experimental##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
using the extraction##2##3##(2008-10#2)
using the first derivative##2##4##(2008-10#2)
using the fluorescence##2##3##(2008-10#1)(2008-8#1)
using the following##4##3##(1993-12#1)(2008-10#3)
using the gene##2##3##(1992-3#1)(2008-11#1)
using the general##2##3##(2008-12#1)(2008-9#1)
using the headspace##2##3##(2008-10#2)
using the human##4##3##(1995-12#1)(1997-2#1)(2008-11#2)
using the information##2##3##(2010-8#1)(2011-3#1)
using the initial##2##3##(2008-10#2)
using the least##2##3##(1995-12#1)(2008-5#1)
using the linear##3##3##(2008-10#2)(2013-1#1)
using the method of constant stimuli##2##6##(1990-11#2)
using the method of standard additions##3##6##(2008-10#3)
using the method of##9##4##(1990-11#2)(1992-9#1)(2008-10#4)(2010-12#1)(2013-1#1)
using the method##12##3##(1990-11#2)(1992-9#1)(2008-10#6)(2010-12#1)(2012-2#1)(2013-1#1)
using the mixture of##2##4##(2008-10#1)(2008-5#1)
using the model##6##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
using the modified##7##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2012-3#1)
using the multiple##2##3##(2008-10#1)(2008-11#1)
using the neighbor-joining##2##3##(2008-10#1)(2008-6#1)
using the new primers##2##4##(2008-10#2)
using the new##6##3##(2008-10#5)(2008-12#1)
using the optimized##3##3##(2008-10#3)
using the oxygen radical absorbance capacity (ORAC) assay##2##8##(2008-10#1)(2008-7#1)
using the peak##2##3##(2008-10#2)
using the polymerase chain reaction to##2##6##(2008-11#1)(2011-2#1)
using the polymerase chain reaction##9##5##(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-2#1)(1997-7#1)(2008-11#1)(2011-2#1)
using the polymerase chain##10##4##(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-2#1)(1996-8#1)(1997-7#1)(2008-11#1)(2011-2#1)
using the present##3##3##(2008-10#3)
using the proposed biosensor##2##4##(2008-10#2)
using the proposed method##3##4##(2008-10#3)
using the proposed methodology##2##4##(2008-10#2)
using the proposed procedure##3##4##(2008-10#3)
using the proposed##21##3##(2008-10#20)(2008-3#1)
using the rat##2##3##(1992-10#1)(1995-2#1)
using the reaction of##3##4##(2008-10#3)
using the reaction##4##3##(2008-10#4)
using the reactors##2##3##(2008-10#2)
using the real-time PCR##2##4##(2008-10#1)(2013-8#1)
using the redox##2##3##(2008-10#2)
using the restriction enzymes##2##4##(2008-10#1)(2009-10#1)
using the same instrument##2##4##(2008-10#1)(2008-6#1)
using the same##14##3##(1990-12#1)(1995-2#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#2)
using the samples##3##3##(1991-1#1)(2008-10#2)
using the slurry##2##3##(2008-10#2)
using the software##2##3##(2010-12#1)(2013-1#1)
using the square wave##2##4##(2008-10#1)(2011-2#1)
using the standard addition method##3##5##(2008-10#3)
using the standard addition##4##4##(2008-10#4)
using the standard##12##3##(1992-12#1)(1994-1#1)(2008-10#8)(2008-7#1)(2013-8#1)
using the statistical##2##3##(2008-10#1)(2011-2#1)
using the stopped-flow##3##3##(2008-10#3)
using the strategy##3##3##(2010-7#3)
using the system##2##3##(2008-10#2)
using the tagging reagent 1##2##5##(2008-10#2)
using the technique of##4##4##(2008-10#3)(2008-11#1)
using the terms##2##3##(2011-2#1)(2013-1#1)
using the three##4##3##(2008-10#3)(2013-1#1)
using the two##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
using the variable##2##3##(2008-10#1)(2008-11#1)
using the yeast##2##3##(2008-7#1)(2008-8#1)
using the zero-crossing approach for determination of##2##7##(2008-10#2)
using the##957##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#3)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#3)(1993-6#2)(1993-8#5)(1994-1#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#3)(1995-1#1)(1995-12#10)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#6)(1996-2#6)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#5)(2006-6#2)(2007-12#2)(2008-1#5)(2008-10#436)(2008-11#55)(2008-12#18)(2008-2#3)(2008-3#16)(2008-4#10)(2008-5#21)(2008-6#8)(2008-7#16)(2008-8#22)(2008-9#29)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#6)(2010-7#7)(2010-8#4)(2011-1#3)(2011-2#34)(2011-3#2)(2011-7#1)(2012-12#11)(2012-2#19)(2012-3#5)(2012-5#1)(2013-1#28)(2013-8#9)
using their##3##2##(2006-6#1)(2008-10#2)
using them##4##2##(1995-6#1)(2008-12#1)(2011-2#2)
using thematic##2##2##(2008-11#1)(2009-12#1)
using thermal##2##2##(2008-10#1)(2008-8#1)
using these antigens##2##3##(2008-10#1)(2011-2#1)
using these data##2##3##(1996-12#1)(2008-10#1)
using these markers##2##3##(2008-9#1)(2013-8#1)
using these methods##3##3##(2008-10#3)
using these primers##2##3##(2008-10#2)
using these techniques##3##3##(2008-10#1)(2008-9#1)(2009-11#1)
using these##35##2##(1990-5#1)(1991-5#1)(1993-9#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
using this &quot##2##3##(2008-10#1)(2008-9#1)
using this analytical##2##3##(2008-10#2)
using this approach##5##3##(1993-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
using this electrode##3##3##(2008-10#3)
using this method for the determination of##2##7##(2008-10#2)
using this method##10##3##(1990-3#1)(1992-2#1)(1997-7#1)(2008-10#6)(2013-8#1)
using this methodology##2##3##(2008-10#2)
using this model##2##3##(2008-10#1)(2008-11#1)
using this new##2##3##(2008-10#1)(2008-12#1)
using this procedure##2##3##(1994-9#1)(2008-10#1)
using this strategy##3##3##(2008-11#2)(2008-9#1)
using this substrate##2##3##(2008-10#2)
using this system##3##3##(1997-8#1)(2008-10#2)
using this technique##6##3##(2008-10#4)(2008-8#1)(2013-8#1)
using this voltammetric##2##3##(2008-10#2)
using this##80##2##(1990-3#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#40)(2008-11#9)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#2)
using three different##6##3##(2008-10#4)(2008-11#2)
using three##18##2##(1995-12#1)(2008-10#13)(2008-11#2)(2010-4#1)(2010-8#1)
using three-dimensional##2##2##(2008-3#1)(2011-2#1)
using time-frequency methods##2##3##(2010-8#2)
using tissue microarray##2##3##(2008-10#1)(2008-11#1)
using tissue##4##2##(1994-2#1)(2008-10#2)(2008-11#1)
using titanium trichloride##2##3##(2008-10#2)
using titanium##4##2##(2008-10#3)(2011-2#1)
using tools from##2##3##(2008-11#1)(2011-2#1)
using topical##2##2##(2008-5#1)(2011-2#1)
using total##4##2##(1992-6#1)(1996-12#1)(2008-10#1)(2008-7#1)
using traditional methods##2##3##(2008-10#1)(2008-5#1)
using traditional##7##2##(2008-10#3)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
using transgenic##2##2##(2009-8#1)(2013-8#1)
using transmission electron microscopy##3##4##(2008-10#3)
using transmission##5##2##(2008-10#4)(2011-2#1)
using tri-n-octylamine##2##2##(2008-10#2)
using tristimulus colorimetry and a quantitative##2##6##(2008-10#2)
using two different##11##3##(2008-10#9)(2008-11#1)(2008-9#1)
using two level##2##3##(2008-10#2)
using two##52##2##(1992-4#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#33)(2008-11#5)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-3#1)
using two-dimensional##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
using two-photon##2##2##(2008-2#2)
using ultra##2##2##(2008-10#2)
using ultrafiltration##3##2##(2008-10#3)
using ultrasonic##3##2##(2008-10#3)
using ultrasound##3##2##(1992-5#1)(2008-10#2)
using ultraviolet##3##2##(2008-10#3)
using ultraviolet-visible spectroscopy##2##3##(2008-10#2)
using uncoated##2##2##(2008-10#2)
using univariate##3##2##(2008-10#3)
using universal protein G-liposomal nanovesicles##2##5##(2008-10#2)
using various##14##2##(1997-3#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-3#1)
using vegetative compatibility##3##3##(2008-10#3)
using very##2##2##(1990-8#1)(2008-9#1)
using visual##3##2##(2008-10#2)(2013-8#1)
using voltammetric##2##2##(2008-10#2)
using water and##2##3##(2008-10#2)
using water##9##2##(2008-10#7)(2009-7#1)(2011-2#1)
using water-soluble##2##2##(1997-2#1)(2008-10#1)
using wavelength##2##2##(2008-10#2)
using wavelet##4##2##(2008-10#4)
using weather##3##2##(2008-10#3)
using whole blood##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
using whole##6##2##(1990-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-3#1)
using whole-cell##2##2##(1995-2#1)(2011-2#1)
using winter##2##2##(2008-10#2)
using wireless##2##2##(2007-9#1)(2008-12#1)
using yeast one-hybrid system##3##4##(2008-8#1)(2008-9#2)
using yeast two-hybrid system##2##4##(2008-8#1)(2008-9#1)
using yeast two-hybrid##4##3##(2008-4#1)(2008-8#1)(2008-9#2)
using yeast##10##2##(1991-5#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#4)
using zero##2##2##(2008-10#1)(2012-2#1)
using zymography##2##2##(2008-11#1)(2011-2#1)
using##6782##1##(1990-11#11)(1990-12#17)(1990-2#15)(1990-3#2)(1990-4#1)(1990-5#17)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#6)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#18)(1991-2#9)(1991-3#17)(1991-5#11)(1991-6#12)(1991-8#2)(1991-9#8)(1992-1#13)(1992-10#3)(1992-11#5)(1992-12#16)(1992-2#15)(1992-3#15)(1992-4#4)(1992-5#3)(1992-6#12)(1992-7#1)(1992-8#3)(1992-9#17)(1993-1#8)(1993-11#7)(1993-12#24)(1993-2#18)(1993-3#20)(1993-5#1)(1993-6#12)(1993-8#17)(1993-9#8)(1994-1#5)(1994-11#23)(1994-12#14)(1994-2#15)(1994-3#17)(1994-5#21)(1994-6#5)(1994-8#11)(1994-9#1)(1995-1#6)(1995-11#20)(1995-12#36)(1995-2#25)(1995-3#9)(1995-5#9)(1995-6#16)(1995-8#15)(1995-9#4)(1996-1#6)(1996-11#4)(1996-12#31)(1996-2#27)(1996-3#18)(1996-5#2)(1996-6#7)(1996-8#4)(1997-1#13)(1997-2#28)(1997-3#16)(1997-4#2)(1997-6#10)(1997-7#14)(1997-8#19)(1997-9#1)(2006-6#5)(2007-11#5)(2007-12#15)(2007-8#4)(2007-9#2)(2008-1#19)(2008-10#3456)(2008-11#421)(2008-12#108)(2008-2#20)(2008-3#69)(2008-4#80)(2008-5#133)(2008-6#43)(2008-7#107)(2008-8#135)(2008-9#207)(2009-1#4)(2009-10#38)(2009-11#12)(2009-12#23)(2009-2#4)(2009-3#20)(2009-4#3)(2009-5#7)(2009-6#13)(2009-7#25)(2009-8#38)(2009-9#10)(2010-1#16)(2010-10#18)(2010-11#18)(2010-12#23)(2010-2#3)(2010-3#10)(2010-4#27)(2010-5#12)(2010-6#30)(2010-7#33)(2010-8#43)(2010-9#3)(2011-1#21)(2011-2#220)(2011-3#16)(2011-7#4)(2011-8#1)(2012-12#35)(2012-2#101)(2012-3#76)(2012-4#3)(2012-5#4)(2013-1#143)(2013-3#2)(2013-8#58)
usitata##2##1##(2008-10#2)
usual care##5##2##(2008-4#2)(2008-8#1)(2010-10#1)(2010-4#1)
usual methods##2##2##(2008-10#2)
usual##70##1##(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#2)(1995-12#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#3)(2008-10#19)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-10#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
usually a combination of##2##4##(1990-9#1)(2011-2#1)
usually a##4##2##(1990-9#1)(1991-3#1)(1991-4#1)(2011-2#1)
usually accompanied by##2##3##(1997-8#1)(2008-10#1)
usually are of##2##3##(1992-9#1)(2008-5#1)
usually are##6##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
usually associated with##7##3##(2008-1#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
usually associated##8##2##(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
usually asymptomatic##2##2##(2008-12#1)(2011-2#1)
usually at pH##2##3##(2008-10#2)
usually at##3##2##(2008-10#2)(2008-11#1)
usually based on##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
usually be##7##2##(1990-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)
usually benign##3##2##(1992-9#1)(2008-11#1)(2013-1#1)
usually between##2##2##(2008-1#1)(2008-10#1)
usually characterised by##2##3##(2008-6#1)(2010-11#1)
usually characterised##3##2##(2008-10#1)(2008-6#1)(2010-11#1)
usually considered##5##2##(2008-10#2)(2008-4#1)(2008-7#1)(2009-7#1)
usually consulted##2##2##(1996-6#1)(1997-4#1)
usually contain##2##2##(2008-10#1)(2012-2#1)
usually cured##2##2##(2011-2#1)(2013-1#1)
usually detected in##2##3##(2008-10#1)(2013-8#1)
usually detected##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
usually develops##2##2##(2008-10#1)(2008-7#1)
usually difficult##2##2##(2008-10#1)(2008-7#1)
usually due to##2##3##(2008-7#1)(2012-3#1)
usually encountered in##3##3##(2008-10#2)(2012-2#1)
usually exhibit##2##2##(2008-10#1)(2013-8#1)
usually found in##3##3##(2008-10#2)(2013-8#1)
usually found##6##2##(1991-6#1)(2008-10#3)(2012-3#1)(2013-8#1)
usually have##3##2##(1997-6#1)(2008-10#1)(2008-3#1)
usually include##2##2##(2008-9#1)(2012-3#1)
usually increased##2##2##(1992-5#1)(2012-2#1)
usually involves##4##2##(2008-10#2)(2008-11#1)(2009-1#1)
usually is##2##2##(2008-10#1)(2011-3#1)
usually leads to##2##3##(1997-6#1)(2013-1#1)
usually located##2##2##(2008-7#1)(2012-12#1)
usually manifests as a##2##4##(2007-12#1)(2010-6#1)
usually more##3##2##(1995-5#1)(2008-10#2)
usually normal##3##2##(2008-4#1)(2010-12#1)(2013-1#1)
usually not##5##2##(1990-12#1)(1993-6#1)(2008-2#1)(2009-6#1)(2013-1#1)
usually occurs in##6##3##(2008-11#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#2)
usually occurs##10##2##(2008-11#1)(2008-7#2)(2009-10#1)(2010-6#2)(2010-7#1)(2012-3#1)(2013-1#2)
usually only##3##2##(1996-12#1)(2011-3#1)(2013-1#1)
usually originate from##2##3##(1997-1#1)(2011-2#1)
usually overcome##2##2##(1995-1#1)(2008-10#1)
usually performed##6##2##(1990-9#1)(1993-6#1)(1997-8#1)(2008-10#2)(2011-2#1)
usually present in##2##3##(2008-10#2)
usually present with##3##3##(2008-12#1)(2009-12#1)(2011-2#1)
usually present##6##2##(2008-10#2)(2008-12#1)(2009-12#1)(2011-2#1)(2012-3#1)
usually presents with##2##3##(2008-11#1)(2012-3#1)
usually presents##4##2##(2008-10#1)(2008-11#1)(2012-3#2)
usually range##2##2##(1997-8#1)(2008-10#1)
usually recommended##2##2##(2008-10#1)(2010-11#1)
usually reduces##2##2##(2008-2#1)(2008-8#1)
usually regarded##2##2##(1995-11#1)(2010-7#1)
usually require##3##2##(1997-3#1)(2008-10#1)(2013-1#1)
usually required##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
usually requires##3##2##(1995-9#1)(2008-10#1)(2008-8#1)
usually results in##2##3##(2008-10#1)(2013-1#1)
usually seen in##3##3##(2008-10#2)(2011-2#1)
usually seen##7##2##(1997-5#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#1)(2012-2#1)
usually several##2##2##(2008-6#1)(2010-6#1)
usually sufficient##2##2##(2009-4#1)(2010-11#1)
usually the only##2##3##(1991-6#1)(2013-8#1)
usually the##5##2##(1991-6#1)(1995-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
usually used in##2##3##(2008-10#2)
usually used##5##2##(2008-10#4)(2008-5#1)
usually were##4##2##(2008-10#3)(2008-8#1)
usually##351##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#3)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#3)(1993-1#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-5#2)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#4)(1997-1#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-8#3)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#92)(2008-11#15)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#11)(2008-8#12)(2008-9#6)(2009-1#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-4#2)(2010-6#5)(2010-7#4)(2011-1#2)(2011-2#18)(2011-3#4)(2012-12#3)(2012-2#9)(2012-3#12)(2013-1#16)(2013-8#7)
uteri##4##1##(1994-12#1)(1994-5#1)(2013-1#1)(2013-7#1)
uterine LMS##4##2##(2012-2#4)
uterine and##2##2##(1990-11#1)(2012-12#1)
uterine atony##2##2##(1995-12#2)
uterine bleeding##6##2##(1991-2#2)(1994-12#1)(1995-3#1)(2008-10#1)(2013-8#1)
uterine cervical neoplasms amongst females from##2##6##(2012-12#2)
uterine cervical neoplasms##3##3##(2012-12#3)
uterine cervical##4##2##(1994-8#1)(2012-12#3)
uterine cervix cancer##3##3##(1990-6#2)(1993-11#1)
uterine cervix##7##2##(1990-6#3)(1993-11#1)(2008-11#1)(2009-11#2)
uterine epithelial cells##10##3##(2008-6#10)
uterine horn##4##2##(1991-3#1)(1992-1#1)(1992-3#2)
uterine leiomyosarcoma##2##2##(2012-2#2)
uterine natural killer cells##2##4##(2013-1#2)
uterine prolapse##2##2##(2008-10#2)
uterine prostanoid synthesis##2##3##(1994-3#2)
uterine retention##2##2##(2008-8#2)
uterine rupture##3##2##(1995-12#2)(2011-1#1)
uterine##92##1##(1990-11#3)(1990-6#4)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#3)(1994-12#3)(1994-3#3)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#4)(1995-3#2)(1996-1#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-6#10)(2008-8#2)(2008-9#1)(2009-11#2)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#1)
utero##13##1##(1991-1#1)(1994-8#2)(2008-10#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#2)
uterus and##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
uterus epithelial cells and##2##4##(2008-9#2)
uterus in##2##2##(1995-11#1)(2008-10#1)
uterus is##2##2##(2008-8#1)(2011-2#1)
uterus with##2##2##(1994-2#1)(2013-1#1)
uterus##28##1##(1991-5#1)(1992-10#1)(1993-1#1)(1994-2#1)(1995-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#2)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)
utilisation in##2##2##(2008-11#1)(2010-9#1)
utilisation of the##2##3##(1993-8#1)(2008-11#1)
utilisation of##8##2##(1993-8#1)(2008-10#4)(2008-11#2)(2010-8#1)
utilisation##20##1##(1993-8#1)(1997-2#1)(2008-10#7)(2008-11#9)(2010-8#1)(2010-9#1)
utilise##7##1##(2006-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2013-1#1)
utilised as##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
utilised for##5##2##(2008-10#4)(2008-11#1)
utilised the##3##2##(2008-10#1)(2008-11#2)
utilised to##6##2##(1993-12#1)(2008-10#3)(2008-11#2)
utilised##24##1##(1993-12#1)(1993-6#1)(1997-2#1)(2007-8#1)(2008-10#11)(2008-11#9)
utilises a##3##2##(2008-10#1)(2008-12#2)
utilises the##5##2##(2006-6#1)(2008-10#4)
utilises##8##1##(2006-6#1)(2008-10#5)(2008-12#2)
utilising the##2##2##(2008-10#1)(2008-12#1)
utilising##9##1##(2008-10#2)(2008-11#2)(2008-12#2)(2012-12#1)(2013-8#2)
utilitarian##3##1##(1997-1#1)(2008-10#1)(2008-11#1)
utilities of##2##2##(2008-10#1)(2012-3#1)
utilities##6##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#2)
utility and##5##2##(1995-1#1)(2008-10#1)(2009-8#1)(2010-4#1)(2010-7#1)
utility for##10##2##(1993-12#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-9#1)
utility in the##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
utility in##10##2##(1992-1#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-1#1)
utility is##2##2##(2008-10#2)
utility of a##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
utility of such##2##3##(1995-5#1)(2008-10#1)
utility of the proposed##3##4##(2008-10#3)
utility of the##30##3##(1994-2#1)(1996-2#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
utility of these##4##3##(2008-10#1)(2008-12#1)(2013-1#2)
utility of this method##2##4##(2008-10#2)
utility of this##8##3##(1994-12#1)(2008-10#3)(2008-8#1)(2010-5#1)(2012-3#1)(2013-8#1)
utility of##100##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#26)(2008-11#8)(2008-12#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#1)
utility##149##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#1)(1992-1#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#40)(2008-11#9)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#7)(2009-12#1)(2009-4#2)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#10)(2013-1#10)(2013-8#3)
utilization among##2##2##(1992-4#1)(2008-12#1)
utilization and access##3##3##(1994-1#1)(1994-2#1)(1995-12#1)
utilization and cost##3##3##(1995-3#1)(1997-2#2)
utilization and costs##2##3##(2008-11#1)(2009-11#1)
utilization and program##2##3##(1991-3#2)
utilization and##29##2##(1991-1#1)(1991-3#2)(1992-1#2)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1997-2#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#2)
utilization as##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
utilization by the##2##3##(1994-12#1)(2011-1#1)
utilization by##6##2##(1994-12#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-1#1)(2011-1#1)
utilization for##4##2##(1993-1#1)(1993-2#1)(2012-2#2)
utilization in a##2##3##(1991-1#1)(2008-6#1)
utilization in##10##2##(1991-1#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2013-8#1)
utilization is##3##2##(2008-11#2)(2012-12#1)
utilization management##6##2##(1991-3#1)(1993-12#2)(1995-2#1)(1997-2#2)
utilization of a##5##3##(1994-5#1)(1995-3#1)(2008-10#2)(2008-11#1)
utilization of drugs##2##3##(1995-1#1)(1997-2#1)
utilization of health care services##4##5##(1993-2#1)(1993-3#1)(1994-1#2)
utilization of mental health##2##4##(1996-12#1)(1996-3#1)
utilization of services##3##3##(1991-12#1)(1994-2#1)(1996-1#1)
utilization of the##7##3##(1994-1#3)(1994-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
utilization of two##3##3##(1993-2#1)(2008-10#1)(2008-9#1)
utilization of very##2##3##(2008-10#1)(2008-11#1)
utilization of##81##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#2)(1992-12#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#6)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#17)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#2)
utilization patterns in##2##3##(1994-2#1)(2008-7#1)
utilization patterns##6##2##(1992-12#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-7#1)
utilization profiles##2##2##(1997-2#1)(2008-10#1)
utilization rate##5##2##(1993-1#1)(2008-11#1)(2008-7#3)
utilization rates##5##2##(1993-1#3)(1994-1#1)(2008-7#1)
utilization review##5##2##(1991-3#2)(1995-12#1)(1996-2#1)(1997-2#1)
utilization was##3##2##(1994-8#1)(2008-7#1)(2011-1#1)
utilization##258##1##(1990-12#2)(1990-5#3)(1990-8#1)(1991-1#5)(1991-12#3)(1991-2#1)(1991-3#5)(1991-7#2)(1992-1#2)(1992-12#6)(1992-4#1)(1993-1#6)(1993-12#4)(1993-2#3)(1993-3#5)(1993-9#1)(1994-1#10)(1994-12#4)(1994-2#6)(1994-3#6)(1994-5#2)(1994-8#5)(1995-1#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#2)(1996-1#3)(1996-12#1)(1996-2#6)(1996-3#2)(1996-6#1)(1997-1#4)(1997-2#10)(1997-4#1)(2008-10#32)(2008-11#18)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#4)(2009-11#2)(2009-4#1)(2009-5#1)(2010-10#2)(2010-11#2)(2010-5#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#5)(2013-8#5)
utilize a##2##2##(1997-3#1)(2011-2#1)
utilize both##2##2##(2008-11#1)(2008-4#1)
utilize the##9##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#2)(2009-6#1)
utilize this##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
utilize##63##1##(1991-3#1)(1994-3#1)(1995-2#1)(1996-12#2)(1997-1#3)(1997-3#2)(1997-7#1)(2008-10#12)(2008-11#10)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-9#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
utilized a##6##2##(1992-10#1)(1995-3#1)(1996-2#1)(2008-10#1)(2010-8#1)(2011-3#1)
utilized an##2##2##(1993-2#1)(1996-2#1)
utilized and##3##2##(1995-8#1)(2010-8#1)(2012-2#1)
utilized as a##7##3##(1996-5#1)(2008-10#3)(2008-11#2)(2008-4#1)
utilized as an##6##3##(1991-9#1)(2008-10#4)(2008-11#1)
utilized as##19##2##(1991-9#1)(1993-3#1)(1996-5#2)(2008-10#8)(2008-11#3)(2008-4#1)(2008-9#1)(2009-10#1)(2013-1#1)
utilized by##6##2##(1993-1#1)(1996-2#1)(2008-10#2)(2008-5#1)(2012-2#1)
utilized epidemiologists##2##2##(2008-11#2)
utilized for a variety of##2##5##(2009-10#2)
utilized for assessment of##2##4##(2008-9#1)(2012-2#1)
utilized for the analysis of##2##5##(1990-12#1)(2008-10#1)
utilized for the##12##3##(1990-12#1)(2008-10#10)(2010-5#1)
utilized for##40##2##(1990-11#1)(1990-12#2)(1992-6#1)(1994-11#1)(2008-10#26)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#2)(2009-2#1)(2010-5#1)(2012-2#2)
utilized in a##3##3##(2008-10#2)(2012-2#1)
utilized in developing##3##3##(1996-3#1)(2008-10#1)(2013-8#1)
utilized in routine##2##3##(2008-10#1)(2008-12#1)
utilized in the##3##3##(2008-12#1)(2010-10#1)(2011-2#1)
utilized in##29##2##(1991-3#1)(1992-9#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#10)(2008-12#4)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
utilized the##4##2##(1994-2#1)(1996-2#1)(2008-10#1)(2010-12#1)
utilized to assess##3##3##(1992-10#1)(1996-1#1)(2008-10#1)
utilized to detect##3##3##(2008-10#3)
utilized to identify##2##3##(2012-12#1)(2013-8#1)
utilized to screen##2##3##(2008-4#1)(2008-9#1)
utilized to##50##2##(1990-2#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-8#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-9#3)(2009-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
utilized##208##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#6)(1996-3#2)(1996-5#2)(1997-1#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#81)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#3)
utilizes a##5##2##(1992-8#1)(1993-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
utilizes its##2##2##(1997-8#1)(2011-2#1)
utilizes the##13##2##(1993-12#1)(1994-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-9#1)(2012-2#1)
utilizes##43##1##(1990-10#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)
utilizing 0##2##2##(1991-7#1)(2008-10#1)
utilizing a redox reaction##2##4##(2008-10#2)
utilizing a##19##2##(1993-9#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)
utilizing an##2##2##(1993-2#1)(2008-10#1)
utilizing in-line preconcentration/separation##2##3##(2008-10#2)
utilizing initial##2##2##(2008-10#1)(2009-7#1)
utilizing more than##2##3##(1996-3#1)(2008-4#1)
utilizing optical##2##2##(2008-5#1)(2009-7#1)
utilizing the##15##2##(1992-1#1)(1993-6#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-7#1)(2012-2#1)
utilizing these##2##2##(1996-2#1)(2013-1#1)
utilizing this##2##2##(2008-7#1)(2013-8#1)
utilizing##125##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-7#2)(1992-1#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#48)(2008-11#10)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#5)(2009-2#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-6#1)(2010-7#2)(2010-9#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
utmost importance##8##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
utmost##10##1##(1991-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
uv##2##1##(1991-6#1)(2008-10#1)
uveal##3##1##(1991-6#2)(2013-8#1)
uveitis##5##1##(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
uvs112##2##1##(1995-9#2)
uvsC##2##1##(1997-4#2)
uvsC114 mutant##2##2##(1997-4#2)
v##154##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#4)(1992-1#1)(1992-12#7)(1992-2#2)(1992-3#14)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#4)(1993-3#3)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#6)(1994-3#3)(1994-8#1)(1995-1#1)(1995-12#5)(1995-2#4)(1995-5#2)(1995-6#5)(1996-12#5)(1996-2#6)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#11)(1997-6#1)(1997-7#1)(2008-1#7)(2008-10#6)(2008-11#1)(2008-5#5)(2008-7#1)(2008-9#1)(2010-8#6)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#5)
v(-1))##2##1##(2008-10#2)
v)##4##1##(2008-10#2)(2008-11#1)(2009-9#1)
v-myc##2##1##(1990-12#1)(2009-7#1)
v-src##2##1##(1995-6#1)(1997-7#1)
v-src-transformed##3##1##(1997-1#3)
v/v in##2##2##(1990-12#1)(2008-10#1)
v/v##19##1##(1990-12#1)(1994-5#1)(1997-1#1)(2008-10#16)
v/v) and the##2##3##(1997-2#1)(2008-10#1)
v/v) and##10##2##(1997-2#1)(2008-10#8)(2008-7#1)
v/v) as##2##2##(2008-10#2)
v/v) at##3##2##(2008-10#3)
v/v) containing##6##2##(2008-10#6)
v/v) eluent containing the##2##4##(2008-10#2)
v/v) eluent containing##3##3##(2008-10#3)
v/v) in##2##2##(2008-10#2)
v/v) solution##2##2##(2008-10#2)
v/v)##64##1##(1995-11#1)(1996-2#1)(1997-2#1)(2008-10#58)(2008-5#1)(2008-7#2)
v/v/v) as mobile phase##2##4##(2008-10#2)
v/v/v)##9##1##(2008-10#9)
v/v/v/v)##2##1##(2008-10#1)(2012-2#1)
v?) =##2##2##(2008-3#2)
vAcCMVBar##2##1##(2008-8#2)
vWA##3##1##(2008-12#3)
vWF gene##3##2##(2008-12#3)
vWF##4##1##(1993-3#1)(2008-12#3)
va##3##1##(2008-10#2)(2012-2#1)
vacancies##4##1##(2008-9#4)
vacancy##9##1##(1991-2#1)(1993-1#1)(2008-8#2)(2008-9#3)(2012-2#2)
vacant##9##1##(1990-6#1)(1991-11#1)(1992-3#1)(1994-3#1)(2008-10#4)(2008-9#1)
vacations##2##1##(1991-3#1)(2008-10#1)
vaccinate##7##1##(1994-9#1)(1996-12#1)(2011-1#4)(2011-2#1)
vaccinated animals##3##2##(1995-9#2)(2008-9#1)
vaccinated chickens##4##2##(1996-11#1)(2008-5#3)
vaccinated with##2##2##(2008-5#1)(2012-3#1)
vaccinated##28##1##(1990-11#2)(1995-5#2)(1995-9#4)(1996-11#2)(1996-12#1)(2008-11#1)(2008-5#7)(2008-9#1)(2009-5#3)(2010-4#1)(2011-2#1)(2012-3#3)
vaccinating##2##1##(2011-1#1)(2013-1#1)
vaccination against##3##2##(1994-9#1)(2013-1#2)
vaccination and the##2##3##(1993-2#1)(2008-7#1)
vaccination and##4##2##(1993-2#1)(1997-2#1)(2008-7#1)(2009-5#1)
vaccination coverage in##3##3##(1996-12#1)(2011-2#2)
vaccination coverage##8##2##(1994-9#1)(1995-3#2)(1996-12#2)(2011-2#3)
vaccination has##2##2##(1997-8#1)(2013-1#1)
vaccination in the##2##3##(1990-6#1)(2010-4#1)
vaccination in##7##2##(1990-6#1)(2008-11#1)(2009-12#1)(2010-4#3)(2011-2#1)
vaccination is recommended for all##2##5##(2009-12#1)(2011-2#1)
vaccination is##5##2##(1995-5#1)(1996-3#2)(2009-12#1)(2011-2#1)
vaccination of##10##2##(1990-3#1)(1992-5#1)(1994-8#1)(2007-11#1)(2008-5#2)(2011-1#1)(2011-2#2)(2013-1#1)
vaccination on the##2##3##(1996-1#1)(1996-3#1)
vaccination on##3##2##(1996-1#1)(1996-3#2)
vaccination was##4##2##(2010-4#1)(2011-2#2)(2013-1#1)
vaccination with a##2##3##(1995-9#1)(2008-9#1)
vaccination with##7##2##(1995-2#1)(1995-3#1)(1995-9#1)(1997-8#1)(2008-5#1)(2008-8#1)(2008-9#1)
vaccination##118##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1992-5#3)(1993-2#1)(1993-3#1)(1994-8#1)(1994-9#6)(1995-2#1)(1995-3#4)(1995-5#11)(1995-9#3)(1996-1#2)(1996-12#2)(1996-3#4)(1996-9#1)(1997-2#1)(1997-8#4)(2007-11#1)(2008-10#7)(2008-11#8)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#4)(2009-5#4)(2009-6#1)(2010-1#1)(2010-4#4)(2010-8#2)(2011-1#1)(2011-2#14)(2012-12#1)(2012-3#4)(2013-1#6)
vaccinations##11##1##(1993-3#1)(1996-12#1)(1997-3#1)(2007-11#1)(2010-8#1)(2011-2#1)(2012-3#4)(2013-1#1)
vaccine (OPV)##2##2##(1994-9#1)(1995-3#1)
vaccine against the##2##3##(1997-7#2)
vaccine against##14##2##(1995-12#1)(1995-2#2)(1995-5#2)(1997-7#3)(2008-5#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
vaccine and##10##2##(1995-5#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
vaccine antigens##3##2##(1995-5#3)
vaccine bank##3##2##(2011-2#3)
vaccine banks##2##2##(2011-2#2)
vaccine can##2##2##(1996-12#1)(2011-2#1)
vaccine candidate##5##2##(1993-2#1)(1993-3#1)(2008-11#2)(2009-6#1)
vaccine candidates##3##2##(1993-3#1)(2008-7#1)(2011-2#1)
vaccine components##2##2##(1995-5#2)
vaccine containing##2##2##(2008-10#1)(2008-11#1)
vaccine delivery##4##2##(1995-5#3)(2010-8#1)
vaccine design##3##2##(1995-5#2)(2007-12#1)
vaccine development##9##2##(1992-12#1)(1993-3#1)(1995-5#1)(1997-7#1)(2010-8#2)(2011-2#2)(2012-3#1)
vaccine doses##2##2##(2008-11#1)(2009-12#1)
vaccine efficacy##6##2##(1995-5#4)(2008-4#1)(2013-1#1)
vaccine for children##2##3##(2008-11#2)
vaccine for##5##2##(1995-5#1)(2008-11#2)(2010-8#1)(2011-2#1)
vaccine formulations##3##2##(1995-5#2)(2008-4#1)
vaccine has##4##2##(1993-3#1)(1995-5#1)(2011-2#2)
vaccine in##4##2##(1990-9#1)(1991-8#1)(1995-5#1)(2013-1#1)
vaccine is##3##2##(1994-9#1)(2009-12#1)(2011-2#1)
vaccine or##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
vaccine safety##3##2##(1995-5#3)
vaccine strain##6##2##(2008-11#1)(2008-9#1)(2013-8#4)
vaccine strains##2##2##(1995-5#1)(2008-11#1)
vaccine to##3##2##(1995-12#1)(1996-8#1)(2008-5#1)
vaccine trials##3##2##(1994-9#1)(1995-5#1)(2008-11#1)
vaccine vector##2##2##(2008-11#2)
vaccine vehicle##2##2##(1995-5#1)(2011-2#1)
vaccine virus##3##2##(1995-5#1)(1995-9#1)(2013-8#1)
vaccine was##4##2##(1996-12#1)(1996-3#1)(2011-2#1)(2011-3#1)
vaccine will be##2##3##(1990-11#1)(2008-11#1)
vaccine##240##1##(1990-11#1)(1990-3#2)(1990-8#1)(1990-9#2)(1991-8#2)(1992-12#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#7)(1994-9#12)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#6)(1995-5#51)(1995-9#3)(1996-12#6)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#6)(2007-11#4)(2007-12#2)(2008-1#2)(2008-10#6)(2008-11#27)(2008-4#4)(2008-5#8)(2008-7#2)(2008-8#3)(2008-9#4)(2009-12#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#4)(2011-2#29)(2011-3#1)(2012-3#6)(2013-1#12)(2013-8#7)
vaccine-associated##2##1##(1995-5#1)(2013-8#1)
vaccine-induced##2##1##(1995-5#1)(1995-9#1)
vaccine-preventable diseases##3##2##(1995-3#1)(1996-12#1)(2013-1#1)
vaccines against##7##2##(1995-5#2)(1997-7#1)(2008-11#2)(2010-8#1)(2012-2#1)
vaccines and##5##2##(1995-5#1)(1997-7#1)(2008-11#1)(2013-8#2)
vaccines are##4##2##(1995-5#1)(1997-7#1)(2008-11#1)(2011-2#1)
vaccines at the##2##3##(1992-5#1)(1995-5#1)
vaccines for##4##2##(1995-5#2)(1997-7#1)(2011-2#1)
vaccines have##3##2##(2008-11#2)(2008-5#1)
vaccines in##8##2##(1994-9#1)(1995-5#2)(2007-11#1)(2008-11#1)(2008-4#1)(2013-1#2)
vaccines must##2##2##(1995-5#2)
vaccines of##2##2##(1995-5#1)(2011-2#1)
vaccines should##3##2##(1995-5#2)(1997-7#1)
vaccines that##2##2##(1995-5#1)(2007-11#1)
vaccines to##4##2##(1995-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
vaccines were##3##2##(1995-5#2)(1996-3#1)
vaccines will depend on##2##4##(1997-7#2)
vaccines will##4##2##(1995-5#1)(1996-12#1)(1997-7#2)
vaccines with##3##2##(1995-5#2)(1997-8#1)
vaccines##149##1##(1992-5#1)(1993-3#1)(1994-9#3)(1995-5#60)(1996-12#4)(1996-3#1)(1996-9#1)(1997-7#7)(1997-8#5)(2007-11#4)(2007-12#2)(2008-10#3)(2008-11#19)(2008-4#5)(2008-5#9)(2008-7#1)(2008-8#2)(2009-8#2)(2010-8#2)(2011-2#10)(2012-2#3)(2013-1#2)(2013-8#2)
vaccinia viral vector##2##3##(2008-8#2)
vaccinia virus##7##2##(1995-6#1)(2008-11#1)(2008-8#3)(2013-1#2)
vaccinia##12##1##(1995-5#1)(1995-6#1)(1997-3#1)(2008-11#1)(2008-8#6)(2013-1#2)
vaccinii were##2##2##(2008-10#2)
vaccinii##4##1##(2008-10#4)
vaccinii-corymbosi and##2##2##(2008-10#2)
vaccinii-corymbosi##11##1##(2008-10#11)
vaccinology##6##1##(2010-8#6)
vacuma and transposa##2##3##(2008-10#2)
vacuma isolates##2##2##(2008-10#2)
vacuma##10##1##(2008-10#10)
vacuolar ATPase##3##2##(1995-6#3)
vacuolar membrane##2##2##(2008-11#1)(2012-2#1)
vacuolar##12##1##(1994-6#1)(1995-3#3)(1995-6#3)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)
vacuolated##2##1##(2008-10#1)(2008-5#1)
vacuole of##3##2##(1990-12#2)(2011-2#1)
vacuole##13##1##(1990-12#2)(2008-11#3)(2008-6#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#2)
vacuoles and##4##2##(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
vacuoles are##3##2##(2007-12#2)(2008-7#1)
vacuoles in chloroquine-induced myopathy-affected muscle##2##5##(1995-12#2)
vacuoles in##3##2##(1995-12#2)(2008-12#1)
vacuoles of##2##2##(2008-10#1)(2008-9#1)
vacuoles##32##1##(1995-12#3)(2007-12#5)(2008-10#4)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-9#1)(2009-10#1)(2012-7#1)
vacuolization of##3##2##(2008-12#1)(2008-9#2)
vacuolization##8##1##(2008-10#2)(2008-12#1)(2008-9#5)
vacuous chewing movements##3##3##(1996-2#3)
vacuum assisted closure##2##3##(2008-11#2)
vacuum disc herniation##3##3##(2012-2#3)
vacuum disc##7##2##(2008-12#2)(2012-2#5)
vacuum heat pump dryer##2##4##(2011-2#2)
vacuum heat pump##3##3##(2011-2#3)
vacuum packaging##3##2##(2011-2#3)
vacuum pump##2##2##(2008-10#1)(2012-3#1)
vacuum was##2##2##(2008-10#1)(2011-2#1)
vacuum##40##1##(1990-11#1)(1990-8#1)(1994-2#1)(1995-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#1)(2010-1#1)(2010-7#1)(2011-2#7)(2012-2#6)(2012-3#1)(2013-8#1)
vacuums##2##1##(2008-10#1)(2008-11#1)
vagal tone##2##2##(1991-1#1)(2011-2#1)
vagal##5##1##(1991-1#1)(1992-6#1)(2008-6#1)(2009-7#1)(2011-2#1)
vagile##2##1##(2008-8#2)
vagina or##2##2##(1992-3#1)(2009-2#1)
vagina syndrome after classical anterior##2##5##(2012-3#2)
vagina syndrome##3##2##(2012-3#3)
vagina##15##1##(1990-2#1)(1991-12#2)(1992-3#1)(1993-1#1)(1994-1#2)(1996-9#1)(2008-11#1)(2009-10#1)(2009-2#1)(2010-11#1)(2012-3#3)
vaginal HPV##2##2##(1992-3#2)
vaginal agenesis##2##2##(1993-1#2)
vaginal and external anogenital condylomas##3##5##(1996-1#3)
vaginal bleeding##4##2##(1991-2#1)(2009-6#1)(2011-2#1)(2012-2#1)
vaginal cylinders##7##2##(2009-2#7)
vaginal delivery##4##2##(1995-12#1)(2010-8#1)(2011-2#2)
vaginal hysterectomies performed by the senior##2##6##(1993-12#2)
vaginal hysterectomies##10##2##(1993-12#4)(1995-1#6)
vaginal hysterectomy in##3##3##(1993-12#2)(1995-12#1)
vaginal hysterectomy with or without##2##5##(1993-2#1)(1994-2#1)
vaginal hysterectomy##27##2##(1991-3#2)(1993-12#11)(1993-2#3)(1993-3#1)(1994-2#4)(1995-1#1)(1995-12#2)(1995-3#2)(2008-12#1)
vaginal operations##2##2##(1992-1#2)
vaginal prolapse##2##2##(2011-2#2)
vaginal route##3##2##(1994-2#1)(1995-1#1)(1995-12#1)
vaginal sex##4##2##(2010-7#2)(2013-1#2)
vaginal surface##2##2##(2009-11#1)(2009-2#1)
vaginal swabs taken##2##3##(2008-12#2)
vaginal ultrasound##2##2##(1992-12#1)(1995-8#1)
vaginal wall##2##2##(1991-12#1)(2011-2#1)
vaginal##118##1##(1990-2#1)(1991-12#2)(1991-2#1)(1991-3#4)(1992-1#3)(1992-12#2)(1992-3#3)(1993-1#2)(1993-12#16)(1993-2#3)(1993-3#1)(1994-1#1)(1994-2#7)(1994-3#1)(1994-8#1)(1995-1#8)(1995-11#1)(1995-12#4)(1995-3#2)(1995-8#1)(1996-1#3)(1996-9#2)(2008-10#3)(2008-11#4)(2008-12#3)(2008-5#3)(2008-8#2)(2009-11#1)(2009-2#11)(2009-6#1)(2010-12#1)(2010-7#3)(2010-8#1)(2011-2#9)(2012-2#2)(2012-3#2)(2013-1#3)
vaginalis##3##1##(2008-10#2)(2012-2#1)
vaginally##3##1##(1991-2#1)(1994-2#1)(2011-2#1)
vaginitis##5##1##(1994-12#1)(2011-2#4)
vaginosis##6##1##(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#3)
vague##7##1##(1995-12#1)(1997-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)
vagus nerve##2##2##(2008-11#1)(2008-7#1)
vagus##5##1##(1994-2#1)(2008-11#1)(2008-7#1)(2011-2#2)
valaciclovir to acyclovir##2##3##(1995-6#2)
valaciclovir##6##1##(1995-6#6)
valence of##2##2##(2008-10#2)
valence##11##1##(2008-10#6)(2008-11#4)(2008-8#1)
valency chlorine species##2##3##(2008-10#2)
valency##3##1##(2008-10#3)
valeric acid##3##2##(1991-5#2)(2008-10#1)
valeric##4##1##(1991-5#3)(2008-10#1)
valgus osteotomy##2##2##(2009-3#2)
valgus##13##1##(2009-3#2)(2009-4#1)(2010-11#1)(2012-2#7)(2013-1#2)
valid and reliable##4##3##(1993-12#1)(1993-2#1)(1996-2#1)(2008-12#1)
valid and##10##2##(1993-12#1)(1993-2#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#1)(2012-12#1)
valid for the##4##3##(1997-8#1)(2008-10#2)(2008-7#1)
valid for##8##2##(1995-3#1)(1997-8#1)(2008-10#3)(2008-3#2)(2008-7#1)
valid in##2##2##(2008-9#2)
valid measures of##2##3##(1994-2#1)(2010-10#1)
valid model##2##2##(1992-12#1)(2010-2#1)
valid tool for##2##3##(2008-7#1)(2010-10#1)
valid##87##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-2#2)(1997-8#1)(2008-10#17)(2008-11#2)(2008-12#4)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#4)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
validate a##7##2##(1996-2#1)(2008-10#4)(2012-2#1)(2013-8#1)
validate an##2##2##(1995-12#1)(2008-10#1)
validate the proposed##2##3##(2008-7#1)(2013-1#1)
validate the##36##2##(1991-5#1)(1993-3#1)(1997-2#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-7#1)(2011-2#7)(2013-1#2)
validate this##3##2##(2008-10#2)(2013-1#1)
validate##62##1##(1991-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#2)(2010-12#2)(2010-7#1)(2011-2#7)(2012-2#2)(2013-1#4)(2013-8#1)
validated and##12##2##(2008-10#10)(2011-1#1)(2013-1#1)
validated as##3##2##(2008-10#2)(2010-8#1)
validated automatic##2##2##(2010-7#2)
validated by Western##2##3##(2010-12#2)
validated by a##3##3##(2008-10#1)(2008-12#2)
validated by analysis of##2##4##(2008-10#2)
validated by analysis##3##3##(2008-10#3)
validated by analyzing a certified reference material##2##7##(2008-10#2)
validated by analyzing##3##3##(2008-10#3)
validated by comparing the##3##4##(2008-10#3)
validated by comparing##4##3##(2008-10#4)
validated by comparison with##4##4##(2008-10#2)(2008-3#2)
validated by comparison##5##3##(2008-10#2)(2008-3#3)
validated by determining the##2##4##(2008-10#1)(2008-5#1)
validated by determining##3##3##(2008-10#2)(2008-5#1)
validated by testing##2##3##(2008-10#1)(2013-8#1)
validated by the analysis of##3##5##(2008-10#3)
validated by the##5##3##(2008-10#5)
validated by using two##2##4##(2008-10#2)
validated by using##8##3##(2008-10#7)(2008-5#1)
validated by##58##2##(1991-11#1)(1996-3#1)(2008-10#44)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#2)(2010-12#2)(2013-1#1)(2013-8#1)
validated for the determination of##2##5##(2008-10#2)
validated for the##4##3##(2008-10#3)(2010-12#1)
validated for##11##2##(2008-10#8)(2008-7#1)(2010-12#1)(2011-7#1)
validated in##10##2##(2008-10#6)(2008-5#1)(2008-7#1)(2012-2#2)
validated model##2##2##(2008-10#1)(2008-11#1)
validated models##2##2##(2008-3#1)(2010-8#1)
validated over the concentration range##2##5##(2008-10#1)(2011-3#1)
validated over##3##2##(2008-10#2)(2011-3#1)
validated questionnaires##2##2##(1991-2#1)(2013-1#1)
validated the proposed method##2##4##(2008-10#2)
validated the##11##2##(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2009-12#1)
validated through the analysis of##2##5##(2008-10#2)
validated through##4##2##(2008-10#4)
validated using a##4##3##(1990-12#1)(1990-2#1)(2008-10#2)
validated using##16##2##(1990-12#1)(1990-2#1)(1997-2#1)(2008-10#11)(2010-7#1)(2011-2#1)
validated with a##6##3##(2008-10#6)
validated with##17##2##(2008-10#14)(2008-11#1)(2008-12#1)(2012-2#1)
validated##220##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-2#2)(2008-10#140)(2008-11#10)(2008-12#4)(2008-3#6)(2008-5#6)(2008-7#3)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#12)(2013-8#2)
validates a##2##2##(2008-7#1)(2011-2#1)
validates the##4##2##(2008-10#4)
validates##6##1##(2008-10#4)(2008-7#1)(2011-2#1)
validating the use of##2##4##(2008-10#2)
validating the##8##2##(2008-10#6)(2008-8#1)(2013-1#1)
validating##14##1##(2008-1#1)(2008-10#7)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
validation and updating of a prognostic model for kidney graft survival##2##11##(1995-9#2)
validation and##7##2##(1995-9#3)(2008-10#2)(2008-3#1)(2008-5#1)
validation cases##2##2##(2008-10#2)
validation data set##2##3##(2008-10#2)
validation data##8##2##(2008-10#8)
validation errors of##2##3##(2008-10#2)
validation in the##2##3##(2008-10#2)
validation in##7##2##(1993-3#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-5#1)
validation is provided##2##3##(2008-7#1)(2010-5#1)
validation is##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
validation method##2##2##(2008-10#1)(2008-2#1)
validation of a##17##3##(1992-9#1)(1995-11#1)(1997-2#1)(2008-10#6)(2008-2#1)(2008-5#2)(2009-12#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
validation of an automated##2##4##(1990-2#1)(2008-10#1)
validation of an##7##3##(1990-2#1)(1996-12#1)(2008-10#3)(2009-12#1)(2013-1#1)
validation of analytical##2##3##(2008-10#2)
validation of molecular##2##3##(2009-4#1)(2010-10#1)
validation of new##2##3##(2008-10#1)(2009-7#1)
validation of the##18##3##(1995-2#1)(2008-1#2)(2008-10#8)(2008-7#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-2#1)(2013-1#1)
validation of this##2##3##(2008-10#1)(2008-5#1)
validation of##70##2##(1990-2#1)(1992-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-1#2)(2008-10#31)(2008-11#4)(2008-2#1)(2008-5#4)(2008-7#2)(2009-12#2)(2009-4#1)(2009-7#3)(2010-10#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#4)
validation protocol##2##2##(2008-10#2)
validation scheme##3##2##(2008-10#3)
validation set##9##2##(1995-9#2)(2008-10#7)
validation sets##4##2##(2008-10#4)
validation studies##7##2##(1990-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)
validation study##2##2##(2008-1#1)(2008-10#1)
validation with##2##2##(2009-11#1)(2011-2#1)
validation##199##1##(1990-2#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-9#5)(1996-12#1)(1996-2#3)(1997-2#1)(1997-7#1)(2008-1#3)(2008-10#108)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#7)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#1)(2009-7#4)(2010-10#2)(2010-11#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#7)(2013-7#1)
validations##4##1##(2008-10#2)(2008-3#1)(2012-2#1)
validity and reliability of##3##4##(1994-6#1)(2010-9#1)(2013-8#1)
validity and reliability##4##3##(1994-6#1)(2010-9#1)(2013-1#1)(2013-8#1)
validity and##14##2##(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-9#1)(2012-2#2)(2013-1#3)(2013-8#1)
validity for##2##2##(1995-5#1)(2008-11#1)
validity of a##2##3##(2008-3#1)(2010-9#1)
validity of both##2##3##(2008-10#1)(2009-12#1)
validity of the instrument##2##4##(1993-3#1)(2009-12#1)
validity of the method##5##4##(2008-10#5)
validity of the new##2##4##(2008-10#1)(2008-3#1)
validity of the##38##3##(1990-5#1)(1993-3#1)(1995-12#1)(1997-2#2)(2007-12#2)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#2)
validity of these##6##3##(1993-12#1)(2008-3#1)(2009-11#1)(2010-10#1)(2010-12#2)
validity of this approach##2##4##(1992-3#1)(2008-5#1)
validity of this##7##3##(1992-3#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-6#1)
validity of##94##2##(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1997-2#2)(1997-4#1)(1997-5#1)(2007-12#3)(2008-10#26)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#3)(2010-10#2)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#2)
validity was##5##2##(2008-10#1)(2008-7#1)(2010-11#2)(2012-2#1)
validity##150##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-3#2)(1994-2#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#2)(1997-2#3)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#4)(2008-10#30)(2008-11#16)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#3)(2009-12#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-2#4)(2012-12#2)(2012-2#6)(2013-1#9)(2013-8#3)
validly##2##1##(2011-2#2)
valine and##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
valine##14##1##(1993-12#1)(1993-8#1)(1994-3#1)(1996-2#3)(1996-6#1)(1997-8#1)(2008-10#5)(2008-11#1)
valinomycin##5##1##(1994-5#1)(2008-10#4)
valley from##2##2##(2008-11#1)(2011-2#1)
valley##20##1##(2008-10#15)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
valleys##4##1##(2008-10#4)
valproate##3##1##(2008-7#2)(2010-7#1)
valproic Acid##2##2##(2011-1#1)(2011-2#1)
valproic acid (VPA)##4##3##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
valproic acid##6##2##(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
valproic##8##1##(2008-11#1)(2008-8#1)(2011-1#2)(2011-2#3)(2013-1#1)
valuable and##3##2##(1991-2#1)(2008-11#1)(2008-12#1)
valuable contribution##2##2##(1997-3#1)(2008-11#1)
valuable cultural##2##2##(2008-10#2)
valuable data##2##2##(2008-7#2)
valuable for the##2##3##(1993-2#1)(2011-3#1)
valuable for##11##2##(1993-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-3#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
valuable in determining##2##3##(2008-10#1)(2008-7#1)
valuable in the##5##3##(1992-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-7#1)
valuable in##15##2##(1990-11#1)(1992-1#1)(1992-2#1)(1995-11#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-7#1)
valuable information about##5##3##(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#2)
valuable information for##2##3##(1996-8#1)(2012-12#1)
valuable information on the##3##4##(2008-10#2)(2012-2#1)
valuable information##14##2##(1994-5#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#2)(2012-2#4)
valuable insights##2##2##(2008-12#1)(2010-11#1)
valuable resource##5##2##(2008-11#2)(2008-12#1)(2012-2#1)(2012-3#1)
valuable services##2##2##(1992-2#2)
valuable therapeutic##3##2##(1990-5#1)(1993-2#1)(2011-3#1)
valuable time##2##2##(1992-3#1)(2008-11#1)
valuable to##6##2##(1993-2#1)(2008-10#1)(2008-9#3)(2013-1#1)
valuable tool for##11##3##(1991-6#1)(1993-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-11#1)
valuable tool##19##2##(1991-6#1)(1993-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-11#2)(2011-2#1)
valuable tools for##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
valuable tools in##2##3##(2008-10#1)(2010-5#1)
valuable tools##8##2##(1991-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-5#1)(2012-3#1)
valuable##163##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#5)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#3)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#21)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#10)(2009-1#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#6)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#10)(2012-3#5)(2012-5#1)(2013-1#3)
valuation of GAP##3##3##(2013-1#3)
valuation of##4##2##(2013-1#4)
valuation##7##1##(2008-11#2)(2013-1#5)
value (p##2##2##(2008-3#2)
value added profile##2##3##(1996-1#1)(1997-1#1)
value after##2##2##(2008-10#2)
value and the##6##3##(1991-5#1)(1993-3#1)(2008-10#2)(2008-3#1)(2010-9#1)
value and##24##2##(1991-5#1)(1993-1#1)(1993-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
value are##2##2##(2008-11#1)(2013-8#1)
value as a##3##3##(1991-12#1)(2008-11#1)(2009-8#1)
value as##6##2##(1991-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)
value at##12##2##(1990-5#1)(1995-8#1)(2008-10#7)(2009-7#1)(2010-1#1)(2011-1#1)
value because##2##2##(1995-11#1)(2008-5#1)
value between##3##2##(1990-9#1)(2008-10#1)(2008-5#1)
value by##2##2##(2008-10#1)(2008-11#1)
value can be obtained##2##4##(2008-10#2)
value can be##4##3##(2008-10#3)(2008-2#1)
value can##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
value compared##2##2##(2008-10#2)
value for [3H]flunitrazepam binding##2##4##(1996-2#2)
value for money##2##3##(1994-2#1)(2008-9#1)
value for the preconcentration##3##4##(2008-10#3)
value for the##19##3##(1994-11#1)(1994-5#1)(1996-11#1)(2007-11#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-5#1)
value for their##3##3##(1993-3#1)(1994-3#1)(1997-1#1)
value for##73##2##(1991-3#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
value has been##2##3##(2008-10#2)
value in about##2##3##(2008-10#1)(2008-5#1)
value in comparison to##2##4##(2008-11#1)(2012-3#1)
value in predicting the##2##4##(2008-12#1)(2008-9#1)
value in routine administration of outcome questionnaires##2##7##(2012-12#2)
value in routine administration of outcome##3##6##(2012-12#3)
value in the##9##3##(1991-2#1)(1993-6#1)(1994-12#1)(2008-11#1)(2009-1#1)(2009-8#1)(2011-2#2)(2012-2#1)
value in##45##2##(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-8#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#2)(2009-1#2)(2009-8#1)(2010-9#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)
value is##9##2##(1994-3#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2011-2#1)
value observed in##3##3##(1996-1#1)(2008-10#2)
value obtained for the##2##4##(1995-11#1)(2008-10#1)
value obtained was##2##3##(2008-10#2)
value obtained##6##2##(1995-11#1)(1995-6#1)(2008-10#3)(2008-11#1)
value of 0##18##3##(1990-8#1)(1991-12#1)(1992-11#1)(1995-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2009-3#2)(2012-2#1)
value of 1##6##3##(1995-6#2)(1996-12#1)(2008-10#2)(2008-11#1)
value of 2##2##3##(2008-10#2)
value of 3##2##3##(1991-5#1)(1994-11#1)
value of 4##4##3##(1990-11#1)(1993-8#1)(2008-10#1)(2008-3#1)
value of 6##3##3##(1994-5#1)(2008-10#2)
value of 7##3##3##(1996-2#2)(2008-10#1)
value of MRI in the##2##5##(1996-11#1)(2010-12#1)
value of N##2##3##(2008-10#2)
value of Q and##2##4##(2008-10#2)
value of R##2##3##(2008-10#2)
value of a##10##3##(1991-6#1)(1992-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-8#1)
value of approximately##3##3##(2008-11#1)(2009-5#1)(2009-7#1)
value of clinical##2##3##(2009-3#1)(2012-12#1)
value of contrast-enhanced MR mammography in patients with breast cancer##2##10##(1997-8#2)
value of contrast-enhanced##3##3##(1997-8#2)(2012-2#1)
value of correlation coefficient##2##4##(2008-10#2)
value of magnetic resonance imaging##2##5##(2008-7#1)(2010-12#1)
value of magnetic resonance##3##4##(1996-11#1)(2008-7#1)(2010-12#1)
value of pull-out strength##2##4##(2007-11#2)
value of role modelling##3##4##(2008-12#3)
value of selected##2##3##(1996-1#1)(2012-3#1)
value of the##50##3##(1990-2#1)(1990-6#1)(1992-9#2)(1993-11#1)(1993-6#1)(1994-1#1)(1994-3#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-12#1)
value of these##2##3##(1992-6#1)(1994-3#1)
value of this assay##2##4##(1991-12#1)(2008-10#1)
value of this##8##3##(1990-6#1)(1991-12#1)(1992-12#2)(2008-10#2)(2008-9#1)(2011-2#1)
value of using##5##3##(1992-2#1)(1995-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
value of v##2##3##(2008-10#1)(2008-5#1)
value of##332##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#5)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#4)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#5)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#102)(2008-11#26)(2008-12#10)(2008-2#2)(2008-3#16)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#11)(2008-9#5)(2009-10#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-8#1)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#5)(2013-8#3)
value on##2##2##(1990-8#1)(2008-9#1)
value over##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
value ranges##3##2##(2008-10#3)
value that##3##2##(1993-2#1)(2008-10#1)(2008-5#1)
value to predict the presence of##2##6##(2012-3#2)
value to the##4##3##(1990-3#1)(1994-1#1)(1997-4#1)(2011-2#1)
value to##20##2##(1990-3#1)(1992-1#1)(1994-1#1)(1994-12#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
value under##2##2##(2010-1#2)
value units##4##2##(1994-1#1)(2012-2#1)(2013-1#2)
value was 0##4##3##(1990-12#1)(2008-5#1)(2011-2#2)
value was found##2##3##(2008-10#1)(2008-12#1)
value was higher than##2##4##(1996-6#1)(2008-10#1)
value was obtained##5##3##(2008-10#4)(2012-12#1)
value was then##2##3##(2008-10#1)(2008-11#1)
value was##34##2##(1990-12#1)(1994-5#1)(1996-2#1)(1996-6#1)(1997-8#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#3)(2008-9#1)(2011-2#3)(2012-12#1)
value were##2##2##(2008-10#2)
value with the##2##3##(2008-10#2)
value within##2##2##(2008-10#2)
value##837##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#4)(1990-9#2)(1991-12#5)(1991-2#6)(1991-3#3)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#3)(1992-1#5)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#4)(1992-6#2)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#5)(1993-3#5)(1993-6#3)(1993-8#6)(1994-1#4)(1994-11#2)(1994-12#12)(1994-2#2)(1994-3#7)(1994-5#4)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#7)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#2)(1996-5#2)(1996-6#3)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#10)(2007-11#6)(2007-12#1)(2008-1#3)(2008-10#290)(2008-11#53)(2008-12#16)(2008-2#8)(2008-3#35)(2008-4#1)(2008-5#25)(2008-6#3)(2008-7#12)(2008-8#16)(2008-9#18)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#7)(2009-8#9)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#3)(2010-4#5)(2010-5#3)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#40)(2011-3#2)(2012-12#13)(2012-2#15)(2012-3#12)(2013-1#11)(2013-8#6)
value) and##2##2##(2008-10#1)(2010-1#1)
value)##9##1##(1993-1#1)(2008-10#4)(2008-5#2)(2010-1#1)(2011-2#1)
value-added##2##1##(1993-1#1)(2008-10#1)
valued##9##1##(1990-5#1)(1991-12#1)(1993-12#1)(2008-11#1)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
values &lt##6##2##(1994-11#1)(2008-10#2)(2008-3#2)(2011-2#1)
values (##3##2##(2008-10#2)(2008-11#1)
values (0##4##2##(1995-6#1)(2008-10#3)
values (6##2##2##(2008-10#2)
values (P &lt##2##3##(1994-3#1)(2008-10#1)
values (P##3##2##(1991-12#1)(1994-3#1)(2008-10#1)
values (R##2##2##(2008-10#2)
values (p##2##2##(2008-3#1)(2013-8#1)
values (the##3##2##(1991-6#1)(2008-10#1)(2008-8#1)
values a##2##2##(2008-10#1)(2008-9#1)
values agreed##2##2##(2008-10#2)
values among##3##2##(2008-10#3)
values and beliefs##3##3##(1995-1#1)(2008-12#2)
values and the##9##3##(2008-10#8)(2011-2#1)
values and those##2##3##(2008-10#2)
values and with##2##3##(2008-10#2)
values and##55##2##(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-12#4)(2008-3#1)(2008-7#3)(2009-10#1)(2010-1#1)(2011-2#4)(2013-8#1)
values are compared with##2##4##(2008-10#1)(2008-11#1)
values are compared##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
values are given##2##3##(2008-10#2)
values are in the range##2##5##(2008-10#2)
values are in the##3##4##(2008-10#3)
values are in##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
values are not##2##3##(2008-10#2)
values are##38##2##(1991-11#1)(1993-8#1)(1995-2#1)(1996-2#1)(2008-10#28)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)
values as a function of##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
values as compared to##2##4##(2008-10#2)
values as##12##2##(1992-9#1)(2008-10#9)(2008-3#1)(2008-5#1)
values associated##2##2##(2008-10#1)(2012-2#1)
values at##17##2##(1992-9#1)(1995-11#1)(2008-10#13)(2008-5#1)(2011-2#1)
values became##4##2##(1990-6#1)(1991-5#2)(1996-2#1)
values being##2##2##(2008-10#1)(2008-5#1)
values below##3##2##(2008-10#2)(2012-3#1)
values between 0##3##3##(2008-10#3)
values between the##2##3##(2008-10#1)(2012-3#1)
values between##17##2##(2008-10#12)(2008-5#2)(2011-2#1)(2012-3#1)(2012-9#1)
values but both##2##3##(1994-12#1)(2008-12#1)
values but##4##2##(1994-12#1)(1995-8#1)(2008-10#1)(2008-12#1)
values by##7##2##(2008-10#7)
values calculated##4##2##(1995-3#1)(2008-10#3)
values correlated well with##2##4##(1991-2#1)(2008-1#1)
values derived from the##2##4##(1997-2#1)(2008-10#1)
values derived##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
values determined##3##2##(1991-5#1)(2008-10#1)(2009-7#1)
values did not##2##3##(2008-10#1)(2008-5#1)
values do##2##2##(1994-8#1)(2008-10#1)
values during##2##2##(1994-2#1)(2010-5#1)
values education##2##2##(1992-2#2)
values far##2##2##(2008-10#2)
values for K(ijk)##2##3##(2008-10#2)
values for a##4##3##(2008-10#3)(2008-2#1)
values for both##2##3##(1994-6#1)(2008-5#1)
values for each##3##3##(1990-3#1)(2008-10#2)
values for isolated##2##3##(1993-8#1)(1994-8#1)
values for odour perception than those##2##6##(2008-7#2)
values for the##36##3##(1990-10#1)(1990-8#1)(1991-9#2)(1992-3#1)(1994-5#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#21)(2008-3#1)(2010-11#1)(2010-8#1)(2013-1#1)
values for these##4##3##(2008-10#2)(2008-6#1)(2013-3#1)
values for##135##2##(1990-10#2)(1990-2#2)(1990-3#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-8#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-2#2)(1995-6#5)(1996-12#1)(1997-2#4)(2008-10#63)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-1#3)(2013-3#2)
values found for##3##3##(2008-10#3)
values found in the##2##4##(2008-10#1)(2008-3#1)
values found##6##2##(1993-2#1)(2008-10#4)(2008-3#1)
values from the##3##3##(2008-10#2)(2008-5#1)
values from##15##2##(1990-2#1)(2008-10#11)(2008-3#1)(2008-5#2)
values generated##2##2##(2008-10#1)(2008-3#1)
values greater than##3##3##(1990-5#1)(2008-10#2)
values have been##2##3##(2008-10#2)
values have##3##2##(2008-10#3)
values higher than##3##3##(1993-2#1)(2008-10#1)(2008-11#1)
values in a##4##3##(1993-2#1)(2008-10#3)
values in relation to##2##4##(1990-5#1)(2013-1#1)
values in the range 0##2##5##(2008-10#2)
values in the range##5##4##(2008-10#5)
values in the##17##3##(1992-9#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#1)(2013-7#1)
values in##52##2##(1990-5#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-6#1)(1997-3#1)(2008-1#1)(2008-10#29)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2012-3#1)(2013-1#3)(2013-7#1)
values indicate that##2##3##(2008-10#1)(2013-8#1)
values indicated that##2##3##(1992-1#1)(2008-10#1)
values instead of##4##3##(2008-10#3)(2008-8#1)
values is##4##2##(2008-10#1)(2008-11#1)(2008-6#2)
values less than##4##3##(1990-12#1)(2008-10#2)(2008-11#1)
values lower than##3##3##(2008-10#3)
values may##2##2##(2008-10#1)(2011-2#1)
values measured##2##2##(2008-10#1)(2011-2#1)
values near##2##2##(2008-10#2)
values observed with##2##3##(1990-2#1)(1992-6#1)
values observed##4##2##(1990-2#1)(1992-6#1)(2008-10#2)
values obtained by##13##3##(1990-2#1)(2008-10#11)(2013-1#1)
values obtained for the##2##4##(2008-10#2)
values obtained for##6##3##(2008-10#5)(2012-2#1)
values obtained from the##2##4##(1991-9#1)(1992-2#1)
values obtained from##8##3##(1991-9#1)(1992-2#1)(1992-3#1)(2008-10#5)
values obtained in the##2##4##(2008-10#2)
values obtained in##4##3##(2008-10#3)(2012-3#1)
values obtained were##3##3##(2008-10#3)
values obtained with##5##3##(2008-10#4)(2008-3#1)
values obtained##47##2##(1990-2#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-3#1)(2008-10#37)(2008-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
values occurred##2##2##(2008-9#2)
values of &lt##3##3##(2008-10#3)
values of 0##17##3##(1993-8#2)(1994-3#1)(1994-5#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-12#3)(2011-2#1)(2012-3#1)
values of 1##4##3##(1990-8#1)(1993-3#1)(2008-10#2)
values of 13##2##3##(1995-8#1)(2008-10#1)
values of 2##2##3##(2008-10#2)
values of 3##3##3##(1995-8#1)(2008-10#2)
values of 4##4##3##(1995-2#1)(2008-11#2)(2013-1#1)
values of LDL alpha-tocopherol##2##4##(1991-12#2)
values of Y##2##3##(2008-7#2)
values of about##2##3##(1993-2#1)(1997-2#1)
values of all##3##3##(2008-10#2)(2013-1#1)
values of dihydroetorphine for the##2##5##(1995-11#2)
values of each##2##3##(2008-10#2)
values of genetic##2##3##(2008-10#2)
values of raw##2##3##(2010-4#2)
values of recoveries##2##3##(2008-10#2)
values of stability##2##3##(2008-10#2)
values of t(1)##2##3##(2008-10#2)
values of the F(1) generation were##2##6##(2008-10#2)
values of the FAPP##2##4##(2008-2#2)
values of the samples##2##4##(2008-10#2)
values of the##57##3##(1990-5#1)(1990-6#1)(1993-8#1)(1994-5#1)(2008-1#1)(2008-10#33)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-1#1)(2010-8#2)(2011-2#3)(2013-8#1)
values of these constants##2##4##(2008-10#2)
values of these##4##3##(2008-10#3)(2008-3#1)
values of total bilirubin##2##4##(2013-1#2)
values of |beta| for selection##2##5##(2008-8#2)
values of##285##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-2#2)(1992-3#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#4)(1994-12#3)(1994-3#2)(1994-5#2)(1994-8#2)(1995-1#1)(1995-11#5)(1995-2#1)(1995-8#6)(1997-2#1)(2007-8#1)(2008-1#3)(2008-10#127)(2008-11#19)(2008-12#6)(2008-2#4)(2008-3#9)(2008-5#5)(2008-7#8)(2008-8#12)(2009-3#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-4#4)(2010-6#1)(2010-8#6)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
values on the##2##3##(2010-6#1)(2011-3#1)
values on##4##2##(2008-10#2)(2010-6#1)(2011-3#1)
values or##2##2##(2008-10#1)(2011-2#1)
values over##4##2##(2008-10#2)(2008-7#1)(2010-11#1)
values ranged between##2##3##(2008-10#2)
values ranged from 0##4##4##(2008-10#3)(2008-5#1)
values ranged from##8##3##(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2012-2#1)
values ranged##11##2##(1991-5#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2012-2#1)
values ranging from 0##2##4##(2008-10#2)
values ranging from 1##2##4##(2008-10#2)
values ranging from##9##3##(2008-1#1)(2008-10#6)(2008-5#1)(2010-4#1)
values reported in the literature##2##5##(1991-3#1)(2008-10#1)
values reported##4##2##(1991-3#1)(2008-10#3)
values significantly##2##2##(2008-10#1)(2011-2#1)
values suggests##2##2##(1996-5#1)(2008-9#1)
values than those##2##3##(2008-10#1)(2011-2#1)
values than##5##2##(2008-10#3)(2011-2#2)
values that are##4##3##(2008-10#1)(2008-3#1)(2010-4#2)
values that were##2##3##(2008-10#1)(2008-5#1)
values that##8##2##(1996-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#2)
values to the##2##3##(2008-10#1)(2008-12#1)
values to##6##2##(1995-12#1)(2008-10#3)(2008-12#1)(2013-1#1)
values using##3##2##(2008-10#3)
values was good##2##3##(2008-10#2)
values was##11##2##(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)
values were 0##2##3##(1990-2#1)(2008-10#1)
values were 1##3##3##(1994-8#1)(2008-10#2)
values were 4##3##3##(2008-10#2)(2008-11#1)
values were also##2##3##(2008-10#2)
values were calculated##3##3##(2008-10#1)(2011-3#1)(2013-1#1)
values were compared to##2##4##(1990-9#1)(2008-10#1)
values were compared##4##3##(1990-9#1)(2008-10#3)
values were determined##6##3##(1995-8#1)(2008-10#2)(2008-5#2)(2009-9#1)
values were found to##2##4##(2008-10#2)
values were found##7##3##(1990-6#1)(2008-10#6)
values were higher in##2##4##(2011-2#2)
values were higher##3##3##(1992-9#1)(2011-2#2)
values were in the##2##4##(2008-10#1)(2008-8#1)
values were in##3##3##(2008-10#2)(2008-8#1)
values were less##2##3##(2008-10#1)(2008-8#1)
values were measured##2##3##(2008-10#2)
values were not significantly different##2##5##(2008-10#2)
values were observed for##2##4##(1996-5#1)(2008-10#1)
values were observed##3##3##(1996-5#1)(2008-10#2)
values were obtained for##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
values were obtained##7##3##(2008-1#1)(2008-10#4)(2008-11#1)(2011-2#1)
values were recorded##2##3##(2011-1#1)(2013-8#1)
values were significantly (P &lt##2##5##(1993-1#1)(2008-5#1)
values were significantly higher##2##4##(2009-1#1)(2012-3#1)
values were significantly##7##3##(1993-1#1)(2008-10#2)(2008-5#1)(2009-1#1)(2012-3#2)
values were##116##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#3)(1992-12#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(2008-1#1)(2008-10#62)(2008-11#3)(2008-5#5)(2008-7#2)(2008-8#2)(2009-1#1)(2009-3#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
values when##4##2##(1994-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
values which are##2##3##(1990-12#1)(2008-11#1)
values which were##3##3##(2008-10#2)(2008-7#1)
values which##7##2##(1990-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)
values will be##2##3##(1992-3#1)(2008-11#1)
values with##8##2##(1991-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)
values within##4##2##(1992-2#1)(2008-10#2)(2012-2#1)
values##1401##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#8)(1990-3#1)(1990-5#7)(1990-6#4)(1990-8#4)(1990-9#3)(1991-11#3)(1991-12#6)(1991-2#5)(1991-3#2)(1991-5#8)(1991-6#4)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#8)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#5)(1993-1#4)(1993-11#3)(1993-12#2)(1993-2#6)(1993-3#1)(1993-6#1)(1993-8#12)(1994-1#3)(1994-11#5)(1994-12#11)(1994-2#2)(1994-3#4)(1994-5#7)(1994-6#2)(1994-8#7)(1994-9#1)(1995-1#2)(1995-11#7)(1995-12#2)(1995-2#5)(1995-3#1)(1995-6#6)(1995-8#11)(1995-9#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#8)(1997-3#2)(2007-8#1)(2008-1#10)(2008-10#729)(2008-11#49)(2008-12#17)(2008-2#12)(2008-3#33)(2008-4#2)(2008-5#45)(2008-6#5)(2008-7#32)(2008-8#36)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#3)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#9)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#10)(2010-5#1)(2010-6#4)(2010-8#8)(2010-9#1)(2011-1#5)(2011-2#45)(2011-3#3)(2012-12#3)(2012-2#11)(2012-3#14)(2012-9#1)(2013-1#31)(2013-3#2)(2013-7#2)(2013-8#8)
values) and##2##2##(2008-10#1)(2011-1#1)
values) of##3##2##(2008-10#3)
values)##17##1##(1992-11#1)(1995-8#1)(2008-10#14)(2011-1#1)
values]##2##1##(1996-2#1)(2010-12#1)
valuing##3##1##(1991-12#1)(2008-11#1)(2011-2#1)
valve and the##2##3##(2008-10#1)(2013-1#1)
valve and##12##2##(1994-5#1)(2008-10#8)(2010-12#1)(2013-1#2)
valve as##2##2##(2008-12#1)(2013-1#1)
valve bladder syndrome##2##3##(2008-10#2)
valve disease##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
valve endocarditis##2##2##(2011-2#2)
valve in##4##2##(1991-3#1)(2008-10#2)(2010-12#1)
valve insufficiency in##2##3##(1997-5#1)(2011-2#1)
valve insufficiency##3##2##(1997-5#1)(2011-2#1)(2012-2#1)
valve is##4##2##(1996-1#2)(2008-11#1)(2013-1#1)
valve of##2##2##(2008-10#2)
valve prosthesis##2##2##(1994-3#1)(1997-5#1)
valve repair##9##2##(2008-10#2)(2011-2#5)(2013-1#2)
valve replacement##12##2##(1994-3#1)(1997-5#2)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#2)
valve was##5##2##(1991-3#2)(2008-10#2)(2013-1#1)
valve with##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
valve##130##1##(1990-9#1)(1991-12#1)(1991-3#4)(1992-3#1)(1993-1#1)(1993-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-1#2)(1997-5#6)(2007-12#1)(2008-10#44)(2008-11#4)(2008-12#2)(2008-8#4)(2009-2#1)(2009-9#1)(2010-12#7)(2011-2#24)(2012-12#1)(2012-2#5)(2013-1#13)(2013-8#2)
valves and##5##2##(1996-2#1)(1997-1#1)(2008-10#3)
valves are##2##2##(2008-10#2)
valves in##2##2##(1996-12#1)(2011-2#1)
valves were##4##2##(2008-10#3)(2010-12#1)
valves##49##1##(1991-12#1)(1991-3#3)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(2006-6#1)(2008-10#27)(2008-11#1)(2008-7#2)(2008-8#1)(2010-12#5)(2010-6#1)(2010-9#1)(2011-2#1)
valvular heart disease##2##3##(2007-8#1)(2012-2#1)
valvular##10##1##(1990-11#1)(1994-3#2)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
valvuloplasty##2##1##(2008-11#1)(2008-12#1)
van der Waals interactions between##3##5##(1993-8#1)(2008-10#2)
van der Waals interactions##4##4##(1991-3#1)(1993-8#1)(2008-10#2)
van der Waals##15##3##(1991-3#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-3#1)(2008-10#4)(2008-5#1)(2009-11#1)(2010-4#1)(2013-1#3)
van der##16##2##(1991-3#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-3#1)(2008-10#5)(2008-5#1)(2009-11#1)(2010-4#1)(2013-1#3)
van##22##1##(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-8#1)(1994-5#1)(1995-3#1)(1997-5#1)(2008-10#7)(2008-5#1)(2009-11#1)(2010-10#1)(2010-4#1)(2013-1#3)
van't Hoff plots##2##3##(2008-10#2)
van't Hoff##4##2##(1997-2#1)(2008-10#3)
vanadate increased##2##2##(1997-1#2)
vanadate##20##1##(1994-11#2)(1994-6#5)(1995-2#1)(1997-1#8)(2008-10#4)
vanadium (IV)##2##2##(1990-5#1)(2008-10#1)
vanadium (V)##4##2##(2008-10#3)(2011-2#1)
vanadium adsorption from the NH(4)VO(3) solution##2##6##(2008-10#2)
vanadium adsorption##3##2##(2008-10#3)
vanadium and molybdenum bearing geological##2##5##(2008-10#2)
vanadium and##10##2##(2008-10#8)(2008-11#1)(2011-2#1)
vanadium at##3##2##(2008-10#3)
vanadium by##6##2##(2008-10#6)
vanadium can be determined##2##4##(2008-10#2)
vanadium can be##3##3##(2008-10#3)
vanadium content in##2##3##(2008-10#2)
vanadium contents##2##2##(2008-10#2)
vanadium determination##3##2##(2008-10#3)
vanadium from##3##2##(2008-10#3)
vanadium in natural waters##3##4##(2008-10#3)
vanadium in the range##3##4##(2008-10#3)
vanadium in the##5##3##(2008-10#5)
vanadium in##32##2##(2008-10#32)
vanadium species in##3##3##(2008-10#3)
vanadium species##5##2##(2008-10#5)
vanadium was##4##2##(1990-5#1)(2008-10#3)
vanadium##123##1##(1990-5#5)(2008-10#113)(2008-11#1)(2011-2#4)
vanadium(IV) and (V)##2##3##(2008-10#2)
vanadium(IV) and vanadium(V)##3##3##(2008-10#3)
vanadium(IV) and##8##2##(2008-10#8)
vanadium(IV) in##2##2##(2008-10#2)
vanadium(IV)##12##1##(2008-10#12)
vanadium(V) and##3##2##(2008-10#3)
vanadium(V) with##4##2##(2008-10#4)
vanadium(V)##21##1##(2008-10#21)
vanadyl sulphate intoxication in mice##2##5##(1990-5#2)
vanadyl##5##1##(1990-5#2)(2008-10#3)
vancomycin and##5##2##(2008-10#4)(2011-2#1)
vancomycin##14##1##(2007-12#1)(2008-10#7)(2008-12#1)(2009-8#1)(2011-2#4)
vanilla beans from##2##3##(2008-10#2)
vanilla beans##3##2##(2008-10#3)
vanilla##9##1##(2008-10#9)
vanillic##2##1##(2008-10#1)(2011-2#1)
vanillin and PHB##3##3##(2008-10#3)
vanillin and##6##2##(2008-10#6)
vanillin##10##1##(2008-10#10)
vanilloid receptor##2##2##(2008-11#2)
vanilloid##3##1##(2008-11#2)(2011-2#1)
vanished##3##1##(2008-5#1)(2009-8#1)(2013-8#1)
vanishing##2##1##(2009-8#1)(2010-12#1)
vantage point##2##2##(1992-12#1)(2008-2#1)
vapor and##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
vapor atomic##10##2##(2008-10#10)
vapor deposition##9##2##(2008-10#3)(2008-2#1)(2008-3#3)(2009-11#1)(2010-4#1)
vapor diffusion##2##2##(2008-8#1)(2008-9#1)
vapor from##2##2##(2008-3#2)
vapor generation##4##2##(2008-10#4)
vapor in##4##2##(2008-10#1)(2008-3#3)
vapor is##3##2##(2008-10#1)(2008-3#2)
vapor phase##5##2##(2008-10#3)(2008-7#1)(2008-8#1)
vapor pressure deficit and##2##4##(2008-10#2)
vapor pressure##3##2##(2008-10#3)
vapor pressures##2##2##(1992-3#1)(2008-10#1)
vapor was##3##2##(2008-10#2)(2008-3#1)
vapor##108##1##(1991-1#1)(1991-5#3)(1992-3#1)(1997-1#1)(2008-10#59)(2008-11#1)(2008-2#4)(2008-3#28)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
vapor-phase##2##1##(2008-10#2)
vaporization and##2##2##(1991-2#1)(2008-10#1)
vaporization behavior of##3##3##(2008-10#3)
vaporization for##2##2##(1991-2#1)(2010-4#1)
vaporization in##2##2##(1996-1#1)(2008-10#1)
vaporization inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
vaporization inductively coupled plasma##6##4##(2008-10#6)
vaporization of##4##2##(1992-3#2)(2008-10#2)
vaporization temperature of##4##3##(2008-10#4)
vaporization temperature##5##2##(2008-10#5)
vaporization##40##1##(1991-2#3)(1992-3#2)(1996-1#1)(2008-10#33)(2010-4#1)
vaporized and##2##2##(1991-2#1)(2008-10#1)
vaporized at##4##2##(1991-2#1)(2008-10#3)
vaporized##12##1##(1991-2#3)(1992-1#2)(1992-3#2)(2008-10#5)
vaporizer##4##1##(2008-10#4)
vapors of##2##2##(2008-10#1)(2008-3#1)
vapors##20##1##(2007-12#1)(2008-10#15)(2008-2#1)(2008-3#3)
vapour atomic absorption##9##3##(2008-10#9)
vapour atomic fluorescence##3##3##(2008-10#3)
vapour atomic##12##2##(2008-10#12)
vapour diffusion##2##2##(1992-11#1)(2008-8#1)
vapour generation and atomic##2##4##(2008-10#2)
vapour generation and##3##3##(2008-10#3)
vapour generation atomic fluorescence spectrometry##2##5##(2008-10#2)
vapour generation##7##2##(2008-10#7)
vapour phase decomposition (VPD) of quartz powder##2##7##(2008-10#2)
vapour phase##7##2##(2008-10#7)
vapour pressure of##5##3##(2008-5#5)
vapour pressure##6##2##(2008-5#6)
vapour##48##1##(1992-11#1)(1996-12#1)(2008-10#36)(2008-5#8)(2008-8#2)
vapour-phase catalyst delivery##2##3##(2008-7#2)
vapour-phase##3##1##(2008-10#1)(2008-7#2)
vapours were##2##2##(2008-10#2)
vapours##15##1##(1991-6#3)(1996-12#1)(2008-10#11)
var##137##1##(2008-10#105)(2008-11#5)(2008-12#7)(2008-5#17)(2009-10#1)(2011-1#1)(2012-3#1)
varenidine##3##1##(2013-8#3)
variabilities##2##1##(2008-10#1)(2008-9#1)
variability among isolates##2##3##(2008-10#2)
variability among the##3##3##(2008-10#3)
variability among##12##2##(1990-2#1)(2008-10#11)
variability and uncertainty##2##3##(1993-3#1)(2008-10#1)
variability and##20##2##(1993-3#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#1)(2010-12#1)(2010-9#1)(2013-8#2)
variability are##2##2##(2008-9#1)(2011-2#1)
variability at##2##2##(2008-10#1)(2013-8#1)
variability between##11##2##(1990-7#1)(1997-3#1)(2008-10#7)(2009-2#1)(2009-6#1)
variability coefficient for the exercise was nearby to the average value for##2##12##(2008-10#2)
variability coefficient##3##2##(2008-10#3)
variability for##2##2##(2008-10#1)(2008-7#1)
variability found in##2##3##(2008-10#1)(2012-2#1)
variability from##2##2##(2008-8#1)(2012-2#1)
variability has##2##2##(2008-11#1)(2012-4#1)
variability in disease incidence##2##4##(2008-10#2)
variability in disease##4##3##(2008-10#4)
variability in per capita population growth rates##2##7##(2008-8#2)
variability in seed output##2##4##(2008-9#2)
variability in seed production##2##4##(2008-9#2)
variability in seed##4##3##(2008-9#4)
variability in species'##2##3##(2008-8#2)
variability in the##15##3##(1990-8#1)(1991-12#2)(1997-5#1)(2008-10#8)(2008-11#2)(2008-8#1)
variability in tumor delineation##2##4##(2009-11#2)
variability in##75##2##(1990-8#1)(1991-12#2)(1991-8#1)(1992-3#1)(1993-2#1)(1995-11#3)(1995-2#1)(1997-5#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#8)(2008-9#6)(2009-11#3)(2009-7#1)(2010-10#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#1)
variability indicators##2##2##(2012-4#2)
variability is##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
variability of BP##2##3##(2008-11#2)
variability of the pathogen##3##4##(2008-10#3)
variability of the##19##3##(1990-11#2)(1991-11#1)(1996-3#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
variability of this##2##3##(2008-10#1)(2008-5#1)
variability of##57##2##(1990-11#2)(1991-11#1)(1992-9#2)(1993-2#1)(1995-11#1)(1995-3#1)(1996-12#2)(1996-3#1)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-4#1)(2009-8#1)(2011-2#4)(2013-1#1)
variability on the##2##3##(1992-9#1)(2011-2#1)
variability on##4##2##(1992-9#1)(2008-10#1)(2011-2#2)
variability over##2##2##(2008-12#1)(2008-9#1)
variability present##2##2##(2008-10#2)
variability was attributable to##2##4##(2008-10#1)(2008-7#1)
variability was##9##2##(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#2)
variability were##2##2##(2013-1#1)(2013-8#1)
variability with##2##2##(2008-10#1)(2013-1#1)
variability within##4##2##(1994-3#1)(2008-10#3)
variability##320##1##(1990-11#2)(1990-2#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#5)(1991-8#1)(1992-3#1)(1992-9#3)(1993-12#2)(1993-2#2)(1993-3#1)(1994-3#1)(1995-11#4)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-5#1)(1997-7#1)(2008-10#130)(2008-11#17)(2008-12#9)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#16)(2008-9#14)(2009-10#1)(2009-11#5)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-2#14)(2011-3#2)(2012-2#4)(2012-3#4)(2012-4#7)(2012-5#4)(2013-1#5)(2013-8#8)
variability)##3##1##(2008-11#1)(2008-8#2)
variable among##3##2##(1997-8#1)(2008-9#1)(2010-8#1)
variable amounts of##2##3##(1995-6#1)(2008-10#1)
variable amounts##3##2##(1995-6#1)(2008-10#1)(2008-2#1)
variable and##9##2##(1996-3#1)(2008-10#5)(2008-12#1)(2008-6#1)(2013-8#1)
variable as a function of##2##5##(2008-10#2)
variable between##3##2##(2008-10#2)(2013-8#1)
variable can##2##2##(2008-8#1)(2011-2#1)
variable clinical##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
variable depending on the##2##4##(1997-8#1)(2008-5#1)
variable depending on##4##3##(1997-8#1)(2008-12#1)(2008-5#1)(2009-8#1)
variable effect##2##2##(2008-10#1)(2008-11#1)
variable environments##2##2##(2008-8#2)
variable for##4##2##(1994-3#1)(1996-6#1)(2008-10#1)(2009-8#1)
variable fragment##4##2##(2008-10#4)
variable from##3##2##(2008-1#1)(2008-5#1)(2013-1#1)
variable growth##2##2##(2008-12#2)
variable in##5##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
variable interval##2##2##(1992-12#1)(1993-6#1)
variable is##2##2##(1995-12#1)(2008-8#1)
variable length##4##2##(1996-2#1)(2008-10#3)
variable levels of##2##3##(2008-8#2)
variable number tandem repeat##2##4##(2008-10#1)(2008-7#1)
variable number##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
variable of##3##2##(1990-11#1)(1990-12#1)(1990-8#1)
variable on the##2##3##(2008-10#2)
variable phenotype##3##2##(1997-3#1)(2008-4#1)(2009-12#1)
variable reflectivity##2##2##(2008-2#2)
variable region##9##2##(1992-6#1)(1993-11#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-8#1)
variable regions##2##2##(1995-11#1)(2008-10#1)
variable responses##2##2##(1994-2#1)(2008-11#1)
variable results##2##2##(2008-10#1)(2008-9#1)
variable sample volume##2##3##(2008-10#2)
variable selection methods##2##3##(2008-10#2)
variable selection##7##2##(2008-10#4)(2010-1#3)
variable severity##2##2##(2008-10#1)(2008-11#1)
variable sites##3##2##(2008-10#3)
variable temperature##2##2##(1996-5#1)(2008-10#1)
variable than those##2##3##(2008-10#1)(2008-9#1)
variable than##3##2##(1993-3#1)(2008-10#1)(2008-9#1)
variable time##2##2##(2008-11#1)(2008-3#1)
variable to##2##2##(2008-10#2)
variable values)##2##2##(2008-10#2)
variable was##4##2##(1992-1#1)(1993-3#1)(2008-10#1)(2008-11#1)
variable wavelength epi-fluorescence microscope##2##4##(2008-10#2)
variable##319##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#7)(1997-6#1)(1997-8#2)(2008-1#3)(2008-10#110)(2008-11#18)(2008-12#7)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#29)(2008-9#11)(2009-11#1)(2009-12#2)(2009-8#5)(2010-1#4)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-10#1)(2011-2#21)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#7)
variable-term computer leases##2##3##(1993-2#2)
variable-tone long calls##2##3##(2008-8#2)
variables (age##2##2##(2008-10#1)(2008-11#1)
variables (e##3##2##(2008-7#3)
variables (pH##2##2##(2008-10#2)
variables (sample##3##2##(2008-10#3)
variables 1##2##2##(2008-7#2)
variables accounted for##2##3##(2008-10#1)(2008-8#1)
variables affect##2##2##(2008-10#1)(2012-3#1)
variables affecting the fluorescence##4##4##(2008-10#4)
variables affecting the##20##3##(2008-10#20)
variables affecting##24##2##(2008-10#23)(2012-2#1)
variables also##2##2##(1995-2#1)(2008-10#1)
variables and surgical management of foot melanoma##2##7##(2012-3#2)
variables and the##3##3##(2008-10#2)(2008-9#1)
variables and their##3##3##(1994-6#1)(2008-10#2)
variables and##27##2##(1994-6#1)(1995-9#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
variables are the##2##3##(2008-10#1)(2008-4#1)
variables are##15##2##(1992-3#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2012-12#1)(2012-3#1)
variables as well as##5##4##(2008-10#4)(2009-8#1)
variables as##7##2##(2008-10#6)(2009-8#1)
variables associated with##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
variables at##3##2##(2008-10#3)
variables based on##2##3##(2008-10#2)
variables being##2##2##(2008-10#2)
variables did not##2##3##(2008-8#1)(2009-7#1)
variables examined##2##2##(2008-10#1)(2011-2#1)
variables for the##4##3##(2008-10#3)(2013-1#1)
variables for##14##2##(1991-3#1)(1992-2#1)(2008-10#8)(2012-2#1)(2012-3#2)(2013-1#1)
variables had##3##2##(1991-3#1)(2008-10#2)
variables have been optimized##3##4##(2008-10#3)
variables have been##4##3##(2008-10#4)
variables in the model##2##4##(2008-10#1)(2008-11#1)
variables in the##6##3##(2008-10#3)(2008-11#2)(2013-1#1)
variables in##18##2##(1991-3#1)(1994-8#1)(1996-12#1)(2008-10#6)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-1#1)
variables including##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
variables influenced##2##2##(2008-11#1)(2008-9#1)
variables influencing the##2##3##(2008-10#2)
variables influencing##3##2##(1994-2#1)(2008-10#2)
variables is##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
variables like##3##2##(2008-10#3)
variables may##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
variables of the##7##3##(2008-10#4)(2008-7#2)(2010-8#1)
variables of##11##2##(1995-1#1)(2008-10#5)(2008-7#3)(2010-8#1)(2011-2#1)
variables on the determination of##2##5##(2008-10#2)
variables on the##5##3##(2008-10#5)
variables on these##2##3##(2008-10#1)(2008-4#1)
variables on##10##2##(2008-10#8)(2008-4#1)(2008-5#1)
variables or##3##2##(1995-12#1)(1995-9#1)(2008-4#1)
variables related to##3##3##(1995-1#1)(2008-10#2)
variables related##4##2##(1995-1#1)(2008-10#2)(2011-1#1)
variables studied##5##2##(1994-3#2)(2008-10#1)(2008-11#1)(2011-2#1)
variables such as nationality##2##4##(2009-8#1)(2011-2#1)
variables such as pH##2##4##(2008-10#2)
variables such as the##5##4##(2008-10#5)
variables such as##27##3##(1993-1#1)(1993-11#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
variables such##28##2##(1993-1#1)(1993-11#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
variables that affect the##2##4##(2008-10#2)
variables that affect##4##3##(2008-10#3)(2008-8#1)
variables that are##2##3##(2008-10#1)(2009-4#1)
variables that could affect the performance of this system were investigated as well as the possible interferents##2##17##(2008-10#2)
variables that influence the##2##4##(2008-10#2)
variables that were##2##3##(2008-11#1)(2011-2#1)
variables that##16##2##(2008-10#12)(2008-11#1)(2008-8#1)(2009-4#1)(2011-2#1)
variables the##2##2##(2008-10#2)
variables to be##4##3##(2008-10#3)(2008-11#1)
variables to##12##2##(2008-10#7)(2008-11#1)(2008-4#1)(2012-2#2)(2013-8#1)
variables using a##2##3##(2008-10#1)(2008-11#1)
variables was completely studied by factorial design analysis##2##8##(2008-10#2)
variables was studied##2##3##(2008-10#2)
variables was##8##2##(1992-2#1)(2008-10#7)
variables were collected##2##3##(2008-10#1)(2011-1#1)
variables were measured in##2##4##(2008-10#1)(2012-12#1)
variables were measured##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
variables were optimized##2##3##(2008-10#2)
variables were studied and optimized##3##5##(2008-10#3)
variables were studied##5##3##(2008-10#5)
variables were##47##2##(1991-12#1)(1995-1#1)(1996-1#1)(1996-3#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
variables with##7##2##(1993-2#1)(1995-12#1)(2008-10#2)(2010-1#1)(2010-10#1)(2011-2#1)
variables##534##1##(1991-12#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#3)(1992-3#3)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-1#4)(1995-12#5)(1995-2#1)(1995-3#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-10#275)(2008-11#24)(2008-12#8)(2008-3#2)(2008-4#5)(2008-5#8)(2008-7#24)(2008-8#12)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#4)(2009-8#6)(2010-1#3)(2010-10#3)(2010-2#2)(2010-4#1)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#25)(2012-12#8)(2012-2#10)(2012-3#13)(2013-1#18)(2013-8#10)
variables)##2##1##(2010-1#1)(2013-1#1)
variably expressed##2##2##(1996-12#1)(2012-3#1)
variably##6##1##(1996-12#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-3#2)
variamine blue##3##2##(2008-10#3)
variance (I)##2##2##(2008-8#2)
variance analysis##3##2##(2008-10#3)
variance and##11##2##(1992-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2013-1#2)
variance between##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
variance can##3##2##(2008-10#1)(2008-8#2)
variance components##2##2##(1994-9#1)(2008-7#1)
variance for##4##2##(2008-10#4)
variance in gain##2##3##(2008-9#2)
variance in population##2##3##(2008-8#2)
variance in the lognormal##2##4##(2008-8#2)
variance in the##12##3##(1995-3#1)(2008-10#3)(2008-4#1)(2008-8#2)(2008-9#3)(2009-12#1)(2012-3#1)
variance in##48##2##(1994-3#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-8#9)(2008-9#9)(2009-12#4)(2009-4#1)(2010-11#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-3#3)(2013-8#2)
variance indicated##3##2##(2008-10#3)
variance is##4##2##(1993-3#1)(2008-10#1)(2008-8#2)
variance of the##5##3##(2008-10#5)
variance of##13##2##(1992-9#1)(2008-10#10)(2008-8#1)(2011-3#1)
variance revealed##4##2##(2008-10#2)(2009-11#1)(2012-3#1)
variance to##2##2##(2008-10#1)(2009-7#1)
variance was##5##2##(1991-2#1)(2008-10#4)
variance with the##3##3##(1995-6#1)(2008-10#1)(2009-6#1)
variance with##7##2##(1995-6#1)(1996-6#1)(2008-10#4)(2009-6#1)
variance##215##1##(1990-2#1)(1991-2#1)(1992-2#1)(1992-9#2)(1993-12#1)(1993-2#3)(1993-3#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(2007-12#2)(2008-10#92)(2008-11#3)(2008-12#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#21)(2008-9#21)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#3)(2010-3#1)(2010-5#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#7)(2013-1#9)(2013-8#2)
variance)##3##1##(2008-10#2)(2008-8#1)
variance-mean relationship##2##2##(2008-10#2)
variance-mean##3##1##(2008-10#3)
variance-to-mean##2##1##(2008-10#2)
variances in##3##2##(1994-9#1)(2008-11#1)(2008-9#1)
variances of##4##2##(1995-5#1)(2008-10#2)(2012-3#1)
variances##26##1##(1994-2#1)(1994-9#1)(1995-12#2)(1995-5#1)(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#4)
variant (Met352----Arg)##2##2##(1990-8#2)
variant and##2##2##(2012-2#1)(2013-1#1)
variant genes##3##2##(2011-2#3)
variant has been##3##3##(1991-12#1)(1993-8#1)(2011-2#1)
variant has##4##2##(1991-12#2)(1993-8#1)(2011-2#1)
variant hepatic##2##2##(2012-2#2)
variant is##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
variant isolates##3##2##(2008-10#3)
variant of 3beta-HSD deficiency CAH##2##5##(2008-4#2)
variant of Wegener's granulomatosis##3##4##(2010-11#3)
variant of the##9##3##(1994-5#1)(1995-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#1)
variant of##33##2##(1990-12#1)(1990-6#1)(1992-2#1)(1992-4#1)(1994-5#1)(1995-11#1)(1996-3#1)(1997-1#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-10#1)(2010-11#3)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#2)
variant was##3##2##(1996-3#1)(2010-12#1)(2011-1#1)
variant with##3##2##(1990-8#2)(1995-6#1)
variant##117##1##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#8)(1991-12#5)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#3)(1994-1#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-11#3)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-2#5)(2012-3#5)(2013-1#5)
variants and##5##2##(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
variants are presented##2##3##(1996-9#1)(2012-2#1)
variants are##5##2##(1996-9#1)(2008-10#1)(2012-2#2)(2012-3#1)
variants at##2##2##(1993-9#1)(2008-12#1)
variants by##3##2##(1995-6#1)(2008-9#1)(2012-3#1)
variants differ##2##2##(1990-6#2)
variants have been##2##3##(2008-9#1)(2012-2#1)
variants have##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
variants in##14##2##(1991-12#1)(1994-12#1)(2008-10#1)(2008-4#3)(2010-1#2)(2010-4#1)(2012-2#3)(2012-3#1)(2013-1#1)
variants is##3##2##(1991-12#1)(1997-7#1)(2010-1#1)
variants may##2##2##(2008-12#1)(2008-9#1)
variants of satellite tobacco mosaic virus##2##6##(2008-10#2)
variants of the##4##3##(1992-4#1)(1996-3#1)(2008-10#1)(2010-4#1)
variants of##26##2##(1990-5#1)(1991-5#1)(1992-4#1)(1993-9#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-9#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#1)
variants tested##2##2##(2008-11#1)(2011-1#1)
variants that##6##2##(1996-2#1)(2008-10#3)(2011-1#1)(2013-1#1)
variants were##7##2##(1991-8#1)(2008-10#3)(2008-8#1)(2011-2#2)
variants with increased##2##3##(2008-8#1)(2013-1#1)
variants with##9##2##(2008-10#1)(2008-11#1)(2008-8#3)(2009-9#1)(2010-12#1)(2011-3#1)(2013-1#1)
variants##147##1##(1990-5#1)(1990-6#6)(1991-12#4)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1995-11#2)(1995-5#1)(1995-6#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#2)(1997-9#1)(2008-10#38)(2008-11#6)(2008-12#3)(2008-4#7)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-6#1)(2009-9#1)(2010-1#5)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-2#11)(2012-3#4)(2013-1#6)
variates##3##1##(1992-9#1)(2008-10#2)
variation &lt##3##2##(2008-10#3)
variation across##3##2##(1994-12#1)(1994-3#1)(1995-8#1)
variation among strains##2##3##(2008-10#2)
variation among the##2##3##(1991-5#1)(2008-10#1)
variation among##15##2##(1991-5#1)(1997-3#1)(1997-9#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
variation and effect of##2##4##(1997-2#1)(2008-10#1)
variation and the##3##3##(1994-3#1)(2008-10#1)(2013-8#1)
variation and variation in##2##4##(2008-10#2)
variation and##34##2##(1992-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-6#1)(1997-2#1)(2008-10#12)(2008-11#2)(2008-7#1)(2008-8#3)(2009-5#1)(2010-1#1)(2010-5#1)(2012-2#2)(2012-3#1)(2012-6#1)(2012-9#1)(2013-8#2)
variation as well as##2##4##(2008-11#1)(2009-7#1)
variation associated with##4##3##(2008-10#2)(2008-11#1)(2010-5#1)
variation at##13##2##(1993-2#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-8#1)(2010-5#1)(2012-3#2)
variation between##11##2##(1994-9#1)(2008-10#6)(2009-7#2)(2009-8#1)(2012-3#1)
variation by##4##2##(1994-12#1)(2008-10#2)(2008-8#1)
variation can be##2##3##(2008-8#2)
variation can##4##2##(1993-3#1)(2008-12#1)(2008-8#2)
variation coefficient of the##2##4##(2008-10#2)
variation coefficient of##3##3##(2008-10#3)
variation coefficient were##3##3##(2008-10#3)
variation coefficient##8##2##(2008-10#8)
variation coefficients of##2##3##(2008-10#2)
variation coefficients##3##2##(2008-10#3)
variation compared##2##2##(2008-10#1)(2008-8#1)
variation continues to##2##3##(1991-12#1)(1996-3#1)
variation depending on##2##3##(2008-10#1)(2010-5#1)
variation due to##2##3##(2008-10#2)
variation for components of aggressiveness##2##5##(2008-10#2)
variation for resistance in##5##4##(2008-10#5)
variation for resistance to##2##4##(2008-10#2)
variation for resistance##8##3##(2008-10#8)
variation for##26##2##(1990-2#1)(2008-10#21)(2008-5#1)(2008-9#2)(2012-3#1)
variation from##3##2##(1995-8#1)(1996-3#1)(2008-7#1)
variation in Bragg wavelength##3##4##(2013-8#3)
variation in a##2##3##(1991-3#1)(2008-12#1)
variation in aggressiveness##2##3##(2008-10#2)
variation in body size and##2##5##(2008-9#1)(2010-8#1)
variation in cell size##2##4##(2008-7#1)(2013-1#1)
variation in competitive##2##3##(2008-8#1)(2008-9#1)
variation in condition##2##3##(2010-8#2)
variation in disease severity##2##4##(2008-10#2)
variation in disease##4##3##(2008-10#4)
variation in epicuticular##2##3##(2008-8#2)
variation in fitness##3##3##(2008-8#3)
variation in growth##3##3##(2008-8#2)(2010-8#1)
variation in host##2##3##(2008-10#1)(2008-9#1)
variation in level##2##3##(1990-5#1)(1996-3#1)
variation in levels of##2##4##(1992-3#1)(1993-11#1)
variation in mammary thermography##2##4##(1990-2#2)
variation in parasitic fitness##2##4##(2008-10#2)
variation in patch density##2##4##(2008-8#2)
variation in patch##3##3##(2008-8#2)(2008-9#1)
variation in pathogenicity##2##3##(2008-10#2)
variation in population density##2##4##(2008-8#2)
variation in population##4##3##(2008-8#3)(2008-9#1)
variation in rectal and bladder doses##2##6##(2009-11#2)
variation in sex##2##3##(2008-8#2)
variation in species richness##4##4##(2008-8#4)
variation in the environment##2##4##(2008-10#1)(2012-3#1)
variation in the##34##3##(1991-5#1)(1993-2#1)(1993-3#1)(1995-11#2)(1995-9#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#3)
variation in their##3##3##(1990-9#1)(1994-5#1)(2008-9#1)
variation in time##2##3##(2008-10#1)(2008-9#1)
variation in urinary cytokine levels in##2##6##(1996-12#2)
variation in virulence##3##3##(2008-10#3)
variation in##247##2##(1990-2#2)(1990-5#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-5#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-6#1)(2008-10#62)(2008-11#8)(2008-12#9)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#51)(2008-9#17)(2009-11#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-4#1)(2010-8#7)(2011-2#4)(2011-3#2)(2012-2#4)(2012-3#15)(2013-1#4)(2013-8#3)
variation influences##2##2##(2011-2#1)(2012-3#1)
variation into##2##2##(2008-10#1)(2012-3#1)
variation is essential##2##3##(2008-10#1)(2008-7#1)
variation is##8##2##(1990-8#1)(1992-3#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#2)
variation method##2##2##(2008-10#2)
variation of influenza##2##3##(2013-8#2)
variation of leaf##2##3##(2011-10#1)(2012-5#1)
variation of the pH##2##4##(2008-10#2)
variation of the##33##3##(1993-1#1)(1993-9#1)(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#17)(2008-3#4)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
variation of##91##2##(1991-11#1)(1992-11#1)(1993-1#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#47)(2008-11#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-5#2)(2013-1#1)(2013-8#5)
variation on##2##2##(2008-10#1)(2008-3#1)
variation or##2##2##(2008-9#1)(2010-5#1)
variation showed##3##2##(1993-8#2)(2008-10#1)
variation shows##2##2##(2008-10#1)(2008-8#1)
variation than##2##2##(2008-8#2)
variation that##2##2##(2008-10#1)(2010-4#1)
variation to##2##2##(2008-10#2)
variation was due to##2##4##(2008-10#2)
variation was found in##2##4##(2012-3#1)(2013-8#1)
variation was found##4##3##(2008-10#2)(2012-3#1)(2013-8#1)
variation was greatest##2##3##(2008-10#2)
variation was observed##5##3##(1996-1#1)(2008-10#2)(2011-2#1)(2012-3#1)
variation was##28##2##(1991-8#1)(1996-1#1)(2008-10#21)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
variation with##3##2##(2008-10#3)
variation within a##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
variation within and among##2##4##(2008-10#2)
variation within and between##2##4##(2008-10#1)(2009-6#1)
variation within and##5##3##(2008-10#4)(2009-6#1)
variation within the population##2##4##(2008-8#1)(2012-3#1)
variation within the##5##3##(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#1)
variation within##21##2##(2008-10#14)(2008-12#1)(2008-8#2)(2008-9#1)(2009-6#1)(2012-3#2)
variation##712##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-8#1)(1993-1#4)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#5)(1993-8#2)(1993-9#2)(1994-12#4)(1994-3#3)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#2)(1996-3#7)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-6#1)(1997-8#2)(1997-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#301)(2008-11#15)(2008-12#12)(2008-2#3)(2008-3#12)(2008-5#16)(2008-6#4)(2008-7#8)(2008-8#78)(2008-9#27)(2009-10#2)(2009-11#2)(2009-5#2)(2009-6#1)(2009-7#7)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#3)(2010-12#1)(2010-4#6)(2010-5#10)(2010-8#11)(2011-10#1)(2011-2#13)(2011-3#5)(2012-2#14)(2012-3#35)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#6)(2013-8#12)
variation)##4##1##(1991-5#1)(1993-1#1)(2008-8#1)(2008-9#1)
variational##2##1##(1990-12#1)(2012-3#1)
variations and pathologic##2##3##(1996-6#2)
variations and##9##2##(1996-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)
variations are##3##2##(1996-3#1)(2008-8#1)(2011-2#1)
variations as##2##2##(2008-2#1)(2008-3#1)
variations between##5##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-2#1)(2011-2#1)
variations by##2##2##(2008-11#1)(2008-3#1)
variations found##2##2##(2008-8#1)(2008-9#1)
variations in disease##2##3##(2008-10#2)
variations in gene##2##3##(2008-10#1)(2012-3#1)
variations in pH and temperature##2##5##(2008-11#1)(2008-5#1)
variations in shape and##2##4##(2008-5#1)(2009-5#1)
variations in the cell##2##4##(2008-11#1)(2008-5#1)
variations in the thickness##2##4##(2008-5#1)(2008-9#1)
variations in the##41##3##(1990-8#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-9#2)(2009-7#1)(2011-2#1)(2013-8#2)
variations in##92##2##(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-3#6)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#2)(2009-7#2)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#6)
variations may##2##2##(2009-11#1)(2011-2#1)
variations of the##9##3##(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)
variations of##34##2##(1990-8#1)(1990-9#1)(1991-11#1)(1992-3#1)(1994-11#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
variations on the##2##3##(2008-11#1)(2013-8#1)
variations on##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#2)
variations ranging from##2##3##(2008-10#1)(2009-7#1)
variations were observed among##2##4##(2008-10#2)
variations were observed##3##3##(1990-8#1)(2008-10#2)
variations were##12##2##(1990-8#1)(1994-3#1)(1995-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)
variations with##2##2##(2008-11#1)(2008-5#1)
variations within##3##2##(1997-8#1)(2008-10#1)(2009-7#1)
variations##217##1##(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#49)(2008-11#12)(2008-12#5)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#22)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#3)(2009-5#2)(2009-7#5)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-3#1)(2011-2#10)(2012-12#1)(2012-3#4)(2012-9#1)(2013-1#2)(2013-8#10)
variceal bleeding##2##2##(1995-8#1)(2009-8#1)
variceal##9##1##(1995-8#1)(2008-8#1)(2009-8#1)(2011-2#5)(2013-1#1)
varicella infection##3##2##(1992-1#1)(1994-3#1)(2008-12#1)
varicella virus##2##2##(2008-11#2)
varicella zoster infection##3##3##(2008-7#3)
varicella##17##1##(1990-6#1)(1992-1#1)(1994-3#1)(2008-11#8)(2008-12#3)(2008-7#3)
varicella-related##3##1##(2008-11#2)(2008-12#1)
varicella-zoster virus##3##2##(2008-12#2)(2008-7#1)
varicelle##5##1##(2013-1#5)
varices##15##1##(1991-11#1)(2009-8#7)(2009-9#2)(2013-1#5)
varicocele in##2##2##(1990-3#2)
varicocele##9##1##(1990-3#8)(1990-9#1)
varicose nerve##2##2##(1990-5#1)(1997-3#1)
varicose##4##1##(1990-5#1)(1997-3#1)(2011-3#2)
varied according to the##2##4##(1993-12#1)(2011-2#1)
varied according to##3##3##(1993-12#1)(2011-2#1)(2012-3#1)
varied across the##3##3##(2008-12#1)(2010-1#1)(2013-8#1)
varied across##4##2##(2008-12#1)(2008-5#1)(2010-1#1)(2013-8#1)
varied among experiments##2##3##(2008-10#2)
varied among the##3##3##(1996-5#1)(2008-10#1)(2008-9#1)
varied among tissues##2##3##(2008-11#2)
varied among##17##2##(1996-5#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
varied and were##2##3##(2008-10#1)(2008-12#1)
varied and##6##2##(1996-2#1)(2008-10#2)(2008-12#1)(2013-1#1)(2013-8#1)
varied at##2##2##(2007-12#1)(2008-8#1)
varied based on##2##3##(2009-7#1)(2013-8#1)
varied between 0##7##3##(2008-10#6)(2008-11#1)
varied between 1 and##2##4##(2008-10#2)
varied between 1##3##3##(2008-10#3)
varied between##23##2##(1992-1#1)(1995-12#1)(2008-10#18)(2008-11#2)(2009-12#1)
varied by the##2##3##(1994-11#1)(2008-3#1)
varied by##9##2##(1992-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(2008-10#2)(2008-3#1)(2009-4#1)(2009-7#1)
varied considerably##2##2##(1994-2#1)(2008-10#1)
varied for##2##2##(1990-2#1)(2008-10#1)
varied from 0 to##2##4##(2008-10#1)(2008-7#1)
varied from 0##11##3##(1993-1#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
varied from 1##5##3##(2008-10#3)(2011-2#1)(2012-2#1)
varied from 10##2##3##(1993-1#1)(2008-10#1)
varied from 2##6##3##(2008-1#1)(2008-10#3)(2008-5#1)(2009-2#1)
varied from 20##2##3##(2008-10#1)(2011-2#1)
varied from 6##2##3##(1995-3#1)(2009-3#1)
varied from 85##2##3##(2008-10#2)
varied from 95##2##3##(2008-10#2)
varied from 97##2##3##(2008-10#2)
varied from##57##2##(1993-1#2)(1995-3#1)(1996-12#1)(1997-1#1)(2006-6#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#1)(2011-2#3)(2012-2#2)(2013-8#1)
varied greatly over##2##3##(2008-10#1)(2008-8#1)
varied greatly##6##2##(1991-12#1)(2008-10#4)(2008-8#1)
varied in a##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
varied in size from##2##4##(2008-5#1)(2012-3#1)
varied in size##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
varied in the range##2##4##(2008-10#2)
varied in the##3##3##(2008-10#2)(2008-8#1)
varied in their##5##3##(1994-5#1)(2008-10#4)
varied in##25##2##(1992-3#2)(1994-11#1)(1994-5#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
varied linearly##2##2##(2008-10#2)
varied more##2##2##(1991-1#1)(2008-10#1)
varied over##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
varied significantly between##2##3##(2011-2#1)(2012-3#1)
varied significantly from##3##3##(2008-10#2)(2013-8#1)
varied significantly##9##2##(1991-12#1)(2008-10#4)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
varied substantially##2##2##(1992-5#1)(1995-3#1)
varied to##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
varied widely in their##2##4##(1991-2#1)(2008-11#1)
varied widely##8##2##(1990-3#1)(1991-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
varied with pH##2##3##(2008-10#2)
varied with the##4##3##(2007-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
varied with##11##2##(1991-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
varied within##2##2##(2008-10#2)
varied##247##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#115)(2008-11#18)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#9)(2008-9#9)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#4)(2010-1#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#7)
variegated##7##1##(2008-10#6)(2011-2#1)
variegatus##7##1##(2008-10#6)(2008-8#1)
varies according to the##2##4##(2008-10#1)(2013-1#1)
varies according to##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
varies among##2##2##(1991-10#1)(2012-3#1)
varies and##2##2##(1992-9#1)(2008-5#1)
varies between##4##2##(1995-11#1)(2008-10#1)(2008-7#2)
varies by##2##2##(2009-9#1)(2013-8#1)
varies considerably##3##2##(1994-12#1)(1994-6#1)(1996-11#1)
varies depending on the##4##4##(1993-8#1)(2006-6#1)(2008-10#1)(2011-1#1)
varies depending on##5##3##(1993-8#1)(1995-1#1)(2006-6#1)(2008-10#1)(2011-1#1)
varies from 0##3##3##(1990-9#1)(2008-10#2)
varies from one##2##3##(1995-1#1)(2010-8#1)
varies from##10##2##(1990-9#1)(1993-2#1)(1995-1#1)(2008-10#4)(2008-3#1)(2008-9#1)(2010-8#1)
varies greatly##2##2##(1995-2#1)(2013-1#1)
varies in##6##2##(1993-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
varies inversely with the##2##4##(2008-10#1)(2009-7#1)
varies linearly with the concentration of##2##6##(2008-10#2)
varies linearly with the##3##4##(2008-10#3)
varies widely##2##2##(2007-11#1)(2008-3#1)
varies with the##9##3##(1990-6#2)(1990-8#1)(1995-12#1)(1996-3#1)(2008-10#2)(2008-3#1)(2009-9#1)
varies with##18##2##(1990-5#1)(1990-6#2)(1990-8#1)(1992-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
varies##80##1##(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1996-11#1)(1996-2#2)(1996-3#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-3#8)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#1)
varietal##4##1##(2008-10#4)
varieties and##4##2##(2008-10#3)(2008-12#1)
varieties have been##2##3##(2008-10#1)(2008-9#1)
varieties of D##3##3##(2008-10#3)
varieties of##18##2##(1997-3#1)(2008-10#9)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)
varieties or##3##2##(2008-10#2)(2008-8#1)
varieties that##3##2##(1995-6#1)(2008-10#2)
varieties were##2##2##(2008-10#2)
varieties##70##1##(1995-6#1)(1996-8#3)(1997-3#1)(2008-10#44)(2008-12#6)(2008-5#1)(2008-8#6)(2008-9#2)(2009-10#2)(2009-6#1)(2011-1#1)(2011-2#2)
variety and##3##2##(1990-6#1)(2008-10#1)(2010-8#1)
variety in##2##2##(2008-10#1)(2010-6#1)
variety of adaptive responses##2##4##(1996-12#2)
variety of anatomical##2##3##(2008-5#1)(2013-1#1)
variety of anions##2##3##(2008-10#2)
variety of applications##9##3##(1995-1#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)
variety of approaches to##2##4##(2008-9#1)(2010-11#1)
variety of approaches##3##3##(2008-9#1)(2010-11#1)(2010-8#1)
variety of cell lines##2##4##(1991-6#1)(2008-11#1)
variety of cell types##4##4##(1996-2#1)(2008-11#2)(2008-9#1)
variety of cell##6##3##(1991-6#1)(1996-2#1)(2008-11#3)(2008-9#1)
variety of cellular##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
variety of clinical##6##3##(1992-9#1)(2008-11#3)(2010-5#1)(2011-1#1)
variety of complex##2##3##(1992-11#1)(1997-2#1)
variety of conditions##3##3##(1990-2#1)(2008-3#1)(2008-6#1)
variety of different##5##3##(1996-11#1)(2008-10#2)(2010-4#1)(2012-2#1)
variety of disciplines##2##3##(2011-2#1)(2013-8#1)
variety of disease##3##3##(2008-10#1)(2008-4#1)(2010-2#1)
variety of diseases in humans and animals##2##7##(2011-1#1)(2012-3#1)
variety of diseases##5##3##(2008-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
variety of drugs##3##3##(1990-11#1)(1992-3#1)(2008-11#1)
variety of environmental##3##3##(2008-10#2)(2009-8#1)
variety of environments##2##3##(2008-3#1)(2008-9#1)
variety of eukaryotic##2##3##(1996-3#1)(2008-4#1)
variety of features##2##3##(2008-6#1)(2011-2#1)
variety of food products##2##4##(2008-10#1)(2011-2#1)
variety of functions##3##3##(1997-6#1)(2008-11#1)(2012-2#1)
variety of genes##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
variety of human##5##3##(2008-8#1)(2011-2#3)(2013-1#1)
variety of interests##2##3##(1992-1#1)(2010-2#1)
variety of methods##5##3##(1993-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-2#1)
variety of molecular##3##3##(2008-10#1)(2010-10#2)
variety of new##2##3##(2010-10#1)(2012-3#1)
variety of organisms##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#1)
variety of other anions and##2##5##(2008-10#2)
variety of other anions##3##4##(2008-10#3)
variety of other cancers##2##4##(2011-2#1)(2011-3#1)
variety of other##21##3##(1993-12#1)(1994-12#1)(2008-10#12)(2008-9#2)(2009-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
variety of potential##2##3##(2009-10#1)(2012-2#1)
variety of psychiatric##2##3##(1996-12#1)(2011-2#1)
variety of recombinant##2##3##(1993-2#1)(2013-8#1)
variety of research##2##3##(2008-10#1)(2009-10#1)
variety of sample types##2##4##(2008-10#1)(2008-3#1)
variety of sample##3##3##(2008-10#2)(2008-3#1)
variety of sensing##2##3##(2008-10#1)(2008-3#1)
variety of specimens##2##3##(2008-9#1)(2010-1#1)
variety of stakeholders##2##3##(1997-2#1)(2008-11#1)
variety of substrates##2##3##(1996-5#1)(2010-4#1)
variety of the##2##3##(1997-8#1)(2008-10#1)
variety of tissues##2##3##(1993-3#1)(1997-8#1)
variety of##480##2##(1990-11#2)(1990-2#2)(1991-12#2)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#4)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#3)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#4)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-6#1)(1997-7#2)(1997-8#3)(2008-1#1)(2008-10#92)(2008-11#44)(2008-12#12)(2008-2#4)(2008-3#10)(2008-4#19)(2008-5#7)(2008-6#8)(2008-7#9)(2008-8#12)(2008-9#25)(2009-1#1)(2009-10#5)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#3)(2009-8#6)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#26)(2011-3#2)(2011-8#1)(2012-12#1)(2012-2#16)(2012-3#10)(2013-1#4)(2013-8#12)
variety was##2##2##(2008-12#1)(2008-5#1)
variety##517##1##(1990-11#2)(1990-2#2)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#4)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#3)(1994-8#3)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#4)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-6#1)(1997-7#2)(1997-8#3)(2008-1#1)(2008-10#99)(2008-11#45)(2008-12#23)(2008-2#4)(2008-3#10)(2008-4#19)(2008-5#12)(2008-6#8)(2008-7#9)(2008-8#12)(2008-9#29)(2009-1#1)(2009-10#5)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#3)(2009-8#6)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#4)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#27)(2011-3#2)(2011-8#1)(2012-12#1)(2012-2#16)(2012-3#11)(2013-1#4)(2013-8#13)
various agents##2##2##(2008-5#1)(2009-8#1)
various ages##2##2##(1996-1#1)(2008-10#1)
various agricultural##2##2##(2008-10#1)(2013-1#1)
various air##2##2##(1995-3#1)(2008-10#1)
various alloys and biological samples##2##5##(2008-10#2)
various amino acids##3##3##(1996-5#1)(2008-10#1)(2012-2#1)
various amounts of##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)
various analytes##2##2##(2008-10#2)
various analytical##4##2##(2008-10#3)(2010-11#1)
various animal##3##2##(1995-6#1)(2008-4#1)(2011-1#1)
various antibiotics##2##2##(1990-5#1)(2008-12#1)
various antigens##2##2##(1995-5#1)(2008-11#1)
various approaches to##2##3##(1993-2#1)(2008-3#1)
various approaches##4##2##(1993-2#1)(2008-10#1)(2008-12#1)(2008-3#1)
various approximations for computing the absorption efficiency and single-scattering albedo of##2##11##(2008-3#2)
various aspects of the##5##4##(1990-9#1)(1997-2#1)(2008-10#1)(2011-2#2)
various aspects of##14##3##(1990-9#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-9#1)(2011-2#3)(2012-3#2)
various aspects##17##2##(1990-9#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-3#2)
various authors##3##2##(1996-3#1)(2009-10#1)(2010-7#1)
various base##3##2##(1995-6#1)(2008-10#2)
various biological##8##2##(1994-8#1)(1995-11#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
various body##2##2##(1992-3#1)(2013-1#1)
various brands of##2##3##(2008-10#1)(2013-1#1)
various cancer cell lines##2##4##(2008-11#2)
various carbohydrates##3##2##(2008-10#3)
various carbon##3##2##(2008-10#2)(2008-8#1)
various cationic##7##2##(2008-10#6)(2008-11#1)
various causes of##2##3##(2008-11#1)(2012-2#1)
various cell types##4##3##(1994-11#1)(2008-11#1)(2010-7#1)(2012-3#1)
various cell##10##2##(1992-10#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-11#3)(2010-7#1)(2012-3#1)(2013-1#1)
various cells##2##2##(2008-11#1)(2008-9#1)
various cellular and##2##3##(1990-3#1)(2008-11#1)
various cellular##3##2##(1990-3#1)(2008-11#1)(2009-8#1)
various cerebral##3##2##(1997-2#2)(1997-3#1)
various challenges##2##2##(2009-9#1)(2011-1#1)
various chemical elements##2##3##(2008-10#1)(2008-5#1)
various chemical modifiers##4##3##(2008-10#4)
various chemical##11##2##(1990-2#1)(1992-4#1)(2008-10#8)(2008-5#1)
various chemistries##2##2##(2008-5#1)(2008-7#1)
various chromatographic##2##2##(2008-10#1)(2011-2#1)
various clinical##3##2##(1991-3#1)(1993-2#1)(2013-1#1)
various combinations of##6##3##(1996-12#2)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
various combinations##9##2##(1993-11#1)(1996-12#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)
various complex##3##2##(2008-10#1)(2008-11#2)
various components of the##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
various components of##6##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
various components##8##2##(1996-3#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
various compounds##5##2##(1993-12#1)(2008-10#3)(2008-11#1)
various concentration of##2##3##(2008-11#1)(2008-12#1)
various concentration##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
various concentrations (0##2##3##(1995-12#1)(2012-2#1)
various concentrations of standard##2##4##(2008-10#2)
various concentrations of##14##3##(1995-12#1)(1995-8#1)(1996-5#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#3)(2012-2#1)(2012-7#1)
various concentrations##19##2##(1993-12#1)(1995-12#2)(1995-8#1)(1996-5#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#3)(2012-2#2)(2012-7#1)
various conditions##7##2##(1996-12#1)(2008-10#5)(2011-3#1)
various countries##5##2##(1993-3#1)(1994-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
various crops##4##2##(2008-10#4)
various cultural##3##2##(2008-8#1)(2009-6#1)(2011-2#1)
various culture##2##2##(2008-11#1)(2008-7#1)
various definitions of##2##3##(2008-5#1)(2009-7#1)
various degrees##3##2##(1993-3#1)(2008-9#1)(2012-2#1)
various diluents having low dielectric constants##2##6##(2008-10#2)
various diluents of low dielectric##2##5##(2008-10#2)
various diluents##6##2##(2008-10#6)
various dimensions of##2##3##(1992-3#1)(2008-11#1)
various diseases##9##2##(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
various doses of##3##3##(2008-11#2)(2008-7#1)
various drugs##3##2##(1994-8#1)(2010-12#1)(2013-8#1)
various effects##2##2##(2007-11#1)(2013-1#1)
various elements##5##2##(1994-3#2)(2008-10#2)(2008-3#1)
various environmental samples##2##3##(2008-10#2)
various environmental##6##2##(2008-10#6)
various enzymatic##2##2##(2008-10#1)(2010-10#1)
various enzymes##2##2##(1992-6#1)(2011-2#1)
various experimental parameters##3##3##(2008-10#2)(2010-4#1)
various experimental##6##2##(2008-10#4)(2008-11#1)(2010-4#1)
various exposure##2##2##(2008-10#2)
various expression##2##2##(1997-8#1)(2008-9#1)
various factors affecting##2##3##(2008-5#1)(2012-12#1)
various factors##16##2##(1992-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
various food##3##2##(2008-10#2)(2011-2#1)
various foreign ions have been investigated##2##6##(2008-10#2)
various foreign ions##3##3##(2008-10#3)
various foreign##6##2##(2008-10#6)
various forms of##9##3##(1991-2#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-3#1)(2013-7#1)(2013-8#1)
various forms##10##2##(1991-2#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-3#1)(2013-7#1)(2013-8#1)
various fractions of##2##3##(2008-10#1)(2008-7#1)
various fractions##3##2##(2008-10#2)(2008-7#1)
various functions##3##2##(2008-7#1)(2008-9#1)(2012-2#1)
various fungi##2##2##(2008-10#2)
various gene##3##2##(2008-11#2)(2011-1#1)
various groups##2##2##(1991-2#1)(2009-6#1)
various growth##3##2##(1996-6#1)(1997-1#1)(2008-5#1)
various habitats##2##2##(2009-6#1)(2011-1#1)
various hair##3##2##(2008-5#3)
various health conditions and diseases##2##5##(2013-7#2)
various health##6##2##(1992-3#1)(1993-2#1)(1996-1#1)(2010-10#1)(2013-7#2)
various host##3##2##(2008-10#2)(2011-2#1)
various hosts and##3##3##(2008-10#3)
various hosts##5##2##(2008-10#5)
various human tissues##4##3##(1991-5#1)(1995-6#1)(2008-8#2)
various human##9##2##(1990-5#1)(1991-5#1)(1993-3#2)(1995-6#1)(2008-10#1)(2008-8#2)(2008-9#1)
various immune##2##2##(2008-10#1)(2008-11#1)
various inflammatory##5##2##(1990-2#1)(2008-5#1)(2012-3#2)(2013-1#1)
various inorganic##3##2##(2008-10#3)
various intervals##2##2##(2008-5#1)(2013-1#1)
various interventions##2##2##(2008-10#1)(2010-10#1)
various ionic strengths##2##3##(2008-10#2)
various ions##4##2##(2008-10#4)
various kinds of##5##3##(1995-2#1)(2008-10#1)(2009-4#1)(2010-1#1)(2012-2#1)
various laboratories##2##2##(2008-10#2)
various levels of suppressiveness##2##4##(2008-10#2)
various levels of##7##3##(1991-11#1)(1996-3#1)(2008-10#4)(2008-5#1)
various levels##10##2##(1991-11#1)(1996-3#1)(2008-10#4)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#1)
various ligands##2##2##(2008-10#1)(2008-4#1)
various locations##4##2##(2008-10#3)(2008-5#1)
various mammalian##2##2##(1995-2#1)(2008-9#1)
various materials##2##2##(2008-10#2)
various matrices##2##2##(2008-10#2)
various matters##3##2##(1995-12#3)
various measures##2##2##(2008-12#1)(2010-6#1)
various media##2##2##(2008-10#2)
various membranes##2##2##(2008-10#1)(2008-7#1)
various metabolic##2##2##(2011-1#1)(2012-2#1)
various metabolites##2##2##(2008-10#1)(2008-11#1)
various metal ions on the##2##5##(2008-10#2)
various metal ions##3##3##(2008-10#3)
various metal##5##2##(2008-10#5)
various methods for##2##3##(2008-12#1)(2008-4#1)
various methods of##4##3##(1992-9#1)(1995-11#1)(1995-9#1)(2009-7#1)
various methods##10##2##(1992-9#1)(1995-11#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2011-2#1)
various model##2##2##(1997-3#1)(2008-11#1)
various models##3##2##(2008-10#1)(2008-11#2)
various molecular##7##2##(2008-10#5)(2009-1#1)(2010-11#1)
various mouse tissues##3##3##(1993-8#1)(2008-11#2)
various mouse##4##2##(1993-8#1)(2008-10#1)(2008-11#2)
various nf harmonics of the background signals##2##7##(2008-3#2)
various nf harmonics of##3##4##(2008-3#3)
various optical##2##2##(1992-9#1)(2008-3#1)
various options##2##2##(2008-10#1)(2008-8#1)
various organic acids##2##3##(2008-10#2)
various organic##11##2##(2008-10#8)(2008-11#1)(2009-10#1)(2009-8#1)
various organizations##2##2##(1991-12#1)(2012-3#1)
various organs of##2##3##(1991-8#1)(1996-12#1)
various organs##10##2##(1990-12#1)(1991-8#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2012-12#1)(2012-3#1)
various other##5##2##(1992-6#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
various pH##3##2##(2008-10#2)(2008-5#1)
various pHs##2##2##(2008-10#2)
various parameters that##2##3##(2008-10#1)(2008-5#1)
various parameters##15##2##(2008-10#9)(2008-4#1)(2008-5#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
various parts of the world##2##5##(2008-10#1)(2011-2#1)
various parts of the##6##4##(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
various parts of##8##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
various pathogenic##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
various pathological conditions##3##3##(1992-2#1)(2011-2#1)(2012-2#1)
various pathological##4##2##(1992-2#1)(2009-3#1)(2011-2#1)(2012-2#1)
various pathways##2##2##(2009-1#1)(2011-2#1)
various patient groups##2##3##(2008-10#1)(2008-6#1)
various patient##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
various pharmacological##2##2##(2008-4#1)(2012-2#1)
various pharmacopoeias are responding with monographs or informational chapters addressing excipient functionality##2##12##(2012-2#2)
various physical##3##2##(1997-2#1)(2007-11#1)(2013-1#1)
various plant##6##2##(1993-11#1)(1995-6#1)(2008-10#4)
various plasticizers##2##2##(2008-10#2)
various portions of the##2##4##(1992-6#1)(2008-5#1)
various portions of##4##3##(1992-6#1)(1993-8#1)(2008-5#2)
various possible##2##2##(1990-3#1)(2013-1#1)
various practical##2##2##(1991-12#1)(2012-2#1)
various problems##2##2##(2008-3#1)(2008-6#1)
various procedures##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
various proportions##4##2##(2007-12#1)(2008-10#3)
various protein##2##2##(1990-8#1)(2010-12#1)
various proteins##5##2##(1997-3#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-2#1)
various protocols##3##2##(1997-1#1)(2008-9#1)(2013-8#1)
various psychiatric disorders##2##3##(1996-6#1)(2012-2#1)
various ratios##2##2##(1993-8#1)(2008-5#1)
various reasons##6##2##(1993-3#1)(1994-5#1)(1995-5#1)(2010-11#1)(2012-3#1)(2013-8#1)
various recombinant proteins##2##3##(2008-11#1)(2008-7#1)
various recombinant##3##2##(1994-8#1)(2008-11#1)(2008-7#1)
various reference materials##2##3##(2008-10#2)
various regimes of##3##3##(1997-2#1)(2008-10#2)
various regions of##2##3##(1995-12#1)(2008-7#1)
various regions##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
various research##2##2##(2008-10#1)(2012-12#1)
various risk factors##3##3##(1991-6#1)(1993-11#1)(2008-7#1)
various risk##4##2##(1991-6#1)(1993-11#1)(2008-7#1)(2009-12#1)
various samples##7##2##(2008-10#7)
various sampling schemes##2##3##(2008-10#2)
various scales##2##2##(2008-3#1)(2008-8#1)
various scattering##3##2##(2008-3#3)
various settings##2##2##(1991-12#1)(2010-5#1)
various shapes##2##2##(2008-10#1)(2010-6#1)
various signaling pathways##3##3##(2008-4#1)(2009-8#1)(2012-2#1)
various sites##4##2##(1990-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
various soilborne##2##2##(2008-10#2)
various solvents##3##2##(2008-10#2)(2008-3#1)
various sources of##2##3##(2008-10#1)(2008-3#1)
various sources##5##2##(1993-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
various species##8##2##(1990-5#1)(1991-12#1)(1991-9#1)(1993-2#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
various spectral##2##2##(2008-10#1)(2008-3#1)
various stages of##15##3##(1991-7#1)(1993-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
various stages##18##2##(1991-7#1)(1993-11#1)(1994-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
various standard alloys and environmental samples##2##6##(2008-10#2)
various standard alloys and##3##4##(2008-10#3)
various standard##4##2##(2008-10#4)
various steps##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
various stimuli##4##2##(1993-6#1)(1995-12#1)(1995-8#1)(2009-3#1)
various strategies##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
various structures of##2##3##(2008-10#1)(2008-8#1)
various studies##3##2##(1990-6#1)(2010-10#1)(2011-2#1)
various subsites##2##2##(1991-6#1)(1992-12#1)
various substrates##2##2##(2008-10#1)(2012-3#1)
various surgical##3##2##(1990-9#1)(1991-3#1)(2008-9#1)
various systems##3##2##(2008-10#2)(2008-9#1)
various techniques have been##2##4##(1996-3#1)(2008-10#1)
various techniques##14##2##(1991-1#1)(1991-2#1)(1994-9#1)(1996-3#1)(2008-10#5)(2008-11#2)(2009-1#1)(2012-3#2)
various time##8##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2013-7#1)
various times after##2##3##(2008-10#1)(2011-2#1)
various times##10##2##(1992-1#1)(1994-8#1)(2008-10#5)(2008-5#1)(2010-8#1)(2011-2#1)
various tissue##2##2##(2008-4#2)
various tissues of##2##3##(1994-5#1)(2008-11#1)
various tissues##13##2##(1992-12#1)(1993-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#1)(2012-2#2)
various total##2##2##(2008-10#1)(2009-7#1)
various treatments##3##2##(2008-5#2)(2012-2#1)
various types of cells##2##4##(1993-3#1)(2008-4#1)
various types of tumors##2##4##(2008-11#2)
various types of##39##3##(1991-12#1)(1991-2#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
various types##44##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
various vertebrate##2##2##(1993-12#1)(1993-8#1)
various visual##2##2##(2008-10#1)(2008-6#1)
various water samples##5##3##(2008-10#5)
various water##6##2##(2008-10#6)
various ways##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
various wheat##2##2##(1991-12#1)(2008-10#1)
various##1362##1##(1990-12#1)(1990-2#4)(1990-3#5)(1990-5#6)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#10)(1991-2#8)(1991-3#6)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#7)(1993-3#12)(1993-6#2)(1993-8#9)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#7)(1994-6#1)(1994-8#8)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#9)(1995-3#4)(1995-5#7)(1995-6#6)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#11)(1996-2#5)(1996-3#7)(1996-5#7)(1996-6#4)(1996-9#1)(1997-1#3)(1997-2#11)(1997-3#8)(1997-4#2)(1997-7#4)(1997-8#12)(2006-6#2)(2007-11#3)(2007-12#3)(2008-1#3)(2008-10#453)(2008-11#93)(2008-12#24)(2008-2#9)(2008-3#42)(2008-4#17)(2008-5#49)(2008-6#9)(2008-7#28)(2008-8#25)(2008-9#28)(2009-1#5)(2009-10#4)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#10)(2009-9#3)(2010-1#3)(2010-10#9)(2010-11#7)(2010-12#8)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#5)(2010-7#6)(2010-8#4)(2010-9#2)(2011-1#10)(2011-2#50)(2011-3#6)(2011-7#3)(2012-12#5)(2012-2#39)(2012-3#26)(2012-7#1)(2013-1#33)(2013-7#6)(2013-8#18)
variously##3##1##(1992-12#1)(1995-12#1)(2007-12#1)
varnish##2##1##(2011-2#2)
varus deformity##2##2##(2009-3#1)(2013-1#1)
varus##4##1##(2009-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
vary according to the##2##4##(1994-9#1)(1995-1#1)
vary according to##5##3##(1990-6#1)(1994-9#1)(1995-1#1)(2008-9#1)(2010-6#1)
vary across##4##2##(1994-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
vary among##2##2##(1991-10#1)(2008-10#1)
vary as a function of##3##5##(2008-2#1)(2009-4#1)(2009-7#1)
vary as the##2##3##(2008-3#1)(2008-7#1)
vary as##6##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-7#1)
vary between 80 and 100%##2##5##(1992-11#1)(2008-10#1)
vary between individuals##2##3##(2007-11#1)(2010-11#1)
vary between##7##2##(1992-11#1)(1996-3#1)(2007-11#1)(2008-10#3)(2010-11#1)
vary by##8##2##(1994-1#1)(1997-2#1)(2008-10#1)(2009-7#1)(2010-11#1)(2011-2#2)(2013-1#1)
vary considerably##6##2##(1991-3#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
vary depending on the##2##4##(2008-5#1)(2008-9#1)
vary for##2##2##(1994-1#1)(2008-10#1)
vary from one##2##3##(2008-5#1)(2013-1#1)
vary from##19##2##(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
vary in a##2##3##(1995-11#1)(2008-12#1)
vary in different##3##3##(2008-10#2)(2010-6#1)
vary in the order of##2##5##(2008-10#2)
vary in the order##4##4##(2008-10#4)
vary in the##8##3##(1997-1#1)(2008-10#6)(2008-8#1)
vary in their##4##3##(1993-9#1)(2008-10#1)(2008-8#2)
vary in##26##2##(1993-9#1)(1995-11#1)(1997-1#1)(2008-10#9)(2008-12#3)(2008-5#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
vary linearly##2##2##(2008-10#1)(2008-3#1)
vary significantly at##2##3##(2008-8#1)(2011-2#1)
vary significantly##8##2##(1996-1#1)(1997-8#1)(2008-10#1)(2008-8#2)(2009-7#2)(2011-2#1)
vary substantially among##2##3##(2008-9#1)(2013-8#1)
vary substantially between##2##3##(2008-10#1)(2008-11#1)
vary substantially##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
vary the##2##2##(2008-3#1)(2008-7#1)
vary widely in##2##3##(2008-11#1)(2008-6#1)
vary widely##7##2##(1995-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-3#1)
vary with##15##2##(1993-6#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#2)(2013-1#1)
vary##147##1##(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-1#4)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#28)(2008-11#6)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#12)(2008-9#7)(2009-12#1)(2009-4#1)(2009-7#5)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#3)(2011-2#6)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#1)
varying amounts of##2##3##(2008-10#1)(2008-5#1)
varying amounts##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
varying between##3##2##(1990-8#1)(2008-10#2)
varying composition##4##2##(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)
varying concentrations of##7##3##(2008-10#5)(2008-11#1)(2009-9#1)
varying degree of##2##3##(2013-1#2)
varying degree##3##2##(2008-10#1)(2013-1#2)
varying degrees of resistance##3##4##(2008-10#3)
varying degrees of##16##3##(1991-6#1)(1993-2#1)(1995-1#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-8#1)
varying degrees##21##2##(1991-6#1)(1993-1#2)(1993-11#1)(1993-2#1)(1994-12#1)(1995-1#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-8#1)
varying doses of##3##3##(1994-11#1)(2008-11#1)(2008-5#1)
varying environmental##2##2##(1992-12#1)(2008-10#1)
varying from 1##3##3##(2008-10#3)
varying from 10##2##3##(2008-10#1)(2010-8#1)
varying from##19##2##(1995-6#1)(2008-10#13)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
varying impacts of factors##2##4##(2010-11#2)
varying in their##2##3##(1991-2#1)(2008-10#1)
varying in##6##2##(1991-2#1)(2008-10#4)(2011-2#1)
varying inbreeding depression##2##3##(2008-8#2)
varying intensity##2##2##(2009-3#1)(2013-8#1)
varying lag times##2##3##(2008-5#2)
varying lengths##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
varying levels of##9##3##(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-3#1)
varying levels##11##2##(2008-10#5)(2008-11#2)(2008-6#1)(2008-9#1)(2011-1#1)(2012-3#1)
varying local##2##2##(2008-12#1)(2008-9#1)
varying molecular##2##2##(1992-12#1)(2009-9#1)
varying pH##3##2##(2008-10#3)
varying proportions##2##2##(2008-10#2)
varying several##2##2##(2008-10#2)
varying stages of##2##3##(2008-4#1)(2008-9#1)
varying temperatures##2##2##(2008-10#1)(2012-4#1)
varying the amount of##3##4##(2008-10#2)(2009-8#1)
varying the metallic##2##3##(2010-6#2)
varying the##32##2##(1991-1#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-6#2)(2012-2#1)
varying types and##2##3##(1997-3#1)(2009-1#1)
varying with the##2##3##(1997-2#1)(2008-2#1)
varying##247##1##(1990-2#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-5#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1997-2#3)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#100)(2008-11#16)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-11#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-2#5)(2012-3#4)(2012-4#2)(2013-1#5)(2013-8#4)
varying-coefficient##2##1##(2010-1#1)(2013-1#1)
vas deferens##10##2##(1992-3#1)(1994-8#2)(1997-8#2)(2008-10#5)
vas##16##1##(1992-3#1)(1994-8#7)(1997-8#2)(2008-10#5)(2011-3#1)
vascular access##8##2##(1991-6#1)(2008-1#1)(2011-2#5)(2013-1#1)
vascular anatomy##2##2##(1993-6#1)(2012-2#1)
vascular and neurological complications##3##4##(2013-1#3)
vascular and neurological##4##3##(2008-7#1)(2013-1#3)
vascular and##10##2##(1990-3#1)(1990-9#1)(1992-12#1)(2008-7#1)(2009-8#1)(2011-2#2)(2013-1#3)
vascular basement membrane##2##3##(1992-12#2)
vascular bed##2##2##(1997-1#1)(2008-10#1)
vascular beds##3##2##(1991-3#1)(2010-9#2)
vascular bundle##3##2##(2008-10#1)(2009-3#2)
vascular bundles##6##2##(2008-10#6)
vascular calcification##4##2##(2009-1#2)(2012-12#2)
vascular cell##2##2##(1995-2#1)(2012-2#1)
vascular cells##4##2##(1994-5#1)(2008-11#1)(2008-5#1)(2012-4#1)
vascular changes##2##2##(1992-6#1)(2008-7#1)
vascular colonization by##2##3##(2008-10#2)
vascular complication##3##2##(1993-2#2)(1994-3#1)
vascular complications and##2##3##(2011-2#2)
vascular complications##9##2##(1992-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#4)
vascular compromise##2##2##(2008-12#2)
vascular dementia (VD)##2##3##(1996-11#1)(2008-7#1)
vascular dementia##6##2##(1996-11#2)(2008-7#4)
vascular density##3##2##(2008-11#2)(2011-2#1)
vascular disease and##2##3##(1992-6#1)(1992-9#1)
vascular disease##21##2##(1992-6#1)(1992-8#1)(1992-9#4)(1993-2#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#2)(2010-10#1)(2010-6#1)(2011-2#2)
vascular diseases##5##2##(1995-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
vascular diseases]##2##2##(1995-11#1)(1996-11#1)
vascular disorder##3##2##(1992-5#1)(2008-10#1)(2008-9#1)
vascular disruption##3##2##(1997-3#3)
vascular endothelial cells##13##3##(1991-5#2)(1994-11#1)(1996-12#3)(1997-1#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#2)
vascular endothelial growth factor (VEGF)##10##5##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
vascular endothelial growth factor##19##4##(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
vascular endothelial growth##21##3##(1994-3#1)(1997-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
vascular endothelial##37##2##(1991-5#2)(1994-11#1)(1994-3#1)(1996-12#4)(1997-1#3)(1997-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#2)
vascular endothelium##2##2##(1994-8#1)(2008-3#1)
vascular events##4##2##(2006-6#1)(2008-8#2)(2013-1#1)
vascular function and##2##3##(2012-12#1)(2013-8#1)
vascular function##5##2##(1993-6#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
vascular graft##2##2##(2011-3#2)
vascular imaging##5##2##(2009-10#3)(2010-8#1)(2013-8#1)
vascular injury##5##2##(1992-12#2)(1992-9#1)(1994-5#1)(2013-1#1)
vascular invasion##2##2##(2011-2#2)
vascular lesion##3##2##(1997-8#2)(2008-7#1)
vascular lesions##5##2##(1996-11#1)(1997-8#2)(2008-12#1)(2012-2#1)
vascular malformation of##2##3##(2012-3#2)
vascular malformation##3##2##(2011-2#1)(2012-3#2)
vascular malformations in##2##3##(2008-7#1)(2012-3#1)
vascular malformations##9##2##(2008-10#1)(2008-7#3)(2011-2#1)(2012-2#1)(2012-3#3)
vascular mapping##2##2##(2013-1#2)
vascular muscle alpha##2##3##(1991-6#2)
vascular muscle##4##2##(1991-6#4)
vascular network##4##2##(1996-1#1)(2008-5#1)(2008-9#1)(2011-2#1)
vascular occlusion##3##2##(2008-4#1)(2009-1#1)(2011-2#1)
vascular or##2##2##(2011-3#1)(2012-12#1)
vascular pathology##2##2##(1991-1#1)(2013-8#1)
vascular permeability##7##2##(1992-12#1)(1992-6#1)(1994-8#1)(2008-1#2)(2008-9#1)(2012-12#1)
vascular plant##6##2##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)
vascular plants##9##2##(2008-8#3)(2008-9#3)(2009-6#1)(2009-8#2)
vascular pressure##2##2##(1997-1#1)(2010-7#1)
vascular prostacyclin##2##2##(1994-5#2)
vascular prosthesis##2##2##(2008-11#1)(2011-3#1)
vascular prosthetic graft##2##3##(2011-3#2)
vascular reactivity##3##2##(2012-2#3)
vascular remodeling##4##2##(2008-1#2)(2012-3#1)(2013-1#1)
vascular resistance of##2##3##(1997-5#1)(2009-5#1)
vascular resistance##11##2##(1990-11#1)(1996-6#1)(1997-5#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2010-10#2)(2012-2#1)
vascular risk factors and##2##4##(2008-7#2)
vascular smooth muscle cell##2##4##(2008-11#1)(2008-9#1)
vascular smooth muscle cells (VSMC)##2##5##(1993-2#1)(2008-1#1)
vascular smooth muscle cells and##3##5##(1990-2#2)(1995-2#1)
vascular smooth muscle cells were##2##5##(1990-8#1)(1992-8#1)
vascular smooth muscle cells##20##4##(1990-12#1)(1990-2#3)(1990-8#3)(1992-8#1)(1993-2#1)(1993-3#1)(1994-11#3)(1995-11#1)(1995-2#2)(1997-1#1)(2008-1#1)(2008-11#1)(2009-1#1)
vascular smooth muscle##28##3##(1990-12#1)(1990-2#3)(1990-8#6)(1991-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-11#4)(1995-11#1)(1995-2#2)(1997-1#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-1#1)(2010-12#1)
vascular structures##2##2##(2010-6#1)(2011-2#1)
vascular surgery##4##2##(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#1)
vascular surgery]##3##2##(1991-3#1)(2009-5#1)(2011-3#1)
vascular system##6##2##(1990-8#1)(2008-10#5)
vascular thrombosis and##2##3##(2008-10#1)(2009-8#1)
vascular thrombosis##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
vascular tissue##8##2##(2008-10#7)(2008-11#1)
vascular tissues of##2##3##(2008-10#1)(2008-8#1)
vascular tissues##13##2##(1993-8#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)
vascular tone##3##2##(1995-2#1)(2010-10#1)(2012-4#1)
vascular tumors##2##2##(2013-1#1)(2013-8#1)
vascular wall##3##2##(2006-6#1)(2008-11#1)(2009-7#1)
vascular wilt##3##2##(2008-10#3)
vascular##458##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-8#7)(1990-9#1)(1991-1#1)(1991-3#5)(1991-5#2)(1991-6#8)(1992-12#6)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#5)(1993-2#6)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-5#5)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#6)(1996-1#1)(1996-11#6)(1996-12#4)(1996-6#1)(1996-9#1)(1997-1#7)(1997-3#7)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(2006-6#2)(2007-8#1)(2008-1#9)(2008-10#52)(2008-11#18)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#27)(2008-8#15)(2008-9#15)(2009-1#6)(2009-10#6)(2009-3#3)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#9)(2010-1#6)(2010-10#6)(2010-12#4)(2010-3#3)(2010-6#6)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#36)(2011-3#10)(2012-12#7)(2012-2#17)(2012-3#12)(2012-4#2)(2013-1#13)(2013-8#13)
vascularity##5##1##(1991-8#1)(2011-2#3)(2013-1#1)
vascularization##12##1##(1990-5#2)(2008-10#1)(2008-11#5)(2009-3#1)(2010-10#1)(2010-7#1)(2012-2#1)
vascularized##9##1##(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)(2010-6#1)(2011-2#1)
vasculature in##4##2##(2008-7#1)(2008-9#2)(2011-2#1)
vasculature##17##1##(1997-1#6)(2008-7#1)(2008-9#3)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
vasculitic leg ulcers associated with hepatitis C virus infection##2##9##(2013-1#2)
vasculitic##3##1##(2010-6#1)(2013-1#2)
vasculitides##2##1##(2012-3#2)
vasculitis in##4##2##(1996-3#1)(1997-5#1)(1997-8#2)
vasculitis that##2##2##(2008-1#1)(2008-8#1)
vasculitis##29##1##(1995-5#1)(1996-3#3)(1996-8#1)(1997-4#5)(1997-5#1)(1997-8#8)(2008-1#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#5)
vasculogenic##2##1##(2009-3#2)
vasculopathy and##2##2##(2011-2#1)(2013-1#1)
vasectomy##2##1##(1992-5#1)(2008-8#1)
vasinfectum from##2##2##(2008-10#2)
vasinfectum race 1##2##3##(2008-10#2)
vasinfectum##10##1##(2008-10#10)
vasoactive intestinal peptide (VIP)##2##4##(1994-11#1)(1994-3#1)
vasoactive intestinal peptide##4##3##(1994-11#1)(1994-3#3)
vasoactive intestinal polypeptide##3##3##(1990-5#1)(1995-11#1)(1997-1#1)
vasoactive intestinal##8##2##(1990-5#1)(1994-11#1)(1994-3#3)(1995-11#1)(1997-1#1)(2008-1#1)
vasoactive peptide##2##2##(1993-3#1)(2011-2#1)
vasoactive peptides##4##2##(1994-9#4)
vasoactive##18##1##(1990-5#1)(1991-6#1)(1993-3#1)(1994-11#1)(1994-3#3)(1994-9#4)(1995-11#1)(1996-3#1)(1997-1#2)(2008-1#2)(2011-2#1)
vasoconstriction and##2##2##(1993-3#1)(1994-2#1)
vasoconstriction effect##2##2##(2011-2#2)
vasoconstriction##9##1##(1991-6#1)(1993-3#2)(1994-2#1)(1997-4#1)(2008-1#1)(2010-7#1)(2011-2#2)
vasoconstrictor##7##1##(1993-1#4)(1997-1#1)(2009-10#1)(2010-10#1)
vasodilatation in man##2##3##(1994-11#2)
vasodilatation##9##1##(1990-8#1)(1992-6#1)(1994-11#2)(2008-11#5)
vasodilation##3##1##(2011-1#1)(2011-2#1)(2013-8#1)
vasodilator##6##1##(1993-3#1)(2008-10#1)(2008-12#2)(2010-10#1)(2012-3#1)
vasodilators##4##1##(1996-11#1)(1997-1#1)(1997-5#1)(2008-10#1)
vasodilatory##3##1##(1992-5#1)(1997-1#1)(2013-8#1)
vasography##2##1##(1997-8#2)
vasomotor##3##1##(1991-12#1)(1992-9#1)(2008-11#1)
vasopressin (40##2##2##(1997-4#2)
vasopressin and angiotensin II stimulate the phosphorylation of##2##8##(1996-2#2)
vasopressin and angiotensin II##3##4##(1996-2#3)
vasopressin immunoreactivity in##2##3##(1994-2#2)
vasopressin immunoreactivity##3##2##(1994-2#3)
vasopressin on sodium intake##2##4##(1997-4#2)
vasopressin receptors##3##2##(1994-2#3)
vasopressin##29##1##(1990-12#1)(1990-5#1)(1991-5#1)(1994-11#2)(1994-2#8)(1996-12#1)(1996-2#4)(1997-4#7)(2008-4#1)(2008-5#1)(2008-6#1)(2010-1#1)
vasopressor##2##1##(2010-5#1)(2013-1#1)
vasorelaxation##4##1##(1993-6#2)(2013-8#2)
vasospasm after AVM rupture##3##4##(2012-3#3)
vasospasm and##2##2##(2008-7#2)
vasospasm in coronary artery bypass grafts##2##6##(2011-2#2)
vasospasm in##4##2##(1991-3#1)(2011-2#2)(2012-3#1)
vasospasm##23##1##(1991-3#1)(1992-9#1)(1995-11#1)(1996-3#1)(1997-3#1)(2008-3#2)(2008-7#6)(2011-2#3)(2012-3#7)
vast amounts of data##3##4##(1995-12#1)(2008-9#1)(2012-3#1)
vast amounts of##4##3##(1995-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
vast majority of patients##2##4##(1997-1#1)(2012-2#1)
vast majority of the##2##4##(2008-1#1)(2011-2#1)
vast majority of##15##3##(1994-3#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-9#1)(2011-2#2)(2012-2#1)
vast##33##1##(1992-2#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-1#2)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-9#3)(2009-12#1)(2009-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
vastly##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
vaterite##3##1##(2008-10#3)
vault##6##1##(1991-12#1)(2008-11#1)(2008-5#1)(2011-2#3)
vcr1##2##1##(2008-10#2)
vcr2##3##1##(2008-10#3)
vdW parameters##3##2##(2008-10#3)
vdW##4##1##(2008-10#4)
vector Polymyxa graminis##2##3##(2008-10#2)
vector and nonvector whiteflies##2##4##(2008-10#2)
vector and nonvector##3##3##(2008-10#3)
vector and the cDNA##2##4##(1994-11#1)(1994-12#1)
vector and the##6##3##(1994-11#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-8#2)
vector and##17##2##(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(2008-10#5)(2008-11#2)(2008-8#4)(2010-5#1)
vector but##2##2##(2008-10#2)
vector by##4##2##(1997-8#1)(2008-4#2)(2008-9#1)
vector can be##2##3##(1990-5#1)(1995-2#1)
vector carrying a##2##3##(2010-5#1)(2011-1#1)
vector carrying the human tissue inhibitor of##2##7##(2010-1#2)
vector carrying##8##2##(2008-8#1)(2008-9#1)(2010-1#4)(2010-5#1)(2011-1#1)
vector competency##2##2##(2008-10#2)
vector containing the##5##3##(1990-5#1)(2008-10#1)(2008-11#2)(2012-3#1)
vector containing##10##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-8#3)(2008-9#2)(2012-3#1)
vector control##4##2##(2010-1#3)(2012-12#1)
vector during##2##2##(2010-8#1)(2011-2#1)
vector ecology##2##2##(2008-10#1)(2010-1#1)
vector expressing##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
vector fields##2##2##(2008-6#2)
vector for the##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
vector for##13##2##(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-8#1)(2008-9#2)(2011-2#2)
vector from##3##2##(2008-10#1)(2008-11#2)
vector has##2##2##(2008-11#1)(2008-9#1)
vector in##9##2##(1990-12#1)(1990-5#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)
vector insects##2##2##(2008-10#2)
vector may##2##2##(1997-6#1)(1997-8#1)
vector of##8##2##(2008-10#2)(2008-11#1)(2008-8#3)(2010-1#1)(2011-2#1)
vector packaging##2##2##(2008-11#1)(2008-8#1)
vector population##4##2##(2008-10#2)(2011-2#1)(2011-3#1)
vector populations##3##2##(2008-10#3)
vector relationships are##2##3##(2008-10#2)
vector resistance##2##2##(2008-10#2)
vector sequences##2##2##(1997-8#1)(2008-11#1)
vector sequential projection##2##3##(2008-10#2)
vector species of##2##3##(2008-10#1)(2013-1#1)
vector species##10##2##(2008-10#9)(2013-1#1)
vector specificity##4##2##(2008-10#4)
vector status##2##2##(2008-10#2)
vector system for efficient##2##4##(2008-11#1)(2011-1#1)
vector system##10##2##(1996-12#1)(1997-7#1)(2008-11#4)(2008-7#1)(2008-8#1)(2011-1#1)(2011-3#1)
vector systems##2##2##(1993-12#1)(1997-1#1)
vector that allows##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
vector that##6##2##(1997-8#1)(2008-11#3)(2008-4#1)(2008-9#1)
vector to##2##2##(2008-8#1)(2011-2#1)
vector transmission of##2##3##(2008-10#2)
vector transmission##5##2##(2008-10#5)
vector under the control##2##4##(1995-6#1)(2008-11#1)
vector via##2##2##(2008-4#1)(2010-7#1)
vector was constructed##3##3##(1995-8#1)(2008-9#1)(2011-1#1)
vector was##13##2##(1993-8#1)(1995-8#1)(1997-8#2)(2008-11#1)(2008-8#3)(2008-9#3)(2010-1#1)(2011-1#1)
vector with##3##2##(2008-8#1)(2008-9#1)(2010-7#1)
vector##405##1##(1990-12#1)(1990-5#8)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#5)(1993-2#1)(1993-6#2)(1993-8#6)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#6)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-6#2)(1995-8#3)(1996-12#3)(1996-2#4)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#14)(2007-11#1)(2007-12#2)(2008-10#112)(2008-11#56)(2008-3#4)(2008-4#6)(2008-6#4)(2008-7#7)(2008-8#44)(2008-9#29)(2009-10#2)(2009-12#1)(2009-8#2)(2010-1#12)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#7)(2011-1#4)(2011-2#14)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
vector-encoded##2##1##(1995-2#1)(1995-5#1)
vector-field##3##1##(2008-2#2)(2009-8#1)
vector-phytoplasma-plant##2##1##(2008-10#2)
vectored by the##2##3##(2008-10#2)
vectored by##5##2##(2008-10#5)
vectored##7##1##(2008-10#7)
vectorial##6##1##(1997-6#2)(2008-11#1)(2008-3#2)(2009-10#1)
vectoring ability##2##2##(2008-10#2)
vectoring##4##1##(2008-10#4)
vectors and a##2##3##(2008-10#2)
vectors and##15##2##(1993-3#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-8#1)(2010-1#2)
vectors are##6##2##(1993-12#3)(1995-2#1)(1997-1#1)(2008-11#1)
vectors can be##2##3##(1993-12#1)(2008-4#1)
vectors can##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
vectors contain##3##2##(2008-11#2)(2008-7#1)
vectors containing the##2##3##(2008-11#2)
vectors containing##7##2##(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
vectors for gene therapy##3##4##(2008-11#3)
vectors for##18##2##(1990-5#1)(1993-12#2)(1993-2#3)(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#7)(2008-9#1)(2011-3#1)
vectors have been##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
vectors have##6##2##(1995-2#1)(1997-1#1)(2008-10#3)(2008-11#1)
vectors in##11##2##(1991-6#1)(1993-12#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-8#2)(2009-5#1)
vectors is##4##2##(1993-9#1)(1995-2#1)(2008-10#1)(2008-8#1)
vectors may be##2##3##(1995-5#1)(2008-10#1)
vectors may##3##2##(1993-12#1)(1995-5#1)(2008-10#1)
vectors of##9##2##(2008-10#7)(2012-12#1)(2012-2#1)
vectors that##4##2##(1995-5#1)(2008-11#1)(2010-1#1)(2012-12#1)
vectors to##5##2##(1994-11#1)(1996-12#1)(2008-10#1)(2008-11#2)
vectors using##2##2##(2008-11#2)
vectors was##2##2##(2008-11#1)(2011-3#1)
vectors were constructed##4##3##(1993-12#1)(2008-8#1)(2008-9#2)
vectors were##9##2##(1993-12#2)(2008-10#2)(2008-8#1)(2008-9#2)(2009-10#1)(2013-8#1)
vectors with##5##2##(1993-12#1)(1993-2#1)(2008-11#2)(2008-9#1)
vectors##209##1##(1990-5#1)(1991-6#1)(1992-12#1)(1993-12#24)(1993-2#5)(1993-3#2)(1993-6#3)(1993-9#3)(1994-11#2)(1994-5#1)(1994-6#2)(1995-2#4)(1995-5#5)(1996-12#1)(1996-6#1)(1997-1#2)(1997-8#3)(2007-11#5)(2008-10#48)(2008-11#53)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#7)(2009-10#2)(2009-5#1)(2010-1#4)(2010-8#1)(2011-2#1)(2011-3#5)(2012-12#3)(2012-2#1)(2013-8#1)
vecuronium##5##1##(1993-1#2)(2010-7#3)
ved##3##1##(2012-12#3)
vegetable consumption##2##2##(1990-8#1)(2009-5#1)
vegetable crops##3##2##(2008-10#3)
vegetable dietary guidelines (p &lt##2##5##(2009-5#2)
vegetable intake##2##2##(2008-10#1)(2013-1#1)
vegetable matrices##2##2##(2008-10#2)
vegetable oil##3##2##(2008-10#2)(2011-2#1)
vegetable oils##8##2##(2008-10#7)(2009-3#1)
vegetable samples##9##2##(2008-10#9)
vegetable##45##1##(1990-8#1)(2008-10#33)(2008-12#2)(2008-5#1)(2009-3#1)(2009-5#3)(2011-2#1)(2013-1#1)(2013-8#2)
vegetables and##6##2##(1994-2#1)(2008-10#4)(2011-2#1)
vegetables may##2##2##(1994-2#2)
vegetables##47##1##(1990-8#1)(1991-2#1)(1994-2#3)(1997-1#1)(2007-12#1)(2008-10#29)(2008-4#1)(2009-3#1)(2010-8#2)(2011-2#2)(2012-2#3)(2013-1#2)
vegetal##5##1##(2008-10#5)
vegetated##4##1##(2008-11#1)(2008-8#3)
vegetation and##2##2##(2008-10#1)(2008-9#1)
vegetation change##2##2##(2008-8#1)(2008-9#1)
vegetation dynamics in##2##3##(1990-8#1)(2008-9#1)
vegetation##46##1##(1990-8#1)(2006-6#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#4)(2008-8#15)(2008-9#10)(2009-8#1)(2013-1#4)
vegetative and reproductive##4##3##(2008-10#1)(2008-8#1)(2009-10#1)(2012-8#1)
vegetative and##6##2##(2008-10#1)(2008-8#1)(2009-10#2)(2012-8#1)(2013-8#1)
vegetative cells of##2##3##(2008-10#1)(2008-11#1)
vegetative cells##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
vegetative compatibility and##2##3##(2008-10#2)
vegetative compatibility group (VCG)##6##4##(2008-10#6)
vegetative compatibility group##7##3##(2008-10#7)
vegetative compatibility groups (VCGs)##11##4##(2008-10#11)
vegetative compatibility groups##15##3##(2008-10#15)
vegetative compatibility##34##2##(2008-10#34)
vegetative growth##2##2##(1996-6#1)(2008-10#1)
vegetative incompatibility (vic) genes##2##4##(2008-10#2)
vegetative incompatibility##4##2##(2008-10#4)
vegetative phase##2##2##(2008-8#2)
vegetative shoots##2##2##(2008-10#2)
vegetative state##5##2##(1990-11#1)(1991-12#1)(1997-5#1)(2008-11#2)
vegetative##82##1##(1990-11#1)(1991-12#1)(1996-6#1)(1997-5#1)(2008-10#54)(2008-11#4)(2008-12#1)(2008-8#7)(2009-10#3)(2009-12#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-8#2)(2013-8#2)
vegetatively compatible##4##2##(2008-10#4)
vegetatively incompatible##3##2##(2008-10#3)
vegetatively##10##1##(1997-6#1)(2008-10#9)
vehicle accident##4##2##(2008-12#1)(2008-7#1)(2009-4#1)(2012-3#1)
vehicle and##2##2##(1996-12#1)(2008-5#1)
vehicle control groups##4##3##(2008-9#4)
vehicle control##7##2##(2008-9#5)(2010-1#1)(2013-1#1)
vehicle controls##7##2##(2008-9#7)
vehicle effects##2##2##(2008-5#2)
vehicle for the##3##3##(1993-6#1)(2008-12#1)(2008-5#1)
vehicle for##11##2##(1991-2#1)(1993-6#1)(1994-1#1)(1995-5#2)(2008-12#1)(2008-5#2)(2008-9#1)(2010-10#1)(2010-2#1)
vehicle in which##3##3##(2008-5#3)
vehicle in##4##2##(1994-8#1)(2008-5#3)
vehicle on##3##2##(1996-2#1)(2008-5#2)
vehicle or##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
vehicle to##7##2##(1992-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
vehicle##91##1##(1990-11#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#3)(1994-1#1)(1994-2#1)(1994-5#2)(1994-8#4)(1995-2#1)(1995-5#4)(1996-12#2)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#23)(2008-7#1)(2008-8#1)(2008-9#13)(2009-4#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
vehicle-treated##2##1##(1992-3#1)(1996-12#1)
vehicles and##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
vehicles for##5##2##(1991-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2012-12#1)
vehicles##24##1##(1990-6#1)(1991-3#1)(1993-1#1)(1995-5#1)(1996-1#1)(2008-10#2)(2008-11#3)(2008-5#7)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#4)
vehicular##2##1##(2008-10#1)(2012-2#1)
veiling glare##4##2##(2008-3#4)
vein and the##4##3##(1992-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
vein and##6##2##(1992-12#1)(2008-7#1)(2009-9#1)(2011-2#2)(2013-1#1)
vein at the##2##3##(1996-9#1)(2011-2#1)
vein endothelial cells##19##3##(1991-5#1)(1994-8#2)(1997-1#2)(2008-10#1)(2008-11#5)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
vein endothelial##21##2##(1991-5#1)(1994-8#2)(1997-1#2)(2008-10#1)(2008-11#7)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
vein formation##3##2##(2009-6#3)
vein graft##3##2##(2006-6#1)(2008-9#1)(2011-3#1)
vein grafts##3##2##(1991-3#1)(2008-7#1)(2008-9#1)
vein in##4##2##(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
vein is a rare##2##4##(2008-11#1)(2010-11#1)
vein is##4##2##(1991-6#1)(1992-12#1)(2008-11#1)(2010-11#1)
vein necrosis##2##2##(2008-10#2)
vein of Galen malformation##4##4##(1996-6#4)
vein of Galen##5##3##(1996-6#4)(1996-9#1)
vein of##12##2##(1995-2#1)(1996-6#5)(1996-9#3)(2011-2#1)(2011-3#1)(2013-1#1)
vein stenosis##5##2##(2008-1#5)
vein thrombosis in##3##3##(1992-9#1)(2009-1#1)(2012-2#1)
vein thrombosis##7##2##(1992-9#2)(2007-12#1)(2009-1#1)(2010-1#1)(2012-2#2)
vein were##2##2##(1993-6#1)(2008-7#1)
vein yellowing##2##2##(2008-10#2)
vein##146##1##(1990-9#3)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#3)(1992-9#2)(1993-6#1)(1994-8#2)(1995-2#1)(1996-3#1)(1996-6#6)(1996-9#5)(1997-1#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#9)(2008-10#25)(2008-11#10)(2008-12#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-1#1)(2009-6#4)(2009-9#2)(2010-1#2)(2010-11#4)(2010-3#1)(2010-4#1)(2011-2#18)(2011-3#7)(2012-2#5)(2012-3#2)(2013-1#3)(2013-2#2)(2013-8#4)
veinal mottle virus##4##3##(2008-10#4)
veinal necrosis##3##2##(2008-10#3)
veinal##7##1##(2008-10#7)
veins and##4##2##(1995-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
veins as##2##2##(2008-10#1)(2008-7#1)
veins in the##2##3##(2009-6#1)(2011-2#1)
veins to##2##2##(1997-1#1)(2006-6#1)
veins were##2##2##(1994-6#1)(2008-10#1)
veins##56##1##(1991-6#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#6)(2011-3#3)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#1)
velocimeter that##2##2##(2008-3#2)
velocimeter##7##1##(2008-3#7)
velocimetry and##3##2##(1994-3#1)(2008-3#2)
velocimetry##13##1##(1994-11#1)(1994-3#3)(2008-3#9)
velocities and##2##2##(1996-6#1)(2008-11#1)
velocities of pandemic spread##2##4##(2008-10#2)
velocities of##3##2##(2008-10#3)
velocities##20##1##(1993-8#1)(1996-2#1)(1996-6#3)(1997-3#1)(2008-10#3)(2008-11#3)(2008-3#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
velocity and temperature##2##3##(2008-2#2)
velocity and the##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
velocity and##10##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2011-2#1)
velocity c##2##2##(2010-8#2)
velocity in the##2##3##(1996-6#1)(2008-2#1)
velocity in##4##2##(1996-3#1)(1996-6#1)(2008-2#1)(2011-2#1)
velocity of a##2##3##(2011-2#2)
velocity of pandemic spread##2##4##(2008-10#2)
velocity of the red cells##2##5##(2008-3#2)
velocity of the##11##3##(1996-3#1)(1996-6#1)(2008-11#1)(2008-3#3)(2008-8#1)(2011-2#4)
velocity of##22##2##(1993-9#1)(1996-3#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#7)
velocity to##4##2##(1993-9#1)(2008-8#2)(2008-9#1)
velocity was##3##2##(1995-3#1)(2008-8#1)(2010-9#1)
velocity##117##1##(1991-9#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#3)(1995-11#1)(1995-3#3)(1996-2#1)(1996-3#2)(1996-6#5)(2007-11#3)(2008-10#9)(2008-11#11)(2008-2#9)(2008-3#11)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-1#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-8#3)(2010-9#2)(2011-2#17)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#4)
velocity)##3##1##(2008-10#1)(2008-9#1)(2010-8#1)
velvetleaf leaves##2##2##(2008-10#2)
velvetleaf##3##1##(2008-10#3)
vena cava and##2##3##(2008-11#1)(2010-4#1)
vena cava##20##2##(1992-9#3)(2008-1#2)(2008-11#5)(2008-12#2)(2010-4#3)(2011-2#3)(2013-1#2)
vena##22##1##(1992-9#3)(2008-1#2)(2008-11#5)(2008-12#2)(2009-5#1)(2010-4#3)(2011-2#3)(2011-3#1)(2013-1#2)
vendor##5##1##(1991-1#1)(1991-3#1)(1997-2#1)(1997-3#1)(2008-10#1)
vendors and users##2##3##(1991-3#2)
vendors##9##1##(1991-3#2)(1993-12#1)(1994-1#2)(1994-2#1)(1994-3#1)(2008-10#1)(2008-9#1)
veneer##3##1##(2013-1#3)
veneering##2##1##(2010-12#1)(2011-2#1)
venipuncture##3##1##(1994-12#1)(2010-11#1)(2011-2#1)
venlafaxine##4##1##(2008-11#1)(2008-9#1)(2012-2#2)
veno-occlusive disease##2##2##(2010-10#2)
venom gland##2##2##(2008-7#2)
venom of Agkistrodon halys Pallas##2##5##(2008-8#2)
venom of##7##2##(1990-5#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-8#1)(2008-8#2)
venom proteins##2##2##(1993-3#2)
venom##19##1##(1990-5#1)(1993-3#4)(1993-6#2)(1994-11#2)(1995-8#1)(2008-10#2)(2008-12#1)(2008-7#4)(2008-8#2)
venous access can##2##3##(2011-2#2)
venous access##3##2##(2011-2#3)
venous and##3##2##(2008-10#1)(2010-12#1)(2011-3#1)
venous anomalies##2##2##(2010-11#1)(2012-3#1)
venous anomaly##2##2##(2010-11#2)
venous blood samples were##2##4##(1991-6#1)(2013-8#1)
venous blood##7##2##(1991-1#1)(1991-6#1)(1997-1#1)(2008-12#1)(2008-9#2)(2013-8#1)
venous catheter##4##2##(2008-7#2)(2010-6#1)(2011-2#1)
venous drainage and##2##3##(1996-9#1)(2008-7#1)
venous drainage of the##2##4##(1996-9#2)
venous drainage##7##2##(1996-9#4)(2008-7#2)(2012-3#1)
venous dysfunction##2##2##(2010-7#2)
venous embolization##3##2##(1997-8#2)(2008-7#1)
venous hypertension##2##2##(2008-7#2)
venous insufficiency and##2##3##(2008-5#1)(2011-3#1)
venous insufficiency may##2##3##(2013-1#2)
venous insufficiency##11##2##(2008-5#1)(2011-3#2)(2013-1#8)
venous leg ulcer##2##3##(1997-3#2)
venous leg ulcers##3##3##(1990-6#1)(1997-3#2)
venous leg##6##2##(1990-6#1)(1997-3#5)
venous outflow##2##2##(2008-7#1)(2009-8#1)
venous outlet##2##2##(1996-9#2)
venous phases##2##2##(2010-12#1)(2013-1#1)
venous plexus##12##2##(1996-9#2)(2011-2#10)
venous plexuses##3##2##(2011-2#3)
venous sinus thrombosis##2##3##(1997-6#2)
venous sinus##4##2##(1996-9#2)(1997-6#2)
venous system in##2##3##(2008-9#1)(2013-2#1)
venous system##6##2##(2008-9#1)(2011-2#2)(2011-3#2)(2013-2#1)
venous thromboembolic##2##2##(1996-3#1)(2013-1#1)
venous thromboembolism after##2##3##(2013-1#2)
venous thromboembolism##9##2##(1996-11#2)(2010-11#3)(2010-7#1)(2013-1#3)
venous thrombosis and pulmonary embolism##3##5##(2008-12#1)(2012-3#1)(2013-1#1)
venous thrombosis in##4##3##(1996-6#1)(2008-9#1)(2010-11#1)(2012-3#1)
venous thrombosis with##2##3##(2008-10#1)(2008-8#1)
venous thrombosis##16##2##(1996-6#2)(1997-3#2)(2008-10#1)(2008-12#1)(2008-8#4)(2008-9#1)(2010-11#1)(2012-3#3)(2013-1#1)
venous wall##2##2##(2009-7#2)
venous##169##1##(1990-3#3)(1990-6#1)(1990-9#1)(1991-1#1)(1991-6#1)(1993-1#1)(1994-3#1)(1994-9#2)(1996-11#2)(1996-3#3)(1996-6#2)(1996-9#16)(1997-1#1)(1997-3#7)(1997-5#1)(1997-6#4)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-5#1)(2008-7#15)(2008-8#4)(2008-9#7)(2009-7#2)(2009-8#3)(2010-11#8)(2010-12#3)(2010-6#1)(2010-7#8)(2011-2#22)(2011-3#6)(2012-12#1)(2012-3#6)(2013-1#18)(2013-2#1)(2013-8#4)
venous-venous anastomoses##2##2##(2008-9#2)
vent##10##1##(1991-3#6)(2008-10#3)(2008-9#1)
ventilated##10##1##(1990-12#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-1#1)(2010-7#1)(2011-2#1)
ventilation and##7##2##(1992-12#1)(1992-5#1)(1994-3#1)(1995-2#1)(1997-1#1)(2008-10#1)(2012-2#1)
ventilation in##5##2##(1994-6#1)(1995-2#1)(1996-2#1)(1996-3#1)(2013-8#1)
ventilation of##3##2##(1990-3#1)(1994-6#2)
ventilation was##2##2##(1990-12#1)(2010-7#1)
ventilation with##2##2##(1991-6#1)(2010-7#1)
ventilation##58##1##(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-6#10)(1995-12#1)(1995-2#3)(1996-12#7)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-5#2)(2010-7#5)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
ventilator associated##2##2##(2008-10#1)(2010-7#1)
ventilator##12##1##(1995-12#2)(2008-10#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#2)
ventilators##8##1##(1994-6#1)(2011-1#4)(2011-2#3)
ventilatory##10##1##(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-2#2)(1997-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
ventral cochlear##2##2##(1996-12#1)(1996-2#1)
ventral eyespots##2##2##(2008-9#2)
ventral ganglia##2##2##(1994-2#1)(2008-5#1)
ventral mesencephalic grafts##3##3##(1996-2#3)
ventral nerve##3##2##(1997-7#1)(2008-5#2)
ventral receptacle##2##2##(2007-12#2)
ventral somite##2##2##(1994-12#2)
ventral striatum##10##2##(1993-6#6)(1994-2#3)(2013-8#1)
ventral subiculum and##2##3##(1993-6#2)
ventral subiculum lesions##2##3##(1993-6#2)
ventral subiculum##5##2##(1993-6#5)
ventral tegmental area (VTA) and##3##5##(1996-12#1)(1996-5#1)(2009-8#1)
ventral tegmental area (VTA)##5##4##(1996-12#2)(1996-5#1)(2008-7#1)(2009-8#1)
ventral tegmental area##8##3##(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#1)(2008-7#1)(2009-8#1)
ventral wing##2##2##(2008-9#2)
ventral##81##1##(1993-6#13)(1994-12#4)(1994-2#5)(1996-12#8)(1996-2#5)(1996-5#1)(1997-2#1)(1997-3#3)(1997-7#1)(2007-12#7)(2008-10#1)(2008-11#3)(2008-5#9)(2008-6#3)(2008-7#1)(2008-9#4)(2009-8#2)(2010-5#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
ventralizing##3##1##(1994-12#1)(2008-6#2)
ventrally##3##1##(1994-12#1)(2007-12#1)(2011-2#1)
ventricle assistance##4##2##(2012-3#4)
ventricle in##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#2)
ventricle of##2##2##(1994-11#1)(1995-12#1)
ventricle presenting##2##2##(2008-7#2)
ventricle##47##1##(1991-12#1)(1991-3#1)(1991-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-7#10)(2009-10#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#6)(2013-1#13)
ventricle]##2##1##(2008-10#1)(2013-1#1)
ventricles of##2##2##(2008-5#1)(2013-1#1)
ventricles##11##1##(1991-2#1)(1991-8#1)(1995-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#3)
ventricular (LV)##3##2##(2011-2#2)(2012-2#1)
ventricular and##2##2##(1995-12#1)(2008-8#1)
ventricular apical##3##2##(2009-6#1)(2010-5#1)(2012-2#1)
ventricular arrhythmias##9##2##(1990-6#1)(1992-6#1)(1996-3#1)(2008-12#1)(2009-10#3)(2010-6#1)(2011-2#1)
ventricular assist devices (VADs)##2##4##(2010-6#2)
ventricular assist devices##5##3##(2008-8#1)(2010-6#4)
ventricular cell models##2##3##(2008-11#2)
ventricular cell##4##2##(2008-11#4)
ventricular cells##2##2##(2008-11#2)
ventricular ejection fraction##7##3##(1997-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
ventricular ejection##8##2##(1997-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
ventricular extrasystoles##2##2##(1996-3#2)
ventricular fibrillation##7##2##(1992-6#1)(1996-3#2)(2008-12#1)(2009-10#1)(2010-1#2)
ventricular function in##3##3##(2009-10#1)(2010-4#1)(2012-2#1)
ventricular function##10##2##(1990-9#2)(2008-3#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
ventricular hypertrophy and##4##3##(2008-1#1)(2010-8#1)(2013-1#1)(2013-8#1)
ventricular hypertrophy is##2##3##(2008-7#1)(2009-1#1)
ventricular hypertrophy##14##2##(1996-11#1)(2008-1#1)(2008-12#2)(2008-7#1)(2009-1#2)(2010-8#2)(2012-12#3)(2013-1#1)(2013-8#1)
ventricular mass##7##2##(1997-8#1)(2011-2#1)(2012-12#1)(2012-3#4)
ventricular myocytes##4##2##(1994-8#3)(2013-1#1)
ventricular outflow tract##2##3##(2012-2#1)(2013-2#1)
ventricular rate##3##2##(1990-9#1)(2010-12#2)
ventricular remodeling##3##2##(2009-10#1)(2012-12#1)(2013-8#1)
ventricular septal##6##2##(2009-5#1)(2012-12#2)(2012-2#3)
ventricular tachycardia and##2##3##(1996-3#1)(2008-12#1)
ventricular tachycardia induction##2##3##(1990-3#2)
ventricular tachycardia##13##2##(1990-3#6)(1996-3#1)(2008-12#2)(2009-10#2)(2013-8#2)
ventricular wall thickness##2##3##(1993-12#1)(2012-2#1)
ventricular wall##5##2##(1991-12#1)(1993-12#2)(2009-1#1)(2012-2#1)
ventricular##210##1##(1990-3#6)(1990-6#1)(1990-9#4)(1991-12#1)(1992-12#2)(1992-6#3)(1993-1#4)(1993-12#2)(1994-11#1)(1994-12#3)(1994-8#4)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-3#14)(1997-5#2)(1997-8#3)(2008-1#2)(2008-10#5)(2008-11#14)(2008-12#21)(2008-3#2)(2008-7#7)(2008-8#2)(2009-1#5)(2009-10#11)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#7)(2010-8#3)(2011-2#16)(2012-12#7)(2012-2#19)(2012-3#8)(2013-1#7)(2013-2#1)(2013-8#4)
ventriculo-peritoneal##2##1##(2008-7#2)
ventriculography##2##1##(1991-2#2)
ventriculomegaly##3##1##(1997-3#2)(2012-3#1)
ventriculoperitoneal##2##1##(2011-2#2)
ventrolateral##7##1##(1994-2#2)(1997-2#2)(2007-12#3)
ventromedial nucleus##3##2##(1994-2#1)(2008-4#1)(2008-9#1)
ventromedial prefrontal cortex##3##3##(2008-11#3)
ventromedial##9##1##(1994-2#3)(2008-11#3)(2008-4#2)(2008-9#1)
venture of##2##2##(2008-3#1)(2008-5#1)
venture##17##1##(1991-12#1)(1991-2#1)(1992-8#1)(1993-5#1)(1994-1#1)(1994-3#4)(2008-11#3)(2008-3#1)(2008-5#3)(2008-9#1)
ventures##13##1##(1991-1#1)(1991-2#1)(1991-9#1)(1993-1#2)(2008-11#8)
venues in##3##2##(2008-1#1)(2008-12#1)(2009-5#1)
venules##4##1##(1997-1#2)(1997-7#1)(2011-2#1)
venus##2##1##(1990-8#1)(1991-5#1)
verapamil and##3##2##(1994-8#1)(1995-11#1)(2011-3#1)
verapamil in##2##2##(1991-8#2)
verapamil##15##1##(1991-8#3)(1994-11#1)(1994-8#2)(1995-11#4)(2008-10#1)(2008-7#1)(2011-2#2)(2011-3#1)
verbal description ability##2##3##(2008-7#2)
verbal or non-verbal##2##3##(1990-11#1)(2008-7#1)
verbal self-monitoring mechanisms##2##3##(2008-9#2)
verbal##26##1##(1990-11#2)(1996-2#3)(2008-10#5)(2008-7#5)(2008-8#1)(2008-9#5)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
verbascoside##5##1##(2008-8#5)
verbatim##4##1##(2008-1#1)(2008-11#3)
verbs and##2##2##(1996-2#1)(2008-11#1)
verbs in##3##2##(1991-2#2)(2008-11#1)
verbs##6##1##(1991-2#2)(1996-2#1)(2008-11#3)
verdict##2##1##(1995-12#2)
verification for the##2##3##(1995-3#1)(2010-9#1)
verification for##3##2##(1995-3#1)(2010-9#1)(2012-3#1)
verification of the##7##3##(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-2#1)
verification of##16##2##(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#3)(2009-2#2)(2009-7#1)(2012-12#1)(2012-2#2)
verification##33##1##(1990-12#1)(1991-2#2)(1995-3#1)(1996-12#1)(1996-2#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-9#4)(2009-2#4)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#4)
verified as##2##2##(2008-10#1)(2008-9#1)
verified by DNA sequencing##2##4##(2008-10#1)(2008-8#1)
verified by a##2##3##(2008-10#1)(2008-3#1)
verified by the analysis of##3##5##(2008-10#3)
verified by the##10##3##(1990-5#1)(2008-10#7)(2008-3#1)(2010-12#1)
verified by##41##2##(1990-5#1)(1990-6#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(2008-10#21)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#2)(2012-3#1)(2012-4#1)
verified experimentally##3##2##(1997-1#1)(1997-6#1)(2008-3#1)
verified for##2##2##(2007-12#1)(2008-10#1)
verified in a##2##3##(2008-10#1)(2008-11#1)
verified in##9##2##(1994-2#1)(2008-10#6)(2008-11#1)(2010-6#1)
verified on##3##2##(2008-10#2)(2010-8#1)
verified that the##5##3##(2008-10#3)(2008-9#1)(2009-12#1)
verified that##10##2##(2008-10#6)(2008-9#2)(2009-12#1)(2013-1#1)
verified the##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
verified to be##2##3##(2008-10#2)
verified to##3##2##(2008-10#2)(2008-7#1)
verified with##4##2##(2008-10#1)(2008-3#1)(2009-2#1)(2012-3#1)
verified##112##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#2)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#58)(2008-11#2)(2008-12#2)(2008-3#8)(2008-7#5)(2008-8#2)(2008-9#5)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#2)(2012-4#1)(2013-1#3)
verifies the##2##2##(2008-3#1)(2009-8#1)
verify our##2##2##(2008-6#1)(2011-2#1)
verify that the##3##3##(1997-8#1)(2008-4#1)(2011-2#1)
verify that##6##2##(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
verify the accuracy##3##3##(2008-10#3)
verify the theoretical##2##3##(2008-3#1)(2010-5#1)
verify the##34##2##(1990-5#1)(1992-3#1)(1997-2#1)(2008-10#13)(2008-3#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2010-5#2)(2010-6#1)(2011-2#1)(2013-8#1)
verify whether##3##2##(2008-10#1)(2008-11#1)(2010-9#1)
verify##64##1##(1990-5#1)(1990-6#1)(1991-9#1)(1992-3#1)(1996-3#1)(1997-2#1)(1997-8#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-2#1)(2010-10#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#3)(2013-8#1)
verifying its##2##2##(2008-10#1)(2008-4#1)
verifying that##2##2##(1994-2#1)(2008-3#1)
verifying##5##1##(1994-2#1)(2008-10#2)(2008-3#1)(2008-4#1)
vermicomposting process##2##2##(2008-12#2)
vermicomposting##4##1##(2008-12#4)
vermiculite##4##1##(2008-10#4)
vermiform appendix##3##2##(2008-12#3)
vernalization##4##1##(2009-8#2)(2012-3#2)
vernalized##3##1##(2008-10#1)(2009-8#2)
vernicifera##2##1##(2008-10#2)
verrucae seborrhoicae##2##2##(2011-2#2)
verrucae vulgares##2##2##(2011-2#2)
verrucae##4##1##(2011-2#4)
verrucous##4##1##(2009-10#1)(2010-6#1)(2010-7#1)(2012-3#1)
vers##2##1##(2009-10#1)(2013-1#1)
versatile and##7##2##(2008-10#3)(2008-4#1)(2008-7#1)(2012-2#2)
versatile derivatization##2##2##(2008-10#2)
versatile##44##1##(1992-3#1)(1996-5#2)(2008-10#25)(2008-11#3)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
versatility and##4##2##(2008-10#1)(2009-10#1)(2010-6#1)(2013-1#1)
versatility of sol-gel##2##3##(2008-10#1)(2010-7#1)
versatility of the##7##3##(1996-5#1)(2008-10#5)(2008-4#1)
versatility of##15##2##(1996-5#1)(2008-10#12)(2008-4#1)(2010-7#1)
versatility##23##1##(1996-2#1)(1996-5#1)(2008-10#14)(2008-11#1)(2008-4#1)(2009-10#1)(2010-6#1)(2010-7#2)(2013-1#1)
versican##4##1##(2008-11#4)
versicolor and##3##2##(2008-5#2)(2011-2#1)
versicolor##16##1##(2008-11#3)(2008-5#8)(2008-6#2)(2008-9#2)(2011-2#1)
version 1##2##2##(2008-10#1)(2008-11#1)
version guarantees##2##2##(1995-6#2)
version is##2##2##(2008-11#1)(2008-9#1)
version of the Hydrolight computer program##2##6##(2008-3#2)
version of the model##3##4##(2008-10#1)(2008-8#1)(2009-4#1)
version of the##35##3##(1991-9#1)(1992-12#1)(1995-2#1)(1997-2#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-3#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
version of this task##2##4##(1994-3#1)(2009-10#1)
version of this##18##3##(1994-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
version of##72##2##(1991-1#1)(1991-9#1)(1992-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#3)(2009-8#1)(2010-1#3)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#2)
version##105##1##(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#4)(1996-3#1)(1997-2#1)(2008-1#2)(2008-10#13)(2008-11#6)(2008-12#1)(2008-3#6)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#12)(2009-10#3)(2009-12#1)(2009-4#3)(2009-8#1)(2010-1#5)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#2)
versions of the##10##3##(1991-9#1)(1994-3#1)(1997-8#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-2#2)
versions of##20##2##(1991-10#1)(1991-9#1)(1994-3#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
versions##24##1##(1991-10#1)(1991-9#1)(1994-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)
versus &gt##3##2##(1997-5#3)
versus 0##5##2##(2008-10#2)(2010-11#1)(2011-2#1)(2012-3#1)
versus 13##2##2##(1997-5#2)
versus 14##3##2##(1997-5#1)(2008-10#1)(2013-1#1)
versus 3##4##2##(1997-5#1)(2008-1#1)(2008-4#1)(2013-1#1)
versus 7##4##2##(1991-9#1)(1994-11#1)(2008-3#1)(2008-7#1)
versus Ag/AgCl in##4##3##(2008-10#4)
versus Ag/AgCl to##2##3##(2008-10#2)
versus Ag/AgCl using##2##3##(2008-10#2)
versus Ag/AgCl##31##2##(2008-10#31)
versus Ag/AgCl)##5##2##(2008-10#5)
versus SCE in##2##3##(2008-10#2)
versus SCE##8##2##(2008-10#8)
versus a reference##2##3##(2008-10#1)(2008-12#1)
versus a##7##2##(1991-11#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-10#1)(2011-1#1)
versus an##2##2##(2008-10#1)(2013-1#1)
versus asexual##2##2##(2008-10#1)(2009-5#1)
versus concentration of##4##3##(2008-10#4)
versus concentration##10##2##(2008-10#10)
versus delayed loading of##2##4##(2013-1#2)
versus delayed##5##2##(2010-1#1)(2010-7#1)(2012-3#1)(2013-1#2)
versus delta plot##2##3##(2008-10#2)
versus full##2##2##(2008-10#1)(2011-2#1)
versus human##2##2##(2007-7#1)(2009-12#1)
versus log##3##2##(2008-10#2)(2008-8#1)
versus low##2##2##(2008-4#2)
versus no##2##2##(1995-12#1)(2008-8#1)
versus old##2##2##(2008-7#2)
versus ordinary##2##2##(2011-1#2)
versus other##4##2##(2008-10#2)(2008-12#1)(2009-12#1)
versus pH##3##2##(2008-10#3)
versus patients with##2##3##(2012-12#1)(2012-3#1)
versus patients##3##2##(1990-6#1)(2012-12#1)(2012-3#1)
versus placebo##4##2##(2008-5#1)(2011-2#3)
versus postoperative##2##2##(1994-8#2)
versus sample##3##2##(2008-10#3)
versus saturated calomel##2##3##(2008-10#2)
versus the control group##2##4##(2008-12#1)(2011-2#1)
versus the##25##2##(1990-6#1)(1991-11#1)(1991-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
versus time##6##2##(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)
versus total##3##2##(2008-10#2)(2008-4#1)
versus wavelength##3##2##(2008-10#2)(2008-3#1)
versus##466##1##(1990-11#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#5)(1991-6#1)(1991-8#6)(1991-9#1)(1992-1#3)(1992-3#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#3)(1997-5#8)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#175)(2008-11#12)(2008-12#8)(2008-3#5)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#15)(2008-8#20)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#4)(2009-5#2)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#22)(2011-3#1)(2011-7#1)(2012-12#10)(2012-2#5)(2012-3#11)(2012-6#1)(2013-1#22)(2013-7#1)(2013-8#7)
vertebra##7##1##(1991-11#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2013-1#2)
vertebrae and##3##2##(2007-11#3)
vertebrae##17##1##(1991-11#1)(1994-12#1)(1996-6#1)(2007-11#5)(2008-7#2)(2011-2#2)(2013-1#3)(2013-8#2)
vertebral artery (VA)##2##3##(2008-7#1)(2012-3#1)
vertebral artery dissecting aneurysm##2##4##(2008-7#2)
vertebral artery dissection##6##3##(1991-8#2)(2008-7#4)
vertebral artery##27##2##(1991-8#3)(1992-6#1)(1993-3#2)(1996-9#2)(1997-6#1)(2008-12#4)(2008-7#9)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
vertebral bodies in##2##3##(1997-3#1)(2011-2#1)
vertebral bodies##3##2##(1997-3#1)(2008-7#1)(2011-2#1)
vertebral body and intervertebral discs wedging in##2##7##(2007-8#2)
vertebral body and##3##3##(2007-11#1)(2007-8#2)
vertebral body height##2##3##(2007-8#2)
vertebral body wedging factor in the##2##6##(2007-8#2)
vertebral body wedging factors##2##4##(2007-8#2)
vertebral body wedging##4##3##(2007-8#4)
vertebral body##15##2##(1996-8#1)(2007-11#2)(2007-8#10)(2009-3#2)
vertebral bone##3##2##(1991-11#1)(2011-2#2)
vertebral column resection##3##3##(2008-8#3)
vertebral column##6##2##(2008-8#3)(2011-2#2)(2013-1#1)
vertebral crush##2##2##(1991-11#2)
vertebral fracture##5##2##(1991-11#3)(2011-2#2)
vertebral fractures in##2##3##(1991-11#1)(2008-11#1)
vertebral fractures##9##2##(1991-11#3)(2008-11#6)
vertebral tumours##2##2##(2008-7#2)
vertebral venous plexus and##2##4##(2011-2#2)
vertebral venous plexus##10##3##(2011-2#10)
vertebral venous##12##2##(2011-2#12)
vertebral##104##1##(1991-11#10)(1991-8#4)(1992-6#1)(1993-3#2)(1996-8#1)(1996-9#4)(1997-3#1)(1997-6#2)(2007-11#2)(2007-8#13)(2008-11#6)(2008-12#6)(2008-7#16)(2008-8#5)(2009-3#2)(2011-2#22)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
vertebrate and invertebrate##2##3##(1992-12#1)(2008-10#1)
vertebrate and##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
vertebrate animals##2##2##(1993-3#1)(2011-2#1)
vertebrate cells##2##2##(1996-2#1)(2008-9#1)
vertebrate defensive##2##2##(1993-3#1)(1994-5#1)
vertebrate embryos##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
vertebrate evolution##3##2##(1997-9#1)(2008-8#1)(2011-2#1)
vertebrate genome##2##2##(1995-2#1)(2011-2#1)
vertebrate model##2##2##(2012-3#2)
vertebrate populations##2##2##(2008-8#1)(2012-3#1)
vertebrate skeletal muscle##3##3##(1993-9#1)(2008-6#1)(2008-9#1)
vertebrate species##2##2##(1993-8#1)(2008-8#1)
vertebrate##76##1##(1990-5#2)(1990-8#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#2)(1997-7#1)(1997-9#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#8)(2010-1#1)(2010-5#3)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#6)(2013-1#1)
vertebrates and##3##2##(2008-7#2)(2009-7#1)
vertebrates is##2##2##(2010-4#1)(2011-1#1)
vertebrates##36##1##(1990-8#1)(1993-2#2)(1993-6#1)(1995-11#3)(1995-2#1)(1996-2#1)(1997-7#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)
vertebrectomy and##2##2##(2008-7#1)(2008-8#1)
vertebrectomy##4##1##(2008-7#2)(2008-8#2)
vertebrobasilar artery##5##2##(1997-3#1)(2008-7#1)(2012-3#3)
vertebrobasilar insufficiency##2##2##(1993-3#1)(2008-12#1)
vertebrobasilar system##2##2##(2008-7#1)(2011-2#1)
vertebrobasilar##12##1##(1993-3#1)(1997-3#1)(2008-12#1)(2008-7#4)(2011-2#1)(2012-3#4)
vertebroplasty##2##1##(2007-8#2)
vertex of the##2##3##(2008-6#1)(2008-9#1)
vertex of##3##2##(2008-6#1)(2008-9#1)(2013-8#1)
vertex##11##1##(1993-9#2)(2008-10#1)(2008-5#1)(2008-6#4)(2008-9#1)(2011-2#1)(2013-8#1)
vertical and horizontal##3##3##(1997-6#1)(2008-11#1)(2008-8#1)
vertical and##5##2##(1992-2#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-8#1)
vertical distribution of##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
vertical distribution##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
vertical infection##4##2##(2011-3#4)
vertical integration##3##2##(1991-3#2)(2010-7#1)
vertical mixing##2##2##(2008-11#1)(2008-3#1)
vertical profiles of pressure and temperature##2##6##(2008-3#2)
vertical profiles of##6##3##(2008-11#1)(2008-2#1)(2008-3#4)
vertical resolution of the##2##4##(2008-3#2)
vertical resolution of##3##3##(2008-3#3)
vertical resolution##6##2##(2007-12#1)(2008-3#5)
vertical scanning##3##2##(2008-3#3)
vertical structure of##2##3##(2008-2#1)(2008-3#1)
vertical structure##5##2##(1990-12#1)(2008-2#1)(2008-3#3)
vertical substance and volume loss##2##5##(2011-2#2)
vertical transmission in##2##3##(2011-3#2)
vertical transmission##6##2##(2008-10#1)(2011-3#4)(2012-3#1)
vertical##82##1##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-2#2)(1996-1#1)(1997-5#1)(1997-6#1)(2007-12#2)(2008-10#8)(2008-11#5)(2008-2#4)(2008-3#20)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#2)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#3)(2011-3#8)(2012-3#1)(2013-1#2)
vertical-cavity surface-emitting laser arrays##2##4##(2008-3#2)
vertical-cavity surface-emitting##3##2##(2008-3#3)
vertically in##2##2##(2008-12#1)(2008-9#1)
vertically polarized##2##2##(2008-3#2)
vertically to##2##2##(2007-12#1)(2008-10#1)
vertically##20##1##(1995-9#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#5)(2008-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-3#1)(2013-1#1)
vertices##3##1##(2008-8#1)(2010-8#1)(2011-2#1)
verticillioides and F##2##3##(2008-10#2)
verticillioides and##4##2##(2008-10#4)
verticillioides in the##2##3##(2008-10#2)
verticillioides in##4##2##(2008-10#4)
verticillioides infection##2##2##(2008-10#2)
verticillioides on##2##2##(2008-10#2)
verticillioides##28##1##(2008-10#28)
verticillioides-inoculated rows##2##2##(2008-10#2)
vertigo and##3##2##(2012-3#2)(2013-7#1)
vertigo##11##1##(1994-9#1)(1997-8#1)(2012-12#1)(2012-3#7)(2013-7#1)
very abundant##2##2##(1992-12#1)(1997-4#1)
very accurate##2##2##(2008-10#2)
very acidic##2##2##(2008-10#1)(2008-4#1)
very active##8##2##(1991-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2013-8#2)
very aggressive##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
very attractive##6##2##(1992-12#1)(2008-1#1)(2008-10#3)(2008-11#1)
very bright##2##2##(1990-2#1)(2008-12#1)
very broad##2##2##(2008-11#1)(2011-2#1)
very challenging##4##2##(1992-3#1)(2008-10#1)(2010-7#1)(2013-1#1)
very close to the##8##4##(1992-1#1)(1993-3#1)(2008-10#3)(2008-11#1)(2012-3#1)(2013-8#1)
very close to##13##3##(1992-1#1)(1993-3#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-8#1)
very close##17##2##(1992-1#1)(1993-3#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
very closely##4##2##(2008-10#4)
very common and##2##3##(2008-10#1)(2008-11#1)
very common in this##2##4##(2008-12#1)(2008-5#1)
very common in##5##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)
very common##14##2##(1991-6#1)(1996-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2009-8#1)(2012-2#2)(2013-1#1)
very complex and##2##3##(2008-9#1)(2012-2#1)
very complex##20##2##(1992-5#1)(1992-9#2)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
very complicated##2##2##(2008-11#1)(2010-11#1)
very convenient##4##2##(2008-10#3)(2008-11#1)
very different from those of##2##5##(1992-1#1)(2008-10#1)
very different from##4##3##(1992-1#1)(2008-10#2)(2010-4#1)
very different##22##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1996-6#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)
very difficult to##14##3##(1994-11#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
very difficult##18##2##(1994-11#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-7#1)(2010-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
very distinct##3##2##(2008-10#3)
very diverse##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
very dry##2##2##(2008-5#2)
very early in##2##3##(1990-9#1)(2008-8#1)
very early stage of##2##4##(2009-7#1)(2010-6#1)
very early##11##2##(1990-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#2)(2010-6#1)
very easy to##2##3##(2008-10#1)(2008-11#1)
very easy##3##2##(2008-10#2)(2008-11#1)
very effective against##2##3##(2008-10#1)(2013-8#1)
very effective for##2##3##(2008-10#1)(2013-1#1)
very effective in##3##3##(1995-5#1)(2010-9#1)(2013-1#1)
very effective##12##2##(1992-9#1)(1994-8#1)(1995-5#1)(2008-10#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
very efficient##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)
very encouraging##2##2##(2008-10#2)
very fast and##2##3##(2008-10#2)
very fast response##2##3##(2008-10#2)
very fast##7##2##(1990-2#1)(2008-10#6)
very few cases have been##2##5##(1997-8#1)(2013-1#1)
very few reports##2##3##(2008-11#1)(2008-9#1)
very few##25##2##(1990-11#1)(1990-6#1)(1991-5#1)(1993-12#1)(1994-9#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
very first##2##2##(1994-1#1)(2008-10#1)
very flexible##2##2##(1994-12#1)(2008-6#1)
very general##2##2##(2008-12#1)(2013-8#1)
very good agreement between the##2##5##(2008-10#2)
very good agreement between##3##4##(2008-10#3)
very good agreement with the##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
very good agreement##6##3##(2008-10#4)(2008-9#1)(2011-2#1)
very good correlation##2##3##(2008-10#2)
very good effect##2##3##(2008-11#2)
very good quality##2##3##(2008-10#1)(2011-3#1)
very good reproducibility##2##3##(1996-6#1)(2008-10#1)
very good results##6##3##(1990-9#1)(1993-3#1)(1996-11#1)(2008-11#1)(2011-3#1)(2013-1#1)
very good selectivity for##3##4##(2008-10#3)
very good selectivity##4##3##(2008-10#4)
very good sensitivity##2##3##(2008-10#2)
very good##55##2##(1990-9#1)(1991-3#2)(1993-3#1)(1994-8#1)(1996-11#1)(1996-6#1)(1997-1#1)(2007-8#1)(2008-10#32)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#3)(2013-1#1)(2013-8#1)
very helpful in differentiating##2##4##(2009-5#1)(2012-12#1)
very helpful in##4##3##(2008-12#1)(2009-5#1)(2010-9#1)(2012-12#1)
very heterogeneous##2##2##(2010-12#1)(2011-2#1)
very high and##2##3##(2008-10#1)(2013-1#1)
very high concentration##2##3##(2008-10#2)
very high concentrations of##2##4##(1990-5#1)(2012-3#1)
very high concentrations##3##3##(1990-5#1)(1996-12#1)(2012-3#1)
very high in the##2##4##(1990-5#1)(1992-5#1)
very high in##5##3##(1990-5#1)(1992-5#1)(2008-1#1)(2008-9#1)(2011-1#1)
very high levels of##5##4##(1997-7#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)
very high levels##7##3##(1997-7#2)(2008-10#2)(2008-8#1)(2010-6#1)(2011-2#1)
very high mortality##3##3##(1996-3#1)(2008-5#1)(2013-1#1)
very high selectivity##2##3##(2008-10#2)
very high specific radioactivity##2##4##(1990-12#2)
very high##84##2##(1990-12#2)(1990-5#2)(1991-12#1)(1991-6#1)(1992-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-6#2)(1997-7#2)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#2)(2013-8#2)
very important and##2##3##(2012-2#1)(2012-3#1)
very important for the##5##4##(1993-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)
very important for##16##3##(1990-12#1)(1992-12#1)(1993-8#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
very important in##4##3##(1990-9#1)(1994-5#1)(2008-10#2)
very important role in##4##4##(1990-9#1)(2007-8#1)(2008-9#1)(2009-2#1)
very important role##5##3##(1990-9#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-2#1)
very important to the##2##4##(2010-7#1)(2013-8#1)
very important to##10##3##(1991-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
very important##62##2##(1990-12#1)(1990-9#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-5#1)(1995-1#1)(1996-11#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
very inexpensive##3##2##(2008-10#3)
very intense##2##2##(2008-10#2)
very interesting##4##2##(1996-5#1)(2008-10#1)(2010-11#1)(2011-2#1)
very isolated##2##2##(2008-9#1)(2011-2#1)
very large##15##2##(1990-8#1)(1992-1#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
very late##3##2##(1997-3#2)(2008-11#1)
very likely that##2##3##(2008-1#1)(2008-9#1)
very likely##5##2##(1992-5#1)(1992-8#1)(2008-1#1)(2008-5#1)(2008-9#1)
very limited##18##2##(1990-5#1)(1993-1#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#2)(2012-7#1)
very little information##2##3##(2008-1#1)(2008-11#1)
very little is known about##2##5##(2008-5#1)(2010-8#1)
very little research has##2##4##(2008-11#1)(2008-9#1)
very little response##2##3##(2008-10#1)(2008-9#1)
very little##35##2##(1992-12#3)(1992-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
very long##6##2##(1992-12#1)(1992-3#1)(1997-7#1)(2008-3#1)(2008-9#1)(2009-12#1)
very low (0##2##3##(2008-10#1)(2008-7#1)
very low at##2##3##(2008-10#1)(2008-5#1)
very low birth weight infants##2##5##(1995-8#2)
very low birth weight##3##4##(1995-8#2)(2011-1#1)
very low birth##4##3##(1994-6#1)(1995-8#2)(2011-1#1)
very low compared with##2##4##(2008-11#1)(2013-1#1)
very low compared##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
very low concentration##3##3##(2008-10#3)
very low concentrations of##2##4##(1991-12#1)(2008-5#1)
very low concentrations##8##3##(1990-12#1)(1991-12#1)(1991-5#1)(1997-4#1)(2008-10#3)(2008-5#1)
very low density lipoprotein (VLDL)##2##5##(1995-6#1)(2008-10#1)
very low density lipoprotein##3##4##(1995-6#2)(2008-10#1)
very low density lipoproteins##4##4##(1991-12#2)(1992-3#1)(1995-2#1)
very low density##7##3##(1991-12#2)(1992-3#1)(1995-2#1)(1995-6#2)(2008-10#1)
very low dose##2##3##(2008-10#1)(2008-7#1)
very low in the##4##4##(1995-11#1)(2008-10#3)
very low in##6##3##(1995-11#1)(2008-10#5)
very low levels of##7##4##(1990-12#1)(1992-10#1)(1993-8#1)(2008-10#2)(2008-11#1)(2009-10#1)
very low levels##13##3##(1990-12#1)(1992-10#1)(1993-3#1)(1993-8#1)(2008-10#5)(2008-11#2)(2008-9#1)(2009-10#1)
very low or undetectable##3##4##(1997-1#1)(2008-10#1)(2012-2#1)
very low or##4##3##(1997-1#1)(2008-10#1)(2008-12#1)(2012-2#1)
very low signal##2##3##(1991-11#1)(2008-10#1)
very low to##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
very low##141##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#3)(1991-12#3)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(1997-9#1)(2008-10#52)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
very mild##2##2##(1991-2#1)(2008-10#1)
very minor##2##2##(1997-6#1)(2008-10#1)
very modest##6##2##(1994-12#1)(2008-1#2)(2008-11#1)(2009-4#1)(2012-3#1)
very much##8##2##(1990-9#1)(1997-1#1)(2008-1#1)(2008-10#3)(2009-3#1)(2009-7#1)
very nonpolar compounds##2##3##(2008-10#2)
very often##4##2##(1995-12#1)(2008-11#1)(2008-9#1)(2011-2#1)
very old age##4##3##(1990-11#1)(2008-7#3)
very old##5##2##(1990-11#1)(1996-8#1)(2008-7#3)
very peculiar##2##2##(1997-4#1)(2011-2#1)
very poor prognosis##2##3##(1991-11#1)(2010-1#1)
very poor##13##2##(1990-4#1)(1991-11#1)(1992-3#1)(1993-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
very popular in##2##3##(2008-10#2)
very popular##3##2##(2008-10#2)(2010-7#1)
very positive##5##2##(1992-12#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
very potent##2##2##(2008-11#1)(2013-8#1)
very powerful##6##2##(1995-12#1)(2008-10#3)(2008-7#1)(2013-1#1)
very precise##4##2##(2008-10#3)(2008-9#1)
very premature infants##2##3##(2007-11#1)(2011-2#1)
very preterm##2##2##(1993-12#1)(1997-5#1)
very prominent##2##2##(2008-10#1)(2008-9#1)
very promising##11##2##(1996-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#2)(2012-2#1)
very pure##2##2##(2008-11#1)(2008-4#1)
very quickly##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
very rapid##6##2##(1991-3#1)(2008-10#3)(2008-4#1)(2009-6#1)
very rapidly##5##2##(1990-8#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-11#1)
very rare and##4##3##(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
very rare##42##2##(1991-3#1)(1992-2#1)(1996-9#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#4)(2008-8#1)(2010-11#2)(2010-12#1)(2010-6#3)(2011-2#7)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#4)
very real##2##2##(1992-2#1)(1994-2#1)
very recently##3##2##(1993-6#1)(2008-11#1)(2008-6#1)
very reliable##4##2##(2008-10#2)(2012-2#2)
very restricted##2##2##(2008-10#1)(2008-8#1)
very satisfactory results##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
very satisfactory##9##2##(1990-5#1)(1991-2#1)(2008-10#5)(2009-10#1)(2011-2#1)
very satisfied with##2##3##(1994-1#1)(2011-2#1)
very selective##3##2##(2008-10#3)
very sensitive and##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
very sensitive method##3##3##(2008-10#3)
very sensitive to##9##3##(1994-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)
very sensitive##34##2##(1990-12#1)(1994-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
very serious##6##2##(1993-12#1)(1995-3#1)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
very severe##5##2##(1996-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
very short response time##2##4##(2008-10#2)
very short##9##2##(1996-12#1)(2008-10#5)(2008-11#2)(2008-5#1)
very sick##2##2##(2008-8#1)(2012-3#1)
very significant##4##2##(1990-8#1)(1997-2#1)(2008-5#1)(2010-6#1)
very similar for##2##3##(2008-10#2)
very similar in##2##3##(1994-11#1)(2008-10#1)
very similar to that of the##2##6##(1991-7#1)(2008-8#1)
very similar to that of##7##5##(1991-7#1)(1993-2#2)(1993-8#1)(1996-12#1)(2008-6#1)(2008-8#1)
very similar to that##10##4##(1991-7#1)(1993-2#2)(1993-8#1)(1994-5#2)(1996-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
very similar to the##4##4##(1993-8#1)(2008-10#2)(2012-2#1)
very similar to those of##2##5##(2008-10#1)(2008-7#1)
very similar to those##5##4##(1993-8#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
very similar to##25##3##(1991-7#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-8#3)(1994-5#2)(1996-12#1)(1997-8#1)(2008-10#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-2#1)
very similar##56##2##(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-5#2)(1996-12#1)(1997-7#1)(1997-8#2)(2008-10#22)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)
very simple and fast##2##4##(2008-10#2)
very simple and##6##3##(2008-10#6)
very simple##28##2##(1990-8#1)(2008-10#25)(2009-6#1)(2012-2#1)
very simply##2##2##(1992-9#1)(2008-10#1)
very slight##2##2##(1996-2#1)(2008-10#1)
very slightly##2##2##(2008-10#2)
very slow##3##2##(2008-1#1)(2008-10#2)
very slowly##4##2##(1991-6#1)(1996-2#1)(2008-12#1)(2008-9#1)
very small amounts of##2##4##(2008-10#2)
very small and##3##3##(2008-10#2)(2013-7#1)
very small fraction of##2##4##(1991-5#1)(2008-11#1)
very small lesions##2##3##(2008-10#1)(2008-9#1)
very small number##2##3##(1995-5#1)(1997-2#1)
very small##35##2##(1990-3#1)(1991-12#1)(1991-5#1)(1993-3#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-10#17)(2008-11#3)(2008-9#4)(2010-5#1)(2011-2#1)(2013-7#2)
very soon##2##2##(2008-10#1)(2011-2#1)
very specific##7##2##(1991-5#1)(1997-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-8#1)
very stable and homogeneous##2##4##(2008-10#2)
very stable and##5##3##(2008-10#4)(2008-11#1)
very stable##19##2##(1990-12#2)(2008-10#15)(2008-11#1)(2008-5#1)
very strong##11##2##(2007-8#1)(2008-10#6)(2008-3#1)(2009-8#1)(2010-4#1)(2012-3#1)
very strongly##3##2##(1993-6#1)(2006-6#1)(2008-10#1)
very successful##6##2##(1993-1#1)(1993-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
very successfully##2##2##(2008-10#2)
very suggestive##2##2##(1993-3#1)(1997-8#1)
very suitable##5##2##(2008-10#4)(2008-5#1)
very susceptible to##2##3##(2008-10#2)
very susceptible##5##2##(2008-10#5)
very thin##3##2##(2008-10#1)(2008-5#2)
very unbalanced##2##2##(1995-12#1)(1995-8#1)
very uncommon##3##2##(1991-6#1)(2008-7#1)(2012-2#1)
very unfavorable##2##2##(1993-2#1)(2012-12#1)
very unstable##2##2##(1992-12#1)(2008-10#1)
very unusual##3##2##(1991-6#1)(1997-8#1)(2013-1#1)
very useful for##12##3##(1997-2#1)(1997-8#1)(2008-10#6)(2008-12#1)(2010-1#1)(2010-10#1)(2010-8#1)
very useful in identifying##2##4##(2008-11#1)(2012-2#1)
very useful in##9##3##(1997-8#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-2#1)(2012-2#2)
very useful to##4##3##(1992-2#1)(1997-3#1)(2008-10#1)(2013-1#1)
very useful##35##2##(1990-11#1)(1991-2#1)(1992-2#1)(1994-2#1)(1997-2#1)(1997-3#1)(1997-8#3)(2008-10#9)(2008-11#5)(2008-12#2)(2008-9#2)(2009-2#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-2#2)(2013-1#2)
very valuable##2##2##(2008-10#1)(2011-2#1)
very weak##13##2##(2008-10#7)(2008-7#3)(2012-2#2)(2013-8#1)
very weakly##3##2##(1993-1#2)(2008-10#1)
very well with the##4##4##(1995-2#1)(2008-10#2)(2010-12#1)
very well with those obtained##2##5##(2008-10#2)
very well with##7##3##(1995-2#1)(2008-10#5)(2010-12#1)
very well##18##2##(1992-11#1)(1992-3#1)(1995-2#1)(2008-10#10)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)
very wide##7##2##(1992-12#1)(1995-3#1)(2008-10#3)(2008-11#1)(2010-7#1)
very young children##2##3##(2008-9#2)
very young##5##2##(1994-9#1)(1997-3#1)(2008-11#1)(2008-9#2)
very##1322##1##(1990-11#4)(1990-12#9)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#8)(1990-6#3)(1990-8#5)(1990-9#7)(1991-1#1)(1991-11#4)(1991-12#8)(1991-2#5)(1991-3#5)(1991-5#7)(1991-6#7)(1991-7#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#12)(1992-2#4)(1992-3#6)(1992-5#4)(1992-8#1)(1992-9#6)(1993-1#4)(1993-11#1)(1993-12#5)(1993-2#6)(1993-3#7)(1993-6#4)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#7)(1994-12#6)(1994-2#7)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#5)(1995-5#4)(1995-6#3)(1995-8#5)(1996-1#3)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#7)(1997-8#12)(1997-9#1)(2006-5#1)(2006-6#2)(2007-11#4)(2007-12#5)(2007-8#3)(2008-1#14)(2008-10#462)(2008-11#82)(2008-12#19)(2008-2#1)(2008-3#8)(2008-4#13)(2008-5#38)(2008-6#8)(2008-7#40)(2008-8#24)(2008-9#42)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#5)(2009-9#1)(2010-1#4)(2010-10#8)(2010-11#10)(2010-12#7)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#7)(2010-7#11)(2010-8#6)(2010-9#3)(2011-1#4)(2011-2#49)(2011-3#4)(2012-12#9)(2012-2#28)(2012-3#15)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#38)(2013-7#2)(2013-8#19)
very-long-chain acyl-CoA##2##2##(1993-3#2)
very-long-chain fatty acid##2##3##(1995-2#2)
very-long-chain fatty##3##2##(1995-2#3)
very-long-chain##5##1##(1993-3#2)(1995-2#3)
vesical##3##1##(1994-5#1)(2008-10#1)(2012-12#1)
vesicarium were exposed to##2##4##(2008-10#2)
vesicarium##8##1##(2008-10#8)
vesicatoria be##2##2##(2008-10#2)
vesicatoria group##2##2##(2008-10#2)
vesicatoria in##2##2##(2008-10#2)
vesicatoria race T1##2##3##(2008-10#2)
vesicatoria##21##1##(2008-10#21)
vesicle aggregation##2##2##(1997-2#2)
vesicle coat proteins##2##3##(2009-6#1)(2011-2#1)
vesicle formation##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
vesicle fusion##3##2##(1995-2#1)(1997-1#1)(2012-2#1)
vesicle is##4##2##(2007-12#1)(2008-11#1)(2011-2#2)
vesicle movement##3##2##(2008-11#3)
vesicle trafficking and exocytosis##2##4##(1995-2#1)(2009-8#1)
vesicle trafficking and##3##3##(1995-2#1)(2008-11#1)(2009-8#1)
vesicle trafficking##5##2##(1995-2#1)(1997-1#1)(2008-11#1)(2009-8#2)
vesicle transport##4##2##(1993-9#1)(1997-1#1)(2008-11#2)
vesicle turnover##2##2##(1997-7#2)
vesicle##63##1##(1991-10#1)(1993-9#1)(1995-2#3)(1996-12#1)(1997-1#4)(1997-2#3)(1997-7#2)(2007-12#2)(2008-10#6)(2008-11#19)(2008-5#1)(2008-7#2)(2009-6#1)(2009-8#3)(2010-6#1)(2011-2#7)(2012-2#3)(2013-1#2)(2013-8#1)
vesicle-mediated##2##1##(2008-10#2)
vesicles and##12##2##(1992-12#1)(1993-12#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#6)(2008-7#1)
vesicles are##3##2##(1997-3#1)(1997-7#1)(2008-7#1)
vesicles as##3##2##(1991-5#1)(2008-11#1)(2012-12#1)
vesicles but##3##2##(1991-5#1)(1994-5#1)(2008-7#1)
vesicles by##4##2##(1995-6#2)(2008-10#2)
vesicles can##3##2##(1994-5#1)(2008-10#1)(2013-8#1)
vesicles containing##7##2##(1992-12#3)(1994-5#1)(1997-6#1)(2007-12#1)(2008-8#1)
vesicles for##2##2##(2008-10#2)
vesicles from##3##2##(1992-12#1)(2008-11#2)
vesicles in##5##2##(1997-1#2)(1997-7#1)(2007-12#1)(2008-10#1)
vesicles increased##2##2##(2008-5#1)(2008-8#1)
vesicles isolated##2##2##(2008-11#2)
vesicles made##2##2##(2008-8#1)(2012-2#1)
vesicles obtained by##2##3##(1991-5#1)(1993-8#1)
vesicles of##4##2##(1994-5#2)(2007-12#1)(2009-10#1)
vesicles prepared from##4##3##(1991-5#2)(1997-8#1)(2008-11#1)
vesicles that##4##2##(1992-12#1)(1994-5#1)(2008-10#1)(2008-11#1)
vesicles to##3##2##(1994-5#1)(2008-11#2)
vesicles was##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
vesicles were##2##2##(2008-10#1)(2008-11#1)
vesicles which##3##2##(1997-7#1)(2008-10#1)(2008-6#1)
vesicles with##5##2##(1990-2#1)(1994-5#1)(1997-3#1)(1997-8#1)(2008-10#1)
vesicles##167##1##(1990-2#2)(1991-5#8)(1991-9#3)(1992-12#6)(1993-12#2)(1993-8#1)(1994-11#1)(1994-5#10)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#4)(1997-1#4)(1997-2#2)(1997-3#5)(1997-6#2)(1997-7#4)(1997-8#7)(2007-12#7)(2008-10#32)(2008-11#20)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#1)(2010-6#2)(2012-12#2)(2012-2#6)(2013-8#6)
vesicles)##2##1##(1991-10#1)(2008-9#1)
vesico-ureteric junction##3##2##(2008-10#2)(2012-3#1)
vesicostomy##2##1##(2008-10#2)
vesicoureteral reflux##8##2##(2008-10#8)
vesicovaginal##2##1##(1993-2#1)(1996-2#1)
vesicular disease##2##2##(2011-2#2)
vesicular fusion##2##2##(1995-2#1)(2008-5#1)
vesicular trafficking##2##2##(2009-7#1)(2011-2#1)
vesicular transport##4##2##(1995-2#1)(1995-8#1)(1996-12#1)(2008-11#1)
vesicular transporter##3##2##(1996-12#3)
vesicular##31##1##(1991-10#1)(1993-6#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-12#6)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
vesiculation##2##1##(1997-3#2)
vessel and the##2##3##(1993-8#1)(2008-10#1)
vessel and##7##2##(1993-8#1)(2008-10#5)(2012-3#1)
vessel diameter##2##2##(2011-2#2)
vessel elements##2##2##(2008-10#2)
vessel failure##2##2##(2008-11#1)(2009-10#1)
vessel is##3##2##(2008-10#2)(2008-12#1)
vessel of##2##2##(2008-10#1)(2008-7#1)
vessel size##2##2##(2009-7#1)(2012-5#1)
vessel tone##2##2##(1995-2#2)
vessel vasculitis##4##2##(1997-8#2)(2008-10#1)(2012-3#1)
vessel wall##11##2##(1992-9#1)(1996-2#1)(1996-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-9#2)(2012-2#1)(2013-1#1)
vessel walls##3##2##(1990-8#1)(2008-11#1)(2009-8#1)
vessel was##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
vessel##115##1##(1990-8#1)(1991-12#1)(1991-8#2)(1992-9#2)(1993-11#1)(1993-8#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#2)(1997-8#2)(2008-10#38)(2008-11#9)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#7)(2008-8#2)(2009-10#8)(2009-3#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#2)(2011-2#5)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#5)(2013-8#2)
vessel)##2##1##(2008-5#1)(2011-2#1)
vessels and##13##2##(1994-9#1)(1996-3#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
vessels are##3##2##(1994-9#1)(2008-1#1)(2008-11#1)
vessels from##2##2##(2011-2#1)(2013-8#1)
vessels in##5##2##(1997-6#1)(2008-10#2)(2008-7#1)(2011-2#1)
vessels is##4##2##(1994-9#1)(1997-8#1)(2010-1#1)(2010-11#1)
vessels of the##4##3##(1997-5#1)(2007-12#1)(2008-10#1)(2013-7#1)
vessels of##11##2##(1997-5#1)(2007-12#1)(2008-10#4)(2008-11#3)(2013-1#1)(2013-7#1)
vessels that##2##2##(1997-8#1)(2008-3#1)
vessels to the##2##3##(2011-2#1)(2012-3#1)
vessels to##3##2##(1996-3#1)(2011-2#1)(2012-3#1)
vessels was##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
vessels were##6##2##(1996-6#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#2)
vessels with##2##2##(2006-6#1)(2008-8#1)
vessels##128##1##(1990-11#1)(1990-8#2)(1993-8#1)(1994-12#1)(1994-9#3)(1995-12#1)(1996-11#1)(1996-3#2)(1996-6#3)(1996-9#3)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#5)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#20)(2008-11#12)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#2)(2009-7#3)(2009-8#1)(2010-1#3)(2010-11#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#14)(2011-3#1)(2012-12#1)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
vested##3##1##(1994-2#1)(2008-11#1)(2008-12#1)
vestibular compensation in the goldfish##2##5##(1991-2#2)
vestibular disorders##2##2##(2012-3#2)
vestibular hypofunction##2##2##(2012-3#2)
vestibular##24##1##(1991-2#7)(1995-8#5)(1996-12#1)(2011-2#4)(2012-3#5)(2013-1#2)
vestibule##2##1##(1993-9#1)(2013-1#1)
vestimentiferans##2##1##(2009-8#2)
vet##2##1##(1997-6#1)(1997-8#1)
veteran##2##1##(1996-1#1)(2013-1#1)
veterans##11##1##(2008-10#1)(2008-4#1)(2011-2#4)(2012-3#2)(2013-1#3)
veterinarians and##2##2##(1997-7#1)(2008-12#1)
veterinarians##3##1##(1991-8#1)(1997-7#1)(2008-12#1)
veterinary and##2##2##(2008-10#1)(2011-2#1)
veterinary antibiotics##2##2##(2008-10#2)
veterinary parasitologists##2##2##(1997-7#2)
veterinary pharmaceuticals##2##2##(2008-10#2)
veterinary research##2##2##(1990-9#1)(1997-7#1)
veterinary scientists##3##2##(2010-1#3)
veterinary surgeons##2##2##(1990-6#1)(1995-9#1)
veterinary##29##1##(1990-6#2)(1990-9#3)(1994-3#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#6)(2008-10#5)(2010-1#4)(2011-2#1)(2012-2#1)(2012-3#1)
veto##3##1##(1992-11#1)(1995-6#1)(1996-5#1)
vetoed##2##1##(1996-5#2)
vexing##3##1##(1996-2#1)(2008-11#1)(2010-12#1)
via Agrobacterium tumefaciens##2##3##(2008-10#1)(2008-9#1)
via RNA##2##2##(2010-5#1)(2012-2#1)
via a limited##2##3##(2008-7#2)
via a pathway##2##3##(1993-8#1)(1995-8#1)
via a##68##2##(1990-8#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-1#2)(2007-12#3)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-7#1)
via activation of##2##3##(2008-11#1)(2008-9#1)
via an##28##2##(1991-8#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-11#4)(2008-4#1)(2008-7#1)(2010-12#4)(2011-2#2)(2012-3#1)(2013-1#2)
via appropriate##2##2##(2011-1#1)(2011-2#1)
via both##2##2##(1995-6#1)(2008-10#1)
via bronchoscopy##3##2##(1994-2#2)(2010-10#1)
via calcium##2##2##(1990-5#1)(2008-8#1)
via complex formation with modifier##2##5##(2008-10#2)
via complex##3##2##(1995-12#1)(2008-10#2)
via conventional##2##2##(2008-10#2)
via different mechanisms##2##3##(1993-6#1)(1997-1#1)
via different##7##2##(1993-6#1)(1994-6#1)(1997-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
via diffusion##2##2##(2008-10#2)
via direct##5##2##(1996-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
via either##2##2##(2008-10#2)
via glutaraldehyde##2##2##(2008-10#1)(2009-10#1)
via glycosylation##2##2##(2008-11#2)
via group##2##2##(1996-5#1)(2008-10#1)
via hyphal anastomosis##2##3##(2008-10#2)
via immunogold##2##2##(2008-9#2)
via inhibition of##2##3##(2008-10#1)(2011-3#1)
via interactive##2##2##(2008-10#1)(2012-3#1)
via its##6##2##(1995-2#1)(2008-10#1)(2009-10#2)(2011-2#1)(2013-7#1)
via laparoscopy##4##2##(1991-3#3)(1996-2#1)
via layer-by-layer##2##2##(2008-10#2)
via mitochondrial##2##2##(1992-10#2)
via modulation of##2##3##(1997-1#1)(2008-5#1)
via multiple##2##2##(2010-5#1)(2011-2#1)
via muscle metaboreflex##2##3##(2013-8#2)
via on-line##3##2##(2008-10#3)
via our##2##2##(1992-2#1)(2008-11#1)
via p53 in##2##3##(2011-2#2)
via particle bombardment##3##3##(2008-10#3)
via potentiometric titration##2##3##(2008-10#2)
via protein-protein interactions##2##3##(1992-3#1)(2009-7#1)
via prunin##2##2##(2008-11#2)
via receptor-mediated endocytosis##2##3##(2008-11#2)
via reduction of##2##3##(2008-10#1)(2008-5#1)
via several##3##2##(1997-1#1)(2011-1#2)
via similar##3##2##(1990-5#1)(2009-6#2)
via stimulation of##2##3##(1995-12#1)(1996-2#1)
via the A1##2##3##(1993-6#1)(1994-11#1)
via the MT1##2##3##(2013-7#2)
via the complex##2##3##(1993-8#1)(2008-10#1)
via the interaction of##2##4##(2008-10#1)(2012-2#1)
via the reaction of##2##4##(1993-6#1)(2008-10#1)
via the reaction##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
via the telephone##2##3##(2013-1#2)
via the transarterial route##2##4##(1997-3#2)
via the##113##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#2)(1997-3#2)(1997-6#1)(2007-12#3)(2008-1#1)(2008-10#27)(2008-11#11)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#13)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#2)
via their##3##2##(2008-4#1)(2010-1#1)(2012-2#1)
via this##2##2##(1993-11#1)(2008-10#1)
via two##2##2##(2008-2#1)(2008-7#1)
via wireless##4##2##(2008-10#2)(2008-9#1)(2010-8#1)
via##626##1##(1990-2#3)(1990-5#4)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#6)(1991-8#2)(1991-9#2)(1992-10#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#3)(1993-5#1)(1993-6#5)(1993-8#2)(1993-9#3)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#3)(1995-8#4)(1996-12#3)(1996-2#5)(1996-3#4)(1996-5#12)(1996-9#2)(1997-1#10)(1997-2#2)(1997-3#3)(1997-4#4)(1997-6#1)(1997-8#1)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#171)(2008-11#52)(2008-12#6)(2008-2#3)(2008-4#10)(2008-5#12)(2008-6#6)(2008-7#17)(2008-8#20)(2008-9#17)(2009-1#1)(2009-10#7)(2009-12#2)(2009-4#2)(2009-6#3)(2009-7#2)(2009-8#6)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#6)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#39)(2011-3#3)(2012-12#2)(2012-2#12)(2012-3#19)(2013-1#18)(2013-7#7)(2013-8#8)
viabilities##8##1##(2008-10#1)(2008-11#7)
viability and growth of##2##4##(1990-6#1)(2009-9#1)
viability and productivity##2##3##(2008-11#2)
viability and proliferation##2##3##(2008-11#1)(2008-5#1)
viability and##29##2##(1990-6#1)(1992-2#1)(1995-2#1)(2008-10#6)(2008-11#12)(2008-5#1)(2008-7#3)(2009-10#1)(2009-9#1)(2012-2#1)(2012-3#1)
viability as##2##2##(2008-11#1)(2013-1#1)
viability assessment##2##2##(2008-9#1)(2012-2#1)
viability costs##2##2##(2008-8#2)
viability during##3##2##(2008-10#1)(2008-11#2)
viability in##14##2##(1995-2#1)(2008-10#5)(2008-11#7)(2013-1#1)
viability of cells##2##3##(2009-12#1)(2013-1#1)
viability of conidia##2##3##(2008-10#2)
viability of the method##4##4##(2008-10#3)(2008-5#1)
viability of the##16##3##(1992-1#1)(1992-5#1)(1996-12#1)(2008-10#4)(2008-11#4)(2008-5#1)(2009-7#1)(2011-2#3)
viability of##57##2##(1990-6#1)(1992-1#1)(1992-5#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(2008-10#17)(2008-11#13)(2008-5#1)(2008-7#2)(2008-9#5)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#3)(2012-3#2)(2013-1#2)
viability or##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
viability than the##2##3##(2008-9#1)(2013-1#1)
viability traits##2##2##(2012-3#2)
viability was observed##2##3##(2008-10#1)(2008-11#1)
viability was##13##2##(1994-5#1)(2008-10#3)(2008-11#6)(2009-9#1)(2012-3#1)(2013-1#1)
viability were##2##2##(2008-11#1)(2008-8#1)
viability##223##1##(1990-6#4)(1991-12#1)(1992-1#1)(1992-2#1)(1992-5#2)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#4)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-8#1)(1997-3#3)(1997-7#1)(2008-10#43)(2008-11#71)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#14)(2009-10#2)(2009-12#3)(2009-4#2)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2011-2#6)(2012-2#4)(2012-3#7)(2013-1#13)(2013-7#1)(2013-8#1)
viable and total cell##2##4##(2008-11#1)(2008-7#1)
viable and##11##2##(1996-8#1)(2008-10#2)(2008-11#2)(2008-7#3)(2008-9#2)(2013-1#1)
viable animal cells##2##3##(2008-11#2)
viable bacterial counts##2##3##(2008-10#2)
viable biomass##2##2##(2008-11#2)
viable but##2##2##(2008-10#1)(2008-9#1)
viable cell concentration##6##3##(2008-11#3)(2008-7#3)
viable cell density and##2##4##(2008-11#2)
viable cell density in##2##4##(2008-11#2)
viable cell density of##3##4##(2008-11#3)
viable cell density##17##3##(2008-11#17)
viable cell number##6##3##(2008-11#6)
viable cell##36##2##(2008-11#33)(2008-7#3)
viable cells for##2##3##(1990-12#1)(2008-9#1)
viable cells in##4##3##(2008-11#4)
viable cells##15##2##(1990-12#1)(2008-10#1)(2008-11#8)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)
viable counts dropped##2##3##(2012-2#2)
viable counts in the##2##4##(2008-10#1)(2013-1#1)
viable counts were##2##3##(1997-5#1)(2008-10#1)
viable counts##10##2##(1997-5#2)(2008-10#4)(2012-2#3)(2013-1#1)
viable for##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
viable hepatocytes##2##2##(2008-11#2)
viable in##3##2##(1994-12#1)(2008-1#1)(2010-11#1)
viable option for the##2##4##(2008-10#1)(2009-10#1)
viable option for##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
viable option##4##2##(2008-10#2)(2009-10#1)(2011-2#1)
viable spores##3##2##(2008-10#2)(2011-2#1)
viable technique for##2##3##(2008-10#1)(2012-4#1)
viable technique##3##2##(2008-10#1)(2008-11#1)(2012-4#1)
viable##194##1##(1990-12#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#2)(2008-1#1)(2008-10#44)(2008-11#64)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#10)(2008-8#3)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#2)(2010-11#4)(2010-12#2)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#9)(2013-8#1)
vial##9##1##(1992-3#1)(1997-4#1)(2008-10#7)
vials##5##1##(2008-10#3)(2008-8#1)(2012-2#1)
vibrating##2##1##(1992-8#1)(2008-11#1)
vibration and##3##2##(1991-12#1)(2008-10#1)(2012-3#1)
vibration of the##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
vibration of##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-8#1)
vibration##30##1##(1991-12#1)(1996-2#1)(2007-12#2)(2008-10#7)(2008-11#5)(2008-2#1)(2008-3#7)(2008-8#1)(2012-3#2)(2013-8#3)
vibrational band##4##2##(2008-3#3)(2008-8#1)
vibrational modes##2##2##(2008-10#1)(2008-3#1)
vibrational##25##1##(1990-8#1)(1991-9#1)(2008-10#4)(2008-2#2)(2008-3#11)(2008-5#1)(2008-8#4)(2010-7#1)
vibrational-rotational Raman##2##2##(2008-3#2)
vibrational-rotational##4##1##(2008-3#4)
vibrations##11##1##(1994-3#1)(1995-3#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
vibrissae##4##1##(1994-2#4)
vibrissal FSC##4##2##(2011-2#4)
vibrissal follicle-sinus complex##2##3##(2011-2#2)
vibrissal##11##1##(2011-2#11)
vic##2##1##(2008-10#2)
vicariance##2##1##(2008-9#2)
vice versa##14##2##(1991-2#1)(1997-1#1)(1997-3#1)(2008-10#6)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
vice##17##1##(1991-2#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-2#1)
viciae-villosae##3##1##(2008-10#3)
vicinal##3##1##(1992-4#1)(1996-11#1)(1996-5#1)
vicinity of the##17##3##(1990-11#1)(1990-2#1)(1990-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-2#1)(2008-10#4)(2008-7#2)(2009-12#1)(2009-7#2)
vicinity of##32##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-11#1)(1996-2#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-7#2)(2009-12#1)(2009-7#2)
vicinity##38##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-11#2)(1996-2#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-7#2)(2009-12#2)(2009-7#2)(2012-12#1)(2012-3#1)
victim of##3##2##(1995-5#1)(2008-10#1)(2009-5#1)
victim to##2##2##(1993-9#1)(1994-3#1)
victim was##2##2##(2008-12#1)(2011-2#1)
victim##14##1##(1992-5#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#3)(2009-10#1)(2009-5#1)(2011-2#1)
victim's##3##1##(1996-3#1)(2008-10#1)(2008-11#1)
victimization among##2##2##(2010-1#1)(2013-1#1)
victimization and##2##2##(2008-12#1)(2013-1#1)
victimization in##4##2##(2009-5#1)(2009-7#2)(2010-1#1)
victimization##25##1##(2008-10#1)(2008-12#4)(2009-5#6)(2009-7#2)(2010-1#3)(2011-2#1)(2013-1#7)(2013-8#1)
victimized##2##1##(2009-7#1)(2010-1#1)
victims and##2##2##(1996-3#1)(2008-11#1)
victims had##2##2##(2009-7#2)
victims of a mass disaster##3##5##(1995-11#3)
victims of domestic##2##3##(1995-12#1)(2011-2#1)
victims of intimate partner violence##2##5##(2012-12#2)
victims of##15##2##(1991-12#2)(1992-1#1)(1995-11#3)(1995-12#1)(1996-11#1)(2008-11#1)(2009-9#2)(2011-2#1)(2012-12#3)
victims were##2##2##(1990-12#1)(1996-11#1)
victims##39##1##(1990-12#1)(1991-12#2)(1991-2#2)(1992-1#2)(1992-2#1)(1995-11#3)(1995-12#1)(1996-11#5)(1996-3#1)(2008-11#4)(2008-8#1)(2009-7#4)(2009-9#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-3#2)
victims'##5##1##(2009-7#4)(2012-3#1)
victoria##3##1##(1996-6#1)(2008-10#1)(2008-8#1)
victoriae##4##1##(2013-8#4)
victory##2##1##(1997-6#2)
video and##3##2##(2008-11#2)(2008-4#1)
video cameras##2##2##(1995-12#1)(2012-2#1)
video clips##2##2##(2008-12#2)
video fluoroscopy##2##2##(2008-9#1)(2013-1#1)
video rate##2##2##(2008-6#2)
video recording##2##2##(1993-3#1)(2008-5#1)
video sequences##3##2##(2008-3#1)(2008-6#2)
video surveillance##2##2##(1996-2#1)(2013-1#1)
video##58##1##(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-12#3)(1996-2#1)(2008-10#6)(2008-11#4)(2008-12#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#10)(2008-8#3)(2008-9#4)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)
video-assisted##4##1##(2007-8#1)(2012-12#2)(2013-7#1)
video-teleconferencing##2##1##(2008-6#2)
videoconferencing##6##1##(2008-11#6)
videos##6##1##(1993-12#1)(1997-6#1)(2008-11#1)(2008-9#2)(2011-2#1)
videos)##2##1##(2012-2#2)
videotape##10##1##(1991-1#2)(1993-2#1)(1994-3#1)(1995-12#2)(2008-8#2)(2008-9#1)(2009-7#1)
videotaped##7##1##(1991-6#1)(1993-2#2)(2007-9#1)(2008-11#1)(2008-8#1)(2012-2#1)
videotapes##8##1##(1991-6#1)(1993-12#1)(1993-2#5)(1994-6#1)
videotaping##2##1##(1995-12#2)
view and##5##2##(1995-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
view angle and##2##3##(2008-3#1)(2011-2#1)
view condition-specific performance measures##2##4##(1997-3#2)
view from the##2##3##(1991-1#1)(2008-11#1)
view from##5##2##(1991-1#1)(1994-1#1)(2008-11#1)(2009-11#1)(2009-6#1)
view into the##3##3##(1994-3#1)(2010-8#1)(2011-7#1)
view into##4##2##(1994-3#1)(2008-4#1)(2010-8#1)(2011-7#1)
view is##2##2##(2010-4#1)(2013-1#1)
view of an##2##3##(2008-10#1)(2008-5#1)
view of health care##2##4##(1993-1#1)(1994-6#1)
view of how##2##3##(1997-7#1)(2008-11#1)
view of life and death##2##5##(1993-11#2)
view of statistical##2##3##(2008-11#1)(2013-8#1)
view of the fact that##2##5##(1997-5#1)(2008-10#1)
view of the high##2##4##(2008-10#1)(2008-7#1)
view of the history of##2##5##(1993-11#1)(1994-12#1)
view of the impact##2##4##(1995-12#1)(2008-10#1)
view of the importance of this##2##6##(2008-10#2)
view of the##54##3##(1990-11#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#13)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-3#1)(2013-1#1)
view of their##4##3##(1994-3#1)(1996-1#1)(2008-10#1)(2008-6#1)
view of##128##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#3)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#25)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
view on##5##2##(1993-6#1)(2008-10#1)(2008-11#1)(2013-1#2)
view that the##4##3##(1990-5#1)(1997-9#1)(2008-12#2)
view that##18##2##(1990-5#1)(1993-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2013-7#1)(2013-8#1)
view the##10##2##(1993-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
view their##3##2##(1993-2#1)(1994-3#1)(1996-1#1)
view this##2##2##(2008-6#1)(2012-3#1)
view to##12##2##(1991-3#1)(1991-6#1)(1997-4#1)(2008-10#6)(2008-11#2)(2011-2#1)
view with##2##2##(1997-1#1)(2008-3#1)
view##288##1##(1990-11#2)(1990-12#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#3)(1991-3#1)(1991-6#3)(1991-8#1)(1992-2#1)(1992-3#4)(1993-1#4)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#5)(1994-6#3)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#4)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(1997-9#1)(2007-12#2)(2008-10#51)(2008-11#17)(2008-12#8)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#6)(2008-6#9)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#2)(2011-2#14)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#7)
viewed as a##7##3##(1992-3#1)(1994-12#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-3#1)
viewed as an##3##3##(1992-12#1)(2008-10#1)(2010-12#1)
viewed as##24##2##(1991-3#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
viewed from##2##2##(2008-10#1)(2011-3#1)
viewed the##2##2##(1996-2#1)(2008-8#1)
viewed through##2##2##(2008-2#1)(2011-7#1)
viewed under##2##2##(2008-3#1)(2008-9#1)
viewed with##2##2##(2008-10#1)(2008-7#1)
viewed##57##1##(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#7)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#2)(2011-3#1)(2011-7#2)(2012-3#1)(2013-1#1)
viewing and##3##2##(2008-4#1)(2008-6#2)
viewing the##3##2##(1991-12#1)(2008-12#1)(2008-8#1)
viewing##26##1##(1991-12#1)(1993-2#1)(1994-3#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#2)
viewpoint of##8##2##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)(2013-1#1)
viewpoint##22##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-12#3)(1994-8#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-6#2)(2008-8#2)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
viewpoints are##2##2##(2008-6#1)(2008-9#1)
viewpoints within##2##2##(2008-6#2)
viewpoints##7##1##(1991-6#1)(2008-6#4)(2008-7#1)(2008-9#1)
views about the##2##3##(2010-12#1)(2013-8#1)
views about##3##2##(2010-12#1)(2013-1#1)(2013-8#1)
views and##8##2##(1994-1#1)(1997-8#1)(2008-11#3)(2008-12#1)(2010-10#1)(2013-1#1)
views are##2##2##(2008-12#1)(2010-12#1)
views in##2##2##(2008-11#1)(2008-12#1)
views of the##11##3##(1991-1#1)(1991-2#1)(1992-2#1)(1997-2#1)(2007-12#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2012-2#1)
views of their##2##3##(2008-11#1)(2011-1#1)
views of##21##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-2#1)(1997-2#1)(2007-12#1)(2008-11#3)(2008-12#5)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2011-1#1)(2012-2#1)
views on the##4##3##(1992-5#1)(1996-3#1)(2008-12#2)
views on##12##2##(1991-2#1)(1992-5#1)(1993-12#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
views##72##1##(1991-1#1)(1991-2#2)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1995-12#1)(1995-5#1)(1996-3#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-11#10)(2008-12#15)(2008-5#1)(2008-6#5)(2008-9#2)(2009-10#1)(2009-5#2)(2010-10#3)(2010-12#3)(2011-1#5)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
vigabatrin##5##1##(1992-3#5)
vigilance regarding##2##2##(2008-10#1)(2011-2#1)
vigilance##6##1##(1992-3#1)(2008-10#2)(2008-9#1)(2009-12#1)(2011-2#1)
vigilant##3##1##(1996-8#1)(2008-10#1)(2010-11#1)
vigintioctopunctata##3##1##(2008-6#3)
vigor index and seedling dry weight##2##6##(2008-12#2)
vigor of##2##2##(2008-10#1)(2008-8#1)
vigor##14##1##(2008-10#9)(2008-12#2)(2008-8#1)(2008-9#1)(2009-10#1)
vigorous physical activity##7##3##(2010-1#1)(2010-11#5)(2013-1#1)
vigorous shaking##2##2##(2008-10#1)(2008-7#1)
vigorous##17##1##(1990-12#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-1#1)(2010-11#5)(2012-3#1)(2013-1#1)
vigorously##2##1##(2008-10#1)(2011-2#1)
village##4##1##(2008-10#2)(2008-5#1)(2012-12#1)
villagers##2##1##(2008-10#2)
villages in##2##2##(2008-10#2)
villages of##2##2##(2008-10#1)(2012-12#1)
villages##12##1##(1994-9#3)(2008-10#7)(2008-12#1)(2012-12#1)
villosa##2##1##(2008-8#2)
villous height in##2##3##(2013-1#2)
villous height##7##2##(2013-1#7)
villous##9##1##(2010-3#1)(2013-1#8)
villus sampling##3##2##(1991-2#1)(2007-7#1)(2008-4#1)
vim##2##1##(2008-8#1)(2008-9#1)
vimentin and##4##2##(1991-6#1)(2008-11#1)(2008-8#1)(2010-12#1)
vimentin##10##1##(1991-6#1)(1994-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
viminalis##5##1##(2012-3#5)
vinblastine##7##1##(1990-2#2)(1991-6#2)(2008-5#1)(2011-1#2)
vinclozolin##21##1##(2008-10#21)
vincristine and##3##2##(1993-8#2)(2013-8#1)
vincristine plus etoposide##2##3##(1993-8#2)
vincristine plus##3##2##(1993-8#3)
vincristine##12##1##(1990-12#1)(1993-8#6)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
vindesine (VDS)##2##2##(1992-12#1)(1993-2#1)
vindesine##3##1##(1992-12#2)(1993-2#1)
vine decline##2##2##(2008-10#2)
vine##9##1##(2008-10#9)
vinegar and##2##2##(2008-10#2)
vinegar##9##1##(2008-10#8)(2008-5#1)
vinegars and##2##2##(2008-10#2)
vinegars##6##1##(2008-10#6)
vinelandii##4##1##(1990-11#4)
vines in##2##2##(2008-10#2)
vines infected with##2##3##(2008-10#2)
vines infected##4##2##(2008-10#4)
vines showing esca symptoms in##2##5##(2008-10#2)
vines that had been inoculated##2##5##(2008-10#2)
vines that##3##2##(2008-10#3)
vines were##3##2##(2008-10#3)
vines##28##1##(2008-10#28)
vineyard soil##2##2##(2008-10#2)
vineyard##8##1##(2008-10#8)
vineyards in##3##2##(2008-10#3)
vineyards##19##1##(2008-10#19)
vinifera 'Chardonnay'##3##2##(2008-10#3)
vinifera L##3##2##(2008-10#1)(2009-8#2)
vinifera cultivars##4##2##(2008-10#4)
vinifera cv##2##2##(2008-10#2)
vinifera##19##1##(2008-10#17)(2009-8#2)
vinifera)##3##1##(2008-10#3)
vinorelbine as a single agent##2##5##(1994-8#2)
vinorelbine as##3##2##(1994-2#1)(1994-8#2)
vinorelbine##6##1##(1994-12#1)(1994-2#1)(1994-8#4)
vintages were##2##2##(2008-10#2)
vintages##3##1##(2008-10#3)
vinyl chloride##2##2##(2008-10#2)
vinyl ether##3##2##(1996-5#3)
vinyl ethers##2##2##(1996-5#1)(2008-10#1)
vinyl groups##4##2##(2008-10#4)
vinyl pyrrolidone##2##2##(2008-5#2)
vinyl##25##1##(1995-11#1)(1996-5#5)(2008-10#12)(2008-5#3)(2009-12#2)(2009-5#1)(2011-2#1)
vinylic##3##1##(1996-5#1)(2009-6#2)
violaceus##4##1##(2008-8#2)(2008-9#2)
violate the##3##2##(1995-8#1)(1996-5#1)(1996-9#1)
violate##9##1##(1993-1#1)(1993-3#1)(1995-8#1)(1996-5#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
violated by##3##2##(1995-2#1)(2008-8#1)(2010-10#1)
violated the##4##2##(1992-9#1)(1995-12#2)(1995-6#1)
violated##16##1##(1992-9#1)(1995-12#4)(1995-2#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
violation of the##5##3##(1993-1#1)(1995-6#1)(2008-3#2)(2008-9#1)
violation of##9##2##(1993-1#1)(1995-6#1)(2008-3#3)(2008-9#1)(2012-2#1)(2013-8#2)
violation##13##1##(1990-12#1)(1992-8#1)(1993-1#1)(1995-12#1)(1995-6#1)(2008-3#3)(2008-9#1)(2009-4#1)(2012-2#1)(2013-8#2)
violations of##6##2##(1994-9#2)(2008-12#1)(2008-8#1)(2010-2#1)(2013-8#1)
violations##16##1##(1990-6#1)(1993-12#2)(1993-3#1)(1994-9#2)(2008-11#2)(2008-12#2)(2008-8#2)(2010-2#1)(2010-7#1)(2011-2#1)(2013-8#1)
violence against##2##2##(1993-2#1)(2008-12#1)
violence and##9##2##(1991-12#1)(1995-12#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-3#1)
violence has##2##2##(2008-12#1)(2008-7#1)
violence in the##3##3##(1991-12#2)(2008-11#1)
violence in##4##2##(1991-1#1)(1991-12#2)(2008-11#1)
violence involvement##2##2##(2013-1#2)
violence is##2##2##(1991-12#1)(1991-3#1)
violence perpetration##2##2##(2013-1#2)
violence victimization##7##2##(2009-5#1)(2013-1#6)
violence were##2##2##(2008-7#1)(2012-12#1)
violence##79##1##(1990-2#1)(1990-6#2)(1991-1#1)(1991-12#4)(1991-3#1)(1993-12#1)(1993-2#1)(1994-9#2)(1995-12#3)(1996-1#1)(1996-12#3)(1996-6#1)(1997-3#1)(2008-11#9)(2008-12#4)(2008-6#1)(2008-7#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#5)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#9)(2012-3#2)(2013-1#12)
violent and psychopathic individuals is##2##5##(2008-11#2)
violent and##3##2##(2008-11#2)(2008-7#1)
violent crime##2##2##(2008-11#1)(2008-12#1)
violent death##2##2##(2009-7#2)
violent situations##3##2##(1991-1#1)(2008-7#2)
violent##19##1##(1990-8#1)(1991-1#1)(1993-12#1)(1994-12#1)(1996-5#1)(1997-7#1)(2008-11#3)(2008-12#1)(2008-7#5)(2009-7#2)(2010-6#1)(2012-3#1)
violet (CV)##3##2##(2008-10#3)
violet (PCV)##3##2##(2008-10#3)
violet and##4##2##(2008-10#4)
violet as a##2##3##(2008-10#2)
violet by potassium periodate##2##4##(2008-10#2)
violet by##3##2##(2008-10#3)
violet colored##2##2##(2008-10#2)
violet dye##2##2##(2008-10#2)
violet method##2##2##(2008-10#1)(2008-9#1)
violet modified carbon paste electrode##2##5##(2008-10#2)
violet##51##1##(1994-5#1)(1996-12#1)(2008-10#44)(2008-11#2)(2008-5#1)(2008-9#2)
violinists##5##1##(2013-8#5)
viologen##5##1##(1991-5#1)(1995-8#1)(2008-10#3)
virVf##2##1##(2008-10#2)
viraemia##4##1##(1994-5#1)(2009-12#2)(2013-1#1)
viral DNA replication##3##3##(1995-6#1)(1997-3#2)
viral DNA##13##2##(1993-8#1)(1995-6#1)(1997-3#3)(2008-10#6)(2008-12#1)(2011-2#1)
viral DNA)##2##2##(2008-10#2)
viral G protein##4##3##(1993-6#4)
viral LTR##2##2##(1992-6#1)(1994-11#1)
viral RNA is##3##3##(2008-10#1)(2008-9#2)
viral RNA was##4##3##(1995-2#1)(1997-3#1)(2008-10#2)
viral RNA##24##2##(1995-2#1)(1997-3#2)(2008-10#13)(2008-8#1)(2008-9#7)
viral RNAs from plant protoplasts##2##5##(2008-9#2)
viral RNAs##10##2##(1997-3#1)(2008-10#5)(2008-9#4)
viral S##3##2##(2008-10#3)
viral accumulation##2##2##(1997-3#1)(2008-10#1)
viral and cellular##3##3##(2008-10#1)(2008-9#2)
viral and viral-like agents##2##4##(2008-11#2)
viral and##9##2##(2008-10#1)(2008-11#4)(2008-9#2)(2011-3#2)
viral assembly##2##2##(2011-3#2)
viral capsid protein##3##3##(2008-10#2)(2009-8#1)
viral capsid##5##2##(1995-2#2)(2008-10#2)(2009-8#1)
viral coat protein (CP)##2##4##(2008-10#2)
viral coat protein##5##3##(2008-10#4)(2008-8#1)
viral complementary##4##2##(2008-10#4)
viral contamination##3##2##(1990-2#1)(2008-11#2)
viral contaminations as##2##3##(2008-11#2)
viral contaminations in##3##3##(2008-11#3)
viral contaminations##6##2##(2008-11#6)
viral disease of##3##3##(2008-10#3)
viral disease##9##2##(2008-10#6)(2008-11#1)(2011-2#1)(2013-1#1)
viral diseases##5##2##(1992-2#1)(2007-12#1)(2008-10#1)(2011-2#1)(2011-3#1)
viral early##2##2##(1995-2#2)
viral factors##3##2##(2008-11#3)
viral gene expression and##2##4##(2008-10#1)(2013-1#1)
viral gene expression##4##3##(2008-10#1)(2008-8#2)(2013-1#1)
viral gene products##2##3##(1995-2#1)(2012-2#1)
viral gene##7##2##(1995-2#1)(2008-10#2)(2008-8#2)(2012-2#1)(2013-1#1)
viral genetic##2##2##(2011-2#1)(2013-1#1)
viral genome##9##2##(1994-11#2)(1997-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2013-8#1)
viral genome-associated protein##2##3##(2008-10#2)
viral genomes##6##2##(1994-11#3)(1995-2#1)(1996-2#1)(2008-11#1)
viral genomic##3##2##(2008-10#1)(2008-11#2)
viral hepatitis and##2##3##(2008-6#1)(2011-2#1)
viral hepatitis##3##2##(2007-12#1)(2008-6#1)(2011-2#1)
viral inactivation##3##2##(2011-3#3)
viral infection and##4##3##(1997-1#1)(2008-11#1)(2008-9#2)
viral infection##15##2##(1996-11#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-7#2)(2008-9#2)(2009-8#3)(2011-2#1)
viral infections##11##2##(1997-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
viral isolates##3##2##(2008-10#1)(2013-8#2)
viral isolation##3##2##(2011-2#1)(2013-8#2)
viral load and##2##3##(2010-12#1)(2013-8#1)
viral load##5##2##(2010-11#1)(2010-12#1)(2013-1#2)(2013-8#1)
viral miRNAs##5##2##(2013-1#5)
viral movement##2##2##(2008-10#2)
viral myocarditis##2##2##(2010-7#2)
viral nucleic acid##2##3##(2008-10#1)(2011-2#1)
viral oncogene##2##2##(1992-9#1)(1995-2#1)
viral or##3##2##(2008-10#1)(2008-4#1)(2010-11#1)
viral particles##2##2##(2011-3#2)
viral pathogen##2##2##(1995-5#1)(2007-12#1)
viral pathogens##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
viral population##2##2##(2008-10#2)
viral populations##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
viral processes##2##2##(2008-11#1)(2013-1#1)
viral production##4##2##(2008-11#3)(2011-3#1)
viral promoters##2##2##(1997-8#2)
viral protein and##2##3##(2008-11#1)(2011-2#1)
viral protein##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2011-3#1)
viral proteins##6##2##(1994-11#1)(1995-2#1)(2008-10#2)(2008-11#1)(2009-8#1)
viral quasispecies##5##2##(2013-8#5)
viral replicase##2##2##(2008-10#2)
viral replication in##2##3##(1995-5#1)(1997-3#1)
viral replication##15##2##(1990-5#1)(1995-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2011-3#1)(2013-1#2)(2013-8#1)
viral shedding##4##2##(1994-6#1)(2009-6#2)(2013-8#1)
viral species##3##2##(2008-10#3)
viral strand##2##2##(2008-10#2)
viral titers##2##2##(2008-11#2)
viral transcripts##2##2##(2008-9#1)(2011-3#1)
viral transmission##2##2##(2008-10#1)(2013-8#1)
viral vaccine##2##2##(2008-11#2)
viral vaccines##5##2##(1995-5#1)(2008-11#3)(2011-2#1)
viral vector containing##2##3##(2008-8#1)(2008-9#1)
viral vector##10##2##(1995-2#2)(2008-8#2)(2008-9#2)(2010-5#2)(2011-2#2)
viral vectors##5##2##(2008-11#3)(2008-8#1)(2008-9#1)
viral##409##1##(1990-12#1)(1990-2#1)(1990-5#3)(1991-2#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-6#4)(1993-8#2)(1994-1#3)(1994-11#9)(1994-12#1)(1994-6#1)(1995-2#19)(1995-5#5)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#9)(1997-4#1)(1997-5#2)(1997-8#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#116)(2008-11#51)(2008-12#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#12)(2008-9#28)(2009-10#1)(2009-6#3)(2009-8#6)(2010-1#3)(2010-11#3)(2010-12#2)(2010-5#3)(2010-7#2)(2011-2#17)(2011-3#15)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#26)(2013-8#16)
viral-cellular##2##1##(2008-9#2)
virally transformed##2##2##(1994-3#1)(2008-4#1)
virally##4##1##(1991-9#1)(1994-3#1)(2008-4#2)
virens##10##1##(2008-10#10)
virga##4##1##(2008-6#4)
virgal##2##1##(2008-6#2)
virgin females##2##2##(2008-8#1)(2013-8#1)
virgin##9##1##(1993-8#1)(2008-10#1)(2008-5#2)(2008-8#2)(2009-3#1)(2013-1#1)(2013-8#1)
virginica##3##1##(2008-7#3)
virgo##3##1##(2008-10#2)(2008-8#1)
viridans##2##1##(1997-8#1)(2008-10#1)
viride S17A##5##2##(2008-10#5)
viride##8##1##(2008-10#8)
viridis##8##1##(1993-8#3)(2008-12#4)(2013-1#1)
virion RNA##3##2##(1997-3#3)
virion preparations##3##2##(2008-10#3)
virion structural protein##2##3##(1993-12#2)
virion##21##1##(1991-5#1)(1993-12#4)(1995-5#1)(1997-3#6)(2008-10#6)(2008-9#3)
virions and##2##2##(1995-2#1)(2008-10#1)
virions of##2##2##(2008-10#2)
virions were observed##2##3##(2008-10#2)
virions were##5##2##(1995-2#1)(2008-10#3)(2008-11#1)
virions##25##1##(1990-5#1)(1993-12#2)(1993-2#2)(1995-2#2)(1997-3#1)(2008-10#15)(2008-11#1)(2008-8#1)
viroid combinations##2##2##(2008-10#2)
viroid mixtures##2##2##(2008-10#2)
viroid##21##1##(2008-10#21)
viroids in##2##2##(2008-10#2)
viroids were##2##2##(2008-10#2)
viroids##14##1##(2008-10#14)
virologic response##2##2##(2013-1#2)
virologic##5##1##(1994-6#1)(2008-4#1)(2009-8#1)(2013-1#2)
virological breakthrough##2##2##(2013-1#2)
virological response##2##2##(2009-8#2)
virological##6##1##(2009-8#2)(2012-3#2)(2013-1#2)
virosomes##3##1##(1990-2#3)
virotherapy##2##1##(2013-1#1)(2013-8#1)
virtual and##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
virtual lesion extension##2##3##(2008-10#2)
virtual lesion##4##2##(2008-10#4)
virtual reality package##2##3##(2008-11#2)
virtual reality##10##2##(2008-11#3)(2009-11#2)(2010-1#1)(2011-7#2)(2012-12#1)(2013-1#1)
virtual##39##1##(1996-2#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-3#1)(2008-6#4)(2008-9#1)(2009-11#2)(2009-3#1)(2010-1#1)(2011-2#2)(2011-3#1)(2011-7#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#3)
virtually absent##3##2##(1990-2#1)(2008-10#1)(2008-8#1)
virtually all##12##2##(1992-1#1)(1992-3#1)(1994-9#1)(1996-12#2)(1997-2#2)(2008-10#2)(2008-3#1)(2012-2#2)
virtually any##2##2##(1994-3#1)(2011-2#1)
virtually eliminated##2##2##(1994-9#1)(2011-2#1)
virtually every##3##2##(1996-12#1)(2008-10#2)
virtually identical##2##2##(2008-10#2)
virtually no##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
virtually specific##2##2##(2008-10#2)
virtually unchanged##2##2##(2008-10#1)(2009-12#1)
virtually##53##1##(1990-2#1)(1990-5#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-12#3)(1997-2#2)(2007-12#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#2)(2009-10#1)(2009-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
virtue of##9##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)
virtue##10##1##(1993-2#1)(1996-2#1)(2008-10#1)(2008-12#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)
virulence and molecular##2##3##(2008-10#2)
virulence and resistance##5##3##(2008-10#2)(2011-10#1)(2012-3#1)(2013-1#1)
virulence and transmission##2##3##(2008-10#1)(2008-8#1)
virulence and##29##2##(2008-10#21)(2008-7#1)(2008-8#3)(2011-10#1)(2012-3#1)(2013-1#2)
virulence are##2##2##(2008-8#1)(2008-9#1)
virulence assays##2##2##(2008-10#2)
virulence associations##2##2##(2008-10#2)
virulence at##2##2##(2008-10#2)
virulence by##5##2##(2008-10#4)(2009-8#1)
virulence complexity was##2##3##(2008-10#2)
virulence complexity##3##2##(2008-10#3)
virulence diversity##2##2##(2008-10#2)
virulence factor of##2##3##(2008-10#2)
virulence factor##8##2##(1996-12#1)(2008-10#4)(2009-8#1)(2011-2#2)
virulence factors of##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
virulence factors##15##2##(1993-12#1)(1996-12#2)(2008-10#5)(2008-5#2)(2008-9#1)(2009-8#1)(2011-1#2)(2013-1#1)
virulence for##3##2##(2008-10#3)
virulence frequency##3##2##(2008-10#3)
virulence gene##5##2##(1995-2#1)(2008-10#3)(2009-8#1)
virulence genes##4##2##(1995-2#1)(2008-10#2)(2012-3#1)
virulence in P##2##3##(2008-10#2)
virulence in the pathogen##3##4##(2008-10#3)
virulence in the##4##3##(2008-10#4)
virulence in##15##2##(2008-10#12)(2008-8#1)(2009-8#1)(2013-1#1)
virulence is##4##2##(2008-10#3)(2008-8#1)
virulence level##2##2##(2008-10#2)
virulence of Pseudomonas syringae##2##4##(2008-10#2)
virulence of isolates##3##3##(2008-10#3)
virulence of pathogens##2##3##(2008-10#1)(2008-8#1)
virulence of the organism##2##4##(2008-7#2)
virulence of the pathogen##2##4##(2008-10#2)
virulence of the##7##3##(2008-10#5)(2008-7#2)
virulence of##34##2##(1996-12#2)(2008-10#23)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#2)(2011-2#1)(2013-1#1)
virulence on a##2##3##(2008-10#2)
virulence on barley##2##3##(2008-10#2)
virulence on the##2##3##(2008-10#2)
virulence on##23##2##(2008-10#22)(2008-9#1)
virulence or##6##2##(2008-10#5)(2011-2#1)
virulence patterns##2##2##(2008-10#2)
virulence phenotype##4##2##(2008-10#4)
virulence phenotypes and##2##3##(2008-10#2)
virulence phenotypes##9##2##(2008-10#9)
virulence polymorphism##2##2##(2008-10#2)
virulence spectrum##5##2##(2008-10#5)
virulence to##11##2##(2008-10#10)(2008-9#1)
virulence toward##2##2##(2008-10#2)
virulence were observed among##2##4##(2008-10#2)
virulence were##6##2##(2008-10#6)
virulence##304##1##(1992-12#1)(1993-12#2)(1993-3#1)(1995-2#3)(1996-12#5)(2008-10#222)(2008-11#4)(2008-5#2)(2008-7#3)(2008-8#22)(2008-9#8)(2009-6#2)(2009-8#7)(2011-1#4)(2011-10#1)(2011-2#7)(2012-3#3)(2013-1#7)
virulences were##4##2##(2008-10#4)
virulences##9##1##(2008-10#9)
virulent (causing lesions##2##3##(2008-10#2)
virulent (mean disease severity was##2##5##(2008-10#2)
virulent C##5##2##(1995-12#1)(1996-12#1)(2008-10#3)
virulent and avirulent##4##3##(2008-10#4)
virulent and##14##2##(2008-10#11)(2008-5#3)
virulent genotypes##2##2##(2008-10#2)
virulent isolate##4##2##(2008-10#4)
virulent isolates of##2##3##(2008-10#2)
virulent isolates produced##2##3##(2008-10#2)
virulent isolates##15##2##(2008-10#15)
virulent on all##2##3##(2008-10#2)
virulent on##12##2##(2008-10#12)
virulent populations of##2##3##(2008-10#2)
virulent populations##6##2##(2008-10#6)
virulent strain##2##2##(1993-12#1)(2008-8#1)
virulent strains of the##3##4##(2008-10#3)
virulent strains##5##2##(1991-3#1)(2008-10#4)
virulent than the##2##3##(2008-10#1)(2008-5#1)
virulent than##10##2##(2008-10#9)(2008-5#1)
virulent to##14##2##(2008-10#14)
virulent virus##3##2##(2008-10#3)
virulent wild-type##2##2##(2008-10#2)
virulent##147##1##(1991-3#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-12#2)(2006-6#2)(2008-10#119)(2008-4#1)(2008-5#11)(2008-8#1)(2008-9#5)(2009-6#1)(2012-2#1)
virulent/avirulent phenotypes##2##2##(2008-10#2)
viruliferous aphids##4##2##(2008-10#4)
viruliferous insects##2##2##(2008-10#2)
viruliferous mites##2##2##(2008-10#2)
viruliferous##15##1##(2008-10#15)
virus (HCV)##15##2##(2008-1#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#2)(2011-2#1)(2013-1#5)(2013-8#1)
virus (HIV) and##2##3##(2008-5#1)(2011-2#1)
virus (HIV)##25##2##(1990-6#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
virus (PHV)##4##2##(2008-10#2)(2008-5#2)
virus (RSV)##4##2##(1996-3#1)(1997-8#1)(2008-11#1)(2011-2#1)
virus (SIV)##3##2##(1992-6#1)(1997-3#1)(2011-2#1)
virus (SPMV)##2##2##(2008-10#2)
virus (WSMV)##2##2##(2008-10#2)
virus (strain)##4##2##(2008-10#4)
virus 40 T##2##3##(1995-6#2)
virus 40##7##2##(1995-2#1)(1995-6#2)(1997-7#1)(1997-8#1)(2008-11#2)
virus A##6##2##(2008-10#5)(2010-5#1)
virus D9964 strain##3##3##(2013-8#3)
virus D9964##4##2##(2013-8#4)
virus DNA polymerase##4##3##(1993-8#1)(1995-2#3)
virus DNA##7##2##(1990-8#1)(1993-8#1)(1995-2#3)(2008-10#1)(2008-11#1)
virus Infection##2##2##(2008-10#2)
virus Is##3##2##(2008-10#3)
virus Isolates##3##2##(2008-10#3)
virus RNA##5##2##(2008-10#3)(2011-2#1)(2013-8#1)
virus Resistance##3##2##(2008-10#3)
virus X (PVX)##6##3##(1997-3#1)(2008-10#5)
virus X##8##2##(1997-3#1)(2008-10#7)
virus Y (PVY)##2##3##(2008-10#2)
virus Y##9##2##(2008-10#8)(2012-3#1)
virus accumulated##2##2##(2008-10#2)
virus accumulation and##2##3##(2008-10#2)
virus accumulation in inoculated##2##4##(2008-10#2)
virus accumulation in##3##3##(2008-10#3)
virus accumulation##18##2##(2008-10#18)
virus acquisition##2##2##(2008-10#2)
virus alone##4##2##(2008-10#4)
virus also##2##2##(1993-11#1)(2008-10#1)
virus and Tomato##3##3##(2008-10#2)(2011-2#1)
virus and its##2##3##(2012-2#1)(2013-1#1)
virus and of##2##3##(2008-10#2)
virus and potato virus##2##4##(2008-10#2)
virus and the##5##3##(1990-5#1)(1994-6#1)(1996-11#1)(1997-7#1)(2008-8#1)
virus and##61##2##(1990-5#1)(1991-8#1)(1994-5#1)(1994-6#1)(1996-11#1)(1997-3#2)(1997-5#1)(1997-7#1)(2008-10#41)(2008-11#2)(2008-5#2)(2008-8#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
virus antigens##2##2##(2008-11#1)(2008-5#1)
virus are##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
virus as a##3##3##(2008-10#2)(2008-11#1)
virus as##7##2##(1990-2#1)(2008-10#3)(2008-11#2)(2008-8#1)
virus at##5##2##(2008-10#3)(2008-11#2)
virus based on##2##3##(2008-10#2)
virus binding##3##2##(2008-11#3)
virus budding##4##2##(1997-1#3)(1997-3#1)
virus by the##2##3##(2008-10#2)
virus by##10##2##(2008-10#9)(2013-8#1)
virus can##3##2##(1994-11#1)(2007-12#1)(2008-10#1)
virus capsid protein##2##3##(2008-10#1)(2009-7#1)
virus caused##2##2##(2008-10#2)
virus coat protein gene##2##4##(2008-10#2)
virus coat protein##3##3##(2008-10#2)(2011-2#1)
virus coat##4##2##(2008-10#3)(2011-2#1)
virus complex##2##2##(2008-10#2)
virus complexes##2##2##(2008-10#2)
virus concentration##2##2##(2008-10#2)
virus content##3##2##(2008-10#3)
virus could be detected##2##4##(2008-10#1)(2013-8#1)
virus could be##5##3##(2008-10#3)(2008-5#1)(2013-8#1)
virus could##7##2##(2008-10#5)(2008-5#1)(2013-8#1)
virus derived from infectious##2##4##(2008-10#2)
virus derived from##5##3##(2008-10#5)
virus detection##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
virus disease##5##2##(2008-10#5)
virus excretion##2##2##(2008-5#1)(2011-2#1)
virus exit process##3##3##(1997-1#3)
virus families have##2##3##(1997-6#1)(2013-1#1)
virus families##4##2##(1997-6#1)(2008-10#1)(2013-1#2)
virus for##4##2##(2008-10#4)
virus from the##2##3##(2008-10#2)
virus from##19##2##(1990-11#1)(1996-11#1)(2008-10#17)
virus genome##3##2##(2008-10#2)(2008-11#1)
virus genomes##2##2##(1997-3#1)(2008-9#1)
virus had##3##2##(1995-9#1)(2008-10#2)
virus has a##2##3##(2008-10#2)
virus has##4##2##(2008-10#3)(2008-9#1)
virus illness##2##2##(1993-1#1)(2009-10#1)
virus in Transgenic##2##3##(2008-10#2)
virus in a##4##3##(1995-5#1)(2008-10#2)(2008-11#1)
virus in the##3##3##(1995-5#1)(2008-10#1)(2012-3#1)
virus in##62##2##(1995-12#2)(1995-5#2)(1997-3#1)(2008-10#42)(2008-11#2)(2008-12#1)(2008-5#4)(2008-9#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
virus infection and##2##3##(2008-10#1)(2013-1#1)
virus infection in##5##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
virus infection is##2##3##(2008-11#1)(2012-3#1)
virus infection was##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
virus infection##34##2##(1991-3#1)(1991-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#3)
virus infections##6##2##(1996-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-8#1)
virus ingestion##2##2##(2008-10#2)
virus inoculum##3##2##(2008-11#3)
virus into##2##2##(1993-6#1)(2008-10#1)
virus is most##2##3##(2008-10#2)
virus is proposed##4##3##(2008-10#4)
virus is##19##2##(1993-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2011-2#2)(2011-3#1)(2013-8#1)
virus isolate from##2##3##(2008-10#1)(2008-8#1)
virus isolate##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
virus isolated from##4##3##(2008-5#2)(2008-8#1)(2008-9#1)
virus isolates##4##2##(1995-5#1)(2008-10#2)(2008-8#1)
virus may##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
virus movement##6##2##(2008-10#6)
virus of##4##2##(1995-2#1)(2008-10#2)(2008-8#1)
virus or##4##2##(1995-6#1)(1997-3#1)(2008-10#2)
virus particle##4##2##(1997-3#1)(2008-10#1)(2011-2#1)(2011-3#1)
virus particles were##5##3##(2008-10#5)
virus particles##17##2##(1990-2#1)(1990-5#1)(1997-3#2)(2008-10#13)
virus per##3##2##(2008-10#2)(2008-12#1)
virus preparations##3##2##(1997-3#1)(2008-10#2)
virus production in##2##3##(2008-11#2)
virus production##8##2##(2008-11#8)
virus recovered from##2##3##(2008-10#2)
virus related to##2##3##(1990-3#1)(2008-10#1)
virus replication and##3##3##(2008-10#2)(2008-9#1)
virus replication was##3##3##(1997-3#1)(2008-10#2)
virus replication##14##2##(1992-12#1)(1995-2#2)(1997-3#1)(2008-10#7)(2008-9#2)(2013-1#1)
virus resistance genes##3##3##(2008-10#3)
virus resistance in wheat##2##4##(2008-10#2)
virus resistance in##3##3##(2008-10#3)
virus resistance##10##2##(2008-10#10)
virus serotype##3##2##(2008-10#1)(2008-5#2)
virus shedding##2##2##(1995-5#2)
virus source##2##2##(2008-10#2)
virus species##3##2##(2008-10#3)
virus spread##6##2##(1992-9#1)(2008-10#5)
virus strain##10##2##(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
virus strains##7##2##(1993-3#1)(2008-10#5)(2013-1#1)
virus structure##3##2##(2008-10#3)
virus surface##6##2##(1994-11#2)(1997-3#1)(2008-8#3)
virus that##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
virus through##2##2##(2008-10#2)
virus titer##5##2##(2008-10#2)(2008-11#3)
virus titers by##2##3##(2008-11#2)
virus titers##5##2##(2008-11#4)(2011-2#1)
virus to##8##2##(2008-10#6)(2008-5#1)(2011-3#1)
virus transmission was##2##3##(2008-10#2)
virus transmission##12##2##(2008-10#11)(2012-2#1)
virus type 1##15##3##(1991-9#2)(1992-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-11#3)(2008-2#3)(2008-9#1)(2011-2#2)
virus type 2##2##3##(1992-6#1)(2013-1#1)
virus type##20##2##(1991-9#2)(1992-6#2)(1993-8#1)(1995-2#1)(1997-3#1)(2008-11#5)(2008-2#3)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
virus using##2##2##(2008-10#2)
virus vaccine candidate##2##3##(2008-11#2)
virus vaccine##8##2##(1992-12#1)(1995-9#2)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)
virus vaccines##5##2##(1995-5#2)(2008-11#2)(2011-2#1)
virus vector##4##2##(1992-12#1)(1996-12#1)(2008-8#1)(2008-9#1)
virus vectors##3##2##(1992-12#1)(2008-11#1)(2008-8#1)
virus viability##2##2##(1997-3#1)(2008-10#1)
virus was also##2##3##(2008-10#2)
virus was detected in##2##4##(2008-10#2)
virus was detected##3##3##(2008-10#3)
virus was identified##2##3##(2008-11#1)(2011-2#1)
virus was isolated from##4##4##(2008-10#4)
virus was isolated##5##3##(2008-10#4)(2008-5#1)
virus was readily transmitted##2##4##(2008-10#2)
virus was transmitted##5##3##(2008-10#5)
virus was used##2##3##(1997-1#1)(2008-10#1)
virus was##43##2##(1996-3#1)(1997-1#1)(2008-10#35)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-8#1)
virus were##4##2##(2008-10#1)(2008-11#1)(2011-3#1)(2013-8#1)
virus with##8##2##(2008-10#7)(2008-8#1)
virus within##2##2##(2008-5#2)
virus yields##2##2##(2008-11#2)
virus##1618##1##(1990-11#2)(1990-2#3)(1990-3#2)(1990-5#6)(1990-6#2)(1990-8#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#5)(1992-12#7)(1992-6#5)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#7)(1993-9#1)(1994-11#13)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#8)(1995-2#14)(1995-5#13)(1995-6#5)(1995-9#3)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#2)(1996-9#2)(1997-1#7)(1997-2#1)(1997-3#30)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#8)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#957)(2008-11#98)(2008-12#15)(2008-2#5)(2008-4#5)(2008-5#44)(2008-7#8)(2008-8#47)(2008-9#40)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#17)(2010-1#3)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#43)(2011-3#13)(2012-12#1)(2012-2#3)(2012-3#14)(2013-1#38)(2013-8#27)
virus)##8##1##(1992-9#1)(2008-10#4)(2008-11#1)(2010-3#1)(2011-2#1)
virus-1##11##1##(1991-9#2)(1992-12#1)(1994-11#1)(1994-5#1)(2008-10#5)(2008-11#1)
virus-2##4##1##(2008-10#4)
virus-binding##2##1##(2008-10#2)
virus-derived##2##1##(1995-2#1)(2008-10#1)
virus-encoded##2##1##(2009-7#1)(2013-1#1)
virus-free counterparts##2##2##(2008-10#2)
virus-free##11##1##(2008-10#9)(2008-11#2)
virus-infected cells##3##2##(1997-3#1)(2008-11#2)
virus-infected lettuce##2##2##(2008-10#2)
virus-infected plants##3##2##(2008-10#3)
virus-infected##13##1##(1995-2#1)(1997-3#1)(2008-10#8)(2008-11#3)
virus-like particles (VLP)##2##3##(2008-10#2)
virus-like particles##5##2##(1995-5#1)(2008-10#4)
virus-like##7##1##(1995-5#1)(2008-10#6)
virus-resistant plants##2##2##(2008-10#2)
virus-resistant##6##1##(2008-10#6)
virus-retention region of##2##3##(2008-10#2)
virus-specific##10##1##(2008-10#8)(2010-5#2)
virus-virus interactions##3##2##(1997-3#1)(2008-10#2)
virus]##3##1##(1990-3#1)(1996-6#1)(2013-8#1)
viruses and a##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
viruses and the##2##3##(2008-11#2)
viruses and viral##2##3##(1995-2#1)(2008-11#1)
viruses and##16##2##(1993-3#1)(1995-12#1)(1995-2#3)(2008-10#4)(2008-11#3)(2008-5#1)(2010-7#2)(2013-8#1)
viruses are##10##2##(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#2)(2013-1#1)(2013-8#1)
viruses as##2##2##(2008-10#1)(2008-11#1)
viruses by multiplex##2##3##(2008-10#2)
viruses by##6##2##(2008-10#5)(2013-1#1)
viruses can##2##2##(2008-10#1)(2010-1#1)
viruses causing##2##2##(2008-10#1)(2013-8#1)
viruses depend on##2##3##(2008-10#1)(2008-9#1)
viruses for the##2##3##(1995-2#1)(2013-8#1)
viruses for##4##2##(1995-2#1)(1997-1#1)(2008-10#1)(2013-8#1)
viruses from the##2##3##(2008-10#2)
viruses from##9##2##(2007-12#1)(2008-10#4)(2008-9#1)(2011-2#2)(2013-1#1)
viruses had##2##2##(2012-3#1)(2013-8#1)
viruses has been##2##3##(1994-9#1)(1997-6#1)
viruses have been##2##3##(2008-8#1)(2011-3#1)
viruses in a##2##3##(2010-7#1)(2011-2#1)
viruses in humans##3##3##(2011-2#2)(2013-1#1)
viruses in the##11##3##(2008-10#9)(2008-5#1)(2013-1#1)
viruses in vivo##2##3##(2007-11#1)(2013-1#1)
viruses in##36##2##(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#5)(2013-8#2)
viruses infect##2##2##(2008-10#2)
viruses is##6##2##(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
viruses isolated from##2##3##(2008-10#2)
viruses isolated##3##2##(1992-6#1)(2008-10#2)
viruses must##2##2##(1994-6#1)(2008-10#1)
viruses of##9##2##(1995-9#1)(2008-10#3)(2008-11#1)(2008-9#2)(2013-8#2)
viruses or virus strains##3##4##(2008-10#3)
viruses or##5##2##(1996-11#1)(2008-10#4)
viruses showed##2##2##(2008-10#2)
viruses simultaneously##2##2##(2008-10#2)
viruses such as##2##3##(2011-3#2)
viruses that cause barley yellow dwarf disease##2##7##(2008-10#2)
viruses that cause##6##3##(2008-10#5)(2013-8#1)
viruses that##8##2##(2008-10#7)(2013-8#1)
viruses to##3##2##(1995-12#1)(2008-10#1)(2012-2#1)
viruses was##9##2##(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#1)
viruses were isolated##2##3##(2013-8#2)
viruses were mechanically##2##3##(2008-10#2)
viruses were##21##2##(2008-10#13)(2008-11#3)(2011-2#1)(2013-8#4)
viruses within the##2##3##(2008-10#2)
viruses within##3##2##(2008-10#3)
viruses##333##1##(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-6#3)(1994-9#5)(1995-12#5)(1995-2#9)(1995-5#1)(1995-9#3)(1996-11#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-8#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#167)(2008-11#23)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#16)(2009-8#1)(2010-1#3)(2010-7#3)(2011-2#10)(2011-3#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#13)(2013-8#30)
viruses]##2##1##(2013-8#2)
vis-à-vis##2##1##(2008-10#1)(2012-2#1)
viscera##8##1##(1990-2#1)(1991-2#1)(1991-6#1)(1992-2#1)(1994-8#1)(2010-6#1)(2012-2#1)(2012-3#1)
visceral and##2##2##(1995-1#1)(1997-4#1)
visceral fat##4##2##(2008-11#3)(2010-6#1)
visceral involvement##2##2##(1997-8#1)(2012-2#1)
visceral leishmaniasis##4##2##(1996-12#1)(2008-12#1)(2012-2#1)(2013-1#1)
visceral obesity##2##2##(2008-10#1)(2013-1#1)
visceral organs##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
visceral##34##1##(1991-12#1)(1992-6#2)(1994-5#1)(1995-1#2)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-2#2)(2012-2#5)(2013-1#2)(2013-8#2)
viscoelastic behavior##2##2##(2009-7#2)
viscoelastic properties##2##2##(2008-9#1)(2012-2#1)
viscoelastic##10##1##(2008-5#3)(2008-9#1)(2009-12#1)(2009-7#3)(2012-2#2)
viscoelasticity##3##1##(2008-10#2)(2008-5#1)
viscosa leaves##2##2##(2008-10#2)
viscosa##6##1##(2008-10#5)(2010-2#1)
viscosities##7##1##(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)
viscosity and density of##2##4##(2008-10#2)
viscosity and density##5##3##(2008-10#5)
viscosity and physical stability##2##4##(2008-5#2)
viscosity and the##2##3##(2008-10#1)(2008-5#1)
viscosity and##17##2##(1991-1#1)(1992-12#1)(1995-3#1)(2008-10#7)(2008-5#5)(2011-2#1)(2011-3#1)
viscosity of the##8##3##(2008-10#4)(2008-3#1)(2008-5#1)(2009-7#1)(2013-1#1)
viscosity of##17##2##(1994-11#3)(2008-10#7)(2008-3#1)(2008-5#3)(2008-8#1)(2009-7#1)(2013-1#1)
viscosity on the##2##3##(2008-10#1)(2009-10#1)
viscosity##68##1##(1991-1#2)(1992-12#2)(1994-11#4)(1995-3#1)(1996-3#1)(2008-10#25)(2008-3#1)(2008-5#14)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#2)(2011-2#4)(2011-3#1)(2013-1#2)
viscous liquid##2##2##(1995-3#1)(2008-12#1)
viscous##11##1##(1995-3#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-10#5)
visibility and##4##2##(1994-2#1)(1996-12#1)(2008-11#1)(2008-3#1)
visibility of the##2##3##(1994-3#1)(2009-11#1)
visibility of##5##2##(1994-3#2)(2009-11#1)(2010-7#1)(2012-3#1)
visibility##13##1##(1994-2#1)(1994-3#3)(1996-12#1)(2008-11#1)(2008-3#3)(2009-11#1)(2010-7#1)(2012-3#2)
visible absorbance##2##2##(1995-2#1)(2008-8#1)
visible and##6##2##(2008-10#2)(2008-3#4)
visible at the##2##3##(1993-12#1)(2008-7#1)
visible at##3##2##(1993-12#1)(2008-3#1)(2008-7#1)
visible by##4##2##(2008-10#3)(2008-7#1)
visible damage##2##2##(2008-10#1)(2008-11#1)
visible in the##6##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
visible in##11##2##(1993-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
visible laser##2##2##(2008-2#1)(2008-3#1)
visible light##12##2##(1992-1#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#2)(2011-1#1)(2011-2#1)
visible necrosis##2##2##(2008-10#2)
visible nucleoli##2##2##(1993-12#2)
visible on##4##2##(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
visible quiescent infections##2##3##(2008-10#2)
visible region##9##2##(2008-10#6)(2008-2#1)(2008-3#2)
visible spectrophotometric##5##2##(2008-10#5)
visible spectrophotometry##2##2##(2008-10#2)
visible spectrum##6##2##(2008-10#3)(2008-3#3)
visible symptoms##6##2##(2008-10#5)(2009-9#1)
visible wavelengths##2##2##(2008-2#1)(2008-3#1)
visible within the##2##3##(2008-11#1)(2008-7#1)
visible##154##1##(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#1)(1993-12#5)(1994-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-1#1)(2008-10#63)(2008-11#8)(2008-2#8)(2008-3#22)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-12#2)(2009-3#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-9#1)(2013-1#1)(2013-8#1)
visibly##5##1##(2008-10#3)(2008-5#1)(2012-3#1)
vision and##9##2##(1993-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
vision as##2##2##(2008-11#1)(2008-7#1)
vision for the##3##3##(1994-3#1)(2008-6#1)(2008-7#1)
vision for##5##2##(1994-3#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
vision in one##2##3##(2008-7#1)(2013-7#1)
vision in##8##2##(1994-8#1)(2008-7#2)(2010-10#1)(2011-2#2)(2013-1#1)(2013-7#1)
vision is##2##2##(1997-8#1)(2008-12#1)
vision loss##2##2##(2008-1#1)(2011-2#1)
vision of the##3##3##(1996-3#1)(2008-11#1)(2012-3#1)
vision of##7##2##(1992-12#1)(1996-1#1)(1996-3#2)(2008-11#1)(2008-12#1)(2012-3#1)
vision that##2##2##(2008-3#1)(2013-8#1)
vision was##5##2##(2008-12#2)(2010-10#1)(2012-12#1)(2012-3#1)
vision were##2##2##(2011-2#1)(2012-3#1)
vision with##2##2##(2011-2#2)
vision##100##1##(1991-12#1)(1992-12#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-1#2)(1994-3#2)(1994-8#1)(1994-9#1)(1996-1#3)(1996-11#1)(1996-3#2)(1996-9#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-11#6)(2008-12#6)(2008-3#4)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#4)(2010-8#2)(2011-1#2)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
visions##2##1##(1995-11#1)(2009-10#1)
visit and##2##2##(1995-12#1)(1996-1#1)
visit in##2##2##(1991-3#1)(2010-8#1)
visit to##2##2##(2008-1#1)(2009-10#1)
visit was##2##2##(1995-12#1)(2012-3#1)
visit##48##1##(1990-6#2)(1991-1#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
visitation##4##1##(2008-8#4)
visited in##2##2##(1990-3#1)(1992-12#1)
visited only##2##2##(1992-12#1)(2008-8#1)
visited our##2##2##(2008-12#1)(2011-2#1)
visited the##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
visited##18##1##(1990-3#1)(1992-12#3)(1994-2#1)(1994-8#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-8#1)
visiting a##3##2##(1990-9#1)(1994-2#1)(2012-2#1)
visiting and involvement##2##3##(1990-6#2)
visiting the##2##2##(1992-12#1)(2013-1#1)
visiting##17##1##(1990-6#2)(1990-9#1)(1992-12#2)(1992-2#2)(1994-2#1)(2008-11#3)(2008-12#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
visitor##3##1##(1993-12#1)(2008-12#1)(2013-8#1)
visitors to##3##2##(1992-2#1)(1996-1#1)(2011-2#1)
visitors##14##1##(1990-12#1)(1992-2#6)(1993-12#1)(1996-1#1)(1996-12#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-2#1)
visits and##3##2##(2008-11#2)(2010-9#1)
visits for##3##2##(1996-3#1)(2009-12#1)(2011-2#1)
visits than##2##2##(1992-2#1)(1994-2#1)
visits to##6##2##(1990-9#1)(1995-12#1)(1997-2#1)(2008-7#1)(2010-8#1)(2013-1#1)
visits with##2##2##(1995-2#1)(2012-3#1)
visits##53##1##(1990-9#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-2#5)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#3)(1997-4#1)(2008-10#2)(2008-11#3)(2008-12#7)(2008-7#2)(2008-8#2)(2009-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-9#1)(2012-3#1)(2013-1#2)
vison##2##1##(2008-6#2)
visors##2##1##(2010-1#2)
vistas##2##1##(1993-2#1)(2008-2#1)
visual access to the##2##4##(2007-9#2)
visual acuities##2##2##(2011-2#1)(2013-1#1)
visual acuity (BCVA)##3##3##(2011-2#3)
visual acuity (VA)##2##3##(2011-2#1)(2013-1#1)
visual acuity and##2##3##(2008-7#1)(2013-1#1)
visual acuity improvement##2##3##(2010-9#1)(2011-2#1)
visual acuity of##4##3##(2010-10#1)(2011-2#2)(2013-7#1)
visual acuity##25##2##(2008-7#1)(2010-10#2)(2010-9#2)(2011-2#14)(2013-1#4)(2013-7#1)(2013-8#1)
visual aids##2##2##(1993-11#2)
visual analog scale##3##3##(2009-3#1)(2012-2#1)(2013-1#1)
visual analog##4##2##(2008-10#1)(2009-3#1)(2012-2#1)(2013-1#1)
visual analogue scale##4##3##(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
visual and digital assessments##2##4##(2008-10#2)
visual and quantitative analysis of different tastes##3##7##(2008-10#3)
visual and##19##2##(1990-8#1)(1991-2#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2013-1#1)(2013-8#2)
visual assessment of disease##2##4##(2008-10#2)
visual assessment of##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
visual assessment##8##2##(2008-10#6)(2008-11#1)(2008-5#1)
visual assessments of##2##3##(2008-10#1)(2008-5#1)
visual association##3##2##(1996-2#2)(2011-2#1)
visual attention##4##2##(2008-11#3)(2010-5#1)
visual autocatalytic##2##2##(2008-10#2)
visual complications##3##2##(2012-3#3)
visual confluency##3##2##(2008-11#3)
visual cortex##26##2##(1990-5#1)(1990-8#3)(1994-3#1)(1996-2#1)(1997-2#1)(2008-11#7)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2011-2#4)(2013-8#1)
visual cortical areas##2##3##(2008-8#1)(2009-10#1)
visual cortical##5##2##(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#1)
visual cue##4##2##(2008-8#3)(2010-5#1)
visual cues##5##2##(1991-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)
visual culture##2##2##(2012-2#2)
visual deprivation##3##2##(2010-9#3)
visual direction and orientation disparity##2##5##(2008-9#2)
visual discrimination and##2##3##(1993-6#1)(1996-2#1)
visual discrimination##3##2##(1991-2#1)(1993-6#1)(1996-2#1)
visual display##3##2##(2008-11#1)(2013-1#2)
visual disturbances##6##2##(2011-2#4)(2012-3#2)
visual estimation of##2##3##(2008-10#2)
visual estimation##3##2##(2008-10#3)
visual field and##4##3##(2011-2#4)
visual field damage in children##2##5##(2011-2#2)
visual field defects in##2##4##(2008-7#2)
visual field##24##2##(1996-2#5)(2008-11#1)(2008-7#3)(2008-9#1)(2011-2#13)(2012-3#1)
visual fields##2##2##(2011-2#1)(2013-1#1)
visual function##5##2##(2011-2#1)(2011-7#1)(2013-1#3)
visual hallucinations##4##2##(2011-2#3)(2013-8#1)
visual impairment in childhood##3##4##(2011-2#3)
visual impairment##7##2##(2011-2#5)(2012-3#1)(2013-8#1)
visual improvement##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
visual information processing##2##3##(1996-2#1)(2008-11#1)
visual information##6##2##(1996-2#1)(2007-9#1)(2008-11#1)(2010-5#1)(2010-9#1)(2011-1#1)
visual input##10##2##(1991-2#7)(2010-10#1)(2012-2#1)(2013-8#1)
visual inspection##4##2##(2008-10#1)(2008-9#1)(2009-8#1)(2012-2#1)
visual latencies##2##2##(1996-2#2)
visual learning##3##2##(2008-11#1)(2008-8#2)
visual loss and##2##3##(2013-7#2)
visual loss##7##2##(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
visual memory of##2##3##(2008-6#2)
visual memory##3##2##(2008-11#1)(2008-6#2)
visual motion detection##2##3##(2011-2#2)
visual motion##3##2##(2011-2#2)(2013-8#1)
visual naming activated##2##3##(1996-2#2)
visual naming##3##2##(1996-2#3)
visual obscurations and headache##2##4##(2008-7#2)
visual observation##2##2##(2008-10#1)(2008-11#1)
visual outcome##2##2##(2011-2#2)
visual pattern##2##2##(1991-2#1)(2012-2#1)
visual perception##3##2##(2008-6#1)(2008-9#1)(2009-10#1)
visual preferences##2##2##(2008-10#1)(2008-8#1)
visual processing##2##2##(1995-5#1)(2008-11#1)
visual responses of##2##3##(2008-8#2)
visual stimuli##8##2##(1993-6#5)(2008-4#1)(2008-8#2)
visual symptoms resolved##2##3##(2011-2#1)(2012-3#1)
visual symptoms##8##2##(2008-10#5)(2011-2#1)(2012-3#1)(2013-8#1)
visual system##15##2##(1995-5#7)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#2)(2011-2#1)
visual task##2##2##(2013-8#2)
visual vertical##2##2##(2013-1#2)
visual##394##1##(1990-5#1)(1990-8#6)(1991-11#1)(1991-2#16)(1991-6#1)(1992-12#2)(1993-11#2)(1993-2#1)(1993-6#6)(1994-3#2)(1995-5#8)(1995-8#1)(1996-11#1)(1996-2#22)(1997-2#1)(1997-4#1)(2007-12#2)(2007-9#3)(2008-10#54)(2008-11#31)(2008-12#1)(2008-4#1)(2008-5#9)(2008-6#7)(2008-7#12)(2008-8#23)(2008-9#13)(2009-10#8)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#3)(2010-8#2)(2010-9#6)(2011-1#2)(2011-2#62)(2011-7#2)(2012-12#1)(2012-2#11)(2012-3#12)(2013-1#17)(2013-7#5)(2013-8#19)
visual-vestibular integration##2##2##(1991-2#2)
visualisation and##2##2##(2008-10#1)(2011-3#1)
visualisation of the##2##3##(2008-10#1)(2012-2#1)
visualisation of##5##2##(2008-10#3)(2011-3#1)(2012-2#1)
visualisation##10##1##(2008-10#5)(2008-11#1)(2011-3#3)(2012-2#1)
visualise##6##1##(2007-12#1)(2008-11#1)(2008-8#1)(2012-2#3)
visualised in##2##2##(2008-11#1)(2012-2#1)
visualised##4##1##(2008-11#2)(2008-8#1)(2012-2#1)
visualization and analysis##2##3##(2008-11#1)(2008-5#1)
visualization and##6##2##(2008-11#2)(2008-5#1)(2008-6#1)(2009-10#1)(2012-12#1)
visualization of cardiac##2##3##(2010-6#1)(2010-8#1)
visualization of complex##2##3##(2011-2#1)(2011-7#1)
visualization of the data##2##4##(2008-10#1)(2008-6#1)
visualization of the##10##3##(1994-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)
visualization of##32##2##(1991-12#1)(1994-3#1)(1996-1#1)(1997-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#4)(2011-7#2)(2012-2#1)
visualization on the##2##3##(1992-12#1)(2008-6#1)
visualization techniques##2##2##(2008-6#2)
visualization##70##1##(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-3#2)(1996-1#1)(1997-8#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#10)(2008-7#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-6#6)(2010-7#1)(2010-8#2)(2011-2#6)(2011-7#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
visualizations##3##1##(2008-6#2)(2010-12#1)
visualize and quantify##2##3##(2012-2#2)
visualize and##4##2##(2008-11#1)(2008-6#1)(2012-2#2)
visualize the##4##2##(1994-5#1)(2008-11#1)(2009-7#1)(2013-8#1)
visualize##18##1##(1990-12#1)(1994-5#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-8#2)
visualized by digital infrared thermography##2##5##(2008-10#2)
visualized by silver staining##2##4##(1992-8#1)(1995-12#1)
visualized by staining##2##3##(2008-8#1)(2013-1#1)
visualized by##21##2##(1992-8#1)(1993-12#1)(1995-12#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#1)(2013-1#1)
visualized in##5##2##(1994-9#1)(1996-2#1)(2008-10#2)(2008-9#1)
visualized on the##2##3##(2008-10#1)(2008-7#1)
visualized on##4##2##(2008-10#3)(2008-7#1)
visualized using##2##2##(2008-10#1)(2008-9#1)
visualized with##2##2##(1996-12#1)(2008-10#1)
visualized within##2##2##(2007-12#1)(2008-9#1)
visualized##49##1##(1992-8#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-8#1)(2007-12#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#7)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#2)
visualizing the##3##2##(2008-10#3)
visualizing##13##1##(2008-10#3)(2008-4#2)(2008-6#2)(2008-9#1)(2009-10#1)(2009-7#1)(2012-12#1)(2012-2#2)
visually and##3##2##(2008-10#1)(2008-5#2)
visually for##2##2##(2008-10#2)
visually presented##2##2##(1990-8#1)(1995-2#1)
visually##29##1##(1990-8#1)(1993-12#1)(1993-8#1)(1995-2#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
visuals##2##1##(2009-9#1)(2013-1#1)
visuo-spatial and##2##2##(2008-7#1)(2011-1#1)
visuospatial##2##1##(2008-11#1)(2009-10#1)
vital capacity in supine##2##4##(2012-3#2)
vital capacity##11##2##(1997-3#1)(2008-1#2)(2008-7#1)(2012-2#3)(2012-3#4)
vital clinical##2##2##(1996-3#1)(2008-11#1)
vital dyes##2##2##(2008-11#1)(2008-9#1)
vital events##2##2##(1993-2#1)(2013-1#1)
vital exhaustion##3##2##(2008-11#3)
vital link##2##2##(1997-3#1)(2008-11#1)
vital records##4##2##(2012-12#4)
vital role##5##2##(1993-12#1)(2008-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
vital signs##6##2##(1995-1#1)(1996-1#1)(2007-9#1)(2008-11#2)(2008-12#1)
vital statistics##3##2##(1991-12#1)(1992-6#1)(1997-3#1)
vital status##2##2##(2008-7#1)(2012-12#1)
vital that the##2##3##(2008-11#1)(2013-1#1)
vital that##4##2##(1997-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
vital to the##6##3##(2008-10#2)(2008-8#1)(2010-10#1)(2010-4#1)(2013-8#1)
vital to##14##2##(1996-2#1)(2008-10#2)(2008-11#4)(2008-8#1)(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-8#2)
vital##114##1##(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#17)(2008-12#4)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#6)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#3)
vitality##8##1##(1990-3#1)(1990-9#1)(2008-1#1)(2008-11#2)(2011-2#3)
vitamin A acetate##7##3##(2008-11#7)
vitamin A deficiency among##2##4##(1991-8#2)
vitamin A deficiency##8##3##(1991-8#6)(1992-9#2)
vitamin A##19##2##(1991-8#6)(1992-9#3)(1993-3#1)(2008-11#7)(2009-8#1)(2011-2#1)
vitamin B(12##2##2##(2008-11#2)
vitamin B(12) deficiency##2##3##(2008-7#2)
vitamin B(12) did not promote##2##5##(2008-11#2)
vitamin B(12)##10##2##(2008-10#1)(2008-11#4)(2008-7#2)(2011-1#3)
vitamin B12 and##2##3##(1993-12#1)(2010-1#1)
vitamin B12 concentration##2##3##(1990-3#2)
vitamin B12 deficiency##5##3##(1990-3#2)(1993-12#1)(1995-11#1)(2007-9#1)
vitamin B12 levels##3##3##(1990-3#2)(1993-12#1)
vitamin B12 or B-complex##2##4##(2010-1#2)
vitamin B12 routine fortification##2##4##(2010-1#2)
vitamin B12##34##2##(1990-3#8)(1993-12#11)(1995-11#3)(2007-9#1)(2008-8#1)(2010-1#10)
vitamin B6##5##2##(1991-2#1)(1992-9#1)(2013-1#3)
vitamin C and##4##3##(1992-9#1)(2008-5#1)(2010-6#1)(2010-7#1)
vitamin C tablet##4##3##(2008-10#4)
vitamin C tablets##2##3##(2008-10#2)
vitamin C##32##2##(1992-9#5)(1997-8#1)(2008-10#15)(2008-5#3)(2009-9#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#4)
vitamin D and##4##3##(1990-11#1)(2008-10#1)(2010-10#1)(2012-3#1)
vitamin D deficiency has##2##4##(2011-2#1)(2012-2#1)
vitamin D deficiency##9##3##(2008-11#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)
vitamin D levels##2##3##(2012-3#2)
vitamin D response##2##3##(1995-8#1)(2012-12#1)
vitamin D status##2##3##(2012-2#2)
vitamin D synthesis##3##3##(2008-10#2)(2011-2#1)
vitamin D was##2##3##(1991-11#1)(2012-3#1)
vitamin D##55##2##(1990-11#1)(1991-11#2)(1991-5#1)(1992-1#5)(1993-11#2)(1994-3#4)(1995-2#3)(1995-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2009-12#1)(2010-10#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#7)(2012-3#9)(2013-1#1)
vitamin D(2) into##3##3##(2008-10#3)
vitamin D(2)##8##2##(2008-10#8)
vitamin D(3)##4##2##(2008-10#2)(2008-11#1)(2012-12#1)
vitamin D3##5##2##(1991-5#2)(1993-3#1)(1994-3#1)(1997-5#1)
vitamin E and##2##3##(1994-5#1)(2011-2#1)
vitamin E deficiency##3##3##(1994-5#3)
vitamin E deficient##3##3##(1994-5#3)
vitamin E in##5##3##(1992-9#3)(1994-5#1)(2008-10#1)
vitamin E sufficient##7##3##(1994-5#7)
vitamin E was##2##3##(1990-8#2)
vitamin E##40##2##(1990-8#3)(1991-12#3)(1992-9#7)(1993-2#1)(1994-5#15)(2008-10#3)(2008-5#2)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
vitamin K(1)##4##2##(2008-10#4)
vitamin K-dependent##2##2##(1990-5#1)(1992-9#1)
vitamin K3##2##2##(2008-10#2)
vitamin and mineral supplements##2##4##(2008-11#2)
vitamin and##6##2##(2008-10#3)(2008-11#2)(2011-2#1)
vitamin d##2##2##(2011-1#2)
vitamin deficiencies##2##2##(1997-8#1)(2010-12#1)
vitamin pills##4##2##(1996-8#1)(2008-10#3)
vitamin status##2##2##(1992-9#2)
vitamin tablets##5##2##(2008-10#5)
vitamin##275##1##(1990-11#2)(1990-3#8)(1990-5#1)(1990-8#4)(1991-11#2)(1991-12#4)(1991-2#2)(1991-5#3)(1991-8#6)(1992-1#5)(1992-9#24)(1993-11#2)(1993-12#11)(1993-2#1)(1993-3#2)(1994-3#5)(1994-5#15)(1994-6#1)(1995-11#4)(1995-2#3)(1995-8#2)(1996-6#1)(1996-8#1)(1997-5#2)(1997-8#2)(2007-9#1)(2008-1#2)(2008-10#58)(2008-11#18)(2008-5#10)(2008-7#4)(2008-8#3)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#10)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#9)(2011-2#7)(2012-12#3)(2012-2#12)(2012-3#9)(2013-1#6)
vitamins A##2##2##(2008-10#1)(2008-11#1)
vitamins and minerals##3##3##(2010-6#1)(2011-2#1)(2013-8#1)
vitamins and##7##2##(2008-11#2)(2008-5#1)(2010-6#1)(2011-2#1)(2013-8#2)
vitamins in pharmaceutical preparations##2##4##(2008-10#2)
vitamins in##5##2##(1992-9#1)(2008-10#3)(2008-5#1)
vitamins on##2##2##(1992-9#1)(2008-10#1)
vitamins was##2##2##(2008-10#2)
vitamins were##2##2##(2008-5#1)(2009-8#1)
vitamins##51##1##(1990-8#1)(1992-9#7)(1997-8#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-5#5)(2008-8#1)(2009-8#1)(2010-1#2)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
vitegnus##2##1##(2008-12#2)
vitellin cleavage products##5##3##(2007-12#5)
vitellin##8##1##(2007-12#6)(2008-6#2)
vitelline envelope and the chorion##2##5##(2008-12#2)
vitelline envelope##4##2##(1994-5#1)(2008-12#3)
vitelline##7##1##(1994-5#2)(2008-10#1)(2008-12#3)(2008-6#1)
vitellogenesis##9##1##(2007-12#2)(2008-12#1)(2008-6#2)(2008-7#2)(2008-8#2)
vitellogenic stage##2##2##(2008-6#2)
vitellogenic##4##1##(2008-6#3)(2010-5#1)
vitellogenin in##2##2##(2008-6#2)
vitellogenin mRNA levels##2##3##(2008-6#2)
vitellogenin receptor##3##2##(1995-2#3)
vitellogenin using##2##2##(2008-10#2)
vitellogenin was##2##2##(2008-6#1)(2010-4#1)
vitellogenin##19##1##(1992-6#2)(1995-2#3)(2008-10#4)(2008-6#7)(2010-4#1)(2010-5#2)
vitellogenins##3##1##(1990-2#2)(1995-2#1)
vitians strains##6##2##(2008-10#6)
vitians##11##1##(2008-10#11)
viticola and##2##2##(2008-10#2)
viticola was##2##2##(2008-10#2)
viticola##24##1##(2008-10#24)
vitiligo##11##1##(1996-1#1)(2008-8#1)(2009-1#1)(2011-2#1)(2013-1#7)
vitiligo-like depigmentation##4##2##(2010-6#4)
vitis##12##1##(2008-10#12)
vitreomacular##3##1##(2011-7#1)(2013-1#2)
vitreoretinal##2##1##(2011-2#1)(2011-7#1)
vitreous and##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
vitreous carbon (RVC)##2##3##(2008-10#2)
vitreous carbon##5##2##(2008-10#5)
vitreous##13##1##(2008-1#1)(2008-10#7)(2008-5#3)(2011-2#1)(2013-1#1)
vitrification##4##1##(2008-10#2)(2012-3#1)(2013-8#1)
vitrified wastes##2##2##(2008-10#2)
vitrified##3##1##(2008-10#3)
vitrinus##2##1##(1996-12#2)
vitro activities of##2##3##(2008-7#1)(2011-3#1)
vitro activities##3##2##(2008-7#1)(2011-3#1)(2012-2#1)
vitro activity of##2##3##(2008-11#1)(2008-7#1)
vitro activity##6##2##(1993-1#2)(1997-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
vitro analysis##3##2##(1995-2#1)(2008-1#1)(2008-10#1)
vitro and in vivo data##2##5##(2008-10#1)(2011-2#1)
vitro and in vivo determinations of sun protection factors##2##9##(2008-5#2)
vitro and in vivo determinations##3##5##(2008-5#3)
vitro and in vivo results##2##5##(1991-2#1)(2012-12#1)
vitro and in vivo##68##4##(1990-2#1)(1991-2#1)(1992-6#1)(1993-1#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-4#1)(2008-5#11)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#2)(2010-11#2)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#6)(2013-8#1)
vitro and in##84##3##(1990-2#1)(1991-2#1)(1992-6#1)(1993-1#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#7)(2008-4#1)(2008-5#12)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#3)(2010-11#3)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#6)(2013-8#1)
vitro and##127##2##(1990-2#1)(1990-5#2)(1991-2#1)(1992-6#3)(1993-1#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#4)(1996-2#1)(1996-8#1)(1997-8#1)(2006-6#3)(2008-1#1)(2008-10#28)(2008-11#13)(2008-4#2)(2008-5#15)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#3)(2009-4#2)(2010-11#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#1)
vitro andin vivo##4##3##(2008-11#2)(2008-8#2)
vitro anergized T##2##3##(2008-11#2)
vitro antagonistic activity##2##3##(2008-12#2)
vitro antifungal susceptibility of clinical isolates##2##6##(2008-5#2)
vitro antifungal susceptibility##3##3##(2008-5#3)
vitro antifungal##6##2##(2008-10#1)(2008-5#5)
vitro antimicrobial activity of##3##4##(2008-11#1)(2012-3#1)(2013-1#1)
vitro antimicrobial##4##2##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
vitro antioxidant activity and in vivo photoprotective effect of a##2##10##(2008-5#2)
vitro antioxidant activity and##3##4##(2008-10#1)(2008-5#2)
vitro as well##3##3##(1992-9#1)(2008-11#1)(2009-5#1)
vitro as##5##2##(1992-9#1)(1995-2#1)(2008-11#1)(2008-3#1)(2009-5#1)
vitro assays##13##2##(1995-2#1)(2008-10#8)(2008-4#1)(2008-9#1)(2010-4#1)(2013-1#1)
vitro assessment of##2##3##(2008-5#2)
vitro assessment##3##2##(2008-11#1)(2008-5#2)
vitro cell##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
vitro comparison of##2##3##(2008-5#1)(2011-3#1)
vitro comparison##4##2##(1991-3#1)(2008-5#1)(2009-4#1)(2011-3#1)
vitro conditions##4##2##(1993-2#1)(2008-11#2)(2008-5#1)
vitro culture of human##2##4##(2008-11#2)
vitro culture##8##2##(2006-6#1)(2008-11#4)(2008-9#1)(2009-6#1)(2013-1#1)
vitro cultured##4##2##(2008-10#1)(2008-11#2)(2008-8#1)
vitro development##6##2##(1996-2#2)(2008-11#2)(2009-12#1)(2012-3#1)
vitro differentiation##6##2##(1995-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)
vitro effect of##3##3##(1991-12#1)(1993-12#1)(1996-11#1)
vitro effects of##3##3##(1995-9#1)(1997-1#1)(2013-1#1)
vitro effects##4##2##(1995-9#1)(1997-1#1)(2008-10#1)(2013-1#1)
vitro experiments##9##2##(1993-12#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)
vitro expression##3##2##(1995-8#1)(2008-10#2)
vitro functional assays##2##3##(1993-8#1)(2008-8#1)
vitro gene##2##2##(1995-2#1)(2008-7#1)
vitro glycation##2##2##(1991-12#1)(1992-12#1)
vitro growth##5##2##(1993-8#1)(2008-10#3)(2009-8#1)
vitro immunization (IVI)##2##3##(2008-11#2)
vitro immunization##15##2##(2008-11#15)
vitro in the presence##2##4##(2008-8#1)(2012-2#1)
vitro in the##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
vitro in##18##2##(1991-2#1)(1992-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-1#1)(2012-2#2)
vitro invasion##4##2##(2008-11#2)(2008-8#1)(2008-9#1)
vitro metabolism of##3##3##(1990-6#2)(1993-11#1)
vitro metabolism##4##2##(1990-11#1)(1990-6#2)(1993-11#1)
vitro models##9##2##(1992-12#1)(2008-11#2)(2008-5#4)(2008-7#2)
vitro photodynamic##2##2##(2012-3#2)
vitro production of##4##3##(1994-8#1)(2008-10#1)(2008-11#2)
vitro protein##4##2##(1993-12#1)(1995-11#1)(1995-3#1)(2011-2#1)
vitro release##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
vitro selection of##2##3##(2008-4#1)(2010-5#1)
vitro selection using modified##2##4##(2008-4#2)
vitro selection using##3##3##(2008-4#3)
vitro selection##13##2##(1990-8#1)(1997-6#1)(2008-11#1)(2008-4#7)(2010-5#1)(2011-3#1)(2013-8#1)
vitro splicing##2##2##(1993-12#2)
vitro stimulation##3##2##(2008-5#2)(2011-2#1)
vitro studies demonstrated that##4##4##(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
vitro studies demonstrated##5##3##(1994-2#1)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
vitro studies have##4##3##(1997-1#1)(2008-5#2)(2013-1#1)
vitro studies##26##2##(1992-9#1)(1994-2#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-8#1)(2008-10#4)(2008-11#5)(2008-5#3)(2009-1#1)(2009-12#1)(2011-2#1)(2013-1#2)
vitro study##12##2##(1990-5#1)(1994-6#1)(2008-11#1)(2011-2#2)(2013-1#6)(2013-8#1)
vitro system##18##2##(1990-2#1)(1990-5#1)(1993-3#1)(1994-6#1)(1995-11#3)(1996-12#2)(2008-10#2)(2008-11#4)(2008-8#1)(2008-9#1)(2013-8#1)
vitro testing##5##2##(1994-2#1)(2008-5#2)(2008-8#1)(2009-7#1)
vitro tests##5##2##(2008-10#2)(2008-5#2)(2009-7#1)
vitro transcription##10##2##(1990-12#1)(1990-5#1)(1993-9#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
vitro translated##3##2##(1991-7#1)(1993-8#1)(1995-2#1)
vitro with##17##2##(1991-2#1)(1993-8#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2011-3#1)
vitro##1214##1##(1990-11#8)(1990-12#6)(1990-2#6)(1990-3#4)(1990-5#8)(1990-6#5)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#9)(1991-2#9)(1991-3#5)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#8)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#7)(1992-8#3)(1992-9#5)(1993-1#8)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#18)(1993-9#4)(1994-11#7)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#10)(1994-6#2)(1994-8#19)(1994-9#1)(1995-11#15)(1995-12#12)(1995-2#20)(1995-3#4)(1995-6#16)(1995-8#8)(1995-9#4)(1996-11#1)(1996-12#13)(1996-2#14)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#5)(1997-3#9)(1997-4#6)(1997-6#8)(1997-7#13)(1997-8#6)(2006-6#7)(2008-1#10)(2008-10#204)(2008-11#169)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#27)(2008-5#98)(2008-6#3)(2008-7#29)(2008-8#41)(2008-9#46)(2009-1#1)(2009-10#4)(2009-12#20)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#6)(2009-7#8)(2009-8#6)(2009-9#1)(2010-1#3)(2010-11#8)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#3)(2010-8#2)(2011-1#5)(2011-2#28)(2011-3#11)(2012-12#1)(2012-2#20)(2012-3#6)(2012-5#1)(2013-1#45)(2013-8#7)
vitro)##4##1##(2008-10#3)(2008-11#1)
vitronectin##4##1##(1995-2#1)(2008-11#3)
vitronectin-bound PAI-1 and latent PAI-1##2##5##(1995-8#2)
vivax malaria in##3##3##(2012-12#3)
vivax malaria##9##2##(2012-12#8)(2012-2#1)
vivax##12##1##(2008-4#1)(2012-12#10)(2012-2#1)
vivid##4##1##(2008-5#1)(2011-2#2)(2012-3#1)
viviparae and nymphs##2##3##(2008-9#2)
viviparous##3##1##(2007-12#2)(2008-8#1)
viviparum##3##1##(2009-5#3)
vivo activities##3##2##(1990-2#1)(1992-6#2)
vivo and in vitro studies##4##5##(1994-8#1)(1995-9#1)(2009-1#1)(2013-1#1)
vivo and in vitro##42##4##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-5#3)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#3)(2011-2#1)(2013-1#1)
vivo and in##46##3##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-5#3)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#3)(2011-2#1)(2013-1#1)
vivo and##64##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#3)(1994-8#4)(1995-11#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(2006-6#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#3)(2011-2#1)(2013-1#2)
vivo antifungal##2##2##(2008-11#2)
vivo approaches##2##2##(2008-10#1)(2008-11#1)
vivo assay##4##2##(2008-11#1)(2008-4#1)(2008-5#2)
vivo assays of##2##3##(2008-10#1)(2008-4#1)
vivo assays##8##2##(2008-10#6)(2008-4#1)(2011-2#1)
vivo by##9##2##(1994-8#1)(1995-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-12#1)(2013-1#1)
vivo characterization of##2##3##(2008-5#1)(2011-2#1)
vivo data##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
vivo effects of##4##3##(1995-12#1)(2008-10#2)(2008-11#1)
vivo experiments##5##2##(1993-8#1)(1994-5#1)(2008-5#3)
vivo for##8##2##(1991-2#1)(1993-12#1)(1995-11#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)
vivo imaging##2##2##(1994-11#1)(2010-7#1)
vivo incubation of the SC resulted in##2##7##(2008-5#2)
vivo microdialysis##5##2##(1994-8#1)(1997-2#2)(2008-10#2)
vivo model of##2##3##(1991-5#1)(2006-6#1)
vivo models##3##2##(2006-6#1)(2011-1#1)(2013-1#1)
vivo monitoring of##3##3##(2008-10#3)
vivo or in vitro##4##4##(1995-2#1)(1996-12#1)(2008-11#1)(2008-9#1)
vivo or in##5##3##(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
vivo or##6##2##(1992-11#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
vivo processing##2##2##(1997-1#2)
vivo proton magnetic resonance spectroscopy##2##5##(1991-1#1)(2008-7#1)
vivo results##3##2##(1991-2#1)(2008-11#1)(2012-12#1)
vivo studies##10##2##(1996-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2010-7#1)(2011-2#1)
vivo study of##2##3##(1993-1#1)(2008-5#1)
vivo study##10##2##(1990-5#1)(1993-1#2)(2008-5#3)(2010-5#1)(2013-1#3)
vivo transfer##2##2##(2008-4#1)(2008-5#1)
vivo tritium contamination##2##3##(1991-5#2)
vivo under##2##2##(2008-5#1)(2008-7#1)
vivo##668##1##(1990-11#6)(1990-2#3)(1990-5#6)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-5#6)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#3)(1992-12#6)(1992-6#8)(1992-8#1)(1992-9#2)(1993-1#5)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#10)(1993-9#4)(1994-11#9)(1994-2#3)(1994-3#3)(1994-5#10)(1994-6#2)(1994-8#9)(1995-10#1)(1995-11#15)(1995-12#7)(1995-2#19)(1995-3#1)(1995-6#9)(1995-9#3)(1996-12#10)(1996-2#9)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-7#8)(1997-8#5)(2006-6#11)(2007-11#1)(2008-1#3)(2008-10#64)(2008-11#74)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#20)(2008-5#69)(2008-6#1)(2008-7#26)(2008-8#14)(2008-9#24)(2009-1#1)(2009-10#2)(2009-12#13)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#3)(2010-1#5)(2010-11#7)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#18)(2011-3#5)(2011-7#2)(2012-12#4)(2012-2#10)(2012-3#2)(2013-1#27)(2013-8#3)
viz##37##1##(1990-12#1)(1991-5#1)(1993-8#1)(2008-10#20)(2008-11#4)(2008-12#2)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#5)
vocabularies##4##1##(2008-9#4)
vocabulary and##6##2##(2008-12#2)(2008-9#2)(2011-2#2)
vocabulary intervention##4##2##(2011-2#4)
vocabulary words##3##2##(2011-2#3)
vocabulary##17##1##(2008-12#5)(2008-9#2)(2011-2#10)
vocal cues##2##2##(2009-10#1)(2013-8#1)
vocal##13##1##(1991-12#1)(2008-11#1)(2008-8#2)(2008-9#4)(2009-10#2)(2010-7#1)(2010-8#1)(2013-8#1)
vocalization##7##1##(1994-8#5)(2008-4#1)(2008-9#1)
vocalizations and##2##2##(2008-9#2)
vocalizations##4##1##(2008-4#1)(2008-9#3)
vocally and morphologically##2##3##(2008-8#2)
vocational and##2##2##(2008-12#1)(2010-1#1)
vocational education##2##2##(1992-2#1)(2008-11#1)
vocational rehabilitation##4##2##(1992-3#2)(1993-3#2)
vocational training schemes##3##3##(1990-3#1)(1996-8#2)
vocational training##4##2##(1990-3#1)(1996-8#2)(2009-7#1)
vocational##16##1##(1990-3#1)(1992-2#1)(1992-3#2)(1993-3#2)(1994-12#1)(1996-8#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-1#2)(2010-9#1)
voice and speech##3##3##(2011-1#3)
voice and##5##2##(1995-2#1)(2009-10#1)(2011-1#3)
voice disorders##2##2##(2013-8#2)
voice in health professional education?##2##5##(2008-12#2)
voice in##3##2##(2008-12#2)(2008-5#1)
voice##29##1##(1993-1#1)(1995-2#1)(1996-5#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#3)(2008-5#1)(2008-9#3)(2009-10#2)(2010-12#1)(2010-8#1)(2011-1#5)(2013-8#3)
voicing##2##1##(2008-12#1)(2008-9#1)
void volume##2##2##(1993-6#1)(2008-10#1)
void##5##1##(1993-1#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
voiding cystourethrogram##3##2##(2008-10#3)
voiding##8##1##(1994-3#1)(2008-10#6)(2012-3#1)
voids in##2##2##(2012-2#1)(2013-1#1)
voids##4##1##(1995-6#1)(2008-10#1)(2012-2#1)(2013-1#1)
voie##3##1##(2008-11#1)(2013-1#2)
vol##14##1##(1990-11#1)(2008-11#3)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
vol/vol)##3##1##(2008-10#3)
volar forearm##2##2##(2008-5#2)
volar locking##2##2##(2008-9#2)
volar##11##1##(2008-10#1)(2008-5#2)(2008-9#8)
volatile and##7##2##(2008-10#5)(2008-11#1)(2009-8#1)
volatile chlorination by-products##3##3##(2008-10#3)
volatile compounds and##2##3##(2008-10#2)
volatile compounds emitted by##2##4##(2009-8#1)(2011-10#1)
volatile compounds from wine##2##4##(2008-10#2)
volatile compounds from##3##3##(2008-10#2)(2009-8#1)
volatile compounds were isolated##3##4##(2008-10#3)
volatile compounds were##4##3##(2008-10#4)
volatile compounds##27##2##(2008-10#23)(2009-8#3)(2011-10#1)
volatile element##2##2##(2008-10#2)
volatile elements##3##2##(2008-10#3)
volatile emissions##3##2##(2009-8#2)(2011-10#1)
volatile flavour compounds were##2##4##(2008-10#2)
volatile flavour compounds##3##3##(2008-10#3)
volatile halogenated organic compounds##2##4##(2008-10#2)
volatile halogenated##3##2##(2008-10#2)(2009-8#1)
volatile hydrocarbons##2##2##(2008-10#2)
volatile odor##4##2##(2008-10#2)(2008-5#2)
volatile oil##2##2##(2008-11#1)(2013-8#1)
volatile oils##5##2##(2008-11#4)(2013-1#1)
volatile organic compounds (VOCs)##4##4##(2008-10#4)
volatile organic compounds in air##2##5##(2008-10#1)(2013-1#1)
volatile organic compounds in##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
volatile organic compounds##20##3##(2008-10#17)(2008-11#1)(2008-3#1)(2013-1#1)
volatile organic##24##2##(2008-10#20)(2008-11#1)(2008-3#2)(2013-1#1)
volatile organochlorine compounds##2##3##(2008-10#2)
volatile sesquiterpene##2##2##(2008-11#2)
volatile signals##2##2##(2009-8#2)
volatile sulfide##4##2##(2008-10#4)
volatile sulfides##2##2##(2008-10#2)
volatile sulfur##2##2##(2008-10#2)
volatile sulphur-containing compounds##2##3##(1997-4#2)
volatile##155##1##(1992-3#1)(1994-3#1)(1997-1#1)(1997-4#2)(2008-10#107)(2008-11#11)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#2)(2009-8#11)(2011-1#1)(2011-10#6)(2012-3#1)(2013-1#2)(2013-8#1)
volatiles and semivolatiles in##2##4##(2008-10#2)
volatiles and##3##2##(2008-10#3)
volatiles are##2##2##(2008-10#1)(2009-8#1)
volatiles emitted by##2##3##(2008-10#2)
volatiles in##4##2##(1990-11#2)(2007-12#1)(2008-10#1)
volatiles on the sporulation##2##4##(2008-10#2)
volatiles on the##3##3##(2008-10#2)(2009-8#1)
volatiles on##4##2##(2008-10#3)(2009-8#1)
volatiles or##2##2##(2009-8#2)
volatiles to##2##2##(1990-11#1)(2009-8#1)
volatiles were##2##2##(2007-12#1)(2009-6#1)
volatiles##34##1##(1990-11#4)(2007-12#2)(2008-10#16)(2009-6#1)(2009-8#9)(2011-10#1)(2013-8#1)
volatility of##3##2##(1991-12#1)(2008-10#2)
volatility##7##1##(1991-12#1)(2008-10#6)
volatilization from##2##2##(2008-10#2)
volatilization##10##1##(2008-10#10)
volcanic##3##1##(1990-6#1)(2008-10#1)(2008-9#1)
vole##5##1##(1994-3#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)
voles (Microtus##2##2##(2008-9#2)
voles born into a##2##4##(1994-8#2)
voles mounted##3##2##(2008-9#3)
voles##22##1##(1994-3#3)(1994-8#6)(2008-9#9)(2012-3#2)(2013-1#2)
volitional##2##1##(2010-9#1)(2013-1#1)
voltage V(c)##2##2##(2008-10#2)
voltage and phase compensation##4##4##(2013-8#4)
voltage and##14##2##(1991-5#1)(2008-10#9)(2013-8#4)
voltage clamp##3##2##(1990-7#1)(1991-5#1)(2008-8#1)
voltage is##3##2##(2008-10#2)(2013-8#1)
voltage of 1##2##3##(2007-11#1)(2010-12#1)
voltage of##16##2##(2007-11#1)(2008-10#13)(2008-3#1)(2010-12#1)
voltage on the##2##3##(2008-10#1)(2008-3#1)
voltage on##3##2##(2008-10#2)(2008-3#1)
voltage was##2##2##(2008-10#2)
voltage were##2##2##(2008-10#1)(2008-3#1)
voltage##100##1##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#3)(1991-9#1)(1992-12#1)(1995-3#1)(1997-2#1)(1997-8#2)(2007-11#2)(2008-10#59)(2008-11#5)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2009-5#2)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#6)
voltage-dependent##12##1##(1993-3#3)(1994-11#1)(1995-11#1)(1996-2#1)(1997-2#3)(2008-8#1)(2009-8#1)(2012-2#1)
voltage-gated Ca2+ channels##3##3##(1994-5#1)(1996-2#1)(2009-7#1)
voltage-gated calcium channels##3##3##(2008-12#1)(2008-9#1)(2012-3#1)
voltage-gated##8##1##(1994-5#1)(1996-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-3#1)
voltage-sensitive dye##2##2##(2008-4#2)
voltage-sensitive##3##1##(2008-4#3)
voltages##3##1##(1997-2#1)(2008-10#1)(2010-8#1)
voltametric##2##1##(2008-10#2)
voltametry##2##1##(2008-10#2)
voltammetric (SWV)##3##2##(2008-10#3)
voltammetric analysis of##5##3##(2008-10#5)
voltammetric analysis##7##2##(2008-10#7)
voltammetric analyzer##2##2##(2008-10#2)
voltammetric approach##2##2##(2008-10#2)
voltammetric behavior of the##2##4##(2008-10#2)
voltammetric behavior of##7##3##(2008-10#7)
voltammetric behavior##9##2##(2008-10#9)
voltammetric behaviour of##6##3##(2008-10#6)
voltammetric behaviour##8##2##(2008-10#8)
voltammetric biosensor##2##2##(2008-10#2)
voltammetric conditions##2##2##(2008-10#2)
voltammetric curves##2##2##(2008-10#2)
voltammetric data##3##2##(2008-10#3)
voltammetric detection of##4##3##(2008-10#4)
voltammetric detection##9##2##(2008-10#9)
voltammetric determination in##2##3##(2008-10#2)
voltammetric determination of copper##2##4##(2008-10#2)
voltammetric determination of the##3##4##(2008-10#3)
voltammetric determination of trace amount##3##5##(2008-10#3)
voltammetric determination of trace##4##4##(2008-10#4)
voltammetric determination of traces of nickel(II)##2##6##(2008-10#2)
voltammetric determination of##32##3##(2008-10#32)
voltammetric determination##35##2##(2008-10#35)
voltammetric enzyme-linked immunoassay system##3##4##(2008-10#3)
voltammetric enzyme-linked immunoassay##4##3##(2008-10#4)
voltammetric experiments##5##2##(2008-10#5)
voltammetric measurement##3##2##(2008-10#3)
voltammetric measurements##7##2##(2008-10#7)
voltammetric method for the determination of##2##6##(2008-10#2)
voltammetric method for the##3##4##(2008-10#3)
voltammetric method for##6##3##(2008-10#6)
voltammetric method is##4##3##(2008-10#4)
voltammetric method was##2##3##(2008-10#2)
voltammetric method##21##2##(2008-10#21)
voltammetric methods##3##2##(2008-10#3)
voltammetric oxidation##2##2##(2008-10#2)
voltammetric peak and##2##3##(2008-10#2)
voltammetric peak at potential of -0##2##6##(2008-10#2)
voltammetric peak at##3##3##(2008-10#3)
voltammetric peak current##2##3##(2008-10#2)
voltammetric peak##11##2##(2008-10#11)
voltammetric peaks##3##2##(2008-10#3)
voltammetric procedure for##3##3##(2008-10#3)
voltammetric procedure##8##2##(2008-10#8)
voltammetric reduction##2##2##(2008-10#2)
voltammetric response in##2##3##(2008-10#2)
voltammetric response of##3##3##(2008-10#3)
voltammetric response was##2##3##(2008-10#2)
voltammetric response##11##2##(2008-10#11)
voltammetric responses of##2##3##(2008-10#2)
voltammetric responses##3##2##(2008-10#3)
voltammetric results##2##2##(2008-10#2)
voltammetric scan##5##2##(2008-10#5)
voltammetric sensor for##2##3##(2008-10#2)
voltammetric sensor##4##2##(2008-10#4)
voltammetric signals##5##2##(2008-10#5)
voltammetric stripping##2##2##(2008-10#2)
voltammetric studies##3##2##(2008-10#1)(2009-9#2)
voltammetric system##2##2##(2008-10#2)
voltammetric systems##2##2##(2008-10#2)
voltammetric technique for the##2##4##(2008-10#2)
voltammetric technique for##4##3##(2008-10#4)
voltammetric technique##5##2##(2008-10#5)
voltammetric techniques##7##2##(2008-10#7)
voltammetric##242##1##(2008-10#239)(2009-9#2)(2010-6#1)
voltammetrically##3##1##(2008-10#3)
voltammetry (CV) and##9##3##(2008-10#9)
voltammetry (CV)##20##2##(2008-10#20)
voltammetry (LSV)##2##2##(2008-10#2)
voltammetry and chronoamperometry##2##3##(2008-10#2)
voltammetry and chronocoulometry##2##3##(2008-10#2)
voltammetry and##24##2##(2008-10#23)(2013-1#1)
voltammetry at a##9##3##(2008-10#9)
voltammetry at the##2##3##(2008-10#2)
voltammetry at##17##2##(2008-10#17)
voltammetry based on the adsorption collection##2##6##(2008-10#2)
voltammetry determination of##2##3##(2008-10#2)
voltammetry experiments##3##2##(2008-10#3)
voltammetry for##2##2##(2008-10#2)
voltammetry has been##2##3##(2008-10#2)
voltammetry have been##2##3##(2008-10#2)
voltammetry in a flow injection system##2##6##(2008-10#2)
voltammetry in##5##2##(2008-10#5)
voltammetry is##3##2##(2008-10#3)
voltammetry methods##2##2##(2008-10#2)
voltammetry of the##5##3##(2008-10#5)
voltammetry of##17##2##(2008-10#16)(2008-12#1)
voltammetry on a##6##3##(2008-10#6)
voltammetry on##8##2##(2008-10#8)
voltammetry to the##2##3##(2008-10#2)
voltammetry using a##2##3##(2008-10#2)
voltammetry using##12##2##(2008-10#12)
voltammetry was used to study the##2##6##(2008-10#1)(2008-8#1)
voltammetry was used to##5##4##(2008-10#4)(2008-8#1)
voltammetry was used##6##3##(2008-10#5)(2008-8#1)
voltammetry was##11##2##(2008-10#10)(2008-8#1)
voltammetry were##4##2##(2008-10#4)
voltammetry with a##6##3##(2008-10#6)
voltammetry with the##2##3##(2008-10#2)
voltammetry with##16##2##(2008-10#14)(2008-4#1)(2009-9#1)
voltammetry##347##1##(2008-10#340)(2008-12#1)(2008-4#2)(2008-8#2)(2009-9#1)(2013-1#1)
voltammetry)##4##1##(2008-10#4)
voltammogram of##3##2##(2008-10#2)(2009-9#1)
voltammogram was##2##2##(2008-10#2)
voltammogram##10##1##(2008-10#9)(2009-9#1)
voltammograms in##2##2##(2008-10#1)(2010-6#1)
voltammograms of the##2##3##(2008-10#2)
voltammograms of##7##2##(1996-5#1)(2008-10#6)
voltammograms recorded##3##2##(2008-10#3)
voltammograms##27##1##(1996-5#1)(2008-10#25)(2010-6#1)
volts)##2##1##(1990-11#1)(1995-3#1)
volume (1##2##2##(2008-10#1)(2013-1#1)
volume (100##2##2##(2008-10#2)
volume analysis##2##2##(1994-12#1)(2010-11#1)
volume and in##2##3##(2008-10#2)
volume and intensity of##2##4##(1991-2#2)
volume and intensity##3##3##(1991-2#3)
volume and is##3##3##(2008-10#1)(2011-2#2)
volume and limit of detection##4##5##(2008-10#4)
volume and##46##2##(1991-2#3)(1992-12#2)(1993-2#1)(1993-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-10#18)(2008-5#2)(2008-7#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#7)(2012-2#1)(2013-1#2)(2013-8#2)
volume are##4##2##(2008-10#2)(2008-5#1)(2008-6#1)
volume as##4##2##(1992-8#1)(1995-2#1)(2008-10#1)(2008-12#1)
volume at##3##2##(2008-10#1)(2008-7#1)(2012-4#1)
volume but##2##2##(2008-10#1)(2008-3#1)
volume changes##4##2##(1990-8#2)(1996-12#1)(2009-1#1)
volume column system was##2##4##(2008-10#2)
volume column system##3##3##(2008-10#3)
volume compressibility##2##2##(1991-5#1)(2008-10#1)
volume decrease##3##2##(1990-2#2)(2013-8#1)
volume density of##2##3##(2008-3#1)(2009-11#1)
volume density##5##2##(1995-8#1)(2008-3#2)(2009-11#2)
volume determination##2##2##(2008-10#2)
volume during##6##2##(2011-2#6)
volume flow##3##2##(2008-11#3)
volume for the##2##3##(2008-10#1)(2012-12#1)
volume for##4##2##(1993-9#2)(2008-10#1)(2012-12#1)
volume fraction of##2##3##(2008-10#1)(2008-11#1)
volume fraction##5##2##(2008-10#1)(2008-11#2)(2008-3#2)
volume from##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
volume group##2##2##(2009-7#2)
volume in a##2##3##(2008-10#1)(2008-3#1)
volume in the##3##3##(2008-5#1)(2008-9#1)(2011-2#1)
volume in##11##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)
volume increased##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
volume injected##3##2##(2008-10#3)
volume is##6##2##(1992-12#1)(2008-10#3)(2008-11#1)(2008-2#1)
volume measurements##4##2##(2008-10#1)(2008-3#1)(2009-3#1)(2010-8#1)
volume mixing ratio##2##3##(2008-3#2)
volume of 0##2##3##(2008-10#2)
volume of 1##2##3##(2008-10#2)
volume of 100 mul##4##4##(2008-10#4)
volume of 100##8##3##(2008-10#8)
volume of 10ml##2##3##(2008-10#2)
volume of 20 mul##2##4##(2008-10#2)
volume of 50 ml##2##4##(2008-10#2)
volume of 50##3##3##(2008-10#3)
volume of CO(2)##2##3##(2008-10#2)
volume of a##3##3##(1996-2#1)(2008-10#2)
volume of an##3##3##(2008-10#3)
volume of aqueous phase and interference of a number of metal ions on the determination of##3##16##(2008-10#3)
volume of aqueous phase and##4##5##(2008-10#4)
volume of aqueous phase##5##4##(2008-10#5)
volume of aqueous##7##3##(2008-10#7)
volume of each##2##3##(2008-10#2)
volume of eluent##3##3##(2008-10#3)
volume of fresh##2##3##(1995-2#1)(2008-11#1)
volume of gas##2##3##(1995-3#2)
volume of organic solvent and##3##5##(2008-10#3)
volume of sample and##2##4##(2008-10#2)
volume of sample##6##3##(2008-10#6)
volume of samples and##2##4##(2008-10#2)
volume of samples##3##3##(2008-10#3)
volume of services##3##3##(1992-2#3)
volume of the sample##3##4##(1990-12#1)(2008-10#2)
volume of the water##2##4##(2008-10#2)
volume of the##28##3##(1990-11#2)(1990-12#1)(1990-5#1)(1995-12#1)(1997-8#1)(2008-10#19)(2008-11#1)(2008-9#1)(2009-11#1)
volume of tissue##2##3##(1991-2#2)
volume of##200##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-2#3)(1992-12#2)(1992-2#3)(1992-6#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#5)(1996-2#3)(1997-2#2)(1997-8#3)(2007-12#1)(2008-10#127)(2008-11#10)(2008-12#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2010-8#3)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
volume on the##2##3##(2008-10#2)
volume on##5##2##(2008-10#4)(2009-7#1)
volume or##2##2##(2008-11#1)(2008-9#1)
volume per testis##2##3##(1992-12#2)
volume per##3##2##(1992-12#2)(2008-11#1)
volume performance##2##2##(1992-2#1)(1993-12#1)
volume ratio of the##2##4##(2008-10#1)(2009-5#1)
volume ratio of##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
volume ratio##10##2##(2008-10#6)(2008-11#1)(2009-5#3)
volume ratios##2##2##(2008-10#1)(2008-4#1)
volume regulation of##3##3##(1990-2#2)(2013-8#1)
volume regulation##4##2##(1990-2#3)(2013-8#1)
volume rendering##2##2##(2008-6#2)
volume samples##2##2##(2008-10#1)(2008-6#1)
volume scattering function##2##3##(2008-3#2)
volume substitution##2##2##(2008-7#2)
volume that##2##2##(2010-4#1)(2012-3#1)
volume to##6##2##(1992-12#1)(1992-3#1)(1996-2#1)(2008-10#2)(2008-7#1)
volume up to##3##3##(2008-10#2)(2008-7#1)
volume was significantly##2##3##(2008-7#1)(2012-3#1)
volume was##19##2##(1991-12#1)(1992-12#1)(1993-2#1)(1994-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-7#4)(2009-7#1)(2011-2#1)(2012-3#2)
volume were investigated##2##3##(2008-10#2)
volume were##8##2##(2008-10#8)
volume with##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
volume##669##1##(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#1)(1990-5#2)(1990-8#2)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#8)(1991-3#2)(1991-5#2)(1992-11#3)(1992-12#12)(1992-2#5)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-12#3)(1993-2#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-12#2)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#7)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-8#3)(2007-11#1)(2007-12#3)(2008-10#311)(2008-11#46)(2008-12#4)(2008-2#7)(2008-3#27)(2008-4#2)(2008-5#5)(2008-6#9)(2008-7#26)(2008-8#3)(2008-9#5)(2009-1#1)(2009-11#5)(2009-2#4)(2009-3#2)(2009-5#3)(2009-7#12)(2010-1#1)(2010-11#3)(2010-4#3)(2010-7#2)(2010-8#5)(2011-2#31)(2011-3#2)(2011-4#1)(2012-12#1)(2012-2#6)(2012-3#9)(2012-4#1)(2013-1#10)(2013-8#5)
volume) were##2##2##(2008-10#1)(2013-1#1)
volume)##15##1##(1991-12#1)(1993-6#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-9#1)(2013-1#1)
volume-mixing ratio for a 1-m path##2##6##(2008-3#2)
volume-mixing##3##1##(2008-3#3)
volumes and solubility parameters of##3##5##(2008-10#3)
volumes and##9##2##(2008-10#6)(2008-7#1)(2009-7#1)(2011-2#1)
volumes are##7##2##(1993-3#1)(2008-10#4)(2008-11#1)(2008-7#1)
volumes for##2##2##(2008-3#1)(2011-2#1)
volumes have##2##2##(2008-10#1)(2009-7#1)
volumes in##3##2##(1992-6#1)(1997-6#1)(2008-10#1)
volumes into a##2##3##(2008-10#1)(2008-9#1)
volumes into##4##2##(2008-10#3)(2008-9#1)
volumes of sample##6##3##(2008-10#5)(2008-9#1)
volumes of the##4##3##(1991-12#1)(2008-10#3)
volumes of##38##2##(1991-11#1)(1991-12#1)(2008-10#27)(2008-3#1)(2008-6#1)(2008-9#2)(2009-7#3)(2011-2#1)(2012-2#1)
volumes ranging from##2##3##(2008-10#2)
volumes were##4##2##(1993-3#1)(1995-5#1)(1996-1#1)(2011-1#1)
volumes##120##1##(1991-11#2)(1991-12#2)(1992-6#2)(1993-2#2)(1993-3#2)(1994-12#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1997-6#2)(2008-1#1)(2008-10#64)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#3)(2008-7#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-7#9)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
volumetric Karl Fischer titration##2##4##(2008-10#2)
volumetric Karl Fischer##4##3##(2008-10#4)
volumetric and##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
volumetric changes##2##2##(2011-2#2)
volumetric flow rate##3##3##(1995-3#2)(2008-10#1)
volumetric flow##4##2##(1995-3#2)(2008-10#1)(2013-8#1)
volumetric lung depth##2##3##(1996-2#2)
volumetric productivity of##2##3##(2008-11#2)
volumetric productivity##3##2##(2008-11#3)
volumetric protein productivity##2##3##(2008-11#1)(2008-7#1)
volumetric spore trap##3##3##(2008-10#2)(2008-5#1)
volumetric spore traps##3##3##(2008-10#2)(2010-5#1)
volumetric spore##6##2##(2008-10#4)(2008-5#1)(2010-5#1)
volumetric titers##3##2##(2008-11#3)
volumetric titration##3##2##(2008-10#3)
volumetric##61##1##(1995-3#2)(1995-5#1)(1996-2#2)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#13)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#1)
voluminous##5##1##(1991-6#1)(1996-11#1)(2008-11#1)(2008-12#1)(2010-3#1)
voluntarily##8##1##(1991-2#1)(1995-1#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
voluntary board##2##2##(1994-2#2)
voluntary contraction (MVC)##2##3##(2010-6#1)(2013-8#1)
voluntary contraction##6##2##(2010-6#3)(2010-9#1)(2013-8#2)
voluntary health##2##2##(1996-3#1)(2008-11#1)
voluntary organizations##3##2##(1991-12#1)(1996-2#2)
voluntary##42##1##(1990-12#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-2#1)(1996-2#3)(1996-3#2)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#6)(2009-11#1)(2010-1#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
volunteer administrator##2##2##(1993-1#1)(1994-1#1)
volunteer and##2##2##(1994-2#2)
volunteer donors##2##2##(2008-10#2)
volunteer experience##3##2##(1992-3#2)(1994-3#1)
volunteer group##2##2##(1993-2#2)
volunteer management##4##2##(1991-12#1)(1991-2#1)(1994-3#2)
volunteer organizations##3##2##(1992-12#1)(1993-12#2)
volunteer program##4##2##(1991-1#1)(1992-1#1)(1993-2#1)(1994-2#1)
volunteer programs##4##2##(1994-2#3)(1994-3#1)
volunteer study##3##2##(2008-10#1)(2008-5#2)
volunteer work##4##2##(1991-12#1)(1994-2#1)(1995-2#2)
volunteer##98##1##(1991-1#2)(1991-12#4)(1991-2#4)(1992-1#3)(1992-12#2)(1992-3#5)(1993-1#1)(1993-12#5)(1993-2#3)(1994-1#1)(1994-12#1)(1994-2#15)(1994-3#16)(1995-11#1)(1995-12#1)(1995-2#8)(1996-1#1)(1996-3#7)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#5)(2013-1#1)
volunteered for##2##2##(2011-2#1)(2013-1#1)
volunteered to##3##2##(2008-11#1)(2008-12#2)
volunteered##6##1##(1993-12#1)(2008-11#1)(2008-12#2)(2011-2#1)(2013-1#1)
volunteerism##6##1##(1991-2#1)(1994-2#5)
volunteers and their##2##3##(1993-12#1)(1994-3#1)
volunteers and##8##2##(1992-3#3)(1993-12#1)(1994-3#3)(1995-12#1)
volunteers are##3##2##(1994-2#1)(1994-3#1)(1996-12#1)
volunteers as##3##2##(1992-2#1)(1994-3#1)(2008-10#1)
volunteers for##3##2##(1991-2#1)(1992-3#1)(2008-10#1)
volunteers in##4##2##(1994-3#1)(1996-2#1)(2008-12#1)(2012-3#1)
volunteers make##2##2##(1994-3#1)(1997-2#1)
volunteers of##2##2##(2008-5#1)(2013-8#1)
volunteers on the##2##3##(2008-10#1)(2008-5#1)
volunteers performed##2##2##(2008-10#1)(2012-2#1)
volunteers to##4##2##(1992-3#1)(1992-6#1)(1994-3#1)(1997-1#1)
volunteers were##4##2##(2008-12#1)(2008-5#2)(2012-3#1)
volunteers while##2##2##(1996-2#1)(1996-3#1)
volunteers##130##1##(1991-1#1)(1991-12#3)(1991-2#2)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#8)(1992-6#1)(1993-12#4)(1993-2#1)(1994-2#7)(1994-3#20)(1995-12#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#2)(1997-1#1)(1997-2#1)(2008-10#15)(2008-11#3)(2008-12#4)(2008-5#18)(2008-7#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#2)
volunteers'##3##1##(1991-12#1)(2008-5#2)
volunteers?##2##1##(1994-3#1)(1997-2#1)
volvulus##6##1##(2010-1#1)(2012-3#4)(2013-1#1)
vomeronasal##5##1##(1994-2#2)(2012-2#3)
vomiting and##9##2##(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
vomiting episodes##2##2##(1990-12#2)
vomiting in##2##2##(1990-12#1)(1990-6#1)
vomiting was##2##2##(1990-6#1)(2013-7#1)
vomiting##54##1##(1990-12#3)(1990-6#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-6#1)(1996-9#1)(1997-7#1)(1997-8#3)(2007-12#2)(2008-10#5)(2008-12#2)(2008-5#1)(2008-7#11)(2008-8#1)(2009-11#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
von Willebrand Factor##3##3##(1994-11#1)(2008-11#1)(2008-12#1)
von Willebrand factor##5##3##(1993-3#2)(1994-11#1)(2009-7#1)(2012-2#1)
von Willebrand##9##2##(1993-3#2)(1994-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2012-2#1)
von Willebrand's Disease##2##3##(2008-12#2)
von##16##1##(1992-9#2)(1993-3#2)(1994-11#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
vortex##10##1##(1991-5#2)(2007-12#2)(2008-10#3)(2009-5#2)(2013-8#1)
vote on May##2##3##(1995-6#1)(1996-5#1)
vote on##4##2##(1991-9#1)(1995-6#1)(1996-5#1)(1997-2#1)
vote##8##1##(1991-9#1)(1993-5#1)(1995-6#2)(1996-5#2)(1997-2#1)(2012-3#1)
voted##3##1##(1991-12#1)(1995-6#1)(1996-5#1)
voters##2##1##(2008-11#1)(2008-6#1)
voxels##2##1##(2008-11#1)(2008-7#1)
vrn-B1##2##1##(2012-3#2)
vs 0##4##2##(2010-1#2)(2013-1#2)
vs 1##6##2##(2008-9#1)(2012-3#1)(2013-1#4)
vs 17##2##2##(1993-2#2)
vs 2##3##2##(1991-7#1)(1992-2#1)(1994-8#1)
vs 3##2##2##(1992-5#1)(2008-1#1)
vs 4##3##2##(1992-2#1)(1994-1#1)(2012-12#1)
vs 7##2##2##(2011-2#1)(2012-3#1)
vs Ag/AgCl##2##2##(2008-10#2)
vs SCE##2##2##(1996-5#1)(2008-10#1)
vs external##2##2##(2008-11#1)(2008-8#1)
vs pH for##2##3##(1991-9#2)
vs pH##3##2##(1991-9#3)
vs##317##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#4)(1994-5#2)(1994-8#2)(1995-12#2)(1995-3#1)(1995-8#2)(1996-1#6)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#4)(1997-8#5)(2008-1#1)(2008-10#37)(2008-11#16)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#17)(2008-8#7)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#13)(2009-9#2)(2010-1#4)(2010-11#4)(2010-4#2)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#22)(2012-12#3)(2012-2#2)(2012-3#28)(2013-1#20)(2013-8#16)
vuittenezi##3##1##(2008-10#3)
vulcanization##3##1##(2008-10#3)
vulgare##8##1##(1995-6#1)(2008-10#5)(2008-11#1)(2008-9#1)
vulgaris L##6##2##(2008-12#2)(2012-3#2)(2013-8#2)
vulgaris tissue homogenate##2##3##(2008-10#2)
vulgaris to##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
vulgaris##39##1##(1991-12#2)(1994-5#1)(1997-8#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-3#3)(2013-8#4)
vulgaris)##18##1##(2008-10#18)
vulgatus##3##1##(1997-2#3)
vulnerabilities##9##1##(1990-6#1)(1995-12#1)(1997-3#2)(2007-12#1)(2008-11#2)(2008-12#2)
vulnerability and##2##2##(2009-4#2)
vulnerability of the##3##3##(1995-11#1)(2011-2#1)(2013-7#1)
vulnerability of##4##2##(1990-5#1)(1995-11#1)(2011-2#1)(2013-7#1)
vulnerability to##9##2##(1995-11#1)(2008-10#1)(2008-8#3)(2009-10#1)(2009-4#1)(2010-10#1)(2013-7#1)
vulnerability##31##1##(1990-5#2)(1991-2#1)(1995-11#2)(2008-10#1)(2008-11#3)(2008-8#4)(2009-10#1)(2009-4#5)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-7#2)
vulnerable groups##2##2##(2008-10#1)(2013-8#1)
vulnerable plaque##4##2##(2012-2#4)
vulnerable plaques##2##2##(2012-2#2)
vulnerable population##4##2##(1993-2#1)(2009-4#1)(2009-5#1)(2009-9#1)
vulnerable populations##9##2##(1991-1#1)(1995-12#2)(1995-2#1)(2008-11#2)(2009-4#1)(2011-2#1)(2012-2#1)
vulnerable prey##2##2##(2008-8#2)
vulnerable to the##2##3##(2007-12#1)(2008-8#1)
vulnerable to##23##2##(1991-1#1)(1994-6#1)(1995-12#2)(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)(2011-2#1)(2011-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
vulnerable##64##1##(1990-2#1)(1991-1#2)(1993-2#1)(1994-6#1)(1995-12#5)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#2)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#4)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-9#2)(2011-2#4)(2011-9#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#1)(2013-8#2)
vulva##10##1##(1992-3#4)(1993-1#2)(1994-1#2)(1997-7#1)(2008-10#1)
vulvar##7##1##(1992-3#5)(1994-1#1)(2013-1#1)
vulvovaginal candidiasis##4##2##(2008-5#4)
vulvovaginal##5##1##(2008-5#4)(2011-2#1)
vvCCL19##3##1##(2013-1#3)
w v(-1)##2##2##(2008-10#2)
w##14##1##(1991-5#3)(1992-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2010-4#2)(2012-2#1)(2012-3#1)
w-3##5##1##(2008-9#5)
w/o##5##1##(2008-5#5)
w/v##8##1##(2008-10#7)(2012-2#1)
w/v)##10##1##(2008-10#5)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
w/w (C(4##6##2##(2008-5#6)
w/w carrier in##2##3##(2008-10#2)
w/w of##2##2##(2008-10#2)
w/w##18##1##(2008-10#9)(2008-5#8)(2008-7#1)
w/w% Ag-zeolite could show a sufficient antimicrobial effect against##2##9##(2008-5#2)
w/w% Ag-zeolite##3##2##(2008-5#3)
w/w%##5##1##(2008-5#5)
w/w) and##2##2##(1993-11#2)
w/w) in##2##2##(2008-10#2)
w/w)##20##1##(1993-11#6)(2008-10#12)(2008-5#2)
waf1/p21##2##1##(2008-9#2)
wafer##8##1##(1992-6#2)(2008-10#4)(2008-3#2)
wafers##5##1##(1992-6#2)(2008-3#1)(2008-4#1)(2012-2#1)
wage and price controls##3##4##(1994-12#3)
wage and salary##2##3##(1994-3#1)(2012-12#1)
wage and##5##2##(1994-12#3)(1994-3#1)(2012-12#1)
wage index##2##2##(1992-12#1)(1992-2#1)
wage rates##2##2##(1992-1#2)
wage##12##1##(1992-1#2)(1992-12#3)(1992-2#1)(1994-12#3)(1994-3#1)(2011-2#1)(2012-12#1)
wages and salaries##2##3##(1992-1#1)(1994-1#1)
wages and##3##2##(1992-1#1)(1994-1#1)(1996-2#1)
wages##8##1##(1992-1#1)(1992-12#1)(1992-3#2)(1994-1#1)(1996-2#1)(1996-3#1)(2008-11#1)
waist circumference to##2##3##(1996-8#1)(2008-11#1)
waist circumference##13##2##(1996-8#1)(2008-11#4)(2008-12#1)(2008-4#1)(2010-4#1)(2011-2#4)(2013-1#1)
waist##19##1##(1996-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-4#1)(2008-9#2)(2010-4#1)(2011-2#6)(2013-1#1)
waist-hip ratio##2##2##(2011-2#2)
waist-hip##3##1##(2008-12#1)(2011-2#2)
waist/hip ratio##2##2##(1994-12#2)
wait for##2##2##(1994-1#1)(1996-11#1)
wait listing##2##2##(1995-12#2)
wait times and##2##3##(2009-3#2)
wait times##4##2##(2009-3#3)(2010-8#1)
wait to##2##2##(2008-8#1)(2008-9#1)
wait##14##1##(1993-3#1)(1994-1#1)(1995-12#2)(1996-11#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-3#4)(2010-8#1)
waited until##2##2##(1994-12#1)(1995-6#1)
waited##3##1##(1992-5#1)(1994-12#1)(1995-6#1)
waiting for##5##2##(1995-1#1)(1997-4#1)(2008-8#1)(2009-12#1)(2013-1#1)
waiting list##11##2##(1991-11#6)(1993-2#3)(2011-3#2)
waiting lists and##2##3##(1991-11#1)(1993-2#1)
waiting lists in##2##3##(1991-11#2)
waiting lists##15##2##(1991-11#7)(1992-12#1)(1993-2#5)(1996-8#1)(2011-3#1)
waiting time and##2##3##(1991-11#1)(2012-2#1)
waiting time for##4##3##(1991-11#3)(1992-12#1)
waiting time##13##2##(1991-11#10)(1992-12#1)(2007-8#1)(2012-2#1)
waiting times##6##2##(1991-11#1)(1995-12#1)(2008-11#2)(2008-9#2)
waiting##59##1##(1991-11#27)(1992-12#2)(1993-2#8)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#3)(2009-12#1)(2011-3#4)(2012-2#2)(2013-1#1)
waiting)##2##1##(2010-10#1)(2011-3#1)
waiver is##2##2##(1992-2#1)(1997-2#1)
waiver patients and##2##3##(1997-2#2)
waiver program is##3##3##(1991-1#1)(1993-1#1)(1997-2#1)
waiver program##4##2##(1991-1#1)(1993-1#2)(1997-2#1)
waiver programs##2##2##(1994-2#1)(1996-2#1)
waiver##31##1##(1991-1#4)(1992-2#5)(1993-1#4)(1993-9#2)(1994-2#1)(1996-12#2)(1996-2#3)(1997-2#9)(2012-3#1)
waivers##2##1##(1991-3#1)(1994-12#1)
waking MW##2##2##(2013-8#2)
waking##7##1##(1992-5#1)(2008-11#1)(2013-1#1)(2013-8#4)
walk distance##4##2##(2010-10#1)(2011-2#1)(2013-1#2)
walk##11##1##(1991-9#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
walked##3##1##(1996-3#1)(2013-1#2)
walker##2##1##(2010-5#1)(2013-1#1)
walkeri##11##1##(2008-10#11)
walkers##6##1##(2013-1#6)
walking aids##2##2##(2008-8#2)
walking and##6##2##(1993-12#1)(2008-9#1)(2013-1#4)
walking distance##3##2##(1995-2#1)(2010-12#1)(2010-4#1)
walking in##2##2##(1997-2#1)(2013-1#1)
walking up##2##2##(2008-7#2)
walking was##2##2##(1993-12#1)(2008-10#1)
walking##50##1##(1993-12#6)(1994-8#1)(1995-2#2)(1996-6#1)(1997-2#3)(2007-12#2)(2008-10#2)(2008-12#1)(2008-7#6)(2008-8#2)(2008-9#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#14)(2013-8#1)
walks##4##1##(1993-1#1)(1994-9#1)(1995-2#1)(2010-4#1)
wall and##18##2##(1990-5#1)(1992-12#1)(1993-9#1)(1997-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
wall apposition##2##2##(2008-10#2)
wall appositions and##3##3##(2008-10#3)
wall appositions##10##2##(2008-10#10)
wall as##2##2##(2008-10#1)(2009-7#1)
wall defect##2##2##(2008-10#1)(2008-9#1)
wall dissolution around invading hyphae##2##5##(2008-10#2)
wall during##3##2##(2008-9#2)(2012-12#1)
wall formation##2##2##(2008-10#1)(2011-2#1)
wall imaging##2##2##(2010-9#2)
wall in##5##2##(1990-9#1)(1991-1#2)(1997-8#1)(2008-11#1)
wall invasion##2##2##(1990-9#2)
wall is##2##2##(1997-8#1)(2008-11#1)
wall jet##2##2##(2008-10#2)
wall may##2##2##(1992-9#1)(2008-7#1)
wall motion##4##2##(2012-2#1)(2013-1#3)
wall of the##21##3##(1990-11#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-12#2)(2008-7#2)(2008-9#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
wall of##30##2##(1990-11#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
wall painting##2##2##(2008-10#2)
wall paintings found in##2##4##(2008-10#2)
wall paintings##5##2##(2008-10#5)
wall permeability##2##2##(2008-9#1)(2010-12#1)
wall pore sensilla##2##3##(2007-12#2)
wall pore##3##2##(2007-12#3)
wall region##2##2##(2008-9#2)
wall revealed##2##2##(1991-12#1)(2008-10#1)
wall shear rate##3##3##(2008-9#3)
wall shear stress##4##3##(2008-11#1)(2009-7#1)(2010-9#1)(2013-1#1)
wall shear##8##2##(2008-11#2)(2008-9#3)(2009-7#1)(2010-9#1)(2013-1#1)
wall stress##4##2##(1996-3#1)(2008-7#1)(2009-1#1)(2009-7#1)
wall surface##2##2##(2008-10#2)
wall thickening##5##2##(1997-8#1)(2008-10#3)(2011-2#1)
wall thickness##12##2##(1993-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2009-1#1)(2009-11#1)(2011-2#4)(2012-2#1)
wall to##3##2##(2008-10#2)(2009-7#1)
wall was##9##2##(1992-12#1)(1995-3#1)(2008-10#3)(2008-8#1)(2008-9#2)(2012-12#1)
wall which##2##2##(2011-2#1)(2013-1#1)
wall with##3##2##(1996-3#1)(2008-9#1)(2009-1#1)
wall##337##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#3)(1991-1#3)(1991-12#6)(1992-12#3)(1992-3#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-9#1)(1995-3#3)(1995-6#4)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#9)(2006-6#2)(2007-11#2)(2007-12#5)(2008-10#108)(2008-11#10)(2008-12#8)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#18)(2009-1#5)(2009-10#4)(2009-11#1)(2009-12#3)(2009-6#1)(2009-7#11)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#5)(2011-10#1)(2011-2#27)(2011-7#1)(2012-12#9)(2012-2#11)(2012-3#2)(2013-1#12)(2013-8#1)
wall)##2##1##(1993-3#1)(2008-10#1)
wall-bound##2##1##(2008-10#2)
wall-jet (flow-onto)##2##2##(2008-10#2)
wall-jet amperometric detection##3##3##(2008-10#3)
wall-jet cell##3##2##(2008-10#3)
wall-jet configuration##3##2##(2008-10#3)
wall-jet detector##2##2##(2008-10#2)
wall-jet##14##1##(2008-10#14)
wall-less##2##1##(2008-10#2)
wall-pore sensilla##3##2##(2008-7#3)
walled##2##1##(2008-7#1)(2012-12#1)
walls and##5##2##(1991-9#1)(2008-10#2)(2012-3#1)(2013-1#1)
walls are##3##2##(1991-6#1)(2007-12#1)(2011-2#1)
walls in##2##2##(2008-10#2)
walls of a##4##3##(1997-2#1)(2008-10#3)
walls of the##9##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2012-2#1)
walls of##31##2##(1997-2#1)(2007-12#4)(2008-10#20)(2008-11#2)(2008-6#1)(2008-9#1)(2009-8#1)(2012-2#1)
walls were##4##2##(2008-10#4)
walls##94##1##(1990-8#1)(1991-12#1)(1991-6#4)(1991-9#1)(1992-12#1)(1995-3#1)(1997-2#1)(2007-12#9)(2008-10#54)(2008-11#3)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
want him to##2##3##(1992-3#2)
want to be##4##3##(1995-12#1)(1997-5#1)(2012-2#1)(2013-8#1)
want to know##2##3##(2008-11#1)(2012-3#1)
want to use##2##3##(2008-4#1)(2011-1#1)
want to##27##2##(1992-1#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
want##36##1##(1992-1#1)(1992-12#1)(1992-3#3)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(2008-10#1)(2008-11#4)(2008-4#3)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
wanted to compare the##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
wanted to compare##4##3##(2008-11#1)(2011-2#2)(2013-1#1)
wanted to determine##2##3##(2008-10#1)(2013-7#1)
wanted to##16##2##(1990-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#7)(2013-1#1)(2013-7#1)
wanted##17##1##(1990-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#7)(2013-1#1)(2013-7#1)
wanting to##2##2##(1992-8#1)(2008-12#1)
wants to##2##2##(1995-5#1)(1996-8#1)
wants##4##1##(1994-12#1)(1995-5#1)(1996-8#1)(2009-5#1)
war in##2##2##(1993-9#1)(2008-11#1)
war##12##1##(1991-3#1)(1993-9#1)(1994-9#2)(1997-6#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-1#1)(2012-12#1)
ward in##2##2##(1993-12#1)(2012-3#1)
ward##24##1##(1990-3#2)(1991-2#1)(1993-12#1)(1993-2#1)(1997-3#1)(2008-11#7)(2008-12#1)(2010-6#1)(2010-8#4)(2011-2#1)(2012-3#1)(2013-1#3)
wards that##3##2##(2008-7#1)(2013-1#2)
wards##15##1##(2008-7#1)(2008-8#1)(2013-1#13)
ware false##2##2##(2011-2#2)
ware##6##1##(2008-10#3)(2011-2#3)
warfare agent##5##2##(2008-11#5)
warfare agents##6##2##(2008-10#1)(2008-11#5)
warfare##17##1##(1991-3#1)(1992-12#5)(2008-10#1)(2008-11#10)
warfarin##4##1##(2008-10#3)(2008-5#1)
warm and##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-6#1)
warm blood cardioplegia##2##3##(1991-3#2)
warm season##3##2##(2008-10#3)
warm##23##1##(1990-12#1)(1990-2#1)(1991-3#2)(2008-10#8)(2008-3#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-4#3)(2012-6#1)(2012-7#1)
warm-up##3##1##(2008-10#1)(2009-1#1)(2013-1#1)
warmer and drier##3##3##(2008-10#2)(2012-7#1)
warmer and##5##2##(2008-10#3)(2012-7#2)
warmer locations##3##2##(2008-10#3)
warmer temperatures##3##2##(2008-10#2)(2008-5#1)
warmer##16##1##(2008-10#10)(2008-5#1)(2008-8#1)(2012-5#2)(2012-7#2)
warming and##6##2##(2012-5#3)(2012-6#2)(2012-7#1)
warming##35##1##(1992-1#1)(1992-3#1)(1995-3#1)(1996-1#1)(2008-12#1)(2008-9#1)(2009-8#1)(2012-5#8)(2012-6#11)(2012-7#2)(2012-8#1)(2012-9#4)(2013-8#2)
warmth##9##1##(2008-11#2)(2009-9#1)(2010-1#6)
warn##4##1##(1990-3#1)(1997-1#1)(2008-8#1)(2009-10#1)
warned##3##1##(2008-11#1)(2008-12#1)(2011-1#1)
warning signs##4##2##(1996-8#1)(2008-11#1)(2008-12#1)(2008-3#1)
warning system was##2##3##(2008-10#2)
warning system##5##2##(2008-10#5)
warning systems##5##2##(2008-10#5)
warning##30##1##(1992-12#1)(1992-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
warnings##3##1##(2008-11#1)(2008-3#1)(2010-9#1)
warrant further study##2##3##(2008-4#1)(2013-8#1)
warrant further##8##2##(1996-2#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
warrant the##2##2##(1995-6#1)(2008-10#1)
warrant##15##1##(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
warranted and##3##2##(1991-12#1)(1996-3#1)(2008-11#1)
warranted in##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
warranted to determine##2##3##(2008-7#1)(2009-4#1)
warranted to##9##2##(1992-12#1)(2008-5#1)(2008-7#4)(2009-4#1)(2011-2#1)(2013-1#1)
warranted##42##1##(1990-12#2)(1991-12#1)(1991-8#1)(1992-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
warranting##4##1##(1992-12#1)(2008-7#1)(2013-1#2)
warrants further##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
warrants##12##1##(1990-8#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#1)
wars##2##1##(1991-3#1)(1992-8#1)
warts##2##1##(1996-1#2)
was &gt##19##2##(1993-1#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#3)(2010-11#1)(2011-2#2)
was &lt##23##2##(2008-10#19)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
was &quot##5##2##(1990-2#2)(2008-11#1)(2009-10#1)(2010-1#1)
was (1)##2##2##(1990-11#1)(1991-3#1)
was +/-0##3##2##(2008-10#3)
was -0##2##2##(2008-10#1)(2013-1#1)
was 0##270##2##(1990-12#2)(1990-2#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-12#1)(1996-6#1)(1996-8#2)(1997-4#1)(2008-10#209)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
was 1 and##3##3##(2008-10#2)(2008-5#1)
was 1 mol of S-1 per##2##6##(1991-5#2)
was 1##136##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-3#2)(1991-5#2)(1991-9#2)(1992-2#2)(1992-3#1)(1992-6#3)(1994-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#2)(1997-9#1)(2008-10#85)(2008-11#3)(2008-5#2)(2008-7#4)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-3#6)(2013-1#1)
was 1%##2##2##(1997-8#1)(2011-3#1)
was 1-10##2##2##(2008-10#2)
was 10##18##2##(1995-3#1)(2008-10#11)(2008-11#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#2)
was 10%##2##2##(2010-6#1)(2011-2#1)
was 100##2##2##(2008-10#2)
was 100% in##2##3##(1994-12#1)(1997-3#1)
was 100%##13##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
was 101##2##2##(1992-11#1)(2008-10#1)
was 107##2##2##(2007-12#1)(2008-1#1)
was 11 months (range##2##4##(1991-6#1)(2008-10#1)
was 11##12##2##(1990-11#1)(1991-3#1)(1991-6#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-9#1)(2013-1#1)
was 11%##2##2##(1990-6#1)(2008-10#1)
was 12 ng##2##3##(2008-10#2)
was 12##12##2##(1990-2#1)(1996-8#1)(1997-7#1)(2008-10#6)(2008-3#1)(2011-2#1)(2013-1#1)
was 12%##2##2##(1994-3#1)(2008-10#1)
was 120##2##2##(2008-10#2)
was 13 months##2##3##(1991-6#1)(2008-10#1)
was 13 ng##2##3##(2008-10#2)
was 13##13##2##(1991-6#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
was 14##10##2##(1990-12#1)(1995-8#1)(2008-10#3)(2008-11#2)(2009-4#1)(2012-3#1)(2013-1#1)
was 15##15##2##(1990-12#1)(1991-1#1)(1992-3#1)(1994-9#1)(2008-10#6)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
was 150##2##2##(2008-10#2)
was 151##2##2##(1997-5#2)
was 16##8##2##(1991-1#1)(1994-6#1)(2008-10#4)(2008-11#1)(2013-8#1)
was 17##7##2##(1990-9#1)(1995-8#1)(1997-4#1)(2008-10#3)(2008-8#1)
was 170##2##2##(2008-10#1)(2008-12#1)
was 18##11##2##(1991-6#1)(2008-10#5)(2008-12#1)(2010-6#1)(2011-2#3)
was 18%##2##2##(2008-10#1)(2011-2#1)
was 19##2##2##(2008-11#1)(2013-1#1)
was 2##89##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#1)(1993-6#1)(2008-10#59)(2008-11#5)(2008-12#5)(2008-3#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
was 2%##4##2##(1990-2#1)(2008-10#3)
was 20##19##2##(1992-3#1)(1995-12#1)(2008-10#12)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#2)
was 20% in##2##3##(2008-10#1)(2008-5#1)
was 200##2##2##(2008-10#1)(2008-9#1)
was 21 months##2##3##(2010-11#1)(2011-1#1)
was 21##4##2##(2008-10#1)(2008-11#1)(2010-11#1)(2011-1#1)
was 210##2##2##(1996-11#1)(2008-10#1)
was 22##5##2##(1992-9#1)(2008-11#1)(2011-2#1)(2012-3#2)
was 22%##3##2##(1997-4#1)(2008-10#1)(2011-2#1)
was 23##4##2##(2008-10#3)(2013-1#1)
was 23%##2##2##(2008-7#1)(2010-3#1)
was 24##4##2##(1991-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
was 25 min##2##3##(1994-3#1)(2008-10#1)
was 25##8##2##(1994-3#1)(2008-10#5)(2008-12#1)(2013-1#1)
was 25% higher in##2##4##(2008-10#1)(2008-11#1)
was 25-fold##2##2##(2008-10#2)
was 26##3##2##(1991-6#1)(1993-11#1)(2012-12#1)
was 27##3##2##(1997-8#1)(2008-10#1)(2008-5#1)
was 27%##2##2##(2011-2#2)
was 28##8##2##(1990-11#1)(1992-12#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#2)
was 29##7##2##(1990-9#1)(1996-6#1)(2008-11#1)(2008-12#2)(2010-1#1)(2012-3#1)
was 2x10(-6)##2##2##(2008-10#2)
was 3 days##2##3##(1997-3#1)(2008-10#1)
was 3##75##2##(1990-2#2)(1991-11#1)(1991-2#3)(1991-5#1)(1991-9#1)(1992-2#1)(1993-1#1)(1995-6#1)(1996-6#1)(1997-3#1)(2008-10#47)(2008-11#3)(2008-12#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
was 3%##4##2##(2008-10#4)
was 30##9##2##(1994-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
was 30%##5##2##(1991-6#1)(1997-5#1)(2008-10#1)(2010-9#1)(2011-2#1)
was 31##4##2##(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)
was 32##3##2##(1991-6#1)(2009-11#1)(2012-3#1)
was 33 +/-##2##3##(2012-3#1)(2013-1#1)
was 33##9##2##(2008-10#2)(2008-11#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-3#2)(2013-1#1)
was 33%##4##2##(1990-6#1)(1991-2#1)(2008-10#1)(2011-2#1)
was 34##2##2##(2007-8#1)(2008-10#1)
was 35##2##2##(2008-9#1)(2012-3#1)
was 36 for##2##3##(2008-10#2)
was 36##8##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
was 36%##2##2##(1990-2#1)(2008-11#1)
was 37##6##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
was 38##4##2##(1995-2#1)(2008-10#2)(2009-3#1)
was 38%##2##2##(2008-5#1)(2011-2#1)
was 39##6##2##(1991-8#1)(2007-12#2)(2008-10#2)(2010-3#1)
was 4 months##2##3##(2008-7#1)(2012-12#1)
was 4##51##2##(1990-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1993-6#1)(1993-8#1)(1996-3#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#26)(2008-12#1)(2008-7#2)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#1)
was 4% for##2##3##(2008-10#2)
was 4%##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
was 40##10##2##(1990-12#1)(1991-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
was 40%##3##2##(1992-12#1)(1995-5#1)(2012-2#1)
was 41##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
was 41%##2##2##(2011-2#1)(2013-1#1)
was 42##5##2##(1994-11#1)(1994-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
was 44##4##2##(2008-10#2)(2009-5#1)(2013-1#1)
was 45##5##2##(1991-2#1)(1993-1#1)(1995-12#1)(2011-2#1)(2013-1#1)
was 46##4##2##(1997-2#1)(1997-3#1)(2008-10#1)(2011-1#1)
was 47##4##2##(1996-3#1)(2011-2#2)(2012-3#1)
was 47%##4##2##(1990-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
was 48##7##2##(1997-5#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
was 49##4##2##(1993-8#1)(2008-1#1)(2012-3#1)(2013-1#1)
was 49%##2##2##(2008-11#1)(2010-12#1)
was 5 months##2##3##(1994-8#1)(2010-3#1)
was 5 x##2##3##(2008-10#1)(2010-11#1)
was 5##41##2##(1990-11#2)(1990-6#1)(1991-6#1)(1993-3#1)(1994-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-10#21)(2008-11#2)(2008-7#1)(2008-9#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
was 5%##5##2##(1990-9#1)(1991-9#1)(2008-10#3)
was 50 min##2##3##(2008-10#1)(2008-11#1)
was 50##9##2##(1990-11#1)(1994-2#1)(2008-10#5)(2008-11#1)(2011-2#1)
was 50%##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
was 500##2##2##(2008-10#2)
was 51##3##2##(1996-12#1)(1997-7#1)(2009-8#1)
was 52##2##2##(2008-10#2)
was 53##3##2##(1991-8#1)(2011-2#1)(2011-7#1)
was 54##5##2##(1992-12#1)(2008-1#1)(2008-10#2)(2010-6#1)
was 55##3##2##(1992-11#1)(1993-2#1)(2008-10#1)
was 56 years##2##3##(2008-11#1)(2011-2#1)
was 56##7##2##(1991-9#1)(1992-3#1)(1994-3#1)(1996-3#1)(1997-7#1)(2008-11#1)(2011-2#1)
was 57##3##2##(1993-8#1)(2011-2#1)(2012-2#1)
was 58##4##2##(1990-3#1)(1991-8#1)(2008-11#2)
was 58%##3##2##(1993-1#1)(2008-10#1)(2008-12#1)
was 59##3##2##(1991-3#1)(1992-3#1)(1997-7#1)
was 6 months##2##3##(2008-8#1)(2011-2#1)
was 6##35##2##(1991-11#1)(1991-5#1)(1993-6#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
was 6%##3##2##(2008-10#2)(2008-7#1)
was 60 min##2##3##(1994-2#1)(2008-10#1)
was 60##10##2##(1990-12#1)(1994-2#1)(1994-5#1)(2008-10#4)(2008-11#1)(2009-11#1)(2011-2#1)
was 60%##2##2##(1992-2#1)(1994-5#1)
was 61##3##2##(1990-9#1)(2008-12#1)(2011-1#1)
was 61%##2##2##(2008-10#1)(2009-8#1)
was 62##2##2##(2009-3#1)(2011-2#1)
was 63##5##2##(1991-8#1)(1993-2#1)(2008-10#2)(2009-3#1)
was 63%##2##2##(2008-10#2)
was 64##3##2##(1996-12#1)(1997-7#1)(2008-12#1)
was 65##4##2##(1990-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
was 65%##3##2##(1993-1#1)(1994-6#1)(2008-10#1)
was 66##6##2##(1990-11#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
was 67##3##2##(1994-3#1)(2008-12#1)(2012-2#1)
was 67%##5##2##(1991-8#2)(2008-10#2)(2012-12#1)
was 68##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
was 7 days##2##3##(2008-11#1)(2012-3#1)
was 7 months##2##3##(1992-2#1)(1994-8#1)
was 7##22##2##(1991-2#1)(1991-8#1)(1992-2#1)(1994-8#1)(2008-10#11)(2008-11#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#2)
was 7%##2##2##(2007-8#1)(2010-12#1)
was 70##7##2##(1991-11#1)(1994-8#1)(2008-1#1)(2008-10#4)
was 70%##3##2##(1992-12#1)(1992-6#1)(2008-7#1)
was 71##3##2##(1994-12#2)(1997-2#1)
was 71%##2##2##(1993-1#1)(2012-3#1)
was 72##2##2##(2008-5#1)(2008-7#1)
was 72%##2##2##(1994-2#1)(2008-11#1)
was 73##2##2##(1991-6#1)(2011-3#1)
was 74##2##2##(2008-7#1)(2009-12#1)
was 75##3##2##(1991-11#1)(2008-10#2)
was 75%##4##2##(1990-6#1)(1992-11#1)(1997-8#1)(2008-10#1)
was 76##5##2##(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-3#1)
was 78##3##2##(1993-1#1)(2008-10#1)(2010-12#1)
was 8##13##2##(1992-2#1)(1994-12#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-7#2)(2013-1#1)
was 80 samples per hour##2##5##(2008-10#2)
was 80##4##2##(2008-10#3)(2012-12#1)
was 82##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
was 84% and##2##3##(2008-3#1)(2008-7#1)
was 85##6##2##(1992-6#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-3#1)
was 86##5##2##(1990-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-3#1)
was 88%##3##2##(1991-2#1)(1991-6#1)(2008-6#1)
was 9##23##2##(1990-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1996-9#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
was 9%##3##2##(1996-3#1)(2008-10#2)
was 90##5##2##(1996-3#1)(1997-5#1)(2008-10#2)(2008-11#1)
was 90s##2##2##(2008-10#2)
was 91%##2##2##(1990-2#1)(1994-1#1)
was 93##4##2##(2008-10#1)(2008-7#1)(2011-3#1)(2012-12#1)
was 94##3##2##(2008-10#1)(2010-3#1)(2011-2#1)
was 94%##2##2##(2008-7#1)(2011-2#1)
was 95##6##2##(1996-12#1)(2008-10#4)(2012-3#1)
was 95%##4##2##(1991-8#1)(1996-12#1)(2008-10#2)
was 96##6##2##(1990-12#1)(1992-3#1)(2008-10#2)(2008-11#1)(2013-8#1)
was 96%##5##2##(1990-6#1)(1993-3#1)(2008-10#2)(2012-3#1)
was 97##3##2##(2008-10#1)(2009-3#1)(2009-4#1)
was 97%##3##2##(1990-2#1)(2008-10#2)
was 98##6##2##(1990-2#1)(1993-8#1)(1996-12#2)(2008-12#1)(2011-2#1)
was 99##6##2##(2008-10#5)(2008-12#1)
was C##2##2##(1997-2#1)(2010-4#1)
was D(m) =##2##3##(2010-7#2)
was HIV-positive##2##2##(1995-12#1)(1996-5#1)
was NOK##3##2##(1995-2#2)(1997-4#1)
was a better##2##3##(2008-10#1)(2010-8#1)
was a case##2##3##(2013-1#1)(2013-8#1)
was a clear##2##3##(1991-2#1)(2008-10#1)
was a common##2##3##(2008-10#1)(2010-4#1)
was a competitive##2##3##(2008-10#2)
was a complete##2##3##(2008-10#1)(2008-11#1)
was a consequence of##2##4##(2008-11#1)(2012-5#1)
was a cross-sectional study##3##4##(2011-2#1)(2012-12#1)(2013-8#1)
was a cross-sectional##5##3##(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
was a decrease in##4##4##(1993-12#1)(1995-12#1)(2008-12#1)(2010-9#1)
was a descriptive##4##3##(2010-10#1)(2011-2#1)(2012-12#2)
was a direct##4##3##(1994-5#1)(2008-10#3)
was a function of##2##4##(2008-10#1)(2008-11#1)
was a function##3##3##(2008-10#2)(2008-11#1)
was a general trend##2##4##(2008-10#2)
was a general##3##3##(2008-10#3)
was a good agreement between the##2##6##(2008-10#2)
was a good predictor of##2##5##(2008-10#1)(2008-8#1)
was a good predictor##3##4##(2008-10#2)(2008-8#1)
was a good##9##3##(2008-10#6)(2008-5#1)(2008-8#1)(2012-12#1)
was a great##3##3##(1994-2#1)(2008-10#1)(2010-11#1)
was a greater##2##3##(2008-10#1)(2008-11#1)
was a high incidence of##2##5##(1994-12#1)(2008-12#1)
was a high prevalence of##2##5##(1994-6#1)(2008-12#1)
was a high##7##3##(1990-5#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-12#2)(2008-9#1)
was a higher incidence of##2##5##(1996-3#1)(2008-9#1)
was a higher##4##3##(1996-3#1)(1996-6#1)(2008-9#1)(2012-3#1)
was a highly significant##3##4##(1994-3#1)(2008-8#2)
was a linear relationship between the##3##6##(2008-10#2)(2008-11#1)
was a linear relationship between##4##5##(2008-10#3)(2008-11#1)
was a linear##7##3##(2008-10#5)(2008-11#1)(2008-12#1)
was a little##4##3##(1992-3#1)(2008-11#2)(2013-8#1)
was a marked##3##3##(1997-4#1)(2007-12#1)(2008-11#1)
was a minor##2##3##(1992-3#1)(2011-1#1)
was a mixture of##2##4##(2008-10#2)
was a negative correlation##2##4##(2008-10#1)(2008-8#1)
was a new##5##3##(2008-10#2)(2008-11#1)(2009-10#1)(2011-3#1)
was a notable##2##3##(1995-11#1)(2012-3#1)
was a novel##2##3##(2008-10#1)(2012-3#1)
was a poor substrate for##2##5##(1994-11#1)(1997-3#1)
was a positive correlation##2##4##(2008-10#2)
was a positive##3##3##(2008-10#2)(2008-12#1)
was a primary##2##3##(1992-2#1)(2008-7#1)
was a qualitative##2##3##(2008-11#1)(2013-1#1)
was a reduction in##5##4##(1990-5#1)(1996-2#1)(1997-1#1)(2010-8#1)(2013-8#1)
was a reduction##7##3##(1990-5#1)(1996-2#1)(1997-1#1)(2008-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
was a relatively##2##3##(1991-12#1)(2008-10#1)
was a result of##2##4##(2008-9#1)(2009-5#1)
was a retrospective##3##3##(2008-9#1)(2012-12#1)(2012-3#1)
was a selective##2##3##(1994-8#2)
was a sensitive parameter##2##4##(2008-10#2)
was a sensitive##3##3##(2008-10#3)
was a shift of##2##4##(1991-12#1)(2008-10#1)
was a significant decrease in##3##5##(2011-2#1)(2012-2#1)(2013-8#1)
was a significant decrease##4##4##(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
was a significant difference between##2##5##(1995-5#1)(2008-7#1)
was a significant difference##4##4##(1995-5#1)(2008-10#1)(2008-7#1)(2008-9#1)
was a significant effect of##3##5##(1996-12#1)(2008-10#1)(2010-7#1)
was a significant increase##5##4##(1995-8#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
was a significant negative correlation##4##5##(1994-2#1)(2008-10#2)(2012-6#1)
was a significant predictor of##2##5##(2012-3#1)(2013-1#1)
was a significant reduction of##2##5##(1996-12#1)(2012-2#1)
was a significant reduction##4##4##(1993-1#1)(1996-1#1)(1996-12#1)(2012-2#1)
was a significant##45##3##(1990-5#1)(1993-1#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#5)(2012-3#1)(2012-4#1)(2012-6#1)(2013-1#2)(2013-8#1)
was a significantly##3##3##(2008-10#1)(2008-4#1)(2010-7#1)
was a simple##4##3##(1995-11#1)(2008-10#3)
was a single##4##3##(1996-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
was a small##2##3##(1992-2#1)(2008-10#1)
was a statistical##3##3##(1990-12#2)(2006-6#1)
was a statistically significant difference##3##5##(2007-12#1)(2013-1#1)(2013-8#1)
was a statistically significant##6##4##(2007-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was a strong correlation between##2##5##(1991-6#1)(2008-10#1)
was a strong correlation##5##4##(1991-6#1)(1994-8#1)(2008-10#3)
was a strong##13##3##(1990-8#1)(1991-6#1)(1994-8#2)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)
was a stronger##2##3##(1994-12#1)(2009-7#1)
was a suitable##2##3##(2008-10#1)(2008-5#1)
was a thin##2##3##(1994-11#1)(2008-7#1)
was a trend toward better##2##5##(1995-11#1)(2009-3#1)
was a trend toward##4##4##(1995-11#1)(2008-10#2)(2009-3#1)
was a trend towards##3##4##(2008-10#1)(2008-7#1)(2009-3#1)
was a trend##11##3##(1990-2#1)(1995-11#1)(1996-6#1)(2008-10#5)(2008-7#1)(2009-3#2)
was a very##3##3##(1992-3#1)(2008-8#1)(2010-1#1)
was a wide##3##3##(1997-3#1)(2008-10#1)(2012-3#1)
was a##432##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#8)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#4)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#5)(1992-3#3)(1992-6#1)(1993-1#2)(1993-12#2)(1993-8#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#7)(1995-11#3)(1995-12#1)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#3)(1996-8#1)(1997-1#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#2)(2006-6#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#122)(2008-11#25)(2008-12#14)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#11)(2008-8#13)(2008-9#17)(2009-10#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#6)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#19)(2011-3#2)(2012-12#7)(2012-2#7)(2012-3#11)(2012-4#1)(2012-5#1)(2012-6#2)(2013-1#14)(2013-8#10)
was abdominal pain##2##3##(1990-9#1)(1991-8#1)
was ablated##4##2##(1991-2#1)(2008-11#2)(2008-3#1)
was able to be##2##4##(2008-11#2)
was able to bind to##2##5##(1993-8#1)(1995-2#1)
was able to detect##3##4##(2010-8#1)(2012-2#1)(2013-1#1)
was able to grow in##2##5##(2008-11#1)(2008-7#1)
was able to grow##5##4##(2008-10#2)(2008-11#2)(2008-7#1)
was able to infect##2##4##(2008-10#2)
was able to significantly##2##4##(1994-11#1)(2008-10#1)
was able to stay##2##4##(1996-12#1)(1997-2#1)
was able to stimulate##2##4##(1994-2#1)(2008-11#1)
was able to substitute for##2##5##(1993-3#1)(1995-2#1)
was able to support the##2##5##(2008-10#2)
was able to support##3##4##(2008-10#3)
was able to##74##3##(1990-2#2)(1991-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-12#2)(1997-2#1)(2008-10#27)(2008-11#8)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-3#1)(2011-7#1)(2012-2#4)(2013-1#5)
was abnormal##2##2##(1997-3#1)(2008-8#1)
was abolished by the##2##4##(1995-11#1)(2013-1#1)
was abolished by##5##3##(1995-11#1)(1995-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
was abolished in the##2##4##(1990-5#1)(1996-12#1)
was abolished in##4##3##(1990-5#1)(1995-11#1)(1996-12#1)(2008-10#1)
was abolished##13##2##(1990-5#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-11#2)(1995-2#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
was about 1##3##3##(2008-10#2)(2013-8#1)
was about 2 times##2##4##(2008-11#1)(2008-6#1)
was about 2##7##3##(1993-2#1)(1997-1#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)
was about 20%##2##3##(1992-12#1)(2008-11#1)
was about 25##3##3##(2008-10#1)(2013-1#2)
was about 3##2##3##(2008-10#1)(2008-11#1)
was about 30##4##3##(2008-10#4)
was about 5##3##3##(2008-10#3)
was about 9##2##3##(1992-9#1)(2008-10#1)
was about the##2##3##(2008-10#1)(2011-2#1)
was about three##2##3##(1996-2#1)(2008-10#1)
was about twice as high##2##5##(2008-11#2)
was about##71##2##(1990-5#2)(1990-6#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-2#1)(1994-8#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#27)(2008-11#13)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-1#3)(2013-8#1)
was above the##2##3##(2008-10#1)(2013-8#1)
was above##7##2##(2008-10#1)(2008-5#2)(2008-9#1)(2011-3#1)(2012-12#1)(2013-8#1)
was abrogated##3##2##(1992-6#1)(1996-12#1)(2008-11#1)
was absent from##3##3##(1994-11#1)(2008-10#1)(2012-2#1)
was absent in##8##3##(1990-12#1)(1990-3#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-2#1)(2008-10#2)
was absent##23##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-9#1)(1993-6#2)(1994-11#2)(1996-12#1)(1996-2#1)(1997-8#2)(2008-10#6)(2008-9#2)(2010-7#1)(2012-2#1)(2013-7#1)
was absorbed##4##2##(1990-6#1)(2008-10#3)
was abundant##2##2##(2008-10#1)(2009-7#1)
was accelerated##2##2##(1995-6#1)(2008-9#1)
was acceptable##5##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
was accepted##2##2##(1990-6#1)(2011-1#1)
was accessed##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
was accompanied by a##9##4##(1991-5#1)(1994-11#1)(2008-10#1)(2008-11#3)(2009-10#1)(2010-8#1)(2013-8#1)
was accompanied by an increase in the##2##7##(2008-10#1)(2011-2#1)
was accompanied by the##2##4##(2008-10#1)(2010-3#1)
was accompanied by##25##3##(1990-5#1)(1991-5#1)(1994-11#1)(1996-12#2)(2008-10#5)(2008-11#4)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
was accompanied with##3##3##(1997-1#1)(2010-6#1)(2011-2#1)
was accompanied##28##2##(1990-5#1)(1991-5#1)(1994-11#1)(1996-12#2)(1997-1#1)(2008-10#5)(2008-11#4)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
was accomplished by using##3##4##(2008-10#3)
was accomplished by##16##3##(1993-3#1)(1993-9#1)(1996-5#1)(2008-10#11)(2008-5#2)
was accomplished in the##2##4##(2010-4#1)(2011-2#1)
was accomplished in##5##3##(2008-10#3)(2010-4#1)(2011-2#1)
was accomplished using a##2##4##(2008-10#1)(2008-5#1)
was accomplished using##6##3##(2008-10#4)(2008-5#2)
was accomplished with a##2##4##(2008-10#1)(2008-3#1)
was accomplished with##6##3##(2008-10#4)(2008-3#1)(2008-8#1)
was accomplished##36##2##(1993-3#1)(1993-9#1)(1996-5#1)(2008-10#23)(2008-11#1)(2008-3#1)(2008-5#4)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)
was accounted for by##2##4##(1994-3#1)(1997-8#1)
was accounted for##3##3##(1994-3#1)(1997-8#1)(2008-10#1)
was accounted##4##2##(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)
was accumulated on##2##3##(2008-10#2)
was accumulated##9##2##(2008-10#6)(2008-11#1)(2010-12#1)(2011-2#1)
was accurately##4##2##(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#1)
was acetonitrile##2##2##(2008-10#1)(2008-5#1)
was achieved after##6##3##(1995-8#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-2#1)
was achieved and##5##3##(2008-10#3)(2008-11#1)(2011-2#1)
was achieved as##3##3##(2008-10#2)(2011-2#1)
was achieved at a##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
was achieved at##10##3##(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)
was achieved by a##4##4##(1996-5#2)(2008-10#1)(2008-11#1)
was achieved by applying##2##4##(2008-10#1)(2008-5#1)
was achieved by the##8##4##(2008-10#7)(2008-11#1)
was achieved by two##3##4##(1996-12#1)(2008-10#2)
was achieved by using a##2##5##(2008-10#2)
was achieved by using the##2##5##(2008-10#1)(2011-2#1)
was achieved by using##9##4##(2008-10#7)(2008-12#1)(2011-2#1)
was achieved by##58##3##(1990-12#1)(1991-3#1)(1991-8#1)(1994-11#1)(1994-3#1)(1996-12#1)(1996-5#2)(2008-10#39)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
was achieved for the##2##4##(2008-10#2)
was achieved for##12##3##(1994-1#1)(2007-12#1)(2008-10#9)(2009-3#1)
was achieved from##2##3##(2008-10#1)(2013-1#1)
was achieved in 29##2##4##(1997-4#1)(2008-10#1)
was achieved in all##3##4##(1997-8#1)(2008-10#1)(2009-3#1)
was achieved in less than##3##5##(2008-10#3)
was achieved in the##2##4##(2008-10#1)(2008-11#1)
was achieved in##27##3##(1990-6#1)(1991-6#1)(1992-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
was achieved on a##2##4##(2008-10#2)
was achieved on the##2##4##(2008-10#1)(2008-11#1)
was achieved on##8##3##(2008-10#6)(2008-11#1)(2013-1#1)
was achieved only##2##3##(2008-10#1)(2008-11#1)
was achieved through a##2##4##(2008-5#1)(2010-3#1)
was achieved through##4##3##(2008-10#1)(2008-5#2)(2010-3#1)
was achieved using a##5##4##(2008-10#4)(2008-5#1)
was achieved using##13##3##(1990-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2011-3#1)
was achieved via##2##3##(1996-5#1)(2008-10#1)
was achieved when the##2##4##(2008-10#1)(2008-11#1)
was achieved when weather supported severe epidemics##2##7##(2008-10#2)
was achieved when weather supported##3##5##(2008-10#3)
was achieved when##13##3##(1995-6#1)(2006-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)
was achieved with 0##2##4##(2008-10#2)
was achieved with a##6##4##(2007-11#1)(2008-10#3)(2008-3#1)(2011-2#1)
was achieved with high##2##4##(2008-10#1)(2008-5#1)
was achieved with the##6##4##(1991-9#1)(2008-10#4)(2011-2#1)
was achieved with##34##3##(1991-9#1)(1994-3#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#4)
was achieved within##4##3##(2008-10#4)
was achieved without any##2##4##(2008-10#1)(2011-2#1)
was achieved##262##2##(1990-12#2)(1990-6#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#155)(2008-11#15)(2008-12#5)(2008-3#7)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)
was achiewed in##2##3##(2007-11#2)
was acquired and##2##3##(1993-6#1)(2008-10#1)
was acquired by##2##3##(2008-10#1)(2012-3#1)
was acquired##7##2##(1993-6#1)(2008-10#5)(2012-3#1)
was acting##2##2##(1992-1#1)(1993-2#1)
was activated by##7##3##(1991-5#1)(1993-3#2)(1995-6#1)(2008-10#1)(2008-11#1)(2010-11#1)
was activated##12##2##(1990-5#1)(1991-5#1)(1993-3#2)(1994-8#1)(1995-6#1)(2008-10#2)(2008-11#2)(2010-11#1)(2010-6#1)
was active against##2##3##(2008-10#1)(2008-11#1)
was active##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
was actually##2##2##(1991-7#1)(2008-7#1)
was adapted for##2##3##(2008-10#2)
was adapted to the##2##4##(1995-1#1)(2008-10#1)
was adapted to##6##3##(1991-5#1)(1995-1#1)(2008-10#3)(2009-10#1)
was adapted##9##2##(1991-5#1)(1995-1#1)(2008-10#5)(2009-10#1)(2012-2#1)
was added after##2##3##(2008-10#2)
was added at##3##3##(2008-10#2)(2008-7#1)
was added in##2##3##(2008-10#2)
was added into the solution##2##5##(2008-10#2)
was added into the##3##4##(2008-10#3)
was added into##4##3##(2008-10#3)(2008-11#1)
was added to a##2##4##(2008-10#1)(2008-11#1)
was added to an##2##4##(1997-2#1)(2008-10#1)
was added to prevent the##2##5##(1990-11#1)(2008-10#1)
was added to the apical side of##2##7##(2008-11#2)
was added to the culture##2##5##(2008-11#2)
was added to the sample solution##2##6##(2008-10#2)
was added to the sample##4##5##(2008-10#4)
was added to the solution##4##5##(2008-10#4)
was added to the##35##4##(1991-3#1)(1994-1#1)(1994-3#1)(2008-10#23)(2008-11#6)(2008-5#2)(2008-7#1)
was added to this##2##4##(2008-10#1)(2011-2#1)
was added to##61##3##(1990-11#1)(1990-2#1)(1991-3#2)(1994-1#1)(1994-3#1)(1997-2#1)(2008-10#36)(2008-11#8)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
was added##98##2##(1990-11#1)(1990-2#1)(1991-3#2)(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-10#59)(2008-11#14)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
was additionally##2##2##(2006-6#1)(2012-3#1)
was additive##3##2##(1995-8#1)(2008-10#2)
was addressed by##2##3##(2008-10#1)(2012-3#1)
was addressed##4##2##(1996-11#1)(2008-10#2)(2012-3#1)
was adequate##3##2##(1991-8#1)(2008-10#2)
was adjusted to 3##2##4##(2008-10#2)
was adjusted to 6##2##4##(2008-10#2)
was adjusted to pH##3##4##(2008-10#2)(2008-7#1)
was adjusted to##9##3##(2008-10#8)(2008-7#1)
was adjusted##13##2##(2008-10#10)(2008-11#1)(2008-7#1)(2012-2#1)
was administered Mao-to from day##2##5##(2010-7#2)
was administered at a##2##4##(1991-2#1)(1994-2#1)
was administered at##4##3##(1991-2#1)(1994-2#1)(2011-2#1)(2013-1#1)
was administered during the##2##4##(1993-12#1)(2008-1#1)
was administered every##2##3##(1992-2#1)(2011-2#1)
was administered for##2##3##(1995-11#1)(2011-2#1)
was administered in##3##3##(2008-12#1)(2010-7#1)(2013-1#1)
was administered intravenously##2##3##(2008-10#1)(2008-11#1)
was administered oral##2##3##(2010-7#2)
was administered orally##2##3##(1991-5#1)(2013-1#1)
was administered to a##3##4##(1996-3#1)(2008-10#1)(2008-11#1)
was administered to##14##3##(1990-5#1)(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2012-3#1)(2013-8#1)
was administered##54##2##(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-7#6)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
was administrated##2##2##(2008-12#1)(2012-3#1)
was admitted for##4##3##(2008-10#1)(2009-12#1)(2009-6#1)(2011-2#1)
was admitted in the##2##4##(2011-2#1)(2013-1#1)
was admitted in##3##3##(2011-2#1)(2013-1#2)
was admitted to our department##2##5##(2008-12#1)(2011-2#1)
was admitted to our hospital##4##5##(1991-12#1)(1993-6#1)(2008-7#1)(2011-2#1)
was admitted to our##7##4##(1991-12#1)(1993-6#1)(2008-12#2)(2008-7#1)(2011-2#2)
was admitted to the hospital because##2##6##(1993-6#1)(2012-3#1)
was admitted to the hospital##4##5##(1993-6#1)(2012-3#1)(2013-1#2)
was admitted to the##5##4##(1993-6#1)(1993-8#1)(2012-3#1)(2013-1#2)
was admitted to##14##3##(1991-12#1)(1993-6#2)(1993-8#1)(2008-12#2)(2008-7#1)(2011-2#4)(2012-3#1)(2013-1#2)
was admitted with##4##3##(1997-5#1)(2013-1#2)(2013-8#1)
was admitted##27##2##(1991-12#1)(1991-8#1)(1993-6#2)(1993-8#1)(1997-5#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-1#1)(2009-12#1)(2009-6#1)(2011-2#6)(2012-3#1)(2013-1#6)(2013-8#1)
was adopted and##2##3##(2008-8#2)
was adopted as a##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
was adopted as##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
was adopted for##3##3##(2008-10#2)(2011-2#1)
was adopted in##3##3##(1993-8#1)(2013-1#2)
was adopted##21##2##(1993-8#1)(1996-3#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2011-2#2)(2013-1#2)
was adsorbed on a small column packed with Sephadex G-25 gel##2##11##(2008-10#2)
was adsorbed on##5##3##(1991-5#1)(2008-10#4)
was adsorbed##6##2##(1991-5#1)(2008-10#4)(2008-7#1)
was advantageous##4##2##(2008-10#4)
was adversely affected##2##3##(2008-10#1)(2008-6#1)
was advised##3##2##(2008-8#1)(2013-1#2)
was affected by the##6##4##(1992-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
was affected by##17##3##(1992-1#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-9#2)(2009-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
was affected in##3##3##(1995-12#1)(1996-3#1)(2008-9#1)
was affected mainly by##4##4##(2008-10#4)
was affected significantly (P &lt##2##5##(1996-6#1)(2008-10#1)
was affected significantly##3##3##(1996-6#1)(2008-10#2)
was affected##33##2##(1992-1#1)(1994-11#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-10#14)(2008-11#4)(2008-7#2)(2008-9#3)(2009-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
was after##2##2##(1992-6#1)(2010-6#1)
was afterwards##2##2##(2008-10#2)
was aggregated##2##2##(1993-6#1)(2008-10#1)
was agreement##2##2##(2008-9#1)(2011-10#1)
was aimed at characterizing##2##4##(1994-2#1)(2008-10#1)
was aimed at##7##3##(1994-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
was aimed to##6##3##(1991-6#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
was aimed##13##2##(1991-6#1)(1994-2#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
was alive##2##2##(1994-12#1)(1996-12#1)
was all##2##2##(2008-10#1)(2010-4#1)
was alleviated by##2##3##(1991-12#1)(1996-3#1)
was alleviated##3##2##(1991-12#1)(1996-3#1)(2009-8#1)
was allowed to dry##2##4##(2008-10#2)
was allowed to##3##3##(2008-10#3)
was allowed##5##2##(1996-3#1)(2008-10#3)(2009-1#1)
was almost the same##2##4##(2008-10#1)(2008-5#1)
was almost##20##2##(1990-5#1)(1991-2#1)(1992-8#1)(1995-12#1)(1995-8#2)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-2#1)
was already done##2##3##(1990-3#2)
was already##8##2##(1990-3#2)(1994-8#1)(2008-10#1)(2008-11#3)(2013-1#1)
was also a significant##4##4##(1994-8#1)(1997-8#1)(2008-10#1)(2012-2#1)
was also a##12##3##(1994-8#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-12#3)(2008-7#1)(2008-9#1)(2012-2#1)
was also able##2##3##(2007-12#1)(2008-10#1)
was also achieved##2##3##(2008-10#2)
was also added to##2##4##(2008-10#1)(2008-11#1)
was also affected by the##2##5##(2008-10#2)
was also affected by##4##4##(1994-11#1)(2008-10#2)(2011-2#1)
was also an##3##3##(1995-3#1)(2008-10#1)(2008-8#1)
was also analysed##2##3##(2008-10#1)(2008-11#1)
was also analyzed##6##3##(1992-2#1)(1997-6#1)(2008-10#3)(2008-11#1)
was also applied to the##2##5##(2008-10#2)
was also applied to##7##4##(2008-10#7)
was also applied##12##3##(2008-10#12)
was also assessed by##2##4##(2008-10#1)(2009-12#1)
was also assessed##8##3##(1994-12#1)(2008-10#4)(2008-5#1)(2009-12#1)(2010-2#1)
was also associated with a##4##5##(1990-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
was also associated with an increased likelihood of##2##8##(2013-1#2)
was also associated with an##3##5##(1993-11#1)(2013-1#2)
was also associated with##13##4##(1990-9#1)(1993-11#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-7#1)(2013-1#4)
was also associated##14##3##(1990-9#1)(1993-11#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2010-7#1)(2013-1#4)
was also carried out##8##4##(2008-10#4)(2008-11#1)(2008-12#1)(2009-7#1)(2010-5#1)
was also conducted##2##3##(2008-5#1)(2013-8#1)
was also confirmed##3##3##(2008-11#1)(2008-7#1)(2009-7#1)
was also decreased##2##3##(1994-2#1)(1995-2#1)
was also demonstrated in##2##4##(1991-5#1)(2008-5#1)
was also demonstrated##16##3##(1990-5#1)(1991-5#1)(1994-3#1)(1997-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)
was also described##4##3##(2008-10#3)(2013-1#1)
was also detected in the##3##5##(1993-3#1)(1996-12#1)(2008-8#1)
was also detected in##9##4##(1993-3#1)(1996-12#2)(2008-10#4)(2008-5#1)(2008-8#1)
was also detected##14##3##(1993-3#1)(1996-12#2)(1996-2#1)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)
was also determined by##3##4##(2008-10#3)
was also determined using##2##4##(2008-10#2)
was also determined##14##3##(2008-10#11)(2008-11#1)(2010-1#1)(2011-2#1)
was also developed for##3##4##(2008-10#3)
was also developed to##2##4##(2008-10#2)
was also developed##7##3##(2008-10#7)
was also discussed##14##3##(1993-3#1)(2008-10#11)(2008-8#1)(2011-3#1)
was also done##2##3##(1992-6#1)(2008-5#1)
was also effective in##2##4##(1994-8#1)(2008-11#1)
was also enhanced##2##3##(1997-4#1)(2008-11#1)
was also evaluated in##2##4##(2008-10#1)(2008-12#1)
was also evaluated using##2##4##(2008-10#1)(2008-11#1)
was also evaluated##20##3##(1997-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2009-2#1)
was also evidence for##2##4##(2008-11#1)(2008-9#1)
was also evident##4##3##(1990-12#1)(2008-10#3)
was also examined in the##2##5##(1997-8#1)(2008-10#1)
was also examined using##2##4##(1992-3#1)(2008-10#1)
was also examined##12##3##(1992-3#1)(1994-11#1)(1997-8#1)(2008-10#8)(2008-11#1)
was also explored##2##3##(2009-10#1)(2010-1#1)
was also expressed in##2##4##(2008-8#1)(2008-9#1)
was also expressed##3##3##(1992-9#1)(2008-8#1)(2008-9#1)
was also followed##2##3##(1994-5#1)(2008-10#1)
was also found at##2##4##(1994-11#1)(2008-10#1)
was also found for##3##4##(2008-10#2)(2008-3#1)
was also found in##8##4##(1995-9#1)(2008-10#4)(2008-11#1)(2010-3#1)(2012-3#1)
was also found that##11##4##(1995-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)
was also found to be##6##5##(1992-12#1)(1996-3#1)(1997-1#1)(2008-10#2)(2012-2#1)
was also found to decrease##2##5##(1990-5#1)(2011-2#1)
was also found to##11##4##(1990-5#1)(1992-12#1)(1995-6#1)(1996-3#2)(1997-1#1)(2008-10#3)(2011-2#1)(2012-2#1)
was also found##43##3##(1990-5#1)(1991-5#1)(1992-12#2)(1994-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#2)(1997-1#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
was also higher in##2##4##(2008-10#1)(2013-1#1)
was also higher##4##3##(1994-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
was also identified in##2##4##(2008-10#2)
was also identified##5##3##(1993-6#1)(2008-1#1)(2008-10#3)
was also improved##2##3##(1996-6#1)(2008-10#1)
was also included in the##2##5##(2008-10#1)(2008-5#1)
was also incorporated##2##3##(2008-10#1)(2010-12#1)
was also increased by##3##4##(1995-3#1)(2008-10#1)(2011-2#1)
was also increased##6##3##(1994-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
was also indicated##2##3##(2008-7#1)(2008-9#1)
was also induced##2##3##(1993-8#1)(2008-10#1)
was also inhibited by##5##4##(1990-5#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-8#1)
was also investigated by##2##4##(2008-10#2)
was also investigated for##2##4##(2008-10#1)(2008-11#1)
was also investigated##24##3##(1992-6#1)(1994-2#1)(1994-5#1)(1996-2#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#2)
was also largely##2##3##(2010-12#1)(2013-1#1)
was also lower##2##3##(2008-9#1)(2013-1#1)
was also measured using a##2##5##(1993-2#1)(2008-5#1)
was also measured##7##3##(1991-3#1)(1993-12#1)(1993-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)
was also not##2##3##(1995-12#1)(2008-10#1)
was also noted in the##2##5##(1996-12#1)(2008-10#1)
was also noted##7##3##(1996-12#1)(1996-5#1)(2008-10#2)(2008-8#1)(2010-7#2)
was also noticed##3##3##(1997-8#1)(2008-5#1)(2011-2#1)
was also observed in the##3##5##(1991-12#1)(2008-10#1)(2008-8#1)
was also observed in##10##4##(1991-12#1)(1991-2#1)(1995-12#1)(1995-8#1)(2008-10#4)(2008-8#1)(2011-2#1)
was also observed on##2##4##(1994-2#1)(2008-10#1)
was also observed that##5##4##(1995-12#1)(2008-10#3)(2008-9#1)
was also observed when##3##4##(1991-5#1)(1993-12#1)(1994-5#1)
was also observed within##2##4##(1991-12#1)(2008-10#1)
was also observed##31##3##(1991-12#2)(1991-2#1)(1991-5#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-8#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
was also obtained##5##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
was also one of the##2##5##(2008-10#2)
was also performed in##2##4##(2008-10#1)(2008-5#1)
was also performed on##2##4##(1994-8#1)(2008-10#1)
was also performed##14##3##(1994-5#1)(1994-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
was also possible##2##3##(2008-10#2)
was also prepared##2##3##(1992-12#1)(1993-8#1)
was also present in the##2##5##(1990-5#1)(2008-10#1)
was also present in##3##4##(1990-5#1)(2008-10#2)
was also present##4##3##(1990-5#1)(2008-10#2)(2012-2#1)
was also presented##2##3##(1996-2#1)(2012-2#1)
was also prevented##2##3##(1994-2#1)(1997-1#1)
was also produced##2##3##(2008-10#1)(2008-11#1)
was also proposed##2##3##(2008-10#1)(2009-11#1)
was also recorded##2##3##(1993-2#1)(2008-12#1)
was also reduced##3##3##(1990-12#1)(2008-10#2)
was also seen in##3##4##(1991-11#1)(1995-11#1)(1996-12#1)
was also seen##4##3##(1991-11#1)(1995-11#1)(1996-12#1)(2008-10#1)
was also shown to be expressed in##2##7##(2010-5#2)
was also shown to be##3##5##(1991-5#1)(2010-5#2)
was also shown to##8##4##(1991-10#1)(1991-5#1)(1992-6#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-5#2)
was also shown##12##3##(1991-10#1)(1991-5#1)(1992-6#1)(1996-6#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-3#1)(2010-5#2)
was also significant##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
was also significantly higher##2##4##(2008-9#1)(2011-2#1)
was also significantly##7##3##(1991-5#1)(1994-8#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
was also stimulated##2##3##(1994-11#1)(1994-3#1)
was also studied and##2##4##(2008-10#2)
was also studied on##2##4##(2008-10#1)(2009-12#1)
was also studied using##2##4##(2008-10#1)(2009-3#1)
was also studied##32##3##(1993-12#1)(1993-2#1)(1996-5#1)(2008-10#23)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
was also successfully##2##3##(2008-10#2)
was also suppressed##2##3##(1991-3#1)(2011-2#1)
was also suspected##2##3##(2008-10#1)(2013-1#1)
was also tested in##2##4##(1997-7#1)(2008-11#1)
was also tested##9##3##(1995-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-1#1)
was also the most##2##4##(2008-10#1)(2008-11#1)
was also undertaken##2##3##(2008-10#1)(2012-3#1)
was also used as a##3##5##(1996-8#1)(2008-10#1)(2008-12#1)
was also used as##4##4##(1996-8#1)(2008-10#2)(2008-12#1)
was also used for the determination of##2##7##(2008-10#2)
was also used for the##3##5##(2008-10#3)
was also used for##9##4##(1996-3#1)(2008-10#8)
was also used in a##2##5##(2008-10#2)
was also used in##4##4##(2008-10#4)
was also used to##9##4##(2008-10#6)(2008-3#1)(2008-5#1)(2011-2#1)
was also used##27##3##(1995-11#1)(1996-3#1)(1996-8#1)(2008-10#20)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
was also utilized##2##3##(1995-8#1)(2012-2#1)
was also verified##4##3##(2008-10#3)(2008-9#1)
was also very##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
was also##630##2##(1990-11#1)(1990-12#3)(1990-5#6)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#5)(1991-6#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#3)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#7)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#6)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#6)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#5)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#273)(2008-11#31)(2008-12#14)(2008-2#3)(2008-3#3)(2008-5#20)(2008-6#3)(2008-7#15)(2008-8#19)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#4)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#18)(2011-3#1)(2012-2#11)(2012-3#5)(2013-1#17)(2013-8#1)
was altered by##2##3##(2008-10#2)
was altered in##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
was altered##8##2##(1993-8#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-8#1)
was always associated with##3##4##(2008-10#3)
was always found to be##2##5##(2008-10#1)(2008-12#1)
was always found##3##3##(2008-10#2)(2008-12#1)
was always higher##2##3##(2008-10#1)(2013-8#1)
was always observed##2##3##(2008-10#1)(2008-11#1)
was always##24##2##(1995-11#1)(1997-3#1)(1997-6#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
was amended with##6##3##(2008-10#6)
was among the##2##3##(2008-10#1)(2008-12#1)
was amplified and sequenced##2##4##(2008-10#2)
was amplified and##4##3##(2008-10#3)(2008-7#1)
was amplified by PCR and##2##5##(1997-8#1)(2008-10#1)
was amplified by PCR##3##4##(1997-8#1)(2008-10#1)(2008-8#1)
was amplified by polymerase chain reaction (PCR) and##2##8##(2008-10#1)(2010-6#1)
was amplified by polymerase chain reaction##3##6##(2008-10#2)(2010-6#1)
was amplified by the##3##4##(1997-7#1)(2008-10#1)(2008-11#1)
was amplified by##13##3##(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-8#3)(2010-6#1)
was amplified from##7##3##(1997-3#1)(1997-9#1)(2008-10#5)
was amplified##30##2##(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#3)(2010-6#1)
was an additional##2##3##(2008-10#1)(2011-2#1)
was an early##3##3##(1990-7#1)(2008-1#1)(2008-10#1)
was an effective tool to##2##5##(2008-10#1)(2010-10#1)
was an effective##6##3##(2008-10#4)(2008-7#1)(2010-10#1)
was an efficient##2##3##(1994-8#1)(2008-10#1)
was an excellent correlation between##2##5##(1992-2#1)(2008-10#1)
was an extremely##2##3##(2010-1#1)(2013-1#1)
was an important##2##3##(2008-5#1)(2011-3#1)
was an improvement in##2##4##(2008-10#1)(2008-7#1)
was an incidental finding during##2##5##(1992-9#1)(2008-12#1)
was an incidental finding##3##4##(1992-9#1)(1995-11#1)(2008-12#1)
was an increase in##8##4##(2008-10#3)(2008-11#3)(2008-9#1)(2013-8#1)
was an increase##9##3##(2008-10#4)(2008-11#3)(2008-9#1)(2013-8#1)
was an increased##2##3##(2008-11#1)(2011-2#1)
was an independent##3##3##(1994-12#2)(2012-3#1)
was an inverse##5##3##(1991-5#1)(2008-10#3)(2012-12#1)
was an##85##2##(1990-2#1)(1990-7#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-12#3)(1994-8#1)(1995-11#1)(1996-12#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
was analysed and##2##3##(1996-12#1)(2008-10#1)
was analysed by##6##3##(1990-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)
was analysed for##5##3##(2008-10#1)(2008-11#2)(2011-2#1)(2012-9#1)
was analysed using##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
was analysed##25##2##(1990-5#1)(1991-12#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-5#2)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#3)(2012-9#1)
was analyzed after##2##3##(2008-10#2)
was analyzed and the##2##4##(1997-8#1)(2008-10#1)
was analyzed and##6##3##(1993-12#1)(1996-11#1)(1997-8#1)(2008-10#2)(2011-2#1)
was analyzed at##2##3##(1994-5#1)(2008-8#1)
was analyzed by the##2##4##(2008-10#1)(2008-12#1)
was analyzed by##27##3##(1995-2#1)(1995-6#1)(1995-8#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
was analyzed for the##3##4##(1997-1#1)(2008-10#1)(2008-11#1)
was analyzed for##13##3##(1992-10#1)(1993-1#1)(1997-1#1)(2008-10#5)(2008-11#2)(2009-2#1)(2010-1#1)(2011-2#1)
was analyzed in the##2##4##(2008-10#2)
was analyzed in##13##3##(1991-3#1)(1993-8#2)(1994-11#1)(1997-5#1)(2008-10#4)(2008-7#2)(2011-2#1)(2013-1#1)
was analyzed on the basis of##2##6##(2008-3#1)(2008-6#1)
was analyzed on##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
was analyzed to##2##3##(2008-10#2)
was analyzed using a##2##4##(2008-10#2)
was analyzed using the##6##4##(1991-2#1)(1992-8#1)(2008-10#3)(2013-1#1)
was analyzed using##17##3##(1991-2#1)(1992-8#1)(2008-10#12)(2013-1#2)(2013-8#1)
was analyzed with##3##3##(2008-8#1)(2011-3#1)(2012-2#1)
was analyzed##111##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#48)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-2#1)(2010-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#6)
was annealed at##2##3##(2013-8#2)
was apoptosis##2##2##(2008-11#2)
was apparent in##2##3##(1991-6#1)(1997-3#1)
was apparent##5##2##(1991-6#1)(1996-12#1)(1997-3#1)(2008-10#2)
was apparently##5##2##(1991-10#1)(1992-6#1)(1995-11#1)(2008-10#1)(2010-12#1)
was applicable to the analysis of##2##6##(2008-10#2)
was applicable to##3##3##(2008-10#3)
was applicable##7##2##(1993-12#1)(2008-10#6)
was applied and##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
was applied as a##5##4##(2008-10#4)(2008-11#1)
was applied as an##2##4##(2008-10#2)
was applied as##11##3##(2008-10#9)(2008-11#1)(2008-12#1)
was applied at##6##3##(2008-10#3)(2010-4#1)(2011-1#1)(2012-2#1)
was applied before##3##3##(1992-2#1)(2008-10#2)
was applied for copper determination in##2##6##(2008-10#2)
was applied for copper determination##3##5##(2008-10#3)
was applied for simultaneous##2##4##(2008-10#1)(2008-2#1)
was applied for the analysis of##3##6##(2008-10#3)
was applied for the determination of drug##2##7##(2008-10#2)
was applied for the determination of the##4##7##(1991-7#1)(2008-10#3)
was applied for the determination of##24##6##(1991-7#1)(2008-10#23)
was applied for the simultaneous##2##5##(2008-10#2)
was applied for the##44##4##(1991-7#1)(2008-10#42)(2008-11#1)
was applied for##72##3##(1991-7#1)(2008-10#66)(2008-11#2)(2008-2#1)(2008-5#1)(2010-4#1)
was applied in order to determine the##2##7##(2008-10#2)
was applied in pharmacokinetic##2##4##(2008-10#1)(2011-3#1)
was applied in the##4##4##(2008-10#4)
was applied in##15##3##(2008-10#11)(2008-11#1)(2008-3#1)(2011-3#1)(2012-3#1)
was applied on the##4##4##(1996-1#1)(2008-10#1)(2011-3#1)(2013-1#1)
was applied on##8##3##(1996-1#1)(2008-10#5)(2011-3#1)(2013-1#1)
was applied over the##2##4##(2008-10#1)(2008-9#1)
was applied over##3##3##(2008-10#2)(2008-9#1)
was applied satisfactorily to the##3##5##(2008-10#3)
was applied satisfactorily to##6##4##(2008-10#6)
was applied successfully for the determination of##2##7##(2008-10#2)
was applied successfully in##2##4##(2008-10#2)
was applied successfully to determine##2##5##(2008-10#2)
was applied successfully to the determination of##13##7##(2008-10#13)
was applied successfully to the##14##5##(2008-10#14)
was applied successfully to##16##4##(2008-10#16)
was applied successfully##20##3##(2008-10#20)
was applied to a##13##4##(1991-12#1)(1995-2#1)(2008-10#11)
was applied to analyse##2##4##(2008-10#2)
was applied to assay##2##4##(2008-10#2)
was applied to commercial##2##4##(2008-10#2)
was applied to detect##4##4##(2008-10#3)(2013-1#1)
was applied to determination of##6##5##(2008-10#6)
was applied to determine the##5##5##(2008-10#5)
was applied to determine zinc##2##5##(2008-10#2)
was applied to determine##17##4##(2008-10#17)
was applied to extract##2##4##(2008-10#2)
was applied to investigate the##2##5##(2008-9#1)(2011-3#1)
was applied to obtain the##2##5##(2008-10#2)
was applied to several##2##4##(2008-10#2)
was applied to study the##3##5##(2008-10#2)(2011-3#1)
was applied to study##4##4##(2008-10#3)(2011-3#1)
was applied to tap water##3##5##(2008-10#3)
was applied to the analysis of certified##2##7##(2008-10#2)
was applied to the analysis of##21##6##(2008-10#21)
was applied to the determination of cadmium in##3##8##(2008-10#3)
was applied to the determination of chloramphenicol##2##7##(2008-10#2)
was applied to the determination of copper in##2##8##(2008-10#2)
was applied to the determination of hydrazine in water samples##2##10##(2008-10#2)
was applied to the determination of molybdenum in##2##8##(2008-10#2)
was applied to the determination of silver in##2##8##(2008-10#2)
was applied to the determination of the drug in##2##9##(2008-10#2)
was applied to the determination of the##3##7##(2008-10#3)
was applied to the determination of these compounds in##3##9##(2008-10#3)
was applied to the determination of these##7##7##(2008-10#7)
was applied to the determination of##85##6##(2008-10#85)
was applied to the direct determination##2##6##(2008-10#2)
was applied to the direct##3##5##(2008-10#3)
was applied to the extraction##2##5##(2008-10#2)
was applied to the simultaneous determination of##2##7##(2008-10#2)
was applied to the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
was applied to the simultaneous##6##5##(2008-10#6)
was applied to the speciation of##3##6##(2008-10#3)
was applied to the speciation##4##5##(2008-10#4)
was applied to the##167##4##(2008-10#157)(2008-11#2)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
was applied to two##4##4##(2008-10#4)
was applied to##315##3##(1991-12#1)(1995-2#2)(1996-12#1)(1997-6#1)(2008-10#281)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#3)(2011-3#3)(2012-2#1)(2012-5#1)(2013-1#5)(2013-8#3)
was applied using a##2##4##(2008-11#1)(2013-1#1)
was applied using##3##3##(2008-11#1)(2013-1#2)
was applied with##4##3##(2008-10#3)(2008-12#1)
was applied##506##2##(1990-2#1)(1991-12#1)(1991-7#1)(1992-2#1)(1995-2#2)(1996-1#1)(1996-12#1)(1997-6#1)(2008-10#439)(2008-11#11)(2008-12#4)(2008-2#3)(2008-3#2)(2008-5#4)(2008-8#1)(2008-9#2)(2010-3#1)(2010-4#3)(2011-1#1)(2011-2#4)(2011-3#5)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#10)(2013-8#3)
was appointed##2##2##(1993-11#1)(2010-1#1)
was appressed##2##2##(2008-10#2)
was approached##2##2##(1991-2#1)(1995-11#1)
was appropriate for##3##3##(2008-1#1)(2008-10#2)
was appropriate##4##2##(2008-1#1)(2008-10#2)(2010-12#1)
was approved by##2##3##(2008-9#1)(2013-1#1)
was approximately 0##3##3##(2008-10#3)
was approximately 1##4##3##(1995-2#1)(2008-10#3)
was approximately 10##2##3##(1991-5#1)(1994-11#1)
was approximately 13%##2##3##(2008-10#1)(2008-8#1)
was approximately 2##2##3##(2008-10#1)(2008-7#1)
was approximately 5##2##3##(1992-4#1)(1996-2#1)
was approximately 50%##2##3##(1994-11#1)(2008-10#1)
was approximately equal##2##3##(1994-11#1)(2008-10#1)
was approximately##48##2##(1991-5#2)(1992-4#1)(1994-11#3)(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-12#1)(2012-12#1)
was around##10##2##(2008-10#7)(2008-11#2)(2012-3#1)
was arrested##2##2##(1995-12#1)(2008-10#1)
was as effective as##2##4##(2008-10#1)(2008-8#1)
was as effective##3##3##(2008-10#2)(2008-8#1)
was as follows##8##3##(1990-2#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
was as low as##6##4##(2008-10#6)
was as##28##2##(1990-2#1)(1994-11#1)(1994-3#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)
was ascertained by##5##3##(2008-10#5)
was ascertained##6##2##(1997-3#1)(2008-10#5)
was asked to##2##3##(1990-11#1)(2008-11#1)
was asked##3##2##(1990-11#1)(1995-2#1)(2008-11#1)
was aspirated##4##2##(2008-10#3)(2010-12#1)
was assayed by##4##3##(2008-10#3)(2008-11#1)
was assayed on##2##3##(2008-10#1)(2008-7#1)
was assayed using##3##3##(1995-8#1)(1997-7#1)(2008-8#1)
was assayed##13##2##(1993-3#1)(1995-8#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)
was assembled for##2##3##(2008-10#1)(2012-2#1)
was assembled with##3##3##(1997-4#1)(2008-10#2)
was assembled##13##2##(1996-6#1)(1997-4#1)(2008-10#8)(2010-5#1)(2012-2#2)
was assessed according to##2##4##(1993-8#1)(2012-3#1)
was assessed as##2##3##(2008-5#1)(2012-2#1)
was assessed at##2##3##(2008-10#1)(2012-3#1)
was assessed by comparing##2##4##(1997-3#1)(2008-10#1)
was assessed by counting colonies formed from spore-bearing splash droplets deposited in sheltered petri plates containing a selective medium##2##19##(2008-10#2)
was assessed by evaluating##2##4##(1993-6#1)(2008-10#1)
was assessed by measuring the##2##5##(1990-5#1)(1995-3#1)
was assessed by the determination of##2##6##(2008-10#2)
was assessed by the##8##4##(1993-3#1)(1993-6#1)(2008-10#3)(2008-5#1)(2009-3#1)(2013-1#1)
was assessed by use of##2##5##(1995-11#1)(2013-1#1)
was assessed by using##2##4##(2008-10#2)
was assessed by##55##3##(1990-5#1)(1993-3#1)(1993-6#2)(1994-5#2)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#26)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
was assessed during##2##3##(2008-10#1)(2013-8#1)
was assessed for the##2##4##(2008-10#2)
was assessed for##3##3##(2008-10#3)
was assessed in a##5##4##(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2013-1#1)
was assessed in field experiments##2##5##(2008-10#2)
was assessed in terms of##3##5##(2008-10#1)(2008-11#1)(2012-2#1)
was assessed in the##3##4##(1990-8#1)(2008-10#1)(2013-1#1)
was assessed in these##2##4##(1994-2#1)(2008-10#1)
was assessed in##30##3##(1990-2#1)(1990-8#1)(1991-12#1)(1994-2#2)(1995-5#1)(1996-2#1)(1996-3#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#2)
was assessed on##2##3##(1990-6#1)(2008-10#1)
was assessed through##6##3##(2008-10#5)(2013-1#1)
was assessed using a##4##4##(2008-10#2)(2009-3#2)
was assessed using the##4##4##(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)
was assessed using##20##3##(1994-12#1)(1994-5#1)(1997-3#1)(2008-10#7)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
was assessed with a##4##4##(1993-12#1)(2008-5#2)(2010-7#1)
was assessed with the##3##4##(2008-10#2)(2008-7#1)
was assessed with##11##3##(1993-12#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-7#1)(2013-1#1)
was assessed##168##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#3)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#4)(1997-8#2)(2008-10#74)(2008-11#2)(2008-12#2)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#3)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2012-5#2)(2013-1#10)(2013-8#4)
was assigned a##2##3##(1993-6#1)(2010-2#1)
was assigned to the##2##4##(1994-11#1)(2008-8#1)
was assigned to##8##3##(1994-11#1)(1997-2#1)(2008-10#5)(2008-8#1)
was assigned##13##2##(1993-6#1)(1994-11#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-8#1)(2010-2#1)
was associated to##2##3##(2008-10#2)
was associated with Buerger's disease##2##5##(1997-8#2)
was associated with a 1##2##5##(2008-11#1)(2013-1#1)
was associated with a decrease##2##5##(1996-6#1)(2008-7#1)
was associated with a higher proportion of##2##7##(1996-2#1)(2008-9#1)
was associated with a reduction in##2##6##(2008-10#1)(2013-1#1)
was associated with a##27##4##(1990-8#1)(1991-6#1)(1991-8#1)(1994-12#1)(1996-2#1)(1996-6#1)(2008-10#7)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#3)(2013-1#3)(2013-8#1)
was associated with abnormal##2##4##(1990-8#1)(2008-9#1)
was associated with an increased risk of##2##7##(1993-11#1)(2010-6#1)
was associated with an increased##4##5##(1990-12#1)(1993-11#1)(2008-11#1)(2010-6#1)
was associated with an##9##4##(1990-12#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
was associated with decreased##4##4##(2008-10#1)(2008-9#1)(2009-12#1)(2013-8#1)
was associated with elevated##3##4##(2008-10#1)(2008-5#1)(2010-7#1)
was associated with enhanced##2##4##(2008-12#1)(2010-11#1)
was associated with greater##6##4##(2008-4#2)(2009-11#1)(2009-5#1)(2010-9#1)(2013-8#1)
was associated with higher##2##4##(1994-12#1)(2008-10#1)
was associated with increased##9##4##(1991-3#1)(1992-8#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-7#1)(2011-2#1)
was associated with less##4##4##(2009-10#1)(2009-11#1)(2009-12#1)(2010-9#1)
was associated with lower##4##4##(2008-7#1)(2009-7#1)(2013-1#2)
was associated with meeting##2##4##(2009-5#2)
was associated with more than one##2##6##(2008-10#2)
was associated with more##6##4##(1995-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#1)
was associated with poorer##2##4##(2008-9#1)(2009-9#1)
was associated with significant##3##4##(2008-10#1)(2010-12#1)(2010-6#1)
was associated with the induction of##2##6##(2008-10#1)(2008-11#1)
was associated with the##13##4##(1993-3#1)(2008-10#5)(2008-11#3)(2008-12#1)(2010-12#1)(2011-1#1)(2013-1#1)
was associated with##180##3##(1990-12#1)(1990-5#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-8#2)(2008-10#52)(2008-11#11)(2008-12#5)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#5)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#3)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#13)(2013-8#8)
was associated##184##2##(1990-12#1)(1990-5#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-8#2)(2008-10#56)(2008-11#11)(2008-12#5)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#5)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#3)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#13)(2013-8#8)
was assumed that##4##3##(2008-10#2)(2008-6#2)
was assumed to be##2##4##(2008-10#2)
was assumed to##4##3##(2008-10#3)(2013-1#1)
was assumed##11##2##(2008-10#7)(2008-5#1)(2008-6#2)(2013-1#1)
was asymptomatic##7##2##(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#3)
was at a##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
was at approximately##2##3##(1993-8#1)(2008-10#1)
was at least as##2##4##(2008-10#1)(2008-8#1)
was at least partly##3##4##(1994-8#1)(2008-10#2)
was at least##9##3##(1993-6#1)(1994-8#1)(2008-10#6)(2008-8#1)
was at the##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
was at##32##2##(1990-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#1)(2008-10#18)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#2)(2011-3#1)
was attached to##4##3##(1997-2#1)(2008-10#3)
was attached##5##2##(1997-2#1)(2008-10#4)
was attained by##2##3##(2008-10#1)(2011-1#1)
was attained in the##2##4##(1993-6#1)(2008-11#1)
was attained in##5##3##(1992-12#1)(1993-6#1)(2008-10#2)(2008-11#1)
was attained within a##2##4##(2008-10#2)
was attained within##3##3##(2008-10#2)(2011-1#1)
was attained##20##2##(1992-12#1)(1993-6#1)(2008-10#12)(2008-11#2)(2008-6#1)(2010-8#1)(2011-1#2)
was attempted##11##2##(1991-8#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)
was attended by##2##3##(2008-5#1)(2010-5#1)
was attended##3##2##(2008-5#1)(2010-5#1)(2012-3#1)
was attenuated by##4##3##(1994-2#2)(1994-5#1)(1997-1#1)
was attenuated##6##2##(1994-2#2)(1994-5#1)(1996-5#1)(1997-1#1)(2008-11#1)
was attributable to##6##3##(2008-10#5)(2008-7#1)
was attributed to a##5##4##(2008-10#3)(2008-7#1)(2010-1#1)
was attributed to the##11##4##(1990-5#1)(1991-12#1)(1996-5#1)(2008-10#6)(2008-7#2)
was attributed to##22##3##(1990-5#1)(1991-12#1)(1996-5#1)(2008-10#14)(2008-12#1)(2008-7#3)(2010-1#1)
was attributed##23##2##(1990-5#1)(1991-12#1)(1996-5#1)(2008-10#14)(2008-12#1)(2008-7#3)(2010-1#1)(2010-4#1)
was augmented##2##2##(1997-8#1)(2008-11#1)
was autoclaved##2##2##(2008-10#1)(2008-11#1)
was automated##2##2##(1997-2#1)(2008-10#1)
was available##5##2##(1991-6#1)(1993-3#1)(2008-10#1)(2008-7#1)(2011-1#1)
was avirulent to##3##3##(2008-10#3)
was avoided by the##2##4##(2008-10#2)
was avoided##4##2##(1990-11#1)(2008-10#2)(2008-11#1)
was awarded##3##2##(1995-12#1)(2008-10#1)(2010-7#1)
was aware of##2##3##(1995-12#1)(2013-1#1)
was aware##4##2##(1995-12#1)(1996-1#1)(2013-1#1)(2013-8#1)
was barely inhibited by inaperisone##2##5##(1992-3#2)
was barely##4##2##(1992-3#2)(2008-9#1)(2013-7#1)
was based on a sample of##2##6##(2010-11#1)(2010-5#1)
was based on a##10##4##(1990-9#1)(2008-10#5)(2008-11#1)(2010-11#1)(2010-5#1)(2011-2#1)
was based on an##2##4##(2008-10#1)(2008-11#1)
was based on the chemiluminescence##2##5##(2008-10#2)
was based on the formation of##2##6##(2008-10#2)
was based on the presence##2##5##(1997-8#1)(2008-10#1)
was based on the reaction##4##5##(2008-10#4)
was based on the reduction of the##2##7##(2008-10#2)
was based on the use of the##2##7##(2008-10#2)
was based on the use of##4##6##(2008-10#4)
was based on the##50##4##(1994-8#1)(1997-8#1)(2008-10#42)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
was based on their##2##4##(2008-10#1)(2013-8#1)
was based on two##2##4##(2008-10#2)
was based on##105##3##(1990-9#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-8#1)(2008-10#71)(2008-11#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
was based upon##3##3##(1993-12#1)(2008-10#2)
was based##111##2##(1990-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-8#1)(2008-10#75)(2008-11#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
was been##2##2##(2008-10#1)(2011-2#1)
was begun##2##2##(2008-11#1)(2010-7#1)
was being treated with##2##4##(1991-11#1)(2010-10#1)
was being##7##2##(1991-11#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-11#1)(2013-1#1)
was below 0##2##3##(2008-10#2)
was below 5##2##3##(1994-12#1)(2008-10#1)
was below the level of##2##5##(2008-10#1)(2008-5#1)
was below the##8##3##(1991-11#1)(1992-6#1)(1993-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
was below##19##2##(1991-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(2008-10#12)(2008-5#1)(2011-2#2)
was best described by the##2##5##(2008-10#2)
was best##8##2##(2008-10#4)(2008-5#1)(2008-7#1)(2009-7#1)(2013-8#1)
was better in##2##3##(1991-2#1)(2011-2#1)
was better than##9##3##(1991-2#1)(1993-3#1)(1995-5#1)(2008-10#6)
was better##20##2##(1991-2#2)(1993-3#1)(1995-5#1)(2008-10#12)(2008-3#1)(2008-6#1)(2011-2#2)
was between 0##7##3##(1990-2#1)(2008-10#6)
was between 1 and##3##4##(2008-10#3)
was between 1##6##3##(2008-10#6)
was between 5 and##2##4##(2008-10#2)
was between 5##3##3##(2008-10#3)
was between 92##2##3##(2008-10#2)
was between the##2##3##(1990-9#1)(1991-3#1)
was between##42##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1997-5#1)(2008-10#28)(2008-11#1)(2008-6#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-1#3)
was biologically##2##2##(1993-8#1)(2008-11#1)
was biopsied##2##2##(2008-10#2)
was blocked by atropine##2##4##(1996-12#1)(2010-4#1)
was blocked by pretreatment##2##4##(1993-6#1)(1995-2#1)
was blocked by the##4##4##(1990-5#1)(1996-2#2)(2008-11#1)
was blocked by##16##3##(1990-5#1)(1991-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1995-2#2)(1996-12#1)(1996-2#2)(1997-3#1)(2008-11#2)(2008-8#1)(2010-4#1)(2012-2#1)
was blocked##23##2##(1990-5#1)(1991-12#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#1)(2008-11#4)(2008-8#1)(2010-4#1)(2012-2#1)
was both##5##2##(1990-2#1)(1995-6#1)(2008-10#1)(2008-9#1)(2012-2#1)
was bound to the##2##4##(2008-10#2)
was bound to##3##3##(1992-6#1)(2008-10#2)
was bound##5##2##(1991-8#1)(1992-6#2)(2008-10#2)
was broad##2##2##(2008-10#1)(2011-10#1)
was broadest among##2##3##(2008-10#2)
was broken##2##2##(1997-3#1)(2008-9#1)
was brought to##2##3##(2008-10#1)(2010-12#1)
was brought##4##2##(2008-10#2)(2010-12#1)(2012-2#1)
was buffered##2##2##(1996-2#1)(2008-10#1)
was built from##2##3##(1994-11#1)(2008-11#1)
was built with##2##3##(2008-10#2)
was built##15##2##(1990-3#1)(1992-2#1)(1994-11#1)(1994-6#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-8#1)(2013-1#1)
was by##6##2##(1994-2#1)(2008-10#3)(2008-11#1)(2008-5#1)
was ca##7##2##(2008-10#7)
was calculated and##4##3##(1995-3#1)(2008-10#3)
was calculated as 1##2##4##(2008-10#1)(2008-12#1)
was calculated as the difference##2##5##(2008-10#2)
was calculated as the##3##4##(2008-10#2)(2008-7#1)
was calculated as##10##3##(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
was calculated at##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
was calculated by##6##3##(2008-10#4)(2008-12#1)(2011-3#1)
was calculated for each##5##4##(2008-10#4)(2010-3#1)
was calculated for##11##3##(1992-6#1)(1993-2#1)(2008-10#5)(2009-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
was calculated from the frequency##2##5##(2008-10#1)(2008-3#1)
was calculated from the##7##4##(2008-10#5)(2008-11#1)(2008-3#1)
was calculated from##10##3##(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)
was calculated to be 4##2##5##(2008-10#2)
was calculated to be 99##2##5##(1996-12#1)(2008-10#1)
was calculated to be##12##4##(1991-12#1)(1996-12#1)(1996-3#1)(2008-10#9)
was calculated to evaluate the##2##5##(2008-10#1)(2012-3#1)
was calculated to##16##3##(1991-12#1)(1991-2#1)(1996-12#1)(1996-3#1)(2008-10#10)(2008-3#1)(2012-3#1)
was calculated using the##2##4##(2008-1#1)(2008-10#1)
was calculated using##5##3##(2008-1#2)(2008-10#2)(2008-11#1)
was calculated##98##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-1#2)(2008-10#54)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
was calibrated using##2##3##(2008-10#2)
was calibrated with a##2##4##(2008-3#2)
was calibrated##8##2##(2008-10#6)(2008-3#2)
was called##3##2##(1990-8#1)(1997-2#1)(2008-10#1)
was capable of moving##2##4##(2008-10#2)
was capable of##12##3##(1995-2#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2013-1#1)
was carried by##3##3##(1996-12#1)(2008-10#2)
was carried out against##2##4##(2008-10#2)
was carried out and##2##4##(2008-10#2)
was carried out as##3##4##(1990-12#1)(2008-10#1)(2008-9#1)
was carried out at 25 degrees C and 25 kV##2##10##(2008-10#2)
was carried out at##14##4##(2008-10#9)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was carried out by a##3##5##(2008-1#1)(2008-10#2)
was carried out by means of##2##6##(2008-10#1)(2011-2#1)
was carried out by the##6##5##(2008-10#4)(2008-7#1)(2012-2#1)
was carried out by using a##3##6##(2008-10#3)
was carried out by using##6##5##(2008-10#6)
was carried out by##45##4##(2008-1#1)(2008-10#36)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
was carried out during##3##4##(2010-1#1)(2011-2#1)(2012-12#1)
was carried out for##4##4##(1991-2#1)(2008-10#2)(2011-2#1)
was carried out in a##5##5##(1994-2#1)(2008-10#3)(2008-11#1)
was carried out in all##2##5##(1990-11#1)(2011-1#1)
was carried out in order to##2##6##(2008-10#2)
was carried out in six##2##5##(2008-5#1)(2012-12#1)
was carried out in the absorbance mode at##2##8##(2008-10#2)
was carried out in the##8##5##(2008-10#5)(2008-5#2)(2013-1#1)
was carried out in##40##4##(1990-11#1)(1991-11#1)(1991-6#1)(1993-11#1)(1994-2#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#4)(2008-9#2)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
was carried out on a##5##5##(2008-10#3)(2008-11#1)(2008-7#1)
was carried out on the##3##5##(2008-8#1)(2011-2#2)
was carried out on##20##4##(1992-12#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#4)(2013-1#1)
was carried out the##2##4##(1991-8#1)(2008-10#1)
was carried out to assess##2##5##(1993-8#1)(1996-6#1)
was carried out to determine the prevalence of##2##8##(1996-12#1)(2011-2#1)
was carried out to determine the##4##6##(1994-3#1)(1996-12#1)(2008-10#1)(2011-2#1)
was carried out to determine##5##5##(1994-3#1)(1996-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
was carried out to evaluate the##2##6##(1990-2#1)(2008-12#1)
was carried out to evaluate##3##5##(1990-11#1)(1990-2#1)(2008-12#1)
was carried out to investigate the##3##6##(1991-6#1)(2008-10#1)(2008-12#1)
was carried out to investigate##5##5##(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
was carried out to##28##4##(1990-11#1)(1990-2#1)(1991-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-6#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-7#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
was carried out using a##5##5##(2008-10#2)(2008-11#1)(2008-9#1)(2010-3#1)
was carried out using the##4##5##(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
was carried out using##28##4##(1991-5#1)(1996-12#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
was carried out with the aim of##2##7##(1997-3#1)(2010-4#1)
was carried out with the##3##5##(1997-3#1)(2008-10#1)(2010-4#1)
was carried out with##10##4##(1997-3#1)(2008-10#6)(2008-5#1)(2009-11#1)(2010-4#1)
was carried out##258##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-8#3)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#137)(2008-11#8)(2008-12#4)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#8)(2013-8#3)
was carried##263##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-8#3)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-12#3)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#139)(2008-11#8)(2008-12#4)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#3)
was catalyzed by##2##3##(2012-2#1)(2013-1#1)
was catalyzed##3##2##(1997-2#1)(2012-2#1)(2013-1#1)
was categorized##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
was caused by a##6##4##(1992-1#1)(1995-6#1)(1996-12#1)(2008-10#3)
was caused by an##2##4##(2008-11#2)
was caused by the##6##4##(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-3#1)
was caused by##25##3##(1992-1#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
was caused##27##2##(1990-9#1)(1991-5#1)(1992-1#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
was centered##2##2##(2008-10#1)(2009-5#1)
was chaired by Professor##2##4##(2008-5#2)
was challenging##2##2##(2008-9#1)(2013-8#1)
was changed from##3##3##(1993-8#1)(2008-10#2)
was changed to##4##3##(1992-6#1)(1997-8#1)(2010-6#1)(2011-1#1)
was changed##14##2##(1992-6#1)(1993-8#2)(1997-8#1)(2008-10#4)(2008-5#2)(2010-1#1)(2010-6#1)(2011-1#1)(2013-1#1)
was characterised by##4##3##(1991-3#1)(2008-10#2)(2011-2#1)
was characterised##7##2##(1991-3#1)(2008-10#4)(2008-11#1)(2011-2#1)
was characteristic of the##2##4##(2008-10#2)
was characteristic of##3##3##(1990-3#1)(2008-10#2)
was characterized as##3##3##(2008-10#3)
was characterized by a##3##4##(1992-12#1)(2008-10#1)(2012-2#1)
was characterized by an##2##4##(1994-5#1)(2008-10#1)
was characterized by means of##2##5##(2008-10#2)
was characterized by surface##2##4##(2008-10#1)(2011-2#1)
was characterized by the presence of##2##6##(2008-10#2)
was characterized by the##6##4##(2008-10#4)(2013-1#2)
was characterized by using##2##4##(2009-9#1)(2011-2#1)
was characterized by##51##3##(1990-11#2)(1992-12#1)(1993-12#1)(1993-3#1)(1994-5#3)(1996-2#1)(1997-5#1)(2007-12#1)(2008-10#31)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
was characterized in##3##3##(2008-10#3)
was characterized using##6##3##(1993-6#1)(1994-5#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-2#1)
was characterized with respect to##2##5##(1996-2#1)(2008-11#1)
was characterized with##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
was characterized##78##2##(1990-11#2)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#4)(1996-2#2)(1997-5#1)(2007-12#1)(2008-10#46)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
was charged with##4##3##(1994-1#2)(1996-5#2)
was charged##6##2##(1992-5#1)(1994-1#2)(1996-5#2)(2008-10#1)
was checked by analysing##2##4##(2008-10#2)
was checked by measuring the##2##5##(2008-10#2)
was checked by the analysis of##2##6##(2008-10#2)
was checked by the use##2##5##(2008-10#2)
was checked by the##4##4##(2008-10#4)
was checked by##21##3##(1995-9#1)(2008-10#20)
was checked for##4##3##(2008-10#4)
was checked with##4##3##(2008-10#3)(2008-11#1)
was checked##41##2##(1995-9#1)(2008-10#37)(2008-11#1)(2008-5#1)(2010-3#1)
was chemically##2##2##(1992-6#1)(2008-10#1)
was chosen as a##5##4##(2008-10#3)(2008-11#1)(2008-7#1)
was chosen as the##7##4##(2008-10#7)
was chosen as##21##3##(1997-6#1)(2008-10#15)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#2)
was chosen for the##2##4##(2008-10#2)
was chosen for this study##2##5##(2008-10#1)(2008-11#1)
was chosen for##5##3##(1991-12#1)(2008-10#3)(2008-11#1)
was chosen to##6##3##(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)
was chosen##43##2##(1991-12#1)(1994-12#1)(1997-6#1)(2008-1#1)(2008-10#25)(2008-11#7)(2008-12#1)(2008-7#1)(2009-9#1)(2011-2#2)(2011-3#2)
was clarified##2##2##(2008-10#1)(2009-6#1)
was classified as##4##3##(2008-10#1)(2008-9#1)(2010-3#1)(2013-8#1)
was classified in##2##3##(1990-2#1)(2008-10#1)
was classified into##4##3##(1996-2#1)(2008-6#1)(2010-8#1)(2012-2#1)
was classified##11##2##(1990-2#1)(1996-2#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
was clear##2##2##(1993-3#1)(2011-2#1)
was cleared##2##2##(2009-3#1)(2013-1#1)
was clearly observed##2##3##(2008-10#1)(2008-11#1)
was clearly##20##2##(1992-6#1)(1996-11#1)(1996-12#1)(2008-10#10)(2008-11#4)(2008-5#1)(2012-12#1)(2013-1#1)
was clinical##2##2##(1994-12#1)(2008-7#1)
was cloned and characterized##3##4##(1995-2#1)(2008-10#2)
was cloned and sequenced##9##4##(1996-12#1)(1996-3#1)(2008-10#5)(2008-8#1)(2008-9#1)
was cloned and the##2##4##(2008-8#2)
was cloned and##20##3##(1993-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)
was cloned by##7##3##(1991-9#1)(1993-2#1)(1994-12#1)(1996-8#1)(2008-11#1)(2008-8#2)
was cloned from the##3##4##(1991-5#1)(1993-9#1)(2008-8#1)
was cloned from##8##3##(1991-5#1)(1993-9#2)(1994-11#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-8#1)
was cloned in the##2##4##(1995-11#1)(2008-9#1)
was cloned in##7##3##(1992-8#1)(1993-12#1)(1995-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
was cloned into a##6##4##(1990-5#1)(1993-12#1)(1993-6#2)(2008-10#2)
was cloned into##11##3##(1990-5#1)(1991-6#1)(1993-12#1)(1993-6#2)(2008-10#2)(2008-8#3)(2008-9#1)
was cloned##66##2##(1990-5#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-8#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-9#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-10#18)(2008-11#3)(2008-5#1)(2008-8#11)(2008-9#4)(2009-3#1)(2010-5#1)
was close to the##5##4##(2008-10#3)(2008-11#1)(2013-8#1)
was close to##12##3##(2008-10#7)(2008-11#1)(2008-5#2)(2008-9#1)(2013-8#1)
was close##13##2##(2008-10#8)(2008-11#1)(2008-5#2)(2008-9#1)(2013-8#1)
was closed##7##2##(1990-12#1)(1991-12#1)(1992-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2012-3#1)
was closely related to the##3##5##(1991-11#1)(2008-10#1)(2008-9#1)
was closely related to##5##4##(1991-11#1)(1994-8#1)(2008-10#2)(2008-9#1)
was closely##9##2##(1991-11#1)(1994-8#1)(1997-7#1)(2008-10#5)(2008-9#1)
was closer to##2##3##(2008-10#2)
was closer##3##2##(2008-10#2)(2013-1#1)
was closest to##2##3##(2008-10#1)(2008-9#1)
was coated with##3##3##(2008-10#2)(2008-2#1)
was coated##7##2##(2008-10#5)(2008-2#1)(2008-7#1)
was coexpressed with##2##3##(1996-12#1)(2008-11#1)
was coexpressed##4##2##(1996-12#1)(2008-11#2)(2008-7#1)
was coincident with##2##3##(1995-2#1)(2008-8#1)
was coined in##2##3##(2013-8#2)
was collected and##3##3##(2008-10#1)(2012-2#1)(2012-5#1)
was collected at##2##3##(2008-10#1)(2012-2#1)
was collected by##3##3##(2011-2#2)(2012-12#1)
was collected from each##2##4##(2008-10#2)
was collected from the##2##4##(2008-10#1)(2013-1#1)
was collected from##13##3##(1991-2#1)(1994-1#1)(2008-10#7)(2008-12#2)(2008-8#1)(2013-1#1)
was collected in a capillary of a sampling arm assembly##2##10##(2008-10#2)
was collected in a##4##4##(2008-10#3)(2008-11#1)
was collected in the##3##4##(2008-10#3)
was collected in##9##3##(2008-10#8)(2008-11#1)
was collected on activated carbon after##2##6##(2008-10#2)
was collected on activated carbon##3##5##(2008-10#3)
was collected on the##2##4##(2008-10#2)
was collected on##6##3##(2008-10#6)
was collected##41##2##(1991-2#1)(1994-1#1)(2008-10#23)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#1)
was combined with the##2##4##(2008-10#2)
was combined with##16##3##(1990-10#1)(1994-2#1)(2008-10#12)(2011-2#1)(2012-7#1)
was combined##17##2##(1990-10#1)(1994-2#1)(2008-10#12)(2008-3#1)(2011-2#1)(2012-7#1)
was common in##2##3##(1991-11#1)(2011-2#1)
was common within a local area of influence that extended##2##10##(2008-10#2)
was common##8##2##(1991-11#1)(2007-12#1)(2008-10#4)(2011-2#1)(2012-3#1)
was commonly##4##2##(1990-3#1)(1995-8#1)(2008-10#1)(2008-3#1)
was comparable in the two##2##5##(2008-7#1)(2012-2#1)
was comparable in the##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
was comparable in##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
was comparable to that in##4##5##(2008-11#2)(2008-12#1)(2008-7#1)
was comparable to that of the##2##6##(1993-6#1)(2008-10#1)
was comparable to that of##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
was comparable to that##8##4##(1993-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#1)
was comparable to the##2##4##(1991-3#1)(2008-10#1)
was comparable to##12##3##(1991-3#1)(1993-6#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-7#1)(2010-8#1)
was comparable with that of##2##5##(1990-8#1)(1991-3#1)
was comparable with that##3##4##(1990-8#1)(1991-3#1)(1993-1#1)
was comparable with##6##3##(1990-8#1)(1991-3#1)(1993-1#1)(2008-10#3)
was comparable##29##2##(1990-8#1)(1991-3#2)(1993-1#1)(1993-6#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-7#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
was compared between the##3##4##(2008-5#1)(2008-9#1)(2012-2#1)
was compared between##6##3##(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#2)(2013-1#1)
was compared by##2##3##(1991-8#1)(1993-3#1)
was compared for##2##3##(1997-2#1)(2013-1#1)
was compared in##3##3##(1993-8#1)(1997-8#1)(2012-2#1)
was compared to a##5##4##(2008-10#1)(2008-11#1)(2009-10#1)(2012-12#1)(2012-3#1)
was compared to that of##4##5##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#1)
was compared to that##6##4##(1991-3#1)(1992-12#1)(1997-3#1)(2008-10#1)(2008-11#2)
was compared to the##2##4##(2008-10#2)
was compared to##21##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#2)(2012-3#1)
was compared using##2##3##(2007-12#1)(2008-7#1)
was compared with a##4##4##(1991-2#1)(2008-10#3)
was compared with other##2##4##(1990-12#1)(2008-10#1)
was compared with that of the##4##6##(1991-12#1)(1991-2#1)(2007-12#1)(2008-10#1)
was compared with that of##9##5##(1991-12#1)(1991-2#1)(1993-11#1)(1995-6#1)(2006-6#1)(2007-12#1)(2008-10#2)(2009-9#1)
was compared with that##12##4##(1991-12#1)(1991-2#1)(1993-11#1)(1995-6#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-9#1)
was compared with the##19##4##(1990-5#1)(1991-2#1)(1992-2#1)(1996-1#1)(1997-8#1)(2008-10#12)(2008-7#1)(2011-2#1)
was compared with##62##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#3)(1992-2#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-8#2)(2006-6#1)(2007-12#1)(2008-10#34)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
was compared##109##2##(1990-12#1)(1990-5#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#4)(2006-6#1)(2007-12#2)(2008-10#47)(2008-11#5)(2008-2#1)(2008-5#4)(2008-7#4)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
was compatible with##3##3##(2008-10#2)(2012-3#1)
was compensated##2##2##(1996-3#1)(2008-10#1)
was competitive##3##2##(1992-3#1)(2008-11#1)(2008-5#1)
was compiled##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
was complete in##3##3##(1991-8#1)(2008-10#2)
was complete##8##2##(1991-8#1)(1993-3#1)(1994-11#1)(2008-10#4)(2008-11#1)
was completed by the##2##4##(2008-10#2)
was completed by##4##3##(1996-1#1)(2008-10#2)(2008-11#1)
was completed in##6##3##(1996-1#1)(2008-10#3)(2008-12#1)(2008-7#1)
was completed to##2##3##(1991-12#1)(2012-12#1)
was completed within##4##3##(1992-2#1)(2008-10#3)
was completed##27##2##(1991-12#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-1#2)(1996-6#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
was completely abolished in##2##4##(1996-2#1)(1997-7#1)
was completely abolished##4##3##(1993-8#1)(1996-2#1)(1997-7#1)(1997-8#1)
was completely blocked by##4##4##(1994-8#1)(1995-6#1)(2008-9#1)(2012-2#1)
was completely blocked##5##3##(1994-8#1)(1995-6#1)(2008-11#1)(2008-9#1)(2012-2#1)
was completely excised##2##3##(2012-12#1)(2013-1#1)
was completely inhibited by##2##4##(1995-2#1)(1995-8#1)
was completely resected##3##3##(2008-7#1)(2009-5#1)(2012-2#1)
was completely##37##2##(1993-1#1)(1993-8#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
was complexed with##4##3##(2008-10#4)
was complicated by##6##3##(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#3)
was complicated##8##2##(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
was composed by##4##3##(2007-12#1)(2008-10#3)
was composed of a##3##4##(1997-6#1)(2008-10#1)(2013-1#1)
was composed of the head##2##5##(2008-8#2)
was composed of the##4##4##(2008-8#2)(2010-6#1)(2013-1#1)
was composed of##24##3##(1990-6#1)(1990-8#1)(1991-8#1)(1994-2#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#8)(2008-7#1)(2008-8#3)(2010-1#1)(2010-12#1)(2010-6#1)(2013-1#2)
was composed##30##2##(1990-6#1)(1990-8#1)(1991-8#1)(1994-2#1)(1995-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-12#1)(2010-6#1)(2013-1#2)
was compressed##2##2##(2008-10#1)(2008-11#1)
was comprised of seven teams##2##5##(2012-2#2)
was comprised of seven##3##4##(2008-10#1)(2012-2#2)
was comprised of##7##3##(2008-10#3)(2008-3#1)(2012-2#2)(2013-1#1)
was computed from the##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
was computed from##5##3##(1993-12#1)(2008-10#1)(2008-3#1)(2012-5#1)(2013-1#1)
was computed using##2##3##(2008-10#1)(2008-7#1)
was computed##11##2##(1990-12#1)(1993-12#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-5#1)(2013-1#1)
was conceived##2##2##(2008-10#1)(2010-5#1)
was concentrated by##2##3##(2008-10#2)
was concentrated in##3##3##(1990-5#1)(2008-10#2)
was concentrated##7##2##(1990-5#1)(2008-10#6)
was concentration dependent and##2##4##(1994-8#1)(2008-7#1)
was concentration##3##2##(1994-11#1)(1994-8#1)(2008-7#1)
was concerned##4##2##(1991-2#1)(1997-8#1)(2008-10#1)(2010-8#1)
was concluded that for##2##4##(2008-10#1)(2008-11#1)
was concluded that one##2##4##(1997-3#1)(2008-10#1)
was concluded that the##15##4##(1991-5#1)(1991-9#1)(1993-11#1)(2008-10#5)(2008-11#1)(2008-5#4)(2008-7#1)(2012-2#1)
was concluded that##50##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
was concluded##53##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
was conducted among##2##3##(2008-12#1)(2012-3#1)
was conducted at the##5##4##(1994-1#1)(2008-12#2)(2011-1#1)(2011-2#1)
was conducted at##7##3##(1994-1#1)(2008-10#1)(2008-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
was conducted by##6##3##(1990-12#1)(1996-12#1)(2008-10#3)(2012-3#1)
was conducted for##2##3##(1996-12#1)(1996-2#1)
was conducted in 2004##2##4##(2008-1#1)(2013-8#1)
was conducted in a##7##4##(2008-10#1)(2008-11#2)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#1)
was conducted in the##2##4##(1992-2#1)(2008-12#1)
was conducted in which##2##4##(1993-1#1)(2012-7#1)
was conducted in##36##3##(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1996-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#1)(2008-9#2)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
was conducted on a##2##4##(1991-7#1)(2012-5#1)
was conducted on##14##3##(1991-7#1)(2008-10#5)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#3)
was conducted over##2##3##(2008-10#2)
was conducted to assess the##3##5##(2008-10#2)(2012-12#1)
was conducted to assess##4##4##(2008-10#3)(2012-12#1)
was conducted to compare##3##4##(2010-8#1)(2012-12#1)(2012-2#1)
was conducted to determine if##3##5##(1992-3#1)(2008-10#2)
was conducted to determine the effect of##2##7##(2008-10#1)(2008-12#1)
was conducted to determine the##7##5##(1995-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2011-2#1)
was conducted to determine whether##3##5##(1995-8#1)(2008-10#1)(2008-7#1)
was conducted to determine##14##4##(1992-3#1)(1995-1#1)(1995-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#1)(2011-2#1)
was conducted to establish##2##4##(2008-10#1)(2011-2#1)
was conducted to evaluate the##6##5##(2008-10#2)(2008-11#1)(2008-6#1)(2010-4#1)(2012-2#1)
was conducted to evaluate##8##4##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2010-4#1)(2012-2#1)
was conducted to examine the##2##5##(2008-10#1)(2008-12#1)
was conducted to examine##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
was conducted to explore the##2##5##(2008-11#1)(2008-12#1)
was conducted to explore##3##4##(2008-11#1)(2008-12#1)(2009-5#1)
was conducted to identify##7##4##(1995-10#1)(1997-1#1)(2008-10#2)(2010-11#1)(2013-1#2)
was conducted to investigate the effect of different##2##8##(2008-12#2)
was conducted to investigate the effect of##3##7##(2008-12#2)(2011-2#1)
was conducted to investigate the effects of##2##7##(1992-2#1)(2011-2#1)
was conducted to investigate the##6##5##(1992-2#1)(2008-10#1)(2008-12#2)(2011-2#2)
was conducted to##69##3##(1990-12#1)(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#19)(2008-11#5)(2008-12#9)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#4)(2013-1#5)
was conducted under the##2##4##(2008-10#1)(2008-11#1)
was conducted using a##4##4##(1991-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
was conducted using##12##3##(1991-12#1)(1996-2#1)(2008-10#3)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
was conducted with##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-3#1)
was conducted##190##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#1)(1994-1#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#3)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#49)(2008-11#11)(2008-12#16)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-5#3)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#13)(2012-12#4)(2012-2#9)(2012-3#7)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#17)(2013-7#1)(2013-8#2)
was conferred by a single##3##5##(2008-10#3)
was conferred by##4##3##(2008-10#4)
was confined to the##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
was confined to##7##3##(1995-8#1)(2008-10#3)(2008-7#1)(2012-2#1)(2012-3#1)
was confirmed after##4##3##(1990-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
was confirmed and##5##3##(1993-8#1)(2008-10#3)(2008-9#1)
was confirmed at##3##3##(2008-10#2)(2011-2#1)
was confirmed by an##2##4##(2008-10#1)(2008-7#1)
was confirmed by analysis of##5##5##(2008-10#5)
was confirmed by culture##2##4##(2009-11#1)(2011-2#1)
was confirmed by experiments##2##4##(2008-11#2)
was confirmed by polymerase chain reaction##3##6##(2008-10#3)
was confirmed by the good concordance between found and certified values in the analysis of certified reference materials##2##18##(2008-10#2)
was confirmed by the##14##4##(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#7)(2008-12#1)(2011-2#2)(2013-1#1)
was confirmed by western blotting##2##5##(2008-10#1)(2008-11#1)
was confirmed by##89##3##(1990-3#1)(1990-8#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#41)(2008-11#11)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#2)
was confirmed experimentally##2##3##(1996-2#1)(2008-7#1)
was confirmed for the##3##4##(2008-10#1)(2008-11#1)(2010-3#1)
was confirmed for##6##3##(2008-10#2)(2008-11#1)(2010-3#2)(2012-3#1)
was confirmed in the##4##4##(1995-11#1)(2008-10#3)
was confirmed in##11##3##(1995-11#1)(2008-10#8)(2008-12#1)(2011-2#1)
was confirmed on##2##3##(2013-7#1)(2013-8#1)
was confirmed that the##2##4##(1991-9#1)(2008-8#1)
was confirmed that##5##3##(1991-9#1)(1995-12#1)(2008-10#2)(2008-8#1)
was confirmed through##3##3##(1995-12#1)(2008-5#1)(2013-1#1)
was confirmed to be##5##4##(1997-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-3#1)
was confirmed to##8##3##(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2012-3#1)
was confirmed using##3##3##(1994-6#1)(2008-10#2)
was confirmed with##3##3##(1995-2#1)(2008-10#1)(2010-5#1)
was confirmed##163##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-9#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#4)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-7#1)(2008-10#71)(2008-11#14)(2008-12#2)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#2)
was confounded##2##2##(2008-10#1)(2008-8#1)
was conjugated to##4##3##(2008-10#3)(2012-2#1)
was conjugated with##2##3##(2010-12#1)(2013-1#1)
was conjugated##6##2##(2008-10#3)(2010-12#1)(2012-2#1)(2013-1#1)
was connected to##3##3##(2008-10#2)(2008-12#1)
was consecutively##2##2##(1994-5#1)(2008-10#1)
was consequently##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
was considerable##4##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
was considerably higher##3##3##(1993-8#1)(2008-11#1)(2013-1#1)
was considerably less##2##3##(1991-12#1)(1992-6#1)
was considerably lower##2##3##(1990-6#1)(2008-10#1)
was considerably reduced in##2##4##(2008-10#1)(2008-12#1)
was considerably reduced##3##3##(1993-2#1)(2008-10#1)(2008-12#1)
was considerably##18##2##(1990-12#1)(1990-6#1)(1991-12#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
was considered a##4##3##(1993-1#1)(2008-1#1)(2010-12#1)(2013-1#1)
was considered as##4##3##(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
was considered by##2##3##(2008-7#2)
was considered in##2##3##(2012-12#2)
was considered the##2##3##(2008-10#1)(2011-2#1)
was considered to be a##3##5##(2008-10#2)(2010-12#1)
was considered to be##8##4##(1996-3#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)
was considered to##9##3##(1996-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)
was considered##42##2##(1991-12#1)(1993-1#1)(1993-12#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-3#1)(2008-7#4)(2009-7#1)(2010-11#2)(2010-12#2)(2010-7#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#5)
was consistent among##2##3##(1997-3#1)(2008-10#1)
was consistent with a##2##4##(2008-10#2)
was consistent with the##12##4##(1993-1#1)(1993-12#1)(1995-12#1)(2008-10#6)(2008-8#2)(2008-9#1)
was consistent with what##2##4##(2007-12#1)(2008-7#1)
was consistent with##29##3##(1990-5#1)(1990-8#1)(1993-1#1)(1993-12#1)(1994-5#2)(1995-12#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-6#1)(2012-3#1)
was consistent##33##2##(1990-5#1)(1990-8#1)(1993-1#1)(1993-12#1)(1994-5#2)(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
was consistently associated with##2##4##(2008-10#1)(2012-12#1)
was consistently isolated from##2##4##(2008-10#2)
was consistently present in##2##4##(2008-10#2)
was consistently##16##2##(1992-10#1)(1992-2#1)(2008-10#9)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
was constant in##2##3##(2011-2#1)(2012-3#1)
was constant##5##2##(1990-12#1)(1993-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
was constantly##2##2##(2008-10#1)(2011-2#1)
was constituted by the##3##4##(2008-10#2)(2010-8#1)
was constituted by##4##3##(1993-11#1)(2008-10#2)(2010-8#1)
was constituted##5##2##(1993-11#1)(2008-10#2)(2008-9#1)(2010-8#1)
was constructed and tested##3##4##(2008-10#3)
was constructed and##17##3##(1991-7#1)(1992-3#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-8#5)(2008-9#1)
was constructed as a##2##4##(2008-10#2)
was constructed by immobilizing##3##4##(2008-10#3)
was constructed by inserting##2##4##(1995-8#1)(2008-8#1)
was constructed by using##3##4##(2008-11#1)(2008-8#1)(2011-3#1)
was constructed by##20##3##(1995-8#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#4)(2008-9#1)(2011-3#2)
was constructed for the##2##4##(2008-10#2)
was constructed for##5##3##(2008-10#3)(2009-10#1)(2011-1#1)
was constructed from a##2##4##(2007-11#1)(2008-10#1)
was constructed from##4##3##(2007-11#1)(2008-10#2)(2010-8#1)
was constructed in which##3##4##(1994-5#1)(2008-10#1)(2010-5#1)
was constructed in##4##3##(1994-5#1)(2008-10#1)(2010-5#1)(2011-2#1)
was constructed to##8##3##(1991-1#1)(2008-10#3)(2008-11#2)(2008-9#2)
was constructed using the##4##4##(1993-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
was constructed using##11##3##(1993-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#4)(2008-9#2)
was constructed with a##2##4##(2008-10#2)
was constructed with##4##3##(2008-10#3)(2008-8#1)
was constructed##103##2##(1991-1#1)(1991-10#1)(1991-7#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#43)(2008-11#5)(2008-12#2)(2008-3#2)(2008-8#19)(2008-9#10)(2009-10#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#2)(2013-8#1)
was consumed##2##2##(2008-11#2)
was contained in##3##3##(1995-8#1)(1997-8#1)(2008-11#1)
was continued at##2##3##(1990-2#1)(2011-1#1)
was continued##6##2##(1990-2#1)(1994-8#1)(2008-11#1)(2008-5#1)(2011-1#2)
was continuous##2##2##(1995-10#1)(2008-10#1)
was continuously monitored by##2##4##(2008-10#2)
was continuously pumped through the##2##5##(2008-10#2)
was continuously##10##2##(2007-12#1)(2008-10#6)(2008-7#1)(2008-8#1)(2010-5#1)
was contrasted##2##2##(2008-10#1)(2008-5#1)
was controlled by a single dominant locus##3##7##(2008-10#3)
was controlled by a single dominant##4##6##(2008-10#4)
was controlled by a##6##4##(2008-10#6)
was controlled by##14##3##(1990-6#1)(2008-10#11)(2008-5#1)(2008-7#1)
was controlled in##3##3##(1990-6#1)(1997-8#1)(2008-10#1)
was controlled with##3##3##(1994-2#1)(2008-11#1)(2013-1#1)
was controlled##25##2##(1990-6#2)(1993-12#1)(1994-2#1)(1997-8#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
was convenient##2##2##(2008-10#2)
was converted to a##3##4##(1993-8#1)(2008-10#2)
was converted to##11##3##(1991-5#1)(1993-8#2)(1994-2#1)(2008-10#5)(2008-11#1)(2010-5#1)
was converted##15##2##(1990-12#1)(1991-5#2)(1993-8#2)(1994-2#1)(1996-5#1)(2008-10#6)(2008-11#1)(2010-5#1)
was corrected by##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
was corrected for##2##3##(2008-10#2)
was corrected##6##2##(2008-10#3)(2008-7#1)(2013-1#1)(2013-8#1)
was correlated to the##3##4##(1992-12#1)(2008-7#1)(2009-10#1)
was correlated to##6##3##(1992-12#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-2#1)
was correlated with an increased##2##5##(2008-10#1)(2008-7#1)
was correlated with the##13##4##(1996-12#1)(2008-10#8)(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
was correlated with##28##3##(1994-2#1)(1994-8#1)(1996-12#1)(2008-10#19)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
was correlated##42##2##(1992-12#1)(1994-2#1)(1994-8#1)(1996-12#1)(2008-10#26)(2008-11#3)(2008-6#1)(2008-7#2)(2009-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
was corroborated by##4##3##(1995-2#1)(1997-3#1)(2008-10#2)
was corroborated##7##2##(1995-2#1)(1997-3#1)(2008-10#5)
was counted##2##2##(2008-12#1)(2008-7#1)
was coupled to a##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
was coupled to##6##3##(1991-5#1)(2008-10#4)(2008-11#1)
was coupled with a##2##4##(1994-1#1)(1996-12#1)
was coupled with##5##3##(1994-1#1)(1995-11#1)(1996-12#1)(2008-11#1)(2008-9#1)
was coupled##11##2##(1991-5#1)(1994-1#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-9#1)
was covalently attached to##2##4##(1993-8#1)(2008-10#1)
was covalently bound##4##3##(1994-5#1)(2008-10#3)
was covalently immobilized on##2##4##(1997-2#1)(2008-10#1)
was covalently immobilized##4##3##(1997-2#1)(2008-10#3)
was covalently##14##2##(1993-8#1)(1994-5#1)(1997-2#1)(2008-10#11)
was covered with##2##3##(2008-10#1)(2013-1#1)
was created by##2##3##(2010-7#1)(2011-2#1)
was created in##4##3##(1996-1#1)(2008-9#1)(2010-5#1)(2013-8#1)
was created to##5##3##(1992-2#1)(2008-10#2)(2008-8#1)(2013-1#1)
was created##20##2##(1992-2#1)(1995-2#1)(1996-1#2)(1996-3#1)(2008-10#5)(2008-8#1)(2008-9#2)(2010-5#1)(2010-7#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
was critical for the##2##4##(2008-11#1)(2010-7#1)
was critical for##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
was critical##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-7#1)
was critically##5##2##(2008-10#3)(2012-3#1)(2013-8#1)
was cross-linked##2##2##(2008-10#2)
was crossed to##2##3##(2008-10#2)
was crossed with an##2##4##(2008-10#2)
was crossed with##6##3##(2008-10#6)
was crossed##9##2##(2008-10#9)
was crosslinked with##2##3##(2008-10#2)
was crosslinked##3##2##(1993-3#1)(2008-10#2)
was crucial in##2##3##(2013-1#2)
was crucial##3##2##(2008-10#1)(2013-1#2)
was crystallized in##2##3##(2008-9#2)
was crystallized##3##2##(1991-3#1)(2008-9#2)
was cultivated in a##2##4##(2008-11#1)(2008-7#1)
was cultivated in##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
was cultivated##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)
was cultured##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
was cut##4##2##(2008-10#2)(2008-9#1)(2011-3#1)
was cytotoxic##3##2##(1993-8#1)(2008-11#1)(2011-2#1)
was decided that##3##3##(2008-10#1)(2008-11#1)(2011-4#1)
was decided##6##2##(1991-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2011-4#1)(2013-1#1)
was decomposed##2##2##(2008-10#2)
was decreased and##2##3##(2012-2#1)(2013-8#1)
was decreased by the##2##4##(1994-6#1)(2008-10#1)
was decreased by##12##3##(1993-1#1)(1994-6#1)(2008-10#5)(2008-11#1)(2010-5#1)(2011-3#1)(2012-3#2)
was decreased in comparison##2##4##(1993-3#1)(2008-8#1)
was decreased in the presence of##2##6##(2008-10#2)
was decreased in the##4##4##(1996-12#1)(2008-10#2)(2008-9#1)
was decreased in##12##3##(1993-3#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-8#1)(2008-9#2)(2009-3#1)(2012-12#1)
was decreased to##2##3##(1994-12#1)(2008-10#1)
was decreased##45##2##(1991-9#1)(1993-1#1)(1993-3#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#13)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
was deduced from the##3##4##(1992-8#1)(2008-10#1)(2008-5#1)
was deduced to be##2##4##(2008-10#1)(2008-8#1)
was deduced to##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
was deduced##7##2##(1992-8#1)(1994-5#1)(2008-10#3)(2008-5#1)(2008-8#1)
was deemed##5##2##(1995-11#1)(2008-10#1)(2008-12#2)(2011-1#1)
was defined as a##3##4##(1995-8#1)(2008-6#1)(2008-8#1)
was defined as an##2##4##(2008-10#1)(2008-11#1)
was defined as the##6##4##(1993-12#1)(2008-10#2)(2008-8#1)(2009-11#1)(2011-2#1)
was defined as##15##3##(1993-12#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2011-2#2)(2013-7#1)
was defined by##2##3##(2010-6#1)(2012-3#1)
was defined using##2##3##(2010-11#1)(2013-1#1)
was defined##23##2##(1992-3#1)(1993-12#1)(1995-8#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
was degraded in##2##3##(2008-10#1)(2008-11#1)
was degraded##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
was delayed and##2##3##(2008-5#1)(2012-3#1)
was delayed for##4##3##(1992-12#1)(2008-10#2)(2010-11#1)
was delayed in##5##3##(1991-9#1)(2008-10#2)(2008-7#1)(2010-6#1)
was delayed until##2##3##(2008-10#1)(2008-7#1)
was delayed##24##2##(1990-6#1)(1991-2#1)(1991-9#1)(1992-12#1)(1997-2#1)(2008-10#9)(2008-5#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-3#1)
was deleted##4##2##(1997-3#1)(1997-7#1)(2008-9#1)(2009-8#1)
was delivered by a##2##4##(1991-2#1)(2008-10#1)
was delivered by##4##3##(1991-2#1)(1997-8#1)(2008-10#1)(2008-4#1)
was delivered in##2##3##(2008-8#1)(2012-2#1)
was delivered to the##2##4##(1994-12#1)(2011-2#1)
was delivered to##3##3##(1994-12#1)(2008-11#1)(2011-2#1)
was delivered via##2##3##(2012-3#1)(2013-1#1)
was delivered##17##2##(1990-12#2)(1991-2#1)(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
was demonstrated after##2##3##(1995-12#1)(2012-3#1)
was demonstrated and##4##3##(1992-12#1)(2008-10#2)(2008-5#1)
was demonstrated at##2##3##(2008-10#1)(2012-3#1)
was demonstrated by analyzing##6##4##(2008-10#6)
was demonstrated by detecting##2##4##(2008-11#2)
was demonstrated by monitoring##2##4##(2008-10#2)
was demonstrated by the##7##4##(2008-10#5)(2012-2#1)(2013-7#1)
was demonstrated by##33##3##(1991-3#1)(1993-12#1)(1996-12#1)(2008-10#23)(2008-11#3)(2008-5#1)(2010-9#1)(2012-2#1)(2013-7#1)
was demonstrated for the##4##4##(2008-10#4)
was demonstrated for##5##3##(2008-10#5)
was demonstrated in a field##2##5##(2008-10#2)
was demonstrated in a##4##4##(2008-10#3)(2009-6#1)
was demonstrated in the##5##4##(1991-5#1)(2008-10#4)
was demonstrated in this##2##4##(2008-10#1)(2008-9#1)
was demonstrated in##20##3##(1990-3#1)(1991-5#1)(1993-1#1)(1994-11#1)(1994-8#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-9#2)(2009-6#1)
was demonstrated on the##3##4##(1996-3#1)(2008-10#2)
was demonstrated on##6##3##(1993-1#1)(1996-3#1)(2008-10#4)
was demonstrated that the##10##4##(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#3)(2008-9#1)
was demonstrated that##19##3##(1993-8#1)(1995-2#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-8#5)(2008-9#1)
was demonstrated the##2##3##(2008-10#2)
was demonstrated to be##4##4##(1995-11#1)(1997-7#1)(2008-10#2)
was demonstrated to##6##3##(1995-11#1)(1997-7#1)(2008-10#4)
was demonstrated using##4##3##(2008-10#2)(2008-11#1)(2010-11#1)
was demonstrated with##2##3##(1990-8#1)(1995-2#1)
was demonstrated##147##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#80)(2008-11#11)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-6#1)(2009-8#2)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
was denied##2##2##(1995-12#1)(2010-10#1)
was density dependent##2##3##(2008-8#1)(2008-9#1)
was dependent on the##14##4##(1992-6#1)(1993-6#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-8#1)(2012-2#1)
was dependent on##24##3##(1990-11#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-2#2)(1996-12#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#1)(2012-2#1)
was dependent upon the##4##4##(1996-5#1)(2008-10#1)(2008-11#2)
was dependent upon##7##3##(1992-12#1)(1993-6#1)(1996-5#1)(2008-10#2)(2008-11#2)
was dependent##33##2##(1990-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-6#2)(1994-5#1)(1994-6#1)(1995-2#2)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-5#3)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
was deployed##2##2##(2008-10#1)(2011-3#1)
was deposited at##2##3##(2008-10#2)
was deposited in the##2##4##(1994-12#2)
was deposited on the##3##4##(2008-10#2)(2009-5#1)
was deposited##13##2##(1994-12#2)(2008-10#8)(2008-2#1)(2008-7#1)(2009-5#1)
was depressed##3##2##(1994-5#1)(2008-12#1)(2008-8#1)
was derivatized with##4##3##(1997-2#1)(2008-10#3)
was derived by##2##3##(2008-10#2)
was derived from the##4##4##(1994-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
was derived from##10##3##(1991-12#1)(1994-11#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-3#1)
was derived to##2##3##(2008-10#1)(2008-3#1)
was derived##23##2##(1991-12#1)(1994-11#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
was described and##3##3##(2008-10#2)(2011-7#1)
was described as a##2##4##(1995-12#1)(2011-2#1)
was described as##4##3##(1995-12#1)(2008-10#1)(2009-9#1)(2011-2#1)
was described by the##2##4##(2008-10#2)
was described by##6##3##(2008-10#4)(2011-1#1)(2013-1#1)
was described for determination of##2##5##(2008-10#2)
was described for the determination of##2##6##(2008-10#2)
was described for the##4##4##(2008-10#3)(2010-4#1)
was described for##6##3##(2008-10#5)(2010-4#1)
was described in##6##3##(1997-5#1)(2008-10#3)(2008-11#1)(2012-3#1)
was described##48##2##(1995-12#1)(1997-5#1)(2008-10#33)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#1)
was designated as##9##3##(1996-2#1)(2008-10#5)(2008-8#2)(2008-9#1)
was designated##14##2##(1996-2#1)(2008-10#10)(2008-8#2)(2008-9#1)
was designed and built##2##4##(2008-11#1)(2008-2#1)
was designed and synthesized##3##4##(2008-8#2)(2008-9#1)
was designed and##14##3##(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-8#1)
was designed as a##3##4##(2008-3#1)(2010-3#1)(2013-1#1)
was designed as##4##3##(2008-3#1)(2009-12#1)(2010-3#1)(2013-1#1)
was designed based on the##2##5##(1993-8#1)(2008-10#1)
was designed by##2##3##(2008-10#1)(2010-10#1)
was designed for##8##3##(1993-9#1)(2008-10#6)(2011-2#1)
was designed to assess the##2##5##(2009-4#1)(2011-2#1)
was designed to assess##4##4##(1994-3#1)(1996-3#1)(2009-4#1)(2011-2#1)
was designed to be##4##4##(1996-2#1)(2007-9#1)(2008-10#2)
was designed to compare##7##4##(1991-12#1)(1996-3#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
was designed to detect##2##4##(2008-10#2)
was designed to determine if##2##5##(1994-2#1)(2008-11#1)
was designed to determine##4##4##(1990-5#1)(1994-2#1)(2008-11#1)(2012-3#1)
was designed to estimate the##2##5##(2010-3#1)(2013-1#1)
was designed to evaluate the##3##5##(1995-8#1)(2011-2#1)(2013-1#1)
was designed to evaluate##4##4##(1995-8#1)(1996-1#1)(2011-2#1)(2013-1#1)
was designed to examine the##4##5##(1992-2#1)(1992-8#1)(2008-10#1)(2008-11#1)
was designed to examine##5##4##(1992-2#1)(1992-8#1)(1993-12#1)(2008-10#1)(2008-11#1)
was designed to investigate the influence of##2##7##(2011-2#2)
was designed to investigate the##7##5##(2008-10#1)(2009-8#1)(2011-2#4)(2012-12#1)
was designed to investigate##8##4##(2008-10#1)(2009-8#1)(2011-2#5)(2012-12#1)
was designed to study##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
was designed to test the##3##5##(1992-1#1)(1997-8#1)(2008-10#1)
was designed to##73##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-6#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-6#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-5#1)(2008-7#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
was designed with a##2##4##(1992-1#1)(2008-3#1)
was designed with##7##3##(1992-1#1)(2008-10#4)(2008-3#1)(2013-1#1)
was designed##130##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-6#1)(1997-8#1)(2007-9#1)(2008-1#2)(2008-10#37)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-8#2)(2011-2#10)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#5)(2013-8#3)
was desorbed##3##2##(2008-10#3)
was detached##2##2##(2011-2#1)(2013-1#1)
was detectable in##3##3##(2008-10#2)(2008-7#1)
was detectable##9##2##(1993-8#1)(2006-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)
was detected after##2##3##(2008-10#1)(2010-11#1)
was detected among all##2##4##(2008-10#2)
was detected among the##2##4##(2008-12#1)(2011-2#1)
was detected among##7##3##(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)
was detected and##3##3##(1996-12#1)(2008-10#2)
was detected as##3##3##(2008-10#2)(2009-6#1)
was detected at the##3##4##(1991-12#1)(1992-3#2)
was detected at##9##3##(1991-12#1)(1992-12#1)(1992-3#2)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
was detected between##6##3##(2008-10#4)(2008-11#1)(2008-8#1)
was detected by Western blot##2##5##(2008-8#1)(2008-9#1)
was detected by a##2##4##(2008-10#1)(2008-7#1)
was detected by direct##2##4##(2012-2#1)(2012-3#1)
was detected by polymerase chain reaction (PCR) in##2##8##(2008-10#2)
was detected by polymerase chain reaction##3##6##(2008-10#2)(2011-2#1)
was detected by the##4##4##(2008-10#3)(2008-12#1)
was detected by##36##3##(1990-5#1)(1992-9#1)(1995-2#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
was detected for##5##3##(1995-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
was detected from##5##3##(1996-6#1)(2008-10#3)(2009-5#1)
was detected in a##3##4##(1997-8#1)(2008-12#1)(2008-9#1)
was detected in about##2##4##(2008-11#1)(2010-5#1)
was detected in all##2##4##(2008-10#1)(2008-11#1)
was detected in both##2##4##(1996-12#1)(2008-10#1)
was detected in human##2##4##(1993-6#1)(1996-12#1)
was detected in only##3##4##(2008-11#1)(2011-2#2)
was detected in plants##2##4##(2008-10#2)
was detected in the inoculated##2##5##(2008-10#1)(2008-8#1)
was detected in the##34##4##(1991-5#1)(1991-6#1)(1992-8#1)(1993-2#1)(1995-12#1)(1995-6#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
was detected in##126##3##(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-6#1)(1997-3#1)(1997-8#2)(2008-10#55)(2008-11#6)(2008-12#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-1#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#1)
was detected on##9##3##(1994-11#1)(1997-8#1)(2008-10#6)(2011-2#1)
was detected only in##3##4##(2008-10#3)
was detected only##5##3##(2008-10#5)
was detected spectrophotometrically##2##3##(2008-10#2)
was detected to##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
was detected using##7##3##(1997-2#1)(2008-10#4)(2008-11#1)(2008-9#1)
was detected when##3##3##(1993-12#1)(2008-10#2)
was detected with a##2##4##(2008-10#1)(2008-11#1)
was detected with the##2##4##(1993-8#1)(2008-10#1)
was detected with##13##3##(1991-12#1)(1993-8#1)(1995-11#1)(1997-8#1)(2008-10#4)(2008-11#2)(2011-2#1)(2011-3#2)
was detected within the##2##4##(2008-10#1)(2008-7#1)
was detected within##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
was detected##309##2##(1990-5#3)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#5)(1996-6#2)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#5)(2008-10#143)(2008-11#15)(2008-12#10)(2008-3#1)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#9)(2009-1#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#2)(2012-12#4)(2012-2#3)(2012-3#6)(2012-6#1)(2013-1#9)(2013-8#3)
was determined according to the##2##5##(2008-10#2)
was determined according to##3##4##(2008-10#2)(2008-7#1)
was determined after##6##3##(1990-2#1)(1990-8#1)(2008-10#4)
was determined and turned out to be identical to##2##9##(1995-6#1)(1997-8#1)
was determined and##10##3##(1993-9#1)(1995-6#1)(1997-8#1)(2008-10#5)(2008-8#2)
was determined as a function of##2##6##(2008-10#2)
was determined as the##3##4##(1992-12#1)(1996-1#1)(2009-8#1)
was determined as##15##3##(1992-12#1)(1996-1#1)(2008-10#11)(2008-11#1)(2009-8#1)
was determined at 2##3##4##(2008-10#2)(2008-8#1)
was determined at##8##3##(1995-8#1)(2008-10#5)(2008-7#1)(2008-8#1)
was determined by GF-AAS##2##4##(2008-10#2)
was determined by HPLC##2##4##(2008-10#1)(2008-7#1)
was determined by a##9##4##(1993-2#1)(2008-10#7)(2008-5#1)
was determined by adsorptive##4##4##(2008-10#4)
was determined by atomic absorption spectrometry##4##6##(2008-10#4)
was determined by atomic##5##4##(2008-10#5)
was determined by both##2##4##(1993-11#1)(2008-10#1)
was determined by flow##2##4##(2008-10#2)
was determined by inoculating##2##4##(2008-10#2)
was determined by matrix-assisted##3##4##(2008-11#3)
was determined by means of##2##5##(2008-10#1)(2012-2#1)
was determined by the##20##4##(1990-3#1)(1990-5#1)(1994-8#1)(2008-10#9)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
was determined by use of##2##5##(2008-3#2)
was determined by##136##3##(1990-3#1)(1990-5#1)(1991-12#1)(1992-1#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-8#2)(2008-10#77)(2008-11#8)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#2)(2010-4#2)(2010-8#2)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
was determined directly##2##3##(2008-10#1)(2008-11#1)
was determined for both##2##4##(2008-10#1)(2008-12#1)
was determined for each##2##4##(1993-12#1)(2008-10#1)
was determined for the##3##4##(1990-5#1)(1993-12#1)(2009-10#1)
was determined for##17##3##(1990-5#1)(1993-12#2)(1994-9#1)(2008-10#7)(2008-12#1)(2008-5#2)(2009-10#1)(2009-7#1)(2013-8#1)
was determined from the##4##4##(2008-10#3)(2008-3#1)
was determined from##13##3##(1993-12#1)(1996-6#1)(2008-10#10)(2008-3#1)
was determined in order to##2##5##(2008-10#2)
was determined in plasma##2##4##(1994-2#1)(1997-3#1)
was determined in rat##2##4##(1994-5#1)(2008-8#1)
was determined in the##8##4##(2008-10#7)(2008-11#1)
was determined in##44##3##(1990-6#1)(1990-9#1)(1991-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1995-11#1)(1997-3#2)(1997-8#1)(2008-10#26)(2008-11#3)(2008-7#1)(2008-8#1)(2012-4#1)(2013-3#1)
was determined mainly by##2##4##(2008-10#2)
was determined on the##2##4##(1994-12#1)(2008-11#1)
was determined on##5##3##(1990-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2013-7#1)
was determined over##5##3##(2008-10#4)(2008-8#1)
was determined spectrophotometrically##2##3##(2008-10#2)
was determined that##3##3##(1991-4#1)(1992-6#1)(2008-10#1)
was determined through##2##3##(2007-9#1)(2008-10#1)
was determined to be (3##2##5##(2008-10#2)
was determined to be 0##5##5##(2008-10#4)(2011-2#1)
was determined to be 2##3##5##(2008-10#3)
was determined to be 3##3##5##(1993-8#1)(2008-10#2)
was determined to be 4##2##5##(1997-8#1)(2008-10#1)
was determined to be a mean of##2##7##(2010-6#2)
was determined to be at the##2##6##(1991-5#1)(2008-10#1)
was determined to be at##3##5##(1991-5#1)(2008-10#1)(2008-11#1)
was determined to be##45##4##(1991-5#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-11#1)(1997-8#1)(2008-10#32)(2008-11#2)(2008-3#1)(2010-11#1)(2010-6#2)(2011-2#1)
was determined to##51##3##(1991-5#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-11#1)(1997-8#1)(2008-10#33)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-6#2)(2011-2#2)(2012-2#1)
was determined using a##3##4##(2008-10#1)(2010-12#1)(2011-2#1)
was determined using the##5##4##(2008-10#4)(2008-9#1)
was determined using##21##3##(1993-9#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
was determined with a##2##4##(2008-10#1)(2008-3#1)
was determined with satisfactory results##2##5##(2008-10#2)
was determined with the##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
was determined with##12##3##(1990-12#1)(1990-5#1)(2008-10#7)(2008-3#1)(2008-8#1)(2009-8#1)
was determined##450##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-6#1)(1993-8#3)(1993-9#3)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#2)(1997-7#2)(1997-8#5)(2007-9#1)(2008-1#1)(2008-10#253)(2008-11#23)(2008-12#5)(2008-3#8)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#14)(2008-9#5)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#2)(2010-8#2)(2011-2#5)(2012-2#6)(2012-3#6)(2012-4#1)(2012-9#1)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#4)
was developed and applied to##2##5##(2008-10#2)
was developed and optimized##3##4##(2008-10#3)
was developed and tested##4##4##(2008-10#4)
was developed and used for the##2##6##(2008-10#1)(2008-7#1)
was developed and used for##3##5##(2008-10#2)(2008-7#1)
was developed and used to study the##2##7##(2008-10#1)(2008-8#1)
was developed and used to##6##5##(2008-10#4)(2008-7#1)(2008-8#1)
was developed and used##10##4##(2008-10#7)(2008-7#2)(2008-8#1)
was developed and utilized##2##4##(2008-10#2)
was developed and validated by##2##5##(2008-10#2)
was developed and validated in##2##5##(2008-10#2)
was developed and validated##9##4##(2008-10#8)(2008-11#1)
was developed and##39##3##(1992-1#1)(1997-2#1)(2007-9#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)
was developed as a##4##4##(1994-3#1)(2008-10#3)
was developed as an##2##4##(1997-2#1)(2011-2#1)
was developed as##6##3##(1994-3#1)(1997-2#1)(2008-10#3)(2011-2#1)
was developed based on a##2##5##(2008-10#2)
was developed based on mitochondrial##2##5##(2008-10#2)
was developed based on the##4##5##(2008-10#3)(2008-8#1)
was developed based on##15##4##(2008-10#12)(2008-12#1)(2008-8#1)(2013-1#1)
was developed by a##4##4##(1995-2#1)(1997-3#1)(2008-10#2)
was developed by coupling##5##4##(2008-10#5)
was developed by immobilizing##2##4##(2008-10#2)
was developed by the##3##4##(1994-3#1)(2008-10#1)(2010-11#1)
was developed by using##3##4##(2008-10#3)
was developed by##25##3##(1990-12#1)(1991-2#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#17)(2010-11#1)(2010-7#1)(2012-2#1)
was developed for a##2##4##(2008-10#1)(2008-11#1)
was developed for determination of##7##5##(2008-10#7)
was developed for identification and##2##5##(1995-12#1)(2008-10#1)
was developed for monitoring##2##4##(2008-10#2)
was developed for quantitative##2##4##(2008-10#2)
was developed for simultaneous determination of##4##6##(2008-10#4)
was developed for simultaneous##6##4##(2008-10#6)
was developed for the analysis of organophosphorus pesticides##2##8##(2008-10#2)
was developed for the analysis of##5##6##(2008-10#5)
was developed for the detection of##5##6##(1990-12#1)(2008-10#4)
was developed for the determination of cadmium in##2##8##(2008-10#2)
was developed for the determination of the##2##7##(2008-10#2)
was developed for the determination of##39##6##(2008-10#37)(2008-11#1)(2011-3#1)
was developed for the direct##2##5##(2008-10#2)
was developed for the quantitation of##2##6##(2008-10#2)
was developed for the rapid##3##5##(2008-10#3)
was developed for the separation and##3##6##(2008-10#3)
was developed for the separation of##2##6##(2008-10#2)
was developed for the separation##5##5##(2008-10#5)
was developed for the simultaneous determination of##3##7##(2008-10#3)
was developed for the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
was developed for the simultaneous##7##5##(2008-10#7)
was developed for the spectrophotometric determination of##2##7##(2008-10#2)
was developed for the##87##4##(1990-12#1)(2008-10#81)(2008-11#3)(2008-6#1)(2011-3#1)
was developed for##137##3##(1990-12#1)(1995-11#1)(1995-12#2)(1997-2#1)(2008-10#121)(2008-11#6)(2008-12#1)(2008-3#1)(2008-6#1)(2009-3#1)(2011-3#1)
was developed from a cross between##2##6##(2008-10#2)
was developed from a##4##4##(2008-10#4)
was developed from##6##3##(1991-2#1)(2008-10#4)(2008-6#1)
was developed in a##3##4##(2008-10#2)(2008-7#1)
was developed in order to##5##5##(1990-2#1)(1991-3#1)(1996-12#1)(2008-10#1)(2008-11#1)
was developed in the##3##4##(2008-10#3)
was developed in this work##3##5##(2008-10#3)
was developed in this##5##4##(2008-10#5)
was developed in which the##2##5##(2008-11#2)
was developed in which##5##4##(1992-3#1)(2008-10#1)(2008-11#2)(2008-3#1)
was developed in##32##3##(1990-2#1)(1991-3#1)(1992-3#1)(1996-12#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
was developed on the##2##4##(2008-10#1)(2008-3#1)
was developed over##2##3##(1997-6#1)(2008-7#1)
was developed recently##2##3##(2008-10#1)(2008-9#1)
was developed that included##2##4##(1997-1#1)(2010-7#1)
was developed that##12##3##(1990-8#1)(1997-1#1)(2008-10#7)(2008-7#1)(2009-6#1)(2010-7#1)
was developed to assess##3##4##(1996-12#1)(2008-11#1)(2010-9#1)
was developed to characterize##2##4##(2008-10#2)
was developed to describe the##2##5##(2008-10#1)(2008-7#1)
was developed to detect the##2##5##(1991-12#1)(2013-1#1)
was developed to detect##3##4##(1991-12#1)(2008-10#1)(2013-1#1)
was developed to determine the##4##5##(2008-10#4)
was developed to determine##14##4##(2008-10#14)
was developed to evaluate##3##4##(1997-2#1)(2008-10#2)
was developed to examine##2##4##(2008-11#1)(2008-9#1)
was developed to generate##2##4##(2008-11#1)(2008-3#1)
was developed to monitor the##2##5##(2008-10#2)
was developed to predict the##2##5##(2008-10#2)
was developed to predict##4##4##(1992-3#1)(2008-10#3)
was developed to provide##3##4##(2008-10#1)(2008-8#1)(2012-2#1)
was developed to quantify##3##4##(2008-10#3)
was developed to separate##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
was developed to study the##4##5##(2008-10#3)(2008-11#1)
was developed to##87##3##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#50)(2008-11#6)(2008-12#3)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
was developed using an##2##4##(2008-10#2)
was developed using##18##3##(1990-2#1)(1992-6#1)(2008-10#14)(2008-11#1)(2013-1#1)
was developed which##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
was developed with a view to##2##6##(2008-10#1)(2008-11#1)
was developed with##12##3##(2008-10#8)(2008-11#1)(2008-12#1)(2009-12#1)(2012-3#1)
was developed##531##2##(1990-12#2)(1990-2#3)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-2#5)(1997-3#2)(1997-6#1)(2007-9#1)(2008-10#383)(2008-11#29)(2008-12#13)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#1)
was devised for##2##3##(2007-12#1)(2008-5#1)
was devised to##2##3##(2008-10#1)(2012-2#1)
was devised##8##2##(1990-8#1)(2007-12#1)(2008-10#4)(2008-5#1)(2012-2#1)
was devoid of##4##3##(1994-5#1)(1996-1#2)(2008-7#1)
was devoted to##2##3##(2008-10#1)(2008-7#1)
was diagnosed and##3##3##(1996-6#1)(2007-12#1)(2010-10#1)
was diagnosed as having a##2##5##(1996-9#1)(2011-2#1)
was diagnosed as having##7##4##(1991-11#1)(1996-9#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
was diagnosed as##12##3##(1991-11#1)(1991-12#1)(1995-2#1)(1996-9#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
was diagnosed at##3##3##(2010-11#1)(2012-3#2)
was diagnosed by##2##3##(2007-8#1)(2011-2#1)
was diagnosed in two##2##4##(1996-3#1)(2008-11#1)
was diagnosed in##13##3##(1991-8#1)(1992-5#1)(1992-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
was diagnosed more often##3##4##(2012-3#1)(2013-1#2)
was diagnosed on the basis of##2##6##(1995-12#1)(2008-11#1)
was diagnosed to have##3##4##(1997-8#1)(2008-12#1)(2012-2#1)
was diagnosed with a##2##4##(1995-12#1)(2012-12#1)
was diagnosed with severe##2##4##(2010-10#1)(2012-3#1)
was diagnosed with the##2##4##(2008-10#1)(2013-8#1)
was diagnosed with##21##3##(1994-1#1)(1995-12#1)(1996-5#1)(1997-3#2)(2008-10#1)(2008-12#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
was diagnosed##76##2##(1991-11#1)(1991-12#1)(1991-8#1)(1992-5#1)(1992-9#1)(1994-1#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-5#3)(1997-8#4)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#2)(2009-1#1)(2009-12#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#7)(2013-8#2)
was different between the##2##4##(2008-10#2)
was different between##3##3##(2008-10#3)
was different for##2##3##(2008-10#2)
was different from that of the##2##6##(2008-10#2)
was different from that of##3##5##(2008-10#3)
was different from that##4##4##(2008-10#3)(2008-11#1)
was different from##7##3##(2008-10#5)(2008-11#1)(2008-8#1)
was different##20##2##(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#12)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)
was difficult to identify##2##4##(2008-10#2)
was difficult to##6##3##(1990-2#1)(2008-10#3)(2008-11#1)(2008-12#1)
was difficult##7##2##(1990-2#1)(2008-10#4)(2008-11#1)(2008-12#1)
was digested with##7##3##(1990-2#1)(1990-5#1)(1994-11#1)(1996-12#1)(2008-10#3)
was digested##8##2##(1990-2#1)(1990-5#1)(1992-6#1)(1994-11#1)(1996-12#1)(2008-10#3)
was diluted##6##2##(1992-3#1)(2008-10#4)(2011-2#1)
was diminished by##2##3##(1993-12#1)(1995-8#1)
was diminished##4##2##(1993-12#1)(1995-8#1)(2008-10#1)(2008-9#1)
was directed by##2##3##(2008-9#1)(2010-1#1)
was directed toward##2##3##(1993-1#1)(2008-9#1)
was directed##5##2##(1993-1#1)(2008-7#1)(2008-9#2)(2010-1#1)
was directly correlated with##2##4##(2008-10#1)(2011-2#1)
was directly determined##2##3##(1993-6#1)(2008-10#1)
was directly introduced##3##3##(2008-10#2)(2008-9#1)
was directly measured##2##3##(2008-10#1)(2008-3#1)
was directly proportional to the##3##5##(2008-10#2)(2008-11#1)
was directly proportional to##4##4##(2008-10#3)(2008-11#1)
was directly related to the##2##5##(1990-5#1)(2008-10#1)
was directly related to##4##4##(1990-5#2)(2008-10#2)
was directly##39##2##(1990-5#2)(1993-6#1)(1995-11#1)(2008-10#27)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
was discarded##2##2##(2008-10#1)(2008-11#1)
was discharged from the hospital##2##5##(2010-12#1)(2011-2#1)
was discharged home##2##3##(2008-12#1)(2010-7#1)
was discharged on the##3##4##(2010-5#1)(2012-12#1)(2013-1#1)
was discharged on##4##3##(2010-5#1)(2012-12#1)(2013-1#2)
was discharged##10##2##(1997-8#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
was disclosed##3##2##(1997-3#2)(2008-8#1)
was discontinued##5##2##(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)
was discovered as a result of##2##6##(1991-11#1)(2008-10#1)
was discovered as a##3##4##(1991-11#1)(2008-10#1)(2011-2#1)
was discovered by##3##3##(1990-5#1)(2008-7#1)(2008-8#1)
was discovered in the##2##4##(2008-9#1)(2010-7#1)
was discovered in##3##3##(1996-8#1)(2008-9#1)(2010-7#1)
was discovered on##3##3##(2010-7#1)(2013-1#1)(2013-8#1)
was discovered that##3##3##(1997-1#1)(2008-10#1)(2012-3#1)
was discovered##26##2##(1990-2#1)(1990-5#1)(1991-11#1)(1994-11#1)(1996-8#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
was discussed and the##2##4##(2008-10#2)
was discussed and##4##3##(2008-10#3)(2009-7#1)
was discussed in##4##3##(1997-8#1)(2008-10#3)
was discussed##34##2##(1995-11#1)(1997-1#1)(1997-8#1)(2008-10#25)(2008-8#4)(2009-7#1)(2011-7#1)
was disease##3##2##(1994-8#1)(2008-10#2)
was dislodged##2##2##(1997-6#1)(2011-2#1)
was dispersed##2##2##(2008-10#2)
was displaced##3##2##(1993-1#1)(1994-11#1)(1994-3#1)
was displayed on##2##3##(1996-2#1)(2013-8#1)
was displayed##3##2##(1993-3#1)(1996-2#1)(2013-8#1)
was disrupted in##3##3##(1993-3#1)(2008-10#2)
was disrupted##7##2##(1993-3#1)(1997-7#1)(2008-10#4)(2008-7#1)
was dissociated##3##2##(1991-12#1)(1993-8#1)(2008-11#1)
was dissolved in##7##3##(2008-10#4)(2008-11#2)(2008-5#1)
was dissolved with##6##3##(2008-10#6)
was dissolved##13##2##(2008-10#10)(2008-11#2)(2008-5#1)
was distinct from that of##3##5##(1992-10#1)(2008-10#1)(2008-6#1)
was distinct from##7##3##(1992-10#1)(2008-10#4)(2008-12#1)(2008-6#1)
was distinct##8##2##(1992-10#1)(2008-10#5)(2008-12#1)(2008-6#1)
was distributed among fields within##2##5##(2008-10#2)
was distributed among fields##3##4##(2008-10#3)
was distributed among##9##3##(2008-10#9)
was distributed in the##2##4##(2008-10#2)
was distributed in##3##3##(2008-10#3)
was distributed within##7##3##(2008-10#7)
was distributed##25##2##(1992-3#1)(1992-6#1)(1996-1#1)(2008-10#22)
was divided into five##2##4##(2008-10#1)(2008-7#1)
was divided into four##2##4##(2008-10#1)(2008-5#1)
was divided into three##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
was divided into two##2##4##(2009-8#1)(2011-2#1)
was divided into##18##3##(1990-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
was divided##21##2##(1990-12#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#3)
was documented in##8##3##(1991-7#1)(1992-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#2)
was documented##14##2##(1991-7#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#3)
was dominant in the##2##4##(1992-3#1)(2008-10#1)
was dominant in##3##3##(1992-3#1)(2008-10#2)
was dominant##4##2##(1992-3#1)(1997-7#1)(2008-10#2)
was dominated by##4##3##(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
was done and##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
was done at##4##3##(1990-3#1)(1995-12#1)(2008-10#1)(2010-7#1)
was done before and##2##4##(2008-10#1)(2012-2#1)
was done by a##2##4##(2010-1#1)(2013-1#1)
was done by comparison##2##4##(2008-10#2)
was done by using the##2##5##(2008-10#1)(2008-11#1)
was done by using##4##4##(2008-10#3)(2008-11#1)
was done by##20##3##(1991-2#1)(1993-11#1)(2008-10#13)(2008-11#1)(2010-1#1)(2010-6#1)(2012-12#1)(2013-1#1)
was done for##2##3##(2012-2#1)(2013-1#1)
was done in a##2##4##(2008-10#1)(2011-2#1)
was done in the##2##4##(2008-10#2)
was done in##11##3##(1994-12#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-12#2)(2011-2#2)
was done on##3##3##(1993-6#1)(1997-7#1)(2012-2#1)
was done through the##2##4##(2012-12#1)(2012-2#1)
was done to compare the##2##5##(2008-10#1)(2010-7#1)
was done to identify##2##4##(2012-12#1)(2013-8#1)
was done to##12##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
was done using##5##3##(1997-8#1)(2008-10#3)(2008-5#1)
was done with the##2##4##(2008-7#1)(2012-12#1)
was done with##7##3##(1990-12#1)(2008-10#1)(2008-7#2)(2011-3#1)(2012-12#1)(2013-8#1)
was done within##3##3##(2012-3#1)(2013-1#2)
was done##97##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#28)(2008-11#2)(2008-12#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-11#1)(2010-1#1)(2010-6#2)(2010-7#2)(2011-2#7)(2011-3#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#5)
was dose dependent##2##3##(1994-11#1)(1995-5#1)
was dose-dependent##4##2##(1994-3#1)(1994-8#1)(1997-1#1)(2008-11#1)
was doubled to##2##3##(2008-11#2)
was doubled##3##2##(2008-11#3)
was doubly##2##2##(1991-3#1)(2008-10#1)
was down to##4##3##(1997-4#1)(2008-10#2)(2008-11#1)
was down##5##2##(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)
was down-regulated##4##2##(1993-8#1)(1995-11#1)(2008-8#2)
was downregulated in##3##3##(2009-8#1)(2010-1#1)(2010-12#1)
was downregulated##4##2##(2009-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
was dramatically##3##2##(1994-2#1)(2008-10#1)(2008-8#1)
was drastically##2##2##(2008-10#2)
was drawn from##2##3##(2008-10#1)(2008-11#1)
was drawn into the syringe##3##5##(2008-10#3)
was drawn##5##2##(2008-10#4)(2008-11#1)
was dried and##2##3##(2008-10#2)
was dried##5##2##(2008-10#5)
was driven by##5##3##(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#1)
was driven##6##2##(2008-10#2)(2008-11#2)(2010-11#1)(2013-1#1)
was due mainly to##4##4##(1994-8#1)(1996-11#1)(2008-10#1)(2008-7#1)
was due to a##6##4##(1993-8#1)(1994-12#1)(1995-8#1)(1997-1#1)(2008-10#2)
was due to both##2##4##(1994-6#1)(2008-9#1)
was due to differences in isolates between groups##2##8##(2008-10#2)
was due to the##11##4##(1994-11#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
was due to##51##3##(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#17)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was due##59##2##(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#21)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was during##2##2##(1991-5#1)(2010-10#1)
was earlier##2##2##(2008-10#1)(2013-1#1)
was early##2##2##(1997-8#1)(2008-10#1)
was easily##12##2##(1992-12#1)(1993-3#1)(2008-10#7)(2008-11#3)
was effected##2##2##(2008-10#1)(2008-11#1)
was effective against##2##3##(2008-10#2)
was effective for##2##3##(2008-10#2)
was effective in##12##3##(1990-12#1)(1990-6#1)(1994-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-12#1)(2009-6#1)(2011-2#2)
was effective##27##2##(1990-12#1)(1990-6#1)(1990-9#1)(1993-12#1)(1994-5#1)(1997-2#1)(2008-10#11)(2008-11#3)(2008-12#1)(2009-12#1)(2009-6#1)(2011-2#4)
was effectively##11##2##(1994-11#1)(2008-10#4)(2008-11#3)(2008-8#1)(2011-1#1)(2012-3#1)
was efficient##3##2##(1993-8#1)(1993-9#1)(2012-2#1)
was efficiently##4##2##(1991-10#1)(1992-8#1)(1995-8#1)(2008-10#1)
was either increased or##2##4##(1991-9#1)(2008-10#1)
was either##11##2##(1991-9#1)(1996-12#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#3)
was electrochemically##3##2##(2008-10#3)
was electrostatically##2##2##(2008-10#2)
was elevated and##2##3##(2008-5#1)(2009-1#1)
was elevated at the##2##4##(2008-10#1)(2011-2#1)
was elevated at##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
was elevated by DON##2##4##(2008-10#2)
was elevated by##6##3##(1993-8#1)(1994-8#1)(2008-10#3)(2012-2#1)
was elevated in##3##3##(1993-6#1)(1994-2#1)(1997-8#1)
was elevated##22##2##(1990-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#2)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
was elicited##4##2##(1997-8#1)(2008-11#1)(2009-10#1)(2012-12#1)
was eliminated by##5##3##(1994-11#1)(2008-10#3)(2008-11#1)
was eliminated in##2##3##(1995-12#1)(2008-10#1)
was eliminated##13##2##(1994-11#1)(1995-12#1)(2008-10#9)(2008-11#1)(2013-8#1)
was eluted from the##2##4##(2008-10#2)
was eluted from##4##3##(1992-6#1)(2008-10#3)
was eluted with a##2##4##(2008-10#2)
was eluted with##3##3##(2008-10#3)
was eluted##8##2##(1992-6#1)(2008-10#6)(2008-11#1)
was embedded in##3##3##(2008-10#3)
was employed and##3##3##(1996-9#1)(2008-10#2)
was employed as the##5##4##(2008-10#3)(2008-2#1)(2008-3#1)
was employed as##9##3##(1990-2#1)(2008-10#6)(2008-2#1)(2008-3#1)
was employed for extraction##2##4##(2008-10#2)
was employed for quantitative determination##3##5##(2008-10#3)
was employed for quantitative##4##4##(2008-10#4)
was employed for the determination of##6##6##(2008-10#6)
was employed for the##10##4##(2008-10#9)(2008-3#1)
was employed for##24##3##(2008-10#23)(2008-3#1)
was employed in order to obtain##2##6##(2008-10#1)(2009-7#1)
was employed in order to##3##5##(2008-10#1)(2008-11#1)(2009-7#1)
was employed in##9##3##(1990-12#1)(1993-1#1)(2008-10#4)(2008-11#1)(2009-7#1)(2013-1#1)
was employed to analyze the##3##5##(2008-10#2)(2008-11#1)
was employed to characterize the##2##5##(2008-10#2)
was employed to determine##4##4##(2008-10#2)(2008-11#2)
was employed to evaluate the##3##5##(2008-10#1)(2008-12#1)(2013-8#1)
was employed to investigate the##2##5##(2008-10#1)(2008-11#1)
was employed to monitor##2##4##(2008-10#2)
was employed to study the##2##5##(2008-10#2)
was employed to##42##3##(1990-6#1)(2008-10#29)(2008-11#6)(2008-12#1)(2008-3#1)(2009-7#2)(2013-8#2)
was employed using##2##3##(2008-10#1)(2009-7#1)
was employed with##3##3##(1992-1#1)(2008-10#1)(2010-5#1)
was employed##108##2##(1990-12#2)(1990-2#1)(1990-6#1)(1992-1#1)(1993-1#1)(1995-9#1)(1996-9#2)(2008-10#79)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2009-7#4)(2010-5#1)(2013-1#1)(2013-8#2)
was enabled by the##2##4##(2011-3#1)(2013-8#1)
was enacted##2##2##(1995-2#1)(2012-3#1)
was encapsulated##2##2##(2008-10#1)(2008-12#1)
was encountered in##2##3##(2008-10#1)(2008-7#1)
was encountered##5##2##(1990-9#1)(1995-5#1)(2008-10#1)(2008-7#2)
was enhanced after##2##3##(1992-6#1)(2008-6#1)
was enhanced and##3##3##(1997-4#1)(2008-10#1)(2008-12#1)
was enhanced by the##3##4##(1992-9#1)(2008-10#2)
was enhanced by##15##3##(1992-9#1)(1993-12#1)(1996-12#1)(1997-7#1)(2006-6#2)(2008-10#6)(2008-11#1)(2008-5#1)(2011-2#1)
was enhanced in##7##3##(2008-10#6)(2008-11#1)
was enhanced only##2##3##(2008-11#1)(2008-7#1)
was enhanced##52##2##(1990-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1994-8#1)(1996-12#3)(1997-4#1)(1997-7#1)(2006-6#2)(2008-10#21)(2008-11#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#1)
was enriched in##2##3##(1995-6#1)(2008-10#1)
was enriched with##2##3##(1996-2#1)(2008-10#1)
was enriched##4##2##(1995-6#1)(1996-2#1)(2008-10#2)
was ensured##2##2##(2008-10#2)
was entirely##2##2##(1991-12#1)(1995-8#1)
was entrapped in the##2##4##(2008-10#2)
was entrapped in##3##3##(2008-10#3)
was entrapped##4##2##(2008-10#4)
was envisaged##2##2##(2008-5#1)(2009-3#1)
was equal to 1##3##4##(1993-12#1)(2008-10#1)(2012-3#1)
was equal to or##3##4##(1990-12#1)(2008-10#1)(2013-1#1)
was equal to##8##3##(1990-12#1)(1993-12#1)(2008-10#3)(2008-3#1)(2012-3#1)(2013-1#1)
was equal##10##2##(1990-12#1)(1993-12#1)(2008-10#4)(2008-3#1)(2012-3#1)(2013-1#2)
was equally##4##2##(1992-12#1)(1992-3#1)(2008-11#2)
was equivalent to a##2##4##(2008-10#2)
was equivalent to##4##3##(2008-10#4)
was equivalent##7##2##(1995-11#1)(2008-10#5)(2010-9#1)
was especially##2##2##(2008-11#1)(2008-8#1)
was essential for the##2##4##(2008-8#1)(2013-1#1)
was essential for##8##3##(1991-9#1)(2008-10#2)(2008-7#1)(2008-8#3)(2013-1#1)
was essential to##2##3##(2008-10#1)(2008-8#1)
was essential##14##2##(1991-9#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#4)(2013-1#1)
was essentially##11##2##(1992-12#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
was established (genes##2##3##(2008-10#2)
was established after##3##3##(2008-10#2)(2012-12#1)
was established and##2##3##(2008-10#2)
was established as the##2##4##(1995-5#1)(2008-10#1)
was established as##6##3##(1995-5#1)(2008-10#4)(2008-12#1)
was established based on##2##4##(2008-10#1)(2013-1#1)
was established between##4##3##(2008-10#3)(2008-5#1)
was established by##14##3##(1990-5#1)(1995-12#1)(2008-10#7)(2008-11#3)(2008-9#1)(2013-8#1)
was established for the##3##4##(2008-10#3)
was established for##7##3##(2008-10#5)(2008-11#1)(2013-1#1)
was established from##2##3##(1994-11#1)(2008-11#1)
was established in the##3##4##(1995-2#1)(2008-10#2)
was established in##11##3##(1993-3#1)(1995-2#1)(1996-1#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-8#1)
was established on##2##3##(1993-6#1)(2007-8#1)
was established that##7##3##(1995-9#1)(2008-10#4)(2008-5#1)(2013-8#1)
was established to determine##2##4##(2008-10#1)(2008-11#1)
was established to##5##3##(1995-11#1)(1997-2#1)(2008-10#2)(2008-11#1)
was established using##3##3##(2008-10#2)(2008-11#1)
was established with the##2##4##(2008-10#2)
was established with##5##3##(1992-3#1)(2008-10#3)(2011-2#1)
was established##117##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-2#1)(2007-8#1)(2008-10#58)(2008-11#10)(2008-12#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#4)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-8#1)(2013-1#2)(2013-8#4)
was estimated according to##2##4##(1991-6#1)(2012-3#1)
was estimated as##12##3##(1990-11#1)(1993-8#1)(1995-1#1)(2008-10#8)(2008-11#1)
was estimated at##9##3##(1992-12#1)(1992-2#1)(2008-10#5)(2008-9#1)(2010-3#1)
was estimated by a##2##4##(1993-3#1)(2008-10#1)
was estimated by analysis of##2##5##(2008-10#2)
was estimated by quantitative##2##4##(2008-10#1)(2008-11#1)
was estimated by##19##3##(1993-3#1)(1994-2#1)(2008-10#12)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
was estimated for##2##3##(2008-10#2)
was estimated from the##2##4##(2008-10#2)
was estimated from##6##3##(1992-10#1)(2008-10#4)(2008-3#1)
was estimated in##4##3##(1996-8#1)(2008-10#2)(2012-2#1)
was estimated to be 0##4##5##(2008-10#3)(2013-1#1)
was estimated to be 1##2##5##(1995-11#1)(2008-10#1)
was estimated to be 2##2##5##(2008-10#2)
was estimated to be approximately##2##5##(2008-10#1)(2008-3#1)
was estimated to be less than##3##6##(2008-10#1)(2008-3#2)
was estimated to be##31##4##(1990-12#1)(1992-12#1)(1994-12#1)(1995-11#2)(1997-6#1)(2008-10#16)(2008-3#5)(2010-8#1)(2011-2#1)(2013-1#2)
was estimated to have##3##4##(1990-5#1)(1991-5#1)(2011-2#1)
was estimated to range##2##4##(2008-10#1)(2010-3#1)
was estimated to##36##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#1)(1994-12#1)(1995-11#2)(1997-6#1)(2008-10#17)(2008-3#5)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#2)
was estimated using##5##3##(2008-10#5)
was estimated with##3##3##(2008-10#3)
was estimated##118##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#2)(1996-8#1)(1997-6#1)(2008-1#1)(2008-10#69)(2008-11#4)(2008-12#1)(2008-3#7)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-3#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)
was evaluated according to the##3##5##(2008-10#1)(2011-1#1)(2013-1#1)
was evaluated according to##4##4##(2008-10#2)(2011-1#1)(2013-1#1)
was evaluated after##2##3##(2008-10#2)
was evaluated against##6##3##(2008-10#2)(2008-5#1)(2012-2#3)
was evaluated and the##2##4##(2008-10#2)
was evaluated and##5##3##(2008-10#5)
was evaluated as a function of##4##6##(2008-10#3)(2008-11#1)
was evaluated as##7##3##(2008-10#5)(2008-11#1)(2008-5#1)
was evaluated at the##3##4##(2008-10#3)
was evaluated at##9##3##(2008-10#7)(2008-5#2)
was evaluated by a##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
was evaluated by analysis of##2##5##(2008-10#2)
was evaluated by analyzing##6##4##(1997-3#1)(2008-10#5)
was evaluated by applying##2##4##(2008-10#1)(2008-5#1)
was evaluated by calculating##2##4##(2008-10#1)(2008-5#1)
was evaluated by comparing##2##4##(2008-10#2)
was evaluated by comparison with##3##5##(2008-10#3)
was evaluated by determining##2##4##(2008-10#2)
was evaluated by means of##5##5##(1991-12#1)(1997-3#1)(1997-4#1)(2008-10#2)
was evaluated by performing##2##4##(2008-10#1)(2013-8#1)
was evaluated by standard##2##4##(2008-10#2)
was evaluated by testing##2##4##(2008-10#1)(2013-8#1)
was evaluated by the##11##4##(2008-10#9)(2009-7#1)(2013-1#1)
was evaluated by using the##2##5##(2008-10#1)(2012-12#1)
was evaluated by using##4##4##(2008-10#3)(2012-12#1)
was evaluated by##74##3##(1991-11#1)(1991-12#1)(1993-1#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-3#2)(1997-4#1)(1997-9#1)(2008-10#45)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2011-3#2)(2012-12#1)(2013-1#3)(2013-8#3)
was evaluated for its##5##4##(2008-10#4)(2009-2#1)
was evaluated for resistance to##2##5##(2008-10#2)
was evaluated for the determination of##3##6##(2008-10#3)
was evaluated for the##9##4##(1997-2#1)(2008-10#7)(2013-1#1)
was evaluated for their##2##4##(2009-3#1)(2011-2#1)
was evaluated for##31##3##(1997-2#1)(2008-10#22)(2008-5#1)(2009-2#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#2)
was evaluated from##6##3##(2008-10#4)(2008-12#1)(2008-7#1)
was evaluated further##3##3##(1992-3#1)(2008-10#2)
was evaluated in a##4##4##(1996-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
was evaluated in an##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
was evaluated in bioassays##2##4##(2008-10#2)
was evaluated in greenhouse trials##2##5##(2008-10#2)
was evaluated in greenhouse##3##4##(2008-10#3)
was evaluated in terms of the##2##6##(2008-10#2)
was evaluated in terms of##3##5##(2008-10#3)
was evaluated in the greenhouse##2##5##(2008-10#2)
was evaluated in the##7##4##(1991-3#1)(2008-10#5)(2008-7#1)
was evaluated in##41##3##(1990-3#1)(1991-3#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-8#1)(2008-10#27)(2008-11#3)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
was evaluated on##9##3##(1993-3#1)(1996-12#1)(2008-10#4)(2008-5#1)(2012-2#2)
was evaluated over a##2##4##(2008-10#2)
was evaluated over##3##3##(2008-10#2)(2012-3#1)
was evaluated through the##2##4##(2008-10#2)
was evaluated through##5##3##(1991-1#1)(2008-10#4)
was evaluated to##6##3##(2008-10#5)(2008-5#1)
was evaluated using a##5##4##(2008-10#2)(2008-7#1)(2010-12#1)(2012-12#1)
was evaluated using the##5##4##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)
was evaluated using##19##3##(2008-10#9)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)
was evaluated with a##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
was evaluated with an##2##4##(2008-10#1)(2013-1#1)
was evaluated with reference##2##4##(2008-10#1)(2008-11#1)
was evaluated with respect to the##2##6##(2008-10#2)
was evaluated with respect to##4##5##(1993-1#1)(2008-10#3)
was evaluated with the##3##4##(1990-5#1)(2008-10#2)
was evaluated with##18##3##(1990-5#1)(1993-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
was evaluated##310##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#185)(2008-11#14)(2008-12#3)(2008-5#17)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#10)(2011-3#2)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#9)(2013-8#5)
was evaporated to dryness##5##4##(2008-10#5)
was evaporated##9##2##(2008-10#7)(2008-11#1)(2008-5#1)
was even more##2##3##(2007-12#1)(2008-5#1)
was even##6##2##(1990-5#1)(1993-3#1)(1995-11#1)(2007-12#1)(2008-5#1)(2012-2#1)
was eventually##2##2##(2008-10#1)(2008-7#1)
was evidence of##5##3##(1992-5#1)(1995-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
was evidence that##2##3##(2008-12#1)(2008-5#1)
was evidence##7##2##(1992-5#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)
was evidenced by##2##3##(1996-5#1)(2008-11#1)
was evidenced##6##2##(1990-8#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
was evident for##4##3##(2008-10#2)(2008-5#1)(2012-3#1)
was evident from the##2##4##(2008-10#1)(2013-1#1)
was evident in##4##3##(2008-10#2)(2008-8#1)(2012-5#1)
was evident##21##2##(1991-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-3#2)(2008-10#8)(2008-11#2)(2008-5#1)(2008-8#1)(2012-3#1)(2012-5#1)(2013-1#1)
was exacerbated by##2##3##(2008-10#1)(2011-10#1)
was examined among##2##3##(2008-10#1)(2012-2#1)
was examined and the##2##4##(1992-6#1)(2008-10#1)
was examined and##6##3##(1991-1#1)(1992-6#1)(2008-10#2)(2008-5#1)(2008-8#1)
was examined as a##5##4##(1994-5#1)(2008-10#2)(2010-1#1)(2012-2#1)
was examined as an##2##4##(2008-10#2)
was examined as##9##3##(1994-5#1)(2008-10#5)(2008-5#1)(2010-1#1)(2012-2#1)
was examined because of##2##4##(2011-2#1)(2012-3#1)
was examined because##3##3##(1994-5#1)(2011-2#1)(2012-3#1)
was examined by measuring##2##4##(2008-10#1)(2008-11#1)
was examined by reverse##2##4##(1995-8#1)(2011-2#1)
was examined by using##4##4##(2008-10#2)(2008-7#1)(2009-12#1)
was examined by##30##3##(1991-2#1)(1995-8#1)(1997-2#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2009-12#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
was examined during##2##3##(2008-10#1)(2012-8#1)
was examined for the##3##4##(1997-8#1)(2008-10#2)
was examined for##10##3##(1991-12#2)(1997-8#1)(2008-10#5)(2011-2#1)(2013-1#1)
was examined in a sample of##2##6##(2008-11#1)(2011-2#1)
was examined in a##6##4##(1991-8#1)(2008-11#1)(2009-3#1)(2011-2#2)(2013-1#1)
was examined in adult##2##4##(1996-12#1)(1997-2#1)
was examined in order to##2##5##(2008-10#2)
was examined in the##6##4##(1990-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2010-8#1)
was examined in##38##3##(1990-5#1)(1990-8#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-5#2)(2008-6#1)(2009-3#1)(2010-8#3)(2011-2#2)(2013-1#1)
was examined on##6##3##(1993-12#1)(1995-3#1)(1997-5#1)(2008-10#3)
was examined to##4##3##(2008-10#2)(2010-8#2)
was examined using a##3##4##(1992-6#1)(2008-10#2)
was examined using light##2##4##(2007-12#1)(2008-10#1)
was examined using##15##3##(1990-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-2#1)(2007-12#1)(2008-10#8)(2008-5#1)
was examined with the##2##4##(2008-10#1)(2009-10#1)
was examined with##3##3##(1996-2#1)(2008-10#1)(2009-10#1)
was examined##190##2##(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#3)(1994-11#3)(1994-2#2)(1994-3#2)(1994-5#4)(1995-3#1)(1995-8#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#3)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#77)(2008-11#9)(2008-12#1)(2008-2#1)(2008-5#13)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-1#2)(2010-8#5)(2011-2#8)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#2)
was excellent in##3##3##(1996-9#1)(2008-10#1)(2011-2#1)
was excellent with##2##3##(2008-10#2)
was excellent##16##2##(1991-8#1)(1993-2#1)(1994-12#1)(1996-8#1)(1996-9#1)(2008-10#6)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
was excised and##2##3##(2009-1#1)(2011-2#1)
was excised through##2##3##(2011-2#1)(2013-1#1)
was excised##5##2##(1992-12#1)(2009-1#1)(2011-2#2)(2013-1#1)
was excluded and##3##3##(1994-12#1)(2008-12#1)(2013-1#1)
was excluded by##2##3##(1991-6#1)(1995-2#1)
was excluded##8##2##(1991-6#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-1#1)(2013-1#1)
was exclusively##2##2##(2007-8#1)(2008-10#1)
was executed##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
was exhibited by##4##3##(2008-10#3)(2012-2#1)
was exhibited in##2##3##(2008-5#1)(2008-8#1)
was exhibited##6##2##(2008-10#3)(2008-5#1)(2008-8#1)(2012-2#1)
was expanded to include##2##4##(2008-10#1)(2012-2#1)
was expanded to##5##3##(2008-10#3)(2011-9#1)(2012-2#1)
was expanded##7##2##(1992-3#1)(2008-10#3)(2008-8#1)(2011-9#1)(2012-2#1)
was expected to be &lt##2##5##(2013-1#2)
was expected to be##3##4##(2008-10#1)(2013-1#2)
was expected##9##2##(1992-3#1)(1993-3#1)(2008-10#3)(2008-8#2)(2013-1#2)
was experimentally determined to be##2##5##(2008-10#2)
was experimentally determined##4##3##(1994-3#1)(2008-10#2)(2011-2#1)
was experimentally##10##2##(1994-3#1)(1995-11#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#1)
was explained by the##3##4##(1992-1#1)(2008-10#1)(2008-9#1)
was explained by##8##3##(1992-1#1)(2008-10#5)(2008-9#2)
was explained##13##2##(1992-1#1)(2008-10#9)(2008-12#1)(2008-9#2)
was exploited to##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
was exploited##6##2##(2008-10#4)(2008-7#1)(2008-8#1)
was explored as a##2##4##(2008-10#1)(2008-8#1)
was explored at the cellular level##2##6##(2008-10#2)
was explored by##3##3##(1995-8#1)(2008-10#2)
was explored in##2##3##(1990-12#1)(2009-10#1)
was explored##21##2##(1990-12#1)(1993-1#1)(1993-6#1)(1995-8#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-5#1)
was exponentially##2##2##(1995-6#1)(2008-10#1)
was exposed to the##2##4##(1990-6#1)(2008-11#1)
was exposed to##13##3##(1990-6#1)(1991-12#1)(1996-12#1)(1997-6#1)(2008-10#5)(2008-11#2)(2010-5#1)(2012-6#1)
was exposed##14##2##(1990-6#1)(1991-12#1)(1996-12#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2010-5#1)(2012-6#1)
was expressed as a##4##4##(1992-6#1)(2008-10#2)(2008-11#1)
was expressed as the percentage of##2##6##(2006-6#1)(2008-10#1)
was expressed as the##3##4##(2006-6#1)(2008-10#2)
was expressed as##9##3##(1992-6#1)(2006-6#1)(2008-10#6)(2008-11#1)
was expressed at high levels##2##5##(1995-2#1)(1996-12#1)
was expressed at##3##3##(1995-2#1)(1996-12#1)(2008-8#1)
was expressed by a##2##4##(2008-10#1)(2008-11#1)
was expressed by all##2##4##(1993-3#1)(2008-7#1)
was expressed by the##2##4##(1993-3#1)(1994-12#1)
was expressed by##10##3##(1990-12#1)(1993-3#3)(1994-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-8#1)
was expressed from##2##3##(2012-3#2)
was expressed in Escherichia coli##3##5##(1990-11#1)(1993-8#1)(2009-3#1)
was expressed in the##4##4##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
was expressed in##25##3##(1990-11#1)(1992-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-6#2)(2008-8#2)(2008-9#3)(2009-3#2)(2010-5#1)(2011-2#1)(2013-7#1)
was expressed inE##2##3##(2008-8#1)(2008-9#1)
was expressed only##2##3##(1992-4#1)(1996-12#1)
was expressed##67##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-6#3)(1996-12#2)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#15)(2008-11#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#5)(2009-3#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
was extended by##2##3##(2008-10#2)
was extended for##2##3##(2008-10#1)(2008-3#1)
was extended from##3##3##(2008-10#1)(2008-11#2)
was extended to##5##3##(2008-10#3)(2008-3#1)(2010-12#1)
was extended##17##2##(1997-8#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#2)(2010-12#1)
was extensive##3##2##(2008-10#2)(2008-9#1)
was extensively##4##2##(1992-1#1)(2008-10#1)(2008-2#1)(2010-11#1)
was extracted and##5##3##(1995-11#1)(2008-10#3)(2008-12#1)
was extracted by##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
was extracted from soil##2##4##(2008-10#2)
was extracted from the##3##4##(2008-10#2)(2008-11#1)
was extracted from##18##3##(2008-10#12)(2008-11#1)(2008-12#1)(2008-9#2)(2010-6#1)(2012-3#1)
was extracted in##3##3##(2008-10#3)
was extracted into the##3##4##(2008-10#3)
was extracted into##4##3##(2008-10#4)
was extracted quantitatively with 10 ml of##2##7##(2008-10#2)
was extracted to##3##3##(2008-10#2)(2009-6#1)
was extracted with TTCTOHA into octan-1-ol as##2##7##(2008-10#2)
was extracted with##8##3##(2008-10#5)(2008-11#2)(2012-2#1)
was extracted##55##2##(1995-11#1)(2008-10#39)(2008-11#3)(2008-12#4)(2008-8#1)(2008-9#2)(2009-6#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
was extremely low##5##3##(1991-12#1)(2008-10#2)(2009-7#1)(2010-6#1)
was extremely##10##2##(1990-12#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-6#1)
was fabricated and##3##3##(2008-10#3)
was fabricated by coating a##2##5##(2008-10#2)
was fabricated by coating##3##4##(2008-10#3)
was fabricated by##8##3##(2008-10#8)
was fabricated from##2##3##(2008-10#2)
was fabricated using##2##3##(2008-10#2)
was fabricated##22##2##(2008-10#19)(2008-2#1)(2008-3#1)(2009-11#1)
was facilitated by##3##3##(1991-7#1)(1995-12#1)(2008-10#1)
was facilitated##5##2##(1991-7#1)(1995-12#1)(1996-6#1)(2008-10#2)
was far below##2##3##(1997-4#1)(2008-10#1)
was far##4##2##(1994-2#1)(1997-3#1)(1997-4#1)(2008-10#1)
was fast and##3##3##(2008-10#3)
was fast##4##2##(2008-10#4)
was faster in the##2##4##(2008-11#1)(2008-8#1)
was faster in##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
was faster than that##2##4##(2008-10#2)
was faster than##3##3##(1994-1#1)(2008-10#2)
was faster##11##2##(1994-1#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
was favorable##2##2##(2009-6#1)(2013-1#1)
was favored by##3##3##(2008-10#3)
was favored##4##2##(2008-10#3)(2008-12#1)
was favourable with##2##3##(2008-5#1)(2010-12#1)
was favourable##4##2##(2008-5#1)(2008-7#2)(2010-12#1)
was feasible##2##2##(2008-10#1)(2008-8#1)
was fed with a low-nutrition diet##2##6##(2011-2#2)
was fed with a normal diet##2##6##(2011-2#2)
was fed with a##5##4##(2011-2#5)
was fed##8##2##(1990-3#1)(2008-10#1)(2008-7#1)(2011-2#5)
was felt to##2##3##(2008-7#1)(2009-5#1)
was felt##4##2##(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)
was filled with##4##3##(2008-10#1)(2008-6#1)(2010-3#1)(2013-1#1)
was filled##6##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-3#1)(2013-1#2)
was finally##7##2##(1994-3#1)(2008-10#5)(2011-2#1)
was finished with Amira 4##2##5##(2012-3#2)
was finished##4##2##(1995-3#1)(2008-10#1)(2012-3#2)
was first applied to##2##4##(2008-10#2)
was first applied##3##3##(2008-10#3)
was first described by##2##4##(2011-1#1)(2011-2#1)
was first described in the##2##5##(2008-10#1)(2012-2#1)
was first described in##5##4##(2008-10#3)(2011-2#1)(2012-2#1)
was first described##10##3##(1992-2#1)(2008-10#5)(2011-1#1)(2011-2#2)(2012-2#1)
was first detected at##2##4##(2008-10#1)(2009-6#1)
was first detected in the hemolymph##2##6##(2008-10#2)
was first detected in the##3##5##(2008-10#3)
was first detected in##4##4##(2008-10#3)(2012-2#1)
was first detected##8##3##(2008-10#5)(2009-6#1)(2012-2#2)
was first developed##2##3##(2008-10#1)(2008-11#1)
was first identified as a##2##5##(1995-2#1)(2008-10#1)
was first identified in##2##4##(2008-10#1)(2013-7#1)
was first identified##4##3##(1995-2#1)(2008-10#2)(2013-7#1)
was first introduced##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
was first noted##2##3##(1990-10#1)(2008-9#1)
was first observed in##3##4##(2008-10#3)
was first observed##5##3##(2008-10#5)
was first performed##2##3##(1994-2#1)(2008-10#1)
was first recognized##2##3##(1997-8#1)(2008-10#1)
was first reported in##4##4##(2008-10#4)
was first reported##6##3##(2008-10#4)(2008-9#1)(2013-1#1)
was first seen##2##3##(1996-12#1)(2011-2#1)
was first used to##2##4##(2008-11#2)
was first used##3##3##(2008-10#1)(2008-11#2)
was first##82##2##(1990-10#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#44)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
was firstly developed for the##2##5##(2008-10#2)
was firstly developed##3##3##(2008-10#3)
was firstly##12##2##(2008-10#9)(2008-9#1)(2011-2#1)(2013-8#1)
was fitted to##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
was fitted with##2##3##(1992-12#1)(2008-10#1)
was fitted##7##2##(1992-12#1)(2008-10#4)(2008-7#1)(2012-3#1)
was fixed at##3##3##(2008-10#2)(2008-5#1)
was fixed in a##2##4##(2008-10#2)
was fixed on##2##3##(2008-10#2)
was fixed##10##2##(2008-10#8)(2008-5#1)(2010-3#1)
was focused##3##2##(1991-6#1)(2007-12#1)(2008-10#1)
was followed at##2##3##(1993-1#1)(2008-10#1)
was followed by a significant##2##5##(1994-3#1)(2008-11#1)
was followed by a##5##4##(1990-11#1)(1994-3#1)(2008-11#2)(2013-1#1)
was followed by formation of##2##5##(2008-10#2)
was followed by##20##3##(1990-11#1)(1994-11#1)(1994-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-11#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was followed for##2##3##(2008-10#2)
was followed in##3##3##(1992-5#1)(2008-10#2)
was followed over##2##3##(2008-10#2)
was followed to##2##3##(2008-10#2)
was followed up##4##3##(2008-10#1)(2011-1#1)(2013-1#2)
was followed##42##2##(1990-11#1)(1992-5#1)(1993-1#1)(1994-11#2)(1994-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#20)(2008-11#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#2)
was for the first time##4##5##(2008-10#4)
was for the##5##3##(2008-10#5)
was for##11##2##(1992-2#1)(1993-11#1)(2008-10#8)(2008-12#1)
was forced to##2##3##(1992-1#1)(2008-10#1)
was forced##3##2##(1992-1#1)(2008-10#1)(2008-2#1)
was formed at the##3##4##(2008-10#2)(2008-11#1)
was formed at##4##3##(2008-10#3)(2008-11#1)
was formed by a##2##4##(2008-10#1)(2011-2#1)
was formed by##8##3##(2008-10#5)(2008-9#1)(2011-2#2)
was formed in##2##3##(2008-10#1)(2008-11#1)
was formed on a##2##4##(2008-10#2)
was formed to##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
was formed##32##2##(1990-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-5#1)(2008-10#15)(2008-11#5)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#3)(2013-1#1)
was formulated and##3##3##(2008-11#1)(2008-5#2)
was formulated to##2##3##(2008-7#1)(2012-2#1)
was formulated##7##2##(1996-8#1)(2008-11#2)(2008-5#2)(2008-7#1)(2012-2#1)
was found after##4##3##(1993-2#1)(2008-11#1)(2008-6#1)(2008-8#1)
was found among the##3##4##(2008-1#1)(2008-5#1)(2008-7#1)
was found among##8##3##(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
was found and##2##3##(2013-1#2)
was found around##2##3##(2008-10#1)(2008-9#1)
was found as 0##2##4##(2008-10#2)
was found as##8##3##(2008-10#7)(2011-1#1)
was found at the##5##4##(2008-10#2)(2008-11#1)(2008-8#1)(2010-9#1)
was found at##11##3##(1990-5#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-9#1)
was found between the determined##2##5##(2008-10#2)
was found between the number of##2##6##(1995-12#1)(2011-2#1)
was found between the##36##4##(1990-12#1)(1990-8#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-2#2)(1993-2#1)(1995-12#1)(1996-11#1)(1997-6#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
was found between##83##3##(1990-12#3)(1990-8#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-2#2)(1994-5#1)(1995-12#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#31)(2008-11#3)(2008-12#2)(2008-7#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-6#1)(2013-1#2)(2013-8#1)
was found by using##3##4##(2008-10#2)(2008-8#1)
was found by##11##3##(1990-6#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-8#1)
was found during##3##3##(1990-3#1)(2008-11#1)(2008-6#1)
was found for the##8##4##(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#2)
was found for##20##3##(1990-12#1)(1992-3#1)(2008-10#10)(2008-12#1)(2008-7#2)(2009-7#1)(2010-4#1)(2011-2#3)
was found from the##3##4##(2008-10#3)
was found from##4##3##(2008-10#3)(2012-12#1)
was found in &gt##2##4##(2008-10#1)(2008-7#1)
was found in 4##2##4##(2007-11#1)(2011-2#1)
was found in a##7##4##(1990-11#1)(1991-10#1)(1996-12#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
was found in all the##2##5##(1993-2#1)(2008-10#1)
was found in all##11##4##(1993-2#1)(1997-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
was found in both##2##4##(1993-2#1)(1997-6#1)
was found in some##2##4##(2008-10#1)(2013-1#1)
was found in the range##2##5##(2008-10#2)
was found in the##41##4##(1990-3#1)(1990-9#1)(1991-6#2)(1992-3#1)(1993-12#1)(1993-8#1)(1994-11#2)(1995-11#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
was found in two##2##4##(2008-10#2)
was found in##148##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#3)(1996-6#1)(1997-6#1)(1997-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#41)(2008-11#11)(2008-12#5)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#7)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
was found mainly in the##2##5##(2008-7#1)(2008-8#1)
was found more##2##3##(2008-10#1)(2008-5#1)
was found of##2##3##(1990-2#1)(1994-8#1)
was found on##6##3##(1993-12#1)(1996-6#1)(2008-10#3)(2008-12#1)
was found only in the##2##5##(1997-3#1)(2008-11#1)
was found only in##9##4##(1994-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
was found only##10##3##(1994-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
was found suitable for##2##4##(2008-11#1)(2008-12#1)
was found that at##3##4##(1991-5#1)(1994-3#1)(2008-10#1)
was found that both the##2##5##(2008-10#2)
was found that both##4##4##(2008-10#2)(2008-11#1)(2010-5#1)
was found that for##2##4##(2007-11#1)(2008-10#1)
was found that in the presence of##3##7##(1993-8#1)(2008-10#2)
was found that in the##5##5##(1993-8#1)(1994-8#1)(2008-10#3)
was found that in##6##4##(1993-1#1)(1993-8#1)(1994-8#1)(2008-10#3)
was found that the distribution of##2##6##(2008-8#2)
was found that the##87##4##(1990-8#1)(1991-1#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#50)(2008-11#3)(2008-12#1)(2008-2#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)
was found that their##2##4##(2008-10#2)
was found that there were##2##5##(1993-2#1)(2008-10#1)
was found that there##5##4##(1993-2#1)(2008-10#2)(2008-3#1)(2008-9#1)
was found that three##2##4##(2008-10#1)(2008-11#1)
was found that while##2##4##(2008-5#1)(2009-11#1)
was found that##211##3##(1990-12#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-11#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#2)(2008-10#99)(2008-11#12)(2008-12#7)(2008-2#3)(2008-3#3)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#15)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-2#1)(2010-5#3)(2010-7#2)(2011-1#1)(2011-2#5)(2013-1#1)
was found through the##2##4##(2008-10#2)
was found to affect##2##4##(2008-10#1)(2008-7#1)
was found to be 0##14##5##(1990-6#1)(2008-10#13)
was found to be 1##8##5##(2008-10#8)
was found to be 2##10##5##(1996-5#1)(2008-10#9)
was found to be 3##3##5##(2008-10#2)(2008-3#1)
was found to be 4##6##5##(1995-12#1)(2008-10#4)(2012-3#1)
was found to be 7##3##5##(1991-5#1)(2008-10#2)
was found to be a more##2##6##(2008-10#2)
was found to be a safe##2##6##(1990-11#1)(2010-7#1)
was found to be a viable##2##6##(2008-10#1)(2013-1#1)
was found to be a##24##5##(1990-11#1)(1990-9#1)(1991-5#1)(1992-12#1)(1993-8#1)(2008-10#9)(2008-11#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#1)
was found to be an efficient##2##6##(2007-12#1)(2012-2#1)
was found to be an##4##5##(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
was found to be approximately##3##5##(2008-10#2)(2008-11#1)
was found to be associated with##3##6##(1993-11#1)(1993-3#1)(2013-1#1)
was found to be better##3##5##(2008-10#3)
was found to be between##4##5##(2008-10#2)(2008-11#1)(2010-4#1)
was found to be close to##2##6##(2008-10#2)
was found to be comparable##2##5##(2008-10#2)
was found to be dependent on the##2##7##(1991-3#1)(2008-10#1)
was found to be dependent on##4##6##(1991-3#1)(1993-8#1)(2008-10#1)(2008-11#1)
was found to be dependent##5##5##(1991-3#1)(1993-8#1)(2008-10#2)(2008-11#1)
was found to be due to##3##6##(1993-9#1)(2008-10#1)(2008-9#1)
was found to be expressed##3##5##(1991-6#1)(2008-10#1)(2008-11#1)
was found to be followed##2##5##(2008-10#2)
was found to be greater##2##5##(1990-12#1)(1993-6#1)
was found to be higher than##2##6##(2008-11#2)
was found to be higher##3##5##(2008-11#3)
was found to be highly##5##5##(1992-12#1)(1995-8#1)(2008-10#3)
was found to be identical to##2##6##(2008-10#2)
was found to be improved##2##5##(2009-3#2)
was found to be in the range of##3##8##(2008-10#3)
was found to be in##4##5##(2008-10#4)
was found to be independent##2##5##(1990-12#1)(2008-10#1)
was found to be influenced by##2##6##(1994-5#1)(2008-11#1)
was found to be insensitive to##2##6##(2008-10#2)
was found to be less than 0##2##7##(2008-10#2)
was found to be less than##3##6##(2008-10#3)
was found to be less##4##5##(2008-10#3)(2008-9#1)
was found to be linear in the range of##2##9##(2008-10#2)
was found to be linear##4##5##(2008-10#3)(2012-2#1)
was found to be more effective##2##6##(2008-10#1)(2012-2#1)
was found to be more##8##5##(1990-12#1)(1990-6#1)(1997-3#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-2#1)
was found to be much##3##5##(2008-10#2)(2009-7#1)
was found to be negligible##2##5##(2008-10#2)
was found to be preferable##3##5##(2008-10#2)(2008-11#1)
was found to be present in##2##6##(2008-1#1)(2008-12#1)
was found to be present##3##5##(2008-1#1)(2008-10#1)(2008-12#1)
was found to be quite##2##5##(2008-10#2)
was found to be significantly higher##2##6##(1994-8#1)(2008-10#1)
was found to be significantly##10##5##(1994-3#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#2)(2013-7#1)
was found to be slightly##2##5##(1990-12#1)(1993-2#1)
was found to be statistically##3##5##(1990-2#2)(2011-2#1)
was found to be strongly##2##5##(2008-10#1)(2008-7#1)
was found to be suitable for the determination of##2##9##(2008-10#2)
was found to be suitable for the##3##7##(2008-10#3)
was found to be suitable for##4##6##(2008-10#4)
was found to be suitable##5##5##(2008-10#5)
was found to be superior to the##2##7##(1996-2#1)(2008-10#1)
was found to be superior##3##5##(1996-2#1)(2008-10#2)
was found to be the best##4##6##(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
was found to be the major##4##6##(2008-10#4)
was found to be the most sensitive##2##7##(2008-10#1)(2008-12#1)
was found to be the most suitable##2##7##(2008-10#1)(2012-2#1)
was found to be the most##8##6##(1992-1#1)(2008-10#3)(2008-12#1)(2008-9#2)(2012-2#1)
was found to be the##21##5##(1992-1#1)(1996-9#1)(2008-10#9)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#1)(2011-2#2)(2012-2#1)
was found to be very##7##5##(2008-10#3)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#1)
was found to be##369##4##(1990-11#2)(1990-12#5)(1990-2#6)(1990-5#1)(1990-6#3)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#2)(1992-1#1)(1992-12#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#201)(2008-11#24)(2008-12#6)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#7)(2008-8#4)(2008-9#5)(2009-11#1)(2009-3#4)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#8)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#1)
was found to bind##2##4##(2008-10#1)(2012-2#1)
was found to consist of##2##5##(1991-10#1)(1993-6#1)
was found to contain##4##4##(1993-6#1)(1994-5#1)(2008-5#1)(2011-2#1)
was found to correlate with##2##5##(1994-2#1)(2013-7#1)
was found to decrease the##4##5##(1997-2#1)(2008-10#1)(2010-4#1)(2012-2#1)
was found to decrease##7##4##(1990-5#1)(1997-2#1)(2008-10#2)(2010-4#1)(2010-8#1)(2012-2#1)
was found to depend on##2##5##(2008-10#2)
was found to depend##3##4##(2008-10#2)(2008-11#1)
was found to display##2##4##(2008-10#1)(2012-2#1)
was found to effectively##2##4##(2008-10#1)(2013-1#1)
was found to enhance the##2##5##(2008-10#1)(2008-11#1)
was found to exist between peak height and the concentration of the##2##12##(2008-10#2)
was found to exist##4##4##(1992-3#1)(2008-10#3)
was found to give satisfactory results##2##6##(2008-10#2)
was found to give the##2##5##(2008-10#1)(2008-11#1)
was found to give##8##4##(2008-10#7)(2008-11#1)
was found to have a highly##2##6##(2008-10#1)(2008-11#1)
was found to have a##18##5##(1992-6#1)(1993-9#1)(1994-11#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
was found to have an##4##5##(2008-10#2)(2008-11#1)(2008-7#1)
was found to have no##2##5##(1992-12#1)(2012-2#1)
was found to have##40##4##(1992-12#1)(1992-6#1)(1993-9#1)(1994-11#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-7#3)(2009-11#1)(2009-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
was found to increase with the##2##6##(2008-10#1)(2008-8#1)
was found to increase##9##4##(1992-8#1)(1994-3#1)(2008-10#4)(2008-11#2)(2008-8#1)
was found to induce##3##4##(1990-5#1)(1994-9#1)(2008-10#1)
was found to inhibit the##2##5##(1994-5#1)(2008-10#1)
was found to inhibit##4##4##(1994-5#2)(2008-10#1)(2008-11#1)
was found to obey##2##4##(2008-10#2)
was found to occur with##2##5##(1990-11#2)
was found to occur##3##4##(1990-11#2)(2008-10#1)
was found to produce a##2##5##(2008-10#2)
was found to produce##5##4##(2008-10#3)(2008-11#1)(2008-12#1)
was found to provide##4##4##(2008-10#3)(2008-3#1)
was found to reduce the##2##5##(1993-2#1)(2008-10#1)
was found to significantly##2##4##(1990-12#1)(2008-10#1)
was found to support##3##4##(2008-10#1)(2008-11#2)
was found to take##2##4##(2008-10#1)(2008-7#1)
was found to vary significantly##2##5##(2008-10#1)(2009-7#1)
was found to##551##3##(1990-11#4)(1990-12#6)(1990-2#6)(1990-5#4)(1990-6#3)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#3)(1992-3#2)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#4)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-6#3)(1995-8#1)(1996-2#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#269)(2008-11#45)(2008-12#11)(2008-2#2)(2008-3#6)(2008-5#9)(2008-6#1)(2008-7#14)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#6)(2009-7#6)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-2#11)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#1)
was found using##2##3##(2008-8#1)(2013-1#1)
was found when the##3##4##(1994-3#2)(2008-3#1)
was found when##7##3##(1994-3#2)(1996-2#1)(2008-3#1)(2008-5#2)(2011-2#1)
was found which is##2##4##(2008-10#2)
was found which##4##3##(1990-11#1)(1990-12#1)(2008-10#2)
was found with other##2##4##(1990-2#1)(2008-10#1)
was found with the##2##4##(1992-2#1)(2008-10#1)
was found with##19##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-6#2)(1994-5#1)(2008-10#4)(2008-7#4)(2011-2#2)(2012-12#1)(2013-1#1)
was found within a##2##4##(1992-9#1)(2008-10#1)
was found within and##2##4##(2008-10#2)
was found within the##2##4##(2008-10#2)
was found within##7##3##(1992-9#1)(2008-10#6)
was found##1256##2##(1990-11#6)(1990-12#14)(1990-2#10)(1990-3#2)(1990-5#9)(1990-6#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#6)(1991-6#6)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#6)(1992-6#3)(1992-8#5)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#10)(1993-3#3)(1993-6#7)(1993-8#5)(1993-9#5)(1994-1#3)(1994-11#4)(1994-2#1)(1994-3#7)(1994-5#9)(1994-6#2)(1994-8#6)(1994-9#1)(1995-11#5)(1995-12#6)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#5)(1996-11#1)(1996-12#5)(1996-2#6)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-6#3)(1997-7#3)(1997-8#4)(1997-9#1)(2006-6#1)(2007-11#5)(2007-12#4)(2007-8#2)(2008-1#4)(2008-10#540)(2008-11#84)(2008-12#32)(2008-2#5)(2008-3#12)(2008-5#29)(2008-6#6)(2008-7#48)(2008-8#31)(2008-9#20)(2009-1#3)(2009-10#2)(2009-11#4)(2009-12#2)(2009-3#9)(2009-4#2)(2009-7#11)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#39)(2011-3#3)(2012-12#5)(2012-2#15)(2012-3#8)(2012-6#1)(2013-1#27)(2013-7#3)(2013-8#8)
was founded in##2##3##(2008-11#1)(2011-2#1)
was founded##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2011-4#1)
was four##5##2##(1990-9#1)(1992-5#1)(2008-10#2)(2011-2#1)
was fractionated on##2##3##(1991-5#1)(2011-2#1)
was fractionated##3##2##(1991-5#1)(2008-12#1)(2011-2#1)
was free from##5##3##(2008-10#5)
was free of##6##3##(1991-8#1)(1992-9#1)(1994-8#1)(2009-1#1)(2011-2#2)
was free##11##2##(1991-8#1)(1992-9#1)(1994-8#1)(2008-10#5)(2009-1#1)(2011-2#2)
was frequency##2##2##(2008-10#1)(2008-2#1)
was frequent in##2##3##(2008-10#1)(2008-7#1)
was frequent##3##2##(2008-10#1)(2008-7#2)
was frequently##4##2##(1997-3#1)(2008-1#1)(2008-11#1)(2013-1#1)
was from 0##3##3##(2008-10#3)
was from 1##6##3##(2008-10#6)
was from 5##4##3##(2008-10#3)(2011-2#1)
was from the##3##3##(1997-6#1)(2008-10#1)(2012-3#1)
was from##32##2##(1997-6#1)(2008-10#24)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was fully##8##2##(1990-8#1)(1993-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-9#1)(2012-3#1)
was functional##2##2##(2008-10#2)
was functionalized##2##2##(2008-10#2)
was functionally##2##2##(1994-8#1)(2008-8#1)
was funded by the##2##4##(2008-10#1)(2012-2#1)
was funded##4##2##(1993-3#1)(1995-3#1)(2008-10#1)(2012-2#1)
was further characterized##2##3##(1990-5#1)(1994-11#1)
was further confirmed by##2##4##(2008-8#1)(2011-2#1)
was further demonstrated by##2##4##(1995-12#1)(2008-5#1)
was further demonstrated##4##3##(1995-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
was further enhanced by##2##4##(2008-10#1)(2008-11#1)
was further examined##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
was further reduced##3##3##(2008-10#2)(2008-11#1)
was further studied##2##3##(2008-10#1)(2008-11#1)
was further supported by##2##4##(2008-10#2)
was further tested##2##3##(2008-10#1)(2011-1#1)
was further used##2##3##(2008-10#1)(2008-12#1)
was further validated by##4##4##(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
was further validated##5##3##(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)
was further##57##2##(1990-11#1)(1990-5#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#19)(2008-11#6)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#6)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
was fused##4##2##(1991-5#1)(1996-3#1)(2008-10#1)(2008-9#1)
was generally poor##2##3##(2008-1#1)(2009-4#1)
was generally##22##2##(1990-2#1)(1991-2#1)(1994-3#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-9#2)(2009-4#1)(2012-2#1)(2012-3#1)
was generated by##9##3##(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
was generated from##6##3##(2008-10#4)(2008-2#1)(2008-3#1)
was generated in##2##3##(2008-10#1)(2013-8#1)
was generated using##2##3##(1991-9#1)(1997-4#1)
was generated##26##2##(1991-9#1)(1997-4#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-1#1)(2013-8#2)
was genetically mapped##2##3##(2008-9#2)
was genetically##3##2##(2008-10#1)(2008-9#2)
was given by the##3##4##(2008-10#3)
was given for##2##3##(2007-8#1)(2008-10#1)
was given in##4##3##(1990-10#1)(1991-8#1)(1993-6#1)(2013-8#1)
was given intravenously##2##3##(1991-6#1)(1996-12#1)
was given to##10##3##(1992-5#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2010-7#1)(2011-2#1)
was given##51##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-6#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#1)(1996-12#2)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-7#3)(2009-11#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was glycated##2##2##(1991-5#1)(1992-12#1)
was good agreement##2##3##(2008-7#1)(2012-3#1)
was good in##2##3##(1996-6#1)(2013-1#1)
was good##13##2##(1990-6#1)(1991-8#1)(1994-3#1)(1996-6#1)(2008-10#5)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
was graded as good##2##4##(1997-3#1)(2010-7#1)
was graded using a##2##4##(2011-2#1)(2012-2#1)
was graded##10##2##(1990-3#1)(1996-6#1)(1997-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#2)(2012-2#2)
was gradually##4##2##(2008-10#1)(2008-11#2)(2010-10#1)
was greater at##6##3##(2008-10#4)(2008-8#1)(2008-9#1)
was greater for##7##3##(2008-10#2)(2008-9#4)(2011-2#1)
was greater in the##3##4##(1992-6#2)(2008-10#1)
was greater in##14##3##(1992-12#1)(1992-6#2)(2008-10#11)
was greater on##2##3##(2008-10#2)
was greater than 95%##4##4##(2008-10#2)(2008-11#2)
was greater than 99%##4##4##(2008-10#3)(2012-3#1)
was greater than or equal to 22##2##7##(1991-8#2)
was greater than or equal to##5##6##(1991-8#3)(2008-10#2)
was greater than that of##4##5##(1994-11#2)(2008-10#2)
was greater than that##7##4##(1991-12#1)(1991-3#1)(1994-11#2)(2008-10#3)
was greater than##31##3##(1991-12#1)(1991-3#1)(1991-8#3)(1992-6#1)(1994-11#2)(2008-10#16)(2008-11#2)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#2)
was greater when##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
was greater##78##2##(1991-12#1)(1991-3#1)(1991-8#3)(1992-12#1)(1992-6#3)(1994-11#2)(1995-1#1)(1995-3#1)(1996-6#1)(1997-2#1)(2008-10#44)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2010-7#1)(2011-2#2)(2012-3#2)
was greatest at##2##3##(2008-10#2)
was greatest between##3##3##(2008-10#3)
was greatest following##2##3##(2008-10#2)
was greatest for 'Spanco'##2##4##(2008-10#2)
was greatest for##4##3##(2008-10#4)
was greatest in the##2##4##(2008-9#1)(2009-7#1)
was greatest in##3##3##(2008-10#1)(2008-9#1)(2009-7#1)
was greatest on##5##3##(2008-10#5)
was greatest when##3##3##(2008-10#3)
was greatest##28##2##(1991-12#1)(1995-2#1)(2008-10#24)(2008-9#1)(2009-7#1)
was greatly enhanced by##2##4##(1997-8#1)(2008-10#1)
was greatly enhanced##6##3##(1991-12#1)(1997-8#1)(2008-10#4)
was greatly improved##3##3##(2008-10#2)(2008-11#1)
was greatly increased##2##3##(2008-10#1)(2008-8#1)
was greatly reduced##6##3##(1990-5#2)(1991-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
was greatly##24##2##(1990-2#1)(1990-5#2)(1991-12#1)(1991-5#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)
was grouped##2##2##(2008-10#2)
was grown in##9##3##(2008-10#6)(2011-2#1)(2012-2#1)(2012-5#1)
was grown on##2##3##(2008-10#1)(2008-7#1)
was grown##15##2##(1996-12#1)(2007-12#1)(2008-10#8)(2008-7#2)(2011-2#1)(2012-2#1)(2012-5#1)
was guided by##2##3##(2010-11#1)(2010-9#1)
was handled##2##2##(2008-11#1)(2009-11#1)
was hardly extracted with##2##4##(2008-10#2)
was hardly##3##2##(1993-6#1)(2008-10#2)
was harvested##6##2##(2008-10#1)(2008-11#2)(2013-1#3)
was heat##2##2##(2008-10#2)
was heat-stable##2##2##(2008-10#1)(2008-11#1)
was heated on a##2##4##(2008-10#2)
was heated##4##2##(2008-10#3)(2008-3#1)
was heavily##2##2##(1994-12#1)(2008-10#1)
was held constant at##2##4##(2008-10#1)(2008-6#1)
was held constant##4##3##(2008-10#3)(2008-6#1)
was held in##7##3##(1997-8#1)(2008-10#1)(2008-12#1)(2009-11#1)(2010-5#1)(2011-2#1)(2011-4#1)
was held##14##2##(1997-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2011-4#1)
was helpful to##2##3##(1994-3#1)(1996-9#1)
was helpful##3##2##(1994-3#1)(1996-9#1)(2008-12#1)
was high (&gt##2##3##(2013-1#2)
was high and##2##3##(2008-10#1)(2009-11#1)
was high at##2##3##(2008-10#2)
was high but##2##3##(1996-2#1)(2013-1#1)
was high for##4##3##(2008-10#2)(2009-3#1)(2009-7#1)
was high in all##3##4##(2008-10#3)
was high in##8##3##(2008-10#5)(2008-8#1)(2010-12#1)(2011-2#1)
was high##51##2##(1990-6#2)(1991-6#2)(1995-3#1)(1996-2#1)(2008-10#24)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#1)
was higher among the##2##4##(2008-5#1)(2011-2#1)
was higher among##3##3##(1993-11#1)(2008-5#1)(2011-2#1)
was higher at##6##3##(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
was higher for the##4##4##(2008-10#2)(2008-11#1)(2013-8#1)
was higher for##7##3##(2008-10#3)(2008-11#1)(2011-2#2)(2013-8#1)
was higher in patients with##2##5##(1990-8#1)(1994-12#1)
was higher in the##7##4##(1991-12#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
was higher in women##2##4##(2008-10#1)(2013-3#1)
was higher in##27##3##(1990-8#2)(1991-12#1)(1991-5#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-3#1)(2013-8#2)
was higher than 301 var##2##5##(2008-12#2)
was higher than 301##4##4##(2008-12#4)
was higher than for##2##4##(2008-8#1)(2008-9#1)
was higher than in##6##4##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)
was higher than that of the##2##6##(2008-5#1)(2009-7#1)
was higher than that of##9##5##(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-3#1)
was higher than that##17##4##(1995-8#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-3#2)(2012-12#1)
was higher than the##6##4##(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-8#1)
was higher than those##2##4##(1992-3#1)(2010-11#1)
was higher than##54##3##(1990-12#2)(1991-3#1)(1992-3#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#13)(2008-11#6)(2008-12#9)(2008-5#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-11#1)(2010-3#2)(2011-2#1)(2011-3#2)(2012-12#1)(2012-6#1)(2013-8#1)
was higher when##4##3##(2008-10#2)(2008-6#1)(2008-7#1)
was higher with##5##3##(1992-12#1)(1997-8#1)(2008-10#1)(2010-7#1)(2013-8#1)
was higher##119##2##(1990-12#2)(1990-8#2)(1991-12#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#3)(2008-10#30)(2008-11#10)(2008-12#10)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#2)(2012-12#1)(2012-3#2)(2012-6#1)(2013-3#1)(2013-8#5)
was highest among the##2##4##(2008-10#1)(2008-11#1)
was highest among##4##3##(2008-10#1)(2008-11#1)(2009-6#1)(2013-1#1)
was highest at##3##3##(2008-10#3)
was highest during##2##3##(2008-11#1)(2010-8#1)
was highest in the##5##4##(1993-3#1)(2008-10#2)(2008-12#1)(2013-3#1)
was highest in##15##3##(1990-8#1)(1993-3#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-7#2)(2011-2#1)(2013-1#1)(2013-3#1)
was highest##30##2##(1990-8#1)(1993-3#1)(1995-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-3#1)(2013-8#1)
was highlighted##2##2##(1993-3#1)(2008-11#1)
was highly conserved##3##3##(1997-7#1)(2008-10#2)
was highly correlated to##2##4##(1990-2#1)(2008-10#1)
was highly correlated with##2##4##(2008-10#2)
was highly correlated##5##3##(1990-2#1)(2008-10#4)
was highly dependent on the##2##5##(1997-8#1)(2008-11#1)
was highly effective in##3##4##(2008-10#2)(2008-5#1)
was highly expressed in##2##4##(1994-8#1)(2013-8#1)
was highly expressed##5##3##(1994-8#1)(2008-6#1)(2008-8#1)(2010-5#1)(2013-8#1)
was highly homologous##3##3##(1990-5#1)(1991-9#1)(1997-4#1)
was highly predictive##2##3##(1993-11#1)(2008-6#1)
was highly purified from##3##4##(1993-3#1)(2008-9#2)
was highly resistant##2##3##(2008-10#2)
was highly selective for##2##4##(1991-7#1)(2010-1#1)
was highly sensitive##2##3##(2008-10#2)
was highly significant##6##3##(1990-4#1)(1990-6#1)(2008-10#4)
was highly specific##3##3##(2008-10#3)
was highly variable##4##3##(2008-10#2)(2008-9#1)(2010-8#1)
was highly##61##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#30)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2010-1#1)(2010-5#1)(2010-8#1)(2011-10#1)(2013-8#1)
was histologically##2##2##(2008-12#1)(2008-7#1)
was homogenized##2##2##(2008-10#2)
was homologous to##2##3##(1997-7#1)(2008-8#1)
was homozygous for resistance to##2##5##(2008-10#2)
was homozygous for##3##3##(1994-11#1)(2008-10#2)
was hospitalized##3##2##(1990-8#1)(1993-6#1)(2009-1#1)
was however##2##2##(1996-12#1)(2008-10#1)
was hybridized to##2##3##(1993-2#1)(2008-10#1)
was hydrolyzed##2##2##(2008-10#2)
was hypothesized that##9##3##(1992-2#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#1)
was hypothesized##11##2##(1992-2#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
was identical in##2##3##(1990-5#1)(2008-10#1)
was identical to that of the##2##6##(1990-5#1)(1990-8#1)
was identical to that##5##4##(1990-5#1)(1990-8#1)(1993-12#1)(2008-10#1)(2008-11#1)
was identical to##8##3##(1990-2#1)(1990-5#1)(1990-8#1)(1993-12#1)(1997-9#1)(2008-10#2)(2008-11#1)
was identical##16##2##(1990-2#1)(1990-5#2)(1990-8#2)(1993-12#1)(1997-9#1)(2008-10#7)(2008-11#1)(2011-2#1)
was identified and##5##3##(1990-8#1)(1994-8#1)(2008-10#2)(2013-8#1)
was identified as a##12##4##(1990-12#1)(1995-6#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#1)
was identified as an##2##4##(2008-10#1)(2008-11#1)
was identified as the most##2##5##(2008-10#1)(2011-2#1)
was identified as the##10##4##(1991-5#1)(1994-1#1)(1994-8#1)(2007-12#1)(2008-10#4)(2010-4#1)(2011-2#1)
was identified as##35##3##(1990-12#1)(1990-2#1)(1991-5#1)(1993-3#1)(1994-1#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-5#3)(2008-7#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
was identified between the##2##4##(2010-12#1)(2011-1#1)
was identified by a##2##4##(2008-10#1)(2008-8#1)
was identified by means of##2##5##(2008-10#1)(2008-11#1)
was identified by##14##3##(1993-2#1)(1993-6#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-8#4)(2012-2#1)
was identified for##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
was identified from##2##3##(2008-10#1)(2008-9#1)
was identified in a##2##4##(2008-10#2)
was identified in the##4##4##(1991-7#2)(1995-11#1)(2008-11#1)
was identified in three##2##4##(2008-10#1)(2012-3#1)
was identified in##25##3##(1990-8#1)(1991-7#2)(1994-11#1)(1995-11#1)(1996-2#3)(2008-10#10)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
was identified on chromosome##2##4##(2008-10#1)(2008-9#1)
was identified on##3##3##(2008-10#2)(2008-9#1)
was identified that##4##3##(2008-10#3)(2008-9#1)
was identified through##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
was identified to be##3##4##(1993-8#2)(2008-9#1)
was identified to##4##3##(1993-8#2)(2008-9#1)(2013-1#1)
was identified whose##2##3##(1995-2#1)(2011-2#1)
was identified with##2##3##(1995-12#1)(2008-8#1)
was identified within the##3##4##(1995-8#1)(1996-3#1)(2013-8#1)
was identified##130##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-5#1)(1991-7#3)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#2)(1995-8#1)(1996-2#3)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#43)(2008-11#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#8)(2008-9#7)(2009-1#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#3)
was illustrated##7##2##(2008-10#6)(2012-3#1)
was immediately##3##2##(2008-10#2)(2010-10#1)
was immobilised on a##2##4##(2008-10#2)
was immobilised on the##2##4##(2008-10#2)
was immobilised on##4##3##(2008-10#4)
was immobilised##6##2##(2008-10#6)
was immobilized at##2##3##(2008-10#1)(2009-3#1)
was immobilized by##3##3##(2008-10#3)
was immobilized in##4##3##(2008-10#3)(2010-3#1)
was immobilized on a##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
was immobilized on porous silica beads (glass##2##7##(2008-10#2)
was immobilized on the surface of##2##6##(2008-10#1)(2008-11#1)
was immobilized on the##6##4##(2008-10#5)(2008-11#1)
was immobilized on##22##3##(1997-2#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)
was immobilized onto##4##3##(2008-10#4)
was immobilized##45##2##(1997-2#1)(2008-10#36)(2008-11#3)(2008-12#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)
was immune##2##2##(1995-6#1)(2008-10#1)
was immunolocalized##2##2##(1995-12#2)
was impaired in##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
was impaired##11##2##(1990-11#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
was implanted in the##2##4##(2011-3#1)(2013-1#1)
was implanted in##3##3##(2011-3#1)(2012-3#1)(2013-1#1)
was implanted##5##2##(2009-4#1)(2011-3#1)(2012-3#1)(2013-1#2)
was implemented by##3##3##(2008-10#2)(2008-3#1)
was implemented for##2##3##(2008-8#1)(2010-8#1)
was implemented in a##3##4##(2008-10#2)(2013-8#1)
was implemented in##5##3##(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
was implemented on##2##3##(1992-3#1)(2010-2#1)
was implemented to evaluate##2##4##(1997-1#1)(2011-1#1)
was implemented to##5##3##(1997-1#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
was implemented##30##2##(1992-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-1#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#2)
was implicated##2##2##(1997-8#1)(2008-10#1)
was important##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)
was impossible##2##2##(2008-10#1)(2008-9#1)
was improved by a factor of##2##6##(2008-10#1)(2011-2#1)
was improved by the##2##4##(2008-10#2)
was improved by using##2##4##(2008-10#2)
was improved by##12##3##(1993-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
was improved in the##3##4##(2008-10#2)(2012-3#1)
was improved to##3##3##(2008-10#3)
was improved using##2##3##(2008-10#2)
was improved when##2##3##(2008-10#1)(2008-11#1)
was improved##36##2##(1993-2#1)(1993-8#1)(1996-6#1)(1997-2#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
was in a##3##3##(1990-11#1)(1996-9#1)(2008-10#1)
was in accordance with the##2##5##(2008-10#1)(2008-5#1)
was in addition##2##3##(2008-10#1)(2008-5#1)
was in agreement with the##2##5##(2008-10#2)
was in agreement with##4##4##(2008-10#4)
was in direct correlation to##2##5##(2008-11#2)
was in good agreement with##2##5##(2008-10#1)(2008-11#1)
was in good##5##3##(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
was in inverse proportion to the##2##6##(1990-8#1)(2008-10#1)
was in the order##3##4##(2008-10#3)
was in the range of 2##2##6##(2008-10#2)
was in the range of##11##5##(2008-10#10)(2011-2#1)
was in the range##18##4##(2008-10#17)(2011-2#1)
was in the##33##3##(1991-12#1)(1992-9#1)(1997-7#1)(2007-12#1)(2008-10#26)(2008-11#1)(2008-12#1)(2011-2#1)
was in##89##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-9#2)(1993-2#1)(1994-1#1)(1994-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#45)(2008-11#6)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-10#1)(2010-4#1)(2011-2#4)(2011-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
was inactivated##3##2##(1993-2#1)(2008-6#1)(2012-2#1)
was inactive##2##2##(1991-5#1)(1992-3#1)
was inadequate##4##2##(1994-3#1)(2008-11#2)(2008-5#1)
was inadequately##2##2##(1997-8#1)(2011-10#1)
was incapable of forming##2##4##(1992-8#1)(1997-3#1)
was included as a##2##4##(2008-11#1)(2010-1#1)
was included as an##2##4##(2008-10#2)
was included as##4##3##(2008-10#2)(2008-11#1)(2010-1#1)
was included in the##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
was included in##5##3##(2008-10#3)(2008-11#1)(2008-6#1)
was included##18##2##(1996-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-6#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
was incomplete##3##2##(1995-2#1)(2008-10#2)
was incompletely occluded##2##3##(1996-9#1)(2013-1#1)
was inconclusive##5##2##(1995-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
was inconsistency##2##2##(2008-11#1)(2011-2#1)
was inconsistent##4##2##(2008-10#2)(2008-8#1)(2010-4#1)
was incorporated in the##2##4##(2008-10#2)
was incorporated in##6##3##(1990-5#1)(2008-10#5)
was incorporated into a##2##4##(1994-11#1)(2008-10#1)
was incorporated into the##5##4##(2008-10#2)(2008-5#2)(2008-8#1)
was incorporated into##10##3##(1994-11#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#2)
was incorporated##21##2##(1990-5#1)(1993-8#1)(1994-11#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-8#3)(2009-9#1)
was incorrect##2##2##(2008-1#1)(2008-10#1)
was increased after##2##3##(1993-6#1)(2008-10#1)
was increased by a factor of##2##6##(1993-9#1)(2008-10#1)
was increased by about##2##4##(2008-10#1)(2008-11#1)
was increased by##23##3##(1991-5#1)(1993-1#1)(1993-9#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
was increased due to the##2##5##(2008-10#1)(2008-5#1)
was increased during##2##3##(1991-12#2)
was increased from##6##3##(1991-2#1)(1993-8#1)(2008-10#4)
was increased in the presence of##2##6##(1990-5#1)(1997-1#1)
was increased in the##7##4##(1990-5#1)(1991-1#1)(1991-5#1)(1994-11#1)(1997-1#1)(2008-9#2)
was increased in##22##3##(1990-2#1)(1990-5#2)(1991-1#1)(1991-5#1)(1992-6#1)(1994-11#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#3)
was increased linearly##2##3##(2008-10#2)
was increased significantly##2##3##(1991-3#1)(2008-11#1)
was increased to##9##3##(1994-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
was increased twofold##2##3##(2008-11#1)(2008-8#1)
was increased under##2##3##(1997-2#2)
was increased when##2##3##(2008-5#2)
was increased with the##2##4##(1994-11#1)(2009-7#1)
was increased##108##2##(1990-2#1)(1990-5#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#1)(1995-6#2)(1996-2#3)(1997-1#2)(1997-2#6)(1997-3#1)(1997-8#1)(2008-10#29)(2008-11#15)(2008-12#1)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#7)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#2)
was increasing##2##2##(2008-12#1)(2008-9#1)
was incubated in##3##3##(2008-10#3)
was incubated on##2##3##(2008-8#1)(2010-3#1)
was incubated with##6##3##(1995-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
was incubated##13##2##(1992-6#1)(1995-2#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
was indeed##4##2##(1992-6#1)(2008-7#1)(2009-8#1)(2010-6#1)
was independent of pH##2##4##(1991-5#1)(2008-10#1)
was independent of the##10##4##(1995-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2013-8#1)
was independent of##17##3##(1991-5#1)(1993-3#1)(1995-6#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-8#2)(2013-8#1)
was independent##19##2##(1991-5#1)(1993-3#1)(1995-6#1)(2008-10#11)(2008-11#1)(2008-6#1)(2008-8#2)(2013-8#1)
was independently associated with##2##4##(2008-7#1)(2013-1#1)
was independently##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
was indicated by the##2##4##(2008-10#2)
was indicated by##4##3##(2008-10#4)
was indicated that the##3##4##(2008-10#1)(2008-8#2)
was indicated that##4##3##(2008-10#1)(2008-8#3)
was indicated##14##2##(1995-11#1)(2008-10#8)(2008-8#3)(2010-3#1)(2013-8#1)
was indirect##2##2##(1991-2#1)(2008-10#1)
was indirectly##3##2##(2008-10#2)(2012-3#1)
was indistinguishable from##2##3##(1993-12#1)(1995-12#1)
was indistinguishable##3##2##(1993-12#1)(1995-12#1)(2008-10#1)
was induced by a##2##4##(2008-10#1)(2008-6#1)
was induced by##22##3##(1990-12#1)(1990-9#1)(1992-4#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-6#2)(2008-8#1)(2012-2#2)(2013-1#1)
was induced in a wheat cultivar-specific manner##2##7##(2008-10#2)
was induced in a##3##4##(1993-8#1)(2008-10#2)
was induced in the##3##4##(1996-12#1)(2010-5#1)(2013-7#1)
was induced in##20##3##(1990-3#1)(1993-8#1)(1995-2#1)(1996-12#3)(2008-10#7)(2008-11#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-3#1)(2013-7#1)(2013-8#1)
was induced only by##2##4##(2008-11#1)(2008-8#1)
was induced only##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
was induced to##2##3##(2008-10#1)(2008-8#1)
was induced with##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
was induced##61##2##(1990-12#1)(1990-3#2)(1990-9#1)(1992-4#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#18)(2008-11#6)(2008-6#2)(2008-7#1)(2008-8#5)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
was inducible by##2##3##(1992-6#1)(1993-9#1)
was ineffective against C##2##4##(2008-10#2)
was ineffective against##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
was ineffective in##2##3##(1997-1#1)(2008-10#1)
was ineffective##12##2##(1990-5#1)(1992-2#1)(1993-8#1)(1997-1#1)(2008-10#5)(2008-4#1)(2011-2#1)(2012-3#1)
was infected by##5##3##(1996-5#1)(2008-10#3)(2008-11#1)
was infected with##2##3##(2008-10#1)(2008-11#1)
was infected##8##2##(1996-5#1)(2008-10#4)(2008-11#2)(2008-12#1)
was infectious in##2##3##(2008-10#2)
was infectious##5##2##(1997-3#1)(2008-10#3)(2008-9#1)
was inferred from##2##3##(1990-5#1)(2008-7#1)
was inferred that##3##3##(2008-10#2)(2008-8#1)
was inferred##6##2##(1990-5#1)(2008-10#3)(2008-7#1)(2008-8#1)
was infested with##2##3##(2008-10#2)
was infiltrated into##2##3##(2008-10#2)
was infiltrated##3##2##(2008-10#2)(2009-1#1)
was inflated##2##2##(1997-6#1)(2013-8#1)
was influenced by the##8##4##(2008-10#6)(2008-11#1)(2008-5#1)
was influenced by##14##3##(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)
was influenced primarily by##2##4##(1991-6#1)(2008-10#1)
was influenced##18##2##(1991-6#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)
was infrequent##2##2##(2008-10#2)
was infused##2##2##(2011-2#1)(2012-2#1)
was inhibited and##2##3##(2008-7#1)(2008-9#1)
was inhibited at##2##3##(2008-10#2)
was inhibited by indomethacin##2##4##(1991-3#1)(1997-1#1)
was inhibited by pretreatment##2##4##(1994-3#1)(2008-11#1)
was inhibited by the addition of##3##6##(1993-8#1)(1994-3#1)(2008-8#1)
was inhibited by the##5##4##(1993-8#1)(1994-3#1)(1994-8#1)(2008-11#1)(2008-8#1)
was inhibited by##55##3##(1990-10#1)(1990-2#3)(1990-5#2)(1990-8#1)(1991-3#1)(1991-5#1)(1992-3#3)(1993-8#2)(1994-11#3)(1994-3#2)(1994-5#1)(1994-8#3)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-1#3)(2006-6#1)(2008-10#7)(2008-11#7)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2012-2#2)
was inhibited in the presence of##2##6##(2008-10#1)(2008-11#1)
was inhibited in##5##3##(1992-6#1)(1994-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
was inhibited##88##2##(1990-10#1)(1990-11#1)(1990-2#3)(1990-5#3)(1990-8#1)(1991-3#1)(1991-5#2)(1992-3#3)(1992-4#1)(1992-6#1)(1993-8#2)(1994-11#5)(1994-3#2)(1994-5#2)(1994-8#4)(1995-2#2)(1995-6#3)(1995-8#3)(1996-12#2)(1996-2#1)(1997-1#3)(2006-6#1)(2008-10#13)(2008-11#9)(2008-7#2)(2008-8#5)(2008-9#3)(2009-3#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)
was inhibition of##2##3##(2008-11#1)(2008-5#1)
was inhibitory to conidial germination##2##5##(2008-10#2)
was inhibitory##4##2##(1995-2#1)(1997-3#1)(2008-10#2)
was initially diagnosed##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
was initially identified##2##3##(2008-12#1)(2012-3#1)
was initially low##2##3##(2008-8#1)(2010-10#1)
was initially thought##2##3##(2009-8#1)(2013-1#1)
was initially treated with##3##4##(2008-7#1)(2013-8#2)
was initially##32##2##(1990-6#1)(1991-2#1)(1991-5#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-7#4)(2008-8#3)(2009-3#1)(2009-8#1)(2010-10#2)(2010-7#1)(2012-3#3)(2013-1#2)(2013-8#2)
was initiated at##2##3##(1990-5#1)(2011-2#1)
was initiated by##2##3##(2008-10#2)
was initiated in##4##3##(1995-2#1)(2008-1#1)(2008-12#1)(2010-10#1)
was initiated on##4##3##(2008-1#1)(2010-12#3)
was initiated to investigate##2##4##(1997-4#1)(2008-10#1)
was initiated to##6##3##(1997-4#1)(2008-10#4)(2008-11#1)
was initiated##32##2##(1990-5#1)(1993-12#1)(1993-3#1)(1995-2#1)(1997-4#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-4#1)(2010-10#1)(2010-12#3)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
was injected and##2##3##(2008-10#1)(2009-4#1)
was injected at##2##3##(2008-7#1)(2011-2#1)
was injected in##3##3##(2008-10#3)
was injected into a water carrier stream##2##7##(2008-10#2)
was injected into a##8##4##(2008-10#8)
was injected into an##2##4##(2008-10#2)
was injected into the carrier stream##2##6##(2008-10#2)
was injected into the##8##4##(2008-10#4)(2008-7#1)(2008-9#2)(2011-2#1)
was injected into##24##3##(2008-10#16)(2008-7#1)(2008-8#1)(2008-9#4)(2010-10#1)(2011-2#1)
was injected intravenously##2##3##(2011-2#1)(2013-1#1)
was injected onto the##2##4##(1992-3#1)(2008-10#1)
was injected onto##3##3##(1992-3#1)(2008-10#2)
was injected to##2##3##(2008-10#2)
was injected##55##2##(1990-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1997-8#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-4#1)(2010-10#1)(2011-2#3)(2013-1#1)
was inoculated onto##2##3##(2008-10#1)(2008-8#1)
was inoculated with 50##2##4##(2008-10#1)(2008-12#1)
was inoculated with##9##3##(2008-10#8)(2008-12#1)
was inoculated##17##2##(2008-10#13)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
was insensitive to##3##3##(1995-11#1)(2006-6#1)(2008-10#1)
was inserted into a gene that encodes a##2##8##(2008-10#2)
was inserted into a##3##4##(2008-10#2)(2008-11#1)
was inserted into the vector##2##5##(2008-8#1)(2010-5#1)
was inserted into the##9##4##(1993-3#1)(1993-9#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-8#2)(2010-5#1)
was inserted into##14##3##(1993-3#1)(1993-9#1)(1995-5#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-8#2)(2010-5#1)
was inserted##26##2##(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-11#4)(2008-7#1)(2008-8#2)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
was insignificant##3##2##(2008-10#3)
was instituted##2##2##(1991-1#1)(2008-7#1)
was instructed to##2##3##(2010-2#1)(2010-6#1)
was insufficient##4##2##(1996-1#1)(2008-11#1)(2010-8#1)(2012-12#1)
was intact##3##2##(1997-2#1)(2009-7#1)(2012-12#1)
was integrated into##2##3##(1996-3#1)(2008-8#1)
was integrated##6##2##(1996-3#1)(2008-10#1)(2008-11#2)(2008-8#2)
was intended to##5##3##(1990-11#1)(1992-1#1)(1992-12#1)(2008-5#1)(2008-7#1)
was intermediate##4##2##(1994-3#1)(2008-10#2)(2008-8#1)
was internalized##3##2##(1991-12#1)(1994-8#2)
was interpreted as##2##3##(2008-3#1)(2012-7#1)
was interpreted to be due to##2##6##(1992-12#1)(2008-10#1)
was interpreted to##3##3##(1992-12#1)(2008-10#2)
was interpreted##8##2##(1992-12#1)(2008-10#5)(2008-3#1)(2012-7#1)
was interrupted by##4##3##(1993-12#1)(1993-2#1)(1993-8#1)(1997-4#1)
was interviewed##3##2##(2008-5#1)(2009-9#1)(2013-1#1)
was introduced and##3##3##(2008-10#2)(2012-3#1)
was introduced as a tool##2##5##(2008-10#1)(2009-10#1)
was introduced as a##4##4##(2008-10#2)(2009-10#1)(2012-2#1)
was introduced as##5##3##(2008-10#2)(2008-12#1)(2009-10#1)(2012-2#1)
was introduced at the##2##4##(1992-5#1)(2010-9#1)
was introduced at##3##3##(1992-5#1)(2008-12#1)(2010-9#1)
was introduced by##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
was introduced for##3##3##(1991-9#1)(2008-10#1)(2012-12#1)
was introduced in a##2##4##(2008-10#1)(2012-12#1)
was introduced in the early##2##5##(1996-3#1)(2010-12#1)
was introduced in the##4##4##(1996-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
was introduced in##12##3##(1993-11#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-12#2)(2010-12#1)(2010-6#1)(2012-12#1)
was introduced into a##2##4##(2008-10#1)(2008-9#1)
was introduced into the flow##2##5##(2008-10#2)
was introduced into the##13##4##(1997-3#1)(1997-6#2)(2008-10#8)(2008-11#2)
was introduced into##31##3##(1990-8#1)(1993-8#1)(1994-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)
was introduced to##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
was introduced##79##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#2)(2008-10#28)(2008-11#8)(2008-12#5)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)
was introgressed from##2##3##(2008-10#2)
was introgressed##3##2##(2008-10#3)
was invaded##3##2##(1995-6#1)(2008-10#2)
was inversely correlated with##3##4##(2008-10#2)(2010-4#1)
was inversely correlated##4##3##(1991-12#1)(2008-10#2)(2010-4#1)
was inversely related to##2##4##(1990-8#1)(2010-8#1)
was inversely##8##2##(1990-8#1)(1991-12#1)(1993-8#1)(2008-10#2)(2010-4#1)(2010-8#1)(2011-3#1)
was investigated against##2##3##(2012-2#1)(2012-3#1)
was investigated and the results##2##5##(2008-10#2)
was investigated and the##5##4##(2008-10#5)
was investigated and##12##3##(2008-10#11)(2008-11#1)
was investigated as a##4##4##(2008-10#3)(2008-3#1)
was investigated as##6##3##(2008-10#4)(2008-3#1)(2008-7#1)
was investigated at various##3##4##(2008-10#3)
was investigated at##9##3##(2008-10#8)(2008-11#1)
was investigated by a##2##4##(1991-6#1)(2008-10#1)
was investigated by analyzing##2##4##(2008-10#1)(2008-9#1)
was investigated by cyclic voltammetry##2##5##(2008-10#2)
was investigated by cyclic##5##4##(2008-10#5)
was investigated by immunohistochemical##2##4##(1991-5#1)(1997-3#1)
was investigated by means of##3##5##(2008-10#1)(2008-9#1)(2012-3#1)
was investigated by measuring##2##4##(2008-10#1)(2008-11#1)
was investigated by the##2##4##(2008-10#1)(2008-11#1)
was investigated by using a##2##5##(2008-10#1)(2008-7#1)
was investigated by using##9##4##(1996-2#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)
was investigated by##62##3##(1990-11#1)(1991-5#1)(1991-6#1)(1992-10#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-10#30)(2008-11#5)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#3)(2011-2#1)(2012-3#1)
was investigated for its ability##2##5##(2008-10#1)(2008-11#1)
was investigated for its##3##4##(2008-10#2)(2008-11#1)
was investigated for the##3##4##(2008-10#3)
was investigated for##13##3##(1994-11#1)(2008-10#10)(2008-11#1)(2012-2#1)
was investigated from##2##3##(1994-6#1)(2008-10#1)
was investigated further##2##3##(2008-10#2)
was investigated in a series of##3##6##(1991-8#1)(2008-10#2)
was investigated in a##6##4##(1991-8#1)(2008-10#3)(2008-7#2)
was investigated in aqueous##2##4##(2008-10#2)
was investigated in cultured##2##4##(1990-2#1)(1995-8#1)
was investigated in detail##2##4##(2008-10#2)
was investigated in different##2##4##(2008-10#2)
was investigated in human##3##4##(1991-5#1)(1993-8#1)(1994-8#1)
was investigated in mice##2##4##(1996-2#1)(2013-8#1)
was investigated in normal##2##4##(2008-10#1)(2010-11#1)
was investigated in order to##3##5##(2008-10#2)(2008-11#1)
was investigated in order##4##4##(2008-10#2)(2008-11#2)
was investigated in terms of##5##5##(1994-8#1)(1996-2#1)(2008-10#3)
was investigated in the##10##4##(1990-12#1)(1992-12#1)(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
was investigated in##78##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-3#1)(2008-10#37)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#3)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
was investigated on##5##3##(1991-2#1)(2008-10#4)
was investigated spectrophotometrically##2##3##(2008-10#2)
was investigated through##2##3##(2008-10#1)(2008-7#1)
was investigated to##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
was investigated under##3##3##(2008-10#2)(2008-11#1)
was investigated using a##6##4##(2008-10#4)(2008-9#1)(2010-4#1)
was investigated using the##2##4##(2008-10#1)(2008-5#1)
was investigated using##23##3##(1993-3#1)(1993-6#1)(1993-8#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2013-8#1)
was investigated with a##3##4##(1991-2#1)(1997-3#1)(2008-5#1)
was investigated with##9##3##(1990-5#1)(1991-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)
was investigated##422##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#4)(1993-6#1)(1993-8#4)(1994-11#4)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#4)(1995-11#2)(1995-12#2)(1995-8#1)(1996-12#2)(1996-2#3)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#249)(2008-11#32)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#10)(2008-7#11)(2008-8#10)(2008-9#4)(2009-7#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#3)
was involved in a##2##4##(2008-7#1)(2012-3#1)
was involved in the##5##4##(1993-8#1)(1997-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
was involved in this##2##4##(1995-11#1)(2012-2#1)
was involved in##12##3##(1993-8#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
was involved##16##2##(1993-8#1)(1995-11#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
was irradiated##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
was irreversible and##3##3##(2008-10#3)
was irreversible##4##2##(1994-11#1)(2008-10#3)
was isolated after##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
was isolated and characterized##5##4##(1993-2#1)(1994-11#1)(1995-3#1)(2008-11#1)(2008-8#1)
was isolated and sequenced##4##4##(1991-5#1)(1993-2#1)(1997-1#1)(2008-10#1)
was isolated and##15##3##(1990-8#1)(1991-5#1)(1991-9#1)(1993-2#2)(1994-11#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)
was isolated by culture##2##4##(2008-5#2)
was isolated by##7##3##(1990-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-6#1)
was isolated for##2##3##(2008-9#1)(2013-1#1)
was isolated from a cosmid##2##5##(1993-12#2)
was isolated from a genomic library##2##6##(1990-5#1)(1993-6#1)
was isolated from a human##3##5##(1993-8#1)(1994-11#1)(2008-9#1)
was isolated from a##18##4##(1990-5#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#2)
was isolated from an##2##4##(1997-7#1)(2011-2#1)
was isolated from both##2##4##(1995-11#1)(2008-10#1)
was isolated from human##2##4##(1992-3#1)(2011-2#1)
was isolated from the liver##2##5##(1995-9#1)(2010-5#1)
was isolated from the##12##4##(1990-2#1)(1994-11#1)(1994-5#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2010-5#1)
was isolated from##71##3##(1990-2#1)(1990-5#1)(1992-3#1)(1993-12#2)(1993-2#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-5#2)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-7#2)(1997-9#1)(2008-10#23)(2008-11#5)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#9)(2012-2#1)
was isolated in##5##3##(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)
was isolated through##2##3##(2008-9#1)(2010-5#1)
was isolated using the##2##4##(1991-6#1)(1995-12#1)
was isolated using##3##3##(1991-6#1)(1995-12#2)
was isolated##129##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-5#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#2)(1997-8#1)(1997-9#1)(2008-10#36)(2008-11#7)(2008-12#1)(2008-5#8)(2008-8#5)(2008-9#5)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-10#1)(2011-2#11)(2012-2#2)(2013-1#1)
was issued##2##2##(2013-1#1)(2013-8#1)
was it##4##2##(1991-3#1)(1993-11#1)(2008-10#1)(2011-2#1)
was its##3##2##(1995-8#1)(2008-10#1)(2008-5#1)
was judged to be##2##4##(2008-10#1)(2008-9#1)
was judged##7##2##(1991-3#1)(1992-2#1)(1997-2#1)(2008-10#2)(2008-9#1)(2012-3#1)
was just as##2##3##(1994-12#1)(2008-9#1)
was just##4##2##(1994-11#1)(1994-12#1)(2008-10#1)(2008-9#1)
was kept at##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
was kept##6##2##(1992-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-1#1)
was kinetically##3##2##(2008-10#3)
was known to be##2##4##(1994-5#1)(2008-5#1)
was known to##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
was known##8##2##(1990-12#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
was labeled with##5##3##(1994-11#1)(2008-10#2)(2008-12#1)(2008-9#1)
was labeled##8##2##(1994-11#1)(1995-6#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-12#1)
was lacking##2##2##(1994-9#1)(2011-2#1)
was large and##2##3##(2008-10#1)(2008-9#1)
was large##5##2##(2008-10#3)(2008-9#1)(2010-5#1)
was largely##11##2##(1990-8#1)(1991-10#1)(1991-5#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#1)
was larger than that##3##4##(1997-7#1)(2008-10#1)(2008-3#1)
was larger than##4##3##(1997-7#1)(2008-10#2)(2008-3#1)
was larger##8##2##(1996-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-9#1)
was later##3##2##(2008-10#2)(2011-2#1)
was launched##2##2##(1993-6#1)(2012-2#1)
was least##2##2##(2008-10#1)(2008-5#1)
was left##5##2##(1991-7#1)(1992-3#1)(1994-9#1)(2008-11#1)(2008-5#1)
was less clear##2##3##(1992-2#1)(2008-10#1)
was less diverse##2##3##(2012-3#1)(2013-1#1)
was less effective##2##3##(2008-10#1)(2008-11#1)
was less frequent in##2##4##(1994-6#1)(2013-1#1)
was less in##4##3##(2008-10#2)(2012-12#1)(2012-2#1)
was less pronounced in##2##4##(1994-2#1)(2012-6#1)
was less satisfactory##2##3##(2008-10#1)(2008-9#1)
was less severe in##2##4##(1994-5#1)(1997-2#1)
was less severe##3##3##(1994-5#1)(1997-2#1)(2008-10#1)
was less than 0##2##4##(2008-10#1)(2011-3#1)
was less than 1##3##4##(1990-2#1)(2008-10#2)
was less than 15%##2##4##(2008-10#1)(2011-3#1)
was less than 2##3##4##(1991-8#1)(2008-10#2)
was less than 40##2##4##(1996-6#1)(2008-10#1)
was less than 5%##6##4##(2008-10#5)(2013-1#1)
was less than 8##3##4##(1995-3#1)(2008-10#2)
was less than that by the##2##6##(2008-9#2)
was less than that##3##4##(1997-4#1)(2008-9#2)
was less than##48##3##(1990-2#1)(1990-5#1)(1991-6#1)(1991-8#1)(1995-3#1)(1996-6#1)(1997-4#1)(2008-10#30)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#2)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#1)
was less##92##2##(1990-2#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1994-2#1)(1994-5#1)(1994-6#3)(1995-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#48)(2008-11#4)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#4)(2009-3#1)(2010-4#1)(2011-10#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#5)
was likely to have##2##4##(1996-2#1)(2008-11#1)
was likely to##5##3##(1996-2#1)(2008-10#1)(2008-11#2)(2012-2#1)
was likely##11##2##(1996-2#1)(2008-10#3)(2008-11#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
was limited by the##5##4##(2008-10#4)(2008-8#1)
was limited by##8##3##(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
was limited to a##2##4##(2008-10#1)(2010-8#1)
was limited to the##3##4##(2008-10#2)(2012-2#1)
was limited to##15##3##(2008-10#8)(2008-8#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
was limited##31##2##(2007-12#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-11#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
was linear between 10##2##4##(2008-10#2)
was linear between##5##3##(2008-10#5)
was linear for the range of concentrations between 0##2##9##(2008-10#2)
was linear for##3##3##(2008-10#3)
was linear from 0##7##4##(1997-2#1)(2008-10#6)
was linear from 1##2##4##(2008-10#2)
was linear from 20 to##2##5##(2008-10#2)
was linear from##15##3##(1997-2#1)(2008-10#14)
was linear in the concentration range from 5##2##8##(2008-10#2)
was linear in the concentration range of##3##7##(2008-10#3)
was linear in the concentration range##6##6##(2008-10#6)
was linear in the range 0##5##6##(2008-10#5)
was linear in the range 3##2##6##(2008-10#2)
was linear in the range of 0##3##7##(2008-10#3)
was linear in the range of 1##2##7##(2008-10#2)
was linear in the range of##8##6##(2008-10#8)
was linear in the range##24##5##(2008-10#24)
was linear in the##33##4##(2008-10#33)
was linear in##34##3##(2008-10#34)
was linear over a##4##4##(2008-10#4)
was linear over about##2##4##(2008-10#2)
was linear over the concentration range from##2##7##(2008-10#2)
was linear over the concentration range of##2##7##(2008-10#2)
was linear over the concentration range##7##6##(2008-10#7)
was linear over the range 0##4##6##(2008-10#4)
was linear over the range 1##3##6##(2008-10#3)
was linear over the range of 2##2##7##(2008-10#2)
was linear over the range of##5##6##(2008-10#5)
was linear over the range##15##5##(2008-10#15)
was linear over the##24##4##(2008-10#24)
was linear over##31##3##(2008-10#31)
was linear to##6##3##(2008-10#6)
was linear up to 0##2##5##(2008-10#2)
was linear up to 100##2##5##(2008-10#2)
was linear up to##11##4##(2008-10#11)
was linear with a correlation coefficient of 0##5##8##(2008-10#5)
was linear with a##7##4##(2008-10#7)
was linear with the##4##4##(2008-10#4)
was linear with##13##3##(2008-10#13)
was linear##124##2##(1992-3#1)(1997-2#1)(2008-10#122)
was linearly correlated with##3##4##(2008-10#2)(2008-7#1)
was linearly dependent on the##2##5##(2008-10#2)
was linearly related to the logarithm of##2##7##(2008-10#2)
was linearly related to the##4##5##(2008-10#4)
was linearly related to##5##4##(2008-10#5)
was linearly##11##2##(2008-10#10)(2008-7#1)
was linked in##3##3##(2008-10#3)
was linked to the##2##4##(1997-2#1)(2008-10#1)
was linked to##7##3##(1997-2#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)
was linked with##3##3##(2008-10#2)(2009-10#1)
was linked##13##2##(1997-2#1)(2008-10#8)(2008-11#1)(2009-10#1)(2011-2#1)(2012-2#1)
was little evidence for##2##4##(2008-5#1)(2010-11#1)
was little##17##2##(1990-11#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-11#1)
was loaded on##3##3##(2008-10#3)
was loaded##5##2##(2008-10#4)(2008-9#1)
was localized in##5##3##(1992-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)
was localized on##2##3##(1991-5#1)(1995-6#1)
was localized only in##2##4##(2008-10#2)
was localized to a##2##4##(1994-2#1)(1995-6#1)
was localized to the##4##4##(1991-11#1)(1992-7#1)(1994-3#1)(2008-11#1)
was localized to##8##3##(1991-11#1)(1992-7#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-11#1)
was localized##24##2##(1991-11#1)(1991-5#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#2)(1997-7#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)
was located at the##2##4##(1996-9#1)(2013-8#1)
was located between##2##3##(2008-9#1)(2012-2#1)
was located in the##5##4##(1990-5#1)(1991-3#1)(1997-8#1)(2008-7#1)(2008-9#1)
was located in##9##3##(1990-5#1)(1991-3#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#2)
was located near##3##3##(2008-10#1)(2012-3#2)
was located on the##4##4##(1992-4#1)(2008-10#2)(2008-8#1)
was located on##10##3##(1992-3#1)(1992-4#1)(1997-8#1)(2008-10#4)(2008-7#1)(2008-8#2)
was located##37##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#2)(2008-10#10)(2008-7#3)(2008-8#2)(2008-9#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
was long and##3##3##(2007-12#2)(2008-10#1)
was long##4##2##(2007-12#2)(2008-10#2)
was longer in##2##3##(1991-5#1)(1996-1#1)
was longer than##2##3##(2008-11#1)(2008-7#1)
was longer##5##2##(1991-5#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
was lost after##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
was lost by##2##3##(2008-11#1)(2008-6#1)
was lost in##4##3##(1991-9#1)(2008-10#1)(2008-7#2)
was lost##14##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2012-3#1)(2013-1#1)
was low (1##2##3##(2010-11#1)(2013-8#1)
was low and##4##3##(1996-2#1)(2008-10#2)(2012-3#1)
was low in all##2##4##(2008-10#1)(2013-1#1)
was low in##8##3##(1990-5#1)(2008-10#3)(2008-11#2)(2011-2#1)(2013-1#1)
was low throughout the##2##4##(2008-10#1)(2010-8#1)
was low with##3##3##(1993-1#1)(2008-10#2)
was low##59##2##(1990-3#1)(1990-5#1)(1992-12#1)(1993-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
was lower at##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
was lower for##5##3##(2008-10#5)
was lower in the##7##4##(1991-11#1)(1994-2#2)(2008-10#2)(2012-3#1)(2013-8#1)
was lower in##15##3##(1990-8#1)(1991-11#1)(1991-6#1)(1994-2#2)(2008-10#6)(2012-3#2)(2013-1#1)(2013-8#1)
was lower than 0##2##4##(2008-10#2)
was lower than 3##2##4##(1990-2#1)(2012-12#1)
was lower than in##5##4##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
was lower than that of##2##5##(2008-10#1)(2011-2#1)
was lower than that##7##4##(1990-6#1)(1992-3#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
was lower than the##3##4##(2008-7#2)(2008-8#1)
was lower than those##2##4##(2008-10#1)(2008-12#1)
was lower than##33##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1992-3#1)(1995-8#1)(1997-8#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-12#1)
was lower##73##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-6#2)(1992-3#1)(1994-2#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#31)(2008-11#5)(2008-12#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
was lowered##2##2##(1992-6#1)(2008-10#1)
was lowest in##4##3##(2008-10#3)(2008-11#1)
was lowest##9##2##(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)
was made among##3##3##(2008-10#2)(2013-1#1)
was made and##4##3##(2008-10#1)(2008-9#1)(2012-12#1)(2013-7#1)
was made based on the##2##5##(1991-6#1)(2011-2#1)
was made based on##3##4##(1991-6#1)(2011-2#1)(2012-3#1)
was made between##7##3##(1994-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)
was made by##16##3##(1992-9#1)(1996-8#1)(2008-1#2)(2008-10#6)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
was made for##5##3##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
was made from##5##3##(2008-10#3)(2010-12#1)(2012-3#1)
was made in##9##3##(1997-2#1)(2008-10#4)(2008-11#2)(2008-5#1)(2013-1#1)
was made of the##6##4##(1991-1#1)(1991-3#1)(1992-6#1)(1994-1#1)(2008-10#2)
was made of##10##3##(1991-1#1)(1991-3#1)(1992-6#1)(1994-1#1)(1996-1#1)(1996-12#1)(2008-10#3)(2012-12#1)
was made on the##3##4##(2008-10#2)(2008-8#1)
was made on##6##3##(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)
was made possible by a##2##5##(2008-12#1)(2008-3#1)
was made possible by##5##4##(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-6#1)
was made to find the##2##5##(2008-5#1)(2010-4#1)
was made to find##3##4##(2008-5#1)(2010-4#1)(2012-2#1)
was made to##14##3##(1990-6#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-2#1)
was made up of##3##4##(1996-1#1)(2008-10#1)(2008-8#1)
was made up##4##3##(1996-1#1)(2008-10#2)(2008-8#1)
was made using##6##3##(2008-10#6)
was made with##4##3##(1995-6#1)(2008-10#2)(2013-1#1)
was made##132##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-3#2)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-3#2)(1995-6#1)(1996-1#2)(1996-12#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#48)(2008-11#7)(2008-12#4)(2008-3#3)(2008-5#5)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)
was mailed to##3##3##(1994-1#1)(1996-3#1)(2009-4#1)
was mainly due to##5##4##(1991-2#1)(2008-10#2)(2008-9#1)(2009-6#1)
was mainly observed##2##3##(2008-10#2)
was mainly specific for##2##4##(2008-7#2)
was mainly##24##2##(1990-12#1)(1991-2#1)(1993-3#1)(1996-1#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-10#1)(2013-1#2)
was maintained at##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
was maintained between##2##3##(2008-10#2)
was maintained for##3##3##(1993-11#1)(2008-5#1)(2011-2#1)
was maintained in a##2##4##(1991-12#1)(2011-2#1)
was maintained in the##2##4##(2010-7#1)(2012-12#1)
was maintained in##4##3##(1991-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
was maintained on##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
was maintained##31##2##(1991-12#2)(1991-2#1)(1992-3#1)(1993-11#1)(2008-10#7)(2008-11#5)(2008-4#1)(2008-5#4)(2008-6#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-7#1)
was managed conservatively##2##3##(2013-1#1)(2013-8#1)
was managed with##2##3##(2008-12#1)(2011-2#1)
was managed##7##2##(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
was manifested by a##3##4##(2008-10#1)(2009-8#2)
was manifested by##4##3##(1995-8#1)(2008-10#1)(2009-8#2)
was manifested##6##2##(1995-8#1)(1997-3#1)(2008-10#2)(2009-8#2)
was manipulated by using##2##4##(1995-2#1)(2008-12#1)
was manipulated##4##2##(1995-2#1)(2008-12#1)(2008-8#1)(2009-8#1)
was mapped in the##2##4##(2008-8#1)(2008-9#1)
was mapped in##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
was mapped on chromosome##2##4##(2008-8#1)(2008-9#1)
was mapped on##3##3##(1995-6#1)(2008-8#1)(2008-9#1)
was mapped to a##2##4##(1994-11#1)(2008-10#1)
was mapped to chromosome##4##4##(1996-6#1)(1997-7#1)(2008-8#2)
was mapped to the short arm of chromosome##2##8##(2008-10#2)
was mapped to the##7##4##(1990-8#1)(1991-10#1)(2008-10#5)
was mapped to##15##3##(1990-8#1)(1991-10#1)(1994-11#1)(1996-6#1)(1997-7#1)(2008-10#7)(2008-8#2)(2011-2#1)
was mapped##26##2##(1990-8#1)(1991-10#1)(1994-11#1)(1995-6#1)(1996-6#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-8#6)(2008-9#2)(2010-8#1)(2011-2#1)(2012-3#1)
was marginally more resistant to##2##5##(2008-10#2)
was marginally##4##2##(1997-8#1)(2008-10#3)
was marked by##2##3##(2008-10#1)(2009-1#1)
was marked##4##2##(1996-11#1)(2008-10#2)(2009-1#1)
was markedly better##2##3##(2008-10#1)(2008-9#1)
was markedly enhanced by##3##4##(1992-8#1)(1993-8#1)(1995-2#1)
was markedly enhanced##4##3##(1990-11#1)(1992-8#1)(1993-8#1)(1995-2#1)
was markedly inhibited by##2##4##(1990-2#1)(1993-8#1)
was markedly more##2##3##(2008-10#1)(2008-5#1)
was markedly reduced in##3##4##(2008-10#2)(2013-1#1)
was markedly reduced##5##3##(1991-5#1)(1993-8#1)(2008-10#2)(2013-1#1)
was markedly##25##2##(1990-11#2)(1990-2#1)(1991-5#1)(1992-8#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-9#1)(2013-1#1)
was massively##2##2##(2008-5#1)(2011-2#1)
was maximal at##2##3##(1991-12#1)(2008-10#1)
was maximal##4##2##(1991-12#1)(1997-1#1)(1997-5#1)(2008-10#1)
was maximally expressed##2##3##(1990-5#1)(2008-11#1)
was maximally##4##2##(1990-5#1)(1995-8#1)(2008-10#1)(2008-11#1)
was maximized##3##2##(2008-11#2)(2013-1#1)
was maximum when##2##3##(2008-10#2)
was maximum##3##2##(2008-10#3)
was measured after staining##2##4##(2008-10#1)(2008-7#1)
was measured after##6##3##(2008-10#2)(2008-12#1)(2008-7#2)(2013-1#1)
was measured and##6##3##(2008-10#1)(2008-11#2)(2008-12#1)(2009-6#1)(2013-8#1)
was measured as a##2##4##(2008-10#2)
was measured as an##3##4##(2008-10#1)(2008-11#2)
was measured as##8##3##(1993-2#1)(2008-10#5)(2008-11#2)
was measured at##20##3##(1990-2#1)(1991-12#1)(2008-10#13)(2008-3#2)(2008-9#1)(2010-12#1)(2013-1#1)
was measured based on##2##4##(2008-2#1)(2013-8#1)
was measured by a##5##4##(1990-6#1)(1992-3#1)(2008-10#2)(2010-3#1)
was measured by the##13##4##(1991-12#1)(1991-2#1)(1991-5#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-1#1)
was measured by using##2##4##(1995-8#1)(2008-10#1)
was measured by##42##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-1#2)(1997-2#1)(2008-10#13)(2008-11#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
was measured directly##3##3##(2008-10#2)(2008-3#1)
was measured during##4##3##(1993-1#1)(1997-1#1)(2008-1#1)(2008-11#1)
was measured for##4##3##(1992-6#1)(2008-10#2)(2008-2#1)
was measured from the date of first##2##7##(1990-8#1)(2008-7#1)
was measured from##3##3##(1990-8#1)(2008-12#1)(2008-7#1)
was measured in a##2##4##(1993-11#1)(2012-2#1)
was measured in four##2##4##(2008-10#1)(2008-5#1)
was measured in situ##2##4##(2008-10#1)(2010-8#1)
was measured in the##8##4##(1993-2#1)(1993-3#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)
was measured in vitro in##2##5##(1991-2#1)(2008-10#1)
was measured in vitro##3##4##(1991-2#1)(2008-10#1)(2008-9#1)
was measured in##36##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-2#1)(1995-11#1)(1996-12#1)(2008-10#11)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
was measured on the##2##4##(2009-2#1)(2010-11#1)
was measured on##4##3##(2008-10#1)(2009-2#1)(2010-11#1)(2012-2#1)
was measured over##3##3##(1997-1#1)(2008-10#2)
was measured through##2##3##(2008-10#1)(2008-3#1)
was measured to be##4##4##(2008-2#2)(2008-3#1)(2008-8#1)
was measured to determine the##2##5##(2008-10#2)
was measured to determine##3##4##(2007-8#1)(2008-10#2)
was measured to##9##3##(1996-6#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)
was measured using a##2##4##(1994-8#1)(2009-7#1)
was measured using the##3##4##(1991-2#1)(2008-11#1)(2012-3#1)
was measured using##15##3##(1991-2#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
was measured via##2##3##(2008-10#1)(2008-12#1)
was measured with a##4##4##(2008-10#3)(2009-11#1)
was measured with both##2##4##(1990-12#1)(2008-5#1)
was measured with the##3##4##(2008-10#2)(2010-7#1)
was measured with##16##3##(1990-12#1)(1996-2#1)(2008-10#7)(2008-5#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-7#1)(2013-1#1)
was measured##223##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#3)(1992-3#1)(1992-6#1)(1993-1#3)(1993-11#1)(1993-2#3)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-6#1)(1997-1#4)(1997-2#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#81)(2008-11#10)(2008-12#5)(2008-2#5)(2008-3#8)(2008-5#5)(2008-7#6)(2008-8#6)(2008-9#3)(2009-1#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#9)(2013-8#3)
was mechanically##2##2##(2008-10#2)
was mediated by##5##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
was mediated##7##2##(1995-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
was merged with##4##3##(2008-10#3)(2011-2#1)
was metabolized by##2##3##(1993-8#1)(2008-11#1)
was metabolized##3##2##(1993-8#1)(2008-11#2)
was mild##2##2##(2008-10#1)(2012-12#1)
was mimicked by##2##3##(1994-11#1)(1995-12#1)
was minimal in##2##3##(1991-2#1)(2012-3#1)
was minimal##8##2##(1990-12#1)(1991-2#1)(1992-6#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
was minimally##2##2##(2008-10#2)
was minimized by##3##3##(2008-10#2)(2008-5#1)
was minimized##5##2##(1995-5#1)(2008-10#3)(2008-5#1)
was misdiagnosed##2##2##(2008-7#1)(2011-2#1)
was missing##2##2##(2008-11#1)(2013-1#1)
was mixed on-line with##2##4##(2008-10#2)
was mixed with the##6##4##(2008-10#6)
was mixed with##14##3##(1992-6#1)(2008-10#13)
was mixed##19##2##(1992-6#1)(2008-10#17)(2008-9#1)
was modeled as a##3##4##(2008-10#1)(2010-3#1)(2013-1#1)
was modeled with##2##3##(2008-10#1)(2008-3#1)
was modeled##7##2##(2008-10#4)(2008-3#1)(2010-3#1)(2013-1#1)
was moderate##5##2##(1994-3#1)(2008-10#2)(2008-11#1)(2010-10#1)
was moderately##4##2##(1991-6#1)(1992-12#1)(2008-10#2)
was modified and##2##3##(2008-10#2)
was modified by##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
was modified to##7##3##(1996-2#1)(1997-6#1)(2008-10#3)(2008-7#1)(2008-8#1)
was modified with##3##3##(2008-10#3)
was modified##23##2##(1992-2#1)(1993-3#1)(1993-6#1)(1996-2#1)(1996-6#1)(1997-6#1)(2008-10#13)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
was modulated by the##2##4##(2008-11#1)(2010-12#1)
was modulated by##5##3##(2008-11#1)(2008-9#1)(2010-12#1)(2013-8#2)
was monitored at the##2##4##(2008-10#2)
was monitored at##9##3##(2008-10#9)
was monitored by a##2##4##(1993-2#1)(2008-10#1)
was monitored by fluorescence##2##4##(2008-10#1)(2008-11#1)
was monitored by measuring##2##4##(2008-10#2)
was monitored by the##2##4##(1990-8#1)(2008-10#1)
was monitored by##21##3##(1990-8#1)(1991-3#1)(1993-12#1)(1993-2#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)
was monitored during##3##3##(2008-10#2)(2008-7#1)
was monitored fluorometrically##2##3##(2008-10#2)
was monitored for##2##3##(2008-10#2)
was monitored in real-time##2##4##(2008-10#2)
was monitored in the##2##4##(2008-10#2)
was monitored in##11##3##(2008-10#10)(2008-11#1)
was monitored spectrophotometrically at##3##4##(2008-10#3)
was monitored spectrophotometrically by measuring the##5##6##(2008-10#5)
was monitored spectrophotometrically##9##3##(2008-10#9)
was monitored through##2##3##(2008-10#1)(2012-7#1)
was monitored using the##3##4##(1996-2#1)(2008-10#1)(2010-4#1)
was monitored using##6##3##(1990-8#1)(1996-2#1)(2008-10#3)(2010-4#1)
was monitored with##3##3##(2008-10#2)(2008-3#1)
was monitored##85##2##(1990-8#2)(1991-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-2#1)(2008-10#66)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-7#1)
was more accurate than##2##4##(2008-10#1)(2013-1#1)
was more active##3##3##(1992-10#1)(2008-10#1)(2008-11#1)
was more affected by##2##4##(2011-2#2)
was more common in patients##2##5##(2010-12#1)(2011-2#1)
was more dependent on##2##4##(2008-10#1)(2012-9#1)
was more effective at##4##4##(2008-10#2)(2010-4#1)(2012-3#1)
was more effective in##3##4##(1997-8#1)(2008-10#1)(2008-5#1)
was more effective than##10##4##(1992-9#1)(1995-11#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2012-12#1)
was more effective##19##3##(1992-9#1)(1994-8#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-5#2)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
was more efficient in##4##4##(2008-10#2)(2009-3#1)(2012-3#1)
was more efficient than##3##4##(2008-10#2)(2012-3#1)
was more efficient##7##3##(2008-10#4)(2009-3#1)(2012-3#2)
was more evident in##2##4##(1992-12#1)(2008-10#1)
was more frequent in##3##4##(2010-12#1)(2013-1#2)
was more frequent##4##3##(2010-12#1)(2011-2#1)(2013-1#2)
was more important than##2##4##(2008-10#1)(2008-8#1)
was more informative than##2##4##(2008-10#2)
was more intense##3##3##(1993-11#1)(1994-5#1)(2008-10#1)
was more likely##2##3##(2008-11#1)(2008-9#1)
was more or less##2##4##(2008-10#1)(2008-11#1)
was more potent in##2##4##(1990-12#1)(1992-3#1)
was more potent##3##3##(1990-12#1)(1992-3#1)(1996-2#1)
was more prevalent in##3##4##(2008-10#2)(2010-1#1)
was more prevalent##5##3##(2008-10#4)(2010-1#1)
was more pronounced at##3##4##(1991-2#1)(2008-10#2)
was more pronounced in the##2##5##(1997-1#1)(2008-7#1)
was more pronounced in##5##4##(1993-2#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-7#1)
was more pronounced##8##3##(1991-2#1)(1993-2#1)(1995-5#1)(1997-1#1)(2008-10#3)(2008-7#1)
was more robust##2##3##(2008-11#2)
was more sensitive than the##2##5##(1994-12#1)(2008-10#1)
was more sensitive than##5##4##(1990-3#1)(1994-12#1)(2008-10#1)(2008-3#1)(2009-6#1)
was more sensitive to##4##4##(1992-7#1)(2008-10#1)(2008-11#2)
was more sensitive##11##3##(1990-3#1)(1992-7#1)(1994-1#1)(1994-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-6#1)
was more severe##3##3##(2008-10#2)(2008-5#1)
was more significant##2##3##(2008-10#1)(2011-2#1)
was more specific##2##3##(2008-3#1)(2011-2#1)
was more stable##3##3##(1990-12#1)(1994-11#1)(2008-12#1)
was more strongly##2##3##(2010-2#1)(2012-3#1)
was more than##20##3##(1990-11#1)(1991-8#1)(1993-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
was more with Group I##2##5##(2010-7#2)
was more with Group##3##4##(2010-7#3)
was more##170##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#57)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#3)(2011-2#13)(2012-12#2)(2012-2#2)(2012-3#6)(2012-9#1)(2013-1#5)(2013-8#1)
was most closely related to##7##5##(1997-8#1)(2008-10#5)(2008-9#1)
was most commonly##2##3##(2008-10#2)
was most dramatic##2##3##(1995-8#1)(2008-10#1)
was most effective in##2##4##(1997-8#1)(2008-4#1)
was most effective##7##3##(1993-6#1)(1997-8#1)(2008-10#4)(2008-4#1)
was most frequently##2##3##(2008-10#2)
was most highly expressed in##2##5##(2013-8#2)
was most likely##5##3##(2008-10#5)
was most prevalent in##2##4##(2008-10#2)
was most prevalent##3##3##(2008-10#3)
was most probably##2##3##(2008-10#1)(2011-2#1)
was most pronounced##4##3##(1993-8#1)(1994-8#1)(2008-11#1)(2013-8#1)
was most##51##2##(1993-6#1)(1993-8#1)(1994-8#1)(1995-8#1)(1997-8#2)(2008-10#30)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#3)
was mostly in the##2##4##(2008-10#2)
was mostly##8##2##(2008-10#6)(2008-12#1)(2011-3#1)
was mounted in##2##3##(2008-10#1)(2008-3#1)
was mounted##3##2##(2008-10#2)(2008-3#1)
was moved##2##2##(2008-10#1)(2009-4#1)
was much faster##2##3##(2007-8#1)(2008-10#1)
was much fewer##2##3##(2008-5#1)(2008-9#1)
was much greater than##2##4##(2008-10#1)(2008-7#1)
was much higher in##3##4##(1997-2#1)(2008-10#2)
was much higher than that##2##5##(2008-10#1)(2010-3#1)
was much higher than##6##4##(2008-10#3)(2008-8#1)(2009-2#1)(2010-3#1)
was much higher##10##3##(1997-2#1)(2008-10#6)(2008-8#1)(2009-2#1)(2010-3#1)
was much larger##3##3##(1995-6#1)(1997-2#1)(2008-10#1)
was much less##4##3##(1994-8#1)(1996-1#1)(1996-2#1)(2008-10#1)
was much lower than that of##2##6##(2008-8#2)
was much lower than that##3##5##(2008-7#1)(2008-8#2)
was much lower than##6##4##(2008-10#1)(2008-7#1)(2008-8#3)(2013-8#1)
was much lower##10##3##(2008-10#4)(2008-7#1)(2008-8#3)(2011-3#1)(2013-8#1)
was much more rapid##2##4##(2008-10#1)(2008-11#1)
was much more##10##3##(1990-2#1)(1991-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)
was much shorter than##2##4##(1991-12#1)(2008-10#1)
was much slower##2##3##(1993-8#1)(2008-8#1)
was much##54##2##(1990-2#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#2)(2007-8#1)(2008-10#21)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#1)(2009-2#1)(2010-3#1)(2011-3#1)(2013-8#1)
was mutated##2##2##(1990-8#1)(2013-8#1)
was named as##2##3##(2008-7#1)(2010-8#1)
was named##14##2##(1991-9#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
was narrowed##2##2##(2008-7#1)(2009-10#1)
was nearly identical to##2##4##(1997-2#1)(2008-10#1)
was nearly identical##5##3##(1997-2#1)(2008-10#3)(2011-2#1)
was nearly##17##2##(1992-8#1)(1993-12#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)
was necessary for##6##3##(1990-5#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
was necessary in##2##3##(2007-8#1)(2011-2#1)
was necessary to##12##3##(1990-2#1)(1990-9#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-5#1)
was necessary##30##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
was needed and##2##3##(1996-1#1)(2008-10#1)
was needed in##2##3##(2008-10#1)(2008-11#1)
was needed to##7##3##(1994-3#1)(1997-2#1)(2008-10#4)(2011-2#1)
was needed##16##2##(1994-3#1)(1996-1#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
was negative and##2##3##(2008-7#1)(2013-1#1)
was negative for##5##3##(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
was negative##20##2##(1990-2#1)(1990-6#1)(1993-6#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
was negatively correlated to##2##4##(2008-10#1)(2012-2#1)
was negatively correlated with plant tissue nitrogen content and positively correlated with##2##12##(2008-10#2)
was negatively correlated with##13##4##(2008-10#9)(2008-9#1)(2009-7#1)(2011-2#2)
was negatively correlated##16##3##(2008-10#11)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)
was negatively##18##2##(2008-10#12)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
was negligible for##3##3##(1991-5#1)(1991-9#1)(2008-10#1)
was negligible##7##2##(1991-5#1)(1991-9#1)(1996-2#1)(1997-8#1)(2008-10#3)
was neither##6##2##(1990-2#1)(1992-3#1)(1995-6#1)(2008-5#1)(2011-2#1)(2013-1#1)
was neurologically##2##2##(2008-7#1)(2011-2#1)
was neutralized##3##2##(1997-1#1)(2008-10#2)
was never observed##3##3##(2008-10#2)(2012-3#1)
was never##10##2##(1990-8#1)(1996-11#1)(2008-10#4)(2008-5#1)(2009-10#1)(2012-3#1)(2013-1#1)
was newly synthesized##2##3##(2008-10#1)(2008-9#1)
was no association with##2##4##(2008-12#1)(2008-9#1)
was no association##5##3##(1993-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
was no change in the##4##5##(1990-5#1)(1991-2#1)(1996-12#1)(2008-7#1)
was no change in##6##4##(1990-5#1)(1991-2#1)(1996-12#2)(2008-7#1)(2013-8#1)
was no change##7##3##(1990-5#1)(1991-2#1)(1996-12#2)(2008-7#1)(2012-3#1)(2013-8#1)
was no clear##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
was no correlation between##9##4##(1991-8#2)(1993-2#1)(1995-2#1)(2008-10#2)(2008-5#1)(2011-2#2)
was no correlation##11##3##(1991-8#2)(1993-2#1)(1995-2#1)(2008-10#3)(2008-5#1)(2011-2#3)
was no difference between the##2##5##(1990-2#1)(2008-9#1)
was no difference between##4##4##(1990-2#1)(1994-3#1)(2008-10#1)(2008-9#1)
was no difference in the##7##5##(1995-12#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
was no difference in##18##4##(1992-12#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-8#4)
was no difference##25##3##(1990-2#1)(1992-12#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-3#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-8#4)
was no effect of##3##4##(1996-12#1)(2008-10#1)(2009-3#1)
was no effect on##3##4##(1992-2#1)(1995-2#1)(1997-6#1)
was no effect##7##3##(1990-5#1)(1992-2#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-10#1)(2009-3#1)
was no evidence of##18##4##(1991-1#1)(1991-6#1)(1992-5#1)(1996-1#1)(1996-3#1)(2008-10#5)(2008-9#3)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
was no evidence that##3##4##(1996-3#1)(2008-10#1)(2008-9#1)
was no evidence##23##3##(1991-1#1)(1991-6#1)(1992-5#1)(1996-1#1)(1996-3#2)(2008-10#7)(2008-9#4)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
was no interference##5##3##(1993-2#1)(2008-10#4)
was no longer##9##3##(1990-5#1)(1991-2#1)(1993-11#1)(1994-6#1)(1995-2#1)(2008-10#2)(2008-11#2)
was no marked##2##3##(2008-11#1)(2013-8#1)
was no recurrence##2##3##(2013-1#1)(2013-8#1)
was no relationship between the##4##5##(1991-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
was no relationship between##9##4##(1991-11#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#2)(2013-1#1)
was no response##2##3##(2008-10#1)(2010-12#1)
was no significant change in##2##5##(2008-6#1)(2013-1#1)
was no significant correlation between DNA##2##6##(1994-12#1)(2008-10#1)
was no significant correlation between##7##5##(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#4)
was no significant correlation##8##4##(1994-12#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#4)
was no significant difference among##3##5##(2008-10#2)(2013-1#1)
was no significant difference between the##5##6##(1997-8#1)(1997-9#1)(2008-10#2)(2008-9#1)
was no significant difference between##13##5##(1991-8#1)(1993-2#1)(1997-8#1)(1997-9#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
was no significant difference in the proportion of##2##8##(2011-2#1)(2012-3#1)
was no significant difference in the##12##6##(1991-2#1)(2008-10#2)(2008-11#3)(2011-2#2)(2012-3#2)(2013-1#2)
was no significant difference in##25##5##(1991-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)
was no significant difference##42##4##(1991-2#1)(1991-8#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#1)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#3)
was no significant interaction##3##4##(2008-10#2)(2008-12#1)
was no significant relationship##2##4##(2008-10#2)
was no significant##66##3##(1991-2#1)(1991-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-8#2)(1997-9#1)(2006-6#1)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#4)(2013-1#5)
was no statistical difference between##4##5##(1996-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
was no statistical difference##6##4##(1990-12#1)(1996-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
was no statistical##7##3##(1990-12#1)(1996-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
was no statistically significant difference##3##5##(2008-11#1)(2008-12#1)(2013-1#1)
was no statistically##4##3##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
was no##271##2##(1990-12#2)(1990-2#1)(1990-5#5)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#4)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#7)(1996-2#3)(1996-3#2)(1997-2#2)(1997-3#3)(1997-6#1)(1997-8#4)(1997-9#1)(2006-6#1)(2008-1#2)(2008-10#68)(2008-11#17)(2008-12#6)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#12)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#15)(2012-12#3)(2012-2#2)(2012-3#9)(2012-8#1)(2013-1#17)(2013-8#8)
was nominated for##2##3##(2008-9#2)
was noncompetitive##3##2##(1992-3#3)
was normal at##2##3##(1991-6#1)(2013-1#1)
was normal in##2##3##(2010-12#1)(2013-1#1)
was normal##20##2##(1990-6#1)(1991-6#1)(1993-1#1)(1993-6#1)(1997-8#2)(2007-12#1)(2008-12#1)(2008-7#3)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
was normalized##2##2##(2008-10#2)
was not a good##2##4##(2008-10#2)
was not a major##3##4##(1994-1#2)(2008-10#1)
was not a significant##3##4##(1996-1#1)(2011-2#2)
was not a##20##3##(1992-9#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-8#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2010-1#1)(2011-2#3)(2013-1#1)
was not able to##2##4##(1992-3#1)(2008-10#1)
was not accompanied by##3##4##(1994-3#1)(1995-2#1)(2008-11#1)
was not active##2##3##(2008-11#1)(2011-3#1)
was not affected by the##4##5##(2008-10#2)(2008-11#1)(2008-9#1)
was not affected by tillage##2##5##(2008-10#2)
was not affected by##20##4##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1993-2#1)(1995-11#1)(1997-1#1)(2008-10#8)(2008-11#2)(2008-9#1)(2011-2#1)(2013-8#1)
was not affected##28##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1993-2#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
was not altered by##2##4##(1994-3#1)(1995-11#1)
was not altered##6##3##(1993-2#1)(1994-3#1)(1995-11#1)(1996-2#1)(2008-10#1)(2011-2#1)
was not always##6##3##(1991-12#1)(2008-10#3)(2008-11#2)
was not anticipated##2##3##(1995-5#1)(2009-10#1)
was not any##2##3##(1995-2#1)(2008-7#1)
was not apparent##2##3##(2008-10#1)(2008-7#1)
was not as effective##3##4##(2008-10#1)(2013-1#2)
was not as sensitive##2##4##(1991-3#1)(2011-2#1)
was not as##7##3##(1991-3#1)(2008-10#3)(2011-2#1)(2013-1#2)
was not associated with a##2##5##(2008-12#1)(2012-2#1)
was not associated with an##2##5##(2009-10#1)(2012-2#1)
was not associated with any##4##5##(2008-10#2)(2008-12#1)(2012-3#1)
was not associated with##20##4##(1995-11#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#1)(2010-6#1)(2012-2#2)(2012-3#2)
was not available##2##3##(2008-11#1)(2008-7#1)
was not blocked by##2##4##(1990-5#1)(1993-6#1)
was not changed##5##3##(1997-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-8#1)
was not clear##2##3##(2008-10#1)(2008-11#1)
was not closely related to##2##5##(2008-10#2)
was not common##3##3##(1991-6#1)(2008-10#2)
was not confirmed in##2##4##(1992-2#1)(2011-2#1)
was not confirmed##4##3##(1990-6#1)(1992-2#1)(2008-11#1)(2011-2#1)
was not considered##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
was not consistent##2##3##(2008-10#2)
was not consistently##3##3##(2008-10#2)(2012-2#1)
was not correlated to##2##4##(1994-6#1)(2008-10#1)
was not correlated with##9##4##(1991-8#1)(1992-9#1)(2008-10#4)(2008-9#1)(2010-6#1)(2011-1#1)
was not correlated##13##3##(1991-8#1)(1992-9#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-9#1)(2010-6#1)(2011-1#1)
was not dependent on the##2##5##(2012-2#1)(2013-8#1)
was not dependent on##3##4##(1995-12#1)(2012-2#1)(2013-8#1)
was not dependent##4##3##(1995-12#1)(2008-10#1)(2012-2#1)(2013-8#1)
was not detectable in##2##4##(1991-5#1)(2008-10#1)
was not detectable##5##3##(1991-12#1)(1991-5#1)(2008-10#2)(2008-9#1)
was not detected at all in##2##6##(1995-11#1)(2008-10#1)
was not detected at##4##4##(1995-11#1)(2008-10#2)(2008-5#1)
was not detected in all##2##5##(2008-10#2)
was not detected in the##7##5##(1990-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
was not detected in##20##4##(1990-9#1)(1996-2#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2012-12#1)(2013-1#1)
was not detected##35##3##(1990-9#1)(1995-11#1)(1995-2#2)(1996-2#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#4)(2008-8#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
was not determined##2##3##(1995-9#1)(2008-10#1)
was not different between##3##4##(1994-5#1)(2012-3#1)(2013-8#1)
was not different from##2##4##(1994-8#1)(2008-10#1)
was not different##7##3##(1994-5#1)(1994-8#1)(2008-10#2)(2009-7#1)(2012-3#1)(2013-8#1)
was not directly##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
was not due to an##2##5##(1990-8#1)(1997-1#1)
was not due to the##3##5##(1995-12#1)(2008-10#1)(2008-11#1)
was not due to##10##4##(1990-8#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-10#2)(2008-11#2)
was not due##11##3##(1990-8#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-7#1)
was not effective in##3##4##(2008-10#2)(2010-1#1)
was not effective##5##3##(2008-10#3)(2008-11#1)(2010-1#1)
was not enhanced by##2##4##(2008-10#1)(2008-11#1)
was not enough to##2##4##(1996-2#1)(2008-9#1)
was not evident##2##3##(2008-10#1)(2008-7#1)
was not exposed##2##3##(1995-12#1)(2008-8#1)
was not followed by##2##4##(1997-3#1)(2010-12#1)
was not found in##6##4##(1991-9#1)(2008-10#4)(2008-9#1)
was not found to be##4##5##(1996-6#1)(2008-10#1)(2008-9#1)(2010-11#1)
was not found to##7##4##(1991-2#1)(1996-6#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-12#1)(2013-1#1)
was not found##20##3##(1991-2#2)(1991-3#1)(1991-9#1)(1996-2#1)(1996-6#1)(2008-10#7)(2008-5#1)(2008-9#2)(2010-11#1)(2010-12#2)(2013-1#1)
was not identified##2##3##(2008-11#1)(2012-3#1)
was not implemented##2##3##(2008-10#1)(2010-10#1)
was not improved##2##3##(2008-10#2)
was not in##3##3##(1993-6#1)(2008-10#1)(2011-2#1)
was not induced by##2##4##(2011-2#1)(2012-2#1)
was not induced##5##3##(1994-8#1)(1996-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
was not influenced by the##3##5##(1991-9#1)(2008-10#1)(2008-11#1)
was not influenced by##6##4##(1990-12#1)(1991-9#1)(1995-2#1)(2008-10#2)(2008-11#1)
was not influenced##7##3##(1990-12#1)(1991-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
was not inhibited by##7##4##(1992-3#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-5#1)
was not inhibited##9##3##(1992-3#1)(1994-11#1)(1995-6#1)(1996-12#2)(1997-8#1)(2008-10#2)(2008-5#1)
was not investigated##2##3##(2008-10#1)(2011-2#1)
was not involved in the##3##5##(1995-2#1)(2008-10#2)
was not involved in##4##4##(1995-2#1)(2008-10#3)
was not involved##5##3##(1995-2#1)(2008-10#3)(2008-11#1)
was not likely##2##3##(2008-10#2)
was not maintained##2##3##(1994-6#1)(2008-4#1)
was not mentioned##2##3##(2008-7#1)(2012-12#1)
was not modified by##2##4##(1994-8#1)(1995-12#1)
was not modified##3##3##(1994-8#2)(1995-12#1)
was not more##2##3##(2008-10#1)(2008-8#1)
was not mutagenic in##2##4##(1995-11#1)(2008-9#1)
was not necessary##4##3##(1995-2#1)(2008-10#3)
was not observed in the##7##5##(1994-11#1)(1995-11#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-1#1)
was not observed in##19##4##(1991-12#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-3#1)(2010-10#1)(2011-1#1)(2012-12#1)
was not observed##37##3##(1990-9#1)(1991-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
was not obtained##3##3##(2008-10#2)(2008-12#1)
was not of##2##3##(2008-10#2)
was not only##7##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2011-2#1)
was not possible because of##2##5##(1991-11#1)(2008-10#1)
was not possible to##6##4##(2008-10#5)(2008-5#1)
was not possible##13##3##(1991-11#1)(2008-10#10)(2008-5#2)
was not present in##2##4##(2008-11#1)(2011-2#1)
was not present##7##3##(1994-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)
was not produced##2##3##(1997-8#1)(2008-11#1)
was not properly##2##3##(1995-6#2)
was not random##2##3##(2008-10#1)(2008-8#1)
was not reached##2##3##(2008-10#1)(2012-12#1)
was not recognized##2##3##(1993-8#1)(2008-10#1)
was not reduced by##2##4##(1995-2#1)(2008-10#1)
was not reduced##7##3##(1995-2#1)(1996-11#1)(2008-10#3)(2011-2#1)(2013-7#1)
was not related to the##3##5##(1992-2#1)(1996-1#1)(2008-10#1)
was not related to##13##4##(1991-12#1)(1992-2#1)(1993-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)
was not related##14##3##(1991-12#1)(1991-8#1)(1992-2#1)(1993-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)
was not reported##3##3##(2008-12#1)(2010-12#1)(2012-12#1)
was not required for the##2##5##(1992-10#1)(2008-11#1)
was not required for##5##4##(1992-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
was not required##8##3##(1992-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
was not restricted to##2##4##(2008-10#1)(2008-11#1)
was not restricted##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
was not retained##2##3##(1992-6#1)(2008-10#1)
was not seen until##2##4##(1997-3#2)
was not seen##6##3##(1990-12#1)(1994-5#1)(1997-3#2)(2008-10#1)(2008-8#1)
was not sensitive to##3##4##(1993-9#1)(2008-11#1)(2012-3#1)
was not shown##3##3##(1992-3#1)(2008-11#1)(2009-10#1)
was not significant (p##2##4##(2008-10#1)(2013-1#1)
was not significant##13##3##(1992-12#1)(1993-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
was not significantly affected by the##2##6##(1996-12#1)(2008-10#1)
was not significantly affected by##6##5##(1990-5#1)(1996-12#1)(2008-10#3)(2008-11#1)
was not significantly affected##11##4##(1990-5#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-6#1)(2010-11#1)(2012-2#1)
was not significantly altered in##2##5##(2008-10#1)(2008-9#1)
was not significantly altered##3##4##(1992-1#1)(2008-10#1)(2008-9#1)
was not significantly changed##2##4##(1992-6#1)(2008-10#1)
was not significantly different (P##2##5##(2008-10#2)
was not significantly different among##2##5##(2008-10#1)(2008-7#1)
was not significantly different between##2##5##(1993-11#1)(2013-8#1)
was not significantly different from that##2##6##(2008-10#2)
was not significantly different from##6##5##(1993-1#1)(1996-12#1)(2008-10#3)(2013-1#1)
was not significantly different##15##4##(1992-12#1)(1993-1#1)(1993-11#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
was not significantly reduced##2##4##(2008-10#1)(2008-9#1)
was not significantly##41##3##(1990-5#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1996-12#2)(1997-8#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
was not so##2##3##(1993-8#1)(2008-10#1)
was not specifically##2##3##(1997-4#1)(2008-10#1)
was not statistically different from##2##5##(2008-10#1)(2012-3#1)
was not statistically different##3##4##(1990-3#1)(2008-10#1)(2012-3#1)
was not statistically significant##10##4##(1990-11#1)(1997-8#1)(2008-12#1)(2009-3#2)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
was not statistically##13##3##(1990-11#1)(1990-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-3#2)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
was not subject to##2##4##(1991-7#1)(2008-10#1)
was not successful##2##3##(2008-10#1)(2008-7#1)
was not sufficient##3##3##(1997-7#1)(2008-10#1)(2010-3#1)
was not suppressed##3##3##(2008-10#2)(2011-1#1)
was not the case for##2##5##(2008-11#1)(2011-2#1)
was not the result of##3##5##(1996-2#1)(1997-1#1)(2008-12#1)
was not the same##2##4##(1997-8#1)(2008-10#1)
was not the##11##3##(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
was not transmitted##3##3##(2008-10#3)
was not uniform##2##3##(2008-11#1)(2010-8#1)
was not used##5##3##(1992-3#1)(1994-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
was not well##2##3##(2008-10#1)(2013-1#1)
was not##681##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#7)(1992-6#4)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#7)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#8)(1995-11#7)(1995-12#5)(1995-2#9)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#8)(1996-2#8)(1996-3#1)(1996-6#1)(1997-1#6)(1997-2#1)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#9)(2007-12#1)(2008-1#1)(2008-10#227)(2008-11#53)(2008-12#13)(2008-3#2)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#18)(2008-8#14)(2008-9#16)(2009-10#5)(2009-3#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#4)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#22)(2011-3#1)(2012-12#11)(2012-2#12)(2012-3#7)(2013-1#20)(2013-7#1)(2013-8#8)
was notable##2##2##(1992-8#1)(1995-12#1)
was noted at##4##3##(1993-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
was noted between##4##3##(2008-4#1)(2008-7#1)(2009-3#1)(2013-1#1)
was noted in the##7##4##(1996-9#1)(1997-1#1)(2008-11#1)(2008-12#1)(2009-1#1)(2009-7#1)(2010-6#1)
was noted in##20##3##(1990-8#1)(1991-3#1)(1994-12#1)(1994-2#1)(1996-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-1#1)(2009-7#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
was noted that##2##3##(2008-10#1)(2008-11#1)
was noted to have##2##4##(2008-1#1)(2013-1#1)
was noted when##3##3##(1996-3#1)(1997-2#1)(2008-10#1)
was noted##51##2##(1990-5#1)(1990-8#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-7#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
was noticed in##2##3##(2008-10#1)(2011-2#1)
was noticed on the##2##4##(2008-11#1)(2010-12#1)
was noticed that##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
was noticed##9##2##(1990-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-3#1)
was obeyed over the range 0##2##6##(2008-10#2)
was obeyed over the range of 0##2##7##(2008-10#2)
was obeyed over the range##6##5##(2008-10#6)
was obeyed over the##8##4##(2008-10#8)
was obeyed##15##2##(2008-10#15)
was observed after addition of##2##5##(1993-8#1)(2013-1#1)
was observed after the##2##4##(1995-2#1)(2011-2#1)
was observed after##8##3##(1993-8#1)(1995-2#1)(1995-8#1)(2011-2#1)(2013-1#3)(2013-7#1)
was observed among isolates of##2##5##(2008-10#1)(2012-2#1)
was observed among isolates##3##4##(2008-10#2)(2012-2#1)
was observed among##8##3##(2008-10#6)(2008-8#1)(2012-2#1)
was observed and the detection##2##5##(2008-10#2)
was observed and the##4##4##(1994-3#1)(2008-10#2)(2008-8#1)
was observed and##11##3##(1994-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)
was observed as##2##3##(1991-2#1)(1994-12#1)
was observed at high##2##4##(2008-10#1)(2008-12#1)
was observed at higher##2##4##(2008-10#2)
was observed at the##3##4##(2008-7#1)(2012-3#1)(2013-1#1)
was observed at##39##3##(1990-5#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-6#1)(2008-7#2)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
was observed because##2##3##(2008-10#1)(2008-12#1)
was observed between the two##2##5##(1990-2#1)(2008-10#1)
was observed between the##19##4##(1990-2#1)(1994-6#1)(1995-8#1)(2008-10#9)(2008-11#1)(2008-7#2)(2010-4#2)(2011-2#1)(2013-1#1)
was observed between##46##3##(1990-2#1)(1990-6#1)(1991-2#1)(1991-6#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-8#1)(2008-10#23)(2008-11#1)(2008-5#4)(2008-7#2)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
was observed by using##3##4##(2008-10#2)(2008-8#1)
was observed by##13##3##(1992-6#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-3#1)(2012-3#1)
was observed due to##2##4##(2008-10#2)
was observed during the##5##4##(1997-3#1)(2008-10#3)(2012-3#1)
was observed during##9##3##(1997-3#1)(2008-10#4)(2008-11#2)(2011-1#1)(2012-3#1)
was observed following##2##3##(1993-3#1)(2008-5#1)
was observed for both##2##4##(2008-10#2)
was observed for the first time##2##6##(2008-10#1)(2008-9#1)
was observed for the##11##4##(1993-6#1)(2008-10#3)(2008-11#4)(2008-9#1)(2009-1#1)(2011-2#1)
was observed for##49##3##(1990-3#1)(1990-6#1)(1991-12#2)(1991-6#1)(1992-2#1)(1992-6#1)(1993-6#1)(1996-2#1)(1997-3#1)(2008-10#19)(2008-11#8)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was observed from the##4##4##(1991-9#1)(2008-10#2)(2012-3#1)
was observed from##13##3##(1991-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2012-3#1)
was observed in 2##2##4##(1992-12#1)(2008-9#1)
was observed in 3 patients##2##5##(1991-8#1)(1997-7#1)
was observed in a##6##4##(1991-8#1)(2008-10#3)(2008-3#1)(2010-4#1)
was observed in all three##2##5##(2008-10#2)
was observed in all##8##4##(1996-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
was observed in both##6##4##(1992-12#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-7#1)(2013-1#1)
was observed in cells##2##4##(1990-8#1)(1995-6#1)
was observed in females##2##4##(1994-6#1)(2008-7#1)
was observed in four##2##4##(1994-12#1)(2008-8#1)
was observed in most##2##4##(2008-6#1)(2013-1#1)
was observed in the absence of##2##6##(2008-11#2)
was observed in the cytoplasm of##2##6##(1995-8#1)(2008-11#1)
was observed in the presence of##5##6##(1992-8#1)(2008-10#4)
was observed in the##55##4##(1990-5#1)(1991-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-8#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#18)(2008-11#7)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
was observed in these##2##4##(1994-3#1)(2008-11#1)
was observed in##212##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#4)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#4)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#60)(2008-11#21)(2008-12#4)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#3)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
was observed on both##2##4##(1990-8#1)(2008-5#1)
was observed on fibronectin and polystyrene##2##6##(2008-11#2)
was observed on the surface##2##5##(2008-10#1)(2008-11#1)
was observed on the##9##4##(1995-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)
was observed on##23##3##(1990-8#1)(1993-3#1)(1994-11#1)(1995-2#2)(2006-6#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#2)(2010-11#1)
was observed only for the##2##5##(2008-10#1)(2008-5#1)
was observed only on##2##4##(2008-10#2)
was observed only##8##3##(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)
was observed over##3##3##(1990-12#1)(2008-10#2)
was observed that the##13##4##(1993-9#1)(2008-10#9)(2009-6#1)(2011-1#1)(2012-12#1)
was observed that##34##3##(1990-5#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
was observed to be linear##2##5##(2008-10#2)
was observed to be##7##4##(1992-3#1)(1993-8#1)(2008-10#3)(2008-11#1)(2013-1#1)
was observed to##18##3##(1992-3#1)(1993-8#3)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#2)
was observed under##5##3##(1993-6#1)(2008-10#3)(2008-11#1)
was observed up to##3##4##(2008-10#2)(2013-8#1)
was observed using##6##3##(1993-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
was observed when HGF was added##2##6##(2008-11#2)
was observed when cells##2##4##(2008-11#2)
was observed when compared with##2##5##(2008-10#1)(2011-2#1)
was observed when the##4##4##(2008-10#2)(2008-5#1)(2010-4#1)
was observed when##27##3##(1990-10#1)(1990-2#1)(1994-11#2)(2008-10#10)(2008-11#7)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
was observed where##2##3##(2008-10#1)(2008-11#1)
was observed with a##2##4##(1990-5#1)(2008-10#1)
was observed with the##2##4##(2008-11#1)(2008-5#1)
was observed with##29##3##(1990-5#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
was observed within the##3##4##(1991-12#1)(2008-10#2)
was observed within##7##3##(1991-12#1)(1994-11#1)(1995-11#1)(2008-10#3)(2012-12#1)
was observed##776##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#1)(1990-5#6)(1990-6#5)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#3)(1991-5#7)(1991-6#3)(1991-8#5)(1991-9#3)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#4)(1993-6#5)(1993-8#5)(1993-9#2)(1994-11#6)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#5)(1995-11#4)(1995-12#6)(1995-2#7)(1995-3#1)(1995-6#3)(1995-8#7)(1996-1#1)(1996-12#8)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#7)(1997-7#2)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#300)(2008-11#74)(2008-12#14)(2008-2#2)(2008-3#7)(2008-5#26)(2008-6#3)(2008-7#20)(2008-8#11)(2008-9#14)(2009-1#2)(2009-11#1)(2009-12#4)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#6)(2010-12#4)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#14)(2011-3#5)(2012-12#3)(2012-2#8)(2012-3#13)(2013-1#24)(2013-7#2)(2013-8#6)
was obtained (r=0##2##3##(2008-10#2)
was obtained after##4##3##(1990-6#1)(2008-10#3)
was obtained and the##2##4##(2008-10#2)
was obtained and##3##3##(2008-10#3)
was obtained around pH 7##2##5##(2008-10#2)
was obtained as##2##3##(2008-10#2)
was obtained at a##5##4##(2008-10#3)(2008-3#1)(2008-6#1)
was obtained at##12##3##(2008-10#9)(2008-12#1)(2008-3#1)(2008-6#1)
was obtained between Vg concentration and##2##6##(2008-10#2)
was obtained between the##12##4##(1993-2#1)(2008-10#11)
was obtained between##18##3##(1993-2#2)(2008-10#16)
was obtained by a##4##4##(1991-2#1)(1995-9#1)(2008-10#1)(2010-9#1)
was obtained by the##6##4##(1995-12#1)(2008-10#4)(2010-12#1)
was obtained by use of##2##5##(2008-2#1)(2008-3#1)
was obtained by using a##3##5##(2008-10#3)
was obtained by using an injected volume of##2##8##(2008-10#2)
was obtained by using the##2##5##(2008-10#1)(2010-7#1)
was obtained by using##12##4##(2008-10#8)(2008-8#2)(2008-9#1)(2010-7#1)
was obtained by##55##3##(1991-2#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2013-1#1)
was obtained compared##2##3##(2008-10#1)(2008-8#1)
was obtained experimentally##2##3##(2008-10#1)(2010-4#1)
was obtained for a##3##4##(2008-10#3)
was obtained for all##3##4##(2008-10#3)
was obtained for arsenic determination between##2##6##(2008-10#2)
was obtained for both##2##4##(2008-10#2)
was obtained for the determination of##2##6##(2008-10#2)
was obtained for the##11##4##(1991-5#1)(2008-10#10)
was obtained for##51##3##(1991-5#1)(1996-12#2)(2008-10#43)(2008-11#2)(2008-3#1)(2008-5#1)(2010-11#1)
was obtained from 0##3##4##(2008-10#3)
was obtained from a##6##4##(1993-2#1)(1994-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
was obtained from an##2##4##(1993-6#1)(2008-10#1)
was obtained from the##12##4##(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
was obtained from##35##3##(1993-2#1)(1993-6#1)(1994-8#1)(1997-4#1)(1997-8#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
was obtained in 0##2##4##(2008-10#2)
was obtained in 11##2##4##(1990-6#1)(1992-12#1)
was obtained in 44##2##4##(1991-6#1)(1991-8#1)
was obtained in a##4##4##(1993-2#1)(2008-10#3)
was obtained in all##2##4##(2008-7#1)(2009-3#1)
was obtained in the concentration range of##2##7##(2008-10#2)
was obtained in the concentration range##3##6##(2008-10#3)
was obtained in the concentration##4##5##(2008-10#4)
was obtained in the presence of##2##6##(1997-2#1)(2008-10#1)
was obtained in the range of##3##6##(2008-10#2)(2008-12#1)
was obtained in the range##8##5##(2008-10#7)(2008-12#1)
was obtained in the##19##4##(1997-2#1)(2008-10#16)(2008-12#1)(2008-5#1)
was obtained in##48##3##(1990-6#2)(1991-6#1)(1991-8#2)(1992-12#1)(1993-2#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#2)
was obtained on the##2##4##(2008-10#2)
was obtained on##8##3##(1991-9#1)(1997-2#1)(2008-10#4)(2008-7#1)(2008-8#1)
was obtained over the##4##4##(2008-10#4)
was obtained over##5##3##(2008-10#5)
was obtained through the##2##4##(2008-10#1)(2008-11#1)
was obtained through##7##3##(2008-10#2)(2008-11#2)(2008-5#1)(2013-8#2)
was obtained under##2##3##(2008-10#2)
was obtained using##7##3##(1997-3#1)(2008-10#5)(2008-11#1)
was obtained when the##3##4##(2008-10#1)(2008-11#2)
was obtained when##6##3##(2008-10#4)(2008-11#2)
was obtained which##2##3##(2008-9#1)(2012-12#1)
was obtained with a##12##4##(1994-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)
was obtained with the##8##4##(2008-10#6)(2008-11#1)(2008-7#1)
was obtained with##42##3##(1994-6#1)(1996-5#1)(2007-11#1)(2008-10#30)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
was obtained within##4##3##(2008-10#4)
was obtained without##2##3##(2008-10#1)(2008-3#1)
was obtained##438##2##(1990-12#1)(1990-2#1)(1990-6#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#1)(1993-2#4)(1993-3#3)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-5#5)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#2)(2007-11#2)(2008-1#1)(2008-10#279)(2008-11#22)(2008-12#5)(2008-2#7)(2008-3#13)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#7)(2009-1#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-8#1)(2013-1#6)(2013-8#2)
was obvious##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
was obviously enhanced##2##3##(2008-11#1)(2013-1#1)
was obviously##4##2##(2008-11#1)(2008-8#1)(2010-1#1)(2013-1#1)
was of 0##4##3##(2008-10#4)
was of 1##2##3##(2008-1#1)(2008-10#1)
was of 4##2##3##(2008-10#2)
was of 5##2##3##(2008-10#2)
was of a##4##3##(1991-2#1)(2008-3#1)(2009-4#1)(2009-8#1)
was of borderline statistical significance##2##5##(2008-11#2)
was of significant##2##3##(2008-10#1)(2010-9#1)
was of the##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
was of##43##2##(1991-2#2)(1992-10#1)(1993-6#1)(1994-6#1)(1996-1#1)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
was offered##4##2##(1995-8#1)(2008-10#1)(2010-10#1)(2010-8#1)
was often##11##2##(1991-3#1)(1993-6#1)(2008-10#3)(2008-11#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
was on##12##2##(1991-2#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#3)
was on-line detected##2##3##(2008-10#2)
was on-line electrogenerated by constant-current electrolysis##2##6##(2008-10#2)
was on-line electrogenerated##3##3##(2008-10#3)
was on-line##6##2##(2008-10#6)
was once##2##2##(1991-11#1)(1996-3#1)
was one of the highest##2##5##(2008-11#1)(2011-2#1)
was one of the most important##2##6##(2010-7#1)(2013-1#1)
was one of the##9##4##(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#2)(2010-7#1)(2011-2#1)(2013-1#1)
was one of these##2##4##(2008-11#2)
was one of##12##3##(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#4)(2010-7#1)(2011-2#2)(2013-1#1)
was one##23##2##(1992-9#1)(1993-12#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-7#3)(2010-6#1)(2010-7#1)(2011-2#3)(2013-1#2)
was only 0##4##3##(1991-5#1)(1993-8#1)(2008-10#1)(2008-11#1)
was only 20%##2##3##(1990-8#1)(1994-5#1)
was only 9##2##3##(2008-10#2)
was only a##4##3##(1995-3#1)(1997-1#1)(2008-10#2)
was only about##4##3##(2008-10#2)(2008-11#1)(2009-11#1)
was only found in##3##4##(1997-6#1)(2008-10#1)(2008-7#1)
was only found##4##3##(1997-6#1)(2008-10#2)(2008-7#1)
was only observed in##2##4##(1997-1#1)(2012-5#1)
was only observed##5##3##(1992-3#1)(1997-1#1)(2008-10#2)(2012-5#1)
was only one##4##3##(1991-3#1)(1996-12#1)(2008-8#1)(2011-1#1)
was only partially##4##3##(1990-5#1)(2008-10#1)(2008-12#1)(2008-7#1)
was only used##2##3##(1997-3#1)(2008-10#1)
was only##81##2##(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-5#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-5#1)(2013-1#2)
was opened##2##2##(1996-6#1)(2011-2#1)
was operated in the##2##4##(2008-10#1)(2012-3#1)
was operated in##3##3##(2008-10#2)(2012-3#1)
was operated##11##2##(2008-10#6)(2008-11#1)(2009-1#1)(2012-3#1)(2013-1#2)
was optimal at pH##2##4##(2008-10#1)(2008-11#1)
was optimal at##6##3##(1995-11#1)(2008-10#4)(2008-11#1)
was optimal##8##2##(1995-11#1)(2008-10#6)(2008-11#1)
was optimised for##3##3##(2008-10#3)
was optimised##6##2##(2008-10#6)
was optimized and##8##3##(2008-10#8)
was optimized as##2##3##(2008-10#2)
was optimized by##7##3##(2008-10#6)(2008-7#1)
was optimized for an##2##4##(2008-10#1)(2008-11#1)
was optimized for##6##3##(2008-10#4)(2008-11#1)(2008-3#1)
was optimized to##3##3##(2008-10#2)(2008-3#1)
was optimized using##3##3##(2008-10#3)
was optimized with respect to##2##5##(2008-10#2)
was optimized##39##2##(2008-10#34)(2008-11#1)(2008-3#2)(2008-7#1)(2010-1#1)
was optimum##2##2##(1990-12#1)(2008-10#1)
was organized by##2##3##(2008-10#1)(2010-5#1)
was organized##4##2##(2008-10#1)(2008-8#1)(2010-11#1)(2010-5#1)
was originally described##2##3##(2008-10#1)(2012-3#1)
was originally##14##2##(1993-6#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
was otherwise##2##2##(2008-11#1)(2013-1#1)
was outlined##2##2##(2008-10#1)(2009-12#1)
was over##14##2##(1995-11#1)(1995-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)
was over-expressed in##2##3##(2008-11#1)(2010-11#1)
was overall##3##2##(1992-1#1)(1992-2#1)(2008-10#1)
was overcome by##5##3##(1997-2#1)(2008-10#2)(2009-6#1)(2011-1#1)
was overexpressed in##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
was overexpressed##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
was oxidized by##4##3##(1992-6#1)(2008-10#3)
was oxidized to##3##3##(2008-10#3)
was oxidized##7##2##(1992-6#1)(2008-10#6)
was pH 4##2##3##(2008-10#2)
was pH##5##2##(1994-8#1)(2008-10#4)
was packed in a##2##4##(2008-10#2)
was packed into##2##3##(2008-10#2)
was packed with##4##3##(2008-10#4)
was packed##8##2##(2008-10#8)
was palpable##2##2##(2008-10#1)(2011-1#1)
was paralleled by a##2##4##(1995-12#1)(2008-7#1)
was paralleled by##3##3##(1991-5#1)(1995-12#1)(2008-7#1)
was paralleled##4##2##(1991-5#1)(1995-12#1)(2008-11#1)(2008-7#1)
was part of a##2##4##(2010-10#1)(2010-7#1)
was part of the##2##4##(2011-2#1)(2012-2#1)
was part of##5##3##(1995-6#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
was partially inhibited by##2##4##(1994-11#1)(1997-4#1)
was partially inhibited##3##3##(1994-11#1)(1997-4#1)(2008-11#1)
was partially overcome##2##3##(1994-8#1)(2008-10#1)
was partially purified from##3##4##(1993-8#1)(1994-8#1)(2008-8#1)
was partially purified##5##3##(1993-8#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-8#1)
was partially##24##2##(1990-5#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#2)(1995-6#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-7#1)
was particularly high##2##3##(1990-6#1)(1993-2#1)
was particularly strong##2##3##(2008-8#2)
was particularly##15##2##(1990-11#1)(1990-6#1)(1991-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#4)(2008-6#1)(2008-8#3)
was partly##5##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#1)
was passed through a##3##4##(1992-12#1)(2008-10#2)
was passed through the##2##4##(2008-10#2)
was passed through##6##3##(1992-12#1)(2008-10#5)
was passed##10##2##(1991-1#1)(1992-12#1)(1993-1#1)(2008-10#5)(2008-11#1)(2008-8#1)
was perceived as##3##3##(1996-2#2)(2008-11#1)
was perceived to##2##3##(1991-2#1)(2008-11#1)
was perceived##6##2##(1991-2#1)(1994-3#1)(1996-2#2)(2008-11#2)
was performed after##9##3##(1990-8#1)(1996-3#2)(2008-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
was performed and a##2##4##(2008-10#1)(2011-2#1)
was performed and the##7##4##(2008-10#3)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
was performed and##16##3##(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2009-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
was performed as##5##3##(1991-2#1)(1995-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
was performed at##12##3##(1990-3#1)(1991-1#1)(1997-8#1)(2008-10#6)(2010-7#1)(2011-2#1)(2012-2#1)
was performed because of##2##4##(1993-6#1)(2011-2#1)
was performed between##3##3##(1994-11#1)(1996-12#1)(2008-10#1)
was performed by a##6##4##(2008-10#6)
was performed by combining##2##4##(2010-12#1)(2012-2#1)
was performed by gas##2##4##(2008-10#2)
was performed by means of##2##5##(2008-10#2)
was performed by measuring the##2##5##(2008-10#1)(2008-11#1)
was performed by the##4##4##(1997-4#1)(1997-7#1)(2008-10#2)
was performed by using##2##4##(1995-12#1)(2008-10#1)
was performed by##60##3##(1991-5#1)(1992-12#2)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#37)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
was performed due to##2##4##(2008-10#1)(2011-2#1)
was performed for each##2##4##(2008-1#1)(2008-10#1)
was performed for the##2##4##(2011-2#1)(2012-3#1)
was performed for##13##3##(2008-1#2)(2008-10#4)(2008-12#2)(2008-5#1)(2008-6#1)(2011-2#2)(2012-3#1)
was performed from##2##3##(2008-1#1)(2013-8#1)
was performed in 11##2##4##(2008-5#1)(2013-1#1)
was performed in 15 cases##2##5##(2008-7#1)(2011-2#1)
was performed in 4##2##4##(1990-6#1)(2008-10#1)
was performed in a##6##4##(1996-6#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
was performed in all patients##3##5##(1990-9#1)(1992-5#1)(1993-3#1)
was performed in all##6##4##(1990-9#1)(1992-5#1)(1993-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
was performed in an##6##4##(1991-11#1)(2008-10#3)(2008-11#1)(2010-11#1)
was performed in order to##4##5##(2008-10#3)(2009-7#1)
was performed in the##6##4##(1996-11#1)(2008-10#2)(2008-3#1)(2011-2#2)
was performed in##71##3##(1990-2#3)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-8#3)(2007-8#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#5)
was performed of##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
was performed on a##7##4##(2008-10#2)(2008-12#2)(2011-2#1)(2011-3#1)(2013-1#1)
was performed on the##9##4##(2008-10#6)(2008-5#1)(2008-7#1)(2012-2#1)
was performed on##36##3##(1990-6#1)(1991-11#1)(1993-11#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
was performed through##4##3##(2008-10#1)(2009-3#1)(2012-12#1)(2013-1#1)
was performed to assess the##2##5##(2012-2#1)(2013-1#1)
was performed to assess##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
was performed to compare##2##4##(2008-7#1)(2013-1#1)
was performed to detect the##2##5##(2008-8#1)(2013-8#1)
was performed to detect##3##4##(2008-8#1)(2011-2#1)(2013-8#1)
was performed to determine##6##4##(2008-10#3)(2008-7#2)(2011-2#1)
was performed to evaluate the feasibility of##2##7##(1992-12#1)(2008-10#1)
was performed to evaluate the##4##5##(1992-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
was performed to evaluate##5##4##(1992-12#1)(1992-3#1)(2008-1#1)(2008-10#1)(2011-2#1)
was performed to obtain##3##4##(1994-11#1)(2007-8#1)(2012-3#1)
was performed to##39##3##(1992-12#1)(1992-3#1)(1994-11#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
was performed under##4##3##(1997-6#1)(2008-5#1)(2008-7#1)(2011-2#1)
was performed using a modified##2##5##(2008-10#1)(2013-1#1)
was performed using a##11##4##(1990-3#1)(2008-10#5)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
was performed using the##12##4##(1992-3#2)(1997-8#1)(2008-10#3)(2008-7#2)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
was performed using##58##3##(1990-3#1)(1991-3#1)(1992-3#2)(1992-9#1)(1995-6#1)(1997-8#2)(2007-11#1)(2008-10#25)(2008-11#1)(2008-5#2)(2008-7#5)(2008-9#1)(2009-3#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#5)
was performed via a##2##4##(2008-10#1)(2011-2#1)
was performed with a##7##4##(1995-3#1)(2008-10#4)(2009-2#1)(2011-2#1)
was performed with the##5##4##(1991-3#1)(2008-10#2)(2008-7#1)(2013-8#1)
was performed with##29##3##(1991-11#1)(1991-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(2008-10#16)(2008-11#2)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#2)(2013-8#1)
was performed##493##2##(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#3)(1991-2#2)(1991-3#3)(1991-5#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#4)(1996-3#5)(1996-5#2)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#8)(1997-9#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-1#5)(2008-10#165)(2008-11#18)(2008-12#15)(2008-3#4)(2008-5#13)(2008-6#1)(2008-7#25)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-2#48)(2011-3#2)(2011-7#1)(2012-12#8)(2012-2#10)(2012-3#8)(2012-5#1)(2013-1#23)(2013-7#1)(2013-8#13)
was permitted##2##2##(2012-2#1)(2013-8#1)
was petrolatum##2##2##(2008-5#2)
was phase##2##2##(2008-3#1)(2008-5#1)
was phosphorylated in vitro by##2##5##(1993-8#1)(1995-2#1)
was phosphorylated##3##2##(1993-8#2)(1995-2#1)
was phylogenetically distinct from##2##4##(2008-10#2)
was phylogenetically##3##2##(2008-10#2)(2012-3#1)
was physically##3##2##(1997-7#1)(2008-10#1)(2013-1#1)
was picked##2##2##(1995-3#1)(1997-3#1)
was placed in a##2##4##(2008-10#1)(2012-3#1)
was placed in the##2##4##(2008-10#1)(2008-3#1)
was placed in##10##3##(1995-8#1)(2008-10#7)(2008-3#1)(2012-3#1)
was placed inside##3##3##(1997-6#1)(2008-10#2)
was placed into a##2##4##(2008-10#2)
was placed on##2##3##(2011-2#2)
was placed##24##2##(1994-11#1)(1995-8#1)(1997-6#1)(2008-10#12)(2008-3#3)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
was planned as a##2##4##(2010-6#1)(2010-7#1)
was planned as##3##3##(1990-6#1)(2010-6#1)(2010-7#1)
was planned to##3##3##(2012-3#1)(2013-1#2)
was planned##11##2##(1990-6#1)(1993-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#4)
was plotted against##2##3##(2008-10#1)(2008-8#1)
was plotted##3##2##(2008-10#2)(2008-8#1)
was pointed out##2##3##(2008-10#2)
was poor in##2##3##(2008-10#1)(2008-9#1)
was poor##7##2##(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2010-8#1)
was positioned on##2##3##(2008-10#2)
was positioned##5##2##(2008-10#3)(2008-6#1)(2013-1#1)
was positive for##2##3##(1990-12#1)(2011-2#1)
was positive in all##2##4##(1995-11#1)(1996-8#1)
was positive in the##2##4##(2008-5#1)(2011-2#1)
was positive in##8##3##(1990-2#1)(1994-1#1)(1995-11#1)(1996-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
was positive with##2##3##(1995-12#1)(2012-2#1)
was positive##17##2##(1990-12#1)(1990-2#1)(1992-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
was positively associated with##3##4##(2008-12#1)(2008-8#1)(2013-1#1)
was positively correlated to##2##4##(2008-10#2)
was positively correlated with children's behavior problems##2##7##(2010-11#2)
was positively correlated with the##5##5##(2008-10#3)(2009-7#1)(2010-1#1)
was positively correlated with##26##4##(1991-12#1)(1994-1#1)(1994-12#1)(1994-6#2)(2008-10#14)(2009-7#1)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#1)(2013-1#1)
was positively correlated##29##3##(1991-12#1)(1994-1#1)(1994-12#1)(1994-6#2)(2008-10#17)(2009-7#1)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#1)(2013-1#1)
was positively related to##7##4##(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
was positively##43##2##(1991-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-12#1)(2008-10#21)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#2)(2013-1#2)
was possible by##3##3##(1996-5#1)(2008-10#2)
was possible for##2##3##(2008-3#1)(2008-9#1)
was possible in##6##3##(1990-12#1)(1991-6#1)(1993-3#1)(2008-11#1)(2010-7#1)(2013-1#1)
was possible to obtain a##3##5##(2008-10#2)(2013-1#1)
was possible to obtain##6##4##(2008-10#5)(2013-1#1)
was possible to##44##3##(1990-6#1)(1991-3#2)(1992-9#1)(1993-8#1)(2008-10#25)(2008-11#5)(2008-7#4)(2008-9#1)(2010-6#1)(2012-3#1)(2013-1#2)
was possible using##3##3##(2008-10#3)
was possible with a##2##4##(2008-10#2)
was possible with##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
was possible##79##2##(1990-12#1)(1990-6#1)(1991-3#2)(1991-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1996-5#1)(2008-10#41)(2008-11#8)(2008-3#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
was possibly##4##2##(1994-12#1)(2008-10#1)(2008-8#1)(2010-5#1)
was postponed##2##2##(2010-5#1)(2013-1#1)
was postulated that##2##3##(2008-10#1)(2009-8#1)
was postulated to be##2##4##(2008-10#1)(2008-7#1)
was postulated to##4##3##(2008-10#3)(2008-7#1)
was postulated##7##2##(2008-10#5)(2008-7#1)(2009-8#1)
was potentiated##2##2##(1994-11#1)(1996-2#1)
was practically##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
was preceded by a##3##4##(1993-12#1)(2008-10#1)(2008-12#1)
was preceded by##5##3##(1993-12#1)(1994-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
was precipitated by##2##3##(2008-10#1)(2008-9#1)
was precipitated in##2##3##(2008-10#2)
was precipitated with##2##3##(2008-10#2)
was precipitated##7##2##(2008-10#6)(2008-9#1)
was precisely##2##2##(2008-10#2)
was precluded##2##2##(2008-10#1)(2009-6#1)
was preconcentrated in a membrane cell##2##6##(2008-10#2)
was preconcentrated in a##3##4##(2008-10#3)
was preconcentrated in##5##3##(2008-10#5)
was preconcentrated on the##2##4##(2008-10#2)
was preconcentrated on##4##3##(2008-10#4)
was preconcentrated onto the##2##4##(2008-10#2)
was preconcentrated##15##2##(2008-10#15)
was predicted by##6##3##(2008-10#2)(2008-12#1)(2008-9#1)(2010-1#1)(2010-2#1)
was predicted from##2##3##(1990-5#1)(2008-10#1)
was predicted##14##2##(1990-5#1)(1992-2#1)(1996-8#1)(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-2#1)
was predominant in##3##3##(2008-10#1)(2008-5#2)
was predominant##7##2##(2008-10#3)(2008-5#4)
was predominantly##11##2##(1992-12#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-2#1)
was preferentially##3##2##(1990-2#1)(1997-1#1)(2008-11#1)
was preferred##4##2##(1991-6#1)(2008-10#1)(2010-8#1)(2013-1#1)
was preformed##2##2##(2008-5#1)(2009-5#1)
was prepared and its##3##4##(2008-10#2)(2008-5#1)
was prepared and used to##2##5##(2008-10#1)(2008-11#1)
was prepared and used##4##4##(2008-10#3)(2008-11#1)
was prepared and##14##3##(1993-9#1)(1994-11#1)(2008-10#9)(2008-11#1)(2008-5#2)
was prepared by a##3##4##(2008-10#2)(2013-1#1)
was prepared by dissolving##2##4##(2008-10#2)
was prepared by sol-gel##2##4##(2008-10#2)
was prepared by the##3##4##(2008-10#3)
was prepared by using##3##4##(2008-10#3)
was prepared by##29##3##(2008-10#24)(2008-11#1)(2008-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
was prepared from##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
was prepared in##3##3##(2008-10#3)
was prepared to##2##3##(1994-8#1)(2008-10#1)
was prepared using##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)
was prepared with##3##3##(2008-10#2)(2011-3#1)
was prepared##77##2##(1993-9#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-5#1)(2008-10#53)(2008-11#6)(2008-12#1)(2008-5#5)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
was prescribed##2##2##(1995-11#1)(2008-9#1)
was present as##2##3##(2008-10#2)
was present at a##3##4##(1991-12#1)(2008-10#2)
was present at##5##3##(1991-12#1)(2008-10#4)
was present for##2##3##(1997-1#1)(2010-6#1)
was present in a##3##4##(2008-10#3)
was present in all##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
was present in the##8##4##(1995-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-4#1)(2012-3#1)
was present in##45##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-8#2)(2006-6#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-7#2)(2010-4#2)(2011-2#1)(2012-3#7)
was present mainly in##2##4##(2008-10#2)
was present only##2##3##(2008-10#2)
was present within##2##3##(2008-10#2)
was present##83##2##(1990-12#1)(1990-3#3)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-8#2)(1997-1#1)(1997-8#1)(2006-6#1)(2008-10#34)(2008-11#1)(2008-12#2)(2008-7#3)(2009-10#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#7)(2013-1#1)
was presented as a new##2##5##(2008-10#1)(2012-2#1)
was presented as a##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
was presented as##5##3##(1997-8#1)(2008-10#2)(2008-12#1)(2012-2#1)
was presented for##2##3##(2008-10#1)(2013-8#1)
was presented in##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
was presented with##5##3##(1996-2#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
was presented##22##2##(1996-2#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
was preserved in##3##3##(2008-11#1)(2009-1#1)(2012-3#1)
was preserved##6##2##(1990-5#1)(1991-10#1)(2008-11#1)(2009-1#1)(2012-12#1)(2012-3#1)
was presumed to##2##3##(2008-4#1)(2009-10#1)
was prevalent##2##2##(2008-10#2)
was prevented by the##2##4##(1994-8#1)(1997-1#1)
was prevented by##8##3##(1994-2#2)(1994-8#1)(1996-12#1)(1996-2#1)(1997-1#2)(2013-1#1)
was prevented in##3##3##(1995-2#1)(1997-1#1)(2013-8#1)
was prevented only##2##3##(1994-5#1)(1995-2#1)
was prevented##19##2##(1994-2#2)(1994-5#1)(1994-8#1)(1995-2#3)(1996-12#2)(1996-2#1)(1997-1#3)(2008-10#3)(2013-1#2)(2013-8#1)
was previously characterized##2##3##(1997-3#1)(2008-10#1)
was previously found to be##2##5##(1994-11#1)(2008-7#1)
was previously found##4##3##(1994-11#2)(1995-11#1)(2008-7#1)
was previously reported to##2##4##(2008-10#1)(2011-2#1)
was previously reported##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
was previously shown to be##3##5##(1993-12#1)(2008-10#1)(2008-9#1)
was previously shown to##5##4##(1990-12#1)(1993-12#1)(2008-10#2)(2008-9#1)
was previously shown##6##3##(1990-12#1)(1993-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
was previously##35##2##(1990-12#1)(1991-12#1)(1991-5#1)(1993-12#1)(1994-11#3)(1995-11#1)(1997-3#1)(2008-10#17)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)
was primarily##9##2##(1993-12#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)
was probably a##2##3##(2008-10#1)(2008-7#1)
was probably an##2##3##(1994-8#1)(2008-9#1)
was probably due to the high##2##6##(2008-10#1)(2010-5#1)
was probably due to##7##4##(1990-8#1)(1996-6#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
was probably the##2##3##(2008-10#2)
was probably##17##2##(1990-8#1)(1991-11#1)(1994-8#1)(1996-6#2)(2008-10#6)(2008-11#1)(2008-7#2)(2008-9#2)(2010-5#1)
was probed##2##2##(1990-8#1)(1992-4#1)
was proceeded##2##2##(2008-10#1)(2008-5#1)
was processed by##3##3##(1996-12#1)(2008-10#1)(2010-11#1)
was processed to##2##3##(1995-8#1)(1997-1#1)
was processed##13##2##(1991-9#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
was produced against##5##3##(1996-12#1)(2008-10#4)
was produced and##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
was produced as##3##3##(2008-10#1)(2010-5#2)
was produced by fusing##2##4##(2008-11#2)
was produced by##15##3##(1991-9#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-8#1)(2010-1#1)
was produced for##2##3##(2008-10#2)
was produced from##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
was produced in Escherichia coli##3##5##(1991-5#1)(1991-9#1)(2010-6#1)
was produced in a##2##4##(2008-11#2)
was produced in the##2##4##(2008-10#1)(2008-7#1)
was produced in##12##3##(1991-5#1)(1991-9#1)(1993-12#2)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)
was produced with##2##3##(2008-10#1)(2008-3#1)
was produced##54##2##(1991-5#1)(1991-9#2)(1993-12#2)(1993-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-7#1)(2008-10#23)(2008-11#8)(2008-3#2)(2008-7#1)(2008-8#2)(2010-1#1)(2010-5#2)(2010-6#1)(2011-2#2)
was programmed##3##2##(1992-3#1)(2008-10#2)
was progressively##5##2##(1991-12#1)(2008-9#1)(2010-1#1)(2010-11#1)(2013-1#1)
was prolonged##6##2##(1997-3#1)(2008-11#1)(2008-8#1)(2008-9#2)(2011-3#1)
was promoted by##2##3##(1995-6#1)(2009-8#1)
was promoted##3##2##(1995-6#1)(2008-11#1)(2009-8#1)
was prompted by##2##3##(1996-12#1)(2008-11#1)
was pronounced##2##2##(1993-3#1)(1996-2#1)
was propagated##2##2##(1993-3#1)(2011-1#1)
was proportional to the concentration of##5##6##(2008-10#5)
was proportional to the##18##4##(1997-3#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-7#1)(2012-2#1)
was proportional to viable cell number##2##6##(2008-11#2)
was proportional to##23##3##(1997-3#1)(1997-8#1)(2008-10#13)(2008-11#4)(2008-3#2)(2008-7#1)(2012-2#1)
was proposed and##4##3##(2008-10#4)
was proposed as a##2##4##(2008-10#1)(2012-2#1)
was proposed as##3##3##(2008-10#1)(2011-3#1)(2012-2#1)
was proposed based on##2##4##(2008-10#2)
was proposed by##2##3##(2008-10#2)
was proposed for the determination of##6##6##(2008-10#6)
was proposed for the##8##4##(2008-10#8)
was proposed for##14##3##(2008-10#12)(2008-2#1)(2010-4#1)
was proposed in##4##3##(2008-10#3)(2008-9#1)
was proposed that##2##3##(2008-9#1)(2010-4#1)
was proposed to be##2##4##(2008-10#2)
was proposed to explain the##2##5##(2008-10#2)
was proposed to##11##3##(2008-10#9)(2008-7#1)(2011-2#1)
was proposed##73##2##(1991-2#1)(1993-8#1)(1994-11#1)(1997-2#1)(2008-10#56)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-4#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
was prospectively##2##2##(1994-12#2)
was protected##2##2##(1992-4#1)(2012-2#1)
was protective##2##2##(2008-7#1)(2011-2#1)
was proved by the##2##4##(2008-10#2)
was proved by##7##3##(1997-3#1)(2008-10#4)(2008-8#1)(2008-9#1)
was proved that the##2##4##(2008-10#1)(2008-9#1)
was proved that##6##3##(2008-10#3)(2008-8#1)(2008-9#2)
was proved to be##5##4##(1996-2#1)(1997-1#1)(2008-10#3)
was proved##26##2##(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#16)(2008-8#2)(2008-9#3)(2012-3#2)
was proven to be##4##4##(1994-11#1)(1995-12#1)(2008-8#1)(2011-2#1)
was proven to##5##3##(1994-11#1)(1995-12#1)(2008-8#1)(2011-2#2)
was proven##8##2##(1994-11#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#2)
was provided by the##3##4##(1996-12#1)(1997-2#1)(2008-8#1)
was provided by##7##3##(1993-8#1)(1996-12#2)(1997-2#1)(2007-9#1)(2008-11#1)(2008-8#1)
was provided##12##2##(1993-1#1)(1993-8#1)(1996-12#2)(1997-2#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-8#1)(2008-9#1)
was published in##2##3##(2012-12#1)(2013-1#1)
was published##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
was pumped through the##2##4##(2008-10#1)(2008-11#1)
was pumped##4##2##(2008-10#3)(2008-11#1)
was purified and used##2##4##(2008-10#1)(2008-8#1)
was purified and##7##3##(1993-8#1)(1995-6#1)(2008-10#3)(2008-12#1)(2008-8#1)
was purified by##11##3##(1992-12#1)(1994-11#1)(1994-8#1)(1997-2#2)(2008-10#2)(2008-11#2)(2008-8#1)(2011-2#1)
was purified from the##2##4##(1991-5#1)(2008-9#1)
was purified from##10##3##(1991-5#1)(1992-9#1)(1994-8#1)(1995-6#1)(2008-10#4)(2008-8#1)(2008-9#1)
was purified to an##2##4##(1990-11#1)(1994-5#1)
was purified to homogeneity by##2##5##(2009-3#1)(2010-4#1)
was purified to homogeneity from##5##5##(1990-5#1)(1992-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
was purified to homogeneity##11##4##(1990-10#1)(1990-5#1)(1992-8#1)(1995-12#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-4#1)
was purified to near homogeneity by##2##6##(1993-6#1)(1994-8#1)
was purified to near homogeneity##3##5##(1990-8#1)(1993-6#1)(1994-8#1)
was purified to##18##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-4#1)
was purified with##2##3##(1995-12#1)(2008-10#1)
was purified##56##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-8#1)(1991-5#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#5)(1995-12#2)(1995-6#3)(1997-2#3)(2008-10#12)(2008-11#4)(2008-12#1)(2008-8#5)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)
was put##2##2##(2010-7#1)(2011-3#1)
was qualified as##2##3##(1991-6#1)(2012-3#1)
was qualified##3##2##(1991-6#1)(2008-9#1)(2012-3#1)
was qualitative##2##2##(2008-10#1)(2011-2#1)
was qualitatively##2##2##(2008-10#2)
was quantified as##2##3##(2008-10#2)
was quantified by the##3##4##(2006-6#1)(2008-10#1)(2008-11#1)
was quantified by##9##3##(2006-6#1)(2008-10#5)(2008-11#1)(2008-7#1)(2012-4#1)
was quantified in##2##3##(2008-10#1)(2013-1#1)
was quantified##21##2##(2006-6#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
was quantitated##2##2##(1994-5#1)(2008-10#1)
was quantitative and##2##3##(2008-10#2)
was quantitative##4##2##(2008-10#4)
was quantitatively analyzed##2##3##(2008-10#2)
was quantitatively extracted with##3##4##(2008-10#3)
was quantitatively extracted##5##3##(2008-10#5)
was quantitatively retained##3##3##(2008-10#3)
was quantitatively##15##2##(1991-10#1)(2008-10#13)(2010-12#1)
was quickly##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
was quite similar##2##3##(2008-10#1)(2008-7#1)
was quite##7##2##(1992-12#1)(2008-10#4)(2008-7#1)(2008-9#1)
was r=0##2##2##(2008-10#1)(2010-11#1)
was race##2##2##(2008-10#2)
was raised in the##2##4##(1991-12#1)(2008-10#1)
was raised in##4##3##(1990-9#1)(1991-12#1)(2008-10#2)
was raised to##2##3##(1990-2#1)(1990-9#1)
was raised##15##2##(1990-2#1)(1990-9#2)(1991-12#1)(1993-6#1)(2007-12#1)(2008-10#5)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
was random##2##2##(2008-10#2)
was randomized##2##2##(1997-2#1)(2008-11#1)
was randomly selected##2##3##(2012-2#1)(2013-1#1)
was randomly##7##2##(1995-2#1)(1995-9#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-1#1)
was rapid and##3##3##(1995-1#1)(2008-10#2)
was rapid##10##2##(1994-3#1)(1994-8#1)(1995-1#1)(2008-10#6)(2008-11#1)
was rapidly##4##2##(1996-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
was rare##6##2##(2008-10#4)(2008-9#1)(2011-3#1)
was rated as##2##3##(1993-2#1)(2011-2#1)
was rated##6##2##(1993-2#3)(2011-2#1)(2012-2#1)(2012-3#1)
was rather##7##2##(1990-5#1)(1992-2#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
was re-evaluated##2##2##(2008-10#1)(2008-12#1)
was reached after 60##2##4##(2008-10#2)
was reached for##2##3##(2008-10#2)
was reached in##5##3##(2008-10#2)(2011-1#2)(2011-2#1)
was reached##19##2##(2008-10#10)(2008-11#4)(2010-5#1)(2011-1#2)(2011-2#2)
was reacted with##7##3##(1991-5#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)
was reacted##8##2##(1991-5#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-12#1)
was reactive with##2##3##(1997-7#1)(2008-5#1)
was read by##2##3##(2008-10#2)
was readily purified##2##3##(1993-9#1)(1994-11#1)
was readily##12##2##(1993-9#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(2008-10#5)(2008-3#1)(2011-2#1)
was realized by##2##3##(2008-10#1)(2012-3#1)
was realized##7##2##(2008-10#4)(2008-3#2)(2012-3#1)
was received##2##2##(1996-12#1)(2013-8#1)
was recently discovered that##2##4##(2009-6#1)(2010-7#1)
was recently found to##2##4##(1994-11#1)(2012-12#1)
was recently found##3##3##(1994-11#1)(2011-2#1)(2012-12#1)
was recently identified as##2##4##(1994-11#1)(2008-10#1)
was recently identified##3##3##(1994-11#2)(2008-10#1)
was recently presented##2##3##(2008-3#2)
was recently proposed##3##3##(2008-10#2)(2008-3#1)
was recently##30##2##(1992-6#1)(1994-11#3)(1997-2#1)(2008-10#7)(2008-12#2)(2008-3#4)(2008-8#1)(2009-10#1)(2009-3#2)(2009-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
was recognized as a##2##4##(2008-3#1)(2012-2#1)
was recognized as##3##3##(2008-3#1)(2008-8#1)(2012-2#1)
was recognized by##4##3##(1990-5#1)(1994-11#1)(1995-12#1)(2008-10#1)
was recognized in##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
was recognized##15##2##(1990-5#1)(1994-11#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)
was recommended##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
was reconstituted in vitro##3##4##(1992-12#1)(1993-8#1)(1994-8#1)
was reconstituted in##4##3##(1992-12#1)(1993-8#1)(1994-8#1)(2008-10#1)
was reconstituted##6##2##(1992-12#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
was reconstructed with##2##3##(2011-2#1)(2013-1#1)
was reconstructed##7##2##(1992-3#1)(1994-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
was recorded and##2##3##(2008-3#1)(2008-7#1)
was recorded as##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
was recorded at##5##3##(2008-1#1)(2008-10#3)(2008-8#1)
was recorded during##3##3##(1993-6#1)(1996-2#1)(2013-1#1)
was recorded for##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
was recorded from 64##2##4##(2008-11#1)(2013-8#1)
was recorded from##6##3##(2008-10#2)(2008-11#1)(2010-9#1)(2013-1#1)(2013-8#1)
was recorded in the##3##4##(1990-3#1)(1991-8#1)(1994-12#1)
was recorded in##20##3##(1990-3#1)(1991-8#1)(1994-12#2)(1996-12#1)(2008-10#5)(2008-12#2)(2008-7#2)(2009-12#1)(2011-2#3)(2013-1#2)
was recorded on##4##3##(1994-3#1)(2008-10#3)
was recorded##67##2##(1990-3#1)(1990-5#1)(1991-8#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#5)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-8#2)(2010-9#1)(2011-2#3)(2013-1#5)(2013-8#3)
was recovered by##2##3##(1993-12#1)(2008-7#1)
was recovered from the##3##4##(2008-10#2)(2008-7#1)
was recovered from##12##3##(1993-12#1)(2008-10#10)(2008-7#1)
was recovered with the dowex resin plus the##2##8##(2008-10#2)
was recovered##29##2##(1993-12#2)(2008-10#20)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#2)(2013-1#1)
was recruited##2##2##(2008-11#1)(2013-8#1)
was reduced (P &lt##2##4##(1992-12#1)(2011-3#1)
was reduced after##3##3##(1990-12#1)(1995-12#1)(2008-10#1)
was reduced and##6##3##(2008-10#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
was reduced as##3##3##(2008-10#1)(2009-7#1)(2010-5#1)
was reduced at a##3##4##(1990-8#1)(2008-10#2)
was reduced at##8##3##(1990-8#1)(1995-8#1)(2008-10#6)
was reduced by about##3##4##(2008-10#2)(2008-6#1)
was reduced by##34##3##(1990-3#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-8#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-4#1)(2013-8#1)
was reduced for##2##3##(2008-10#1)(2011-2#1)
was reduced from 10##2##4##(2008-10#2)
was reduced from##7##3##(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#4)
was reduced in a##2##4##(1990-5#1)(2008-10#1)
was reduced in the##7##4##(1993-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)(2013-1#1)
was reduced in##18##3##(1990-5#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2013-1#2)
was reduced significantly in##2##4##(2008-7#1)(2011-2#1)
was reduced significantly##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
was reduced to Cr(III)##2##4##(2008-10#2)
was reduced to##20##3##(1990-5#1)(1991-5#1)(1992-4#1)(1993-1#1)(1994-3#1)(1995-12#2)(1995-6#1)(2008-10#10)(2008-11#1)(2013-1#1)
was reduced when##2##3##(2008-10#2)
was reduced with##2##3##(2008-10#1)(2012-2#1)
was reduced##139##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1993-1#2)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(1997-1#2)(1997-4#1)(1997-8#3)(2007-12#1)(2008-10#66)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#6)(2013-8#1)
was referred because of##3##4##(1995-5#1)(2012-3#1)(2013-1#1)
was referred for evaluation##2##4##(1997-3#1)(2013-8#1)
was referred for##5##3##(1997-3#1)(2008-8#1)(2009-3#1)(2012-3#1)(2013-8#1)
was referred to our hospital for##3##6##(2011-2#2)(2013-8#1)
was referred to our##6##4##(2008-10#1)(2010-10#1)(2011-2#3)(2013-8#1)
was referred to##11##3##(1994-9#1)(1995-12#1)(2008-10#1)(2008-12#1)(2010-10#2)(2011-1#1)(2011-2#3)(2013-8#1)
was referred##23##2##(1991-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-12#3)(2008-8#1)(2009-3#1)(2010-10#2)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
was refined at 2##2##4##(1992-4#1)(1993-8#1)
was refined##5##2##(1992-4#1)(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
was reflected by##3##3##(1992-3#1)(1994-11#1)(1994-12#1)
was reflected in the##2##4##(1990-5#1)(1992-6#1)
was reflected in##8##3##(1990-5#1)(1992-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-8#1)
was reflected##11##2##(1990-5#1)(1992-3#1)(1992-6#2)(1994-11#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-8#1)
was regarded as##3##3##(1990-3#1)(2008-11#1)(2010-7#1)
was regenerated by##2##3##(2008-10#2)
was regenerated##3##2##(2008-10#3)
was registered in##2##3##(1993-11#1)(2008-10#1)
was registered##6##2##(1991-2#1)(1993-11#1)(2008-10#2)(2010-5#1)(2011-2#1)
was regulated by##4##3##(1991-9#1)(1995-11#1)(1997-6#1)(2009-3#1)
was regulated##5##2##(1991-5#1)(1991-9#1)(1995-11#1)(1997-6#1)(2009-3#1)
was rejected for##2##3##(1991-1#1)(2012-3#1)
was rejected##4##2##(1991-1#1)(2008-10#2)(2012-3#1)
was related to a##2##4##(2008-11#1)(2008-9#1)
was related to the concentration of##2##6##(2008-10#2)
was related to the##23##4##(1992-12#1)(1994-3#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
was related to##50##3##(1990-5#2)(1992-12#1)(1994-3#2)(1996-12#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#2)(2010-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
was related##55##2##(1990-5#2)(1991-2#1)(1992-12#1)(1994-3#2)(1996-12#1)(2008-10#25)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#2)(2010-10#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
was relatively high##5##3##(2008-10#4)(2008-9#1)
was relatively rare##2##3##(2011-2#1)(2013-1#1)
was relatively small##2##3##(2008-10#1)(2010-5#1)
was relatively##21##2##(1991-2#1)(1992-12#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-12#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#1)
was released by##2##3##(1994-11#1)(2008-10#1)
was released from the##2##4##(1991-5#1)(2011-2#1)
was released from##3##3##(1991-5#1)(2008-10#1)(2011-2#1)
was released into the##2##4##(1990-2#1)(2011-2#1)
was released##10##2##(1990-2#1)(1991-5#1)(1994-11#1)(2008-10#3)(2008-11#1)(2010-6#1)(2011-2#2)
was reliable and##4##3##(1991-3#1)(2008-10#3)
was reliable for##3##3##(2008-10#3)
was reliable##8##2##(1991-3#1)(2008-10#7)
was relieved by##2##3##(1991-5#1)(2008-7#1)
was relieved##6##2##(1991-12#1)(1991-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
was remarkably inhibited##2##3##(2008-8#1)(2008-9#1)
was remarkably##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
was removed and##2##3##(2008-12#1)(2011-2#1)
was removed by##2##3##(1991-6#1)(2011-2#1)
was removed from the minicolumn with##2##6##(2008-10#2)
was removed from the##5##4##(2008-10#4)(2008-11#1)
was removed from##7##3##(2008-10#5)(2008-11#2)
was removed##21##2##(1991-6#1)(1994-8#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2010-3#1)(2010-9#1)(2011-2#2)(2013-1#1)
was rendered##2##2##(2008-10#1)(2008-7#1)
was repaired##5##2##(2008-12#3)(2008-7#1)(2012-3#1)
was repeated in##2##3##(2010-6#1)(2011-1#1)
was repeated three times##3##4##(1990-8#1)(1994-2#1)(2008-10#1)
was repeated until##2##3##(1997-6#1)(2008-1#1)
was repeated with##2##3##(2011-3#1)(2012-12#1)
was repeated##17##2##(1990-8#1)(1994-2#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
was replaced by a single##2##5##(2008-10#2)
was replaced by a##3##4##(2008-10#3)
was replaced by the##3##4##(1990-2#1)(1997-3#1)(2008-8#1)
was replaced by##18##3##(1990-10#1)(1990-2#1)(1992-10#1)(1992-9#1)(1994-5#1)(1995-6#1)(1997-3#2)(2008-10#5)(2008-8#1)(2008-9#3)(2013-1#1)
was replaced with##10##3##(1990-5#1)(1993-8#1)(1995-2#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
was replaced##30##2##(1990-10#1)(1990-2#1)(1990-5#1)(1992-10#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-2#2)(1997-3#2)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#4)(2010-3#1)(2012-3#1)(2013-1#2)
was replicated##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
was reported as##2##3##(1997-2#1)(2013-8#1)
was reported by##5##3##(1990-12#1)(1991-8#1)(1995-6#1)(1996-6#1)(2013-1#1)
was reported for##2##3##(1995-2#1)(2013-8#1)
was reported in the##3##4##(1994-9#1)(1996-5#1)(2008-12#1)
was reported in this##2##4##(2008-10#1)(2011-2#1)
was reported in##14##3##(1990-6#1)(1991-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#2)
was reported on##2##3##(2008-10#2)
was reported that the##2##4##(2008-11#1)(2010-7#1)
was reported that##3##3##(2008-11#2)(2010-7#1)
was reported to be##5##4##(1996-12#1)(1996-8#1)(2008-10#1)(2008-7#1)(2009-5#1)
was reported##47##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
was representative of##2##3##(1992-2#1)(2009-11#1)
was represented by a##2##4##(2008-10#2)
was represented by##3##3##(1994-8#1)(2008-10#2)
was represented##6##2##(1992-12#1)(1994-8#1)(2008-10#3)(2008-5#1)
was reproduced##2##2##(2008-10#1)(2008-11#1)
was reproducible and##2##3##(2008-10#2)
was reproducible within##2##3##(2008-10#2)
was reproducible##4##2##(2008-10#4)
was reproducibly induced by##2##4##(2008-11#1)(2011-2#1)
was requested##2##2##(2008-11#1)(2012-12#1)
was required as##2##3##(2008-10#1)(2008-11#1)
was required for##11##3##(1990-5#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#2)
was required in the##2##4##(2008-1#1)(2009-11#1)
was required in##5##3##(1990-2#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-7#1)
was required to##11##3##(1990-2#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2013-1#1)
was required##41##2##(1990-2#2)(1990-5#1)(1991-1#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-11#1)(2010-7#1)(2013-1#1)
was rescued by##2##3##(1995-2#1)(1996-3#1)
was resected and##2##3##(2012-12#1)(2012-2#1)
was resected##5##2##(1991-9#1)(1992-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
was resistant to all##3##4##(2008-10#2)(2008-5#1)
was resistant to##8##3##(1993-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)
was resistant##10##2##(1993-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)
was resolved by##2##3##(1991-12#1)(2008-10#1)
was resolved##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
was respectively##3##2##(1991-8#1)(1995-6#1)(2008-10#1)
was responsible for the##4##4##(1990-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
was responsible for##13##3##(1990-6#1)(1991-2#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-8#2)(2013-1#1)(2013-7#1)
was responsive to##2##3##(2008-8#1)(2011-9#1)
was responsive##3##2##(1990-8#1)(2008-8#1)(2011-9#1)
was restored by##6##3##(1991-5#2)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)
was restored in##4##3##(1997-3#1)(2008-11#1)(2012-3#2)
was restored with a##3##4##(2013-1#3)
was restored with##4##3##(2012-3#1)(2013-1#3)
was restored##19##2##(1991-5#2)(1993-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#3)
was restricted by the##2##4##(2008-10#1)(2008-11#1)
was restricted to a##2##4##(1997-1#1)(2013-8#1)
was restricted to the##7##4##(1995-6#1)(2008-10#4)(2008-11#1)(2008-8#1)
was restricted to##14##3##(1993-12#1)(1995-6#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-8#1)(2013-8#1)
was restricted##21##2##(1993-12#1)(1995-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-8#1)(2013-8#1)
was retained and##3##3##(1995-2#2)(2008-10#1)
was retained by##2##3##(1993-1#1)(2008-10#1)
was retained in the##2##4##(2008-10#2)
was retained in##3##3##(2008-10#2)(2008-7#1)
was retained##13##2##(1990-5#1)(1993-1#1)(1995-2#2)(1996-3#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-7#1)
was retrospective##3##2##(2007-11#1)(2012-3#1)(2013-1#1)
was retrospectively reviewed##2##3##(2012-3#1)(2013-1#1)
was retrospectively##3##2##(2010-1#1)(2012-3#1)(2013-1#1)
was revealed by##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
was revealed that the##2##4##(2008-10#1)(2008-12#1)
was revealed that##7##3##(1993-12#1)(2008-10#5)(2008-12#1)
was revealed##20##2##(1990-5#1)(1992-3#1)(1993-12#1)(1993-8#1)(1997-4#1)(2008-10#9)(2008-12#3)(2008-3#1)(2008-9#1)(2012-12#1)
was reversed by the##2##4##(2008-10#1)(2008-7#1)
was reversed by##4##3##(1990-5#1)(1994-2#1)(2008-10#1)(2008-7#1)
was reversed##11##2##(1990-5#1)(1994-2#1)(1997-7#1)(2008-10#5)(2008-7#1)(2009-11#1)(2012-3#1)
was reversible##4##2##(1993-6#1)(1994-8#1)(2008-10#2)
was reviewed##2##2##(1994-2#1)(2008-6#1)
was revised##2##2##(1993-6#1)(2009-8#1)
was rotated##3##2##(1993-6#1)(1997-5#1)(2008-11#1)
was roughly##4##2##(1991-2#1)(1997-6#1)(2008-10#1)(2008-6#1)
was routinely##2##2##(2008-10#1)(2011-2#1)
was ruled out##5##3##(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(2010-12#1)
was run##5##2##(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
was safe and##2##3##(2012-12#1)(2012-3#1)
was sampled from##2##3##(1990-5#1)(2008-10#1)
was sampled##5##2##(1990-5#1)(2008-10#3)(2008-11#1)
was satisfactorily applied to the determination of##6##7##(2008-10#6)
was satisfactorily applied to the##7##5##(2008-10#7)
was satisfactorily applied to##8##4##(2008-10#8)
was satisfactorily applied##9##3##(2008-10#9)
was satisfactorily##12##2##(2008-10#11)(2011-1#1)
was satisfactory in both cases##3##5##(2008-10#1)(2011-2#2)
was satisfactory in##5##3##(1997-8#1)(2008-10#1)(2008-7#1)(2011-2#2)
was satisfactory##15##2##(1991-11#1)(1991-3#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
was satisfied##2##2##(2008-10#1)(2008-11#1)
was saturable and inhibited by##2##5##(1994-6#1)(1994-8#1)
was saturable##3##2##(1993-8#1)(1994-6#1)(1994-8#1)
was scanned##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
was scarcely##2##2##(1995-11#1)(2008-11#1)
was scored according to##2##4##(1994-3#1)(2008-10#1)
was scored##6##2##(1994-3#1)(1997-3#1)(2008-10#3)(2008-5#1)
was screened for##5##3##(1993-6#1)(1995-2#1)(2008-10#3)
was screened in##2##3##(2008-8#1)(2008-9#1)
was screened out##2##3##(2008-8#2)
was screened using##6##3##(1992-3#1)(1992-6#1)(2008-10#1)(2008-8#2)(2013-1#1)
was screened with##4##3##(1990-8#2)(1991-6#1)(2008-8#1)
was screened##25##2##(1990-6#1)(1990-8#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-8#6)(2008-9#2)(2013-1#1)(2013-8#2)
was searched##2##2##(2011-1#1)(2011-2#1)
was secreted by##2##3##(1992-12#1)(2008-7#1)
was secreted in##2##3##(1995-8#1)(1997-2#1)
was secreted into the##2##4##(1993-3#1)(1993-9#1)
was secreted##11##2##(1990-8#1)(1992-10#1)(1992-12#2)(1993-3#2)(1993-9#1)(1995-8#1)(1997-2#1)(2008-7#1)(2008-8#1)
was sectioned##3##2##(2008-9#1)(2009-4#1)(2013-1#1)
was seedborne##2##2##(2008-10#2)
was seen after##6##3##(1991-8#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2010-11#1)
was seen as an##2##4##(2008-10#1)(2012-12#1)
was seen as##7##3##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
was seen at the##2##4##(2008-10#1)(2010-3#1)
was seen at##6##3##(1990-5#1)(1991-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2010-3#1)
was seen between##3##3##(2008-10#1)(2008-5#2)
was seen during##2##3##(1990-12#1)(2008-7#1)
was seen following##2##3##(1991-3#1)(1993-6#1)
was seen in all##3##4##(2008-10#2)(2011-2#1)
was seen in cells##2##4##(1994-8#1)(1995-8#1)
was seen in the##9##4##(1993-6#1)(1996-12#4)(1997-2#1)(2008-11#1)(2008-5#1)(2012-3#1)
was seen in##34##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#5)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#2)
was seen to have##2##4##(2008-5#1)(2012-3#1)
was seen to##4##3##(1991-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
was seen when##2##3##(1994-11#1)(2008-10#1)
was seen with the##2##4##(1995-11#1)(2008-10#1)
was seen with##5##3##(1994-11#1)(1995-11#1)(2008-10#1)(2008-5#1)(2010-3#1)
was seen##91##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-6#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#2)(2008-10#14)(2008-11#4)(2008-12#1)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2011-2#3)(2012-12#2)(2012-3#4)
was selected as a##3##4##(1996-1#1)(2008-10#2)
was selected as the##5##4##(2008-10#4)(2008-5#1)
was selected as##10##3##(1996-1#1)(2008-10#8)(2008-5#1)
was selected by##4##3##(1997-6#1)(2008-10#1)(2013-1#2)
was selected for its##2##4##(2008-10#2)
was selected for the determination of##2##6##(2008-10#2)
was selected for the##7##4##(2008-10#7)
was selected for##16##3##(1994-2#1)(1996-12#1)(2008-10#11)(2008-9#1)(2010-11#1)(2012-12#1)
was selected on the basis of its##2##7##(2008-10#1)(2008-3#1)
was selected##42##2##(1991-2#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1997-6#1)(2008-10#28)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-12#1)(2013-1#2)
was selective for##2##3##(1994-8#1)(2008-10#1)
was selective##7##2##(1994-8#1)(2008-10#4)(2011-3#2)
was selectively##7##2##(1990-2#1)(1995-11#1)(1996-5#1)(2008-10#3)(2011-2#1)
was sensed again##3##3##(2008-10#3)
was sensed by the##2##4##(2008-10#2)
was sensed by##3##3##(2008-10#3)
was sensed##7##2##(2008-10#7)
was sensitive and##2##3##(2008-10#1)(2008-5#1)
was sensitive to##7##3##(1993-3#1)(1993-9#1)(2008-10#3)(2008-11#1)(2008-9#1)
was sensitive##11##2##(1993-3#1)(1993-9#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)
was sent to a##4##4##(1993-2#1)(1997-3#1)(2008-9#1)(2013-1#1)
was sent to all##3##4##(2008-11#1)(2012-2#2)
was sent to##14##3##(1990-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#3)(2012-2#2)(2013-1#1)
was sent##15##2##(1990-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#3)(2012-2#2)(2013-1#1)
was separated by centrifugation and##2##5##(2008-10#1)(2008-5#1)
was separated by##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
was separated from sample##2##4##(2008-10#2)
was separated from the##4##4##(2008-10#4)
was separated from##9##3##(2008-10#9)
was separated in##2##3##(2008-10#2)
was separated into##2##3##(2008-10#2)
was separated on a##2##4##(2008-10#2)
was separated##26##2##(2008-10#23)(2008-5#1)(2008-8#1)(2008-9#1)
was sequenced and analyzed##2##4##(1992-3#1)(1993-2#1)
was sequenced and##7##3##(1990-11#1)(1991-9#1)(1992-3#1)(1993-2#1)(2008-10#2)(2008-8#1)
was sequenced for##2##3##(2008-10#2)
was sequenced from##2##3##(2008-10#1)(2008-12#1)
was sequenced##19##2##(1990-11#1)(1991-9#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-9#1)(1997-9#1)(2008-10#10)(2008-12#1)(2008-8#1)
was set at##4##3##(2008-10#2)(2010-1#1)(2013-1#1)
was set to##4##3##(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
was set up##8##3##(2008-10#4)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
was set##18##2##(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
was severely impaired##2##3##(2008-10#2)
was severely inhibited##3##3##(1993-8#1)(1994-8#1)(2009-6#1)
was severely##11##2##(1993-8#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2009-7#1)(2012-2#1)
was shaped by##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
was shifted by##2##3##(1990-9#1)(1997-7#1)
was shifted from##2##3##(1994-3#1)(2008-11#1)
was shifted to a##2##4##(1991-9#1)(1995-8#1)
was shifted to the##2##4##(1995-8#1)(2010-5#1)
was shifted to##5##3##(1991-9#1)(1995-8#2)(2010-5#1)(2012-3#1)
was shifted##11##2##(1990-9#1)(1991-9#1)(1993-3#1)(1994-3#1)(1995-8#2)(1997-7#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
was shorter than that of##2##5##(2010-4#1)(2010-8#1)
was shorter than##3##3##(2010-4#1)(2010-8#1)(2013-8#1)
was shorter##7##2##(2008-10#2)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
was showed##2##2##(2008-10#2)
was shown at##2##3##(2008-10#2)
was shown by the##3##4##(1990-12#1)(2008-10#2)
was shown by##13##3##(1990-12#2)(1992-10#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-9#1)(2013-1#1)
was shown for the first time##2##6##(2008-10#2)
was shown for##3##3##(2008-10#3)
was shown in##4##3##(1991-1#1)(1996-3#1)(2008-10#1)(2008-5#1)
was shown that a##2##4##(1990-3#1)(2008-8#1)
was shown that only##2##4##(2008-10#1)(2008-11#1)
was shown that the##14##4##(1992-6#1)(1992-9#1)(1994-11#1)(2008-10#8)(2008-11#1)(2008-8#2)
was shown that##52##3##(1990-3#1)(1990-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#2)(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#5)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
was shown to activate##2##4##(1995-2#1)(2008-7#1)
was shown to be a##7##5##(1993-12#1)(1994-11#1)(2008-10#3)(2011-2#1)(2012-12#1)
was shown to be an##2##5##(2008-10#2)
was shown to be dependent on the##2##7##(1991-5#1)(2008-11#1)
was shown to be highly##2##5##(1993-3#1)(1996-2#1)
was shown to be present##2##5##(1996-8#1)(2008-4#1)
was shown to be regulated by##2##6##(1993-8#1)(1997-2#1)
was shown to be the major##2##6##(2008-11#1)(2008-7#1)
was shown to be the##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
was shown to be##49##4##(1990-12#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#21)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#1)
was shown to bind##2##4##(1990-10#1)(1995-12#1)
was shown to depend on the##2##6##(1992-12#1)(1994-11#1)
was shown to exist##2##4##(1995-8#1)(2008-9#1)
was shown to have a##2##5##(1994-5#1)(2008-10#1)
was shown to have##4##4##(1990-12#1)(1994-5#1)(2008-10#2)
was shown to occur##2##4##(2008-10#2)
was shown to produce##3##4##(1997-7#1)(2007-12#1)(2011-1#1)
was shown to provide##3##4##(2008-7#1)(2008-9#1)(2009-1#1)
was shown to##96##3##(1990-10#1)(1990-12#2)(1991-5#4)(1991-9#2)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-10#35)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-6#1)(2011-1#3)(2011-2#3)(2012-12#1)
was shown##184##2##(1990-10#1)(1990-12#4)(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#4)(1991-9#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-5#2)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#2)(2007-12#1)(2008-10#69)(2008-11#14)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#7)(2008-9#6)(2009-1#1)(2009-6#1)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
was significant (P##2##3##(2008-10#2)
was significant at##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
was significant correlation of##2##4##(2008-10#2)
was significant correlation##3##3##(2008-10#3)
was significant for##2##3##(2010-6#1)(2011-2#1)
was significant in##4##3##(1990-11#1)(2008-10#3)
was significant##32##2##(1990-11#1)(1990-6#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2010-4#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
was significantly (P &lt##8##4##(2008-10#7)(2010-7#1)
was significantly (P = 0##2##5##(1996-8#1)(2008-10#1)
was significantly (P =##3##4##(1996-8#1)(2008-10#1)(2008-8#1)
was significantly (P##11##3##(1996-8#1)(2008-10#8)(2008-8#1)(2010-7#1)
was significantly (P&lt##2##3##(2008-10#1)(2012-3#1)
was significantly (p &lt##2##4##(1993-3#1)(2008-11#1)
was significantly (p##3##3##(1993-3#1)(2008-11#1)(2008-12#1)
was significantly affected by##3##4##(2008-10#1)(2008-12#1)(2010-2#1)
was significantly affected##5##3##(2008-10#1)(2008-12#1)(2010-11#1)(2010-2#2)
was significantly associated with a##2##5##(1997-4#1)(2013-8#1)
was significantly associated with##15##4##(1990-9#2)(1997-4#1)(2008-10#3)(2008-12#1)(2009-5#2)(2012-2#2)(2012-3#1)(2013-8#3)
was significantly associated##18##3##(1990-9#2)(1991-6#1)(1997-4#1)(2008-10#4)(2008-12#1)(2009-5#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#3)
was significantly better##2##3##(2008-10#2)
was significantly correlated with the##5##5##(2008-10#2)(2011-2#1)(2012-5#1)(2013-8#1)
was significantly correlated with##8##4##(1991-8#1)(2008-10#4)(2011-2#1)(2012-5#1)(2013-8#1)
was significantly decreased in##2##4##(2008-10#1)(2008-7#1)
was significantly decreased##7##3##(1993-1#1)(1994-2#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
was significantly delayed##2##3##(1997-3#1)(2011-2#1)
was significantly different between##2##4##(2008-10#2)
was significantly different from##2##4##(2008-10#2)
was significantly different in##2##4##(2008-12#2)
was significantly different##13##3##(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-12#3)(2010-4#1)
was significantly elevated in the##2##5##(1996-12#1)(2008-10#1)
was significantly elevated in##3##4##(1996-12#2)(2008-10#1)
was significantly elevated##6##3##(1993-12#1)(1996-12#2)(2008-10#1)(2008-12#1)(2009-6#1)
was significantly enhanced by##2##4##(2008-10#1)(2008-11#1)
was significantly enhanced##6##3##(2008-10#5)(2008-11#1)
was significantly greater for##3##4##(1995-2#1)(2009-7#1)(2013-1#1)
was significantly greater in the##7##5##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#1)
was significantly greater in##10##4##(1992-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#1)
was significantly greater than that##2##5##(2008-10#1)(2008-5#1)
was significantly greater than##6##4##(2008-10#3)(2008-5#1)(2010-9#1)(2013-1#1)
was significantly greater##22##3##(1992-12#1)(1995-2#1)(2008-10#8)(2008-4#1)(2008-5#2)(2008-7#3)(2009-7#1)(2010-9#1)(2011-2#1)(2013-1#3)
was significantly high##2##3##(2012-2#1)(2012-3#1)
was significantly higher at##2##4##(2008-10#2)
was significantly higher for##2##4##(1992-12#1)(2011-2#1)
was significantly higher in patients with##3##6##(1992-12#1)(2010-4#1)(2013-1#1)
was significantly higher in patients##4##5##(1991-6#1)(1992-12#1)(2010-4#1)(2013-1#1)
was significantly higher in studies conducted using##2##7##(2008-10#2)
was significantly higher in the##9##5##(1992-3#1)(1993-1#1)(2008-10#2)(2008-11#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
was significantly higher in##36##4##(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1996-12#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)
was significantly higher on##2##4##(2008-10#1)(2008-5#1)
was significantly higher than in##4##5##(1990-11#1)(1995-3#1)(1997-8#1)(2008-11#1)
was significantly higher than that of##3##6##(2008-10#1)(2011-2#1)(2011-3#1)
was significantly higher than that##5##5##(1994-11#1)(1997-7#1)(2008-10#1)(2011-2#1)(2011-3#1)
was significantly higher than the##3##5##(2008-10#1)(2009-10#1)(2011-2#1)
was significantly higher than##16##4##(1990-11#1)(1993-11#1)(1994-11#1)(1995-3#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#2)(2011-3#1)(2013-8#1)
was significantly higher##67##3##(1990-11#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#2)(1994-11#1)(1995-3#1)(1996-12#2)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#17)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
was significantly improved##3##3##(2008-10#1)(2008-9#1)(2010-7#1)
was significantly increased at##2##4##(1995-12#1)(2008-10#1)
was significantly increased by##2##4##(1996-12#1)(2012-6#1)
was significantly increased in##11##4##(1990-2#1)(1994-11#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)
was significantly increased##29##3##(1990-2#1)(1991-2#1)(1992-12#2)(1994-11#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-8#1)(2011-2#2)(2012-6#1)
was significantly influenced by the##2##5##(1992-5#1)(2008-10#1)
was significantly influenced##3##3##(1992-5#1)(1995-12#1)(2008-10#1)
was significantly inhibited##2##3##(1997-4#1)(2008-8#1)
was significantly larger in##2##4##(2012-3#1)(2013-8#1)
was significantly larger##4##3##(1993-11#1)(1995-3#1)(2012-3#1)(2013-8#1)
was significantly less for##3##4##(2008-10#3)
was significantly less in##2##4##(1996-3#1)(2008-10#1)
was significantly less than in##3##5##(1995-12#1)(2008-10#2)
was significantly less than##5##4##(1994-12#1)(1995-12#1)(2008-10#3)
was significantly less##14##3##(1994-12#1)(1994-8#1)(1995-12#1)(1996-3#1)(2008-10#9)(2011-2#1)
was significantly longer in##2##4##(2008-5#1)(2011-2#1)
was significantly longer##4##3##(1993-1#1)(2008-5#1)(2008-9#1)(2011-2#1)
was significantly lower (p##3##4##(1992-3#1)(2008-1#1)(2013-1#1)
was significantly lower for##4##4##(1990-12#1)(1993-11#1)(2008-10#1)(2011-2#1)
was significantly lower in##7##4##(1992-3#1)(1995-5#1)(2008-10#4)(2010-1#1)
was significantly lower than in##5##5##(1990-11#1)(1997-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
was significantly lower than that of##2##6##(1994-8#1)(2008-9#1)
was significantly lower than that##4##5##(1994-8#1)(1995-8#1)(1996-2#1)(2008-9#1)
was significantly lower than the##2##5##(1996-12#1)(2008-7#1)
was significantly lower than##12##4##(1990-11#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)
was significantly lower##32##3##(1990-11#1)(1990-12#1)(1991-6#1)(1992-3#2)(1993-11#1)(1993-3#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-7#1)(2008-9#1)(2010-1#2)(2011-2#3)(2013-1#1)
was significantly more common in##3##5##(2008-7#2)(2010-4#1)
was significantly more common##4##4##(2008-7#2)(2010-4#1)(2012-3#1)
was significantly more effective##3##4##(2008-10#2)(2013-1#1)
was significantly more in##2##4##(1992-12#1)(2012-2#1)
was significantly more##16##3##(1992-12#1)(2008-10#7)(2008-5#1)(2008-7#2)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#1)
was significantly observed##2##3##(2008-10#1)(2008-11#1)
was significantly reduced by##9##4##(1995-11#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2010-10#1)(2012-3#1)
was significantly reduced in plants##2##5##(2008-10#2)
was significantly reduced in##15##4##(1996-12#3)(1997-2#1)(2008-10#6)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
was significantly reduced##34##3##(1993-8#1)(1995-11#1)(1996-12#5)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
was significantly related to##5##4##(2008-10#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
was significantly retarded (P##2##4##(2008-10#2)
was significantly shorter in##2##4##(2008-5#1)(2011-2#1)
was significantly slower##2##3##(2008-10#2)
was significantly smaller than that##2##5##(2008-10#2)
was significantly smaller than##3##4##(1995-12#1)(2008-10#2)
was significantly smaller##4##3##(1995-12#1)(2008-10#3)
was significantly suppressed##3##3##(1994-8#2)(2012-3#1)
was significantly##357##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-9#2)(1991-2#1)(1991-6#3)(1991-8#1)(1992-12#7)(1992-3#3)(1992-5#2)(1993-1#3)(1993-11#4)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#4)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#12)(1996-2#3)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#116)(2008-11#15)(2008-12#10)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#7)(2009-10#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#5)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#20)(2011-3#1)(2012-2#8)(2012-3#13)(2012-5#1)(2012-6#1)(2013-1#9)(2013-8#7)
was silenced##2##2##(2008-9#1)(2011-2#1)
was similar among##3##3##(1994-11#1)(2008-11#1)(2013-8#1)
was similar and##2##3##(1996-3#1)(2008-10#1)
was similar between the##2##4##(2008-10#2)
was similar between##4##3##(1995-8#1)(2008-10#2)(2010-4#1)
was similar for all the##2##5##(2008-10#1)(2008-3#1)
was similar for all##3##4##(2008-10#2)(2008-3#1)
was similar for both groups##2##5##(2008-10#1)(2009-11#1)
was similar for both##5##4##(1995-8#1)(1996-1#1)(2008-10#2)(2009-11#1)
was similar for##11##3##(1990-2#1)(1995-8#1)(1996-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)
was similar in both##4##4##(1990-3#1)(2008-10#1)(2008-9#1)(2011-2#1)
was similar in the two##2##5##(1992-3#1)(2012-3#1)
was similar in the##5##4##(1992-3#1)(2008-10#2)(2011-3#1)(2012-3#1)
was similar in##19##3##(1990-3#1)(1992-3#1)(1995-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#4)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)
was similar to a##3##4##(1991-7#1)(1995-2#1)(2008-9#1)
was similar to other##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
was similar to that observed in##3##6##(1991-12#1)(1993-8#1)(1997-2#1)
was similar to that observed##4##5##(1991-12#1)(1993-8#1)(1997-2#1)(2008-10#1)
was similar to that of control##3##6##(1993-8#1)(2008-9#2)
was similar to that of the##5##6##(1992-6#1)(1993-6#1)(2008-8#1)(2008-9#2)
was similar to that of##15##5##(1990-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#5)(2010-8#1)
was similar to that##24##4##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#3)(1996-2#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#5)(2010-8#1)
was similar to the##14##4##(1993-8#1)(1995-11#1)(2008-10#6)(2008-11#2)(2008-7#1)(2010-4#1)(2010-7#1)(2012-2#1)
was similar to##61##3##(1990-12#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#4)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#10)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
was similar##112##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-6#1)(1993-8#4)(1994-11#1)(1995-11#2)(1995-2#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-10#33)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#11)(2009-11#1)(2010-10#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
was similarly inhibited##2##3##(1993-3#1)(1995-8#1)
was similarly##8##2##(1992-1#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-8#1)(2008-10#1)(2013-1#2)
was simple and##6##3##(1996-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
was simple##12##2##(1993-11#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-7#1)
was simply##5##2##(1996-3#1)(2008-10#4)
was simulated by##2##3##(2008-3#1)(2008-8#1)
was simulated using a##3##4##(2008-10#3)
was simulated##9##2##(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)
was simultaneously##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
was situated##2##2##(2009-3#1)(2011-2#1)
was skewed##2##2##(2008-10#1)(2008-7#1)
was slight##2##2##(2008-10#1)(2013-8#1)
was slightly but significantly##2##4##(2008-10#2)
was slightly different from##2##4##(1996-6#1)(2008-11#1)
was slightly different##4##3##(1991-8#1)(1996-6#1)(2008-10#1)(2008-11#1)
was slightly higher in the##2##5##(2008-11#1)(2011-2#1)
was slightly higher in##4##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
was slightly higher than that in##2##6##(1994-12#1)(2008-11#1)
was slightly higher than##5##4##(1994-12#1)(2008-10#2)(2008-11#1)(2010-3#1)
was slightly higher##12##3##(1992-12#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
was slightly increased##2##3##(2008-10#1)(2010-10#1)
was slightly more effective than##2##5##(2008-10#1)(2008-11#1)
was slightly more##4##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
was slightly##39##2##(1990-9#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1994-12#1)(1996-6#1)(1997-5#1)(2008-10#11)(2008-11#9)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-3#1)
was slow and##2##3##(1990-7#1)(2008-10#1)
was slow##4##2##(1990-7#1)(1990-9#1)(2008-10#2)
was slower in##2##3##(2008-10#1)(2012-3#1)
was slower than that##2##4##(2008-10#2)
was slower##5##2##(2008-10#4)(2012-3#1)
was slowly##2##2##(1990-6#1)(1992-3#1)
was small in##2##3##(1993-8#1)(2010-8#1)
was small##13##2##(1991-11#1)(1993-8#1)(2008-10#8)(2008-8#1)(2010-8#1)(2012-2#1)
was smaller and##2##3##(1996-2#1)(2008-7#1)
was smaller in##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
was smaller than that##2##4##(1993-8#1)(1995-11#1)
was smaller than##6##3##(1993-8#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-7#1)
was smaller##15##2##(1993-8#1)(1994-5#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2012-3#1)
was so##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
was solubilized and##2##3##(1994-11#1)(2008-10#1)
was solubilized in##2##3##(1990-2#1)(1995-11#1)
was solubilized##5##2##(1990-2#1)(1994-11#1)(1995-11#1)(2008-10#2)
was soluble##2##2##(1992-7#1)(1994-11#1)
was solved with##2##3##(1996-3#1)(2011-3#1)
was solved##4##2##(1992-12#1)(1996-3#1)(2008-7#1)(2011-3#1)
was some evidence of##2##4##(2008-10#1)(2010-8#1)
was some evidence##4##3##(2008-10#2)(2009-6#1)(2010-8#1)
was some##8##2##(1991-12#1)(2008-10#2)(2008-9#2)(2009-6#1)(2010-8#1)(2013-1#1)
was sometimes##2##2##(1990-3#1)(2008-10#1)
was somewhat##8##2##(1991-6#1)(1991-8#1)(1995-12#1)(2008-10#4)(2013-8#1)
was sorbed on##2##3##(2008-10#2)
was specific and##2##3##(2008-10#1)(2008-11#1)
was specific for##7##3##(1990-12#1)(1990-5#1)(1993-11#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)
was specific to##2##3##(2008-10#2)
was specific##13##2##(1990-12#1)(1990-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-2#1)(2008-10#4)(2008-11#2)
was specifically expressed in##3##4##(2008-8#2)(2008-9#1)
was specifically##9##2##(1993-3#1)(1994-8#1)(1995-2#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-11#1)
was spent##3##2##(1997-2#1)(1997-3#1)(2010-8#1)
was splenectomized##2##2##(1994-9#2)
was split into two##2##4##(2008-10#1)(2013-8#1)
was split into##3##3##(2008-10#2)(2013-8#1)
was split##4##2##(2008-10#3)(2013-8#1)
was stabilized##2##2##(1997-8#1)(2008-10#1)
was stable and##4##3##(1990-9#1)(2008-10#3)
was stable for##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
was stable over##4##3##(1997-2#1)(2008-10#3)
was stable to##2##3##(2008-10#1)(2008-6#1)
was stable##25##2##(1990-9#1)(1992-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-1#1)(2012-3#1)
was stably expressed by##2##4##(2008-11#2)
was stably##8##2##(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#2)
was standardised as##2##3##(2008-10#2)
was started at the##2##4##(2008-7#1)(2011-2#1)
was started in##3##3##(1991-12#1)(1996-6#1)(2013-8#1)
was started on##4##3##(2007-12#1)(2008-12#1)(2009-11#1)(2011-1#1)
was started with##2##3##(1991-6#1)(2011-1#1)
was started within##2##3##(1992-2#1)(2011-2#1)
was started##22##2##(1991-12#1)(1991-6#1)(1992-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#3)(2011-2#3)(2013-8#3)
was stated##3##2##(2007-11#1)(2007-8#2)
was statistically evaluated##3##3##(2008-10#3)
was statistically significant (P &lt##2##5##(1996-12#1)(2008-5#1)
was statistically significant (P##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
was statistically significant (p &lt##2##5##(2010-7#1)(2011-2#1)
was statistically significant (p##3##4##(2010-7#1)(2011-2#1)(2013-1#1)
was statistically significant##14##3##(1990-3#1)(1995-9#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-7#1)(2011-2#6)(2013-1#1)
was statistically##24##2##(1990-3#1)(1995-9#1)(1996-12#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-6#1)(2010-7#1)(2011-2#6)(2012-3#1)(2013-1#3)
was still maintained##2##3##(2008-10#1)(2008-11#1)
was still##22##2##(1993-6#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)
was stimulated by spermine##2##4##(1990-3#2)
was stimulated by##9##3##(1990-3#2)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-3#1)
was stimulated in the##2##4##(1990-12#1)(2008-6#1)
was stimulated##13##2##(1990-12#1)(1990-3#2)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#2)(2009-3#1)
was stopped and##2##3##(1993-1#1)(2010-12#1)
was stopped because##2##3##(2011-2#1)(2013-1#1)
was stopped##12##2##(1993-1#1)(1996-3#1)(1997-1#2)(1997-6#1)(2008-1#1)(2008-7#1)(2010-1#2)(2010-12#1)(2011-2#1)(2013-1#1)
was stored##3##2##(1993-8#1)(2008-11#1)(2008-12#1)
was strengthened##2##2##(2009-12#1)(2013-8#1)
was strictly controlled##2##3##(2008-8#1)(2008-9#1)
was strictly##4##2##(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
was stripped from the##2##4##(2008-10#2)
was stripped from##3##3##(2008-10#3)
was stripped with##2##3##(2008-10#2)
was stripped##6##2##(2008-10#6)
was strong but that of##2##5##(2008-8#2)
was strong##8##2##(1994-9#1)(1996-12#1)(2008-10#1)(2008-8#2)(2009-7#1)(2012-2#1)(2012-9#1)
was stronger for##2##3##(2010-1#1)(2013-1#1)
was stronger in##2##3##(2008-9#1)(2011-2#1)
was stronger than that of##2##5##(2008-10#1)(2009-8#1)
was stronger than that##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
was stronger than##6##3##(2008-10#1)(2008-8#3)(2009-8#1)(2010-9#1)
was stronger##14##2##(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#1)
was strongly and##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
was strongly associated with##6##4##(2008-10#4)(2008-3#1)(2013-1#1)
was strongly correlated with##3##4##(1991-8#1)(2008-10#2)
was strongly dependent on the##2##5##(2008-10#1)(2008-9#1)
was strongly dependent on##4##4##(1994-9#1)(2008-10#2)(2008-9#1)
was strongly dependent##5##3##(1994-9#1)(2008-10#3)(2008-9#1)
was strongly inhibited##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
was strongly reduced##3##3##(1995-2#1)(2008-10#1)(2008-5#1)
was strongly suggested##2##3##(1990-5#1)(2008-10#1)
was strongly##39##2##(1990-5#1)(1991-8#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-8#1)(2008-10#18)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#2)
was structured##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
was studied and compared with##2##5##(2008-10#2)
was studied and compared##3##4##(2008-10#3)
was studied and optimized##2##4##(2008-10#2)
was studied and the##3##4##(2008-10#2)(2008-12#1)
was studied and##14##3##(1990-12#1)(2008-10#11)(2008-12#1)(2008-3#1)
was studied as a##5##4##(2008-10#5)
was studied as##8##3##(2008-10#7)(2008-8#1)
was studied at 25 degrees C and in##2##8##(2008-10#2)
was studied at the##2##4##(2007-12#1)(2008-10#1)
was studied at##11##3##(1995-12#1)(2007-12#1)(2008-10#7)(2008-7#1)(2008-9#1)
was studied by comparing##2##4##(2008-10#1)(2010-4#1)
was studied by cyclic voltammetry at a glassy carbon electrode##3##10##(2008-10#3)
was studied by cyclic voltammetry##5##5##(2008-10#5)
was studied by measuring##2##4##(2008-8#1)(2008-9#1)
was studied by potentiometric##2##4##(2008-10#2)
was studied by the##2##4##(2008-10#2)
was studied by using##2##4##(2008-10#1)(2008-8#1)
was studied by##57##3##(1993-2#1)(1993-8#2)(1994-11#1)(1995-8#1)(1997-1#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#5)(2008-9#2)(2010-4#2)(2011-2#1)(2011-3#1)(2012-2#1)
was studied for the first time##2##6##(2008-10#1)(2010-4#1)
was studied for the##5##4##(1992-3#1)(2008-10#2)(2009-2#1)(2010-4#1)
was studied for##11##3##(1992-3#1)(1994-8#1)(2008-10#6)(2008-7#1)(2009-2#1)(2010-4#1)
was studied from##3##3##(2008-10#3)
was studied in a##10##4##(1993-11#1)(1994-5#1)(2008-10#6)(2008-11#1)(2008-12#1)
was studied in an##3##4##(1993-12#1)(2008-7#1)(2008-9#1)
was studied in aqueous##3##4##(2008-10#3)
was studied in batch##2##4##(2008-10#1)(2008-11#1)
was studied in crosses##2##4##(2008-10#2)
was studied in cultured##2##4##(1994-6#1)(1995-11#1)
was studied in detail##8##4##(1991-12#1)(2008-10#7)
was studied in isolated rat##2##5##(1995-8#2)
was studied in order to##2##5##(2008-10#2)
was studied in rats##2##4##(1991-5#1)(1994-5#1)
was studied in the field##2##5##(2008-10#2)
was studied in the presence of##2##6##(2008-10#2)
was studied in the presence##3##5##(2008-10#3)
was studied in the rat##2##5##(1996-12#2)
was studied in the##13##4##(1995-8#1)(1996-12#3)(1997-2#1)(2008-10#6)(2008-5#1)(2008-8#1)
was studied in this paper##3##5##(2008-10#3)
was studied in vitro##2##4##(2008-10#1)(2008-11#1)
was studied in##104##3##(1990-11#1)(1990-2#1)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-8#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#3)(1996-12#3)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-10#49)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#3)(2011-2#1)(2012-2#2)(2012-3#1)
was studied on a##4##4##(2008-10#4)
was studied on##9##3##(1990-8#1)(2008-10#7)(2009-8#1)
was studied spectrophotometrically##2##3##(2008-10#2)
was studied through##3##3##(2008-10#2)(2008-9#1)
was studied to##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
was studied under##4##3##(1997-2#1)(2008-10#2)(2008-12#1)
was studied using a##5##4##(2008-10#3)(2008-9#1)(2010-10#1)
was studied using an##2##4##(2008-10#2)
was studied using flow##2##4##(2008-10#2)
was studied using##31##3##(1991-12#1)(1991-6#1)(1993-2#1)(1996-12#1)(1997-8#1)(2008-10#19)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-8#1)
was studied with the##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
was studied with##10##3##(1990-5#1)(1991-3#1)(1994-6#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)
was studied##401##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#4)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-8#3)(1994-11#2)(1994-5#2)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-8#4)(1996-12#4)(1996-2#5)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#238)(2008-11#9)(2008-12#6)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#15)(2008-9#11)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#4)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
was subcloned into##3##3##(1996-12#1)(2008-11#1)(2008-9#1)
was subcloned##5##2##(1990-5#1)(1991-9#1)(1996-12#1)(2008-11#1)(2008-9#1)
was subject to##7##3##(1997-8#1)(2008-10#1)(2008-12#2)(2009-3#1)(2012-12#1)(2013-1#1)
was subjected to acid and alkali hydrolysis##2##7##(2008-10#2)
was subjected to an electrochemical pretreatment in order to improve the##2##11##(2008-10#2)
was subjected to the##2##4##(2008-10#2)
was subjected to##19##3##(1994-11#1)(1997-1#1)(2008-10#11)(2008-11#3)(2008-7#1)(2011-2#1)(2013-1#1)
was submitted to##5##3##(1996-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)
was submitted##6##2##(1992-3#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)
was subsequently found to have##2##5##(2008-7#1)(2012-2#1)
was subsequently shown##2##3##(1991-2#1)(1992-6#1)
was subsequently used##2##3##(2008-10#1)(2010-6#1)
was subsequently##18##2##(1991-11#1)(1991-2#1)(1992-6#1)(1996-1#1)(1996-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#1)
was substantial##3##2##(1995-1#1)(2008-10#1)(2008-7#1)
was substantially##6##2##(1995-2#2)(1995-6#1)(1997-3#1)(2008-10#2)
was substantiated by the##2##4##(1994-2#1)(2008-10#1)
was substantiated by##4##3##(1994-2#1)(2008-10#3)
was substantiated##5##2##(1991-10#1)(1994-2#1)(2008-10#3)
was substituted by##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
was substituted##9##2##(1995-11#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-8#2)
was successful in##10##3##(1993-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
was successful##16##2##(1993-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
was successfully achieved##2##3##(2008-10#1)(2008-9#1)
was successfully applied for determination of##2##6##(2008-10#2)
was successfully applied for the assay of##2##7##(2008-10#2)
was successfully applied for the determination of##9##7##(2008-10#9)
was successfully applied for the##16##5##(2008-10#15)(2009-8#1)
was successfully applied for##23##4##(2008-10#22)(2009-8#1)
was successfully applied in the##3##5##(2008-10#3)
was successfully applied in##5##4##(2008-10#4)(2011-3#1)
was successfully applied to determination of##2##6##(2008-10#2)
was successfully applied to the analysis of##10##7##(2008-10#10)
was successfully applied to the determination of Cr(III) and##2##9##(2008-10#2)
was successfully applied to the determination of copper in##2##9##(2008-10#2)
was successfully applied to the determination of trace##4##8##(2008-10#4)
was successfully applied to the determination of##52##7##(2008-10#52)
was successfully applied to the determination##53##6##(2008-10#53)
was successfully applied to the direct determination##2##7##(2008-10#2)
was successfully applied to the extraction and determination of##4##9##(2008-10#4)
was successfully applied to the simultaneous determination of##9##8##(2008-10#9)
was successfully applied to the simultaneous##10##6##(2008-10#10)
was successfully applied to the speciation of##2##7##(2008-10#2)
was successfully applied to the speciation##3##6##(2008-10#3)
was successfully applied to the##89##5##(2008-10#89)
was successfully applied to##110##4##(2008-10#108)(2008-11#1)(2012-2#1)
was successfully applied##142##3##(2008-10#137)(2008-11#1)(2008-3#1)(2009-8#1)(2011-3#1)(2012-2#1)
was successfully constructed##2##3##(2008-10#1)(2010-1#1)
was successfully employed for the##2##5##(2008-10#2)
was successfully employed in the##2##5##(2008-10#2)
was successfully employed##6##3##(2008-10#5)(2011-1#1)
was successfully evaluated##2##3##(2008-10#2)
was successfully identified##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
was successfully performed##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
was successfully removed##2##3##(2008-7#2)
was successfully tested##3##3##(2008-10#2)(2008-3#1)
was successfully treated by##2##4##(2008-7#1)(2013-1#1)
was successfully treated with surgical##2##5##(2008-10#1)(2013-8#1)
was successfully treated with##13##4##(2008-10#2)(2008-7#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
was successfully treated##17##3##(1997-5#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
was successfully used as##3##4##(2008-10#3)
was successfully used for the determination of##5##7##(2008-10#5)
was successfully used for the##7##5##(2008-10#7)
was successfully used for##9##4##(2008-10#9)
was successfully used in##2##4##(2008-10#1)(2011-3#1)
was successfully used to##6##4##(2008-10#2)(2008-11#2)(2008-5#1)(2013-1#1)
was successfully used##20##3##(2008-10#15)(2008-11#2)(2008-5#1)(2011-3#1)(2013-1#1)
was successfully validated##2##3##(2008-10#2)
was successfully##225##2##(1995-12#1)(1997-5#1)(1997-8#1)(2007-12#2)(2008-10#180)(2008-11#6)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#4)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
was successively##2##2##(1993-8#1)(2008-10#1)
was such that##2##3##(1997-2#1)(2012-2#1)
was such##3##2##(1997-2#1)(1997-3#1)(2012-2#1)
was suffering from##2##3##(2008-12#1)(2012-12#1)
was sufficient for##4##3##(2008-10#3)(2011-2#1)
was sufficient to##13##3##(1992-12#2)(1994-11#1)(2008-10#8)(2008-11#1)(2013-1#1)
was sufficient##21##2##(1992-12#2)(1994-11#1)(2008-10#15)(2008-11#1)(2011-2#1)(2013-1#1)
was sufficiently low to##2##4##(2008-10#2)
was sufficiently##9##2##(2008-10#8)(2008-11#1)
was suggested and##3##3##(2008-10#1)(2012-12#2)
was suggested that the##4##4##(1993-3#1)(1993-8#1)(1995-11#1)(1996-2#1)
was suggested that##14##3##(1991-1#1)(1993-3#1)(1993-8#1)(1995-11#1)(1996-12#2)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
was suggested to be##2##4##(2008-7#1)(2008-9#1)
was suggested to##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
was suggested##29##2##(1991-1#1)(1993-3#1)(1993-8#1)(1995-11#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-9#2)(2009-12#1)(2011-2#1)(2011-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
was suitable for use##2##4##(2008-10#1)(2008-9#1)
was suitable for##9##3##(2008-10#6)(2008-9#1)(2011-2#2)
was suitable##10##2##(2008-10#7)(2008-9#1)(2011-2#2)
was suitably##2##2##(2008-10#1)(2008-3#1)
was superior in terms of##2##5##(2008-10#1)(2009-2#1)
was superior in##3##3##(2008-10#2)(2009-2#1)
was superior to that of##2##5##(1996-2#1)(2008-10#1)
was superior to that##4##4##(1993-2#1)(1996-2#1)(2008-10#2)
was superior to the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
was superior to##13##3##(1993-12#1)(1993-2#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-3#1)(2010-4#1)(2011-2#1)
was superior##17##2##(1993-12#1)(1993-2#1)(1996-2#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#1)
was supplemented with##3##3##(2008-10#2)(2008-5#1)
was supplemented##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
was supplied to the##2##4##(1995-3#1)(2008-10#1)
was supported by the##3##4##(2008-10#3)
was supported by##17##3##(1990-12#1)(1993-9#1)(1996-6#1)(2008-10#11)(2008-12#1)(2010-11#1)(2011-2#1)
was supported further by##2##4##(2008-10#2)
was supported##21##2##(1990-12#1)(1993-9#1)(1996-6#1)(2008-10#14)(2008-12#1)(2008-8#1)(2010-11#1)(2011-2#1)
was suppressed after##2##3##(2008-10#1)(2008-11#1)
was suppressed by##11##3##(1990-2#1)(1992-8#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-7#1)
was suppressed in all##2##4##(2008-10#2)
was suppressed in##3##3##(2008-10#2)(2011-2#1)
was suppressed when compared##2##4##(2008-10#1)(2008-12#1)
was suppressed##29##2##(1990-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
was suppressive##2##2##(2008-10#2)
was surgically##4##2##(1993-2#1)(2007-12#1)(2013-1#2)
was surrounded by a##2##4##(2008-10#2)
was surrounded by##3##3##(2008-10#3)
was surveyed in##4##3##(1992-3#1)(1997-3#1)(2008-10#1)(2011-1#1)
was surveyed##5##2##(1992-3#1)(1997-3#1)(2008-10#2)(2011-1#1)
was susceptible to##7##3##(2008-10#6)(2008-11#1)
was susceptible##8##2##(2008-10#7)(2008-11#1)
was suspected on the basis of##2##6##(1990-3#1)(2008-7#1)
was suspected on##3##3##(1990-3#1)(2008-7#1)(2012-2#1)
was suspected to be##2##4##(2008-10#1)(2010-6#1)
was suspected##13##2##(1990-3#1)(1994-9#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#2)(2012-2#1)(2013-1#1)(2013-8#1)
was sustained for##3##3##(1990-10#1)(1997-7#1)(2008-7#1)
was sustained##5##2##(1990-10#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-7#1)
was swallowed##2##2##(1990-6#1)(2008-10#1)
was swept##2##2##(2008-10#1)(2008-3#1)
was switched##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
was symmetric##2##2##(2008-8#2)
was symptomatic##2##2##(2008-7#1)(2011-3#1)
was synergistically increased by##2##4##(1997-1#2)
was synthesized and characterized##2##4##(1993-8#1)(2008-10#1)
was synthesized and its##2##4##(2008-10#2)
was synthesized and##10##3##(1992-8#1)(1993-8#1)(2008-10#5)(2008-12#1)(2008-8#1)(2012-12#1)
was synthesized as a##2##4##(1990-8#1)(2008-10#1)
was synthesized by a##3##4##(2008-10#3)
was synthesized by using##2##4##(2008-10#2)
was synthesized by##11##3##(1992-3#1)(1994-8#1)(2008-10#9)
was synthesized from##2##3##(2008-10#2)
was synthesized using##3##3##(2008-10#3)
was synthesized with##2##3##(1990-5#1)(1994-5#1)
was synthesized##41##2##(1990-5#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#1)(2008-10#29)(2008-12#2)(2008-8#1)(2012-12#1)
was systematically studied##2##3##(1991-12#1)(2008-10#1)
was systematically##4##2##(1991-12#1)(2008-10#2)(2013-8#1)
was tagged with##2##3##(2008-10#2)
was tailored##2##2##(2009-9#1)(2012-12#1)
was taken as the##2##4##(2008-2#1)(2011-1#1)
was taken as##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
was taken for##3##3##(2008-10#2)(2012-2#1)
was taken from##2##3##(2008-10#1)(2013-1#1)
was taken into account##3##4##(1994-9#1)(2008-10#2)
was taken to##4##3##(2008-10#2)(2010-12#1)(2011-2#1)
was taken up by the##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
was taken up by##4##4##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
was taken up##5##3##(1991-12#1)(2008-10#1)(2008-11#2)(2008-5#1)
was taken##35##2##(1991-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-12#1)(2008-10#11)(2008-11#5)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
was taking an##2##3##(1995-6#2)
was taking##5##2##(1994-12#1)(1995-6#3)(2007-12#1)
was taught##2##2##(2010-9#1)(2013-8#1)
was temperature##2##2##(1993-12#1)(2008-10#1)
was ten##2##2##(1993-1#1)(2008-9#1)
was tentatively##2##2##(2008-10#2)
was terminated by##2##3##(1995-12#1)(2008-12#1)
was terminated##4##2##(1990-5#1)(1995-12#1)(2008-12#1)(2011-4#1)
was tested against##8##3##(1996-3#1)(2008-10#5)(2008-12#1)(2008-5#1)
was tested and##4##3##(2008-10#3)(2013-8#1)
was tested as an##2##4##(2008-10#2)
was tested as##3##3##(2008-10#3)
was tested by analysing a##3##5##(2008-10#3)
was tested by analysing##5##4##(2008-10#5)
was tested by analyzing##2##4##(2008-10#1)(2011-2#1)
was tested by measuring##2##4##(2008-11#1)(2008-8#1)
was tested by the##4##4##(2008-10#2)(2008-5#1)(2013-8#1)
was tested by##33##3##(1991-9#1)(1995-12#1)(1997-3#1)(2008-10#22)(2008-11#1)(2008-5#2)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
was tested experimentally by##2##4##(2008-10#1)(2008-7#1)
was tested for its ability to##2##6##(2008-10#2)
was tested for its##4##4##(2008-10#4)
was tested for the determination of##2##6##(2008-10#2)
was tested for##24##3##(1991-3#1)(1991-6#1)(1994-8#1)(2008-10#18)(2008-11#1)(2008-9#1)(2011-2#1)
was tested in a##4##4##(2008-10#1)(2008-11#2)(2010-10#1)
was tested in an##2##4##(2008-10#1)(2008-7#1)
was tested in the analysis of##2##6##(2008-10#2)
was tested in the determination of##2##6##(2008-10#2)
was tested in the laboratory##2##5##(2008-10#2)
was tested in the presence##2##5##(2008-11#1)(2013-1#1)
was tested in the##13##4##(2008-10#9)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
was tested in vitro##2##4##(2008-10#1)(2008-5#1)
was tested in##34##3##(1996-12#1)(2008-10#20)(2008-11#3)(2008-5#3)(2008-7#2)(2008-9#1)(2010-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
was tested on##13##3##(2008-10#9)(2008-12#3)(2008-3#1)
was tested through##3##3##(2010-10#1)(2011-2#1)(2013-8#1)
was tested under##2##3##(2008-10#1)(2012-3#1)
was tested using a##2##4##(2008-10#2)
was tested using##9##3##(2008-10#6)(2008-11#1)(2008-12#1)(2008-9#1)
was tested with##6##3##(2008-10#6)
was tested##169##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-8#2)(1995-12#1)(1996-12#2)(1996-3#1)(1997-3#2)(2008-10#110)(2008-11#7)(2008-12#5)(2008-3#1)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#3)(2010-10#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#5)
was that of a##2##4##(2008-11#1)(2011-2#1)
was that of##6##3##(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#2)(2012-12#1)
was that the##8##3##(1991-6#1)(2008-10#4)(2008-8#1)(2010-5#1)(2011-1#1)
was that##28##2##(1991-6#1)(1992-12#1)(1996-3#1)(1996-6#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#3)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
was the aim of##2##4##(2008-11#1)(2009-10#1)
was the best choice for##2##5##(2008-10#2)
was the best##5##3##(2008-10#4)(2008-5#1)
was the case##5##3##(1991-7#1)(1995-6#1)(2008-10#2)(2013-1#1)
was the commonest species##2##4##(2008-5#2)
was the commonest##4##3##(1997-8#1)(2008-1#1)(2008-5#2)
was the development and##2##4##(2008-5#1)(2013-1#1)
was the development of##4##4##(2008-10#3)(2008-3#1)
was the development##6##3##(2008-10#3)(2008-3#1)(2008-5#1)(2013-1#1)
was the dominant species##2##4##(2008-10#2)
was the dominant##5##3##(2008-10#4)(2008-12#1)
was the finding of##2##4##(1996-12#1)(2011-2#1)
was the finding##3##3##(1994-8#1)(1996-12#1)(2011-2#1)
was the first##4##3##(1992-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
was the highest among##2##4##(1996-3#1)(2008-12#1)
was the highest in##2##4##(2008-10#1)(2009-7#1)
was the highest##7##3##(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#1)
was the implementation##2##3##(1994-1#1)(2008-10#1)
was the lack of##2##4##(2008-10#1)(2008-11#1)
was the last##3##3##(1991-3#2)(2012-2#1)
was the least##5##3##(2008-10#5)
was the limiting##2##3##(2008-10#1)(2011-2#1)
was the lowest among the##2##5##(2008-5#1)(2011-3#1)
was the lowest##5##3##(1994-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-3#1)
was the main##8##3##(1996-6#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-12#1)
was the major##13##3##(1990-6#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-8#1)(2010-11#1)
was the most active against##2##5##(2008-7#2)
was the most active##4##4##(1991-12#1)(2008-7#2)(2013-8#1)
was the most appropriate##2##4##(2008-10#2)
was the most common toxicity during##2##6##(2008-10#2)
was the most common##9##4##(1990-6#1)(2008-10#3)(2008-12#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
was the most effective in##2##5##(2008-10#2)
was the most effective##10##4##(2008-10#9)(2008-6#1)
was the most frequent symptom##2##5##(1991-8#1)(1995-11#1)
was the most frequent##5##4##(1991-8#2)(1995-11#1)(2012-12#1)(2012-3#1)
was the most potent##2##4##(1994-3#1)(1996-2#1)
was the most prevalent##3##4##(1992-3#1)(2008-10#1)(2013-1#1)
was the most resistant##3##4##(2008-10#3)
was the most sensitive##5##4##(2008-10#4)(2008-8#1)
was the most significant##2##4##(2008-10#1)(2008-8#1)
was the most suitable##2##4##(2008-10#1)(2008-12#1)
was the most##68##3##(1990-6#1)(1991-12#1)(1991-8#2)(1992-3#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-4#1)(2008-10#36)(2008-12#3)(2008-6#1)(2008-7#3)(2008-8#2)(2010-1#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
was the only factor##2##4##(1991-2#1)(2012-2#1)
was the only race##2##4##(2008-10#2)
was the only significant##2##4##(1993-1#1)(2012-2#1)
was the only variable##2##4##(1990-8#1)(2013-1#1)
was the only##29##3##(1990-8#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-2#1)(1995-11#1)(1996-11#1)(1997-6#1)(2008-10#9)(2008-12#1)(2008-5#2)(2008-7#1)(2010-8#3)(2012-2#2)(2013-1#1)(2013-8#1)
was the optimal##2##3##(1995-8#1)(2008-10#1)
was the predominant mode##3##4##(2008-10#3)
was the predominant species##3##4##(1994-11#1)(1996-12#1)(2008-10#1)
was the predominant##15##3##(1992-6#1)(1994-11#1)(1996-12#1)(2008-10#10)(2013-1#1)(2013-8#1)
was the preferred strategy##3##4##(2012-3#3)
was the presence of##2##4##(2009-8#1)(2012-3#1)
was the primary diagnosis in##2##5##(1992-1#2)
was the primary##7##3##(1992-1#2)(2008-10#4)(2013-1#1)
was the production of##2##4##(1996-2#1)(2012-2#1)
was the same as that of##3##6##(1990-5#1)(1993-9#1)(2008-10#1)
was the same as that##4##5##(1990-5#1)(1993-9#1)(2008-10#2)
was the same as##11##4##(1990-5#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-3#1)
was the same for both##3##5##(1995-11#1)(1996-2#1)(2008-5#1)
was the same for##4##4##(1995-11#1)(1996-2#1)(2008-10#1)(2008-5#1)
was the same in both##2##5##(1994-3#1)(2008-11#1)
was the same##20##3##(1990-5#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-3#1)
was the selected##2##3##(2008-10#2)
was the sole##5##3##(1994-8#1)(1996-3#1)(2008-10#2)(2008-11#1)
was the species##2##3##(2008-12#1)(2008-5#1)
was the strongest predictor of##4##5##(2008-3#1)(2008-9#1)(2010-10#1)(2012-3#1)
was the strongest##5##3##(2008-3#2)(2008-9#1)(2010-10#1)(2012-3#1)
was the third##2##3##(1992-2#1)(2008-12#1)
was the use of##3##4##(2008-10#2)(2013-1#1)
was the work of##2##4##(1996-1#1)(2008-10#1)
was the##387##2##(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#4)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1993-1#3)(1993-12#3)(1993-2#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#4)(1995-11#4)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#6)(2008-10#141)(2008-11#14)(2008-12#14)(2008-3#3)(2008-5#15)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#6)(2009-10#2)(2009-5#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-5#2)(2010-8#3)(2011-2#10)(2011-3#2)(2012-12#4)(2012-2#9)(2012-3#11)(2013-1#14)(2013-7#1)(2013-8#8)
was their##2##2##(1991-12#1)(1992-3#1)
was then applied to##3##4##(2008-10#2)(2012-2#1)
was then applied##5##3##(2008-10#4)(2012-2#1)
was then assessed##2##3##(2008-10#1)(2013-1#1)
was then confirmed by##2##4##(2010-12#1)(2012-12#1)
was then confirmed##3##3##(2008-12#1)(2010-12#1)(2012-12#1)
was then converted to##2##4##(1994-3#1)(2008-10#1)
was then determined by##2##4##(2008-10#2)
was then determined##3##3##(2008-10#3)
was then eluted with##2##4##(2008-10#2)
was then evaluated##2##3##(2008-10#1)(2008-11#1)
was then extracted##3##3##(2008-10#2)(2008-5#1)
was then followed##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
was then mixed with the reagent##2##6##(2008-10#2)
was then performed by##2##4##(2008-10#2)
was then performed##5##3##(2008-10#3)(2008-11#1)(2011-2#1)
was then purified##2##3##(1994-8#1)(2008-5#1)
was then repeated##3##3##(1993-2#1)(2008-10#2)
was then tested##2##3##(2008-10#1)(2008-5#1)
was then used for##2##4##(2008-10#2)
was then used to##5##4##(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
was then used##8##3##(2008-10#5)(2008-5#1)(2008-7#1)(2012-2#1)
was then##109##2##(1990-8#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#56)(2008-11#7)(2008-12#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#7)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
was there##2##2##(1996-5#1)(2010-11#1)
was therefore##18##2##(1990-5#1)(1991-8#1)(1992-3#1)(1994-12#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
was thoroughly##2##2##(1990-5#1)(2008-10#1)
was thought to be a##2##5##(2008-10#1)(2008-8#1)
was thought to be##11##4##(1993-1#1)(1993-3#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
was thought to occur##2##4##(2008-10#1)(2008-7#1)
was thought to##17##3##(1993-1#1)(1993-3#1)(1993-9#1)(1996-11#1)(2008-10#3)(2008-11#2)(2008-7#3)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)
was thought##20##2##(1993-1#1)(1993-3#1)(1993-9#1)(1996-11#1)(2008-10#4)(2008-11#4)(2008-7#3)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)
was three times greater##2##4##(2008-10#2)
was through binding##2##3##(2008-11#2)
was through##4##2##(2008-11#2)(2008-7#1)(2010-12#1)
was thus demonstrated##2##3##(2008-10#1)(2008-11#1)
was thus##14##2##(1990-6#1)(1990-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#1)(2009-8#1)(2011-2#1)
was tightly##2##2##(1995-2#1)(1997-6#1)
was titrated##3##2##(1994-5#1)(2008-10#2)
was to analyse the##3##4##(2008-5#1)(2008-6#1)(2011-1#1)
was to analyse##6##3##(2008-5#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
was to analyze the##8##4##(1995-8#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-3#2)
was to analyze##13##3##(1995-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-9#1)(2011-2#3)(2012-3#3)
was to apply a##2##4##(2008-10#1)(2008-5#1)
was to apply##3##3##(2008-10#2)(2008-5#1)
was to assess the influence of##3##6##(2008-5#1)(2009-8#1)(2013-1#1)
was to assess the possible##2##5##(2012-3#1)(2012-8#1)
was to assess the##24##4##(1991-6#1)(1992-1#1)(1992-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(2008-12#1)(2008-5#4)(2008-7#3)(2008-9#2)(2009-2#1)(2009-8#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
was to assess whether##2##4##(2009-7#1)(2012-2#1)
was to assess##33##3##(1991-6#1)(1992-1#1)(1992-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#4)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
was to be##2##3##(2010-1#1)(2012-12#1)
was to characterize the##4##4##(2008-10#1)(2008-11#2)(2010-4#1)
was to characterize##8##3##(1993-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-4#1)
was to clarify the##2##4##(2009-8#1)(2011-2#1)
was to compare differences in##2##5##(2008-12#1)(2011-2#1)
was to compare laparoscopically assisted vaginal hysterectomy##2##7##(1993-12#1)(1994-2#1)
was to compare the##12##4##(1996-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#3)
was to compare##26##3##(1990-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#3)(2013-1#5)
was to confirm##2##3##(2008-10#1)(2012-2#1)
was to create awareness##2##4##(1992-12#1)(2013-8#1)
was to define the##3##4##(1995-2#1)(2007-11#1)(2011-2#1)
was to define##4##3##(1995-2#1)(2007-11#1)(2008-3#1)(2011-2#1)
was to demonstrate the##3##4##(2008-10#2)(2011-2#1)
was to describe the##7##4##(1992-3#1)(2008-11#1)(2009-3#1)(2010-10#1)(2010-5#1)(2013-1#2)
was to describe##11##3##(1992-3#1)(1995-12#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-10#1)(2010-5#2)(2011-7#1)(2013-1#2)
was to detect##3##3##(2008-7#1)(2010-8#1)(2012-3#1)
was to determine if the##3##5##(2008-10#1)(2008-11#1)(2011-2#1)
was to determine if##12##4##(1993-2#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
was to determine the prevalence of##3##6##(2008-12#1)(2012-2#1)(2013-1#1)
was to determine the##53##4##(1991-11#1)(1991-8#1)(1994-5#1)(2008-1#1)(2008-10#9)(2008-12#5)(2008-5#4)(2008-6#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#5)(2013-3#1)(2013-8#3)
was to determine whether the##2##5##(1990-8#1)(2008-10#1)
was to determine whether##14##4##(1990-8#1)(1994-11#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-3#2)
was to determine which##6##4##(1991-6#1)(1994-3#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
was to determine##92##3##(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#2)(1996-6#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#2)(2012-6#1)(2013-1#6)(2013-3#1)(2013-8#5)
was to develop a##9##4##(1997-2#1)(2008-10#3)(2008-5#2)(2010-7#1)(2011-1#1)(2012-4#1)
was to develop an##7##4##(1991-9#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#2)
was to develop and##4##4##(2008-10#2)(2010-9#1)(2012-2#1)
was to develop##25##3##(1991-9#1)(1993-12#1)(1997-2#1)(2008-10#7)(2008-11#4)(2008-5#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-4#1)
was to elucidate the##2##4##(1994-3#1)(1995-6#1)
was to elucidate##3##3##(1994-3#1)(1995-6#1)(2009-9#1)
was to establish whether##2##4##(2008-11#1)(2011-2#1)
was to establish##6##3##(2008-11#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
was to estimate the##3##4##(2008-10#1)(2008-12#1)(2009-8#1)
was to estimate##4##3##(2008-10#1)(2008-12#1)(2009-8#1)(2013-1#1)
was to evaluate the role of##2##6##(2008-10#1)(2011-2#1)
was to evaluate the##51##4##(1990-11#1)(1991-3#1)(1993-11#1)(1997-8#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#7)(2008-9#2)(2009-11#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#12)
was to evaluate##76##3##(1990-11#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-6#1)(1997-8#6)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#4)(2008-5#7)(2008-7#2)(2008-9#2)(2009-11#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#5)(2012-3#2)(2013-1#13)(2013-8#2)
was to examine the effects of a##2##7##(2009-3#1)(2013-8#1)
was to examine the effects of##4##6##(1991-12#1)(2009-3#1)(2013-8#2)
was to examine the##28##4##(1991-12#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#3)
was to examine##37##3##(1991-12#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-11#5)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
was to explore the##4##4##(2008-12#1)(2010-11#1)(2011-2#2)
was to explore##11##3##(2008-11#2)(2008-12#3)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-3#1)
was to find out##2##4##(1990-2#1)(2008-5#1)
was to find##6##3##(1990-2#1)(1990-5#1)(1995-11#1)(2008-10#2)(2008-5#1)
was to formulate##2##3##(2008-3#1)(2008-5#1)
was to further evaluate##2##4##(2011-2#2)
was to further##4##3##(1992-12#1)(2008-11#1)(2011-2#2)
was to gain##2##3##(2010-9#1)(2012-12#1)
was to highlight##2##3##(2008-5#1)(2013-1#1)
was to identify genes##2##4##(2008-9#1)(2012-3#1)
was to identify risk factors##2##5##(1996-12#1)(2013-1#1)
was to identify the##10##4##(1992-2#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-1#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#1)
was to identify##23##3##(1990-2#1)(1992-2#1)(1994-5#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-9#2)(2009-1#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#2)
was to improve the##2##4##(2008-11#1)(2010-8#1)
was to improve##4##3##(2008-10#1)(2008-11#2)(2010-8#1)
was to increase##2##3##(1997-1#1)(2008-10#1)
was to investigate the association between##2##6##(2011-2#1)(2013-1#1)
was to investigate the relationships between##2##6##(2008-10#1)(2010-6#1)
was to investigate the##48##4##(1994-12#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
was to investigate whether##6##4##(1992-12#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
was to investigate##70##3##(1992-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-12#5)(2008-3#1)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#1)
was to measure the##3##4##(1994-3#1)(2008-5#1)(2010-10#1)
was to measure##4##3##(1994-3#1)(2008-11#1)(2008-5#1)(2010-10#1)
was to observe##3##3##(2008-10#2)(2013-1#1)
was to obtain##5##3##(1992-12#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-7#1)
was to perform a##2##4##(2008-10#1)(2011-2#1)
was to perform##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
was to present##5##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
was to produce##2##3##(1996-12#1)(2008-7#1)
was to provide a##3##4##(1995-2#1)(2010-6#1)(2012-2#1)
was to provide an##2##4##(2008-5#1)(2010-11#1)
was to provide##9##3##(1995-2#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
was to quantify the##3##4##(2008-10#2)(2009-5#1)
was to quantify##4##3##(1996-6#1)(2008-10#2)(2009-5#1)
was to review the##4##4##(1991-12#1)(2008-10#2)(2011-7#1)
was to review##5##3##(1991-12#1)(2008-10#2)(2011-7#1)(2012-2#1)
was to search##2##3##(2008-12#1)(2013-1#1)
was to study the relationship##2##5##(1991-11#1)(2008-7#1)
was to study the##7##4##(1991-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
was to study##8##3##(1991-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
was to systematically##2##3##(1993-2#1)(2013-1#1)
was to test the##2##4##(1990-8#1)(2012-2#1)
was to test##5##3##(1990-8#1)(1993-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
was to understand the##2##4##(2008-11#1)(2012-3#1)
was to use##6##3##(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)
was to validate the##2##4##(2009-12#1)(2013-1#1)
was to verify the##4##4##(1992-3#1)(2008-10#2)(2008-7#1)
was to verify##7##3##(1992-3#1)(1996-3#1)(2008-10#3)(2008-7#1)(2010-9#1)
was to##630##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#5)(1992-2#3)(1992-3#3)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#3)(1997-1#3)(1997-2#3)(1997-3#5)(1997-4#1)(1997-8#11)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#86)(2008-11#44)(2008-12#34)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#40)(2008-6#2)(2008-7#19)(2008-8#3)(2008-9#20)(2009-1#2)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#8)(2010-11#5)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#8)(2010-7#4)(2010-8#5)(2010-9#4)(2011-1#7)(2011-2#54)(2011-7#2)(2012-12#5)(2012-2#23)(2012-3#18)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#54)(2013-3#1)(2013-8#13)
was too low##2##3##(2008-10#1)(2008-11#1)
was too small to##3##4##(1991-3#1)(1994-12#1)(2008-10#1)
was too##11##2##(1990-6#1)(1991-3#1)(1994-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-5#1)(2011-2#1)
was topically##2##2##(2008-5#2)
was total##2##2##(2008-7#1)(2008-9#1)
was totally removed##2##3##(2008-7#1)(2012-3#1)
was totally##7##2##(1992-6#1)(2008-7#3)(2011-2#1)(2012-3#1)(2013-1#1)
was toxic##4##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
was traced to the##2##4##(2008-10#1)(2012-2#1)
was traced to##3##3##(2008-10#1)(2009-9#1)(2012-2#1)
was traced##5##2##(2008-10#3)(2009-9#1)(2012-2#1)
was trained as a##2##4##(2010-7#2)
was trained##8##2##(2008-10#5)(2008-5#1)(2010-7#2)
was transcribed in##3##3##(2008-8#3)
was transcribed##5##2##(1993-12#1)(1997-3#1)(2008-8#3)
was transfected into##2##3##(1990-5#1)(1990-8#1)
was transfected##4##2##(1990-5#1)(1990-8#1)(2008-10#1)(2008-11#1)
was transferable##2##2##(1996-3#1)(2008-10#1)
was transferred into##8##3##(2008-10#3)(2008-11#1)(2008-8#4)
was transferred to the##2##4##(2013-1#2)
was transferred to##4##3##(2008-9#1)(2013-1#2)(2013-8#1)
was transferred##15##2##(1997-3#1)(2008-10#4)(2008-11#1)(2008-8#4)(2008-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
was transformed by##2##3##(2008-8#1)(2010-3#1)
was transformed into##5##3##(1997-1#1)(2008-10#2)(2008-9#1)(2013-1#1)
was transformed to##2##3##(2008-11#2)
was transformed with##3##3##(2008-10#2)(2008-8#1)
was transformed##13##2##(1997-1#1)(2008-10#4)(2008-11#2)(2008-8#3)(2008-9#1)(2010-3#1)(2013-1#1)
was transient##4##2##(1991-12#1)(1994-3#1)(1995-2#1)(2008-11#1)
was transiently##3##2##(1995-8#1)(2008-11#2)
was translated##2##2##(2008-10#2)
was translocated from the cytosol to##2##6##(1992-6#1)(2011-2#1)
was translocated##4##2##(1992-6#1)(1993-2#1)(2008-10#1)(2011-2#1)
was transmissible##2##2##(2008-10#2)
was transmitted by##8##3##(2008-10#7)(2010-1#1)
was transmitted##14##2##(1996-5#1)(2008-10#11)(2008-12#1)(2010-1#1)
was transplanted into##2##3##(2008-10#1)(2010-11#1)
was transported by##2##3##(1993-8#1)(2008-10#1)
was transported to the##3##4##(2008-10#3)
was transported to##4##3##(2008-10#4)
was transported##6##2##(1993-8#1)(2008-10#5)
was treated by##4##3##(1990-8#1)(2008-10#1)(2008-12#2)
was treated conservatively##5##3##(2008-12#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
was treated medically##2##3##(2008-10#1)(2008-12#1)
was treated successfully##3##3##(1990-9#1)(2008-1#1)(2009-11#1)
was treated surgically##4##3##(2008-12#1)(2009-1#1)(2011-2#1)(2013-1#1)
was treated using##2##3##(2011-2#1)(2013-1#1)
was treated with intravenous##2##4##(2010-10#1)(2013-1#1)
was treated with the##2##4##(2008-10#1)(2011-2#1)
was treated with##39##3##(1990-2#1)(1990-6#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#2)(1997-8#1)(2008-10#5)(2008-11#5)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
was treated##63##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1996-11#1)(1996-12#2)(1996-5#3)(1996-6#2)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#5)(2008-7#2)(2009-1#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#11)(2013-8#1)
was triggered##3##2##(1990-11#1)(2008-10#2)
was true for##2##3##(2008-11#1)(2012-2#1)
was turned##2##2##(1991-8#1)(2008-11#1)
was twice as high as##2##5##(2008-10#1)(2008-11#1)
was twice as##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
was twice that in##2##4##(1991-5#1)(2008-10#1)
was twice that of##2##4##(2008-10#1)(2008-11#1)
was twice that##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
was twice##8##2##(1991-5#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)
was two##3##2##(1993-11#1)(2008-11#1)(2008-7#1)
was typical of##4##3##(2008-10#3)(2010-4#1)
was typical##6##2##(2007-11#1)(2008-10#3)(2008-12#1)(2010-4#1)
was typically##4##2##(2008-10#2)(2008-12#1)(2012-12#1)
was unable to infect##4##4##(2008-10#4)
was unable to##12##3##(1995-6#1)(2008-10#8)(2008-3#1)(2008-5#1)(2012-2#1)
was unaffected by##14##3##(1993-12#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-11#2)(1995-12#2)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#2)
was unaffected##23##2##(1993-12#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2009-9#1)
was unaltered##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
was unambiguously##2##2##(2008-10#2)
was unchanged by##2##3##(2008-10#1)(2008-8#1)
was unchanged in##2##3##(1990-5#1)(2008-10#1)
was unchanged##11##2##(1990-5#1)(1990-6#1)(1994-2#1)(1994-6#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
was unclear##4##2##(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
was uncommon##3##2##(1994-2#1)(2008-8#1)(2008-9#1)
was under##7##2##(1990-5#1)(1993-3#1)(2008-10#2)(2008-11#1)(2010-12#2)
was understood##2##2##(2007-12#1)(2008-10#1)
was undertaken by##2##3##(2008-10#1)(2008-11#1)
was undertaken for articles published##4##5##(2012-12#4)
was undertaken in##6##3##(1992-2#1)(2008-11#2)(2008-7#1)(2012-2#1)(2013-7#1)
was undertaken of##2##3##(1990-12#1)(2010-1#1)
was undertaken on##3##3##(1990-12#1)(2012-2#1)(2012-3#1)
was undertaken to assess##3##4##(1991-12#1)(1995-11#1)(2008-10#1)
was undertaken to determine the##2##5##(1995-12#1)(2008-12#1)
was undertaken to determine##5##4##(1995-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)
was undertaken to establish the##2##5##(2008-7#1)(2012-2#1)
was undertaken to establish##5##4##(1993-2#1)(2008-10#1)(2008-7#1)(2012-2#2)
was undertaken to estimate##2##4##(2008-10#2)
was undertaken to evaluate the##4##5##(1996-1#1)(1996-11#1)(2008-11#1)(2008-12#1)
was undertaken to identify##2##4##(1993-3#1)(2012-12#1)
was undertaken to investigate the##4##5##(1991-2#1)(1994-12#1)(2008-7#1)(2012-2#1)
was undertaken to##42##3##(1991-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(2008-10#9)(2008-11#6)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)
was undertaken using##2##3##(2008-10#1)(2008-7#1)
was undertaken with##2##3##(1990-12#1)(2008-12#1)
was undertaken within##2##3##(2008-11#2)
was undertaken##84##2##(1990-12#3)(1990-6#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-11#1)(2008-10#16)(2008-11#15)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#5)(2012-12#5)(2012-2#5)(2012-3#2)(2013-7#1)
was undetectable in the##2##4##(1994-11#1)(1996-12#1)
was undetectable in##3##3##(1991-5#1)(1994-11#1)(1996-12#1)
was undetectable##5##2##(1991-5#1)(1994-11#1)(1996-12#1)(2008-10#1)(2012-3#1)
was uneven##3##2##(1992-5#1)(2008-8#1)(2008-9#1)
was unevenly distributed##2##3##(2008-10#2)
was uneventful##10##2##(1991-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
was unexpectedly##2##2##(2008-11#1)(2013-1#1)
was uniformly##2##2##(2008-10#1)(2008-9#1)
was unique in that##2##4##(1994-5#1)(2009-8#1)
was unique##4##2##(1994-5#1)(2008-10#1)(2009-8#1)(2011-2#1)
was uniquely##2##2##(2008-10#1)(2009-7#1)
was unknown##2##2##(2008-10#1)(2012-2#1)
was unlikely##4##2##(1995-6#1)(2008-10#1)(2009-3#1)(2010-2#1)
was unrelated to##3##3##(2008-10#2)(2009-4#1)
was unstable##2##2##(2008-10#1)(2008-11#1)
was unsuccessful##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
was unsuitable##2##2##(2008-10#1)(2008-11#1)
was up to##11##3##(1991-11#1)(1992-12#1)(2008-10#4)(2008-11#1)(2008-8#3)(2013-8#1)
was up-regulated in##2##3##(1995-11#1)(2008-10#1)
was up-regulated##4##2##(1995-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
was upregulated in##4##3##(1996-12#1)(2009-4#1)(2010-12#2)
was upregulated##5##2##(1996-12#1)(2008-1#1)(2009-4#1)(2010-12#2)
was urgently##3##2##(2008-12#1)(2010-1#1)(2011-3#1)
was used after##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
was used and the##9##4##(2008-10#9)
was used and##12##3##(2008-10#10)(2008-11#1)(2011-3#1)
was used as a control##3##5##(1995-12#1)(2008-11#1)(2008-5#1)
was used as a positive##2##5##(1992-12#1)(1996-12#1)
was used as a probe##3##5##(1997-1#1)(2008-10#1)(2008-8#1)
was used as a sample##2##5##(2008-10#2)
was used as a solid##2##5##(2008-10#2)
was used as a support material for##2##7##(2008-10#2)
was used as a working electrode in##2##7##(2008-10#2)
was used as a working electrode##3##6##(2008-10#3)
was used as a##65##4##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#42)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#1)
was used as amperometric##2##4##(2008-10#2)
was used as an amperometric##3##5##(2008-10#3)
was used as an indicator electrode##4##6##(2008-10#4)
was used as an indicator##5##5##(2008-10#4)(2008-7#1)
was used as an internal standard##7##6##(1993-3#1)(2008-10#6)
was used as an##28##4##(1993-3#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
was used as both supporting electrolyte and##2##7##(2008-10#2)
was used as chemical modifier##4##5##(2008-10#4)
was used as control##2##4##(2008-12#1)(2008-5#1)
was used as internal standard##3##5##(2008-10#3)
was used as internal##4##4##(2008-10#4)
was used as model##2##4##(2008-10#2)
was used as reference##2##4##(2008-1#1)(2012-3#1)
was used as template##2##4##(2008-10#1)(2008-9#1)
was used as the analytical##2##5##(2008-10#2)
was used as the chemical modifier##3##6##(2008-10#3)
was used as the indicator##2##5##(2008-10#2)
was used as the internal standard##2##6##(2008-10#2)
was used as the model##2##5##(2008-10#1)(2008-7#1)
was used as the##40##4##(1992-6#1)(2008-10#33)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)
was used as working electrode##2##5##(2008-10#2)
was used as##187##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#140)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2010-4#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
was used at##3##3##(2008-10#2)(2008-5#1)
was used by##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
was used for a##4##4##(2008-1#1)(2008-10#2)(2010-10#1)
was used for analysis##2##4##(2008-10#2)
was used for data analysis##2##5##(2008-10#1)(2010-11#1)
was used for data##5##4##(2008-10#1)(2008-11#1)(2010-11#1)(2013-1#1)(2013-8#1)
was used for detection##2##4##(2008-10#2)
was used for determination of##5##5##(2008-10#5)
was used for evaluating##2##4##(2008-10#2)
was used for evaluation of##2##5##(2008-7#2)
was used for fabrication of##2##5##(2008-10#1)(2008-3#1)
was used for genomic##2##4##(1995-12#1)(2008-10#1)
was used for identification##2##4##(2008-10#2)
was used for preconcentration of##2##5##(2008-10#2)
was used for quantification##2##4##(2008-10#1)(2008-11#1)
was used for statistical##2##4##(2008-10#1)(2012-3#1)
was used for the assay of##2##6##(2008-10#2)
was used for the determination of trace##3##7##(2008-10#3)
was used for the determination of##19##6##(2008-10#19)
was used for the electroanalytical determination of##2##7##(2008-10#2)
was used for the first time to##2##7##(2008-10#2)
was used for the immobilization of##2##6##(2008-10#2)
was used for the quantitative determination of##3##7##(2008-10#3)
was used for the quantitative##4##5##(2008-10#4)
was used for the simultaneous##2##5##(2008-10#2)
was used for the##73##4##(1993-2#1)(1996-5#1)(2008-10#65)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2010-9#1)
was used for this purpose##3##5##(2008-10#3)
was used for##186##3##(1991-6#1)(1992-1#1)(1993-2#1)(1994-11#1)(1995-12#2)(1995-9#1)(1996-1#2)(1996-5#1)(1997-2#2)(2008-1#1)(2008-10#136)(2008-11#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
was used here##2##3##(2008-10#2)
was used in a##5##4##(1996-12#1)(2008-10#2)(2008-2#1)(2008-5#1)
was used in conjunction with##3##5##(2008-10#2)(2008-3#1)
was used in determination of##2##5##(2008-10#2)
was used in order to determine##2##6##(2008-10#2)
was used in order to##6##5##(2008-10#4)(2008-12#1)(2008-7#1)
was used in the study##2##5##(1996-1#1)(2008-10#1)
was used in the##13##4##(1996-1#1)(2008-10#11)(2008-8#1)
was used in this study##2##5##(2008-10#1)(2008-8#1)
was used in this##3##4##(2008-10#2)(2008-8#1)
was used in##60##3##(1990-11#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-10#36)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#2)(2010-1#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
was used instead of##2##4##(1990-11#1)(2008-10#1)
was used on##3##3##(2008-10#1)(2009-5#1)(2013-8#1)
was used prior to##3##4##(1992-2#1)(2008-10#2)
was used successfully for the##2##5##(2008-10#2)
was used successfully for##3##4##(2008-10#2)(2008-2#1)
was used successfully##4##3##(2008-10#3)(2008-2#1)
was used to achieve##5##4##(2008-10#3)(2008-11#1)(2013-8#1)
was used to aid##2##4##(2008-11#1)(2008-7#1)
was used to amplify##4##4##(1991-7#1)(1992-6#1)(2008-10#2)
was used to analyze the##5##5##(1992-1#1)(2007-12#1)(2008-10#2)(2011-2#1)
was used to analyze##9##4##(1992-1#1)(2007-12#1)(2008-10#4)(2011-2#1)(2012-3#1)(2013-1#1)
was used to assay##2##4##(1996-12#1)(2008-11#1)
was used to assess the##8##5##(2008-10#5)(2008-7#1)(2009-10#1)(2011-2#1)
was used to assess##16##4##(1993-1#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
was used to calculate the##3##5##(2008-1#1)(2008-10#1)(2008-11#1)
was used to calculate##4##4##(2008-1#1)(2008-10#1)(2008-11#2)
was used to catalyze##2##4##(2008-7#1)(2009-6#1)
was used to characterise##2##4##(2008-10#1)(2008-5#1)
was used to characterize the interfacial##3##6##(2008-10#3)
was used to characterize the##4##5##(2008-10#4)
was used to characterize##7##4##(2008-10#6)(2012-2#1)
was used to collect the##2##5##(2008-10#1)(2008-9#1)
was used to collect##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
was used to compare the##3##5##(2008-7#1)(2008-9#1)(2010-6#1)
was used to compare##8##4##(1994-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#2)(2010-9#2)
was used to concentrate##2##4##(2008-10#2)
was used to confirm the##2##5##(2008-10#2)
was used to confirm##3##4##(2008-10#3)
was used to construct a recombinant##2##6##(1992-3#1)(2008-8#1)
was used to construct a##8##5##(1992-3#1)(1996-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)
was used to construct##9##4##(1992-3#1)(1996-6#1)(2008-10#3)(2008-5#1)(2008-8#2)(2011-1#1)
was used to control##2##4##(2008-10#1)(2012-2#1)
was used to demonstrate that##4##5##(1991-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
was used to demonstrate the##6##5##(1994-11#1)(2008-10#4)(2008-11#1)
was used to demonstrate##10##4##(1991-2#1)(1994-11#1)(2008-10#5)(2008-11#2)(2008-7#1)
was used to detect the##2##5##(2008-10#2)
was used to detect##12##4##(1996-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2009-3#1)
was used to determine the amount of##2##7##(2008-10#2)
was used to determine the concentration of##3##7##(1991-12#1)(2008-10#2)
was used to determine the spatial distribution of##2##8##(2008-10#2)
was used to determine the stoichiometry of##2##7##(1993-8#1)(1995-11#1)
was used to determine the##24##5##(1991-12#1)(1992-2#1)(1993-8#1)(1995-11#1)(2008-10#17)(2008-11#1)(2008-5#1)(2011-2#1)
was used to determine these##2##5##(2008-10#2)
was used to determine whether##3##5##(1993-8#1)(2008-10#1)(2013-8#1)
was used to determine##52##4##(1991-12#1)(1991-2#1)(1992-2#1)(1993-8#3)(1995-11#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#38)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
was used to develop a##4##5##(1990-12#1)(1994-5#1)(2008-10#2)
was used to develop an##5##5##(1993-3#1)(2008-10#4)
was used to develop the##3##5##(2008-10#3)
was used to develop##14##4##(1990-12#1)(1993-3#1)(1994-5#1)(2008-10#11)
was used to enhance the##3##5##(2008-10#3)
was used to establish##2##4##(2008-10#2)
was used to estimate the##8##5##(1995-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)
was used to estimate##13##4##(1995-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-8#2)(2011-2#1)
was used to evaluate the effects of##4##7##(1996-2#1)(1997-2#1)(2008-11#1)(2009-11#1)
was used to evaluate the##12##5##(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
was used to evaluate##16##4##(1991-3#1)(1994-12#1)(1996-2#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
was used to examine the##9##5##(1991-10#1)(1991-5#1)(1995-3#1)(2008-10#3)(2008-8#1)(2012-3#1)(2013-1#1)
was used to examine##16##4##(1991-10#1)(1991-5#1)(1995-3#1)(1996-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
was used to explore##2##4##(2008-1#1)(2008-11#1)
was used to extend the##2##5##(2008-10#1)(2009-3#1)
was used to extract##9##4##(2008-10#9)
was used to fabricate##2##4##(2008-10#1)(2013-1#1)
was used to find the##3##5##(2008-10#3)
was used to find##7##4##(2008-10#7)
was used to follow##3##4##(1990-11#1)(1996-12#1)(2008-10#1)
was used to generate##5##4##(2008-10#3)(2008-11#1)(2009-8#1)
was used to identify a##2##5##(2008-10#1)(2008-11#1)
was used to identify the##3##5##(2008-10#1)(2008-12#1)(2010-6#1)
was used to identify##23##4##(1990-11#1)(1995-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
was used to improve the##2##5##(2008-10#2)
was used to indicate##2##4##(1991-6#1)(2008-12#1)
was used to initiate##2##4##(2008-10#2)
was used to introduce##2##4##(1994-5#1)(2008-10#1)
was used to investigate the##8##5##(1990-2#1)(1994-5#1)(2008-10#2)(2008-8#2)(2008-9#1)(2010-6#1)
was used to investigate##11##4##(1990-2#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)(2010-6#1)
was used to isolate##3##4##(1994-8#1)(2008-10#2)
was used to map##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
was used to measure the##6##5##(1992-12#1)(2008-10#3)(2010-9#1)(2011-3#1)
was used to measure##20##4##(1990-2#1)(1992-12#1)(1992-3#1)(2008-10#6)(2008-11#1)(2008-3#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-3#1)(2013-1#2)
was used to model##3##4##(2008-10#1)(2008-3#1)(2010-6#1)
was used to modify##2##4##(1992-9#1)(2008-10#1)
was used to monitor the##8##5##(2008-10#7)(2008-11#1)
was used to monitor##15##4##(1991-5#1)(2008-10#11)(2008-11#1)(2008-7#1)(2010-5#1)
was used to observe the##3##5##(2008-10#3)
was used to observe##4##4##(1993-3#1)(2008-10#3)
was used to obtain the##4##5##(1993-8#1)(2008-10#2)(2013-8#1)
was used to obtain##9##4##(1993-8#1)(1994-3#1)(1994-5#1)(2008-10#5)(2013-8#1)
was used to optimize the##2##5##(2008-10#2)
was used to optimize##3##4##(2008-10#2)(2008-5#1)
was used to perform##4##4##(2008-10#2)(2013-1#1)(2013-8#1)
was used to predict##3##4##(1996-12#1)(2008-10#2)
was used to prepare a##2##5##(1990-11#1)(2008-10#1)
was used to prepare the##3##5##(2008-10#3)
was used to prepare##5##4##(1990-11#1)(2008-10#4)
was used to produce##2##4##(2008-11#2)
was used to provide##3##4##(1997-8#1)(2008-3#1)(2008-8#1)
was used to quantify the##2##5##(1990-7#1)(2008-11#1)
was used to quantify##6##4##(1990-7#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-12#1)
was used to recover##2##4##(2008-10#1)(2013-1#1)
was used to reduce the##2##5##(1995-12#1)(2008-10#1)
was used to relate##2##4##(2008-10#2)
was used to remove the##2##5##(2008-10#2)
was used to remove##4##4##(1990-12#1)(2008-10#3)
was used to screen##5##4##(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-8#1)
was used to select the number of factors##4##8##(2008-10#4)
was used to select the##8##5##(2008-10#7)(2008-11#1)
was used to select##11##4##(2008-10#9)(2008-11#1)(2012-12#1)
was used to separate##3##4##(1992-12#1)(2008-10#2)
was used to show that##3##5##(1991-3#1)(2008-10#2)
was used to study the##13##5##(1990-12#1)(1993-8#2)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)
was used to study##18##4##(1990-12#1)(1990-9#1)(1993-8#2)(1994-11#1)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#1)
was used to support##2##4##(2008-10#1)(2011-9#1)
was used to test the##6##5##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2013-1#1)
was used to test##10##4##(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2013-1#2)
was used to the determination of##2##6##(2008-10#2)
was used to the##4##4##(2008-10#4)
was used to transduce##2##4##(1992-12#1)(2008-8#1)
was used to transform##2##4##(1997-7#1)(2008-10#1)
was used to validate the##4##5##(2008-10#1)(2011-2#3)
was used to verify the##2##5##(2008-10#1)(2010-5#1)
was used to##549##3##(1990-11#3)(1990-12#3)(1990-2#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#2)(1993-8#6)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#1)(1996-12#4)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#4)(2007-12#2)(2008-1#3)(2008-10#289)(2008-11#33)(2008-12#6)(2008-2#1)(2008-3#7)(2008-5#8)(2008-7#11)(2008-8#16)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#6)(2010-9#4)(2011-1#3)(2011-2#8)(2011-3#1)(2011-9#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#16)(2013-8#9)
was used with##5##3##(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
was used##1157##2##(1990-11#6)(1990-12#5)(1990-2#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#4)(1991-6#2)(1991-7#2)(1992-1#4)(1992-12#6)(1992-2#4)(1992-3#2)(1992-6#4)(1992-9#3)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#6)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#6)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#3)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#2)(1997-2#6)(1997-7#3)(1997-8#7)(2006-6#2)(2007-12#2)(2007-8#1)(2008-1#6)(2008-10#682)(2008-11#55)(2008-12#10)(2008-2#7)(2008-3#14)(2008-5#19)(2008-7#27)(2008-8#24)(2008-9#15)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#6)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#1)(2010-8#1)(2010-9#6)(2011-1#3)(2011-2#15)(2011-3#5)(2011-9#1)(2012-12#6)(2012-2#8)(2012-3#9)(2013-1#30)(2013-8#15)
was used) was##2##3##(2008-10#1)(2008-3#1)
was useful for##5##3##(2008-10#5)
was useful in the##3##4##(1994-12#1)(2008-10#2)
was useful in##8##3##(1990-2#1)(1994-12#1)(2008-10#5)(2008-9#1)
was useful to##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
was useful##17##2##(1990-2#1)(1992-12#1)(1994-12#1)(2008-10#11)(2008-11#1)(2008-7#1)(2008-9#1)
was usually##2##2##(1991-6#1)(2008-7#1)
was utilised for##2##3##(2008-10#2)
was utilised in##2##3##(2008-10#1)(2008-11#1)
was utilised to##2##3##(2008-11#2)
was utilised##8##2##(1997-2#1)(2008-10#4)(2008-11#3)
was utilized as a##2##4##(2008-10#1)(2008-11#1)
was utilized for sample##2##4##(2008-10#2)
was utilized for##10##3##(2008-10#7)(2008-11#1)(2009-2#1)(2012-2#1)
was utilized in##4##3##(1991-3#1)(2008-10#1)(2010-10#1)(2012-2#1)
was utilized to assess##2##4##(1992-10#1)(1996-1#1)
was utilized to determine the##3##5##(2008-10#1)(2008-12#1)(2010-4#1)
was utilized to estimate the##2##5##(2008-11#1)(2010-3#1)
was utilized to map the##2##5##(1995-2#1)(2008-10#1)
was utilized to##20##3##(1990-2#1)(1992-10#1)(1992-12#1)(1992-6#1)(1995-2#1)(1996-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-9#1)(2010-3#1)(2010-4#1)
was utilized##40##2##(1990-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-2#2)
was validated by comparing the##2##5##(2008-10#2)
was validated by the analysis of##2##6##(2008-10#2)
was validated by the##3##4##(2008-10#3)
was validated by##18##3##(1996-3#1)(2008-10#16)(2013-8#1)
was validated in##4##3##(2008-10#2)(2012-2#2)
was validated using two##2##4##(2008-10#2)
was validated using##10##3##(1997-2#1)(2008-10#9)
was validated with a##3##4##(2008-10#3)
was validated with##8##3##(2008-10#7)(2008-11#1)
was validated##54##2##(1996-3#1)(1997-2#1)(2008-10#47)(2008-11#1)(2011-3#1)(2012-2#2)(2013-8#1)
was vaporized at##2##3##(1991-2#1)(2008-10#1)
was vaporized##3##2##(1991-2#1)(2008-10#2)
was variability##3##2##(1990-7#1)(2008-10#1)(2012-2#1)
was variable##7##2##(1997-8#1)(2008-10#4)(2008-12#1)(2011-2#1)
was varied by##2##3##(1992-6#1)(1994-11#1)
was varied from##2##3##(2008-10#1)(2008-7#1)
was varied in response to##2##5##(2008-10#2)
was varied##13##2##(1992-6#1)(1993-3#1)(1994-11#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#1)
was verified by the##5##4##(1990-5#1)(2008-10#4)
was verified by##18##3##(1990-5#1)(1990-6#1)(1992-3#1)(1993-9#1)(2008-10#14)
was verified in the##3##4##(2008-10#3)
was verified in##5##3##(2008-10#4)(2008-11#1)
was verified through##2##3##(2008-10#2)
was verified to##2##3##(2008-10#1)(2008-7#1)
was verified##38##2##(1990-5#1)(1990-6#1)(1992-3#1)(1993-9#1)(2008-10#29)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-3#1)
was very good##4##3##(1994-8#1)(2008-10#3)
was very high in##2##4##(2008-1#1)(2008-9#1)
was very high##7##3##(1995-5#1)(2008-1#1)(2008-10#4)(2008-9#1)
was very low##8##3##(1990-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2012-3#1)
was very similar to that of##3##6##(1991-7#1)(1993-2#1)(2008-6#1)
was very similar to that##4##5##(1991-7#1)(1993-2#1)(2008-6#1)(2008-7#1)
was very similar to##6##4##(1991-7#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
was very simple##3##3##(2008-10#3)
was very stable##2##3##(2008-10#2)
was very##63##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-8#1)(2008-1#4)(2008-10#26)(2008-11#5)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
was via##2##2##(2009-6#1)(2011-2#1)
was viewed##2##2##(2008-11#1)(2008-12#1)
was violated by##2##3##(1995-2#1)(2008-8#1)
was violated##3##2##(1995-12#1)(1995-2#1)(2008-8#1)
was virulent##2##2##(2008-10#2)
was visible in the##2##4##(2008-5#1)(2009-8#1)
was visible##5##2##(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)
was visualized in##2##3##(2008-10#1)(2008-9#1)
was visualized##8##2##(1992-8#1)(2008-10#4)(2008-9#3)
was washed##2##2##(1992-6#1)(2008-10#1)
was weak##7##2##(1993-8#1)(2008-10#3)(2008-3#1)(2008-8#2)
was weakly inhibited by##2##4##(1992-3#1)(2009-9#1)
was weakly##7##2##(1992-3#1)(2008-10#4)(2008-9#1)(2009-9#1)
was well described by a##4##5##(1995-8#1)(2008-10#3)
was well described by##5##4##(1995-8#1)(2008-10#4)
was well tolerated and##3##4##(2007-11#1)(2008-7#1)(2011-2#1)
was well tolerated by##2##4##(1992-12#1)(2007-8#1)
was well tolerated##10##3##(1990-6#1)(1992-12#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-3#1)
was well##23##2##(1990-2#1)(1990-6#1)(1992-12#2)(1994-8#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
was well-tolerated and##2##3##(2008-5#2)
was well-tolerated##4##2##(2008-5#4)
was whether##2##2##(1996-11#1)(1997-3#1)
was widely##4##2##(1992-2#1)(2008-10#1)(2008-11#2)
was widespread##2##2##(2008-10#2)
was with the##3##3##(2008-10#2)(2011-2#1)
was with##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
was within +/-20%##2##3##(2008-10#2)
was within the##2##3##(2008-3#1)(2010-11#1)
was within##12##2##(1996-5#1)(2008-10#9)(2008-3#1)(2010-11#1)
was without effect on##2##4##(1991-6#1)(1995-8#1)
was without effect##4##3##(1991-6#1)(1995-8#1)(1996-2#1)(1997-1#1)
was worked out##2##3##(1990-2#1)(2008-11#1)
was wrapped##2##2##(2008-7#1)(2010-3#1)
was written##6##2##(1994-3#2)(1996-5#1)(2008-10#1)(2011-2#1)(2013-8#1)
was##29160##1##(1990-10#12)(1990-11#61)(1990-12#122)(1990-2#116)(1990-3#49)(1990-4#1)(1990-5#157)(1990-6#81)(1990-7#5)(1990-8#86)(1990-9#43)(1991-1#23)(1991-10#19)(1991-11#47)(1991-12#105)(1991-2#107)(1991-3#85)(1991-4#1)(1991-5#111)(1991-6#89)(1991-7#23)(1991-8#79)(1991-9#46)(1992-1#34)(1992-10#16)(1992-11#7)(1992-12#115)(1992-2#74)(1992-3#121)(1992-4#12)(1992-5#18)(1992-6#89)(1992-7#3)(1992-8#23)(1992-9#34)(1993-1#74)(1993-11#47)(1993-12#104)(1993-2#85)(1993-3#105)(1993-6#113)(1993-8#159)(1993-9#33)(1994-1#30)(1994-11#153)(1994-12#90)(1994-2#87)(1994-3#89)(1994-5#91)(1994-6#43)(1994-8#141)(1994-9#22)(1995-1#15)(1995-10#2)(1995-11#108)(1995-12#146)(1995-2#125)(1995-3#42)(1995-5#29)(1995-6#126)(1995-8#110)(1995-9#13)(1996-1#51)(1996-11#21)(1996-12#212)(1996-2#127)(1996-3#81)(1996-5#61)(1996-6#71)(1996-8#30)(1996-9#15)(1997-1#93)(1997-2#131)(1997-3#150)(1997-4#37)(1997-5#27)(1997-6#45)(1997-7#68)(1997-8#185)(1997-9#10)(2006-6#20)(2007-11#28)(2007-12#79)(2007-8#37)(2007-9#5)(2008-1#82)(2008-10#12846)(2008-11#1719)(2008-12#572)(2008-2#63)(2008-3#241)(2008-4#24)(2008-5#638)(2008-6#97)(2008-7#729)(2008-8#647)(2008-9#626)(2009-1#35)(2009-10#57)(2009-11#42)(2009-12#36)(2009-2#16)(2009-3#90)(2009-4#25)(2009-5#34)(2009-6#43)(2009-7#88)(2009-8#87)(2009-9#27)(2010-1#80)(2010-10#75)(2010-11#81)(2010-12#104)(2010-2#27)(2010-3#59)(2010-4#88)(2010-5#77)(2010-6#91)(2010-7#96)(2010-8#106)(2010-9#37)(2011-1#145)(2011-10#7)(2011-2#1023)(2011-3#102)(2011-4#5)(2011-7#7)(2011-9#6)(2012-12#205)(2012-2#384)(2012-3#449)(2012-4#4)(2012-5#16)(2012-6#10)(2012-7#5)(2012-8#5)(2012-9#4)(2013-1#835)(2013-3#4)(2013-7#30)(2013-8#349)
wasenhanced##2##1##(2008-11#2)
wash##10##1##(2008-10#4)(2008-11#1)(2008-5#4)(2009-3#1)
washed and##4##2##(1992-6#1)(2008-10#3)
washed free of##2##3##(2008-10#2)
washed off##2##2##(2008-10#1)(2008-11#1)
washed roots##3##2##(2008-10#3)
washed with water##2##3##(2008-10#2)
washed with##4##2##(2008-10#3)(2008-8#1)
washed##33##1##(1992-2#1)(1992-6#1)(1995-11#1)(1996-2#2)(1996-3#1)(2008-10#19)(2008-11#1)(2008-8#4)(2009-3#1)(2011-1#1)(2011-2#1)
washes##9##1##(1993-6#1)(1994-11#2)(2008-10#3)(2008-11#1)(2008-9#1)(2013-1#1)
washing and##6##2##(2008-10#3)(2008-5#1)(2008-7#1)(2013-1#1)
washing for##2##2##(1991-3#1)(2013-8#1)
washing of the##2##3##(2008-10#1)(2008-7#1)
washing of##4##2##(1993-3#1)(2008-10#2)(2008-7#1)
washing powders##2##2##(2008-10#2)
washing step##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
washing the##6##2##(2008-10#5)(2008-5#1)
washing with water##2##3##(2008-10#2)
washing with##5##2##(2008-10#5)
washing##48##1##(1990-3#1)(1991-3#1)(1993-3#1)(1994-6#1)(1997-2#1)(2008-10#31)(2008-11#1)(2008-5#7)(2008-7#2)(2013-1#1)(2013-8#1)
washings##5##1##(1990-2#1)(2008-10#2)(2008-5#1)(2010-12#1)
washington state##2##2##(2008-10#2)
washington##3##1##(2008-10#3)
washout period##2##2##(1990-11#1)(1994-2#1)
washout solution##2##2##(2008-11#2)
washout##8##1##(1990-11#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#2)(2010-12#1)
wasn't##5##1##(1990-6#1)(1993-12#1)(1995-12#1)(1997-3#1)(2012-2#1)
wasobtained##2##1##(2008-11#2)
wasp Cotesia##2##2##(1990-11#1)(2008-8#1)
wasp size##2##2##(2008-9#2)
wasp##13##1##(1990-11#1)(1992-6#1)(2008-10#2)(2008-8#2)(2008-9#5)(2010-4#1)(2013-8#1)
wasperformed##2##1##(2009-8#1)(2013-8#1)
wasps##13##1##(1990-11#1)(2007-12#2)(2008-10#4)(2008-8#2)(2008-9#4)
wasshown to be##2##3##(2008-11#2)
wasshown##3##1##(2008-11#3)
wastage of##2##2##(1996-9#1)(2008-10#1)
wastage##4##1##(1996-9#3)(2008-10#1)
waste and##3##2##(2008-10#2)(2011-2#1)
waste compost##2##2##(2008-10#2)
waste disposal##3##2##(2008-12#3)
waste effluent##2##2##(2008-10#2)
waste from##2##2##(1997-2#1)(2013-1#1)
waste generation##13##2##(2008-10#13)
waste management system in Mashad##2##5##(2008-12#2)
waste management##6##2##(2008-10#1)(2008-12#4)(2009-12#1)
waste materials##2##2##(2008-10#2)
waste of##3##2##(1994-2#1)(2012-2#1)(2013-8#1)
waste plastics##3##2##(2008-10#3)
waste polymers##4##2##(2008-10#4)
waste production##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
waste products##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
waste samples##3##2##(2008-10#3)
waste solution##2##2##(2008-10#2)
waste streams and##2##3##(2008-10#1)(2008-11#1)
waste water and##5##3##(2008-10#5)
waste water by##2##3##(2008-10#2)
waste water samples##6##3##(2008-10#6)
waste water##30##2##(2008-10#30)
waste waters and##2##3##(2008-10#2)
waste waters##14##2##(2008-10#14)
waste##162##1##(1990-3#1)(1993-1#1)(1993-11#1)(1994-2#2)(1997-2#2)(1997-3#1)(2008-10#123)(2008-11#5)(2008-12#12)(2008-9#2)(2009-12#1)(2011-2#3)(2012-2#4)(2013-1#3)(2013-8#1)
waste-water##6##1##(2008-10#6)
wastes and the##2##3##(2008-10#2)
wastes and##6##2##(1991-7#1)(2008-10#5)
wastes by##2##2##(2008-10#2)
wastes in the process of endovascular stent procurement in interventional radiology##2##11##(2012-2#2)
wastes##36##1##(1991-7#1)(1992-3#1)(2008-10#28)(2008-12#2)(2008-7#1)(2012-2#3)
wastewater and##5##2##(2008-10#5)
wastewater from a##2##3##(2008-10#2)
wastewater from an electroplating plant##2##5##(2008-10#2)
wastewater from an##3##3##(2008-10#3)
wastewater from##6##2##(2008-10#6)
wastewater of##2##2##(2008-10#1)(2012-2#1)
wastewater quality##4##2##(2008-10#4)
wastewater samples from##2##3##(2008-10#2)
wastewater samples with##3##3##(2008-10#3)
wastewater samples##19##2##(2008-10#19)
wastewater toxicity assessment##3##3##(2008-10#3)
wastewater treatment plant (WWTP)##3##4##(2008-10#3)
wastewater treatment plant##5##3##(2008-10#3)(2008-12#2)
wastewater treatment plants##3##3##(2008-10#3)
wastewater treatment##12##2##(2008-10#8)(2008-12#2)(2008-7#1)(2009-4#1)
wastewater was##2##2##(2008-10#2)
wastewater##90##1##(2008-10#81)(2008-12#5)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
wastewater)##3##1##(2008-10#3)
wastewaters##12##1##(2008-10#11)(2008-7#1)
wasting##5##1##(1994-9#1)(1997-3#1)(2009-12#1)(2010-6#1)(2010-8#1)
watch##7##1##(1993-1#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)
watching##5##1##(2008-11#1)(2010-10#1)(2010-6#1)(2010-8#1)(2012-12#1)
water (0##3##2##(2008-10#3)
water (EC =##3##3##(2008-10#3)
water (pH##4##2##(2008-10#4)
water absorption capacity##2##3##(2008-5#2)
water absorption##3##2##(2008-3#1)(2008-5#2)
water activities##2##2##(2008-7#2)
water activity (a(w))##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
water activity##9##2##(1994-3#1)(2008-10#2)(2008-5#1)(2008-7#5)
water addition##2##2##(2008-10#2)
water after preconcentration of##2##4##(2008-10#2)
water after preconcentration##3##3##(2008-10#3)
water after##7##2##(2008-10#7)
water agar##10##2##(2008-10#10)
water analysis and##2##3##(2008-10#2)
water analysis##14##2##(2008-10#14)
water and 0##2##3##(1993-2#1)(2008-10#1)
water and a phosphate buffer##2##5##(2008-10#2)
water and a##4##3##(2008-10#4)
water and acetonitrile##3##3##(2008-10#3)
water and acid extracts from coal##2##6##(2008-10#2)
water and alloy samples##2##4##(2008-10#2)
water and also##3##3##(2008-10#3)
water and biological##3##3##(2008-10#3)
water and estimated##2##3##(2008-10#2)
water and fruit juice##4##4##(2008-10#4)
water and fumonisin-producing fungus added##2##5##(2013-1#2)
water and in##8##3##(1992-12#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
water and mineral water samples##2##5##(2008-10#2)
water and natural##3##3##(2008-10#2)(2008-11#1)
water and other##2##3##(2008-10#2)
water and river water##4##4##(2008-10#4)
water and river##5##3##(2008-10#5)
water and sediment##3##3##(2008-10#3)
water and soil##2##3##(2008-10#2)
water and some##3##3##(2008-10#3)
water and stream sediment##2##4##(2008-10#2)
water and synthetic##2##3##(2008-10#2)
water and tap water##3##4##(2008-10#3)
water and the##7##3##(2008-10#6)(2010-8#1)
water and urine##2##3##(2008-10#2)
water and vegetable samples##4##4##(2008-10#4)
water and very##2##3##(2008-10#1)(2012-12#1)
water and wastewater samples##4##4##(2008-10#4)
water and wastewater##6##3##(2008-10#6)
water and well water##2##4##(2008-10#2)
water and##188##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#154)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
water are##9##2##(2008-10#6)(2008-2#1)(2008-3#1)(2011-2#1)
water as a##7##3##(2008-10#4)(2008-7#1)(2008-9#1)(2011-2#1)
water as solvent##3##3##(2008-10#1)(2012-2#2)
water as##19##2##(1991-6#1)(2008-10#13)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)
water at the##3##3##(2008-10#3)
water at##14##2##(1992-9#1)(2008-10#10)(2008-12#1)(2011-2#1)(2013-8#1)
water availability##4##2##(2008-10#1)(2011-2#1)(2012-5#1)(2012-8#1)
water barrier##3##2##(2008-5#3)
water bath##6##2##(2008-10#5)(2008-9#1)
water before##2##2##(2008-11#1)(2011-2#1)
water body##2##2##(2008-10#1)(2013-1#1)
water but##3##2##(2008-10#3)
water by a##2##3##(2008-10#2)
water by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
water by graphite furnace atomic absorption spectrometry##3##7##(2008-10#3)
water by inductively coupled##2##4##(2008-10#2)
water by using##3##3##(2008-10#2)(2011-2#1)
water by##49##2##(1995-3#1)(2008-10#47)(2011-2#1)
water can be##4##3##(2008-10#4)
water can##6##2##(2008-10#6)
water column##5##2##(2008-2#1)(2008-3#1)(2008-8#2)(2012-2#1)
water compared##2##2##(2008-10#2)
water conservation##3##2##(2008-9#3)
water containing 0##9##3##(2008-10#3)(2008-9#6)
water containing##19##2##(2008-10#10)(2008-11#1)(2008-5#1)(2008-9#7)
water content and##3##3##(2008-10#1)(2008-5#1)(2012-7#1)
water content determination##3##3##(2008-10#3)
water content in the SC##2##5##(2008-5#2)
water content in the##4##4##(2008-10#2)(2008-5#2)
water content in##7##3##(2008-10#3)(2008-12#2)(2008-5#2)
water content is##3##3##(2008-10#3)
water content of the##3##4##(2008-10#1)(2008-5#1)(2009-6#1)
water content of##6##3##(2008-10#2)(2008-5#1)(2009-6#1)(2012-8#1)(2013-1#1)
water content was##2##3##(2008-10#2)
water content##47##2##(2008-10#23)(2008-12#2)(2008-5#9)(2009-6#3)(2009-9#2)(2012-12#2)(2012-2#1)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#1)
water correlated strongly with##2##4##(1993-2#2)
water correlated##3##2##(1993-2#2)(2008-10#1)
water deficit##5##2##(2009-8#4)(2012-5#1)
water depth on##2##3##(2008-10#2)
water depth##4##2##(2008-10#2)(2009-11#2)
water determination##2##2##(1993-2#2)
water diffusion across the##2##4##(1991-5#2)
water disinfection##4##2##(2008-10#2)(2008-9#2)
water droplet##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
water droplets##3##2##(2008-10#1)(2008-3#2)
water during##3##2##(1996-6#1)(2008-10#2)
water eluent##3##2##(2008-10#3)
water environment##2##2##(2008-10#1)(2008-9#1)
water extract##9##2##(2008-10#8)(2009-6#1)
water extraction and##3##3##(2008-10#3)
water extraction##11##2##(2008-10#11)
water extracts of propolis##3##4##(2008-11#3)
water extracts of##4##3##(2008-10#1)(2008-11#3)
water extracts##7##2##(2008-10#4)(2008-11#3)
water for the##4##3##(2008-10#3)(2008-7#1)
water for##22##2##(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#6)(2013-1#1)
water fraction##5##2##(2008-10#5)
water from a##2##3##(2008-10#2)
water from the##7##3##(1992-5#1)(1997-2#1)(2008-10#4)(2011-2#1)
water from##13##2##(1992-5#1)(1997-2#1)(2008-10#9)(2011-2#2)
water has been developed##5##4##(2008-10#5)
water has been##12##3##(2008-10#11)(2008-7#1)
water has##14##2##(2008-10#12)(2008-3#1)(2008-7#1)
water have been##7##3##(1992-9#1)(2008-10#5)(2012-5#1)
water have##8##2##(1992-9#1)(2008-10#5)(2008-7#1)(2012-5#1)
water holding capacity##2##3##(2010-4#1)(2013-1#1)
water immersion##3##2##(2008-5#3)
water in the presence of##2##5##(2008-10#2)
water in the##11##3##(2008-10#9)(2008-7#2)
water in##38##2##(1992-9#1)(1996-2#1)(2008-10#26)(2008-11#3)(2008-7#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
water insoluble##2##2##(2008-10#1)(2008-5#1)
water into##5##2##(2008-10#4)(2008-7#1)
water is described##3##3##(2008-10#3)
water is proposed##2##3##(2008-10#2)
water is reported##2##3##(2008-10#2)
water is##28##2##(2008-10#25)(2008-11#1)(2008-2#1)(2008-5#1)
water loss (TEWL) and##3##4##(2008-5#3)
water loss (TEWL)##5##3##(2008-5#5)
water loss from##2##3##(2008-10#1)(2008-5#1)
water loss##11##2##(2008-10#2)(2008-5#9)
water matrices##2##2##(2008-10#2)
water matrix##3##2##(2008-10#3)
water may be performed##2##4##(2008-10#1)(2008-5#1)
water may##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
water maze task##3##3##(1994-3#3)
water maze##11##2##(1993-3#1)(1994-3#5)(1994-8#1)(2008-12#3)(2011-2#1)
water medium##4##2##(2008-10#3)(2008-3#1)
water miscible##3##2##(2008-10#3)
water mist##3##2##(1991-2#3)
water mobile phase was##2##4##(2008-10#2)
water mobile phase##9##3##(2008-10#9)
water molecule##2##2##(1992-12#1)(2008-8#1)
water molecules##18##2##(1991-3#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-8#1)(1994-5#1)(2008-10#8)(2008-8#1)(2008-9#1)(2010-12#1)
water movement##2##2##(2008-10#2)
water near##2##2##(1992-9#1)(2008-3#1)
water of##9##2##(1991-11#2)(2008-10#7)
water on##5##2##(1996-5#1)(2008-10#3)(2009-1#1)
water or in##3##3##(1994-8#1)(2008-10#2)
water or##16##2##(1994-3#1)(1994-8#1)(1995-11#1)(2008-10#9)(2008-9#1)(2009-7#1)(2010-1#1)(2013-1#1)
water permeability##3##2##(1991-5#1)(1995-6#1)(2008-7#1)
water phase##4##2##(1991-5#1)(2008-10#2)(2008-5#1)
water potential##6##2##(2008-10#5)(2012-7#1)
water potentials##3##2##(2008-10#2)(2008-12#1)
water quality##11##2##(2008-10#10)(2013-1#1)
water reference##2##2##(1993-2#1)(2008-10#1)
water regain##3##2##(2008-10#3)
water relations and##2##3##(2009-8#2)
water resistance##3##2##(2008-5#3)
water resources##4##2##(2008-10#2)(2008-12#2)
water sample and##3##3##(2008-10#3)
water sample by##2##3##(2008-10#2)
water sample containing##2##3##(2008-10#2)
water sample is##3##3##(2008-10#2)(2008-3#1)
water sample##41##2##(2008-10#39)(2008-3#1)(2012-2#1)
water sample)##2##2##(2008-10#2)
water samples (0##2##3##(2008-10#2)
water samples (relative standard deviation (R##2##6##(2008-10#2)
water samples (tap##3##3##(2008-10#3)
water samples after preconcentration of##2##5##(2008-10#2)
water samples after##6##3##(2008-10#6)
water samples and##20##3##(2008-10#20)
water samples are##4##3##(2008-10#4)
water samples as##2##3##(2008-10#1)(2008-11#1)
water samples at##4##3##(2008-10#4)
water samples by electrothermal##2##4##(2008-10#2)
water samples by flame atomic absorption spectrometry##2##7##(2008-10#2)
water samples by flame##3##4##(2008-10#3)
water samples by flow##2##4##(2008-10#2)
water samples by solid phase##2##5##(2008-10#2)
water samples by using##4##4##(2008-10#4)
water samples by##31##3##(2008-10#31)
water samples can be##2##4##(2008-10#2)
water samples collected from##2##4##(2008-10#2)
water samples collected##3##3##(2008-10#3)
water samples containing##5##3##(2008-10#5)
water samples for##2##3##(2008-10#2)
water samples from##8##3##(2008-10#8)
water samples has been developed##3##5##(2008-10#3)
water samples has been##5##4##(2008-10#5)
water samples have been##2##4##(2008-10#2)
water samples in##5##3##(2008-10#5)
water samples is described##4##4##(2008-10#4)
water samples is presented##2##4##(2008-10#2)
water samples is successful##2##4##(2008-10#2)
water samples is##14##3##(2008-10#14)
water samples obtained from##2##4##(2008-10#2)
water samples of##3##3##(2008-10#3)
water samples on the##2##4##(2008-10#2)
water samples on##3##3##(2008-10#3)
water samples spiked with##4##4##(2008-10#4)
water samples using a##2##4##(2008-10#2)
water samples using##14##3##(2008-10#14)
water samples was also##3##4##(2008-10#3)
water samples was##16##3##(2008-10#16)
water samples were analyzed##3##4##(2008-10#3)
water samples were demonstrated##2##4##(2008-10#2)
water samples were##17##3##(2008-10#16)(2008-11#1)
water samples when##2##3##(2008-10#2)
water samples with a##5##4##(2008-10#5)
water samples with satisfactory results##7##5##(2008-10#7)
water samples with##19##3##(2008-10#19)
water samples##389##2##(2008-10#386)(2008-11#2)(2012-2#1)
water solubility of##2##3##(1994-8#1)(2008-10#1)
water solubility##4##2##(1994-8#1)(2008-10#2)(2008-5#1)
water soluble polymer##3##3##(2008-10#3)
water soluble##10##2##(1990-11#1)(2008-10#7)(2008-3#1)(2009-7#1)
water solution is##2##3##(2008-10#1)(2008-3#1)
water solution##11##2##(1991-5#1)(1995-2#1)(2008-10#6)(2008-12#2)(2008-3#1)
water solutions of##2##3##(2008-10#2)
water solutions##5##2##(2008-10#5)
water sorption and solubility##2##4##(2013-1#2)
water sorption and##3##3##(2008-5#1)(2013-1#2)
water sorption##4##2##(2008-5#2)(2013-1#2)
water sources##5##2##(2008-10#5)
water spiked with##4##3##(2008-10#4)
water spiked##5##2##(2008-10#5)
water stream##4##2##(2008-10#4)
water stress in##2##3##(2008-8#1)(2012-7#1)
water stress##20##2##(2008-10#6)(2008-12#3)(2008-8#3)(2009-8#3)(2012-7#5)
water stress-induced ABA accumulation##4##4##(2008-8#4)
water studies)##4##2##(2008-9#4)
water supplies##5##2##(1996-6#3)(2008-10#1)(2008-9#1)
water supply##4##2##(2008-10#1)(2008-11#1)(2011-2#2)
water surface##5##2##(1990-11#1)(2008-10#1)(2008-5#2)(2008-9#1)
water suspensions##2##2##(2008-10#2)
water system##2##2##(2008-10#1)(2008-9#1)
water systems##5##2##(2008-10#3)(2010-4#1)(2012-2#1)
water tank##2##2##(2011-2#2)
water temperature##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)
water than##4##2##(1993-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
water that must be##2##4##(2008-5#2)
water that##5##2##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
water through##2##2##(2008-10#1)(2011-2#1)
water to the##3##3##(2008-10#3)
water to##10##2##(2008-10#9)(2008-9#1)
water toxicity##4##2##(2008-10#4)
water transport##4##2##(2007-12#1)(2008-10#2)(2009-8#1)
water treatment facilities##2##3##(2008-10#1)(2013-1#1)
water treatment##8##2##(1992-5#1)(2008-10#6)(2013-1#1)
water types##3##2##(2008-10#2)(2008-3#1)
water use##2##2##(2009-6#1)(2011-2#1)
water used##4##2##(2008-10#4)
water using a##2##3##(2008-10#2)
water using##15##2##(2008-10#14)(2008-3#1)
water vapor are presented##2##4##(2008-3#2)
water vapor##16##2##(1991-5#3)(1997-1#1)(2008-10#2)(2008-3#9)(2013-8#1)
water was developed##2##3##(2008-10#2)
water was found to be##2##5##(1993-2#1)(2008-10#1)
water was studied##2##3##(2008-10#2)
water was used as##3##4##(2008-1#1)(2008-12#1)(2008-5#1)
water was##25##2##(1990-5#1)(1991-2#1)(1993-2#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#2)(2010-8#2)(2012-2#1)
water were##17##2##(2008-10#15)(2008-2#1)(2008-5#1)
water with a##4##3##(2008-10#4)
water with low##2##3##(2008-10#2)
water with satisfactory results##8##4##(2008-10#8)
water with##26##2##(2008-10#24)(2008-5#2)
water##2120##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#2)(1991-11#6)(1991-2#6)(1991-3#2)(1991-5#13)(1991-6#3)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#2)(1992-5#3)(1992-9#8)(1993-11#1)(1993-2#18)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#10)(1994-5#1)(1994-8#8)(1994-9#1)(1995-11#4)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#4)(1997-1#2)(1997-2#3)(1997-3#1)(2007-12#6)(2008-1#1)(2008-10#1548)(2008-11#44)(2008-12#20)(2008-2#10)(2008-3#48)(2008-4#1)(2008-5#81)(2008-6#1)(2008-7#22)(2008-8#18)(2008-9#49)(2009-1#1)(2009-11#2)(2009-5#2)(2009-6#7)(2009-7#6)(2009-8#13)(2009-9#2)(2010-1#2)(2010-12#1)(2010-4#5)(2010-7#1)(2010-8#6)(2011-2#26)(2011-3#1)(2012-12#5)(2012-2#13)(2012-3#2)(2012-5#7)(2012-6#1)(2012-7#9)(2012-8#3)(2012-9#2)(2013-1#21)(2013-7#1)(2013-8#5)
water) and##3##2##(1991-5#1)(2008-10#2)
water) was##2##2##(2008-10#2)
water)##26##1##(1991-5#1)(1994-9#1)(1996-12#1)(1996-2#1)(2008-10#20)(2008-5#1)(2012-3#1)
water-##3##1##(2008-10#3)
water-accessible##2##1##(1991-11#1)(1992-4#1)
water-based##2##1##(2008-10#1)(2013-1#1)
water-containing##2##1##(2008-10#1)(2013-8#1)
water-cooled##2##1##(2008-10#1)(2008-3#1)
water-ethanol##2##1##(2008-10#2)
water-in-oil emulsion##3##2##(2008-10#2)(2012-2#1)
water-in-oil microemulsion##3##2##(2008-10#1)(2008-5#2)
water-in-oil##6##1##(2008-10#3)(2008-5#2)(2012-2#1)
water-insoluble##4##1##(2008-10#4)
water-leaving radiance##3##2##(2008-2#1)(2008-3#2)
water-leaving##4##1##(2008-2#1)(2008-3#3)
water-maze task##3##2##(1994-8#3)
water-maze##5##1##(1993-3#1)(1994-8#3)(2008-7#1)
water-microemulsion-oil systems##2##2##(2008-10#2)
water-only##2##1##(2008-10#2)
water-soaked lesions on##2##3##(2008-10#2)
water-soaked##5##1##(2008-10#5)
water-soaking##2##1##(2008-10#2)
water-soluble antioxidant##2##2##(1992-9#1)(2008-10#1)
water-soluble fraction##5##2##(2008-11#5)
water-soluble organic compounds##2##3##(2008-10#2)
water-soluble organic##5##2##(2008-10#5)
water-soluble polymer##5##2##(2008-10#2)(2008-7#2)(2012-2#1)
water-soluble polymers##3##2##(2008-10#3)
water-soluble porphyrin##2##2##(2008-10#2)
water-soluble tertiary amines##2##3##(2008-10#2)
water-soluble vitamins excreted in human urine##2##6##(2008-10#2)
water-soluble vitamins excreted in##3##4##(2008-10#3)
water-soluble vitamins##9##2##(2008-10#9)
water-soluble##67##1##(1990-8#1)(1991-3#2)(1991-5#2)(1992-7#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-2#1)(2008-10#39)(2008-11#6)(2008-5#2)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#3)(2013-1#1)
water-temperature sensors##2##2##(2008-3#2)
water-treated##3##1##(2008-10#3)
water-vapor concentration##2##2##(2008-3#2)
water-vapor measurements##3##2##(2008-3#3)
water-vapor mixing##4##2##(2008-3#4)
water-vapor##20##1##(2007-12#1)(2008-2#3)(2008-3#16)
water/acetonitrile##2##1##(2008-10#2)
water/methanol##2##1##(2008-10#2)
waterborne##4##1##(1996-6#1)(2008-10#3)
watered##3##1##(2008-10#3)
watermelon and##3##2##(2008-10#3)
watermelon blossoms##2##2##(2008-10#2)
watermelon cultivars##3##2##(2008-10#3)
watermelon fruit##2##2##(2008-10#2)
watermelon plants##2##2##(2008-10#2)
watermelon silver mottle virus##2##4##(2008-10#2)
watermelon##30##1##(2008-10#30)
waters and the##2##3##(2008-10#2)
waters and##33##2##(2008-10#31)(2008-3#2)
waters are##3##2##(2008-10#2)(2008-9#1)
waters as well as in##2##5##(2008-10#1)(2008-12#1)
waters as well as##3##4##(2008-10#2)(2008-12#1)
waters based on##3##3##(2008-10#2)(2008-3#1)
waters by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
waters by electrothermal##3##3##(2008-10#3)
waters by the##4##3##(2008-10#4)
waters by use of##2##4##(2008-10#1)(2008-3#1)
waters by##27##2##(2008-10#26)(2008-3#1)
waters can be##2##3##(2008-10#1)(2008-3#1)
waters containing##3##2##(2008-10#3)
waters from##3##2##(2008-10#3)
waters has been determined##2##4##(2008-10#2)
waters has been##3##3##(2008-10#3)
waters in##2##2##(2008-10#2)
waters is described##4##3##(2008-10#4)
waters is proposed##2##3##(2008-10#2)
waters is##8##2##(2008-10#8)
waters of the##4##3##(2008-10#3)(2010-5#1)
waters of##8##2##(1990-11#1)(1997-1#1)(2008-10#5)(2010-5#1)
waters samples##4##2##(2008-10#4)
waters to##2##2##(2008-10#2)
waters using a##3##3##(2008-10#3)
waters using##14##2##(2008-10#13)(2010-4#1)
waters was also##2##3##(2008-10#2)
waters were determined##2##3##(2008-10#2)
waters were##6##2##(2008-10#6)
waters with the##2##3##(2008-10#2)
waters with##13##2##(2008-10#11)(2008-3#1)(2010-8#1)
waters without##2##2##(2008-10#2)
waters##277##1##(1990-11#1)(1994-11#1)(1997-1#1)(2008-10#252)(2008-11#1)(2008-12#3)(2008-3#13)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)
waters)##5##1##(2008-10#5)
watershed management##2##2##(2008-10#2)
watershed##4##1##(2008-10#3)(2008-9#1)
watertight dural closure##2##3##(2012-3#1)(2013-8#1)
watertight##4##1##(2012-3#2)(2013-8#2)
watery##3##1##(1993-8#1)(2011-1#1)(2012-3#1)
wave UV-light##2##2##(1991-6#2)
wave activity##3##2##(1991-2#1)(2008-3#1)(2008-7#1)
wave adsorptive stripping voltammetric##2##4##(2008-10#2)
wave adsorptive stripping##9##3##(2008-10#9)
wave analysis##2##2##(2009-5#1)(2013-8#1)
wave and##10##2##(1990-8#1)(2008-10#4)(2008-3#3)(2010-1#2)
wave at -0##2##3##(2008-10#2)
wave at##4##2##(2008-10#4)
wave biosensors##2##2##(2009-3#2)
wave blocking##2##2##(2009-8#2)
wave by##4##2##(2007-12#1)(2008-10#1)(2009-10#2)
wave condition##2##2##(2008-3#2)
wave front##3##2##(2008-3#3)
wave in a##2##3##(2008-3#2)
wave in the##3##3##(1996-3#1)(2008-3#2)
wave in##7##2##(1996-3#1)(2008-11#1)(2008-3#5)
wave is##2##2##(2008-10#2)
wave mode##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
wave of##8##2##(1991-12#1)(1995-11#1)(2008-10#4)(2010-5#1)(2012-2#1)
wave pattern##3##2##(2011-2#3)
wave theory##2##2##(2008-2#1)(2008-3#1)
wave velocity##2##2##(2013-3#1)(2013-7#1)
wave voltammetry##30##2##(2008-10#28)(2008-8#2)
wave was##5##2##(1995-11#1)(2008-10#3)(2008-11#1)
wave were##2##2##(2008-5#1)(2011-2#1)
wave##253##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-1#2)(1993-3#1)(1993-5#1)(1994-8#2)(1995-11#2)(1995-3#1)(1996-1#3)(1996-11#1)(1996-3#1)(1996-6#4)(1997-6#2)(2007-12#7)(2008-1#1)(2008-10#123)(2008-11#8)(2008-2#5)(2008-3#32)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#4)(2009-3#5)(2009-5#2)(2009-8#3)(2010-1#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#1)(2013-3#1)(2013-7#1)(2013-8#1)
wave-front tilt##2##2##(2008-3#2)
wave-front##6##1##(2008-3#6)
wave-guiding layer##2##2##(2008-10#2)
waveband##4##1##(2008-10#1)(2013-8#3)
wavebands##2##1##(2008-10#2)
waveform and##3##2##(2008-10#2)(2010-1#1)
waveform of##2##2##(1994-2#1)(2008-10#1)
waveform was##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
waveform##23##1##(1992-12#3)(1994-2#1)(2008-10#12)(2008-11#1)(2008-2#3)(2010-1#2)(2010-8#1)
waveforms are##3##2##(2008-2#2)(2008-3#1)
waveforms##10##1##(2008-10#1)(2008-2#3)(2008-3#2)(2013-1#4)
waveguide (LCW)##4##2##(2008-10#4)
waveguide and the##2##3##(2007-12#1)(2008-2#1)
waveguide and##3##2##(2007-12#2)(2008-2#1)
waveguide capillary##3##2##(2008-10#3)
waveguide delivery##2##2##(2008-3#1)(2008-7#1)
waveguide gratings##7##2##(2008-3#7)
waveguide is##2##2##(2008-10#1)(2008-3#1)
waveguide laser##4##2##(2008-3#4)
waveguide made of##2##3##(2008-10#2)
waveguide mode##2##2##(2008-10#2)
waveguide that##2##2##(2007-12#1)(2008-3#1)
waveguide was##2##2##(2008-10#2)
waveguide##99##1##(1992-3#1)(1992-8#1)(2007-11#2)(2007-12#10)(2008-10#45)(2008-2#9)(2008-3#30)(2008-7#1)
waveguides and##3##2##(2007-12#2)(2008-3#1)
waveguides are##2##2##(2007-12#2)
waveguides by##3##2##(2008-10#1)(2008-3#2)
waveguides for##2##2##(2008-10#1)(2008-2#1)
waveguides with discrete translational symmetry##2##5##(2007-12#2)
waveguides##36##1##(2007-12#10)(2008-10#4)(2008-2#12)(2008-3#10)
waveguiding##3##1##(2008-2#2)(2008-3#1)
wavelength absorption##2##2##(2008-10#1)(2008-7#1)
wavelength and the##7##3##(2008-10#3)(2008-3#3)(2008-7#1)
wavelength and##14##2##(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#5)(2008-7#2)
wavelength at which##2##3##(2008-3#2)
wavelength at##9##2##(2008-10#7)(2008-3#2)
wavelength dependence##2##2##(2007-11#1)(2008-3#1)
wavelength dispersive X-ray fluorescence spectroscopy##2##5##(2008-10#2)
wavelength dispersive##3##2##(2008-10#3)
wavelength emission##2##2##(2008-10#2)
wavelength for##5##2##(2008-10#2)(2008-3#1)(2010-1#1)(2011-7#1)
wavelength has been##2##3##(2008-3#2)
wavelength interval##2##2##(2008-10#2)
wavelength is at##2##3##(2008-10#2)
wavelength is##11##2##(2008-10#4)(2008-2#1)(2008-3#3)(2013-8#3)
wavelength light##3##2##(2008-10#1)(2011-7#1)(2013-1#1)
wavelength modulation SPR biosensor##3##4##(2008-10#3)
wavelength modulation spectroscopy with##2##4##(2008-3#2)
wavelength modulation spectroscopy##3##3##(2008-3#3)
wavelength modulation##12##2##(2008-10#8)(2008-3#4)
wavelength of 1##6##3##(2008-2#2)(2008-3#4)
wavelength of the##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
wavelength of##59##2##(1991-3#1)(1997-2#2)(2007-12#2)(2008-10#34)(2008-11#1)(2008-2#7)(2008-3#11)(2013-8#1)
wavelength pairs##5##2##(2008-10#3)(2008-3#2)
wavelength programming##2##2##(2008-10#2)
wavelength range and##2##3##(2008-10#2)
wavelength range of##3##3##(2008-10#1)(2008-3#2)
wavelength range##24##2##(2006-6#1)(2008-10#14)(2008-2#1)(2008-3#8)
wavelength ranges of##2##3##(2008-10#1)(2008-3#1)
wavelength ranges##3##2##(2008-10#2)(2008-3#1)
wavelength region##6##2##(2008-10#3)(2008-3#3)
wavelength regions##2##2##(2008-10#2)
wavelength scanning##2##2##(2008-10#2)
wavelength selection in##2##3##(2008-10#2)
wavelength selection##8##2##(2008-10#7)(2008-3#1)
wavelength the##2##2##(2008-3#1)(2008-5#1)
wavelength tuning and##2##3##(2008-3#1)(2008-9#1)
wavelength tuning##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
wavelength value of##2##3##(2008-10#2)
wavelength was##7##2##(2007-12#1)(2008-10#4)(2008-3#2)
wavelength were##2##2##(2008-10#1)(2008-2#1)
wavelength with##2##2##(1990-8#1)(2007-11#1)
wavelength##306##1##(1990-8#1)(1991-3#2)(1993-5#1)(1994-5#2)(1996-2#1)(1997-2#3)(2006-6#1)(2007-11#2)(2007-12#11)(2008-10#145)(2008-11#2)(2008-2#23)(2008-3#90)(2008-5#6)(2008-7#4)(2008-9#3)(2010-1#1)(2011-7#3)(2013-1#1)(2013-8#4)
wavelength)##3##1##(2008-3#3)
wavelength-dependent angular##2##2##(2008-2#2)
wavelength-dependent##7##1##(1995-6#1)(2008-2#3)(2008-3#3)
wavelength-division multiplexing##4##2##(2007-12#2)(2008-3#2)
wavelength-division##6##1##(2007-12#2)(2008-3#4)
wavelength-division-multiplexing##2##1##(2008-2#2)
wavelength-modulated##4##1##(2008-3#4)
wavelength-modulation spectrometry##3##2##(2008-3#3)
wavelength-modulation##6##1##(2008-2#1)(2008-3#5)
wavelength-selective photodetector##2##2##(2008-3#2)
wavelengths (e##2##2##(2008-3#2)
wavelengths (i##2##2##(2008-11#2)
wavelengths and##8##2##(1995-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
wavelengths are##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
wavelengths at which the##2##4##(2008-10#2)
wavelengths at##4##2##(2008-10#4)
wavelengths employed##2##2##(1990-2#1)(2008-2#1)
wavelengths for##3##2##(2008-10#1)(2008-3#2)
wavelengths from##2##2##(2008-3#2)
wavelengths in the visible##2##4##(2008-3#1)(2009-12#1)
wavelengths in##5##2##(2008-10#1)(2008-3#2)(2009-12#1)(2011-2#1)
wavelengths is##2##2##(2008-3#1)(2013-8#1)
wavelengths of##16##2##(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)
wavelengths ranging from##2##3##(2008-2#2)
wavelengths were##10##2##(2008-10#9)(2008-3#1)
wavelengths##132##1##(1990-2#1)(1990-8#2)(1991-5#1)(1995-6#2)(2008-1#1)(2008-10#57)(2008-11#3)(2008-2#11)(2008-3#42)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
wavelet MRA and##2##3##(2008-10#2)
wavelet MRA##4##2##(2008-10#4)
wavelet analysis##2##2##(2008-10#2)
wavelet neural network##2##3##(2008-10#2)
wavelet transform##16##2##(2008-10#14)(2008-3#2)
wavelet transforms##2##2##(2008-10#2)
wavelet##44##1##(2008-10#37)(2008-3#4)(2010-8#3)
wavenumber##5##1##(2008-10#5)
wavenumbers was##2##2##(2008-10#2)
wavenumbers##5##1##(2008-10#5)
waves and##4##2##(1991-9#1)(1994-5#1)(2008-10#1)(2008-3#1)
waves are##4##2##(1991-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
waves at##3##2##(2008-10#1)(2009-9#1)(2010-7#1)
waves for##2##2##(2012-3#1)(2013-8#1)
waves generated##2##2##(1994-5#1)(2010-6#1)
waves in a##3##3##(1990-12#1)(1995-12#1)(2008-3#1)
waves in the##2##3##(1994-8#1)(2008-5#1)
waves in##11##2##(1990-12#1)(1993-1#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-5#1)
waves of##7##2##(2008-10#3)(2008-11#1)(2008-3#1)(2013-8#2)
waves was##2##2##(2008-10#1)(2008-5#1)
waves were##2##2##(2008-10#2)
waves with##2##2##(2007-11#1)(2013-8#1)
waves##72##1##(1990-12#1)(1991-3#4)(1991-9#1)(1993-1#3)(1993-3#1)(1994-5#2)(1994-8#3)(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#8)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#3)(2010-6#1)(2010-7#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#5)
wax and oil##5##3##(2008-5#5)
wax matrix at the surface region##2##6##(2008-5#2)
wax matrix##12##2##(2008-5#12)
wax##40##1##(1991-2#1)(1992-6#4)(2008-10#14)(2008-11#1)(2008-5#18)(2011-2#1)(2013-1#1)
wax-encased##5##1##(2008-10#5)
waxes were##2##2##(2008-10#2)
waxes##6##1##(2008-10#6)
way a##4##2##(1990-9#1)(1992-6#1)(2008-10#1)(2008-8#1)
way and##4##2##(2008-12#1)(2011-2#1)(2012-3#2)
way are##3##2##(1996-3#1)(2008-10#2)
way around##2##2##(1991-9#1)(1992-1#1)
way as##9##2##(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#5)(2008-4#1)
way by##2##2##(1997-2#1)(2008-12#1)
way for the##4##3##(1994-2#1)(2008-10#2)(2009-8#1)
way for##27##2##(1992-1#1)(1993-1#1)(1994-2#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#2)
way forward for##2##3##(1996-8#1)(2009-10#1)
way forward in##2##3##(2008-10#1)(2008-11#1)
way forward##6##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#2)
way from##3##2##(1992-11#1)(1994-3#1)(2008-3#1)
way have##2##2##(2008-10#1)(2008-4#1)
way in the##2##3##(1995-3#1)(2008-10#1)
way in which##16##3##(1992-1#1)(1993-2#1)(1993-8#1)(1994-9#1)(1997-4#1)(1997-7#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-2#2)
way in##23##2##(1991-11#1)(1992-1#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-7#2)(2011-1#1)(2012-2#2)
way into the##2##3##(1994-3#1)(2008-11#1)
way is##2##2##(2008-10#1)(2008-11#1)
way it##4##2##(1992-12#1)(1992-3#1)(1994-12#1)(2009-10#1)
way of comparing##2##3##(1994-6#1)(2008-10#1)
way of improving##2##3##(2010-12#1)(2010-8#1)
way of thinking##2##3##(1994-12#1)(2008-9#1)
way of##62##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-3#2)(1994-12#1)(1994-6#1)(1996-9#1)(1997-8#1)(2008-10#12)(2008-11#4)(2008-12#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#5)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
way on##3##2##(1995-5#1)(1996-6#1)(2008-10#1)
way that it##4##3##(2008-11#2)(2008-3#1)(2011-2#1)
way that the##8##3##(1994-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)
way that##37##2##(1990-12#1)(1991-2#1)(1991-5#1)(1994-1#1)(1997-5#3)(2007-12#1)(2008-10#7)(2008-11#7)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
way the##9##2##(1997-2#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2010-11#1)
way they##5##2##(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2013-8#1)
way to assess##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
way to classify##2##3##(1995-12#1)(2008-5#1)
way to elucidate the##2##4##(2009-6#1)(2012-3#1)
way to evaluate the##2##4##(1991-2#1)(1993-12#1)
way to extend##2##3##(2007-11#1)(2008-6#1)
way to improve the##2##4##(1993-3#1)(2008-11#1)
way to improve##4##3##(1992-11#1)(1993-3#1)(1997-3#1)(2008-11#1)
way to integrate##3##3##(1993-2#1)(1997-2#1)(2008-9#1)
way to measure##2##3##(2008-10#1)(2008-5#1)
way to obtain##2##3##(2008-10#1)(2008-11#1)
way to predict##2##3##(2008-7#1)(2008-8#1)
way to prevent or##2##4##(2008-10#1)(2010-7#1)
way to prevent##4##3##(2008-10#2)(2010-7#1)(2011-2#1)
way to produce##2##3##(2008-10#1)(2008-4#1)
way to provide##2##3##(1991-2#1)(2008-11#1)
way to study the##2##4##(2008-10#1)(2008-9#1)
way to the##3##3##(1997-1#1)(2010-7#1)(2013-8#1)
way to treat the##2##4##(2008-12#1)(2013-1#1)
way to treat##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
way to##119##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-5#2)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#4)(1994-9#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#23)(2008-11#12)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#6)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
way using##2##2##(2008-10#1)(2013-1#1)
way we##10##2##(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-8#1)(2010-7#1)(2011-2#2)(2013-7#1)
way##478##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-5#3)(1991-6#3)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#5)(1993-8#1)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#6)(1994-6#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#1)(1997-5#4)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#99)(2008-11#46)(2008-12#22)(2008-2#2)(2008-3#16)(2008-4#5)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#17)(2008-9#14)(2009-10#6)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#7)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#7)(2010-9#3)(2011-1#3)(2011-2#14)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#7)(2013-7#2)(2013-8#9)
way&quot##2##1##(2008-12#2)
ways and##4##2##(1995-5#1)(2008-10#1)(2010-5#1)(2010-9#1)
ways for##3##2##(1997-1#1)(2008-10#2)
ways forward##2##2##(2008-10#1)(2012-2#1)
ways in which the##3##4##(1995-3#1)(2008-10#1)(2008-2#1)
ways in which##24##3##(1992-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#3)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
ways in##27##2##(1992-12#1)(1993-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#3)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
ways of providing##2##3##(1992-12#1)(1994-3#1)
ways of##28##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-3#2)(1994-6#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-9#1)(2010-10#1)(2010-11#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
ways that##12##2##(1995-5#1)(2008-10#1)(2008-12#3)(2008-9#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#3)
ways to eliminate##2##3##(2008-4#1)(2010-11#1)
ways to help##2##3##(1994-1#1)(1995-9#1)
ways to improve the##2##4##(2008-8#1)(2008-9#1)
ways to improve##3##3##(1997-3#1)(2008-8#1)(2008-9#1)
ways to increase##2##3##(1996-9#1)(2008-10#1)
ways to overcome the##2##4##(1991-2#1)(2008-10#1)
ways to prevent##3##3##(1996-5#1)(2008-11#2)
ways to##57##2##(1991-2#2)(1992-12#2)(1993-1#1)(1993-12#1)(1994-1#2)(1994-12#2)(1994-2#2)(1995-1#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-10#2)(2010-11#2)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
ways##193##1##(1990-3#2)(1990-6#1)(1991-1#1)(1991-2#3)(1991-3#1)(1992-11#1)(1992-12#5)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-6#1)(1995-1#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-3#4)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#27)(2008-11#17)(2008-12#9)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#4)(2010-11#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#7)(2012-2#4)(2012-3#4)(2012-9#1)(2013-1#10)(2013-8#3)
wcmmVtg##4##1##(2010-5#4)
we achieved an##3##3##(2008-2#1)(2008-3#2)
we achieved##7##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)
we adapt the##2##3##(2008-8#2)
we add a##2##3##(2008-3#1)(2012-2#1)
we address key##2##3##(2008-11#2)
we address the##2##3##(2010-9#1)(2013-8#1)
we address##6##2##(2008-11#2)(2008-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
we administered##2##2##(2012-12#1)(2013-1#1)
we adopted##2##2##(1996-5#1)(2008-9#1)
we advocate##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
we aim to##3##3##(2010-7#1)(2011-2#1)(2013-1#1)
we aimed to##7##3##(2008-11#1)(2008-7#2)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
we aimed##8##2##(2008-11#2)(2008-7#2)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
we all##2##2##(1995-1#1)(2012-2#1)
we also demonstrate the##2##4##(2008-3#1)(2012-2#1)
we also demonstrate##3##3##(1993-12#1)(2008-3#1)(2012-2#1)
we also discuss the##2##4##(1992-5#1)(2009-8#1)
we also discuss##3##3##(1992-5#1)(2008-11#1)(2009-8#1)
we also examined##2##3##(2008-11#1)(2011-2#1)
we also found##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
we also investigate##3##3##(2008-6#1)(2008-8#2)
we also investigated the##2##4##(1994-6#1)(2008-10#1)
we also investigated##4##3##(1993-6#1)(1994-6#1)(2008-10#1)(2008-3#1)
we also##34##2##(1992-2#1)(1992-5#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#3)(2011-2#3)(2012-2#1)(2012-3#1)
we amplified##2##2##(2008-11#2)
we analyse the##2##3##(2008-11#1)(2012-5#1)
we analyse##4##2##(2008-11#1)(2011-2#1)(2011-3#1)(2012-5#1)
we analyze the##5##3##(2008-11#2)(2008-6#1)(2008-8#2)
we analyze##12##2##(1993-6#1)(1995-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
we analyzed the##18##3##(1990-9#1)(1991-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(2008-10#2)(2008-11#3)(2009-12#1)(2010-8#1)(2011-2#2)(2013-1#3)
we analyzed whether##2##3##(2008-10#1)(2013-1#1)
we analyzed##38##2##(1990-9#1)(1991-3#2)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-8#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-11#6)(2008-6#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-8#1)
we and##3##2##(1990-6#1)(2008-11#1)(2013-1#1)
we applied##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-8#1)
we apply##4##2##(2008-11#1)(2008-8#1)(2010-2#1)(2010-8#1)
we approach##2##2##(2008-4#1)(2013-7#1)
we are able to##6##4##(1994-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)
we are developing##2##3##(1995-2#1)(2008-11#1)
we are going##4##3##(2009-5#1)(2013-1#3)
we are in a##2##4##(2008-11#1)(2008-3#1)
we are now##2##3##(2010-5#1)(2011-2#1)
we are presenting##2##3##(2008-10#1)(2010-7#1)
we are to##3##3##(1992-9#1)(2008-12#1)(2013-1#1)
we are##36##2##(1991-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#4)(2008-3#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#6)(2013-8#1)
we argue that the##2##4##(1992-2#1)(2008-8#1)
we argue that##9##3##(1992-2#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
we argue##10##2##(1992-2#1)(2008-11#2)(2008-8#2)(2008-9#1)(2010-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
we ask##2##2##(2008-7#1)(2011-2#1)
we asked whether##3##3##(2008-8#1)(2008-9#1)(2012-7#1)
we asked##6##2##(1990-11#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-7#1)
we assess##3##2##(1996-2#1)(2008-8#2)
we assessed the effects of##3##5##(2009-10#1)(2012-3#2)
we assessed the##8##3##(1993-1#1)(1996-2#1)(2009-10#1)(2012-3#3)(2013-1#1)(2013-8#1)
we assessed##16##2##(1993-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-6#2)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
we assume that##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#1)
we assume##6##2##(1995-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#2)
we assumed that##2##3##(1995-6#1)(2008-8#1)
we attempt to##3##3##(2008-11#1)(2008-7#1)(2009-10#1)
we attempted to evaluate##2##4##(2008-10#1)(2008-11#1)
we attempted to identify##2##4##(2008-10#1)(2012-12#1)
we attempted to##15##3##(1994-9#1)(1995-12#1)(2008-10#3)(2008-11#4)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
we attempted##16##2##(1994-9#1)(1995-12#1)(2008-10#3)(2008-11#4)(2008-6#1)(2008-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
we attribute to the##2##4##(2008-7#1)(2008-9#1)
we attribute##3##2##(2008-7#1)(2008-9#1)(2010-2#1)
we begin to##2##3##(2009-12#1)(2010-11#1)
we begin##3##2##(2008-11#1)(2009-12#1)(2010-11#1)
we believe is##2##3##(2008-3#1)(2008-9#1)
we believe that the##4##4##(1992-2#1)(1995-12#1)(1996-11#1)(2008-9#1)
we believe that##9##3##(1992-2#1)(1995-12#1)(1996-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
we believe##20##2##(1992-2#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#2)(2008-9#4)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
we breathe##2##2##(2009-6#2)
we briefly discuss##3##3##(2008-11#2)(2012-2#1)
we briefly##7##2##(2008-11#3)(2010-12#1)(2010-7#1)(2012-2#2)
we calculated a##2##3##(1992-9#1)(1995-2#1)
we calculated##6##2##(1992-9#1)(1995-2#1)(2008-3#1)(2010-8#1)(2012-5#1)(2013-1#1)
we call##2##2##(1997-3#1)(2008-8#1)
we called##2##2##(2008-5#1)(2010-8#1)
we can conclude that##3##4##(2011-2#1)(2011-7#1)(2013-1#1)
we can conclude##4##3##(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
we can learn##2##3##(1993-12#2)
we can now##2##3##(2008-10#1)(2010-4#1)
we cannot completely discount the##2##5##(2008-10#2)
we cannot##8##2##(1990-8#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#2)(2012-2#1)
we carried out Northern blot analysis##2##6##(1993-8#1)(1997-8#1)
we carried out a##3##4##(2010-1#1)(2010-12#1)(2012-2#1)
we carried out##9##3##(1993-8#1)(1997-3#1)(1997-8#1)(2008-5#1)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#2)
we characterize##2##2##(2009-12#1)(2010-12#1)
we characterized an##2##3##(2008-10#1)(2009-8#1)
we characterized the##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
we characterized##8##2##(2008-10#3)(2008-11#1)(2009-8#1)(2012-2#2)(2012-3#1)
we chose##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
we cloned the##2##3##(1997-7#1)(2008-5#1)
we cloned##8##2##(1993-6#1)(1995-12#1)(1996-8#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-4#1)
we collected##2##2##(2011-2#1)(2013-1#1)
we combine##2##2##(2008-8#1)(2010-4#1)
we combined##7##2##(1994-12#1)(2008-9#1)(2009-8#1)(2010-1#1)(2012-3#2)(2013-1#1)
we comment on##2##3##(1991-12#1)(2010-9#1)
we compare the##6##3##(2008-10#1)(2008-11#1)(2009-6#1)(2010-9#1)(2012-2#1)(2012-5#1)
we compare##15##2##(1996-3#1)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2012-5#1)
we compared performance under eight##2##5##(2008-6#2)
we compared the##13##3##(1991-12#1)(1993-11#1)(1995-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)
we compared##22##2##(1991-12#1)(1993-11#1)(1995-11#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-8#1)
we compute the##3##3##(2008-2#1)(2008-7#1)(2009-3#1)
we compute##4##2##(2008-2#1)(2008-7#2)(2009-3#1)
we concentrate on##2##3##(2008-11#1)(2013-8#1)
we conclude that the##8##4##(1991-5#1)(1994-8#1)(1997-8#1)(2007-12#1)(2008-10#4)
we conclude that these##2##4##(1990-2#1)(1991-2#1)
we conclude that##34##3##(1990-2#2)(1990-8#1)(1991-2#1)(1991-5#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-2#2)(1995-6#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
we conclude##37##2##(1990-2#2)(1990-8#1)(1991-2#1)(1991-5#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-2#2)(1995-6#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#4)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
we concluded that the##2##4##(2008-10#1)(2008-11#1)
we concluded that##7##3##(1995-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-5#3)
we conduct##2##2##(2007-8#1)(2009-7#1)
we conducted a##7##3##(2008-10#3)(2008-11#1)(2009-10#1)(2010-8#1)(2011-2#1)
we conducted##16##2##(1997-4#1)(2008-10#4)(2008-11#3)(2008-5#2)(2009-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
we confirmed that##2##3##(2011-2#1)(2012-2#1)
we consider a##3##3##(2008-10#1)(2009-10#1)(2013-8#1)
we consider our##2##3##(2008-10#1)(2008-11#1)
we consider the##8##3##(1995-5#1)(1996-1#1)(2008-3#1)(2008-8#2)(2011-2#1)(2011-3#1)(2013-8#1)
we consider##27##2##(1990-9#1)(1995-5#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
we construct a##2##3##(2008-6#1)(2008-8#1)
we construct##3##2##(2008-6#1)(2008-8#1)(2011-2#1)
we constructed a cDNA library##3##5##(1993-3#1)(2008-8#1)(2008-9#1)
we constructed a##12##3##(1991-6#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#1)
we constructed##18##2##(1991-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#3)(2008-8#1)(2008-9#3)(2009-8#1)(2012-3#1)
we continually strive to compare our group's performance to accepted standards of cost and production##2##15##(1994-3#2)
we continually##3##2##(1994-3#2)(2008-10#1)
we continue to##2##3##(1995-9#1)(2010-12#1)
we could detect##4##3##(1993-8#1)(1995-12#1)(1996-12#1)(1997-6#1)
we could not detect##2##4##(1993-8#1)(1994-8#1)
we could not##4##3##(1993-8#1)(1994-8#1)(2008-8#1)(2010-7#1)
we could show that the##2##5##(1997-7#1)(2008-11#1)
we could show that##3##4##(1997-7#1)(2008-11#1)(2009-6#1)
we could show##4##3##(1997-7#1)(2008-11#1)(2009-12#1)(2009-6#1)
we could##22##2##(1993-8#2)(1994-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#2)(2009-6#1)(2010-7#1)
we create a##2##3##(2008-2#1)(2008-8#1)
we create##3##2##(2008-2#1)(2008-6#1)(2008-8#1)
we created a##4##3##(2009-10#2)(2011-2#1)(2012-3#1)
we critically evaluate##2##3##(2012-2#2)
we critically##4##2##(2008-10#1)(2009-12#1)(2012-2#2)
we currently use##2##3##(2010-7#1)(2011-2#1)
we deal with##2##3##(2007-8#1)(2011-2#1)
we decided to##2##3##(2008-11#1)(2013-7#1)
we define##3##2##(2008-10#2)(2008-6#1)
we defined four##2##3##(2008-10#1)(2011-2#1)
we defined##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
we demonstrate a novel##2##4##(2008-11#1)(2012-2#1)
we demonstrate a simple##2##4##(2008-10#1)(2008-3#1)
we demonstrate a##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#2)
we demonstrate how our lab##2##5##(2008-8#2)
we demonstrate how##5##3##(2008-10#1)(2008-6#1)(2008-8#2)(2013-1#1)
we demonstrate that the##6##4##(1993-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(2009-5#1)(2011-2#1)
we demonstrate that##29##3##(1992-7#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
we demonstrate the##9##3##(1990-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-2#1)
we demonstrate##63##2##(1990-12#2)(1992-7#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#7)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2011-2#3)(2012-2#8)(2012-3#1)(2013-1#4)(2013-8#1)
we demonstrated that the##5##4##(1997-2#1)(2008-9#2)(2009-8#1)(2011-2#1)
we demonstrated that this##2##4##(1996-2#1)(2008-5#1)
we demonstrated that##20##3##(1990-4#1)(1992-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#1)
we demonstrated the##2##3##(2008-3#1)(2013-1#1)
we demonstrated##23##2##(1990-4#1)(1992-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
we derive a##3##3##(2008-10#1)(2008-8#2)
we derive##8##2##(1995-5#1)(2008-10#1)(2008-8#2)(2008-9#2)(2011-2#1)(2013-8#1)
we derived##2##2##(2012-2#2)
we describe a case of##4##5##(2010-6#1)(2010-7#1)(2013-1#2)
we describe a method##3##4##(1990-12#1)(2008-12#1)(2011-2#1)
we describe a new method##2##5##(2008-11#1)(2012-2#1)
we describe a new##4##4##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
we describe a novel##2##4##(2008-10#1)(2009-12#1)
we describe a simple##2##4##(1990-11#1)(2008-11#1)
we describe a##26##3##(1990-11#1)(1990-12#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
we describe an##8##3##(1995-11#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-3#1)
we describe how the##2##4##(2008-10#1)(2008-9#1)
we describe how##4##3##(1992-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
we describe our##2##3##(1997-9#1)(2011-2#1)
we describe some of##2##4##(1991-3#1)(2010-7#1)
we describe that##2##3##(2008-10#1)(2011-2#1)
we describe the application of##3##5##(2008-10#1)(2013-1#2)
we describe the construction of a##2##6##(1990-8#1)(2008-11#1)
we describe the construction of##3##5##(1990-8#1)(2008-11#1)(2011-1#1)
we describe the features of this organism##13##7##(2011-2#13)
we describe the features of this##14##6##(2011-2#14)
we describe the features of##18##5##(2011-2#18)
we describe the in##2##4##(2008-11#1)(2012-12#1)
we describe the results of##3##5##(2008-2#1)(2008-6#1)(2013-8#1)
we describe the use of##2##5##(2008-10#1)(2008-11#1)
we describe the##65##3##(1990-8#1)(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#2)(1995-11#1)(1997-7#1)(2008-10#6)(2008-11#6)(2008-2#1)(2008-6#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#23)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
we describe two##2##3##(2008-9#1)(2012-2#1)
we describe##130##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#2)(1995-11#2)(1995-2#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-9#1)(2008-10#16)(2008-11#10)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#32)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#9)(2013-8#2)
we designed a##3##3##(1996-2#1)(2008-1#1)(2008-7#1)
we designed and##2##3##(2008-10#1)(2008-9#1)
we designed##9##2##(1993-12#1)(1996-2#2)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#2)
we detected a##2##3##(1992-6#1)(1993-3#1)
we detected##7##2##(1992-6#1)(1993-3#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-11#1)
we determine the##2##3##(2008-10#1)(2008-2#1)
we determine##4##2##(2008-10#1)(2008-2#1)(2009-10#1)(2012-3#1)
we determined that##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
we determined the##13##3##(1993-8#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
we determined##26##2##(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
we develop a##11##3##(1996-3#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#2)
we develop an##2##3##(2008-8#2)
we develop and##2##3##(2008-9#1)(2012-3#1)
we develop##18##2##(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-8#4)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
we developed a new##4##4##(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
we developed a rapid##2##4##(2008-11#2)
we developed a##29##3##(1993-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
we developed an##2##3##(2008-10#1)(2010-4#1)
we developed and optimized##2##4##(1997-2#1)(2008-10#1)
we developed and##5##3##(1997-2#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-8#1)
we developed novel##2##3##(2008-10#2)
we developed two in vitro##2##5##(2008-10#1)(2012-2#1)
we developed two##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
we developed##51##2##(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#18)(2008-11#4)(2008-5#2)(2008-6#1)(2008-8#3)(2009-6#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
we diagnosed this##3##3##(2009-1#1)(2010-6#2)
we diagnosed##6##2##(1997-8#1)(2008-10#1)(2009-1#1)(2010-6#2)(2011-2#1)
we did not##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
we directly##3##2##(1995-6#1)(2008-8#1)(2013-8#1)
we discovered that##5##3##(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
we discovered##7##2##(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
we discuss a##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
we discuss in##2##3##(2009-8#1)(2012-2#1)
we discuss our##2##3##(2008-10#1)(2012-3#1)
we discuss possible##2##3##(2009-8#2)
we discuss recent advances in##2##5##(1994-3#1)(2010-7#1)
we discuss recent##4##3##(1994-3#1)(2010-5#1)(2010-7#1)(2011-2#1)
we discuss several##3##3##(1994-2#1)(1995-9#1)(2008-11#1)
we discuss some##3##3##(2008-11#2)(2010-5#1)
we discuss the implications of##2##5##(2008-8#1)(2011-2#1)
we discuss the importance of##3##5##(2008-11#2)(2011-2#1)
we discuss the possible##3##4##(2009-6#1)(2009-8#1)(2011-2#1)
we discuss the potential##2##4##(2009-8#2)
we discuss the role of##3##5##(2011-2#2)(2013-8#1)
we discuss the##39##3##(2008-10#3)(2008-11#6)(2008-12#3)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#6)(2010-1#2)(2011-2#9)(2012-3#2)(2013-1#1)(2013-8#2)
we discuss these##3##3##(2009-8#1)(2010-12#1)(2010-6#1)
we discuss##78##2##(1992-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-9#1)(1997-8#1)(2008-10#6)(2008-11#12)(2008-12#3)(2008-7#2)(2008-8#4)(2009-3#1)(2009-6#1)(2009-8#11)(2010-1#2)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#15)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#3)
we distinguish##2##2##(2008-7#1)(2010-3#1)
we do not know how##2##5##(1991-3#1)(2012-3#1)
we do not know##4##4##(1991-3#1)(2008-10#2)(2012-3#1)
we do not##10##3##(1991-12#1)(1991-3#1)(1993-12#1)(2008-10#2)(2008-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-3#1)
we do with##3##3##(2008-8#1)(2010-10#2)
we do##23##2##(1990-9#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#5)(2010-10#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
we document the##4##3##(1995-6#1)(2008-11#1)(2008-9#1)(2011-3#1)
we documented##3##2##(2008-10#1)(2008-9#1)(2010-9#1)
we doing##2##2##(1991-3#1)(2008-11#1)
we draw##2##2##(2008-9#1)(2011-2#1)
we emphasize the##3##3##(2008-5#1)(2009-8#1)(2011-2#1)
we emphasize##4##2##(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
we employed a##2##3##(2006-6#1)(2008-10#1)
we employed##7##2##(2006-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
we engineered##2##2##(2008-10#1)(2011-2#1)
we establish a##2##3##(2008-9#1)(2010-8#1)
we established a##7##3##(1997-1#1)(2008-10#4)(2009-10#1)(2010-8#1)
we established rat astrocyte cell lines containing the plasmid for production of recombinant rat Epo##2##15##(2008-11#2)
we established##12##2##(1997-1#1)(2008-10#5)(2008-11#4)(2009-10#1)(2010-8#1)
we estimate that##6##3##(1993-12#1)(1994-9#1)(1996-11#1)(2008-10#1)(2008-11#2)
we estimate##9##2##(1993-12#1)(1994-9#1)(1996-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-3#1)
we estimated that##3##3##(1992-9#1)(2008-10#1)(2008-8#1)
we estimated the##7##3##(1990-2#1)(1995-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2013-7#1)
we estimated##10##2##(1990-2#1)(1992-9#1)(1995-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-7#1)
we evaluate##4##2##(1992-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
we evaluated the effect of##3##5##(1995-6#1)(2008-10#1)(2008-11#1)
we evaluated the effects of##2##5##(2008-11#1)(2013-1#1)
we evaluated the##22##3##(1990-12#1)(1992-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-8#1)(2008-10#2)(2008-11#4)(2010-4#1)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#1)
we evaluated whether##2##3##(1997-3#1)(2013-1#1)
we evaluated##30##2##(1990-12#1)(1992-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-3#1)(1997-8#2)(2008-10#2)(2008-11#5)(2008-12#1)(2010-4#1)(2011-2#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)
we examine a##2##3##(2008-9#1)(2010-3#1)
we examine how the##2##4##(2010-10#1)(2010-7#1)
we examine how##3##3##(2008-8#1)(2010-10#1)(2010-7#1)
we examine the##7##3##(1991-2#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
we examine whether##2##3##(2008-8#1)(2009-10#1)
we examine##24##2##(1991-2#1)(1992-2#1)(1992-6#1)(1994-1#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
we examined how##2##3##(2008-11#1)(2008-9#1)
we examined relationships##2##3##(2008-12#1)(2010-7#1)
we examined the ability of##2##5##(1995-8#1)(2008-10#1)
we examined the effect of##7##5##(1993-2#1)(1995-12#1)(2008-10#1)(2008-11#3)(2011-2#1)
we examined the effects of##11##5##(1992-8#1)(1993-3#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-7#1)(2009-8#1)
we examined the expression of##2##5##(1996-12#2)
we examined the##46##3##(1990-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-8#3)(1996-12#3)(2007-12#1)(2008-10#5)(2008-11#12)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
we examined whether##7##3##(1996-12#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-6#1)(2011-2#1)
we examined##82##2##(1990-2#1)(1990-8#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1995-8#3)(1996-12#4)(1997-8#1)(2007-12#3)(2008-10#6)(2008-11#20)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#2)
we expect that##2##3##(2008-3#1)(2011-2#1)
we expect to##2##3##(2008-8#1)(2013-7#1)
we expect##6##2##(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-7#2)
we experimentally##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
we explain##3##2##(2008-10#2)(2008-9#1)
we explore the##12##3##(1993-12#1)(1995-9#1)(2008-11#1)(2008-12#2)(2008-8#4)(2009-8#2)(2010-6#1)
we explore##17##2##(1993-12#1)(1994-3#1)(1995-9#1)(1996-2#1)(2008-11#1)(2008-12#2)(2008-8#4)(2009-8#2)(2010-6#1)(2012-2#2)(2012-3#1)
we explored the##3##3##(1997-3#1)(2008-10#1)(2009-8#1)
we explored##5##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)
we expressed##2##2##(1994-11#1)(2008-7#1)
we extend the##3##3##(2008-8#1)(2009-7#1)(2010-3#1)
we extend##6##2##(1996-12#1)(1996-3#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-3#1)
we extended the##2##3##(2011-2#1)(2012-3#1)
we extract##3##2##(1992-12#1)(2008-9#1)(2011-2#1)
we extracted##2##2##(1997-2#1)(1997-6#1)
we fabricated##2##2##(2009-5#1)(2012-2#1)
we faced##2##2##(2008-10#1)(2012-2#1)
we fed##2##2##(1990-6#1)(2008-11#1)
we find a##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
we find that the##4##4##(1992-3#1)(2008-11#1)(2008-3#1)(2012-12#1)
we find that##21##3##(1991-9#1)(1992-3#1)(1994-11#1)(1995-11#1)(1997-1#1)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
we find##32##2##(1991-9#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-11#1)(1997-1#1)(2008-11#1)(2008-3#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)
we first##9##2##(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-1#1)(2011-10#1)
we fit##2##2##(2008-9#1)(2012-2#1)
we focus on a##3##4##(2008-9#1)(2010-10#1)(2013-8#1)
we focus on how##2##4##(2009-5#1)(2009-6#1)
we focus on the effects of##2##6##(2008-11#2)
we focus on the##6##4##(2008-11#2)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)
we focus on##19##3##(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
we focus##23##2##(2008-10#2)(2008-11#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
we focused on##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
we followed a##2##3##(2008-7#1)(2009-8#1)
we followed the##2##3##(2008-10#2)
we followed##4##2##(2008-10#2)(2008-7#1)(2009-8#1)
we found a significant##3##4##(2008-11#1)(2013-1#1)(2013-8#1)
we found a specific##2##4##(2009-10#2)
we found a##12##3##(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#2)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
we found an##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
we found evidence of##2##4##(2012-3#1)(2013-1#1)
we found evidence##5##3##(2008-11#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
we found in the##4##4##(1994-8#1)(2008-10#1)(2008-11#2)
we found in##5##3##(1994-8#1)(1996-8#1)(2008-10#1)(2008-11#2)
we found no differences##2##4##(1995-5#1)(2013-1#1)
we found no evidence for##2##5##(1995-12#1)(2009-8#1)
we found no evidence##4##4##(1995-12#1)(2008-6#1)(2009-8#1)(2013-1#1)
we found no##12##3##(1994-11#1)(1994-6#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
we found that the##25##4##(1990-11#1)(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)(2013-7#1)(2013-8#1)
we found that##65##3##(1990-11#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-9#1)(1997-2#1)(2008-10#9)(2008-11#12)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
we found the following##2##4##(2008-8#1)(2008-9#1)
we found the##6##3##(1996-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)
we found two##2##3##(1995-2#1)(2008-3#1)
we found##142##2##(1990-11#2)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#3)(1996-8#1)(1996-9#2)(1997-2#1)(2007-12#1)(2008-10#15)(2008-11#19)(2008-12#2)(2008-3#5)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#9)(2008-9#7)(2009-10#4)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#4)(2011-2#14)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#6)
we generated transgenic##2##3##(2008-11#1)(2012-12#1)
we generated##8##2##(1995-8#1)(2008-11#5)(2008-8#1)(2012-12#1)
we give a##2##3##(1992-9#1)(2009-3#1)
we give##5##2##(1991-6#1)(1992-9#1)(2009-10#1)(2009-3#1)(2010-11#1)
we grouped##2##2##(2008-8#1)(2012-3#1)
we had##9##2##(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
we have a##3##3##(1997-1#2)(2009-3#1)
we have also##2##3##(2008-12#1)(2008-3#1)
we have analyzed##2##3##(1990-5#1)(2008-11#1)
we have attempted to##2##4##(2008-11#1)(2012-12#1)
we have been able to##4##5##(2008-11#1)(2008-5#2)(2010-8#1)
we have been informed by the head of the Department of Chemistry at Sri Venkateswara University that the university authorities have taken disciplinary action against##2##25##(2008-10#2)
we have been##9##3##(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2010-8#1)
we have characterized the##3##4##(1993-8#1)(1995-2#1)(2008-10#1)
we have characterized##6##3##(1991-2#1)(1993-8#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#1)
we have cloned##3##3##(1993-6#1)(1997-7#1)(2008-5#1)
we have combined##2##3##(2008-11#1)(2013-1#1)
we have compared the##3##4##(1997-7#1)(2008-10#1)(2008-5#1)
we have compared##5##3##(1995-11#1)(1997-7#1)(2008-10#2)(2008-5#1)
we have concluded that the##2##5##(2008-3#1)(2011-2#1)
we have concluded that##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
we have constructed a##4##4##(1997-2#1)(2008-11#3)
we have constructed##6##3##(1993-8#1)(1997-2#1)(2008-11#3)(2008-9#1)
we have demonstrated that##7##4##(1992-6#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-3#1)
we have demonstrated##10##3##(1992-6#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
we have described the##2##4##(1995-12#1)(2008-10#1)
we have designed##3##3##(1990-12#1)(2008-10#2)
we have determined a##2##4##(2008-10#1)(2008-8#1)
we have determined its##2##4##(1994-11#1)(1997-7#1)
we have determined the##2##4##(1993-6#1)(1997-3#1)
we have determined##7##3##(1992-9#1)(1993-6#1)(1994-11#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-8#1)
we have developed a##11##4##(1993-3#1)(1994-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
we have developed an##4##4##(1993-8#1)(1994-12#1)(2008-11#1)(2011-2#1)
we have developed##24##3##(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-3#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
we have devised a##2##4##(2008-10#1)(2008-7#1)
we have discovered##2##3##(1991-3#1)(2008-8#1)
we have established two##2##4##(2008-10#1)(2008-5#1)
we have established##6##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2013-8#1)
we have evaluated the##2##4##(1993-6#1)(2008-11#1)
we have evaluated##3##3##(1993-6#1)(2008-11#1)(2012-3#1)
we have examined the##7##4##(1991-3#1)(1997-4#1)(1997-7#1)(2008-11#2)(2008-7#2)
we have examined##9##3##(1990-12#1)(1991-3#1)(1997-4#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-7#2)
we have explored##2##3##(2008-10#2)
we have expressed##2##3##(1995-6#1)(1997-7#1)
we have found that the##3##5##(1994-11#1)(2008-11#1)(2010-11#1)
we have found that##8##4##(1994-11#1)(1995-2#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-11#1)(2010-5#1)
we have found##10##3##(1994-11#1)(1994-2#1)(1995-2#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)
we have generated##2##3##(1995-2#1)(2008-11#1)
we have identified and##2##4##(1995-2#1)(2008-10#1)
we have identified the##5##4##(1990-7#1)(1995-2#1)(1995-9#1)(2010-4#1)(2011-2#1)
we have identified##16##3##(1990-7#1)(1991-5#1)(1993-3#1)(1993-8#1)(1995-2#3)(1995-9#1)(1996-12#1)(2008-10#2)(2009-10#2)(2010-4#1)(2010-5#1)(2011-2#1)
we have increased the##2##4##(2007-11#1)(2008-3#1)
we have initiated a##2##4##(1995-11#1)(2012-3#1)
we have initiated##4##3##(1995-11#2)(2008-10#1)(2012-3#1)
we have investigated the role of##2##6##(2008-10#1)(2008-7#1)
we have investigated the##10##4##(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-7#2)(2012-2#1)
we have investigated whether##2##4##(1994-2#1)(2012-2#1)
we have investigated##12##3##(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-7#2)(2012-2#2)
we have isolated a##5##4##(1993-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
we have isolated##11##3##(1992-10#1)(1992-9#1)(1993-2#2)(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
we have learned##3##3##(2008-3#1)(2009-8#1)(2010-12#1)
we have located##2##3##(1996-12#1)(2008-2#1)
we have made an##2##4##(2009-7#1)(2011-2#1)
we have made##5##3##(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2011-2#1)
we have mapped the##3##4##(1994-12#1)(2008-11#1)(2008-7#1)
we have modified the##3##4##(2008-10#1)(2008-11#2)
we have named##3##3##(2008-10#2)(2008-11#1)
we have now##5##3##(1990-9#1)(1993-6#1)(1995-2#1)(1997-7#1)(2009-6#1)
we have observed a##2##4##(1990-3#1)(1996-3#1)
we have observed##6##3##(1990-3#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-3#1)(2008-10#1)
we have obtained a##2##4##(1994-11#1)(2008-11#1)
we have obtained##5##3##(1992-9#1)(1994-11#1)(2008-11#2)(2008-9#1)
we have optimized the##2##4##(2008-11#1)(2011-2#1)
we have optimized##3##3##(2008-11#2)(2011-2#1)
we have performed##3##3##(2008-11#1)(2008-3#1)(2012-12#1)
we have prepared##2##3##(1994-11#1)(2008-11#1)
we have previously shown to be##2##6##(2008-10#1)(2008-11#1)
we have previously shown##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
we have previously##8##3##(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)(2013-1#1)
we have produced##6##3##(1995-12#2)(2008-10#1)(2008-7#2)(2010-11#1)
we have recently shown that##4##5##(2008-11#1)(2009-8#3)
we have recently##8##3##(1997-3#1)(2008-11#2)(2009-8#5)
we have reported that##2##4##(2009-8#1)(2011-2#1)
we have reported##4##3##(2008-10#2)(2009-8#1)(2011-2#1)
we have reviewed the##2##4##(1996-6#1)(2008-10#1)
we have reviewed##4##3##(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#1)
we have shown that a##3##5##(2008-11#1)(2008-7#1)(2011-2#1)
we have shown that the##4##5##(1995-12#1)(2008-11#1)(2009-8#1)(2013-8#1)
we have shown that##14##4##(1993-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(2008-11#2)(2008-7#1)(2009-8#2)(2011-2#2)(2013-1#2)(2013-8#1)
we have shown the##2##4##(2008-7#1)(2010-11#1)
we have shown##20##3##(1993-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2009-8#2)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
we have studied the##7##4##(1993-1#1)(1993-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
we have studied##11##3##(1990-5#1)(1993-1#1)(1993-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
we have taken##2##3##(1997-3#1)(2013-1#1)
we have termed##3##3##(1995-6#1)(1995-8#1)(2008-10#1)
we have tested the##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
we have tested##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
we have to##4##3##(1992-12#1)(1995-5#1)(2010-7#1)(2011-2#1)
we have undertaken a##2##4##(2008-11#1)(2010-9#1)
we have used a##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
we have used the##4##4##(1995-2#1)(2008-10#1)(2008-11#1)(2010-4#1)
we have used##19##3##(1991-12#1)(1992-10#1)(1995-2#1)(1996-12#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#3)(2010-4#1)(2010-8#1)(2012-3#1)
we have utilized##2##3##(1995-2#1)(2008-10#1)
we have##380##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#4)(1993-8#4)(1993-9#1)(1994-11#7)(1994-12#3)(1994-2#5)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#4)(1995-12#6)(1995-2#11)(1995-5#2)(1995-6#5)(1995-8#1)(1995-9#2)(1996-12#5)(1996-3#4)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#2)(1997-7#8)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#59)(2008-11#54)(2008-12#4)(2008-2#2)(2008-3#8)(2008-5#17)(2008-6#1)(2008-7#15)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#12)(2010-1#1)(2010-11#4)(2010-12#1)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#12)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#8)(2013-8#4)
we here##2##2##(2012-2#1)(2012-3#1)
we herein##2##2##(2009-8#1)(2010-11#1)
we highlight##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
we hypothesize that##4##3##(1996-9#1)(2008-11#1)(2008-7#1)(2009-8#1)
we hypothesize##6##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-1#1)
we hypothesized that the##3##4##(1994-2#1)(2011-2#1)(2012-3#1)
we hypothesized that##6##3##(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
we identified a novel##2##4##(2008-10#1)(2009-8#1)
we identified a##9##3##(1995-8#1)(1996-12#1)(2008-10#2)(2008-2#2)(2009-6#1)(2009-8#1)(2011-1#1)
we identified four##2##3##(1994-11#1)(2012-3#1)
we identified the##2##3##(2008-10#1)(2008-11#1)
we identified two##3##3##(1990-11#1)(2008-10#1)(2012-3#1)
we identified##47##2##(1990-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-5#1)(2008-7#1)(2009-10#4)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
we identify a##2##3##(2008-7#1)(2008-9#1)
we identify##9##2##(1991-1#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-3#1)(2012-3#1)(2013-1#1)
we illustrate how##2##3##(1996-3#1)(2013-1#1)
we illustrate the##2##3##(2008-10#2)
we illustrate##4##2##(1996-3#1)(2008-10#2)(2013-1#1)
we improve##3##2##(1992-5#1)(2009-7#1)(2012-2#1)
we in##3##2##(1991-3#1)(1994-11#1)(2009-7#1)
we include##2##2##(2008-3#1)(2013-8#1)
we increase##3##2##(1991-2#1)(2008-5#1)(2012-2#1)
we inferred##2##2##(1993-12#1)(2013-1#1)
we injected##2##2##(1997-2#1)(2008-11#1)
we insist##2##2##(2009-5#1)(2012-3#1)
we intend to##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
we introduce a##3##3##(2008-3#1)(2008-9#1)(2013-8#1)
we introduce##6##2##(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-7#1)(2013-8#1)
we introduced##4##2##(1993-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
we investigate the##6##3##(2008-11#1)(2008-2#1)(2009-7#1)(2009-9#1)(2010-11#1)(2012-2#1)
we investigate whether##2##3##(2008-11#1)(2012-3#1)
we investigate##15##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)
we investigated how##2##3##(2008-10#1)(2008-11#1)
we investigated the direct##2##4##(2008-10#1)(2013-1#1)
we investigated the effect of##11##5##(1992-6#1)(1994-2#1)(1996-2#1)(1997-2#1)(2008-12#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
we investigated the effects of the##2##6##(2008-11#2)
we investigated the effects of##5##5##(1993-11#1)(1997-3#1)(2008-10#1)(2008-11#2)
we investigated the efficacy of##3##5##(2008-10#1)(2011-2#2)
we investigated the expression##2##4##(2012-3#1)(2013-1#1)
we investigated the possibility##2##4##(2010-4#1)(2011-2#1)
we investigated the potential##2##4##(2008-10#1)(2008-7#1)
we investigated the regulation of##2##5##(1996-12#1)(2010-11#1)
we investigated the response to##2##5##(1995-2#1)(2009-8#1)
we investigated the role of##3##5##(1995-12#1)(2008-6#1)(2010-6#1)
we investigated the##70##3##(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#3)(1995-2#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#3)(2010-11#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
we investigated their##2##3##(1993-8#1)(2010-6#1)
we investigated whether##8##3##(1995-8#1)(1996-12#1)(1996-2#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-6#2)
we investigated##100##2##(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#3)(1995-2#2)(1995-8#1)(1996-12#4)(1996-2#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#1)(2008-10#13)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#2)(2009-8#4)(2010-11#2)(2010-4#1)(2010-6#4)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#4)(2013-8#4)
we isolated a##2##3##(1993-12#1)(1993-6#1)
we isolated and characterized##3##4##(1991-2#1)(2009-8#1)(2010-5#1)
we isolated and##4##3##(1991-2#1)(1995-11#1)(2009-8#1)(2010-5#1)
we isolated##11##2##(1991-2#1)(1991-5#1)(1993-12#1)(1993-6#1)(1995-11#1)(2008-10#2)(2008-11#2)(2009-8#1)(2010-5#1)
we know how##2##3##(2012-12#1)(2012-2#1)
we know##14##2##(1991-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-10#2)(2012-12#1)(2012-2#1)(2013-1#1)
we learn from##3##3##(1991-3#1)(1993-6#1)(2010-1#1)
we learn##6##2##(1991-3#1)(1993-12#1)(1993-6#1)(2009-8#1)(2010-1#1)(2011-2#1)
we learned from##2##3##(2009-4#1)(2012-2#1)
we learned##3##2##(1997-3#1)(2009-4#1)(2012-2#1)
we live##2##2##(2008-1#1)(2009-8#1)
we look##2##2##(1997-3#1)(2008-12#1)
we made a##2##3##(1996-6#1)(1997-7#1)
we made##5##2##(1996-6#1)(1997-7#1)(2008-3#1)(2009-12#1)(2013-8#1)
we make##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
we mapped##2##2##(2008-10#2)
we may##12##2##(1993-11#1)(1994-8#1)(1995-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
we measure##4##2##(1991-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
we measured serum##2##3##(1991-8#1)(1993-2#1)
we measured the##8##3##(1991-2#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#2)(2012-3#1)(2013-8#1)
we measured##21##2##(1991-2#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-2#1)(1996-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
we model##5##2##(2008-2#1)(2008-8#1)(2013-1#2)(2013-8#1)
we monitored##4##2##(1996-2#1)(2008-10#2)(2010-4#1)
we must also##2##3##(1995-5#1)(2010-12#1)
we must##12##2##(1991-12#1)(1993-2#1)(1995-5#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#4)(2010-3#1)(2011-2#1)
we named##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)
we need to##11##3##(1991-1#1)(1991-12#1)(1993-12#1)(1994-1#1)(1995-9#2)(1997-1#1)(2008-4#1)(2011-3#1)(2012-12#1)(2012-2#1)
we need##17##2##(1991-1#1)(1991-12#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-9#2)(1997-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2010-9#1)(2011-3#1)(2012-12#1)(2012-2#1)
we newly##2##2##(1995-8#1)(1996-2#1)
we not##2##2##(1993-2#2)
we note that##2##3##(2008-10#1)(2009-10#1)
we now know##2##3##(2008-1#1)(2013-7#1)
we now report##3##3##(1991-12#1)(1993-2#1)(2008-8#1)
we now##11##2##(1991-12#2)(1992-6#1)(1993-2#1)(1994-12#1)(1996-9#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
we numerically##2##2##(2008-2#1)(2012-2#1)
we observe that##3##3##(1997-2#1)(2008-11#1)(2009-8#1)
we observe##9##2##(1993-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-7#1)(2009-8#1)(2012-2#1)
we observed a##9##3##(1995-12#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)
we observed that the##6##4##(1991-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
we observed that##14##3##(1991-5#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
we observed the##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
we observed##44##2##(1991-5#1)(1992-8#1)(1995-12#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
we obtain##4##2##(1995-5#1)(1995-9#1)(2008-10#1)(2012-2#1)
we obtained a##5##3##(1994-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-6#1)
we obtained the##2##3##(2008-10#1)(2008-9#1)
we obtained##23##2##(1992-3#1)(1994-6#1)(1995-6#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2013-1#1)
we offer a##2##3##(2008-9#1)(2011-2#1)
we offer##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2013-7#1)
we outline a##3##3##(2008-10#1)(2008-11#2)
we outline the##3##3##(2008-9#1)(2010-5#1)(2012-3#1)
we outline##9##2##(1992-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-5#1)(2012-2#2)(2012-3#1)
we perform##2##2##(2008-10#1)(2008-3#1)
we performed a##9##3##(1992-12#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
we performed the##3##3##(1997-2#1)(2009-8#1)(2013-1#1)
we performed##29##2##(1991-6#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-11#3)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
we predict that##2##3##(2008-11#1)(2012-2#1)
we predict the##2##3##(1992-9#1)(2008-3#1)
we predict##4##2##(1992-9#1)(2008-11#1)(2008-3#1)(2012-2#1)
we predicted##3##2##(1993-12#1)(2009-8#1)(2011-2#1)
we prepared a##2##3##(1993-6#1)(2008-9#1)
we prepared##5##2##(1993-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
we present a case of##8##5##(1997-7#1)(2008-12#1)(2009-8#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#2)
we present a case##10##4##(1997-7#1)(2008-12#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
we present a methodology##2##4##(2008-10#1)(2008-12#1)
we present a new##4##4##(1997-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
we present a novel##2##4##(2008-5#1)(2008-8#1)
we present a patient who##2##5##(1990-9#1)(2013-1#1)
we present a patient##3##4##(1990-9#1)(2008-9#1)(2013-1#1)
we present a study on##2##5##(2012-3#2)
we present a technique for##2##5##(2008-10#1)(2013-1#1)
we present a##35##3##(1990-9#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
we present an analysis of##2##5##(1995-8#1)(2008-8#1)
we present an overview of##2##5##(2008-10#1)(2012-3#1)
we present an##11##3##(1995-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-9#1)(2012-3#1)(2013-1#2)
we present evidence from##3##4##(1994-3#1)(2008-4#1)(2009-10#1)
we present evidence that##2##4##(1994-11#1)(2008-7#1)
we present evidence##6##3##(1994-11#1)(1994-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)
we present experimental##3##3##(2008-3#1)(2008-9#1)(2009-3#1)
we present new##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
we present our##6##3##(2008-7#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-3#1)
we present results from##2##4##(1995-5#1)(2008-8#1)
we present results of##2##4##(1995-5#1)(2008-11#1)
we present results##4##3##(1995-5#2)(2008-11#1)(2008-8#1)
we present the first case##2##5##(2008-10#1)(2010-12#1)
we present the first##3##4##(2008-10#1)(2010-12#1)(2013-8#1)
we present the most##3##4##(2008-10#1)(2008-9#1)(2010-9#1)
we present the results obtained##2##5##(1995-11#1)(2008-10#1)
we present the results##3##4##(1995-11#1)(2008-10#1)(2010-9#1)
we present the##22##3##(1994-3#1)(1995-11#1)(2008-10#7)(2008-11#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
we present two cases of##2##5##(2008-10#1)(2008-12#1)
we present two##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
we present##118##2##(1990-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#15)(2008-11#8)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-9#3)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#4)
we presented##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
we previously demonstrated##2##3##(2008-11#1)(2008-8#1)
we previously##8##2##(1993-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)
we produced##5##2##(1994-5#1)(1995-12#1)(1996-12#1)(2008-3#1)(2013-1#1)
we propose a method##3##4##(1994-9#1)(2008-3#1)(2010-8#1)
we propose a model for##3##5##(1991-5#1)(2008-7#1)(2009-8#1)
we propose a new approach to##2##6##(2012-3#1)(2013-8#1)
we propose a new##5##4##(1993-9#1)(2008-11#1)(2009-8#1)(2012-3#1)(2013-8#1)
we propose a novel##2##4##(2010-8#1)(2013-1#1)
we propose a simple##2##4##(2008-11#1)(2008-8#1)
we propose a##26##3##(1991-5#1)(1993-9#1)(1994-9#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-10#1)(2010-8#2)(2012-3#1)(2013-1#1)(2013-8#3)
we propose an alternative##3##4##(2008-11#1)(2012-2#1)(2012-3#1)
we propose an##8##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
we propose that a##3##4##(1996-2#1)(2008-5#1)(2008-8#1)
we propose that it##2##4##(2008-10#1)(2008-3#1)
we propose that the##8##4##(1991-9#1)(1992-12#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)
we propose that these##2##4##(2008-10#1)(2008-6#1)
we propose that this##2##4##(1996-6#1)(2008-9#1)
we propose that##31##3##(1991-9#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
we propose the##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
we propose to##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
we propose##79##2##(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#15)(2008-11#6)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
we proposed a##5##3##(2008-10#1)(2008-11#2)(2009-8#1)(2011-2#1)
we proposed that##2##3##(2008-10#1)(2008-11#1)
we proposed##11##2##(2008-10#5)(2008-11#3)(2009-8#1)(2010-8#1)(2011-2#1)
we proved that##2##3##(2008-9#1)(2011-2#1)
we provide a comprehensive overview of##2##6##(2008-11#1)(2011-2#1)
we provide a##9##3##(2008-11#2)(2008-4#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
we provide an overview of the##2##6##(2012-2#1)(2012-3#1)
we provide an overview of##3##5##(2012-2#2)(2012-3#1)
we provide an overview##4##4##(2010-11#1)(2012-2#2)(2012-3#1)
we provide an##5##3##(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
we provide evidence that##6##4##(1990-11#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
we provide the first##2##4##(2008-10#1)(2008-9#1)
we provide the##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
we provide##29##2##(1990-11#1)(1992-6#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#2)
we purified##5##2##(1992-10#1)(1992-7#1)(1995-2#1)(1996-12#1)(1997-1#1)
we quantified##5##2##(1990-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
we quantify the##2##3##(2008-10#1)(2012-3#1)
we quantify##4##2##(2008-10#1)(2008-8#1)(2012-3#2)
we raised##2##2##(2008-10#1)(2008-5#1)
we really##4##2##(1992-3#1)(2008-10#1)(2010-12#1)(2012-12#1)
we recently reported##3##3##(2008-5#1)(2009-8#1)(2011-2#1)
we recently##6##2##(2008-5#1)(2009-12#1)(2009-8#2)(2011-2#2)
we recombinantly##2##2##(1995-6#1)(2013-1#1)
we recommend that##3##3##(1990-3#1)(1994-2#1)(2010-8#1)
we recommend the##2##3##(2008-8#1)(2011-2#1)
we recommend##10##2##(1990-12#1)(1990-3#1)(1991-11#1)(1993-12#1)(1994-2#1)(1996-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
we recorded##2##2##(1993-12#1)(2008-8#1)
we recovered##2##2##(2008-9#1)(2012-3#1)
we reexamine##2##2##(2008-8#2)
we refer to##6##3##(1992-6#1)(2008-10#3)(2008-11#1)(2011-2#1)
we regard##2##2##(2012-2#2)
we remove##2##2##(2008-5#1)(2008-8#1)
we report a 30-year-old##2##4##(2012-12#1)(2013-1#1)
we report a case of a##3##6##(2011-1#1)(2012-3#2)
we report a case of##12##5##(2007-8#1)(2008-11#1)(2010-11#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
we report a new##2##4##(2008-12#1)(2012-2#1)
we report a novel##3##4##(2009-7#1)(2012-2#1)(2012-3#1)
we report a patient who##2##5##(2008-7#1)(2011-1#1)
we report a##34##3##(1991-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#2)(2009-7#4)(2010-11#1)(2010-6#4)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
we report an##7##3##(1996-12#1)(2008-11#1)(2008-7#2)(2010-10#1)(2011-2#1)(2013-1#1)
we report for the first time##2##6##(1995-6#1)(2008-10#1)
we report here##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
we report on a##3##4##(2008-11#1)(2008-9#1)(2012-3#1)
we report on the##7##4##(1995-11#1)(2008-10#2)(2008-7#2)(2010-12#1)(2011-2#1)
we report on##13##3##(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-3#1)
we report our experience##2##4##(1991-9#1)(2011-2#1)
we report that the##7##4##(1991-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-5#1)(2008-7#1)(2012-2#1)
we report that##29##3##(1990-5#2)(1991-9#1)(1992-3#1)(1993-6#2)(1994-11#2)(1994-8#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-10#1)(2009-8#1)(2012-2#5)
we report the NMR spectral##2##5##(2009-7#2)
we report the NMR##3##4##(2009-7#3)
we report the case of a##2##6##(2008-9#1)(2013-8#1)
we report the case##3##4##(2008-9#1)(2013-1#1)(2013-8#1)
we report the construction of##3##5##(1997-8#1)(2008-10#1)(2008-11#1)
we report the development of##2##5##(2008-10#1)(2013-8#1)
we report the expression##2##4##(2009-3#1)(2009-9#1)
we report the first##3##4##(2008-3#1)(2009-7#1)(2012-3#1)
we report the identification of a##3##6##(2008-10#1)(2009-6#1)(2012-3#1)
we report the identification of##5##5##(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#1)
we report the identification##6##4##(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#1)(2013-8#1)
we report the isolation of##2##5##(1995-2#1)(2008-10#1)
we report the results of a##3##6##(2008-11#1)(2008-9#1)(2013-1#1)
we report the results of##5##5##(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
we report the synthesis of##3##5##(2008-10#1)(2009-6#1)(2012-2#1)
we report the synthesis##4##4##(2008-10#2)(2009-6#1)(2012-2#1)
we report the use of##2##5##(2008-10#1)(2008-11#1)
we report the##64##3##(1991-2#1)(1991-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#2)(2008-9#2)(2009-3#1)(2009-6#2)(2009-7#11)(2009-9#1)(2010-4#2)(2010-6#1)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#2)(2013-8#3)
we report two##2##3##(2010-2#1)(2011-1#1)
we report##174##2##(1990-5#2)(1991-2#2)(1991-6#1)(1991-9#2)(1992-3#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-8#2)(1995-11#2)(1995-2#3)(1995-6#2)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-11#14)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#7)(2008-9#3)(2009-10#3)(2009-3#2)(2009-6#2)(2009-7#17)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#5)(2011-1#7)(2011-2#8)(2012-12#2)(2012-2#16)(2012-3#7)(2012-4#1)(2013-1#5)(2013-8#4)
we reported a##3##3##(2009-8#1)(2011-2#2)
we reported that##7##3##(1990-2#1)(2008-10#1)(2008-11#2)(2009-8#1)(2009-9#1)(2011-2#1)
we reported##13##2##(1990-2#1)(1991-5#1)(1992-12#1)(2008-10#1)(2008-11#2)(2009-8#3)(2009-9#1)(2011-2#3)
we retrospectively##2##2##(2011-2#1)(2013-1#1)
we reveal that##2##3##(2008-7#1)(2013-1#1)
we review how##2##3##(2008-8#1)(2012-3#1)
we review major##2##3##(2009-6#1)(2013-8#1)
we review our##3##3##(2010-5#1)(2010-8#1)(2011-2#1)
we review recent studies##2##4##(2012-2#1)(2013-1#1)
we review recent##7##3##(2008-11#3)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
we review the current knowledge##2##5##(2008-1#1)(2008-11#1)
we review the current##5##4##(2008-1#1)(2008-10#1)(2008-11#1)(2010-9#1)(2013-1#1)
we review the currently##2##4##(2008-10#1)(2011-2#1)
we review the development##2##4##(2008-10#1)(2008-11#1)
we review the literature on##2##5##(2011-2#2)
we review the literature##3##4##(1996-9#1)(2011-2#2)
we review the most##2##4##(2008-10#1)(2010-7#1)
we review the##30##3##(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
we review this##2##3##(2008-10#1)(2013-1#1)
we review those##2##3##(2008-11#1)(2009-5#1)
we review##62##2##(1992-12#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-7#1)(2008-8#3)(2009-1#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
we reviewed the##2##3##(2008-9#1)(2011-2#1)
we reviewed##6##2##(1996-11#1)(2008-7#1)(2008-9#1)(2011-2#2)(2011-3#1)
we sampled##2##2##(2008-10#1)(2009-11#1)
we screened the##2##3##(2008-8#1)(2011-2#1)
we screened##10##2##(2008-10#2)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
we searched for##6##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-3#1)
we see##6##2##(2008-11#2)(2008-12#1)(2008-3#1)(2009-4#1)(2010-10#1)
we seek to##2##3##(2013-1#1)(2013-8#1)
we selected a##2##3##(2008-5#2)
we selected##10##2##(1996-6#1)(1997-2#1)(2008-11#2)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
we sequenced##3##2##(2008-8#1)(2012-3#2)
we set##2##2##(2010-9#1)(2013-8#1)
we shall describe the##2##4##(2008-10#1)(2013-1#1)
we shall##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
we should not##2##3##(2008-8#1)(2010-12#1)
we should##5##2##(1996-6#1)(1997-7#1)(2008-10#1)(2008-8#1)(2010-12#1)
we show a##2##3##(2008-12#1)(2008-7#1)
we show for##3##3##(1992-10#1)(2011-2#1)(2012-2#1)
we show how the##3##4##(2008-10#1)(2008-5#1)(2010-11#1)
we show how this##2##4##(2008-11#1)(2008-9#1)
we show how##11##3##(1991-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#1)
we show that a##3##4##(2011-2#2)(2012-2#1)
we show that an##5##4##(1990-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
we show that both##2##4##(1993-8#1)(2012-12#1)
we show that in##4##4##(1997-1#1)(1997-7#1)(2008-9#2)
we show that positive##2##4##(1994-12#1)(2008-9#1)
we show that such a##2##5##(2008-11#1)(2012-2#1)
we show that the##32##4##(1990-5#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)
we show that there is a##2##6##(1997-1#1)(2008-3#1)
we show that there is##3##5##(1997-1#1)(2008-3#2)
we show that there##6##4##(1997-1#1)(2008-12#1)(2008-3#2)(2009-8#1)(2009-9#1)
we show that these##2##4##(1995-8#1)(2007-12#1)
we show that this##5##4##(1991-5#1)(1993-1#1)(2007-12#1)(2012-12#1)(2013-1#1)
we show that##132##3##(1990-5#5)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#6)(1995-6#1)(1995-8#3)(1995-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#4)(2007-12#3)(2008-10#7)(2008-11#10)(2008-12#2)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#7)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-3#2)(2010-6#1)(2011-2#8)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#6)(2013-8#2)
we show the##3##3##(1993-6#1)(2009-3#1)(2012-2#1)
we show##166##2##(1990-5#6)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-6#2)(1995-8#3)(1995-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#4)(2007-12#3)(2008-10#8)(2008-11#13)(2008-12#3)(2008-3#5)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#11)(2008-9#9)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#3)(2010-11#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-2#11)(2012-12#2)(2012-2#10)(2012-3#6)(2013-1#6)(2013-8#2)
we showed that a##2##4##(2008-10#1)(2012-3#1)
we showed that the##5##4##(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-2#1)
we showed that##23##3##(1990-5#1)(1991-7#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-2#2)(2008-10#3)(2008-11#2)(2008-6#1)(2008-9#3)(2009-8#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
we showed##26##2##(1990-5#1)(1991-7#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-2#2)(2008-10#4)(2008-11#4)(2008-6#1)(2008-9#3)(2009-8#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
we simulated the##2##3##(2008-11#1)(2008-9#1)
we sought to determine##2##4##(1991-2#1)(1994-2#1)
we sought to identify##2##4##(2008-10#1)(2008-9#1)
we sought to##6##3##(1991-2#1)(1994-2#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-9#1)
we sought##7##2##(1991-2#1)(1994-2#1)(1996-6#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-9#1)
we speculate on the##2##4##(1996-3#1)(2007-12#1)
we speculate on##4##3##(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)
we speculate that##5##3##(1997-3#1)(2008-10#2)(2008-7#1)(2012-3#1)
we speculate##11##2##(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-3#1)
we still##3##2##(1994-9#1)(2008-10#1)(2008-2#1)
we studied the effects of##4##5##(1993-1#1)(1994-5#1)(1995-11#1)(1997-1#1)
we studied the##23##3##(1992-6#1)(1993-1#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2012-9#1)(2013-8#1)
we studied##41##2##(1991-6#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-8#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#2)(2009-8#3)(2010-7#1)(2011-2#1)(2012-9#1)(2013-1#1)(2013-8#1)
we study a##3##3##(2008-5#1)(2010-1#1)(2013-8#1)
we study the##5##3##(2008-10#1)(2008-8#2)(2009-8#1)(2013-8#1)
we study##14##2##(1995-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#3)(2009-8#1)(2010-1#1)(2013-8#3)
we succeeded in##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
we successfully##3##2##(1995-8#1)(2008-10#1)(2008-2#1)
we suggest that the##7##4##(1992-12#1)(1994-12#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)
we suggest that##25##3##(1990-12#1)(1990-6#2)(1992-12#1)(1994-11#1)(1994-12#1)(1995-11#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-3#1)(2013-8#1)
we suggest the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
we suggest##35##2##(1990-12#1)(1990-6#2)(1992-12#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
we summarize our##2##3##(2009-8#1)(2010-6#1)
we summarize recent##3##3##(2008-9#1)(2010-5#1)(2011-2#1)
we summarize the##7##3##(1995-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#2)
we summarize##19##2##(1995-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#4)
we summarized##2##2##(2008-11#1)(2009-12#1)
we surveyed##2##2##(2008-11#1)(2011-10#1)
we synthesize##2##2##(2008-6#1)(2010-5#1)
we systematically##2##2##(2008-11#1)(2013-8#1)
we take##4##2##(1992-12#1)(2008-5#1)(2010-3#1)(2012-3#1)
we teach##2##2##(2008-3#1)(2012-2#1)
we test the##3##3##(2008-9#1)(2009-8#1)(2012-2#1)
we test this##2##3##(2008-9#1)(2011-2#1)
we test##6##2##(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)
we tested a##4##3##(1994-3#1)(2008-11#1)(2008-5#1)(2009-7#1)
we tested the##9##3##(1992-8#1)(2008-10#2)(2008-11#2)(2009-6#1)(2009-8#1)(2013-1#2)
we tested whether##4##3##(1993-9#1)(1994-3#1)(2012-2#1)(2013-1#1)
we tested##25##2##(1992-8#1)(1993-9#1)(1994-3#2)(1995-6#1)(2008-10#3)(2008-11#5)(2008-5#2)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-5#1)(2012-2#1)(2013-1#3)
we then##2##2##(1992-9#1)(2008-10#1)
we think that##2##3##(1995-6#1)(1997-3#1)
we thought##2##2##(1994-2#1)(2011-2#1)
we transfected##2##2##(1990-5#1)(2008-11#1)
we treated with##2##3##(1996-9#1)(2008-8#1)
we treated##4##2##(1991-8#1)(1996-9#1)(2008-8#1)(2008-9#1)
we tried to##8##3##(1990-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-12#1)
we try to##2##3##(2008-3#1)(2010-12#1)
we uncovered a##2##3##(2008-8#2)
we understand##2##2##(2008-10#1)(2008-3#1)
we undertook##2##2##(2008-5#1)(2013-8#1)
we use a simple##2##4##(2008-10#2)
we use a##11##3##(1995-9#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2011-2#1)
we use the##8##3##(1992-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#1)
we use##43##2##(1992-2#1)(1995-2#1)(1995-8#1)(1995-9#1)(2008-10#10)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
we used a combination of##3##5##(2008-11#1)(2008-5#1)(2009-8#1)
we used a##20##3##(1994-2#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
we used an##4##3##(1993-3#1)(2008-10#1)(2008-2#1)(2010-1#1)
we used in##2##3##(2008-3#1)(2013-1#1)
we used the##15##3##(1991-3#1)(1992-9#1)(1994-12#1)(1994-8#1)(2008-10#3)(2008-11#4)(2008-3#2)(2009-10#1)(2012-3#1)
we used to##2##3##(1990-2#1)(2008-8#1)
we used two##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
we used##95##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#15)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#8)(2008-5#3)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#3)
we utilized a##2##3##(1992-10#1)(2010-8#1)
we utilized##3##2##(1992-10#1)(2010-12#1)(2010-8#1)
we verified the##2##3##(2008-11#1)(2008-3#1)
we want to##4##3##(1994-3#1)(2008-11#1)(2009-8#1)(2012-12#1)
we wanted to compare the##2##5##(2011-2#1)(2013-1#1)
we wanted to compare##3##4##(2011-2#2)(2013-1#1)
we wanted to##7##3##(2008-10#1)(2011-1#1)(2011-2#4)(2013-1#1)
we were able to identify##2##5##(2008-8#1)(2011-2#1)
we were able to##15##4##(1991-9#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)
we were not able to##2##5##(2008-10#1)(2012-12#1)
we were##25##2##(1991-9#1)(1993-8#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
we will briefly##2##3##(1996-1#1)(2012-2#1)
we will describe##2##3##(2008-10#1)(2013-8#1)
we will discuss the##6##4##(2008-11#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-10#1)(2013-1#1)
we will discuss##14##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
we will explore##2##3##(1994-1#1)(1994-12#1)
we will focus on the##2##5##(2008-11#1)(2011-2#1)
we will have##3##3##(1995-2#1)(1997-3#1)(2013-8#1)
we will provide##2##3##(2008-7#1)(2012-2#1)
we will review the##2##4##(2009-1#1)(2012-3#1)
we will review##3##3##(2009-1#1)(2009-12#1)(2012-3#1)
we will summarize our##2##4##(2011-2#1)(2013-8#1)
we will summarize##3##3##(2011-1#1)(2011-2#1)(2013-8#1)
we will try to##2##4##(2008-10#1)(2013-1#1)
we will##56##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-3#2)(2008-10#9)(2008-11#4)(2008-12#3)(2008-4#4)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
we wished to##2##3##(1995-5#1)(2008-11#1)
we would##2##2##(1995-5#1)(2008-10#1)
we##3948##1##(1990-11#6)(1990-12#10)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#14)(1990-6#5)(1990-7#1)(1990-8#4)(1990-9#6)(1991-1#3)(1991-11#2)(1991-12#12)(1991-2#11)(1991-3#14)(1991-5#10)(1991-6#8)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#5)(1992-12#13)(1992-2#7)(1992-3#11)(1992-5#3)(1992-6#13)(1992-7#2)(1992-8#4)(1992-9#15)(1993-1#6)(1993-11#6)(1993-12#25)(1993-2#12)(1993-3#12)(1993-6#19)(1993-8#21)(1993-9#5)(1994-1#6)(1994-11#32)(1994-12#24)(1994-2#17)(1994-3#14)(1994-5#5)(1994-6#5)(1994-8#15)(1994-9#5)(1995-1#5)(1995-11#17)(1995-12#37)(1995-2#46)(1995-3#1)(1995-5#21)(1995-6#28)(1995-8#21)(1995-9#12)(1996-1#3)(1996-11#5)(1996-12#34)(1996-2#22)(1996-3#11)(1996-5#3)(1996-6#7)(1996-8#8)(1996-9#7)(1997-1#13)(1997-2#24)(1997-3#30)(1997-4#3)(1997-6#5)(1997-7#25)(1997-8#17)(1997-9#1)(2006-6#3)(2007-11#3)(2007-12#23)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#484)(2008-11#405)(2008-12#56)(2008-2#24)(2008-3#107)(2008-4#11)(2008-5#99)(2008-6#40)(2008-7#108)(2008-8#184)(2008-9#133)(2009-1#7)(2009-10#46)(2009-11#9)(2009-12#21)(2009-3#13)(2009-4#9)(2009-5#14)(2009-6#25)(2009-7#44)(2009-8#112)(2009-9#8)(2010-1#16)(2010-10#25)(2010-11#26)(2010-12#31)(2010-2#6)(2010-3#15)(2010-4#19)(2010-5#17)(2010-6#23)(2010-7#24)(2010-8#26)(2010-9#15)(2011-1#26)(2011-10#2)(2011-2#264)(2011-3#8)(2011-7#2)(2012-12#29)(2012-2#146)(2012-3#132)(2012-4#1)(2012-5#6)(2012-7#3)(2012-9#1)(2013-1#138)(2013-7#14)(2013-8#94)
we'll##4##1##(2009-10#2)(2011-2#1)(2013-1#1)
we've##3##1##(2008-6#1)(2010-12#1)(2012-3#1)
weak CL##4##2##(2008-10#4)
weak acid##3##2##(2008-10#3)
weak acidic##3##2##(2008-10#3)
weak acids##7##2##(2008-10#6)(2008-9#1)
weak affinity for##2##3##(1992-12#1)(1997-1#1)
weak and transient##2##3##(1997-7#1)(2008-8#1)
weak and##7##2##(1997-1#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-8#1)
weak association equilibria##2##3##(2008-10#2)
weak competitors##2##2##(2008-8#2)
weak electric##2##2##(2008-10#1)(2010-4#1)
weak fluorescent##2##2##(2008-10#1)(2008-4#1)
weak for##2##2##(2008-10#1)(2011-2#1)
weak in##2##2##(1996-12#1)(2008-9#1)
weak link##2##2##(2008-10#1)(2008-12#1)
weak modes##2##2##(2010-10#2)
weak negative##2##2##(1994-12#1)(2008-9#1)
weak or##3##2##(1992-3#1)(2008-11#1)(2012-2#1)
weak photorefractive##2##2##(2008-3#2)
weak points of##2##3##(1995-11#1)(2008-5#1)
weak tetanus##2##2##(1995-12#2)
weak to##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
weak##183##1##(1990-11#2)(1990-2#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#4)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#2)(1997-3#1)(1997-7#2)(2008-10#72)(2008-11#7)(2008-12#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#13)(2008-9#8)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
weak)##2##1##(2008-8#1)(2012-2#1)
weaken the##4##2##(1995-1#1)(2008-10#1)(2008-5#1)(2009-5#1)
weakened##7##1##(1995-9#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-8#1)(2013-1#1)
weakening of the##2##3##(1996-6#1)(2008-5#1)
weakening of##3##2##(1996-6#1)(2008-5#1)(2008-8#1)
weakening##7##1##(1996-6#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-5#1)
weaker and##2##2##(2008-10#2)
weaker in##3##2##(1992-12#1)(2008-8#1)(2008-9#1)
weaker than##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
weaker with age##2##3##(2008-7#1)(2009-7#1)
weaker##30##1##(1992-12#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#2)(2011-2#1)(2012-12#1)(2012-3#2)
weakest##5##1##(2008-5#1)(2008-7#1)(2009-11#1)(2012-3#2)
weakfish Cynoscion##2##2##(2010-8#2)
weakly acidic medium##3##3##(2008-10#3)
weakly acidic##8##2##(2008-10#8)
weakly and##2##2##(1990-11#1)(2008-9#1)
weakly associated with##2##3##(2008-10#1)(2013-7#1)
weakly basic##4##2##(1996-5#1)(2008-10#3)
weakly bound##2##2##(1991-5#1)(2010-7#1)
weakly coordinating##2##2##(2008-10#2)
weakly electric fish##2##3##(2010-8#2)
weakly expressed in##3##3##(1990-8#1)(2008-9#1)(2009-8#1)
weakly immobilized##2##2##(2008-11#2)
weakly inhibited##3##2##(1990-5#1)(1992-3#1)(2009-9#1)
weakly or not at all##2##5##(1992-10#1)(2008-11#1)
weakly or##3##2##(1992-10#1)(1994-3#1)(2008-11#1)
weakly pathogenic to##3##3##(2008-10#3)
weakly pathogenic##5##2##(2008-10#5)
weakly related to##3##3##(2008-10#2)(2010-12#1)
weakly virulent isolates##2##3##(2008-10#2)
weakly virulent##4##2##(2008-10#4)
weakly with##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
weakly##85##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-1#2)(1993-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-8#1)(2008-10#36)(2008-11#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#5)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#4)(2013-7#1)
weakness and##7##2##(1992-3#1)(1995-5#1)(2008-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
weakness as##2##2##(2009-3#1)(2012-2#1)
weakness in##3##2##(2012-3#3)
weakness of her##2##3##(1991-12#1)(2009-3#1)
weakness of##7##2##(1991-12#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
weakness with##2##2##(1994-3#1)(2008-7#1)
weakness##48##1##(1990-9#1)(1991-12#3)(1991-8#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-3#3)(2009-9#1)(2010-11#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#8)(2013-7#1)(2013-8#1)
weaknesses of##9##2##(1992-12#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)
weaknesses##22##1##(1992-12#1)(1993-1#1)(1994-1#1)(1994-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2011-1#1)(2011-2#3)(2013-1#2)
wealth and##2##2##(2011-2#2)
wealth of information to##2##4##(2010-11#1)(2011-10#1)
wealth of information##5##3##(1994-3#1)(1996-2#1)(2008-7#1)(2010-11#1)(2011-10#1)
wealth of##14##2##(1993-1#1)(1994-3#1)(1996-2#1)(1997-7#2)(2008-10#1)(2008-11#3)(2008-7#1)(2010-11#1)(2010-7#1)(2011-10#1)(2011-2#1)
wealth##20##1##(1991-2#2)(1993-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-7#2)(2008-10#1)(2008-11#3)(2008-7#1)(2010-11#1)(2010-7#1)(2011-10#1)(2011-2#4)
wealthy##3##1##(1994-1#1)(2008-11#1)(2010-11#1)
weaned lambs##3##2##(1996-12#1)(2008-9#2)
weaned##6##1##(1996-12#4)(2008-9#2)
weaning and##2##2##(2008-11#1)(2013-1#1)
weaning##14##1##(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-7#1)(2013-1#7)
weaning&quot##2##1##(1994-8#2)
weapon in the##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
weapon##12##1##(1990-5#1)(1995-11#1)(1995-2#2)(1996-2#2)(2008-10#2)(2008-11#1)(2010-6#1)(2010-7#1)(2011-2#1)
weapons##10##1##(1992-12#4)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)(2010-7#1)
wear and##2##2##(2008-8#1)(2008-9#1)
wear damage##2##2##(2008-8#2)
wear in##2##2##(2008-8#1)(2012-12#1)
wear metals##5##2##(2008-10#5)
wear of##2##2##(2008-8#1)(2011-2#1)
wear resistance##2##2##(2011-2#2)
wear was found for the##2##5##(2011-2#2)
wear was##3##2##(2008-8#1)(2011-2#2)
wear##44##1##(2008-10#7)(2008-8#13)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#2)(2011-2#6)(2012-12#5)(2012-2#1)(2013-1#6)
wearable##3##1##(2008-3#1)(2010-8#1)(2013-1#1)
wearers##7##1##(1993-11#2)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
wearing the PK##2##3##(2013-1#2)
wearing the##3##2##(2013-1#3)
wearing##10##1##(2008-10#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-7#1)(2013-1#5)
wears##2##1##(1995-6#1)(2008-5#1)
weasel M##4##2##(2008-6#4)
weasel##8##1##(1994-8#3)(2008-6#5)
weather and##4##2##(1990-8#1)(2008-10#3)
weather as a##2##3##(2008-10#2)
weather conditions and##2##3##(2008-10#2)
weather conditions##15##2##(2008-10#13)(2013-1#2)
weather data##7##2##(2008-10#7)
weather patterns##2##2##(2008-10#1)(2012-3#1)
weather variable##3##2##(2008-10#3)
weather variables and##2##3##(2008-10#2)
weather variables at##2##3##(2008-10#2)
weather variables only##3##3##(2008-10#3)
weather variables prior to the##2##5##(2012-3#2)
weather variables##19##2##(2008-10#15)(2012-3#4)
weather##80##1##(1990-8#1)(2008-10#65)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
weather-based##2##1##(2008-10#2)
weathered oil in##2##3##(2008-11#2)
weathered oil##4##2##(2008-11#4)
weathered##7##1##(2008-10#3)(2008-11#4)
weathering##7##1##(2008-10#6)(2010-7#1)
weaver##2##1##(1996-12#2)
web of##5##2##(2008-10#1)(2008-11#2)(2009-8#1)(2013-1#1)
web site##2##2##(2008-11#1)(2008-4#1)
web space##4##2##(2008-9#4)
web stability##2##2##(2008-9#2)
web tools##2##2##(2011-2#2)
web##41##1##(1990-5#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-4#2)(2008-7#1)(2008-8#5)(2008-9#15)(2009-8#1)(2010-4#2)(2011-2#3)(2012-3#1)(2013-1#1)
web-based course##2##2##(2010-10#2)
web-based learning##2##2##(2008-11#1)(2008-12#1)
web-based##14##1##(2008-10#2)(2008-11#2)(2008-12#1)(2009-9#1)(2010-10#5)(2010-5#1)(2011-3#1)(2012-3#1)
webs and##3##2##(2008-8#1)(2008-9#2)
webs##17##1##(2008-8#5)(2008-9#9)(2012-12#2)(2012-2#1)
website approaches##2##2##(2013-1#2)
website messaging##2##2##(2013-1#2)
website##13##1##(2008-11#1)(2008-12#2)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#5)
websites maintained by##2##3##(2013-1#2)
websites to engage##2##3##(2012-2#1)(2013-1#1)
websites to##3##2##(2012-2#1)(2013-1#2)
websites##13##1##(2008-11#1)(2008-12#2)(2008-8#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#5)
wedge low tibial osteotomy##2##4##(2011-2#2)
wedge resections of##3##3##(2011-2#3)
wedge##13##1##(1991-6#1)(1992-9#1)(2008-9#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#1)
wedging##6##1##(2007-8#6)
weed habitats##3##2##(2008-10#3)
weed hosts##3##2##(2008-10#3)
weed in##2##2##(2008-10#2)
weed species##3##2##(2008-10#2)(2008-12#1)
weed##28##1##(2008-10#23)(2008-12#2)(2008-8#1)(2011-1#2)
weeds and##3##2##(2008-10#2)(2008-12#1)
weeds in the##3##3##(2008-10#1)(2008-12#2)
weeds in##8##2##(2008-10#4)(2008-11#1)(2008-12#3)
weeds or##2##2##(2008-10#2)
weeds##27##1##(2008-10#18)(2008-11#1)(2008-12#8)
weeds)##2##1##(2008-10#1)(2008-12#1)
week 12##2##2##(1991-3#1)(2008-5#1)
week 24##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
week 7##2##2##(1992-8#1)(2011-2#1)
week after immunization##2##3##(1990-12#1)(2013-1#1)
week after the##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
week after##13##2##(1990-12#1)(1991-2#2)(1996-12#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2013-1#2)
week and##2##2##(2011-2#1)(2013-8#1)
week by##3##2##(1997-4#1)(2008-5#1)(2011-2#1)
week following##2##2##(1991-2#1)(1996-8#1)
week for 6 weeks##2##4##(2008-10#1)(2009-1#1)
week for 6##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-1#1)
week for 8 weeks##2##4##(2010-1#1)(2013-1#1)
week for##21##2##(1991-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#4)(2009-1#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
week from##4##2##(1996-11#1)(2008-10#2)(2012-2#1)
week history of##2##3##(1996-9#1)(2008-12#1)
week in##10##2##(1990-11#1)(1990-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
week of gestation##2##3##(1996-11#2)
week of treatment##2##3##(1992-3#1)(2011-2#1)
week of##16##2##(1992-3#1)(1994-12#1)(1995-6#2)(1996-11#2)(1996-5#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#2)(2012-3#1)
week old##2##2##(1994-6#1)(1995-12#1)
week or##2##2##(2008-10#1)(2008-5#1)
week period##4##2##(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
week postinfection##2##2##(2009-8#2)
week postinoculation##2##2##(2008-10#2)
week study##5##2##(1995-12#2)(1996-1#1)(2008-5#2)
week when##2##2##(1993-8#1)(2008-10#1)
week##179##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#4)(1995-3#1)(1995-6#4)(1996-1#3)(1996-11#4)(1996-12#3)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2008-1#1)(2008-10#28)(2008-11#16)(2008-12#5)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-1#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#15)(2013-8#4)
week)##5##1##(1991-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
week-long##2##1##(2008-11#2)
weekend physical therapy##2##3##(1994-3#2)
weekend##6##1##(1994-3#6)
weekly Kt/V urea##5##3##(2011-2#5)
weekly applications of##2##3##(2008-10#2)
weekly applications##3##2##(2008-10#3)
weekly dose##2##2##(1991-6#1)(1994-8#1)
weekly during the##2##3##(2008-10#1)(2011-2#1)
weekly during##3##2##(2008-10#2)(2011-2#1)
weekly for##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
weekly from##3##2##(2008-10#1)(2008-12#1)(2012-6#1)
weekly schedule##2##2##(1993-2#1)(1994-8#1)
weekly to##2##2##(1997-3#1)(2008-1#1)
weekly##62##1##(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-5#1)(1994-8#2)(1997-3#2)(2008-1#2)(2008-10#21)(2008-11#4)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#7)(2011-9#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#3)
weeks (1##2##2##(2008-10#2)
weeks (equivalent to average daily doses of approximately##4##8##(2008-9#4)
weeks (range##2##2##(2011-2#2)
weeks 2##2##2##(2009-12#2)
weeks after application##2##3##(2008-10#2)
weeks after birth##2##3##(1995-2#1)(2012-2#1)
weeks after exposure to##2##4##(2008-7#1)(2008-8#1)
weeks after exposure##3##3##(1996-8#1)(2008-7#1)(2008-8#1)
weeks after fruit set##2##4##(2008-10#2)
weeks after harvest##3##3##(2008-10#3)
weeks after infection##2##3##(2009-10#1)(2010-7#1)
weeks after injury##5##3##(2012-3#5)
weeks after inoculation##13##3##(1995-2#1)(2008-10#12)
weeks after the initial##2##4##(2009-3#1)(2012-2#1)
weeks after the surgery##2##4##(2009-7#1)(2011-2#1)
weeks after the##16##3##(1990-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-7#3)(2009-3#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
weeks after treatment##3##3##(1992-12#1)(2008-10#1)(2010-12#1)
weeks after##85##2##(1990-12#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#3)(1996-12#2)(1996-2#1)(1996-8#1)(1997-3#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-6#1)(2009-7#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#4)
weeks and a##2##3##(2008-10#1)(2008-9#1)
weeks and in##5##3##(1991-9#1)(2008-9#4)
weeks and##35##2##(1990-3#1)(1991-11#2)(1991-2#2)(1991-8#1)(1991-9#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#6)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
weeks at 25 degrees C##2##5##(2008-10#1)(2008-8#1)
weeks at##3##2##(2008-10#2)(2008-8#1)
weeks before commercial harvest##2##4##(2008-10#2)
weeks before##15##2##(1990-12#1)(1992-5#1)(1996-11#1)(1996-12#1)(2008-10#8)(2008-7#1)(2008-8#1)(2013-1#1)
weeks during the##2##3##(2008-10#1)(2008-12#1)
weeks earlier in##2##3##(2008-10#2)
weeks following the##3##3##(1993-11#1)(2008-7#1)(2009-3#1)
weeks following##9##2##(1993-11#1)(1995-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#2)
weeks gestation##3##2##(1991-2#1)(2008-12#1)(2008-7#1)
weeks gestational age##4##3##(2008-11#2)(2010-11#1)(2012-12#1)
weeks had##3##2##(1995-9#1)(2008-7#1)(2011-2#1)
weeks in a##2##3##(2008-10#1)(2013-1#1)
weeks in the##3##3##(1995-8#1)(1997-8#1)(2008-10#1)
weeks in treated animals than in controls##2##7##(2011-2#2)
weeks in##23##2##(1993-3#2)(1993-6#2)(1994-12#1)(1995-8#1)(1996-11#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#2)(2013-1#3)
weeks later after##2##3##(1993-12#1)(2012-2#1)
weeks later##20##2##(1991-9#1)(1992-1#1)(1992-3#2)(1993-12#1)(1994-9#1)(1996-11#1)(2008-10#8)(2008-12#1)(2008-8#1)(2009-3#1)(2012-2#1)(2012-3#1)
weeks of age##13##3##(1990-3#1)(1991-6#2)(1993-3#1)(1994-6#1)(1995-8#1)(1997-5#1)(2008-10#2)(2008-5#1)(2011-2#3)
weeks of gestation##9##3##(1997-3#1)(2008-11#3)(2012-2#1)(2012-3#1)(2013-1#3)
weeks of life and##2##4##(2008-5#2)
weeks of life##4##3##(1993-12#1)(2008-5#2)(2011-1#1)
weeks of pregnancy##4##3##(1994-3#2)(1995-8#1)(2009-1#1)
weeks of storage##2##3##(2008-10#2)
weeks of the##3##3##(1993-12#1)(2008-5#1)(2008-7#1)
weeks of therapy##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
weeks of treatment##8##3##(1990-11#1)(1991-11#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-6#2)(2013-1#1)
weeks of##75##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-3#1)(1997-5#1)(2008-10#11)(2008-11#5)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
weeks old##3##2##(1997-5#1)(2008-10#2)
weeks on##3##2##(2008-10#1)(2009-1#1)(2013-1#1)
weeks one##2##2##(1996-6#1)(2008-10#1)
weeks or##4##2##(2008-10#2)(2008-7#1)(2008-9#1)
weeks post##2##2##(2008-10#1)(2010-12#1)
weeks post-capture##3##2##(2008-5#3)
weeks post-injury##2##2##(2011-2#2)
weeks postbloom##8##2##(2008-10#8)
weeks postinoculation##3##2##(2008-10#3)
weeks postoperatively##6##2##(1992-2#1)(1994-3#1)(2008-10#1)(2012-12#2)(2012-3#1)
weeks postsurgery##2##2##(1991-3#1)(1992-12#1)
weeks prior to the##2##4##(1994-8#1)(2008-10#1)
weeks prior to##3##3##(1994-8#1)(2008-10#2)
weeks provided##2##2##(1991-6#1)(2008-5#1)
weeks resulted in##2##3##(2008-10#2)
weeks the##2##2##(1996-5#1)(2008-5#1)
weeks to##9##2##(1991-3#1)(1991-8#1)(1993-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
weeks under##2##2##(2008-10#2)
weeks was##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
weeks were##4##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-9#1)
weeks with##6##2##(1990-9#1)(2008-5#1)(2008-6#1)(2008-9#3)
weeks without any##2##3##(2008-10#2)
weeks without##3##2##(2008-10#3)
weeks##654##1##(1990-11#1)(1990-12#4)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#3)(1991-11#4)(1991-2#7)(1991-3#5)(1991-6#11)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#4)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#12)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-5#3)(1997-8#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#178)(2008-11#28)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#27)(2008-6#5)(2008-7#17)(2008-8#7)(2008-9#72)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#11)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#2)(2010-11#3)(2010-12#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#29)(2011-3#1)(2012-12#8)(2012-2#10)(2012-3#13)(2013-1#36)(2013-8#9)
weeks' gestation##10##2##(1993-12#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#2)
weeks'##12##1##(1993-12#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-7#1)(2011-2#2)
weeks) and##4##2##(1990-3#2)(1994-3#1)(2008-10#1)
weeks) in##4##2##(1992-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
weeks)##25##1##(1990-3#3)(1992-12#3)(1992-3#1)(1994-3#1)(1995-2#2)(1995-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#3)(2012-2#3)(2013-1#1)
weevil##6##1##(2008-10#3)(2011-10#2)(2013-8#1)
weigh##5##1##(1991-9#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-9#1)
weighed in the##2##3##(2008-10#2)
weighed in##3##2##(2008-10#3)
weighed##21##1##(1993-3#2)(1994-1#1)(1994-6#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
weighing less than 1500 g##2##5##(2008-11#2)
weighing##20##1##(1991-6#2)(1994-3#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#1)
weight (BW)##2##2##(2008-10#1)(2010-7#1)
weight (β = 0##2##4##(2011-2#2)
weight among##2##2##(2008-11#1)(2013-1#1)
weight and body##2##3##(1996-8#1)(2012-2#1)
weight and mandible weight##2##4##(2008-7#2)
weight and the##3##3##(2008-12#1)(2008-5#1)(2011-3#1)
weight and volume##2##3##(1990-11#1)(2011-2#1)
weight and##47##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-8#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
weight are##4##2##(1991-11#1)(1991-2#1)(2008-10#1)(2008-5#1)
weight as well as##2##4##(1990-9#1)(2008-10#1)
weight as##4##2##(1990-9#1)(1992-6#1)(2008-10#1)(2008-12#1)
weight at##3##2##(1991-11#1)(1997-5#1)(2008-7#1)
weight basis##2##2##(2008-10#1)(2008-7#1)
weight change##5##2##(1991-2#2)(2010-8#2)(2013-1#1)
weight changes##3##2##(2011-2#1)(2013-8#2)
weight control##5##2##(2010-12#1)(2012-2#4)
weight does not##2##3##(1994-12#1)(2009-6#1)
weight for##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
weight gain and##4##3##(1991-12#1)(1995-10#1)(2008-5#1)(2010-1#1)
weight gain in##3##3##(1991-2#1)(2012-2#1)(2013-1#1)
weight gain was##2##3##(2011-2#1)(2013-1#1)
weight gain##27##2##(1991-12#1)(1991-2#2)(1995-10#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#11)
weight gains##5##2##(1991-12#1)(2008-5#3)(2011-2#1)
weight heparin##7##2##(2008-10#2)(2008-3#1)(2013-1#4)
weight in diabetes##2##3##(2008-12#2)
weight in the##2##3##(1993-8#1)(2009-6#1)
weight in##13##2##(1991-11#1)(1991-12#1)(1993-8#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-9#1)
weight is##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
weight loss and##8##3##(1991-12#1)(1993-12#1)(1995-9#1)(2008-1#1)(2008-3#1)(2012-3#2)(2013-1#1)
weight loss diets##3##3##(2008-3#3)
weight loss in##2##3##(2008-3#1)(2013-8#1)
weight loss is##2##3##(1994-11#2)
weight loss of##2##3##(2013-8#2)
weight loss program##2##3##(2008-4#1)(2013-8#1)
weight loss##52##2##(1991-12#2)(1992-12#1)(1993-12#2)(1993-2#1)(1994-11#3)(1995-2#1)(1995-9#1)(2008-1#3)(2008-10#2)(2008-12#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#9)
weight management##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
weight of 1##3##3##(2008-10#1)(2008-8#2)
weight of different body organs (breast##2##6##(2008-12#2)
weight of the evidence##2##4##(2008-10#1)(2008-11#1)
weight of the##22##3##(1990-11#1)(1994-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2009-1#1)(2010-3#1)(2010-5#1)(2012-12#2)(2013-1#3)
weight of##93##2##(1990-11#2)(1990-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-8#2)(1997-2#1)(2008-1#1)(2008-10#22)(2008-11#7)(2008-12#7)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#8)(2008-9#3)(2009-1#1)(2009-12#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#5)(2013-1#6)
weight or##4##2##(1994-12#1)(1996-11#1)(2008-1#1)(2012-2#1)
weight per##3##2##(1996-12#2)(2009-6#1)
weight preoperatively##2##2##(2010-8#2)
weight proteins##2##2##(2008-10#1)(2008-7#1)
weight ranged##2##2##(2010-7#1)(2011-2#1)
weight ratio and##2##3##(1994-6#1)(2011-2#1)
weight ratio##3##2##(1994-6#1)(2008-10#1)(2011-2#1)
weight ratios##2##2##(2008-10#1)(2008-11#1)
weight reduction##6##2##(1996-11#1)(2008-3#2)(2011-2#1)(2013-8#2)
weight status##7##2##(2011-2#4)(2013-1#2)(2013-8#1)
weight than the##2##3##(1991-12#1)(2008-10#1)
weight to##6##2##(1991-1#1)(1993-1#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-4#1)
weight was##13##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#2)(1996-8#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
weight were examined##2##3##(1992-2#1)(2008-11#1)
weight were##11##2##(1991-2#1)(1992-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2011-2#1)
weight within##2##2##(2008-10#1)(2008-11#1)
weight##662##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-5#3)(1990-6#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#16)(1991-2#8)(1991-3#2)(1991-5#4)(1991-6#3)(1991-9#5)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#4)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#5)(1993-2#1)(1993-3#8)(1993-6#1)(1993-8#3)(1994-11#4)(1994-12#4)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#5)(1995-9#1)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#3)(1996-6#2)(1996-8#6)(1997-2#1)(1997-5#1)(1997-8#4)(2007-12#2)(2007-8#1)(2008-1#5)(2008-10#131)(2008-11#36)(2008-12#36)(2008-3#14)(2008-4#6)(2008-5#16)(2008-6#3)(2008-7#26)(2008-8#15)(2008-9#12)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#6)(2009-7#1)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#7)(2010-12#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#11)(2010-9#2)(2011-1#6)(2011-2#28)(2011-3#2)(2012-12#4)(2012-2#17)(2012-3#18)(2012-5#1)(2013-1#47)(2013-7#1)(2013-8#20)
weight)##14##1##(1994-5#1)(1994-8#1)(2008-10#4)(2008-11#2)(2008-6#1)(2010-11#2)(2012-2#3)
weight-bearing##3##1##(1997-5#1)(2008-12#1)(2010-5#1)
weight-loss dynamics##4##2##(2013-8#4)
weight-loss##5##1##(2013-8#5)
weight-related beliefs and##3##3##(2011-2#3)
weight-related##4##1##(2011-2#3)(2013-1#1)
weighted DH(w)##2##2##(2008-10#2)
weighted average##2##2##(1992-12#1)(1995-1#1)
weighted cases##2##2##(1992-12#2)
weighted imaging##2##2##(2012-12#1)(2012-2#1)
weighted mean of##3##3##(2008-10#3)
weighted mean##5##2##(2008-10#5)
weighted##36##1##(1992-12#3)(1992-2#1)(1992-3#1)(1995-1#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)
weighting##4##1##(1995-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
weights and##5##2##(1993-1#1)(1995-12#1)(2008-10#2)(2008-9#1)
weights are##7##2##(1993-1#3)(1996-2#1)(2008-8#1)(2008-9#1)(2011-3#1)
weights calculated##2##2##(1992-12#2)
weights for##4##2##(1991-2#1)(2008-10#2)(2010-3#1)
weights in 256 mg/kg##2##4##(2008-9#2)
weights in##3##2##(2008-11#1)(2008-9#2)
weights of the##4##3##(1997-7#1)(2008-11#1)(2008-9#1)(2011-2#1)
weights of thymus##2##3##(2008-5#2)
weights of##38##2##(1990-12#1)(1990-5#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#5)(2008-8#3)(2008-9#11)(2011-2#1)(2013-1#2)
weights to##2##2##(1993-1#1)(2008-9#1)
weights were increased##2##3##(2008-9#2)
weights were significantly decreased in 800 mg/L##2##7##(2008-9#2)
weights were significantly##3##3##(2008-9#3)
weights were##12##2##(1995-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#7)
weights with##2##2##(1993-1#1)(2009-10#1)
weights##114##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#7)(1992-2#2)(1993-1#10)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-7#1)(2008-10#22)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#24)(2009-10#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#3)(2013-8#1)
weihenstephanensis##5##1##(2011-2#5)
weirii##2##1##(2008-10#2)
welcome##6##1##(1991-1#1)(1995-2#1)(2007-12#1)(2008-8#1)(2009-6#1)(2011-2#1)
welcomed the##2##2##(1993-11#1)(1993-6#1)
welcomed##4##1##(1993-11#1)(1993-12#1)(1993-6#1)(2008-11#1)
weld##3##1##(2008-10#1)(2008-3#2)
welding fume##3##2##(2008-10#3)
welding##10##1##(1996-1#1)(2008-10#5)(2008-3#4)
welfare of##2##2##(1995-11#1)(2008-10#1)
welfare services##2##2##(1996-2#2)
welfare##24##1##(1992-1#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#5)(1995-11#1)(1995-3#1)(1996-2#4)(1996-3#2)(1997-2#2)(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#1)
well above##2##2##(1994-1#1)(2009-7#1)
well accepted by##2##3##(1991-6#1)(1994-8#1)
well accepted that##2##3##(1991-1#1)(2008-10#1)
well accepted##8##2##(1991-1#1)(1991-6#1)(1994-8#1)(2008-10#4)(2008-5#1)
well adapted to the##2##4##(2012-2#1)(2012-3#1)
well adapted to##4##3##(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
well adapted##5##2##(1997-7#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
well advised to##2##3##(2008-11#1)(2012-12#1)
well after##5##2##(1992-2#1)(1997-5#1)(2008-1#1)(2008-10#1)(2013-1#1)
well agree with those obtained by the method of standard additions##2##11##(2008-10#2)
well and##7##2##(2008-10#4)(2008-11#1)(2009-1#1)(2011-2#1)
well are##2##2##(1996-2#1)(2008-11#1)
well as a large##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
well as a##58##3##(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-6#1)(1996-12#1)(1996-3#2)(2007-12#1)(2008-10#17)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
well as an##19##3##(1995-2#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
well as for the##13##4##(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#2)
well as for##40##3##(1993-3#1)(1994-12#2)(1997-7#1)(2008-10#13)(2008-11#4)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
well as having##2##3##(2008-11#1)(2011-2#1)
well as in##113##3##(1990-12#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-12#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#32)(2008-11#11)(2008-12#4)(2008-3#1)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)
well as other##24##3##(1991-3#2)(1992-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-2#2)(2013-1#1)
well as that of##6##4##(1993-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
well as the##301##3##(1990-12#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#1)(1992-1#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#3)(1995-11#3)(1995-12#1)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#3)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#91)(2008-11#23)(2008-12#4)(2008-3#9)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#8)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#4)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#7)(2013-8#5)
well as to##40##3##(1992-1#1)(1994-11#1)(1994-2#2)(1995-2#1)(1996-5#1)(1996-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-9#3)(2010-10#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
well as##1627##2##(1990-12#6)(1990-2#1)(1990-5#5)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#5)(1991-11#3)(1991-12#6)(1991-2#5)(1991-3#8)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#9)(1993-1#2)(1993-11#3)(1993-12#10)(1993-2#2)(1993-3#4)(1993-6#7)(1993-8#7)(1994-1#5)(1994-11#6)(1994-12#13)(1994-2#5)(1994-3#6)(1994-5#3)(1994-8#10)(1995-11#10)(1995-12#8)(1995-2#14)(1995-3#3)(1995-5#8)(1995-6#11)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#11)(1996-3#6)(1996-5#5)(1996-6#2)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#2)(1997-4#4)(1997-6#6)(1997-7#10)(1997-8#7)(1997-9#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#9)(2007-8#2)(2008-1#9)(2008-10#411)(2008-11#130)(2008-12#35)(2008-2#7)(2008-3#37)(2008-4#24)(2008-5#38)(2008-6#14)(2008-7#32)(2008-8#38)(2008-9#57)(2009-10#16)(2009-11#4)(2009-12#8)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#11)(2009-7#11)(2009-8#18)(2009-9#1)(2010-1#8)(2010-10#13)(2010-11#10)(2010-12#10)(2010-2#3)(2010-3#2)(2010-4#9)(2010-5#8)(2010-6#12)(2010-7#8)(2010-8#8)(2010-9#2)(2011-1#10)(2011-2#81)(2011-3#5)(2011-4#1)(2011-7#2)(2011-8#1)(2012-12#12)(2012-2#60)(2012-3#30)(2013-1#55)(2013-7#3)(2013-8#24)
well at##6##2##(1991-2#1)(2008-10#1)(2008-11#3)(2008-12#1)
well be applied##2##3##(2008-10#1)(2010-8#1)
well be##5##2##(2008-10#3)(2008-11#1)(2010-8#1)
well before##2##2##(2008-10#1)(2012-2#1)
well being##8##2##(1995-1#3)(2008-1#2)(2008-11#1)(2009-1#1)(2011-2#1)
well below the##3##3##(1995-12#1)(2008-10#2)
well below##7##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)(2012-2#1)
well by##6##2##(1991-3#1)(1992-4#1)(2008-10#3)(2008-9#1)
well characterized##8##2##(1991-12#1)(1992-6#1)(1994-8#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#1)
well connected##2##2##(2008-8#1)(2009-7#1)
well conserved##6##2##(1990-5#1)(1991-12#1)(1996-12#1)(2008-6#1)(2008-7#1)(2010-10#1)
well controlled##7##2##(1994-12#2)(1997-8#1)(2008-10#1)(2008-12#2)(2010-10#1)
well defined and##2##3##(1990-2#1)(2011-1#1)
well defined at##2##3##(2008-7#1)(2010-6#1)
well defined but##2##3##(1992-2#1)(2008-11#1)
well defined flow conditions##2##4##(2008-10#1)(2008-11#1)
well defined in##2##3##(2008-10#1)(2008-3#1)
well defined##25##2##(1990-2#1)(1990-9#1)(1992-2#1)(1994-12#1)(1997-4#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-6#1)(2011-1#2)(2011-2#2)
well described by a##5##4##(1995-8#1)(2008-10#3)(2008-3#1)
well described by the beta-binomial##2##5##(2008-10#2)
well described by the##5##4##(1992-2#1)(2008-10#2)(2008-2#1)(2008-5#1)
well described by##12##3##(1992-2#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
well described for##2##3##(2009-11#1)(2009-12#1)
well described in##2##3##(2009-12#1)(2013-1#1)
well described##24##2##(1992-12#1)(1992-2#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#2)(2010-4#1)(2011-2#4)(2013-1#1)(2013-8#1)
well developed##7##2##(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-9#1)
well differentiated##2##2##(2008-8#2)
well distributed##2##2##(2008-8#1)(2009-7#1)
well do##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
well documented and##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2009-12#1)
well documented in##3##3##(1997-8#1)(2008-12#1)(2009-6#1)
well documented##26##2##(1990-6#1)(1992-12#1)(1993-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
well established and##2##3##(2008-11#1)(2013-1#1)
well established as##2##3##(2008-11#1)(2013-8#1)
well established in the##2##4##(2009-10#1)(2013-1#1)
well established in##3##3##(2009-10#2)(2013-1#1)
well established that##5##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
well established##36##2##(1991-12#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#3)
well explained##2##2##(2008-8#1)(2013-8#1)
well extracted##2##2##(2008-10#1)(2008-7#1)
well fitted##2##2##(2008-10#1)(2011-2#1)
well for all##2##3##(2008-10#1)(2008-12#1)
well for the##2##3##(1993-3#1)(1995-9#1)
well for##13##2##(1993-3#1)(1995-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2011-2#2)(2013-1#1)
well have##2##2##(1992-2#1)(2008-10#1)
well in the pH range##2##5##(2008-10#2)
well in the##7##3##(2008-10#5)(2008-11#2)
well in##24##2##(1996-1#1)(1996-12#1)(1996-3#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
well informed about the##4##4##(1997-6#1)(2008-10#1)(2008-9#1)(2009-9#1)
well informed##5##2##(1996-2#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-9#1)
well into the##2##3##(1996-2#1)(2008-10#1)
well into##3##2##(1996-2#1)(2008-10#1)(2009-5#1)
well known and##3##3##(1990-2#1)(1996-3#1)(1997-5#1)
well known in##3##3##(1995-2#1)(2008-12#1)(2009-10#1)
well known that the##3##4##(1993-3#1)(1997-2#1)(2013-1#1)
well known that##17##3##(1991-6#1)(1993-3#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
well known to be##3##4##(1994-11#1)(2008-11#1)(2008-7#1)
well known to##8##3##(1994-11#1)(1997-1#1)(2008-11#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
well known##65##2##(1990-2#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
well matched##2##2##(2008-10#1)(2008-11#1)
well mixed##2##2##(2008-8#2)
well of a##2##3##(2008-11#1)(2008-9#1)
well of##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
well on##3##2##(2008-11#2)(2009-4#1)
well or better##2##3##(2008-11#1)(2008-9#1)
well over a wide##3##4##(2007-11#1)(2008-10#2)
well over a##8##3##(2007-11#1)(2008-10#5)(2008-3#1)(2011-2#1)
well over##9##2##(2007-11#1)(2008-10#6)(2008-3#1)(2011-2#1)
well plate##2##2##(2008-11#2)
well prepared##2##2##(1994-1#1)(2008-9#1)
well preserved##4##2##(1990-11#1)(2008-10#1)(2010-7#1)(2012-3#1)
well protected##2##2##(2008-10#1)(2008-9#1)
well proven##2##2##(1997-3#1)(2010-7#1)
well received by##2##3##(2008-11#1)(2008-12#1)
well received##3##2##(1996-3#1)(2008-11#1)(2008-12#1)
well recognised##3##2##(1993-12#1)(2008-7#1)(2012-2#1)
well recognized##7##2##(1990-2#2)(1990-9#1)(1996-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
well reproduced##2##2##(2011-2#2)
well resolved##6##2##(2008-10#4)(2009-9#2)
well separated within##5##3##(2008-10#5)
well separated##15##2##(2008-10#15)
well studied##6##2##(1991-12#1)(2008-1#2)(2008-5#1)(2008-8#1)(2011-2#1)
well suitable for##2##3##(2008-10#2)
well suited for the##2##4##(1997-6#1)(2008-10#1)
well suited for##16##3##(1995-2#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#3)(2010-8#1)(2011-1#1)
well suited to##10##3##(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
well suited##27##2##(1993-2#1)(1995-2#1)(1997-6#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
well that##2##2##(2011-2#1)(2013-1#1)
well the##12##2##(1990-11#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#2)(2011-4#1)
well to the##2##3##(1993-12#1)(2008-10#1)
well to##15##2##(1993-12#1)(1995-10#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-3#2)(2013-3#1)
well tolerated and##5##3##(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
well tolerated by##5##3##(1992-11#1)(1992-12#1)(2007-8#1)(2008-5#1)(2009-4#1)
well tolerated in##4##3##(1996-1#1)(2008-11#2)(2008-9#1)
well tolerated with##3##3##(1997-3#1)(2008-7#1)(2011-2#1)
well tolerated##39##2##(1990-12#2)(1990-3#1)(1990-6#1)(1991-11#1)(1992-11#1)(1992-12#2)(1994-12#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
well trained##4##2##(1993-11#1)(1994-8#1)(1996-2#1)(2012-2#1)
well understand the##2##3##(2008-10#2)
well understood in##3##3##(2008-10#2)(2011-2#1)
well understood##30##2##(1993-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
well using##2##2##(2008-10#1)(2009-6#1)
well validated##4##2##(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
well vascularized##2##2##(2008-12#1)(2008-7#1)
well water and##2##3##(2008-10#2)
well water##6##2##(2008-10#6)
well when##2##2##(2008-10#2)
well with a##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
well with corresponding##2##3##(2008-10#1)(2008-3#1)
well with experimental##2##3##(2008-11#1)(2009-7#1)
well with literature values##2##4##(2008-10#1)(2008-7#1)
well with that##5##3##(1996-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
well with the certified values##2##5##(2008-10#2)
well with the certified##3##4##(2008-10#3)
well with the corresponding##2##4##(2008-10#1)(2008-11#1)
well with the experimental##2##4##(2008-10#1)(2008-3#1)
well with the literature##2##4##(2008-10#2)
well with the results##3##4##(1990-11#1)(2008-10#2)
well with the standard##2##4##(2008-10#2)
well with the##40##3##(1990-11#1)(1990-8#1)(1991-12#1)(1995-2#1)(1997-6#1)(2008-1#2)(2008-10#23)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)
well with those found##3##4##(2008-10#3)
well with those obtained by a##2##6##(2008-10#2)
well with those obtained by the##6##6##(2008-10#6)
well with those obtained by##11##5##(2008-10#11)
well with those obtained with##2##5##(2008-10#2)
well with those obtained##14##4##(2008-10#14)
well with those##19##3##(2008-10#19)
well with##108##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-1#3)(2008-10#59)(2008-11#8)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)
well within the##3##3##(2008-10#1)(2008-2#1)(2010-7#1)
well within##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)
well##2577##1##(1990-11#3)(1990-12#8)(1990-2#6)(1990-3#2)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#8)(1990-9#6)(1991-1#6)(1991-11#4)(1991-12#12)(1991-2#8)(1991-3#12)(1991-5#5)(1991-6#8)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#3)(1992-11#4)(1992-12#11)(1992-2#8)(1992-3#8)(1992-4#2)(1992-6#10)(1992-7#1)(1992-8#3)(1992-9#13)(1993-1#3)(1993-11#6)(1993-12#14)(1993-2#3)(1993-3#7)(1993-6#10)(1993-8#11)(1993-9#1)(1994-1#8)(1994-11#8)(1994-12#23)(1994-2#6)(1994-3#6)(1994-5#4)(1994-8#14)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#10)(1995-12#12)(1995-2#20)(1995-3#5)(1995-5#10)(1995-6#11)(1995-8#6)(1995-9#3)(1996-1#5)(1996-11#4)(1996-12#10)(1996-2#22)(1996-3#12)(1996-5#6)(1996-6#3)(1996-9#3)(1997-1#11)(1997-2#12)(1997-3#7)(1997-4#6)(1997-5#3)(1997-6#10)(1997-7#11)(1997-8#13)(1997-9#1)(2006-5#1)(2006-6#2)(2007-11#4)(2007-12#13)(2007-8#4)(2008-1#21)(2008-10#694)(2008-11#213)(2008-12#49)(2008-2#18)(2008-3#57)(2008-4#33)(2008-5#55)(2008-6#21)(2008-7#63)(2008-8#59)(2008-9#74)(2009-1#4)(2009-10#21)(2009-11#6)(2009-12#16)(2009-3#6)(2009-4#8)(2009-5#3)(2009-6#14)(2009-7#17)(2009-8#22)(2009-9#5)(2010-1#11)(2010-10#19)(2010-11#15)(2010-12#19)(2010-2#3)(2010-3#6)(2010-4#11)(2010-5#12)(2010-6#15)(2010-7#13)(2010-8#16)(2010-9#2)(2011-1#17)(2011-2#124)(2011-3#7)(2011-4#2)(2011-7#3)(2011-8#1)(2012-12#17)(2012-2#76)(2012-3#45)(2012-4#1)(2013-1#83)(2013-3#1)(2013-7#5)(2013-8#37)
well-balanced##3##1##(1993-12#2)(2008-10#1)
well-being and##9##2##(1991-8#2)(2008-1#1)(2008-12#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-7#1)(2012-2#1)
well-being in##2##2##(2011-2#1)(2012-2#1)
well-being of the##3##3##(1991-9#1)(2008-11#1)(2010-9#1)
well-being of youth##2##3##(2010-11#1)(2010-9#1)
well-being of##13##2##(1991-9#1)(1992-3#2)(1995-12#1)(2008-11#4)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#2)
well-being was##2##2##(1991-8#1)(2012-2#1)
well-being##93##1##(1990-2#2)(1991-8#6)(1991-9#1)(1992-2#1)(1992-3#7)(1995-1#2)(1995-12#1)(1995-2#1)(1996-11#2)(1997-3#1)(2008-1#5)(2008-11#8)(2008-12#4)(2008-7#4)(2009-10#1)(2009-11#2)(2009-5#1)(2009-6#1)(2009-7#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-9#2)(2011-2#3)(2012-12#1)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#7)(2013-8#2)
well-characterized##16##1##(1992-1#1)(1994-8#1)(1996-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
well-child##3##1##(1996-1#2)(2010-8#1)
well-conceived##2##1##(1991-2#1)(2009-1#1)
well-conserved##2##1##(2009-8#1)(2012-2#1)
well-controlled##4##1##(1996-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
well-defined and##6##2##(1994-5#1)(2006-6#1)(2008-10#3)(2010-4#1)
well-defined anodic##2##2##(2008-10#2)
well-defined cathodic wave##2##3##(2008-10#2)
well-defined cathodic##3##2##(2008-10#3)
well-defined oxidation peak##2##3##(2008-10#2)
well-defined oxidation##3##2##(2008-10#3)
well-defined peak##2##2##(2008-10#2)
well-defined redox peaks##3##3##(2008-10#3)
well-defined redox##5##2##(2008-10#5)
well-defined reduction peak##2##3##(2008-10#2)
well-defined##63##1##(1990-12#1)(1993-8#1)(1994-5#2)(1997-3#1)(1997-5#1)(2006-6#2)(2008-10#36)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
well-designed studies##2##2##(2012-3#1)(2013-1#1)
well-designed##6##1##(1995-1#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
well-developed##9##1##(1993-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-2#1)
well-differentiated liposarcoma##2##2##(2013-1#2)
well-differentiated##7##1##(1990-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2012-3#1)(2013-1#2)
well-documented in Caucasian##2##3##(1997-3#1)(2010-3#1)
well-documented##11##1##(1996-12#1)(1997-1#1)(1997-3#2)(2008-10#1)(2008-11#3)(2010-3#1)(2012-3#1)(2013-1#1)
well-established method##2##2##(2008-10#1)(2008-3#1)
well-established##21##1##(1991-3#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#3)(2009-10#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#2)
well-known endemic areas in##2##4##(1996-11#2)
well-known endemic##3##2##(1996-11#3)
well-known risks of##2##3##(1994-6#1)(2013-1#1)
well-known##54##1##(1991-12#1)(1991-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-11#4)(1996-6#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#3)(2008-9#1)(2009-8#3)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
well-mixed##3##1##(2008-11#1)(2008-2#1)(2008-8#1)
well-nourished##6##1##(2008-11#6)
well-plate##2##1##(2008-11#2)
well-proven##2##1##(1990-2#1)(1997-6#1)
well-recognized##3##1##(2010-7#1)(2011-2#1)(2012-3#1)
well-resolved##3##1##(2008-10#3)
well-separated##3##1##(2008-10#3)
well-studied##6##1##(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)
well-suited for##2##2##(1993-1#1)(2008-6#1)
well-supported##3##1##(2008-10#3)
well-tolerated and##3##2##(2008-5#2)(2013-1#1)
well-tolerated##9##1##(1994-8#1)(1995-5#1)(2008-11#1)(2008-5#4)(2013-1#2)
well-trained##2##1##(1994-3#1)(2010-7#1)
wellbeing##8##1##(2008-10#1)(2008-7#1)(2010-10#2)(2011-2#2)(2012-12#1)(2013-1#1)
wellness and##5##2##(2008-11#1)(2013-1#1)(2013-8#3)
wellness##17##1##(1992-12#1)(1994-12#1)(1995-1#1)(1997-3#1)(2008-11#2)(2010-5#1)(2010-7#1)(2013-1#2)(2013-8#7)
wells in##2##2##(1992-6#1)(2013-1#1)
wells to##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
wells##22##1##(1990-12#1)(1992-6#2)(1994-2#1)(1994-5#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-2#6)(2008-3#1)(2010-11#1)(2013-1#2)
wenrichi##2##1##(2008-9#2)
went down##2##2##(1990-8#1)(1995-5#1)
went far beyond##2##3##(1992-12#1)(1995-6#1)
went from a median of##3##5##(2013-1#3)
went from##5##2##(2008-10#2)(2013-1#3)
went home##3##2##(1992-2#1)(1995-3#2)
went on to##3##3##(2008-10#2)(2008-12#1)
went on##4##2##(1992-1#1)(2008-10#2)(2008-12#1)
went to##5##2##(1991-1#2)(1992-12#1)(1995-12#1)(2009-10#1)
went##29##1##(1990-8#2)(1991-1#3)(1992-1#1)(1992-12#2)(1992-2#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-12#1)(2013-1#4)
were &gt##10##2##(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-7#1)(2012-3#1)
were &lt##15##2##(1995-2#1)(2008-10#10)(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
were &quot##7##2##(1991-9#2)(2008-7#2)(2009-5#1)(2010-11#1)(2011-2#1)
were (0##2##2##(2010-12#2)
were (1) to##2##3##(2009-1#1)(2013-1#1)
were (1)##3##2##(2009-1#1)(2013-1#2)
were (i)##3##2##(2008-10#3)
were 0##138##2##(1990-2#2)(1990-6#1)(1991-12#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#104)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#3)
were 1 and##2##3##(2008-10#2)
were 1##55##2##(1991-3#2)(1991-5#1)(1992-3#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
were 10 and##2##3##(1992-3#1)(2008-10#1)
were 10##13##2##(1991-11#1)(1992-3#1)(1996-6#1)(2008-10#7)(2008-11#1)(2011-2#1)(2012-3#1)
were 10(-3)##2##2##(2008-10#1)(2008-3#1)
were 100##3##2##(2008-1#1)(2008-10#1)(2011-3#1)
were 100%##5##2##(2008-10#4)(2008-12#1)
were 11 and##2##3##(1997-2#1)(2008-7#1)
were 11##10##2##(1992-3#1)(1993-1#1)(1994-12#1)(1997-2#1)(2008-10#4)(2008-7#1)(2011-2#1)
were 12##7##2##(1990-6#1)(1990-8#1)(1994-6#1)(2008-10#3)(2008-8#1)
were 13 and##2##3##(2008-10#2)
were 13##6##2##(1997-2#1)(2008-10#5)
were 14##2##2##(2008-10#1)(2008-12#1)
were 15##6##2##(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2011-3#1)
were 152##2##2##(2008-10#2)
were 16##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
were 17##7##2##(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
were 18 and##2##3##(2008-10#1)(2008-12#1)
were 18##6##2##(2008-10#2)(2008-12#2)(2009-10#1)(2013-1#1)
were 19##2##2##(2008-10#2)
were 2##50##2##(1991-2#1)(1992-11#1)(1993-1#2)(1993-3#1)(1993-6#1)(1995-11#1)(1996-12#1)(1997-8#1)(2008-10#31)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-3#1)(2013-8#1)
were 20 and##3##3##(2008-10#2)(2013-1#1)
were 20##9##2##(1991-12#1)(2008-10#5)(2008-9#1)(2010-4#1)(2013-1#1)
were 200##4##2##(1990-12#1)(2008-10#2)(2008-11#1)
were 21##2##2##(2008-10#1)(2013-1#1)
were 22##3##2##(2008-10#3)
were 24##4##2##(1993-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
were 26##3##2##(1995-12#1)(2008-5#1)(2011-2#1)
were 27##2##2##(1994-8#1)(2011-2#1)
were 28##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
were 29##3##2##(1994-3#1)(2008-10#1)(2012-3#1)
were 3 and##2##3##(2008-10#2)
were 3##38##2##(1990-11#1)(1990-3#1)(1991-9#2)(1992-3#1)(1997-6#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
were 30##10##2##(1990-12#1)(1991-8#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-2#1)(2013-1#1)
were 33##2##2##(2008-10#1)(2008-12#1)
were 351##2##2##(2009-7#1)(2011-1#1)
were 36##2##2##(1992-2#1)(2012-2#1)
were 37##2##2##(2008-11#1)(2011-1#1)
were 39##5##2##(1991-12#1)(1995-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
were 4##20##2##(1995-11#2)(1996-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
were 40##3##2##(1992-5#1)(2008-10#2)
were 400##2##2##(2008-10#1)(2008-11#1)
were 42##2##2##(2008-10#1)(2013-1#1)
were 44##2##2##(2008-10#1)(2008-7#1)
were 45 to##2##3##(2008-10#1)(2008-11#1)
were 45##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
were 46##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
were 49##2##2##(1995-10#1)(2008-10#1)
were 5 and##2##3##(2008-10#2)
were 5##28##2##(1993-2#1)(1993-9#1)(1997-8#1)(2008-10#21)(2008-11#1)(2010-11#1)(2011-1#1)(2012-3#1)
were 50##3##2##(1990-11#1)(1991-2#1)(1993-8#1)
were 56##2##2##(2008-10#1)(2013-8#1)
were 57##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
were 58##5##2##(2008-1#1)(2008-10#4)
were 6##18##2##(1991-2#1)(1993-2#1)(1996-6#1)(2008-10#12)(2009-11#1)(2009-2#1)(2011-2#1)
were 62##2##2##(2008-7#2)
were 7##11##2##(1994-12#1)(1996-11#1)(2008-10#8)(2009-11#1)
were 72##2##2##(2008-12#1)(2008-9#1)
were 76##2##2##(2011-2#1)(2013-1#1)
were 8##11##2##(1994-12#1)(1996-12#1)(1996-6#1)(1997-4#1)(2008-10#6)(2010-10#1)
were 80##3##2##(1993-2#1)(2008-10#1)(2008-7#1)
were 84##3##2##(2008-10#2)(2008-12#1)
were 9##4##2##(1994-12#1)(2008-10#2)(2008-5#1)
were 90##2##2##(2008-10#2)
were 91##2##2##(2008-10#1)(2008-12#1)
were 92##2##2##(2008-10#2)
were 94##4##2##(2008-10#4)
were 95##3##2##(2008-1#1)(2008-10#2)
were 96##2##2##(2008-10#1)(2013-8#1)
were 97##3##2##(1994-12#1)(2008-1#1)(2008-5#1)
were 98##4##2##(2008-10#1)(2008-5#1)(2010-1#1)(2012-2#1)
were 99##4##2##(2008-10#4)
were Aseptic##3##2##(1991-2#3)
were CVA16##2##2##(2013-8#2)
were Escherichia coli##2##3##(1996-8#1)(2008-7#1)
were Group##2##2##(2008-10#2)
were HEV71##2##2##(2013-8#2)
were HIV positive##4##3##(1993-11#2)(1997-6#1)(2011-2#1)
were L##2##2##(2008-10#2)
were NPD##5##2##(2008-12#5)
were P##3##2##(2008-10#2)(2013-1#1)
were R##2##2##(2008-10#2)
were S##2##2##(2008-11#1)(2013-8#1)
were Salmonella##3##2##(2011-2#3)
were Soxhlet extracted##2##3##(2008-10#1)(2008-11#1)
were T cells##3##3##(1992-6#1)(2008-11#1)(2008-9#1)
were T##4##2##(1992-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
were a few##3##3##(2008-12#1)(2008-9#2)
were a random##2##3##(2008-10#1)(2012-3#1)
were a##30##2##(1991-5#1)(1993-12#1)(1995-9#1)(1996-6#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
were able to achieve##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
were able to adhere##2##4##(1996-12#1)(2011-2#1)
were able to demonstrate##2##4##(2008-7#1)(2012-2#1)
were able to detect as little as##2##7##(2008-10#2)
were able to detect##4##4##(2008-10#4)
were able to distinguish##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
were able to grow##2##4##(2008-10#1)(2011-2#1)
were able to identify##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
were able to induce##5##4##(1991-5#1)(1995-12#1)(2008-10#2)(2008-11#1)
were able to obtain##2##4##(1992-2#1)(2008-5#1)
were able to produce##3##4##(1991-12#1)(2008-5#1)(2008-8#1)
were able to reproduce##2##4##(2008-10#1)(2008-11#1)
were able to significantly##2##4##(2008-10#1)(2008-11#1)
were able to transmit##3##4##(2008-10#3)
were able to##100##3##(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#37)(2008-11#11)(2008-12#4)(2008-3#1)(2008-5#7)(2008-7#3)(2008-8#3)(2008-9#2)(2009-7#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#3)
were able##101##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#37)(2008-11#12)(2008-12#4)(2008-3#1)(2008-5#7)(2008-7#3)(2008-8#3)(2008-9#2)(2009-7#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#3)
were abolished by##2##3##(1990-2#1)(1997-4#1)
were abolished##4##2##(1990-2#1)(1990-5#1)(1997-4#2)
were about 1##2##3##(2008-10#1)(2008-11#1)
were about 2##2##3##(2008-10#2)
were about##17##2##(1990-2#1)(1996-2#1)(1997-3#2)(2008-10#10)(2008-11#1)(2008-8#1)(2010-11#1)
were above##4##2##(1990-6#1)(2008-10#3)
were absent in##6##3##(1995-10#1)(1997-3#1)(2008-10#2)(2008-11#1)(2012-3#1)
were absent##15##2##(1994-6#1)(1995-10#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#3)
were absorbed in##2##3##(2008-10#1)(2009-8#1)
were absorbed##3##2##(2008-10#2)(2009-8#1)
were abundant##2##2##(2008-10#1)(2008-7#1)
were accepted as##2##3##(2008-11#1)(2011-1#1)
were accompanied by##8##3##(1994-5#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-7#1)(2008-9#2)(2013-1#1)
were accomplished by##2##3##(1990-9#1)(2008-10#1)
were accomplished##7##2##(1990-9#1)(2008-10#6)
were accounted for by##2##4##(1990-5#1)(2008-10#1)
were accounted for##4##3##(1990-5#1)(2008-10#3)
were achieved after##2##3##(2008-11#1)(2008-5#1)
were achieved at##2##3##(1992-6#1)(2008-3#1)
were achieved by using##2##4##(2008-10#2)
were achieved by##8##3##(1991-6#1)(2008-10#6)(2008-3#1)
were achieved for the##2##4##(2008-10#2)
were achieved for##12##3##(1994-1#1)(2008-10#11)
were achieved in##12##3##(1997-8#2)(2008-10#8)(2008-2#1)(2008-9#1)
were achieved using##6##3##(1990-5#1)(2008-10#3)(2008-7#1)(2008-9#1)
were achieved when the experiments were carried out##2##8##(2008-10#2)
were achieved when##3##3##(2008-10#3)
were achieved with a##2##4##(2008-10#2)
were achieved with##7##3##(2008-10#7)
were achieved within##2##3##(2008-10#2)
were achieved without##2##3##(2008-10#1)(2008-2#1)
were achieved##86##2##(1990-5#1)(1991-6#1)(1992-6#1)(1994-1#1)(1996-9#1)(1997-8#2)(2008-10#64)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#3)(2013-1#4)
were acquired by##2##3##(2008-10#2)
were acquired on a 1##2##5##(2008-5#1)(2010-12#1)
were acquired##13##2##(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-3#1)
were activated by##5##3##(1990-8#1)(2008-11#2)(2008-7#1)(2008-9#1)
were activated in HC##2##4##(2008-11#2)
were activated in##3##3##(2008-11#2)(2008-9#1)
were activated##8##2##(1990-8#1)(2008-11#4)(2008-7#1)(2008-9#2)
were active##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2011-3#1)
were actively##3##2##(1996-1#1)(1996-12#1)(2008-8#1)
were actually##2##2##(1994-11#1)(2013-1#1)
were adapted from##2##3##(2012-2#1)(2012-3#1)
were adapted to##5##3##(2008-10#1)(2008-11#3)(2010-11#1)
were adapted##8##2##(2008-10#1)(2008-11#4)(2010-11#1)(2012-2#1)(2012-3#1)
were added as##2##3##(2008-10#1)(2008-11#1)
were added in the##2##4##(1997-8#1)(2013-1#1)
were added in##4##3##(1997-8#1)(2008-10#2)(2013-1#1)
were added to a##2##4##(1991-5#1)(2008-10#1)
were added to soil lacking##2##5##(2008-10#2)
were added to soil##4##4##(2008-10#4)
were added to the medium##2##5##(2008-11#1)(2008-5#1)
were added to the##15##4##(1991-6#1)(1992-6#1)(1996-1#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)
were added to##33##3##(1991-5#1)(1991-6#1)(1992-6#1)(1996-1#1)(1996-12#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)
were added##49##2##(1990-11#1)(1990-9#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-6#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-1#1)
were additionally##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
were additive##4##2##(1990-5#1)(2008-10#1)(2008-11#2)
were addressed##2##2##(2008-10#1)(2008-9#1)
were adequate for##3##3##(1991-1#1)(2008-10#2)
were adequate##4##2##(1991-1#1)(2008-10#2)(2012-2#1)
were adjacent##2##2##(2008-10#1)(2013-1#1)
were adjusted for##4##3##(1993-3#1)(2008-3#1)(2010-6#1)(2011-2#1)
were adjusted to##2##3##(2008-10#2)
were adjusted##9##2##(1993-3#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)
were administered a##2##3##(1994-5#1)(2011-2#1)
were administered in##2##3##(1994-12#1)(1997-8#1)
were administered the##2##3##(2008-11#1)(2009-11#1)
were administered to each##2##4##(1991-2#1)(1994-8#1)
were administered to##8##3##(1991-2#1)(1994-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
were administered with##2##3##(2008-10#1)(2008-7#1)
were administered##39##2##(1990-5#1)(1991-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#1)
were administrated with##3##3##(2011-3#1)(2012-3#2)
were administrated##7##2##(2011-3#1)(2012-3#5)(2013-1#1)
were admitted in##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
were admitted to our##2##4##(1997-8#1)(2012-12#1)
were admitted to##4##3##(1997-8#1)(2008-3#1)(2012-12#1)(2012-3#1)
were admitted with##2##3##(1997-8#1)(2010-12#1)
were admitted##11##2##(1997-8#3)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
were adopted##2##2##(1995-5#1)(2008-10#1)
were adsorbed##4##2##(2008-10#3)(2008-9#1)
were adult##2##2##(1996-11#1)(2012-3#1)
were advised to##2##3##(1997-8#1)(2008-10#1)
were affected by LH##2##4##(2009-10#2)
were affected by the##5##4##(2008-10#3)(2008-11#1)(2011-2#1)
were affected by##16##3##(1990-5#1)(1990-9#2)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#2)(2010-4#1)(2011-2#1)(2013-8#1)
were affected in##2##3##(2008-10#1)(2012-9#1)
were affected more than##2##4##(2008-10#1)(2008-11#1)
were affected more##3##3##(2008-10#2)(2008-11#1)
were affected significantly##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
were affected##34##2##(1990-5#1)(1990-9#2)(1991-1#1)(1992-1#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-4#1)(2011-2#6)(2012-9#1)(2013-8#1)
were affiliated##2##2##(2008-10#1)(2011-2#1)
were affinity##2##2##(1990-11#1)(2010-3#1)
were after##2##2##(1995-12#2)
were age##2##2##(1994-12#1)(1996-9#1)
were aged##4##2##(2008-7#1)(2009-10#1)(2011-2#1)(2012-3#1)
were aggregated##3##2##(2008-10#2)(2013-1#1)
were aggressive##2##2##(2008-10#1)(2010-1#1)
were agreeing##2##2##(2008-7#1)(2011-2#1)
were aligned##3##2##(1991-5#1)(2008-10#1)(2009-10#1)
were alive at##2##3##(1991-8#1)(2011-2#1)
were alive of which##2##4##(2008-12#2)
were alive##12##2##(1990-6#1)(1991-2#1)(1991-8#3)(2008-12#3)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
were all below##3##3##(2008-10#3)
were all found to##3##4##(1991-12#1)(2008-11#1)(2008-8#1)
were all lower than 1%##3##5##(2008-10#3)
were all significantly##3##3##(2008-10#3)
were all statistically##2##3##(1992-2#1)(2008-10#1)
were all within##2##3##(2008-10#1)(2008-11#1)
were all##45##2##(1990-9#1)(1991-12#1)(1992-2#1)(1992-6#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
were allocated to##2##3##(1991-8#1)(2009-8#1)
were allocated##3##2##(1991-8#1)(2008-10#1)(2009-8#1)
were allotted##2##2##(2008-5#1)(2008-9#1)
were allowed to##6##3##(1990-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)
were allowed##10##2##(1990-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#2)
were almost completely##2##3##(1995-6#1)(2008-10#1)
were almost the same as##2##5##(1997-8#1)(2008-10#1)
were almost##18##2##(1992-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#2)
were alpha-pinene##2##2##(2008-10#1)(2008-12#1)
were already##8##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#2)
were also able to##2##4##(2008-12#1)(2009-8#1)
were also achieved##5##3##(2008-10#5)
were also affected##3##3##(1990-6#1)(1992-5#1)(2009-12#1)
were also analysed##2##3##(2008-10#2)
were also analyzed in##2##4##(1997-6#1)(2011-2#1)
were also analyzed##8##3##(1994-12#1)(1997-6#1)(2008-10#3)(2009-8#1)(2011-2#1)(2012-12#1)
were also apparent##2##3##(2008-5#1)(2008-9#1)
were also asked to##2##4##(2008-11#1)(2010-12#1)
were also assessed##4##3##(1991-8#1)(1995-2#1)(2008-11#1)(2013-1#1)
were also avoided##2##3##(2012-12#2)
were also calculated and the##2##5##(1994-8#1)(2008-10#1)
were also calculated and##3##4##(1994-8#1)(2008-10#2)
were also calculated##8##3##(1994-8#1)(1996-3#1)(2008-10#4)(2010-6#1)(2011-2#1)
were also carried out##3##4##(2008-10#2)(2008-5#1)
were also characterized by##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
were also characterized##4##3##(2008-10#2)(2008-7#1)(2009-8#1)
were also collected##2##3##(2008-10#1)(2012-12#1)
were also compared with##4##4##(2008-10#2)(2008-2#1)(2011-10#1)
were also compared##6##3##(2008-10#3)(2008-2#1)(2011-10#1)(2012-12#1)
were also conducted##2##3##(2013-1#2)
were also confirmed by##2##4##(2008-10#2)
were also considered##3##3##(2008-10#3)
were also correlated##2##3##(2008-10#2)
were also defined##2##3##(2009-10#1)(2009-8#1)
were also demonstrated##2##3##(1991-10#1)(2007-11#1)
were also detected in the##3##5##(2008-10#1)(2009-12#1)(2010-5#1)
were also detected in##5##4##(1996-12#1)(2008-10#1)(2009-12#1)(2010-5#1)(2012-2#1)
were also detected on##2##4##(2008-10#1)(2008-8#1)
were also detected##14##3##(1996-12#1)(2006-6#1)(2008-10#8)(2008-8#1)(2009-12#1)(2010-5#1)(2012-2#1)
were also determined##11##3##(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
were also developed##2##3##(2008-10#2)
were also discussed##6##3##(2008-3#1)(2008-8#2)(2010-12#1)(2011-7#1)(2013-8#1)
were also evaluated##5##3##(2008-10#3)(2008-7#1)(2009-8#1)
were also evident##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
were also examined by##2##4##(2007-12#1)(2008-9#1)
were also examined for##2##4##(2008-10#1)(2009-12#1)
were also examined to##2##4##(2008-10#1)(2009-7#1)
were also examined##16##3##(1993-1#1)(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#8)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#1)
were also exposed to##2##4##(2008-11#1)(2012-3#1)
were also extracted##2##3##(2008-10#2)
were also found in##3##4##(1994-5#1)(2008-10#1)(2010-8#1)
were also found to be##3##5##(2009-10#1)(2012-2#2)
were also found to##7##4##(1997-1#1)(2008-11#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-2#2)
were also found##20##3##(1994-3#1)(1994-5#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
were also identified##7##3##(2008-10#3)(2008-11#1)(2008-8#1)(2009-6#1)(2011-2#1)
were also included in the##2##5##(1996-3#1)(2008-10#1)
were also included##4##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
were also inhibited by##3##4##(2011-2#1)(2011-3#1)(2013-1#1)
were also integrated##2##3##(2008-10#2)
were also investigated and##2##4##(2008-10#2)
were also investigated##25##3##(2008-10#22)(2008-12#2)(2011-3#1)
were also isolated##2##3##(1993-6#1)(2008-5#1)
were also made##3##3##(2008-10#2)(2011-2#1)
were also measured at 25 degrees C##2##7##(2008-10#2)
were also measured at##3##4##(1991-6#1)(2008-10#2)
were also measured##17##3##(1990-11#1)(1990-3#1)(1991-6#1)(1994-12#1)(1997-3#1)(2008-10#9)(2008-3#1)(2008-9#1)(2011-2#1)
were also more##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)
were also not##2##3##(1993-6#1)(2008-10#1)
were also observed among##2##4##(2008-10#1)(2008-11#1)
were also observed for##2##4##(1997-3#1)(2008-9#1)
were also observed in the##5##5##(1995-6#1)(2008-10#1)(2008-5#2)(2008-7#1)
were also observed in##8##4##(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)
were also observed##22##3##(1990-6#1)(1993-3#1)(1995-6#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
were also obtained from##4##4##(1992-12#1)(2008-10#1)(2008-5#2)
were also obtained##11##3##(1992-12#1)(1996-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-8#2)
were also operated on##2##4##(1991-2#1)(2010-8#1)
were also optimized##2##3##(2008-10#2)
were also performed with##2##4##(1994-5#1)(1996-1#1)
were also performed##3##3##(1994-5#1)(1996-1#1)(2008-10#1)
were also positive for##2##4##(1992-6#1)(2008-10#1)
were also present in##3##4##(1994-2#1)(1995-12#1)(2008-10#1)
were also present##5##3##(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#2)
were also reported##2##3##(1993-1#1)(2011-2#1)
were also resistant##2##3##(2008-10#1)(2008-5#1)
were also revealed##2##3##(1991-1#1)(2011-2#1)
were also seen in the##2##5##(1991-10#1)(2008-7#1)
were also selected##2##3##(2008-10#1)(2009-12#1)
were also shown to be##2##5##(1992-3#1)(2010-7#1)
were also shown to##4##4##(1992-3#1)(2008-10#1)(2010-7#1)(2012-2#1)
were also significantly##3##3##(2008-12#1)(2009-5#1)(2011-2#1)
were also similar to##2##4##(2008-10#1)(2008-8#1)
were also similar##5##3##(2008-10#1)(2008-8#2)(2009-12#1)(2011-1#1)
were also stained##3##3##(1995-12#1)(1996-12#1)(2008-5#1)
were also studied in detail##2##5##(2008-10#2)
were also studied in##3##4##(1995-1#1)(2008-10#2)
were also studied##21##3##(1991-11#1)(1995-1#1)(2008-10#14)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
were also subject##2##3##(2010-6#1)(2012-2#1)
were also successfully##2##3##(2008-10#2)
were also tested for##2##4##(2008-10#2)
were also tested in##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
were also tested on##2##4##(1993-3#1)(2008-9#1)
were also tested##12##3##(1993-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2013-1#1)
were also the##2##3##(2009-8#1)(2013-1#1)
were also up-regulated in##2##4##(2008-10#1)(2008-11#1)
were also used to##6##4##(2008-10#5)(2010-7#1)
were also used##11##3##(2008-10#10)(2010-7#1)
were also very##3##3##(1990-5#1)(2008-10#2)
were also##453##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#2)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-6#1)(1996-1#2)(1996-12#7)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#5)(1997-6#2)(1997-8#3)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#192)(2008-11#17)(2008-12#10)(2008-2#3)(2008-3#2)(2008-5#15)(2008-6#2)(2008-7#12)(2008-8#15)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#7)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#6)(2010-1#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#21)(2011-3#2)(2011-7#1)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#11)(2013-8#2)
were altered by##2##3##(1996-12#2)
were altered##3##2##(1996-12#2)(2013-8#1)
were always##11##2##(1990-5#1)(1991-11#1)(1994-2#1)(2008-10#4)(2008-11#2)(2008-8#2)
were amended with##2##3##(2008-10#2)
were among the##4##3##(1990-9#1)(1996-1#1)(2008-10#1)(2013-1#1)
were among##7##2##(1990-9#1)(1992-6#2)(1996-1#1)(1997-5#1)(2008-10#1)(2013-1#1)
were amplified and sequenced##4##4##(2008-10#2)(2008-12#1)(2013-8#1)
were amplified and##7##3##(1992-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-8#1)
were amplified by PCR and##2##5##(2008-10#1)(2008-8#1)
were amplified by polymerase chain reaction##2##6##(2008-10#2)
were amplified by the##3##4##(1995-12#1)(1995-6#1)(2008-10#1)
were amplified by##10##3##(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-5#1)
were amplified from the##2##4##(2008-10#1)(2010-4#1)
were amplified from##8##3##(1994-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-4#1)(2013-8#1)
were amplified using##2##3##(2008-10#1)(2008-11#1)
were amplified with##2##3##(1997-8#1)(2008-10#1)
were amplified##31##2##(1992-6#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-5#1)(2013-8#3)
were an##7##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2009-7#1)(2013-1#1)
were analysed according to##2##4##(2008-7#1)(2008-9#1)
were analysed after##2##3##(2008-10#2)
were analysed and##7##3##(1990-2#1)(2008-10#5)(2008-9#1)
were analysed as##2##3##(2011-2#1)(2012-8#1)
were analysed by gas chromatography##3##5##(2008-10#3)
were analysed by gas##4##4##(1990-5#1)(2008-10#3)
were analysed by means of##4##5##(1991-8#2)(2008-5#1)(2009-6#1)
were analysed by##27##3##(1990-5#1)(1991-8#2)(1993-6#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-7#1)(2009-6#1)(2013-1#2)
were analysed for the##3##4##(2008-10#1)(2008-11#2)
were analysed for##11##3##(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-6#1)
were analysed in##7##3##(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2013-1#1)
were analysed to##2##3##(1996-8#1)(2008-10#1)
were analysed using a##2##4##(2008-11#1)(2011-2#1)
were analysed using##11##3##(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)(2011-2#2)
were analysed with a##2##4##(2008-10#1)(2008-11#1)
were analysed with the##3##4##(2008-10#3)
were analysed with##8##3##(2008-10#6)(2008-11#1)(2008-7#1)
were analysed##108##2##(1990-2#1)(1990-5#1)(1991-8#3)(1992-5#1)(1993-6#1)(1994-8#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#43)(2008-11#7)(2008-12#5)(2008-5#2)(2008-7#5)(2008-9#4)(2009-6#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-6#1)(2012-8#1)(2013-1#5)
were analytically##2##2##(2008-10#1)(2008-11#1)
were analyzed according to the type of##2##7##(1993-11#1)(2012-3#1)
were analyzed according to the##3##5##(1993-11#1)(1995-12#1)(2012-3#1)
were analyzed according to##4##4##(1993-11#1)(1995-12#1)(2011-2#1)(2012-3#1)
were analyzed along##3##3##(2008-10#3)
were analyzed and the results##2##5##(2008-10#2)
were analyzed and the##3##4##(2008-10#3)
were analyzed and##13##3##(1991-12#1)(1993-12#1)(2008-10#8)(2009-10#1)(2012-3#1)(2013-1#1)
were analyzed as##3##3##(2008-10#2)(2010-7#1)
were analyzed based on##2##4##(2008-10#1)(2008-11#1)
were analyzed by GC and GC/MS##2##6##(2008-11#1)(2008-12#1)
were analyzed by GC and##3##5##(2008-11#1)(2008-12#1)(2012-2#1)
were analyzed by a##6##4##(2008-10#2)(2008-3#1)(2008-9#1)(2010-9#1)(2013-1#1)
were analyzed by gas chromatography##2##5##(2008-10#1)(2008-9#1)
were analyzed by gas chromatography-mass spectrometry##2##6##(2008-10#1)(2013-8#1)
were analyzed by gas##4##4##(2008-10#2)(2008-9#1)(2013-8#1)
were analyzed by means of##2##5##(2008-10#1)(2008-7#1)
were analyzed by real-time##2##4##(2008-10#1)(2012-3#1)
were analyzed by reverse##3##4##(1990-12#1)(1996-12#1)(2008-11#1)
were analyzed by scanning##2##4##(2007-12#1)(2009-7#1)
were analyzed by the proposed method##2##6##(2008-10#2)
were analyzed by the proposed##3##5##(2008-10#3)
were analyzed by the##8##4##(2008-10#6)(2011-2#1)(2013-1#1)
were analyzed by this##3##4##(1993-12#1)(2008-10#2)
were analyzed by using the##2##5##(2008-10#2)
were analyzed by using##5##4##(1997-7#1)(2008-10#4)
were analyzed by##77##3##(1990-12#2)(1990-2#1)(1993-12#1)(1993-8#1)(1996-12#2)(1997-7#1)(2007-12#1)(2008-10#34)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-7#1)(2010-1#1)(2010-9#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
were analyzed during##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
were analyzed following##2##3##(2008-10#2)
were analyzed for a##2##4##(2008-10#1)(2009-8#1)
were analyzed for copper##2##4##(2008-10#2)
were analyzed for the##4##4##(1997-2#1)(2008-10#2)(2011-2#1)
were analyzed for virulence##2##4##(2008-10#2)
were analyzed for##41##3##(1990-5#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#25)(2008-11#2)(2009-2#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-5#1)(2013-8#1)
were analyzed in a##4##4##(1994-1#1)(2008-12#1)(2008-9#1)(2012-2#1)
were analyzed in order to##2##5##(1990-2#1)(2008-10#1)
were analyzed in terms of##4##5##(1995-6#1)(1997-6#1)(2008-10#2)
were analyzed in the##3##4##(2008-10#3)
were analyzed in this##2##4##(2008-7#1)(2012-3#1)
were analyzed in##23##3##(1990-2#1)(1991-6#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-6#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
were analyzed retrospectively##2##3##(1990-6#1)(1997-8#1)
were analyzed to determine the##3##5##(1995-1#1)(2008-10#1)(2008-3#1)
were analyzed to determine##5##4##(1995-1#1)(1995-12#1)(2008-10#2)(2008-3#1)
were analyzed to##11##3##(1995-1#1)(1995-12#1)(2008-10#5)(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
were analyzed under##2##3##(2010-9#1)(2011-2#1)
were analyzed using the##4##4##(2008-10#1)(2008-12#2)(2010-12#1)
were analyzed using##23##3##(1994-11#1)(1994-6#1)(2008-10#9)(2008-12#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-7#1)(2012-3#1)(2013-1#3)
were analyzed with the##4##4##(2008-10#3)(2011-1#1)
were analyzed with##14##3##(1994-11#1)(2008-10#9)(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
were analyzed##296##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-6#2)(1996-12#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#133)(2008-11#15)(2008-12#7)(2008-3#2)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#10)(2012-2#5)(2012-3#13)(2012-5#1)(2013-1#17)(2013-8#8)
were anesthetized##4##2##(1992-3#2)(2011-2#2)
were antigenically related##2##3##(2008-5#2)
were antigenically##5##2##(1992-6#2)(2008-5#2)(2013-8#1)
were any##3##2##(1994-12#1)(2008-11#1)(2011-3#1)
were apparent##5##2##(1990-6#1)(2008-10#2)(2008-5#1)(2013-1#1)
were apparently##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
were applied alone##2##3##(2008-10#2)
were applied as##2##3##(2008-10#2)
were applied at##4##3##(2008-10#4)
were applied for the simultaneous determination of##2##7##(2008-10#2)
were applied for the##5##4##(2008-10#5)
were applied for##14##3##(2008-10#10)(2008-11#1)(2011-2#3)
were applied in##9##3##(2008-10#6)(2008-5#1)(2009-10#1)(2012-8#1)
were applied into the##2##4##(1995-12#1)(2008-10#1)
were applied satisfactorily to the determination of##2##7##(2008-10#2)
were applied to all##2##4##(2008-10#1)(2011-2#1)
were applied to determine##2##4##(2008-10#1)(2013-1#1)
were applied to the analysis of##4##6##(2008-10#4)
were applied to the determination of##11##6##(2008-10#11)
were applied to the determination##12##5##(2008-10#12)
were applied to the same##2##5##(1991-8#1)(2008-10#1)
were applied to the##37##4##(1991-8#1)(2008-10#29)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2012-2#1)
were applied to##79##3##(1991-8#1)(1994-9#1)(1997-2#1)(2008-10#60)(2008-11#2)(2008-5#2)(2008-7#3)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#2)(2013-1#1)
were applied##134##2##(1991-8#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-10#94)(2008-11#4)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-3#2)(2011-2#7)(2012-2#2)(2012-8#2)(2013-1#2)
were approached##3##2##(2007-12#1)(2008-11#1)(2010-12#1)
were appropriate in##2##3##(2010-12#2)
were appropriate##4##2##(1996-3#1)(2010-12#2)(2012-12#1)
were approximately 1##2##3##(2008-10#2)
were approximately 3##2##3##(2008-10#2)
were approximately##19##2##(1993-8#1)(1995-2#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)
were around##2##2##(2008-10#2)
were arranged in a##3##4##(2008-10#3)
were arranged in##5##3##(2008-10#4)(2008-12#1)
were arranged##9##2##(1997-2#1)(2008-10#4)(2008-12#1)(2008-3#2)(2009-1#1)
were arrayed##2##2##(2008-10#1)(2008-9#1)
were arrived at##3##3##(2008-10#3)
were artificially inoculated##4##3##(2008-10#4)
were artificially##5##2##(2008-10#4)(2013-1#1)
were as follows##25##3##(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#2)(1993-12#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(2008-10#7)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
were as##34##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
were asked for##2##3##(2008-10#1)(2008-11#1)
were asked to complete##5##4##(1993-1#1)(2008-10#1)(2008-11#2)(2008-7#1)
were asked to rate##3##4##(1991-6#1)(1995-3#1)(2008-12#1)
were asked to##26##3##(1991-6#1)(1993-1#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-11#11)(2008-12#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-8#1)(2013-1#2)(2013-8#1)
were asked##32##2##(1991-6#1)(1993-1#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#3)(2008-11#12)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-8#1)(2013-1#2)(2013-8#1)
were assayed for##11##3##(1990-12#1)(1993-2#1)(1994-5#1)(1995-6#1)(2008-10#7)
were assayed in##4##3##(1991-10#1)(2006-6#1)(2008-10#1)(2008-7#1)
were assayed##31##2##(1990-12#1)(1990-5#1)(1991-10#1)(1992-6#1)(1993-2#1)(1994-5#1)(1995-6#1)(1995-8#1)(2006-6#1)(2008-10#18)(2008-5#1)(2008-7#1)(2008-9#2)
were assembled in##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
were assessed at baseline##2##4##(2008-4#1)(2012-3#1)
were assessed at##7##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
were assessed by##14##3##(1992-2#1)(1997-3#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2009-1#1)(2012-4#1)(2013-8#2)
were assessed following##3##3##(2008-10#1)(2010-6#1)(2013-8#1)
were assessed for their ability to##2##6##(1990-11#1)(1995-11#1)
were assessed for their##3##4##(1990-11#1)(1995-11#1)(2008-10#1)
were assessed for##15##3##(1990-11#1)(1995-11#1)(1996-1#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#2)(2010-7#1)(2012-3#2)
were assessed in##10##3##(1990-11#1)(1993-11#1)(1996-1#1)(2008-10#3)(2008-12#1)(2009-9#1)(2010-11#1)(2010-8#1)
were assessed on a##2##4##(2008-2#1)(2013-8#1)
were assessed on##4##3##(1997-7#1)(2008-2#1)(2012-2#1)(2013-8#1)
were assessed over##2##3##(2008-5#1)(2011-2#1)
were assessed using the##5##4##(2008-7#2)(2008-9#1)(2010-6#1)(2013-1#1)
were assessed using##9##3##(2006-6#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-6#1)(2013-1#1)(2013-8#1)
were assessed with##3##3##(2012-2#1)(2013-1#1)(2013-8#1)
were assessed##112##2##(1990-11#2)(1990-5#1)(1992-2#1)(1993-11#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-1#2)(1996-6#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#2)(2008-10#30)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#5)(2009-1#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#6)(2012-4#2)(2013-1#6)(2013-8#7)
were assigned on##2##3##(1996-12#1)(1996-6#1)
were assigned randomly to one of##2##6##(1991-1#1)(1992-1#1)
were assigned randomly to receive##2##5##(2008-8#1)(2009-6#1)
were assigned randomly to##4##4##(1991-1#1)(1992-1#1)(2008-8#1)(2009-6#1)
were assigned randomly##5##3##(1991-1#1)(1992-1#1)(1995-3#1)(2008-8#1)(2009-6#1)
were assigned to concurrent##2##4##(2008-10#2)
were assigned to six##2##4##(2008-10#2)
were assigned to the##2##4##(1991-12#2)
were assigned to##15##3##(1991-12#3)(1996-12#1)(2008-10#8)(2010-8#1)(2012-2#1)(2013-1#1)
were assigned##30##2##(1991-1#1)(1991-12#3)(1991-2#1)(1992-1#1)(1995-3#1)(1996-12#2)(1996-6#1)(2008-10#12)(2008-8#1)(2009-6#1)(2009-7#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
were associated with a##5##4##(1996-8#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
were associated with decreased##2##4##(2011-2#2)
were associated with greater##3##4##(2008-12#1)(2012-12#1)(2013-1#1)
were associated with increased##3##4##(1993-3#1)(2008-10#1)(2009-5#1)
were associated with less##2##4##(2008-10#1)(2009-9#1)
were associated with lower##3##4##(1995-3#1)(2008-7#1)(2010-7#1)
were associated with more##5##4##(1995-8#1)(2008-10#2)(2008-11#1)(2010-1#1)
were associated with partial resistance##2##5##(2008-10#2)
were associated with resistance##2##4##(2008-10#2)
were associated with significant##2##4##(2008-10#1)(2010-8#1)
were associated with the same##2##5##(2008-10#1)(2008-9#1)
were associated with the##10##4##(1993-2#1)(1993-6#1)(2008-10#3)(2008-11#1)(2008-9#2)(2011-2#2)
were associated with##101##3##(1991-12#1)(1991-5#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-10#37)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#11)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
were associated##108##2##(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#40)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#11)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
were assumed to##4##3##(1990-5#1)(2008-10#2)(2012-12#1)
were assumed##6##2##(1990-5#1)(1990-6#1)(2008-10#2)(2008-3#1)(2012-12#1)
were asymptomatic##4##2##(1997-3#1)(2008-10#2)(2012-2#1)
were at gametic equilibrium##2##4##(2008-10#2)
were at high risk##2##4##(2010-10#2)
were at least##4##3##(1993-12#1)(2008-10#1)(2008-11#1)(2010-8#1)
were at risk##2##3##(2008-12#1)(2008-7#1)
were at##19##2##(1990-3#1)(1993-12#1)(1996-2#1)(1997-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-7#1)(2010-10#2)(2010-8#1)(2011-2#1)
were attached to the##2##4##(2008-10#1)(2008-11#1)
were attached to##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
were attached##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#1)
were attained##6##2##(1990-2#1)(2008-10#3)(2008-11#1)(2013-8#1)
were attempted##2##2##(2008-7#1)(2011-2#1)
were attending##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
were attracted##2##2##(2008-10#1)(2009-8#1)
were attributable to##2##3##(1995-6#1)(2012-2#1)
were attributable##3##2##(1990-9#1)(1995-6#1)(2012-2#1)
were attributed to differences in##2##5##(2008-10#2)
were attributed to the##3##4##(2008-10#2)(2008-9#1)
were attributed to##10##3##(2008-10#6)(2008-5#1)(2008-9#3)
were attributed##12##2##(2008-10#8)(2008-5#1)(2008-9#3)
were atypical##2##2##(2008-10#1)(2011-2#1)
were audited##2##2##(1996-9#1)(2013-1#1)
were automatically##4##2##(1994-6#2)(2008-10#2)
were available and##3##3##(2008-10#1)(2011-3#1)(2012-12#1)
were available for analysis##2##4##(2008-10#1)(2012-3#1)
were available for##5##3##(2008-10#2)(2008-12#1)(2012-12#1)(2012-3#1)
were available in##2##3##(2008-8#1)(2012-2#1)
were available to##2##3##(2010-8#1)(2012-3#1)
were available##18##2##(2008-10#6)(2008-12#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)
were avirulent on##2##3##(2008-10#2)
were avirulent##4##2##(2008-10#4)
were aware of the##3##4##(2008-11#1)(2008-12#1)(2009-10#1)
were aware of##4##3##(1996-1#1)(2008-11#1)(2008-12#1)(2009-10#1)
were aware##6##2##(1995-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2012-12#1)
were based on a##2##4##(2008-10#1)(2012-2#1)
were based on the##7##4##(1990-9#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-1#1)
were based on##21##3##(1990-12#1)(1990-9#1)(1991-6#1)(1995-2#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
were based upon##2##3##(1990-8#1)(1996-5#1)
were based##23##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-6#1)(1995-2#1)(1996-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
were basically##3##2##(2008-10#3)
were being##4##2##(1995-12#1)(2007-8#1)(2008-12#1)(2008-9#1)
were below 0##2##3##(2008-10#2)
were below 10##3##3##(1991-11#1)(2008-10#1)(2011-3#1)
were below 9%##3##3##(2008-10#3)
were below##23##2##(1991-11#1)(2008-10#17)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-3#1)
were benign##2##2##(1990-2#1)(1991-11#1)
were better than 0##2##4##(2008-10#2)
were better than those obtained by##2##6##(2008-10#2)
were better than those obtained##3##5##(2008-10#3)
were better than##7##3##(2008-10#7)
were better##14##2##(1992-2#1)(2008-10#9)(2008-11#1)(2010-1#1)(2013-1#2)
were between 0##8##3##(2008-10#7)(2008-5#1)
were between 1 and##2##4##(2008-10#2)
were between 91##2##3##(2008-10#2)
were between 92 and##3##4##(2008-10#3)
were between##35##2##(2008-10#32)(2008-12#1)(2008-5#1)(2008-9#1)
were biased##2##2##(1992-3#1)(2008-10#1)
were bilateral##2##2##(2008-5#2)
were bilaterally##3##2##(1991-2#1)(2010-9#1)(2013-1#1)
were biologically##3##2##(2008-10#2)(2008-11#1)
were blocked by##6##3##(1995-11#1)(1995-2#2)(1996-2#2)(2010-4#1)
were blocked in##2##3##(2008-10#1)(2008-11#1)
were blocked##9##2##(1995-11#1)(1995-2#2)(1996-2#2)(2008-10#2)(2008-11#1)(2010-4#1)
were born at the##2##4##(1991-11#1)(1995-2#1)
were born in##2##3##(1990-12#1)(2012-12#1)
were born##8##2##(1990-12#1)(1990-2#1)(1991-11#1)(1993-12#1)(1994-1#1)(1995-2#1)(2008-5#1)(2012-12#1)
were both at##2##3##(2008-10#1)(2008-8#1)
were both immobilized on an anion-exchange column##2##7##(2008-10#2)
were both tested##2##3##(2008-10#2)
were both##34##2##(1990-8#1)(1992-12#1)(1993-1#1)(1995-11#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
were bound to##2##3##(2008-10#2)
were bound##3##2##(2008-10#3)
were breast-fed##2##2##(1991-11#2)
were breathing normally##2##3##(1996-3#2)
were brought##3##2##(1991-11#1)(2008-11#1)(2011-2#1)
were built with##2##3##(2008-10#2)
were built##6##2##(1992-12#1)(1993-11#1)(2008-10#4)
were buried in##2##3##(2008-10#2)
were buried##7##2##(2008-10#7)
were by far##2##3##(1994-11#1)(2008-11#1)
were by##4##2##(1994-11#1)(2008-10#1)(2008-11#2)
were ca##3##2##(2008-10#3)
were caged with##2##3##(2008-10#2)
were calculated and compared##2##4##(2008-10#1)(2013-1#1)
were calculated and the##2##4##(2008-10#1)(2013-8#1)
were calculated and##12##3##(2008-10#7)(2008-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
were calculated as##4##3##(1991-6#1)(2008-10#3)
were calculated at##2##3##(2008-10#2)
were calculated based on##2##4##(2008-10#2)
were calculated based##3##3##(2008-10#3)
were calculated by the##2##4##(1993-3#1)(2008-11#1)
were calculated by using the##2##5##(2008-10#1)(2009-1#1)
were calculated by##6##3##(1993-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-1#1)(2011-1#1)
were calculated for each##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
were calculated for the##2##4##(1994-1#1)(2008-10#1)
were calculated for##15##3##(1994-1#1)(2008-10#12)(2011-2#1)(2013-1#1)
were calculated from the##4##4##(2008-10#3)(2008-11#1)
were calculated from##8##3##(2008-10#6)(2008-11#1)(2009-8#1)
were calculated in##2##3##(2008-10#1)(2012-12#1)
were calculated to be##4##4##(1993-1#1)(2008-10#2)(2011-1#1)
were calculated to##7##3##(1993-1#1)(2008-10#3)(2008-7#1)(2011-1#2)
were calculated using the method##2##5##(2008-10#2)
were calculated using the##8##4##(2008-10#5)(2008-11#1)(2011-2#1)(2011-3#1)
were calculated using##10##3##(2008-10#6)(2008-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
were calculated with##2##3##(2008-10#2)
were calculated##120##2##(1990-9#1)(1991-6#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-11#1)(1997-4#1)(2008-10#79)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#3)
were calibrated##3##2##(1993-3#1)(2008-10#2)
were called upon to##3##4##(2008-10#3)
were called##4##2##(1991-2#1)(2008-10#3)
were capable of infecting##3##4##(2008-10#3)
were capable of##18##3##(1993-12#1)(1995-6#1)(1997-8#1)(2008-10#10)(2008-11#2)(2009-12#1)(2010-5#1)(2012-2#1)
were captured by##2##3##(2011-2#2)
were captured in##3##3##(2008-10#2)(2010-8#1)
were captured##7##2##(2008-10#3)(2008-5#1)(2010-8#1)(2011-2#2)
were carefully studied##3##3##(2008-10#3)
were carefully##7##2##(2008-10#7)
were carried out and##2##4##(2008-10#1)(2008-5#1)
were carried out as##2##4##(2008-10#1)(2012-3#1)
were carried out at##7##4##(1996-5#1)(2008-10#4)(2008-11#1)(2009-8#1)
were carried out by using##2##5##(2008-10#2)
were carried out by##16##4##(1991-5#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#11)(2008-5#1)
were carried out for##2##4##(2008-10#2)
were carried out in a##6##5##(2008-10#5)(2013-1#1)
were carried out in order to##2##6##(2008-10#2)
were carried out in the##6##5##(1997-1#1)(2008-10#3)(2008-2#1)(2011-2#1)
were carried out in##22##4##(1990-6#1)(1991-6#1)(1997-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
were carried out on the##6##5##(2008-10#4)(2008-5#1)(2009-12#1)
were carried out on##11##4##(1994-5#1)(2008-10#5)(2008-12#1)(2008-5#2)(2009-12#1)(2011-2#1)
were carried out over the##2##5##(2008-10#2)
were carried out to clarify the##2##6##(2008-6#1)(2010-5#1)
were carried out to determine the influence of##2##8##(2008-5#1)(2011-2#1)
were carried out to determine the##5##6##(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
were carried out to evaluate the##2##6##(2008-10#1)(2008-12#1)
were carried out to##19##4##(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-2#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#1)
were carried out under##2##4##(2008-10#2)
were carried out using a##2##5##(2008-10#2)
were carried out using##10##4##(2008-10#9)(2010-3#1)
were carried out with an##2##5##(1991-6#1)(2008-5#1)
were carried out with##13##4##(1991-6#1)(1993-6#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-5#1)(2008-7#1)
were carried out##131##3##(1990-6#1)(1991-5#1)(1991-6#2)(1993-2#1)(1993-6#1)(1994-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-11#2)(2008-10#80)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#7)(2011-3#1)(2012-3#3)(2013-1#2)(2013-8#1)
were carried##136##2##(1990-6#1)(1991-3#1)(1991-5#1)(1991-6#2)(1993-2#1)(1993-6#1)(1994-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-11#2)(2008-10#82)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#8)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#7)(2011-3#1)(2012-3#3)(2013-1#2)(2013-8#1)
were carriers of##2##3##(2013-8#2)
were carriers##3##2##(2008-9#1)(2013-8#2)
were cast onto##2##3##(2008-10#2)
were cast##3##2##(2008-10#3)
were categorised##2##2##(1997-3#1)(2008-1#1)
were categorized by##2##3##(2010-10#1)(2013-3#1)
were categorized##6##2##(1995-12#1)(2008-8#1)(2010-10#1)(2013-1#2)(2013-3#1)
were caught##2##2##(1995-3#1)(2008-7#1)
were caused by##9##3##(1990-6#1)(1994-12#1)(1996-11#1)(2008-10#3)(2009-3#1)(2011-2#1)(2013-8#1)
were caused##10##2##(1990-6#1)(1991-5#1)(1994-12#1)(1996-11#1)(2008-10#3)(2009-3#1)(2011-2#1)(2013-8#1)
were certified##2##2##(1991-9#1)(2012-12#1)
were challenged with##7##3##(2008-10#6)(2008-9#1)
were challenged##10##2##(1997-1#1)(2008-10#8)(2008-9#1)
were changed##4##2##(1993-8#1)(2008-10#2)(2010-1#1)
were changes in the##2##4##(1990-5#1)(2008-10#1)
were changes in##4##3##(1990-5#1)(1991-1#1)(2008-10#1)(2008-3#1)
were changes##5##2##(1990-5#1)(1991-1#1)(2008-10#1)(2008-3#1)(2008-6#1)
were characterised##8##2##(1996-12#1)(2008-10#5)(2008-11#1)(2012-12#1)
were characteristic for##2##3##(1997-3#1)(2011-2#1)
were characteristic##4##2##(1992-8#1)(1997-3#1)(2008-10#1)(2011-2#1)
were characterized and the##2##4##(2008-10#1)(2008-9#1)
were characterized and##9##3##(1995-12#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-9#1)
were characterized as##5##3##(1992-3#1)(2008-10#3)(2008-8#1)
were characterized based on##2##4##(2008-10#2)
were characterized by a##3##4##(1995-12#1)(2008-10#1)(2008-12#1)
were characterized by an##2##4##(2008-10#1)(2009-11#1)
were characterized by determining##2##4##(2008-10#1)(2008-8#1)
were characterized by mating type##2##5##(2008-10#2)
were characterized by pathogenicity##3##4##(2008-10#3)
were characterized by restriction##2##4##(1992-3#1)(2008-10#1)
were characterized by various molecular methods and##3##7##(2008-10#3)
were characterized by various molecular methods##4##6##(2008-10#4)
were characterized by##44##3##(1992-3#1)(1992-6#1)(1993-12#1)(1995-12#1)(2008-10#28)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#2)
were characterized for##8##3##(1993-6#1)(1995-11#1)(2008-10#6)
were characterized in terms of##2##5##(2008-10#1)(2008-5#1)
were characterized in##8##3##(1994-8#1)(1995-2#1)(2008-10#4)(2008-5#1)(2013-8#1)
were characterized using vegetative compatibility group (VCG)##2##7##(2008-10#2)
were characterized using##13##3##(2008-10#12)(2008-9#1)
were characterized with##2##3##(2008-10#2)
were characterized##108##2##(1990-9#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-8#1)(1997-8#1)(2008-10#71)(2008-11#4)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
were checked on##2##3##(2008-10#2)
were checked using##2##3##(2008-10#2)
were checked##8##2##(2008-10#5)(2008-3#1)(2012-12#1)(2012-3#1)
were chemically##3##2##(2008-10#2)(2012-2#1)
were chosen and##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
were chosen as model##2##4##(2008-10#2)
were chosen as##9##3##(1993-8#1)(2008-10#8)
were chosen based on##2##4##(2008-10#1)(2010-6#1)
were chosen by##2##3##(2008-10#1)(2013-1#1)
were chosen for each##2##4##(2008-10#1)(2009-2#1)
were chosen for##7##3##(1996-8#1)(2007-12#1)(2008-10#3)(2009-2#1)(2011-2#1)
were chosen from##2##3##(2008-10#2)
were chosen in##2##3##(2008-10#2)
were chosen to be##2##4##(2008-10#2)
were chosen to##7##3##(1993-6#1)(2008-10#4)(2008-11#1)(2010-5#1)
were chosen##41##2##(1993-6#1)(1993-8#1)(1996-2#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-9#1)(2009-2#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#1)
were chronic##2##2##(2008-5#1)(2012-12#1)
were cinnabar##2##2##(2008-10#1)(2008-5#1)
were clarified##2##2##(1994-5#1)(2008-8#1)
were classified according to the##2##5##(1991-8#1)(2012-3#1)
were classified according to##4##4##(1991-8#1)(1996-3#1)(2008-7#1)(2012-3#1)
were classified as##23##3##(1990-8#1)(1991-6#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1996-3#2)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#2)
were classified by##6##3##(1995-12#1)(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)
were classified into four##2##4##(2008-10#1)(2009-12#1)
were classified into three groups##2##5##(1997-6#1)(2013-8#1)
were classified into three##4##4##(1990-12#1)(1997-6#1)(2008-10#1)(2013-8#1)
were classified into two##2##4##(2008-10#2)
were classified into##17##3##(1990-12#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-6#1)(2013-8#1)
were classified##55##2##(1990-12#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-3#3)(1997-2#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
were clearly differentiated##2##3##(2008-10#2)
were clearly##14##2##(1992-12#1)(1995-11#1)(1996-2#1)(2008-10#7)(2008-11#1)(2010-6#1)(2011-2#1)(2012-3#1)
were clinical##2##2##(2010-6#1)(2012-3#1)
were clinically improved##2##3##(2008-5#2)
were clinically significant##2##3##(1997-8#1)(2012-3#1)
were clinically##8##2##(1990-9#1)(1992-2#1)(1997-8#1)(2008-11#1)(2008-5#2)(2011-1#1)(2012-3#1)
were cloned and expressed in Escherichia coli##2##7##(1997-3#1)(2008-10#1)
were cloned and sequenced##11##4##(1992-6#1)(1993-12#1)(2008-10#8)(2008-8#1)
were cloned and##17##3##(1992-10#1)(1992-6#1)(1993-12#1)(1997-3#2)(2008-10#10)(2008-8#1)(2008-9#1)
were cloned from a##2##4##(1994-11#1)(2008-10#1)
were cloned from##11##3##(1990-5#1)(1993-12#1)(1994-11#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-6#1)(2010-5#1)
were cloned in##2##3##(2008-8#1)(2010-10#1)
were cloned into the##2##4##(2008-8#2)
were cloned into##6##3##(2008-10#2)(2008-11#1)(2008-8#2)(2010-6#1)
were cloned##41##2##(1990-5#1)(1992-10#1)(1992-6#1)(1993-12#2)(1994-11#1)(1995-6#1)(1995-8#1)(1997-3#2)(2008-10#17)(2008-11#1)(2008-6#1)(2008-8#7)(2008-9#1)(2010-10#1)(2010-5#1)(2010-6#2)
were close to 100%##4##4##(2008-10#4)
were close to those obtained##2##5##(2008-10#2)
were close to those##3##4##(2008-10#2)(2008-8#1)
were close to##11##3##(1992-2#1)(2008-10#7)(2008-8#1)(2008-9#1)(2010-4#1)
were closed##2##2##(1997-8#1)(2013-8#1)
were closely associated with the##2##5##(1990-5#1)(2008-10#1)
were closely correlated##2##3##(1990-5#1)(1992-5#1)
were closely linked##2##3##(2008-10#1)(2008-8#1)
were closely related to##2##4##(2008-10#2)
were closely related##5##3##(2008-10#4)(2010-12#1)
were closely##12##2##(1990-5#2)(1991-8#1)(1992-5#1)(2008-10#6)(2008-8#1)(2010-12#1)
were clustered into##2##3##(2008-10#2)
were clustered within##2##3##(1996-6#1)(2013-1#1)
were clustered##12##2##(1996-6#1)(2008-10#7)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
were co-cultured##2##2##(2008-5#1)(2012-4#1)
were co-inoculated##4##2##(2008-10#4)
were coated with##3##3##(1990-12#1)(2008-10#2)
were coated##5##2##(1990-12#1)(2008-10#3)(2009-7#1)
were coded##2##2##(2008-12#1)(2012-12#1)
were coinoculated with##4##3##(2008-10#4)
were coinoculated##5##2##(2008-10#5)
were collected and analyzed##5##4##(1992-1#1)(2008-10#2)(2011-2#1)(2013-8#1)
were collected and##12##3##(1992-1#1)(2008-10#4)(2008-11#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
were collected as##4##3##(1996-3#1)(2008-10#2)(2008-11#1)
were collected at the##2##4##(2008-10#1)(2008-5#1)
were collected at##9##3##(1991-6#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-1#1)(2013-1#2)
were collected by means of##2##5##(1992-5#1)(2009-12#1)
were collected by##8##3##(1992-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-12#1)(2011-2#1)
were collected during 1994##2##4##(2008-10#2)
were collected during a##2##4##(1991-6#1)(1993-2#1)
were collected during##7##3##(1991-6#1)(1993-2#1)(1995-12#1)(2008-10#2)(2008-5#1)(2010-8#1)
were collected for a##2##4##(2008-10#1)(2011-2#1)
were collected for each##2##4##(2008-10#1)(2008-11#1)
were collected for##12##3##(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2011-2#1)
were collected from 1##3##4##(2008-10#3)
were collected from a##4##4##(2008-12#1)(2010-3#1)(2010-5#1)(2012-12#1)
were collected from four##2##4##(2008-10#1)(2011-2#1)
were collected from patients##2##4##(1991-7#1)(2012-3#1)
were collected from the##7##4##(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
were collected from##64##3##(1991-7#1)(1993-12#1)(1995-8#1)(2008-10#31)(2008-11#1)(2008-12#7)(2008-5#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
were collected in four##2##4##(1994-6#1)(2008-10#1)
were collected in the##6##4##(1996-12#1)(2008-10#4)(2013-1#1)
were collected in two##2##4##(2008-10#1)(2008-11#1)
were collected in##18##3##(1990-6#1)(1994-6#1)(1996-12#2)(2008-10#9)(2008-11#1)(2008-12#2)(2012-2#1)(2013-1#1)
were collected on##8##3##(1993-6#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-5#1)(2012-3#1)
were collected over a##2##4##(2008-10#1)(2012-2#1)
were collected over##4##3##(2008-10#2)(2010-8#1)(2012-2#1)
were collected prospectively##2##3##(1996-11#1)(2011-2#1)
were collected randomly from##2##4##(2008-10#1)(2008-12#1)
were collected through##6##3##(1994-2#1)(2010-10#1)(2012-3#3)(2013-8#1)
were collected to##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
were collected using a##3##4##(2008-10#1)(2010-6#1)(2013-1#1)
were collected using##6##3##(2008-10#2)(2008-11#1)(2010-6#1)(2013-1#2)
were collected while##2##3##(2008-10#1)(2008-11#1)
were collected##210##2##(1990-12#1)(1990-6#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-3#2)(1997-2#2)(2008-1#1)(2008-10#80)(2008-11#10)(2008-12#16)(2008-5#9)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#15)(2013-8#6)
were colocalised in##2##3##(1997-3#2)
were colonized by the##2##4##(2008-10#2)
were colonized by##8##3##(1991-3#1)(2008-10#7)
were colonized##9##2##(1991-3#1)(2008-10#8)
were combined and analyzed##2##4##(2008-10#1)(2012-3#1)
were combined and##4##3##(2008-10#3)(2012-3#1)
were combined for##2##3##(2008-10#2)
were combined in the##2##4##(2008-10#2)
were combined in##4##3##(2008-10#4)
were combined to##2##3##(2008-10#2)
were combined with##5##3##(1992-3#1)(1994-12#1)(2008-10#2)(2009-9#1)
were combined##23##2##(1992-11#1)(1992-3#1)(1994-1#1)(1994-12#1)(1995-8#1)(2008-10#13)(2008-8#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-3#1)
were comfortable##2##2##(2008-11#1)(2009-5#1)
were common in##4##3##(1997-3#1)(2008-10#2)(2012-3#1)
were common to##2##3##(2008-10#1)(2012-2#1)
were common##9##2##(1997-3#1)(2008-10#4)(2011-2#1)(2012-2#2)(2012-3#1)
were commonly isolated from##2##4##(2008-10#2)
were commonly isolated##3##3##(2008-10#3)
were commonly##6##2##(2008-10#5)(2012-3#1)
were comparable in##2##3##(2008-10#1)(2009-11#1)
were comparable to that of##2##5##(2008-10#2)
were comparable to those obtained by##2##6##(2008-10#2)
were comparable to those obtained##3##5##(2008-10#3)
were comparable to those of##2##5##(2008-10#2)
were comparable to those##12##4##(2008-10#10)(2008-11#1)(2008-8#1)
were comparable to##21##3##(2008-10#16)(2008-11#3)(2008-8#1)(2013-1#1)
were comparable with those obtained by##2##6##(2008-10#2)
were comparable with those obtained##3##5##(2008-10#3)
were comparable with##7##3##(1995-6#1)(2008-10#4)(2009-11#1)(2013-8#1)
were comparable##39##2##(1995-6#1)(2007-12#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-7#3)(2008-8#1)(2009-11#2)(2013-1#1)(2013-8#1)
were compared according to##2##4##(2008-7#1)(2013-1#1)
were compared among##4##3##(1995-6#1)(2008-10#2)(2012-2#1)
were compared and discussed##3##4##(2008-10#3)
were compared and it was##2##5##(2008-10#1)(2008-3#1)
were compared and the##2##4##(2008-10#1)(2008-11#1)
were compared and##11##3##(2008-10#8)(2008-11#2)(2008-3#1)
were compared between the##2##4##(2011-2#2)
were compared between##8##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#3)(2012-5#1)(2013-1#1)
were compared by##7##3##(1991-12#1)(1993-2#1)(2008-10#4)(2013-1#1)
were compared for the##4##4##(1996-12#1)(2008-10#3)
were compared for their##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
were compared for##17##3##(1990-8#1)(1991-1#1)(1996-12#1)(1997-7#1)(2008-10#10)(2008-12#1)(2008-5#1)(2011-2#1)
were compared in different##2##4##(2008-12#1)(2008-8#1)
were compared in##13##3##(1994-2#1)(1996-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
were compared on##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
were compared statistically##2##3##(1994-3#1)(2008-10#1)
were compared to a##2##4##(1994-2#1)(2008-9#1)
were compared to determine the##2##5##(2010-1#1)(2010-8#1)
were compared to the reference##2##5##(2008-10#2)
were compared to the##10##4##(1991-12#1)(1991-2#1)(1993-8#1)(1997-8#1)(2008-10#3)(2008-9#2)(2009-7#1)
were compared to those obtained by the##2##7##(2008-10#2)
were compared to those obtained by##4##6##(2008-10#4)
were compared to those obtained##6##5##(2008-10#6)
were compared to those of##6##5##(1990-9#1)(2008-10#2)(2010-4#2)(2011-2#1)
were compared to those##16##4##(1990-9#1)(1994-1#1)(2008-10#9)(2008-12#1)(2008-8#1)(2010-4#2)(2011-2#1)
were compared to##49##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1997-8#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
were compared using a##2##4##(2008-10#2)
were compared using##11##3##(1995-12#1)(2008-10#8)(2009-3#1)(2010-12#1)
were compared when##2##3##(2008-8#1)(2008-9#1)
were compared with P##2##4##(2008-10#2)
were compared with a##8##4##(1991-8#1)(1997-1#1)(2008-10#5)(2010-12#1)
were compared with conventional##2##4##(2008-10#2)
were compared with each other and##2##6##(2008-10#2)
were compared with each other##3##5##(2008-10#2)(2008-11#1)
were compared with other##4##4##(1993-11#1)(2008-10#2)(2013-8#1)
were compared with previous##2##4##(2008-11#1)(2012-3#1)
were compared with respect to the##2##6##(1994-12#1)(2012-12#1)
were compared with respect to##4##5##(1992-10#1)(1994-12#1)(2011-1#1)(2012-12#1)
were compared with results obtained##2##5##(2006-6#1)(2008-10#1)
were compared with results##3##4##(2006-6#1)(2008-10#1)(2011-2#1)
were compared with that##2##4##(2008-10#1)(2008-8#1)
were compared with the results obtained using##2##7##(2008-10#2)
were compared with the results obtained##3##6##(2008-10#3)
were compared with the##27##4##(1992-10#1)(1994-3#1)(1994-8#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-5#1)(2013-1#2)
were compared with those from##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
were compared with those in##2##5##(2008-10#2)
were compared with those obtained by the##3##7##(2008-10#3)
were compared with those obtained by##9##6##(2008-10#9)
were compared with those obtained using##5##6##(2008-10#5)
were compared with those obtained with##3##6##(2008-10#3)
were compared with those obtained##18##5##(2008-10#18)
were compared with those of a##2##6##(1994-8#1)(2008-10#1)
were compared with those of the##3##6##(2008-10#2)(2008-11#1)
were compared with those of##13##5##(1990-5#1)(1991-3#1)(1994-8#1)(2008-10#9)(2008-11#1)
were compared with those##46##4##(1990-5#1)(1991-3#1)(1992-1#1)(1994-8#1)(2008-10#39)(2008-11#2)(2008-8#1)
were compared with##157##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#93)(2008-11#10)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
were compared##370##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-6#2)(1996-12#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-10#200)(2008-11#19)(2008-12#5)(2008-3#2)(2008-5#5)(2008-7#8)(2008-8#8)(2008-9#9)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#3)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#3)(2012-2#4)(2012-3#6)(2012-4#1)(2012-5#1)(2013-1#7)(2013-8#5)
were compatible with the##2##4##(1990-8#1)(2008-7#1)
were compatible with##7##3##(1990-8#1)(1991-8#2)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
were compatible##8##2##(1990-8#1)(1991-8#2)(2008-10#2)(2008-7#1)(2010-6#1)(2011-2#1)
were competitive inhibitors##2##3##(1991-5#1)(1994-5#1)
were complementary to##2##3##(2008-10#2)
were completed by##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
were completed in##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
were completed##13##2##(1993-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#2)(2011-2#2)(2013-1#3)(2013-8#1)
were completely resistant##2##3##(2008-10#2)
were completely separated##3##3##(2008-10#3)
were completely##33##2##(1990-5#2)(1991-3#1)(1993-6#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
were complex##2##2##(2008-10#1)(2012-4#1)
were complexed with##2##3##(1996-2#1)(2008-10#1)
were composed of##5##3##(1991-8#1)(1996-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
were computed and##2##3##(2008-10#1)(2008-9#1)
were computed for##2##3##(2008-10#1)(2010-12#1)
were computed##10##2##(2007-12#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)
were concentrated by##4##3##(1996-12#1)(2008-10#3)
were concentrated in##2##3##(2008-10#2)
were concentrated##11##2##(1996-12#1)(1996-6#1)(2008-10#8)(2008-11#1)
were concerned about##4##3##(1995-6#2)(2013-8#2)
were concerned##5##2##(1991-6#1)(1995-6#2)(2013-8#2)
were conditioned##2##2##(2008-10#2)
were conducted and##2##3##(1991-12#1)(2008-11#1)
were conducted at##7##3##(2008-10#5)(2008-11#2)
were conducted by##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
were conducted from##2##3##(2008-10#1)(2009-12#1)
were conducted in 1997##2##4##(2008-10#2)
were conducted in order to##2##5##(2008-10#1)(2012-3#1)
were conducted in##24##3##(1991-9#1)(1993-8#1)(1994-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-8#1)
were conducted on the##3##4##(2008-10#1)(2008-3#1)(2010-10#1)
were conducted on##5##3##(2008-10#3)(2008-3#1)(2010-10#1)
were conducted to assess the impact of##2##7##(2008-10#2)
were conducted to assess##3##4##(2008-10#2)(2010-8#1)
were conducted to determine##7##4##(1991-5#1)(1992-3#1)(2008-10#3)(2010-11#1)(2011-2#1)
were conducted to evaluate the##2##5##(2008-10#2)
were conducted to##27##3##(1991-5#1)(1992-3#1)(1996-2#1)(2008-10#17)(2008-11#2)(2008-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
were conducted using a##4##4##(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
were conducted using##8##3##(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-1#1)
were conducted with a##2##4##(1997-3#1)(2008-12#1)
were conducted with##18##3##(1995-1#1)(1996-1#1)(1997-3#2)(2008-10#5)(2008-12#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
were conducted##114##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#56)(2008-11#10)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#2)
were confined to the##3##4##(2008-5#1)(2008-7#2)
were confined to##4##3##(1995-1#1)(2008-5#1)(2008-7#2)
were confined##5##2##(1995-1#1)(2008-10#1)(2008-5#1)(2008-7#2)
were confirmed at##2##3##(2008-10#1)(2011-2#1)
were confirmed by the##2##4##(2008-10#1)(2008-11#1)
were confirmed by##16##3##(1993-12#1)(1994-11#1)(1994-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)
were confirmed for##2##3##(1997-2#1)(2009-6#1)
were confirmed in##2##3##(2008-10#1)(2008-11#1)
were confirmed to be##3##4##(2008-10#2)(2013-1#1)
were confirmed to##5##3##(1996-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
were confirmed using##2##3##(1990-6#1)(2008-5#1)
were confirmed with##7##3##(2008-10#2)(2008-8#1)(2010-12#1)(2011-3#2)(2012-12#1)
were confirmed##42##2##(1990-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#12)(2008-11#5)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#4)(2011-3#3)(2012-12#2)(2013-1#1)
were conjugated##2##2##(2008-5#1)(2012-12#1)
were connected with##3##3##(1990-2#1)(2008-12#1)(2011-2#1)
were connected##6##2##(1990-2#1)(2008-10#3)(2008-12#1)(2011-2#1)
were conserved##4##2##(1994-11#1)(1995-8#1)(2008-10#1)(2008-5#1)
were considerable##2##2##(1990-9#1)(1995-12#1)
were considerably##5##2##(1992-8#1)(1995-3#1)(2008-10#2)(2008-5#1)
were considered appropriate##2##3##(2010-12#2)
were considered as chemical descriptors to##2##6##(2008-10#2)
were considered as chemical descriptors##3##5##(2008-10#3)
were considered as##12##3##(1991-2#1)(1992-9#1)(2008-10#6)(2008-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
were considered for##3##3##(2008-10#2)(2012-12#1)
were considered good##2##3##(2007-8#1)(2011-2#1)
were considered normal##2##3##(2008-7#1)(2012-2#1)
were considered significant##3##3##(1995-1#1)(2011-2#1)(2013-1#1)
were considered the most reliable##2##5##(1993-12#2)
were considered the##4##3##(1993-12#2)(2008-10#1)(2008-7#1)
were considered to be##7##4##(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
were considered to##11##3##(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
were considered##75##2##(1990-11#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-12#3)(1994-3#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-9#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
were consistent between AxB(I) and##2##5##(2008-10#2)
were consistent in##2##3##(2008-10#2)
were consistent with a diagnosis of##2##6##(1991-8#1)(2008-11#1)
were consistent with a##6##4##(1991-12#1)(1991-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
were consistent with an##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
were consistent with the##14##4##(1990-6#1)(1992-9#1)(1994-8#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#1)(2013-1#2)
were consistent with##39##3##(1990-6#1)(1991-12#1)(1991-8#2)(1992-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#14)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
were consistent##48##2##(1990-6#1)(1991-12#1)(1991-8#2)(1992-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#19)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
were consistently detected in##2##4##(2008-10#1)(2008-9#1)
were consistently greater##2##3##(2008-10#2)
were consistently observed in##3##4##(1995-5#1)(2008-10#2)
were consistently observed##4##3##(1995-5#1)(2008-10#2)(2013-1#1)
were consistently##22##2##(1990-6#1)(1995-11#1)(1995-5#1)(1997-2#1)(2008-10#13)(2008-12#1)(2008-8#1)(2008-9#2)(2013-1#1)
were constructed and##12##3##(1997-3#1)(2008-10#6)(2008-11#1)(2008-8#3)(2013-1#1)
were constructed based on##2##4##(1995-6#1)(2008-12#1)
were constructed by##7##3##(1993-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)
were constructed for the##2##4##(2008-10#2)
were constructed for##6##3##(1993-6#1)(2008-10#4)(2012-12#1)
were constructed from##6##3##(2008-10#4)(2008-9#1)(2011-2#1)
were constructed of##2##3##(2008-10#1)(2011-2#1)
were constructed on##2##3##(1994-5#1)(2008-10#1)
were constructed to##4##3##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
were constructed using##7##3##(2008-10#3)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
were constructed with##2##3##(2008-10#1)(2008-9#1)
were constructed##72##2##(1991-10#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-5#1)(1995-6#2)(1997-2#1)(1997-3#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#9)(2008-9#5)(2009-7#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
were consumed##2##2##(2008-10#1)(2010-6#1)
were contacted by##2##3##(1997-3#1)(2012-12#1)
were contacted##3##2##(1996-1#1)(1997-3#1)(2012-12#1)
were contaminated with##3##3##(2008-10#2)(2008-12#1)
were contaminated##7##2##(2008-10#3)(2008-11#2)(2008-12#2)
were continuous##2##2##(2008-10#2)
were continuously##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
were contributed by the##2##4##(2008-10#2)
were contributed##3##2##(2008-10#2)(2011-1#1)
were controlled by a##4##4##(1994-12#1)(2008-10#3)
were controlled by##9##3##(1991-8#1)(1994-12#1)(2008-10#5)(2008-9#1)(2011-2#1)
were controlled##11##2##(1991-8#1)(1994-12#1)(2008-10#6)(2008-9#1)(2011-2#2)
were conventionally##2##2##(2008-10#2)
were converted into a##2##4##(1997-3#1)(2008-5#1)
were converted into the##2##4##(2008-10#2)
were converted into##6##3##(1995-6#1)(1997-3#1)(2008-10#3)(2008-5#1)
were converted to laparotomy##2##4##(1995-3#1)(1996-1#1)
were converted to##7##3##(1995-11#1)(1995-3#1)(1996-1#1)(2008-10#4)
were converted##14##2##(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2008-10#8)(2008-5#1)
were coordinated##2##2##(2008-10#1)(2011-2#1)
were corrected for##3##3##(1991-5#1)(1991-8#1)(2008-9#1)
were correctly classified##2##3##(2008-10#1)(2008-7#1)
were correctly##5##2##(1993-6#1)(1995-9#1)(1997-6#1)(2008-10#1)(2008-7#1)
were correlated to the##2##4##(1996-12#1)(2008-10#1)
were correlated to##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
were correlated with the##8##4##(1992-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2012-3#1)(2013-1#1)
were correlated with##23##3##(1992-3#1)(1995-11#1)(1995-3#2)(1997-8#2)(2008-10#11)(2008-11#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were correlated##32##2##(1992-3#1)(1995-11#1)(1995-3#2)(1996-12#1)(1997-6#1)(1997-8#2)(2008-10#16)(2008-11#2)(2008-4#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were countable##2##2##(2008-10#2)
were counted in##2##3##(2008-11#1)(2008-8#1)
were counted##10##2##(1992-12#1)(1994-11#1)(2008-10#5)(2008-11#1)(2008-8#1)(2013-1#1)
were coupled to##2##3##(2008-10#1)(2010-7#1)
were coupled##4##2##(2008-10#2)(2010-7#1)(2011-2#1)
were covalently##2##2##(2008-10#2)
were covered with a##3##4##(2008-10#3)
were covered with##4##3##(1997-2#1)(2008-10#3)
were covered##5##2##(1997-2#1)(2008-10#3)(2010-8#1)
were created and assessed##2##4##(2008-10#1)(2008-11#1)
were created by##2##3##(2008-10#1)(2008-3#1)
were created in##2##3##(2008-7#1)(2010-6#1)
were created using a##2##4##(1992-1#1)(2010-10#1)
were created##19##2##(1991-12#1)(1992-1#1)(1993-1#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2013-1#1)
were critically evaluated##2##3##(2008-10#1)(2013-1#1)
were critically##3##2##(2008-10#2)(2013-1#1)
were cross-linked##2##2##(1993-8#1)(2008-6#1)
were cross-resistant to##3##3##(2008-5#3)
were crossed with the##2##4##(2008-10#2)
were crossed with##5##3##(2008-10#5)
were crossed##8##2##(2008-10#7)(2012-3#1)
were cultivated in##6##3##(2008-11#6)
were cultivated##9##2##(2008-10#2)(2008-11#6)(2011-3#1)
were cultured and##2##3##(2008-9#1)(2013-1#1)
were cultured for##4##3##(1995-11#1)(1995-8#1)(2008-11#1)(2013-1#1)
were cultured in a medium containing##2##6##(2008-10#1)(2008-9#1)
were cultured in the##5##4##(2008-11#5)
were cultured in##19##3##(1993-12#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-11#11)(2008-12#1)(2008-9#1)(2011-2#1)(2012-4#1)
were cultured on##3##3##(2008-11#3)
were cultured with##3##3##(1993-3#1)(1995-12#1)(2011-3#1)
were cultured##39##2##(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2006-6#2)(2008-10#2)(2008-11#19)(2008-12#1)(2008-9#2)(2011-2#1)(2011-3#1)(2012-4#1)(2013-1#2)
were cured##5##2##(1995-11#1)(2008-1#1)(2008-5#2)(2008-7#1)
were cut from##2##3##(2009-7#1)(2011-2#1)
were cut##8##2##(1997-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#2)(2011-2#1)(2012-3#1)
were cytotoxic##2##2##(2008-10#1)(2012-3#1)
were decreased at##2##3##(2008-10#1)(2008-9#1)
were decreased by##5##3##(1992-5#1)(1993-1#1)(1994-5#1)(2008-10#1)(2012-3#1)
were decreased in##2##3##(2008-10#1)(2009-6#1)
were decreased##20##2##(1991-9#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#1)(2007-8#1)(2008-10#6)(2008-9#2)(2009-6#1)(2011-3#1)(2012-3#2)(2013-1#1)
were deduced##2##2##(1991-5#1)(2008-5#1)
were deemed##5##2##(1993-3#1)(1997-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
were deficient in##2##3##(2008-10#2)
were defined as##4##3##(2008-10#1)(2008-8#1)(2012-4#1)(2013-1#1)
were defined by##4##3##(2008-10#3)(2010-1#1)
were defined in##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
were defined##18##2##(1990-2#1)(1992-3#1)(2008-10#7)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-1#1)(2012-4#1)(2013-1#2)
were degraded##2##2##(2008-11#1)(2008-8#1)
were delayed##3##2##(1991-6#1)(2008-10#1)(2011-2#1)
were delineated##2##2##(2008-10#1)(2009-11#1)
were delivered at##2##3##(2008-10#2)
were delivered into##2##3##(2008-10#2)
were delivered##7##2##(2008-10#4)(2011-2#1)(2011-3#1)(2013-1#1)
were demonstrated by##2##3##(2008-10#2)
were demonstrated in the##3##4##(1991-10#1)(1997-3#1)(1997-8#1)
were demonstrated in##7##3##(1990-12#1)(1991-10#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-5#1)
were demonstrated to be##5##4##(2008-10#2)(2008-11#2)(2013-1#1)
were demonstrated##30##2##(1990-12#1)(1990-8#1)(1991-10#1)(1997-3#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#2)(2011-3#2)(2013-1#1)(2013-8#1)
were dependent on the##3##4##(1995-8#1)(2008-10#1)(2008-6#1)
were dependent on##5##3##(1995-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-1#1)
were dependent##6##2##(1995-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-1#1)
were deployed##3##2##(2008-10#3)
were deposited by electron beam evaporation##2##6##(2008-10#2)
were deposited onto##2##3##(2008-3#1)(2009-12#1)
were deposited##10##2##(1992-12#1)(1997-1#1)(2008-10#6)(2008-3#1)(2009-12#1)
were derived from a##2##4##(1997-3#1)(2008-10#1)
were derived from the##4##4##(1997-8#1)(2008-10#1)(2008-2#1)(2010-11#1)
were derived from##19##3##(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)
were derived to##2##3##(2008-10#2)
were derived using##2##3##(2008-10#2)
were derived##30##2##(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
were described as##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
were described by##2##3##(1997-3#1)(2008-10#1)
were described for##2##3##(2008-1#1)(2010-1#1)
were described in##4##3##(1997-3#1)(2012-2#1)(2012-3#1)(2012-4#1)
were described##32##2##(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#1)
were designated as race 0##2##5##(2008-10#2)
were designated as race 2##3##5##(2008-10#3)
were designated as race##6##4##(2008-10#6)
were designated as##9##3##(1997-8#1)(2008-10#6)(2008-8#1)(2008-9#1)
were designated race##2##3##(2008-10#2)
were designated##14##2##(1997-8#1)(2008-10#11)(2008-8#1)(2008-9#1)
were designed and synthesized##7##4##(2008-10#2)(2008-11#1)(2011-3#3)(2012-12#1)
were designed and##13##3##(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2011-3#3)(2012-12#1)
were designed based on the##2##5##(2008-10#2)
were designed for the##2##4##(2008-10#2)
were designed for##5##3##(2008-10#5)
were designed from conserved regions of##2##6##(2008-10#2)
were designed from##3##3##(2008-10#2)(2008-8#1)
were designed specifically for##2##4##(2008-10#2)
were designed to amplify##3##4##(2008-10#3)
were designed to evaluate the##3##5##(2008-10#1)(2008-5#1)(2012-12#1)
were designed to perform##2##4##(2008-10#2)
were designed to provide##2##4##(1994-1#1)(2008-3#1)
were designed to##25##3##(1991-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2009-8#1)(2010-9#1)(2012-12#1)
were designed using##4##3##(2008-10#3)(2013-1#1)
were designed##65##2##(1991-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(2008-10#35)(2008-11#5)(2008-12#2)(2008-3#3)(2008-5#1)(2008-8#3)(2009-8#1)(2010-4#1)(2010-9#1)(2011-3#3)(2012-12#2)(2013-1#1)(2013-8#1)
were desorbed into##2##3##(2008-10#1)(2011-2#1)
were detectable##10##2##(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)
were detected among isolates##2##4##(2008-10#2)
were detected among##7##3##(2008-10#7)
were detected and##4##3##(1995-6#1)(2008-10#3)
were detected as early as##3##5##(2008-10#2)(2009-7#1)
were detected as##10##3##(2007-12#1)(2008-10#6)(2008-9#2)(2009-7#1)
were detected at##9##3##(1990-9#1)(1993-6#1)(1995-11#1)(1997-2#1)(2008-10#5)
were detected between##4##3##(2008-10#3)(2012-2#1)
were detected but##2##3##(2008-5#1)(2008-8#1)
were detected by Western##2##4##(2012-2#1)(2012-3#1)
were detected by the##3##4##(1990-5#1)(1997-4#1)(2008-8#1)
were detected by using##2##4##(2008-10#1)(2008-12#1)
were detected by##28##3##(1990-12#1)(1990-5#1)(1991-7#1)(1993-3#1)(1996-12#1)(1997-4#1)(2008-10#14)(2008-12#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
were detected consistently##2##3##(2008-10#2)
were detected during the##2##4##(2008-10#2)
were detected during##3##3##(1991-12#1)(2008-10#2)
were detected for the##2##4##(2008-10#1)(2011-2#1)
were detected for##6##3##(2008-10#4)(2008-9#1)(2011-2#1)
were detected from##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
were detected in Abyssinian 14##2##5##(2008-10#2)
were detected in all##2##4##(2008-10#2)
were detected in both##4##4##(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#1)
were detected in other##2##4##(2008-10#1)(2008-8#1)
were detected in patients##2##4##(1991-2#1)(1992-3#1)
were detected in the brain of the##2##7##(1994-2#1)(1996-12#1)
were detected in the##23##4##(1994-11#1)(1994-2#1)(1995-6#1)(1996-12#2)(1997-2#1)(1997-3#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)
were detected in these##2##4##(2008-10#2)
were detected in##105##3##(1990-12#1)(1990-2#1)(1991-2#2)(1992-3#1)(1992-6#1)(1993-2#1)(1994-11#2)(1994-2#4)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#3)(1997-2#1)(1997-3#1)(2008-10#57)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
were detected on chromosomes##2##4##(2008-10#2)
were detected on##5##3##(2008-10#4)(2008-8#1)
were detected using a##4##4##(1997-8#1)(2008-10#3)
were detected using##6##3##(1997-8#1)(2008-10#5)
were detected when##3##3##(2008-10#2)(2008-5#1)
were detected with the##3##4##(2008-10#3)
were detected with##7##3##(1997-8#1)(2008-10#6)
were detected within##3##3##(1993-3#1)(2008-10#1)(2009-8#1)
were detected##275##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#4)(1994-2#5)(1994-8#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#5)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#3)(2007-12#1)(2008-10#153)(2008-11#5)(2008-12#5)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#12)(2008-9#8)(2009-10#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#7)(2011-3#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
were determined according to the##3##5##(1997-8#1)(2008-5#2)
were determined according to##4##4##(1997-6#1)(1997-8#1)(2008-5#2)
were determined and compared with those of##2##7##(2008-10#1)(2011-2#1)
were determined and compared with those##4##6##(1990-9#1)(2008-10#2)(2011-2#1)
were determined and compared with##5##5##(1990-9#1)(2008-10#3)(2011-2#1)
were determined and compared##8##4##(1990-9#1)(1997-2#1)(2008-10#4)(2008-11#1)(2011-2#1)
were determined and the##3##4##(2008-10#2)(2010-8#1)
were determined and their##2##4##(2008-10#1)(2008-11#1)
were determined and##21##3##(1990-9#1)(1991-5#1)(1997-2#2)(2008-10#13)(2008-11#2)(2010-8#1)(2011-2#1)
were determined as well as##2##5##(2008-10#2)
were determined as##9##3##(1990-5#1)(2008-10#6)(2008-12#1)(2008-5#1)
were determined at 25 degrees C##5##6##(2008-10#5)
were determined at different##2##4##(2008-10#2)
were determined at##12##3##(2008-10#11)(2010-4#1)
were determined based on the##2##5##(2008-10#2)
were determined based on##5##4##(2008-10#4)(2009-7#1)
were determined between##2##3##(2008-10#2)
were determined by a flame atomic absorption spectrometer##2##8##(2008-10#2)
were determined by a##4##4##(1990-5#1)(2008-10#3)
were determined by capillary electrophoresis##2##5##(2008-10#2)
were determined by flame atomic absorption##2##6##(2008-10#2)
were determined by flame##3##4##(2008-10#3)
were determined by gas chromatography##2##5##(2008-10#1)(2009-8#1)
were determined by high##2##4##(2008-10#2)
were determined by inductively coupled plasma mass spectrometry##2##8##(2008-10#2)
were determined by inductively coupled plasma##3##6##(2008-10#3)
were determined by inductively coupled##4##5##(2008-10#4)
were determined by inductively##5##4##(2008-10#5)
were determined by least-squares fitting of theoretical##2##7##(2008-2#1)(2008-3#1)
were determined by matrix-assisted laser desorption/ionization##2##6##(2008-11#2)
were determined by the proposed##2##5##(2008-10#2)
were determined by the##9##4##(2008-10#5)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)
were determined by using the##3##5##(2008-10#2)(2010-11#1)
were determined by using##7##4##(2008-10#6)(2010-11#1)
were determined by##95##3##(1990-5#1)(1991-2#1)(1992-6#1)(1993-8#1)(1994-11#2)(1995-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#56)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#5)(2008-9#2)(2009-8#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
were determined for each species##2##5##(2011-2#1)(2012-12#1)
were determined for each##6##4##(2008-10#4)(2011-2#1)(2012-12#1)
were determined for the##2##4##(1995-8#1)(2008-10#1)
were determined for##17##3##(1995-8#2)(2008-10#10)(2008-11#1)(2008-2#1)(2010-11#1)(2011-2#1)(2012-12#1)
were determined from the##9##4##(1991-11#1)(1996-5#1)(1997-2#1)(2008-10#4)(2009-8#1)(2009-9#1)
were determined from##21##3##(1991-11#1)(1991-2#1)(1991-9#1)(1996-5#1)(1997-2#1)(2008-10#11)(2008-7#1)(2009-7#1)(2009-8#2)(2009-9#1)
were determined in a##3##4##(2008-10#3)
were determined in all##2##4##(1995-3#1)(2008-10#1)
were determined in aqueous##2##4##(2008-10#2)
were determined in the##5##4##(1994-11#1)(2008-10#3)(2009-8#1)
were determined in##55##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#36)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-9#1)(2013-1#1)
were determined on the##2##4##(1997-8#1)(2008-10#1)
were determined on##4##3##(1997-8#1)(2008-10#3)
were determined potentiometrically##3##3##(2008-10#3)
were determined satisfactorily##3##3##(2008-10#3)
were determined simultaneously##2##3##(2008-10#2)
were determined to assess the viability of the method##2##9##(2008-10#2)
were determined to be 0##3##5##(2008-10#2)(2008-8#1)
were determined to be 10##2##5##(2008-10#2)
were determined to be##17##4##(1990-8#1)(1995-2#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-8#1)
were determined to##24##3##(1990-8#1)(1995-2#1)(1997-2#1)(2008-10#18)(2008-11#2)(2008-8#1)
were determined using a##2##4##(1991-2#1)(2013-8#1)
were determined using the##5##4##(2008-10#3)(2008-12#1)(2013-1#1)
were determined using##24##3##(1991-2#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
were determined with satisfactory##3##4##(2008-10#3)
were determined with the##3##4##(2008-10#3)
were determined with##17##3##(2008-10#15)(2008-11#1)(2008-9#1)
were determined without##3##3##(2008-10#3)
were determined##454##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-8#3)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#7)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#3)(2007-8#1)(2008-10#286)(2008-11#16)(2008-12#8)(2008-2#2)(2008-3#2)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#6)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#5)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#2)
were developed and##7##3##(2008-10#4)(2008-12#1)(2010-11#1)(2010-8#1)
were developed as##2##3##(2008-6#1)(2013-1#1)
were developed based on the##3##5##(2008-10#3)
were developed based on##5##4##(1993-3#1)(2008-10#4)
were developed by a##2##4##(2008-3#1)(2010-12#1)
were developed by the##2##4##(1990-12#1)(2008-10#1)
were developed by##10##3##(1990-12#1)(2008-10#6)(2008-3#2)(2010-12#1)
were developed for the determination of##4##6##(2008-10#4)
were developed for the##8##4##(2008-10#8)
were developed for##14##3##(2008-10#11)(2008-3#1)(2009-10#1)(2010-12#1)
were developed from the##2##4##(1997-8#1)(2011-2#1)
were developed from##7##3##(1997-8#1)(2008-10#4)(2008-7#1)(2011-2#1)
were developed in this##2##4##(2008-10#1)(2008-8#1)
were developed in##7##3##(1990-6#1)(1991-9#1)(2008-10#3)(2008-5#1)(2008-8#1)
were developed that were##2##4##(2008-10#2)
were developed that##4##3##(2008-10#4)
were developed to detect##2##4##(2008-10#2)
were developed to study the##2##5##(2008-10#2)
were developed to##12##3##(1994-9#1)(2008-10#9)(2010-4#1)(2012-3#1)
were developed using a##2##4##(2008-10#2)
were developed using##9##3##(2008-10#9)
were developed with##3##3##(2008-10#3)
were developed##116##2##(1990-12#1)(1990-6#1)(1991-9#1)(1993-3#1)(1994-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-8#1)(2008-10#79)(2008-11#2)(2008-12#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
were devoid of##2##3##(1994-5#1)(2008-10#1)
were diagnosed as having##2##4##(1991-4#1)(1996-6#1)
were diagnosed as##4##3##(1991-11#1)(1991-4#1)(1996-6#1)(2008-10#1)
were diagnosed in##6##3##(1992-2#1)(1992-5#1)(1995-11#1)(1995-12#1)(2008-10#1)(2012-3#1)
were diagnosed with pre-eclampsia##2##4##(2011-2#2)
were diagnosed with##5##3##(2008-6#1)(2008-7#1)(2011-2#2)(2012-3#1)
were diagnosed##22##2##(1991-11#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#3)(2012-3#2)(2013-1#1)
were differences in##5##3##(1996-2#1)(2008-10#2)(2008-7#1)(2012-8#1)
were different and##2##3##(1994-11#1)(2008-10#1)
were different for##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
were different from that seen after DEX##2##7##(1995-12#2)
were different from##5##3##(1995-12#2)(2008-10#3)
were different in##2##3##(2008-10#1)(2011-3#1)
were different##21##2##(1993-1#1)(1994-11#1)(1995-12#2)(2008-10#10)(2008-7#1)(2008-8#3)(2011-3#1)(2013-1#2)
were differentially##4##2##(2008-10#2)(2009-10#1)(2009-8#1)
were differentiated by##2##3##(2008-10#1)(2011-3#1)
were differentiated from##2##3##(2008-10#2)
were differentiated##8##2##(2008-10#5)(2008-7#1)(2009-11#1)(2011-3#1)
were difficult to##3##3##(2008-10#2)(2008-7#1)
were difficult##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
were diffusely positive##2##3##(2008-11#1)(2013-8#1)
were digested by##3##3##(2008-10#2)(2009-3#1)
were digested in##2##3##(2008-10#2)
were digested with##3##3##(1997-2#2)(2008-10#1)
were digested##11##2##(1992-6#1)(1997-2#2)(2008-10#7)(2009-3#1)
were diluted with##3##3##(2008-10#2)(2008-12#1)
were diluted##8##2##(1992-6#1)(2008-10#6)(2008-12#1)
were diminished##3##2##(1992-3#1)(2008-3#1)(2013-1#1)
were dipped in a##2##4##(1990-6#1)(2008-10#1)
were dipped in##3##3##(1990-6#2)(2008-10#1)
were dipped##4##2##(1990-6#2)(2008-10#2)
were direct##3##2##(1995-11#1)(1995-8#1)(2009-6#1)
were directed against the##2##4##(1993-8#1)(2008-10#1)
were directed to##3##3##(1995-11#1)(1995-12#1)(2008-11#1)
were directed##6##2##(1993-8#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#1)
were directly correlated with##2##4##(1996-9#1)(2008-10#1)
were directly introduced##2##3##(1995-2#1)(2008-10#1)
were directly related to##2##4##(1993-11#1)(2008-10#1)
were directly##20##2##(1990-8#1)(1993-11#1)(1995-2#1)(1996-6#1)(1996-9#1)(2008-10#14)(2008-11#1)
were discharged to##3##3##(1990-12#2)(2011-2#1)
were discharged##6##2##(1990-12#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
were discovered in##3##3##(1996-3#1)(2008-5#1)(2012-3#1)
were discovered##6##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-5#1)(2010-6#1)(2012-3#1)
were discriminated##2##2##(1997-6#1)(2008-10#1)
were discussed and##6##3##(1992-3#1)(2008-10#3)(2009-8#1)(2010-2#1)
were discussed in detail##3##4##(2008-10#3)
were discussed in##7##3##(2008-10#5)(2008-11#1)(2008-12#1)
were discussed##41##2##(1992-3#1)(1996-2#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-1#1)(2010-2#1)(2011-3#1)(2011-7#1)
were dispensed##3##2##(2008-10#2)(2008-11#1)
were dispersed##2##2##(2008-10#2)
were disrupted##4##2##(2008-10#2)(2009-10#1)(2009-3#1)
were dissected from##3##3##(2008-10#3)
were dissected##6##2##(1994-5#1)(2008-10#3)(2008-9#1)(2009-1#1)
were dissolved in##3##3##(2008-10#3)
were dissolved##4##2##(2008-10#4)
were distinct from the##2##4##(2008-10#2)
were distinct from##6##3##(2008-10#6)
were distinct##11##2##(2008-10#10)(2008-11#1)
were distinctly##3##2##(1993-12#1)(2008-10#2)
were distinguished among the##2##4##(2008-10#2)
were distinguished from each other by##2##6##(2008-10#2)
were distinguished from##3##3##(1995-12#1)(2008-10#2)
were distinguished using##2##3##(2008-10#2)
were distinguished##15##2##(1995-12#1)(2008-10#10)(2008-3#1)(2008-9#1)(2009-7#1)(2012-3#1)
were distributed in##5##3##(1996-12#1)(2008-10#3)(2013-8#1)
were distributed over all##2##4##(2008-10#2)
were distributed over##3##3##(1993-12#1)(2008-10#2)
were distributed throughout the##2##4##(2008-10#2)
were distributed##23##2##(1993-12#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
were divergent##2##2##(2008-10#2)
were divided between##2##3##(1996-8#1)(2008-10#1)
were divided in##4##3##(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
were divided into 4 groups##2##5##(2008-11#1)(2008-8#1)
were divided into five groups##3##5##(1990-12#1)(2008-10#1)(2011-2#1)
were divided into five##6##4##(1990-12#1)(1995-12#1)(2008-10#3)(2011-2#1)
were divided into four groups##7##5##(1991-2#1)(1992-1#1)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)
were divided into four##8##4##(1991-2#1)(1992-1#1)(2008-11#1)(2008-7#2)(2011-2#2)(2013-1#1)
were divided into three groups##2##5##(2013-1#1)(2013-8#1)
were divided into three##4##4##(2008-10#2)(2013-1#1)(2013-8#1)
were divided into two distinct##2##5##(2008-10#2)
were divided into two groups based on##2##7##(2008-10#2)
were divided into two groups##12##5##(1995-3#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
were divided into two##15##4##(1995-3#1)(2008-10#7)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
were divided into##47##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-1#1)(1993-2#1)(1995-12#1)(1995-3#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-6#1)(2011-1#2)(2011-2#5)(2013-1#6)(2013-8#1)
were divided##55##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1992-1#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-8#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-6#1)(2011-1#3)(2011-2#6)(2013-1#7)(2013-8#1)
were documented by##2##3##(1993-2#1)(2008-11#1)
were documented in the##2##4##(1994-8#1)(2008-12#1)
were documented in##4##3##(1994-8#1)(2008-12#1)(2013-1#2)
were documented##10##2##(1993-2#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2011-2#1)(2013-1#2)
were dominant in##2##3##(2008-10#2)
were dominant##4##2##(2008-10#3)(2011-2#1)
were dominated by the##3##4##(2008-10#1)(2008-9#1)(2011-10#1)
were dominated by##8##3##(2008-1#1)(2008-10#4)(2008-9#1)(2011-1#1)(2011-10#1)
were dominated##9##2##(2008-1#1)(2008-10#5)(2008-9#1)(2011-1#1)(2011-10#1)
were done at##2##3##(1993-12#1)(2008-10#1)
were done by##4##3##(2008-10#3)(2013-1#1)
were done in##3##3##(1996-3#1)(2008-5#1)(2013-1#1)
were done on##2##3##(2008-12#1)(2008-5#1)
were done to##5##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
were done using##2##3##(2008-10#1)(2012-2#1)
were done with##2##3##(1996-12#1)(2013-1#1)
were done##28##2##(1990-5#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-3#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#4)
were dose-dependent##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
were down##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
were down-regulated##2##2##(2008-10#1)(2013-8#1)
were downregulated##3##2##(2010-12#2)(2011-2#1)
were dramatically##3##2##(2008-6#1)(2008-9#1)(2013-8#1)
were drawn from##5##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
were drawn##12##2##(1991-6#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
were dried##2##2##(2008-10#2)
were driven by##2##3##(2008-10#1)(2008-9#1)
were dropped##2##2##(2008-10#1)(2008-12#1)
were due to a##3##4##(1991-5#1)(1997-1#1)(2008-10#1)
were due to##9##3##(1991-5#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2012-3#1)(2013-1#2)
were each##7##2##(1995-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2012-3#1)
were early##2##2##(1990-6#1)(2009-8#1)
were easily identified by##2##4##(1992-2#1)(1996-12#1)
were easily##11##2##(1991-6#1)(1992-2#1)(1996-11#1)(1996-12#1)(2008-10#6)(2008-7#1)
were easy to##2##3##(1993-2#1)(2008-10#1)
were ecologically##2##2##(2008-10#1)(2008-8#1)
were effective for##2##3##(2008-10#2)
were effective in the##2##4##(2008-10#1)(2012-2#1)
were effective in##10##3##(1990-5#1)(1992-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2012-2#1)
were effective##15##2##(1990-5#1)(1992-1#1)(1995-11#1)(2008-10#8)(2008-11#1)(2008-5#2)(2012-2#1)
were effectively##7##2##(2008-10#1)(2008-11#2)(2008-8#1)(2009-12#1)(2009-7#1)(2012-2#1)
were efficient##5##2##(1997-3#1)(2008-10#3)(2008-3#1)
were efficiently transmitted##2##3##(2008-10#2)
were efficiently##7##2##(1991-6#1)(2008-10#4)(2008-11#1)(2008-8#1)
were eight##2##2##(1993-12#1)(1997-5#1)
were either not##2##3##(2008-10#1)(2008-7#1)
were either##26##2##(1990-2#1)(1993-6#1)(1994-1#1)(1995-8#3)(1996-12#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2013-8#1)
were elaborated##2##2##(2008-10#1)(2008-2#1)
were electrically stimulated##2##3##(1997-2#1)(2013-1#1)
were electrochemically##2##2##(2008-10#2)
were electrodeposited##2##2##(2008-10#2)
were elegible for##2##3##(1992-12#1)(2013-1#1)
were elevated in##6##3##(1994-3#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-6#1)
were elevated##8##2##(1994-3#1)(1995-2#1)(1996-2#1)(1996-6#1)(2008-10#1)(2008-8#1)(2009-6#1)(2013-1#1)
were elicited##3##2##(1996-2#1)(2008-8#1)(2010-2#1)
were eligible for evaluation##2##4##(1997-7#2)
were eligible for the##2##4##(1997-7#1)(2012-3#1)
were eligible for##7##3##(1997-7#3)(2007-12#1)(2012-3#1)(2013-1#2)
were eligible##8##2##(1990-6#1)(1997-7#3)(2007-12#1)(2012-3#1)(2013-1#2)
were eliminated by the##2##4##(2008-10#2)
were eliminated by##4##3##(1991-12#1)(2008-10#3)
were eliminated with##3##3##(2008-10#3)
were eliminated##12##2##(1991-12#1)(2008-10#8)(2008-11#1)(2011-3#1)(2012-2#1)
were elucidated##5##2##(2008-10#3)(2011-2#1)(2011-3#1)
were eluted from the##4##4##(2008-10#4)
were eluted from##5##3##(2008-10#5)
were eluted in##2##3##(2008-10#2)
were eluted using##2##3##(1993-2#1)(2008-10#1)
were eluted with##5##3##(2008-10#5)
were eluted##20##2##(1993-2#1)(1997-2#1)(2008-10#18)
were embedded in##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
were emphasised##2##2##(2008-10#1)(2010-2#1)
were employed as##3##3##(2008-10#3)
were employed for the##6##4##(2008-10#6)
were employed for##10##3##(2008-10#10)
were employed in##4##3##(1997-7#1)(2008-11#1)(2008-12#1)(2010-11#1)
were employed to##16##3##(1994-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#3)(2009-7#1)(2011-3#1)(2013-8#1)
were employed##53##2##(1990-8#2)(1991-5#1)(1992-2#1)(1993-1#1)(1994-11#1)(1996-12#1)(1997-7#1)(2008-10#25)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-7#2)(2010-11#1)(2010-7#1)(2011-3#1)(2013-8#1)
were enclosed##2##2##(2008-10#2)
were encountered in##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
were encountered##7##2##(1991-2#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
were engaged in##3##3##(2008-11#1)(2008-5#1)(2013-7#1)
were engaged##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
were enhanced by##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
were enhanced in the latently infected strain##2##7##(2008-10#2)
were enhanced##10##2##(2008-10#7)(2008-11#2)(2011-2#1)
were enlarged##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
were enriched in the##2##4##(2008-10#2)
were enriched in##5##3##(1990-12#1)(2008-10#3)(2009-8#1)
were enriched with##3##3##(2008-10#1)(2008-11#2)
were enriched##10##2##(1990-12#1)(2008-10#6)(2008-11#2)(2009-8#1)
were enrolled for the##2##4##(2010-7#1)(2012-3#1)
were enrolled in the study##3##5##(2008-11#1)(2010-12#1)(2011-1#1)
were enrolled in the##4##4##(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
were enrolled in this study##3##5##(1994-12#1)(2012-3#1)(2013-1#1)
were enrolled in this##5##4##(1994-12#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
were enrolled in##16##3##(1991-12#1)(1994-12#1)(2008-10#1)(2008-11#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
were enrolled##28##2##(1991-12#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#4)(2013-1#4)(2013-8#1)
were entered into##2##3##(2008-1#1)(2011-1#1)
were entered##3##2##(2008-1#1)(2008-7#1)(2011-1#1)
were entirely##3##2##(2008-10#3)
were equal in##2##3##(2008-10#1)(2012-3#1)
were equal to##2##3##(1995-3#1)(2008-10#1)
were equal##9##2##(1995-3#1)(2008-10#5)(2008-8#1)(2011-2#1)(2012-3#1)
were equally effective against##2##4##(2008-10#2)
were equally effective##5##3##(2008-10#3)(2008-4#1)(2013-8#1)
were equally susceptible to##2##4##(1995-11#1)(2008-10#1)
were equally susceptible##3##3##(1995-11#1)(2008-10#2)
were equally##16##2##(1992-3#1)(1994-2#1)(1995-11#1)(1997-9#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
were equivalent to##2##3##(1993-8#1)(2008-11#1)
were equivalent##7##2##(1993-8#1)(1994-5#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
were essential for##2##3##(2008-10#2)
were essential##3##2##(2008-10#3)
were essentially##6##2##(1990-5#1)(1992-2#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
were established and##3##3##(2008-10#1)(2008-9#2)
were established as##6##3##(2008-10#4)(2008-11#1)(2012-3#1)
were established by##6##3##(2008-10#3)(2008-11#3)
were established for the##4##4##(2008-10#3)(2011-2#1)
were established for##7##3##(2008-10#6)(2011-2#1)
were established from##3##3##(2008-10#1)(2008-11#2)
were established in the##3##4##(2008-10#3)
were established in##6##3##(2008-10#5)(2013-8#1)
were established to##5##3##(2008-10#5)
were established with##3##3##(2008-10#1)(2008-9#1)(2009-3#1)
were established##78##2##(1991-2#1)(1992-8#1)(1994-9#1)(1997-3#1)(1997-9#1)(2008-10#52)(2008-11#9)(2008-5#2)(2008-8#1)(2008-9#5)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
were estimated and##2##3##(2008-10#2)
were estimated as 0##2##4##(2008-10#2)
were estimated as##8##3##(2008-10#8)
were estimated at each##2##4##(2008-10#2)
were estimated at##5##3##(1991-1#1)(2008-10#4)
were estimated by using##3##4##(1994-5#1)(2008-10#2)
were estimated by##14##3##(1994-5#1)(2008-10#11)(2008-5#1)(2009-8#1)
were estimated for each##2##4##(2008-10#1)(2011-2#1)
were estimated for##7##3##(2008-10#6)(2011-2#1)
were estimated from the analytical curves##2##6##(2008-10#2)
were estimated from the##5##4##(2008-10#4)(2008-12#1)
were estimated from##9##3##(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
were estimated in##2##3##(2008-11#1)(2008-12#1)
were estimated to be##8##4##(1992-3#1)(2008-10#5)(2008-5#1)(2010-8#1)
were estimated to##12##3##(1992-3#1)(1993-3#1)(2008-10#6)(2008-5#1)(2010-8#1)(2012-2#2)
were estimated using##2##3##(2008-11#1)(2009-11#1)
were estimated##78##2##(1991-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-5#1)(2008-10#52)(2008-11#2)(2008-12#2)(2008-5#4)(2008-7#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
were evaluated according to##2##4##(2008-10#1)(2013-1#1)
were evaluated and compared with##2##5##(2008-10#2)
were evaluated and compared##3##4##(2008-10#3)
were evaluated and the results##2##5##(2008-10#2)
were evaluated and the##6##4##(1991-5#1)(2008-10#5)
were evaluated and##16##3##(1991-5#1)(1992-3#1)(2008-10#13)(2008-11#1)
were evaluated as##3##3##(2008-10#3)
were evaluated at four##2##4##(2008-10#1)(2008-11#1)
were evaluated at##5##3##(2008-10#3)(2008-11#1)(2013-1#1)
were evaluated by a##2##4##(2007-8#1)(2008-11#1)
were evaluated by comparing the##2##5##(2008-10#2)
were evaluated by comparing##3##4##(2008-10#2)(2008-5#1)
were evaluated by means of the##2##6##(2008-10#1)(2008-11#1)
were evaluated by means of##4##5##(1991-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
were evaluated by the analysis of##2##6##(2008-10#2)
were evaluated by the##4##4##(2008-10#4)
were evaluated by using##2##4##(2008-10#1)(2008-8#1)
were evaluated by##37##3##(1991-12#1)(1992-12#1)(1992-3#1)(1995-3#1)(2007-8#1)(2008-10#22)(2008-11#3)(2008-5#1)(2008-8#2)(2011-2#2)(2012-12#1)(2013-1#1)
were evaluated every##2##3##(2013-8#2)
were evaluated for gray leaf spot##2##6##(2008-10#2)
were evaluated for resistance to##4##5##(2008-10#4)
were evaluated for the determination of##2##6##(2008-10#2)
were evaluated for the##12##4##(1991-5#1)(2008-10#8)(2008-11#2)(2011-3#1)
were evaluated for their ability to##3##6##(1992-9#1)(2008-10#2)
were evaluated for their effects on##3##6##(2008-10#3)
were evaluated for their##11##4##(1992-9#1)(2008-10#9)(2011-1#1)
were evaluated for trace enrichment of metal ions##2##8##(2008-10#2)
were evaluated for##59##3##(1991-5#1)(1992-3#1)(1992-9#1)(2008-10#45)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
were evaluated from##2##3##(2008-10#1)(2008-5#1)
were evaluated in a##2##4##(2008-3#1)(2008-7#1)
were evaluated in greenhouse##2##4##(2008-10#2)
were evaluated in terms of##2##5##(2008-10#1)(2008-9#1)
were evaluated in the greenhouse for##2##6##(2008-10#2)
were evaluated in the presence of##2##6##(2008-10#1)(2008-12#1)
were evaluated in the presence##3##5##(2008-10#1)(2008-11#1)(2008-12#1)
were evaluated in the##10##4##(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
were evaluated in three##2##4##(2008-10#2)
were evaluated in##37##3##(1990-3#1)(1994-8#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#4)(2008-9#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
were evaluated on a##2##4##(2008-10#1)(2013-1#1)
were evaluated on the basis of##2##6##(1991-1#1)(2008-5#1)
were evaluated on the##3##4##(1991-1#1)(2008-5#1)(2013-8#1)
were evaluated on##7##3##(1991-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
were evaluated over##2##3##(2008-10#1)(2011-1#1)
were evaluated to determine the##2##5##(2008-10#2)
were evaluated to determine their##2##5##(2008-10#2)
were evaluated to determine##4##4##(2008-10#4)
were evaluated to##10##3##(1997-3#1)(2008-10#9)
were evaluated under controlled##2##4##(2008-10#2)
were evaluated under##4##3##(2008-10#4)
were evaluated using##16##3##(1992-12#1)(1994-5#1)(1994-8#1)(1996-3#1)(2008-10#11)(2010-8#1)
were evaluated with respect to##2##5##(2008-10#1)(2012-2#1)
were evaluated with the##3##4##(1996-11#1)(2008-10#1)(2013-1#1)
were evaluated with transvaginal color Doppler##2##6##(1995-3#2)
were evaluated with##11##3##(1995-2#1)(1995-3#2)(1996-11#1)(2008-10#5)(2012-2#1)(2013-1#1)
were evaluated##318##2##(1990-3#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#2)(1995-3#3)(1996-11#1)(1996-3#1)(1997-3#2)(2007-8#1)(2008-10#196)(2008-11#12)(2008-12#5)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#8)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#14)(2013-8#6)
were evaporated to dryness##2##4##(2008-10#2)
were evaporated##3##2##(2008-10#2)(2008-11#1)
were even##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
were evenly distributed##2##3##(2008-12#1)(2010-8#1)
were ever##2##2##(1995-1#1)(1997-3#1)
were evidenced in##2##3##(1994-3#1)(2008-10#1)
were evidenced##5##2##(1994-3#2)(2008-10#2)(2012-3#1)
were evident among##2##3##(1994-1#1)(2008-10#1)
were evident from##2##3##(2008-10#1)(2008-11#1)
were evident in##3##3##(1996-3#1)(2010-1#1)(2010-8#1)
were evident##23##2##(1994-1#1)(1994-2#2)(1994-5#1)(1996-3#1)(1997-3#1)(2008-10#8)(2008-11#2)(2009-10#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#2)
were examined after##4##3##(1993-8#2)(1997-5#1)(2008-10#1)
were examined among##2##3##(1992-2#1)(2009-5#1)
were examined and compared##2##4##(2008-10#2)
were examined and the##2##4##(2008-10#2)
were examined and##12##3##(1994-1#1)(1996-6#1)(2008-10#8)(2011-2#1)(2013-1#1)
were examined as##6##3##(2008-10#4)(2009-8#1)(2011-2#1)
were examined at different##2##4##(2008-8#1)(2011-2#1)
were examined at the##2##4##(1996-6#1)(2008-10#1)
were examined at##6##3##(1996-5#1)(1996-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
were examined by light microscopy##2##5##(2008-11#1)(2008-7#1)
were examined by scanning electron microscopy##2##6##(2008-10#1)(2013-1#1)
were examined by##30##3##(1990-11#1)(1991-5#1)(1992-3#1)(1994-5#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#3)(2008-8#2)(2010-9#1)(2011-2#1)(2013-1#2)
were examined for the presence of##2##6##(2008-10#2)
were examined for the##8##4##(1992-3#1)(2008-10#7)
were examined for their ability to##3##6##(2008-10#2)(2009-4#1)
were examined for their##7##4##(1993-12#1)(2008-10#5)(2009-4#1)
were examined for##33##3##(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-11#1)(1997-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2009-4#1)(2012-2#1)
were examined in a##3##4##(2008-10#2)(2008-9#1)
were examined in detail##2##4##(2008-10#2)
were examined in order to##2##5##(1996-12#1)(2008-10#1)
were examined in the##5##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
were examined in this study##4##5##(1991-4#1)(1992-9#1)(2008-10#2)
were examined in two##2##4##(1993-12#1)(2008-1#1)
were examined in vitro##2##4##(2008-10#2)
were examined in##42##3##(1990-3#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-8#1)(1996-12#1)(1996-2#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
were examined on##3##3##(1995-12#1)(2010-7#1)(2010-8#1)
were examined to determine whether##2##5##(1992-12#1)(1993-8#1)
were examined to determine which##2##5##(2008-10#2)
were examined to determine##6##4##(1992-12#1)(1993-8#1)(2008-10#4)
were examined to##9##3##(1992-12#1)(1993-8#1)(2008-10#6)(2008-11#1)
were examined using a##3##4##(1994-5#1)(2008-10#2)
were examined using an##2##4##(1994-11#1)(2008-11#1)
were examined using the##2##4##(1992-6#1)(2008-7#1)
were examined using##16##3##(1990-7#1)(1992-6#2)(1994-11#1)(1994-5#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-4#1)(2013-8#1)
were examined with the##2##4##(1997-3#1)(2008-10#1)
were examined with##9##3##(1991-10#1)(1997-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-2#1)
were examined##273##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#4)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#114)(2008-11#15)(2008-12#4)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#1)
were excellent##4##2##(1992-6#1)(1992-9#1)(1996-9#1)(2008-10#1)
were exchanged##3##2##(2008-10#2)(2009-5#1)
were excised##4##2##(1996-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
were excited by##2##3##(1997-3#1)(2008-3#1)
were excited##4##2##(1997-3#1)(2008-10#1)(2008-3#2)
were excluded from the analysis##2##5##(1993-12#1)(1996-11#1)
were excluded from the study##4##5##(2008-10#1)(2011-2#2)(2013-1#1)
were excluded from the##7##4##(1993-12#1)(1995-2#1)(1996-11#1)(2008-10#1)(2011-2#2)(2013-1#1)
were excluded from##9##3##(1993-12#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#2)(2013-1#1)
were excluded if they##3##4##(2012-12#2)(2013-1#1)
were excluded##24##2##(1991-2#1)(1993-12#1)(1995-2#1)(1996-11#1)(1997-8#1)(2008-10#3)(2008-3#1)(2009-8#2)(2011-2#2)(2012-12#5)(2013-1#4)(2013-8#2)
were exclusively##4##2##(2008-10#3)(2010-6#1)
were executed##2##2##(2008-10#1)(2008-3#1)
were exhausted##3##2##(2008-10#1)(2010-8#1)(2011-3#1)
were exhibited##2##2##(1996-2#1)(2008-10#1)
were expanded in##2##3##(1990-8#1)(2008-9#1)
were expected to##3##3##(1996-5#1)(2008-10#1)(2008-12#1)
were expected##8##2##(1991-2#1)(1996-5#1)(2008-10#2)(2008-12#1)(2009-5#1)(2009-7#1)(2013-1#1)
were experimentally##4##2##(1997-6#1)(2007-11#1)(2008-10#1)(2012-9#1)
were explained by assuming the presence of##2##7##(2008-10#2)
were explained by assuming the##3##5##(2008-10#3)
were explained by the##2##4##(2008-10#1)(2008-12#1)
were explained by##7##3##(2008-10#4)(2008-12#1)(2008-8#2)
were explained##10##2##(2008-10#7)(2008-12#1)(2008-8#2)
were explanted and##2##3##(2008-9#1)(2012-3#1)
were explanted##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
were exploited##2##2##(2008-10#1)(2008-11#1)
were explored in a##2##4##(2008-10#1)(2010-1#1)
were explored in##3##3##(2008-10#2)(2010-1#1)
were explored##7##2##(1993-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-1#1)(2013-8#1)
were exponentially distributed with an overall median of##2##8##(2008-8#2)
were exposed in##2##3##(2008-10#1)(2012-3#1)
were exposed only##2##3##(2008-9#2)
were exposed to 25##2##4##(2008-10#2)
were exposed to a##6##4##(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#1)(2011-1#1)
were exposed to constant##2##4##(2008-10#1)(2012-4#1)
were exposed to different##2##4##(2008-10#2)
were exposed to the##5##4##(1995-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
were exposed to##58##3##(1990-5#1)(1990-8#1)(1992-6#1)(1993-8#2)(1995-12#1)(1995-8#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#8)(2009-12#1)(2009-7#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-4#1)(2012-8#1)(2013-1#2)
were exposed##72##2##(1990-5#1)(1990-8#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#4)(2008-9#11)(2009-12#1)(2009-7#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#2)
were expressed as##6##3##(1993-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
were expressed at##2##3##(1995-11#1)(1996-2#1)
were expressed in a##4##4##(1993-8#1)(1995-8#1)(1997-7#1)(2008-11#1)
were expressed in the##4##4##(1995-2#1)(2009-3#1)(2009-8#1)(2011-2#1)
were expressed in vitro##2##4##(1995-8#1)(2008-10#1)
were expressed in##21##3##(1992-6#1)(1993-3#1)(1993-8#2)(1995-2#1)(1995-8#2)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#3)(2009-3#1)(2009-8#1)(2011-2#3)
were expressed##43##2##(1992-6#1)(1993-3#1)(1993-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#5)(2008-5#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-7#1)(2013-1#2)
were extended##2##2##(2008-10#1)(2008-11#1)
were extracted and##5##3##(2008-10#1)(2008-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
were extracted by##7##3##(1991-7#1)(2008-10#5)(2008-11#1)
were extracted for##2##3##(2008-10#2)
were extracted from the##4##4##(2008-10#4)
were extracted from##21##3##(1993-2#1)(2008-10#14)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
were extracted in##2##3##(2008-10#2)
were extracted into chloroform##2##4##(2008-10#2)
were extracted into##4##3##(2008-10#4)
were extracted with a##2##4##(2008-10#2)
were extracted with##11##3##(2008-10#10)(2008-5#1)
were extracted##61##2##(1990-2#1)(1991-7#1)(1993-2#1)(2008-10#44)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
were extremely sensitive##2##3##(2008-10#1)(2008-9#1)
were extremely##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
were fabricated and characterized##2##4##(2008-10#2)
were fabricated and##3##3##(2008-10#2)(2008-3#1)
were fabricated by##6##3##(2008-10#2)(2008-2#1)(2009-5#1)(2009-7#1)(2013-8#1)
were fabricated with##2##3##(2007-12#1)(2008-3#1)
were fabricated##21##2##(2007-12#1)(2008-10#8)(2008-2#4)(2008-3#3)(2009-12#1)(2009-5#1)(2009-7#1)(2013-1#1)(2013-8#1)
were fairly##6##2##(1996-12#1)(2008-10#4)(2010-1#1)
were far more##2##3##(2008-10#1)(2013-1#1)
were far##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
were faster to##2##3##(2008-9#1)(2010-5#1)
were fed inhibitors of##2##4##(2008-8#2)
were fed on##4##3##(1997-8#1)(2008-10#3)
were fed with##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
were fed##20##2##(1993-11#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
were female##4##2##(1997-8#1)(2008-11#1)(2010-6#1)(2011-2#1)
were females and##3##3##(1991-8#1)(1992-5#1)(1995-10#1)
were females##5##2##(1991-8#1)(1992-5#1)(1995-10#1)(2008-1#1)(2010-3#1)
were fever##2##2##(2008-1#1)(2012-3#1)
were few##6##2##(1995-11#1)(1995-3#1)(2008-10#3)(2010-8#1)
were fewer hyphae##2##3##(2008-10#2)
were fewer##4##2##(2008-10#4)
were filled with##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
were finally##4##2##(1996-3#1)(2008-10#3)
were first applied to##2##4##(2008-8#1)(2011-2#1)
were first described##3##3##(2008-5#2)(2011-2#1)
were first evaluated##2##3##(1997-6#1)(2008-10#1)
were first observed in##2##4##(2008-10#1)(2008-7#1)
were first observed##5##3##(2008-10#4)(2008-7#1)
were first##34##2##(1993-3#1)(1994-11#1)(1995-11#1)(1996-12#1)(1997-6#1)(2008-10#13)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-3#1)
were firstly##2##2##(2008-10#2)
were fit to the##3##4##(2008-10#3)
were fit to##6##3##(2008-10#5)(2013-1#1)
were fitted to a model##3##5##(2008-10#2)(2008-3#1)
were fitted to a##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
were fitted to the##3##4##(2008-10#3)
were fitted to##12##3##(2008-10#8)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
were fitted with##2##3##(2008-10#1)(2008-9#1)
were fitted##16##2##(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)
were five##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
were fixed and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
were fixed##9##2##(2008-10#4)(2008-11#1)(2008-7#2)(2009-12#1)(2011-2#1)
were flat##3##2##(2008-8#2)(2011-2#1)
were focused##2##2##(2008-10#1)(2008-11#1)
were follow-up with colour-Doppler##2##4##(2011-2#2)
were followed by##3##3##(1995-12#1)(2007-12#1)(2008-10#1)
were followed for##6##3##(1996-1#1)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#2)
were followed over##2##3##(2008-10#1)(2012-7#1)
were followed to##2##3##(1993-12#1)(2007-12#1)
were followed up at##4##4##(1995-3#1)(2008-10#1)(2008-11#1)(2010-6#1)
were followed up for##4##4##(1991-9#1)(1996-9#1)(2008-9#1)(2011-2#1)
were followed up##12##3##(1991-11#1)(1991-9#1)(1995-3#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
were followed with##2##3##(2008-7#1)(2013-1#1)
were followed##37##2##(1991-11#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-11#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#2)(2012-7#1)(2013-1#5)
were followed-up at##2##3##(1991-6#1)(2011-2#1)
were for##5##2##(1995-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
were forced##2##2##(1996-6#1)(2008-1#1)
were formed by##6##3##(1991-5#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
were formed from the##2##4##(2008-11#1)(2012-2#1)
were formed from##4##3##(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
were formed in the##2##4##(2008-10#2)
were formed in##6##3##(1995-6#1)(2008-10#4)(2008-7#1)
were formed on the##2##4##(2008-10#2)
were formed on##5##3##(2008-10#5)
were formed##30##2##(1990-11#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-7#2)(2010-4#1)(2010-7#1)(2012-2#2)(2012-5#1)
were formulated as##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
were formulated in##2##3##(1994-12#1)(2008-5#1)
were formulated with##3##3##(1996-1#1)(2008-10#1)(2010-4#1)
were formulated##12##2##(1994-12#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-5#3)(2010-4#1)(2011-2#1)
were fortified##2##2##(2008-10#1)(2008-11#1)
were found after##4##3##(1994-8#1)(1995-2#1)(2008-10#2)
were found among the three##2##5##(2008-10#1)(2012-5#1)
were found among the##8##4##(1993-2#1)(1997-3#1)(2008-10#3)(2008-5#1)(2012-2#1)(2012-5#1)
were found among##15##3##(1993-2#1)(1997-3#1)(2008-10#9)(2008-5#1)(2012-2#1)(2012-3#1)(2012-5#1)
were found and##5##3##(1997-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
were found as##8##3##(2008-10#3)(2008-11#3)(2008-12#1)(2012-12#1)
were found at the##5##4##(2008-10#3)(2008-12#2)
were found at##10##3##(2008-10#6)(2008-12#2)(2011-2#1)(2012-2#1)
were found between the##14##4##(1991-5#1)(1992-3#1)(1993-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)
were found between##34##3##(1990-8#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-2#2)(1996-1#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-7#4)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-5#1)(2013-1#1)
were found by the##2##4##(1990-9#1)(2008-3#1)
were found by##4##3##(1990-9#1)(2008-10#2)(2008-3#1)
were found concerning##2##3##(2012-12#1)(2013-1#1)
were found during##2##3##(1995-9#1)(2010-9#1)
were found for some##2##4##(2008-10#2)
were found for spiked concentration levels from##2##7##(2008-10#2)
were found for the determination of##2##6##(2008-10#2)
were found for the##9##4##(1996-6#1)(2008-10#6)(2008-7#1)(2011-1#1)
were found for##36##3##(1996-6#1)(1997-1#2)(1997-4#1)(1997-8#1)(2008-10#20)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
were found from##2##3##(2008-10#2)
were found in 90% of##2##5##(2007-8#1)(2008-10#1)
were found in a##3##4##(2008-10#2)(2011-2#1)
were found in all##7##4##(1994-11#1)(2008-10#4)(2008-5#1)(2010-1#1)
were found in an##2##4##(1993-1#1)(2008-10#1)
were found in areas##2##4##(2008-10#2)
were found in both##4##4##(1994-2#1)(2008-10#2)(2008-7#1)
were found in concentrations##2##4##(2008-10#1)(2008-11#1)
were found in seven##2##4##(1997-3#1)(2008-10#1)
were found in the##37##4##(1990-11#1)(1990-3#1)(1991-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-7#2)(2008-9#2)(2010-1#1)(2010-5#2)(2013-1#2)(2013-8#1)
were found in these##2##4##(2008-10#1)(2008-5#1)
were found in two##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
were found in##140##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#2)(1991-11#1)(1991-12#3)(1991-5#2)(1992-12#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#4)(1994-3#1)(1995-2#2)(1996-11#1)(1996-2#1)(1996-8#1)(1997-3#3)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#51)(2008-11#7)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-5#1)(2010-1#2)(2010-5#2)(2010-8#1)(2011-10#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
were found infected##2##3##(2008-10#2)
were found mainly in##2##4##(1990-9#1)(2008-10#1)
were found mainly##3##3##(1990-9#1)(2008-10#2)
were found most##2##3##(1991-10#1)(1992-3#1)
were found on##7##3##(1991-2#1)(2008-10#6)
were found only in##4##4##(2008-10#4)
were found only within##2##4##(2008-10#1)(2008-7#1)
were found only##6##3##(2008-10#5)(2008-7#1)
were found to be &gt##2##5##(2008-10#2)
were found to be 0##10##5##(2008-10#10)
were found to be 1##8##5##(2008-10#7)(2013-1#1)
were found to be 2##8##5##(2008-10#8)
were found to be 3##3##5##(2008-10#2)(2012-2#1)
were found to be 4##4##5##(1994-5#1)(2008-10#3)
were found to be 5##3##5##(2008-10#3)
were found to be 99##3##5##(2008-10#3)
were found to be a##2##5##(2008-10#2)
were found to be able to##2##6##(2008-10#2)
were found to be associated##2##5##(2008-11#1)(2011-2#1)
were found to be better than##2##6##(2008-10#1)(2008-5#1)
were found to be between##2##5##(2008-10#2)
were found to be comparable to those##2##7##(2008-10#1)(2008-7#1)
were found to be comparable to##3##6##(2008-10#2)(2008-7#1)
were found to be comparable with##3##6##(2008-10#3)
were found to be comparable##6##5##(2008-10#5)(2008-7#1)
were found to be consistent with##2##6##(2008-10#1)(2008-3#1)
were found to be consistent##3##5##(2008-10#1)(2008-3#1)(2009-12#1)
were found to be dependent on##2##6##(1995-3#1)(2008-10#1)
were found to be higher##2##5##(2008-11#1)(2011-2#1)
were found to be highly resistant to##2##7##(2008-10#1)(2008-8#1)
were found to be highly##5##5##(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)
were found to be important##2##5##(2009-12#1)(2009-7#1)
were found to be in the range of##2##8##(2008-10#2)
were found to be in##8##5##(2008-10#8)
were found to be inactive when tested for##3##8##(1996-5#3)
were found to be infected by##2##6##(2008-10#2)
were found to be less##3##5##(2008-10#2)(2008-11#1)
were found to be linearly##2##5##(1995-3#1)(2008-10#1)
were found to be located##2##5##(1997-6#1)(2008-8#1)
were found to be rather##2##5##(2008-10#2)
were found to be related to##2##6##(2008-7#2)
were found to be relatively##3##5##(2008-10#2)(2010-7#1)
were found to be significantly##6##5##(1992-12#1)(1996-1#1)(2007-12#1)(2008-12#1)(2008-7#1)(2012-2#1)
were found to be similar to##2##6##(2008-10#2)
were found to be similar##4##5##(2008-10#3)(2008-3#1)
were found to be stable##2##5##(1992-6#1)(2008-10#1)
were found to be statistically##2##5##(2008-10#1)(2010-8#1)
were found to be the main##2##6##(2008-10#1)(2008-11#1)
were found to be the same##2##6##(2008-7#1)(2008-8#1)
were found to be the##8##5##(1990-9#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
were found to be tolerable##2##5##(2008-10#2)
were found to be useful##2##5##(2008-11#1)(2008-12#1)
were found to be##243##4##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#4)(1993-8#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#5)(1996-2#2)(1996-5#3)(1997-2#4)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#132)(2008-11#12)(2008-12#3)(2008-3#3)(2008-5#5)(2008-7#9)(2008-8#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
were found to carry##2##4##(1993-6#1)(1995-9#1)
were found to contain##6##4##(1997-2#1)(1997-3#1)(2008-10#4)
were found to correlate with##2##5##(2008-10#1)(2011-1#1)
were found to correspond to##2##5##(2008-10#2)
were found to decrease in##2##5##(1994-5#1)(2008-10#1)
were found to decrease##4##4##(1994-5#1)(2008-10#2)(2008-7#1)
were found to enhance the##3##5##(2008-10#1)(2008-11#2)
were found to have a##3##5##(1993-3#1)(2012-2#1)(2013-8#1)
were found to have significant influence on extraction efficiency##2##9##(2008-10#2)
were found to have significant##3##5##(2008-10#3)
were found to have##29##4##(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#13)(2008-11#3)(2008-9#3)(2012-2#3)(2012-3#1)(2013-8#1)
were found to inhibit##4##4##(1994-8#1)(2008-10#1)(2008-8#1)(2011-3#1)
were found to stimulate##2##4##(1990-10#1)(1995-2#1)
were found to vary##5##4##(1995-3#1)(1997-3#1)(2008-10#3)
were found to##361##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#5)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#2)(1994-5#3)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#3)(1996-5#3)(1997-2#6)(1997-3#3)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#179)(2008-11#25)(2008-12#5)(2008-3#3)(2008-5#8)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-7#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#2)(2011-3#1)(2012-2#8)(2012-3#3)(2013-1#5)(2013-8#2)
were found when##3##3##(1997-8#1)(2008-10#2)
were found which##2##3##(2011-2#1)(2012-12#1)
were found with##7##3##(2008-10#3)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
were found within##6##3##(1993-12#1)(1995-12#1)(2006-6#1)(2008-10#2)(2008-7#1)
were found##782##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#8)(1993-2#5)(1993-3#1)(1993-6#4)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#3)(1994-8#4)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#3)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#5)(1996-5#3)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#6)(1997-3#10)(1997-4#3)(1997-6#1)(1997-8#4)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#356)(2008-11#41)(2008-12#20)(2008-3#5)(2008-4#1)(2008-5#14)(2008-7#30)(2008-8#12)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#4)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#8)(2011-10#1)(2011-2#20)(2011-3#2)(2012-12#7)(2012-2#11)(2012-3#11)(2012-4#1)(2012-5#3)(2013-1#17)(2013-8#5)
were founded##2##2##(1997-5#1)(2010-10#1)
were four##4##2##(2008-10#3)(2008-8#1)
were fractionated by##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
were fractionated##7##2##(2008-10#4)(2008-11#1)(2008-5#1)(2013-8#1)
were free of##7##3##(1990-12#1)(1994-12#1)(1994-2#1)(2008-10#3)(2011-2#1)
were free##8##2##(1990-12#1)(1994-12#1)(1994-2#1)(2008-10#4)(2011-2#1)
were frequently present##2##3##(1994-12#1)(2012-12#1)
were frequently##12##2##(1990-12#1)(1994-12#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-8#1)
were from 0##2##3##(2008-10#2)
were from different##2##3##(2008-10#1)(2010-4#1)
were from the same##2##4##(2008-10#1)(2008-9#1)
were from the##4##3##(2008-10#2)(2008-9#2)
were from##27##2##(1996-12#1)(1996-2#1)(2008-10#20)(2008-11#1)(2008-9#2)(2010-4#1)(2012-3#1)
were fully##7##2##(1996-2#1)(2008-10#6)
were functioning##2##2##(1990-11#1)(2009-11#1)
were further analyzed using##2##4##(2008-10#1)(2010-6#1)
were further characterized##3##3##(2008-10#2)(2011-1#1)
were further confirmed by##2##4##(1996-2#1)(1997-1#1)
were further confirmed##3##3##(1996-2#1)(1997-1#1)(2008-10#1)
were further evaluated##3##3##(1992-8#1)(1992-9#1)(2008-10#1)
were further investigated##2##3##(2008-10#1)(2008-11#1)
were further studied##2##3##(1992-5#1)(2008-10#1)
were further##34##2##(1990-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-1#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
were fused by##2##3##(1991-5#1)(2008-9#1)
were fused to##4##3##(1991-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
were fused##7##2##(1991-10#1)(1991-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
were gathered from##2##3##(2009-5#1)(2010-9#1)
were gathered in##2##3##(2008-10#2)
were gathered##8##2##(1995-2#1)(1997-8#1)(2008-10#2)(2008-12#2)(2009-5#1)(2010-9#1)
were generally higher##2##3##(2008-10#1)(2013-8#1)
were generally less##2##3##(2008-9#1)(2010-10#1)
were generally small##2##3##(2008-10#1)(2012-3#1)
were generally##31##2##(1991-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1995-11#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#2)
were generated and##6##3##(1995-12#1)(1997-9#1)(2008-12#2)(2008-3#1)(2011-2#1)
were generated by##8##3##(1994-12#1)(1995-6#1)(2008-10#5)(2008-11#1)
were generated for##4##3##(2008-10#3)(2008-3#1)
were generated from##11##3##(1990-2#1)(1995-6#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
were generated in the##3##4##(1993-8#1)(1997-2#1)(2008-10#1)
were generated in##4##3##(1993-8#1)(1997-2#1)(2008-10#2)
were generated with##4##3##(1993-6#1)(1996-12#1)(2008-10#2)
were generated##52##2##(1990-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-12#1)(1997-2#1)(1997-6#1)(1997-9#1)(2007-11#1)(2008-10#23)(2008-11#4)(2008-12#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#2)
were genetically similar to##2##4##(2008-10#2)
were genetically similar##3##3##(2008-10#3)
were genetically##10##2##(2008-10#10)
were genotyped at##2##3##(2008-10#2)
were genotyped by##2##3##(2008-10#1)(2013-8#1)
were genotyped for the##2##4##(2008-10#2)
were genotyped for##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
were genotyped##12##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#2)
were genotypically distinct##3##3##(2008-10#3)
were genotypically##5##2##(2008-10#5)
were girls and##2##3##(2008-12#2)
were girls##4##2##(2008-12#2)(2010-1#1)(2013-1#1)
were given a gluten-free diet##2##5##(1991-2#2)
were given a##7##3##(1991-2#2)(1996-11#1)(2008-1#1)(2008-3#1)(2009-2#1)(2011-2#1)
were given at different##2##4##(1993-3#1)(1994-8#1)
were given at##3##3##(1993-3#1)(1994-8#1)(2012-3#1)
were given the##4##3##(2008-10#1)(2008-11#1)(2009-11#1)(2012-3#1)
were given two##2##3##(1993-11#1)(2009-12#1)
were given##49##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
were glutamine##2##2##(2008-11#2)
were good##7##2##(2008-10#4)(2009-7#1)(2012-12#1)(2013-1#1)
were gradually increased##2##3##(1997-8#1)(2013-1#1)
were gradually##4##2##(1994-11#1)(1997-8#1)(2008-9#1)(2013-1#1)
were grafted##2##2##(2008-10#1)(2009-7#1)
were greater for the##2##4##(1995-3#1)(2008-5#1)
were greater in cv##2##4##(2008-10#2)
were greater in##7##3##(1995-8#1)(2008-10#5)(2008-9#1)
were greater than##9##3##(1993-2#1)(2008-10#6)(2008-11#1)(2008-9#1)
were greater##22##2##(1993-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-9#2)
were greatest in##2##3##(2008-10#2)
were greatest##4##2##(2008-10#4)
were greatly enhanced by##2##4##(2008-10#2)
were greatly reduced##2##3##(2008-10#1)(2008-7#1)
were greatly##7##2##(2008-10#5)(2008-3#1)(2008-7#1)
were grossly##2##2##(1995-6#1)(1996-11#1)
were ground##2##2##(2008-10#2)
were grouped according to##3##4##(1997-8#1)(2008-10#1)(2011-2#1)
were grouped by##2##3##(2008-12#1)(2011-2#1)
were grouped in two##2##4##(2008-10#2)
were grouped in##4##3##(2008-10#4)
were grouped into the##2##4##(2008-10#1)(2013-1#1)
were grouped into three##2##4##(2008-4#1)(2011-1#1)
were grouped into##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
were grouped##23##2##(1993-2#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
were growing##4##2##(1994-8#1)(1995-3#1)(2008-10#1)(2011-2#1)
were grown at##3##3##(2008-10#2)(2008-11#1)
were grown for##2##3##(1993-8#1)(2008-12#1)
were grown hydroponically in##2##4##(2008-10#2)
were grown hydroponically##3##3##(2008-10#2)(2008-9#1)
were grown in a##3##4##(2008-10#1)(2008-11#2)
were grown in soil##3##4##(2008-10#2)(2010-11#1)
were grown in the presence of##2##6##(2008-10#2)
were grown in the##4##4##(2008-10#4)
were grown in##20##3##(2008-10#14)(2008-11#3)(2008-8#1)(2010-11#1)(2012-9#1)
were grown on microcarriers##2##4##(2008-11#2)
were grown on##7##3##(1995-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2013-1#1)
were grown under##2##3##(2008-10#2)
were grown with##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
were grown##45##2##(1993-8#1)(1995-9#1)(2008-10#26)(2008-11#7)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-11#1)(2011-2#1)(2012-9#1)(2013-1#1)
were hardly##2##2##(2008-10#2)
were harvested and##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
were harvested for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
were harvested##13##2##(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
were healed##2##2##(1992-2#1)(2011-2#1)
were healthy##2##2##(2012-3#1)(2013-1#1)
were heard##2##2##(1996-5#1)(1997-8#1)
were held in##2##3##(2008-10#1)(2009-5#1)
were held##6##2##(1996-1#1)(2008-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-2#1)
were heterogeneous##2##2##(2008-10#1)(2013-1#1)
were heterozygous##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
were high (0##2##3##(2008-10#2)
were high affinity (Kd = 0##2##6##(1994-8#2)
were high in the##2##4##(1990-11#1)(2013-1#1)
were high in##5##3##(1990-11#1)(2008-10#2)(2008-8#1)(2013-1#1)
were high##24##2##(1990-11#1)(1990-9#1)(1991-5#1)(1994-8#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(2008-10#6)(2008-8#1)(2009-11#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
were higher by##2##3##(2008-10#2)
were higher for##5##3##(2008-10#3)(2009-2#1)(2013-8#1)
were higher in both##2##4##(2008-10#1)(2010-4#1)
were higher in left-pawed##2##4##(1997-2#2)
were higher in non reactional##2##5##(2011-2#2)
were higher in smokers##2##4##(2008-10#2)
were higher in the##4##4##(1991-12#1)(1997-7#1)(2008-11#1)(2013-8#1)
were higher in##27##3##(1991-12#2)(1992-1#1)(1992-9#1)(1997-2#2)(1997-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#3)(2013-8#1)
were higher than 95%##2##4##(2008-10#2)
were higher than in##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
were higher than the##5##4##(1990-2#1)(2008-10#1)(2008-12#1)(2011-1#1)(2013-8#1)
were higher than those for##2##5##(2008-10#1)(2008-9#1)
were higher than those of##4##5##(2008-10#2)(2008-7#1)(2012-2#1)
were higher than those##10##4##(1995-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
were higher than##32##3##(1990-2#1)(1991-8#1)(1992-1#1)(1993-3#1)(1995-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#4)(2008-7#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-8#1)
were higher then control group##2##5##(2008-12#2)
were higher##85##2##(1990-2#1)(1991-1#1)(1991-12#2)(1991-8#1)(1992-1#2)(1992-9#2)(1993-3#1)(1995-8#1)(1997-2#2)(1997-7#1)(2008-1#1)(2008-10#30)(2008-11#6)(2008-12#7)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#2)(2012-6#1)(2013-1#1)(2013-8#4)
were highest at##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
were highest for##2##3##(1993-1#1)(2008-9#1)
were highest in the adult adrenal##2##6##(1996-12#2)
were highest in the##5##4##(1996-12#3)(2008-10#1)(2013-8#1)
were highest in##9##3##(1996-12#3)(2008-10#3)(2008-7#1)(2008-9#1)(2013-8#1)
were highest##18##2##(1993-1#1)(1993-3#1)(1996-12#3)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
were highly conserved##2##3##(1995-6#1)(2008-10#1)
were highly correlated with##5##4##(1995-11#1)(2008-10#2)(2008-9#1)(2011-9#1)
were highly correlated##10##3##(1990-8#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-9#1)(2011-9#1)
were highly dependent on##2##4##(2008-10#2)
were highly differentiated##2##3##(1990-9#1)(2008-10#1)
were highly effective in##3##4##(2008-10#2)(2008-5#1)
were highly expressed in##4##4##(2008-11#1)(2008-8#1)(2010-12#1)(2012-3#1)
were highly homologous to##2##4##(1995-6#1)(2008-8#1)
were highly homologous##4##3##(1995-6#1)(1995-8#1)(2008-5#1)(2008-8#1)
were highly pathogenic on bean cultivars of both gene pools##2##10##(2008-10#2)
were highly pathogenic on##5##4##(2008-10#5)
were highly reproducible##2##3##(1995-12#1)(2008-10#1)
were highly resistant to##3##4##(2008-10#1)(2008-8#2)
were highly significant (P &lt##4##5##(2008-10#4)
were highly significant (P = 0##2##6##(2008-10#2)
were highly significant (P##6##4##(2008-10#6)
were highly significant##9##3##(2008-10#8)(2008-8#1)
were highly similar##3##3##(2008-10#2)(2012-2#1)
were highly specific and##2##4##(2008-10#2)
were highly susceptible##2##3##(2008-10#2)
were highly variable##5##3##(2008-10#2)(2008-8#1)(2009-8#2)
were highly virulent##2##3##(2008-10#2)
were highly##82##2##(1990-8#1)(1990-9#1)(1991-7#1)(1992-10#1)(1992-3#1)(1993-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#46)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#1)(2009-8#3)(2010-12#1)(2011-9#1)(2012-2#1)(2012-3#1)
were homologous to other known genes##2##6##(1996-12#2)
were homologous to##3##3##(1996-12#2)(1997-8#1)
were homozygous for the##2##4##(1995-12#1)(1995-2#1)
were hospitalized##3##2##(1992-5#1)(2008-11#1)(2009-12#1)
were host specific##2##3##(2008-10#2)
were housed##3##2##(1991-2#1)(1993-6#1)(2008-11#1)
were hybridized with##2##3##(1997-8#1)(2008-10#1)
were hybridized##3##2##(1997-8#1)(2008-10#2)
were hydrolyzed##4##2##(1994-5#1)(1995-6#1)(2006-6#1)(2008-10#1)
were hypothesized to be##2##4##(1992-3#1)(2008-7#1)
were hypothesized to##3##3##(1992-3#1)(2008-12#1)(2008-7#1)
were identical for##2##3##(2008-10#2)
were identical or similar to hypothetical genes registered in databases##2##10##(1996-12#2)
were identical to the##3##4##(2008-10#2)(2008-12#1)
were identical to those of##2##5##(1993-1#1)(2008-10#1)
were identical to those##11##4##(1990-8#2)(1991-9#1)(1992-12#1)(1993-1#1)(2008-10#6)
were identical to##20##3##(1990-8#2)(1991-9#1)(1992-12#1)(1993-1#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-12#1)
were identical##35##2##(1990-8#2)(1991-9#1)(1992-12#1)(1993-1#1)(1995-3#1)(1996-12#2)(1996-6#1)(1997-8#1)(2008-10#20)(2008-11#3)(2008-12#1)(2011-2#1)
were identified among the##6##4##(2008-10#5)(2013-8#1)
were identified among##11##3##(2008-10#9)(2013-8#2)
were identified and##20##3##(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#8)(2008-5#1)(2008-9#1)(2012-2#3)(2012-5#1)(2013-1#2)
were identified as P##3##4##(2008-10#3)
were identified as S##2##4##(2008-10#2)
were identified as T##3##4##(1996-12#1)(2008-10#2)
were identified as X##2##4##(2008-10#2)
were identified as a##2##4##(1995-6#1)(2008-11#1)
were identified as independent##2##4##(2012-3#1)(2013-8#1)
were identified as members of the##2##6##(1996-12#1)(2008-10#1)
were identified as optimal##2##4##(1996-12#1)(2012-3#1)
were identified as potential##2##4##(2008-10#1)(2009-6#1)
were identified as the##4##4##(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
were identified as##70##3##(1990-5#1)(1991-5#2)(1995-12#1)(1995-6#1)(1996-1#2)(1996-12#3)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-5#3)(2008-9#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-8#4)
were identified at##2##3##(2008-10#1)(2008-9#1)
were identified based on##2##4##(1997-6#1)(2008-10#1)
were identified based upon##2##4##(2008-10#2)
were identified based##4##3##(1997-6#1)(2008-10#3)
were identified between##2##3##(2008-9#1)(2013-1#1)
were identified by gas##2##4##(2008-10#1)(2008-7#1)
were identified by the##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
were identified by their##3##4##(2008-10#1)(2008-11#2)
were identified by##40##3##(1991-12#1)(1991-5#1)(1993-12#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#2)(2010-12#1)(2012-3#1)(2013-8#4)
were identified during##2##3##(2009-3#1)(2012-3#1)
were identified for inclusion##2##4##(2012-3#1)(2013-1#1)
were identified for resistance to##2##5##(2008-10#2)
were identified for resistance##3##4##(2008-10#3)
were identified for##9##3##(1991-12#1)(1995-12#1)(2008-10#3)(2008-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
were identified from the##6##4##(2008-10#4)(2008-11#1)(2013-8#1)
were identified from##16##3##(2008-10#9)(2008-11#2)(2008-9#2)(2009-10#1)(2011-2#1)(2013-8#1)
were identified in the##13##4##(1991-6#1)(1991-7#1)(1996-8#1)(1997-2#1)(2008-10#6)(2009-10#1)(2011-2#1)(2012-12#1)
were identified in##34##3##(1991-6#1)(1991-7#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#19)(2008-11#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
were identified including##2##3##(2008-12#1)(2011-2#1)
were identified on chromosomes 1##2##5##(2008-10#1)(2008-9#1)
were identified on chromosomes##3##4##(2008-10#2)(2008-9#1)
were identified on##6##3##(1997-2#1)(2007-12#1)(2008-10#3)(2008-9#1)
were identified that are##2##4##(2008-10#1)(2012-3#1)
were identified that could##2##4##(2008-10#1)(2008-9#1)
were identified that##6##3##(2008-10#4)(2008-9#1)(2012-3#1)
were identified through##2##3##(1995-12#1)(2008-10#1)
were identified throughout the##2##4##(2008-11#1)(2013-1#1)
were identified to##7##3##(2008-10#3)(2008-11#1)(2008-9#1)(2010-1#1)(2013-8#1)
were identified using##11##3##(2008-10#6)(2008-11#2)(2010-8#1)(2011-2#1)(2012-3#1)
were identified which##3##3##(1994-11#1)(2008-11#1)(2008-7#1)
were identified with a##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
were identified with##10##3##(1997-9#1)(2008-10#6)(2011-2#1)(2011-3#1)(2012-3#1)
were identified within the##3##4##(2008-10#2)(2012-2#1)
were identified within##4##3##(2008-10#3)(2012-2#1)
were identified##368##2##(1990-12#2)(1990-5#1)(1991-1#1)(1991-12#2)(1991-5#4)(1991-6#2)(1991-7#1)(1992-1#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1995-1#1)(1995-12#5)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#2)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#166)(2008-11#19)(2008-12#8)(2008-5#7)(2008-7#5)(2008-8#3)(2008-9#11)(2009-10#2)(2009-3#3)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-3#2)(2010-5#2)(2010-8#3)(2011-1#3)(2011-2#12)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#11)(2012-5#1)(2013-1#13)(2013-8#14)
were illustrated##3##2##(2008-10#2)(2010-1#1)
were imaged##3##2##(2008-11#1)(2008-3#1)(2009-5#1)
were immediately##4##2##(1992-9#1)(2008-3#1)(2010-12#1)(2013-1#1)
were immersed in##3##3##(2008-10#2)(2008-6#1)
were immobilized in a##2##4##(2008-10#1)(2008-11#1)
were immobilized in##5##3##(2008-10#3)(2008-11#2)
were immobilized on the##2##4##(2008-10#2)
were immobilized on##5##3##(2008-10#5)
were immobilized onto##3##3##(2008-10#3)
were immobilized##16##2##(2008-10#14)(2008-11#2)
were immune to##2##3##(2008-10#2)
were immunized with##2##3##(1990-12#1)(2008-7#1)
were immunized##5##2##(1990-12#1)(1995-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
were immunohistochemically##2##2##(1992-6#1)(2011-2#1)
were immunoprecipitated with##2##3##(1990-5#1)(1996-2#1)
were immunoreactive for##3##3##(1997-2#3)
were impaired in##2##3##(2008-10#1)(2008-7#1)
were impaired##3##2##(2008-10#2)(2008-7#1)
were implant##3##2##(2013-1#3)
were implanted and##2##3##(2008-3#1)(2008-9#1)
were implanted in##2##3##(1990-8#1)(2009-3#1)
were implanted into##2##3##(1993-1#1)(2008-5#1)
were implanted##8##2##(1990-8#1)(1993-1#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
were implemented and##2##3##(2008-10#1)(2008-3#1)
were implemented by##2##3##(2008-11#1)(2012-2#1)
were implemented in the Health##2##5##(1994-1#1)(1997-2#1)
were implemented in the##3##4##(1994-1#1)(1997-2#1)(2008-10#1)
were implemented in##5##3##(1994-1#2)(1997-2#1)(2008-10#2)
were implemented##10##2##(1994-1#2)(1994-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)
were implicated##3##2##(2008-1#1)(2008-11#1)(2010-1#1)
were important for##2##3##(2008-10#1)(2008-11#1)
were important##9##2##(1990-8#1)(1993-6#1)(1996-1#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#2)
were improved after##2##3##(1996-6#1)(2008-7#1)
were improved by##2##3##(2008-11#1)(2008-12#1)
were improved in##2##3##(1991-6#1)(2008-10#1)
were improved significantly##2##3##(2008-10#1)(2012-2#1)
were improved##11##2##(1991-6#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#2)
were in Child's grade C##2##5##(2012-3#2)
were in VCG##3##3##(2008-10#3)
were in VCG1A##2##3##(2008-10#2)
were in a good agreement with the##2##7##(2008-10#2)
were in a good##4##4##(2008-10#2)(2008-7#2)
were in a##12##3##(1993-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#3)
were in accordance with the##2##5##(2008-10#1)(2009-8#1)
were in agreement with certified values##2##6##(2008-10#2)
were in agreement with the certified##3##6##(2008-10#3)
were in agreement with the##4##5##(2008-10#4)
were in agreement with those obtained by a##2##8##(2008-10#2)
were in agreement with those obtained by the##2##8##(2008-10#2)
were in agreement with those obtained by##6##7##(2008-10#6)
were in agreement with those obtained with##2##7##(2008-10#2)
were in agreement with those obtained##9##6##(2008-10#8)(2008-5#1)
were in agreement with those##11##5##(1992-1#1)(2008-10#9)(2008-5#1)
were in agreement with##18##4##(1992-1#1)(2008-10#15)(2008-12#1)(2008-5#1)
were in agreement##21##3##(1992-1#1)(2008-10#17)(2008-12#1)(2008-5#1)(2010-11#1)
were in all##3##3##(2008-10#3)
were in different##2##3##(2008-10#1)(2013-8#1)
were in excellent agreement##2##4##(2008-10#2)
were in general##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
were in genotype##2##3##(2008-10#2)
were in good agreement with certified values##3##7##(2008-10#3)
were in good agreement with the certified values and##2##9##(2008-10#2)
were in good agreement with the certified values##5##8##(2008-10#5)
were in good agreement with the certified##6##7##(2008-10#6)
were in good agreement with the##12##6##(2008-10#12)
were in good agreement with those obtained by an##2##9##(2008-10#2)
were in good agreement with those obtained by##8##8##(2008-10#8)
were in good agreement with those obtained##10##7##(2008-10#10)
were in good agreement with those reported by the##2##9##(2008-10#2)
were in good agreement with those reported##3##7##(2008-10#3)
were in good agreement with those##16##6##(2008-10#16)
were in good agreement with##38##5##(2008-10#37)(2008-3#1)
were in good agreement##44##4##(2008-10#42)(2008-3#2)
were in good##45##3##(2008-10#42)(2008-12#1)(2008-3#2)
were in satisfactory##2##3##(2008-10#2)
were in the immediate vicinity of##2##6##(2008-10#2)
were in the range 0##2##5##(2008-10#1)(2008-3#1)
were in the range 1##3##5##(2008-10#3)
were in the range of 0##4##6##(2008-10#4)
were in the range of##14##5##(2008-10#14)
were in the range##23##4##(2008-10#22)(2008-3#1)
were in the ranges of 1##2##6##(2008-10#2)
were in the ranges of##4##5##(2008-10#4)
were in the ranges##6##4##(2008-10#6)
were in the same clade##2##5##(2008-10#2)
were in the same##3##4##(2008-10#2)(2008-11#1)
were in the size range##3##5##(1995-3#1)(2008-7#2)
were in the##66##3##(1993-8#2)(1995-3#1)(1996-2#1)(1996-6#1)(2008-10#44)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-8#1)(2012-3#3)(2013-8#1)
were in vitro sensitive to##2##5##(1991-2#2)
were in##210##2##(1990-2#2)(1991-12#2)(1991-2#2)(1991-6#1)(1991-9#1)(1992-1#1)(1993-1#1)(1993-8#3)(1994-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-8#1)(1997-9#1)(2008-10#138)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#6)(2013-1#1)(2013-8#2)
were inactivated by##2##3##(1991-5#1)(2008-11#1)
were inadequate##3##2##(1992-12#1)(2008-10#2)
were included and##2##3##(2008-10#2)
were included as##2##3##(1996-1#1)(2008-12#1)
were included for##3##3##(1994-12#1)(2008-10#1)(2013-1#1)
were included in a##2##4##(1997-7#1)(2008-10#1)
were included in the experiments##2##5##(2008-11#2)
were included in the study##12##5##(1990-11#1)(1992-9#1)(1997-8#1)(2008-11#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
were included in the##26##4##(1990-11#1)(1992-9#1)(1997-8#1)(2008-10#3)(2008-11#5)(2008-7#3)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
were included in this retrospective##2##5##(2011-1#2)
were included in this study##9##5##(1994-3#1)(2008-10#1)(2008-9#1)(2010-7#1)(2012-3#3)(2013-1#2)
were included in this##15##4##(1994-3#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-3#3)(2013-1#3)
were included in##53##3##(1990-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-11#5)(2008-3#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#5)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
were included##97##2##(1990-11#1)(1991-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#16)(2008-11#6)(2008-12#3)(2008-3#2)(2008-7#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#13)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#4)
were incompatible with##2##3##(2008-10#1)(2008-9#1)
were inconclusive##3##2##(1993-8#1)(2008-10#1)(2008-12#1)
were incorporated into##3##3##(2008-10#2)(2009-7#1)
were incorporated to##2##3##(2013-1#2)
were incorporated##8##2##(2008-10#3)(2008-11#1)(2009-3#1)(2009-7#1)(2013-1#2)
were increased by##8##3##(1991-3#1)(1992-9#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#2)
were increased from##4##3##(2008-10#3)(2008-11#1)
were increased in 400##2##4##(2008-9#2)
were increased in males and females##2##6##(2008-9#2)
were increased in males##3##4##(2008-9#3)
were increased in the##4##4##(1995-11#1)(2008-10#2)(2008-11#1)
were increased in##15##3##(1991-12#1)(1992-4#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-9#5)(2009-3#1)(2009-8#1)(2013-1#1)
were increased incidences##3##3##(2008-9#3)
were increased to##4##3##(1990-6#1)(1993-8#1)(1995-12#1)(1996-2#1)
were increased up to##2##4##(2008-10#2)
were increased##54##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#12)(2008-11#5)(2008-7#1)(2008-8#1)(2008-9#11)(2009-3#1)(2009-8#1)(2011-2#2)(2011-3#4)(2013-1#2)
were increasingly##2##2##(1990-12#1)(2008-9#1)
were incubated at##6##3##(2008-10#6)
were incubated for##4##3##(1995-11#1)(1995-8#1)(2008-12#1)(2012-3#1)
were incubated in a##2##4##(2008-10#1)(2008-8#1)
were incubated in the##2##4##(1991-3#1)(2008-10#1)
were incubated in##11##3##(1991-3#1)(2008-10#5)(2008-11#4)(2008-8#1)
were incubated on##2##3##(2008-10#1)(2010-3#1)
were incubated with the##2##4##(1990-12#2)
were incubated with##20##3##(1990-10#1)(1990-12#2)(1990-2#1)(1991-12#2)(1993-11#1)(1993-3#1)(1994-11#2)(1994-8#2)(1995-11#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#1)
were incubated##49##2##(1990-10#1)(1990-12#2)(1990-2#1)(1991-12#2)(1991-3#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-11#1)(2010-3#1)(2012-3#1)
were indeed##2##2##(1997-8#1)(2008-5#1)
were independent of the##5##4##(1993-6#1)(2008-10#2)(2008-5#1)(2008-8#1)
were independent of##10##3##(1990-2#1)(1993-6#1)(2008-10#4)(2008-5#2)(2008-8#1)(2012-3#1)
were independent##14##2##(1990-2#1)(1993-11#1)(1993-6#1)(1994-8#1)(2008-10#4)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
were independently##4##2##(1993-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
were indicative of a##2##4##(2008-10#1)(2013-1#1)
were indicative of##6##3##(1993-1#1)(2008-10#2)(2010-10#1)(2012-12#1)(2013-1#1)
were indistinguishable from##3##3##(2008-10#2)(2008-12#1)
were indistinguishable##8##2##(2008-10#6)(2008-11#1)(2008-12#1)
were individually##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
were induced by##7##3##(1997-8#1)(2008-10#3)(2008-11#1)(2011-10#1)(2013-1#1)
were induced from##2##3##(2008-12#1)(2013-1#1)
were induced in experimental##2##4##(2008-10#1)(2009-8#1)
were induced in##4##3##(2008-10#2)(2009-7#1)(2009-8#1)
were induced to##2##3##(1993-3#1)(2008-9#1)
were induced with##3##3##(1995-12#1)(2008-10#1)(2010-7#1)
were induced##28##2##(1993-3#1)(1993-8#1)(1995-12#1)(1997-8#1)(2006-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#2)(2011-10#1)(2013-1#2)
were ineffective in##2##3##(2008-10#2)
were ineffective##10##2##(1993-3#1)(1994-6#1)(1994-8#2)(2008-10#4)(2008-12#1)(2009-7#1)
were infected and##2##3##(2008-10#2)
were infected by##8##3##(1995-9#1)(2008-10#6)(2012-3#1)
were infected with the##2##4##(1994-5#1)(2008-10#1)
were infected with##17##3##(1994-5#1)(1997-3#1)(2008-10#9)(2008-5#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
were infected##38##2##(1994-5#1)(1995-9#1)(1996-11#1)(1997-3#1)(2008-10#23)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
were infectious on##2##3##(2008-10#1)(2008-9#1)
were infectious##6##2##(1997-3#1)(2008-10#4)(2008-9#1)
were inferior##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
were inferred from##2##3##(2008-10#1)(2008-6#1)
were inferred##4##2##(2008-10#2)(2008-6#2)
were infested with##8##3##(1996-12#2)(2008-10#6)
were infested##9##2##(1996-12#2)(2008-10#7)
were infiltrated##2##2##(1990-2#1)(2008-10#1)
were influenced by the##3##4##(1992-12#1)(1993-8#1)(1995-11#1)
were influenced by##6##3##(1992-12#1)(1993-6#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-9#1)
were influenced##7##2##(1992-12#1)(1993-6#1)(1993-8#1)(1995-11#1)(2008-10#2)(2008-9#1)
were influenza##2##2##(1992-6#2)
were inhibited by the##2##4##(1993-3#1)(2008-11#1)
were inhibited by##9##3##(1991-5#1)(1993-3#1)(1994-3#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#3)
were inhibited##15##2##(1991-5#1)(1993-3#1)(1994-3#1)(1994-5#2)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#3)(2009-10#1)(2010-8#1)(2011-2#1)
were inhibitory to##3##3##(2008-10#3)
were inhibitory##4##2##(1994-3#1)(2008-10#3)
were initially##15##2##(1991-3#1)(1991-5#1)(1992-8#1)(1995-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-9#1)(2011-2#2)
were initiated##5##2##(1991-2#1)(1993-1#1)(2008-10#1)(2010-10#1)(2013-1#1)
were injected directly into##3##4##(2008-10#3)
were injected i##3##3##(1997-4#1)(2010-1#2)
were injected in##2##3##(2008-10#1)(2011-1#1)
were injected into a##2##4##(2008-10#2)
were injected into the graphite tube##2##6##(2008-10#2)
were injected into the##10##4##(2008-10#7)(2008-11#1)(2008-12#1)(2012-3#1)
were injected into##14##3##(2008-10#10)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
were injected intraperitoneally##2##3##(2008-11#1)(2010-5#1)
were injected onto a##2##4##(2008-10#2)
were injected onto##3##3##(2008-10#2)(2008-11#1)
were injected with##4##3##(1990-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
were injected##40##2##(1990-12#1)(1990-7#1)(1997-4#1)(2008-10#22)(2008-11#3)(2008-12#1)(2010-1#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#2)
were injured by##2##3##(2008-8#1)(2011-2#1)
were injured in##2##3##(1990-9#1)(2012-3#1)
were injured##4##2##(1990-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
were inoculated and incubated in##2##5##(2008-10#2)
were inoculated and incubated##3##4##(2008-10#3)
were inoculated and##4##3##(2008-10#4)
were inoculated at the##4##4##(2008-10#4)
were inoculated at##10##3##(2008-10#10)
were inoculated by##2##3##(2008-10#2)
were inoculated in the##2##4##(2008-10#2)
were inoculated in##6##3##(2008-10#4)(2008-5#2)
were inoculated into##4##3##(1991-12#1)(2008-10#2)(2008-5#1)
were inoculated onto a##2##4##(2008-10#2)
were inoculated onto##4##3##(2008-10#3)(2012-2#1)
were inoculated together##2##3##(2008-10#2)
were inoculated with P##3##4##(2008-10#3)
were inoculated with a##5##4##(2008-10#4)(2011-2#1)
were inoculated with an##2##4##(2008-10#2)
were inoculated with conidia of##2##5##(2008-10#2)
were inoculated with conidial suspensions of##2##6##(2008-10#2)
were inoculated with the##2##4##(2008-10#2)
were inoculated with##40##3##(2008-10#38)(2011-2#1)(2012-2#1)
were inoculated##92##2##(1991-12#1)(2008-10#82)(2008-12#1)(2008-5#4)(2011-10#1)(2011-2#1)(2012-2#2)
were insensitive to the toxin##2##5##(2008-10#2)
were insensitive to##5##3##(2008-10#4)(2008-11#1)
were inserted in##2##3##(2013-1#1)(2013-8#1)
were inserted into the##4##4##(1991-5#1)(2010-6#2)(2011-2#1)
were inserted into##8##3##(1991-5#1)(1995-2#1)(1997-6#1)(2008-8#1)(2010-6#2)(2011-2#1)(2013-1#1)
were inserted##12##2##(1991-5#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-6#2)(2011-2#1)(2013-1#2)(2013-8#1)
were instructed to perform##2##4##(2010-9#1)(2011-2#1)
were instructed to##5##3##(1991-2#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
were instructed##8##2##(1991-2#1)(2008-11#2)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)
were insufficient to##2##3##(2008-10#1)(2008-8#1)
were integrated into the##2##4##(1997-7#1)(2008-9#1)
were integrated into##3##3##(1997-7#1)(2008-12#1)(2008-9#1)
were integrated##5##2##(1997-7#1)(2008-10#2)(2008-12#1)(2008-9#1)
were intensely##2##2##(1995-12#1)(2008-7#1)
were intensively##2##2##(2008-10#1)(2008-7#1)
were interested in##2##3##(2010-2#1)(2011-9#1)
were intermediate in##2##3##(2008-10#2)
were intermediate##5##2##(2008-10#4)(2008-12#1)
were internally##3##2##(2008-10#1)(2013-8#2)
were interpersonal##2##2##(2008-9#1)(2009-3#1)
were interpreted as##5##3##(1993-6#1)(2008-10#1)(2008-5#2)(2013-8#1)
were interpreted in terms of complex##2##6##(2008-10#2)
were interpreted in##3##3##(2008-10#2)(2012-3#1)
were interpreted to be##2##4##(1996-2#1)(2008-10#1)
were interpreted to##4##3##(1996-2#1)(2008-10#3)
were interpreted##15##2##(1990-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1996-2#1)(2008-10#6)(2008-5#2)(2012-3#1)(2013-8#1)
were interviewed about their##2##4##(1996-6#1)(2009-9#1)
were interviewed about##3##3##(1996-6#1)(2008-11#1)(2009-9#1)
were interviewed and##2##3##(1995-1#1)(2008-12#1)
were interviewed during##2##3##(2009-6#1)(2012-3#1)
were interviewed in##3##3##(1990-12#1)(1992-3#1)(2008-1#1)
were interviewed to##3##3##(1990-8#1)(1994-1#1)(2010-10#1)
were interviewed using a semistructured##2##5##(2010-9#1)(2011-1#1)
were interviewed using a##5##4##(2009-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
were interviewed using the##2##4##(1992-2#1)(2008-7#1)
were interviewed using##7##3##(1992-2#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
were interviewed##42##2##(1990-12#2)(1990-8#1)(1991-6#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-1#2)(1996-6#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-7#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
were interwoven##2##2##(2009-9#1)(2010-1#1)
were introduced as##3##3##(1997-8#1)(2008-10#2)
were introduced by##2##3##(2008-10#1)(2008-8#1)
were introduced in the##3##4##(1996-2#1)(2008-10#2)
were introduced in##5##3##(1996-2#1)(2008-10#3)(2008-8#1)
were introduced into the##4##4##(2008-10#4)
were introduced into##14##3##(1993-8#1)(2008-10#9)(2008-11#1)(2008-8#2)(2008-9#1)
were introduced to the##2##4##(1994-1#1)(2008-10#1)
were introduced to##3##3##(1994-1#1)(2008-10#1)(2008-3#1)
were introduced##40##2##(1990-11#1)(1990-8#1)(1993-8#1)(1994-1#1)(1996-2#1)(1997-8#1)(2008-10#22)(2008-11#3)(2008-3#1)(2008-8#6)(2008-9#1)(2011-2#1)
were inversely correlated with##2##4##(1997-4#1)(2008-9#1)
were inversely related to##2##4##(1995-12#1)(2008-9#1)
were inversely related##3##3##(1995-12#1)(2008-12#1)(2008-9#1)
were inversely##5##2##(1995-12#1)(1997-4#1)(2008-12#1)(2008-9#2)
were inverted##2##2##(2008-10#1)(2008-11#1)
were investigated and compared with the##3##6##(2008-10#1)(2008-3#1)(2013-1#1)
were investigated and optimized##3##4##(2008-10#3)
were investigated and the##3##4##(2008-10#3)
were investigated and##13##3##(2008-10#10)(2008-3#1)(2009-3#1)(2013-1#1)
were investigated as##6##3##(2008-10#4)(2008-7#1)(2012-5#1)
were investigated at##3##3##(2008-10#3)
were investigated by means of a##2##6##(1990-8#1)(2008-3#1)
were investigated by means of##4##5##(1990-8#1)(2008-10#2)(2008-3#1)
were investigated by measuring##2##4##(1991-9#1)(2008-5#1)
were investigated by transmission electron microscopy##2##6##(2008-10#2)
were investigated by univariate method##2##5##(2008-10#2)
were investigated by using##2##4##(2008-10#1)(2009-7#1)
were investigated by##30##3##(1990-8#1)(1991-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)
were investigated during##2##3##(2008-10#1)(2008-12#1)
were investigated experimentally##3##3##(1997-2#1)(2008-10#2)
were investigated for the##4##4##(1993-8#1)(2008-10#2)(2011-2#1)
were investigated for their##2##4##(2009-12#1)(2012-2#1)
were investigated for##19##3##(1993-8#1)(2006-6#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
were investigated from##2##3##(2008-10#1)(2008-5#1)
were investigated in a##9##4##(1997-4#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#2)
were investigated in detail and optimized##3##6##(2008-10#3)
were investigated in detail and##4##5##(2008-10#4)
were investigated in detail##16##4##(2008-10#16)
were investigated in order to##3##5##(2008-10#3)
were investigated in rats##3##4##(1994-3#1)(1995-2#1)(1996-2#1)
were investigated in the##2##4##(2008-10#1)(2008-5#1)
were investigated in this##2##4##(2008-10#2)
were investigated in vitro##3##4##(1990-11#1)(1996-12#1)(2006-6#1)
were investigated in vivo##3##4##(1990-11#1)(1990-5#1)(1996-12#1)
were investigated in##76##3##(1990-11#2)(1990-5#1)(1991-3#1)(1991-6#1)(1993-1#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#4)(1997-1#3)(1997-3#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)(2012-4#1)
were investigated on##3##3##(2008-10#1)(2008-9#1)(2010-7#1)
were investigated through##2##3##(2008-10#1)(2009-7#1)
were investigated to acquire the optimum##2##6##(2008-10#2)
were investigated to determine the##2##5##(2008-10#1)(2013-1#1)
were investigated to##19##3##(1991-12#1)(2008-10#16)(2008-3#1)(2013-1#1)
were investigated under##2##3##(1996-6#1)(2008-10#1)
were investigated using the##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
were investigated using##25##3##(1991-5#1)(1993-12#1)(1993-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-5#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#2)
were investigated with regard to##2##5##(2008-10#2)
were investigated with the##3##4##(2008-10#3)
were investigated with##16##3##(1995-11#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
were investigated##393##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#3)(1995-2#3)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#7)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2006-6#2)(2007-12#2)(2008-1#1)(2008-10#234)(2008-11#18)(2008-12#6)(2008-3#6)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#7)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#6)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2013-1#3)
were invited to attend##3##4##(1992-5#1)(2008-10#1)(2012-2#1)
were invited to participate##3##4##(2008-11#1)(2011-1#1)(2012-12#1)
were invited to##10##3##(1991-6#1)(1992-5#1)(2008-10#2)(2008-11#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
were invited##13##2##(1991-6#2)(1992-5#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-11#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
were involved in the##5##4##(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
were involved in##14##3##(1994-5#1)(1994-8#1)(1995-1#1)(1996-5#1)(2008-10#3)(2008-11#2)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)
were involved##17##2##(1994-5#1)(1994-8#1)(1995-1#1)(1996-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)
were irradiated at##2##3##(1991-2#1)(2008-10#1)
were irradiated by##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
were irradiated with##4##3##(1996-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
were irradiated##12##2##(1991-2#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)
were isolated and characterized##2##4##(2008-10#1)(2013-8#1)
were isolated and cloned##2##4##(2008-8#2)
were isolated and purified##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
were isolated and sequenced##2##4##(1991-6#1)(1993-3#1)
were isolated and##16##3##(1991-6#1)(1993-3#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#3)(2008-9#1)(2012-2#1)(2013-8#1)
were isolated as##2##3##(1990-2#1)(2008-11#1)
were isolated at##5##3##(2008-10#4)(2008-12#1)
were isolated by a##2##4##(1993-3#1)(2008-10#1)
were isolated by##11##3##(1993-3#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-8#1)(2009-8#1)
were isolated for##2##3##(2008-5#1)(2008-7#1)
were isolated from a P1 library of the Arabidopsis thaliana##2##10##(1997-6#1)(1997-8#1)
were isolated from a human##2##5##(1994-11#1)(2008-11#1)
were isolated from a##13##4##(1993-6#1)(1993-9#1)(1994-11#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)
were isolated from diseased##2##4##(2008-10#2)
were isolated from human##4##4##(1996-12#1)(2008-11#2)(2008-8#1)
were isolated from the##14##4##(1991-12#1)(1991-9#1)(1994-11#1)(1994-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2011-3#1)(2012-2#1)
were isolated from this##2##4##(2008-10#1)(2011-3#1)
were isolated from tobacco##3##4##(2008-10#3)
were isolated from two##2##4##(1990-8#1)(2008-8#1)
were isolated from##89##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-9#1)(1996-12#1)(1997-6#1)(1997-8#3)(2008-10#42)(2008-11#7)(2008-12#3)(2008-5#2)(2008-6#1)(2008-8#7)(2010-6#1)(2011-2#1)(2011-3#2)(2012-2#4)(2013-1#1)(2013-8#1)
were isolated in##4##3##(2008-10#3)(2008-12#1)
were isolated that##3##3##(1990-8#1)(1994-11#1)(2008-10#1)
were isolated using##2##3##(1993-8#1)(1997-7#1)
were isolated##167##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#2)(1997-6#1)(1997-7#1)(1997-8#5)(2008-10#70)(2008-11#14)(2008-12#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#14)(2008-9#2)(2009-8#1)(2010-6#2)(2011-2#2)(2011-3#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#4)
were isolates from##2##3##(2008-10#2)
were isolates##3##2##(2008-10#3)
were issued##2##2##(2010-7#1)(2011-2#1)
were judged to be##5##4##(1992-12#1)(1996-8#1)(2008-10#1)(2008-11#2)
were judged##8##2##(1992-12#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-10#1)
were kept at##2##3##(2008-10#1)(2008-11#1)
were kept in##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
were kept##16##2##(1996-12#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
were key##2##2##(2008-10#1)(2010-1#1)
were killed##7##2##(1996-12#1)(2008-10#4)(2008-5#1)(2008-7#1)
were labeled by##3##3##(1995-6#1)(2008-10#1)(2010-12#1)
were labeled with##3##3##(1994-5#1)(1997-2#1)(2009-8#1)
were labeled##8##2##(1994-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#2)(2009-8#1)(2010-12#1)
were labelled##3##2##(1993-2#1)(1993-6#1)(1997-8#1)
were lacking##2##2##(2008-10#2)
were large##7##2##(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#1)
were largely##5##2##(2008-10#2)(2009-10#1)(2009-7#1)(2010-10#1)
were larger than those produced in##2##6##(2008-10#2)
were larger than those##4##4##(1991-5#1)(2008-10#2)(2009-7#1)
were larger than##5##3##(1991-5#1)(2008-10#2)(2009-7#1)(2010-9#1)
were larger##8##2##(1991-5#1)(1996-2#1)(2008-10#3)(2008-7#1)(2009-7#1)(2010-9#1)
were later##2##2##(2008-11#1)(2013-1#1)
were learned##3##2##(1991-2#1)(1996-2#1)(2008-12#1)
were least##4##2##(1992-2#1)(2008-10#3)
were left##5##2##(1992-2#1)(2008-11#1)(2008-7#1)(2013-1#2)
were less abundant##2##3##(1994-2#1)(2008-6#1)
were less affected##2##3##(2008-11#1)(2008-8#1)
were less effective##3##3##(1995-11#1)(2008-10#2)
were less efficient##2##3##(2008-10#2)
were less likely to be##2##5##(2008-4#1)(2009-5#1)
were less likely to provide##2##5##(1995-12#1)(2011-2#1)
were less likely to##12##4##(1995-12#3)(1997-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-3#1)
were less likely##13##3##(1995-12#3)(1995-2#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-3#1)
were less sensitive##2##3##(2008-10#1)(2010-10#1)
were less susceptible to##2##4##(1996-12#1)(2008-10#1)
were less than 1##4##4##(2008-10#3)(2012-2#1)
were less than the mean of the components##2##8##(2008-10#2)
were less than the##3##4##(1996-12#1)(2008-10#2)
were less than those of the vehicle##2##7##(2008-9#2)
were less than those of the##5##6##(2008-9#5)
were less than those of##6##5##(1991-3#1)(2008-9#5)
were less than those##7##4##(1991-3#1)(1995-12#1)(2008-9#5)
were less than##25##3##(1990-12#1)(1991-12#1)(1991-3#1)(1995-12#1)(1996-12#2)(2008-10#13)(2008-9#5)(2012-2#1)
were less virulent##2##3##(2008-10#2)
were less##91##2##(1990-12#1)(1991-12#1)(1991-3#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-6#1)(1996-12#3)(1997-2#1)(2008-10#35)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#7)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)
were liberated##2##2##(2008-10#1)(2009-8#1)
were light##2##2##(2008-10#2)
were like##2##2##(1992-12#1)(2010-6#1)
were likely to##2##3##(2008-10#1)(2008-8#1)
were likely##6##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)
were limited to the##3##4##(2008-10#2)(2008-5#1)
were limited to##4##3##(2008-10#3)(2008-5#1)
were limited##7##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)
were linear (r&gt##2##3##(2008-10#2)
were linear between##3##3##(2008-10#3)
were linear for##2##3##(2008-10#2)
were linear from##3##3##(2008-10#3)
were linear in the concentration range##2##6##(2008-10#2)
were linear in the concentration##4##5##(2008-10#4)
were linear in the range of##6##6##(2008-10#6)
were linear in the range##8##5##(2008-10#8)
were linear in the##15##4##(2008-10#15)
were linear in##16##3##(2008-10#16)
were linear over the concentration range of##2##7##(2008-10#2)
were linear over the range##6##5##(2008-10#6)
were linear over the##9##4##(2008-10#9)
were linear over##12##3##(2008-10#12)
were linear up to##2##4##(2008-10#2)
were linear##44##2##(2008-10#44)
were linearly related to the##2##5##(1994-11#1)(2008-10#1)
were linearly related##3##3##(1994-11#1)(2008-10#1)(2008-6#1)
were linearly##6##2##(1994-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
were lined by##2##3##(1990-6#2)
were linked by##2##3##(1997-1#1)(2008-9#1)
were linked to the##5##4##(2008-10#3)(2009-12#1)(2011-2#1)
were linked to##13##3##(2008-10#7)(2008-11#1)(2008-12#1)(2009-12#1)(2010-8#1)(2011-2#2)
were linked##17##2##(1997-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#2)(2009-12#1)(2010-8#1)(2011-2#2)
were listed##2##2##(2008-10#1)(2011-3#1)
were living with##3##3##(1992-9#1)(2008-6#1)(2008-7#1)
were living##4##2##(1992-9#1)(2008-6#1)(2008-7#1)(2011-2#1)
were loaded##4##2##(1994-2#1)(2008-11#1)(2009-7#1)(2013-1#1)
were localized in the##2##4##(2008-10#2)
were localized in##8##3##(1993-11#1)(2008-10#7)
were localized to##4##3##(1996-12#1)(1997-2#1)(1997-3#1)(2008-11#1)
were localized##13##2##(1993-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#1)
were located at the##3##4##(1997-3#1)(2008-12#1)(2008-7#1)
were located at##4##3##(1997-3#1)(2008-12#1)(2008-7#1)(2010-5#1)
were located in the##9##4##(1991-8#1)(1994-2#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
were located in##15##3##(1991-8#1)(1994-2#1)(1995-11#1)(1996-2#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
were located near##3##3##(2008-10#2)(2013-8#1)
were located on chromosome##2##4##(1997-2#1)(2008-8#1)
were located on chromosomes##2##4##(1996-12#1)(2008-8#1)
were located on##8##3##(1996-12#2)(1997-2#1)(2008-10#3)(2008-8#2)
were located##38##2##(1991-8#1)(1994-2#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#5)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
were longer than##2##3##(2011-2#1)(2012-2#1)
were lost to follow-up##2##4##(2008-11#1)(2013-1#1)
were lost to##5##3##(1993-12#1)(1996-3#1)(2008-11#2)(2013-1#1)
were lost##6##2##(1990-3#1)(1993-12#1)(1996-3#1)(2008-11#2)(2013-1#1)
were low affinity (Kd = 0##2##6##(1994-8#2)
were low compared##2##3##(2008-10#1)(2010-8#1)
were low enough##2##3##(1995-3#1)(1995-8#1)
were low in##2##3##(2008-10#2)
were low##18##2##(1994-8#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#9)(2010-11#1)(2010-8#1)(2013-8#1)
were lower and##2##3##(2008-12#1)(2010-8#1)
were lower at##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
were lower for##2##3##(1995-1#1)(2008-12#1)
were lower in the##5##4##(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
were lower in##13##3##(1993-1#1)(1997-2#1)(2008-10#4)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#2)(2013-8#1)
were lower than 0##2##4##(2008-10#2)
were lower than 2%##2##4##(2008-10#2)
were lower than 3##3##4##(2008-10#3)
were lower than in controls##2##5##(1992-11#1)(2008-7#1)
were lower than in those##2##5##(2011-2#2)
were lower than in##6##4##(1992-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)
were lower than those of##2##5##(1995-8#1)(2008-10#1)
were lower than those##4##4##(1995-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
were lower than##31##3##(1990-9#1)(1992-11#1)(1994-2#1)(1995-1#1)(1995-8#1)(2008-10#18)(2008-12#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
were lower##57##2##(1990-9#1)(1992-11#1)(1993-1#1)(1994-2#1)(1995-1#2)(1995-8#1)(1997-2#1)(2008-10#25)(2008-12#5)(2008-4#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#2)
were lowered##3##2##(1993-8#1)(2008-11#1)(2012-2#1)
were lowest##3##2##(2008-10#2)(2008-9#1)
were lyophilized##2##2##(2008-10#2)
were made at##3##3##(2008-10#3)
were made between##3##3##(2008-10#3)
were made by using##3##4##(2008-10#3)
were made by##14##3##(1991-3#1)(1994-12#1)(1995-11#1)(2008-10#9)(2008-7#1)(2008-9#1)
were made directly##2##3##(2008-11#1)(2008-9#1)
were made during##2##3##(1996-1#1)(2008-10#1)
were made for each##2##4##(2008-10#2)
were made for##6##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
were made from##13##3##(1995-12#1)(1995-2#1)(2008-10#7)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
were made in a##2##4##(2008-10#1)(2008-3#1)
were made in order to##2##5##(2008-11#1)(2012-7#1)
were made in##13##3##(1995-12#1)(1997-9#1)(2008-10#6)(2008-11#2)(2008-3#1)(2009-5#1)(2012-7#1)
were made of the##3##4##(1991-3#1)(1997-8#1)(2008-10#1)
were made of##5##3##(1991-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2012-3#1)
were made over##3##3##(2008-10#2)(2010-8#1)
were made to##11##3##(1993-2#1)(1997-5#1)(2008-10#5)(2008-12#2)(2011-2#1)(2012-2#1)
were made using a##3##4##(1995-11#1)(2008-10#2)
were made using both##2##4##(2008-10#2)
were made using##11##3##(1991-5#1)(1995-11#1)(2008-10#7)(2008-11#1)(2008-7#1)
were made with##2##3##(2008-10#1)(2008-7#1)
were made##116##2##(1991-3#3)(1991-5#1)(1993-2#1)(1994-12#1)(1995-11#2)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#61)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#1)(2009-7#1)(2010-10#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#1)
were mailed##4##2##(1991-8#1)(1993-12#1)(2008-1#1)(2010-11#1)
were mainly associated with##2##4##(2008-10#1)(2011-3#1)
were mainly##18##2##(1991-12#1)(1991-5#1)(1997-8#1)(2008-10#6)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
were maintained at##4##3##(2008-10#3)(2008-7#1)
were maintained for##5##3##(1990-6#1)(2008-10#1)(2008-11#3)
were maintained in the##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
were maintained in##8##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
were maintained on##3##3##(1994-8#1)(2008-10#1)(2010-8#1)
were maintained under##2##3##(2008-11#2)
were maintained##28##2##(1990-6#1)(1994-8#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-8#1)(2013-8#1)
were major##2##2##(2009-6#1)(2013-1#1)
were male##7##2##(1997-8#1)(2008-11#1)(2008-3#1)(2010-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
were males##6##2##(2008-1#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-3#1)(2013-7#1)
were managed conservatively##2##3##(2008-11#1)(2013-1#1)
were managed using##2##3##(2008-12#1)(2008-3#1)
were managed##10##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#3)(2013-7#1)
were manipulated in##2##3##(2008-10#1)(2012-3#1)
were manipulated##4##2##(2008-10#2)(2010-10#1)(2012-3#1)
were manufactured##2##2##(2008-10#1)(2008-5#1)
were mapped at##2##3##(2008-10#2)
were mapped in##2##3##(2008-10#2)
were mapped on the##4##4##(1996-8#1)(1997-8#1)(2008-8#1)(2013-8#1)
were mapped to##4##3##(1993-12#1)(1996-3#1)(2008-10#1)(2013-1#1)
were mapped##17##2##(1993-12#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-8#2)(2013-1#1)(2013-8#1)
were markedly altered##2##3##(2008-10#2)
were markedly decreased##3##3##(2008-10#2)(2008-8#1)
were markedly##12##2##(1991-12#1)(1995-6#1)(1996-2#1)(2008-10#6)(2008-8#1)(2010-7#1)(2013-7#1)
were married##5##2##(1994-6#1)(1996-5#1)(2009-10#1)(2012-3#1)(2013-1#1)
were matched for##2##3##(1991-12#1)(1996-3#1)
were matched to##2##3##(2008-11#1)(2008-9#1)
were matched with##2##3##(1993-1#1)(1995-2#1)
were matched##7##2##(1991-12#1)(1993-1#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-9#1)(2013-1#1)
were mated##4##2##(1992-3#2)(2008-10#2)
were measured after##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
were measured and compared with##2##5##(2008-10#1)(2008-3#1)
were measured and##7##3##(1997-8#1)(2008-10#3)(2008-3#1)(2012-3#1)(2013-1#1)
were measured as a function of##2##6##(2008-10#1)(2008-3#1)
were measured as##7##3##(1995-2#1)(2008-10#4)(2008-3#1)(2013-1#1)
were measured at four##3##4##(2008-11#1)(2010-5#1)(2013-3#1)
were measured at the##4##4##(2008-10#2)(2010-7#1)(2012-4#1)
were measured at##17##3##(1996-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-4#1)(2013-1#1)(2013-3#1)
were measured before##2##3##(2009-3#1)(2011-1#1)
were measured by a##3##4##(2008-10#1)(2008-3#1)(2011-3#1)
were measured by the##5##4##(1992-3#1)(2008-10#3)(2011-1#1)
were measured by using##2##4##(2008-10#1)(2008-5#1)
were measured by##34##3##(1991-11#1)(1991-6#1)(1992-3#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-12#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-5#2)(2009-1#1)(2009-10#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
were measured directly##2##3##(2008-10#2)
were measured for the##2##4##(1996-5#1)(2008-5#1)
were measured for##8##3##(1991-5#1)(1994-5#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-8#1)
were measured from the##2##4##(1991-5#1)(2008-12#1)
were measured from##3##3##(1991-5#1)(2008-11#1)(2008-12#1)
were measured in a series of##2##6##(2008-7#1)(2008-8#1)
were measured in a##3##4##(1996-2#1)(2008-7#1)(2008-8#1)
were measured in both##2##4##(1994-3#1)(2013-7#1)
were measured in the##10##4##(1994-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)
were measured in vitro##2##4##(1990-6#1)(2008-10#1)
were measured in##47##3##(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1993-2#1)(1994-11#2)(1994-2#2)(1994-3#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-7#1)
were measured including##2##3##(2008-12#2)
were measured on##4##3##(1995-5#1)(2008-10#2)(2012-3#1)
were measured over a##2##4##(1991-9#1)(2011-2#1)
were measured over##4##3##(1991-9#1)(2008-3#1)(2011-2#1)(2013-8#1)
were measured simultaneously##3##3##(2008-10#2)(2008-2#1)
were measured to determine##2##4##(2008-10#1)(2010-4#1)
were measured to##5##3##(2008-1#1)(2008-10#2)(2008-3#1)(2010-4#1)
were measured under##2##3##(2008-10#1)(2008-8#1)
were measured using a##4##4##(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)
were measured using the##3##4##(1993-2#2)(2008-7#1)
were measured using##14##3##(1990-5#1)(1993-2#2)(1994-2#1)(2008-10#4)(2008-11#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-5#1)
were measured with a##3##4##(2007-11#1)(2008-3#2)
were measured with an##2##4##(2008-10#1)(2008-5#1)
were measured with##15##3##(1994-6#1)(1995-3#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)
were measured within the##2##4##(2008-10#1)(2008-11#1)
were measured within##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
were measured##232##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#3)(1994-11#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#72)(2008-11#13)(2008-12#6)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#5)(2012-4#1)(2012-5#1)(2013-1#6)(2013-3#1)(2013-7#1)(2013-8#7)
were meeting##2##2##(2007-12#1)(2012-12#1)
were members of a##2##4##(1991-7#1)(2008-10#1)
were members of the##2##4##(2008-10#2)
were members of##5##3##(1991-7#1)(2008-10#4)
were men##5##2##(1990-6#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)
were mentally retarded##2##3##(1991-6#1)(1997-8#1)
were merged with##3##3##(1993-3#1)(2008-10#2)
were merged##4##2##(1993-3#1)(2008-10#2)(2011-2#1)
were metabolised##2##2##(1994-8#2)
were methylated##2##2##(2009-10#1)(2010-11#1)
were minimal##6##2##(1990-6#1)(1991-8#1)(1992-2#1)(1993-2#1)(1997-7#1)(2008-10#1)
were minimized by##3##3##(1997-2#1)(2008-10#2)
were minimized##4##2##(1997-2#1)(2008-10#3)
were minor##2##2##(2008-10#2)
were missed##2##2##(2008-11#1)(2012-12#1)
were misused in the context of##2##6##(2013-8#2)
were mixed and##3##3##(2008-10#2)(2009-9#1)
were mixed in different##2##4##(2008-10#1)(2013-8#1)
were mixed in##4##3##(1990-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
were mixed##13##2##(1990-12#1)(1990-2#1)(2008-10#5)(2008-2#1)(2008-9#1)(2009-7#2)(2009-9#1)(2013-8#1)
were modeled##2##2##(2013-1#2)
were modelled using##2##3##(2010-4#1)(2011-2#1)
were moderate##2##2##(1991-2#1)(2012-5#1)
were moderated by##2##3##(2010-1#1)(2010-2#1)
were moderately##5##2##(1993-9#1)(2008-10#3)(2010-4#1)
were modest##2##2##(1997-3#1)(2009-7#1)
were modified by##3##3##(2008-10#3)
were modified##8##2##(2008-10#6)(2008-9#1)(2011-2#1)
were modulated by##3##3##(2008-11#2)(2013-1#1)
were modulated##4##2##(2008-11#2)(2010-4#1)(2013-1#1)
were molecularly##3##2##(2008-10#3)
were monitored by##8##3##(1991-3#1)(1996-3#1)(2008-10#5)(2008-11#1)
were monitored during##2##3##(2008-10#1)(2013-8#1)
were monitored for##7##3##(2008-10#5)(2008-11#1)(2008-5#1)
were monitored in real time using##2##6##(1995-12#1)(2008-10#1)
were monitored in real time##3##5##(1995-12#1)(2008-10#2)
were monitored in##8##3##(1995-12#1)(2008-10#5)(2008-7#2)
were monitored over a##3##4##(2008-10#3)
were monitored over##5##3##(2008-10#5)
were monitored using##3##3##(2008-10#2)(2010-8#1)
were monitored##44##2##(1990-9#1)(1991-3#1)(1994-5#1)(1995-12#1)(1996-3#1)(2008-10#28)(2008-11#3)(2008-5#1)(2008-7#2)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
were more abundant in the##2##5##(2008-10#1)(2009-10#1)
were more abundant##3##3##(2008-10#2)(2009-10#1)
were more activated in the script event##2##7##(1996-2#2)
were more active in##2##4##(1994-5#1)(2011-2#1)
were more active##3##3##(1994-5#1)(2011-2#2)
were more closely related to each other##2##7##(2008-10#2)
were more closely related to##4##5##(2008-10#4)
were more closely related##5##4##(2008-10#5)
were more common in##2##4##(2008-9#1)(2013-1#1)
were more common##3##3##(1997-4#1)(2008-9#1)(2013-1#1)
were more effective at##2##4##(2008-10#1)(2013-1#1)
were more effective in##4##4##(1995-8#1)(2008-10#2)(2008-5#1)
were more effective than##5##4##(2008-10#3)(2008-11#1)(2008-4#1)
were more effective##11##3##(1995-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
were more evident at##2##4##(2008-12#1)(2008-5#1)
were more evident##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
were more favourable in##2##4##(2011-1#1)(2012-2#1)
were more favourable##3##3##(1990-9#1)(2011-1#1)(2012-2#1)
were more frequent in##2##4##(1990-8#1)(2013-1#1)
were more frequent##4##3##(1990-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
were more frequently mechanically ventilated##2##5##(1990-12#1)(2011-2#1)
were more frequently##9##3##(1990-12#2)(1993-8#1)(2008-10#2)(2008-7#1)(2011-2#3)
were more impaired in##2##4##(2008-12#2)
were more impaired##3##3##(2008-12#3)
were more important##2##3##(2008-5#1)(2008-9#1)
were more likely than##5##4##(1993-1#1)(2008-12#2)(2010-10#1)(2012-3#1)
were more likely to be##13##5##(1993-12#1)(1994-3#1)(1996-3#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-5#1)(2013-1#3)
were more likely to have##5##5##(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-11#1)
were more likely to report##3##5##(1995-12#1)(2009-5#1)(2013-1#1)
were more likely to survive##2##5##(1995-2#1)(2008-8#1)
were more likely to##38##4##(1991-12#1)(1993-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-3#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#3)(2010-11#1)(2012-12#3)(2012-3#1)(2013-1#6)
were more likely##43##3##(1991-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-3#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#5)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#3)(2010-10#1)(2010-11#1)(2012-12#3)(2012-3#2)(2013-1#6)
were more often##3##3##(1996-6#1)(2008-7#2)
were more persistent##2##3##(2008-12#1)(2008-8#1)
were more prevalent##3##3##(1996-12#2)(2008-10#1)
were more pronounced##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
were more resistant than##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
were more resistant##5##3##(2008-10#2)(2008-11#1)(2011-2#2)
were more responsive to##2##4##(1994-11#1)(2008-10#1)
were more sensitive than##2##4##(2008-10#1)(2008-11#1)
were more sensitive to##5##4##(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)
were more sensitive##9##3##(2008-10#4)(2008-11#2)(2008-12#2)(2008-9#1)
were more severe##2##3##(2008-5#1)(2011-2#1)
were more severely##2##3##(1994-1#1)(2008-10#1)
were more strongly##2##3##(1997-2#1)(2012-3#1)
were more susceptible to##9##4##(1991-12#1)(1994-11#1)(1994-5#1)(2008-10#5)(2012-12#1)
were more than##9##3##(1990-8#1)(1993-3#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
were more tolerant##2##3##(2008-12#1)(2012-9#1)
were more uniform and##2##4##(2008-10#2)
were more variable##2##3##(2008-10#2)
were more virulent##2##3##(2008-10#2)
were more##212##2##(1990-12#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(2008-1#2)(2008-10#66)(2008-11#8)(2008-12#15)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#6)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#4)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#10)(2012-12#4)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#12)
were morphologically indistinguishable from##2##4##(2008-10#2)
were morphologically##5##2##(2008-10#5)
were most common##3##3##(1994-12#1)(2012-3#2)
were most evident##2##3##(1996-12#1)(2008-11#1)
were most likely to##2##4##(1995-3#1)(2013-1#1)
were most susceptible##2##3##(2008-10#2)
were most##29##2##(1994-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
were mostly##18##2##(1991-2#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#2)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#3)(2013-1#1)
were mounted in a##2##4##(2008-10#1)(2013-1#1)
were mounted in##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
were mounted##4##2##(1993-8#1)(2008-10#1)(2009-3#1)(2013-1#1)
were much better##2##3##(1992-2#1)(2008-10#1)
were much higher than those##2##5##(2008-10#1)(2008-8#1)
were much higher than##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
were much higher##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
were much less affected##2##4##(1991-5#1)(1996-2#1)
were much less##5##3##(1991-5#1)(1992-1#1)(1994-8#1)(1996-2#1)(2008-11#1)
were much lower##2##3##(2008-10#1)(2008-5#1)
were much more##4##3##(1993-8#1)(2008-10#1)(2008-8#1)(2012-8#1)
were much##21##2##(1990-11#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-8#1)(1994-8#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-8#1)(2013-1#1)
were named##2##2##(2008-10#1)(2008-8#1)
were narrow and##2##3##(2008-10#1)(2008-7#1)
were narrow##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
were near##4##2##(1997-3#1)(2008-10#3)
were nearly##5##2##(1992-2#1)(2008-10#4)
were nebulized and##2##3##(1991-1#1)(2008-10#1)
were necessary for the##3##4##(2008-10#2)(2008-8#1)
were necessary for##5##3##(1997-3#1)(2008-10#3)(2008-8#1)
were necessary to##5##3##(1997-5#1)(2008-10#3)(2013-1#1)
were necessary##13##2##(1997-3#1)(1997-5#1)(2008-10#6)(2008-8#1)(2010-7#1)(2012-12#1)(2013-1#2)
were needed to##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
were needed##5##2##(1996-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
were negative for##4##3##(1990-2#1)(1992-2#1)(2008-12#1)(2012-3#1)
were negative in##4##3##(1997-8#1)(2008-10#1)(2011-10#1)(2011-2#1)
were negative##19##2##(1990-2#1)(1992-2#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#2)(2009-8#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#4)
were negatively associated with##2##4##(2011-2#2)
were negatively correlated with##4##4##(2008-10#3)(2010-12#1)
were negatively correlated##7##3##(2008-10#4)(2008-9#1)(2010-12#1)(2013-8#1)
were negatively related to##2##4##(1992-2#1)(2008-10#1)
were negatively##12##2##(1992-2#1)(2008-10#5)(2008-2#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-8#1)
were negligible##4##2##(1991-8#1)(2008-10#2)(2008-6#1)
were neither##2##2##(1993-12#1)(2012-12#1)
were never##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
were newly identified as##2##4##(1995-12#1)(1995-2#1)
were newly##4##2##(1995-12#1)(1995-2#1)(2008-12#1)(2008-3#1)
were no cases of##3##4##(1991-2#1)(2011-2#2)
were no clinically significant changes in##2##6##(1996-1#1)(2007-11#1)
were no differences in the##3##5##(2008-11#1)(2011-2#1)(2013-8#1)
were no differences in##8##4##(1993-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
were no differences##10##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
were no interferences##2##3##(2008-10#2)
were no longer significant##2##4##(2010-8#1)(2012-5#1)
were no longer##7##3##(1993-1#1)(1995-2#1)(2008-10#3)(2010-8#1)(2012-5#1)
were no recurrences##2##3##(1995-5#1)(2010-3#1)
were no significant (P##2##4##(2008-10#2)
were no significant changes in##3##5##(2007-8#1)(2008-9#1)(2011-2#1)
were no significant changes##4##4##(2007-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
were no significant differences between groups##2##6##(2011-2#1)(2013-1#1)
were no significant differences between##4##5##(1997-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
were no significant differences in the##3##6##(1994-12#1)(2010-12#1)(2013-1#1)
were no significant differences in##15##5##(1991-2#1)(1993-1#1)(1994-12#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#2)
were no significant differences##24##4##(1991-2#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
were no significant##37##3##(1991-2#1)(1993-1#2)(1994-12#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
were no signs of##4##4##(1993-1#1)(1993-6#1)(2008-10#1)(2011-2#1)
were no statistically significant differences between##4##6##(2010-12#2)(2013-1#2)
were no statistically significant differences##5##5##(2010-12#2)(2013-1#3)
were no treatment-related##3##3##(2008-9#3)
were no##116##2##(1990-2#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-1#5)(1993-12#1)(1993-6#2)(1994-12#3)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#20)(2008-11#4)(2008-12#4)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#10)(2009-11#1)(2009-3#2)(2010-12#3)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#7)(2013-8#4)
were non-linear##2##2##(1995-8#1)(2008-10#1)
were non-smokers##2##2##(1993-2#1)(2011-2#1)
were nonpathogenic on##4##3##(2008-10#4)
were nonpathogenic##10##2##(2008-10#10)
were normal but##2##3##(2012-2#1)(2013-1#1)
were normal##23##2##(1990-6#1)(1990-9#2)(1993-6#2)(1993-8#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-7#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
were normalized##6##2##(1990-9#1)(1993-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
were normally##2##2##(1990-12#1)(1995-6#1)
were not able to##5##4##(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)
were not affected by the##5##5##(1990-11#1)(2008-10#2)(2008-11#1)(2008-4#1)
were not affected by##16##4##(1990-11#1)(1992-6#1)(1993-2#1)(1994-2#1)(1994-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2013-1#1)
were not affected##22##3##(1990-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-2#1)(1994-8#2)(1996-2#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2013-1#1)
were not all##2##3##(2008-10#2)
were not altered by##3##4##(1990-5#1)(1993-8#1)(2008-11#1)
were not altered##4##3##(1990-5#1)(1993-8#1)(2008-11#2)
were not always##3##3##(2008-10#1)(2009-4#1)(2010-8#1)
were not amplified from##2##4##(2008-10#2)
were not apparent##2##3##(2008-10#1)(2013-1#1)
were not as##4##3##(2008-10#3)(2009-7#1)
were not associated with the##2##5##(1996-12#1)(2008-10#1)
were not associated with##9##4##(1992-2#1)(1996-12#1)(2008-10#2)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-8#1)
were not conducted##2##3##(1991-12#1)(2008-10#1)
were not considered##2##3##(2008-10#2)
were not consistent with##2##4##(2008-10#1)(2008-11#1)
were not consistent##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
were not correlated with##4##4##(2008-10#4)
were not correlated##5##3##(2008-10#5)
were not detectable##2##3##(2010-12#1)(2012-3#1)
were not detected at##2##4##(2008-10#1)(2008-5#1)
were not detected in the##2##5##(1994-12#1)(2008-10#1)
were not detected in##8##4##(1991-12#1)(1994-12#1)(1997-3#1)(2008-10#5)
were not detected within the confines of the plot sizes tested##2##11##(2008-10#2)
were not detected##19##3##(1991-12#1)(1994-12#1)(1994-8#1)(1997-3#1)(1997-6#1)(2008-10#8)(2008-12#2)(2008-5#3)(2013-8#1)
were not different##3##3##(2008-10#2)(2008-7#1)
were not due to the##2##5##(2008-7#1)(2011-1#1)
were not due to##5##4##(1994-2#1)(1994-3#1)(1995-8#1)(2008-7#1)(2011-1#1)
were not effective##2##3##(1994-11#1)(2008-11#1)
were not formed##3##3##(2008-10#3)
were not found in the##2##5##(1993-12#1)(1995-6#1)
were not found in##5##4##(1990-3#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-8#1)
were not found to be##3##5##(1995-6#1)(1997-3#1)(2011-2#1)
were not found to##5##4##(1995-6#1)(1996-3#1)(1997-3#1)(2008-5#1)(2011-2#1)
were not found##15##3##(1990-3#1)(1992-2#1)(1993-12#1)(1995-6#2)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-10#1)(2011-2#1)
were not fully##2##3##(2008-3#1)(2011-2#1)
were not greatly affected by##2##5##(2008-10#1)(2008-7#1)
were not higher than##3##4##(1990-5#1)(2008-10#2)
were not higher##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
were not identified##2##3##(1990-11#1)(2008-10#1)
were not included in##3##4##(2008-11#1)(2010-1#1)(2012-3#1)
were not included##4##3##(1990-9#1)(2008-11#1)(2010-1#1)(2012-3#1)
were not infected##3##3##(2008-10#2)(2008-5#1)
were not influenced##2##3##(2008-11#1)(2012-2#1)
were not involved in##2##4##(1993-6#1)(2008-6#1)
were not involved##3##3##(1993-6#1)(2008-6#1)(2011-2#1)
were not likely to##2##4##(1992-2#1)(2008-12#1)
were not linked to##2##4##(2008-10#2)
were not more##2##3##(1991-3#1)(2008-12#1)
were not observed in the##2##5##(2008-10#1)(2010-12#1)
were not observed in##5##4##(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)
were not observed to##2##4##(1991-7#1)(2008-10#1)
were not observed##15##3##(1991-6#1)(1991-7#1)(1992-6#1)(1993-8#1)(1996-2#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-12#1)
were not only##3##3##(1996-9#1)(2008-10#1)(2009-7#1)
were not or##2##3##(2008-10#2)
were not predictive of##3##4##(2008-10#1)(2008-11#1)(2010-11#1)
were not predictive##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
were not present in the##2##5##(2008-10#1)(2008-12#1)
were not present##4##3##(2008-10#2)(2008-12#1)(2010-6#1)
were not previously##2##3##(2008-10#1)(2010-4#1)
were not recovered##2##3##(2008-10#2)
were not related to##9##4##(1993-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-12#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)
were not seen##2##3##(1995-11#1)(1997-3#1)
were not significant for##2##4##(2008-10#1)(2008-12#1)
were not significant##10##3##(1992-2#2)(1994-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2012-12#1)
were not significantly correlated with##2##5##(2008-10#1)(2008-7#1)
were not significantly correlated##3##4##(1990-8#1)(2008-10#1)(2008-7#1)
were not significantly different among##2##5##(2008-10#2)
were not significantly different between##2##5##(1996-12#1)(2008-10#1)
were not significantly different from the##2##6##(2008-10#1)(2012-3#1)
were not significantly different from##11##5##(1991-12#1)(1995-12#1)(2008-10#7)(2010-8#1)(2012-3#1)
were not significantly different in the##2##6##(1992-3#1)(2008-11#1)
were not significantly different##27##4##(1991-12#1)(1992-3#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
were not significantly##41##3##(1990-8#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#18)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
were not so##2##3##(1992-2#1)(2008-11#1)
were not spatially##2##3##(2008-10#2)
were not stable##2##3##(2008-10#1)(2009-9#1)
were not statistically different between##2##5##(2012-3#2)
were not statistically different##8##4##(1994-2#1)(1997-8#1)(2008-10#2)(2009-1#1)(2011-2#1)(2012-3#2)
were not statistically significant (p##2##5##(2008-1#1)(2008-12#1)
were not statistically significant##13##4##(1992-2#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
were not statistically##22##3##(1992-2#1)(1994-2#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-8#1)(2009-1#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
were not successful##5##3##(1990-5#1)(1991-2#1)(2008-10#3)
were not taking their##2##4##(2010-1#2)
were not taking##5##3##(2008-7#1)(2010-1#4)
were not the##2##3##(2008-10#1)(2011-1#1)
were not treated##2##3##(1996-6#1)(2008-11#1)
were not uniform##2##3##(1991-1#1)(2008-10#1)
were not useful##2##3##(2008-10#1)(2011-2#1)
were not validated##2##3##(2008-10#1)(2011-2#1)
were not very##2##3##(1991-2#1)(2013-8#1)
were not##432##2##(1990-11#2)(1990-3#1)(1990-5#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-12#3)(1992-2#8)(1992-3#3)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#4)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-6#3)(1995-8#1)(1996-12#5)(1996-2#4)(1996-3#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#2)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#164)(2008-11#18)(2008-12#13)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#19)(2011-3#1)(2012-12#8)(2012-2#3)(2012-3#5)(2013-1#14)(2013-8#9)
were noted among##3##3##(1994-1#1)(2008-10#1)(2008-7#1)
were noted at##2##3##(2010-8#1)(2013-1#1)
were noted during##2##3##(1990-8#1)(1993-1#1)
were noted for##2##3##(2008-10#2)
were noted in the##4##4##(1997-7#1)(2008-10#1)(2008-12#1)(2012-3#1)
were noted in##11##3##(1992-1#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
were noted to##2##3##(2008-12#1)(2012-2#1)
were noted##43##2##(1990-2#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-1#2)(1994-1#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#7)(2008-12#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
were noticed in##2##3##(1996-1#1)(2008-10#1)
were noticed##5##2##(1994-2#1)(1996-1#1)(2008-10#1)(2008-6#1)(2010-6#1)
were notified##2##2##(2010-10#1)(2012-12#1)
were observed (P##2##3##(1994-12#1)(2013-1#1)
were observed after##9##3##(1990-2#1)(2008-10#3)(2008-12#2)(2008-7#1)(2009-10#1)(2012-3#1)
were observed among different##2##4##(2008-10#1)(2013-1#1)
were observed among isolates in##2##5##(2008-10#2)
were observed among isolates##4##4##(2008-10#4)
were observed among##13##3##(2008-10#10)(2008-12#1)(2013-1#2)
were observed and##3##3##(1991-3#1)(2008-11#1)(2008-12#1)
were observed as##3##3##(2008-10#2)(2008-11#1)
were observed associated##2##3##(1995-2#1)(2013-1#1)
were observed at the end of the##2##7##(2008-8#1)(2013-1#1)
were observed at the end of##3##6##(2008-8#1)(2011-2#1)(2013-1#1)
were observed at the##10##4##(1993-3#1)(1993-8#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)(2013-1#1)
were observed at##24##3##(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-3#1)(1997-6#2)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-1#1)
were observed between control and##2##5##(1991-5#1)(2008-10#1)
were observed between the two groups##2##6##(2008-10#1)(2011-2#1)
were observed between the two##3##5##(2008-10#2)(2011-2#1)
were observed between the##9##4##(1994-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#2)
were observed between##25##3##(1990-8#1)(1991-12#1)(1991-5#1)(1994-2#2)(1997-8#1)(2008-10#10)(2008-11#2)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#3)
were observed by##8##3##(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)
were observed during the##5##4##(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)
were observed during##7##3##(1993-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)
were observed for all the##2##5##(2008-10#2)
were observed for all##4##4##(2008-10#4)
were observed for mouth and pharynx##2##6##(1990-8#2)
were observed for the##9##4##(1991-1#1)(1992-12#1)(1994-2#1)(1996-5#1)(2008-10#4)(2011-2#1)
were observed for##31##3##(1990-8#3)(1991-1#1)(1991-2#1)(1992-12#1)(1994-2#1)(1996-5#1)(2008-10#19)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
were observed from##7##3##(2008-10#6)(2011-2#1)
were observed in a##4##4##(1990-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
were observed in all##2##4##(2008-10#1)(2011-1#1)
were observed in any##2##4##(1996-12#1)(2008-10#1)
were observed in both##2##4##(2008-12#1)(2012-2#1)
were observed in male and female##2##6##(1995-11#1)(2008-9#1)
were observed in only##3##4##(1990-2#1)(1990-9#1)(1993-12#1)
were observed in poults fed##2##5##(2008-5#2)
were observed in some##2##4##(1994-5#1)(2008-10#1)
were observed in the control##2##5##(1994-5#1)(2008-10#1)
were observed in the olfactory bulb##2##6##(2008-6#1)(2008-7#1)
were observed in the ultraendurance runners##2##6##(2013-8#2)
were observed in the##52##4##(1990-5#1)(1990-6#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-9#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-5#2)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
were observed in this##2##4##(1992-3#1)(2008-10#1)
were observed in##140##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-8#2)(1996-12#4)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#47)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
were observed on the##3##4##(1991-6#1)(2008-10#1)(2008-12#1)
were observed on##12##3##(1991-6#1)(2008-10#9)(2008-12#1)(2008-8#1)
were observed once##2##3##(2011-2#1)(2012-6#1)
were observed only at##2##4##(1994-3#1)(2013-1#1)
were observed only in the##6##5##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#2)
were observed only##8##3##(1994-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2013-1#1)
were observed over##4##3##(2008-10#3)(2013-8#1)
were observed regardless of##2##4##(2008-11#1)(2008-9#1)
were observed to be##4##4##(2008-10#2)(2008-11#1)(2012-12#1)
were observed to##11##3##(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
were observed under##2##3##(2008-10#1)(2008-9#1)
were observed when the two##2##5##(1991-8#1)(2008-10#1)
were observed when the##5##4##(1991-8#1)(2008-10#2)(2008-11#1)(2008-3#1)
were observed when##12##3##(1991-8#1)(1992-2#1)(1994-3#1)(2008-10#6)(2008-11#2)(2008-3#1)
were observed with the##4##4##(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#1)
were observed with##15##3##(1991-1#1)(1995-11#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-5#2)(2009-12#1)(2011-3#1)
were observed within##3##3##(1996-12#1)(2008-10#2)
were observed without##2##3##(1990-11#1)(1997-3#1)
were observed##502##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#2)(1990-8#5)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-10#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#6)(1994-3#2)(1994-5#4)(1994-8#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#3)(1996-5#1)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#4)(1997-9#1)(2007-8#1)(2008-10#204)(2008-11#20)(2008-12#11)(2008-2#2)(2008-3#3)(2008-5#14)(2008-6#4)(2008-7#14)(2008-8#8)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#3)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#5)(2011-1#1)(2011-2#12)(2011-3#4)(2012-12#4)(2012-2#6)(2012-3#7)(2012-6#1)(2013-1#19)(2013-8#8)
were obtained after the##2##4##(2008-9#2)
were obtained after##4##3##(1990-2#1)(2008-10#1)(2008-9#2)
were obtained and one of##2##5##(2008-8#1)(2008-9#1)
were obtained and the##4##4##(2008-10#4)
were obtained and##15##3##(1997-3#1)(2008-10#8)(2008-2#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)
were obtained as##5##3##(2008-10#4)(2008-3#1)
were obtained at a##2##4##(2008-10#1)(2008-3#1)
were obtained at the##5##4##(2007-12#1)(2008-10#4)
were obtained at##15##3##(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#1)
were obtained both##2##3##(1991-2#1)(2008-10#1)
were obtained by Southern blot##2##5##(2008-10#1)(2008-9#1)
were obtained by a##3##4##(1993-12#1)(1996-8#1)(2008-10#1)
were obtained by single##2##4##(2008-10#1)(2013-1#1)
were obtained by the##4##4##(2008-10#4)
were obtained by using a##2##5##(2008-10#1)(2011-1#1)
were obtained by using electrodes##2##5##(2008-10#2)
were obtained by using##9##4##(2008-10#7)(2008-8#1)(2011-1#1)
were obtained by##46##3##(1993-12#1)(1994-8#1)(1996-5#1)(1996-8#1)(2007-11#2)(2008-10#30)(2008-5#1)(2008-8#3)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
were obtained compared with##2##4##(2008-10#2)
were obtained for 0##4##4##(2008-10#4)
were obtained for all elements##2##5##(2011-2#2)
were obtained for all the##3##5##(2008-10#3)
were obtained for all##8##4##(2008-10#6)(2011-2#2)
were obtained for both##3##4##(2008-10#3)
were obtained for different##2##4##(2008-10#1)(2008-3#1)
were obtained for each compound##2##5##(2008-10#2)
were obtained for each##6##4##(2008-10#5)(2013-1#1)
were obtained for most##2##4##(2008-10#2)
were obtained for the determination of##4##6##(2008-10#4)
were obtained for the three##3##5##(2008-10#2)(2010-12#1)
were obtained for the##22##4##(1994-11#1)(2008-10#19)(2008-11#1)(2010-12#1)
were obtained for untreated and NEM-treated cells##2##7##(1995-8#2)
were obtained for##101##3##(1991-1#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-8#2)(1996-12#1)(2008-10#78)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
were obtained from 0##2##4##(2008-10#2)
were obtained from 15##2##4##(2008-7#1)(2011-2#1)
were obtained from 5##2##4##(1993-2#1)(1995-8#1)
were obtained from a##6##4##(1997-7#1)(2008-1#1)(2008-10#2)(2011-2#1)(2013-1#1)
were obtained from diseased##2##4##(2008-10#2)
were obtained from rice##2##4##(2008-10#2)
were obtained from the results##2##5##(2008-10#1)(2010-2#1)
were obtained from the##14##4##(2008-10#8)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-1#1)
were obtained from##75##3##(1990-2#1)(1990-8#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-1#2)(2008-10#35)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
were obtained in all##2##4##(1993-8#1)(2008-10#1)
were obtained in both cases##2##5##(2008-10#2)
were obtained in both##3##4##(2008-10#3)
were obtained in the concentration range##2##6##(2008-10#2)
were obtained in the##15##4##(2008-10#13)(2008-11#1)(2008-8#1)
were obtained in##42##3##(1991-6#1)(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#28)(2008-11#3)(2008-5#3)(2008-7#2)(2008-8#1)(2009-8#1)
were obtained on##3##3##(1995-12#1)(2007-12#1)(2008-9#1)
were obtained over##5##3##(2008-10#3)(2008-2#1)(2012-4#1)
were obtained showing##2##3##(1991-3#1)(2008-10#1)
were obtained through the##3##4##(2008-10#1)(2013-1#2)
were obtained through##6##3##(2008-10#1)(2008-9#2)(2012-3#1)(2013-1#2)
were obtained to determine##2##4##(1994-3#1)(2008-10#1)
were obtained to##5##3##(1994-3#1)(2008-10#2)(2008-7#1)(2011-2#1)
were obtained under the##2##4##(2008-10#2)
were obtained upon##2##3##(2008-10#1)(2009-6#1)
were obtained using a##9##4##(1994-5#1)(2008-10#6)(2008-5#1)(2009-10#1)
were obtained using the##5##4##(2008-10#4)(2008-3#1)
were obtained using##22##3##(1994-5#1)(1995-11#1)(2008-10#15)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)
were obtained when##11##3##(2008-10#10)(2008-6#1)
were obtained with a##11##4##(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-5#1)
were obtained with the##8##4##(1995-8#1)(1997-3#1)(2008-10#5)(2008-11#1)
were obtained with##39##3##(1995-12#1)(1995-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
were obtained##556##2##(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#3)(1995-8#4)(1996-12#1)(1996-5#2)(1996-8#1)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#6)(2007-11#2)(2007-12#4)(2008-1#3)(2008-10#351)(2008-11#25)(2008-12#4)(2008-2#3)(2008-3#8)(2008-5#13)(2008-6#1)(2008-7#9)(2008-8#15)(2008-9#12)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-9#1)(2011-1#3)(2011-2#12)(2011-3#2)(2012-2#4)(2012-3#5)(2012-4#1)(2012-5#1)(2013-1#9)(2013-8#3)
were obvious##2##2##(2008-10#1)(2008-9#1)
were obviously##3##2##(1992-6#1)(2008-10#1)(2008-9#1)
were occasionally##3##2##(2008-10#3)
were of 0##2##3##(2008-10#2)
were of particular interest##2##4##(1991-12#1)(1996-12#1)
were of the order of##4##5##(2008-10#4)
were of the##10##3##(2008-10#9)(2008-5#1)
were of##33##2##(1990-6#1)(1991-12#1)(1994-2#1)(1994-5#1)(1996-12#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-5#2)(2009-11#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-3#1)
were offered##9##2##(1991-1#1)(1992-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)
were offset by##2##3##(1993-12#1)(2013-8#1)
were often observed##2##3##(1993-12#1)(2008-7#1)
were often##21##2##(1990-3#1)(1990-5#1)(1991-8#1)(1993-12#1)(1996-2#2)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-7#1)(2011-2#3)
were older than##2##3##(1994-6#1)(2008-7#1)
were older##3##2##(1994-6#1)(2008-7#1)(2010-11#1)
were on average##3##3##(1996-11#1)(2008-10#1)(2008-11#1)
were on##14##2##(1993-3#1)(1995-10#1)(1996-11#1)(2008-1#2)(2008-10#3)(2008-11#3)(2011-2#1)(2012-5#1)(2013-1#1)
were on-line##3##2##(2008-10#3)
were once##3##2##(1990-8#1)(2008-10#1)(2008-8#1)
were one##2##2##(1996-12#1)(2008-10#1)
were only a##2##3##(1997-3#1)(1997-7#1)
were only detected in##2##4##(2008-10#1)(2008-11#1)
were only detected##3##3##(2008-10#2)(2008-11#1)
were only observed##2##3##(1994-6#1)(2009-7#1)
were only weakly pathogenic to##2##5##(2008-10#2)
were only##32##2##(1990-2#1)(1990-6#1)(1991-6#1)(1993-8#1)(1994-6#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-8#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-12#1)
were open##4##2##(1992-9#1)(1994-11#1)(2008-10#2)
were opened##2##2##(1997-6#1)(2008-7#1)
were operated for##3##3##(1990-5#1)(1992-5#1)(2011-2#1)
were operated on for##2##4##(1991-8#1)(2007-8#1)
were operated on##5##3##(1991-8#1)(1992-1#1)(1993-2#1)(1993-3#1)(2007-8#1)
were operated upon##2##3##(1991-3#1)(1997-3#1)
were operated##15##2##(1990-5#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-11#2)(1993-2#1)(1993-3#1)(1995-3#1)(1997-3#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
were operating in##2##3##(1991-3#1)(2008-5#1)
were operative##2##2##(2008-10#2)
were optimal##2##2##(2008-7#1)(2012-3#1)
were optimally##2##2##(1992-6#1)(2008-10#1)
were optimised by experimental##2##4##(2008-10#2)
were optimised by##5##3##(2008-10#5)
were optimised for the##2##4##(2008-10#2)
were optimised in order to##3##5##(2008-10#3)
were optimised to##2##3##(2008-10#2)
were optimised using##3##3##(2008-10#3)
were optimised##31##2##(2008-10#31)
were optimized and a##2##4##(2008-10#2)
were optimized and the##2##4##(2008-10#2)
were optimized and##8##3##(2008-10#8)
were optimized by a##2##4##(2008-10#2)
were optimized by both static and dynamic methods##2##8##(2008-10#2)
were optimized by##12##3##(1995-5#1)(2008-10#11)
were optimized for the##6##4##(2008-10#6)
were optimized for##12##3##(2008-10#11)(2010-5#1)
were optimized in terms of##2##5##(2008-10#1)(2011-3#1)
were optimized in##4##3##(2008-10#3)(2011-3#1)
were optimized to obtain##2##4##(2008-10#2)
were optimized to##5##3##(2008-10#4)(2008-3#1)
were optimized using a##2##4##(2008-10#2)
were optimized using##4##3##(2008-10#4)
were optimized##90##2##(1995-5#1)(2008-10#82)(2008-3#2)(2010-5#1)(2011-3#1)(2013-1#1)(2013-8#2)
were organized into##3##3##(1993-12#1)(1996-3#1)(2008-8#1)
were organized##4##2##(1992-12#1)(1993-12#1)(1996-3#1)(2008-8#1)
were oriented##2##2##(2008-6#2)
were originally developed##2##3##(2008-10#2)
were originally isolated##2##3##(2008-10#1)(2011-2#1)
were originally##10##2##(1992-10#1)(1997-1#1)(2008-10#5)(2008-11#2)(2011-2#1)
were otherwise##3##2##(1992-5#1)(2008-7#1)(2008-9#1)
were out of##2##3##(1994-6#1)(1997-9#1)
were over##9##2##(1995-12#1)(1997-2#1)(2008-10#4)(2008-5#1)(2012-12#1)(2013-8#1)
were overexpressed##3##2##(1997-7#1)(2008-11#1)(2010-12#1)
were overweight and##2##3##(2008-10#1)(2011-1#1)
were overweight##3##2##(2008-10#2)(2011-1#1)
were oxidized by##2##3##(2008-10#2)
were oxidized##6##2##(2008-10#4)(2008-11#1)(2011-2#1)
were pH##5##2##(2008-10#5)
were packaged into##2##3##(1995-8#1)(2008-8#1)
were packed into a##2##4##(2008-10#2)
were packed##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
were paid##2##2##(1995-3#1)(2008-10#1)
were part of a##2##4##(1991-6#1)(2008-11#1)
were part of the##4##4##(1991-9#1)(1997-3#1)(2008-10#1)(2009-10#1)
were part of##8##3##(1991-6#1)(1991-9#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-10#1)
were partially##11##2##(1993-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
were particularly##3##2##(2008-10#1)(2009-1#1)(2012-12#1)
were partly##2##2##(1995-12#1)(2012-5#1)
were pathogenic on##14##3##(2008-10#14)
were pathogenic to##7##3##(2008-10#7)
were pathogenic##24##2##(2008-10#23)(2008-5#1)
were patients##2##2##(2008-9#1)(2013-1#1)
were penetrated by the##2##4##(2008-10#2)
were perceived by##2##3##(1992-2#1)(2008-11#1)
were performed and##4##3##(2008-10#2)(2008-9#1)(2012-2#1)
were performed as##2##3##(1995-2#1)(2006-6#1)
were performed at 10##2##4##(2008-10#1)(2012-3#1)
were performed at##9##3##(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
were performed between##2##3##(2008-10#2)
were performed by##22##3##(1993-3#1)(1995-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
were performed during the##2##4##(1996-6#1)(1996-9#1)
were performed during##3##3##(1996-6#1)(1996-9#1)(2012-2#1)
were performed for each##2##4##(2008-10#1)(2008-8#1)
were performed for the##4##4##(2008-10#4)
were performed for##14##3##(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#1)(2013-1#1)
were performed from##2##3##(1990-5#1)(2008-10#1)
were performed in a##4##4##(2008-10#3)(2008-11#1)
were performed in order to##3##5##(2008-10#2)(2008-7#1)
were performed in the##4##4##(1995-11#1)(2009-11#1)(2012-12#1)(2013-1#1)
were performed in##32##3##(1990-6#1)(1990-8#1)(1993-12#1)(1993-6#1)(1995-11#2)(1997-8#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#2)
were performed on a##2##4##(2008-11#1)(2010-6#1)
were performed on an##2##4##(2008-10#2)
were performed on day##2##4##(1993-12#1)(1997-3#1)
were performed on the##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
were performed on##28##3##(1990-8#1)(1993-12#1)(1995-2#1)(1997-3#1)(2008-10#14)(2008-11#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
were performed regarding##2##3##(1997-8#1)(2009-10#1)
were performed to assess the##2##5##(1995-11#1)(2013-1#1)
were performed to assess##3##4##(1995-11#1)(2013-1#1)(2013-8#1)
were performed to better##2##4##(2008-10#2)
were performed to determine if##2##5##(1997-3#1)(2008-10#1)
were performed to determine the##4##5##(1990-9#1)(1997-6#1)(2008-10#1)(2008-7#1)
were performed to determine##10##4##(1990-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-7#1)
were performed to elucidate##2##4##(2008-10#2)
were performed to estimate the##2##5##(2010-11#1)(2013-1#1)
were performed to evaluate the##2##5##(2008-3#1)(2008-5#1)
were performed to examine the##2##5##(1995-12#1)(2009-7#1)
were performed to select##2##4##(2008-10#1)(2011-3#1)
were performed to study the##2##5##(2008-10#1)(2011-2#1)
were performed to##41##3##(1990-9#1)(1991-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
were performed under##2##3##(1994-12#1)(2011-3#1)
were performed using a##2##4##(2008-10#1)(2008-5#1)
were performed using##11##3##(1993-1#1)(2008-10#7)(2008-5#1)(2011-2#1)(2012-12#1)
were performed with a##6##4##(1990-12#1)(1995-2#1)(2008-10#2)(2008-3#2)
were performed with several##2##4##(2008-10#2)
were performed with the##3##4##(2008-11#2)(2012-3#1)
were performed with##20##3##(1990-12#1)(1992-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-3#2)(2010-10#1)(2012-2#1)(2012-3#1)
were performed within##2##3##(2008-10#1)(2011-2#1)
were performed##253##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-12#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#5)(2006-6#1)(2007-12#2)(2008-10#94)(2008-11#11)(2008-12#1)(2008-3#9)(2008-5#9)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#2)(2011-2#13)(2011-3#5)(2012-12#7)(2012-2#4)(2012-3#8)(2013-1#10)(2013-8#3)
were performing##2##2##(2008-10#1)(2008-11#1)
were periodically##3##2##(2008-10#3)
were permeabilized##2##2##(1992-6#1)(1993-8#1)
were persistent##2##2##(1997-8#1)(2008-9#1)
were phenotypically##2##2##(1997-8#1)(2008-10#1)
were physically##2##2##(2008-7#1)(2009-5#1)
were phytotoxic to##2##3##(2008-10#2)
were placed in a##4##4##(2008-10#2)(2008-6#1)(2012-12#1)
were placed in contact with##2##5##(2008-10#2)
were placed in the##5##4##(2008-10#3)(2009-7#1)(2010-10#1)
were placed in##22##3##(1995-2#1)(1995-8#1)(2008-10#15)(2008-6#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-12#1)
were placed into##3##3##(2008-10#2)(2008-8#1)
were placed on the##2##4##(2008-10#2)
were placed on##5##3##(2008-10#4)(2013-1#1)
were placed under##2##3##(1995-2#1)(2008-10#1)
were placed##44##2##(1993-12#1)(1995-2#2)(1995-8#1)(1997-3#1)(2008-10#27)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
were planted in a##2##4##(2008-10#2)
were planted in##10##3##(2008-10#8)(2008-12#1)(2008-9#1)
were planted with three##2##4##(2008-10#2)
were planted with##3##3##(2008-10#3)
were planted##16##2##(2008-10#14)(2008-12#1)(2008-9#1)
were plated in##3##3##(2008-12#1)(2013-1#2)
were plated on a##2##4##(2008-10#1)(2012-4#1)
were plated on the##2##4##(1992-6#1)(2012-4#1)
were plated on##6##3##(1992-6#1)(2008-10#2)(2008-5#1)(2012-4#2)
were plated##9##2##(1992-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-4#2)(2013-1#2)
were plotted against those##2##4##(2008-10#1)(2008-5#1)
were plotted against##4##3##(2008-10#3)(2008-5#1)
were plotted##5##2##(2008-10#3)(2008-5#1)(2013-1#1)
were polymerase chain reaction##2##4##(2008-10#2)
were polymerase chain##3##3##(2008-10#3)
were polymorphic and##2##3##(2008-10#2)
were polymorphic##7##2##(2008-10#7)
were poor##7##2##(1994-3#1)(1995-8#1)(1996-11#1)(2008-10#3)(2011-2#1)
were poorly##6##2##(1992-6#1)(1995-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-8#1)
were positioned##4##2##(1992-9#1)(1996-6#1)(2008-10#1)(2011-1#1)
were positive for##11##3##(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#2)(2013-8#2)
were positive in##6##3##(1995-12#1)(1997-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
were positive to##2##3##(1990-2#1)(1996-6#1)
were positive##29##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#1)(1995-12#2)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-5#3)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
were positively associated with##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
were positively associated##5##3##(2008-11#1)(2008-8#1)(2011-2#2)(2013-1#1)
were positively correlated to##2##4##(2008-10#1)(2008-7#1)
were positively correlated with infection##2##5##(2008-10#1)(2010-12#1)
were positively correlated with##11##4##(2008-10#5)(2010-11#1)(2010-12#1)(2011-10#2)(2011-2#1)(2013-1#1)
were positively correlated##13##3##(2008-10#6)(2008-7#1)(2010-11#1)(2010-12#1)(2011-10#2)(2011-2#1)(2013-1#1)
were positively identified##2##3##(2008-10#2)
were positively related to##3##4##(1992-2#1)(2008-9#1)(2011-2#1)
were positively##24##2##(1992-2#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-10#2)(2011-2#4)(2013-1#2)
were possible##6##2##(2008-1#1)(2008-10#5)
were postulated to be##2##4##(2008-10#2)
were potent##2##2##(1994-6#1)(2008-10#1)
were pre-trained by##2##3##(2008-6#2)
were pre-treated with##3##3##(2008-10#2)(2008-11#1)
were preceded by##2##3##(1991-3#1)(2013-8#1)
were preceded##3##2##(1991-3#1)(2012-3#1)(2013-8#1)
were precisely##3##2##(1997-2#1)(2008-11#1)(2012-3#1)
were preconcentrated in a membrane cell##2##6##(2008-10#2)
were preconcentrated in##3##3##(2008-10#3)
were preconcentrated on the##2##4##(2008-10#2)
were preconcentrated on##3##3##(2008-10#3)
were preconcentrated##10##2##(2008-10#10)
were predicted by the##2##4##(2008-10#1)(2008-4#1)
were predicted in the##2##4##(1997-6#1)(2008-8#1)
were predicted in##3##3##(1997-6#1)(2008-8#1)(2011-2#1)
were predicted to##2##3##(1995-12#1)(2008-10#1)
were predicted##11##2##(1995-12#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#1)
were predictive of##3##3##(2008-12#1)(2010-11#1)(2012-3#1)
were predominant in##4##3##(1994-2#1)(2008-10#1)(2009-12#1)(2011-2#1)
were predominant##7##2##(1993-12#1)(1994-2#2)(2008-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
were predominantly##10##2##(1994-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-12#1)
were preferably##2##2##(2008-10#1)(2008-11#1)
were preferred##2##2##(2008-10#2)
were preformed##2##2##(2011-2#2)
were preincubated##2##2##(1994-3#1)(2008-8#1)
were premedicated with##2##3##(1996-6#1)(2012-3#1)
were prepared and analysed##3##4##(1995-8#1)(2008-10#1)(2008-5#1)
were prepared and evaluated##3##4##(1992-12#1)(2008-10#1)(2008-5#1)
were prepared and investigated as##3##5##(2008-10#3)
were prepared and##17##3##(1992-12#1)(1995-8#1)(2008-10#8)(2008-12#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-9#1)
were prepared as##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
were prepared by a##2##4##(2008-10#2)
were prepared by dissolving##2##4##(2008-5#1)(2010-4#1)
were prepared by incorporating##2##4##(2008-10#2)
were prepared by mixing##2##4##(2008-10#2)
were prepared by the##4##4##(2008-10#2)(2008-12#2)
were prepared by using##2##4##(2008-10#2)
were prepared by##32##3##(1992-6#1)(1997-9#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-4#1)(2012-2#2)
were prepared for##7##3##(1992-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-7#1)
were prepared from##11##3##(1990-12#1)(1994-2#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)
were prepared in##5##3##(1996-5#1)(2008-10#3)(2008-11#1)
were prepared spiking##2##3##(2008-10#2)
were prepared to##2##3##(2008-10#2)
were prepared using##7##3##(1990-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-2#1)
were prepared via##2##3##(2008-10#2)
were prepared with a##2##4##(2008-10#2)
were prepared with##6##3##(1994-2#1)(2008-10#2)(2008-5#2)(2008-9#1)
were prepared##114##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-9#1)(2008-10#59)(2008-11#4)(2008-12#4)(2008-5#10)(2008-7#4)(2008-8#3)(2008-9#4)(2009-7#2)(2009-9#1)(2010-4#2)(2011-2#2)(2011-7#1)(2012-2#2)(2013-1#1)
were prescribed##9##2##(1997-6#1)(2008-11#4)(2010-1#1)(2010-12#1)(2010-6#1)(2013-7#1)
were present among##2##3##(2008-10#2)
were present as##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
were present at##10##3##(1993-9#1)(1995-9#1)(2008-10#6)(2011-3#1)(2012-12#1)
were present in a##2##4##(1992-3#1)(1992-6#1)
were present in all##2##4##(2008-10#2)
were present in collections from##2##5##(2008-10#2)
were present in only##2##4##(1990-12#1)(2010-4#1)
were present in the##15##4##(1992-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(2008-10#6)(2008-6#1)(2008-7#1)(2008-9#2)(2012-3#1)
were present in these##2##4##(2008-10#1)(2008-3#1)
were present in##46##3##(1990-12#2)(1990-9#1)(1991-3#2)(1992-3#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(2008-10#21)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2010-4#1)(2011-2#1)(2012-3#1)
were present on the##2##4##(1991-6#1)(2012-3#1)
were present on##3##3##(1991-6#1)(2008-10#1)(2012-3#1)
were present throughout the##2##4##(2008-10#1)(2008-7#1)
were present throughout##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
were present together##2##3##(2008-10#1)(2012-7#1)
were present within##2##3##(1994-12#1)(2008-10#1)
were present##95##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#3)(1991-6#2)(1992-3#2)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#43)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)(2012-7#1)(2013-8#1)
were presented as##2##3##(1991-12#1)(2008-10#1)
were presented at the##4##4##(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
were presented for##2##3##(2008-11#1)(2009-10#1)
were presented in the##2##4##(2008-5#1)(2008-9#1)
were presented in##4##3##(2008-5#2)(2008-9#1)(2013-8#1)
were presented to##5##3##(1996-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#1)
were presented with##4##3##(1997-5#1)(2008-11#1)(2008-8#1)(2013-8#1)
were presented##29##2##(1991-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2012-12#1)(2013-1#1)(2013-8#3)
were preserved in##2##3##(1996-12#1)(2008-11#1)
were preserved with##2##3##(2008-10#2)
were preserved##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
were presumably##3##2##(1992-3#1)(2008-10#2)
were pretreated with##3##3##(1991-12#1)(1993-3#1)(1993-8#1)
were prevalent##4##2##(2008-10#3)(2012-3#1)
were prevented by##4##3##(1994-3#1)(2008-11#1)(2008-8#1)(2012-3#1)
were prevented##6##2##(1994-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
were previously extracted from##2##4##(2008-10#2)
were previously identified##2##3##(1994-9#1)(2008-10#1)
were previously reported##3##3##(1996-12#2)(2011-2#1)
were previously shown to##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
were previously##27##2##(1991-5#1)(1992-9#1)(1994-9#1)(1995-6#1)(1996-12#2)(1996-2#1)(2008-10#13)(2008-11#2)(2008-7#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)
were primarily##6##2##(1997-8#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)
were primary##2##2##(1990-12#1)(2010-8#1)
were primed##2##2##(2008-10#1)(2013-1#1)
were prior##2##2##(1995-5#1)(2011-2#1)
were probably##7##2##(1991-12#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
were probed##3##2##(2008-10#2)(2008-3#1)
were processed by##4##3##(2008-10#4)
were processed for##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
were processed##12##2##(1990-5#1)(2008-10#6)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
were produced against##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
were produced and##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
were produced by fusing##2##4##(2008-11#2)
were produced by##13##3##(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
were produced from##4##3##(1994-11#1)(2008-10#3)
were produced in an##2##4##(1994-5#1)(2008-11#1)
were produced in less##2##4##(2008-11#1)(2008-9#1)
were produced in the##2##4##(1993-1#1)(2008-10#1)
were produced in##16##3##(1990-5#1)(1993-1#1)(1993-6#1)(1994-5#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-9#1)(2012-3#1)
were produced on the##3##4##(2008-10#3)
were produced on##7##3##(2008-10#7)
were produced with##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
were produced##75##2##(1990-5#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-5#1)(1996-1#1)(1996-12#4)(1997-2#1)(2007-12#1)(2008-10#35)(2008-11#12)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2010-4#1)(2011-2#1)(2012-3#2)
were profiled##2##2##(2008-10#1)(2008-5#1)
were prolonged##4##2##(1992-6#1)(1996-3#2)(2008-7#1)
were propagated##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
were prophylactic##2##2##(2011-2#1)(2013-1#1)
were proportional to the concentration of##2##6##(1990-8#1)(2008-10#1)
were proportional to the##4##4##(1990-8#1)(2008-10#3)
were proportional to##6##3##(1990-8#1)(2008-10#4)(2008-5#1)
were proposed and##2##3##(2008-10#2)
were proposed for the assay of##3##6##(2008-10#3)
were proposed for the##4##4##(2008-10#4)
were proposed for##5##3##(2008-10#5)
were proposed##15##2##(1996-12#1)(2008-10#13)(2008-8#1)
were prospectively##5##2##(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
were protected against##3##3##(1995-12#1)(1995-2#1)(2008-9#1)
were protected from##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
were protected##10##2##(1995-12#1)(1995-2#2)(1995-5#4)(2008-10#1)(2008-7#1)(2008-9#1)
were proved to##2##3##(1993-2#1)(2008-10#1)
were provided by##2##3##(2010-4#1)(2011-2#1)
were provided for##2##3##(1996-3#1)(2008-10#1)
were provided with##3##3##(2008-11#2)(2013-8#1)
were provided##18##2##(1991-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-10#3)(2008-11#3)(2010-4#2)(2011-2#1)(2013-1#3)(2013-8#2)
were published in##2##3##(1997-8#1)(2011-2#1)
were published##9##2##(1991-1#1)(1997-8#1)(2008-10#1)(2008-4#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
were pulmonary##2##2##(2008-1#1)(2011-2#1)
were purified and##2##3##(1994-5#1)(2008-10#1)
were purified by using##2##4##(2008-8#1)(2010-12#1)
were purified by##5##3##(1991-9#1)(1995-12#1)(2008-8#1)(2008-9#1)(2010-12#1)
were purified from##11##3##(1991-9#1)(1993-8#1)(1994-11#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#2)
were purified##20##2##(1991-9#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1997-3#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#1)(2010-12#1)
were put in##2##3##(2010-1#2)
were put##3##2##(2008-10#1)(2010-1#2)
were qualified##3##2##(2008-11#1)(2012-3#2)
were qualitatively##2##2##(2008-10#1)(2008-11#1)
were quality##2##2##(2013-1#1)(2013-8#1)
were quantified by##5##3##(2006-6#1)(2008-10#3)(2008-7#1)
were quantified in##3##3##(2008-10#3)
were quantified using##5##3##(2008-10#3)(2008-7#1)(2009-7#1)
were quantified##20##2##(2006-6#1)(2008-10#13)(2008-5#1)(2008-7#3)(2009-7#1)(2013-1#1)
were quantitative##6##2##(1992-11#1)(2008-10#5)
were quantitatively determined##2##3##(2008-10#1)(2011-2#1)
were quantitatively evaluated##2##3##(1995-8#1)(2012-2#1)
were quantitatively recovered##3##3##(2008-10#3)
were quantitatively##15##2##(1995-8#1)(2008-10#11)(2008-8#1)(2011-2#1)(2012-2#1)
were questioned about##2##3##(1991-11#1)(2012-12#1)
were quite similar to those##2##5##(1993-6#1)(2008-11#1)
were quite similar##3##3##(1993-6#1)(2008-11#1)(2008-5#1)
were quite variable##2##3##(1994-3#1)(2012-3#1)
were quite##9##2##(1993-6#1)(1994-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-3#1)
were race 2##3##3##(2008-10#3)
were race##4##2##(2008-10#4)
were raised in##3##3##(1992-9#1)(2008-10#1)(2008-5#1)
were raised##12##2##(1992-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)
were random##2##2##(2008-10#2)
were randomized in two groups##2##5##(2011-2#2)
were randomized in##3##3##(1993-8#1)(2011-2#2)
were randomized into two groups##2##5##(1991-2#1)(2008-8#1)
were randomized into##5##3##(1991-2#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
were randomized to receive##3##4##(2011-2#2)(2013-1#1)
were randomized to##10##3##(2008-4#2)(2010-4#2)(2011-2#2)(2012-3#1)(2013-1#3)
were randomized##18##2##(1991-2#1)(1993-8#1)(2008-4#2)(2008-8#1)(2010-4#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)
were randomly allocated into##2##4##(2007-8#1)(2012-3#1)
were randomly allocated to receive##3##5##(2010-12#1)(2010-7#1)(2013-1#1)
were randomly allocated to##4##4##(2008-5#1)(2010-12#1)(2010-7#1)(2013-1#1)
were randomly allocated##7##3##(2007-8#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-3#2)(2013-1#1)
were randomly assigned into two groups##2##6##(2010-7#1)(2013-8#1)
were randomly assigned into##3##4##(2010-7#1)(2013-1#1)(2013-8#1)
were randomly assigned to 1##2##5##(2008-12#1)(2013-8#1)
were randomly assigned to a##4##5##(2008-12#2)(2012-2#1)(2013-1#1)
were randomly assigned to either a##2##6##(2008-12#1)(2008-4#1)
were randomly assigned to either the##2##6##(2008-11#1)(2009-11#1)
were randomly assigned to either##4##5##(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)
were randomly assigned to one of four groups##2##8##(2011-2#2)
were randomly assigned to one of##4##6##(2008-4#1)(2010-4#1)(2011-2#2)
were randomly assigned to receive##4##5##(1993-1#1)(1994-2#1)(2011-2#1)(2012-2#1)
were randomly assigned to three groups##2##6##(2009-3#1)(2011-2#1)
were randomly assigned to three##3##5##(2009-3#1)(2010-10#1)(2011-2#1)
were randomly assigned to##30##4##(1992-12#1)(1993-1#2)(1994-2#1)(2008-11#1)(2008-12#7)(2008-4#2)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#5)(2012-2#2)(2013-1#3)(2013-8#1)
were randomly assigned##34##3##(1992-12#1)(1993-1#2)(1994-2#1)(2008-11#1)(2008-12#7)(2008-4#2)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#4)(2013-8#2)
were randomly divided into five groups##3##6##(2010-1#1)(2010-7#1)(2011-3#1)
were randomly divided into two groups##2##6##(1993-2#1)(2013-1#1)
were randomly divided into##9##4##(1993-2#1)(2010-1#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
were randomly sampled##2##3##(2008-10#2)
were randomly selected for##3##4##(1996-12#1)(2008-5#1)(2013-1#1)
were randomly selected##7##3##(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-3#1)(2013-1#1)
were randomly##66##2##(1992-12#1)(1993-1#2)(1993-2#1)(1994-2#1)(1996-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#9)(2008-4#2)(2008-5#2)(2009-11#1)(2009-3#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#4)(2011-1#2)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#2)
were ranked##6##2##(1991-6#1)(1993-12#1)(1995-1#1)(2008-5#1)(2011-2#2)
were rapid##2##2##(2008-10#1)(2008-12#1)
were rapidly##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
were rare##9##2##(2008-10#5)(2008-9#1)(2011-2#2)(2012-3#1)
were rarely found##2##3##(1991-12#1)(1991-3#1)
were rarely observed##3##3##(1990-3#1)(1997-3#1)(2008-10#1)
were rarely##6##2##(1990-3#1)(1991-12#1)(1991-3#1)(1997-3#1)(2008-10#1)(2010-1#1)
were rated as##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
were rated by##3##3##(1991-2#1)(2008-10#1)(2008-12#1)
were rated##12##2##(1991-2#1)(1993-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2009-7#1)(2010-12#2)(2011-2#1)
were re-examined##2##2##(1991-8#1)(1995-12#1)
were re-tested##2##2##(1994-8#1)(2011-2#1)
were reached with##2##3##(1990-12#1)(2008-10#1)
were reached##9##2##(1990-12#1)(2008-10#6)(2008-11#1)(2008-5#1)
were reacted with##2##3##(2006-6#1)(2008-11#1)
were reacted##3##2##(2006-6#1)(2008-10#1)(2008-11#1)
were reactive with##2##3##(1995-12#1)(1996-12#1)
were reactive##4##2##(1994-8#1)(1995-12#1)(1996-12#1)(2008-11#1)
were readily##10##2##(1992-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
were reanalysed##2##2##(2008-10#2)
were reared in##2##3##(2008-12#2)
were reared on##2##3##(2008-9#1)(2013-1#1)
were reared##6##2##(1997-7#1)(2008-12#2)(2008-9#1)(2010-8#1)(2013-1#1)
were reasonably##3##2##(2008-10#2)(2008-11#1)
were recalculated##2##2##(1994-1#1)(2008-10#1)
were received##7##2##(1992-12#1)(2008-10#3)(2010-1#1)(2012-3#2)
were receiving##2##2##(1995-12#1)(2011-2#1)
were recently##5##2##(2008-10#2)(2008-2#1)(2009-10#1)(2012-2#1)
were recognized by the##3##4##(1995-2#1)(1995-8#1)(2008-10#1)
were recognized by##4##3##(1995-2#1)(1995-8#1)(2008-10#1)(2008-8#1)
were recognized on##2##3##(1995-12#1)(2008-9#1)
were recognized##14##2##(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#5)(2008-8#2)(2008-9#1)(2011-2#1)
were reconstructed##8##2##(1990-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
were recorded and the##2##4##(1996-3#1)(2008-8#1)
were recorded and##4##3##(1996-3#1)(2008-10#2)(2008-8#1)
were recorded as##2##3##(2008-10#1)(2010-11#1)
were recorded at the##2##4##(2008-10#1)(2008-7#1)
were recorded at##5##3##(2008-10#4)(2008-7#1)
were recorded before##2##3##(1992-12#1)(1993-1#1)
were recorded between##2##3##(2008-10#2)
were recorded by##3##3##(2007-12#1)(2008-8#1)(2012-2#1)
were recorded during##4##3##(1996-3#1)(2008-7#1)(2013-8#2)
were recorded every 5 min##2##5##(1993-6#1)(2012-3#1)
were recorded every##3##3##(1993-6#1)(2008-7#1)(2012-3#1)
were recorded for##6##3##(1991-9#1)(2008-10#3)(2008-11#1)(2010-12#1)
were recorded from##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
were recorded in a##2##4##(1993-6#1)(2008-10#1)
were recorded in the##2##4##(2008-10#1)(2008-9#1)
were recorded in##10##3##(1993-6#1)(1994-8#1)(1997-6#1)(2008-10#4)(2008-9#1)(2011-2#1)(2013-1#1)
were recorded over the##2##4##(2008-10#1)(2008-7#1)
were recorded over##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
were recorded using##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
were recorded with##5##3##(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)
were recorded##89##2##(1990-11#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#2)(1994-8#1)(1996-3#2)(1996-6#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#3)(2008-3#5)(2008-7#8)(2008-8#3)(2008-9#4)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#3)
were recovered and##2##3##(2008-10#2)
were recovered by##2##3##(2008-10#1)(2013-8#1)
were recovered from a##3##4##(2008-10#3)
were recovered from diseased##2##4##(2008-10#2)
were recovered from the##3##4##(2008-10#2)(2008-5#1)
were recovered from##25##3##(2008-10#22)(2008-12#1)(2008-5#1)(2008-8#1)
were recovered in##2##3##(2008-10#2)
were recovered on##2##3##(2008-10#2)
were recovered##50##2##(1990-3#1)(2008-10#42)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
were recruited and##2##3##(2008-4#1)(2013-1#1)
were recruited for the study##2##5##(2011-2#1)(2012-12#1)
were recruited for the##3##4##(2010-12#1)(2011-2#1)(2012-12#1)
were recruited for this study##3##5##(1995-3#1)(2008-1#1)(2008-12#1)
were recruited for this##4##4##(1995-3#1)(2008-1#1)(2008-12#1)(2013-8#1)
were recruited for##7##3##(1995-3#1)(2008-1#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
were recruited from two##2##4##(2008-9#1)(2013-1#1)
were recruited from##6##3##(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#3)
were recruited in##2##3##(2009-2#1)(2013-8#1)
were recruited into the##2##4##(2008-1#1)(2008-4#1)
were recruited into##4##3##(1994-3#1)(2008-1#1)(2008-4#1)(2013-1#1)
were recruited through##2##3##(1995-1#1)(2013-8#1)
were recruited##30##2##(1994-3#1)(1995-1#1)(1995-3#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#7)(2013-8#4)
were rectilinear##3##2##(2008-10#3)
were reduced as##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
were reduced by the##2##4##(2008-10#2)
were reduced by##9##3##(1990-8#1)(1991-6#1)(1997-1#1)(2008-10#6)
were reduced in the##2##4##(1996-12#1)(2010-7#1)
were reduced in##10##3##(1992-12#1)(1996-12#2)(2008-10#3)(2008-7#3)(2010-7#1)
were reduced to##6##3##(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
were reduced under##2##3##(2012-6#1)(2013-1#1)
were reduced##46##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#2)(1993-3#1)(1993-8#1)(1996-12#2)(1997-1#1)(1997-2#1)(2008-10#21)(2008-11#2)(2008-5#2)(2008-7#3)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-6#1)(2013-1#2)
were reexamined##2##2##(2008-10#1)(2008-9#1)
were referred by##2##3##(1990-12#2)
were referred for##2##3##(1990-2#1)(2008-10#1)
were referred to the##2##4##(1990-12#1)(1993-3#1)
were referred to##3##3##(1990-12#1)(1993-3#1)(1995-11#1)
were referred##7##2##(1990-12#3)(1990-2#1)(1993-3#1)(1995-11#1)(2008-10#1)
were reflected in the##3##4##(2008-5#1)(2008-6#1)(2008-8#1)
were reflected in##5##3##(1994-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
were reflected##6##2##(1994-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
were refused##2##2##(1995-12#1)(1995-6#1)
were regarded as factors in the optimization##3##7##(2008-10#3)
were regarded as factors in the##4##6##(2008-10#4)
were regarded as##5##3##(2008-10#4)(2008-11#1)
were regenerated##4##2##(2008-9#2)(2013-1#2)
were registered in a##2##4##(1996-6#1)(2008-7#1)
were registered in##3##3##(1991-6#1)(1996-6#1)(2008-7#1)
were registered##12##2##(1991-11#1)(1991-6#1)(1993-1#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2012-2#1)(2013-1#1)
were regressed##2##2##(2008-10#2)
were regular##2##2##(1993-3#1)(2008-10#1)
were regularly##2##2##(2008-12#1)(2011-2#1)
were rejected##2##2##(2008-9#2)
were related to a##2##4##(1991-8#1)(2010-11#1)
were related to the##9##4##(1996-6#1)(2008-1#1)(2008-10#3)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
were related to their##2##4##(1991-2#1)(2008-10#1)
were related to##38##3##(1991-2#1)(1991-8#1)(1992-6#1)(1996-1#1)(1996-3#1)(1996-6#2)(2008-1#1)(2008-10#10)(2008-5#2)(2008-7#3)(2008-9#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-5#1)(2013-1#3)(2013-8#1)
were related with##2##3##(1993-12#1)(2012-3#1)
were related##45##2##(1991-2#1)(1991-8#1)(1992-6#1)(1993-12#1)(1996-1#1)(1996-3#1)(1996-6#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
were relatively##14##2##(1992-8#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)
were released from the##2##4##(1994-5#1)(2008-10#1)
were released from##4##3##(1994-5#1)(2008-10#2)(2013-1#1)
were released with##2##3##(1994-11#1)(2008-10#1)
were released##15##2##(1991-1#1)(1992-8#1)(1994-11#1)(1994-5#1)(2008-10#8)(2010-8#1)(2011-2#1)(2013-1#1)
were remarkable##2##2##(1993-2#1)(2011-2#1)
were remarkably similar##2##3##(1991-1#1)(1995-6#1)
were remarkably##4##2##(1991-1#1)(1995-6#1)(2008-10#1)(2008-8#1)
were removed and##5##3##(1993-8#1)(2008-12#2)(2008-7#1)(2013-1#1)
were removed by##7##3##(1993-6#1)(2008-10#4)(2008-11#1)(2011-2#1)
were removed for##2##3##(2006-6#1)(2008-10#1)
were removed from the##6##4##(1996-12#1)(2008-10#4)(2008-7#1)
were removed from##11##3##(1991-3#1)(1994-8#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)
were removed surgically and##2##4##(2010-7#1)(2011-2#1)
were removed within##3##3##(2008-10#2)(2011-2#1)
were removed##44##2##(1990-8#1)(1991-3#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-12#2)(2006-6#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-7#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#1)
were rendered##4##2##(1996-2#1)(1997-2#1)(1997-7#1)(2011-7#1)
were repeated##5##2##(1992-2#1)(2008-10#2)(2008-11#1)(2013-1#1)
were repeatedly##3##2##(2008-7#1)(2009-8#1)(2012-2#1)
were replaced by##4##3##(1994-5#1)(1995-11#1)(2008-9#1)(2013-8#1)
were replaced with##2##3##(1995-6#1)(1996-2#1)
were replaced##7##2##(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-9#1)(2013-8#1)
were replanted##3##2##(2008-10#2)(2008-9#1)
were reported by##2##3##(2009-10#1)(2010-7#1)
were reported for the first time##2##6##(2008-11#1)(2010-9#1)
were reported for##4##3##(1995-1#1)(2008-10#1)(2008-11#1)(2010-9#1)
were reported in the##2##4##(1991-12#1)(2008-10#1)
were reported in##10##3##(1991-11#1)(1991-12#1)(1996-8#1)(1997-3#2)(2008-10#2)(2011-2#2)(2013-8#1)
were reported to be##3##4##(2008-10#1)(2008-7#1)(2009-10#1)
were reported to the Norwegian##2##5##(1994-9#1)(1997-8#1)
were reported to##6##3##(1992-5#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-10#1)
were reported##51##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-8#2)(1997-3#2)(1997-8#1)(2008-10#13)(2008-11#2)(2008-7#1)(2009-10#2)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
were representative of the##2##4##(2008-10#1)(2010-11#1)
were represented by##3##3##(2008-10#3)
were represented##6##2##(1994-9#1)(2008-10#4)(2008-11#1)
were requested to##2##3##(2008-11#1)(2010-1#1)
were requested##3##2##(2008-11#2)(2010-1#1)
were required for##8##3##(1995-6#1)(2008-10#5)(2008-11#2)
were required to complete##2##4##(2008-12#1)(2013-7#1)
were required to##11##3##(1994-3#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-7#1)
were required##23##2##(1994-3#2)(1995-6#1)(1996-2#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
were resected##2##2##(2011-2#1)(2013-1#1)
were resident##3##2##(2008-1#1)(2010-8#1)(2013-1#1)
were resistant to both##5##4##(1991-2#1)(2008-10#4)
were resistant to##34##3##(1991-2#1)(1993-11#1)(1994-11#1)(1996-12#1)(2008-10#18)(2008-12#1)(2008-5#2)(2010-12#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
were resistant##39##2##(1991-2#1)(1993-11#1)(1994-11#1)(1996-12#1)(2008-10#22)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
were resolved and##2##3##(2008-10#2)
were resolved by consensus##5##4##(2009-9#1)(2010-2#1)(2012-12#3)
were resolved by##14##3##(1990-5#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#3)(2009-9#1)(2010-2#1)(2012-12#3)
were resolved##24##2##(1990-5#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-12#3)
were respectively##9##2##(2008-10#6)(2008-11#1)(2008-8#1)(2011-2#1)
were responsible for the##3##4##(1995-6#1)(2008-10#1)(2013-8#1)
were responsible for##13##3##(1990-12#1)(1993-3#1)(1995-6#1)(2008-10#8)(2010-1#1)(2013-8#1)
were restored##2##2##(1990-12#1)(2013-1#1)
were restrained##3##2##(1996-2#1)(2008-7#2)
were restricted to the##2##4##(2008-10#2)
were restricted to##8##3##(1995-6#1)(2007-12#1)(2008-10#5)(2008-5#1)
were restricted##10##2##(1995-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)
were retained##6##2##(1996-12#1)(2008-10#4)(2008-5#1)
were retested##2##2##(1994-3#1)(2013-1#1)
were retrieved in##2##3##(2008-10#1)(2013-8#1)
were retrieved##6##2##(1993-11#1)(2008-10#3)(2008-3#1)(2013-8#1)
were retrospectively analyzed##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
were retrospectively reviewed##8##3##(1997-8#1)(2008-12#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
were retrospectively studied##3##3##(1995-10#1)(2008-1#1)(2011-2#1)
were retrospectively##19##2##(1991-2#1)(1995-10#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)
were returned##3##2##(1996-3#1)(1997-3#1)(2010-11#1)
were revealed by##2##3##(1995-8#1)(2008-10#1)
were revealed to##3##3##(1990-5#1)(2008-11#1)(2008-8#1)
were revealed##14##2##(1990-5#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
were reversed##3##2##(1996-12#1)(2008-12#1)(2009-9#1)
were reviewed and##2##3##(1996-3#1)(2009-8#1)
were reviewed at##3##3##(1996-1#1)(2008-8#1)(2010-10#1)
were reviewed by##2##3##(1996-1#1)(2011-2#1)
were reviewed for##2##3##(1995-12#1)(2008-9#1)
were reviewed with##2##3##(1990-3#1)(1996-6#1)
were reviewed##30##2##(1990-3#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
were rewarmed##2##2##(1990-9#1)(1992-1#1)
were rich in##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
were risk factors##2##3##(2008-7#1)(2013-8#1)
were robust##2##2##(2008-9#1)(2012-3#1)
were routinely##3##2##(1990-3#1)(1991-11#1)(1993-8#1)
were ruled out##3##3##(1990-3#1)(2010-2#1)(2012-12#1)
were sacrificed at##6##3##(1994-2#1)(1995-11#1)(2008-10#1)(2008-7#1)(2010-1#1)(2013-1#1)
were sacrificed##13##2##(1992-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#1)
were safe and well tolerated##2##5##(1996-1#1)(2008-8#1)
were safe##3##2##(1996-1#1)(2008-8#1)(2012-3#1)
were sampled and##2##3##(2008-10#2)
were sampled from brown spot lesions##2##6##(2008-10#2)
were sampled from##13##3##(2008-10#11)(2008-8#1)(2009-7#1)
were sampled in##4##3##(2008-10#4)
were sampled three times##3##4##(2008-10#3)
were sampled three##4##3##(2008-10#3)(2013-8#1)
were sampled##34##2##(2008-10#29)(2008-4#1)(2008-8#1)(2009-7#1)(2010-5#1)(2013-8#1)
were satisfactorily##4##2##(2008-10#4)
were satisfactory for##2##3##(2008-10#2)
were satisfactory with##2##3##(2008-10#2)
were satisfactory##16##2##(2008-1#1)(2008-10#14)(2008-7#1)
were satisfied with the##8##4##(1991-1#1)(1991-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
were satisfied with##11##3##(1990-2#1)(1991-1#1)(1991-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#2)(2011-2#1)(2013-1#1)
were satisfied##13##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#2)(2011-2#1)(2013-1#1)
were scarcely##2##2##(2008-10#1)(2008-9#1)
were scored for variation at##2##5##(2008-10#2)
were scored for##5##3##(1997-8#1)(2008-10#3)(2008-7#1)
were scored##9##2##(1997-8#2)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
were screened against the##2##4##(2008-10#2)
were screened and##4##3##(2008-10#2)(2011-3#1)(2012-3#1)
were screened by##3##3##(2008-10#1)(2008-9#1)(2010-1#1)
were screened for resistance to##2##5##(2008-10#2)
were screened for the presence of##2##6##(1994-11#1)(2008-10#1)
were screened for the##3##4##(1994-11#1)(2008-10#2)
were screened for their##4##4##(1990-5#1)(2008-10#1)(2008-12#1)(2012-2#1)
were screened for##24##3##(1990-2#1)(1990-5#1)(1994-11#1)(1996-6#1)(2008-1#1)(2008-10#14)(2008-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
were screened to##4##3##(2008-10#2)(2011-2#1)(2011-3#1)
were screened##45##2##(1990-2#1)(1990-5#1)(1994-11#1)(1996-6#1)(2008-1#1)(2008-10#23)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)
were searched for##7##3##(1994-3#1)(2008-11#1)(2009-10#1)(2009-7#1)(2011-2#2)(2012-3#1)
were searched##16##2##(1994-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-7#1)(2009-9#1)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#1)
were secreted into the##2##4##(1993-3#1)(1993-6#1)
were secreted##3##2##(1993-3#1)(1993-6#1)(2008-11#1)
were seeded on##2##3##(1990-8#1)(2008-10#1)
were seeded with##2##3##(2008-10#1)(2012-2#1)
were seeded##8##2##(1990-8#1)(2008-10#2)(2008-11#2)(2012-2#1)(2012-3#1)(2012-4#1)
were seen at##2##3##(1991-11#1)(2008-9#1)
were seen in both##2##4##(1996-12#1)(2008-10#1)
were seen in the##15##4##(1990-12#1)(1991-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#5)(2008-7#1)(2010-11#1)(2011-2#2)(2012-3#1)
were seen in##38##3##(1990-12#1)(1991-12#4)(1991-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#5)(2008-7#2)(2008-9#2)(2010-1#1)(2010-11#1)(2011-2#3)(2012-3#2)
were seen on##2##3##(1995-12#1)(2011-2#1)
were seen to have##2##4##(2008-11#1)(2008-12#1)
were seen to##7##3##(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)(2013-8#1)
were seen with##2##3##(2008-10#1)(2008-11#1)
were seen##67##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#4)(1991-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-3#2)(2008-10#12)(2008-11#7)(2008-12#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#3)(2010-1#1)(2010-11#1)(2010-3#1)(2011-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
were selected according to##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
were selected and##2##3##(2008-10#1)(2013-1#1)
were selected as analytical wavelengths##2##5##(2008-10#2)
were selected as the##2##4##(2008-10#1)(2012-2#1)
were selected as##7##3##(2008-10#6)(2012-2#1)
were selected by##5##3##(1993-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
were selected for further##2##4##(2008-10#2)
were selected for increased sensitivity to##2##6##(2008-8#2)
were selected for resistance##2##4##(2008-10#2)
were selected for the##6##4##(2008-10#3)(2009-12#1)(2011-2#1)(2013-8#1)
were selected for their##2##4##(2008-10#2)
were selected for##29##3##(1990-2#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
were selected from a##2##4##(1997-8#1)(2013-1#1)
were selected from the##4##4##(1997-8#1)(2008-10#2)(2013-8#1)
were selected from##11##3##(1997-8#2)(2008-10#4)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
were selected in the##2##4##(2008-10#1)(2008-11#1)
were selected in##3##3##(2008-10#2)(2008-11#1)
were selected on the basis of##2##6##(1995-8#1)(2008-1#1)
were selected randomly from##2##4##(1994-3#1)(2008-10#1)
were selected to represent##2##4##(1991-12#1)(2008-10#1)
were selected to##17##3##(1991-12#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-9#1)(2009-10#1)(2012-2#2)(2013-8#1)
were selected##100##2##(1990-2#1)(1991-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-8#3)(2006-6#1)(2008-1#1)(2008-10#49)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#4)(2013-1#3)(2013-8#3)
were selective##3##2##(2008-10#3)
were selectively##8##2##(1991-5#1)(2008-10#5)(2008-8#1)(2012-2#1)
were self-administered##2##2##(2009-5#1)(2010-9#1)
were sensitive to all##2##4##(2008-10#1)(2011-2#1)
were sensitive to metalaxyl##3##4##(2008-10#3)
were sensitive to##18##3##(1991-2#1)(1992-2#1)(1995-8#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#2)
were sensitive##25##2##(1991-2#1)(1992-2#1)(1995-8#1)(1996-12#1)(2008-10#16)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#2)
were sent to##5##3##(1990-6#1)(1995-11#1)(1997-8#1)(2010-10#1)(2011-1#1)
were sent##7##2##(1990-6#1)(1993-12#1)(1995-11#1)(1997-8#1)(2010-10#1)(2011-1#1)(2012-12#1)
were separated and quantified##2##4##(1997-2#1)(2008-10#1)
were separated and##4##3##(1993-8#1)(1997-2#1)(2008-10#1)(2008-12#1)
were separated by capillary##2##4##(2008-10#2)
were separated by cation exchange chromatography##2##6##(2008-10#1)(2009-3#1)
were separated by native gel electrophoresis##2##6##(2008-11#2)
were separated by##21##3##(1990-10#1)(1990-11#1)(1991-12#1)(1992-6#1)(1997-1#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2013-1#1)
were separated from the##3##4##(2008-10#2)(2008-11#1)
were separated from##11##3##(1991-2#1)(2008-10#6)(2008-11#1)(2008-6#1)(2009-8#1)(2011-3#1)
were separated in##9##3##(2008-10#9)
were separated into##7##3##(2008-10#4)(2008-11#1)(2008-12#1)(2009-7#1)
were separated on a##3##4##(2008-10#2)(2008-5#1)
were separated on the stationary phase##2##6##(2008-10#2)
were separated on the##4##4##(2008-10#4)
were separated on##7##3##(2008-10#6)(2008-5#1)
were separated quantitatively##2##3##(2008-10#2)
were separated with a##2##4##(2008-10#2)
were separated with##3##3##(2008-10#3)
were separated without##2##3##(2008-10#2)
were separated##75##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-8#1)(1997-1#1)(1997-2#1)(2008-10#48)(2008-11#4)(2008-12#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-3#1)(2013-1#2)
were sequenced and compared##2##4##(2008-10#1)(2009-10#1)
were sequenced and##7##3##(1996-2#1)(2008-10#4)(2009-10#1)(2013-8#1)
were sequenced##22##2##(1991-12#1)(1993-2#1)(1994-12#1)(1996-2#1)(1997-3#1)(1997-9#1)(2008-10#11)(2008-6#1)(2008-8#2)(2009-10#1)(2013-8#1)
were sequentially aspirated##2##3##(2008-10#2)
were sequentially##7##2##(2008-10#6)(2008-11#1)
were serologically##2##2##(1996-12#1)(2008-10#1)
were set up##2##3##(2008-10#1)(2008-5#1)
were set##7##2##(1995-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-12#1)
were seven##2##2##(2008-5#1)(2011-2#1)
were several##4##2##(1991-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
were severely##4##2##(1990-5#1)(2008-1#1)(2008-10#2)
were sexually active##2##3##(2013-1#2)
were sexually##4##2##(1996-11#1)(2008-10#1)(2013-1#2)
were shared##5##2##(1997-9#1)(2008-10#3)(2010-10#1)
were shifted##2##2##(1990-12#1)(2013-8#1)
were shorter and##2##3##(2010-6#1)(2011-1#1)
were shorter##3##2##(1994-11#1)(2010-6#1)(2011-1#1)
were showed##2##2##(2008-10#1)(2011-2#1)
were showing##2##2##(2008-11#2)
were shown in##3##3##(2008-10#2)(2013-8#1)
were shown to be covalently##2##5##(1993-6#1)(2008-5#1)
were shown to be##26##4##(1992-3#1)(1992-6#1)(1993-6#1)(1995-6#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
were shown to have##7##4##(1997-6#1)(2008-10#3)(2009-10#1)(2009-7#2)
were shown to##56##3##(1992-3#1)(1992-6#1)(1993-6#1)(1995-5#1)(1995-6#2)(1997-6#1)(1997-8#1)(2008-10#20)(2008-11#9)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
were shown##65##2##(1992-3#1)(1992-6#1)(1993-6#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#24)(2008-11#9)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
were significant associations between##2##4##(2008-3#1)(2010-1#1)
were significant correlations between##2##4##(1992-2#1)(2008-7#1)
were significant differences among##4##4##(1993-2#1)(2008-10#2)(2013-8#1)
were significant differences between the##3##5##(1991-9#1)(2008-10#1)(2009-12#1)
were significant differences between##7##4##(1991-9#1)(1993-2#1)(2008-10#2)(2008-12#1)(2009-12#1)(2013-1#1)
were significant differences in##4##4##(1995-12#1)(2008-10#2)(2013-1#1)
were significant differences##16##3##(1991-9#1)(1993-2#2)(1995-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2009-12#1)(2013-1#2)(2013-8#1)
were significant predictors of##4##4##(1996-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
were significant##46##2##(1991-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-8#2)(1995-12#1)(1995-3#1)(1996-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-1#1)(2011-2#4)(2013-1#3)(2013-8#1)
were significantly (P &lt##11##4##(1993-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-1#1)(2013-1#1)
were significantly (P&lt##2##3##(2008-10#2)
were significantly (p &lt##3##4##(1997-4#1)(2008-12#1)(2008-9#1)
were significantly affected by##5##4##(1995-12#1)(2008-10#3)(2008-5#1)
were significantly associated with##9##4##(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#2)(2012-2#1)(2013-1#1)
were significantly associated##11##3##(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#2)(2012-2#1)(2013-1#1)
were significantly attenuated##2##3##(1994-11#1)(2008-7#1)
were significantly correlated in##2##4##(2011-2#2)
were significantly correlated with##5##4##(2008-10#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
were significantly correlated##9##3##(2008-10#2)(2008-7#1)(2011-2#3)(2012-3#1)(2012-5#1)(2013-8#1)
were significantly decreased in##4##4##(2008-10#1)(2008-12#1)(2008-9#2)
were significantly decreased##12##3##(1991-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-12#2)(2008-9#3)(2011-2#1)
were significantly different among##3##4##(2008-10#1)(2008-9#1)(2010-7#1)
were significantly different from the##3##5##(1992-11#1)(2008-10#1)(2013-1#1)
were significantly different from##8##4##(1992-11#1)(1993-8#1)(2008-10#5)(2013-1#1)
were significantly different in##2##4##(2008-10#2)
were significantly different##25##3##(1991-6#1)(1992-11#1)(1993-8#1)(2008-10#11)(2008-12#3)(2008-3#1)(2008-8#2)(2008-9#1)(2010-7#1)(2013-1#2)(2013-8#1)
were significantly differentiated##4##3##(2008-10#3)(2012-5#1)
were significantly elevated##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
were significantly enhanced##2##3##(1994-8#1)(2008-11#1)
were significantly greater in##2##4##(2008-10#1)(2008-7#1)
were significantly greater than##4##4##(2008-10#2)(2008-5#1)(2008-9#1)
were significantly greater##8##3##(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)
were significantly higher for both##2##5##(2008-10#1)(2009-1#1)
were significantly higher in patients with##2##6##(1993-11#1)(2013-1#1)
were significantly higher in the##6##5##(1992-12#1)(2008-7#2)(2010-12#1)(2012-3#1)(2013-1#1)
were significantly higher in those##2##5##(2009-6#1)(2012-3#1)
were significantly higher in##22##4##(1992-12#2)(1993-11#1)(1993-2#1)(2008-1#1)(2008-10#2)(2008-7#4)(2009-6#2)(2010-12#1)(2011-2#2)(2012-3#3)(2012-5#1)(2013-1#2)
were significantly higher on##2##4##(2008-10#1)(2012-9#1)
were significantly higher than control##2##5##(2008-11#1)(2009-11#1)
were significantly higher than in##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
were significantly higher than those in the##2##7##(1994-3#1)(2011-2#1)
were significantly higher than those in##3##6##(1993-3#1)(1994-3#1)(2011-2#1)
were significantly higher than those of the##2##7##(2008-10#1)(2011-1#1)
were significantly higher than those of##5##6##(1994-12#1)(2008-10#2)(2010-8#1)(2011-1#1)
were significantly higher than those##9##5##(1993-3#1)(1994-12#1)(1994-3#1)(2008-10#3)(2010-8#1)(2011-1#1)(2011-2#1)
were significantly higher than##16##4##(1993-3#1)(1994-12#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
were significantly higher##48##3##(1992-12#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-6#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#3)(2012-5#1)(2012-9#1)(2013-1#3)
were significantly impaired##2##3##(1993-3#1)(1994-3#1)
were significantly improved##3##3##(1991-8#1)(2011-2#1)(2011-3#1)
were significantly increased by##4##4##(1995-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
were significantly increased from##2##4##(1994-3#1)(2011-2#1)
were significantly increased in 400 and 800 mg/L females##2##9##(2008-9#2)
were significantly increased in all exposed groups of males##2##9##(2008-9#2)
were significantly increased in both##2##5##(2008-10#1)(2008-9#1)
were significantly increased in the##4##5##(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)
were significantly increased in##16##4##(1993-2#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#9)(2011-2#1)
were significantly increased##29##3##(1993-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#10)(2011-2#2)(2013-1#1)
were significantly less than##2##4##(1991-11#1)(2008-10#1)
were significantly less##9##3##(1991-1#1)(1991-11#1)(2008-10#4)(2009-10#1)(2009-12#1)(2010-7#1)
were significantly lower for##4##4##(1990-12#1)(2008-10#3)
were significantly lower in the##2##5##(2008-10#1)(2009-8#1)
were significantly lower in##6##4##(2008-10#2)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
were significantly lower than the##3##5##(2008-10#2)(2008-5#1)
were significantly lower than those##2##5##(2008-10#1)(2011-2#1)
were significantly lower than##8##4##(1993-2#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
were significantly lower##24##3##(1990-12#1)(1993-2#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
were significantly lowered##3##3##(1994-8#1)(2008-11#1)(2010-5#1)
were significantly more aggressive than##2##5##(2008-10#2)
were significantly more likely to##2##5##(2008-12#1)(2008-9#1)
were significantly more likely##3##4##(2008-12#1)(2008-9#1)(2013-1#1)
were significantly more virulent than##2##5##(2008-10#2)
were significantly more##12##3##(1995-11#1)(2008-10#7)(2008-12#1)(2008-9#2)(2013-1#1)
were significantly reduced at##2##4##(2008-10#1)(2008-7#1)
were significantly reduced in the##2##5##(1995-11#1)(2013-1#1)
were significantly reduced in##8##4##(1995-11#2)(1995-8#1)(1996-12#1)(2008-10#3)(2013-1#1)
were significantly reduced##15##3##(1995-11#2)(1995-8#1)(1996-12#1)(2008-10#5)(2008-7#2)(2010-4#1)(2011-10#1)(2012-2#1)(2013-1#1)
were significantly shorter##2##3##(2008-10#1)(2008-11#1)
were significantly smaller##3##3##(1991-11#1)(2008-7#1)(2012-3#1)
were significantly suppressed##3##3##(2008-11#1)(2009-10#1)(2011-2#1)
were significantly##279##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#3)(1995-11#4)(1995-12#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#86)(2008-11#8)(2008-12#12)(2008-3#1)(2008-5#7)(2008-7#12)(2008-8#3)(2008-9#22)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#19)(2011-3#1)(2012-2#4)(2012-3#6)(2012-5#3)(2012-9#1)(2013-1#15)(2013-8#5)
were similar and##2##3##(2008-10#1)(2008-11#1)
were similar between treatment##2##4##(2012-12#1)(2012-3#1)
were similar between##7##3##(1992-12#1)(1994-11#1)(1995-8#1)(2008-10#1)(2012-12#1)(2012-3#1)(2012-5#1)
were similar for both##2##4##(2008-10#1)(2008-11#1)
were similar for each##2##4##(2008-10#2)
were similar for##13##3##(1992-12#1)(2008-10#7)(2008-11#1)(2008-9#1)(2011-10#1)(2012-12#1)(2013-8#1)
were similar in both groups##6##5##(1991-12#1)(1994-12#1)(1997-2#1)(2008-5#2)(2009-3#1)
were similar in both##9##4##(1991-12#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-5#2)(2009-3#1)(2011-2#1)
were similar in the##3##4##(2008-10#2)(2012-2#1)
were similar in##31##3##(1991-12#2)(1991-7#1)(1993-8#2)(1994-12#2)(1994-2#1)(1995-12#1)(1996-1#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-5#3)(2008-9#1)(2009-3#1)(2011-2#3)(2012-12#1)(2012-2#1)
were similar or##2##3##(2008-10#1)(2012-12#1)
were similar to each other##3##5##(1997-8#1)(2008-10#2)
were similar to the##9##4##(1992-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2012-2#1)(2013-8#1)
were similar to those observed in the##2##7##(1997-8#1)(2008-10#1)
were similar to those observed in##3##6##(1994-5#1)(1997-8#1)(2008-10#1)
were similar to those obtained##2##5##(2008-10#2)
were similar to those of the##6##6##(1993-8#1)(2008-12#1)(2008-5#1)(2008-9#2)(2011-2#1)
were similar to those of##16##5##(1990-3#1)(1993-8#1)(1994-12#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#4)(2011-2#1)
were similar to those##24##4##(1990-3#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#4)(2011-2#1)
were similar to##47##3##(1990-3#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-8#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#4)(2011-2#1)(2012-2#1)(2013-8#1)
were similar with the##2##4##(1990-2#1)(2008-3#1)
were similar with##3##3##(1990-2#1)(1991-2#1)(2008-3#1)
were similar##137##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-8#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#1)(1997-2#2)(1997-8#2)(2008-10#45)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#8)(2008-6#1)(2008-8#4)(2008-9#7)(2009-3#1)(2010-12#1)(2011-10#1)(2011-2#7)(2012-12#4)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#3)
were simulated using##2##3##(2013-1#2)
were simulated##5##2##(1993-12#1)(1993-9#1)(2009-3#1)(2013-1#2)
were simultaneously amplified##2##3##(2008-10#2)
were simultaneously determined by##2##4##(2008-10#2)
were simultaneously determined in##3##4##(2008-10#3)
were simultaneously determined##5##3##(2008-10#5)
were simultaneously studied##2##3##(2008-10#1)(2008-5#1)
were simultaneously##21##2##(1994-5#1)(2008-10#17)(2008-5#1)(2008-6#1)(2013-1#1)
were singly##2##2##(2008-10#1)(2008-3#1)
were six##2##2##(2008-10#1)(2008-9#1)
were slaughtered##3##2##(1996-12#1)(1997-5#1)(2008-9#1)
were slightly better##2##3##(2008-10#2)
were slightly lower##2##3##(1994-2#1)(2008-11#1)
were slightly##13##2##(1991-11#1)(1994-2#1)(1994-8#1)(1995-6#1)(2008-10#6)(2008-11#2)(2012-5#1)
were slow##2##2##(2008-10#1)(2008-11#1)
were slower##3##2##(1993-6#1)(2008-7#2)
were small##8##2##(1991-6#1)(1994-2#1)(2008-10#4)(2009-7#1)(2011-2#1)
were smaller and produced##2##4##(2008-10#2)
were smaller than those##2##4##(2008-10#1)(2008-5#1)
were smaller than##6##3##(1992-5#1)(2008-10#3)(2008-5#2)
were smaller##11##2##(1992-5#1)(2008-10#7)(2008-11#1)(2008-5#2)
were smokers##6##2##(1996-8#1)(2008-10#2)(2011-2#2)(2013-8#1)
were soaked in a##2##4##(2008-10#2)
were soaked##4##2##(2008-10#4)
were some differences in##2##4##(1991-6#1)(2008-5#1)
were some differences##3##3##(1991-6#1)(2008-5#1)(2012-12#1)
were some##5##2##(1991-6#1)(2008-11#1)(2008-5#1)(2010-1#1)(2012-12#1)
were sometimes##4##2##(1991-5#1)(2008-10#1)(2010-8#1)(2013-1#1)
were somewhat##4##2##(1991-1#1)(1995-6#1)(1996-5#1)(2008-10#1)
were sorbed##4##2##(2008-10#4)
were sought using##3##3##(2008-11#2)(2008-12#1)
were sought##5##2##(2008-11#2)(2008-12#1)(2012-12#1)(2013-1#1)
were spatially correlated in##2##4##(2008-10#2)
were spatially##4##2##(2008-10#4)
were specific for##5##3##(2008-10#5)
were specific to##3##3##(2008-10#3)
were specific##11##2##(1991-9#1)(1995-8#1)(1997-1#1)(2008-10#8)
were specifically##3##2##(2008-10#2)(2008-9#1)
were spiked with##8##3##(2008-10#8)
were spiked##9##2##(2008-10#9)
were spontaneously##2##2##(1996-11#1)(2008-11#1)
were sprayed on##2##3##(2008-10#2)
were sprayed with a##2##4##(2008-10#2)
were sprayed with the##2##4##(2008-10#2)
were sprayed with##8##3##(2008-10#6)(2008-8#1)(2011-2#1)
were sprayed##11##2##(2008-10#9)(2008-8#1)(2011-2#1)
were spread over##2##3##(2008-10#2)
were spread##3##2##(2008-10#2)(2008-9#1)
were stabilized##3##2##(1994-11#1)(2008-10#2)
were stable for at least##3##5##(1993-8#1)(2008-10#2)
were stable for##4##3##(1993-8#1)(2008-10#3)
were stable over##3##3##(2008-10#2)(2008-11#1)
were stable##16##2##(1991-2#1)(1993-8#1)(1995-12#1)(2008-10#9)(2008-11#1)(2008-9#1)(2010-8#1)(2013-1#1)
were stably transfected##2##3##(1995-2#1)(2008-11#1)
were stably##3##2##(1993-2#1)(1995-2#1)(2008-11#1)
were staged##2##2##(1990-8#1)(1992-6#1)
were stained by##2##3##(1996-12#1)(2008-10#1)
were stained in##2##3##(2008-12#2)
were stained with the##2##4##(1991-5#1)(2008-11#1)
were stained with##4##3##(1991-5#1)(2008-11#1)(2008-12#1)(2008-5#1)
were stained##13##2##(1991-5#1)(1996-12#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)
were standardized##3##2##(1993-8#1)(2008-10#1)(2008-12#1)
were statistically analyzed##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
were statistically comparable with those obtained by##2##7##(2008-10#2)
were statistically compared with##4##4##(2008-10#4)
were statistically compared##5##3##(2008-10#5)
were statistically evaluated##2##3##(2008-10#1)(2008-12#1)
were statistically higher##2##3##(2010-1#1)(2010-12#1)
were statistically significant predictors of##2##5##(2008-11#1)(2011-2#1)
were statistically significant##14##3##(1994-1#1)(1994-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#3)
were statistically similar##3##3##(2008-10#1)(2013-1#2)
were statistically##38##2##(1994-1#1)(1994-12#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#2)
were still being##2##3##(1991-8#1)(2008-11#1)
were still##25##2##(1990-12#2)(1991-8#1)(1991-9#1)(1993-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#2)(1997-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2009-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
were stimulated by##3##3##(1990-11#1)(1995-8#1)(2008-11#1)
were stimulated for##2##3##(1994-6#1)(1997-3#1)
were stimulated with##5##3##(1991-3#1)(1992-6#1)(2008-10#2)(2008-11#1)
were stimulated##15##2##(1990-11#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)
were stored##2##2##(2008-12#1)(2011-2#1)
were strain##2##2##(1994-8#1)(2008-10#1)
were stratified according to##2##4##(1994-12#1)(2011-2#1)
were stratified by##2##3##(2008-7#1)(2011-2#1)
were stratified into a##2##4##(2011-2#2)
were stratified into three categories##2##5##(2010-12#2)
were stratified into##4##3##(2010-12#2)(2011-2#2)
were stratified##10##2##(1994-12#1)(1995-11#1)(2008-7#1)(2010-12#2)(2011-2#4)(2012-5#1)
were strictly##2##2##(2008-10#1)(2008-11#1)
were strong##5##2##(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#1)
were strongly correlated##2##3##(2008-10#1)(2012-3#1)
were strongly##12##2##(1991-6#1)(1991-8#1)(2008-10#6)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
were structured##2##2##(2008-11#1)(2008-8#1)
were studied and compared##4##4##(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#1)
were studied and optimized##9##4##(2008-10#9)
were studied and the##5##4##(2008-10#5)
were studied and were##2##4##(2008-10#2)
were studied and##29##3##(2008-10#25)(2008-12#1)(2008-7#1)(2011-2#1)(2011-3#1)
were studied as well as##2##5##(2008-10#2)
were studied as well##3##4##(2008-10#3)
were studied as##5##3##(2008-10#5)
were studied at##7##3##(1990-6#1)(1995-10#1)(1995-11#1)(2008-10#3)(2010-5#1)
were studied by differential scanning calorimetry##2##6##(1993-8#1)(2011-2#1)
were studied by flow##2##4##(1994-5#1)(2008-10#1)
were studied by principal component analysis (PCA)##2##7##(2008-10#2)
were studied by using##6##4##(2008-10#4)(2008-11#1)(2008-9#1)
were studied by##42##3##(1991-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-5#2)(1995-11#1)(1996-5#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
were studied during##2##3##(2008-10#1)(2008-5#1)
were studied for the first time##2##6##(2008-10#1)(2008-12#1)
were studied for the##4##4##(1990-8#1)(2008-10#2)(2008-12#1)
were studied for their##2##4##(1995-12#1)(2008-11#1)
were studied for##12##3##(1990-8#1)(1995-12#1)(2008-10#7)(2008-11#2)(2008-12#1)
were studied in a##7##4##(1991-8#1)(2008-10#3)(2008-3#1)(2008-7#2)
were studied in an##2##4##(2008-10#1)(2008-11#1)
were studied in detail##5##4##(2008-10#5)
were studied in male Fischer 344 rats##2##7##(1992-12#1)(2008-7#1)
were studied in order to##3##5##(2008-10#3)
were studied in relation to##2##5##(2008-10#1)(2008-5#1)
were studied in the##13##4##(1990-11#1)(1990-3#1)(1990-5#2)(1993-12#1)(1996-2#2)(1997-3#1)(2008-10#3)(2008-5#1)(2008-8#1)
were studied in two##2##4##(2008-10#1)(2011-2#1)
were studied in##64##3##(1990-11#1)(1990-3#1)(1990-5#2)(1991-8#1)(1992-12#1)(1993-1#2)(1993-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-3#1)(2008-10#25)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2010-6#1)(2010-8#2)(2011-2#1)
were studied on the##2##4##(2008-10#1)(2008-11#1)
were studied on##5##3##(1994-8#1)(2008-10#2)(2008-11#1)(2011-10#1)
were studied potentiometrically (H(+)-glass electrode)##2##5##(2008-10#2)
were studied potentiometrically in aqueous solution##2##6##(2008-10#2)
were studied potentiometrically##4##3##(2008-10#4)
were studied to determine their##2##5##(2008-11#1)(2008-12#1)
were studied to determine##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
were studied to evaluate##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
were studied to##14##3##(1991-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)
were studied under different##2##4##(2008-10#2)
were studied under the##2##4##(2008-10#1)(2009-5#1)
were studied under##9##3##(1992-8#1)(2008-10#5)(2008-12#1)(2009-5#1)(2010-11#1)
were studied using a##2##4##(2008-10#2)
were studied using the##4##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
were studied using##24##3##(1990-5#1)(1993-3#1)(1996-2#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
were studied with the##2##4##(2008-7#1)(2012-3#1)
were studied with##7##3##(1991-11#1)(2008-10#4)(2008-7#1)(2012-3#1)
were studied##422##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-8#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#4)(1996-5#1)(1997-2#5)(1997-3#1)(1997-8#5)(2008-1#1)(2008-10#242)(2008-11#16)(2008-12#12)(2008-3#2)(2008-5#12)(2008-7#8)(2008-8#7)(2008-9#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-10#1)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#8)(2013-1#1)(2013-8#5)
were studies and##2##3##(1991-2#1)(2008-10#1)
were subcloned into the##2##4##(1994-5#1)(2008-10#1)
were subcloned##3##2##(1992-3#1)(1994-5#1)(2008-10#1)
were subcultured##3##2##(2008-10#3)
were subdivided into##2##3##(1997-1#1)(2012-3#1)
were subject to##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
were subjected to a##5##4##(2008-10#2)(2008-11#1)(2010-1#1)(2013-1#1)
were subjected to different##2##4##(2008-10#1)(2008-11#1)
were subjected to the##3##4##(2008-10#2)(2008-12#1)
were subjected to##63##3##(1990-11#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-10#20)(2008-11#5)(2008-12#5)(2008-5#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-1#2)(2011-1#2)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#5)
were subjected##64##2##(1990-11#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-10#21)(2008-11#5)(2008-12#5)(2008-5#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-1#2)(2011-1#2)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#5)
were submitted to a##4##4##(1991-12#1)(1994-2#1)(2011-2#1)(2013-1#1)
were submitted to the##2##4##(2008-11#1)(2010-6#1)
were submitted to##12##3##(1991-12#1)(1991-2#1)(1994-2#1)(2008-10#2)(2008-11#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2013-1#1)
were submitted##14##2##(1991-12#1)(1991-2#1)(1993-3#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2013-1#1)
were subsequently analyzed##2##3##(1996-12#1)(2008-10#1)
were subsequently determined##2##3##(2008-10#2)
were subsequently##25##2##(1991-2#1)(1993-6#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-10#15)(2008-11#2)(2010-10#1)(2013-1#2)
were substantially higher##2##3##(1995-8#1)(1996-12#1)
were substantially lower##2##3##(1997-2#1)(2008-10#1)
were substantially reduced##3##3##(2008-5#1)(2010-5#1)(2012-2#1)
were substantially##10##2##(1994-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-5#1)(2010-5#1)(2012-2#1)
were substituted##2##2##(1995-6#1)(2008-7#1)
were substrates##2##2##(1992-6#1)(1994-8#1)
were successful in##5##3##(1997-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
were successful##12##2##(1993-9#1)(1995-1#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
were successfully analyzed using the proposed method##2##7##(2008-10#2)
were successfully analyzed##4##3##(2008-10#4)
were successfully applied for the determination of##2##7##(2008-10#2)
were successfully applied for the##6##5##(2008-10#6)
were successfully applied to the determination of##3##7##(2008-10#3)
were successfully applied to the##4##5##(2008-10#4)
were successfully applied to##6##4##(2008-10#5)(2008-5#1)
were successfully applied##12##3##(2008-10#11)(2008-5#1)
were successfully determined by##2##4##(2008-10#2)
were successfully determined##5##3##(2008-10#5)
were successfully isolated##2##3##(1997-3#1)(2008-8#1)
were successfully obtained##2##3##(2007-12#1)(2008-8#1)
were successfully separated##3##3##(2008-10#3)
were successfully treated by##2##4##(1991-8#1)(2008-7#1)
were successfully used for##2##4##(2008-10#2)
were successfully used in##2##4##(2008-10#2)
were successfully used to separate##2##5##(2008-10#2)
were successfully used##6##3##(2008-10#6)
were successfully##64##2##(1991-8#1)(1994-5#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#40)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2010-8#1)(2011-2#2)(2013-1#2)
were suffering from##3##3##(1992-9#1)(2013-1#2)
were sufficient for the##2##4##(2008-10#1)(2011-2#1)
were sufficient for##3##3##(2008-10#2)(2011-2#1)
were sufficient to##2##3##(2008-10#1)(2008-5#1)
were sufficient##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
were suggested##5##2##(1994-8#1)(1997-8#1)(2008-10#2)(2013-1#1)
were suitable for the##2##4##(2008-10#2)
were suitable for##4##3##(2008-10#3)(2008-11#1)
were suitable##5##2##(2008-10#4)(2008-11#1)
were superior to##2##3##(1992-8#1)(2008-11#1)
were superior##4##2##(1992-8#1)(2008-10#2)(2008-11#1)
were supplemented##2##2##(2008-10#1)(2011-2#1)
were supplied##2##2##(2008-10#1)(2008-11#1)
were supported by##7##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-6#1)(2013-1#1)
were supported##11##2##(1993-12#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-12#1)(2010-6#3)(2013-1#1)
were suppressed by##2##3##(1995-11#1)(2008-11#1)
were suppressed in##2##3##(1996-6#1)(2008-11#1)
were suppressed##4##2##(1995-11#1)(1996-6#1)(2008-11#2)
were surgically treated##2##3##(1992-9#1)(2011-2#1)
were surgically##3##2##(1992-9#1)(2011-2#2)
were surveyed in the##2##4##(2008-10#1)(2008-11#1)
were surveyed in##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
were surveyed regarding##3##3##(1993-1#1)(1995-1#1)(2008-9#1)
were surveyed to determine how##2##5##(1996-1#1)(2007-12#1)
were surveyed to determine##3##4##(1996-1#1)(2007-12#1)(2008-10#1)
were surveyed to##4##3##(1995-1#1)(1996-1#1)(2007-12#1)(2008-10#1)
were surveyed with##2##3##(1995-12#1)(2010-2#1)
were surveyed##24##2##(1993-1#1)(1994-2#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-9#1)(2010-1#1)(2010-11#1)(2010-2#2)(2012-12#1)
were susceptible to both##2##4##(1993-6#1)(2008-11#1)
were susceptible to infection##2##4##(2008-10#2)
were susceptible to race##2##4##(2008-10#2)
were susceptible to the##2##4##(2008-10#1)(2008-5#1)
were susceptible to##20##3##(1993-6#1)(1995-2#1)(2008-10#13)(2008-11#1)(2008-5#2)(2011-10#1)(2012-2#1)
were susceptible##23##2##(1993-6#1)(1995-2#1)(2008-10#15)(2008-11#1)(2008-5#2)(2011-10#2)(2012-2#1)
were suspended in##5##3##(1996-1#1)(2008-10#2)(2008-5#1)(2012-2#1)
were suspended##6##2##(1996-1#1)(2008-10#3)(2008-5#1)(2012-2#1)
were sustained##3##2##(1991-12#1)(2008-8#1)(2008-9#1)
were symptomatic##4##2##(1996-8#1)(2008-1#1)(2012-2#1)(2012-3#1)
were synthesised##2##2##(2008-10#1)(2011-2#1)
were synthesized and evaluated##2##4##(1992-12#1)(1993-1#1)
were synthesized and secreted##2##4##(1993-12#1)(2009-3#1)
were synthesized and tested##2##4##(1993-3#1)(2008-11#1)
were synthesized and their##3##4##(1991-7#1)(2008-10#1)(2008-11#1)
were synthesized and used as##2##5##(2008-10#2)
were synthesized and##24##3##(1991-7#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-8#1)(1996-2#1)(2008-10#10)(2008-11#3)(2008-8#1)(2009-3#1)(2013-1#1)
were synthesized by sol-gel method##2##5##(2008-10#2)
were synthesized by using##2##4##(1991-3#1)(2008-10#1)
were synthesized by##8##3##(1991-3#1)(1992-6#1)(1993-8#1)(2008-10#4)(2008-9#1)
were synthesized chemically##2##3##(1994-8#1)(2008-8#1)
were synthesized for##2##3##(2008-10#2)
were synthesized from##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
were synthesized in##4##3##(1992-12#1)(2008-10#2)(2010-6#1)
were synthesized on##2##3##(1992-6#1)(2008-10#1)
were synthesized using##2##3##(2008-10#2)
were synthesized via##2##3##(1996-5#1)(2008-11#1)
were synthesized with##2##3##(2008-10#1)(2008-5#1)
were synthesized##67##2##(1990-5#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-6#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-8#2)(1995-2#1)(1996-2#1)(1996-5#1)(2008-10#28)(2008-11#7)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
were systematically investigated##5##3##(2008-10#5)
were systematically studied##2##3##(2008-10#2)
were systematically##13##2##(1996-2#1)(2008-10#9)(2008-5#1)(2012-12#1)(2013-1#1)
were tagged##2##2##(2008-8#1)(2010-8#1)
were taken and##2##3##(2008-10#1)(2013-1#1)
were taken as inputs for##2##5##(2008-10#2)
were taken as##3##3##(2008-10#2)(2008-11#1)
were taken at 1##2##4##(2013-1#2)
were taken at##5##3##(2008-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
were taken before and##2##4##(2008-10#1)(2013-8#1)
were taken before##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
were taken from the##3##4##(1997-5#1)(2008-10#1)(2008-11#1)
were taken from##14##3##(1996-11#1)(1997-5#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#2)
were taken in##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
were taken into account##3##4##(1990-9#1)(2008-10#1)(2010-3#1)
were taken into##4##3##(1990-9#1)(2008-10#2)(2010-3#1)
were taken on##4##3##(1993-1#1)(2008-9#1)(2010-12#1)(2010-6#1)
were taken to##2##3##(1991-2#1)(2012-12#1)
were taken##57##2##(1990-11#1)(1990-9#1)(1991-2#1)(1993-1#1)(1996-11#1)(1997-5#2)(2007-12#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-5#3)(2008-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#3)
were taking##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-4#1)(2013-1#1)
were taught##3##2##(1993-12#2)(2008-10#1)
were tentatively##2##2##(1996-2#1)(2008-10#1)
were tested against##8##3##(1996-12#1)(2008-10#5)(2008-11#1)(2008-7#1)
were tested and the##3##4##(1991-3#1)(1996-12#1)(2008-11#1)
were tested and##11##3##(1991-3#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)
were tested as solid##2##4##(2008-10#2)
were tested as##8##3##(1994-11#1)(1995-5#1)(2008-10#4)(2008-11#2)
were tested at##9##3##(1992-2#1)(2008-10#3)(2008-5#1)(2010-3#1)(2011-2#2)(2013-1#1)
were tested between##2##3##(2012-12#1)(2013-1#1)
were tested by##9##3##(1994-12#1)(1995-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2011-2#1)
were tested for differences in##2##5##(2008-10#2)
were tested for resistance to##2##5##(2008-10#2)
were tested for susceptibility to##2##5##(2008-10#2)
were tested for the presence of##3##6##(1992-9#1)(2008-10#1)(2013-1#1)
were tested for the##8##4##(1992-9#1)(1994-2#1)(2008-10#4)(2008-7#1)(2013-1#1)
were tested for their ability to inhibit##3##7##(1994-5#1)(1994-8#1)(2008-10#1)
were tested for their ability to transmit##2##7##(2008-10#2)
were tested for their ability to##8##6##(1994-5#1)(1994-8#1)(2008-10#6)
were tested for their##20##4##(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#2)(2008-10#12)(2008-5#1)(2013-1#2)
were tested for virulence##3##4##(2008-10#3)
were tested for##64##3##(1991-6#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-2#1)(2008-1#1)(2008-10#35)(2008-11#3)(2008-5#5)(2008-7#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#3)
were tested in a##3##4##(2008-10#1)(2008-7#2)
were tested in an##4##4##(1990-11#1)(2008-10#2)(2008-11#1)
were tested in order to##2##5##(2008-10#2)
were tested in the##6##4##(1990-6#1)(1993-3#1)(2008-10#2)(2008-5#1)(2011-1#1)
were tested in##27##3##(1990-11#1)(1990-6#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#1)(2013-8#1)
were tested on##9##3##(1992-3#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-1#1)
were tested separately and together for suppression of Botrytis cinerea on strawberry leaves##2##13##(2008-10#2)
were tested to evaluate the##2##5##(1992-2#1)(2008-10#1)
were tested to##9##3##(1990-5#1)(1992-2#1)(2008-10#6)(2008-12#1)
were tested under##3##3##(2008-10#1)(2009-3#2)
were tested using a##2##4##(2008-12#1)(2011-2#1)
were tested using the##2##4##(2008-10#1)(2011-2#1)
were tested using##11##3##(1990-2#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#2)
were tested with the##2##4##(2008-10#1)(2008-7#1)
were tested with##18##3##(1993-6#1)(1996-2#2)(1996-8#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#1)
were tested##242##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#5)(1996-2#2)(1996-8#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#124)(2008-11#12)(2008-12#3)(2008-2#1)(2008-5#15)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#3)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
were that##2##2##(1994-3#1)(2008-11#1)
were the best##2##3##(1992-8#1)(2011-2#1)
were the following##2##3##(1990-12#1)(2008-10#1)
were the highest in##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
were the highest##4##3##(1995-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
were the important##2##3##(2008-11#1)(2008-9#1)
were the lower values than##2##5##(2011-2#2)
were the lowest##2##3##(2008-10#2)
were the main##7##3##(1991-11#1)(1993-3#1)(2008-10#1)(2009-8#1)(2011-2#2)(2013-8#1)
were the major##2##3##(2008-10#1)(2008-12#1)
were the most abundant##2##4##(2008-8#1)(2010-8#1)
were the most common##4##4##(1990-6#1)(1992-2#1)(1997-3#1)(2011-2#1)
were the most frequent##3##4##(2008-5#1)(2013-1#2)
were the most frequently detected and occurred in##2##8##(2008-10#2)
were the most frequently##5##4##(2008-10#2)(2008-11#2)(2010-1#1)
were the most important##3##4##(1994-6#1)(2008-10#1)(2008-7#1)
were the most potent##3##4##(1993-1#1)(1994-8#1)(2008-8#1)
were the most prevalent##2##4##(2008-10#1)(2008-5#1)
were the most prominent##2##4##(2008-10#2)
were the most sensitive##3##4##(2008-10#1)(2008-5#2)
were the most severe##2##4##(2008-10#2)
were the most##52##3##(1990-6#1)(1991-2#1)(1991-6#2)(1992-2#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-6#1)(1994-8#1)(1997-3#1)(2008-10#17)(2008-11#4)(2008-5#5)(2008-7#2)(2008-8#3)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#3)(2013-1#2)
were the only##7##3##(2008-10#3)(2008-11#1)(2008-12#1)(2010-3#1)(2012-3#1)
were the predominant##6##3##(1991-11#1)(2008-10#2)(2008-7#2)(2013-1#1)
were the result of##3##4##(2008-10#3)
were the results of##2##4##(2009-8#1)(2012-3#1)
were the same as that##2##5##(2008-11#1)(2008-9#1)
were the same for all##2##5##(2008-10#2)
were the same or##2##4##(1991-2#1)(1996-2#1)
were the same##12##3##(1991-2#1)(1993-8#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-9#1)
were the surgical##2##3##(2011-2#1)(2013-1#1)
were the transition##2##3##(2008-10#1)(2012-12#1)
were the two##2##3##(2008-10#1)(2010-4#1)
were the use of##2##4##(2008-10#1)(2011-2#1)
were the variables##2##3##(2008-10#1)(2012-12#1)
were the##192##2##(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#2)(1991-6#3)(1991-7#1)(1992-12#1)(1992-2#4)(1992-8#1)(1993-1#1)(1993-3#2)(1993-8#2)(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#73)(2008-11#10)(2008-12#5)(2008-3#1)(2008-5#9)(2008-7#7)(2008-8#5)(2008-9#4)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-2#13)(2012-12#2)(2012-3#3)(2013-1#6)(2013-8#3)
were then applied to##2##4##(2008-10#1)(2008-11#1)
were then asked to##2##4##(2008-10#1)(2008-9#1)
were then characterized by##2##4##(1992-6#1)(2008-10#1)
were then compared to##3##4##(1993-11#1)(2008-10#1)(2008-7#1)
were then compared##5##3##(1993-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
were then eluted##4##3##(1990-12#1)(2008-10#3)
were then evaluated##2##3##(2008-10#1)(2008-11#1)
were then irradiated##2##3##(2008-3#1)(2013-1#1)
were then measured##2##3##(1990-12#1)(1991-3#1)
were then separated##2##3##(1995-2#1)(1997-2#1)
were then sequentially##3##3##(1997-2#1)(2008-10#2)
were then subjected to##2##4##(2008-12#1)(2009-7#1)
were then tested##2##3##(1991-9#1)(2008-10#1)
were then transferred to##2##4##(1994-5#1)(2008-10#1)
were then transferred##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
were then used for##2##4##(1992-6#1)(2011-1#1)
were then used to##6##4##(2008-10#4)(2008-12#1)(2008-7#1)
were then used##8##3##(1992-6#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-1#1)
were then##91##2##(1990-12#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-11#2)(1994-5#2)(1995-11#1)(1995-2#1)(1996-3#1)(1997-2#3)(1997-7#1)(2008-10#34)(2008-11#8)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#1)
were therefore##2##2##(1990-9#1)(2008-10#1)
were thoroughly investigated##3##3##(2008-10#3)
were thoroughly##5##2##(2008-10#4)(2008-7#1)
were those##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2012-3#1)
were thought to##2##3##(2008-10#1)(2008-7#1)
were thought##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
were three##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
were thus determined in the ranges##2##6##(2008-10#2)
were thus determined##3##3##(2008-10#3)
were thus##11##2##(1994-12#1)(1995-2#1)(2008-10#8)(2010-3#1)
were thymol##2##2##(2008-12#1)(2012-2#1)
were tightly##2##2##(1995-6#1)(2008-10#1)
were titrated##2##2##(1994-5#1)(2008-10#1)
were to (1)##2##3##(2009-7#1)(2013-1#1)
were to (i) determine##2##4##(2008-10#2)
were to (i)##4##3##(2008-10#3)(2010-12#1)
were to assess the##2##4##(2008-10#1)(2012-3#1)
were to be used##3##4##(1992-2#1)(2013-1#2)
were to be##5##3##(1992-2#1)(2008-12#1)(2011-1#1)(2013-1#2)
were to determine the##7##4##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#2)
were to determine##10##3##(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#2)(2013-1#1)
were to develop##2##3##(2008-10#1)(2013-1#1)
were to establish##2##3##(2008-10#1)(2013-1#1)
were to examine the##4##4##(2008-11#1)(2010-11#1)(2012-2#1)(2013-8#1)
were to investigate the##2##4##(2008-9#1)(2010-2#1)
were to study the##4##4##(2008-10#2)(2013-1#2)
were to##73##2##(1992-12#2)(1992-2#1)(1993-1#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#4)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#12)(2013-8#1)
were tolerant##3##2##(2008-10#2)(2011-10#1)
were tolerated at##3##3##(1997-3#1)(2008-10#2)
were tolerated##4##2##(1997-3#1)(2008-10#3)
were too##5##2##(1994-9#1)(1996-3#1)(2008-10#2)(2013-8#1)
were totally removed##2##3##(2008-7#2)
were totally##5##2##(2008-10#1)(2008-7#2)(2009-10#1)(2010-3#1)
were toxic to##2##3##(2008-10#1)(2008-7#1)
were toxic##3##2##(2008-10#2)(2008-7#1)
were traced##2##2##(2008-10#2)
were trained in##2##3##(1991-2#1)(1997-4#1)
were trained on a##2##4##(1993-3#2)
were trained on##3##3##(1993-3#2)(1997-2#1)
were trained##10##2##(1991-2#1)(1992-12#1)(1993-3#2)(1993-6#1)(1997-2#1)(1997-4#1)(2008-9#1)(2010-7#1)(2010-8#1)
were transcribed##4##2##(1992-3#1)(1993-3#1)(1993-8#1)(2008-11#1)
were transfected into##6##3##(1993-3#1)(1994-6#1)(2008-11#2)(2008-8#2)
were transfected with a plasmid##2##5##(2008-11#1)(2010-11#1)
were transfected with a##3##4##(2008-11#1)(2008-8#1)(2010-11#1)
were transfected with the##2##4##(1994-8#1)(2008-11#1)
were transfected with##11##3##(1994-8#1)(2008-10#1)(2008-11#4)(2008-8#1)(2010-11#2)(2011-2#1)(2012-3#1)
were transfected##18##2##(1993-3#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-11#7)(2008-8#3)(2010-11#2)(2011-2#1)(2012-3#1)
were transferred from##2##3##(2008-10#1)(2008-7#1)
were transferred into##7##3##(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-6#1)
were transferred to a##3##4##(2008-10#1)(2008-11#2)
were transferred to##11##3##(1990-9#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)
were transferred##24##2##(1990-9#1)(1997-2#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-7#1)(2008-8#2)(2008-9#3)(2010-6#1)(2010-8#1)
were transformed into##2##3##(1996-5#1)(2008-10#1)
were transformed to##3##3##(2008-10#2)(2008-11#1)
were transformed with a##2##4##(2008-10#2)
were transformed with the##3##4##(2008-10#3)
were transformed with##7##3##(2008-10#7)
were transformed##14##2##(1996-5#1)(2008-10#11)(2008-11#2)
were transient##2##2##(2008-1#1)(2008-10#1)
were transiently expressed in##2##4##(2008-8#2)
were translocated##2##2##(2008-10#1)(2009-8#1)
were transmitted##7##2##(1997-8#1)(2007-9#1)(2008-10#4)(2013-1#1)
were transplanted into##4##3##(2008-10#2)(2009-12#1)(2011-2#1)
were transplanted##6##2##(2008-10#3)(2009-12#1)(2010-11#1)(2011-2#1)
were trapped in##2##3##(2008-10#2)
were trapped##5##2##(1994-11#1)(2008-10#4)
were trauma##2##2##(2007-11#1)(2013-1#1)
were treated and##2##3##(2008-11#1)(2008-7#1)
were treated as##3##3##(2008-10#2)(2011-1#1)
were treated at our##3##4##(1990-6#1)(1990-9#1)(2011-2#1)
were treated at the##3##4##(1991-6#1)(1993-6#1)(2008-10#1)
were treated at##6##3##(1990-6#1)(1990-9#1)(1991-6#1)(1993-6#1)(2008-10#1)(2011-2#1)
were treated by a##4##4##(1990-12#1)(1996-11#1)(1997-3#1)(2008-10#1)
were treated by##34##3##(1990-12#2)(1990-3#1)(1991-2#3)(1991-3#2)(1991-8#2)(1992-9#1)(1993-3#1)(1994-12#2)(1995-11#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-7#6)(2008-9#1)(2009-4#1)(2011-2#1)(2012-3#1)
were treated conservatively##4##3##(1997-8#1)(2008-7#2)(2013-1#1)
were treated for##7##3##(1990-9#1)(1991-8#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
were treated in our##2##4##(1991-2#1)(1993-6#1)
were treated in##11##3##(1991-2#1)(1993-6#1)(1995-11#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-7#1)(2009-1#1)(2011-2#2)
were treated successfully##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
were treated surgically##3##3##(1997-2#1)(2008-7#1)(2013-1#1)
were treated twice##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
were treated using##2##3##(1990-3#1)(2008-10#1)
were treated with CO2 laser##2##5##(1995-2#1)(1996-1#1)
were treated with a combination of##2##6##(1991-2#1)(2011-2#1)
were treated with a##9##4##(1991-2#1)(1992-3#1)(1992-5#1)(1997-8#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
were treated with the##4##4##(1991-5#1)(1997-7#1)(2008-10#1)(2012-3#1)
were treated with##95##3##(1990-12#2)(1990-2#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#4)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
were treated##203##2##(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#4)(1991-9#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#3)(1995-2#2)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#5)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#7)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#21)(2008-8#3)(2008-9#5)(2009-1#1)(2009-4#1)(2009-8#1)(2010-6#2)(2011-1#2)(2011-2#13)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#3)
were tried##2##2##(2008-10#1)(2008-7#1)
were twice##2##2##(2008-11#1)(2009-11#1)
were two##11##2##(1990-2#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-9#1)(2010-11#1)(2012-3#1)
were type##2##2##(2008-12#1)(2009-3#1)
were typed##2##2##(2008-5#1)(2011-2#1)
were typical of the##2##4##(1994-11#1)(2008-10#1)
were typical of##3##3##(1994-11#1)(2008-10#2)
were typical##4##2##(1994-11#1)(2008-10#3)
were typically##2##2##(2008-10#2)
were ultrasound##2##2##(1996-3#1)(2008-10#1)
were unable to achieve##3##4##(2008-10#1)(2008-12#1)(2010-12#1)
were unable to demonstrate##2##4##(1997-3#1)(2009-9#1)
were unable to transmit##2##4##(2008-10#2)
were unable to##21##3##(1993-8#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
were unaffected by the presence of##2##6##(2008-10#2)
were unaffected by the presence or absence of##2##8##(2008-10#2)
were unaffected by the presence##4##5##(2008-10#4)
were unaffected by the##5##4##(1996-12#1)(2008-10#4)
were unaffected by##9##3##(1994-11#1)(1994-8#1)(1996-12#1)(2008-10#5)(2013-1#1)
were unaffected##13##2##(1991-10#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-4#1)(2008-10#5)(2008-12#1)(2009-12#1)(2013-1#1)
were unaltered##3##2##(1993-8#1)(2008-8#1)(2012-2#1)
were unchanged##13##2##(1993-3#1)(1993-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)
were under the##2##3##(2008-9#1)(2013-8#1)
were under##4##2##(2008-10#1)(2008-9#1)(2009-6#1)(2013-8#1)
were undertaken to##5##3##(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(2008-10#1)
were undertaken##12##2##(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2013-1#1)
were undetectable in##4##3##(1990-11#2)(1992-3#1)(1995-6#1)
were undetectable##5##2##(1990-11#2)(1992-3#1)(1995-6#1)(2008-12#1)
were unexpectedly##2##2##(1996-12#1)(2008-8#1)
were uniform##2##2##(2008-10#2)
were uniformly susceptible to##2##4##(2008-10#2)
were uniformly susceptible##3##3##(2008-10#3)
were uniformly##5##2##(2008-10#5)
were unilaterally##2##2##(1990-6#1)(2009-7#1)
were unique in##2##3##(1990-4#1)(2008-11#1)
were unique to CLP##2##4##(2012-3#2)
were unique to##7##3##(1991-12#1)(2008-10#4)(2012-3#2)
were unique##11##2##(1990-4#1)(1991-12#1)(2008-10#5)(2008-11#1)(2012-3#2)(2013-8#1)
were unlikely to be##3##4##(2008-10#1)(2008-5#1)(2010-1#1)
were unrelated to##6##3##(1995-8#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-4#1)
were unremarkable##2##2##(1995-11#1)(2012-3#1)
were unresponsive##2##2##(2008-11#1)(2011-2#1)
were unstable##2##2##(2008-11#1)(2012-2#1)
were unsuccessful##3##2##(1997-8#1)(2008-10#2)
were up to 1##2##4##(2008-10#2)
were up to##7##3##(2008-10#6)(2008-11#1)
were up-regulated in##2##3##(1995-11#1)(2011-3#1)
were up-regulated##7##2##(1995-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-3#1)(2013-8#1)
were upregulated in##2##3##(2010-12#1)(2013-1#1)
were upregulated##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
were used alone##2##3##(1991-1#1)(2008-10#1)
were used and compared##2##4##(2008-10#2)
were used and##5##3##(1990-3#1)(2008-10#2)(2010-4#1)(2013-1#1)
were used as a model##3##5##(1991-5#1)(2008-10#1)(2010-8#1)
were used as a##8##4##(1991-5#1)(2008-10#5)(2008-11#1)(2010-8#1)
were used as age-matched controls##2##5##(2008-7#2)
were used as an##2##4##(1992-2#1)(2008-10#1)
were used as chemical##2##4##(2008-10#2)
were used as controls##3##4##(1990-12#1)(1995-8#1)(2008-5#1)
were used as criteria##2##4##(2008-10#1)(2008-12#1)
were used as input for##2##5##(2008-10#1)(2012-12#1)
were used as internal standards##2##5##(2008-10#2)
were used as markers##3##4##(2008-10#3)
were used as substrates##3##4##(1994-5#2)(1994-8#1)
were used as test##3##4##(1995-8#1)(2008-10#2)
were used as the basis for##2##6##(2008-10#1)(2010-3#1)
were used as the##12##4##(1991-12#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-3#1)(2012-9#1)
were used as##93##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-2#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#2)(2008-10#48)(2008-11#5)(2008-12#5)(2008-2#1)(2008-5#2)(2008-7#3)(2008-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2012-6#1)(2012-9#1)(2013-1#2)(2013-8#2)
were used at##4##3##(2008-10#3)(2008-11#1)
were used by##3##3##(1997-9#1)(2008-10#1)(2012-2#1)
were used for a##3##4##(1994-1#1)(1996-8#1)(2008-10#1)
were used for analysis##3##4##(2008-10#1)(2010-6#1)(2012-12#1)
were used for calibration##3##4##(2008-10#3)
were used for comparison##2##4##(2008-10#2)
were used for determination of##2##5##(2008-10#1)(2008-7#1)
were used for each##2##4##(2008-10#2)
were used for sequential injection chromatographic separations in our study##2##10##(2008-10#2)
were used for statistical##2##4##(1996-12#1)(2008-9#1)
were used for the determination of##4##6##(2008-10#4)
were used for the##30##4##(2008-10#24)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2011-2#1)
were used for this purpose##2##5##(2008-10#1)(2012-2#1)
were used for this study##3##5##(1993-3#1)(2008-10#1)(2008-5#1)
were used for this##6##4##(1993-3#1)(1996-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
were used for##106##3##(1993-3#1)(1994-1#1)(1996-12#3)(1996-2#1)(1996-6#1)(1996-8#1)(2008-10#65)(2008-11#6)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
were used in a##7##4##(1996-3#1)(2008-10#5)(2013-8#1)
were used in all##3##4##(2008-10#1)(2011-2#2)
were used in combination##2##4##(2008-10#1)(2008-11#1)
were used in conjunction with##4##5##(1992-9#1)(1996-2#1)(1996-9#1)(2009-12#1)
were used in order to##5##5##(2008-10#3)(2008-11#1)(2008-12#1)
were used in the##14##4##(2008-10#11)(2008-12#1)(2010-8#1)(2011-2#1)
were used in this study to##2##6##(1996-12#1)(2011-2#1)
were used in this study##10##5##(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
were used in this##11##4##(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
were used in##77##3##(1992-9#1)(1994-5#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-1#2)(2008-10#41)(2008-11#5)(2008-12#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were used to address##2##4##(2008-10#1)(2011-2#1)
were used to amplify##2##4##(2008-10#2)
were used to analyse##2##4##(2008-10#2)
were used to analyze the##6##5##(2008-10#2)(2008-8#2)(2012-2#1)(2013-1#1)
were used to analyze##8##4##(2008-10#3)(2008-12#1)(2008-8#2)(2012-2#1)(2013-1#1)
were used to assess the impact of##2##7##(2008-10#1)(2008-11#1)
were used to assess the##7##5##(2008-10#3)(2008-11#1)(2008-5#1)(2010-1#1)(2012-2#1)
were used to assess##16##4##(1990-7#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
were used to build##2##4##(2008-10#2)
were used to calculate the##2##5##(2008-10#1)(2008-7#1)
were used to calculate##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#2)
were used to characterize the##4##5##(2008-10#4)
were used to characterize##8##4##(2008-10#6)(2008-11#2)
were used to check the prediction ability of the##2##9##(2008-10#2)
were used to check the##3##5##(2008-10#2)(2008-12#1)
were used to check##5##4##(2008-10#4)(2008-12#1)
were used to classify##2##4##(1993-12#1)(1995-2#1)
were used to collect data##5##5##(2008-11#2)(2010-10#1)(2012-3#2)
were used to collect##7##4##(2008-10#1)(2008-11#3)(2010-10#1)(2012-3#2)
were used to compare the##2##5##(2008-10#1)(2011-1#1)
were used to compare##3##4##(2008-10#2)(2011-1#1)
were used to confirm##2##4##(2008-10#1)(2011-2#1)
were used to construct##4##4##(1997-2#1)(2008-10#3)
were used to create##2##4##(1995-6#1)(2010-4#1)
were used to define the##2##5##(1997-3#1)(2010-10#1)
were used to define##3##4##(1990-11#1)(1997-3#1)(2010-10#1)
were used to demonstrate the feasibility of##2##7##(2008-10#2)
were used to demonstrate the##4##5##(2008-10#3)(2008-5#1)
were used to demonstrate##5##4##(2008-10#4)(2008-5#1)
were used to derive##2##4##(2008-11#1)(2011-2#1)
were used to describe the##3##5##(1994-2#1)(2008-10#2)
were used to describe##4##4##(1993-3#1)(1994-2#1)(2008-10#2)
were used to design##4##4##(2008-10#4)
were used to detect the##2##5##(2008-10#2)
were used to detect##4##4##(2008-10#3)(2008-5#1)
were used to determine the##12##5##(1992-11#1)(1994-12#1)(2007-11#1)(2008-10#6)(2008-8#1)(2012-3#2)
were used to determine whether##3##5##(2007-12#1)(2008-10#2)
were used to determine##28##4##(1992-11#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-8#1)(2012-2#2)(2012-3#2)(2013-7#1)
were used to develop the##2##5##(2008-10#1)(2013-8#1)
were used to develop##11##4##(1993-3#1)(1995-1#1)(1996-3#1)(2008-10#4)(2008-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
were used to differentiate##2##4##(2008-5#1)(2008-7#1)
were used to drive the##2##5##(2008-8#1)(2009-8#1)
were used to elucidate##2##4##(2008-10#2)
were used to enhance##2##4##(2008-10#2)
were used to establish##2##4##(1991-1#1)(2012-2#1)
were used to estimate the##6##5##(1997-2#1)(2007-8#1)(2008-10#4)
were used to estimate##11##4##(1990-9#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-8#1)
were used to evaluate the##8##5##(1993-1#1)(2008-10#6)(2013-1#1)
were used to evaluate##11##4##(1993-1#1)(1994-3#1)(2008-10#7)(2011-2#1)(2013-1#1)
were used to examine the##4##5##(1994-11#1)(1996-12#1)(2008-10#2)
were used to examine##9##4##(1994-11#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-8#1)
were used to explore the##3##5##(2009-12#1)(2009-5#1)(2012-2#1)
were used to explore##6##4##(1997-3#1)(2008-10#2)(2009-12#1)(2009-5#1)(2012-2#1)
were used to express##2##4##(2008-11#1)(2008-9#1)
were used to fit the##2##5##(2008-10#1)(2008-9#1)
were used to fit##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
were used to follow the##2##5##(1991-12#1)(2008-10#1)
were used to further clarify the nature of##2##8##(2008-10#2)
were used to generate##4##4##(2008-10#4)
were used to identify and##2##5##(1994-8#1)(2011-2#1)
were used to identify markers linked to##2##7##(2008-10#2)
were used to identify the##6##5##(2008-10#1)(2011-2#1)(2013-1#2)(2013-8#2)
were used to identify##24##4##(1994-8#1)(2008-10#10)(2008-11#1)(2008-3#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
were used to improve the##2##5##(2008-10#1)(2008-3#1)
were used to inoculate##4##4##(2008-10#4)
were used to investigate the effects of##2##7##(2008-8#1)(2009-8#1)
were used to investigate the##12##5##(1991-5#1)(1992-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
were used to investigate##16##4##(1991-5#1)(1992-12#1)(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
were used to make##2##4##(2008-9#1)(2010-10#1)
were used to measure the##2##5##(1990-12#1)(1994-5#1)
were used to measure##6##4##(1990-12#1)(1991-2#1)(1993-9#1)(1994-5#1)(2008-5#1)(2008-8#1)
were used to model the##3##5##(2008-10#2)(2009-7#1)
were used to monitor##3##4##(2008-10#2)(2008-7#1)
were used to obtain##4##4##(1991-11#1)(2007-11#1)(2008-10#2)
were used to predict the##2##5##(1992-4#1)(2009-6#1)
were used to predict##7##4##(1992-4#1)(2008-10#4)(2009-6#1)(2013-1#1)
were used to prepare##2##4##(2008-10#1)(2012-2#1)
were used to probe##2##4##(1991-12#1)(2008-8#1)
were used to produce the##2##5##(2008-3#1)(2011-3#1)
were used to produce##6##4##(1992-9#1)(2008-10#3)(2008-3#1)(2011-3#1)
were used to quantify##2##4##(2008-10#2)
were used to rapidly detect microbial contamination##2##7##(2012-2#2)
were used to represent##2##4##(2008-10#1)(2008-12#1)
were used to screen##2##4##(2008-8#1)(2008-9#1)
were used to secure the##2##5##(2008-10#1)(2013-1#1)
were used to separate##2##4##(2008-10#2)
were used to show that##2##5##(1994-9#1)(2008-11#1)
were used to show##3##4##(1994-9#1)(2008-10#1)(2008-11#1)
were used to study the effect of##3##7##(1992-3#1)(2008-7#1)(2008-8#1)
were used to study the relationship between##2##7##(2008-10#2)
were used to study the##14##5##(1992-3#1)(1993-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)
were used to study##20##4##(1990-9#1)(1992-3#1)(1993-8#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#2)
were used to test the##3##5##(2008-10#2)(2008-11#1)
were used to test##7##4##(2008-10#4)(2008-11#1)(2011-2#1)(2011-3#1)
were used to validate the##5##5##(2008-10#5)
were used to##369##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#3)(1997-3#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#185)(2008-11#19)(2008-12#6)(2008-3#5)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#13)(2008-9#8)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#13)(2011-3#2)(2012-12#1)(2012-2#9)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#4)
were used together##2##3##(2008-10#1)(2008-3#1)
were used with##5##3##(1990-2#1)(2008-1#2)(2008-10#2)
were used##757##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#4)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#6)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#8)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#2)(1997-9#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#5)(2008-10#386)(2008-11#39)(2008-12#22)(2008-2#1)(2008-3#8)(2008-5#13)(2008-6#6)(2008-7#16)(2008-8#16)(2008-9#14)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#5)(2010-1#1)(2010-10#4)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#26)(2011-3#4)(2012-12#5)(2012-2#14)(2012-3#10)(2012-6#1)(2012-9#1)(2013-1#24)(2013-7#1)(2013-8#9)
were useful for##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
were useful in##2##3##(2008-7#1)(2011-2#1)
were useful to##2##3##(1996-1#1)(2008-10#1)
were useful##8##2##(1992-2#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-7#1)(2011-2#2)
were using an##2##3##(2013-1#2)
were using##10##2##(2008-10#1)(2008-11#4)(2008-9#1)(2013-1#4)
were usually##2##2##(1996-6#1)(2008-8#1)
were utilised to##3##3##(2008-10#3)
were utilized as##2##3##(1993-3#1)(1996-5#1)
were utilized for the##3##4##(2008-10#3)
were utilized for##6##3##(2008-10#5)(2012-2#1)
were utilized in##4##3##(1992-9#1)(1995-3#1)(1996-2#1)(2008-10#1)
were utilized to##5##3##(1995-1#1)(2008-10#2)(2011-2#1)(2013-8#1)
were utilized##19##2##(1992-9#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(2008-10#10)(2011-2#1)(2012-2#1)(2013-8#1)
were vaccinated##3##2##(1995-9#1)(2008-5#1)(2010-4#1)
were validated as##2##3##(2008-10#1)(2010-8#1)
were validated by using##3##4##(2008-10#3)
were validated by##10##3##(2008-10#9)(2010-12#1)
were validated over##2##3##(2008-10#2)
were validated##18##2##(2008-10#15)(2010-12#1)(2010-7#1)(2010-8#1)
were variable##4##2##(2008-10#3)(2012-12#1)
were varied between 0##2##4##(2008-10#2)
were varied##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
were vegetatively compatible##3##3##(2008-10#3)
were vegetatively incompatible##2##3##(2008-10#2)
were vegetatively##7##2##(2008-10#7)
were verified by##4##3##(1991-5#1)(1993-8#1)(2010-12#1)(2012-4#1)
were verified##10##2##(1990-12#1)(1991-5#1)(1993-8#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-6#1)(2012-4#1)
were very low##7##3##(1995-11#1)(2008-10#4)(2012-8#1)(2013-1#1)
were very positive##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
were very similar to##3##4##(1992-3#1)(1996-12#1)(2008-10#1)
were very similar##8##3##(1992-3#1)(1996-12#1)(2008-10#5)(2008-11#1)
were very specific##2##3##(2008-10#1)(2010-8#1)
were very weakly labeled##2##4##(1993-1#2)
were very##40##2##(1990-4#1)(1992-3#1)(1993-1#2)(1994-1#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-3#1)(2008-10#18)(2008-11#4)(2008-12#2)(2010-8#1)(2011-2#2)(2012-8#1)(2013-1#1)(2013-7#1)
were viable##4##2##(1995-2#1)(2008-10#2)(2013-1#1)
were viewed as##3##3##(2008-10#1)(2008-8#1)(2009-10#1)
were viewed##4##2##(1991-2#1)(2008-10#1)(2008-8#1)(2009-10#1)
were virtually##2##2##(1990-5#1)(2008-8#1)
were virulent on##4##3##(2008-10#4)
were virulent to##2##3##(2008-10#2)
were virulent##7##2##(2008-10#6)(2008-5#1)
were visible in##2##3##(1993-12#1)(2013-8#1)
were visible##8##2##(1993-12#1)(2008-10#6)(2013-8#1)
were visualized by##6##3##(2008-10#4)(2010-3#1)(2013-1#1)
were visualized##10##2##(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2010-3#1)(2013-1#1)
were warranted##2##2##(1996-3#1)(2011-3#1)
were washed from##2##3##(2008-10#2)
were washed##6##2##(2008-10#5)(2008-8#1)
were weak##2##2##(1994-8#1)(2008-12#1)
were weaker but##2##3##(1993-6#1)(1997-2#1)
were weakly##4##2##(2008-10#4)
were weighed and##2##3##(1993-3#1)(2008-10#1)
were weighed##3##2##(1993-3#2)(2008-10#1)
were well resolved##2##3##(2008-10#2)
were well separated and##3##4##(2008-10#3)
were well separated in##2##4##(2008-10#2)
were well separated##7##3##(2008-10#7)
were well tolerated##3##3##(1997-8#1)(2008-11#1)(2010-4#1)
were well##29##2##(1996-3#1)(1997-7#1)(1997-8#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-2#1)
were widely distributed##3##3##(1997-4#1)(2008-10#2)
were widely##6##2##(1990-6#1)(1997-4#1)(2008-10#3)(2008-11#1)
were widespread##2##2##(2008-10#1)(2008-8#1)
were willing to participate in a national health campaign to screen blood pressure of dental##2##15##(2008-1#2)
were willing to participate in##3##5##(1994-12#1)(2008-1#2)
were willing to##6##3##(1992-12#1)(1994-12#1)(2008-1#2)(2008-8#1)(2013-1#1)
were willing##7##2##(1992-12#1)(1994-12#1)(2008-1#2)(2008-12#1)(2008-8#1)(2013-1#1)
were with##7##2##(1991-2#1)(1992-1#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
were withdrawn##4##2##(1996-12#1)(2008-11#2)(2008-12#1)
were within normal range##4##4##(2008-7#4)
were within normal##5##3##(2008-7#4)(2008-9#1)
were within the##7##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)
were within##25##2##(1992-1#1)(1997-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2011-1#1)(2012-3#1)
were without effect on the##2##5##(1993-6#1)(2008-10#1)
were without effect##3##3##(1993-6#1)(1994-6#1)(2008-10#1)
were without##8##2##(1993-1#1)(1993-6#1)(1994-6#1)(1995-3#1)(1996-2#1)(2008-10#3)
were women##6##2##(1994-12#1)(1996-8#1)(2009-1#1)(2010-11#1)(2010-9#1)(2011-2#1)
were worked out##5##3##(2008-10#5)
were young##2##2##(2008-10#1)(2012-3#1)
were younger##3##2##(1995-3#1)(2009-5#1)(2010-2#1)
were##23190##1##(1990-10#4)(1990-11#46)(1990-12#82)(1990-2#70)(1990-3#35)(1990-4#2)(1990-5#69)(1990-6#59)(1990-7#4)(1990-8#58)(1990-9#53)(1991-1#32)(1991-10#10)(1991-11#34)(1991-12#90)(1991-2#95)(1991-3#49)(1991-4#3)(1991-5#70)(1991-6#70)(1991-7#13)(1991-8#58)(1991-9#38)(1992-1#26)(1992-10#8)(1992-11#8)(1992-12#73)(1992-2#63)(1992-3#65)(1992-4#4)(1992-5#20)(1992-6#62)(1992-8#16)(1992-9#34)(1993-1#71)(1993-11#27)(1993-12#100)(1993-2#70)(1993-3#89)(1993-6#68)(1993-8#111)(1993-9#13)(1994-1#30)(1994-11#66)(1994-12#80)(1994-2#77)(1994-3#70)(1994-5#84)(1994-6#29)(1994-8#99)(1994-9#15)(1995-1#35)(1995-10#6)(1995-11#97)(1995-12#124)(1995-2#93)(1995-3#45)(1995-5#18)(1995-6#73)(1995-8#71)(1995-9#11)(1996-1#50)(1996-11#28)(1996-12#191)(1996-2#109)(1996-3#74)(1996-5#29)(1996-6#55)(1996-8#26)(1996-9#13)(1997-1#31)(1997-2#113)(1997-3#137)(1997-4#29)(1997-5#16)(1997-6#43)(1997-7#35)(1997-8#158)(1997-9#14)(2006-6#21)(2007-11#19)(2007-12#47)(2007-8#23)(2007-9#1)(2008-1#87)(2008-10#10224)(2008-11#1220)(2008-12#539)(2008-2#34)(2008-3#183)(2008-4#40)(2008-5#574)(2008-6#83)(2008-7#529)(2008-8#448)(2008-9#535)(2009-1#19)(2009-10#67)(2009-11#36)(2009-12#51)(2009-2#14)(2009-3#44)(2009-4#13)(2009-5#44)(2009-6#35)(2009-7#96)(2009-8#83)(2009-9#22)(2010-1#90)(2010-10#58)(2010-11#75)(2010-12#89)(2010-2#28)(2010-3#34)(2010-4#78)(2010-5#42)(2010-6#68)(2010-7#57)(2010-8#105)(2010-9#28)(2011-1#123)(2011-10#24)(2011-2#849)(2011-3#88)(2011-7#6)(2011-9#3)(2012-12#184)(2012-2#253)(2012-3#404)(2012-4#18)(2012-5#24)(2012-6#7)(2012-7#7)(2012-8#7)(2012-9#6)(2013-1#708)(2013-3#2)(2013-7#12)(2013-8#336)
weren't##2##1##(2008-11#1)(2012-3#1)
west of Iran##3##3##(2008-12#2)(2012-12#1)
west of the##2##3##(2008-10#2)
west of##10##2##(1996-11#1)(2008-10#4)(2008-12#2)(2009-6#1)(2012-12#1)(2013-8#1)
west##24##1##(1992-11#1)(1995-10#1)(1996-11#1)(1997-3#1)(2008-10#11)(2008-12#3)(2009-6#1)(2010-8#2)(2012-12#1)(2013-8#2)
western Canada##5##2##(1994-3#1)(2008-10#3)(2013-8#1)
western France##2##2##(2008-10#1)(2008-7#1)
western Germany##4##2##(2008-11#1)(2009-10#3)
western Minnesota##2##2##(2008-10#2)
western North America##10##3##(2008-10#8)(2008-2#1)(2008-8#1)
western United States##4##3##(2008-10#3)(2013-1#1)
western Washington##2##2##(2008-10#2)
western analysis##2##2##(2008-10#1)(2008-4#1)
western and central##3##3##(2008-10#3)
western blot analysis##5##3##(2008-10#4)(2008-11#1)
western blot##8##2##(2008-10#6)(2008-11#1)(2008-4#1)
western blots##3##2##(2008-4#1)(2008-5#1)(2009-9#1)
western blotting using##2##3##(1996-12#1)(2008-11#1)
western blotting##12##2##(1996-12#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-5#1)(2012-12#1)
western countries##3##2##(1990-3#1)(1992-9#1)(2008-10#1)
western flower thrips##4##3##(2008-10#3)(2009-8#1)
western immunoblot##2##2##(2008-10#2)
western immunoblotting##2##2##(2008-10#2)
western isolates##2##2##(2008-10#2)
western medical injections were##2##4##(2011-2#2)
western medical injections##5##3##(2011-2#5)
western medical##6##2##(2011-2#5)(2013-8#1)
western populations##8##2##(2008-10#7)(2008-12#1)
western redbud##2##2##(2008-10#2)
western white pine##10##3##(2008-10#10)
western world##2##2##(1997-7#1)(2008-11#1)
western yellows##4##2##(2008-10#4)
western##137##1##(1990-3#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-7#3)(2008-1#1)(2008-10#79)(2008-11#9)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#3)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#11)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
wet and dry##3##3##(2008-10#2)(2010-8#1)
wet and##4##2##(1997-5#1)(2008-10#2)(2010-8#1)
wet ashing with H(2)SO(4)##2##4##(2008-10#2)
wet ashing##7##2##(2008-10#7)
wet chemical procedures##2##3##(2008-10#2)
wet chemical##3##2##(2008-10#3)
wet conditions##3##2##(2008-10#3)
wet digestion methods##5##3##(2008-10#5)
wet digestion procedure##2##3##(2008-10#2)
wet digestion##9##2##(2008-10#9)
wet heat##2##2##(2008-10#1)(2011-2#1)
wet mass of##2##3##(2010-8#2)
wet mass##3##2##(2010-8#3)
wet period of##2##3##(2008-10#2)
wet period##9##2##(2008-10#9)
wet periods##2##2##(2008-10#2)
wet weight##2##2##(1990-2#1)(2008-10#1)
wet wt##2##2##(2008-11#2)
wet wt)##2##2##(2008-11#2)
wet##81##1##(1990-2#1)(1990-8#1)(1996-12#1)(1997-5#1)(2008-10#58)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-7#1)(2010-8#4)(2011-2#1)(2012-2#1)
wet&quot##2##1##(2011-2#2)
wet-chemical##2##1##(2009-5#1)(2010-4#1)
wet-lab##2##1##(2008-8#2)
wetness and##6##2##(2008-10#6)
wetness duration (WD)##2##3##(2008-10#2)
wetness duration and##3##3##(2008-10#3)
wetness duration at##3##3##(2008-10#3)
wetness duration on##3##3##(2008-10#3)
wetness duration##26##2##(2008-10#26)
wetness durations##5##2##(2008-10#5)
wetness for##3##2##(2008-10#3)
wetness of##2##2##(2008-10#2)
wetness periods##2##2##(2008-10#2)
wetness regimes##2##2##(2008-10#2)
wetness was required##2##3##(2008-10#2)
wetness was##8##2##(2008-10#8)
wetness were##2##2##(2008-10#2)
wetness##99##1##(2008-10#98)(2008-5#1)
wetness)##2##1##(2008-10#2)
wettability of the##2##3##(2008-10#1)(2008-5#1)
wettability##3##1##(2008-10#1)(2008-5#1)(2009-7#1)
wettable##2##1##(2008-10#2)
wetted##2##1##(2008-10#2)
wetter##2##1##(2008-10#2)
wetting and drying##4##3##(2008-10#4)
wetting film extraction system##2##4##(2008-10#2)
wetting film extraction##3##3##(2008-10#3)
wetting film##8##2##(2008-10#8)
wetting##26##1##(1990-12#1)(2008-10#20)(2008-5#1)(2009-11#1)(2010-10#1)(2012-2#2)
whale##3##1##(1994-5#2)(2012-2#1)
what a##3##2##(1991-2#2)(1993-11#1)
what are the##6##3##(1994-2#1)(1996-11#1)(1996-2#1)(2008-10#1)(2010-11#1)(2012-3#1)
what are they and##2##4##(1994-3#1)(1997-3#1)
what are we##2##3##(1991-3#1)(1992-2#1)
what are##10##2##(1991-3#1)(1992-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-2#1)(1997-3#1)(2008-10#1)(2010-11#1)(2012-3#1)
what can be done##2##4##(1997-1#1)(2008-11#1)
what can be##5##3##(1997-1#1)(2008-11#2)(2008-12#1)(2012-3#1)
what can we##2##3##(1991-3#1)(1993-2#1)
what can##9##2##(1991-3#1)(1993-2#1)(1997-1#1)(2008-11#2)(2008-12#1)(2009-6#1)(2012-12#1)(2012-3#1)
what causes##2##2##(1996-6#1)(2008-11#1)
what confidence##2##2##(1991-12#1)(2008-12#1)
what constitute##2##2##(1996-2#1)(2009-4#1)
what constitutes a good##2##4##(2010-10#1)(2012-2#1)
what constitutes a##3##3##(1992-9#1)(2010-10#1)(2012-2#1)
what constitutes an##2##3##(2010-12#1)(2013-1#1)
what constitutes##10##2##(1992-9#1)(1994-12#1)(1995-2#1)(2010-10#2)(2010-12#1)(2012-2#1)(2013-1#3)
what do##6##2##(1994-12#1)(1994-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)
what does the##2##3##(2008-11#1)(2012-3#1)
what does##7##2##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-12#1)(2012-3#1)
what each##2##2##(1996-2#1)(2011-2#1)
what employers##2##2##(1996-2#1)(2008-6#1)
what exactly is##2##3##(1997-3#1)(2009-9#1)
what exactly##3##2##(1997-3#1)(2008-5#1)(2009-9#1)
what extent is##2##3##(2009-8#1)(2011-2#1)
what extent##18##2##(1992-1#1)(1992-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
what factors##4##2##(1996-1#1)(2008-7#1)(2008-9#1)(2012-3#1)
what happened to##2##3##(2008-10#1)(2008-7#1)
what has been found in##2##5##(2008-10#1)(2008-5#1)
what has been##8##3##(1993-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
what has##10##2##(1993-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)
what have we##2##3##(2008-8#1)(2009-4#1)
what information##2##2##(1997-8#1)(2011-1#1)
what is being##2##3##(2008-11#1)(2010-1#1)
what is currently##2##3##(2008-11#1)(2008-7#1)
what is expected##2##3##(1992-12#1)(2008-8#1)
what is known about the##4##5##(1994-9#1)(2008-11#1)(2008-9#2)
what is known about##6##4##(1994-9#1)(2008-11#3)(2008-9#2)
what is known##7##3##(1994-9#1)(2008-11#3)(2008-9#2)(2010-8#1)
what is observed##2##3##(1995-12#1)(2012-3#1)
what is required to##2##4##(2008-10#1)(2008-11#1)
what is seen##2##3##(2008-11#1)(2008-12#1)
what is the##5##3##(1991-12#1)(1994-3#1)(2008-10#1)(2009-12#1)(2011-1#1)
what is to our knowledge the first##4##7##(2007-12#2)(2008-2#2)
what is to##5##3##(2007-12#2)(2008-2#2)(2012-3#1)
what is##64##2##(1991-12#1)(1992-12#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#11)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#1)
what it means to##4##4##(1996-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
what it means##5##3##(1996-12#1)(2008-11#1)(2008-5#1)(2013-1#2)
what it##13##2##(1990-11#1)(1993-12#1)(1995-1#1)(1996-12#1)(2008-11#2)(2008-5#1)(2009-10#1)(2010-5#1)(2012-3#2)(2013-1#2)
what kind of##4##3##(1994-6#1)(2008-8#1)(2010-8#1)(2012-2#1)
what makes##4##2##(1996-6#1)(2008-10#2)(2008-11#1)
what may##3##2##(1995-6#1)(2008-1#1)(2013-1#1)
what might##3##2##(1991-12#1)(2008-12#1)(2008-4#1)
what role##4##2##(1993-12#1)(1997-8#1)(2008-11#1)(2009-7#1)
what seems##2##2##(1991-3#1)(2009-5#1)
what should##3##2##(1991-3#1)(2008-11#1)(2010-12#1)
what the facility should##2##4##(1994-12#2)
what the public##2##3##(2008-10#1)(2013-1#1)
what the##18##2##(1990-2#1)(1991-2#1)(1991-3#1)(1994-12#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
what these##2##2##(2008-5#1)(2010-10#1)
what they can##2##3##(2008-12#1)(2009-9#1)
what they have##2##3##(1994-12#1)(1996-11#1)
what they wanted##2##3##(2009-5#1)(2011-2#1)
what they##19##2##(1992-11#1)(1992-12#3)(1994-12#2)(1995-1#1)(1996-11#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
what to##2##2##(1994-1#1)(1996-2#1)
what tobacco##2##2##(1990-2#1)(2009-7#1)
what was expected##2##3##(1993-3#1)(2008-8#1)
what was##8##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
what we believe to be##3##5##(2008-3#2)(2008-9#1)
what we believe##4##3##(2008-3#3)(2008-9#1)
what we do with what we know##2##7##(2010-10#2)
what we have##2##3##(2008-9#1)(2010-12#1)
what we know##3##3##(2009-5#1)(2010-10#2)
what we need to do##2##5##(2008-4#1)(2012-12#1)
what we##19##2##(1991-12#1)(1994-2#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-1#1)(2010-10#4)(2010-12#1)(2012-12#1)
what will##5##2##(1991-12#1)(1993-3#1)(2008-1#1)(2008-12#2)
what works##2##2##(2008-11#1)(2008-4#1)
what would be##4##3##(1992-6#1)(1993-12#1)(2008-7#1)(2009-7#1)
what would##5##2##(1992-6#1)(1993-12#1)(2008-6#1)(2008-7#1)(2009-7#1)
what you##3##2##(1994-2#2)(1994-3#1)
what##392##1##(1990-11#1)(1990-2#3)(1990-5#1)(1991-1#1)(1991-12#6)(1991-2#7)(1991-3#7)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1994-1#6)(1994-12#9)(1994-2#4)(1994-3#6)(1994-6#4)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#5)(1996-12#1)(1996-2#6)(1996-3#2)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#3)(2006-6#1)(2007-12#3)(2007-8#2)(2008-1#3)(2008-10#23)(2008-11#43)(2008-12#19)(2008-2#2)(2008-3#4)(2008-4#9)(2008-5#9)(2008-6#5)(2008-7#8)(2008-8#11)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#5)(2009-9#5)(2010-1#3)(2010-10#13)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#4)(2011-1#3)(2011-2#13)(2012-12#6)(2012-2#7)(2012-3#12)(2012-7#1)(2013-1#14)(2013-7#1)(2013-8#4)
what&quot##2##1##(1994-2#1)(2013-8#1)
what's##3##1##(2007-12#1)(2008-1#1)(2012-12#1)
whatever the##5##2##(1997-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
whatever##12##1##(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1995-11#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)
whatsoever##3##1##(1992-1#1)(1996-6#1)(2008-7#1)
wheals##3##1##(2010-6#3)
wheat (T##3##2##(2008-10#2)(2012-3#1)
wheat (Triticum aestivum##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
wheat (Triticum aestivum) and##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
wheat (Triticum aestivum) worldwide##2##4##(2008-10#2)
wheat (Triticum aestivum)##10##3##(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)
wheat (Triticum and Aegilops spp##2##5##(2008-10#2)
wheat (Triticum##18##2##(2008-10#12)(2008-11#2)(2008-12#2)(2008-9#1)(2012-3#1)
wheat DH##3##2##(2008-8#3)
wheat DHs##2##2##(2008-8#2)
wheat and barley##8##3##(2008-10#8)
wheat and corn##2##3##(2008-10#2)
wheat and to##2##3##(1990-3#1)(2008-10#1)
wheat and##24##2##(1990-3#1)(2008-10#21)(2008-11#1)(2008-8#1)
wheat bran and##2##3##(1993-11#1)(1997-2#1)
wheat bran##7##2##(1993-11#3)(1997-2#1)(2008-10#3)
wheat bugs##5##2##(2013-8#5)
wheat chromosome 1B##2##3##(2008-10#2)
wheat chromosome##7##2##(2008-10#6)(2008-9#1)
wheat chromosomes##2##2##(2008-8#1)(2008-9#1)
wheat crop##3##2##(2008-10#2)(2008-12#1)
wheat cropping##2##2##(2008-10#1)(2013-8#1)
wheat cultivar##6##2##(2008-10#6)
wheat cultivar-specific##3##2##(2008-10#3)
wheat cultivars and##2##3##(2008-10#2)
wheat cultivars differing in##2##4##(2008-10#1)(2008-12#1)
wheat cultivars in the##2##4##(2008-10#2)
wheat cultivars than in##2##4##(2008-10#2)
wheat cultivars were##2##3##(2008-10#2)
wheat cultivars with##2##3##(2008-10#1)(2011-10#1)
wheat cultivars##25##2##(2008-10#23)(2008-12#1)(2011-10#1)
wheat cultivation##2##2##(2008-10#2)
wheat cv##8##2##(2008-10#8)
wheat cvs##3##2##(2008-10#3)
wheat debris##2##2##(2008-10#2)
wheat differential##2##2##(2008-10#2)
wheat fields in eastern##2##4##(2008-10#2)
wheat fields in##4##3##(2008-10#3)(2013-8#1)
wheat fields##8##2##(2008-10#7)(2013-8#1)
wheat flour with##2##3##(2008-10#2)
wheat flour##12##2##(2008-10#12)
wheat for##2##2##(2008-10#2)
wheat from the##2##3##(2008-10#1)(2013-7#1)
wheat from##10##2##(2008-10#9)(2013-7#1)
wheat genotypes##14##2##(2008-10#13)(2012-3#1)
wheat germ agglutinin (WGA)##3##4##(1991-12#1)(1994-11#1)(2008-7#1)
wheat germ agglutinin##9##3##(1991-12#1)(1992-6#3)(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
wheat germ agglutinin/ovomucoid-gold complex##3##4##(2008-10#3)
wheat germ plasm##2##3##(2008-10#2)
wheat germ##18##2##(1991-12#1)(1992-6#3)(1993-8#1)(1994-11#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#2)
wheat gluten##2##2##(2008-10#1)(2008-11#1)
wheat grain##3##2##(2008-10#2)(2008-12#1)
wheat grown in a##2##4##(2008-10#2)
wheat grown in##3##3##(2008-10#3)
wheat in France##2##3##(2008-10#1)(2008-8#1)
wheat in North America##2##4##(2008-10#2)
wheat in the##3##3##(2008-10#3)
wheat in##16##2##(2008-10#12)(2008-8#3)(2013-8#1)
wheat infected##2##2##(2008-10#2)
wheat is##7##2##(2008-10#7)
wheat leaf rust severity##2##4##(2008-10#2)
wheat leaf rust##10##3##(2008-10#10)
wheat leaf##12##2##(2008-10#12)
wheat leaves##7##2##(2008-10#7)
wheat line##3##2##(2008-10#2)(2008-8#1)
wheat lines with##2##3##(2008-10#1)(2008-8#1)
wheat lines##13##2##(2008-10#12)(2008-8#1)
wheat may be##2##3##(2008-10#1)(2011-10#1)
wheat mosaic virus (SBWMV)##2##4##(2008-10#1)(2008-8#1)
wheat mosaic virus##6##3##(2008-10#2)(2008-8#4)
wheat or##3##2##(2008-10#2)(2010-1#1)
wheat particles##2##2##(2008-8#2)
wheat planting##2##2##(2008-10#2)
wheat plants were##2##3##(2008-10#2)
wheat plants##8##2##(2008-10#7)(2011-10#1)
wheat powdery mildew##5##3##(2008-10#5)
wheat production##2##2##(2008-10#2)
wheat protein fractions##2##3##(1991-12#2)
wheat protein##3##2##(1991-12#2)(2008-11#1)
wheat resistance to##2##3##(2008-10#2)
wheat roots##2##2##(2008-10#2)
wheat samples##3##2##(2008-10#3)
wheat seed##2##2##(2008-10#2)
wheat seedlings##3##2##(2008-10#3)
wheat spikes##5##2##(2008-10#5)
wheat starch##3##2##(1991-12#2)(2010-8#1)
wheat straw##2##2##(2008-10#1)(2011-1#1)
wheat streak mosaic##2##3##(2008-10#2)
wheat stubble##2##2##(2008-10#2)
wheat than##3##2##(2008-10#3)
wheat that##4##2##(2008-10#4)
wheat tissues##2##2##(2008-10#2)
wheat to##4##2##(2008-10#3)(2010-6#1)
wheat treated with##2##3##(2008-10#1)(2008-12#1)
wheat type##2##2##(2008-10#2)
wheat using##2##2##(2008-10#2)
wheat was##8##2##(2008-10#6)(2008-12#1)(2008-8#1)
wheat were##5##2##(2008-10#5)
wheat with##3##2##(2008-10#3)
wheat worldwide##4##2##(2008-10#3)(2011-10#1)
wheat yield##5##2##(2008-10#2)(2008-12#2)(2008-8#1)
wheat##574##1##(1990-3#1)(1991-12#8)(1992-12#1)(1992-6#3)(1993-11#3)(1993-8#1)(1994-11#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#457)(2008-11#8)(2008-12#14)(2008-5#3)(2008-7#2)(2008-8#30)(2008-9#8)(2009-12#3)(2010-1#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-10#6)(2012-3#5)(2013-7#1)(2013-8#9)
wheat) and##2##2##(2008-10#2)
wheat)##6##1##(2008-10#6)
wheat-cultivated##2##1##(2008-10#2)
wheat-dependent##2##1##(2010-6#2)
wheat-germ agglutinin and##2##3##(1995-11#2)
wheat-germ agglutinin##4##2##(1995-11#4)
wheat-growing region##2##2##(2008-10#2)
wheat-growing regions##4##2##(2008-10#4)
wheat-growing##6##1##(2008-10#6)
wheat-producing##2##1##(2008-10#2)
wheats##2##1##(2008-10#2)
wheelchair and wheelchair passenger##2##4##(2013-1#2)
wheelchair and##3##2##(2013-1#3)
wheelchair passenger##4##2##(2013-1#4)
wheelchair##12##1##(2009-3#1)(2013-1#11)
wheezing illness##2##2##(2008-10#1)(2010-5#1)
wheezing##9##1##(2008-1#3)(2008-10#1)(2010-2#1)(2010-5#2)(2010-6#2)
when 0##2##2##(2008-10#2)
when 1##4##2##(1990-6#1)(2008-10#3)
when 11##2##2##(2008-10#1)(2012-12#1)
when 50##2##2##(2008-10#1)(2008-11#1)
when AmB##2##2##(1997-2#2)
when C##2##2##(2008-10#1)(2011-1#1)
when DNA was##2##3##(2008-10#1)(2009-6#1)
when DNA##3##2##(2008-10#2)(2009-6#1)
when HGF was added##3##4##(2008-11#3)
when Hb &lt##2##3##(1996-12#2)
when I was##2##3##(2008-10#1)(2010-8#1)
when I##4##2##(1992-3#1)(2008-10#1)(2010-8#1)(2010-9#1)
when P##4##2##(2008-10#3)(2012-3#1)
when PCR##2##2##(2008-10#2)
when R##2##2##(2008-10#2)
when RIW credit##2##3##(1991-12#2)
when T##2##2##(2008-10#1)(2008-5#1)
when [L]/[M(+)]##2##2##(2008-10#2)
when a 0##2##3##(1997-8#1)(2008-10#1)
when a change##2##3##(2008-9#1)(2009-10#1)
when a child##2##3##(2008-10#1)(2008-11#1)
when a free##2##3##(1990-9#1)(2012-12#1)
when a general satisfaction question appears##2##6##(1993-12#2)
when a high##2##3##(2008-10#1)(2008-8#1)
when a large volume##2##4##(1995-3#1)(2008-10#1)
when a large##3##3##(1995-3#1)(2008-10#2)
when a sample##2##3##(2008-10#2)
when a##89##2##(1990-5#1)(1990-6#1)(1990-9#1)(1992-3#1)(1993-12#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#3)(2007-11#1)(2008-10#32)(2008-11#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#3)(2009-6#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#3)
when accompanied##2##2##(2008-11#1)(2011-2#1)
when actin##2##2##(1991-5#1)(2012-2#1)
when active##2##2##(2008-10#1)(2011-10#1)
when added to the##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
when added to##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)
when added##7##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-7#1)
when additional##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
when administered in##4##3##(2008-5#1)(2011-2#1)(2013-7#2)
when administered to##2##3##(1994-2#1)(2013-1#1)
when administered##13##2##(1994-2#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#1)(2013-7#2)
when adsorbed on##2##3##(2008-10#2)
when air##2##2##(2008-10#2)
when all of##2##3##(2008-4#1)(2013-8#1)
when all the##2##3##(2008-10#1)(2010-10#1)
when all##12##2##(1993-12#1)(2008-10#4)(2008-4#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#2)
when an appropriate##2##3##(2008-10#2)
when an##22##2##(1993-12#2)(1996-12#1)(1996-3#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-3#3)
when analysing##2##2##(2008-10#1)(2008-7#1)
when analyzing##5##2##(1993-3#1)(2008-10#3)(2008-4#1)
when and how to##2##4##(2008-9#1)(2009-8#1)
when and how##6##3##(1994-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)
when animals were##2##3##(1993-6#1)(1997-1#1)
when animals##3##2##(1993-6#1)(1997-1#1)(2008-11#1)
when aphids were fed on source plants containing##2##8##(2008-10#2)
when applied at##2##3##(2008-10#1)(2012-8#1)
when applied in combination with##2##5##(2008-10#2)
when applied in##4##3##(2008-10#4)
when applied to normal##2##4##(2008-11#1)(2008-5#1)
when applied to the##2##4##(2008-10#2)
when applied to##19##3##(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#2)
when applied##37##2##(1995-12#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-3#1)(2012-8#1)(2013-8#2)
when applying##2##2##(2008-10#1)(2008-5#1)
when appropriate##4##2##(1993-12#1)(1995-12#1)(2008-11#1)(2011-2#1)
when assayed in##4##3##(1990-10#1)(1995-11#1)(1995-2#2)
when assayed##6##2##(1990-10#1)(1995-11#1)(1995-2#2)(2008-10#1)(2008-11#1)
when assessed##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
when assessing the##2##3##(1996-9#1)(2008-8#1)
when assessing##6##2##(1996-9#1)(2008-1#1)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#1)
when associated##2##2##(1994-6#1)(2008-5#1)
when attempting to##5##3##(2008-4#3)(2008-7#1)(2009-1#1)
when available##2##2##(2009-7#1)(2011-1#1)
when avirulent strains##2##3##(2008-10#2)
when both##15##2##(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-10#1)(2012-7#1)
when calculated##2##2##(2008-10#1)(2008-3#1)
when calculating##3##2##(1992-12#1)(2008-10#2)
when carried out##2##3##(1990-9#1)(2008-7#1)
when cells are stimulated##2##4##(1990-12#1)(2008-4#1)
when cells were##4##3##(1995-9#1)(2008-10#2)(2008-11#1)
when cells##9##2##(1990-12#1)(1995-9#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)
when challenged with##3##3##(2008-10#2)(2012-2#1)
when challenged##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
when changing##2##2##(1993-2#1)(2008-2#1)
when children were##2##3##(2009-10#2)
when choosing##5##2##(1993-12#1)(2008-11#2)(2008-7#1)(2008-8#1)
when cloacal##2##2##(1996-12#2)
when cocultured with##2##3##(1995-2#1)(2008-7#1)
when coinoculated with##2##3##(2008-10#2)
when coinoculated##4##2##(2008-10#4)
when combined with##12##3##(1993-12#1)(1993-2#1)(1995-5#1)(1996-2#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-8#1)
when compared to a##2##4##(2008-10#2)
when compared to bare metal stents##2##6##(2008-11#1)(2008-12#1)
when compared to control##3##4##(1993-6#1)(2008-10#1)(2008-11#1)
when compared to infection with##2##5##(2008-7#2)
when compared to normal##2##4##(1992-8#1)(1993-11#1)
when compared to solvent extraction##2##5##(2008-10#2)
when compared to that of##2##5##(1997-7#1)(2008-10#1)
when compared to the control group##2##6##(2010-7#1)(2012-2#1)
when compared to the control##3##5##(2008-12#1)(2010-7#1)(2012-2#1)
when compared to the reference##2##5##(2008-10#1)(2008-12#1)
when compared to the##24##4##(1990-6#1)(1991-2#1)(1993-1#1)(1994-8#2)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-7#1)(2009-6#1)(2010-7#1)(2010-9#1)(2012-2#2)
when compared to their##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
when compared to those##4##4##(1995-12#1)(2008-10#1)(2008-7#2)
when compared to##75##3##(1990-6#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-2#1)(1997-7#2)(2008-10#20)(2008-11#15)(2008-12#4)(2008-5#2)(2008-7#5)(2009-3#1)(2009-6#3)(2009-8#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
when compared with a##5##4##(2008-10#4)(2011-2#1)
when compared with data##2##4##(2008-1#1)(2008-10#1)
when compared with other##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
when compared with patients with##2##5##(2011-2#1)(2012-3#1)
when compared with the control##3##5##(2008-10#2)(2010-12#1)
when compared with the standard##2##5##(2008-10#2)
when compared with the##21##4##(1990-12#1)(1991-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#10)(2008-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)
when compared with##80##3##(1990-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-4#1)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-3#3)(2013-1#2)(2013-8#1)
when compared##157##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#3)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#55)(2008-11#19)(2008-12#9)(2008-3#1)(2008-5#3)(2008-7#6)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
when comparing the##5##3##(1996-3#1)(2008-10#3)(2008-8#1)
when comparing##12##2##(1996-2#1)(1996-3#1)(2008-10#7)(2008-12#1)(2008-8#1)(2008-9#1)
when competition between##2##3##(2008-8#1)(2009-10#1)
when competition was##2##3##(2008-8#2)
when competition##5##2##(2008-8#4)(2009-10#1)
when complexed##2##2##(1994-3#1)(2008-10#1)
when concentrated H(2)SO(4)##2##3##(2008-10#2)
when concentration of##2##3##(2008-11#1)(2011-2#1)
when concentration##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
when concentrations of##2##3##(2008-10#1)(2008-6#1)
when conditioned##2##2##(2008-11#2)
when conditions##2##2##(2008-10#2)
when conducting##2##2##(2008-9#1)(2009-10#1)
when confronted##2##2##(2008-10#1)(2008-7#1)
when conservative##2##2##(1991-6#1)(1997-8#1)
when considered##2##2##(2008-7#1)(2011-2#1)
when considering##4##2##(2008-8#1)(2011-2#1)(2013-8#2)
when cooperation##2##2##(2008-8#2)
when copper##2##2##(2008-5#2)
when coupled with##2##3##(2008-11#1)(2013-1#1)
when coupled##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
when crossed with##2##3##(2008-10#2)
when cultivated##3##2##(2008-11#3)
when cultured in the##2##4##(2008-11#2)
when cultured in##6##3##(2008-11#4)(2008-7#1)(2012-4#1)
when cultured with##2##3##(1993-8#1)(2008-11#1)
when cultured##9##2##(1993-8#1)(2008-11#6)(2008-7#1)(2012-4#1)
when data##2##2##(1995-12#1)(2009-11#1)
when day shifts were supported##2##5##(2010-6#2)
when dealing with##3##3##(1996-1#1)(1996-6#1)(2008-10#1)
when delivered##3##2##(1994-2#1)(1996-2#1)(1997-2#1)
when designing a##3##3##(2010-8#2)(2011-2#1)
when designing##4##2##(2008-4#1)(2010-8#2)(2011-2#1)
when determined##2##2##(2008-10#1)(2008-11#1)
when determining 0##2##3##(2008-10#2)
when determining the##3##3##(1993-12#1)(2008-11#1)(2008-12#1)
when determining##9##2##(1993-12#1)(1993-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#1)
when developed##2##2##(2008-10#2)
when developing a##2##3##(2008-10#1)(2012-2#1)
when developing##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
when different##4##2##(2008-10#4)
when disease##6##2##(2008-10#5)(2010-7#1)
when drugs##2##2##(1991-2#1)(1997-4#1)
when each should be##2##4##(1992-12#1)(2008-4#1)
when each##6##2##(1992-12#1)(1996-2#2)(2008-10#1)(2008-4#1)(2008-7#1)
when either##6##2##(1992-10#1)(2008-10#4)(2008-4#1)
when electrophoresis was performed##2##4##(2008-5#2)
when elevated##2##2##(2011-2#1)(2012-7#1)
when environmental##2##2##(2008-10#1)(2008-8#1)
when evaluating##3##2##(1993-2#1)(2013-1#1)(2013-8#1)
when evidence is##2##3##(1993-12#2)
when examined by##4##3##(2008-10#3)(2008-7#1)
when examined##5##2##(1994-5#1)(2008-10#3)(2008-7#1)
when excluding##2##2##(1997-3#1)(2008-10#1)
when experiments##2##2##(2008-10#2)
when exposed to##10##3##(1990-11#1)(1990-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2013-8#1)
when exposed##12##2##(1990-11#1)(1990-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2013-8#1)
when expressed as a##2##4##(2007-12#1)(2009-6#1)
when expressed as##3##3##(2007-12#2)(2009-6#1)
when expressed in##6##3##(1991-2#1)(1992-10#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-8#1)
when expressed##13##2##(1991-2#1)(1992-10#1)(1995-2#2)(1996-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)
when faced with a##3##4##(2008-10#1)(2010-8#1)(2011-2#1)
when faced with##5##3##(1994-6#1)(2008-10#1)(2010-10#1)(2010-8#1)(2011-2#1)
when facing##2##2##(2008-7#1)(2013-8#1)
when females##2##2##(2008-9#2)
when few##3##2##(2008-10#2)(2008-9#1)
when followed by##2##3##(2010-6#1)(2011-1#1)
when frequency-doubled##2##2##(2008-3#2)
when fruit##2##2##(2008-10#2)
when fused to##2##3##(1991-10#1)(2010-10#1)
when fused##3##2##(1991-10#1)(2008-10#1)(2010-10#1)
when given as a##2##4##(1991-6#1)(1992-12#1)
when given##8##2##(1991-6#1)(1992-12#2)(1994-5#1)(1997-1#1)(2008-10#2)(2012-3#1)
when grown at 33##2##4##(2008-10#2)
when grown at##3##3##(2008-10#3)
when grown in MS medium##2##5##(2008-10#2)
when grown in##7##3##(1995-2#1)(2008-10#5)(2011-1#1)
when grown on##3##3##(1991-9#1)(2008-10#2)
when grown##16##2##(1991-9#1)(1995-2#1)(2008-10#11)(2008-11#1)(2011-1#1)(2011-2#1)
when growth took place under vacuum##2##6##(2011-2#2)
when growth##3##2##(2011-2#3)
when he##6##2##(1993-11#1)(2007-12#2)(2008-12#1)(2010-8#1)(2013-1#1)
when healthy##2##2##(2008-10#1)(2008-9#1)
when high##2##2##(2008-10#1)(2008-7#1)
when immobilized on##2##3##(2008-10#1)(2008-11#1)
when immobilized##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
when implementing##2##2##(2008-11#1)(2013-1#1)
when in a##2##3##(2008-11#1)(2009-8#1)
when in the##3##3##(2009-10#1)(2009-8#1)(2013-1#1)
when in##10##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
when increasing amounts of##2##4##(1991-5#2)
when increasing##5##2##(1990-11#1)(1991-5#2)(2008-10#1)(2013-1#1)
when incubated at##3##3##(1997-1#1)(2008-6#1)(2008-9#1)
when incubated with##4##3##(1993-8#1)(1994-5#1)(1997-7#1)(2008-7#1)
when incubated##9##2##(1993-8#1)(1994-5#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)
when indicated##2##2##(1994-2#1)(2008-5#1)
when individually##2##2##(1993-12#1)(2012-3#1)
when individuals##2##2##(2008-9#2)
when infected by##2##3##(2008-10#2)
when infected with##3##3##(2008-10#2)(2011-10#1)
when infected##6##2##(2008-10#5)(2011-10#1)
when information##2##2##(2008-4#1)(2008-6#1)
when injected i##2##3##(1994-11#1)(1997-4#1)
when injected into##2##3##(1997-3#1)(2008-6#1)
when injected##8##2##(1994-11#1)(1997-3#1)(1997-4#2)(2008-10#1)(2008-6#2)(2008-8#1)
when inoculated at anthesis##2##4##(2008-10#2)
when inoculated at##3##3##(2008-10#3)
when inoculated onto##2##3##(2008-10#2)
when inoculated with a##2##4##(2008-10#1)(2008-12#1)
when inoculated with##4##3##(2008-10#3)(2008-12#1)
when inoculated##16##2##(2008-10#15)(2008-12#1)
when inserted##2##2##(1991-3#1)(1991-6#1)
when interpreting##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
when introduced##2##2##(2008-10#2)
when investigating##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
when irradiated##2##2##(2008-11#1)(2010-1#1)
when is it##2##3##(1991-12#1)(1995-3#1)
when is##3##2##(1991-12#2)(1995-3#1)
when isolated##3##2##(2007-8#1)(2008-10#2)
when it comes to##2##4##(1991-3#1)(1996-9#1)
when it comes##3##3##(1991-3#1)(1995-12#1)(1996-9#1)
when it is used##2##4##(2008-3#1)(2008-9#1)
when it is##22##3##(1990-9#1)(1991-1#1)(2008-10#6)(2008-3#3)(2008-9#3)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-2#1)
when it occurs##2##3##(2010-11#1)(2013-8#1)
when it was applied to the##3##6##(2008-10#2)(2010-4#1)
when it was assumed that the##2##6##(2008-6#2)
when it was##17##3##(1990-6#1)(1991-3#1)(1992-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-4#1)
when it##57##2##(1990-6#1)(1990-9#1)(1991-1#1)(1991-3#3)(1992-2#1)(1994-1#1)(1995-12#1)(1995-6#1)(1996-9#1)(2008-10#15)(2008-11#3)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#2)
when its##6##2##(1990-8#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
when lactofen was applied at the##2##6##(2008-10#2)
when large##2##2##(2008-10#2)
when larger##2##2##(2008-10#1)(2012-2#1)
when lasR is controlled by##2##5##(1995-2#2)
when leaves were soaked##2##4##(2008-10#2)
when leaves were##4##3##(2008-10#4)
when leaves##5##2##(2008-10#4)(2008-9#1)
when linked##2##2##(1994-2#1)(2008-10#1)
when living##2##2##(2010-10#1)(2010-9#1)
when lophophores are tightly packed and excurrents are vented through chimneys##2##11##(2008-9#2)
when maintained##3##2##(1997-1#1)(2008-10#1)(2010-8#1)
when making##6##2##(1994-1#2)(1997-3#1)(2008-11#2)(2008-8#1)
when male##2##2##(2008-8#1)(2008-9#1)
when mean##2##2##(2008-10#1)(2008-7#1)
when measured##2##2##(1991-12#1)(2008-10#1)
when measuring##2##2##(2008-10#1)(2008-12#1)
when medical##2##2##(1990-11#1)(2009-4#1)
when mixed with##2##3##(1994-8#1)(2011-3#1)
when mixed##4##2##(1994-8#1)(2008-10#2)(2011-3#1)
when more than 50 % of the population were##2##9##(2012-12#2)
when more than##3##3##(2008-5#1)(2012-12#2)
when more##7##2##(1994-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)
when moving##2##2##(2008-10#1)(2010-4#1)
when myogenic autoregulation is##2##4##(2009-1#2)
when myosin##2##2##(1991-5#2)
when necessary##3##2##(1992-9#1)(1995-10#1)(1995-12#1)
when needed##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
when neither##2##2##(2008-9#1)(2010-1#1)
when no##9##2##(2008-10#4)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
when normalized##2##2##(2008-10#1)(2008-2#1)
when obtaining##2##2##(1991-9#1)(1996-12#1)
when offspring##2##2##(2008-8#2)
when one control measure##2##4##(2008-10#2)
when one has##2##3##(1995-9#1)(2013-8#1)
when one is##2##3##(2008-3#2)
when one of the parents##2##5##(2008-5#1)(2013-1#1)
when one of the##3##4##(2008-3#1)(2008-5#1)(2013-1#1)
when one or##2##3##(2008-2#1)(2008-9#1)
when one##17##2##(1992-9#1)(1995-9#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#1)(2013-8#1)
when only a##3##3##(1995-12#1)(2008-3#1)(2009-12#1)
when only##10##2##(1990-6#1)(1992-4#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)
when open##2##2##(1991-12#1)(1994-3#1)
when other group members were##2##5##(2008-9#2)
when other##8##2##(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)
when p was 0##2##4##(2008-10#2)
when p was##3##3##(2008-10#2)(2013-1#1)
when p##5##2##(2008-10#4)(2013-1#1)
when parental##2##2##(2008-9#1)(2010-1#1)
when parents##2##2##(2008-9#1)(2010-1#1)
when participants##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
when pathogen##3##2##(2008-10#3)
when patients##3##2##(2011-2#1)(2013-8#2)
when performed by##2##3##(2009-10#2)
when performed in##2##3##(2008-10#1)(2012-2#1)
when performed##6##2##(1996-11#1)(2008-10#1)(2009-10#2)(2012-12#1)(2012-2#1)
when performing a##2##3##(1991-5#1)(1995-2#1)
when performing##4##2##(1991-5#1)(1995-2#1)(2008-11#1)(2012-12#1)
when placed##2##2##(1993-3#1)(2008-10#1)
when planning##2##2##(1995-2#1)(2013-8#1)
when plant##2##2##(2008-10#1)(2008-9#1)
when plants were##3##3##(2008-10#2)(2008-8#1)
when playing on##2##3##(1990-6#1)(2013-1#1)
when possible##3##2##(1991-2#1)(1994-5#1)(2013-1#1)
when predation is present##2##4##(2008-9#2)
when predation##3##2##(2008-8#1)(2008-9#2)
when predator##2##2##(2008-9#1)(2012-3#1)
when present at##2##3##(1993-8#1)(2008-10#1)
when present in##3##3##(1994-3#1)(2008-10#2)
when present##7##2##(1993-8#1)(1994-3#1)(2008-10#4)(2013-8#1)
when presented in##2##3##(2009-8#1)(2010-7#1)
when presented##3##2##(2009-6#1)(2009-8#1)(2010-7#1)
when produced##2##2##(2008-10#1)(2008-9#1)
when protein##2##2##(1990-12#1)(2011-2#1)
when pumped##2##2##(2008-3#2)
when rain begins at night##2##5##(2008-10#2)
when recombinant##2##2##(1991-3#1)(2011-2#1)
when repeated##2##2##(1996-3#2)
when required##2##2##(1994-5#1)(2008-10#1)
when resources are##2##3##(2008-9#1)(2009-10#1)
when reviewing##3##2##(2009-4#2)(2010-4#1)
when sampling##2##2##(2008-10#1)(2008-5#1)
when sated##4##2##(1993-6#4)
when searching for##2##3##(1990-11#1)(2008-8#1)
when searching##3##2##(1990-11#1)(1994-3#1)(2008-8#1)
when selecting##2##2##(1991-12#1)(2008-7#1)
when serum##2##2##(1992-3#1)(2008-11#1)
when several##2##2##(2008-3#1)(2008-6#1)
when severe##2##2##(2011-10#1)(2012-12#1)
when sexual##2##2##(2009-9#1)(2012-3#1)
when she##2##2##(1995-6#1)(2013-1#1)
when small amounts of##2##4##(2008-10#2)
when soil was##2##3##(2008-10#2)
when soils were##2##3##(2008-10#2)
when spatial##2##2##(2008-8#1)(2013-8#1)
when species##4##2##(2008-8#3)(2008-9#1)
when sperm are##2##3##(1994-8#1)(2008-8#1)
when spermatozoa were##2##3##(2008-8#2)
when spermatozoa##3##2##(2008-8#3)
when starting up with research##2##5##(2008-7#2)
when starting##3##2##(2008-7#2)(2011-2#1)
when stimulated with the aedeagi of##2##6##(2008-8#2)
when stimulated with##4##3##(1991-2#1)(2008-8#3)
when stored at##3##3##(2008-10#3)
when strains##2##2##(2008-10#1)(2011-1#1)
when students##2##2##(2008-11#2)
when studying the##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
when studying##5##2##(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-3#1)
when subjected to##4##3##(2008-11#3)(2008-9#1)
when subjects##3##2##(2008-11#3)
when submitted to##2##3##(2008-10#1)(2008-5#1)
when such##2##2##(2008-11#1)(2008-4#1)
when supplemented with##2##3##(2008-10#1)(2011-1#1)
when surgical##3##2##(1997-3#1)(2011-2#1)(2012-2#1)
when targeted against##2##3##(2008-10#2)
when targeted##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
when temperatures##2##2##(2008-10#1)(2008-11#1)
when tested against##2##3##(2011-2#2)
when tested by##3##3##(1994-5#1)(1995-12#1)(2008-6#1)
when tested with##3##3##(1990-12#1)(2008-10#2)
when tested##15##2##(1990-12#1)(1994-5#1)(1995-12#1)(1996-5#3)(2008-10#4)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#2)
when the age of##2##4##(2008-10#1)(2013-8#1)
when the air temperature##2##4##(2008-10#1)(2008-6#1)
when the animals##3##3##(1990-5#1)(1992-12#1)(2013-8#1)
when the appropriate##2##3##(2007-12#1)(2008-11#1)
when the bacteria were applied##2##5##(2008-10#2)
when the calibration##2##3##(1995-9#1)(2008-10#1)
when the cell density was##2##5##(2008-11#2)
when the cell density##3##4##(2008-11#3)
when the cell growth##2##4##(2008-11#2)
when the cell##8##3##(2008-11#7)(2008-8#1)
when the cells are##2##4##(1991-5#1)(1992-6#1)
when the cells were enriched with##2##6##(2008-11#2)
when the cells were##5##4##(1994-3#1)(1995-8#1)(2008-11#3)
when the cells##8##3##(1991-5#2)(1992-6#1)(1994-3#1)(1995-8#1)(2008-11#3)
when the child##3##3##(1990-12#1)(2010-6#1)(2013-1#1)
when the concentration of IAA##2##5##(2008-9#2)
when the concentration of##5##4##(1994-8#1)(2008-10#2)(2008-9#2)
when the concentration ratio##2##4##(2008-10#2)
when the concentration##8##3##(1994-8#1)(2008-10#5)(2008-9#2)
when the culture##2##3##(2008-10#1)(2008-11#1)
when the data are##2##4##(1995-12#1)(2013-8#1)
when the data##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
when the diagnosis is made##2##5##(2008-7#1)(2013-1#1)
when the diagnosis is##3##4##(2008-7#1)(2012-2#1)(2013-1#1)
when the diagnosis##4##3##(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
when the difference of female fecundity is##2##7##(2008-9#2)
when the dose##2##3##(1991-2#1)(2007-11#1)
when the drug##2##3##(1992-3#1)(1994-5#1)
when the epithelium##2##3##(1995-8#1)(2009-10#1)
when the flow rate##3##4##(2008-10#3)
when the frequency##2##3##(2008-10#2)
when the infant##2##3##(1991-11#2)
when the initial##2##3##(2008-10#1)(2008-8#1)
when the interval##2##3##(2008-10#1)(2008-5#1)
when the knee is extended##2##5##(1997-8#2)
when the knee is flexed##2##5##(1997-8#2)
when the knee is##4##4##(1997-8#4)
when the knee was extended and##2##6##(1997-8#2)
when the knee was extended##3##5##(1997-8#3)
when the knee was flexed##3##5##(1997-8#3)
when the knee was##6##4##(1997-8#6)
when the knee##10##3##(1997-8#10)
when the latter##2##3##(2008-10#1)(2010-2#1)
when the main vector species is##4##6##(2008-10#4)
when the median##2##3##(2008-10#2)
when the membranes were##2##4##(1993-8#1)(2008-10#1)
when the number of##4##4##(1992-9#1)(2008-10#1)(2008-11#1)(2008-9#1)
when the pH of##2##4##(2008-10#1)(2008-11#1)
when the pH##3##3##(2008-10#2)(2008-11#1)
when the particle##2##3##(2008-10#2)
when the patient suffered##2##4##(1993-2#1)(2008-12#1)
when the patient was##3##4##(1991-11#1)(2009-11#1)(2011-2#1)
when the patient##8##3##(1991-11#1)(1992-3#1)(1993-2#1)(2008-12#1)(2009-11#1)(2011-2#2)(2011-3#1)
when the patients##3##3##(1993-1#1)(1993-11#1)(1995-2#1)
when the probability##2##3##(2008-3#1)(2012-3#1)
when the protein##2##3##(1990-12#1)(1993-12#1)
when the ratio of##2##4##(2008-10#2)
when the same##2##3##(2008-10#1)(2009-11#1)
when the sample##3##3##(2008-10#2)(2011-2#1)
when the samples were##2##4##(2008-5#1)(2010-6#1)
when the separation##2##3##(2008-10#1)(2008-2#1)
when the target##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
when the threshold##3##3##(2008-9#1)(2009-8#1)(2013-8#1)
when the two##6##3##(1991-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)
when the value of##2##4##(1996-3#1)(2008-8#1)
when the volume of##4##4##(1992-12#1)(1997-8#1)(2008-10#2)
when the water content##2##4##(2008-10#2)
when the##473##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#5)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#3)(1991-8#1)(1992-10#1)(1992-12#4)(1992-3#5)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#5)(1994-11#1)(1994-12#1)(1994-3#5)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#3)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-5#6)(1997-7#1)(1997-8#12)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#141)(2008-11#44)(2008-12#3)(2008-2#5)(2008-3#24)(2008-4#2)(2008-5#7)(2008-6#6)(2008-7#9)(2008-8#17)(2008-9#22)(2009-10#3)(2009-11#3)(2009-5#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#5)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#10)
when their UPDRS-III##2##3##(2008-7#2)
when their concentration is##3##4##(2008-10#2)(2008-11#1)
when their##15##2##(1990-2#1)(1995-3#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
when there are##8##3##(1996-3#1)(2008-10#1)(2008-4#1)(2008-9#2)(2011-2#2)(2012-3#1)
when there is a##7##4##(1991-1#1)(1993-8#1)(2008-10#2)(2008-3#2)(2013-1#1)
when there is no##2##4##(2008-10#1)(2008-9#1)
when there is##14##3##(1991-1#1)(1993-8#1)(2008-10#5)(2008-3#2)(2008-9#2)(2009-4#1)(2012-3#1)(2013-1#1)
when there was##2##3##(2008-10#2)
when there##25##2##(1991-1#1)(1993-8#1)(1996-3#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#4)(2009-4#1)(2011-2#2)(2012-3#2)(2013-1#1)
when these two##2##3##(1991-12#1)(1992-11#1)
when these##18##2##(1991-12#1)(1992-11#1)(1993-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)
when they are##11##3##(1990-12#1)(1995-2#1)(1996-3#1)(1997-2#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
when they were##12##3##(1991-3#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-6#1)
when they##45##2##(1990-12#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-5#2)(1997-6#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#6)(2009-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#2)
when this##12##2##(1990-10#1)(1992-6#1)(1993-12#1)(1993-8#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-11#1)
when those##3##2##(1992-2#1)(2008-11#1)(2008-8#1)
when to##8##2##(1992-9#1)(1993-12#1)(1995-3#1)(1996-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
when topically applied##2##3##(2008-5#2)
when transfected into##2##3##(1991-6#1)(2008-9#1)
when transfected##3##2##(1991-6#1)(1996-2#1)(2008-9#1)
when transitioning from##2##3##(2008-10#1)(2009-8#1)
when transitioning##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
when transplanted##2##2##(2008-11#1)(2011-2#1)
when treated with##3##3##(1994-11#1)(2008-11#1)(2012-2#1)
when treated##5##2##(1994-11#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-2#1)
when treating##4##2##(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
when treatment##2##2##(1996-3#1)(2011-10#1)
when trees were##2##3##(2008-10#2)
when trees##3##2##(2008-10#3)
when trying to##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)
when two##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
when used alone##5##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#1)
when used as##9##3##(2008-10#4)(2008-11#2)(2009-12#2)(2012-3#1)
when used in a##2##4##(2008-10#2)
when used in combination##2##4##(1992-1#1)(2008-10#1)
when used in##12##3##(1992-1#1)(2008-10#4)(2008-11#4)(2008-5#1)(2009-8#1)(2012-12#1)
when used to##5##3##(1991-12#1)(1996-12#1)(2008-10#3)
when used with##3##3##(1991-2#1)(1997-1#1)(2010-7#1)
when used##38##2##(1991-12#1)(1991-2#1)(1992-1#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-5#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-3#1)
when using a##2##3##(2008-10#2)
when using the##11##3##(1996-3#1)(2008-10#7)(2008-12#2)(2010-7#1)
when using this##3##3##(1992-2#1)(2008-10#1)(2008-12#1)
when using##40##2##(1990-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-6#1)(1996-3#1)(2008-10#21)(2008-11#4)(2008-12#4)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
when viewed##2##2##(2008-10#2)
when visiting##2##2##(1992-12#1)(2008-11#1)
when visual##2##2##(2007-9#1)(2010-9#1)
when water##2##2##(1993-2#1)(2008-10#1)
when we used##2##3##(2008-2#2)
when we##9##2##(1993-2#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2010-12#1)(2013-7#1)
when weather supported mild epidemics##3##5##(2008-10#3)
when weather supported severe epidemics##4##5##(2008-10#4)
when weather supported##7##3##(2008-10#7)
when words##2##2##(1996-2#1)(2010-7#1)
when working with##2##3##(2008-10#1)(2008-11#1)
when working##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
when##2645##1##(1990-10#2)(1990-11#5)(1990-12#9)(1990-2#6)(1990-3#1)(1990-5#5)(1990-6#7)(1990-8#2)(1990-9#7)(1991-1#2)(1991-10#2)(1991-11#6)(1991-12#17)(1991-2#11)(1991-3#15)(1991-5#9)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#5)(1992-11#1)(1992-12#11)(1992-2#6)(1992-3#13)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#2)(1992-9#7)(1993-1#7)(1993-11#6)(1993-12#28)(1993-2#12)(1993-3#7)(1993-6#11)(1993-8#16)(1993-9#2)(1994-1#6)(1994-11#6)(1994-12#4)(1994-2#7)(1994-3#16)(1994-5#16)(1994-6#4)(1994-8#10)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#7)(1995-12#15)(1995-2#21)(1995-3#4)(1995-5#4)(1995-6#14)(1995-8#6)(1995-9#6)(1996-1#3)(1996-11#7)(1996-12#18)(1996-2#19)(1996-3#13)(1996-5#7)(1996-6#3)(1996-8#1)(1996-9#4)(1997-1#8)(1997-2#14)(1997-3#7)(1997-4#6)(1997-5#8)(1997-6#2)(1997-7#11)(1997-8#21)(2006-6#2)(2007-11#2)(2007-12#8)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#829)(2008-11#216)(2008-12#44)(2008-2#13)(2008-3#71)(2008-4#24)(2008-5#54)(2008-6#25)(2008-7#68)(2008-8#109)(2008-9#109)(2009-1#4)(2009-10#22)(2009-11#6)(2009-12#3)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#13)(2009-7#9)(2009-8#23)(2009-9#6)(2010-1#14)(2010-10#11)(2010-11#11)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#14)(2010-5#5)(2010-6#9)(2010-7#10)(2010-8#12)(2010-9#5)(2011-1#12)(2011-10#8)(2011-2#78)(2011-3#5)(2011-7#1)(2012-12#13)(2012-2#37)(2012-3#30)(2012-4#2)(2012-7#3)(2012-8#1)(2013-1#52)(2013-7#4)(2013-8#46)
whenever a##3##2##(1993-11#1)(2008-10#2)
whenever the##2##2##(2008-10#1)(2008-8#1)
whenever##18##1##(1993-11#2)(1995-6#1)(1996-8#1)(1997-8#1)(2008-10#7)(2008-8#2)(2008-9#2)(2011-2#1)(2013-8#1)
whenthe##3##1##(2008-11#3)
where 0 = not at all appropriate/useful and 10 = very appropriate/useful)##2##12##(2013-1#2)
where A##4##2##(1997-8#2)(2008-10#2)
where Cr(III) is##2##3##(2008-10#2)
where I(0) and I(100) represent the detected##2##7##(2008-10#2)
where L##2##2##(2008-10#2)
where N##2##2##(2008-3#1)(2008-8#1)
where P##2##2##(2008-10#2)
where Phytophthora##2##2##(2008-10#2)
where a more##2##3##(1992-3#1)(2009-10#1)
where a##28##2##(1992-3#1)(1994-3#1)(1997-2#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-7#1)(2013-1#2)
where all##2##2##(1992-1#1)(2008-9#1)
where an##7##2##(1991-5#1)(1994-12#1)(2008-10#2)(2009-9#1)(2011-2#1)(2013-1#1)
where and##2##2##(1994-3#1)(2008-10#1)
where antibiotics are##2##3##(1992-6#2)
where appropriate##5##2##(1991-6#1)(1995-2#1)(2008-10#2)(2008-9#1)
where are we##4##3##(1990-6#1)(2008-10#1)(2013-1#2)
where are##5##2##(1990-6#1)(1995-12#1)(2008-10#1)(2013-1#2)
where as##4##2##(2008-10#1)(2010-5#1)(2012-2#1)(2013-1#1)
where both##10##2##(1996-1#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-9#2)(2012-3#1)
where cell##4##2##(2008-11#3)(2008-5#1)
where cells are##2##3##(2008-11#2)
where cells##3##2##(2008-11#2)(2008-7#1)
where different##2##2##(2008-10#1)(2008-8#1)
where disease pressure was##3##4##(2008-10#3)
where do##2##2##(2008-8#1)(2013-1#1)
where epidemics occur##2##3##(2008-10#2)
where extensive##3##2##(1994-12#1)(1994-8#1)(2008-7#1)
where females##2##2##(2008-8#2)
where growth was##2##3##(2008-8#2)
where growth##3##2##(2008-10#1)(2008-8#2)
where he##2##2##(2008-10#1)(2010-1#1)
where high##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
where host##2##2##(2008-10#1)(2008-8#1)
where in the##2##3##(1993-3#1)(2008-10#1)
where in##5##2##(1993-3#1)(2008-10#2)(2008-12#1)(2011-2#1)
where increasing##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
where infected##2##2##(2008-10#2)
where is the##2##3##(1994-12#1)(1996-2#1)
where it can##3##3##(2008-10#2)(2008-7#1)
where it has been##2##4##(2008-10#1)(2008-11#1)
where it is##15##3##(1990-5#1)(1992-7#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-6#1)(2010-11#1)(2013-1#1)(2013-8#1)
where it mediates##2##3##(1997-2#1)(2012-2#1)
where it was##7##3##(1994-8#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)
where it##46##2##(1990-5#1)(1992-7#1)(1993-12#1)(1994-8#2)(1995-2#2)(1995-3#1)(1997-2#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
where its##3##2##(2008-10#2)(2011-2#1)
where lambda is the##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
where m##3##2##(2008-10#3)
where many##2##2##(1995-5#1)(2008-10#1)
where medical##2##2##(1994-12#1)(1997-8#1)
where more##2##2##(1990-6#1)(2011-2#1)
where most##3##2##(1997-6#1)(2008-12#1)(2009-7#1)
where mostly##2##2##(1996-12#2)
where multiple##2##2##(2008-10#1)(2012-12#1)
where neither##2##2##(2008-10#1)(2012-2#1)
where next?##2##2##(1997-2#1)(2008-1#1)
where no##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
where one##5##2##(1992-3#1)(2008-10#1)(2008-8#1)(2011-2#2)
where only the##4##3##(1994-5#1)(2008-10#2)(2008-12#1)
where only##12##2##(1990-5#1)(1994-5#1)(2008-10#6)(2008-12#2)(2008-8#2)
where other##3##2##(1991-12#1)(1996-3#1)(2008-10#1)
where participants##2##2##(2008-11#2)
where people##3##2##(1991-3#1)(1996-5#1)(2011-2#1)
where possible##5##2##(1992-12#1)(1992-9#1)(2008-10#2)(2011-2#1)
where reduction of##2##3##(1992-9#1)(2008-10#1)
where research##2##2##(2013-1#1)(2013-8#1)
where selected##2##2##(1991-9#1)(2008-10#1)
where she##2##2##(1997-3#1)(2011-2#1)
where simple##2##2##(1993-3#1)(2008-8#1)
where small##2##2##(2008-4#1)(2010-7#1)
where soil##2##2##(2008-10#1)(2008-12#1)
where some##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
where strain 70T01##2##3##(2008-10#2)
where students##4##2##(1997-3#1)(2008-11#2)(2008-12#1)
where substantial##2##2##(1993-12#1)(2008-10#1)
where such##2##2##(1993-12#1)(2012-12#1)
where temperature##2##2##(2008-10#2)
where the analyte##3##3##(2008-10#2)(2008-7#1)
where the analytes are##2##4##(2008-10#2)
where the analytical signal##2##4##(2008-10#2)
where the coating##2##3##(2008-3#2)
where the corresponding FTIR##2##4##(2008-10#2)
where the corresponding##3##3##(2008-10#3)
where the data##2##3##(1994-2#1)(2013-8#1)
where the disease is##2##4##(1995-3#1)(2008-10#1)
where the disease was first##2##5##(2008-10#2)
where the disease was##3##4##(1993-1#1)(2008-10#2)
where the disease##6##3##(1993-1#1)(1995-3#1)(2008-10#4)
where the electrode##4##3##(2008-10#4)
where the first##2##3##(2008-10#2)
where the flux averaged##2##4##(2008-5#2)
where the fungus##2##3##(2008-10#2)
where the major##2##3##(1997-7#1)(2009-10#1)
where the maximum##2##3##(2008-10#2)
where the mean time to co-invasion##2##6##(2008-8#2)
where the palm##2##3##(2008-10#2)
where the presence of##2##4##(1993-8#1)(2008-10#1)
where the protein##2##3##(1995-6#1)(2010-10#1)
where the sexual state##2##4##(2008-10#2)
where the sorption##2##3##(2008-10#2)
where the##201##2##(1990-12#2)(1990-5#1)(1990-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-12#3)(1995-3#3)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#82)(2008-11#11)(2008-12#1)(2008-3#9)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#4)(2009-10#4)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
where their##2##2##(1995-2#1)(2008-10#1)
where there are##3##3##(1997-5#1)(2008-10#1)(2008-9#1)
where there is a##3##4##(2008-6#1)(2008-8#1)(2010-2#1)
where there is no##3##4##(2008-1#1)(2008-10#1)(2008-6#1)
where there is##10##3##(1996-5#1)(2008-1#1)(2008-10#1)(2008-6#3)(2008-8#3)(2010-2#1)
where there was##5##3##(1991-12#1)(2008-10#4)
where there##22##2##(1991-12#1)(1996-5#1)(1997-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#1)(2010-2#1)(2011-2#1)
where these##5##2##(2008-10#1)(2008-11#2)(2008-4#1)(2012-3#1)
where they are introduced than##2##5##(2008-8#2)
where they are##10##3##(1995-6#1)(1996-1#1)(2008-10#1)(2008-4#2)(2008-8#3)(2009-12#1)(2011-2#1)
where they can##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
where they may##2##3##(1994-1#1)(2008-10#1)
where they were##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
where they##31##2##(1994-1#1)(1995-2#1)(1995-6#1)(1996-1#2)(1997-1#1)(2008-1#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#2)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
where this is##2##3##(2011-2#2)
where this##12##2##(1991-12#1)(1991-6#1)(2008-10#4)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
where three##2##2##(2008-10#1)(2008-5#1)
where time##2##2##(2008-11#1)(2008-9#1)
where two##6##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#1)
where we are going##2##4##(2009-5#1)(2013-1#1)
where we are##3##3##(2009-5#1)(2013-1#2)
where we can##2##3##(1991-12#1)(2009-10#1)
where we##6##2##(1991-12#1)(1997-2#1)(2009-10#1)(2009-5#1)(2013-1#2)
where weather##2##2##(2008-10#2)
where you##2##2##(1996-1#2)
where##956##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-5#8)(1990-6#4)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#8)(1991-2#1)(1991-3#2)(1991-5#4)(1991-6#3)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#8)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#5)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#7)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#6)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#3)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#8)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#6)(2007-12#3)(2007-8#1)(2008-1#7)(2008-10#317)(2008-11#63)(2008-12#20)(2008-2#2)(2008-3#19)(2008-4#15)(2008-5#20)(2008-6#8)(2008-7#19)(2008-8#58)(2008-9#21)(2009-10#9)(2009-12#4)(2009-3#1)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#4)(2009-9#3)(2010-1#5)(2010-10#6)(2010-11#5)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#2)(2011-2#33)(2011-9#2)(2012-12#6)(2012-2#14)(2012-3#10)(2012-5#1)(2013-1#30)(2013-7#1)(2013-8#13)
whereas 11##2##2##(2008-11#1)(2010-3#1)
whereas 16##2##2##(1991-8#1)(2013-8#1)
whereas Cr(VI)##2##2##(2008-10#2)
whereas MICs##2##2##(2008-5#1)(2008-7#1)
whereas P##3##2##(2008-10#3)
whereas Rufous-breasted Hermit##2##3##(2008-9#2)
whereas S##2##2##(2008-10#2)
whereas a significant association##2##4##(1990-8#1)(1992-2#1)
whereas a significant##3##3##(1990-8#1)(1992-2#1)(1995-8#1)
whereas a##25##2##(1990-8#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-8#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
whereas all##8##2##(1991-6#1)(2008-10#5)(2008-3#1)(2012-3#1)
whereas an increase##2##3##(1990-12#1)(2008-10#1)
whereas an##5##2##(1990-12#1)(2008-10#3)(2008-5#1)
whereas both##5##2##(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
whereas chasmogamous cultivars##2##3##(2008-10#2)
whereas complex pathotypes##2##3##(2008-10#2)
whereas female##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
whereas five##3##2##(2008-10#3)
whereas for the##2##3##(2008-10#2)
whereas for##10##2##(1995-5#1)(2008-10#7)(2008-5#1)(2010-6#1)
whereas genes##2##2##(2008-10#1)(2012-3#1)
whereas high##3##2##(2008-10#3)
whereas higher##2##2##(2009-6#1)(2011-2#1)
whereas human##2##2##(1992-2#1)(1997-7#1)
whereas in the second##2##4##(2008-10#1)(2010-7#1)
whereas in the##9##3##(1990-2#1)(1991-10#1)(2008-10#4)(2008-6#1)(2010-7#1)(2013-1#1)
whereas in##38##2##(1990-2#1)(1990-9#1)(1991-10#1)(1992-9#1)(1996-5#1)(1997-2#1)(2008-10#17)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
whereas isolates from##3##3##(2008-10#3)
whereas isolates in##2##3##(2008-10#2)
whereas isolates of##3##3##(2008-10#3)
whereas isolates##9##2##(2008-10#9)
whereas it had##2##3##(1993-12#1)(1996-2#1)
whereas it inhibited##2##3##(1994-11#1)(2008-11#1)
whereas it is##6##3##(1990-6#1)(2008-10#3)(2008-7#1)(2011-2#1)
whereas it was##6##3##(1993-11#1)(1994-12#1)(2008-10#3)(2008-11#1)
whereas it##27##2##(1990-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#8)(2008-11#4)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
whereas its##2##2##(1990-12#1)(2013-1#1)
whereas less##2##2##(2006-6#1)(2008-4#1)
whereas lower##3##2##(2008-11#1)(2009-10#1)(2012-2#1)
whereas men##2##2##(2010-6#1)(2013-8#1)
whereas more##2##2##(2008-6#1)(2008-9#1)
whereas most of the##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
whereas most##4##2##(1990-5#1)(2008-10#2)(2008-5#1)
whereas neither##2##2##(1994-6#1)(1997-7#1)
whereas no significant##3##3##(1991-6#1)(2008-5#2)
whereas no transmission##2##3##(2008-10#2)
whereas no##19##2##(1990-2#2)(1991-6#2)(1993-6#2)(1994-2#1)(1996-6#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-11#1)
whereas only a##5##3##(2008-10#2)(2008-12#1)(2010-4#1)(2010-6#1)
whereas only##14##2##(1995-11#1)(2008-10#8)(2008-12#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)
whereas other##6##2##(1990-8#1)(1996-2#1)(2008-10#3)(2012-3#1)
whereas others##9##2##(2008-10#5)(2008-4#1)(2008-9#1)(2011-1#1)(2012-3#1)
whereas plasma##3##2##(2008-12#1)(2008-7#2)
whereas some##2##2##(2008-10#1)(2010-2#1)
whereas that of##4##3##(1990-3#1)(1997-2#1)(2008-10#2)
whereas that##6##2##(1990-3#1)(1997-2#2)(2008-10#3)
whereas the A##2##3##(1993-11#1)(2011-2#1)
whereas the PM of##2##4##(2008-7#2)
whereas the control group##2##4##(2008-12#1)(2013-1#1)
whereas the corresponding##4##3##(1990-9#1)(1992-12#1)(2008-10#1)(2008-3#1)
whereas the effect of##2##4##(2008-10#1)(2008-8#1)
whereas the exponential##2##3##(2008-10#2)
whereas the level of tryptophan##2##5##(2009-8#2)
whereas the opposite##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
whereas the other two##2##4##(2008-10#2)
whereas the other##14##3##(1990-2#1)(1992-6#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2013-8#1)
whereas the pair##2##3##(2008-10#1)(2008-12#1)
whereas the patients##2##3##(1990-2#1)(1993-8#1)
whereas the performance of the##2##5##(1993-3#1)(2010-7#1)
whereas the remaining##2##3##(1993-1#1)(2008-10#1)
whereas the same##4##3##(1990-11#1)(1994-8#1)(1995-12#1)(2010-10#1)
whereas the second##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
whereas the third##2##3##(2008-10#1)(2009-7#1)
whereas the virus##2##3##(2008-10#2)
whereas the##213##2##(1990-11#2)(1990-2#4)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-5#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#3)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#77)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#7)(2009-12#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#12)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#2)
whereas their##2##2##(1991-5#1)(2008-9#1)
whereas there was no##2##4##(1991-8#1)(1992-12#1)
whereas there was##5##3##(1991-8#1)(1992-12#1)(1996-12#1)(2008-10#2)
whereas there were##2##3##(1994-9#1)(1995-5#1)
whereas there##8##2##(1991-8#1)(1992-12#1)(1994-9#1)(1995-5#1)(1996-12#1)(2008-10#2)(2013-7#1)
whereas they##4##2##(1994-11#1)(1995-3#1)(1997-7#1)(2008-10#1)
whereas this##5##2##(1990-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2013-7#1)
whereas those collected##2##3##(2008-10#1)(2008-3#1)
whereas those in##2##3##(2008-10#2)
whereas those infected by##2##4##(2008-10#2)
whereas those of##3##3##(2008-10#2)(2008-5#1)
whereas those with##3##3##(1991-2#1)(1994-12#1)(2008-3#1)
whereas those##18##2##(1991-2#1)(1994-12#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#2)(2010-4#1)
whereas total##2##2##(2008-10#2)
whereas two##3##2##(1993-3#1)(2008-10#1)(2008-8#1)
whereas weight##2##2##(1993-2#1)(2008-7#1)
whereas when##3##2##(1992-10#1)(2008-11#1)(2008-3#1)
whereas with##4##2##(1990-9#1)(1993-8#1)(1995-11#1)(2008-3#1)
whereas##894##1##(1990-11#2)(1990-12#3)(1990-2#9)(1990-3#2)(1990-5#7)(1990-6#3)(1990-8#7)(1990-9#5)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#5)(1991-6#5)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-6#3)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#8)(1993-6#5)(1993-8#6)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#11)(1994-9#1)(1995-11#5)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#4)(1996-12#6)(1996-2#12)(1996-5#4)(1996-6#4)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#6)(1997-8#6)(2006-6#3)(2007-11#2)(2007-12#2)(2008-10#344)(2008-11#49)(2008-12#12)(2008-2#2)(2008-3#14)(2008-4#6)(2008-5#21)(2008-6#4)(2008-7#28)(2008-8#22)(2008-9#19)(2009-10#3)(2009-11#2)(2009-12#2)(2009-6#2)(2009-7#1)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#4)(2011-1#2)(2011-10#1)(2011-2#31)(2011-3#1)(2012-12#1)(2012-2#11)(2012-3#18)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#14)(2013-7#2)(2013-8#10)
whereby a well-defined cathodic##2##4##(2008-10#2)
whereby a##3##2##(2008-10#3)
whereby the##7##2##(1991-2#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)
whereby they##2##2##(1994-3#1)(2008-12#1)
whereby##37##1##(1990-8#1)(1991-2#1)(1994-2#1)(1994-3#1)(1995-2#3)(1995-5#1)(1996-1#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#3)(2013-1#1)(2013-8#1)
wherein the##6##2##(1993-9#1)(1996-5#1)(2008-11#1)(2009-9#1)(2010-8#1)(2012-3#1)
wherein##13##1##(1993-9#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
whereupon##2##1##(2008-10#2)
wherever##4##1##(1997-1#1)(2008-10#2)(2013-1#1)
whether OCT##2##2##(2011-2#1)(2013-1#1)
whether a clade constitutes##2##4##(2008-8#2)
whether a##32##2##(1991-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-6#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-12#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
whether an##5##2##(1996-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
whether and how##5##3##(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#2)
whether and##7##2##(1997-3#1)(2006-6#1)(2008-10#1)(2008-11#2)(2011-2#2)
whether any##3##2##(1992-12#1)(1995-11#1)(2008-11#1)
whether cells##2##2##(1996-2#1)(2008-4#1)
whether children##2##2##(2008-12#1)(2012-2#1)
whether clinical##2##2##(2011-2#1)(2012-3#1)
whether deficits in communication skills##2##5##(2012-2#2)
whether differences##2##2##(2008-10#1)(2011-2#1)
whether different##3##2##(2010-2#1)(2011-2#1)(2012-3#1)
whether expressed per mg protein or per total kidney cortex##2##10##(1994-8#2)
whether expressed##3##2##(1994-8#2)(2009-8#1)
whether human##2##2##(1997-1#1)(2009-12#1)
whether in##2##2##(2008-12#1)(2011-2#1)
whether increased##2##2##(1992-2#1)(2012-3#1)
whether it is a##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
whether it is possible to##2##5##(2008-10#1)(2008-11#1)
whether it is##17##3##(1995-12#1)(1995-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
whether it was##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2013-7#1)
whether it##28##2##(1990-5#1)(1994-6#1)(1995-12#1)(1995-9#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-5#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
whether or not a##2##4##(2008-11#2)
whether or not the##6##4##(1994-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-8#1)
whether or not##25##3##(1990-11#1)(1991-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-7#2)(2008-9#3)(2009-10#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)
whether patients with##2##3##(2008-7#2)
whether patients##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
whether patients' perception of early##2##5##(2013-1#2)
whether similar##4##2##(2008-10#3)(2008-8#1)
whether single##2##2##(1996-12#1)(2010-6#1)
whether skin##2##2##(2008-11#1)(2013-1#1)
whether social##3##2##(2009-10#1)(2009-12#1)(2012-3#1)
whether such##7##2##(1997-4#1)(2008-10#1)(2008-2#1)(2008-8#2)(2009-8#1)(2013-1#1)
whether the adjective described##2##4##(2008-11#2)
whether the adjective##3##3##(2008-11#3)
whether the effects##2##3##(2008-10#1)(2009-11#1)
whether the instrument##2##3##(2008-3#1)(2010-10#1)
whether the use of##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
whether the##133##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#19)(2008-11#14)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#8)(2008-9#3)(2009-10#3)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
whether their##2##2##(1993-1#1)(2010-3#1)
whether there are differences##2##4##(2009-3#1)(2010-7#1)
whether there are##6##3##(1996-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-2#1)
whether there is a##5##4##(1995-2#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
whether there is##7##3##(1992-12#1)(1995-2#1)(2008-11#2)(2010-10#1)(2011-2#1)(2013-1#1)
whether there was##5##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
whether there##23##2##(1992-12#1)(1995-12#1)(1995-2#2)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#2)(2009-3#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
whether these effects are##2##4##(2009-11#1)(2012-2#1)
whether these##15##2##(1993-12#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-8#1)
whether they are##5##3##(1994-9#1)(1996-2#1)(2009-4#1)(2011-2#1)(2012-2#1)
whether they were##5##3##(1995-1#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
whether they##24##2##(1990-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-2#2)(1997-1#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#2)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
whether this is a##2##4##(2008-5#1)(2008-7#1)
whether this is##5##3##(1994-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
whether this new##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
whether this##29##2##(1990-5#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
whether those##2##2##(2012-2#1)(2013-1#1)
whether to apply or##2##4##(2008-10#2)
whether to apply##3##3##(2008-10#3)
whether to leave the##2##4##(2008-8#1)(2008-9#1)
whether to use##2##3##(2008-12#1)(2012-2#1)
whether to##18##2##(1990-2#1)(1991-1#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#2)(2008-9#2)(2010-12#1)(2012-2#1)(2013-1#1)
whether transcription##2##2##(1993-2#1)(2010-10#1)
whether treatment##2##2##(1990-11#1)(2011-1#1)
whether we##2##2##(1996-12#1)(2008-11#1)
whether##696##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#7)(1990-6#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#6)(1993-6#4)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#4)(1994-6#3)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#6)(1996-2#9)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#7)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#2)(2006-6#2)(2007-12#1)(2008-1#4)(2008-10#78)(2008-11#68)(2008-12#21)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#19)(2008-6#8)(2008-7#22)(2008-8#40)(2008-9#27)(2009-1#3)(2009-10#8)(2009-11#6)(2009-12#8)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#40)(2011-3#1)(2012-12#1)(2012-2#19)(2012-3#22)(2012-5#2)(2012-7#1)(2013-1#32)(2013-7#3)(2013-8#12)
whey components##3##2##(2008-10#3)
whey protein isolate##2##3##(2013-1#2)
whey protein##4##2##(2008-10#1)(2010-4#1)(2013-1#2)
whey##20##1##(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#4)(2010-4#1)(2013-1#2)
whiH##2##1##(2008-8#2)
which &quot##2##2##(2008-1#1)(2013-8#1)
which 1##2##2##(1997-1#1)(2011-3#1)
which 13##2##2##(2008-7#1)(2011-2#1)
which 26##2##2##(1995-12#1)(2008-8#1)
which 4##3##2##(2008-10#1)(2008-9#2)
which A##2##2##(2008-10#1)(2012-3#1)
which Buffon##2##2##(2008-12#2)
which DNA is##2##3##(2008-10#2)
which DNA##5##2##(2008-10#5)
which Gd(3+) has the greatest enhancement##2##6##(2008-10#2)
which I##4##2##(1995-2#1)(2008-11#1)(2008-9#1)(2013-8#1)
which Medicare##2##2##(1997-3#1)(2012-3#1)
which P##2##2##(2008-10#2)
which S##2##2##(2008-10#1)(2012-7#1)
which T cells##2##3##(1995-2#1)(2008-8#1)
which T##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
which UV##2##2##(2008-10#1)(2011-2#1)
which Wolbachia##2##2##(2008-8#1)(2008-9#1)
which a subject##3##3##(2008-11#1)(2010-8#1)(2012-3#1)
which a##83##2##(1990-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#17)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#1)(2009-6#1)(2010-10#2)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
which account for##2##3##(2011-2#2)
which accounted for##6##3##(2008-10#5)(2010-5#1)
which accounts for##4##3##(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
which act as##3##3##(1994-5#1)(2008-11#1)(2008-5#1)
which act##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
which activate##4##2##(1992-8#1)(1994-11#1)(2008-10#1)(2008-11#1)
which activates##2##2##(2008-9#2)
which actively##2##2##(2008-12#1)(2013-1#1)
which acts as a##4##4##(1992-4#1)(2008-11#1)(2008-2#1)(2008-3#1)
which acts as an##2##4##(2008-4#1)(2013-1#1)
which acts as the##2##4##(1994-5#1)(2008-10#1)
which acts as##8##3##(1992-4#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
which acts##11##2##(1992-4#1)(1994-5#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
which affect the##5##3##(1993-9#1)(2008-10#2)(2008-8#1)(2010-8#1)
which affect##9##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-8#1)
which affected##2##2##(1995-11#1)(2010-8#1)
which affects##6##2##(1997-8#1)(2008-10#3)(2013-8#2)
which aim##2##2##(2008-10#1)(2011-2#1)
which aimed to##3##3##(2012-3#3)
which aimed##4##2##(2008-10#1)(2012-3#3)
which aims to##2##3##(2008-11#1)(2009-12#1)
which aims##3##2##(2008-11#1)(2009-12#1)(2010-1#1)
which all the##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
which all were##2##3##(2008-11#1)(2010-1#1)
which all##21##2##(1990-9#1)(1991-1#1)(1991-2#1)(1993-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-8#2)(2010-1#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)
which allow the##4##3##(1993-6#1)(2008-10#2)(2008-4#1)
which allow##10##2##(1993-6#1)(1996-6#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)
which allowed the determination of##3##5##(2008-10#3)
which allowed the##9##3##(1993-1#1)(2008-10#6)(2008-11#1)(2009-7#1)
which allowed##19##2##(1993-1#1)(1993-6#1)(2008-10#14)(2008-11#1)(2008-7#1)(2009-7#1)
which allows a##2##3##(1997-6#1)(2008-10#1)
which allows for##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
which allows one to##2##4##(2007-12#1)(2008-10#1)
which allows the##12##3##(1992-9#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-12#1)(2010-7#1)
which allows to##2##3##(2007-8#1)(2012-3#1)
which allows us to##2##4##(1990-2#1)(2012-3#1)
which allows##41##2##(1990-2#1)(1992-9#1)(1995-9#1)(1996-1#1)(1997-6#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
which alone##2##2##(1997-1#1)(2009-6#1)
which already##2##2##(1991-9#1)(1996-3#1)
which also includes##2##3##(1993-9#1)(2008-10#1)
which also provides a##2##4##(1997-1#1)(2008-10#1)
which also##40##2##(1990-7#1)(1991-1#1)(1991-12#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
which alters##2##2##(1995-8#1)(2008-7#1)
which an intense##2##3##(2008-10#2)
which an##20##2##(1990-8#1)(1991-12#1)(1991-2#1)(1993-12#1)(1996-11#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#2)(2011-8#1)(2013-1#1)
which antibody##2##2##(1993-8#1)(1995-2#1)
which apothecia##2##2##(2008-10#2)
which apparently##2##2##(1997-8#1)(2013-1#1)
which appear to be##4##4##(1995-12#1)(2008-10#1)(2008-9#1)(2009-8#1)
which appear to##8##3##(1994-5#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)
which appear##10##2##(1994-5#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
which appeared in##2##3##(1992-2#1)(1994-8#1)
which appeared to be##4##4##(2008-10#1)(2008-11#2)(2008-5#1)
which appeared to##10##3##(1990-5#1)(1990-6#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-5#1)
which appeared##15##2##(1990-5#1)(1990-6#1)(1992-2#1)(1992-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2010-8#1)
which appears in##2##3##(2008-9#1)(2010-5#1)
which appears to be##4##4##(1990-9#1)(1991-4#1)(1994-11#1)(2008-7#1)
which appears to##5##3##(1990-9#1)(1991-4#1)(1994-11#1)(2008-7#1)(2012-2#1)
which appears##9##2##(1990-9#1)(1991-4#1)(1994-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
which are able to##2##4##(2008-10#1)(2010-7#1)
which are acceptable##2##3##(1994-3#1)(2012-2#1)
which are also##2##3##(1991-5#1)(2011-3#1)
which are associated with the##2##5##(1995-5#1)(2008-10#1)
which are associated with##6##4##(1995-5#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#1)
which are attached##2##3##(2008-10#1)(2009-1#1)
which are based on##6##4##(1992-9#1)(1994-9#1)(1995-9#1)(2008-10#3)
which are both##2##3##(2008-10#1)(2011-2#1)
which are characteristic for a given molecule (fluorophore)##2##8##(2008-1#1)(2008-4#1)
which are characteristic for##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
which are characteristic##4##3##(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#1)
which are characterized##2##3##(2008-8#2)
which are commonly used##2##4##(1995-12#1)(2008-10#1)
which are commonly##5##3##(1995-12#1)(2008-10#3)(2011-2#1)
which are considered##2##3##(2008-10#1)(2013-8#1)
which are consistent with##3##4##(2008-10#1)(2008-8#1)(2009-12#1)
which are critical for##2##4##(1993-8#1)(2008-11#1)
which are currently being##2##4##(2008-11#1)(2008-12#1)
which are currently##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
which are differentially expressed##2##4##(1992-6#1)(2008-10#1)
which are endemic in##2##4##(2007-12#1)(2012-12#1)
which are essential to##2##4##(1995-5#1)(2008-11#1)
which are essential##4##3##(1995-5#1)(2008-11#1)(2012-2#1)(2013-1#1)
which are expressed##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
which are extremely##2##3##(1995-5#1)(2008-10#1)
which are features of##2##4##(2008-10#1)(2012-2#1)
which are formed##3##3##(1996-5#1)(2008-10#2)
which are generally associated##2##4##(1997-1#1)(2010-12#1)
which are generally##7##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
which are highly##5##3##(2008-10#3)(2008-7#1)(2010-12#1)
which are important for the##2##5##(1997-4#1)(2008-10#1)
which are important for##4##4##(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
which are important##7##3##(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-2#1)
which are in##8##3##(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-3#1)(2013-7#1)
which are involved in##4##4##(1995-6#1)(2008-10#2)(2008-11#1)
which are known to be##4##5##(2008-1#1)(2008-11#3)
which are known to interfere with other previously suggested sensors##2##10##(2008-10#2)
which are known to interfere with##3##6##(2008-10#3)
which are known to interfere##4##5##(2008-10#4)
which are known to##15##4##(1995-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-7#1)(2008-9#1)(2009-2#1)(2013-1#1)
which are likely to##2##4##(2009-7#1)(2013-8#1)
which are linked to##2##4##(2008-5#1)(2010-10#1)
which are located##2##3##(1994-12#1)(2008-8#1)
which are more##5##3##(1991-3#1)(2008-10#2)(2008-8#1)(2013-1#1)
which are most##2##3##(1996-3#1)(2008-10#1)
which are not##16##3##(1990-12#1)(1991-12#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-5#1)(1995-2#1)(1995-9#1)(2008-10#4)(2008-11#2)(2008-9#1)(2011-2#1)
which are often##5##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
which are present in the##2##5##(1993-11#1)(2008-11#1)
which are present in##4##4##(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
which are produced##2##3##(2008-10#2)
which are readily##2##3##(2008-10#1)(2008-7#1)
which are related to the##2##5##(2008-10#1)(2010-4#1)
which are required for##2##4##(1997-7#1)(2008-10#1)
which are resistant to##2##4##(2008-10#2)
which are resistant##3##3##(2008-10#3)
which are responsible for the##3##5##(1991-2#1)(2008-5#1)(2011-2#1)
which are responsible for##4##4##(1991-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
which are sensitive to##2##4##(2008-8#1)(2011-2#1)
which are similar to##3##4##(1993-12#1)(2008-10#1)(2013-1#1)
which are specific to##2##4##(1992-6#1)(2008-7#1)
which are specific##3##3##(1992-6#1)(2008-7#2)
which are suitable##2##3##(2008-10#1)(2008-4#1)
which are the##9##3##(1993-8#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-5#1)(2012-2#1)
which are then##2##3##(2008-10#1)(2013-1#1)
which are thought to##3##4##(1994-2#1)(2008-12#1)(2008-7#1)
which are tightly##2##3##(2012-2#1)(2013-7#1)
which are to##2##3##(1996-8#1)(2008-11#1)
which are typical##2##3##(2008-3#1)(2008-7#1)
which are unable to##2##4##(1994-3#1)(2008-10#1)
which are used as##2##4##(2008-10#1)(2010-7#1)
which are used in##2##4##(2007-12#1)(2008-5#1)
which are used##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-7#1)(2010-8#1)
which are useful##2##3##(1996-5#1)(2008-4#1)
which are usually##3##3##(2008-10#2)(2011-2#1)
which are valuable##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
which are yet##2##3##(2008-11#1)(2009-3#1)
which are##377##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#3)(1993-8#4)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#5)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#4)(1995-6#2)(1995-9#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#2)(1996-8#4)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#5)(2008-1#5)(2008-10#90)(2008-11#42)(2008-12#4)(2008-3#2)(2008-4#6)(2008-5#14)(2008-6#4)(2008-7#15)(2008-8#15)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#13)(2011-3#2)(2012-12#1)(2012-2#10)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#5)
which arise##3##2##(1990-7#1)(1992-10#1)(2008-11#1)
which arose from##2##3##(2008-10#1)(2008-7#1)
which arrest##2##2##(2008-11#2)
which assess##2##2##(2008-10#1)(2012-3#1)
which assists##2##2##(2008-10#1)(2013-1#1)
which assumes that the##3##4##(1992-2#1)(2008-10#1)(2008-5#1)
which at least##2##3##(1997-6#1)(2008-7#1)
which at##4##2##(1997-6#1)(2008-10#2)(2008-7#1)
which bacteria##2##2##(2008-10#2)
which based on the##2##4##(2008-10#2)
which bears##2##2##(2008-11#1)(2008-9#1)
which became##3##2##(1994-2#1)(2008-10#1)(2008-4#1)
which become##2##2##(1995-6#1)(2010-5#1)
which becomes##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
which began in##2##3##(1995-12#1)(2009-7#1)
which began##3##2##(1995-12#1)(1997-8#1)(2009-7#1)
which belong to the##2##4##(2008-12#1)(2008-5#1)
which belong to##3##3##(2008-12#1)(2008-5#2)
which belongs to the##7##4##(1996-12#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-2#1)
which belongs to##8##3##(1996-12#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
which belongs##9##2##(1996-12#1)(2008-10#3)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
which bind to##3##3##(1993-6#1)(1995-6#1)(1997-7#1)
which bind##6##2##(1990-5#1)(1993-6#2)(1995-2#1)(1995-6#1)(1997-7#1)
which binds the##2##3##(1993-8#1)(2009-7#1)
which binds to##8##3##(1991-5#1)(1992-4#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(2008-2#1)
which binds##15##2##(1991-5#1)(1992-4#1)(1992-9#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-2#1)(2008-9#1)(2009-7#1)(2011-2#1)
which block##2##2##(1991-2#1)(2011-3#1)
which blocks##2##2##(1994-2#1)(1995-2#1)
which both##18##2##(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#6)(2008-3#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-2#2)
which bound to##5##3##(1990-12#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-8#1)
which builds##2##2##(1997-1#1)(2008-10#1)
which can also be##3##4##(2008-3#1)(2008-4#1)(2010-7#1)
which can also##4##3##(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)
which can be applied##5##4##(1995-5#1)(2008-10#4)
which can be detected##2##4##(1993-12#1)(2009-7#1)
which can be determined by##2##5##(1990-8#1)(2008-10#1)
which can be divided into two##2##6##(2008-11#1)(2008-8#1)
which can be easily##3##4##(2008-10#1)(2010-12#1)(2011-2#1)
which can be identified##2##4##(1993-3#1)(1993-6#1)
which can be implemented##2##4##(1993-9#1)(2008-3#1)
which can be induced by##2##5##(1997-8#1)(2008-11#1)
which can be induced##3##4##(1997-8#1)(2008-11#2)
which can be interpreted##2##4##(1995-3#1)(1996-5#1)
which can be mainly##2##4##(2008-11#1)(2012-2#1)
which can be seen in##2##5##(2008-12#1)(2008-7#1)
which can be solved##2##4##(2008-7#2)
which can be treated##2##4##(1990-12#1)(1996-11#1)
which can be used as a##2##6##(1996-3#1)(2008-10#1)
which can be used for the##3##6##(2008-10#3)
which can be used for##9##5##(1994-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#1)
which can be used to##7##5##(1990-12#1)(1991-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
which can be used##22##4##(1990-12#1)(1991-1#1)(1991-3#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)
which can be##109##3##(1990-12#2)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#2)(2008-10#27)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-6#2)(2011-2#5)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#4)
which can cause##4##3##(2008-10#1)(2008-5#1)(2010-8#1)(2011-1#1)
which can convert##2##3##(1993-12#1)(2013-1#1)
which can either##2##3##(1992-6#1)(2008-11#1)
which can give##2##3##(2008-8#1)(2010-6#1)
which can have a##2##4##(2012-2#1)(2013-1#1)
which can increase##2##3##(2008-10#1)(2008-9#1)
which can influence##2##3##(2008-10#1)(2013-1#1)
which can inhibit##2##3##(2008-5#1)(2011-3#1)
which can interfere##2##3##(2008-10#2)
which can lead to##5##4##(1990-6#1)(2008-12#1)(2008-9#1)(2010-7#1)(2012-2#1)
which can measure##2##3##(1997-6#1)(2009-9#1)
which can not be reduced on the Hg electrode##2##9##(2008-10#2)
which can often##2##3##(2008-8#1)(2010-6#1)
which can play a##2##4##(2008-10#1)(2008-8#1)
which can result in##2##4##(2008-9#1)(2011-2#1)
which can serve as a##2##5##(2008-11#2)
which can##203##2##(1990-12#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#2)(2008-10#46)(2008-11#21)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#9)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#4)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#2)(2011-7#1)(2012-2#7)(2012-3#3)(2013-1#11)(2013-8#1)
which cannot be##8##3##(1991-5#1)(2008-10#3)(2008-11#2)(2009-12#1)(2013-7#1)
which cannot##10##2##(1991-5#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-12#1)(2013-7#1)
which capabilities##2##2##(2008-11#1)(2011-2#1)
which carried the##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
which carried##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)
which carries##4##2##(1995-8#1)(1996-12#1)(2008-10#2)
which catalyzes the conversion of##2##5##(2008-10#1)(2008-11#1)
which catalyzes the reversible##2##4##(1990-11#1)(1993-8#1)
which catalyzes the##6##3##(1990-11#1)(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
which catalyzes##8##2##(1990-11#1)(1992-3#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
which cause the##2##3##(1996-12#1)(2008-10#1)
which cause##10##2##(1996-12#1)(1997-6#1)(2008-10#3)(2008-9#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#1)
which caused symptoms##2##3##(2008-10#2)
which caused##7##2##(1992-2#1)(1994-3#1)(2008-10#5)
which causes a##2##3##(2008-10#2)
which causes severe##2##3##(2008-10#1)(2010-11#1)
which causes the##3##3##(1993-3#1)(2008-10#1)(2009-8#1)
which causes##23##2##(1993-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#10)(2008-6#1)(2009-7#3)(2009-8#1)(2010-11#1)(2011-2#1)
which cell proliferation##2##3##(1991-2#1)(2008-7#1)
which cell##4##2##(1991-2#1)(2008-11#2)(2008-7#1)
which cells##2##2##(2006-6#1)(2010-10#1)
which characterize##2##2##(2008-10#1)(2011-2#1)
which children##2##2##(2009-9#1)(2010-9#1)
which clearly showed##2##3##(1995-2#1)(2008-10#1)
which clearly##7##2##(1991-5#1)(1995-2#1)(2008-10#2)(2010-1#1)(2011-3#1)(2012-3#1)
which clinical##2##2##(1992-2#1)(2008-4#1)
which closely##2##2##(2008-9#1)(2010-1#1)
which clustered##2##2##(1993-2#1)(2008-10#1)
which code##2##2##(1990-5#1)(1996-8#1)
which coded for##2##3##(1990-5#2)
which codes for the##5##4##(1991-9#1)(1993-12#1)(2008-10#2)(2008-7#1)
which coincided with the##2##4##(1993-8#1)(2008-5#1)
which coincided with##5##3##(1993-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
which coincides with the##3##4##(1995-8#1)(2008-10#2)
which combined the##3##3##(2008-10#2)(2008-8#1)
which combines an##2##3##(2008-10#2)
which combines the##2##3##(2008-10#1)(2012-2#1)
which combines##8##2##(1993-2#1)(2008-10#4)(2010-6#1)(2012-2#1)(2013-1#1)
which commonly##3##2##(2008-10#2)(2011-2#1)
which compared##3##2##(2008-7#1)(2012-12#2)
which compares favourably with##2##4##(1991-9#1)(2008-7#1)
which compares##6##2##(1991-9#1)(2008-10#4)(2008-7#1)
which competition##2##2##(2008-8#1)(2009-10#1)
which component of the##2##4##(1995-5#1)(2008-10#1)
which comprises##3##2##(2008-11#1)(2011-2#2)
which condition##3##2##(2008-10#2)(2011-1#1)
which conditions##3##2##(2008-10#3)
which confer##3##2##(2008-5#1)(2009-10#1)(2013-1#1)
which conferred##2##2##(2008-10#1)(2008-11#1)
which confirmed##3##2##(1995-11#1)(2008-8#1)(2010-5#1)
which confirms the##2##3##(1991-6#1)(1992-5#1)
which consider the##3##3##(1992-3#1)(2008-11#1)(2008-12#1)
which considers the##2##3##(1990-12#1)(2008-4#1)
which considers##3##2##(1990-12#1)(2008-4#1)(2008-7#1)
which consist of##2##3##(1992-1#1)(1992-3#1)
which consisted of the##2##4##(2008-10#1)(2008-11#1)
which consisted of##11##3##(1990-2#1)(1991-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
which consisted##12##2##(1990-2#1)(1991-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
which consists in determining the##2##5##(2008-2#2)
which consists of a##2##4##(2008-3#1)(2012-2#1)
which consists of the##3##4##(1995-6#1)(1997-8#1)(2008-7#1)
which consists of two##2##4##(1994-5#1)(2008-11#1)
which consists of##17##3##(1994-5#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
which consists##19##2##(1994-5#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
which constitute the##2##3##(2008-10#2)
which constitute##5##2##(1995-2#1)(2008-10#3)(2008-11#1)
which constitutes the##3##3##(1990-11#1)(2008-10#1)(2009-8#1)
which constitutes##6##2##(1990-11#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)(2011-2#1)
which contain DOM##2##3##(2008-10#2)
which contain leader region of##2##5##(2008-9#2)
which contain the##2##3##(1991-9#1)(2012-2#1)
which contain##18##2##(1991-9#1)(1994-11#1)(1994-9#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)
which contained a##2##3##(2008-10#2)
which contained an##2##3##(1995-2#1)(2008-10#1)
which contained the##2##3##(2008-10#1)(2008-11#1)
which contained##21##2##(1992-6#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-7#2)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
which contains a##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
which contains the##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2010-5#1)
which contains##27##2##(1991-5#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-9#1)(2008-10#5)(2008-11#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
which continuously##2##2##(2008-11#2)
which contrasts with##2##3##(1990-5#1)(2008-8#1)
which contrasts##4##2##(1990-5#1)(2008-10#1)(2008-8#2)
which contribute to##2##3##(2008-7#1)(2013-8#1)
which contribute##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
which contributed to##2##3##(1995-3#1)(2008-11#1)
which contributes to##2##3##(2008-10#1)(2012-2#1)
which control##4##2##(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#1)
which controls##6##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#1)
which converts##2##2##(1992-8#1)(1997-1#1)
which correlate##2##2##(2010-12#1)(2013-8#1)
which correlated with##3##3##(1993-8#1)(1996-12#1)(2008-10#1)
which correlated##5##2##(1993-8#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-7#1)
which correlates with the##2##4##(1997-9#1)(2007-12#1)
which correlates##3##2##(1997-1#1)(1997-9#1)(2007-12#1)
which correspond to the##4##4##(1996-3#1)(1997-2#1)(2008-10#1)(2010-8#1)
which correspond to##11##3##(1994-8#1)(1995-9#3)(1996-2#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-8#1)(2010-8#1)
which correspond with##2##3##(2008-10#1)(2012-3#1)
which correspond##14##2##(1994-8#1)(1995-9#3)(1996-2#1)(1996-3#1)(1997-2#2)(2008-10#3)(2008-8#1)(2010-8#1)(2012-3#1)
which corresponded to the##2##4##(1990-5#1)(2008-11#1)
which corresponded to##5##3##(1990-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
which corresponds to a##5##4##(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#1)
which corresponds to an##2##4##(2008-2#1)(2011-2#1)
which corresponds to the##6##4##(1990-8#1)(1994-11#1)(1994-5#1)(1997-1#1)(2008-10#2)
which corresponds to##18##3##(1990-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2010-7#1)(2011-2#1)
which could affect the##2##4##(2008-10#2)
which could also be##2##4##(2008-10#1)(2010-5#1)
which could be a##3##4##(1990-11#1)(2008-12#1)(2012-3#1)
which could be detected##3##4##(1993-9#1)(2008-10#1)(2008-8#1)
which could be used to##2##5##(2008-10#2)
which could be used##3##4##(1990-2#1)(2008-10#2)
which could be##44##3##(1990-11#1)(1990-2#1)(1991-3#1)(1993-8#2)(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2012-5#1)
which could easily##2##3##(2010-1#1)(2012-3#1)
which could explain##3##3##(1996-5#1)(2008-10#1)(2011-10#1)
which could indicate##2##3##(2008-10#1)(2013-8#1)
which could involve##2##3##(2008-11#1)(2013-7#1)
which could lead to##3##4##(2011-2#2)(2013-1#1)
which could mediate##2##3##(1997-7#1)(2007-11#1)
which could not be explained##2##5##(1990-8#1)(2012-2#1)
which could not be##5##4##(1990-8#1)(1995-6#1)(2008-10#1)(2010-8#1)(2012-2#1)
which could not##7##3##(1990-8#1)(1993-2#1)(1995-6#1)(1997-3#1)(2008-10#1)(2010-8#1)(2012-2#1)
which could potentially##2##3##(1990-5#1)(2008-10#1)
which could##102##2##(1990-11#3)(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#28)(2008-11#7)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#5)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-10#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#6)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
which couples##2##2##(1993-8#1)(2013-8#1)
which cover##3##2##(1994-12#1)(1995-9#1)(2011-2#1)
which covered##3##2##(1997-2#2)(2008-9#1)
which covers the##4##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
which covers##5##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#2)
which created##2##2##(2008-10#1)(2011-2#1)
which current##3##2##(2008-11#1)(2008-8#2)
which damage##2##2##(2008-10#1)(2009-8#1)
which decreased##2##2##(1995-8#1)(2008-10#1)
which defeats##2##2##(2008-10#2)
which delivers##2##2##(2008-8#1)(2008-9#1)
which demonstrate that##2##3##(1995-5#1)(2010-4#1)
which demonstrate##4##2##(1995-5#1)(2008-11#1)(2010-4#1)(2012-3#1)
which demonstrated a##2##3##(2008-12#1)(2008-5#1)
which demonstrated that##2##3##(2008-5#1)(2009-8#1)
which demonstrated##6##2##(2008-12#1)(2008-5#3)(2008-7#1)(2009-8#1)
which demonstrates that##2##3##(2008-9#1)(2012-2#1)
which demonstrates the##3##3##(2008-10#3)
which demonstrates##6##2##(2008-10#3)(2008-9#1)(2012-2#1)(2013-1#1)
which depend on the##3##4##(2008-8#1)(2009-8#1)(2010-4#1)
which depend on##5##3##(2008-11#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)
which depends on the##3##4##(1994-6#1)(2008-10#1)(2011-2#1)
which depends on##4##3##(1994-6#1)(2008-10#2)(2011-2#1)
which depends##7##2##(1994-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)
which describe##2##2##(2008-10#1)(2008-6#1)
which describes the dependence##2##4##(2008-10#2)
which describes the##5##3##(2008-10#3)(2008-3#1)(2013-8#1)
which detailed##3##2##(1990-8#1)(1995-5#1)(1995-6#1)
which determine the##3##3##(1991-3#1)(2008-10#2)
which developed##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
which did not react with##2##5##(1997-7#1)(2008-5#1)
which did not##13##3##(1991-5#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2010-1#1)(2012-2#1)(2012-5#1)(2013-8#1)
which died##2##2##(1991-8#1)(1995-9#1)
which differ in the##2##4##(1992-9#1)(2008-10#1)
which differ in##4##3##(1992-9#1)(1995-2#1)(1996-2#1)(2008-10#1)
which differ##8##2##(1992-9#1)(1995-2#1)(1996-2#1)(1997-9#1)(2008-10#2)(2008-12#1)(2008-8#1)
which differed in the##2##4##(2008-10#1)(2010-4#1)
which differed in##5##3##(2008-10#2)(2008-8#1)(2010-1#1)(2010-4#1)
which differed##9##2##(2008-10#4)(2008-11#1)(2008-8#1)(2010-1#1)(2010-4#1)(2011-2#1)
which different##6##2##(1997-7#1)(2008-10#1)(2008-8#3)(2011-2#1)
which differentiate##2##2##(2008-11#1)(2008-5#1)
which differs from the##3##4##(1991-9#1)(2008-10#1)(2010-5#1)
which differs from##5##3##(1991-9#1)(2008-10#1)(2010-5#1)(2011-2#2)
which differs##6##2##(1991-9#1)(2008-10#2)(2010-5#1)(2011-2#2)
which direct##4##2##(1994-2#1)(1994-5#1)(2007-12#1)(2008-10#1)
which directly##2##2##(1994-5#1)(1996-2#1)
which disappeared##2##2##(2008-11#2)
which disease##3##2##(2008-10#2)(2008-9#1)
which dispersal##2##2##(2008-10#1)(2008-8#1)
which display##2##2##(1996-5#1)(2012-2#1)
which displays##4##2##(1990-12#1)(1992-3#1)(1994-11#1)(2011-1#1)
which distinguish##2##2##(1991-6#1)(2008-11#1)
which diverged##2##2##(2009-8#1)(2012-3#1)
which do not exhibit##3##4##(1997-6#1)(1997-8#1)(2008-10#1)
which do not##15##3##(1996-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
which do##17##2##(1996-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
which does not allow##2##4##(2008-10#2)
which does not produce##3##4##(2008-10#3)
which does not require a##2##5##(2008-10#1)(2011-2#1)
which does not require##5##4##(2008-10#3)(2008-7#1)(2011-2#1)
which does not##27##3##(1992-6#1)(1994-2#1)(1996-12#1)(2008-10#14)(2008-11#2)(2008-5#3)(2008-7#1)(2009-10#1)(2010-9#1)(2011-2#2)
which dominated##2##2##(2008-10#1)(2010-8#1)
which each##10##2##(1994-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)
which effectively##2##2##(2008-10#1)(2008-5#1)
which either##3##2##(2008-10#1)(2008-8#2)
which electrochemical##2##2##(2008-10#2)
which eliminates##2##2##(2008-11#1)(2008-4#1)
which emerged from##2##3##(2008-11#1)(2010-12#1)
which emerged##5##2##(1992-4#1)(2008-10#2)(2008-11#1)(2010-12#1)
which emphasized the##2##3##(2008-4#2)
which emphasizes##2##2##(1994-2#1)(2012-3#1)
which employs##2##2##(2008-10#1)(2008-3#1)
which enable##3##2##(1992-9#1)(1993-1#1)(2011-2#1)
which enabled##2##2##(1991-6#1)(2008-11#1)
which enables the##11##3##(1991-2#1)(2008-10#6)(2008-11#2)(2008-4#1)(2010-3#1)
which enables us to##3##4##(1996-3#1)(2009-10#1)(2013-8#1)
which enables##22##2##(1990-3#1)(1991-2#1)(1992-3#1)(1996-3#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-3#1)(2013-1#1)(2013-8#1)
which encode##10##2##(1990-11#1)(1990-8#1)(1992-4#1)(1993-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-9#2)(2009-8#1)
which encoded##4##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-9#1)
which encodes a novel##3##4##(1992-7#1)(1992-9#1)(1993-8#1)
which encodes a protein of##2##5##(1992-9#1)(1994-11#1)
which encodes a protein with##2##5##(2008-8#2)
which encodes a protein##4##4##(1992-9#1)(1994-11#1)(2008-8#2)
which encodes a small##2##4##(1993-8#1)(1996-8#1)
which encodes a##17##3##(1990-11#1)(1990-6#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-8#2)(1994-11#2)(1996-8#1)(1997-7#1)(2008-8#2)(2008-9#1)(2012-3#1)
which encodes an##2##3##(2008-10#2)
which encodes the##5##3##(1993-2#1)(1993-3#1)(1995-12#1)(1995-6#1)(2008-11#1)
which encodes##29##2##(1990-11#1)(1990-6#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)(2012-3#1)
which enhance the##2##3##(2008-10#1)(2008-4#1)
which enhance##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
which enhances the##2##3##(2008-10#1)(2008-7#1)
which enhances##7##2##(1992-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#1)
which ensures##2##2##(1991-11#1)(2008-6#1)
which environmental##2##2##(2008-11#1)(2008-7#1)
which equals##2##2##(2008-7#1)(2008-8#1)
which established##2##2##(2008-10#2)
which eventually##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
which exceeded##2##2##(2008-10#2)
which exhibit a##2##3##(1990-6#1)(2008-10#1)
which exhibit##9##2##(1990-6#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
which exhibited a##2##3##(1994-8#1)(2008-11#1)
which exhibited##8##2##(1993-8#1)(1994-8#1)(1997-2#1)(2008-10#3)(2008-11#1)(2011-2#1)
which exhibits##7##2##(2008-10#7)
which exist in##3##3##(1995-3#1)(2008-9#1)(2011-2#1)
which exists in##2##3##(1993-3#1)(2008-8#1)
which exists##4##2##(1992-4#1)(1993-3#1)(2008-10#1)(2008-8#1)
which exogenous##2##2##(2007-11#1)(2008-7#1)
which experimental##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
which explained##2##2##(2009-12#1)(2013-1#1)
which explains the##2##3##(2009-7#1)(2013-1#1)
which express##5##2##(1993-8#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-8#1)
which expressed##4##2##(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
which expresses##4##2##(1993-12#1)(1993-3#1)(1997-1#1)(2008-10#1)
which extend##2##2##(1997-1#1)(2008-10#1)
which facilitate the##2##3##(1993-6#1)(2009-8#1)
which facilitate##3##2##(1993-6#1)(2008-10#1)(2009-8#1)
which facilitated the##2##3##(2011-2#1)(2013-1#1)
which facilitated##3##2##(2009-7#1)(2011-2#1)(2013-1#1)
which facilitates##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
which factors##2##2##(1991-6#1)(2012-2#1)
which fail to##2##3##(1995-1#1)(2008-10#1)
which favors genotypes##2##3##(2008-8#2)
which favors##4##2##(2008-10#1)(2008-8#3)
which females##4##2##(2008-8#2)(2008-9#2)
which finally##2##2##(2008-10#1)(2011-2#1)
which focus on##4##3##(1990-9#1)(1996-2#1)(2008-12#1)(2010-8#1)
which focuses on##2##3##(2010-2#1)(2010-8#1)
which foods##2##2##(1994-3#1)(2008-4#1)
which form meiotic##3##3##(2008-12#3)
which form##9##2##(1990-5#1)(1993-8#1)(2008-10#2)(2008-12#3)(2010-3#1)(2013-1#1)
which formed a##2##3##(2008-10#1)(2008-8#1)
which formed##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
which forms a##4##3##(1993-9#1)(2008-10#3)
which forms the##3##3##(1992-6#1)(1997-9#1)(2008-10#1)
which forms##10##2##(1992-6#1)(1993-9#1)(1997-9#1)(2008-10#6)(2008-11#1)
which found##3##2##(1992-1#1)(1997-2#1)(2008-12#1)
which four##5##2##(1991-2#1)(1991-7#1)(1993-12#1)(2008-10#1)(2008-7#1)
which fragments##2##2##(1993-2#1)(1993-8#1)
which frequently##2##2##(1996-2#1)(2010-8#1)
which function##2##2##(1995-8#1)(2008-11#1)
which functional##2##2##(2009-10#1)(2012-2#1)
which functions as a##2##4##(1995-9#1)(2012-12#1)
which functions##3##2##(1994-5#1)(1995-9#1)(2012-12#1)
which further##5##2##(1994-3#1)(2008-10#2)(2009-11#1)(2009-8#1)
which gave rise to the##2##5##(2008-8#1)(2009-8#1)
which gave##4##2##(2008-10#2)(2008-8#1)(2009-8#1)
which gene##2##2##(2008-10#1)(2010-10#1)
which generally was found to be sustained in the 2-year survey##2##11##(2013-1#2)
which generally##3##2##(1993-3#1)(2013-1#2)
which generate##2##2##(1991-3#1)(2008-10#1)
which generated##2##2##(2008-10#1)(2008-3#1)
which generates##4##2##(1997-2#1)(1997-3#1)(1997-9#1)(2010-3#1)
which give rise to##3##4##(2007-12#1)(2009-7#1)(2009-8#1)
which give##4##2##(2007-12#1)(2008-10#1)(2009-7#1)(2009-8#1)
which gives a##2##3##(2008-10#1)(2009-5#1)
which gives rise to##2##4##(2008-11#1)(2008-3#1)
which gives the##2##3##(1996-5#1)(2008-10#1)
which gives##9##2##(1991-5#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-5#1)(2010-7#1)
which greatly increases the selectivity##3##5##(2008-10#3)
which greatly simplifies the##2##4##(2008-10#1)(2008-3#1)
which greatly##6##2##(2008-10#4)(2008-3#1)(2012-3#1)
which had a##4##3##(2008-10#2)(2013-8#2)
which had been##20##3##(1994-11#1)(1994-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-11#4)(2010-4#1)
which had little##2##3##(1991-10#1)(2008-11#1)
which had the##3##3##(2008-10#2)(2008-9#1)
which had##58##2##(1991-10#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#2)(1997-5#1)(1997-8#2)(2008-10#18)(2008-11#9)(2008-12#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#3)
which has a high##5##4##(2008-10#3)(2008-5#1)(2013-8#1)
which has a maximum absorption peak at##2##7##(2008-10#2)
which has a##20##3##(1990-2#1)(1993-8#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-8#1)
which has an absorption maximum at##3##6##(2008-10#3)
which has an##9##3##(1990-2#1)(1997-7#1)(2008-10#7)
which has as##2##3##(1994-2#1)(2008-10#1)
which has been reported##2##4##(2008-10#1)(2011-1#1)
which has been shown to be##6##6##(1991-5#1)(1992-12#1)(1994-2#1)(1994-5#1)(2007-11#1)(2011-2#1)
which has been shown to##11##5##(1991-5#1)(1992-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-11#3)(2008-7#1)(2011-2#1)
which has been shown##12##4##(1991-5#1)(1992-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-11#3)(2008-7#1)(2010-5#1)(2011-2#1)
which has been used##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
which has been##46##3##(1990-5#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-8#1)(1996-1#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#2)
which has high affinity for##2##5##(1994-8#1)(2011-2#1)
which has high##7##3##(1994-8#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
which has increased##2##3##(1994-1#1)(2008-10#1)
which has led to##3##4##(1990-11#1)(2008-10#1)(2011-2#1)
which has never been##2##4##(1991-5#1)(2012-12#1)
which has no##2##3##(2008-10#2)
which has not been previously reported##2##6##(1996-12#1)(2008-10#1)
which has not been previously##3##5##(1996-12#1)(2008-10#1)(2008-7#1)
which has not been##7##4##(1991-6#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-7#1)
which has not##9##3##(1991-6#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-7#1)
which has provided##3##3##(2008-10#1)(2009-11#1)(2012-2#1)
which has received##2##3##(2008-10#1)(2008-11#1)
which has the potential to##2##5##(1994-11#1)(2009-10#1)
which has the##9##3##(1994-11#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-6#1)
which has##168##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#58)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#4)(2009-10#3)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#4)
which have a##10##3##(1992-11#1)(1992-6#1)(1997-5#1)(2008-10#2)(2008-5#1)(2008-7#3)(2011-2#1)
which have already been##2##4##(1996-2#1)(2008-11#1)
which have been developed##2##4##(1991-12#1)(2009-12#1)
which have been proposed##2##4##(1990-8#1)(2013-8#1)
which have been reported to##2##5##(1994-12#1)(2008-10#1)
which have been reported##3##4##(1994-12#1)(1997-2#1)(2008-10#1)
which have been shown to##3##5##(2008-5#1)(2008-7#1)(2009-3#1)
which have been##39##3##(1990-8#1)(1991-12#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-6#2)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#2)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
which have high##2##3##(1994-11#1)(1995-2#1)
which have incorporated##2##3##(2008-9#2)
which have limited##3##3##(1992-2#1)(2008-8#1)(2012-2#1)
which have not been##2##4##(1993-2#1)(2008-1#1)
which have previously been##2##4##(1996-3#1)(2008-8#1)
which have the##3##3##(1990-2#1)(1996-1#1)(2011-2#1)
which have to be##3##4##(1994-1#1)(2008-11#1)(2012-3#1)
which have##124##2##(1990-11#3)(1990-2#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#11)(2008-12#2)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-7#1)(2011-10#1)(2011-2#5)(2012-2#2)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
which he had##2##3##(1996-2#1)(2008-11#1)
which he##7##2##(1994-3#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-6#1)(2010-1#1)
which health##3##2##(1997-2#1)(1997-3#1)(2008-11#1)
which help##2##2##(2008-10#1)(2008-9#1)
which helps to reduce the##2##5##(2008-10#1)(2008-3#1)
which helps to##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
which helps##6##2##(1997-2#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-12#1)
which highly##2##2##(2008-11#1)(2009-10#1)
which home##2##2##(1995-3#1)(2008-11#1)
which however##2##2##(2008-8#1)(2013-8#1)
which identified##2##2##(2008-11#1)(2011-1#1)
which ignore##2##2##(1995-12#1)(2009-7#1)
which illustrate##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
which imaging##2##2##(2011-2#2)
which impeded##2##2##(2008-12#1)(2008-5#1)
which implies that##2##3##(2008-7#1)(2012-3#1)
which implies##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
which improve##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
which improved the##2##3##(2008-10#2)
which improved##3##2##(2008-10#2)(2008-11#1)
which improves##2##2##(1990-11#1)(2008-10#1)
which in the##7##3##(1992-1#1)(2008-10#4)(2008-12#1)(2010-1#1)
which in turn activates##2##4##(1995-2#1)(1995-6#1)
which in turn are##2##4##(1996-12#1)(2008-10#1)
which in turn has##2##4##(1996-6#1)(2008-11#1)
which in turn is##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)
which in turn may##2##4##(1996-12#1)(2009-8#1)
which in turn##41##3##(1990-2#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
which in##58##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-12#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-11#7)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
which include##19##2##(1991-5#1)(1992-9#1)(1994-12#1)(1995-9#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
which included a##4##3##(2008-11#1)(2009-2#1)(2012-12#1)(2013-1#1)
which included the##4##3##(1993-6#1)(2008-10#1)(2008-7#1)(2011-3#1)
which included##22##2##(1990-12#1)(1991-6#1)(1993-6#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#3)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
which includes the##9##3##(1990-8#1)(1991-9#1)(1993-12#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-12#1)(2010-8#1)
which includes##31##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-9#2)(1993-12#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
which incorporates##4##2##(1991-12#1)(1996-3#1)(2008-12#1)(2012-2#1)
which increase the##2##3##(2008-10#1)(2008-7#1)
which increase##4##2##(1994-8#1)(1995-8#1)(2008-10#1)(2008-7#1)
which increased the##5##3##(1991-3#1)(2008-10#3)(2008-6#1)
which increased with##2##3##(1991-9#1)(1996-2#1)
which increased##10##2##(1991-3#1)(1991-9#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2012-3#1)
which increases the##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
which increases with##2##3##(2008-9#1)(2013-7#1)
which increases##10##2##(1992-3#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-7#1)
which indicate that##5##3##(2008-10#3)(2008-11#2)
which indicate##6##2##(1993-3#1)(2008-10#3)(2008-11#2)
which indicated that##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
which indicated the occurrence of##2##5##(2008-11#1)(2008-3#1)
which indicated the##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
which indicated##8##2##(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#1)
which indicates a##2##3##(2008-10#2)
which indicates that the##6##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
which indicates that##18##3##(1995-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-2#2)(2013-8#1)
which indicates the##4##3##(1992-1#1)(2008-12#1)(2008-8#1)(2013-8#1)
which indicates##27##2##(1992-1#1)(1995-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-8#1)(2011-2#3)(2013-8#2)
which individuals##4##2##(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)
which induced a##2##3##(1993-8#1)(2008-10#1)
which induced##5##2##(1993-8#1)(1994-6#1)(2008-10#1)(2008-11#2)
which induces##8##2##(1992-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)
which influence the##3##3##(2008-11#1)(2008-8#1)(2013-8#1)
which influence their##2##3##(2010-9#1)(2013-8#1)
which influence##10##2##(1995-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-8#2)
which information is##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
which inhibit the##2##3##(1996-2#1)(2008-10#1)
which inhibit##6##2##(1996-2#1)(2006-6#1)(2008-10#1)(2009-12#1)(2009-8#1)(2012-2#1)
which inhibits the##4##3##(1994-11#1)(1996-2#1)(2008-10#1)(2013-1#1)
which inhibits##10##2##(1991-5#1)(1994-11#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
which integrate##2##2##(1995-5#1)(2008-11#1)
which integrates##3##2##(2009-7#1)(2011-2#1)(2012-2#1)
which interact##2##2##(1993-8#1)(1995-2#1)
which interfere with##2##3##(2008-10#1)(2008-11#1)
which interfere##4##2##(2008-10#3)(2008-11#1)
which involved##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#2)
which involves a##2##3##(1996-5#1)(2011-3#1)
which involves gamma phosphate cleavage from ATP##2##7##(2013-1#2)
which involves the##2##3##(1997-8#1)(2008-10#1)
which involves##11##2##(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2011-3#1)(2013-1#2)
which is 2##2##3##(2007-11#1)(2011-2#1)
which is 4##2##3##(2008-7#1)(2008-9#1)
which is a common##2##4##(1993-12#1)(2008-7#1)
which is a component of##3##5##(1994-2#1)(1994-8#1)(2008-11#1)
which is a component##4##4##(1994-2#1)(1994-8#1)(2008-11#1)(2013-1#1)
which is a direct##2##4##(2008-10#2)
which is a key##3##4##(1991-2#1)(2008-10#1)(2008-8#1)
which is a liquid at##2##5##(1996-1#1)(1996-2#1)
which is a major##3##4##(1992-12#1)(2007-12#1)(2011-9#1)
which is a more##3##4##(2008-10#2)(2009-5#1)
which is a potent##2##4##(2008-5#1)(2008-7#1)
which is a prerequisite for##2##5##(2008-11#1)(2008-4#1)
which is a specific##2##4##(2008-11#2)
which is a substrate for##2##5##(1992-7#2)
which is a##75##3##(1991-2#1)(1992-12#1)(1992-4#1)(1992-7#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2006-6#1)(2007-12#2)(2008-10#22)(2008-11#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#3)(2010-3#1)(2010-6#1)(2011-2#3)(2011-9#1)(2012-3#1)(2013-1#3)
which is able to##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
which is about##3##3##(2008-10#2)(2009-5#1)
which is accepted##2##3##(2008-10#1)(2008-11#1)
which is almost constant over a pH range of##2##9##(2008-10#2)
which is almost##4##3##(1995-12#1)(2008-10#3)
which is already##2##3##(1990-12#1)(2011-2#1)
which is also##10##3##(1990-5#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-6#1)
which is an autosomal##2##4##(2008-7#1)(2013-8#1)
which is an essential##2##4##(2008-11#1)(2009-6#1)
which is an extension of##2##5##(2008-3#1)(2013-8#1)
which is an important##7##4##(1995-2#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
which is an indicator##2##4##(2008-10#1)(2008-12#1)
which is an##25##3##(1995-2#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
which is applicable to many##2##5##(1994-3#1)(2008-8#1)
which is approximately##4##3##(1994-2#1)(2007-12#1)(2008-11#1)(2008-2#1)
which is associated with a##2##5##(1990-8#1)(2008-10#1)
which is associated with the##2##5##(1993-8#1)(2006-6#1)
which is associated with##6##4##(1990-8#1)(1993-8#1)(1995-12#1)(2006-6#1)(2008-10#1)(2008-11#1)
which is attributed to##3##4##(2008-8#1)(2009-6#1)(2012-2#1)
which is available to authorized users##12##6##(2010-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
which is available##14##3##(1992-3#1)(2008-10#1)(2010-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)
which is based on the##6##5##(2008-10#6)
which is based on##18##4##(2008-10#12)(2008-11#1)(2008-5#1)(2010-7#1)(2011-10#1)(2012-2#1)(2013-1#1)
which is believed to be##2##5##(1994-11#1)(1994-5#1)
which is believed to##3##4##(1994-11#1)(1994-5#1)(1996-1#1)
which is both##2##3##(1995-1#1)(2011-2#1)
which is calculated##2##3##(2008-3#1)(2008-9#1)
which is called##2##3##(2008-11#1)(2012-3#1)
which is capable of##4##4##(1990-2#1)(2007-11#1)(2008-10#1)(2008-9#1)
which is caused by the##2##5##(2008-10#1)(2013-8#1)
which is caused by##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
which is caused##5##3##(2008-10#3)(2008-8#1)(2013-8#1)
which is characterized by##5##4##(1995-8#1)(2008-10#2)(2008-5#1)(2010-6#1)
which is closely##2##3##(2008-10#1)(2008-8#1)
which is commercially##2##3##(2008-10#1)(2010-4#1)
which is commonly used##2##4##(1992-11#1)(2008-10#1)
which is commonly##5##3##(1992-11#1)(2008-10#2)(2012-3#1)(2013-8#1)
which is comparable to##2##4##(2008-10#2)
which is compatible with##3##4##(1993-8#1)(2008-9#1)(2011-2#1)
which is complete##2##3##(1990-2#1)(2008-10#1)
which is composed of##3##4##(1990-8#1)(2008-10#1)(2008-11#1)
which is conserved##3##3##(1992-6#1)(2008-10#1)(2008-8#1)
which is considered to be##4##5##(1994-11#1)(2008-11#1)(2011-2#1)(2013-8#1)
which is considered to##6##4##(1994-11#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
which is considered##9##3##(1992-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
which is consistent with a##2##5##(2008-10#1)(2008-2#1)
which is consistent with the##4##5##(2008-10#1)(2008-8#1)(2008-9#2)
which is consistent with##11##4##(2008-10#4)(2008-2#2)(2008-8#1)(2008-9#3)(2013-1#1)
which is consistent##12##3##(2008-10#4)(2008-2#2)(2008-8#1)(2008-9#3)(2011-2#1)(2013-1#1)
which is coupled##2##3##(2008-11#1)(2008-2#1)
which is critical for##5##4##(1992-12#1)(1995-6#1)(1996-2#1)(2008-10#1)(2011-2#1)
which is critical##6##3##(1992-12#1)(1995-6#1)(1996-2#1)(2008-10#1)(2009-7#1)(2011-2#1)
which is crucial for##2##4##(2008-7#1)(2009-8#1)
which is currently the##2##4##(2008-10#1)(2011-2#1)
which is currently##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
which is decreased linearly by addition of##2##7##(2008-10#2)
which is defined as the##4##5##(2008-10#2)(2008-3#1)(2008-9#1)
which is defined as##5##4##(1992-2#1)(2008-10#2)(2008-3#1)(2008-9#1)
which is defined##6##3##(1992-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-9#1)
which is dependent on##2##4##(1990-11#1)(2008-10#1)
which is dependent##3##3##(1990-11#1)(2008-10#1)(2009-10#1)
which is described in##2##4##(1997-6#1)(2013-1#1)
which is detected spectrophotometrically at##2##5##(2008-10#2)
which is detected##5##3##(2008-10#4)(2008-9#1)
which is determined##2##3##(2008-10#1)(2013-1#1)
which is different from##4##4##(1991-1#1)(1993-8#1)(2008-10#1)(2008-7#1)
which is different##5##3##(1991-1#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
which is directed##2##3##(1994-5#1)(2006-6#1)
which is directly##2##3##(2008-10#1)(2009-8#1)
which is discussed##2##3##(2009-8#1)(2010-2#1)
which is distributed##2##3##(2009-8#1)(2010-6#1)
which is due to##2##4##(2008-10#1)(2008-3#1)
which is equivalent to##2##4##(2008-10#2)
which is equivalent##3##3##(2008-10#2)(2008-11#1)
which is essential for the##2##5##(2008-11#2)
which is essential for##5##4##(2008-11#2)(2008-9#1)(2009-10#1)(2012-2#1)
which is essential##6##3##(2008-11#3)(2008-9#1)(2009-10#1)(2012-2#1)
which is expected to##2##4##(2008-10#1)(2010-6#1)
which is expressed##3##3##(1993-12#1)(1997-7#1)(2008-10#1)
which is facilitated by##2##4##(1990-2#1)(2008-11#1)
which is found in##2##4##(1990-11#1)(1993-9#1)
which is found##3##3##(1990-11#1)(1993-9#1)(2012-2#1)
which is generated##2##3##(2008-11#1)(2008-8#1)
which is higher than##2##4##(2008-10#1)(2009-4#1)
which is highly selective##2##4##(2008-10#2)
which is highly##9##3##(1995-8#1)(1997-3#1)(2008-10#5)(2008-9#2)
which is important for##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
which is in agreement with the##2##6##(2008-10#1)(2008-7#1)
which is in agreement with##3##5##(2008-10#2)(2008-7#1)
which is in contrast to the##2##6##(2008-10#1)(2008-11#1)
which is in contrast to##4##5##(2008-10#3)(2008-11#1)
which is in contrast##5##4##(2008-10#4)(2008-11#1)
which is in good agreement with##2##6##(2008-10#1)(2008-3#1)
which is in turn##2##4##(1990-8#1)(2008-10#1)
which is in##21##3##(1990-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
which is indispensable for##2##4##(1997-3#1)(2008-11#1)
which is induced by##2##4##(2008-11#1)(2011-2#1)
which is introduced##2##3##(2008-10#2)
which is involved in the##4##5##(1990-8#1)(1994-8#1)(2008-5#1)(2008-8#1)
which is involved in##8##4##(1990-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
which is known to be a##2##6##(1994-11#1)(2008-11#1)
which is known to##8##4##(1991-3#1)(1992-12#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#2)(2012-2#1)
which is largely##2##3##(2008-11#1)(2013-1#1)
which is linked to##2##4##(2008-10#1)(2008-5#1)
which is located in the##2##5##(2008-9#1)(2013-8#1)
which is located##6##3##(1995-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
which is mainly##2##3##(2008-11#1)(2009-7#1)
which is measured at##2##4##(2008-10#2)
which is measured##6##3##(2008-10#6)
which is mediated by##4##4##(1993-3#1)(1997-2#1)(2008-11#1)(2012-3#1)
which is monitored at##2##4##(2008-10#2)
which is monitored##3##3##(2008-10#3)
which is more sensitive##2##4##(1991-8#1)(1992-8#1)
which is more##8##3##(1991-2#1)(1991-8#1)(1992-8#1)(2007-12#2)(2008-10#1)(2009-8#1)(2013-1#1)
which is most##3##3##(1994-12#1)(2008-11#1)(2012-2#1)
which is much##6##3##(2008-10#3)(2008-3#1)(2011-2#1)(2012-3#1)
which is necessary for##3##4##(1997-7#1)(2008-4#1)(2010-7#1)
which is necessary##4##3##(1997-7#1)(2008-4#2)(2010-7#1)
which is normally##2##3##(1994-11#1)(2008-10#1)
which is not possible##2##4##(2008-10#1)(2011-2#1)
which is not sensitive to##2##5##(1991-6#1)(2007-11#1)
which is not##25##3##(1990-5#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-4#1)(1994-8#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#1)
which is now##6##3##(1992-1#1)(1994-5#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#1)
which is of##6##3##(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#2)
which is often##6##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
which is one of the most common##2##7##(2008-4#1)(2013-1#1)
which is one of the most##4##6##(2008-10#2)(2008-4#1)(2013-1#1)
which is one of the##10##5##(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
which is one of##11##4##(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
which is one##12##3##(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2013-1#1)
which is only##2##3##(1996-12#1)(1996-6#1)
which is part of##2##4##(1997-7#1)(2008-11#1)
which is poorly##2##3##(2008-10#1)(2010-12#1)
which is present in the##2##5##(1993-6#1)(2008-10#1)
which is present in##5##4##(1990-2#1)(1993-6#1)(2008-10#2)(2013-1#1)
which is present##6##3##(1990-2#1)(1993-6#1)(2008-10#2)(2009-6#1)(2013-1#1)
which is probably related to##2##5##(1996-2#1)(2011-1#1)
which is probably##4##3##(1996-2#1)(2008-5#1)(2010-12#1)(2011-1#1)
which is produced by##3##4##(2008-10#1)(2008-3#1)(2009-12#1)
which is produced##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)
which is proportional##2##3##(2008-10#1)(2008-3#1)
which is proposed to be##2##5##(2008-5#1)(2011-2#1)
which is reflected in##2##4##(1996-12#1)(2009-11#1)
which is related##2##3##(1994-2#1)(2008-10#1)
which is relatively##2##3##(1994-2#1)(2008-10#1)
which is reported##2##3##(1991-8#1)(2008-11#1)
which is represented by##2##4##(1990-12#1)(1997-8#1)
which is required for the##2##5##(1996-8#1)(2008-10#1)
which is required for##5##4##(1996-2#1)(1996-8#1)(2008-10#1)(2009-6#1)(2013-8#1)
which is resistant to##2##4##(2008-10#1)(2011-2#1)
which is responsible for the##4##5##(1993-9#1)(1996-2#1)(2008-10#1)(2010-5#1)
which is responsible for##6##4##(1993-9#1)(1996-2#2)(2008-10#1)(2008-5#1)(2010-5#1)
which is sensitive to##2##4##(2008-10#1)(2008-12#1)
which is sensitive##4##3##(2008-10#3)(2008-12#1)
which is shown to##2##4##(2008-10#1)(2011-2#1)
which is shown##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
which is significantly##3##3##(1993-8#1)(2008-11#1)(2008-12#1)
which is similar to the##3##5##(1992-3#1)(2008-10#1)(2012-3#1)
which is similar to##5##4##(1991-9#1)(1992-3#1)(2008-10#2)(2012-3#1)
which is specific for##2##4##(1990-5#1)(2013-8#1)
which is stable##2##3##(1991-5#1)(2008-10#1)
which is strongly associated with##3##5##(1997-8#1)(2011-2#1)(2011-7#1)
which is strongly##4##3##(1997-8#1)(2008-10#1)(2011-2#1)(2011-7#1)
which is subsequently##3##3##(1993-9#1)(1997-2#1)(2008-10#1)
which is suitable for##2##4##(2008-10#2)
which is susceptible to##3##4##(2008-10#3)
which is susceptible##4##3##(2008-10#4)
which is synthesised##2##3##(1992-8#1)(2013-7#1)
which is the basis for the##2##6##(1997-6#1)(2008-7#1)
which is the basis##3##4##(1997-6#1)(2008-10#1)(2008-7#1)
which is the first##4##4##(1995-8#1)(2008-10#2)(2013-8#1)
which is the major##2##4##(2008-10#1)(2008-11#1)
which is the most severe##2##5##(2008-10#1)(2013-8#1)
which is the most widely##2##5##(2008-3#1)(2008-8#1)
which is the most##10##4##(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#2)
which is the primary##2##4##(2008-7#1)(2010-8#1)
which is the same as that##3##6##(1993-8#1)(2008-10#1)(2008-8#1)
which is the same as##4##5##(1993-8#1)(2008-10#2)(2008-8#1)
which is the same##6##4##(1993-8#1)(1995-11#1)(2008-10#2)(2008-8#1)(2012-2#1)
which is the type##2##4##(2011-2#2)
which is the##54##3##(1991-5#1)(1991-9#1)(1993-1#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-3#3)(2008-7#2)(2008-8#2)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-8#3)
which is then##6##3##(2008-10#4)(2008-11#1)(2008-5#1)
which is thought to be##2##5##(1994-9#1)(2008-7#1)
which is thought to##4##4##(1991-12#1)(1993-3#1)(1994-9#1)(2008-7#1)
which is tightly##2##3##(2008-10#1)(2012-2#1)
which is to##2##3##(1993-6#1)(2013-1#1)
which is typical of##2##4##(2008-12#1)(2010-10#1)
which is under##2##3##(2008-5#2)
which is unique to the##2##5##(2009-10#1)(2011-2#1)
which is unique##3##3##(1990-5#1)(2009-10#1)(2011-2#1)
which is used as##2##4##(2008-10#1)(2011-2#1)
which is used in the##2##5##(1996-9#1)(2010-8#1)
which is used in##4##4##(1992-12#1)(1996-9#1)(2010-8#1)(2011-2#1)
which is used to##3##4##(1997-3#1)(2008-10#1)(2008-11#1)
which is used##9##3##(1992-12#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#2)
which is useful for##3##4##(1996-12#1)(2008-10#1)(2008-4#1)
which is useful##4##3##(1996-12#1)(2008-10#1)(2008-4#2)
which is usually##2##3##(2008-7#1)(2010-6#1)
which is very close to the##2##6##(2008-10#1)(2012-3#1)
which is very similar##2##4##(1994-11#1)(2008-10#1)
which is very##9##3##(1994-11#1)(2008-10#4)(2008-5#2)(2010-12#1)(2012-3#1)
which is well##3##3##(1995-12#1)(2008-10#1)(2008-2#1)
which is widely used##2##4##(2008-10#1)(2008-11#1)
which is widely##3##3##(2008-10#2)(2008-11#1)
which is##907##2##(1990-11#3)(1990-12#3)(1990-2#4)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#9)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#6)(1993-8#9)(1993-9#4)(1994-11#8)(1994-12#2)(1994-2#6)(1994-3#1)(1994-5#5)(1994-8#8)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#6)(1995-3#4)(1995-6#7)(1995-8#7)(1996-1#2)(1996-12#3)(1996-2#9)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#6)(1997-6#8)(1997-7#3)(1997-8#7)(2006-6#4)(2007-11#3)(2007-12#8)(2008-1#4)(2008-10#262)(2008-11#67)(2008-12#18)(2008-2#6)(2008-3#23)(2008-4#7)(2008-5#24)(2008-7#21)(2008-8#21)(2008-9#24)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#5)(2009-7#5)(2009-8#12)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#6)(2010-7#4)(2010-8#5)(2011-1#4)(2011-10#1)(2011-2#41)(2011-3#2)(2011-7#1)(2011-9#1)(2012-2#19)(2012-3#21)(2013-1#26)(2013-7#2)(2013-8#13)
which it can##2##3##(2008-11#1)(2012-3#1)
which it has##2##3##(2008-10#2)
which it is##5##3##(1994-12#1)(2008-10#1)(2008-11#2)(2008-4#1)
which it may##2##3##(1995-9#1)(2007-11#1)
which it was##4##3##(1991-5#1)(2008-1#1)(2008-10#1)(2009-11#1)
which it##28##2##(1991-2#1)(1991-5#1)(1994-12#2)(1995-9#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-4#2)(2009-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
which its##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
which lacked##2##2##(1994-3#1)(2008-10#1)
which lacks the##6##3##(1991-5#1)(1995-12#1)(1997-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
which lacks##11##2##(1991-5#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
which large##3##2##(2008-10#1)(2008-11#2)
which lasted##2##2##(1991-6#1)(2008-11#1)
which lead to##4##3##(2008-11#2)(2009-8#1)(2010-9#1)
which lead##5##2##(2008-10#1)(2008-11#2)(2009-8#1)(2010-9#1)
which leads to a##4##4##(1992-8#1)(2008-10#1)(2010-12#1)(2013-1#1)
which leads to an##2##4##(1992-1#1)(2008-10#1)
which leads to the##2##4##(2008-10#1)(2008-7#1)
which leads to##25##3##(1991-2#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
which leads##26##2##(1991-2#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
which led to a##2##4##(2008-10#1)(2011-2#1)
which led to##7##3##(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
which led##8##2##(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
which lies##2##2##(1992-12#1)(1997-3#1)
which life##2##2##(2010-1#1)(2011-2#1)
which limit##2##2##(2008-10#1)(2009-7#1)
which limits##2##2##(2010-1#1)(2011-2#1)
which links##3##2##(1991-3#1)(2008-10#1)(2008-6#1)
which live##2##2##(2008-5#2)
which looks##2##2##(1994-2#1)(2008-5#1)
which low##2##2##(2008-10#1)(2012-2#1)
which made##3##2##(2008-10#2)(2013-8#1)
which mainly##2##2##(2008-10#1)(2013-1#1)
which maintains##2##2##(2008-10#1)(2008-9#1)
which make them##2##3##(2008-10#2)
which make up the##2##4##(2008-5#2)
which make##10##2##(1995-3#1)(1997-2#2)(2008-10#3)(2008-5#2)(2009-7#1)(2013-8#1)
which makes it##7##3##(1993-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2012-3#1)(2013-8#1)
which makes possible a##2##4##(2008-10#1)(2008-11#1)
which makes the system##2##4##(2008-10#1)(2008-11#1)
which makes the##8##3##(1993-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-8#1)
which makes them##3##3##(2008-10#2)(2011-2#1)
which makes##26##2##(1993-2#1)(1993-9#1)(1996-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#2)
which manifests itself##2##3##(2008-5#1)(2010-8#1)
which manifests##3##2##(2008-11#1)(2008-5#1)(2010-8#1)
which maps##2##2##(1993-3#1)(1997-7#1)
which matched the##2##3##(1995-2#1)(2008-11#1)
which may act as##2##4##(1996-2#1)(2012-2#1)
which may affect the##2##4##(2008-12#1)(2012-3#1)
which may affect##6##3##(1991-11#1)(1994-9#1)(2008-11#2)(2008-12#1)(2012-3#1)
which may be associated with the##2##6##(1992-12#1)(1996-3#1)
which may be attributed to##3##5##(1996-8#1)(2008-10#1)(2012-3#1)
which may be considered##2##4##(2008-12#1)(2010-8#1)
which may be due to the##2##6##(2008-9#1)(2012-3#1)
which may be due to##3##5##(2008-10#1)(2008-9#1)(2012-3#1)
which may be due##4##4##(2008-10#1)(2008-9#2)(2012-3#1)
which may be involved in##2##5##(1991-6#1)(1994-8#1)
which may be more##3##4##(1991-2#1)(2008-8#1)(2011-2#1)
which may be of##4##4##(1994-8#1)(1995-8#1)(2008-11#1)(2010-4#1)
which may be present##2##4##(2008-10#2)
which may be related to##2##5##(1991-6#1)(2010-2#1)
which may be responsible for the##2##6##(1993-12#1)(1994-3#1)
which may be responsible for##5##5##(1990-8#1)(1993-12#1)(1994-3#1)(1996-12#1)(2008-10#1)
which may be the##2##4##(1997-3#1)(2008-12#1)
which may be##69##3##(1990-8#1)(1991-2#2)(1991-6#2)(1992-12#1)(1992-9#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#11)(2008-11#6)(2008-12#3)(2008-8#3)(2008-9#3)(2009-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
which may cause##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
which may contain##4##3##(1990-5#1)(2007-12#1)(2008-5#1)(2008-8#1)
which may contribute to the##3##5##(1992-6#1)(1994-3#1)(2011-2#1)
which may contribute to##5##4##(1992-6#1)(1994-3#1)(2010-12#1)(2011-2#1)(2011-7#1)
which may enable the##2##4##(2008-10#1)(2011-2#1)
which may explain the##2##4##(1990-12#1)(1996-5#1)
which may function as##2##4##(1992-9#1)(2008-5#1)
which may have##6##3##(2008-10#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
which may help to explain##2##5##(2009-12#1)(2012-2#1)
which may help to##4##4##(2008-5#1)(2009-12#1)(2012-2#1)(2012-9#1)
which may help##5##3##(2008-10#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-9#1)
which may include##2##3##(2008-7#1)(2013-8#1)
which may increase##3##3##(1994-2#1)(2008-3#1)(2008-7#1)
which may indicate##2##3##(2008-10#1)(2008-9#1)
which may involve##3##3##(1990-5#1)(1992-9#1)(1993-8#1)
which may justify a##2##4##(1990-12#1)(1997-8#1)
which may justify##3##3##(1990-12#1)(1997-8#1)(2008-5#1)
which may lead to##7##4##(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
which may not##2##3##(2008-11#2)
which may occur in##2##4##(1990-8#1)(2010-4#1)
which may occur##4##3##(1990-8#1)(2010-4#1)(2010-8#1)(2011-2#1)
which may play##2##3##(1991-11#1)(1992-10#1)
which may provide##3##3##(1994-2#1)(2007-11#1)(2008-10#1)
which may represent##2##3##(2008-10#1)(2010-12#1)
which may result from##2##4##(2008-8#1)(2012-2#1)
which may result in##3##4##(2008-10#2)(2008-5#1)
which may result##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)
which may##192##2##(1990-12#2)(1990-5#3)(1990-8#3)(1991-11#2)(1991-2#2)(1991-3#1)(1991-6#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#3)(1993-12#4)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#3)(2007-11#1)(2007-12#2)(2008-10#28)(2008-11#14)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#7)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#10)(2012-3#5)(2012-9#1)(2013-1#7)(2013-8#3)
which means that the##2##4##(2008-5#1)(2008-8#1)
which means that##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
which means##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)
which meant that##2##3##(2008-10#1)(2011-3#1)
which measured exposure during##2##4##(1993-1#2)
which measured##5##2##(1993-1#2)(2008-11#1)(2008-12#1)(2010-2#1)
which measures the##2##3##(1990-8#1)(2008-2#1)
which measures##5##2##(1990-8#1)(1991-6#1)(1992-1#1)(2008-2#1)(2013-8#1)
which mechanism##2##2##(1997-1#1)(2010-11#1)
which mediate##3##2##(1991-6#1)(2008-8#1)(2012-2#1)
which mediates the##2##3##(1993-2#1)(2009-7#1)
which mediates##6##2##(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1997-2#1)(2009-7#1)
which membrane##2##2##(2008-6#1)(2009-5#1)
which might be due to##2##5##(1993-8#1)(2008-10#1)
which might be##11##3##(1992-12#1)(1993-8#1)(1995-8#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-4#1)(2011-2#1)
which might explain the##2##4##(1991-11#1)(2008-5#1)
which might explain##3##3##(1991-11#1)(2008-5#1)(2009-6#1)
which might have a protective effect##2##6##(2008-7#1)(2011-2#1)
which might have a##3##4##(1996-3#1)(2008-7#1)(2011-2#1)
which might have##4##3##(1996-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
which might induce##2##3##(2008-11#1)(2011-2#1)
which might##33##2##(1991-11#1)(1991-6#1)(1992-12#2)(1993-8#2)(1994-5#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-4#1)(2011-2#4)(2012-2#1)
which modify##3##2##(2008-10#1)(2011-1#1)(2013-7#1)
which monitors##2##2##(2008-10#1)(2008-7#1)
which more##5##2##(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
which most likely##2##3##(1994-2#1)(2008-7#1)
which most##5##2##(1994-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
which must be taken into##2##5##(1991-11#1)(1995-3#1)
which must be##5##3##(1991-11#1)(1994-9#1)(1995-3#1)(1997-3#1)(2011-2#1)
which nearly##2##2##(2008-9#1)(2009-8#1)
which need to be##2##4##(1997-8#1)(2008-12#1)
which need to##3##3##(1997-8#1)(2008-11#1)(2008-12#1)
which need##4##2##(1997-8#1)(2008-11#1)(2008-12#1)(2011-2#1)
which neither##2##2##(1992-1#1)(2006-6#1)
which neural##2##2##(1996-2#1)(2008-11#1)
which new##2##2##(1997-7#1)(2008-1#1)
which no##10##2##(1990-11#1)(1992-9#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#1)
which normally##4##2##(2008-10#1)(2008-11#1)(2009-10#1)(2010-7#1)
which not only##5##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-8#1)
which now##3##2##(1991-11#1)(1997-1#1)(2008-10#1)
which nursing##2##2##(2008-11#1)(2008-12#1)
which obeys##2##2##(2008-10#2)
which occur in these##2##4##(1994-5#1)(2008-7#1)
which occur in##5##3##(1993-2#1)(1994-5#1)(2008-7#1)(2009-6#1)(2010-11#1)
which occur##7##2##(1991-9#1)(1993-2#1)(1994-5#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-11#1)
which occurred as a##2##4##(2010-11#1)(2012-12#1)
which occurred at##2##3##(2008-10#1)(2008-11#1)
which occurred in a##2##4##(1991-11#1)(2008-11#1)
which occurred in##4##3##(1990-9#1)(1991-11#1)(1995-8#1)(2008-11#1)
which occurred##13##2##(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1995-8#1)(2008-10#2)(2008-11#2)(2010-11#1)(2012-12#2)(2013-1#1)
which occurs in the##2##4##(1995-6#1)(2008-5#1)
which occurs in##8##3##(1994-3#1)(1994-8#1)(1995-6#2)(2008-10#2)(2008-5#2)
which occurs##18##2##(1993-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#3)(1996-5#1)(2008-1#2)(2008-10#3)(2008-5#2)(2009-11#1)(2012-3#1)(2013-7#1)
which of the##3##3##(1994-3#1)(2008-8#1)(2009-8#1)
which of these##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
which of##8##2##(1994-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)
which offers##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
which often##6##2##(1994-5#1)(2006-6#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
which on##3##2##(1990-2#1)(1991-3#1)(2008-8#1)
which one can##2##3##(2008-2#1)(2008-3#1)
which one##12##2##(1991-9#1)(1996-3#1)(1996-9#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)
which only##16##2##(1990-9#1)(1992-3#1)(2008-10#4)(2008-3#1)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2013-8#1)
which operates##2##2##(1994-8#1)(2008-3#1)
which originates from##2##3##(2008-10#2)
which overcomes the##2##3##(2008-10#2)
which overexpress##2##2##(2008-11#1)(2011-1#1)
which overlapped##2##2##(2008-10#2)
which oxidizes the##2##3##(1991-7#1)(2008-10#1)
which parents are##2##3##(1992-2#1)(1995-12#1)
which parents##4##2##(1992-2#1)(1995-12#1)(2010-10#1)(2012-12#1)
which partially##2##2##(2008-10#2)
which passes##2##2##(1994-8#1)(2008-10#1)
which patients with##2##3##(1994-2#1)(2008-11#1)
which patients##10##2##(1993-12#1)(1994-2#2)(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
which peaked##2##2##(2008-10#1)(2008-11#1)
which permit##2##2##(2007-11#1)(2008-5#1)
which permits the determination of##2##5##(2008-10#2)
which permits the##4##3##(1995-3#1)(2008-10#2)(2008-3#1)
which permits to classify the present method as green##2##9##(2008-10#2)
which permits##11##2##(1990-12#1)(1991-2#1)(1995-3#1)(2008-10#5)(2008-3#2)(2010-11#1)
which permitted##4##2##(2008-10#2)(2008-6#1)(2012-2#1)
which persisted##3##2##(1992-9#1)(2008-7#1)(2012-2#1)
which pesticides##2##2##(2008-10#2)
which physiologic##2##2##(1994-3#1)(2010-7#1)
which plants##2##2##(2008-10#2)
which play a role in##2##5##(2008-5#1)(2010-7#1)
which play a##4##3##(1990-5#1)(2008-10#1)(2008-5#1)(2010-7#1)
which play an important role in##2##6##(2008-10#1)(2012-2#1)
which play an important##3##4##(1995-6#1)(2008-10#1)(2012-2#1)
which play##9##2##(1990-5#1)(1995-6#1)(2008-10#3)(2008-5#1)(2009-8#1)(2010-7#1)(2012-2#1)
which plays a key role in the##2##7##(1991-5#1)(2011-1#1)
which plays##4##2##(1991-5#1)(2008-10#2)(2011-1#1)
which populations of##2##3##(2008-10#2)
which possess intrinsic tyrosine kinase activity##2##6##(1992-7#1)(1995-8#1)
which possess##3##2##(1992-7#1)(1995-8#1)(2008-11#1)
which possessed##2##2##(2008-10#2)
which possesses a##2##3##(1990-7#1)(2008-10#1)
which possesses##5##2##(1990-10#1)(1990-7#1)(2008-10#2)(2008-11#1)
which predicts##2##2##(1997-6#1)(2008-3#1)
which preferentially binds##2##3##(1995-11#1)(2008-11#1)
which present##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
which presented to##2##3##(2013-1#2)
which presented with##2##3##(2008-7#1)(2013-1#1)
which presented##6##2##(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#3)
which presents a##3##3##(1990-3#1)(2008-10#1)(2012-3#1)
which presents##4##2##(1990-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
which prevented##2##2##(1991-3#1)(2008-11#1)
which prevents##4##2##(1996-9#1)(1997-6#1)(2008-10#1)(2008-11#1)
which previously##3##2##(1997-6#1)(2008-10#1)(2008-12#1)
which primarily##2##2##(1996-2#1)(2012-2#1)
which probably##4##2##(1991-8#1)(1992-6#1)(2007-12#1)(2008-10#1)
which produce##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
which produced##5##2##(1990-8#1)(1991-9#1)(1995-2#1)(2008-10#2)
which produces##7##2##(1994-12#1)(1994-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)
which products##3##2##(2008-11#1)(2011-2#2)
which promote##3##2##(1995-6#1)(1996-3#1)(1996-5#1)
which protect##2##2##(1995-11#2)
which protein##2##2##(2010-4#1)(2011-2#1)
which proved to be##2##4##(2008-1#1)(2008-10#1)
which proved##4##2##(2008-1#1)(2008-10#2)(2009-3#1)
which provide##2##2##(1996-1#1)(2011-2#1)
which provided a##2##3##(2008-10#2)
which provided the##2##3##(1995-6#1)(2008-10#1)
which provided##7##2##(1995-6#1)(2008-10#6)
which provides a##6##3##(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-7#1)
which provides both##3##3##(2008-10#1)(2008-7#1)(2010-11#1)
which provides##22##2##(1991-3#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-11#2)(2013-1#1)(2013-7#1)
which public health##2##3##(1996-3#1)(1997-3#1)
which quantify##2##2##(2008-10#1)(2008-8#1)
which range##2##2##(2008-10#1)(2012-3#1)
which ranged from 0##3##4##(2008-10#1)(2009-12#2)
which ranged from##5##3##(1993-8#1)(1996-12#1)(2008-10#1)(2009-12#2)
which ranged##6##2##(1993-8#1)(1996-12#1)(2008-10#2)(2009-12#2)
which ranges from##2##3##(2008-10#1)(2008-12#1)
which reached##2##2##(1996-2#1)(2008-10#1)
which reacts with##8##3##(1995-12#1)(1997-1#1)(2008-10#5)(2008-8#1)
which reacts##10##2##(1990-5#1)(1995-12#1)(1997-1#1)(2008-10#6)(2008-8#1)
which received##10##2##(1991-11#1)(1994-3#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(1996-8#1)(2008-12#1)(2013-8#1)
which recognize##2##2##(1992-6#1)(2008-11#1)
which recognized##2##2##(2008-10#1)(2008-8#1)
which recognizes an##2##3##(1996-2#1)(2008-10#1)
which recognizes##5##2##(1994-5#1)(1995-12#1)(1996-2#1)(2008-10#1)(2009-8#1)
which reduced the##2##3##(2008-10#2)
which reduced##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
which reduces sample##2##3##(2008-10#1)(2010-11#1)
which reduces the##2##3##(1996-2#1)(2008-3#1)
which reduces##5##2##(1996-2#1)(2008-10#1)(2008-3#1)(2010-1#1)(2010-11#1)
which reflect##2##2##(1995-12#1)(2008-9#1)
which reflects the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
which reflects##5##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
which regulate##4##2##(2008-11#2)(2008-7#1)(2009-8#1)
which regulates##3##2##(1995-12#1)(2008-1#1)(2009-9#1)
which related to##2##3##(2008-10#2)
which relates##2##2##(2008-10#1)(2008-5#1)
which release##2##2##(1994-2#1)(2009-8#1)
which releases##2##2##(2008-10#2)
which relies on the##2##4##(1992-5#1)(2008-9#1)
which remain##5##2##(1994-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
which remains a##2##3##(2008-7#1)(2012-3#1)
which remains to be##2##4##(1995-12#1)(1997-7#1)
which remains##6##2##(1993-1#1)(1995-12#1)(1997-7#1)(2008-7#1)(2012-3#2)
which removes lesions##2##3##(2008-11#2)
which reported##2##2##(2010-11#1)(2012-12#1)
which represent an##2##3##(2011-2#1)(2013-1#1)
which represent the##3##3##(1990-8#1)(1993-6#1)(2010-7#1)
which represent##7##2##(1990-8#1)(1993-6#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
which represented##2##2##(2008-10#2)
which represents a##5##3##(1991-2#1)(2008-10#1)(2008-7#2)(2010-6#1)
which represents the##4##3##(1990-8#1)(2008-10#2)(2010-8#1)
which represents##12##2##(1990-8#1)(1991-2#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-6#1)(2010-8#1)
which require##10##2##(1990-12#1)(2008-10#1)(2008-11#3)(2009-8#1)(2011-2#1)(2013-1#3)
which required##6##2##(1992-12#1)(1996-2#1)(2008-10#3)(2008-7#1)
which requires a##2##3##(1994-1#1)(2011-2#1)
which requires no##2##3##(2007-12#1)(2008-10#1)
which requires##11##2##(1994-1#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-9#1)(2011-2#1)
which resemble##3##2##(1991-5#1)(1994-6#1)(2012-2#1)
which resembles##2##2##(2008-6#1)(2013-1#1)
which respectively##2##2##(2008-8#1)(2008-9#1)
which respond to##2##3##(1992-9#1)(2011-1#1)
which respond##3##2##(1992-9#1)(2008-10#1)(2011-1#1)
which responded##3##2##(1993-6#1)(1995-9#1)(2008-11#1)
which responds to##2##3##(2008-10#1)(2009-8#1)
which responds##3##2##(1996-2#1)(2008-10#1)(2009-8#1)
which restrict##2##2##(1992-12#1)(1992-4#1)
which restricts##2##2##(1994-8#1)(2008-10#1)
which result from a##2##4##(1996-1#1)(1996-5#1)
which result from##3##3##(1994-8#1)(1996-1#1)(1996-5#1)
which result in##6##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-10#1)
which result##9##2##(1991-9#1)(1994-8#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-10#1)
which resulted in a sensitive fluorescence derivatizing##2##7##(2008-10#2)
which resulted in a##7##4##(1995-3#1)(2008-10#3)(2008-11#2)(2008-7#1)
which resulted in the##4##4##(1993-3#1)(2008-10#1)(2008-11#2)
which resulted in##23##3##(1990-8#1)(1993-3#1)(1995-3#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-7#2)(2009-9#1)(2012-3#1)(2013-1#1)
which resulted##24##2##(1990-8#1)(1993-3#1)(1995-3#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#2)(2009-9#1)(2012-3#1)(2013-1#1)
which results from the##2##4##(2007-12#1)(2008-11#1)
which results from##4##3##(1993-6#1)(2007-12#1)(2008-11#1)(2008-4#1)
which results in a lower##2##5##(1992-3#1)(2008-10#1)
which results in a##7##4##(1990-8#1)(1992-1#1)(1992-3#1)(2008-10#2)(2008-4#1)(2008-9#1)
which results in the formation of##2##6##(1996-5#1)(2008-10#1)
which results in the##5##4##(1996-5#1)(2008-10#2)(2008-4#1)(2010-12#1)
which results in##24##3##(1990-8#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-6#1)(1996-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
which results##29##2##(1990-8#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-6#2)(1996-5#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-4#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
which retained##2##2##(1995-2#1)(2008-8#1)
which reveal##2##2##(1994-5#1)(2008-3#1)
which revealed a##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
which revealed that##4##3##(1995-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
which revealed##9##2##(1995-2#1)(2008-10#2)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
which reveals##3##2##(1993-6#1)(2008-10#1)(2009-3#1)
which rural##2##2##(1996-3#2)
which samples##2##2##(2008-10#1)(2010-8#1)
which scores accuracy as null##2##5##(2013-1#2)
which seek##2##2##(1991-6#1)(1991-7#1)
which seem to be##3##4##(1995-12#1)(2008-10#2)
which seemed##2##2##(2008-10#1)(2008-7#1)
which seems to be##2##4##(2008-10#2)
which seems to##3##3##(2008-10#2)(2008-7#1)
which seems##4##2##(1992-1#1)(2008-10#2)(2008-7#1)
which selectively##2##2##(1992-3#1)(1994-2#1)
which separates##2##2##(2008-11#1)(2008-9#1)
which serve as##2##3##(2008-10#1)(2011-2#1)
which serve##3##2##(2008-10#2)(2011-2#1)
which served##2##2##(2008-10#1)(2008-3#1)
which serves as##3##3##(2008-10#2)(2008-7#1)
which serves##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
which seven##2##2##(2008-8#1)(2011-2#1)
which several##5##2##(1996-5#1)(2008-10#2)(2008-8#1)(2012-2#1)
which sex##2##2##(2008-8#1)(2008-9#1)
which shared##2##2##(2008-11#1)(2010-4#1)
which shares##5##2##(1991-6#1)(1997-3#1)(1997-7#1)(2008-7#1)(2009-9#1)
which she##2##2##(2009-10#1)(2009-3#1)
which should be considered##2##4##(1991-8#1)(2011-2#1)
which should be performed##2##4##(1996-11#1)(2011-2#1)
which should be the##2##4##(1991-8#1)(1993-12#1)
which should be##22##3##(1991-6#1)(1991-8#2)(1993-12#1)(1995-5#1)(1996-11#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-9#1)(2011-2#4)(2011-8#1)(2013-8#1)
which should##30##2##(1991-6#1)(1991-8#2)(1993-12#1)(1995-5#1)(1996-11#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#5)(2011-8#1)(2013-8#1)
which show a##4##3##(1990-6#1)(1994-5#1)(2008-10#1)(2011-2#1)
which show some##3##3##(1994-6#1)(1996-2#1)(2012-3#1)
which show the existence of##2##5##(2008-10#2)
which show##14##2##(1990-6#1)(1991-11#1)(1994-5#1)(1994-6#1)(1996-2#2)(1997-2#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-3#1)
which showed a##10##3##(1991-12#1)(1991-6#1)(1994-11#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-8#1)
which showed high##3##3##(1993-12#1)(2008-10#1)(2013-1#1)
which showed low##2##3##(1996-12#1)(2008-10#1)
which showed no##2##3##(1990-3#1)(2008-10#1)
which showed that the##3##4##(1991-5#1)(1992-12#1)(2008-11#1)
which showed that##8##3##(1991-5#1)(1992-12#1)(1993-8#1)(1997-3#1)(2008-11#2)(2008-8#1)(2008-9#1)
which showed the##4##3##(1990-11#1)(1995-11#1)(1996-2#1)(2011-2#1)
which showed##47##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(2008-10#7)(2008-11#7)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-10#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#2)
which shows a##3##3##(2008-10#2)(2008-8#1)
which shows that##2##3##(2008-10#1)(2008-8#1)
which shows the##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
which shows##14##2##(1996-12#1)(2008-10#7)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)
which signals##2##2##(1997-7#1)(2008-11#1)
which simulates##3##2##(1996-3#1)(2008-8#1)(2009-10#1)
which simultaneously##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
which small##2##2##(2008-10#2)
which some##4##2##(1990-5#1)(1994-3#1)(2008-8#1)(2009-10#1)
which species##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
which specifically recognized##2##3##(1995-8#1)(2008-11#1)
which specifically##5##2##(1995-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
which sperm##2##2##(1994-5#1)(2007-12#1)
which stabilizes##2##2##(2008-11#1)(2013-8#1)
which states that##2##3##(2012-2#1)(2013-8#1)
which statistical##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
which stimulates##6##2##(1994-11#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-11#1)(2011-2#1)
which strongly##2##2##(2008-10#1)(2008-9#1)
which students##4##2##(1996-1#1)(2008-11#3)
which subjects##2##2##(2008-11#1)(2009-8#1)
which subsequently##8##2##(1996-12#1)(1996-5#1)(2008-10#5)(2008-8#1)
which such##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
which suggest##3##2##(2007-12#1)(2008-10#2)
which suggested that the##2##4##(2008-10#2)
which suggested that##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
which suggested##12##2##(1993-8#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)
which suggests that S##2##4##(2008-10#1)(2008-8#1)
which suggests that the##4##4##(2008-11#1)(2008-4#1)(2008-8#2)
which suggests that these##2##4##(1995-2#1)(2010-3#1)
which suggests that this##3##4##(1994-3#1)(2008-11#1)(2008-5#1)
which suggests that##20##3##(1991-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#5)(2010-11#1)(2010-3#1)
which suggests##23##2##(1991-9#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-2#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#5)(2010-11#1)(2010-3#1)(2011-2#1)
which summarizes##3##2##(2008-10#3)
which support##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
which supports the##3##3##(1997-4#1)(2008-11#1)(2013-8#1)
which supports##5##2##(1995-2#1)(1997-4#1)(2008-11#2)(2013-8#1)
which suppresses##2##2##(1994-3#1)(1997-1#1)
which survived##2##2##(2008-10#1)(2008-6#1)
which symptoms##2##2##(2008-10#1)(2012-2#1)
which synthesized##2##2##(1995-8#1)(2008-5#1)
which take##3##2##(1990-3#1)(2008-10#1)(2009-12#1)
which takes into account##3##4##(1996-5#1)(2008-3#1)(2009-10#1)
which takes place##2##3##(2008-10#2)
which takes##8##2##(1996-3#1)(1996-5#1)(2008-10#3)(2008-3#2)(2009-10#1)
which target##2##2##(2009-12#1)(2012-2#1)
which targeted##2##2##(1994-3#1)(2012-12#1)
which targets##2##2##(2010-12#2)
which the amount of##2##4##(1991-11#1)(2008-12#1)
which the analyte##3##3##(2008-10#3)
which the animals were##2##4##(1994-3#1)(2009-3#1)
which the animals##4##3##(1993-3#1)(1994-3#1)(2008-8#1)(2009-3#1)
which the brain##2##3##(2008-4#1)(2008-9#1)
which the cells were##2##4##(1991-12#1)(2008-11#1)
which the cells##4##3##(1991-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
which the enzyme##3##3##(1993-8#1)(2008-10#1)(2009-5#1)
which the expression##2##3##(2007-11#1)(2013-1#1)
which the first##3##3##(1996-6#1)(2008-10#1)(2013-1#1)
which the gamma 1(34##2##4##(1995-2#2)
which the gene##2##3##(2008-10#1)(2008-4#1)
which the influences of##2##4##(2008-10#1)(2008-9#1)
which the latter##2##3##(2008-8#1)(2011-2#1)
which the main##3##3##(1997-8#2)(2008-10#1)
which the majority of##2##4##(1990-2#1)(2010-5#1)
which the majority##3##3##(1990-2#1)(2008-8#1)(2010-5#1)
which the most##3##3##(1996-12#1)(2008-10#2)
which the number of##2##4##(2007-11#1)(2008-9#1)
which the population##2##3##(2008-10#1)(2008-9#1)
which the sample##4##3##(1992-12#1)(2008-10#3)
which the solution##2##3##(2008-10#2)
which the spatial##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
which the surface##2##3##(2008-10#1)(2008-3#1)
which the target##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)
which the theory##2##3##(1997-2#1)(2011-2#1)
which the virus##2##3##(2008-10#2)
which the##418##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-5#4)(1991-9#3)(1992-1#5)(1992-10#2)(1992-12#1)(1992-2#2)(1992-8#1)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#2)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#2)(1997-8#3)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#129)(2008-11#25)(2008-12#2)(2008-2#2)(2008-3#20)(2008-4#9)(2008-5#12)(2008-6#1)(2008-7#13)(2008-8#21)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#2)(2010-9#1)(2011-2#14)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#12)(2013-8#5)
which their##5##2##(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)
which themselves##2##2##(1991-6#1)(2007-12#1)
which then##10##2##(2007-12#1)(2008-10#2)(2008-3#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
which there is a##2##4##(1997-3#1)(2011-1#1)
which there is no##5##4##(2008-12#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
which there is##12##3##(1990-3#1)(1996-9#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
which there##18##2##(1990-3#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
which therefore##2##2##(1991-12#1)(2008-7#1)
which these##21##2##(1990-6#1)(1991-12#1)(1993-2#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)
which they are##10##3##(1991-8#1)(1992-2#1)(1993-1#1)(1996-12#1)(2008-10#1)(2008-8#3)(2011-2#1)(2013-1#1)
which they can##3##3##(2008-9#1)(2011-2#2)
which they generate##2##3##(1995-2#1)(1996-2#1)
which they had previously##2##4##(2008-12#1)(2010-4#1)
which they had##5##3##(1996-3#1)(2008-12#1)(2008-8#1)(2010-4#1)(2013-7#1)
which they have been##3##4##(1991-12#1)(1997-5#1)(2011-2#1)
which they have##4##3##(1991-12#1)(1997-5#1)(2008-8#1)(2011-2#1)
which they perceive##2##3##(2008-10#1)(2008-11#1)
which they shared##2##3##(2008-10#1)(2010-11#1)
which they were##12##3##(1993-6#1)(1994-3#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-11#1)
which they will##3##3##(1996-3#2)(2008-9#1)
which they##82##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-2#1)(1993-1#2)(1993-6#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-10#14)(2008-11#5)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#7)(2008-9#4)(2009-10#1)(2010-11#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#9)(2012-2#2)(2013-1#1)(2013-7#1)
which this effect##2##3##(2008-10#1)(2010-1#1)
which this occurs are##2##4##(2008-11#1)(2012-12#1)
which this occurs##6##3##(1992-9#1)(2008-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
which this##21##2##(1990-6#1)(1992-9#1)(1996-1#1)(1996-12#1)(1996-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#2)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
which three##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
which time##4##2##(1997-1#1)(2008-10#1)(2008-6#1)(2013-1#1)
which to base##4##3##(1997-1#1)(2008-11#1)(2008-7#1)(2012-2#1)
which to examine the##3##4##(1992-2#1)(2009-8#1)(2013-8#1)
which to improve##2##3##(2008-3#1)(2013-8#1)
which to make##2##3##(2008-3#1)(2011-8#1)
which to study##5##3##(1994-8#1)(1995-2#1)(1997-3#1)(2008-4#1)(2012-3#1)
which to##32##2##(1990-11#1)(1991-3#1)(1992-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-8#1)(2012-2#1)(2012-3#3)(2013-8#3)
which together with the##2##4##(1997-7#1)(2009-10#1)
which together with##3##3##(1997-7#1)(2008-8#1)(2009-10#1)
which together##7##2##(1991-7#1)(1993-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-10#1)
which took##2##2##(2008-12#1)(2009-6#1)
which training##2##2##(1996-3#1)(2013-8#1)
which transfer##2##2##(1990-8#1)(2008-10#1)
which treatment is##2##3##(2010-12#1)(2013-1#1)
which treatment##4##2##(2008-7#1)(2010-1#1)(2010-12#1)(2013-1#1)
which triggers##3##2##(1995-12#1)(2012-3#2)
which turns##2##2##(1993-2#1)(2008-11#1)
which two##13##2##(1992-12#1)(1992-9#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-12#1)
which type of##2##3##(1993-2#1)(2013-1#1)
which types of##2##3##(1994-2#1)(2008-11#1)
which typically##3##2##(2008-10#1)(2009-8#1)(2013-7#1)
which ultimately##4##2##(1992-10#1)(2008-10#1)(2008-6#1)(2012-2#1)
which under##2##2##(1995-2#1)(2008-10#1)
which undergo##3##2##(1996-12#1)(2008-7#1)(2010-7#1)
which undergoes a##3##3##(1996-5#2)(2008-10#1)
which undergoes##5##2##(1996-5#2)(2008-10#1)(2009-8#1)(2011-2#1)
which underlie##2##2##(1994-12#1)(2008-5#1)
which use##2##2##(2008-10#1)(2009-10#1)
which used the##2##3##(1996-2#1)(2008-10#1)
which used##4##2##(1990-11#1)(1996-2#1)(2008-10#1)(2010-10#1)
which uses a##4##3##(2008-10#3)(2008-9#1)
which uses an##2##3##(1996-12#1)(2008-3#1)
which uses##16##2##(1990-12#1)(1991-2#1)(1995-6#3)(1996-12#1)(2008-10#6)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
which usually##4##2##(1990-5#1)(2008-1#1)(2008-10#1)(2012-3#1)
which utilize##2##2##(2008-10#1)(2008-11#1)
which utilizes##4##2##(1990-10#1)(1993-3#1)(2008-10#2)
which varies##3##2##(2006-6#1)(2008-10#2)
which various##3##2##(2007-11#1)(2008-8#1)(2010-4#1)
which was a##6##3##(1994-11#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-6#1)(2011-2#1)
which was abolished##2##3##(1996-12#1)(2013-1#1)
which was about##2##3##(2008-11#2)
which was absent in##3##4##(1993-6#1)(1994-11#1)(2008-10#1)
which was achieved##2##3##(2008-10#1)(2008-12#1)
which was added to the##2##5##(2008-10#2)
which was administered to##2##4##(1996-3#1)(2008-11#1)
which was adopted##2##3##(2008-10#1)(2011-2#1)
which was also##5##3##(1990-5#1)(2008-10#2)(2008-9#1)(2011-2#1)
which was associated with##3##4##(1991-6#1)(1992-8#1)(2008-10#1)
which was based on##6##4##(2008-10#3)(2008-9#1)(2010-5#1)(2013-1#1)
which was based upon##2##4##(2008-10#2)
which was based##8##3##(2008-10#5)(2008-9#1)(2010-5#1)(2013-1#1)
which was blocked by##2##4##(1993-3#1)(2012-2#1)
which was blocked##3##3##(1993-3#1)(2008-11#1)(2012-2#1)
which was caused by the##2##5##(2008-8#1)(2012-3#1)
which was caused by##3##4##(2008-8#1)(2011-2#1)(2012-3#1)
which was confirmed by the##2##5##(2008-10#2)
which was confirmed by##4##4##(2008-10#2)(2008-11#2)
which was confirmed##7##3##(2008-10#3)(2008-11#2)(2008-7#1)(2011-2#1)
which was considerably##2##3##(1994-11#1)(2012-2#1)
which was consistent with the##3##5##(2008-10#2)(2008-9#1)
which was consistent with##5##4##(1990-5#1)(2008-10#2)(2008-9#1)(2010-6#1)
which was constructed##2##3##(2008-10#2)
which was detected##3##3##(2008-11#1)(2009-6#1)(2009-7#1)
which was determined##2##3##(2008-11#1)(2008-8#1)
which was developed in##3##4##(2008-10#2)(2008-12#1)
which was developed##6##3##(1990-12#1)(2008-10#4)(2008-12#1)
which was different##2##3##(2008-8#1)(2009-10#1)
which was first##4##3##(1993-8#1)(1994-2#1)(2008-10#2)
which was flanked by##2##4##(2008-8#1)(2012-3#1)
which was followed##2##3##(1990-11#1)(2013-8#1)
which was found to be the most##2##7##(2008-10#1)(2008-9#1)
which was found to be the##3##6##(2008-10#2)(2008-9#1)
which was found to be##7##5##(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
which was found to##10##4##(1993-6#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
which was found##14##3##(1993-6#1)(1995-11#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
which was further##4##3##(1996-5#1)(2008-10#1)(2010-10#1)(2013-1#1)
which was higher##2##3##(1997-7#1)(2008-12#1)
which was in##4##3##(1990-8#1)(2008-10#2)(2008-11#1)
which was induced by##2##4##(1990-12#1)(2008-6#1)
which was inhibited by##2##4##(1995-6#1)(1997-1#1)
which was inhibited##3##3##(1995-6#1)(1997-1#1)(2011-3#1)
which was introduced##2##3##(1997-7#1)(2008-10#1)
which was located##2##3##(1997-3#1)(2013-8#1)
which was made##2##3##(1995-6#1)(2008-10#1)
which was managed##2##3##(2008-10#1)(2011-2#1)
which was mapped##2##3##(1995-6#1)(2008-10#1)
which was measured at##2##4##(2008-10#2)
which was measured by##2##4##(2008-11#1)(2012-3#1)
which was measured##5##3##(2008-10#3)(2008-11#1)(2012-3#1)
which was monitored##3##3##(2008-10#2)(2008-3#1)
which was more##2##3##(2008-11#2)
which was named##2##3##(2008-10#1)(2008-8#1)
which was never##2##3##(2008-5#1)(2012-3#1)
which was not detected##2##4##(2008-10#1)(2012-2#1)
which was not found in##2##5##(2008-10#1)(2008-9#1)
which was not found##3##4##(2008-10#2)(2008-9#1)
which was not observed##2##4##(1994-11#1)(2008-7#1)
which was not##22##3##(1991-5#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
which was observed with##2##4##(2008-10#1)(2008-5#1)
which was observed##6##3##(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
which was obtained from##2##4##(1994-8#1)(1997-8#1)
which was only##2##3##(2008-5#1)(2008-8#1)
which was packed with a molybdate-form ion exchange resin##2##9##(2008-10#2)
which was packed##3##3##(2008-10#3)
which was positively##2##3##(2008-10#1)(2008-8#1)
which was present in##2##4##(1991-5#1)(2008-10#1)
which was prevented by##2##4##(1994-2#1)(1996-12#1)
which was previously##4##3##(1991-12#1)(1994-11#1)(2008-10#1)(2011-2#1)
which was proportional to the##2##5##(2008-10#1)(2008-7#1)
which was proved##2##3##(1996-2#1)(2008-10#1)
which was recovered##2##3##(1993-12#1)(2013-1#1)
which was related to##2##4##(2008-10#2)
which was responsible for##3##4##(1990-6#1)(1991-2#1)(2007-8#1)
which was set##2##3##(2008-10#2)
which was significantly##6##3##(1996-12#2)(2008-10#2)(2008-5#1)(2013-8#1)
which was similar to##2##4##(1993-8#1)(2012-2#1)
which was similar##3##3##(1993-8#1)(2008-11#1)(2012-2#1)
which was simple##2##3##(2008-10#2)
which was stimulated by##2##4##(2008-10#1)(2008-9#1)
which was subsequently##2##3##(1991-2#1)(2008-7#1)
which was successfully treated with##2##5##(2008-10#1)(2011-2#1)
which was successfully treated##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
which was successfully##5##3##(2008-10#1)(2008-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
which was supported##2##3##(2008-10#1)(2008-12#1)
which was the most##2##4##(1991-8#1)(2008-10#1)
which was the##4##3##(1991-8#1)(2008-10#2)(2012-3#1)
which was then##7##3##(1994-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)
which was to##2##3##(1994-12#1)(2010-1#1)
which was treated##4##3##(1990-9#1)(2008-12#3)
which was used as the##2##5##(2008-10#2)
which was used as##3##4##(2008-10#3)
which was used for##2##4##(2008-10#1)(2008-3#1)
which was used in##3##4##(2008-10#3)
which was used to##4##4##(1991-3#1)(2008-10#3)
which was used##12##3##(1991-3#1)(2008-10#10)(2008-3#1)
which was verified by##2##4##(2008-10#2)
which was##414##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#2)(1994-11#8)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#3)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-6#6)(1995-8#1)(1996-1#1)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-3#3)(1997-7#5)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#134)(2008-11#32)(2008-12#13)(2008-2#1)(2008-3#7)(2008-5#10)(2008-6#2)(2008-7#10)(2008-8#13)(2008-9#11)(2009-10#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#16)(2011-3#4)(2012-12#3)(2012-2#7)(2012-3#6)(2013-1#11)(2013-8#8)
which we designate##2##3##(1993-6#1)(1994-11#1)
which we found##2##3##(2011-2#1)(2012-3#1)
which we have previously##3##4##(1996-12#1)(2008-11#1)(2008-5#1)
which we have termed##2##4##(1995-8#1)(2008-10#1)
which we have##8##3##(1992-9#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
which we identified##3##3##(1997-2#1)(2008-5#1)(2010-12#1)
which we now##2##3##(1994-12#1)(2013-1#1)
which we refer to##2##4##(1992-6#1)(2011-2#1)
which we##53##2##(1990-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-12#2)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
which were also##2##3##(2008-10#2)
which were amplified by##3##4##(1996-12#1)(2008-10#1)(2008-11#1)
which were both##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
which were characterized##2##3##(1997-8#1)(2008-10#1)
which were collected##2##3##(2008-11#1)(2010-12#1)
which were considered##2##3##(1992-1#1)(2012-2#1)
which were detected##2##3##(1994-8#1)(2008-11#1)
which were either##2##3##(2008-10#2)
which were eluted from the column through##2##7##(2008-10#2)
which were found##2##3##(1994-3#1)(2008-10#1)
which were from##2##3##(2008-10#2)
which were identified as##2##4##(1991-5#1)(2008-10#1)
which were identified##4##3##(1991-5#1)(1997-2#1)(2007-12#1)(2008-10#1)
which were immunoreactive for##2##4##(1997-2#2)
which were initially##2##3##(1997-3#1)(1997-8#1)
which were inversely##2##3##(1997-4#1)(2008-12#1)
which were isolated from##3##4##(2008-10#1)(2008-11#2)
which were kept under##2##4##(2008-9#1)(2011-3#1)
which were not##7##3##(1993-8#1)(2008-10#5)(2010-10#1)
which were obtained from##2##4##(1995-6#1)(2008-10#1)
which were obtained##3##3##(1995-6#1)(2008-10#2)
which were oxidized##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
which were packed##2##3##(2008-5#1)(2008-9#1)
which were prepared##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
which were present##2##3##(2008-10#2)
which were presented at the##2##5##(2008-6#1)(2013-8#1)
which were recognized##2##3##(2008-10#1)(2008-9#1)
which were related to the##2##5##(2008-10#2)
which were set##2##3##(1995-3#1)(2012-12#1)
which were similar to those##2##5##(1997-8#1)(2008-10#1)
which were similar to##3##4##(1997-8#1)(2008-10#2)
which were similar##4##3##(1997-8#1)(2008-10#2)(2011-2#1)
which were subjected to##2##4##(2008-10#1)(2008-11#1)
which were the most##2##4##(2010-1#1)(2011-2#1)
which were the##5##3##(1991-2#1)(1995-12#1)(2008-10#1)(2010-1#1)(2011-2#1)
which were treated by##2##4##(1990-3#1)(2008-11#1)
which were used for##2##4##(1996-6#1)(2008-11#1)
which were used##6##3##(1996-6#1)(2007-8#1)(2008-11#2)(2010-8#1)(2012-2#1)
which were##226##2##(1990-11#1)(1990-3#2)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#4)(1995-3#1)(1995-6#2)(1996-12#5)(1996-2#1)(1996-6#2)(1997-2#4)(1997-3#4)(1997-4#2)(1997-8#5)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#71)(2008-11#22)(2008-12#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#12)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#3)
which when##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
which will appear in the##2##5##(1995-1#1)(2010-5#1)
which will be discussed##2##4##(2008-10#1)(2008-12#1)
which will be##9##3##(1993-2#1)(1994-2#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-2#1)
which will##32##2##(1992-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#2)(2010-5#1)(2011-2#4)(2012-3#1)(2013-8#1)
which would be##4##3##(2008-11#1)(2010-12#1)(2011-2#2)
which would result in a##2##5##(1993-9#1)(2008-10#1)
which would##17##2##(1993-2#1)(1993-9#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#3)
which yielded##4##2##(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)
which yields a##2##3##(2008-10#1)(2009-10#1)
which yields##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2009-10#1)
which##7500##1##(1990-10#2)(1990-11#27)(1990-12#22)(1990-2#22)(1990-3#9)(1990-5#40)(1990-6#9)(1990-7#5)(1990-8#33)(1990-9#9)(1991-1#8)(1991-10#2)(1991-11#17)(1991-12#33)(1991-2#34)(1991-3#22)(1991-4#1)(1991-5#41)(1991-6#29)(1991-7#7)(1991-8#12)(1991-9#21)(1992-1#22)(1992-10#8)(1992-11#5)(1992-12#31)(1992-2#21)(1992-3#23)(1992-4#9)(1992-5#6)(1992-6#15)(1992-7#4)(1992-8#9)(1992-9#28)(1993-1#14)(1993-11#5)(1993-12#34)(1993-2#31)(1993-3#39)(1993-6#39)(1993-8#64)(1993-9#19)(1994-1#8)(1994-11#44)(1994-12#35)(1994-2#50)(1994-3#39)(1994-5#44)(1994-6#8)(1994-8#44)(1994-9#12)(1995-1#9)(1995-11#24)(1995-12#57)(1995-2#53)(1995-3#26)(1995-5#16)(1995-6#58)(1995-8#36)(1995-9#17)(1996-1#18)(1996-11#5)(1996-12#59)(1996-2#55)(1996-3#43)(1996-5#33)(1996-6#17)(1996-8#15)(1996-9#10)(1997-1#37)(1997-2#46)(1997-3#41)(1997-4#15)(1997-5#6)(1997-6#32)(1997-7#43)(1997-8#46)(1997-9#4)(2006-6#16)(2007-11#20)(2007-12#54)(2007-8#8)(2008-1#34)(2008-10#1909)(2008-11#594)(2008-12#129)(2008-2#25)(2008-3#140)(2008-4#76)(2008-5#191)(2008-6#36)(2008-7#217)(2008-8#270)(2008-9#206)(2009-1#5)(2009-10#47)(2009-11#12)(2009-12#24)(2009-2#2)(2009-3#17)(2009-4#5)(2009-5#16)(2009-6#25)(2009-7#37)(2009-8#78)(2009-9#13)(2010-1#31)(2010-10#36)(2010-11#29)(2010-12#43)(2010-2#7)(2010-3#10)(2010-4#23)(2010-5#26)(2010-6#29)(2010-7#41)(2010-8#44)(2010-9#11)(2011-1#35)(2011-10#3)(2011-2#308)(2011-3#32)(2011-7#4)(2011-8#4)(2011-9#1)(2012-12#41)(2012-2#156)(2012-3#127)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#186)(2013-7#19)(2013-8#108)
whichis##2##1##(2008-11#2)
while 100 microM##2##3##(1990-8#1)(2009-6#1)
while 2##6##2##(1996-12#1)(1997-3#1)(2008-10#2)(2008-5#1)(2012-3#1)
while 3##3##2##(1991-11#1)(2008-10#1)(2008-12#1)
while B##4##2##(2008-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
while CMV infection##2##3##(2012-2#2)
while Cr(VI) is##2##3##(2008-10#2)
while Cr(VI)##4##2##(2008-10#4)
while D-leucine did not##2##4##(2008-11#2)
while Western blotting##2##3##(2008-9#2)
while Western##3##2##(2008-9#2)(2009-9#1)
while a##22##2##(1991-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)
while activation of the##2##4##(1992-8#1)(2009-5#1)
while activation of##3##3##(1992-8#1)(2009-5#1)(2013-1#1)
while activity##2##2##(1992-6#1)(2008-11#1)
while adjusting for##2##3##(2013-1#2)
while all##7##2##(1994-11#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
while allowing##3##2##(1991-3#1)(2008-10#1)(2008-12#1)
while also##2##2##(1991-9#1)(2008-10#1)
while an increase##2##3##(2007-8#1)(2008-8#1)
while an##7##2##(1991-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-1#1)
while another##5##2##(1994-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
while at pH 4##2##4##(1994-5#1)(2008-10#1)
while at pH##3##3##(1994-5#1)(2008-10#2)
while at the same time##3##5##(2008-12#1)(2009-10#1)(2009-8#1)
while at the##4##3##(2008-10#1)(2008-12#1)(2009-10#1)(2009-8#1)
while at##10##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)
while avoiding##2##2##(1992-2#1)(1995-12#1)
while being##4##2##(1992-8#1)(1996-12#1)(2008-11#1)(2008-8#1)
while both##3##2##(2008-10#1)(2008-9#1)(2009-7#1)
while carrying a##2##3##(2008-9#2)
while cell##4##2##(1995-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
while cells##5##2##(2008-11#5)
while concentrations##2##2##(2008-10#2)
while controlling for##2##3##(2011-2#1)(2013-8#1)
while decreasing##3##2##(2008-11#1)(2010-1#1)(2011-1#1)
while degradation##2##2##(1990-8#1)(2008-11#1)
while differences##2##2##(1993-1#1)(1994-3#1)
while each##2##2##(1995-2#1)(2011-3#1)
while either##2##2##(2008-9#1)(2011-2#1)
while enhancing##2##2##(1997-1#1)(2011-1#1)
while ensuring##4##2##(2008-1#1)(2008-4#1)(2009-8#1)(2010-8#1)
while ethanol and##2##3##(2009-12#2)
while ethanol##3##2##(2008-10#1)(2009-12#2)
while exerting##2##2##(2012-2#1)(2013-1#1)
while expression of##2##3##(1997-7#1)(2008-11#1)
while feeding on##2##3##(2008-10#2)
while five##3##2##(1994-12#1)(1995-12#1)(2013-1#1)
while for the other##3##4##(2008-10#2)(2013-1#1)
while for the##6##3##(1992-11#1)(2008-10#3)(2008-9#1)(2013-1#1)
while for##12##2##(1992-11#1)(2008-10#9)(2008-9#1)(2013-1#1)
while four##2##2##(1996-6#1)(2010-3#1)
while friction##2##2##(2010-10#1)(2012-2#1)
while further##2##2##(1991-12#1)(2013-1#1)
while girls##2##2##(1994-12#1)(2012-2#1)
while group##2##2##(2006-6#1)(2010-7#1)
while having##3##2##(1991-3#1)(1997-1#1)(2008-11#1)
while high##2##2##(1992-11#1)(2010-6#1)
while higher##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
while in 7##2##3##(1990-12#1)(1991-6#1)
while in all##2##3##(2008-10#1)(2011-2#1)
while in the##9##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
while in##35##2##(1990-12#1)(1991-1#1)(1991-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
while increased##2##2##(2008-10#1)(2011-2#1)
while individuals of##2##3##(2008-8#2)
while individuals##3##2##(2008-11#1)(2008-8#2)
while inhibiting##2##2##(1996-2#1)(2012-2#1)
while inorganic##2##2##(2008-10#1)(2010-11#1)
while it has##2##3##(2008-10#1)(2010-6#1)
while it inhibited##2##3##(1997-4#1)(2008-11#1)
while it is##5##3##(1995-11#1)(2008-10#3)(2011-2#1)
while it was##2##3##(2008-10#1)(2012-3#1)
while it##16##2##(1990-5#1)(1993-1#1)(1993-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(1997-4#1)(2008-10#5)(2008-11#1)(2010-6#1)(2011-2#1)(2012-3#1)
while its##4##2##(1993-8#1)(1995-11#1)(2008-11#1)(2008-9#1)
while keeping##3##2##(1996-2#1)(2008-10#1)(2009-12#1)
while late##2##2##(2011-2#1)(2012-7#1)
while leaving##2##2##(2008-10#1)(2012-2#1)
while limiting##2##2##(2008-7#1)(2012-2#1)
while maintaining a##2##3##(2008-3#1)(2010-10#1)
while maintaining good##2##3##(2008-10#2)
while maintaining high##2##3##(2008-10#2)
while maintaining patient##3##3##(2008-10#1)(2008-11#2)
while maintaining quality##2##3##(1997-2#1)(2008-11#1)
while maintaining the##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
while maintaining##21##2##(1990-6#1)(1991-3#1)(1997-2#1)(2008-10#7)(2008-11#6)(2008-3#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
while minimizing##3##2##(2008-10#2)(2013-1#1)
while moisture##2##2##(2008-10#1)(2010-4#1)
while more##2##2##(2008-10#1)(2008-12#1)
while most of##2##3##(2008-11#1)(2010-4#1)
while most##7##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#1)
while no changes were observed in##2##6##(1994-8#1)(2008-7#1)
while no changes were##3##4##(1994-8#1)(2008-7#1)(2012-3#1)
while no differences were##2##4##(2008-7#1)(2010-12#1)
while no effect was##2##4##(1996-12#1)(2008-10#1)
while no##18##2##(1992-12#1)(1994-8#1)(1995-8#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
while none of the##2##4##(2008-9#1)(2012-12#1)
while none##3##2##(1995-12#1)(2008-9#1)(2012-12#1)
while not##4##2##(1994-3#1)(2008-10#2)(2008-9#1)
while on the##2##3##(1991-3#1)(2007-12#1)
while on##6##2##(1991-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-1#1)
while one of##2##3##(1991-6#1)(2008-10#1)
while one##3##2##(1991-6#1)(2008-10#1)(2010-12#1)
while only##13##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-5#1)(1996-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2013-8#2)
while operating at##2##3##(2008-10#1)(2008-3#1)
while other##11##2##(1993-3#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-11#2)
while others are##2##3##(1996-2#1)(2013-8#1)
while others do not##4##4##(2008-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
while others##17##2##(1992-5#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#3)(2009-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
while performing axillary##2##3##(2013-1#2)
while performing##5##2##(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#2)
while plant##2##2##(2008-10#2)
while playing##2##2##(1990-6#1)(2008-11#1)
while preserving the##2##3##(2008-3#1)(2011-1#1)
while preserving##3##2##(2008-3#1)(2008-6#1)(2011-1#1)
while progesterone##2##2##(1990-11#1)(2010-8#1)
while providing##7##2##(2008-11#4)(2008-12#2)(2011-2#1)
while reading##2##2##(2008-11#1)(2013-8#1)
while recombinant##2##2##(2008-11#2)
while recoveries##2##2##(2008-10#2)
while reducing##3##2##(2008-10#2)(2008-11#1)
while relatively##2##2##(1997-8#1)(2008-9#1)
while remaining##3##2##(1995-12#1)(2010-8#1)(2011-2#1)
while retaining the##2##3##(2008-10#1)(2008-3#1)
while retaining##7##2##(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-5#1)
while root##2##2##(2008-10#1)(2008-9#1)
while sitting##2##2##(2010-9#2)
while some##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
while sparing##2##2##(1994-5#1)(2012-3#1)
while still##3##2##(1991-12#1)(2008-11#1)(2012-2#1)
while strains##2##2##(2008-10#2)
while subjects##3##2##(2008-11#1)(2010-11#1)(2013-8#1)
while substantial##2##2##(1992-3#1)(1995-12#1)
while temperature##3##2##(2008-10#2)(2008-9#1)
while that for##3##3##(1991-5#1)(2008-10#1)(2008-7#1)
while that from##2##3##(1994-8#1)(2008-10#1)
while that in##2##3##(1993-2#1)(2008-10#1)
while that of the##4##4##(1990-11#1)(1991-5#1)(2008-11#1)(2008-8#1)
while that of##11##3##(1990-11#1)(1991-5#2)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)
while that##20##2##(1990-11#1)(1991-5#3)(1993-2#1)(1994-8#1)(2008-10#6)(2008-11#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)
while the best##2##3##(2008-10#2)
while the cells##2##3##(2008-11#1)(2013-1#1)
while the effect##2##3##(1996-2#1)(2008-10#1)
while the expression##3##3##(2008-8#2)(2009-6#1)
while the final##2##3##(2008-10#1)(2008-11#1)
while the laser##2##3##(2008-3#2)
while the level of##2##4##(2008-10#1)(2013-8#1)
while the lowest##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
while the monoesters##4##3##(1992-12#4)
while the most##4##3##(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
while the number of##2##4##(1991-8#1)(2008-11#1)
while the other five##2##4##(2008-10#1)(2008-11#1)
while the other##18##3##(1990-5#1)(1993-12#1)(1995-6#1)(1995-9#1)(2008-10#9)(2008-11#2)(2008-7#1)(2009-5#1)(2013-1#1)
while the others##2##3##(1995-2#1)(2007-12#1)
while the patient##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
while the percentage of##3##4##(2008-10#1)(2008-11#2)
while the population size##2##4##(2008-10#1)(2008-8#1)
while the population##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
while the rate of detected chromosome##2##6##(2012-3#2)
while the rate##3##3##(1997-7#1)(2012-3#2)
while the reaction##2##3##(1996-5#1)(2008-11#1)
while the remaining four##2##4##(1991-12#1)(2008-7#1)
while the remaining##9##3##(1991-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
while the response to##2##4##(2008-10#1)(2008-6#1)
while the response##3##3##(2008-10#2)(2008-6#1)
while the same##2##3##(2008-10#1)(2008-11#1)
while the second##4##3##(2008-10#2)(2008-4#1)(2013-1#1)
while the specific##2##3##(2008-11#2)
while the third##3##3##(2008-10#2)(2008-8#1)
while the total##3##3##(1991-9#1)(2008-10#2)
while the variation of transmission among ten gratings is 0##2##10##(2013-8#2)
while the##325##2##(1990-5#4)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#4)(1992-6#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-8#3)(1994-12#2)(1994-2#3)(1994-3#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#4)(2007-12#3)(2008-1#1)(2008-10#96)(2008-11#31)(2008-12#5)(2008-3#3)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#14)(2008-9#11)(2009-10#2)(2009-11#2)(2009-3#4)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#11)(2013-8#9)
while their##7##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)
while there was a##2##4##(2008-11#1)(2011-2#1)
while there was no##2##4##(2008-7#1)(2010-12#1)
while there was##5##3##(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#1)
while there##7##2##(2007-12#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-12#1)(2011-2#1)
while these##2##2##(2008-11#1)(2011-10#1)
while they are##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
while they were##2##3##(1996-3#1)(2013-8#1)
while they##16##2##(1990-8#1)(1993-2#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
while those from##3##3##(2008-10#2)(2008-11#1)
while those in##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
while those of##5##3##(1990-12#1)(2008-10#2)(2008-8#1)(2009-9#1)
while those with##3##3##(1996-2#1)(2008-10#1)(2009-8#1)
while those##21##2##(1990-12#1)(1996-2#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-3#1)
while tissue##2##2##(1996-12#1)(2009-3#1)
while total##5##2##(1993-12#1)(1994-8#1)(1996-2#1)(2008-5#1)(2012-7#1)
while two other##2##3##(1993-12#1)(1995-6#1)
while two##8##2##(1993-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
while under the influence of psilocybin##2##6##(2013-8#2)
while under the influence of##3##5##(2008-7#1)(2013-8#2)
while under##4##2##(2008-7#1)(2008-9#1)(2013-8#2)
while unladen##2##2##(2008-9#2)
while using##4##2##(2008-10#1)(2008-9#1)(2010-10#1)(2013-8#1)
while varying the##3##3##(2008-10#2)(2008-8#1)
while varying##5##2##(1991-2#1)(2008-10#3)(2008-8#1)
while very##2##2##(1997-3#1)(2011-2#1)
while##1379##1##(1990-11#5)(1990-12#5)(1990-3#1)(1990-5#8)(1990-6#3)(1990-8#4)(1990-9#2)(1991-1#3)(1991-11#4)(1991-12#4)(1991-2#2)(1991-3#11)(1991-5#9)(1991-6#6)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#3)(1993-11#5)(1993-12#11)(1993-2#4)(1993-3#7)(1993-6#5)(1993-8#12)(1993-9#2)(1994-11#5)(1994-12#8)(1994-2#4)(1994-3#4)(1994-5#9)(1994-6#4)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#11)(1995-2#8)(1995-3#2)(1995-5#2)(1995-6#8)(1995-8#8)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#12)(1996-2#14)(1996-3#11)(1996-5#3)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#10)(1997-3#5)(1997-4#4)(1997-6#2)(1997-7#5)(1997-8#8)(2006-6#2)(2007-12#10)(2007-8#1)(2008-1#5)(2008-10#347)(2008-11#124)(2008-12#28)(2008-2#3)(2008-3#15)(2008-4#7)(2008-5#23)(2008-6#7)(2008-7#39)(2008-8#47)(2008-9#53)(2009-1#1)(2009-10#11)(2009-11#4)(2009-12#6)(2009-3#7)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#7)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#10)(2010-12#13)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#5)(2011-1#11)(2011-10#3)(2011-2#46)(2011-3#6)(2012-12#9)(2012-2#29)(2012-3#25)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#57)(2013-7#1)(2013-8#34)
whilst in the##2##3##(2008-12#1)(2008-5#1)
whilst in##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
whilst the##3##2##(1992-6#1)(2008-10#1)(2012-2#1)
whilst##51##1##(1991-2#2)(1992-6#1)(1994-2#2)(1994-8#1)(1995-12#2)(1997-2#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#4)(2008-5#3)(2008-8#3)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
whisker stimulation##3##2##(1997-3#3)
white and red wines##2##4##(2008-10#2)
white and red##3##3##(2008-10#3)
white and yellow##2##3##(2008-12#1)(2009-10#1)
white and##11##2##(2008-10#7)(2008-12#1)(2009-10#1)(2010-11#1)(2011-2#1)
white blood cell count##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
white blood cells in##2##4##(1996-9#1)(2008-9#1)
white blood cells##8##3##(1994-8#2)(1996-9#1)(2008-9#2)(2011-2#2)(2013-8#1)
white blood##11##2##(1994-8#2)(1996-9#1)(2008-7#1)(2008-9#2)(2011-2#3)(2013-1#1)(2013-8#1)
white cell##3##2##(1991-3#2)(2008-10#1)
white cells##2##2##(1991-3#1)(2008-9#1)
white cloud mountain minnow##4##4##(2010-5#4)
white crests##3##2##(2008-9#3)
white fir##9##2##(2008-10#9)
white follicles##4##2##(2008-12#4)
white leaf##3##2##(2008-10#3)
white man##2##2##(1992-2#1)(2011-2#1)
white matter##18##2##(1996-11#2)(1997-2#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#9)(2012-3#1)
white men##2##2##(1990-3#1)(2009-5#1)
white mold##4##2##(2008-10#2)(2012-2#2)
white paper##3##2##(2008-3#1)(2012-2#2)
white pine (P##2##3##(2008-10#2)
white pine (Pinus##5##3##(2008-10#5)
white pine blister rust##17##4##(2008-10#17)
white pine blister##18##3##(2008-10#18)
white pine species##2##3##(2008-10#2)
white pine##38##2##(2008-10#38)
white rot fungus##2##3##(2008-6#1)(2009-9#1)
white rot##6##2##(2008-10#2)(2008-6#1)(2009-9#3)
white spruce##2##2##(2008-10#2)
white to##2##2##(2008-10#2)
white wine samples##2##3##(2008-10#2)
white wine##7##2##(2008-10#7)
white wines by their##2##4##(2008-10#2)
white wines##12##2##(2008-10#12)
white##242##1##(1990-3#1)(1991-11#2)(1991-3#3)(1991-8#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-8#2)(1995-12#3)(1995-2#3)(1996-1#1)(1996-11#2)(1996-9#1)(1997-2#2)(1997-5#1)(2007-12#1)(2008-10#117)(2008-11#5)(2008-12#9)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#9)(2009-10#2)(2009-5#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#9)(2010-4#2)(2010-5#4)(2010-8#1)(2011-2#10)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#1)
white-noise-like images##2##2##(2008-3#2)
white-rot fungus##2##2##(2008-11#1)(2011-1#1)
whiteflies that##3##2##(2008-10#3)
whiteflies were##2##2##(2008-10#2)
whiteflies##18##1##(2008-10#18)
whitefly (Bemisia##2##2##(2008-10#2)
whitefly survival##2##2##(2008-10#2)
whitefly transmission##2##2##(2008-10#2)
whitefly vector##5##2##(2008-10#5)
whitefly##26##1##(2008-10#26)
whitefly-transmitted geminivirus from##2##3##(2008-10#2)
whitefly-transmitted geminivirus##5##2##(2008-10#5)
whitefly-transmitted##11##1##(2008-10#11)
whitening agent##2##2##(2008-5#2)
whitening effect##2##2##(2008-5#2)
whitening##11##1##(2008-5#9)(2011-2#2)
whites##11##1##(1991-11#1)(1995-12#2)(1996-3#1)(1997-3#1)(2010-12#1)(2011-2#5)
whitish type##2##2##(2008-10#2)
who achieved##4##2##(1990-12#1)(2012-3#2)(2013-1#1)
who acquire##2##2##(1990-9#1)(2008-8#1)
who also##3##2##(1990-11#1)(2009-4#1)(2010-11#1)
who are &quot##2##3##(1992-2#1)(2009-6#1)
who are able to##2##4##(2008-11#2)
who are already##4##3##(1991-2#1)(2008-6#1)(2011-2#2)
who are at an##2##4##(2008-12#1)(2012-3#1)
who are at risk for##3##5##(2008-1#2)(2008-11#1)
who are at risk##5##4##(1990-9#1)(2008-1#2)(2008-11#1)(2008-12#1)
who are at##12##3##(1990-9#1)(1991-12#1)(1994-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-11#1)(2012-3#1)
who are committed to##2##4##(1994-2#1)(2012-3#1)
who are concerned about##2##4##(1993-11#1)(1993-3#1)
who are deaf##2##3##(2011-2#2)
who are exposed to##2##4##(2009-7#1)(2011-2#1)
who are immunosuppressed##2##3##(2007-12#1)(2009-8#1)
who are likely to be##2##5##(2007-12#1)(2008-11#1)
who are likely to##4##4##(2007-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
who are not##8##3##(1995-12#1)(1995-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#2)(2013-8#1)
who are obese##2##3##(2008-3#1)(2009-9#1)
who are on a ddI- and/or d4T-containing antiretroviral drug regimen##2##10##(2008-11#2)
who are on##3##3##(2008-11#2)(2011-2#1)
who are refractory to##2##4##(2011-2#1)(2012-3#1)
who are responsible for##3##4##(1993-3#1)(1997-2#1)(2008-12#1)
who are responsible##4##3##(1993-3#1)(1997-2#1)(2008-11#1)(2008-12#1)
who are suspected of having##2##5##(2010-12#1)(2012-12#1)
who are undergoing##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
who are##126##2##(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-2#4)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-2#3)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#16)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#1)
who attended##2##2##(1995-1#1)(2010-10#1)
who became##3##2##(1996-5#1)(2008-10#1)(2012-2#1)
who can##8##2##(1996-2#1)(2008-11#3)(2008-3#1)(2009-8#1)(2010-10#1)(2010-5#1)
who cannot##3##2##(1994-2#1)(2008-1#1)(2008-11#1)
who care for children with complex##2##6##(2008-11#2)
who care for##5##3##(1992-3#1)(2008-11#3)(2012-3#1)
who claimed##4##2##(1995-12#2)(1995-6#2)
who complained of##3##3##(2008-5#1)(2011-2#2)
who completed an##2##3##(2008-1#1)(2010-10#1)
who completed##6##2##(2008-1#1)(2008-4#1)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
who continue to##2##3##(1993-11#1)(2008-10#1)
who continued##3##2##(1991-3#1)(2008-11#1)(2013-8#1)
who contracted HIV##2##3##(1996-5#2)
who contracted##3##2##(1996-5#3)
who could be##2##3##(1995-5#1)(1997-2#1)
who could not##2##3##(2008-1#1)(2008-11#1)
who could##5##2##(1995-5#1)(1997-2#1)(2008-1#1)(2008-11#2)
who desire##2##2##(2007-8#1)(2008-9#1)
who developed a##7##3##(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
who developed an##2##3##(2008-10#1)(2008-7#1)
who developed##33##2##(1990-3#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
who did not receive##5##4##(1993-1#1)(1994-6#1)(1995-1#1)(2008-7#1)(2012-3#1)
who did not respond to##2##5##(1990-2#1)(1994-12#1)
who did not##21##3##(1990-2#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#1)(2011-2#4)(2012-3#3)(2013-1#3)
who did the under-five##2##4##(2008-2#2)
who did##27##2##(1990-2#1)(1993-1#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#3)
who died at##2##3##(1991-8#1)(2008-7#1)
who died during the##2##4##(1997-4#1)(2013-1#1)
who died during##3##3##(1991-7#1)(1997-4#1)(2013-1#1)
who died from##2##3##(1994-9#1)(1995-6#1)
who died##13##2##(1991-7#1)(1991-8#2)(1991-9#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-4#1)(2008-7#2)(2012-12#1)(2012-3#1)(2013-1#1)
who do not have##2##4##(1996-1#1)(2009-10#1)
who do not respond to##3##5##(1996-5#1)(1997-8#1)(2011-2#1)
who do not##9##3##(1996-1#1)(1996-5#1)(1997-8#1)(2008-11#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
who do##13##2##(1994-3#1)(1996-1#1)(1996-5#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
who does##2##2##(1991-3#1)(1994-2#1)
who engage in##2##3##(2008-6#1)(2013-1#1)
who engaged in sexting##2##4##(2013-1#2)
who engaged in##3##3##(1996-5#1)(2013-1#2)
who entered the study##2##4##(1991-2#1)(1995-1#1)
who exhibited##3##2##(1997-3#1)(2011-2#2)
who experience##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
who experienced##3##2##(1992-1#1)(2008-7#1)(2013-1#1)
who expressed##3##2##(1991-2#1)(2011-1#1)(2012-2#1)
who fail##2##2##(2008-11#1)(2011-3#1)
who failed to##3##3##(1995-2#1)(2008-1#1)(2012-2#1)
who failed##5##2##(1995-2#1)(2008-1#1)(2008-11#2)(2012-2#1)
who fell##2##2##(1996-9#1)(2013-1#1)
who felt##2##2##(1997-1#1)(2013-7#1)
who gave##2##2##(2010-1#1)(2012-3#1)
who had a##15##3##(1997-3#2)(1997-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-6#1)(2009-7#1)(2010-6#2)(2011-1#1)(2012-3#1)(2013-1#1)
who had attempted##2##3##(1992-1#1)(2008-11#1)
who had been treated##3##4##(1995-11#1)(2008-10#1)(2011-2#1)
who had been##14##3##(1991-12#1)(1991-3#1)(1992-9#1)(1995-11#1)(1996-11#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
who had experienced##3##3##(1994-6#1)(2008-12#1)(2010-7#1)
who had had##5##3##(1993-2#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
who had never used##2##4##(2013-1#1)(2013-8#1)
who had never##3##3##(2013-1#2)(2013-8#1)
who had no##3##3##(1991-11#1)(2008-11#1)(2012-3#1)
who had not undergone##2##4##(2008-11#1)(2012-3#1)
who had not##9##3##(1991-2#1)(1993-1#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
who had previously undergone##2##4##(1997-7#1)(2008-9#1)
who had received##5##3##(1990-2#1)(1991-3#1)(2008-9#2)(2011-2#1)
who had residual##2##3##(1997-8#1)(2012-3#1)
who had severe##2##3##(2008-11#1)(2008-7#1)
who had the##2##3##(1992-12#1)(2011-1#1)
who had undergone a##2##4##(2008-9#2)
who had undergone##18##3##(1990-9#1)(1991-8#1)(1994-12#1)(1994-3#4)(1996-6#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-11#1)(2010-10#1)(2012-2#2)(2013-1#2)
who had used##2##3##(2011-10#1)(2013-8#1)
who had##158##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-2#2)(1994-12#4)(1994-3#4)(1994-6#2)(1995-11#1)(1995-2#1)(1996-11#1)(1996-6#4)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#16)(2008-12#5)(2008-3#1)(2008-5#2)(2008-7#6)(2008-9#7)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-6#3)(2010-7#3)(2011-1#4)(2011-10#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#9)(2013-1#12)(2013-7#1)(2013-8#7)
who has been##4##3##(2008-9#2)(2010-11#1)(2012-3#1)
who has##9##2##(1996-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-9#2)(2010-11#1)(2012-3#1)(2013-1#1)
who have a##6##3##(1993-12#1)(2008-11#2)(2009-10#1)(2012-2#2)
who have been##9##3##(1991-12#1)(1995-1#1)(1995-12#2)(1995-3#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-3#1)
who have failed##3##3##(1994-5#1)(2008-5#1)(2008-9#1)
who have had limited##2##4##(1992-3#1)(1996-1#1)
who have had##4##3##(1992-3#1)(1996-1#1)(2008-12#1)(2011-1#1)
who have not##2##3##(1993-2#1)(1993-3#1)
who have received##3##3##(1994-9#1)(2008-9#1)(2013-8#1)
who have sex with men (MSM)##4##6##(2009-5#3)(2011-2#1)
who have sex with men##9##5##(1996-5#1)(2009-5#7)(2011-2#1)
who have suffered a##2##4##(2008-12#1)(2009-10#1)
who have sustained##2##3##(2010-9#1)(2013-1#1)
who have the clinical##2##4##(1992-3#1)(2010-10#1)
who have the##3##3##(1992-3#1)(1996-2#1)(2010-10#1)
who have undergone##7##3##(1990-9#1)(1996-3#1)(2008-7#1)(2010-10#1)(2010-6#1)(2012-12#1)(2013-1#1)
who have##87##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-3#4)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#7)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#3)(2009-5#9)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
who in##4##2##(1996-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
who is also##2##3##(1992-12#1)(2010-9#1)
who is##20##2##(1990-11#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-4#2)(2008-1#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
who knew their##2##3##(1990-6#1)(2012-3#1)
who lack##2##2##(2007-12#1)(2008-10#1)
who lacked##2##2##(2008-1#1)(2008-9#1)
who leave##2##2##(1992-3#1)(1996-1#1)
who lose##2##2##(1995-6#1)(2010-9#1)
who lost##2##2##(1994-2#1)(1995-12#1)
who made##2##2##(1992-1#1)(2011-2#1)
who may be##3##3##(1996-12#1)(2008-11#2)
who may not have##2##4##(1993-12#1)(2008-6#1)
who may not##3##3##(1993-12#1)(2008-6#1)(2012-12#1)
who may##12##2##(1993-12#1)(1995-12#1)(1996-12#1)(2008-11#3)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
who meets##2##2##(2011-2#1)(2012-12#1)
who met the##5##3##(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
who met##7##2##(2010-2#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#1)
who might##2##2##(1991-3#1)(2008-12#1)
who must##2##2##(1994-1#1)(2008-9#1)
who need##6##2##(1991-3#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-12#1)(2008-3#1)
who needs##2##2##(1996-1#1)(2008-9#1)
who never had##2##3##(1990-8#1)(2009-12#1)
who never##4##2##(1990-8#1)(1997-3#1)(2009-12#1)(2013-8#1)
who participate in##2##3##(2008-11#2)
who participated in the##2##4##(1996-1#1)(2011-2#1)
who participated in##6##3##(1996-1#1)(2008-8#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
who perceived##2##2##(2010-1#1)(2010-11#1)
who performed##2##2##(2011-1#1)(2012-3#1)
who present to##2##3##(2008-3#1)(2009-6#1)
who present with##6##3##(2008-10#1)(2008-12#1)(2009-7#1)(2011-1#1)(2011-2#2)
who present##10##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#2)
who presented at##2##3##(2008-11#1)(2008-12#1)
who presented to##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
who presented with a##12##4##(1996-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#2)
who presented with acute##2##4##(2008-12#1)(2010-8#1)
who presented with an##4##4##(2008-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
who presented with subarachnoid haemorrhage##2##5##(2008-7#2)
who presented with##55##3##(1992-12#1)(1994-12#2)(1996-6#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
who presented##69##2##(1991-11#1)(1991-2#1)(1992-12#1)(1994-12#2)(1996-6#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#5)(2008-5#2)(2008-7#6)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#3)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#3)
who presents with##6##3##(1997-3#1)(2006-5#4)(2010-6#1)
who presents##8##2##(1997-3#1)(2006-5#6)(2010-6#1)
who provide care##2##3##(1991-2#1)(2008-9#1)
who provide##6##2##(1991-2#1)(1993-12#1)(2008-11#1)(2008-9#2)(2009-11#1)
who provided##3##2##(1996-5#1)(1997-3#1)(2008-11#1)
who quit smoking##2##3##(2008-11#1)(2013-1#1)
who receive##10##2##(1994-5#1)(1994-6#2)(1996-12#1)(1997-6#1)(2008-6#1)(2009-11#1)(2010-4#2)(2012-2#1)
who received a##2##3##(2008-10#1)(2008-11#1)
who received home##2##3##(1997-4#1)(2012-12#1)
who received the##2##3##(2008-12#1)(2010-4#1)
who received##31##2##(1990-6#2)(1992-12#1)(1993-1#2)(1994-6#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#2)(2008-7#3)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
who refused##2##2##(1995-12#1)(1995-6#1)
who report##2##2##(1996-6#1)(2013-8#1)
who reported high##2##3##(2008-11#1)(2008-7#1)
who reported##16##2##(1993-1#4)(1994-1#1)(2008-11#3)(2008-7#1)(2009-5#2)(2010-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
who represented##2##2##(1991-8#1)(2008-12#1)
who require##3##2##(1992-1#1)(1994-6#1)(2010-10#1)
who required##5##2##(1993-1#1)(1994-1#1)(1995-8#1)(1996-3#1)(2013-1#1)
who returned##3##2##(2008-11#1)(2009-10#1)(2011-2#1)
who said##2##2##(1995-6#1)(2008-10#1)
who score##2##2##(2009-7#1)(2011-2#1)
who served##2##2##(1993-2#1)(2010-1#1)
who should have a thorough understanding of how it works##2##10##(2008-4#2)
who should##6##2##(1993-12#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-5#1)
who showed##5##2##(1991-11#1)(2008-12#1)(2011-2#2)(2013-1#1)
who smoked (2##2##3##(2011-2#2)
who smoked##4##2##(2011-2#3)(2013-8#1)
who started sexual activity##2##4##(2013-8#2)
who started##3##2##(2011-2#1)(2013-8#2)
who stayed##2##2##(2012-3#1)(2013-1#1)
who suffer from chronic##2##4##(2008-11#1)(2012-2#1)
who suffer from##4##3##(1990-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
who suffer##5##2##(1990-5#1)(1997-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
who suffered a##2##3##(1990-9#1)(1996-3#1)
who suffered an##2##3##(1991-3#1)(2013-8#1)
who suffered from##3##3##(1993-9#1)(2011-2#1)(2013-1#1)
who suffered##8##2##(1990-9#1)(1991-3#1)(1993-9#1)(1996-3#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
who supported##2##2##(2008-11#2)
who survived##4##2##(1995-2#1)(2008-11#1)(2011-2#1)(2011-3#1)
who sustained a##2##3##(2009-10#1)(2010-1#1)
who sustained##5##2##(2009-10#1)(2009-4#1)(2010-1#1)(2012-2#1)(2013-1#1)
who take##2##2##(1996-2#1)(2008-11#1)
who undergo##5##2##(1993-1#1)(1996-5#1)(2009-5#1)(2010-4#1)(2013-1#1)
who underwent PD+HD therapy##2##4##(2011-2#2)
who underwent a##4##3##(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
who underwent an endoscopic##2##4##(2011-2#2)
who underwent an##3##3##(2007-8#1)(2011-2#2)
who underwent cardiac##2##3##(2008-11#1)(2012-3#1)
who underwent surgery##6##3##(2008-7#2)(2008-8#1)(2011-2#2)(2013-1#1)
who underwent surgical treatment##2##4##(1993-6#1)(2011-2#1)
who underwent surgical##4##3##(1993-6#1)(1996-3#1)(2011-2#1)(2012-3#1)
who underwent the##2##3##(2011-2#1)(2012-12#1)
who underwent##75##2##(1990-8#1)(1991-1#2)(1991-6#2)(1991-8#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-3#2)(1996-9#1)(1997-7#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2010-11#1)(2010-12#1)(2011-2#21)(2012-12#2)(2012-2#2)(2012-3#9)(2013-1#8)(2013-8#1)
who use##7##2##(1992-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
who used##13##2##(1995-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-11#1)(2012-12#3)(2012-3#1)(2013-8#3)
who uses##2##2##(1994-6#1)(1995-3#1)
who utilized##2##2##(1996-2#1)(2012-3#1)
who volunteer##2##2##(1991-12#1)(1994-2#1)
who want to##3##3##(1993-12#1)(1994-1#1)(2008-10#1)
who was admitted with##2##4##(1997-5#1)(2013-1#1)
who was admitted##3##3##(1997-5#1)(2011-2#1)(2013-1#1)
who was diagnosed##2##3##(1994-1#1)(2008-11#1)
who was found##2##3##(1997-3#1)(2008-12#1)
who was initially diagnosed##2##4##(2008-7#1)(2012-3#1)
who was on##2##3##(2010-12#1)(2013-1#1)
who was referred##2##3##(2008-12#2)
who was successfully treated with##2##5##(2011-2#2)
who was successfully treated##3##4##(2011-2#2)(2013-1#1)
who was treated##4##3##(1997-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
who was##39##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#2)(1994-1#1)(1994-9#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#4)(2012-3#2)(2013-1#6)
who watch##2##2##(1995-2#1)(2009-7#1)
who went home##2##3##(1995-3#2)
who were admitted in##2##4##(2011-2#1)(2012-3#1)
who were admitted##4##3##(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
who were at##2##3##(2008-11#1)(2008-12#1)
who were born##2##3##(1994-1#1)(2012-12#1)
who were diagnosed with##2##4##(2008-6#1)(2012-3#1)
who were diagnosed##3##3##(1996-6#1)(2008-6#1)(2012-3#1)
who were discharged##2##3##(2008-7#1)(2012-12#1)
who were enrolled in##4##4##(2012-12#2)(2012-3#1)(2013-1#1)
who were examined##4##3##(1991-3#1)(1993-3#2)(1996-6#1)
who were exposed to##2##4##(2009-12#1)(2009-7#1)
who were given##2##3##(1997-8#1)(2008-5#1)
who were in##2##3##(1991-12#1)(2010-11#1)
who were interviewed##2##3##(2008-11#1)(2009-6#1)
who were involved in##3##4##(1995-1#1)(2008-11#1)(2010-11#1)
who were more##2##3##(1994-1#1)(2008-12#1)
who were newly##2##3##(1995-2#1)(2008-3#1)
who were not##4##3##(1992-3#1)(2008-7#1)(2009-5#1)(2011-1#1)
who were randomly##2##3##(2010-3#1)(2013-8#1)
who were sexually##2##3##(1996-11#1)(2013-1#1)
who were symptomatic at baseline##2##5##(2012-2#1)(2012-3#1)
who were symptomatic##3##3##(2008-1#1)(2012-2#1)(2012-3#1)
who were then##2##3##(1996-3#1)(2008-9#1)
who were treated by##3##4##(1995-11#1)(1996-11#1)(2008-7#1)
who were treated for##2##4##(2008-11#1)(2008-4#1)
who were treated##11##3##(1991-12#1)(1995-11#1)(1996-11#1)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
who were unable to##2##4##(2011-2#1)(2013-1#1)
who were##137##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-3#3)(1994-1#3)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-11#2)(1996-3#1)(1996-6#2)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#4)(2008-11#8)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#4)(2009-6#1)(2009-7#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#12)(2012-12#6)(2012-2#3)(2012-3#8)(2012-5#1)(2013-1#9)(2013-8#3)
who will perform##2##3##(1990-6#1)(1993-3#1)
who will work##2##3##(1994-1#1)(1995-6#1)
who will##17##2##(1990-6#1)(1993-3#1)(1994-1#3)(1994-2#1)(1994-5#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-10#1)(2009-4#1)(2012-3#1)
who wish to use##2##4##(2008-12#1)(2010-5#1)
who wish to##11##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1996-5#1)(2007-12#1)(2008-12#3)(2009-5#1)(2010-5#1)
who work in##4##3##(1991-2#1)(1994-12#1)(1996-12#1)(2013-1#1)
who work with older people##2##5##(2010-10#2)
who work with older##3##4##(1991-12#1)(2010-10#2)
who work with##4##3##(1991-12#1)(2008-11#1)(2010-10#2)
who work within##2##3##(2008-1#1)(2010-10#1)
who work##13##2##(1991-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-11#1)(2010-10#3)(2011-2#1)(2013-1#2)
who worked in##2##3##(1993-1#2)
who worked##3##2##(1993-1#2)(2008-11#1)
who would be##2##3##(1994-3#1)(2012-12#1)
who would##10##2##(1994-3#1)(2008-1#4)(2008-11#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)
who##1461##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#9)(1990-8#5)(1990-9#7)(1991-1#2)(1991-11#6)(1991-12#15)(1991-2#10)(1991-3#14)(1991-4#1)(1991-6#4)(1991-7#1)(1991-8#6)(1991-9#1)(1992-1#9)(1992-12#6)(1992-2#5)(1992-3#17)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#18)(1993-11#5)(1993-12#9)(1993-2#9)(1993-3#11)(1993-6#1)(1993-9#1)(1994-1#15)(1994-12#14)(1994-2#13)(1994-3#13)(1994-5#3)(1994-6#10)(1994-9#5)(1995-1#13)(1995-11#5)(1995-12#15)(1995-2#12)(1995-3#4)(1995-5#2)(1995-6#10)(1995-8#1)(1995-9#1)(1996-1#10)(1996-11#5)(1996-12#4)(1996-2#8)(1996-3#9)(1996-5#15)(1996-6#11)(1996-8#3)(1996-9#5)(1997-1#5)(1997-2#10)(1997-3#15)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#9)(2006-5#7)(2007-12#5)(2007-8#5)(2008-1#29)(2008-10#44)(2008-11#124)(2008-12#52)(2008-2#12)(2008-3#9)(2008-4#7)(2008-5#11)(2008-6#6)(2008-7#51)(2008-8#10)(2008-9#28)(2009-1#2)(2009-10#8)(2009-11#6)(2009-12#5)(2009-3#5)(2009-4#6)(2009-5#22)(2009-6#7)(2009-7#14)(2009-8#4)(2009-9#7)(2010-1#12)(2010-10#19)(2010-11#15)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#7)(2010-5#9)(2010-6#12)(2010-7#9)(2010-8#3)(2010-9#6)(2011-1#23)(2011-10#1)(2011-2#115)(2011-3#3)(2012-12#29)(2012-2#30)(2012-3#65)(2012-5#1)(2013-1#101)(2013-7#5)(2013-8#43)
who?##2##1##(1993-1#1)(2008-12#1)
whole analysis##3##2##(2008-10#3)
whole and##5##2##(1995-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
whole animal##2##2##(2008-11#1)(2008-7#1)
whole blood and##3##3##(2006-6#2)(2008-10#1)
whole blood by##3##3##(2008-10#3)
whole blood samples##4##3##(2008-10#4)
whole blood using##2##3##(2008-10#2)
whole blood water##4##3##(1993-2#4)
whole blood were##2##3##(2008-10#2)
whole blood##58##2##(1990-12#1)(1990-2#1)(1991-2#2)(1993-2#6)(1996-12#3)(2006-6#4)(2008-10#27)(2008-11#1)(2008-4#4)(2008-9#3)(2011-2#5)(2013-1#1)
whole body autoradiography##2##3##(1994-5#1)(2008-10#1)
whole body dose##2##3##(2008-7#2)
whole body glucose##2##3##(2008-1#2)
whole body sweat rate##3##4##(2008-5#3)
whole body##22##2##(1992-3#1)(1994-5#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-5#4)(2008-7#6)(2012-2#1)(2012-3#1)
whole brain##3##2##(1990-12#1)(1997-8#1)(2008-7#1)
whole cell##9##2##(1990-11#1)(1991-12#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-3#1)
whole cells##6##2##(1995-12#2)(1995-3#1)(2008-10#1)(2008-9#1)(2010-7#1)
whole concentration##2##2##(2008-10#2)
whole egg and##2##3##(2011-2#2)
whole genome analysis##3##3##(2008-4#1)(2009-10#1)(2012-3#1)
whole genome sequencing##3##3##(2009-9#1)(2010-5#1)(2012-3#1)
whole genome##13##2##(2008-4#2)(2008-7#4)(2009-10#2)(2009-9#1)(2010-10#1)(2010-5#1)(2012-3#2)
whole genomic sequence##2##3##(2008-10#1)(2010-7#1)
whole grain##4##2##(2010-1#4)
whole grains##8##2##(2010-1#7)(2012-2#1)
whole hand prehension##2##3##(1996-2#2)
whole in##2##2##(2008-10#1)(2012-3#1)
whole intact E##2##3##(2008-10#2)
whole intact##3##2##(2008-10#3)
whole is##2##2##(1992-3#1)(2009-10#1)
whole kidney##2##2##(2008-10#1)(2008-12#1)
whole lung lavage##2##3##(2010-7#2)
whole method was##2##3##(2008-10#2)
whole method##4##2##(2008-10#3)(2008-11#1)
whole milk##4##2##(2008-10#2)(2012-2#2)
whole milk)##2##2##(2008-10#2)
whole mount##3##2##(1997-7#1)(2008-8#1)(2008-9#1)
whole new##4##2##(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
whole organism##3##2##(2008-12#1)(2008-7#1)(2010-9#1)
whole plant##5##2##(2008-10#5)
whole plants##8##2##(2008-10#8)
whole plasma##3##2##(1990-5#1)(2008-10#1)(2008-3#1)
whole procedure were##2##3##(2008-10#2)
whole procedure##6##2##(2008-10#4)(2008-11#1)(2011-2#1)
whole process##7##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-8#1)
whole rat##2##2##(1991-3#1)(1995-12#1)
whole serum and the non-protein fraction of serum##2##8##(2008-7#2)
whole set of##4##3##(2008-10#3)(2008-3#1)
whole skull##2##2##(2008-11#2)
whole tissue##2##2##(2008-11#1)(2008-4#1)
whole transcriptome##2##2##(2009-12#2)
whole##399##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#2)(1991-9#1)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#5)(1993-2#8)(1993-8#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#4)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-7#3)(1997-8#2)(2006-6#4)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#130)(2008-11#19)(2008-12#7)(2008-2#1)(2008-3#7)(2008-4#11)(2008-5#11)(2008-7#18)(2008-8#12)(2008-9#14)(2009-10#4)(2009-12#2)(2009-8#1)(2009-9#1)(2010-1#12)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#6)(2010-8#5)(2010-9#1)(2011-2#16)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#6)(2012-9#1)(2013-1#6)(2013-8#8)
whole-blood##6##1##(2008-9#6)
whole-body concentrations of 11-ketotestosterone##2##4##(2010-8#2)
whole-body extracts##2##2##(2013-8#2)
whole-body vibration##2##2##(2013-8#2)
whole-body##14##1##(1992-3#2)(1996-3#1)(2010-8#2)(2012-2#1)(2013-8#8)
whole-brain irradiation##3##2##(1997-4#3)
whole-brain##5##1##(1997-3#1)(1997-4#3)(2013-1#1)
whole-cell and##2##2##(1995-2#1)(2011-3#1)
whole-cell biocatalysis##2##2##(2011-1#1)(2012-2#1)
whole-cell currents##2##2##(1993-3#1)(2008-8#1)
whole-cell recordings##2##2##(1997-7#1)(2008-11#1)
whole-cell##22##1##(1993-3#2)(1994-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#3)(2011-2#1)(2011-3#2)(2012-2#2)(2012-3#1)
whole-genome##9##1##(2008-4#1)(2008-7#4)(2010-10#1)(2012-2#2)(2012-3#1)
whole-leaf##2##1##(2008-10#2)
whole-organism##4##1##(2008-10#1)(2008-9#1)(2009-8#1)(2010-5#1)
whole-plant##7##1##(2008-10#6)(2009-8#1)
wholesome diet##2##2##(2010-6#2)
wholly##5##1##(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-1#1)
whom a##7##2##(1990-3#1)(1991-2#1)(1993-2#1)(2008-1#1)(2008-7#1)(2011-3#1)(2013-1#1)
whom an##2##2##(1997-6#1)(2013-1#1)
whom it was##2##3##(1990-3#1)(2012-3#1)
whom it##6##2##(1990-3#1)(1991-11#1)(2008-1#1)(2010-7#1)(2012-3#2)
whom no##2##2##(1990-2#1)(2010-6#1)
whom the##15##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-3#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
whom##114##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#2)(1991-11#6)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#2)(1992-2#2)(1992-3#3)(1993-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-6#3)(2008-1#4)(2008-10#5)(2008-11#8)(2008-3#3)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#12)
whooping cough##5##2##(1995-5#1)(1997-8#2)(2008-8#2)
whose activity is##3##3##(1991-3#1)(2008-11#1)(2009-8#1)
whose activity##5##2##(1991-3#1)(1991-6#1)(2008-10#1)(2008-11#1)(2009-8#1)
whose back electrochemical reduction was detected on##2##7##(2008-10#2)
whose binding##3##2##(1991-5#1)(2008-10#1)(2010-11#1)
whose cerebellar##3##2##(1994-2#1)(2011-2#2)
whose electrochemical reduction back to##2##5##(2008-10#2)
whose expression is##3##3##(1994-2#1)(1995-11#1)(2008-10#1)
whose expression was##3##3##(1993-6#1)(2008-10#1)(2008-8#1)
whose expression##11##2##(1993-6#1)(1994-2#1)(1995-11#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
whose formation##2##2##(1996-2#1)(2008-7#1)
whose function is##2##3##(2008-8#1)(2009-8#1)
whose function##3##2##(2008-8#1)(2009-8#1)(2012-2#1)
whose functions##2##2##(1994-12#1)(1996-12#1)
whose genome##2##2##(2008-4#1)(2011-10#1)
whose growth##3##2##(2008-8#1)(2009-9#1)(2012-3#1)
whose high##2##2##(2008-11#1)(2008-9#1)
whose individual##2##2##(2008-10#1)(2008-8#1)
whose last##2##2##(2008-9#2)
whose levels##2##2##(2008-10#1)(2008-11#1)
whose main##4##2##(1992-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
whose mothers did not have pre-eclampsia##3##6##(2011-2#3)
whose mothers had pre-eclampsia were##2##5##(2011-2#2)
whose mothers##6##2##(2011-2#6)
whose parameters##2##2##(2008-11#1)(2008-5#1)
whose parents were##4##3##(1994-6#3)(2008-11#1)
whose parents##9##2##(1991-2#1)(1994-6#3)(2008-11#1)(2008-12#1)(2010-11#3)
whose predicted response is##2##4##(2012-2#2)
whose preparatory work was initiated on##3##6##(2010-12#3)
whose presence##3##2##(1993-8#1)(1994-2#1)(2009-5#1)
whose product##2##2##(1995-2#1)(1995-6#1)
whose tertiary structure##2##3##(1992-4#1)(2008-4#1)
whose##273##1##(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#2)(1992-1#2)(1992-12#3)(1992-3#1)(1992-4#1)(1993-1#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#1)(1995-6#4)(1996-11#1)(1996-12#1)(1996-2#6)(1996-3#3)(1996-5#1)(1996-6#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#3)(2007-12#2)(2008-10#43)(2008-11#20)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-11#4)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#18)(2011-3#1)(2012-12#2)(2012-2#11)(2012-3#7)(2013-1#6)(2013-8#7)
why a##5##2##(1994-2#1)(1996-12#1)(2008-9#1)(2010-4#1)(2010-6#1)
why are##4##2##(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#1)
why certain##3##2##(2008-10#2)(2013-8#1)
why do##3##2##(1991-6#1)(1995-2#1)(1997-6#1)
why healthcare##3##2##(1991-9#1)(1992-12#1)(1996-12#1)
why it is important for##2##5##(2009-9#1)(2011-2#1)
why it is necessary to##2##5##(1991-1#1)(2011-1#1)
why it is##5##3##(1991-1#1)(1997-9#1)(2009-9#1)(2011-1#1)(2011-2#1)
why no##2##2##(2008-10#1)(2012-2#1)
why some##4##2##(2008-12#1)(2008-8#1)(2009-5#1)(2012-3#1)
why the##21##2##(1992-2#1)(1992-9#1)(1994-12#1)(1994-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
why these##3##2##(2008-10#2)(2009-8#1)
why they##4##2##(2008-11#1)(2008-6#1)(2009-11#1)(2010-12#1)
why##128##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-9#1)(1993-1#2)(1993-2#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-2#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-9#1)(2008-1#1)(2008-10#16)(2008-11#13)(2008-12#4)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#3)
wide acceptance##2##2##(2008-10#2)
wide and##3##2##(1991-12#1)(2008-10#1)(2008-8#1)
wide application of##2##3##(1994-3#1)(2008-10#1)
wide application##3##2##(1994-3#1)(2008-10#2)
wide applications in##3##3##(2008-10#2)(2012-3#1)
wide area of##2##3##(2008-10#1)(2008-3#1)
wide area##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
wide areas##2##2##(1990-6#1)(2013-1#1)
wide concentration range (1##9##4##(2008-10#9)
wide concentration range of##4##4##(2008-10#4)
wide concentration range##32##3##(1993-8#1)(2008-10#31)
wide concentration ranges##3##3##(2008-10#3)
wide concentration##35##2##(1993-8#1)(2008-10#34)
wide distribution of##2##3##(1994-11#1)(2008-5#1)
wide distribution##5##2##(1994-11#1)(1996-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
wide dynamic range##3##3##(1997-2#1)(2008-10#2)
wide dynamic##4##2##(1997-2#1)(2008-10#2)(2010-7#1)
wide excision of##2##3##(1992-2#2)
wide excision##3##2##(1992-2#2)(2010-11#1)
wide interindividual##2##2##(1993-12#1)(2008-12#1)
wide linear dynamic##2##3##(2008-10#2)
wide linear range and##3##4##(2008-10#3)
wide linear range from##2##4##(2008-10#2)
wide linear range##8##3##(2008-10#8)
wide linear##12##2##(2008-10#12)
wide local excision##4##3##(1990-2#1)(1994-12#1)(2008-9#2)
wide neck##2##2##(1997-3#2)
wide pH range of 3##2##5##(2008-10#2)
wide pH range of##4##4##(2008-10#4)
wide pH range##14##3##(1993-8#1)(2008-10#13)
wide pH##17##2##(1993-8#1)(2008-10#16)
wide range in##2##3##(2008-10#2)
wide range of applications##3##4##(2008-10#2)(2010-12#1)
wide range of biological##2##4##(2008-11#1)(2012-3#1)
wide range of different##2##4##(1997-6#1)(2009-10#1)
wide range of pH##6##4##(2008-10#5)(2013-1#1)
wide range of##141##3##(1990-11#1)(1990-2#1)(1991-2#1)(1992-1#1)(1992-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#57)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
wide range##147##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-1#1)(1992-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#63)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
wide ranging##2##2##(2009-1#1)(2009-8#1)
wide resection##3##2##(1992-9#1)(2008-9#2)
wide size##2##2##(2008-10#1)(2010-8#1)
wide spectrum of##11##3##(1991-2#1)(1993-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#2)(2013-1#1)
wide spectrum##14##2##(1990-12#1)(1991-2#1)(1993-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#2)(2013-1#1)
wide use##2##2##(2008-10#2)
wide variation in##9##3##(1996-12#1)(1996-3#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-1#1)(2012-3#1)
wide variation##10##2##(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-1#1)(2012-3#1)
wide variations##2##2##(1997-8#1)(2008-11#1)
wide variety of other metal ions##5##6##(2008-10#5)
wide variety of other##12##4##(1994-12#1)(2008-10#10)(2011-3#1)
wide variety of sequence##2##4##(2008-2#1)(2008-4#1)
wide variety of##76##3##(1990-2#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-8#1)(2008-10#23)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#5)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#3)(2013-8#1)
wide virulence##2##2##(2008-10#2)
wide working##2##2##(2008-10#2)
wide##468##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#201)(2008-11#28)(2008-12#7)(2008-2#4)(2008-3#16)(2008-4#4)(2008-5#11)(2008-6#4)(2008-7#11)(2008-8#11)(2008-9#17)(2009-1#3)(2009-10#3)(2009-12#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#3)(2011-2#17)(2011-3#1)(2012-2#6)(2012-3#7)(2012-5#1)(2013-1#9)(2013-8#3)
wide-angle##3##1##(2008-3#3)
wide-field##2##1##(2008-1#1)(2008-9#1)
wide-ranging##4##1##(1991-3#1)(1995-12#1)(2008-3#1)(2010-7#1)
wide-scale##2##1##(2008-10#2)
wide-spread##4##1##(1992-6#1)(2008-1#1)(2009-10#1)(2013-8#1)
wideband ultrasound detection##2##3##(2009-5#2)
widely accepted as a##2##4##(2008-11#1)(2013-1#1)
widely accepted as##4##3##(1993-12#1)(2008-11#2)(2013-1#1)
widely accepted that##5##3##(1994-9#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-3#1)
widely accepted##19##2##(1991-3#1)(1991-6#1)(1993-12#2)(1994-9#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
widely acknowledged in the literature##2##5##(2008-11#2)
widely acknowledged##3##2##(1997-5#1)(2008-11#2)
widely adopted##2##2##(2008-10#1)(2008-8#1)
widely applicable##4##2##(2008-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
widely applied##3##2##(2008-11#1)(2010-12#1)(2013-8#1)
widely appreciated##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
widely assumed##2##2##(2008-8#1)(2013-1#1)
widely available##8##2##(2008-11#1)(2008-6#1)(2009-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
widely between the##2##3##(2008-11#1)(2012-3#1)
widely comparable##2##2##(2008-10#2)
widely considered a##2##3##(2009-4#1)(2009-6#1)
widely cultivated##2##2##(2008-10#1)(2008-12#1)
widely different##4##2##(1993-8#1)(1994-5#1)(1997-8#1)(2008-10#1)
widely differing##2##2##(2008-10#1)(2008-9#1)
widely discussed##4##2##(1994-2#1)(2008-11#1)(2009-6#1)(2013-1#1)
widely disseminated to##2##3##(1996-1#1)(1996-2#1)
widely disseminated##3##2##(1995-6#1)(1996-1#1)(1996-2#1)
widely distributed among##2##3##(2008-12#1)(2008-8#1)
widely distributed in the##2##4##(1993-11#1)(2009-12#1)
widely distributed in##6##3##(1993-11#1)(2008-10#4)(2009-12#1)
widely distributed throughout##2##3##(2008-10#1)(2010-5#1)
widely distributed##21##2##(1990-8#1)(1993-11#1)(1995-5#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2012-3#2)
widely employed##3##2##(2008-10#1)(2008-11#2)
widely expressed##3##2##(1993-12#1)(1997-7#1)(2012-3#1)
widely from##3##2##(1997-3#1)(2008-10#1)(2012-3#1)
widely grown in##2##3##(2008-10#2)
widely held##2##2##(2008-7#1)(2010-10#1)
widely in the##2##3##(2008-11#1)(2011-3#1)
widely in their ability to##2##5##(1991-2#1)(2008-5#1)
widely in their##4##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
widely in##13##2##(1991-2#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-3#1)(2013-8#1)
widely investigated##2##2##(2008-5#1)(2012-2#1)
widely recognised##2##2##(2008-11#2)
widely recognized as the##3##4##(2008-12#1)(2008-9#1)(2010-12#1)
widely recognized##6##2##(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)
widely reported in##2##3##(2009-3#1)(2013-1#1)
widely reported##4##2##(2008-11#2)(2009-3#1)(2013-1#1)
widely separated##2##2##(1995-2#1)(2008-11#1)
widely throughout##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
widely to##3##2##(1993-11#1)(2008-10#1)(2010-10#1)
widely tunable##4##2##(2007-12#1)(2008-2#3)
widely used as a model##3##5##(2008-9#1)(2009-9#1)(2010-1#1)
widely used as a##6##4##(2008-10#2)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#1)
widely used as an##2##4##(1996-8#1)(2008-5#1)
widely used as##11##3##(1996-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#1)
widely used by##2##3##(2008-8#1)(2008-9#1)
widely used for the production of recombinant proteins##2##8##(2008-11#2)
widely used for the##7##4##(1997-8#1)(2008-10#3)(2008-11#2)(2008-7#1)
widely used for##18##3##(1997-8#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
widely used herbicide##4##3##(1995-8#1)(2008-10#3)
widely used in Japan##3##4##(2008-10#2)(2010-6#1)
widely used in clinical##2##4##(2008-10#1)(2010-11#1)
widely used in cosmetics and##2##5##(2008-5#2)
widely used in the##6##4##(2008-1#1)(2008-10#1)(2008-11#2)(2010-12#1)(2010-6#1)
widely used in##34##3##(1990-6#1)(1994-12#1)(1996-1#1)(1996-6#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#2)(2011-1#1)(2012-3#2)(2013-1#2)
widely used method##2##3##(2008-4#1)(2013-8#1)
widely used to assess##2##4##(2008-11#1)(2010-5#1)
widely used to monitor patients##2##5##(1990-2#1)(2008-10#1)
widely used to##8##3##(1990-2#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
widely used##130##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-1#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#35)(2008-11#17)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#7)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#3)(2010-7#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#1)
widely utilized for##2##3##(2008-10#1)(2008-9#1)
widely utilized##5##2##(2008-10#1)(2008-4#1)(2008-9#2)(2009-11#1)
widely##322##1##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#71)(2008-11#45)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#14)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#4)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#4)(2010-5#2)(2010-6#3)(2010-7#2)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#12)(2013-1#15)(2013-8#3)
widely-used##3##1##(2008-10#1)(2008-11#1)(2008-8#1)
widen the horizon of##2##4##(2008-12#1)(2010-8#1)
widen the##4##2##(2008-10#2)(2008-12#1)(2010-8#1)
widen##5##1##(2007-12#1)(2008-10#2)(2008-12#1)(2010-8#1)
widened##5##1##(1995-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
widening in##3##2##(2011-2#3)
widening of##3##2##(2010-1#1)(2013-1#2)
widening##14##1##(1997-8#3)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#4)(2011-3#1)(2013-1#2)
widens##2##1##(2008-12#1)(2008-8#1)
wider and the##2##3##(2008-10#2)
wider applicability##2##2##(2008-2#1)(2012-2#1)
wider dynamic range##2##3##(2008-10#1)(2008-3#1)
wider spectrum##2##2##(2008-9#1)(2013-8#1)
wider than the range of##2##5##(2008-8#2)
wider than##3##2##(2008-10#1)(2008-8#2)
wider use##2##2##(1992-1#1)(1997-2#1)
wider virulence##2##2##(2008-10#2)
wider##64##1##(1991-6#1)(1992-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
widespread among##3##2##(1995-8#1)(2007-12#1)(2011-2#1)
widespread and##4##2##(1997-3#1)(2008-10#2)(2012-3#1)
widespread application in the##2##4##(2010-7#1)(2011-2#1)
widespread application in##3##3##(2008-7#1)(2010-7#1)(2011-2#1)
widespread application##4##2##(1997-1#1)(2008-7#1)(2010-7#1)(2011-2#1)
widespread attention##3##2##(2008-5#1)(2008-6#1)(2011-2#1)
widespread deployment of##2##3##(2008-10#2)
widespread deployment##3##2##(2008-10#3)
widespread disease##4##2##(2008-10#4)
widespread distribution of##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
widespread distribution##6##2##(2008-10#3)(2008-11#1)(2012-3#2)
widespread environmental##3##2##(1994-3#1)(2008-10#2)
widespread in##3##2##(2008-10#3)
widespread loss of##2##3##(2008-7#1)(2013-1#1)
widespread occurrence in##2##3##(2008-10#1)(2008-9#1)
widespread occurrence of##4##3##(1996-12#1)(1997-7#1)(2008-10#1)(2008-9#1)
widespread occurrence##6##2##(1996-12#1)(1997-7#1)(2008-10#2)(2008-9#2)
widespread over##2##2##(2010-1#1)(2013-1#1)
widespread pain##3##2##(1997-4#2)(2011-2#1)
widespread use of##7##3##(1993-12#1)(1996-11#1)(1997-8#1)(2008-11#1)(2008-7#2)(2012-2#1)
widespread use##13##2##(1990-2#1)(1991-12#1)(1993-12#1)(1993-3#1)(1996-11#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-7#2)(2012-12#1)(2012-2#1)(2012-3#1)
widespread##140##1##(1990-2#1)(1990-6#1)(1991-12#2)(1991-3#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#45)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#7)(2009-11#1)(2010-1#3)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)
widowbird##2##1##(2008-8#2)
width and##10##2##(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#2)(2010-10#1)(2013-1#1)
width as##2##2##(2008-3#1)(2012-12#1)
width at##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
width between##2##2##(2008-10#1)(2008-11#1)
width for##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
width is approximately##2##3##(2008-2#1)(2008-3#1)
width of the##13##3##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2011-2#1)(2012-12#1)
width of##25##2##(1993-12#1)(1994-9#1)(1997-3#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-3#7)(2011-2#1)(2012-12#1)(2013-1#1)
width was##2##2##(2008-10#2)
width##94##1##(1993-12#3)(1994-9#1)(1997-3#1)(2007-11#1)(2007-12#4)(2008-10#33)(2008-11#3)(2008-2#5)(2008-3#17)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#2)(2009-12#1)(2010-10#5)(2011-2#2)(2012-12#6)(2012-3#1)(2013-1#4)
widths and##2##2##(2007-11#1)(2008-10#1)
widths of##2##2##(1991-12#1)(2008-3#1)
widths were##2##2##(2008-7#2)
widths##11##1##(1991-12#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-7#3)(2008-8#1)
wife##6##1##(1990-11#1)(1996-5#1)(1997-6#1)(2008-11#1)(2009-1#1)(2012-2#1)
wigs after xenogeneic hair transplantation##2##5##(2012-3#2)
wigs##9##1##(2012-3#9)
wild Senegal doves##2##3##(2008-5#2)
wild Solanum spp##5##3##(2008-10#5)
wild Solanum##7##2##(2008-10#7)
wild and cultivated##5##3##(2008-10#4)(2013-8#1)
wild and domestic##2##3##(1990-3#1)(2011-2#1)
wild and##10##2##(1990-3#1)(2008-10#4)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
wild annual sunflowers (Helianthus spp##2##5##(2008-8#2)
wild birds##3##2##(2011-2#3)
wild grass-infecting##2##2##(2008-10#2)
wild host##3##2##(2008-10#3)
wild mammals kept in##2##4##(1996-12#2)
wild mouse##2##2##(1994-12#1)(2008-10#1)
wild oats##4##2##(2008-10#4)
wild olive##2##2##(2008-10#2)
wild plants##2##2##(2008-10#2)
wild populations##2##2##(2008-9#1)(2013-8#1)
wild species##5##2##(2008-10#1)(2008-9#2)(2011-2#1)(2013-1#1)
wild type (WT)##5##3##(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
wild type alpha2M##2##3##(2008-11#2)
wild type and latently infected strains##2##6##(2008-10#2)
wild type and mutant##2##4##(2008-8#2)
wild type and##7##3##(2008-10#3)(2008-11#1)(2008-8#3)
wild type is##2##3##(2008-8#2)
wild type on##2##3##(1997-3#1)(2008-10#1)
wild type strain##7##3##(2008-12#1)(2008-8#4)(2008-9#2)
wild type strains##2##3##(1990-5#1)(1997-8#1)
wild type were##2##3##(1995-2#1)(2008-10#1)
wild type##88##2##(1990-12#1)(1990-5#2)(1991-5#1)(1992-6#1)(1993-3#3)(1993-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1997-3#3)(1997-7#2)(1997-8#3)(2008-10#24)(2008-11#9)(2008-12#2)(2008-5#1)(2008-8#14)(2008-9#5)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#3)
wild type)##2##2##(1995-2#1)(2008-10#1)
wild vegetation without trees##2##4##(2013-1#2)
wild vegetation##4##2##(2013-1#4)
wild##197##1##(1990-12#1)(1990-3#1)(1990-5#2)(1991-5#1)(1992-6#1)(1993-3#3)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-9#1)(1996-12#2)(1997-3#3)(1997-7#2)(1997-8#3)(2008-10#76)(2008-11#12)(2008-12#5)(2008-5#4)(2008-7#1)(2008-8#25)(2008-9#9)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#8)
wild-caught##3##1##(2008-8#1)(2010-4#1)(2010-8#1)
wild-type (WT) and##2##3##(2012-3#1)(2013-1#1)
wild-type (WT)##4##2##(2008-10#1)(2012-3#2)(2013-1#1)
wild-type CN##3##2##(2008-9#3)
wild-type MRP##2##2##(2008-11#2)
wild-type Mb##3##2##(1994-5#3)
wild-type P##2##2##(2008-10#2)
wild-type Philippine strain##2##3##(2008-10#2)
wild-type TRbeta1##3##2##(1995-8#3)
wild-type X##2##2##(2008-10#2)
wild-type and mutant##8##3##(1991-6#1)(1992-4#1)(1993-8#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-7#1)
wild-type and rtN236T mutant##2##4##(2013-1#2)
wild-type and rtN236T##3##3##(2013-1#3)
wild-type and##22##2##(1991-6#1)(1992-4#1)(1993-8#1)(1995-6#1)(1997-3#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#3)(2010-10#1)(2011-3#1)(2013-1#3)
wild-type animals##3##2##(1996-2#1)(2009-8#1)(2012-3#1)
wild-type barley##2##2##(2008-10#2)
wild-type cells##4##2##(1991-7#1)(1995-9#1)(1996-3#1)(2009-9#1)
wild-type colonies##2##2##(2008-10#2)
wild-type enzyme##16##2##(1990-10#4)(1991-5#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-6#7)
wild-type gene##3##2##(1990-5#1)(1991-12#1)(1992-9#1)
wild-type histidase##2##2##(1994-5#2)
wild-type isolate##6##2##(2008-10#6)
wild-type isolates##7##2##(2008-10#7)
wild-type mice##4##2##(1993-12#1)(1996-12#1)(2010-11#1)(2011-2#1)
wild-type or kinase-negative receptors##2##4##(1997-7#2)
wild-type or##4##2##(1997-7#3)(2008-9#1)
wild-type p53 protein##3##3##(1990-12#1)(1991-5#1)(1994-9#1)
wild-type p53##7##2##(1990-12#1)(1991-5#3)(1993-11#2)(1994-9#1)
wild-type parent##2##2##(1995-2#1)(2008-10#1)
wild-type strain of##3##3##(2008-10#3)
wild-type strain##25##2##(2008-10#23)(2008-7#1)(2009-6#1)
wild-type strains and##3##3##(2008-10#3)
wild-type strains in##2##3##(2008-10#2)
wild-type strains##11##2##(2008-10#9)(2011-2#1)(2012-3#1)
wild-type virus##8##2##(1993-6#1)(2008-10#5)(2011-3#1)(2013-1#1)
wild-type viruses##2##2##(2008-10#1)(2013-1#1)
wild-type##248##1##(1990-10#4)(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#3)(1991-5#6)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-4#2)(1992-6#1)(1992-9#4)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#7)(1994-5#8)(1994-9#1)(1995-12#2)(1995-2#8)(1995-6#10)(1995-8#5)(1995-9#3)(1996-12#1)(1996-2#1)(1996-3#3)(1997-3#4)(1997-7#4)(1997-8#1)(2008-10#94)(2008-11#4)(2008-2#1)(2008-7#3)(2008-8#7)(2008-9#9)(2009-10#3)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2011-1#3)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#7)(2013-8#1)
wildlife forensic##2##2##(2008-12#2)
wildlife species##2##2##(2008-12#2)
wildlife##15##1##(1990-3#4)(2008-10#1)(2008-12#7)(2008-9#1)(2013-1#2)
wildtype##3##1##(2008-10#2)(2012-2#1)
will &quot##2##2##(1994-3#1)(2008-10#1)
will accomplish##2##2##(1997-7#1)(2008-10#1)
will achieve its##2##3##(1991-12#1)(1994-1#1)
will achieve##6##2##(1991-12#1)(1994-1#3)(2008-8#1)(2010-5#1)
will activate##2##2##(2007-8#1)(2008-7#1)
will address the##7##3##(1994-3#2)(1996-1#1)(2008-10#3)(2008-7#1)
will address##10##2##(1994-3#2)(1995-5#1)(1996-1#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-7#1)
will affect the##9##3##(1991-1#1)(2008-10#3)(2008-12#1)(2008-9#2)(2009-5#1)(2010-9#1)
will affect##10##2##(1991-1#1)(2008-10#3)(2008-12#1)(2008-9#2)(2009-5#1)(2010-9#1)(2012-2#1)
will aid in the development of##3##6##(2008-11#1)(2008-7#1)(2012-2#1)
will aid in##4##3##(2008-11#1)(2008-7#1)(2010-9#1)(2012-2#1)
will aid##7##2##(1997-2#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
will allow for##3##3##(1997-3#1)(2008-10#2)
will allow the##8##3##(1990-9#1)(1991-2#1)(1994-3#1)(1994-5#2)(2008-10#1)(2008-5#1)(2009-7#1)
will allow us to##3##4##(1993-2#1)(2008-10#1)(2008-7#1)
will allow##37##2##(1990-9#1)(1991-2#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
will also be discussed##3##4##(2010-12#1)(2011-2#2)
will also be##12##3##(1992-2#2)(1997-1#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2013-8#1)
will also discuss the##2##4##(1993-12#1)(2008-10#1)
will also discuss##4##3##(1993-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
will also help##3##3##(1994-12#1)(2008-8#1)(2008-9#1)
will also##43##2##(1991-12#1)(1992-2#2)(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
will always be##2##3##(1991-2#1)(1995-1#1)
will and##2##2##(1992-1#1)(2008-12#1)
will appear##4##2##(1993-12#2)(1995-1#1)(2010-5#1)
will apply##2##2##(1994-3#1)(2008-10#1)
will argue that##2##3##(1996-2#1)(2010-3#1)
will assist in##4##3##(2008-10#2)(2008-5#1)(2009-7#1)
will assist##7##2##(2008-10#3)(2008-11#2)(2008-5#1)(2009-7#1)
will attempt to##2##3##(1996-5#1)(2012-2#1)
will be a useful tool##2##5##(2008-10#1)(2008-11#1)
will be a##11##3##(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
will be able to##11##4##(1991-12#1)(1991-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-8#1)(2012-3#2)(2013-8#1)
will be achieved##2##3##(2008-5#1)(2011-2#1)
will be addressed##4##3##(2008-1#1)(2008-10#1)(2009-12#1)(2011-2#1)
will be also discussed##2##4##(2008-11#2)
will be also##4##3##(2008-11#2)(2008-12#1)(2011-2#1)
will be an##7##3##(1996-1#1)(2008-10#1)(2008-11#3)(2008-9#1)(2012-2#1)
will be at##2##3##(1992-6#1)(2008-5#1)
will be available##2##3##(1990-11#1)(1997-1#1)
will be beneficial for##2##4##(2008-10#1)(2012-12#1)
will be beneficial in##2##4##(2008-10#1)(2008-3#1)
will be beneficial##6##3##(2008-10#2)(2008-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
will be better##3##3##(1997-1#1)(2008-11#1)(2008-8#1)
will be compared##2##3##(1995-2#1)(2008-10#1)
will be considered a##2##4##(1994-12#1)(1994-2#1)
will be defined##2##3##(1995-12#1)(1997-3#1)
will be demonstrated##2##3##(1995-2#1)(2008-10#1)
will be dependent##2##3##(1995-1#1)(1997-8#1)
will be described in##2##4##(1995-3#1)(2008-5#1)
will be described##8##3##(1995-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-4#1)(2011-3#1)
will be determined##2##3##(1995-8#1)(2008-3#1)
will be developed##2##3##(1997-1#1)(2008-11#1)
will be difficult##3##3##(1991-7#1)(1994-12#1)(1997-6#1)
will be discussed##30##3##(1995-3#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-7#1)
will be essential for##3##4##(2010-8#1)(2011-2#2)
will be essential##5##3##(1996-3#1)(2008-10#1)(2010-8#1)(2011-2#2)
will be evaluated##3##3##(2008-10#2)(2013-7#1)
will be examined##3##3##(1996-1#1)(2008-1#1)(2008-11#1)
will be explained##2##3##(1997-3#1)(2008-7#1)
will be explored##2##3##(2008-11#2)
will be facilitated by the##2##5##(1995-1#1)(1995-12#1)
will be given##3##3##(2008-11#3)
will be helpful to##4##4##(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
will be helpful##5##3##(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-7#1)
will be highlighted##2##3##(2012-12#1)(2012-2#1)
will be identified##2##3##(1997-2#1)(2008-11#1)
will be illustrated##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
will be implemented##3##3##(1991-2#1)(1996-8#1)(2012-12#1)
will be important in##2##4##(2008-6#1)(2010-10#1)
will be important to##2##4##(1997-7#1)(2008-10#1)
will be important##5##3##(1995-12#1)(1997-7#1)(2008-10#1)(2008-6#1)(2010-10#1)
will be inadequate##2##3##(1993-3#1)(2008-8#1)
will be included to##2##4##(2008-12#1)(2008-4#1)
will be included##4##3##(2008-10#1)(2008-12#1)(2008-4#2)
will be increased##2##3##(2008-11#1)(2011-2#1)
will be instrumental##2##3##(1996-3#1)(2012-2#1)
will be introduced##2##3##(2010-11#1)(2011-3#1)
will be invaluable##2##3##(1995-1#1)(2008-7#1)
will be launched##2##3##(2008-3#1)(2008-5#1)
will be less##2##3##(1993-1#1)(2008-10#1)
will be minimized##2##3##(1995-9#1)(2008-3#1)
will be more##8##3##(1997-3#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-8#2)(2011-2#2)
will be necessary to##3##4##(2008-5#1)(2009-7#1)(2012-2#1)
will be necessary##6##3##(1992-3#2)(2008-5#1)(2009-7#1)(2009-8#1)(2012-2#1)
will be needed to##3##4##(1991-12#1)(2008-10#2)
will be needed##6##3##(1990-6#1)(1991-12#1)(2008-10#4)
will be no##2##3##(1995-8#1)(2008-10#1)
will be of##3##3##(2008-10#2)(2010-8#1)
will be on##2##3##(1996-5#1)(2008-11#1)
will be outlined##4##3##(2008-11#1)(2008-12#1)(2009-10#1)(2012-2#1)
will be possible##5##3##(1991-12#1)(1992-3#1)(1992-9#1)(2008-8#1)(2009-8#1)
will be presented and##2##4##(2008-11#1)(2012-2#1)
will be presented##7##3##(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2012-2#1)(2013-7#1)
will be proposed##2##3##(1997-1#1)(2009-7#1)
will be provided##3##3##(2008-12#1)(2008-8#1)(2012-3#1)
will be published in the summer##2##6##(1995-1#1)(1996-1#1)
will be published in the##4##5##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)
will be published on December 31##2##6##(2010-12#2)
will be published on##3##4##(2010-12#3)
will be published##7##3##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2010-12#3)
will be required to##5##4##(1992-2#1)(1993-12#1)(2008-11#1)(2008-12#1)(2008-4#1)
will be required##9##3##(1990-6#1)(1992-2#1)(1993-12#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-2#1)
will be reviewed##9##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
will be sent to##2##4##(2009-12#1)(2011-3#1)
will be shown##2##3##(2008-10#2)
will be summarized##3##3##(1993-2#1)(1997-1#1)(2013-7#1)
will be the development of##2##5##(1996-3#2)
will be the key to##2##5##(1994-3#1)(2011-9#1)
will be the key##3##4##(1994-3#1)(2009-8#1)(2011-9#1)
will be the##13##3##(1991-12#2)(1994-1#1)(1994-3#1)(1996-11#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-10#1)(2011-9#1)
will be to##3##3##(1994-9#1)(1995-6#1)(2008-10#1)
will be treated##2##3##(1994-9#1)(2008-10#1)
will be unable to##2##4##(1992-2#1)(1997-7#1)
will be used to##7##4##(1992-2#1)(1993-2#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
will be used##10##3##(1992-2#1)(1993-2#1)(1995-2#1)(1997-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
will be useful for further##2##5##(2008-10#1)(2011-1#1)
will be useful for studying##2##5##(1995-2#1)(2008-11#1)
will be useful for the##5##5##(2008-10#2)(2008-12#1)(2008-5#1)(2010-11#1)
will be useful for##13##4##(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-1#1)
will be useful in the##2##5##(1991-5#1)(1997-8#1)
will be useful in##8##4##(1991-5#1)(1992-3#1)(1997-8#2)(2008-10#3)(2013-8#1)
will be useful to##4##4##(2008-11#2)(2008-8#1)(2012-2#1)
will be useful##26##3##(1991-5#1)(1992-3#1)(1995-2#1)(1996-12#1)(1997-8#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
will be valuable for future##2##5##(2008-10#1)(2012-3#1)
will be valuable##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
will be##437##2##(1990-11#1)(1990-6#3)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#3)(1992-3#9)(1992-6#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#1)(1994-1#3)(1994-12#3)(1994-2#5)(1994-3#1)(1994-6#1)(1994-9#6)(1995-1#6)(1995-12#7)(1995-2#8)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#6)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#7)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#5)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#4)(2008-1#4)(2008-10#71)(2008-11#44)(2008-12#11)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#18)(2008-6#2)(2008-7#7)(2008-8#19)(2008-9#6)(2009-10#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#5)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#12)(2011-3#7)(2011-9#1)(2012-12#4)(2012-2#12)(2012-3#7)(2013-1#3)(2013-7#6)(2013-8#5)
will become a##2##3##(1992-2#1)(2008-10#1)
will become the##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
will become##12##2##(1992-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
will benefit##3##2##(1996-2#1)(2008-10#2)
will briefly##3##2##(1996-1#1)(2010-5#1)(2012-2#1)
will bring##3##2##(1994-8#1)(2008-11#1)(2012-3#1)
will cause##5##2##(1994-12#1)(1996-12#1)(2008-3#1)(2011-2#2)
will center##3##2##(1992-3#1)(1995-1#1)(1997-1#1)
will centre on##2##3##(2008-10#2)
will certainly##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
will change##3##2##(2008-8#2)(2010-11#1)
will characterize##2##2##(2008-8#1)(2008-9#1)
will come into##2##3##(2008-11#2)
will come##5##2##(1992-3#1)(2008-10#1)(2008-11#2)(2012-3#1)
will conclude##4##2##(1994-1#2)(2008-1#1)(2008-7#1)
will consider the##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
will consider##4##2##(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
will consist##2##2##(1995-6#1)(2008-5#1)
will continue to be##2##4##(1997-1#1)(2008-9#1)
will continue to offer##2##4##(1997-8#1)(2010-7#1)
will continue to##20##3##(1990-11#1)(1992-3#1)(1993-1#1)(1994-6#1)(1995-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-6#1)(2013-8#1)
will continue##23##2##(1990-11#1)(1991-2#1)(1992-3#1)(1993-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-6#1)(2013-8#1)
will contribute to the understanding of##2##6##(2008-9#1)(2010-5#1)
will contribute to the##4##4##(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)
will contribute to understanding##2##4##(2008-11#1)(2012-9#1)
will contribute to##9##3##(1996-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-9#1)
will contribute##12##2##(1996-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#2)(2012-9#1)
will decide##3##2##(2008-1#1)(2008-10#1)(2013-7#1)
will decrease##4##2##(1996-2#1)(1996-9#1)(2008-8#1)(2008-9#1)
will demand##3##2##(1992-3#1)(1993-12#1)(2011-2#1)
will demonstrate that##3##3##(2008-10#1)(2008-5#2)
will demonstrate##4##2##(2008-10#1)(2008-12#1)(2008-5#2)
will depend on the##7##4##(1990-2#1)(1994-12#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-8#1)
will depend on##11##3##(1990-2#1)(1994-12#1)(1996-2#1)(1997-1#1)(1997-7#2)(2008-10#2)(2008-8#1)(2010-3#1)(2012-3#1)
will describe some##2##3##(2008-5#1)(2013-8#1)
will describe the##2##3##(2008-9#1)(2010-10#1)
will describe##7##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)(2013-8#2)
will determine##2##2##(1992-12#1)(2013-8#1)
will develop a##2##3##(1994-12#1)(1996-1#1)
will develop##7##2##(1994-12#1)(1996-1#2)(1997-3#1)(2008-12#1)(2008-4#1)(2008-7#1)
will differ in##2##3##(2008-8#1)(2012-6#1)
will direct##2##2##(1994-8#1)(2009-10#1)
will discuss about##2##3##(2012-3#2)
will discuss how##4##3##(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)
will discuss recent##2##3##(2009-6#1)(2011-2#1)
will discuss the development of##2##5##(2008-10#1)(2008-11#1)
will discuss the##15##3##(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
will discuss##36##2##(2008-10#5)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
will do##2##2##(1994-3#1)(2008-11#1)
will dramatically##2##2##(1997-3#1)(2008-11#1)
will enable the##6##3##(1996-9#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#2)
will enable##13##2##(1993-2#1)(1996-9#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2010-9#1)(2011-2#2)
will encourage##2##2##(1992-12#1)(2008-12#1)
will enhance our understanding of the##2##6##(1991-3#1)(2008-7#1)
will enhance our understanding of##3##5##(1991-3#1)(2008-7#1)(2013-1#1)
will enhance our##5##3##(1991-3#1)(1996-2#1)(2008-7#1)(2012-12#1)(2013-1#1)
will enhance the##5##3##(1993-3#1)(1995-1#1)(1997-1#1)(2009-6#1)(2011-2#1)
will enhance##12##2##(1991-3#1)(1993-3#1)(1995-1#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
will ensure##2##2##(1994-2#1)(2008-11#1)
will establish a##2##3##(1990-12#1)(2008-7#1)
will evaluate##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
will eventually be##2##3##(1992-3#1)(1992-6#1)
will eventually##5##2##(1992-3#1)(1992-6#1)(1993-12#1)(2008-10#2)
will evolve##2##2##(1992-12#1)(2008-8#1)
will examine the##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
will examine##6##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-2#1)
will experience##5##2##(1990-12#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
will explore a##2##3##(1994-12#1)(2008-11#1)
will explore the##3##3##(1991-12#1)(1996-1#1)(2008-11#1)
will explore##8##2##(1991-12#1)(1994-1#3)(1994-12#1)(1996-1#1)(2008-11#2)
will extend the##3##3##(1994-5#1)(2008-11#1)(2008-3#1)
will face##4##2##(1994-1#1)(1997-1#1)(1997-3#1)(2008-4#1)
will facilitate map-based cloning of the##2##6##(2008-8#1)(2008-9#1)
will facilitate the positional cloning##2##5##(1995-6#1)(2008-9#1)
will facilitate the##10##3##(1992-10#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-9#1)(2009-10#1)(2013-1#2)
will facilitate##23##2##(1992-10#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-6#1)(1997-8#1)(2008-10#7)(2008-8#1)(2008-9#3)(2009-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
will fall##2##2##(2008-10#1)(2008-5#1)
will find##4##2##(1994-1#2)(2008-10#1)(2012-3#1)
will first##4##2##(2008-12#1)(2008-4#1)(2012-2#1)(2013-8#1)
will focus on chief technologists and will be published in the##2##11##(1995-1#1)(1995-2#1)
will focus on the##11##4##(1994-3#1)(1995-12#1)(1997-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-2#1)
will focus on##26##3##(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
will focus##27##2##(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
will form##2##2##(1994-3#1)(2008-7#1)
will further##5##2##(1993-1#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
will gain##2##2##(2008-4#1)(2011-2#1)
will generally##2##2##(2008-10#2)
will get##2##2##(1996-5#1)(2008-11#1)
will give##5##2##(1990-9#1)(1991-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
will go##2##2##(1993-2#1)(2008-4#1)
will greatly##4##2##(1994-1#1)(1996-8#1)(1997-7#1)(2008-10#1)
will grow##2##2##(2008-7#1)(2008-8#1)
will have a##8##3##(1991-6#1)(1992-1#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-8#1)(2009-9#1)(2011-2#1)
will have properties##2##3##(2008-3#1)(2008-8#1)
will have the##5##3##(1993-12#1)(1994-1#1)(2008-10#1)(2008-4#1)(2013-8#1)
will have to be##4##4##(1995-11#1)(1997-8#1)(2009-5#1)(2012-2#1)
will have to##8##3##(1992-2#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-8#1)(2009-5#1)(2012-2#1)
will have##43##2##(1990-6#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#1)(1994-1#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
will help elucidate the##2##4##(1997-7#1)(2012-2#1)
will help in##5##3##(1995-6#1)(2009-12#2)(2011-2#1)(2013-1#1)
will help the##3##3##(1993-1#1)(2008-11#1)(2008-8#1)
will help to develop##2##4##(1994-5#1)(2008-10#1)
will help to##8##3##(1994-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)
will help us##3##3##(2010-11#1)(2010-5#1)(2011-2#1)
will help you##2##3##(1993-1#1)(1995-2#1)
will help##33##2##(1993-1#2)(1994-5#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)
will hopefully##4##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
will identify the##2##3##(2008-11#1)(2009-2#1)
will identify##6##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-2#1)
will impact##2##2##(1994-1#1)(2013-8#1)
will improve the##3##3##(1991-11#1)(1997-7#1)(2008-3#1)
will improve##10##2##(1991-11#1)(1994-1#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-3#1)(2009-4#1)(2009-6#1)(2012-12#1)
will in##2##2##(1992-6#1)(2012-3#1)
will include the##2##3##(2008-11#2)
will include##3##2##(2008-11#3)
will increase the##5##3##(1993-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-7#1)
will increase##19##2##(1990-12#1)(1991-1#1)(1992-2#1)(1993-11#1)(1994-2#2)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
will increasingly##2##2##(1991-3#1)(2013-8#1)
will inevitably##3##2##(2008-3#1)(2011-2#1)(2012-5#1)
will influence the##3##3##(1994-9#1)(2011-3#1)(2012-6#1)
will influence##6##2##(1990-12#1)(1994-9#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-6#1)
will introduce the##2##3##(2008-4#1)(2010-11#1)
will involve##3##2##(1993-11#1)(2008-10#1)(2013-1#1)
will it be##2##3##(1997-8#1)(2008-9#1)
will it##3##2##(1997-8#1)(2008-11#1)(2008-9#1)
will keep##3##2##(1994-3#2)(2008-10#1)
will know##2##2##(1997-3#1)(1997-4#1)
will lead to a##4##4##(1990-3#1)(2008-10#1)(2010-7#1)(2011-2#1)
will lead to the##2##4##(2008-5#1)(2008-8#1)
will lead to##15##3##(1990-3#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-3#3)
will lead##18##2##(1990-3#1)(1991-3#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-3#3)
will likely result in##2##4##(1996-2#1)(2009-3#1)
will likely##11##2##(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-8#1)(2012-3#1)(2013-8#1)
will limit the##2##3##(2008-11#1)(2008-3#1)
will limit##3##2##(1997-1#1)(2008-11#1)(2008-3#1)
will look at##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
will make it##4##3##(1996-5#1)(1997-1#1)(2008-10#1)(2009-8#1)
will make##10##2##(1993-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2009-8#1)(2013-7#1)
will mature##2##2##(1994-2#1)(2008-10#1)
will maximize##2##2##(2012-2#1)(2012-3#1)
will meet the##3##3##(1994-12#1)(2008-11#1)(2008-3#1)
will more##2##2##(1995-12#1)(2012-5#1)
will most##5##2##(1996-1#1)(1997-8#1)(2008-1#1)(2011-3#1)(2012-3#1)
will move##2##2##(2008-11#1)(2009-5#1)
will need to be##4##4##(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
will need to develop##2##4##(1992-2#1)(1994-12#1)
will need to##10##3##(1992-2#1)(1992-9#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
will need##11##2##(1992-2#1)(1992-9#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
will no doubt##3##3##(1992-1#1)(1995-5#1)(2013-8#1)
will not be available##2##4##(1997-8#1)(2008-10#1)
will not be##14##3##(1994-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-4#1)
will not only##4##3##(1994-2#1)(1997-1#1)(2008-10#1)(2013-1#1)
will not##38##2##(1991-12#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-1#3)(1997-8#2)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#2)(2010-4#1)(2011-3#2)(2012-5#1)(2013-1#1)
will now be##2##3##(1997-1#1)(2011-2#1)
will occur at##2##3##(2008-10#1)(2011-2#1)
will occur##8##2##(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
will often be##4##3##(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)
will often##8##2##(2008-11#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
will only be##4##3##(1997-7#1)(2008-7#1)(2008-8#1)(2008-9#1)
will only##8##2##(1995-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)
will operate##2##2##(2008-9#1)(2012-3#1)
will outline the##2##3##(2008-7#1)(2010-6#1)
will outline##4##2##(1994-1#2)(2008-7#1)(2010-6#1)
will pass##2##2##(2008-10#1)(2008-3#1)
will pay##5##2##(1992-12#1)(1995-6#2)(1997-2#1)(2010-4#1)
will permit##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
will play an important role##3##5##(2008-3#1)(2008-7#1)(2012-2#1)
will play an##4##3##(2008-3#1)(2008-7#1)(2011-7#1)(2012-2#1)
will play##6##2##(2008-3#1)(2008-7#1)(2011-7#1)(2012-2#1)(2012-3#2)
will present a##3##3##(1994-3#1)(2008-10#1)(2009-6#1)
will present the##2##3##(1993-2#1)(2009-12#1)
will present##7##2##(1993-2#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-6#1)
will probably be##4##3##(1994-6#1)(2008-10#1)(2008-12#1)(2010-1#1)
will probably##10##2##(1991-12#1)(1994-6#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-1#1)(2010-1#1)
will produce##5##2##(1995-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)
will progress##3##2##(2008-7#1)(2009-10#2)
will promote the##2##3##(2008-10#1)(2008-11#1)
will promote##6##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-11#2)(2011-2#1)
will provide a##14##3##(1994-3#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#2)
will provide an overview of the##2##6##(2009-4#1)(2011-2#1)
will provide an##4##3##(2006-6#1)(2008-10#1)(2009-4#1)(2011-2#1)
will provide important##2##3##(2011-2#1)(2013-1#1)
will provide new##2##3##(2008-11#2)
will provide the##4##3##(1995-2#1)(2008-9#1)(2009-12#1)(2011-10#1)
will provide##47##2##(1991-1#1)(1991-2#1)(1994-2#1)(1994-3#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(2006-6#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-4#3)(2010-5#1)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
will reach##4##2##(1993-3#1)(1994-9#1)(1997-6#1)(2013-8#1)
will receive either GS-4104 or placebo for##2##7##(2008-5#2)
will receive##4##2##(1993-12#1)(1995-1#1)(2008-5#2)
will recognize##2##2##(1996-1#1)(2013-7#1)
will reduce the##4##3##(1991-2#1)(2008-10#1)(2008-9#1)(2012-3#1)
will reduce##10##2##(1991-2#1)(1991-3#1)(1992-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)
will remain##8##2##(1992-3#1)(1993-8#1)(1996-1#1)(1996-3#1)(1997-1#2)(2007-12#1)(2012-3#1)
will require a##4##3##(1992-3#1)(1994-1#1)(1997-7#1)(2011-2#1)
will require more##2##3##(2008-10#1)(2008-11#1)
will require the##3##3##(1995-5#1)(2008-10#2)
will require##27##2##(1992-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-3#2)(1997-7#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#3)(2013-1#1)
will result in a##3##4##(1991-2#1)(1994-12#1)(2013-8#1)
will result in the##2##4##(2006-6#1)(2011-2#1)
will result in##7##3##(1991-2#1)(1994-12#1)(1994-3#1)(2006-6#1)(2011-2#2)(2013-8#1)
will result##8##2##(1991-2#1)(1994-12#1)(1994-3#1)(2006-6#1)(2008-7#1)(2011-2#2)(2013-8#1)
will review the##11##3##(1994-3#1)(1995-2#1)(1997-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-3#1)
will review these##2##3##(1995-1#1)(2008-7#1)
will review##20##2##(1991-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-1#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
will see##2##2##(1996-12#1)(2008-11#1)
will serve as a##2##4##(1991-6#1)(2008-7#1)
will serve##4##2##(1991-6#1)(1996-3#1)(2008-11#1)(2008-7#1)
will show that##8##3##(1994-1#2)(1994-3#2)(1996-1#1)(2008-11#1)(2008-5#1)(2012-2#1)
will show##9##2##(1994-1#2)(1994-3#2)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
will significantly##2##2##(1997-1#1)(2008-11#1)
will soon be##2##3##(2008-10#1)(2012-3#1)
will soon##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
will spend##2##2##(2008-7#1)(2011-2#1)
will still##2##2##(1992-3#1)(1996-6#1)
will stimulate##2##2##(2008-10#1)(2008-11#1)
will suggest that##2##3##(2008-12#1)(2013-1#1)
will summarize##8##2##(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
will support##3##2##(1993-12#1)(1995-12#1)(2008-10#1)
will survive##2##2##(1994-12#1)(2008-10#1)
will take##6##2##(1992-3#1)(1994-9#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#1)
will test##2##2##(1993-2#1)(2012-3#1)
will the##2##2##(1994-9#1)(1997-1#1)
will then##6##2##(1993-3#1)(1995-6#1)(1996-2#1)(2009-7#1)(2010-11#1)(2013-8#1)
will therefore##2##2##(1997-1#1)(2008-11#1)
will to##3##2##(2008-11#1)(2008-4#1)(2009-7#1)
will try to##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
will typically##2##2##(2010-10#1)(2011-2#1)
will ultimately##3##2##(1994-8#1)(1996-2#1)(1997-3#1)
will undoubtedly be##2##3##(1995-12#1)(1996-11#1)
will undoubtedly##6##2##(1991-12#1)(1995-12#1)(1996-11#1)(2008-7#2)(2008-8#1)
will use the##2##3##(2008-10#1)(2008-4#1)
will use##4##2##(1991-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
will usually##2##2##(1995-1#1)(2008-8#1)
will vary##6##2##(1994-1#1)(1997-1#1)(2008-10#2)(2008-9#1)(2010-3#1)
will want##2##2##(1992-3#1)(2008-4#1)
will work##4##2##(1994-1#1)(1994-12#1)(1995-6#1)(2008-5#1)
will##1659##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#6)(1990-9#2)(1991-1#6)(1991-11#3)(1991-12#15)(1991-2#9)(1991-3#5)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#4)(1992-10#1)(1992-12#6)(1992-2#11)(1992-3#21)(1992-6#4)(1992-9#8)(1993-1#7)(1993-11#3)(1993-12#20)(1993-2#11)(1993-3#11)(1993-8#1)(1994-1#31)(1994-11#1)(1994-12#20)(1994-2#15)(1994-3#24)(1994-5#6)(1994-6#4)(1994-8#4)(1994-9#10)(1995-1#17)(1995-11#1)(1995-12#19)(1995-2#20)(1995-3#7)(1995-5#8)(1995-6#13)(1995-8#3)(1995-9#1)(1996-1#23)(1996-11#2)(1996-12#10)(1996-2#13)(1996-3#23)(1996-5#15)(1996-6#2)(1996-8#3)(1996-9#4)(1997-1#33)(1997-2#15)(1997-3#21)(1997-4#5)(1997-6#7)(1997-7#13)(1997-8#13)(2006-6#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#21)(2008-10#210)(2008-11#136)(2008-12#35)(2008-2#2)(2008-3#22)(2008-4#23)(2008-5#45)(2008-6#14)(2008-7#56)(2008-8#64)(2008-9#42)(2009-1#3)(2009-10#13)(2009-11#3)(2009-12#12)(2009-2#2)(2009-3#6)(2009-4#5)(2009-5#6)(2009-6#6)(2009-7#9)(2009-8#11)(2009-9#5)(2010-1#4)(2010-10#12)(2010-11#10)(2010-12#12)(2010-3#4)(2010-4#10)(2010-5#8)(2010-6#3)(2010-7#5)(2010-8#9)(2010-9#5)(2011-1#3)(2011-10#3)(2011-2#62)(2011-3#12)(2011-7#1)(2011-9#1)(2012-12#11)(2012-2#40)(2012-3#35)(2012-5#3)(2012-6#3)(2012-9#1)(2013-1#25)(2013-7#9)(2013-8#34)
willing to participate in the##3##5##(1994-12#1)(1994-2#1)(2012-2#1)
willing to participate in##5##4##(1994-12#1)(1994-2#1)(2008-1#2)(2012-2#1)
willing to##18##2##(1991-2#1)(1992-12#2)(1994-1#1)(1994-12#1)(1994-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-8#2)(2012-2#1)(2013-1#1)
willing##19##1##(1991-2#1)(1992-12#2)(1994-1#1)(1994-12#1)(1994-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#2)(2012-2#1)(2013-1#1)
willingness of a young child to cooperate##2##7##(1996-2#2)
willingness to##8##2##(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-11#1)(2008-11#1)(2011-1#1)
willingness##11##1##(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-11#1)(1996-2#2)(2008-11#1)(2011-1#1)(2012-2#1)
willow##3##1##(2008-8#2)(2012-3#1)
wilt and canker##2##3##(2008-10#2)
wilt and##8##2##(2008-10#8)
wilt by##2##2##(2008-10#2)
wilt caused by##2##3##(2008-10#2)
wilt development##5##2##(2008-10#5)
wilt disease##11##2##(2008-10#8)(2008-12#3)
wilt diseases##3##2##(2008-10#3)
wilt epidemics##5##2##(2008-10#5)
wilt in some##2##3##(2008-10#2)
wilt in##6##2##(2008-10#6)
wilt incidence and severity##4##4##(2008-10#4)
wilt incidence##6##2##(2008-10#6)
wilt of chickpea##4##3##(2008-10#4)
wilt of radish##2##3##(2008-10#2)
wilt of tomato##5##3##(2008-10#5)
wilt of##23##2##(2008-10#23)
wilt on##3##2##(2008-10#3)
wilt pathogen##5##2##(2008-10#5)
wilt resistance in##2##3##(2008-10#2)
wilt resistance##4##2##(2008-10#4)
wilt symptom development##2##3##(2008-10#2)
wilt symptom##3##2##(2008-10#3)
wilt symptoms in response to##2##5##(2008-10#2)
wilt symptoms in##4##3##(2008-10#4)
wilt symptoms were##2##3##(2008-10#2)
wilt symptoms when##2##3##(2008-10#2)
wilt symptoms##14##2##(2008-10#14)
wilt virus##32##2##(2008-10#32)
wilt was##4##2##(2008-10#4)
wilt##179##1##(2008-10#176)(2008-12#3)
wilt&quot##2##1##(2008-10#2)
wilted##3##1##(2008-10#3)
wilting in##2##2##(2008-10#2)
wilting symptoms##2##2##(2008-10#2)
wilting##7##1##(2008-10#7)
win their##2##2##(1991-3#1)(1996-1#1)
win##15##1##(1990-8#1)(1991-3#1)(1992-2#2)(1995-12#1)(1996-1#3)(2008-8#2)(2008-9#2)(2009-7#1)(2009-9#1)(2013-8#1)
win&quot##2##1##(2008-11#1)(2008-8#1)
wind and##4##2##(2008-11#1)(2008-3#1)(2008-5#2)
wind currents##2##2##(2008-10#1)(2012-2#1)
wind direction##5##2##(2008-10#2)(2008-12#1)(2008-5#2)
wind patterns##2##2##(2008-10#1)(2012-2#1)
wind speed##10##2##(2008-10#7)(2008-3#2)(2009-7#1)
wind speeds##2##2##(2008-10#2)
wind tunnel##4##2##(2008-10#2)(2008-3#1)(2009-6#1)
wind##55##1##(2008-10#22)(2008-11#4)(2008-12#1)(2008-3#13)(2008-5#8)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2012-2#2)
wind-dispersed##3##1##(2008-10#2)(2009-8#1)
wind-driven rains##2##2##(2008-10#2)
windborne ascospores##2##2##(2008-10#2)
windborne##3##1##(2008-10#3)
window for##3##2##(2008-7#1)(2009-8#1)(2012-2#1)
window of opportunity##3##3##(2008-3#2)(2013-1#1)
window of##7##2##(2008-10#3)(2008-3#2)(2010-9#1)(2013-1#1)
window technique##2##2##(1990-5#1)(2013-1#1)
window to##2##2##(2008-10#1)(2012-3#1)
window was##3##2##(2008-10#3)
window##54##1##(1990-5#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#7)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#1)
window&quot##2##1##(1995-5#1)(2008-9#1)
windowing##2##1##(2008-3#1)(2009-2#1)
windows and##2##2##(2008-10#1)(2012-2#1)
windows##5##1##(2008-10#2)(2008-6#2)(2012-2#1)
winds##9##1##(2008-3#9)
windshields##2##1##(2008-10#2)
wine and beer##2##3##(2008-10#1)(2009-7#1)
wine and##9##2##(2008-10#6)(2008-7#1)(2009-7#1)(2011-1#1)
wine by##2##2##(2008-10#2)
wine fermentation##2##2##(2012-3#2)
wine quality and##2##3##(2008-10#2)
wine quality##3##2##(2008-10#3)
wine samples by##2##3##(2008-10#2)
wine samples from##2##3##(2008-10#2)
wine samples##24##2##(2008-10#24)
wine type##2##2##(2008-10#2)
wine using##4##2##(2008-10#4)
wine was##2##2##(2008-10#2)
wine yeast##3##2##(2012-3#3)
wine##111##1##(1996-11#1)(1997-1#1)(2007-11#1)(2008-10#94)(2008-7#4)(2009-3#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#5)
wines according to their##2##4##(2008-10#2)
wines according to##5##3##(2008-10#5)
wines and##8##2##(2008-10#8)
wines are##2##2##(2008-10#2)
wines based on##2##3##(2008-10#2)
wines by their##3##3##(2008-10#3)
wines by##6##2##(2008-10#6)
wines from the##4##3##(2008-10#4)
wines from##10##2##(2008-10#10)
wines of##2##2##(2008-10#2)
wines using a##2##3##(2008-10#2)
wines using the##2##3##(2008-10#2)
wines using##6##2##(2008-10#6)
wines was determined##3##3##(2008-10#3)
wines was##4##2##(2008-10#4)
wines were##2##2##(2008-10#2)
wines##87##1##(2008-10#87)
wing fanning##2##2##(2013-8#2)
wing##8##1##(1991-11#2)(2008-10#1)(2008-9#3)(2013-8#2)
wings##4##1##(1990-9#1)(2008-11#1)(2008-12#1)(2013-8#1)
winner##2##1##(2012-3#1)(2013-8#1)
winner's##2##1##(2011-2#2)
winners##3##1##(1993-1#1)(1995-12#1)(1996-3#1)
winning##6##1##(1992-11#1)(1996-3#1)(2008-9#2)(2009-10#1)(2013-1#1)
wins##5##1##(1993-1#1)(1993-12#1)(1996-12#1)(2008-10#1)(2011-2#1)
winter and spring##4##3##(2008-10#3)(2008-11#1)
winter and##6##2##(2008-10#5)(2008-11#1)
winter barley (Hordeum##2##3##(2008-10#1)(2008-11#1)
winter barley cv##2##3##(2008-10#2)
winter barley##9##2##(2008-10#7)(2008-11#2)
winter cereals##2##2##(2008-10#2)
winter months##6##2##(1991-8#2)(2008-10#1)(2008-5#1)(2009-11#1)(2011-1#1)
winter oilseed rape##3##3##(2008-10#3)
winter rye##2##2##(2008-10#1)(2008-12#1)
winter season##2##2##(2008-10#1)(2008-5#1)
winter survival##2##2##(2008-10#2)
winter temperatures prevailing##2##3##(2008-10#2)
winter temperatures##4##2##(2008-10#3)(2010-8#1)
winter to##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
winter wheat cultivars##5##3##(2008-10#5)
winter wheat were##2##3##(2008-10#2)
winter wheat##26##2##(2008-10#25)(2008-12#1)
winter##111##1##(1991-8#2)(1994-12#1)(1997-3#1)(2008-10#72)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#8)(2008-8#2)(2009-11#1)(2010-5#1)(2010-8#7)(2011-1#1)(2011-2#1)(2012-2#1)(2012-4#1)
winter) at##2##2##(2008-10#2)
winter)##3##1##(2008-10#3)
winter/spring##3##1##(2011-2#2)(2012-3#1)
winterform and summerform pear psylla##2##5##(2008-10#2)
winters##3##1##(2008-9#1)(2010-8#1)(2012-4#1)
wire and a##2##3##(2008-10#2)
wire and##5##2##(2008-10#2)(2009-3#3)
wire as##2##2##(2008-10#2)
wire electrode##2##2##(2008-10#2)
wire grid polarizers##2##3##(2008-3#2)
wire in the##2##3##(1996-6#1)(2008-11#1)
wire is##2##2##(2008-10#2)
wire was##2##2##(2008-10#2)
wire##52##1##(1992-11#1)(1996-6#1)(2008-10#30)(2008-11#2)(2008-3#5)(2009-3#8)(2009-5#1)(2010-9#1)(2011-2#3)
wire)##2##1##(2008-10#2)
wireless ECG##3##2##(2010-8#3)
wireless personal digital##2##3##(2008-12#2)
wireless telephone system##2##3##(2010-2#2)
wireless telephone##4##2##(2010-2#4)
wireless##23##1##(2007-9#1)(2008-10#3)(2008-12#3)(2008-9#1)(2009-8#1)(2010-2#4)(2010-8#9)(2012-3#1)
wirelessly##2##1##(2008-12#1)(2012-3#1)
wires in##2##2##(2008-4#2)
wires or##2##2##(1992-3#1)(2011-2#1)
wires were##2##2##(2008-10#2)
wires##18##1##(1991-8#1)(1992-3#1)(1992-8#1)(1996-6#1)(2008-10#3)(2008-4#2)(2009-3#2)(2010-12#2)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
wiring for chronic total##2##4##(2008-11#2)
wiring##6##1##(2008-10#2)(2008-11#3)(2011-1#1)
wisdom##6##1##(1993-12#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-8#2)
wise to##2##2##(1994-2#1)(2013-1#1)
wise##4##1##(1994-2#1)(1995-12#1)(2012-3#1)(2013-1#1)
wisely##4##1##(1993-3#1)(2008-11#1)(2008-12#1)(2010-12#1)
wish to pursue##3##3##(1992-1#1)(2008-11#1)(2012-2#1)
wish to use##3##3##(1991-6#1)(2008-12#1)(2010-5#1)
wish to##20##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1995-5#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#3)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
wish##26##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-3#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-9#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#3)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
wishes to##3##2##(1993-12#1)(2010-10#1)(2012-3#1)
wishes##9##1##(1990-11#1)(1990-6#1)(1991-2#1)(1993-12#1)(1997-2#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
wishing to##10##2##(1994-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-3#2)(2010-10#1)(2010-12#1)(2012-12#1)
wit##3##1##(2008-10#2)(2011-2#1)
witchcraft##5##1##(1993-11#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)
witches' broom##2##2##(2008-10#2)
witches'-broom in##2##2##(2008-10#2)
witches'-broom##14##1##(2008-10#14)
with &gt##8##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
with &lt##3##2##(2008-10#2)(2008-12#1)
with &quot##16##2##(1990-11#1)(1993-12#1)(1993-2#2)(1994-12#2)(1995-2#1)(2008-10#2)(2008-5#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
with (i)##2##2##(2008-10#1)(2008-11#1)
with -0##2##2##(2008-10#1)(2011-2#1)
with 0##108##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-7#1)(1993-1#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-8#1)(1997-2#2)(1997-8#1)(2008-10#73)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-8#1)(2011-2#3)(2013-1#6)
with 1 M##5##3##(1993-3#1)(1995-6#1)(2008-10#3)
with 1 and##5##3##(1990-11#1)(1995-12#1)(2008-10#3)
with 1 mM##4##3##(1991-3#1)(1993-6#1)(1993-8#1)(1995-8#1)
with 1 ml of##3##4##(1992-3#1)(2008-10#2)
with 1 ml##5##3##(1992-3#1)(1996-12#1)(2008-10#3)
with 1 x##3##3##(2008-10#3)
with 1##86##2##(1990-11#2)(1991-3#1)(1991-5#1)(1992-3#1)(1993-1#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-10#51)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
with 1%##7##2##(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-7#1)
with 1-(2-pyridylazo)-2-naphthol (PAN)##3##3##(2008-10#3)
with 1-(2-pyridylazo)-2-naphthol##5##2##(2008-10#5)
with 1-(2-thiasolylazo)-2-naphthol##2##2##(2008-10#2)
with 10 ml of##5##4##(2008-10#5)
with 10 nematodes##2##3##(2008-10#2)
with 10##32##2##(1991-5#1)(1993-3#1)(1995-12#1)(2008-10#21)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-2#1)
with 10% FBS##2##3##(2008-11#2)
with 10% fat##3##3##(2010-4#3)
with 10%##10##2##(2008-10#3)(2008-11#3)(2010-4#4)
with 10(-7)##2##2##(2008-11#2)
with 100 lice##2##3##(1996-12#2)
with 100 mg/kg##2##3##(1991-3#1)(1992-3#1)
with 100 microM acetylcholine##2##4##(1995-11#2)
with 100 micrograms##2##3##(1990-6#1)(1991-12#1)
with 100 mul##2##3##(2008-10#2)
with 100 nM alpha-MSH for##2##5##(1995-2#2)
with 100 nM alpha-MSH##3##4##(1995-2#3)
with 100##19##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-3#1)(1995-11#2)(1995-2#3)(1996-12#2)(2008-10#5)(2008-5#1)(2008-7#1)
with 100%##4##2##(2008-10#3)(2012-12#1)
with 105##2##2##(2008-12#1)(2010-2#1)
with 11##3##2##(2008-10#3)
with 11-mercaptoundecanoic acid##2##3##(2008-10#2)
with 12##8##2##(1991-11#1)(1997-7#1)(2008-10#3)(2008-9#1)(2009-3#1)(2010-12#1)
with 12-##2##2##(2008-10#2)
with 120##2##2##(1996-3#1)(2008-5#1)
with 125I-TSST-1 for binding to class II MHC##2##8##(1993-3#2)
with 13##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
with 132##2##2##(1995-2#1)(2008-11#1)
with 14##5##2##(2008-10#3)(2008-9#1)(2011-2#1)
with 15 isolates##2##3##(2008-10#2)
with 15 ml of##2##4##(2008-10#2)
with 15##10##2##(1994-9#1)(2008-10#7)(2009-11#1)(2013-1#1)
with 15-crown-5##2##2##(2008-10#2)
with 16##4##2##(1996-8#1)(2008-10#2)(2012-3#1)
with 16-membered cyclic tetrathioether##2##4##(2008-10#2)
with 18##2##2##(1990-6#1)(2008-10#1)
with 180##2##2##(2008-10#1)(2008-5#1)
with 186##2##2##(2008-8#1)(2010-5#1)
with 19##2##2##(2008-10#2)
with 1M nitric acid##2##4##(2008-10#2)
with 1M##3##2##(2008-10#3)
with 1moll(-1)##2##2##(2008-10#2)
with 2 M##3##3##(2008-10#3)
with 2 mg of oral granisetron##2##6##(2010-12#2)
with 2 mg##3##3##(2010-12#2)(2011-2#1)
with 2 ml##2##3##(1996-12#1)(2008-10#1)
with 2 mol l(-1)##6##4##(2008-10#6)
with 2 or 3##2##4##(2008-10#1)(2013-1#1)
with 2##65##2##(1993-6#1)(1996-12#2)(1997-2#1)(1997-4#1)(2008-10#36)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#2)(2011-2#2)(2013-1#4)
with 2% of##2##3##(2008-10#1)(2008-11#1)
with 2%##9##2##(1993-1#1)(2008-10#3)(2008-11#4)(2013-1#1)
with 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol (5-Br-PADAP)##2##3##(2008-10#2)
with 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##4##2##(2008-10#4)
with 2-acetylpyridine-4-phenyl-3-thiosemicarbazone##2##2##(2008-10#2)
with 2-aminothiophenol##2##2##(2008-10#1)(2012-2#1)
with 2-chloro-1-methylpyridinium iodide##2##3##(2008-10#2)
with 2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester (PC-88A)##2##7##(2008-10#2)
with 2-methacryloyloxyethyl##2##2##(2008-11#2)
with 2-methyl-8-quinolinol (HMQ)##3##3##(2008-10#3)
with 2-methyl-8-quinolinol##5##2##(2008-10#5)
with 2-naphthol-3##2##2##(2008-10#2)
with 20 microM##2##3##(1990-5#1)(1996-2#1)
with 20##8##2##(1990-5#1)(1996-2#1)(2008-10#5)(2010-8#1)
with 20%##7##2##(2008-10#5)(2008-5#1)(2010-6#1)
with 200##2##2##(1990-6#1)(2008-11#1)
with 20mM##2##2##(2008-10#2)
with 20ml##2##2##(2008-10#2)
with 21##3##2##(2008-10#1)(2010-10#2)
with 218##2##2##(2008-10#1)(2010-4#1)
with 23##4##2##(1997-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
with 24##6##2##(1997-2#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
with 24-h##2##2##(1995-11#1)(2008-10#1)
with 25 mM##2##3##(2008-10#2)
with 25##8##2##(1993-12#1)(2008-10#6)(2010-3#1)
with 25%##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
with 250##5##2##(1993-11#1)(1993-12#1)(2008-10#2)(2008-6#1)
with 25mg of##2##3##(2008-10#2)
with 26##2##2##(2008-7#1)(2008-8#1)
with 27##2##2##(2007-12#1)(2008-1#1)
with 28##2##2##(1995-1#1)(2008-10#1)
with 29##4##2##(2008-10#1)(2008-7#1)(2009-5#1)(2013-1#1)
with 2moll(-1) HCl##2##3##(2008-10#2)
with 3 and##2##3##(1995-8#1)(2008-10#1)
with 3 mL of 2##2##5##(2013-1#2)
with 3##32##2##(1990-12#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-8#1)(1997-8#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-6#1)(2011-2#1)(2013-1#2)
with 3%##2##2##(2008-10#1)(2010-4#1)
with 3(1-imidazolyl)propyl##2##2##(2008-10#2)
with 3-methyl##2##2##(2008-10#1)(2008-11#1)
with 30 microM##2##3##(1990-11#1)(1997-8#1)
with 30##14##2##(1990-11#1)(1991-12#1)(1993-2#1)(1996-8#1)(1997-8#1)(2008-10#6)(2009-7#1)(2009-8#1)(2011-2#1)
with 30%##4##2##(1994-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
with 32##3##2##(2008-7#1)(2008-8#1)(2010-10#1)
with 35##3##2##(1991-12#1)(2008-10#1)(2010-10#1)
with 36##2##2##(2008-5#1)(2010-7#1)
with 37##4##2##(1996-2#1)(2008-7#1)(2010-7#1)(2011-2#1)
with 38%##2##2##(2008-10#1)(2008-5#1)
with 3D##4##2##(1995-11#2)(2009-10#1)(2011-2#1)
with 4 M HCl##2##4##(2008-10#2)
with 4##25##2##(1992-11#1)(1997-8#1)(2008-10#14)(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
with 4% (v/v)##2##3##(2008-10#2)
with 4%##4##2##(2008-10#4)
with 4-(2-pyridylazo)-resorcinol (PAR)##2##3##(2008-10#2)
with 4-(2-pyridylazo)-resorcinol##3##2##(2008-10#3)
with 4-aminoantipyrine in the presence of##2##6##(2008-10#2)
with 4-aminoantipyrine in##3##3##(2008-10#3)
with 4-aminoantipyrine##4##2##(2008-10#4)
with 4-bromomethyl-7-methoxycoumarin##2##2##(1993-2#2)
with 40##3##2##(2008-10#2)(2008-5#1)
with 40%##3##2##(2008-10#2)(2010-9#1)
with 400##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
with 42##3##2##(1993-1#1)(2008-10#2)
with 45##2##2##(1997-4#1)(2011-2#1)
with 47##2##2##(2010-11#1)(2012-12#1)
with 5 mM glycine##2##4##(1997-1#2)
with 5 mM##5##3##(1990-8#1)(1994-2#1)(1997-1#2)(2008-10#1)
with 5 ml of##5##4##(2008-10#5)
with 5 x 10(3)##3##4##(1996-12#2)(2008-10#1)
with 5 x##4##3##(1996-12#2)(2008-10#1)(2008-7#1)
with 5##36##2##(1990-8#1)(1991-7#1)(1993-1#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-8#1)(2008-10#19)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
with 5% formalin##2##3##(1996-12#2)
with 5%##12##2##(1994-3#1)(1996-12#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2013-1#1)
with 5-Br-PADAP and##2##3##(2008-10#2)
with 5-Br-PADAP##3##2##(2008-10#3)
with 5-FU##2##2##(1993-8#1)(2008-11#1)
with 5-NO(2)##2##2##(2008-10#2)
with 5-fluorouracil##3##2##(1992-12#2)(1992-2#1)
with 50 mM##2##3##(1994-2#2)
with 50 microM PQ##2##4##(1995-8#2)
with 50 microM##3##3##(1994-3#1)(1995-8#2)
with 50##13##2##(1992-5#1)(1994-2#2)(1994-3#1)(1995-8#3)(2008-10#3)(2008-12#1)(2008-7#1)(2009-3#1)
with 50%##2##2##(1992-6#1)(1994-5#1)
with 500##2##2##(2008-10#1)(2008-11#1)
with 51%##2##2##(1996-6#1)(2011-2#1)
with 53##3##2##(1997-8#1)(2008-5#1)(2008-7#1)
with 58##2##2##(2008-10#1)(2008-5#1)
with 5mum##2##2##(2008-10#2)
with 6##8##2##(1991-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#2)
with 62##3##2##(1996-3#1)(2008-11#1)(2008-12#1)
with 64##2##2##(1996-9#1)(2008-4#1)
with 7##2##2##(2008-11#1)(2008-12#1)
with 7-amino-3-(2-bromoethoxy)-4-chloroisocoumarin##2##2##(1991-3#2)
with 7-mx##2##2##(2010-1#2)
with 71%##2##2##(1991-12#1)(2008-7#1)
with 73%##2##2##(2008-10#1)(2008-7#1)
with 79% of##2##3##(2008-12#1)(2013-1#1)
with 8##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2013-8#1)
with 8-hydroxyquinoline and##2##3##(2008-10#2)
with 8-hydroxyquinoline immobilized polyacrylonitrile##2##4##(2008-10#2)
with 8-hydroxyquinoline immobilized##3##3##(2008-10#3)
with 8-hydroxyquinoline##8##2##(1990-2#1)(2008-10#7)
with 80##2##2##(2008-10#1)(2010-8#1)
with 800##2##2##(2007-11#1)(2008-10#1)
with 83%##2##2##(1991-8#1)(2008-10#1)
with 89##2##2##(2008-10#1)(2009-11#1)
with 9##7##2##(1992-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)
with 90%##3##2##(2008-10#2)(2008-8#1)
with 95##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
with 95% confidence intervals##2##4##(2010-11#1)(2011-2#1)
with 95%##5##2##(2008-11#1)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
with A##7##2##(2008-10#6)(2012-3#1)
with A1 + A2 sporangia##3##5##(2008-10#3)
with A23187##2##2##(1995-11#2)
with AA##3##2##(1993-8#2)(2008-10#1)
with AAL-TA##2##2##(2008-10#2)
with AAS##2##2##(2008-10#2)
with ACD##2##2##(2009-8#2)
with ACE##2##2##(1996-6#1)(2008-9#1)
with ACS##3##2##(2008-3#2)(2010-4#1)
with AD##6##2##(1991-1#1)(1996-2#1)(2008-5#1)(2008-7#2)(2011-2#1)
with ADHD and##4##3##(2010-8#1)(2012-2#3)
with ADHD##10##2##(1996-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#3)
with AFP##4##2##(2008-10#3)(2013-1#1)
with AIDS and that##2##4##(2008-11#2)
with AIDS and##7##3##(1994-3#1)(1995-6#2)(1996-11#1)(2008-11#2)(2011-2#1)
with AIDS##35##2##(1993-2#1)(1993-3#1)(1994-3#1)(1995-12#4)(1995-2#4)(1995-6#6)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-6#2)(2008-10#1)(2008-11#4)(2008-5#1)(2011-2#1)(2012-3#4)
with ALL##3##2##(2010-6#1)(2011-2#2)
with AM1##2##2##(1997-7#2)
with AMD##2##2##(2011-2#2)
with AMI##4##2##(1990-12#2)(1995-12#2)
with AML##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
with AOD and##2##3##(2012-12#1)(2012-3#1)
with AOD##4##2##(2012-12#3)(2012-3#1)
with APDC and##2##3##(2008-10#2)
with APDC##6##2##(2008-10#6)
with APP and##2##3##(1995-12#1)(2008-11#1)
with AR##4##2##(2008-10#1)(2011-2#3)
with AR-mediated##2##2##(2008-9#1)(2010-12#1)
with AS##2##2##(2008-10#1)(2011-2#1)
with ASAD##2##2##(2012-2#2)
with ASD##3##2##(2011-2#1)(2012-2#2)
with ASM##5##2##(2008-10#5)
with ATP and##2##3##(1991-9#1)(1996-2#1)
with ATP##3##2##(1991-9#1)(1996-2#1)(2009-7#1)
with Ag(+)##3##2##(2008-10#3)
with Al(2)(SO(4))(3)##4##2##(2008-10#4)
with Alizarin Red S (ARS)##2##5##(2008-10#2)
with Alizarin Red S##7##4##(2008-10#7)
with Alzheimer paired helical filaments##2##5##(1992-6#2)
with Alzheimer##3##2##(1992-6#2)(2013-8#1)
with Alzheimer's disease (AD)##3##4##(2008-6#1)(2008-7#2)
with Alzheimer's disease##11##3##(1991-1#1)(1991-7#2)(1996-12#1)(1996-8#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-9#1)
with Amberlite XAD-4 resin##2##4##(2008-10#2)
with Amberlite XAD-4##4##3##(2008-10#4)
with Amberlite##8##2##(2008-10#8)
with Amberlyst 36##2##3##(2008-10#2)
with Anorexia##2##2##(2008-11#2)
with Antega stem##2##3##(2013-1#2)
with Antega##3##2##(2013-1#3)
with Arsenazo III##3##3##(2008-10#3)
with AsA##2##2##(2008-11#2)
with Aspergillus flavus and##2##4##(2008-10#2)
with Aspergillus##4##2##(2008-10#3)(2008-7#1)
with Au##3##2##(2008-10#3)
with B##20##2##(1996-12#2)(2008-10#14)(2008-4#2)(2008-9#1)(2012-3#1)
with B18C6##2##2##(2008-10#2)
with BABA##4##2##(2008-10#4)
with BCGC cocultures##2##3##(2008-11#2)
with BII phobia##2##3##(2012-2#2)
with BNR 48 h prior to their challenge##2##8##(2008-10#2)
with BNR##5##2##(2008-10#5)
with BOS##2##2##(2012-2#2)
with BPD##2##2##(2009-9#1)(2010-5#1)
with BSA##2##2##(2008-10#1)(2008-11#1)
with BYDV##2##2##(2008-10#1)(2008-8#1)
with Bacillus thuringiensis##2##3##(2008-10#2)
with Bayer##2##2##(2008-10#1)(2008-5#1)
with Bayesian##3##2##(2008-10#2)(2008-8#1)
with Beet##2##2##(2008-10#2)
with Biological Control##2##3##(2008-10#2)
with Botryosphaeria dothidea##2##3##(2008-10#2)
with Botryosphaeria##3##2##(2008-10#2)(2011-10#1)
with Botrytis cinerea##2##3##(2008-10#2)
with Buerger's disease##3##3##(1997-8#3)
with C##27##2##(1992-3#1)(2008-10#19)(2008-5#2)(2008-8#2)(2008-9#2)(2013-1#1)
with C(18)##3##2##(2008-10#3)
with C(60)-SIMS##2##2##(2012-12#2)
with C-terminal##2##2##(1994-11#2)
with C1##2##2##(1997-5#1)(2012-3#1)
with C3##2##2##(1991-2#1)(2008-10#1)
with CA##3##2##(2008-10#1)(2011-2#2)
with CA15##3##2##(1990-8#3)
with CAA##2##2##(2007-8#2)
with CBF-A and CBF-B##2##4##(1995-2#2)
with CBF-A##3##2##(1995-2#3)
with CC##2##2##(1991-8#2)
with CCEs##2##2##(2008-10#2)
with CD8(+) T cell exhaustion##2##5##(2010-5#2)
with CE##2##2##(2008-10#1)(2008-5#1)
with CEUS##2##2##(2010-12#2)
with CFC##2##2##(1996-1#1)(1996-2#1)
with CGRP##3##2##(1992-6#3)
with CGRP-like immunoreactivity##2##3##(1992-6#1)(1997-3#1)
with CH(2)Cl(2)##2##2##(2008-10#2)
with CHARGE##2##2##(2008-9#2)
with CHCl(3) and##2##3##(2008-10#2)
with CHD##3##2##(2010-10#1)(2010-9#2)
with CHO cells##2##3##(2008-11#2)
with CHX##2##2##(2013-1#2)
with CKD##3##2##(2009-1#1)(2010-4#2)
with CL reagent##2##3##(2008-10#2)
with CL##4##2##(2008-10#4)
with CMV##4##2##(2008-10#4)
with CNBr##2##2##(1990-5#1)(1993-8#1)
with CO(2)##2##2##(2008-10#1)(2012-3#1)
with CO2 laser laparoscopy##2##4##(1995-2#2)
with CO2 laser##4##3##(1991-6#1)(1995-2#2)(1996-1#1)
with COPD##10##2##(1997-1#1)(2009-1#1)(2010-10#4)(2011-2#1)(2013-8#3)
with CP##2##2##(2008-10#1)(2011-2#1)
with CRC##3##2##(2009-12#1)(2012-3#2)
with CRF##3##2##(2008-1#2)(2011-2#1)
with CS##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
with CS-20##2##2##(2008-10#2)
with CT##4##2##(1997-8#1)(2008-1#1)(2008-2#1)(2011-2#1)
with CWM treatments##2##3##(2008-10#2)
with CWM##3##2##(2008-10#3)
with CYC##2##2##(2010-12#2)
with Cancer##2##2##(2010-7#1)(2012-2#1)
with Candida albicans##2##3##(2008-5#2)
with Candida##6##2##(2008-10#1)(2008-12#1)(2008-5#3)(2013-1#1)
with Castleman disease##2##3##(2011-2#2)
with Cd##2##2##(1990-5#1)(2008-10#1)
with Cd(2+)##3##2##(2008-10#3)
with Cd(II)##2##2##(2008-10#2)
with Ce##3##2##(2008-10#2)(2008-3#1)
with Chelex-100##2##2##(2008-10#2)
with Citrus##2##2##(2008-10#2)
with Clostridium##3##2##(1992-3#1)(2008-6#1)(2013-1#1)
with Co##2##2##(2008-10#2)
with Co(II) and##2##3##(2008-10#2)
with Co(II) in the presence of##2##6##(2008-10#2)
with Co(II)##5##2##(1990-12#1)(2008-10#4)
with Colletotrichum##2##2##(2008-10#2)
with ConA and##2##3##(1995-12#2)
with ConA##3##2##(1995-12#3)
with Cor Pulmonale##2##3##(2012-12#2)
with Coxsakievirus A16##2##3##(2008-8#2)
with Cr(III)##2##2##(2008-10#1)(2011-2#1)
with Crohn's disease who was##2##5##(1997-5#1)(2010-12#1)
with Crohn's disease who##4##4##(1997-5#1)(2008-10#1)(2010-12#2)
with Crohn's disease##10##3##(1997-5#1)(2008-10#1)(2008-11#1)(2010-12#6)(2011-2#1)
with Cu##3##2##(2008-10#1)(2008-11#2)
with Cu(2+)##2##2##(2008-10#1)(2009-8#1)
with Cu(I)##2##2##(2008-10#2)
with Cu(II) and##3##3##(2008-10#3)
with Cu(II)##6##2##(2008-10#6)
with Cyanex 923##3##3##(2008-10#3)
with Cyanex##4##2##(2008-10#4)
with D##6##2##(2008-10#6)
with DB18C6##2##2##(2008-10#2)
with DBMBSA##2##2##(2008-10#2)
with DDTC##2##2##(2008-10#2)
with DI##2##2##(1997-8#1)(2008-10#1)
with DIC##2##2##(2010-3#2)
with DMI history##2##3##(2008-10#2)
with DMSO##3##2##(2008-10#3)
with DNA and##2##3##(1994-5#1)(2008-10#1)
with DNA fingerprint##2##3##(2008-10#2)
with DNA from##4##3##(2008-10#4)
with DNA is##3##3##(2008-10#2)(2008-9#1)
with DNA recombination##2##3##(2008-9#2)
with DNA##44##2##(1990-12#1)(1991-3#1)(1991-5#1)(1994-5#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#22)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#4)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
with DNAbeta##2##2##(2008-10#2)
with DO##2##2##(2008-10#2)
with DS##2##2##(1991-1#2)
with DeltaFerrin(TM)##2##2##(2008-11#2)
with Depression##2##2##(2009-12#1)(2012-2#1)
with Diabetes##3##2##(2012-3#2)(2013-1#1)
with Different##3##2##(2008-10#2)(2008-11#1)
with Disabilities##25##2##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(2008-12#1)(2012-2#1)
with Down syndrome##8##3##(2008-11#1)(2008-12#2)(2013-1#5)
with Down##9##2##(2008-11#1)(2008-12#2)(2013-1#6)
with Down's##2##2##(1991-1#1)(1991-8#1)
with Dr Weed##2##3##(2010-8#2)
with Dr##3##2##(2010-8#2)(2012-3#1)
with E##9##2##(2008-10#4)(2008-11#3)(2009-12#1)(2012-12#1)
with E2##3##2##(1990-11#2)(2010-5#1)
with E2F##2##2##(2012-2#2)
with EBV##3##2##(1993-8#1)(1995-2#1)(2008-9#1)
with EC50##4##2##(2008-11#2)(2011-3#2)
with ECB##2##2##(2008-10#2)
with ECG##2##2##(1996-3#1)(2008-3#1)
with EDTA##21##2##(2008-10#19)(2008-5#1)(2010-3#1)
with EE##2##2##(2009-11#1)(2013-8#1)
with EGF##5##2##(1990-8#1)(1991-12#1)(1992-7#1)(1993-3#2)
with ERCP##2##2##(2008-2#1)(2013-1#1)
with ET##2##2##(2008-10#1)(2012-3#1)
with ETAAS##2##2##(2008-10#2)
with English as an additional language##3##6##(2008-2#3)
with English##4##2##(2008-2#3)(2008-8#1)
with Entecavir 0##2##3##(2013-1#2)
with Eriochrome##2##2##(2008-10#2)
with Erwinia amylovora##2##3##(2008-10#2)
with Escherichia coli##2##3##(1995-12#1)(2008-11#1)
with Essential##2##2##(2011-2#1)(2013-1#1)
with European##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
with Exosurf##2##2##(1997-1#2)
with F##11##2##(1995-8#1)(2008-10#8)(2008-12#1)(2011-10#1)
with FA##2##2##(2008-10#1)(2008-8#1)
with FAs##2##2##(2008-10#2)
with FGF-2##3##2##(2008-11#3)
with FHP##2##2##(2010-9#2)
with FI-FAAS##2##2##(2008-10#2)
with FISH##2##2##(1997-3#1)(2008-9#1)
with FITC-conjugated##2##2##(2006-6#1)(2008-5#1)
with FN##3##2##(2008-7#2)(2012-2#1)
with FPG##3##2##(1994-12#3)
with Fabry-Perot arms##2##3##(2008-3#2)
with Fe at 56 and 112 mug/ml compared with##2##9##(2008-10#2)
with Fe##3##2##(2008-10#3)
with Fe(II)##3##2##(2008-10#3)
with Fe(III) in the##2##4##(2008-10#2)
with Fe(III)##6##2##(2008-10#6)
with Foc-5##3##2##(2008-10#3)
with Full Text##2##3##(2013-1#2)
with Fusarium graminearum##4##3##(2008-10#4)
with Fusarium oxysporum f##3##4##(2008-10#3)
with Fusarium##11##2##(2008-10#11)
with G##3##2##(1995-11#1)(1995-6#1)(2008-10#1)
with GA##2##2##(2008-10#2)
with GB##2##2##(2013-8#2)
with GC/ECD##2##2##(2008-10#2)
with GE7##2##2##(2008-8#2)
with GFP##2##2##(2008-10#1)(2008-11#1)
with GHD##2##2##(2012-3#2)
with GR##2##2##(2011-2#2)
with Gaucher disease##2##3##(1994-11#1)(2008-10#1)
with Glomerella##2##2##(2008-10#2)
with Glucolevel##2##2##(2008-10#2)
with Group I##3##3##(2010-7#3)
with Group P##3##3##(2010-7#3)
with Group##6##2##(2010-7#6)
with H##7##2##(2008-10#5)(2008-12#1)(2008-5#1)
with H(+)##2##2##(2008-10#2)
with H(2)##2##2##(2008-7#1)(2011-2#1)
with H(2)O(2)##5##2##(2008-10#5)
with H(2)SO(4)##3##2##(2008-10#3)
with H2O2 in##2##3##(1995-8#1)(1997-8#1)
with H2O2##5##2##(1995-8#3)(1997-8#2)
with HBV##6##2##(1995-2#1)(2008-10#2)(2009-8#1)(2013-1#2)
with HC##4##2##(2008-11#1)(2012-3#3)
with HCC##4##2##(1993-2#1)(2008-10#2)(2013-8#1)
with HCMV##2##2##(1997-3#2)
with HCV##5##2##(2008-1#1)(2009-8#2)(2013-1#2)
with HCl and HNO(3)##2##4##(2008-10#2)
with HCl and##4##3##(2008-10#4)
with HCl##7##2##(2008-10#7)
with HFA134a##3##2##(1996-1#2)(1996-2#1)
with HIPAA's NPI##2##3##(2008-4#1)(2008-6#1)
with HIV and##4##3##(1993-5#1)(1995-12#1)(2008-10#1)(2011-2#1)
with HIV disease##2##3##(1992-1#1)(1995-6#1)
with HIV infection##6##3##(1992-9#1)(1996-11#1)(1996-3#1)(1996-8#1)(2008-7#1)(2010-12#1)
with HIV or##2##3##(1993-1#1)(1995-6#1)
with HIV##41##2##(1991-1#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-8#1)(1995-12#5)(1995-6#4)(1996-11#3)(1996-12#1)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-6#2)(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#3)(2011-2#4)(2013-1#2)
with HIV-1 infection##6##3##(1990-2#2)(2008-11#1)(2008-2#1)(2010-11#2)
with HIV-1##10##2##(1990-2#2)(1992-12#1)(1992-9#1)(1997-3#1)(2008-11#1)(2008-2#1)(2010-11#2)(2011-3#1)
with HIV/AIDS##6##2##(2008-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2013-1#2)
with HLA-B52##3##2##(1997-8#3)
with HLE##2##2##(1992-12#1)(1993-8#1)
with HMO(4)Q##3##2##(2008-10#3)
with HMQ into##2##3##(2008-10#2)
with HNO(3) alone##2##3##(2008-10#2)
with HNO(3) and H(2)O(2)##2##4##(2008-10#2)
with HNO(3) and##3##3##(2008-10#3)
with HNO(3)##9##2##(2008-10#9)
with HPE##2##2##(2011-1#2)
with HPLC##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2011-3#1)
with HRP##2##2##(2008-10#2)
with HSA##4##2##(2008-10#4)
with HSP70-peptides##2##2##(2008-9#2)
with HUS##2##2##(2013-1#2)
with HbA1c##3##2##(2012-4#1)(2012-5#2)
with Helicobacter pylori##3##3##(1996-11#1)(1997-1#1)(2008-12#1)
with Hg(II)##5##2##(2008-10#5)
with High##2##2##(1997-3#1)(2008-3#1)
with HpaG(Xooc)##2##2##(2008-10#2)
with IBA##2##2##(2008-10#1)(2008-12#1)
with IC(50)##2##2##(2008-11#1)(2011-2#1)
with IC50 values of##3##4##(1990-8#2)(1992-3#1)
with IC50##6##2##(1990-8#2)(1992-3#1)(2008-11#1)(2011-3#2)
with ICP-MS detection##2##3##(2008-10#2)
with ICP-MS##6##2##(2008-10#6)
with IDC##2##2##(1997-3#2)
with IDDM##3##2##(1995-3#3)
with IGF-I##2##2##(2008-6#1)(2010-5#1)
with IL-1##5##2##(1990-12#3)(1995-12#1)(1995-6#1)
with IL-2 and##2##3##(1995-12#1)(2008-11#1)
with IL-2##5##2##(1991-6#2)(1994-11#1)(1995-12#1)(2008-11#1)
with IL-6##2##2##(1996-12#1)(2011-2#1)
with IP##3##2##(2008-10#1)(2008-7#2)
with IR##2##2##(2008-10#1)(2013-8#1)
with ISIS 12449##2##3##(2008-10#2)
with ITS##2##2##(2008-10#2)
with IgA nephropathy##2##3##(2009-6#1)(2013-8#1)
with IgA##3##2##(1996-12#1)(2009-6#1)(2013-8#1)
with Impaired Glucose Tolerance##2##4##(2008-3#1)(2012-3#1)
with Impaired##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
with Infliximab##2##2##(2010-12#2)
with JH##2##2##(1992-6#1)(1995-11#1)
with Japanese##3##2##(1995-12#1)(2008-10#1)(2012-12#1)
with K(2)S(2)O(8)##2##2##(2008-10#2)
with KBr##2##2##(2008-10#2)
with KBrO(3)##2##2##(2008-10#2)
with KCl##2##2##(1996-2#1)(2008-10#1)
with KI##3##2##(2008-10#3)
with KMnO(4)##3##2##(2008-10#3)
with KOH##2##2##(2008-10#1)(2008-5#1)
with KP1 and##2##3##(1991-2#2)
with KT##3##2##(2011-2#1)(2013-1#2)
with Kasabach-Merritt syndrome##2##3##(2008-7#2)
with Km##4##2##(1991-5#1)(1995-2#1)(1995-6#1)(1997-8#1)
with L##6##2##(1996-12#1)(2008-10#4)(2008-11#1)
with L-arginine##3##2##(1991-6#1)(1997-2#2)
with LAK cells##2##3##(1990-12#2)
with LBP##2##2##(2012-12#2)
with LC and##2##3##(2008-10#2)
with LC##3##2##(2008-10#3)
with LChD##5##2##(2008-10#5)
with LED##2##2##(2008-11#1)(2008-7#1)
with LFS##2##2##(1990-12#2)
with LIF##2##2##(2008-11#2)
with LPL##2##2##(1991-12#2)
with LPS##3##2##(2008-11#2)(2011-2#1)
with Lewy bodies##5##3##(2008-7#5)
with Listeria monocytogenes##3##3##(1996-12#2)(2012-2#1)
with Lys##2##2##(1990-5#1)(2008-11#1)
with M##14##2##(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#3)
with M(r)##2##2##(1995-11#1)(2012-3#1)
with MBTH##2##2##(2008-10#2)
with MCAD deficiency##2##3##(1990-8#2)
with MCI##2##2##(2009-10#2)
with MEKC##2##2##(2008-10#2)
with MEL##3##2##(2008-11#2)(2008-9#1)
with MHC class II##2##4##(1995-5#1)(2008-9#1)
with MHC class##3##3##(1995-5#1)(2008-9#2)
with MIMS##2##2##(2008-10#2)
with MINTEQA2##2##2##(2008-10#2)
with MPTP or DPM individually##2##5##(2008-7#2)
with MPTP##5##2##(2008-7#5)
with MRI##4##2##(2008-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
with MS##6##2##(1995-12#1)(2008-5#1)(2010-12#4)
with MTs##3##2##(2008-10#2)(2008-11#1)
with Marfan syndrome##3##3##(2008-8#2)(2009-3#1)
with Marfan##4##2##(2008-8#3)(2009-3#1)
with Medicaid##3##2##(1994-1#1)(1994-3#1)(1997-2#1)
with Medicare##2##2##(1994-1#1)(1995-12#1)
with Metastatic##2##2##(2008-11#1)(2010-6#1)
with Mg levels##2##3##(2008-10#2)
with Mg##3##2##(2008-10#3)
with Microsoft##2##2##(2008-10#2)
with Microsphaeropsis sp##4##3##(2008-10#4)
with Monilinia fructicola##2##3##(2008-10#2)
with Monte Carlo simulations##2##4##(2008-3#2)
with Monte Carlo##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
with Mycobacterium tuberculosis##2##3##(1996-11#1)(2008-7#1)
with Mycosphaerella graminicola##2##3##(2008-10#2)
with N at##2##3##(2008-10#2)
with N##23##2##(1991-8#1)(2008-10#21)(2008-5#1)
with N(2)##3##2##(1997-6#1)(2008-3#2)
with N-(1-naphthyl)ethylenediamine##3##2##(2008-10#3)
with N-acetylcysteine##3##2##(1991-11#1)(1992-6#1)(2008-10#1)
with N-bromosuccinimide##4##2##(2008-10#4)
with N-fatty acyl##2##3##(1990-12#2)
with N-n-octylaniline##4##2##(2008-10#4)
with N-terminal##2##2##(1991-10#1)(1994-11#1)
with NF-kappa B##3##3##(1995-12#3)
with NIDDM##2##2##(1991-7#2)
with NIRS##2##2##(2008-10#2)
with NaBH(4)##2##2##(1996-5#1)(2008-10#1)
with NaCl##5##2##(1995-11#1)(2008-10#4)
with NaIO(4)##2##2##(1996-5#1)(2008-11#1)
with NaNO(2)##2##2##(2008-10#2)
with NaOH##2##2##(2008-10#1)(2012-2#1)
with Nafion##3##2##(2008-10#3)
with Nernstian compliance (29##2##4##(2008-10#2)
with Nernstian slope of##3##4##(2008-10#3)
with Nernstian##5##2##(2008-10#5)
with Ni3S2##2##2##(1994-5#2)
with NifA##2##2##(2008-9#2)
with O##4##2##(2008-10#4)
with O(2)##2##2##(2008-10#1)(2010-7#1)
with OA (p##2##3##(1992-3#1)(1993-2#1)
with OA##6##2##(1992-3#2)(1993-2#1)(1994-11#1)(2010-11#2)
with OCT##3##2##(2011-2#2)(2011-7#1)
with OPV##3##2##(1995-5#3)
with OVA##3##2##(1993-12#2)(2008-11#1)
with Oasis##2##2##(2008-10#2)
with Ophiostoma##2##2##(2008-10#2)
with Other##2##2##(2008-10#1)(2012-3#1)
with P##32##2##(2008-10#28)(2010-3#1)(2012-12#3)
with PAH##2##2##(2010-10#2)
with PAN##4##2##(2008-10#4)
with PAR##3##2##(2008-10#3)
with PBN##2##2##(1993-6#2)
with PCA##2##2##(2008-10#2)
with PCNA##2##2##(1995-6#1)(2009-8#1)
with PCR##6##2##(1994-5#1)(1997-8#1)(2008-10#2)(2008-12#2)
with PD and##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
with PD##12##2##(2008-10#1)(2008-7#3)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#3)
with PDS##2##2##(2011-1#2)
with PEG 6000##2##3##(2008-12#2)
with PEG##3##2##(2008-12#2)(2008-7#1)
with PF-68##2##2##(2011-2#2)
with PHA##4##2##(1995-8#1)(2013-1#3)
with PLS##2##2##(2008-10#2)
with PMA##2##2##(1995-2#1)(1997-1#1)
with PMMA##2##2##(2008-10#2)
with PPHP##2##2##(2010-6#2)
with PPy-calcion film as the active part##2##7##(2008-10#2)
with PPy-calcion##3##2##(2008-10#3)
with PSV##3##2##(2008-10#3)
with PVA##3##2##(1997-6#1)(2012-3#2)
with PVC##2##2##(2008-10#2)
with PVX##5##2##(2008-10#5)
with Pantoea##3##2##(2008-10#3)
with Parkinson disease##3##3##(2013-1#1)(2013-8#2)
with Parkinson##5##2##(2013-1#1)(2013-8#4)
with Parkinson's disease (PD)##6##4##(2008-7#5)(2013-1#1)
with Parkinson's disease##20##3##(1991-5#1)(1993-2#1)(2008-7#12)(2009-10#1)(2011-2#1)(2012-12#2)(2013-1#2)
with Pb(II)##2##2##(2008-10#2)
with Peg-Interferon and##2##3##(2013-1#2)
with Phytophthora cinnamomi##2##3##(2008-10#2)
with Phytophthora##3##2##(2008-10#3)
with Plasmodium##2##2##(1993-8#1)(2012-12#1)
with Poly-lys##2##2##(1990-6#2)
with Potato##2##2##(2008-10#2)
with Practice Nurses##2##3##(2008-11#2)
with Przhevalskiana larvae##2##3##(2008-12#2)
with Ps95##2##2##(2008-10#2)
with Pseudomonas fluorescens B5##2##4##(2008-10#2)
with Pseudomonas fluorescens##4##3##(2008-10#4)
with Pseudomonas##6##2##(2008-10#6)
with Psoriasis and##2##3##(2010-6#1)(2013-1#1)
with Pythium##3##2##(2008-10#3)
with QCT##2##2##(1994-8#2)
with QRS durations##2##3##(2008-10#2)
with QRS##3##2##(2008-10#3)
with R##40##2##(2008-10#39)(2009-6#1)
with R-PIA##4##2##(1997-1#4)
with RA or##2##3##(1993-3#1)(2008-11#1)
with RA##8##2##(1991-9#1)(1993-2#1)(1993-3#1)(2008-11#2)(2008-5#1)(2010-12#1)(2012-3#1)
with RAPs##2##2##(2008-10#2)
with RCC##2##2##(2011-2#1)(2013-1#1)
with RH##2##2##(2008-10#2)
with RM##3##2##(1994-12#3)
with RNA##3##2##(1994-3#1)(2009-7#1)(2013-1#1)
with RSD =##2##3##(2008-10#2)
with RSD##3##2##(2008-10#3)
with RT-PCR##3##2##(2008-8#2)(2012-2#1)
with Related##2##2##(2008-10#2)
with Resistance to##3##3##(2008-10#3)
with Rhizoctonia solani##4##3##(2008-10#4)
with Rhodamine##2##2##(2008-10#1)(2008-3#1)
with RsaI##2##2##(2008-10#2)
with S##19##2##(1995-9#1)(1996-8#1)(2008-10#13)(2008-9#1)(2009-6#1)(2012-3#2)
with SBWMV##2##2##(2008-10#1)(2008-8#1)
with SCN(-)##2##2##(2008-10#2)
with SHLI##2##2##(2011-2#2)
with SIV-PBj14##3##2##(1997-3#3)
with SK##2##2##(1993-8#2)
with SLCV-E##2##2##(2008-10#2)
with SLE##3##2##(2011-2#2)(2012-12#1)
with SMV##2##2##(2008-10#2)
with SPE clean-up and##2##4##(2008-10#2)
with SS##7##2##(2007-11#6)(2009-11#1)
with STS##3##2##(1996-6#1)(2008-10#1)(2008-11#1)
with Saccharomyces cerevisiae##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
with Sclerotinia sclerotiorum##2##3##(2008-10#2)
with Sephadex##3##2##(2008-10#3)
with Sertoli##2##2##(2009-10#1)(2011-2#1)
with Sevoflurane##2##2##(2012-3#2)
with Shc##2##2##(2012-2#2)
with Southern blot##2##3##(2008-8#1)(2008-9#1)
with Soxhlet##2##2##(2008-10#2)
with Soybean##2##2##(2008-10#2)
with Special Reference to##2##4##(1996-9#1)(2008-6#1)
with Special##4##2##(1994-3#1)(1996-9#1)(2008-6#1)(2009-10#1)
with Specific Language Impairment##2##4##(2009-8#1)(2011-1#1)
with SsEno##2##2##(2009-6#2)
with Staphylococcus aureus V8 proteinase##2##5##(1990-5#2)
with Staphylococcus aureus##4##3##(1990-5#3)(2010-6#1)
with Streptococcus##2##2##(2009-6#1)(2011-2#1)
with T antigen##2##3##(1993-8#2)
with T cell##4##3##(1991-9#1)(1994-11#1)(2008-4#1)(2008-9#1)
with T##19##2##(1991-8#1)(1991-9#1)(1993-8#2)(1994-11#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
with T1##2##2##(2008-10#2)
with T3##3##2##(2008-10#2)(2008-12#1)
with T4##2##2##(2008-10#1)(2011-1#1)
with T7##2##2##(1995-8#1)(2008-8#1)
with TA##2##2##(1997-8#2)
with TAN##2##2##(2008-10#2)
with TB##2##2##(2008-1#1)(2010-5#1)
with TBI##2##2##(2008-10#1)(2013-1#1)
with TCD##2##2##(1996-6#2)
with TGF-beta##3##2##(1990-5#1)(2008-11#2)
with TLS##2##2##(2008-10#1)(2008-7#1)
with TMA dust##2##3##(2008-10#2)
with TMA##3##2##(1995-11#1)(2008-10#2)
with TMAH##2##2##(2008-10#2)
with TNF-alpha##3##2##(1995-12#1)(2008-8#1)(2008-9#1)
with TPA##3##2##(1990-12#1)(1994-6#1)(1995-8#1)
with TRH##2##2##(2013-7#2)
with TSH##3##2##(1993-8#1)(2011-1#1)(2012-3#1)
with TTA##2##2##(2008-10#2)
with TYLCV##4##2##(2008-10#4)
with Taiwan strains##3##3##(2008-8#3)
with Takayasu arteritis##7##3##(1997-8#7)
with Those of##2##3##(2008-10#2)
with TiO(2)##3##2##(2013-1#3)
with Tomato spotted wilt virus (TSWV)##2##6##(2008-10#2)
with Tomato spotted wilt virus##4##5##(2008-10#4)
with Tomato##5##2##(2008-10#5)
with Trichinella##2##2##(1990-12#1)(1996-12#1)
with Trichoderma##7##2##(2008-10#7)
with Triton X-100##2##3##(1994-3#1)(2008-7#1)
with TuMV##3##2##(2008-10#3)
with Two##2##2##(2008-3#2)
with Type 1 diabetes##2##4##(2010-9#1)(2011-1#1)
with Type 2##3##3##(1994-12#2)(2013-1#1)
with Type##5##2##(1994-12#2)(2010-9#1)(2011-1#1)(2013-1#1)
with U##6##2##(1994-1#1)(2008-10#5)
with UCS##2##2##(2008-11#2)
with UES##2##2##(2013-8#2)
with UV absorbance##2##3##(2008-10#2)
with UV and##2##3##(2008-10#2)
with UV detection at##4##4##(2008-10#4)
with UV detection was##2##4##(2008-10#2)
with UV detection##18##3##(2008-10#18)
with UV light##7##3##(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)
with UV##33##2##(2008-10#26)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)
with UV-vis##2##2##(2008-10#2)
with University##2##2##(2008-11#1)(2010-11#1)
with Upper Gastrointestinal bleeding##2##4##(2013-1#2)
with V##5##2##(2008-10#5)
with V108LRUH1##2##2##(2008-10#2)
with VPA##5##2##(2011-2#5)
with Viral##2##2##(2008-10#1)(2010-7#1)
with WD##3##2##(2008-10#1)(2008-8#2)
with Waardenburg syndrome##5##3##(2008-9#5)
with Western blotting##2##3##(2010-12#1)(2011-3#1)
with Western##3##2##(2010-12#1)(2011-2#1)(2011-3#1)
with X##2##2##(2008-10#2)
with X-ray##2##2##(2008-10#2)
with X-rays and##2##3##(1996-6#1)(2011-2#1)
with X-rays##4##2##(1996-6#1)(2008-4#1)(2011-2#1)(2013-1#1)
with XACML##2##2##(2010-8#2)
with XRCC4##2##2##(1997-7#2)
with Xanthomonas campestris pv##2##4##(2008-10#2)
with Xanthomonas##3##2##(2008-10#3)
with Zeeman##2##2##(2008-10#2)
with Zeeman-effect background##2##3##(2008-10#2)
with Zn(2+)##3##2##(2008-10#3)
with ZnSO(4) prevented##2##3##(2008-10#2)
with ZnSO(4)##3##2##(2008-10#3)
with a &quot##4##3##(1995-5#1)(1997-6#1)(2008-10#1)(2008-11#1)
with a 0##6##3##(2008-10#5)(2008-3#1)
with a 1 mm##2##4##(2008-10#2)
with a 1##15##3##(1993-8#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2013-1#1)
with a 1-mm-thick##2##3##(2007-12#1)(2008-3#1)
with a 10##2##3##(2008-10#1)(2008-2#1)
with a 100% water mobile phase##2##6##(2008-10#2)
with a 100%##4##3##(2007-12#1)(2008-10#2)(2013-1#1)
with a 2##5##3##(1993-3#1)(2008-10#3)(2008-2#1)
with a 2-week##2##3##(2008-10#2)
with a 20##2##3##(2008-10#2)
with a 20%##2##3##(2008-5#1)(2013-8#1)
with a 3##5##3##(1996-2#1)(2008-11#2)(2008-3#1)(2013-1#1)
with a 3-4-fold##2##3##(1994-8#1)(2008-10#1)
with a 30##2##3##(2008-10#1)(2011-2#1)
with a 4##3##3##(2008-10#1)(2013-1#2)
with a 5##3##3##(2008-10#2)(2011-2#1)
with a 50%##2##3##(1995-11#1)(2011-2#1)
with a 9##2##3##(2008-10#1)(2012-2#1)
with a 90%##3##3##(2008-10#2)(2010-5#1)
with a =##2##3##(1992-12#1)(1992-9#1)
with a Bragg grating##2##4##(2008-3#2)
with a C##2##3##(2008-10#2)
with a C(18)##2##3##(2008-10#2)
with a Fabry-Perot interferometer##3##4##(2008-3#3)
with a Fourier-transform##2##3##(2008-3#2)
with a Gaussian##2##3##(2008-3#2)
with a Kd of##4##4##(1990-10#1)(1993-8#1)(1994-8#1)(1995-8#1)
with a Kd##5##3##(1990-10#1)(1990-11#1)(1993-8#1)(1994-8#1)(1995-8#1)
with a Ki of##3##4##(1991-5#1)(1993-8#1)(1994-3#1)
with a LOD##2##3##(2008-10#2)
with a Nafion(R)-membrane##2##3##(2008-10#2)
with a Nernstian slope of 29##3##6##(2008-10#3)
with a Nernstian slope of 59##3##6##(2008-10#3)
with a Nernstian slope of##12##5##(2008-10#12)
with a PCR##2##3##(1990-8#1)(2008-10#1)
with a PCR-based##2##3##(1997-8#1)(2008-10#1)
with a R##9##3##(1997-2#1)(2008-10#8)
with a RSD##2##3##(2008-10#2)
with a Rasch model##2##4##(2012-2#2)
with a baculovirus expressing##2##4##(2008-11#1)(2008-7#1)
with a baculovirus expression vector system##2##6##(2008-11#2)
with a baculovirus##4##3##(2008-11#3)(2008-7#1)
with a balloon##3##3##(1996-6#1)(2013-1#2)
with a baseline established between##2##5##(2008-10#2)
with a baseline##5##3##(1996-1#1)(2008-10#3)(2008-6#1)
with a basic##3##3##(2008-10#2)(2013-8#1)
with a better##11##3##(1994-6#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#2)(2013-1#1)
with a binary##3##3##(2008-10#3)
with a biphasic##2##3##(1990-2#1)(1993-11#1)
with a blood##2##3##(2008-10#1)(2008-7#1)
with a brief introduction to##2##5##(2008-7#1)(2012-2#1)
with a brief##4##3##(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
with a broad range of##3##5##(2008-11#1)(2008-7#1)(2012-3#1)
with a broad spectrum of##3##5##(2008-10#1)(2011-2#1)(2013-7#1)
with a broad##8##3##(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-7#1)
with a bulk acoustic wave sensor##2##6##(2008-10#2)
with a bulk acoustic##3##4##(2008-10#3)
with a cDNA##2##3##(1991-9#1)(1995-2#1)
with a calcium##2##3##(1991-6#1)(2008-11#1)
with a calculated molecular mass of##2##6##(1993-3#1)(1996-6#1)
with a calculated molecular##3##4##(1993-3#1)(1995-6#1)(1996-6#1)
with a calculated##6##3##(1990-11#1)(1993-3#1)(1993-9#1)(1995-6#1)(1996-6#1)(2008-10#1)
with a carbon fiber##2##4##(2008-10#2)
with a carbon##5##3##(2008-10#5)
with a carrier##3##3##(1997-3#1)(2008-10#2)
with a case##2##3##(2008-11#1)(2008-9#1)
with a cationic slope of##3##5##(2008-10#3)
with a cationic##8##3##(2008-10#8)
with a cell##4##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
with a cellulose acetate##2##4##(2008-10#2)
with a cellulose##3##3##(2008-10#3)
with a center##3##3##(2008-10#2)(2008-3#1)
with a central##5##3##(2007-12#2)(2008-10#2)(2009-4#1)
with a cerebral##2##3##(1997-3#1)(2011-2#1)
with a certain##2##3##(2008-10#1)(2011-2#1)
with a certified reference material##2##5##(2008-10#2)
with a certified##3##3##(2008-10#3)
with a challenging##3##3##(2008-10#1)(2013-8#2)
with a change in the##2##5##(1991-9#1)(2008-10#1)
with a change in##4##4##(1991-9#2)(2008-10#1)(2008-11#1)
with a characteristic##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
with a charged##2##3##(1997-2#1)(2009-1#1)
with a chemical##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)
with a chemiluminescence##4##3##(2008-10#3)(2008-5#1)
with a chief complaint of##3##5##(2008-12#2)(2012-12#1)
with a choice##2##3##(2008-9#2)
with a chronic##2##3##(2008-7#1)(2012-2#1)
with a clear##4##3##(1991-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
with a clinical diagnosis of##2##5##(2008-7#1)(2011-2#1)
with a clinical##7##3##(1990-3#1)(2007-12#1)(2008-7#1)(2011-2#2)(2013-1#2)
with a close##2##3##(1990-9#1)(1997-8#1)
with a coarse##2##3##(2009-7#1)(2012-3#1)
with a cochlear implant##5##4##(2008-9#5)
with a coefficient of variation##2##5##(2008-10#2)
with a coefficient of##4##4##(1990-2#1)(2008-10#3)
with a colorimetric##2##3##(2008-10#2)
with a combination of the##2##5##(1992-3#1)(2013-8#1)
with a combination of##15##4##(1991-2#1)(1992-3#1)(1993-8#2)(1994-8#1)(1995-3#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
with a combination##16##3##(1991-2#1)(1992-3#1)(1993-8#2)(1994-8#1)(1995-3#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
with a commercial##10##3##(2008-10#7)(2008-2#1)(2008-5#1)(2012-2#1)
with a commercially available##5##4##(1991-12#1)(2008-10#3)(2008-5#1)
with a common##9##3##(1991-3#1)(1991-9#1)(1993-12#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
with a compact##2##3##(2008-3#2)
with a comparable##2##3##(2008-11#1)(2013-1#1)
with a compartmental##2##3##(1992-9#1)(2010-10#1)
with a compatible##2##3##(2008-10#2)
with a complete##3##3##(1996-2#1)(1996-5#1)(2008-10#1)
with a complex of##2##4##(2008-10#1)(2008-4#1)
with a complex##5##3##(1995-12#1)(2008-10#1)(2008-4#1)(2010-10#1)(2011-2#1)
with a composite##2##3##(2012-2#2)
with a comprehensive##2##3##(1995-12#1)(2008-12#1)
with a concentration gradient##2##4##(2008-10#1)(2012-2#1)
with a concentration of##6##4##(1990-8#1)(2008-10#5)
with a concentration##11##3##(1990-8#1)(2008-10#9)(2012-2#1)
with a concomitant##4##3##(1992-6#1)(1993-8#1)(1996-6#1)(2010-2#1)
with a conditionally processed##2##4##(1993-8#2)
with a conidial suspension##4##4##(2008-10#4)
with a consequent##2##3##(1995-12#1)(2008-10#1)
with a constant##6##3##(1991-11#1)(2008-10#2)(2008-11#1)(2008-3#2)
with a continuous##6##3##(2008-10#3)(2008-3#3)
with a continuous-wave (cw) laser##2##5##(2008-2#1)(2008-3#1)
with a continuous-wave##5##3##(2008-2#3)(2008-3#2)
with a control##5##3##(1991-2#1)(2008-10#2)(2012-2#1)(2013-1#1)
with a convenient##2##3##(2008-10#1)(2008-11#1)
with a conventional##6##3##(2008-10#3)(2008-12#1)(2009-2#1)(2009-4#1)
with a copper##2##3##(2008-10#1)(2008-11#1)
with a correlation coefficient of 0##21##6##(2008-10#21)
with a correlation coefficient of linear regression of 0##2##9##(2008-10#2)
with a correlation coefficient of##23##5##(2008-10#23)
with a correlation coefficient##27##4##(2008-10#26)(2008-8#1)
with a correlation factor##2##4##(2008-10#2)
with a correlation##30##3##(2008-10#29)(2008-8#1)
with a corresponding increase in##2##5##(1991-3#1)(2008-5#1)
with a corresponding##4##3##(1991-3#1)(2008-10#1)(2008-5#1)(2013-8#1)
with a coupled##3##3##(2008-10#2)(2008-3#1)
with a cutoff##2##3##(2011-3#1)(2012-2#1)
with a decrease in the##4##5##(2008-10#2)(2008-7#1)(2012-2#1)
with a decrease in##12##4##(1990-12#1)(1994-3#1)(1996-2#1)(2008-10#4)(2008-7#2)(2009-9#1)(2011-2#1)(2012-2#1)
with a decrease of##4##4##(1996-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
with a decrease##16##3##(1990-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
with a decreased risk of##2##5##(1996-9#1)(2011-2#1)
with a decreased##5##3##(1996-9#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
with a defective##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
with a definitive##2##3##(1997-8#1)(2013-1#1)
with a degree##3##3##(1991-2#1)(1995-5#1)(2008-12#1)
with a delay##4##3##(2008-10#1)(2008-5#2)(2008-6#1)
with a deletion##2##3##(2008-10#1)(2008-9#1)
with a dense##3##3##(1996-1#1)(2008-9#1)(2010-6#1)
with a description of##4##4##(1991-2#1)(2008-12#1)(2008-8#1)(2013-1#1)
with a detailed##3##3##(2008-3#1)(2010-8#1)(2011-2#1)
with a detection limit (3sigma) of 0##4##7##(2008-10#4)
with a detection limit (S/N=3) of 0##2##7##(2008-10#2)
with a detection limit 1##2##5##(2008-10#2)
with a detection limit of 0##44##6##(1992-11#1)(2008-10#41)(2008-11#1)(2010-4#1)
with a detection limit of 1 muM##2##7##(2008-10#2)
with a detection limit of 1##24##6##(2008-10#24)
with a detection limit of 1ppm##2##6##(2008-10#2)
with a detection limit of 2##7##6##(2008-10#7)
with a detection limit of 3##3##6##(2008-10#3)
with a detection limit of 4##6##6##(2008-10#6)
with a detection limit of 5##6##6##(2008-10#6)
with a detection limit of 6##4##6##(2008-10#4)
with a detection limit of 8##4##6##(2008-10#4)
with a detection limit of 9##2##6##(2008-10#2)
with a detection limit of c(L)=0##2##6##(2008-10#2)
with a detection limit of##122##5##(1992-11#1)(2008-10#118)(2008-11#2)(2010-4#1)
with a detection limit##135##4##(1992-11#1)(2008-10#131)(2008-11#2)(2010-4#1)
with a detection##136##3##(1992-11#1)(2008-10#132)(2008-11#2)(2010-4#1)
with a diagnosis of##10##4##(1991-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
with a diameter of##5##4##(2007-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
with a diameter##8##3##(2007-12#1)(2008-10#2)(2008-3#3)(2008-7#1)(2013-1#1)
with a different##6##3##(2008-10#3)(2008-11#1)(2008-7#1)(2010-10#1)
with a differential##2##3##(1997-3#1)(2008-2#1)
with a diffraction grating##2##4##(2007-12#1)(2008-2#1)
with a digital##2##3##(2008-10#1)(2008-3#1)
with a diode array detector##2##5##(2008-10#2)
with a diode##3##3##(2008-10#2)(2008-2#1)
with a direct##2##3##(1992-9#1)(1994-11#1)
with a discussion of some of the##2##7##(1997-3#1)(2008-4#1)
with a discussion of the##6##5##(1994-3#1)(1995-3#1)(2008-12#1)(2010-5#1)(2010-9#1)(2012-2#1)
with a discussion of##13##4##(1994-3#1)(1995-3#1)(1997-3#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-9#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-2#1)
with a discussion##14##3##(1994-3#1)(1995-3#1)(1997-3#1)(2008-11#2)(2008-12#2)(2008-4#2)(2008-9#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-2#1)
with a disease##2##3##(2008-10#2)
with a distinct##5##3##(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
with a diverse##2##3##(1990-8#1)(2013-1#1)
with a domain arrangement of##2##5##(1990-5#2)
with a dorsal##2##3##(2008-9#2)
with a dose##3##3##(1991-6#1)(2008-12#1)(2009-11#1)
with a double membrane##2##4##(2008-10#1)(2008-9#1)
with a double##6##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)
with a doubling time of##2##5##(2008-11#2)
with a drop in##2##4##(1996-2#1)(2008-10#1)
with a dry##2##3##(2007-11#1)(2008-5#1)
with a dual enzyme electrode##2##5##(2008-10#2)
with a duration##3##3##(1997-8#1)(2008-9#1)(2013-1#1)
with a dye##2##3##(2008-11#1)(2008-9#1)
with a dynamic range of##2##5##(2008-10#2)
with a dynamic##3##3##(2008-10#3)
with a family history of##2##5##(2013-1#1)(2013-8#1)
with a family history##3##4##(2008-8#1)(2013-1#1)(2013-8#1)
with a fast response##3##4##(2008-10#3)
with a fatal##3##3##(2008-12#1)(2008-2#1)(2013-1#1)
with a favorable##2##3##(2010-7#1)(2012-3#1)
with a few exceptions##2##4##(2011-1#1)(2012-3#1)
with a few noted exceptions##2##5##(2008-10#2)
with a few##10##3##(1995-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#2)
with a final##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2013-8#1)
with a fine##3##3##(2008-10#2)(2008-3#1)
with a finite##2##3##(2008-11#1)(2008-3#1)
with a first##2##3##(2008-10#1)(2011-1#1)
with a first-order##2##3##(1995-6#1)(2008-10#1)
with a flexible##2##3##(1995-8#1)(2010-7#1)
with a flow injection (FI) system##2##6##(2008-10#2)
with a flow injection system##2##5##(2008-10#2)
with a flow injection##5##4##(2008-10#5)
with a flow rate of 1##2##6##(2008-10#2)
with a flow rate of##3##5##(2008-10#3)
with a flow##10##3##(2008-10#8)(2008-9#1)(2012-2#1)
with a flow-through##3##3##(2008-10#2)(2013-1#1)
with a fluid-fluid level##2##4##(2011-2#2)
with a fluorescein derivative##2##4##(2008-10#2)
with a fluorescence detector##2##4##(2008-10#2)
with a fluorescence##3##3##(1997-3#1)(2008-10#2)
with a fluorinated##2##3##(1992-12#1)(2008-10#1)
with a focus on the##5##5##(1995-12#1)(2008-10#1)(2010-7#1)(2011-10#1)(2013-1#1)
with a focus on##16##4##(1994-1#1)(1995-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
with a form of##2##4##(1991-12#1)(1995-8#1)
with a free##2##3##(1996-5#1)(2011-2#1)
with a frequency of##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
with a full##2##3##(2008-10#1)(2013-1#1)
with a fungicide##3##3##(2008-10#3)
with a galvanic hydrogen cyanide sensor##2##6##(2008-10#2)
with a gas##2##3##(2008-10#1)(2008-11#1)
with a general##2##3##(1997-5#1)(2010-1#1)
with a genetic##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
with a giant##5##3##(1993-6#1)(2009-8#1)(2010-6#1)(2011-2#2)
with a given##2##3##(1997-2#1)(2008-9#1)
with a glass impact bead##2##5##(2008-10#2)
with a glass##3##3##(2008-10#3)
with a glucose##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
with a gold##2##3##(2008-10#2)
with a good precision##3##4##(2008-10#3)
with a good prognosis##2##4##(2008-10#1)(2012-3#1)
with a good##19##3##(2008-10#12)(2008-11#1)(2008-5#2)(2008-9#1)(2012-3#1)(2013-8#2)
with a gradient##3##3##(2008-10#2)(2008-4#1)
with a gradual##2##3##(2008-10#2)
with a great##4##3##(1997-6#1)(1997-8#1)(2008-10#1)(2012-12#1)
with a greater##5##3##(1995-2#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
with a green fluorescent protein (GFP)##2##6##(2008-10#2)
with a group of##4##4##(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
with a group##5##3##(1991-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
with a hanging mercury drop electrode##2##6##(2008-10#2)
with a hanging##3##3##(2008-10#2)(2008-11#1)
with a high correlation##2##4##(2008-10#1)(2011-2#1)
with a high degree of selectivity##2##6##(2008-10#2)
with a high degree of sensitivity##2##6##(2008-10#2)
with a high degree of##13##5##(1996-5#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2013-1#1)
with a high flow##2##4##(1995-3#1)(1996-9#1)
with a high level of##5##5##(1994-8#1)(2008-10#2)(2009-12#1)(2010-11#1)
with a high molecular weight##3##5##(1995-6#1)(1996-12#1)(2008-10#1)
with a high number of##2##5##(2008-10#1)(2008-7#1)
with a high numerical aperture##2##5##(2007-12#1)(2008-3#1)
with a high percentage of##3##5##(1996-3#1)(2008-11#1)(2012-3#1)
with a high probability##2##4##(2008-10#1)(2008-11#1)
with a high rate of##4##5##(1991-6#1)(2008-12#1)(2008-7#1)(2012-12#1)
with a high risk of##3##5##(1990-3#1)(2010-8#1)(2012-12#1)
with a high success rate##2##5##(1996-11#1)(2012-12#1)
with a high##92##3##(1990-3#1)(1990-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#24)(2008-11#7)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#2)(2010-11#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-3#3)(2013-1#3)(2013-8#2)
with a higher incidence of##2##5##(2008-10#1)(2013-1#1)
with a higher##17##3##(1995-12#1)(1996-2#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#3)
with a highly##4##3##(1993-2#1)(1994-12#1)(2008-10#1)(2008-3#1)
with a history of hysterectomy##2##5##(2010-12#1)(2012-3#1)
with a history of##45##4##(1990-3#1)(1992-6#1)(1996-12#2)(1996-8#1)(1997-5#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#3)
with a history##46##3##(1990-3#1)(1992-6#1)(1996-12#2)(1996-8#1)(1997-5#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#4)
with a hitherto##2##3##(1995-6#1)(2013-1#1)
with a hollow##2##3##(2008-7#2)
with a homogeneous##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
with a human c-myc gene##2##5##(1993-3#1)(2008-11#1)
with a human##5##3##(1993-3#1)(1995-12#1)(1995-2#1)(2008-11#2)
with a hydrophobic##2##3##(1993-6#1)(2008-10#1)
with a hydroxyl group##2##4##(2008-11#2)
with a hypothetical protein##2##4##(1995-9#1)(1996-3#1)
with a hypothetical##3##3##(1995-11#1)(1995-9#1)(1996-3#1)
with a juvenile hormone##2##4##(1995-11#1)(2008-8#1)
with a known##7##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
with a laboratory##2##3##(2008-10#1)(2008-11#1)
with a lack of##2##4##(2008-7#1)(2009-8#1)
with a large excess of##2##5##(1991-11#1)(1995-2#1)
with a large number of##2##5##(2008-7#1)(2008-9#1)
with a large proportion of##2##5##(1992-12#1)(2008-10#1)
with a large variety of##2##5##(2008-10#1)(2008-3#1)
with a large##29##3##(1991-11#1)(1992-12#1)(1992-5#1)(1995-2#1)(1997-3#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
with a larger##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
with a laser diode##2##4##(2008-3#2)
with a laser##6##3##(1995-6#1)(2008-3#4)(2012-3#1)
with a layer of##2##4##(2008-10#1)(2008-5#1)
with a learning##3##3##(2008-10#1)(2008-11#2)
with a left##3##3##(2008-1#2)(2008-7#1)
with a length of##3##4##(1992-12#1)(1997-8#1)(2008-3#1)
with a lesion##2##3##(1996-2#1)(2013-1#1)
with a less##3##3##(1992-5#1)(1996-11#1)(2008-3#1)
with a lesser##2##3##(1997-1#1)(2008-3#1)
with a light##3##3##(1992-3#1)(2008-10#1)(2012-3#1)
with a limit of detection of 0##4##7##(2008-10#4)
with a limit of detection of 1##2##7##(2008-10#2)
with a limit of detection of##11##6##(2008-10#11)
with a limit of detection##16##5##(2008-10#16)
with a limit of##17##4##(2008-10#17)
with a limited number of##2##5##(1993-9#1)(2008-5#1)
with a limited##3##3##(1993-9#1)(2007-12#1)(2008-5#1)
with a linear calibration##2##4##(2008-10#2)
with a linear correlation coefficient of 0##2##7##(2008-10#2)
with a linear dynamic range##3##5##(2008-10#3)
with a linear range between 1##2##6##(2008-10#2)
with a linear range from##3##5##(2008-10#3)
with a linear range of 0##2##6##(2008-10#2)
with a linear range of##4##5##(2008-10#4)
with a linear range##9##4##(2008-10#9)
with a linear response over##2##5##(2008-10#1)(2010-3#1)
with a linear response##3##4##(2008-10#2)(2010-3#1)
with a linear##24##3##(2008-10#22)(2008-8#1)(2010-3#1)
with a list of##2##4##(2008-10#1)(2009-12#1)
with a live##3##3##(1995-9#1)(2008-5#1)(2011-2#1)
with a logarithmic##2##3##(2008-10#1)(2009-7#1)
with a long##6##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
with a longer duration##2##4##(2008-11#1)(2012-3#1)
with a longer##4##3##(1990-12#1)(1993-11#1)(2008-11#1)(2012-3#1)
with a loss of##3##4##(1992-3#1)(2011-2#1)(2013-8#1)
with a low degree of##3##5##(1991-6#1)(1996-3#1)(2011-2#1)
with a low detection limit of##2##6##(2008-10#2)
with a low detection limit##3##5##(2008-10#3)
with a low incidence of##3##5##(2008-5#1)(2011-2#2)
with a low rate of##2##5##(1993-6#1)(2009-12#1)
with a low risk##2##4##(1992-5#1)(2009-3#1)
with a low##31##3##(1991-6#1)(1992-5#1)(1993-6#2)(1995-11#1)(1996-3#1)(1996-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#3)(2012-2#1)(2013-8#2)
with a low-volume##2##3##(1997-8#1)(2008-10#1)
with a lower detection limit of##3##6##(2008-10#3)
with a lower limit of detection of##2##7##(2008-10#2)
with a lower##13##3##(1990-9#1)(2008-10#6)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
with a magnetic stirrer##2##4##(2008-10#1)(2008-11#1)
with a male##2##3##(2008-1#1)(2008-12#1)
with a marked decrease in the##2##6##(1994-3#1)(1997-7#1)
with a marked reduction in##2##5##(1992-3#1)(2008-10#1)
with a marked##9##3##(1992-3#1)(1994-3#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-5#1)
with a mass spectrometer##2##4##(2008-10#2)
with a mass##5##3##(2008-10#5)
with a matched##3##3##(1993-8#1)(1997-1#1)(2013-1#1)
with a maximal viable cell density##2##6##(2008-11#2)
with a maximal##5##3##(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#2)
with a maximum at##3##4##(2008-10#2)(2013-8#1)
with a maximum##15##3##(1991-2#1)(1991-3#1)(1993-12#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2013-8#1)
with a mean age of##13##5##(1995-10#1)(1996-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
with a mean age##14##4##(1995-10#1)(1996-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
with a mean duration##2##4##(2008-7#1)(2012-2#1)
with a mean follow-up of##2##5##(1996-6#1)(2008-10#1)
with a mean relative error of e(r)&lt##2##7##(2008-10#2)
with a mean relative error of##3##6##(2008-10#3)
with a mean##40##3##(1991-11#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-10#1)(1996-2#1)(1996-6#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#3)(2008-3#1)(2008-7#3)(2009-1#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
with a measure of##2##4##(2008-10#1)(2008-9#1)
with a median age of##4##5##(1992-5#1)(2011-1#2)(2013-1#1)
with a median of##5##4##(1997-2#1)(2008-10#3)(2008-7#1)
with a median##14##3##(1990-12#1)(1992-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#2)
with a medical##2##3##(1994-12#1)(2012-2#1)
with a membrane##6##3##(2008-10#4)(2008-11#1)(2009-5#1)
with a membrane-permeable##2##3##(1994-2#1)(2008-8#1)
with a mental##2##3##(1994-1#1)(1995-12#1)
with a mercury film##2##4##(2008-10#2)
with a mercury##3##3##(2008-10#3)
with a metal##2##3##(2008-10#2)
with a method that##2##4##(1990-12#1)(2008-4#1)
with a method##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
with a micellar##2##3##(2008-10#1)(2009-8#1)
with a microfabricated##2##3##(2007-11#1)(2008-10#1)
with a miniature##2##3##(2008-10#1)(2008-3#1)
with a minimal##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
with a minimally##2##3##(2010-9#1)(2011-2#1)
with a minimum detectability (S/N=3) of##2##6##(2008-10#2)
with a minimum of##4##4##(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
with a minimum##11##3##(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#1)
with a mitochondrial##2##3##(2008-10#1)(2012-2#1)
with a mixture of nitric##2##5##(2008-10#2)
with a mixture of##21##4##(1990-12#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-8#1)
with a mobile phase of##2##5##(2008-10#2)
with a mobile phase##5##4##(2008-10#5)
with a mobile##6##3##(2008-10#5)(2008-7#1)
with a model##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
with a moderate##3##3##(1993-6#1)(1997-4#1)(2008-10#1)
with a moderately##2##3##(1996-2#1)(2008-10#1)
with a modified##8##3##(2008-10#4)(2008-7#1)(2012-3#1)(2013-1#2)
with a molar absorptivity of##2##5##(2008-10#2)
with a molar absorptivity##3##4##(2008-10#3)
with a molar mass##2##4##(2008-10#1)(2013-1#1)
with a molar ratio##2##4##(2008-10#2)
with a molar##7##3##(2008-10#6)(2013-1#1)
with a molecular mass of##9##5##(1993-6#1)(1994-11#1)(1994-8#1)(1997-7#1)(2008-10#4)(2008-11#1)
with a molecular mass##11##4##(1993-6#1)(1994-11#1)(1994-8#1)(1997-7#1)(2008-10#6)(2008-11#1)
with a molecular weight of##3##5##(1991-5#1)(1993-12#1)(2008-11#1)
with a molecular weight##5##4##(1991-5#1)(1993-12#1)(2008-10#1)(2008-11#2)
with a molecular##16##3##(1991-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1997-7#1)(2008-10#7)(2008-11#3)
with a monoclonal antibody against the##2##6##(1993-8#1)(1993-9#1)
with a monoclonal antibody against##4##5##(1992-11#1)(1993-8#1)(1993-9#1)(1995-12#1)
with a monoclonal antibody##5##4##(1990-12#1)(1992-11#1)(1993-8#1)(1993-9#1)(1995-12#1)
with a moral##2##3##(2008-11#1)(2010-10#1)
with a more##7##3##(1990-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
with a much##2##3##(1994-5#1)(2008-10#1)
with a multivariate##2##3##(2008-10#1)(2009-12#1)
with a narrow##2##3##(2008-10#1)(2009-11#1)
with a near##2##3##(2008-10#2)
with a near-Nernstian slope##2##4##(2008-10#2)
with a near-Nernstian##3##3##(2008-10#3)
with a negative##3##3##(1991-6#1)(2008-10#1)(2010-7#1)
with a network of##2##4##(2008-10#1)(2008-5#1)
with a neutral##3##3##(2008-10#2)(2012-9#1)
with a new fluorescent probe 1##2##6##(2008-10#2)
with a new##29##3##(1990-2#1)(1990-9#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2009-10#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
with a newly designed##2##4##(2008-10#2)
with a newly##3##3##(2008-10#2)(2008-11#1)
with a non-ionic##2##3##(2008-10#1)(2008-5#1)
with a normal##8##3##(2008-10#2)(2008-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
with a novel double##2##4##(2008-10#2)
with a novel##11##3##(1991-9#1)(1993-9#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-7#1)
with a nucleotide diversity of 0##2##6##(2008-10#2)
with a nucleotide##3##3##(2008-10#3)
with a number of##14##4##(1992-4#1)(1992-5#1)(1992-6#1)(1995-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-5#1)
with a pH##3##3##(2008-10#2)(2008-9#1)
with a pair of##2##4##(2008-10#1)(2008-3#1)
with a palpable##2##3##(2013-1#2)
with a panel of monoclonal antibodies##2##6##(1990-12#1)(1991-2#1)
with a panel of##3##4##(1990-12#1)(1991-2#1)(1996-6#1)
with a partial##2##3##(1992-3#1)(2008-10#1)
with a particular emphasis##2##4##(2011-2#1)(2012-2#1)
with a particular focus on the##2##6##(1996-2#1)(2008-9#1)
with a particular focus on##3##5##(1996-2#1)(2008-9#1)(2010-12#1)
with a particular##7##3##(1996-2#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
with a patient##2##3##(1994-1#1)(2010-8#1)
with a percentage of##2##4##(2008-11#1)(2013-1#1)
with a perimesencephalic##2##3##(2008-7#2)
with a periodically##2##3##(2008-10#1)(2008-3#1)
with a peripheral##2##3##(2008-7#1)(2011-2#1)
with a persistent##4##3##(1991-6#1)(2008-10#1)(2008-12#1)(2010-7#1)
with a photo-diode array detector##3##5##(2008-10#3)
with a photo-diode array##4##4##(2008-10#4)
with a photodiode array detector##3##5##(2008-10#3)
with a photodiode##4##3##(2008-10#4)
with a photon scanning tunneling microscope##2##6##(2007-12#2)
with a plant##3##3##(2008-10#3)
with a plasmid encoding##2##4##(2010-11#1)(2010-6#1)
with a plasmid##4##3##(2008-10#1)(2008-11#1)(2010-11#1)(2010-6#1)
with a plug##3##3##(2008-10#2)(2011-2#1)
with a polarized laser beam##2##5##(2008-3#2)
with a polyclonal antiserum##2##4##(2008-10#2)
with a polyclonal##4##3##(1992-6#1)(1997-1#1)(2008-10#2)
with a poor prognosis##9##4##(1994-12#1)(1994-6#1)(1997-5#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
with a poor##12##3##(1994-12#1)(1994-6#1)(1997-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
with a portable##2##3##(2008-10#2)
with a positive zeta potential##2##5##(2008-5#2)
with a positive##7##3##(1990-6#1)(1992-3#1)(2008-4#1)(2008-5#3)(2011-2#1)
with a potassium##2##3##(1992-3#1)(2011-2#1)
with a potential##5##3##(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#2)
with a potentially##3##3##(1995-2#1)(1996-6#1)(2008-11#1)
with a potentiometric##3##3##(2008-10#3)
with a power##2##3##(2007-12#1)(2008-10#1)
with a pre-concentration##2##3##(2008-10#2)
with a precision of 2##2##5##(2008-10#2)
with a precision of##6##4##(2008-10#5)(2008-3#1)
with a precision##12##3##(2008-10#8)(2008-3#4)
with a preconcentration##3##3##(2008-10#3)
with a predicted##4##3##(1990-12#1)(1991-9#1)(1994-6#1)(2008-10#1)
with a prevalence of##2##4##(2008-5#1)(2008-6#1)
with a previous history of##2##5##(2008-10#1)(2010-12#1)
with a previous##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)
with a previously described##2##4##(2008-10#1)(2008-5#1)
with a previously published##2##4##(2008-10#1)(2010-10#1)
with a previously##8##3##(2008-10#5)(2008-5#1)(2010-10#1)(2010-5#1)
with a primary##4##3##(1993-6#1)(1997-3#1)(2008-10#1)(2011-2#1)
with a prior##3##3##(1997-3#1)(2008-11#1)(2010-12#1)
with a probe##2##3##(1994-5#1)(2008-10#1)
with a profile of##2##4##(1995-2#1)(2013-1#1)
with a progressive##2##3##(1990-12#1)(2008-7#1)
with a pronounced##2##3##(2008-10#2)
with a protecting##2##3##(2008-10#2)
with a protein##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
with a pulse##4##3##(2007-12#2)(2008-10#1)(2008-2#1)
with a pulsed##3##3##(2008-10#1)(2008-3#2)
with a purity of &gt##2##5##(1994-6#1)(2009-3#1)
with a quadratic##2##3##(2007-11#1)(2008-10#1)
with a quadrupole mass##2##4##(2008-10#2)
with a quartz##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
with a radial##2##3##(2008-10#1)(2011-2#1)
with a random distribution of##2##5##(2008-12#1)(2008-3#1)
with a random##3##3##(1996-2#1)(2008-12#1)(2008-3#1)
with a range of 0##2##5##(2008-10#1)(2013-1#1)
with a range of health##2##5##(2008-10#1)(2013-1#1)
with a range of linearity##2##5##(2008-10#2)
with a range of##17##4##(1990-5#1)(2008-10#10)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#3)
with a range##19##3##(1990-5#1)(2008-10#11)(2008-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#3)
with a rapid##7##3##(1995-6#1)(2008-10#2)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
with a rapidly##2##3##(1993-2#1)(2009-3#1)
with a rare##3##3##(2009-11#1)(2010-3#1)(2012-3#1)
with a rat##2##3##(1993-2#1)(2008-11#1)
with a rate constant##2##4##(2008-10#1)(2008-7#1)
with a rather##2##3##(2008-8#1)(2013-8#1)
with a reagent stream##2##4##(2008-10#2)
with a reagent##3##3##(2008-10#3)
with a real-time##2##3##(2008-10#1)(2008-6#1)
with a recently##2##3##(2008-10#1)(2011-2#1)
with a recombinant baculovirus##4##4##(1993-6#1)(1993-8#1)(2008-10#1)(2008-7#1)
with a recombinant##8##3##(1991-9#1)(1993-6#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)
with a recovery of##4##4##(1995-12#1)(2008-10#3)
with a recovery##7##3##(1995-12#1)(2008-10#6)
with a redox##2##3##(2008-10#2)
with a reduced##2##3##(2008-10#1)(2008-3#1)
with a reduction in the##3##5##(2008-10#3)
with a reduction in##14##4##(1990-11#1)(1996-12#1)(2008-10#5)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
with a reduction of##5##4##(1990-12#1)(1993-12#1)(2008-10#2)(2009-7#1)
with a reduction##19##3##(1990-11#1)(1990-12#1)(1993-12#1)(1996-12#1)(2008-10#7)(2009-7#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
with a reference##6##3##(1996-12#1)(2008-10#4)(2008-3#1)
with a reflective##2##3##(2007-12#1)(2008-10#1)
with a regression coefficient of##2##5##(2008-10#2)
with a relative error of##3##5##(2008-10#3)
with a relative error##4##4##(2008-10#4)
with a relative molecular mass of##3##6##(1991-12#1)(1993-8#1)(2008-11#1)
with a relative standard deviation (R##5##6##(2008-10#5)
with a relative standard deviation (RSD) of##2##7##(2008-10#2)
with a relative standard deviation of &lt##2##7##(2008-10#2)
with a relative standard deviation of 0##2##7##(2008-10#2)
with a relative standard deviation of 1##6##7##(2008-10#6)
with a relative standard deviation of 2##5##7##(2008-10#5)
with a relative standard deviation of 4##2##7##(2008-10#2)
with a relative standard deviation of less than##5##8##(2008-10#5)
with a relative standard deviation of##26##6##(2008-10#26)
with a relative standard deviation##36##5##(2008-10#36)
with a relative##53##3##(1991-12#1)(1991-3#1)(1993-8#1)(2008-10#45)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
with a relatively low##2##4##(2008-4#1)(2012-2#1)
with a relatively##9##3##(1990-11#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-2#1)
with a release of##2##4##(1994-3#1)(2008-10#1)
with a repeatability##2##3##(2008-10#2)
with a repetition rate##2##4##(2007-11#1)(2007-12#1)
with a repetitive DNA probe##2##5##(2008-10#2)
with a reported##4##3##(1994-9#1)(2008-10#2)(2010-8#1)
with a reporter gene under the control of##2##8##(1994-5#2)
with a resolution of##2##4##(2008-10#1)(2008-3#1)
with a response rate of##2##5##(1992-2#1)(2011-2#1)
with a response time of##3##5##(2008-10#3)
with a response time##4##4##(2008-10#4)
with a response##9##3##(1992-2#1)(2008-10#6)(2011-2#1)(2012-2#1)
with a restriction enzyme that##2##5##(1996-12#1)(1997-7#1)
with a review of the literature##9##6##(1991-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
with a review of the relevant##2##6##(2012-2#1)(2013-1#1)
with a review of the##14##5##(1991-2#1)(1991-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#3)(2012-2#2)(2013-1#2)
with a review##15##3##(1991-2#1)(1991-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-2#3)(2012-2#2)(2013-1#2)
with a right##2##3##(1993-3#1)(1995-8#1)
with a ring##2##3##(2008-10#1)(2008-3#1)
with a rise in##3##4##(2008-10#3)
with a rise##4##3##(2008-10#4)
with a risk of##2##4##(2009-7#1)(2012-12#1)
with a role in##4##4##(2009-10#1)(2009-6#1)(2012-2#1)(2012-3#1)
with a role of##2##4##(1996-3#1)(2013-8#1)
with a role##9##3##(1990-3#1)(1993-12#1)(1996-12#1)(1996-3#1)(2009-10#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
with a rotating##2##3##(1990-12#1)(2008-3#1)
with a sample of##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
with a sample throughput of##4##5##(2008-10#4)
with a sample##15##3##(2008-10#12)(2008-11#1)(2008-12#1)(2012-2#1)
with a sampling frequency of##9##5##(2008-10#8)(2010-9#1)
with a sampling rate of about##2##6##(2008-10#2)
with a sampling rate of##5##5##(2008-10#5)
with a sampling##17##3##(2008-10#15)(2010-9#1)(2012-2#1)
with a scenario of##3##4##(2008-10#3)
with a second##10##3##(1990-12#2)(1993-2#2)(1997-7#1)(2008-10#2)(2008-2#1)(2009-11#1)(2010-5#1)
with a second-order##2##3##(1994-5#1)(2008-3#1)
with a secondary##2##3##(1990-9#1)(2011-2#1)
with a selective##2##3##(1995-12#1)(2008-10#1)
with a self-assembled monolayer##3##4##(2008-10#3)
with a semiconductor##2##3##(2008-3#2)
with a sensitivity of 0##2##5##(2008-10#2)
with a sensitivity of 2##2##5##(2008-10#2)
with a sensitivity of##6##4##(2008-10#5)(2008-3#1)
with a sensitivity that##2##4##(2008-10#2)
with a sensitivity##10##3##(2008-10#9)(2008-3#1)
with a separation##2##3##(2008-10#1)(2011-2#1)
with a sequential injection##3##4##(2008-10#3)
with a series of##5##4##(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)
with a set of##5##4##(2008-10#2)(2008-11#2)(2013-1#1)
with a severe##7##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
with a shift##2##3##(1993-1#1)(1993-8#1)
with a short##11##3##(1991-10#1)(1991-12#1)(1997-9#1)(2008-10#3)(2008-3#1)(2008-9#2)(2012-2#1)(2013-1#1)
with a shorter length of##2##5##(2008-9#1)(2013-1#1)
with a shorter##5##3##(1993-11#1)(1997-2#1)(2008-2#1)(2008-9#1)(2013-1#1)
with a signal-to-noise ratio of 3##2##6##(2008-10#1)(2008-3#1)
with a signal-to-noise ratio of##4##5##(2008-10#2)(2008-3#2)
with a signal-to-noise##5##3##(2008-10#2)(2008-3#3)
with a significant decrease in##3##5##(1997-1#1)(2008-10#1)(2012-3#1)
with a significant increase##3##4##(1990-9#1)(2008-1#1)(2012-12#1)
with a significant rise in##2##5##(2008-12#1)(2013-8#1)
with a significant##18##3##(1990-9#1)(1994-11#1)(1994-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with a significantly increased##3##4##(2008-1#1)(2008-9#2)
with a significantly##6##3##(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-3#1)
with a silica##2##3##(2008-10#2)
with a similar potency and##2##5##(1993-8#2)
with a similar potency##3##4##(1993-8#2)(1994-8#1)
with a similar##16##3##(1993-3#1)(1993-8#3)(1994-1#1)(1994-8#1)(1996-1#1)(1996-12#2)(2008-10#5)(2008-7#1)(2008-8#1)
with a simple##11##3##(1991-2#1)(1997-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)
with a simulated##2##3##(2008-3#2)
with a single##32##3##(1990-12#1)(1990-5#1)(1992-8#1)(1993-2#1)(1995-2#1)(1995-6#1)(1997-5#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-2#1)(2013-8#1)
with a size##4##3##(1995-3#1)(1997-3#1)(2008-10#1)(2008-8#1)
with a slab optical waveguide##2##5##(2008-10#2)
with a slope efficiency of##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
with a slope of -0##2##5##(2008-10#2)
with a slope of 28##2##5##(2008-10#2)
with a slope of 29##5##5##(2008-10#5)
with a slope of 58##2##5##(2008-10#2)
with a slope of##27##4##(2008-10#27)
with a slope##34##3##(2007-12#2)(2008-10#30)(2008-2#1)(2008-3#1)
with a small number of cases##2##6##(1994-9#1)(2010-12#1)
with a small number of##3##5##(1994-9#1)(2008-10#1)(2010-12#1)
with a small volume of##7##5##(2008-10#7)
with a small##19##3##(1994-9#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
with a smaller##3##3##(1997-1#1)(2008-10#1)(2011-2#1)
with a solid phase##2##4##(2008-10#2)
with a solid##6##3##(1994-3#1)(2008-10#4)(2013-1#1)
with a solitary##4##3##(2008-7#1)(2010-6#2)(2012-12#1)
with a solution of##5##4##(2008-10#5)
with a solution##7##3##(2008-10#7)
with a solvent extraction##2##4##(2008-10#2)
with a spacer device##2##4##(1996-1#2)
with a spacer##8##3##(1996-1#3)(2007-11#2)(2008-10#2)(2008-8#1)
with a spatial resolution of##2##5##(2008-3#1)(2008-5#1)
with a spatial##3##3##(2008-3#1)(2008-5#1)(2011-3#1)
with a special focus on##2##5##(2009-7#1)(2011-2#1)
with a special reference to##3##5##(1993-8#1)(1996-2#1)(2008-7#1)
with a special##7##3##(1993-8#1)(1996-2#1)(2008-10#2)(2008-7#1)(2009-7#1)(2011-2#1)
with a specific##9##3##(1994-1#1)(1994-5#1)(1995-12#1)(2008-10#2)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
with a spectrophotometer##2##3##(2008-10#1)(2008-3#1)
with a spectrophotometric reference method##2##5##(2008-10#2)
with a spouse##2##3##(1994-2#1)(2012-12#1)
with a standard deviation of 0##2##6##(2008-3#1)(2009-2#1)
with a standard deviation of##3##5##(2008-10#1)(2008-3#1)(2009-2#1)
with a standard deviation##4##4##(2008-10#2)(2008-3#1)(2009-2#1)
with a standard reference##2##4##(2008-10#2)
with a standard##22##3##(2008-10#15)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)
with a steady-state##2##3##(2008-10#2)
with a stream of##3##4##(2008-10#3)
with a strict##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
with a strictly##2##3##(2008-10#2)
with a strong##6##3##(1992-1#1)(1994-12#1)(1995-12#1)(2008-10#2)(2013-1#1)
with a strongly##2##3##(2008-10#1)(2013-8#1)
with a sub-sample of##2##4##(2008-10#1)(2008-12#1)
with a subsequent##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
with a subset of the##2##5##(2012-3#1)(2013-1#1)
with a suitable##4##3##(2008-10#4)
with a superior##2##3##(1997-6#1)(2009-12#1)
with a susceptible##2##3##(2008-10#2)
with a suspension containing##2##4##(2008-10#1)(2008-5#1)
with a suspension##3##3##(2008-10#2)(2008-5#1)
with a synchrotron##2##3##(2008-4#1)(2008-5#1)
with a synthetic##6##3##(1993-9#1)(1995-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
with a target##4##3##(2008-10#3)(2011-2#1)
with a targeted##2##3##(1993-9#1)(1994-9#1)
with a temperature##2##3##(2008-3#2)
with a temperature-sensitive##2##3##(1995-6#1)(1995-9#1)
with a test##2##3##(2008-10#1)(2008-11#1)
with a theoretical##2##3##(2008-3#2)
with a thin film##2##4##(2008-10#2)
with a thin##5##3##(2008-10#2)(2008-11#2)(2012-2#1)
with a three##2##3##(2008-10#1)(2012-2#1)
with a threshold##2##3##(1995-11#1)(2012-2#1)
with a time##4##3##(1997-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
with a torque between 25 to 35 Ncm##2##8##(2013-1#2)
with a torque##3##3##(2013-1#3)
with a total length of##2##5##(2013-8#2)
with a total of##8##4##(1991-11#1)(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with a total##14##3##(1991-11#1)(1992-11#1)(1997-3#1)(2008-10#4)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
with a trace##2##3##(2008-5#2)
with a traditional##4##3##(2008-1#1)(2008-10#2)(2008-5#1)
with a trend##2##3##(2008-11#1)(2010-3#1)
with a tumor##4##3##(1990-12#1)(1994-12#1)(2013-1#2)
with a tunable##2##3##(2008-3#2)
with a tungsten tube atomizer##2##5##(2008-10#2)
with a tungsten##4##3##(2008-10#4)
with a unique##10##3##(1992-1#1)(1993-1#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#1)
with a value of##3##4##(2008-10#1)(2008-3#2)
with a variable##3##3##(2008-2#2)(2011-2#1)
with a variety of##22##4##(1991-3#1)(1995-12#1)(1996-5#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#3)(2012-2#1)(2012-3#2)
with a vertical##2##3##(2008-11#1)(2008-3#1)
with a very high##5##4##(1990-12#1)(1996-3#1)(1997-6#1)(2008-5#1)(2009-12#1)
with a very low##4##4##(1990-5#1)(1992-9#1)(2008-10#2)
with a very##15##3##(1990-12#1)(1990-5#1)(1991-8#1)(1992-9#1)(1996-3#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-5#1)(2009-12#1)(2012-12#1)
with a viability##2##3##(2008-11#2)
with a view to defining##2##5##(1991-6#1)(1997-4#1)
with a view to##8##4##(1991-3#1)(1991-6#1)(1997-4#1)(2008-10#3)(2008-11#2)
with a view##9##3##(1991-3#1)(1991-6#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-12#1)
with a virus titer of 10(6##2##6##(2008-11#2)
with a virus##4##3##(1997-1#1)(2008-10#1)(2008-11#2)
with a visual##2##3##(2008-10#1)(2008-7#1)
with a volume of##3##4##(1996-2#1)(2008-11#1)(2010-8#1)
with a volume##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
with a wall-jet##4##3##(2008-10#4)
with a water##7##3##(1991-2#1)(2008-10#4)(2008-11#1)(2008-7#1)
with a wavelength of##2##4##(2008-10#1)(2008-3#1)
with a wavelength##4##3##(2008-10#1)(2008-3#3)
with a weakly##2##3##(2008-10#1)(2010-3#1)
with a wide range of##4##5##(2008-10#2)(2008-11#1)(2008-7#1)
with a wide spectrum of##2##5##(2008-7#1)(2013-1#1)
with a wide##9##3##(1994-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2013-1#2)
with a wild-type##2##3##(2008-11#1)(2011-1#1)
with a working##4##3##(1993-8#1)(2008-10#3)
with a##3743##2##(1990-10#1)(1990-11#7)(1990-12#16)(1990-2#4)(1990-3#9)(1990-5#9)(1990-6#3)(1990-8#7)(1990-9#9)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#12)(1991-2#13)(1991-3#8)(1991-5#5)(1991-6#14)(1991-7#1)(1991-8#6)(1991-9#10)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#5)(1992-3#11)(1992-4#1)(1992-5#6)(1992-6#6)(1992-8#2)(1992-9#6)(1993-1#5)(1993-11#5)(1993-12#10)(1993-2#14)(1993-3#6)(1993-6#13)(1993-8#26)(1993-9#7)(1994-1#5)(1994-11#11)(1994-12#13)(1994-2#2)(1994-3#9)(1994-5#11)(1994-6#7)(1994-8#11)(1994-9#6)(1995-10#1)(1995-11#12)(1995-12#20)(1995-2#20)(1995-3#6)(1995-5#4)(1995-6#14)(1995-8#7)(1995-9#4)(1996-1#9)(1996-11#5)(1996-12#14)(1996-2#16)(1996-3#9)(1996-5#6)(1996-6#9)(1996-8#4)(1996-9#6)(1997-1#12)(1997-2#13)(1997-3#24)(1997-4#9)(1997-5#9)(1997-6#7)(1997-7#9)(1997-8#17)(1997-9#2)(2006-5#1)(2006-6#1)(2007-11#14)(2007-12#37)(2007-8#3)(2007-9#2)(2008-1#18)(2008-10#1527)(2008-11#177)(2008-12#56)(2008-2#51)(2008-3#180)(2008-4#25)(2008-5#75)(2008-6#15)(2008-7#102)(2008-8#52)(2008-9#71)(2009-1#8)(2009-10#7)(2009-11#6)(2009-12#10)(2009-2#2)(2009-3#9)(2009-4#6)(2009-5#10)(2009-6#4)(2009-7#9)(2009-8#15)(2009-9#7)(2010-1#10)(2010-10#14)(2010-11#7)(2010-12#18)(2010-2#2)(2010-3#9)(2010-4#6)(2010-5#8)(2010-6#15)(2010-7#12)(2010-8#12)(2010-9#5)(2011-1#16)(2011-10#1)(2011-2#129)(2011-3#9)(2011-9#1)(2012-12#32)(2012-2#58)(2012-3#60)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#135)(2013-2#1)(2013-7#4)(2013-8#53)
with abdominal pain##8##3##(1993-6#1)(1997-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
with abdominal##16##2##(1990-9#1)(1993-6#1)(1995-12#1)(1997-8#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-12#2)(2011-2#4)(2012-12#1)(2013-1#2)
with aberrant##2##2##(2010-1#1)(2011-2#1)
with ability to##2##3##(2008-12#1)(2009-6#1)
with abnormal##16##2##(1990-6#1)(1990-8#1)(1992-12#1)(1993-11#4)(1994-12#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
with about##9##2##(1991-1#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#1)
with absence of the##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
with absence of##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
with absorption bands##2##3##(2008-10#2)
with absorption##4##2##(2008-10#4)
with abundant##3##2##(2008-1#1)(2008-10#1)(2009-8#1)
with academic##3##2##(2008-12#2)(2011-1#1)
with acarbose##3##2##(1994-12#3)
with acceptable accuracy and precision##2##5##(2008-10#2)
with acceptable results##2##3##(2011-3#1)(2012-12#1)
with acceptable##8##2##(2008-10#4)(2008-7#1)(2011-2#1)(2011-3#1)(2012-12#1)
with accompanying##2##2##(2008-10#1)(2012-2#1)
with accumulation##2##2##(2008-10#2)
with accuracy of##3##3##(1997-6#1)(2008-10#2)
with accuracy##4##2##(1997-6#1)(2008-10#2)(2009-5#1)
with acetate##2##2##(1996-5#1)(2008-10#1)
with acetic acid##2##3##(2008-10#2)
with acetic anhydride##2##3##(2008-10#1)(2008-11#1)
with acetic##4##2##(2008-10#3)(2008-11#1)
with acetone##2##2##(2008-10#1)(2008-5#1)
with acetonitrile##9##2##(1997-2#1)(2008-10#8)
with acetonitrile-water mixtures##2##3##(2008-10#2)
with acetonitrile-water##4##2##(2008-10#4)
with achalasia##3##2##(1990-12#1)(1992-9#1)(2013-1#1)
with acid##3##2##(1996-3#1)(2008-10#2)
with acidic molybdate##2##3##(2008-10#2)
with acidic potassium permanganate in the presence of##2##8##(2008-10#2)
with acidic potassium permanganate##5##4##(2008-10#5)
with acidic##10##2##(2008-10#9)(2008-8#1)
with acidified##4##2##(2008-10#3)(2011-2#1)
with acquired immunodeficiency syndrome##3##4##(1991-12#2)(2008-2#1)
with acquired##4##2##(1991-12#2)(2008-2#1)(2011-2#1)
with acquisition##2##2##(1993-6#1)(1994-8#1)
with acridone-N-acetyl chloride##2##3##(2008-10#2)
with acrylic glue##4##3##(1997-3#2)(1997-6#2)
with actin##3##2##(1991-5#1)(2009-8#1)(2012-2#1)
with activated carbon##5##3##(2008-10#5)
with activated##10##2##(2008-10#8)(2008-11#1)(2008-5#1)
with activation of the##2##4##(1990-5#1)(2010-12#1)
with activation of##4##3##(1990-5#2)(2010-10#1)(2010-12#1)
with activation##6##2##(1990-5#2)(1995-8#1)(2008-5#1)(2010-10#1)(2010-12#1)
with active##13##2##(1991-6#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-1#1)(2010-12#2)(2010-5#1)(2012-3#2)(2013-1#1)
with activity in the##2##4##(2008-11#1)(2010-3#1)
with activity##6##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-3#1)
with actual##2##2##(1992-12#1)(2010-7#1)
with acute and chronic liver disease##2##6##(2013-1#2)
with acute asthma##2##3##(2008-1#1)(2008-10#1)
with acute coronary syndrome in the##3##6##(2008-3#2)(2008-7#1)
with acute coronary syndrome##12##4##(2008-11#5)(2008-3#3)(2008-7#1)(2011-2#3)
with acute coronary##16##3##(2008-11#5)(2008-3#4)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#3)(2013-8#1)
with acute ischemic stroke##4##4##(2008-10#1)(2009-6#1)(2012-12#2)
with acute leukemia##3##3##(2011-2#2)(2012-3#1)
with acute lymphoblastic##2##3##(2008-10#1)(2008-7#1)
with acute myeloid leukemia##2##4##(1994-5#1)(2008-11#1)
with acute myeloid##3##3##(1994-5#1)(2008-11#1)(2012-3#1)
with acute myocardial infarction##8##4##(1992-3#1)(1992-9#2)(1995-12#2)(2008-10#1)(2008-3#1)(2010-11#1)
with acute myocardial##9##3##(1990-12#1)(1992-3#1)(1992-9#2)(1995-12#2)(2008-10#1)(2008-3#1)(2010-11#1)
with acute onset of##3##4##(1997-3#1)(2008-7#1)(2011-2#1)
with acute pancreatitis##3##3##(1990-3#1)(2008-3#1)(2009-8#1)
with acute respiratory##4##3##(2012-12#1)(2013-8#3)
with acute##97##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#2)(1997-3#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#6)(2008-5#1)(2008-7#5)(2008-8#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#13)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#4)(2013-8#5)
with adaptive##3##2##(2008-3#2)(2008-8#1)
with added##5##2##(1993-8#1)(1996-5#1)(2008-10#1)(2010-4#1)(2013-1#1)
with addition of##7##3##(2008-10#4)(2008-11#2)(2009-8#1)
with additional##20##2##(1994-3#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#4)(2009-7#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
with additive effects##3##3##(2008-10#3)
with additive##4##2##(2008-10#4)
with adenoregulin##2##2##(1994-5#2)
with adenovirus##2##2##(2008-11#1)(2008-8#1)
with adequate##9##2##(1992-9#1)(1993-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
with adherence##3##2##(1996-3#1)(2010-11#1)(2013-1#1)
with adhesion##2##2##(1993-6#1)(1994-6#1)
with adjacent##6##2##(1993-1#1)(2008-10#1)(2009-10#2)(2010-6#1)(2011-2#1)
with adjunctive##2##2##(1996-3#1)(2010-12#1)
with adsorbed##2##2##(2008-11#1)(2013-8#1)
with adsorptive##4##2##(2008-10#4)
with adult##4##2##(1992-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
with adults##2##2##(1992-11#1)(2008-12#1)
with advanced breast cancer##5##4##(1991-6#2)(1992-2#1)(1994-8#1)(1997-7#1)
with advanced breast##6##3##(1991-6#2)(1992-2#1)(1994-8#1)(1997-7#1)(2011-2#1)
with advanced cancer##3##3##(1992-5#1)(2008-7#1)(2012-3#1)
with advanced disease##2##3##(2008-9#1)(2010-7#1)
with advanced##31##2##(1990-8#1)(1991-6#3)(1991-8#2)(1992-2#1)(1992-5#1)(1994-2#1)(1994-8#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#4)
with advancing age##4##3##(1993-3#1)(2008-7#2)(2008-9#1)
with advancing##5##2##(1993-3#1)(2008-7#2)(2008-9#1)(2012-2#1)
with adverse drug reactions##2##4##(2008-11#1)(2013-8#1)
with adverse##9##2##(1995-5#1)(2008-11#2)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with aerosols##3##2##(1997-1#1)(2008-10#1)(2008-3#1)
with affinity for##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
with affinity##5##2##(1996-12#1)(2008-10#3)(2008-11#1)
with aflatoxin content##2##3##(2008-10#2)
with aflatoxin##4##2##(2008-10#4)
with agar##2##2##(2008-10#1)(2012-2#1)
with agarose gel##2##3##(2008-10#1)(2008-9#1)
with age (P##2##3##(1991-9#1)(1993-2#1)
with age and##4##3##(1994-6#1)(2008-7#1)(2009-9#1)(2011-2#1)
with age in brain##2##4##(1990-3#2)
with age in the##2##4##(1990-11#1)(2008-7#1)
with age in##9##3##(1990-11#1)(1990-3#4)(1995-8#1)(2008-10#1)(2008-7#2)
with age of##3##3##(2008-10#2)(2008-5#1)
with age while##2##3##(1997-7#1)(2012-3#1)
with age##84##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#6)(1990-5#1)(1990-6#1)(1991-8#1)(1991-9#1)(1993-2#1)(1994-6#1)(1994-8#1)(1995-8#2)(1996-3#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-5#9)(2008-7#19)(2008-8#3)(2008-9#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-8#1)(2011-2#7)(2012-3#3)(2013-1#3)(2013-3#2)(2013-7#2)(2013-8#1)
with age-related macular degeneration##2##4##(2011-2#2)
with age-related macular##3##3##(2011-2#3)
with ageing##2##2##(2008-11#1)(2008-5#1)
with ages##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
with aggressive management##2##3##(2011-2#1)(2013-1#1)
with aggressive##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
with aging are##2##3##(2011-2#1)(2013-7#1)
with aging##12##2##(1991-1#1)(1993-1#3)(2007-11#1)(2008-7#3)(2009-8#1)(2011-2#1)(2013-7#2)
with air##8##2##(1993-2#1)(2008-10#4)(2008-12#1)(2010-12#1)(2013-1#1)
with airway##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
with alanine##3##2##(1994-11#2)(1995-6#1)
with alcohol dependence##2##3##(2008-10#1)(2010-1#1)
with alcohol##7##2##(1992-12#1)(1997-8#3)(2008-10#1)(2010-1#1)(2011-2#1)
with alcoholic liver disease##2##4##(2008-8#1)(2010-12#1)
with aldehydes##2##2##(1996-5#2)
with alendronate##3##2##(2008-11#3)
with alfalfa##2##2##(2008-10#1)(2008-11#1)
with alkali##3##2##(2008-10#2)(2008-5#1)
with alkaline earth##2##3##(2008-10#2)
with alkaline phosphatase##2##3##(2008-10#2)
with alkaline sodium##2##3##(2008-10#2)
with alkaline##11##2##(2008-10#10)(2008-9#1)
with alkylating##2##2##(2008-11#2)
with all of##2##3##(1992-3#1)(1994-9#1)
with all other##4##3##(2008-10#3)(2013-8#1)
with all the##3##3##(2008-10#2)(2008-12#1)
with all three##7##3##(1995-12#1)(2008-10#4)(2008-5#1)(2008-8#1)
with all types of##2##4##(1990-12#1)(1992-3#1)
with all##52##2##(1990-12#1)(1991-6#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-2#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#1)(2010-6#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
with allele##2##2##(1993-3#1)(2008-10#1)
with allergic rhinitis##2##3##(2012-12#2)
with allograft##4##2##(2008-7#1)(2009-10#1)(2009-3#1)(2012-3#1)
with almost##2##2##(2008-10#2)
with alpha##5##2##(1994-5#1)(1995-11#1)(1995-6#1)(1996-5#1)(2011-2#1)
with alpha-(2-benzimidazolyl)-alpha'##2##2##(2008-10#2)
with alteration of the host hyphae prior to contact with the antagonist##2##12##(2008-10#2)
with alteration##3##2##(2008-10#2)(2008-11#1)
with altered##6##2##(1993-3#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
with alternating##3##2##(1991-5#1)(2008-10#2)
with alternative##6##2##(1993-2#1)(1993-6#1)(1995-2#1)(2008-10#3)
with altitude##2##2##(2008-3#1)(2008-8#1)
with aluminium##4##2##(2008-10#4)
with aluminon##2##2##(2008-10#2)
with ambiguous genitalia##2##3##(2008-10#2)
with ambiguous##5##2##(1993-6#1)(2008-10#2)(2011-2#2)
with amines##2##2##(2008-10#2)
with amino acid sequences of##2##5##(1994-11#1)(2008-10#1)
with amino acid sequences##3##4##(1994-11#1)(1995-9#1)(2008-10#1)
with amino acid##4##3##(1992-11#1)(1994-11#1)(1995-9#1)(2008-10#1)
with amino acids##2##3##(2008-10#1)(2008-11#1)
with amino##7##2##(1992-11#1)(1994-11#1)(1995-9#1)(2008-10#3)(2008-11#1)
with ammonia and##2##3##(2008-10#2)
with ammonia##6##2##(2008-10#6)
with ammonium diethyl dithiophosphate##2##4##(2008-10#2)
with ammonium molybdate##2##3##(2008-10#2)
with ammonium pyrrolidine dithiocarbamate (APDC) and##3##6##(2008-10#3)
with ammonium pyrrolidine dithiocarbamate (APDC)##6##5##(2008-10#6)
with ammonium pyrrolidine dithiocarbamate##7##4##(2008-10#7)
with ammonium thiocyanate solution##2##4##(2008-10#2)
with ammonium##23##2##(1990-11#1)(1990-6#1)(1991-12#1)(2008-10#20)
with amperometric detection at a##2##5##(2008-10#2)
with amperometric detection at anodized##2##5##(2008-10#2)
with amperometric detection at##6##4##(2008-10#6)
with amperometric detection using##3##4##(2008-10#3)
with amperometric detection was##2##4##(2008-10#2)
with amperometric detection##25##3##(2008-10#25)
with amphetamine##2##2##(1993-6#1)(1996-6#1)
with amplified fragment length polymorphism (AFLP) markers##2##7##(2008-10#2)
with amplified fragment length polymorphism (AFLP)##4##6##(2008-10#4)
with amplified fragment length polymorphism##5##5##(2008-10#5)
with amplified sensitivity##2##3##(2008-10#2)
with amplified##7##2##(2008-10#7)
with amputation's##2##2##(2013-1#2)
with an AVM##2##3##(2008-7#2)
with an ED50 of##2##4##(1992-3#1)(1994-8#1)
with an ED50##3##3##(1992-3#1)(1994-8#1)(1996-2#1)
with an ESR spectrometer##2##4##(2008-10#2)
with an IC50 of 20 microM##2##6##(1994-8#2)
with an IC50 of##5##4##(1994-8#2)(1995-8#1)(1996-2#2)
with an IC50##7##3##(1994-8#2)(1995-8#1)(1996-2#2)(2008-12#1)(2008-5#1)
with an R##3##3##(2008-10#3)
with an STI##2##3##(2008-12#2)
with an abdominal##2##3##(1992-5#1)(2010-1#1)
with an ability to##2##4##(1994-2#1)(2009-6#1)
with an abnormal##3##3##(1993-11#1)(1997-3#1)(2008-10#1)
with an acceptable##4##3##(1991-3#1)(1997-6#1)(2008-5#1)(2010-7#1)
with an accumulation##3##3##(1994-5#1)(2008-10#2)
with an accuracy of##6##4##(2008-10#4)(2008-11#1)(2008-3#1)
with an accuracy##8##3##(2008-10#4)(2008-11#1)(2008-3#2)(2008-9#1)
with an acid##2##3##(2008-10#2)
with an acidified methanolic solution##2##5##(2008-10#2)
with an activated carbon##2##4##(2008-10#2)
with an active##2##3##(1990-12#1)(2013-7#1)
with an acute onset of##2##5##(2008-11#1)(2012-12#1)
with an acute##5##3##(2008-11#3)(2009-9#1)(2012-12#1)
with an additional##7##3##(1997-8#1)(2008-10#5)(2012-3#1)
with an adequate##5##3##(1991-3#1)(1994-3#1)(1996-2#1)(2008-10#2)
with an advanced##2##3##(1991-8#1)(2008-10#1)
with an aggressive##2##3##(1993-3#1)(2008-10#1)
with an agrocin##2##3##(2008-10#2)
with an all-solid-state##2##3##(2008-10#1)(2008-3#1)
with an altered##2##3##(2008-10#1)(2013-8#1)
with an alternative##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
with an amino##3##3##(2008-10#1)(2008-11#2)
with an ammonium##2##3##(2008-10#2)
with an analysis##2##3##(2008-10#2)
with an analytical##2##3##(2008-10#2)
with an anion##2##3##(2008-10#2)
with an annual##2##3##(2008-10#1)(2012-12#1)
with an antibiotic##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
with an antibody specific for the##2##6##(1994-11#1)(1995-2#1)
with an antibody##8##3##(1994-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-12#1)
with an antisense RNA transcript##2##5##(1994-11#1)(1995-2#1)
with an apparent molar absorptivity of##3##6##(2008-10#3)
with an apparent molecular##2##4##(1997-2#1)(2008-10#1)
with an apparent##14##3##(1990-6#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#7)
with an application##2##3##(1992-9#1)(2008-10#1)
with an appropriate##7##3##(2008-10#3)(2008-11#1)(2009-8#1)(2010-1#1)(2011-2#1)
with an aqueous##3##3##(2008-10#2)(2011-2#1)
with an array of##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
with an artificial##2##3##(2008-10#1)(2008-11#1)
with an assay##2##3##(2008-10#1)(2008-6#1)
with an association##2##3##(1996-5#1)(2012-3#1)
with an attractive##2##3##(2008-10#1)(2008-11#1)
with an atypically##2##3##(2008-10#1)(2012-3#1)
with an automated##2##3##(2008-10#1)(2008-11#1)
with an autosomal dominant##2##4##(1997-6#1)(2008-7#1)
with an average age of##5##5##(1990-12#1)(1994-12#1)(2008-9#2)(2013-1#1)
with an average insert size of##3##6##(1997-2#1)(1997-6#1)(2008-8#1)
with an average molecular weight of##2##6##(2008-10#2)
with an average molecular##3##4##(1990-5#1)(2008-10#2)
with an average of 0##2##5##(2008-10#2)
with an average of##10##4##(2008-1#1)(2008-10#6)(2008-7#1)(2008-9#2)
with an average relative##2##4##(2008-10#2)
with an average value of##2##5##(1990-8#1)(2008-10#1)
with an average##43##3##(1990-12#1)(1990-5#1)(1990-8#1)(1993-9#1)(1994-12#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)
with an earlier##3##3##(1995-3#1)(2008-1#1)(2013-8#1)
with an early##3##3##(1990-8#1)(1997-1#1)(2013-1#1)
with an effective##2##3##(2008-10#2)
with an efficiency that##2##4##(2008-10#1)(2009-5#1)
with an efficiency##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
with an efficient##2##3##(1993-3#1)(2012-2#1)
with an elastic##3##3##(2008-11#1)(2010-4#1)(2011-2#1)
with an electrochemical##2##3##(2008-10#1)(2008-6#1)
with an electron##4##3##(2008-10#4)
with an electronic##2##3##(2008-10#2)
with an elevated##2##3##(2009-10#1)(2011-2#1)
with an emphasis on the##2##5##(2010-9#1)(2012-2#1)
with an emphasis on##6##4##(1992-12#1)(2008-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2012-2#1)
with an emphasis##8##3##(1992-1#1)(1992-12#1)(1996-6#1)(2008-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2012-2#1)
with an epifluorescence microscope##2##4##(1994-5#1)(2008-10#1)
with an equal number of##2##5##(1991-7#1)(2012-2#1)
with an equal##3##3##(1991-7#1)(1992-6#1)(2012-2#1)
with an equilibrium##2##3##(2008-10#2)
with an error of##2##4##(2008-10#2)
with an error##3##3##(2008-10#3)
with an established##2##3##(1992-9#1)(2011-2#1)
with an estimated molecular weight of##2##6##(2008-10#1)(2009-9#1)
with an estimated molecular##3##4##(1995-2#1)(2008-10#1)(2009-9#1)
with an estimated##10##3##(1995-2#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)
with an excellent correlation##2##4##(2008-10#1)(2008-5#1)
with an excellent##8##3##(1996-5#1)(2008-10#3)(2008-5#1)(2008-9#2)(2013-1#1)
with an excess of##4##4##(1990-12#1)(1996-5#1)(2008-10#1)(2008-8#1)
with an excess##5##3##(1990-12#1)(1996-5#1)(2008-10#1)(2008-8#2)
with an excitation wavelength of##3##5##(1997-2#1)(2008-10#2)
with an excitation##4##3##(1997-2#1)(2008-10#3)
with an expanded##2##3##(2008-10#1)(2008-11#1)
with an experienced##2##3##(2008-11#1)(2011-2#1)
with an extraction efficiency of##2##5##(2008-10#2)
with an extraction##3##3##(2008-10#3)
with an extremely##4##3##(2008-11#1)(2008-3#1)(2009-4#1)(2011-2#1)
with an eye on##2##4##(2008-11#1)(2008-12#1)
with an eye toward##2##4##(1993-3#1)(2008-4#1)
with an eye##4##3##(1993-3#1)(2008-11#1)(2008-12#1)(2008-4#1)
with an important##3##3##(1993-8#1)(1995-5#1)(2008-5#1)
with an improved##7##3##(1992-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#1)
with an improvement in##4##4##(1991-12#1)(1991-8#1)(2011-2#1)(2013-1#1)
with an in situ##3##4##(2008-3#3)
with an in vitro##2##4##(1996-2#1)(2008-5#1)
with an in vivo##2##4##(1994-11#1)(1996-12#1)
with an in##7##3##(1994-11#1)(1996-12#1)(1996-2#1)(2008-3#3)(2008-5#1)
with an incidence of##2##4##(2010-10#1)(2013-1#1)
with an incidence##4##3##(2009-9#1)(2010-10#1)(2013-1#2)
with an increase in leaf##2##5##(2008-10#1)(2012-9#1)
with an increase in temperature##2##5##(1997-2#2)
with an increase in the maximum rate of resource##2##9##(2008-8#2)
with an increase in the ratio of##2##7##(2008-6#1)(2011-1#1)
with an increase in the##12##5##(1993-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
with an increase in##32##4##(1990-6#1)(1993-11#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-2#2)(2008-10#6)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-1#1)(2013-7#1)
with an increase of##4##4##(1990-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
with an increase##37##3##(1990-6#1)(1990-8#1)(1993-11#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-2#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-1#2)(2013-7#1)
with an increased density##2##4##(2008-11#1)(2008-7#1)
with an increased risk of##7##5##(1992-8#1)(1993-11#1)(2009-10#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
with an increased risk##11##4##(1992-8#1)(1993-11#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
with an increased##32##3##(1990-12#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#3)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)
with an increasing##3##3##(2008-10#1)(2008-3#1)(2009-4#1)
with an independent##2##3##(2008-10#2)
with an index of refraction##2##5##(2008-3#2)
with an initial##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
with an injection##3##3##(1993-1#1)(1994-9#1)(2008-10#1)
with an insertion##2##3##(1993-6#1)(2013-1#1)
with an interference##2##3##(1997-7#1)(2009-10#1)
with an internal diameter of##2##5##(2008-10#1)(2013-1#1)
with an internal##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
with an interval of##3##4##(1991-6#1)(1996-12#1)(1997-4#1)
with an inverted repeat at the 5' and 3' ends and two open reading frames##2##15##(2008-10#2)
with an inverted##4##3##(2008-10#2)(2009-11#1)(2013-1#1)
with an ion##3##3##(2008-10#3)
with an isolated##6##3##(1994-5#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
with an on-line sample##2##4##(2008-10#2)
with an on-line##3##3##(2008-10#3)
with an open##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
with an opportunity to##4##4##(1997-3#1)(2008-11#2)(2012-3#1)
with an optical slope efficiency of##2##6##(2008-2#2)
with an optical##8##3##(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)
with an optimal##3##3##(1991-12#1)(1992-8#1)(2008-10#1)
with an optimized##2##3##(2007-12#1)(2008-7#1)
with an optimum at##2##4##(2008-10#2)
with an optimum range##2##4##(2008-10#2)
with an optimum##6##3##(1994-8#1)(2008-10#5)
with an oral##2##3##(1990-8#1)(2008-5#1)
with an order of potency##2##5##(1994-3#2)
with an organic solvent##2##4##(1992-3#1)(2008-10#1)
with an organic##4##3##(1992-3#1)(2008-10#3)
with an orientation##2##3##(1994-5#1)(2008-8#1)
with an outer diameter of##2##5##(2008-8#1)(2012-2#1)
with an outer##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
with an outlier##2##3##(1993-12#1)(1993-3#1)
with an output##2##3##(2008-3#2)
with an overall##9##3##(1997-8#1)(2008-10#3)(2008-8#2)(2009-12#1)(2011-2#1)(2012-2#1)
with an overinstrumented apex##2##4##(2013-1#2)
with an overpotential##2##3##(2008-10#2)
with an uncertainty of##2##4##(2008-2#1)(2008-3#1)
with an uncertainty##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
with an uncoated##2##3##(2007-12#2)
with an underlying##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
with an unusual presentation##3##4##(1997-8#1)(2008-7#1)(2012-3#1)
with an unusual##4##3##(1990-6#1)(1997-8#1)(2008-7#1)(2012-3#1)
with an##841##2##(1990-12#5)(1990-5#4)(1990-6#3)(1990-8#4)(1990-9#1)(1991-11#3)(1991-12#4)(1991-3#4)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#5)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#3)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#7)(1994-8#7)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#8)(1996-5#5)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#5)(2007-12#7)(2008-1#3)(2008-10#266)(2008-11#58)(2008-12#12)(2008-2#8)(2008-3#51)(2008-4#7)(2008-5#18)(2008-6#4)(2008-7#31)(2008-8#16)(2008-9#17)(2009-10#7)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#6)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#3)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#28)(2011-3#2)(2012-12#3)(2012-2#13)(2012-3#13)(2012-5#1)(2012-9#1)(2013-1#35)(2013-7#3)(2013-8#5)
with anabolic##2##2##(1991-3#2)
with analgesic##3##2##(2008-10#1)(2010-6#1)(2013-1#1)
with analogous##2##2##(2008-10#2)
with analyses##2##2##(1995-12#1)(2008-11#1)
with analysis by##2##3##(2008-10#2)
with analysis of##2##3##(1994-12#1)(2012-2#1)
with analysis##7##2##(1994-12#1)(2008-10#4)(2008-3#1)(2012-2#1)
with analyte##3##2##(1997-2#1)(2008-10#2)
with analytical##5##2##(2008-10#4)(2008-9#1)
with anaphylaxis##3##2##(2008-8#1)(2013-1#2)
with and without a##3##4##(1991-12#1)(2007-12#1)(2008-3#1)
with and without dementia in##3##5##(2008-7#2)(2012-3#1)
with and without half-visors##2##4##(2010-1#2)
with and without large-volume sample stacking##2##6##(2008-10#2)
with and without oesophageal varices##2##5##(2009-8#1)(2013-1#1)
with and without the##4##4##(1994-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
with and without##90##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-11#1)(1994-3#1)(1995-2#2)(1995-6#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#2)(2010-12#1)(2011-2#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#1)
with and##112##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-12#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#1)
with androgen##4##2##(1995-12#1)(2008-11#1)(2012-3#1)(2013-8#1)
with anemia##4##2##(1992-6#1)(2008-7#1)(2011-2#2)
with aneurysmal##3##2##(1995-11#1)(2013-1#2)
with aneurysms##3##2##(2011-2#2)(2013-8#1)
with angiogenesis##2##2##(1996-10#1)(2010-6#1)
with angiography##2##2##(1993-6#1)(2011-2#1)
with angiotensin II##2##3##(1995-11#2)
with angular perturbations##2##3##(2013-1#2)
with angular##3##2##(2008-10#1)(2013-1#2)
with animal cells##2##3##(2008-11#2)
with animal models##2##3##(1992-1#1)(2011-2#1)
with animal##5##2##(1990-5#1)(1992-1#1)(2008-11#2)(2011-2#1)
with anion##2##2##(2008-10#2)
with anion-exchange##2##2##(2008-10#2)
with anionic sites##2##3##(2008-10#2)
with anionic##5##2##(2008-10#4)(2008-5#1)
with anomalous##2##2##(2011-2#1)(2013-8#1)
with anoplasty##2##2##(1990-3#2)
with anorexia##2##2##(1991-11#1)(2013-8#1)
with another##19##2##(1990-12#1)(1991-5#1)(1992-12#1)(1993-12#2)(1993-3#1)(1994-2#1)(1996-1#1)(1996-9#1)(2008-10#4)(2008-6#1)(2008-9#2)(2009-6#1)(2009-8#1)(2012-3#1)
with antagonist##2##2##(2008-10#2)
with antagonists##2##2##(2008-10#2)
with anterior##2##2##(2008-7#1)(2012-3#1)
with anti-Fas antibody##2##3##(2008-8#2)
with anti-IL-6##2##2##(2008-10#1)(2013-1#1)
with anti-angiogenic therapies##2##3##(1997-1#1)(2013-8#1)
with anti-psychotic##2##2##(2013-8#2)
with antibiotic##2##2##(1991-3#1)(2008-12#1)
with antibiotics alone##2##3##(1991-1#1)(2010-5#1)
with antibiotics and##2##3##(1996-11#2)
with antibiotics##11##2##(1991-1#1)(1991-4#1)(1994-12#1)(1995-11#1)(1996-11#2)(1996-6#1)(2010-5#1)(2011-2#2)(2013-1#1)
with antibodies against##5##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
with antibodies and##2##3##(2008-10#1)(2008-9#1)
with antibodies specific for##2##4##(1993-6#1)(1995-12#1)
with antibodies to##5##3##(1990-8#1)(1996-12#1)(1997-2#1)(2008-5#1)(2008-7#1)
with antibodies##18##2##(1990-8#1)(1992-6#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)
with antibody##4##2##(1995-5#1)(2008-10#2)(2008-12#1)
with anticancer##2##2##(1993-1#1)(2009-9#1)
with anticoagulants##2##2##(2008-7#2)
with anticonvulsant##3##2##(1994-2#1)(1997-3#1)(2008-9#1)
with antidepressants##2##2##(2008-9#1)(2009-7#1)
with antifungal agents##2##3##(2011-2#1)(2013-8#1)
with antigen##4##2##(2008-1#1)(2008-10#2)(2008-11#1)
with antimicrobial##3##2##(2008-5#1)(2010-4#1)(2012-3#1)
with antineoplastic##2##2##(1991-6#1)(2012-3#1)
with antioxidants such as glutathione##2##5##(2008-5#2)
with antiphospholipid syndrome##2##3##(1997-8#1)(2012-3#1)
with antiphospholipid##3##2##(1992-5#1)(1997-8#1)(2012-3#1)
with antiplatelet##2##2##(1990-11#1)(2013-8#1)
with antisocial personality disorder##2##4##(1991-1#1)(2011-2#1)
with antitumor##2##2##(1994-5#1)(2008-9#1)
with anxiety##3##2##(2008-12#1)(2008-4#1)(2013-1#1)
with any of the##9##4##(1994-11#1)(1997-8#1)(2008-10#5)(2008-7#1)(2012-3#1)
with any of##10##3##(1994-11#1)(1997-8#1)(2008-10#6)(2008-7#1)(2012-3#1)
with any other##5##3##(1993-11#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-12#1)
with any##36##2##(1991-3#1)(1993-11#1)(1994-11#1)(1994-3#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#13)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with aortic##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
with aphid##2##2##(2008-10#2)
with aplastic anaemia##2##3##(2012-2#2)
with apocrine##3##2##(1993-1#2)(2008-12#1)
with apoptosis##4##2##(2008-10#1)(2008-9#2)(2009-9#1)
with apparent molecular masses##2##4##(1997-2#1)(2008-10#1)
with apparent molecular##4##3##(1990-5#1)(1996-12#1)(1997-2#1)(2008-10#1)
with apparent##8##2##(1990-5#1)(1993-8#2)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2012-3#1)
with apple##3##2##(2008-10#3)
with application of##5##3##(2007-11#1)(2008-10#4)
with applications in##2##3##(2008-11#1)(2010-11#1)
with applications to##2##3##(2008-10#1)(2010-6#1)
with applications##4##2##(2008-10#1)(2008-11#1)(2010-11#1)(2010-6#1)
with appropriate analytical##2##3##(2008-10#2)
with appropriate##18##2##(1990-12#1)(1990-3#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-1#2)(2013-8#1)
with approximately 50%##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
with approximately##14##2##(1990-2#1)(1991-3#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-8#1)
with aqua regia##2##3##(2008-10#2)
with aqueous acetonitrile##2##3##(2008-10#2)
with aqueous solutions##3##3##(2008-10#2)(2011-2#1)
with aqueous standards##5##3##(2008-10#5)
with aqueous##19##2##(1994-11#1)(1996-5#1)(2008-10#16)(2011-2#1)
with arachidonic acid##3##3##(1995-11#2)(2010-1#1)
with arbitrary location and##2##4##(2008-2#1)(2008-3#1)
with arbitrary##8##2##(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#1)
with arginine##2##2##(1996-2#1)(2008-9#1)
with aromatic##4##2##(1994-8#1)(1996-5#1)(2008-10#2)
with arsenic##2##2##(2008-10#2)
with arsenobetaine##2##2##(2008-10#2)
with arteriovenous fistulae##2##3##(1996-9#2)
with arteriovenous##6##2##(1996-6#1)(1996-9#2)(1997-6#1)(2008-7#1)(2012-3#1)
with arthritis##2##2##(2008-1#1)(2013-8#1)
with artificial neural##3##3##(2008-10#3)
with artificial##8##2##(1994-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)
with as few as##2##4##(2012-12#1)(2013-8#1)
with as little as##3##4##(1993-9#1)(2008-4#1)(2011-2#1)
with as##6##2##(1993-9#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
with ascites and##2##3##(2008-10#2)
with ascites##4##2##(2008-10#2)(2011-2#2)
with ascorbic acid and##2##4##(2008-10#2)
with ascorbic acid##5##3##(1993-12#1)(2008-10#3)(2008-5#1)
with ascospores##2##2##(2008-10#2)
with aspartate in the##2##4##(1995-6#2)
with aspartate##3##2##(1995-6#3)
with aspect ratios##2##3##(1991-12#1)(2008-3#1)
with aspects##2##2##(1992-2#1)(2008-5#1)
with aspirin##5##2##(1996-11#1)(1997-6#1)(2008-11#2)(2013-8#1)
with associated##7##2##(1991-2#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
with asthma and##4##3##(2012-12#3)(2013-1#1)
with asthma##21##2##(1993-1#1)(1993-9#1)(1996-2#2)(2007-11#1)(2008-1#2)(2008-11#1)(2008-7#1)(2008-8#2)(2010-9#2)(2012-12#6)(2012-2#1)(2013-1#1)
with asymptomatic severe##2##3##(2008-8#1)(2011-2#1)
with asymptomatic##7##2##(1994-12#1)(1996-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
with at least one##2##4##(1991-12#1)(2013-1#1)
with at least##9##3##(1991-12#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)
with at##12##2##(1991-12#1)(1991-3#1)(1994-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)
with ataxia telangiectasia##2##3##(2008-7#2)
with atlantoaxial##3##2##(2008-12#2)(2012-12#1)
with atomic absorption spectrometry##6##4##(2008-10#6)
with atomic absorption##9##3##(1992-3#1)(2008-10#8)
with atomic fluorescence spectrometry##2##4##(2008-10#2)
with atomic fluorescence##3##3##(2008-10#3)
with atomic force microscopy (AFM)##2##5##(2008-10#2)
with atomic force microscopy##3##4##(2008-10#3)
with atomic##17##2##(1992-3#1)(2008-10#16)
with atracurium##2##2##(2010-7#2)
with atrial fibrillation##4##3##(2008-12#1)(2008-3#1)(2009-12#1)(2013-1#1)
with atropine##2##2##(1994-8#1)(2008-8#1)
with attention deficit hyperactivity disorder##3##5##(2008-11#1)(2009-12#1)(2010-1#1)
with attention deficit##4##3##(2008-11#1)(2008-9#1)(2009-12#1)(2010-1#1)
with attention deficit/hyperactivity disorder##2##4##(1997-8#1)(2011-2#1)
with attention to##2##3##(1996-2#1)(2012-3#1)
with attention##8##2##(1996-2#1)(1997-8#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-3#1)
with atypical##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-3#1)
with auditory##2##2##(1996-2#1)(2008-9#1)
with autism##4##2##(1997-8#1)(2008-11#2)(2012-2#1)
with autistic##2##2##(1997-8#1)(2012-2#1)
with autogenous##3##2##(2008-7#1)(2010-5#1)(2012-3#1)
with autoimmune##5##2##(1996-11#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
with autologous##2##2##(1990-12#1)(2008-11#1)
with automated##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2011-2#2)
with automatic##2##2##(2008-10#1)(2012-2#1)
with automation##3##2##(2008-10#3)
with autonomic dysfunction##2##3##(2008-12#2)
with autonomic nerve differentiation##2##4##(2009-7#2)
with autonomic##4##2##(2008-12#2)(2009-7#2)
with autosomal dominant##4##3##(1997-1#2)(1997-8#1)(2013-1#1)
with available##7##2##(1992-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#1)
with average recovery##2##3##(2008-10#2)
with average##18##2##(1991-12#1)(1993-11#1)(1993-3#1)(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-9#1)(2011-2#2)
with axial##4##2##(1995-6#1)(2008-3#2)(2008-7#1)
with azomethine-H##2##2##(2008-10#2)
with azoxystrobin##2##2##(2008-10#2)
with bFGF##3##2##(1994-11#1)(2008-11#2)
with bPL##2##2##(1995-11#2)
with back pain##7##3##(2007-11#1)(2008-12#2)(2009-1#1)(2010-12#2)(2013-1#1)
with back propagation##2##3##(2008-10#1)(2010-8#1)
with back##10##2##(1996-6#1)(2007-11#1)(2008-10#1)(2008-12#2)(2009-1#1)(2010-12#2)(2010-8#1)(2013-1#1)
with background##3##2##(2008-10#1)(2008-6#1)(2009-11#1)
with bacterial culture##2##3##(2008-10#1)(2008-12#1)
with bacterial populations##2##3##(2008-10#2)
with bacterial##15##2##(1990-12#1)(1996-12#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2012-3#1)
with baculovirus##2##2##(2008-11#1)(2008-7#1)
with bad##2##2##(1995-8#1)(2011-3#1)
with balloon##2##2##(1991-3#1)(2008-11#1)
with band ligation##4##3##(2013-1#4)
with bands of##2##3##(2007-12#1)(2008-10#1)
with bare##5##2##(2008-10#4)(2008-11#1)
with barium##2##2##(2008-10#2)
with base##3##2##(1992-3#1)(1994-5#1)(1997-7#1)
with baseline resolution##2##3##(2008-10#2)
with baseline##12##2##(1996-6#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#3)
with basic##2##2##(2008-11#1)(2011-1#1)
with bcl-2##2##2##(2008-11#2)
with bead injection##4##3##(2008-10#4)
with behavioral##5##2##(2008-6#1)(2008-9#1)(2009-11#1)(2009-8#1)(2013-8#1)
with being##3##2##(1996-5#1)(2012-2#2)
with benign endometrial tissue##2##4##(1995-3#2)
with benign prostatic##3##3##(1990-11#1)(1990-9#2)
with benign##13##2##(1990-11#1)(1990-9#4)(1991-8#1)(1992-5#1)(1994-8#1)(1995-3#2)(2008-12#1)(2011-1#1)(2013-1#1)
with benzene##2##2##(2008-10#2)
with benzo-18-crown-6##2##2##(2008-10#2)
with best##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
with beta 2 and gamma 2L subunits##2##7##(1995-11#2)
with beta##6##2##(1990-5#1)(1993-8#1)(1995-11#2)(2008-10#1)(2013-1#1)
with beta-CD##6##2##(2008-10#5)(2008-11#1)
with beta-cyclodextrin (beta-CD)##5##3##(2008-10#5)
with beta-cyclodextrin##11##2##(2008-10#11)
with better prognosis##2##3##(2008-6#1)(2011-2#1)
with better##15##2##(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
with bilateral disease##2##3##(2012-2#2)
with bilateral##24##2##(1991-11#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2012-2#4)(2013-1#5)(2013-8#1)
with bilayers##3##2##(2008-10#3)
with biliary##3##2##(1994-6#1)(2012-2#1)(2013-1#1)
with binding sites##2##3##(2008-10#1)(2008-11#1)
with binding##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
with bioactivity##2##2##(2008-10#1)(2008-11#1)
with biochemical and##2##3##(1990-9#1)(2013-1#1)
with biocontrol agents##2##3##(2008-10#2)
with biological control##3##3##(2008-10#3)
with biological data##2##3##(2008-10#1)(2011-2#1)
with biological##8##2##(1997-6#1)(2008-10#5)(2011-1#1)(2011-2#1)
with biopolymer##2##2##(2008-10#2)
with biopsy##4##2##(1990-11#1)(1991-6#1)(1997-8#1)(2008-7#1)
with biotic##2##2##(2008-10#1)(2008-8#1)
with biotin##2##2##(1992-6#1)(2008-4#1)
with biotinylated protein##2##3##(1990-12#2)
with biotinylated##3##2##(1990-12#2)(1993-6#1)
with bipolar disorder##7##3##(2008-8#1)(2009-11#3)(2012-3#3)
with bipolar##8##2##(1995-3#1)(2008-8#1)(2009-11#3)(2012-3#3)
with birth weights##2##3##(2008-11#2)
with birth##3##2##(2008-11#2)(2012-3#1)
with birthing##2##2##(1996-12#1)(2009-6#1)
with bismuth film##2##3##(2008-10#2)
with bismuth##5##2##(2008-10#4)(2010-11#1)
with bisphosphonate therapy##2##3##(2008-11#1)(2012-12#1)
with black and##2##3##(2011-2#2)
with bladder exstrophy##4##3##(2008-10#4)
with bladder##8##2##(1995-2#1)(2008-10#6)(2013-1#1)
with bleeding##4##2##(1991-9#1)(2009-12#1)(2013-1#2)
with blood##6##2##(2008-10#2)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
with body mass index##2##4##(2011-1#1)(2011-2#1)
with body size##3##3##(2007-12#1)(2008-8#1)(2009-8#1)
with body##7##2##(1994-8#1)(2007-12#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)
with bone grafting##2##3##(1996-3#1)(2011-2#1)
with bone marrow##3##3##(1992-2#1)(2010-11#1)(2010-6#1)
with bone metastasis##2##3##(1990-2#1)(1994-12#1)
with bone##18##2##(1990-2#2)(1991-11#1)(1992-2#1)(1994-12#1)(1996-3#2)(2008-10#2)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-3#2)
with bootstrap##2##2##(2008-10#2)
with borate##2##2##(2008-10#2)
with borderline##2##2##(1992-1#1)(2009-9#1)
with both a##4##3##(1997-8#1)(2008-10#1)(2008-3#2)
with both fluoroionophores##2##3##(2008-10#2)
with both methods##2##3##(2008-10#2)
with both of these##3##4##(1993-6#1)(1997-2#1)(2008-11#1)
with both of##4##3##(1993-6#1)(1997-2#1)(2008-10#1)(2008-11#1)
with both parents##2##3##(2011-2#1)(2013-1#1)
with both pathogens##2##3##(2008-10#2)
with both sexual and asexual reproduction##2##6##(2008-10#2)
with both techniques##2##3##(1997-8#1)(2008-10#1)
with both the##19##3##(1991-10#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(2008-10#7)(2008-11#2)(2008-7#1)(2008-8#2)(2013-8#1)
with both types of##3##4##(2008-10#2)(2011-2#1)
with both viruses##3##3##(1995-12#1)(2008-10#2)
with both##152##2##(1990-12#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-8#2)(2008-10#51)(2008-11#15)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
with bottom##2##2##(2008-10#1)(2011-2#1)
with bovine serum albumin (BSA)##7##5##(2008-10#6)(2008-11#1)
with bovine serum albumin##10##4##(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)
with bovine##14##2##(1994-5#1)(1997-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
with brain lesions##2##3##(1991-2#1)(1994-3#1)
with brain##11##2##(1991-12#1)(1991-2#3)(1994-3#1)(1995-8#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-3#1)(2012-3#1)
with breast cancer and primary biliary cirrhosis##2##7##(1992-12#2)
with breast cancer and their##3##5##(1994-3#1)(1996-3#1)(2013-1#1)
with breast cancer and##9##4##(1990-12#1)(1990-2#1)(1992-12#2)(1993-11#1)(1994-3#1)(1996-3#1)(2008-7#1)(2013-1#1)
with breast cancer##38##3##(1990-12#2)(1990-2#1)(1990-8#1)(1992-12#2)(1993-1#1)(1993-11#4)(1994-12#3)(1994-3#2)(1995-12#1)(1995-9#1)(1996-3#1)(1997-7#1)(1997-8#3)(2008-10#2)(2008-4#2)(2008-7#2)(2011-2#1)(2012-3#2)(2013-1#6)
with breast or prostate cancer##2##5##(2008-7#2)
with breast##49##2##(1990-12#2)(1990-2#1)(1990-8#2)(1991-6#1)(1992-12#2)(1993-1#1)(1993-11#5)(1993-2#1)(1994-12#3)(1994-3#2)(1995-12#1)(1995-9#1)(1996-3#1)(1997-7#1)(1997-8#3)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#6)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#7)
with brief##6##2##(1991-2#1)(2008-11#1)(2012-12#3)(2012-3#1)
with broad##2##2##(2008-10#2)
with broccoli##2##2##(2008-10#2)
with bromate##2##2##(2008-10#2)
with bromide##2##2##(2008-10#2)
with bromine in CCl(4)##2##4##(1996-5#2)
with bromine##6##2##(1996-5#2)(2008-10#4)
with buffered saline##2##3##(1994-11#2)
with bulky cations##2##3##(2008-10#2)
with bullying##2##2##(2008-11#1)(2009-7#1)
with butterfly##2##2##(2012-3#1)(2013-1#1)
with butyrate##2##2##(1993-6#1)(2008-11#1)
with cAMP##2##2##(1991-3#1)(1992-6#1)
with cDNA##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
with cabergoline##2##2##(2008-7#2)
with caffeine##5##2##(1995-8#3)(1996-5#1)(2008-8#1)
with calcein##2##2##(2008-10#2)
with calcification##4##2##(1990-6#1)(2008-7#1)(2012-3#2)
with calcifications##3##2##(1997-8#2)(2011-2#1)
with calcium##10##2##(1995-11#1)(1995-12#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-9#1)
with calculated##3##2##(1993-8#1)(1993-9#1)(2008-8#1)
with calculations##3##2##(2008-3#3)
with calibration##3##2##(2008-10#3)
with calmodulin##5##2##(1993-6#4)(1994-3#1)
with cancer and##4##3##(1993-3#1)(1995-2#1)(2008-7#1)(2012-2#1)
with cancer have##2##3##(2008-11#1)(2008-7#1)
with cancer of the##7##4##(1990-9#3)(1991-2#2)(1991-8#1)(2012-3#1)
with cancer##60##2##(1990-6#1)(1990-9#3)(1991-2#3)(1991-8#1)(1993-3#1)(1995-2#1)(1996-11#1)(1997-7#1)(2008-11#3)(2008-2#2)(2008-5#1)(2008-7#9)(2009-12#1)(2009-5#1)(2009-9#1)(2010-11#9)(2010-4#1)(2010-7#2)(2010-9#2)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
with canonical##2##2##(2008-10#1)(2013-1#1)
with canopy size##2##3##(2008-10#2)
with capillary electrophoresis##6##3##(2008-10#6)
with capillary isotachophoresis##2##3##(2008-10#2)
with capillary##10##2##(2008-10#10)
with capsaicin##3##2##(1992-6#1)(2008-11#2)
with captopril##4##2##(1990-11#1)(1992-12#1)(1994-5#1)(1995-8#1)
with carbohydrate##2##2##(1990-2#1)(2011-2#1)
with carbon dioxide##2##3##(1996-12#1)(2008-10#1)
with carbon##9##2##(1992-6#1)(1996-12#2)(2008-10#5)(2008-4#1)
with carbon-13##3##2##(2008-10#3)
with carboxylic ligands##3##3##(2008-10#3)
with carboxylic##5##2##(2008-10#5)
with carcinoma##3##2##(1992-5#2)(2013-1#1)
with cardiac magnetic resonance imaging##3##5##(2008-3#2)(2013-3#1)
with cardiac magnetic resonance##4##4##(2008-3#3)(2013-3#1)
with cardiac##11##2##(1994-3#1)(2008-10#2)(2008-12#2)(2008-3#3)(2010-10#1)(2012-12#1)(2013-3#1)
with cardiogenic shock##2##3##(1997-5#1)(2008-11#1)
with cardiovascular disease##3##3##(2010-4#1)(2011-2#1)(2012-3#1)
with cardiovascular risk##2##3##(2008-11#1)(2013-1#1)
with cardiovascular##13##2##(2008-11#1)(2008-7#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)
with care of the##2##4##(2008-11#1)(2013-1#1)
with care##9##2##(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#2)(2008-11#2)(2008-5#1)(2013-1#1)
with careful##3##2##(1991-3#1)(2010-1#1)(2013-8#1)
with carotid##3##2##(1991-12#1)(2008-1#1)(2008-11#1)
with carrier##2##2##(2008-11#1)(2008-7#1)
with cartilage##3##2##(2008-9#1)(2009-1#1)(2010-10#1)
with carvacrol##2##2##(2008-11#2)
with cases##2##2##(2012-12#1)(2012-2#1)
with catalytic##7##2##(2008-10#5)(2008-11#2)
with catechol##4##2##(2008-10#4)
with catheter##2##2##(1995-11#1)(2010-12#1)
with cathodic##2##2##(2008-10#2)
with cation##2##2##(2008-10#2)
with cationic slopes of##2##4##(2008-10#2)
with cationic##7##2##(1994-5#1)(1995-2#1)(2008-10#4)(2011-2#1)
with caveolin##3##2##(1995-6#3)
with celiac disease##2##3##(2012-12#1)(2013-8#1)
with cell cycle##3##3##(1992-10#1)(1995-9#1)(1997-7#1)
with cell membranes##2##3##(2008-11#2)
with cell##18##2##(1992-10#1)(1995-9#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#6)(2009-3#1)(2010-8#1)
with cells##10##2##(1992-6#1)(1993-6#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)
with cellular##5##2##(1994-11#1)(1994-3#1)(2008-11#1)(2008-9#1)(2012-3#1)
with central##6##2##(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)
with cerebellar##3##2##(1995-6#1)(2008-7#2)
with cerebral sequelae##2##3##(1990-12#2)
with cerebral##7##2##(1990-12#2)(1990-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
with cerebroside B##2##3##(2008-10#2)
with cerebrospinal fluid##2##3##(2008-7#1)(2011-2#1)
with cerebrovascular##2##2##(1996-11#1)(2008-7#1)
with cerium##2##2##(2008-10#2)
with cerium(IV) in sulfuric acid media##2##6##(2008-10#2)
with cerium(IV) in sulfuric acid##3##5##(2008-10#3)
with cerium(IV) in##4##3##(2008-10#4)
with cerium(IV)##6##2##(2008-10#6)
with certain##10##2##(1993-12#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2013-1#1)
with certified values at##2##4##(2008-10#2)
with certified values of standard reference materials##3##7##(2008-10#3)
with certified values##16##3##(2008-10#16)
with certified##20##2##(2008-10#20)
with cervical intraepithelial neoplasia (CIN)##2##5##(1991-2#1)(2011-2#1)
with cervical intraepithelial neoplasia##3##4##(1991-2#1)(2011-2#2)
with cervical##10##2##(1991-2#1)(1997-3#1)(2007-12#1)(2008-12#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#2)
with cervicogenic headache##4##3##(2008-12#4)
with cesium##2##2##(2007-12#1)(2008-10#1)
with cessation##4##2##(2010-2#2)(2013-1#2)
with change in 4 &quot##2##5##(1991-8#2)
with change in##3##3##(1991-8#2)(2012-12#1)
with changes in##10##3##(2008-10#1)(2008-8#1)(2008-9#3)(2010-10#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
with changes##12##2##(1994-3#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#3)(2010-10#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
with changing##2##2##(1993-3#1)(1997-3#1)
with characteristic##8##2##(1992-12#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)
with characteristics that##2##3##(2008-10#1)(2008-5#1)
with characteristics##6##2##(1995-8#1)(2008-10#2)(2008-5#2)(2013-1#1)
with cheap and##2##3##(2008-10#2)
with chemical sensors##2##3##(2008-10#2)
with chemical##14##2##(1991-3#1)(1992-6#1)(2008-10#7)(2008-3#1)(2010-10#2)(2010-8#1)(2012-2#1)
with chemically##4##2##(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
with chemiluminescence (CL) detection##2##4##(2008-10#2)
with chemiluminescence (CL)##3##3##(2008-10#3)
with chemiluminescence detection is##2##4##(2008-10#2)
with chemiluminescence detection##11##3##(2008-10#11)
with chemiluminescence##15##2##(2008-10#15)
with chemiluminescent##2##2##(1992-9#1)(2008-10#1)
with chemometric##3##2##(2008-10#3)
with chemotherapy##10##2##(1991-6#2)(1992-12#1)(1993-2#1)(2008-7#4)(2012-3#1)(2013-1#1)
with chest pain in##3##4##(1991-3#1)(2008-3#2)
with chest pain##8##3##(1991-3#1)(1992-6#1)(2008-3#2)(2010-10#1)(2011-1#1)(2012-2#2)
with chest##9##2##(1991-3#1)(1992-6#1)(2008-3#2)(2010-10#1)(2011-1#1)(2012-2#2)(2013-1#1)
with chief##2##2##(1997-1#1)(2011-2#1)
with childhood##5##2##(2008-10#1)(2010-6#1)(2011-1#2)(2011-2#1)
with children with##3##3##(1997-2#1)(2008-11#1)(2008-9#1)
with children##11##2##(1990-12#1)(1995-5#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#3)(2009-10#1)(2011-2#1)
with children's##4##2##(2010-11#3)(2011-2#1)
with chimeric##3##2##(1997-3#1)(1997-9#1)(2008-10#1)
with chinolon group antibiotics##2##4##(2007-11#2)
with chiral##2##2##(1990-6#1)(2011-2#1)
with chloramphenicol##2##2##(2008-10#1)(2013-1#1)
with chloride in##3##3##(2008-10#3)
with chloride ions##2##3##(2008-10#1)(2009-8#1)
with chloride##7##2##(2008-10#6)(2009-8#1)
with chlorine##4##2##(2008-10#4)
with chloroform and##2##3##(2008-10#2)
with chloroform##9##2##(1993-8#1)(2008-10#7)(2008-7#1)
with cholera toxin B subunit##2##5##(2008-11#2)
with cholesterol oxidase##2##3##(2008-10#2)
with cholesterol##5##2##(1997-2#1)(2008-10#3)(2008-6#1)
with chorea##2##2##(2008-7#2)
with chromatomembrane cell and##2##4##(2008-10#2)
with chromatomembrane##4##2##(2008-10#4)
with chromium(VI)##3##2##(2008-10#3)
with chromosomal##2##2##(2011-2#1)(2012-3#1)
with chromosome##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
with chromotropic acid (CA)##2##4##(2008-10#2)
with chromotropic acid##6##3##(2008-10#6)
with chronic ankle##2##3##(2010-7#1)(2013-1#1)
with chronic conditions##2##3##(1997-1#1)(1997-2#1)
with chronic hepatitis B##6##4##(2009-8#4)(2011-2#2)
with chronic hepatitis C##5##4##(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#2)
with chronic hepatitis##13##3##(2009-10#1)(2009-8#5)(2010-4#1)(2011-2#3)(2013-1#3)
with chronic illness##3##3##(1992-2#1)(1993-3#1)(1997-2#1)
with chronic illnesses##3##3##(1993-3#3)
with chronic kidney disease##5##4##(2008-11#1)(2010-4#1)(2011-2#1)(2012-3#2)
with chronic kidney##6##3##(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)
with chronic liver disease who are at risk for##2##9##(2008-1#2)
with chronic liver disease##6##4##(1991-11#1)(1991-8#1)(2008-1#2)(2008-10#1)(2009-8#1)
with chronic low back pain##3##5##(2012-12#2)(2013-1#1)
with chronic medical conditions##2##4##(2008-7#1)(2010-2#1)
with chronic mental##2##3##(1993-3#1)(1994-2#1)
with chronic obstructive pulmonary disease (COPD)##2##6##(2011-2#2)
with chronic obstructive pulmonary disease##3##5##(2010-10#1)(2011-2#2)
with chronic obstructive pulmonary##4##4##(1993-11#1)(2010-10#1)(2011-2#2)
with chronic obstructive##5##3##(1993-11#1)(2008-1#1)(2010-10#1)(2011-2#2)
with chronic pain##5##3##(2008-12#1)(2008-4#2)(2008-9#1)(2012-3#1)
with chronic renal failure##9##4##(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-5#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
with chronic renal##11##3##(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-5#1)(2008-1#2)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
with chronic venous insufficiency##2##4##(2013-1#2)
with chronic venous##3##3##(2010-7#1)(2013-1#2)
with chronic wrist pain##4##4##(2008-9#4)
with chronic##135##2##(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-2#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#6)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1995-2#2)(1995-5#1)(1997-1#2)(1997-2#3)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#2)(2008-12#4)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#6)(2009-10#2)(2009-8#11)(2010-1#2)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#3)(2011-2#14)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#14)(2013-8#2)
with cigarette smoking##3##3##(2008-10#2)(2013-1#1)
with cigarette##5##2##(1993-8#1)(2008-10#2)(2013-1#2)
with ciprofloxacin##3##2##(1991-4#2)(2011-2#1)
with circular##4##2##(1995-2#1)(2008-2#1)(2008-3#2)
with circulating##4##2##(2008-10#1)(2008-7#2)(2008-9#1)
with circumferential spine fusion##2##4##(2008-8#2)
with cirrhosis and##3##3##(1993-2#1)(2011-2#1)(2013-1#1)
with cirrhosis##5##2##(1993-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
with cisplatin and##2##3##(1993-2#1)(1994-12#1)
with cisplatin##4##2##(1992-12#2)(1993-2#1)(1994-12#1)
with citric acid##2##3##(2008-10#2)
with clarity##3##2##(2008-11#1)(2008-12#1)(2009-5#1)
with class I molecules##2##4##(1990-5#2)
with class##3##2##(1990-5#2)(1993-3#1)
with classic CAH##3##3##(2010-2#3)
with classic##5##2##(2008-10#1)(2010-2#4)
with classical##9##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2009-9#1)
with clay##2##2##(2008-10#2)
with clear##4##2##(1991-8#1)(2008-7#2)(2011-2#1)
with clenbuterol##3##2##(2010-6#3)
with clients##2##2##(1993-2#1)(2008-11#1)
with climacteric blooding##2##3##(2008-11#2)
with clinical and##4##3##(2011-2#2)(2012-2#2)
with clinical signs of##2##4##(2011-2#1)(2012-12#1)
with clinical signs##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
with clinical##38##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
with clinically diagnosed##2##3##(1996-11#1)(2008-7#1)
with clinically significant##2##3##(1992-6#1)(2010-7#1)
with clinically##8##2##(1992-3#1)(1992-6#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-7#1)(2010-7#1)(2010-9#1)
with clinicians##2##2##(2008-8#1)(2010-4#1)
with co-occurring##6##2##(2008-10#1)(2012-3#1)(2013-8#4)
with coat##2##2##(1994-12#1)(2008-8#1)
with coated##2##2##(1991-3#1)(2008-10#1)
with cobalt##3##2##(2008-10#2)(2008-11#1)
with cobalt(II) and##2##3##(2008-10#2)
with cochlear implant##2##3##(2008-9#2)
with cochlear implants##13##3##(2008-9#11)(2012-2#2)
with cochlear##15##2##(2008-9#13)(2012-2#2)
with coefficients of &gt##2##4##(2008-10#2)
with coefficients of variation##4##4##(2008-10#3)(2008-5#1)
with coefficients of##6##3##(2008-10#5)(2008-5#1)
with coefficients##8##2##(2008-10#5)(2008-3#2)(2008-5#1)
with coexistent##4##2##(1992-3#1)(1993-1#1)(1994-11#1)(2007-12#1)
with coexisting##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
with cognitive impairment##2##3##(2008-7#1)(2010-7#1)
with cognitive impairments##2##3##(1991-1#1)(2008-12#1)
with cognitive##5##2##(1991-1#1)(2008-12#1)(2008-7#1)(2010-7#1)(2013-1#1)
with coils##4##2##(1997-8#4)
with cold##2##2##(2008-10#2)
with collagen##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
with collapse of##2##3##(1995-2#1)(2008-10#1)
with collapse##4##2##(1991-11#1)(1991-8#1)(1995-2#1)(2008-10#1)
with colloidal##2##2##(2008-10#1)(2010-11#1)
with colonic##3##2##(2009-12#2)(2011-2#1)
with colonization##2##2##(2008-10#2)
with colony size##3##3##(2008-9#3)
with colony##5##2##(2008-10#2)(2008-9#3)
with colorectal##4##2##(2009-12#1)(2011-2#2)(2013-1#1)
with column##3##2##(2008-10#3)
with combination##2##2##(1996-3#1)(2011-2#1)
with combinations of##2##3##(2008-10#1)(2008-5#1)
with combinatorial##2##2##(1997-7#1)(2009-12#1)
with combined day and night capability for tropospheric water-vapor profile measurements##2##11##(2008-2#2)
with combined##10##2##(1993-6#1)(1994-3#1)(2008-2#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
with comments on##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
with comments##4##2##(1992-3#1)(2007-12#1)(2008-3#1)(2008-8#1)
with commercial##6##2##(2008-10#3)(2008-3#2)(2008-5#1)
with commercially available##4##3##(1992-2#1)(2008-10#3)
with commercially##5##2##(1992-2#1)(2008-10#3)(2009-7#1)
with common##13##2##(1997-8#1)(2008-10#7)(2008-11#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
with community pharmacists in error prevention and management##2##8##(2011-1#2)
with community pharmacists##3##3##(2011-1#3)
with community##6##2##(1997-2#2)(2008-11#1)(2011-1#3)
with comparable##4##2##(1990-3#1)(1997-2#1)(2008-10#1)(2008-5#1)
with comparatively##2##2##(2011-2#2)
with comparisons##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
with competitive##2##2##(2008-8#1)(2008-9#1)
with complaints of##8##3##(1994-3#1)(2008-10#1)(2008-12#2)(2010-12#1)(2010-3#1)(2013-7#1)(2013-8#1)
with complement##3##2##(1994-6#1)(2008-10#1)(2008-4#1)
with complementary##5##2##(2008-10#4)(2008-9#1)
with complete recovery##2##3##(1991-11#1)(1991-8#1)
with complete resistance to##4##4##(2008-10#4)
with complete##19##2##(1991-11#1)(1991-8#1)(1992-12#1)(1993-12#1)(1994-2#1)(1996-5#1)(1997-7#1)(2008-10#7)(2008-6#1)(2008-7#2)(2010-7#2)
with complex and##2##3##(2008-11#1)(2010-8#1)
with complex##20##2##(1994-8#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-8#2)(2011-2#2)(2013-8#1)
with complicated malaria##2##3##(2012-12#2)
with complicated##4##2##(1991-6#1)(2010-12#1)(2012-12#2)
with complications such as##3##4##(1996-11#1)(2007-12#1)(2012-12#1)
with complications##5##2##(1996-11#1)(2007-12#1)(2010-12#1)(2012-12#1)(2012-3#1)
with composite##5##2##(1990-9#1)(2008-10#1)(2013-1#3)
with composition##4##2##(2008-10#4)
with compost##4##2##(2008-10#4)
with composted##2##2##(2008-10#2)
with comprehensive##3##2##(1992-2#1)(1997-8#1)(2008-7#1)
with compromised##2##2##(2008-9#1)(2009-8#1)
with computed tomography##2##3##(2012-12#1)(2012-2#1)
with computer##6##2##(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
with concentrated##4##2##(2008-10#3)(2010-1#1)
with concentration of##2##3##(2008-10#2)
with concentration##8##2##(2008-10#7)(2012-2#1)
with concentrations##4##2##(2008-10#4)
with concomitant##13##2##(1992-6#1)(1994-11#1)(1994-8#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)
with concurrent##7##2##(1992-12#1)(2008-10#4)(2009-8#2)
with conditioned reinforcement##3##3##(1993-6#3)
with confidence##4##2##(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#1)
with confirmed##3##2##(2009-11#1)(2010-6#1)(2012-2#1)
with congenital and acquired heart##2##5##(2009-12#1)(2012-2#1)
with congenital anomalies##3##3##(2008-11#3)
with congenital heart disease (CHD)##3##5##(2010-10#1)(2010-9#1)(2012-2#1)
with congenital heart disease##13##4##(1990-11#1)(2008-11#1)(2009-10#2)(2010-10#2)(2010-6#1)(2010-9#2)(2011-2#1)(2012-2#3)
with congenital nephrogenic diabetes insipidus##2##5##(1994-11#2)
with congenital##29##2##(1990-11#1)(1990-12#1)(1992-5#1)(1994-11#2)(1997-3#1)(2008-11#4)(2008-9#1)(2009-10#2)(2009-12#1)(2010-10#2)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#2)
with congestive cardiac failure##2##4##(1996-6#2)
with conidia of##4##3##(2008-10#4)
with conidia##5##2##(2008-10#5)
with conidial suspensions of##3##4##(2008-10#3)
with conidial suspensions##4##3##(2008-10#4)
with conidial##6##2##(2008-10#6)
with conjugate##2##2##(2006-6#1)(2010-8#1)
with consequent##5##2##(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
with conservative management##2##3##(2008-10#1)(2013-1#1)
with conservative treatment##2##3##(2008-7#1)(2011-2#1)
with conservative##6##2##(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
with conserved##4##2##(1993-12#1)(1997-3#1)(2008-10#1)(2009-5#1)
with considerable##7##2##(1990-8#1)(1993-3#2)(2008-10#1)(2008-5#1)(2010-10#1)(2012-3#1)
with considerably##2##2##(2008-10#2)
with considerations of##2##3##(2008-8#1)(2013-1#1)
with considerations##3##2##(2008-8#1)(2013-1#2)
with consistent##3##2##(1991-12#1)(2008-10#2)
with constant##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
with constitutional##3##2##(2008-9#1)(2011-1#2)
with consumers##2##2##(2011-1#1)(2013-1#1)
with contact dermatitis##2##3##(1997-2#1)(2012-3#1)
with contact lenses##2##3##(1993-11#2)
with contact##5##2##(1993-11#2)(1995-11#1)(1997-2#1)(2012-3#1)
with content##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
with continued##3##2##(1992-3#1)(2008-7#1)(2010-12#1)
with continuous and##2##3##(2008-10#1)(2013-1#1)
with continuous##20##2##(1991-11#1)(1992-1#1)(1993-3#1)(1995-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
with continuous-flow##3##2##(2008-10#1)(2010-6#2)
with continuous-wave##2##2##(2008-3#2)
with continuum##2##2##(2008-10#1)(2009-7#1)
with contrast##3##2##(1990-9#1)(2011-2#1)(2012-2#1)
with contrasting##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
with control plants##3##3##(2008-10#3)
with control##21##2##(1993-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
with controllable##2##2##(1996-12#1)(2009-12#1)
with controlled##5##2##(2008-10#2)(2008-7#1)(2009-7#1)(2010-7#1)
with controls##10##2##(1994-8#1)(1995-12#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#2)
with convective##2##2##(2008-10#1)(2008-3#1)
with conventional Soxhlet##2##3##(2008-10#2)
with conventional ion-selective electrodes##2##4##(2008-10#2)
with conventional methods##4##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
with conventional techniques##3##3##(1994-3#1)(1997-7#1)(2008-11#1)
with conventional tillage##2##3##(2008-10#2)
with conventional##53##2##(1990-8#1)(1991-5#1)(1993-1#1)(1994-3#2)(1994-6#1)(1997-5#1)(1997-7#1)(2008-10#25)(2008-11#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#4)(2011-7#1)(2012-3#1)(2013-1#1)
with conventionally##2##2##(2008-10#2)
with coordinating##3##2##(1994-1#2)(1997-2#1)
with copper bactericides##2##3##(2008-10#2)
with copper ions##3##3##(2008-10#3)
with copper##17##2##(1990-5#1)(2008-10#15)(2008-2#1)
with copper(II)##3##2##(2008-10#3)
with copra oil##2##3##(2013-1#2)
with coronary artery disease##5##4##(1990-3#1)(1995-3#1)(1997-8#1)(2011-2#1)(2013-7#1)
with coronary artery##7##3##(1990-3#1)(1995-3#1)(1997-8#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
with coronary##16##2##(1990-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1995-3#2)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
with correction##2##2##(2008-10#1)(2011-2#1)
with correlation coefficient of 0##5##5##(2008-10#5)
with correlation coefficient##7##3##(2008-10#6)(2009-3#1)
with correlation coefficients (r)##2##4##(2008-10#2)
with correlation coefficients##5##3##(2008-10#5)
with correlation##14##2##(2008-10#13)(2009-3#1)
with corresponding detection limits of 0##2##6##(2008-10#2)
with corresponding##14##2##(1990-2#1)(2008-10#9)(2008-11#1)(2008-3#1)(2010-12#1)(2012-3#1)
with cortical##5##2##(1993-3#1)(1996-9#1)(2008-7#1)(2008-9#1)(2013-1#1)
with corticosteroid##3##2##(1993-2#1)(2008-1#2)
with costs of##2##3##(1995-1#1)(2008-8#1)
with costs##3##2##(1995-1#1)(2008-7#1)(2008-8#1)
with coulometric##2##2##(2008-10#1)(2009-8#1)
with county population##2##3##(1991-3#1)(1996-3#1)
with cranial nerve##2##3##(2007-12#1)(2008-7#1)
with cranial##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
with crop##2##2##(2008-10#1)(2013-1#1)
with crossed##2##2##(2008-3#2)
with crown##2##2##(2008-10#2)
with crushed grains under the pigment layer##2##7##(2008-10#2)
with crystal violet##2##3##(2008-10#2)
with cultural##2##2##(2008-1#1)(2013-8#1)
with cumulative##2##2##(1995-9#1)(2008-10#1)
with cupferron##2##2##(2008-10#2)
with current##21##2##(1994-6#1)(1995-12#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-4#1)(2010-1#1)(2010-12#2)(2013-1#1)
with cutaneous##5##2##(1997-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
with cv##3##2##(2008-10#3)
with cyanex 302##2##3##(2008-10#2)
with cyanex##3##2##(2008-10#3)
with cyanogen bromide##3##3##(1990-5#2)(1994-5#1)
with cyclic voltammetry##2##3##(2008-10#2)
with cyclic##5##2##(1993-8#1)(1994-11#1)(2008-10#3)
with cyclodextrin and##2##3##(2008-10#1)(2008-5#1)
with cyclodextrin##3##2##(2008-10#2)(2008-5#1)
with cyclodextrins##3##2##(2008-10#3)
with cyclophosphamide and##2##3##(2008-1#1)(2008-5#1)
with cyclophosphamide##9##2##(1991-8#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2013-8#1)
with cylindrical##3##2##(2008-10#2)(2008-3#1)
with cyst##3##2##(1997-8#2)(2013-1#1)
with cysteine##5##2##(2008-10#5)
with cystic fibrosis##5##3##(1991-12#2)(1991-2#1)(1994-12#1)(2008-10#1)
with cystic##6##2##(1991-12#2)(1991-2#1)(1994-12#1)(2008-10#1)(2008-7#1)
with cytochrome##2##2##(2009-10#1)(2011-1#1)
with cytokines##4##2##(1990-8#1)(2008-11#1)(2008-8#1)(2010-11#1)
with cytotoxic##3##2##(2008-11#1)(2009-12#1)(2012-3#1)
with daily activities##2##3##(2008-11#1)(2009-11#1)
with daily##4##2##(2008-11#2)(2009-11#1)(2010-5#1)
with dandruff##2##2##(2008-5#2)
with dark##2##2##(2008-10#1)(2009-9#1)
with data for the##2##4##(1996-2#1)(2008-10#1)
with data for##3##3##(1996-2#1)(2008-1#1)(2008-10#1)
with data from##11##3##(1990-12#1)(1992-9#1)(1993-6#1)(1994-9#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#1)
with data obtained by atomic absorption##2##6##(2008-10#2)
with data obtained by##4##4##(2008-10#4)
with data obtained using##4##4##(2008-10#4)
with data obtained##10##3##(2008-10#8)(2008-11#1)(2008-5#1)
with data on patch##2##4##(2008-9#2)
with data on##7##3##(2008-8#3)(2008-9#2)(2011-8#1)(2013-1#1)
with data##43##2##(1990-12#1)(1992-1#1)(1992-9#1)(1993-6#1)(1994-9#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-12#1)(2011-1#1)(2011-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
with daunomycin##3##2##(2008-10#2)(2008-7#1)
with de novo##3##3##(2008-10#1)(2010-1#1)(2011-1#1)
with dead##2##2##(2007-12#1)(2008-9#1)
with death##4##2##(1991-2#1)(2008-11#3)
with declining mobility##2##3##(2008-7#2)
with declining##4##2##(1992-12#1)(2008-7#2)(2011-2#1)
with decompensated##2##2##(2009-8#1)(2012-3#1)
with decreased maternal age##3##4##(1997-3#3)
with decreased##18##2##(1997-3#3)(2008-10#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-10#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
with decreasing##10##2##(2007-12#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-9#2)
with dedicated##2##2##(2012-2#1)(2013-7#1)
with deep##4##2##(1992-5#1)(2007-12#1)(2011-1#1)(2012-3#1)
with defective##2##2##(1993-9#1)(2011-2#1)
with defects in##2##3##(1991-7#1)(2008-10#1)
with deficiency of##2##3##(1993-3#1)(1995-8#1)
with deficient##2##2##(1993-2#1)(2009-7#1)
with deficits in##3##3##(2008-2#1)(2008-7#1)(2011-1#1)
with defined##6##2##(1995-5#2)(2008-10#2)(2008-7#1)(2008-8#1)
with definitive##3##2##(2009-4#1)(2011-2#1)(2013-1#1)
with degenerate primers##3##3##(1993-2#1)(1997-7#1)(2008-10#1)
with degenerate##4##2##(1993-2#1)(1997-7#1)(2008-10#1)(2008-8#1)
with degenerative##6##2##(1993-2#1)(2009-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
with deionized water##2##3##(2008-10#2)
with delay in the##2##4##(2007-11#1)(2013-1#1)
with delay##4##2##(2007-11#1)(2013-1#1)(2013-8#2)
with delayed diagnosis##3##3##(2008-11#1)(2010-12#2)
with delayed##4##2##(1991-2#1)(2008-11#1)(2010-12#2)
with delirium##4##2##(2010-10#3)(2013-1#1)
with delivery##2##2##(2008-11#1)(2010-11#1)
with dementia and##4##3##(2008-11#1)(2010-10#1)(2010-11#1)(2013-8#1)
with dementia in##2##3##(2013-1#1)(2013-8#1)
with dementia##22##2##(1991-1#2)(1992-3#2)(1996-11#1)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2010-10#3)(2010-11#1)(2013-1#1)(2013-8#5)
with dendritic##2##2##(2008-9#1)(2013-1#1)
with dense mycelium##2##3##(2008-10#2)
with dense##3##2##(2007-12#1)(2008-10#2)
with density##3##2##(2008-11#1)(2008-8#2)
with dental##2##2##(1993-1#1)(2013-1#1)
with depression and##2##3##(1996-11#1)(2008-12#1)
with depression##7##2##(1991-1#1)(1996-11#1)(2008-12#1)(2009-12#1)(2010-2#2)(2012-2#1)
with depressive symptoms##2##3##(2010-1#1)(2010-10#1)
with depressive##4##2##(1992-2#1)(2008-7#1)(2010-1#1)(2010-10#1)
with depth##2##2##(2008-10#1)(2008-5#1)
with derivatives##2##2##(1994-5#1)(2008-11#1)
with desirable##4##2##(2008-11#1)(2008-8#1)(2009-7#1)(2012-2#1)
with desired##2##2##(2008-10#1)(2008-11#1)
with detached##2##2##(2008-10#2)
with detailed##5##2##(1990-3#1)(2008-11#1)(2008-4#1)(2008-9#2)
with details##2##2##(2008-11#1)(2008-4#1)
with detectable##3##2##(2008-10#2)(2008-7#1)
with detection at##3##3##(2008-10#3)
with detection by inductively coupled plasma mass spectrometry##2##8##(2008-10#2)
with detection by##4##3##(2008-10#4)
with detection limit of 0##5##5##(2008-10#5)
with detection limit of 1##2##5##(2008-10#2)
with detection limit of##13##4##(2008-10#13)
with detection limit##18##3##(2008-10#18)
with detection limits (S/N=3)##3##4##(2008-10#3)
with detection limits of 0##8##5##(2008-10#8)
with detection limits of##16##4##(2008-10#16)
with detection limits ranging from##2##5##(2008-10#2)
with detection limits##27##3##(2008-10#27)
with detection##56##2##(2008-10#55)(2009-9#1)
with determination of##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
with determination##7##2##(1997-2#1)(2008-10#5)(2008-7#1)
with developing##2##2##(2008-10#1)(2008-12#1)
with development of##2##3##(2008-10#1)(2010-10#1)
with developmental##10##2##(1992-1#1)(1993-3#1)(1995-1#2)(2009-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
with dexamethasone##4##2##(1990-11#1)(1994-3#2)(1994-8#1)
with dexrazoxane##2##2##(2008-11#2)
with dextran-conjugated calcium indicators in##2##5##(2008-4#2)
with dextrocardia##2##2##(2010-8#2)
with diabetes have##3##3##(1996-11#1)(2008-1#1)(2010-10#1)
with diabetes in##2##3##(1994-12#1)(2008-1#1)
with diabetes mellitus##12##3##(1994-11#1)(1994-6#2)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
with diabetes##43##2##(1994-11#1)(1994-12#1)(1994-6#3)(1995-2#3)(1995-3#1)(1996-11#2)(1996-3#1)(1997-3#1)(2008-1#5)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2010-10#4)(2010-9#1)(2011-2#2)(2012-3#4)(2013-1#5)(2013-8#1)
with diabetic##5##2##(1991-9#1)(1994-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
with diagnosed##2##2##(1992-12#1)(2011-2#1)
with diagnosis of##4##3##(1997-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
with diagnosis##5##2##(1997-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
with diazomethane##3##2##(2008-10#3)
with dichloromethane##6##2##(2008-10#6)
with diet##4##2##(1991-2#1)(1994-12#2)(2013-7#1)
with diethyl ether##4##3##(1997-2#1)(2008-10#1)(2008-11#2)
with differences in the##5##4##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
with differences in##12##3##(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#2)(2013-1#2)(2013-8#2)
with differences##16##2##(2008-10#7)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#2)(2013-1#2)(2013-8#2)
with different amounts of each chemical##2##6##(2008-10#2)
with different amounts of##5##4##(2008-10#5)
with different analytical##2##3##(2008-10#2)
with different anions and##2##4##(1993-12#2)
with different batches##2##3##(2008-10#1)(2011-2#1)
with different cell##2##3##(2008-11#1)(2012-3#1)
with different chemical structures##2##4##(1995-11#1)(2008-10#1)
with different chemical##5##3##(1995-11#1)(2008-10#3)(2008-11#1)
with different clinical forms##2##4##(2008-5#1)(2013-1#1)
with different clinical##3##3##(2008-5#1)(2013-1#2)
with different concentrations of##5##4##(1993-8#1)(2008-10#2)(2008-3#1)(2012-3#1)
with different concentrations##6##3##(1993-8#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
with different degrees of##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
with different detection##2##3##(2008-10#2)
with different doses and##2##4##(1992-2#1)(2012-2#1)
with different doses##3##3##(1992-2#1)(2012-2#1)(2013-1#1)
with different forms of##3##4##(1997-2#1)(2008-12#1)(2008-7#1)
with different fractions of##2##4##(1997-1#1)(2008-10#1)
with different kinds##2##3##(2008-12#1)(2011-3#1)
with different levels of##4##4##(2008-10#3)(2008-8#1)
with different numbers of##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
with different patterns##2##3##(2008-10#1)(2010-2#1)
with different permanent modifiers##2##4##(2008-10#2)
with different phenotypes##2##3##(1997-3#1)(2008-10#1)
with different properties##3##3##(1996-2#1)(2009-5#1)(2010-8#1)
with different responses to##2##4##(1991-2#1)(2008-10#1)
with different substrate##2##3##(2008-10#1)(2011-2#1)
with different target##2##3##(2008-10#1)(2008-11#1)
with different techniques##3##3##(2008-10#2)(2008-11#1)
with different type of##2##4##(2012-3#1)(2013-1#1)
with different type##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
with different types of##5##4##(2008-10#1)(2009-7#1)(2010-5#1)(2011-2#2)
with different##254##2##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-3#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#2)(2007-11#1)(2008-10#112)(2008-11#17)(2008-12#7)(2008-2#2)(2008-3#5)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#4)(2009-11#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#10)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#11)(2013-8#5)
with differential pulse voltammetry (DPV)##2##5##(2008-10#2)
with differential pulse##3##3##(2008-10#3)
with differential##10##2##(2008-10#7)(2008-3#1)(2008-7#1)(2010-7#1)
with differing##2##2##(1997-3#1)(2008-10#1)
with diffuse##7##2##(1990-9#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
with digital##2##2##(1991-12#1)(2008-9#1)
with dignity##3##2##(1993-1#1)(2012-12#2)
with dihydropyridine binding##2##3##(1995-11#2)
with dilated cardiomyopathy##5##3##(1993-2#3)(2011-2#1)(2012-2#1)
with diluted##3##2##(2008-10#3)
with dimethyl##4##2##(1996-5#3)(2008-10#1)
with dimethylglyoxime##2##2##(2008-10#2)
with diminished##2##2##(2011-2#1)(2012-5#1)
with diode array detection##4##4##(2008-10#4)
with diode array detector##3##4##(2008-10#3)
with diode array##7##3##(2008-10#7)
with diode-array##2##2##(2008-10#2)
with dipalmitoyl phosphatidylcholine (DPPC)##2##4##(2008-10#2)
with direct conductivity detection##2##4##(2008-10#2)
with direct sample injection##2##4##(2008-10#2)
with direct##24##2##(1991-2#1)(1996-1#1)(1996-9#1)(2008-10#10)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
with disabilities and##2##3##(1994-2#1)(1996-1#1)
with disabilities in Medicare and Medicaid##2##6##(1997-2#2)
with disabilities in##5##3##(1995-6#1)(1996-1#2)(1997-2#2)
with disabilities##30##2##(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#3)(1995-6#2)(1996-1#9)(1997-1#1)(1997-2#3)(2009-6#3)(2010-11#3)(2012-2#1)
with disability##4##2##(1993-6#1)(1996-12#1)(1997-1#2)
with disabling##2##2##(1997-7#1)(2008-5#1)
with disc##2##2##(2008-7#1)(2011-2#1)
with discrepancies in##2##3##(2008-10#1)(2012-2#1)
with discrete##5##2##(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)
with discussion of##3##3##(2008-4#1)(2009-3#1)(2013-8#1)
with discussion##5##2##(1996-11#1)(2008-12#1)(2008-4#1)(2009-3#1)(2013-8#1)
with disease activity##2##3##(1992-3#1)(2009-6#1)
with disease incidence##5##3##(2008-10#5)
with disease management##2##3##(1995-3#1)(2008-10#1)
with disease severity##4##3##(2008-10#3)(2013-1#1)
with disease suppressiveness##2##3##(2008-10#2)
with disease##27##2##(1990-12#1)(1992-3#1)(1995-3#1)(1997-7#1)(2008-10#18)(2009-6#1)(2010-4#1)(2013-1#2)(2013-8#1)
with diseased##4##2##(2008-10#4)
with disodium##2##2##(2008-10#2)
with disorders##2##2##(1991-12#1)(2012-2#1)
with dispersal##2##2##(2008-9#1)(2010-4#1)
with displaced fractures##2##3##(2013-1#2)
with dissimilar##3##2##(1994-2#1)(2008-10#1)(2008-8#1)
with distal metaphyseal##2##3##(2013-1#2)
with distal##8##2##(1991-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#3)
with distance from the##3##4##(2008-10#3)
with distance##5##2##(2008-10#4)(2008-9#1)
with distant metastases##2##3##(1993-1#2)
with distilled water and##2##4##(2008-10#1)(2008-12#1)
with distilled water##4##3##(1996-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
with distilled##5##2##(1996-12#1)(2008-10#2)(2008-12#1)(2013-1#1)
with distinct##10##2##(1995-11#1)(1995-12#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2011-2#1)
with distinctive##2##2##(1991-12#1)(2009-8#1)
with dithiothreitol##2##2##(2008-5#1)(2012-2#1)
with dithizone and zinc dithizonate##2##5##(2008-10#2)
with dithizone and##3##3##(2008-10#3)
with dithizone##5##2##(2008-10#5)
with diurnal##2##2##(2008-10#1)(2013-1#1)
with divalent##2##2##(2008-10#2)
with diverse populations##3##3##(2008-6#1)(2010-8#1)(2012-2#1)
with diverse##9##2##(1990-12#1)(2008-10#2)(2008-6#1)(2009-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
with division of labor##2##4##(2008-8#2)
with doctors##2##2##(2008-11#2)
with documented##4##2##(1993-2#1)(2008-11#1)(2008-9#1)(2010-2#1)
with dominant##4##2##(1991-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
with dopamine##4##2##(1993-6#1)(1994-8#1)(1995-11#1)(2008-7#1)
with dopaminergic##2##2##(1997-2#1)(2008-7#1)
with double stranded##2##3##(1990-12#1)(2008-10#1)
with double##14##2##(1990-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#1)
with double-focusing##2##2##(2008-10#2)
with double-stranded DNA in large excess##2##6##(2008-10#2)
with double-stranded##4##2##(2008-10#3)(2010-4#1)
with doxorubicin (12 mg/kg##2##4##(2011-2#2)
with doxorubicin##3##2##(2008-11#1)(2011-2#2)
with drought##2##2##(2012-7#2)
with drug addiction##3##3##(2009-7#3)
with drug##11##2##(1990-2#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-8#1)(2008-1#1)(2008-11#1)(2009-7#3)(2011-2#1)
with drug-eluting##2##2##(2008-11#1)(2008-12#1)
with drugs and##2##3##(1994-9#1)(2013-1#1)
with drugs##9##2##(1993-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(2008-10#2)(2011-2#1)(2013-1#1)
with dry##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
with dsDNA and##2##3##(2008-10#2)
with dual##2##2##(2008-10#1)(2009-8#1)
with duodenal ulcer is##2##4##(1992-11#1)(2008-12#1)
with duodenal##4##2##(1992-11#1)(1997-1#1)(2008-12#2)
with durable resistance to##2##4##(2008-10#2)
with durable resistance##3##3##(2008-10#3)
with dural arteriovenous##3##3##(1996-9#3)
with dural##4##2##(1996-9#4)
with duration of##5##3##(1991-9#1)(1994-6#1)(2008-10#1)(2008-7#1)(2010-12#1)
with duration##6##2##(1991-9#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-7#1)(2010-12#1)
with dynamic surface tension detection##2##5##(2008-10#2)
with dynamic##6##2##(2008-10#3)(2008-3#1)(2010-10#1)(2012-2#1)
with dyslexia may##2##3##(2008-12#2)
with dyslexia##6##2##(2008-12#6)
with dysphagia and##3##3##(1997-8#1)(2008-1#1)(2013-1#1)
with dysphagia##5##2##(1997-8#1)(2008-1#2)(2010-7#1)(2013-1#1)
with dyspnoea##2##2##(2009-4#1)(2011-2#1)
with each antibiotic##2##3##(1996-6#2)
with each of the##4##4##(1990-12#1)(1995-2#1)(2008-10#2)
with each of##7##3##(1990-12#1)(1995-2#1)(2008-10#4)(2011-2#1)
with each other and with the##2##6##(2008-10#1)(2010-7#1)
with each other and with##3##5##(2008-10#2)(2010-7#1)
with each other and##6##4##(1996-2#1)(2008-10#4)(2010-7#1)
with each other for##2##4##(1995-6#1)(2008-4#1)
with each other in the##2##5##(1996-2#1)(2008-7#1)
with each other in##3##4##(1995-2#1)(1996-2#1)(2008-7#1)
with each other to form a##2##6##(1995-2#1)(2008-8#1)
with each other##41##3##(1991-10#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
with each probe##2##3##(2008-10#1)(2008-8#1)
with each sample##2##3##(2008-10#2)
with each##84##2##(1990-12#1)(1990-6#1)(1991-10#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-2#2)(1996-6#2)(1997-1#1)(1997-5#1)(2007-12#4)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2013-1#2)(2013-8#1)
with earlier reports##2##3##(1993-6#1)(1996-6#1)
with earlier work##2##3##(2008-10#2)
with earlier##11##2##(1993-6#1)(1993-8#1)(1996-6#1)(2008-10#5)(2008-8#1)(2009-5#1)(2010-12#1)
with early breast cancer##4##4##(1994-12#1)(2011-2#3)
with early cervical cancer##2##4##(2010-11#1)(2012-3#1)
with early##29##2##(1990-9#1)(1994-12#1)(1994-6#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-8#2)(2009-8#1)(2010-11#1)(2011-2#7)(2012-3#4)(2013-1#1)(2013-8#3)
with easily##2##2##(2008-10#2)
with eating disorders##4##3##(1997-3#1)(2008-11#3)
with eating##5##2##(1997-3#1)(2008-11#4)
with ecological##2##2##(2008-10#1)(2008-9#1)
with ectopic##3##2##(2011-2#1)(2013-1#2)
with eczema##2##2##(2010-6#1)(2013-1#1)
with education##2##2##(1996-5#1)(2011-2#1)
with educational##3##2##(1990-9#1)(2008-11#1)(2009-7#1)
with effect##2##2##(2008-9#1)(2013-1#1)
with effective##3##2##(1997-1#1)(2008-10#1)(2008-4#1)
with effects##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
with effusion##2##2##(2008-9#1)(2011-2#1)
with eight##12##2##(1992-12#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-8#1)(2013-8#1)
with either ACh or (1S##2##5##(1996-5#2)
with either S##2##3##(1995-5#1)(2008-10#1)
with either a fixed##2##4##(2008-10#1)(2008-8#1)
with either a##11##3##(1996-2#1)(1996-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
with either of##3##3##(2008-10#2)(2008-12#1)
with either pathogen##2##3##(2008-10#2)
with either the##9##3##(1991-5#1)(1994-5#1)(1995-9#1)(1996-2#1)(2008-10#4)(2008-4#1)
with either##94##2##(1990-11#1)(1990-7#1)(1991-5#1)(1993-6#1)(1994-2#3)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#41)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#3)(2011-1#1)(2011-2#5)(2013-1#1)
with elastic##3##2##(2008-3#1)(2008-9#1)(2010-4#1)
with electric eel AChE##2##4##(2008-10#1)(2009-8#1)
with electric##3##2##(2008-10#2)(2009-8#1)
with electrochemical detection of##2##4##(2008-10#2)
with electrochemical detection##12##3##(2008-10#12)
with electrochemical##18##2##(2008-10#17)(2010-11#1)
with electrode I and##2##4##(2008-10#2)
with electrode##5##2##(2008-10#5)
with electrogenerated##2##2##(2008-10#2)
with electron capture detection##4##4##(2008-10#4)
with electron capture##5##3##(2008-10#5)
with electron##10##2##(2008-10#9)(2008-5#1)
with electrophysiological##2##2##(2007-12#1)(2008-12#1)
with electropolymerized##2##2##(2008-10#2)
with electrospray MS detection##2##4##(2008-10#2)
with electrospray ionization##2##3##(2008-10#1)(2011-3#1)
with electrospray##5##2##(2008-10#4)(2011-3#1)
with electrosurgery##2##2##(1996-1#2)
with electrothermal atomic absorption spectrometry (ETAAS)##2##6##(2008-10#2)
with electrothermal atomic absorption spectrometry##3##5##(2008-10#3)
with electrothermal##4##2##(2008-10#4)
with elevated concentrations of##4##4##(1991-6#1)(2008-10#2)(2013-1#1)
with elevated levels of##6##4##(1990-9#1)(1994-2#1)(2008-10#2)(2008-5#1)(2013-1#1)
with elevated##30##2##(1990-9#1)(1991-6#1)(1991-8#1)(1994-2#1)(1996-12#1)(1996-2#1)(2006-6#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#4)(2009-8#1)(2010-12#1)(2010-7#1)(2012-5#1)(2012-7#2)(2013-1#2)
with elimination##2##2##(1990-5#1)(2008-10#1)
with emergency##2##2##(1993-12#1)(1994-12#1)
with emerging##2##2##(1994-12#1)(1996-3#1)
with emotionally challenging##2##3##(2008-11#1)(2008-7#1)
with emotionally##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
with emphasis on depression##3##4##(1995-1#1)(1995-2#1)(1995-3#1)
with emphasis on the##10##4##(1991-3#1)(1991-8#1)(1993-2#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-7#1)
with emphasis on##31##3##(1990-12#1)(1991-3#1)(1991-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#4)(2013-1#1)(2013-8#1)
with emphasis##32##2##(1990-12#1)(1991-3#1)(1991-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#4)(2013-1#1)(2013-8#1)
with empirical##2##2##(2008-10#2)
with employers##2##2##(1992-11#2)
with end stage renal##2##4##(1995-1#1)(1997-8#1)
with end-stage renal disease##3##4##(2008-1#2)(2013-1#1)
with end-stage renal##4##3##(2008-1#2)(2013-1#2)
with end-stage##8##2##(1994-3#1)(2008-1#2)(2011-2#1)(2011-3#1)(2013-1#3)
with endocrine differentiation##2##3##(1991-8#1)(1992-2#1)
with endogenous##4##2##(1993-6#1)(2008-1#1)(2008-11#1)(2009-8#1)
with endometrial##3##2##(1995-3#2)(2012-3#1)
with endoscopic##2##2##(2013-1#2)
with endothelial cells##2##3##(1993-3#1)(2008-9#1)
with endothelial##3##2##(1993-3#1)(2006-6#1)(2008-9#1)
with enhanced surface##2##3##(1994-5#1)(2008-11#1)
with enhanced##24##2##(1990-12#1)(1992-11#1)(1993-2#1)(1994-5#1)(2007-11#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
with enriched stable isotopes##3##4##(2010-8#3)
with enriched##4##2##(2010-8#4)
with enrichment factor of##2##4##(2008-10#2)
with enrichment##5##2##(2008-10#3)(2008-8#2)
with ensuring##2##2##(1996-12#1)(1997-5#1)
with environmental##8##2##(1991-12#2)(1992-12#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-3#2)
with enzyme##6##2##(1991-7#1)(2008-10#3)(2008-3#1)(2011-3#1)
with enzymes##2##2##(2008-10#2)
with epidemiological##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
with epidermolysis bullosa##3##3##(2012-3#3)
with epilepsy##8##2##(1997-8#1)(2008-11#3)(2008-12#1)(2010-8#2)(2011-2#1)
with epinephrine and##2##3##(2008-10#1)(2010-1#1)
with epinephrine##5##2##(1990-5#1)(1993-1#2)(2008-10#1)(2010-1#1)
with episodic##2##2##(2011-1#1)(2012-3#1)
with epithelial##2##2##(1994-12#1)(2008-5#1)
with epoxy##3##2##(2008-10#2)(2009-7#1)
with equal##5##2##(1994-5#1)(1996-3#1)(2008-10#2)(2008-8#1)
with equimolar##2##2##(1994-5#1)(2008-10#1)
with equivalent##3##2##(1994-11#1)(2008-10#1)(2012-2#1)
with erbium hydroxide##2##3##(2008-10#2)
with ergosterol##2##2##(1997-2#2)
with erythema##2##2##(2008-7#1)(2008-8#1)
with erythropoietin##3##2##(2008-1#1)(2008-11#2)
with essential hypertension##5##3##(2008-10#1)(2008-5#2)(2010-4#1)(2013-7#1)
with essential##7##2##(1993-3#1)(1995-10#1)(2008-10#1)(2008-5#2)(2010-4#1)(2013-7#1)
with established##5##2##(1994-2#1)(2008-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
with estrogen receptor##3##3##(2008-11#2)(2011-2#1)
with estrogen##7##2##(1997-7#2)(2008-11#4)(2011-2#1)
with estrogenic##2##2##(2008-10#1)(2008-11#1)
with ethanol or##2##3##(1994-8#1)(2008-10#1)
with ethanol##22##2##(1991-1#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-10#11)(2008-11#2)(2009-7#1)(2009-8#3)(2012-2#1)
with ethyl acetate as the##2##5##(2008-10#2)
with ethyl acetate##6##3##(2008-10#4)(2008-11#1)(2011-3#1)
with ethyl##11##2##(1996-5#3)(2008-10#5)(2008-11#2)(2011-3#1)
with eukaryotic##3##2##(1995-6#1)(1997-7#1)(2010-4#1)
with evaporative light scattering detection##3##5##(2008-10#3)
with every##7##2##(1995-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2011-3#1)(2012-6#1)
with evidence of##7##3##(1991-12#2)(1992-2#1)(1994-6#1)(2009-8#1)(2012-3#1)(2013-7#1)
with evidence##9##2##(1991-12#2)(1992-2#1)(1994-6#1)(2009-8#1)(2010-5#1)(2012-3#1)(2012-4#1)(2013-7#1)
with evidence-based##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
with exact##2##2##(1993-12#1)(2008-6#1)
with examples of##3##3##(1991-3#1)(1996-2#1)(2008-12#1)
with examples##4##2##(1991-3#1)(1996-2#1)(2008-12#1)(2009-12#1)
with excellent cosmetic##2##3##(2008-10#1)(2008-9#1)
with excellent results##2##3##(1996-3#1)(2011-3#1)
with excellent sensitivity##2##3##(2008-10#1)(2008-9#1)
with excellent##16##2##(1996-3#1)(2008-10#8)(2008-5#1)(2008-9#3)(2011-3#1)(2013-1#2)
with exception of##2##3##(2008-10#1)(2012-2#1)
with exception##4##2##(2008-10#2)(2009-4#1)(2012-2#1)
with excess iodide in acidic medium##2##6##(2008-10#2)
with excess##10##2##(2008-10#8)(2008-11#1)(2012-2#1)
with excessive##2##2##(2012-4#1)(2013-1#1)
with excipient##2##2##(2008-5#2)
with excised##2##2##(2008-10#1)(2008-5#1)
with excision of the##2##4##(2008-10#1)(2013-8#1)
with excitation at##4##3##(2008-10#4)
with excitation##5##2##(2008-10#5)
with excited delirium##2##3##(2010-1#2)
with exercise##4##2##(1996-6#1)(2008-10#1)(2010-12#1)(2013-8#1)
with existing techniques##2##3##(2008-10#1)(2008-2#1)
with existing##7##2##(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)
with exogenous##4##2##(1994-11#1)(1995-12#1)(2008-8#1)(2010-11#1)
with expectations for##2##3##(2008-10#1)(2008-8#1)
with expectations##5##2##(1997-2#1)(2008-10#2)(2008-8#1)(2008-9#1)
with expected##2##2##(2008-10#1)(2008-9#1)
with experience##2##2##(1995-1#1)(1996-1#1)
with experimental and##2##3##(2008-3#1)(2008-7#1)
with experimental data##3##3##(2008-2#1)(2010-10#1)(2011-2#1)
with experimental measurements##3##3##(2008-3#1)(2009-7#1)(2010-10#1)
with experimental results##4##3##(1996-5#1)(2008-3#1)(2013-1#2)
with experimental##17##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-7#1)(2010-10#2)(2011-2#1)(2011-3#1)(2013-1#2)
with experimentally##3##2##(1995-12#1)(2008-3#2)
with experiments##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
with expert##3##2##(1991-2#1)(1993-12#1)(1996-6#1)
with explicit##2##2##(1995-1#1)(2008-11#1)
with exposure to##3##3##(1991-12#1)(2008-10#1)(2008-9#1)
with exposure##7##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)
with expression of##4##3##(1992-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
with expression##7##2##(1992-6#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
with exstrophy##4##2##(2008-10#4)
with extended##4##2##(1995-3#1)(1996-1#1)(2008-10#2)
with extended-release##2##2##(2010-4#2)
with extension into the##3##4##(2008-7#2)(2009-8#1)
with extension##4##2##(2008-7#2)(2009-8#1)(2013-8#1)
with extensive##11##2##(1992-2#2)(1994-6#1)(2008-10#1)(2008-6#1)(2008-8#3)(2009-7#1)(2011-2#1)(2012-2#1)
with external##10##2##(1990-12#1)(1991-11#1)(1992-12#1)(1992-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-7#1)(2013-1#1)
with extracorporeal##4##2##(2010-5#1)(2012-3#3)
with extracted##4##2##(1995-2#1)(2008-8#1)(2010-5#2)
with extraction##3##2##(2008-10#2)(2013-1#1)
with extracts##2##2##(2008-10#1)(2008-11#1)
with extreme##4##2##(1992-5#1)(2008-9#1)(2011-7#1)(2012-2#1)
with extremely high##2##3##(1993-3#1)(2008-10#1)
with extremely##6##2##(1992-3#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2010-4#1)
with eyes closed##2##3##(2008-7#2)
with fMRI##3##2##(2008-11#1)(2009-8#1)(2013-8#1)
with facial nerve##4##3##(2008-7#1)(2008-9#1)(2011-2#2)
with factor Xa##2##3##(1994-5#2)
with factor##8##2##(1990-5#1)(1994-5#3)(1995-12#1)(1995-2#1)(2008-5#1)(2009-6#1)
with failed##4##2##(2008-10#2)(2012-3#2)
with failure##3##2##(2010-12#1)(2010-6#1)(2012-3#1)
with false##2##2##(1996-6#2)
with familial##7##2##(1990-2#1)(1992-8#1)(1996-5#1)(2008-12#1)(2009-12#1)(2010-12#1)(2011-2#1)
with families##3##2##(2010-9#1)(2012-3#2)
with family##4##2##(1990-12#1)(2008-7#1)(2010-11#1)(2012-3#1)
with fast furnace analysis##2##4##(2008-10#2)
with fast##6##2##(1995-8#1)(2008-10#4)(2008-3#1)
with fat##3##2##(2013-1#3)
with fatal##2##2##(1997-3#1)(2009-1#1)
with fatty acid binding protein##2##5##(1994-8#2)
with fatty acid##4##3##(1994-8#2)(2008-10#1)(2009-8#1)
with fatty acids##2##3##(1992-6#1)(1995-2#1)
with fatty##6##2##(1992-6#1)(1994-8#2)(1995-2#1)(2008-10#1)(2009-8#1)
with favourable##3##2##(2008-5#1)(2009-5#1)(2010-5#1)
with features of##7##3##(2008-1#1)(2008-11#1)(2008-12#1)(2010-5#1)(2011-1#1)(2013-1#2)
with features##11##2##(1993-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
with feeding##2##2##(1994-2#1)(2009-8#1)
with female L(S)##2##3##(2010-8#2)
with female##4##2##(1997-3#1)(1997-7#1)(2010-8#2)
with femoral##2##2##(2010-3#1)(2013-1#1)
with femtosecond pulses##2##3##(2007-11#1)(2008-2#1)
with fentanyl##2##2##(1993-1#1)(2010-7#1)
with ferbam##2##2##(2008-10#2)
with ferrozine by flow-injection analysis##2##5##(2008-10#2)
with ferrozine##3##2##(2008-10#3)
with fetal##4##2##(1991-2#1)(1994-3#1)(2008-11#1)(2012-3#1)
with fever##9##2##(1996-12#1)(2006-5#2)(2008-11#1)(2009-11#2)(2010-12#1)(2011-1#1)(2013-1#1)
with few##12##2##(1991-10#1)(1994-6#1)(1997-3#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-7#1)(2011-3#1)(2013-1#1)
with fewer side effects##3##4##(2009-12#2)(2011-2#1)
with fewer##12##2##(2008-10#1)(2008-11#3)(2008-7#1)(2009-12#2)(2009-8#1)(2011-2#2)(2012-2#2)
with fiber##2##2##(2007-12#1)(2008-10#1)
with fibroblast##2##2##(2008-11#1)(2011-2#1)
with fibrous##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
with field##3##2##(2008-10#2)(2008-8#1)
with files and##2##3##(2008-12#1)(2008-9#1)
with filters##2##2##(1997-1#1)(2008-6#1)
with final##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
with financial##3##2##(1994-2#1)(2008-11#1)(2010-10#1)
with findings in##2##3##(1990-12#1)(1997-3#1)
with findings##4##2##(1990-12#1)(1997-3#2)(2012-12#1)
with fine##4##2##(2008-10#2)(2008-7#1)(2010-4#1)
with firm##2##2##(1992-1#1)(1993-3#1)
with first##2##2##(1990-12#1)(2011-1#1)
with fish##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
with fitness##3##2##(1995-2#1)(2008-8#2)
with five different##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
with five injections##2##3##(2008-10#2)
with five restriction enzymes##2##4##(2008-10#2)
with five##21##2##(1990-12#1)(1990-9#1)(1996-6#1)(2008-10#15)(2008-8#1)(2010-11#1)(2010-4#1)
with fixed##6##2##(1992-2#1)(2008-10#3)(2008-9#1)(2013-1#1)
with flame atomic absorption spectrometry (FAAS)##5##6##(2008-10#5)
with flame atomic absorption spectrometry##9##5##(2008-10#9)
with flame atomic absorption##10##4##(2008-10#10)
with flame ionisation detection##2##4##(2008-10#2)
with flame photometric##2##3##(2008-10#2)
with flame##17##2##(2008-10#17)
with flat##3##2##(1995-2#1)(2008-3#2)
with flexible##3##2##(1993-12#1)(2008-6#1)(2008-8#1)
with flow injection (FI)##3##4##(2008-10#3)
with flow injection analysis (FIA)##2##5##(2008-10#2)
with flow injection analysis##7##4##(2008-10#7)
with flow injection##15##3##(2008-10#15)
with flow##18##2##(2008-10#16)(2008-5#1)(2011-3#1)
with flow-injection analysis (FIA)##2##4##(2008-10#2)
with flow-injection analysis##3##3##(2008-10#3)
with flow-injection##5##2##(2008-10#5)
with flower##2##2##(2008-10#2)
with fluence rates of##2##4##(2008-7#2)
with fluorescein##3##2##(2008-10#2)(2008-9#1)
with fluorescence detection (HPLC-FD)##2##4##(2008-10#2)
with fluorescence detection and##4##4##(2008-10#4)
with fluorescence detection##15##3##(2008-10#14)(2008-11#1)
with fluorescence spectroscopy and multivariate calibration##2##6##(2008-10#2)
with fluorescence##24##2##(1993-2#1)(2008-10#20)(2008-11#2)(2013-1#1)
with fluorescent dyes##2##3##(2006-6#1)(2008-10#1)
with fluorescent##4##2##(2006-6#1)(2008-10#2)(2008-4#1)
with fluoride and 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##2##4##(2008-10#2)
with fluoride##7##2##(2008-10#6)(2009-5#1)
with fluorimetric detection##8##3##(2008-10#8)
with fluorimetric##9##2##(2008-10#9)
with fluorometric##2##2##(1995-11#1)(2008-10#1)
with focal 6-o'-clock Nd##2##4##(2011-2#2)
with focal##8##2##(1997-3#1)(1997-8#1)(2008-11#1)(2011-2#2)(2013-1#3)
with focus##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
with follicular##4##2##(2010-11#2)(2010-3#1)(2012-3#1)
with follow-up of##2##3##(2008-7#1)(2012-12#1)
with follow-up##6##2##(1994-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
with food##4##2##(1993-6#2)(1995-10#1)(2009-3#1)
with foods##2##2##(2007-12#1)(2008-11#1)
with foreign##2##2##(1994-12#1)(1997-6#1)
with forest##2##2##(1995-3#1)(2008-10#1)
with formaldehyde and##3##3##(2008-10#3)
with formaldehyde##6##2##(1995-2#1)(2008-10#4)(2008-2#1)
with formation of a##2##4##(1994-5#1)(2008-10#1)
with formation of##6##3##(1994-5#1)(1996-5#1)(2008-10#2)(2008-5#1)(2010-3#1)
with formic acid##2##3##(2008-10#1)(2008-11#1)
with formic##3##2##(2008-10#2)(2008-11#1)
with forskolin##5##2##(1995-12#1)(1995-8#2)(1997-1#1)(2008-11#1)
with four enzymes##2##3##(2008-10#2)
with four other##2##3##(2008-10#2)
with four replications##2##3##(2008-10#1)(2008-12#1)
with four##34##2##(1997-7#1)(2007-12#1)(2008-10#18)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-9#1)(2013-8#1)
with fracture##3##2##(1991-11#1)(2011-2#1)(2013-1#1)
with free standing##2##3##(2008-10#2)
with free##7##2##(1992-9#1)(1994-5#1)(2008-10#4)(2012-2#1)
with frequencies##2##2##(1994-11#1)(2007-12#1)
with frequent##8##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-6#1)(2012-2#1)(2013-8#1)
with fresh water##3##3##(2008-10#2)(2012-5#1)
with fresh##7##2##(2008-10#3)(2008-11#2)(2012-5#2)
with friends and##3##3##(2010-8#2)(2011-2#1)
with fruit##3##2##(2008-10#3)
with full##13##2##(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#4)
with fumigated##2##2##(2008-10#1)(2008-11#1)
with fumonisin##2##2##(2008-10#2)
with functional##7##2##(1995-3#1)(2008-11#2)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
with funding##3##2##(2008-11#2)(2010-10#1)
with fungal infection##2##3##(2008-10#2)
with fungal##5##2##(2008-10#4)(2010-7#1)
with fungicide##2##2##(2008-10#2)
with fura-2##2##2##(1992-6#1)(1994-2#1)
with furosemide##2##2##(2008-10#1)(2012-2#1)
with furrow##3##2##(2008-10#3)
with further##8##2##(2008-10#4)(2008-12#2)(2008-6#1)(2008-9#1)
with fusion for##2##3##(2008-10#1)(2012-12#1)
with fusion##8##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#4)
with future##5##2##(1996-2#1)(2008-11#1)(2010-8#2)(2013-1#1)
with gallbladder##2##2##(1991-8#1)(2010-1#1)
with gamma##2##2##(2008-8#1)(2010-6#1)
with gamma-knife##2##2##(2008-7#2)
with gas cell measurements and##2##5##(2008-3#2)
with gas chromatography##3##3##(2008-10#3)
with gas chromatography-mass spectrometry (GC-MS)##4##5##(2008-10#4)
with gas chromatography-mass spectrometry##5##4##(2008-10#5)
with gas##17##2##(2008-10#14)(2008-3#2)(2013-1#1)
with gastric cancer##4##3##(2011-2#4)
with gastric ulcer##2##3##(2008-11#1)(2008-12#1)
with gastric##13##2##(1990-2#2)(1992-9#1)(2008-11#1)(2008-12#3)(2011-2#4)(2012-12#1)(2013-1#1)
with gastrointestinal##6##2##(1990-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2009-12#1)
with gelatin using glutaraldehyde and fixed on##2##7##(2008-10#2)
with gelatin##6##2##(2008-10#5)(2008-4#1)
with gender and age##2##4##(2011-2#2)
with gender and##4##3##(2008-12#1)(2011-1#1)(2011-2#2)
with gender##6##2##(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#3)
with gene constructs##2##3##(2008-10#1)(2008-11#1)
with gene expression in##2##4##(2008-10#1)(2008-11#1)
with gene expression##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
with gene##8##2##(2008-10#2)(2008-11#2)(2008-8#1)(2012-2#1)(2012-3#2)
with general##2##2##(1993-1#1)(2011-2#1)
with generalised##2##2##(2008-7#1)(2011-2#1)
with generalized linear##2##3##(2008-10#2)
with generalized weakness and##2##4##(2010-8#1)(2012-2#1)
with generalized##9##2##(1995-8#1)(2008-10#2)(2009-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with generating##2##2##(1993-3#1)(2010-5#1)
with genes from other organisms##2##5##(1996-3#1)(1997-6#1)
with genes##7##2##(1994-12#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-9#1)(2011-2#1)
with genetic algorithms##2##3##(2008-3#2)
with genetic##13##2##(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2013-8#1)
with genital##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
with genomic DNA##4##3##(1990-12#1)(2008-10#2)(2008-2#1)
with genomic##8##2##(1990-12#1)(1993-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-12#1)
with geographical##2##2##(2008-10#1)(2008-9#1)
with geriatric clients##2##3##(1991-12#2)
with gestational diabetes mellitus##5##4##(1992-12#3)(2008-10#2)
with gestational##6##2##(1992-12#3)(1995-8#1)(2008-10#2)
with giant##6##2##(1996-9#1)(2007-12#1)(2008-7#1)(2011-2#2)(2012-3#1)
with glass##3##2##(1990-2#1)(2008-10#2)
with glassy carbon electrode##3##4##(2008-10#3)
with glioblastoma##5##2##(2008-11#1)(2012-3#4)
with gliosis##2##2##(2008-7#2)
with global budgets##2##3##(2008-11#2)
with global##7##2##(1994-2#1)(2008-11#3)(2008-3#1)(2008-8#1)(2011-3#1)
with glucose and##3##3##(1994-12#1)(2008-11#2)
with glucose concentration##2##3##(2008-10#2)
with glucose oxidase##3##3##(2008-10#3)
with glucose##21##2##(1991-5#1)(1991-7#1)(1994-12#1)(2008-10#8)(2008-11#6)(2008-7#3)(2012-4#1)
with glutamate##2##2##(2008-10#1)(2008-11#1)
with glutaraldehyde 0##4##3##(2008-5#4)
with glutaraldehyde and##3##3##(2008-10#2)(2008-11#1)
with glutaraldehyde##23##2##(1990-12#1)(1992-12#1)(2008-10#15)(2008-11#1)(2008-5#5)
with glutathione##3##2##(1990-12#1)(1993-6#1)(1995-6#1)
with glycemic status##3##3##(2012-2#3)
with glycine##2##2##(1993-8#1)(1994-5#1)
with glycogen##2##2##(1993-8#1)(2008-10#1)
with gold nanoparticles##2##3##(2008-10#2)
with gold##4##2##(2008-10#3)(2008-5#1)
with gold-labeled##2##2##(2008-10#1)(2008-5#1)
with good accuracy and precision##2##5##(2008-10#2)
with good accuracy##5##3##(2008-10#4)(2008-3#1)
with good agreement##2##3##(2008-10#2)
with good clinical##2##3##(1997-6#1)(2010-5#1)
with good evolution##2##3##(2009-1#1)(2013-1#1)
with good precision and accuracy##2##5##(2008-10#2)
with good precision##5##3##(2008-10#5)
with good recoveries##2##3##(2008-10#2)
with good repeatability##3##3##(2008-10#3)
with good reproducibility##10##3##(2008-10#10)
with good resolution##2##3##(2008-10#2)
with good response##3##3##(2011-2#3)
with good results in##2##4##(2008-10#2)
with good results##11##3##(1991-3#1)(1991-9#1)(2008-10#7)(2008-9#1)(2012-2#1)
with good sensitivity##2##3##(2008-10#2)
with good stability##2##3##(2008-10#1)(2012-2#1)
with good##73##2##(1991-3#1)(1991-9#1)(1993-2#1)(1994-12#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-10#48)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#3)
with government##2##2##(1994-12#1)(2007-12#1)
with grade 1##2##3##(2012-2#2)
with grade III in##2##4##(2008-8#2)
with grade III##3##3##(2008-7#1)(2008-8#2)
with grade IV##2##3##(2008-7#1)(2011-2#1)
with grade##10##2##(2008-7#4)(2008-8#2)(2011-2#1)(2012-2#3)
with gradient##6##2##(2008-10#6)
with granulomatous##2##2##(1997-8#1)(2008-5#1)
with grapevine##2##2##(2008-10#2)
with grass pollen##2##3##(2011-2#2)
with great##8##2##(1991-2#1)(1995-2#2)(2008-10#1)(2008-4#1)(2008-9#2)(2012-12#1)
with greater##32##2##(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with greatest##2##2##(1995-12#1)(2010-10#1)
with greatly enhanced##2##3##(2008-10#2)
with greatly##3##2##(1991-12#1)(2008-10#2)
with grooming##2##2##(1994-8#1)(1995-9#1)
with gross hematuria##5##3##(2008-10#2)(2008-11#3)
with gross##7##2##(2008-10#2)(2008-11#3)(2012-3#2)
with group A##2##3##(2010-7#2)
with group##8##2##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#2)
with groups##2##2##(2008-10#1)(2008-11#1)
with growth factors##3##3##(1991-5#1)(2008-11#2)
with growth of##2##3##(1992-1#1)(2008-10#1)
with growth##17##2##(1991-5#1)(1992-1#1)(1992-12#1)(1994-5#1)(2008-10#2)(2008-11#4)(2008-7#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
with guest##2##2##(2008-10#2)
with habitat##2##2##(2008-8#2)
with haematological##2##2##(1990-10#1)(2009-3#1)
with haematuria##4##2##(1996-6#1)(2008-10#2)(2009-1#1)
with haemophilia##2##2##(1990-5#1)(2009-3#1)
with hallux valgus##2##3##(2010-11#1)(2012-2#1)
with hand OA##2##3##(2013-1#2)
with hand##5##2##(2008-12#1)(2010-4#1)(2013-1#3)
with head injury##2##3##(2008-7#1)(2013-8#1)
with head##4##2##(1990-3#1)(2008-7#1)(2010-4#1)(2013-8#1)
with headache##2##2##(2012-3#1)(2013-8#1)
with headaches##2##2##(2008-12#1)(2009-1#1)
with health care##7##3##(1991-2#1)(1991-3#1)(1993-2#1)(1994-1#1)(1995-12#1)(1996-2#1)(1996-3#1)
with health insurance##2##3##(2009-5#1)(2012-12#1)
with health##17##2##(1991-2#1)(1991-3#1)(1993-2#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2009-5#1)(2010-5#2)(2012-12#1)
with healthcare##2##2##(2009-8#1)(2011-1#1)
with healthy##6##2##(1991-7#1)(1991-8#2)(1997-8#1)(2008-10#2)
with hearing##4##2##(1990-12#1)(2008-1#1)(2008-9#1)(2011-2#1)
with heart failure##4##3##(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
with heart##10##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
with heat##2##2##(1993-8#1)(2013-8#1)
with heavily##2##2##(1992-2#1)(2008-10#1)
with heavy metal##2##3##(2008-10#1)(2013-1#1)
with heavy##6##2##(1991-12#1)(1995-11#1)(1995-3#1)(2007-8#1)(2008-10#1)(2013-1#1)
with height##2##2##(2008-2#1)(2011-1#1)
with helpers##2##2##(2008-8#1)(2008-9#1)
with hematologic malignancies##5##3##(2008-7#4)(2013-1#1)
with hematological##2##2##(1993-2#1)(2011-2#1)
with hemin##2##2##(2008-10#2)
with hemodialysis##2##2##(2008-10#1)(2011-2#1)
with hemoglobin##5##2##(1992-12#1)(2008-10#4)
with hemophilia##2##2##(1996-5#1)(2008-11#1)
with hemorrhage##3##2##(2008-12#1)(2008-7#2)
with hemorrhagic##2##2##(2009-12#1)(2010-5#1)
with heparan sulfate##2##3##(1995-6#1)(2008-5#1)
with heparin##6##2##(1991-6#1)(1994-6#1)(2008-10#3)(2010-3#1)
with hepatic##7##2##(1990-5#1)(1994-8#1)(2008-1#1)(2009-8#1)(2013-1#1)(2013-8#2)
with hepatitis B##2##3##(2012-3#1)(2013-8#1)
with hepatitis##6##2##(1996-11#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
with hepatocellular carcinoma##3##3##(2008-12#1)(2013-1#1)(2013-7#1)
with hepatocellular##4##2##(2008-12#1)(2009-8#1)(2013-1#1)(2013-7#1)
with hepatocyte growth factor##2##4##(2008-9#1)(2010-12#1)
with hereditary spherocytosis##3##3##(2008-12#3)
with hereditary##6##2##(1993-1#2)(2008-12#3)(2010-9#1)
with heterologous##2##2##(2008-10#2)
with hexane and##2##3##(2008-11#1)(2013-8#1)
with hexane##6##2##(2008-10#4)(2008-11#1)(2013-8#1)
with high ICA titers##2##4##(1994-12#2)
with high accuracy and precision##2##5##(2008-10#2)
with high accuracy and##4##4##(2008-10#3)(2011-2#1)
with high accuracy##9##3##(2008-10#6)(2008-3#1)(2011-2#2)
with high affinity (Kd##2##4##(1990-11#1)(1996-2#1)
with high affinity and##4##4##(1993-1#1)(1995-11#1)(1995-2#1)(2012-2#1)
with high affinity##14##3##(1990-11#1)(1993-1#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
with high binding##2##3##(2008-5#1)(2008-8#1)
with high blood pressure##2##4##(2008-3#1)(2009-1#1)
with high concentrations of##6##4##(1990-2#1)(1991-2#1)(1994-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
with high contrast##3##3##(2008-5#1)(2010-1#1)(2010-6#1)
with high density##2##3##(2008-11#1)(2008-7#1)
with high dispersal##3##3##(2008-8#3)
with high dose##2##3##(1990-12#1)(1991-9#1)
with high doses of##6##4##(1991-6#1)(1994-3#1)(1997-4#1)(2008-11#1)(2012-12#1)(2012-2#1)
with high efficiency##6##3##(2008-10#2)(2008-11#1)(2008-8#3)
with high fatality##2##3##(1990-2#1)(2008-5#1)
with high frequency##4##3##(1994-6#2)(1997-2#1)(2010-7#1)
with high levels of##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
with high morbidity and mortality##3##5##(1996-3#1)(2009-7#1)(2013-1#1)
with high mortality##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
with high performance liquid chromatography (HPLC)##5##6##(2008-10#4)(2008-8#1)
with high performance liquid chromatography##7##5##(2008-10#6)(2008-8#1)
with high precision and accuracy##2##5##(2008-10#2)
with high precision and##4##4##(2008-10#3)(2008-3#1)
with high precision##6##3##(2008-10#5)(2008-3#1)
with high predictive##2##3##(2011-2#1)(2012-3#1)
with high pressure##2##3##(2008-10#2)
with high rates of##5##4##(2008-1#1)(2008-8#2)(2009-10#1)(2012-2#1)
with high reliability##2##3##(2008-10#2)
with high resolution##5##3##(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-3#1)
with high risk of##2##4##(2011-2#1)(2013-1#1)
with high risk##5##3##(1990-3#1)(2008-11#1)(2011-2#1)(2013-1#2)
with high selectivity and sensitivity##2##5##(2008-10#2)
with high selectivity##4##3##(1991-3#1)(2008-10#3)
with high sensitivity and selectivity##2##5##(2008-10#1)(2008-9#1)
with high sensitivity and##3##4##(2008-10#2)(2008-9#1)
with high sensitivity##6##3##(2008-10#4)(2008-3#1)(2008-9#1)
with high spatial and temporal##2##5##(2008-10#1)(2008-11#1)
with high spatial##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2009-1#1)
with high specificity##8##3##(1991-5#1)(1993-8#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-7#1)
with high stability##3##3##(2008-10#2)(2008-3#1)
with high surface areas##2##4##(2008-10#2)
with high surface##3##3##(2008-10#3)
with high##253##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#78)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#8)(2008-7#4)(2008-8#17)(2008-9#7)(2009-1#3)(2009-10#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#13)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#11)(2013-8#3)
with high-affinity##2##2##(1994-8#1)(2010-5#1)
with high-dose##4##2##(2008-7#2)(2010-10#1)(2012-3#1)
with high-performance liquid chromatography##6##4##(2008-10#6)
with high-performance##7##2##(2008-10#7)
with high-resolution##5##2##(2008-10#2)(2008-9#1)(2010-2#1)(2011-2#1)
with high-risk HPV##2##3##(2011-2#2)
with high-risk##11##2##(1997-1#1)(2008-11#1)(2011-2#6)(2013-1#3)
with higher dimensional##3##3##(2008-10#3)
with higher levels of##6##4##(1991-1#1)(2008-10#3)(2008-11#1)(2008-8#1)
with higher levels##7##3##(1991-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
with higher likelihood##2##3##(2008-12#1)(2012-3#1)
with higher rates of##4##4##(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
with higher##71##2##(1990-8#1)(1991-1#1)(1991-9#1)(1993-1#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#4)
with highest##3##2##(1996-12#1)(1997-1#1)(2008-7#1)
with highly virulent##3##3##(2008-10#1)(2008-5#2)
with highly##14##2##(1993-3#1)(1997-2#3)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2012-2#2)(2012-3#1)
with hilar##2##2##(2012-2#1)(2013-1#1)
with his##5##2##(1995-1#1)(1995-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
with histamine##2##2##(1992-6#1)(1994-6#1)
with histidine##3##2##(2008-10#3)
with histological##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2010-5#1)
with histologically proven##4##3##(1990-2#1)(1991-2#1)(1994-1#1)(2008-7#1)
with histologically##7##2##(1990-2#1)(1991-2#1)(1994-1#1)(1994-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
with histopathological findings##2##3##(2011-2#1)(2012-2#1)
with histopathological##4##2##(2011-2#3)(2012-2#1)
with histoplasmin##2##2##(2008-5#2)
with historical##3##2##(1991-8#1)(1992-12#1)(2008-10#1)
with history of##5##3##(2011-2#4)(2013-1#1)
with history##7##2##(2008-10#1)(2008-9#1)(2011-2#4)(2013-1#1)
with home##4##2##(1995-2#2)(2012-12#2)
with homogeneous T1-SI identical to the SI of subcutaneous fat##2##10##(2012-2#2)
with homogeneous##3##2##(2008-10#1)(2012-2#2)
with homologous##2##2##(2008-5#1)(2008-9#1)
with homozygous##2##2##(1994-12#1)(2011-2#1)
with hormone##2##2##(1991-6#1)(2008-11#1)
with hormones and##2##3##(2009-5#1)(2010-8#1)
with hormones##3##2##(1990-11#1)(2009-5#1)(2010-8#1)
with horseradish peroxidase (HRP)##3##4##(1990-5#1)(2008-10#1)(2012-2#1)
with horseradish peroxidase##8##3##(1990-5#1)(1996-12#1)(1997-3#1)(2008-10#4)(2012-2#1)
with hospitals##2##2##(1995-2#1)(1996-3#1)
with host cells##2##3##(2008-5#1)(2008-9#1)
with host or##2##3##(2008-10#2)
with host size##2##3##(2008-10#1)(2008-9#1)
with host##15##2##(1995-9#1)(2006-6#1)(2008-10#9)(2008-5#1)(2008-9#2)(2010-8#1)
with hot##2##2##(2008-10#2)
with house dust mite allergens##2##5##(2011-2#2)
with human B cell line##2##5##(2008-8#2)
with human immunodeficiency virus (HIV)##4##5##(1995-12#1)(1997-8#1)(2008-11#1)(2009-12#1)
with human immunodeficiency virus##9##4##(1995-12#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-11#1)(2011-2#1)
with human volunteers##2##3##(2008-11#1)(2008-5#1)
with human##41##2##(1990-6#1)(1991-3#1)(1991-5#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#2)(1997-9#1)(2008-10#1)(2008-11#8)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with humans##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
with humic acids##3##3##(2008-10#3)
with humic##5##2##(2008-10#5)
with hybrid##2##2##(1994-5#1)(2008-10#1)
with hydranencephaly##3##2##(1997-3#3)
with hydride generation atomic##2##4##(2008-10#2)
with hydride generation##6##3##(2008-10#6)
with hydride##7##2##(2008-10#7)
with hydrochloric acid##6##3##(2008-10#6)
with hydrocortisone##3##2##(1993-1#1)(2008-11#2)
with hydrodynamic##2##2##(2008-10#1)(2008-11#1)
with hydrogen peroxide in a##2##5##(2008-10#2)
with hydrogen peroxide in aqueous##2##5##(2008-10#1)(2009-5#1)
with hydrogen peroxide in##7##4##(1995-8#1)(2008-10#5)(2009-5#1)
with hydrogen peroxide##25##3##(1994-5#1)(1995-8#1)(2008-10#21)(2008-11#1)(2009-5#1)
with hydrogen##27##2##(1993-1#1)(1994-5#1)(1995-8#1)(2008-10#21)(2008-11#1)(2009-5#1)(2010-11#1)
with hydrophobic##3##2##(2008-10#2)(2012-2#1)
with hydroquinone##3##2##(2008-10#2)(2008-5#1)
with hydroxyl##3##2##(2008-10#2)(2008-4#1)
with hypercalcemia##2##2##(1990-2#1)(1996-9#1)
with hypercholesterolemia##3##2##(1991-6#1)(2008-7#1)(2013-1#1)
with hypereosinophilia##2##2##(2008-11#2)
with hypereosinophilic syndrome##2##3##(2008-7#2)
with hypertension and##2##3##(2008-7#1)(2013-1#1)
with hypertension##6##2##(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#2)(2013-1#1)
with hypertonic saline##2##3##(2010-1#1)(2010-12#1)
with hypertonic##3##2##(1994-8#1)(2010-1#1)(2010-12#1)
with hyphal growth##2##3##(2008-10#2)
with hypobromite##3##2##(2008-10#3)
with hypochlorite and##3##3##(2008-10#3)
with hypoplastic##4##2##(1994-6#1)(2008-10#3)
with hypospadias and##2##3##(2008-10#2)
with hypospadias##4##2##(2008-10#4)
with hypoxanthine##2##2##(2008-11#2)
with identical##7##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
with identification of##2##3##(2008-4#1)(2008-9#1)
with identified##2##2##(2008-7#1)(2013-1#1)
with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial##2##16##(1991-5#2)
with idiopathic##17##2##(1991-5#3)(1995-10#2)(1997-8#2)(2008-10#1)(2008-7#4)(2009-10#1)(2010-10#1)(2013-1#2)(2013-8#1)
with image##2##2##(2008-10#1)(2008-3#1)
with imiglucerase##3##2##(2008-10#3)
with iminodiacetic##2##2##(1997-2#1)(2008-10#1)
with immature##3##2##(2009-3#1)(2010-6#1)(2011-2#1)
with immobilised##3##2##(2008-10#3)
with immobilized reagents##2##3##(2008-10#2)
with immobilized##11##2##(1995-3#1)(2008-10#10)
with immune##5##2##(1996-12#1)(2008-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
with immunity##3##2##(1995-5#1)(2008-8#1)(2012-3#1)
with immunization##2##2##(1996-12#1)(2008-9#1)
with immunocytochemistry##2##2##(1990-5#1)(1991-10#1)
with immunoglobulin##2##2##(2009-8#1)(2013-1#1)
with immunohistochemical##2##2##(1991-7#1)(1994-8#1)
with immunohistochemistry##3##2##(2011-2#2)(2011-3#1)
with impaired glucose tolerance (IGT)##3##5##(1994-12#1)(2008-3#1)(2012-3#1)
with impaired glucose tolerance##4##4##(1994-12#1)(2008-3#1)(2010-10#1)(2012-3#1)
with impaired growth##2##3##(1996-6#1)(2008-10#1)
with impaired##9##2##(1990-9#1)(1994-12#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-3#1)
with implant##2##2##(2008-9#1)(2012-12#1)
with implantation of##3##3##(1990-5#1)(1991-3#1)(2008-8#1)
with implantation##4##2##(1990-5#1)(1991-3#1)(2008-8#1)(2008-9#1)
with implants##2##2##(2008-11#1)(2008-5#1)
with implementing##3##2##(1991-1#1)(1993-12#1)(2008-11#1)
with implications for##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
with implications##4##2##(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
with important##2##2##(2008-8#1)(2012-2#1)
with improved selectivity##2##3##(2008-10#1)(2010-7#1)
with improved sensitivity##4##3##(1996-2#1)(2008-10#3)
with improved##35##2##(1993-8#1)(1994-3#1)(1996-2#1)(1997-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#2)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with improvements in##4##3##(2008-2#1)(2008-7#1)(2011-2#2)
with improving##2##2##(2013-1#2)
with impulse control##2##3##(2012-12#1)(2013-8#1)
with in situ##5##3##(1996-6#1)(2008-10#1)(2008-3#3)
with in vitro transcripts of##2##5##(2008-10#2)
with in vitro transcripts##3##4##(2008-10#3)
with in vitro##5##3##(1993-8#1)(2008-10#3)(2011-2#1)
with in vivo##4##3##(1991-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
with in##21##2##(1990-11#1)(1991-1#1)(1993-8#1)(1996-6#1)(2008-10#10)(2008-11#1)(2008-3#3)(2008-5#1)(2011-2#1)(2013-1#1)
with in-line##4##2##(2008-10#4)
with in-phase##2##2##(1997-8#2)
with in-valve column##2##3##(2008-10#2)
with incarceration of##3##3##(2008-12#1)(2011-2#2)
with incidence and##2##3##(1994-9#1)(2008-10#1)
with incidence of##2##3##(2008-10#1)(2013-1#1)
with incidence##6##2##(1994-2#1)(1994-9#1)(2008-10#3)(2013-1#1)
with incompatible strains of##2##4##(2008-10#2)
with incompatible strains##3##3##(2008-10#2)(2008-9#1)
with incomplete##5##2##(1994-8#1)(2008-1#1)(2008-12#1)(2013-1#1)(2013-8#1)
with incorporated##2##2##(2008-10#2)
with increase in sample##2##4##(2008-10#2)
with increase in the##3##4##(2008-10#3)
with increase in##9##3##(2008-10#5)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
with increase##10##2##(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
with increased ICP##2##3##(2008-12#2)
with increased disease severity##2##4##(2008-10#2)
with increased intracranial pressure##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
with increased muscle##2##3##(2008-12#1)(2010-6#1)
with increased potency##2##3##(1994-5#1)(2009-8#1)
with increased risk for##6##4##(1993-12#2)(1993-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
with increased risk##12##3##(1993-12#2)(1993-3#1)(2006-5#1)(2008-11#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with increased risks of##2##4##(2008-8#1)(2013-1#1)
with increased wetness duration at##2##5##(2008-10#2)
with increased##108##2##(1991-12#1)(1991-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-5#1)(2008-10#19)(2008-11#10)(2008-12#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-12#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#9)(2013-8#1)
with increases in##5##3##(1991-5#1)(1994-8#1)(2008-10#2)(2010-5#1)
with increases of##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
with increases##8##2##(1991-5#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)
with increasing PEG concentrations##2##4##(2008-12#2)
with increasing [NaOH](T)##2##3##(2008-10#2)
with increasing age and##2##4##(1990-2#1)(2008-7#1)
with increasing age##14##3##(1990-11#1)(1990-2#1)(1994-6#1)(1996-6#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-3#1)
with increasing amounts of##2##4##(2008-10#1)(2008-7#1)
with increasing atomic number##2##4##(2008-10#2)
with increasing concentration##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
with increasing concentrations of##5##4##(1994-8#1)(2008-10#2)(2008-11#2)
with increasing concentrations##7##3##(1994-8#1)(2008-10#3)(2008-11#2)(2011-3#1)
with increasing distance##2##3##(2008-11#1)(2008-3#1)
with increasing doses of##2##4##(1997-4#1)(2008-7#1)
with increasing doses##3##3##(1997-4#1)(2008-7#2)
with increasing duration##2##3##(1995-3#1)(2008-11#1)
with increasing flower age at inoculation##2##6##(2008-10#2)
with increasing frequency##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
with increasing humidity##2##3##(2008-10#2)
with increasing inoculum##2##3##(2008-10#2)
with increasing ionic strength##2##4##(1991-9#1)(1997-6#1)
with increasing larval density##2##4##(2009-10#2)
with increasing leaf age##2##4##(2008-10#2)
with increasing leaf##4##3##(2008-10#4)
with increasing load##2##3##(2009-7#1)(2010-12#1)
with increasing mu##3##3##(2008-10#3)
with increasing numbers of##2##4##(2008-11#1)(2008-9#1)
with increasing numbers##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
with increasing orchard block age##2##5##(2008-10#2)
with increasing osmolarity##4##3##(1991-11#4)
with increasing pCO2##2##3##(2008-11#2)
with increasing pH and##2##4##(2008-10#2)
with increasing pH##5##3##(1990-5#1)(1993-8#2)(2008-10#2)
with increasing population##2##3##(2008-9#2)
with increasing root length##2##4##(2008-10#2)
with increasing speed##2##3##(1994-8#1)(2008-9#1)
with increasing stocking rate##2##4##(1996-12#2)
with increasing strain##2##3##(2009-7#2)
with increasing temperature##13##3##(1990-9#1)(1993-8#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-9#1)(2009-7#2)
with increasing the atomic number##2##5##(2008-10#2)
with increasing the concentration of cell inoculation##2##7##(2008-9#2)
with increasing the##8##3##(2008-10#6)(2008-9#2)
with increasing time since##2##4##(1991-12#1)(2010-11#1)
with increasing time##6##3##(1990-12#1)(1991-12#1)(2008-10#2)(2008-9#1)(2010-11#1)
with increasing water activity##2##4##(2008-7#2)
with increasing water##3##3##(2008-7#3)
with increasing##200##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#1)(1991-9#1)(1992-5#1)(1993-8#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#3)(1995-3#1)(1995-5#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-10#77)(2008-11#15)(2008-12#6)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#13)(2008-8#8)(2008-9#11)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#5)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
with increasingly##2##2##(1997-5#1)(2010-10#1)
with incubation##2##2##(1991-5#1)(2008-9#1)
with independent##8##2##(1996-2#1)(2008-10#3)(2008-3#2)(2008-5#1)(2012-2#1)
with indirect##3##2##(2008-10#3)
with indium##2##2##(2008-10#2)
with individual##15##2##(2007-12#1)(2008-10#4)(2008-12#2)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#2)(2013-1#2)
with indomethacin##3##2##(1992-2#1)(1994-8#1)(1995-6#1)
with induced##2##2##(2008-10#2)
with inductively coupled mass##2##4##(2008-10#2)
with inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
with inductively coupled plasma mass spectrometry (ICP-MS)##2##7##(2008-10#2)
with inductively coupled plasma mass spectrometry##6##6##(2008-10#5)(2010-11#1)
with inductively coupled plasma##11##4##(2008-10#10)(2010-11#1)
with inductively coupled##14##3##(2008-10#13)(2010-11#1)
with industrial and##2##3##(2008-10#1)(2008-7#1)
with industrial##3##2##(2008-10#2)(2008-7#1)
with industry##2##2##(2009-4#1)(2010-7#1)
with infantile##4##2##(1991-2#1)(2009-4#2)(2012-3#1)
with infected##4##2##(2008-10#3)(2008-12#1)
with infection##11##2##(2008-10#7)(2008-11#1)(2008-7#1)(2010-12#1)(2011-3#1)
with infectious##7##2##(1997-8#1)(2008-10#4)(2008-5#1)(2011-2#1)
with infertility##2##2##(1992-1#1)(2012-3#1)
with infiltration of##2##3##(1994-5#1)(2010-12#1)
with inflammatory bowel disease##8##4##(1992-6#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
with inflammatory bowel##10##3##(1992-6#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
with inflammatory##13##2##(1992-12#1)(1992-6#1)(1994-11#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
with infliximab##2##2##(2010-12#2)
with influenza A/H1N1 and A/H3N2 viruses##2##6##(2011-2#2)
with influenza##6##2##(2008-10#2)(2011-2#2)(2012-3#1)(2013-1#1)
with influenza-like illness##2##3##(2011-2#2)
with informal##2##2##(1994-1#1)(1996-3#1)
with information from##2##3##(2008-10#1)(2008-2#1)
with information obtained from##2##4##(2008-10#1)(2013-1#1)
with information##8##2##(1997-3#2)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#2)
with infrared##3##2##(2008-10#1)(2008-3#2)
with infrarenal##2##2##(2008-10#1)(2011-2#1)
with inhaled corticosteroids##4##3##(2007-11#1)(2008-11#2)(2011-2#1)
with inhaled##7##2##(2007-11#3)(2008-11#2)(2010-2#1)(2011-2#1)
with inherited##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
with inhibition of##4##3##(1994-3#1)(1996-12#1)(1997-7#1)(2008-11#1)
with inhibition##5##2##(1994-3#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-11#1)
with inhibitors##3##2##(2008-10#1)(2011-2#1)(2011-3#1)
with initial##15##2##(1990-6#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#3)(2009-8#1)(2010-12#1)(2010-8#1)(2013-1#2)
with injection of##2##3##(2008-10#1)(2013-8#1)
with injection##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
with innate##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
with inoculum##2##2##(2008-10#2)
with inorganic thioanions##2##3##(2008-10#2)
with inorganic##11##2##(1990-5#1)(2008-10#9)(2008-11#1)
with inosine##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
with insertion of##2##3##(1991-12#1)(2009-3#1)
with insights into##2##3##(2008-6#1)(2009-3#1)
with instrumental##2##2##(2008-10#1)(2008-5#1)
with instrumentation and##2##3##(2008-8#1)(2012-12#1)
with instrumentation##3##2##(2008-8#2)(2012-12#1)
with insufficient##3##2##(1991-12#1)(1997-3#1)(2010-1#1)
with insulin resistance and##3##4##(2010-10#1)(2011-1#2)
with insulin resistance##6##3##(2010-10#1)(2011-1#4)(2013-1#1)
with insulin##15##2##(1992-6#2)(1994-11#1)(1996-11#1)(1997-8#1)(2008-11#1)(2009-9#2)(2010-10#1)(2011-1#4)(2013-1#1)(2013-8#1)
with insulin-dependent diabetes mellitus##2##4##(1995-3#1)(1995-9#1)
with intact##7##2##(1990-11#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
with integrated pulsed amperometric detection##2##5##(2008-10#2)
with integrated##7##2##(1997-1#1)(2008-10#4)(2008-11#2)
with intellectual##3##2##(2010-10#1)(2012-2#1)(2013-1#1)
with intense##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2010-6#1)
with intensive##6##2##(2008-10#3)(2009-11#1)(2009-4#1)(2012-2#1)
with interactions##3##2##(1990-2#1)(2008-10#1)(2008-9#1)
with interdigitated##2##2##(2008-10#2)
with interferon##2##2##(1997-1#1)(2013-1#1)
with interferon-gamma##2##2##(1996-2#1)(1997-1#1)
with interleukin-2##2##2##(1994-6#1)(1994-8#1)
with interlocking intramedullary nail##3##4##(2013-1#3)
with interlocking##5##2##(1997-3#1)(2013-1#4)
with intermediate##5##2##(1996-2#1)(2008-10#2)(2008-8#2)
with intermittent##3##2##(1995-2#1)(1996-2#1)(2008-10#1)
with internal fixation##2##3##(2010-12#1)(2012-2#1)
with internal##15##2##(1990-5#1)(1992-12#1)(1995-12#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
with international##3##2##(1996-2#1)(2008-1#1)(2008-11#1)
with intestinal##5##2##(1995-10#1)(1997-1#1)(2009-12#1)(2012-3#2)
with intracellular##4##2##(1995-5#1)(2006-6#1)(2008-9#1)(2011-2#1)
with intracranial##6##2##(1991-2#1)(1995-11#1)(1996-6#1)(2008-7#2)(2012-12#1)
with intrahepatic##2##2##(1997-8#1)(2009-8#1)
with intramedullary##2##2##(2012-3#1)(2013-1#1)
with intranasal##2##2##(2007-11#1)(2013-1#1)
with intraocular lens##2##3##(1991-2#1)(2011-2#1)
with intrapleural##2##2##(1991-6#2)
with intrauterine##2##2##(1994-12#1)(1996-3#1)
with intravenous immunoglobulin##2##3##(2010-8#2)
with intravenous midazolam##2##3##(1993-1#2)
with intravenous##15##2##(1991-6#1)(1993-1#2)(1993-11#1)(1995-11#1)(1997-7#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-8#2)(2012-12#2)(2013-1#2)
with intrinsic##2##2##(1995-2#1)(1997-8#1)
with invasive##3##2##(1990-11#1)(2007-12#1)(2008-10#1)
with inversion##3##2##(1992-7#1)(1996-5#1)(2008-3#1)
with investigation times##2##3##(1994-3#2)
with involvement of the##2##4##(1994-5#1)(2008-11#1)
with involvement of##3##3##(1994-5#1)(2008-11#1)(2013-1#1)
with involvement##4##2##(1994-5#1)(2008-11#1)(2012-3#1)(2013-1#1)
with iodide in##2##3##(2008-10#2)
with iodide##8##2##(2008-10#8)
with iodine##6##2##(2008-10#5)(2008-8#1)
with ion chromatography for##2##4##(2008-10#2)
with ion chromatography##5##3##(2008-10#5)
with ion exchange##2##3##(2008-10#2)
with ion##11##2##(2008-10#9)(2008-11#1)(2011-2#1)
with ion-selective##3##2##(2008-10#3)
with ionic##2##2##(2008-10#2)
with ipsilateral##2##2##(2010-5#1)(2013-1#1)
with iron ions##3##3##(1993-8#3)
with iron##7##2##(1993-8#3)(2008-10#3)(2011-2#1)
with iron(II) in hydrochloric acid##2##5##(2008-10#2)
with iron(II)##6##2##(2008-10#6)
with iron(III) in the presence of 1##2##7##(2008-10#2)
with iron(III) in##3##3##(2008-10#3)
with iron(III)##5##2##(2008-10#5)
with irregular##2##2##(2010-6#1)(2011-2#1)
with ischaemic heart disease##2##4##(2008-5#1)(2012-2#1)
with ischaemic##4##2##(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
with ischemic heart disease##2##4##(2008-7#1)(2012-3#1)
with ischemic##4##2##(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
with isobaric bypivacain (5mg/ml)##2##4##(2012-3#2)
with isobaric bypivacain##3##3##(2012-3#3)
with isobutyl methyl ketone (IBMK)##3##5##(2008-10#3)
with isobutyl methyl ketone##4##4##(2008-10#4)
with isolated##8##2##(1994-8#1)(1996-5#1)(1997-8#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
with isolates from##7##3##(2008-10#6)(2011-2#1)
with isolates of morphotype A##3##5##(2008-10#3)
with isolates of##8##3##(2008-10#8)
with isolates##20##2##(2008-10#18)(2011-2#2)
with isolation and##2##3##(2008-6#1)(2012-2#1)
with isoniazid##2##2##(2008-10#2)
with isotonic##2##2##(1994-8#1)(2008-10#1)
with it##9##2##(1991-5#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
with its 5##2##3##(2011-2#2)
with its ability to##2##4##(1993-2#1)(2011-2#1)
with its cognate##2##3##(1995-8#1)(2011-1#1)
with its degree##2##3##(1990-6#1)(2008-11#1)
with its receptor##2##3##(1994-8#1)(1995-6#1)
with its respective##2##3##(2011-2#1)(2013-1#1)
with its use##2##3##(1993-1#1)(2010-8#1)
with its##117##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-6#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-3#3)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-4#1)(1997-8#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-10#3)(2009-5#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#32)(2011-3#2)(2011-7#1)(2012-2#1)(2013-1#5)(2013-8#1)
with jaundice##3##2##(1992-9#2)(2008-11#1)
with just a##2##3##(2008-7#1)(2012-3#1)
with just##4##2##(2008-7#1)(2011-2#2)(2012-3#1)
with keeping##2##2##(2008-10#2)
with keratoconjunctivitis##5##2##(2011-2#5)
with key informants##2##3##(1996-3#1)(2008-1#1)
with key##8##2##(1995-2#1)(1996-3#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-2#1)
with knee osteoarthritis##3##3##(2012-2#1)(2013-1#2)
with knee##5##2##(2012-2#1)(2012-3#1)(2013-1#3)
with knowledge##2##2##(2008-10#1)(2008-9#1)
with known amounts of##5##4##(1993-6#1)(2008-10#4)
with known concentrations##2##3##(2008-10#1)(2008-3#1)
with known genes##2##3##(2008-10#1)(2008-9#1)
with known or##3##3##(1997-6#1)(1997-8#1)(2013-1#1)
with known##44##2##(1990-12#1)(1991-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#17)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
with l-cysteine##4##2##(2008-10#4)
with lab-at-valve (LAV) approach for on-line liquid-liquid micro-extraction##2##8##(2008-10#2)
with lab-at-valve (LAV) approach for##3##5##(2008-10#3)
with labeled##4##2##(1991-5#1)(2008-10#2)(2008-4#1)
with laboratory##2##2##(1994-12#1)(2008-10#1)
with laccase##2##2##(2008-10#2)
with lactate##2##2##(1994-8#1)(2008-10#1)
with lanthanide##2##2##(2008-10#2)
with laparotomy##4##2##(1991-3#1)(1994-3#1)(1996-1#1)(1996-3#1)
with large amount of##2##4##(2008-10#2)
with large intestine##2##3##(2009-8#1)(2013-1#1)
with large numbers of##2##4##(2008-5#1)(2008-7#1)
with large quantities of##3##4##(2008-11#1)(2008-9#1)(2009-7#1)
with large##38##2##(1994-1#2)(1994-2#1)(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#2)(2013-8#2)
with larger numbers of##2##4##(1995-12#1)(2012-2#1)
with larger##9##2##(1992-12#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
with largest##2##2##(2010-7#1)(2012-5#1)
with larvae##3##2##(2008-7#1)(2008-9#1)(2010-10#1)
with laser laparoscopy##2##3##(1995-2#2)
with laser sampling##2##3##(2008-10#2)
with laser##13##2##(1991-9#1)(1995-2#2)(1995-3#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-2#1)
with laser-induced fluorescence detection##2##4##(2008-10#2)
with laser-induced fluorescence##4##3##(2008-10#4)
with laser-induced##6##2##(2008-10#6)
with late##7##2##(1993-6#1)(1997-4#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)
with late-onset##2##2##(2009-8#2)
with latent##2##2##(2008-10#2)
with later##2##2##(2008-1#1)(2008-8#1)
with lateral##2##2##(2008-12#1)(2008-5#1)
with lead##2##2##(2008-10#2)
with lead(II)##3##2##(2008-10#3)
with leaf rust##2##3##(2008-10#2)
with leaf##6##2##(2008-10#5)(2008-9#1)
with learning and##2##3##(2008-10#1)(2008-11#1)
with learning difficulties##6##3##(2008-11#6)
with learning disabilities##6##3##(2008-12#1)(2011-1#5)
with learning##16##2##(1997-7#1)(2008-10#1)(2008-11#7)(2008-12#1)(2011-1#6)
with left lung hypoplasia##2##4##(2013-1#2)
with left sided##3##3##(1997-6#1)(2010-11#1)(2013-1#1)
with left ventricular##2##3##(2008-12#1)(2010-6#1)
with left##18##2##(1991-8#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-12#1)(2009-10#3)(2010-11#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#5)
with legal##2##2##(2008-10#1)(2009-9#1)
with lesbian##3##2##(2008-12#1)(2012-2#2)
with lesion##4##2##(2008-10#2)(2010-6#1)(2012-2#1)
with lesions in the##2##4##(2008-10#1)(2008-11#1)
with lesions in##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
with lesions of##2##3##(1996-5#1)(2009-11#1)
with lesions##8##2##(1991-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-11#1)
with less severe##2##3##(2009-11#1)(2011-2#1)
with less than optimal##2##4##(1996-11#1)(2013-1#1)
with less than##14##3##(1991-6#1)(1992-2#1)(1993-11#1)(1996-11#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
with less##46##2##(1991-12#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
with lesser amounts##2##3##(2008-11#1)(2008-7#1)
with lesser##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
with leukemia##5##2##(1992-3#2)(2008-10#1)(2010-11#1)(2012-3#1)
with leukocytes##3##2##(2008-1#2)(2008-5#1)
with leukotriene receptor##2##3##(2008-1#1)(2012-12#1)
with levamisole##2##2##(1991-8#1)(1996-6#1)
with level##3##2##(1993-3#1)(1994-12#1)(2011-1#1)
with levels of##5##3##(1996-12#1)(1997-8#1)(2008-10#1)(2008-6#1)(2010-11#1)
with levels##7##2##(1996-12#1)(1997-8#1)(2008-10#2)(2008-6#1)(2009-8#1)(2010-11#1)
with life##5##2##(1997-4#1)(2008-11#1)(2009-11#1)(2009-5#1)(2010-10#1)
with lifetimes of##2##3##(1996-2#1)(2008-10#1)
with light and##3##3##(2008-10#3)
with light##15##2##(2008-10#10)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
with likely##2##2##(1991-12#2)
with limb##3##2##(1991-8#1)(2008-10#1)(2012-2#1)
with limited English proficiency##3##4##(2008-12#1)(2010-8#2)
with limited##25##2##(1992-3#1)(1993-12#1)(1996-2#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-10#1)(2010-8#2)(2010-9#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#2)
with limits of detection in the##2##6##(2008-10#2)
with limits of detection##5##4##(2008-10#3)(2008-3#1)(2010-11#1)
with lineage##2##2##(2008-10#2)
with linear and##2##3##(2008-10#2)
with linear best fit##2##4##(2008-10#2)
with linear##16##2##(1990-5#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)
with linoleic acid##2##3##(2008-11#2)
with lipid bilayers##3##3##(1990-5#1)(2008-10#2)
with lipid##10##2##(1990-2#1)(1990-5#1)(1993-8#1)(2008-10#5)(2010-12#1)(2011-2#1)
with lipids##2##2##(1990-2#1)(2008-10#1)
with lipophilic##4##2##(2008-10#4)
with lipopolysaccharide##3##2##(1993-3#1)(1996-12#2)
with liposomes##2##2##(1996-2#1)(2008-10#1)
with liquid chromatography##4##3##(2008-10#4)
with liquid##11##2##(2007-12#1)(2008-10#8)(2008-7#2)
with liquid-liquid extraction##2##3##(2008-10#2)
with literature data##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
with literature values##3##3##(2008-10#2)(2008-7#1)
with literature##7##2##(1990-5#1)(1991-6#1)(2008-10#3)(2008-7#1)(2011-2#1)
with lithium##5##2##(1996-12#1)(1996-5#1)(2008-10#1)(2008-2#1)(2009-8#1)
with little bias##2##3##(2008-10#1)(2009-7#1)
with little or no##5##4##(1990-2#1)(1995-9#1)(2008-11#1)(2008-4#1)(2013-1#1)
with little##29##2##(1990-2#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2012-3#1)(2013-1#1)
with live##5##2##(1991-8#1)(1995-5#1)(2008-10#1)(2008-5#2)
with liver cirrhosis##5##3##(1992-2#1)(2008-10#1)(2010-12#2)(2010-8#1)
with liver##16##2##(1990-5#1)(1990-8#1)(1991-11#1)(1992-2#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-12#2)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#2)
with living##3##2##(1993-3#1)(2008-11#1)(2011-2#1)
with local anesthesia##2##3##(1993-1#1)(2013-1#1)
with local##16##2##(1990-11#1)(1993-1#1)(1993-9#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#3)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
with localized scleroderma##3##3##(2011-2#3)
with localized##6##2##(1995-12#1)(1996-12#1)(2011-2#3)(2012-12#1)
with locally advanced##5##3##(1990-6#1)(2008-10#2)(2011-3#1)(2013-8#1)
with locally##6##2##(1990-6#1)(1990-8#1)(2008-10#2)(2011-3#1)(2013-8#1)
with lomefloxacin##2##2##(2008-10#2)
with long alkyl##2##3##(2008-10#1)(2008-5#1)
with long histories##2##3##(1991-8#1)(2013-8#1)
with long##16##2##(1991-8#1)(1994-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
with long-acting agents##2##3##(2009-9#2)
with long-chain##2##2##(2008-10#2)
with long-standing##4##2##(1993-6#1)(2008-10#1)(2008-7#1)(2010-1#1)
with long-term follow-up##4##3##(2008-10#2)(2012-12#2)
with long-term psychiatric backgrounds##2##4##(1993-1#2)
with long-term##16##2##(1992-11#1)(1993-1#2)(1993-2#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-12#2)(2013-1#1)
with longer follow-up##3##3##(2011-2#2)(2012-12#1)
with longer##10##2##(1991-7#1)(1996-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)
with longstanding##3##2##(2008-12#1)(2012-3#1)(2012-4#1)
with loop##2##2##(1996-1#1)(2008-11#1)
with loss of##10##3##(1997-1#1)(1997-3#1)(2008-10#3)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)
with loss##11##2##(1997-1#1)(1997-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)
with low back pain##6##4##(2008-12#4)(2010-1#1)(2013-1#1)
with low birth weight##2##4##(1996-11#1)(2012-3#1)
with low birth##3##3##(1994-6#1)(1996-11#1)(2012-3#1)
with low body##2##3##(2008-7#1)(2009-5#1)
with low concentrations of the##2##5##(1991-5#1)(2008-5#1)
with low concentrations of##3##4##(1991-5#1)(2008-5#2)
with low concentrations##4##3##(1991-5#1)(2008-5#3)
with low cost##2##3##(2008-10#1)(2009-1#1)
with low detection limits##3##4##(2008-10#3)
with low disease##3##3##(2008-10#3)
with low fluorescence##2##3##(2008-10#2)
with low initial##2##3##(2008-10#1)(2008-9#1)
with low levels of##5##4##(1994-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2010-1#1)
with low sample##3##3##(2008-10#3)
with low virulence##2##3##(2008-10#2)
with low##114##2##(1990-11#1)(1991-2#1)(1991-5#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-8#1)(2008-10#47)(2008-11#4)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#4)(2010-12#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
with low-dose alpha-2b interferon##2##4##(1990-6#2)
with low-dose##6##2##(1990-6#2)(1992-12#2)(1994-12#1)(2011-2#1)
with low-risk##2##2##(2011-2#2)
with lower concentrations##2##3##(2008-10#2)
with lower levels of##4##4##(1995-3#1)(2008-12#1)(2008-9#1)(2012-2#1)
with lower total##2##3##(2008-10#1)(2008-7#1)
with lower##41##2##(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-7#2)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)
with lowest##2##2##(2008-11#1)(2012-5#1)
with lumbar lateral recess syndrome##2##5##(2011-2#2)
with lumbar##7##2##(1993-1#1)(2011-2#2)(2012-12#3)(2013-1#1)
with luminescence##2##2##(2008-10#2)
with luminol##3##2##(2008-10#3)
with lung cancer##5##3##(1991-12#1)(1991-2#1)(1991-8#1)(2009-11#1)(2009-7#1)
with lung disease##3##3##(1996-2#2)(2008-10#1)
with lung##14##2##(1991-12#1)(1991-2#1)(1991-8#1)(1996-2#2)(2008-10#1)(2008-11#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-2#3)
with lymph node metastases##2##4##(2008-9#1)(2013-8#1)
with lymph node metastasis##2##4##(2013-1#2)
with lymph node##6##3##(1991-6#1)(2008-9#1)(2013-1#2)(2013-8#2)
with lymphadenectomy##2##2##(1992-9#1)(1993-3#1)
with lysine##2##2##(1993-8#1)(1995-2#1)
with mRNA##2##2##(1994-11#1)(1994-8#1)
with macrocyclic##2##2##(2008-10#2)
with macrophages##2##2##(1995-3#1)(2010-12#1)
with magnesium##3##2##(1991-12#1)(1991-5#1)(1996-6#1)
with magnetic resonance imaging (MRI)##2##5##(2010-9#1)(2012-2#1)
with magnetic resonance imaging##3##4##(1992-3#1)(2010-9#1)(2012-2#1)
with magnetic resonance##4##3##(1992-3#1)(2009-1#1)(2010-9#1)(2012-2#1)
with magnetic##5##2##(1992-3#1)(2008-7#1)(2009-1#1)(2010-9#1)(2012-2#1)
with main##5##2##(1991-9#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-2#1)
with major##19##2##(1990-6#1)(1991-6#1)(1995-2#3)(1996-11#1)(2008-10#4)(2008-12#1)(2008-8#2)(2009-10#1)(2009-8#2)(2011-2#2)(2012-2#1)
with malaria##3##2##(2012-12#3)
with male##4##2##(1993-12#1)(2008-6#1)(2008-8#1)(2012-12#1)
with males##2##2##(2008-12#1)(2008-8#1)
with malignancies##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
with malignancy##3##2##(1991-12#1)(1991-8#1)(2009-12#1)
with malignant diseases##2##3##(1990-11#1)(1990-2#1)
with malignant melanoma##3##3##(1990-6#1)(2011-2#2)
with malignant##17##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1992-12#1)(1994-12#2)(1997-2#1)(2008-7#1)(2009-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-7#1)(2013-8#1)
with mammalian cells##3##3##(2008-9#3)
with mammalian##5##2##(1996-8#1)(2008-11#1)(2008-9#3)
with mammals##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
with managed care organizations##2##4##(1997-1#1)(1997-3#1)
with managed care plans##2##4##(1995-12#2)
with managed care##6##3##(1995-12#2)(1996-2#2)(1997-1#1)(1997-3#1)
with manual##2##2##(1995-2#1)(2008-12#1)
with many of the##4##4##(1996-1#1)(2008-10#2)(2008-5#1)
with many other##4##3##(2008-10#1)(2008-11#1)(2010-8#1)(2012-3#1)
with many potential##2##3##(1995-9#1)(2008-10#1)
with many##33##2##(1990-11#1)(1992-1#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-6#1)(1996-9#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-5#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
with marked##13##2##(1991-12#1)(1993-11#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
with markers for##2##3##(1991-8#1)(1995-6#1)
with marketing##2##2##(1993-12#1)(1995-1#1)
with mass spectrometric##5##3##(2008-10#5)
with mass spectrometry##7##3##(2008-10#4)(2008-5#1)(2010-7#1)(2012-2#1)
with mass##17##2##(1996-6#2)(2008-1#1)(2008-10#10)(2008-5#1)(2010-7#1)(2010-8#1)(2012-2#1)
with massive##6##2##(1991-6#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
with matched##5##2##(1992-8#1)(2008-7#1)(2010-12#2)(2012-5#1)
with matching##2##2##(2008-10#1)(2012-12#1)
with material##2##2##(2008-7#1)(2011-1#1)
with maternal##7##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#1)(2012-3#1)
with maternally derived##2##3##(1997-3#2)
with mating##2##2##(2008-8#1)(2008-9#1)
with maximal##8##2##(1990-12#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2010-8#1)
with maximizing##2##2##(2008-9#2)
with maximum adsorption capacity##2##4##(2008-10#2)
with maximum levels##2##3##(1996-12#1)(2008-5#1)
with maximum likelihood##2##3##(2012-3#2)
with maximum striga##3##3##(2008-10#3)
with maximum##18##2##(1996-12#1)(2007-12#1)(2008-10#11)(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#2)
with mean age of##2##4##(2009-8#2)
with mean##21##2##(1996-6#1)(1997-5#1)(2008-10#12)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#2)(2011-1#1)(2012-2#1)
with measurable##2##2##(1990-12#1)(2013-8#1)
with measured##5##2##(2008-10#2)(2008-3#3)
with measurement of##3##3##(2008-9#2)(2010-7#1)
with measurements from##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
with measurements of##3##3##(2008-10#1)(2008-11#2)
with measurements##15##2##(1992-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-9#1)(2009-7#1)(2012-2#1)
with measures##3##2##(1995-1#1)(2008-7#1)(2008-9#1)
with measuring##2##2##(1994-3#1)(2008-9#1)
with mechanical neck pain##3##4##(2008-12#3)
with mechanical##5##2##(2008-10#1)(2008-12#3)(2013-1#1)
with median##5##2##(1997-8#1)(2008-10#3)(2011-2#1)
with medical care##2##3##(1996-2#2)
with medical procedures##2##3##(2008-11#1)(2009-9#1)
with medical therapy##3##3##(1990-11#1)(2008-7#1)(2013-1#1)
with medical##16##2##(1990-11#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-2#2)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#5)
with medication##2##2##(2011-1#1)(2013-8#1)
with medications##2##2##(2008-7#1)(2008-8#1)
with medicines##2##2##(1996-3#1)(2008-7#1)
with medium##7##2##(2008-11#4)(2008-5#1)(2013-1#2)
with medulloblastoma##5##2##(1994-3#1)(1997-3#4)
with melanin##2##2##(2008-11#1)(2013-1#1)
with members of the##5##4##(1994-6#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-4#1)
with members of##11##3##(1991-1#1)(1994-6#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-9#1)
with membrane##9##2##(1990-2#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
with membranes containing##2##3##(2008-10#2)
with membranes##4##2##(1994-5#2)(2008-10#2)
with men and##2##3##(2008-11#1)(2009-5#1)
with men in##2##3##(1990-2#1)(2009-5#1)
with men undergoing AS for prostate cancer##2##7##(2010-10#2)
with men##16##2##(1990-2#1)(1991-7#1)(1996-5#1)(2008-11#2)(2008-4#1)(2009-5#7)(2010-10#2)(2011-2#1)
with menstruation##2##2##(1991-3#1)(2013-1#1)
with mental health problems##7##4##(1992-1#1)(1993-1#3)(2008-11#3)
with mental health##8##3##(1992-1#1)(1993-1#3)(1997-2#1)(2008-11#3)
with mental illness##6##3##(2008-11#1)(2011-1#5)
with mental retardation##4##3##(1993-3#2)(1995-1#1)(1997-8#1)
with mental##20##2##(1992-1#1)(1993-1#3)(1993-3#2)(1995-1#1)(1997-2#2)(1997-8#1)(2008-11#4)(2011-1#5)(2012-3#1)
with mercuric##2##2##(2008-10#2)
with mercury##4##2##(2008-10#4)
with metabolic control##2##3##(2011-1#1)(2011-2#1)
with metabolic syndrome##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
with metabolic##11##2##(1990-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
with metachromatic##3##2##(1997-3#2)(2008-5#1)
with metal ions##5##3##(1996-5#1)(2008-10#3)(2008-4#1)
with metal##8##2##(1996-5#1)(1997-3#1)(2008-10#5)(2008-4#1)
with metallic thin film##2##4##(2008-3#2)
with metallic##3##2##(2008-10#1)(2008-3#2)
with metastasis to the##2##4##(1992-2#1)(1997-8#1)
with metastasis##4##2##(1992-2#1)(1992-5#1)(1997-8#1)(2010-3#1)
with metastatic melanoma##2##3##(1990-6#1)(1992-2#1)
with metastatic##14##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1991-7#1)(1991-8#1)(1992-2#1)(1997-8#1)(2008-11#2)(2009-1#1)(2010-8#1)(2012-12#1)(2013-8#1)
with methanol as##2##3##(2008-10#1)(2012-2#1)
with methanol in##2##3##(1996-5#1)(2008-10#1)
with methanol##9##2##(1996-5#1)(2008-10#7)(2012-2#1)
with methodology##2##2##(2008-10#1)(2011-2#1)
with methods##3##2##(2008-9#2)(2009-8#1)
with methotrexate##3##2##(1997-8#1)(2008-11#1)(2013-1#1)
with methyl bromide##5##3##(2008-10#5)
with methyl jasmonate##2##3##(2008-10#1)(2011-10#1)
with methyl methacrylate##2##3##(2008-7#2)
with methyl##16##2##(1996-5#4)(2008-10#9)(2008-7#2)(2011-10#1)
with methylene blue##2##3##(2008-10#2)
with methylene##3##2##(2008-10#3)
with methylprednisolone##4##2##(1993-6#1)(2008-5#1)(2013-8#2)
with methylthiosalicylate (TS-gel)##2##3##(2008-10#2)
with methylthymol blue##2##3##(2008-10#2)
with metoprolol##2##2##(1996-3#1)(2010-4#1)
with micafungin##2##2##(2008-10#2)
with microbial antagonists##2##3##(2008-10#2)
with microbial##3##2##(2008-10#2)(2008-7#1)
with microcrystalline naphthalene##2##3##(2008-10#2)
with microcrystalline phenolphthalein modified by crystal violet##2##7##(2008-10#2)
with microcrystalline##4##2##(2008-10#4)
with microdialysis sampling##2##3##(2008-10#2)
with microdialysis##6##2##(2008-10#5)(2008-7#1)
with microelectrodes##2##2##(2008-10#2)
with microfluidic capillary electrophoresis##2##4##(2008-10#2)
with microorganisms##2##2##(2008-11#1)(2011-1#1)
with microreaction chamber##2##3##(2008-10#2)
with microsatellite##2##2##(2008-10#2)
with microvascular##3##2##(1995-11#1)(2011-2#2)
with microvilli##3##2##(2007-12#1)(2008-5#1)(2008-6#1)
with microwave heating##2##3##(2008-10#2)
with microwave##8##2##(2008-10#8)
with microwaves##3##2##(2008-10#3)
with migraine with aura##3##4##(2008-9#2)(2011-2#1)
with migration of##2##3##(2012-12#1)(2012-3#1)
with migration##4##2##(2008-8#2)(2012-12#1)(2012-3#1)
with mild to moderate##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
with mild##13##2##(1993-8#1)(1997-3#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
with mild-to-moderate##2##2##(1991-6#1)(2013-1#1)
with minimal amount of##2##4##(2008-10#2)
with minimal effects on##2##4##(1995-6#1)(2013-8#1)
with minimal morbidity##4##3##(2011-2#3)(2013-1#1)
with minimal sample##3##3##(2008-10#3)
with minimal##50##2##(1991-2#1)(1991-3#1)(1992-12#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-11#1)(2008-10#13)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
with minimally invasive##3##3##(2010-8#1)(2011-2#2)
with minimized##2##2##(2008-10#1)(2012-2#1)
with minimum##11##2##(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#5)(2009-8#1)(2010-7#1)(2011-1#1)
with minor##11##2##(1990-6#1)(1992-6#1)(1996-3#1)(1996-8#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)
with mitochondrial##4##2##(1994-11#1)(2008-8#1)(2009-9#1)(2013-8#1)
with mitotic##2##2##(2008-10#1)(2010-5#1)
with mitoxantrone##3##2##(1991-6#2)(1994-12#1)
with mixed##4##2##(1997-5#1)(2008-10#2)(2008-11#1)
with mixtures of##6##3##(2008-10#6)
with mixtures##9##2##(2008-10#9)
with mobile phase##2##3##(2008-10#1)(2008-5#1)
with mobile##3##2##(2008-10#2)(2008-5#1)
with mobility##4##2##(2008-7#1)(2008-9#3)
with model lipid##2##3##(2008-10#1)(2008-5#1)
with model##10##2##(1994-12#1)(1994-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)
with modeled##2##2##(2008-10#1)(2008-3#1)
with modem##2##2##(1991-12#1)(2008-8#1)
with moderate and##4##3##(1993-8#1)(2008-7#2)(2011-2#1)
with moderate or severe asthma##3##5##(2008-11#3)
with moderate size parameters##2##4##(2008-3#2)
with moderate to severe##2##4##(2008-10#2)
with moderate##19##2##(1990-8#1)(1993-3#2)(1993-8#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-7#2)(2009-11#1)(2011-2#1)(2013-1#1)
with moderately##2##2##(1993-3#1)(2008-10#1)
with modern analytical##2##3##(2008-10#1)(2010-7#1)
with modern##8##2##(1997-6#1)(2008-10#1)(2010-7#1)(2012-2#2)(2012-9#1)(2013-1#2)
with modification of##2##3##(2008-10#1)(2008-9#1)
with modifications of##2##3##(1996-12#1)(2008-11#1)
with modified##7##2##(1990-3#1)(2008-10#5)(2009-4#1)
with modifier##3##2##(2008-10#3)
with molar absorptivity being##2##4##(2008-10#2)
with molar absorptivity of 1##2##5##(2008-10#2)
with molar absorptivity of##3##4##(2008-10#3)
with molar absorptivity##8##3##(2008-10#8)
with molar##9##2##(2008-10#9)
with molecular and##2##3##(2009-10#1)(2009-8#1)
with molecular weight of##6##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
with molecular##21##2##(1992-4#1)(1993-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#1)
with molecules of larger##2##4##(2008-10#2)
with molybdate##5##2##(2008-10#5)
with monitored##2##2##(2008-10#1)(2012-2#1)
with monoarthritis of##2##3##(2008-12#2)
with monoclonal antibodies##3##3##(1995-12#1)(2008-11#1)(2008-9#1)
with monoclonal antibody##4##3##(1992-11#2)(2006-6#1)(2008-10#1)
with monoclonal##7##2##(1992-11#2)(1995-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
with monosomy##2##2##(1992-12#1)(2013-1#1)
with monovalent##2##2##(2008-10#1)(2012-3#1)
with mood##2##2##(2008-7#1)(2013-8#1)
with more complete##2##3##(2008-10#1)(2011-2#1)
with more efficient##2##3##(2008-10#2)
with more or##2##3##(1993-3#1)(2013-8#1)
with more severe##2##3##(2008-10#1)(2008-4#1)
with more stable##2##3##(2008-10#1)(2010-10#1)
with more than 1##2##4##(2008-10#1)(2008-11#1)
with more than four##3##4##(1990-12#1)(2012-12#2)
with more than one##3##4##(2008-10#2)(2011-2#1)
with more than##18##3##(1990-12#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-3#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#1)
with more##68##2##(1990-12#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-3#1)(1995-3#3)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#2)(2008-10#19)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
with morin##2##2##(2008-10#2)
with morphine inhibited##2##3##(2008-12#2)
with morphine##7##2##(1991-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-12#3)
with morphological identification##2##3##(2008-10#2)
with morphological##4##2##(1996-6#1)(2008-10#2)(2008-6#1)
with mortality##4##2##(2008-10#1)(2008-7#2)(2012-12#1)
with most isolates##2##3##(2008-10#2)
with most of the##7##4##(2008-1#1)(2008-10#3)(2008-4#1)(2010-1#1)(2010-11#1)
with most of##9##3##(2008-1#1)(2008-10#4)(2008-4#1)(2010-1#1)(2010-11#1)(2011-2#1)
with most##26##2##(1992-12#1)(1993-11#1)(1996-12#2)(1996-2#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
with mothers##3##2##(2008-6#1)(2010-1#1)(2012-2#1)
with motilin##2##2##(1994-11#2)
with motor##2##2##(2008-11#2)
with mouse IgG##2##3##(2008-10#1)(2008-12#1)
with mouse myeloma cells##2##4##(2008-11#2)
with mouse myeloma##3##3##(2008-11#3)
with mouse##9##2##(1991-6#1)(2008-10#1)(2008-11#5)(2008-12#1)(2011-2#1)
with movement##2##2##(2008-12#1)(2008-8#1)
with moyamoya disease##2##3##(2008-7#2)
with much higher##2##3##(2007-11#1)(2008-10#1)
with much##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
with multi-drug##2##2##(2011-3#1)(2012-2#1)
with multidimensional##2##2##(2008-11#1)(2010-7#1)
with multidrug##2##2##(2013-1#1)(2013-8#1)
with multilevel##4##2##(2012-12#4)
with multiple males##2##3##(2008-8#2)
with multiple myeloma##2##3##(2011-2#2)
with multiple outputs##2##3##(2008-10#2)
with multiple partners##2##3##(1997-3#1)(2013-1#1)
with multiple sclerosis##4##3##(2011-2#2)(2011-7#1)(2012-12#1)
with multiple supernumerary teeth##2##4##(2013-1#2)
with multiple tendinous xanthomas##2##4##(1997-8#2)
with multiple##67##2##(1992-12#3)(1993-2#1)(1994-2#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-3#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#10)(2011-3#1)(2011-7#1)(2012-12#3)(2013-1#6)(2013-8#1)
with multiples##2##2##(2008-11#2)
with multivariate calibration##3##3##(2008-10#3)
with multivariate##6##2##(2008-10#5)(2008-11#1)
with municipal##2##2##(1995-9#1)(2010-1#1)
with murine##4##2##(1990-5#1)(2008-10#1)(2008-4#2)
with muscle##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
with mutant##2##2##(2008-8#1)(2008-9#1)
with mutations at the##2##4##(1992-9#1)(2008-10#1)
with mutations##7##2##(1992-9#2)(2008-10#1)(2008-8#2)(2009-8#1)(2012-3#1)
with mutual##3##2##(1990-12#1)(1996-2#1)(1996-3#1)
with my##3##2##(1992-3#1)(2010-1#2)
with myasthenia gravis##2##3##(1991-2#1)(2012-3#1)
with mycelial compatibility##2##3##(2008-10#2)
with mycelium of##2##3##(2008-10#2)
with mycelium##7##2##(1994-8#1)(2008-10#6)
with mycotoxins##3##2##(2008-10#2)(2010-7#1)
with myelodysplastic syndromes##2##3##(1992-12#1)(2008-11#1)
with myocardial infarction##4##3##(1996-2#3)(2008-8#1)
with myocardial##6##2##(1996-2#3)(2008-11#1)(2008-3#1)(2008-8#1)
with myogenic##2##2##(1995-6#1)(2008-11#1)
with myosin##2##2##(1994-5#1)(2011-2#1)
with n##2##2##(2008-10#2)
with n-butanol##2##2##(2008-10#1)(2008-5#1)
with n-hexane##3##2##(2008-10#3)
with nanoparticles##3##2##(2008-10#1)(2008-7#2)
with naproxen##2##2##(1994-3#1)(2008-10#1)
with narrow##3##2##(2008-10#3)
with narrow-band##2##2##(2008-2#1)(2008-3#1)
with nasal##3##2##(2011-2#2)(2013-1#1)
with national##3##2##(2007-12#1)(2008-11#1)(2012-3#1)
with native##12##2##(1992-3#1)(1993-12#1)(1995-11#1)(1995-8#2)(2008-10#5)(2008-4#1)(2009-8#1)
with natural light##2##3##(2008-3#2)
with natural##8##2##(1991-2#1)(1997-2#1)(2008-10#3)(2008-3#2)(2008-5#1)
with naturally##4##2##(2008-10#4)
with near-Nernstian slope of##2##4##(2008-10#2)
with near-Nernstian##3##2##(2008-10#3)
with near-infrared##3##2##(2008-10#1)(2008-3#2)
with nearly##2##2##(2008-10#2)
with neck pain and##3##4##(1991-8#1)(2008-12#1)(2009-3#1)
with neck pain##8##3##(1991-8#1)(2008-11#1)(2008-12#4)(2009-3#1)(2010-12#1)
with neck##13##2##(1991-8#2)(2008-11#3)(2008-12#4)(2008-7#1)(2009-3#1)(2010-12#1)(2013-1#1)
with negative margins##2##3##(1994-6#1)(2011-2#1)
with negative##11##2##(1994-12#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#3)
with negligible##4##2##(1995-2#1)(2008-10#3)
with neither##2##2##(2008-11#2)
with nematode##2##2##(2008-12#2)
with nematodes##2##2##(2008-10#2)
with neonatal##5##2##(1994-3#1)(1994-6#1)(1997-1#2)(2010-6#1)
with neoplastic##3##2##(1992-3#1)(2012-2#1)(2012-3#1)
with nephrotic syndrome##4##3##(2008-1#2)(2009-6#2)
with nerve##2##2##(2008-11#1)(2008-9#1)
with net##2##2##(1996-5#1)(2008-11#1)
with neural##2##2##(2010-11#1)(2010-5#1)
with neuroacanthocytosis##2##2##(2008-7#2)
with neuroendocrine##3##2##(1992-11#2)(2008-11#1)
with neurofibromatosis type 1##2##4##(2009-1#2)
with neurological deterioration##2##3##(1996-9#1)(2012-12#1)
with neurological##8##2##(1990-2#2)(1993-2#1)(1996-9#1)(1997-6#1)(2008-12#1)(2012-12#1)(2013-1#1)
with neuronal properties##2##3##(1992-6#2)
with neuronal##5##2##(1991-8#1)(1992-6#2)(2009-8#1)(2010-12#1)
with neurons##3##2##(1996-12#1)(2011-2#2)
with neutral##4##2##(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
with neutron-induced (186)Os and (188)Os##2##5##(2008-10#2)
with new procedures##2##3##(2008-10#1)(2008-7#1)
with new##21##2##(1990-11#1)(1992-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-9#1)(2011-3#2)(2012-3#1)
with newly diagnosed##6##3##(1994-12#1)(1996-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
with newly##8##2##(1990-11#1)(1994-12#1)(1996-11#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
with nickel##3##2##(2008-10#3)
with nighttime##2##2##(2008-10#1)(2008-3#1)
with nine##5##2##(2008-10#1)(2008-12#1)(2008-5#2)(2010-11#1)
with niobium(V) oxide##3##3##(2008-10#3)
with nitric acid and hydrogen peroxide##2##6##(2008-10#2)
with nitric acid and##4##4##(2008-10#4)
with nitric acid##9##3##(2008-10#9)
with nitrite in##2##3##(1990-6#1)(2008-10#1)
with nitrite##6##2##(1990-6#2)(2008-10#4)
with nitrogen##7##2##(2008-10#3)(2008-3#1)(2008-9#1)(2009-7#2)
with no apparent##2##3##(1993-8#1)(2010-12#1)
with no clinical##2##3##(2012-3#1)(2013-1#1)
with no detectable##5##3##(1992-12#1)(1996-5#1)(2008-10#3)
with no difference##3##3##(1993-2#1)(1995-8#1)(2010-1#1)
with no effect on##3##4##(1996-1#1)(2008-8#1)(2013-8#1)
with no effective##2##3##(1990-9#1)(2013-1#1)
with no evidence of recurrence##2##5##(1993-1#1)(2013-8#1)
with no evidence of##6##4##(1992-9#1)(1993-1#1)(2008-10#1)(2010-6#1)(2013-1#1)(2013-8#1)
with no evidence##7##3##(1992-9#1)(1993-1#1)(2008-10#1)(2010-11#1)(2010-6#1)(2013-1#1)(2013-8#1)
with no further##2##3##(2008-10#1)(2011-2#1)
with no history of##6##4##(2008-10#1)(2008-7#1)(2010-1#1)(2010-9#1)(2012-2#1)(2013-8#1)
with no interference from##2##4##(2008-10#2)
with no interference##4##3##(2008-10#4)
with no known##4##3##(2008-10#2)(2010-3#1)(2012-3#1)
with no loss of##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
with no need##2##3##(2008-10#2)
with no obvious##2##3##(1996-1#1)(2011-2#1)
with no previously##2##3##(1993-12#1)(2012-3#1)
with no prior##6##3##(2008-10#3)(2010-12#1)(2011-2#1)(2013-1#1)
with no restrictions##2##3##(2007-12#1)(2008-10#1)
with no sample##2##3##(2008-10#2)
with no sign of##2##4##(1992-9#1)(1994-3#1)
with no significant difference##2##4##(2008-10#1)(2010-9#1)
with no significant##11##3##(1990-11#1)(1991-3#1)(2008-10#5)(2008-11#1)(2010-10#1)(2010-9#1)(2011-2#1)
with no signs of##2##4##(2006-6#1)(2012-3#1)
with no specific##3##3##(2008-10#1)(2013-1#2)
with no statistically significant difference##2##5##(2012-3#1)(2013-1#1)
with no statistically significant##3##4##(1997-7#1)(2012-3#1)(2013-1#1)
with no##184##2##(1990-11#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#51)(2008-11#6)(2008-12#2)(2008-3#4)(2008-5#3)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-9#2)(2011-2#12)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#8)(2013-8#5)
with node##2##2##(2008-10#1)(2008-8#1)
with non variceal##2##3##(2011-2#2)
with non##8##2##(1991-11#1)(1992-11#1)(1994-8#1)(2007-12#1)(2010-11#1)(2011-2#3)
with non-Bayesian and Bayesian##2##4##(2008-10#2)
with non-Bayesian##3##2##(2008-10#3)
with non-human##2##2##(2008-10#1)(2010-10#1)
with non-malignant##3##2##(1990-2#2)(1993-2#1)
with non-specific##2##2##(1990-11#1)(2008-10#1)
with nonactin as ionophore##2##4##(2008-10#2)
with nonlinear##3##2##(2007-12#1)(2008-3#1)(2009-8#1)
with nonoverlapping##2##2##(2008-10#1)(2008-8#1)
with nonpathogenic##3##2##(2008-10#3)
with nonspecific##3##2##(1993-8#1)(2011-2#2)
with nontreated##3##2##(2008-10#3)
with nonviral##3##2##(1997-3#2)(2008-8#1)
with norepinephrine##2##2##(2008-11#1)(2013-8#1)
with normal and##5##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
with normal growth##2##3##(1994-8#1)(2011-1#1)
with normal lung##2##3##(1996-2#2)
with normal subjects##2##3##(1991-8#1)(1995-5#1)
with normal urinary##2##3##(1997-8#1)(2008-10#1)
with normal##63##2##(1991-11#1)(1991-12#2)(1991-8#1)(1992-11#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-6#1)(1997-8#2)(2008-10#7)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#5)(2013-7#1)
with novel##12##2##(1995-5#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
with np-BNR and infected with R##2##6##(2008-10#2)
with np-BNR##4##2##(2008-10#4)
with nuclear extracts from##2##4##(1993-6#1)(2008-10#1)
with nuclear##9##2##(1991-3#1)(1993-6#1)(2008-10#2)(2008-7#2)(2008-9#1)(2011-2#2)
with nucleic acids and##2##4##(1991-5#1)(2008-10#1)
with nucleic acids was##2##4##(2008-10#2)
with nucleic acids##6##3##(1991-5#1)(2008-10#5)
with nucleic##7##2##(1991-5#1)(2008-10#5)(2008-8#1)
with nucleoside##2##2##(1996-11#1)(2008-10#1)
with nucleotide##2##2##(2008-10#2)
with number of##2##3##(1990-12#1)(1994-6#1)
with numbers of##2##3##(2008-10#1)(2008-9#1)
with numbers##3##2##(1994-6#1)(2008-10#1)(2008-9#1)
with numerical##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
with numerous##10##2##(1991-7#1)(2008-10#4)(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
with nurse##2##2##(2008-11#1)(2008-12#1)
with nursing home##2##3##(2008-11#1)(2008-12#1)
with nursing##4##2##(2008-11#1)(2008-12#3)
with o-NPOE##3##2##(2008-10#3)
with o-phthalaldehyde (OPA)##3##3##(2008-10#3)
with o-phthalaldehyde##7##2##(1991-12#1)(2008-10#6)
with o-tolidine##2##2##(2008-10#2)
with oat##2##2##(2008-10#2)
with obesity##9##2##(2008-10#1)(2008-12#3)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
with objective##3##2##(1990-3#1)(1994-3#1)(2008-5#1)
with observations##5##2##(1995-8#1)(1996-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
with observed##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
with obstetric##2##2##(2013-1#2)
with obstructive##3##2##(1997-4#1)(2008-12#1)(2008-7#1)
with occlusion of the##2##4##(1996-6#1)(2013-8#1)
with occlusion of##3##3##(1996-6#1)(2013-1#1)(2013-8#1)
with occult##3##2##(1990-6#1)(2008-10#1)(2008-12#1)
with occupational##3##2##(1990-3#1)(2007-12#1)(2010-9#1)
with oesophageal##2##2##(2008-11#1)(2011-2#1)
with often##2##2##(1993-12#1)(2013-1#1)
with oil##2##2##(2008-10#1)(2011-2#1)
with okadaic acid##4##3##(1992-8#1)(1994-11#2)(2008-4#1)
with old##2##2##(2008-10#1)(2013-1#1)
with older adults##2##3##(1991-12#1)(2010-11#1)
with older people in##2##4##(2010-10#2)
with older people##5##3##(1994-12#1)(2010-10#4)
with older##12##2##(1991-12#1)(1994-12#1)(1997-3#1)(2009-11#1)(2010-10#6)(2010-11#1)(2012-12#1)
with omphalocele##2##2##(1997-3#2)
with on-line atomic##2##3##(2008-10#2)
with on-line detection by##2##4##(2008-10#2)
with on-line detection##3##3##(2008-10#3)
with on-line preconcentration##2##3##(2008-10#2)
with on-line sample##2##3##(2008-10#2)
with on-line##28##2##(2008-10#25)(2008-11#1)(2008-4#2)
with one another##9##3##(1991-3#1)(1995-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-1#1)
with one exception##2##3##(2008-10#2)
with one isolate##2##3##(2008-10#2)
with one of the##4##4##(2008-10#2)(2008-5#1)(2010-2#1)
with one of these##2##4##(1993-8#1)(2012-2#1)
with one of three##3##4##(2008-10#2)(2008-4#1)
with one of two##2##4##(2008-10#1)(2013-8#1)
with one of##12##3##(1993-8#1)(1996-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#1)(2013-8#1)
with one or more doses of##3##6##(1995-5#3)
with one or more##10##4##(1991-7#1)(1995-5#3)(2008-10#3)(2011-2#1)(2013-1#2)
with one or two##6##4##(1991-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-5#1)
with one or##17##3##(1991-2#1)(1991-7#1)(1995-3#1)(1995-5#3)(2007-12#1)(2008-10#4)(2008-4#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
with one population##2##3##(2008-10#1)(2008-8#1)
with one##88##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-6#1)(1993-2#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-12#2)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#34)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
with one-photon and two-photon##2##4##(2008-3#2)
with ongoing##2##2##(2008-10#1)(2008-6#1)
with only 15##2##3##(2009-3#1)(2013-1#1)
with only a few##6##4##(1994-3#1)(2008-10#2)(2008-11#1)(2010-5#1)(2013-1#1)
with only a slight##2##4##(2008-10#1)(2008-12#1)
with only a##15##3##(1994-3#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
with only minor##2##3##(2008-10#1)(2008-4#1)
with only one##10##3##(2008-10#6)(2008-9#1)(2009-5#1)(2010-1#1)(2012-3#1)
with only the##5##3##(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#1)
with only three##2##3##(2011-2#1)(2012-2#1)
with only two##3##3##(1993-1#1)(2008-10#1)(2008-8#1)
with only##63##2##(1991-3#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-10#27)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)
with onset##4##2##(1990-3#1)(2008-1#1)(2009-10#1)(2011-2#1)
with opaque cytoplasm##2##3##(2012-2#2)
with open##8##2##(2008-10#3)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
with opioid receptor antagonists##2##4##(1995-11#1)(2009-7#1)
with opioid##3##2##(1995-11#1)(1995-3#1)(2009-7#1)
with opportunistic##2##2##(1996-6#1)(2009-7#1)
with opsonized##2##2##(1991-2#2)
with optic neuritis##2##3##(1995-12#1)(2012-3#1)
with optic##3##2##(1995-12#1)(2008-7#1)(2012-3#1)
with optical##10##2##(2008-10#2)(2008-2#2)(2008-3#2)(2009-12#1)(2009-5#1)(2011-7#1)(2013-8#1)
with optimal##9##2##(1990-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)(2011-3#2)(2012-3#1)
with optimum##6##2##(2006-6#2)(2008-10#4)
with or without 1##2##4##(2008-11#1)(2012-12#1)
with or without a##4##4##(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#1)
with or without concomitant##2##4##(2008-12#1)(2013-1#1)
with or without renaturation##2##4##(2008-10#2)
with or without the addition of##2##6##(2008-10#2)
with or without the presence of##2##6##(2008-10#1)(2008-11#1)
with or without the##7##4##(1996-9#1)(2008-10#3)(2008-11#2)(2012-2#1)
with or without##92##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#3)(1996-9#2)(1997-3#1)(1997-5#1)(1997-8#2)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-6#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#2)
with or##98##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#3)(1996-9#2)(1997-3#1)(1997-5#1)(1997-8#2)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-6#1)(2009-7#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#2)
with oral poliovirus##2##3##(1995-3#2)
with oral##18##2##(1990-11#1)(1990-3#1)(1991-4#1)(1994-9#1)(1995-3#2)(1996-10#1)(1996-6#1)(1997-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)
with orbital complications##2##3##(2013-1#2)
with orbital##6##2##(1991-6#1)(2008-10#1)(2013-1#4)
with ordinary##2##2##(2008-10#2)
with organic matter##2##3##(2008-10#1)(2008-12#1)
with organic solvent and##2##4##(2008-10#1)(2008-8#1)
with organic solvents##3##3##(2008-10#3)
with organic##11##2##(2008-10#8)(2008-12#1)(2008-8#1)(2009-4#1)
with organisms##2##2##(2008-10#1)(2008-8#1)
with organizing##2##2##(2010-12#1)(2013-1#1)
with original##2##2##(2008-10#1)(2008-8#1)
with orthogonal##2##2##(2007-11#1)(2008-10#1)
with osmium##2##2##(2008-10#2)
with osseous##2##2##(1991-11#1)(2008-7#1)
with ossified cochleae##3##3##(2008-9#3)
with osteoarthritis##2##2##(2010-11#1)(2013-1#1)
with osteoporosis##2##2##(2008-11#1)(2013-1#1)
with other amino acids##2##4##(2008-10#2)
with other common##2##3##(2008-10#2)
with other disease##2##3##(1997-7#1)(2008-10#1)
with other diseases##2##3##(1997-1#1)(2008-4#1)
with other drugs##4##3##(1990-2#1)(1993-11#1)(2008-11#1)(2008-3#1)
with other four##2##3##(2008-10#2)
with other genes##2##3##(2008-10#2)
with other groups##2##3##(1993-12#1)(2009-10#1)
with other health##2##3##(1994-6#1)(2008-11#1)
with other isolates##2##3##(2008-10#1)(2011-2#1)
with other known##4##3##(1996-2#1)(2008-10#1)(2012-3#1)(2013-8#1)
with other mammals##2##3##(1992-12#1)(2013-1#1)
with other members of the##5##5##(1992-3#1)(2008-10#3)(2008-11#1)
with other methods##4##3##(1996-3#1)(2008-10#1)(2008-11#2)
with other molecules##2##3##(1995-2#1)(2013-1#1)
with other organizations##2##3##(1994-12#1)(2012-2#1)
with other published##2##3##(2013-1#1)(2013-8#1)
with other reported##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
with other reports##2##3##(1990-3#1)(1991-6#1)
with other seasonal allergens##2##4##(2011-2#2)
with other service##2##3##(2008-11#1)(2012-3#1)
with other species of##2##4##(2008-10#1)(2008-12#1)
with other studies##5##3##(1994-1#1)(1997-9#1)(2008-12#2)(2008-7#1)
with other tospoviruses##2##3##(2008-10#2)
with other tumors##2##3##(1997-8#1)(2011-2#1)
with other##250##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#2)(1990-8#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-3#3)(1997-7#2)(1997-8#2)(1997-9#1)(2008-1#1)(2008-10#69)(2008-11#19)(2008-12#8)(2008-3#2)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-5#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#14)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#5)
with others##9##2##(1991-5#1)(1992-1#1)(1995-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#2)
with our earlier##2##3##(1991-6#1)(2013-8#1)
with our optimized##2##3##(2008-11#1)(2008-5#1)
with our previous##7##3##(1990-5#1)(1990-8#1)(1995-12#2)(1996-12#1)(1996-2#1)(2008-10#1)
with our##32##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-3#1)(1994-1#2)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-6#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
with outcome##2##2##(1992-1#1)(2013-1#1)
with outcomes##3##2##(2008-12#2)(2008-9#1)
with outpatient##2##2##(1995-12#1)(1996-3#1)
with outside##3##2##(1991-12#1)(1992-2#1)(1997-2#1)
with ovarian##9##2##(1990-2#1)(1991-6#1)(1994-2#1)(1996-1#1)(1996-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
with over##7##2##(1991-1#1)(1991-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
with overall##4##2##(1990-8#1)(2008-10#2)(2008-3#1)
with overexpression of##2##3##(1992-12#1)(2008-11#1)
with overlapping##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
with oxidant##3##2##(2008-10#3)
with oxidative##4##2##(2009-8#1)(2009-9#2)(2010-9#1)
with oxidized LDL##2##3##(1996-2#2)
with oxine##2##2##(2008-10#2)
with oxygen saturation##2##3##(2010-7#2)
with oxygen##10##2##(1993-3#1)(1996-12#1)(2008-10#5)(2010-7#2)(2011-2#1)
with oxytetracycline##2##2##(1991-3#2)
with ozone##4##2##(1996-1#1)(2007-8#1)(2008-10#2)
with p21##2##2##(1995-6#2)
with p53##5##2##(1993-8#1)(2008-9#1)(2011-2#3)
with pH 7##2##3##(2008-10#2)
with pH and##3##3##(1993-6#1)(2008-10#1)(2011-2#1)
with pH##20##2##(1992-12#1)(1993-6#1)(2008-10#16)(2008-5#1)(2011-2#1)
with pT3##2##2##(2011-2#2)
with pain##12##2##(1994-3#1)(1997-8#1)(2008-7#2)(2008-9#1)(2009-12#3)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#1)
with painful##4##2##(1991-3#1)(1991-4#1)(2008-7#1)(2010-5#1)
with painless##2##2##(2010-11#1)(2011-2#1)
with paired##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2010-7#1)
with pairwise##2##2##(1994-5#1)(2008-10#1)
with palladium##3##2##(2008-10#3)
with palliative##3##2##(1990-9#1)(2008-7#2)
with panic##2##2##(1990-11#1)(2010-2#1)
with papillary##3##2##(1990-9#1)(2008-12#1)(2012-3#1)
with paracetamol##7##2##(1990-2#1)(1995-11#5)(2008-10#1)
with parallel##2##2##(1990-5#1)(2008-10#1)
with parameters##2##2##(2008-10#2)
with parasite virulence##2##3##(2008-8#2)
with parental##2##2##(1996-2#1)(2008-10#1)
with parenting##2##2##(1995-1#1)(2009-11#1)
with parents of children##2##4##(1992-2#1)(2012-2#1)
with parents of high-risk infants##2##5##(2008-11#2)
with parents of##4##3##(1992-2#1)(2008-11#2)(2012-2#1)
with parents##11##2##(1990-6#1)(1992-2#1)(2008-11#3)(2009-7#3)(2012-2#1)(2013-1#1)(2013-8#1)
with partial least squares regression##2##5##(2008-10#2)
with partial least squares##4##4##(2008-10#4)
with partial least-squares##2##3##(2008-10#2)
with partial resistance to##5##4##(2008-10#5)
with partial resistance##9##3##(2008-10#9)
with partial##25##2##(1992-6#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#15)(2008-11#2)(2008-7#2)(2012-3#2)
with partially##6##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
with participating##2##2##(1991-2#1)(2013-1#1)
with particles of##2##3##(1996-3#1)(2008-10#1)
with particles##4##2##(1995-11#1)(1996-3#1)(2008-10#1)(2008-3#1)
with particular attention to##4##4##(1993-12#1)(1994-1#1)(2008-8#1)(2011-2#1)
with particular emphasis on the##5##5##(2008-10#1)(2008-11#3)(2012-12#1)
with particular emphasis on##7##4##(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#3)(2012-12#1)
with particular emphasis##8##3##(1995-12#1)(1996-1#1)(2008-10#2)(2008-11#3)(2012-12#1)
with particular reference to the##3##5##(1996-6#1)(2008-5#1)(2008-7#1)
with particular reference to their##2##5##(2008-7#1)(2008-8#1)
with particular reference to##7##4##(1992-2#1)(1996-6#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)
with particular regard to##2##4##(1991-12#1)(2008-11#1)
with particular##25##2##(1991-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-6#1)(2008-10#2)(2008-11#5)(2008-5#2)(2008-7#2)(2008-8#3)(2011-2#2)(2012-12#1)
with partners##5##2##(2008-7#1)(2008-8#1)(2009-5#2)(2012-2#1)
with passive dosimeters##2##3##(1993-1#2)
with past##3##2##(1996-3#1)(2008-8#1)(2010-9#1)
with paternally derived deletions##2##4##(1997-3#2)
with pathogenic##6##2##(2008-10#3)(2008-9#1)(2010-5#1)(2013-7#1)
with pathogens##2##2##(2008-10#2)
with pathologic##2##2##(2008-9#1)(2012-2#1)
with pathological##3##2##(1992-5#1)(2008-11#1)(2012-3#1)
with patient##9##2##(1992-12#1)(1992-2#1)(1995-2#1)(2008-12#1)(2008-4#2)(2008-6#1)(2010-7#1)(2013-1#1)
with patients and##2##3##(1992-5#1)(2008-11#1)
with patients who##2##3##(2008-4#1)(2011-2#1)
with patients with##5##3##(2008-12#1)(2010-12#1)(2011-2#2)(2012-3#1)
with patients##31##2##(1992-5#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#2)(1997-1#2)(1997-3#1)(1997-7#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
with patients'##4##2##(1995-3#1)(2010-7#1)(2012-2#1)(2012-4#1)
with payments##2##2##(1992-1#1)(1992-2#1)
with peak##4##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
with pelvic##5##2##(1992-1#2)(1994-1#1)(1994-2#2)
with penetrating##2##2##(2010-10#1)(2010-7#1)
with penicillamine##3##2##(1991-8#1)(2008-10#2)
with pentane##2##2##(2008-10#2)
with people who##2##3##(1992-3#1)(2013-8#1)
with people with##3##3##(1995-12#1)(2008-11#1)(2009-6#1)
with people##7##2##(1992-3#1)(1995-12#1)(2008-11#1)(2009-6#1)(2010-7#1)(2013-8#2)
with pepsin##2##2##(1996-12#1)(2008-1#1)
with peptide##5##2##(1992-6#1)(1994-5#2)(2008-10#1)(2009-10#1)
with perchlorate##3##2##(2008-10#3)
with perchloric acid##2##3##(2008-10#2)
with perchloric##3##2##(2008-10#3)
with percutaneous##3##2##(2008-12#1)(2011-2#2)
with perfect##2##2##(2008-10#1)(2010-8#1)
with periodic##3##2##(2007-12#1)(2008-10#2)
with periodontitis##2##2##(2013-1#2)
with periods##2##2##(1990-6#1)(2011-2#1)
with peripheral blood##2##3##(2008-11#1)(2008-8#1)
with peripheral##6##2##(1995-2#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
with peritoneal dialysis##2##3##(2011-2#2)
with permanent##2##2##(2008-10#1)(2011-1#1)
with permanganate##2##2##(2008-10#2)
with peroxidase##5##2##(1995-3#1)(2008-10#4)
with peroxyl radicals##2##3##(2008-10#2)
with persistent##12##2##(1991-8#1)(1992-5#1)(1994-3#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
with personal##3##2##(1994-6#1)(1997-2#1)(2008-11#1)
with petroleum##2##2##(2008-10#1)(2008-12#1)
with phage##3##2##(2008-8#2)(2012-2#1)
with phenol##2##2##(2008-10#2)
with phenolic##2##2##(2008-10#1)(2011-2#1)
with phenotype##2##2##(1997-3#1)(2011-2#1)
with phenotypes##2##2##(1997-6#1)(2008-10#1)
with phenyl##3##2##(2008-10#3)
with phenylephrine##4##2##(1991-3#2)(2008-11#1)(2011-2#1)
with pheochromocytoma##2##2##(2009-1#1)(2012-12#1)
with phorbol 12-myristate 13-acetate (PMA)##2##5##(1994-3#1)(2008-11#1)
with phorbol 12-myristate 13-acetate##3##4##(1994-3#1)(2008-11#2)
with phorbol 12-myristate##4##3##(1994-3#1)(1994-8#1)(2008-11#2)
with phorbol myristate acetate (PMA)##2##5##(1993-6#1)(1994-6#1)
with phorbol myristate##3##3##(1991-5#1)(1993-6#1)(1994-6#1)
with phorbol##10##2##(1991-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-11#2)(2010-12#1)
with phosphatidylcholine##2##2##(1995-8#1)(1996-2#1)
with phosphatidylethanolamine##2##2##(1994-5#1)(1995-8#1)
with phospholipase A2##2##3##(1991-12#1)(1994-5#1)
with phospholipase##4##2##(1991-12#1)(1994-3#1)(1994-5#1)(2010-6#1)
with phospholipid monolayers and##2##4##(1994-5#2)
with phospholipid monolayers##3##3##(1994-5#3)
with phospholipid##5##2##(1994-5#4)(2008-11#1)
with phosphorus##2##2##(1990-5#1)(1991-11#1)
with photodiode array detection##2##4##(1997-2#1)(2008-10#1)
with photodiode array##5##3##(1997-2#2)(2008-10#3)
with photodiode-array##2##2##(1997-2#1)(2008-10#1)
with photodynamic therapy##2##3##(1994-1#1)(2012-3#1)
with photosystem II##2##3##(2008-10#1)(2008-8#1)
with physical activity##2##3##(2008-3#1)(2009-5#1)
with physical or##2##3##(2008-11#1)(2008-4#1)
with physical##12##2##(1995-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)
with physicians and patients##3##4##(1993-3#1)(1995-2#1)(1996-1#1)
with physicians and##4##3##(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#1)
with physicians##10##2##(1993-3#2)(1993-5#1)(1994-3#1)(1995-2#1)(1996-1#2)(1996-3#1)(2008-11#1)(2013-1#1)
with physiological##2##2##(1991-11#1)(2006-6#1)
with physiologically##2##2##(2008-10#1)(2009-12#1)
with picrate anion##2##3##(2008-10#2)
with piezoelectric quartz crystal##2##4##(2008-10#2)
with piezoelectric##6##2##(1990-8#1)(2008-10#5)
with pituitary resistance to thyroid hormone##2##6##(1995-8#2)
with pituitary##4##2##(1991-6#1)(1995-8#2)(2013-1#1)
with placebo##4##2##(1996-1#1)(2008-1#1)(2010-10#1)(2013-1#1)
with placement of a##2##4##(1993-11#1)(2010-5#1)
with plant growth##2##3##(2008-10#2)
with plant material##2##3##(2008-9#2)
with plant##14##2##(2007-12#1)(2008-10#8)(2008-9#5)
with planting density in##2##4##(2008-10#2)
with planting##3##2##(2008-10#2)(2008-9#1)
with plants##9##2##(2008-10#7)(2008-8#1)(2008-9#1)
with plasma##11##2##(1990-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1996-8#2)(1997-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
with plasmid DNA##3##3##(2008-10#2)(2008-11#1)
with plasmid##6##2##(1990-5#1)(1993-3#1)(2008-10#2)(2008-11#2)
with plasmids##2##2##(2008-10#2)
with plastic##5##2##(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#1)
with platelet##4##2##(1991-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
with pneumococcal meningitis##4##3##(1996-3#1)(2011-2#3)
with pneumococcal##5##2##(1996-3#1)(2011-2#4)
with polarization##3##2##(2007-12#2)(2008-3#1)
with polarization-dependent##2##2##(2008-3#2)
with polarized##2##2##(2008-10#2)
with polarizing activity##2##3##(1993-12#2)
with polarizing##3##2##(1993-12#3)
with poly (A)##2##3##(2008-11#1)(2010-4#1)
with poly##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2010-4#1)
with polyclonal##3##2##(1993-12#1)(2008-10#2)
with polycystic ovarian##2##3##(2008-11#1)(2010-11#1)
with polycystic ovary syndrome##2##4##(2012-12#1)(2012-3#1)
with polycystic##4##2##(2008-11#1)(2010-11#1)(2012-12#1)(2012-3#1)
with polyethylene##2##2##(1990-12#1)(2008-10#1)
with polymer##3##2##(2009-7#1)(2011-3#1)(2012-12#1)
with polymerase##2##2##(1995-2#1)(2008-10#1)
with polystyrene##2##2##(2008-10#2)
with polyurethane foam##3##3##(2008-10#3)
with polyvinyl alcohol (PVA)##2##4##(2008-10#1)(2012-3#1)
with polyvinyl alcohol##3##3##(2008-10#1)(2012-3#2)
with polyvinyl##4##2##(2008-10#1)(2012-2#1)(2012-3#2)
with pooled##2##2##(2008-10#1)(2012-2#1)
with poor outcomes##3##3##(2009-1#1)(2009-8#1)(2013-8#1)
with poor prognosis##5##3##(1997-5#1)(2011-2#2)(2011-3#1)(2013-1#1)
with poor##23##2##(1991-2#1)(1994-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#6)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
with poorer health##2##3##(1996-2#1)(2008-1#1)
with poorer prognostic features##2##4##(2011-1#2)
with poorer##10##2##(1996-2#1)(2008-1#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#2)(2013-1#2)
with poorly##2##2##(2008-10#1)(2012-3#1)
with population##6##2##(1996-2#1)(2008-12#2)(2008-9#1)(2010-10#1)(2011-2#1)
with populations that##2##3##(2008-10#2)
with populations##5##2##(2008-10#4)(2008-9#1)
with porous microcarrier##2##3##(2008-11#2)
with porous##3##2##(2008-11#3)
with positional##2##2##(2008-10#2)
with positive chemical ionization##2##4##(2008-10#2)
with positive discography##4##3##(2012-12#4)
with positive results##3##3##(1993-3#2)(2008-11#1)
with positive##26##2##(1991-6#1)(1992-12#1)(1993-3#2)(1994-9#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#6)(2012-12#5)
with positron emission tomography##4##4##(1995-2#1)(1996-2#2)(2013-8#1)
with possible##6##2##(2008-10#2)(2009-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
with post-column##3##2##(2008-10#3)
with posterior urethral##2##3##(2008-10#2)
with posterior##7##2##(1991-2#1)(2008-10#3)(2008-7#1)(2012-2#1)(2012-3#1)
with postmeningitic deafness##2##3##(2008-9#2)
with postoperative##8##2##(1990-8#1)(1991-8#1)(1994-3#1)(1995-2#1)(2008-7#1)(2010-7#2)(2011-2#1)
with postpartum##2##2##(2012-2#1)(2013-1#1)
with potassium dichromate##2##3##(2008-10#2)
with potassium iodide##3##3##(2008-10#3)
with potassium permanganate in##3##4##(2008-10#3)
with potassium permanganate##4##3##(2008-10#4)
with potassium##30##2##(1994-11#1)(1996-5#2)(1996-6#1)(2008-10#26)
with potassium-dihydro-bispyrazolyl-borate##2##2##(2008-10#2)
with potato##4##2##(2008-10#4)
with potent##6##2##(1994-5#1)(2008-8#1)(2011-3#2)(2012-3#2)
with potential for the##2##4##(2008-10#1)(2008-5#1)
with potential for##5##3##(1997-7#1)(2008-10#2)(2008-5#1)(2009-12#1)
with potential to##3##3##(2008-10#1)(2008-7#1)(2009-12#1)
with potential##28##2##(1991-7#1)(1992-3#1)(1992-6#1)(1993-1#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-8#2)(2010-1#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
with potentially##4##2##(2008-1#1)(2008-11#1)(2009-4#1)(2012-3#1)
with practical##5##2##(1995-3#1)(2008-10#2)(2009-12#1)(2010-7#1)
with practice##3##2##(1991-2#1)(2008-11#1)(2010-10#1)
with practitioners to##3##3##(1996-3#1)(2008-12#2)
with practitioners##5##2##(1995-12#1)(1996-3#1)(2008-1#1)(2008-12#2)
with praseodymium##2##2##(2007-12#1)(2008-10#1)
with precisely##2##2##(2008-5#1)(2008-8#1)
with precision##5##2##(2008-10#5)
with preconcentration##3##2##(2008-10#3)
with predictable##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
with predictions of the##2##4##(2008-10#1)(2008-8#1)
with predictions of##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
with predictions##4##2##(2008-10#1)(2008-3#1)(2008-8#2)
with predominance of##3##3##(2008-12#1)(2011-2#1)(2012-3#1)
with preeclampsia##3##2##(2008-11#1)(2009-8#2)
with preferential##2##2##(1993-8#1)(2012-2#1)
with pregnancy##2##2##(2008-10#1)(2012-3#1)
with pregnant women##2##3##(1995-6#1)(2009-4#1)
with premature##4##2##(2008-4#3)(2011-2#1)
with preoperative embolization##2##3##(2008-7#2)
with preoperative##8##2##(1992-3#1)(2008-7#3)(2008-9#1)(2012-3#2)(2013-1#1)
with prescription drug##2##3##(1995-1#1)(2013-8#1)
with preservation of##2##3##(2008-11#1)(2009-1#1)
with pressure##2##2##(2008-10#1)(2008-3#1)
with presumed##3##2##(1997-3#1)(2008-7#2)
with pretreatment of##2##3##(2008-10#2)
with pretreatment##3##2##(2008-10#3)
with prevalence of##2##3##(2012-3#2)
with prevention of##2##3##(1995-5#1)(2011-2#1)
with preventive##3##2##(2008-11#1)(2010-9#1)(2012-2#1)
with previous estimates##2##3##(2008-10#1)(2008-9#1)
with previous findings##5##3##(1994-12#1)(1994-5#1)(2008-7#2)(2011-2#1)
with previous measurements##2##3##(2008-11#1)(2008-8#1)
with previous observations##3##3##(1991-9#1)(1997-2#1)(2008-10#1)
with previous reports##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
with previous results##2##3##(2008-11#2)
with previous studies##8##3##(1995-11#1)(2008-10#2)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#2)
with previous treatment##2##3##(2013-8#2)
with previous##43##2##(1990-11#1)(1991-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-3#4)(2013-8#2)
with previously reported##7##3##(1993-6#1)(2008-10#5)(2012-2#1)
with previously##19##2##(1991-8#1)(1993-6#1)(2007-11#1)(2008-10#11)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
with pricing##2##2##(1997-6#2)
with primary and secondary##2##4##(2008-10#1)(2013-1#1)
with primary and##3##3##(2008-10#1)(2013-1#2)
with primary##35##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#3)(1991-8#1)(1992-11#1)(1992-9#1)(1993-2#1)(1995-10#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
with primer##2##2##(2008-10#2)
with primers from##3##3##(1994-11#1)(2008-10#2)
with primers that amplify##2##4##(2008-10#2)
with primers##11##2##(1994-11#1)(2008-10#9)(2008-9#1)
with prior##6##2##(1995-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-8#1)
with private insurance##2##3##(1996-3#1)(1997-2#1)
with private##6##2##(1992-3#1)(1994-1#1)(1996-12#1)(1996-3#2)(1997-2#1)
with probable##4##2##(1991-12#1)(2008-7#2)(2013-1#1)
with probe RG57##2##3##(2008-10#2)
with probe##6##2##(2008-10#5)(2012-3#1)
with probes that##2##3##(1996-12#1)(2008-10#1)
with probes##4##2##(1996-12#1)(1997-2#1)(2008-10#2)
with problem based learning##2##4##(2008-11#1)(2008-12#1)
with problem##3##2##(2008-11#1)(2008-12#2)
with procedures##2##2##(2008-10#1)(2008-4#1)
with product##2##2##(2008-10#1)(2012-2#1)
with productivity##7##2##(2008-8#5)(2008-9#2)
with professional##3##2##(1990-12#1)(1993-3#1)(1997-2#1)
with profound hearing loss##3##4##(2008-9#3)
with profound##6##2##(2008-9#4)(2011-2#2)
with progeny##2##2##(2008-10#2)
with prognosis##2##2##(2012-3#2)
with progression of##4##3##(1992-2#1)(2007-8#1)(2010-11#1)(2011-2#1)
with progressive neurological##2##3##(2008-7#1)(2011-2#1)
with progressive##10##2##(1991-3#1)(1992-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
with prolonged##7##2##(1991-2#1)(1992-12#1)(2008-11#2)(2009-8#1)(2011-2#2)
with promising results##2##3##(2012-12#1)(2012-3#1)
with pronounced##2##2##(2008-10#2)
with proper##6##2##(1993-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
with properties##2##2##(1993-2#1)(2010-9#1)
with propidium iodide##2##3##(1994-2#1)(2008-9#1)
with propofol##6##2##(2010-7#2)(2011-2#3)(2012-3#1)
with proposed##2##2##(2008-10#1)(2010-8#1)
with prostaglandin##2##2##(1993-8#1)(1994-6#1)
with prostate cancer##8##3##(2008-7#1)(2008-8#1)(2009-5#4)(2012-3#2)
with prostate##9##2##(2008-7#1)(2008-8#1)(2009-5#4)(2012-3#2)(2013-1#1)
with protective##4##2##(1994-11#1)(1994-2#1)(1996-12#1)(2008-6#1)
with protein kinase C zeta##2##5##(1994-11#2)
with protein kinase##4##3##(1990-10#1)(1994-11#2)(2010-12#1)
with protein##19##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-5#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#4)(2008-11#3)(2009-8#1)(2010-12#1)(2013-1#1)
with proteinase K##2##3##(2008-10#2)
with proteinase##3##2##(2008-10#3)
with proteinaseK##2##2##(2008-8#2)
with proteins and##2##3##(2008-10#1)(2009-8#1)
with proteins##8##2##(1990-5#1)(1991-9#1)(1997-2#1)(2008-10#4)(2009-8#1)
with proven##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
with proximal and distal##2##4##(2007-12#1)(2008-7#1)
with proximal##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
with psoriasis and##2##3##(2013-1#2)
with psoriasis##3##2##(2008-6#1)(2013-1#2)
with psychiatric disabilities##8##3##(1993-3#1)(1997-1#3)(2009-6#4)
with psychiatric##10##2##(1993-3#1)(1997-1#3)(2009-6#4)(2010-10#1)(2013-1#1)
with psychotic##2##2##(2008-11#1)(2011-2#1)
with published data##3##3##(1992-7#1)(2008-5#1)(2008-9#1)
with published##6##2##(1992-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
with pulmonary edema##2##3##(2008-11#1)(2010-5#1)
with pulmonary embolism##2##3##(2008-7#2)
with pulmonary hypertension##4##3##(2008-12#1)(2010-10#1)(2010-12#1)(2012-3#1)
with pulmonary##18##2##(1994-6#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#4)(2010-10#2)(2010-12#1)(2010-5#1)(2012-3#3)
with pulse##6##2##(1993-1#1)(2007-12#1)(2008-3#2)(2008-7#1)(2008-8#1)
with pulsed amperometric detection for##2##5##(2008-10#2)
with pulsed amperometric detection##7##4##(1991-7#2)(1992-1#1)(2008-10#4)
with pure red cell##2##4##(2008-12#2)
with pure##4##2##(2008-10#2)(2008-12#2)
with purified rat##2##3##(1990-5#1)(1994-8#1)
with purified##10##2##(1990-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(2008-10#5)(2008-8#1)
with puromycin##2##2##(1997-1#1)(2009-6#1)
with purulent##2##2##(2008-10#1)(2011-2#1)
with putative##2##2##(1995-9#1)(2008-10#1)
with pycnidia##2##2##(2008-10#2)
with pyridine##3##2##(2008-10#3)
with pyridinium poly(hydrogen fluoride)##2##4##(1992-12#2)
with pyridylazo##2##2##(2008-10#2)
with pyruvate##2##2##(1994-8#1)(1997-1#1)
with quadrat size##2##3##(2008-10#2)
with quadrupole##2##2##(2008-10#2)
with quality##3##2##(1994-12#1)(1996-2#2)
with quantitative##5##2##(2008-10#2)(2008-9#1)(2009-5#1)(2012-3#1)
with quantum##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
with quaternary ammonium cations (Q(+))##2##5##(2008-10#2)
with quaternary ammonium counter ions##2##5##(2008-10#2)
with quaternary ammonium##5##3##(2008-10#5)
with quercetin##2##2##(2008-10#2)
with quinine modified resin##2##4##(2008-10#2)
with quinine##3##2##(1993-8#1)(2008-10#2)
with quinolinic acid##3##3##(1994-8#1)(1995-12#1)(2008-5#1)
with quite##2##2##(2008-1#1)(2008-10#1)
with r(2) values of &gt##2##5##(2008-10#2)
with r(2)##4##2##(2008-10#4)
with r(2)=0##8##2##(2008-10#8)
with r=0##2##2##(2008-10#2)
with rabbit##5##2##(1990-5#1)(1993-2#1)(2008-11#2)(2008-5#1)
with race 7##2##3##(2008-10#2)
with race##9##2##(2008-10#9)
with races 1 and##2##4##(2008-10#2)
with races 1##3##3##(2008-10#3)
with races##4##2##(2008-10#4)
with racial##2##2##(1994-3#2)
with radial##6##2##(1990-9#1)(1997-3#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
with radiation##4##2##(1993-9#1)(2008-7#1)(2013-1#1)(2013-8#1)
with radical##3##2##(1990-12#1)(2011-2#2)
with radiculopathy##3##2##(2008-12#1)(2012-12#1)(2012-3#1)
with radioactive sugars##2##3##(2008-1#2)
with radioactive##4##2##(1994-8#1)(2008-1#2)(2008-10#1)
with radiosurgery##3##2##(1997-4#1)(2008-7#2)
with radiotherapy and/or chemotherapy##2##4##(1990-5#1)(2012-3#1)
with radiotherapy##9##2##(1990-5#1)(1990-6#1)(1991-9#1)(1997-3#1)(2008-11#2)(2008-7#2)(2012-3#1)
with rainfall##3##2##(2008-10#3)
with raised##3##2##(1991-12#1)(2010-12#2)
with random amplified polymorphic DNA (RAPD)##2##6##(2008-10#2)
with random amplified polymorphic DNA##3##5##(2008-10#3)
with random##16##2##(1992-9#1)(1995-9#1)(1996-3#1)(2008-10#7)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
with randomly##2##2##(2008-10#2)
with ranges##2##2##(2008-10#2)
with rapid progression##2##3##(2009-10#1)(2011-2#1)
with rapid##7##2##(1997-3#1)(2007-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#1)
with rare##6##2##(1992-6#1)(2008-10#2)(2008-12#1)(2010-5#1)(2011-2#1)
with rat and##2##3##(1990-7#1)(1996-12#1)
with rat hepatic##2##3##(1990-11#1)(1995-2#1)
with rat liver##2##3##(1991-5#1)(1994-8#1)
with rat##8##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-11#1)
with rate##2##2##(2008-10#1)(2010-11#1)
with rates##4##2##(2008-10#1)(2009-6#1)(2011-2#2)
with rather high##2##3##(1991-11#1)(2008-10#1)
with rats##5##2##(1990-5#1)(2008-11#1)(2008-5#3)
with raw##2##2##(2008-10#1)(2011-2#1)
with reactions##2##2##(2008-10#2)
with reagent##3##2##(2008-10#3)
with real##2##2##(1993-2#1)(2008-10#1)
with real-time polymerase chain reaction##2##5##(2008-10#2)
with real-time##6##2##(2007-9#1)(2008-10#3)(2008-8#1)(2012-2#1)
with reasonable##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-7#1)
with recent onset of##2##4##(2012-12#1)(2013-1#1)
with recent published##2##3##(1995-11#1)(2006-6#1)
with recent reports##2##3##(1990-5#1)(1991-2#1)
with recent##15##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-6#1)(1995-11#1)(2006-6#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
with recent-onset##2##2##(2008-11#2)
with receptor##2##2##(1990-4#1)(1996-12#1)
with receptors##2##2##(1991-5#1)(2008-4#1)
with recombinant baculoviruses##2##3##(1997-8#1)(2008-7#1)
with recombinant human##2##3##(1995-12#1)(2011-2#1)
with recombinant##21##2##(1991-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
with recommendations for##2##3##(2008-11#1)(2010-5#1)
with recommendations##5##2##(1995-12#1)(2008-11#1)(2009-4#1)(2010-5#1)(2013-1#1)
with reconstruction##2##2##(2008-7#1)(2011-2#1)
with recoveries between##3##3##(2008-10#3)
with recoveries of##4##3##(2008-10#4)
with recoveries ranging from##2##4##(2008-10#2)
with recoveries ranging##3##3##(2008-10#3)
with recoveries##14##2##(2008-10#14)
with recovery of##2##3##(1990-3#1)(2008-10#1)
with recovery##10##2##(1990-3#1)(2008-10#7)(2008-8#1)(2009-8#1)
with recurrence##2##2##(2008-11#1)(2010-7#1)
with recurrent meningitis##2##3##(2013-7#2)
with recurrent urinary tract##3##4##(1990-11#1)(2008-10#1)(2013-1#1)
with recurrent##22##2##(1990-11#1)(1991-6#1)(1994-1#1)(1994-12#2)(1994-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-7#2)
with red##2##2##(2008-10#1)(2012-2#1)
with reduced incidence of##2##4##(2008-10#1)(2010-1#1)
with reduced##38##2##(1990-11#1)(1990-9#1)(1993-8#3)(1994-5#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2010-1#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-5#1)(2013-1#1)(2013-7#1)
with reducing##2##2##(1992-12#1)(2008-10#1)
with reduction of haemoglobin##2##4##(2013-1#2)
with reduction of##5##3##(2008-10#1)(2009-8#1)(2013-1#3)
with reduction##8##2##(2008-10#2)(2009-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
with reductions##5##2##(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
with reference to the literature##2##5##(2008-10#1)(2008-11#1)
with reference to the##6##4##(1990-5#1)(1991-6#1)(2008-10#2)(2008-11#1)(2008-9#1)
with reference to##13##3##(1990-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#2)(2011-1#1)
with reference##19##2##(1990-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-9#2)(2011-1#1)
with refractory angina##2##3##(2008-12#1)(2010-6#1)
with refractory##5##2##(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#2)
with regard to future##2##4##(2008-12#1)(2013-8#1)
with regard to the##17##4##(1993-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
with regard to their##7##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
with regard to what##2##4##(1994-6#1)(2008-12#1)
with regard to##87##3##(1990-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#2)(1994-6#1)(1995-3#2)(1996-6#1)(1997-2#1)(1997-8#2)(2008-10#18)(2008-11#15)(2008-12#8)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#1)
with regards to the##3##4##(2009-10#1)(2011-2#2)
with regards to##8##3##(2008-10#2)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#3)
with regional##2##2##(1992-6#1)(1994-3#1)
with registered nurses##2##3##(2008-12#1)(2008-7#1)
with regression coefficients##3##3##(2008-10#3)
with regular##6##2##(1991-12#1)(1996-11#1)(1996-6#1)(2008-12#1)(2010-7#1)(2011-2#1)
with regulatory##2##2##(1992-3#1)(1993-9#1)
with relapse##2##2##(1993-11#1)(2009-11#1)
with relapsed##2##2##(2010-11#2)
with related##3##2##(1995-8#1)(1996-2#1)(2008-5#1)
with relation to##4##3##(2008-10#2)(2009-3#1)(2013-1#1)
with relative S##2##3##(2008-10#2)
with relative error##3##3##(2008-10#3)
with relative errors##2##3##(2008-10#2)
with relative standard deviation (RSD)##3##5##(2008-10#3)
with relative standard deviation of 2##2##6##(2008-10#2)
with relative standard deviation of##3##5##(2008-10#3)
with relative standard deviation##10##4##(2008-10#10)
with relative standard deviations of 2##3##6##(2008-10#3)
with relative standard deviations of##6##5##(2008-10#6)
with relative standard deviations##10##4##(2008-10#10)
with relative standard##20##3##(2008-10#20)
with relative##33##2##(1993-6#1)(1995-6#1)(2008-10#27)(2008-3#1)(2009-3#1)(2011-2#2)
with relatively few##2##3##(1991-12#1)(2008-8#1)
with relatively high sensitivity##3##4##(2008-10#3)
with relatively high##5##3##(2008-10#5)
with relatively low##4##3##(2008-10#3)(2008-12#1)
with relatively short##2##3##(2008-10#1)(2008-5#1)
with relatively small##2##3##(2008-10#2)
with relatively##19##2##(1991-12#1)(1994-12#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-2#1)
with relaxation##3##2##(1990-5#1)(1994-8#1)(2010-7#1)
with release of##2##3##(1994-8#1)(2008-7#1)
with relevance##2##2##(2008-11#1)(2012-2#1)
with relevant##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
with remarkable##3##2##(1991-2#1)(2008-11#1)(2009-12#1)
with removal of the##2##4##(1991-8#1)(2008-7#1)
with removal of##3##3##(1990-2#1)(1991-8#1)(2008-7#1)
with renal dysfunction##2##3##(2012-3#2)
with renal##15##2##(1991-2#1)(1991-8#1)(1996-6#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#3)(2013-1#5)
with repeat##5##2##(2008-11#4)(2009-10#1)
with repeated##10##2##(1993-6#1)(1996-6#1)(1997-6#1)(2008-5#1)(2008-9#1)(2010-7#1)(2013-8#4)
with repetitive##6##2##(1991-5#1)(2008-10#2)(2008-11#2)(2012-3#1)
with replicates##2##2##(2008-10#1)(2008-11#1)
with replication fork##2##3##(2012-3#2)
with reported data##2##3##(1992-5#1)(2013-8#1)
with reported values##2##3##(2008-10#1)(2009-11#1)
with reported##5##2##(1992-5#1)(2008-10#2)(2009-11#1)(2013-8#1)
with reporter gene##2##3##(1997-1#1)(2008-9#1)
with reporter##6##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2013-8#1)
with reports of##2##3##(1997-3#1)(2010-4#1)
with reports##3##2##(1995-12#1)(1997-3#1)(2010-4#1)
with representative##2##2##(2008-10#2)
with representatives of##2##3##(1997-2#1)(2008-10#1)
with representatives##3##2##(1997-2#1)(2008-10#2)
with reproductive##4##2##(1990-6#1)(2011-2#2)(2012-3#1)
with research##3##2##(1990-11#1)(2008-7#2)
with resection##3##2##(2008-10#1)(2012-3#2)
with residues of##3##3##(2008-10#3)
with resistance and tolerance##2##4##(2011-10#2)
with resistance and##3##3##(2008-10#1)(2011-10#2)
with resistance to two##2##4##(2008-10#2)
with resistance to##20##3##(2008-10#18)(2008-5#1)(2008-8#1)
with resistance##39##2##(2008-10#34)(2008-5#1)(2008-8#1)(2008-9#1)(2011-10#2)
with resistant genotypes##2##3##(2008-10#2)
with resistant##5##2##(2008-10#4)(2012-3#1)
with resolution##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
with respect to T##2##4##(2008-10#2)
with respect to W##2##4##(2008-10#2)
with respect to a large number of inorganic##2##8##(2008-10#2)
with respect to a large##3##5##(1990-12#1)(2008-10#2)
with respect to a##4##4##(1990-12#1)(2008-10#2)(2008-11#1)
with respect to age##3##4##(1991-2#1)(2008-7#1)(2013-8#1)
with respect to both##2##4##(1994-9#1)(2008-5#1)
with respect to clinical##2##4##(2011-1#2)
with respect to common##3##4##(2008-10#3)
with respect to control animals##2##5##(2006-6#1)(2013-1#1)
with respect to data##2##4##(2008-10#1)(2009-10#1)
with respect to different##3##4##(2008-6#2)(2008-7#1)
with respect to each##2##4##(2008-10#1)(2012-12#1)
with respect to escalation##2##4##(2009-10#2)
with respect to female breast cancer##2##6##(1990-12#2)
with respect to gravity##3##4##(2008-11#3)
with respect to growth##2##4##(2008-10#1)(2011-2#1)
with respect to human health##2##5##(2008-10#1)(2012-2#1)
with respect to its##9##4##(1993-8#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
with respect to pain and functional outcomes##2##7##(2012-12#2)
with respect to pain##3##4##(2008-9#1)(2012-12#2)
with respect to simplicity##2##4##(2008-10#1)(2008-11#1)
with respect to the other##3##5##(2008-10#2)(2008-5#1)
with respect to the presence or absence of overweight##2##9##(2008-10#2)
with respect to the##87##4##(1990-11#2)(1990-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-6#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#26)(2008-11#4)(2008-2#4)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with respect to their##19##4##(1992-10#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2013-1#1)
with respect to those obtained##3##5##(2008-10#3)
with respect to those##4##4##(1991-6#1)(2008-10#3)
with respect to##285##3##(1990-11#2)(1990-12#3)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#5)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-12#5)(2008-1#1)(2008-10#96)(2008-11#17)(2008-12#4)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#7)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#6)(2013-8#3)
with respect##289##2##(1990-11#2)(1990-12#3)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#5)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-12#5)(2008-1#1)(2008-10#98)(2008-11#18)(2008-12#4)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#7)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#6)(2013-8#3)
with respective##3##2##(1991-12#1)(2008-10#2)
with respiratory distress##2##3##(1990-11#1)(2010-1#1)
with respiratory##9##2##(1990-11#1)(1994-6#1)(1997-1#1)(2008-1#1)(2008-11#1)(2010-1#1)(2010-7#1)(2012-12#1)(2013-1#1)
with response##2##2##(2008-10#2)
with responses to##2##3##(1993-6#1)(1996-2#1)
with responses##3##2##(1993-6#1)(1996-2#1)(2009-8#1)
with restoration of##2##3##(2008-10#1)(2008-9#1)
with restriction enzymes##2##3##(2008-10#2)
with restriction fragment length polymorphism (RFLP) markers##2##7##(2008-10#2)
with restriction fragment length polymorphism##3##5##(2008-10#3)
with restriction##8##2##(1993-6#1)(1995-6#1)(2008-10#6)
with resultant##3##2##(2008-8#1)(2009-1#1)(2011-2#1)
with results comparable to those##2##5##(1991-2#1)(2008-10#1)
with results determined by##2##4##(2008-10#2)
with results for##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
with results from##6##3##(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
with results obtained by##3##4##(1991-9#1)(2008-10#2)
with results obtained using##2##4##(2008-10#2)
with results obtained##8##3##(1991-9#1)(2006-6#1)(2008-10#5)(2008-3#1)
with results that##2##3##(1994-5#1)(2008-10#1)
with results##32##2##(1991-2#1)(1991-9#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2011-2#1)
with resveratrol##3##2##(2008-10#2)(2012-4#1)
with retention of##3##3##(1992-7#1)(2008-10#1)(2009-5#1)
with retention times of##2##4##(2008-10#2)
with retention##5##2##(1992-7#1)(2008-10#3)(2009-5#1)
with retroviral##2##2##(2008-10#1)(2008-11#1)
with revenue##2##2##(1992-12#2)
with reverse##5##2##(1993-3#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
with reversed##2##2##(2008-10#2)
with reversible##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
with review of literature##3##4##(2008-11#1)(2008-12#1)(2012-3#1)
with review of the literature##2##5##(2008-12#1)(2012-2#1)
with review of the##3##4##(2008-12#2)(2012-2#1)
with review of##6##3##(2008-11#1)(2008-12#3)(2012-2#1)(2012-3#1)
with rhFKBP12##2##2##(2008-9#2)
with rhabdomyolysis##4##2##(2008-10#2)(2011-2#2)
with rheumatoid arthritis##6##3##(1990-2#1)(1993-1#1)(2007-11#1)(2008-9#1)(2010-12#1)(2013-1#1)
with rheumatoid##7##2##(1990-2#1)(1993-1#1)(2007-11#2)(2008-9#1)(2010-12#1)(2013-1#1)
with rhodamine 6G##2##3##(2008-10#2)
with rhodamine##4##2##(1994-2#1)(2008-10#3)
with ribavirin##2##2##(1990-10#1)(1994-6#1)
with rice##2##2##(2008-10#1)(2008-9#1)
with right atrial##2##3##(1997-5#1)(2012-12#1)
with right##8##2##(1991-8#1)(1996-2#1)(1997-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
with rigid##2##2##(2007-12#1)(2008-10#1)
with rigorous##2##2##(2008-3#2)
with rising##2##2##(1993-8#1)(2008-2#1)
with risk factors for##2##4##(2012-12#1)(2012-2#1)
with risk factors##5##3##(1996-3#1)(2011-2#1)(2012-12#1)(2012-2#2)
with risk of##6##3##(1996-6#1)(2008-11#1)(2008-6#1)(2010-4#1)(2012-2#1)(2013-8#1)
with risk##14##2##(1991-3#1)(1996-3#1)(1996-6#1)(2008-11#2)(2008-6#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
with rituximab##3##2##(2009-8#1)(2013-1#2)
with rival##2##2##(2008-10#1)(2008-8#1)
with root##4##2##(2008-10#3)(2012-8#1)
with roots##2##2##(2008-10#2)
with ropivacain##2##2##(2012-3#2)
with rotation##2##2##(1996-2#1)(2008-6#1)
with round##2##2##(1991-8#1)(1995-12#1)
with routine##2##2##(1997-3#1)(2011-2#1)
with rubeanic acid##3##3##(2008-10#3)
with rubisco activase##4##3##(1991-9#4)
with rupture of the##2##4##(1990-11#1)(2012-3#1)
with rupture##3##2##(1990-11#1)(2010-7#1)(2012-3#1)
with ruptured##2##2##(2010-7#1)(2011-2#1)
with rural##2##2##(1997-7#1)(2008-11#1)
with s(L)=0##2##2##(2008-10#2)
with sDON##2##2##(1995-12#2)
with salicylic acid##3##3##(2008-10#2)(2008-5#1)
with saline water##6##3##(2008-10#6)
with saline##13##2##(1994-8#1)(2008-10#7)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#2)
with salt##2##2##(1993-6#1)(2008-9#1)
with samarium hydroxide##2##3##(2008-10#2)
with samarium##3##2##(2008-10#3)
with same##3##2##(2008-3#1)(2012-3#1)(2013-8#1)
with sample##12##2##(2008-10#8)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
with samples from##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2013-8#1)
with samples of##2##3##(2008-10#1)(2008-7#1)
with samples##9##2##(1997-3#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-8#1)
with sampling rate of about##2##5##(2008-10#2)
with sampling##3##2##(2008-10#3)
with sand##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
with satisfaction##2##2##(2009-3#1)(2010-2#1)
with satisfactory accuracy and precision in the presence of##2##9##(2008-10#2)
with satisfactory accuracy and precision##4##5##(2008-10#4)
with satisfactory results and##2##4##(2008-10#2)
with satisfactory results##71##3##(2008-10#71)
with satisfactory##81##2##(2008-10#80)(2009-3#1)
with saturated##2##2##(1997-2#1)(2008-10#1)
with sawdust##2##2##(2008-12#2)
with scab##2##2##(2008-10#2)
with scanning##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
with scenarios##2##2##(2010-3#1)(2013-8#1)
with schizophrenia and##2##3##(2009-7#1)(2010-1#1)
with schizophrenia##16##2##(1995-12#1)(1995-5#1)(2008-11#2)(2009-12#2)(2009-6#2)(2009-7#2)(2010-1#2)(2012-3#2)(2013-8#2)
with sclerotherapy##3##2##(2013-1#3)
with sclerotia##3##2##(2008-10#3)
with screening##2##2##(2008-11#1)(2008-4#1)
with seasonal allergens##2##3##(2011-2#2)
with seasonal##4##2##(2009-7#1)(2011-2#2)(2012-3#1)
with second-order calibration##2##3##(2008-10#2)
with secondary osteoarthritis##2##3##(2013-1#2)
with secondary##14##2##(1991-11#2)(1991-3#1)(1993-3#1)(1996-11#1)(1996-3#2)(1997-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
with seed##3##2##(2008-10#2)(2009-10#1)
with segments##4##2##(2008-10#3)(2008-4#1)
with seizure##3##2##(2008-12#1)(2010-1#1)(2012-3#1)
with seizures##2##2##(1997-3#1)(2008-4#1)
with selected##11##2##(1992-4#1)(2008-10#8)(2010-3#1)(2011-2#1)
with selective##3##2##(1991-2#1)(2008-10#1)(2008-6#1)
with selenium##3##2##(2008-10#2)(2008-4#1)
with self-assembled##3##2##(2008-10#3)
with senescence##2##2##(1995-8#1)(2013-1#1)
with senior##2##2##(1993-2#1)(2008-12#1)
with sensilla##2##2##(2007-12#2)
with sensitivity of##2##3##(2008-10#2)
with sensitivity to trastuzumab##2##4##(2012-3#2)
with sensitivity##8##2##(2008-10#6)(2012-3#2)
with sensitized##2##2##(2008-10#2)
with separate##3##2##(1992-12#1)(1996-12#1)(2008-11#1)
with separation##2##2##(2008-10#2)
with sepsis and##2##3##(1992-12#1)(2013-1#1)
with sepsis##5##2##(1992-12#1)(2007-12#1)(2011-2#1)(2013-1#2)
with septic##2##2##(2011-2#1)(2013-8#1)
with sequence##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
with sequences##3##2##(1995-9#1)(2008-10#2)
with sequential injection##2##3##(2008-10#2)
with sequential##4##2##(2008-10#3)(2012-3#1)
with serial##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
with serious mental##2##3##(1997-3#1)(2009-6#1)
with serious##8##2##(1997-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
with serum creatinine##2##3##(2008-1#1)(2013-1#1)
with serum##14##2##(1991-12#1)(1992-11#1)(2008-1#1)(2008-11#6)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
with serum-free medium##2##3##(2008-11#2)
with service##3##2##(1993-12#1)(2008-11#1)(2009-6#1)
with seven##12##2##(1995-8#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2010-8#1)(2012-3#1)
with several clinical##2##3##(2011-2#1)(2013-1#1)
with several of the##2##4##(1990-11#1)(2008-10#1)
with several other##4##3##(1997-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
with several sexual partners##2##4##(2008-5#1)(2013-1#1)
with several##55##2##(1990-11#2)(1990-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#20)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#5)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
with severe acute##4##3##(1990-12#1)(1992-3#1)(1997-1#1)(2009-8#1)
with severe burns##2##3##(2008-10#1)(2008-7#1)
with severe fibrosis##2##3##(2013-1#1)(2013-8#1)
with severe haemophilia##2##3##(2009-3#2)
with severe hemophilia##2##3##(2009-3#1)(2012-12#1)
with severe mental##3##3##(1993-1#1)(1993-3#1)(2010-1#1)
with severe mitral##2##3##(2009-5#1)(2010-5#1)
with severe respiratory syncytial virus bronchiolitis##2##6##(1994-6#2)
with severe respiratory##3##3##(1994-6#2)(2012-12#1)
with severe sepsis##8##3##(2009-6#5)(2011-2#3)
with severe##86##2##(1990-12#2)(1990-9#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#3)(1993-8#1)(1994-12#1)(1994-6#2)(1996-1#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#3)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#11)(2012-12#5)(2012-3#3)(2013-1#4)(2013-8#4)
with severity of##4##3##(1991-9#1)(1996-12#1)(2008-7#1)(2013-1#1)
with sex##2##2##(1991-6#1)(2008-8#1)
with sexual##6##2##(1995-12#1)(1996-5#1)(2009-5#2)(2010-4#1)(2013-1#1)
with shaking##2##2##(1996-12#2)
with sham##2##2##(1993-3#1)(2012-3#1)
with shampoo##2##2##(2008-5#2)
with sharp##4##2##(2008-3#2)(2010-11#1)(2010-7#1)
with sheep red blood cells (SRBC)##2##6##(2008-10#1)(2008-7#1)
with sheep red blood cells##5##5##(2008-10#3)(2008-7#2)
with sheep##6##2##(2008-10#3)(2008-7#2)(2010-4#1)
with short##11##2##(1994-1#1)(1994-2#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
with sickle-cell disease##3##3##(2006-5#1)(2008-10#2)
with sickle-cell##4##2##(2006-5#1)(2008-10#2)(2013-1#1)
with side effects##2##3##(2008-10#1)(2008-8#1)
with signal##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
with signaling##2##2##(2009-6#1)(2011-2#1)
with significant differences##3##3##(1993-2#1)(2008-5#2)
with significant increases##2##3##(2008-10#1)(2010-12#1)
with significant reduction in##2##4##(1996-12#1)(2011-1#1)
with significant structural##2##3##(1996-2#1)(2012-2#1)
with significant##42##2##(1991-6#1)(1991-9#1)(1993-2#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
with significantly different##4##3##(1991-12#1)(2008-10#2)(2012-3#1)
with significantly greater##2##3##(2008-10#2)
with significantly higher##3##3##(1994-2#1)(2008-9#1)(2013-8#1)
with significantly##15##2##(1991-12#1)(1993-3#1)(1994-2#1)(2008-10#7)(2008-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
with signs of##3##3##(1991-11#1)(2008-7#1)(2013-1#1)
with silent##2##2##(1992-6#1)(2009-8#1)
with silica gel##7##3##(2008-10#7)
with silica##11##2##(2008-10#9)(2008-12#1)(2010-7#1)
with silicotungstic acid in acidic medium to form a##2##9##(2008-10#2)
with silver##10##2##(1991-1#1)(2008-10#8)(2008-8#1)
with silylated bases##2##3##(1996-5#2)
with silylated thymine##2##3##(1996-5#2)
with silylated##4##2##(1996-5#4)
with similar clinical##2##3##(1995-2#1)(2013-8#1)
with similar efficacy##2##3##(1994-3#1)(2008-10#1)
with similar efficiency##2##3##(2008-10#1)(2008-12#1)
with similar magnitude##3##3##(2008-10#1)(2008-11#2)
with similar mechanisms##2##3##(2008-10#1)(2011-1#1)
with similar potency##2##3##(1997-1#1)(2008-12#1)
with similar results##2##3##(2008-10#1)(2008-11#1)
with similar##60##2##(1990-12#1)(1991-12#2)(1991-5#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#16)(2008-11#4)(2008-12#4)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-8#1)
with similarity to##2##3##(2008-10#2)
with simple sequence repeat##2##4##(2008-10#1)(2008-9#1)
with simple##7##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
with simulated data##2##3##(2008-10#1)(2008-3#1)
with simulated##7##2##(2008-10#4)(2008-3#1)(2008-7#1)(2010-3#1)
with simulations and##2##3##(1994-9#1)(2010-1#1)
with simulations##6##2##(1994-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-1#1)
with simultaneous addition of three analytes##2##6##(2008-10#2)
with simultaneous##13##2##(2008-10#5)(2008-3#2)(2008-4#2)(2008-8#1)(2010-4#1)(2012-12#1)(2013-8#1)
with simultaneously##2##2##(2008-10#1)(2008-3#1)
with single amino acid##2##4##(1994-5#1)(2008-8#1)
with single extraction##2##3##(2008-10#2)
with single output##2##3##(2008-10#2)
with single##24##2##(1994-5#1)(2008-10#18)(2008-12#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
with single-base##2##2##(2008-10#1)(2008-9#1)
with single-gene##2##2##(2009-5#2)
with single-level C-ADR##2##3##(2012-12#2)
with single-level##3##2##(2012-12#3)
with sinus##3##2##(2008-7#2)(2012-12#1)
with site##2##2##(1992-12#1)(2008-10#1)
with sites##3##2##(2008-10#3)
with six primary##2##3##(1990-12#1)(2013-8#1)
with six##14##2##(1990-12#1)(1991-8#1)(1993-1#1)(1997-4#1)(2008-10#6)(2008-7#1)(2009-9#1)(2010-10#1)(2013-8#1)
with skilled##2##2##(1995-5#1)(2008-11#1)
with skimmer interface##3##3##(2008-10#3)
with skin types I##2##4##(2008-5#1)(2011-2#1)
with skin##6##2##(1991-8#1)(2008-12#1)(2008-5#2)(2010-6#1)(2011-2#1)
with slight##2##2##(2008-10#1)(2008-5#1)
with slightly##5##2##(1994-11#1)(2008-10#1)(2008-7#2)(2010-6#1)
with slope##4##2##(2008-10#3)(2008-9#1)
with slopes##3##2##(2008-10#3)
with slurry##3##2##(2008-10#3)
with small cell##2##3##(1996-2#1)(2009-1#1)
with small surface##2##3##(1990-8#1)(2010-4#1)
with small##23##2##(1990-8#1)(1990-9#1)(1992-12#1)(1992-8#1)(1993-8#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2010-4#2)(2010-7#1)(2011-2#1)(2013-1#2)
with smaller##5##2##(2008-10#4)(2008-5#1)
with smokers##2##2##(1993-11#1)(2009-7#1)
with smoking cessation##2##3##(2008-7#1)(2010-2#1)
with smoking##13##2##(1990-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#3)
with smooth muscle cells##2##4##(2010-12#1)(2012-2#1)
with smooth muscle##6##3##(1991-6#1)(1997-8#1)(2010-12#3)(2012-2#1)
with social phobia##3##3##(2008-4#3)
with social##8##2##(1993-3#1)(2008-11#1)(2008-4#3)(2009-10#1)(2010-10#1)(2010-4#1)
with sodium borohydride##3##3##(2008-10#3)
with sodium cyclotetramethylenedithiocarbamate##2##3##(2008-10#2)
with sodium diethyldithiocarbamate##2##3##(2008-10#2)
with sodium dodecyl sulfate##2##4##(1991-12#1)(2008-10#1)
with sodium dodecyl##3##3##(1991-12#1)(2008-10#2)
with sodium fluoride##2##3##(1991-11#2)
with sodium hydroxide##5##3##(2008-10#5)
with sodium tetraphenyl borate##2##4##(2008-10#2)
with sodium tetraphenylborate##2##3##(2008-10#2)
with sodium##41##2##(1991-11#2)(1991-12#2)(1993-8#1)(1994-11#1)(1995-2#1)(1997-2#1)(2008-10#27)(2008-5#2)(2008-8#1)(2008-9#2)(2010-11#1)
with soft tissue##5##3##(1995-2#1)(2008-12#1)(2008-9#1)(2009-3#1)(2012-12#1)
with soft##7##2##(1991-2#1)(1995-2#1)(1997-2#1)(2008-12#1)(2008-9#1)(2009-3#1)(2012-12#1)
with software##2##2##(2009-12#1)(2011-2#1)
with soil##5##2##(2008-10#3)(2008-11#2)
with soils##2##2##(2008-10#2)
with solid phase extraction##4##4##(2008-10#4)
with solid tumors##2##3##(2008-7#1)(2010-11#1)
with solid##10##2##(2008-10#6)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)
with solitary##2##2##(1990-12#1)(2013-1#1)
with soluble##6##2##(1995-11#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
with solutions of##3##3##(2008-10#3)
with solutions##4##2##(2008-10#4)
with solvent##2##2##(2008-10#2)
with somatostatin##2##2##(1990-5#1)(1997-4#1)
with some aromatic##2##3##(2008-10#1)(2011-3#1)
with some of the##3##4##(2008-10#1)(2010-3#1)(2011-2#1)
with some of##4##3##(2008-10#2)(2010-3#1)(2011-2#1)
with some other##2##3##(2008-10#1)(2008-12#1)
with some promising##2##3##(1992-3#1)(2011-3#1)
with some thoughts on##2##4##(2008-6#1)(2010-11#1)
with some thoughts##3##3##(2008-6#1)(2010-11#2)
with some types of##2##4##(2008-10#1)(2008-7#1)
with some##83##2##(1990-5#1)(1991-1#1)(1991-10#1)(1992-3#2)(1993-12#2)(1993-8#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#30)(2008-11#3)(2008-12#6)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2010-11#3)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#2)(2012-3#1)(2012-7#1)(2013-1#3)
with someone##3##2##(1994-2#1)(2008-6#1)(2012-12#1)
with soybean PC##2##3##(1995-8#2)
with soybean##4##2##(1995-8#2)(2008-10#2)
with sparing of##2##3##(1992-3#1)(2008-9#1)
with sparse##2##2##(2008-10#2)
with spatial##5##2##(1991-5#1)(1994-2#1)(2008-10#2)(2008-3#1)
with spatially##3##2##(2008-3#1)(2008-8#1)(2009-8#1)
with special attention to##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-3#1)
with special attention##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2011-3#1)
with special emphasis on the##5##5##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
with special emphasis on##16##4##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
with special focus on##2##4##(1990-6#1)(2011-2#1)
with special health care needs##8##5##(1995-12#4)(1995-3#2)(1997-2#2)
with special health needs##2##4##(1992-2#1)(1994-3#1)
with special health##10##3##(1992-2#1)(1994-3#1)(1995-12#4)(1995-3#2)(1997-2#2)
with special interest##2##3##(1991-3#1)(2013-1#1)
with special needs in##2##4##(1997-2#1)(2012-3#1)
with special needs##5##3##(1997-2#2)(2012-3#3)
with special reference to##3##4##(1997-5#1)(2008-10#1)(2008-11#1)
with special regard to the##2##5##(1991-6#1)(2008-10#1)
with special regard to##3##4##(1991-6#1)(2007-11#1)(2008-10#1)
with special##48##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-2#2)(1993-3#1)(1994-3#1)(1995-12#4)(1995-3#2)(1996-3#1)(1997-2#4)(1997-5#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#3)(2011-3#1)(2012-3#3)(2013-1#2)
with specialized##5##2##(1991-3#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-6#1)
with species-specific##2##2##(2008-12#1)(2012-8#1)
with specific focus on##2##4##(2011-2#1)(2013-1#1)
with specific primers##3##3##(1997-8#1)(2008-10#2)
with specific reference to##3##4##(1991-3#1)(1992-12#1)(1993-1#1)
with specific virulence to major resistance genes##2##7##(2008-10#2)
with specific virulence to##3##4##(2008-10#3)
with specific##54##2##(1990-6#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-6#1)(1993-8#1)(1995-3#1)(1997-8#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#3)
with spectra##2##2##(2008-10#1)(2008-3#1)
with spectral overlapping##2##3##(2008-10#2)
with spectrophotometric detection is##2##4##(2008-10#2)
with spectrophotometric detection using##2##4##(2008-10#2)
with spectrophotometric detection##13##3##(2008-10#13)
with spectrophotometric##18##2##(2008-10#18)
with spectrophotometry##4##2##(2008-10#4)
with spectroscopic##2##2##(2008-10#1)(2011-2#1)
with spherical##2##2##(2008-10#1)(2008-3#1)
with spiked##3##2##(2008-10#3)
with spina bifida##2##3##(2008-10#1)(2012-2#1)
with spinal cord injuries##3##4##(1991-6#2)(2008-11#1)
with spinal cord injury##5##4##(1993-2#1)(2008-7#2)(2013-1#2)
with spinal cord##11##3##(1991-6#4)(1993-2#2)(2008-11#1)(2008-7#2)(2013-1#2)
with spinal##16##2##(1991-6#4)(1993-2#2)(2008-11#1)(2008-12#1)(2008-7#3)(2011-2#1)(2012-3#1)(2013-1#3)
with spleen##2##2##(1996-2#1)(1997-8#1)
with splenic##2##2##(1992-2#1)(2011-2#1)
with spontaneous##10##2##(1990-11#1)(2008-10#1)(2011-2#6)(2012-12#1)(2012-3#1)
with spores of##2##3##(2008-10#1)(2011-2#1)
with spores##4##2##(2008-10#1)(2010-10#1)(2011-2#2)
with sporulating lesions##2##3##(2008-10#2)
with sporulation##2##2##(2008-10#2)
with squamous##2##2##(1993-8#1)(2009-6#1)
with square-wave##2##2##(2008-10#2)
with ssDNA##4##2##(2008-10#2)(2008-4#2)
with stability##2##2##(2008-10#1)(2010-4#1)
with stable disease##2##3##(1990-2#1)(1992-12#1)
with stable##8##2##(1990-2#1)(1992-12#1)(1994-8#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-2#1)
with staff##4##2##(2008-11#1)(2010-10#2)(2013-1#1)
with stage##9##2##(1990-6#1)(1990-9#1)(1991-12#1)(1992-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-4#1)
with stainless steel##2##3##(2008-10#1)(2009-3#1)
with standard deviations##3##3##(2008-10#1)(2008-3#1)(2010-1#1)
with standard methods##2##3##(2008-10#1)(2008-11#1)
with standard solutions##2##3##(2008-10#2)
with standard##35##2##(1993-12#1)(1996-11#1)(2008-10#17)(2008-11#2)(2008-3#3)(2008-7#1)(2009-8#2)(2010-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
with standardized##2##2##(2008-12#1)(2008-8#1)
with standards in##2##3##(2008-10#2)
with standards##3##2##(2008-10#3)
with static##3##2##(2008-10#1)(2011-2#2)
with stationary##2##2##(2008-10#1)(2008-9#1)
with statistical regression##2##3##(2008-10#1)(2011-1#1)
with statistical significance##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
with statistical##11##2##(1990-2#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
with statistically##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
with staurosporine##3##2##(1990-12#1)(1993-6#1)(2008-11#1)
with stearic acid##2##3##(1991-3#1)(2008-10#1)
with stem cell##2##3##(1996-11#1)(2013-8#1)
with stem##5##2##(1996-11#1)(2008-10#2)(2013-8#2)
with stenosis##3##2##(1990-9#1)(1993-8#2)
with stent-assisted##2##2##(2012-3#2)
with sterile##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
with steroids##3##2##(1992-5#1)(1996-11#1)(2012-2#1)
with strain##6##2##(2008-10#4)(2008-5#1)(2008-9#1)
with strains from##3##3##(2008-10#2)(2011-2#1)
with strains of##3##3##(2008-10#3)
with strains##9##2##(2008-10#7)(2008-5#1)(2011-2#1)
with streptomycin sulfate##2##3##(2008-10#1)(2008-8#1)
with streptomycin##4##2##(2008-10#3)(2008-8#1)
with stress-induced birefringence##2##3##(2008-3#2)
with striking##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
with strong connections to##2##4##(1996-2#1)(2013-1#1)
with strong homology to##2##4##(1996-6#1)(1997-7#1)
with strong peer connections##2##4##(2013-1#2)
with strong##29##2##(1991-7#1)(1993-12#2)(1996-2#2)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#5)(2011-2#1)(2012-3#1)(2013-1#5)
with stronger##3##2##(2009-11#1)(2009-8#1)(2012-2#1)
with strongly##2##2##(1997-7#1)(2011-1#1)
with structural##2##2##(1997-9#1)(2008-11#1)
with structurally##2##2##(2008-10#1)(2008-12#1)
with structures##2##2##(1997-6#1)(2012-2#1)
with students who##3##3##(2008-11#2)(2011-2#1)
with students##9##2##(2008-11#2)(2008-12#3)(2010-3#1)(2011-2#2)(2012-3#1)
with studies of##2##3##(1991-5#1)(2008-8#1)
with studies##5##2##(1991-5#1)(2008-10#1)(2008-12#1)(2008-8#2)
with styrene##3##2##(1996-5#1)(2008-10#1)(2008-12#1)
with subacute##2##2##(2008-10#1)(2012-3#1)
with subarachnoid haemorrhage (SAH)##4##4##(2008-7#4)
with subarachnoid haemorrhage##10##3##(1996-9#1)(1997-3#1)(2008-7#8)
with subarachnoid hemorrhage##2##3##(1991-8#1)(1995-11#1)
with subarachnoid hemorrhages##2##3##(2008-12#1)(2011-2#1)
with subarachnoid##14##2##(1991-8#1)(1995-11#1)(1996-9#1)(1997-3#1)(2008-12#1)(2008-7#8)(2011-2#1)
with subcutaneous##2##2##(1992-12#1)(2009-12#1)
with subdural##2##2##(2008-11#1)(2009-9#1)
with subsequent attachment of##2##4##(2008-10#2)
with subsequent determination##2##3##(2008-10#2)
with subsequent##30##2##(1990-12#1)(1993-11#1)(1994-2#1)(1996-6#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
with substance abuse##4##3##(1995-12#1)(2008-6#2)(2008-9#1)
with substance use disorders##2##4##(2008-6#1)(2010-6#1)
with substance use##4##3##(2008-6#1)(2009-11#2)(2010-6#1)
with substance##9##2##(1995-12#1)(2008-6#3)(2008-9#1)(2009-11#2)(2010-6#1)(2013-8#1)
with substantial##3##2##(1991-2#1)(2008-10#1)(2011-2#1)
with substantially##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
with substituted##4##2##(2008-10#3)(2012-3#1)
with substrate##3##2##(1994-11#1)(1994-5#1)(2008-7#1)
with subtle##2##2##(2011-2#1)(2013-1#1)
with subtrochanteric femoral shortening osteotomy fixed with##2##7##(2013-1#2)
with subtrochanteric##3##2##(2009-3#1)(2013-1#2)
with success##4##2##(1992-11#1)(1993-3#1)(2008-6#1)(2013-8#1)
with successful##5##2##(1994-3#1)(2008-10#1)(2008-9#1)(2010-6#1)(2013-8#1)
with successive##2##2##(1992-3#1)(2008-11#1)
with such a##4##3##(1996-3#1)(2008-2#1)(2008-3#1)(2013-1#1)
with such patients##2##3##(2008-1#1)(2011-3#1)
with such##17##2##(1992-11#1)(1994-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
with sucrose and##3##3##(2008-10#1)(2011-2#2)
with sudden gains##2##3##(2009-11#2)
with sudden onset##6##3##(2008-10#1)(2008-7#4)(2013-1#1)
with sudden##15##2##(1990-11#1)(1991-11#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#4)(2009-11#2)(2010-10#1)(2011-2#2)(2013-1#1)
with sufficient accuracy##2##3##(2008-10#2)
with sufficient##8##2##(1993-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-8#1)
with suicidal##2##2##(1992-1#1)(1993-2#1)
with suitable##2##2##(2008-10#1)(2008-9#1)
with sulfanilamide and##2##3##(2008-10#2)
with sulfate groups of heparin##2##5##(2008-10#2)
with sulfate groups##3##3##(2008-10#3)
with sulfuric acid##2##3##(2008-10#2)
with sulphuric acid##2##3##(2008-10#2)
with supercritical carbon dioxide##3##4##(2008-10#3)
with supercritical fluid extraction##2##4##(2008-10#2)
with supercritical fluid##5##3##(2008-10#5)
with supercritical##9##2##(2008-10#9)
with superimposed##2##2##(2008-3#1)(2010-12#1)
with superior##2##2##(2008-10#1)(2008-11#1)
with supported entry##2##3##(2008-11#2)
with suppression##3##2##(2008-10#2)(2012-3#1)
with suppressiveness##2##2##(2008-10#2)
with surface##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
with surfaces and matrices##2##4##(1990-2#2)
with surfaces##3##2##(1990-2#2)(2009-12#1)
with surfactant##4##2##(1990-11#1)(1997-2#1)(2008-10#2)
with surgery and chemotherapy##2##4##(2012-3#2)
with surgery and##3##3##(2011-2#1)(2012-3#2)
with surgery##9##2##(1995-5#1)(2008-7#1)(2011-2#2)(2012-3#4)(2013-8#1)
with surgical removal of##2##4##(1996-9#1)(2011-2#1)
with surgical##9##2##(1996-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
with surgically##4##2##(1990-2#1)(1997-5#1)(2008-11#1)(2010-12#1)
with surrounding##2##2##(1997-8#1)(2008-7#1)
with survival rates##2##3##(2008-10#1)(2008-7#1)
with survival##8##2##(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#2)
with survivors##2##2##(2008-11#1)(2011-2#1)
with susceptibility to##3##3##(1995-5#1)(2008-10#2)
with susceptibility##4##2##(1995-5#1)(2008-10#2)(2011-2#1)
with susceptible cvs##2##3##(2008-10#2)
with susceptible##10##2##(2008-10#9)(2008-12#1)
with suspected##21##2##(1990-11#1)(1990-2#1)(1990-6#1)(1997-8#1)(2008-12#2)(2008-2#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#4)(2013-1#1)
with suspended mirrors##3##3##(2008-3#3)
with suspicion of##3##3##(2008-12#1)(2010-10#1)(2010-12#1)
with sustained##2##2##(1990-3#1)(2010-12#1)
with sutures##2##2##(1994-2#1)(2008-9#1)
with sweet potato##3##3##(2008-10#3)
with symmetric##2##2##(1993-8#1)(2008-10#1)
with symmetrical peak and##2##4##(2008-10#2)
with symmetrical##6##2##(2008-10#5)(2013-1#1)
with sympathovagal##2##2##(2012-2#1)(2013-8#1)
with symptom##2##2##(2008-1#1)(2008-10#1)
with symptomatic##11##2##(1993-1#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-7#2)(2009-8#1)(2011-2#2)(2012-3#1)
with symptoms and##5##3##(1990-3#1)(2008-11#1)(2008-12#2)(2012-12#1)
with symptoms of##11##3##(1995-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)
with symptoms##23##2##(1990-3#1)(1995-5#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#3)(2012-12#2)
with synchronous##3##2##(1990-6#1)(2008-10#1)(2009-1#1)
with syndrome of differentiated dysplasia of connective##2##7##(2013-1#2)
with syndrome##3##2##(2008-12#1)(2013-1#2)
with syngeneic spinal cord and incomplete Freund's adjuvant##2##8##(1995-12#2)
with synthetic fertilizers##2##3##(2008-10#2)
with synthetic##12##2##(1992-3#1)(1992-6#1)(1994-11#1)(2008-10#6)(2008-4#1)(2013-1#2)
with syringe##3##2##(2008-10#3)
with systemic antibiotics##3##3##(1994-12#2)(2013-8#1)
with systemic corticosteroids##2##3##(2008-5#1)(2013-1#1)
with systemic lupus##4##3##(1990-12#1)(1992-5#1)(2011-2#1)(2013-1#1)
with systemic##19##2##(1990-12#1)(1992-5#1)(1994-12#2)(2008-10#4)(2008-5#2)(2010-10#1)(2011-2#3)(2013-1#4)(2013-8#1)
with tandem##3##2##(2008-10#1)(2011-3#1)(2012-12#1)
with tap water##3##3##(2008-10#2)(2008-12#1)
with target cells##2##3##(2008-11#2)
with target##3##2##(1990-11#1)(2008-11#2)
with tax-exempt##2##2##(1992-8#1)(2008-11#1)
with taxol##2##2##(2009-10#1)(2011-2#1)
with teachers##2##2##(2008-12#2)
with technical##2##2##(2008-1#1)(2012-3#1)
with techniques##2##2##(2008-10#1)(2008-8#1)
with teenagers##2##2##(2008-9#1)(2013-1#1)
with temperature##19##2##(2008-10#13)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
with temperatures##3##2##(2008-10#2)(2008-3#1)
with temporal lobe##2##3##(1991-12#1)(2008-4#1)
with temporary or permanent##2##4##(2010-4#2)
with ten##3##2##(1996-12#2)(2008-12#1)
with terminal##3##2##(1994-12#1)(1997-7#1)(2010-6#1)
with test##3##2##(2008-10#2)(2008-3#1)
with tester isolates##2##3##(2008-10#2)
with tester strains of##2##4##(2008-10#2)
with tester##4##2##(2008-10#4)
with testosterone##2##2##(1990-11#2)
with tests##2##2##(2008-10#1)(2008-12#1)
with tetanus##2##2##(1995-2#1)(1996-8#1)
with tetra-substituted sulphonated aluminum phthalocyanine##2##5##(2008-10#2)
with tetra-substituted##3##2##(2008-10#3)
with tetrabutylammonium##2##2##(2008-10#2)
with tetracycline##3##2##(2008-10#3)
with tetramethylammonium hydroxide (TMAH)##3##4##(2008-10#3)
with tetramethylammonium hydroxide##5##3##(2008-10#5)
with that from##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
with that in primary##2##4##(2008-11#2)
with that in the##4##4##(1993-1#1)(2008-10#1)(2008-8#1)(2011-3#1)
with that in##17##3##(1993-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-8#3)(2009-6#1)(2011-3#1)
with that observed at##2##4##(2008-10#2)
with that observed##6##3##(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)
with that obtained##3##3##(2008-10#3)
with that of a##9##4##(1996-2#1)(2007-12#1)(2008-10#5)(2008-3#1)(2012-2#1)
with that of its##2##4##(1997-7#1)(2012-3#1)
with that of other##5##4##(1993-6#1)(1997-3#1)(2008-10#1)(2008-3#2)
with that of the general population##3##6##(1991-2#1)(1993-1#1)(2008-12#1)
with that of the##34##4##(1990-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#2)(1993-1#1)(1993-6#1)(1994-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#4)(2008-9#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
with that of##106##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-6#2)(1994-11#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-10#34)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
with that predicted by##2##4##(2008-3#2)
with that##172##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-6#3)(1993-1#3)(1993-11#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-10#60)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#11)(2008-5#3)(2008-7#4)(2008-8#11)(2008-9#4)(2009-3#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)
with the &quot##2##3##(1997-4#1)(2012-2#1)
with the 0##2##3##(2008-10#2)
with the 10##2##3##(2008-10#1)(2008-3#1)
with the 12##2##3##(2008-10#1)(2011-2#1)
with the 18q- syndrome##2##4##(1997-3#2)
with the 2nd antibody##2##4##(2008-10#2)
with the 3'##2##3##(2008-4#1)(2011-2#1)
with the 5'##4##3##(1991-5#1)(1997-7#1)(2008-10#2)
with the 67 K protein##2##5##(1995-12#2)
with the AFLP##3##3##(2008-10#3)
with the American##4##3##(1991-1#1)(1996-5#1)(2008-11#1)(2008-3#1)
with the B##2##3##(1997-3#1)(2008-10#1)
with the BCR procedure##2##4##(2008-10#2)
with the Bratton-Marshall reagent##2##4##(2008-10#2)
with the C##2##3##(2008-10#2)
with the C-terminal##2##3##(1994-5#1)(2011-2#1)
with the D##2##3##(2008-10#1)(2008-9#1)
with the DNA##3##3##(2008-10#2)(2008-12#1)
with the ELISA##2##3##(1991-12#1)(1995-2#1)
with the El Niño##2##4##(2008-9#1)(2010-8#1)
with the European##2##3##(2008-10#2)
with the FIA##2##3##(2008-10#2)
with the GM modified PLGA particles##2##6##(2009-7#2)
with the Glasgow##2##3##(2011-2#1)(2012-3#1)
with the HPLC method##3##4##(2008-10#2)(2009-8#1)
with the HPLC##6##3##(2008-10#5)(2009-8#1)
with the IGF-I##2##3##(1996-2#2)
with the International##2##3##(2008-10#1)(2008-11#1)
with the M##2##3##(2008-10#1)(2011-10#1)
with the Maquet##2##3##(2008-12#1)(2011-2#1)
with the N##2##3##(2008-10#1)(2012-3#1)
with the National##5##3##(2008-10#3)(2008-5#1)(2013-1#1)
with the Nd##3##3##(1991-3#2)(1994-2#1)
with the New##2##3##(1997-3#1)(2008-10#1)
with the Nucleus##3##3##(2008-9#3)
with the OVA/IL12 protein produced##2##5##(2008-11#2)
with the QTL##2##3##(2008-10#2)
with the R##2##3##(1993-6#1)(2008-10#1)
with the RT##2##3##(1997-3#2)
with the S##2##3##(1993-2#1)(1996-6#1)
with the Semliki Forest Virus##2##5##(2008-11#2)
with the SmartWire##2##3##(1996-6#2)
with the Spectra Optia compared with the MCS+ procedures##2##9##(2011-2#2)
with the T##3##3##(1993-8#1)(1995-8#1)(2008-10#1)
with the TEMPO+##3##3##(2008-9#3)
with the U##2##3##(1993-2#1)(2008-10#1)
with the US##2##3##(2008-11#1)(2008-5#1)
with the USP##2##3##(2008-10#1)(2008-5#1)
with the Unified##2##3##(2008-7#1)(2013-8#1)
with the ability of##2##4##(1995-11#1)(2009-9#1)
with the ability to##4##4##(1992-10#1)(2006-6#1)(2008-3#1)(2010-7#1)
with the ability##6##3##(1992-10#1)(1995-11#1)(2006-6#1)(2008-3#1)(2009-9#1)(2010-7#1)
with the above##4##3##(1997-2#1)(2008-10#2)(2008-9#1)
with the absence of##5##4##(2008-9#1)(2010-10#1)(2010-4#1)(2013-1#2)
with the absorption##2##3##(2008-10#2)
with the academic##3##3##(1990-2#1)(2013-8#2)
with the accumulation of##2##4##(2008-10#1)(2008-11#1)
with the acronym##2##3##(1996-12#1)(2008-3#1)
with the activation of##3##4##(2008-10#1)(2009-12#1)(2012-2#1)
with the activation##4##3##(1990-2#1)(2008-10#1)(2009-12#1)(2012-2#1)
with the active site of##3##5##(1994-5#2)(2008-8#1)
with the active site##5##4##(1991-5#1)(1994-5#2)(2008-8#2)
with the activity of the##2##5##(1991-12#1)(2012-3#1)
with the activity of##4##4##(1991-12#1)(1991-3#1)(1993-8#1)(2012-3#1)
with the activity##5##3##(1991-12#1)(1991-3#1)(1993-8#1)(1994-12#1)(2012-3#1)
with the actual##3##3##(1992-2#1)(2008-10#1)(2009-4#1)
with the added##2##3##(2008-10#1)(2008-4#1)
with the addition of the##2##5##(1995-1#1)(2008-8#1)
with the addition of##17##4##(1992-9#1)(1995-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
with the adoption of##2##4##(1991-12#1)(1993-3#1)
with the advantage of##4##4##(1996-8#1)(2008-3#1)(2010-12#1)(2012-3#1)
with the advantages of##3##4##(1990-9#1)(1991-3#1)(2008-10#1)
with the advent of##4##4##(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
with the aforementioned##2##3##(2008-10#1)(2008-8#1)
with the age of the##2##5##(1990-6#1)(2008-10#1)
with the age of##5##4##(1990-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
with the age##7##3##(1990-6#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)
with the agent##2##3##(1991-3#1)(2008-7#1)
with the aggressive##2##3##(2009-3#1)(2011-2#1)
with the aid of a##7##5##(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)
with the aid of an##2##5##(1990-5#1)(2008-10#1)
with the aid of the##3##5##(1992-9#1)(2008-10#2)
with the aid of##23##4##(1990-5#1)(1992-9#1)(1994-11#1)(1997-6#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
with the aim of detecting##2##5##(2008-5#1)(2010-6#1)
with the aim of improving##2##5##(2008-7#1)(2010-3#1)
with the aim of obtaining##2##5##(2008-10#2)
with the aim of##23##4##(1992-2#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
with the aim to##9##4##(1990-9#1)(1992-6#1)(2008-10#3)(2008-11#2)(2010-11#1)(2012-2#1)
with the aim##33##3##(1990-9#1)(1992-2#1)(1992-6#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-3#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with the airway##3##3##(1994-2#1)(1997-2#1)(2010-12#1)
with the alkali metal##3##4##(2008-10#3)
with the alkali##4##3##(2008-10#4)
with the alpha##2##3##(1991-5#1)(1993-2#1)
with the amount of##8##4##(1991-12#1)(1996-9#1)(2008-10#2)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)
with the analogous##2##3##(1996-5#1)(2008-10#1)
with the analysis of##6##4##(2008-10#5)(2008-9#1)
with the analysis##9##3##(1997-2#1)(2008-10#7)(2008-9#1)
with the analyte##5##3##(2008-10#5)
with the analytical##3##3##(2008-10#3)
with the anionic surfactant##2##4##(2008-10#2)
with the anionic##3##3##(2008-10#3)
with the antagonist##4##3##(2008-10#4)
with the anti-TNF-alpha mAb##2##4##(2008-10#2)
with the antibiotic##3##3##(1994-5#1)(1995-6#1)(2008-10#1)
with the antibody##2##3##(1995-8#1)(2008-8#1)
with the antigen receptor##2##4##(1995-6#2)
with the antigen##6##3##(1995-6#2)(2008-10#3)(2008-8#1)
with the antioxidant##2##3##(1993-12#1)(1993-6#1)
with the apparent##2##3##(1990-9#1)(1994-11#1)
with the appearance of a##2##5##(1992-10#1)(2007-12#1)
with the appearance of##8##4##(1992-10#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
with the appearance##9##3##(1992-10#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
with the apple##3##3##(2008-10#3)
with the application of the##2##5##(2008-10#2)
with the application of##9##4##(2008-10#7)(2008-5#1)(2010-11#1)
with the application##10##3##(2008-10#8)(2008-5#1)(2010-11#1)
with the applied##2##3##(2008-10#1)(2009-5#1)
with the appropriate##5##3##(1995-12#1)(2008-10#2)(2008-4#1)(2011-2#1)
with the aqueous##2##3##(2008-10#2)
with the assessment of##2##4##(1991-1#1)(2010-11#1)
with the assistance of##2##4##(2008-12#1)(2011-1#1)
with the associated##2##3##(2008-3#1)(2013-1#1)
with the assumption of##2##4##(2008-3#1)(2011-2#1)
with the assumption that##2##4##(1996-3#1)(2008-8#1)
with the assumption##4##3##(1996-3#1)(2008-3#1)(2008-8#1)(2011-2#1)
with the automatic##2##3##(2008-10#2)
with the available##3##3##(1993-1#1)(2008-3#2)
with the average##7##3##(1992-12#1)(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
with the basal transcription##3##4##(1995-2#1)(1995-6#2)
with the basal##4##3##(1995-2#1)(1995-6#2)(2008-12#1)
with the basolateral##2##3##(1990-5#1)(2008-11#1)
with the batch##2##3##(2008-10#1)(2012-2#1)
with the beam quality##2##4##(2008-3#2)
with the behavior of##2##4##(2008-10#1)(2011-2#1)
with the benefits of##2##4##(2008-11#2)
with the best##10##3##(1995-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
with the beta##2##3##(1993-12#1)(2010-6#1)
with the binding of##2##4##(2006-6#1)(2013-1#1)
with the biological##2##3##(2009-3#1)(2013-8#1)
with the birds##2##3##(1991-11#2)
with the buffer##2##3##(2008-10#2)
with the c-myc gene##2##4##(1993-3#1)(2008-11#1)
with the cDNA##4##3##(1990-8#1)(1992-6#1)(1994-11#1)(1995-6#1)
with the calculated##5##3##(2008-10#2)(2008-3#2)(2012-12#1)
with the calibration##3##3##(2008-10#3)
with the capability of##3##4##(2008-10#3)
with the capability##4##3##(1995-12#1)(2008-10#3)
with the capacity to##2##4##(1996-2#1)(2008-10#1)
with the capacity##4##3##(1996-2#1)(2008-10#3)
with the carbon##2##3##(1993-8#1)(2008-10#1)
with the carboxyl##2##3##(1993-3#1)(2008-10#1)
with the cardiovascular##2##3##(1994-3#1)(2010-6#1)
with the carrier##2##3##(2008-10#2)
with the catalytic##4##3##(1991-10#1)(1996-2#2)(2008-10#1)
with the cell##5##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)
with the cellular##2##3##(1990-2#1)(2008-9#1)
with the central##2##3##(1995-6#1)(2013-8#1)
with the certified ones##2##4##(2008-10#2)
with the certified or recommended values##2##6##(2008-10#2)
with the certified value of##3##5##(2008-10#3)
with the certified value##12##4##(2008-10#12)
with the certified values and the##2##6##(2008-10#2)
with the certified values and##5##5##(2008-10#5)
with the certified values##20##4##(2008-10#20)
with the certified##40##3##(2008-10#40)
with the cervical spine##2##4##(2008-12#2)
with the change##2##3##(1991-5#1)(2008-10#1)
with the changes##3##3##(1994-2#1)(2013-1#2)
with the chemical##4##3##(2008-10#2)(2008-11#2)
with the chicken##2##3##(1997-1#1)(2008-5#1)
with the chief complaint of##2##5##(2013-1#2)
with the chief##4##3##(2013-1#4)
with the child##2##3##(2008-11#1)(2009-11#1)
with the choice of##2##4##(2010-11#1)(2010-12#1)
with the claimed values##2##4##(2008-10#2)
with the classical##5##3##(1990-3#1)(1996-6#1)(2008-10#2)(2008-5#1)
with the classification##2##3##(2008-10#1)(2011-2#1)
with the clinical and##2##4##(1990-2#1)(2009-8#1)
with the clinical stage##2##4##(1990-9#1)(2008-1#1)
with the clinical status of##2##5##(1995-11#1)(2009-5#1)
with the clinical##13##3##(1990-2#1)(1990-9#1)(1992-12#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-11#1)(2009-5#1)(2009-8#1)(2012-12#1)(2012-3#1)
with the coat protein##3##4##(2008-10#3)
with the colorimetric method##2##4##(2008-10#2)
with the colorimetric##3##3##(2008-10#3)
with the column##3##3##(2008-10#3)
with the combination of##7##4##(1993-8#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-9#1)
with the combined##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
with the commercial##2##3##(2008-10#1)(2008-5#1)
with the common##4##3##(1992-5#1)(2008-1#1)(2008-10#1)(2008-7#1)
with the community##4##3##(1991-2#1)(1992-1#1)(2008-12#1)(2009-4#1)
with the competitive##2##3##(1992-8#1)(1995-11#1)
with the complete##21##3##(1993-3#1)(2011-2#20)
with the complex##5##3##(1997-1#1)(2008-10#2)(2008-11#1)(2010-5#1)
with the complexation##2##3##(2008-10#2)
with the components of##2##4##(2008-10#1)(2011-2#1)
with the composition of##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
with the concentration of##18##4##(2008-10#15)(2008-12#1)(2008-5#1)(2009-6#1)
with the concentration##23##3##(2008-10#20)(2008-12#1)(2008-5#1)(2009-6#1)
with the concentrations of##2##4##(2008-10#2)
with the concentrations##3##3##(2008-10#3)
with the concept of##3##4##(1997-1#2)(2012-12#1)
with the conclusion that##2##4##(1993-3#1)(2008-12#1)
with the condition##2##3##(2008-10#1)(2013-1#1)
with the consequences of##2##4##(1993-12#1)(2008-11#1)
with the constraints of##2##4##(2008-10#2)
with the control group##7##4##(1993-3#1)(1994-3#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
with the control##23##3##(1993-1#1)(1993-3#2)(1994-3#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#1)
with the controlled and##2##4##(2008-10#1)(2011-2#1)
with the controls##5##3##(1991-8#1)(2008-10#4)
with the conventional##19##3##(2008-10#16)(2008-9#1)(2011-2#1)(2013-8#1)
with the corresponding##18##3##(1991-2#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#2)(2012-3#2)
with the coupling##3##3##(2008-10#1)(2008-4#2)
with the course##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
with the critical##2##3##(2008-10#2)
with the crystal##2##3##(1994-5#1)(2011-1#1)
with the culture##2##3##(2008-11#2)
with the cumulative##2##3##(2008-10#1)(2009-7#1)
with the current##8##3##(1992-3#1)(1996-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2012-3#1)
with the cytoplasmic##2##3##(1995-6#1)(2008-9#1)
with the daily##2##3##(2008-10#1)(2008-3#1)
with the data obtained by##2##5##(2008-10#2)
with the data obtained##4##4##(2008-10#3)(2013-1#1)
with the data##9##3##(2008-10#5)(2008-7#1)(2008-8#1)(2013-1#2)
with the decrease##2##3##(2008-10#1)(2008-12#1)
with the degenerate primers##2##4##(1996-8#1)(2008-10#1)
with the degree of##15##4##(1991-7#1)(1992-12#2)(1996-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-5#1)(2013-1#1)
with the delay in t(is) and##2##6##(2008-10#2)
with the delay in##3##4##(1992-3#1)(2008-10#2)
with the delay introduced in the##2##6##(2013-8#2)
with the delay##6##3##(1992-3#1)(2008-10#2)(2013-8#3)
with the delivery of##3##4##(1993-3#1)(1994-1#1)(2008-7#1)
with the deposition##2##3##(2008-10#2)
with the depth##2##3##(2007-12#1)(2008-10#1)
with the detection limit of 0##2##6##(2008-10#2)
with the detection limit of 1##4##6##(2008-10#4)
with the detection limit of##9##5##(2008-10#9)
with the detection limit##12##4##(2008-10#12)
with the detection limits of 0##2##6##(2008-10#2)
with the detection limits##3##4##(2008-10#3)
with the detection##17##3##(2008-10#16)(2013-1#1)
with the determination of##6##4##(2008-10#5)(2010-11#1)
with the determination##11##3##(2008-10#10)(2010-11#1)
with the developed##3##3##(2008-10#3)
with the development of a##5##5##(1994-3#2)(2008-10#1)(2010-8#1)(2011-7#1)
with the development of new##2##5##(2008-7#1)(2010-6#1)
with the development of##26##4##(1994-3#2)(1995-2#2)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-2#1)(2013-8#1)
with the development##27##3##(1994-3#2)(1995-2#2)(1997-1#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#1)(2013-8#1)
with the device##3##3##(2008-10#2)(2008-9#1)
with the diagnosis of##6##4##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
with the diagnosis##7##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
with the different##12##3##(2008-10#8)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
with the difficulty##2##3##(2008-5#1)(2012-12#1)
with the dilemma of##2##4##(1992-1#1)(2008-11#1)
with the direct##2##3##(1991-12#1)(2008-10#1)
with the direction of##2##4##(2008-10#1)(2012-2#1)
with the discharge##2##3##(2008-10#2)
with the disease##10##3##(1992-3#1)(1995-3#1)(2008-10#3)(2013-1#2)(2013-8#3)
with the disorder##2##3##(2008-12#1)(2011-1#1)
with the dissociation##2##3##(1993-8#1)(2008-10#1)
with the diurnal schedule of##2##5##(2008-6#2)
with the drug##2##3##(1990-2#1)(2008-11#1)
with the duration of the##2##5##(1991-12#1)(2008-8#1)
with the duration of##6##4##(1991-11#1)(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
with the dynamics##2##3##(1997-4#1)(2008-10#1)
with the earlier##2##3##(1991-12#1)(2008-10#1)
with the effect of##5##4##(1990-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
with the effect##6##3##(1990-8#1)(1992-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
with the effects of##3##4##(1990-5#1)(1993-8#1)(2008-10#1)
with the eight##2##3##(2008-10#2)
with the electron##2##3##(1997-3#1)(2008-8#1)
with the emergence of##2##4##(2008-10#1)(2008-11#1)
with the emission##2##3##(2008-10#2)
with the end##2##3##(2007-12#1)(2012-3#1)
with the endogenous##3##3##(1992-8#1)(2008-9#1)(2009-8#1)
with the endoplasmic reticulum##2##4##(1993-8#1)(2011-2#1)
with the enhanced##2##3##(1997-8#1)(2011-2#1)
with the enhancement of##3##4##(1996-2#1)(2008-10#1)(2008-8#1)
with the entire##3##3##(1995-12#1)(2008-10#1)(2012-2#1)
with the environment##2##3##(2010-5#1)(2010-7#1)
with the enzymatic##2##3##(2008-10#2)
with the enzyme from##2##4##(1992-3#1)(1996-2#1)
with the enzyme##9##3##(1992-3#1)(1993-3#1)(1994-11#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)
with the enzyme-linked immunosorbent assay (ELISA)##2##6##(1996-9#1)(2008-10#1)
with the enzyme-linked immunosorbent##3##4##(1996-9#1)(2008-10#2)
with the errors##2##3##(2008-10#2)
with the established##2##3##(1992-3#1)(2012-12#1)
with the estimation##2##3##(2012-2#1)(2013-8#1)
with the estrogen receptor##3##4##(2008-11#3)
with the exception of a##2##5##(1991-9#1)(2008-12#1)
with the exception of mancozeb##3##5##(2008-10#3)
with the exception of the##7##5##(1993-12#1)(1993-8#1)(1997-7#1)(2008-10#2)(2008-3#1)(2011-2#1)
with the exception of those##3##5##(1994-3#1)(2008-10#2)
with the exception of##48##4##(1990-5#1)(1991-12#2)(1991-9#1)(1992-3#1)(1993-12#2)(1993-8#2)(1994-3#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#18)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
with the exception that##3##4##(2008-10#2)(2010-12#1)
with the exception##51##3##(1990-5#1)(1991-12#2)(1991-9#1)(1992-3#1)(1993-12#2)(1993-8#2)(1994-3#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#20)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
with the exceptions of##4##4##(1997-2#1)(2008-10#3)
with the existence##2##3##(2008-10#1)(2008-8#1)
with the existing##3##3##(2008-10#2)(2013-1#1)
with the expected##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
with the experimental data##5##4##(1996-5#1)(2008-10#1)(2008-3#2)(2012-2#1)
with the experimental results##4##4##(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
with the experimental values##2##4##(1995-6#1)(2008-10#1)
with the experimental##15##3##(1990-6#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-3#4)(2011-2#1)(2012-2#1)(2013-8#1)
with the experiments##2##3##(2008-10#1)(2008-2#1)
with the expression of##2##4##(2008-8#1)(2009-9#1)
with the expression##3##3##(2008-11#1)(2008-8#1)(2009-9#1)
with the extracted##2##3##(2008-10#1)(2008-8#1)
with the extraction##2##3##(2008-10#2)
with the extracts##3##3##(2008-10#1)(2013-1#2)
with the fact that the##2##5##(1990-8#1)(2008-11#1)
with the fact that##4##4##(1990-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
with the fewest##2##3##(2008-10#1)(2008-8#1)
with the first tumor occurring##2##5##(1997-3#2)
with the first##14##3##(1996-12#1)(1996-8#1)(1997-3#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-7#1)(2011-2#1)
with the five##2##3##(1993-12#1)(2008-4#1)
with the flow injection##2##4##(2008-10#2)
with the flow##9##3##(2008-10#8)(2009-7#1)
with the fluorescence##3##3##(2008-10#2)(2008-2#1)
with the fluorescent##2##3##(1995-6#1)(2008-8#1)
with the fluorogenic reagent##3##4##(2008-10#3)
with the focus on##2##4##(2008-10#2)
with the focus##3##3##(2008-10#2)(2013-8#1)
with the following##14##3##(1992-2#1)(1993-6#1)(1994-12#1)(1995-12#1)(2008-10#6)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
with the formation of a##2##5##(1991-9#1)(2008-10#1)
with the formation of the##2##5##(2008-10#2)
with the formation of##11##4##(1991-9#1)(1993-8#1)(1995-6#1)(1996-5#1)(2008-10#5)(2008-8#1)(2013-8#1)
with the formation##13##3##(1991-9#1)(1993-8#1)(1995-6#1)(1996-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
with the former##2##3##(2010-2#1)(2011-2#1)
with the frequency of##3##4##(2011-2#1)(2012-3#1)(2013-8#1)
with the frequency##4##3##(2007-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
with the full##4##3##(1994-12#1)(2008-10#1)(2012-3#2)
with the fungus##3##3##(2008-10#1)(2008-11#2)
with the gamma##2##3##(2008-2#1)(2008-7#1)
with the gene##6##3##(1993-2#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-9#2)
with the general##8##3##(1992-12#1)(1992-2#1)(1995-1#1)(2008-10#4)(2008-9#1)
with the generation of##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
with the genetic##2##3##(1995-12#1)(2008-9#1)
with the geographic##2##3##(2008-10#1)(2009-8#1)
with the glass##2##3##(1995-3#1)(2008-10#1)
with the global##2##3##(2008-10#1)(2008-12#1)
with the goal of##7##4##(1994-1#1)(1996-2#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#1)(2011-8#1)
with the goal##9##3##(1994-1#1)(1996-2#1)(2008-10#1)(2008-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-8#1)(2012-3#1)
with the goals##2##3##(1994-12#1)(1996-3#1)
with the greater##2##3##(2008-10#1)(2008-7#1)
with the greatest##9##3##(2008-10#4)(2008-11#2)(2008-7#1)(2010-7#1)(2012-12#1)
with the group##2##3##(1995-12#1)(2011-2#1)
with the growing##2##3##(1995-2#1)(2013-8#1)
with the growth of##2##4##(1997-3#1)(2008-10#1)
with the growth##6##3##(1997-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#1)
with the guidance of##2##4##(2011-2#2)
with the hands##2##3##(1995-5#1)(2010-5#1)
with the health care team##2##5##(1995-2#1)(2008-7#1)
with the health care##3##4##(1995-2#1)(1997-3#1)(2008-7#1)
with the health##4##3##(1995-2#1)(1997-3#1)(2008-7#2)
with the heart##2##3##(1990-9#1)(2013-1#1)
with the heated##2##3##(2008-10#2)
with the help of a##3##5##(2008-10#2)(2012-3#1)
with the help of##9##4##(1993-8#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2012-3#2)
with the herbicide##2##3##(2008-10#2)
with the herbicides##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
with the heterologous##3##3##(1990-8#1)(2008-10#2)
with the high initial##2##4##(1990-3#1)(2008-10#1)
with the high level of##2##5##(2008-10#2)
with the high##12##3##(1990-3#1)(1990-8#1)(1993-1#1)(2008-10#5)(2008-9#1)(2010-1#1)(2012-2#1)(2012-3#1)
with the high-level##2##3##(2008-8#1)(2010-7#1)
with the higher##6##3##(1993-12#1)(1994-2#1)(1997-4#1)(2008-10#3)
with the highest concentration##2##4##(2008-5#1)(2013-1#1)
with the highest disease##2##4##(2008-10#2)
with the highest expression##2##4##(2008-9#1)(2012-2#1)
with the highest frequency##2##4##(2008-10#1)(2008-12#1)
with the highest levels##2##4##(2008-10#1)(2008-8#1)
with the highest specific##2##4##(1992-6#1)(2008-10#1)
with the highest##41##3##(1990-5#1)(1992-5#1)(1992-6#1)(1994-9#1)(1997-1#1)(1997-8#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
with the highly##7##3##(1993-2#1)(1996-2#1)(2008-10#2)(2009-6#1)(2011-2#1)(2013-1#1)
with the histopathological##2##3##(2011-2#1)(2012-12#1)
with the history##2##3##(2008-12#1)(2013-1#1)
with the homologous##7##3##(1990-4#1)(1992-4#1)(1995-9#1)(2008-10#3)(2008-5#1)
with the hospital##3##3##(1991-11#1)(2011-3#1)(2012-3#1)
with the host of origin##2##5##(2008-10#2)
with the host##9##3##(2008-10#3)(2008-5#1)(2009-3#1)(2011-2#3)(2013-1#1)
with the human immunodeficiency##2##4##(1991-2#1)(1996-6#1)
with the human##12##3##(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-8#2)(1995-8#1)(1996-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
with the hydrogen##2##3##(2008-10#2)
with the hypotheses##2##3##(2008-10#1)(2009-11#1)
with the hypothesis of##6##4##(2008-10#4)(2011-2#1)(2013-8#1)
with the hypothesis that the##7##5##(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)
with the hypothesis that##23##4##(1990-12#1)(1990-5#1)(1991-2#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)
with the hypothesis##29##3##(1990-12#1)(1990-5#1)(1991-2#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#2)(2013-8#1)
with the hypovirulent Pn117 and##2##5##(2008-10#2)
with the hypovirulent Pn117##3##4##(2008-10#3)
with the idea that##4##4##(1990-10#1)(2008-10#1)(2009-10#1)(2009-11#1)
with the idea##5##3##(1990-10#1)(2008-10#2)(2009-10#1)(2009-11#1)
with the identical##2##3##(2008-11#1)(2008-7#1)
with the identification of##5##4##(1992-9#1)(2008-10#2)(2009-8#1)(2010-12#1)
with the impact##2##3##(2008-12#1)(2010-2#1)
with the implementation of##5##4##(1995-12#1)(2008-10#2)(2008-11#1)(2010-2#1)
with the important##2##3##(2012-2#1)(2012-3#1)
with the in vitro##2##4##(2009-6#1)(2010-5#1)
with the in vivo##2##4##(1993-12#1)(1996-12#1)
with the in##5##3##(1993-12#1)(1996-12#1)(2008-10#1)(2009-6#1)(2010-5#1)
with the inability##2##3##(2009-7#1)(2012-12#1)
with the incidence of##5##4##(1993-8#1)(2008-10#1)(2008-8#1)(2010-5#1)(2013-1#1)
with the incidence##6##3##(1993-8#1)(2008-10#2)(2008-8#1)(2010-5#1)(2013-1#1)
with the inclusion of##3##4##(1990-8#1)(2008-10#2)
with the inclusion##5##3##(1990-8#1)(2008-10#3)(2013-1#1)
with the increase in##8##4##(1993-3#1)(2008-10#1)(2008-11#4)(2012-2#1)(2013-1#1)
with the increase of the##5##5##(2008-10#4)(2011-3#1)
with the increase of workload##2##5##(2011-2#2)
with the increase of##18##4##(1993-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2011-2#2)(2011-3#1)
with the increase##26##3##(1993-3#1)(1993-8#1)(2008-10#8)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
with the increased##2##3##(1995-5#1)(2008-12#1)
with the increasing##10##3##(1991-3#1)(1992-6#1)(1994-8#1)(2008-10#3)(2008-8#3)(2011-2#1)
with the incubation##2##3##(2008-10#1)(2008-9#1)
with the index of##2##4##(2008-10#2)
with the induction of##6##4##(1990-5#1)(1991-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
with the influence##3##3##(1994-3#2)(2008-10#1)
with the information##5##3##(1993-12#1)(2008-11#1)(2009-12#1)(2009-8#1)(2010-5#1)
with the inhibition of##2##4##(1991-2#1)(2008-11#1)
with the inhibition##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
with the inhibitory##3##3##(1996-2#1)(2008-5#1)(2012-3#1)
with the initial##2##3##(2008-10#2)
with the initiation##2##3##(2008-7#1)(2010-8#1)
with the inner##3##3##(1990-5#1)(2008-10#2)
with the inorganic##3##3##(1990-5#1)(2008-10#1)(2010-4#1)
with the insignificant biases##2##4##(2008-10#2)
with the intent of##3##4##(1994-1#1)(2008-12#1)(2010-5#1)
with the intention##2##3##(1995-3#1)(2013-8#1)
with the interaction between##3##4##(1993-8#1)(2006-6#1)(2008-11#1)
with the interaction##5##3##(1993-8#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-9#1)
with the interactions##2##3##(1993-1#1)(2008-9#1)
with the intracellular##2##3##(1994-3#1)(1996-12#1)
with the introduction of##6##4##(1993-1#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-12#1)
with the involvement of##3##4##(1994-3#1)(1995-11#1)(2008-10#1)
with the ion pair of 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol and##2##7##(2008-10#2)
with the ion pair of##4##5##(2008-10#4)
with the ion##6##3##(2008-10#5)(2009-11#1)
with the irradiation##2##3##(2008-10#2)
with the issue of##3##4##(2008-11#1)(2008-12#2)
with the issue##4##3##(2008-10#1)(2008-11#1)(2008-12#2)
with the job##2##3##(1991-2#1)(1996-1#1)
with the jury##2##3##(1995-6#2)
with the karyosome##2##3##(2007-12#1)(2008-7#1)
with the knowledge##2##3##(2008-10#1)(2008-9#1)
with the known##4##3##(1994-8#1)(1995-12#1)(1996-11#1)(2008-11#1)
with the laparoscopic##2##3##(1995-3#1)(2013-1#1)
with the large subunit##2##4##(1993-8#1)(1995-12#1)
with the larger##4##3##(1991-6#1)(2008-10#1)(2009-10#1)(2010-11#1)
with the largest##4##3##(1994-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
with the laser##3##3##(2008-3#3)
with the latest##2##3##(2008-10#1)(2011-2#1)
with the latter##6##3##(1995-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
with the learning##2##3##(1993-12#1)(2008-11#1)
with the least##3##3##(2008-10#3)
with the level of##7##4##(1992-2#1)(1993-12#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-9#1)(2012-12#1)
with the ligand##4##3##(1997-2#1)(2008-10#2)(2008-8#1)
with the limit of##3##4##(2008-10#3)
with the limitation of##2##4##(2008-10#2)
with the limited##4##3##(1992-3#1)(1994-12#1)(2008-8#1)(2009-8#1)
with the linear range##3##4##(2008-10#3)
with the linear##4##3##(2008-10#3)(2013-1#1)
with the lipid##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
with the literature##7##3##(1990-3#1)(1993-3#1)(2008-10#4)(2012-3#1)
with the location of##2##4##(2013-1#2)
with the location##3##3##(2012-2#1)(2013-1#2)
with the logarithm of##2##4##(2008-10#2)
with the longest##2##3##(1990-8#1)(2008-9#1)
with the loss of##3##4##(1995-2#1)(2008-11#1)(2011-3#1)
with the low##3##3##(1990-8#1)(1996-12#1)(2011-2#1)
with the lowest friction##2##4##(1997-3#2)
with the lowest incidence##2##4##(2008-10#2)
with the lowest infection##2##4##(2008-10#2)
with the lowest##20##3##(1997-3#2)(2008-10#9)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#2)(2012-2#2)(2013-1#1)
with the mRNA##2##3##(1994-12#1)(2008-8#1)
with the magnetic##3##3##(2008-10#3)
with the magnitude of##2##4##(1997-2#1)(2008-3#1)
with the magnitude##3##3##(1997-2#1)(2008-3#1)(2009-10#1)
with the main##6##3##(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2011-3#1)
with the major##3##3##(1993-8#1)(2008-10#2)
with the majority of##6##4##(1993-8#1)(2008-10#3)(2011-10#1)(2013-1#1)
with the majority##8##3##(1993-8#1)(2008-10#3)(2008-9#1)(2009-4#1)(2011-10#1)(2013-1#1)
with the mammalian##2##3##(1995-11#1)(1997-3#1)
with the manifestation of##2##4##(2008-11#1)(2011-2#1)
with the manual##2##3##(2008-10#2)
with the maximum##7##3##(2008-10#7)
with the mean of##2##4##(1994-3#1)(2008-10#1)
with the mean##4##3##(1994-3#1)(2008-10#2)(2008-12#1)
with the measured##4##3##(1996-12#1)(2008-3#3)
with the measures of##2##4##(2008-10#1)(2013-1#1)
with the medical##3##3##(1993-12#1)(2008-10#1)(2008-12#1)
with the medium##3##3##(2008-10#1)(2008-11#2)
with the membrane##4##3##(1991-5#1)(2008-10#2)(2009-9#1)
with the mental health##2##4##(1997-3#1)(2008-12#1)
with the mental##3##3##(1997-3#1)(2008-12#1)(2012-3#1)
with the metabolic syndrome##8##4##(2008-1#4)(2010-4#3)(2011-2#1)
with the metal##3##3##(2008-10#3)
with the method of##2##4##(1990-11#1)(2011-3#1)
with the method##6##3##(1990-11#1)(2008-10#3)(2008-12#1)(2011-3#1)
with the methods##2##3##(1991-3#1)(2013-1#1)
with the minimal##2##3##(1993-12#1)(2012-2#1)
with the minimum##6##3##(1996-1#1)(2008-10#3)(2008-5#1)(2013-8#1)
with the mixture##2##3##(2008-10#2)
with the mobile phase of##2##5##(2008-10#2)
with the mobile phase##5##4##(2008-10#4)(2011-3#1)
with the model##7##3##(1995-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
with the modified##7##3##(1990-8#1)(2008-10#5)(2008-3#1)
with the more severe##2##4##(1997-3#1)(2012-2#1)
with the more##5##3##(1997-3#1)(2008-10#2)(2012-2#1)(2012-3#1)
with the morphological##2##3##(2007-12#1)(2008-7#1)
with the most##10##3##(1991-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
with the motor##2##3##(1993-6#1)(2008-7#1)
with the mutant##2##3##(1990-8#1)(2008-10#1)
with the mutation##2##3##(1997-7#1)(2012-12#1)
with the native##2##3##(1990-2#1)(2008-11#1)
with the natural##5##3##(1993-2#1)(2008-11#1)(2008-5#1)(2011-2#2)
with the necessary##2##3##(2008-10#1)(2008-11#1)
with the need for##7##4##(1993-3#1)(1996-1#1)(1997-7#1)(2006-6#1)(2008-3#1)(2008-5#1)(2011-2#1)
with the need to##4##4##(1994-12#1)(1996-1#1)(1997-1#1)(2008-10#1)
with the need##11##3##(1993-3#1)(1994-12#1)(1996-1#2)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
with the negative##2##3##(1995-3#1)(2008-10#1)
with the nematode##3##3##(2008-10#3)
with the nerve##2##3##(2008-11#1)(2008-5#1)
with the neurosurgeons##2##3##(2012-3#1)(2013-1#1)
with the neutral##4##3##(1995-2#1)(2008-10#2)(2008-8#1)
with the new##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#2)
with the normal##10##3##(1990-11#1)(1990-8#1)(1991-2#1)(1994-5#1)(1996-2#1)(2007-12#1)(2010-10#1)(2011-3#1)(2012-2#2)
with the notion that##3##4##(1990-8#1)(2011-2#2)
with the novel##2##3##(2008-11#1)(2008-9#1)
with the number of##15##4##(1990-2#1)(1990-6#1)(1993-6#1)(1994-9#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-8#2)(2010-10#1)(2011-2#1)
with the objective of##3##4##(1994-6#1)(2008-10#1)(2012-3#1)
with the objective##4##3##(1994-6#1)(2008-10#2)(2012-3#1)
with the observation that##3##4##(2008-10#2)(2011-2#1)
with the observed##8##3##(1993-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
with the obtained##2##3##(2008-10#2)
with the occurrence of##4##4##(1991-10#1)(1995-2#1)(2012-2#1)(2013-1#1)
with the official methods##2##4##(2008-10#2)
with the official##3##3##(2008-10#3)
with the ones##2##3##(1990-2#1)(2008-10#1)
with the ongoing##2##3##(1994-1#1)(2008-10#1)
with the onset of##3##4##(1994-3#1)(2008-7#1)(2012-2#1)
with the opportunity##2##3##(2008-1#1)(2008-11#1)
with the optical##2##3##(2007-12#1)(2008-10#1)
with the optimal##2##3##(2008-6#1)(2012-3#1)
with the optimum at##2##4##(2008-10#2)
with the optimum##3##3##(2008-10#3)
with the order of##2##4##(2008-10#1)(2008-8#1)
with the organic##2##3##(2008-10#1)(2009-7#1)
with the original##2##3##(1991-6#1)(2008-10#1)
with the other three##2##4##(2008-10#2)
with the other two##5##4##(1995-2#1)(2008-10#2)(2010-6#1)(2012-3#1)
with the other##24##3##(1992-12#1)(1993-11#1)(1995-2#1)(2006-6#1)(2008-10#12)(2008-12#1)(2008-8#4)(2010-6#1)(2011-2#1)(2012-3#1)
with the others##3##3##(2008-10#2)(2013-1#1)
with the outcome of##3##4##(1990-9#1)(1995-9#1)(2008-7#1)
with the outcome##4##3##(1990-9#1)(1995-9#1)(2008-7#1)(2008-9#1)
with the overall##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
with the oxygen##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
with the pH##7##3##(2008-10#7)
with the parameters##2##3##(1990-2#1)(2008-10#1)
with the parental##4##3##(1993-6#1)(2008-10#3)
with the pathogen##16##3##(2008-10#16)
with the patient##6##3##(1990-6#1)(1997-5#1)(2012-3#1)(2013-1#1)(2013-8#2)
with the patient's##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
with the patients##4##3##(2008-10#1)(2009-12#1)(2011-2#1)(2013-8#1)
with the pattern of##2##4##(2008-8#1)(2012-2#1)
with the peak heights##2##4##(2008-10#2)
with the peak##3##3##(1996-12#1)(2008-10#2)
with the peptide##3##3##(1994-5#1)(2008-10#2)
with the performance of##4##4##(1991-1#1)(1993-2#1)(2008-10#1)(2008-3#1)
with the period of##2##4##(2008-10#1)(2008-5#1)
with the personality##2##3##(2009-5#1)(2011-2#1)
with the phenol group##2##4##(1994-5#2)
with the plant##3##3##(2008-10#3)
with the plasma membrane##2##4##(1992-12#1)(2008-11#1)
with the plasmid expressing##2##4##(2008-11#1)(2008-9#1)
with the plasmid##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
with the plate##2##3##(2008-10#2)
with the point-spread##2##3##(2008-3#2)
with the polar##2##3##(1991-5#1)(2013-8#1)
with the polymer##4##3##(2008-10#4)
with the polymerase chain##2##4##(1990-8#2)
with the polymerase##3##3##(1990-8#3)
with the possible##2##3##(1990-9#1)(2013-8#1)
with the potential of being##2##5##(2008-10#1)(2008-7#1)
with the potential of##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
with the potential to encode##2##5##(2008-10#1)(2013-8#1)
with the potential to##4##4##(1997-1#1)(2008-10#1)(2010-12#1)(2013-8#1)
with the potential##9##3##(1990-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-8#1)
with the precision of##2##4##(2008-10#2)
with the preconcentration##4##3##(2008-10#4)
with the predicted##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
with the predictions##2##3##(1990-8#1)(2008-3#1)
with the preparation of##2##4##(2008-10#1)(2009-7#1)
with the prescribed medication##2##4##(1993-11#1)(1995-2#1)
with the presence of##23##4##(1991-8#1)(1992-3#1)(1992-5#1)(1993-1#1)(1995-2#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
with the presence##24##3##(1991-8#1)(1992-3#1)(1992-5#1)(1993-1#1)(1995-2#1)(1996-12#1)(2008-10#10)(2008-11#2)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
with the present chelating##2##4##(2008-10#2)
with the present method##2##4##(2008-10#2)
with the present##10##3##(1990-12#2)(1991-1#1)(2008-10#7)
with the prevalence of##3##4##(1993-5#1)(2008-3#1)(2011-2#1)
with the prevalence##4##3##(1993-5#1)(2008-3#1)(2011-2#1)(2013-1#1)
with the previous introduction of##2##5##(2008-10#2)
with the previous##10##3##(1996-11#1)(1997-2#1)(2008-10#6)(2008-6#1)(2012-2#1)
with the previously described##3##4##(2008-10#2)(2008-3#1)
with the previously reported##3##4##(1995-11#1)(2008-10#1)(2008-5#1)
with the previously##9##3##(1995-11#1)(2008-10#6)(2008-3#1)(2008-5#1)
with the primary##4##3##(1994-12#1)(1997-1#1)(2008-10#1)(2013-1#1)
with the principles and##2##4##(1993-11#1)(2008-11#1)
with the privacy##2##3##(1995-6#1)(2007-12#1)
with the probe##2##3##(2008-10#1)(2008-9#1)
with the problem##5##3##(1992-1#1)(1994-6#1)(2008-10#1)(2012-3#1)(2013-8#1)
with the problems##3##3##(1990-6#1)(1993-2#1)(1994-2#1)
with the process of##2##4##(2008-10#1)(2008-5#1)
with the production of##4##4##(2006-6#1)(2008-10#2)(2008-8#1)
with the program##2##3##(1997-2#1)(2008-8#1)
with the progress##2##3##(2008-10#1)(2008-9#1)
with the progression of##2##4##(1993-12#1)(1997-1#1)
with the progressive##2##3##(1990-8#1)(2008-9#1)
with the properties of##2##4##(2008-10#2)
with the proportion of##3##4##(1992-9#1)(2008-10#1)(2008-7#1)
with the proposed flow##2##4##(2008-10#2)
with the proposed method and the##2##6##(2008-10#2)
with the proposed method##9##4##(2008-10#9)
with the proposed##18##3##(2008-10#16)(2008-11#1)(2008-3#1)
with the protein kinase C##2##5##(1992-8#1)(1994-11#1)
with the protein##6##3##(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)
with the provision of##2##4##(1997-8#1)(2012-3#1)
with the published##2##3##(1993-12#1)(1995-11#1)
with the pure##2##3##(1990-8#1)(2008-10#1)
with the purpose of##2##4##(1996-5#1)(2011-3#1)
with the purpose##3##3##(1996-5#1)(2008-10#1)(2011-3#1)
with the quality of##2##4##(1994-12#1)(2008-9#1)
with the rabbit##3##3##(1990-12#1)(1994-8#1)(1995-6#1)
with the radiation##3##3##(2008-10#1)(2008-7#2)
with the range of##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
with the rapid##3##3##(1996-2#1)(2008-8#1)(2012-3#1)
with the rare##6##3##(2008-10#3)(2012-3#2)(2013-8#1)
with the rat##2##3##(1993-8#1)(2010-12#1)
with the rate of the##2##5##(1991-12#1)(2008-8#1)
with the rate of##3##4##(1991-12#1)(2008-8#1)(2010-8#1)
with the rate##4##3##(1991-12#1)(2008-10#1)(2008-8#1)(2010-8#1)
with the ratio of##4##4##(1991-12#1)(1995-8#1)(2008-2#1)(2010-6#1)
with the ratio##7##3##(1991-12#1)(1995-8#1)(2008-10#3)(2008-2#1)(2010-6#1)
with the reaction##2##3##(1995-6#1)(2008-10#1)
with the reagent stream##3##4##(2008-10#3)
with the reagent##7##3##(2008-10#7)
with the recent##6##3##(1991-6#1)(1995-6#1)(2008-10#2)(2009-5#1)(2010-1#1)
with the recently##5##3##(1995-6#1)(1997-9#1)(2008-10#2)(2008-5#1)
with the receptor##3##3##(1990-4#1)(1996-2#1)(2008-8#1)
with the recognition of##2##4##(2008-10#1)(2011-2#1)
with the recognition##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
with the recombinant##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2011-3#1)
with the recommendations##2##3##(1990-6#1)(2013-1#1)
with the recommended##2##3##(2008-10#1)(2010-6#1)
with the recoveries of##2##4##(2008-10#2)
with the recovery of##6##4##(2008-10#5)(2008-11#1)
with the reduction of the##2##5##(2008-10#1)(2008-11#1)
with the reduction of##5##4##(2008-10#4)(2008-11#1)
with the reduction##6##3##(2008-10#5)(2008-11#1)
with the reference method##2##4##(2008-10#2)
with the reference standard##2##4##(2008-10#2)
with the reference values##3##4##(2008-10#3)
with the reference##16##3##(2008-10#13)(2008-11#1)(2009-10#1)(2013-8#1)
with the regression coefficient is 0##2##6##(2008-10#2)
with the regression coefficient##3##4##(2008-10#3)
with the regression##5##3##(2008-10#5)
with the regulation of##2##4##(1997-8#1)(2013-8#1)
with the regulatory##4##3##(1990-7#1)(1996-2#1)(2009-6#1)(2010-11#1)
with the relative standard deviation of 3##2##7##(2008-10#2)
with the relative standard deviation##5##5##(2008-10#5)
with the relative standard deviations##2##5##(2008-10#2)
with the relative standard##7##4##(2008-10#7)
with the relative##10##3##(1993-8#1)(2008-10#8)(2008-11#1)
with the relevant##2##3##(1995-12#1)(2008-6#1)
with the remainder##4##3##(1994-12#1)(2008-10#2)(2012-2#1)
with the remaining##2##3##(1995-6#1)(2011-2#1)
with the reported##12##3##(1995-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2013-1#1)
with the reporter##2##3##(2008-11#1)(2008-9#1)
with the residual##2##3##(2008-10#1)(2008-3#1)
with the resin##2##3##(2008-10#2)
with the resistance gene##2##4##(2008-10#2)
with the resistance##4##3##(2008-10#4)
with the response##4##3##(2008-10#4)
with the responsibility of##2##4##(1993-1#1)(2009-10#1)
with the responsibility##3##3##(1993-1#1)(1994-12#1)(2009-10#1)
with the rest of the##2##5##(2011-2#1)(2013-1#1)
with the rest of##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
with the result##3##3##(1990-2#1)(1992-2#1)(2008-10#1)
with the results from the##2##5##(2008-10#2)
with the results obtained by##6##5##(2008-10#6)
with the results obtained from##3##5##(2008-10#3)
with the results obtained using##3##5##(2008-10#3)
with the results obtained##14##4##(2008-10#14)
with the results of recent##2##5##(1996-11#1)(2008-10#1)
with the results of the##5##5##(2008-10#2)(2008-3#2)(2013-1#1)
with the results of##15##4##(1996-11#2)(2008-10#4)(2008-3#4)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
with the results##40##3##(1990-11#1)(1995-2#1)(1996-11#2)(2008-10#24)(2008-11#1)(2008-3#5)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
with the right##4##3##(1991-6#1)(2008-11#1)(2010-9#1)(2011-2#1)
with the risk of##8##4##(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#2)(2010-12#2)(2013-8#1)
with the role##2##3##(2010-10#1)(2011-2#1)
with the root##2##3##(2008-10#2)
with the same DNA##2##4##(1993-12#1)(2009-10#1)
with the same efficiency##2##4##(1990-5#1)(2008-10#1)
with the same volume##2##4##(2008-3#1)(2012-3#1)
with the same##71##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-7#1)(1993-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-7#1)(2008-10#31)(2008-11#4)(2008-3#4)(2008-5#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
with the sample##5##3##(1990-12#1)(2008-10#4)
with the sampling##3##3##(2008-10#2)(2008-8#1)
with the secondary##3##3##(1996-5#1)(2008-1#1)(2008-10#1)
with the selection of##2##4##(2008-10#2)
with the semi-batch system##2##4##(2008-10#2)
with the sensing phase##2##4##(2008-10#2)
with the sensitivity of##4##4##(2008-10#3)(2008-9#1)
with the sensitivity##6##3##(2008-10#5)(2008-9#1)
with the separation and##2##4##(2008-12#2)
with the separation of##2##4##(2008-10#2)
with the separation##4##3##(2008-10#2)(2008-12#2)
with the sequence of##4##4##(1990-11#1)(1990-5#1)(1993-8#1)(1994-11#1)
with the sequence##5##3##(1990-11#1)(1990-5#1)(1992-10#1)(1993-8#1)(1994-11#1)
with the service##3##3##(1992-1#1)(1997-2#1)(2011-2#1)
with the severe##3##3##(2008-10#1)(2009-12#1)(2010-2#1)
with the severity of##7##4##(1995-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#2)(2010-7#1)
with the severity##8##3##(1995-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#2)(2010-7#1)(2012-3#1)
with the shift to##2##4##(2008-11#2)
with the shift##3##3##(1993-12#1)(2008-11#2)
with the short bowel syndrome##2##5##(1991-12#1)(1994-3#1)
with the short##3##3##(1991-12#1)(1994-3#1)(2008-10#1)
with the signal##3##3##(1996-2#2)(1997-8#1)
with the simulated##2##3##(2008-10#2)
with the simultaneous determination of##2##5##(2008-10#2)
with the simultaneous##3##3##(2008-10#2)(2008-7#1)
with the single##4##3##(2008-10#2)(2011-2#2)
with the situation##3##3##(1992-5#1)(1995-11#1)(2013-1#1)
with the size of the##5##5##(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)
with the size of##7##4##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-2#1)
with the skin of##2##4##(1992-3#1)(2008-5#1)
with the skin##3##3##(1992-3#1)(2008-10#1)(2008-5#1)
with the slope##2##3##(2008-10#2)
with the slow##2##3##(2008-7#1)(2008-9#1)
with the small##3##3##(1996-9#1)(2008-10#1)(2008-3#1)
with the smallest##2##3##(2008-10#1)(2011-2#1)
with the sole##3##3##(1990-9#1)(2008-10#1)(2013-8#1)
with the solid##2##3##(2008-10#2)
with the sorbent##2##3##(2008-10#2)
with the source##3##3##(2008-10#2)(2009-2#1)
with the specific energy dissipation rate##2##6##(2008-7#2)
with the specific energy dissipation##3##5##(2008-7#3)
with the specific##9##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#2)
with the spectrophotometric##3##3##(2008-10#3)
with the square root of##2##5##(2008-10#1)(2008-9#1)
with the stage of##2##4##(1990-8#1)(2007-12#1)
with the stage##3##3##(1990-8#1)(1992-9#1)(2007-12#1)
with the standard addition method##2##5##(2008-10#2)
with the standard addition##4##4##(2008-10#4)
with the standard##23##3##(1996-3#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-9#1)
with the state of##2##4##(1993-8#1)(2008-2#1)
with the static##2##3##(2008-10#2)
with the strongest##3##3##(2008-10#2)(2008-7#1)
with the structural##3##3##(2008-10#2)(2009-10#1)
with the structure of the##2##5##(2008-10#2)
with the structure of##3##4##(2008-10#2)(2008-12#1)
with the study of##2##4##(2008-10#1)(2011-2#1)
with the study##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
with the subsequent##2##3##(2008-11#2)
with the substrate##3##3##(2008-10#2)(2008-5#1)
with the supplement##3##3##(2013-8#3)
with the support of##5##4##(1991-2#1)(1994-12#1)(1997-6#1)(2008-5#1)(2011-2#1)
with the support##6##3##(1991-2#1)(1994-12#1)(1997-6#1)(2008-5#1)(2011-2#2)
with the surface of##2##4##(1990-5#1)(2008-10#1)
with the surface##4##3##(1990-5#1)(2008-10#2)(2008-3#1)
with the surfactant##2##3##(2008-10#1)(2008-5#1)
with the surgical procedures##2##4##(1996-9#1)(2012-2#1)
with the surgical##5##3##(1994-12#1)(1996-9#1)(2011-2#1)(2011-3#1)(2012-2#1)
with the surrounding##2##3##(2008-10#1)(2008-11#1)
with the survival##2##3##(1995-12#1)(2008-10#1)
with the susceptible##5##3##(2008-10#5)
with the synthesis##2##3##(1994-8#1)(2008-10#1)
with the system##6##3##(1991-5#1)(2008-10#4)(2008-3#1)
with the systemic##2##3##(2008-10#1)(2012-3#1)
with the target##10##3##(2008-10#5)(2008-9#1)(2009-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
with the teicoplanin chiral selector##2##5##(2008-10#2)
with the temperature##4##3##(1997-2#1)(2008-10#2)(2008-9#1)
with the terminal##2##3##(1993-6#1)(2008-10#1)
with the test##2##3##(1990-12#1)(2008-11#1)
with the theoretical##6##3##(2008-10#2)(2008-3#4)
with the therapy##2##3##(2011-3#1)(2013-7#1)
with the three##8##3##(1993-2#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-9#1)
with the thylakoid bioassay##2##4##(2008-11#2)
with the time##2##3##(1991-11#1)(2008-8#1)
with the titration##2##3##(1991-9#1)(2008-10#1)
with the total protein##2##4##(1993-12#1)(2008-10#1)
with the total##9##3##(1993-12#1)(2008-10#4)(2008-3#2)(2010-10#1)(2010-4#1)
with the traditional##3##3##(1996-12#1)(2008-2#1)(2010-12#1)
with the training and##2##4##(1996-12#1)(2008-8#1)
with the training##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
with the transcriptional##2##3##(2013-1#2)
with the transformed##2##3##(1990-8#1)(2008-11#1)
with the transport of##3##4##(1992-3#2)(1995-6#1)
with the treatment of##2##4##(1991-2#1)(2012-2#1)
with the treatment##6##3##(1991-2#1)(1995-11#1)(1996-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
with the true##2##3##(2008-10#1)(2012-7#1)
with the tumor##2##3##(1992-1#1)(2008-11#1)
with the two##16##3##(1991-2#1)(1993-6#1)(1997-8#1)(2006-6#1)(2008-10#10)(2008-5#1)(2010-5#1)
with the type of##6##4##(1996-3#1)(1997-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
with the type strain##2##4##(2008-10#2)
with the type##9##3##(1996-3#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#1)
with the underlying##2##3##(2009-10#1)(2010-11#1)
with the unmodified##2##3##(2008-10#1)(2009-7#1)
with the urinary##2##3##(1996-12#1)(2011-2#1)
with the use of a##8##5##(2008-10#5)(2008-7#1)(2008-9#1)(2010-10#1)
with the use of the##8##5##(1992-1#1)(1997-3#1)(2008-10#4)(2009-6#1)(2012-3#1)
with the use of two##2##5##(1997-6#1)(2008-10#1)
with the use of##65##4##(1990-5#1)(1990-9#1)(1992-1#1)(1992-3#1)(1994-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#26)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#3)(2010-6#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
with the usual##5##3##(2008-10#2)(2008-3#2)(2008-5#1)
with the vaccine##2##3##(2008-10#1)(2013-8#1)
with the value##4##3##(1995-6#1)(2008-11#2)(2008-9#1)
with the values obtained by##3##5##(2008-10#3)
with the values obtained from##2##5##(2008-10#2)
with the values obtained##6##4##(2008-10#6)
with the values of##2##4##(1991-12#1)(2008-10#1)
with the values##10##3##(1991-12#1)(2008-10#9)
with the variation##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
with the various##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
with the vascular##3##3##(1991-6#1)(2008-10#2)
with the vector##3##3##(1991-9#1)(2008-10#2)
with the vehicle group##2##4##(2013-8#2)
with the vehicle##3##3##(2010-1#1)(2013-8#2)
with the view##3##3##(1997-9#1)(2008-10#1)(2009-7#1)
with the viral##2##3##(2013-8#2)
with the virulent##2##3##(2008-10#1)(2008-9#1)
with the vital dye##2##4##(2008-11#1)(2008-9#1)
with the volume of##2##4##(1992-2#1)(2008-10#1)
with the walls of the##2##5##(2008-11#1)(2008-9#1)
with the water##2##3##(2008-10#1)(2012-9#1)
with the weight of##2##4##(2008-10#1)(2010-9#1)
with the well-established##2##3##(2008-10#2)
with the well-known##2##3##(2009-8#1)(2013-1#1)
with the whole##3##3##(2008-10#1)(2010-9#1)(2012-2#1)
with the widespread distribution of##2##5##(2008-10#1)(2008-11#1)
with the widespread##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
with the wild type##2##4##(1997-8#1)(2008-10#1)
with the wild-type enzyme##2##4##(1992-9#1)(1995-6#1)
with the wild-type strain##4##4##(2008-10#4)
with the wild-type##8##3##(1992-4#1)(1992-9#1)(1995-6#1)(2008-10#5)
with the yeast##2##3##(2008-10#2)
with the yeast-phase##2##3##(2008-5#2)
with the##4571##2##(1990-10#1)(1990-11#6)(1990-12#15)(1990-2#22)(1990-3#5)(1990-4#2)(1990-5#19)(1990-6#6)(1990-7#1)(1990-8#22)(1990-9#13)(1991-1#5)(1991-10#3)(1991-11#7)(1991-12#22)(1991-2#24)(1991-3#10)(1991-5#15)(1991-6#12)(1991-7#2)(1991-8#4)(1991-9#6)(1992-1#8)(1992-10#5)(1992-11#1)(1992-12#13)(1992-2#11)(1992-3#21)(1992-4#3)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#4)(1992-9#12)(1993-1#12)(1993-11#7)(1993-12#29)(1993-2#19)(1993-3#22)(1993-5#1)(1993-6#15)(1993-8#47)(1993-9#3)(1994-1#11)(1994-11#18)(1994-12#24)(1994-2#13)(1994-3#20)(1994-5#19)(1994-6#6)(1994-8#13)(1994-9#5)(1995-1#7)(1995-10#1)(1995-11#22)(1995-12#25)(1995-2#38)(1995-3#13)(1995-5#8)(1995-6#35)(1995-8#17)(1995-9#7)(1996-1#11)(1996-11#7)(1996-12#19)(1996-2#35)(1996-3#14)(1996-5#15)(1996-6#7)(1996-8#5)(1996-9#5)(1997-1#19)(1997-2#22)(1997-3#34)(1997-4#7)(1997-5#4)(1997-6#9)(1997-7#11)(1997-8#22)(1997-9#4)(2006-6#11)(2007-11#7)(2007-12#26)(2007-8#2)(2008-1#21)(2008-10#1757)(2008-11#231)(2008-12#60)(2008-2#34)(2008-3#131)(2008-4#15)(2008-5#90)(2008-6#17)(2008-7#98)(2008-8#113)(2008-9#115)(2009-1#2)(2009-10#18)(2009-11#13)(2009-12#8)(2009-2#5)(2009-3#16)(2009-4#4)(2009-5#6)(2009-6#13)(2009-7#23)(2009-8#28)(2009-9#8)(2010-1#8)(2010-10#13)(2010-11#9)(2010-12#18)(2010-2#6)(2010-3#1)(2010-4#16)(2010-5#14)(2010-6#11)(2010-7#15)(2010-8#20)(2010-9#4)(2011-1#10)(2011-10#2)(2011-2#167)(2011-3#15)(2011-7#2)(2011-8#1)(2012-12#20)(2012-2#68)(2012-3#63)(2012-5#3)(2012-7#1)(2012-9#1)(2013-1#116)(2013-7#3)(2013-8#74)
with their ability to##3##4##(1993-8#1)(2008-10#2)
with their complementary##2##3##(2008-10#2)
with their corresponding##3##3##(2008-10#3)
with their counterparts##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
with their dependence on##2##4##(2008-10#1)(2008-3#1)
with their human##2##3##(1991-6#1)(1997-7#1)
with their infant##2##3##(2008-10#1)(2010-10#1)
with their own##3##3##(1995-2#1)(2008-12#1)(2011-2#1)
with their parents##2##3##(1990-12#1)(2009-7#1)
with their physicians##2##3##(2009-5#2)
with their previous##2##3##(2008-11#1)(2011-10#1)
with their respective##3##3##(2008-10#1)(2013-1#2)
with their risk status##2##4##(1995-9#2)
with their use##6##3##(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
with their##143##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#4)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#3)(1996-1#1)(1996-2#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#29)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#6)(2008-9#7)(2009-12#1)(2009-3#1)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#3)(2011-3#2)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#8)(2013-8#1)
with them##16##2##(1991-3#1)(1992-2#1)(1995-6#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-2#1)
with theoretical patterns derived from Mie theory##2##7##(2008-3#2)
with theoretical predictions##3##3##(2008-3#2)(2012-3#1)
with theoretical##9##2##(2008-10#2)(2008-3#5)(2008-9#1)(2012-3#1)
with theoretically##2##2##(2008-10#1)(2008-3#1)
with therapeutic##5##2##(2008-10#1)(2008-12#2)(2009-8#1)(2011-2#1)
with therapy##3##2##(1997-2#1)(2008-7#1)(2009-6#1)
with thermal##6##2##(1991-2#1)(2008-10#3)(2013-1#1)(2013-8#1)
with thermodynamic calculations##2##3##(2008-10#2)
with thermodynamic##3##2##(2008-10#3)
with thermogravimetric##2##2##(2008-10#2)
with thermostability##2##2##(2008-10#2)
with these changes##2##3##(1990-5#1)(1993-2#1)
with these compounds##3##3##(1993-12#1)(2007-11#1)(2008-10#1)
with these disorders##3##3##(1997-3#1)(1997-8#1)(2012-3#1)
with these drugs##7##3##(1991-1#1)(1994-5#2)(2008-11#1)(2010-5#2)(2012-2#1)
with these factors##3##3##(1991-2#1)(2008-9#1)(2009-12#1)
with these groups##2##3##(1994-9#1)(2008-7#1)
with these increases##2##3##(1990-10#1)(1992-3#1)
with these lesions##2##3##(2008-10#1)(2008-7#1)
with these new##2##3##(2008-10#1)(2008-11#1)
with these problems##2##3##(2010-10#2)
with these results##2##3##(2008-10#1)(2008-11#1)
with these systems##2##3##(2008-11#1)(2008-7#1)
with these two##6##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-8#1)
with these##107##2##(1990-10#1)(1990-11#2)(1990-5#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#24)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#1)
with thiamine##2##2##(2008-10#2)
with thick##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
with thiocyanate##3##2##(2008-10#3)
with thiol cotton##3##3##(2008-10#3)
with thiol groups##2##3##(2008-10#2)
with thiol##6##2##(2008-10#6)
with thiolated oligonucleotides##2##3##(2008-10#2)
with thiols##3##2##(2008-10#1)(2008-11#2)
with thiopentone##2##2##(2008-10#1)(2010-7#1)
with third##2##2##(1994-5#1)(1996-11#1)
with this approach##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
with this condition##5##3##(2008-10#2)(2008-11#1)(2008-12#2)
with this disease##5##3##(1993-3#1)(1993-6#1)(2008-10#1)(2008-7#1)(2010-5#1)
with this hypothesis##3##3##(1990-5#1)(1994-3#1)(2008-10#1)
with this increase in##2##4##(1990-10#1)(2009-7#1)
with this method##11##3##(1990-9#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-4#1)
with this new##3##3##(1990-9#1)(2008-10#1)(2008-8#1)
with this prediction##2##3##(2008-4#1)(2008-9#1)
with this syndrome##2##3##(1997-6#1)(2008-12#1)
with this system##4##3##(2008-10#3)(2012-3#1)
with this tablet##2##3##(2008-10#2)
with this technique and##2##4##(1997-1#1)(2008-7#1)
with this technique##8##3##(1991-11#1)(1991-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
with this type of##6##4##(1991-11#1)(2009-1#2)(2010-3#1)(2010-8#1)(2013-1#1)
with this##171##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#2)(1992-10#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-6#2)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#51)(2008-11#8)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-1#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
with thoracic##8##2##(1997-5#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
with those achieved##4##3##(1991-3#1)(2008-10#3)
with those available##2##3##(2008-10#1)(2008-11#1)
with those by the##3##4##(2008-10#3)
with those by##4##3##(2008-10#4)
with those determined by##3##4##(2008-10#3)
with those determined##5##3##(1990-9#1)(2008-10#4)
with those for##2##3##(1993-8#1)(2008-10#1)
with those found by##6##4##(2008-10#6)
with those found in##2##4##(2010-12#1)(2011-2#1)
with those found##10##3##(2008-10#7)(2008-5#1)(2010-12#1)(2011-2#1)
with those from a##3##4##(1992-9#1)(2008-10#2)
with those from the##3##4##(2008-10#3)
with those from##11##3##(1992-9#1)(2008-10#8)(2008-11#1)(2008-8#1)
with those furnished by the reference procedure##2##7##(2008-10#2)
with those given by##5##4##(2008-10#4)(2008-3#1)
with those in##12##3##(1994-3#1)(1995-11#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2012-12#2)
with those obtained by HPLC##2##5##(2008-10#2)
with those obtained by ICP-MS##2##5##(2008-10#2)
with those obtained by a batch##2##6##(2008-10#2)
with those obtained by a conventional method##2##7##(2008-10#2)
with those obtained by a##10##5##(2008-10#10)
with those obtained by an##5##5##(2008-10#5)
with those obtained by conventional##3##5##(2008-10#3)
with those obtained by means of##3##6##(2008-10#3)
with those obtained by other##2##5##(2008-10#1)(2008-5#1)
with those obtained by the British Pharmacopoeia##2##7##(2008-10#2)
with those obtained by the British##3##6##(2008-10#3)
with those obtained by the conventional##2##6##(2008-10#2)
with those obtained by the official##2##6##(2008-10#1)(2008-11#1)
with those obtained by the reference##2##6##(2008-10#2)
with those obtained by the##29##5##(2008-10#28)(2008-11#1)
with those obtained by##87##4##(2008-10#82)(2008-11#2)(2008-3#2)(2008-5#1)
with those obtained from a##2##5##(2008-10#2)
with those obtained from other##2##5##(2008-5#1)(2008-7#1)
with those obtained from##10##4##(2008-10#8)(2008-5#1)(2008-7#1)
with those obtained through##2##4##(2008-10#2)
with those obtained using a##3##5##(2008-10#3)
with those obtained using the##2##5##(2008-10#2)
with those obtained using##11##4##(1995-6#1)(2008-10#10)
with those obtained with a##5##5##(2008-10#4)(2008-3#1)
with those obtained with the##4##5##(2008-10#4)
with those obtained with##19##4##(2008-10#16)(2008-2#1)(2008-3#2)
with those obtained##134##3##(1995-6#1)(2008-10#122)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2013-1#1)
with those of P##2##4##(2008-10#1)(2008-5#1)
with those of a##7##4##(1994-8#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#3)
with those of control##2##4##(1995-3#1)(2008-10#1)
with those of other tospoviruses##2##5##(2008-10#2)
with those of other##9##4##(2008-10#7)(2008-3#2)
with those of previous studies##2##5##(2008-10#1)(2011-2#1)
with those of previous##4##4##(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
with those of reported tospoviruses##2##5##(2008-10#2)
with those of the##23##4##(1991-12#1)(1991-6#1)(1992-1#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-7#2)(2010-11#1)(2010-6#1)(2010-7#1)(2013-1#1)
with those of##112##3##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-7#2)(2008-10#55)(2008-11#5)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with those on##3##3##(1996-12#1)(1997-8#1)(2008-10#1)
with those previously##2##3##(1994-11#1)(2008-10#1)
with those provided by the##2##5##(2008-10#2)
with those provided by##3##4##(2008-10#3)
with those reported in the literature##2##6##(2008-10#1)(2008-8#1)
with those reported in##3##4##(2008-10#2)(2008-8#1)
with those reported##6##3##(2008-10#5)(2008-8#1)
with those that##5##3##(2008-10#3)(2008-2#1)(2008-9#1)
with those using##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
with those who##2##3##(1993-12#1)(2008-11#1)
with those with##7##3##(2008-10#2)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
with those##365##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#1)(2008-10#244)(2008-11#14)(2008-2#3)(2008-3#11)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
with thousands of##2##3##(2010-10#1)(2012-3#1)
with three different##7##3##(1990-9#1)(1997-1#1)(2008-10#4)(2008-11#1)
with three independent data sets##2##5##(2008-10#1)(2008-8#1)
with three independent##3##3##(2008-10#2)(2008-8#1)
with three other##3##3##(2008-10#2)(2011-2#1)
with three replicates##3##3##(2008-10#3)
with three replications##4##3##(2008-10#1)(2008-12#2)(2010-4#1)
with three successive 28-day##2##4##(2008-10#2)
with three trophic levels##3##4##(2008-9#3)
with three types of##2##4##(1991-5#1)(2010-12#1)
with three##70##2##(1990-9#1)(1991-5#1)(1993-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#39)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#4)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
with thrombin##3##2##(1992-6#3)
with thrombocytosis##2##2##(2006-6#1)(2011-2#1)
with thrombospondin##2##2##(1994-5#1)(2009-7#1)
with thymopentin##2##2##(1991-3#2)
with thyroid disorders had##2##4##(2013-1#2)
with thyroid disorders##4##3##(2013-1#4)
with thyroid##10##2##(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#6)
with time after inoculation##3##4##(2008-10#3)
with time after##4##3##(2008-10#4)
with time and##3##3##(1990-5#1)(2008-10#1)(2010-8#1)
with time in the##2##4##(1990-11#1)(2010-12#1)
with time##40##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-8#1)(2008-10#16)(2008-11#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
with time-of-flight mass spectrometry (GCxGC-TOFMS)##2##5##(2008-10#2)
with time-of-flight mass spectrometry##3##4##(2008-10#3)
with time-varying##2##2##(1992-3#1)(2010-1#1)
with tin(II) chloride##2##3##(2008-10#2)
with tin(II)##3##2##(2008-10#3)
with tissue plasminogen activator##3##4##(2007-9#1)(2008-7#2)
with tissue##6##2##(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)
with titanium##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
with tobacco##2##2##(2008-10#1)(2012-2#1)
with tolerance##4##2##(2008-10#3)(2011-10#1)
with toluene##4##2##(1994-8#1)(2008-10#2)(2008-7#1)
with toluidine blue and##2##4##(1992-12#1)(2008-10#1)
with tooth##3##2##(1996-3#1)(2013-1#2)
with topical application of##2##4##(1996-10#1)(2008-5#1)
with topical##7##2##(1990-11#1)(1991-3#1)(1996-10#1)(2008-10#1)(2008-5#1)(2011-2#2)
with topics##2##2##(2008-11#1)(2011-2#1)
with total cell##2##3##(1995-11#1)(2008-11#1)
with total##19##2##(1991-2#1)(1993-6#1)(1994-2#1)(1995-11#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
with trace##2##2##(2008-10#2)
with tracheostomy##3##2##(2012-2#3)
with traditional##10##2##(1991-2#1)(1992-1#1)(1997-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)
with training in##2##3##(1994-1#1)(2010-4#1)
with transcription##2##2##(1994-11#1)(2008-9#1)
with transcriptional factor##2##3##(2008-9#2)
with transcriptional##4##2##(2008-9#2)(2009-10#1)(2011-2#1)
with translocation of##2##3##(1997-1#1)(2010-11#1)
with transmission##2##2##(2008-10#2)
with transplanted##2##2##(2011-2#1)(2012-12#1)
with transtibial prostheses##2##3##(2013-1#2)
with transtrapezium approach for##2##4##(2008-9#2)
with trastuzumab##3##2##(2012-3#2)(2013-1#1)
with traumatic brain injury##3##4##(1991-12#1)(1994-12#1)(2008-7#1)
with traumatic##6##2##(1991-12#1)(1991-6#1)(1994-12#1)(2008-7#2)(2011-2#1)
with treated##2##2##(2008-12#1)(2013-1#1)
with treatment selection##2##3##(2012-2#2)
with treatment with##2##3##(1995-2#1)(2009-6#1)
with treatment##17##2##(1995-2#1)(1996-11#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-7#4)(2009-12#1)(2009-6#1)(2010-6#1)(2012-2#2)(2013-8#1)
with trees##2##2##(2008-10#1)(2008-9#1)
with trehalose##2##2##(2008-10#1)(2013-1#1)
with tremolite##3##2##(1991-12#3)
with trichloroacetic##2##2##(2008-10#2)
with triethylamine##3##2##(1996-5#2)(2008-10#1)
with trimeperidine and##2##3##(2012-3#2)
with trimethyl orthoformate##2##3##(1996-5#2)
with tris(2##6##2##(2008-10#6)
with trisomy##2##2##(1997-4#2)
with trypsin##9##2##(1990-2#1)(1993-8#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-8#2)
with tryptophan##2##2##(2008-10#2)
with tuberculous##2##2##(2011-2#1)(2013-7#1)
with tubular##2##2##(1990-12#1)(1993-3#1)
with tubulin##3##2##(1993-6#2)(2009-7#1)
with tumor necrosis##2##3##(2013-1#1)(2013-8#1)
with tumor regression##2##3##(1991-8#2)
with tumor##10##2##(1991-8#2)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#2)(2013-8#1)
with two cycles of##2##4##(2008-10#2)
with two different levels of##2##5##(1990-2#1)(2008-10#1)
with two different##15##3##(1990-2#1)(1995-5#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#9)(2008-9#1)
with two flow##2##3##(2008-10#2)
with two isolates of##3##4##(2008-10#3)
with two isolates##5##3##(2008-10#5)
with two major##2##3##(2008-10#1)(2008-11#1)
with two new##5##3##(2008-10#4)(2011-2#1)
with two other##4##3##(2008-10#1)(2010-4#1)(2012-2#2)
with two parameters##3##3##(2008-10#2)(2008-2#1)
with two putative##2##3##(1995-2#1)(1997-7#1)
with two to four##2##4##(2010-8#1)(2013-8#1)
with two types of##5##4##(1992-3#1)(1997-7#2)(2008-10#1)(2009-12#1)
with two##145##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-11#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#5)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#72)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
with two-dimensional geometry##4##3##(2008-11#4)
with two-dimensional##6##2##(2007-12#1)(2008-11#5)
with two-photon##2##2##(2008-3#2)
with type 1##3##3##(2011-1#1)(2012-4#2)
with type 2 diabetes mellitus##2##5##(2008-3#1)(2010-10#1)
with type 2 diabetes##16##4##(1996-11#1)(2008-3#3)(2009-1#1)(2010-10#2)(2011-2#4)(2012-12#1)(2012-3#1)(2012-5#2)(2013-1#1)
with type 2##19##3##(1996-11#1)(2008-3#3)(2009-1#1)(2010-10#2)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#3)(2013-1#1)
with type I mucopolysaccharidosis##3##4##(2012-3#3)
with type I##6##3##(1995-2#1)(2011-2#1)(2012-3#4)
with type II diabetes##3##4##(1995-8#1)(1996-11#1)(2008-7#1)
with type##35##2##(1995-2#1)(1995-8#1)(1996-11#2)(2008-10#1)(2008-12#2)(2008-3#3)(2008-7#1)(2009-1#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#5)(2012-4#2)(2012-5#3)(2013-1#1)
with typical##13##2##(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
with tyrosine##2##2##(1996-5#1)(2008-4#1)
with ulcerative colitis (UC)##2##4##(2010-12#1)(2011-2#1)
with ulcerative colitis##4##3##(2010-12#3)(2011-2#1)
with ultra##2##2##(1992-3#1)(2008-9#1)
with ultrafiltration##2##2##(2011-2#1)(2013-8#1)
with ultrasonic nebulization##3##3##(1991-1#1)(2008-10#2)
with ultrasonic##5##2##(1991-1#1)(2008-10#3)(2012-3#1)
with ultrasound##3##2##(1995-3#1)(2013-8#2)
with ultraviolet detection at##2##4##(1997-2#1)(2008-10#1)
with ultraviolet detection##4##3##(1997-2#1)(2008-10#3)
with ultraviolet light##3##3##(2007-11#1)(2008-10#2)
with ultraviolet##11##2##(1997-2#1)(2007-11#1)(2008-10#8)(2008-5#1)
with uncertainties in##2##3##(2008-10#1)(2008-3#1)
with uncertainties##3##2##(2008-10#1)(2008-3#2)
with uncertainty##3##2##(1997-3#1)(2008-11#1)(2010-11#1)
with unclear##2##2##(1995-12#1)(2013-1#1)
with uncommon##2##2##(2008-7#2)
with underlying##4##2##(1990-3#1)(2010-10#1)(2011-2#1)(2012-12#1)
with undetectable##3##2##(2008-7#1)(2009-8#1)(2013-1#1)
with undiagnosed##2##2##(2013-1#2)
with unequal##3##2##(1995-12#1)(1996-3#1)(2008-8#1)
with unexpected##2##2##(1996-3#1)(2009-7#1)
with unexplained medical symptoms##2##4##(2008-11#2)
with unexplained##5##2##(2008-11#3)(2008-8#1)(2012-3#1)
with unfavorable##2##2##(1990-8#1)(2009-7#1)
with unidentified##2##2##(1993-3#1)(1997-2#1)
with uniform##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2010-1#1)
with uniformly##2##2##(2008-4#1)(2009-7#1)
with unilateral##7##2##(1996-12#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
with unique##6##2##(2008-10#3)(2009-6#1)(2011-3#1)(2012-2#1)
with unknown function##3##3##(2007-12#1)(2008-10#2)
with unknown##8##2##(1992-12#1)(2007-12#1)(2008-10#5)(2008-11#1)
with unlimited##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
with unmodified##2##2##(2008-10#2)
with unsafe##2##2##(1994-9#1)(2008-11#1)
with unstable angina##5##3##(1990-12#3)(2008-10#1)(2013-1#1)
with unstable##8##2##(1990-12#3)(2008-10#1)(2008-12#1)(2009-4#1)(2013-1#1)(2013-8#1)
with untransformed##2##2##(1997-4#1)(2008-10#1)
with untreated##7##2##(1993-8#1)(1995-2#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-3#2)
with unusual presentation##2##3##(2009-8#1)(2010-11#1)
with unusual##7##2##(2008-1#1)(2008-12#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
with up to##9##3##(1993-2#1)(1994-11#1)(1995-9#1)(1997-1#1)(2008-10#3)(2008-2#1)(2011-2#1)
with upper##3##2##(1991-11#1)(2011-2#1)(2012-3#1)
with uranium##2##2##(2008-10#1)(2013-1#1)
with urea##2##2##(2008-10#2)
with uremic parathyroid hyperplasia##2##4##(2008-5#2)
with uremic##3##2##(2008-5#2)(2011-2#1)
with urethritis##2##2##(2011-2#1)(2013-1#1)
with uricase##2##2##(1997-2#1)(2008-10#1)
with urinary##6##2##(1990-2#2)(2007-7#1)(2008-10#3)
with urine##3##2##(1992-9#1)(2008-10#2)
with use of a##2##4##(2008-10#1)(2008-2#1)
with use of an##2##4##(1993-2#1)(2008-10#1)
with use of the##2##4##(1996-3#1)(2008-10#1)
with use of##15##3##(1992-9#1)(1993-2#1)(1993-9#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
with use##16##2##(1992-9#1)(1993-2#1)(1993-9#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-8#1)
with useful##3##2##(2008-4#2)(2008-5#1)
with using##7##2##(2008-10#4)(2008-11#1)(2008-12#1)(2012-3#1)
with vaccination of##2##3##(2011-1#1)(2011-2#1)
with vaccination##3##2##(1995-5#1)(2011-1#1)(2011-2#1)
with vacuum disc##2##3##(2008-12#2)
with vacuum##3##2##(2008-12#2)(2008-7#1)
with vaginal##5##2##(1995-1#1)(1996-1#1)(2009-6#1)(2010-8#1)(2011-2#1)
with values obtained by##3##4##(1990-2#1)(2008-10#2)
with values of##3##3##(1993-2#1)(1993-8#1)(2008-10#1)
with values ranging from##3##4##(2008-10#3)
with values##14##2##(1990-2#1)(1993-2#1)(1993-8#1)(2008-10#7)(2008-3#3)(2011-2#1)
with vanadate##5##2##(1994-6#3)(1997-1#1)(2008-10#1)
with vanadium##2##2##(2008-10#2)
with variable##13##2##(2008-10#4)(2008-8#2)(2008-9#1)(2010-6#1)(2010-7#1)(2011-10#1)(2011-2#3)
with variant##2##2##(2011-2#2)
with variation of##2##3##(2008-10#1)(2008-3#1)
with variation##3##2##(2008-10#2)(2008-3#1)
with variations in the##4##4##(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
with variations in##7##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
with varied##4##2##(2008-11#1)(2013-1#1)(2013-8#2)
with various amounts of##2##4##(2008-10#1)(2008-3#1)
with various concentrations of##2##4##(2008-11#1)(2008-12#1)
with various pathologies##2##3##(2011-3#1)(2012-12#1)
with various types of##3##4##(1991-12#1)(1996-3#1)(2012-2#1)
with various##64##2##(1991-12#1)(1992-11#1)(1993-2#2)(1993-8#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-10#25)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
with varying concentrations of##2##4##(2008-10#1)(2009-9#1)
with varying degrees of##6##4##(1997-2#1)(2008-10#2)(2008-11#2)(2008-5#1)
with varying levels of##5##4##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
with varying results##2##3##(1990-2#1)(2008-10#1)
with varying##30##2##(1990-2#1)(1992-12#1)(1994-11#1)(1997-2#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
with vascular##14##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
with vecuronium##3##2##(1993-1#1)(2010-7#2)
with vehicle##3##2##(1990-11#1)(2008-9#1)(2013-1#1)
with vein##3##2##(1991-3#1)(1996-9#1)(2008-10#1)
with venous leg ulcers##2##4##(1997-3#2)
with venous leg##3##3##(1997-3#3)
with venous##5##2##(1996-6#1)(1997-3#3)(2008-7#1)
with ventricular##2##2##(2008-11#1)(2009-5#1)
with versatile##2##2##(2008-10#1)(2011-2#1)
with vertebral##2##2##(1991-11#1)(2008-7#1)
with vertical##4##2##(1991-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
with very active##2##3##(2013-8#2)
with very different##5##3##(1991-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
with very few##2##3##(1990-11#1)(1991-5#1)
with very good accuracy##2##4##(2008-10#1)(2013-8#1)
with very good results##2##4##(1993-3#1)(2008-11#1)
with very good##10##3##(1993-3#1)(1996-6#1)(2008-10#5)(2008-11#2)(2013-8#1)
with very high##6##3##(1991-6#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
with very low birth##2##4##(1994-6#1)(2011-1#1)
with very low serum##2##4##(1993-3#1)(1995-5#1)
with very low##9##3##(1993-3#1)(1994-11#1)(1994-6#1)(1995-5#1)(2008-10#3)(2011-1#1)(2011-2#1)
with very poor##2##3##(2008-10#1)(2010-1#1)
with very satisfactory results##2##4##(2008-10#1)(2009-10#1)
with very##47##2##(1990-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-3#2)(1994-11#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-6#1)(2008-10#15)(2008-11#3)(2008-4#1)(2008-5#3)(2008-8#1)(2009-10#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-8#3)
with victimization##4##2##(2008-12#1)(2009-5#3)
with villous height##3##3##(2013-1#3)
with villous##4##2##(2010-3#1)(2013-1#3)
with vinblastine##2##2##(1990-2#1)(1991-6#1)
with viral##10##2##(1995-5#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2013-1#1)
with virions##2##2##(1997-3#1)(2008-10#1)
with virtually##3##2##(1994-9#1)(2008-10#2)
with virulence on##2##3##(2008-10#2)
with virulence##6##2##(2008-10#6)
with virulent##5##2##(1995-2#1)(1996-12#1)(2008-10#2)(2008-5#1)
with viruliferous whiteflies##2##3##(2008-10#2)
with viruliferous##4##2##(2008-10#4)
with virus##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
with virus-specific##2##2##(2008-10#2)
with viruses##4##2##(1996-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
with visceral##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
with visible##2##2##(1992-1#1)(2008-10#1)
with visual##4##2##(2008-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
with vitamin B12##3##3##(1993-12#2)(2007-9#1)
with vitamin D deficiency##2##4##(2011-1#1)(2012-2#1)
with vitamin##9##2##(1991-12#1)(1993-12#2)(1997-5#1)(2007-9#1)(2008-11#1)(2011-1#2)(2012-2#1)
with vitiligo##2##2##(2013-1#2)
with voltammetric##2##2##(2008-10#2)
with vomiting##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2013-7#1)
with wall-jet##3##2##(2008-10#3)
with warm temperature##2##3##(2008-10#1)(2012-4#1)
with warm##3##2##(1990-2#1)(2008-10#1)(2012-4#1)
with water and##9##3##(2008-10#6)(2008-5#2)(2009-5#1)
with water at##2##3##(2008-10#1)(2011-2#1)
with water for##3##3##(2008-10#3)
with water##52##2##(1990-11#1)(1991-2#1)(2008-10#37)(2008-11#2)(2008-12#2)(2008-5#5)(2008-9#1)(2009-5#1)(2011-2#2)
with water)##2##2##(2008-10#2)
with wavelength##4##2##(2008-10#1)(2008-3#3)
with wax##3##2##(2008-10#3)
with weak##2##2##(2011-2#1)(2012-3#1)
with weaker##2##2##(2008-10#1)(2008-11#1)
with well-controlled##3##2##(2010-4#1)(2010-9#1)(2011-2#1)
with well-known##2##2##(1995-6#1)(2008-10#1)
with western medical injections##2##4##(2011-2#2)
with western##3##2##(2011-2#3)
with what has been##2##4##(2007-12#1)(2008-5#1)
with what is##2##3##(1994-9#1)(2008-10#1)
with what we##3##3##(1994-2#1)(2010-10#2)
with what would be expected##2##5##(1992-6#1)(2008-7#1)
with what##11##2##(1991-12#1)(1992-6#1)(1994-2#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#2)
with wheat germ agglutinin##2##4##(1992-6#1)(2008-11#1)
with wheat##7##2##(1992-6#1)(2008-10#4)(2008-11#2)
with when the knee##2##4##(1997-8#2)
with which a##2##3##(1992-2#1)(1993-2#1)
with which all##2##3##(1990-9#1)(2012-12#1)
with which it##4##3##(1994-12#1)(2008-10#1)(2013-1#2)
with which the##9##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-5#1)
with which they are##2##4##(1992-2#1)(2011-2#1)
with which they##7##3##(1992-2#1)(1995-3#1)(2008-10#3)(2008-9#1)(2011-2#1)
with which to##11##3##(1990-11#1)(1991-3#1)(1996-2#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#1)(2013-8#1)
with which##46##2##(1990-11#1)(1990-9#1)(1991-3#1)(1992-2#3)(1993-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
with white##4##2##(2008-3#1)(2008-6#1)(2010-12#1)(2013-1#1)
with whole##2##2##(2008-10#1)(2008-12#1)
with whom family doctors participated in euthanasia or assisted suicide##2##10##(1991-8#2)
with whom patients had##2##4##(2010-4#2)
with whom##7##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-8#2)(2010-4#2)
with wide spectrum##3##3##(1990-12#1)(2008-5#2)
with wide##8##2##(1990-12#1)(2006-6#1)(2008-11#1)(2008-5#2)(2009-1#1)(2010-11#1)(2010-7#1)
with widely##4##2##(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
with widespread##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
with wild type strain##2##4##(2008-12#1)(2008-8#1)
with wild type##6##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
with wild vegetation##3##3##(2013-1#3)
with wild##10##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#4)
with wild-type and##2##3##(2008-10#1)(2008-11#1)
with wild-type virus##2##3##(1993-6#1)(2011-3#1)
with wild-type##19##2##(1993-6#1)(1993-8#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#8)(2008-11#2)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)
with wind##3##2##(2008-10#3)
with wireless##2##2##(2010-8#2)
with women##6##2##(1991-11#1)(1992-3#1)(1997-3#1)(2008-12#1)(2010-6#1)(2011-2#1)
with worsening##2##2##(1995-8#1)(2010-10#1)
with written##2##2##(2008-12#1)(2011-2#1)
with xerotic skin##3##3##(2008-5#3)
with xylenol orange##3##3##(2008-10#3)
with yeast HAP2##2##3##(1995-2#1)(2008-9#1)
with yeast and mammalian cells##2##5##(2008-4#1)(2008-9#1)
with yeast two-hybrid system##2##4##(2008-8#2)
with yeast##14##2##(1992-3#1)(1995-2#1)(1996-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2012-3#1)
with yields of##2##3##(1990-5#1)(2013-1#1)
with you##2##2##(1993-12#1)(1994-1#1)
with young##7##2##(1990-5#1)(1996-2#1)(2008-7#2)(2009-9#1)(2010-2#1)(2012-2#1)
with your##6##2##(1993-2#1)(1993-3#1)(1994-1#2)(1994-3#2)
with yttrium phosphate##2##3##(2008-10#2)
with zero##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
with zinc##4##2##(1992-9#1)(2008-10#2)(2008-11#1)
with zirconium permanent##2##3##(2008-10#2)
with zirconium##7##2##(2008-10#7)
with zymosan##2##2##(1991-5#1)(2008-12#1)
with##35960##1##(1990-10#8)(1990-11#97)(1990-12#156)(1990-2#111)(1990-3#59)(1990-4#5)(1990-5#115)(1990-6#65)(1990-7#3)(1990-8#81)(1990-9#78)(1991-1#44)(1991-10#14)(1991-11#72)(1991-12#154)(1991-2#134)(1991-3#129)(1991-4#5)(1991-5#88)(1991-6#106)(1991-7#31)(1991-8#94)(1991-9#53)(1992-1#56)(1992-10#13)(1992-11#38)(1992-12#126)(1992-2#77)(1992-3#120)(1992-4#13)(1992-5#40)(1992-6#89)(1992-7#7)(1992-8#23)(1992-9#77)(1993-1#108)(1993-11#72)(1993-12#132)(1993-2#129)(1993-3#141)(1993-5#6)(1993-6#134)(1993-8#195)(1993-9#31)(1994-1#57)(1994-11#121)(1994-12#175)(1994-2#99)(1994-3#133)(1994-5#137)(1994-6#76)(1994-8#128)(1994-9#39)(1995-1#44)(1995-10#16)(1995-11#121)(1995-12#208)(1995-2#220)(1995-3#98)(1995-5#75)(1995-6#159)(1995-8#115)(1995-9#41)(1996-1#84)(1996-10#4)(1996-11#73)(1996-12#185)(1996-2#206)(1996-3#115)(1996-5#138)(1996-6#97)(1996-8#35)(1996-9#44)(1997-1#150)(1997-2#181)(1997-3#228)(1997-4#56)(1997-5#48)(1997-6#72)(1997-7#101)(1997-8#202)(1997-9#16)(2006-5#9)(2006-6#38)(2007-11#74)(2007-12#181)(2007-7#3)(2007-8#23)(2007-9#8)(2008-1#175)(2008-10#12482)(2008-11#1887)(2008-12#654)(2008-2#214)(2008-3#837)(2008-4#219)(2008-5#691)(2008-6#154)(2008-7#1017)(2008-8#766)(2008-9#841)(2009-1#54)(2009-10#136)(2009-11#83)(2009-12#105)(2009-2#11)(2009-3#81)(2009-4#45)(2009-5#102)(2009-6#95)(2009-7#130)(2009-8#238)(2009-9#68)(2010-1#122)(2010-10#189)(2010-11#141)(2010-12#250)(2010-2#40)(2010-3#60)(2010-4#127)(2010-5#115)(2010-6#139)(2010-7#162)(2010-8#136)(2010-9#66)(2011-1#196)(2011-10#18)(2011-2#1610)(2011-3#126)(2011-5#2)(2011-7#17)(2011-8#2)(2011-9#2)(2012-12#325)(2012-2#596)(2012-3#748)(2012-4#16)(2012-5#23)(2012-6#4)(2012-7#10)(2012-8#4)(2012-9#7)(2013-1#1326)(2013-2#1)(2013-3#4)(2013-7#40)(2013-8#489)
with/without##5##1##(2008-7#2)(2010-1#1)(2011-2#1)(2012-3#1)
withDrosophila GGPPS##2##2##(2008-8#2)
withanolide A and##2##3##(2012-2#2)
withanolide A##3##2##(2012-2#3)
withanolide##4##1##(2012-2#4)
withdraw##5##1##(1995-12#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-3#1)
withdrawal and##3##2##(1994-3#1)(1996-12#1)(2010-6#1)
withdrawal from##3##2##(1992-12#1)(2011-2#2)
withdrawal in##4##2##(1991-1#3)(2013-1#1)
withdrawal movement##2##2##(2011-2#2)
withdrawal of the##4##3##(1997-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
withdrawal of##11##2##(1996-2#2)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)
withdrawal response##3##2##(2011-2#3)
withdrawal symptoms##5##2##(1992-3#1)(1995-11#1)(2009-7#1)(2011-1#2)
withdrawal syndrome##2##2##(2009-5#1)(2013-1#1)
withdrawal##57##1##(1991-1#7)(1992-12#1)(1992-3#1)(1994-3#1)(1995-11#2)(1996-12#5)(1996-2#3)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-11#3)(2009-5#1)(2009-7#1)(2010-11#2)(2010-6#1)(2011-1#3)(2011-2#8)(2013-1#2)
withdrawing##5##1##(1991-2#2)(1995-1#1)(2008-10#1)(2011-2#1)
withdrawn at##2##2##(1996-12#1)(2008-4#1)
withdrawn##23##1##(1992-5#1)(1993-3#1)(1994-3#1)(1996-12#1)(1996-9#2)(2008-10#3)(2008-11#10)(2008-12#1)(2008-4#1)(2012-3#1)(2013-8#1)
withdrew from##2##2##(2008-7#1)(2013-1#1)
withdrew##6##1##(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
withheld##3##1##(1996-5#1)(1997-2#1)(2007-11#1)
withhold a##2##2##(2008-10#1)(2011-2#1)
withholding and withdrawing life-support##2##4##(1991-2#2)
withholding##4##1##(1991-2#2)(2013-8#2)
within &quot##2##2##(2008-10#1)(2012-2#1)
within +/-0##2##2##(2008-10#2)
within +/-10%##2##2##(2008-10#1)(2008-3#1)
within +/-20%##3##2##(2008-10#3)
within 0##10##2##(1990-2#2)(1993-12#1)(2008-10#5)(2008-3#2)
within 1 h after##2##4##(1995-8#1)(2008-10#1)
within 1 h of##2##4##(1992-8#1)(1993-3#1)
within 1 h##5##3##(1992-8#1)(1993-3#1)(1995-8#1)(2008-10#2)
within 1 min##4##3##(1996-2#1)(1997-8#1)(2008-10#1)(2008-7#1)
within 1 month##3##3##(1991-12#1)(2011-1#1)(2011-2#1)
within 1 week##3##3##(1994-12#1)(2008-10#2)
within 1##21##2##(1991-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-8#1)(2008-10#7)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
within 1%##3##2##(2008-3#3)
within 10 h##2##3##(2008-10#1)(2008-11#1)
within 10 min##6##3##(1991-2#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-5#1)
within 10##12##2##(1991-2#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-1#1)
within 10%##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
within 12 hours##2##3##(2008-3#1)(2009-11#1)
within 12 min##3##3##(2008-10#3)
within 12##10##2##(1993-8#1)(1997-7#1)(2008-10#4)(2008-3#1)(2009-11#1)(2012-2#2)
within 14##3##2##(2008-10#2)(2010-11#1)
within 15 days##2##3##(1995-2#1)(2008-11#1)
within 15 min##4##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
within 15##6##2##(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#1)
within 2 and##2##3##(1990-6#1)(1996-2#1)
within 2 days##2##3##(1996-2#1)(2013-8#1)
within 2 h##5##3##(1995-11#1)(1996-12#1)(2008-10#2)(2009-6#1)
within 2 months##2##3##(2008-10#1)(2012-2#1)
within 2 weeks after##3##4##(1996-12#1)(2008-10#2)
within 2 weeks of##2##4##(1995-1#1)(2008-10#1)
within 2 weeks##10##3##(1995-1#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-11#1)
within 2 years##2##3##(2008-7#1)(2011-2#1)
within 2##27##2##(1990-6#1)(1995-1#1)(1995-11#1)(1996-12#2)(1996-2#2)(1997-3#1)(2008-10#11)(2008-11#2)(2008-7#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
within 2-3%##2##2##(2008-10#2)
within 20##5##2##(1994-3#1)(2008-10#4)
within 20min##2##2##(2008-10#2)
within 21 days##2##3##(2008-11#1)(2011-2#1)
within 21##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
within 24 h after##4##4##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
within 24 h of##3##4##(1990-10#1)(2008-10#1)(2008-7#1)
within 24 h##16##3##(1990-10#1)(1994-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#3)(2013-1#1)
within 24 hours of##3##4##(1993-2#1)(2011-2#1)(2012-3#1)
within 24 hours##5##3##(1993-2#1)(1995-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
within 24##22##2##(1990-10#1)(1993-2#1)(1994-5#1)(1995-8#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#4)(2012-3#1)(2013-1#1)
within 28 days##2##3##(2008-7#1)(2008-8#1)
within 28##3##2##(1996-6#1)(2008-7#1)(2008-8#1)
within 2min##2##2##(2008-10#2)
within 3 h##3##3##(1993-12#1)(2008-10#1)(2010-6#1)
within 3 months##2##3##(1991-8#1)(2013-1#1)
within 3 years of##2##4##(2008-10#1)(2008-11#1)
within 3##19##2##(1990-6#1)(1991-8#1)(1993-12#1)(1995-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
within 3-5##2##2##(2008-11#1)(2009-9#1)
within 30 days##2##3##(2008-11#1)(2012-3#1)
within 30 min##2##3##(2008-10#1)(2008-11#1)
within 30##8##2##(1995-2#1)(2008-10#3)(2008-11#2)(2012-3#2)
within 36 h##3##3##(2008-10#3)
within 36##5##2##(2008-10#4)(2010-7#1)
within 4 days##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
within 4 h##4##3##(1994-3#1)(1994-8#1)(1995-11#1)(1997-2#1)
within 4 months##2##3##(1992-5#1)(2008-5#1)
within 4 weeks##3##3##(2008-10#3)
within 4##18##2##(1992-2#1)(1992-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#6)(2008-5#2)(2008-7#1)
within 4%##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
within 48 h after##2##4##(1990-6#1)(2008-10#1)
within 48 h of##2##4##(2008-10#2)
within 48 h##6##3##(1990-6#1)(1990-7#1)(2008-10#4)
within 48##8##2##(1990-6#1)(1990-7#1)(2008-10#4)(2012-12#1)(2012-3#1)
within 5 min##6##3##(1993-1#1)(2008-10#4)(2012-2#1)
within 5 minutes##2##3##(1994-11#1)(1995-3#1)
within 5 mm##2##3##(1994-12#1)(2011-2#1)
within 5 s##2##3##(1997-1#1)(1997-2#1)
within 5 years##2##3##(1990-6#1)(1995-2#1)
within 5##20##2##(1990-6#1)(1993-1#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#9)(2011-2#1)(2012-2#1)
within 6 days after##2##4##(2008-10#2)
within 6 h##4##3##(2008-10#4)
within 6 min##2##3##(1990-2#1)(2008-10#1)
within 6 months##2##3##(1994-12#1)(2011-2#1)
within 6##13##2##(1990-2#1)(1992-12#1)(1994-12#1)(1995-2#1)(2008-10#7)(2011-2#1)(2012-3#1)
within 7 days after##2##4##(1995-8#1)(2008-10#1)
within 7 days##5##3##(1995-8#1)(2008-10#3)(2008-11#1)
within 7##6##2##(1995-8#1)(2008-10#4)(2008-11#1)
within 72 h##5##3##(1993-12#1)(2008-10#4)
within 72 hours##4##3##(2013-1#4)
within 72##9##2##(1993-12#1)(2008-10#4)(2013-1#4)
within 8 days##2##3##(1996-2#1)(2008-12#1)
within 8##4##2##(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)
within 90 days##3##3##(2011-2#3)
within 90##4##2##(2008-10#1)(2011-2#3)
within AG-2##3##2##(2008-10#3)
within Australia##4##2##(1992-1#1)(1994-12#2)(2008-12#1)
within C##2##2##(2008-10#2)
within F##3##2##(2008-10#3)
within Gonyleptidae##2##2##(2007-12#2)
within M##2##2##(2008-10#2)
within MPFC##2##2##(2008-11#2)
within P##3##2##(2008-10#2)(2008-12#1)
within X##2##2##(2008-10#2)
within a 79##2##3##(2008-12#2)
within a cluster of fatty acid biosynthetic genes##2##8##(1992-4#2)
within a cluster of##4##4##(1992-4#2)(2008-10#2)
within a cluster##5##3##(1992-4#2)(2008-10#3)
within a complex system##2##4##(2008-11#1)(2008-6#1)
within a complex##4##3##(2008-11#1)(2008-6#1)(2009-12#1)(2012-12#1)
within a context##2##3##(2010-10#1)(2013-8#1)
within a few days##3##4##(1991-4#1)(2008-10#1)(2010-4#1)
within a few hours##3##4##(1990-9#1)(1994-3#1)(2011-2#1)
within a few seconds##2##4##(2008-10#2)
within a few weeks##2##4##(1996-11#1)(2008-10#1)
within a few##12##3##(1990-9#1)(1991-4#1)(1994-3#1)(1996-11#1)(2008-10#5)(2008-5#1)(2010-4#1)(2011-2#1)
within a field##5##3##(2008-10#5)
within a given##4##3##(1994-5#1)(1995-11#1)(2008-10#1)(2010-7#1)
within a group of##3##4##(2007-12#1)(2011-2#2)
within a health##3##3##(1993-1#1)(1994-1#1)(2008-11#1)
within a large##2##3##(2010-11#1)(2012-2#1)
within a layer##2##3##(1992-9#2)
within a leaf##2##3##(2008-10#2)
within a local area##3##4##(2008-10#3)
within a metapopulation##2##3##(2008-10#1)(2008-8#1)
within a period of##2##4##(2008-10#1)(2012-3#1)
within a population of##3##4##(1991-12#1)(2008-10#1)(2008-9#1)
within a population##6##3##(1991-12#1)(2008-10#3)(2008-8#1)(2008-9#1)
within a public health care##2##5##(1994-9#2)
within a range of##5##4##(2008-10#2)(2008-11#1)(2010-10#1)(2011-2#1)
within a range##6##3##(2008-10#2)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
within a reasonable time##2##4##(2008-11#1)(2008-4#1)
within a region##2##3##(2008-10#1)(2011-2#1)
within a relatively##2##3##(2008-11#1)(2009-7#1)
within a sample of##2##4##(2008-10#1)(2012-3#1)
within a sample##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
within a set of##2##4##(2008-10#1)(2008-3#1)
within a short period##2##4##(1990-8#1)(2008-11#1)
within a short##3##3##(1990-8#1)(2008-11#1)(2008-9#1)
within a single field##2##4##(2008-10#2)
within a single season##2##4##(2008-10#1)(2008-8#1)
within a single tree##2##4##(2008-10#2)
within a single##19##3##(1994-5#1)(2008-10#11)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
within a species##2##3##(2008-10#1)(2012-3#1)
within a specific##2##3##(2008-11#1)(2008-2#1)
within a standard##2##3##(2009-11#1)(2011-2#1)
within a year##3##3##(1992-5#1)(2008-8#1)(2010-12#1)
within a##267##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-9#3)(1993-1#2)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#91)(2008-11#27)(2008-12#8)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#13)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#6)(2012-5#1)(2012-9#1)(2013-1#6)(2013-8#4)
within about##2##2##(2008-10#1)(2011-2#1)
within all##3##2##(1992-6#1)(2008-10#2)
within an allozyme genotype##2##4##(2008-10#2)
within an individual##2##3##(2008-10#1)(2009-8#1)
within an##32##2##(1990-8#1)(1991-10#1)(1995-12#1)(1995-2#1)(1995-9#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
within and across##5##3##(2008-10#1)(2008-11#1)(2012-3#3)
within and adjacent to##2##4##(2008-10#2)
within and among##10##3##(2008-10#8)(2008-8#1)(2008-9#1)
within and between patches##3##4##(2008-8#3)
within and between species##3##4##(2009-6#1)(2012-3#2)
within and between the##3##4##(2008-10#2)(2010-7#1)
within and between##21##3##(1990-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(2008-10#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2010-7#1)(2012-3#2)
within and outside of the##2##5##(2008-10#1)(2008-12#1)
within and outside of##3##4##(1993-1#1)(2008-10#1)(2008-12#1)
within and outside##4##3##(1993-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
within and##47##2##(1990-12#1)(1992-9#1)(1993-1#2)(1993-12#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2010-7#1)(2012-2#1)(2012-3#5)(2013-1#1)
within approximately##2##2##(2008-10#1)(2008-2#1)
within biofilms##2##2##(2008-10#1)(2008-9#1)
within biological systems##2##3##(2009-10#1)(2010-11#1)
within both##3##2##(1996-6#1)(2008-10#2)
within cankers##2##2##(2008-10#2)
within cells##5##2##(1993-9#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-2#1)
within certain##3##2##(2008-10#2)(2008-2#1)
within clinical practice##3##3##(1996-3#1)(2008-11#2)
within clinical##4##2##(1994-12#1)(1996-3#1)(2008-11#2)
within cluster correlation##2##3##(2010-11#2)
within clusters##2##2##(2008-12#1)(2008-8#1)
within current##2##2##(2008-11#1)(2008-9#1)
within day##4##2##(2008-10#1)(2010-12#3)
within days##5##2##(1993-2#1)(1995-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
within droplets##2##2##(2008-3#2)
within each community##2##3##(2008-10#1)(2008-8#1)
within each group##4##3##(2007-12#1)(2008-10#1)(2008-6#1)(2011-2#1)
within each of the##4##4##(1995-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
within each of these##3##4##(2008-10#2)(2008-9#1)
within each of##9##3##(1993-1#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-3#1)
within each population##2##3##(2008-10#2)
within each stage##2##3##(1995-1#1)(2008-10#1)
within each subpopulation##2##3##(2008-10#2)
within each##49##2##(1991-2#1)(1993-1#1)(1994-9#1)(1995-1#2)(1995-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#24)(2008-11#3)(2008-6#2)(2008-8#3)(2008-9#2)(2010-11#1)(2010-9#1)(2011-2#2)(2012-3#2)
within electropolymerized##2##2##(2008-10#2)
within eukaryotic##2##2##(2008-4#1)(2010-5#1)
within experimental error##3##3##(2008-10#3)
within families##4##2##(2009-5#1)(2011-1#1)(2012-3#2)
within field##2##2##(2008-10#2)
within fields##8##2##(2008-10#8)
within fifteen##2##2##(1997-1#1)(2008-11#1)
within five##2##2##(1992-5#1)(2008-9#1)
within groups##8##2##(1996-6#3)(2008-10#2)(2008-8#2)(2008-9#1)
within health care##2##3##(1992-2#1)(1993-3#1)
within health sectors##2##3##(2008-12#2)
within health##5##2##(1992-2#1)(1993-3#1)(1995-12#1)(2008-12#2)
within host##2##2##(2008-9#1)(2012-2#1)
within individual trees##2##3##(2008-10#2)
within individual##5##2##(2008-10#4)(2009-7#1)
within infected cells##2##3##(2008-10#2)
within infected##3##2##(2008-10#3)
within intact cells##2##3##(1992-12#1)(2008-11#1)
within isolates of##3##3##(2008-10#3)
within isolates##4##2##(2008-10#4)
within it##3##2##(2007-12#1)(2008-12#1)(2010-10#1)
within its##10##2##(1991-5#1)(1991-6#1)(1992-1#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-8#1)(2012-2#1)
within large##2##2##(2008-10#1)(2008-3#1)
within local##2##2##(2008-10#1)(2008-8#1)
within normal limits##2##3##(2008-9#1)(2010-7#1)
within normal range##6##3##(2006-6#1)(2008-7#4)(2012-2#1)
within normal##10##2##(2006-6#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
within nursing homes##2##3##(1995-2#1)(2010-8#1)
within nursing##6##2##(1995-2#1)(1997-2#1)(2008-11#3)(2010-8#1)
within one##17##2##(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-12#1)(1997-1#1)(2008-11#8)(2010-11#1)(2010-12#1)(2010-6#1)
within only##2##2##(2008-10#2)
within or between##2##3##(2009-7#1)(2012-2#1)
within or close to##2##4##(1992-6#1)(1996-8#1)
within or##7##2##(1991-6#1)(1992-6#1)(1996-8#2)(2008-10#1)(2009-7#1)(2012-2#1)
within our discipline##2##3##(2008-12#2)
within our society##2##3##(1994-12#1)(1997-2#1)
within our##10##2##(1994-12#2)(1997-2#2)(1997-3#1)(2008-12#3)(2008-9#1)(2010-10#1)
within pH##2##2##(2008-10#2)
within pathotypes##2##2##(2008-10#2)
within physiological##2##2##(2008-10#1)(2011-2#1)
within plant##2##2##(2008-10#2)
within plots##3##2##(2008-10#3)
within population##2##2##(2008-10#2)
within populations and##2##3##(2008-10#1)(2008-8#1)
within populations of the##3##4##(2008-10#1)(2008-8#2)
within populations of##6##3##(2008-10#4)(2008-8#2)
within populations##22##2##(2008-10#17)(2008-8#3)(2008-9#1)(2012-7#1)
within primary health care for older people##2##7##(2010-10#2)
within primary health care for##3##5##(2010-10#3)
within primary##4##2##(1996-12#1)(2010-10#3)
within quadrats##2##2##(2008-10#1)(2008-8#1)
within range of##2##3##(2013-1#2)
within regions##9##2##(1994-3#1)(2008-10#7)(2011-2#1)
within restricted##2##2##(2011-2#1)(2012-2#1)
within root##2##2##(2008-10#2)
within rows##4##2##(2008-10#2)(2008-12#2)
within sampling units##2##3##(2008-10#2)
within sampling##5##2##(2008-10#5)
within schools of public health##2##5##(1997-2#2)
within several##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
within single##2##2##(2008-10#1)(2008-5#1)
within six##3##2##(1991-11#1)(1991-6#1)(2008-12#1)
within small##2##2##(2008-10#1)(2013-1#1)
within some##3##2##(2008-10#2)(2008-7#1)
within species##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
within subpopulations##7##2##(2008-10#7)
within such##5##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
within that##2##2##(2008-5#1)(2010-10#1)
within the 5'-flanking##2##3##(1993-8#1)(1994-2#1)
within the A##2##3##(2008-10#1)(2008-3#1)
within the DNA region that##2##5##(1991-9#1)(1993-2#1)
within the F##2##3##(2008-10#2)
within the ITS region##2##4##(2008-10#2)
within the N-terminal##2##3##(1993-8#1)(1996-3#1)
within the NAc##2##3##(2008-7#2)
within the STR pairs##2##4##(2008-12#2)
within the Singapore Chinese Health Study##2##6##(2010-6#2)
within the U##2##3##(2008-10#2)
within the UK##2##3##(2008-10#1)(2010-4#1)
within the United States##3##4##(2008-10#2)(2008-11#1)
within the University of##2##4##(2008-12#2)
within the University##3##3##(2008-11#1)(2008-12#2)
within the acceptable range##2##4##(2008-10#1)(2008-11#1)
within the acceptable##3##3##(2008-10#2)(2008-11#1)
within the appropriate##2##3##(2008-3#1)(2012-3#1)
within the area##2##3##(2008-10#1)(2008-11#1)
within the body##3##3##(1994-1#1)(2008-9#1)(2013-7#1)
within the cavity of a##2##5##(2008-2#1)(2008-3#1)
within the cell##9##3##(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)
within the cells##2##3##(2008-11#1)(2011-2#1)
within the central metabolism##2##4##(2008-7#2)
within the central nervous system##6##5##(1991-7#1)(1995-2#1)(2008-7#3)(2013-1#1)
within the central##9##3##(1991-7#1)(1995-2#1)(2008-7#5)(2008-9#1)(2013-1#1)
within the class##2##3##(2008-10#1)(2011-2#1)
within the clinical##3##3##(1991-2#1)(2008-12#2)
within the coding region and##2##5##(1990-6#1)(1993-6#1)
within the coding region##3##4##(1990-6#1)(1993-6#1)(2008-10#1)
within the colonies##2##3##(2008-10#1)(2008-9#1)
within the community##7##3##(1991-12#1)(1994-1#2)(2008-11#2)(2008-12#1)(2008-6#1)
within the concentration range of 0##2##6##(2008-10#2)
within the concentration range of##4##5##(2008-10#4)
within the concentration range##7##4##(2008-10#7)
within the concentration##8##3##(2008-10#8)
within the confines of##3##4##(2008-10#2)(2008-11#1)
within the context of the##8##5##(1991-3#1)(1992-3#1)(1993-3#1)(2008-11#2)(2011-2#1)(2012-12#2)
within the context of##18##4##(1991-3#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-11#6)(2008-3#2)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-8#1)
within the core##4##3##(1996-2#1)(1997-2#1)(2012-2#1)(2013-1#1)
within the country##3##3##(1994-9#1)(1997-8#1)(2008-10#1)
within the crystal##2##3##(1992-4#1)(2008-2#1)
within the current##2##3##(2008-11#1)(2008-12#1)
within the curriculum##2##3##(2008-11#1)(2008-12#1)
within the cytoplasm of##2##4##(2006-6#1)(2008-10#1)
within the cytoplasm##4##3##(2006-6#2)(2008-10#2)
within the developing##2##3##(2007-12#1)(2008-12#1)
within the device##2##3##(1996-2#1)(2008-3#1)
within the embryo##2##3##(2007-12#1)(2008-5#1)
within the facility##2##3##(1991-12#2)
within the family Cucurbitaceae##2##4##(2008-10#2)
within the family##6##3##(2008-10#4)(2008-12#2)
within the first 2 weeks of treatment##2##7##(2008-6#2)
within the first 2##4##4##(2008-10#1)(2008-6#2)(2008-7#1)
within the first few##2##4##(1996-1#1)(2008-9#1)
within the first second after stimulation##2##6##(2013-8#2)
within the first second after##3##5##(2013-8#3)
within the first year##2##4##(2008-7#1)(2009-10#1)
within the first##26##3##(1992-1#1)(1992-4#1)(1993-8#1)(1995-6#1)(1996-1#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#3)
within the framework of a##3##5##(1995-5#1)(2008-2#1)(2008-3#1)
within the framework of the##4##5##(1990-6#1)(1994-6#1)(2008-2#1)(2008-3#1)
within the framework of##12##4##(1990-6#1)(1991-3#1)(1994-6#1)(1995-5#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-3#2)
within the genus##6##3##(2008-10#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)
within the given##2##3##(2008-10#1)(2008-7#1)
within the group of##3##4##(2008-10#1)(2009-9#1)(2011-2#1)
within the group##4##3##(2008-10#1)(2009-9#1)(2010-3#1)(2011-2#1)
within the hair##2##3##(2007-12#1)(2008-5#1)
within the health care##5##4##(1991-1#1)(1997-2#1)(2008-11#1)(2008-7#1)(2011-1#1)
within the home and##2##4##(2009-5#2)
within the hospital##3##3##(1990-3#1)(2010-9#1)(2013-8#1)
within the host##3##3##(2008-10#2)(2008-11#1)
within the human respiratory tract##2##5##(2011-2#1)(2013-1#1)
within the human##4##3##(1997-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
within the interval##2##3##(1994-11#1)(2013-8#1)
within the last few years##2##5##(2008-5#1)(2012-12#1)
within the last##8##3##(1990-6#1)(1995-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#1)
within the leading##2##3##(2008-10#2)
within the left##2##3##(1997-6#1)(2013-8#1)
within the limits##2##3##(2008-10#1)(2008-11#1)
within the linear##2##3##(2008-10#2)
within the lymphatic##2##3##(2008-9#1)(2010-1#1)
within the matrix##3##3##(2008-10#2)(2008-8#1)
within the measurement##2##3##(2008-3#2)
within the median domain##2##4##(2007-12#2)
within the membrane##4##3##(1990-5#1)(1991-5#1)(1993-6#1)(1994-5#1)
within the microenvironment##2##3##(2009-3#2)
within the middle ear cavity##2##5##(1991-3#1)(2013-7#1)
within the necrotic##2##3##(2008-10#2)
within the next##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
within the normal range##2##4##(2008-12#1)(2011-2#1)
within the normal##4##3##(2008-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
within the nucleus of##2##4##(1994-11#1)(1994-6#1)
within the nucleus##7##3##(1993-6#1)(1994-11#1)(1994-6#1)(2007-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
within the nursing##3##3##(2008-11#2)(2008-12#1)
within the one##2##3##(1995-12#1)(2008-11#1)
within the oocyte nucleus##2##4##(2007-12#2)
within the oocyte##3##3##(1994-9#1)(2007-12#2)
within the orchards##2##3##(2008-10#2)
within the organization##2##3##(1995-1#1)(1997-1#1)
within the pH range##2##4##(2008-10#2)
within the pH##3##3##(2008-10#3)
within the past 100##2##4##(1994-3#1)(2013-8#1)
within the patch##2##3##(2008-8#2)
within the pathogen##2##3##(2008-10#2)
within the pentose phosphate pathway##2##5##(1991-5#1)(2008-7#1)
within the pharmaceutical##2##3##(2008-10#1)(2008-11#1)
within the phylum##2##3##(2011-2#2)
within the physiological range##2##4##(2008-10#2)
within the plant##2##3##(2008-10#2)
within the population##7##3##(1996-3#1)(2008-10#2)(2008-8#2)(2010-5#1)(2012-3#1)
within the pores of##2##4##(2008-10#2)
within the pores##3##3##(2008-10#2)(2010-12#1)
within the postero-medial NAS##2##4##(1993-6#2)
within the previous 12 months##2##5##(2009-5#1)(2010-10#1)
within the previously##2##3##(2008-10#1)(2012-3#1)
within the profession##2##3##(1994-12#1)(1996-1#1)
within the program##2##3##(1994-5#1)(1995-1#1)
within the protein##2##3##(1990-5#1)(1994-5#1)
within the pyramid and##2##4##(2008-6#2)
within the quadrat##3##3##(2008-10#3)
within the range 0##2##4##(2008-10#2)
within the range 2##2##4##(2008-10#2)
within the range of 0##3##5##(2008-10#2)(2010-11#1)
within the range of 100 to##2##6##(2008-11#1)(2010-11#1)
within the range of##14##4##(1995-2#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-9#1)(2010-11#2)(2013-1#1)
within the range##26##3##(1991-2#1)(1995-2#1)(2008-10#16)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#2)(2013-1#1)
within the ranges of##2##4##(2008-10#1)(2008-5#1)
within the ranges##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
within the rat##2##3##(1993-6#1)(2010-6#1)
within the region##3##3##(1996-12#1)(2008-11#1)(2008-8#1)
within the regions##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
within the same##18##3##(1993-6#1)(1994-8#1)(1995-12#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
within the sample##2##3##(2008-10#2)
within the sat-RNA##2##3##(2008-10#2)
within the scope of##2##4##(2008-11#1)(2008-7#1)
within the sinus##2##3##(2008-7#1)(2013-1#1)
within the subgroup##2##3##(2008-10#2)
within the system##2##3##(2008-3#1)(2008-8#1)
within the thymus##2##3##(1997-9#1)(2013-7#1)
within the tumor microenvironment##3##4##(2009-3#1)(2013-1#2)
within the tumor##4##3##(1993-11#1)(2009-3#1)(2013-1#2)
within the vector##2##3##(2008-10#1)(2011-3#1)
within the vertebral##2##3##(2008-12#1)(2011-2#1)
within the work-family##2##3##(2009-10#2)
within the working range of the##2##6##(2008-10#2)
within the##857##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#5)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#4)(1992-4#4)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#9)(1993-8#6)(1994-1#3)(1994-11#2)(1994-12#3)(1994-2#6)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#5)(1995-5#1)(1995-6#6)(1995-8#1)(1996-1#2)(1996-12#4)(1996-2#5)(1996-3#3)(1996-6#1)(1997-1#3)(1997-2#4)(1997-3#7)(1997-6#2)(1997-7#3)(1997-8#5)(1997-9#4)(2006-6#2)(2007-12#12)(2008-1#4)(2008-10#248)(2008-11#73)(2008-12#28)(2008-2#8)(2008-3#21)(2008-4#3)(2008-5#16)(2008-6#7)(2008-7#29)(2008-8#19)(2008-9#21)(2009-10#9)(2009-12#3)(2009-3#4)(2009-4#2)(2009-5#4)(2009-7#6)(2009-8#1)(2009-9#2)(2010-1#6)(2010-10#7)(2010-11#6)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#31)(2011-3#3)(2012-12#4)(2012-2#15)(2012-3#12)(2013-1#22)(2013-7#3)(2013-8#18)
within their##13##2##(1992-6#1)(1994-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-12#1)(2012-2#1)(2013-8#1)
within them##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
within therapeutic##2##2##(2008-12#1)(2008-3#1)
within these##9##2##(1991-5#1)(1992-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-10#1)(2012-3#1)
within this genus##2##3##(2008-9#1)(2010-10#1)
within this population##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
within this range##2##3##(2008-10#2)
within this sequence##2##3##(1993-3#1)(2011-2#1)
within this species##2##3##(2008-10#2)
within this##31##2##(1993-12#1)(1993-3#1)(1995-2#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#2)
within those##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
within three months##3##3##(1991-9#1)(2008-11#1)(2013-1#1)
within three##6##2##(1991-9#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
within tissue##3##2##(2008-10#1)(2008-3#2)
within trials##2##2##(2008-10#1)(2008-12#1)
within two hours##2##3##(1990-9#1)(2010-6#1)
within two months##2##3##(1995-9#1)(2008-8#1)
within two##11##2##(1990-12#1)(1990-9#1)(1992-1#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2010-6#1)
within vessels of##2##3##(2008-10#2)
within wards that used measurement tools##2##6##(2013-1#2)
within weeks##4##2##(1991-8#2)(2008-7#1)(2008-9#1)
within which a##2##3##(1992-12#1)(1997-1#1)
within which##11##2##(1991-2#1)(1992-12#1)(1993-2#1)(1994-2#2)(1995-3#1)(1997-1#1)(2008-1#2)(2008-10#2)
within years##2##2##(2008-10#2)
within your##3##2##(1991-2#1)(1993-12#1)(1993-2#1)
within##2260##1##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#6)(1990-3#1)(1990-5#4)(1990-6#9)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#14)(1991-2#9)(1991-3#7)(1991-4#1)(1991-5#8)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#4)(1992-10#1)(1992-12#10)(1992-2#6)(1992-3#5)(1992-4#7)(1992-5#4)(1992-6#6)(1992-8#1)(1992-9#7)(1993-1#8)(1993-11#2)(1993-12#15)(1993-2#6)(1993-3#6)(1993-6#11)(1993-8#9)(1993-9#3)(1994-1#4)(1994-11#6)(1994-12#13)(1994-2#11)(1994-3#8)(1994-5#10)(1994-6#3)(1994-8#3)(1994-9#7)(1995-1#6)(1995-11#4)(1995-12#14)(1995-2#17)(1995-3#6)(1995-5#2)(1995-6#12)(1995-8#5)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#12)(1996-2#17)(1996-3#6)(1996-5#1)(1996-6#11)(1996-8#3)(1997-1#10)(1997-2#12)(1997-3#10)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#6)(1997-8#7)(1997-9#5)(2006-6#3)(2007-11#1)(2007-12#22)(2008-1#12)(2008-10#787)(2008-11#179)(2008-12#67)(2008-2#13)(2008-3#61)(2008-4#9)(2008-5#36)(2008-6#13)(2008-7#48)(2008-8#69)(2008-9#60)(2009-1#1)(2009-10#15)(2009-11#4)(2009-12#9)(2009-3#5)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#14)(2009-8#6)(2009-9#3)(2010-1#6)(2010-10#20)(2010-11#17)(2010-12#12)(2010-3#3)(2010-4#6)(2010-5#4)(2010-6#8)(2010-7#9)(2010-8#9)(2010-9#3)(2011-1#14)(2011-2#74)(2011-3#5)(2012-12#8)(2012-2#40)(2012-3#38)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#51)(2013-7#3)(2013-8#30)
within- and##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
within-brood##2##1##(2008-9#2)
within-day##5##1##(1991-2#1)(2008-10#4)
within-family##3##1##(2008-10#1)(2008-12#1)(2009-5#1)
within-field spread of##2##3##(2008-10#2)
within-field##9##1##(2008-10#9)
within-group##6##1##(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
within-host##2##1##(2008-9#1)(2013-1#1)
within-row##3##1##(2008-10#3)
within-run and between-run##3##3##(1990-2#1)(2008-10#2)
within-run##6##1##(1990-2#1)(2008-10#5)
within-state##2##1##(1997-1#2)
without AIDS##3##2##(2011-2#3)
without BSA##3##2##(1991-5#3)
without CP##2##2##(2012-2#2)
without HF##2##2##(2008-10#2)
without PD##2##2##(2009-10#1)(2013-1#1)
without a high##2##3##(2010-8#1)(2011-2#1)
without a history of dysfunction##2##5##(2010-9#2)
without a history of##6##4##(1991-3#1)(2010-9#2)(2011-2#2)(2013-8#1)
without a significant##3##3##(1992-12#1)(1992-2#1)(2010-10#1)
without a##55##2##(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
without access to##3##3##(1990-6#1)(2009-5#1)(2013-1#1)
without acetonitrile##2##2##(2008-10#2)
without activating##2##2##(1995-11#1)(2009-7#1)
without added##2##2##(2008-10#2)
without adding##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
without addition of##6##3##(2008-10#5)(2008-11#1)
without additional##5##2##(1990-11#1)(1996-2#1)(2008-10#2)(2008-7#1)
without adverse##2##2##(1997-1#1)(2010-4#1)
without affecting quality##2##3##(1992-1#1)(2011-2#1)
without affecting the binding of##2##5##(1993-3#1)(1994-6#1)
without affecting the##4##3##(1993-3#2)(1994-6#1)(2008-7#1)
without affecting##23##2##(1992-1#1)(1993-3#2)(1993-6#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
without altering the##4##3##(1990-12#1)(1993-3#1)(2008-11#2)
without altering##5##2##(1990-12#1)(1993-3#1)(2008-11#2)(2011-2#1)
without an##12##2##(1991-3#1)(1991-6#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
without and with##3##3##(2008-10#1)(2010-3#1)(2011-2#1)
without antibiotics##3##2##(1994-3#1)(1997-4#1)(2006-5#1)
without any adverse effect##2##4##(2008-10#1)(2008-3#1)
without any apparent##3##3##(1995-2#1)(2008-11#1)(2013-1#1)
without any appreciable##2##3##(2008-10#2)
without any chemical##2##3##(2008-10#2)
without any complications##2##3##(1991-12#1)(2012-3#1)
without any considerable divergence in potentials##2##6##(2008-10#2)
without any considerable divergence in##4##5##(2008-10#4)
without any considerable##6##3##(2008-10#6)
without any decrease in##2##4##(2008-10#1)(2011-2#1)
without any divergence in potential##2##5##(2008-10#2)
without any divergence in##3##4##(2008-10#3)
without any doubt##2##3##(1997-4#1)(2008-9#1)
without any effect on the##2##5##(1991-11#1)(2008-11#1)
without any effect on##3##4##(1991-11#1)(1995-3#1)(2008-11#1)
without any evidence of##2##4##(2008-5#1)(2008-9#1)
without any further##5##3##(2007-12#1)(2008-10#3)(2012-12#1)
without any interference from##2##4##(2008-10#2)
without any major##2##3##(1992-2#1)(2008-10#1)
without any other##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
without any pre-treatment##4##3##(2008-10#4)
without any pretreatment##6##3##(2008-10#6)
without any previous##4##3##(2008-10#4)
without any prior separation##2##4##(2008-10#2)
without any prior##4##3##(2008-10#4)
without any purification##2##3##(2008-10#2)
without any sample##2##3##(2008-10#2)
without any significant##7##3##(2008-10#3)(2010-2#1)(2011-2#1)(2013-1#2)
without any signs##3##3##(1990-8#1)(1996-9#1)(2008-11#1)
without any symptoms##2##3##(2008-10#1)(2008-12#1)
without any treatment##2##3##(1997-3#1)(2008-10#1)
without any##149##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#77)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2011-2#13)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
without apparent##2##2##(1997-1#1)(1997-8#1)
without appreciable##2##2##(1991-5#1)(2012-2#1)
without associated##5##2##(1992-3#1)(1995-1#1)(1997-1#1)(2008-9#1)(2009-5#1)
without being##3##2##(1990-8#1)(2008-5#1)(2008-7#1)
without benefit##2##2##(1997-7#1)(2008-10#1)
without blood transfusion]##2##3##(1990-2#2)
without bone##5##2##(1993-11#1)(1994-12#2)(2011-2#2)
without brain##4##2##(1991-2#1)(1995-3#1)(2012-3#2)
without breast cancer##2##3##(2013-1#2)
without breast##3##2##(1994-12#1)(2013-1#2)
without broccoli##2##2##(2008-10#2)
without cardiac##2##2##(2008-3#1)(2013-1#1)
without cardiopulmonary bypass##2##3##(2011-3#1)(2013-8#1)
without causing any##2##3##(2008-10#2)
without causing significant##2##3##(2007-11#1)(2013-1#1)
without causing##10##2##(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#2)(2013-1#1)
without cervical##2##2##(1991-2#1)(1993-12#1)
without changes in the##3##4##(1991-5#1)(2008-11#2)
without changes in##6##3##(1991-5#1)(2008-11#3)(2008-5#1)(2008-8#1)
without changing the##3##3##(1994-5#1)(2008-10#2)
without chemical##3##2##(1994-5#1)(2008-10#2)
without chronic##2##2##(2008-7#1)(2008-9#1)
without clinical##2##2##(1997-6#1)(2008-10#1)
without complications##3##2##(1990-9#1)(2013-1#2)
without compromise##2##2##(2008-10#1)(2011-2#1)
without compromising the##2##3##(1992-2#1)(2012-2#1)
without compromising##6##2##(1992-2#1)(2008-10#1)(2008-7#1)(2010-10#1)(2012-2#2)
without concomitant##4##2##(2008-12#1)(2008-4#2)(2013-1#1)
without considerable##2##2##(1991-6#1)(2008-10#1)
without contamination for a long time##2##6##(2008-10#2)
without coronary##2##2##(1991-3#1)(2008-11#1)
without cross##2##2##(2008-11#1)(2009-8#1)
without culture##2##2##(2008-11#1)(2009-6#1)
without cytoplasmic fusion##2##3##(1991-5#2)
without delay##2##2##(2009-12#1)(2013-1#1)
without dementia##5##2##(2008-7#4)(2012-3#1)
without derivatization##3##2##(2008-10#2)(2008-5#1)
without detectable##2##2##(1990-3#1)(1991-11#1)
without diabetes##4##2##(2008-11#1)(2010-10#1)(2010-4#1)(2012-3#1)
without differences in##2##3##(1991-12#1)(1993-2#1)
without differences##3##2##(1991-12#1)(1993-2#1)(2011-2#1)
without disease progress##2##3##(2008-10#2)
without disease##3##2##(2008-10#2)(2012-12#1)
without dissection##2##2##(1994-3#1)(2008-10#1)
without disturbance##2##2##(2008-10#1)(2008-9#1)
without disturbing the##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
without effect on##4##3##(1991-6#1)(1993-6#1)(1995-8#1)(2008-10#1)
without effect##9##2##(1991-6#1)(1993-6#1)(1994-6#1)(1995-8#2)(1996-2#1)(1997-1#1)(2006-6#1)(2008-10#1)
without effects on##2##3##(2008-10#2)
without evidence of disease##2##4##(1990-2#1)(2012-12#1)
without evidence of##9##3##(1990-2#1)(1995-12#1)(1997-5#1)(1997-6#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
without exposure to##2##3##(2008-11#1)(2011-2#1)
without exposure##3##2##(2008-11#1)(2011-2#2)
without extended##2##2##(2008-7#2)
without extraction##3##2##(2008-10#3)
without fear of##3##3##(1996-5#1)(2008-10#1)(2013-8#1)
without feedback##2##2##(1990-3#1)(2009-10#1)
without forming##2##2##(1994-5#1)(2008-10#1)
without fracture##2##2##(1991-11#1)(2012-3#1)
without further##10##2##(1991-12#1)(1994-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
without gas##2##2##(2008-11#1)(2012-12#1)
without genetic alteration of p53##2##5##(1994-12#2)
without glucose##2##2##(2008-11#1)(2008-7#1)
without glutamine##2##2##(2008-11#2)
without having to##4##3##(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)
without having##6##2##(1995-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)
without history of##3##3##(1992-6#1)(2008-12#1)(2008-9#1)
without immigration##3##2##(2008-8#3)
without improvement##2##2##(2012-3#1)(2013-8#1)
without increase##2##2##(2008-10#1)(2012-3#1)
without increasing the risk##2##4##(1997-3#1)(2008-9#1)
without increasing the##5##3##(1994-5#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-9#1)
without increasing##8##2##(1990-2#1)(1994-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)
without inducing##3##2##(2008-10#2)(2008-11#1)
without infection had##2##3##(2008-10#2)
without infection##4##2##(2008-10#3)(2012-3#1)
without influencing the##2##3##(1995-11#1)(2008-10#1)
without influencing##3##2##(1995-11#1)(2008-10#1)(2008-7#1)
without interference from##3##3##(2008-10#3)
without interference of the matrix##2##5##(2008-10#2)
without interference of##3##3##(2008-10#3)
without interference##8##2##(2008-10#8)
without interferences##2##2##(2008-10#2)
without interfering##2##2##(2008-10#1)(2008-5#1)
without interruption of the##2##4##(2008-10#1)(2008-11#1)
without intravenous##2##2##(1992-12#1)(2008-5#1)
without involvement of##3##3##(1996-6#1)(2010-11#1)(2011-2#1)
without its##4##2##(1993-12#1)(2008-12#2)(2010-11#1)
without known##3##2##(1997-5#1)(2008-12#1)(2008-9#1)
without local##2##2##(1994-6#1)(2013-1#1)
without loss of prediction capacity using spectrophotometric method##2##8##(2008-10#2)
without loss of##12##3##(1993-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#1)
without major complications##2##3##(1992-5#1)(2011-2#1)
without matrix matching##2##3##(2008-10#2)
without matrix##5##2##(2008-10#5)
without metastasis##3##2##(1992-5#1)(1993-3#1)(2012-3#1)
without mishap##2##2##(1997-6#1)(2008-7#1)
without modifier##7##2##(2008-10#7)
without much##4##2##(1997-2#1)(1997-6#1)(2008-1#1)(2008-2#1)
without need for##2##3##(2008-10#1)(2008-11#1)
without need##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
without neurological##2##2##(1997-6#1)(2008-7#1)
without noticeable##3##2##(2008-10#3)
without observing any deviation##2##4##(2008-10#2)
without observing any##5##3##(2008-10#5)
without obvious##3##2##(1994-9#1)(2008-10#1)(2009-1#1)
without or with##2##3##(2008-10#1)(2008-12#1)
without overt##3##2##(2011-2#3)
without particular##2##2##(1991-3#1)(1993-6#1)
without perforation##2##2##(1993-6#2)
without photoradiation##2##2##(1990-6#2)
without pre-treatment of the##2##4##(2008-10#2)
without pre-treatment##3##2##(2008-10#3)
without preconcentration and##2##3##(2008-10#2)
without preconcentration##3##2##(2008-10#3)
without pretreatment##3##2##(1995-6#1)(2008-10#2)
without previous extraction##2##3##(2008-10#2)
without previous separation##4##3##(2008-10#4)
without previous separations##2##3##(2008-10#2)
without previous treatment##3##3##(2008-10#2)(2013-8#1)
without previous##17##2##(1992-2#1)(1994-5#1)(1996-12#1)(2008-10#11)(2011-2#1)(2013-1#1)(2013-8#1)
without prior sample##3##3##(2008-10#3)
without prior separation steps##2##4##(2008-10#2)
without prior separation##3##3##(2008-10#3)
without prior treatment##2##3##(2008-10#2)
without prior##15##2##(1992-3#1)(1996-1#1)(2008-1#2)(2008-10#9)(2010-12#1)(2010-4#1)
without recourse to##2##3##(2008-10#1)(2008-5#1)
without recurrence##2##2##(2008-7#2)
without reducing the##4##3##(1994-2#1)(1996-11#1)(2008-10#1)(2008-2#1)
without reducing##5##2##(1994-2#1)(1996-11#1)(2008-10#1)(2008-2#1)(2010-5#1)
without reduction of##3##3##(2008-10#1)(2008-12#1)(2009-11#1)
without relief##2##2##(1995-10#1)(2008-9#1)
without removing the##2##3##(2008-10#1)(2008-9#1)
without remuneration##2##2##(2008-1#2)
without renal##3##2##(1990-3#1)(2012-3#2)
without requiring##5##2##(1995-2#1)(2008-10#2)(2008-7#1)(2013-1#1)
without risking##2##2##(2008-10#1)(2011-2#1)
without sacrificing##2##2##(2008-5#1)(2009-9#1)
without sample pre-treatment##2##3##(2008-10#2)
without sample##4##2##(2008-10#4)
without scrototomy##2##2##(1997-8#2)
without selection##2##2##(1993-9#1)(2008-10#1)
without separation##3##2##(2008-10#3)
without serious##2##2##(2008-3#1)(2010-11#1)
without serum##5##2##(1996-2#1)(2008-11#4)
without side##2##2##(1997-3#1)(2010-1#1)
without significant change in##2##4##(2008-3#1)(2008-7#1)
without significant differences##2##3##(2008-11#1)(2008-9#1)
without significant##15##2##(1991-12#1)(1991-2#1)(1992-4#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2013-1#1)
without signs of##3##3##(1991-11#1)(1993-1#1)(2012-12#1)
without some##3##2##(1992-12#1)(1995-5#1)(2008-11#1)
without statistically significant##2##3##(2008-10#2)
without stenosis##2##2##(1993-8#1)(2013-1#1)
without substantial##2##2##(2008-10#1)(2010-10#1)
without such##3##2##(1991-2#1)(1994-2#1)(2008-7#1)
without supplementary##2##2##(1993-2#1)(1996-2#1)
without symptoms##2##2##(2008-10#1)(2008-12#1)
without systemic##2##2##(2008-7#1)(2013-8#1)
without temperature##2##2##(2008-10#1)(2008-2#1)
without the addition of##7##4##(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)
without the adsorptive accumulation##2##4##(2008-10#2)
without the interference of##3##4##(2008-10#3)
without the interference##4##3##(2008-10#4)
without the necessity##2##3##(1995-8#1)(2008-9#1)
without the need for a##2##5##(2008-10#1)(2008-11#1)
without the need for further##2##5##(1993-6#1)(2008-4#1)
without the need for tedious##2##5##(2008-10#2)
without the need for##19##4##(1993-6#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2013-8#1)
without the need of a##2##5##(2008-10#1)(2008-11#1)
without the need of##4##4##(2008-10#3)(2008-11#1)
without the need to##2##4##(2008-10#2)
without the need##25##3##(1993-6#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2013-8#1)
without the presence of##5##4##(2008-10#3)(2008-11#1)(2011-2#1)
without the previous accumulation##2##4##(2008-10#2)
without the routine use of ultrasonography##2##6##(2011-2#2)
without the routine use of##3##5##(2011-2#3)
without the traditional##2##3##(1993-2#1)(2013-1#1)
without the use of##9##4##(1992-3#1)(1992-4#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-3#1)
without the##115##2##(1990-7#1)(1991-5#1)(1992-10#1)(1992-3#2)(1992-4#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#43)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-7#2)(2011-2#9)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
without their##2##2##(1995-12#1)(2008-7#1)
without titration has been developed##2##5##(2008-10#2)
without titration##8##2##(2008-10#8)
without treatment##5##2##(1990-11#1)(1991-11#1)(2008-7#1)(2010-9#1)(2012-12#1)
without urinary##2##2##(2008-10#1)(2012-12#1)
without use of##2##3##(1990-11#1)(2011-2#1)
without using a##2##3##(1991-6#1)(2008-10#1)
without using any##3##3##(2008-10#2)(2008-3#1)
without using internal##2##3##(1997-2#1)(2008-10#1)
without using of##2##3##(2008-10#2)
without using the##3##3##(2008-10#2)(2010-6#1)
without using##19##2##(1990-2#1)(1991-6#1)(1996-12#1)(1996-6#1)(1997-2#2)(2008-10#11)(2008-3#1)(2010-6#1)
without wetness##3##2##(2008-10#3)
without##1518##1##(1990-11#6)(1990-12#2)(1990-2#8)(1990-3#6)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#8)(1991-12#8)(1991-2#5)(1991-3#7)(1991-5#8)(1991-6#5)(1991-8#3)(1992-1#2)(1992-10#1)(1992-12#6)(1992-2#6)(1992-3#10)(1992-4#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#6)(1993-11#3)(1993-12#9)(1993-2#8)(1993-3#6)(1993-5#1)(1993-6#10)(1993-8#5)(1993-9#3)(1994-11#4)(1994-12#13)(1994-2#9)(1994-3#7)(1994-5#7)(1994-6#5)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#7)(1995-3#5)(1995-5#1)(1995-6#4)(1995-8#6)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#11)(1996-3#2)(1996-5#3)(1996-6#5)(1996-8#3)(1996-9#6)(1997-1#5)(1997-2#8)(1997-3#11)(1997-4#5)(1997-5#4)(1997-6#13)(1997-7#8)(1997-8#10)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#7)(2007-8#3)(2008-1#10)(2008-10#461)(2008-11#93)(2008-12#21)(2008-2#7)(2008-3#25)(2008-4#12)(2008-5#30)(2008-6#6)(2008-7#52)(2008-8#25)(2008-9#38)(2009-1#1)(2009-10#6)(2009-11#5)(2009-12#5)(2009-3#5)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#9)(2009-9#2)(2010-1#6)(2010-10#13)(2010-11#3)(2010-12#11)(2010-2#1)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#9)(2010-7#8)(2010-8#7)(2010-9#3)(2011-1#1)(2011-10#1)(2011-2#73)(2011-3#2)(2012-12#16)(2012-2#23)(2012-3#28)(2012-4#1)(2013-1#72)(2013-3#1)(2013-7#1)(2013-8#25)
withstand the##2##2##(2008-11#1)(2010-12#1)
withstand##7##1##(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2012-3#1)
withstands##2##1##(1997-2#1)(2008-9#1)
witness##5##1##(1993-12#1)(1994-3#1)(2008-8#1)(2012-2#1)(2013-8#1)
witnessed a##2##2##(2008-11#1)(2009-12#1)
witnessed##9##1##(1991-2#1)(1994-12#1)(1997-2#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-10#1)(2012-2#1)(2013-8#1)
witnesses##4##1##(1994-2#1)(1995-12#2)(2011-2#1)
witnessing##2##1##(2009-4#2)
wk##4##1##(1993-1#1)(2008-10#2)(2008-8#1)
wk)##2##1##(1994-2#1)(2008-9#1)
wks##4##1##(2012-3#4)
wo##2##1##(2008-11#2)
wobble##2##1##(2008-3#1)(2008-9#1)
wobbler##2##1##(1996-12#2)
woc##2##1##(2012-3#2)
woesei##5##1##(1993-9#1)(2011-2#4)
wolves##2##1##(1996-12#2)
woman aged##5##2##(1990-6#1)(1991-3#1)(1995-12#1)(1997-8#1)(2011-2#1)
woman and##5##2##(1990-2#1)(1995-6#1)(2009-1#1)(2009-10#1)(2010-12#1)
woman developed##2##2##(1991-9#1)(2013-1#1)
woman had##3##2##(1992-12#1)(1997-5#1)(2010-6#1)
woman in##4##2##(1991-12#1)(2008-1#1)(2008-11#1)(2012-2#1)
woman presented with a##4##4##(2009-3#1)(2010-6#1)(2012-3#1)(2013-7#1)
woman presented with##13##3##(1990-6#1)(2008-1#1)(2008-12#1)(2009-3#2)(2010-11#1)(2010-6#2)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
woman presented##14##2##(1990-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-3#2)(2010-11#1)(2010-6#2)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
woman presenting with##2##3##(2008-4#1)(2013-1#1)
woman received##2##2##(1995-8#1)(2008-5#1)
woman referred##2##2##(2008-12#1)(2009-8#1)
woman suffering from##2##3##(2012-2#1)(2013-1#1)
woman was admitted to our hospital##2##6##(1991-12#1)(2008-7#1)
woman was admitted to##3##4##(1991-12#1)(2008-7#1)(2011-2#1)
woman was admitted##4##3##(1991-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
woman was referred because of an##2##6##(2012-3#1)(2013-1#1)
woman was##11##2##(1991-12#1)(1993-6#1)(1995-2#1)(1995-8#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
woman who developed##2##3##(2008-7#1)(2010-3#1)
woman who had##2##3##(2010-6#1)(2013-8#1)
woman who presented with a##3##5##(2008-10#1)(2013-1#1)(2013-8#1)
woman who presented with##7##4##(1994-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
woman who presented##8##3##(1994-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
woman who was##2##3##(2007-8#1)(2011-2#1)
woman who##22##2##(1994-12#1)(1995-12#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#4)
woman with a history of##2##5##(2010-7#1)(2012-3#1)
woman with a##10##3##(1991-6#1)(1994-6#1)(1997-3#1)(2008-7#1)(2009-1#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
woman with an##3##3##(1991-11#1)(2011-2#1)(2013-1#1)
woman with early##2##3##(2008-8#1)(2012-3#1)
woman with known##2##3##(1990-12#1)(2011-2#1)
woman with##34##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-6#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-5#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#5)(2012-12#3)(2012-3#4)(2013-1#4)
woman##166##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#4)(1991-11#2)(1991-12#3)(1991-3#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#2)(1996-11#2)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#4)(2008-4#2)(2008-5#3)(2008-7#10)(2008-8#1)(2009-1#5)(2009-10#1)(2009-3#3)(2009-8#2)(2010-11#3)(2010-12#3)(2010-3#3)(2010-6#4)(2010-7#1)(2011-2#17)(2012-12#6)(2012-2#3)(2012-3#9)(2013-1#15)(2013-7#1)(2013-8#6)
woman's own##2##2##(1997-2#1)(2008-1#1)
woman's##9##1##(1995-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2010-10#1)(2013-1#1)
women &quot##2##2##(2008-12#1)(2009-4#1)
women (n =##2##3##(2008-11#1)(2011-2#1)
women 50##2##2##(1990-6#1)(1997-1#1)
women aged 18 to 27##2##5##(1992-1#2)
women aged 18 to##3##4##(1992-1#2)(2008-1#1)
women aged 60##2##3##(1996-6#1)(2011-2#1)
women aged between##3##3##(2010-3#1)(2011-2#2)
women aged##22##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1992-1#2)(1993-1#1)(1994-2#1)(1994-9#1)(1996-6#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-3#2)(2011-2#3)(2012-12#2)(2013-8#1)
women among##2##2##(1993-6#1)(2008-10#1)
women and 10%##2##3##(1991-11#1)(2010-11#1)
women and children##6##3##(1990-2#3)(1995-6#1)(1997-2#1)(2009-9#1)
women and men aged##3##4##(1991-6#2)(2009-10#1)
women and men from##2##4##(2011-2#1)(2012-2#1)
women and men##9##3##(1991-6#2)(1991-8#1)(1996-1#1)(2008-5#1)(2009-10#2)(2011-2#1)(2012-2#1)
women and the##3##3##(1996-2#1)(2008-12#1)(2008-9#1)
women and their##5##3##(1992-12#1)(2007-12#1)(2008-10#1)(2012-2#2)
women and##56##2##(1990-2#3)(1990-6#1)(1991-11#2)(1991-6#4)(1991-8#5)(1992-12#2)(1994-3#1)(1995-6#2)(1996-1#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#3)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#3)(2009-5#2)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)
women are more##2##3##(2008-4#1)(2012-2#1)
women are##16##2##(1991-11#1)(1993-3#1)(1994-2#1)(1995-12#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
women as##4##2##(1992-12#2)(1993-2#1)(1993-3#1)
women at risk for##2##4##(2008-4#1)(2011-2#1)
women at risk##3##3##(1990-9#1)(2008-4#1)(2011-2#1)
women at##7##2##(1990-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
women attending a##2##3##(1993-2#1)(1996-6#1)
women attending the##2##3##(2011-2#1)(2013-1#1)
women attending##4##2##(1993-2#1)(1996-6#1)(2011-2#1)(2013-1#1)
women before##2##2##(1997-4#1)(1997-8#1)
women between##4##2##(1995-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
women but##2##2##(1991-12#1)(2009-8#1)
women can##2##2##(2009-9#1)(2012-3#1)
women compared with##2##3##(2008-4#1)(2013-1#1)
women continue to##2##3##(1995-12#1)(2008-11#1)
women demonstrated##2##2##(2011-2#1)(2013-1#1)
women did not##2##3##(1996-1#1)(2010-6#1)
women did##3##2##(1996-1#1)(1996-6#1)(2010-6#1)
women during##3##2##(1995-12#1)(2008-4#1)(2010-9#1)
women experience more##2##3##(2008-7#2)
women for##2##2##(1990-2#1)(1996-2#1)
women from##7##2##(1994-9#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#2)
women had a##3##3##(1991-2#1)(1992-2#1)(2008-11#1)
women had had##2##3##(1990-6#1)(1990-8#1)
women had##17##2##(1990-6#2)(1990-8#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-8#1)(1997-4#1)(2008-11#3)(2008-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
women have not##2##3##(1994-6#1)(2009-4#1)
women have##6##2##(1991-2#1)(1994-6#1)(2008-11#2)(2008-4#1)(2009-4#1)
women in Japan##2##3##(1997-8#1)(2011-2#1)
women in New##3##3##(1994-9#1)(2008-1#2)
women in a rural##2##4##(2010-4#1)(2010-6#1)
women in a##3##3##(2008-12#1)(2010-4#1)(2010-6#1)
women in most##2##3##(2009-10#1)(2012-3#1)
women in the##9##3##(1993-3#1)(1993-6#2)(1996-9#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
women in their##2##3##(1991-3#1)(2008-5#1)
women in this group had##2##5##(2008-11#1)(2012-3#1)
women in this##4##3##(1994-2#1)(2008-11#1)(2010-6#1)(2012-3#1)
women in##62##2##(1990-12#1)(1990-6#3)(1991-3#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-6#5)(1994-2#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-11#4)(2008-12#3)(2008-5#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-6#3)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#2)
women is##6##2##(2009-10#1)(2010-3#3)(2013-1#2)
women living in##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
women living with##2##3##(1996-3#1)(2008-1#1)
women living##5##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
women may be##2##3##(2008-12#2)
women may##3##2##(2008-11#1)(2008-12#2)
women of reproductive age##3##4##(2011-1#2)(2011-2#1)
women of the##2##3##(1990-2#1)(1993-2#1)
women of##10##2##(1990-2#2)(1990-6#1)(1993-2#1)(1996-5#1)(2008-11#1)(2011-1#2)(2011-2#1)(2013-1#1)
women on##3##2##(1994-6#1)(2008-11#1)(2008-6#1)
women out of 100##2##4##(1992-2#1)(2008-11#1)
women over##4##2##(1990-8#1)(1991-3#1)(2008-5#1)(2012-3#1)
women physicians##2##2##(1993-6#2)
women referred##2##2##(1994-1#1)(2008-11#1)
women reported##5##2##(1990-12#1)(1990-6#1)(1990-8#1)(1997-3#1)(2008-12#1)
women seeking##2##2##(2008-11#1)(2013-8#1)
women still smoke##2##3##(1991-11#2)
women suffering from##3##3##(2008-11#1)(2013-1#2)
women taking##4##2##(2008-11#3)(2009-8#1)
women tended to##2##3##(2011-2#2)
women than for##2##3##(2008-12#1)(2011-2#1)
women than men##3##3##(2010-6#1)(2011-2#1)(2012-3#1)
women than##5##2##(2008-12#1)(2010-6#1)(2011-2#2)(2012-3#1)
women the##3##2##(1994-2#1)(1994-9#1)(2008-5#1)
women to##6##2##(1990-2#1)(1995-9#1)(1996-1#1)(2008-12#1)(2010-10#1)(2010-2#1)
women treated##5##2##(1991-2#1)(1992-3#1)(1994-12#1)(2008-5#1)(2011-2#1)
women under##2##2##(1992-2#1)(1997-2#1)
women undergoing##4##2##(1993-12#1)(1995-12#1)(2008-4#1)(2012-3#1)
women underwent##2##2##(1991-11#1)(1994-2#1)
women versus##2##2##(2008-12#1)(2013-1#1)
women volunteers##3##2##(1994-2#1)(2008-5#1)(2013-8#1)
women was##7##2##(1991-11#1)(1991-6#1)(1994-9#1)(1997-4#1)(2009-9#1)(2010-3#2)
women were more##2##3##(1990-12#1)(2008-1#1)
women were randomized to receive##2##5##(2011-2#2)
women were recruited from##2##4##(2013-1#2)
women were##27##2##(1990-12#1)(1990-6#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-12#2)(1995-3#2)(1996-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#4)(2012-3#2)(2013-1#4)
women who are medically underserved##2##5##(1997-1#2)
women who are##8##3##(1990-9#1)(1992-3#1)(1995-6#1)(1995-9#1)(1997-1#2)(2008-3#1)(2012-3#1)
women who had had##2##4##(1993-2#1)(2011-2#1)
women who had##4##3##(1990-12#1)(1993-2#1)(2011-2#2)
women who required##2##3##(1993-1#1)(1995-8#1)
women who stalk##2##3##(2009-9#2)
women who subsequently##2##3##(1994-3#1)(1996-8#1)
women who were##3##3##(1990-6#1)(2011-2#1)(2013-1#1)
women who##35##2##(1990-12#1)(1990-6#1)(1990-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2009-9#2)(2010-11#1)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#1)
women with CTTH##2##3##(2010-9#2)
women with Down syndrome##4##4##(2013-1#4)
women with a##4##3##(2008-11#2)(2008-8#1)(2012-3#1)
women with advanced##2##3##(1991-6#1)(1992-5#1)
women with age average##2##4##(2011-2#2)
women with an average age of##2##6##(1994-12#1)(2008-9#1)
women with and without##2##4##(1990-3#1)(2013-1#1)
women with apocrine##2##3##(1993-1#1)(2008-12#1)
women with breast cancer and their##2##6##(1994-3#1)(2013-1#1)
women with breast cancer and##4##5##(1990-12#1)(1994-3#1)(2008-7#1)(2013-1#1)
women with breast cancer##17##4##(1990-12#2)(1994-12#1)(1994-3#2)(2008-10#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#6)
women with breast##19##3##(1990-12#2)(1994-12#1)(1994-3#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#6)
women with cervical intraepithelial neoplasia##2##5##(2011-2#2)
women with epilepsy##3##3##(2008-11#3)
women with gestational diabetes mellitus##3##5##(1992-12#3)
women with low obstetric risk##3##5##(2013-1#3)
women with migraine with aura##2##5##(2008-9#1)(2011-2#1)
women with polycystic##2##3##(2008-11#1)(2012-3#1)
women with recurrent##2##3##(1990-11#1)(2008-5#1)
women with risk##3##3##(1996-6#1)(2012-2#2)
women with##116##2##(1990-11#2)(1990-12#2)(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-3#2)(1992-5#1)(1993-1#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#3)(1995-3#3)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#2)(2007-7#1)(2008-10#3)(2008-11#12)(2008-12#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2010-10#1)(2010-11#1)(2010-9#2)(2011-2#12)(2012-2#4)(2012-3#9)(2013-1#18)(2013-8#1)
women without##2##2##(1991-3#1)(2013-1#1)
women##875##1##(1990-11#2)(1990-12#11)(1990-2#17)(1990-3#1)(1990-6#19)(1990-8#7)(1990-9#2)(1991-1#2)(1991-11#14)(1991-12#4)(1991-2#5)(1991-3#4)(1991-6#6)(1991-8#15)(1991-9#3)(1992-1#7)(1992-12#9)(1992-2#7)(1992-3#8)(1992-5#2)(1992-9#1)(1993-1#4)(1993-12#2)(1993-2#7)(1993-3#3)(1993-6#11)(1993-9#2)(1994-1#2)(1994-12#13)(1994-2#14)(1994-3#9)(1994-6#3)(1994-8#1)(1994-9#9)(1995-1#4)(1995-12#7)(1995-2#3)(1995-3#5)(1995-6#5)(1995-8#5)(1995-9#4)(1996-1#6)(1996-11#4)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#2)(1996-6#8)(1996-8#7)(1996-9#3)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#8)(1997-6#1)(1997-8#9)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#18)(2008-10#17)(2008-11#53)(2008-12#42)(2008-3#1)(2008-4#16)(2008-5#16)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#16)(2009-11#8)(2009-12#1)(2009-4#7)(2009-5#6)(2009-8#6)(2009-9#6)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#13)(2010-4#3)(2010-6#12)(2010-7#2)(2010-8#4)(2010-9#7)(2011-1#9)(2011-2#82)(2011-3#1)(2011-7#2)(2012-12#13)(2012-2#15)(2012-3#36)(2013-1#80)(2013-3#1)(2013-8#17)
women's access to##2##3##(2008-11#1)(2011-2#1)
women's experiences##2##2##(2008-12#1)(2013-8#1)
women's health and##3##3##(2008-11#2)(2009-10#1)
women's health##18##2##(1994-3#8)(1995-6#1)(1996-11#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-11#4)(2009-10#1)
women's lives##2##2##(1996-1#1)(1997-5#1)
women's personal##2##2##(1994-12#1)(1996-1#1)
women's reports##2##2##(1995-8#1)(2009-5#1)
women's##62##1##(1990-8#1)(1994-12#2)(1994-3#11)(1994-8#1)(1995-1#2)(1995-6#1)(1995-8#1)(1996-1#4)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(2008-1#2)(2008-10#2)(2008-11#12)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#2)(2010-3#1)(2010-7#1)(2011-2#3)(2011-3#1)(2013-8#1)
women)##18##1##(1991-6#2)(1992-3#1)(1994-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-7#1)(2010-9#3)(2012-12#1)(2013-1#5)
women]##9##1##(1991-11#1)(1991-9#2)(1993-2#1)(1996-3#1)(1996-8#1)(2008-12#1)(2012-3#2)
won##4##1##(1992-2#1)(1994-2#1)(1994-3#1)(2010-1#1)
won't help##3##2##(1994-1#1)(1997-3#1)(2008-11#1)
won't##10##1##(1991-3#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-1#1)(1994-3#1)(1996-1#1)(1997-3#1)(2008-11#1)
wonderful##3##1##(1991-2#1)(2008-10#1)(2013-8#1)
wood and##5##2##(2008-10#4)(2013-8#1)
wood ashes##2##2##(2008-10#2)
wood by##2##2##(2013-1#1)(2013-8#1)
wood decay##3##2##(2008-10#3)
wood frogs##3##2##(2008-8#3)
wood in##2##2##(2008-10#2)
wood is##2##2##(2012-9#1)(2013-1#1)
wood residue##3##2##(2009-3#3)
wood samples##3##2##(2008-10#3)
wood to##2##2##(2007-12#1)(2008-10#1)
wood were##2##2##(2008-10#2)
wood##60##1##(1990-6#1)(2007-12#1)(2008-10#28)(2008-8#3)(2008-9#2)(2009-3#3)(2009-8#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2012-9#1)(2013-1#6)(2013-8#6)
wood-rotting##3##1##(2008-10#2)(2013-1#1)
woodborer##3##1##(2007-12#1)(2013-8#2)
wooden object##2##2##(2013-1#2)
wooden##8##1##(2008-10#6)(2013-1#2)
woodland songbirds##2##2##(2008-9#2)
woodland##3##1##(2008-9#2)(2010-3#1)
woody hosts##4##2##(2008-10#4)
woody plants in##2##3##(2008-9#1)(2012-5#1)
woody plants##14##2##(2008-10#4)(2008-8#2)(2008-9#6)(2009-8#1)(2012-5#1)
woody species##5##2##(2008-10#2)(2008-8#1)(2011-10#1)(2012-5#1)
woody##28##1##(2008-10#13)(2008-8#3)(2008-9#6)(2009-8#1)(2011-10#1)(2012-5#2)(2012-6#1)(2012-7#1)
wool and##2##2##(2008-11#1)(2008-5#1)
wool fast blue BL (lambda(max)=540##2##5##(2008-10#2)
wool fast blue BL##3##4##(2008-10#3)
wool fibre##3##2##(2008-10#1)(2008-5#2)
wool##17##1##(2008-10#13)(2008-11#1)(2008-5#3)
word and##3##2##(2008-11#1)(2008-9#1)(2012-2#1)
word on##4##2##(1993-12#1)(1994-2#1)(2011-2#2)
word pairs##2##2##(2008-9#2)
word problem##3##2##(2009-12#3)
word processing and##2##3##(2008-11#2)
word processing##7##2##(2008-11#6)(2008-12#1)
word reading efficiency in##2##4##(2012-2#2)
word reading skills##2##3##(2008-12#2)
word reading##5##2##(2008-12#3)(2012-2#2)
word recognition##4##2##(2008-11#3)(2011-2#1)
word##65##1##(1990-8#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-2#2)(1995-5#2)(1996-2#3)(2008-11#14)(2008-12#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#4)(2009-8#2)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#3)(2013-8#3)
word-learning##5##1##(2011-1#5)
words and##6##2##(1990-8#3)(1996-2#1)(2009-4#1)(2011-2#1)
words are##2##2##(1991-6#1)(2010-7#1)
words for##2##2##(1995-3#1)(2011-1#1)
words in##5##2##(2008-11#1)(2009-8#1)(2010-7#1)(2011-2#2)
words were##2##2##(2011-1#1)(2013-1#1)
words##74##1##(1990-8#6)(1991-2#2)(1991-6#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#6)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#10)(2010-4#1)(2010-7#5)(2011-1#3)(2011-2#9)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
wore##7##1##(2008-9#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
work a##8##2##(2008-10#6)(2009-10#1)(2011-2#1)
work accidents##2##2##(1991-3#1)(2009-10#1)
work addresses##2##2##(1994-3#1)(2008-11#1)
work aimed##2##2##(1997-4#1)(2008-8#1)
work and the##3##3##(1995-5#1)(1997-3#1)(2012-12#1)
work and##28##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
work are##4##2##(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
work area##4##2##(1991-12#1)(2010-7#3)
work as a team##2##4##(2008-11#1)(2008-12#1)
work as a##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-3#1)
work as##9##2##(1993-11#1)(1993-12#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2011-3#1)
work at##3##2##(2008-10#2)(2008-4#1)
work being##3##2##(1997-2#1)(1997-3#1)(2008-4#1)
work better##2##2##(2008-9#1)(2011-2#1)
work but##2##2##(2008-10#1)(2008-12#1)
work by##6##2##(2008-10#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
work carried out##4##3##(1994-2#1)(2008-10#3)
work collaboratively with##2##3##(1995-3#1)(2008-12#1)
work continues to##2##3##(1997-4#1)(2012-3#1)
work could##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
work deals with the application of##2##6##(2008-10#2)
work deals with the##3##4##(2008-10#2)(2009-7#1)
work demonstrates that##4##3##(1995-2#1)(2008-7#1)(2009-8#1)(2010-10#1)
work demonstrates##6##2##(1995-2#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-10#1)
work described here##2##3##(2008-10#1)(2013-1#1)
work described##3##2##(1997-3#1)(2008-10#1)(2013-1#1)
work describes a novel##2##4##(2008-10#1)(2008-11#1)
work describes a##5##3##(2008-10#4)(2008-11#1)
work describes the development##2##4##(2008-10#1)(2013-1#1)
work describes the##9##3##(2008-10#7)(2008-11#1)(2013-1#1)
work describes##18##2##(2008-10#13)(2008-11#2)(2009-7#1)(2009-8#1)(2013-1#1)
work differently##2##2##(1991-1#1)(2008-11#1)
work disability##2##2##(1991-11#1)(1995-5#1)
work done##3##2##(1995-3#1)(2008-8#1)(2008-9#1)
work environment and health##2##4##(2012-12#2)
work environment and##3##3##(2012-12#3)
work environment##6##2##(1994-3#2)(2008-11#1)(2012-12#3)
work examining the##2##3##(1994-11#1)(2008-11#1)
work focuses on##3##3##(2007-8#1)(2008-10#2)
work for##10##2##(1991-9#1)(1994-3#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-4#1)(2011-2#1)
work force##12##2##(1991-9#1)(1993-3#1)(1994-1#1)(1995-2#1)(1997-2#6)(2008-11#2)
work from##2##2##(2009-8#1)(2011-3#1)
work gives##4##2##(1992-7#1)(2008-10#1)(2011-3#1)(2013-8#1)
work has been##4##3##(2008-10#4)
work has demonstrated that##2##4##(1993-6#1)(2008-10#1)
work has demonstrated##3##3##(1993-6#1)(1997-6#1)(2008-10#1)
work has shown that##6##4##(1994-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
work has shown##8##3##(1994-8#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
work has##32##2##(1991-3#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#10)(2008-11#5)(2008-5#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
work have##3##2##(1994-3#1)(2008-11#1)(2009-3#1)
work hours##4##2##(1992-3#1)(1993-1#2)(1995-6#1)
work in partnership with##4##4##(1993-12#1)(2008-11#1)(2008-12#2)
work in partnership##6##3##(1993-12#1)(1996-2#1)(2008-11#2)(2008-12#2)
work in the##5##3##(1994-12#1)(2008-10#1)(2008-12#1)(2008-7#2)
work in this##3##3##(1994-1#1)(2008-11#1)(2008-6#1)
work in##41##2##(1991-12#2)(1991-2#1)(1991-6#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#2)(2008-10#6)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-9#1)(2013-1#2)(2013-8#3)
work involved##2##2##(1997-2#1)(2008-3#1)
work involves the##2##3##(2010-8#1)(2011-3#1)
work is a##3##3##(1996-12#1)(2008-11#1)(2010-12#1)
work is needed to##2##4##(2008-10#1)(2010-6#1)
work is needed##3##3##(2008-10#2)(2010-6#1)
work is related to##2##4##(2012-2#1)(2012-3#1)
work is required to##2##4##(2006-6#1)(2008-10#1)
work is required##3##3##(2006-6#1)(2008-10#1)(2010-4#1)
work is still##2##3##(1997-1#1)(2008-11#1)
work is the study of##2##5##(2008-10#2)
work is the##7##3##(2008-10#6)(2008-4#1)
work is to study the##2##5##(1997-2#1)(2008-10#1)
work is to##14##3##(1997-2#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
work is##55##2##(1990-6#1)(1993-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
work it is##2##3##(2008-10#1)(2008-4#1)
work it##3##2##(2008-10#2)(2008-4#1)
work load##3##2##(1994-6#1)(2008-7#2)
work of adhesion##3##3##(2008-7#3)
work of the##8##3##(1991-3#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2012-2#1)
work of##40##2##(1991-12#1)(1991-3#1)(1991-6#1)(1994-1#1)(1994-2#1)(1996-1#3)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-7#3)(2009-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2012-2#6)(2012-3#1)(2013-1#3)
work on normal##2##3##(1994-2#2)
work on the##4##3##(2008-10#2)(2008-12#1)(2010-1#1)
work on##27##2##(1991-1#1)(1994-2#2)(1995-3#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-5#1)(2010-1#1)(2010-7#2)(2010-8#1)(2011-2#3)(2011-3#1)(2013-1#1)
work or##2##2##(1995-2#1)(2013-1#1)
work output##2##2##(2012-2#1)(2013-1#1)
work performed##2##2##(1990-3#1)(2008-10#1)
work presented##3##2##(1991-12#1)(2008-10#2)
work presents##11##2##(2008-10#8)(2010-10#1)(2010-8#1)(2011-2#1)
work provides a##3##3##(2008-10#2)(2012-3#1)
work provides##6##2##(2008-10#3)(2011-3#1)(2012-3#1)(2013-8#1)
work related disorders##2##3##(1996-8#1)(2008-11#1)
work related injury and ill-health##2##5##(2008-11#2)
work related##5##2##(1996-8#1)(2008-11#3)(2008-12#1)
work reported here##2##3##(2008-10#1)(2011-2#1)
work reports a##3##3##(2008-10#3)
work reports the development of a##2##6##(2008-10#1)(2008-5#1)
work reports the results##2##4##(2008-10#1)(2008-11#1)
work reports the##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2010-4#1)
work reports##11##2##(2008-10#8)(2008-11#1)(2008-5#1)(2010-4#1)
work sampling##2##2##(1996-3#2)
work shift##2##2##(2010-7#1)(2012-12#1)
work showed that##2##3##(2008-10#2)
work showed##3##2##(2008-10#2)(2011-2#1)
work shows that the##2##4##(2008-10#1)(2008-5#1)
work shows that##4##3##(2008-10#1)(2008-5#2)(2008-9#1)
work shows the##3##3##(2008-10#3)
work shows##7##2##(2008-10#4)(2008-5#2)(2008-9#1)
work studies the##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
work suggests that manipulating the##2##5##(2008-10#1)(2010-7#1)
work suggests that##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-7#1)
work suggests##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-2#1)
work supports the hypothesis that##2##5##(2008-10#1)(2011-1#1)
work supports the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
work that##5##2##(2008-10#3)(2008-11#2)
work the##9##2##(1995-5#1)(2008-10#7)(2008-5#1)
work to##13##2##(1991-12#1)(1991-9#1)(1992-10#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)
work together in a##2##4##(2008-7#1)(2013-1#1)
work together to##4##3##(1995-1#1)(1996-3#1)(2012-2#1)(2013-8#1)
work together##10##2##(1991-12#2)(1995-1#1)(1996-3#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
work towards##2##2##(2008-11#1)(2012-12#1)
work up##4##2##(1992-6#1)(2008-10#1)(2008-7#1)(2012-12#1)
work using##2##2##(2008-10#1)(2008-7#1)
work validates##2##2##(2008-10#1)(2008-7#1)
work values emerged -##2##4##(2010-10#2)
work values##8##2##(2010-10#8)
work was to develop a##2##5##(1997-2#1)(2011-1#1)
work was to develop and validate##2##6##(2008-10#1)(2012-2#1)
work was to develop##4##4##(1997-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
work was to evaluate the##7##5##(1993-11#1)(1997-8#1)(2008-10#1)(2008-5#3)(2012-2#1)
work was to evaluate##8##4##(1993-11#1)(1997-8#1)(2008-10#1)(2008-5#3)(2012-2#1)(2013-8#1)
work was to find##2##4##(2008-10#1)(2008-5#1)
work was to investigate whether##2##5##(1992-12#1)(2008-5#1)
work was to investigate##3##4##(1992-12#1)(2007-12#1)(2008-5#1)
work was to study the##3##5##(2008-10#1)(2008-5#1)(2013-1#1)
work was to##34##3##(1992-12#1)(1993-11#1)(1993-12#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#8)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
work was##57##2##(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-5#8)(2008-9#3)(2009-7#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
work we study the##2##4##(2008-10#1)(2009-8#1)
work we##20##2##(1990-5#1)(2008-10#9)(2008-11#5)(2009-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
work well##5##2##(1991-3#1)(2008-10#3)(2008-8#1)
work were##3##2##(1995-2#1)(2008-10#2)
work which##2##2##(1997-8#1)(2012-3#1)
work will##6##2##(1991-1#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-8#1)(2013-1#1)
work with both##2##3##(2008-11#1)(2008-7#1)
work with the##3##3##(1995-6#1)(1997-2#1)(2008-8#1)
work with##25##2##(1991-12#1)(1992-12#1)(1994-1#2)(1995-5#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#2)
work within##3##2##(2008-1#1)(2008-10#1)(2010-10#1)
work would##2##2##(1994-3#1)(2008-8#1)
work##1071##1##(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#2)(1991-1#3)(1991-11#1)(1991-12#16)(1991-2#4)(1991-3#4)(1991-6#5)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#6)(1993-11#2)(1993-12#16)(1993-2#2)(1993-3#7)(1993-5#1)(1993-6#1)(1993-8#2)(1994-1#9)(1994-11#1)(1994-12#5)(1994-2#8)(1994-3#13)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#11)(1995-3#5)(1995-5#7)(1995-6#4)(1995-9#1)(1996-1#13)(1996-12#4)(1996-2#5)(1996-3#7)(1996-5#1)(1996-8#1)(1997-1#4)(1997-2#17)(1997-3#8)(1997-4#5)(1997-6#2)(1997-7#3)(1997-8#6)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#330)(2008-11#77)(2008-12#34)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#25)(2008-6#3)(2008-7#27)(2008-8#14)(2008-9#19)(2009-10#7)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#2)(2009-6#4)(2009-7#8)(2009-8#14)(2009-9#1)(2010-1#2)(2010-10#24)(2010-11#3)(2010-12#7)(2010-4#12)(2010-5#4)(2010-6#2)(2010-7#19)(2010-8#10)(2010-9#6)(2011-1#4)(2011-10#1)(2011-2#26)(2011-3#9)(2012-12#18)(2012-2#27)(2012-3#18)(2013-1#26)(2013-8#15)
work-based learning approach##2##3##(2008-11#2)
work-based learning##10##2##(2008-11#10)
work-based##12##1##(1992-1#1)(2008-11#11)
work-family##5##1##(2009-10#5)
work-related##5##1##(1995-2#1)(1996-1#1)(2008-4#1)(2010-9#1)(2012-12#1)
work-up of##2##2##(2012-2#1)(2013-1#1)
work-up procedures##2##2##(2008-10#2)
work-up##18##1##(1996-3#1)(1997-3#2)(1997-6#1)(2008-10#4)(2010-10#4)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
work?##7##1##(1993-1#1)(1994-3#1)(1995-2#1)(1997-3#1)(1997-6#1)(2008-11#1)(2013-1#1)
work]##4##1##(1990-12#1)(1990-6#1)(1994-2#1)(1995-5#1)
workable##3##1##(2008-10#1)(2012-2#2)
workbook##2##1##(2008-12#2)
workday##5##1##(2010-6#1)(2012-12#4)
worked as a##2##3##(1995-11#1)(2008-10#1)
worked as##3##2##(1995-11#1)(1997-5#1)(2008-10#1)
worked for##2##2##(1991-2#1)(1993-3#1)
worked in the##3##3##(1991-12#1)(1994-1#1)(2008-12#1)
worked in##11##2##(1991-12#1)(1991-6#1)(1993-1#2)(1994-1#1)(2008-12#2)(2008-5#1)(2011-1#1)(2011-3#1)(2013-1#1)
worked on##2##2##(1990-9#1)(2010-1#1)
worked out##10##2##(1990-2#1)(1991-11#1)(2008-10#6)(2008-11#1)(2010-1#1)
worked well##4##2##(1993-12#1)(2008-10#1)(2009-6#1)(2010-5#1)
worked with##2##2##(2008-5#1)(2013-1#1)
worked##52##1##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-1#2)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-5#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-5#2)(2008-9#1)(2009-6#1)(2010-1#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
worker policing##4##2##(2008-8#4)
worker production##2##2##(2008-8#2)
worker safety##2##2##(2008-10#1)(2008-11#1)
worker who##2##2##(1995-12#2)
worker##37##1##(1991-12#2)(1993-1#1)(1993-12#2)(1994-1#2)(1995-11#2)(1995-12#3)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#3)(2008-8#8)(2010-11#1)(2012-3#1)(2013-1#4)(2013-8#1)
worker's##2##1##(1991-2#1)(2008-8#1)
workers and the public##3##4##(2008-12#2)(2009-12#1)
workers and the##5##3##(1992-3#1)(2008-12#2)(2008-7#1)(2009-12#1)
workers and##12##2##(1992-3#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)(2009-12#1)(2009-5#1)(2013-8#1)
workers are##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
workers as a##3##3##(1991-12#1)(2008-8#1)(2009-12#1)
workers employed in##2##3##(2009-12#1)(2013-1#1)
workers exposed to##4##3##(1992-3#1)(2011-2#1)(2013-1#2)
workers for##2##2##(1992-2#1)(2008-6#1)
workers from a##2##3##(1991-12#1)(2012-3#1)
workers from##3##2##(1991-12#1)(2008-11#1)(2012-3#1)
workers had##2##2##(1995-2#1)(2011-2#1)
workers have##3##2##(1991-1#1)(2008-8#1)(2009-12#1)
workers in the United States##2##5##(1991-12#2)
workers in the##5##3##(1991-12#2)(2008-11#1)(2008-6#1)(2011-2#1)
workers in##21##2##(1991-12#3)(1992-2#1)(1993-2#1)(1996-12#2)(2008-11#2)(2008-6#1)(2009-10#1)(2009-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
workers is##2##2##(1995-11#1)(2008-8#1)
workers may##2##2##(2008-11#1)(2013-1#1)
workers of a##2##3##(2009-12#1)(2011-2#1)
workers of the##3##3##(2007-12#2)(2008-10#1)
workers of##8##2##(1991-12#1)(1996-3#1)(2007-12#3)(2008-10#1)(2009-12#1)(2011-2#1)
workers that##2##2##(2008-6#1)(2008-8#1)
workers to##3##2##(2007-12#1)(2008-8#1)(2010-11#1)
workers were##4##2##(1991-12#1)(1992-3#2)(2008-6#1)
workers who##9##2##(1992-1#1)(1993-1#2)(1994-1#1)(1994-12#1)(1995-12#2)(2008-11#1)(2010-11#1)
workers with##2##2##(2008-5#1)(2010-7#1)
workers##189##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#23)(1991-3#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#8)(1992-5#1)(1993-1#4)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1996-11#1)(1996-12#5)(1996-3#5)(1996-8#1)(1997-2#4)(1997-3#1)(1997-6#1)(2007-12#4)(2008-10#7)(2008-11#14)(2008-12#3)(2008-5#1)(2008-6#6)(2008-7#2)(2008-8#22)(2008-9#1)(2009-10#3)(2009-12#14)(2009-5#1)(2010-1#1)(2010-11#4)(2010-7#1)(2011-2#8)(2012-12#4)(2012-3#4)(2013-1#9)(2013-8#2)
workers' compensation##6##2##(1992-2#1)(1994-12#1)(1995-1#2)(1997-1#1)(2012-12#1)
workers'##17##1##(1992-2#1)(1994-12#1)(1995-1#2)(1995-2#3)(1997-1#1)(2008-10#1)(2008-8#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
workers)##2##1##(2008-10#1)(2008-8#1)
workers]##2##1##(2008-10#1)(2008-11#1)
workflow##3##1##(2008-11#1)(2009-12#1)(2010-11#1)
workforce in##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
workforce of##2##2##(2008-11#1)(2010-11#1)
workforce##24##1##(1997-3#2)(2008-1#1)(2008-11#5)(2008-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2012-12#6)(2012-2#4)(2013-1#1)
workhorses for##2##2##(2008-3#1)(2011-2#1)
working and learning##2##3##(2008-11#2)
working and##9##2##(1992-2#1)(2008-10#2)(2008-11#5)(2008-7#1)
working as##2##2##(2008-10#1)(2011-2#1)
working at the##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
working at##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2011-1#1)
working calibration range##2##3##(2008-10#2)
working calibration##5##2##(2008-10#5)
working capacity##3##2##(2012-2#3)
working concentration range##5##3##(2008-10#5)
working concentration##7##2##(2008-10#7)
working conditions and##3##3##(1992-5#2)(2012-12#1)
working conditions were##3##3##(2008-10#3)
working conditions##25##2##(1992-5#2)(1993-2#1)(1996-1#1)(2008-10#18)(2009-12#1)(2010-10#1)(2012-12#1)
working curve##3##2##(2008-10#3)
working days##2##2##(1992-3#1)(2008-10#1)
working distance##2##2##(2011-2#1)(2012-2#1)
working electrode and the##3##4##(2008-10#3)
working electrode and##4##3##(2008-10#4)
working electrode for##2##3##(2008-10#2)
working electrode in the##3##4##(2008-10#3)
working electrode in##6##3##(2008-10#6)
working electrode surface##5##3##(2008-10#5)
working electrode was##6##3##(2008-10#6)
working electrode were##2##3##(2008-10#2)
working electrode##57##2##(1991-7#1)(2008-10#56)
working electrodes and##2##3##(2008-10#2)
working electrodes##6##2##(2008-10#6)
working environment##5##2##(1991-12#1)(1995-2#1)(1996-2#1)(2008-11#1)(2010-10#1)
working frequency##2##2##(2008-10#1)(2008-11#1)
working group on##2##3##(1993-2#1)(2008-12#1)
working group##5##2##(1993-2#1)(1995-12#1)(2008-12#2)(2013-1#1)
working groups##5##2##(1995-6#1)(2008-10#1)(2008-11#1)(2012-2#2)
working in a##5##3##(1997-5#1)(2008-10#1)(2008-11#2)(2010-7#1)
working in clinical##2##3##(2008-11#1)(2012-2#1)
working in concert with##2##4##(2012-2#2)
working in the market##2##4##(2012-12#2)
working in the##13##3##(1991-12#1)(1991-2#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-9#1)(2012-12#4)(2013-8#1)
working in##44##2##(1990-6#1)(1991-12#1)(1991-2#1)(1993-1#2)(1993-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-5#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2009-12#1)(2010-1#2)(2010-10#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-8#2)
working life##6##2##(1992-3#1)(2008-10#1)(2008-11#2)(2008-9#2)
working medium##3##2##(2008-10#3)
working memory (WM)##2##3##(1994-8#2)
working memory##15##2##(1993-3#2)(1994-3#1)(1994-8#2)(2008-11#4)(2008-8#2)(2012-3#3)(2013-8#1)
working of the##2##3##(2008-10#2)
working of##4##2##(2008-10#4)
working on##4##2##(1997-3#1)(2008-10#2)(2008-3#1)
working out##2##2##(1990-3#1)(2008-6#1)
working outside##2##2##(1991-12#1)(1993-1#1)
working pH range of##2##4##(2008-10#2)
working pH range##5##3##(2008-10#5)
working pH##9##2##(2008-10#8)(2008-11#1)
working parameters##2##2##(2008-10#2)
working party##2##2##(1991-9#1)(2008-11#1)
working potential##3##2##(2008-10#3)
working practice##2##2##(2008-10#1)(2011-2#1)
working principle##2##2##(2008-10#1)(2009-5#1)
working range 0##2##3##(2008-10#2)
working range for##2##3##(2008-10#2)
working range is##2##3##(2008-10#2)
working range of the##3##4##(2008-10#3)
working range of##8##3##(2008-10#8)
working range##30##2##(2008-10#30)
working ranges##3##2##(2008-10#3)
working relationship##3##2##(1995-12#1)(2008-12#1)(2010-9#1)
working relationships of public health nurses and high-priority families in##2##10##(2010-9#2)
working solution##2##2##(2008-10#2)
working time##3##2##(1995-2#1)(2008-10#2)
working to develop##2##3##(1996-2#1)(2009-6#1)
working to##5##2##(1995-3#1)(1996-2#1)(2008-11#1)(2009-6#1)(2010-1#1)
working under##2##2##(2008-10#1)(2008-3#1)
working waveband##2##2##(2013-8#2)
working with patients##2##3##(2008-12#1)(2010-3#1)
working with the##3##3##(1994-9#1)(2008-10#2)
working with##34##2##(1991-12#1)(1992-3#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#4)(2010-1#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
working##413##1##(1990-3#1)(1990-6#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#2)(1993-1#4)(1993-12#1)(1993-2#4)(1993-3#3)(1993-8#1)(1994-1#4)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#4)(1995-3#1)(1995-6#4)(1996-1#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-5#4)(2008-1#1)(2008-10#206)(2008-11#38)(2008-12#8)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#6)(2010-10#3)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#6)(2011-1#1)(2011-2#8)(2012-12#8)(2012-2#12)(2012-3#8)(2013-1#5)(2013-8#7)
working-age##2##1##(1997-6#1)(2012-2#1)
workload and##2##2##(2008-12#1)(2010-8#1)
workload in##4##2##(1997-8#3)(2012-2#1)
workload##20##1##(1993-2#1)(1995-2#1)(1997-8#3)(2008-11#1)(2008-12#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#1)
workplace by##2##2##(2008-10#1)(2008-7#1)
workplace of##2##2##(2008-10#1)(2013-8#1)
workplace provision##2##2##(2011-2#1)(2012-2#1)
workplace substance use##2##3##(2012-12#2)
workplace substance##3##2##(1992-1#1)(2012-12#2)
workplace violence##5##2##(1996-12#1)(2008-7#3)(2010-10#1)
workplace##61##1##(1991-12#2)(1991-2#1)(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-5#2)(1996-12#2)(1996-2#1)(1997-4#2)(2008-10#6)(2008-11#10)(2008-12#5)(2008-6#1)(2008-7#4)(2008-9#4)(2010-10#2)(2010-6#1)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-8#1)
workplaces##4##1##(1997-6#1)(2008-9#1)(2010-5#1)(2012-2#1)
works and the##2##3##(1990-12#1)(2008-10#1)
works and##3##2##(1990-12#1)(2008-10#1)(2012-2#1)
works dealing with##2##3##(2008-10#1)(2011-2#1)
works have##3##2##(1997-7#1)(2010-10#1)(2012-3#1)
works in##3##2##(2008-10#2)(2012-3#1)
works of art by##2##4##(2008-10#2)
works of art##9##3##(2008-10#9)
works of##10##2##(2008-10#9)(2008-12#1)
works on##3##2##(1993-12#1)(2008-10#1)(2010-4#1)
works satisfactorily in the##2##4##(2008-10#2)
works to##2##2##(2008-11#1)(2010-8#1)
works together with##2##3##(2008-3#1)(2012-2#1)
works under##2##2##(2008-10#1)(2008-9#1)
works well in##4##3##(2008-10#4)
works well over a wide concentration range##2##7##(2008-10#2)
works well over a##4##4##(2008-10#4)
works well##10##2##(2008-10#9)(2008-11#1)
works with##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
works##78##1##(1990-12#1)(1990-5#1)(1992-12#1)(1992-3#1)(1993-12#2)(1995-6#1)(1996-3#2)(1996-6#1)(1997-7#1)(2008-10#34)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#2)(2012-7#1)
workshop included##3##2##(1996-2#1)(2008-10#1)(2013-8#1)
workshop on##8##2##(1992-1#1)(1994-2#1)(1994-3#1)(2008-10#4)(2012-2#1)
workshop participants##2##2##(2008-10#2)
workshop was##6##2##(2008-10#2)(2008-12#1)(2012-2#1)(2013-8#2)
workshop##51##1##(1990-11#1)(1992-1#1)(1992-12#3)(1992-5#3)(1993-1#2)(1994-2#1)(1994-3#1)(1996-2#4)(2008-10#11)(2008-11#7)(2008-12#2)(2008-6#2)(2008-8#1)(2011-2#5)(2012-2#3)(2013-1#1)(2013-8#3)
workshops on##2##2##(2008-10#1)(2008-11#1)
workshops##21##1##(1991-12#1)(2008-10#3)(2008-11#4)(2008-12#10)(2010-10#1)(2011-2#1)(2012-2#1)
workstation##2##1##(1991-12#1)(2009-8#1)
workstations##5##1##(1991-12#1)(1993-2#1)(1996-12#1)(2008-10#2)
workup of##3##2##(1992-1#1)(1993-3#1)(2012-2#1)
workup##10##1##(1991-6#1)(1992-1#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-11#2)(2012-2#2)(2012-3#1)
world and##10##2##(1994-9#1)(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-5#1)(2012-2#2)
world are##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
world have##3##2##(2010-8#1)(2012-12#1)(2013-1#1)
world in##4##2##(2008-11#2)(2011-2#1)(2013-8#1)
world is##5##2##(2008-10#1)(2009-10#1)(2009-3#1)(2010-5#1)(2011-2#1)
world literature##3##2##(1992-2#1)(2007-8#1)(2012-3#1)
world of##14##2##(1991-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(2008-10#1)(2010-8#1)(2013-8#1)
world population##2##2##(1994-9#2)
world to##3##2##(1997-2#1)(1997-7#1)(2008-10#1)
world total##2##2##(1991-6#2)
world where##3##2##(1996-1#1)(2008-12#1)(2011-2#1)
world wide##2##2##(2008-10#1)(2008-5#1)
world##238##1##(1990-11#1)(1990-12#1)(1990-2#2)(1991-3#1)(1991-6#3)(1992-2#1)(1992-5#1)(1993-1#1)(1993-2#2)(1994-1#4)(1994-2#1)(1994-9#9)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#4)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#5)(1997-8#1)(2007-8#1)(2008-1#4)(2008-10#50)(2008-11#20)(2008-12#11)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#3)(2009-12#2)(2009-3#1)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#7)(2010-12#9)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#13)(2012-12#2)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#9)(2013-8#6)
world's##12##1##(1990-2#1)(1993-3#1)(1995-2#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#1)(2009-6#1)(2012-12#1)
world-wide##7##1##(2008-10#4)(2008-11#1)(2008-7#1)(2011-3#1)
worlds##6##1##(2008-11#1)(2008-5#3)(2009-11#1)(2012-2#1)
worldwide airline network##2##3##(2010-3#2)
worldwide and##4##2##(2008-1#1)(2008-10#2)(2008-11#1)
worldwide as a##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
worldwide as##6##2##(2008-10#2)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)
worldwide collection of##7##3##(2008-10#7)
worldwide condemnation##2##2##(1992-12#2)
worldwide distribution of##2##3##(2008-10#2)
worldwide from##2##2##(1990-2#1)(1994-9#1)
worldwide had##2##2##(2008-10#2)
worldwide have been treated with##2##5##(2011-1#1)(2011-2#1)
worldwide have##4##2##(2011-1#1)(2011-2#2)(2012-12#1)
worldwide in##2##2##(2008-10#1)(2010-10#1)
worldwide is##2##2##(2011-2#1)(2012-2#1)
worldwide that##2##2##(2008-10#1)(2011-2#1)
worldwide to##2##2##(2008-7#1)(2009-7#1)
worldwide were##3##2##(2008-10#2)(2012-2#1)
worldwide##169##1##(1990-12#1)(1990-2#1)(1992-12#2)(1992-3#2)(1993-12#1)(1994-1#1)(1994-3#2)(1994-9#2)(1995-10#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(2007-12#1)(2008-1#2)(2008-10#80)(2008-11#7)(2008-5#2)(2008-7#4)(2008-8#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-5#2)(2010-6#1)(2011-1#2)(2011-10#1)(2011-2#16)(2012-12#2)(2012-2#3)(2013-1#12)(2013-8#3)
worm burdens##4##2##(1996-12#4)
worm##14##1##(1991-8#1)(1996-12#7)(1997-6#1)(1997-7#1)(2008-9#2)(2009-7#2)
worms per##2##2##(1996-12#2)
worms##10##1##(1995-3#1)(1996-12#3)(2008-11#1)(2009-8#2)(2010-8#1)(2011-2#1)(2013-8#1)
worn##2##1##(1995-6#1)(1996-2#1)
worried about##2##2##(2008-11#1)(2013-1#1)
worried##3##1##(1997-6#1)(2008-11#1)(2013-1#1)
worries about##2##2##(1991-11#1)(2013-1#1)
worrisome##2##1##(2012-2#1)(2013-8#1)
worry about##2##2##(1990-6#1)(2008-4#1)
worry##10##1##(1990-6#1)(1994-12#2)(1995-9#1)(1996-3#1)(2008-4#3)(2011-2#2)
worse for##2##2##(2008-10#1)(2008-11#1)
worse in##4##2##(1990-12#1)(1991-2#1)(2008-11#1)(2008-7#1)
worse prognosis in##3##3##(1990-8#1)(2009-10#1)(2011-2#1)
worse prognosis##9##2##(1990-12#1)(1990-8#2)(1991-8#1)(2008-10#1)(2009-10#1)(2011-2#2)(2013-1#1)
worse than##6##2##(1995-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
worse##40##1##(1990-12#2)(1990-8#2)(1991-2#1)(1991-8#1)(1994-2#3)(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#8)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#5)(2012-3#1)(2013-1#2)
worsen the##2##2##(1996-12#1)(1996-3#1)
worsen##7##1##(1992-12#1)(1995-2#2)(1996-12#1)(1996-3#1)(2008-8#1)(2010-12#1)
worsened in##3##2##(2008-7#2)(2011-2#1)
worsened significantly##2##2##(2008-10#1)(2008-7#1)
worsened##13##1##(1995-6#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#4)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
worsening asthma##2##2##(2008-10#1)(2012-12#1)
worsening dyspnoea##2##2##(2010-10#2)
worsening of the##3##3##(1991-11#1)(2009-1#1)(2011-3#1)
worsening of##11##2##(1991-11#1)(1992-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-8#1)(2009-1#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
worsening the##2##2##(2008-10#1)(2013-1#1)
worsening##33##1##(1991-11#1)(1991-8#1)(1992-12#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-1#2)(2009-11#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2012-4#1)(2013-1#5)
worsens##4##1##(1993-2#1)(2008-7#1)(2010-4#1)(2013-1#1)
worst##13##1##(1990-6#1)(1991-6#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
worth being##2##2##(2008-10#1)(2008-8#1)
worth of##2##2##(2008-10#1)(2013-1#1)
worth the##2##2##(1991-6#1)(1992-3#1)
worth##18##1##(1991-3#2)(1991-6#1)(1992-3#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
worthwhile##7##1##(1991-12#1)(1992-5#1)(1996-1#1)(1996-8#1)(1997-5#1)(2008-11#1)(2008-12#1)
worthy of further##2##3##(1991-3#1)(2008-11#1)
worthy of##3##2##(1991-3#1)(2008-11#1)(2011-2#1)
wortmannin##11##1##(1992-6#4)(1994-11#2)(1995-8#2)(1996-2#1)(2008-11#2)
would administer##2##2##(1992-2#1)(2008-1#1)
would allow for##2##3##(2008-10#1)(2008-11#1)
would allow the##3##3##(1995-11#1)(2008-3#1)(2008-7#1)
would allow##13##2##(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
would also##8##2##(1990-5#1)(1993-1#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2013-8#1)
would appear that##3##3##(1991-11#1)(1997-2#1)(2011-2#1)
would appear to##2##3##(1991-2#1)(2010-1#1)
would appear##8##2##(1991-11#1)(1991-2#1)(1991-6#1)(1997-2#1)(2008-11#1)(2009-10#1)(2010-1#1)(2011-2#1)
would be a##5##3##(2008-10#2)(2010-12#2)(2011-2#1)
would be able to##2##4##(2013-1#2)
would be an effective##2##4##(2008-10#1)(2011-2#1)
would be an##7##3##(1990-11#1)(1993-1#1)(1994-5#1)(2008-10#1)(2008-11#1)(2011-2#2)
would be beneficial to##2##4##(2008-9#1)(2012-12#1)
would be beneficial##4##3##(2008-10#1)(2008-9#1)(2009-7#1)(2012-12#1)
would be best##4##3##(1994-2#1)(1995-1#1)(2008-10#2)
would be better##2##3##(2010-3#1)(2011-2#1)
would be characterized##2##3##(1992-12#1)(2008-10#1)
would be considered##2##3##(2008-10#1)(2011-2#1)
would be expected based##2##4##(1992-6#1)(2008-11#1)
would be expected in##2##4##(2008-10#2)
would be expected##8##3##(1992-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-10#1)
would be extremely difficult##2##4##(1996-1#1)(2008-10#1)
would be helpful##3##3##(2008-10#1)(2008-9#1)(2009-4#1)
would be in a##2##4##(2008-11#2)
would be more##7##3##(1994-1#2)(2007-12#1)(2008-10#2)(2008-7#1)(2010-7#1)
would be most appropriate to##2##5##(1995-1#1)(2008-11#1)
would be necessary##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
would be needed to##4##4##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
would be needed##6##3##(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-7#1)
would be obtained##2##3##(1994-5#1)(2008-10#1)
would be of##4##3##(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
would be present##2##3##(2008-10#1)(2008-8#1)
would be reduced##2##3##(2008-10#1)(2013-8#1)
would be required to##3##4##(1993-3#1)(2008-10#2)
would be required##6##3##(1993-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)
would be the most##2##4##(2008-10#1)(2012-9#1)
would be the##6##3##(1992-3#1)(1996-1#1)(2008-10#1)(2008-12#1)(2012-9#1)(2013-1#1)
would be to##5##3##(1995-5#1)(2008-10#2)(2013-1#2)
would be useful as a##2##5##(2008-10#2)
would be useful for##5##4##(1990-8#1)(2008-10#2)(2011-1#1)(2013-8#1)
would be useful in developing##2##5##(1994-11#1)(2011-3#1)
would be useful to##4##4##(2008-11#1)(2008-12#1)(2010-12#1)(2013-8#1)
would be useful##13##3##(1990-8#1)(1994-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-3#1)(2013-8#2)
would be##193##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#39)(2008-11#18)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#3)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#12)(2011-3#2)(2012-12#5)(2012-3#4)(2012-9#1)(2013-1#10)(2013-8#5)
would benefit from a##2##4##(1991-2#1)(2008-11#1)
would benefit from##7##3##(1991-2#1)(1992-12#1)(2008-11#2)(2010-3#1)(2010-9#1)(2012-12#1)
would benefit##9##2##(1991-2#1)(1992-12#1)(1994-12#1)(2008-11#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)
would bring##2##2##(1992-12#1)(1993-6#1)
would cause##4##2##(1997-2#1)(2008-10#1)(2008-8#2)
would consent to##2##3##(1993-2#1)(2008-11#1)
would consider an OAH##3##4##(2008-7#3)
would consider##4##2##(2008-7#4)
would contribute to the##2##4##(2008-1#1)(2008-10#1)
would contribute to##4##3##(2008-1#1)(2008-10#1)(2008-11#2)
would contribute##5##2##(2008-1#1)(2008-10#1)(2008-11#3)
would correspond to##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
would cost##2##2##(1990-2#1)(1994-2#1)
would create##4##2##(1995-1#1)(1995-6#1)(1996-5#1)(2008-8#1)
would do##3##2##(1992-2#1)(1995-5#1)(2008-8#1)
would enable the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
would enable##7##2##(1992-12#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#2)
would encode a##2##3##(1993-2#2)
would encourage##2##2##(1997-2#1)(2008-7#1)
would eventually##2##2##(2008-10#1)(2013-1#1)
would explain##2##2##(1997-8#1)(2008-8#1)
would favor##4##2##(2008-7#1)(2008-9#2)(2009-10#1)
would first##2##2##(1993-6#1)(2008-11#1)
would follow##2##2##(1994-8#1)(2008-1#1)
would form##2##2##(2008-10#2)
would further##6##2##(1997-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-3#1)(2013-1#1)
would greatly##3##2##(1990-12#1)(1996-8#1)(2008-7#1)
would have a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
would have been##13##3##(1991-10#1)(1991-6#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#3)(2012-12#1)
would have died##2##3##(2008-10#2)
would have higher##2##3##(2008-10#1)(2008-11#1)
would have increased##2##3##(1993-1#1)(2008-11#1)
would have resulted##2##3##(1994-12#1)(2008-9#1)
would have the##2##3##(1994-3#1)(1995-2#1)
would have to##2##3##(1995-6#2)
would have##47##2##(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-3#1)(1994-12#3)(1994-3#1)(1995-2#1)(1995-6#3)(1996-5#3)(1997-2#1)(1997-6#1)(2008-10#9)(2008-11#6)(2008-2#1)(2008-5#1)(2008-7#4)(2008-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
would help avoid##2##3##(2008-5#1)(2009-6#1)
would help##8##2##(1990-2#1)(1993-2#1)(1995-12#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-10#1)
would improve##7##2##(1994-12#1)(2008-10#2)(2008-11#2)(2012-2#2)
would include##5##2##(1992-12#1)(1996-3#1)(2008-1#1)(2008-7#1)(2011-2#1)
would increase##6##2##(1994-1#3)(2008-10#1)(2008-11#1)(2009-5#1)
would indicate##2##2##(2008-10#1)(2008-8#1)
would influence##5##2##(1993-1#1)(2008-12#1)(2009-5#1)(2010-10#1)(2013-8#1)
would involve##3##2##(1992-2#1)(2008-10#1)(2008-9#1)
would lead to the##2##4##(2008-7#1)(2013-8#1)
would lead to##8##3##(1995-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2013-8#1)
would like to##9##3##(1991-2#1)(1992-3#3)(2008-12#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
would likely be##2##3##(2008-10#1)(2008-8#1)
would likely##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
would maintain##2##2##(1996-9#1)(2012-2#1)
would make##5##2##(1990-2#1)(2008-7#1)(2008-9#1)(2010-4#2)
would need to be##4##4##(1992-2#1)(1995-6#1)(2008-8#1)(2011-1#1)
would need##5##2##(1992-2#1)(1995-6#1)(2008-1#1)(2008-8#1)(2011-1#1)
would not be##6##3##(1990-2#1)(1991-1#1)(1994-12#1)(1995-12#1)(1996-12#1)(2011-2#1)
would not have##2##3##(1994-12#1)(2008-10#1)
would not##22##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
would occur##4##2##(1992-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
would only be##2##3##(1995-6#1)(2009-3#1)
would otherwise##9##2##(1991-6#1)(1996-3#1)(2008-10#3)(2008-8#3)(2011-2#1)
would probably##3##2##(1996-3#1)(1997-8#1)(2008-11#1)
would produce a##2##3##(1992-9#1)(2008-8#1)
would produce##7##2##(1990-2#1)(1992-9#1)(1997-9#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#1)
would provide the##2##3##(2008-11#1)(2012-3#1)
would provide valuable information##2##4##(1996-8#1)(2012-12#1)
would provide valuable##3##3##(1996-8#1)(2008-7#1)(2012-12#1)
would provide##15##2##(1994-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
would reach##2##2##(2010-8#1)(2011-2#1)
would reduce the##4##3##(1993-9#1)(2008-10#2)(2013-1#1)
would remain##3##2##(1996-1#1)(1996-12#1)(2013-1#1)
would represent##2##2##(2008-11#1)(2009-3#1)
would require a##2##3##(1996-12#1)(2009-12#1)
would require disclosure of##2##4##(1995-12#1)(2009-7#1)
would require##12##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-6#1)(2009-12#1)(2009-7#1)(2010-7#1)(2013-1#1)
would result in a##4##4##(1991-3#1)(1993-9#1)(1995-2#1)(2008-10#1)
would result in an##2##4##(1995-3#1)(2009-7#1)
would result in the##2##4##(2008-10#2)
would result in##8##3##(1991-3#1)(1993-9#1)(1995-2#1)(1995-3#1)(2008-10#3)(2009-7#1)
would result##10##2##(1991-3#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#3)(2009-7#1)(2012-12#1)
would seem to be##2##4##(2008-10#1)(2008-11#1)
would seem to##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
would seem##7##2##(1991-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-1#1)
would show##3##2##(2008-11#1)(2008-4#1)(2009-11#1)
would significantly##2##2##(1995-1#1)(2009-11#1)
would suggest a##3##3##(2008-10#1)(2012-12#2)
would suggest that the##2##4##(2008-11#1)(2008-7#1)
would suggest that##7##3##(1990-11#1)(1990-2#1)(1994-8#1)(2008-11#2)(2008-7#1)(2011-7#1)
would suggest the##2##3##(1990-8#1)(2008-7#1)
would suggest##12##2##(1990-11#1)(1990-2#1)(1990-8#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2011-7#1)(2012-12#2)
would then##2##2##(1997-7#1)(2010-11#1)
would therefore be##2##3##(2008-11#1)(2013-1#1)
would use##2##2##(1992-12#1)(2008-1#1)
would yield##2##2##(1997-1#1)(1997-8#1)
would##664##1##(1990-11#3)(1990-12#2)(1990-2#7)(1990-3#1)(1990-5#1)(1990-6#5)(1990-8#2)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#2)(1991-5#2)(1991-6#4)(1991-9#2)(1992-12#11)(1992-2#8)(1992-3#5)(1992-6#2)(1992-9#1)(1993-1#5)(1993-12#4)(1993-2#5)(1993-3#5)(1993-6#3)(1993-9#2)(1994-1#5)(1994-11#2)(1994-12#9)(1994-2#5)(1994-3#3)(1994-5#3)(1994-8#3)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#11)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#14)(1995-8#1)(1996-1#6)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#5)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#11)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#5)(1997-9#1)(2007-12#4)(2007-8#1)(2008-1#7)(2008-10#101)(2008-11#64)(2008-12#12)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#11)(2008-6#3)(2008-7#26)(2008-8#26)(2008-9#12)(2009-1#2)(2009-10#6)(2009-11#3)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#7)(2009-8#2)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#5)(2011-10#1)(2011-2#22)(2011-3#3)(2011-7#1)(2012-12#13)(2012-2#7)(2012-3#8)(2012-9#1)(2013-1#26)(2013-8#11)
would-be##2##1##(1995-12#1)(2012-2#1)
wound and##6##2##(1991-6#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
wound area##2##2##(2008-11#2)
wound care##2##2##(2008-7#2)
wound closure##6##2##(2008-7#5)(2011-2#1)
wound complications##2##2##(1992-1#1)(2012-2#1)
wound dehiscence##3##2##(2008-7#3)
wound dressing##6##2##(2011-2#5)(2013-7#1)
wound healing and##3##3##(2008-11#1)(2010-6#1)(2012-3#1)
wound healing was##3##3##(2007-8#1)(2008-11#1)(2013-1#1)
wound healing##21##2##(1990-9#1)(1994-11#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#5)(2013-1#3)
wound infection and##2##3##(2008-7#2)
wound infection incidence##2##3##(1990-3#2)
wound infection##8##2##(1990-3#2)(1995-12#1)(2008-7#2)(2010-3#1)(2011-2#2)
wound infections##2##2##(1990-3#2)
wound infiltration with bupivacaine##2##4##(2008-7#2)
wound infiltration##4##2##(1991-3#1)(2008-7#3)
wound site pain##3##3##(2012-12#3)
wound site##6##2##(2008-10#3)(2012-12#3)
wound was##4##2##(1991-6#1)(2008-11#2)(2013-1#1)
wound##116##1##(1990-2#1)(1990-3#4)(1990-9#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-1#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#2)(2007-8#1)(2008-10#15)(2008-11#10)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#15)(2008-9#4)(2009-12#1)(2009-8#1)(2010-12#5)(2010-3#2)(2010-6#1)(2011-2#13)(2012-12#5)(2012-2#2)(2012-3#10)(2013-1#7)(2013-7#1)
wound-induced##2##1##(2008-10#1)(2009-8#1)
wounded maize##2##2##(2008-10#2)
wounded tissues##2##2##(2008-10#2)
wounded##17##1##(2008-10#17)
wounding and##4##2##(2008-10#3)(2009-8#1)
wounding of##2##2##(2008-10#2)
wounding##13##1##(1993-12#1)(2008-10#11)(2009-8#1)
wounds and##4##2##(1990-6#1)(2008-10#2)(2011-2#1)
wounds are##2##2##(1990-2#1)(2011-2#1)
wounds below the fourth intercostal space##2##6##(1990-2#2)
wounds below##3##2##(1990-2#2)(2008-10#1)
wounds in rats##2##3##(2008-11#2)
wounds in##3##2##(2008-11#3)
wounds of the##3##3##(2007-8#1)(2012-12#2)
wounds of##5##2##(2007-8#1)(2008-10#1)(2008-9#1)(2012-12#2)
wounds on##3##2##(2008-10#2)(2012-3#1)
wounds or##3##2##(2008-10#2)(2013-1#1)
wounds that##2##2##(2008-10#1)(2008-9#1)
wounds to the##2##3##(1995-11#2)
wounds to##3##2##(1995-11#2)(2012-3#1)
wounds were##3##2##(1992-2#1)(2008-10#1)(2008-12#1)
wounds##67##1##(1990-2#4)(1990-6#1)(1991-3#1)(1992-2#3)(1995-11#2)(2007-8#3)(2008-10#26)(2008-11#6)(2008-12#2)(2008-8#1)(2008-9#7)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)
woven##2##1##(1997-1#1)(2012-2#1)
wrapped around a##2##3##(2008-10#2)
wrapped around the##2##3##(1993-9#1)(2010-3#1)
wrapped around##4##2##(1993-9#1)(2008-10#2)(2010-3#1)
wrapped##6##1##(1993-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-3#1)
wrapping##2##1##(2008-11#1)(2008-8#1)
wrestler##3##1##(2010-1#2)(2012-3#1)
wrightii##3##1##(2009-8#3)
wrinkles##3##1##(1991-6#1)(2008-5#1)(2011-2#1)
wrinkling##2##1##(1994-11#1)(2011-2#1)
wrist and##2##2##(2008-12#2)
wrist ganglion##3##2##(2008-9#3)
wrist instability##2##2##(2008-9#1)(2013-1#1)
wrist pain##11##2##(2008-9#10)(2012-3#1)
wrist radiography is not##2##4##(2008-9#2)
wrist radiography##3##2##(2008-9#3)
wrist##42##1##(1991-11#1)(1991-6#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-12#3)(2008-9#26)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)
write a##2##2##(2008-9#1)(2010-7#1)
write##5##1##(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-7#1)
writer##2##1##(1995-2#1)(2009-3#1)
writers##3##1##(2008-8#1)(2009-4#1)(2013-8#1)
writes##2##1##(1993-3#1)(1994-12#1)
writhing##2##1##(1992-3#1)(1996-2#1)
writing a##2##2##(1996-6#1)(2009-4#1)
writing an##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
writing and##5##2##(1997-7#1)(2008-11#1)(2008-12#2)(2009-9#1)
writing in##2##2##(2010-10#1)(2010-6#1)
writing of the##2##3##(2008-12#1)(2011-2#1)
writing of##5##2##(1991-1#1)(2008-12#1)(2011-2#2)(2013-7#1)
writing power##3##2##(2008-3#3)
writing skills##2##2##(2008-12#2)
writing##42##1##(1991-1#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-7#1)(2008-11#7)(2008-12#9)(2008-3#4)(2009-11#1)(2009-12#1)(2009-4#2)(2009-9#3)(2010-10#2)(2010-6#1)(2011-2#5)(2012-2#1)(2013-7#1)
writings##6##1##(2008-12#2)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
written about the##6##3##(1992-1#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#1)
written about##11##2##(1992-1#1)(1994-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2010-10#1)(2012-2#2)(2013-8#1)
written and##4##2##(1994-12#1)(1996-11#1)(2008-8#1)(2010-3#1)
written at##3##2##(2008-12#3)
written by##3##2##(1996-5#1)(2008-11#1)(2008-9#1)
written for the##2##3##(2008-10#2)
written for##3##2##(1991-12#1)(2008-10#2)
written in order to##3##4##(1994-3#2)(2008-11#1)
written in##15##2##(1994-3#2)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#1)(2013-1#1)
written materials##2##2##(1996-5#1)(2008-4#1)
written on##2##2##(1994-2#1)(2007-12#1)
written to##2##2##(2010-8#1)(2011-2#1)
written##93##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1993-12#1)(1993-2#4)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#4)(1997-3#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#3)(2010-10#2)(2010-3#1)(2010-8#3)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
written/updated##3##1##(2012-12#3)
wrong##12##1##(1991-3#1)(1991-5#1)(1994-1#2)(1995-6#1)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-12#1)(2010-11#1)(2013-8#1)
wrong?##2##1##(2009-12#1)(2011-2#1)
wrongful##3##1##(1991-12#1)(1995-12#1)(1995-6#1)
wrongly##2##1##(1991-12#1)(1995-11#1)
wrote##9##1##(1991-3#1)(1992-3#1)(1993-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)(2013-1#1)
wrought##2##1##(2009-7#2)
ws##2##1##(2008-11#2)
wt##33##1##(1993-11#1)(1993-6#1)(2008-10#18)(2008-11#2)(2008-5#5)(2008-9#1)(2010-1#2)(2012-3#1)(2013-1#2)
wt%##6##1##(2008-10#3)(2009-11#1)(2009-7#2)
wt)##4##1##(1991-11#1)(2008-11#3)
wt-p53 in##2##2##(1997-7#2)
wt-p53##7##1##(1993-11#2)(1997-7#5)
wt/wt)##2##1##(2008-10#2)
wt/wt/wt##3##1##(2008-10#3)
wv/wv mice##4##2##(1996-12#4)
www##4##1##(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)
x &lt##2##2##(2010-4#2)
x 0##9##2##(2008-10#6)(2008-11#1)(2008-2#2)
x 1##4##2##(1997-8#2)(2008-11#1)(2011-2#1)
x 10##3##2##(1993-9#1)(1994-6#1)(2008-10#1)
x 10(-1) mol 1(-1)##3##4##(2008-10#3)
x 10(-1) mol##4##3##(2008-10#4)
x 10(-1)##6##2##(2008-10#6)
x 10(-10) M##7##3##(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-3#1)(2008-10#2)
x 10(-10) and##2##3##(1995-11#1)(2008-3#1)
x 10(-10) mol l(-1)##2##4##(2008-10#2)
x 10(-10)##17##2##(1991-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#3)(1996-3#1)(2008-10#6)(2008-2#1)(2008-3#2)
x 10(-10)mol##2##2##(2008-10#2)
x 10(-11) M##2##3##(2008-10#1)(2008-11#1)
x 10(-11) mol 1(-1) (AdS-DPV)##2##5##(2008-10#2)
x 10(-11) to##2##3##(2008-10#1)(2008-2#1)
x 10(-11)##7##2##(1995-11#1)(2008-10#4)(2008-11#1)(2008-2#1)
x 10(-12)##3##2##(1991-5#1)(2008-10#1)(2008-8#1)
x 10(-13)##2##2##(1990-12#1)(2008-3#1)
x 10(-16)##2##2##(2008-3#2)
x 10(-2) M##2##3##(2008-10#2)
x 10(-2)##6##2##(2008-10#4)(2008-3#1)(2009-6#1)
x 10(-2))##3##2##(2008-10#3)
x 10(-2)mol##2##2##(2008-10#2)
x 10(-3) kg m(-1) s(-1)##2##5##(2008-7#2)
x 10(-3) mg/L for##4##4##(2008-10#4)
x 10(-3) mol l(-1)##4##4##(2008-10#4)
x 10(-3) s-1##2##3##(1994-5#1)(1995-11#1)
x 10(-3)##21##2##(1990-8#1)(1994-5#1)(1995-11#1)(2008-10#11)(2008-2#2)(2008-3#3)(2008-7#2)
x 10(-3)mol##2##2##(2008-10#2)
x 10(-4 )pg/cell##2##3##(2008-11#2)
x 10(-4) M##3##3##(2008-10#2)(2008-11#1)
x 10(-4) and##3##3##(2008-10#1)(2008-11#2)
x 10(-4) for##3##3##(2008-10#1)(2008-3#2)
x 10(-4) mg aragonite per mm(2) of pellet at##2##9##(2008-10#2)
x 10(-4) mg##4##3##(2008-10#4)
x 10(-4)##24##2##(1990-8#1)(1994-5#1)(1995-11#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#4)
x 10(-4)M range in##3##4##(2008-10#3)
x 10(-4)M##5##2##(2008-10#5)
x 10(-4)moll(-1)##5##2##(2008-10#5)
x 10(-40) cm6/s##2##3##(2008-3#2)
x 10(-5) M and##2##4##(1992-6#1)(2008-10#1)
x 10(-5) M or greater##2##5##(1994-5#2)
x 10(-5) M##7##3##(1992-6#2)(1994-11#1)(1994-5#2)(2008-10#2)
x 10(-5) mol l(-1)##2##4##(2008-10#2)
x 10(-5) mol##3##3##(2008-10#3)
x 10(-5) to 1##4##4##(2008-10#4)
x 10(-5) to 2##3##4##(2008-10#3)
x 10(-5) to##9##3##(2008-10#9)
x 10(-5)##27##2##(1990-8#1)(1992-6#2)(1994-11#1)(1994-5#2)(2008-10#17)(2008-2#1)(2008-3#1)(2010-1#1)(2010-4#1)
x 10(-5))-(1##3##2##(2008-10#3)
x 10(-5)M##5##2##(1995-8#1)(2008-10#4)
x 10(-5)mol l(-1)##2##3##(2008-10#2)
x 10(-5)mol##3##2##(2008-10#3)
x 10(-6) M with##2##4##(1991-5#1)(2008-10#1)
x 10(-6) M##8##3##(1991-5#3)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#2)
x 10(-6) M)##2##3##(1991-5#1)(2008-10#1)
x 10(-6) and 1##5##4##(1995-11#2)(2008-10#3)
x 10(-6) and##6##3##(1995-11#2)(2008-10#4)
x 10(-6) cm/s for##2##4##(1992-3#2)
x 10(-6) mol l(-1) for##2##5##(2008-10#2)
x 10(-6) mol l(-1)##5##4##(2008-10#5)
x 10(-6) mol##7##3##(2008-10#7)
x 10(-6) to 1##4##4##(2008-10#4)
x 10(-6) to##6##3##(2008-10#6)
x 10(-6)##39##2##(1990-8#2)(1991-5#4)(1992-3#2)(1994-5#1)(1995-11#3)(1996-12#1)(1997-8#1)(2008-10#22)(2008-3#2)(2008-5#1)
x 10(-6)-1 x##3##3##(2008-10#3)
x 10(-6)-1##5##2##(2008-10#5)
x 10(-6)-2 x 10(-4)M range in##2##6##(2008-10#2)
x 10(-6)M##5##2##(2008-10#5)
x 10(-6)mol L(-1)##3##3##(2008-10#3)
x 10(-6)mol l(-1)##3##3##(2008-10#3)
x 10(-6)mol##6##2##(2008-10#6)
x 10(-6)mug ml(-1) for##2##4##(2008-10#2)
x 10(-7) M##5##3##(1990-10#1)(1995-11#1)(2008-10#3)
x 10(-7) mol l(-1) for##3##5##(2008-10#3)
x 10(-7) mol l(-1)##7##4##(2008-10#7)
x 10(-7) mol##11##3##(2008-10#11)
x 10(-7) to##10##3##(2008-10#9)(2008-3#1)
x 10(-7)##33##2##(1990-10#1)(1990-8#1)(1994-2#1)(1995-11#1)(2008-10#25)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
x 10(-7)M for##2##3##(2008-10#2)
x 10(-7)M##4##2##(2008-10#4)
x 10(-7)mol L(-1) and##3##4##(2008-10#3)
x 10(-7)mol l(-1)##2##3##(2008-10#2)
x 10(-7)mol##5##2##(2008-10#5)
x 10(-8) M CXB##2##4##(2008-10#2)
x 10(-8) M##7##3##(1991-5#1)(2008-10#6)
x 10(-8) cm(2)/W##2##3##(2008-3#2)
x 10(-8) g ml(-1)##3##4##(2008-10#3)
x 10(-8) mol##2##3##(2008-10#2)
x 10(-8) to 1##2##4##(2008-10#2)
x 10(-8) to##5##3##(2008-10#5)
x 10(-8)##24##2##(1991-5#1)(1995-11#1)(2008-10#19)(2008-3#3)
x 10(-8)M##2##2##(2008-10#2)
x 10(-8)mol L(-1)##2##3##(2008-10#2)
x 10(-8)mol/L##2##2##(2008-10#2)
x 10(-9) M##6##3##(1991-5#1)(1995-11#1)(2008-10#4)
x 10(-9) and 4##2##4##(2008-10#2)
x 10(-9) and 5##2##4##(1995-11#1)(2008-10#1)
x 10(-9) and##4##3##(1995-11#1)(2008-10#3)
x 10(-9)##18##2##(1991-5#1)(1995-11#3)(2008-10#11)(2008-3#2)(2008-8#1)
x 10(-9)mol##2##2##(2008-10#2)
x 10(-9)molL(-1)##2##2##(2008-10#2)
x 10(1) TCID(50)##3##3##(2009-6#3)
x 10(10)##3##2##(2008-10#1)(2008-11#2)
x 10(11)##3##2##(2008-8#2)(2010-1#1)
x 10(12)##2##2##(2008-7#1)(2008-9#1)
x 10(18) cm(-3)##2##3##(2008-3#2)
x 10(2)##2##2##(2008-10#1)(2009-7#1)
x 10(3) Pa##6##3##(2008-10#6)
x 10(3) Pa)##2##3##(2008-10#2)
x 10(3) to##2##3##(2008-10#2)
x 10(3)##24##2##(1996-12#3)(1996-5#1)(2008-10#17)(2008-3#1)(2008-5#1)(2009-7#1)
x 10(4) 1 mol(-1)##2##4##(2008-10#2)
x 10(4) M-1 and##2##4##(1994-5#2)
x 10(4) M-1##4##3##(1993-1#1)(1993-8#1)(1994-5#2)
x 10(4) l mol(-1) cm(-1) and##3##6##(2008-10#3)
x 10(4) l mol(-1) cm(-1)##5##5##(2008-10#5)
x 10(4)##26##2##(1993-1#1)(1993-8#1)(1994-5#2)(1997-3#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)
x 10(5) cells ml(-1)##2##4##(2008-10#1)(2008-11#1)
x 10(5) cells per##2##4##(1995-3#1)(2010-6#1)
x 10(5) cells##6##3##(1995-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)
x 10(5) conidia##2##3##(2008-10#2)
x 10(5)##29##2##(1990-5#2)(1992-10#1)(1994-8#1)(1995-3#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-9#2)(2010-6#1)
x 10(5))##3##2##(1991-9#1)(2008-10#2)
x 10(5)CFU/ml##2##2##(2008-10#2)
x 10(6) CFU##3##3##(2008-10#3)
x 10(6) IU##2##3##(1990-12#1)(1992-2#1)
x 10(6) M-1 s-1##3##4##(1993-8#1)(1994-5#2)
x 10(6) M-1##6##3##(1992-10#1)(1993-1#1)(1993-8#1)(1994-5#2)(1995-2#1)
x 10(6) M-1)##3##3##(1992-4#3)
x 10(6) and##3##3##(1991-12#1)(2008-11#1)(2008-7#1)
x 10(6) c/ml##2##3##(2008-11#2)
x 10(6) cells ml(-1)##6##4##(2008-10#1)(2008-11#5)
x 10(6) cells ml(-1))##3##4##(2008-11#3)
x 10(6) cells##10##3##(2008-10#1)(2008-11#9)
x 10(6) cells/ml##4##3##(2008-11#2)(2008-7#2)
x 10(6) conidia per##3##4##(2008-10#3)
x 10(6) conidia##4##3##(2008-10#4)
x 10(6) ml(-1)##3##3##(2008-11#3)
x 10(6)##59##2##(1990-12#1)(1991-12#2)(1992-10#1)(1992-2#1)(1992-4#3)(1993-1#1)(1993-8#1)(1994-5#2)(1995-2#1)(1996-5#1)(2008-10#20)(2008-11#19)(2008-3#1)(2008-7#3)(2008-9#2)
x 10(6))##2##2##(2008-10#1)(2008-11#1)
x 10(7) cells ml(-1)##6##4##(2008-10#1)(2008-11#5)
x 10(7) cells##7##3##(2008-10#1)(2008-11#6)
x 10(7) conidia per ml)##2##5##(2008-10#2)
x 10(7)##22##2##(1995-2#1)(2008-10#11)(2008-11#9)(2008-9#1)
x 10(8) U/mg##2##3##(1990-12#2)
x 10(8)##12##2##(1990-12#3)(1993-1#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)
x 10(9) cells in the##2##5##(2008-11#2)
x 10(9) cells##4##3##(2008-10#1)(2008-11#3)
x 10(9) s(-1)##2##3##(2008-8#2)
x 10(9)##13##2##(1990-11#1)(1995-2#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#2)(2008-9#2)
x 10(9)mol(-1)##2##2##(2008-10#2)
x 10(9)mol(-1))##2##2##(2008-10#2)
x 100##2##2##(1992-12#1)(2011-2#1)
x 109/l##4##2##(2008-10#4)
x 12##2##2##(2008-10#1)(2012-3#1)
x 128##2##2##(1991-2#1)(1997-8#1)
x 2 cm##3##3##(2010-3#1)(2010-6#1)(2011-2#1)
x 2##13##2##(1994-3#1)(1995-9#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-3#1)(2010-6#1)(2011-2#2)(2011-3#1)(2013-1#1)
x 200##2##2##(1995-8#1)(2008-12#1)
x 25##2##2##(2008-11#2)
x 3 cm##2##3##(2008-12#1)(2009-5#1)
x 3##8##2##(1994-2#2)(2008-10#3)(2008-12#1)(2008-3#1)(2009-5#1)
x 4##10##2##(1993-9#1)(1997-2#1)(2008-10#5)(2008-5#1)(2009-7#1)(2009-8#1)
x 5 days) +##2##4##(1992-2#2)
x 5 mm##2##3##(2008-10#1)(2013-8#1)
x 5##8##2##(1992-2#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
x 7##2##2##(1993-9#1)(2010-11#1)
x 8##6##2##(1993-9#2)(2008-10#1)(2008-3#2)(2012-3#1)
x =##3##2##(1995-12#1)(2008-5#1)(2010-4#1)
x A##3##2##(2008-10#3)
x B37HtN##2##2##(2008-10#2)
x BMR##3##2##(2008-9#3)
x C##3##2##(2008-10#2)(2008-12#1)
x D##3##2##(2008-10#3)
x G##2##2##(2008-10#1)(2008-9#1)
x Hor2596##3##2##(2008-10#3)
x L##2##2##(2008-10#2)
x L(-1))##5##2##(2011-3#5)
x MX169##3##2##(2008-10#3)
x P##7##2##(2008-10#7)
x SP##5##2##(2008-10#5)
x Tex6##6##2##(2008-10#6)
x ananassa##3##2##(2008-10#3)
x cm(-2)##2##2##(2011-3#2)
x cultivar interaction##2##3##(2008-10#2)
x cultivar##3##2##(2008-10#3)
x domestica##2##2##(2008-10#2)
x environment##2##2##(2008-10#2)
x is##2##2##(2008-10#2)
x mL(-1) for ethinylestradiol##2##4##(2011-3#2)
x mL(-1) for gestodene and etonogestrel and##2##7##(2011-3#2)
x mL(-1) for##4##3##(2011-3#4)
x min(-1)##4##2##(2011-3#4)
x susceptible##2##2##(2008-10#2)
x##890##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#1)(1990-5#2)(1990-8#8)(1991-12#2)(1991-2#1)(1991-5#9)(1991-9#2)(1992-10#2)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#3)(1992-6#2)(1993-1#3)(1993-3#1)(1993-8#6)(1993-9#5)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#10)(1994-6#1)(1994-8#2)(1995-11#14)(1995-12#3)(1995-2#5)(1995-3#1)(1995-8#3)(1995-9#2)(1996-12#5)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-8#4)(2008-10#508)(2008-11#63)(2008-12#12)(2008-2#13)(2008-3#51)(2008-4#1)(2008-5#5)(2008-7#15)(2008-8#10)(2008-9#17)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#1)(2010-1#2)(2010-11#1)(2010-3#2)(2010-4#5)(2010-6#3)(2011-2#9)(2011-3#26)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
x(-)##3##1##(2008-11#3)
x-##2##1##(2008-10#1)(2012-3#1)
x-ray absorptiometry##2##2##(2008-8#1)(2010-1#1)
x-ray absorption##3##2##(2012-2#3)
x-ray beams##2##2##(1993-9#1)(2008-2#1)
x-ray crystallographic##2##2##(1991-12#1)(1991-3#1)
x-ray diffraction (XRD)##2##3##(2008-10#1)(2010-4#1)
x-ray diffraction##6##2##(1991-5#1)(1991-6#1)(1992-8#1)(1995-6#1)(2008-10#1)(2010-4#1)
x-ray emission##2##2##(2010-1#1)(2012-2#1)
x-ray imaging##2##2##(2008-8#1)(2010-4#1)
x-ray##51##1##(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#4)(1992-11#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-9#1)(1995-6#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-8#2)(2008-9#1)(2009-11#1)(2010-1#8)(2010-12#5)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
x-rays and##3##2##(1992-6#1)(2011-1#1)(2012-12#1)
x-rays##9##1##(1992-6#1)(1995-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
x// 1##3##2##(2009-1#3)
x2##2##1##(1995-12#1)(2008-10#1)
x3##3##1##(2008-10#2)(2008-11#1)
x4##5##1##(2008-10#4)(2013-1#1)
x=0##3##1##(2008-10#3)
xa5##5##1##(2008-10#5)
xagP##2##1##(2008-10#2)
xanthate##6##1##(2008-10#6)
xanthene dye##2##2##(2008-10#2)
xanthene##4##1##(1993-12#1)(2008-10#3)
xanthenone##3##1##(1993-12#1)(2008-11#2)
xanthii##3##1##(2008-10#3)
xanthine oxidase (XO)##2##3##(2008-10#1)(2008-11#1)
xanthine oxidase and##2##3##(1990-5#1)(2008-11#1)
xanthine oxidase##7##2##(1990-5#1)(1993-6#1)(2008-10#2)(2008-11#3)
xanthine##8##1##(1990-5#1)(1993-6#1)(2008-10#2)(2008-11#4)
xanthoastrocytoma##6##1##(2008-12#2)(2008-7#3)(2013-8#1)
xanthogranulomatous pyelonephritis##2##2##(2013-1#2)
xanthogranulomatous##4##1##(1991-8#2)(2013-1#2)
xanthomonads##4##1##(2008-10#4)
xanthomonas strains##2##2##(2008-10#2)
xanthomonas##4##1##(2008-10#4)
xanthorrhiza##2##1##(1996-9#2)
xanthosine##5##1##(1997-2#2)(2009-12#3)
xcolumbiana##5##1##(2008-10#5)
xemilofiban##3##1##(2008-5#3)
xeno-endothelial cells##2##2##(2008-8#2)
xenobiotic##5##1##(1993-11#1)(2008-10#2)(2008-12#1)(2008-7#1)
xenobiotics in the##5##3##(1990-6#1)(2008-10#1)(2008-11#3)
xenobiotics in##8##2##(1990-6#1)(1994-3#1)(2008-10#1)(2008-11#5)
xenobiotics##20##1##(1990-6#1)(1994-3#1)(1994-8#1)(2008-10#4)(2008-11#10)(2008-7#2)(2012-2#1)
xenogeneic##7##1##(2011-2#3)(2012-3#3)(2013-7#1)
xenograft##10##1##(2008-8#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#3)
xenografted##5##1##(2008-11#3)(2013-1#2)
xenografts were##3##2##(1997-7#2)(2009-3#1)
xenografts##16##1##(1997-7#7)(2008-8#1)(2009-3#3)(2012-2#2)(2013-1#1)(2013-8#2)
xenon lamp##2##2##(2008-10#2)
xenon##7##1##(1991-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
xerophthalmia##3##1##(1991-8#3)
xerosis##9##1##(1991-8#1)(2008-5#8)
xerostomia##2##1##(1993-9#1)(2008-5#1)
xerotic skin##7##2##(2008-5#7)
xerotic##8##1##(2008-5#8)
xi##5##1##(2008-3#5)
xii##2##1##(1990-11#1)(1990-8#1)
xiv##2##1##(1990-11#1)(1990-8#1)
xorIIM homolog##2##2##(2008-10#2)
xpolyantha##2##1##(2008-10#2)
xrFNDI##2##1##(2008-4#2)
xrs-6##2##1##(1996-2#2)
xuefu zhuyu##3##2##(2012-3#1)(2013-8#2)
xylE##2##1##(1990-5#2)
xylan##8##1##(2008-8#2)(2011-1#6)
xylanase from alkalothermophilic Bacillus sp##2##5##(1993-3#2)
xylanase from##3##2##(1993-3#2)(2008-10#1)
xylanase##8##1##(1993-3#3)(2008-10#4)(2011-2#1)
xylanases##2##1##(2008-10#1)(2011-2#1)
xylanolytic bacterium##2##2##(2008-8#2)
xylanolytic##3##1##(2008-10#1)(2008-8#2)
xylariaceous##2##1##(2008-11#2)
xylazine##7##1##(2012-3#7)
xylem and phloem##4##3##(2008-10#1)(2012-8#3)
xylem and##6##2##(2008-10#2)(2008-11#1)(2012-8#3)
xylem elements##2##2##(2007-12#1)(2008-10#1)
xylem flow##2##2##(2008-11#2)
xylem of##3##2##(2012-8#3)
xylem parenchyma cells##3##3##(2008-10#1)(2008-11#2)
xylem structure##2##2##(2012-5#2)
xylem vessels and##2##3##(2007-12#1)(2008-10#1)
xylem vessels of##3##3##(2007-12#1)(2008-10#2)
xylem vessels##10##2##(2007-12#2)(2008-10#8)
xylem##43##1##(2007-12#3)(2008-10#22)(2008-11#6)(2009-8#1)(2012-5#4)(2012-8#7)
xylem-limited##2##1##(2008-10#2)
xylene and##2##2##(1994-8#1)(2008-10#1)
xylene as##3##2##(2008-10#3)
xylene##26##1##(1994-8#1)(2008-10#25)
xylenes##3##1##(2008-10#3)
xylenol orange (XO)##2##3##(2008-10#2)
xylenol orange##8##2##(2008-10#8)
xylophilus##8##1##(2008-10#8)
xyloporosis##4##1##(2008-10#4)
xylose and##2##2##(2011-1#1)(2012-3#1)
xylose fermentation##2##2##(2012-3#2)
xylose utilization of##2##3##(2012-3#2)
xylose utilization##3##2##(2012-3#3)
xylose##18##1##(1996-6#2)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#11)
xylostella##4##1##(2010-4#4)
y is##4##2##(1995-12#1)(2008-10#2)(2008-11#1)
y##18##1##(1995-12#2)(1997-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2009-1#1)(2009-11#1)(2009-9#1)(2011-3#1)(2012-2#1)
y)##8##1##(2008-10#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-10#1)(2012-2#1)
y/o)##4##1##(2011-2#4)
yak meat##3##2##(2010-4#3)
yak##6##1##(2010-4#6)
yaks (Bos grunniens) with keratoconjunctivitis##2##5##(2011-2#2)
yaks with keratoconjunctivitis##2##3##(2011-2#2)
yaks##11##1##(2011-2#11)
yallundae and T##5##3##(2008-10#5)
yallundae and##6##2##(2008-10#6)
yallundae##13##1##(2008-10#13)
yang##2##1##(2008-10#2)
yard##6##1##(2008-10#6)
yards##3##1##(2008-10#2)(2013-1#1)
yb##2##1##(2008-3#2)
year 1991##3##2##(1992-1#1)(1995-12#1)(1997-1#1)
year 2000##21##2##(1990-2#1)(1991-9#1)(1993-3#1)(1994-9#2)(1995-6#1)(1996-11#1)(1997-2#3)(1997-3#3)(1997-6#4)(2008-11#1)(2008-12#1)(2010-5#1)(2010-7#1)
year 2000]##2##2##(1993-2#1)(1996-11#1)
year after his##2##3##(1997-6#1)(2010-1#1)
year after the initial##2##4##(2013-1#2)
year after the procedure##2##4##(2008-11#1)(2010-10#1)
year after the##10##3##(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#2)(2013-1#2)
year after transplantation##3##3##(2011-2#2)(2012-3#1)
year after##29##2##(1991-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-1#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#5)
year age group##2##3##(2008-12#2)
year and location##2##3##(2008-10#2)
year and then##2##3##(1995-8#1)(2008-12#1)
year and##24##2##(1990-12#1)(1990-6#1)(1991-2#1)(1995-8#1)(1997-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#1)(2013-1#3)(2013-8#1)
year apart##2##2##(1994-12#1)(2008-7#1)
year before the##3##3##(1990-12#1)(1990-2#1)(2010-12#1)
year during the##2##3##(2008-1#1)(2008-10#1)
year during##4##2##(1994-1#1)(2008-1#1)(2008-10#2)
year earlier##2##2##(2008-11#1)(2011-2#1)
year follow-up##5##2##(1991-2#1)(1994-2#1)(1997-8#1)(2010-3#1)(2013-8#1)
year for##6##2##(2008-10#4)(2010-8#1)(2011-1#1)
year from##5##2##(1992-12#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
year had##2##2##(2008-10#1)(2008-11#1)
year in the##4##3##(1995-5#1)(2008-10#2)(2008-12#1)
year in##16##2##(1990-12#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2013-8#1)
year later##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
year medical students##2##3##(2008-10#1)(2008-11#1)
year nursing##2##2##(2008-11#1)(2008-12#1)
year of a##3##3##(1995-3#1)(2008-11#1)(2008-12#1)
year of age##3##3##(1991-11#1)(1991-6#1)(1995-8#1)
year of birth##2##3##(1991-2#1)(2008-7#1)
year of diagnosis##2##3##(2011-1#2)
year of disease##2##3##(2011-1#2)
year of life##9##3##(1991-8#2)(1994-2#1)(1995-8#1)(1996-11#2)(2008-12#1)(2008-7#2)
year of the prospective payment system##2##6##(1991-2#1)(1992-12#1)
year of the##14##3##(1991-2#1)(1991-3#1)(1992-12#2)(1993-3#1)(1995-5#1)(1996-12#1)(2008-10#5)(2008-12#1)(2008-4#1)
year of treatment##2##3##(1991-11#1)(2013-1#1)
year of##69##2##(1990-11#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#3)(1993-11#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1997-1#1)(2008-10#9)(2008-11#4)(2008-12#4)(2008-4#1)(2008-7#4)(2008-9#1)(2009-12#1)(2011-1#6)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#4)(2013-8#1)
year offollow up##4##3##(2013-8#4)
year old DS cases##2##4##(1991-1#2)
year old boy with##2##4##(1991-11#1)(2010-8#1)
year old boy##4##3##(1991-11#1)(1996-6#1)(2010-8#1)(2012-3#1)
year old child##2##3##(1995-11#1)(2010-5#1)
year old female with##2##4##(2011-2#1)(2012-2#1)
year old female##4##3##(2011-2#2)(2012-2#1)(2012-3#1)
year old male##2##3##(2013-1#2)
year old man with##2##4##(1997-6#1)(2009-8#1)
year old man##5##3##(1990-9#1)(1992-9#1)(1997-6#1)(2009-8#1)(2011-2#1)
year old patient with##2##4##(1994-5#1)(2012-2#1)
year old patient##3##3##(1994-5#1)(2012-2#1)(2013-1#1)
year old woman##6##3##(1990-2#1)(1990-6#1)(1991-8#1)(1993-6#1)(1994-8#1)(1997-6#1)
year old##41##2##(1990-2#1)(1990-6#1)(1990-9#2)(1991-1#3)(1991-11#2)(1991-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#2)(2008-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
year on##2##2##(2008-10#2)
year or more##3##3##(1990-8#1)(2008-9#1)(2012-12#1)
year or##7##2##(1990-6#1)(1990-8#1)(1997-3#1)(2008-10#2)(2008-9#1)(2012-12#1)
year period##14##2##(1990-3#1)(1990-6#1)(1991-3#1)(1991-9#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-5#2)(2008-7#3)(2010-6#1)(2012-3#1)
year risk##2##2##(2008-1#1)(2013-7#1)
year since##3##2##(1994-9#1)(2010-10#1)(2011-2#1)
year students of##2##3##(1997-3#1)(2013-1#1)
year students##4##2##(1997-3#1)(2008-12#2)(2013-1#1)
year survival##5##2##(1990-6#2)(1993-1#1)(2008-10#1)(2011-2#1)
year the##2##2##(1993-8#1)(2008-8#1)
year to year##9##3##(2008-10#3)(2008-12#1)(2008-8#3)(2011-2#1)(2013-1#1)
year to##14##2##(1991-12#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#3)(2011-1#1)(2011-2#1)(2013-1#1)
year two##2##2##(1997-2#1)(2008-11#1)
year undergraduate students##2##3##(2008-11#1)(2008-12#1)
year was##5##2##(1993-12#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
year were##7##2##(1991-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2012-12#1)
year when##4##2##(2008-10#2)(2008-8#2)
year with a##3##3##(1994-9#1)(2008-10#2)
year with##7##2##(1994-3#1)(1994-9#1)(2008-10#4)(2012-3#1)
year##621##1##(1990-11#1)(1990-12#6)(1990-2#4)(1990-3#2)(1990-6#7)(1990-8#1)(1990-9#2)(1991-1#7)(1991-11#5)(1991-12#1)(1991-2#10)(1991-3#3)(1991-6#3)(1991-8#7)(1991-9#3)(1992-1#3)(1992-12#9)(1992-2#1)(1992-3#1)(1992-5#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#5)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#7)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#3)(1996-11#5)(1996-12#9)(1996-2#3)(1996-5#3)(1996-6#3)(1996-8#3)(1997-1#3)(1997-2#8)(1997-3#8)(1997-4#3)(1997-5#2)(1997-6#8)(1997-8#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#116)(2008-11#46)(2008-12#29)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#12)(2008-7#19)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#14)(2011-2#23)(2012-12#8)(2012-2#8)(2012-3#15)(2012-5#1)(2012-6#1)(2013-1#25)(2013-7#1)(2013-8#15)
year's##7##1##(1990-11#1)(1990-2#1)(1991-2#1)(2008-10#4)
year)##8##1##(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-2#2)(2013-8#1)
year-old children##2##2##(1995-8#1)(2012-12#1)
year-old group##2##2##(2008-7#2)
year-old man##2##2##(1990-8#1)(2013-1#1)
year-old woman##2##2##(1995-2#1)(2008-5#1)
year-old##15##1##(1990-8#1)(1995-2#1)(1995-8#1)(1996-9#1)(2008-5#1)(2008-7#3)(2010-1#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#2)
year-round residency in##2##3##(2008-8#2)
year-round##4##1##(2008-10#1)(2008-8#2)(2011-9#1)
year-to-year##2##1##(1991-3#1)(2008-10#1)
yearly and##2##2##(2008-10#1)(2013-1#1)
yearly applications of Pseudomonas putida 06909-rif/nal##2##6##(2008-10#2)
yearly applications of##3##3##(2008-10#3)
yearly##20##1##(1991-6#1)(1991-8#1)(1994-12#1)(1997-8#1)(2008-10#10)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#1)
years (average##2##2##(2008-5#1)(2010-3#1)
years (mean 3##2##3##(1997-3#1)(2013-1#1)
years (mean##10##2##(1990-6#1)(1992-9#1)(1993-1#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-9#1)(2013-1#3)
years (range 2##2##3##(2008-9#1)(2012-12#1)
years (range##20##2##(1990-11#1)(1991-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1995-2#1)(2008-5#1)(2008-9#4)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)
years 6 months##2##3##(2008-7#1)(2008-9#1)
years a##2##2##(2012-2#1)(2012-3#1)
years after diagnosis##3##3##(2008-7#2)(2011-2#1)
years after operation##2##3##(1990-2#1)(1993-11#1)
years after surgery##4##3##(1991-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
years after surgical resection##2##4##(1991-12#1)(2011-2#1)
years after surgical##4##3##(1991-12#1)(1991-6#1)(1994-3#1)(2011-2#1)
years after the first##2##4##(1994-9#1)(2008-5#1)
years after the initial operation##3##5##(2011-2#2)(2012-3#1)
years after the initial##4##4##(2011-2#2)(2012-3#1)(2013-8#1)
years after the##23##3##(1991-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-3#1)(2011-2#4)(2012-3#1)(2013-8#1)
years after their##3##3##(1996-3#1)(2010-9#1)(2013-1#1)
years after treatment##2##3##(1995-11#1)(1997-5#1)
years after##76##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#2)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2008-10#7)(2008-11#1)(2008-12#6)(2008-5#1)(2008-7#8)(2008-9#2)(2009-12#1)(2009-3#1)(2010-3#2)(2010-9#1)(2011-2#9)(2011-3#2)(2012-12#1)(2012-3#3)(2013-1#9)(2013-8#1)
years ago and##2##3##(2010-8#1)(2012-3#1)
years ago the##2##3##(1994-12#1)(2012-2#1)
years ago##56##2##(1990-11#1)(1990-6#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)
years ahead##3##2##(1992-2#1)(1996-9#1)(2008-10#1)
years and 2 months##2##4##(2009-3#2)
years and 2##3##3##(2009-3#3)
years and 6##2##3##(2011-2#1)(2012-3#1)
years and 9##3##3##(1997-7#1)(2008-11#1)(2012-3#1)
years and at##2##3##(2008-10#1)(2013-8#1)
years and older##2##3##(2009-5#1)(2012-2#1)
years and one##2##3##(2008-10#2)
years and over##3##3##(2008-7#3)
years and that##2##3##(1995-8#1)(2008-12#1)
years and the##4##3##(2008-1#1)(2008-10#2)(2012-3#1)
years and##76##2##(1990-12#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-8#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-8#1)(1995-9#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#1)
years are##8##2##(1996-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-11#1)(2011-2#2)(2012-12#1)
years as a means of##2##5##(1996-1#1)(2012-2#1)
years as a##3##3##(1996-1#1)(2007-8#1)(2012-2#1)
years as##7##2##(1993-12#1)(1996-1#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-2#1)
years at the##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
years at various##2##3##(1990-3#1)(2008-10#1)
years at##12##2##(1990-3#1)(1995-11#1)(2007-12#1)(2008-10#6)(2008-7#1)(2012-2#1)(2012-3#1)
years been##2##2##(2008-11#1)(2009-6#1)
years before the##2##3##(1990-12#1)(1991-7#1)
years before##15##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-7#2)(1993-3#1)(1994-3#1)(1994-9#1)(2008-1#2)(2008-10#2)(2008-7#1)(2010-12#1)(2012-3#1)
years between##3##2##(1996-11#1)(2009-10#1)(2012-12#1)
years by a##2##3##(1994-3#1)(2012-3#1)
years by the##2##3##(1997-6#1)(2013-1#1)
years by##11##2##(1994-3#1)(1997-6#1)(2008-10#5)(2011-2#1)(2012-3#1)(2013-1#2)
years duration and##2##3##(1994-12#1)(2010-11#1)
years duration##3##2##(1994-12#2)(2010-11#1)
years during##2##2##(1997-7#1)(2008-10#1)
years earlier##9##2##(1991-12#1)(1991-6#1)(1995-12#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#2)
years experience at##2##3##(1991-2#1)(2010-11#1)
years experience in##2##3##(1990-3#1)(1994-12#1)
years experience##8##2##(1990-3#1)(1991-2#1)(1994-12#1)(1997-2#1)(2010-11#1)(2011-2#1)(2012-2#2)
years follow-up##5##2##(1997-8#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
years following##5##2##(2008-12#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-12#1)
years for boys##2##3##(1990-9#1)(2013-1#1)
years for the##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
years for##22##2##(1990-12#2)(1990-9#2)(1992-9#1)(1993-1#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-4#3)(2008-10#3)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#4)
years from a##2##3##(1994-6#1)(2008-12#1)
years from##9##2##(1991-12#1)(1994-6#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)
years has been##2##3##(1997-4#1)(2010-6#1)
years has##7##2##(1996-11#1)(1997-4#1)(2008-2#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
years have provided##2##3##(2010-1#1)(2011-2#1)
years have##8##2##(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#1)(2013-8#1)
years in St##2##3##(1995-12#1)(2008-10#1)
years in a##2##3##(1997-2#1)(1997-8#1)
years in age##2##3##(1994-3#1)(2008-12#1)
years in four##2##3##(1991-6#1)(2008-1#1)
years in prison##4##3##(1996-5#4)
years in the##7##3##(1997-2#2)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
years in##52##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-6#2)(1992-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-5#5)(1997-2#3)(1997-5#1)(1997-7#2)(1997-8#1)(2008-1#2)(2008-10#12)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
years is presented##2##3##(2008-10#1)(2008-7#1)
years is##6##2##(1994-12#1)(2008-10#3)(2008-7#1)(2010-5#1)
years it has been shown that##2##6##(1990-11#1)(1995-9#1)
years it has been##3##4##(1990-11#1)(1995-9#1)(2008-12#1)
years it##4##2##(1990-11#1)(1995-9#1)(2008-12#1)(2009-1#1)
years later##25##2##(1991-11#1)(1991-6#3)(1993-2#1)(1994-12#1)(1994-3#1)(1996-3#2)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
years many##4##2##(1990-9#1)(2008-10#1)(2012-3#1)(2013-1#1)
years of age and##5##4##(2008-11#1)(2008-12#1)(2009-10#1)(2012-12#2)
years of age at##2##4##(2008-11#1)(2010-10#1)
years of age group##2##4##(1997-3#1)(2012-3#1)
years of age or##4##4##(1991-12#1)(1991-3#1)(1992-1#1)(1993-12#1)
years of age were##4##4##(1995-12#1)(1996-1#1)(2008-10#2)
years of age##74##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-7#4)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#10)(2012-12#6)(2012-3#5)(2013-1#5)(2013-8#2)
years of age)##4##3##(2008-10#1)(2008-7#2)(2012-12#1)
years of cochlear implant##2##4##(2008-9#2)
years of data##2##3##(1995-12#1)(2008-8#1)
years of diagnosis##2##3##(1990-6#1)(2008-11#1)
years of education##3##3##(2008-12#1)(2010-6#1)(2011-2#1)
years of experience in##2##4##(1993-12#1)(2010-12#1)
years of experience##10##3##(1993-12#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
years of field experiments##2##4##(2008-10#1)(2008-12#1)
years of field##4##3##(2008-10#3)(2008-12#1)
years of follow up##3##4##(2012-2#1)(2013-1#2)
years of human##2##3##(2012-3#1)(2013-7#1)
years of life##5##3##(1992-6#1)(1995-8#1)(1996-9#1)(2008-12#1)(2013-8#1)
years of research##3##3##(2008-10#1)(2009-8#1)(2010-8#1)
years of the study##7##4##(1996-3#1)(1997-8#1)(2008-10#4)(2012-3#1)
years of the##18##3##(1991-3#1)(1993-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#8)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
years of their##2##3##(2007-12#1)(2008-11#1)
years of##205##2##(1990-3#1)(1990-6#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#3)(1992-6#2)(1992-7#1)(1993-12#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#32)(2008-11#11)(2008-12#6)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#18)(2011-3#1)(2012-12#11)(2012-2#4)(2012-3#11)(2013-1#9)(2013-7#1)(2013-8#5)
years old and##3##3##(2012-12#2)(2013-1#1)
years old are##2##3##(2008-5#1)(2011-2#1)
years old female##3##3##(2011-2#2)(2013-1#1)
years old in##2##3##(1997-7#1)(2011-2#1)
years old lady##2##3##(2012-2#1)(2013-7#1)
years old man##3##3##(1991-11#1)(1993-2#1)(2012-3#1)
years old patient##2##3##(2007-8#1)(2011-2#1)
years old were##3##3##(2008-1#1)(2011-2#1)(2012-12#1)
years old woman##2##3##(1990-12#1)(2013-8#1)
years old##75##2##(1990-12#1)(1990-6#4)(1991-11#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-9#2)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#10)(2012-12#5)(2012-2#1)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#2)
years old) and##2##3##(2010-12#1)(2013-8#1)
years old) normal subjects##2##4##(2009-8#2)
years old)##12##2##(1996-8#1)(2008-8#1)(2009-8#2)(2010-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
years on PD##2##3##(2011-2#2)
years on##9##2##(1993-2#1)(1996-11#1)(2008-10#3)(2008-11#1)(2011-2#2)(2011-3#1)
years only##2##2##(1994-12#1)(2008-7#1)
years or greater##2##3##(2008-10#2)
years or less##3##3##(1990-12#1)(2012-3#1)(2013-1#1)
years or locations##2##3##(2008-10#2)
years or more##3##3##(1995-2#1)(1996-6#1)(2013-1#1)
years or older##2##3##(1992-5#1)(2008-11#1)
years or##18##2##(1990-12#1)(1992-5#1)(1994-6#2)(1995-2#1)(1996-6#1)(2008-10#4)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
years participated in the study##2##5##(2008-12#1)(2008-9#1)
years post-implant##4##2##(2008-9#4)
years postoperatively##4##2##(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
years previously##3##2##(1994-12#1)(2008-10#1)(2010-6#1)
years several##2##2##(1993-3#1)(2008-10#1)
years since the##2##3##(1993-6#1)(1997-5#1)
years since##5##2##(1991-12#1)(1993-6#1)(1997-5#1)(2008-10#1)(2013-1#1)
years than##2##2##(1992-1#1)(2008-10#1)
years that##4##2##(1993-6#1)(2008-11#1)(2008-2#1)(2010-12#1)
years the##6##2##(1990-6#1)(1991-6#1)(2008-11#3)(2011-2#1)
years their##2##2##(1994-12#1)(2008-5#1)
years there has been##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
years there have been##3##4##(1990-11#1)(1994-9#1)(2008-11#1)
years there##8##2##(1990-11#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
years to a##2##3##(1995-12#1)(2008-10#1)
years to come##8##3##(1993-2#1)(1994-6#1)(1996-3#2)(1997-1#1)(1997-8#1)(2008-11#1)(2010-6#1)
years to##30##2##(1990-2#1)(1990-3#1)(1991-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
years two##3##2##(1996-6#1)(2008-11#1)(2010-7#1)
years using##2##2##(2008-11#1)(2008-12#1)
years versus##2##2##(1995-8#1)(2011-2#1)
years was##14##2##(1991-11#1)(1991-2#1)(1991-6#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-3#2)
years we##2##2##(1997-4#1)(2011-2#1)
years were identified##2##3##(2012-12#1)(2012-3#1)
years were##19##2##(1993-3#1)(1994-12#2)(1996-12#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-2#1)(2011-1#2)(2012-12#3)(2012-3#1)(2013-8#1)
years when##2##2##(1996-3#1)(2008-10#1)
years who##3##2##(1990-9#1)(2010-10#1)(2013-1#1)
years with##11##2##(1991-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-2#1)(2011-2#2)(2013-1#1)
years without any##3##3##(1991-12#1)(2008-11#1)(2011-2#1)
years without##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
years##1879##1##(1990-11#8)(1990-12#8)(1990-2#4)(1990-3#7)(1990-6#25)(1990-8#4)(1990-9#8)(1991-1#4)(1991-11#12)(1991-12#14)(1991-2#14)(1991-3#12)(1991-4#1)(1991-5#1)(1991-6#15)(1991-7#3)(1991-8#14)(1991-9#5)(1992-1#7)(1992-11#1)(1992-12#7)(1992-2#11)(1992-3#7)(1992-5#6)(1992-6#5)(1992-7#1)(1992-9#6)(1993-1#8)(1993-11#6)(1993-12#9)(1993-2#8)(1993-3#9)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#24)(1994-2#3)(1994-3#10)(1994-5#2)(1994-6#12)(1994-8#2)(1994-9#11)(1995-1#7)(1995-10#1)(1995-11#6)(1995-12#12)(1995-2#8)(1995-3#4)(1995-5#4)(1995-6#2)(1995-8#6)(1995-9#3)(1996-1#7)(1996-11#15)(1996-12#10)(1996-2#7)(1996-3#19)(1996-5#5)(1996-6#5)(1996-8#4)(1996-9#9)(1997-1#5)(1997-2#14)(1997-3#20)(1997-4#12)(1997-5#10)(1997-6#8)(1997-7#11)(1997-8#28)(2007-11#1)(2007-12#4)(2007-8#9)(2008-1#23)(2008-10#307)(2008-11#89)(2008-12#40)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#27)(2008-7#83)(2008-8#11)(2008-9#47)(2009-1#4)(2009-10#10)(2009-12#3)(2009-3#14)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#20)(2009-9#1)(2010-1#15)(2010-10#4)(2010-11#10)(2010-12#17)(2010-2#1)(2010-3#11)(2010-4#1)(2010-5#5)(2010-6#16)(2010-7#11)(2010-8#11)(2010-9#5)(2011-1#11)(2011-2#161)(2011-3#13)(2011-7#4)(2012-12#46)(2012-2#35)(2012-3#74)(2012-5#1)(2013-1#107)(2013-7#3)(2013-8#32)
years' experience##3##2##(1990-3#1)(1995-11#1)(2012-12#1)
years'##7##1##(1990-3#1)(1995-11#1)(1995-5#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
years) and the##2##3##(2008-5#1)(2008-9#1)
years) and##14##2##(1993-11#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-1#1)(2012-12#1)
years) in##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
years) of##2##2##(2012-3#2)
years) participated in##2##3##(2013-1#2)
years) received##2##2##(2010-1#1)(2013-1#1)
years) to##2##2##(2008-11#1)(2012-3#1)
years) treated##2##2##(2008-7#1)(2009-3#1)
years) were##8##2##(1990-12#1)(1990-2#1)(1993-11#1)(1996-1#1)(2010-9#1)(2012-3#1)(2013-8#2)
years) who##3##2##(1993-1#1)(2008-11#1)(2011-2#1)
years) with a##2##3##(2012-3#1)(2013-1#1)
years) with##8##2##(1990-8#1)(1992-9#1)(1994-3#1)(2009-3#1)(2011-3#1)(2012-3#1)(2013-1#2)
years)##133##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#3)(1992-12#1)(1992-9#3)(1993-1#1)(1993-11#2)(1994-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#6)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#12)(2008-9#7)(2009-3#2)(2009-7#1)(2009-8#2)(2010-1#4)(2010-9#3)(2011-2#12)(2011-3#2)(2012-12#4)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#2)
years]##7##1##(1991-9#1)(1992-3#1)(2008-11#1)(2011-2#3)(2013-1#1)
yeast (Saccharomyces cerevisiae)##2##3##(2008-10#1)(2008-4#1)
yeast Candida oleophila##3##3##(2008-10#3)
yeast Candida##7##2##(1990-5#1)(1991-9#1)(1996-12#1)(1997-2#1)(2008-10#3)
yeast HAP2 and HAP3##2##4##(1995-2#2)
yeast HAP2##4##2##(1995-2#2)(2008-9#2)
yeast L17A##2##2##(1991-6#2)
yeast P-450(14)DM##2##2##(1992-3#2)
yeast Pichia pastoris##5##3##(1994-11#1)(1997-7#1)(2008-7#1)(2009-9#1)(2010-5#1)
yeast RNA and denatured DNA##2##5##(2008-10#2)
yeast RNA##11##2##(2008-10#10)(2008-4#1)
yeast Saccharomyces cerevisiae##11##3##(1990-12#1)(1993-8#2)(1994-3#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-7#2)(2008-10#1)(2012-3#1)
yeast Schizosaccharomyces pombe##6##3##(1995-2#1)(1995-9#1)(1997-3#2)(2008-9#1)(2012-3#1)
yeast and bacteria##2##3##(1994-5#1)(2011-1#1)
yeast and mammalian cells##4##4##(1997-3#2)(2008-4#1)(2008-9#1)
yeast and##17##2##(1992-3#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-6#1)(1997-3#3)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2011-1#1)
yeast are##3##2##(1992-10#1)(1996-3#1)(2008-7#1)
yeast artificial chromosome##4##3##(1996-8#1)(1997-8#2)(2008-4#1)
yeast artificial chromosomes##2##3##(1995-6#1)(1997-2#1)
yeast artificial##6##2##(1995-6#1)(1996-8#1)(1997-2#1)(1997-8#2)(2008-4#1)
yeast autonomously##2##2##(1997-8#1)(2008-8#1)
yeast beta Tub##2##3##(1993-6#2)
yeast cell cycle##3##3##(1991-5#1)(2008-9#1)(2010-1#1)
yeast cell##10##2##(1991-5#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-2#1)
yeast cells by##2##3##(1996-6#1)(2008-9#1)
yeast cells in##2##3##(2008-10#1)(2011-1#1)
yeast cells were##2##3##(2008-5#2)
yeast cells##27##2##(1990-2#1)(1993-8#1)(1994-12#1)(1996-6#2)(1997-3#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-9#3)(2009-6#1)(2010-10#1)(2011-1#1)
yeast chromosome XIV##3##3##(1995-9#1)(1996-3#1)(1996-6#1)
yeast chromosome##4##2##(1995-9#1)(1996-3#1)(1996-6#2)
yeast containing human DDK##2##4##(2012-3#2)
yeast could##2##2##(1996-3#1)(2011-2#1)
yeast expressed sequence tags##2##4##(1995-9#1)(1996-6#1)
yeast expression vectors##2##3##(1993-12#2)
yeast expression##4##2##(1993-12#2)(1993-9#1)(2008-9#1)
yeast extract and##2##3##(2008-5#1)(2008-7#1)
yeast extract##6##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)
yeast fermentation##2##2##(2008-7#1)(2012-3#1)
yeast flocculation##4##2##(2008-10#1)(2008-7#3)
yeast gene##3##2##(1991-6#1)(1995-9#1)(1997-8#1)
yeast genes##2##2##(1995-12#1)(1995-9#1)
yeast homologues##2##2##(1995-2#2)
yeast in##5##2##(1995-9#1)(1996-12#1)(2008-10#1)(2011-1#2)
yeast is##8##2##(1993-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-7#1)(2012-3#1)
yeast lanosterol 14##2##3##(1991-5#1)(1992-3#1)
yeast mitochondria##2##2##(2012-2#1)(2013-8#1)
yeast mitochondrial##2##2##(1995-6#1)(1997-8#1)
yeast of##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
yeast one-hybrid system##4##3##(2008-8#1)(2008-9#3)
yeast or##3##2##(1995-9#1)(2008-10#1)(2009-8#1)
yeast polysaccharides##2##2##(2008-10#2)
yeast populations##3##2##(1995-9#1)(1997-7#1)(2010-10#1)
yeast species##3##2##(1996-6#2)(2008-4#1)
yeast strain##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)
yeast strains claimed##2##3##(2010-7#2)
yeast strains were##2##3##(2008-10#1)(2010-7#1)
yeast strains##22##2##(1992-10#2)(1993-12#1)(1993-8#1)(1996-6#3)(2008-10#6)(2010-7#6)(2012-3#2)(2013-1#1)
yeast to##4##2##(1995-2#1)(1995-6#1)(2011-1#2)
yeast tubulin##3##2##(1993-8#3)
yeast two-hybrid system##13##3##(1997-7#1)(2008-8#8)(2008-9#4)
yeast two-hybrid##17##2##(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#8)(2008-9#6)
yeast was##4##2##(2008-11#1)(2008-5#2)(2011-1#1)
yeast with##3##2##(2008-10#1)(2008-5#1)(2010-7#1)
yeast##463##1##(1990-12#2)(1990-2#2)(1990-5#3)(1991-2#1)(1991-5#4)(1991-6#3)(1991-9#2)(1992-10#3)(1992-2#1)(1992-3#5)(1993-12#7)(1993-2#5)(1993-6#3)(1993-8#14)(1993-9#11)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-9#1)(1995-12#2)(1995-2#13)(1995-3#2)(1995-5#1)(1995-6#12)(1995-9#13)(1996-12#3)(1996-2#1)(1996-3#9)(1996-6#20)(1996-8#1)(1997-2#4)(1997-3#7)(1997-4#2)(1997-6#3)(1997-7#11)(1997-8#11)(2008-10#92)(2008-11#15)(2008-4#9)(2008-5#13)(2008-7#16)(2008-8#19)(2008-9#24)(2009-10#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#11)(2011-1#9)(2011-2#11)(2012-2#6)(2012-3#23)(2013-1#1)(2013-8#3)
yeast-phase exo-antigen of##2##3##(2008-5#2)
yeast-phase exo-antigen##3##2##(2008-5#3)
yeast-phase##6##1##(2008-5#6)
yeastolate##3##1##(2008-11#3)
yeasts and##3##2##(1995-6#1)(2008-10#1)(2013-8#1)
yeasts in##4##2##(1993-12#1)(2008-10#1)(2013-1#2)
yeasts of##2##2##(2008-5#1)(2013-1#1)
yeasts showed##2##2##(2013-1#2)
yeasts to##2##2##(2008-10#1)(2008-5#1)
yeasts##33##1##(1993-12#3)(1995-6#1)(2008-10#9)(2008-11#1)(2008-5#9)(2009-6#1)(2013-1#8)(2013-8#1)
yellow alleles were##2##3##(2008-8#2)
yellow and##4##2##(2008-10#4)
yellow colour##2##2##(2008-10#2)
yellow complex##3##2##(2008-10#3)
yellow dwarf disease##3##3##(2008-10#3)
yellow dwarf virus (BYDV)##5##4##(2008-10#4)(2008-8#1)
yellow dwarf virus in##2##4##(2008-10#2)
yellow dwarf virus##19##3##(2008-10#18)(2008-8#1)
yellow dwarf viruses##2##3##(2008-10#2)
yellow dwarf##35##2##(2008-10#34)(2008-8#1)
yellow gene##4##2##(2008-8#4)
yellow leaf curl virus##17##4##(2008-10#17)
yellow leaf curl##25##3##(2008-10#25)
yellow leaf syndrome##2##3##(2008-10#2)
yellow leaf##29##2##(2008-10#29)
yellow mosaic virus (TYMV)##2##4##(1997-3#1)(2008-10#1)
yellow mosaic virus from Venezuela##2##5##(2008-10#2)
yellow mosaic virus from##3##4##(2008-10#3)
yellow mosaic virus##21##3##(1997-3#2)(2008-10#17)(2008-8#2)
yellow mosaic##23##2##(1997-3#2)(2008-10#19)(2008-8#2)
yellow mottle virus##4##3##(2008-10#3)(2008-9#1)
yellow mottle##5##2##(2008-10#4)(2008-9#1)
yellow ochre##2##2##(2008-10#2)
yellow preovulatory follicles##3##3##(2008-12#3)
yellow rust##4##2##(2008-10#4)
yellow spot virus##7##3##(2008-10#7)
yellow stripe virus##2##3##(2008-10#2)
yellow stripe##3##2##(2008-10#3)
yellow strips##2##2##(2008-10#2)
yellow stunt##4##2##(2008-10#2)(2008-8#2)
yellow stunting disorder virus##6##4##(2008-10#6)
yellow superimposed on both red and pink##2##7##(2008-10#2)
yellow vein virus##11##3##(2008-10#11)
yellow vein##17##2##(2008-10#17)
yellow vine disease##4##3##(2008-10#4)
yellow##213##1##(1994-2#1)(1997-3#2)(2008-10#173)(2008-11#3)(2008-12#7)(2008-3#1)(2008-8#12)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)
yellow-green##2##1##(2008-10#1)(2011-1#1)
yellow-necked mice##2##2##(2012-3#2)
yellow-necked##3##1##(2011-2#1)(2012-3#2)
yellowing and##4##2##(2008-10#4)
yellowing in##2##2##(2008-10#1)(2008-11#1)
yellowing symptoms##2##2##(2008-10#2)
yellowing##18##1##(2008-10#13)(2008-11#3)(2008-9#2)
yellowish##3##1##(1996-12#1)(2008-10#1)(2008-6#1)
yellows phytoplasma##6##2##(2008-10#6)
yellows virus##6##2##(2008-10#6)
yellows##43##1##(2008-10#43)
yersinia##2##1##(1990-6#1)(2008-7#1)
yes##5##1##(1991-12#1)(1992-1#1)(1993-5#1)(1995-12#1)(1996-3#1)
yet another##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
yet are##5##2##(2008-10#2)(2008-6#1)(2009-12#1)(2010-8#1)
yet available for##2##3##(2008-9#1)(2011-2#1)
yet available##5##2##(1990-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
yet be##3##2##(1991-11#1)(1996-11#1)(2008-10#1)
yet been established##2##3##(2008-10#1)(2011-2#1)
yet been##32##2##(1990-8#1)(1993-1#1)(1993-3#1)(1993-9#2)(1996-12#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
yet complex##2##2##(1992-8#1)(2008-10#1)
yet direct##2##2##(1995-12#1)(2008-5#1)
yet effective##2##2##(2008-10#1)(2008-11#1)
yet in##2##2##(1991-2#1)(2008-9#1)
yet it##5##2##(1997-7#1)(2008-10#2)(2013-1#1)(2013-8#1)
yet most##3##2##(2008-9#1)(2010-10#1)(2013-1#1)
yet necessary##2##2##(1992-1#1)(2008-11#1)
yet no##4##2##(1995-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
yet only##2##2##(2008-10#1)(2010-11#1)
yet showed##2##2##(1995-12#1)(1997-3#1)
yet some##2##2##(1997-7#1)(2008-10#1)
yet the disease##2##3##(1997-7#1)(2008-10#1)
yet the##8##2##(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2009-8#1)(2012-3#1)(2013-1#1)
yet their reported satisfaction did not change##2##7##(2013-1#2)
yet their##3##2##(2009-5#1)(2013-1#2)
yet there is no##2##4##(2008-10#1)(2010-3#1)
yet there is##4##3##(2008-10#1)(2009-7#1)(2010-3#1)(2012-2#1)
yet there##5##2##(2008-10#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-2#1)
yet they##2##2##(1995-12#1)(2009-8#1)
yet to be determined##5##4##(1994-8#1)(1995-2#1)(2008-1#1)(2009-12#1)(2013-1#1)
yet to be established##3##4##(2008-10#1)(2009-5#1)(2012-12#1)
yet to be fully##2##4##(2008-10#1)(2008-11#1)
yet to be identified##3##4##(1995-2#1)(1997-7#1)(2011-2#1)
yet to be investigated##2##4##(2008-8#1)(2010-5#1)
yet to be reported##2##4##(2008-10#1)(2008-12#1)
yet to be##32##3##(1991-2#1)(1991-7#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
yet to##38##2##(1991-2#1)(1991-7#1)(1991-8#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
yet unidentified##5##2##(1995-9#1)(2008-10#2)(2008-5#1)(2008-9#1)
yet unknown mechanisms##2##3##(1990-11#1)(1993-9#1)
yet unknown##6##2##(1990-11#1)(1993-9#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)
yet##292##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#5)(1995-5#2)(1995-6#2)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#3)(2008-1#3)(2008-10#51)(2008-11#22)(2008-12#6)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#6)(2008-8#5)(2008-9#11)(2009-12#2)(2009-3#4)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#5)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#3)(2011-2#10)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#14)(2013-8#7)
yield a##16##2##(1995-2#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)
yield after##2##2##(2008-10#1)(2008-11#1)
yield an EC(50) value of##2##5##(2008-10#2)
yield an##4##2##(1995-6#1)(2008-10#3)
yield and quality reductions##2##4##(2008-10#2)
yield and quality##5##3##(2008-10#4)(2008-11#1)
yield and##24##2##(1996-5#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-7#1)(2011-2#2)
yield are##3##2##(2008-10#2)(2008-11#1)
yield at the##2##3##(2008-9#1)(2010-7#1)
yield benefits##2##2##(2008-10#1)(2008-9#1)
yield by the##2##3##(2008-10#1)(2012-2#1)
yield by##8##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
yield components##4##2##(2008-10#1)(2008-12#3)
yield decreased##4##2##(2008-10#1)(2008-11#3)
yield expression##2##2##(1994-8#1)(2008-11#1)
yield from the##2##3##(2008-10#2)
yield from##5##2##(1997-8#1)(2008-10#4)
yield higher##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
yield in farmer-managed plot##2##4##(2008-12#2)
yield in the presence of##2##5##(1996-5#1)(2008-11#1)
yield in the##4##3##(1996-5#1)(2008-10#2)(2008-11#1)
yield in##21##2##(1990-3#1)(1992-2#1)(1996-5#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-12#5)(2008-9#1)(2013-1#1)
yield increased##3##2##(2008-10#1)(2008-11#2)
yield increases##2##2##(2008-10#2)
yield information about the##2##4##(1996-3#1)(2008-4#1)
yield information##3##2##(1996-3#1)(2008-2#1)(2008-4#1)
yield insight into the##2##4##(2008-6#1)(2013-1#1)
yield insight into##3##3##(2008-6#1)(2008-8#1)(2013-1#1)
yield is##2##2##(2008-10#1)(2008-11#1)
yield less##2##2##(2008-10#2)
yield loss##16##2##(2008-10#16)
yield losses and management efficiencies##2##5##(2008-10#2)
yield losses and##3##3##(2008-10#2)(2011-10#1)
yield losses in##3##3##(2008-10#3)
yield losses of up to##2##5##(2008-10#2)
yield losses##21##2##(2008-10#20)(2011-10#1)
yield measurement errors of roughly##2##5##(2008-10#2)
yield more##3##2##(1993-12#1)(1997-1#1)(2008-10#1)
yield obtained##2##2##(2008-10#1)(2008-11#1)
yield of plots planted with##2##5##(2008-10#2)
yield of processing##2##3##(2008-10#2)
yield of recombinant##3##3##(1993-2#1)(2008-8#1)(2011-2#1)
yield of the##11##3##(1992-11#1)(1994-8#2)(2008-10#4)(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)
yield of##63##2##(1990-3#1)(1992-11#1)(1993-2#1)(1994-8#2)(1996-5#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#6)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-4#1)(2013-1#2)
yield on##2##2##(1996-5#1)(2008-10#1)
yield point##2##2##(2013-1#2)
yield quality##2##2##(2008-10#2)
yield quantity##2##2##(2008-10#2)
yield reductions##3##2##(2008-10#3)
yield satisfactory results##2##3##(2008-10#1)(2010-11#1)
yield similar results##2##3##(1994-9#1)(2008-2#1)
yield similar##3##2##(1991-3#1)(1994-9#1)(2008-2#1)
yield specific##2##2##(2012-2#2)
yield strength of##2##3##(2009-7#2)
yield strength was##2##3##(2009-7#2)
yield strength##10##2##(2009-11#1)(2009-7#7)(2012-2#2)
yield the##14##2##(1991-6#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
yield tip-displacement values that are##2##5##(2010-4#2)
yield to##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
yield under##3##2##(1995-8#1)(2008-10#1)(2008-12#1)
yield useful##2##2##(1992-5#1)(2008-8#1)
yield was lower##2##3##(2008-10#1)(2008-11#1)
yield was not##4##3##(2008-10#4)
yield was obtained##2##3##(2008-10#1)(2008-7#1)
yield was recorded##2##3##(2008-12#2)
yield was##26##2##(1995-12#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-7#4)(2011-10#1)(2011-2#2)
yield were##6##2##(2008-10#5)(2008-7#1)
yield with##2##2##(2008-10#1)(2008-11#1)
yield##492##1##(1990-3#2)(1990-8#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-9#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-3#1)(1996-5#10)(1997-1#2)(1997-3#2)(1997-4#2)(1997-8#3)(2007-11#1)(2008-10#211)(2008-11#46)(2008-12#23)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#21)(2008-8#9)(2008-9#18)(2009-11#1)(2009-12#1)(2009-7#8)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#3)(2010-7#3)(2011-1#2)(2011-10#2)(2011-2#16)(2011-3#1)(2012-2#13)(2012-3#1)(2012-4#1)(2013-1#11)(2013-8#3)
yield)##3##1##(1994-11#1)(2008-10#1)(2008-11#1)
yield-limiting##2##1##(2008-10#2)
yielded a linear##2##3##(2008-10#2)
yielded a pA2 value of 7##2##6##(1996-2#2)
yielded a##31##2##(1992-12#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-7#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2013-1#3)
yielded almost##2##2##(2008-10#1)(2008-5#1)
yielded an##3##2##(1993-8#1)(2008-10#2)
yielded by##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
yielded endocervical cells in##2##4##(1992-1#2)
yielded four##2##2##(1997-3#1)(2011-3#1)
yielded good##2##2##(1997-6#1)(2008-3#1)
yielded no##4##2##(1995-2#1)(2008-10#2)(2008-6#1)
yielded only##4##2##(1992-12#1)(2008-10#2)(2008-12#1)
yielded results##4##2##(2008-10#4)
yielded significant results only on##2##5##(1994-3#1)(2010-2#1)
yielded significant##3##2##(1994-3#1)(2008-6#1)(2010-2#1)
yielded similar##2##2##(2008-10#1)(2011-2#1)
yielded slightly##2##2##(1997-2#1)(1997-7#1)
yielded the following##3##3##(1995-11#1)(2008-10#1)(2008-12#1)
yielded the same##3##3##(1994-11#1)(2008-10#2)
yielded the##14##2##(1993-8#1)(1994-11#1)(1995-11#1)(2008-10#6)(2008-12#2)(2010-2#1)(2010-4#1)(2012-12#1)
yielded three##2##2##(2008-10#1)(2010-9#1)
yielded two##4##2##(1990-5#1)(1997-6#1)(2008-10#2)
yielded##161##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#2)(1992-1#2)(1992-10#1)(1992-12#2)(1992-6#1)(1993-8#4)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2008-10#67)(2008-11#7)(2008-12#6)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#3)
yielding a pink##2##3##(2008-10#2)
yielding a##12##2##(1994-8#1)(1997-8#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
yielding an##6##2##(1994-3#1)(1995-6#1)(2008-10#3)(2008-12#1)
yielding improved##2##2##(2007-11#1)(2008-10#1)
yielding information##2##2##(2009-5#1)(2011-2#1)
yielding one##3##2##(1991-12#1)(2008-10#1)(2009-12#1)
yielding the##6##2##(2007-12#1)(2008-10#3)(2008-12#1)(2011-3#1)
yielding##65##1##(1991-12#1)(1991-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#31)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
yields a##15##2##(1990-5#1)(1995-6#1)(2008-10#9)(2008-2#1)(2008-7#1)(2009-10#1)(2010-4#1)
yields an##3##2##(1996-3#2)(2008-11#1)
yields and##10##2##(1996-5#3)(2008-10#3)(2008-12#2)(2008-7#1)(2008-8#1)
yields are low##3##3##(2008-11#2)(2008-8#1)
yields are##7##2##(2008-10#2)(2008-11#3)(2008-8#1)(2011-1#1)
yields as##4##2##(2008-10#1)(2008-11#2)(2012-12#1)
yields at##3##2##(1996-5#1)(2011-2#1)(2013-1#1)
yields by##3##2##(1996-5#2)(2008-5#1)
yields for##2##2##(2008-12#1)(2011-2#1)
yields from##3##2##(2008-11#2)(2013-1#1)
yields in##8##2##(1994-12#1)(1997-3#1)(2008-10#5)(2011-2#1)
yields information##3##2##(2008-3#2)(2008-9#1)
yields obtained in##2##3##(2008-11#2)
yields obtained##3##2##(2008-10#1)(2008-11#2)
yields of 0##2##3##(1990-5#1)(2008-12#1)
yields of the##3##3##(2008-10#2)(2008-4#1)
yields of##21##2##(1990-5#1)(1990-8#1)(1990-9#1)(1993-6#1)(1994-1#1)(1995-12#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
yields sufficient##2##2##(1994-11#1)(2008-4#1)
yields than##2##2##(2008-10#1)(2008-11#1)
yields the best##2##3##(2008-10#1)(2008-11#1)
yields the##12##2##(1993-2#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)
yields to##2##2##(2008-11#1)(2008-7#1)
yields were calculated##2##3##(2008-10#2)
yields were increased##2##3##(1995-12#1)(2008-11#1)
yields were obtained##2##3##(2008-10#1)(2008-11#1)
yields were##12##2##(1995-12#1)(2008-10#9)(2008-11#2)
yields with##3##2##(2008-10#1)(2010-7#2)
yields##190##1##(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#10)(1997-3#1)(2007-12#1)(2008-10#67)(2008-11#27)(2008-12#6)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#5)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
yin##2##1##(2008-10#2)
ylide##2##1##(1997-4#1)(2010-6#1)
yoghurt##4##1##(2008-10#4)
yohimbine##3##1##(1990-5#1)(1992-2#1)(2008-10#1)
yolk by##2##2##(2008-10#2)
yolk granules##7##2##(2007-12#7)
yolk proteins##4##2##(1995-2#1)(2008-12#1)(2010-5#2)
yolk sac##5##2##(1993-12#1)(1993-8#1)(2007-12#1)(2008-5#1)(2008-9#1)
yolk sacs##3##2##(2007-12#3)
yolk##28##1##(1993-12#1)(1993-8#1)(1995-2#1)(2007-12#11)(2008-10#5)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#2)
yolkless##2##1##(1995-2#2)
you are##3##2##(1994-12#1)(1995-2#1)(1996-1#1)
you can##5##2##(1994-1#1)(1994-2#1)(1995-2#1)(1997-1#1)(2011-2#1)
you choose##2##2##(1995-1#1)(2011-2#1)
you do##4##2##(1993-3#1)(1994-2#1)(1995-2#1)(2008-11#1)
you don't##2##2##(1994-2#1)(1997-7#1)
you ever##3##2##(1992-1#1)(1994-2#1)(1995-12#1)
you have to##2##3##(1991-1#1)(1994-2#1)
you have##4##2##(1991-1#1)(1991-3#1)(1994-2#1)(2008-11#1)
you know##3##2##(1993-1#1)(2008-11#1)(2008-9#1)
you may##3##2##(1993-12#1)(1994-2#1)(1994-3#1)
you measure##2##2##(1995-2#1)(2010-10#1)
you must##2##2##(1993-3#1)(1994-2#1)
you need to##2##3##(1996-1#1)(2011-2#1)
you need##3##2##(1994-3#1)(1996-1#1)(2011-2#1)
you see##2##2##(1997-7#1)(2009-12#1)
you think##4##2##(1993-5#1)(2008-8#3)
you to##4##2##(1993-1#1)(1995-2#1)(1996-3#1)(2008-10#1)
you want to##5##3##(1992-1#1)(1994-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
you want##6##2##(1992-1#1)(1994-3#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
you##114##1##(1991-1#1)(1991-12#1)(1991-3#10)(1992-1#3)(1993-1#4)(1993-12#3)(1993-3#4)(1993-5#1)(1994-1#3)(1994-12#1)(1994-2#9)(1994-3#11)(1995-1#1)(1995-12#3)(1995-2#7)(1996-1#3)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#3)(2008-11#8)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#2)(2010-10#2)(2010-12#1)(2011-2#7)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
you'll##2##1##(1994-12#1)(2010-9#1)
young (1 and 3 months old) animals##2##7##(1993-12#2)
young (aged##2##2##(2008-5#1)(2008-9#1)
young Japanese##2##2##(2008-10#2)
young adult##17##2##(1990-3#1)(1991-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(2008-12#1)(2008-8#1)(2010-2#1)(2010-7#6)(2012-3#1)
young adulthood##2##2##(2010-7#1)(2012-3#1)
young adults in##3##3##(1995-5#1)(2013-1#2)
young adults with##4##3##(1990-3#1)(2008-11#1)(2008-8#1)(2012-2#1)
young adults##47##2##(1990-12#1)(1990-3#2)(1991-1#1)(1991-11#2)(1993-12#1)(1995-3#3)(1995-5#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
young adults' current financial learning##2##5##(2010-10#2)
young adults'##4##2##(2008-12#1)(2009-12#1)(2010-10#2)
young age##9##2##(1991-2#1)(1994-12#1)(1994-9#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
young and adult rats##2##4##(2013-7#2)
young and adult##6##3##(1997-9#1)(2008-7#1)(2012-3#2)(2013-7#2)
young and middle-aged adults##2##4##(2008-7#1)(2009-12#1)
young and middle-aged##3##3##(2008-7#2)(2009-12#1)
young and old rats##5##4##(1994-8#1)(2008-7#4)
young and old##10##3##(1990-3#1)(1994-8#2)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#4)
young and older##3##3##(2008-11#1)(2008-5#1)(2009-10#1)
young and##34##2##(1990-3#2)(1990-5#1)(1994-8#3)(1994-9#1)(1995-8#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-11#2)(2008-5#2)(2008-7#8)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
young athletes##9##2##(1996-6#1)(2010-1#4)(2012-3#4)
young black##2##2##(2011-2#1)(2013-1#1)
young child##6##2##(1993-3#1)(1996-2#2)(2008-2#1)(2008-9#2)
young children and##3##3##(1997-1#1)(2008-11#1)(2012-2#1)
young children is##2##3##(2008-9#1)(2010-6#1)
young children with##2##3##(1997-1#1)(2008-4#1)
young children##33##2##(1991-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#4)(1997-8#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-9#6)(2009-9#2)(2010-6#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
young cirrhotics##5##2##(2012-3#5)
young deaf##2##2##(2008-9#1)(2011-2#1)
young erythrocytes##2##2##(2008-9#2)
young female##10##2##(2008-12#3)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
young females##2##2##(1997-8#1)(2008-10#1)
young individuals##5##2##(1993-1#1)(2008-12#1)(2008-7#2)(2008-9#1)
young injection drug users##2##4##(2013-8#2)
young leaves##3##2##(2008-10#3)
young male buffalo meat##2##4##(2010-4#2)
young male rats##2##3##(2008-7#2)
young male##13##2##(1990-6#2)(1996-3#1)(1996-8#1)(2008-11#1)(2008-7#3)(2010-4#3)(2010-7#1)(2012-2#1)
young man with##2##3##(2012-3#2)
young man##4##2##(1991-11#1)(2012-3#2)(2013-1#1)
young maternal age is##2##4##(2009-12#2)
young maternal age##3##3##(2009-12#2)(2012-12#1)
young men in##2##3##(1990-6#1)(2008-10#1)
young men##7##2##(1990-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#2)(2013-8#1)
young or##5##2##(2008-7#1)(2008-9#1)(2012-3#2)(2013-7#1)
young patient##4##2##(2008-7#1)(2011-2#2)(2013-1#1)
young patients with severe##2##4##(2009-3#2)
young patients with##5##3##(2008-8#1)(2009-3#2)(2011-2#1)(2013-1#1)
young patients##12##2##(1990-3#1)(1991-2#1)(1991-8#1)(1992-3#1)(2007-8#1)(2008-8#1)(2009-3#2)(2011-2#1)(2012-3#1)(2013-1#2)
young people in##3##3##(1990-6#1)(2008-10#1)(2012-2#1)
young people with##2##3##(2008-7#1)(2013-1#1)
young people##18##2##(1990-3#1)(1990-6#1)(1991-6#1)(1995-8#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)
young persons##2##2##(1991-3#1)(2010-8#1)
young pigs##3##2##(1997-4#1)(2013-1#1)(2013-8#1)
young rats##8##2##(1990-3#1)(1990-5#1)(2008-7#3)(2013-7#3)
young scientists##2##2##(1997-2#1)(2012-2#1)
young subjects##4##2##(1993-1#2)(2008-7#1)(2008-8#1)
young volunteers##3##2##(2008-7#2)(2012-2#1)
young woman with##4##3##(1991-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
young woman##9##2##(1990-2#1)(1991-3#1)(1992-12#2)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
young women with breast cancer##3##5##(2013-1#3)
young women with##6##3##(2008-9#1)(2013-1#5)
young women##21##2##(1992-5#1)(1997-8#2)(2008-11#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#7)
young workers##2##2##(1997-2#1)(2008-6#1)
young##434##1##(1990-12#1)(1990-2#1)(1990-3#15)(1990-5#3)(1990-6#4)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#3)(1993-12#5)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-2#5)(1996-3#2)(1996-6#2)(1996-8#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#6)(1997-9#2)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#19)(2008-12#10)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#39)(2008-8#7)(2008-9#22)(2009-10#5)(2009-12#6)(2009-3#2)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#5)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#10)(2010-8#3)(2010-9#1)(2011-2#22)(2012-12#2)(2012-2#21)(2012-3#31)(2012-9#1)(2013-1#26)(2013-7#7)(2013-8#13)
younger age group##2##3##(1996-11#1)(2012-3#1)
younger age##10##2##(1996-11#1)(1996-12#1)(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
younger and older##3##3##(2008-4#1)(2008-5#1)(2013-8#1)
younger and##4##2##(1995-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
younger children##5##2##(2008-10#1)(2008-9#1)(2009-12#1)(2012-2#2)
younger leaves##2##2##(2008-10#2)
younger men##3##2##(2009-5#3)
younger mothers##2##2##(1990-6#1)(1997-3#1)
younger patients##9##2##(1991-12#1)(1991-2#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#2)
younger subjects##2##2##(1996-2#1)(2008-12#1)
younger than 2 months of age##2##6##(2006-5#2)
younger than 65 years##4##4##(2009-8#3)(2011-2#1)
younger than##13##2##(1993-8#1)(1996-12#1)(2006-5#3)(2008-11#2)(2009-8#3)(2011-2#2)(2012-12#1)
younger women##4##2##(1990-6#1)(1994-3#1)(1996-6#1)(2010-9#1)
younger##94##1##(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2006-5#3)(2008-10#6)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#5)(2009-8#6)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#2)
youngest##9##1##(1996-2#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)
youngsters##3##1##(1993-2#1)(2009-10#1)(2011-2#1)
your Patient Focused Care program##3##5##(1994-1#1)(1994-2#2)
your Patient Focused Care program)!&quot##2##5##(1994-1#2)
your Patient Focused Care##5##4##(1994-1#3)(1994-2#2)
your Patient Focused communications##2##4##(1994-1#2)
your Patient Focused restructuring##2##4##(1994-2#1)(1994-3#1)
your Patient Focused##11##3##(1993-3#1)(1994-1#5)(1994-2#3)(1994-3#2)
your clinical##3##2##(1997-2#1)(2008-11#1)(2011-2#1)
your diagnosis?##5##2##(1992-6#1)(1993-11#1)(1994-5#1)(2007-12#2)
your educational##4##2##(1994-1#1)(1995-12#3)
your efforts##2##2##(1992-1#1)(1996-1#1)
your facility##3##2##(2011-1#1)(2011-2#2)
your health care facility##2##4##(1991-1#1)(1991-12#1)
your health care organization##2##4##(1996-1#2)
your health care##4##3##(1991-1#1)(1991-12#1)(1996-1#2)
your health##5##2##(1991-1#1)(1991-12#1)(1996-1#2)(2008-10#1)
your healthcare institution##2##3##(1993-2#2)
your hospital##8##2##(1991-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-2#1)
your hospital's##2##2##(1993-2#1)(1994-12#1)
your institution##4##2##(1994-2#1)(1994-3#1)(1996-1#1)(2011-2#1)
your mind##2##2##(2008-10#1)(2013-8#1)
your organization may##2##3##(1991-2#1)(1994-1#1)
your organization##9##2##(1991-2#1)(1993-1#2)(1994-1#1)(1996-1#2)(1996-2#2)(1997-2#1)
your organizational##2##2##(1994-3#1)(1996-1#1)
your own##4##2##(1993-12#1)(1994-2#2)(2009-3#1)
your particular##2##2##(1992-12#1)(1993-12#1)
your patient focused care program##2##5##(1993-2#2)
your patient focused##3##3##(1993-2#3)
your patient##6##2##(1992-1#1)(1993-2#3)(1994-3#1)(1995-2#1)
your patients and##2##3##(2011-2#2)
your patients##3##2##(1994-3#1)(2011-2#2)
your practice##3##2##(2008-1#1)(2012-3#2)
your program##2##2##(1993-2#1)(1993-3#1)
your research##2##2##(2008-11#1)(2013-7#1)
your restructuring initiative##4##3##(1994-12#1)(1994-3#1)(1996-1#2)
your restructuring##5##2##(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#2)
your strategic##2##2##(1994-3#1)(1996-3#1)
your##192##1##(1991-1#4)(1991-12#1)(1991-2#1)(1991-3#4)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#4)(1993-11#1)(1993-12#5)(1993-2#10)(1993-3#5)(1993-8#1)(1994-1#12)(1994-12#5)(1994-2#9)(1994-3#21)(1994-5#1)(1995-12#4)(1995-2#14)(1995-3#1)(1996-1#15)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#6)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#7)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-12#1)(2009-3#1)(2010-4#1)(2010-9#3)(2011-1#1)(2011-2#16)(2012-3#5)(2013-7#1)(2013-8#3)
yourself##3##1##(1994-3#1)(2011-2#1)(2012-3#1)
youth and##4##2##(2008-11#2)(2013-8#2)
youth are##2##2##(2009-7#1)(2011-2#1)
youth development##4##2##(2009-7#2)(2013-1#2)
youth health##2##2##(2008-11#1)(2012-2#1)
youth in##3##2##(2008-8#1)(2010-5#1)(2013-1#1)
youth is##2##2##(2008-12#1)(2012-12#1)
youth to##2##2##(2009-7#1)(2012-12#1)
youth using##2##2##(2012-2#2)
youth who##4##2##(2008-11#1)(2009-6#1)(2010-1#1)(2012-12#1)
youth with disabilities or##3##4##(2010-11#3)
youth with##6##2##(1992-3#1)(2009-12#1)(2010-1#1)(2010-11#3)
youth##78##1##(1990-12#1)(1992-3#1)(1997-6#1)(2008-11#12)(2008-12#3)(2008-8#1)(2009-12#1)(2009-6#3)(2009-7#7)(2009-9#1)(2010-1#5)(2010-11#4)(2010-5#3)(2010-9#4)(2011-2#1)(2012-12#3)(2012-2#14)(2013-1#10)(2013-8#3)
youth's achievement##2##2##(2009-7#2)
youth's##7##1##(2009-7#7)
youthful##2##1##(2010-2#1)(2011-2#1)
youths reported##3##2##(2008-9#3)
youths##16##1##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#8)(2009-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
youths' engagement##2##2##(2008-12#2)
youths'##4##1##(2008-12#3)(2009-7#1)
yperite##5##1##(2008-10#2)(2008-11#3)
yr of##3##2##(2008-8#1)(2008-9#2)
yr versus##2##2##(2008-7#2)
yr##36##1##(2008-11#1)(2008-7#8)(2008-8#10)(2008-9#12)(2009-10#1)(2009-9#1)(2010-10#1)(2010-4#1)(2012-3#1)
yr)##2##1##(2008-9#2)
yrs and##2##2##(2010-10#1)(2012-3#1)
yrs##7##1##(2008-12#1)(2010-10#1)(2011-2#2)(2012-3#3)
yrs)##4##1##(1997-3#1)(2008-12#1)(2012-3#2)
ytterbium##6##1##(1997-8#1)(2008-10#5)
ytterbium(III)##2##1##(2008-10#2)
yttrium in##2##2##(2008-10#2)
yttrium##18##1##(2008-10#14)(2008-2#2)(2008-7#1)(2012-2#1)
yuan##2##1##(2008-9#1)(2013-1#1)
z##12##1##(1992-12#2)(2008-10#5)(2008-3#2)(2008-8#1)(2009-11#1)(2013-1#1)
z-VAD-Fmk##2##1##(2011-2#2)
z-VAD-fmk##2##1##(2013-1#2)
z-score##2##1##(2008-10#1)(2011-1#1)
z-scores##3##1##(2008-10#1)(2011-1#2)
zFP538##4##1##(2009-9#4)
zNosetrade mark##6##2##(2008-10#6)
zNosetrade##7##1##(2008-10#7)
zea cell##3##2##(2008-11#3)
zea cells showed a preference for##2##6##(2008-11#2)
zea cells##4##2##(2008-11#4)
zea##8##1##(2008-11#8)
zeae from##2##2##(2008-10#2)
zeae in##3##2##(2008-10#3)
zeae were collected##3##3##(2008-10#3)
zeae##31##1##(2008-10#31)
zeae)##2##1##(2008-10#2)
zeae-maydis##11##1##(2008-10#11)
zeamatin##2##1##(2008-10#2)
zearalenone (ZEN)##2##2##(2008-10#1)(2013-1#1)
zearalenone determination in##2##3##(2008-10#2)
zearalenone##6##1##(2008-10#3)(2010-7#1)(2013-1#2)
zeaxanthin and##2##2##(1992-9#1)(2008-11#1)
zeaxanthin dipalmitate##2##2##(2008-11#2)
zeaxanthin##5##1##(1992-9#1)(2008-11#3)(2008-12#1)
zeaxanthins##3##1##(2008-11#3)
zebra fish##2##2##(2010-1#2)
zebrafish (Danio rerio)##3##3##(2008-9#2)(2013-1#1)
zebrafish FSH##3##2##(2010-5#3)
zebrafish and##2##2##(1997-7#1)(2008-9#1)
zebrafish fibroblasts by nucleofection##2##4##(2008-11#2)
zebrafish##28##1##(1993-12#2)(1997-7#1)(2008-10#1)(2008-11#4)(2008-4#3)(2008-9#4)(2009-5#1)(2010-5#4)(2012-3#5)(2013-1#3)
zebrin##3##1##(1992-9#3)
zein signal sequence##2##3##(1991-10#2)
zenith angle##3##2##(2008-3#3)
zenith angles##4##2##(2008-3#4)
zenith radiance##2##2##(2008-3#2)
zenith##14##1##(2008-3#13)(2011-2#1)
zeolite##9##1##(2008-10#9)
zeolites##4##1##(2008-10#4)
zeolitic material##2##2##(2008-10#2)
zeolitic##3##1##(2008-10#3)
zero and##2##2##(2008-10#1)(2010-1#1)
zero at##3##2##(1991-11#1)(2008-10#1)(2013-8#1)
zero crossing##2##2##(2008-10#2)
zero geometric loss##2##3##(2008-3#2)
zero in##4##2##(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)
zero net##2##2##(2007-11#1)(2008-10#1)
zero order##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
zero to##2##2##(2008-10#1)(2008-11#1)
zero value##2##2##(2008-10#1)(2010-1#1)
zero##77##1##(1991-11#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-8#1)(1996-6#1)(1997-2#1)(1997-6#2)(2007-11#1)(2008-10#33)(2008-11#5)(2008-12#4)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-11#1)(2010-1#2)(2010-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
zero-crossing first-order derivative UV-spectrophotometric technique##2##5##(2008-10#2)
zero-crossing points##2##2##(2008-10#2)
zero-crossing wavelengths##2##2##(2008-10#2)
zero-crossing##10##1##(2008-10#10)
zero-crossing' point of##2##3##(2008-10#2)
zero-order##3##1##(2008-11#1)(2008-3#2)
zeta potential of##2##3##(2008-10#1)(2008-5#1)
zeta potential##6##2##(2008-10#1)(2008-5#5)
zeta##10##1##(1994-11#2)(2008-10#3)(2008-5#5)
zeta-COP##3##1##(2009-7#3)
zhuyu##4##1##(2012-3#1)(2013-8#3)
zidovudine therapy##2##2##(1992-3#1)(1992-6#1)
zidovudine##6##1##(1992-3#1)(1992-6#1)(2008-7#2)(2011-3#2)
zif 268 and c-fos##2##4##(1997-3#2)
zigzag##7##1##(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#1)
zinc (II)##2##2##(2008-10#2)
zinc and copper##6##3##(1990-8#2)(2008-10#3)(2013-7#1)
zinc and lead##2##3##(2008-10#2)
zinc and nickel in##3##4##(2008-10#3)
zinc and nickel##5##3##(2008-10#5)
zinc and##21##2##(1990-8#2)(1992-3#1)(1992-6#1)(2008-10#15)(2008-11#1)(2013-7#1)
zinc at##4##2##(1994-5#1)(2008-10#3)
zinc but##2##2##(1994-5#1)(2008-10#1)
zinc by##4##2##(2008-10#4)
zinc chelates##2##2##(1990-5#1)(2008-10#1)
zinc chloride##3##2##(2008-10#2)(2012-2#1)
zinc compounds##4##2##(2008-10#4)
zinc concentrations##2##2##(1990-5#1)(1993-2#1)
zinc deficiency##2##2##(2008-11#1)(2012-2#1)
zinc determination##6##2##(2008-10#6)
zinc dithizonate##3##2##(2008-10#3)
zinc finger domain##2##3##(1996-6#1)(2009-7#1)
zinc finger protein##3##3##(1992-7#2)(1996-6#1)
zinc finger##9##2##(1991-10#1)(1992-7#2)(1996-6#2)(2008-8#1)(2009-7#1)(2011-2#1)(2013-7#1)
zinc fingers##3##2##(1997-7#2)(2008-10#1)
zinc from the##2##3##(2008-10#2)
zinc from##7##2##(2008-10#7)
zinc in milkvetch##2##3##(2008-10#2)
zinc in plant samples by##2##5##(2008-10#2)
zinc in plant##3##3##(2008-10#3)
zinc in the##5##3##(2008-10#4)(2012-2#1)
zinc in##31##2##(2008-10#29)(2012-2#1)(2013-8#1)
zinc into##2##2##(2008-10#2)
zinc ions in##2##3##(2008-10#2)
zinc ions##9##2##(2008-10#5)(2008-11#1)(2010-11#1)(2013-7#2)
zinc is##6##2##(2008-10#5)(2013-7#1)
zinc nanostructured films is##2##4##(2009-12#2)
zinc nanostructured films were##2##4##(2009-12#2)
zinc nanostructured films##5##3##(2009-12#5)
zinc on the##2##3##(1994-6#1)(2008-10#1)
zinc on##5##2##(1994-6#1)(2008-10#3)(2013-8#1)
zinc oxide (ZnO)##2##3##(2008-5#1)(2009-5#1)
zinc per enzyme subunit##2##4##(1994-5#2)
zinc per##4##2##(1994-5#4)
zinc pyrithione in##2##3##(2008-10#1)(2008-5#1)
zinc pyrithione##8##2##(2008-10#1)(2008-11#1)(2008-5#6)
zinc separation and##2##3##(2008-10#2)
zinc separation##3##2##(2008-10#3)
zinc sulfate##3##2##(1990-5#1)(2008-10#2)
zinc traces##5##2##(2008-10#5)
zinc using##4##2##(2008-10#4)
zinc was##3##2##(2008-10#3)
zinc white##2##2##(2008-10#2)
zinc with##4##2##(1994-5#1)(2008-10#3)
zinc##291##1##(1990-5#7)(1990-8#4)(1991-10#2)(1992-3#6)(1992-6#3)(1992-7#2)(1992-9#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-5#9)(1994-6#1)(1996-6#2)(1997-4#1)(1997-7#2)(2008-10#198)(2008-11#6)(2008-12#2)(2008-5#7)(2008-8#1)(2009-12#5)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-6#3)(2011-2#2)(2012-2#4)(2013-1#3)(2013-7#9)(2013-8#3)
zinc(II) and cadmium(II)##2##3##(2008-10#2)
zinc(II) and lead(II)##2##3##(2008-10#2)
zinc(II) and##5##2##(2008-10#5)
zinc(II) sulphate##2##2##(2008-10#2)
zinc(II)##25##1##(1991-5#4)(2008-10#21)
zinc)##3##1##(2008-10#1)(2008-11#1)(2013-7#1)
zinc-binding##2##1##(1992-6#1)(2013-7#1)
zinc-finger domain##5##2##(1995-2#5)
zinc-finger##7##1##(1993-12#1)(1993-2#1)(1995-2#5)
zip code##2##2##(2011-2#2)
zipper motifs##2##2##(1996-2#1)(1996-6#1)
zipper##5##1##(1993-12#2)(1996-2#1)(1996-6#1)(2008-10#1)
ziram and zineb respectively##2##4##(2008-10#2)
ziram and zineb##4##3##(2008-10#4)
zircon##5##1##(2008-10#5)
zirconate acid##2##2##(2008-10#2)
zirconate##3##1##(2008-10#3)
zirconia and##2##2##(2008-10#1)(2010-12#1)
zirconia content of the fume##2##5##(2008-10#2)
zirconia stationary phase##4##3##(2008-10#4)
zirconia surface##2##2##(2008-10#2)
zirconia##20##1##(2008-10#19)(2010-12#1)
zirconia-coated silica##2##2##(2008-10#2)
zirconium and hafnium##3##3##(2008-10#3)
zirconium and##5##2##(2008-10#5)
zirconium oxychloride##2##2##(2008-10#2)
zirconium permanent##3##2##(2008-10#3)
zirconium##34##1##(1990-5#5)(2008-10#28)(2008-5#1)
zirconium(IV)##10##1##(2008-10#10)
zona incerta##3##2##(1996-12#2)(2012-3#1)
zona pellucida##5##2##(1996-9#1)(2008-4#2)(2008-9#1)(2013-1#1)
zona##13##1##(1990-5#2)(1996-12#2)(1996-9#1)(2008-4#3)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
zonal##3##1##(2008-10#1)(2008-4#1)(2011-2#1)
zone and##5##2##(2008-10#5)
zone between the##2##3##(2008-10#1)(2008-11#1)
zone between##3##2##(1991-3#1)(2008-10#1)(2008-11#1)
zone by##2##2##(2008-10#2)
zone diagrams for##2##3##(2008-10#2)
zone diagrams##4##2##(2008-10#4)
zone electrophoresis (CZE) with##3##4##(2008-10#3)
zone electrophoresis (CZE)##16##3##(2008-10#16)
zone electrophoresis##58##2##(1992-12#2)(2008-10#56)
zone for##2##2##(1994-12#1)(2011-2#1)
zone from##2##2##(2008-10#1)(2008-8#1)
zone in the##2##3##(2008-5#1)(2011-2#1)
zone in##4##2##(1990-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
zone is##8##2##(2008-10#6)(2008-11#1)(2012-12#1)
zone of the##7##3##(2008-3#1)(2008-7#1)(2009-10#1)(2012-12#4)
zone of##31##2##(1992-12#1)(1993-12#2)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-8#1)(2012-12#4)(2013-1#1)
zone was then##2##3##(2008-10#2)
zone was##11##2##(1991-2#1)(1997-3#1)(2008-10#9)
zone where the##2##3##(2008-8#2)
zone where##3##2##(2008-8#2)(2011-2#1)
zone##220##1##(1990-11#3)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#3)(1993-12#2)(1994-12#1)(1994-2#3)(1996-12#2)(1996-2#3)(1997-1#1)(1997-3#1)(2008-10#125)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-7#10)(2008-8#6)(2008-9#6)(2009-10#2)(2009-5#1)(2009-8#10)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#6)(2012-12#6)(2012-3#3)(2013-1#3)
zone&quot##2##1##(1994-6#1)(1995-3#1)
zone) and##2##2##(2008-10#2)
zone)##3##1##(2008-10#3)
zones and##4##2##(1997-7#1)(2008-10#2)(2013-1#1)
zones are##2##2##(2008-10#2)
zones as##2##2##(2008-10#1)(2008-8#1)
zones for##2##2##(1991-3#1)(2008-12#1)
zones in##4##2##(1997-3#1)(2008-10#1)(2013-1#2)
zones is##4##2##(1997-3#1)(2008-10#1)(2008-3#2)
zones of the##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
zones of##13##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)
zones to##2##2##(2008-3#1)(2010-10#1)
zones was##3##2##(2008-10#1)(2008-12#2)
zones were##2##2##(2009-7#1)(2012-2#1)
zones with##6##2##(2008-10#3)(2008-3#1)(2012-3#1)(2013-1#1)
zones##92##1##(1991-3#1)(1992-9#1)(1995-12#1)(1997-3#2)(1997-7#2)(2008-10#37)(2008-11#3)(2008-12#5)(2008-3#7)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#2)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#1)
zoo##2##1##(1990-3#2)
zooming##3##1##(2008-6#2)(2013-1#1)
zoonoses##2##1##(2011-2#2)
zoonosis##4##1##(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
zoonotic##9##1##(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#5)(2013-1#1)
zoophilic##2##1##(2010-1#2)
zooplankton##4##1##(2008-12#1)(2008-8#2)(2010-8#1)
zoosporangia##8##1##(2008-10#8)
zoospore concentrations##3##2##(2008-10#3)
zoospore inoculation##2##2##(2008-10#2)
zoospore isolates##7##2##(2008-10#7)
zoospore##17##1##(2008-10#17)
zoospores of##4##2##(2008-10#4)
zoospores per ml##2##3##(2008-10#2)
zoospores per##3##2##(2008-10#3)
zoospores##28##1##(2008-10#28)
zooxanthellae##3##1##(2008-5#3)
zoster##9##1##(1991-6#1)(1994-3#3)(2008-5#1)(2008-7#4)
zosteric acid##4##2##(2008-10#4)
zosteric##5##1##(2008-10#5)
zucchini squash##5##2##(2008-10#5)
zucchini##15##1##(2008-10#15)
zwitterionic surfactants##2##2##(2008-10#2)
zwitterionic##8##1##(1991-5#1)(1995-2#1)(1996-5#1)(2008-10#5)
zygomycosis in##2##2##(2008-5#2)
zygomycosis##5##1##(1992-2#1)(2008-5#4)
zygotes and##2##2##(2009-12#2)
zygotes##6##1##(2008-8#1)(2009-12#4)(2009-8#1)
zygotic embryos##2##2##(2009-12#2)
zygotic##3##1##(2009-12#3)
zymogen##3##1##(1995-6#1)(2008-4#2)
zymogenic cells##3##2##(1995-6#3)
zymogenic##5##1##(1995-6#5)
zymogram and##2##2##(2008-11#1)(2009-6#1)
zymogram##3##1##(2008-11#1)(2009-6#2)
zymography##9##1##(2008-1#1)(2008-11#1)(2010-3#2)(2011-2#1)(2012-3#3)(2013-8#1)
zymosan particles##2##2##(1991-5#2)
zymosan with##3##2##(1994-6#1)(2008-12#2)
zymosan##11##1##(1991-2#1)(1991-5#3)(1994-11#1)(1994-6#3)(2008-12#3)
zymosan-activated##2##1##(2008-10#1)(2008-12#1)
zymosan-induced peritonitis##2##2##(2008-12#2)
|beta|##3##1##(2008-8#3)
|j-z|##2##1##(2008-10#2)
|z|&lt##2##1##(2008-10#2)
~ 36 y/o)##2##3##(2011-2#2)
~##5##1##(1996-9#1)(2011-2#4)
~0##7##1##(2007-12#1)(2008-3#2)(2010-4#4)
~1##11##1##(2007-11#2)(2008-2#1)(2008-3#6)(2011-2#1)(2012-2#1)
~11##2##1##(2008-3#2)
~2##4##1##(2007-12#1)(2008-3#2)(2012-12#1)
~3##3##1##(2008-3#3)
~400##2##1##(2008-2#1)(2013-8#1)
~60##2##1##(2008-12#1)(2008-3#1)
 0##15##1##(2012-5#7)(2013-1#2)(2013-3#1)(2013-8#5)
 africana##2##1##(2012-5#2)
 alternifolia##2##1##(2012-8#2)
 cereus##2##1##(2011-2#2)
 geophilum on##2##2##(2012-6#2)
 geophilum##8##1##(2012-6#8)
 graminearum##3##1##(2011-10#3)
 graminicola##3##1##(2011-10#3)
 hupehensis##3##1##(2011-10#3)
 ilex##2##1##(2011-10#2)
 maculans##2##1##(2011-10#2)
 petraea and Q##4##3##(2012-6#1)(2012-7#1)(2012-9#2)
 petraea with##2##2##(2012-5#2)
 petraea##14##1##(2012-5#6)(2012-6#3)(2012-7#2)(2012-9#3)
 petraea)##2##1##(2012-5#2)
 pubescens had##2##2##(2012-6#1)(2012-9#1)
 pubescens##10##1##(2012-5#2)(2012-6#6)(2012-7#1)(2012-9#1)
 pubescens)##5##1##(2012-5#1)(2012-6#2)(2012-7#1)(2012-9#1)
 rhamnoides and##2##2##(2012-8#2)
 robur and Q##5##3##(2012-5#4)(2012-6#1)
 robur than##2##2##(2012-5#1)(2012-7#1)
 robur##13##1##(2012-5#7)(2012-6#2)(2012-7#2)(2012-9#2)
 sylvestris##2##1##(2011-10#2)
© 2010 American Institute of Chemical Engineers Biotechnol##16##8##(2011-2#16)
© 2010 International Society for Advancement of Cytometry##3##8##(2011-2#3)
© 2010 Wiley-Liss##16##3##(2011-2#16)
© 2010##45##2##(2011-2#43)(2012-2#2)
© 2011 American Cancer Society##2##5##(2012-3#2)
© 2011 John Wiley &amp##6##5##(2011-2#1)(2012-2#3)(2012-3#2)
© 2011 Wiley Periodicals##2##4##(2012-2#1)(2012-3#1)
© 2011##11##2##(2011-2#2)(2012-2#4)(2012-3#5)
© 2012##11##2##(2012-2#1)(2012-3#1)(2012-4#1)(2012-5#1)(2013-1#7)
©##67##1##(2011-2#45)(2012-2#7)(2012-3#6)(2012-4#1)(2012-5#1)(2013-1#7)
°C and##6##2##(2011-2#5)(2013-8#1)
°C to##3##2##(2011-2#2)(2012-12#1)
°C##20##1##(2010-12#2)(2011-1#3)(2011-2#12)(2012-12#2)(2013-8#1)
°C)##2##1##(2011-2#1)(2013-8#1)
± 0##32##2##(2010-10#2)(2010-11#5)(2010-9#5)(2011-2#3)(2012-3#7)(2013-1#8)(2013-8#2)
± 1 °C##2##3##(2011-2#2)
± 1##15##2##(2010-9#3)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#5)
± 10##2##2##(2013-1#2)
± 11##7##2##(2012-3#3)(2013-1#3)(2013-8#1)
± 14##2##2##(2012-3#1)(2013-8#1)
± 18##2##2##(2012-3#2)
± 2##5##2##(2010-11#1)(2011-2#1)(2012-3#2)(2013-8#1)
± 20##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
± 3##7##2##(2010-9#1)(2011-2#1)(2012-3#2)(2013-8#3)
± 4##10##2##(2010-11#3)(2010-9#1)(2011-2#3)(2012-3#1)(2013-8#2)
± 8##2##2##(2011-2#1)(2012-3#1)
± 9##5##2##(2012-3#3)(2013-1#2)
± SD##5##2##(2012-3#1)(2013-1#2)(2013-8#2)
± standard##2##2##(2011-2#1)(2013-1#1)
±##122##1##(2010-10#2)(2010-11#9)(2010-9#11)(2011-2#19)(2012-3#27)(2013-1#25)(2013-8#29)
µ(E)##5##1##(2012-2#5)
µM##4##1##(2011-2#3)(2012-2#1)
µSBS##5##1##(2013-1#5)
µg/L##2##1##(2011-2#1)(2013-1#1)
µg/d)##2##1##(2013-1#2)
µg/g)##2##1##(2011-1#2)
µm median##2##2##(2013-1#2)
µm##5##1##(2011-2#1)(2013-1#4)
Å##5##1##(1996-5#3)(2012-12#1)(2012-2#1)
× 10##3##2##(2011-2#1)(2013-8#2)
× 10(-4)##2##2##(2010-12#1)(2011-2#1)
× 10(-7))##2##2##(2012-3#2)
× 10(6) cells##2##3##(2011-2#2)
× 10(8)##2##2##(2012-2#2)
× 10(9)##2##2##(2012-2#2)
×##25##1##(2010-11#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#6)
ß-cells##2##1##(2010-11#2)
à l'âge adulte##2##3##(2008-11#1)(2011-2#1)
à la nicotine##3##3##(2013-1#3)
à la##6##2##(2011-2#1)(2013-1#5)
à un##2##2##(2008-11#1)(2013-1#1)
à une##5##2##(2011-2#1)(2013-1#4)
à##41##1##(1996-11#1)(2008-11#4)(2008-3#2)(2008-5#2)(2011-2#5)(2013-1#27)
âgé##3##1##(2013-1#3)
était##3##1##(2011-2#1)(2013-1#2)
étude rétrospective##2##2##(2013-1#2)
étude##3##1##(2013-1#3)
été##13##1##(2011-2#2)(2013-1#11)
évoqué##2##1##(2013-1#2)
être##3##1##(2013-1#3)
ďun##2##1##(2013-1#2)
ΔE##2##1##(2013-1#2)
Σ(2) (m)##2##2##(2013-1#2)
Ψ(PD)##3##1##(2012-7#3)
α##11##1##(2010-11#2)(2010-12#3)(2011-2#2)(2012-3#1)(2013-1#3)
α- and##2##2##(2011-10#1)(2011-2#1)
α-amylase##4##1##(2011-2#1)(2013-8#3)
α-glucosidase activity in##3##3##(2010-11#3)
α-glucosidase##7##1##(2010-11#7)
α=0##2##1##(2011-2#1)(2013-1#1)
β cell##2##2##(2013-7#2)
β cells##3##2##(2010-11#1)(2013-7#2)
β##15##1##(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#6)(2013-7#5)
β(1)-##2##1##(2010-12#2)
β(2)-##2##1##(2010-12#2)
β-actin mRNA##4##2##(2012-2#4)
β-adrenergic receptor##2##2##(2011-2#2)
β-carotene##2##1##(2013-8#2)
β-catenin##7##1##(2013-1#7)
β-cell damage##2##2##(2010-11#2)
β-cell function##2##2##(2010-10#2)
β-cell mass##5##2##(2010-11#5)
β-cell proliferation##3##2##(2010-11#3)
β-cell regeneration##3##2##(2010-11#3)
β-cell replication##2##2##(2010-11#2)
β-cell##25##1##(2010-10#5)(2010-11#19)(2013-7#1)
β-cells##12##1##(2010-10#1)(2010-11#10)(2010-12#1)
β-cyclodextrin##3##1##(2011-2#3)
β-lactam antibiotics##2##2##(2011-1#1)(2013-1#1)
β-lactam##5##1##(2011-1#2)(2011-2#1)(2013-1#2)
β-lactamase##2##1##(2011-2#2)
β-tropomyosin##2##1##(2010-12#2)
γ##2##1##(2013-1#1)(2013-8#1)
γ2 chain##3##2##(2013-8#3)
γ2##4##1##(2010-10#1)(2013-8#3)
ε##2##1##(2010-12#1)(2013-8#1)
λ(max)##2##1##(2012-2#2)
μM##3##1##(2010-11#1)(2012-2#1)(2013-1#1)
μg Se/g##2##2##(2012-2#2)
μg/ml)##2##1##(2011-1#2)
μg·l-1##3##1##(2013-1#3)
μm based on##3##3##(2010-10#3)
μm to 6##2##3##(2010-10#2)
μm to##4##2##(2010-10#4)
μm##12##1##(2009-12#1)(2010-10#8)(2011-2#1)(2012-2#2)
μmol/L##4##1##(2012-2#4)
  A descriptive##2##3##(2013-1#2)
  A survey was conducted to obtain feedback from registered nurses as end-users of standardized nursing terminology for care planning in an electronic health record##2##25##(2013-1#2)
  A##11##2##(2010-10#4)(2011-2#2)(2013-1#5)
  Acute pain occurs in over 50% of hospitalized children##2##10##(2013-1#2)
  An##2##2##(2010-10#1)(2013-1#1)
  Data were obtained through the author's clinical practice in emergency nursing and literature sources##2##15##(2013-1#2)
  Data were##3##3##(2012-12#1)(2013-1#2)
  Despite the increasing demands for reliable nursing data as a basis for measuring nursing effects on nursing outcomes and safety##2##21##(2013-1#2)
  Despite the##3##3##(2010-10#1)(2013-1#2)
  Diagnosis of acute pain increased in the postimplementation period##2##10##(2013-1#2)
  Given the centrality of CS to interpreting research findings and applying them to practice##2##15##(2013-1#2)
  Hepatitis B virus (HBV)##2##5##(2013-1#2)
  Hepatitis B##3##3##(2013-1#3)
  In the postimplementation##2##4##(2013-1#2)
  In this##2##3##(2012-12#1)(2012-2#1)
  In total##2##3##(2010-10#1)(2013-1#1)
  In##8##2##(2010-10#2)(2012-12#1)(2012-2#1)(2013-1#4)
  It##3##2##(2010-10#2)(2013-1#1)
  NANDA International Classification##2##4##(2013-1#2)
  Nurses reported a more positive agreement with the changes at 6 months compared with baseline##2##16##(2013-1#2)
  One##2##2##(2010-10#2)
  Our results##2##3##(2010-10#1)(2011-2#1)
  Overall##3##2##(2013-1#3)
  Qualitative##3##2##(2010-10#3)
  Serum##2##2##(2012-12#1)(2013-1#1)
  Staying in the stream of life##2##7##(2010-10#2)
  The aim of the present study was to##2##9##(2010-10#2)
  The aim of the study was to##2##8##(2010-10#2)
  The aim of the##4##5##(2010-10#4)
  The aim of this##2##5##(2010-10#2)
  The aim of##6##4##(2010-10#6)
  The current literature and research studies##2##7##(2013-1#2)
  The development of strategies for improvement of diagnostic accuracy is warranted##2##12##(2013-1#2)
  The disparate uses of CS negatively impact standardizing and quantifying research outcomes to discern EBPs##2##16##(2013-1#2)
  The introduction of nonvalidated instruments in Italian hospitals needs to be restricted because of the short- and long-term negative effects these nonvalidated instruments may have##2##26##(2013-1#2)
  The main##2##3##(2010-10#1)(2012-2#1)
  The most immediate and tangible advantages to a common conceptual definition and meaning of CS terminologies by nursing##2##19##(2013-1#2)
  The most##3##3##(2012-12#1)(2013-1#2)
  The patient plan of care in the electronic record is expected to offer nurses the ability to communicate the needs of the patient and assess outcomes of care##2##29##(2013-1#2)
  The purpose of this study was to describe the implementation strategies of measurement instruments and their validity as adopted in Italian hospital nursing practice##2##25##(2013-1#2)
  The results show that##2##5##(2010-10#2)
  The results##3##3##(2010-10#3)
  The sample was divided into##2##6##(2013-1#2)
  The sample##3##3##(2013-1#3)
  The study aims to##2##5##(2013-1#2)
  The study##4##3##(2010-10#1)(2013-1#3)
  The survey was conducted pre-##2##6##(2013-1#2)
  The##54##2##(2010-10#22)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#26)
  This case study focused on the emergency nursing care of a 32-year-old female##2##14##(2013-1#2)
  This case study provides emergency nurses and students with the pertinent nursing diagnoses##2##14##(2013-1#2)
  This case study##4##4##(2013-1#4)
  This paper analyzes the concept of clinical significance (CS) in relation to evidence-based practice (EBP)##2##16##(2013-1#2)
  This paper##5##3##(2010-10#2)(2010-9#1)(2013-1#2)
  This study##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
  This##16##2##(2010-10#5)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#7)
  Three##2##2##(2010-10#2)
  To explore##2##3##(2010-10#1)(2012-12#1)
  To##9##2##(2010-10#4)(2011-2#1)(2012-12#3)(2013-1#1)
  Two##2##2##(2010-10#1)(2013-1#1)
  While##2##2##(2010-10#1)(2012-12#1)
 ##211##1##(2010-10#83)(2010-9#1)(2011-2#24)(2012-12#24)(2012-2#5)(2013-1#74)
 0##28##1##(2011-2#1)(2012-2#1)(2013-1#26)
 A systematic review was undertaken for articles published up to October 2011##3##12##(2012-12#3)
 A systematic review##4##3##(2012-12#4)
 A systematic search##2##3##(2012-12#2)
 A systematic##6##2##(2012-12#6)
 A##10##1##(2012-12#9)(2013-1#1)
 From##3##1##(2012-12#3)
 Retrospective##4##1##(2012-12#4)
 Systematic review##7##2##(2012-12#7)
 The overall strength of evidence evaluating the diagnostic characteristics was low due to inconsistent findings between studies and uncertainty of the impact of false-negatives##2##24##(2012-12#2)
 The##7##1##(2012-12#7)
 There is##2##2##(2012-12#2)
 To determine##2##2##(2012-12#2)
 To##6##1##(2012-12#6)
 Two##3##1##(2012-12#3)
 What##3##1##(2012-12#3)
 ##4##1##(2012-2#1)(2013-1#3)
 0##16##1##(2010-11#9)(2011-2#3)(2012-2#1)(2013-1#3)
•##2##1##(2011-2#2)
∼10##2##1##(2011-2#2)
∼25%##2##1##(2012-3#1)(2013-8#1)
∼4##2##1##(2011-2#1)(2012-3#1)
≈##2##1##(2012-2#1)(2013-1#1)
≤ 0##7##2##(2011-2#1)(2012-3#3)(2013-8#3)
≤##8##1##(2010-12#1)(2011-2#1)(2012-3#3)(2013-8#3)
≥ 1##3##2##(2012-12#2)(2013-1#1)
≥##15##1##(2011-2#3)(2012-12#3)(2012-3#4)(2013-1#3)(2013-8#2)
≥3##3##1##(2013-1#3)
≥65 years##2##2##(2012-12#2)
≥75 years##2##2##(2012-3#2)
・・0##7##1##(2011-2#7)
